PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Ali, AY; Abedini, MR; Tsang, BK				Ali, A. Y.; Abedini, M. R.; Tsang, B. K.			The oncogenic phosphatase PPM1D confers cisplatin resistance in ovarian carcinoma cells by attenuating checkpoint kinase 1 and p53 activation	ONCOGENE			English	Article						cisplatin resistance; apoptosis; ovarian cancer; PPM1D; Chk1; p53	DNA-DAMAGE-RESPONSE; CANCER-CELLS; WIP1 PHOSPHATASE; TUMOR-SUPPRESSOR; 7-HYDROXYSTAUROSPORINE UCN-01; P53-INDUCED PHOSPHATASE; P53-DEFICIENT CELLS; INHIBITORY PROTEIN; CHK1; PHOSPHORYLATION	Cisplatin (CDDP: cis-diamminedichloroplatinum) resistance is a major hurdle in the treatment of human ovarian cancer (OVCA). A better understanding of the mechanisms of CDDP resistance can greatly improve therapeutic outcome for patients. A determinant of CDDP sensitivity in OVCA, p53, is activated by checkpoint kinase 1 (Chk1) in response to DNA damage. Although the oncogenic phosphatase protein phosphatase magnesium-dependent 1 (PPM1D) can deactivate both p53 and Chk1 through site-specific dephosphorylation, whether PPM1D has a role in CDDP resistance is unknown. Here, using pair-matched wild-type p53 CDDP-sensitive (OV2008) and -resistant (C13*) cells, and p53-compromised CDDP-resistant cells (A2780cp, OCC-1, OVCAR-3 and SKOV3), we have demonstrated (i) the existence of site-specific differences in phospho-Ser-Chk1 content between sensitive and resistant cells in response to CDDP; (ii) PPM1D, but not phosphoinositide-3-kinase-related kinase (ataxia telangiectasia and Rad3 related protein (ATR)), is important in the regulation of CDDP-induced Chk1 activation and OVCA cell chemosensitivity; (iii) PPM1D downregulation sensitizes resistant cells to CDDP primarily by activating Chk1 and p53. Our findings establish for the first time that PPM1D confers CDDP resistance in OVCA cells through attenuating CDDP-induced, Chk1-mediated, p53-dependent apoptosis. These findings extend the current knowledge on the molecular and cellular basis of cisplatin resistance and offer the rationale for PPMID as a potential target for treatment of chemoresistant OVCA. Oncogene (2012) 31, 2175-2186; doi:10.1038/onc.2011.399; published online 19 September 2011	[Tsang, B. K.] Univ Ottawa, Ottawa Hosp Res Inst, Dept Obstet & Gynaecol, Chron Dis Program, Ottawa, ON K1Y 4E9, Canada; [Ali, A. Y.; Abedini, M. R.; Tsang, B. K.] Univ Ottawa, Dept Cellular Med, Ottawa, ON K1Y 4E9, Canada; [Ali, A. Y.; Abedini, M. R.; Tsang, B. K.] Univ Ottawa, Dept Mol Med, Ottawa, ON K1Y 4E9, Canada; [Abedini, M. R.] Birjand Univ Med Sci, Dept Physiol & Pharmacol, Birjand, Iran; [Tsang, B. K.] Univ Ottawa, Dept Obstet & Gynaecol, Ottawa, ON K1Y 4E9, Canada; [Tsang, B. K.] Seoul Natl Univ, Coll Agr & Life Sci, Dept Agr Biotechnol, World Class Univ WCU Biomodulat Major, Seoul, South Korea	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; University of Ottawa; Seoul National University (SNU)	Tsang, BK (corresponding author), Univ Ottawa, Ottawa Hosp Res Inst, Dept Obstet & Gynaecol, Chron Dis Program, 725 Parkdale Ave, Ottawa, ON K1Y 4E9, Canada.	btsang@ohri.ca	Darmian, Faezeh Vahedi/AAF-7755-2019; amiri, omolbanin/G-4425-2017	amiri, omolbanin/0000-0002-3815-5716; Tsang, Benjamin K./0000-0003-1213-3946	Canadian Institutes of Health Research [MOP-15691]; World Class University (WCU) through the National Research Foundation of Korea [R31-10056]; Ministry of Education, Science and Technology	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); World Class University (WCU) through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by grants from the Canadian Institutes of Health Research (MOP-15691), the World Class University (WCU) program (R31-10056) through the National Research Foundation of Korea, funded by the Ministry of Education, Science and Technology.	Abedini MR, 2010, ONCOGENE, V29, P11, DOI 10.1038/onc.2009.300; Abedini MR, 2008, CANCER RES, V68, P4511, DOI 10.1158/0008-5472.CAN-08-0673; Bulavin DV, 2002, NAT GENET, V31, P210, DOI 10.1038/ng894; Bunch RT, 1996, CLIN CANCER RES, V2, P791; Busby EC, 2000, CANCER RES, V60, P2108; Canadian Cancer Society, 2009, CAN CANC STAT; Capasso H, 2002, J CELL SCI, V115, P4555, DOI 10.1242/jcs.00133; Carrassa L, 2004, CELL CYCLE, V3, P1177; Chen ZH, 2006, INT J CANCER, V119, P2784, DOI 10.1002/ijc.22198; Chew J, 2009, NAT CELL BIOL, V11, P659, DOI 10.1038/ncb1873; Choi J, 2000, GENOMICS, V64, P298, DOI 10.1006/geno.2000.6134; Chuman Y, 2008, PROTEIN PEPTIDE LETT, V15, P938, DOI 10.2174/092986608785849236; Damia G, 2001, NEOPLASIA, V3, P10, DOI 10.1038/sj.neo.7900122; Fraser M, 2008, INT J CANCER, V122, P534, DOI 10.1002/ijc.23086; Graves PR, 2000, J BIOL CHEM, V275, P5600, DOI 10.1074/jbc.275.8.5600; Hirasawa A, 2003, CLIN CANCER RES, V9, P1995; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; JEKUNEN AP, 1994, CANCER RES, V54, P2680; Jiang KC, 2003, J BIOL CHEM, V278, P25207, DOI 10.1074/jbc.M300070200; Jurvansuu J, 2007, J MOL BIOL, V372, P397, DOI 10.1016/j.jmb.2007.06.077; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Lakin ND, 1999, ONCOGENE, V18, P7644, DOI 10.1038/sj.onc.1203015; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Lu XB, 2005, CELL CYCLE, V4, P1060; Lu XB, 2004, CELL CYCLE, V3, P1363, DOI 10.4161/cc.3.11.1241; Lu XB, 2008, CANCER METAST REV, V27, P123, DOI 10.1007/s10555-008-9127-x; Lu XB, 2007, CANCER CELL, V12, P342, DOI 10.1016/j.ccr.2007.08.033; MISTRY P, 1992, CANCER RES, V52, P6188; Ouyang GL, 2009, CELL BIOL INT, V33, P1237, DOI 10.1016/j.cellbi.2009.08.011; Pan Y, 2009, CANCER BIOL THER, V8, P1559, DOI 10.4161/cbt.8.16.8955; Perego P, 2003, INT J CANCER, V105, P617, DOI 10.1002/ijc.11140; Perego P, 1996, CANCER RES, V56, P556; Playle LC, 2002, BRIT J CANCER, V87, P352, DOI 10.1038/sj.bjc.6600492; Qu YH, 2005, MOL BIOL CELL, V16, P1684; Rauta J, 2006, BREAST CANCER RES TR, V95, P257, DOI 10.1007/s10549-005-9017-7; Reinhardt HC, 2007, CANCER CELL, V11, P175, DOI 10.1016/j.ccr.2006.11.024; Rong JJ, 2010, CANCER LETT, V296, P55, DOI 10.1016/j.canlet.2010.03.016; Sasaki H, 2000, CANCER RES, V60, P5659; Shao RG, 1997, CANCER RES, V57, P4029; Shaw TJ, 2004, MOL THER, V10, P1032, DOI 10.1016/j.ymthe.2004.08.013; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Shieh SY, 1999, EMBO J, V18, P1815, DOI 10.1093/emboj/18.7.1815; Shieh SY, 2000, GENE DEV, V14, P289; Sugiyama K, 2000, INT J CANCER, V85, P703, DOI 10.1002/(SICI)1097-0215(20000301)85:5<703::AID-IJC17>3.0.CO;2-7; Tan DSP, 2009, CLIN CANCER RES, V15, P2269, DOI 10.1158/1078-0432.CCR-08-2403; Traven A, 2005, BIOESSAYS, V27, P397, DOI 10.1002/bies.20204; Wagner JM, 2009, MOL PHARMACOL, V76, P208, DOI 10.1124/mol.109.055178; Wilsker D, 2008, P NATL ACAD SCI USA, V105, P20752, DOI 10.1073/pnas.0806917106; Yamaguchi H, 2007, BIOCHEMISTRY-US, V46, P12594, DOI 10.1021/bi701096s; Yang X, 2008, BRIT J CANCER, V98, P803, DOI 10.1038/sj.bjc.6604223; Yang XK, 2006, CANCER RES, V66, P3126, DOI 10.1158/0008-5472.CAN-05-0425; Yazlovitskaya EM, 2003, ANTICANCER RES, V23, P2275; Zhang WH, 2008, CELL CYCLE, V7, P1668, DOI 10.4161/cc.7.11.5982; Zhang XN, 2009, CANCER RES, V69, P7960, DOI 10.1158/0008-5472.CAN-09-0634; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001	55	52	54	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR	2012	31	17					2175	2186		10.1038/onc.2011.399	http://dx.doi.org/10.1038/onc.2011.399			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	934BS	21927021				2022-12-25	WOS:000303415900006
J	Kristiansen, G; Hu, JM; Wichmann, D; Stiehl, DP; Rose, M; Gerhardt, J; Bohnert, A; ten Haaf, A; Moch, H; Raleigh, J; Varia, MA; Subarsky, P; Scandurra, FM; Gnaiger, E; Gleixner, E; Bicker, A; Gassmann, M; Hankeln, T; Dahl, E; Gorr, TA				Kristiansen, Glen; Hu, Junmin; Wichmann, Daniela; Stiehl, Daniel P.; Rose, Michael; Gerhardt, Josefine; Bohnert, Annette; ten Haaf, Anette; Moch, Holger; Raleigh, James; Varia, Mahesh A.; Subarsky, Patrick; Scandurra, Francesca M.; Gnaiger, Erich; Gleixner, Eva; Bicker, Anne; Gassmann, Max; Hankeln, Thomas; Dahl, Edgar; Gorr, Thomas A.			Endogenous Myoglobin in Breast Cancer Is Hypoxia-inducible by Alternative Transcription and Functions to Impair Mitochondrial Activity A ROLE IN TUMOR SUPPRESSION?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISCHEMIA-REPERFUSION INJURY; HUMAN SKELETAL-MUSCLE; SMOOTH-MUSCLE; EXPRESSION; OXYGEN; CELLS; RESPIRATION; GENE; PHOSPHORYLATION; FIBROBLASTS	Recently, immunohistochemical analysis of myoglobin (MB) in human breast cancer specimens has revealed a surprisingly widespread expression of MB in this nonmuscle context. The positive correlation with hypoxia-inducible factor 2 alpha (HIF-2 alpha) and carbonic anhydrase IX suggested that oxygen regulates myoglobin expression in breast carcinomas. Here, we report that MB mRNA and protein levels are robustly induced by prolonged hypoxia in breast cancer cell lines, in part via HIF-1/2-dependent transactivation. The hypoxia-induced MB mRNA originated from a novel alternative transcription start site 6 kb upstream of the ATG codon. MB regulation in normal and tumor tissue may thus be fundamentally different. Functionally, the knockdown of MB in MDA-MB468 breast cancer cells resulted in an unexpected increase of O-2 uptake and elevated activities of mitochondrial enzymes during hypoxia. Silencing of MB transcription attenuated proliferation rates and motility capacities of hypoxic cancer cells and, surprisingly, also fully oxygenated breast cancer cells. Endogenous MB in cancer cells is apparently involved in controlling oxidative cell energy metabolism, contrary to earlier findings on mouse heart, where the targeted disruption of the Mb gene did not effect myocardial energetics and O-2 consumption. This control function of MB seemingly impacts mitochondria and influences cell proliferation and motility, but it does so in ways not directly related to the facilitated diffusion or storage of O-2. Hypothetically, the mitochondrion-impairing role of MB in hypoxic cancer cells is part of a novel tumor-suppressive function.	[Kristiansen, Glen] Univ Hosp Bonn, Inst Pathol, D-53127 Bonn, Germany; [Hu, Junmin; Wichmann, Daniela; Gassmann, Max; Gorr, Thomas A.] Univ Zurich, Zurich Ctr Integrat Human Physiol, Vetsuisse Fac, Inst Vet Physiol, CH-8057 Zurich, Switzerland; [Stiehl, Daniel P.] Univ Zurich, Inst Physiol, CH-8057 Zurich, Switzerland; [Rose, Michael; ten Haaf, Anette; Dahl, Edgar] Univ Hosp RWTH, Inst Pathol, D-52074 Aachen, Germany; [Gerhardt, Josefine; Bohnert, Annette; Moch, Holger] Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland; [Raleigh, James; Varia, Mahesh A.] Univ N Carolina, Sch Med, Chapel Hill, NC USA; [Subarsky, Patrick; Scandurra, Francesca M.; Gnaiger, Erich] Med Univ Innsbruck, D Swarovski Res Lab, Dept Visceral Transplant & Thorac Surg, A-6020 Innsbruck, Austria; [Gleixner, Eva; Bicker, Anne; Hankeln, Thomas] Johannes Gutenberg Univ Mainz, Inst Mol Genet, D-55099 Mainz, Germany; [Gorr, Thomas A.] Univ Med Ctr Freiburg, Ctr Pediat & Adolescent Med, D-79106 Freiburg, Germany	University of Bonn; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Zurich; RWTH Aachen University; RWTH Aachen University Hospital; University of Zurich; University Zurich Hospital; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Medical University of Innsbruck; Johannes Gutenberg University of Mainz; University of Freiburg	Kristiansen, G (corresponding author), Univ Hosp Bonn UKB, Inst Pathol, Sigmund Freud Str 25, D-53127 Bonn, Germany.	glen.kristiansen@ukb.uni-bonn.de	Stiehl, Daniel/A-3622-2008	Gassmann, Max/0000-0003-2750-8878; Stiehl, Daniel/0000-0002-0076-4874; Gorr, Thomas/0000-0002-6023-4234; Gnaiger, Erich/0000-0003-3647-5895; Bicker, Anne/0000-0003-4364-9777	Swiss National Science Foundation; Faculty of Medicine, RWTH Aachen (START network)	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Faculty of Medicine, RWTH Aachen (START network)	This work was supported in part by grants from the Swiss National Science Foundation (to M. G.), a grant from the Faculty of Medicine, RWTH Aachen (START network) (to E. D.), and by contributions from K-Regio Project Mito-Com Tyrol (to E. G.). Parts of this paper have been presented at the International Congress of Respiratory Science, August 9-13, 2009, Bad Honnef, Germany.	Aguirre E, 2010, BBA-BIOENERGETICS, V1797, P557, DOI 10.1016/j.bbabio.2010.01.033; Ameln H, 2005, FASEB J, V19, P1009, DOI 10.1096/fj.04-2304fje; Arcasoy MO, 2002, LAB INVEST, V82, P911, DOI 10.1097/01.LAB.0000020415.72863.40; BLANCHETOT A, 1986, EUR J BIOCHEM, V159, P469, DOI 10.1111/j.1432-1033.1986.tb09909.x; Brown JM, 1999, CANCER RES, V59, P5863; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Chang H, 2003, CLIN SCI, V105, P447, DOI 10.1042/CS20030088; Enoki Y., 1988, Advances in Experimental Medicine and Biology, V222, P709; EUSEBI V, 1984, AM J SURG PATHOL, V8, P51, DOI 10.1097/00000478-198401000-00005; Flogel U, 2001, P NATL ACAD SCI USA, V98, P735, DOI 10.1073/pnas.011460298; Flogel U, 2004, FASEB J, V18, P1156, DOI 10.1096/fj.03-1382fje; Flonta SE, 2009, AM J PATHOL, V175, P201, DOI 10.2353/ajpath.2009.081124; Fordel E, 2004, IUBMB LIFE, V56, P681, DOI 10.1080/15216540500037406; Fraser J, 2006, P NATL ACAD SCI USA, V103, P2977, DOI 10.1073/pnas.0508270103; Galluzzo M, 2009, J CLIN INVEST, V119, P865, DOI 10.1172/JCI36579; Garry DJ, 1998, NATURE, V395, P905, DOI 10.1038/27681; Gnaiger E, 1995, J BIOENERG BIOMEMBR, V27, P583, DOI 10.1007/BF02111656; Gnaiger E, 2001, RESP PHYSIOL, V128, P277, DOI 10.1016/S0034-5687(01)00307-3; Godecke A, 1999, P NATL ACAD SCI USA, V96, P10495, DOI 10.1073/pnas.96.18.10495; Gorr TA, 2011, ACTA PHYSIOL, V202, P563, DOI 10.1111/j.1748-1716.2010.02205.x; Hendgen-Cotta UB, 2008, P NATL ACAD SCI USA, V105, P10256, DOI 10.1073/pnas.0801336105; Hutter E, 2004, BIOCHEM J, V380, P919, DOI 10.1042/BJ20040095; ISEKI M, 1990, AM J SURG PATHOL, V14, P395, DOI 10.1097/00000478-199004000-00014; JURGENS KD, 1994, P NATL ACAD SCI USA, V91, P3829, DOI 10.1073/pnas.91.9.3829; Kanatous SB, 2009, AM J PHYSIOL-CELL PH, V296, pC393, DOI 10.1152/ajpcell.00428.2008; Khan KK, 1998, EUR J BIOCHEM, V257, P547, DOI 10.1046/j.1432-1327.1998.2570547.x; Kristiansen G, 2010, BRIT J CANCER, V102, P1736, DOI 10.1038/sj.bjc.6605702; Loots GG, 2004, NUCLEIC ACIDS RES, V32, pW217, DOI 10.1093/nar/gkh383; Nisoli E, 2007, CIRC RES, V100, P795, DOI 10.1161/01.RES.0000259591.97107.6c; Nitta T, 2003, J SURG RES, V110, P322, DOI 10.1016/S0022-4804(02)00066-5; Ordway GA, 2004, J EXP BIOL, V207, P3441, DOI 10.1242/jeb.01172; Pesta D, 2011, MITOCHONDRIAL BIOENE; Qiu Y, 1998, J BIOL CHEM, V273, P23426, DOI 10.1074/jbc.273.36.23426; REYNAFARJE B, 1962, J APPL PHYSIOL, V17, P301, DOI 10.1152/jappl.1962.17.2.301; Roesner A, 2008, FEBS J, V275, P3633, DOI 10.1111/j.1742-4658.2008.06508.x; Rosman DS, 2008, CANCER RES, V68, P1319, DOI 10.1158/0008-5472.CAN-07-5424; Scandurra FM, 2010, ADV EXP MED BIOL, V662, P7, DOI 10.1007/978-1-4419-1241-1_2; Schenkman KA, 2001, AM J PHYSIOL-HEART C, V281, pH2463, DOI 10.1152/ajpheart.2001.281.6.H2463; SMITH TW, 1984, CANCER, V54, P323, DOI 10.1002/1097-0142(19840715)54:2<323::AID-CNCR2820540225>3.0.CO;2-5; Smolkova K, 2010, J BIOENERG BIOMEMBR, V42, P55, DOI 10.1007/s10863-009-9267-x; Sriram R, 2008, FEBS LETT, V582, P3643, DOI 10.1016/j.febslet.2008.09.047; SteinlechnerMaran R, 1996, AM J PHYSIOL-CELL PH, V271, pC2053, DOI 10.1152/ajpcell.1996.271.6.C2053; Thews O, 1998, BRIT J CANCER, V78, P752, DOI 10.1038/bjc.1998.572; Thierry-Mieg D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s12; Tomita A, 2010, J EXP BIOL, V213, P2748, DOI 10.1242/jeb.042994; VAUPEL P, 1991, CANCER RES, V51, P3316; Vogt M, 2001, J APPL PHYSIOL, V91, P173, DOI 10.1152/jappl.2001.91.1.173; WELLER P, 1984, EMBO J, V3, P439, DOI 10.1002/j.1460-2075.1984.tb01825.x; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Whitlock NA, 2005, INVEST OPHTH VIS SCI, V46, P1092, DOI 10.1167/iovs.04-0043; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Wirthner R, 2008, CARCINOGENESIS, V29, P2306, DOI 10.1093/carcin/bgn231; WITTENBERG BA, 1975, J BIOL CHEM, V250, P9038; Wittenberg BA, 2009, AM J PHYSIOL-CELL PH, V296, pC390, DOI 10.1152/ajpcell.00002.2009; WITTENBERG JB, 1970, PHYSIOL REV, V50, P559, DOI 10.1152/physrev.1970.50.4.559; Wystub S, 2004, CYTOGENET GENOME RES, V105, P65, DOI 10.1159/000078011; Zhang PJ, 2003, MODERN PATHOL, V16, P229, DOI 10.1097/01.MP.0000056630.76035.F3	57	36	37	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 16	2011	286	50					43417	43428		10.1074/jbc.M111.227553	http://dx.doi.org/10.1074/jbc.M111.227553			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866AF	21930697	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000298351300061
J	Liu, ZY; Swindall, AF; Kesterson, RA; Schoeb, TR; Bullard, DC; Bellis, SL				Liu, Zhongyu; Swindall, Amanda F.; Kesterson, Robert A.; Schoeb, Trenton R.; Bullard, Daniel C.; Bellis, Susan L.			ST6Gal-I Regulates Macrophage Apoptosis via alpha 2-6 Sialylation of the TNFR1 Death Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYELOID FIBRONECTIN RECEPTORS; NECROSIS-FACTOR-ALPHA; CELL-DEATH; DENDRITIC CELLS; LEUKEMIA CELLS; U937 CELLS; SURFACE; SIALYLTRANSFERASE; GLYCOSYLATION; ACTIVATION	Macrophages play a central role in innate immunity, however mechanisms regulating macrophage survival are not fully understood. Herein we describe a novel apoptotic pathway involving alpha 2-6 sialylation of the TNFR1 death receptor by the ST6Gal-I sialyltransferase. Variant glycosylation of TNFR1 has not previously been implicated in TNFR1 function, and little is known regarding the TNFR1 glycan composition. To study sialylation in macrophages, we treated U937 monocytic cells with PMA, which stimulates both macrophage differentiation and apoptosis. Interestingly, macrophage differentiation induces ST6Gal-I down-regulation, leading to reduced alpha 2-6 sialylation of selected receptors. To prevent loss of alpha 2-6 sialylation, we forced constitutive expression of ST6Gal-I, and found that this strongly inhibited PMA-induced apoptosis. Given that PMA-mediated apoptosis is thought to result from up-regulation of TNF alpha, which then activates TNFR1, we next evaluated the alpha 2-6 sialylation of TNFR1. U937 cells with forced ST6Gal-I displayed TNFR1 with elevated alpha 2-6 sialylation, and this was associated with diminished TNF alpha-stimulated apoptosis. Correspondingly, removal of alpha 2-6 sialylation from TNFR1 through either neuraminidase treatment or expression of ST6Gal-I shRNA markedly enhanced TNF alpha-mediated apoptosis. To confirm the physiologic importance of TNFR1 sialylation, we generated over-expressing ST6Gal-I transgenic mice. Peritoneal macrophages from transgenic lines displayed TNFR1 with elevated alpha 2-6 sialylation, and these cells were significantly protected against TNF alpha-stimulated apoptosis. Moreover, greater numbers of thioglycollate-induced peritoneal cells were observed in transgenic mice. These collective results highlight a new mechanism of TNFR1 regulation, and further intimate that loss of alpha 2-6 sialylation during macrophage differentiation may limit macrophage lifespan by sensitizing cells to TNF alpha-stimulated apoptosis.	[Liu, Zhongyu; Swindall, Amanda F.; Bellis, Susan L.] Univ Alabama, Dept Physiol & Biophys, Birmingham, AL 35294 USA; [Kesterson, Robert A.; Schoeb, Trenton R.; Bullard, Daniel C.] Univ Alabama, Dept Genet, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Bellis, SL (corresponding author), 1918 Univ Blvd,982A MCLM, Birmingham, AL 35294 USA.	bellis@uab.edu	Swindall, Amanda/F-3935-2012		National Institutes of Health [R01 CA84248, P30AR48311]; UAB Rheumatic Diseases Core Center; American Heart Association; NATIONAL CANCER INSTITUTE [R01CA084248] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UAB Rheumatic Diseases Core Center; American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by Grants R01 CA84248 (to S. L. B.) and P30AR48311 from the National Institutes of Health, the UAB Rheumatic Diseases Core Center, and the American Heart Association (Grant-in-Aid to S.L.B.).	Al-Lamki RS, 2005, FASEB J, V19, P1637, DOI 10.1096/fj.05-3841com; Amano M, 2003, J BIOL CHEM, V278, P7469, DOI 10.1074/jbc.M209595200; Cartee L, 2002, MOL PHARMACOL, V61, P1313, DOI 10.1124/mol.61.6.1313; Chan J, 1998, BLOOD, V92, P1423, DOI 10.1182/blood.V92.4.1423.416k31_1423_1431; Comelli EM, 2006, J IMMUNOL, V177, P2431, DOI 10.4049/jimmunol.177.4.2431; CORTI A, 1995, J INTERF CYTOK RES, V15, P143, DOI 10.1089/jir.1995.15.143; Dall'Olio Fabio, 2000, Glycoconjugate Journal, V17, P669, DOI 10.1023/A:1011077000164; DEVENTE J, 1995, CELL GROWTH DIFFER, V6, P371; Gonzalez-Guerrico AM, 2005, J BIOL CHEM, V280, P38982, DOI 10.1074/jbc.M506767200; Greenlee MC, 2009, INFLAMM RES, V58, P909, DOI 10.1007/s00011-009-0064-0; Guicciardi ME, 2009, FASEB J, V23, P1625, DOI 10.1096/fj.08-111005; Harduin-Lepers A, 2001, BIOCHIMIE, V83, P727, DOI 10.1016/S0300-9084(01)01301-3; Hennet T, 1998, P NATL ACAD SCI USA, V95, P4504, DOI 10.1073/pnas.95.8.4504; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; Jenner J, 2006, EXP HEMATOL, V34, P1212, DOI 10.1016/j.exphem.2006.04.016; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Keppler OT, 1999, GLYCOBIOLOGY, V9, P557, DOI 10.1093/glycob/9.6.557; Kitazume S, 2010, J BIOL CHEM, V285, P6515, DOI 10.1074/jbc.M109.073106; Kohne C, 1999, J CELL BIOCHEM, V75, P446; Leppanen A, 2005, J BIOL CHEM, V280, P5549, DOI 10.1074/jbc.m412019200; Marino JH, 2008, GLYCOBIOLOGY, V18, P719, DOI 10.1093/glycob/cwn051; Meesmann HM, 2010, J CELL SCI, V123, P3347, DOI 10.1242/jcs.066696; Nasirikenari M, 2006, BLOOD, V108, P3397, DOI 10.1182/blood-2006-04-014779; O'Sullivan AW, 2009, J SURG RES, V151, P138, DOI 10.1016/j.jss.2008.02.031; Parameswaran N, 2010, CRIT REV EUKAR GENE, V20, P87, DOI 10.1615/CritRevEukarGeneExpr.v20.i2.10; PETER ME, 1995, CELL DEATH DIFFER, V2, P163; Rahmani M, 2002, EXP CELL RES, V277, P31, DOI 10.1006/excr.2002.5548; Seales EC, 2005, J BIOL CHEM, V280, P37610, DOI 10.1074/jbc.M508476200; Semel AC, 2002, J BIOL CHEM, V277, P32830, DOI 10.1074/jbc.M202493200; Stowell SR, 2008, J BIOL CHEM, V283, P10109, DOI 10.1074/jbc.M709545200; Swindall AF, 2011, J BIOL CHEM, V286, P22982, DOI 10.1074/jbc.M110.211375; Takada Y, 1999, J BIOL CHEM, V274, P28286, DOI 10.1074/jbc.274.40.28286; Takashima S, 2008, BIOSCI BIOTECH BIOCH, V72, P1155, DOI 10.1271/bbb.80025; Taniguchi A, 1998, FEBS LETT, V441, P191, DOI 10.1016/S0014-5793(98)01548-8; Thorburn A, 2004, CELL SIGNAL, V16, P139, DOI 10.1016/j.cellsig.2003.08.007; Toscano MA, 2007, NAT IMMUNOL, V8, P825, DOI 10.1038/ni1482; Videira PA, 2008, GLYCOCONJUGATE J, V25, P259, DOI 10.1007/s10719-007-9092-6; Wagner KW, 2007, NAT MED, V13, P1070, DOI 10.1038/nm1627; Woodard-Grice AV, 2008, J BIOL CHEM, V283, P26364, DOI 10.1074/jbc.M800836200; Zhang J, 2008, BIOCHEM BIOPH RES CO, V366, P579, DOI 10.1016/j.bbrc.2007.12.011; Zhang LS, 2010, HUM MOL GENET, V19, P2754, DOI 10.1093/hmg/ddq172; Zhuo Y, 2008, J BIOL CHEM, V283, P22177, DOI 10.1074/jbc.M8000015200; Zhuo Y, 2011, J BIOL CHEM, V286, P5935, DOI 10.1074/jbc.R110.191429	43	66	68	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39654	39662		10.1074/jbc.M111.276063	http://dx.doi.org/10.1074/jbc.M111.276063			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21930713	Green Published, hybrid			2022-12-25	WOS:000296759800082
J	Nam, HK; Liu, J; Li, Y; Kragor, A; Hatch, NE				Nam, Hwa Kyung; Liu, Jin; Li, Yan; Kragor, Andrew; Hatch, Nan E.			Ectonucleotide Pyrophosphatase/Phosphodiesterase-1 (ENPP1) Protein Regulates Osteoblast Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTERIOR LONGITUDINAL LIGAMENT; CELL MEMBRANE GLYCOPROTEIN-1; INORGANIC PYROPHOSPHATE GENERATION; NONSPECIFIC ALKALINE-PHOSPHATASE; NUCLEOTIDE PYROPHOSPHATASE; PATHOLOGICAL CALCIFICATION; DEFICIENT MICE; MOUSE MODEL; PC-1; EXPRESSION	ENPP1 (ectonucleotide pyrophosphatase/phosphodiesterase-1) is an established regulator of tissue mineralization. Previous studies demonstrated that ENPP1 is expressed in differentiated osteoblasts and that ENPP1 influences matrix mineralization by increasing extracellular levels of inorganic pyrophosphate. ENPP1 is also expressed in osteoblastic precursor cells when stimulated with FGF2, but the role of ENPP1 in preosteoblastic and other precursor cells is unknown. Here we investigate the function of ENPP1 in preosteoblasts. We find that ENPP1 expression is critical for osteoblastic differentiation and that this effect is not mediated by changes in extracellular concentration levels of phosphate or pyrophosphate or ENPP1 catalytic activity. MC3T3E1(C4) preosteoblastic cells, in which ENPP1 expression was suppressed by ENPP1-specific shRNA, and calvarial cells isolated from Enpp1 knock-out mice show defective osteoblastic differentiation upon stimulation with ascorbate, as indicated by a lack of cellular morphological change, a lack of osteoblast marker gene expression, and an inability to mineralize matrix. Additionally, MC3T3E1(C4) cells, in which wild type or catalytic inactive ENPP1 expression was increased, exhibited an increased tendency to differentiate, as evidenced by increased osteoblast marker gene expression and increased mineralization. Notably, treatment of cells with inorganic phosphate or pyrophosphate inhibited, as opposed to enhanced, expression of multiple genes that are expressed in association with osteoblast differentiation, matrix deposition, and mineralization. Our results indicate that ENPP1 plays multiple and distinct roles in the development of mineralized tissues and that the influence of ENPP1 on osteoblast differentiation and gene expression may include a mechanism that is independent of its catalytic activity.	[Nam, Hwa Kyung; Liu, Jin; Kragor, Andrew; Hatch, Nan E.] Univ Michigan, Dept Orthodont & Pediat Dent, Ann Arbor, MI 48109 USA; [Li, Yan] Univ Michigan, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Hatch, NE (corresponding author), Univ Michigan, Dept Orthodont & Pediat Dent, 1011 N Univ Ave, Ann Arbor, MI 48109 USA.	nhatch@umich.edu	Hatch, Nan/AAQ-8465-2020; Hatch, Nan/ABC-9177-2020	Hatch, Nan/0000-0002-2632-0841; 				Addison WN, 2007, J BIOL CHEM, V282, P15872, DOI 10.1074/jbc.M701116200; Addison WN, 2010, J BONE MINER RES, V25, P695, DOI 10.1359/jbmr.090832; Anderson HC, 2005, AM J PATHOL, V166, P1711, DOI 10.1016/S0002-9440(10)62481-9; Anderson HC, 2004, AM J PATHOL, V164, P841, DOI 10.1016/S0002-9440(10)63172-0; Babij P, 2009, J BONE MINER RES, V24, P1552, DOI [10.1359/JBMR.090417, 10.1359/jbmr.090417]; Beck GR, 2000, P NATL ACAD SCI USA, V97, P8352, DOI 10.1073/pnas.140021997; BELLI SI, 1995, EUR J BIOCHEM, V228, P669, DOI 10.1111/j.1432-1033.1995.tb20308.x; Chen L, 2003, BONE, V33, P169, DOI 10.1016/S8756-3282(03)00222-9; Cohen MM, 1996, INT J ORAL MAX SURG, V25, P45; Eswarakumar VP, 2004, P NATL ACAD SCI USA, V101, P12555, DOI 10.1073/pnas.0405031101; EVANS WH, 1973, BIOCHEM J, V135, P819, DOI 10.1042/bj1350819; Ferron M, 2010, CELL, V142, P296, DOI 10.1016/j.cell.2010.06.003; FLEISCH H, 1966, AM J PHYSIOL, V211, P821, DOI 10.1152/ajplegacy.1966.211.3.821; FRANCESCHI RT, 1992, J BONE MINER RES, V7, P235; Fulzele K, 2010, CELL, V142, P309, DOI 10.1016/j.cell.2010.06.002; GRUPE A, 1995, J BIOL CHEM, V270, P22085, DOI 10.1074/jbc.270.38.22085; Harmey D, 2004, AM J PATHOL, V164, P1199, DOI 10.1016/S0002-9440(10)63208-7; Hatch NE, 2009, J BONE MINER RES, V24, P652, DOI 10.1359/JBMR.081213; Hatch NE, 2005, CONNECT TISSUE RES, V46, P184, DOI 10.1080/03008200500237203; Hessle L, 2002, P NATL ACAD SCI USA, V99, P9445, DOI 10.1073/pnas.142063399; Hirakawa H, 2004, J ORTHOP SCI, V9, P591, DOI 10.1007/s00776-004-0823-2; Hosoda Y, 1981, Ryumachi, V21 Suppl, P157; HUNTER GK, 1994, BIOCHEM J, V300, P723, DOI 10.1042/bj3000723; James MJ, 2006, J BONE MINER RES, V21, P1034, DOI 10.1359/JBMR.060413; Johnson K, 1999, ARTHRITIS RHEUM-US, V42, P1986, DOI 10.1002/1529-0131(199909)42:9<1986::AID-ANR26>3.0.CO;2-O; Johnson K, 2005, FRONT BIOSCI-LANDMRK, V10, P988, DOI 10.2741/1593; Johnson K, 2003, J BONE MINER RES, V18, P994, DOI 10.1359/jbmr.2003.18.6.994; Johnson K, 2001, ARTHRITIS RHEUM, V44, P1071, DOI 10.1002/1529-0131(200105)44:5<1071::AID-ANR187>3.0.CO;2-3; Johnson K, 2005, ARTERIOSCL THROM VAS, V25, P686, DOI 10.1161/01.ATV.0000154774.71187.f0; Johnson K, 1999, J BONE MINER RES, V14, P883, DOI 10.1359/jbmr.1999.14.6.883; Johnson K, 2001, J RHEUMATOL, V28, P2681; Johnson KA, 2000, AM J PHYSIOL-REG I, V279, pR1365, DOI 10.1152/ajpregu.2000.279.4.R1365; Koshizuka Y, 2001, CYTOGENET CELL GENET, V94, P163, DOI 10.1159/000048809; Koshizuka Y, 2002, J BONE MINER RES, V17, P138, DOI 10.1359/jbmr.2002.17.1.138; Kreiborg S, 1981, Scand J Plast Reconstr Surg Suppl, V18, P1; Li Y, 2010, J CELL BIOCHEM, V111, P1346, DOI 10.1002/jcb.22861; Liang J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000882; Meyre D, 2005, NAT GENET, V37, P863, DOI 10.1038/ng1604; Nakamura I, 1999, HUM GENET, V104, P492, DOI 10.1007/s004390050993; Okawa A, 1998, NAT GENET, V19, P271, DOI 10.1038/956; Okawa A, 1999, CALCIFIED TISSUE INT, V64, P239, DOI 10.1007/s002239900610; Pizzuti A, 1999, DIABETES, V48, P1881, DOI 10.2337/diabetes.48.9.1881; Polewski MD, 2010, BONE, V46, P81, DOI 10.1016/j.bone.2009.08.055; REGISTER TC, 1985, BONE, V6, P307, DOI 10.1016/8756-3282(85)90320-5; Roca H, 2005, J BIOL CHEM, V280, P30845, DOI 10.1074/jbc.M503942200; Ruf Nico, 2005, Hum Mutat, V25, P98, DOI 10.1002/humu.9297; Rutsch F, 2003, NAT GENET, V34, P379, DOI 10.1038/ng1221; SAKAMOTO M, 1994, PATHOL INT, V44, P420, DOI 10.1111/j.1440-1827.1994.tb01705.x; Sali A.F.J.M., 1999, ECTO ATPASES RELATED, P267; Schroeder Tania M., 2005, Birth Defects Research, V75, P213, DOI 10.1002/bdrc.20043; TERKELTAUB R, 1994, ARTHRITIS RHEUM, V37, P934, DOI 10.1002/art.1780370624; Terkeltaub RA, 2001, AM J PHYSIOL-CELL PH, V281, pC1, DOI 10.1152/ajpcell.2001.281.1.C1; Terkeltaub Robert, 2006, Purinergic Signal, V2, P371, DOI 10.1007/s11302-005-5304-3; Yoshiko Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011782; Zhou YX, 2000, HUM MOL GENET, V9, P2001, DOI 10.1093/hmg/9.13.2001	55	49	50	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39059	39071		10.1074/jbc.M111.221689	http://dx.doi.org/10.1074/jbc.M111.221689			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21930712	hybrid, Green Published			2022-12-25	WOS:000296759800025
J	Bhattacharyya, S; Sargent, JL; Du, P; Lin, S; Tourtellotte, WG; Takehara, K; Whitfield, ML; Varga, J				Bhattacharyya, Swati; Sargent, Jennifer L.; Du, Pan; Lin, Simon; Tourtellotte, Warren G.; Takehara, Kazuhiko; Whitfield, Michael L.; Varga, John			Egr-1 Induces a Profibrotic Injury/Repair Gene Program Associated with Systemic Sclerosis	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; EXPRESSION; RESPONSE-1; INHIBITION; MODULATION; ACTIVATION; FIBROSIS; COLLAGEN; TARGET	Transforming growth factor-beta (TGF-beta) signaling is implicated in the pathogenesis of fibrosis in scleroderma or systemic sclerosis (SSc), but the precise mechanisms are poorly understood. The immediate-early gene Egr-1 is an inducible transcription factor with key roles in mediating fibrotic TGF-beta responses. To elucidate Egr-1 function in SSc-associated fibrosis, we examined change in gene expression induced by Egr-1 in human fibroblasts at the genome-wide level. Using microarray expression analysis, we derived a fibroblast "Egr-1-responsive gene signature'' comprising over 600 genes involved in cell proliferation, TGF-beta signaling, wound healing, extracellular matrix synthesis and vascular development. The experimentally derived "Egr-1-responsiv gene signature'' was then evaluated in an expression microarray dataset comprising skin biopsies from 27 patients with localized and systemic forms of scleroderma and six healthy controls. We found that the "Egr-1 responsive gene signature'' was substantially enriched in the "diffuse-proliferation'' subset comprising exclusively of patients with diffuse cutaneous SSc (dcSSc) of skin biopsies. A number of Egr-1-regulated genes was also associated with the "inflammatory'' intrinsic subset. Only a minority of Egr-1-regulated genes was concordantly regulated by TGF-beta. These results indicate that Egr-1 induces a distinct profibrotic/wound healing gene expression program in fibroblasts that is associated with skin biopsies from SSc patients with diffuse cutaneous disease. These observations suggest that targeting Egr-1 expression or activity might be a novel therapeutic strategy to control fibrosis in specific SSc subsets.	[Bhattacharyya, Swati; Varga, John] Northwestern Univ, Div Rheumatol, Feinberg Sch Med, Chicago, IL 60611 USA; [Sargent, Jennifer L.; Whitfield, Michael L.] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Dept Genet, Hanover, NH 03756 USA; [Du, Pan; Lin, Simon] Northwestern Univ, Clin & Translat Sci Inst, Chicago, IL 60611 USA; [Tourtellotte, Warren G.] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA; [Tourtellotte, Warren G.] Northwestern Univ, Dept Neurol, Feinberg Sch Med, Chicago, IL 60611 USA; [Takehara, Kazuhiko] Kanazawa Univ, Dept Dermatol, Kanazawa, Ishikawa, Japan	Northwestern University; Feinberg School of Medicine; Dartmouth College; Northwestern University; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Kanazawa University	Bhattacharyya, S (corresponding author), Northwestern Univ, Div Rheumatol, Feinberg Sch Med, Chicago, IL 60611 USA.	s-bhattacharyya@northwestern.edu; j-varga@northwestern.edu	Varga, John/AAK-6472-2021; Whitfield, Michael/AAC-5010-2020; Bhattacharyya, Swati/W-8145-2019		National Institutes of Health [AR-04239]; Department of Defense [DOD PR054101]; Scleroderma Foundation; Scleroderma Research Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [K26OD010945] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Scleroderma Foundation; Scleroderma Research Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from the National Institutes of Health (AR-04239), Department of Defense (DOD PR054101) and the Scleroderma Foundation. JLS and MLW were supported by a grant from the Scleroderma Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bea F, 2003, ATHEROSCLEROSIS, V167, P187, DOI 10.1016/S0021-9150(02)00387-8; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhattacharyya S, 2009, ONCOGENE, V28, P1285, DOI 10.1038/onc.2008.479; Bhattacharyya S, 2008, AM J PATHOL, V173, P1085, DOI 10.2353/ajpath.2008.080382; Bhattacharyya S, 2011, MATRIX BIOL, V30, P235, DOI 10.1016/j.matbio.2011.03.005; Chen SJ, 2006, J BIOL CHEM, V281, P21183, DOI 10.1074/jbc.M603270200; DU P, 2007, BIOL DIRECT, P2; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Ehrengruber MU, 2000, GENE, V258, P63, DOI 10.1016/S0378-1119(00)00445-5; Farivar AS, 2005, J HEART LUNG TRANSPL, V24, P2235, DOI 10.1016/j.healun.2005.06.005; Farivar AS, 2005, ANN THORAC SURG, V79, P1010, DOI 10.1016/j.athoracsur.2004.08.078; Fu MG, 2003, GENE, V315, P33, DOI 10.1016/S0378-1119(03)00730-3; Jimenez SA, 2004, ANN INTERN MED, V140, P37, DOI 10.7326/0003-4819-140-1-200401060-00010; Khachigian LM, 2006, CIRC RES, V98, P186, DOI 10.1161/01.RES.0000200177.53882.c3; Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075; Milano A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002696; Mori Y, 2004, ARTHRITIS RHEUM-US, V50, P4008, DOI 10.1002/art.20658; Okada M, 2002, FASEB J, V16, P1861, DOI 10.1096/fj.02-0503com; Rosenbloom J, 2010, ANN INTERN MED, V152, P159, DOI 10.7326/0003-4819-152-3-201002020-00007; Sargent JL, 2010, J INVEST DERMATOL, V130, P694, DOI 10.1038/jid.2009.318; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Thiel G, 2002, J CELL PHYSIOL, V193, P287, DOI 10.1002/jcp.10178; VARGA J, 1987, BIOCHEM J, V247, P597, DOI 10.1042/bj2470597; Varga John, 2009, Front Biosci (Schol Ed), V1, P226, DOI 10.2741/s22; Varga J, 2009, NAT REV RHEUMATOL, V5, P200, DOI 10.1038/nrrheum.2009.26; Wu MH, 2009, AM J PATHOL, V174, P519, DOI 10.2353/ajpath.2009.080574	26	30	31	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2011	6	9							e23082	10.1371/journal.pone.0023082	http://dx.doi.org/10.1371/journal.pone.0023082			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZV	21931594	gold, Green Submitted, Green Published			2022-12-25	WOS:000295321800003
J	Otazu, GH; Leibold, C				Otazu, Gonzalo H.; Leibold, Christian			A Corticothalamic Circuit Model for Sound Identification in Complex Scenes	PLOS ONE			English	Article							AUDITORY-CORTEX; PERCEPTUAL ORGANIZATION; FUNCTIONAL-ORGANIZATION; RECEPTIVE-FIELDS; REPRESENTATIONS; PROJECTIONS; RESPONSES	The identification of the sound sources present in the environment is essential for the survival of many animals. However, these sounds are not presented in isolation, as natural scenes consist of a superposition of sounds originating from multiple sources. The identification of a source under these circumstances is a complex computational problem that is readily solved by most animals. We present a model of the thalamocortical circuit that performs level-invariant recognition of auditory objects in complex auditory scenes. The circuit identifies the objects present from a large dictionary of possible elements and operates reliably for real sound signals with multiple concurrently active sources. The key model assumption is that the activities of some cortical neurons encode the difference between the observed signal and an internal estimate. Reanalysis of awake auditory cortex recordings revealed neurons with patterns of activity corresponding to such an error signal.	[Otazu, Gonzalo H.; Leibold, Christian] Univ Munich, Div Neurobiol, Dept Biol 2, Munich, Germany; [Otazu, Gonzalo H.; Leibold, Christian] Bernstein Ctr Computat Neurosci, Munich, Germany	University of Munich	Otazu, GH (corresponding author), Univ Munich, Div Neurobiol, Dept Biol 2, Munich, Germany.	ghotazu@gmail.com	Leibold, Christian/AAT-8895-2021	Leibold, Christian/0000-0002-4859-8000; Otazu, Gonzalo/0000-0002-3576-2537	Bundesministerium fur Bildung und Forschung (BMBF) [01GQ0440]	Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by the Bundesministerium fur Bildung und Forschung (BMBF) under grant number 01GQ0440 (Bernstein Center for Computational Neuroscience, Munich). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agus TR, 2010, NEURON, V66, P610, DOI 10.1016/j.neuron.2010.04.014; Anderson SE, 2006, HEARING RES, V213, P107, DOI 10.1016/j.heares.2005.12.011; Asari H, 2006, J NEUROSCI, V26, P7477, DOI 10.1523/JNEUROSCI.1563-06.2006; Astrom K.J., 2013, ADAPTIVE CONTROL; Atencio CA, 2008, J NEUROSCI, V28, P3897, DOI 10.1523/JNEUROSCI.5366-07.2008; Atiani S, 2009, NEURON, V61, P467, DOI 10.1016/j.neuron.2008.12.027; Bandyopadhyay S, 2010, NAT NEUROSCI, V13, P361, DOI 10.1038/nn.2490; Bregman A.S., 1990, AUDITORY SCENE ANAL; CAICEDO A, 1993, J COMP NEUROL, V328, P377, DOI 10.1002/cne.903280305; Carlyon RP, 2004, TRENDS COGN SCI, V8, P465, DOI 10.1016/j.tics.2004.08.008; Chechik G, 2006, NEURON, V51, P359, DOI 10.1016/j.neuron.2006.06.030; Chen SSB, 2001, SIAM REV, V43, P129, DOI 10.1137/S1064827596304010; Elhilali M, 2009, NEURON, V61, P317, DOI 10.1016/j.neuron.2008.12.005; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Fritz J, 2003, NAT NEUROSCI, V6, P1216, DOI 10.1038/nn1141; Grimault N, 2000, J ACOUST SOC AM, V108, P263, DOI 10.1121/1.429462; HOPFIELD JJ, 1991, P NATL ACAD SCI USA, V88, P6462, DOI 10.1073/pnas.88.15.6462; Hromadka T, 2008, PLOS BIOL, V6, P124, DOI 10.1371/journal.pbio.0060016; Jehee JFM, 2006, J PHYSIOL-PARIS, V100, P125, DOI 10.1016/j.jphysparis.2006.09.011; Jehee JFM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000373; Jortner RA, 2007, J NEUROSCI, V27, P1659, DOI 10.1523/JNEUROSCI.4171-06.2007; Kalman R. E, 1960, J BASIC ENG, V82, P35, DOI [10.1115/1.3662552, DOI 10.1115/1.3662552]; Lee CC, 2011, NAT NEUROSCI, V14, P108, DOI 10.1038/nn.2713; Lewicki MS, 2000, NEURAL COMPUT, V12, P337, DOI 10.1162/089976600300015826; MALLAT SG, 1993, IEEE T SIGNAL PROCES, V41, P3397, DOI 10.1109/78.258082; Micheyl C, 2005, NEURON, V48, P139, DOI 10.1016/j.neuron.2005.08.039; Nelken I, 1999, NATURE, V397, P154, DOI 10.1038/16456; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Otazu GH, 2009, NAT NEUROSCI, V12, P646, DOI 10.1038/nn.2306; Oviedo HV, 2010, NAT NEUROSCI, V13, P1413, DOI 10.1038/nn.2659; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Rothschild G, 2010, NAT NEUROSCI, V13, P353, DOI 10.1038/nn.2484; Russ BE, 2008, J NEUROPHYSIOL, V99, P87, DOI 10.1152/jn.01069.2007; Sadagopan S, 2009, J NEUROSCI, V29, P11192, DOI 10.1523/JNEUROSCI.1286-09.2009; Sakata S, 2009, NEURON, V64, P404, DOI 10.1016/j.neuron.2009.09.020; SALLY SL, 1988, J NEUROPHYSIOL, V59, P1627, DOI 10.1152/jn.1988.59.5.1627; Smith EC, 2006, NATURE, V439, P978, DOI 10.1038/nature04485; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; Stettler DD, 2009, NEURON, V63, P854, DOI 10.1016/j.neuron.2009.09.005; Wang XQ, 2005, NATURE, V435, P341, DOI 10.1038/nature03565; WILLSHAW DJ, 1969, NATURE, V222, P960, DOI 10.1038/222960a0; Winer JA, 2001, J COMP NEUROL, V430, P27	42	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2011	6	9							e24270	10.1371/journal.pone.0024270	http://dx.doi.org/10.1371/journal.pone.0024270			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZV	21931668	Green Published, gold, Green Submitted			2022-12-25	WOS:000295321800022
J	Yan, J; Wang, ZY; Yang, HZ; Liu, HZ; Mi, S; Lv, XX; Fu, XM; Yan, HM; Zhang, XW; Zhan, QM; Hu, ZW				Yan, Jun; Wang, Zi-Yan; Yang, Hong-Zhen; Liu, Han-Zhi; Mi, Su; Lv, Xiao-Xi; Fu, Xiao-Ming; Yan, Hui-Min; Zhang, Xiao-Wei; Zhan, Qi-Min; Hu, Zhuo-Wei			Timing Is Critical for an Effective Anti-Metastatic Immunotherapy: The Decisive Role of IFN gamma/STAT1-Mediated Activation of Autophagy	PLOS ONE			English	Article							CANCER-IMMUNOTHERAPY; INNATE IMMUNITY; SUPPRESSION; RECEPTORS; AGONISTS; STAT3; TLR4; GENE	Background: Immunotherapy is often recommended as an adjuvant treatment to reduce the chance of cancer recurrence or metastasis. Interestingly, timing is very important for a successful immunotherapy against metastasis, although the precise mechanism is still unknown. Methods and Findings: Using a mouse model of melanoma metastasis induced by intravenous injection of B16-F10 cells, we investigated the mechanism responsible for the diverse efficacy of the prophylactic or therapeutic TLR4 and TLR9 agonist complex against metastasis. We found that the activation of TLR4 and TLR9 prevented, but did not reverse, metastasis because the potency of this combination was neither sufficient to overcome the tumor cell-educated immune tolerance nor to induce efficacious autophagy in tumor cells. The prophylactic application of the complex promoted antimetastatic immunity, leading to the autophagy-associated death of melanoma cells via IFN gamma/STAT1 activation and attenuated tumor metastasis. IFN gamma neutralization reversed the prophylactic benefit induced by the complex by suppressing STAT1 activation and attenuating autophagy in mice. However, the therapeutic application of the complex did not suppress metastasis because the complex could not reverse tumor cell-induced STAT3 activation and neither activate IFN gamma/STAT1 signaling and autophagy. Suppressing STAT3 activation with the JAK/STAT antagonist AG490 restored the antimetastatic effect of the TLR4/9 agonist complex. Activation of autophagy after tumor inoculation by using rapamycin, with or without the TLR4/9 agonist complex, could suppress metastasis. Conclusion and Significance: Our studies suggest that activation of IFN gamma/STAT1 signaling and induction of autophagy are critical for an efficacious anti-metastatic immunotherapy and that autophagy activators may overcome the timing barrier for immunotherapy against metastasis.	[Yan, Jun; Wang, Zi-Yan; Yang, Hong-Zhen; Liu, Han-Zhi; Mi, Su; Lv, Xiao-Xi; Fu, Xiao-Ming; Yan, Hui-Min; Zhang, Xiao-Wei; Hu, Zhuo-Wei] Chinese Acad Med Sci, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Mol Immunol & Pharmacol Lab, Beijing 100050, Peoples R China; [Yan, Jun; Wang, Zi-Yan; Yang, Hong-Zhen; Liu, Han-Zhi; Mi, Su; Lv, Xiao-Xi; Fu, Xiao-Ming; Yan, Hui-Min; Zhang, Xiao-Wei; Zhan, Qi-Min; Hu, Zhuo-Wei] Peking Union Med Coll, Beijing 100021, Peoples R China; [Zhan, Qi-Min] Chinese Acad Med Sci, Inst Canc, State Key Lab Mol Oncol, Beijing 100050, Peoples R China; [Zhan, Qi-Min] Chinese Acad Med Sci, Canc Hosp, Beijing 100050, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS	Yan, J (corresponding author), Chinese Acad Med Sci, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Mol Immunol & Pharmacol Lab, Beijing 100050, Peoples R China.	huzhuowei@imm.ac.cn	Wang, Ziyan/HII-8458-2022	Yan, Jun/0000-0002-3261-0749	National Major Basic Research Program of China [2006CB503808]; Creation of Major New Drugs [2009ZX09301-003-13, 2009ZX09301-003-9-1]; National Nature Scientific Foundation [30973557]; Ph.D. Programs Foundation of Ministry of Education of China [20070023035]	National Major Basic Research Program of China(National Basic Research Program of China); Creation of Major New Drugs; National Nature Scientific Foundation; Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China)	This study was supported by grants from the National Major Basic Research Program of China (2006CB503808, http://www.973.gov.cn/English/Index.aspx), Creation of Major New Drugs (2009ZX09301-003-13; 2009ZX09301-003-9-1, http://program.most.gov.cn/), National Nature Scientific Foundation (30973557, http://www.nsfc.gov.cn), and Ph.D. Programs Foundation of Ministry of Education of China (20070023035, http://www.cutech.edu.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avraham R, 2010, BRAIN BEHAV IMMUN, V24, P952, DOI 10.1016/j.bbi.2010.03.010; Bafica A, 2007, J IMMUNOL, V179, P5514, DOI 10.4049/jimmunol.179.8.5514; Blattman JN, 2004, SCIENCE, V305, P200, DOI 10.1126/science.1100369; Burdelya L, 2002, MOL CANCER THER, V1, P893; Chang YP, 2010, J BIOL CHEM, V285, P28715, DOI 10.1074/jbc.M110.133355; Cully M, 2006, NAT REV CANCER, V6, P184, DOI 10.1038/nrc1819; Curiel TJ, 2007, J CLIN INVEST, V117, P1167, DOI 10.1172/JCI31202; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Delgado MA, 2009, CELL DEATH DIFFER, V16, P976, DOI 10.1038/cdd.2009.40; Deretic V, 2009, CURR OPIN IMMUNOL, V21, P53, DOI 10.1016/j.coi.2009.02.002; Fournier P, 2009, EXPERT REV VACCINES, V8, P51, DOI 10.1586/14760584.8.1.51; Haehnel PS, 2008, CANCER RES, V68, P3899, DOI 10.1158/0008-5472.CAN-07-6286; Ho HH, 2006, J BIOL CHEM, V281, P14111, DOI 10.1074/jbc.M511797200; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jin SK, 2007, AUTOPHAGY, V3, P28, DOI 10.4161/auto.3269; Kanzler H, 2007, NAT MED, V13, P552, DOI 10.1038/nm1589; Kenific CM, 2010, CURR OPIN CELL BIOL, V22, P241, DOI 10.1016/j.ceb.2009.10.008; Kim HS, 2007, CELL SIGNAL, V19, P454, DOI 10.1016/j.cellsig.2006.09.003; Klinman D, 2008, J LEUKOCYTE BIOL, V84, P958, DOI 10.1189/jlb.1107775; Kopfstein L, 2006, CELL MOL LIFE SCI, V63, P449, DOI 10.1007/s00018-005-5296-8; Kortylewski M, 2009, CANCER RES, V69, P2497, DOI 10.1158/0008-5472.CAN-08-3031; Lasaro MO, 2010, CURR OPIN IMMUNOL, V22, P385, DOI 10.1016/j.coi.2010.04.005; Li JCB, 2011, AIDS, V25, P15, DOI 10.1097/QAD.0b013e328340fd61; Liu YY, 2008, J IMMUNOL, V180, P7349, DOI 10.4049/jimmunol.180.11.7349; Marx J, 2006, SCIENCE, V312, P1160, DOI 10.1126/science.312.5777.1160; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Molavi O, 2008, IMMUNOL CELL BIOL, V86, P506, DOI 10.1038/icb.2008.27; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Noguchi M, 2001, CANCER GENE THER, V8, P421, DOI 10.1038/sj.cgt.7700320; Park HJ, 2011, MOL IMMUNOL, V48, P720, DOI 10.1016/j.molimm.2010.10.020; Raman VS, 2010, J IMMUNOL, V185, P1701, DOI 10.4049/jimmunol.1000238; Romagne F, 2007, DRUG DISCOV TODAY, V12, P80, DOI 10.1016/j.drudis.2006.11.007; Rosenberg SA, 2004, NAT MED, V10, P909, DOI 10.1038/nm1100; Rubartelli A, 2007, TRENDS IMMUNOL, V28, P429, DOI 10.1016/j.it.2007.08.004; Ruttinger D, 2010, ONCOLOGIST, V15, P112, DOI 10.1634/theoncologist.2009-0213; Salazar M, 2009, J CLIN INVEST, V119, P1359, DOI 10.1172/JCI37948; Schmidt C, 2007, NAT BIOTECHNOL, V25, P825, DOI 10.1038/nbt0807-825; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Sinnberg T, 2009, J INVEST DERMATOL, V129, P1500, DOI 10.1038/jid.2008.379; Theiner G, 2008, MOL IMMUNOL, V45, P244, DOI 10.1016/j.molimm.2007.02.021; Umansky V, 2009, FUTURE ONCOL, V5, P941, DOI [10.2217/fon.09.62, 10.2217/FON.09.62]; Van Grol J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011733; Yang HZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006520; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734	44	26	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2011	6	9							e24705	10.1371/journal.pone.0024705	http://dx.doi.org/10.1371/journal.pone.0024705			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZV	21931823	Green Published, Green Submitted, gold			2022-12-25	WOS:000295321800051
J	Bjorkelund, H; Gedda, L; Barta, P; Malmqvist, M; Andersson, K				Bjorkelund, Hanna; Gedda, Lars; Barta, Pavel; Malmqvist, Magnus; Andersson, Karl			Gefitinib Induces Epidermal Growth Factor Receptor Dimers Which Alters the Interaction Characteristics with I-125-EGF	PLOS ONE			English	Article							TYROSINE KINASE; SIGNAL-TRANSDUCTION; BREAST-CANCER; ZD1839 IRESSA; LIVING CELLS; LUNG-CANCER; TUMOR-CELLS; INHIBITOR; AFFINITY; EGFR	The tyrosine kinase inhibitor gefitinib inhibits growth in some tumor types by targeting the epidermal growth factor receptor (EGFR). Previous studies show that the affinity of the EGF-EGFR interaction varies between hosting cell line, and that gefitinib increases the affinity for some cell lines. In this paper, we investigate possible mechanisms behind these observations. Real-time interaction analysis in LigandTracer (R) Grey revealed that the HER2 dimerization preventing antibody pertuzumab clearly modified the binding of I-125-EGF to EGFR on HER2 overexpressing SKOV3 cells in the presence of gefitinib. Pertuzumab did not affect the binding on A431 cells, which express low levels of HER2. Cross-linking measurements showed that gefitinib increased the amount of EGFR dimers 3.0-3.8 times in A431 cells in the absence of EGF. In EGF stimulated SKOV3 cells the amount of EGFR dimers increased 1.8-2.2 times by gefitinib, but this effect was cancelled by pertuzumab. Gefitinib treatment did not alter the number of EGFR or HER2 expressed in tumor cell lines A431, U343, SKOV3 and SKBR3. Real-time binding traces were further analyzed in a novel tool, Interaction Map, which deciphered the different components of the measured interaction and supports EGF binding to multiple binding sites. EGFR and HER2 expression affect the levels of EGFR monomers, homodimers and heterodimers and EGF binds to the various monomeric/dimeric forms of EGFR with unique binding properties. Taken together, we conclude that dimerization explains the varying affinity of EGF - EGFR in different cells, and we propose that gefitinib induces EGFR dimmers, which alters the interaction characteristics with I-125-EGF.	[Bjorkelund, Hanna; Gedda, Lars; Malmqvist, Magnus; Andersson, Karl] Uppsala Univ, Dept Radiol Oncol & Radiat Sci, Uppsala, Sweden; [Bjorkelund, Hanna; Malmqvist, Magnus; Andersson, Karl] Ridgeview Instruments AB, Uppsala, Sweden; [Barta, Pavel] Charles Univ Prague, Fac Pharm Hradec Kralove, Dept Pharmacol & Toxicol, Prague, Czech Republic; [Malmqvist, Magnus] Bioventia AB, Uppsala, Sweden	Uppsala University; Charles University Prague	Bjorkelund, H (corresponding author), Uppsala Univ, Dept Radiol Oncol & Radiat Sci, Uppsala, Sweden.	hanna@ridgeviewinstruments.com	Barta, Pavel/AAP-6716-2020; Barta, Pavel/S-5613-2017	Barta, Pavel/0000-0001-5445-5658; Barta, Pavel/0000-0001-5445-5658; Andersson, Karl/0000-0001-9141-9242; Gedda, Lars/0000-0002-3746-6811	Uppsala University; Ridgeview Instruments AB (RIAB)	Uppsala University; Ridgeview Instruments AB (RIAB)	This project was jointly funded by Uppsala University and Ridgeview Instruments AB (RIAB). Hanna Bjorkelund, Magnus Malmqvist, and Karl Andersson participated in the study on the same conditions as university employees, i.e., without any restrictions on study design and what data to include in the publication. Uppsala University had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The role of RIAB was solely to provide access to LigandTracer devices and to pay the salaries of Hanna Bjorkelund, Magnus Malmqvist, and Karl Andersson.	Aguilar Z, 1999, ONCOGENE, V18, P6050, DOI 10.1038/sj.onc.1202993; Andersson K., 2008, Patent application, Patent No. [WO 2010033069, 2010033069]; BARTA P, 2011, NUCL MED CO IN PRESS; Baselga J, 2006, SCIENCE, V312, P1175, DOI 10.1126/science.1125951; Bjorke H, 2006, APPL RADIAT ISOTOPES, V64, P901, DOI 10.1016/j.apradiso.2006.03.002; Bjorkelund H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016536; Bjorkelund H, 2011, J MOL RECOGNIT, V24, P81, DOI 10.1002/jmr.1026; Brennan PJ, 2000, ONCOGENE, V19, P6093, DOI 10.1038/sj.onc.1203967; Bublil EM, 2007, CURR OPIN CELL BIOL, V19, P124, DOI 10.1016/j.ceb.2007.02.008; Bublil EM, 2010, FASEB J, V24, P4744, DOI 10.1096/fj.10-166199; Ciardiello F, 2000, DRUGS, V60, P25, DOI 10.2165/00003495-200060001-00003; Crespo A, 2008, J MED CHEM, V51, P4890, DOI 10.1021/jm800453a; FANGER BO, 1989, FASEB J, V3, P71, DOI 10.1096/fasebj.3.1.2783412; Hommelgaard AM, 2004, MOL BIOL CELL, V15, P1557, DOI 10.1091/mbc.E03-08-0596; Hughes JB, 2009, MOL CANCER THER, V8, P1885, DOI 10.1158/1535-7163.MCT-09-0291; Hulme EC, 2010, BRIT J PHARMACOL, V161, P1219, DOI 10.1111/j.1476-5381.2009.00604.x; HUNTER WM, 1962, NATURE, V194, P495, DOI 10.1038/194495a0; Kris MG, 2003, JAMA-J AM MED ASSOC, V290, P2149, DOI 10.1001/jama.290.16.2149; LAX I, 1989, EMBO J, V8, P421, DOI 10.1002/j.1460-2075.1989.tb03393.x; Liu P, 2007, BIOPHYS J, V93, P684, DOI 10.1529/biophysj.106.102087; Moasser MM, 2001, CANCER RES, V61, P7184; Nestor M, 2010, TUMOR BIOL, V31, P141, DOI 10.1007/s13277-010-0018-8; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Ozcan F, 2006, P NATL ACAD SCI USA, V103, P5735, DOI 10.1073/pnas.0601469103; SHECHTER Y, 1978, P NATL ACAD SCI USA, V75, P5788, DOI 10.1073/pnas.75.12.5788; SORKIN A, 1991, J BIOL CHEM, V266, P23453; Spector N, 2008, CLIN BREAST CANCER, V8, pS94, DOI 10.3816/CBC.2008.s.005; Stamos J, 2002, J BIOL CHEM, V277, P46265, DOI 10.1074/jbc.M207135200; Stern DF, 2008, J MAMMARY GLAND BIOL, V13, P215, DOI 10.1007/s10911-008-9083-7; Svitel J, 2003, BIOPHYS J, V84, P4062, DOI 10.1016/S0006-3495(03)75132-7; Tao RH, 2008, J CELL SCI, V121, P3207, DOI 10.1242/jcs.033399; Tzahar E, 1996, MOL CELL BIOL, V16, P5276; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; Wakeling AE, 2002, CANCER RES, V62, P5749; WESTERMARK B, 1982, J NEUROSCI RES, V8, P491, DOI 10.1002/jnr.490080236; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1443, DOI 10.1021/bi00379a035; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017	39	64	66	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2011	6	9							e24739	10.1371/journal.pone.0024739	http://dx.doi.org/10.1371/journal.pone.0024739			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CO	21931838	Green Published, Green Submitted, gold			2022-12-25	WOS:000294803200045
J	Flores, CL; Gancedo, C; Petit, T				Flores, Carmen-Lisset; Gancedo, Carlos; Petit, Thomas			Disruption of Yarrowia lipolytica TPS1 Gene Encoding Trehalose-6-P Synthase Does Not Affect Growth in Glucose but Impairs Growth at High Temperature	PLOS ONE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; SHOCK TRANSCRIPTION FACTOR; CITRIC-ACID PRODUCTION; HEAT-SHOCK; MOLECULAR-CLONING; SCHIZOSACCHAROMYCES-POMBE; HANSENULA-POLYMORPHA; PHOSPHATE SYNTHASE; METABOLIC PATHWAYS; ASPERGILLUS-NIGER	We have cloned the Yarrowia lipolytica TPS1 gene encoding trehalose-6-P synthase by complementation of the lack of growth in glucose of a Saccharomyces cerevisiae tps1 mutant. Disruption of YlTPS1 could only be achieved with a cassette placed in the 3'half of its coding region due to the overlap of its sequence with the promoter of the essential gene YlTFC1. The Yltps1 mutant grew in glucose although the Y. lipolytica hexokinase is extremely sensitive to inhibition by trehalose-6-P. The presence of a glucokinase, insensitive to trehalose-6-P, that constitutes about 80% of the glucose phosphorylating capacity during growth in glucose may account for the growth phenotype. Trehalose content was below 1 nmol/mg dry weight in Y. lipolytica, but it increased in strains expressing YlTPS1 under the control of the YlTEF1promoter or with a disruption of YALI0D15598 encoding a putative trehalase. mRNA levels of YlTPS1 were low and did not respond to thermal stresses, but that of YlTPS2 (YALI0D14476) and YlTPS3 (YALI0E31086) increased 4 and 6 times, repectively, by heat treatment. Disruption of YlTPS1 drastically slowed growth at 35 degrees C. Homozygous Yltps1 diploids showed a decreased sporulation frequency that was ascribed to the low level of YALI0D20966 mRNA an homolog of the S. cerevisiae MCK1 which encodes a protein kinase that activates early meiotic gene expression.	[Flores, Carmen-Lisset; Gancedo, Carlos] UAM, CSIC, Inst Invest Biomed Alberto Sols, Dept Metab & Cell Signalling, Madrid, Spain; [Petit, Thomas] Univ La Reunion, Lab Chim Subst Nat & Sci Aliments, Inst Univ Technol, Dept Genie Biol, St Pierre, France	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); University of La Reunion	Flores, CL (corresponding author), UAM, CSIC, Inst Invest Biomed Alberto Sols, Dept Metab & Cell Signalling, Madrid, Spain.	clflores@iib.uam.es	Flores, Carmen-Lisset/F-9598-2017; Gancedo, Carlos/E-9831-2016; PETIT, Thomas/G-1658-2017	Flores, Carmen-Lisset/0000-0002-2439-5030; Gancedo, Carlos/0000-0002-6278-3667; PETIT, Thomas/0000-0002-3450-5782	Spanish Ministry of Science and Innovation (MICINN) [BFU2007-66063-C02-01/BMC, BFU2010-19628-CO2-02]	Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was partially supported by Grants BFU2007-66063-C02-01/BMC and BFU2010-19628-CO2-02 from the Spanish Ministry of Science and Innovation (MICINN; URL:www.micinn.es) to CG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Adachi N, 2002, CELL, V109, P807, DOI 10.1016/S0092-8674(02)00758-4; Al-Bader N, 2010, INFECT IMMUN, V78, P3007, DOI 10.1128/IAI.00813-09; Amaral PFF, 2006, YEAST, V23, P867, DOI 10.1002/yea.1405; Arguelles JC, 1997, FEMS MICROBIOL LETT, V146, P65, DOI 10.1016/S0378-1097(96)00455-7; ArisanAtac I, 1996, FEMS MICROBIOL LETT, V140, P77, DOI 10.1016/0378-1097(96)00164-4; Barth G, 1997, FEMS MICROBIOL REV, V19, P219, DOI 10.1016/S0168-6445(97)00002-8; Barth G, 1996, NONCONVENTIONAL YEAS, P313, DOI [DOI 10.1007/978-3-642-79856-6_10, 10.1007/978-3-642-79856-6_10]; BECKER DM, 1991, P NATL ACAD SCI USA, V88, P1968, DOI 10.1073/pnas.88.5.1968; Belinchon NM, 2004, FEMS YEAST RES, V4, P751, DOI 10.1016/j.femsyr.2004.02.004; BELL W, 1992, EUR J BIOCHEM, V209, P951, DOI 10.1111/j.1432-1033.1992.tb17368.x; Beopoulos A, 2009, PROG LIPID RES, V48, P375, DOI 10.1016/j.plipres.2009.08.005; BLANCHINROLAND S, 1994, MOL CELL BIOL, V14, P327, DOI 10.1128/MCB.14.1.327; BLAZQUEZ MA, 1994, J BACTERIOL, V176, P3895; BLAZQUEZ MA, 1993, FEBS LETT, V329, P51, DOI 10.1016/0014-5793(93)80191-V; Bulman AL, 2001, J BIOL CHEM, V276, P40254, DOI 10.1074/jbc.M106301200; CABIB E, 1958, J BIOL CHEM, V231, P259; Castells-Roca L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017272; Chen QF, 2004, J EXP BIOL, V207, P3125, DOI 10.1242/jeb.01133; Cherry JM, 1997, NATURE, V387, P67, DOI 10.1038/387s067; Conlin LK, 2007, MOL CELL BIOL, V27, P1505, DOI 10.1128/MCB.01158-06; CONWAY EJ, 1950, BIOCHEM J, V47, P347, DOI 10.1042/bj0470347; Lopez MD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010654; De Silva-Udawatta MN, 2001, MOL MICROBIOL, V40, P1345, DOI 10.1046/j.1365-2958.2001.02477.x; DEVIRGILIO C, 1993, EUR J BIOCHEM, V212, P315; Dujon B, 2006, TRENDS GENET, V22, P375, DOI 10.1016/j.tig.2006.05.007; Eastmond PJ, 2002, PLANT J, V29, P225, DOI 10.1046/j.1365-313x.2002.01220.x; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; Fillinger S, 2001, MICROBIOL-SGM, V147, P1851, DOI 10.1099/00221287-147-7-1851; Flores CL, 2005, MICROBIOL-SGM, V151, P1465, DOI 10.1099/mic.0.27856-0; Flores CL, 2005, EUKARYOT CELL, V4, P356, DOI 10.1128/EC.4.2.356-364.2005; Francois J, 2001, FEMS MICROBIOL REV, V25, P125, DOI 10.1111/j.1574-6976.2001.tb00574.x; GAILLARDIN C, 1987, CURR GENET, V11, P369, DOI 10.1007/BF00378179; GAILLARDIN CM, 1973, ARCH MIKROBIOL, V92, P69, DOI 10.1007/BF00409513; GAMO FJ, 1993, FEMS MICROBIOL LETT, V106, P233, DOI 10.1111/j.1574-6968.1993.tb05969.x; Gancedo C, 2004, FEMS YEAST RES, V4, P351, DOI 10.1016/S1567-1356(03)00222-8; GANCEDO JM, 1977, J BIOL CHEM, V252, P4443; Goddijn OJM, 1997, PLANT PHYSIOL, V113, P181, DOI 10.1104/pp.113.1.181; Goldberg D.M., 1987, METHODS ENZYMATIC AN, P258; GONZALEZ MI, 1992, YEAST, V8, P183, DOI 10.1002/yea.320080304; HERRERO P, 1995, YEAST, V11, P137, DOI 10.1002/yea.320110205; HIRAI M, 1975, BIOCHIM BIOPHYS ACTA, V391, P282, DOI 10.1016/0005-2744(75)90252-1; Holz M, 2009, APPL MICROBIOL BIOT, V81, P1087, DOI 10.1007/s00253-008-1725-6; Huang Y, 2000, J BIOL CHEM, V275, P31480, DOI 10.1074/jbc.M004635200; Hurtado CAR, 1999, J BACTERIOL, V181, P3051, DOI 10.1128/JB.181.10.3051-3057.1999; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Jardon R, 2008, EUKARYOT CELL, V7, P1742, DOI 10.1128/EC.00169-08; Kamzolova SV, 2003, FEMS YEAST RES, V3, P217, DOI 10.1016/S1567-1356(02)00188-5; Kandror O, 2004, MOL CELL, V13, P771, DOI 10.1016/S1097-2765(04)00148-0; KIENLE I, 1993, YEAST, V9, P607, DOI 10.1002/yea.320090607; KOBAYASHI N, 1993, MOL CELL BIOL, V13, P248, DOI 10.1128/MCB.13.1.248; Kormish JD, 2005, DEV BIOL, V287, P35, DOI 10.1016/j.ydbio.2005.08.027; Kramarenko T, 2000, FOLIA MICROBIOL, V45, P521, DOI 10.1007/BF02818721; KRETSCHMER A, 1983, BIOCHIM BIOPHYS ACTA, V753, P306, DOI 10.1016/0005-2760(83)90053-X; LeDall MT, 1996, CURR GENET, V29, P446, DOI 10.1007/BF02221513; Lin XR, 2005, EUKARYOT CELL, V4, P1746, DOI 10.1128/EC.4.10.1746-1754.2005; LOPEZ MC, 1994, J CELL BIOL, V125, P113, DOI 10.1083/jcb.125.1.113; Lowe RGT, 2009, FUNGAL GENET BIOL, V46, P381, DOI 10.1016/j.fgb.2009.02.002; LUYTEN K, 1993, EUR J BIOCHEM, V217, P701, DOI 10.1111/j.1432-1033.1993.tb18296.x; Madzak C, 2004, J BIOTECHNOL, V109, P63, DOI 10.1016/j.jbiotec.2003.10.027; MARCHLER G, 1993, EMBO J, V12, P1997, DOI 10.1002/j.1460-2075.1993.tb05849.x; MartinezPastor MT, 1996, EMBO J, V15, P2227, DOI 10.1002/j.1460-2075.1996.tb00576.x; MoradasFerreira P, 1996, MOL MICROBIOL, V19, P651, DOI 10.1046/j.1365-2958.1996.403940.x; Morin M, 2007, J MASS SPECTROM, V42, P1453, DOI 10.1002/jms.1284; MULLER J, 1995, PLANTA, V197, P362, DOI 10.1007/BF00202658; Muller J, 2001, PLANT PHYSIOL, V125, P1086, DOI 10.1104/pp.125.2.1086; NAVAS MA, 1993, P NATL ACAD SCI USA, V90, P1290, DOI 10.1073/pnas.90.4.1290; NEVES MJ, 1995, CURR GENET, V27, P110, DOI 10.1007/BF00313424; Ngamskulrungroj P, 2009, INFECT IMMUN, V77, P4584, DOI 10.1128/IAI.00565-09; NUTTLEY WM, 1993, YEAST, V9, P507, DOI 10.1002/yea.320090506; Paul MJ, 2008, ANNU REV PLANT BIOL, V59, P417, DOI 10.1146/annurev.arplant.59.032607.092945; Petit T, 1999, YEAST, V15, P1573, DOI 10.1002/(SICI)1097-0061(199911)15:15<1573::AID-YEA478>3.3.CO;2-V; Petit T, 1996, FEBS LETT, V378, P185, DOI 10.1016/0014-5793(95)01451-9; Reinders A, 1999, J BACTERIOL, V181, P4665, DOI 10.1128/JB.181.15.4665-4668.1999; Reinders A, 1997, MOL MICROBIOL, V24, P687, DOI 10.1046/j.1365-2958.1997.3861749.x; Sakai Y, 2006, BBA-MOL CELL RES, V1763, P1767, DOI 10.1016/j.bbamcr.2006.08.023; Sherman DJ, 2009, NUCLEIC ACIDS RES, V37, pD550, DOI 10.1093/nar/gkn859; SIKORSKI RS, 1989, GENETICS, V122, P19; SWANSON RN, 1991, P NATL ACAD SCI USA, V88, P4887, DOI 10.1073/pnas.88.11.4887; Teusink B, 1998, TRENDS BIOCHEM SCI, V23, P162, DOI 10.1016/S0968-0004(98)01205-5; THEVELEIN JM, 1995, TRENDS BIOCHEM SCI, V20, P3, DOI 10.1016/S0968-0004(00)88938-0; Tzvetkov M, 2003, MICROBIOL-SGM, V149, P1659, DOI 10.1099/mic.0.26205-0; VANAELST L, 1993, MOL MICROBIOL, V8, P927; Vergne I, 1998, FRONT BIOSCI, V3, pd865; WALLENFELS K, 1962, METHOD ENZYMOL, V5, P212, DOI 10.1016/S0076-6879(62)05207-6; Wang HJ, 1998, YEAST, V14, P1373, DOI 10.1002/(SICI)1097-0061(199811)14:15<1373::AID-YEA332>3.0.CO;2-1; Wilson JE, 2003, J EXP BIOL, V206, P2049, DOI 10.1242/jeb.00241; Wolschek M, 1998, CITRIC ACID BIOTECHN, P11; Wolschek MF, 1997, J BIOL CHEM, V272, P2729, DOI 10.1074/jbc.272.5.2729; Yarrow D., 1998, P77, DOI 10.1016/B978-044481312-1/50014-9; Ye YR, 2009, BIOCHEM BIOPH RES CO, V385, P357, DOI 10.1016/j.bbrc.2009.05.071	90	21	21	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2011	6	9							e23695	10.1371/journal.pone.0023695	http://dx.doi.org/10.1371/journal.pone.0023695			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CO	21931609	Green Published, gold			2022-12-25	WOS:000294803200004
J	Wu, ZF; Li, X; Sunkara, M; Spearman, H; Morris, AJ; Huang, C				Wu, Zhaofei; Li, Xiang; Sunkara, Manjula; Spearman, Heather; Morris, Andrew J.; Huang, Cai			PIPKI gamma Regulates Focal Adhesion Dynamics and Colon Cancer Cell Invasion	PLOS ONE			English	Article							CALPAIN-MEDIATED PROTEOLYSIS; PHOSPHATE KINASE; INTEGRIN-BINDING; TALIN; MIGRATION; ACTIN; PAXILLIN; PHOSPHORYLATION; MOTILITY; ISOFORM	Focal adhesion assembly and disassembly are essential for cell migration and cancer invasion, but the detailed molecular mechanisms regulating these processes remain to be elucidated. Phosphatidylinositol phosphate kinase type I gamma (PIPKI gamma) binds talin and is required for focal adhesion formation in EGF-stimulated cells, but its role in regulating focal adhesion dynamics and cancer invasion is poorly understood. We show here that overexpression of PIPKI gamma promoted focal adhesion formation, whereas cells expressing either PIPKI gamma(K188,200R) or PIPKI gamma(D316K), two kinase-dead mutants, had much fewer focal adhesions than those expressing WT PIPKI gamma in CHO-K1 cells and HCT116 colon cancer cells. Furthermore, overexpression of PIPKI gamma, but not PIPKI gamma(K188,200R), resulted in an increase in both focal adhesion assembly and disassembly rates. Depletion of PIPKI gamma by using shRNA strongly inhibited formation of focal adhesions in HCT116 cells. Overexpression of PIPKI gamma(K188,200R) or depletion of PIPKI gamma reduced the strength of HCT116 cell adhesion to fibronection and inhibited the invasive capacities of HCT116 cells. PIPKI gamma depletion reduced PIP2 levels to similar to 40% of control and PIP3 to undetectable levels, and inhibited vinculin localizing to focal adhesions. Taken together, PIPKI gamma positively regulates focal adhesion dynamics and cancer invasion, most probably through PIP2-mediated vinculin activation.	[Wu, Zhaofei; Li, Xiang; Spearman, Heather; Huang, Cai] Univ Kentucky, Markey Canc Ctr, Lexington, KY 40536 USA; [Sunkara, Manjula; Morris, Andrew J.] Univ Kentucky, Div Cardiovasc Med, Lexington, KY USA; [Morris, Andrew J.] Univ Kentucky, Dept Internal Med, Lexington, KY USA; [Huang, Cai] Univ Kentucky, Dept Mol & Biomed Pharmacol, Lexington, KY USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky	Wu, ZF (corresponding author), Univ Kentucky, Markey Canc Ctr, Lexington, KY 40536 USA.	cai-huang@uky.edu	sunkara, Manjula/H-7944-2016; wu, zhaofei/J-3149-2014	sunkara, Manjula/0000-0001-6151-1929; wu, zhaofei/0000-0002-2463-242X	Markey Cancer Center (University of Kentucky); Migration Consortium [NIH GM64346]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024598] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM064346] Funding Source: NIH RePORTER	Markey Cancer Center (University of Kentucky); Migration Consortium; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The study was supported by Markey Cancer Center Start-up fund (University of Kentucky) (to Cai Huang) and partially by Migration Consortium grant (NIH GM64346) (to Ken Jacobson, University of North Carolina-Chapel Hill). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calderwood DA, 2003, NAT CELL BIOL, V5, P694, DOI 10.1038/ncb0803-694; Chan KT, 2010, J BIOL CHEM, V285, P11418, DOI 10.1074/jbc.M109.090746; Clark J, 2011, NAT METHODS, V8, P267, DOI 10.1038/NMETH.1564; Comoglio PM, 2002, J CLIN INVEST, V109, P857, DOI 10.1172/JCI200215392; Cortesio CL, 2011, J BIOL CHEM, V286, P9998, DOI 10.1074/jbc.M110.187294; Di Paolo G, 2002, NATURE, V420, P85, DOI 10.1038/nature01147; Dubash AD, 2009, INT REV CEL MOL BIO, V277, P1, DOI 10.1016/S1937-6448(09)77001-7; El Sayegh TY, 2007, MOL BIOL CELL, V18, P3026, DOI 10.1091/mbc.E06-12-1159; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175; Friedl P, 2009, CANCER METAST REV, V28, P129, DOI 10.1007/s10555-008-9174-3; Gilmore AP, 1996, NATURE, V381, P531, DOI 10.1038/381531a0; Giudici ML, 2004, BIOCHEM J, V379, P489, DOI 10.1042/BJ20031394; HONEYMAN TW, 1983, BIOCHEM J, V212, P489, DOI 10.1042/bj2120489; Hsia DA, 2003, J CELL BIOL, V160, P753, DOI 10.1083/jcb.200212114; Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745; Huang C, 2010, BIOTECHNIQUES, V49, P881, DOI 10.2144/000113550; Huang C, 2009, NAT CELL BIOL, V11, P624, DOI 10.1038/ncb1868; Ishihara H, 1998, J BIOL CHEM, V273, P8741, DOI 10.1074/jbc.273.15.8741; Joshi B, 2008, CANCER RES, V68, P8210, DOI 10.1158/0008-5472.CAN-08-0343; Le PU, 2010, ONCOGENE, V29, P4636, DOI 10.1038/onc.2010.216; Li S, 2005, ANNU REV BIOMED ENG, V7, P105, DOI 10.1146/annurev.bioeng.7.060804.100340; Ling K, 2002, NATURE, V420, P89, DOI 10.1038/nature01082; Ling K, 2007, J CELL BIOL, V176, P343, DOI 10.1083/jcb.200606023; Ling K, 2006, TRENDS CELL BIOL, V16, P276, DOI 10.1016/j.tcb.2006.03.007; Martel V, 2001, J BIOL CHEM, V276, P21217, DOI 10.1074/jbc.M102373200; Nayal A, 2004, CURR OPIN CELL BIOL, V16, P94, DOI 10.1016/j.ceb.2003.11.007; Nayal A, 2006, J CELL BIOL, V173, P587, DOI 10.1083/jcb.200509075; Priddle H, 1998, J CELL BIOL, V142, P1121, DOI 10.1083/jcb.142.4.1121; Qin J, 2009, ONCOGENE, V28, P1853, DOI 10.1038/onc.2009.30; Romer LH, 2006, CIRC RES, V98, P606, DOI 10.1161/01.RES.0000207408.31270.db; Saltel F, 2009, J CELL BIOL, V187, P715, DOI 10.1083/jcb.200908134; Schlaepfer DD, 2004, CURR OPIN GENET DEV, V14, P92, DOI 10.1016/j.gde.2003.12.002; Schober M, 2007, J CELL BIOL, V176, P667, DOI 10.1083/jcb.200608010; Sun Y, 2007, J CELL BIOL, V178, P297, DOI 10.1083/jcb.200701078; Sun Y, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2471; Tall EG, 2000, CURR BIOL, V10, P743, DOI 10.1016/S0960-9822(00)00541-8; van den Bout I, 2009, J CELL SCI, V122, P3837, DOI 10.1242/jcs.056127; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Wu XY, 2008, CELL, V135, P137, DOI 10.1016/j.cell.2008.07.045; Xu YJ, 2010, J EXP MED, V207, P2421, DOI 10.1084/jem.20100433	42	32	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2011	6	9							e24775	10.1371/journal.pone.0024775	http://dx.doi.org/10.1371/journal.pone.0024775			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CO	21931851	Green Published, gold, Green Submitted			2022-12-25	WOS:000294803200050
J	Abdi, MM; Abdullah, LC; Sadrolhosseini, AR; Yunus, WMM; Moksin, MM; Tahir, PM				Abdi, Mahnaz M.; Abdullah, Luqman Chuah; Sadrolhosseini, Amir R.; Yunus, Wan Mahmood Mat; Moksin, Mohd Maarof; Tahir, Paridah Md			Surface Plasmon Resonance Sensing Detection of Mercury and Lead Ions Based on Conducting Polymer Composite	PLOS ONE			English	Article							POLYPYRROLE; BINDING	A new sensing area for a sensor based on surface plasmon resonance (SPR) was fabricated to detect trace amounts of mercury and lead ions. The gold surface used for SPR measurements were modified with polypyrrole-chitosan (PPy-CHI) conducting polymer composite. The polymer layer was deposited on the gold surface by electrodeposition. This optical sensor was used for monitoring toxic metal ions with and without sensitivity enhancement by chitosan in water samples. The higher amounts of resonance angle unit (Delta RU) were obtained for PPy-CHI film due to a specific binding of chitosan with Pb2+ and Hg2+ ions. The Pb2+ ion bind to the polymer films most strongly, and the sensor was more sensitive to Pb2+ compared to Hg2+. The concentrations of ions in the parts per million range produced the changes in the SPR angle minimum in the region of 0.03 to 0.07. Data analysis was done by Matlab software using Fresnel formula for multilayer system.	[Abdi, Mahnaz M.; Abdullah, Luqman Chuah; Tahir, Paridah Md] Univ Putra Malaysia, Inst Trop Forestry & Forest Prod INTROP, Lab Biopolymer & Derivat, Serdang, Selangor, Malaysia; [Sadrolhosseini, Amir R.; Yunus, Wan Mahmood Mat; Moksin, Mohd Maarof] Univ Putra Malaysia, Fac Sci, Dept Phys, Serdang, Selangor, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia	Abdi, MM (corresponding author), Univ Putra Malaysia, Inst Trop Forestry & Forest Prod INTROP, Lab Biopolymer & Derivat, Serdang, Selangor, Malaysia.	mahnaz@introp.upm.edu.my	Abdullah, Luqman Chuah/L-8915-2016	Abdullah, Luqman Chuah/0000-0003-4785-9296; M. Abdi, Mahnaz/0000-0003-0844-9884; MD. TAHIR, PARIDAH/0000-0002-2961-6031	Ministry of Higher Education of Malaysia (GRF); University Putra Malaysia	Ministry of Higher Education of Malaysia (GRF); University Putra Malaysia	This work was supported by Ministry of Higher Education of Malaysia (GRF) and University Putra Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi MM, 2010, POLYM SCI SER B+, V52, P662, DOI 10.1134/S1560090410110059; Abdi MM, 2009, J MATER SCI, V44, P3682, DOI 10.1007/s10853-009-3491-y; Barisci JN, 2002, SENSOR ACTUAT B-CHEM, V84, P252, DOI 10.1016/S0925-4005(02)00033-3; Damos FS, 2006, ELECTROCHIM ACTA, V51, P1304, DOI 10.1016/j.electacta.2005.06.019; de Souza JEG, 2003, SENSOR ACTUAT B-CHEM, V88, P246, DOI 10.1016/S0925-4005(02)00344-1; Garland JE, 2003, ANAL CHIM ACTA, V475, P47, DOI 10.1016/S0003-2670(02)01224-2; Kim DY, 2000, PROG POLYM SCI, V25, P1089, DOI 10.1016/S0079-6700(00)00034-4; Nomanbhay SM, 2005, ELECTRON J BIOTECHN, V8, P43; Park JS, 2007, TALANTA, V72, P859, DOI 10.1016/j.talanta.2006.12.021; Pearce JMS, 2007, EUR NEUROL, V57, P118, DOI 10.1159/000098100; Pedrorotti LF, 2007, INTRO OPTICS, P476; Peyghambarian N., 1993, INTRO SEMICONDUCTOR; Sanjay B, 1994, US Patent, Patent No. 5368632; Sathawara NG, 2004, B ENVIRON CONTAM TOX, V73, P756, DOI 10.1007/s00128-004-0490-1; Skoog D.A., 1992, PRINCIPLES INSTRUMEN, P206; Tang Y, 2010, ENVIRON POLLUT, V158, P2074, DOI 10.1016/j.envpol.2010.03.001; Tudos AJ, 2008, HANDBOOK OF SURFACE PLASMON RESONANCE, P1, DOI 10.1039/9781847558220-00001; Yu JCC, 2004, SENSOR ACTUAT B-CHEM, V101, P236, DOI 10.1016/j.snb.2004.03.007; Zhang X, 2002, J MATER CHEM, V12, P2733, DOI 10.1039/b201364a; Zhang YT, 2007, SENSOR ACTUAT B-CHEM, V123, P784, DOI 10.1016/j.snb.2006.10.019	20	55	56	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2011	6	9							e24578	10.1371/journal.pone.0024578	http://dx.doi.org/10.1371/journal.pone.0024578			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CN	21931763	Green Submitted, Green Published, gold			2022-12-25	WOS:000294803100044
J	Arnold, TW; Zink, RM				Arnold, Todd W.; Zink, Robert M.			Collision Mortality Has No Discernible Effect on Population Trends of North American Birds	PLOS ONE			English	Article							COMMUNICATION TOWERS; DECLINES; CLIMATE; LIGHTS	Avian biodiversity is threatened by numerous anthropogenic factors and migratory species are especially at risk. Migrating birds frequently collide with manmade structures and such losses are believed to represent the majority of anthropogenic mortality for North American birds. However, estimates of total collision mortality range across several orders of magnitude and effects on population dynamics remain unknown. Herein, we develop a novel method to assess relative vulnerability to anthropogenic threats, which we demonstrate using 243,103 collision records from 188 species of eastern North American landbirds. After correcting mortality estimates for variation attributable to population size and geographic overlap with potential collision structures, we found that per capita vulnerability to collision with buildings and towers varied over more than four orders of magnitude among species. Species that migrate long distances or at night were much more likely to be killed by collisions than year-round residents or diurnal migrants. However, there was no correlation between relative collision mortality and long-term population trends for these same species. Thus, although millions of North American birds are killed annually by collisions with manmade structures, this source of mortality has no discernible effect on populations.	[Arnold, Todd W.] Univ Minnesota, Dept Fisheries Wildlife & Conservat Biol, St Paul, MN 55108 USA; [Zink, Robert M.] Univ Minnesota, Bell Museum, St Paul, MN 55108 USA; [Zink, Robert M.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Arnold, TW (corresponding author), Univ Minnesota, Dept Fisheries Wildlife & Conservat Biol, St Paul, MN 55108 USA.	arnol065@umn.edu	Arnold, Todd W./H-6945-2019	Arnold, Todd/0000-0002-7920-772X				Banks RC, 1979, HUMAN RELATED MORTAL; Brashares JS, 2004, SCIENCE, V306, P1180, DOI 10.1126/science.1102425; Crawford RL, 2001, J FIELD ORNITHOL, V72, P380, DOI 10.1648/0273-8570-72.3.380; Drewitt AL, 2008, ANN NY ACAD SCI, V1134, P233, DOI 10.1196/annals.1439.015; Erickson Wallace P., 2005, U S Forest Service General Technical Report PSW, V191, P1029; Evans Ogden LJ, 1996, FATAL LIGHT AWARE PR, V1, P3; Gehring J, 2009, ECOL APPL, V19, P505, DOI 10.1890/07-1708.1; Grafen A, 2006, USERS GUIDE SAS IMPL; Hager SB, 2008, WILSON J ORNITHOL, V120, P550, DOI 10.1676/07-075.1; Kemper Charles, 1996, Passenger Pigeon, V58, P219; KLEM D, 1990, J FIELD ORNITHOL, V61, P120; Klem D, 2009, WILSON J ORNITHOL, V121, P126, DOI 10.1676/08-068.1; Kousky C, 2004, BUILDING LESS BRIGHT; Lepczyk CA, 2004, BIOL CONSERV, V115, P191, DOI 10.1016/S0006-3207(03)00107-1; Longcore T, 2008, AUK, V125, P485, DOI 10.1525/auk.2008.06253; MacMynowski DP, 2007, INT J BIOMETEOROL, V51, P361, DOI 10.1007/s00484-006-0084-1; Moller AP, 2008, P NATL ACAD SCI USA, V105, P16195, DOI 10.1073/pnas.0803825105; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; *NAT GEOGR SOC, 1987, FIELD GUID BIRDS N A; Poole A, BIRDS N AM ONLINE; RAPPOLE JH, 1994, AUK, V111, P652; Rich TD, 2005, PARTNERS FLIGHT N AM; ROBBINS CS, 1989, P NATL ACAD SCI USA, V86, P7658, DOI 10.1073/pnas.86.19.7658; Sanderson FJ, 2006, BIOL CONSERV, V131, P93, DOI 10.1016/j.biocon.2006.02.008; SAS Institute, 2009, SAS 9 2 WIND; SAUER JR, 2011, N AM BREEDING BIRD S; Shire G. G., 2000, COMMUNICATION TOWERS; US Fish & Wildlife Service, 2010, AD HARV MAN 2010 HUN; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; Wilcove DS, 2008, PLOS BIOL, V6, P1361, DOI 10.1371/journal.pbio.0060188	30	61	65	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2011	6	9							e24708	10.1371/journal.pone.0024708	http://dx.doi.org/10.1371/journal.pone.0024708			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CN	21931824	Green Submitted, Green Published, gold			2022-12-25	WOS:000294803100060
J	Levitt, JM; McLaughlin-Drubin, ME; Munger, K; Georgakoudi, I				Levitt, Jonathan M.; McLaughlin-Drubin, Margaret E.; Muenger, Karl; Georgakoudi, Irene			Automated Biochemical, Morphological, and Organizational Assessment of Precancerous Changes from Endogenous Two-Photon Fluorescence Images	PLOS ONE			English	Article							CERVICAL INTRAEPITHELIAL NEOPLASIA; FRACTAL DIMENSION; AUTOFLUORESCENCE SPECTROSCOPY; CELL-NUCLEI; SEGMENTATION; EXPRESSION; MICROSCOPY; MODEL; DIFFERENTIATION; EPITHELIUM	Background: Multi-photon fluorescence microscopy techniques allow for non-invasive interrogation of live samples in their native environment. These methods are particularly appealing for identifying pre-cancers because they are sensitive to the early changes that occur on the microscopic scale and can provide additional information not available using conventional screening techniques. Methodology/Principal Findings: In this study, we developed novel automated approaches, which can be employed for the real-time analysis of two-photon fluorescence images, to non-invasively discriminate between normal and pre-cancerous/HPV-immortalized engineered tissues by concurrently assessing metabolic activity, morphology, organization, and keratin localization. Specifically, we found that the metabolic activity was significantly enhanced and more uniform throughout the depths of the HPV-immortalized epithelia, based on our extraction of the NADH and FAD fluorescence contributions. Furthermore, we were able to separate the keratin contribution from metabolic enzymes to improve the redox estimates and to use the keratin localization as a means to discriminate between tissue types. To assess morphology and organization, Fourier-based, power spectral density (PSD) approaches were employed. The nuclear size distribution throughout the epithelial depths was quantified by evaluating the variance of the corresponding spatial frequencies, which was found to be greater in the normal tissue compared to the HPV-immortalized tissues. The PSD was also used to calculate the Hurst parameter to identify the level of organization in the tissues, assuming a fractal model for the fluorescence intensity fluctuations within a field. We found the range of organization was greater in the normal tissue and closely related to the level of differentiation. Conclusions/Significance: A wealth of complementary morphological, biochemical and organizational tissue parameters can be extracted from high resolution images that are acquired based entirely on endogenous sources of contrast. They are promising diagnostic parameters for the non-invasive identification of early cancerous changes and could improve significantly diagnosis and treatment for numerous patients.	[Levitt, Jonathan M.; Georgakoudi, Irene] Tufts Univ, Dept Biomed Engn, Medford, MA 02155 USA; [McLaughlin-Drubin, Margaret E.; Muenger, Karl] Harvard Univ, Brigham & Womens Hosp, Dept Med, Sch Med, Boston, MA 02115 USA	Tufts University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Levitt, JM (corresponding author), Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel.	Irene.Georgakoudi@tufts.edu		Munger, Karl/0000-0003-3288-9935	American Cancer Society [RSG-09-174-01-CCE]; NATIONAL CANCER INSTITUTE [K01CA143010] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by American Cancer Society Research Scholar grant RSG-09-174-01-CCE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahammer H, 2001, FRACTALS, V9, P61, DOI 10.1142/S0218348X01000488; Akgul B, 2007, EXP DERMATOL, V16, P590, DOI 10.1111/j.1600-0625.2007.00569.x; ASSELINEAU D, 1986, J INVEST DERMATOL, V86, P181, DOI 10.1111/1523-1747.ep12284237; AVIDOR Y, 1962, J BIOL CHEM, V237, P2377; Carrilho C, 2004, HUM PATHOL, V35, P546, DOI 10.1016/j.humpath.2004.01.021; CHANCE B, 1989, J APPL CARDIOL, V4, P207; CHANCE B, 1979, J BIOL CHEM, V254, P4764; Chang SK, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2187979; Coffin CS, 2006, MODERN PATHOL, V19, P832, DOI 10.1038/modpathol.3800605; Cokkinides V, 2007, CANC PREVENTION EARL; CREEK KE, 1995, ADV EXP MED BIOL, V375, P117; Cross SS, 1997, J PATHOL, V182, P1; de Solorzano CO, 1999, J MICROSC-OXFORD, V193, P212, DOI 10.1046/j.1365-2818.1999.00463.x; Dey P, 2005, ANAL QUANT CYTOL, V27, P284; Drezek R, 2001, PHOTOCHEM PHOTOBIOL, V73, P636, DOI 10.1562/0031-8655(2001)073<0636:AMOFCT>2.0.CO;2; Einstein AJ, 1998, PHYS REV LETT, V80, P397, DOI 10.1103/PhysRevLett.80.397; Garcia M, 2007, GLOBAL CANC FACTS FI; Georgakoudi I, 2002, AM J OBSTET GYNECOL, V186, P374, DOI 10.1067/mob.2002.121075; Goutzanis L, 2008, ORAL ONCOL, V44, P345, DOI 10.1016/j.oraloncology.2007.04.005; Huang SH, 2002, BIOPHYS J, V82, P2811, DOI 10.1016/S0006-3495(02)75621-X; Jones DL, 1997, GENE DEV, V11, P2101, DOI 10.1101/gad.11.16.2101; Kirkpatrick ND, 2005, PHOTOCHEM PHOTOBIOL, V81, P125, DOI 10.1562/2004-08-09-RA-267.1; LANDINI G, 1993, ANAL QUANT CYTOL, V15, P144; Levitt JM, 2007, OPT LETT, V32, P3305, DOI 10.1364/OL.32.003305; Levitt JM, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2401149; Li LZ, 2009, P NATL ACAD SCI USA, V106, P6608, DOI 10.1073/pnas.0901807106; Lin G, 2007, CYTOM PART A, V71A, P724, DOI 10.1002/cyto.a.20430; Luck BL, 2005, IEEE T IMAGE PROCESS, V14, P1265, DOI 10.1109/TIP.2005.852460; Maddox P, 1999, J CLIN PATHOL, V52, P41, DOI 10.1136/jcp.52.1.41; Mandelbrot B., 2000, FRACTAL GEOMETRY NAT; MCCANCE DJ, 1988, P NATL ACAD SCI USA, V85, P7169, DOI 10.1073/pnas.85.19.7169; Meyers C, 1997, J VIROL, V71, P7381, DOI 10.1128/JVI.71.10.7381-7386.1997; Moreno-Sanchez R, 2007, FEBS J, V274, P1393, DOI 10.1111/j.1742-4658.2007.05686.x; MUELLER MG, 2001, MULTIEXCITATION FLUO, P114; Mujat C, 2008, INT J CANCER, V122, P363, DOI 10.1002/ijc.23120; Munoz N, 2004, INT J CANCER, V111, P278, DOI 10.1002/ijc.20244; Oda D, 1996, EXP CELL RES, V226, P164, DOI 10.1006/excr.1996.0215; Palero JA, 2006, OPT EXPRESS, V14, P4395, DOI 10.1364/OE.14.004395; Palero JA, 2008, PHOTOCH PHOTOBIO SCI, V7, P1422, DOI 10.1039/b808776h; Pavlova I, 2003, PHOTOCHEM PHOTOBIOL, V77, P550, DOI 10.1562/0031-8655(2003)077<0550:MABOON>2.0.CO;2; Pena AM, 2005, OPT EXPRESS, V13, P6268, DOI 10.1364/OPEX.13.006268; PIRISI L, 1987, J VIROL, V61, P1061, DOI 10.1128/JVI.61.4.1061-1066.1987; Pohlman S, 1996, MED PHYS, V23, P1337, DOI 10.1118/1.597707; Rajadhyaksha M, 1999, J INVEST DERMATOL, V113, P293, DOI 10.1046/j.1523-1747.1999.00690.x; RAMANUJAM N, 1994, P NATL ACAD SCI USA, V91, P10193, DOI 10.1073/pnas.91.21.10193; Rangayyan RM, 2007, J DIGIT IMAGING, V20, P223, DOI 10.1007/s10278-006-0860-9; Rice WL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010075; Rocheleau JV, 2004, J BIOL CHEM, V279, P31780, DOI 10.1074/jbc.M314005200; Schmitt JM, 1996, OPT LETT, V21, P1310, DOI 10.1364/OL.21.001310; Sedivy R, 1999, GYNECOL ONCOL, V75, P78, DOI 10.1006/gyno.1999.5516; Simeonov R, 2006, VET CLIN PATH, V35, P446, DOI 10.1111/j.1939-165X.2006.tb00162.x; Skala MC, 2007, P NATL ACAD SCI USA, V104, P19494, DOI 10.1073/pnas.0708425104; SMEDTS F, 1993, AM J PATHOL, V142, P403; SMEDTS F, 1992, AM J PATHOL, V141, P497; Subramanian H, 2009, CANCER RES, V69, P5357, DOI 10.1158/0008-5472.CAN-08-3895; THOMPSON D, 1993, ANAL QUANT CYTOL, V15, P236; Tian-Gang L, 2007, COMPUT MED IMAG GRAP, V31, P665, DOI 10.1016/j.compmedimag.2007.08.002; Wan F, 2008, INT J CANCER, V123, P32, DOI 10.1002/ijc.23463; Wu YC, 2006, OPT LETT, V31, P1833, DOI 10.1364/OL.31.001833; Wu YC, 2005, OPT LETT, V30, P3045, DOI 10.1364/OL.30.003045; Wu YC, 2005, OPT EXPRESS, V13, P382, DOI 10.1364/OPEX.13.000382; Wu YC, 2004, OPT EXPRESS, V12, P3218, DOI 10.1364/OPEX.12.003218; XIAO J, 1994, ANAL QUANT CYTOL, V16, P240; Zhuo SM, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3505762	64	32	34	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2011	6	9							e24765	10.1371/journal.pone.0024765	http://dx.doi.org/10.1371/journal.pone.0024765			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CN	21931846	gold, Green Published, Green Submitted			2022-12-25	WOS:000294803100066
J	Wang, Y; Wang, S; Gao, YS; Chen, Z; Zhou, HM; Yan, YB				Wang, Yin; Wang, Sha; Gao, Yan-Song; Chen, Zhe; Zhou, Hai-Meng; Yan, Yong-Bin			Dissimilarity in the Folding of Human Cytosolic Creatine Kinase Isoenzymes	PLOS ONE			English	Article							GUANIDINE-HYDROCHLORIDE; QUATERNARY STRUCTURE; CRYSTAL-STRUCTURE; SKELETAL-MUSCLE; STABILITY; BINDING; UREA; FLUORESCENCE; EQUILIBRIUM; PATHWAY	Creatine kinase (CK, EC 2.7.3.2) plays a key role in the energy homeostasis of excitable cells. The cytosolic human CK isoenzymes exist as homodimers (HMCK and HBCK) or a heterodimer (MBCK) formed by the muscle CK subunit (M) and/or brain CK subunit (B) with highly conserved three-dimensional structures composed of a small N-terminal domain (NTD) and a large C-terminal domain (CTD). The isoforms of CK provide a novel system to investigate the sequence/structural determinants of multimeric/multidomain protein folding. In this research, the role of NTD and CTD as well as the domain interactions in CK folding was investigated by comparing the equilibrium and kinetic folding parameters of HMCK, HBCK, MBCK and two domain-swapped chimeric forms (BnMc and MnBc). Spectroscopic results indicated that the five proteins had distinct structural features depending on the domain organizations. MBCK BnMc had the smallest CD signals and the lowest stability against guanidine chloride-induced denaturation. During the biphasic kinetic refolding, three proteins (HMCK, BnMc and MnBc), which contained either the NTD or CTD of the M subunit and similar microenvironments of the Trp fluorophores, refolded about 10-fold faster than HBCK for both the fast and slow phase. The fast folding of these three proteins led to an accumulation of the aggregation-prone intermediate and slowed down the reactivation rate thereby during the kinetic refolding. Our results suggested that the intra-and inter-subunit domain interactions modified the behavior of kinetic refolding. The alternation of domain interactions based on isoenzymes also provides a valuable strategy to improve the properties of multidomain enzymes in biotechnology.	[Wang, Yin; Wang, Sha; Gao, Yan-Song; Chen, Zhe; Yan, Yong-Bin] Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Sch Life Sci, Beijing 100084, Peoples R China; [Wang, Yin; Gao, Yan-Song; Chen, Zhe; Zhou, Hai-Meng] Tsinghua Univ, Prot Sci Lab, Minist Educ, Sch Life Sci, Beijing 100084, Peoples R China; [Zhou, Hai-Meng] Tsinghua Univ, Zhejiang Prov Key Lab Appl Enzymol, Yangtze Delta Reg Inst, Hangzhou, Zhejiang, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University	Wang, Y (corresponding author), Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Sch Life Sci, Beijing 100084, Peoples R China.	ybyan@tsinghua.edu.cn	Yan, Yong-Bin/A-4282-2008; Chen, Zhe/E-4278-2015; Chen, Zhe/H-1417-2016	Yan, Yong-Bin/0000-0002-8565-3558; Chen, Zhe/0000-0002-8209-0999; 	National Key Basic Research and Development (973) Program of China [2010CB912402, 2007CB914401]; National Natural Science Foundation of China [30970635]	National Key Basic Research and Development (973) Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by funds from the National Key Basic Research and Development (973) Program of China (2010CB912402 and 2007CB914401) and the National Natural Science Foundation of China (No. 30970635). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An Y, 2009, MOL IMMUNOL, V46, P2666, DOI 10.1016/j.molimm.2009.04.001; Bong SM, 2008, FEBS LETT, V582, P3959, DOI 10.1016/j.febslet.2008.10.039; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burstein EA, 2001, BIOPHYS J, V81, P1699, DOI 10.1016/S0006-3495(01)75823-7; Bushmarina NA, 2001, CHEMBIOCHEM, V2, P813, DOI 10.1002/1439-7633(20011105)2:11<813::AID-CBIC813>3.0.CO;2-W; Chen LH, 2000, J PROTEIN CHEM, V19, P59, DOI 10.1023/A:1007047026691; Chen Z, 2011, BIOCHEM J, V436, P437, DOI 10.1042/BJ20102007; COUTHON F, 1995, EUR J BIOCHEM, V234, P160, DOI 10.1111/j.1432-1033.1995.160_c.x; Eder M, 1999, PROTEIN SCI, V8, P2258; Fan YX, 1998, PROTEIN SCI, V7, P2631, DOI 10.1002/pro.5560071217; Feng S, 2007, INT J BIOCHEM CELL B, V39, P392, DOI 10.1016/j.biocel.2006.09.004; Gao YS, 2010, INT J MOL SCI, V11, P2584, DOI 10.3390/ijms11072584; Gao YS, 2010, INT J BIOL MACROMOL, V47, P27, DOI 10.1016/j.ijbiomac.2010.03.025; He HW, 2007, INT J BIOCHEM CELL B, V39, P1816, DOI 10.1016/j.biocel.2007.04.028; He HW, 2005, BIOPHYS J, V89, P2650, DOI 10.1529/biophysj.105.066142; Hornemann T, 2000, J CELL BIOL, V149, P1225, DOI 10.1083/jcb.149.6.1225; Jaenicke R, 1999, PROG BIOPHYS MOL BIO, V71, P155, DOI 10.1016/S0079-6107(98)00032-7; Kuum M, 2009, CARDIOVASC RES, V83, P89, DOI 10.1093/cvr/cvp125; Kuznetsova IM, 2002, BBA-PROTEIN STRUCT M, V1596, P138, DOI 10.1016/S0167-4838(02)00212-1; Leydier C, 1998, BIOCHEMISTRY-US, V37, P17579, DOI 10.1021/bi981828p; Li XH, 2011, INT J BIOL MACROMOL, V48, P239, DOI 10.1016/j.ijbiomac.2010.09.018; LILIE H, 1995, J MOL BIOL, V248, P190, DOI 10.1006/jmbi.1995.0211; Liu YM, 2009, INT J BIOL MACROMOL, V44, P271, DOI 10.1016/j.ijbiomac.2008.12.016; McLeish MJ, 2005, CRIT REV BIOCHEM MOL, V40, P1, DOI 10.1080/10409230590918577; MORRIS GE, 1987, BIOCHEM J, V248, P53, DOI 10.1042/bj2480053; Park YD, 2001, BIOCHEM CELL BIOL, V79, P479, DOI 10.1139/bcb-79-4-479; Park YD, 2001, J PROTEIN CHEM, V20, P67, DOI 10.1023/A:1011046814606; Perraut C, 1998, PROTEINS, V32, P43, DOI 10.1002/(SICI)1097-0134(19980701)32:1<43::AID-PROT6>3.0.CO;2-F; PICKERING L, 1985, P NATL ACAD SCI USA, V82, P2310, DOI 10.1073/pnas.82.8.2310; Povarova OI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015035; PRICE NC, 1982, BIOCHEM J, V201, P171, DOI 10.1042/bj2010171; Rao JK, 1998, FEBS LETT, V439, P133; Shen YQ, 2001, ACTA CRYSTALLOGR D, V57, P1196, DOI 10.1107/S0907444901007703; Stolz M, 1998, J CELL SCI, V111, P1207; Streijger F, 2009, PHYSIOL BEHAV, V97, P76, DOI 10.1016/j.physbeh.2009.02.003; TUROVEROV KK, 1976, FEBS LETT, V62, P4, DOI 10.1016/0014-5793(76)80003-8; WALLIMANN T, 1994, MOL CELL BIOCHEM, V133, P193, DOI 10.1007/BF01267955; WALLIMANN T, 1992, BIOCHEM J, V281, P21, DOI 10.1042/bj2810021; WALLIMANN T, 1977, J CELL BIOL, V75, P297, DOI 10.1083/jcb.75.2.297; Watts DC, 1973, CREATINE KINASE ADEN, P383; YAO QZ, 1982, SCI SIN B-CHEM B A M, V25, P1296; Zhang YF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005000; Zhang YL, 1998, BIOCHEM BIOPH RES CO, V246, P609, DOI 10.1006/bbrc.1998.8673; Zhao TJ, 2005, J BIOL CHEM, V280, P13470, DOI 10.1074/jbc.M413882200; Zhao TJ, 2007, J BIOL CHEM, V282, P12022, DOI 10.1074/jbc.M610363200; Zhao TJ, 2006, FEBS LETT, V580, P3835, DOI 10.1016/j.febslet.2006.05.076; Zhao TJ, 2006, INT J BIOCHEM CELL B, V38, P1614, DOI 10.1016/j.biocel.2006.04.002; ZHOU HM, 1986, BIOCHIM BIOPHYS ACTA, V869, P69, DOI 10.1016/0167-4838(86)90311-0; Zhou JM, 1997, FEBS LETT, V415, P183, DOI 10.1016/S0014-5793(97)01120-4; Zhu L, 2001, BBA-PROTEIN STRUCT M, V1544, P320, DOI 10.1016/S0167-4838(00)00244-2	50	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2011	6	9							e24681	10.1371/journal.pone.0024681	http://dx.doi.org/10.1371/journal.pone.0024681			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CN	21931810	gold, Green Published, Green Submitted			2022-12-25	WOS:000294803100056
J	Balija, MBG; Griesinger, C; Herzig, A; Zweckstetter, M; Jackle, H				Balija, Madhu Babu Gajula; Griesinger, Christian; Herzig, Alf; Zweckstetter, Markus; Jaeckle, Herbert			Pre-Fibrillar alpha-Synuclein Mutants Cause Parkinson's Disease-Like Non-Motor Symptoms in Drosophila	PLOS ONE			English	Article							EXCESSIVE DAYTIME SLEEPINESS; TARGETED GENE-EXPRESSION; LOCOMOTOR-ACTIVITY; MUSHROOM BODIES; MELANOGASTER; PROTEIN; MODEL; DOPAMINE; CELL; INSIGHTS	Parkinson's disease (PD) is linked to the formation of insoluble fibrillar aggregates of the presynaptic protein alpha-Synuclein (alpha S) in neurons. The appearance of such aggregates coincides with severe motor deficits in human patients. These deficits are often preceded by non-motor symptoms such as sleep-related problems in the patients. PD-like motor deficits can be recapitulated in model organisms such as Drosophila melanogaster when alpha S is pan-neurally expressed. Interestingly, both these deficits are more severe when alpha S mutants with reduced aggregation properties are expressed in flies. This indicates that that alpha S aggregation is not the primary cause of the PD-like motor symptoms. Here we describe a model for PD in Drosophila which utilizes the targeted expression of alpha S mutants in a subset of dopadecarboxylase expressing serotonergic and dopaminergic (DA) neurons. Our results show that targeted expression of pre-fibrillar alpha S mutants not only recapitulates PD-like motor symptoms but also the preceding non-motor symptoms such as an abnormal sleep-like behavior, altered locomotor activity and abnormal circadian periodicity. Further, the results suggest that the observed non-motor symptoms in flies are caused by an early impairment of neuronal functions rather than by the loss of neurons due to cell death.	[Balija, Madhu Babu Gajula; Herzig, Alf; Jaeckle, Herbert] Max Planck Inst Biophys Chem, Abt Mol Entwicklungsbiol, Gottingen, Germany; [Griesinger, Christian; Zweckstetter, Markus] Max Planck Inst Biophys Chem, Abt NMR Basierte Strukturbiol, D-37077 Gottingen, Germany	Max Planck Society; Max Planck Society	Balija, MBG (corresponding author), Max Planck Inst Biophys Chem, Abt Mol Entwicklungsbiol, Gottingen, Germany.	hjaeckl@gwdg.de	G.B., Madhubabu/AAA-6191-2021	G.B., Madhubabu/0000-0003-2035-7819; Zweckstetter, Markus/0000-0002-2536-6581; Herzig, Alf/0000-0003-4246-4666	Max-Planck-Society	Max-Planck-Society(Max Planck Society)	Max-Planck-Society. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andretic R, 2000, P NATL ACAD SCI USA, V97, P1873, DOI 10.1073/pnas.97.4.1873; Arnulf I, 2008, CURR OPIN NEUROL, V21, P472, DOI 10.1097/WCO.0b013e328305044d; Baines RA, 2001, J NEUROSCI, V21, P1523, DOI 10.1523/JNEUROSCI.21-05-01523.2001; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chanana B, 2009, P NATL ACAD SCI USA, V106, P11984, DOI 10.1073/pnas.0901148106; Chaudhuri KR, 2009, LANCET NEUROL, V8, P464, DOI 10.1016/S1474-4422(09)70068-7; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Ebstein RP, 2010, NEURON, V65, P831, DOI 10.1016/j.neuron.2010.02.020; Factor S., 2002, PARKINSONS DIS DIAGN; Farrer MJ, 2006, NAT REV GENET, V7, P306, DOI 10.1038/nrg1831; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; GEORGE JM, 1995, NEURON, V15, P361, DOI 10.1016/0896-6273(95)90040-3; Harbison ST, 2009, TRENDS GENET, V25, P262, DOI 10.1016/j.tig.2009.04.003; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; Hirsh J, 2010, CURR BIOL, V20, P209, DOI 10.1016/j.cub.2009.11.037; Ho KS, 2005, METHOD ENZYMOL, V393, P772, DOI 10.1016/S0076-6879(05)93041-3; HOCH M, 1994, DEVELOPMENT, V120, P3439; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; Joiner WJ, 2006, NATURE, V441, P757, DOI 10.1038/nature04811; Karpinar DP, 2009, EMBO J, V28, P3256, DOI 10.1038/emboj.2009.257; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Kume K, 2005, J NEUROSCI, V25, P7377, DOI 10.1523/JNEUROSCI.2048-05.2005; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Li H, 2000, CURR BIOL, V10, P211, DOI 10.1016/S0960-9822(00)00340-7; Maries E, 2003, NAT REV NEUROSCI, V4, P727, DOI 10.1038/nrn1199; Pitman JL, 2006, NATURE, V441, P753, DOI 10.1038/nature04739; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rosato E, 2006, NAT PROTOC, V1, P559, DOI 10.1038/nprot.2006.79; Rye DB, 2006, CURR NEUROL NEUROSCI, V6, P169, DOI 10.1007/s11910-996-0041-8; Schapira AH, 2004, NEUROLOGY, V63, pS24, DOI 10.1212/WNL.63.8_suppl_3.S24; Seugnet L, 2009, SLEEP, V32, P984, DOI 10.1093/sleep/32.8.984; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Suh J, 2007, NEURON, V55, P435, DOI 10.1016/j.neuron.2007.06.038; White BH, 2001, NEURON, V31, P699, DOI 10.1016/S0896-6273(01)00415-9; Whitehead DL, 2008, MOVEMENT DISORD, V23, P1137, DOI 10.1002/mds.22057; Zimmerman JE, 2008, TRENDS NEUROSCI, V31, P371, DOI 10.1016/j.tins.2008.05.001	40	31	31	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e24701	10.1371/journal.pone.0024701	http://dx.doi.org/10.1371/journal.pone.0024701			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CK	21931820	Green Published, gold, Green Submitted			2022-12-25	WOS:000294802800085
J	Hickford, MJH; Schiel, DR				Hickford, Michael J. H.; Schiel, David R.			Synergistic Interactions within Disturbed Habitats between Temperature, Relative Humidity and UVB Radiation on Egg Survival in a Diadromous Fish	PLOS ONE			English	Article							ULTRAVIOLET-RADIATION; GALAXIAS-MACULATUS; NEW-ZEALAND; JUVENILE GALAXIAS; LARVAE; MORTALITY; EMBRYOS; PISCES; MASSES; RISK	Anthropogenic impacts, including urbanization, deforestation, farming, and livestock grazing have altered riparian margins worldwide. One effect of changes to riparian vegetation is that the ground-level light, temperature, and humidity environment has also been altered. Galaxias maculatus, one of the most widely distributed fishes of the southern hemisphere, lays eggs almost exclusively beneath riparian vegetation in tidally influenced reaches of rivers. We hypothesized that the survival of these eggs is greatly affected by the micro-environment afforded by vegetation, particularly relating to temperature, humidity and UVB radiation. We experimentally reduced riparian vegetation height and altered shading characteristics, tracked egg survival, and used small ground-level temperature, humidity and UVB sensors to relate survival to ground-level effects around egg masses. The ground-level physical environment was markedly different from the surrounding ambient conditions. Tall dense riparian vegetation modified ambient conditions to produce a buffered temperature regime with constant high relative humidity, generally above 90%, and negligible UVB radiation at ground-level. Where vegetation height was reduced, frequent high temperatures, low humidity, and high UVB irradiances reduced egg survival by up to 95%. Temperature effects on egg survival were probably indirect, through reduced humidity, because developing eggs are known to survive in a wide range of temperatures. In this study, it was remarkable how such small variations in relatively small sites could have such a large effect on egg survival. It appears that modifications to riparian vegetation and the associated changes in the physical conditions of egg laying sites are major mechanisms affecting egg survival. The impacts associated with vegetational changes through human-induced disturbances are complex yet potentially devastating. These effects are particularly important because they affect a very small portion of habitat that is required to complete the life history of a species, despite the wide distribution of adults and juveniles across aquatic and marine environments.	[Hickford, Michael J. H.; Schiel, David R.] Univ Canterbury, Marine Ecol Res Grp, Sch Biol Sci, Christchurch 1, New Zealand	University of Canterbury	Hickford, MJH (corresponding author), Univ Canterbury, Marine Ecol Res Grp, Sch Biol Sci, Christchurch 1, New Zealand.	michael.hickford@canterbury.ac.nz		Hickford, Michael/0000-0002-0275-6632	New Zealand Ministry of Science and Innovation (formerly Foundation for Research, Science and Technology) [C01X1002]	New Zealand Ministry of Science and Innovation (formerly Foundation for Research, Science and Technology)	This work was funded through a grant from the New Zealand Ministry of Science and Innovation (formerly Foundation for Research, Science and Technology; http://www.frst.govt.nz/) to the National Institute of Water and Atmospheric Research (C01X1002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M. J., 2002, DISTLM V 2 FORTRAN C; Anderson MJ, 2008, PERMANOVA PRIMER GUI; Bais A F, 2007, SCI ASSESSMENT OZONE; Baker CF, 2004, WATER ATMOS, V12, P18; Baker CF, 2006, J ROY SOC NEW ZEAL, V36, P143, DOI 10.1080/03014223.2006.9517806; Battini M, 2000, FRESHWATER BIOL, V44, P547, DOI 10.1046/j.1365-2427.2000.00600.x; Benzie V., 1968, Proceedings of the New Zealand Ecological Society, VNo. 15, P31; BENZIE V, 1968, New Zealand Journal of Marine and Freshwater Research, V2, P606; Browman HI, 2003, PHOTOCHEM PHOTOBIOL, V77, P397, DOI 10.1562/0031-8655(2003)077<0397:UNDDIT>2.0.CO;2; Finn RN, 2007, AQUAT TOXICOL, V81, P337, DOI 10.1016/j.aquatox.2006.12.021; Fukunishi Y, 2010, J FISH BIOL, V76, P734, DOI 10.1111/j.1095-8649.2009.02517.x; Geiger R., 2003, CLIMATE NEAR GROUND; Hader DP, 2007, PHOTOCH PHOTOBIO SCI, V6, P267, DOI 10.1039/b700020k; Harzmeyer JR, 2006, EFFECTS SALINITY TEM; Hickford MJH, 2011, OECOLOGIA, V166, P131, DOI 10.1007/s00442-010-1834-7; Hickford MJH, 2010, J EXP MAR BIOL ECOL, V385, P66, DOI 10.1016/j.jembe.2010.01.010; Hinrichs M. A., 1925, Journal of Morphology Philadelphia, V41, P239, DOI 10.1002/jmor.1050410111; Huff DD, 2004, T AM FISH SOC, V133, P718, DOI 10.1577/T03-048.1; Kennish MJ, 2002, ENVIRON CONSERV, V29, P78, DOI 10.1017/S0376892902000061; Marco A, 2001, J HERPETOL, V35, P510, DOI 10.2307/1565973; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:fmmtcd]2.0.co;2; McDowall RM, 2006, FISH FISH, V7, P153, DOI 10.1111/j.1467-2979.2006.00217.x; McDOWALL R. M., 1965, NEW ZEAL J SCI, V8, P285; MCDOWALL R M, 1980, New Zealand Fisheries Research Division Fisheries Research Bulletin, P1; McDowall R.M., 1968, NZ MAR DEP FISH RES, V2, P1; MCDOWALL RM, 1994, B MAR SCI, V54, P385; MCDOWALL RM, 1990, NZ FRESHWATER FISHES; McKenzie R, 1999, SCIENCE, V285, P1709, DOI 10.1126/science.285.5434.1709; McKenzie RL, 2010, UV RADIATION IN GLOBAL CLIMATE CHANGE, P21, DOI 10.1007/978-3-642-03313-1_2; McKenzie RL, 2003, PHOTOCH PHOTOBIO SCI, V2, P5, DOI 10.1039/b211155c; MITCHELL CP, 1989, NEW ZEAL J MAR FRESH, V23, P325, DOI 10.1080/00288330.1989.9516369; Mitchell CP, 1992, NZ FRESHW FISH MISC, V127, P1; NEHLSEN W, 1991, FISHERIES, V16, P4, DOI 10.1577/1548-8446(1991)016&lt;0004:PSATCS&gt;2.0.CO;2; Olson MH, 2006, ECOL APPL, V16, P328, DOI 10.1890/05-0287; ROWE DK, 1992, NEW ZEAL J MAR FRESH, V26, P219, DOI 10.1080/00288330.1992.9516517; Russell J, 2009, MAR BIOL, V156, P579, DOI 10.1007/s00227-008-1109-6; Taylor M.J., 2002, Science for Conservation (Wellington), V188, P1; Taylor MJ, 1996, WATER ATMOS, V4, P23; TERNER C, 1968, COMP BIOCHEM PHYSIOL, V25, P989, DOI 10.1016/0010-406X(68)90586-0; Underwood A.J., 1981, Oceanography and Marine Biology an Annual Review, V19, P513; Vredenburg VT, 2010, COPEIA, P502, DOI 10.1643/CH-09-101; Wiegand MD, 2004, J FISH BIOL, V64, P1242, DOI 10.1111/j.0022-1112.2004.00388.x; Wraith J, 2006, J CHEM ECOL, V32, P993, DOI 10.1007/s10886-006-9054-7; Yabu T, 2003, FISHERIES SCI, V69, P1218, DOI 10.1111/j.0919-9268.2003.00748.x	44	14	14	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e24318	10.1371/journal.pone.0024318	http://dx.doi.org/10.1371/journal.pone.0024318			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CK	21931680	Green Published, Green Submitted, gold			2022-12-25	WOS:000294802800039
J	Mahajan, A; Tabassum, R; Chavali, S; Dwivedi, OP; Chauhan, G; Ghosh, S; Tandon, N; Bharadwaj, D				Mahajan, Anubha; Tabassum, Rubina; Chavali, Sreenivas; Dwivedi, Om Prakash; Chauhan, Ganesh; Ghosh, Saurabh; Tandon, Nikhil; Bharadwaj, Dwaipayan			Common Variants in CRP and LEPR Influence High Sensitivity C-Reactive Protein Levels in North Indians	PLOS ONE			English	Article							GENE; POLYMORPHISMS; RISK; INTERLEUKIN-6; PROMOTER; DISEASE; ASSOCIATION; VARIABILITY; POPULATION; HEALTH	Background: High sensitivity C-reactive protein (hsCRP) levels are shown to be influenced by genetic variants in Europeans; however, little is explored in Indian population. Methods: Herein, we comprehensively evaluated association of all previously reported genetic determinants of hsCRP levels, including 18 cis (proximal to CRP gene) and 73 trans-acting (distal to CRP gene) variants in 4,200 North Indians of Indo-European ethnicity. First, we evaluated association of 91 variants from 12 candidate loci with hsCRP levels in 2,115 North Indians (1,042 non-diabetic subjects and 1,073 patients with type 2 diabetes). Then, cis and trans-acting variants contributing maximally to hsCRP level variation were further replicated in an independent 2,085 North Indians (1,047 patients with type 2 diabetes and 1,038 non-diabetic subjects). Results: We found association of 12 variants from CRP, LEPR, IL1A, IL6, and IL6R with hsCRP levels in non-diabetic subjects. However, only rs3093059-CRP [beta = 0.33, P = 9.6x10(-5)] and the haplotype harboring rs3093059 risk allele [beta = 0.32 mu g/mL, P = 1.4x10(-4)/P-perm = 9.0x10(-4)] retained significance after correcting for multiple testing. The cis-acting variant rs3093059-CRP had maximum contribution to the variance in hsCRP levels (1.14%). Among, trans-acting variants, rs1892534-LEPR was observed to contribute maximally to hsCRP level variance (0.59%). Associations of rs3093059-CRP and rs1892534-LEPR were confirmed by replication and attained higher significance after meta-analysis [beta(meta) = 0.26/0.22; P-meta = 4.3x10(-7)/7.4x10(-3) and beta(meta) = -0.15/-0.12; P-meta = 2.0x10(-6)/1.6x10(-6) for rs3093059 and rs1892534, respectively in non-diabetic subjects and all subjects taken together]. Conclusion: In conclusion, we identified rs3093059 in CRP and rs1892534 in LEPR as major cis and trans-acting contributor respectively, to the variance in hsCRP levels in North Indian population.	[Mahajan, Anubha; Tabassum, Rubina; Chavali, Sreenivas; Dwivedi, Om Prakash; Chauhan, Ganesh; Bharadwaj, Dwaipayan] CSIR Inst Genom & Integrat Biol, Genom & Mol Med Unit, Delhi, India; [Ghosh, Saurabh] Indian Stat Inst, Human Genet Unit, Kolkata, India; [Tandon, Nikhil] All India Inst Med Sci, Dept Endocrinol, New Delhi, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Indian Statistical Institute; Indian Statistical Institute Kolkata; All India Institute of Medical Sciences (AIIMS) New Delhi	Mahajan, A (corresponding author), CSIR Inst Genom & Integrat Biol, Genom & Mol Med Unit, Delhi, India.	nikhil_tandon@hotmail.com; db@igib.res.in	CHAUHAN, GANESH/AAI-5110-2021	Mahajan, Anubha/0000-0001-5585-3420; Chauhan, Ganesh/0000-0002-8564-5021; Tabassum, Rubina/0000-0002-3120-3041; Bharadwaj, Dwaipayan/0000-0001-5268-8482	Diabetes mellitus-New drug discovery R&D, molecular mechanisms and genetic & epidemiological factors [NWP0032-12]; Council of Scientific and Industrial Research (CSIR), Government of India	Diabetes mellitus-New drug discovery R&D, molecular mechanisms and genetic & epidemiological factors; Council of Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by 'Diabetes mellitus-New drug discovery R&D, molecular mechanisms and genetic & epidemiological factors' (NWP0032-12) funded by Council of Scientific and Industrial Research (CSIR), Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brahmachari SK, 2008, J GENET, V87, P3; Carlson CS, 2005, AM J HUM GENET, V77, P64, DOI 10.1086/431366; Crawford DC, 2006, CIRCULATION, V114, P2458, DOI 10.1161/CIRCULATIONAHA.106.615740; Dehghan A, 2011, CIRCULATION, V123, P731, DOI 10.1161/CIRCULATIONAHA.110.948570; Elliott P, 2009, JAMA-J AM MED ASSOC, V302, P37, DOI 10.1001/jama.2009.954; Gauderman WJ, 2003, GENET EPIDEMIOL, V25, P327, DOI 10.1002/gepi.10262; Kathiresan S, 2006, CIRCULATION, V113, P1415, DOI 10.1161/CIRCULATIONAHA.105.591271; MacGregor AJ, 2004, CLIN CHEM, V50, P130, DOI 10.1373/clinchem.2003.028258; Mahajan A, 2010, J MOL MED, V88, P515, DOI 10.1007/s00109-010-0594-5; Mahajan A, 2009, J CLIN ENDOCR METAB, V94, P2123, DOI 10.1210/jc.2008-2754; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qi L, 2009, DIABETES, V58, P275, DOI 10.2337/db08-0968; Reiner AP, 2008, AM J HUM GENET, V82, P1193, DOI 10.1016/j.ajhg.2008.03.017; Ridker PM, 2008, AM J HUM GENET, V82, P1185, DOI 10.1016/j.ajhg.2008.03.015; Ridker PM, 2009, CLIN CHEM, V55, P209, DOI 10.1373/clinchem.2008.119214; Sainz J, 2008, J CLIN IMMUNOL, V28, P473, DOI 10.1007/s10875-008-9197-0; Shen R, 2005, MUTAT RES-FUND MOL M, V573, P70, DOI 10.1016/j.mrfmmm.2004.07.022; Szalai AJ, 2005, J MOL MED, V83, P440, DOI 10.1007/s00109-005-0658-0; Tabassum R, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-35; Vickers MA, 2002, CARDIOVASC RES, V53, P1029, DOI 10.1016/S0008-6363(01)00534-X; Wu Y, 2011, INFLAMMATION; Zhang YY, 2007, ATHEROSCLEROSIS, V191, P121, DOI 10.1016/j.atherosclerosis.2006.02.043	23	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e24645	10.1371/journal.pone.0024645	http://dx.doi.org/10.1371/journal.pone.0024645			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CK	21931794	Green Submitted, gold, Green Published			2022-12-25	WOS:000294802800081
J	Savory, FR; Sait, SM; Hope, IA				Savory, Fiona R.; Sait, Steven M.; Hope, Ian A.			DAF-16 and Delta(9) Desaturase Genes Promote Cold Tolerance in Long-Lived Caenorhabditis elegans age-1 Mutants	PLOS ONE			English	Article							MEMBRANE-LIPID-COMPOSITION; LIFE-SPAN; HEAT-SHOCK; C-ELEGANS; OVERWINTERING LARVAE; STRESS RESISTANCE; PHASE-TRANSITIONS; RECEPTOR HOMOLOG; OXIDATIVE STRESS; LONGEVITY	In Caenorhabditis elegans, mutants of the conserved insulin/IGF-1 signalling (IIS) pathway are long-lived and stress resistant due to the altered expression of DAF-16 target genes such as those involved in cellular defence and metabolism. The three Delta(9) desaturase genes, fat-5, fat-6 and fat-7, are included amongst these DAF-16 targets, and it is well established that Delta(9) desaturase enzymes play an important role in survival at low temperatures. However, no assessment of cold tolerance has previously been reported for IIS mutants. We demonstrate that long-lived age-1(hx546) mutants are remarkably resilient to low temperature stress relative to wild type worms, and that this is dependent upon daf-16. We also show that cold tolerance following direct transfer to low temperatures is increased in wild type worms during the facultative, daf-16 dependent, dauer stage. Although the cold tolerant phenotype of age-1(hx546) mutants is predominantly due to the Delta(9) desaturase genes, additional transcriptional targets of DAF-16 are also involved. Surprisingly, survival of wild type adults following a rapid temperature decline is not dependent upon functional daf-16, and cellular distributions of a DAF-16::GFP fusion protein indicate that DAF-16 is not activated during low temperature stress. This suggests that cold-induced physiological defences are not specifically regulated by the IIS pathway and DAF-16, but expression of DAF-16 target genes in IIS mutants and dauers is sufficient to promote cross tolerance to low temperatures in addition to other forms of stress.	[Savory, Fiona R.; Sait, Steven M.; Hope, Ian A.] Univ Leeds, Inst Integrat & Comparat Biol, Fac Biol Sci, Leeds, W Yorkshire, England	University of Leeds	Savory, FR (corresponding author), Univ Leeds, Inst Integrat & Comparat Biol, Fac Biol Sci, Leeds, W Yorkshire, England.	i.a.hope@leeds.ac.uk	Hope, Ian/M-4186-2018	Hope, Ian/0000-0002-8990-3163	White Rose University	White Rose University	This work was supported by a White Rose University Consortium studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 2013, CATEGORICAL DATA ANA, V3rd; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Bale JS, 2010, J EXP BIOL, V213, P980, DOI 10.1242/jeb.037911; Barsyte D, 2001, FASEB J, V15, P627, DOI 10.1096/fj.99-0966com; Benoit JB, 2009, COMP BIOCHEM PHYS A, V152, P518, DOI 10.1016/j.cbpa.2008.12.009; BOGGS JM, 1985, BIOCHIM BIOPHYS ACTA, V816, P221, DOI 10.1016/0005-2736(85)90489-4; Bonafe M, 2003, J CLIN ENDOCR METAB, V88, P3299, DOI 10.1210/jc.2002-021810; BRESLOW NE, 1993, J AM STAT ASSOC, V88, P9, DOI 10.1080/01621459.1993.10594284; Brock TJ, 2007, GENETICS, V176, P865, DOI 10.1534/genetics.107.071860; Brock TJ, 2006, PLOS GENET, V2, P997, DOI 10.1371/journal.pgen.0020108; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; COSSINS AR, 1994, PORTL PR P, P63; CROWE JH, 1992, ANNU REV PHYSIOL, V54, P579, DOI 10.1146/annurev.ph.54.030192.003051; Dai F, 2009, BIOL PLANTARUM, V53, P257, DOI 10.1007/s10535-009-0048-5; David RJ, 1998, J THERM BIOL, V23, P291, DOI 10.1016/S0306-4565(98)00020-5; Denlinger DL, 2002, ANNU REV ENTOMOL, V47, P93, DOI 10.1146/annurev.ento.47.091201.145137; DUSENBERY DB, 1980, J COMP PHYSIOL, V137, P353, DOI 10.1007/BF00657114; FRIEDMAN DB, 1988, J GERONTOL, V43, pB102, DOI 10.1093/geronj/43.4.B102; Garsin DA, 2003, SCIENCE, V300, P1921, DOI 10.1126/science.1080147; Gasparetti AL, 2003, J PHYSIOL-LONDON, V552, P149, DOI 10.1113/jphysiol.2003.050369; GOLDEN JW, 1984, DEV BIOL, V102, P368, DOI 10.1016/0012-1606(84)90201-X; Gracey AY, 2004, P NATL ACAD SCI USA, V101, P16970, DOI 10.1073/pnas.0403627101; HAZEL JR, 1995, ANNU REV PHYSIOL, V57, P19, DOI 10.1146/annurev.ph.57.030195.000315; Henderson ST, 2006, J GERONTOL A-BIOL, V61, P444, DOI 10.1093/gerona/61.5.444; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Honda Y, 2010, AGING CELL, V9, P558, DOI 10.1111/j.1474-9726.2010.00582.x; Horikawa M, 2009, BIOCHEM BIOPH RES CO, V390, P1402, DOI 10.1016/j.bbrc.2009.11.006; IshizakiNishizawa O, 1996, NAT BIOTECHNOL, V14, P1003, DOI 10.1038/nbt0896-1003; Jagdale GB, 2005, J PARASITOL, V91, P988, DOI 10.1645/GE-504R.1; Joanisse DR, 1996, J EXP BIOL, V199, P1483; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Khani A, 2007, EUR J ENTOMOL, V104, P385, DOI 10.14411/eje.2007.057; Kultz D, 2005, ANNU REV PHYSIOL, V67, P225, DOI 10.1146/annurev.physiol.67.040403.103635; Lamitina ST, 2005, AM J PHYSIOL-CELL PH, V288, pC467, DOI 10.1152/ajpcell.00451.2004; LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905; LEE RE, 1987, SCIENCE, V238, P1415, DOI 10.1126/science.238.4832.1415; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; LITHGOW GJ, 1994, J GERONTOL, V49, pB270, DOI 10.1093/geronj/49.6.B270; Luckinbill LS, 1998, J GERONTOL A-BIOL, V53, pB147, DOI 10.1093/gerona/53A.2.B147; LYONS JM, 1975, J NEMATOL, V7, P98; McElwee JJ, 2006, MECH AGEING DEV, V127, P458, DOI 10.1016/j.mad.2006.01.006; McElwee JJ, 2004, J BIOL CHEM, V279, P44533, DOI 10.1074/jbc.M406207200; Murakami S, 1996, GENETICS, V143, P1207; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Murray P, 2007, P NATL ACAD SCI USA, V104, P5489, DOI 10.1073/pnas.0609590104; Norry FM, 2002, J EVOLUTION BIOL, V15, P775, DOI 10.1046/j.1420-9101.2002.00438.x; Overgaard J, 2005, J INSECT PHYSIOL, V51, P1173, DOI 10.1016/j.jinsphys.2005.06.007; Pacheco A, 2009, MICROBIOL-SGM, V155, P2021, DOI 10.1099/mic.0.025981-0; R Development Core Team, 2010, R A LANG ENV STAT CO; Reis RJS, 2011, AGING-US, V3, P125, DOI 10.18632/aging.100275; Rinehart JP, 2007, P NATL ACAD SCI USA, V104, P11130, DOI 10.1073/pnas.0703538104; Schade B, 2004, MOL BIOL CELL, V15, P5492, DOI 10.1091/mbc.E04-03-0167; Schuster E, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.54; Scott BA, 2002, SCIENCE, V296, P2388, DOI 10.1126/science.1072302; Sim C, 2008, P NATL ACAD SCI USA, V105, P6777, DOI 10.1073/pnas.0802067105; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Tiku PE, 1996, SCIENCE, V271, P815, DOI 10.1126/science.271.5250.815; Torsoni MA, 2003, AM J PHYSIOL-ENDOC M, V285, pE216, DOI 10.1152/ajpendo.00031.2003; Troemel ER, 2006, PLOS GENET, V2, P1725, DOI 10.1371/journal.pgen.0020183; UEMURA M, 1995, PLANT PHYSIOL, V109, P15, DOI 10.1104/pp.109.1.15; Van Gilst MR, 2005, PLOS BIOL, V3, P301, DOI 10.1371/journal.pbio.0030053; van Heemst D, 2005, AGING CELL, V4, P79, DOI 10.1111/j.1474-9728.2005.00148.x; VANFLETEREN JR, 1993, BIOCHEM J, V292, P605, DOI 10.1042/bj2920605; WADA H, 1990, NATURE, V347, P200, DOI 10.1038/347200a0; Wang J, 2003, DEVELOPMENT, V130, P1621, DOI 10.1242/dev.00363; Watts JL, 2000, BIOCHEM BIOPH RES CO, V272, P263, DOI 10.1006/bbrc.2000.2772; Williams KD, 2006, P NATL ACAD SCI USA, V103, P15911, DOI 10.1073/pnas.0604592103; Wolf M, 2008, J CELL PHYSIOL, V214, P721, DOI 10.1002/jcp.21269; Yang FJ, 2006, NATURE, V442, P700, DOI 10.1038/nature04942	76	32	39	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e24550	10.1371/journal.pone.0024550	http://dx.doi.org/10.1371/journal.pone.0024550			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CK	21931751	Green Published, Green Submitted, gold			2022-12-25	WOS:000294802800065
J	Uh, HW; Eilers, PHC				Uh, Hae-Won; Eilers, Paul H. C.			Haplotype Estimation from Fuzzy Genotypes Using Penalized Likelihood	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; MAXIMUM-LIKELIHOOD; STATISTICAL-METHOD; INFERENCE; POPULATION; ALGORITHM; ASSOCIATION; FREQUENCIES; UNCERTAINTY	The Composite Link Model is a generalization of the generalized linear model in which expected values of observed counts are constructed as a sum of generalized linear components. When combined with penalized likelihood, it provides a powerful and elegant way to estimate haplotype probabilities from observed genotypes. Uncertain ("fuzzy") genotypes, like those resulting from AFLP scores, can be handled by adding an extra layer to the model. We describe the model and the estimation algorithm. We apply it to a data set of accurate human single nucleotide polymorphism (SNP) and to a data set of fuzzy tomato AFLP scores.	[Uh, Hae-Won] Leiden Univ Med Ctr, Dept Med Stat & Bioinformat, Leiden, Netherlands; [Eilers, Paul H. C.] Erasmus MC, Rotterdam, Netherlands; [Eilers, Paul H. C.] Ctr Biosyst Genom, Wageningen, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Erasmus University Rotterdam; Erasmus MC; Centre for BioSystems Genomics	Uh, HW (corresponding author), Leiden Univ Med Ctr, Dept Med Stat & Bioinformat, Leiden, Netherlands.	h.uh@lumc.nl		Uh, Hae-Won/0000-0003-4195-7872	Centre for BioSystems Genomics (CBSG), which is part of the Netherlands Genomics Initiative / Netherlands Organisation for Scientific Research	Centre for BioSystems Genomics (CBSG), which is part of the Netherlands Genomics Initiative / Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This project was co-financed by the Centre for BioSystems Genomics (CBSG), which is part of the Netherlands Genomics Initiative / Netherlands Organisation for Scientific Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, INFORM THEORY EXTENS; Ayers KL, 2008, BIOINFORMATICS, V24, P1596, DOI 10.1093/bioinformatics/btn236; CLAYTON D, SNPHAP PROGRAM ESTIM; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Hastie TJ., 1990, GEN ADDITIVE MODELS; HAWLEY ME, 1995, J HERED, V86, P409, DOI 10.1093/oxfordjournals.jhered.a111613; Kang HS, 2004, AM J HUM GENET, V74, P495, DOI 10.1086/382284; Lin S, 2002, AM J HUM GENET, V71, P1129, DOI 10.1086/344347; LONG JC, 1995, AM J HUM GENET, V56, P799; Marchini J, 2006, AM J HUM GENET, V78, P437, DOI 10.1086/500808; Mehta AM, 2007, GENE CHROMOSOME CANC, V46, P577, DOI 10.1002/gcc.20441; Niu TH, 2002, AM J HUM GENET, V70, P157, DOI 10.1086/338446; Qin ZHS, 2002, AM J HUM GENET, V71, P1242, DOI 10.1086/344207; Slager SL, 2001, AM J HUM GENET, V68, P1457, DOI 10.1086/320608; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Thompson R., 1981, Applied Statistics, V30, P125, DOI 10.2307/2346381; Uh HW, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-54; UH HW, 2008, P 23 INT WORKSH STAT; van Berloo R, 2008, THEOR APPL GENET, V117, P89, DOI 10.1007/s00122-008-0755-x; Zaykin DV, 2006, AM J HUM GENET, V78, P737, DOI 10.1086/503710	21	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e24219	10.1371/journal.pone.0024219	http://dx.doi.org/10.1371/journal.pone.0024219			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CK	21931662	gold, Green Published			2022-12-25	WOS:000294802800033
J	Baid, R; Scheinman, RI; Shinohara, T; Singh, DP; Kompella, UB				Baid, Rinku; Scheinman, Robert I.; Shinohara, Toshimichi; Singh, Dhirendra P.; Kompella, Uday B.			LEDGF(1-326) Decreases P23H and Wild Type Rhodopsin Aggregates and P23H Rhodopsin Mediated Cell Damage in Human Retinal Pigment Epithelial Cells	PLOS ONE			English	Article							DOMINANT RETINITIS-PIGMENTOSA; GROWTH-FACTOR; HEAT-SHOCK; HIV-1 INTEGRASE; LEDGF; DEGENERATION; MUTATIONS; EXPRESSION; PROTECTION; MECHANISM	Background: P23H rhodopsin, a mutant rhodopsin, is known to aggregate and cause retinal degeneration. However, its effects on retinal pigment epithelial (RPE) cells are unknown. The purpose of this study was to determine the effect of P23H rhodopsin in RPE cells and further assess whether LEDGF(1-326), a protein devoid of heat shock elements of LEDGF, a cell survival factor, reduces P23H rhodopsin aggregates and any associated cellular damage. Methods: ARPE-19 cells were transiently transfected/cotransfected with pLEDGF(1-326) and/or pWT-Rho (wild type)/pP23H-Rho. Rhodopsin mediated cellular damage and rescue by LEDGF(1-326) was assessed using cell viability, cell proliferation, and confocal microscopy assays. Rhodopsin monomers, oligomers, and their reduction in the presence of LEDGF(1-326) were quantified by western blot analysis. P23H rhodopsin mRNA levels in the presence and absence of LEDGF(1-326) was determined by real time quantitative PCR. Principal Findings: P23H rhodopsin reduced RPE cell viability and cell proliferation in a dose dependent manner, and disrupted the nuclear material. LEDGF(1-326) did not alter P23H rhodopsin mRNA levels, reduced its oligomers, and significantly increased RPE cell viability as well as proliferation, while reducing nuclear damage. WT rhodopsin formed oligomers, although to a smaller extent than P23H rhodopsin. Further, LEDGF(1-326) decreased WT rhodopsin aggregates. Conclusions: P23H rhodopsin as well as WT rhodopsin form aggregates in RPE cells and LEDGF(1-326) decreases these aggregates. Further, LEDGF(1-326) reduces the RPE cell damage caused by P23H rhodopsin. LEDGF(1-326) might be useful in treating cellular damage associated with protein aggregation diseases such as retinitis pigmentosa.	[Baid, Rinku; Scheinman, Robert I.; Kompella, Uday B.] Univ Colorado, Dept Pharmaceut Sci, Aurora, CO USA; [Shinohara, Toshimichi; Singh, Dhirendra P.] Univ Nebraska Med Ctr, Dept Ophthalmol, Omaha, NE USA; [Kompella, Uday B.] Univ Colorado, Dept Ophthalmol, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Nebraska System; University of Nebraska Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus	Baid, R (corresponding author), Univ Colorado, Dept Pharmaceut Sci, Anschutz Med Campus, Aurora, CO USA.	uday.kompella@ucdenver.edu		Shinohara, Toshimichi/0000-0002-7197-9039	NIH [1 R21EY17360, RC1EY020361]; NATIONAL EYE INSTITUTE [R21EY017360, R01EY018172, R01EY013394, RC1EY020361] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported in part by NIH grants 1 R21EY17360 and RC1EY020361. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; COLLEY NJ, 1995, P NATL ACAD SCI USA, V92, P3070, DOI 10.1073/pnas.92.7.3070; Fatma N, 2004, AM J PHYSIOL-CELL PH, V287, pC508, DOI 10.1152/ajpcell.00076.2004; Illing ME, 2002, J BIOL CHEM, V277, P34150, DOI 10.1074/jbc.M204955200; Itoh H, 1999, BIOCHEM J, V343, P697, DOI 10.1042/0264-6021:3430697; KAUSHAL S, 1994, BIOCHEMISTRY-US, V33, P6121, DOI 10.1021/bi00186a011; Kubo E, 2003, HISTOCHEM CELL BIOL, V119, P289, DOI 10.1007/s00418-003-0518-3; KURADA P, 1995, NEURON, V14, P571, DOI 10.1016/0896-6273(95)90313-5; Lem J, 1999, P NATL ACAD SCI USA, V96, P736, DOI 10.1073/pnas.96.2.736; Machida S, 2001, INVEST OPHTH VIS SCI, V42, P1087; Maertens G, 2003, J BIOL CHEM, V278, P33528, DOI 10.1074/jbc.M303594200; Mendes HF, 2005, TRENDS MOL MED, V11, P177, DOI 10.1016/j.molmed.2005.02.007; Michaelson D, 2006, METHOD ENZYMOL, V406, P296, DOI 10.1016/S0076-6879(06)06022-8; Milam AH, 1998, PROG RETIN EYE RES, V17, P175; Nishikawa S, 1998, EXP EYE RES, V67, P509, DOI 10.1006/exer.1998.0538; Raz-Prag D, 2009, INVEST OPHTH VIS SCI, V50, P3897, DOI 10.1167/iovs.08-3153; Saliba RS, 2002, J CELL SCI, V115, P2907; Sharma P, 2003, J BIOL CHEM, V278, P20037, DOI 10.1074/jbc.M212016200; Singh DP, 1999, INVEST OPHTH VIS SCI, V40, P1444; Singh DP, 2006, J MOL BIOL, V355, P379, DOI 10.1016/j.jmb.2005.10.054; Singh DP, 2001, BIOCHEM BIOPH RES CO, V283, P943, DOI 10.1006/bbrc.2001.4887; Stojanovic A, 2002, RECEPTOR CHANNEL, V8, P33, DOI 10.1080/10606820212137; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; SUNG CH, 1993, J BIOL CHEM, V268, P26645; Treweek TM, 2000, BBA-PROTEIN STRUCT M, V1481, P175, DOI 10.1016/S0167-4838(00)00109-6; WYSZYNSKI RE, 1989, INVEST OPHTH VIS SCI, V30, P2341	26	5	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2011	6	9							e24616	10.1371/journal.pone.0024616	http://dx.doi.org/10.1371/journal.pone.0024616			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CH	21915354	Green Submitted, gold, Green Published			2022-12-25	WOS:000294802500062
J	Papaleo, E; Pasi, M; Tiberti, M; De Gioia, L				Papaleo, Elena; Pasi, Marco; Tiberti, Matteo; De Gioia, Luca			Molecular Dynamics of Mesophilic-Like Mutants of a Cold-Adapted Enzyme: Insights into Distal Effects Induced by the Mutations	PLOS ONE			English	Article							PSYCHROPHILIC ALPHA-AMYLASE; SALT BRIDGES; EVOLUTIONARY CONSERVATION; ALTEROMONAS-HALOPLANCTIS; STRUCTURAL DETERMINANTS; TEMPERATURE ADAPTATION; SUBSTRATE-BINDING; PROTEIN DYNAMICS; ACTIVE ENZYME; STABILITY	Networks and clusters of intramolecular interactions, as well as their "communication" across the three-dimensional architecture have a prominent role in determining protein stability and function. Special attention has been dedicated to their role in thermal adaptation. In the present contribution, seven previously experimentally characterized mutants of a cold-adapted alpha-amylase, featuring mesophilic-like behavior, have been investigated by multiple molecular dynamics simulations, essential dynamics and analyses of correlated motions and electrostatic interactions. Our data elucidate the molecular mechanisms underlying the ability of single and multiple mutations to globally modulate dynamic properties of the cold-adapted alpha-amylase, including both local and complex unpredictable distal effects. Our investigation also shows, in agreement with the experimental data, that the conversion of the cold-adapted enzyme in a warm-adapted variant cannot be completely achieved by the introduction of few mutations, also providing the rationale behind these effects. Moreover, pivotal residues, which are likely to mediate the effects induced by the mutations, have been identified from our analyses, as well as a group of suitable candidates for protein engineering. In fact, a subset of residues here identified (as an isoleucine, or networks of mesophilic-like salt bridges in the proximity of the catalytic site) should be considered, in experimental studies, to get a more efficient modification of the features of the cold-adapted enzyme.	[Papaleo, Elena; Pasi, Marco; Tiberti, Matteo; De Gioia, Luca] Univ Milano Bicocca, Dept Biosci & Biotechnol, Milan, Italy	University of Milano-Bicocca	Papaleo, E (corresponding author), Univ Milano Bicocca, Dept Biosci & Biotechnol, Milan, Italy.	elena.papaleo@unimib.it	Papaleo, Elena/M-6629-2014; Tiberti, Matteo/AGU-8969-2022; De Gioia, Luca/K-6439-2016; Pasi, Marco/L-6777-2015	Papaleo, Elena/0000-0002-7376-5894; Pasi, Marco/0000-0001-9804-7322; , Elena/0000-0003-2296-898X	CASPUR (Consorzio Interuniversitario per le Applicazio-ni di Supercalcolo per Universita e Ricerca)	CASPUR (Consorzio Interuniversitario per le Applicazio-ni di Supercalcolo per Universita e Ricerca)	This work was supported by CASPUR (Consorzio Interuniversitario per le Applicazio-ni di Supercalcolo per Universita e Ricerca) Standard HPC Grant 2010 to EP. The funders had no role in study design, data analysis, decision to publish or preparation of the manuscript.	Aghajari N, 1998, STRUCTURE, V6, P1503, DOI 10.1016/S0969-2126(98)00149-X; Aghajari N, 1998, PROTEIN SCI, V7, P564, DOI 10.1002/pro.5560070304; Aghajari N, 2002, PROTEIN SCI, V11, P1435, DOI 10.1110/ps.0202602; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Amaro RE, 2007, BIOCHEMISTRY-US, V46, P2156, DOI 10.1021/bi061708e; Andre G, 2004, BIOPOLYMERS, V75, P95, DOI 10.1002/bip.20096; Angelova K, 2011, CELL MOL LIFE SCI, V68, P1227, DOI 10.1007/s00018-010-0519-z; Arnold FH, 2001, TRENDS BIOCHEM SCI, V26, P100, DOI 10.1016/S0968-0004(00)01755-2; Bae E, 2004, J BIOL CHEM, V279, P28202, DOI 10.1074/jbc.M401865200; Bosshard HR, 2004, J MOL RECOGNIT, V17, P1, DOI 10.1002/jmr.657; BRAYER GD, 1995, PROTEIN SCI, V4, P1730, DOI 10.1002/pro.5560040908; Casanueva A, 2010, TRENDS MICROBIOL, V18, P374, DOI 10.1016/j.tim.2010.05.002; Caves LSD, 1998, PROTEIN SCI, V7, P649, DOI 10.1002/pro.5560070314; D'Amico S, 2006, EMBO REP, V7, P385, DOI 10.1038/sj.embor.7400662; D'Amico S, 2002, BIOLOGIA, V57, P213; D'Amico S, 2003, J MOL BIOL, V332, P981, DOI 10.1016/j.jmb.2003.07.014; D'Amico S, 2002, J BIOL CHEM, V277, P46110, DOI 10.1074/jbc.M207253200; D'Amico S, 2001, J BIOL CHEM, V276, P25791, DOI 10.1074/jbc.M102741200; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; de Bakker PIW, 1999, J MOL BIOL, V285, P1811, DOI 10.1006/jmbi.1998.2397; Debe DA, 1999, J MOL BIOL, V294, P619, DOI 10.1006/jmbi.1999.3278; Elcock AH, 1998, J MOL BIOL, V284, P489, DOI 10.1006/jmbi.1998.2159; Fedoy AE, 2007, J MOL BIOL, V372, P130, DOI 10.1016/j.jmb.2007.06.040; FELLER G, 1994, EUR J BIOCHEM, V222, P441, DOI 10.1111/j.1432-1033.1994.tb18883.x; Feller G, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/32/323101; Fields PA, 2001, COMP BIOCHEM PHYS A, V129, P417, DOI 10.1016/S1095-6433(00)00359-7; Friedman R, 2010, PROTEINS, V78, P1575, DOI 10.1002/prot.22674; Fuhrmans M, 2010, THEOR CHEM ACC, V125, P335, DOI 10.1007/s00214-009-0590-4; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Georlette D, 2004, FEMS MICROBIOL REV, V28, P25, DOI 10.1016/j.femsre.2003.07.003; Gerday C, 2000, TRENDS BIOTECHNOL, V18, P103, DOI 10.1016/S0167-7799(99)01413-4; Gianese G, 2002, PROTEINS, V47, P236, DOI 10.1002/prot.10084; Goldstein RA, 2007, PROTEIN SCI, V16, P1887, DOI 10.1110/ps.072947007; Gottschalk TE, 2001, BIOCHEMISTRY-US, V40, P12844, DOI 10.1021/bi0108608; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; HUNENBERGER PH, 1995, J MOL BIOL, V252, P492, DOI 10.1006/jmbi.1995.0514; Johnson E, 2011, J BIOMOL NMR, V50, P59, DOI 10.1007/s10858-011-9504-6; JONES DD, 1975, J THEOR BIOL, V50, P167, DOI 10.1016/0022-5193(75)90031-4; Joseph B, 2008, BIOTECHNOL ADV, V26, P457, DOI 10.1016/j.biotechadv.2008.05.003; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Karplus M, 2005, P NATL ACAD SCI USA, V102, P6679, DOI 10.1073/pnas.0408930102; Kumar S, 2004, CHEMBIOCHEM, V5, P280, DOI 10.1002/cbic.200300627; Kumar S, 2002, CHEMBIOCHEM, V3, P604, DOI 10.1002/1439-7633(20020703)3:7<604::AID-CBIC604>3.0.CO;2-X; Kumar S, 2002, BIOPHYS J, V83, P1595, DOI 10.1016/S0006-3495(02)73929-5; Kumar S, 2001, CELL MOL LIFE SCI, V58, P1216, DOI 10.1007/PL00000935; Law AB, 2009, J AM CHEM SOC, V131, P6322, DOI 10.1021/ja809915a; Leiros HKS, 2007, J BIOL CHEM, V282, P21973, DOI 10.1074/jbc.M610174200; Loccisano AE, 2004, J MOL GRAPH MODEL, V22, P369, DOI 10.1016/j.jmgm.2003.12.004; Lonhienne T, 2000, BBA-PROTEIN STRUCT M, V1543, P1, DOI 10.1016/S0167-4838(00)00210-7; Maguid S, 2008, GENE, V422, P7, DOI 10.1016/j.gene.2008.06.002; Marcos E, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000738; Marx JC, 2008, PROTEINS, V70, P320, DOI 10.1002/prot.21594; Missimer JH, 2007, PROTEIN SCI, V16, P1349, DOI 10.1110/ps.062542907; MITCHELL JBO, 1994, J MOL BIOL, V239, P315, DOI 10.1006/jmbi.1994.1370; Miyazaki K, 2000, J MOL BIOL, V297, P1015, DOI 10.1006/jmbi.2000.3612; Monticelli L, 2008, J COMPUT CHEM, V29, P1740, DOI 10.1002/jcc.20935; Morra G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000323; Motono C, 2008, PROTEINS, V71, P655, DOI 10.1002/prot.21729; Nashine VC, 2010, CURR OPIN CHEM BIOL, V14, P644, DOI 10.1016/j.cbpa.2010.07.020; Papaleo E, 2008, FEBS LETT, V582, P1008, DOI 10.1016/j.febslet.2008.02.048; Papaleo E, 2009, J MOL GRAPH MODEL, V27, P889, DOI 10.1016/j.jmgm.2009.01.006; Pasi M, 2009, J PHYS CHEM B, V113, P13585, DOI 10.1021/jp900790n; Raimondi F, 2010, STRUCTURE, V18, P402, DOI 10.1016/j.str.2009.12.015; Ramasubbu N, 2003, J MOL BIOL, V325, P1061, DOI 10.1016/S0022-2836(02)01326-8; Rodrigues DF, 2008, APPL ENVIRON MICROB, V74, P1677, DOI 10.1128/AEM.02000-07; Shen HB, 2008, J STRUCT BIOL, V164, P281, DOI 10.1016/j.jsb.2008.09.003; Siddiqui KS, 2006, PROTEINS, V64, P486, DOI 10.1002/prot.20989; Siddiqui KS, 2006, ANNU REV BIOCHEM, V75, P403, DOI 10.1146/annurev.biochem.75.103004.142723; Siguroardottir AG, 2009, BBA-PROTEINS PROTEOM, V1794, P512, DOI 10.1016/j.bbapap.2008.11.018; Smalas A O, 2000, Biotechnol Annu Rev, V6, P1, DOI 10.1016/S1387-2656(00)06018-X; Southall NT, 2002, J PHYS CHEM B, V106, P2812, DOI 10.1021/jp020104r; Tiberti M, 2011, J STRUCT BIOL, V174, P69, DOI 10.1016/j.jsb.2011.01.006; Trivedi S, 2006, GENET MOL RES, V5, P816; Vijayabaskar MS, 2010, BIOPHYS J, V99, P3704, DOI 10.1016/j.bpj.2010.08.079; Villali J, 2010, CURR OPIN CHEM BIOL, V14, P636, DOI 10.1016/j.cbpa.2010.08.007; Wintrode PL, 2001, ADV PROTEIN CHEM, V55, P161, DOI 10.1016/S0065-3233(01)55004-4; Zhu S, 2010, J CHEM THEORY COMPUT, V6, P1293, DOI 10.1021/ct1000704	78	32	32	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2011	6	9							e24214	10.1371/journal.pone.0024214	http://dx.doi.org/10.1371/journal.pone.0024214			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CH	21915299	Green Submitted, gold, Green Published			2022-12-25	WOS:000294802500035
J	Salerno, B; Anne, G; Bryant, FR				Salerno, Brenda; Anne, Geetha; Bryant, Floyd R.			DNA Binding Compatibility of the Streptococcus pneumoniae SsbA and SsbB Proteins	PLOS ONE			English	Article							PURIFICATION; MODES	Background: Streptococcus pneumoniae has two paralogous, homotetrameric, single-stranded DNA binding (SSB) proteins, designated SsbA and SsbB. Previous studies demonstrated that SsbA and SsbB have different solution-dependent binding mode preferences with variable DNA binding capacities. The impact of these different binding properties on the assembly of multiple SsbAs and SsbBs onto single-stranded DNA was investigated. Methodology/Principal Findings: The complexes that were formed by the SsbA and SsbB proteins on dT(n) oligomers of defined lengths were examined by polyacrylamide gel electrophoresis. Complexes containing either two SsbAs or two SsbBs, or mixed complexes containing one SsbA and one SsbB, could be formed readily, provided the dT(n) oligomer was long enough to satisfy the full binding mode capacities of each of the bound proteins under the particular solution conditions. Complexes containing two SsbAs or two SsbBs could also be formed on shorter dT(n) oligomers via a "shared-strand binding" mechanism in which one or both proteins were bound using only a portion of their potential binding capacity. Mixed complexes were not formed on these shorter oligomers, however, indicating that SsbA and SsbB were incompatible for shared-strand binding. Additional experiments suggested that this shared-strand binding incompatibility may be due in part to differences in the structure of a loop region on the outer surface of the subunits of the SsbA and SsbB proteins. Conclusion/Significance: These results indicate that the SsbA and SsbB proteins may co-assemble on longer DNA segments where independent binding is possible, but not on shorter DNA segments where coordinated interactions between adjacent SSBs are required. The apparent compatibility requirement for shared-strand binding could conceivably serve as a self-recognition mechanism that regulates the manner in which SsbA and SsbB interact in S. pneumoniae.	[Salerno, Brenda; Anne, Geetha; Bryant, Floyd R.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Salerno, B (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21218 USA.	fbryant@jhsph.edu			Johns Hopkins University Bloomberg School of Public Health	Johns Hopkins University Bloomberg School of Public Health	This work was supported by funds from the Johns Hopkins University Bloomberg School of Public Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Claverys JP, 2009, FEMS MICROBIOL REV, V33, P643, DOI 10.1111/j.1574-6976.2009.00164.x; Grove DE, 2006, J BIOL CHEM, V281, P2087, DOI 10.1074/jbc.M510884200; Grove DE, 2005, J BIOL CHEM, V280, P11067, DOI 10.1074/jbc.M414057200; Hedayati MA, 2005, PROTEIN EXPRES PURIF, V43, P133, DOI 10.1016/j.pep.2005.03.034; LOHMAN TM, 1994, ANNU REV BIOCHEM, V63, P527, DOI 10.1146/annurev.biochem.63.1.527; Morrison DA, 2007, J BACTERIOL, V189, P6497, DOI 10.1128/JB.00687-07; Raghunathan S, 2000, NAT STRUCT BIOL, V7, P648, DOI 10.1038/77943; Saikrishnan K, 2005, ACTA CRYSTALLOGR D, V61, P1140, DOI 10.1107/S0907444905016896; Shereda RD, 2008, CRIT REV BIOCHEM MOL, V43, P289, DOI [10.1080/10409230802341296, 10.1080/10409230802341296 ]; Steffen SE, 2001, ARCH BIOCHEM BIOPHYS, V388, P165, DOI 10.1006/abbi.2001.2286	10	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2011	6	9							e24305	10.1371/journal.pone.0024305	http://dx.doi.org/10.1371/journal.pone.0024305			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CH	21915308	gold, Green Published, Green Submitted			2022-12-25	WOS:000294802500037
J	Tamaru, T; Hattori, M; Honda, K; Benjamin, I; Ozawa, T; Takamatsu, K				Tamaru, Teruya; Hattori, Mitsuru; Honda, Kousuke; Benjamin, Ivor; Ozawa, Takeaki; Takamatsu, Ken			Synchronization of Circadian Per2 Rhythms and HSF1-BMAL1: CLOCK Interaction in Mouse Fibroblasts after Short-Term Heat Shock Pulse	PLOS ONE			English	Article							CULTURED FIBROBLASTS; TRANSCRIPTION FACTOR; GENE-EXPRESSION; MAMMALIAN CLOCK; TEMPERATURE; PROTEIN; BMAL1; OSCILLATORS; RESPONSES; STRATEGY	Circadian rhythms are the general physiological processes of adaptation to daily environmental changes, such as the temperature cycle. A change in temperature is a resetting cue for mammalian circadian oscillators, which are possibly regulated by the heat shock (HS) pathway. The HS response (HSR) is a universal process that provides protection against stressful conditions, which promote protein-denaturation. Heat shock factor 1 (HSF1) is essential for HSR. In the study presented here, we investigated whether a short-term HS pulse can reset circadian rhythms. Circadian Per2 rhythm and HSF1-mediated gene expression were monitored by a real-time bioluminescence assay for mPer2 promoter-driven luciferase and HS element (HSE; HSF1-binding site)-driven luciferase activity, respectively. By an optimal duration HS pulse (43 degrees C for approximately 30 minutes), circadian Per2 rhythm was observed in the whole mouse fibroblast culture, probably indicating the synchronization of the phases of each cell. This rhythm was preceded by an acute elevation in mPer2 and HSF1-mediated gene expression. Mutations in the two predicted HSE sites adjacent (one of them proximally) to the E-box in the mPer2 promoter dramatically abolished circadian mPer2 rhythm. Circadian Per2 gene/protein expression was not observed in HSF1-deficient cells. These findings demonstrate that HSF1 is essential to the synchronization of circadian rhythms by the HS pulse. Importantly, the interaction between HSF1 and BMAL1:CLOCK heterodimer, a central circadian transcription factor, was observed after the HS pulse. These findings reveal that even a short-term HS pulse can reset circadian rhythms and cause the HSF1-BMAL1:CLOCK interaction, suggesting the pivotal role of crosstalk between the mammalian circadian and HSR systems.	[Tamaru, Teruya; Takamatsu, Ken] Toho Univ, Sch Med, Dept Physiol, Tokyo, Japan; [Tamaru, Teruya; Takamatsu, Ken] Toho Univ, Sch Med, Adv Res Ctr Med Sci, Tokyo, Japan; [Hattori, Mitsuru; Honda, Kousuke; Ozawa, Takeaki] Univ Tokyo, Dept Chem, Sch Sci, Tokyo 1330033, Japan; [Benjamin, Ivor] Univ Utah, Hlth Sci Ctr, Salt Lake City, UT USA	Toho University; Toho University; University of Tokyo; Utah System of Higher Education; University of Utah	Tamaru, T (corresponding author), Toho Univ, Sch Med, Dept Physiol, Tokyo, Japan.	tetamaru@med.toho-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) [20500344]; Toho University; Takeda Science Foundation; Japan Society for the Promotion of Science (JSPS); Advanced Research Center for Medical Science at Toho University; Grants-in-Aid for Scientific Research [23590283, 21675001] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Toho University(Toho University); Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Advanced Research Center for Medical Science at Toho University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) (KAKENHI no. 20500344), Project Research of Toho University, the Takeda Science Foundation (T. Tamaru), the Japan Society for the Promotion of Science (JSPS), and the Advanced Research Center for Medical Science at Toho University (K. Takamatsu). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anckar J, 2007, ADV EXP MED BIOL, V594, P78; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Biro S, 2003, EXP BIOL MED, V228, P1245, DOI 10.1177/153537020322801023; Bittencourt LRA, 2010, J OCCUP REHABIL, V20, P21, DOI 10.1007/s10926-009-9213-0; Bozek K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004882; Brown SA, 2002, CURR BIOL, V12, P1574, DOI 10.1016/S0960-9822(02)01145-4; Buhr ED, 2010, SCIENCE, V330, P379, DOI 10.1126/science.1195262; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Harms E, 2004, J BIOL RHYTHM, V19, P361, DOI 10.1177/0748730404268111; Hertoghe T, 2005, ANN NY ACAD SCI, V1057, P448, DOI 10.1196/annals.1322.035; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; RABINDRAN SK, 1994, MOL CELL BIOL, V14, P6552, DOI 10.1128/MCB.14.10.6552; Reddy AB, 2010, TRENDS CELL BIOL, V20, P36, DOI 10.1016/j.tcb.2009.10.005; Reinke H, 2008, GENE DEV, V22, P331, DOI 10.1101/gad.453808; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Sahar S, 2009, NAT REV CANCER, V9, P886, DOI 10.1038/nrc2747; Sato TK, 2006, NAT GENET, V38, P312, DOI 10.1038/ng1745; Shi YH, 1998, GENE DEV, V12, P654, DOI 10.1101/gad.12.5.654; Skitzki JJ, 2009, CURR OPIN INVEST DR, V10, P550; Tamaru T, 2003, GENES CELLS, V8, P973, DOI 10.1046/j.1365-2443.2003.00686.x; Tamaru T, 2000, J NEUROSCI, V20, P7525; Tamaru T, 2009, NAT STRUCT MOL BIOL, V16, P446, DOI 10.1038/nsmb.1578; Tsuchiya Y, 2003, GENES CELLS, V8, P713, DOI 10.1046/j.1365-2443.2003.00669.x; Uchida Y, 2010, BIOL PHARM BULL, V33, P535, DOI 10.1248/bpb.33.535; Walther W, 2009, ADV DRUG DELIVER REV, V61, P641, DOI 10.1016/j.addr.2009.02.009; Westerheide SD, 2005, J BIOL CHEM, V280, P33097, DOI 10.1074/jbc.R500010200; Whitesell L, 2009, EXPERT OPIN THER TAR, V13, P469, DOI [10.1517/14728220902832697, 10.1517/14728220902832697 ]; Xiao XZ, 1999, EMBO J, V18, P5943, DOI 10.1093/emboj/18.21.5943; Yagita K, 2001, SCIENCE, V292, P278, DOI 10.1126/science.1059542	31	75	77	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2011	6	9							e24521	10.1371/journal.pone.0024521	http://dx.doi.org/10.1371/journal.pone.0024521			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CH	21915348	gold, Green Published, Green Submitted			2022-12-25	WOS:000294802500057
J	von Kries, R; Weiss, S; Falkenhorst, G; Wirth, S; Kaiser, P; Huppertz, HI; Tenenbaum, T; Schroten, H; Streng, A; Liese, J; Shai, S; Niehues, T; Girschick, H; Kuscher, E; Sauerbrey, A; Peters, J; von Koenig, CHW; Ruckinger, S; Hampl, W; Michel, D; Mertens, T				von Kries, Ruediger; Weiss, Susanne; Falkenhorst, Gerhard; Wirth, Stephan; Kaiser, Petra; Huppertz, Hans-Iko; Tenenbaum, Tobias; Schroten, Horst; Streng, Andrea; Liese, Johannes; Shai, Sonu; Niehues, Tim; Girschick, Hermann; Kuscher, Ellen; Sauerbrey, Axel; Peters, Jochen; von Koenig, Carl Heinz Wirsing; Rueckinger, Simon; Hampl, Walter; Michel, Detlef; Mertens, Thomas			Post-Pandemic Seroprevalence of Pandemic Influenza A (H1N1) 2009 Infection (Swine Flu) among Children < 18 Years in Germany	PLOS ONE			English	Article							HEMAGGLUTINATION INHIBITION; VACCINE; PREVALENCE; ANTIBODY; RISK	Background: We determined antibodies to the pandemic influenza A (H1N1) 2009 virus in children to assess: the incidence of (H1N1) 2009 infections in the 2009/2010 season in Germany, the proportion of subclinical infections and to compare titers in vaccinated and infected children. Methodology/Principal Findings: Eight pediatric hospitals distributed over Germany prospectively provided sera from in-or outpatients aged 1 to 17 years from April 1(st) to July 31(st) 2010. Vaccination history, recall of infections and sociodemographic factors were ascertained. Antibody titers were measured with a sensitive and specific in-house hemagglutination inhibition test (HIT) and compared to age-matched sera collected during 6 months before the onset of the pandemic in Germany. We analyzed 1420 post-pandemic and 300 pre-pandemic sera. Among unvaccinated children aged 1-4 and 5-17 years the prevalence of HI titers (>= 1:10) was 27.1% (95% CI: 23.5-31.3) and 53.5% (95% CI: 50.9-56.2) compared to 1.7% and 5.5%, respectively, for pre-pandemic sera, accounting for a serologically determined incidence of influenza A (H1N1) 2009 during the season 2009/2010 of 25,4% (95% CI : 19.3-30.5) in children aged 1-4 years and 48.0% (95% CI: 42.6-52.0) in 5-17 year old children. Of children with HI titers >= 1: 10, 25.5% (95% CI: 22.5-28.8) reported no history of any infectious disease since June 2009. Among vaccinated children, 92% (95%-CI: 87.0-96.6) of the 5-17 year old but only 47.8% (95%-CI: 33.5-66.5) of the 1-4 year old children exhibited HI titers against influenza A virus (H1N1) 2009. Conclusion: Serologically determined incidence of influenza A (H1N1) 2009 infections in children indicates high infection rates with older children (5-17 years) infected twice as often as younger children. In about a quarter of the children with HI titers after the season 2009/2010 subclinical infections must be assumed. Low HI titers in young children after vaccination with the AS03(B)-adjuvanted split virion vaccine need further scrutiny.	[von Kries, Ruediger; Weiss, Susanne; Rueckinger, Simon; Mertens, Thomas] Univ Munich, Inst Soziale Padiatrie & Jugendmed, Munich, Germany; [Falkenhorst, Gerhard; Mertens, Thomas] Robert Koch Inst, Abt Infekt Epidemiol, D-1000 Berlin, Germany; [Wirth, Stephan] Univ Witten Herdecke, Helios Klinikum, Zentrum Kinder & Jugendmed, Wuppertal, Germany; [Kaiser, Petra; Huppertz, Hans-Iko] Klinikum Bremen Mitte, Prof Hess Kinderklin, Bremen, Germany; [Tenenbaum, Tobias; Schroten, Horst] Heidelberg Univ, Univ Kinderklin, D-6800 Mannheim, Germany; [Streng, Andrea; Liese, Johannes] Univ Kinderklin, Wurzburg, Germany; [von Koenig, Carl Heinz Wirsing] HELIOS Klin, Inst Hyg & Lab Med, Krefeld, Germany; [Girschick, Hermann] Vivantes Klinikum Friedrichshain, Klin Kinder & Jugendmed, Berlin, Germany; [Kuscher, Ellen; Sauerbrey, Axel] HELIOS Klin, Erfurt, Germany; [Peters, Jochen] Klinikum Dritter Orden, Abt Kinder & Jugendmed, Munich, Germany; [Hampl, Walter; Michel, Detlef] Univ Ulm Klinikum, Inst Virol, Ulm, Germany	University of Munich; Robert Koch Institute; Helios Kliniken; Witten Herdecke University; Klinikum Bremen-Mitte; Ruprecht Karls University Heidelberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Wurzburg; Helios Kliniken; Helios Kliniken; Ulm University	von Kries, R (corresponding author), Univ Munich, Inst Soziale Padiatrie & Jugendmed, Munich, Germany.	thomas.mertens@uniklinik-ulm.de	Mertens, Thomas M/E-9826-2013; Streng, Andrea/AAR-4986-2020	Streng, Andrea/0000-0003-2377-7106				Allwinn R, 2010, MED MICROBIOL IMMUN, V199, P117, DOI 10.1007/s00430-010-0143-4; Andrews N, 2011, J INFECT DIS, V203, P32, DOI 10.1093/infdis/jiq014; [Anonymous], 2010, Wkly Epidemiol Rec, V85, P229; Bandaranayake D, 2010, SEROPREVALENCE 2009, P1; Carmona A, 2010, VACCINE, V28, P5837, DOI 10.1016/j.vaccine.2010.06.065; Cowling BJ, 2010, NEW ENGL J MED, V362, P2175, DOI 10.1056/NEJMoa0911530; Eichelberger M, 2008, VACCINE, V26, P4299, DOI 10.1016/j.vaccine.2008.06.012; Fiore AE, 2010, JAMA-J AM MED ASSOC, V303, P73, DOI 10.1001/jama.2009.1929; Glasser J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012777; Hardelid P, 2010, HEALTH TECHNOL ASSES, V14, P115, DOI 10.3310/hta14550-03; Janjua NZ, 2010, CLIN INFECT DIS, V51, P1017, DOI 10.1086/656586; Lee VJ, 2010, J INFECT DIS, V202, P1319, DOI 10.1086/656480; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Papenburg J, 2010, CLIN INFECT DIS, V51, P1033, DOI 10.1086/656582; Plennevaux E, 2010, LANCET, V375, P41, DOI 10.1016/S0140-6736(09)62026-2; Rizzo C, 2010, VACCINE, V28, P3558, DOI 10.1016/j.vaccine.2010.03.006; Robert Koch-Institut, 2010, EPIDEMIOL B, V25, P237; Robert Koch-Institut Paul-Ehrlich-Institut, 2009, EPIDEMIOL B, V50, P519; Roman F, 2010, CLIN INFECT DIS, V51, P668, DOI 10.1086/655830; Statistisches Bundesamt Deutschland, 2008, FACHSERIE, V1.3, P1; Stephenson I, 2009, EMERG INFECT DIS, V15, P1250, DOI 10.3201/eid1508.081754; Tandale BV, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-255; UK Health Protection Agency, 2009, PAND H1N1 2009 ENGL, P1; Van Buynder PG, 2010, INFLUENZA OTHER RESP, V4, P171, DOI 10.1111/j.1750-2659.2010.00146.x; Waddington CS, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2649; Webster R, 2002, WHO MANUAL ANIMAL IN, P1; Wichmann O, 2010, EURO SURVEILL, V15; Yoon KJ, 2004, J VET DIAGN INVEST, V16, P197, DOI 10.1177/104063870401600304; Zimmer SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011601	30	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2011	6	9							e23955	10.1371/journal.pone.0023955	http://dx.doi.org/10.1371/journal.pone.0023955			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CH	21915270	Green Published, Green Submitted, gold			2022-12-25	WOS:000294802500020
J	Bin, BH; Fukada, T; Hosaka, T; Yamasaki, S; Ohashi, W; Hojyo, S; Miyai, T; Nishida, K; Yokoyama, S; Hirano, T				Bin, Bum-Ho; Fukada, Toshiyuki; Hosaka, Toshiaki; Yamasaki, Satoru; Ohashi, Wakana; Hojyo, Shintaro; Miyai, Tomohiro; Nishida, Keigo; Yokoyama, Shigeyuki; Hirano, Toshio			Biochemical Characterization of Human ZIP13 Protein A HOMO-DIMERIZED ZINC TRANSPORTER INVOLVED IN THE SPONDYLOCHEIRO DYSPLASTIC EHLERS-DANLOS SYNDROME	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIV-1 SUBFAMILY; SECRETORY PATHWAY; MEMBER; ARCHITECTURE; SYMPORTER; COMPLEXES; REVEALS; GROWTH; CELLS; CTR1	The human SLC39A13 gene encodes ZIP13, a member of the LZT (LIV-1 subfamily of ZIP zinc transporters) family. The ZIP13 protein is important for connective tissue development, and its loss of function is causative for the spondylocheiro dysplastic form of Ehlers-Danlos syndrome. However, this protein has not been characterized in detail. Here we report the first detailed biochemical characterization of the human ZIP13 protein using its ectopic expressed and the purified recombinant protein. Protease accessibility, microscopic, and computational analyses demonstrated that ZIP13 contains eight putative transmembrane domains and a unique hydrophilic region and that it resides with both its N and C termini facing the luminal side on the Golgi. Analyses including cross-linking, immunoprecipitation, Blue Native-PAGE, and size-exclusion chromatography experiments indicated that the ZIP13 protein may form a homodimer. We also demonstrated that ZIP13 mediates zinc influx, as assessed by monitoring the expression of the metallothionein gene and by detecting the intracellular zinc level with a zinc indicator, FluoZin-3. Our data indicate that ZIP13 is a homodimerized zinc transporter that possesses some domains that are not found in other LZT family members. This is the first biochemical characterization of the physiologically important protein ZIP13 and the demonstration of homo-dimerization for a mammalian ZIP zinc transporter family member. This biochemical characterization of the human ZIP13 protein provides important information for further investigations of its structural characteristics and function.	[Bin, Bum-Ho; Fukada, Toshiyuki; Yamasaki, Satoru; Ohashi, Wakana; Hojyo, Shintaro; Miyai, Tomohiro; Nishida, Keigo; Hirano, Toshio] RIKEN Res Ctr Allergy & Immunol, Lab Cytokine Signaling, Yokohama, Kanagawa 2300045, Japan; [Fukada, Toshiyuki] Osaka Univ, Grad Sch Med, Dept Allergy & Immunol, Suita, Osaka 5650871, Japan; [Bin, Bum-Ho; Miyai, Tomohiro; Nishida, Keigo; Hirano, Toshio] Osaka Univ, Grad Sch Med, Japan Sci & Technol Agcy Core Res Evolut Sci & Te, Lab Dev Immunol,Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Bin, Bum-Ho; Miyai, Tomohiro; Nishida, Keigo; Hirano, Toshio] Osaka Univ, Grad Sch Med, WPI Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan; [Hosaka, Toshiaki; Yokoyama, Shigeyuki] RIKEN Syst & Struct Biol Ctr, Yokohama, Kanagawa 2300045, Japan; [Yokoyama, Shigeyuki] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130033, Japan; [Bin, Bum-Ho] AmorePacific Corp R&D Ctr, Biosci Inst, Yongin 446729, Gyeounggi Do, South Korea	RIKEN; Osaka University; Japan Science & Technology Agency (JST); Osaka University; Osaka University; RIKEN; University of Tokyo	Fukada, T (corresponding author), 1-7-22 Suehiro Cho,Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan.	fukada@rcai.riken.jp	Yokoyama, Shigeyuki/N-6911-2015	Yokoyama, Shigeyuki/0000-0003-3133-7338; Miyai, Tomohiro/0000-0003-1952-0228	KAKENHI; Japan Science and Technology Agency; Naito Foundation	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Naito Foundation(Naito Memorial Foundation)	This work was supported by KAKENHI and the Japan Science and Technology Agency-Core Research for Evolutional Science and Technology program and the Naito Foundation (to T. F.).	Aller SG, 2006, P NATL ACAD SCI USA, V103, P3627, DOI 10.1073/pnas.0509929103; Andreini C, 2006, J PROTEOME RES, V5, P196, DOI 10.1021/pr050361j; Bi YY, 2004, BIOCHEM J, V380, P695, DOI 10.1042/BJ20031677; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Foster M, 2010, ATHEROSCLEROSIS, V210, P344, DOI 10.1016/j.atherosclerosis.2009.11.038; Fukada T, 2011, J BIOL INORG CHEM, V16, P1123, DOI 10.1007/s00775-011-0797-4; Fukada T, 2011, METALLOMICS, V3, P662, DOI 10.1039/c1mt00011j; Fukada T, 2011, J ORAL BIOSCI, V53, P1, DOI 10.2330/joralbiosci.53.1; Fukada T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003642; Fukunaka A, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.227173; Fukunaka A, 2009, J BIOL CHEM, V284, P30798, DOI 10.1074/jbc.M109.026435; Girijashanker K, 2008, MOL PHARMACOL, V73, P1413, DOI 10.1124/mol.107.043588; Gitan RS, 2000, BIOCHEM J, V346, P329, DOI 10.1042/0264-6021:3460329; He L, 2006, MOL PHARMACOL, V70, P171, DOI 10.1124/mol.106.021521; Hershfinkel M, 2007, MOL MED, V13, P331, DOI 10.2119/2006-00038.Hershfinkel; Hirano T, 2008, ADV IMMUNOL, V97, P149, DOI 10.1016/S0065-2776(08)00003-5; Hogstrand C, 2009, TRENDS MOL MED, V15, P101, DOI 10.1016/j.molmed.2009.01.004; Hojyo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018059; Kambe T, 2004, CELL MOL LIFE SCI, V61, P49, DOI 10.1007/s00018-003-3148-y; Kambe T, 2009, MOL CELL BIOL, V29, P129, DOI 10.1128/MCB.00963-08; Lin W, 2010, J BIOL CHEM, V285, P39013, DOI 10.1074/jbc.M110.180620; Liu Z, 2008, BIOCHEM BIOPH RES CO, V365, P814, DOI 10.1016/j.bbrc.2007.11.067; Lopez V, 2011, CANCER LETT, V304, P41, DOI 10.1016/j.canlet.2011.01.027; Lu M, 2009, NAT STRUCT MOL BIOL, V16, P1063, DOI 10.1038/nsmb.1662; MacDonald RS, 2000, J NUTR, V130, p1500S, DOI 10.1093/jn/130.5.1500S; Mao XQ, 2007, J BIOL CHEM, V282, P6992, DOI 10.1074/jbc.M610552200; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Nishida K, 2009, J EXP MED, V206, P1351, DOI 10.1084/jem.20082533; Nose Y, 2006, TRENDS BIOCHEM SCI, V31, P604, DOI 10.1016/j.tibs.2006.09.003; Paetzel M, 2002, CHEM REV, V102, P4549, DOI 10.1021/cr010166y; Pawa S, 2008, AM J MED SCI, V336, P430, DOI 10.1097/MAJ.0b013e31815f2c05; PRASAD AS, 1995, NUTRITION, V11, P93; Stout JG, 1996, BIOCHEMISTRY-US, V35, P8289, DOI 10.1021/bi960563g; Suzuki T, 2005, J BIOL CHEM, V280, P30956, DOI 10.1074/jbc.M506902200; Taylor KM, 2008, ENDOCRINOLOGY, V149, P4912, DOI 10.1210/en.2008-0351; Taylor KM, 2005, FEBS LETT, V579, P427, DOI 10.1016/j.febslet.2004.12.006; Taylor KM, 2004, BIOCHEM J, V377, P131, DOI 10.1042/BJ20031183; Taylor KM, 2003, BBA-BIOMEMBRANES, V1611, P16, DOI 10.1016/S0005-2736(03)00048-8; Yamaguchi M, 2010, MOL CELL BIOCHEM, V338, P241, DOI 10.1007/s11010-009-0358-0; Yamasaki S, 2007, J CELL BIOL, V177, P637, DOI 10.1083/jcb.200702081; Zimmermann R, 2011, BBA-BIOMEMBRANES, V1808, P912, DOI 10.1016/j.bbamem.2010.06.015	41	107	111	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40255	40265		10.1074/jbc.M111.256784	http://dx.doi.org/10.1074/jbc.M111.256784			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21917916	Green Published, hybrid			2022-12-25	WOS:000296925700057
J	Saha, S; Bhanja, P; Kabarriti, R; Liu, LB; Alfieri, AA; Guha, C				Saha, Subhrajit; Bhanja, Payel; Kabarriti, Rafi; Liu, Laibin; Alfieri, Alan A.; Guha, Chandan			Bone Marrow Stromal Cell Transplantation Mitigates Radiation-Induced Gastrointestinal Syndrome in Mice	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; SMALL-INTESTINE; GROWTH-FACTOR; R-SPONDIN1; MYOFIBROBLASTS; MACROPHAGES; SURVIVAL; COLITIS; MOUSE; NICHE	Background: Nuclear accidents and terrorism presents a serious threat for mass casualty. While bone-marrow transplantation might mitigate hematopoietic syndrome, currently there are no approved medical countermeasures to alleviate radiation-induced gastrointestinal syndrome (RIGS), resulting from direct cytocidal effects on intestinal stem cells (ISC) and crypt stromal cells. We examined whether bone marrow-derived adherent stromal cell transplantation (BMSCT) could restitute irradiated intestinal stem cells niche and mitigate radiation-induced gastrointestinal syndrome. Methodology/Principal Findings: Autologous bone marrow was cultured in mesenchymal basal medium and adherent cells were harvested for transplantation to C57Bl6 mice, 24 and 72 hours after lethal whole body irradiation (10.4 Gy) or abdominal irradiation (16-20 Gy) in a single fraction. Mesenchymal, endothelial and myeloid population were characterized by flow cytometry. Intestinal crypt regeneration and absorptive function was assessed by histopathology and xylose absorption assay, respectively. In contrast to 100% mortality in irradiated controls, BMSCT mitigated RIGS and rescued mice from radiation lethality after 18 Gy of abdominal irradiation or 10.4 Gy whole body irradiation with 100% survival (p<0.0007 and p<0.0009 respectively) beyond 25 days. Transplantation of enriched myeloid and non-myeloid fractions failed to improve survival. BMASCT induced ISC regeneration, restitution of the ISC niche and xylose absorption. Serum levels of intestinal radioprotective factors, such as, R-Spondin1, KGF, PDGF and FGF2, and anti-inflammatory cytokines were elevated, while inflammatory cytokines were down regulated. Conclusion/Significance: Mitigation of lethal intestinal injury, following high doses of irradiation, can be achieved by intravenous transplantation of marrow-derived stromal cells, including mesenchymal, endothelial and macrophage cell population. BMASCT increases blood levels of intestinal growth factors and induces regeneration of the irradiated host ISC niche, thus providing a platform to discover potential radiation mitigators and protectors for acute radiation syndromes and chemo-radiation therapy of abdominal malignancies.	[Saha, Subhrajit; Bhanja, Payel; Kabarriti, Rafi; Liu, Laibin; Alfieri, Alan A.; Guha, Chandan] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Radiat Oncol, Bronx, NY 10467 USA; [Guha, Chandan] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA	Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Saha, S (corresponding author), Montefiore Med Ctr, Albert Einstein Coll Med, Dept Radiat Oncol, Bronx, NY 10467 USA.	cguhamd@pol.net	SAHA, SUBHRAJIT/AAJ-9272-2021	SAHA, SUBHRAJIT/0000-0002-7287-073X	National Institute of Allergy and Infectious Diseases [1 RC2 AI087612-01, 1U19AI091175-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [RC2AI087612, U19AI091175] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work has been supported by 1 RC2 AI087612-01 and 1U19AI091175-01 on Centers for Medical Countermeasures against Radiation from the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Mageed AS, 2009, BLOOD, V113, P1201, DOI 10.1182/blood-2008-07-170936; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bhanja P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008014; Binnerts ME, 2007, P NATL ACAD SCI USA, V104, P14700, DOI 10.1073/pnas.0702305104; Brittan M, 2005, GASTROENTEROLOGY, V128, P1984, DOI 10.1053/j.gastro.2005.03.028; Brittan M, 2002, GUT, V50, P752, DOI 10.1136/gut.50.6.752; Brittan M, 2002, J PATHOL, V197, P492, DOI 10.1002/path.1155; Durand EM, 2010, CURR OPIN HEMATOL, V17, P308, DOI 10.1097/MOH.0b013e32833a888c; EBERTS TJ, 1979, CLIN CHEM, V25, P1440; GERACI JP, 1985, RADIAT RES, V101, P442, DOI 10.2307/3576503; Ghia JE, 2008, AM J PHYSIOL-GASTR L, V294, pG770, DOI 10.1152/ajpgi.00453.2007; Goessling W, 2011, CELL STEM CELL, V8, P445, DOI 10.1016/j.stem.2011.02.003; Goessling W, 2009, CELL, V136, P1136, DOI 10.1016/j.cell.2009.01.015; Gregory CA, 2005, EXP CELL RES, V306, P330, DOI 10.1016/j.yexcr.2005.03.018; HEIDENREICH S, 1989, J IMMUNOL, V143, P1198; Khan WB, 1997, RADIAT RES, V148, P248, DOI 10.2307/3579609; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7; MASON KA, 1989, RADIAT RES, V117, P480, DOI 10.2307/3577353; Mills JC, 2001, P NATL ACAD SCI USA, V98, P12334, DOI 10.1073/pnas.231487198; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Okamoto R, 2002, NAT MED, V8, P1011, DOI 10.1038/nm755; Parekkadan B, 2008, STEM CELLS, V26, P1913, DOI 10.1634/stemcells.2007-0790; Paris F, 2001, SCIENCE, V293, P293, DOI 10.1126/science.1060191; POTTEN CS, 1990, INT J RADIAT BIOL, V58, P925, DOI 10.1080/09553009014552281; Potten CS, 1997, INT J EXP PATHOL, V78, P219, DOI 10.1046/j.1365-2613.1997.280362.x; Powell DW, 1999, AM J PHYSIOL-CELL PH, V277, pC183, DOI 10.1152/ajpcell.1999.277.2.C183; Pull SL, 2005, P NATL ACAD SCI USA, V102, P99, DOI 10.1073/pnas.0405979102; Riehl T, 2000, GASTROENTEROLOGY, V118, P1106, DOI 10.1016/S0016-5085(00)70363-5; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Semont A, 2010, CELL DEATH DIFFER, V17, P952, DOI 10.1038/cdd.2009.187; Stenson WF, 2004, CURR OPIN GASTROEN, V20, P61, DOI 10.1097/00001574-200403000-00002; Tanaka F, 2008, LIFE SCI, V83, P771, DOI 10.1016/j.lfs.2008.09.016; TERRY NHA, 1989, INT J RADIAT ONCOL, V17, P569, DOI 10.1016/0360-3016(89)90108-9; WITHERS HR, 1970, INT J RADIAT BIOL RE, V17, P261, DOI 10.1080/09553007014550291; Zhang J, 2008, J BIOMED SCI, V15, P585, DOI 10.1007/s11373-008-9256-9; Zhao JS, 2009, P NATL ACAD SCI USA, V106, P2331, DOI 10.1073/pnas.0805159106	37	88	98	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24072	10.1371/journal.pone.0024072	http://dx.doi.org/10.1371/journal.pone.0024072			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21935373	Green Published, gold, Green Submitted			2022-12-25	WOS:000295041700008
J	Genoux, A; Pons, V; Radojkovic, C; Roux-Dalvai, F; Combes, G; Rolland, C; Malet, N; Monsarrat, B; Lopez, F; Ruidavets, JB; Perret, B; Martinez, LO				Genoux, Annelise; Pons, Veronique; Radojkovic, Claudia; Roux-Dalvai, Florence; Combes, Guillaume; Rolland, Corinne; Malet, Nicole; Monsarrat, Bernard; Lopez, Frederic; Ruidavets, Jean-Bernard; Perret, Bertrand; Martinez, Laurent O.			Mitochondrial Inhibitory Factor 1 (IF1) Is Present in Human Serum and Is Positively Correlated with HDL-Cholesterol	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; ATP SYNTHASE; BOVINE F-1-ATPASE; SELECTIVE UPTAKE; CELL-SURFACE; HEPG2 CELLS; I RECEPTOR; PROTEIN; ENDOCYTOSIS; METABOLISM	Background: Mitochondrial ATP synthase is expressed as a plasma membrane receptor for apolipoprotein A-I (apoA-I), the major protein component in High Density Lipoproteins (HDL). On hepatocytes, apoA-I binds to cell surface ATP synthase (namely ecto-F(1)-ATPase) and stimulates its ATPase activity, generating extracellular ADP. This production of extracellular ADP activates a P2Y(13)-mediated HDL endocytosis pathway. Conversely, exogenous IF1, classically known as a natural mitochondrial specific inhibitor of F(1)-ATPase activity, inhibits ecto-F(1)-ATPase activity and decreases HDL endocytosis by both human hepatocytes and perfused rat liver. Methodology/Principal Findings: Since recent reports also described the presence of IF1 at the plasma membrane of different cell types, we investigated whether IF1 is present in the systemic circulation in humans. We first unambiguously detected IF1 in human serum by immunoprecipitation and mass spectrometry. We then set up a competitive ELISA assay in order to quantify its level in human serum. Analyses of IF1 levels in 100 normolipemic male subjects evidenced a normal distribution, with a median value of 0.49 mu g/mL and a 95% confidence interval of 0.22-0.82 mu g/mL. Correlations between IF1 levels and serum lipid levels demonstrated that serum IF1 levels are positively correlated with HDL-cholesterol and negatively with triglycerides (TG). Conclusions/Significance: Altogether, these data support the view that, in humans, circulating IF1 might affect HDL levels by inhibiting hepatic HDL uptake and also impact TG metabolism.	[Genoux, Annelise; Pons, Veronique; Radojkovic, Claudia; Combes, Guillaume; Rolland, Corinne; Malet, Nicole; Lopez, Frederic; Perret, Bertrand; Martinez, Laurent O.] Fac Med Toulouse, INSERM, UMR1048, Inst Malad Metab & Cardiovasc, F-31073 Toulouse, France; [Genoux, Annelise; Pons, Veronique; Radojkovic, Claudia; Combes, Guillaume; Rolland, Corinne; Malet, Nicole; Lopez, Frederic; Ruidavets, Jean-Bernard; Perret, Bertrand; Martinez, Laurent O.] Univ Toulouse, UPS, Toulouse, France; [Genoux, Annelise; Perret, Bertrand] CHU Toulouse, Hop Purpan, Toulouse, France; [Roux-Dalvai, Florence; Monsarrat, Bernard] CNRS, IPBS, Toulouse, France; [Ruidavets, Jean-Bernard] Fac Med Toulouse, INSERM, UMR1027, F-31073 Toulouse, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU de Toulouse; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Genoux, A (corresponding author), Fac Med Toulouse, INSERM, UMR1048, Inst Malad Metab & Cardiovasc, U317, F-31073 Toulouse, France.	Laurent.Martinez@inserm.fr	Martinez, Laurent O/B-8343-2015; PERRET, Bertrand/Y-2326-2019; Martinez, Laurent O./ABD-6880-2020; ROUX-DALVAI, Florence/ABD-4524-2020; Roux-Dalvai, Florence/AAY-4134-2020	Martinez, Laurent O/0000-0002-0985-3152; Martinez, Laurent O./0000-0002-0985-3152; ROUX-DALVAI, Florence/0000-0002-9961-8964; PONS, Veronique/0000-0001-5821-8481; Bertrand, PERRET/0000-0001-7568-445X; Genoux, Annelise/0000-0003-0637-1710	INSERM; National Research Agency [102 01, ANR-2010-EMMA-03501]; l'Agence de Valorisation de la Recherche en Midi-Pyrenees (AVAMIP); Programa de Mejoramiento de la Calidad y la Equidad de la Educacion Superior (MECESUP) [UCO O2O2]; Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT/ambassade de France); Fondation pour la Recherche Medicale (FRM); Region Midi-Pyrenees; Genopole Toulouse Midi-Pyrenees	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); National Research Agency(French National Research Agency (ANR)); l'Agence de Valorisation de la Recherche en Midi-Pyrenees (AVAMIP)(French National Research Agency (ANR)); Programa de Mejoramiento de la Calidad y la Equidad de la Educacion Superior (MECESUP); Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT/ambassade de France)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Region Midi-Pyrenees(Region Provence-Alpes-Cote d'AzurRegion Occitanie); Genopole Toulouse Midi-Pyrenees(Region Occitanie)	This study was supported by the INSERM Avenir Grant, the National Research Agency (GENO #102 01 and ANR EMERGENCE # ANR-2010-EMMA-03501) and l'Agence de Valorisation de la Recherche en Midi-Pyrenees (AVAMIP). V.P. was a recipient of an INSERM young scientist fellowship. C.R. was a recipient of a fellowship from the "Programa de Mejoramiento de la Calidad y la Equidad de la Educacion Superior'' (MECESUP #UCO O2O2) and from the "Comision Nacional de Investigacion Cientifica y Tecnologica'' (CONICYT/ambassade de France). The proteomic work was supported by grants from the Fondation pour la Recherche Medicale (FRM), the Region Midi-Pyrenees and the Genopole Toulouse Midi-Pyrenees. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakaki N, 2007, FEBS LETT, V581, P3405, DOI 10.1016/j.febslet.2007.06.041; Blom D, 2010, BBA-MOL CELL BIOL L, V1801, P1349, DOI 10.1016/j.bbalip.2010.08.013; Burwick NR, 2005, J BIOL CHEM, V280, P1740, DOI 10.1074/jbc.M405947200; Cabezon E, 2000, J BIOL CHEM, V275, P28353, DOI 10.1074/jbc.C000427200; Cabezon E, 2000, J BIOL CHEM, V275, P25460, DOI 10.1074/jbc.M003859200; Cabezon E, 2003, NAT STRUCT BIOL, V10, P744, DOI 10.1038/nsb966; Campanella M, 2008, CELL METAB, V8, P13, DOI 10.1016/j.cmet.2008.06.001; Collet X, 1999, J LIPID RES, V40, P1185; Contessi S, 2004, BIOCHEM PHARMACOL, V67, P1843, DOI 10.1016/j.bcp.2004.02.001; Contessi S, 2007, J BIOENERG BIOMEMBR, V39, P291, DOI 10.1007/s10863-007-9091-0; Cortes-Hernandez P, 2005, BIOCHEM BIOPH RES CO, V330, P844, DOI 10.1016/j.bbrc.2005.03.064; Fabre AC, 2010, HEPATOLOGY, V52, P1477, DOI 10.1002/hep.23897; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Giorgio V, 2010, J BIOENERG BIOMEMBR, V42, P117, DOI 10.1007/s10863-010-9270-2; Graf GA, 1999, J BIOL CHEM, V274, P12043, DOI 10.1074/jbc.274.17.12043; Grau M, 2010, ARCH CARDIOVASC DIS, V103, P80, DOI 10.1016/j.acvd.2009.11.006; Green DW, 2000, BBA-BIOENERGETICS, V1458, P343, DOI 10.1016/S0005-2728(00)00085-2; Harder CJ, 2006, J LIPID RES, V47, P492, DOI 10.1194/jlr.M500444-JLR200; Isaacs A, 2004, J CLIN ENDOCR METAB, V89, P3858, DOI 10.1210/jc.2004-0188; Jacquet S, 2005, CELL MOL LIFE SCI, V62, P2508, DOI 10.1007/s00018-005-5194-0; Lange V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.61; Mangiullo R, 2008, BBA-BIOENERGETICS, V1777, P1326, DOI 10.1016/j.bbabio.2008.08.003; Martinez LO, 2003, NATURE, V421, P75, DOI 10.1038/nature01250; Myszka DG, 1998, TRENDS BIOCHEM SCI, V23, P149, DOI 10.1016/S0968-0004(98)01183-9; PULLMAN ME, 1963, J BIOL CHEM, V238, P3762; Rader DJ, 2006, J CLIN INVEST, V116, P3090, DOI 10.1172/JCI30163; Rohrl C, 2010, HISTOCHEM CELL BIOL, V133, P261, DOI 10.1007/s00418-009-0672-3; Vantourout P, 2010, WORLD J GASTROENTERO, V16, P5925, DOI 10.3748/wjg.v16.i47.5925	28	22	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2011	6	9							e23949	10.1371/journal.pone.0023949	http://dx.doi.org/10.1371/journal.pone.0023949			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JC	21935367	Green Published, Green Submitted, gold			2022-12-25	WOS:000295039700006
J	Kashani, AH; Kirkman, E; Martin, G; Humayun, MS				Kashani, Amir H.; Kirkman, Erlinda; Martin, Gabriel; Humayun, Mark S.			Hyperspectral Computed Tomographic Imaging Spectroscopy of Vascular Oxygen Gradients in the Rabbit Retina In Vivo	PLOS ONE			English	Article							SATURATION; VESSELS; FUNDUS; BLOOD; COMBINATION; CALIBRATION; WAVELENGTH; OXIMETRY; CAMERA	Diagnosis of retinal vascular diseases depends on ophthalmoscopic findings that most often occur after severe visual loss (as in vein occlusions) or chronic changes that are irreversible (as in diabetic retinopathy). Despite recent advances, diagnostic imaging currently reveals very little about the vascular function and local oxygen delivery. One potentially useful measure of vascular function is measurement of hemoglobin oxygen content. In this paper, we demonstrate a novel method of accurately, rapidly and easily measuring oxygen saturation within retinal vessels using in vivo imaging spectroscopy. This method uses a commercially available fundus camera coupled to two-dimensional diffracting optics that scatter the incident light onto a focal plane array in a calibrated pattern. Computed tomographic algorithms are used to reconstruct the diffracted spectral patterns into wavelength components of the original image. In this paper the spectral components of oxy- and deoxyhemoglobin are analyzed from the vessels within the image. Up to 76 spectral measurements can be made in only a few milliseconds and used to quantify the oxygen saturation within the retinal vessels over a 10-15 degree field. The method described here can acquire 10-fold more spectral data in much less time than conventional oximetry systems (while utilizing the commonly accepted fundus camera platform). Application of this method to animal models of retinal vascular disease and clinical subjects will provide useful and novel information about retinal vascular disease and physiology.	[Kashani, Amir H.; Humayun, Mark S.] Univ So Calif, Doheny Eye Inst, Los Angeles, CA 90089 USA; [Kirkman, Erlinda] Univ So Calif, Dept Anim Resources & Vet Med, Los Angeles, CA USA; [Martin, Gabriel] Reichert Technol, Buffalo, NY USA; [Humayun, Mark S.] Univ So Calif, Keck Sch Med, Dept Ophthalmol, Los Angeles, CA 90033 USA; [Humayun, Mark S.] Univ So Calif, Dept Biomed Engn, Viterbi Sch Engn, Los Angeles, CA 90033 USA	Doheny Eye Institute; University of Southern California; University of Southern California; University of Southern California; University of Southern California	Kashani, AH (corresponding author), Univ So Calif, Doheny Eye Inst, Los Angeles, CA 90089 USA.	kashani.ah@gmail.com			National Science Foundation (NSF) Engineering Research Center for Biomimetic and Microelectronic Systems at the University of Southern California [NSF EEC-0310723]; National Institutes of Health (NIH) Core Biostatistics Module at the Doheny Eye Institute [5P30EY003040-30]; Jean Perkins Foundation; Reichert Technologies; NATIONAL EYE INSTITUTE [P30EY003040] Funding Source: NIH RePORTER	National Science Foundation (NSF) Engineering Research Center for Biomimetic and Microelectronic Systems at the University of Southern California(National Science Foundation (NSF)); National Institutes of Health (NIH) Core Biostatistics Module at the Doheny Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Jean Perkins Foundation; Reichert Technologies; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors would like to acknowledge funding support from the National Science Foundation (NSF) Engineering Research Center for Biomimetic and Microelectronic Systems at the University of Southern California (NSF EEC-0310723), National Institutes of Health (NIH) Core Biostatistics Module at the Doheny Eye Institute (NIH Core Grant 5P30EY003040-30), the Jean Perkins Foundation and Reichert Technologies. Reichert Technologies has provided some research funding for development of the hardware and software for this project and has a role in the data analysis but not in the conception, design or execution of the experimental methods. The other funders had no role in study design, data collection and data analysis, decision to publish, or preparation of the manuscript.	Basiri A, 2010, OPT EXPRESS, V18, P3244, DOI 10.1364/OE.18.003244; Beach JM, 1999, J APPL PHYSIOL, V86, P748, DOI 10.1152/jappl.1999.86.2.748; Blackburn GA, 2007, J EXP BOT, V58, P855, DOI 10.1093/jxb/erl123; COHEN AJ, 1976, IEEE T BIO-MED ENG, V23, P391, DOI 10.1109/TBME.1976.324650; DELORI FC, 1988, APPL OPTICS, V27, P1113, DOI 10.1364/AO.27.001113; DESCOUR M, 1995, APPL OPTICS, V34, P4817, DOI 10.1364/AO.34.004817; DESCOUR MR, 1995, P SOC PHOTO-OPT INS, V2480, P48, DOI 10.1117/12.210908; DULING BR, 1979, PFLUG ARCH EUR J PHY, V383, P29, DOI 10.1007/BF00584471; GLOSTER J, 1967, EXP EYE RES, V6, P187, DOI 10.1016/S0014-4835(67)80032-0; Gorman A, 2010, OPT EXPRESS, V18, P5602, DOI 10.1364/OE.18.005602; Hammer H., 2001, International Ophthalmology, V23, P291, DOI 10.1023/A:1014430009122; Hammer M, 2001, IEEE T BIO-MED ENG, V48, P592, DOI 10.1109/10.918598; HAMMER M, 2010, INVEST OPHTH VIS SCI, V52, P274; Hammer M, 2009, GRAEF ARCH CLIN EXP, V247, P1025, DOI 10.1007/s00417-009-1078-6; Hammer M, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2976032; Hardarson SH, 2006, INVEST OPHTH VIS SCI, V47, P5011, DOI 10.1167/iovs.06-0039; Hardarson SH, 2010, AM J OPHTHALMOL, V150, P871, DOI 10.1016/j.ajo.2010.06.020; Hardarson SH, 2009, INVEST OPHTH VIS SCI, V50, P2308, DOI 10.1167/iovs.08-2576; Harris A, 2003, OPHTHAL SURG LAS IM, V34, P152, DOI 10.3928/1542-8877-20030301-16; HICKAM JB, 1963, CIRCULATION, V27, P375, DOI 10.1161/01.CIR.27.3.375; Hirohara Y, 2007, OPT REV, V14, P151, DOI 10.1007/BF02919416; HYVARINEN L, 1967, ACTA OPHTHALMOL, V45, P862; HYVARINEN L, 1967, ACTA OPHTHALMOL, V45, P852; HYVARINEN L, 1967, ACTA OPHTHALMOL, V45, P100; Johnson WR, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2434950; Khoobehi B, 2004, INVEST OPHTH VIS SCI, V45, P1464, DOI 10.1167/iovs.03-1069; LAING RA, 1975, INVEST OPHTH VISUAL, V14, P606; LIPMAN NS, 1987, LAB ANIM SCI, V37, P474; MARINI RP, 1992, LAB ANIM SCI, V42, P57; Martin ME, 2006, ANN BIOMED ENG, V34, P1061, DOI 10.1007/s10439-006-9121-9; Mordant DJ, 2011, EYE, V25, P309, DOI 10.1038/eye.2010.222; Ninomiya H, 2008, J VET MED SCI, V70, P887, DOI 10.1292/jvms.70.887; Nourrit V, 2010, J FR OPHTALMOL, V33, P686, DOI 10.1016/j.jfo.2010.10.010; PITTMAN RN, 1975, J APPL PHYSIOL, V38, P321, DOI 10.1152/jappl.1975.38.2.321; PITTMAN RN, 1975, J APPL PHYSIOL, V38, P315, DOI 10.1152/jappl.1975.38.2.315; Prahl S., OPTICAL ABSORPTION H; Schultz RA, 2001, CYTOMETRY, V43, P239, DOI 10.1002/1097-0320(20010401)43:4<239::AID-CYTO1056>3.0.CO;2-Z; Schweitzer D, 1999, IEEE T BIO-MED ENG, V46, P1454, DOI 10.1109/10.804573; Sorg BS, 2005, J BIOMED OPT, V10, DOI 10.1117/1.2003369; Styp-Rekowska B, 2007, MICROCIRCULATION, V14, P207, DOI 10.1080/10739680601139302; SUGIYAMA K, 1992, INVEST OPHTH VIS SCI, V33, P2251; Timlin JA, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-72; Traustason S, 2009, BRIT J OPHTHALMOL, V93, P1064, DOI 10.1136/bjo.2008.148460; Wankhede M, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3316299	44	26	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2011	6	9							e24482	10.1371/journal.pone.0024482	http://dx.doi.org/10.1371/journal.pone.0024482			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZV	21931729	Green Submitted, Green Published, gold			2022-12-25	WOS:000295321800027
J	Reed, DS; Smith, L; Dunsmore, T; Trichel, A; Ortiz, LA; Cole, KS; Barry, E				Reed, Douglas S.; Smith, Le'Kneitah; Dunsmore, Tammy; Trichel, Anita; Ortiz, Luis A.; Cole, Kelly Stefano; Barry, Eileen			Pneumonic Tularemia in Rabbits Resembles the Human Disease as Illustrated by Radiographic and Hematological Changes after Infection	PLOS ONE			English	Article							FRANCISELLA-TULARENSIS; RESPIRATORY CHALLENGE; MARTHAS-VINEYARD; VACCINE; IMMUNIZATION; PATHOGENESIS; BLOOD	Background: Pneumonic tularemia is caused by inhalation of the gram negative bacterium, Francisella tularensis. Because of concerns that tularemia could be used as a bioterrorism agent, vaccines and therapeutics are urgently needed. Animal models of pneumonic tularemia with a pathophysiology similar to the human disease are needed to evaluate the efficacy of these potential medical countermeasures. Principal Findings: Rabbits exposed to aerosols containing Francisella tularensis strain SCHU S4 developed a rapidly progressive fatal pneumonic disease. Clinical signs became evident on the third day after exposure with development of a fever (> 40.5 degrees C) and a sharp decline in both food and water intake. Blood samples collected on day 4 found lymphopenia and a decrease in platelet counts coupled with elevations in erythrocyte sedimentation rate, alanine aminotransferase, cholesterol, granulocytes and monocytes. Radiographs demonstrated the development of pneumonia and abnormalities of intestinal gas consistent with ileus. On average, rabbits were moribund 5.1 days after exposure; no rabbits survived exposure at any dose (190-54,000 cfu). Gross evaluation of tissues taken at necropsy showed evidence of pathology in the lungs, spleen, liver, kidney and intestines. Bacterial counts confirmed bacterial dissemination from the lungs to the liver and spleen. Conclusions/Significance: The pathophysiology of pneumonic tularemia in rabbits resembles what has been reported for humans. Rabbits therefore are a relevant model of the human disease caused by type A strains of F. tularensis.	[Reed, Douglas S.; Smith, Le'Kneitah; Dunsmore, Tammy; Trichel, Anita; Cole, Kelly Stefano] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA 15260 USA; [Ortiz, Luis A.] Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA USA; [Barry, Eileen] Univ Maryland, Ctr Vaccine Dev, Baltimore, MD 21201 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Maryland; University of Maryland Baltimore	Reed, DS (corresponding author), Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA 15260 USA.	dsreed@pitt.edu	Reed, Douglas/AAA-2587-2020; ortiz, luis a/H-9851-2013	Reed, Douglas/0000-0003-0076-9023; ortiz, luis a/0000-0003-4510-7066	National Institute of Allergy and Infectious Diseases (NIAID) [U01 AI077909-01, U54 AI57168]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057168, U01AI077909] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	These studies were funded by the National Institute of Allergy and Infectious Diseases (NIAID) grants U01 AI077909-01 and U54 AI57168. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	BARRY EM, 2011, 2011 ASM BIOD EM INF; BASKERVILLE A, 1976, BRIT J EXP PATHOL, V57, P339; BURKE DS, 1977, J INFECT DIS, V135, P55, DOI 10.1093/infdis/135.1.55; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; Feldman KA, 2001, NEW ENGL J MED, V345, P1601, DOI 10.1056/NEJMoa011374; Food and Drug Administration HHS, 2002, Fed Regist, V67, P37988; HAMBLETON P, 1977, BRIT J EXP PATHOL, V58, P644; Hepburn MJ, 2006, CLIN INFECT DIS, V43, P711, DOI 10.1086/506348; HORNICK RB, 1966, BACTERIOL REV, V30, P532, DOI 10.1128/MMBR.30.3.532-538.1966; Lamps LW, 2004, MODERN PATHOL, V17, P489, DOI 10.1038/modpathol.3800087; Lyons CR, 2007, ANN NY ACAD SCI, V1105, P238, DOI 10.1196/annals.1409.003; Matyas BI, 2007, ANN NY ACAD SCI, V1105, P351, DOI 10.1196/annals.1409.013; MCCRUMB FR, 1961, BACTERIOL REV, V25, P262, DOI 10.1128/MMBR.25.3.262-267.1961; Pasetti MF, 2008, VACCINE, V26, P1773, DOI 10.1016/j.vaccine.2008.01.005; Pechous RD, 2009, MICROBIOL MOL BIOL R, V73, P684, DOI 10.1128/MMBR.00028-09; Ray HJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009952; Raymond CR, 2009, MICROB PATHOGENESIS, V46, P231, DOI 10.1016/j.micpath.2009.01.002; Rohmer L, 2006, INFECT IMMUN, V74, P6895, DOI 10.1128/IAI.01006-06; Roy CJ, 2005, BIODEFENSE RES METHO, P61; SASLAW S, 1961, ARCH INTERN MED, V107, P702, DOI 10.1001/archinte.1961.03620050068007; SASLAW S, 1961, AM J MED SCI, V241, P689, DOI 10.1097/00000441-196106000-00001; Sese B. T., 1996, World Rabbit Science, V4, P15; TULIS JJ, 1970, AM J PATHOL, V58, P329; Twine SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010000; Wu TH, 2009, VACCINE, V27, P4684, DOI 10.1016/j.vaccine.2009.05.060	25	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2011	6	9							e24654	10.1371/journal.pone.0024654	http://dx.doi.org/10.1371/journal.pone.0024654			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZV	21931798	Green Published, gold, Green Accepted			2022-12-25	WOS:000295321800044
J	Alkaabi, JM; Al Neyadi, M; Al Darei, F; Al Mazrooei, M; Al Yazedi, J; Abdulle, AM				Alkaabi, Juma M.; Al Neyadi, Mariam; Al Darei, Fakhra; Al Mazrooei, Mariam; Al Yazedi, Jawaher; Abdulle, Abdishakur M.			Terrestrial Snakebites in the South East of the Arabian Peninsula: Patient Characteristics, Clinical Presentations, and Management	PLOS ONE			English	Article							BITES	Background: To describe the characteristics, clinical presentations, management and complications of snakebites in the border region between Al-Ain, United Arab Emirates (UAE) and Buraimi, Sultanate of Oman. Methodology/Principal Findings: We carried out a retrospective review of medical records to study snakebite cases over four-year duration at three tertiary hospitals. Overall, 64 snakebite cases were studied with median hospitalization of 2 (interquartile range [IQR] 1-4) days. The majority of cases were male (87.5%), and most (61%) of the incidents occurred during summer months. The bite sites were predominantly (95%) to the feet and hands. Main clinical features included pain, local swelling, and coagulopathy, blistering and skin peeling. Overall, there were no deaths, but few major complications occurred; extensive skin peeling (n = 5, 8%), multi-organ failure (n = 1, 1.5%), and compartment syndrome (n = 1, 1.5%). Polyvalent anti snake venom (ASV), analgesia, tetanus toxoid, intravenous fluids, and antibiotics such as ampicillin, cloxacillin, and cephalosporins were commonly instituted as part of treatment protocols in the three hospitals. Conclusion: The overwhelming majority of bites occurred during summer months, and envenomations were more common in, relatively, young male farmers, but with no serious clinical complications. Prevention and treatment strategies should include increasing public awareness, developing management guidelines, and manufacturing specific ASV for a wide spectrum of the local venomous snakes.	[Alkaabi, Juma M.; Al Neyadi, Mariam; Al Darei, Fakhra; Al Mazrooei, Mariam; Abdulle, Abdishakur M.] United Arab Emirates Univ, Dept Internal Med, Fac Med & Hlth Sci, Al Ain, U Arab Emirates; [Al Yazedi, Jawaher] Buraimi Hosp, Dept Internal Med, Buraimi, Oman	United Arab Emirates University	Alkaabi, JM (corresponding author), United Arab Emirates Univ, Dept Internal Med, Fac Med & Hlth Sci, Al Ain, U Arab Emirates.	j.kaabi@uaeu.ac.ae		Alkaabi, Juma/0000-0003-2477-0408				Arroyo O., 1980, Bulletin of the Pan American Health Organization, V14, P280; Cheng Allen C, 2004, J Intensive Care Med, V19, P259, DOI 10.1177/0885066604265799; Chippaux JP, 1998, B WORLD HEALTH ORGAN, V76, P515; Cruz LS, 2009, ETHN DIS, V19; Egan D, 2007, SNAKES ARABIA FIELD, P20; Gardner AS, 2009, ZOOKEYS, P165, DOI 10.3897/zookeys.31.133; Garg A, 2009, J INFECT DEV COUNTR, V3, P221; Harrison RA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000569; Ismail M, 2003, INT J ANTIMICROB AG, V21, P164, DOI 10.1016/S0924-8579(02)00292-3; Kasturiratne A, 2008, PLOS MED, V5, P1591, DOI 10.1371/journal.pmed.0050218; Kerrigan KR, 1997, WORLD J SURG, V21, P369, DOI 10.1007/PL00012255; LEDBETTER EO, 1969, ARCH ENVIRON HEALTH, V19, P770, DOI 10.1080/00039896.1969.10666929; MALIK GM, 1995, AM J TROP MED HYG, V52, P314, DOI 10.4269/ajtmh.1995.52.314; Mandell GL, 1995, MANDELL DOUGLAS BENN; Mohan KN, 1988, J POSTGRAD DOCT MIDD, V11, P24; SCHULCHYNSKACASTEL H, 1986, ISRAEL J MED SCI, V22, P880; Scrimegeour EM, 2001, OMAN MED J, V18, P20; WARRELL DA, 1993, BRIT MED BULL, V49, P423, DOI 10.1093/oxfordjournals.bmb.a072619; WHO, 2007, RAB ENV NEGL PUBL HL	19	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2011	6	9							e24637	10.1371/journal.pone.0024637	http://dx.doi.org/10.1371/journal.pone.0024637			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CO	21931788	gold, Green Published			2022-12-25	WOS:000294803200034
J	Gleason, JE; Corrigan, DJ; Cox, JE; Reddi, AR; McGinnis, LA; Culotta, VC				Gleason, Julie E.; Corrigan, David J.; Cox, James E.; Reddi, Amit R.; McGinnis, Lauren A.; Culotta, Valeria C.			Analysis of Hypoxia and Hypoxia-Like States through Metabolite Profiling	PLOS ONE			English	Article							AMINO-ACID PERMEASES; YEAST IRON REGULON; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTORS; MEMBRANE-PROTEINS; ESCHERICHIA-COLI; SENSING PATHWAY; GENE-EXPRESSION; COBALT STRESS; OXYGEN	Background: In diverse organisms, adaptation to low oxygen (hypoxia) is mediated through complex gene expression changes that can, in part, be mimicked by exposure to metals such as cobalt. Although much is known about the transcriptional response to hypoxia and cobalt, little is known about the all-important cell metabolism effects that trigger these responses. Methods and Findings: Herein we use a low molecular weight metabolome profiling approach to identify classes of metabolites in yeast cells that are altered as a consequence of hypoxia or cobalt exposures. Key findings on metabolites were followed-up by measuring expression of relevant proteins and enzyme activities. We find that both hypoxia and cobalt result in a loss of essential sterols and unsaturated fatty acids, but the basis for these changes are disparate. While hypoxia can affect a variety of enzymatic steps requiring oxygen and heme, cobalt specifically interferes with diiron-oxo enzymatic steps for sterol synthesis and fatty acid desaturation. In addition to diiron-oxo enzymes, cobalt but not hypoxia results in loss of labile 4Fe-4S dehydratases in the mitochondria, but has no effect on homologous 4Fe-4S dehydratases in the cytosol. Most striking, hypoxia but not cobalt affected cellular pools of amino acids. Amino acids such as aromatics were elevated whereas leucine and methionine, essential to the strain used here, dramatically decreased due to hypoxia induced down-regulation of amino acid permeases. Conclusions: These studies underscore the notion that cobalt targets a specific class of iron proteins and provide the first evidence for hypoxia effects on amino acid regulation. This research illustrates the power of metabolite profiling for uncovering new adaptations to environmental stress.	[Gleason, Julie E.; Corrigan, David J.; Reddi, Amit R.; McGinnis, Lauren A.; Culotta, Valeria C.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21218 USA; [Cox, James E.] Univ Utah, Sch Med, Metab Core Res Facil, Salt Lake City, UT USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Utah System of Higher Education; University of Utah	Gleason, JE (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21218 USA.	vculotta@jhsph.edu		Corrigan, David/0000-0002-8239-129X	NIH [RO1 ES08996, F32 GM093550]; NIEHS [T32 ES07141]; NIDDK [P30 DK072437]; JHU NIEHS center [P30 ES003819]; NATIONAL CANCER INSTITUTE [T32CA009110] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072437] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007141, P30ES003819, R01ES008996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM093550] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); JHU NIEHS center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The study was funded by the following: NIH RO1 ES08996 to VCC; NIEHS T32 ES07141 to JEG and ARR; NIH post doc fellowship F32 GM093550 to ARR; Center of Excellence Grant in Molecular Hemotology NIDDK P30 DK072437 to JEC; and JHU NIEHS center P30 ES003819. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Sater F, 2004, GENETICS, V166, P1727, DOI 10.1534/genetics.166.4.1727; Borenstein X, 2010, NITRIC OXIDE-BIOL CH, V23, P234, DOI 10.1016/j.niox.2010.07.003; BRAUS GH, 1991, MICROBIOL REV, V55, P349, DOI 10.1128/MMBR.55.3.349-370.1991; Chellappa R, 2001, J BIOL CHEM, V276, P43548, DOI 10.1074/jbc.M107845200; Chen OS, 2004, J BIOL CHEM, V279, P29513, DOI 10.1074/jbc.M403209200; Chin CS, 2008, PLOS BIOL, V6, P1343, DOI 10.1371/journal.pbio.0060146; Davies BSJ, 2006, GENETICS, V174, P191, DOI 10.1534/genetics.106.059964; Ecker N, 2010, AUTOPHAGY, V6, P879, DOI 10.4161/auto.6.7.12753; Forsberg H, 2001, MOL CELL BIOL, V21, P814, DOI 10.1128/MCB.21.3.814-826.2001; GEBER A, 1995, ANTIMICROB AGENTS CH, V39, P2708, DOI 10.1128/AAC.39.12.2708; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GIACOMINI A, 1992, FEMS MICROBIOL LETT, V79, P87; Hirsila M, 2005, FASEB J, V19, P1308, DOI 10.1096/fj.04-3399fje; Hoenig MR, 2008, CURR DRUG TARGETS, V9, P422, DOI 10.2174/138945008784221215; Inoue Y, 2010, SEMIN CELL DEV BIOL, V21, P664, DOI 10.1016/j.semcdb.2010.03.009; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jensen LT, 2003, J BIOL CHEM, V278, P42036, DOI 10.1074/jbc.M307413200; Jensen LT, 2002, J MOL BIOL, V318, P251, DOI 10.1016/S0022-2836(02)00093-1; Jiang YD, 2001, MOL CELL BIOL, V21, P6161, DOI 10.1128/MCB.21.18.6161-6169.2001; Kota J, 2007, J CELL BIOL, V176, P617, DOI 10.1083/jcb.200612100; Kundaje A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000224; Kwast KE, 1999, P NATL ACAD SCI USA, V96, P5446, DOI 10.1073/pnas.96.10.5446; Lawrence C.W., 1978, METHODS YEAST GENETI, P178; Lee H, 2007, MOL MICROBIOL, V65, P1018, DOI 10.1111/j.1365-2958.2007.05844.x; Li Q, 2009, CARCINOGENESIS, V30, P1243, DOI 10.1093/carcin/bgp088; Ljungdahl PO, 2009, BIOCHEM SOC T, V37, P242, DOI 10.1042/BST0370242; Lund EG, 1998, J BIOL CHEM, V273, P34316, DOI 10.1074/jbc.273.51.34316; Macomber L, 2009, P NATL ACAD SCI USA, V106, P8344, DOI 10.1073/pnas.0812808106; Mao XR, 2010, MOL CELL BIOL, V30, P5033, DOI 10.1128/MCB.00922-10; Martel CM, 2010, ANTIMICROB AGENTS CH, V54, P3578, DOI 10.1128/AAC.00303-10; Martin CE, 2007, BBA-MOL CELL BIOL L, V1771, P271, DOI 10.1016/j.bbalip.2006.06.010; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Omura F, 2001, BIOCHEM BIOPH RES CO, V287, P1045, DOI 10.1006/bbrc.2001.5697; Portnoy ME, 2000, MOL CELL BIOL, V20, P7893, DOI 10.1128/MCB.20.21.7893-7902.2000; Ranquet C, 2007, J BIOL CHEM, V282, P30442, DOI 10.1074/jbc.M702519200; Regenberg B, 1999, CURR GENET, V36, P317, DOI 10.1007/s002940050506; Rutherford JC, 2005, J BIOL CHEM, V280, P10135, DOI 10.1074/jbc.M413731200; Salnikow K, 2004, J BIOL CHEM, V279, P40337, DOI 10.1074/jbc.M403057200; SEMENZA GL, 2007, SCI STKE, pCM8, DOI DOI 10.1126/STKE.4072007CM8; Semenza GL, 2009, BLOOD, V114, P2015, DOI 10.1182/blood-2009-05-189985; Shakoury-Elizeh M, 2010, J BIOL CHEM, V285, P14823, DOI 10.1074/jbc.M109.091710; Skovran E, 2004, J BACTERIOL, V186, P7626, DOI 10.1128/JB.186.22.7626-7634.2004; Slocum RH, 1991, TECHNIQUES DIAGNOSTI, P87; Solberg R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009606; Stadler JA, 2002, J BIOL CHEM, V277, P39649, DOI 10.1074/jbc.M203924200; STUKEY JE, 1989, J BIOL CHEM, V264, P16537; Taylor CT, 2008, BIOCHEM J, V409, P19, DOI 10.1042/BJ20071249; Thorgersen MP, 2007, J BACTERIOL, V189, P7774, DOI 10.1128/JB.00962-07; Varghese S, 2003, J BACTERIOL, V185, P221, DOI 10.1128/JB.185.1.221-230.2003; Wagatsuma A, 2011, MOL CELL BIOCHEM, V347, P145, DOI 10.1007/s11010-010-0622-3; Wang PJ, 1997, MOL CELL BIOL, V17, P6114, DOI 10.1128/MCB.17.10.6114; Yuan Y, 2003, J BIOL CHEM, V278, P15911, DOI 10.1074/jbc.M300463200; Zargari A, 2007, J BIOL CHEM, V282, P594, DOI 10.1074/jbc.M609201200	53	26	26	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2011	6	9							e24741	10.1371/journal.pone.0024741	http://dx.doi.org/10.1371/journal.pone.0024741			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CO	21931840	Green Published, Green Submitted, gold			2022-12-25	WOS:000294803200046
J	Metkar, SS; Wang, BK; Catalan, E; Anderluh, G; Gilbert, RJC; Pardo, J; Froelich, CJ				Metkar, Sunil S.; Wang, Baikun; Catalan, Elena; Anderluh, Gregor; Gilbert, Robert J. C.; Pardo, Julian; Froelich, Christopher J.			Perforin Rapidly Induces Plasma Membrane Phospholipid Flip-Flop	PLOS ONE			English	Article							PORE-FORMING PROTEIN; GRANZYME-B; TARGET-CELLS; CYTOSOLIC DELIVERY; EQUINATOXIN-II; GRANULES; CYTOTOXICITY; MECHANISM; DEATH; LYMPHOCYTES	The cytotoxic cell granule secretory pathway is essential for host defense. This pathway is fundamentally a form of intracellular protein delivery where granule proteases (granzymes) from cytotoxic lymphocytes are thought to diffuse through barrel stave pores generated in the plasma membrane of the target cell by the pore forming protein perforin (PFN) and mediate apoptotic as well as additional biological effects. While recent electron microscopy and structural analyses indicate that recombinant PFN oligomerizes to form pores containing 20 monomers (20 nm) when applied to liposomal membranes, these pores are not observed by propidium iodide uptake in target cells. Instead, concentrations of human PFN that encourage granzyme-mediated apoptosis are associated with pore structures that unexpectedly favor phosphatidylserine flip-flop measured by Annexin-V and Lactadherin. Efforts that reduce PFN mediated Ca influx in targets did not reduce Annexin-V reactivity. Antigen specific mouse CD8 cells initiate a similar rapid flip-flop in target cells. A lipid that augments plasma membrane curvature as well as cholesterol depletion in target cells enhance flip-flop. Annexin-V staining highly correlated with apoptosis after Granzyme B (GzmB) treatment. We propose the structures that PFN oligomers form in the membrane bilayer may include arcs previously observed by electron microscopy and that these unusual structures represent an incomplete mixture of plasma membrane lipid and PFN oligomers that may act as a flexible gateway for GzmB to translocate across the bilayer to the cytosolic leaflet of target cells.	[Metkar, Sunil S.; Wang, Baikun; Froelich, Christopher J.] NorthShore Univ, Dept Med, HealthSyst Res Inst, Evanston, IL 60201 USA; [Anderluh, Gregor] Univ Ljubljana, Dept Biol, Biotech Fac, Ljubljana, Slovenia; [Gilbert, Robert J. C.] Henry Wellcome Bldg Genom Med, Div Struct Biol, Oxford, England; [Catalan, Elena; Pardo, Julian] Univ Zaragoza, Dept Bioquim & Biol Mol & Celullar, Zaragoza, Spain; [Pardo, Julian] Fdn Aragon I D, Zaragoza, Spain	NorthShore University Health System; University of Ljubljana; University of Oxford; University of Zaragoza	Metkar, SS (corresponding author), NorthShore Univ, Dept Med, HealthSyst Res Inst, Evanston, IL 60201 USA.	cfroelich@uchicago.edu	Anderluh, Gregor/C-6905-2014; Pardo, Julián/K-6764-2014	Anderluh, Gregor/0000-0002-9916-8465; Pardo, Julián/0000-0003-0154-0730; Gilbert, Robert/0000-0001-9336-5604	National Institute of Allergy and Infectious diseases, National Institutes of Health [5RO1AI04494-03]; Slovenian Research Agency; Fundacion Agencia Aragonesa para la Investigacion y Desarrollo; Spanish Ministry of Science and Innovation [SAF2008-02139, SAF2007-65144]	National Institute of Allergy and Infectious diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Slovenian Research Agency(Slovenian Research Agency - Slovenia); Fundacion Agencia Aragonesa para la Investigacion y Desarrollo; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	CF was supported through 5RO1AI04494-03 from the National Institute of Allergy and Infectious diseases, National Institutes of Health. RG is a Royal Society University Research Fellow. GA received financial support from the Slovenian Research Agency. JP was supported by Fundacion Agencia Aragonesa para la Investigacion y Desarrollo and grant SAF2008-02139 from Spanish Ministry of Science and Innovation. EC is a pre-doctoral fellow ascribed to grant SAF2007-65144 from Spanish Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allende D, 2005, BIOPHYS J, V88, P1828, DOI 10.1529/biophysj.104.049817; Almers W, 2001, NATURE, V409, P567, DOI 10.1038/35054637; Anderluh G, 2003, J BIOL CHEM, V278, P45216, DOI 10.1074/jbc.M305916200; Andersson A, 2007, BBA-BIOMEMBRANES, V1768, P115, DOI 10.1016/j.bbamem.2006.07.009; Apellaniz B, 2010, BIOPHYS J, V99, P3619, DOI 10.1016/j.bpj.2010.09.027; Basanez G, 2002, J BIOL CHEM, V277, P49360, DOI 10.1074/jbc.M206069200; Browne KA, 1999, MOL CELL BIOL, V19, P8604; CRIADO M, 1985, J IMMUNOL, V135, P4245; Czajkowsky DM, 2004, EMBO J, V23, P3206, DOI 10.1038/sj.emboj.7600350; DOURMASHKIN RR, 1980, CLIN EXP IMMUNOL, V42, P554; FATTAL E, 1994, BIOCHEMISTRY-US, V33, P6721, DOI 10.1021/bi00187a044; Frangez R, 2008, TOXICON, V51, P1416, DOI 10.1016/j.toxicon.2008.03.013; Froelich CJ, 1996, BIOCHEM BIOPH RES CO, V229, P44, DOI 10.1006/bbrc.1996.1755; Froelich CJ, 1996, J BIOL CHEM, V271, P29073, DOI 10.1074/jbc.271.46.29073; Gilbert RJC, 2005, STRUCTURE, V13, P1097, DOI 10.1016/j.str.2005.04.019; Gilbert RJC, 2010, ADV EXP MED BIOL, V677, P56; Gurtovenko AA, 2007, J PHYS CHEM B, V111, P13554, DOI 10.1021/jp077094k; Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456; HENKART PA, 1984, J EXP MED, V160, P75, DOI 10.1084/jem.160.1.75; HENKART PA, 1985, ANNU REV IMMUNOL, V3, P31, DOI 10.1146/annurev.iy.03.040185.000335; Hirt UA, 2000, J IMMUNOL, V164, P6520, DOI 10.4049/jimmunol.164.12.6520; Idone V, 2008, J CELL BIOL, V180, P905, DOI 10.1083/jcb.200708010; Keefe D, 2005, IMMUNITY, V23, P249, DOI 10.1016/j.immuni.2005.08.001; Korchev YE, 1997, FASEB J, V11, P600, DOI 10.1096/fasebj.11.7.9212084; Law RHP, 2010, NATURE, V468, P447, DOI 10.1038/nature09518; MASSON D, 1987, CELL, V49, P679, DOI 10.1016/0092-8674(87)90544-7; Metkar SS, 2005, J IMMUNOL METHODS, V299, P117, DOI 10.1016/j.jim.2005.02.003; Metkar SS, 2003, J CELL BIOL, V160, P875, DOI 10.1083/jcb.200210158; Metkar SS, 2002, IMMUNITY, V16, P417, DOI 10.1016/S1074-7613(02)00286-8; Metkar SS, 2008, IMMUNITY, V29, P720, DOI 10.1016/j.immuni.2008.08.014; Mihailescu M, 2011, BIOPHYS J, V100, P1455, DOI 10.1016/j.bpj.2011.01.035; Moreno RU, 2009, BLOOD, V113, P338, DOI 10.1182/blood-2008-08-172924; OJCIUS DM, 1990, MOL IMMUNOL, V27, P257, DOI 10.1016/0161-5890(90)90138-P; ORTALDO JR, 1992, J LEUKOCYTE BIOL, V52, P483, DOI 10.1002/jlb.52.5.483; Pardo J, 2008, CELL DEATH DIFFER, V15, P567, DOI 10.1038/sj.cdd.4402289; PETERS R, 1990, EMBO J, V9, P2447, DOI 10.1002/j.1460-2075.1990.tb07421.x; Pipkin ME, 2007, CURR OPIN IMMUNOL, V19, P301, DOI 10.1016/j.coi.2007.04.011; PODACK ER, 1983, NATURE, V302, P442, DOI 10.1038/302442a0; Praper T, 2011, J BIOL CHEM, V286, P2946, DOI 10.1074/jbc.M110.169417; Praper T, 2010, MOL IMMUNOL, V47, P2492, DOI 10.1016/j.molimm.2010.06.001; Qian S, 2008, P NATL ACAD SCI USA, V105, P17379, DOI 10.1073/pnas.0807764105; RADOSEVIC K, 1995, CYTOMETRY, V20, P281, DOI 10.1002/cyto.990200403; Regner M, 2009, J IMMUNOL, V183, P37, DOI 10.4049/jimmunol.0900466; SAUER H, 1991, BIOCHIM BIOPHYS ACTA, V1063, P137, DOI 10.1016/0005-2736(91)90363-D; Sobko AA, 2004, FEBS LETT, V576, P205, DOI 10.1016/j.febslet.2004.09.016; Sobko AA, 2006, J BIOL CHEM, V281, P14408, DOI 10.1074/jbc.M513634200; Teissie J, 2005, BBA-GEN SUBJECTS, V1724, P270, DOI 10.1016/j.bbagen.2005.05.006; TSCHOPP J, 1986, J IMMUNOL, V137, P1950; TSCHOPP J, 1989, NATURE, V337, P272, DOI 10.1038/337272a0; Voskoboinik I, 2005, J BIOL CHEM, V280, P8426, DOI 10.1074/jbc.M413303200; Voskoboinik I, 2006, NAT REV IMMUNOL, V6, P940, DOI 10.1038/nri1983; WEAVER JC, 1994, ANN NY ACAD SCI, V720, P141, DOI 10.1111/j.1749-6632.1994.tb30442.x; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; YOUNG JDE, 1986, CELL, V44, P849, DOI 10.1016/0092-8674(86)90007-3; YOUNG JDE, 1986, J EXP MED, V164, P144, DOI 10.1084/jem.164.1.144; Yu Y, 2010, J AM CHEM SOC, V132, P195, DOI 10.1021/ja9059014; Zweifach A, 2000, BIOCHEM J, V349, P255, DOI 10.1042/0264-6021:3490255	57	41	42	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2011	6	9							e24286	10.1371/journal.pone.0024286	http://dx.doi.org/10.1371/journal.pone.0024286			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CO	21931672	Green Published, Green Submitted, gold			2022-12-25	WOS:000294803200011
J	Chang, I; Heiske, M; Letellier, T; Wallace, D; Baldi, P				Chang, Ivan; Heiske, Margit; Letellier, Thierry; Wallace, Douglas; Baldi, Pierre			Modeling of Mitochondria Bioenergetics Using a Composable Chemiosmotic Energy Transduction Rate Law: Theory and Experimental Validation	PLOS ONE			English	Article							OXIDATIVE-PHOSPHORYLATION; KINETICS; HEART; OXIDOREDUCTASE; METABOLISM; REDUCTION; TRANSPORT	Mitochondrial bioenergetic processes are central to the production of cellular energy, and a decrease in the expression or activity of enzyme complexes responsible for these processes can result in energetic deficit that correlates with many metabolic diseases and aging. Unfortunately, existing computational models of mitochondrial bioenergetics either lack relevant kinetic descriptions of the enzyme complexes, or incorporate mechanisms too specific to a particular mitochondrial system and are thus incapable of capturing the heterogeneity associated with these complexes across different systems and system states. Here we introduce a new composable rate equation, the chemiosmotic rate law, that expresses the flux of a prototypical energy transduction complex as a function of: the saturation kinetics of the electron donor and acceptor substrates; the redox transfer potential between the complex and the substrates; and the steady-state thermodynamic force-to-flux relationship of the overall electro-chemical reaction. Modeling of bioenergetics with this rate law has several advantages: (1) it minimizes the use of arbitrary free parameters while featuring biochemically relevant parameters that can be obtained through progress curves of common enzyme kinetics protocols; (2) it is modular and can adapt to various enzyme complex arrangements for both in vivo and in vitro systems via transformation of its rate and equilibrium constants; (3) it provides a clear association between the sensitivity of the parameters of the individual complexes and the sensitivity of the system's steady-state. To validate our approach, we conduct in vitro measurements of ETC complex I, III, and IV activities using rat heart homogenates, and construct an estimation procedure for the parameter values directly from these measurements. In addition, we show the theoretical connections of our approach to the existing models, and compare the predictive accuracy of the rate law with our experimentally fitted parameters to those of existing models. Finally, we present a complete perturbation study of these parameters to reveal how they can significantly and differentially influence global flux and operational thresholds, suggesting that this modeling approach could help enable the comparative analysis of mitochondria from different systems and pathological states. The procedures and results are available in Mathematica notebooks at http://www.igb.uci.edu/tools/sb/mitochondria-modeling.html.	[Chang, Ivan] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92697 USA; [Chang, Ivan; Baldi, Pierre] Univ Calif Irvine, Inst Genom Biol, Irvine, CA USA; [Heiske, Margit; Letellier, Thierry] Univ Bordeaux 2, INSERM, U688, F-33076 Bordeaux, France; [Wallace, Douglas] Univ Calif Irvine, Dept Biochem, Irvine, CA 92717 USA; [Wallace, Douglas] Univ Calif Irvine, Ctr Mitochondrial & Mol Med & Genet MAMMAG, Irvine, CA USA; [Wallace, Douglas; Baldi, Pierre] Univ Calif Irvine, Dept Comp Sci, Irvine, CA USA	University of California System; University of California Irvine; University of California System; University of California Irvine; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Chang, I (corresponding author), Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92697 USA.	pfbaldi@ics.uci.edu			National Institutes of Health (NIH) [5T15LM007743, NS21328, AG24373, AG13154, DK73691]; National Science Foundation [MRI EIA-0321390]; Institute for Genomics and Bioinformatics at UCI; ARRA [RFA-MH-09-170]; Doris Duke Clinical Interfaces grant; California Institute for Regenerative Medicine [RC1-00353-1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073691] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG024373, R01AG013154] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Institute for Genomics and Bioinformatics at UCI; ARRA; Doris Duke Clinical Interfaces grant; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Work supported by National Institutes of Health (NIH) Biomedical Informatics Training Program Grant 5T15LM007743 and National Science Foundation Grant MRI EIA-0321390 to PB and the Institute for Genomics and Bioinformatics at UCI, and NIH grants NS21328, AG24373, AG13154, DK73691, and ARRA(RFA-MH-09-170) as well as a Doris Duke Clinical Interfaces grant and a California Institute for Regenerative Medicine Comprehensive grant RC1-00353-1 award to DCW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazil JN, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000632; Beard DA, 2005, PLOS COMPUT BIOL, V1, P252, DOI 10.1371/journal.pcbi.0010036; Beard DA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001825; Beard DA, 2006, PLOS COMPUT BIOL, V2, P1093, DOI 10.1371/journal.pcbi.0020107; Benard G, 2006, AM J PHYSIOL-CELL PH, V291, pC1172, DOI 10.1152/ajpcell.00195.2006; Benard G, 2007, J CELL SCI, V120, P838, DOI 10.1242/jcs.03381; Boekema EJ, 2007, J BIOL CHEM, V282, P1, DOI 10.1074/jbc.R600031200; BRAND M, 2005, BIOCHEM SOC T, V33; Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607; Brandon MC, 2009, HUM MUTAT, V30, P1, DOI 10.1002/humu.20801; Chen XW, 2010, BIOPHYS J, V99, P1426, DOI 10.1016/j.bpj.2010.06.063; CLELAND WW, 1963, BIOCHIM BIOPHYS ACTA, V67, P104, DOI 10.1016/0926-6569(63)90211-6; Cortassa S, 2009, BIOPHYS J, V96, P2466, DOI 10.1016/j.bpj.2008.12.3893; DEMIN OV, 1998, MOL CELL BIOCHEM, V184, P2133; Fato R, 1996, BIOCHEMISTRY-US, V35, P2705, DOI 10.1021/bi9516034; Guillaud F, 2008, ACTA BIOTHEOR, V56, P157, DOI 10.1007/s10441-008-9035-z; Hill T. L., 1989, FREE ENERGY TRANSDUC, DOI 10.1007/978-1-4612-3558-3; Hill T.L., 1977, FREE ENERGY TRANSDUC; Jin QS, 2003, APPL ENVIRON MICROB, V69, P2340, DOI 10.1128/AEM.69.4.2340-2348.2003; Jin QS, 2002, BIOPHYS J, V83, P1797, DOI 10.1016/S0006-3495(02)73945-3; Kacser H, 1973, Symp Soc Exp Biol, V27, P65; Klamt S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100191; Korzeniewski B, 2005, BIOPHYS CHEM, V116, P145, DOI 10.1016/j.bpc.2005.04.001; Korzeniewski B, 2001, BIOPHYS CHEM, V92, P17, DOI 10.1016/S0301-4622(01)00184-3; Kushnareva Y, 2002, BIOCHEM J, V368, P545, DOI 10.1042/BJ20021121; LALES C, 2009, ARXIV09013910; LETELLIER T, 1994, BIOCHEM J, V302, P171, DOI 10.1042/bj3020171; Letellier T, 1998, MOL CELL BIOCHEM, V184, P409, DOI 10.1023/A:1006826927220; Loeb LA, 2005, P NATL ACAD SCI USA, V102, P18769, DOI 10.1073/pnas.0509776102; Marangoni A.G., 2003, ENZYME KINETICS MODE; Mitchell P., 1969, THEORETICAL EXPT BIO, V2, P159; Modre-Osprian R, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-2; Nelson N, 2002, NAT REV MOL CELL BIO, V3, P876, DOI 10.1038/nrm955; Nguyen MHT, 2007, AM J PHYSIOL-CELL PH, V292, pC2004, DOI 10.1152/ajpcell.00271.2006; Nicholls D., 2002, BIOENERGETICS, V3; Onsager L, 1931, PHYS REV, V37, P405, DOI 10.1103/PhysRev.37.405; Plank G, 2008, PHILOS T R SOC A, V366, P3381, DOI 10.1098/rsta.2008.0112; Rocher C, 2008, J BIOENERG BIOMEMBR, V40, P59, DOI 10.1007/s10863-008-9130-5; Rossignol R, 1999, J BIOL CHEM, V274, P33426, DOI 10.1074/jbc.274.47.33426; Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594; Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927; STRYER L, 1995, FREEMAN CO, P86; Wu F, 2007, J BIOL CHEM, V282, P24525, DOI 10.1074/jbc.M701024200; Wu F, 2007, AM J PHYSIOL-CELL PH, V292, pC115, DOI 10.1152/ajpcell.00237.2006; Yao J, 2009, P NATL ACAD SCI USA, V106, P14670, DOI 10.1073/pnas.0903563106; Yugi K, 2004, BIOINFORMATICS, V20, P1795, DOI 10.1093/bioinformatics/bth125; YUGI K, 2000, GENOME INFORMATICS S; Zhou LF, 2005, AM J PHYSIOL-HEART C, V288, pH2400, DOI 10.1152/ajpheart.01030.2004	49	6	7	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e14820	10.1371/journal.pone.0014820	http://dx.doi.org/10.1371/journal.pone.0014820			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CK	21931590	Green Published, gold			2022-12-25	WOS:000294802800001
J	Miyagi, Y; Higashiyama, M; Gochi, A; Akaike, M; Ishikawa, T; Miura, T; Saruki, N; Bando, E; Kimura, H; Imamura, F; Moriyama, M; Ikeda, I; Chiba, A; Oshita, F; Imaizumi, A; Yamamoto, H; Miyano, H; Horimoto, K; Tochikubo, O; Mitsushima, T; Yamakado, M; Okamoto, N				Miyagi, Yohei; Higashiyama, Masahiko; Gochi, Akira; Akaike, Makoto; Ishikawa, Takashi; Miura, Takeshi; Saruki, Nobuhiro; Bando, Etsuro; Kimura, Hideki; Imamura, Fumio; Moriyama, Masatoshi; Ikeda, Ichiro; Chiba, Akihiko; Oshita, Fumihiro; Imaizumi, Akira; Yamamoto, Hiroshi; Miyano, Hiroshi; Horimoto, Katsuhisa; Tochikubo, Osamu; Mitsushima, Toru; Yamakado, Minoru; Okamoto, Naoyuki			Plasma Free Amino Acid Profiling of Five Types of Cancer Patients and Its Application for Early Detection	PLOS ONE			English	Article							PERIPHERAL-BLOOD; LUNG-CANCER; BREAST; DIAGNOSIS; METABOLITE; URINE; REAGENTS; OVARIAN; INDEX; HMGB1	Background: Recently, rapid advances have been made in metabolomics-based, easy-to-use early cancer detection methods using blood samples. Among metabolites, profiling of plasma free amino acids (PFAAs) is a promising approach because PFAAs link all organ systems and have important roles in metabolism. Furthermore, PFAA profiles are known to be influenced by specific diseases, including cancers. Therefore, the purpose of the present study was to determine the characteristics of the PFAA profiles in cancer patients and the possibility of using this information for early detection. Methods and Findings: Plasma samples were collected from approximately 200 patients from multiple institutes, each diagnosed with one of the following five types of cancer: lung, gastric, colorectal, breast, or prostate cancer. Patients were compared to gender-and age-matched controls also used in this study. The PFAA levels were measured using high-performance liquid chromatography (HPLC)-electrospray ionization (ESI)-mass spectrometry (MS). Univariate analysis revealed significant differences in the PFAA profiles between the controls and the patients with any of the five types of cancer listed above, even those with asymptomatic early-stage disease. Furthermore, multivariate analysis clearly discriminated the cancer patients from the controls in terms of the area under the receiver-operator characteristics curve (AUC of ROC >0.75 for each cancer), regardless of cancer stage. Because this study was designed as case-control study, further investigations, including model construction and validation using cohorts with larger sample sizes, are necessary to determine the usefulness of PFAA profiling. Conclusions: These findings suggest that PFAA profiling has great potential for improving cancer screening and diagnosis and understanding disease pathogenesis. PFAA profiles can also be used to determine various disease diagnoses from a single blood sample, which involves a relatively simple plasma assay and imposes a lower physical burden on subjects when compared to existing screening methods.	[Miyagi, Yohei] Kanagawa Canc Ctr, Mol Pathol & Genet Div, Yokohama, Kanagawa 2410815, Japan; [Higashiyama, Masahiko] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Thorac Surg, Osaka, Japan; [Gochi, Akira] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gastroenterol Surg Transplant & Surg Oncol, Okayama, Japan; [Akaike, Makoto] Kanagawa Canc Ctr, Dept Gastrointestinal Surg, Yokohama, Kanagawa 2410815, Japan; [Ishikawa, Takashi] Yokohama City Univ, Med Ctr, Dept Breast & Thyroid Surg, Yokohama, Kanagawa, Japan; [Miura, Takeshi] Kanagawa Canc Ctr, Dept Urol, Yokohama, Kanagawa 2410815, Japan; [Saruki, Nobuhiro] Gunma Prefectural Canc Ctr, Dept Anesthesia, Ohta, Gunma, Japan; [Bando, Etsuro] Shizuoka Prefectural Canc Ctr, Div Gastr Surg, Nagaizumi, Shizuoka, Japan; [Kimura, Hideki] Chiba Prefectural Canc Ctr, Div Thorac Dis, Chiba, Japan; [Imamura, Fumio] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Pulm Oncol, Osaka, Japan; [Moriyama, Masatoshi] Yokohama Municipal Citizens Hosp, Dept Urol, Yokohama, Kanagawa, Japan; [Ikeda, Ichiro] Yokohama Minami Kyosai Hosp, Dept Urol, Yokohama, Kanagawa, Japan; [Chiba, Akihiko] Kanagawa Canc Ctr, Dept Breast & Thyroid Surg, Yokohama, Kanagawa 2410815, Japan; [Oshita, Fumihiro] Kanagawa Canc Ctr, Dept Thorac Oncol, Yokohama, Kanagawa 2410815, Japan; [Imaizumi, Akira; Yamamoto, Hiroshi; Miyano, Hiroshi] Ajinomoto Co Inc, Inst Innovat, Kawasaki, Kanagawa, Japan; [Horimoto, Katsuhisa] Natl Inst Adv Ind Sci & Technol, Computat Biol Res Ctr, Tokyo, Japan; [Tochikubo, Osamu] Kanagawa Hlth Serv Assoc, Yokohama, Kanagawa, Japan; [Mitsushima, Toru] Kameda Med Ctr Makuhari, Dept Gastroenterol, Chiba, Japan; [Yamakado, Minoru] Mitsui Mem Hosp, Ctr Multiphas Hlth Testing & Serv, Tokyo 101, Japan; [Okamoto, Naoyuki] Kanagawa Canc Ctr, Dept Epidemiol, Yokohama, Kanagawa 2410815, Japan	Kanagawa Prefectural Cancer Center; Osaka Medical Center for Cancer & Cardiovascular Diseases; Okayama University; Kanagawa Prefectural Cancer Center; Yokohama City University; Kanagawa Prefectural Cancer Center; Osaka Medical Center for Cancer & Cardiovascular Diseases; Kanagawa Prefectural Cancer Center; Kanagawa Prefectural Cancer Center; Ajinomoto Co Inc; National Institute of Advanced Industrial Science & Technology (AIST); Mitsui Memorial Hospital; Kanagawa Prefectural Cancer Center	Miyagi, Y (corresponding author), Kanagawa Canc Ctr, Mol Pathol & Genet Div, 1-1-2 Nakao, Yokohama, Kanagawa 2410815, Japan.	miyagi@gancen.asahi.yokohama.jp; akira_imaizumi@ajinomoto.com		Imaizumi, Akira/0000-0002-8615-1007	Ministry of Education, Culture, Sports, Science and Technology of Japan [17390195]; Ajinomoto, Co., Inc.	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ajinomoto, Co., Inc.	This work has been supported by Grant-in-Aid for Scientific Research on Basic Research B (No. 17390195) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Ajinomoto, Co., Inc. did have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: Dr. Horimoto, Dr. Tochikubo, Dr. Yamakado, and Dr. Okamoto have been consultants for Ajinomoto, Co., Inc. and receive consultancy fees from Ajinomoto, Co., Inc. Dr. Imaizumi, Dr. Yamamoto, and Dr. Miyano are employees of Ajinomoto, Co., Inc. Dr. Miyagi, Dr. Higashiyama, Dr. Gochi, Dr. Akaike, Dr. Ishikawa, Dr. Miura, Dr. Saruki, Dr. Bando, Dr. Kimura, Dr. Imamura, Dr. Moriyama, Dr. Ikeda, Dr. Chiba, Dr. Oshita, Dr. Tochikubo, Dr. Mitsushima, Dr. Yamakado, and Dr. Okamoto received research grants from Ajinomoto, Co., Inc. Dr. Higashiyama, Dr. Imamura, Dr. Imaizumi, and Dr. Okamoto have applied for patents for plasma amino-acid profiling using multivariate analysis as a diagnostic tool for lung cancer and cancers (WO2008/016111 and WO2009/110517), Dr. Gochi, Dr. Imaizumi, and Dr. Yamamoto have applied for patents for plasma amino-acid profiling using multivariate analysis as a diagnostic tool for gastric cancer (WO2009/099005), Dr. Imaizumi and Dr. Okamoto have applied for patents for plasma amino-acid profiling using multivariate analysis as a diagnostic tool for colorectal cancer (WO2008/075663), Dr. Imaizumi and Dr. Okamoto have applied for patents for plasma amino-acid profiling using multivariate analysis as a diagnostic tool for breast cancer (WO2008/075662), Dr. Miyagi, Dr. Miura, Dr. Imaizumi, Dr. Yamamoto, and Dr. Okamoto have applied for patents for plasma amino-acid profiling using multivariate analysis as a diagnostic tool for prostate cancer (WO2009/154297), and Dr. Miyano has applied for patents for plasma amino acid measurement systems(WO2003/069328 and WO2005/116629). This does not alter the authors' adherence to all the PLoS One policies on sharing data and materials.	Abate-Shen C, 2009, NATURE, V457, P799, DOI 10.1038/457799a; Asiago VM, 2010, CANCER RES, V70, P8309, DOI 10.1158/0008-5472.CAN-10-1319; Bictash M, 2010, J CLIN EPIDEMIOL, V63, P970, DOI 10.1016/j.jclinepi.2009.10.001; Blaise BJ, 2009, ANAL CHEM, V81, P6242, DOI 10.1021/ac9007754; Borgan E, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-628; Bossola M, 2009, J RENAL NUTR, V19, P2, DOI 10.1053/j.jrn.2008.10.003; CASCINO A, 1995, ANTICANCER RES, V15, P507; Chadeau-Hyam M, 2010, J PROTEOME RES, V9, P4620, DOI 10.1021/pr1003449; Chung HW, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-38; Couzin J, 2009, SCIENCE, V323, P865, DOI 10.1126/science.323.5916.865a; Denkert C, 2006, CANCER RES, V66, P10795, DOI 10.1158/0008-5472.CAN-06-0755; FELIG P, 1970, DIABETES, V19, P727, DOI 10.2337/diab.19.10.727; FISCHER JE, 1976, SURGERY, V80, P77; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HEBER D, 1985, CANCER, V55, P225, DOI 10.1002/1097-0142(19850101)55:1+<225::AID-CNCR2820551304>3.0.CO;2-7; Hirayama A, 2009, CANCER RES, V69, P4918, DOI 10.1158/0008-5472.CAN-08-4806; Holm E, 1999, Curr Opin Clin Nutr Metab Care, V2, P47, DOI 10.1097/00075197-199901000-00009; Hong S Y, 1998, J Ren Nutr, V8, P34, DOI 10.1016/S1051-2276(98)90035-8; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Jewett H J, 1975, Urol Clin North Am, V2, P105; Kim Y, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S2-S4; Kimura T, 2009, CURR OPIN CLIN NUTR, V12, P49, DOI 10.1097/MCO.0b013e3283169242; KUBOTA A, 1992, CANCER, V69, P2343, DOI 10.1002/1097-0142(19920501)69:9<2343::AID-CNCR2820690924>3.0.CO;2-S; Lai HS, 2005, SEMIN CANCER BIOL, V15, P267, DOI 10.1016/j.semcancer.2005.04.003; Lob S, 2009, CANCER IMMUNOL IMMUN, V58, P153, DOI 10.1007/s00262-008-0513-6; Lob S, 2009, NAT REV CANCER, V9, P445, DOI 10.1038/nrc2639; Lotze Michael T, 2003, Curr Opin Investig Drugs, V4, P1405; Maeda J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-690; MORRISON WL, 1988, EUR J CLIN INVEST, V18, P648, DOI 10.1111/j.1365-2362.1988.tb01282.x; Muller AJ, 2005, NAT MED, V11, P312, DOI 10.1038/nm1196; Nevedomskaya E, 2010, J PROTEOME RES, V9, P4869, DOI 10.1021/pr100634d; Noguchi Y, 2006, AM J CLIN NUTR, V83, p513S; NORTON JA, 1985, CANCER, V56, P1181, DOI 10.1002/1097-0142(19850901)56:5<1181::AID-CNCR2820560535>3.0.CO;2-8; Okamoto N, 2009, INT J MED MED SCI, V1, P1; Pasikanti KK, 2010, J PROTEOME RES, V9, P2988, DOI 10.1021/pr901173v; Polge A, 1997, AGE AGEING, V26, P457, DOI 10.1093/ageing/26.6.457; Proenza AM, 2003, J NUTR BIOCHEM, V14, P133, DOI 10.1016/S0955-2863(02)00225-5; Qiu YP, 2009, J PROTEOME RES, V8, P4844, DOI 10.1021/pr9004162; Rocha CM, 2010, J PROTEOME RES, V9, P319, DOI 10.1021/pr9006574; Roth C, 2011, MOL ONCOL, V5, P281, DOI 10.1016/j.molonc.2011.02.002; Roth C, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2766; Rubtsov DV, 2010, ANAL CHEM, V82, P4479, DOI 10.1021/ac100344m; Shimbo K, 2010, BIOMED CHROMATOGR, V24, P683, DOI 10.1002/bmc.1346; Shimbo K, 2009, ANAL CHEM, V81, P5172, DOI 10.1021/ac900470w; Shimbo K, 2009, RAPID COMMUN MASS SP, V23, P1483, DOI 10.1002/rcm.4026; Sims GP, 2010, ANNU REV IMMUNOL, V28, P367, DOI 10.1146/annurev.immunol.021908.132603; Slupsky CM, 2010, CLIN CANCER RES, V16, P5835, DOI 10.1158/1078-0432.CCR-10-1434; Sobin LH, TNM CLASSIFICATION M; Tiziani S, 2009, NEOPLASIA, V11, P269, DOI 10.1593/neo.81396; Urayama S, 2010, RAPID COMMUN MASS SP, V24, P613, DOI 10.1002/rcm.4420; Vissers YLJ, 2005, AM J CLIN NUTR, V81, P1142; Zamanakou M, 2007, IMMUNOL LETT, V111, P69, DOI 10.1016/j.imlet.2007.06.001; Zhang QW, 2006, HEPATOL RES, V34, P170, DOI 10.1016/j.hepres.2005.12.006	53	295	307	1	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2011	6	9							e24143	10.1371/journal.pone.0024143	http://dx.doi.org/10.1371/journal.pone.0024143			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CH	21915291	gold, Green Published, Green Submitted			2022-12-25	WOS:000294802500030
J	Alves, ID; Bechara, C; Walrant, A; Zaltsman, Y; Jiao, CY; Sagan, S				Alves, Isabel D.; Bechara, Cherine; Walrant, Astrid; Zaltsman, Yefim; Jiao, Chen-Yu; Sagan, Sandrine			Relationships between Membrane Binding, Affinity and Cell Internalization Efficacy of a Cell-Penetrating Peptide: Penetratin as a Case Study	PLOS ONE			English	Article							SURFACE-PLASMON RESONANCE; WAVE-GUIDE RESONANCE; CHONDROITIN SULFATE PROTEOGLYCAN; HEPARAN-SULFATE; DEPENDENT TRANSLOCATION; BIOPHYSICAL PROPERTIES; ANTENNAPEDIA HOMEOBOX; AMMONIUM-CHLORIDE; PROTEIN SYSTEMS; LIPID-BILAYERS	Background: Penetratin is a positively charged cell-penetrating peptide (CPP) that has the ability to bind negatively charged membrane components, such as glycosaminoglycans and anionic lipids. Whether this primary interaction of penetratin with these cell surface components implies that the peptide will be further internalized is not clear. Methodology: Using mass spectrometry, the amount of internalized and membrane bound penetratin remaining after washings, were quantified in three different cell lines: wild type (WT), glycosaminoglycans-(GAG(neg)) and sialic acid-deficient (SA(neg)) cells. Additionally, the affinity and kinetics of the interaction of penetratin to membrane models composed of pure lipids and membrane fragments from the referred cell lines was investigated, as well as the thermodynamics of such interactions using plasmon resonance and calorimetry. Principal Findings: Penetratin internalized with the same efficacy in the three cell lines at 1 mu M, but was better internalized at 10 mu M in SA(neg)>WT>GAG(neg). The heat released by the interaction of penetratin with these cells followed the ranking order of internalization efficiency. Penetratin had an affinity of 10 nM for WT cells and mM for SA(neg) and GAG(neg) cells and model membrane of phospholipids. The remaining membrane-bound penetratin after cells washings was similar in WT and GAG(neg) cells, which suggested that these binding sites relied on membrane phospholipids. The interaction of penetratin with carbohydrates was more superficial and reversible while it was stronger with phospholipids, likely because the peptide can intercalate between the fatty acid chains. Conclusion/Significance: These results show that accumulation and high-affinity binding of penetratin at the cell-surface do not reflect the internalization efficacy of the peptide. Altogether, these data further support translocation (membrane phospholipids interaction) as being the internalization pathway used by penetratin at low micromolecular concentration, while endocytosis is activated at higher concentration and requires accumulation of the peptide on GAG and GAG clustering.	[Alves, Isabel D.; Bechara, Cherine; Walrant, Astrid; Zaltsman, Yefim; Jiao, Chen-Yu; Sagan, Sandrine] Univ Paris 06, UPMC, UMR 7203, LBM, Paris, France; [Alves, Isabel D.; Bechara, Cherine; Walrant, Astrid; Zaltsman, Yefim; Jiao, Chen-Yu; Sagan, Sandrine] LBM, CNRS, UMR 7203, Paris, France; [Alves, Isabel D.; Bechara, Cherine; Walrant, Astrid; Zaltsman, Yefim; Jiao, Chen-Yu; Sagan, Sandrine] LBM, ENS, UMR 7203, Paris, France	Arts et Metiers Institute of Technology; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); Arts et Metiers Institute of Technology; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); Arts et Metiers Institute of Technology; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN)	Alves, ID (corresponding author), CBMN, UMR 5248, Pessac, France.	i.alves@cbmn.u-bordeaux.fr; sandrine.sagan@upmc.fr	QI, DANDAN/GVR-9324-2022; s, s/GYR-2278-2022; s, s/HIK-1178-2022; SAGAN, Sandrine/AAA-8537-2022; s, s/HHD-0404-2022; Alves, Isabel D/R-9613-2016; Walrant, Astrid/C-4667-2016; S, SAGAN/I-8132-2013; Bechara, Cherine/R-1341-2018	Alves, Isabel D/0000-0003-3193-2436; Walrant, Astrid/0000-0003-4054-905X; S, SAGAN/0000-0003-0083-4411; Bechara, Cherine/0000-0002-5539-6327; Zaltsman, Yefim/0000-0002-2979-8197	Centre National de la Recherche Scientifique (CNRS); French Ministere de l'Enseignement Superieur et de la Recherche; University Pierre and Marie Curie (UPMC); NSF [CHE-0755225]; University of Florida	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); French Ministere de l'Enseignement Superieur et de la Recherche; University Pierre and Marie Curie (UPMC); NSF(National Science Foundation (NSF)); University of Florida(University of Florida)	Support for this research was provided by the Centre National de la Recherche Scientifique (CNRS), the French Ministere de l'Enseignement Superieur et de la Recherche (PhD fellowships for CB, AW and CYJ), and the University Pierre and Marie Curie (UPMC-Univ Paris06). YZ was supported by NSF Grant No CHE-0755225 for a fellowship sponsored by University of Florida. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves ID, 2006, BIOCHEMISTRY-US, V45, P5309, DOI 10.1021/bi052586d; Alves ID, 2008, BBA-GEN SUBJECTS, V1780, P948, DOI 10.1016/j.bbagen.2008.04.004; Alves ID, 2010, BBA-BIOMEMBRANES, V1798, P2231, DOI 10.1016/j.bbamem.2010.02.009; Alves ID, 2009, J PEPT SCI, V15, P200, DOI 10.1002/psc.1070; Amand HL, 2008, BIOCHEM BIOPH RES CO, V371, P621, DOI 10.1016/j.bbrc.2008.04.039; Amand HL, 2011, BBA-BIOMEMBRANES, V1808, P1860, DOI 10.1016/j.bbamem.2011.03.011; Aubry S, 2009, FASEB J, V23, P2956, DOI 10.1096/fj.08-127563; Balayssac S, 2006, BIOCHEMISTRY-US, V45, P1408, DOI 10.1021/bi0518390; Binder H, 2003, BIOPHYS J, V85, P982, DOI 10.1016/S0006-3495(03)74537-8; Burlina F, 2005, ANGEW CHEM INT EDIT, V44, P4244, DOI 10.1002/anie.200500477; Christiaens B, 2004, EUR J BIOCHEM, V271, P1187, DOI 10.1111/j.1432-1033.2004.04022.x; Christiaens B, 2002, EUR J BIOCHEM, V269, P2918, DOI 10.1046/j.1432-1033.2002.02963.x; Cuellar K, 2007, J BIOL CHEM, V282, P5195, DOI 10.1074/jbc.M611048200; DEROSSI D, 1994, J BIOL CHEM, V269, P10444; Derossi D, 1998, TRENDS CELL BIOL, V8, P84, DOI 10.1016/S0962-8924(97)01214-2; DEUTSCHER SL, 1984, CELL, V39, P295, DOI 10.1016/0092-8674(84)90007-2; Dom G, 2003, NUCLEIC ACIDS RES, V31, P556, DOI 10.1093/nar/gkg160; Drin G, 2003, J BIOL CHEM, V278, P31192, DOI 10.1074/jbc.M303938200; Drin G, 2001, EUR J BIOCHEM, V268, P1304, DOI 10.1046/j.1432-1327.2001.01997.x; Eiriksdottir E, 2010, BIOCONJUGATE CHEM, V21, P1662, DOI 10.1021/bc100174y; ESKO JD, 1988, SCIENCE, V241, P1092, DOI 10.1126/science.3137658; Ghibaudi E, 2005, J PEPT SCI, V11, P401, DOI 10.1002/psc.633; Goncalves E, 2005, BIOCHEMISTRY-US, V44, P2692, DOI 10.1021/bi048046i; Gump JM, 2010, J BIOL CHEM, V285, P1500, DOI 10.1074/jbc.M109.021964; HARPER JR, 1986, J BIOL CHEM, V261, P3600; Henriques ST, 2010, BIOPOLYMERS, V94, P314, DOI 10.1002/bip.21367; Henriques ST, 2005, FEBS LETT, V579, P4498, DOI 10.1016/j.febslet.2005.06.085; Howe J, 2007, THERMOCHIM ACTA, V458, P34, DOI 10.1016/j.tca.2007.01.018; Jiao CY, 2009, J BIOL CHEM, V284, P33957, DOI 10.1074/jbc.M109.056309; JOLIOT A, 1991, P NATL ACAD SCI USA, V88, P1864, DOI 10.1073/pnas.88.5.1864; Joliot A, 2008, ADV DRUG DELIVER REV, V60, P608, DOI 10.1016/j.addr.2007.09.004; Letoha T, 2005, J PEPT SCI, V11, P805, DOI 10.1002/psc.678; Letoha T, 2010, BBA-BIOMEMBRANES, V1798, P2258, DOI 10.1016/j.bbamem.2010.01.022; Lindberg M, 2003, EUR J BIOCHEM, V270, P3055, DOI 10.1046/j.1432-1033.2003.03685.x; Lindgren M, 2000, BIOCONJUGATE CHEM, V11, P619, DOI 10.1021/bc990156s; Marty C, 2004, CELL MOL LIFE SCI, V61, P1785, DOI 10.1007/s00018-004-4166-0; Melo MN, 2009, NAT REV MICROBIOL, V7, P245, DOI 10.1038/nrmicro2095; PEREZ F, 1992, J CELL SCI, V102, P717; Roselin LS, 2010, BIOTECHNOL J, V5, P85, DOI 10.1002/biot.200900092; Saalik P, 2011, J CONTROL RELEASE, V153, P117, DOI 10.1016/j.jconrel.2011.03.011; Sachon E, 2002, J BIOL CHEM, V277, P50409, DOI 10.1074/jbc.M207242200; Sagan S, 1997, MOL PHARMACOL, V52, P120, DOI 10.1124/mol.52.1.120; Salamon Z, 1997, BBA-REV BIOMEMBRANES, V1331, P131, DOI 10.1016/S0304-4157(97)00003-8; Salamon Z, 1997, BIOPHYS J, V73, P2791, DOI 10.1016/S0006-3495(97)78308-5; Salamon Z, 2004, BIOPHYS J, V86, P2508, DOI 10.1016/S0006-3495(04)74306-4; Salamon Z, 1997, BBA-REV BIOMEMBRANES, V1331, P117, DOI 10.1016/S0304-4157(97)00004-X; Salamon Z, 2003, BIOPHYS J, V84, P1796, DOI 10.1016/S0006-3495(03)74987-X; SPIRO RC, 1986, J BIOL CHEM, V261, P5121; Szeto HH, 2004, FASEB J, V18, P118, DOI 10.1096/fj.04-1982fje; Terrone D, 2003, BIOCHEMISTRY-US, V42, P13787, DOI 10.1021/bi035293y; Thoren PEG, 2000, FEBS LETT, V482, P265, DOI 10.1016/S0014-5793(00)02072-X; Thoren PEG, 2004, BIOCHEMISTRY-US, V43, P3471, DOI 10.1021/bi0360049; Thoren PEG, 2003, BIOCHEM BIOPH RES CO, V307, P100, DOI 10.1016/S0006-291X(03)01135-5; Trehin R, 2004, PHARM RES-DORDR, V21, P33, DOI 10.1023/B:PHAM.0000012149.83119.bf; Walrant A, 2011, BBA-BIOMEMBRANES, V1808, P382, DOI 10.1016/j.bbamem.2010.09.009; Watkins CL, 2009, BIOCHEM J, V420, P179, DOI 10.1042/BJ20090042; Wollack JW, 2009, J AM CHEM SOC, V131, P7293, DOI 10.1021/ja805174z; Yang H, 2010, J BIOL CHEM, V285, P25666, DOI 10.1074/jbc.M109.089417; Zhang WY, 2005, BIOCHEMISTRY-US, V44, P10110, DOI 10.1021/bi050341v; Ziegler A, 2008, BIOPHYS J, V94, P2142, DOI 10.1529/biophysj.107.113472; Ziegler A, 2011, BIOCHEMISTRY-US, V50, P4650, DOI 10.1021/bi1019429	61	78	78	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2011	6	9							e24096	10.1371/journal.pone.0024096	http://dx.doi.org/10.1371/journal.pone.0024096			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817QP	21915283	Green Submitted, gold, Green Published			2022-12-25	WOS:000294689200019
J	Koumangoye, RB; Sakwe, AM; Goodwin, JS; Patel, T; Ochieng, J				Koumangoye, Rainelli B.; Sakwe, Amos M.; Goodwin, J. Shawn; Patel, Tina; Ochieng, Josiah			Detachment of Breast Tumor Cells Induces Rapid Secretion of Exosomes Which Subsequently Mediate Cellular Adhesion and Spreading	PLOS ONE			English	Article							CARCINOMA CELLS; PROTEINS; VESICLES; CANCER; EXPRESSION; GALECTIN-3; SURFACE; MICROVESICLES; ANGIOGENESIS; BIOGENESIS	Exosomes are nano-vesicles secreted by a wide range of mammalian cell types. These vesicles are abundant in serum and other extracellular fluids and contain a large repertoire of proteins, mRNA and microRNA. Exosomes have been implicated in cell to cell communication, the transfer of infectious agents, and neurodegenerative diseases as well as tumor progression. However, the precise mechanisms by which they are internalized and/or secreted remain poorly understood. In order to follow their release and uptake in breast tumor cells in real time, cell-derived exosomes were tagged with green fluorescent protein (GFP)-CD63 while human serum exosomes were rhodamine isothiocynate-labeled. We show that detachment of adherent cells from various substrata induces a rapid and substantial secretion of exosomes, which then concentrate on the cell surfaces and mediate adhesion to various extracellular matrix proteins. We also demonstrate that disruption of lipid rafts with methyl-beta-cyclodextrin (M beta CD) inhibits the internalization of exosomes and that annexins are essential for the exosomal uptake mechanisms. Taken together, these data suggest that cellular detachment is accompanied by significant release of exosomes while cellular adhesion and spreading are enhanced by rapid uptake and disposition of exosomes on the cell surface.	[Koumangoye, Rainelli B.; Sakwe, Amos M.; Goodwin, J. Shawn; Patel, Tina; Ochieng, Josiah] Meharry Med Coll, Dept Biochem & Canc Biol, Nashville, TN 37208 USA	Meharry Medical College	Koumangoye, RB (corresponding author), Meharry Med Coll, Dept Biochem & Canc Biol, Nashville, TN 37208 USA.	jochieng@mmc.edu	Sakwe, Amos/AAU-7639-2020	Sakwe, Amos/0000-0002-2283-794X	NIH-NCI [1SC1 CA134018-01]; DOD [W81XWH-07-1- 0254];  [NIH/NCRR/RCMI-2G12RR003032-22]; NATIONAL CANCER INSTITUTE [U54CA163069, SC1CA134018] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR026140, S10RR025497, G12RR003032] Funding Source: NIH RePORTER	NIH-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DOD(United States Department of Defense); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funding was provided by NIH-NCI 1SC1 CA134018-01; DOD W81XWH-07-1- 0254; and NIH/NCRR/RCMI-2G12RR003032-22. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAO Y, 2011, GENE THER, V19, P395; Al-Nedawi K, 2009, P NATL ACAD SCI USA, V106, P3794, DOI 10.1073/pnas.0804543106; Anavekar Nandan S, 2010, Curr Infect Dis Rep, V12, P253, DOI 10.1007/s11908-010-0115-2; Babbin BA, 2007, AM J PATHOL, V170, P951, DOI 10.2353/ajpath.2007.060647; Baptiste TA, 2007, EXP CELL RES, V313, P652, DOI 10.1016/j.yexcr.2006.11.005; Barres C, 2010, BLOOD, V115, P696, DOI 10.1182/blood-2009-07-231449; Booth AM, 2006, J CELL BIOL, V172, P923, DOI 10.1083/jcb.200508014; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Calzolari A, 2006, J CELL SCI, V119, P4486, DOI 10.1242/jcs.03228; Camussi G, 2010, KIDNEY INT, V78, P838, DOI 10.1038/ki.2010.278; Cantin R, 2008, J IMMUNOL METHODS, V338, P21, DOI 10.1016/j.jim.2008.07.007; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; Chen TY, 2011, J IMMUNOL, V186, P2219, DOI 10.4049/jimmunol.1002991; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; Feng D, 2010, TRAFFIC, V11, P675, DOI 10.1111/j.1600-0854.2010.01041.x; Gangalum RK, 2011, J BIOL CHEM, V286, P3261, DOI 10.1074/jbc.M110.160135; Gastpar R, 2005, CANCER RES, V65, P5238, DOI 10.1158/0008-5472.CAN-04-3804; Graner MW, 2007, J NEUROSCI, V27, P11214, DOI 10.1523/JNEUROSCI.3588-07.2007; Hao HF, 2009, ONCOL REP, V22, P973, DOI 10.3892/or_00000524; Iurisci I, 2000, CLIN CANCER RES, V6, P1389; Janowska-Wieczorek A, 2005, INT J CANCER, V113, P752, DOI 10.1002/ijc.20657; Klibi J, 2009, BLOOD, V113, P1957, DOI 10.1182/blood-2008-02-142596; Little KM, 2010, SEMIN THROMB HEMOST, V36, P845, DOI 10.1055/s-0030-1267038; MATHEW A, 1995, BIOCHEM J, V308, P823, DOI 10.1042/bj3080823; Mathivanan S, 2009, PROTEOMICS, V9, P4997, DOI 10.1002/pmic.200900351; Mould AP, 1996, J CELL SCI, V109, P2613; Ochieng J, 2009, EXP CELL RES, V315, P1875, DOI 10.1016/j.yexcr.2009.03.010; Ogawa Y, 2008, BIOL PHARM BULL, V31, P1059, DOI 10.1248/bpb.31.1059; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Parolini I, 2009, J BIOL CHEM, V284, P34211, DOI 10.1074/jbc.M109.041152; Pelchen-Matthews A, 2004, TRENDS MICROBIOL, V12, P310, DOI 10.1016/j.tim.2004.05.004; Poliakov A, 2009, PROSTATE, V69, P159, DOI 10.1002/pros.20860; Quinn PJ, 2010, PROG LIPID RES, V49, P390, DOI 10.1016/j.plipres.2010.05.002; Sakwe AM, 2011, EXP CELL RES, V317, P823, DOI 10.1016/j.yexcr.2010.12.008; Sakwe AM, 2010, J BIOL CHEM, V285, P41827, DOI 10.1074/jbc.M110.128926; Sharma MR, 2006, EXP MOL PATHOL, V81, P146, DOI 10.1016/j.yexmp.2006.03.003; Smalheiser NR, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-35; Stoorvogel W, 2002, TRAFFIC, V3, P321, DOI 10.1034/j.1600-0854.2002.30502.x; Thery C, 2001, J IMMUNOL, V166, P7309, DOI 10.4049/jimmunol.166.12.7309; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thomsen P, 2002, MOL BIOL CELL, V13, P238, DOI 10.1091/mbc.01-06-0317; Tian TA, 2010, J CELL BIOCHEM, V111, P488, DOI 10.1002/jcb.22733; Warfield PR, 1997, INVAS METAST, V17, P101; Wong CHY, 2010, CARDIOVASC RES, V86, P183, DOI 10.1093/cvr/cvq040; Zhao QC, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-154; Zigler M, 2010, MINERVA MED, V101, P149; Zomer Anoek, 2010, Commun Integr Biol, V3, P447, DOI 10.4161/cib.3.5.12339	47	139	151	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2011	6	9							e24234	10.1371/journal.pone.0024234	http://dx.doi.org/10.1371/journal.pone.0024234			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817QP	21915303	Green Published, Green Submitted, gold			2022-12-25	WOS:000294689200029
J	Bruel, L; Sulzenbacher, G; Tison, MC; Pujol, A; Nicoletti, C; Perrier, J; Galinier, A; Ropartz, D; Fons, M; Pompeo, F; Giardina, T				Bruel, Laetitia; Sulzenbacher, Gerlind; Tison, Marine Cervera; Pujol, Ange; Nicoletti, Cendrine; Perrier, Josette; Galinier, Anne; Ropartz, David; Fons, Michel; Pompeo, Frederique; Giardina, Thierry			alpha-Galactosidase/Sucrose Kinase (AgaSK), a Novel Bifunctional Enzyme from the Human Microbiome Coupling Galactosidase and Kinase Activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUT MICROBIOME; LACTOBACILLUS; SUBSTRATE; GALACTOOLIGOSACCHARIDES; PURIFICATION; NOMENCLATURE; SEQUENCES; ECOLOGY; OBESITY; CLONING	alpha-Cialactosides are non-digestible carbohydrates widely distributed in plants. They are a potential source of energy in our daily food, and their assimilation by microbiota may play a role in obesity. In the intestinal tract, they are degraded by microbial glycosidases, which are often modular enzymes with catalytic domains linked to carbohydrate-binding modules. Here we introduce a bifunctional enzyme from the human intestinal bacterium Ruminococcus gnavus E1, alpha-galactosidase/sucrose kinase (AgaSK). Sequence analysis showed that AgaSK is composed of two domains: one closely related to alpha-galactosidases from glycoside hydrolase family GH36 and the other containing a nucleotide-binding motif. Its biochemical characterization showed that AgaSK is able to hydrolyze melibiose and raffinose to galactose and either glucose or sucrose, respectively, and to specifically p hosphorylate sucrose on the C6 position of glucose in the presence of ATP. The production of sucrose-6-P directly from raffinose points toward a glycolytic pathway in bacteria, not described so far. The crystal structures of the galactosidase domain in the apo form and in complex with the product shed light onto the reaction and substrate recognition mechanisms and highlight an oligorneric state necessary for efficient substrate binding and suggesting a cross-talk between the galactose and kinase domains.	[Bruel, Laetitia; Tison, Marine Cervera; Pujol, Ange; Nicoletti, Cendrine; Perrier, Josette; Fons, Michel; Giardina, Thierry] Univ Paul Cezanne, Fac Sci & Tech St Jerome, ISM2 BiosCiences, CNRS,UMR 6263,Serv 342, F-13397 Marseille 20, France; [Sulzenbacher, Gerlind] Univ Aix Marseille, CNRS, UMR 6098, F-13288 Marseille 09, France; [Bruel, Laetitia; Galinier, Anne; Pompeo, Frederique] CNRS, UPR 9043, IMM, Chim Bacterienne Lab, F-13402 Marseille 20, France; [Ropartz, David] INRA, Lab Spectrometrie Masse, UR Biopolymeres Interact Assemblages 1268, F-44316 Nantes 3, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; INRAE	Giardina, T (corresponding author), Univ Paul Cezanne, Fac Sci & Tech St Jerome, ISM2 BiosCiences, CNRS,UMR 6263,Serv 342, F-13397 Marseille 20, France.	thierry.giardina@univ-cezanne.fr	Pompeo, Frederique/Q-5772-2017; Sulzenbacher, Gerlind/A-6801-2018; Giardina, Thierry/AAA-4003-2020	Sulzenbacher, Gerlind/0000-0003-4844-2820; Ropartz, David/0000-0003-4767-6940; Fons, Michel/0000-0001-8263-3669	CNRS; Agence Nationale de la Recherche (ANR); Ministere de l'Enseignement Superieur	CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Ministere de l'Enseignement Superieur	This work was supported by the CNRS, the Agence Nationale de la Recherche (ANR) contract "P-loop proteins," and the "Ministere de l'Enseignement Superieur."	Ademark P, 2001, ENZYME MICROB TECH, V29, P441, DOI 10.1016/S0141-0229(01)00415-X; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Armougom F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007125; ASLANIDIS C, 1989, J BACTERIOL, V171, P6753, DOI 10.1128/jb.171.12.6753-6763.1989; Barrangou R, 2006, P NATL ACAD SCI USA, V103, P3816, DOI 10.1073/pnas.0511287103; Blaut Michael, 2002, European Journal of Nutrition, V41, P11; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; CAPUTTO R, 1949, J BIOL CHEM, V179, P497; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Comfort DA, 2007, BIOCHEMISTRY-US, V46, P3319, DOI 10.1021/bi061521n; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; Dore J, 1998, SYST APPL MICROBIOL, V21, P65, DOI 10.1016/S0723-2020(98)80009-X; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Forouhar F, 2008, J BIOL CHEM, V283, P11832, DOI 10.1074/jbc.M710352200; Fredslund F, 2011, J MOL BIOL, V412, P466, DOI 10.1016/j.jmb.2011.07.057; Garman SC, 2004, J MOL BIOL, V337, P319, DOI 10.1016/j.jmb.2004.01.035; Garman SC, 2002, STRUCTURE, V10, P425, DOI 10.1016/S0969-2126(02)00726-8; Goulas T, 2009, APPL MICROBIOL BIOT, V82, P471, DOI 10.1007/s00253-008-1750-5; Greiner T, 2011, TRENDS ENDOCRIN MET, V22, P117, DOI 10.1016/j.tem.2011.01.002; HASHIMOTO H, 1995, BIOSCI BIOTECH BIOCH, V59, P619, DOI 10.1271/bbb.59.619; Henrissat B, 1996, BIOCHEM J, V316, P695, DOI 10.1042/bj3160695; Hugouvieux-Cotte-Pattat N, 2009, J BACTERIOL, V191, P6960, DOI 10.1128/JB.00594-09; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kitaoka M, 2002, TRENDS GLYCOSCI GLYC, V14, P35, DOI 10.4052/tigg.14.35; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Leslie AGW, 1992, PROTEIN CRYSTALLOGR, V26, P27; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; MATSUI I, 1991, J BIOCHEM-TOKYO, V109, P566, DOI 10.1093/oxfordjournals.jbchem.a123420; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakai H, 2010, FEBS J, V277, P3538, DOI 10.1111/j.1742-4658.2010.07763.x; Neyrinck AM, 2010, CURR OPIN CLIN NUTR, V13, P722, DOI 10.1097/MCO.0b013e32833ec3fb; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rastall RA, 2005, FEMS MICROBIOL ECOL, V52, P145, DOI 10.1016/j.femsec.2005.01.003; Reid SJ, 2005, APPL MICROBIOL BIOT, V67, P312, DOI 10.1007/s00253-004-1885-y; Rigden DJ, 2002, FEBS LETT, V523, P17, DOI 10.1016/S0014-5793(02)02879-X; SILVERSTEIN R, 1967, J BIOL CHEM, V242, P1338; Spangenberg P, 2000, CARBOHYD RES, V329, P65, DOI 10.1016/S0008-6215(00)00170-1; Tison MC, 2009, BBA-PROTEINS PROTEOM, V1794, P438, DOI 10.1016/j.bbapap.2008.11.024; TRUGO LC, 1995, FOOD CHEM, V52, P385, DOI 10.1016/0308-8146(95)93286-Z; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Tzortzis G, 2004, APPL MICROBIOL BIOT, V64, P106, DOI 10.1007/s00253-003-1427-z; Tzortzis G, 2003, APPL MICROBIOL BIOT, V63, P286, DOI 10.1007/s00253-003-1426-0; Van Laere KMJ, 1999, APPL MICROBIOL BIOT, V52, P681, DOI 10.1007/s002530051579; Venema K, 2010, CURR OPIN CLIN NUTR, V13, P432, DOI 10.1097/MCO.0b013e32833a8b60; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Zhao H, 2008, FEMS MICROBIOL LETT, V285, P278, DOI 10.1111/j.1574-6968.2008.01246.x	55	27	28	1	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40814	40823		10.1074/jbc.M111.286039	http://dx.doi.org/10.1074/jbc.M111.286039			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21931163	Green Published, hybrid			2022-12-25	WOS:000297315400042
J	Li, LT; Jia, X; Ward, DM; Kaplan, J				Li, Liangtao; Jia, Xuan; Ward, Diane M.; Kaplan, Jerry			Yap5 Protein-regulated Transcription of the TYW1 Gene Protects Yeast from High Iron Toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; SULFUR CLUSTER; SUBCELLULAR-LOCALIZATION; SIGNALING PATHWAY; MITOCHONDRIAL; REGULON; TRANSPORT; IDENTIFICATION; BIOSYNTHESIS; TRAFFICKING	The budding yeast Saccharomyces cerevisiae responds to high cytosolic iron by inducing Yap5-mediated transcription. We identified genes regulated by Yap5 in response to iron and show that one of the genes induced is TYW1, which encodes an iron-sulfur cluster enzyme that participates in the synthesis of wybutosine-modified tRNA. Strains deleted for TYW1 do not show a phenotype in standard yeast medium. In contrast, overexpression of TYW1 results in decreased cell growth and induction of the iron regulon, leading to increased expression of the high affinity iron transporters. We identified a minimal domain of S. cerevisiae Tyw1 that is sufficient to induce the iron regulon. CCC1, a vacuolar iron importer, is a Yap5-regulated gene, and deletion of either CCC1 or YAP5 resulted in high iron sensitivity. Deletion of TYW1 in a Delta ccc1 strain led to increased iron sensitivity. The increased iron sensitivity of Delta ccc1 Delta tyw1 could be suppressed by overexpression of iron-sulfur cluster enzymes. We conclude that the Yap5-mediated induction of TYW1 provides protection from high iron toxicity by the consumption of free cytosolic iron through the formation of protein-bound iron-sulfur clusters.	[Li, Liangtao; Jia, Xuan; Ward, Diane M.; Kaplan, Jerry] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah	Kaplan, J (corresponding author), Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84132 USA.	jerry.kaplan@path.utah.edu			National Institutes of Health from NIDDK [030534]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK030534] Funding Source: NIH RePORTER	National Institutes of Health from NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant 030534 from NIDDK.	ASKWITH C, 1994, CELL, V76, P403, DOI 10.1016/0092-8674(94)90346-8; Chen OS, 2004, J BIOL CHEM, V279, P29513, DOI 10.1074/jbc.M403209200; Fernandes L, 1997, MOL CELL BIOL, V17, P6982, DOI 10.1128/MCB.17.12.6982; Kumanovics A, 2008, J BIOL CHEM, V283, P10276, DOI 10.1074/jbc.M801160200; Kumanovics A, 2006, J BIOL CHEM, V281, P22566, DOI 10.1074/jbc.M604730200; Kumar A, 2002, GENE DEV, V16, P707, DOI 10.1101/gad.970902; Li L, 2008, MOL CELL BIOL, V28, P1326, DOI 10.1128/MCB.01219-07; Li LT, 2010, J BIOL CHEM, V285, P10232, DOI 10.1074/jbc.M109.096859; Li LT, 2004, J BIOL CHEM, V279, P33653, DOI 10.1074/jbc.M403146200; Li LT, 1996, J BIOL CHEM, V271, P16927, DOI 10.1074/jbc.271.28.16927; Li LT, 2001, J BIOL CHEM, V276, P29515, DOI 10.1074/jbc.M103944200; Li LT, 1997, J BIOL CHEM, V272, P28485, DOI 10.1074/jbc.272.45.28485; Lin HL, 2011, J BIOL CHEM, V286, P3851, DOI 10.1074/jbc.M110.190959; Moreno-Cermeno A, 2010, J BIOL CHEM, V285, P41653, DOI 10.1074/jbc.M110.149443; Muhlenhoff U, 2010, CELL METAB, V12, P373, DOI 10.1016/j.cmet.2010.08.001; Noma A, 2006, EMBO J, V25, P2142, DOI 10.1038/sj.emboj.7601105; Philpott CC, 2008, EUKARYOT CELL, V7, P20, DOI 10.1128/EC.00354-07; Radisky DC, 1997, P NATL ACAD SCI USA, V94, P5662, DOI 10.1073/pnas.94.11.5662; Rutherford JC, 2005, J BIOL CHEM, V280, P10135, DOI 10.1074/jbc.M413731200; Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011; Yamaguchi-Iwai Y, 2002, J BIOL CHEM, V277, P18914, DOI 10.1074/jbc.M200949200; YamaguchiIwai Y, 1996, EMBO J, V15, P3377, DOI 10.1002/j.1460-2075.1996.tb00703.x; YUAN DS, 1995, P NATL ACAD SCI USA, V92, P2632, DOI 10.1073/pnas.92.7.2632; Yun CW, 2000, J BIOL CHEM, V275, P10709, DOI 10.1074/jbc.275.14.10709	24	39	40	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38488	38497		10.1074/jbc.M111.286666	http://dx.doi.org/10.1074/jbc.M111.286666			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21917924	hybrid, Green Published			2022-12-25	WOS:000296594200063
J	De Bie, HMA; Oostrom, KJ; Boersma, M; Veltman, DJ; Barkhof, F; Delemarre-van de Waal, HA; van den Heuvel, MP				De Bie, Henrica M. A.; Oostrom, Kim J.; Boersma, Maria; Veltman, Dick J.; Barkhof, Frederik; Delemarre-van de Waal, Henriette A.; van den Heuvel, Martijn P.			Global and Regional Differences in Brain Anatomy of Young Children Born Small for Gestational Age	PLOS ONE			English	Article							INTRAUTERINE GROWTH RESTRICTION; CHRONIC PLACENTAL INSUFFICIENCY; CEREBRAL-CORTEX; 15-YEAR-OLD ADOLESCENTS; CORTICAL DEVELOPMENT; FETAL-GROWTH; TERM; RETARDATION; THICKNESS; CHILDHOOD	In children who are born small for gestational age (SGA), an adverse intrauterine environment has led to underdevelopment of both the body and the brain. The delay in body growth is (partially) restored during the first two years in a majority of these children. In addition to a negative influence on these physical parameters, decreased levels of intelligence and cognitive impairments have been described in children born SGA. In this study, we used magnetic resonance imaging to examine brain anatomy in 4-to 7-year-old SGA children with and without complete bodily catch-up growth and compared them to healthy children born appropriate for gestational age. Our findings demonstrate that these children strongly differ on brain organisation when compared with healthy controls relating to both global and regional anatomical differences. Children born SGA displayed reduced cerebral and cerebellar grey and white matter volumes, smaller volumes of subcortical structures and reduced cortical surface area. Regional differences in prefrontal cortical thickness suggest a different development of the cerebral cortex. SGA children with bodily catch-up growth constitute an intermediate between those children without catch-up growth and healthy controls. Therefore, bodily catch-up growth in children born SGA does not implicate full catch-up growth of the brain.	[De Bie, Henrica M. A.; Delemarre-van de Waal, Henriette A.] Vrije Univ Med Ctr, Dept Pediat, Amsterdam, Netherlands; [Oostrom, Kim J.] Vrije Univ Univ Med Ctr, Dept Pediat Psychol, Amsterdam, Netherlands; [Boersma, Maria] Vrije Univ Univ Med Ctr, Dept Clin Neurophysiol, Amsterdam, Netherlands; [Barkhof, Frederik] Vrije Univ Univ Med Ctr, Dept Radiol, Amsterdam, Netherlands; [Delemarre-van de Waal, Henriette A.] Leiden Univ Med Ctr, Dept Pediat, Leiden, Netherlands; [van den Heuvel, Martijn P.] Univ Med Ctr Utrecht, Neuroimaging Div, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands; [Veltman, Dick J.] Vrije Univ Univ Med Ctr, Dept Psychiat, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Leiden University; Leiden University Medical Center (LUMC); Utrecht University; Utrecht University Medical Center; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	De Bie, HMA (corresponding author), Vrije Univ Med Ctr, Dept Pediat, Amsterdam, Netherlands.	h.debie@vumc.nl	Barkhof, Frederik/AAJ-6226-2020; van den Heuvel, Martijn/AFR-3213-2022	Barkhof, Frederik/0000-0003-3543-3706; van den Heuvel, Martijn/0000-0003-1570-1195	Pfizer bv, The Netherlands	Pfizer bv, The Netherlands(Netherlands Government)	This work was supported by an unrestricted educational grant from Pfizer bv, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BISIGNANO M, 1988, INT J DEV NEUROSCI, V6, P453, DOI 10.1016/0736-5748(88)90051-2; de Bie HMA, 2010, HORM RES PAEDIAT, V73, P6, DOI 10.1159/000271911; de Bie HMA, 2010, EUR J PEDIATR, V169, P1079, DOI 10.1007/s00431-010-1181-z; Dieni S, 2003, J NEUROBIOL, V55, P41, DOI 10.1002/neu.10194; Dubois J, 2008, BRAIN, V131, P2028, DOI 10.1093/brain/awn137; Duncan JR, 2000, AM J OBSTET GYNECOL, V183, P1013, DOI 10.1067/mob.2000.107321; Fewtrell MS, 2001, AM J CLIN NUTR, V74, P516; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Frisk V, 2002, DEV NEUROPSYCHOL, V22, P565, DOI 10.1207/S15326942DN2203_2; Geva R, 2006, PEDIATRICS, V118, P91, DOI 10.1542/peds.2005-2343; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Gilmore JH, 2007, J NEUROSCI, V27, P1255, DOI 10.1523/JNEUROSCI.3339-06.2007; Hackman DA, 2010, NAT REV NEUROSCI, V11, P651, DOI 10.1038/nrn2897; Hollo O, 2002, ARCH PEDIAT ADOL MED, V156, P179, DOI 10.1001/archpedi.156.2.179; Huppi PS, 1998, ANN NEUROL, V43, P224, DOI 10.1002/ana.410430213; Jiao Y, 2010, NEUROIMAGE, V50, P589, DOI 10.1016/j.neuroimage.2009.12.047; Kapellou O, 2006, PLOS MED, V3, P1382, DOI 10.1371/journal.pmed.0030265; Kaufman AS, 1996, J CLIN CHILD PSYCHOL, V25, P97, DOI 10.1207/s15374424jccp2501_11; Kingdom J, 2000, EUR J OBSTET GYN R B, V92, P35, DOI 10.1016/S0301-2115(00)00423-1; Larroque B, 2001, PEDIATRICS, V108, P111, DOI 10.1542/peds.108.1.111; Lee PA, 2003, PEDIATRICS, V111, P1253, DOI 10.1542/peds.111.6.1253; Lodygensky GA, 2008, PEDIATR RES, V63, P438, DOI 10.1203/PDR.0b013e318165c005; Lundgren EM, 2001, PEDIATR RES, V50, P91, DOI 10.1203/00006450-200107000-00017; Mallard C, 2000, NEUROSCIENCE, V100, P327, DOI 10.1016/S0306-4522(00)00271-2; Mallard EC, 1998, PEDIATR RES, V43, P262, DOI 10.1203/00006450-199802000-00018; Martinussen M, 2005, BRAIN, V128, P2588, DOI 10.1093/brain/awh610; Martinussen M, 2009, J PEDIATR-US, V155, P848, DOI 10.1016/j.jpeds.2009.06.015; Morley R, 2004, PEDIATRICS, V113, P515, DOI 10.1542/peds.113.3.515; Mortensen LH, 2008, J EPIDEMIOL COMMUN H, V62, P325, DOI 10.1136/jech.2007.061473; MUGLER JP, 1990, MAGNET RESON MED, V15, P152, DOI 10.1002/mrm.1910150117; NITSOS I, 1990, INT J DEV NEUROSCI, V8, P233, DOI 10.1016/0736-5748(90)90029-2; O'Donnell S, 2005, NEUROIMAGE, V24, P948, DOI 10.1016/j.neuroimage.2004.10.014; Peterson BS, 2000, JAMA-J AM MED ASSOC, V284, P1939, DOI 10.1001/jama.284.15.1939; REES S, 1988, J DEV PHYSIOL, V10, P211; Rees S, 2008, INT J DEV NEUROSCI, V26, P3, DOI 10.1016/j.ijdevneu.2007.08.020; Rehn AE, 2004, NEUROSCIENCE, V129, P381, DOI 10.1016/j.neuroscience.2004.07.047; Resnik R, 2002, OBSTET GYNECOL, V99, P490, DOI 10.1016/S0029-7844(01)01780-X; Roza SJ, 2008, AM J EPIDEMIOL, V168, P1145, DOI 10.1093/aje/kwn233; Saenger P, 2007, ENDOCR REV, V28, P219, DOI 10.1210/er.2006-0039; Sasaki J, 2000, EARLY HUM DEV, V58, P91, DOI 10.1016/S0378-3782(00)00069-4; Schumann CM, 2010, J NEUROSCI, V30, P4419, DOI 10.1523/JNEUROSCI.5714-09.2010; Shaw P, 2006, NATURE, V440, P676, DOI 10.1038/nature04513; Shaw P, 2008, J NEUROSCI, V28, P3586, DOI 10.1523/JNEUROSCI.5309-07.2008; Sizonenko SV, 2006, MOL CELL ENDOCRINOL, V254, P163, DOI 10.1016/j.mce.2006.04.035; Sommerfelt K, 2000, ARCH DIS CHILD, V83, P25, DOI 10.1136/adc.83.1.25; Strauss RS, 2000, JAMA-J AM MED ASSOC, V283, P625, DOI 10.1001/jama.283.5.625; Theodore RF, 2009, EUR J PEDIATR, V168, P1217, DOI 10.1007/s00431-008-0913-9; Thompson PM, 2001, NAT NEUROSCI, V4, P1253, DOI 10.1038/nn758; TOFT PB, 1995, EARLY HUM DEV, V43, P15, DOI 10.1016/0378-3782(95)01657-O; Tolsa CB, 2004, PEDIATR RES, V56, P132, DOI 10.1203/01.PDR.0000128983.54614.7E; TORCHE F, 2011, INT J EPIDEMIOL; *UNESCO UIS, 1997, UNESCO INT STAND CLA; van den Heuvel MP, 2009, HUM BRAIN MAPP, V30, P3127, DOI 10.1002/hbm.20737; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; Volpe J., 2017, VOLPES NEUROLOGY NEW, V6th edn; Volpe JJ, 2000, MENT RETARD DEV D R, V6, P1; Wolosin SM, 2009, HUM BRAIN MAPP, V30, P175, DOI 10.1002/hbm.20496	58	39	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2011	6	9							e24116	10.1371/journal.pone.0024116	http://dx.doi.org/10.1371/journal.pone.0024116			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZV	21931650	Green Published, gold			2022-12-25	WOS:000295321800018
J	Bielecki, P; Puchalka, J; Wos-Oxley, ML; Loessner, H; Glik, J; Kawecki, M; Nowak, M; Tummler, B; Weiss, S; dos Santos, VAPM				Bielecki, Piotr; Puchalka, Jacek; Wos-Oxley, Melissa L.; Loessner, Holger; Glik, Justyna; Kawecki, Marek; Nowak, Mariusz; Tuemmler, Burkhard; Weiss, Siegfried; dos Santos, Vitor A. P. Martins			In-Vivo Expression Profiling of Pseudomonas aeruginosa Infections Reveals Niche-Specific and Strain-Independent Transcriptional Programs	PLOS ONE			English	Article							METABOLIC NETWORK ANALYSIS; GENE-EXPRESSION; VIRULENCE; IDENTIFICATION; PLANT; CARBON; MODEL; RNA; LIPOPOLYSACCHARIDE; PATHOGENICITY	Pseudomonas aeruginosa is a threatening, opportunistic pathogen causing disease in immunocompromised individuals. The hallmark of P. aeruginosa virulence is its multi-factorial and combinatorial nature. It renders such bacteria infectious for many organisms and it is often resistant to antibiotics. To gain insights into the physiology of P. aeruginosa during infection, we assessed the transcriptional programs of three different P. aeruginosa strains directly after isolation from burn wounds of humans. We compared the programs to those of the same strains using two infection models: a plant model, which consisted of the infection of the midrib of lettuce leaves, and a murine tumor model, which was obtained by infection of mice with an induced tumor in the abdomen. All control conditions of P. aeruginosa cells growing in suspension and as a biofilm were added to the analysis. We found that these different P. aeruginosa strains express a pool of distinct genetic traits that are activated under particular infection conditions regardless of their genetic variability. The knowledge herein generated will advance our understanding of P. aeruginosa virulence and provide valuable cues for the definition of prospective targets to develop novel intervention strategies.	[Bielecki, Piotr; Loessner, Holger; Weiss, Siegfried] Helmholtz Ctr Infect Res HZI, Mol Immunol Res Grp, Braunschweig, Germany; [Tuemmler, Burkhard] Hannover Med Sch, Klin Forschergrp, D-30623 Hannover, Germany; [Glik, Justyna; Kawecki, Marek; Nowak, Mariusz] Ctr Burn Treatment, Siemianowice Slaskie, Poland; [Glik, Justyna; Kawecki, Marek] Tech Humanist Acad, Dept Hlth Sci, Bielsko Biala, Poland; [dos Santos, Vitor A. P. Martins] Wageningen Univ, Lab Syst & Synthet Biol Agrotechnol & Food Sci, Wageningen, Netherlands; [Bielecki, Piotr] Ctr Expt & Clin Infect Res, Dept Pathophysiol Bacterial Biofilms, Twincore, Hanover, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; Hannover Medical School; Wageningen University & Research	Bielecki, P (corresponding author), Helmholtz Ctr Infect Res HZI, Mol Immunol Res Grp, Braunschweig, Germany.	vitor.martinsdossantos@wur.nl		Kawecki, Marek/0000-0001-9925-5297	Helmholtz Centre for Infection Research, Germany [1100187]; Wageningen University; European Union [029104, 241587]	Helmholtz Centre for Infection Research, Germany; Wageningen University(European Commission); European Union(European Commission)	This work was funded by the Helmholtz Centre for Infection Research, Germany (project: Systems Biology of Pseudomonas, number 1100187), the Wageningen University, and The Netherlands and the European Union (Probactys project, contract nr. 029104 and the SysteMTB, contract nr. 241587). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Anderson MJ, 2005, PERMANOVA FORTRAN CO; BAECKER PA, 1986, J BIOL CHEM, V261, P8738; Bielecki P, 2008, BIOTECHNOL LETT, V30, P777, DOI 10.1007/s10529-007-9620-2; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Butte A, 2002, NAT REV DRUG DISCOV, V1, P951, DOI 10.1038/nrd961; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; CRYZ SJ, 1984, INFECT IMMUN, V44, P508, DOI 10.1128/IAI.44.2.508-513.1984; D'Argenio DA, 2001, J BACTERIOL, V183, P1466, DOI 10.1128/JB.183.4.1466-1471.2001; DASGUPTA T, 1994, INFECT IMMUN, V62, P809, DOI 10.1128/IAI.62.3.809-817.1994; Filiatrault MJ, 2006, INFECT IMMUN, V74, P4237, DOI 10.1128/IAI.02014-05; Francois P, 2007, J MICROBIOL METH, V68, P385, DOI 10.1016/j.mimet.2006.09.022; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; He JX, 2004, P NATL ACAD SCI USA, V101, P2530, DOI 10.1073/pnas.0304622101; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Jeffery IB, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-359; Juhas M, 2004, MICROBIOL-SGM, V150, P831, DOI 10.1099/mic.0.26906-0; Lee DG, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r90; Li W, 2007, J BACTERIOL, V189, P5413, DOI 10.1128/JB.00432-07; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; Mathee K, 2008, P NATL ACAD SCI USA, V105, P3100, DOI 10.1073/pnas.0711982105; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:fmmtcd]2.0.co;2; McLennan AG, 2006, CELL MOL LIFE SCI, V63, P123, DOI 10.1007/s00018-005-5386-7; Nishijyo T, 2001, MOL MICROBIOL, V40, P917, DOI 10.1046/j.1365-2958.2001.02435.x; Oberhardt MA, 2008, J BACTERIOL, V190, P2790, DOI 10.1128/JB.01583-07; Oberhardt MA, 2010, J BACTERIOL, V192, P5534, DOI 10.1128/JB.00900-10; Ochsner UA, 2002, MOL MICROBIOL, V45, P1277, DOI 10.1046/j.1365-2958.2002.03084.x; QUIN GP, 2002, EXPT DESIGN DATA ANA; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Rahme LG, 1997, P NATL ACAD SCI USA, V94, P13245, DOI 10.1073/pnas.94.24.13245; Rumbaugh KP, 1999, INFECT IMMUN, V67, P5854, DOI 10.1128/IAI.67.11.5854-5862.1999; Saravanamuthu SS, 2004, J BACTERIOL, V186, P7015, DOI 10.1128/JB.186.20.7015-7018.2004; Schobert M, 2010, FUTURE MICROBIOL, V5, P603, DOI 10.2217/FMB.10.16; Schreiber K, 2006, J BACTERIOL, V188, P659, DOI 10.1128/JB.188.2.659-668.2006; Singh PK, 2000, NATURE, V407, P762, DOI 10.1038/35037627; Sonnleitner E, 2009, P NATL ACAD SCI USA, V106, P21866, DOI 10.1073/pnas.pnas.0910308106; Starkey M, 2009, NAT PROTOC, V4, P117, DOI 10.1038/nprot.2008.224; Stepanovic S, 2000, J MICROBIOL METH, V40, P175, DOI 10.1016/S0167-7012(00)00122-6; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Tan MW, 1999, P NATL ACAD SCI USA, V96, P2408, DOI 10.1073/pnas.96.5.2408; Vallet I, 2001, P NATL ACAD SCI USA, V98, P6911, DOI 10.1073/pnas.111551898; Vallet-Gely I, 2007, J BACTERIOL, V189, P8667, DOI 10.1128/JB.01344-07; Weir TL, 2008, APPL ENVIRON MICROB, V74, P5784, DOI 10.1128/AEM.00860-08; Whiteley M, 1999, P NATL ACAD SCI USA, V96, P13904, DOI 10.1073/pnas.96.24.13904; Wiehlmann L, 2007, P NATL ACAD SCI USA, V104, P8101, DOI 10.1073/pnas.0609213104; Yahr TL, 2006, MOL MICROBIOL, V62, P631, DOI 10.1111/j.1365-2958.2006.05412.x	47	41	42	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2011	6	9							e24235	10.1371/journal.pone.0024235	http://dx.doi.org/10.1371/journal.pone.0024235			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CO	21931663	Green Submitted, gold, Green Published			2022-12-25	WOS:000294803200008
J	Erb, I; van Nimwegen, E				Erb, Ionas; van Nimwegen, Erik			Transcription Factor Binding Site Positioning in Yeast: Proximal Promoter Motifs Characterize TATA-Less Promoters	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; IN-VIVO; REGULATORY NETWORK; GENE-EXPRESSION; SEQUENCE PREFERENCES; COMPARATIVE GENOMICS; MESSENGER-RNA; CORE PROMOTER; CELL-CYCLE; ELEMENTS	The availability of sequence specificities for a substantial fraction of yeast's transcription factors and comparative genomic algorithms for binding site prediction has made it possible to comprehensively annotate transcription factor binding sites genome-wide. Here we use such a genome-wide annotation for comprehensively studying promoter architecture in yeast, focusing on the distribution of transcription factor binding sites relative to transcription start sites, and the architecture of TATA and TATA-less promoters. For most transcription factors, binding sites are positioned further upstream and vary over a wider range in TATA promoters than in TATA-less promoters. In contrast, a group of 6 'proximal promoter motifs' (GAT1/GLN3/DAL80, FKH1/2, PBF1/2, RPN4, NDT80, and ROX1) occur preferentially in TATA-less promoters and show a strong preference for binding close to the transcription start site in these promoters. We provide evidence that suggests that pre-initiation complexes are recruited at TATA sites in TATA promoters and at the sites of the other proximal promoter motifs in TATA-less promoters. TATA-less promoters can generally be classified by the proximal promoter motif they contain, with different classes of TATA-less promoters showing different patterns of transcription factor binding site positioning and nucleosome coverage. These observations suggest that different modes of regulation of transcription initiation may be operating in the different promoter classes. In addition we show that, across all promoter classes, there is a close match between nucleosome free regions and regions of highest transcription factor binding site density. This close agreement between transcription factor binding site density and nucleosome depletion suggests a direct and general competition between transcription factors and nucleosomes for binding to promoters.	[Erb, Ionas] Ctr Genom Regulat, Bioinformat & Genom Program, Barcelona, Spain; [Erb, Ionas] Pompeu Fabra Univ, Barcelona, Spain; [van Nimwegen, Erik] Univ Basel, Biozentrum, Basel, Switzerland; [van Nimwegen, Erik] Swiss Inst Bioinformat, Basel, Switzerland	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; University of Basel; Swiss Institute of Bioinformatics	Erb, I (corresponding author), Ctr Genom Regulat, Bioinformat & Genom Program, Barcelona, Spain.	erik.vannimwegen@unibas.ch	van Nimwegen, Erik/ABF-1085-2021	van Nimwegen, Erik/0000-0001-6338-1312; Erb, Ionas/0000-0002-2331-9714	SNF (Swiss National Science Foundation) [31003A-118318]	SNF (Swiss National Science Foundation)(Swiss National Science Foundation (SNSF))	The work of IE and EvN was supported by SNF (Swiss National Science Foundation) grant 31003A-118318. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaji S, 2006, J MOL BIOL, V360, P213, DOI 10.1016/j.jmb.2006.04.029; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Bertram PG, 2000, J BIOL CHEM, V275, P35727, DOI 10.1074/jbc.M004235200; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; Coffman JA, 1997, J BACTERIOL, V179, P3416, DOI 10.1128/jb.179.11.3416-3429.1997; Cox KH, 2000, J BIOL CHEM, V275, P17611, DOI 10.1074/jbc.M001648200; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; ERB I, 2006, IEE P 1 INT C COMP S, P112; Frith MC, 2008, GENOME RES, V18, P1, DOI 10.1101/gr.6831208; Graber JH, 2002, NUCLEIC ACIDS RES, V30, P1851, DOI 10.1093/nar/30.8.1851; Guelzim N, 2002, NAT GENET, V31, P60, DOI 10.1038/ng873; Guo ZJ, 1996, TRENDS BIOCHEM SCI, V21, P477, DOI 10.1016/S0968-0004(96)10057-8; Hampsey M, 2006, NAT STRUCT MOL BIOL, V13, P564, DOI 10.1038/nsmb0706-564; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hollenhorst PC, 2001, GENE DEV, V15, P2445, DOI 10.1101/gad.906201; Ioshikhes IP, 2006, NAT GENET, V38, P1210, DOI 10.1038/ng1878; Kaplan N, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-140; Kastaniotis AJ, 2000, ADV EXP MED BIOL, V475, P185; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Kim SK, 1996, MOL MICROBIOL, V22, P135, DOI 10.1111/j.1365-2958.1996.tb02663.x; Kuehner JN, 2006, J BIOL CHEM, V281, P14119, DOI 10.1074/jbc.M601937200; Landry CR, 2007, SCIENCE, V317, P118, DOI 10.1126/science.1140247; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117; Lippman SI, 2009, P NATL ACAD SCI USA, V106, P19928, DOI 10.1073/pnas.0907027106; Locke G, 2010, P NATL ACAD SCI USA, V107, P20998, DOI 10.1073/pnas.1003838107; MacIsaac KD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-113; Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9; Maslov S, 2005, PHYS BIOL, V2, pS94, DOI 10.1088/1478-3975/2/4/S03; Mavrich TN, 2008, GENOME RES, V18, P1073, DOI 10.1101/gr.078261.108; Miura F, 2006, P NATL ACAD SCI USA, V103, P17846, DOI 10.1073/pnas.0605645103; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; O'Sullivan JM, 2004, NAT GENET, V36, P1014, DOI 10.1038/ng1411; Pachkov M, 2007, NUCLEIC ACIDS RES, V35, pD127, DOI 10.1093/nar/gkl857; Pierce M, 2003, MOL CELL BIOL, V23, P4814, DOI 10.1128/MCB.23.14.4814-4825.2003; Segal E, 2009, TRENDS GENET, V25, P335, DOI 10.1016/j.tig.2009.06.002; Sherriff JA, 2007, MOL CELL BIOL, V27, P2848, DOI 10.1128/MCB.01798-06; Shin ME, 2010, MOL CELL BIOL, V30, P2996, DOI 10.1128/MCB.01682-09; Siddharthan R, 2005, PLOS COMPUT BIOL, V1, P534, DOI 10.1371/journal.pcbi.0010067; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Stein A, 2010, NUCLEIC ACIDS RES, V38, P709, DOI 10.1093/nar/gkp1043; Sudarsanam P, 2002, GENOME RES, V12, P1723, DOI 10.1101/gr.301202; Sugihara F, 2011, NUCLEIC ACIDS RES, V39, P59, DOI 10.1093/nar/gkq741; Tirosh I, 2008, GENOME RES, V18, P1084, DOI 10.1101/gr.076059.108; van Helden J, 2000, NUCLEIC ACIDS RES, V28, P1000; van Nimwegen E, 2002, P NATL ACAD SCI USA, V99, P7323, DOI 10.1073/pnas.112690399; van Nimwegen E, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S4; Venters BJ, 2009, GENOME RES, V19, P360, DOI 10.1101/gr.084970.108; Wade C, 2001, MOL CELL BIOL, V21, P8638, DOI 10.1128/MCB.21.24.8638-8650.2001; Wang XG, 2008, GENETICS, V180, P1945, DOI 10.1534/genetics.108.094524; Xie YM, 2001, P NATL ACAD SCI USA, V98, P3056, DOI 10.1073/pnas.071022298; Yang CH, 2007, GENE, V389, P52, DOI 10.1016/j.gene.2006.09.029; Zhang Y, 2009, NAT STRUCT MOL BIOL, V16, P847, DOI 10.1038/nsmb.1636; Zhang ZH, 2005, NUCLEIC ACIDS RES, V33, P2838, DOI 10.1093/nar/gki583; Zhu C, 2009, GENOME RES, V19, P556, DOI 10.1101/gr.090233.108; Zhu GF, 2000, NATURE, V406, P90, DOI 10.1038/35017581; Zhu J, 1999, BIOINFORMATICS, V15, P607, DOI 10.1093/bioinformatics/15.7.607	60	24	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2011	6	9							e24279	10.1371/journal.pone.0024279	http://dx.doi.org/10.1371/journal.pone.0024279			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CN	21931670	gold, Green Submitted, Green Published			2022-12-25	WOS:000294803100016
J	Su, XH; Chu, YG; Li, H; Hou, YJ; Zhang, BY; Huang, QJ; Hu, ZM; Huang, RF; Tian, YC				Su, Xiaohua; Chu, Yanguang; Li, Huan; Hou, Yingjie; Zhang, Bingyu; Huang, Qinjun; Hu, Zanmin; Huang, Rongfeng; Tian, Yingchuan			Expression of Multiple Resistance Genes Enhances Tolerance to Environmental Stressors in Transgenic Poplar (Populus x euramericana 'Guariento')	PLOS ONE			English	Article							WATER-USE EFFICIENCY; SALT TOLERANCE; VITREOSCILLA HEMOGLOBIN; DROUGHT RESISTANCE; CHLOROPHYLL FLUORESCENCE; WATERLOGGING TOLERANCE; PROLINE ACCUMULATION; PLANTS; RICE; IMPROVEMENT	Commercial and non-commercial plants face a variety of environmental stressors that often cannot be controlled. In this study, transgenic hybrid poplar (Populus x euramericana 'Guariento') harboring five effector genes (vgb, SacB, JERF36, BtCry3A and OC-I) were subjected to drought, salinity, waterlogging and insect stressors in greenhouse or laboratory conditions. Field trials were also conducted to investigate long-term effects of transgenic trees on insects and salt tolerance in the transformants. In greenhouse studies, two transgenic lines D5-20 and D5-21 showed improved growth, as evidenced by greater height and basal diameter increments and total biomass relative to the control plants after drought or salt stress treatments. The improved tolerance to drought and salt was primarily attributed to greater instantaneous water use efficiency (WUEi) in the transgenic trees. The chlorophyll concentrations tended to be higher in the transgenic lines under drought or saline conditions. Transformed trees in drought conditions accumulated more fructan and proline and had increased Fv/Fm ratios (maximum quantum yield of photosystem II) under waterlogging stress. Insect-feeding assays in the laboratory revealed a higher total mortality rate and lower exuviation index of leaf beetle [Plagiodera versicolora (Laicharting)] larvae fed with D5-21 leaves, suggesting enhanced insect resistance in the transgenic poplar. In field trials, the dominance of targeted insects on 2-year-old D5-21 transgenic trees was substantially lower than that of the controls, indicating enhanced resistance to Coleoptera. The average height and DBH (diameter at breast height) of 2.5-year-old transgenic trees growing in naturally saline soil were 3.80% and 4.12% greater than those of the control trees, but these increases were not significant. These results suggested that multiple stress-resistance properties in important crop tree species could be simultaneously improved, although additional research is needed to fully understand the relationships between the altered phenotypes and the function of each transgene in multigene transformants.	[Su, Xiaohua; Chu, Yanguang; Li, Huan; Hou, Yingjie; Zhang, Bingyu; Huang, Qinjun] Chinese Acad Forestry, Res Inst Forestry, State Forestry Adm, Key Lab Tree Breeding & Cultivat, Beijing, Peoples R China; [Hu, Zanmin] Chinese Acad Sci, Inst Genet & Dev Biol, Beijing, Peoples R China; [Huang, Rongfeng] Chinese Acad Agr Sci, Biotechnol Res Inst, Beijing 100193, Peoples R China; [Tian, Yingchuan] Chinese Acad Sci, Inst Microbiol, Beijing, Peoples R China	Chinese Academy of Forestry; Research Institute of Forestry, CAF; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Agricultural Sciences; Biotechnology Research Institute, CAAS; Chinese Academy of Sciences; Institute of Microbiology, CAS	Su, XH (corresponding author), Chinese Acad Forestry, Res Inst Forestry, State Forestry Adm, Key Lab Tree Breeding & Cultivat, Beijing, Peoples R China.	suxh@caf.ac.cn	Campos, Gustavo R C Ribeiro/O-3981-2017		Ministry of Agriculture of China for transgenic research [2009ZX08009-098B]; Public Benefit Research Foundation from the Ministry of Finance of China [201004004]	Ministry of Agriculture of China for transgenic research; Public Benefit Research Foundation from the Ministry of Finance of China	This work was financially supported by the project from the Ministry of Agriculture of China for transgenic research (2009ZX08009-098B) and the Public Benefit Research Foundation from the Ministry of Finance of China (201004004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, STAT WORLDS FOR; Bartels D, 2005, CRIT REV PLANT SCI, V24, P23, DOI 10.1080/07352680590910410; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Bhatnagar-Mathur P, 2008, PLANT CELL REP, V27, P411, DOI 10.1007/s00299-007-0474-9; Blum A, 2005, AUST J AGR RES, V56, P1159, DOI 10.1071/AR05069; Bulow L, 1999, TRENDS BIOTECHNOL, V17, P21, DOI 10.1016/S0167-7799(98)01252-9; Condon AG, 2004, J EXP BOT, V55, P2447, DOI 10.1093/jxb/erh277; De Ronde JA, 2004, J PLANT PHYSIOL, V161, P1211, DOI 10.1016/j.jplph.2004.01.014; Demel RA, 1998, BBA-BIOMEMBRANES, V1375, P36, DOI 10.1016/S0005-2736(98)00138-2; Dubouzet JG, 2003, PLANT J, V33, P751, DOI 10.1046/j.1365-313X.2003.01661.x; Ferry N, 2006, TRANSGENIC RES, V15, P13, DOI 10.1007/s11248-005-4803-x; Garg AK, 2002, P NATL ACAD SCI USA, V99, P15898, DOI 10.1073/pnas.252637799; Genissel A, 2003, MOL BREEDING, V11, P103, DOI 10.1023/A:1022453220496; Guerreiro O, 1998, CURR MICROBIOL, V36, P175; Haggman H, 2003, PLANT BIOTECHNOL J, V1, P287, DOI 10.1046/j.1467-7652.2003.00027.x; Halpin C, 2005, PLANT BIOTECHNOL J, V3, P141, DOI 10.1111/j.1467-7652.2004.00113.x; Halpin C, 2003, TRENDS PLANT SCI, V8, P363, DOI 10.1016/S1360-1385(03)00155-9; Halpin C, 2001, PLANT MOL BIOL, V47, P295, DOI 10.1023/A:1010604120234; Hilder VA, 1999, CROP PROT, V18, P177, DOI 10.1016/S0261-2194(99)00028-9; Holmberg N, 1997, NAT BIOTECHNOL, V15, P244, DOI 10.1038/nbt0397-244; Hsieh TH, 2002, PLANT PHYSIOL, V130, P618, DOI 10.1104/pp.006783; Hu HH, 2006, P NATL ACAD SCI USA, V103, P12987, DOI 10.1073/pnas.0604882103; Huang XY, 2009, GENE DEV, V23, P1805, DOI 10.1101/gad.1812409; INSKEEP WP, 1985, PLANT PHYSIOL, V77, P483, DOI 10.1104/pp.77.2.483; Jobling SA, 2002, NAT BIOTECHNOL, V20, P295, DOI 10.1038/nbt0302-295; JONES CG, 1988, OECOLOGIA, V76, P51, DOI 10.1007/BF00379599; Karaba A, 2007, P NATL ACAD SCI USA, V104, P15270, DOI 10.1073/pnas.0707294104; Li L, 2003, P NATL ACAD SCI USA, V100, P4939, DOI 10.1073/pnas.0831166100; [李义良 Li Yiliang], 2009, [林业科学, Scientia Silvae Sinicae], V45, P26; Li YL, 2009, TREE PHYSIOL, V29, P273, DOI 10.1093/treephys/tpn025; Li YiLiang, 2007, Journal of Beijing Forestry University, V29, P1; MA JKC, 1995, SCIENCE, V268, P716, DOI 10.1126/science.7732380; Magurran A., 1991, ECOLOGICAL DIVERSITY; Mao ZC, 2003, ACTA BOT SIN, V45, P205; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; MOAT AG, 1988, MICROBIAL PHYSL, P166; Nanjo T, 1999, PLANT J, V18, P185, DOI 10.1046/j.1365-313X.1999.00438.x; Nataraja KN, 1999, PHOTOSYNTHETICA, V36, P89, DOI 10.1023/A:1007070820925; Nelson DE, 2007, P NATL ACAD SCI USA, V104, P16450, DOI 10.1073/pnas.0707193104; Park KW, 2002, J BIOL CHEM, V277, P33334, DOI 10.1074/jbc.M203820200; Pilon-Smits EAH, 1999, PLANT PHYSIOL BIOCH, V37, P313, DOI 10.1016/S0981-9428(99)80030-8; PILONSMITS EAH, 1995, PLANT PHYSIOL, V107, P125, DOI 10.1104/pp.107.1.125; Polley HW, 2002, CROP SCI, V42, P131, DOI 10.2135/cropsci2002.0131; Rohacek K, 2002, PHOTOSYNTHETICA, V40, P13, DOI 10.1023/A:1020125719386; Sairam RK, 2008, BIOL PLANTARUM, V52, P401, DOI 10.1007/s10535-008-0084-6; Tang QY., 2002, DPS DATA PROCESSING; TSAI PS, 1995, BIOTECHNOL BIOENG, V47, P347, DOI 10.1002/bit.260470309; VANDERMEER IM, 1994, PLANT CELL, V6, P561, DOI 10.1105/tpc.6.4.561; VANRENSBURG L, 1993, J PLANT PHYSIOL, V141, P188, DOI 10.1016/S0176-1617(11)80758-3; Verbruggen N, 2008, AMINO ACIDS, V35, P753, DOI 10.1007/s00726-008-0061-6; Vereyken IJ, 2001, BBA-BIOMEMBRANES, V1510, P307, DOI 10.1016/S0005-2736(00)00363-1; Wang JG, 2007, CHINESE SCI BULL, V52, P224, DOI 10.1007/s11434-007-0034-2; Wickens G. E., 1991, Unasylva, V42, P3; Wu LJ, 2008, PLANT PHYSIOL, V148, P1953, DOI 10.1104/pp.108.126813; Ye XD, 2000, SCIENCE, V287, P303, DOI 10.1126/science.287.5451.303; Zhang Bing-yu, 2005, Forest Research, V18, P364	56	41	47	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2011	6	9							e24614	10.1371/journal.pone.0024614	http://dx.doi.org/10.1371/journal.pone.0024614			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CN	21931776	Green Submitted, Green Published, gold			2022-12-25	WOS:000294803100048
J	Chariyalertsak, S; Kosachunhanan, N; Saokhieo, P; Songsupa, R; Wongthanee, A; Chariyalertsak, C; Visarutratana, S; Beyrer, C				Chariyalertsak, Suwat; Kosachunhanan, Natthapol; Saokhieo, Pongpun; Songsupa, Radchanok; Wongthanee, Antika; Chariyalertsak, Chonlisa; Visarutratana, Surasing; Beyrer, Chris			HIV Incidence, Risk Factors, and Motivation for Biomedical Intervention among Gay, Bisexual Men, and Transgender Persons in Northern Thailand	PLOS ONE			English	Article							SEX	Background: HIV prevalence among men who have sex with men (MSM) and transgender (TG) persons is high and increasing in Chiang Mai, northern Thailand. Objectives: To describe demographic, socioeconomic, sexual behavior and interest in future HIV prevention trials among gay and bisexual MSM and TG presenting for HIV testing (VCT) and pre-screening for the iPrEx pre-exposure chemoprophylaxis trail. Methods: In 2008-09, MSM/TG participants attending VCT were interviewed and tested for HIV and STI. Univariate and multivariate regression analyses were done to assess associations with HIV infection. Results: A total of 551 MSM clients (56.1% gay, 25.4% TG, and 18.5% bisexual (BS)) were enrolled. The mean age was 23.9 years. HIV prevalence among MSM overall was 12.9% (71/551); 16.5% among gay men, 9.3% among TG, and 6.9% among BS. Consistent use of condom was low, 33.3% in insertive anal sex and 31.9% in receptive anal sex. Interest in participation was high, 86.3% for PrEP, 69.7% for HIV vaccine trials, but 29.9% for circumcision. HIV was independently associated with being gay identified, aOR 2.8, p = 0.037 and with being aged 25-29, aOR 2.7, p = 0.027. Among repeat testers, HIV incidence was 8.2/100 PY, 95% CI, 3.7/100PY to 18.3/100PY. Conclusion: HIV risks and rates varied by self-reported sexual orientation and gender identity. HIV was associated with sexual practices, age, and being gay-identified. These are populations are in need of novel prevention strategies and willing to participate in prevention research.	[Chariyalertsak, Suwat; Kosachunhanan, Natthapol; Saokhieo, Pongpun; Songsupa, Radchanok; Wongthanee, Antika] Chiang Mai Univ, Res Inst Hlth Sci, Chiang Mai 50000, Thailand; [Chariyalertsak, Chonlisa; Visarutratana, Surasing] Minist Publ Hlth, Chiang Mai Prov Hlth Off, Chiang Mai, Thailand; [Beyrer, Chris] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA	Chiang Mai University; Ministry of Public Health - Thailand; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Chariyalertsak, S (corresponding author), Chiang Mai Univ, Res Inst Hlth Sci, Chiang Mai 50000, Thailand.	cbeyrer@jhsph.edu						Beyrer C, 2005, AIDS, V19, P1535, DOI 10.1097/01.aids.0000183122.01583.c7; BEYRER C, 1995, AIDS, V9, P171, DOI 10.1097/00002030-199509020-00009; BEYRER C, 2010, EPIDEMIOL REV; Chemnasiri T, 2010, AIDS EDUC PREV, V22, P100, DOI 10.1521/aeap.2010.22.2.100; GRANT R, 2010, NEJM; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; GUADAMUZ T, 2010, AIDS BEHAV; Newman PA, 2010, VACCINE, V28, P958, DOI 10.1016/j.vaccine.2009.10.142; van Griensven F, 2005, AIDS, V19, P521, DOI 10.1097/01.aids.0000162341.50933.e8; van Griensven F, 2009, J ACQUIR IMMUNE DEFI	10	64	65	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e24295	10.1371/journal.pone.0024295	http://dx.doi.org/10.1371/journal.pone.0024295			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	819CK	21931673	gold, Green Submitted, Green Published			2022-12-25	WOS:000294802800036
J	Dermody, BJ; Tanner, CJ; Jackson, AL				Dermody, Brian J.; Tanner, Colby J.; Jackson, Andrew L.			The Evolutionary Pathway to Obligate Scavenging in Gyps Vultures	PLOS ONE			English	Article							INFORMATION-CENTER HYPOTHESIS; LOCAL ENHANCEMENT; FORAGING SUCCESS; BEHAVIOR; FOOD; BIRDS; CENTERS; RATHER; FLOCKS	The evolutionary pathway to obligate scavenging in Gyps vultures remains unclear. We propose that communal roosting plays a central role in setting up the information transfer network critical for obligate scavengers in ephemeral environments and that the formation of a flotilla-like foraging group is a likely strategy for foraging Gyps vultures. Using a spatial, individual-based, optimisation model we find that the communal roost is critical for establishing the information network that enables information transfer owing to the spatial-concentration of foragers close to the roost. There is also strong selection pressure for grouping behaviour owing to the importance of maintaining network integrity and hence information transfer during foraging. We present a simple mechanism for grouping, common in many animal species, which has the added implication that it negates the requirement for roost-centric information transfer. The formation of a flotilla-like foraging group also improves foraging efficiency through the reduction of overlapping search paths. Finally, we highlight the importance of consideration of information transfer mechanisms in order to maximise the success of vulture reintroduction programmes.	[Dermody, Brian J.; Tanner, Colby J.; Jackson, Andrew L.] Trinity Coll Dublin, Sch Nat Sci, Dept Zool, Dublin, Ireland; [Dermody, Brian J.] Copernicus Inst Sustainable Dev, Dept Environm Sci, Utrecht, Netherlands	Trinity College Dublin	Dermody, BJ (corresponding author), Trinity Coll Dublin, Sch Nat Sci, Dept Zool, Dublin, Ireland.	b.dermody@uu.nl	Tanner, Colby/H-4653-2012; Dermody, Brian/M-5004-2013; Jackson, Andrew L/D-3441-2009	Dermody, Brian/0000-0002-0961-2471; Jackson, Andrew L/0000-0001-7334-0434	Irish Research Council for Science, Engineering and Technology (IRCSET); Department of Zoology, Trinity College Dublin	Irish Research Council for Science, Engineering and Technology (IRCSET)(Irish Research Council for Science, Engineering and Technology); Department of Zoology, Trinity College Dublin	BJD received no funding for this research. CJT was funded by an Irish Research Council for Science, Engineering and Technology (IRCSET) postdoctoral fellowship. ALJ was funded by the Department of Zoology, Trinity College Dublin in his capacity as a lecturer in the department. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballerini M, 2008, P NATL ACAD SCI USA, V105, P1232, DOI 10.1073/pnas.0711437105; Barta Z, 2001, BEHAV ECOL, V12, P121, DOI 10.1093/beheco/12.2.121; Bates D, IME4 LINEAR MIXED EF; Buckley NJ, 1996, AUK, V113, P473, DOI 10.2307/4088913; Buckley NJ, 1997, AM NAT, V149, P1091, DOI 10.1086/286040; Buckley NJ, 1997, BEHAV ECOL SOCIOBIOL, V41, P267, DOI 10.1007/s002650050388; Courchamp F, 2008, ALLEE EFFECTS IN ECOLOGY AND CONSERVATION, P1; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Couzin ID, 2002, J THEOR BIOL, V218, P1, DOI 10.1006/jtbi.2002.3065; Dall SRX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004530; Dall SRX, 2002, BEHAV ECOL, V13, P42, DOI 10.1093/beheco/13.1.42; De Jong K., 2008, P 2008 GECCO C GEN E, P2245; Deygout C, 2009, ECOL MODEL, V220, P1826, DOI 10.1016/j.ecolmodel.2009.04.030; Fernandez-Juricic E, 2004, BEHAV ECOL SOCIOBIOL, V55, P502, DOI 10.1007/s00265-003-0698-9; Gilbert M, 2007, BIRD CONSERV INT, V17, P63, DOI 10.1017/S0959270906000621; GOTMARK F, 1986, NATURE, V319, P589, DOI 10.1038/319589a0; Hirzel AH, 2004, J APPL ECOL, V41, P1103, DOI 10.1111/j.0021-8901.2004.00980.x; HOUSTON D C, 1974, East African Wildlife Journal, V12, P63; Houston D. C, 1979, SERENGETI DYNAMICS E; Jackson AL, 2005, OIKOS, V111, P473, DOI 10.1111/j.1600-0706.2005.14200.x; Jackson AL, 2008, BIOL LETTERS, V4, P311, DOI 10.1098/rsbl.2008.0038; Jackson AL, 2006, BEHAV ECOL, V17, P532, DOI 10.1093/beheco/arj060; KREBS JR, 1974, BEHAVIOUR, V51, P99, DOI 10.1163/156853974X00165; Makris NC, 2006, SCIENCE, V311, P660, DOI 10.1126/science.1121756; PENNYCUICK CJ, 1972, IBIS, V114, P178, DOI 10.1111/j.1474-919X.1972.tb02603.x; Pennycuick CJ, 1998, J AVIAN BIOL, V29, P33, DOI 10.2307/3677338; Rands SA, 2006, BEHAV ECOL SOCIOBIOL, V60, P572, DOI 10.1007/s00265-006-0202-4; RICHNER H, 1991, ANIM BEHAV, V41, P433, DOI 10.1016/S0003-3472(05)80844-9; Ruxton GD, 2004, J THEOR BIOL, V228, P431, DOI 10.1016/j.jtbi.2004.02.005; Ruxton GD, 2003, P ROY SOC B-BIOL SCI, V270, P731, DOI 10.1098/rspb.2002.2279; Ruxton GD, 2002, AFR J ECOL, V40, P260, DOI 10.1046/j.1365-2028.2002.00368.x; RUXTON GD, 1995, ECOL MODEL, V82, P277, DOI 10.1016/0304-3800(94)00098-3; Swarup D, 2007, ANIM CONSERV, V10, P192, DOI 10.1111/j.1469-1795.2006.00086.x; TUCKER VA, 1988, J EXP BIOL, V140, P325; Virani MZ, 2011, BIOL CONSERV, V144, P746, DOI 10.1016/j.biocon.2010.10.024; WALLACE MP, 1987, AUK, V104, P290, DOI 10.1093/auk/104.2.290; WARD P, 1973, IBIS, V115, P517, DOI 10.1111/j.1474-919X.1973.tb01990.x; Wilensky U, 1999, NETLOGO; Wilensky U, 1998, NETLOGO FLOCKING MOD	39	30	30	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e24635	10.1371/journal.pone.0024635	http://dx.doi.org/10.1371/journal.pone.0024635			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CK	21931786	Green Published, Green Submitted, gold			2022-12-25	WOS:000294802800077
J	Du, J; Zhang, JZ; Su, Y; Liu, M; Ospina, JK; Yang, SY; Zhu, AJ				Du, Juan; Zhang, Junzheng; Su, Ying; Liu, Min; Ospina, Jason K.; Yang, Shengyuan; Zhu, Alan Jian			In Vivo RNAi Screen Reveals Neddylation Genes as Novel Regulators of Hedgehog Signaling	PLOS ONE			English	Article							UBIQUITIN-LIKE PROTEIN; TARGETS CUBITUS-INTERRUPTUS; DROSOPHILA EYE DEVELOPMENT; ACTIVATING ENZYME UBA1; CYCLIN-E; TRANSCRIPTIONAL ACTIVITY; TRANSGENIC RNAI; DEEP-ORANGE; NEDD8; MELANOGASTER	Hedgehog (Hh) signaling is highly conserved in all metazoan animals and plays critical roles in many developmental processes. Dysregulation of the Hh signaling cascade has been implicated in many diseases, including cancer. Although key components of the Hh pathway have been identified, significant gaps remain in our understanding of the regulation of individual Hh signaling molecules. Here, we report the identification of novel regulators of the Hh pathway, obtained from an in vivo RNA interference (RNAi) screen in Drosophila. By selectively targeting critical genes functioning in post-translational modification systems utilizing ubiquitin (Ub) and Ub-like proteins, we identify two novel genes (dUba3 and dUbc12) that negatively regulate Hh signaling activity. We provide in vivo and in vitro evidence illustrating that dUba3 and dUbc12 are essential components of the neddylation pathway; they function in an enzyme cascade to conjugate the ubiquitin-like NEDD8 modifier to Cullin proteins. Neddylation activates the Cullin-containing ubiquitin ligase complex, which in turn promotes the degradation of Cubitus interruptus (Ci), the downstream transcription factor of the Hh pathway. Our study reveals a conserved molecular mechanism of the neddylation pathway in Drosophila and sheds light on the complex post-translational regulations in Hh signaling.	[Du, Juan] Peking Univ, Sch Life Sci, Beijing 100871, Peoples R China; [Du, Juan; Zhang, Junzheng; Su, Ying; Liu, Min; Ospina, Jason K.; Yang, Shengyuan; Zhu, Alan Jian] Cleveland Clin, Dept Cell Biol, Lerner Res Inst, Cleveland, OH 44106 USA	Peking University; Cleveland Clinic Foundation	Du, J (corresponding author), Peking Univ, Sch Life Sci, Beijing 100871, Peoples R China.	zhua@ccf.org	Su, Ying/ABA-8545-2021; Zhang, JunZheng/AAS-3285-2021; Du, Juan/AAQ-5466-2020; Su, Ying/M-5825-2013	Su, Ying/0000-0002-8466-0043; Su, Ying/0000-0002-8466-0043; Zhang, Junzheng/0000-0002-0088-151X; Liu, Min/0000-0002-8077-0130	March of Dimes Basil O1Connor Starter Scholar Award [5-FY07-41]; NIH/NIGMS [R01GM085175]; American Heart Association [10POST4110011, 0825591D]; NIH/NICHD [T32HD007104]; Cleveland Clinic; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD007104] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085175] Funding Source: NIH RePORTER	March of Dimes Basil O1Connor Starter Scholar Award; NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Heart Association(American Heart Association); NIH/NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Cleveland Clinic; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Cleveland Clinic Startup fund, a March of Dimes Basil O1Connor Starter Scholar Award (5-FY07-41) and an NIH/NIGMS grant (R01GM085175) to AJZ, American Heart Association Postdoctoral Fellowship Awards (10POST4110011 and 0825591D) to JZ and YS, and an NIH/NICHD postdoctoral training grant (T32HD007104) to JKO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abida WM, 2007, J BIOL CHEM, V282, P1797, DOI 10.1074/jbc.M609001200; AzaBlanc P, 1997, CELL, V89, P1043, DOI 10.1016/S0092-8674(00)80292-5; Baker NE, 2009, DEV BIOL, V335, P356, DOI 10.1016/j.ydbio.2009.09.008; Barakat MT, 2010, TRENDS MOL MED, V16, P337, DOI 10.1016/j.molmed.2010.05.003; Belote JM, 2002, GENESIS, V34, P80, DOI 10.1002/gene.10131; Bhaskar V, 2000, J BIOL CHEM, V275, P4033, DOI 10.1074/jbc.275.6.4033; Broemer M, 2010, MOL CELL, V40, P810, DOI 10.1016/j.molcel.2010.11.011; Casso DJ, 2008, GENETICS, V178, P1399, DOI 10.1534/genetics.107.081638; Chan Y, 2008, J CELL SCI, V121, P3218, DOI 10.1242/jcs.030445; Chanut-Delalande H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010245; Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552; Collins RT, 2005, GENETICS, V170, P173, DOI 10.1534/genetics.104.039420; Crozatier M, 1999, DEVELOPMENT, V126, P1495; Dai P, 2003, DEV CELL, V4, P917, DOI 10.1016/S1534-5807(03)00158-8; Dealy MJ, 1999, NAT GENET, V23, P245, DOI 10.1038/13886; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Furthauer M, 2009, TRAFFIC, V10, P792, DOI 10.1111/j.1600-0854.2009.00914.x; Haines N, 2000, GENETICS, V156, P1777; Harper JW, 2006, CELL, V124, P1133, DOI 10.1016/j.cell.2006.03.009; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Huang DT, 2009, MOL CELL, V33, P483, DOI 10.1016/j.molcel.2009.01.011; Huang DT, 2004, NAT STRUCT MOL BIOL, V11, P927, DOI 10.1038/nsmb826; Huntzicker EG, 2006, GENE DEV, V20, P276, DOI 10.1101/gad.1380906; Ito K, 1997, DEVELOPMENT, V124, P761; Jia HG, 2010, J BIOL CHEM, V285, P37218, DOI 10.1074/jbc.M110.174565; Jia JH, 2005, DEV CELL, V9, P819, DOI 10.1016/j.devcel.2005.10.006; Jiang J, 1998, NATURE, V391, P493, DOI 10.1038/35154; Kamitani T, 1997, J BIOL CHEM, V272, P28557, DOI 10.1074/jbc.272.45.28557; Kent D, 2006, DEVELOPMENT, V133, P2001, DOI 10.1242/dev.02370; Kim HJ, 2007, CELL DEATH DIFFER, V14, P103, DOI 10.1038/sj.cdd.4401935; Kim SH, 2010, DEV BIOL, V346, P247, DOI 10.1016/j.ydbio.2010.07.031; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Kuo CT, 2005, P NATL ACAD SCI USA, V102, P15230, DOI 10.1073/pnas.0507393102; Lee TV, 2008, DEVELOPMENT, V135, P43, DOI 10.1242/dev.011288; Lloyd TE, 2002, CELL, V108, P261, DOI 10.1016/S0092-8674(02)00611-6; Long XM, 2000, J BIOL CHEM, V275, P40765, DOI 10.1074/jbc.M003949200; Lum L, 2003, SCIENCE, V299, P2039, DOI 10.1126/science.1081403; Merlet J, 2009, CELL MOL LIFE SCI, V66, P1924, DOI 10.1007/s00018-009-8712-7; MOTZNY CK, 1995, MECH DEVELOP, V52, P137, DOI 10.1016/0925-4773(95)00397-J; Mummery-Widmer JL, 2009, NATURE, V458, P987, DOI 10.1038/nature07936; Murata S, 2009, NAT REV MOL CELL BIO, V10, P104, DOI 10.1038/nrm2630; Noureddine MA, 2002, DEV CELL, V2, P757, DOI 10.1016/S1534-5807(02)00164-8; Nybakken K, 2005, NAT GENET, V37, P1323, DOI 10.1038/ng1682; OH CE, 1994, J NEUROSCI, V14, P3166; Oh SW, 2003, GENETICS, V163, P195; Osaka F, 1998, GENE DEV, V12, P2263, DOI 10.1101/gad.12.15.2263; Ou CY, 2007, DEV BIOL, V308, P106, DOI 10.1016/j.ydbio.2007.05.008; Ou CY, 2002, GENE DEV, V16, P2403, DOI 10.1101/gad.1011402; Pan ZQ, 2004, ONCOGENE, V23, P1985, DOI 10.1038/sj.onc.1207414; Pfleger CM, 2007, FLY, V1, P95, DOI 10.4161/fly.4285; Pignoni F, 1997, DEVELOPMENT, V124, P271; Rabut G, 2008, EMBO REP, V9, P969, DOI 10.1038/embor.2008.183; Rathke C, 2007, J CELL SCI, V120, P1689, DOI 10.1242/jcs.004663; Rencus-Lazar S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002239; Saj A, 2010, DEV CELL, V18, P862, DOI 10.1016/j.devcel.2010.03.013; Schuldiner O, 2008, DEV CELL, V14, P227, DOI 10.1016/j.devcel.2007.11.001; Schulman BA, 2009, NAT REV MOL CELL BIO, V10, P319, DOI 10.1038/nrm2673; Semple CAM, 2003, GENOME RES, V13, P1389, DOI 10.1101/gr.980303; Seong KH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015365; Sevrioukov EA, 1999, MOL CELL, V4, P479, DOI 10.1016/S1097-2765(00)80199-9; Shih HP, 2002, J CELL SCI, V115, P1259; Singer JD, 1999, GENE DEV, V13, P2375, DOI 10.1101/gad.13.18.2375; Skowyra D, 1999, SCIENCE, V284, P662, DOI 10.1126/science.284.5414.662; Smelkinson MG, 2006, CURR BIOL, V16, P110, DOI 10.1016/j.cub.2005.12.012; Sriram V, 2003, J CELL BIOL, V161, P593, DOI 10.1083/jcb.200210166; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Su Y, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001747; UDVARDY A, 1993, J BIOL CHEM, V268, P9055; VANLEEUWEN F, 1994, NATURE, V368, P342, DOI 10.1038/368342a0; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Vegh M, 2003, GENETICS, V163, P1427; Wang YF, 2008, MOL CELL BIOL, V28, P5555, DOI 10.1128/MCB.00524-08; Watts RJ, 2003, NEURON, V38, P871, DOI 10.1016/S0896-6273(03)00295-2; Wilson CW, 2010, DEVELOPMENT, V137, P2079, DOI 10.1242/dev.045021; Wimuttisuk W, 2007, MOL BIOL CELL, V18, P899, DOI 10.1091/mbc.E06-06-0542; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Wu JT, 2005, NAT CELL BIOL, V7, P1014, DOI 10.1038/ncb1301; Wu JT, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1185; Xirodimas DP, 2008, BIOCHEM SOC T, V36, P802, DOI 10.1042/BST0360802; Xirodimas DP, 2004, CELL, V118, P83, DOI 10.1016/j.cell.2004.06.016; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Yi CH, 2007, J CELL BIOL, V179, P619, DOI 10.1083/jcb.200708090; Zhang Q, 2006, DEV CELL, V10, P719, DOI 10.1016/j.devcel.2006.05.004; Zhang Q, 2009, P NATL ACAD SCI USA, V106, P21191, DOI 10.1073/pnas.0912008106; Zhu AJ, 2003, GENE DEV, V17, P1240, DOI 10.1101/gad.1080803	89	14	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e24168	10.1371/journal.pone.0024168	http://dx.doi.org/10.1371/journal.pone.0024168			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CK	21931660	Green Published, Green Submitted, gold			2022-12-25	WOS:000294802800031
J	Huston, WM; Tyndall, JDA; Lott, WB; Stansfield, SH; Timms, P				Huston, Wilhelmina M.; Tyndall, Joel D. A.; Lott, William B.; Stansfield, Scott H.; Timms, Peter			Unique Residues Involved in Activation of the Multitasking Protease/Chaperone HtrA from Chlamydia trachomatis	PLOS ONE			English	Article							HIGH-TEMPERATURE REQUIREMENT; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; STRESS-RESPONSE; PDZ DOMAINS; PROTEASE; DEGP; CHAPERONE; SPECIFICITY; PROTEOLYSIS	DegP, a member of the HtrA family of proteins, conducts critical bacterial protein quality control by both chaperone and proteolysis activities. The regulatory mechanisms controlling these two distinct activities, however, are unknown. DegP activation is known to involve a unique mechanism of allosteric binding, conformational changes and oligomer formation. We have uncovered a novel role for the residues at the PDZ1: protease interface in oligomer formation specifically for chaperone substrates of Chlamydia trachomatis HtrA (DegP homolog). We have demonstrated that CtHtrA proteolysis could be activated by allosteric binding and oligomer formation. The PDZ1 activator cleft was required for the activation and oligomer formation. However, unique to CtHtrA was the critical role for residues at the PDZ1: protease interface in oligomer formation when the activator was an in vitro chaperone substrate. Furthermore, a potential in vivo chaperone substrate, the major outer membrane protein (MOMP) from Chlamydia, was able to activate CtHtrA and induce oligomer formation. Therefore, we have revealed novel residues involved in the activation of CtHtrA which are likely to have important in vivo implications for outer membrane protein assembly.	[Huston, Wilhelmina M.; Lott, William B.; Stansfield, Scott H.; Timms, Peter] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Kelvin Grove, Qld, Australia; [Tyndall, Joel D. A.] Univ Otago, Sch Pharm, Dunedin, New Zealand	Queensland University of Technology (QUT); University of Otago	Huston, WM (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Kelvin Grove, Qld, Australia.	w.huston@qut.edu.au	Timms, Peter/I-9556-2012; tyndall, joel/C-2803-2008; Lott, William B/J-1062-2012; Huston, Wilhelmina/B-9984-2008; Huston, Wilhelmina/S-7269-2019	tyndall, joel/0000-0003-0783-1635; Lott, William B/0000-0001-7118-7560; Huston, Wilhelmina/0000-0002-0879-1287; Timms, Peter/0000-0002-1682-0025	National Health and Medical Research Council (NHMRC) [553020]; QUT IHBI	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); QUT IHBI	This work was funded by a National Health and Medical Research Council (NHMRC) Peter Doherty Postdoctoral Fellowship awarded to WMH, an NHMRC Project Grant 553020 awarded to WMH and PT, and a QUT IHBI Visiting Researcher Grant awarded to JDAT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baud C, 2009, MOL MICROBIOL, V74, P315, DOI 10.1111/j.1365-2958.2009.06860.x; Baud C, 2011, MOL MICROBI IN PRESS, DOI 10.111/ j.1365-2958.2011.07672. x; Berry LJ, 2004, INFECT IMMUN, V72, P1019, DOI 10.1128/IAI.72.2.1019-1028.2004; Clausen T, 2011, NAT REV MOL CELL BIO, V12, P152, DOI 10.1038/nrm3065; DELMAR EG, 1980, BIOCHEMISTRY-US, V19, P468, DOI 10.1021/bi00544a011; Eswar N, 2006, CURR PROTOC BIOINFOR, V15, P561, DOI DOI 10.1002/0471250953; Hasselblatt H, 2007, GENE DEV, V21, P2659, DOI 10.1101/gad.445307; Hauske P, 2009, BIOORGAN MED CHEM, V17, P2920, DOI 10.1016/j.bmc.2009.01.073; Horn M, 2004, SCIENCE, V304, P728, DOI 10.1126/science.1096330; Huston WM, 2007, FEBS LETT, V581, P3382, DOI 10.1016/j.febslet.2007.06.039; Huston WM, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-190; Iwanczyk J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018944; Kim DY, 2005, J BIOCHEM MOL BIOL, V38, P266; Krojer T, 2002, NATURE, V416, P455, DOI 10.1038/416455a; Krojer T, 2002, NATURE, V417, P102, DOI 10.1038/417102c; Krojer T, 2008, P NATL ACAD SCI USA, V105, P7702, DOI 10.1073/pnas.0803392105; Krojer T, 2008, NATURE, V453, P885, DOI 10.1038/nature07004; Krojer T, 2010, NAT STRUCT MOL BIOL, V17, P844, DOI 10.1038/nsmb.1840; LIPINSKA B, 1989, J BACTERIOL, V171, P1574, DOI 10.1128/jb.171.3.1574-1584.1989; LIPINSKA B, 1990, J BACTERIOL, V172, P1791, DOI 10.1128/jb.172.4.1791-1797.1990; Martins LM, 2003, J BIOL CHEM, V278, P49417, DOI 10.1074/jbc.M308659200; McCoy AJ, 2005, MOL MICROBIOL, V57, P41, DOI 10.1111/j.1365-2958.2005.04661.x; Merdanovic M, 2010, NAT STRUCT MOL BIOL, V17, P837, DOI 10.1038/nsmb.1839; Misra R, 2000, J BACTERIOL, V182, P4882, DOI 10.1128/JB.182.17.4882-4888.2000; MohamedMohaideen NN, 2008, BIOCHEMISTRY-US, V47, P6092, DOI 10.1021/bi701929m; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Page MJ, 2008, J BIOL CHEM, V283, P30010, DOI 10.1074/jbc.M804650200; Pedersen LL, 2001, INFECT IMMUN, V69, P2569, DOI 10.1128/IAI.69.4.2569-2579.2001; Polkinghorne A, 2006, MICROBES INFECT, V8, P61, DOI 10.1016/j.micinf.2005.05.018; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Schilling O, 2008, NAT BIOTECHNOL, V26, P685, DOI 10.1038/nbt1408; Shen QT, 2009, P NATL ACAD SCI USA, V106, P4858, DOI 10.1073/pnas.0811780106; Spiers A, 2002, J BIOL CHEM, V277, P39443, DOI 10.1074/jbc.M202790200; STRAUCH KL, 1989, J BACTERIOL, V171, P2689, DOI 10.1128/jb.171.5.2689-2696.1989; Tsirigos KD, 2011, NUCLEIC ACIDS RES, V39, pD324, DOI 10.1093/nar/gkq863; Walther DM, 2009, CELL MOL LIFE SCI, V66, P2789, DOI 10.1007/s00018-009-0029-z; Wilken C, 2004, CELL, V117, P483, DOI 10.1016/S0092-8674(04)00454-4; Winkler C, 2007, ELECTROPHORESIS, V28, P2095, DOI 10.1002/elps.200600670	38	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e24547	10.1371/journal.pone.0024547	http://dx.doi.org/10.1371/journal.pone.0024547			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CK	21931748	Green Published, Green Submitted, gold			2022-12-25	WOS:000294802800063
J	Milane, L; Duan, ZF; Amiji, M				Milane, Lara; Duan, Zhenfeng; Amiji, Mansoor			Therapeutic Efficacy and Safety of Paclitaxel/Lonidamine Loaded EGFR-Targeted Nanoparticles for the Treatment of Multi-Drug Resistant Cancer	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1; PEPTIDE LIGAND; CELLS; GLYCOLYSIS; APOPTOSIS; GROWTH; DELIVERY; WARBURG; OXYGEN	The treatment of multi-drug resistant (MDR) cancer is a clinical challenge. Many MDR cells over-express epidermal growth factor receptor (EGFR). We exploit this expression through the development of EGFR-targeted, polymer blend nanocarriers for the treatment of MDR cancer using paclitaxel (a common chemotherapeutic agent) and lonidamine (an experimental drug; mitochondrial hexokinase 2 inhibitor). An orthotopic model of MDR human breast cancer was developed in nude mice and used to evaluate the safety and efficacy of nanoparticle treatment. The efficacy parameters included tumor volume measurements from day 0 through 28 days post-treatment, terminal tumor weight measurements, tumor density and morphology assessment through hematoxylin and eosin staining of excised tumors, and immunohistochemistry of tumor sections for MDR protein markers (P-glycoprotein, Hypoxia Inducible Factor, EGFR, Hexokinase 2, and Stem Cell Factor). Toxicity was assessed by tracking changes in animal body weight from day 0 through 28 days post-treatment, by measuring plasma levels of the liver enzymes ALT (Alanine Aminotransferase) and LDH (lactate dehydrogenase), and by white blood cell and platelet counts. In these studies, this nanocarrier system demonstrated superior efficacy relative to combination (paclitaxel/lonidamine) drug solution and single agent treatments in nanoparticle and solution form. The combination nanoparticles were the only treatment group that decreased tumor volume, sustaining this decrease until the 28 day time point. In addition, treatment with the EGFR-targeted lonidamine/paclitaxel nanoparticles decreased tumor density and altered the MDR phenotype of the tumor xenografts. These EGFR-targeted combination nanoparticles were considerably less toxic than solution treatments. Due to the flexible design and simple conjugation chemistry, this nanocarrier system could be used as a platform for the development of other MDR cancer therapies; the use of this system for EGFR-targeted, combination paclitaxel/lonidamine therapy is an advance in personalized medicine.	[Milane, Lara; Amiji, Mansoor] Northeastern Univ, Dept Pharmaceut Sci, Sch Pharm, Boston, MA 02115 USA; [Duan, Zhenfeng] Massachusetts Gen Hosp, Dept Orthopaed Surg, Boston, MA 02114 USA; [Duan, Zhenfeng] Massachusetts Gen Hosp, Ctr Sarcoma & Connect Tissue Oncol, Sarcoma Biol Lab, Boston, MA 02114 USA	Northeastern University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Milane, L (corresponding author), Northeastern Univ, Dept Pharmaceut Sci, Sch Pharm, Boston, MA 02115 USA.	m.amiji@neu.edu	Amiji, Mansoor M/AAK-1531-2020; Amiji, Mansoor M/A-4365-2014	Amiji, Mansoor M/0000-0001-6170-881X; 	National Cancer Institute, National Institutes of Health [R01 CA-119617, R01 CA-119617S1, R21 CA-135594]; NATIONAL CANCER INSTITUTE [R01CA119617, R21CA135594] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the National Cancer Institute, National Institutes of Health through grants R01 CA-119617 and R01 CA-119617S1 (ARRA Supplement), and R21 CA-135594. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brawer Michael K, 2005, Rev Urol, V7 Suppl 7, pS21; Chawla JS, 2002, INT J PHARM, V249, P127, DOI 10.1016/S0378-5173(02)00483-0; Cosse JP, 2008, ANTI-CANCER AGENT ME, V8, P790, DOI 10.2174/187152008785914798; DelBufalo D, 1996, J CLIN INVEST, V98, P1165, DOI 10.1172/JCI118900; Ditonno Pasquale, 2005, Rev Urol, V7 Suppl 7, pS27; Franovic A, 2007, P NATL ACAD SCI USA, V104, P13092, DOI 10.1073/pnas.0702387104; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Han ZB, 2008, CARCINOGENESIS, V29, P1853, DOI 10.1093/carcin/bgn066; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; HARRIS AL, 1992, ACTA ONCOL, V31, P205, DOI 10.3109/02841869209088904; Li YC, 2002, LIFE SCI, V71, P2729, DOI 10.1016/S0024-3205(02)02103-3; Li ZH, 2005, FASEB J, V19, P1978, DOI 10.1096/fj.05-4058com; Lopez-Lazaro M, 2008, ANTI-CANCER AGENT ME, V8, P305, DOI 10.2174/187152008783961932; Mathupala SP, 2006, ONCOGENE, V25, P4777, DOI 10.1038/sj.onc.1209603; MILANE L, 2010, MOL PHARM; MILANE L, 2011, NANOMEDICINE; Pedersen PL, 2007, J BIOENERG BIOMEMBR, V39, P211, DOI 10.1007/s10863-007-9094-x; Ravagnan L, 1999, ONCOGENE, V18, P2537, DOI 10.1038/sj.onc.1202625; Semenza GL, 2002, BIOCHEM PHARMACOL, V64, P993, DOI 10.1016/S0006-2952(02)01168-1; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2008, IUBMB LIFE, V60, P591, DOI 10.1002/iub.93; Song SX, 2008, INT J PHARMACEUT, V363, P155, DOI 10.1016/j.ijpharm.2008.07.012; Yague E, 2007, CANCER RES, V67, P1130, DOI 10.1158/0008-5472.CAN-06-2574	23	76	78	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e24075	10.1371/journal.pone.0024075	http://dx.doi.org/10.1371/journal.pone.0024075			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CK	21931642	gold, Green Published, Green Submitted			2022-12-25	WOS:000294802800020
J	Young, A; Jiang, MS; Wang, Y; Ahmedli, NB; Ramirez, J; Reese, BE; Birnbaumer, L; Farber, DB				Young, Alejandra; Jiang, Meisheng; Wang, Ying; Ahmedli, Novruz B.; Ramirez, John; Reese, Benjamin E.; Birnbaumer, Lutz; Farber, Debora B.			Specific Interaction of G alpha i3 with the Oa1 G-Protein Coupled Receptor Controls the Size and Density of Melanosomes in Retinal Pigment Epithelium	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION SYSTEM; HETEROTRIMERIC G-PROTEIN; LINKED OCULAR ALBINISM; TRIMERIC G-PROTEINS; CYTOPLASMIC DOMAINS; GENE-PRODUCT; FUSION; EXPRESSION; BIOGENESIS; ACTIVATION	Background: Ocular albinism type 1, an X-linked disease characterized by the presence of enlarged melanosomes in the retinal pigment epithelium (RPE) and abnormal crossing of axons at the optic chiasm, is caused by mutations in the OA1 gene. The protein product of this gene is a G-protein-coupled receptor (GPCR) localized in RPE melanosomes. The Oa1-/- mouse model of ocular albinism reproduces the human disease. Oa1 has been shown to immunoprecipitate with the G alpha i subunit of heterotrimeric G proteins from human skin melanocytes. However, the G alpha i subfamily has three highly homologous members, G alpha i1, G alpha i2 and G alpha i3 and it is possible that one or more of them partners with Oa1. We had previously shown by in-vivo studies that G alpha i3-/- and Oa1-/- mice have similar RPE phenotype and decussation patterns. In this paper we analyze the specificity of the Oa1-G alpha i interaction. Methodology: By using the genetic mouse models G alpha i1-/-, G alpha i2-/-, G alpha i3-/- and the double knockout G alpha i1-/-, G alpha i3-/- that lack functional G alpha i1, G alpha i2, G alpha i3, or both G alpha i1 and G alpha i3 proteins, respectively, we show that G alpha i3 is critical for the maintenance of a normal melanosomal phenotype and that its absence is associated with changes in melanosomal size and density. GST-pull-down and immunoprecipitation assays conclusively demonstrate that G alpha i3 is the only G alpha i that binds to Oa1. Western blots show that G alpha i3 expression is barely detectable in the Oa1-/- RPE, strongly supporting a previously unsuspected role for G alpha i3 in melanosomal biogenesis. Conclusion: Our results identify the Oa1 transducer G alpha i3 as the first downstream component in the Oa1 signaling pathway.	[Young, Alejandra; Ahmedli, Novruz B.; Ramirez, John; Farber, Debora B.] Univ Calif Los Angeles, Jules Stein Eye Inst, Los Angeles, CA 90024 USA; [Young, Alejandra; Farber, Debora B.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Jiang, Meisheng; Wang, Ying] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA USA; [Reese, Benjamin E.] Univ Calif Santa Barbara, Dept Psychol & Brain Sci, Santa Barbara, CA 93106 USA; [Birnbaumer, Lutz] Natl Inst Environm Hlth Sci, Neurobiol Lab, Div Intramural Res, NIH, Res Triangle Pk, NC USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Santa Barbara; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Young, A (corresponding author), Univ Calif Los Angeles, Jules Stein Eye Inst, Los Angeles, CA 90024 USA.	farber@jsei.ucla.edu		Young, Alejandra/0000-0002-1855-0559; Farber, Debora/0000-0002-3207-697X	National Institutes of Health (NIH) [EY015141]; Vision of Children Foundation; NATIONAL EYE INSTITUTE [R01EY015141, P30EY000331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES101684] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vision of Children Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institutes of Health (NIH) Grant EY015141 to DBF, BER, and MJ and by The Vision of Children Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bourne HR, 1997, CURR OPIN CELL BIOL, V9, P134, DOI 10.1016/S0955-0674(97)80054-3; CODINA J, 1991, J RECEPTOR RES, V11, P587, DOI 10.3109/10799899109066429; COLOMBO MI, 1992, SCIENCE, V255, P1695, DOI 10.1126/science.1348148; Cortese K, 2005, INVEST OPHTH VIS SCI, V46, P4358, DOI 10.1167/iovs.05-0834; ERCOLANI L, 1990, P NATL ACAD SCI USA, V87, P4635, DOI 10.1073/pnas.87.12.4635; FRANGIONI JV, 1993, ANAL BIOCHEM, V210, P179, DOI 10.1006/abio.1993.1170; GAO B, 1987, P NATL ACAD SCI USA, V84, P6122, DOI 10.1073/pnas.84.17.6122; GARNER A, 1980, HISTOPATHOLOGY, V4, P243, DOI 10.1111/j.1365-2559.1980.tb02919.x; Giordano F, 2009, HUM MOL GENET, V18, P4530, DOI 10.1093/hmg/ddp415; Gohla A, 2007, P NATL ACAD SCI USA, V104, P3003, DOI 10.1073/pnas.0611434104; HAWES BE, 1994, J BIOL CHEM, V269, P15776; Jiang MS, 2002, METHOD ENZYMOL, V344, P277; Jiang MS, 1998, P NATL ACAD SCI USA, V95, P3269, DOI 10.1073/pnas.95.6.3269; King R.C., 2006, DICT GENETICS; LEYTE A, 1992, EMBO J, V11, P4795, DOI 10.1002/j.1460-2075.1992.tb05585.x; LUTTRELL LM, 1993, SCIENCE, V259, P1453, DOI 10.1126/science.8383880; Luttrell LM, 1997, J BIOL CHEM, V272, P4637, DOI 10.1074/jbc.272.7.4637; NAMBA T, 1993, NATURE, V365, P166, DOI 10.1038/365166a0; Nurnberg B, 1996, FEBS LETT, V389, P61, DOI 10.1016/0014-5793(96)00584-4; ODONNELL FE, 1976, ARCH OPHTHALMOL-CHIC, V94, P1883, DOI 10.1001/archopht.1976.03910040593001; Oetting W S, 1994, Metab Pediatr Syst Ophthalmol (1985), V17, P5; Samaraweera P, 2001, EXP EYE RES, V72, P319, DOI 10.1006/exer.2000.0962; Sattar AA, 2002, J BIOCHEM, V131, P815, DOI 10.1093/oxfordjournals.jbchem.a003170; Schiaffino MV, 1999, NAT GENET, V23, P108, DOI 10.1038/12715; Schiaffino MV, 2005, PIGM CELL RES, V18, P227, DOI 10.1111/j.1600-0749.2005.00240.x; Schiaffino MV, 1996, P NATL ACAD SCI USA, V93, P9055, DOI 10.1073/pnas.93.17.9055; SEDMAK JJ, 1977, ANAL BIOCHEM, V79, P544, DOI 10.1016/0003-2697(77)90428-6; SHEN B, 2001, PIGMENT CELL RES, V14, P43; STOW JL, 1991, J CELL BIOL, V114, P1113, DOI 10.1083/jcb.114.6.1113; Wess J, 1997, FASEB J, V11, P346, DOI 10.1096/fasebj.11.5.9141501; WYLIE F, 1999, AM J PHYSIOL, V276, P497; Young A, 2008, INVEST OPHTH VIS SCI, V49, P3245, DOI 10.1167/iovs.08-1806	32	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e24376	10.1371/journal.pone.0024376	http://dx.doi.org/10.1371/journal.pone.0024376			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CK	21931697	Green Submitted, Green Published, gold			2022-12-25	WOS:000294802800044
J	Ferdowsian, HR; Beck, N				Ferdowsian, Hope R.; Beck, Nancy			Ethical and Scientific Considerations Regarding Animal Testing and Research	PLOS ONE			English	Article							PAIN; TRANSLATION; EVOLUTION; MODELS; FISH		[Ferdowsian, Hope R.; Beck, Nancy] Phys Comm Responsible Med, Washington, DC USA; [Ferdowsian, Hope R.] George Washington Univ, Dept Med, Washington, DC USA	George Washington University	Ferdowsian, HR (corresponding author), Phys Comm Responsible Med, Washington, DC USA.	hferdowsian@pcrm.org			National Science Foundation [SES-0957163]; Arcus Foundation [0902-34]	National Science Foundation(National Science Foundation (NSF)); Arcus Foundation	The authors are grateful to the National Science Foundation (grant SES-0957163) and the Arcus Foundation (grant 0902-34) for the financial support for the corresponding conference, Animals, Research, and Alternatives: Measuring Progress 50 Years Later. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen ME, 2009, TOXICOL SCI, V107, P324, DOI 10.1093/toxsci/kfn255; [Anonymous], 1979, BELM REP; Balcombe J, 2009, APPL ANIM BEHAV SCI, V118, P208, DOI 10.1016/j.applanim.2009.02.012; Balcombe JP, 2004, CONTEMP TOP LAB ANIM, V43, P42; Beauchamp T. Lamar, 2008, HUMAN USE ANIMALS CA; Boysen ST, 1999, ANNU REV PSYCHOL, V50, P683, DOI 10.1146/annurev.psych.50.1.683; Bradshaw GA, 2008, J TRAUMA DISSOCIATIO, V9, P9, DOI 10.1080/15299730802073619; Bradshaw GA, 2007, ETHOLOGY, V113, P426, DOI 10.1111/j.1439-0310.2007.01333.x; Bradshaw GA, 2005, NATURE, V433, P807, DOI 10.1038/433807a; Burghardt GM, 2005, GENESIS OF ANIMAL PLAY: TESTING THE LIMITS, P1; Charney DS, 2004, AM J PSYCHIAT, V161, P1, DOI 10.1176/appi.ajp.161.1.1; Committee on Toxicity Testing and Assessment of Environmental Agents N. R. C., 2007, TOX TEST 21 CENT VIS; De Waal Frans, 2009, AGE EMPATHY NATURES; Emery NJ, 2004, SCIENCE, V306, P1903, DOI 10.1126/science.1098410; Gamble JR, 2002, ANIM BEHAV, V63, P339, DOI 10.1006/anbe.2001.1903; Garber K, 2006, J NATL CANCER I, V98, P1176, DOI 10.1093/jnci/djj381; GOSSEL PP, 1985, J HIST MED ALL SCI, V40, P397, DOI 10.1093/jhmas/40.4.397; Grass GM, 2001, DRUG DISCOV TODAY, V6, pS54; Gregory NG, 2004, PHYSIOLOGY AND BEHAVIOUR OF ANIMAL SUFFERING, P1, DOI 10.1002/9780470752494; Hackam DG, 2006, JAMA-J AM MED ASSOC, V296, P1731, DOI 10.1001/jama.296.14.1731; Hartung T, 2009, NATURE, V460, P208, DOI 10.1038/460208a; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; Higbee RG, 2009, ATLA-ALTERN LAB ANIM, V37, P19, DOI 10.1177/026119290903701S05; Horrobin DF, 2003, NAT REV DRUG DISCOV, V2, P151, DOI 10.1038/nrd1012; Ibrahim DM, 2006, U CHIC LEG FOR 2006; Institute of Laboratory Animal Resources Commission on Life Sciences National Research Council, 2009, REC ALL PAIN DISTR L; Ioannidis JPA, 2006, PLOS CLIN TRIALS, V1, DOI 10.1371/journal.pctr.0010036; Koob GF, ANIMAL MODELS DEPRES; Langford DJ, 2006, SCIENCE, V312, P1967, DOI 10.1126/science.1128322; Langley G, 2007, BIOESSAYS, V29, P918, DOI 10.1002/bies.20628; Lederer S., 1995, SUBJECTED SCI; Macleod M, 2005, INT J NEUROPROT NEUR, V1, P201; Matthews RAJ, 2008, J ROY SOC MED, V101, P95, DOI 10.1258/jrsm.2007.070164; McMillan FD, MENTAL HLTH WELL BEI; Office of Laboratory Animal Welfare, 2002, PUBL HLTH SERV POL H; Office of Laboratory Animal Welfare, 2002, US GOV PRINC UT CAR; ORTEGA JC, 1987, AUK, V104, P338, DOI 10.1093/auk/104.2.338; Panksepp J., 2004, AFFECTIVE NEUROSCIEN; Perel P, 2007, BMJ-BRIT MED J, V334, P197, DOI 10.1136/bmj.39048.407928.BE; Posner LP, 2009, ILAR J, V50, P327, DOI 10.1093/ilar.50.4.327; Pound P, 2004, BMJ-BRIT MED J, V328, P514, DOI 10.1136/bmj.328.7438.514; Rollin BE, 2006, THEOR MED BIOETH, V27, P285, DOI 10.1007/s11017-006-9007-8; Rusche B, 2003, ALTEX-ALTERN TIEREXP, V20, P63; RUSH DK, 1982, BEHAV RES THER, V20, P135, DOI 10.1016/0005-7967(82)90113-9; Russell W.M.S., 1959, PRINCIPLES HUMANE EX, V238; SELIGMAN ME, 1972, ANNU REV MED, V23, P407, DOI 10.1146/annurev.me.23.020172.002203; Shettleworth, 2010, COGNITION EVOLUTION; Sneddon LU, 2009, ILAR J, V50, P338, DOI 10.1093/ilar.50.4.338; Taylor K, 2008, ATLA-ALTERN LAB ANIM, V36, P327, DOI 10.1177/026119290803600310; WMA, 1964, 18 WMA GEN ASSEMBLY	51	69	72	5	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2011	6	9							e24059	10.1371/journal.pone.0024059	http://dx.doi.org/10.1371/journal.pone.0024059			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	819CH	21915280	Green Published, gold			2022-12-25	WOS:000294802500024
J	LaRocca, J; Pietruska, J; Hixon, M				LaRocca, Jessica; Pietruska, Jodie; Hixon, Mary			Akt1 Is Essential for Postnatal Mammary Gland Development, Function, and the Expression of Btn1a1	PLOS ONE			English	Article							PROTEIN-KINASE B/AKT; BREAST-CANCER; KEY STAGES; END BUD; ACTIVATION; CELLS; DIFFERENTIATION; BUTYROPHILIN; PROGRESSION; INVOLUTION	Akt1, a serine-threonine protein kinase member of the PKB/Akt gene family, plays critical roles in the regulation of multiple cellular processes, and has previously been implicated in lactation and breast cancer development. In this study, we utilized Akt1+/+ and Akt1-/- C57/Bl6 female mice to assess the role that Akt1 plays in normal mammary gland postnatal development and function. We examined postnatal morphology at multiple time points, and analyzed gene and protein expression changes that persist into adulthood. Akt1 deficiency resulted in several mammary gland developmental defects, including ductal outgrowth and defective terminal end bud formation. Adult Akt1-/- mammary gland composition remained altered, exhibiting fewer alveolar buds coupled with increased epithelial cell apoptosis. Microarray analysis revealed that Akt1 deficiency altered expression of genes involved in numerous biological processes in the mammary gland, including organismal development, cell death, and tissue morphology. Of particular importance, a significant decrease in expression of Btn1a1, a gene involved in milk lipid secretion, was observed in Akt1-/- mammary glands. Additionally, pseudopregnant Akt1-/- females failed to induce Btn1a1 expression in response to hormonal stimulation compared to their wild-type counterparts. Retroviral-mediated shRNA knockdown of Akt1 and Btn1a1 in MCF-7 human breast epithelial further illustrated the importance of Akt1 in mammary epithelial cell proliferation, as well as in the regulation of Btn1a1 and subsequent expression of beta-casein, a gene that encodes for milk protein. Overall these findings provide mechanistic insight into the role of Akt1 in mammary morphogenesis and function.	[LaRocca, Jessica; Pietruska, Jodie; Hixon, Mary] Brown Univ, Dept Pathol & Lab Med, Providence, RI 02912 USA	Brown University	LaRocca, J (corresponding author), Brown Univ, Dept Pathol & Lab Med, Providence, RI 02912 USA.	jessica_larocca@brown.edu			National Institute of Environmental Health Sciences/National Institutes of Health (NIH) [ES015704]; NIH [2T32E5007272]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015704] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences/National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by ES015704 from the National Institute of Environmental Health Sciences/National Institutes of Health (NIH) to MH. JL was supported by 2T32E5007272 from the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Anderson SM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1653; Ball SM, 1998, ANAT REC, V250, P459, DOI 10.1002/(SICI)1097-0185(199804)250:4<459::AID-AR9>3.0.CO;2-S; Boxer RB, 2006, CELL METAB, V4, P475, DOI 10.1016/j.cmet.2006.10.011; Brown C, 2010, BIOL REPROD, V82, P246, DOI 10.1095/biolreprod.109.077925; Campbell RA, 2001, J BIOL CHEM, V276, P9817, DOI 10.1074/jbc.M010840200; Chen CC, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2640; Dillon RL, 2010, CANCER RES, V70, P4260, DOI 10.1158/0008-5472.CAN-10-0266; Fayard E, 2005, J CELL SCI, V118, P5675, DOI 10.1242/jcs.02724; Hennighausen L, 2005, NAT REV MOL CELL BIO, V6, P715, DOI 10.1038/nrm1714; Hinck L, 2005, BREAST CANCER RES, V7, P245, DOI 10.1186/bcr1331; Ju XM, 2007, P NATL ACAD SCI USA, V104, P7438, DOI 10.1073/pnas.0605874104; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Maroulakou IG, 2008, J CELL PHYSIOL, V217, P468, DOI 10.1002/jcp.21518; Medina D, 2005, J CELL SCI, V118, P123, DOI 10.1242/jcs.01597; Ogg SL, 2004, P NATL ACAD SCI USA, V101, P10084, DOI 10.1073/pnas.0402930101; Pietruska JR, 2007, CANCER RES, V67, P3637, DOI 10.1158/0008-5472.CAN-05-3727; Richert MM, 2000, J MAMMARY GLAND BIOL, V5, P227, DOI 10.1023/A:1026499523505; Rieger ME, 2010, MOL CELL BIOL, V30, P4267, DOI 10.1128/MCB.01418-09; RUSSO IH, 1978, J NATL CANCER I, V61, P1439; Schwertfeger KL, 2001, MOL ENDOCRINOL, V15, P867, DOI 10.1210/me.15.6.867; Smalley M, 2003, NAT REV CANCER, V3, P832, DOI 10.1038/nrc1212; Smith IA, 2010, J IMMUNOL, V184, P3514, DOI 10.4049/jimmunol.0900416; Sternlicht MD, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1368; Testa JR, 2005, ONCOGENE, V24, P7391, DOI 10.1038/sj.onc.1209100; Wiseman BS, 2002, SCIENCE, V296, P1046, DOI 10.1126/science.1067431; Yang ZZ, 2003, J BIOL CHEM, V278, P32124, DOI 10.1074/jbc.M302847200; Yang ZZ, 2004, BIOCHEM SOC T, V32, P350, DOI 10.1042/BST0320350	28	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2011	6	9							e24432	10.1371/journal.pone.0024432	http://dx.doi.org/10.1371/journal.pone.0024432			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CH	21915327	Green Published, gold, Green Submitted			2022-12-25	WOS:000294802500045
J	Sakazaki, Y; Hoshino, T; Takei, S; Sawada, M; Oda, H; Takenaka, S; Imaoka, H; Matsunaga, K; Ota, T; Abe, Y; Miki, I; Fujimoto, K; Kawayama, T; Kato, S; Aizawa, H				Sakazaki, Yuki; Hoshino, Tomoaki; Takei, Satoko; Sawada, Masanori; Oda, Hanako; Takenaka, Shin-ichi; Imaoka, Haruki; Matsunaga, Kazuko; Ota, Toshio; Abe, Yuzuru; Miki, Ichiro; Fujimoto, Kiminori; Kawayama, Tomotaka; Kato, Seiya; Aizawa, Hisamichi			Overexpression of Chitinase 3-Like 1/YKL-40 in Lung-Specific IL-18-Transgenic Mice, Smokers and COPD	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; MAMMALIAN CHITINASE; POTENTIAL ROLE; SERUM YKL-40; IL-18; INTERLEUKIN-18; INFLAMMATION; EXPRESSION; EMPHYSEMA; TH2	We analyzed the lung mRNA expression profiles of a murine model of COPD developed using a lung-specific IL-18-transgenic mouse. In this transgenic mouse, the expression of 608 genes was found to vary more than 2-fold in comparison with control WT mice, and was clustered into 4 groups. The expression of 140 genes was constitutively increased at all ages, 215 genes increased gradually with aging, 171 genes decreased gradually with aging, and 82 genes decreased temporarily at 9 weeks of age. Interestingly, the levels of mRNA for the chitinase-related genes chitinase 3-like 1 (Chi3l1), Chi3l3, and acidic mammalian chitinase (AMCase) were significantly higher in the lungs of transgenic mice than in control mice. The level of Chi3l1 protein increased significantly with aging in the lungs and sera of IL-18 transgenic, but not WT mice. Previous studies have suggested Chi3l3 and AMCase are IL-13-driven chitinase-like proteins. However, IL-13 gene deletion did not reduce the level of Chi3l1 protein in the lungs of IL-18 transgenic mice. Based on our murine model gene expression data, we analyzed the protein level of YKL-40, the human homolog of Chi3l1, in sera of smokers and COPD patients. Sixteen COPD patients had undergone high resolution computed tomography (HRCT) examination. Emphysema was assessed by using a density mask with a cutoff of -950 Hounsfield units to calculate the low-attenuation area percentage (LAA%). We observed significantly higher serum levels in samples from 28 smokers and 45 COPD patients compared to 30 non-smokers. In COPD patients, there was a significant negative correlation between serum level of YKL-40 and %FEV1. Moreover, there was a significant positive correlation between the serum levels of YKL-40 and LAA% in COPD patients. Thus our results suggest that chitinase-related genes may play an important role in establishing pulmonary inflammation and emphysematous changes in smokers and COPD patients.	[Sakazaki, Yuki; Hoshino, Tomoaki; Takei, Satoko; Sawada, Masanori; Oda, Hanako; Takenaka, Shin-ichi; Imaoka, Haruki; Matsunaga, Kazuko; Kawayama, Tomotaka; Aizawa, Hisamichi] Kurume Univ, Sch Med, Dept Med, Div Respirol Neurol & Rheumatol, Fukuoka, Japan; [Ota, Toshio; Abe, Yuzuru; Miki, Ichiro] Kyowa Hakko Kirin Co Ltd, Drug Discovery Res Labs, Shizuoka, Japan; [Fujimoto, Kiminori] Kurume Univ, Sch Med, Dept Radiol, Fukuoka, Japan; [Fujimoto, Kiminori] Kurume Univ, Sch Med, Ctr Diagnost Imaging, Dept Med, Fukuoka, Japan; [Kato, Seiya] Univ Ryukyus, Grad Sch, Div Pathol & Cell Biol, Okinawa, Japan; [Kato, Seiya] Univ Ryukyus, Fac Med, Okinawa, Japan	Kurume University; Kyowa Kirin Ltd; Kurume University; Kurume University; University of the Ryukyus; University of the Ryukyus	Sakazaki, Y (corresponding author), Kurume Univ, Sch Med, Dept Med, Div Respirol Neurol & Rheumatol, Fukuoka, Japan.	hoshino@med.kurume-u.ac.jp			Ministry of Education, Science, Sports, and Culture of Japan [21590977]; Ministry of Health, Labor and Welfare, Japan	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a Grant-in-Aid for Scientific Research (C) (no. 21590977: TH) from the Ministry of Education, Science, Sports, and Culture of Japan and by a grant to the Respiratory Failure Research Group from the Ministry of Health, Labor and Welfare, Japan (HA). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. TO, YA, and IM are employed by Kyowa Hakko Kirin Co., Ltd., and these authors performed and analyzed the experiments.	Agapov E, 2009, AM J RESP CELL MOL, V41, P379, DOI [10.1165/2009-0122R, 10.1165/2009-0122RC]; [Anonymous], 2001, JAP RESP SOC STAT JA; Barnes PJ, 2008, NAT REV IMMUNOL, V8, P183, DOI 10.1038/nri2254; Barnes PJ, 2003, EUR RESPIR J, V22, P672, DOI 10.1183/09031936.03.00040703; Bussink AP, 2007, GENETICS, V177, P959, DOI 10.1534/genetics.107.075846; Camp PG, 2009, CHEST, V136, P1480, DOI 10.1378/chest.09-0676; Chupp GL, 2007, NEW ENGL J MED, V357, P2016, DOI 10.1056/NEJMoa073600; Elias JA, 2005, J ALLERGY CLIN IMMUN, V116, P497, DOI 10.1016/j.jaci.2005.06.028; Elias Jack A, 2006, Proc Am Thorac Soc, V3, P494, DOI 10.1513/pats.200603-068MS; Foronjy RF, 2006, AM J RESP CRIT CARE, V173, P623, DOI 10.1164/rccm.200506-850OC; Gevenois PA, 1996, AM J RESP CRIT CARE, V154, P187, DOI 10.1164/ajrccm.154.1.8680679; *GOLD, 2006, GLOB STRAT DIAGN MAN; Hoshino T, 1999, J IMMUNOL, V162, P5070; Hoshino T, 2001, J IMMUNOL, V166, P7014, DOI 10.4049/jimmunol.166.12.7014; Hoshino T, 2000, EUR J IMMUNOL, V30, P1998, DOI 10.1002/1521-4141(200007)30:7<1998::AID-IMMU1998>3.0.CO;2-U; Hoshino T, 2007, AM J RESP CRIT CARE, V176, P49, DOI 10.1164/rccm.200603-316OC; Hoshino T, 2009, AM J RESP CELL MOL, V41, P661, DOI 10.1165/rcmb.2008-0182OC; Imaoka H, 2008, EUR RESPIR J, V31, P287, DOI 10.1183/09031936.00019207; Johansen JS, 2006, CANCER EPIDEM BIOMAR, V15, P194, DOI 10.1158/1055-9965.EPI-05-0011; Kawase Y, 2003, J INVEST DERMATOL, V121, P502, DOI 10.1046/j.1523-1747.2003.12407.x; Kinoshita T, 2007, BIOCHEM BIOPH RES CO, V354, P712, DOI 10.1016/j.bbrc.2007.01.053; Kitasato Y, 2004, AM J RESP CELL MOL, V31, P619, DOI 10.1165/rcmb.2003-0306OC; Lee CG, 2009, J EXP MED, V206, P1149, DOI 10.1084/jem.20081271; Letuve S, 2008, J IMMUNOL, V181, P5167, DOI 10.4049/jimmunol.181.7.5167; MacNee W, 2000, CHEST, V117, p303S, DOI 10.1378/chest.117.5_suppl_1.303S-a; Matsuura H, 2011, AM J RESP CELL MOL, V44, P777, DOI 10.1165/rcmb.2010-0081OC; Nakanishi K, 2001, ANNU REV IMMUNOL, V19, P423, DOI 10.1146/annurev.immunol.19.1.423; Ober C, 2008, NEW ENGL J MED, V358, P1682, DOI 10.1056/NEJMoa0708801; Okamoto M, 2002, BLOOD, V99, P1289, DOI 10.1182/blood.V99.4.1289; Pauwels RA, 2004, LANCET, V364, P613, DOI 10.1016/S0140-6736(04)16855-4; Peto R, 1999, NAT MED, V5, P15, DOI 10.1038/4691; Recklies AD, 2005, J BIOL CHEM, V280, P41213, DOI 10.1074/jbc.M510146200; Saeta M, 1999, AM J RESP CRIT CARE, V160, P711, DOI 10.1164/ajrccm.160.2.9812020; SAETTA M, 1993, AM REV RESPIR DIS, V147, P301, DOI 10.1164/ajrccm/147.2.301; Sims JE, 2002, CURR OPIN IMMUNOL, V14, P117, DOI 10.1016/S0952-7915(01)00306-5; Suzuki A, 2001, J EXP MED, V193, P471, DOI 10.1084/jem.193.4.471; Toda R, 2009, INTERNAL MED, V48, P513, DOI 10.2169/internalmedicine.48.1781; Wang YZ, 2008, SCAND CARDIOVASC J, V42, P295, DOI 10.1080/14017430802220567; Wang ZD, 2000, J EXP MED, V192, P1587, DOI 10.1084/jem.192.11.1587; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Zhu Z, 2004, SCIENCE, V304, P1678, DOI 10.1126/science.1095336	41	32	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2011	6	9							e24177	10.1371/journal.pone.0024177	http://dx.doi.org/10.1371/journal.pone.0024177			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CH	21915293	Green Published, Green Submitted, gold			2022-12-25	WOS:000294802500032
J	Collins, AM; Jones, HDT; Han, DX; Hu, Q; Beechem, TE; Timlin, JA				Collins, Aaron M.; Jones, Howland D. T.; Han, Danxiang; Hu, Qiang; Beechem, Thomas E.; Timlin, Jerilyn A.			Carotenoid Distribution in Living Cells of Haematococcus pluvialis (Chlorophyceae)	PLOS ONE			English	Article							GREEN-ALGA; LEAST-SQUARES; IN-VIVO; RAMAN-SPECTROSCOPY; SECONDARY CAROTENOIDS; ASTAXANTHIN FORMATION; LIGHT; BIOSYNTHESIS; ACCUMULATION; MICROSPECTROSCOPY	Haematococcus pluvialis is a freshwater unicellular green microalga belonging to the class Chlorophyceae and is of commercial interest for its ability to accumulate massive amounts of the red ketocarotenoid astaxanthin (3,3'-dihydroxy-beta,beta-carotene-4,4'-dione). Using confocal Raman microscopy and multivariate analysis, we demonstrate the ability to spectrally resolve resonance-enhanced Raman signatures associated with astaxanthin and beta-carotene along with chlorophyll fluorescence. By mathematically isolating these spectral signatures, in turn, it is possible to locate these species independent of each other in living cells of H. pluvialis in various stages of the life cycle. Chlorophyll emission was found only in the chloroplast whereas astaxanthin was identified within globular and punctate regions of the cytoplasmic space. Moreover, we found evidence for beta-carotene to be co-located with both the chloroplast and astaxanthin in the cytosol. These observations imply that beta-carotene is a precursor for astaxanthin and the synthesis of astaxanthin occurs outside the chloroplast. Our work demonstrates the broad utility of confocal Raman microscopy to resolve spectral signatures of highly similar chromophores in living cells.	[Collins, Aaron M.; Jones, Howland D. T.; Timlin, Jerilyn A.] Sandia Natl Labs, Dept Bioenergy & Def Technol, Albuquerque, NM 87185 USA; [Beechem, Thomas E.] Sandia Natl Labs, Dept Nanomat Sci, Albuquerque, NM 87185 USA; [Han, Danxiang; Hu, Qiang] Arizona State Univ, Dept Appl Sci & Math, Lab Algae Res & Biotechnol, Mesa, AZ USA	United States Department of Energy (DOE); Sandia National Laboratories; United States Department of Energy (DOE); Sandia National Laboratories; Arizona State University	Collins, AM (corresponding author), Sandia Natl Labs, Dept Bioenergy & Def Technol, POB 5800, Albuquerque, NM 87185 USA.	jatimli@sandia.gov		Timlin, Jerilyn/0000-0003-2953-1721; Beechem, Thomas/0000-0002-7536-0719	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-SC 0001035]; U.S. Department of Energy [DE-EE0003372]; Sandia National Laboratory's Directed Research and Development (LDRD) funds; U.S. Department of Energy's National Nuclear Security Administration [DE-AC04-94AL85000]	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); U.S. Department of Energy(United States Department of Energy (DOE)); Sandia National Laboratory's Directed Research and Development (LDRD) funds; U.S. Department of Energy's National Nuclear Security Administration(National Nuclear Security Administration)	This material is based upon work partially supported as part of the Photosynthetic Antenna Research Center (PARC), an Energy Frontier Research Center funded by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under Award Number DE-SC 0001035. PARC's role was to provide the purified carotenoid standards, along with postdoctoral support to Aaron M. Collins. In addition, this work was also partially supported by the U.S. Department of Energy funded Sustainable Algal Biofuels Consortium (Award # DE-EE0003372) through support of Howland D. T. Jones. This work was also partially supported by Sandia National Laboratory's Directed Research and Development (LDRD) funds, whose role, through the employment of Aaron M. Collins, Howland D. T. Jones, Thomas E. Beechem, and Jerilyn A. Timlin was to conceive, design and perform the live cell experiments, and to analyze the data.; The authors have read the journal's policy and have the following conflicts: This study was partly funded by Sandia National Laboratory Directed Research and Development (LDRD) funds. Sandia National Laboratories is a multi-program laboratory managed and operated by Sandia Corporation, a wholly owned subsidiary of Lockheed Martin Corporation, for the U.S. Department of Energy's National Nuclear Security Administration under contract DE-AC04-94AL85000. Aaron M. Collins, Howland D. T. Jones, Thomas E. Beechem, and Jerilyn A. Timlin are employees of Sandia National Laboratories. There are no patents, products in development or marketed products	Abbas A, 2011, CHEMOMETR INTELL LAB, V107, P174, DOI 10.1016/j.chemolab.2011.03.004; ALLEN MM, 1968, J PHYCOL, V4, P1, DOI 10.1111/j.1529-8817.1968.tb04667.x; BENSON RC, 1979, J HISTOCHEM CYTOCHEM, V27, P44, DOI 10.1177/27.1.438504; Billinton N, 2001, ANAL BIOCHEM, V291, P175, DOI 10.1006/abio.2000.5006; BOLD HAROLD C., 1949, BULL TORREY BOT CLUB, V76, P101, DOI 10.2307/2482218; BOROWITZKA MA, 1991, J APPL PHYCOL, V3, P295, DOI 10.1007/BF02392882; BOUSSIBA S, 1992, METHOD ENZYMOL, V213, P386; Bro R, 1997, J CHEMOMETR, V11, P393, DOI 10.1002/(SICI)1099-128X(199709/10)11:5<393::AID-CEM483>3.3.CO;2-C; CZYGAN FC, 1968, ARCH MIKROBIOL, V61, P81, DOI 10.1007/BF00704294; De Gelder J, 2007, J RAMAN SPECTROSC, V38, P1133, DOI 10.1002/jrs.1734; Demmig-Adams B, 2002, SCIENCE, V298, P2149, DOI 10.1126/science.1078002; ELSTNER EF, 1982, ANNU REV PLANT PHYS, V33, P73, DOI 10.1146/annurev.pp.33.060182.000445; Fan L, 1995, PLANT CELL PHYSIOL, V36, P1519; Goss R, 2010, PHOTOSYNTH RES, V106, P103, DOI 10.1007/s11120-010-9536-x; Grunewald K, 2001, J BIOL CHEM, V276, P6023, DOI 10.1074/jbc.M006400200; Grunewald K, 2001, J APPL PHYCOL, V13, P89, DOI 10.1023/A:1008183328839; Haaland DM, 2009, APPL SPECTROSC, V63, P271, DOI 10.1366/000370209787598843; HAALAND DM, 1985, APPL SPECTROSC, V39, P73, DOI 10.1366/0003702854249376; HARKER M, 1995, EUR J PHYCOL, V30, P179, DOI 10.1080/09670269500650961; Heraud P, 2007, FEMS MICROBIOL LETT, V275, P24, DOI 10.1111/j.1574-6968.2007.00861.x; Huang YY, 2010, BIOTECHNOL BIOENG, V105, P889, DOI 10.1002/bit.22617; Jin E, 2006, J MICROBIOL BIOTECHN, V16, P821; Jones HDT, 2008, J CHEMOMETR, V22, P482, DOI 10.1002/cem.1170; Kaczor A, 2011, ANALYST, V136, P1109, DOI 10.1039/c0an00553c; KAKIZONO T, 1992, J FERMENT BIOENG, V74, P403, DOI 10.1016/0922-338X(92)90041-R; Keenan MR, 2004, SURF INTERFACE ANAL, V36, P203, DOI 10.1002/sia.1657; KOBAYASHI M, 1992, J FERMENT BIOENG, V74, P61, DOI 10.1016/0922-338X(92)90271-U; Kotula PG, 2003, MICROSC MICROANAL, V9, P1, DOI 10.1017/S1431927603030058; Lemoine Y, 2010, PHOTOSYNTH RES, V106, P155, DOI 10.1007/s11120-010-9583-3; Li Y, 2008, J PLANT PHYSIOL, V165, P1783, DOI 10.1016/j.jplph.2007.12.007; Li YT, 2010, J APPL PHYCOL, V22, P253, DOI 10.1007/s10811-009-9453-6; Margalith PZ, 1999, APPL MICROBIOL BIOT, V51, P431, DOI 10.1007/s002530051413; MOULIN P, 2011, HDB PLANT CROP STRES, P407; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; Niedzwiedzki DM, 2006, J PHYS CHEM B, V110, P22872, DOI 10.1021/jp0622738; RIMAI L, 1973, J AM CHEM SOC, V95, P4493, DOI 10.1021/ja00795a005; RMIKI NE, 1999, HDB PLANT CROP STRES, P465; Ruban AV, 2001, J BIOL CHEM, V276, P24862, DOI 10.1074/jbc.M103263200; Samek O, 2010, SENSORS-BASEL, V10, P8635, DOI 10.3390/s100908635; SANTOS MF, 1984, CYTOLOGIA, V49, P215; Sarada R, 2002, PROCESS BIOCHEM, V37, P623, DOI 10.1016/S0032-9592(01)00246-1; Sestak Z., 2004, CAROTENOIDS, V42, DOI 10.1023/b:phot.0000040641.40049.19,2; Solovchenko AE, 2011, RUSS J PLANT PHYSL+, V58, P9, DOI 10.1134/S1021443710061056; Tan S, 1995, J PHYCOL, V31, P897, DOI 10.1111/j.0022-3646.1995.00897.x; Timlin JA, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-72; TJAHJONO AE, 1994, BIOTECHNOL LETT, V16, P133, DOI 10.1007/BF01021659; Urban PL, 2011, ANAL CHEM, V83, P1843, DOI 10.1021/ac102702m; Van Benthem MH, 2002, J CHEMOMETR, V16, P613, DOI 10.1002/cem.761; Vermaas WFJ, 2008, P NATL ACAD SCI USA, V105, P4050, DOI 10.1073/pnas.0708090105; Weiss TL, 2010, J BIOL CHEM, V285, P32458, DOI 10.1074/jbc.M110.157230; Wu HW, 2011, P NATL ACAD SCI USA, V108, P3809, DOI 10.1073/pnas.1009043108	51	111	120	3	146	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2011	6	9							e24302	10.1371/journal.pone.0024302	http://dx.doi.org/10.1371/journal.pone.0024302			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817QP	21915307	Green Submitted, gold, Green Published			2022-12-25	WOS:000294689200032
J	Flores-Rodriguez, N; Rogers, SS; Kenwright, DA; Waigh, TA; Woodman, PG; Allan, VJ				Flores-Rodriguez, Neftali; Rogers, Salman S.; Kenwright, David A.; Waigh, Thomas A.; Woodman, Philip G.; Allan, Victoria J.			Roles of Dynein and Dynactin in Early Endosome Dynamics Revealed Using Automated Tracking and Global Analysis	PLOS ONE			English	Article							TUG-OF-WAR; CYTOPLASMIC DYNEIN; IN-VIVO; MEDIATED TRANSPORT; PARTICLE TRACKING; AXONAL-TRANSPORT; CARGO TRANSPORT; MICROTUBULE; MOTOR; KINESIN	Microtubule-dependent movement is crucial for the spatial organization of endosomes in most eukaryotes, but as yet there has been no systematic analysis of how a particular microtubule motor contributes to early endosome dynamics. Here we tracked early endosomes labeled with GFP-Rab5 on the nanometer scale, and combined this with global, first passage probability (FPP) analysis to provide an unbiased description of how the minus-end microtubule motor, cytoplasmic dynein, supports endosome motility. Dynein contributes to short-range endosome movement, but in particular drives 85-98% of long, inward translocations. For these, it requires an intact dynactin complex to allow membrane-bound p150(Glued) to activate dynein, since p50 over-expression, which disrupts the dynactin complex, inhibits inward movement even though dynein and p150(Glued) remain membrane-bound. Long dynein-dependent movements occur via bursts at up to similar to 8 mu ms(-1) that are linked by changes in rate or pauses. These peak speeds during rapid inward endosome movement are still seen when cellular dynein levels are 50-fold reduced by RNAi knock-down of dynein heavy chain, while the number of movements is reduced 5-fold. Altogether, these findings identify how dynein helps define the dynamics of early endosomes.	[Flores-Rodriguez, Neftali; Kenwright, David A.; Woodman, Philip G.; Allan, Victoria J.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Rogers, Salman S.; Kenwright, David A.; Waigh, Thomas A.] Univ Manchester, Sch Phys & Astron, Manchester, Lancs, England; [Kenwright, David A.; Waigh, Thomas A.; Allan, Victoria J.] Univ Manchester, Photon Sci Inst, Manchester, Lancs, England	University of Manchester; University of Manchester; University of Manchester	Flores-Rodriguez, N (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	philip.woodman@manchester.ac.uk; viki.allan@manchester.ac.uk		Allan, Victoria/0000-0003-4583-0836	UK MRC [G0600253, G0900930]; Wellcome Trust [086077/z/08/z]; BBSRC [BB/H017828/1] Funding Source: UKRI; MRC [G0701140, G0601775, G0600253, G0900930] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C512929/1, BB/H017828/1] Funding Source: researchfish; Medical Research Council [G0701140, G0600253, G0900930, G0601775] Funding Source: researchfish	UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	UK MRC (G0600253; G0900930) and Wellcome Trust (086077/z/08/z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abenza JF, 2009, TRAFFIC, V10, P57, DOI 10.1111/j.1600-0854.2008.00848.x; Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; ALLAN V, 2011, BIOCH SOC T IN PRESS, V39; Ally S, 2009, J CELL BIOL, V187, P1071, DOI 10.1083/jcb.200908075; Bananis E, 2000, J CELL BIOL, V151, P179, DOI 10.1083/jcb.151.1.179; Bananis E, 2003, J CELL SCI, V116, P2749, DOI 10.1242/jcs.00478; CAVISTON JP, 2010, MOL BIOL CELL; Chibalina MV, 2007, J CELL SCI, V120, P4278, DOI 10.1242/jcs.014217; Cho C, 2008, J BIOL CHEM, V283, P25839, DOI 10.1074/jbc.M802951200; Coumailleau F, 2009, NATURE, V458, P1051, DOI 10.1038/nature07854; Cui BX, 2007, P NATL ACAD SCI USA, V104, P13666, DOI 10.1073/pnas.0706192104; Doyotte A, 2008, P NATL ACAD SCI USA, V105, P6308, DOI 10.1073/pnas.0707601105; Driskell OJ, 2007, NAT CELL BIOL, V9, P113, DOI 10.1038/ncb1525; Encalada SE, 2011, CELL, V144, P551, DOI 10.1016/j.cell.2011.01.021; Faire K, 1999, J CELL SCI, V112, P4243; Gennerich A, 2007, CELL, V131, P952, DOI 10.1016/j.cell.2007.10.016; Gross SP, 2002, J CELL BIOL, V156, P715, DOI 10.1083/jcb.200109047; Gross SP, 2000, J CELL BIOL, V148, P945, DOI 10.1083/jcb.148.5.945; Ha JH, 2008, J CELL BIOL, V181, P1027, DOI 10.1083/jcb.200803150; Haghnia M, 2007, MOL BIOL CELL, V18, P2081, DOI 10.1091/mbc.E06-08-0695; Hendricks AG, 2010, CURR BIOL, V20, P697, DOI 10.1016/j.cub.2010.02.058; Hoepfner S, 2005, CELL, V121, P437, DOI 10.1016/j.cell.2005.02.017; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; Kardon JR, 2009, P NATL ACAD SCI USA, V106, P5669, DOI 10.1073/pnas.0900976106; Kulic IM, 2008, P NATL ACAD SCI USA, V105, P10011, DOI 10.1073/pnas.0800031105; Kumar S, 2001, EMBO REP, V2, P939, DOI 10.1093/embo-reports/kve202; Kunwar A, 2008, CURR BIOL, V18, P1173, DOI 10.1016/j.cub.2008.07.027; Kural C, 2005, SCIENCE, V308, P1469, DOI 10.1126/science.1108408; Lakadamyali M, 2003, P NATL ACAD SCI USA, V100, P9280, DOI 10.1073/pnas.0832269100; Lalli G, 2003, J CELL SCI, V116, P4639, DOI 10.1242/jcs.00727; Lam C, 2010, J CELL SCI, V123, P202, DOI 10.1242/jcs.059337; Levi V, 2006, BIOPHYS J, V90, P318, DOI 10.1529/biophysj.105.067843; Loubery S, 2008, TRAFFIC, V9, P492, DOI 10.1111/j.1600-0854.2008.00704.x; Mallik R, 2005, CURR BIOL, V15, P2075, DOI 10.1016/j.cub.2005.10.039; Mallik R, 2004, NATURE, V427, P649, DOI 10.1038/nature02293; Martinez JE, 2007, BIOCHEM BIOPH RES CO, V353, P835, DOI 10.1016/j.bbrc.2006.12.120; McKenney RJ, 2010, CELL, V141, P304, DOI 10.1016/j.cell.2010.02.035; Miller AL, 2009, NAT CELL BIOL, V11, P71, DOI 10.1038/ncb1814; Morel E, 2009, DEV CELL, V16, P445, DOI 10.1016/j.devcel.2009.01.007; Nada S, 2009, EMBO J, V28, P477, DOI 10.1038/emboj.2008.308; Nath S, 2007, MOL BIOL CELL, V18, P1839, DOI 10.1091/mbc.E06-06-0524; Nielsen E, 1999, NAT CELL BIOL, V1, P376, DOI 10.1038/14075; Pal A, 2006, J CELL BIOL, V172, P605, DOI 10.1083/jcb.200509091; Palmer KJ, 2009, MOL BIOL CELL, V20, P2885, DOI 10.1091/mbc.E08-12-1160; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; Redner S, 2001, GUIDE 1 PASSAGE PROC; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Rogers SS, 2007, PHYS BIOL, V4, P220, DOI 10.1088/1478-3975/4/3/008; Rogers SS, 2010, PHYS CHEM CHEM PHYS, V12, P3753, DOI 10.1039/b921874b; Ross JL, 2008, BIOPHYS J, V94, P3115, DOI 10.1529/biophysj.107.120014; Ross JL, 2006, NAT CELL BIOL, V8, P562, DOI 10.1038/ncb1421; Salas-Cortes L, 2005, J CELL SCI, V118, P4823, DOI 10.1242/jcs.02607; Satoh D, 2008, NAT CELL BIOL, V10, P1164, DOI 10.1038/ncb1776; Savin T, 2005, BIOPHYS J, V88, P623, DOI 10.1529/biophysj.104.04245; Schroeder HW, 2010, CURR BIOL, V20, P687, DOI 10.1016/j.cub.2010.03.024; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; Schuster M, 2011, P NATL ACAD SCI USA, V108, P3618, DOI 10.1073/pnas.1015839108; Shubeita GT, 2008, CELL, V135, P1098, DOI 10.1016/j.cell.2008.10.021; Soldati T, 2006, NAT REV MOL CELL BIO, V7, P897, DOI 10.1038/nrm2060; Soppina V, 2009, P NATL ACAD SCI USA, V106, P19381, DOI 10.1073/pnas.0906524106; Stepanova T, 2003, J NEUROSCI, V23, P2655; Taub N, 2007, MOL BIOL CELL, V18, P4698, DOI 10.1091/mbc.E07-02-0098; Tomishige M, 2002, SCIENCE, V297, P2263, DOI 10.1126/science.1073386; Traer CJ, 2007, NAT CELL BIOL, V9, P1370, DOI 10.1038/ncb1656; Valetti C, 1999, MOL BIOL CELL, V10, P4107, DOI 10.1091/mbc.10.12.4107; Wassmer T, 2009, DEV CELL, V17, P110, DOI 10.1016/j.devcel.2009.04.016; Wedlich-Soldner R, 2002, EMBO J, V21, P2946, DOI 10.1093/emboj/cdf296; Welte MA, 2004, CURR BIOL, V14, pR525, DOI 10.1016/j.cub.2004.06.045; Zekert N, 2009, MOL BIOL CELL, V20, P673, DOI 10.1091/mbc.E08-07-0685; Zhang J, 2011, J CELL BIOL, V193, P1245, DOI 10.1083/jcb.201011022	70	40	42	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2011	6	9							e24479	10.1371/journal.pone.0024479	http://dx.doi.org/10.1371/journal.pone.0024479			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817QP	21915335	Green Submitted, Green Published, gold			2022-12-25	WOS:000294689200047
J	Valdes, JL; Tang, JR; McDermott, MI; Kuo, JC; Zimmerman, SP; Wincovitch, SM; Waterman, CM; Milgram, SL; Playford, MP				Valdes, Julie L.; Tang, Jingrong; McDermott, Mark I.; Kuo, Jean-Cheng; Zimmerman, Seth P.; Wincovitch, Stephen M.; Waterman, Clare M.; Milgram, Sharon L.; Playford, Martin P.			Sorting Nexin 27 Protein Regulates Trafficking of a p21-activated Kinase (PAK) Interacting Exchange Factor (beta-Pix)-G Protein-coupled Receptor Kinase Interacting Protein (GIT) Complex via a PDZ Domain Interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; BETA-PIX; CELL-MIGRATION; MEMBRANE; FAMILY; IDENTIFICATION; ACTIVATION; BINDING; ROLES; ACTIN	Sorting nexin 27 (SNX27) is a 62-kDa protein localized to early endosomes and known to regulate the intracellular trafficking of ion channels and receptors. In addition to a PX domain, SNX27 is the only sorting family member that contains a PDZ domain. To identify novel SNX27-PDZ binding partners, we performed a proteomic screen in mouse principal kidney cortical collecting duct cells using a GST-SNX27 fusion construct as bait. We found that beta-Pix (p21-activated kinase-interactive exchange factor), a guanine nucleotide exchange factor for the Rho family of small GTPases known to regulate cell motility directly interacted with SNX27. The association of beta-Pix and SNX27 is specific for beta-Pix isoforms terminating in the type-1 PDZ binding motif (ETNL). In the same screen we also identified Git1/2 as a potential SNX27 interacting protein. The interaction between SNX27 and Git1/2 is indirect and mediated by beta-Pix. Furthermore, we show recruitment of the beta-Pix.Git complex to endosomal sites in a SNX27-dependent manner. Finally, migration assays revealed that depletion of SNX27 from HeLa and mouse principal kidney cortical collecting duct cells significantly decreases cell motility. We propose a model by which SNX27 regulates trafficking of beta-Pix to focal adhesions and thereby influences cell motility.	[Valdes, Julie L.; Tang, Jingrong; McDermott, Mark I.; Kuo, Jean-Cheng; Zimmerman, Seth P.; Wincovitch, Stephen M.; Waterman, Clare M.; Milgram, Sharon L.; Playford, Martin P.] NHLBI, Cell Biol & Physiol Ctr, NIH, Bethesda, MD 20982 USA; [Kuo, Jean-Cheng] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Yang Ming Chiao Tung University	Playford, MP (corresponding author), NIH, Bldg 10,Rm 6N256,9000 Rockville Pike, Bethesda, MD 20892 USA.	playfordmp@nhlbi.nih.gov		Waterman, Clare/0000-0001-6142-6775	National Institutes of Health; NHLBI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005108, ZIAHL005105, ZIAHL005104] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZICHG200348] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported, in whole or in part, by a National Institutes of Health grant from the NHLBI.	Audebert S, 2004, CURR BIOL, V14, P987, DOI 10.1016/j.cub.2004.05.051; Bagrodia S, 1999, J BIOL CHEM, V274, P22393, DOI 10.1074/jbc.274.32.22393; Botrugno OA, 2006, EUR J CELL BIOL, V85, P35, DOI 10.1016/j.ejcb.2005.09.018; Cai L, 2011, MOL CELL BIOL, V31, P1734, DOI 10.1128/MCB.01044-10; Campa F, 2006, CELL RES, V16, P759, DOI 10.1038/sj.cr.7310091; Chao WT, 2010, MOL CELL BIOL, V30, P4463, DOI 10.1128/MCB.01207-09; Cullen PJ, 2008, NAT REV MOL CELL BIO, V9, P574, DOI 10.1038/nrm2427; Di Cesare A, 2000, NAT CELL BIOL, V2, P521, DOI 10.1038/35019561; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; Ezratty EJ, 2009, J CELL BIOL, V187, P733, DOI 10.1083/jcb.200904054; Feng QY, 2010, J BIOL CHEM, V285, P18806, DOI 10.1074/jbc.M109.098079; Frank SR, 2008, SEMIN CELL DEV BIOL, V19, P234, DOI 10.1016/j.semcdb.2008.01.002; Gould GW, 2009, NAT REV MOL CELL BIO, V10, P287, DOI 10.1038/nrm2652; Hoefen RJ, 2006, J CELL SCI, V119, P1469, DOI 10.1242/jcs.02925; Hsu RM, 2010, MOL BIOL CELL, V21, P287, DOI 10.1091/mbc.E09-03-0232; Jelen F, 2003, ACTA BIOCHIM POL, V50, P985; Jones NP, 2007, MOL CELL BIOL, V27, P5790, DOI 10.1128/MCB.00778-07; Joubert L, 2004, J CELL SCI, V117, P5367, DOI 10.1242/jcs.01379; Kajii Y, 2003, MOL PSYCHIATR, V8, P434, DOI 10.1038/sj.mp.4001258; Koh CG, 2001, J CELL SCI, V114, P4239; Kuo JC, 2011, NAT CELL BIOL, V13, P383, DOI 10.1038/ncb2216; Lahuna O, 2005, EMBO J, V24, P1364, DOI 10.1038/sj.emboj.7600616; Lamorte L, 2003, MOL BIOL CELL, V14, P2818, DOI 10.1091/mbc.E02-08-0497; Lauffer BEL, 2010, J CELL BIOL, V190, P565, DOI 10.1083/jcb.201004060; Lee HJ, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-8; Lee J, 2005, EXP CELL RES, V307, P315, DOI 10.1016/j.yexcr.2005.03.028; Lee SH, 2001, J BIOL CHEM, V276, P25066, DOI 10.1074/jbc.M010892200; Liu FM, 2010, MOL CELL BIOL, V30, P1971, DOI 10.1128/MCB.01247-09; Loo TH, 2004, MOL CELL BIOL, V24, P3849, DOI 10.1128/MCB.24.9.3849-3859.2004; Lunn ML, 2007, NAT NEUROSCI, V10, P1249, DOI 10.1038/nn1953; MacNeil AJ, 2007, BIOCHEM BIOPH RES CO, V359, P848, DOI 10.1016/j.bbrc.2007.05.162; Manabe R, 2002, J CELL SCI, V115, P1497; Manser E, 1998, MOL CELL, V1, P183, DOI 10.1016/S1097-2765(00)80019-2; Matafora V, 2001, J CELL SCI, V114, P4509; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Pellinen T, 2008, DEV CELL, V15, P371, DOI 10.1016/j.devcel.2008.08.001; Premont RT, 2004, CELL SIGNAL, V16, P1001, DOI 10.1016/j.cellsig.2004.02.002; Rincon E, 2007, MOL CELL PROTEOMICS, V6, P1073, DOI 10.1074/mcp.M700047-MCP200; Schlenker O, 2009, J MOL BIOL, V386, P280, DOI 10.1016/j.jmb.2008.12.050; ten Klooster JP, 2006, J CELL BIOL, V172, P759, DOI 10.1083/jcb.200509096; Turner CE, 1999, J CELL BIOL, V145, P851, DOI 10.1083/jcb.145.4.851; Worby CA, 2002, NAT REV MOL CELL BIO, V3, P919, DOI 10.1038/nrm974; Za L, 2006, J CELL SCI, V119, P2654, DOI 10.1242/jcs.02996	44	32	34	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39403	39416		10.1074/jbc.M111.260802	http://dx.doi.org/10.1074/jbc.M111.260802			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21926430	hybrid, Green Published			2022-12-25	WOS:000296759800058
J	Staron, P; Forchhammer, K; Maldener, I				Staron, Peter; Forchhammer, Karl; Maldener, Iris			Novel ATP-driven Pathway of Glycolipid Export Involving TolC Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SP STRAIN PCC-7120; MULTIDRUG EFFLUX SYSTEM; BLUE-GREEN-ALGA; ABC-TRANSPORTER; ESCHERICHIA-COLI; HETEROCYST GLYCOLIPIDS; CRYSTAL-STRUCTURE; BACTERIAL LIPOPROTEINS; PERIPLASMIC COMPONENT; SIGNAL-TRANSDUCTION	Upon depletion of combined nitrogen, N-2-fixing heterocysts are formed from vegetative cells in the case of the filamentous cyanobacterium Anabaena sp. strain PCC 7120. A heterocyst-specific layer composed of glycolipids (heterocyst envelope glycolipids (HGLs)) that functions as an O-2 diffusion barrier is deposited over the heterocyst outer membrane and is surrounded by an outermost heterocyst polysaccharide envelope. Mutations in any gene of the devBCA operon or tolC result in the absence of the HGL layer, preventing growth on N-2 used as the sole nitrogen source. However, those mutants do not have impaired HGL synthesis. In this study, we show that DevBCA and TolC form an ATP-driven efflux pump required for the export of HGLs across the Gram-negative cell wall. By performing protein-protein interaction studies (in vivo formaldehyde cross-linking, surface plasmon resonance, and isothermal titration calorimetry), we determined the kinetics and stoichiometric relations for the transport process. For sufficient glycolipid export, the membrane fusion protein DevB had to be in a hexameric form to connect the inner membrane factor DevC and the outer membrane factor TolC. A mutation that impaired the ability of DevB to form a hexameric arrangement abolished the ability of DevC to recognize its substrate. The physiological relevance of a hexameric DevB is shown in complementation studies. We provide insights into a novel pathway of glycolipid export across the Gram-negative cell wall.	[Staron, Peter; Forchhammer, Karl; Maldener, Iris] Univ Tubingen, Interfac Inst Microbiol & Infect Med Tubingen, Dept Microbiol Organism Interact, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen	Maldener, I (corresponding author), Univ Tubingen, Interfac Inst Microbiol & Infect Med Tubingen, Dept Microbiol Organism Interact, Morgenstelle 28, D-72076 Tubingen, Germany.	iris.maldener@uni-tuebingen.de			Deutsche Forschungsgemeinschaft [DFG-Ma1359/5-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG-Ma1359/5-1).	Awai K, 2007, FEMS MICROBIOL LETT, V266, P98, DOI 10.1111/j.1574-6968.2006.00512.x; Bauersachs T, 2009, PHYTOCHEMISTRY, V70, P2034, DOI 10.1016/j.phytochem.2009.08.014; BLACK K, 1995, J BACTERIOL, V177, P6440, DOI 10.1128/jb.177.22.6440-6448.1995; Campbell EL, 1997, ARCH MICROBIOL, V167, P251, DOI 10.1007/s002030050440; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; CARDEMIL L, 1976, J BIOL CHEM, V251, P2967; Deininger KNW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018960; Eckford PDW, 2010, BIOCHEM J, V429, P195, DOI 10.1042/BJ20100144; Eswaran J, 2004, CURR OPIN STRUC BIOL, V14, P741, DOI 10.1016/j.sbi.2004.10.003; Fan Q, 2005, MOL MICROBIOL, V58, P227, DOI 10.1111/j.1365-2958.2005.04818.x; FAY P, 1992, MICROBIOL REV, V56, P340, DOI 10.1128/MMBR.56.2.340-373.1992; Ferhat M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007732; Fiedler G, 1998, BBA-BIOMEMBRANES, V1375, P140, DOI 10.1016/S0005-2736(98)00147-3; Fiedler G, 1998, MOL MICROBIOL, V27, P1193, DOI 10.1046/j.1365-2958.1998.00762.x; Fokina O, 2010, J MOL BIOL, V399, P410, DOI 10.1016/j.jmb.2010.04.018; Gambacorta A, 1998, PHYTOCHEMISTRY, V48, P801, DOI 10.1016/S0031-9422(97)00954-0; Garti-Levi S, 2008, MOL MICROBIOL, V69, P1018, DOI 10.1111/j.1365-2958.2008.06340.x; Hantke K, 2011, J BACTERIOL, V193, P1086, DOI 10.1128/JB.01399-10; HAURY JF, 1978, J BACTERIOL, V136, P688, DOI 10.1128/JB.136.2.688-692.1978; Higgins MK, 2004, P NATL ACAD SCI USA, V101, P9994, DOI 10.1073/pnas.0400375101; Holland IB, 2005, MOL MEMBR BIOL, V22, P29, DOI 10.1080/09687860500042013; Kaneko T, 2001, DNA RES, V8, P205, DOI 10.1093/dnares/8.5.205; Kaul G, 2011, INDIAN J BIOCHEM BIO, V48, P7; Kim HM, 2010, J BACTERIOL, V192, P4498, DOI 10.1128/JB.00334-10; Koronakis V, 2004, ANNU REV BIOCHEM, V73, P467, DOI 10.1146/annurev.biochem.73.011303.074104; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Lin HT, 2009, J BIOL CHEM, V284, P1145, DOI 10.1074/jbc.M806964200; Lobedanz S, 2007, P NATL ACAD SCI USA, V104, P4612, DOI 10.1073/pnas.0610160104; Maldener I, 2003, FEMS MICROBIOL LETT, V224, P205, DOI 10.1016/S0378-1097(03)00444-0; Martins M, 2011, IN VIVO, V25, P171; Mikolosko J, 2006, STRUCTURE, V14, P577, DOI 10.1016/j.str.2005.11.015; Moslavac S, 2007, J BACTERIOL, V189, P7887, DOI 10.1128/JB.00750-07; Narita S, 2006, FEBS LETT, V580, P1164, DOI 10.1016/j.febslet.2005.10.038; Narita S, 2010, METHODS MOL BIOL, V619, P117, DOI 10.1007/978-1-60327-412-8_7; Nicolalsen K, 2009, J BASIC MICROB, V49, P5, DOI 10.1002/jobm.200800300; Olmedo-Verd E, 2006, J BACTERIOL, V188, P6694, DOI 10.1128/JB.00509-06; Pinero-Fernandez S, 2011, J BACTERIOL, V193, P1793, DOI 10.1128/JB.01477-10; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; RAETZ CRH, 1991, FASEB J, V5, P2652, DOI 10.1096/fasebj.5.12.1916089; Ramirez ME, 2005, J BACTERIOL, V187, P2326, DOI 10.1128/JB.187.7.2326-2331.2005; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Saier M H Jr, 1999, J Mol Microbiol Biotechnol, V1, P257; Schmidt KL, 2004, J BACTERIOL, V186, P785, DOI 10.1128/JB.186.3.785-793.2004; Schultze M, 2009, BBA-BIOENERGETICS, V1787, P1479, DOI 10.1016/j.bbabio.2009.06.010; Shi L, 2007, J BACTERIOL, V189, P5075, DOI 10.1128/JB.00323-07; Siarheyeva A, 2009, BIOCHEM J, V419, P317, DOI 10.1042/BJ20081364; Symmons MF, 2009, P NATL ACAD SCI USA, V106, P7173, DOI 10.1073/pnas.0900693106; Tikhonova EB, 2007, MOL MICROBIOL, V63, P895, DOI 10.1111/j.1365-2958.2006.05549.x; Tikhonova EB, 2009, P NATL ACAD SCI USA, V106, P16416, DOI 10.1073/pnas.0906601106; Touze T, 2004, MOL MICROBIOL, V53, P697, DOI 10.1111/j.1365-2958.2004.04158.x; Tseng Tsai-Tien, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P107; Wilks JC, 2007, J BACTERIOL, V189, P5601, DOI 10.1128/JB.00615-07; WINKENBACH F, 1972, PLANTA, V107, P69, DOI 10.1007/BF00398015; Wolk C.P., 1994, MOL BIOL CYANOBACTER, P769, DOI DOI 10.1007/978-94-011-0227-8_27; WOLK CP, 1984, P NATL ACAD SCI-BIOL, V81, P1561, DOI 10.1073/pnas.81.5.1561; Xu Y, 2011, J BIOL CHEM, V286, P13541, DOI 10.1074/jbc.M110.202598; Xu YB, 2010, BIOCHEM BIOPH RES CO, V394, P962, DOI 10.1016/j.bbrc.2010.03.097; Xu Y, 2009, BIOCHEMISTRY-US, V48, P5218, DOI 10.1021/bi900415t; Yum SW, 2009, J MOL BIOL, V387, P1286, DOI 10.1016/j.jmb.2009.02.048	59	28	29	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38202	38210		10.1074/jbc.M111.269332	http://dx.doi.org/10.1074/jbc.M111.269332			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21917923	Green Published, hybrid			2022-12-25	WOS:000296594200034
J	Feng, JY; Su, WJ; Chiu, YC; Huang, SF; Lin, YY; Huang, RM; Lin, CH; Hwang, JJ; Lee, JJ; Yu, MC; Yu, KW; Lee, YC				Feng, Jia-Yih; Su, Wei-Juin; Chiu, Yu-Chi; Huang, Shiang-Fen; Lin, Yung-Yang; Huang, Ruay-Ming; Lin, Ching-Hsiung; Hwang, Jhi-Jhu; Lee, Jen-Jyh; Yu, Ming-Chih; Yu, Kwok-Woon; Lee, Yu-Chin			Initial Presentations Predict Mortality in Pulmonary Tuberculosis Patients - A Prospective Observational Study	PLOS ONE			English	Article							BEIJING GENOTYPE; INFECTION; DIAGNOSIS; IMPACT; RISK	Background: Despite effective anti-TB treatments, tuberculosis remains a serious threat to public health and is associated with high mortality. Old age and multiple co-morbidities are known risk factors for death. The association of clinical presentations with mortality in pulmonary tuberculosis patients remains an issue of controversy. Methods: This prospective observational study enrolled newly diagnosed, culture-proven pulmonary tuberculosis patients from five medical centers and one regional hospital, which were referral hospitals of TB patients. Radiographic findings and clinical symptoms were determined at the time of diagnosis. Patients who died for any reason during the course of anti-TB treatment were defined as mortality cases and death that occurred within 30 days of initiating treatment was defined as early mortality. Clinical factors associated with overall mortality and early mortality were investigated. Results: A total of 992 patients were enrolled and 195 (19.7%) died. Nearly one-third (62/195, 31.8%) of the deaths occurred before or within 30 days of treatment initiation. Older age (RR = 1.04, 95% CI: 1.03-1.05), malignancy (RR = 2.42, 95% CI: 1.77-3.31), renal insufficiency (RR = 1.77, 95% CI: 1.12-2.80), presence of chronic cough (RR = 0.63, 95% CI: 0.47-0.84), fever (RR = 1.45, 95% CI: 1.09-1.94), and anorexia (RR = 1.49, 95% CI: 1.07-2.06) were independently associated with overall mortality. Kaplan-Meier survival analysis demonstrated significantly higher mortality in patients present with fever (p<0.001), anorexia (p = 0.005), and without chronic cough (p, 0.001). Among patients of mortality, those with respiratory symptoms of chronic cough (RR = 0.56, 95% CI: 0.33-0.98) and dyspnea (HR = 0.51, 95% CI: 0.27-0.98) were less likely to experience early mortality. The radiological features were comparable between survivors and non-survivors. Conclusions: In addition to demographic characteristics, clinical presentations including the presence of fever, anorexia, and the absence of chronic cough, were also independent predictors for on-treatment mortality in pulmonary tuberculosis patients.	[Feng, Jia-Yih; Su, Wei-Juin; Chiu, Yu-Chi; Huang, Shiang-Fen; Lee, Yu-Chin] Taipei Vet Gen Hosp, Dept Chest Med, Taipei, Taiwan; [Feng, Jia-Yih; Lin, Yung-Yang] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Su, Wei-Juin; Lee, Yu-Chin] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Lin, Yung-Yang] Natl Yang Ming Univ, Inst Brain Sci, Taipei 112, Taiwan; [Lin, Yung-Yang] Taipei Vet Gen Hosp, Neurophysiol Lab, Taipei, Taiwan; [Lin, Yung-Yang] Taipei Vet Gen Hosp, Dept Neurol, Taipei, Taiwan; [Huang, Ruay-Ming] Hua Lien Hosp, Dept Hlth, Executive Yuan, Hua Lien County, Taiwan; [Lin, Ching-Hsiung] Changhua Christian Hosp, Dept Internal Med, Div Chest Med, Changhua, Taiwan; [Hwang, Jhi-Jhu] Kaohsiung Med Univ, Chung Ho Mem Hosp, Dept Internal Med, Div Pulm & Crit Care, Kaohsiung, Taiwan; [Lee, Jen-Jyh] Tzu Chi Univ, Buddhist Tzu Chi Gen Hosp, Dept Internal Med, Hualien, Taiwan; [Yu, Ming-Chih] Wan Fang Hosp, Dept Internal Med, Taipei, Taiwan; [Yu, Kwok-Woon] Taipei Vet Gen Hosp, Div Clin Microbiol, Dept Pathol & Lab Med, Taipei, Taiwan	Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; Changhua Christian Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University; Taipei Municipal WanFang Hospital; Taipei Veterans General Hospital	Su, WJ (corresponding author), Taipei Vet Gen Hosp, Dept Chest Med, Taipei, Taiwan.	wjsu@vghtpe.gov.tw	Huang, Shiang-Fen/ABA-5375-2021	Huang, Shiang-Fen/0000-0003-0390-9108; Lin, Ching-Hsiung/0000-0001-9407-8578; Huang, Shiang-Fen/0000-0002-6685-8259	Institute for Biotechnology and Medicine Industry, Taiwan; Taipei Veterans General Hospital [V97C1-064, V98C1-039, V98A-086, V99C1-181, V99A-023, V100A-002]	Institute for Biotechnology and Medicine Industry, Taiwan; Taipei Veterans General Hospital(Taipei Veterans General Hospital)	This work has been funded by the Institute for Biotechnology and Medicine Industry, Taiwan, and the Taipei Veterans General Hospital (V97C1-064, V98C1-039, V98A-086, V99C1-181, V99A-023 and V100A-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beadsworth MBJ, 2008, INT J TUBERC LUNG D, V12, P314; Chiang CY, 2009, INT J TUBERC LUNG D, V13, P105; Feng JY, 2009, INT J TUBERC LUNG D, V13, P1387; Feng JY, 2008, J CLIN MICROBIOL, V46, P3127, DOI 10.1128/JCM.01132-08; Garin B, 1997, LANCET, V350, P1298, DOI 10.1016/S0140-6736(05)62475-0; Glynn JR, 2006, EMERG INFECT DIS, V12, P736, DOI 10.3201/eid1205.050400; Harries AD, 2001, INT J TUBERC LUNG D, V5, P1000; Harries AD, 2001, LANCET, V357, P1519, DOI 10.1016/S0140-6736(00)04639-0; Hoa NP, 2006, INT J TUBERC LUNG D, V10, P851; Kawai V, 2006, AM J TROP MED HYG, V75, P1027, DOI 10.4269/ajtmh.2006.75.1027; Kim HJ, 2010, INT J TUBERC LUNG D, V14, P79; Kliiman K, 2010, INT J TUBERC LUNG D, V14, P454; Kourbatova EV, 2006, INT J TUBERC LUNG D, V10, P1224; Lan NTN, 2003, EMERG INFECT DIS, V9, P1633, DOI 10.3201/eid0912.030169; Liu YC, 2010, INT J TUBERC LUNG D, V14, P72; Low S, 2009, INT J TUBERC LUNG D, V13, P328; Mugusi FM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-409; Najera-Ortiz JC, 2008, INT J EPIDEMIOL, V37, P786, DOI 10.1093/ije/dyn089; PablosMendez A, 1996, JAMA-J AM MED ASSOC, V276, P1223, DOI 10.1001/jama.276.15.1223; Rao VK, 1998, CHEST, V114, P1244, DOI 10.1378/chest.114.5.1244; Silva DR, 2010, LUNG, V188, P33, DOI 10.1007/s00408-009-9224-9; Sterling TR, 2006, INT J TUBERC LUNG D, V10, P542; Su WJ, 2001, INT J TUBERC LUNG D, V5, P380; Tocque K, 2005, INT J TUBERC LUNG D, V9, P797; Van Rie A, 1999, NEW ENGL J MED, V341, P1174, DOI 10.1056/NEJM199910143411602; WHO, 2008, GLOBAL TUBERCULOSIS; YANG CH, 2009, 2009 49 ICAAC; Zahar JR, 2001, INTENS CARE MED, V27, P513, DOI 10.1007/s001340000849	28	26	27	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2011	6	9							e23715	10.1371/journal.pone.0023715	http://dx.doi.org/10.1371/journal.pone.0023715			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZV	21931610	Green Submitted, gold, Green Published			2022-12-25	WOS:000295321800007
J	Gardiner, MM; O'Neal, ME; Landis, DA				Gardiner, Mary M.; O'Neal, Matthew E.; Landis, Douglas A.			Intraguild Predation and Native Lady Beetle Decline	PLOS ONE			English	Article							BIOLOGICAL-CONTROL; COCCINELLA-NOVEMNOTATA; GENERALIST PREDATORS; NATURAL ENEMIES; NORTH-AMERICA; SOYBEAN APHID; COLEOPTERA; LANDSCAPE; EGGS; ADULT	Coccinellid communities across North America have experienced significant changes in recent decades, with declines in several native species reported. One potential mechanism for these declines is interference competition via intraguild predation; specifically, increased predation of native coccinellid eggs and larvae following the introduction of exotic coccinellids. Our previous studies have shown that agricultural fields in Michigan support a higher diversity and abundance of exotic coccinellids than similar fields in Iowa, and that the landscape surrounding agricultural fields across the north central U. S. influences the abundance and activity of coccinellid species. The goal of this study was to quantify the amount of egg predation experienced by a native coccinellid within Michigan and Iowa soybean fields and explore the influence of local and large-scale landscape structure. Using the native lady beetle Coleomegilla maculata as a model, we found that sentinel egg masses were subject to intense predation within both Michigan and Iowa soybean fields, with 60.7% of egg masses attacked and 43.0% of available eggs consumed within 48 h. In Michigan, the exotic coccinellids Coccinella septempunctata and Harmonia axyridis were the most abundant predators found in soybean fields whereas in Iowa, native species including C. maculata, Hippodamia parenthesis and the soft-winged flower beetle Collops nigriceps dominated the predator community. Predator abundance was greater in soybean fields within diverse landscapes, yet variation in predator numbers did not influence the intensity of egg predation observed. In contrast, the strongest predictor of native coccinellid egg predation was the composition of edge habitats bordering specific fields. Field sites surrounded by semi-natural habitats including forests, restored prairies, old fields, and pasturelands experienced greater egg predation than fields surrounded by other croplands. This study shows that intraguild predation by both native and exotic predators may contribute to native coccinellid decline, and that landscape structure interacts with local predator communities to shape the specific outcomes of predator-predator interactions.	[Gardiner, Mary M.; Landis, Douglas A.] Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA; [O'Neal, Matthew E.] Iowa State Univ, Dept Entomol, Ames, IA USA	Michigan State University; Iowa State University	Gardiner, MM (corresponding author), Ohio State Univ, Ohio Agr Res & Dev Ctr, Dept Entomol, Wooster, OH 44691 USA.	gardiner.29@osu.edu	Gardiner, Mary/B-3733-2012; Landis, Douglas A./L-7991-2019		USDA CSREES [2004-51101-02210]; Division Of Environmental Biology [1027253] Funding Source: National Science Foundation	USDA CSREES(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research is the result of a multi-state collaborative effort funded by the USDA CSREES Risk Avoidance and Mitigation Program, grant number 2004-51101-02210. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alyokhin A, 2004, BIOL INVASIONS, V6, P463, DOI 10.1023/B:BINV.0000041554.14539.74; Bianchi FJJA, 2008, BIOL CONTROL, V46, P400, DOI 10.1016/j.biocontrol.2008.04.010; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Colunga-Garcia M, 1998, ENVIRON ENTOMOL, V27, P1574, DOI 10.1093/ee/27.6.1574; Costamagna AC, 2007, BIOL CONTROL, V42, P16, DOI 10.1016/j.biocontrol.2007.04.001; Costamagna AC, 2006, ECOL APPL, V16, P1619, DOI 10.1890/1051-0761(2006)016[1619:PETCOS]2.0.CO;2; Cottrell TE, 2004, BIOL CONTROL, V31, P362, DOI 10.1016/j.biocontrol.2004.06.004; Cottrell TE, 2005, BIOL CONTROL, V34, P159, DOI 10.1016/j.biocontrol.2005.04.008; Cottrell TE, 2007, ENVIRON ENTOMOL, V36, P390, DOI 10.1603/0046-225X(2007)36[390:PBAALL]2.0.CO;2; Crowder DW, 2010, BIOL INVASIONS, V12, P2857, DOI 10.1007/s10530-010-9733-8; Day WH, 2006, ENTOMOL NEWS, V117, P491, DOI 10.3157/0013-872X(2006)117[491:CIAONA]2.0.CO;2; Decker KB, 2008, ENVIRON ENTOMOL, V37, P670, DOI 10.1603/0046-225X(2008)37[670:SPANEO]2.0.CO;2; Denys C, 2002, OECOLOGIA, V130, P315, DOI 10.1007/s004420100796; Elliott N, 1996, OECOLOGIA, V105, P537, DOI 10.1007/BF00330017; Gardiner MM, 2007, BIOL CONTROL, V40, P386, DOI 10.1016/j.biocontrol.2006.11.005; Gardiner MM, 2009, DIVERS DISTRIB, V15, P554, DOI 10.1111/j.1472-4642.2009.00563.x; Gardiner MM, 2009, ECOL APPL, V19, P143, DOI 10.1890/07-1265.1; Gardiner MA, 2010, BIOENERG RES, V3, P6, DOI 10.1007/s12155-009-9065-7; Hoogendoorn M, 2004, ENTOMOL EXP APPL, V111, P19, DOI 10.1111/j.0013-8703.2004.00157.x; Juen A, 2005, OECOLOGIA, V142, P344, DOI 10.1007/s00442-004-1736-7; Landis DA, 2000, ANNU REV ENTOMOL, V45, P175, DOI 10.1146/annurev.ento.45.1.175; Losey JE, 2007, J INSECT CONSERV, V11, P415, DOI 10.1007/s10841-007-9077-6; McCune B., 2011, PC ORD MULTIVARIATE; Pfannenstiel RS, 2002, ENVIRON ENTOMOL, V31, P232, DOI 10.1603/0046-225X-31.2.232; POLIS GA, 1992, TRENDS ECOL EVOL, V7, P151, DOI 10.1016/0169-5347(92)90208-S; R Development Core Team, 2005, R LANG ENV STAT COMP; Ribic CA, 2001, AM MIDL NAT, V146, P105, DOI 10.1674/0003-0031(2001)146[0105:AOGBWL]2.0.CO;2; *SAS I INC, 1999, SAS STAT US GUID, V1; Schmidt NP, 2008, ANN ENTOMOL SOC AM, V101, P341, DOI 10.1603/0013-8746(2008)101[341:APIISA]2.0.CO;2; Shao J., 2003, MATH STAT; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Snyder WE, 2004, OECOLOGIA, V140, P559, DOI 10.1007/s00442-004-1612-5; Snyder WE, 2006, ANNU REV ECOL EVOL S, V37, P95, DOI 10.1146/annurev.ecolsys.37.091305.110107; WHEELER AG, 1995, P ENTOMOL SOC WASH, V97, P701; Wilcove DS, 1998, BIOSCIENCE, V48, P607, DOI 10.2307/1313420	35	50	52	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2011	6	9							e23576	10.1371/journal.pone.0023576	http://dx.doi.org/10.1371/journal.pone.0023576			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZV	21931606	Green Published, Green Submitted, gold			2022-12-25	WOS:000295321800005
J	Nilsson, OB; Adedoyin, J; Rhyner, C; Neimert-Andersson, T; Grundstrom, J; Berndt, KD; Crameri, R; Gronlund, H				Nilsson, Ola B.; Adedoyin, Justus; Rhyner, Claudio; Neimert-Andersson, Theresa; Grundstrom, Jeanette; Berndt, Kurt D.; Crameri, Reto; Gronlund, Hans			In Vitro Evolution of Allergy Vaccine Candidates, with Maintained Structure, but Reduced B Cell and T Cell Activation Capacity	PLOS ONE			English	Article							BIRCH POLLEN ALLERGEN; CAT ALLERGEN; ENVIRONMENTAL INTERVENTION; PEPTIDE IMMUNOTHERAPY; ASTHMATIC REACTIONS; IGE; FEL-D-1; SENSITIZATION; ANTIBODIES; EPITOPES	Allergy and asthma to cat (Felis domesticus) affects about 10% of the population in affluent countries. Immediate allergic symptoms are primarily mediated via IgE antibodies binding to B cell epitopes, whereas late phase inflammatory reactions are mediated via activated T cell recognition of allergen-specific T cell epitopes. Allergen-specific immunotherapy relieves symptoms and is the only treatment inducing a long-lasting protection by induction of protective immune responses. The aim of this study was to produce an allergy vaccine designed with the combined features of attenuated T cell activation, reduced anaphylactic properties, retained molecular integrity and induction of efficient IgE blocking IgG antibodies for safer and efficacious treatment of patients with allergy and asthma to cat. The template gene coding for rFel d 1 was used to introduce random mutations, which was subsequently expressed in large phage libraries. Despite accumulated mutations by up to 7 rounds of iterative error-prone PCR and biopanning, surface topology and structure was essentially maintained using IgE-antibodies from cat allergic patients for phage enrichment. Four candidates were isolated, displaying similar or lower IgE binding, reduced anaphylactic activity as measured by their capacity to induce basophil degranulation and, importantly, a significantly lower T cell reactivity in lymphoproliferative assays compared to the original rFel d 1. In addition, all mutants showed ability to induce blocking antibodies in immunized mice. The approach presented here provides a straightforward procedure to generate a novel type of allergy vaccines for safer and efficacious treatment of allergic patients.	[Nilsson, Ola B.; Adedoyin, Justus; Neimert-Andersson, Theresa; Grundstrom, Jeanette] Karolinska Inst, Dept Med, Stockholm, Sweden; [Rhyner, Claudio; Crameri, Reto] Univ Zurich, Swiss Inst Allergy & Asthma Res SIAF, Davos, Switzerland; [Berndt, Kurt D.] Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden; [Gronlund, Hans] Karolinska Inst, Ctr Allergy Res, Stockholm, Sweden	Karolinska Institutet; Swiss Institute of Allergy & Asthma Research; University of Zurich; Karolinska Institutet; Karolinska Institutet	Nilsson, OB (corresponding author), Karolinska Inst, Dept Med, Stockholm, Sweden.	hans.gronlund@ki.se	Berndt, Kurt/J-8574-2015	Berndt, Kurt/0000-0002-3049-967X; Gronlund, Hans/0000-0003-4882-7624	Swedish Asthma and Allergy Association's Research Foundation; Consul Th. C. Bergh's Foundation; Cancer and Allergy Foundation; Centre for Allergy Research at Karolinska Institutet; Bernard Osher Initiative for Research on Severe Asthma	Swedish Asthma and Allergy Association's Research Foundation; Consul Th. C. Bergh's Foundation; Cancer and Allergy Foundation; Centre for Allergy Research at Karolinska Institutet(Karolinska Institutet); Bernard Osher Initiative for Research on Severe Asthma	This work was supported in part by The Swedish Asthma and Allergy Association's Research Foundation, the Consul Th. C. Bergh's Foundation, the Cancer and Allergy Foundation, the Centre for Allergy Research at Karolinska Institutet and the Bernard Osher Initiative for Research on Severe Asthma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali FR, 2007, THORAX, V62, P750, DOI 10.1136/thx.2006.072041; Ball T, 1999, FASEB J, V13, P1277, DOI 10.1096/fasebj.13.11.1277; Bousquet J, 1998, J ALLERGY CLIN IMMUN, V102, P558, DOI 10.1016/S0091-6749(98)70271-4; Campbell JD, 2009, J EXP MED, V206, P1535, DOI 10.1084/jem.20082901; Counsell CM, 1996, J ALLERGY CLIN IMMUN, V98, P884, DOI 10.1016/S0091-6749(96)80004-2; Crameri R, 1996, ADV EXP MED BIOL, V409, P103; Crameri R, 2007, EXPERT REV VACCINES, V6, P991, DOI 10.1586/14760584.6.6.991; Engel E, 1997, J BIOL CHEM, V272, P28630, DOI 10.1074/jbc.272.45.28630; FREW AJ, 1993, J ALLERGY CLIN IMMUN, V125, pS306; Gafvelin G, 2005, INT ARCH ALLERGY IMM, V138, P59, DOI 10.1159/000087358; Gehlhar K, 1999, CLIN EXP ALLERGY, V29, P497; Gronlund H, 2003, J BIOL CHEM, V278, P40144, DOI 10.1074/jbc.M301416200; Haselden BM, 1999, J EXP MED, V189, P1885, DOI 10.1084/jem.189.12.1885; Infuhr D, 2005, ALLERGY, V60, P977, DOI 10.1111/j.1398-9995.2005.00832.x; Jardetzky TS, 1996, P NATL ACAD SCI USA, V93, P734, DOI 10.1073/pnas.93.2.734; Kaiser L, 2003, J BIOL CHEM, V278, P37730, DOI 10.1074/jbc.M304740200; Kattan M, 2005, J ALLERGY CLIN IMMUN, V116, P1058, DOI 10.1016/j.jaci.2005.07.032; Larche M, 2007, J ALLERGY CLIN IMMUN, V119, P906, DOI 10.1016/j.jaci.2007.02.015; Larche M, 2006, NAT REV IMMUNOL, V6, P761, DOI 10.1038/nri1934; Lau S, 2005, ALLERGY, V60, P766, DOI 10.1111/j.1398-9995.2005.00781.x; LAVER WG, 1990, CELL, V61, P553, DOI 10.1016/0092-8674(90)90464-P; MADHURANTAKAM C, 2001, J MOL BIOL; Mellerup MT, 2000, CLIN EXP ALLERGY, V30, P1423, DOI 10.1046/j.1365-2222.2000.00910.x; Morgan WJ, 2004, NEW ENGL J MED, V351, P1068, DOI 10.1056/NEJMoa032097; Neimert-Andersson T, 2008, ALLERGY, V63, P518, DOI 10.1111/j.1398-9995.2008.01644.x; Niederberger V, 2004, P NATL ACAD SCI USA, V101, P14677, DOI 10.1073/pnas.0404735101; Niemi M, 2007, STRUCTURE, V15, P1413, DOI 10.1016/j.str.2007.09.012; Oldfield WLG, 2002, LANCET, V360, P47, DOI 10.1016/S0140-6736(02)09332-7; Partti-Pellinen K, 2000, ALLERGY, V55, P65, DOI 10.1034/j.1398-9995.2000.00226.x; Plaschke P, 1999, J ALLERGY CLIN IMMUN, V104, P58, DOI 10.1016/S0091-6749(99)70114-4; Plaschke P, 1996, ALLERGY, V51, P461, DOI 10.1111/j.1398-9995.1996.tb00163.x; Purohit A, 2008, CLIN EXP ALLERGY, V38, P1514, DOI 10.1111/j.1365-2222.2008.03042.x; Saarne T, 2003, INT ARCH ALLERGY IMM, V130, P258, DOI 10.1159/000070212; SAARNE T, 2009, PEDIAT ALLERGY IMMUN; Schmitz N, 2009, J EXP MED, V206, P1941, DOI 10.1084/jem.20090199; Strait RT, 2006, J CLIN INVEST, V116, P833, DOI 10.1172/JCI25575; Valenta R, 2007, J ALLERGY CLIN IMMUN, V119, P826, DOI 10.1016/j.jaci.2007.01.025; van Neerven RJJ, 1999, J IMMUNOL, V163, P2944; van Ree R, 1999, J ALLERGY CLIN IMMUN, V104, P1223, DOI 10.1016/S0091-6749(99)70017-5; Werfel T, 2006, ALLERGY, V61, P202, DOI 10.1111/j.1398-9995.2006.00974.x; Williams GS, 1998, EUR J IMMUNOL, V28, P3763, DOI 10.1002/(SICI)1521-4141(199811)28:11<3763::AID-IMMU3763>3.0.CO;2-D; Zhu DC, 2005, NAT MED, V11, P446, DOI 10.1038/nm1219	42	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2011	6	9							e24558	10.1371/journal.pone.0024558	http://dx.doi.org/10.1371/journal.pone.0024558			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZV	21931754	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000295321800032
J	Shimizu, Y; Tsuru, S; Ito, Y; Ying, BW; Yomo, T				Shimizu, Yoshihiro; Tsuru, Saburo; Ito, Yoichiro; Ying, Bei-Wen; Yomo, Tetsuya			Stochastic Switching Induced Adaptation in a Starved Escherichia coli Population	PLOS ONE			English	Article							FLUCTUATING ENVIRONMENTS; TRYPTOPHAN OPERON; GENE-EXPRESSION; SINGLE-CELL; NOISE; TRANSCRIPTION; REVEALS; MODEL; CONSTRUCTION; CIRCUITS	Population adaptation can be determined by stochastic switching in living cells. To examine how stochastic switching contributes to the fate decision for a population under severe stress, we constructed an Escherichia coli strain crucially dependent on the expression of a rewired gene. The gene essential for tryptophan biosynthesis, trpC, was removed from the native regulatory unit, the Trp operon, and placed under the extraneous control of the lactose utilisation network. Bistability of the network provided the cells two discrete phenotypes: the induced and suppressed level of trpC. The two phenotypes permitted the cells to grow or not, respectively, under conditions of tryptophan depletion. We found that stochastic switching between the two states allowed the initially suppressed cells to form a new population with induced trpC in response to tryptophan starvation. However, the frequency of the transition from suppressed to induced state dropped off dramatically in the starved population, in comparison to that in the nourished population. This reduced switching rate was compensated by increasing the initial population size, which probably provided the cell population more chances to wait for the rarely appearing fit cells from the unfit cells. Taken together, adaptation of a starved bacterial population because of stochasticity in the gene rewired from the ancient regulon was experimentally confirmed, and the nutritional status and the population size played a great role in stochastic adaptation.	[Shimizu, Yoshihiro; Tsuru, Saburo; Ito, Yoichiro; Ying, Bei-Wen; Yomo, Tetsuya] Osaka Univ, Grad Sch Informat Sci & Technol, Osaka, Japan; [Yomo, Tetsuya] Osaka Univ, Grad Sch Frontier Biosci, Osaka, Japan; [Yomo, Tetsuya] Japan Sci & Technol Agcy JST, Exploratory Res Adv Technol ERATO, Osaka, Japan	Osaka University; Osaka University; Japan Science & Technology Agency (JST)	Shimizu, Y (corresponding author), Osaka Univ, Grad Sch Informat Sci & Technol, Osaka, Japan.	yomo@ist.osaka-u.ac.jp	Tsuru, Saburo/M-5069-2017; Ying, Bei-Wen/Q-9750-2019	Tsuru, Saburo/0000-0002-7182-1637; Ying, Bei-Wen/0000-0003-2517-5686	Ministry of Education, Culture, Sports, Science and Technology, Japan;  [22657059]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 	This work was partially supported by Grants-in-Aid for Challenging Exploratory Research 22657059 (to BWY) and the "Global COE (Centers of Excellence) program" of the Ministry of Education, Culture, Sports, Science and Technology, Japan. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar M, 2005, NATURE, V435, P228, DOI 10.1038/nature03524; Acar M, 2008, NAT GENET, V40, P471, DOI 10.1038/ng.110; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Gama-Castro S, 2008, NUCLEIC ACIDS RES, V36, pD120, DOI 10.1093/nar/gkm994; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Henkin TM, 2002, BIOESSAYS, V24, P700, DOI 10.1002/bies.10125; HOROWITZ H, 1982, J MOL BIOL, V156, P257, DOI 10.1016/0022-2836(82)90327-8; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; Isalan M, 2008, NATURE, V452, P840, DOI 10.1038/nature06847; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; Kashiwagi A, 2009, METAB ENG, V11, P56, DOI 10.1016/j.ymben.2008.08.002; Kramers HA, 1940, PHYSICA, V7, P284, DOI 10.1016/S0031-8914(40)90098-2; Kussell E, 2005, GENETICS, V169, P1807, DOI 10.1534/genetics.104.035352; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Luscombe NM, 2004, NATURE, V431, P308, DOI 10.1038/nature02782; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Robert L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.12; Srivatsan A, 2008, CURR OPIN MICROBIOL, V11, P100, DOI 10.1016/j.mib.2008.02.001; Stern S, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100147; Stolovicki E, 2006, GENETICS, V173, P75, DOI 10.1534/genetics.106.055442; Tan C, 2009, NAT CHEM BIOL, V5, P842, DOI 10.1038/nchembio.218; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; Traxler MF, 2008, MOL MICROBIOL, V68, P1128, DOI 10.1111/j.1365-2958.2008.06229.x; Tsuru S, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.24; van Hoek M, 2007, PLOS COMPUT BIOL, V3, P1071, DOI 10.1371/journal.pcbi.0030111; YAGIL G, 1971, BIOPHYS J, V11, P11, DOI 10.1016/S0006-3495(71)86192-1; YANOFSKY C, 1981, NUCLEIC ACIDS RES, V9, P6647, DOI 10.1093/nar/9.24.6647; Ying BW, 2010, J BIOSCI BIOENG, V110, P529, DOI 10.1016/j.jbiosc.2010.05.014	34	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2011	6	9							e23953	10.1371/journal.pone.0023953	http://dx.doi.org/10.1371/journal.pone.0023953			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZV	21931628	Green Published, gold, Green Submitted			2022-12-25	WOS:000295321800010
J	Wang, W; Lang, JK; Suzuki, G; Canty, JM; Cimato, T				Wang, Wen; Lang, Jennifer K.; Suzuki, Gen; Canty, John M., Jr.; Cimato, Thomas			Statins Enhance Clonal Growth of Late Outgrowth Endothelial Progenitors and Increase Myocardial Capillary Density in the Chronically Ischemic Heart	PLOS ONE			English	Article							CELLS; ANGIOGENESIS; IDENTIFICATION; ATORVASTATIN; PRAVASTATIN; CD133(+); ORIGIN	Background: Coronary artery disease and ischemic heart disease are leading causes of heart failure and death. Reduced blood flow to heart tissue leads to decreased heart function and symptoms of heart failure. Therapies to improve heart function in chronic coronary artery disease are important to identify. HMG-CoA reductase inhibitors (statins) are an important therapy for prevention of coronary artery disease, but also have non-cholesterol lowering effects. Our prior work showed that pravastatin improves contractile function in the chronically ischemic heart in pigs. Endothelial progenitor cells are a potential source of new blood vessels in ischemic tissues. While statins are known to increase the number of early outgrowth endothelial progenitor cells, their effects on late outgrowth endothelial progenitor cells (LOEPCs) and capillary density in ischemic heart tissue are not known. We hypothesized that statins exert positive effects on the mobilization and growth of late outgrowth EPCs, and capillary density in ischemic heart tissue. Methodology/Principal Findings: We determined the effects of statins on the mobilization and growth of late outgrowth endothelial progenitor cells from pigs. We also determined the density of capillaries in myocardial tissue in pigs with chronic myocardial ischemia with or without treatment with pravastatin. Pravastatin therapy resulted in greater than two-fold increase in CD31+ LOEPCs versus untreated animals. Addition of pravastatin or simvastatin to blood mononuclear cells increased the number of LOEPCs greater than three fold in culture. Finally, in animals with chronic myocardial ischemia, pravastatin increased capillary density 46%. Conclusions: Statins promote the derivation, mobilization, and clonal growth of LOEPCs. Pravastatin therapy in vivo increases myocardial capillary density in chronically ischemic myocardium, providing an in vivo correlate for the effects of statins on LOEPC growth in vitro. Our findings provide evidence that statin therapy can increase the density of capillaries in the chronically ischemic heart.	[Wang, Wen] Capital Med Univ, Dept Pathophysiol, Beijing, Peoples R China; [Lang, Jennifer K.; Suzuki, Gen; Canty, John M., Jr.; Cimato, Thomas] SUNY Buffalo, Sch Med & Biomed Sci, Dept Med Cardiovasc Med, Buffalo, NY 14260 USA	Capital Medical University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Wang, W (corresponding author), Capital Med Univ, Dept Pathophysiol, Beijing, Peoples R China.	tcimato@buffalo.edu	Canty, John M/C-5349-2009	Cimato, Thomas/0000-0001-9230-4463	American Heart Association; U.S. Department of Veterans Affairs; National Institutes of Health/NHLBI; New York State Stem Cell Science ESSC Board; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061610] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); U.S. Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); New York State Stem Cell Science ESSC Board; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding was provided by the American Heart Association-Scientist Development Grant: Thomas Cimato, U.S. Department of Veterans Affairs, National Institutes of Health/NHLBI, and the New York State Stem Cell Science ESSC Board: John Canty, Gen Suzuki, and Thomas Cimato. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaoutova I, 2010, NAT PROTOC, V5, P628, DOI 10.1038/nprot.2010.6; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Bearzi C, 2009, P NATL ACAD SCI USA, V106, P15885, DOI 10.1073/pnas.0907622106; Boodhwani M, 2006, J THORAC CARDIOV SUR, V132, P1299, DOI 10.1016/j.jtcvs.2006.05.060; Broxmeyer HE, 2006, METHOD ENZYMOL, V419, P439, DOI 10.1016/S0076-6879(06)19018-7; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Case J, 2007, EXP HEMATOL, V35, P1109, DOI 10.1016/j.exphem.2007.04.002; Choi K, 1998, DEVELOPMENT, V125, P725; Dimmeler S, 2001, J CLIN INVEST, V108, P391, DOI 10.1172/JCI200113152; Dubois C, 2010, J AM COLL CARDIOL, V55, P2232, DOI 10.1016/j.jacc.2009.10.081; Fallavollita JA, 1997, CIRCULATION, V95, P1900; Gheorghiade M, 1998, CIRCULATION, V97, P282, DOI 10.1161/01.CIR.97.3.282; Hatanaka T, 2000, CLIN PHARMACOKINET, V39, P397, DOI 10.2165/00003088-200039060-00002; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Hirschi KK, 2008, ARTERIOSCL THROM VAS, V28, P1584, DOI 10.1161/ATVBAHA.107.155960; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Ingram DA, 2007, STEM CELLS, V25, P297, DOI 10.1634/stemcells.2006-0340; KUBOTA Y, 1988, J CELL BIOL, V107, P1589, DOI 10.1083/jcb.107.4.1589; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Mason RP, 2005, AM J CARDIOL, V96, p11F, DOI 10.1016/j.amjcard.2005.06.008; Oberlin E, 2002, DEVELOPMENT, V129, P4147; Skaletz-Rorowski A, 2003, CURR OPIN LIPIDOL, V14, P599, DOI 10.1097/00041433-200312000-00008; Skaletz-Rorowski Adriane, 2004, Semin Vasc Med, V4, P395, DOI 10.1055/s-2004-869596; Suzuki G, 2009, CIRC RES, V104, P255, DOI 10.1161/CIRCRESAHA.108.188730; Thavendiranathan P, 2006, ARCH INTERN MED, V166, P2307, DOI 10.1001/archinte.166.21.2307; Timmermans F, 2007, ARTERIOSCL THROM VAS, V27, P1572, DOI 10.1161/ATVBAHA.107.144972; Ueno H, 2006, DEV CELL, V11, P519, DOI 10.1016/j.devcel.2006.08.001; Urbich C, 2002, CIRC RES, V90, P737, DOI 10.1161/01.RES.0000014081.30867.F8; Vaklavas C, 2009, ATHEROSCLEROSIS, V202, P18, DOI 10.1016/j.atherosclerosis.2008.05.021; Weis M, 2002, CIRCULATION, V105, P739, DOI 10.1161/hc0602.103393; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471; Yoder MC, 2010, ARTERIOSCL THROM VAS, V30, P1094, DOI 10.1161/ATVBAHA.109.191635	32	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2011	6	9							e24868	10.1371/journal.pone.0024868	http://dx.doi.org/10.1371/journal.pone.0024868			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZV	21931862	Green Published, gold, Green Submitted			2022-12-25	WOS:000295321800072
J	Zhang, J; Yang, Y; Wang, Y; Zhang, JY; Wang, ZJ; Yin, M; Shen, XD				Zhang, Jing; Yang, Yue; Wang, Yin; Zhang, Jinyuan; Wang, Zejian; Yin, Ming; Shen, Xudong			Identification of Hub Genes Related to the Recovery Phase of Irradiation Injury by Microarray and Integrated Gene Network Analysis	PLOS ONE			English	Article							DIFFERENTIALLY EXPRESSED GENES; HEMATOPOIETIC-CELLS; STEM; RADIATION; STRESS; PROLIFERATION; INDUCTION; EXPOSURE; KIDNEY; DAMAGE	Background: Irradiation commonly causes long-term bone marrow injury charactertized by defective HSC self-renewal and a decrease in HSC reserve. However, the effect of high-dose IR on global gene expression during bone marrow recovery remains unknown. Methodology: Microarray analysis was used to identify differentially expressed genes that are likely to be critical for bone marrow recovery. Multiple bioinformatics analyses were conducted to identify key hub genes, pathways and biological processes. Principal Findings: 1) We identified 1302 differentially expressed genes in murine bone marrow at 3, 7, 11 and 21 days after irradiation. Eleven of these genes are known to be HSC self-renewal associated genes, including Adipoq, Ccl3, Ccnd1, Ccnd2, Cdkn1a, Cxcl12, Junb, Pten, Tal1, Thy1 and Tnf; 2) These 1302 differentially expressed genes function in multiple biological processes of immunity, including hematopoiesis and response to stimuli, and cellular processes including cell proliferation, differentiation, adhesion and signaling; 3) Dynamic Gene Network analysis identified a subgroup of 25 core genes that participate in immune response, regulation of transcription and nucleosome assembly; 4) A comparison of our data with known irradiation-related genes extracted from literature showed 42 genes that matched the results of our microarray analysis, thus demonstrated consistency between studies; 5) Protein-protein interaction network and pathway analyses indicated several essential protein-protein interactions and signaling pathways, including focal adhesion and several immune-related signaling pathways. Conclusions: Comparisons to other gene array datasets indicate that global gene expression profiles of irradiation damaged bone marrow show significant differences between injury and recovery phases. Our data suggest that immune response (including hematopoiesis) can be considered as a critical biological process in bone marrow recovery. Several critical hub genes that are key members of significant pathways or gene networks were identified by our comprehensive analysis.	[Zhang, Jing; Yang, Yue; Wang, Zejian; Yin, Ming] Shanghai Jiao Tong Univ, Sch Pharm, Shanghai 200030, Peoples R China; [Zhang, Jing; Wang, Yin; Zhang, Jinyuan; Shen, Xudong] 455 Hosp, Dept Internal Med, Shanghai, Peoples R China	Shanghai Jiao Tong University	Zhang, J (corresponding author), Shanghai Jiao Tong Univ, Sch Pharm, Shanghai 200030, Peoples R China.	myin@sjtu.edu.cn; shxd455@sina.com			Army Medical Research Grant [09MA027, 10MA025]; National Comprehensive Technology Platforms for Innovative Drug RD [2009ZX09301-007]	Army Medical Research Grant; National Comprehensive Technology Platforms for Innovative Drug RD	This work was supported by Army Medical Research Grant (09MA027 and 10MA025) and National Comprehensive Technology Platforms for Innovative Drug R&D (2009ZX09301-007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundson SA, 2001, RADIAT RES, V156, P657, DOI 10.1667/0033-7587(2001)156[0657:IOGEAA]2.0.CO;2; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Banfi A, 2001, LEUKEMIA LYMPHOMA, V42, P863, DOI 10.3109/10428190109097705; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Berger SI, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000723; Capo Gerardo, 2004, J Support Oncol, V2, P65; Chen F, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-240; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; Chiba S, 2002, BONE MARROW TRANSPL, V29, P935, DOI 10.1038/sj.bmt.1703568; Dai JM, 2006, INT J RADIAT BIOL, V82, P511, DOI 10.1080/09553000600857389; Dupuy D, 2007, NAT BIOTECHNOL, V25, P663, DOI 10.1038/nbt1305; Ellis SJ, 2010, CELL TISSUE RES, V339, P121, DOI 10.1007/s00441-009-0828-4; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Ford JM, 2005, MUTAT RES-FUND MOL M, V577, P195, DOI 10.1016/j.mrfmmm.2005.04.005; GE Y, 2010, FUNCT INTEGR GENOMIC; Goel HC, 2003, MOL CELL BIOCHEM, V254, P73, DOI 10.1023/A:1027308230204; Gupta M, 2005, ONCOGENE, V24, P7170, DOI 10.1038/sj.onc.1208847; Han W, 2006, CELL RES, V16, P189, DOI 10.1038/sj.cr.7310026; Harris MA, 2006, NUCLEIC ACIDS RES, V34, pD322, DOI 10.1093/nar/gkj021; Herodin F, 2005, EXP HEMATOL, V33, P1071, DOI 10.1016/j.exphem.2005.04.007; Hoffman B, 2009, J CELL PHYSIOL, V218, P26, DOI 10.1002/jcp.21582; Hosseinimehr SJ, 2007, DRUG DISCOV TODAY, V12, P794, DOI 10.1016/j.drudis.2007.07.017; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kargiotis O, 2010, J NEURO-ONCOL, V100, P323, DOI 10.1007/s11060-010-0199-4; Kiel MJ, 2008, NAT REV IMMUNOL, V8, P290, DOI 10.1038/nri2279; Kirouac DC, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.71; Kruse JJCM, 2004, RADIAT RES, V161, P28, DOI 10.1667/RR3097; Li G, 2005, J IMMUNOTHER, V28, P420, DOI 10.1097/01.cji.0000170360.99714.3f; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahmoud-Ahmed AS, 2006, RADIAT RES, V165, P142, DOI 10.1667/RR3485.1; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Pawlik A, 2011, RADIAT RES, V175, P66, DOI 10.1667/RR2282.1; Prieto C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003911; Prise KM, 2005, LANCET ONCOL, V6, P520, DOI 10.1016/S1470-2045(05)70246-1; Pujana MA, 2007, NAT GENET, V39, P1338, DOI 10.1038/ng.2007.2; Santaguida M, 2009, CANCER CELL, V15, P341, DOI 10.1016/j.ccr.2009.02.016; Schlitt T, 2003, GENOME RES, V13, P2568, DOI 10.1101/gr.1111403; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Taki K, 2009, J RADIAT RES, V50, P241, DOI 10.1269/jrr.09011; Vemula S, 2010, BLOOD, V116, P4103, DOI 10.1182/blood-2010-01-262790; von Mering C, 2002, NATURE, V417, P797, DOI 10.1038/417797a; Wang Y, 2006, BLOOD, V107, P358, DOI 10.1182/blood-2005-04-1418; Wang Y, 2010, FREE RADICAL BIO MED, V48, P348, DOI 10.1016/j.freeradbiomed.2009.11.005; West CML, 2007, CLIN ONCOL-UK, V19, P470, DOI 10.1016/j.clon.2007.02.016; Wong CW, 2010, STEM CELLS, V28, P1510, DOI 10.1002/stem.477; Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007; Yang L, 2009, BIOINFORMATICS, V25, P2244, DOI 10.1093/bioinformatics/btp369; Zhang J, 2009, BIOMED PHARMACOTHER, V63, P501, DOI 10.1016/j.biopha.2008.09.014; Zhao WL, 2006, CLIN CANCER RES, V12, P3823, DOI 10.1158/1078-0432.CCR-05-2418	49	17	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2011	6	9							e24680	10.1371/journal.pone.0024680	http://dx.doi.org/10.1371/journal.pone.0024680			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZV	21931809	Green Published, Green Submitted, gold			2022-12-25	WOS:000295321800048
J	Kleynhans, L; Du Plessis, N; Black, GF; Loxton, AG; Kidd, M; van Helden, PD; Walzl, G; Ronacher, K				Kleynhans, Leanie; Du Plessis, Nelita; Black, Gillian F.; Loxton, Andre G.; Kidd, Martin; van Helden, Paul D.; Walzl, Gerhard; Ronacher, Katharina			Medroxyprogesterone Acetate Alters Mycobacterium Bovis BCG-Induced Cytokine Production in Peripheral Blood Mononuclear Cells of Contraceptive Users	PLOS ONE			English	Article							VITAMIN-A-DEFICIENCY; HORMONAL CONTRACEPTION; IMMUNE-RESPONSES; GLUCOCORTICOID-RECEPTOR; TUBERCULOSIS INFECTION; INTERLEUKIN-12 IL-12; HUMAN-LYMPHOCYTES; DEPO-PROVERA; REACTIVATION; TYPE-1	Most individuals latently infected with Mycobacterium tuberculosis (M.tb) contain the infection by a balance of effector and regulatory immune responses. This balance can be influenced by steroid hormones such as glucocorticoids. The widely used contraceptive medroxyprogesterone acetate (MPA) possesses glucocorticoid activity. We investigated the effect of this hormone on immune responses to BCG in household contacts of active TB patients. Multiplex bead array analysis revealed that MPA demonstrated both glucocorticoid and progestogenic properties at saturating and pharmacological concentrations in peripheral blood mononuclear cells (PBMCs) and suppressed antigen specific cytokine production. Furthermore we showed that PBMCs from women using MPA produced significantly lower levels of IL-1 alpha, IL-12p40, IL-10, IL-13 and G-CSF in response to BCG which corresponded with lower numbers of circulating monocytes observed in these women. Our research study is the first to show that MPA impacts on infections outside the genital tract due to a systemic effect on immune function. Therefore MPA use could alter susceptibility to TB, TB disease severity as well as change the efficacy of new BCG-based vaccines, especially prime-boost vaccine strategies which may be administered to adult or adolescent women in the future.	[Kleynhans, Leanie; Du Plessis, Nelita; Black, Gillian F.; Loxton, Andre G.; van Helden, Paul D.; Walzl, Gerhard; Ronacher, Katharina] Univ Stellenbosch, Div Mol Biol & Human Genet, MRC Ctr Mol & Cellular Biol, DST NRF Ctr Excellence Biomed TB Res,Fac Hlth Sci, ZA-7505 Tygerberg, South Africa; [Kidd, Martin] Univ Stellenbosch, Dept Stat & Actuarial Sci, ZA-7600 Stellenbosch, South Africa	National Research Foundation - South Africa; Stellenbosch University; Stellenbosch University	Kleynhans, L (corresponding author), Univ Stellenbosch, Div Mol Biol & Human Genet, MRC Ctr Mol & Cellular Biol, DST NRF Ctr Excellence Biomed TB Res,Fac Hlth Sci, ZA-7505 Tygerberg, South Africa.	kron@sun.ac.za	Ronacher, Katharina/N-9603-2016; Walzl, Gerhard/N-6371-2016	Ronacher, Katharina/0000-0002-6371-1462; Black, Gillian/0000-0002-5081-274X; Walzl, Gerhard/0000-0003-2487-125X; Kleynhans, Leanie/0000-0003-1635-253X; Loxton, Andre/0000-0003-0659-9803; du Plessis, Nelita/0000-0001-7881-925X	National Research Foundation of South Africa [FA2007022300004]; South African Tuberculosis and AIDS Training (SATBAT) program [1U2RTW007370/3]; National Institute of Health/Fogarty International Center [1U2RTW007370/3]; Harry Crossley Foundation; Bill and Melinda Gates Foundation through Grand Challenges in Global Health (GCGH) [37772]; FOGARTY INTERNATIONAL CENTER [U2RTW007370] Funding Source: NIH RePORTER	National Research Foundation of South Africa(National Research Foundation - South Africa); South African Tuberculosis and AIDS Training (SATBAT) program; National Institute of Health/Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Harry Crossley Foundation; Bill and Melinda Gates Foundation through Grand Challenges in Global Health (GCGH)(Bill & Melinda Gates Foundation); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This work was supported by the National Research Foundation of South Africa [grant number FA2007022300004] to KR; The South African Tuberculosis and AIDS Training (SATBAT) program, funded by the National Institute of Health/Fogarty International Center [grant number 1U2RTW007370/3] to KR; SATBAT [grant number 1U2RTW007370/3] to LK and the Harry Crossley Foundation. This work was also supported by the Bill and Melinda Gates Foundation through Grand Challenges in Global Health (GCGH), grant no. 37772. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACK DJ, 1990, CLIN PHARMACOKINET, V18, P472, DOI 10.2165/00003088-199018060-00004; Bamberger CM, 1999, J CLIN ENDOCR METAB, V84, P4055, DOI 10.1210/jc.84.11.4055; Bigrigg A, 1999, BRIT J FAM PLAN, V25, P69; Biondi M, 1997, PSYCHOTHER PSYCHOSOM, V66, P3, DOI 10.1159/000289101; Black GF, 2001, INT J TUBERC LUNG D, V5, P664; COOPER AM, 1995, IMMUNOLOGY, V84, P423; Cooper AM, 2002, J IMMUNOL, V168, P1322, DOI 10.4049/jimmunol.168.3.1322; Cooper AM, 1997, J EXP MED, V186, P39, DOI 10.1084/jem.186.1.39; DANDREA A, 1993, J EXP MED, V178, P1041, DOI 10.1084/jem.178.3.1041; Elenkov IJ, 2004, ANN NY ACAD SCI, V1024, P138, DOI 10.1196/annals.1321.010; Fang S., 2004, J REPROD CONTRACEPTI, V15, P157; Heimbeck I, 2010, CYTOM PART A, V77A, P823, DOI 10.1002/cyto.a.20942; Higgins DM, 2009, TUBERCULOSIS, V89, P149, DOI 10.1016/j.tube.2009.01.001; Howard AD, 1999, CLIN EXP IMMUNOL, V115, P428; JEPPSSON S, 1982, ACTA ENDOCRINOL-COP, V99, P339, DOI 10.1530/acta.0.0990339; Jick SS, 2006, ARTHRIT RHEUM-ARTHR, V55, P19, DOI 10.1002/art.21705; Juffermans NP, 2000, J INFECT DIS, V182, P902, DOI 10.1086/315771; Kaushic C, 2003, J VIROL, V77, P4558, DOI 10.1128/JVI.77.8.4558-4565.2003; KOBAYASHI M, 1989, J EXP MED, V170, P827, DOI 10.1084/jem.170.3.827; KONTULA K, 1983, BIOCHEM PHARMACOL, V32, P1511, DOI 10.1016/0006-2952(83)90474-4; Koubovec D, 2005, MOL CELL ENDOCRINOL, V242, P23, DOI 10.1016/j.mce.2005.07.001; Leclerc PM, 2008, CONTRACEPTION, V77, P371, DOI 10.1016/j.contraception.2008.01.012; Liberman AC, 2007, FASEB J, V21, P1177, DOI 10.1096/fj.06-7452com; Liu ZG, 2009, CYTOKINE, V45, P141, DOI 10.1016/j.cyto.2008.12.003; Mahuad C, 2004, SCAND J IMMUNOL, V60, P639, DOI 10.1111/j.0300-9475.2004.01514.x; Manabe YC, 2008, TUBERCULOSIS, V88, P187, DOI 10.1016/j.tube.2007.10.006; Maneechotesuwan K, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000076; MANETTI R, 1993, J EXP MED, V177, P1199, DOI 10.1084/jem.177.4.1199; Morrison CS, 2011, JAIDS-J ACQ IMM DEF, V57, P157, DOI 10.1097/QAI.0b013e318214ba4a; Morrison CS, 2010, AIDS, V24, P1778, DOI 10.1097/QAD.0b013e32833a2537; Mostad SB, 1997, LANCET, V350, P922, DOI 10.1016/S0140-6736(97)04240-2; Mostad SB, 2000, J INFECT DIS, V181, P58, DOI 10.1086/315188; Myer L, 2007, INT J EPIDEMIOL, V36, P166, DOI 10.1093/ije/dyl251; ORTIZ A, 1977, J CLIN ENDOCR METAB, V44, P32, DOI 10.1210/jcem-44-1-32; Overton ET, 2008, CONTRACEPTION, V78, P125, DOI 10.1016/j.contraception.2008.03.015; Pettifor A, 2009, CONTRACEPTION, V80, P555, DOI 10.1016/j.contraception.2009.06.007; POWRIE F, 1993, IMMUNOL TODAY, V14, P270, DOI 10.1016/0167-5699(93)90044-L; Redford PS, 2010, EUR J IMMUNOL, V40, P2200, DOI 10.1002/eji.201040433; Scanga CA, 1999, INFECT IMMUN, V67, P4531, DOI 10.1128/IAI.67.9.4531-4538.1999; Shi LB, 2003, P NATL ACAD SCI USA, V100, P241, DOI 10.1073/pnas.0136863100; Smoak KA, 2004, MECH AGEING DEV, V125, P697, DOI 10.1016/j.mad.2004.06.010; Sugawara I, 2001, MICROBIOL IMMUNOL, V45, P743, DOI 10.1111/j.1348-0421.2001.tb01310.x; Trunova N, 2006, VIROLOGY, V352, P169, DOI 10.1016/j.virol.2006.04.004; Unterberger C, 2008, MOL IMMUNOL, V45, P3230, DOI 10.1016/j.molimm.2008.02.020; World Health Organization, 2008, GLOB HLTH OBS GHO TB	45	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e24639	10.1371/journal.pone.0024639	http://dx.doi.org/10.1371/journal.pone.0024639			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CK	21931790	Green Published, Green Submitted, gold			2022-12-25	WOS:000294802800078
J	Mouquet, H; Klein, F; Scheid, JF; Warncke, M; Pietzsch, J; Oliveira, TYK; Velinzon, K; Seaman, MS; Nussenzweig, MC				Mouquet, Hugo; Klein, Florian; Scheid, Johannes F.; Warncke, Malte; Pietzsch, John; Oliveira, Thiago Y. K.; Velinzon, Klara; Seaman, Michael S.; Nussenzweig, Michel C.			Memory B Cell Antibodies to HIV-1 gp140 Cloned from Individuals Infected with Clade A and B Viruses	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN MONOCLONAL-ANTIBODIES; BROADLY NEUTRALIZING ANTIBODIES; PROXIMAL EXTERNAL REGION; ENVELOPE GLYCOPROTEIN; TYPE-1 INFECTION; PASSIVE TRANSFER; MACAQUE MONKEYS; CHIMERIC VIRUS; EPITOPE	Understanding the antibody response to HIV-1 in humans that show broad neutralizing serologic activity is a crucial step in trying to reproduce such responses by vaccination. Investigating antibodies with cross clade reactivity is particularly important as these antibodies may target conserved epitopes on the HIV envelope gp160 protein. To this end we have used a clade B YU-2 gp140 trimeric antigen and single-cell antibody cloning methods to obtain 189 new anti-gp140 antibodies representing 51 independent B cell clones from the IgG memory B cells of 3 patients infected with HIV-1 clade A or B viruses and exhibiting broad neutralizing serologic activity. Our results support previous findings showing a diverse antibody response to HIV gp140 envelope protein, characterized by differentially expanded B-cell clones producing highly hypermutated antibodies with heterogenous gp140-specificity and neutralizing activity. In addition to their high-affinity binding to the HIV spike, the vast majority of the new anti-gp140 antibodies are also polyreactive. Although none of the new antibodies are as broad or potent as VRC01 or PG9, two clonally-related antibodies isolated from a clade A HIV-1 infected donor, directed against the gp120 variable loop 3, rank in the top 5% of the neutralizers identified in our large collection of 185 unique gp140-specific antibodies in terms of breadth and potency.	[Mouquet, Hugo; Klein, Florian; Scheid, Johannes F.; Pietzsch, John; Oliveira, Thiago Y. K.; Velinzon, Klara; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA; [Scheid, Johannes F.] Charite, D-13353 Berlin, Germany; [Warncke, Malte] Univ Klinikum Hamburg Eppendorf, Hamburg, Germany; [Pietzsch, John] Free Univ Berlin, Dept Biol, D-1000 Berlin, Germany; [Oliveira, Thiago Y. K.] Univ Sao Paulo, Med Sch Ribeirao Preto, Natl Inst Sci & Technol Stem Cells & Cell Therapy, Dept Genet, Ribeirao Preto, Brazil; [Oliveira, Thiago Y. K.] Ctr Cell Based Therapy, Ribeirao Preto, Brazil; [Seaman, Michael S.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA	Rockefeller University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Hamburg; University Medical Center Hamburg-Eppendorf; Free University of Berlin; Harvard University; Beth Israel Deaconess Medical Center; Howard Hughes Medical Institute; Rockefeller University	Mouquet, H (corresponding author), Rockefeller Univ, Lab Mol Immunol, 1230 York Ave, New York, NY 10021 USA.	nussen@mail.rockefeller.edu	Oliveira, Thiago Y/ABF-5186-2020; Mouquet, Hugo/M-2750-2014; Oliveira, Thiago Y/HGA-3848-2022; Nussenzweig, Michel/AAE-7292-2019	Oliveira, Thiago Y/0000-0002-2654-0879; Mouquet, Hugo/0000-0002-4230-610X; Oliveira, Thiago Y/0000-0002-2654-0879; Warncke, Malte/0000-0002-8774-0145	Rockefeller University; National Institutes of Health (NIH) [1 PO1 AI081677]; International AIDS Vaccine Initiative; Bill and Melinda Gates Foundation (MSS -Comprehensive Antibody-Vaccine Immune Monitoring Consortium) [38619]; German Research Foundation (DFG) [KL 2389/1-1]; German National Academic Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI081677] Funding Source: NIH RePORTER	Rockefeller University; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International AIDS Vaccine Initiative; Bill and Melinda Gates Foundation (MSS -Comprehensive Antibody-Vaccine Immune Monitoring Consortium)(Bill & Melinda Gates Foundation); German Research Foundation (DFG)(German Research Foundation (DFG)); German National Academic Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Rockefeller University, the National Institutes of Health (NIH 1 PO1 AI081677), the International AIDS Vaccine Initiative and the Bill and Melinda Gates Foundation (MSS -Comprehensive Antibody-Vaccine Immune Monitoring Consortium grant #38619). FK was supported by the German Research Foundation (DFG, KL 2389/1-1). MW was supported by the German National Academic Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam SM, 2007, J IMMUNOL, V178, P4424, DOI 10.4049/jimmunol.178.7.4424; Alam SM, 2009, P NATL ACAD SCI USA, V106, P20234, DOI 10.1073/pnas.0908713106; Binley JM, 2008, J VIROL, V82, P11651, DOI 10.1128/JVI.01762-08; BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; BURTON DR, 1991, P NATL ACAD SCI USA, V88, P10134, DOI 10.1073/pnas.88.22.10134; Cheskis B, 1996, BIOCHEMISTRY-US, V35, P3309, DOI 10.1021/bi952283r; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Decks SG, 2006, J VIROL, V80, P6155, DOI 10.1128/JVI.00093-06; Dhillon AK, 2007, J VIROL, V81, P6548, DOI 10.1128/JVI.02749-06; Diskin R, 2010, NAT STRUCT MOL BIOL, V17, P608, DOI 10.1038/nsmb.1796; Doria-Rose NA, 2009, J VIROL, V83, P188, DOI 10.1128/JVI.01583-08; GRAY D, 1993, ANNU REV IMMUNOL, V11, P49, DOI 10.1146/annurev.immunol.11.1.49; Gray ES, 2009, J VIROL, V83, P8925, DOI 10.1128/JVI.00758-09; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Hedestam GBK, 2008, NAT REV MICROBIOL, V6, P143, DOI 10.1038/nrmicro1819; Hessell AJ, 2010, J VIROL, V84, P1302, DOI 10.1128/JVI.01272-09; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Hessell AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000433; Hioe CE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010254; Keitel T, 1997, CELL, V91, P811, DOI 10.1016/S0092-8674(00)80469-9; Klein U, 2008, NAT REV IMMUNOL, V8, P22, DOI 10.1038/nri2217; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Mascola JR, 2007, NATURE, V449, P29, DOI 10.1038/449029a; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Matyas GR, 2009, BBA-BIOMEMBRANES, V1788, P660, DOI 10.1016/j.bbamem.2008.11.015; Meffre E, 2004, J EXP MED, V199, P145, DOI 10.1084/jem.20031550; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; Montefiori DC, 2009, CURR OPIN HIV AIDS, V4, P347, DOI 10.1097/COH.0b013e32832f4a4d; Mouquet H, 2006, J IMMUNOL, V177, P6517, DOI 10.4049/jimmunol.177.9.6517; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Ng CT, 2010, NAT MED; Pantophlet R, 2007, VIROLOGY, V364, P441, DOI 10.1016/j.virol.2007.03.007; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; Pietzsch J, 2010, J EXP MED, V207, P1995, DOI 10.1084/jem.20101176; Pietzsch J, 2010, J VIROL, V84, P5032, DOI 10.1128/JVI.00154-10; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Scheid JF, 2009, J IMMUNOL METHODS, V343, P65, DOI 10.1016/j.jim.2008.11.012; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Scherer EM, 2010, P NATL ACAD SCI USA, V107, P1529, DOI 10.1073/pnas.0909680107; Shibata R, 1999, NAT MED, V5, P204, DOI 10.1038/5568; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; THALI M, 1991, J VIROL, V65, P6188, DOI 10.1128/JVI.65.11.6188-6193.1991; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Tiller T, 2007, IMMUNITY, V26, P205, DOI 10.1016/j.immuni.2007.01.009; Trkola A, 2005, NAT MED, V11, P615, DOI 10.1038/nm1244; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; Veazey RS, 2003, NAT MED, V9, P343, DOI 10.1038/nm833; Veiga AS, 2009, CHEMBIOCHEM, V10, P1032, DOI 10.1002/cbic.200800609; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; XU JY, 1991, J VIROL, V65, P4832, DOI 10.1128/JVI.65.9.4832-4838.1991; Yurasov S, 2005, J EXP MED, V201, P703, DOI 10.1084/jem.20042251; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zolla-Pazner S, 2004, NAT REV IMMUNOL, V4, P199, DOI 10.1038/nri1307; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	64	91	93	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e24078	10.1371/journal.pone.0024078	http://dx.doi.org/10.1371/journal.pone.0024078			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CK	21931643	gold, Green Submitted, Green Published			2022-12-25	WOS:000294802800021
J	Rintoul, JL; Wang, JH; Gammon, DB; van Buuren, NJ; Garson, K; Jardine, K; Barry, M; Evans, DH; Bell, JC				Rintoul, Julia L.; Wang, Jiahu; Gammon, Don B.; van Buuren, Nicholas J.; Garson, Kenneth; Jardine, Karen; Barry, Michele; Evans, David H.; Bell, John C.			A Selectable and Excisable Marker System for the Rapid Creation of Recombinant Poxviruses	PLOS ONE			English	Article							VACCINIA VIRUS RECOMBINANTS; GENE-THERAPY; DOMINANT SELECTION; VIRAL REPLICATION; EXPRESSION VECTOR; GM-CSF; DNA; CANCER; BACTERIOPHAGE-P1; IMMUNOGENICITY	Background: Genetic manipulation of poxvirus genomes through attenuation, or insertion of therapeutic genes has led to a number of vector candidates for the treatment of a variety of human diseases. The development of recombinant poxviruses often involves the genomic insertion of a selectable marker for purification and selection purposes. The use of marker genes however inevitably results in a vector that contains unwanted genetic information of no therapeutic value. Methodology/Principal Findings: Here we describe an improved strategy that allows for the creation of marker-free recombinant poxviruses of any species. The Selectable and Excisable Marker (SEM) system incorporates a unique fusion marker gene for the efficient selection of poxvirus recombinants and the Cre/loxP system to facilitate the subsequent removal of the marker. We have defined and characterized this new methodological tool by insertion of a foreign gene into vaccinia virus, with the subsequent removal of the selectable marker. We then analyzed the importance of loxP orientation during Cre recombination, and show that the SEM system can be used to introduce site-specific deletions or inversions into the viral genome. Finally, we demonstrate that the SEM strategy is amenable to other poxviruses, as demonstrated here with the creation of an ectromelia virus recombinant lacking the EVM002 gene. Conclusion/Significance: The system described here thus provides a faster, simpler and more efficient means to create clinic-ready recombinant poxviruses for therapeutic gene therapy applications.	[Rintoul, Julia L.; Bell, John C.] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Rintoul, Julia L.; Wang, Jiahu; Garson, Kenneth; Jardine, Karen; Bell, John C.] Ottawa Hosp Res Inst, Ctr Canc Therapeut, Ottawa, ON, Canada; [Gammon, Don B.; van Buuren, Nicholas J.; Barry, Michele; Evans, David H.] Univ Alberta, Dept Med Microbiol & Immunol, Fac Med & Dent, Li Ka Shing Inst Virol, Edmonton, AB, Canada	University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Alberta	Rintoul, JL (corresponding author), Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada.	jbell@ohri.ca	Gammon, Don/AAP-2181-2020; Evans, David H/M-1912-2016	Evans, David H/0000-0001-5871-299X; van Buuren, Nicholas/0000-0003-2746-4422	National Cancer Institute of Canada; Terry Fox Foundation; Natural Sciences Engineering Research Council; Canadian Institutes of Health Research (CIHR); Lymphoma Research Foundation of Canada; Province of Alberta; NSERC Canada; Alberta Heritage Foundation; Tier 1 Canada Research Chair; Alberta Heritage for Medical Research Senior Scholar award	National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Terry Fox Foundation; Natural Sciences Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Lymphoma Research Foundation of Canada; Province of Alberta; NSERC Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Heritage Foundation(Alberta Heritage Foundation for Medical Research); Tier 1 Canada Research Chair(Canada Research Chairs); Alberta Heritage for Medical Research Senior Scholar award	This work was supported by grants from the National Cancer Institute of Canada, Terry Fox Foundation, Natural Sciences Engineering Research Council, and the Canadian Institutes of Health Research to JB, DE and MB. JLR was supported by a CIHR Doctoral award: Frederick Banting and Charles Best Canada Graduate Scholarship. JW was supported by a Lymphoma Research Foundation of Canada Research Fellowship. DBG was supported by a Ralph Steinhauer Award of Distinction from the Province of Alberta. NJVB was supported by a Doctoral NSERC Canada Graduate Scholarship and an Alberta Heritage Foundation for Medical Research Incentive Award. MB holds a Tier 1 Canada Research Chair, a Howard Hughes International Scholar Award and an Alberta Heritage for Medical Research Senior Scholar award. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alejo A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005175; Bejon P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000707; CADOZ M, 1992, LANCET, V339, P1429, DOI 10.1016/0140-6736(92)92027-D; CARROLL MW, 1995, BIOTECHNIQUES, V19, P352; CHAKRABARTI S, 1985, MOL CELL BIOL, V5, P3403, DOI 10.1128/MCB.5.12.3403; Chakrabarti S, 1997, BIOTECHNIQUES, V23, P1094, DOI 10.2144/97236st07; Committee for the Proprietary Medicinal Products (CPMP), 2001, NOT GUID QUAL PRECL; Dasgupta S, 2006, MOL THER, V13, P183, DOI 10.1016/j.ymthe.2005.06.481; Demmin GL, 2001, J VIROL, V75, P10856, DOI 10.1128/JVI.75.22.10856-10869.2001; Erbs P, 2008, CANCER GENE THER, V15, P18, DOI 10.1038/sj.cgt.7701098; Evgin L, 2010, MOL THER, V18, P896, DOI 10.1038/mt.2010.14; FALKNER FG, 1988, J VIROL, V62, P1849, DOI 10.1128/JVI.62.6.1849-1854.1988; FALKNER FG, 1990, J VIROL, V64, P3108, DOI 10.1128/JVI.64.6.3108-3111.1990; FENNER F, 1958, VIROLOGY, V5, P530, DOI 10.1016/0042-6822(58)90043-6; Fenner F, SMALLPOX ITS ERADICA; FRANKE CA, 1985, MOL CELL BIOL, V5, P1918, DOI 10.1128/MCB.5.8.1918; Gammon DB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000984; Gammon DB, 2009, J VIROL, V83, P4236, DOI 10.1128/JVI.02255-08; Gilbert Philippe-Alexandre, 2006, Recent Pat Antiinfect Drug Discov, V1, P309, DOI 10.2174/157489106778777592; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Harrop R, 2007, CLIN CANCER RES, V13, P4487, DOI 10.1158/1078-0432.CCR-07-0704; Huygen K, 1996, NAT MED, V2, P893, DOI 10.1038/nm0896-893; ISAACS SN, 1990, VIROLOGY, V178, P626, DOI 10.1016/0042-6822(90)90367-Z; Kanesa-thasan N, 2000, VACCINE, V19, P483, DOI 10.1016/S0264-410X(00)00191-2; Kantoff PW, 2010, J CLIN ONCOL, V28, P1099, DOI 10.1200/JCO.2009.25.0597; Kim JH, 2006, MOL THER, V14, P361, DOI 10.1016/j.ymthe.2006.05.008; Krumsiek J, 2007, BIOINFORMATICS, V23, P1026, DOI 10.1093/bioinformatics/btm039; Lin YCJ, 2008, J VIROL, V82, P5922, DOI 10.1128/JVI.02723-07; Lorenz MGO, 1999, HUM GENE THER, V10, P1095, DOI 10.1089/10430349950018094; Luker KE, 2005, VIROLOGY, V341, P284, DOI 10.1016/j.virol.2005.06.049; Lun XQ, 2010, CANCER RES, V70, P598, DOI 10.1158/0008-5472.CAN-09-1510; MACKETT M, 1984, J VIROL, V49, P857, DOI 10.1128/JVI.49.3.857-864.1984; Mastrangelo MJ, 1999, CANCER GENE THER, V6, P409, DOI 10.1038/sj.cgt.7700066; McCart JA, 2001, CANCER RES, V61, P8751; Meyer Hermann, 2004, Methods Mol Biol, V269, P119; Moroziewicz D, 2005, CURR OPIN MOL THER, V7, P317; NAKANO E, 1982, P NATL ACAD SCI-BIOL, V79, P1593, DOI 10.1073/pnas.79.5.1593; PICCINI A, 1987, METHOD ENZYMOL, V153, P545; SAUER B, 1988, P NATL ACAD SCI USA, V85, P5166, DOI 10.1073/pnas.85.14.5166; Scheiflinger F, 1998, ARCH VIROL, V143, P467, DOI 10.1007/s007050050303; Shearwin KE, 2005, TRENDS GENET, V21, P339, DOI 10.1016/j.tig.2005.04.009; Shor B, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-28; SMITH GL, 1983, GENE, V25, P21, DOI 10.1016/0378-1119(83)90163-4; SONEOKA Y, 1995, NUCLEIC ACIDS RES, V23, P628, DOI 10.1093/nar/23.4.628; STERNBERG N, 1981, J MOL BIOL, V150, P467, DOI 10.1016/0022-2836(81)90375-2; Xiang H, 2006, MOL CELL BIOL, V26, P8599, DOI 10.1128/MCB.01062-06; Zhu BG, 2007, BIOTECHNIQUES, V43, P356, DOI 10.2144/000112536	47	31	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e24643	10.1371/journal.pone.0024643	http://dx.doi.org/10.1371/journal.pone.0024643			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CK	21931792	Green Published, Green Submitted, gold			2022-12-25	WOS:000294802800080
J	Robery, S; Mukanowa, J; du Sert, NP; Andrews, PLR; Williams, RSB				Robery, Steven; Mukanowa, Janina; du Sert, Nathalie Percie; Andrews, Paul L. R.; Williams, Robin S. B.			Investigating the Effect of Emetic Compounds on Chemotaxis in Dictyostelium Identifies a Non-Sentient Model for Bitter and Hot Tastant Research	PLOS ONE			English	Article							HOUSE MUSK SHREW; ADVERSE-EFFECT LEVEL; ORAL COPPER-SULFATE; SUNCUS-MURINUS; INDUCED EMESIS; CAENORHABDITIS-ELEGANS; GASTROINTESTINAL-TRACT; RECEPTOR ANTAGONISTS; CAPSAICIN ANALOG; INDUCE EMESIS	Novel chemical entities (NCEs) may be investigated for emetic liability in a range of unpleasant experiments involving retching, vomiting or conditioned taste aversion/food avoidance in sentient animals. We have used a range of compounds with known emetic /aversive properties to examine the possibility of using the social amoeba, Dictyostelium discoideum, for research into identifying and understanding emetic liability, and hence reduce adverse animal experimentation in this area. Twenty eight emetic or taste aversive compounds were employed to investigate the acute (10 min) effect of compounds on Dictyostelium cell behaviour (shape, speed and direction of movement) in a shallow chemotaxic gradient (Dunn chamber). Compound concentrations were chosen based on those previously reported to be emetic or aversive in in vivo studies and results were recorded and quantified by automated image analysis. Dictyostelium cell motility was rapidly and strongly inhibited by four structurally distinct tastants (three bitter tasting compounds - denatonium benzoate, quinine hydrochloride, phenylthiourea, and the pungent constituent of chilli peppers - capsaicin). In addition, stomach irritants (copper chloride and copper sulphate), and a phosphodiesterase IV inhibitor also rapidly blocked movement. A concentration-dependant relationship was established for five of these compounds, showing potency of inhibition as capsaicin (IC50 = 11.9 +/- 4.0 mu M) > quinine hydrochloride (IC50 = 44.3 +/- 6.8 mu M) > denatonium benzoate (IC50 = 129 +/- 4 mu M) > phenylthiourea (IC50 = 366 +/- 5 mu M) > copper sulphate (IC50 = 1433 +/- 3 mu M). In contrast, 21 compounds within the cytotoxic and receptor agonist/antagonist classes did not affect cell behaviour. Further analysis of bitter and pungent compounds showed that the effect on cell behaviour was reversible and not cytotoxic, suggesting an uncharacterised molecular mechanism of action for these compounds. These results therefore demonstrate that Dictyostelium has potential as a non-sentient model in the analysis of the molecular effects of tastants, although it has limited utility in identification of emetic agents in general.	[Robery, Steven; Mukanowa, Janina; Williams, Robin S. B.] Royal Holloway Univ London, Sch Biol Sci, Ctr Biomed Sci, Egham, Surrey, England; [du Sert, Nathalie Percie; Andrews, Paul L. R.] St Georges Univ London, Div Biomed Sci, London, England	University of London; Royal Holloway University London; St Georges University London	Robery, S (corresponding author), Royal Holloway Univ London, Sch Biol Sci, Ctr Biomed Sci, Egham, Surrey, England.	robin.williams@rhul.ac.uk	Williams, Robin/G-6807-2011; du Sert, Nathalie Percie/G-2534-2011	du Sert, Nathalie Percie/0000-0002-9478-0540	South Western Academic Network (SWan); Wellcome Trust [082640]; National Centre for Replacement Refinement and Reduction [G0900775]; National Centre for the Replacement [G0900775/1] Funding Source: researchfish	South Western Academic Network (SWan); Wellcome Trust(Wellcome TrustEuropean Commission); National Centre for Replacement Refinement and Reduction; National Centre for the Replacement	University Federation for Animal Welfare (UFAW) summer studentship to JM and UFAW PhD studentship to SR, a South Western Academic Network (SWan) small equipment grant to RSBW and PLRA, and a Wellcome Trust Project Grant 082640 and National Centre for Replacement Refinement and Reduction (NC3R)s Project grant G0900775 to RSBW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Alexander SP, 2008, BRIT J PHARM S, P209; Andrews P, 1996, EUR J PHARMACOL, V307, P305, DOI 10.1016/0014-2999(96)00275-0; Andrews P, 2000, DEV BRAIN RES, V121, P29, DOI 10.1016/S0165-3806(00)00022-5; Andrews PLR, 2006, AUTON NEUROSCI-BASIC, V125, P100, DOI 10.1016/j.autneu.2006.01.008; ANDREWS PLR, 1993, NEUROPHARMACOLOGY, V32, P799, DOI 10.1016/0028-3908(93)90189-A; Andrews PLR, 2001, NEUROSCI LETT, V314, P102, DOI 10.1016/S0304-3940(01)02269-8; ANDREWS PLR, 1990, CAN J PHYSIOL PHARM, V68, P325, DOI 10.1139/y90-047; Andrews PLR, 2000, BRIT J PHARMACOL, V130, P1247, DOI 10.1038/sj.bjp.0703428; Andrews PLR., 2004, ROLE TACHYKININS TAC, P359; Aoki M, 2001, J PHARMACOL EXP THER, V298, P1142; Araya M, 2003, REGUL TOXICOL PHARM, V38, P389, DOI 10.1016/j.yrtph.2003.08.001; Araya M, 2001, REGUL TOXICOL PHARM, V34, P137, DOI 10.1006/rtph.2001.1492; Bader S, 2007, BIOCHEM J, V402, P153, DOI 10.1042/BJ20061153; Bagorda A, 2006, THROMB HAEMOSTASIS, V95, P12, DOI 10.1160/TH05-07-0483; Bavan S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-17; BHANDARI P, 1992, NEUROPHARMACOLOGY, V31, P735, DOI 10.1016/0028-3908(92)90034-M; BOBKOV I G, 1964, Fiziol Zh SSSR Im I M Sechenova, V50, P187; Boeckeler K., 2007, ENCY LIFE SCI; BORISON HL, 1952, J PHARMACOL EXP THER, V105, P317; BORISON HL, 1983, DRUGS, V25, P8, DOI 10.2165/00003495-198300251-00003; Burlando B, 2002, BIOCHEM BIOPH RES CO, V291, P476, DOI 10.1006/bbrc.2002.6463; Carter SK, 1981, CHEMOTHERAPY CANC, P169; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Chen MC, 2006, AM J PHYSIOL-CELL PH, V291, pC726, DOI 10.1152/ajpcell.00003.2006; Cheng FHM, 2005, EUR J PHARMACOL, V508, P231, DOI 10.1016/j.ejphar.2004.12.022; Clapp TR, 2008, FEBS LETT, V582, P3783, DOI 10.1016/j.febslet.2008.10.007; Cubeddu LX, 2000, N-S ARCH PHARMACOL, V361, P85, DOI 10.1007/s002109900152; Davis TG, 2009, J PHARMACOL EXP THER, V330, P922, DOI 10.1124/jpet.109.152454; des Gachons CP, 2011, CURR BIOL, V21, pR247, DOI 10.1016/j.cub.2011.02.028; Devantier HR, 2008, BEHAV PHARMACOL, V19, P673, DOI 10.1097/FBP.0b013e3283123cd6; du Sert NP, 2011, CANCER CHEMOTH PHARM, V67, P667, DOI 10.1007/s00280-010-1339-4; EGLEN RM, 1993, J PHARMACOL EXP THER, V266, P535; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Ezak MJ, 2010, GENETICS, V185, P233, DOI 10.1534/genetics.110.115188; Francione L, 2009, DIS MODEL MECH, V2, P479, DOI 10.1242/dmm.003319; Francione LM, 2011, SEMIN CELL DEV BIOL, V22, P120, DOI 10.1016/j.semcdb.2010.11.004; Fujiwara-Sawada M, 2003, J PHARM PHARMACOL, V55, P271, DOI 10.1211/002235702496; FUKUI H, 1993, NEUROPHARMACOLOGY, V32, P959, DOI 10.1016/0028-3908(93)90060-G; Gaddum H J, 1961, PHARM ZINC SULPHATE; Glendinning JI, 2008, PHYSIOL BEHAV, V93, P757, DOI 10.1016/j.physbeh.2007.11.029; GOLD H, 1952, AM J MED, V13, P124, DOI 10.1016/0002-9343(52)90152-6; Gordesky-Gold B, 2008, CHEM SENSES, V33, P301, DOI 10.1093/chemse/bjm088; Green BG, 2003, PHYSIOL BEHAV, V79, P811, DOI 10.1016/S0031-9384(03)00213-0; Green BG, 2005, PHYSIOL BEHAV, V86, P526, DOI 10.1016/j.physbeh.2005.08.038; HEASLIP RJ, 1995, EUR J PHARMACOL, V286, P281, DOI 10.1016/0014-2999(95)00457-2; Hilliard MA, 2004, EMBO J, V23, P1101, DOI 10.1038/sj.emboj.7600107; Hirose R, 2007, EUR J PHARMACOL, V573, P93, DOI 10.1016/j.ejphar.2007.06.045; Hoffmann Irene S, 2003, Am J Ther, V10, P447, DOI 10.1097/00045391-200311000-00012; Holmes AM, 2009, BRIT J PHARMACOL, V157, P865, DOI 10.1111/j.1476-5381.2009.00176.x; Horn CC, 2004, AUTON NEUROSCI-BASIC, V115, P74, DOI 10.1016/j.autneu.2004.08.011; Horn CC, 2009, AM J PHYSIOL-REG I, V297, pR1375, DOI 10.1152/ajpregu.00284.2009; Ishimaru Y, 2005, MECH DEVELOP, V122, P1310, DOI 10.1016/j.mod.2005.07.005; Isono K, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00020; Javid FA, 2002, PHARMACOL BIOCHEM BE, V73, P979, DOI 10.1016/S0091-3057(02)00955-3; Jin T, 2009, IMMUNOL RES, V43, P118, DOI 10.1007/s12026-008-8056-7; JORENBY DE, 1995, JAMA-J AM MED ASSOC, V274, P1347, DOI 10.1001/jama.274.17.1347; Kan KKW, 2003, EUR J PHARMACOL, V477, P247, DOI 10.1016/j.ejphar.2003.08.020; Kan KKW, 2002, EUR J PHARMACOL, V453, P299, DOI 10.1016/S0014-2999(02)02424-X; KARNIOL IG, 1978, PSYCHOPHARMACOLOGY, V57, P289, DOI 10.1007/BF00426753; KAYASHIMA N, 1978, JPN J PHARMACOL, V28, P797, DOI 10.1254/jjp.28.797; KAYASHIMA N, 1978, JPN J PHARMACOL, V28, P775, DOI 10.1254/jjp.28.775; King J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011151; King JS, 2009, TRENDS CELL BIOL, V19, P523, DOI 10.1016/j.tcb.2009.07.004; King JS, 2009, DIS MODEL MECH, V2, P306, DOI 10.1242/dmm.001271; KNOX AP, 1993, BRAIN RES BULL, V31, P477, DOI 10.1016/0361-9230(93)90112-O; Kris MG, 1996, CANCER, V78, P2193, DOI 10.1002/(SICI)1097-0142(19961115)78:10<2193::AID-CNCR22>3.0.CO;2-T; LAFFAN RJ, 1957, J PHARMACOL EXP THER, V121, P468; Lalueza-Fox C, 2009, BIOL LETTERS, V5, P809, DOI 10.1098/rsbl.2009.0532; LEE KY, 1985, DIGEST DIS SCI, V30, P22, DOI 10.1007/BF01318366; Li GC, 2000, MICROBIOL-SGM, V146, P2219, DOI 10.1099/00221287-146-9-2219; Liman E. R., 2007, V179, P287; Liu YL, 2005, PHYSIOL BEHAV, V85, P271, DOI 10.1016/j.physbeh.2005.04.009; Ludlow MJ, 2009, J BIOL CHEM, V284, P35227, DOI 10.1074/jbc.M109.045674; MAKALE MT, 1992, AM J PHYSIOL, V263, pR284, DOI 10.1152/ajpregu.1992.263.2.R284; Manahan CL, 2004, ANNU REV CELL DEV BI, V20, P223, DOI 10.1146/annurev.cellbio.20.011303.132633; Masuho I, 2005, CHEM SENSES, V30, P281, DOI 10.1093/chemse/bji022; MATSUKI N, 1988, JPN J PHARMACOL, V48, P303, DOI 10.1254/jjp.48.303; McBride CS, 2007, GENETICS, V177, P1395, DOI 10.1534/genetics.107.078683; McMains VC, 2008, AGEING RES REV, V7, P234, DOI 10.1016/j.arr.2008.04.003; McMains VC, 2010, DIS MODEL MECH, V3, P581, DOI 10.1242/dmm.004457; Min JX, 2005, EUKARYOT CELL, V4, P178, DOI 10.1128/EC.4.1.178-189.2005; Nakayama H, 2004, J PHARMACOL SCI, V96, P301, DOI 10.1254/jphs.FPJ04035X; NIIJIMA A, 1987, NEUROSCI LETT, V80, P71, DOI 10.1016/0304-3940(87)90497-6; Oike H, 2007, J NEUROSCI, V27, P5584, DOI 10.1523/JNEUROSCI.0651-07.2007; Olivares M, 2001, REGUL TOXICOL PHARM, V33, P271, DOI 10.1006/rtph.2000.1440; Osinski MA, 2005, PHARMACOL BIOCHEM BE, V81, P211, DOI 10.1016/j.pbb.2005.03.012; Pakes NK, 2011, J R SOC INTERFACE, V8, P1185, DOI 10.1098/rsif.2010.0696; Parker LA, 2009, PHYSIOL BEHAV, V97, P121, DOI 10.1016/j.physbeh.2009.02.014; PARSONS JA, 1971, BRIT J PHARMACOL, V42, P143, DOI 10.1111/j.1476-5381.1971.tb07094.x; Perez CA, 2002, NAT NEUROSCI, V5, P1169, DOI 10.1038/nn952; POLLERA CF, 1989, AM J CLIN ONCOL-CANC, V12, P524, DOI 10.1097/00000421-198912000-00014; Pronin AN, 2004, CHEM SENSES, V29, P583, DOI 10.1093/chemse/bjh064; Rascon A, 2000, MOL BIOCHEM PARASIT, V106, P283, DOI 10.1016/S0166-6851(99)00224-8; Rudd JA, 2001, EUR J PHARMACOL, V422, P185, DOI 10.1016/S0014-2999(01)01041-X; Russ M, 2006, BIOCHEM BIOPH RES CO, V345, P516, DOI 10.1016/j.bbrc.2006.04.047; Saito R, 2003, J PHARMACOL SCI, V91, P87; Sanger GJ, 2011, TRENDS PHARMACOL SCI, V32, P402, DOI 10.1016/j.tips.2011.03.009; SCOTT TR, 1987, PHYSIOL BEHAV, V41, P315, DOI 10.1016/0031-9384(87)90394-5; Seeley RJ, 2000, J NEUROSCI, V20, P1616; Seymour MT, 1993, PHARMACOKINETICS PHA, P9; Shi P, 2006, MOL BIOL EVOL, V23, P292, DOI 10.1093/molbev/msj028; SIBERT JR, 1991, ARCH EMERG MED, V8, P1; Smith JE, 2002, EXP PHYSIOL, V87, P563, DOI 10.1113/eph8702424; Stern RM, 2011, NAUSEA MECH MANAGEME, P171; SWISS ED, 1952, J PHARMACOL EXP THER, V104, P76; Tajima T, 2001, J BIOSCI BIOENG, V91, P322, DOI 10.1016/S1389-1723(01)80144-4; Talavera K, 2008, FASEB J, V22, P1343, DOI 10.1096/fj.07-9591com; Tao YP, 1996, CELL SIGNAL, V8, P27, DOI 10.1016/0898-6568(95)02011-X; Tepper BJ, 2009, ANN NY ACAD SCI, V1170, P126, DOI 10.1111/j.1749-6632.2009.03916.x; Terbach N, 2011, J CELL SCI, V124, P2267, DOI 10.1242/jcs.084285; Tordoff MG, 2008, PHYSIOL BEHAV, V95, P308, DOI 10.1016/j.physbeh.2008.06.010; TORII Y, 1991, JPN J PHARMACOL, V55, P107, DOI 10.1254/jjp.55.107; TORII Y, 1994, BRIT J PHARMACOL, V111, P431, DOI 10.1111/j.1476-5381.1994.tb14753.x; Williams RSB, 2006, TRENDS MOL MED, V12, P415, DOI 10.1016/j.molmed.2006.07.003; Williams RSB, 2002, NATURE, V417, P292, DOI 10.1038/417292a; Xu XH, 2007, EUKARYOT CELL, V6, P899, DOI 10.1128/EC.00104-06; Yamamoto K, 2004, PHYSIOL BEHAV, V83, P151, DOI 10.1016/j.physbeh.2004.08.006; Yamamoto K, 2007, EUR J PHARMACOL, V554, P34, DOI 10.1016/j.ejphar.2006.09.058; ZICHA D, 1991, J CELL SCI, V99, P769	120	13	13	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e24439	10.1371/journal.pone.0024439	http://dx.doi.org/10.1371/journal.pone.0024439			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CK	21931717	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000294802800053
J	Santiveri, CM; Mirassou, Y; Rico-Lastres, P; Martinez-Lumbreras, S; Perez-Canadillas, JM				Santiveri, Clara M.; Mirassou, Yasmina; Rico-Lastres, Palma; Martinez-Lumbreras, Santiago; Manuel Perez-Canadillas, Jose			Pub1p C-Terminal RRM Domain Interacts with Tif4631p through a Conserved Region Neighbouring the Pab1p Binding Site	PLOS ONE			English	Article							RNA RECOGNITION MOTIF; PRE-MESSENGER-RNA; TRANSLATION INITIATION; STRESS GRANULES; STRUCTURAL BASIS; CRYSTAL-STRUCTURE; GENE-EXPRESSION; GLOBAL ANALYSIS; CHEMICAL-SHIFT; P-BODIES	Pub1p, a highly abundant poly(A)+ mRNA binding protein in Saccharomyces cerevisiae, influences the stability and translational control of many cellular transcripts, particularly under some types of environmental stresses. We have studied the structure, RNA and protein recognition modes of different Pub1p constructs by NMR spectroscopy. The structure of the C-terminal RRM domain (RRM3) shows a non-canonical N-terminal helix that packs against the canonical RRM fold in an original fashion. This structural trait is conserved in Pub1p metazoan homologues, the TIA-1 family, defining a new class of RRM-type domains that we propose to name TRRM (TIA-1 C-terminal domain-like RRM). Pub1p TRRM and the N-terminal RRM1-RRM2 tandem bind RNA with high selectivity for U-rich sequences, with TRRM showing additional preference for UA-rich ones. RNA-mediated chemical shift changes map to beta-sheet and protein loops in the three RRMs. Additionally, NMR titration and biochemical in vitro cross-linking experiments determined that Pub1p TRRM interacts specifically with the N-terminal region (1-402) of yeast eIF4G1 (Tif4631p), very likely through the conserved Box1, a short sequence motif neighbouring the Pab1p binding site in Tif4631p. The interaction involves conserved residues of Pub1p TRRM, which define a protein interface that mirrors the Pab1p-Tif4631p binding mode. Neither protein nor RNA recognition involves the novel N-terminal helix, whose functional role remains unclear. By integrating these new results with the current knowledge about Pub1p, we proposed different mechanisms of Pub1p recruitment to the mRNPs and Pub1p-mediated mRNA stabilization in which the Pub1p/Tif4631p interaction would play an important role.	[Santiveri, Clara M.; Mirassou, Yasmina; Rico-Lastres, Palma; Martinez-Lumbreras, Santiago; Manuel Perez-Canadillas, Jose] CSIC, Inst Quim Fis Rocasolano, Dept Biol Phys Chem, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR)	Santiveri, CM (corresponding author), CSIC, Ctr Invest Biol, Dept Chem & Phys Biol, Madrid, Spain.	jmperez@iqfr.csic.es	Pérez-Cañadillas, Jose Manuel/AAN-1864-2020; Perez-Canadillas, Jose M/J-5748-2013; Martínez Lumbreras, Santiago/AHA-6695-2022	Perez-Canadillas, Jose M/0000-0002-8266-5502; Martinez-Lumbreras, Santiago/0000-0002-8617-0566; Santiveri, Clara M./0000-0001-6095-7224	C.S.I.C. [200880I088]; MICINN [CTQ2008-00080/BQU]; Comunidad Autonoma de Madrid [CCG07-CSIC GEN2333]; Consejeria de Educacion de la Comunidad Autonoma de Madrid; European Social Fund; Junta de Ampliacion de Estudios (JAE)	C.S.I.C.; MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission); Comunidad Autonoma de Madrid(Comunidad de Madrid); Consejeria de Educacion de la Comunidad Autonoma de Madrid(Comunidad de Madrid); European Social Fund(European Social Fund (ESF)); Junta de Ampliacion de Estudios (JAE)	This work was supported by C.S.I.C. (http://www.csic.es/) Special Intramural project [200880I088], MICINN (http://www.micinn.es/) project [CTQ2008-00080/BQU] and "Comunidad Autonoma de Madrid" (http://www.madrimasd.org/) project [CCG07-CSIC GEN2333]. SML is holder of an undergraduate contract from the "Consejeria de Educacion de la Comunidad Autonoma de Madrid" (http://www.madrimasd.org/) and the European Social Fund (http://ec.europa.eu/employment_social/esf/index_en.htm). YM is holder of a Predoctoral "Junta de Ampliacion de Estudios (JAE)" contract (http://www.csic.es/web/guest/programa-jae). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAM SA, 1986, MOL CELL BIOL, V6, P2932, DOI 10.1128/MCB.6.8.2932; ANDERSON JT, 1993, MOL CELL BIOL, V13, P6102, DOI 10.1128/MCB.13.10.6102; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Anderson P, 2009, CURR BIOL, V19, pR397, DOI 10.1016/j.cub.2009.03.013; Anderson P, 2009, NAT REV MOL CELL BIO, V10, P430, DOI 10.1038/nrm2694; Auweter SD, 2006, EMBO J, V25, P163, DOI 10.1038/sj.emboj.7600918; Auweter SD, 2007, J MOL BIOL, V367, P174, DOI 10.1016/j.jmb.2006.12.053; Berset C, 2003, RNA, V9, P871, DOI 10.1261/rna.5380903; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Brengues M, 2007, MOL BIOL CELL, V18, P2592, DOI 10.1091/mbc.E06-12-1149; Buchan JR, 2008, J CELL BIOL, V183, P441, DOI 10.1083/jcb.200807043; Buchan JR, 2011, J CELL SCI, V124, P228, DOI 10.1242/jcs.078444; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Clery A, 2008, CURR OPIN STRUC BIOL, V18, P290, DOI 10.1016/j.sbi.2008.04.002; Colombrita C, 2009, J NEUROCHEM, V111, P1051, DOI 10.1111/j.1471-4159.2009.06383.x; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Cukier CD, 2010, NAT STRUCT MOL BIOL; de Silanes IL, 2005, MOL CELL BIOL, V25, P9520, DOI 10.1128/MCB.25.21.9520-9531.2005; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deo RC, 1999, CELL, V98, P835, DOI 10.1016/S0092-8674(00)81517-2; Dominguez C, 2010, PROG NUCL M IN PRESS; Duttagupta R, 2005, MOL CELL BIOL, V25, P5499, DOI 10.1128/MCB.25.13.5499-5513.2005; Fadoulogiou VE, 2008, ANAL BIOCHEM, V373, P404, DOI 10.1016/j.ab.2007.10.027; Fielding L, 2007, PROG NUCL MAGN RESON, V51; Forch P, 2000, MOL CELL, V6, P1089, DOI 10.1016/S1097-2765(00)00107-6; Forch P, 2002, EMBO J, V21, P6882, DOI 10.1093/emboj/cdf668; Freibaum BD, 2010, J PROTEOME RES, V9, P1104, DOI 10.1021/pr901076y; Thomas MG, 2011, CELL SIGNAL, V23, P324, DOI 10.1016/j.cellsig.2010.08.011; Gal-Mark N, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000717; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Groft CM, 2002, MOL CELL, V9, P1273, DOI 10.1016/S1097-2765(02)00555-5; Gross JD, 2003, CELL, V115, P739, DOI 10.1016/S0092-8674(03)00975-9; Grousl T, 2009, J CELL SCI, V122, P2078, DOI 10.1242/jcs.045104; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Handa N, 1999, NATURE, V398, P579, DOI 10.1038/19242; Hernandez G, 2010, TRENDS BIOCHEM SCI, V35, P63, DOI 10.1016/j.tibs.2009.10.009; Hoyle NP, 2007, J CELL BIOL, V179, P65, DOI 10.1083/jcb.200707010; Izquierdo JM, 2005, MOL CELL, V19, P475, DOI 10.1016/j.molcel.2005.06.015; Jung YS, 2004, J BIOMOL NMR, V30, P11, DOI 10.1023/B:JNMR.0000042954.99056.ad; Kato K, 2011, YEAST, V28, P339, DOI 10.1002/yea.1842; KAY LE, 1993, J MAGN RESON SER B, V101, P333, DOI 10.1006/jmrb.1993.1053; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Kessler SH, 1998, MOL CELL BIOL, V18, P51, DOI 10.1128/MCB.18.1.51; Kielkopf CL, 2004, GENE DEV, V18, P1513, DOI 10.1101/gad.1206204; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KUMAR A, 1980, BIOCHEM BIOPH RES CO, V95, P1, DOI 10.1016/0006-291X(80)90695-6; Kuo PH, 2009, NUCLEIC ACIDS RES, V37, P1799, DOI 10.1093/nar/gkp013; Li H, 2010, J STRUCT BIOL, V171, P291, DOI 10.1016/j.jsb.2010.04.014; Liu-Yesucevitz L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013250; Lui J, 2010, BIOCHEM SOC T, V38, P1131, DOI 10.1042/BST0381131; Maquat LE, 2010, CELL, V142, P368, DOI 10.1016/j.cell.2010.07.022; Marintchev A, 2009, CELL, V136, P447, DOI 10.1016/j.cell.2009.01.014; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; MATUNIS MJ, 1993, MOL CELL BIOL, V13, P6114, DOI 10.1128/MCB.13.10.6114; Moser JJ, 2010, INT J BIOCHEM CELL B, V42, P828, DOI 10.1016/j.biocel.2009.11.018; NAGAI K, 1995, TRENDS BIOCHEM SCI, V20, P235, DOI 10.1016/S0968-0004(00)89024-6; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Oberstrass FC, 2005, SCIENCE, V309, P2054, DOI 10.1126/science.1114066; Otero LJ, 1999, EMBO J, V18, P3153, DOI 10.1093/emboj/18.11.3153; PALMER AG, 1992, J MAGN RESON, V96, P416, DOI 10.1016/0022-2364(92)90097-Q; Park EH, 2011, EMBO J, V30, P302, DOI 10.1038/emboj.2010.312; Perez-Canadillas JM, 2001, CURR OPIN STRUC BIOL, V11, P53, DOI 10.1016/S0959-440X(00)00164-0; Perez-Canadillas JM, 2006, EMBO J, V25, P3167, DOI 10.1038/sj.emboj.7601190; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Preiss T, 1999, CURR OPIN GENET DEV, V9, P515, DOI 10.1016/S0959-437X(99)00005-2; Puig O, 1999, GENE DEV, V13, P569, DOI 10.1101/gad.13.5.569; Ruiz-Echevarria MJ, 2000, CELL, V101, P741, DOI 10.1016/S0092-8674(00)80886-7; SACHS AB, 1986, CELL, V45, P827, DOI 10.1016/0092-8674(86)90557-X; Sachs AB, 1997, CELL, V89, P831, DOI 10.1016/S0092-8674(00)80268-8; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schutz P, 2008, P NATL ACAD SCI USA, V105, P9564, DOI 10.1073/pnas.0800418105; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Spriggs KA, 2010, MOL CELL, V40, P228, DOI 10.1016/j.molcel.2010.09.028; SUDMEIER JL, 1980, J MAGN RESON, V40, P377, DOI 10.1016/0022-2364(80)90261-9; Swisher KD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010006; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Tarun SZ, 1997, P NATL ACAD SCI USA, V94, P9046, DOI 10.1073/pnas.94.17.9046; Tsuda K, 2009, NUCLEIC ACIDS RES, V37, P5151, DOI 10.1093/nar/gkp546; Vasudevan S, 2005, MOL CELL BIOL, V25, P9753, DOI 10.1128/MCB.25.22.9753-9763.2005; Vasudevan S, 2001, MOL CELL, V7, P1191, DOI 10.1016/S1097-2765(01)00279-9; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang XQ, 2001, NAT STRUCT BIOL, V8, P141, DOI 10.1038/84131; Warkocki Z, 2009, NAT STRUCT MOL BIOL, V16, P1237, DOI 10.1038/nsmb.1729; Wickens M, 1997, CURR OPIN GENET DEV, V7, P220, DOI 10.1016/S0959-437X(97)80132-3; WISHART DS, 1994, METHOD ENZYMOL, V239, P363; Zhang D, 1999, GENE DEV, V13, P581, DOI 10.1101/gad.13.5.581	89	9	9	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e24481	10.1371/journal.pone.0024481	http://dx.doi.org/10.1371/journal.pone.0024481			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CK	21931728	Green Submitted, Green Published, gold			2022-12-25	WOS:000294802800057
J	Fristedt, R; Vener, AV				Fristedt, Rikard; Vener, Alexander V.			High Light Induced Disassembly of Photosystem II Supercomplexes in Arabidopsis Requires STN7-Dependent Phosphorylation of CP29	PLOS ONE			English	Article							HARVESTING-COMPLEX-II; ALGA CHLAMYDOMONAS-REINHARDTII; PROTEIN-KINASE STT7; STATE TRANSITIONS; PHOTOSYNTHETIC MEMBRANES; THYLAKOID MEMBRANES; MASS-SPECTROMETRY; CORE PROTEINS; IN-VIVO; THALIANA	Photosynthetic oxidation of water and production of oxygen by photosystem II (PSII) in thylakoid membranes of plant chloroplasts is highly affected by changes in light intensities. To minimize damage imposed by excessive sunlight and sustain the photosynthetic activity PSII, organized in supercomplexes with its light harvesting antenna, undergoes conformational changes, disassembly and repair via not clearly understood mechanisms. We characterized the phosphoproteome of the thylakoid membranes from Arabidopsis thaliana wild type, stn7, stn8 and stn7stn8 mutant plants exposed to high light. The high light treatment of the wild type and stn8 caused specific increase in phosphorylation of Lhcb4.1 and Lhcb4.2 isoforms of the PSII linker protein CP29 at five different threonine residues. Phosphorylation of CP29 at four of these residues was not found in stn7 and stn7stn8 plants lacking the STN7 protein kinase. Blue native gel electrophoresis followed by immunological and mass spectrometric analyses of the membrane protein complexes revealed that the high light treatment of the wild type caused redistribution of CP29 from PSII supercomplexes to PSII dimers and monomers. A similar high-light-induced disassembly of the PSII supercomplexes occurred in stn8, but not in stn7 and stn7stn8. Transfer of the high-light-treated wild type plants to normal light relocated CP29 back to PSII supercomplexes. We postulate that disassembly of PSII supercomplexes in plants exposed to high light involves STN7-kinase-dependent phosphorylation of the linker protein CP29. Disruption of this adaptive mechanism can explain dramatically retarded growth of the stn7 and stn7stn8 mutants under fluctuating normal/high light conditions, as previously reported.	[Fristedt, Rikard; Vener, Alexander V.] Linkoping Univ, Div Cell Biol, Dept Clin & Expt Med, Linkoping, Sweden	Linkoping University	Fristedt, R (corresponding author), Linkoping Univ, Div Cell Biol, Dept Clin & Expt Med, Linkoping, Sweden.	alexander.vener@liu.se			Swedish Research Council; Swedish Research Council for Environment, Agriculture and Spatial Planning	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council for Environment, Agriculture and Spatial Planning(Swedish Research Council Formas)	This work was supported by grants from the Swedish Research Council and from the Swedish Research Council for Environment, Agriculture and Spatial Planning. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn TK, 2008, SCIENCE, V320, P794, DOI 10.1126/science.1154800; Barber J, 2006, BIOCHEM SOC T, V34, P619, DOI 10.1042/BST0340619; Bellafiore S, 2005, NATURE, V433, P892, DOI 10.1038/nature03286; BERGANTINO E, 1995, J BIOL CHEM, V270, P8474, DOI 10.1074/jbc.270.15.8474; Betterle N, 2009, J BIOL CHEM, V284, P15255, DOI 10.1074/jbc.M808625200; Caffarri S, 2004, BIOCHEMISTRY-US, V43, P9467, DOI 10.1021/bi036265i; Chen YE, 2009, BIOCHEMISTRY-US, V48, P9757, DOI 10.1021/bi901308x; Ciambella C, 2005, PROTEOMICS, V5, P746, DOI 10.1002/pmic.200401129; Dekker JP, 2005, BBA-BIOENERGETICS, V1706, P12, DOI 10.1016/j.bbabio.2004.09.009; Depege N, 2003, SCIENCE, V299, P1572, DOI 10.1126/science.1081397; Ficarro SB, 2002, NAT BIOTECHNOL, V20, P301, DOI 10.1038/nbt0302-301; Fristedt R, 2009, BIOCHEMISTRY-US, V48, P499, DOI 10.1021/bi8016334; Fristedt R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010963; Fristedt R, 2009, PLANT CELL, V21, P3950, DOI 10.1105/tpc.109.069435; Goral TK, 2010, PLANT J, V62, P948, DOI [10.1111/j.1365-313X.2010.04207.x, 10.1111/j.0960-7412.2010.04207.x]; Hansson M, 2003, MOL CELL PROTEOMICS, V2, P550, DOI 10.1074/mcp.M300050-MCP200; Horton P, 2008, FEBS J, V275, P1069, DOI 10.1111/j.1742-4658.2008.06263.x; Kargul J, 2005, FEBS J, V272, P4797, DOI 10.1111/j.1742-4658.2005.04894.x; Kirchhoff H, 2008, TRENDS PLANT SCI, V13, P201, DOI 10.1016/j.tplants.2008.03.001; Kouril R, 2005, BIOCHEMISTRY-US, V44, P10935, DOI 10.1021/bi051097a; Lemeille S, 2010, MOL CELL PROTEOMICS, V9, P1281, DOI 10.1074/mcp.M000020-MCP201; Lemeille S, 2009, PLOS BIOL, V7, P664, DOI 10.1371/journal.pbio.1000045; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Liu WJ, 2009, BBA-BIOENERGETICS, V1787, P1238, DOI 10.1016/j.bbabio.2009.04.012; Mozzo M, 2008, BBA-BIOENERGETICS, V1777, P1263, DOI 10.1016/j.bbabio.2008.04.036; Mullineaux CW, 2005, TRENDS PLANT SCI, V10, P521, DOI 10.1016/j.tplants.2005.09.001; Noren H, 2004, PHYSIOL PLANTARUM, V121, P343, DOI 10.1111/j.0031-9317.2004.00350.x; Pribil M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000288; Pursiheimo S, 2001, PLANT J, V26, P317, DOI 10.1046/j.1365-313X.2001.01033.x; Reiland S, 2009, PLANT PHYSIOL, V150, P889, DOI 10.1104/pp.109.138677; Rintamaki E, 1997, J BIOL CHEM, V272, P30476, DOI 10.1074/jbc.272.48.30476; Rochaix JD, 2007, FEBS LETT, V581, P2768, DOI 10.1016/j.febslet.2007.04.038; Shapiguzov A, 2010, P NATL ACAD SCI USA, V107, P4782, DOI 10.1073/pnas.0913810107; Shevchenko A, 2002, MOL BIOTECHNOL, V20, P107, DOI 10.1385/MB:20:1:107; Shimoni E, 2005, PLANT CELL, V17, P2580, DOI 10.1105/tpc.105.035030; Steen H, 2005, P NATL ACAD SCI USA, V102, P3948, DOI 10.1073/pnas.0409536102; Takahashi H, 2006, P NATL ACAD SCI USA, V103, P477, DOI 10.1073/pnas.0509952103; Takahashi S, 2008, TRENDS PLANT SCI, V13, P178, DOI 10.1016/j.tplants.2008.01.005; Tikkanen M, 2008, BBA-BIOENERGETICS, V1777, P1432, DOI 10.1016/j.bbabio.2008.08.004; Tikkanen M, 2006, PLANT MOL BIOL, V62, P779, DOI 10.1007/s11103-006-9044-8; Tikkanen M, 2010, PLANT PHYSIOL, V152, P723, DOI 10.1104/pp.109.150250; Tokutsu R, 2009, J BIOL CHEM, V284, P7777, DOI 10.1074/jbc.M809360200; Turkina MV, 2006, MOL CELL PROTEOMICS, V5, P1412, DOI 10.1074/mcp.M600066-MCP200; Vainonen JP, 2005, J BIOL CHEM, V280, P33679, DOI 10.1074/jbc.M505729200; Vainonen JP, 2008, FEBS J, V275, P1767, DOI 10.1111/j.1742-4658.2008.06335.x; van Oort B, 2010, BIOPHYS J, V98, P922, DOI 10.1016/j.bpj.2009.11.012; Vener AV, 2007, BBA-BIOENERGETICS, V1767, P449, DOI 10.1016/j.bbabio.2006.11.007; Vener AV, 2001, J BIOL CHEM, V276, P6959, DOI 10.1074/jbc.M009394200; Yakushevska AE, 2003, BIOCHEMISTRY-US, V42, P608, DOI 10.1021/bi027109z; Zybailov B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001994	50	65	65	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2011	6	9							e24565	10.1371/journal.pone.0024565	http://dx.doi.org/10.1371/journal.pone.0024565			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CH	21915352	Green Submitted, Green Published, gold			2022-12-25	WOS:000294802500061
J	Fu, M; Sun, CK; Lin, YC; Wang, CJ; Wu, CJ; Ko, SF; Chua, S; Sheu, JJ; Chiang, CH; Shao, PL; Leu, S; Yip, HK				Fu, Morgan; Sun, Cheuk-Kwan; Lin, Yu-Chun; Wang, Ching-Jen; Wu, Chiung-Jen; Ko, Sheung-Fat; Chua, Sarah; Sheu, Jiunn-Jye; Chiang, Chiang-Hua; Shao, Pei-Lin; Leu, Steve; Yip, Hon-Kan			Extracorporeal Shock Wave Therapy Reverses Ischemia-Related Left Ventricular Dysfunction and Remodeling: Molecular-Cellular and Functional Assessment	PLOS ONE			English	Article							CORONARY REVASCULARIZATION; DIABETIC-PATIENTS; HEART FUNCTION; BONE; ANGINA; CELLS; EXPRESSION; MANAGEMENT; OUTCOMES; PLACEBO	An optimal treatment for patients with diffuse obstructive arterial disease unsuitable for catheter-based or surgical intervention is still pending. This study tested the hypothesis that extracorporeal shock wave (ECSW) therapy may be a therapeutic alternative under such clinical situation. Myocardial ischemia was induced in male mini-pigs through applying an ameroid constrictor over mid-left anterior descending artery (LAD). Twelve mini-pigs were equally randomized into group 1 (Constrictor over LAD only) and group 2 (Constrictor over LAD plus ECSW [800 impulses at 0.09 mJ/mm(2)] once 3 months after the procedure). Results showed that the parameters measured by echocardiography did not differ between two groups on days 0 and 90. However, echocardiography and left ventricular (LV) angiography showed higher LV ejection fraction and lower LV end-systolic dimension and volume in group 2 on day 180 (p < 0.035). Besides, mRNA and protein expressions of CXCR4 and SDF-1 alpha were increased in group 2 (p < 0.04). Immunofluorescence staining also showed higher number of vWF-, CD31-, SDF-1 alpha-, and CXCR4-positive cells in group 2 (all p < 0.04). Moreover, immunohistochemical staining showed notably higher vessel density but lower mean fibrosis area, number of CD40-positive cells and apoptotic nuclei in group 2 (all p < 0.045). Mitochondrial protein expression of oxidative stress was lower, whereas cytochrome-C was higher in group 2 (all p < 0.03). Furthermore, mRNA expressions of MMP-9, Bax and caspase-3 were lower, whereas Bcl-2, eNOS, VEGF and PGC-1 alpha were higher in group 2 (all p < 0.01). In conclusion, ECSW therapy effectively reversed ischemia-elicited LV dysfunction and remodeling through enhancing angiogenesis and attenuating inflammation and oxidative stress.	[Fu, Morgan; Lin, Yu-Chun; Wu, Chiung-Jen; Chua, Sarah; Leu, Steve; Yip, Hon-Kan] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Cardiol, Kaohsiung, Taiwan; [Fu, Morgan; Sun, Cheuk-Kwan; Lin, Yu-Chun; Wang, Ching-Jen; Wu, Chiung-Jen; Ko, Sheung-Fat; Chua, Sarah; Sheu, Jiunn-Jye; Leu, Steve; Yip, Hon-Kan] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Sun, Cheuk-Kwan] I Shou Univ, E Da Hosp, Dept Emergency Med, Kaohsiung, Taiwan; [Sun, Cheuk-Kwan] Kaohsiung Chang Gung Mem Hosp, Dept Surg, Div Gen Surg, Kaohsiung, Taiwan; [Lin, Yu-Chun; Leu, Steve; Yip, Hon-Kan] Kaohsiung Chang Gung Mem Hosp, Ctr Translat Res Biomed Sci, Kaohsiung, Taiwan; [Wang, Ching-Jen] Kaohsiung Chang Gung Mem Hosp, Dept Orthoped Surg, Kaohsiung, Taiwan; [Ko, Sheung-Fat] Kaohsiung Chang Gung Mem Hosp, Dept Radiol, Kaohsiung, Taiwan; [Sheu, Jiunn-Jye] Kaohsiung Chang Gung Mem Hosp, Dept Surg, Div Thorac & Cardiovasc Surg, Kaohsiung, Taiwan; [Chiang, Chiang-Hua] Natl Pingtung Univ Sci & Technol, Dept Vet Med, Pingtung, Taiwan; [Shao, Pei-Lin] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; E-Da Hospital; I Shou University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; National Pingtung University Science & Technology; Kaohsiung Medical University	Fu, M (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Cardiol, Kaohsiung, Taiwan.	han.gung@msa.hinet.net		Leu, Steve/0000-0002-1738-1028; Sun, Cheuk-Kwan/0000-0002-2524-9684	Chang Gung Memorial Hospital, Chang Gung University [CMRPG 870341]	Chang Gung Memorial Hospital, Chang Gung University(Chang Gung Memorial Hospital)	This study was supported by a program grant from Chang Gung Memorial Hospital, Chang Gung University (grant no. CMRPG 870341). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aicher A, 2006, CIRCULATION, V114, P2823, DOI 10.1161/CIRCULATIONAHA.106.628623; [Anonymous], 1982, Lancet, V2, P1173; Azar RR, 2000, AM J CARDIOL, V86, P485, DOI 10.1016/S0002-9149(00)00998-X; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Chua S, 2009, ACTA CARDIOL SIN, V25, P64; Corti R, 2003, J AM COLL CARDIOL, V41, p7S, DOI 10.1016/S0735-1097(02)02833-4; Desai NR, 2010, JACC-CARDIOVASC INTE, V3, P571, DOI 10.1016/j.jcin.2010.04.008; Detre KM, 1999, CIRCULATION, V99, P633, DOI 10.1161/01.CIR.99.5.633; Fraker Theodore D Jr, 2007, Circulation, V116, P2762, DOI 10.1161/CIRCULATIONAHA.107.187930; Garrido AM, 2009, MOL CELL ENDOCRINOL, V302, P148, DOI 10.1016/j.mce.2008.11.003; Ito Y, 2010, CORONARY ARTERY DIS, V21, P304, DOI 10.1097/MCA.0b013e32833aec62; Jalife J, 1999, J CARDIOVASC ELECTR, V10, P1649, DOI 10.1111/j.1540-8167.1999.tb00230.x; Kikuchi Y, 2010, CIRC J, V74, P589, DOI 10.1253/circj.CJ-09-1028; Larking AM, 2010, CLIN REHABIL, V24, P222, DOI 10.1177/0269215509346083; Ma HZ, 2007, CALCIFIED TISSUE INT, V81, P124, DOI 10.1007/s00223-007-9046-9; MANSKE CL, 1992, LANCET, V340, P998, DOI 10.1016/0140-6736(92)93010-K; Nishida T, 2004, CIRCULATION, V110, P3055, DOI 10.1161/01.CIR.0000148849.51177.97; Ogden JA, 2001, CLIN ORTHOP RELAT R, P8; Oi K, 2008, TOHOKU J EXP MED, V214, P151, DOI 10.1620/tjem.214.151; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Saggini R, 2008, ULTRASOUND MED BIOL, V34, P1261, DOI 10.1016/j.ultrasmedbio.2008.01.010; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; Sun CK, 2009, CRIT CARE MED, V37, P1197, DOI 10.1097/CCM.0b013e31819c0667; Turco MA, 2007, J AM COLL CARDIOL, V49, P1676, DOI 10.1016/j.jacc.2007.01.069; VANDERWAL AC, 1994, CIRCULATION, V89, P36, DOI 10.1161/01.CIR.89.1.36; Vozzi C, 1999, J MOL CELL CARDIOL, V31, P991, DOI 10.1006/jmcc.1999.0937; Wang CJ, 2003, J ORTHOP RES, V21, P984, DOI 10.1016/S0736-0266(03)00104-9; Wang CJ, 2002, J FOOT ANKLE SURG, V41, P16, DOI DOI 10.1016/S1067-2516(02)80005-9; Wang Y, 2010, CLIN CARDIOL, V33, P693, DOI 10.1002/clc.20811; Yip HK, 2003, AM J CARDIOL, V92, P1331, DOI 10.1016/j.amjcard.2003.08.019; Yip HK, 2008, CIRC J, V72, P1336, DOI 10.1253/circj.72.1336; Yip HK, 2008, CIRC J, V72, P150, DOI 10.1253/circj.72.150; YUSUF S, 1994, LANCET, V344, P563, DOI 10.1016/S0140-6736(94)91963-1; Zeller M, 2008, ARTERIOSCL THROM VAS, V28, P954, DOI 10.1161/ATVBAHA.108.162768; Zimpfer D, 2009, J THORAC CARDIOV SUR, V137, P963, DOI 10.1016/j.jtcvs.2008.11.006	35	77	83	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2011	6	9							e24342	10.1371/journal.pone.0024342	http://dx.doi.org/10.1371/journal.pone.0024342			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817QP	21915315	gold, Green Published, Green Submitted			2022-12-25	WOS:000294689200038
J	Lambertz, C; Leidel, N; Havelius, KGV; Noth, J; Chernev, P; Winkler, M; Happe, T; Haumann, M				Lambertz, Camilla; Leidel, Nils; Havelius, Kajsa G. V.; Noth, Jens; Chernev, Petko; Winkler, Martin; Happe, Thomas; Haumann, Michael			O-2 Reactions at the Six-iron Active Site (H-cluster) in [FeFe]-Hydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAY-ABSORPTION SPECTROSCOPY; IRON-SULFUR CLUSTER; DRIVEN HYDROGEN-PRODUCTION; RALSTONIA-EUTROPHA H16; FE-ONLY HYDROGENASE; DESULFOVIBRIO-DESULFURICANS; MANGANESE COMPLEX; NIFE HYDROGENASE; REGULATORY HYDROGENASE; OXYGEN	Irreversible inhibition by molecular oxygen (09) complicates the use of [FeFe] -hydrogenases (HydA) for biotechnological hydrogen (H-2) production. Modification by O-2 of the active site six-iron complex denoted as the H-cluster ([4Fe4S]-2Fe(H)) of HydA1 from the green alga Chlamydomonas reinhardtii was characterized by x-ray absorption spectroscopy at the iron K-edge. In a time-resolved approach, HydA1 protein samples were prepared after increasing O-2 exposure periods at 0 degrees C. A kinetic analysis of changes in their x-ray absorption near edge structure and extended X-ray absorption fine structure spectra revealed three phases of O-2 reactions. The first phase (tau(1) <= 4 s) is characterized by the formation of an increased number of Fe-O,C bonds, elongation of the Fe-Fe distance in the binuclear unit (2Fe(H)), and oxidation of one iron ion. The second phase (tau(2) approximate to 15 s) causes a similar to 50% decrease of the number of similar to 2.7-parallel to Fe-Fe distances in the [4Fe4S] subcluster and the oxidation of one more iron ion. The final phase (tau(3) <= 1000 s) leads to the disappearance of most Fe-Fe and Fe-S interactions and further iron oxidation. These results favor a reaction sequence, which involves 1) oxygenation at 2Fe(H+) leading to the formation of a reactive oxygen species-like superoxide (O-2(-)), followed by 2) H-cluster inactivation and destabilization due to ROS attack on the [4Fe4S] cluster to convert it into an apparent [3Fe4S](+) unit, leading to 3) complete O-2-induced degradation of the remainders of the H-cluster. This mechanism suggests that blocking of ROS diffusion paths and/or altering the redox potential of the [4Fe4S] cubane by genetic engineering may yield improved O-2 tolerance in [FeFe]-hydrogenase.	[Lambertz, Camilla; Noth, Jens; Winkler, Martin; Happe, Thomas] Ruhr Univ Bochum, Lehrstuhl Biochem Pflanzen, AG Photobiotechnol, D-44780 Bochum, Germany; [Leidel, Nils; Havelius, Kajsa G. V.; Chernev, Petko; Haumann, Michael] Free Univ Berlin, Inst Expt Phys, D-14195 Berlin, Germany	Ruhr University Bochum; Free University of Berlin	Happe, T (corresponding author), Ruhr Univ Bochum, Lehrstuhl Biochem Pflanzen, AG Photobiotechnol, D-44780 Bochum, Germany.	thomas.happe@rub.de	MS-Powder+MS-Surfdiff+Micro-XAS+Super-XAS, SLS/M-1551-2019; Chernev, Petko/F-9964-2018; MIchael, Haumann/A-7087-2013	Chernev, Petko/0000-0002-2836-838X; Sigfridsson Clauss, Kajsa/0000-0002-7604-251X; Happe, Thomas/0000-0003-1206-5234	EU; Deutsche Forschungsgemeinschaft (DFG) [Ha3265/3-1]; Unicat Cluster of Excellence Berlin; "Stiftelsen Bengt Lundgvist minne"; Wenner-Gren Foundation; Bundesministerium fur Bildung und Forschung (BMBF, Design Cells Consortium); Volkswagen Foundation [Lig H2t]	EU(European Commission); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Unicat Cluster of Excellence Berlin; "Stiftelsen Bengt Lundgvist minne"; Wenner-Gren Foundation; Bundesministerium fur Bildung und Forschung (BMBF, Design Cells Consortium)(Federal Ministry of Education & Research (BMBF)); Volkswagen Foundation(Volkswagen)	This work was supported by the EU-SolarH2 program, (to M. H.) and by Deutsche Forschungsgemeinschaft (DFG) Grant Ha3265/3-1, and the Unicat Cluster of Excellence Berlin.; Recipient of "Stiftelsen Bengt Lundgvist minne" and Wenner-Gren Foundation fellowships.; Supported by the Bundesministerium fur Bildung und Forschung (BMBF, Design Cells Consortium) and by Volkswagen Foundation Grant Lig H2t. To whom correspondence may be addressed. Tel.: 49-234-32-27026; E-mail: thomas.happe@rub.de.; Recipient of a DFG Heisenberg-Fellowship. To whom correspondence may be addressed. Tel.: 49-30-8385-6101; E-mail: michaeLhaurnann@fu-berlin.de.	ADAMS MWW, 1990, BIOCHIM BIOPHYS ACTA, V1020, P115, DOI 10.1016/0005-2728(90)90044-5; Albracht SPJ, 2003, BBA-BIOENERGETICS, V1557, P41, DOI 10.1016/S0005-2728(02)00393-6; Baffert C, 2008, ANGEW CHEM INT EDIT, V47, P2052, DOI 10.1002/anie.200704313; Baffert C, 2011, J AM CHEM SOC, V133, P2096, DOI 10.1021/ja110627b; Barra M, 2006, BIOCHEMISTRY-US, V45, P14523, DOI 10.1021/bi061842z; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruschi M, 2008, INORG CHEM, V47, P6056, DOI 10.1021/ic8006298; Brzoska K, 2006, ACTA BIOCHIM POL, V53, P685; Buhrke T, 2005, J BIOL CHEM, V280, P23791, DOI 10.1074/jbc.M503260200; Burgdorf T, 2005, J MOL MICROB BIOTECH, V10, P181, DOI 10.1159/000091564; Crack JC, 2007, P NATL ACAD SCI USA, V104, P2092, DOI 10.1073/pnas.0609514104; Czech I, 2011, FEBS LETT, V585, P225, DOI 10.1016/j.febslet.2010.11.052; Czech I, 2010, FEBS LETT, V584, P638, DOI 10.1016/j.febslet.2009.12.016; Dau H, 2003, ANAL BIOANAL CHEM, V376, P562, DOI 10.1007/s00216-003-1982-2; Dementin S, 2009, J AM CHEM SOC, V131, P10156, DOI 10.1021/ja9018258; DOUGLAS E, 1964, J PHYS CHEM-US, V68, P169, DOI 10.1021/j100783a028; Driesener RC, 2010, ANGEW CHEM INT EDIT, V49, P1687, DOI 10.1002/anie.200907047; Duche O, 2005, FEBS J, V272, P3899, DOI 10.1111/j.1742-4658.2005.04806.x; Fiedler AT, 2005, INORG CHEM, V44, P9322, DOI 10.1021/ic050946f; Friedrich B, 2011, CURR OPIN BIOTECH, V22, P358, DOI 10.1016/j.copbio.2011.01.006; Fritsch J, 2011, BIOCHEMISTRY-US, V50, P5858, DOI 10.1021/bi200367u; Ghirardi ML, 2005, BIOCHEM SOC T, V33, P70, DOI 10.1042/BST0330070; Goldet G, 2009, J AM CHEM SOC, V131, P14979, DOI [10.1021/ja905388j, 10.1021/ja905388i]; Goris T, 2011, NAT CHEM BIOL, V7, P310, DOI 10.1038/nchembio.555; Green J, 2009, CURR OPIN MICROBIOL, V12, P145, DOI 10.1016/j.mib.2009.01.008; HATCHIKIAN EC, 1992, EUR J BIOCHEM, V209, P357, DOI 10.1111/j.1432-1033.1992.tb17297.x; Ihara M, 2006, PHOTOCHEM PHOTOBIOL, V82, P676, DOI 10.1562/2006-01-16-RA-778; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Imsande J, 1999, PLANT PHYSIOL BIOCH, V37, P87, DOI 10.1016/S0981-9428(99)80070-9; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Kamp C, 2008, BBA-BIOENERGETICS, V1777, P410, DOI 10.1016/j.bbabio.2008.02.002; King PW, 2006, J BACTERIOL, V188, P2163, DOI 10.1128/JB.188.6.2163-2172.2006; Klockenkamper R., 1996, TOTAL REFLECTION XRA; Krassen H, 2009, ACS NANO, V3, P4055, DOI 10.1021/nn900748j; Kuchenreuther JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020346; Kuchenreuther JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015491; Lautier T, 2011, FARADAY DISCUSS, V148, P385, DOI 10.1039/c004099c; Liebgott PP, 2011, J AM CHEM SOC, V133, P986, DOI 10.1021/ja108787s; Loscher S, 2010, CHEMPHYSCHEM, V11, P1297, DOI 10.1002/cphc.200901007; Loscher S, 2007, INORG CHEM, V46, P11094, DOI 10.1021/ic701255p; Lubitz W, 2007, CHEM REV, V107, P4331, DOI 10.1021/cr050186q; Lubitz W, 2007, CHEM REV, V107, P3900, DOI 10.1021/cr050200z; Lubner CE, 2010, BIOCHEMISTRY-US, V49, P10264, DOI 10.1021/bi1016167; Melis A, 2001, PLANT PHYSIOL, V127, P740, DOI 10.1104/pp.127.3.740; Meyer J, 2007, CELL MOL LIFE SCI, V64, P1063, DOI 10.1007/s00018-007-6477-4; Nicolet Y, 2000, TRENDS BIOCHEM SCI, V25, P138, DOI 10.1016/S0968-0004(99)01536-4; Nicolet Y, 1999, STRUCTURE, V7, P13, DOI 10.1016/S0969-2126(99)80005-7; Nicolet Y, 2001, J AM CHEM SOC, V123, P1596, DOI 10.1021/ja0020963; Ogata H, 2010, J MOL BIOL, V402, P428, DOI 10.1016/j.jmb.2010.07.041; Pandelia ME, 2011, P NATL ACAD SCI USA, V108, P6097, DOI 10.1073/pnas.1100610108; Peters JW, 1998, SCIENCE, V282, P1853, DOI 10.1126/science.282.5395.1853; Pilet E, 2009, FEBS LETT, V583, P506, DOI 10.1016/j.febslet.2009.01.004; Posewitz MC, 2004, J BIOL CHEM, V279, P25711, DOI 10.1074/jbc.M403206200; Pospisil P, 2003, BIOPHYS J, V84, P1370, DOI 10.1016/S0006-3495(03)74952-2; Roseboom W, 2006, J BIOL INORG CHEM, V11, P102, DOI 10.1007/s00775-005-0040-2; Ryde U, 2010, J AM CHEM SOC, V132, P4512, DOI 10.1021/ja909194f; Saggu M, 2010, PHYS CHEM CHEM PHYS, V12, P2139, DOI 10.1039/b922236g; Salomone-Stagni M, 2010, DALTON T, V39, P3057, DOI 10.1039/b922557a; Shepard EM, 2011, CURR OPIN CHEM BIOL, V15, P319, DOI 10.1016/j.cbpa.2011.02.012; Shepard EM, 2010, J AM CHEM SOC, V132, P9247, DOI 10.1021/ja1012273; Shepard EM, 2010, P NATL ACAD SCI USA, V107, P10448, DOI 10.1073/pnas.1001937107; Silakov A, 2009, BIOCHEMISTRY-US, V48, P7780, DOI 10.1021/bi9009105; Silakov A, 2009, PHYS CHEM CHEM PHYS, V11, P6592, DOI 10.1039/b905841a; Stiebritz MT, 2009, INORG CHEM, V48, P7127, DOI 10.1021/ic9002127; Stripp S, 2009, BIOCHEMISTRY-US, V48, P5042, DOI 10.1021/bi900010b; Stripp ST, 2009, DALTON T, P9960, DOI 10.1039/b916246a; Stripp ST, 2009, P NATL ACAD SCI USA, V106, P17331, DOI 10.1073/pnas.0905343106; Tye JW, 2008, INORG CHEM, V47, P2380, DOI 10.1021/ic7013732; van der Linden E, 2004, EUR J BIOCHEM, V271, P801, DOI 10.1111/j.1432-1033.2004.03984.x; VanderSpek TM, 1996, EUR J BIOCHEM, V237, P629; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Vincent KA, 2005, J AM CHEM SOC, V127, P18179, DOI 10.1021/ja055160v; Volbeda A, 2005, J BIOL INORG CHEM, V10, P239, DOI 10.1007/s00775-005-0632-x; von Abendroth G, 2008, INT J HYDROGEN ENERG, V33, P6076, DOI 10.1016/j.ijhydene.2008.07.122; Westre TE, 1997, J AM CHEM SOC, V119, P6297, DOI 10.1021/ja964352a; Winkler M, 2011, BIORESOURCE TECHNOL, V102, P8493, DOI 10.1016/j.biortech.2011.05.019; Xu XM, 2008, CHEMBIOCHEM, V9, P2355, DOI 10.1002/cbic.200800384; ZABINSKY SI, 1995, PHYS REV B, V52, P2995, DOI 10.1103/PhysRevB.52.2995	79	76	77	1	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40614	40623		10.1074/jbc.M111.283648	http://dx.doi.org/10.1074/jbc.M111.283648			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21930709	Green Published, hybrid			2022-12-25	WOS:000297315400022
J	Gorleku, OA; Barns, AM; Prescott, GR; Greaves, J; Chamberlain, LH				Gorleku, Oforiwa A.; Barns, Anna-Marie; Prescott, Gerald R.; Greaves, Jennifer; Chamberlain, Luke H.			Endoplasmic Reticulum Localization of DHHC Palmitoyltransferases Mediated by Lysine-based Sorting Signals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-RICH DOMAIN; PROTEIN PALMITOYLATION; SACCHAROMYCES-CEREVISIAE; MEMBRANE INTERACTIONS; STRING PROTEIN; TRANSFERASES; RAS; PATHWAY; SNAP25; YEAST	Intracellular palmitoylation dynamics are regulated by a family of 24 DHHC (aspartate-histidine-histidine-cysteine) palmitoyltransferases, which are localized in a compartment-specific manner. The majority of DHHC proteins localize to endoplasmic reticulum (ER) and Golgi membranes, and a small number target to post-Golgi membranes. To date, there are no reports of the fine mapping of sorting signals in mammalian DHHC proteins; thus, it is unclear how spatial distribution of the DHHC family is achieved. Here, we have identified and characterized lysine-based sorting signals that determine the restricted localization of DHHC4 and DHHC6 to ER membranes. The ER targeting signal in DHHC6 conforms to a KKXX motif, whereas the signal in DHHC4 is a distinct KXX motif. The identified dilysine signals are sufficient to specify ER localization as adding the C-terminal pentapeptide sequences from DHHC4 or DHHC6, which contain these KXX and KKXX motifs, to the C terminus of DHHC3, redistributes this palmitoyltransferase from Golgi to ER membranes. Recent work proposed that palmitoylation of newly synthesized peripheral membrane proteins occurs predominantly at the Golgi. Indeed, previous analyses of the peripheral membrane proteins, SNAP25 and cysteine string protein, are fully consistent with their initial palmitoylation being mediated by Golgi-localized DHHC proteins. Interestingly, ER-localized DHHC3 is able to palmitoylate SNAP25 and cysteine string protein to a similar level as wild-type Golgi-localized DHHC3 in co-expression studies. These results suggest that targeting of intrinsically active DHHC proteins to defined membrane compartments is an important factor contributing to spatially restricted patterns of substrate palmitoylation.	[Gorleku, Oforiwa A.; Barns, Anna-Marie; Greaves, Jennifer; Chamberlain, Luke H.] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow G4 0RE, Lanark, Scotland; [Prescott, Gerald R.] Univ St Andrews, Sch Biol, St Andrews KY16 9TF, Fife, Scotland	University of Strathclyde; University of St Andrews	Chamberlain, LH (corresponding author), Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, 161 Cathedral St, Glasgow G4 0RE, Lanark, Scotland.	Luke.Chamberlain@strath.ac.uk		Greaves, Jennifer/0000-0001-8445-789X	United Kingdom Medical Research Council; MRC [G0601597] Funding Source: UKRI; Medical Research Council [G0601597] Funding Source: researchfish	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a senior non-clinical fellowship award from the United Kingdom Medical Research Council (to L. H. C.).	Andersson H, 1999, J BIOL CHEM, V274, P15080, DOI 10.1074/jbc.274.21.15080; Bartels DJ, 1999, MOL CELL BIOL, V19, P6775, DOI 10.1128/mcb.19.10.6775; Fang C, 2006, J NEUROSCI, V26, P12758, DOI 10.1523/JNEUROSCI.4214-06.2006; Fernandez-Hernando C, 2006, J CELL BIOL, V174, P369, DOI 10.1083/jcb.200601051; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Fukata Y, 2010, NAT REV NEUROSCI, V11, P161, DOI 10.1038/nrn2788; Girotti M, 1996, J CELL SCI, V109, P2915; Gonzalo S, 1998, MOL BIOL CELL, V9, P585, DOI 10.1091/mbc.9.3.585; Goodwin JS, 2005, J CELL BIOL, V170, P261, DOI 10.1083/jcb.200502063; Greaves J, 2008, J BIOL CHEM, V283, P25014, DOI 10.1074/jbc.M802140200; Greaves J, 2007, J CELL BIOL, V176, P249, DOI 10.1083/jcb.200610151; Greaves J, 2006, MOL BIOL CELL, V17, P4748, DOI 10.1091/mbc.E06-03-0183; Greaves J, 2011, MOL BIOL CELL, V22, P1887, DOI 10.1091/mbc.E10-11-0924; Greaves J, 2011, J CELL SCI, V124, P1351, DOI 10.1242/jcs.079095; Greaves J, 2011, TRENDS BIOCHEM SCI, V36, P245, DOI 10.1016/j.tibs.2011.01.003; Greaves J, 2010, J BIOL CHEM, V285, P24629, DOI 10.1074/jbc.M110.119289; Greaves J, 2009, MOL BIOL CELL, V20, P1845, DOI 10.1091/mbc.E08-09-0944; Hannoush AN, 2010, NAT CHEM BIOL, V6, P498, DOI [10.1038/NCHEMBIO.388, 10.1038/nchembio.388]; Huang K, 2009, FASEB J, V23, P2605, DOI 10.1096/fj.08-127399; JACKSON MR, 1993, J CELL BIOL, V121, P317, DOI 10.1083/jcb.121.2.317; Kang RJ, 2008, NATURE, V456, P904, DOI 10.1038/nature07605; Lemale J, 2008, BBA-MOL CELL RES, V1783, P2234, DOI 10.1016/j.bbamcr.2008.07.023; Levy AD, 2011, MOL BIOL CELL, V22, P1930, DOI 10.1091/mbc.E10-10-0824; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Lobo S, 2002, J BIOL CHEM, V277, P41268, DOI 10.1074/JBC.M206573200; Melkonian KA, 1999, J BIOL CHEM, V274, P3910, DOI 10.1074/jbc.274.6.3910; Ohno Y, 2006, BBA-MOL CELL BIOL L, V1761, P474, DOI 10.1016/j.bbalip.2006.03.010; Palmer ZJ, 2008, BIOCHEM J, V413, P479, DOI 10.1042/BJ20080069; Patterson GH, 2008, CELL, V133, P1055, DOI 10.1016/j.cell.2008.04.044; Rickman C, 2007, J BIOL CHEM, V282, P12097, DOI 10.1074/jbc.M700227200; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Rocks O, 2010, CELL, V141, P458, DOI 10.1016/j.cell.2010.04.007; Roth AF, 2002, J CELL BIOL, V159, P23, DOI 10.1083/jcb.200206120; Roth AF, 2006, CELL, V125, P1003, DOI 10.1016/j.cell.2006.03.042; Salaun C, 2010, J CELL BIOL, V191, P1229, DOI 10.1083/jcb.201008160; Singaraja RR, 2011, HUM MOL GENET, V20, P3899, DOI 10.1093/hmg/ddr308; Swarthout JT, 2005, J BIOL CHEM, V280, P31141, DOI 10.1074/jbc.M504113200; Vetrivel KS, 2009, J BIOL CHEM, V284, P3793, DOI 10.1074/jbc.M808920200	38	50	53	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39573	39584		10.1074/jbc.M111.272369	http://dx.doi.org/10.1074/jbc.M111.272369			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21926431	Green Published, hybrid			2022-12-25	WOS:000296759800074
J	Morgan, JL; Song, YJ; Barbar, E				Morgan, Jessica L.; Song, Yujuan; Barbar, Elisar			Structural Dynamics and Multiregion Interactions in Dynein-Dynactin Recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-CHAIN BINDS; CYTOPLASMIC DYNEIN; INTERMEDIATE-CHAIN; SECONDARY STRUCTURE; GENETIC-ANALYSIS; PROTEIN; LC8; PREDICTION; COMPLEX; DROSOPHILA	Cytoplasmic dynein is a 1.2-MDa multisubunit motor protein complex that, together with its activator dynactin, is responsible for the majority of minus end microtubule-based motility. Dynactin targets dynein to specific cellular locations, links dynein to cargo, and increases dynein processivity. These two macromolecular complexes are connected by a direct interaction between dynactin's largest subunit, p150(Glued), and dynein intermediate chain (IC) subunit. Here, we demonstrate using NMR spectroscopy and isothermal titration calorimetry that the binding footprint of p150(Glued) on IC involves two noncontiguous recognition regions, and both are required for full binding affinity. In apo-IC, the helical structure of region 1, the nascent helix of region 2, and the disorder in the rest of the chain are determined from coupling constants, amide-amide sequential NOEs, secondary chemical shifts, and various dynamics measurements. When bound to p150(Glued), different patterns of spectral exchange broadening suggest that region 1 forms a coiled-coil and region 2 a packed stable helix, with the intervening residues remaining disordered. In the 150-kDa complex of p150(Glued), IC, and two light chains, the noninterface segments remain disordered. The multiregion IC binding interface, the partial disorder of region 2 and its potential for post-translational modification, and the modulation of the length of the longer linker by alternative splicing may provide a basis for elegant and multifaceted regulation of binding between IC and p150(Glued). The long disordered linker between the p150(Glued) binding segments and the dynein light chain consensus sequences could also provide an attractive recognition platform for diverse cargoes.	[Morgan, Jessica L.; Song, Yujuan; Barbar, Elisar] Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA	Oregon State University	Barbar, E (corresponding author), Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA.	barbare@science.oregonstate.edu		Barbar, Elisar/0000-0003-4892-5259; Morgan, Jessica/0000-0001-5532-9864	National Science Foundation [MCB 0818896]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant MCB 0818896.	Barbar E, 2001, BIOCHEMISTRY-US, V40, P1596, DOI 10.1021/bi002278+; Benison G, 2007, J MAGN RESON, V189, P173, DOI 10.1016/j.jmr.2007.09.009; Benison G, 2007, J MOL BIOL, V371, P457, DOI 10.1016/j.jmb.2007.05.046; Benison G, 2006, J MOL BIOL, V362, P1082, DOI 10.1016/j.jmb.2006.08.006; Boylan K, 2000, MOL BIOL CELL, V11, P3791, DOI 10.1091/mbc.11.11.3791; Boylan KLM, 2002, GENETICS, V162, P1211; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; COLLINS CA, 1989, CELL MOTIL CYTOSKEL, V14, P491, DOI 10.1002/cm.970140407; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; GILL SR, 1991, J CELL BIOL, V115, P1639, DOI 10.1083/jcb.115.6.1639; GRZESIEK S, 1992, J MAGN RESON, V96, P432, DOI 10.1016/0022-2364(92)90099-S; GRZESIEK S, 1993, J MAGN RESON SER B, V101, P114, DOI 10.1006/jmrb.1993.1019; Hall J, 2010, J BIOL CHEM, V285, P22566, DOI 10.1074/jbc.M110.103861; Hall J, 2009, J BIOL CHEM, V284, P33115, DOI 10.1074/jbc.M109.048587; HOLZBAUR ELF, 1991, NATURE, V351, P579, DOI 10.1038/351579a0; Hwang TL, 1998, J BIOMOL NMR, V11, P221, DOI 10.1023/A:1008276004875; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kardon JR, 2009, NAT REV MOL CELL BIO, V10, P854, DOI 10.1038/nrm2804; Kardon JR, 2009, P NATL ACAD SCI USA, V106, P5669, DOI 10.1073/pnas.0900976106; KARKI S, 1995, J BIOL CHEM, V270, P28806, DOI 10.1074/jbc.270.48.28806; KAY LE, 1990, J MAGN RESON, V89, P496, DOI 10.1016/0022-2364(90)90333-5; King SJ, 2000, NAT CELL BIOL, V2, P20, DOI 10.1038/71338; King SJ, 2003, MOL BIOL CELL, V14, P5089, DOI 10.1091/mbc.E03-01-0025; Kjaergaard M, 2011, J BIOMOL NMR, V49, P139, DOI 10.1007/s10858-011-9472-x; Kuipers BJH, 2007, J AGR FOOD CHEM, V55, P5445, DOI 10.1021/jf070337l; Lo KWH, 2001, J BIOL CHEM, V276, P14059, DOI 10.1074/jbc.M010320200; Makokha M, 2004, PROTEIN SCI, V13, P727, DOI 10.1110/ps.03462204; Makokha M, 2002, BIOCHEMISTRY-US, V41, P4302, DOI 10.1021/bi011970h; Markley JL, 1998, PURE APPL CHEM, V70, P117, DOI 10.1351/pac199870010117; McDonnell AV, 2006, BIOINFORMATICS, V22, P356, DOI 10.1093/bioinformatics/bti797; Mok YK, 2001, J BIOL CHEM, V276, P14067, DOI 10.1074/jbc.M011358200; Nurminsky DI, 1998, MOL CELL BIOL, V18, P6816, DOI 10.1128/MCB.18.11.6816; Nyarko A, 2004, BIOCHEMISTRY-US, V43, P15595, DOI 10.1021/bi048451+; Nyarko A, 2011, J BIOL CHEM, V286, P1556, DOI 10.1074/jbc.M110.171686; Panchal SC, 2001, J BIOMOL NMR, V20, P135, DOI 10.1023/A:1011239023422; Pfister KK, 2006, PLOS GENET, V2, P11, DOI 10.1371/journal.pgen.0020001; Quintyne NJ, 1999, J CELL BIOL, V147, P321, DOI 10.1083/jcb.147.2.321; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; Susalka SJ, 2002, J BIOL CHEM, V277, P32939, DOI 10.1074/jbc.M205510200; Uversky VN, 2011, CHEM SOC REV, V40, P1623, DOI 10.1039/c0cs00057d; Vallee RB, 2004, J NEUROBIOL, V58, P189, DOI 10.1002/neu.10314; VAUGHAN KT, 1995, J CELL BIOL, V131, P1507, DOI 10.1083/jcb.131.6.1507; Vaughan PS, 2002, J CELL BIOL, V158, P305, DOI 10.1083/jcb.200201029; Vaughan PS, 2001, J BIOL CHEM, V276, P26171, DOI 10.1074/jbc.M102649200; VUISTER GW, 1993, J AM CHEM SOC, V115, P7772, DOI 10.1021/ja00070a024; Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195; Williams JC, 2007, P NATL ACAD SCI USA, V104, P10028, DOI 10.1073/pnas.0703614104; WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q; Zhou TH, 2006, P NATL ACAD SCI USA, V103, P9039, DOI 10.1073/pnas.0602916103	51	26	26	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39349	39359		10.1074/jbc.M111.296277	http://dx.doi.org/10.1074/jbc.M111.296277			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21931160	hybrid, Green Published			2022-12-25	WOS:000296759800053
J	Pawlak, KJ; Prasad, M; Thomas, JL; Whittal, RM; Bose, HS				Pawlak, Kevin J.; Prasad, Manoj; Thomas, James L.; Whittal, Randy M.; Bose, Himangshu S.			Inner Mitochondrial Translocase Tim50 Interacts with 3 beta-Hydroxysteroid Dehydrogenase Type 2 to Regulate Adrenal and Gonadal Steroidogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERMEMBRANE-SPACE DOMAIN; CHAIN CLEAVAGE SYSTEM; PROTEIN IMPORT; PREPROTEIN TRANSLOCASE; GEL-ELECTROPHORESIS; MOLECULAR-BIOLOGY; TIM23 COMPLEX; MEMBRANES; COMPONENT; TOM22	In the adrenals, testes, and ovaries, 3 beta-hydroxysteroid dehydrogenase type 2 (3 beta HSD2) catalyzes the conversion of pregnenolone to progesterone and dehydroepiandrostenedione to androstenedione. Alterations in this pathway can have deleterious effects, including sexual development impairment, spontaneous abortion, and breast cancer. 3 beta HSD2, synthesized in the cytosol, is imported into the inner mitochondrial membrane (IMM) by translocases. Steroidogenesis requires that 3 beta HSD2 acts as both a dehydrogenase and isomerase. To achieve this dual functionality, 3 beta HSD2 must undergo a conformational change; however, what triggers that change remains unknown. We propose that 3 beta HSD2 associates with IMM or outer mitochondrial membrane translocases facing the intermembrane space (IMS) and that this interaction promotes the conformational change needed for full activity. Fractionation assays demonstrate that 3 beta HSD2 associated with the IMM but did not integrate into the membrane. Through mass spectrometry and Western blotting of mitochondrial complexes and density gradient ultracentrifugation, we show that that 3 beta HSD2 formed a transient association with the translocases Tim50 and Tom22 and with Tim23. This association occurred primarily through the interaction of Tim50 with the N terminus of 3 beta HSD2 and contributed to enzymatic activity. Tim50 knockdown inhibited catalysis of dehydroepiandrostenedione to androstenedione and pregnenolone to progesterone. Although Tim50 knock-down decreased 3 beta HSD2 expression, restoration of expression via proteasome and protease inhibition did not rescue activity. In addition, protein fingerprinting and CD spectroscopy reveal the flexibility of 3 beta HSD2, a necessary characteristic for forming multiple associations. In summary, Tim50 regulates 3 beta HSD2 expression and activity, representing a new role for translocases in steroidogenesis.	[Bose, Himangshu S.] Mercer Univ Sch Med, Dept Biochem, Div Biomed Sci, Savannah, GA 31404 USA; [Bose, Himangshu S.] Mem Univ Med Ctr, Savannah, GA 31404 USA; [Thomas, James L.] Mercer Univ Sch Med, Dept Biochem, Div Basic Med Sci, Macon, GA 31207 USA; [Whittal, Randy M.] Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada	Mercer University; Mercer University; University of Alberta	Bose, HS (corresponding author), Mercer Univ Sch Med, Dept Biochem, Div Biomed Sci, Hoskins Res Bldg,4700 Waters Ave, Savannah, GA 31404 USA.	bose_hs@mercer.edu	Prasad, Manoj/I-9623-2014; Pawlak, Kevin/HDO-6979-2022	Whittal, Randy/0000-0003-1174-8172	National Institutes of Health [HD057876]; Anderson Cancer Institute; Mercer University School of Medicine; Canada Foundation for Innovation; Alberta Science and Research Investment Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057876] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Anderson Cancer Institute; Mercer University School of Medicine; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Alberta Science and Research Investment Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grant HD057876 (to H. S. B.).; Supported by the Anderson Cancer Institute and the Mercer University School of Medicine. To whom correspondence should be addressed: Dept. of Biochemistry, Division of Biomedical Sciences, Mercer University School of Medicine and Memorial University Medical Center, Hoskins Research Bldg., 4700 Waters Ave., Savannah, GA 31404. Tel.: 912-350-1710; Fax: 912-350-1765; E-mail: bose_hs@mercer.edu and bosehi1@memorialhealth.com.; We are thankful to Drs. Toshio Endo for Tim50 and Walter Miller for the P450c17 antibody. Funding for equipment in the Mass Spectrometry Facility at the University of Alberta was supported by the Canada Foundation for Innovation and Alberta Science and Research Investment Program.	Bellot G, 2007, CELL DEATH DIFFER, V14, P785, DOI 10.1038/sj.cdd.4402055; BERTHOLD J, 1995, CELL, V81, P1085, DOI 10.1016/S0092-8674(05)80013-3; BLACK SM, 1993, ENDOCRINOLOGY, V132, P539, DOI 10.1210/en.132.2.539; Bolender N, 2008, EMBO REP, V9, P42, DOI 10.1038/sj.embor.7401126; Bose HS, 1998, BIOCHEMISTRY-US, V37, P9768, DOI 10.1021/bi980588a; Bose HS, 1996, NEW ENGL J MED, V335, P1870, DOI 10.1056/NEJM199612193352503; Bose M, 2008, ELECTROPHORESIS, V29, P753, DOI 10.1002/elps.200700782; Bose M, 2007, J MOL ENDOCRINOL, V39, P67, DOI 10.1677/JME-07-0051; Briere N, 1997, J HISTOCHEM CYTOCHEM, V45, P1409; Chacinska A, 2005, CELL, V120, P817, DOI 10.1016/j.cell.2005.01.011; Court DA, 1996, MOL CELL BIOL, V16, P4035; de la Cruz L, 2010, PROTEIN SCI, V19, P2045, DOI 10.1002/pro.482; Dekker PJT, 1997, EMBO J, V16, P5408, DOI 10.1093/emboj/16.17.5408; Endo T, 2003, J CELL SCI, V116, P3259, DOI 10.1242/jcs.00667; Gevorkyan-Airapetov L, 2009, J BIOL CHEM, V284, P4865, DOI 10.1074/jbc.M807041200; Guo Y, 2004, J BIOL CHEM, V279, P24813, DOI 10.1074/jbc.M402049200; HARIKRISHNA JA, 1993, DNA CELL BIOL, V12, P371, DOI 10.1089/dna.1993.12.371; Herrmann JM, 2000, CURR OPIN MICROBIOL, V3, P210, DOI 10.1016/S1369-5274(00)00077-1; HORST M, 1995, EMBO J, V14, P2293, DOI 10.1002/j.1460-2075.1995.tb07223.x; JOHNSON WC, 1988, ANNU REV BIOPHYS BIO, V17, P145, DOI 10.1146/annurev.bb.17.060188.001045; Koehler CM, 2004, ANNU REV CELL DEV BI, V20, P309, DOI 10.1146/annurev.cellbio.20.010403.105057; Komarov AG, 2005, BIOPHYS J, V89, P3950, DOI 10.1529/biophysj.105.070037; Kutik S, 2007, J CELL BIOL, V179, P585, DOI 10.1083/jcb.200708199; Labrie F, 2001, FRONT NEUROENDOCRIN, V22, P185, DOI 10.1006/frne.2001.0216; Meinecke M, 2006, SCIENCE, V312, P1523, DOI 10.1126/science.1127628; Miller WL, 2011, ENDOCR REV, V32, P81, DOI 10.1210/er.2010-0013; Moczko M, 1997, MOL CELL BIOL, V17, P6574, DOI 10.1128/MCB.17.11.6574; Mokranjac D, 2003, EMBO J, V22, P816, DOI 10.1093/emboj/cdg090; Nair KS, 2006, NEW ENGL J MED, V355, P1647, DOI 10.1056/NEJMoa054629; NAKAJIN S, 1981, J BIOL CHEM, V256, P3871; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Pfanner N, 2000, CURR BIOL, V10, pR412, DOI 10.1016/S0960-9822(00)00507-8; PFANNER N, 1992, CELL, V68, P999, DOI 10.1016/0092-8674(92)90069-O; Praporski S, 2009, J BIOL CHEM, V284, P33224, DOI 10.1074/jbc.M109.006064; Rehling P, 2004, NAT REV MOL CELL BIO, V5, P519, DOI 10.1038/nrm1426; ROSENFELD J, 1992, ANAL BIOCHEM, V203, P173, DOI 10.1016/0003-2697(92)90061-B; Schatz G, 1996, SCIENCE, V271, P1519, DOI 10.1126/science.271.5255.1519; Schnell DJ, 2003, CELL, V112, P491, DOI 10.1016/S0092-8674(03)00110-7; Schwartz MP, 1999, P NATL ACAD SCI USA, V96, P13086, DOI 10.1073/pnas.96.23.13086; Simard J, 2005, ENDOCR REV, V26, P525, DOI 10.1210/er.2002-0050; Sugiyama S, 2007, GENETICS, V176, P927, DOI 10.1534/genetics.107.072074; Tamura Y, 2009, J CELL BIOL, V184, P129, DOI 10.1083/jcb.200808068; Thomas JL, 2010, J STEROID BIOCHEM, V120, P192, DOI 10.1016/j.jsbmb.2010.04.015; Thomas JL, 2009, MOL CELL ENDOCRINOL, V301, P174, DOI 10.1016/j.mce.2008.09.029; Thomas JL, 2003, J BIOL CHEM, V278, P35483, DOI 10.1074/jbc.M304752200; THOMAS JL, 1989, J STEROID BIOCHEM, V33, P209, DOI 10.1016/0022-4731(89)90296-3; TINKER DA, 1988, J BIOL CHEM, V263, P5024; van Wilpe S, 1999, NATURE, V401, P485, DOI 10.1038/46802; Welzel M, 2008, J CLIN ENDOCR METAB, V93, P1418, DOI 10.1210/jc.2007-1874; Woody RW, 1996, CIRCULAR DICHROISM C, P109; Yamamoto H, 2002, CELL, V111, P519, DOI 10.1016/S0092-8674(02)01053-X	52	30	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39130	39140		10.1074/jbc.M111.290031	http://dx.doi.org/10.1074/jbc.M111.290031			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21930695	Green Published, hybrid			2022-12-25	WOS:000296759800032
J	Hashizume, R; Maki, Y; Mizutani, K; Takahashi, N; Matsubara, H; Sugita, A; Sato, K; Yamaguchi, S; Mikami, B				Hashizume, Ryota; Maki, Yukiko; Mizutani, Kimihiko; Takahashi, Nobuyuki; Matsubara, Hiroyuki; Sugita, Akiko; Sato, Kimihiko; Yamaguchi, Shotaro; Mikami, Bunzo			Crystal Structures of Protein Glutaminase and Its Pro Forms Converted into Enzyme-Substrate Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHRYSEOBACTERIUM-PROTEOLYTICUM; FUNCTIONAL-PROPERTIES; SECONDARY-STRUCTURE; FOOD PROTEINS; DEAMIDATION; PROGRAM; TRANSGLUTAMINASE; MOLSCRIPT	Protein glutaminase, which converts a protein glutamine residue to a glutamate residue, is expected to be useful as a new food-processing enzyme. The crystal structures of the mature and pro forms of the enzyme were refined at 1.15 and 1.73 angstrom resolution, respectively. The overall structure of the mature enzyme has a weak homology to the core domain of human transglutaminase-2. The catalytic triad (Cys-His-Asp) common to transglutaminases and cysteine proteases is located in the bottom of the active site pocket. The structure of the recombinant pro form shows that a short loop between S2 and S3 in the proregion covers and interacts with the active site of the mature region, mimicking the protein substrate of the enzyme. Ala-47 is located just above the pocket of the active site. Two mutant structures (A47Q-1 and A47Q-2) refined at 1.5 angstrom resolution were found to correspond to the enzyme-substrate complex and an S-acyl intermediate. Based on these structures, the catalytic mechanism of protein glutaminase is proposed.	[Hashizume, Ryota; Maki, Yukiko; Mizutani, Kimihiko; Takahashi, Nobuyuki; Mikami, Bunzo] Kyoto Univ, Lab Appl Struct Biol, Div Appl Life Sci, Grad Sch Agr, Kyoto 6110011, Japan; [Matsubara, Hiroyuki; Sugita, Akiko; Sato, Kimihiko; Yamaguchi, Shotaro] Amano Enzyme Inc, Gifu R&D Ctr, Gifu 5090108, Japan	Kyoto University	Mikami, B (corresponding author), Kyoto Univ, Lab Appl Struct Biol, Div Appl Life Sci, Grad Sch Agr, Kyoto 6110011, Japan.	mikami@kais.kyoto-u.ac.jp			Ministry of Education, Science, Sports, and Culture of Japan	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant-in-aid for scientific research from the Ministry of Education, Science, Sports, and Culture of Japan.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; BURGI HB, 1973, J AM CHEM SOC, V95, P5065, DOI 10.1021/ja00796a058; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esnouf RM, 1999, ACTA CRYSTALLOGR D, V55, P938, DOI 10.1107/S0907444998017363; GILL BP, 1985, IRISH J FOOD SCI TEC, V9, P33; Gu YS, 2001, J AGR FOOD CHEM, V49, P5999, DOI 10.1021/jf010287z; HAMADA JS, 1994, CRIT REV FOOD SCI, V34, P283, DOI 10.1080/10408399409527664; HAMADA JS, 1988, J FOOD SCI, V53, P671, DOI 10.1111/j.1365-2621.1988.tb07788.x; HAMADA JS, 1992, J AGR FOOD CHEM, V40, P719, DOI 10.1021/jf00017a003; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KAMPHUIS IG, 1985, J MOL BIOL, V182, P317, DOI 10.1016/0022-2836(85)90348-1; KAMPHUIS IG, 1984, J MOL BIOL, V179, P233, DOI 10.1016/0022-2836(84)90467-4; Katona G, 2002, J BIOL CHEM, V277, P21962, DOI 10.1074/jbc.M200676200; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kumeta H, 2010, J BIOMOL NMR, V46, P251, DOI 10.1007/s10858-010-9399-7; LARRE C, 1994, J FOOD BIOCHEM, V17, P267; MADEJ T, 1995, PROTEINS, V23, P356, DOI 10.1002/prot.340230309; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Noguchi K, 2001, J BIOL CHEM, V276, P12055, DOI 10.1074/jbc.M009862200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PEDERSEN LC, 1994, PROTEIN SCI, V3, P1131, DOI 10.1002/pro.5560030720; Pinkas DM, 2007, PLOS BIOL, V5, P2788, DOI 10.1371/journal.pbio.0050327; Riha WE, 1996, CRIT REV FOOD SCI, V36, P225, DOI 10.1080/10408399609527724; Scheuplein RJ, 2007, REGUL TOXICOL PHARM, V49, P79, DOI 10.1016/j.yrtph.2007.06.001; Schwenke K.D., 2017, FOOD PROTEINS THEIR, P393; SHELDRICK G, 1984, ACTA CRYSTALLOGR A, V40, pC440, DOI 10.1107/S010876738408702X; Sheldrick GM, 1997, METHOD ENZYMOL, V277, P319, DOI 10.1016/S0076-6879(97)77018-6; Sheldrick GM, 2002, Z KRISTALLOGR, V217, P644, DOI 10.1524/zkri.217.12.644.20662; Tanabe S, 1996, BIOCHEM BIOPH RES CO, V219, P290, DOI 10.1006/bbrc.1996.0225; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; Thornton J. M., 1993, J APPL CRYSTALLOGR, V26, P283; Uson I, 1999, CURR OPIN STRUC BIOL, V9, P643, DOI 10.1016/S0959-440X(99)00020-2; Yamaguchi S, 2001, EUR J BIOCHEM, V268, P1410, DOI 10.1046/j.1432-1327.2001.02019.x; Yamaguchi S, 2000, APPL ENVIRON MICROB, V66, P3337, DOI 10.1128/AEM.66.8.3337-3343.2000; YEE VC, 1994, P NATL ACAD SCI USA, V91, P7296, DOI 10.1073/pnas.91.15.7296; Yong YH, 2004, J AGR FOOD CHEM, V52, P7094, DOI 10.1021/jf040133u; Yong YH, 2006, J AGR FOOD CHEM, V54, P6034, DOI 10.1021/jf060344u; Zayas J.F.., 1997, FUNCTIONALITY PROTEI, DOI [10.1007/978-3-642-59116-7_2, DOI 10.1007/978-3-642-59116-7_2]	43	19	20	9	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38691	38702		10.1074/jbc.M111.255133	http://dx.doi.org/10.1074/jbc.M111.255133			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21926168	hybrid, Green Published			2022-12-25	WOS:000296594200081
J	Montalbetti, N; Denis, MFL; Pignataro, OP; Kobatake, E; Lazarowski, ER; Schwarzbaum, PJ				Montalbetti, Nicolas; Denis, Maria F. Leal; Pignataro, Omar P.; Kobatake, Eiry; Lazarowski, Eduardo R.; Schwarzbaum, Pablo J.			Homeostasis of Extracellular ATP in Human Erythrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEYDIG-CELL STEROIDOGENESIS; SIGNAL-TRANSDUCTION PATHWAY; RED-BLOOD-CELLS; PROTEIN A-LUCIFERASE; GOLDFISH HEPATOCYTES; RECEPTOR SUBTYPES; ADENINE-NUCLEOTIDES; ENDOTHELIAL-CELLS; P2X(7) RECEPTOR; VOLUME CHANGES	We explored the intra- and extracellular processes governing the kinetics of extracellular ATP (ATPe) in human erythrocytes stimulated with agents that increase cAMP. Using the luciferin-luciferase reaction in off-line luminometry we found both direct adenylyl cyclase activation by forskolin and indirect activation through beta-adrenergic stimulation with isoproterenol-enhanced [ATP]e in a concentration-dependent manner. A mixture (3V) containing a combination of these agents and the phosphodiesterase inhibitor papaverine activated ATP release, leading to a 3-fold increase in [ATP]e, and caused increases in cAMP concentration (3-fold for forskolin + papaverine, and 10-fold for 3V). The pannexin 1 inhibitor carbenoxolone and a pannexin 1 blocking peptide ((10)Panx1) decreased [ATP]e by 75-84%. The residual efflux of ATP resulted from unavoidable mechanical perturbations stimulating a novel, carbenoxolone-insensitive pathway. In real-time luminometry experiments using soluble luciferase, addition of 3V led to an acute increase in [ATP]e to a constant value of similar to 1 pmol x (10(6) cells)(-1). A similar treatment using a surface attached luciferase (proA-luc) triggered a rapid accumulation of surface ATP levels to a peak concentration of 2.4 pmol x (10(6) cells)(-1), followed by a slower exponential decay (t(1/2) = 3.7 min) to a constant value of 1.3 pmol x (10(6) cells)(-1). Both for soluble luciferase and proA-luc, ATP efflux was fully blocked by carbenoxolone, pointing to a 3V-induced mechanism of ATP release mediated by pannexin 1. Ecto-ATPase activity was extremely low (similar to 28 fmol x (10(6) cells min)(-1)), but nevertheless physiologically relevant considering the high density of erythrocytes in human blood.	[Schwarzbaum, Pablo J.] Univ Buenos Aires, Fac Farm & Bioquim, Sch Pharm & Biochem, Dept Biol Chem,IQUIFIB, Buenos Aires, DF, Argentina; [Pignataro, Omar P.] Univ Buenos Aires, Sch Sci, Dept Biol Chem, Buenos Aires, DF, Argentina; [Pignataro, Omar P.] Inst Biol & Expt Med CONICET, Lab Mol Endocrinol & Signal Transduct, RA-1428 Buenos Aires, DF, Argentina; [Kobatake, Eiry] Tokyo Inst Technol, Dept Biol Informat, Grad Sch Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Lazarowski, Eduardo R.] Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC 27599 USA	University of Buenos Aires; University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Tokyo Institute of Technology; University of North Carolina; University of North Carolina Chapel Hill	Schwarzbaum, PJ (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, Sch Pharm & Biochem, Dept Biol Chem,IQUIFIB, Junin 956,C1113AAD, Buenos Aires, DF, Argentina.	pjs@qb.ffyb.uba.ar	Montalbetti, Nicolas/T-4212-2019	Montalbetti, Nicolas/0000-0003-2897-9540; schwarzbaum, pablo/0000-0002-5176-089X; Leal Denis, Florencia/0000-0002-6209-4378	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP 1187]; Secretaria de Ciencia y Tecnica; Universidad de Buenos Aires [20020100100090]; Agencia Nacional de Promocion Cientifica y Tecnologica of Argentina [0151]	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Secretaria de Ciencia y Tecnica(Secretaria de Ciencia y Tecnologia (SECYT)); Universidad de Buenos Aires(University of Buenos Aires); Agencia Nacional de Promocion Cientifica y Tecnologica of Argentina(ANPCyT)	This work was supported in part by Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) Grant PIP 1187, Secretaria de Ciencia y Tecnica, Universidad de Buenos Aires Grant 20020100100090, and Agencia Nacional de Promocion Cientifica y Tecnologica Grant 0151 of Argentina.	Bao L, 2004, FEBS LETT, V572, P65, DOI 10.1016/j.febslet.2004.07.009; Beigi R, 1999, AM J PHYSIOL-CELL PH, V276, pC267, DOI 10.1152/ajpcell.1999.276.1.C267; Bencic DC, 1997, PHYSIOL ZOOL, V70, P621, DOI 10.1086/515873; Brown A. M, 1980, RED CELL MEMBRANES M, P223; Burnstock G, 2008, PHARMACOL REP, V60, P12; Chara O, 2009, B MATH BIOL, V71, P1025, DOI 10.1007/s11538-008-9392-4; COADE SB, 1989, CIRC RES, V65, P531, DOI 10.1161/01.RES.65.3.531; DelPunta K, 1996, ENDOCRINOLOGY, V137, P5337, DOI 10.1210/en.137.12.5337; Ebihara T, 2002, BIOTECHNOL LETT, V24, P147, DOI 10.1023/A:1013858814175; Ellsworth ML, 2009, PHYSIOLOGY, V24, P107, DOI 10.1152/physiol.00038.2008; Erlinge D, 2008, PURINERG SIGNAL, V4, P1, DOI 10.1007/s11302-007-9078-7; EYLAR EH, 1962, J BIOL CHEM, V237, P1992; Gheorghiu M, 2004, EUR BIOPHYS J BIOPHY, V33, P412, DOI 10.1007/s00249-003-0375-y; Gorman MW, 2007, CLIN CHEM, V53, P318, DOI 10.1373/clinchem.2006.076364; Gorman MW, 2003, LUMINESCENCE, V18, P173, DOI 10.1002/bio.721; Hamann S, 2002, J FLUORESC, V12, P139, DOI 10.1023/A:1016832027325; Hanson MS, 2009, MICROCIRCULATION, V16, P424, DOI 10.1080/10739680902855218; Hategan A, 2004, BIOPHYS J, V87, P3547, DOI 10.1529/biophysj.104.041475; Jensen FB, 2009, J EXP BIOL, V212, P3387, DOI 10.1242/jeb.023697; Joseph SM, 2003, J BIOL CHEM, V278, P23331, DOI 10.1074/jbc.M302680200; Koziak K, 1999, THROMB HAEMOSTASIS, V82, P1538; Kunapuli SP, 1998, BIOCHEM J, V336, P513, DOI 10.1042/bj3360513; KWANT W O, 1970, Journal of General Physiology, V55, P208, DOI 10.1085/jgp.55.2.208; Lazarowski ER, 2003, MOL PHARMACOL, V64, P785, DOI 10.1124/mol.64.4.785; Lecklin T, 2000, J EXP BIOL, V203, P3025; Locovei S, 2006, FEBS LETT, V580, P239, DOI 10.1016/j.febslet.2005.12.004; Locovei S, 2007, FEBS LETT, V581, P483, DOI 10.1016/j.febslet.2006.12.056; Locovei S, 2006, P NATL ACAD SCI USA, V103, P7655, DOI 10.1073/pnas.0601037103; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUTHJE J, 1988, EUR J BIOCHEM, V173, P241, DOI 10.1111/j.1432-1033.1988.tb13990.x; Misiti F, 2008, BIOCHEM CELL BIOL, V86, P501, DOI 10.1139/O08-139; Mondillo C, 2005, BIOL REPROD, V73, P899, DOI 10.1095/biolreprod.105.041285; Mondillo C, 2009, BIOL REPROD, V80, P144, DOI 10.1095/biolreprod.108.069484; Olearczyk J J, 2001, Med Sci Monit, V7, P669; Olearczyk JJ, 2004, AM J PHYSIOL-HEART C, V287, pH748, DOI 10.1152/ajpheart.00161.2004; Olearczyk JJ, 2004, J PHARMACOL EXP THER, V309, P1079, DOI 10.1124/jpet.103.064709; Olearczyk JJ, 2004, AM J PHYSIOL-HEART C, V286, pH940, DOI 10.1152/ajpheart.00677.2003; Pafundo DE, 2008, AM J PHYSIOL-REG I, V294, pR220, DOI 10.1152/ajpregu.00522.2007; Pafundo DE, 2010, J BIOL CHEM, V285, P6134, DOI 10.1074/jbc.M109.078246; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Pirotton S, 1996, J AUTON PHARMACOL, V16, P353, DOI 10.1111/j.1474-8673.1996.tb00052.x; Qiu F, 2009, AM J PHYSIOL-CELL PH, V296, pC250, DOI 10.1152/ajpcell.00433.2008; REMALEY AT, 1991, J BIOL CHEM, V266, P24176; Robson Simon C, 2006, Purinergic Signal, V2, P409, DOI 10.1007/s11302-006-9003-5; Schwarzbaum PJ, 1998, AM J PHYSIOL-REG I, V274, pR1031, DOI 10.1152/ajpregu.1998.274.4.R1031; SCHWARZBAUM PJ, 1995, BBA-BIOMEMBRANES, V1233, P33, DOI 10.1016/0005-2736(94)00229-I; Schwiebert EM, 2003, BBA-BIOMEMBRANES, V1615, P7, DOI 10.1016/S0005-2736(03)00210-4; Sevigny J, 1997, BBA-GEN SUBJECTS, V1334, P73, DOI 10.1016/S0304-4165(96)00079-7; SMITH RM, 1991, PURE APPL CHEM, V63, P1015, DOI 10.1351/pac199163071015; Sprague RS, 2008, MICROCIRCULATION, V15, P461, DOI 10.1080/10739680701833804; Sprague RS, 2007, TRENDS ENDOCRIN MET, V18, P350, DOI 10.1016/j.tem.2007.08.008; Sprague RS, 2001, AM J PHYSIOL-CELL PH, V281, pC1158, DOI 10.1152/ajpcell.2001.281.4.C1158; Sprague RS, 1998, AM J PHYSIOL-HEART C, V275, pH1726, DOI 10.1152/ajpheart.1998.275.5.H1726; Sridharan M, 2010, AM J PHYSIOL-HEART C, V299, pH1146, DOI 10.1152/ajpheart.00301.2010; STEINER AL, 1969, P NATL ACAD SCI USA, V64, P367, DOI 10.1073/pnas.64.1.367; Strehler B L, 1968, Methods Biochem Anal, V16, P99, DOI 10.1002/9780470110348.ch2; VAZQUEZ A, 1991, J BIOCHEM BIOPH METH, V23, P45, DOI 10.1016/0165-022X(91)90049-3; Wang JJ, 2007, AM J PHYSIOL-CELL PH, V293, pC1112, DOI 10.1152/ajpcell.00097.2007; Wang LW, 2005, CIRC RES, V96, P189, DOI 10.1161/01.RES.0000153670.07559.E4; Zhang XM, 2000, ANAL BIOCHEM, V282, P65, DOI 10.1006/abio.2000.4584	60	54	58	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38397	38407		10.1074/jbc.M111.221713	http://dx.doi.org/10.1074/jbc.M111.221713			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21921036	Green Published, hybrid			2022-12-25	WOS:000296594200054
J	Benned-Jensen, T; Mokrosinski, J; Rosenkilde, MM				Benned-Jensen, Tau; Mokrosinski, Jacek; Rosenkilde, Mette M.			The E92K Melanocortin 1 Receptor Mutant Induces cAMP Production and Arrestin Recruitment but Not ERK Activity Indicating Biased Constitutive Signaling	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; CRYSTAL-STRUCTURE; EXTRACELLULAR LOOP; INVERSE AGONISM; AGOUTI PROTEIN; FEATHER COLOR; COAT COLOR; MC1R GENE; MUTATIONS; ACTIVATION	Background: The melanocortin 1 receptor (MC1R) constitutes a key regulator of melanism. Consequently, many naturally-occurring MC1R mutations are associated with a change in color. An example is the Glu-to-Lys substitution found at position II: 20/2.60 in the top of transmembrane helix II which has been identified in melanic mice and several other species. This mutation induces a pronounced increase in MC1R constitutive activity suggesting a link between constitutive activity and melanism which is corroborated by the attenuation of alpha-melanocyte stimulating hormone (alpha MSH) induced activation. However, the mechanism by which the mutation induces constitutive activity is currently not known. Methodology/Principal Findings: Here we characterize the constitutive activity, cell surface expression and internalization of the mouse mutant, Mc1r E92K. As previously reported, only positively charged residues at position II: 20/2.60 induced an increase in constitutive activity as measured by cAMP accumulation and CREB activation. Furthermore, the mutation induced a constitutive recruitment of beta-arrestin. This phenomenon is only observed in MC1R, however, as the equivalent mutations in MC2-5R had no effect on receptor signaling. Interestingly, the mutation did not induce constitutive ERK1/2 phosphorylation or increase the internalization rate indicating the constitutive activity to be biased. Finally, to identify regions of importance for the increased constitutive activity of Mc1r E92K, we employed a chimeric approach and identified G102 and L110 in the extracellular loop 1 to be selectively important for the constitutive activity as this, but not alpha MSH-mediated activation, was abolished upon Ala substitution. Conclusions/Significance: It is concluded that the E92K mutation induces an active conformation distinct from that induced by alpha MSH and that the extracellular loop 1 is involved in maintaining this conformational state. In turn, the results suggest that in MC1R, which lacks an extracellular loop 2, the first extracellular loop may play a more prominent role during receptor activation than in general.	[Benned-Jensen, Tau; Mokrosinski, Jacek; Rosenkilde, Mette M.] Univ Copenhagen, Mol Pharmacol Lab, Dept Neurosci & Pharmacol, Fac Hlth Sci, Copenhagen, Denmark	University of Copenhagen	Benned-Jensen, T (corresponding author), Univ Copenhagen, Mol Pharmacol Lab, Dept Neurosci & Pharmacol, Fac Hlth Sci, Copenhagen, Denmark.	rosenkilde@sund.ku.dk	Mokrosinski, Jacek/M-1963-2019; Mokrosinski, Jacek/J-9506-2012	Mokrosinski, Jacek/0000-0001-5008-0457; Mokrosinski, Jacek/0000-0003-1710-1679; Rosenkilde, Mette Marie/0000-0001-9600-3254	Danish Medical Research Council; European Community [LSHB-CT-2005-518167]; NovoNordisk Foundation; Lundbeck Foundation; AP-Moller Foundation; Aase and Einer Danielsen Foundation	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Community(European Commission); NovoNordisk Foundation(Novo Nordisk Foundation); Lundbeck Foundation(Lundbeckfonden); AP-Moller Foundation; Aase and Einer Danielsen Foundation	The study was supported by the Danish Medical Research Council, the European Community's Sixth Framework Program (INNOCHEM: LSHB-CT-2005-518167), the NovoNordisk Foundation, the Lundbeck Foundation, AP-Moller Foundation and the Aase and Einer Danielsen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastiaens MT, 2001, AM J HUM GENET, V68, P884, DOI 10.1086/319500; Benned-Jensen T, 2010, BRIT J PHARMACOL, V159, P1092, DOI 10.1111/j.1476-5381.2009.00633.x; Benned-Jensen T, 2008, MOL PHARMACOL, V74, P1008, DOI 10.1124/mol.108.049676; Biebermann H, 2011, THYROID RES, V4, DOI 10.1186/1756-6614-4-S1-S8; Buch TRH, 2009, J BIOL CHEM, V284, P26411, DOI 10.1074/jbc.M109.039339; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Duffy DL, 2004, HUM MOL GENET, V13, P447, DOI 10.1093/hmg/ddh043; Eberle AN, 2001, J RECEPT SIGNAL TR R, V21, P25, DOI 10.1081/RRS-100107140; Eizirik E, 2003, CURR BIOL, V13, P448, DOI 10.1016/S0960-9822(03)00128-3; Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; Fillion D, 2010, J MED CHEM, V53, P2063, DOI 10.1021/jm9015747; Fontanesi L, 2006, ANIM GENET, V37, P489, DOI 10.1111/j.1365-2052.2006.01494.x; Garcia-Borron JC, 2005, PIGM CELL RES, V18, P393, DOI 10.1111/j.1600-0749.2005.00278.x; Harterich S, 2008, BIOORGAN MED CHEM, V16, P9359, DOI 10.1016/j.bmc.2008.08.051; Haitina T, 2007, MOL BIOL EVOL, V24, P2001, DOI 10.1093/molbev/msm134; Hauser M, 2007, J BIOL CHEM, V282, P10387, DOI 10.1074/jbc.M608903200; Herraiz C, 2011, MOL ENDOCRINOL, V25, P138, DOI 10.1210/me.2010-0217; Holst B, 2003, ANN NY ACAD SCI, V994, P1, DOI 10.1111/j.1749-6632.2003.tb03156.x; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jaeschke H, 2006, ENDOCRINOLOGY, V147, P1753, DOI 10.1210/en.2005-1138; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; KERJE S, 2003, ANIM GENET, V34; Kijas JMH, 1998, GENETICS, V150, P1177; Klco JM, 2006, J BIOL CHEM, V281, P12010, DOI 10.1074/jbc.M600548200; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Ling MK, 2003, EUR J BIOCHEM, V270, P1441, DOI 10.1046/j.1432-1033.2003.03506.x; Lu DS, 1998, MOL ENDOCRINOL, V12, P592, DOI 10.1210/me.12.4.592; LU DS, 1994, NATURE, V371, P799, DOI 10.1038/371799a0; Mas JS, 2002, EUR J BIOCHEM, V269, P6133, DOI 10.1046/j.1432-1033.2002.03329.x; McRobie H, 2009, J HERED, V100, P709, DOI 10.1093/jhered/esp059; Miao YW, 2010, SCI CHINA LIFE SCI, V53, P267, DOI 10.1007/s11427-010-0026-3; Mirzadegan T, 2003, BIOCHEMISTRY-US, V42, P2759, DOI 10.1021/bi027224+; Nadeau NJ, 2006, ANIM GENET, V37, P287, DOI 10.1111/j.1365-2052.2006.01442.x; Nawaratne V, 2010, J BIOL CHEM, V285, P19012, DOI 10.1074/jbc.M110.125096; Nijenhuis WAJ, 2003, J BIOL CHEM, V278, P22939, DOI 10.1074/jbc.M211326200; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Peeters MC, 2011, TRENDS PHARMACOL SCI, V32, P35, DOI 10.1016/j.tips.2010.10.001; ROBBINS LS, 1993, CELL, V72, P827, DOI 10.1016/0092-8674(93)90572-8; Rosenkilde MM, 2006, J BIOL CHEM, V281, P13199, DOI 10.1074/jbc.M602245200; Sanchez-Mas J, 2004, PIGM CELL RES, V17, P386, DOI 10.1111/j.1600-0749.2004.00160.x; Schmidt D, 2006, NATURE, V444, P775, DOI 10.1038/nature05416; Siegrist W, 1997, J RECEPT SIGNAL TR R, V17, P75, DOI 10.3109/10799899709036595; Srinivasan S, 2004, J CLIN INVEST, V114, P1158, DOI 10.1172/JCI200421927; Sura-Trueba S, 2009, ENDOCRINOLOGY, V150, P1043, DOI 10.1210/en.2008-1145; Takeuchi S, 1996, BBA-GENE STRUCT EXPR, V1306, P122, DOI 10.1016/0167-4781(96)00026-7; Takeuchi S, 1996, BBA-GENE STRUCT EXPR, V1308, P164, DOI 10.1016/0167-4781(96)00100-5; Tarnow P, 2003, J BIOL CHEM, V278, P48666, DOI 10.1074/jbc.M309941200; Theron E, 2001, CURR BIOL, V11, P550, DOI 10.1016/S0960-9822(01)00158-0; Vage DI, 1997, NAT GENET, V15, P311, DOI 10.1038/ng0397-311; Vage DI, 1999, MAMM GENOME, V10, P39, DOI 10.1007/s003359900939; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Xu YP, 2008, NATURE, V451, P826, DOI 10.1038/nature06618; Zhang Y, 2006, PLOS COMPUT BIOL, V2, P88, DOI 10.1371/journal.pcbi.0020013	55	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2011	6	9							e24644	10.1371/journal.pone.0024644	http://dx.doi.org/10.1371/journal.pone.0024644			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZV	21931793	Green Submitted, Green Published, gold			2022-12-25	WOS:000295321800042
J	Bish, LT; George, I; Maybaum, S; Yang, J; Chen, JM; Sweeney, HL				Bish, Lawrence T.; George, Isaac; Maybaum, Simon; Yang, Jonathan; Chen, Jonathan M.; Sweeney, H. Lee			Myostatin Is Elevated in Congenital Heart Disease and After Mechanical Unloading	PLOS ONE			English	Article							SKELETAL-MUSCLE; GROWTH; EXPRESSION; FAILURE; MYOCARDIUM; DEFICIENCY	Background: Myostatin is a negative regulator of skeletal muscle mass whose activity is upregulated in adult heart failure (HF); however, its role in congenital heart disease (CHD) is unknown. Methods: We studied myostatin and IGF-1 expression via Western blot in cardiac tissue at varying degrees of myocardial dysfunction and after biventricular support in CHD by collecting myocardial biopsies from four patient cohorts: A) adult subjects with no known cardiopulmonary disease (left ventricle, LV), (Adult Normal), (n = 5); B) pediatric subjects undergoing congenital cardiac surgery with normal RV size and function (right ventricular outflow tract, RVOT), (n = 3); C) pediatric subjects with worsening but hemodynamically stable LV failure [LV and right ventricle (LV, RV,)] with biopsy collected at the time of orthotopic heart transplant (OHT), (n = 7); and D) pediatric subjects with decompensated bi-ventricular failure on BiVAD support with biopsy collected at OHT (LV, RV, BiVAD), (n = 3). Results: The duration of HF was longest in OHT patients compared to BIVAD. The duration of BiVAD support was 4.3 +/- 1.9 days. Myostatin expression was significantly increased in LV-OHT compared to RV-OHT and RVOT, and was increased more than double in decompensated biventricular HF (BiVAD) compared to both OHT and RVOT. An increased myostatin/IGF-1 ratio was associated with ventricular dysfunction. Conclusions: Myostatin expression in increased in CHD, and the myostatin/IGF-1 ratio increases as ventricular function deteriorates. Future investigation is necessary to determine if restoration of the physiologic myostatin/IGF-1 ratio has therapeutic potential in HF.	[Bish, Lawrence T.; Sweeney, H. Lee] Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; [George, Isaac; Yang, Jonathan; Chen, Jonathan M.] Columbia Univ, Coll Phys & Surg, Dept Surg, Div Cardiothorac Surg, New York, NY USA; [Maybaum, Simon] Albert Einstein Coll Med, Dept Med, Div Cardiol, New York, NY USA	University of Pennsylvania; Columbia University; Yeshiva University	Bish, LT (corresponding author), Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA.	bish@mail.med.upenn.edu	Sweeney, H Lee/F-1862-2010		National Heart Lung and Blood Institute [P01-HL059407]; Parent Project Muscular Dystrophy; Wellstone Muscular Dystrophy Cooperative Center [U54-AR052646, T32-HL-007748]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007748, P01HL059407] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [U54AR052646] Funding Source: NIH RePORTER	National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Parent Project Muscular Dystrophy; Wellstone Muscular Dystrophy Cooperative Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Funding was provided by National Heart Lung and Blood Institute (P01-HL059407) to HS; Parent Project Muscular Dystrophy to HS; Wellstone Muscular Dystrophy Cooperative Center Grant (U54-AR052646) to HS; T32-HL-007748 to LB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DL, 2011, MED SCI SPORT EXER, V43, P1828, DOI 10.1249/MSS.0b013e3182178bb4; Cittadini A, 2009, J CLIN ENDOCR METAB, V94, P3329, DOI 10.1210/jc.2009-0533; Fernandez K, 2010, AM J PATHOL, V176, P416, DOI 10.2353/ajpath.2010.090405; Fernandez-Sola J, 2011, ALCOHOL CLIN EXP RES, V35, P1220, DOI 10.1111/j.1530-0277.2011.01456.x; Gaussin V, 2005, CARDIOVASC RES, V68, P347, DOI 10.1016/j.cardiores.2005.09.007; George I, 2010, EUR J HEART FAIL, V12, P444, DOI 10.1093/eurjhf/hfq039; Gruson D, 2011, EUR J HEART FAIL, V13, P734, DOI 10.1093/eurjhf/hfr024; Heineke J, 2010, CIRCULATION, V121, P419, DOI 10.1161/CIRCULATIONAHA.109.882068; Hittel DS, 2010, MED SCI SPORT EXER, V42, P2023, DOI 10.1249/MSS.0b013e3181e0b9a8; Ji M, 2008, CELL SIGNAL, V20, P1452, DOI 10.1016/j.cellsig.2008.03.013; Jiang MS, 2004, BIOCHEM BIOPH RES CO, V315, P525, DOI 10.1016/j.bbrc.2004.01.085; Lenk K, 2012, EUR J PREV CARDIOL, V19, P404, DOI 10.1177/1741826711402735; Lenk K, 2009, EUR J HEART FAIL, V11, P342, DOI 10.1093/eurjhf/hfp020; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Morine KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009176; Morissette MR, 2006, CIRC RES, V99, P15, DOI 10.1161/01.RES.0000231290.45676.d4; Sacca L, 2009, CIRC-HEART FAIL, V2, P151, DOI 10.1161/CIRCHEARTFAILURE.108.821892; Sharma M, 1999, J CELL PHYSIOL, V180, P1; Shyu KG, 2006, EUR J CLIN INVEST, V36, P713, DOI 10.1111/j.1365-2362.2006.01718.x; Shyu KG, 2005, CARDIOVASC RES, V68, P405, DOI 10.1016/j.cardiores.2005.06.028; Sillje HHW, 2010, EUR J HEART FAIL, V12, P420, DOI 10.1093/eurjhf/hfq044; Zamora E, 2010, REV ESP CARDIOL, V63, P992, DOI 10.1016/S0300-8932(10)70212-8	22	15	18	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2011	6	9							e23818	10.1371/journal.pone.0023818	http://dx.doi.org/10.1371/journal.pone.0023818			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZV	21931616	Green Submitted, Green Published, gold			2022-12-25	WOS:000295321800009
J	Lu, L; Ma, JL; Li, ZY; Lan, Q; Chen, MG; Liu, Y; Xia, ZX; Wang, J; Han, YP; Shi, W; Quesniaux, V; Ryffel, B; Brand, D; Li, B; Liu, ZM; Zheng, SG				Lu, Ling; Ma, Jilin; Li, Zhiyuan; Lan, Qin; Chen, Maogen; Liu, Ya; Xia, Zanxian; Wang, Julie; Han, Yuanping; Shi, Wei; Quesniaux, Valerie; Ryffel, Bernhard; Brand, David; Li, Bin; Liu, Zhongmin; Zheng, Song Guo			All-Trans Retinoic Acid Promotes TGF-beta-Induced Tregs via Histone Modification but Not DNA Demethylation on Foxp3 Gene Locus	PLOS ONE			English	Article							REGULATORY T-CELLS; HOST-DISEASE; TH17 CELLS; EXPRESSION; SMAD3; BINDING; DIFFERENTIATION; ACTIVATION; RECEPTORS; INDUCTION	Background: It has been documented all-trans retinoic acid (atRA) promotes the development of TGF-beta-induced CD4(+) Foxp3(+) regulatory T cells (iTreg) that play a vital role in the prevention of autoimmune responses, however, molecular mechanisms involved remain elusive. Our objective, therefore, was to determine how atRA promotes the differentiation of iTregs. Methodology/Principal Findings: Addition of atRA to naive CD4(+)CD25(-) cells stimulated with anti-CD3/CD28 antibodies in the presence of TGF-beta not only increased Foxp3(+) iTreg differentiation, but maintained Foxp3 expression through apoptosis inhibition. atRA/TGF-beta-treated CD4(+) cells developed complete anergy and displayed increased suppressive activity. Infusion of atRA/TGF-beta-treated CD4(+) cells resulted in the greater effects on suppressing symptoms and protecting the survival of chronic GVHD mice with typical lupus-like syndromes than did CD4(+) cells treated with TGF-beta alone. atRA did not significantly affect the phosphorylation levels of Smad2/3 and still promoted iTreg differentiation in CD4(+) cells isolated from Smad3 KO and Smad2 conditional KO mice. Conversely, atRA markedly increased ERK1/2 activation, and blockade of ERK1/2 signaling completely abolished the enhanced effects of atRA on Foxp3 expression. Moreover, atRA significantly increased histone methylation and acetylation within the promoter and conserved non-coding DNA sequence (CNS) elements at the Foxp3 gene locus and the recruitment of phosphor-RNA polymerase II, while DNA methylation in the CNS3 was not significantly altered. Conclusions/Significance: We have identified the cellular and molecular mechanism(s) by which atRA promotes the development and maintenance of iTregs. These results will help to enhance the quantity and quality of development of iTregs and may provide novel insights into clinical cell therapy for patients with autoimmune diseases and those needing organ transplantation.	[Lu, Ling; Lan, Qin; Chen, Maogen; Liu, Ya; Xia, Zanxian; Wang, Julie; Zheng, Song Guo] Univ So Calif, Keck Sch Med, Childrens Hosp Los Angeles, Saban Res Inst,Dept Med,Div Rheumat, Los Angeles, CA 90033 USA; [Han, Yuanping] Univ So Calif, Keck Sch Med, Childrens Hosp Los Angeles, Saban Res Inst,Dept Surg, Los Angeles, CA 90033 USA; [Shi, Wei] Univ So Calif, Keck Sch Med, Childrens Hosp Los Angeles, Saban Res Inst,Dev Biol & Regenerat Med Program, Los Angeles, CA 90033 USA; [Lu, Ling] Key Lab Living Donor Liver Transplantat, Nanjing, Peoples R China; [Ma, Jilin] Zhejiang Tradit Chinese Med & Western Med Hosp, Div Rheumatol Immunol & Nephrol, Hangzhou, Zhejiang, Peoples R China; [Lan, Qin; Liu, Zhongmin] Tongji Univ, Immune Tolerance Ctr, Shanghai E Hosp, Shanghai 200092, Peoples R China; [Quesniaux, Valerie; Ryffel, Bernhard; Zheng, Song Guo] Univ & Ctr Natl Rech Sci, UMR6218, Orleans, France; [Brand, David] Vet Affairs Med Ctr, Res Serv, Memphis, TN USA; [Li, Zhiyuan; Li, Bin] Chinese Acad Sci, Unit Mol Immunol, Inst Pasteur Shanghai, Shanghai, Peoples R China	Children's Hospital Los Angeles; University of Southern California; Children's Hospital Los Angeles; University of Southern California; Children's Hospital Los Angeles; University of Southern California; Tongji University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP)	Lu, L (corresponding author), Univ So Calif, Keck Sch Med, Childrens Hosp Los Angeles, Saban Res Inst,Dept Med,Div Rheumat, Los Angeles, CA 90033 USA.	zhongmin_liu@sina.com	li, zhiyuan/HGD-9581-2022; Maogen, Chen/AAN-1551-2021; lI, Bin/AAR-4966-2021	Maogen, Chen/0000-0001-9319-5334; lI, Bin/0000-0002-7640-8884; Brand, David/0000-0002-9260-7963	National Institutes of Health [R01 AR059103, R01 AR051558, R01 HL068597]; ACR; Arthritis Foundation; National Natural Science Foundation of China [30728007, 30772150, 81001307, 81100270]; Zhejiang Province National Natural Science Foundation of China [Y2090918]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068597] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051558, R01AR059103] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ACR; Arthritis Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Province National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health grants R01 AR059103, R01 AR051558, and R01 HL068597; ACR Within Our Reach; the Arthritis Foundation; an Outstanding Youth Scientist Award from the National Natural Science Foundation of China (30728007); the National Natural Science Foundation of China (30772150, 81001307, and 81100270); and Zhejiang Province National Natural Science Foundation of China (Y2090918). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alique M, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-1; Chapman RD, 2007, SCIENCE, V318, P1780, DOI 10.1126/science.1145977; Fischle W, 2003, NATURE, V425, P475, DOI 10.1038/nature02017; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; GIGUERE V, 1994, ENDOCR REV, V15, P61, DOI 10.1210/er.15.1.61; Hill JA, 2008, IMMUNITY, V29, P758, DOI 10.1016/j.immuni.2008.09.018; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jinnin M, 2006, MOL PHARMACOL, V69, P597, DOI 10.1124/mol.105.017483; Kang SG, 2007, J IMMUNOL, V179, P3724, DOI 10.4049/jimmunol.179.6.3724; Kim HP, 2007, J EXP MED, V204, P1543, DOI 10.1084/jem.20070109; Komi Y, 2010, LAB INVEST, V90, P52, DOI 10.1038/labinvest.2009.110; Li B, 2007, P NATL ACAD SCI USA, V104, P4571, DOI 10.1073/pnas.0700298104; Li B, 2009, J IMMUNOL, V182, P7625, DOI 10.4049/jimmunol.0804192; Lu L, 2010, J IMMUNOL, V184, P4295, DOI 10.4049/jimmunol.0903418; Lu L, 2010, EUR J IMMUNOL, V40, P142, DOI 10.1002/eji.200939618; Maynard CL, 2009, J EXP MED, V206, P343, DOI 10.1084/jem.20080950; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Ng HH, 2000, TRENDS BIOCHEM SCI, V25, P121; Nolting J, 2009, J EXP MED, V206, P2131, DOI 10.1084/jem.20090639; NUGENT P, 1995, EXP CELL RES, V220, P495, DOI 10.1006/excr.1995.1341; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; RACKE MK, 1995, J IMMUNOL, V154, P450; Reifen R, 2002, J NUTR, V132, P2743, DOI 10.1093/jn/132.9.2743; ROLINK AG, 1982, J EXP MED, V155, P1501, DOI 10.1084/jem.155.5.1501; Sakoe Y, 2010, BLOOD, V115, P3787, DOI 10.1182/blood-2009-05-222976; Samanta A, 2008, P NATL ACAD SCI USA, V105, P14023, DOI 10.1073/pnas.0806726105; Schambach F, 2007, EUR J IMMUNOL, V37, P2396, DOI 10.1002/eji.200737621; Takimoto T, 2010, J IMMUNOL, V185, P842, DOI 10.4049/jimmunol.0904100; Tone Y, 2008, NAT IMMUNOL, V9, P194, DOI 10.1038/ni1549; Ueki S, 2008, J IMMUNOL, V181, P7689, DOI 10.4049/jimmunol.181.11.7689; van Loosdregt J, 2010, BLOOD, V115, P965, DOI 10.1182/blood-2009-02-207118; Van YH, 2009, DIABETES, V58, P146, DOI 10.2337/db08-1154; Verrier L, 2011, BIOL CELL, V103, P381, DOI 10.1042/BC20110028; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Winoto A, 2002, CELL, V109, pS57, DOI 10.1016/S0092-8674(02)00710-9; Xiao S, 2008, J IMMUNOL, V181, P2277, DOI 10.4049/jimmunol.181.4.2277; Xu LL, 2010, IMMUNITY, V33, P313, DOI 10.1016/j.immuni.2010.09.001; Zhang H, 2004, INT J ONCOL, V25, P1241; Zhang Q, 2007, NAT MED, V13, P1341, DOI 10.1038/nm1659; Zheng SG, 2004, J IMMUNOL, V172, P1531, DOI 10.4049/jimmunol.172.3.1531; Zheng SG, 2007, J IMMUNOL, V178, P2018, DOI 10.4049/jimmunol.178.4.2018; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Zhou XH, 2010, J IMMUNOL, V185, P2675, DOI 10.4049/jimmunol.1000598; Zhou XH, 2010, J MOL CELL BIOL, V2, P164, DOI 10.1093/jmcb/mjq007; Zunino SJ, 2007, J NUTR, V137, P1216, DOI 10.1093/jn/137.5.1216	45	67	75	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2011	6	9							e24590	10.1371/journal.pone.0024590	http://dx.doi.org/10.1371/journal.pone.0024590			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZV	21931768	Green Submitted, gold, Green Published			2022-12-25	WOS:000295321800035
J	Lu, YM; Huang, JY; Shioda, N; Fukunaga, K; Shirasaki, Y; Li, XM; Han, F				Lu, Ying-Mei; Huang, Jiyun; Shioda, Norifumi; Fukunaga, Kohji; Shirasaki, Yasufumi; Li, Xiao-ming; Han, Feng			CaMKII delta B Mediates Aberrant NCX1 Expression and the Imbalance of NCX1/SERCA in Transverse Aortic Constriction-Induced Failing Heart	PLOS ONE			English	Article							CA2+/CALMODULIN-DEPENDENT PROTEIN-KINASE; SARCOPLASMIC-RETICULUM CA2+-ATPASE; NA+-CA2+ EXCHANGER GENE; PRESSURE-OVERLOAD; CARDIAC-HYPERTROPHY; TRANSGENIC MOUSE; UP-REGULATION; FAILURE; CARDIOMYOCYTES; MYOCYTES	Ca2+/calmodulin-dependent protein kinase II delta B (CaMKII delta B) is one of the predominant isoforms of CaMKII in the heart. The precise role of CaMKII delta B in the transcriptional cross-talk of Ca2+-handling proteins during heart failure remains unclear. In this work, we aim to determine the mechanism of CaMKII delta B in modulating the expression of sarcolemmal Na+-Ca2+ exchange (NCX1). We also aim to address the potential effects of calmodulin antagonism on the imbalance of NCX1 and sarcoendoplasmic reticulum Ca2+ ATPase (SERCA) during heart failure. Eight weeks after transverse aortic constriction (TAC)-induced heart failure in mice, we found that the heart weight/tibia length (HW/TL) ratio and the lung weight/body weight (LW/BW) ratio increased by 59% and 133%, respectively. We further found that the left ventricle-shortening fraction decreased by 40% compared with the sham-operated controls. Immunoblotting revealed that the phosphorylation of CaMKIIdB significantly increased 8 weeks after TAC-induced heart failure. NCX1 protein levels were also elevated, whereas SERCA2 protein levels decreased in the same animal model. Moreover, transfection of active CaMKIIdB significantly increased NCX1 protein levels in adult mouse cardiomyocytes via class IIa histone deacetylase (HDAC)/myocyte enhancer factor-2 (MEF2)-dependent signaling. In addition, pharmacological inhibition of calmodulin/CaMKII delta B activity improved cardiac function in TAC mice, which partially normalized the imbalance between NCX1 and SERCA2. These data identify NCX1 as a cellular target for CaMKIIdB. We also suggest that the CaMKII delta B-induced imbalance between NCX1 and SERCA2 is partially responsible for the disturbance of intracellular Ca2+ homeostasis and the pathological process of heart failure.	[Lu, Ying-Mei; Li, Xiao-ming] Zhejiang Univ, Sch Med, Dept Neurobiol, Hangzhou 310003, Zhejiang, Peoples R China; [Huang, Jiyun; Han, Feng] Zhejiang Univ, Inst Pharmacol Toxicol & Biochem Pharmaceut, Hangzhou 310003, Zhejiang, Peoples R China; [Lu, Ying-Mei; Shioda, Norifumi; Fukunaga, Kohji] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol, Sendai, Miyagi 980, Japan; [Shirasaki, Yasufumi] Daiichi Sankyo Pharmaceut Co Ltd, Biol Res Labs, Tokyo, Japan	Zhejiang University; Zhejiang University; Tohoku University; Daiichi Sankyo Company Limited	Lu, YM (corresponding author), Zhejiang Univ, Sch Med, Dept Neurobiol, Hangzhou 310003, Zhejiang, Peoples R China.	changhuahan@zju.edu.cn	Fukunaga, Kohji/AAI-8811-2021	Fukunaga, Kohji/0000-0001-8526-2824	Uehara Memorial Foundation, Japan; Ministry of Education, Science, Sports and Culture of Japan [19390150]; Science and Technology Planning Project of Zhejiang Province, China [2009C34021]; Fundamental Research Funds for the Central Universities, China	Uehara Memorial Foundation, Japan(Uehara Memorial Foundation); Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Science and Technology Planning Project of Zhejiang Province, China; Fundamental Research Funds for the Central Universities, China(Fundamental Research Funds for the Central Universities)	This work was supported by The Uehara Memorial Foundation, Japan to Y.M.L., Grants-in-aid for Scientific Research from the Ministry of Education, Science, Sports and Culture of Japan (19390150) to K. F., The Science and Technology Planning Project of Zhejiang Province (2009C34021), China to F. H., and The Fundamental Research Funds for the Central Universities, China to F. H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson KB, 2009, J MOL CELL CARDIOL, V47, P180, DOI 10.1016/j.yjmcc.2009.03.013; Anwar A, 2008, PFLUG ARCH EUR J PHY, V457, P485, DOI 10.1007/s00424-008-0520-7; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bodi I, 2005, J CLIN INVEST, V115, P3306, DOI 10.1172/JCI27167; Cheng GM, 1999, J BIOL CHEM, V274, P12819, DOI 10.1074/jbc.274.18.12819; Day SM, 2006, NAT MED, V12, P181, DOI 10.1038/nm1346; Han F, 2010, J PHARMACOL EXP THER, V332, P421, DOI 10.1124/jpet.109.161646; HASENFUSS G, 1994, CIRC RES, V75, P434, DOI 10.1161/01.RES.75.3.434; Hobai IA, 2001, CIRCULATION, V103, P1577; KENT RL, 1993, AM J PHYSIOL, V265, pH1024, DOI 10.1152/ajpheart.1993.265.3.H1024; Kohlhaas M, 2006, CIRC RES, V98, P235, DOI 10.1161/01.RES.0000200739.90811.9f; Li XM, 2009, CLIN EXP PHARMACOL P, V36, P1054, DOI 10.1111/j.1440-1681.2009.05243.x; Ling HY, 2009, J CLIN INVEST, V119, P1230, DOI 10.1172/JCI38022; Little GH, 2007, J BIOL CHEM, V282, P7219, DOI 10.1074/jbc.M604281200; Lu YM, 2007, BIOCHEM PHARMACOL, V74, P1727, DOI 10.1016/j.bcp.2007.08.022; Lu YM, 2010, BBA-GENE REGUL MECH, V1799, P429, DOI 10.1016/j.bbagrm.2010.02.004; Lu YM, 2009, MOL PHARMACOL, V75, P101, DOI 10.1124/mol.108.050716; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; Menick DR, 2007, ANN NY ACAD SCI, V1099, P195, DOI 10.1196/annals.1387.058; Menick DR, 1996, ANN NY ACAD SCI, V779, P489, DOI 10.1111/j.1749-6632.1996.tb44823.x; Moorjani N, 2006, J AM COLL CARDIOL, V48, P1451, DOI 10.1016/j.jacc.2006.05.065; Muller JG, 2002, CIRC RES, V90, P158, DOI 10.1161/hh0202.103231; Petrashevskaya NN, 2002, CARDIOVASC RES, V54, P117, DOI 10.1016/S0008-6363(02)00241-9; Pogwizd SM, 2001, CIRC RES, V88, P1159, DOI 10.1161/hh1101.091193; Ramirez MT, 1997, J BIOL CHEM, V272, P31203, DOI 10.1074/jbc.272.49.31203; Randriamboavonjy V, 2008, CIRCULATION, V117, P52, DOI 10.1161/CIRCULATIONAHA.107.719807; TOYOFUKU T, 1994, J BIOL CHEM, V269, P26492; XU A, 1993, J BIOL CHEM, V268, P8394; Yang DM, 2007, CIRC RES, V100, P399, DOI 10.1161/01.RES.0000258022.13090.55; Youn HD, 2000, J BIOL CHEM, V275, P22563, DOI 10.1074/jbc.C000304200; Zhang T, 2002, J BIOL CHEM, V277, P1261, DOI 10.1074/jbc.M108525200	31	22	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2011	6	9							e24724	10.1371/journal.pone.0024724	http://dx.doi.org/10.1371/journal.pone.0024724			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZV	21931829	Green Submitted, Green Published, gold			2022-12-25	WOS:000295321800055
J	Suliman, S; Tan, J; Xu, KL; Kousis, PC; Kowalski, PE; Chang, G; Egan, SE; Guidos, C				Suliman, Sara; Tan, Joanne; Xu, Keli; Kousis, Philaretos C.; Kowalski, Paul E.; Chang, Greg; Egan, Sean E.; Guidos, Cynthia			Notch3 Is Dispensable for Thymocyte beta-Selection and Notch1-Induced T Cell Leukemogenesis	PLOS ONE			English	Article							DELTA-LIKE 4; ALPHA-BETA; PRE-TCR; LINEAGE COMMITMENT; SIGNALING PROMOTES; GENE-EXPRESSION; C-MYC; MATURATION; REQUIREMENT; ACTIVATION	Notch1 (N1) signaling induced by intrathymic Delta-like (DL) ligands is required for T cell lineage commitment as well as self-renewal during "beta-selection" of TCR beta(+) CD4(-)CD8(-) double negative 3 (DN3) T cell progenitors. However, over-expression of the N1 intracellular domain (ICN1) renders N1 activation ligand-independent and drives leukemic transformation during beta-selection. DN3 progenitors also express Notch3 (N3) mRNA, and over-expression of ligand-independent mutant N3 (ICN3) influences beta-selection and drives T cell leukemogenesis. However, the importance of ligand-activated N3 in promoting beta-selection and ICN1-induced T cell leukemogenesis has not been examined. To address these questions we generated mice lacking functional N3. We confirmed that DN3 progenitors express N3 protein using a N3-specific antibody. Surprisingly however, N3-deficient DN3 thymocytes were not defective in generating DP thymocytes under steady state conditions or in more stringent competition assays. To determine if N3 co-operates with N1 to regulate beta-selection, we generated N1; N3 compound mutants. However, N3 deficiency did not exacerbate the competitive defect of N1(+/-) DN3 progenitors, demonstrating that N3 does not compensate for limiting N1 during T cell development. Finally, N3 deficiency did not attenuate T cell leukemogenesis induced by conditional expression of ICN1 in DN3 thymocytes. Importantly, we showed that in contrast to N1, N3 has a low binding affinity for DL4, the most abundant intrathymic DL ligand. Thus, despite the profound effects of ectopic ligand-independent N3 activation on T cell development and leukemogenesis, physiologically activated N3 is dispensable for both processes, likely because N3 interacts poorly with intrathymic DL4.	[Suliman, Sara; Tan, Joanne; Xu, Keli; Kousis, Philaretos C.; Kowalski, Paul E.; Chang, Greg; Egan, Sean E.; Guidos, Cynthia] Hosp Sick Children, Res Inst, Program Stem Cell & Dev Biol, Toronto, ON M5G 1X8, Canada; [Suliman, Sara; Tan, Joanne; Guidos, Cynthia] Univ Toronto, Fac Med, Dept Immunol, Toronto, ON, Canada; [Egan, Sean E.] Univ Toronto, Fac Med, Dept Mol Genet, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Suliman, S (corresponding author), Hosp Sick Children, Res Inst, Program Stem Cell & Dev Biol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	cynthiaguidos@sickkids.ca			Canadian Institute for Health Research [CJG: FRN 11530]; Genome Canada Competition III through the Ontario Genomics Institute; Hospital for Sick Children Research Institute	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Genome Canada Competition III through the Ontario Genomics Institute; Hospital for Sick Children Research Institute	This work was supported by funding from the Canadian Institute for Health Research (CJG: FRN 11530) and Genome Canada Competition III through the Ontario Genomics Institute (CJG and SEE). SS and JBT were supported by the Research Training Competition fund from the Hospital for Sick Children Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arboleda-Velasquez JF, 2008, P NATL ACAD SCI USA, V105, P4856, DOI 10.1073/pnas.0709867105; Aster JC, 2011, J PATHOL, V223, P262, DOI 10.1002/path.2789; Bellavia D, 2000, EMBO J, V19, P3337, DOI 10.1093/emboj/19.13.3337; Bellavia D, 2002, P NATL ACAD SCI USA, V99, P3788, DOI 10.1073/pnas.062050599; Bellavia D, 2007, EMBO J, V26, P1670, DOI 10.1038/sj.emboj.7601626; Besseyrias V, 2007, J EXP MED, V204, P331, DOI 10.1084/jem.20061442; Boulos N, 2011, HYPERTENSION, V57, P1176, DOI 10.1161/HYPERTENSIONAHA.111.170746; Chadwick N, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-35; Ciofani M, 2004, J IMMUNOL, V172, P5230, DOI 10.4049/jimmunol.172.9.5230; Ciofani M, 2005, NAT IMMUNOL, V6, P881, DOI 10.1038/ni1234; Deftos ML, 2000, IMMUNITY, V13, P73, DOI 10.1016/S1074-7613(00)00009-1; Domenga V, 2004, GENE DEV, V18, P2730, DOI 10.1101/gad.308904; Fowlkes BJ, 2002, J IMMUNOL, V169, P1817, DOI 10.4049/jimmunol.169.4.1817; Garbe AI, 2006, J EXP MED, V203, P1579, DOI 10.1084/jem.20060474; GUIDOS CJ, 1989, J IMMUNOL, V142, P3773; GUIDOS CJ, 1989, P NATL ACAD SCI USA, V86, P7542, DOI 10.1073/pnas.86.19.7542; Hamada Y, 1999, DEVELOPMENT, V126, P3415; Hoffman ES, 1996, GENE DEV, V10, P948, DOI 10.1101/gad.10.8.948; Hozumi K, 2008, J EXP MED, V205, P2507, DOI 10.1084/jem.20080134; Huang EY, 2003, J IMMUNOL, V171, P2296, DOI 10.4049/jimmunol.171.5.2296; JEANNET R, 2010, BLOOD PREPUBLIS 0909; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Kelly AP, 2007, EMBO J, V26, P3441, DOI 10.1038/sj.emboj.7601761; Kitamoto T, 2005, BIOCHEM BIOPH RES CO, V331, P1154, DOI 10.1016/j.bbrc.2005.03.241; Koch U, 2001, IMMUNITY, V15, P225, DOI 10.1016/S1074-7613(01)00189-3; Koch U, 2008, J EXP MED, V205, P2515, DOI 10.1084/jem.20080829; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Krebs LT, 2003, GENESIS, V37, P139, DOI 10.1002/gene.10241; Krebs LT, 2000, GENE DEV, V14, P1343; Li K, 2008, J BIOL CHEM, V283, P8046, DOI 10.1074/jbc.M800170200; Li XD, 2009, NAT MED, V15, P1289, DOI 10.1038/nm.2021; Lin LP, 2010, CANCER RES, V70, P632, DOI 10.1158/0008-5472.CAN-09-3293; Liu HD, 2010, GENE DEV, V24, P2395, DOI 10.1101/gad.1975210; Maillard I, 2006, J EXP MED, V203, P2239, DOI 10.1084/jem.20061020; Mitchell KJ, 2001, NAT GENET, V28, P241, DOI 10.1038/90074; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; Nam YS, 2007, P NATL ACAD SCI USA, V104, P2103, DOI 10.1073/pnas.0611092104; Ohashi S, 2010, GASTROENTEROLOGY, V139, P2113, DOI 10.1053/j.gastro.2010.08.040; Ong CT, 2006, J BIOL CHEM, V281, P5106, DOI 10.1074/jbc.M506108200; Palomero T, 2006, P NATL ACAD SCI USA, V103, P18261, DOI 10.1073/pnas.0606108103; Park JT, 2006, CANCER RES, V66, P6312, DOI 10.1158/0008-5472.CAN-05-3610; Qiu XH, 2009, DEV GENES EVOL, V219, P339, DOI 10.1007/s00427-009-0296-6; Raafat A, 2011, J CELL PHYSIOL, V226, P1940, DOI 10.1002/jcp.22526; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Reizis B, 2002, GENE DEV, V16, P295, DOI 10.1101/gad.960702; Sambandam A, 2005, NAT IMMUNOL, V6, P663, DOI 10.1038/ni1216; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Shimizu K, 2002, BIOCHEM BIOPH RES CO, V291, P775, DOI 10.1006/bbrc.2002.6528; Taghon T, 2006, IMMUNITY, V24, P53, DOI 10.1016/j.immuni.2005.11.012; Taghon TN, 2005, GENE DEV, V19, P965, DOI 10.1101/gad.1298305; Tan JB, 2005, NAT IMMUNOL, V6, P671, DOI 10.1038/ni1217; Visan I, 2006, NAT IMMUNOL, V7, P634, DOI 10.1038/ni1345; Visan I, 2010, J IMMUNOL, V185, P4609, DOI 10.4049/jimmunol.1002008; Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406; Witt CM, 2003, MOL CELL BIOL, V23, P8637, DOI 10.1128/MCB.23.23.8637-8650.2003; Wolfer A, 2002, IMMUNITY, V16, P869, DOI 10.1016/S1074-7613(02)00330-8; Xu KL, 2010, AM J PHYSIOL-LUNG C, V298, pL45, DOI 10.1152/ajplung.90550.2008; Yuan JS, 2011, BLOOD, V117, P1184, DOI 10.1182/blood-2010-07-296616; Yuan JS, 2010, ANNU REV IMMUNOL, V28, P343, DOI 10.1146/annurev.immunol.021908.132719; Yui MA, 2010, J IMMUNOL, V185, P284, DOI 10.4049/jimmunol.1000679	60	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2011	6	9							e24937	10.1371/journal.pone.0024937	http://dx.doi.org/10.1371/journal.pone.0024937			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZV	21931869	Green Published, Green Submitted, gold			2022-12-25	WOS:000295321800077
J	Yu, B; Zhou, SL; Wang, YJ; Ding, GH; Ding, F; Gu, XS				Yu, Bin; Zhou, Songlin; Wang, Yongjun; Ding, Guohui; Ding, Fei; Gu, Xiaosong			Profile of MicroRNAs following Rat Sciatic Nerve Injury by Deep Sequencing: Implication for Mechanisms of Nerve Regeneration	PLOS ONE			English	Article							DORSAL-ROOT GANGLION; GENE-EXPRESSION; MYELINATION; GROWTH; DIFFERENTIATION; PLASTICITY; TARGETS; ABILITY; FIBERS; MIRNAS	Unlike the central nervous system, peripheral nerves can regenerate when damaged. MicroRNA (miRNA) is a novel class of small, non-coding RNA that regulates gene expression at the post-transcriptional level. Here, we report regular alterations of miRNA expression following rat sciatic nerve injury using deep sequencing. We harvested dorsal root ganglia tissues and the proximal stumps of the nerve, and identified 201 and 225 known miRNAs with significant expression variance at five time points in these tissues after sciatic nerve transaction, respectively. Subsequently, hierarchical clustering, miRNA expression pattern and co-expression network were performed. We screened out specific miRNAs and further obtained the intersection genes through target analysis software (Targetscan and miRanda). Moreover, GO and KEGG enrichment analyses of these intersection genes were performed. The bioinformatics analysis indicated that the potential targets for these miRNAs were involved in nerve regeneration, including neurogenesis, neuron differentiation, vesicle-mediated transport, homophilic cell adhesion and negative regulation of programmed cell death that were known to play important roles in regulating nerve repair. Finally, we combined differentially expressed mRNA with the predicted targets for selecting inverse miRNA-target pairs. Our results show that the abnormal expression of miRNA may contribute to illustrate the molecular mechanisms of nerve regeneration and that miRNAs are potential targets for therapeutic interventions and may enhance intrinsic regenerative ability.	[Yu, Bin; Zhou, Songlin; Wang, Yongjun; Ding, Fei; Gu, Xiaosong] Nantong Univ, Jiangsu Key Lab Neuroregenerat, Nantong, Peoples R China; [Ding, Guohui] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China	Nantong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Yu, B (corresponding author), Nantong Univ, Jiangsu Key Lab Neuroregenerat, Nantong, Peoples R China.	neurongu@public.nt.js.cn			National Natural Science Foundation of China [30870811]; Jiangsu Provincial Natural Science Foundation [BK2008010]; Jiangsu Education Department [08KJA310002]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Provincial Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Jiangsu Education Department; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This study was supported by the National Natural Science Foundation of China (Grant No. 30870811), the Jiangsu Provincial Natural Science Foundation (Grant No. BK2008010), the Basic Research Program of Jiangsu Education Department (Grant No. 08KJA310002), and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AVDONIN PP, 2010, IZV AKAD NAUK BIOL+, V3, P283; Blin M, 2008, MOL CELL NEUROSCI, V39, P592, DOI 10.1016/j.mcn.2008.08.006; Braun S, 1996, J NEUROL SCI, V136, P17, DOI 10.1016/0022-510X(95)00315-S; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Che YH, 2002, J CHEM NEUROANAT, V24, P147, DOI 10.1016/S0891-0618(02)00056-X; Christie KJ, 2010, J NEUROSCI, V30, P9306, DOI 10.1523/JNEUROSCI.6271-09.2010; Costigan M, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-16; Eacker SM, 2009, NAT REV NEUROSCI, V10, P837, DOI 10.1038/nrn2726; Edbauer D, 2010, NEURON, V65, P373, DOI 10.1016/j.neuron.2010.01.005; Fields RD, 2002, SCIENCE, V298, P556, DOI 10.1126/science.298.5593.556; Fineberg SK, 2009, NEURON, V64, P303, DOI 10.1016/j.neuron.2009.10.020; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Griffin JW, 2010, EXP NEUROL, V223, P60, DOI 10.1016/j.expneurol.2009.12.033; Gruart A, 2003, BRAIN, V126, P115, DOI 10.1093/brain/awg008; Gu XS, 2011, PROG NEUROBIOL, V93, P204, DOI 10.1016/j.pneurobio.2010.11.002; Hirata H, 2001, GLIA, V36, P245, DOI 10.1002/glia.1113; Hoffman PN, 2010, EXP NEUROL, V223, P11, DOI 10.1016/j.expneurol.2009.09.006; Huang JC, 2007, NAT METHODS, V4, P1045, DOI 10.1038/nmeth1130; Jagadeeswaran G, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-52; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; Krichevsky AM, 2009, J CELL MOL MED, V13, px, DOI 10.1111/j.1582-4934.2008.00556.x; Kury P, 2001, CURR OPIN NEUROL, V14, P635, DOI 10.1097/00019052-200110000-00013; Lee K, 2009, DESALIN WATER TREAT, V2, P1; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li XB, 2005, PLANT CELL, V17, P859, DOI 10.1105/tpc.104.029629; Liu K, 2010, NAT NEUROSCI, V13, P1075, DOI 10.1038/nn.2603; Liu NK, 2009, EXP NEUROL, V219, P424, DOI 10.1016/j.expneurol.2009.06.015; Magnani P, 1996, METABOLISM, V45, P1466, DOI 10.1016/S0026-0495(96)90174-2; Martin DM, 2004, DEV BIOL, V267, P93, DOI 10.1016/j.ydbio.2003.10.035; Mellios N, 2008, HUM MOL GENET, V17, P3030, DOI 10.1093/hmg/ddn201; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Nagarajan R, 2002, P NATL ACAD SCI USA, V99, P8998, DOI 10.1073/pnas.132080999; Nakanishi K, 2010, SPINAL CORD, V48, P192, DOI 10.1038/sc.2009.89; Navarro X, 2007, PROG NEUROBIOL, V82, P163, DOI 10.1016/j.pneurobio.2007.06.005; Nave KA, 2010, NATURE, V468, P244, DOI 10.1038/nature09614; Oudega M, 1999, BRAIN RES, V818, P431, DOI 10.1016/S0006-8993(98)01314-6; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Parrinello S, 2010, CELL, V143, P145, DOI 10.1016/j.cell.2010.08.039; Radstake TRDJ, 2010, NAT GENET, V42, P426, DOI 10.1038/ng.565; Redell JB, 2011, J NEUROSCI RES, V89, P212, DOI 10.1002/jnr.22539; Rishal I, 2010, EXP NEUROL, V223, P5, DOI 10.1016/j.expneurol.2009.08.010; Rossi F, 2007, PROG NEUROBIOL, V81, P1, DOI 10.1016/j.pneurobio.2006.12.001; Schulte JH, 2010, NUCLEIC ACIDS RES, V38, P5919, DOI 10.1093/nar/gkq342; Stark MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009685; Volakakis N, 2010, P NATL ACAD SCI USA, V107, P12317, DOI 10.1073/pnas.1007088107; Wang HY, 2010, IMMUNOL LETT, V128, P148, DOI 10.1016/j.imlet.2009.10.010; Wang KH, 2011, J BIOL CHEM, V286, P9468, DOI 10.1074/jbc.M110.178335; Wayman GA, 2008, P NATL ACAD SCI USA, V105, P9093, DOI 10.1073/pnas.0803072105; Xiao HS, 2002, P NATL ACAD SCI USA, V99, P8360, DOI 10.1073/pnas.122231899; Zhang HY, 2011, BRAIN RES, V1383, P62, DOI 10.1016/j.brainres.2011.01.067; Zhang JY, 2000, EUR J NEUROSCI, V12, P4171, DOI 10.1046/j.1460-9568.2000.01312.x; Zhou SL, 2011, NEUROSCI LETT, V494, P89, DOI 10.1016/j.neulet.2011.02.064	52	73	76	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2011	6	9							e24612	10.1371/journal.pone.0024612	http://dx.doi.org/10.1371/journal.pone.0024612			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZV	21931774	Green Published, gold, Green Submitted			2022-12-25	WOS:000295321800039
J	Kye, MJ; Neveu, P; Lee, YS; Zhou, M; Steen, JA; Sahin, M; Kosik, KS; Silva, AJ				Kye, Min Jeong; Neveu, Pierre; Lee, Yong-Seok; Zhou, Miou; Steen, Judith A.; Sahin, Mustafa; Kosik, Kenneth S.; Silva, Alcino J.			NMDA Mediated Contextual Conditioning Changes miRNA Expression	PLOS ONE			English	Article							SYNAPTIC PLASTICITY; PROTEIN-SYNTHESIS; TRANSLATIONAL CONTROL; MICRORNA EXPRESSION; HOST GENE; MEMORY; BRAIN; TARGETS; FAMILY; HIPPOCAMPUS	We measured the expression of 187 miRNAs using quantitative real time PCR in the hippocampal CA1 region of contextually conditioned mice and cultured embryonic rat hippocampal neurons after neuronal stimulation with either NMDA or bicuculline. Many of the changes in miRNA expression after these three types of stimulation were similar. Surprisingly, the expression level of half of the 187 measured miRNAs was changed in response to contextual conditioning in an NMDA receptor-dependent manner. Genes that control miRNA biogenesis and components of the RISC also exhibited activity induced expression changes and are likely to contribute to the widespread changes in the miRNA profile. The widespread changes in miRNA expression are consistent with the finding that genes up-regulated by contextual conditioning have longer 39 UTRs and more predicted binding sites for miRNAs. Among the miRNAs that changed their expression after contextual conditioning, several inhibit inhibitors of the mTOR pathway. These findings point to a role for miRNAs in learning and memory that includes mTOR-dependent modulation of protein synthesis.	[Kye, Min Jeong; Neveu, Pierre; Kosik, Kenneth S.] Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA; [Kye, Min Jeong; Kosik, Kenneth S.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Neveu, Pierre] Univ Calif Santa Barbara, Kavli Inst Theoret Phys, Santa Barbara, CA 93106 USA; [Lee, Yong-Seok; Zhou, Miou; Silva, Alcino J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurobiol, Brain Res Inst,Integrat Ctr Learning & Memory, Los Angeles, CA 90095 USA; [Lee, Yong-Seok; Zhou, Miou; Silva, Alcino J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat, Brain Res Inst,Integrat Ctr Learning & Memory, Los Angeles, CA 90095 USA; [Lee, Yong-Seok; Zhou, Miou; Silva, Alcino J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychol, Brain Res Inst,Integrat Ctr Learning & Memory, Los Angeles, CA 90095 USA; [Kye, Min Jeong; Steen, Judith A.; Sahin, Mustafa] Harvard Univ, Sch Med, Dept Neurol, FM Kirby Neurobiol Ctr,Childrens Hosp Boston, Boston, MA 02115 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Harvard University; Boston Children's Hospital; Harvard Medical School	Kye, MJ (corresponding author), Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA.	kosik@lifesci.ucsb.edu	Silva, Alcino/ABD-7684-2021; Kye, Min Jeong/ABC-3439-2020; Zhou, Miou/AAK-1515-2021; Neveu, Pierre/C-1170-2009; SAHIN, MUSTAFA/I-8653-2019	Silva, Alcino/0000-0002-1587-4558; Kye, Min Jeong/0000-0002-1323-7256; Zhou, Miou/0000-0001-8188-7392; SAHIN, MUSTAFA/0000-0001-7044-2953; Silva, Alcino/0000-0001-5525-0494; Neveu, Pierre/0000-0003-4939-3418	National Science Foundation [PHY05-51164]; National Institutes of Health [P50-MH0779720, R01-NS058956]; NARSAD; W. M. Keck Foundation; Adelson Medical Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058956] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NARSAD(NARSAD); W. M. Keck Foundation(W.M. Keck Foundation); Adelson Medical Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	MK was a California Institute for Regenerative Medicine scholar. PN research is supported in part by the National Science Foundation under Grant No. PHY05-51164. This work was funded by a grant from the National Institutes of Health to AJS (P50-MH0779720), MS (R01-NS058956), a NARSAD Young Investigator Award to MZ, and grants from the W. M. Keck Foundation and Adelson Medical Foundation to KSK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar N, 2010, ARTHRITIS RHEUM-US, V62, P1361, DOI 10.1002/art.27329; Ashraf SI, 2006, CELL, V124, P191, DOI 10.1016/j.cell.2005.12.017; Babiarz JE, 2011, RNA, V17, P1489, DOI 10.1261/rna.2442211; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Banerjee S, 2009, NEURON, V64, P871, DOI 10.1016/j.neuron.2009.11.023; Bar N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010859; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Batassa EM, 2010, NEUROSCI LETT, V471, P185, DOI 10.1016/j.neulet.2010.01.038; Beveridge NJ, 2010, MOL PSYCHIATR, V15, P1176, DOI 10.1038/mp.2009.84; Blundell J, 2008, NEUROBIOL LEARN MEM, V90, P28, DOI 10.1016/j.nlm.2007.12.004; Boissonneault V, 2009, J BIOL CHEM, V284, P1971, DOI 10.1074/jbc.M807530200; Bramham CR, 2008, J NEUROSCI, V28, P11760, DOI 10.1523/JNEUROSCI.3864-08.2008; Cao GJ, 2010, BIOCHEM BIOPH RES CO, V396, P978, DOI 10.1016/j.bbrc.2010.05.037; Chai G, 2010, CANC SCI; Cheever A, 2010, RNA, V16, P1530, DOI 10.1261/rna.2022210; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chinchilla A, 2010, CARDIOVASC RES; Chinchilla A, 2011, CARDIOVASC RES, V89, P98, DOI 10.1093/cvr/cvq264; Choi YJ, 2008, GENE DEV, V22, P2485, DOI 10.1101/gad.1685008; Conaco C, 2006, P NATL ACAD SCI USA, V103, P2422, DOI 10.1073/pnas.0511041103; Conte I, 2010, P NATL ACAD SCI USA, V107, P15491, DOI 10.1073/pnas.0914785107; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Crist CG, 2009, P NATL ACAD SCI USA, V106, P13383, DOI 10.1073/pnas.0900210106; Du TT, 2005, DEVELOPMENT, V132, P4645, DOI 10.1242/dev.02070; Duursma AM, 2008, RNA, V14, P872, DOI 10.1261/rna.972008; Edbauer D, 2010, NEURON, V65, P373, DOI 10.1016/j.neuron.2010.01.005; Eulalio A, 2009, RNA, V15, P1433, DOI 10.1261/rna.1703809; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Fenelon K, 2011, P NATL ACAD SCI USA, V108, P4447, DOI 10.1073/pnas.1101219108; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; FLEXNER LB, 1964, P NATL ACAD SCI USA, V52, P1165, DOI 10.1073/pnas.52.5.1165; Gao J, 2010, NATURE, V466, P1105, DOI 10.1038/nature09271; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Guttilla IK, 2009, J BIOL CHEM, V284, P23204, DOI 10.1074/jbc.M109.031427; Haflidadottir BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011574; Hasseine LK, 2009, BIOCHEM BIOPH RES CO, V390, P1278, DOI 10.1016/j.bbrc.2009.10.135; Hebert SS, 2009, NEUROBIOL DIS, V33, P422, DOI 10.1016/j.nbd.2008.11.009; Helmstetter FJ, 2008, NEUROBIOL LEARN MEM, V89, P324, DOI 10.1016/j.nlm.2007.09.002; Huang WH, 2009, INT J NEUROPSYCHOPH, V12, P537, DOI 10.1017/S1461145708009528; Huff NC, 2006, J NEUROSCI, V26, P1616, DOI 10.1523/JNEUROSCI.4964-05.2006; Iliopoulos D, 2010, MOL CELL, V39, P493, DOI 10.1016/j.molcel.2010.07.023; Ivanovska I, 2008, MOL CELL BIOL, V28, P2167, DOI 10.1128/MCB.01977-07; Jennewein C, 2010, J BIOL CHEM, V285, P11846, DOI 10.1074/jbc.M109.066399; Jesus ABD, 2009, CELL CYCLE, V8, P394; Jiao J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010551; Kato M, 2009, NAT CELL BIOL, V11, P881, DOI 10.1038/ncb1897; Kefas B, 2009, J NEUROSCI, V29, P15161, DOI 10.1523/JNEUROSCI.4966-09.2009; Khudayberdiev Sharof, 2009, Commun Integr Biol, V2, P411; Konopka W, 2010, J NEUROSCI, V30, P14835, DOI 10.1523/JNEUROSCI.3030-10.2010; Kosik KS, 2006, NATURE, V439, P138, DOI 10.1038/439138a; Kye MJ, 2007, RNA, V13, P1224, DOI 10.1261/rna.480407; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; Lee YS, 2009, NAT REV NEUROSCI, V10, P126, DOI 10.1038/nrn2572; Lein ES, 2004, J NEUROSCI, V24, P3879, DOI 10.1523/JNEUROSCI.4710-03.2004; Moriarty CH, 2010, J BIOL CHEM, V285, P20541, DOI 10.1074/jbc.M110.121012; Myatt SS, 2010, CANCER RES, V70, P367, DOI 10.1158/0008-5472.CAN-09-1891; Ohno M, 2001, NAT NEUROSCI, V4, P1238, DOI 10.1038/nn771; Olive V, 2009, GENE DEV, V23, P2839, DOI 10.1101/gad.1861409; Park SY, 2009, NAT STRUCT MOL BIOL, V16, P23, DOI 10.1038/nsmb.1533; Peleg S, 2010, SCIENCE, V328, P753, DOI 10.1126/science.1186088; Poliseno L, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000594; Rajasethupathy P, 2009, NEURON, V63, P803, DOI 10.1016/j.neuron.2009.05.029; Saunders LR, 2010, AGING-US, V2, P415, DOI 10.18632/aging.100176; Schaar DG, 2009, EXP HEMATOL, V37, P245, DOI 10.1016/j.exphem.2008.10.002; Schratt G, 2009, CURR OPIN NEUROBIOL, V19, P213, DOI 10.1016/j.conb.2009.05.015; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shioya M, 2010, NEUROPATH APPL NEURO, V36, P320, DOI 10.1111/j.1365-2990.2010.01076.x; Siegel G, 2009, NAT CELL BIOL, V11, P705, DOI 10.1038/ncb1876; Sood P, 2006, P NATL ACAD SCI USA, V103, P2746, DOI 10.1073/pnas.0511045103; Stark KL, 2008, NAT GENET, V40, P751, DOI 10.1038/ng.138; Stoica L, 2011, P NATL ACAD SCI US; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Urdinguio RG, 2010, EPIGENETICS-US, V5, P656, DOI 10.4161/epi.5.7.13055; van den Berg A, 2008, BBA-GENE REGUL MECH, V1779, P668, DOI 10.1016/j.bbagrm.2008.07.005; Wang HL, 2010, BRAIN RES, V1357, P166, DOI 10.1016/j.brainres.2010.08.023; Wang WX, 2008, J NEUROSCI, V28, P1213, DOI 10.1523/JNEUROSCI.5065-07.2008; Wang WX, 2010, AM J PATHOL, V177, P334, DOI 10.2353/ajpath.2010.091202; Wayman GA, 2008, P NATL ACAD SCI USA, V105, P9093, DOI 10.1073/pnas.0803072105; Xiong J, 2010, ONCOGENE, V29, P4980, DOI 10.1038/onc.2010.241; Xu Y, 2010, SCHIZOPHR RES, V119, P219, DOI 10.1016/j.schres.2010.02.1070; Zhang JG, 2010, CLIN CHIM ACTA, V411, P846, DOI 10.1016/j.cca.2010.02.074; Zhang J, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-62; Zhu Z, 2010, DOMEST ANIM ENDOCRIN, V38, P200, DOI 10.1016/j.domaniend.2009.10.004	84	50	51	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2011	6	9							e24682	10.1371/journal.pone.0024682	http://dx.doi.org/10.1371/journal.pone.0024682			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CO	21931811	Green Published, Green Submitted, gold			2022-12-25	WOS:000294803200038
J	Orecchia, A; Scarponi, C; Di Felice, F; Cesarini, E; Avitabile, S; Mai, A; Mauro, ML; Sirri, V; Zambruno, G; Albanesi, C; Camilloni, G; Failla, CM				Orecchia, Angela; Scarponi, Claudia; Di Felice, Francesca; Cesarini, Elisa; Avitabile, Simona; Mai, Antonello; Mauro, Maria Luisa; Sirri, Valentina; Zambruno, Giovanna; Albanesi, Cristina; Camilloni, Giorgio; Failla, Cristina M.			Sirtinol Treatment Reduces Inflammation in Human Dermal Microvascular Endothelial Cells	PLOS ONE			English	Article							ADHESION MOLECULES; GROWTH-FACTOR; SIRT1; INHIBITORS; DEACETYLASE; PROTEINS; SIRTUINS; DISEASE; TRANSCRIPTION; SENESCENCE	Histone deacetylases (HDAC) are key enzymes in the epigenetic control of gene expression. Recently, inhibitors of class I and class II HDAC have been successfully employed for the treatment of different inflammatory diseases such as rheumatoid arthritis, colitis, airway inflammation and asthma. So far, little is known so far about a similar therapeutic effect of inhibitors specifically directed against sirtuins, the class III HDAC. In this study, we investigated the expression and localization of endogenous sirtuins in primary human dermal microvascular endothelial cells (HDMEC), a cell type playing a key role in the development and maintenance of skin inflammation. We then examined the biological activity of sirtinol, a specific sirtuin inhibitor, in HDMEC response to pro-inflammatory cytokines. We found that, even though sirtinol treatment alone affected only long-term cell proliferation, it diminishes HDMEC inflammatory responses to tumor necrosis factor (TNF)alpha and interleukin (IL)-1 beta. In fact, sirtinol significantly reduced membrane expression of adhesion molecules in TNFa- or IL-1 beta-stimulated cells, as well as the amount of CXCL10 and CCL2 released by HDMEC following TNF alpha treatment. Notably, sirtinol drastically decreased monocyte adhesion on activated HDMEC. Using selective inhibitors for Sirt1 and Sirt2, we showed a predominant involvement of Sirt1 inhibition in the modulation of adhesion molecule expression and monocyte adhesion on activated HDMEC. Finally, we demonstrated the in vivo expression of Sirt1 in the dermal vessels of normal and psoriatic skin. Altogether, these findings indicated that sirtuins may represent a promising therapeutic target for the treatment of inflammatory skin diseases characterized by a prominent microvessel involvement.	[Orecchia, Angela; Di Felice, Francesca; Avitabile, Simona; Zambruno, Giovanna; Failla, Cristina M.] IDI IRCCS, Mol & Cell Biol Lab, Rome, Italy; [Scarponi, Claudia; Albanesi, Cristina] IDI IRCCS, Expt Immunol Lab, Rome, Italy; [Cesarini, Elisa; Mauro, Maria Luisa; Camilloni, Giorgio] Univ Roma La Sapienza, Dept Biol & Biotechnol C Darwin, Rome, Italy; [Mai, Antonello] Univ Roma La Sapienza, Dept Drug Chem & Technol, Inst Pasteur, Cenci Bolognetti Fdn, Rome, Italy; [Sirri, Valentina] Univ Paris 06, CNRS, RNA Biol, FRE3402, Paris, France; [Camilloni, Giorgio] CNR, Ist Biol & Patol Mol, Rome, Italy	IRCCS Istituto Dermopatico dell'Immacolata (IDI); IRCCS Istituto Dermopatico dell'Immacolata (IDI); Sapienza University Rome; Fondazione Cenci Bolognetti; Sapienza University Rome; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR)	Orecchia, A (corresponding author), IDI IRCCS, Mol & Cell Biol Lab, Rome, Italy.	c.failla@idi.it	Felice, Francesca/C-3882-2009; Zambruno, Giavanna/K-2933-2018; Albanesi, Cristina/K-4699-2016; Failla, Cristina M./AAA-2881-2019; Mai, Antonello/AAC-2144-2019	Felice, Francesca/0000-0001-8968-2228; Albanesi, Cristina/0000-0002-7537-6833; Mai, Antonello/0000-0001-9176-2382; Mauro, Maria Luisa/0000-0002-0296-0342; Failla, Cristina/0000-0001-5991-8914; Camilloni, Giorgio/0000-0002-1195-6142; Zambruno, Giovanna/0000-0002-1295-056X	Italian Ministry of Health [RF06-Conv.74.2]; Fondazione Roma; Istituto Pasteur-Fondazione Cenci Bolognetti, University of Rome (La Sapienza)	Italian Ministry of Health(Ministry of Health, Italy); Fondazione Roma(Fondazione RomaEuropean Commission); Istituto Pasteur-Fondazione Cenci Bolognetti, University of Rome (La Sapienza)(Istituto Pasteur Italia Fondazione Cenci Bolognetti)	This work was supported by the Italian Ministry of Health, RF06-Conv.74.2, by Fondazione Roma, and by the Istituto Pasteur-Fondazione Cenci Bolognetti, University of Rome (La Sapienza). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adcock IM, 2007, BRIT J PHARMACOL, V150, P829, DOI 10.1038/sj.bjp.0707166; Beekhuizen H, 1998, TRANSPL P, V30, P4251, DOI 10.1016/S0041-1345(98)01405-5; Choi JH, 2005, CLIN EXP ALLERGY, V35, P89, DOI 10.1111/j.1365-2222.2004.02006.x; Craig LE, 1998, MICROVASC RES, V55, P65, DOI 10.1006/mvre.1997.2045; Danese S, 2007, J IMMUNOL, V178, P6017, DOI 10.4049/jimmunol.178.10.6017; DICORLETO PE, 1985, J CLIN INVEST, V75, P1153, DOI 10.1172/JCI111810; Dong J, 2010, GENE DEV, V24, P1709, DOI 10.1101/gad.1958410; Donmez G, 2010, AGING CELL, V9, P285, DOI 10.1111/j.1474-9726.2010.00548.x; Failla CM, 2000, J INVEST DERMATOL, V115, P388, DOI 10.1046/j.1523-1747.2000.00085.x; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Ford E, 2006, GENE DEV, V20, P1075, DOI 10.1101/gad.1399706; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Galli M, 2011, BIOCHEM PHARMACOL, V81, P569, DOI 10.1016/j.bcp.2010.12.010; Glauben R, 2006, J IMMUNOL, V176, P5015, DOI 10.4049/jimmunol.176.8.5015; Grabiec AM, 2010, J IMMUNOL, V184, P2718, DOI 10.4049/jimmunol.0901467; Grob A, 2009, J CELL SCI, V122, P489, DOI 10.1242/jcs.042382; Grozinger CM, 2001, J BIOL CHEM, V276, P38837, DOI 10.1074/jbc.M106779200; Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029; Hillyer P, 2003, CLIN EXP IMMUNOL, V134, P431, DOI 10.1111/j.1365-2249.2003.02323.x; Hsieh TC, 2010, INT J MOL MED, V26, P741, DOI 10.3892/ijmm_00000521; Inoue K, 2006, ARTERIOSCL THROM VAS, V26, P2652, DOI 10.1161/01.ATV.0000247247.89787.e7; Kim SR, 2010, J ALLERGY CLIN IMMUN, V125, P449, DOI 10.1016/j.jaci.2009.08.009; KUBOTA Y, 1988, J CELL BIOL, V107, P1589, DOI 10.1083/jcb.107.4.1589; Lang I, 2003, EUR J CELL BIOL, V82, P163, DOI 10.1078/0171-9335-00306; Mai A, 2005, J MED CHEM, V48, P7789, DOI 10.1021/jm050100l; Mattagajasingh I, 2007, P NATL ACAD SCI USA, V104, P14855, DOI 10.1073/pnas.0704329104; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Nakamura Y, 2008, BIOCHEM BIOPH RES CO, V366, P174, DOI 10.1016/j.bbrc.2007.11.122; Napper AD, 2005, J MED CHEM, V48, P8045, DOI 10.1021/jm050522v; Nayagam VM, 2006, J BIOMOL SCREEN, V11, P959, DOI 10.1177/1087057106294710; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; Oberdoerffer P, 2008, CELL, V135, P907, DOI 10.1016/j.cell.2008.10.025; Orecchia A, 2003, J CELL SCI, V116, P3479, DOI 10.1242/jcs.00673; Ota H, 2007, J MOL CELL CARDIOL, V43, P571, DOI 10.1016/j.yjmcc.2007.08.008; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; Potente M, 2007, GENE DEV, V21, P2644, DOI 10.1101/gad.435107; Sestito R, 2011, FASEB J, V25, P916, DOI 10.1096/fj.10-172288; Shen Z, 2009, AM J PHYSIOL-GASTR L, V296, pG1047, DOI 10.1152/ajpgi.00016.2009; SWERLICK RA, 1993, J INVEST DERMATOL, V100, pS111, DOI 10.1111/1523-1747.ep12356595; VAPORCIYAN AA, 1993, J IMMUNOL METHODS, V159, P93, DOI 10.1016/0022-1759(93)90145-W; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yoshizaki T, 2009, MOL CELL BIOL, V29, P1363, DOI 10.1128/MCB.00705-08; Zu Y, 2010, CIRC RES, V106, P1384, DOI 10.1161/CIRCRESAHA.109.215483	43	54	55	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2011	6	9							e24307	10.1371/journal.pone.0024307	http://dx.doi.org/10.1371/journal.pone.0024307			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CO	21931678	Green Published, gold, Green Submitted			2022-12-25	WOS:000294803200013
J	Hsieh, JY; Yang, JY; Lin, CL; Liu, GY; Hung, HC				Hsieh, Ju-Yi; Yang, Jung-Yen; Lin, Chih-Li; Liu, Guang-Yaw; Hung, Hui-Chih			Minimal Antizyme Peptide Fully Functioning in the Binding and Inhibition of Ornithine Decarboxylase and Antizyme Inhibitor	PLOS ONE			English	Article							CELL-GROWTH; ANALYTICAL ULTRACENTRIFUGATION; ODC ANTIZYME; POLYAMINES; PROTEIN; DEGRADATION; EXPRESSION; TRANSFORMATION; OVEREXPRESSION; TARGET	Antizyme (AZ) is a protein with 228 amino acid residues that regulates ornithine decarboxylase (ODC) by binding to ODC and dissociating its homodimer, thus inhibiting its enzyme activity. Antizyme inhibitor (AZI) is homologous to ODC, but has a higher affinity than ODC for AZ. In this study, we quantified the biomolecular interactions between AZ and ODC as well as AZ and AZI to identify functional AZ peptides that could bind to ODC and AZI and inhibit their function as efficiently as the full-length AZ protein. For these AZ peptides, the inhibitory ability of AZ_95-228 was similar to that of AZ_WT. Furthermore, AZ_95-176 displayed an inhibition (IC50: 0.20 mu M) similar to that of AZ-95-228 (IC50: 0.16 mM), even though a large segment spanning residues 177-228 was deleted. However, further deletion of AZ_95-176 from either the N-terminus or the C-terminus decreased its ability to inhibit ODC. The AZ_100-176 and AZ_95-169 peptides displayed a noteworthy decrease in ability to inhibit ODC, with IC50 values of 0.43 and 0.37 mM, respectively. The AZ_95-228, AZ_100-228 and AZ_95-176 peptides had IC50 values comparable to that of AZ_WT and formed AZ-ODC complexes with K-d,K-AZ-ODC values of 1.5, 5.3 and 5.6 mu M, respectively. Importantly, our data also indicate that AZI can rescue AZ peptide-inhibited ODC enzyme activity and that it can bind to AZ peptides with a higher affinity than ODC. Together, these data suggest that these truncated AZ proteins retain their AZI-binding ability. Thus, we suggest that AZ_ 95-176 is the minimal AZ peptide that is fully functioning in the binding of ODC and AZI and inhibition of their function.	[Hsieh, Ju-Yi; Hung, Hui-Chih] Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan; [Hsieh, Ju-Yi; Hung, Hui-Chih] Natl Chung Hsing Univ, Inst Bioinformat, Taichung 40227, Taiwan; [Yang, Jung-Yen] Natl Chiao Tung Univ, Natl Nano Device Labs, Hsinchu, Taiwan; [Yang, Jung-Yen] Natl Chiao Tung Univ, Dept Elect Engn, Hsinchu, Taiwan; [Lin, Chih-Li] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Liu, Guang-Yaw] Chung Shan Med Univ, Inst Microbiol & Immunol, Taichung, Taiwan; [Liu, Guang-Yaw] Chung Shan Med Univ Hosp, Div Rheumatol Allergy & Immunol, Taichung, Taiwan; [Hung, Hui-Chih] Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung 40227, Taiwan	National Chung Hsing University; National Chung Hsing University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; National Chung Hsing University	Hsieh, JY (corresponding author), Natl Chung Hsing Univ, Dept Life Sci, Taichung 40227, Taiwan.	liugy@csmu.edu.tw; hchung@dragon.nchu.edu.tw	Hung, Hui-Chih/G-4485-2013; Lin, Chih-Li/H-9515-2019; Hung, Hui-Chih/L-8061-2019; Lin, Chih-Li/GQZ-6480-2022	Hung, Hui-Chih/0000-0003-0180-1822; Lin, Chih-Li/0000-0003-4553-3727; Hung, Hui-Chih/0000-0003-0180-1822; 	National Science Council, Republic of China [NSC-99-2113-M-005-010, NSC-99-2314-B-040-002-MY3]; Ministry of Education, Taiwan, Republic of China	National Science Council, Republic of China(Ministry of Science and Technology, Taiwan); Ministry of Education, Taiwan, Republic of China(Ministry of Education, Taiwan)	This work was supported by the National Science Council, Republic of China (NSC-99-2113-M-005-010 and NSC-99-2314-B-040-002-MY3) and in part, by the Ministry of Education, Taiwan, Republic of China under the Aim of Top University plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albeck S, 2008, PROTEIN SCI, V17, P793, DOI 10.1110/ps.073427208; Almrud JJ, 2000, J MOL BIOL, V295, P7, DOI 10.1006/jmbi.1999.3331; AUVINEN M, 1992, NATURE, V360, P355, DOI 10.1038/360355a0; BELLOFERNANDEZ C, 1993, P NATL ACAD SCI USA, V90, P7804, DOI 10.1073/pnas.90.16.7804; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown Patrick H, 2008, Curr Protoc Immunol, VChapter 18, DOI 10.1002/0471142735.im1815s81; Chen H, 2002, J BIOL CHEM, V277, P45957, DOI 10.1074/jbc.M206799200; Childs AC, 2003, CELL MOL LIFE SCI, V60, P1394, DOI 10.1007/s00018-003-2332-4; Coffino P, 2001, NAT REV MOL CELL BIO, V2, P188, DOI 10.1038/35056508; Cohavi O, 2009, J MOL BIOL, V390, P503, DOI 10.1016/j.jmb.2009.05.029; Dam J, 2005, BIOPHYS J, V89, P651, DOI 10.1529/biophysj.105.059584; Feith DJ, 2006, CARCINOGENESIS, V27, P1090, DOI 10.1093/carcin/bgi343; Fong LYY, 2003, CANCER RES, V63, P3945; FUJITA K, 1982, BIOCHEM J, V204, P647, DOI 10.1042/bj2040647; Gandre S, 2002, EUR J BIOCHEM, V269, P1316, DOI 10.1046/j.1432-1033.2002.02774.x; Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454; GHODA L, 1989, SCIENCE, V243, P1493, DOI 10.1126/science.2928784; HELLER JS, 1976, P NATL ACAD SCI USA, V73, P1858, DOI 10.1073/pnas.73.6.1858; Hoffman DW, 2005, BIOCHEMISTRY-US, V44, P11777, DOI 10.1021/bi051081k; ICHIBA T, 1994, BIOCHEM BIOPH RES CO, V200, P1721, DOI 10.1006/bbrc.1994.1651; Ivanov IP, 2000, P NATL ACAD SCI USA, V97, P4808, DOI 10.1073/pnas.070055897; Ivanov IP, 1998, GENOMICS, V52, P119, DOI 10.1006/geno.1998.5434; Ivanov IP, 2000, NUCLEIC ACIDS RES, V28, P3185, DOI 10.1093/nar/28.17.3185; Iwata S, 1999, ONCOGENE, V18, P165, DOI 10.1038/sj.onc.1202275; Jackson LK, 2003, BIOCHEMISTRY-US, V42, P2933, DOI 10.1021/bi026795z; Kahana C, 2009, CELL MOL LIFE SCI, V66, P2479, DOI 10.1007/s00018-009-0033-3; Keren-Paz A, 2006, ONCOGENE, V25, P5163, DOI 10.1038/sj.onc.1209521; Kim SW, 2006, J CELL SCI, V119, P2853, DOI 10.1242/jcs.02966; KITANI T, 1989, BIOCHIM BIOPHYS ACTA, V991, P44, DOI 10.1016/0304-4165(89)90026-3; Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250; Laue T.M., 1992, ANAL ULTRACENTRIFUGA; LI XQ, 1993, MOL CELL BIOL, V13, P2377, DOI 10.1128/MCB.13.4.2377; LI XQ, 1994, MOL CELL BIOL, V14, P87, DOI 10.1128/MCB.14.1.87; Li XQ, 1996, J BIOL CHEM, V271, P4441; Mangold U, 2006, CELL MOL LIFE SCI, V63, P2095, DOI 10.1007/s00018-005-5583-4; Mangold U, 2005, IUBMB LIFE, V57, P671, DOI 10.1080/15216540500307031; Mangold U, 2005, BIOCHEM J, V385, P21, DOI 10.1042/BJ20040547; MARTON LJ, 1995, ANNU REV PHARMACOL, V35, P55, DOI 10.1146/annurev.pa.35.040195.000415; MATSUFUJI S, 1995, CELL, V80, P51, DOI 10.1016/0092-8674(95)90450-6; MCCANN PP, 1992, PHARMACOL THERAPEUT, V54, P195, DOI 10.1016/0163-7258(92)90032-U; MOSHIER JA, 1993, CANCER RES, V53, P2618; MURAKAMI Y, 1994, BIOCHEM J, V304, P183, DOI 10.1042/bj3040183; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; Murakami Y, 1996, J BIOL CHEM, V271, P3340, DOI 10.1074/jbc.271.7.3340; Nilsson J, 2000, BIOCHEM J, V346, P699, DOI 10.1042/0264-6021:3460699; Palanimurugan R, 2004, EMBO J, V23, P4857, DOI 10.1038/sj.emboj.7600473; PEGG AE, 1982, AM J PHYSIOL, V243, pC212, DOI 10.1152/ajpcell.1982.243.5.C212; Pegg AE, 2006, J BIOL CHEM, V281, P14529, DOI 10.1074/jbc.R500031200; ROM E, 1994, P NATL ACAD SCI USA, V91, P3959, DOI 10.1073/pnas.91.9.3959; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Shantz LM, 1998, CANCER RES, V58, P2748; Snapir Z, 2009, BIOCHEM J, V419, P99, DOI 10.1042/BJ20081874; Su KL, 2009, J BIOL CHEM, V284, P26768, DOI 10.1074/jbc.M109.007807; TABOR CW, 1984, ANNU REV BIOCHEM, V53, P749, DOI 10.1146/annurev.bi.53.070184.003533; Thomas T, 2001, CELL MOL LIFE SCI, V58, P244, DOI 10.1007/PL00000852; Zhang MS, 2003, EMBO J, V22, P1488, DOI 10.1093/emboj/cdg158; Zhu C, 1999, J BIOL CHEM, V274, P26425, DOI 10.1074/jbc.274.37.26425	58	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2011	6	9							e24366	10.1371/journal.pone.0024366	http://dx.doi.org/10.1371/journal.pone.0024366			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CN	21931692	gold, Green Submitted, Green Published			2022-12-25	WOS:000294803100022
J	Miguelez, C; Aristieta, A; Cenci, MA; Ugedo, L				Miguelez, Cristina; Aristieta, Asier; Cenci, Maria Angela; Ugedo, Luisa			The locus coeruleus Is Directly Implicated in L-DOPA-Induced Dyskinesia in Parkinsonian Rats: An Electrophysiological and Behavioural Study	PLOS ONE			English	Article							ABNORMAL INVOLUNTARY MOVEMENTS; CENTRAL NORADRENERGIC NEURONS; LEVODOPA-INDUCED DYSKINESIA; LESIONED PRIMATE MODEL; SUBSTANTIA-NIGRA; SUBTHALAMIC NUCLEUS; COERULEUS NEURONS; DOPAMINERGIC STIMULATION; RECEPTOR ANTAGONIST; MONOAMINE-OXIDASE	Despite being the most effective treatment for Parkinson's disease, L-DOPA causes a development of dyskinetic movements in the majority of treated patients. L-DOPA-induced dyskinesia is attributed to a dysregulated dopamine transmission within the basal ganglia, but serotonergic and noradrenergic systems are believed to play an important modulatory role. In this study, we have addressed the role of the locus coeruleus nucleus (LC) in a rat model of L-DOPA-induced dyskinesia. Single-unit extracellular recordings in vivo and behavioural and immunohistochemical approaches were applied in rats rendered dyskinetic by the destruction of the nigrostriatal dopamine neurons followed by chronic treatment with L-DOPA. The results showed that L-DOPA treatment reversed the change induced by 6-hydroxydopamine lesions on LC neuronal activity. The severity of the abnormal involuntary movements induced by L-DOPA correlated with the basal firing parameters of LC neuronal activity. Systemic administration of the LC-selective noradrenergic neurotoxin N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine did not modify axial, limb, and orolingual dyskinesia, whereas chemical destruction of the LC with ibotenic acid significantly increased the abnormal involuntary movement scores. These results are the first to demonstrate altered LC neuronal activity in 6-OHDA lesioned rats treated with L-DOPA, and indicate that an intact noradrenergic system may limit the severity of this movement disorder.	[Miguelez, Cristina; Aristieta, Asier; Ugedo, Luisa] Univ Basque Country, Fac Med & Dent, Dept Pharmacol, Vizcaya, Spain; [Cenci, Maria Angela] Lund Univ, Basal Ganglia Pathophysiol Unit, Dept Expt Med Sci, Lund, Sweden	University of Basque Country; Lund University	Miguelez, C (corresponding author), Univ Basque Country, Fac Med & Dent, Dept Pharmacol, Vizcaya, Spain.	luisa.ugedo@ehu.es	Ugedo, Luisa/H-4244-2015; Miguelez, Cristina/I-6213-2015	Ugedo, Luisa/0000-0001-5993-0606; Miguelez, Cristina/0000-0001-6624-2932; Cenci Nilsson, M. Angela/0000-0003-2216-2900	Ministry of Science and Technology [SAF 2009-08664]; Basque Government [SAIOTEK SA 2010/00033, GIC07/143-IT-201-07]; University of the Basque Country (UPV/EHU)	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Basque Government(Basque Government); University of the Basque Country (UPV/EHU)	This study was supported by the Ministry of Science and Technology (SAF 2009-08664) and the Basque Government (SAIOTEK SA 2010/00033 and GIC07/143-IT-201-07). CM has a fellowship from the Basque Government and AA a grant from the University of the Basque Country (UPV/EHU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE ED, 1989, J NEUROSCI, V9, P4062; Ahlskog JE, 2001, MOVEMENT DISORD, V16, P448, DOI 10.1002/mds.1090; Alachkar A, 2006, NEUROSCI LETT, V395, P138, DOI 10.1016/j.neulet.2005.10.069; Alachkar A, 2011, J MOL NEUROSCI; Alachkar A, 2010, NEUROSCI RES, V67, P245, DOI 10.1016/j.neures.2010.03.008; Arai A, 2008, SYNAPSE, V62, P632, DOI 10.1002/syn.20535; Arai R, 1998, NEUROSCI LETT, V250, P41, DOI 10.1016/S0304-3940(98)00429-7; Archer T, 2006, J NEURAL TRANSM, V113, P1119, DOI 10.1007/s00702-005-0402-5; Berretta N, 2000, NEUROSCIENCE, V98, P599, DOI 10.1016/S0306-4522(00)00135-4; Berthet A, 2009, PARKINSONISM RELAT D, V15, pS8, DOI 10.1016/S1353-8020(09)70827-2; Bilbao G, 2006, BRAIN RES, V1084, P175, DOI 10.1016/j.brainres.2006.02.052; Boraud T, 2001, BRAIN, V124, P546, DOI 10.1093/brain/124.3.546; Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9; Buck K, 2010, J NEUROCHEM, V112, P444, DOI 10.1111/j.1471-4159.2009.06482.x; Carlsson T, 2005, BRAIN, V128, P559, DOI 10.1093/brain/awh374; Carta M, 2006, J NEUROCHEM, V96, P1718, DOI 10.1111/j.1471-4159.2006.03696.x; CEDARBAUM JM, 1977, EUR J PHARMACOL, V44, P375, DOI 10.1016/0014-2999(77)90312-0; CEDARBAUM JM, 1976, BRAIN RES, V112, P413, DOI 10.1016/0006-8993(76)90297-3; Cenci M, 2009, DOPAMINE HDB, P434; Cenci MA, 2007, CURR OPIN NEUROBIOL, V17, P665, DOI 10.1016/j.conb.2008.01.004; Cenci MA, 2010, PROG BRAIN RES, V183, P209, DOI 10.1016/S0079-6123(10)83011-0; Cenci MA, 1998, EUR J NEUROSCI, V10, P2694, DOI 10.1046/j.1460-9568.1998.t01-1-00285.x; Cenci MA, 2007, CURR PROTOC NEUROSCI; CHERGUI K, 1994, NEUROREPORT, V5, P1185, DOI 10.1097/00001756-199406020-00006; Dawe GS, 2001, BIOL PSYCHIAT, V50, P510, DOI 10.1016/S0006-3223(01)01171-4; Dekundy A, 2007, BEHAV BRAIN RES, V179, P76, DOI 10.1016/j.bbr.2007.01.013; DUTTON A, 1979, J PHYSIOL-LONDON, V290, P433, DOI 10.1113/jphysiol.1979.sp012781; ELAM M, 1986, NEUROPHARMACOLOGY, V25, P1003, DOI 10.1016/0028-3908(86)90194-2; Fornai F, 2007, CURR MED CHEM, V14, P2330, DOI 10.2174/092986707781745550; Fox SH, 2001, MOVEMENT DISORD, V16, P642, DOI 10.1002/mds.1148; Frisina PG, 2009, PARKINSONISM RELAT D, V15, P144, DOI 10.1016/j.parkreldis.2008.04.038; FRITSCHY JM, 1989, NEUROSCIENCE, V30, P181, DOI 10.1016/0306-4522(89)90364-3; FRITSCHY JM, 1991, EXP NEUROL, V111, P123, DOI 10.1016/0014-4886(91)90058-K; Fulceri F, 2007, BRAIN RES, V1135, P219, DOI 10.1016/j.brainres.2006.12.030; GEHLERT DR, 1995, J NEUROCHEM, V64, P2792; GEHLERT DR, 1993, NEUROSCI LETT, V157, P203, DOI 10.1016/0304-3940(93)90737-6; Gesi M, 2000, NEUROSCI BIOBEHAV R, V24, P655, DOI 10.1016/S0149-7634(00)00028-2; GIBSON CJ, 1988, J PHARM PHARMACOL, V40, P258, DOI 10.1111/j.2042-7158.1988.tb05239.x; GOMEZMANCILLA B, 1993, CLIN NEUROPHARMACOL, V16, P418, DOI 10.1097/00002826-199310000-00004; GONON FG, 1988, NEUROSCIENCE, V24, P19, DOI 10.1016/0306-4522(88)90307-7; GRACE AA, 1984, J NEUROSCI, V4, P2877; Grondin R, 2000, N-S ARCH PHARMACOL, V361, P181, DOI 10.1007/s002109900167; Henry B, 1998, EXP NEUROL, V151, P334, DOI 10.1006/exnr.1998.6819; Henry B, 1999, MOVEMENT DISORD, V14, P744, DOI 10.1002/1531-8257(199909)14:5<744::AID-MDS1006>3.0.CO;2-7; Hida T, 1998, BRAIN RES, V814, P209, DOI 10.1016/S0006-8993(98)00939-1; Holmberg M, 1999, NEUROSCIENCE, V93, P1323, DOI 10.1016/S0306-4522(99)00260-2; Hornykiewicz O, 1998, NEUROLOGY, V51, pS2, DOI 10.1212/WNL.51.2_Suppl_2.S2; Hutchison WD, 1997, ANN NEUROL, V42, P767, DOI 10.1002/ana.410420513; Kaehler ST, 1999, N-S ARCH PHARMACOL, V360, P428, DOI 10.1007/s002109900094; Kaehler ST, 1999, N-S ARCH PHARMACOL, V359, P386, DOI 10.1007/PL00005365; KISH SJ, 1988, NEW ENGL J MED, V318, P876, DOI 10.1056/NEJM198804073181402; Lee CS, 2000, BRAIN, V123, P1365, DOI 10.1093/brain/123.7.1365; Lin Y, 2008, SYNAPSE, V62, P516, DOI 10.1002/syn.20517; Lindgren HS, 2007, BEHAV BRAIN RES, V177, P150, DOI 10.1016/j.bbr.2006.09.019; Lindgren HS, 2010, J NEUROCHEM, V112, P1465, DOI 10.1111/j.1471-4159.2009.06556.x; LUNDBERG JM, 1986, NEUROSCI LETT, V63, P96, DOI 10.1016/0304-3940(86)90020-0; Lundblad M, 2002, EUR J NEUROSCI, V15, P120, DOI 10.1046/j.0953-816x.2001.01843.x; MAGNUSON DSK, 1993, BRAIN RES, V628, P317, DOI 10.1016/0006-8993(93)90972-P; Marin C, 2008, J NEURAL TRANSM; Meissner W, 2006, NEUROBIOL DIS, V22, P586, DOI 10.1016/j.nbd.2006.01.009; Mela F, 2007, J NEUROCHEM, V101, P483, DOI 10.1111/j.1471-4159.2007.04456.x; Mercuri NB, 2005, TRENDS PHARMACOL SCI, V26, P341, DOI 10.1016/j.tips.2005.05.002; Miguelez C, 2009, NEUROPHARMACOLOGY, V56, P1068, DOI 10.1016/j.neuropharm.2009.03.004; Miguelez C, 2010, INT J NEUROPSYCHOPH, P1; Morera-Herreras T, 2008, NEUROSCIENCE, V151, P817, DOI 10.1016/j.neuroscience.2007.11.016; Morera-Herreras T, 2010, SYNAPSE, V64, P20, DOI 10.1002/syn.20701; Obeso JA, 2000, TRENDS NEUROSCI, V23, pS2, DOI 10.1016/S1471-1931(00)00031-8; OLPE HR, 1983, NEUROSCI LETT, V40, P81, DOI 10.1016/0304-3940(83)90096-4; Pavese N, 2006, NEUROLOGY, V67, P1612, DOI 10.1212/01.wnl.0000242888.30755.5d; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Perez V, 2009, J NEURAL TRANSM, V116, P1257, DOI 10.1007/s00702-009-0291-0; Perez V, 2007, EUR J PHARMACOL, V576, P83, DOI 10.1016/j.ejphar.2007.08.024; Pineda J, 1997, J PHARMACOL EXP THER, V281, P690; Pineda J, 1995, Ann N Y Acad Sci, V763, P501, DOI 10.1111/j.1749-6632.1995.tb32441.x; Rascol O, 2001, MOVEMENT DISORD, V16, P708, DOI 10.1002/mds.1143; Remy P, 2005, BRAIN, V128, P1314, DOI 10.1093/brain/awh445; Rosin DL, 1996, J COMP NEUROL, V372, P135; ROSS SB, 1976, BRIT J PHARMACOL, V58, P521, DOI 10.1111/j.1476-5381.1976.tb08619.x; RUIZORTEGA JA, 1995, N-S ARCH PHARMACOL, V352, P121; Samii A, 2004, LANCET, V363, P1783, DOI 10.1016/S0140-6736(04)16305-8; Savola JM, 2003, MOVEMENT DISORD, V18, P872, DOI 10.1002/mds.10464; SCHEININ M, 1994, MOL BRAIN RES, V21, P133, DOI 10.1016/0169-328X(94)90386-7; Srinivasan J, 2003, EUR J NEUROSCI, V17, P2586, DOI 10.1046/j.1460-9568.2003.02684.x; Szot P, 2010, NEUROSCIENCE, V166, P279, DOI 10.1016/j.neuroscience.2009.12.027; Visanji NP, 2009, J PHARMACOL EXP THER, V328, P276, DOI 10.1124/jpet.108.144097; Wang Y, 2010, BRAIN RES, V1310, P189, DOI 10.1016/j.brainres.2009.10.070; Winkler C, 2002, NEUROBIOL DIS, V10, P165, DOI 10.1006/nbdi.2002.0499; WOLFMAN C, 1994, NEUROCHEM INT, V25, P395, DOI 10.1016/0197-0186(94)90147-3; Zarow C, 2003, ARCH NEUROL-CHICAGO, V60, P337, DOI 10.1001/archneur.60.3.337	89	41	41	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2011	6	9							e24679	10.1371/journal.pone.0024679	http://dx.doi.org/10.1371/journal.pone.0024679			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CN	21931808	gold, Green Published, Green Submitted			2022-12-25	WOS:000294803100055
J	Tang, F; Wang, B; Li, N; Wu, YF; Jia, JY; Suo, TL; Chen, Q; Liu, YJ; Tang, J				Tang, Fei; Wang, Bin; Li, Na; Wu, Yanfang; Jia, Junying; Suo, Talin; Chen, Quan; Liu, Yong-Jun; Tang, Jie			RNF185, a Novel Mitochondrial Ubiquitin E3 Ligase, Regulates Autophagy through Interaction with BNIP1	PLOS ONE			English	Article							BCL-2 FAMILY-MEMBERS; CELL-DEATH; SELECTIVE AUTOPHAGY; FLUORESCENT PROTEIN; QUALITY-CONTROL; MITOPHAGY; APOPTOSIS; DEGRADATION; MECHANISMS; BECLIN-1	Autophagy is an evolutionarily conserved catabolic process that allows recycling of cytoplasmic organelles, such as mitochondria, to offer a bioenergetically efficient pathway for cell survival. Considerable progress has been made in characterizing mitochondrial autophagy. However, the dedicated ubiquitin E3 ligases targeting mitochondria for autophagy have not been revealed. Here we show that human RNF185 is a mitochondrial ubiquitin E3 ligase that regulates selective mitochondrial autophagy in cultured cells. The two C-terminal transmembrane domains of human RNF185 mediate its localization to mitochondrial outer membrane. RNF185 stimulates LC3II accumulation and the formation of autophagolysosomes in human cell lines. We further identified the Bcl-2 family protein BNIP1 as one of the substrates for RNF185. Human BNIP1 colocalizes with RNF185 at mitochondria and is polyubiquitinated by RNF185 through K63-based ubiquitin linkage in vivo. The polyubiquitinated BNIP1 is capable of recruiting autophagy receptor p62, which simultaneously binds both ubiquitin and LC3 to link ubiquitination and autophagy. Our study might reveal a novel RNF185-mediated mechanism for modulating mitochondrial homeostasis through autophagy.	[Tang, Fei; Li, Na; Wu, Yanfang; Jia, Junying; Suo, Talin; Tang, Jie] Chinese Acad Sci, Inst Biophys, Key Lab Infect & Immun, Beijing 100080, Peoples R China; [Wang, Bin; Chen, Quan] Chinese Acad Sci, Inst Zool, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100080, Peoples R China; [Tang, Fei; Wang, Bin; Suo, Talin] Chinese Acad Sci, Grad Univ, Beijing 100080, Peoples R China; [Liu, Yong-Jun] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Liu, Yong-Jun] Univ Texas MD Anderson Canc Ctr, Ctr Canc Immunol Res, Houston, TX 77030 USA	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Tang, F (corresponding author), Chinese Acad Sci, Inst Biophys, Key Lab Infect & Immun, Beijing 100080, Peoples R China.	jtang@ibp.ac.cn	Tang, Fei/L-6750-2016	Tang, Fei/0000-0003-1475-5028; Chen, Quan/0000-0001-7539-8728	Ministry of Science and Technololgy of China [2006CB504304]; Ministry of Health of China [008ZX10002-008]	Ministry of Science and Technololgy of China; Ministry of Health of China	This work was supported by grants from Ministry of Science and Technololgy of China (2006CB504304) and Ministry of Health of China (008ZX10002-008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellot G, 2009, MOL CELL BIOL, V29, P2570, DOI 10.1128/MCB.00166-09; BOYD JM, 1994, CELL, V79, P341, DOI 10.1016/0092-8674(94)90202-X; Broemer M, 2009, TRENDS CELL BIOL, V19, P130, DOI 10.1016/j.tcb.2009.01.004; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Cheng WC, 2008, BBA-MOL CELL RES, V1783, P1272, DOI 10.1016/j.bbamcr.2008.04.012; Codogno P, 2006, NAT CELL BIOL, V8, P1045, DOI 10.1038/ncb1006-1045; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; ELLIS RE, 1991, ANNU REV CELL BIOL, V7, P663, DOI 10.1146/annurev.cb.07.110191.003311; Elmore SP, 2001, FASEB J, V15, P2286, DOI 10.1096/fj.01-0206fje; Erlich S, 2007, AUTOPHAGY, V3, P561, DOI 10.4161/auto.4713; Etxebarria A, 2009, J BIOL CHEM, V284, P4200, DOI 10.1074/jbc.M808050200; Fang S, 2004, CELL MOL LIFE SCI, V61, P1546, DOI 10.1007/s00018-004-4129-5; Furukawa Manabu, 2005, V301, P37; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Germain M, 2010, CLIN SCI, V118, P173, DOI 10.1042/CS20090310; Hailey DW, 2010, CELL, V141, P656, DOI 10.1016/j.cell.2010.04.009; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Jin SK, 2006, AUTOPHAGY, V2, P80, DOI 10.4161/auto.2.2.2460; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kanki T, 2010, AUTOPHAGY, V6, P433, DOI 10.4161/auto.6.3.11420; Kanki T, 2009, DEV CELL, V17, P98, DOI 10.1016/j.devcel.2009.06.014; Karbowski M, 2007, J CELL BIOL, V178, P71, DOI 10.1083/jcb.200611064; KATAOKA N, 1995, NUCLEIC ACIDS RES, V23, P3638, DOI 10.1093/nar/23.18.3638; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Kobayashi T, 2000, MOL BIOL CELL, V11, P1829, DOI 10.1091/mbc.11.5.1829; Kraft C, 2010, NAT CELL BIOL, V12, P836, DOI 10.1038/ncb0910-836; Kundu M, 2005, CELL DEATH DIFFER, V12, P1484, DOI 10.1038/sj.cdd.4401780; Levine B, 2008, AUTOPHAGY, V4, P600, DOI 10.4161/auto.6260; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001487; Long J, 2008, J BIOL CHEM, V283, P5427, DOI 10.1074/jbc.M704973200; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Maiuri MC, 2007, AUTOPHAGY, V3, P374, DOI 10.4161/auto.4237; Martinet W, 2009, CLIN SCI, V116, P697, DOI 10.1042/CS20080508; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; McEwan DG, 2010, CELL, V141, P564, DOI 10.1016/j.cell.2010.04.030; Mijaljica D, 2007, AUTOPHAGY, V3, P4, DOI 10.4161/auto.3011; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Nakajima K, 2004, EMBO J, V23, P3216, DOI 10.1038/sj.emboj.7600333; Nakamura N, 2006, EMBO REP, V7, P1019, DOI 10.1038/sj.embor.7400790; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Neutzner A, 2008, ANN NY ACAD SCI, V1147, P242, DOI 10.1196/annals.1427.012; Nishizawa K, 2006, PLANT CELL REP, V25, P1355, DOI 10.1007/s00299-006-0210-x; Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256; Okamoto K, 2009, DEV CELL, V17, P87, DOI 10.1016/j.devcel.2009.06.013; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pickart CM, 2004, BBA-MOL CELL RES, V1695, P55, DOI 10.1016/j.bbamcr.2004.09.019; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Rashmi R, 2008, ONCOGENE, V27, P1366, DOI 10.1038/sj.onc.1210783; RIZZUTO R, 1995, CURR BIOL, V5, P635, DOI 10.1016/S0960-9822(95)00128-X; Scherz-Shouval R, 2007, AUTOPHAGY, V3, P371, DOI 10.4161/auto.4214; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; Schon EA, 2010, TRENDS MOL MED, V16, P268, DOI 10.1016/j.molmed.2010.04.007; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Takahashi Y, 2007, NAT CELL BIOL, V9, P1142, DOI 10.1038/ncb1634; Tan JMM, 2008, AUTOPHAGY, V4, P251, DOI 10.4161/auto.5444; Tasdemir Ezgi, 2008, V445, P29, DOI 10.1007/978-1-59745-157-4_3; Tasdemir E, 2007, CELL CYCLE, V6, P2263, DOI 10.4161/cc.6.18.4681; Tolkovsky AM, 2009, BBA-MOL CELL RES, V1793, P1508, DOI 10.1016/j.bbamcr.2009.03.002; Twig G, 2008, BBA-BIOENERGETICS, V1777, P1092, DOI 10.1016/j.bbabio.2008.05.001; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Wang RC, 2010, FEBS LETT, V584, P1417, DOI 10.1016/j.febslet.2010.01.009; Wrighton KH, 2010, NAT REV MOL CELL BIO, V11, DOI [10.1038/nrm2920, 10.1038/nrm2930]; Yasuda M, 2000, ONCOGENE, V19, P2363, DOI 10.1038/sj.onc.1203565; Yoshimori T, 2004, BIOCHEM BIOPH RES CO, V313, P453, DOI 10.1016/j.bbrc.2003.07.023; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Yu L, 2008, AUTOPHAGY, V4, P567, DOI 10.4161/auto.5902; Zhang H, 1999, FEBS LETT, V448, P23, DOI 10.1016/S0014-5793(99)00335-X; Zhang HM, 2003, APOPTOSIS, V8, P229, DOI 10.1023/A:1023616620970; Zhang J, 2009, CELL DEATH DIFFER, V16, P939, DOI 10.1038/cdd.2009.16	78	19	24	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2011	6	9							e24367	10.1371/journal.pone.0024367	http://dx.doi.org/10.1371/journal.pone.0024367			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CN	21931693	Green Published, gold, Green Submitted			2022-12-25	WOS:000294803100023
J	Vinuela, A; Snoek, LB; Riksen, JAG; Kammenga, JE				Vinuela, Ana; Snoek, L. Basten; Riksen, Joost A. G.; Kammenga, Jan E.			Gene Expression Modifications by Temperature-Toxicants Interactions in Caenorhabditis elegans	PLOS ONE			English	Article							ZEBRAFISH-DANIO-RERIO; CDNA MICROARRAY DATA; ORGANOPHOSPHORUS PESTICIDES; DEVELOPMENTAL NEUROTOXICITY; CHEMICAL-MIXTURES; BINARY-MIXTURES; HEAT-STRESS; C-ELEGANS; TOXICITY; CHLORPYRIFOS	Although organophosphorus pesticides (OP) share a common mode of action, there is increased awareness that they elicit a diverse range of gene expression responses. As yet however, there is no clear understanding of these responses and how they interact with ambient environmental conditions. In the present study, we investigated genome-wide gene expression profiles in the nematode Caenorhabditis elegans exposed to two OP, chlorpyrifos and diazinon, in single and combined treatments at different temperatures. Our results show that chlorpyrifos and diazinon induced expression of different genes and that temperature affected the response of detoxification genes to the pesticides. The analysis of transcriptional responses to a combination of chlorpyrifos and diazinon shows interactions between toxicants that affect gene expression. Furthermore, our combined analysis of the transcriptional responses to OP at different temperatures suggests that the combination of OP and high temperatures affect detoxification genes and modified the toxic levels of the pesticides.	[Vinuela, Ana; Snoek, L. Basten; Riksen, Joost A. G.; Kammenga, Jan E.] Wageningen Univ, Nematol Lab, Wageningen, Netherlands	Wageningen University & Research	Vinuela, A (corresponding author), Kings Coll London, Dept Twin Res & Genet Epidemiol, St Thomas Hosp Campus, London WC2R 2LS, England.	Jan.Kammenga@wur.nl	Viñuela, Ana/L-5015-2019; Snoek, Basten L/E-4713-2014	Viñuela, Ana/0000-0003-3771-8537; Snoek, Basten L/0000-0001-5321-2996	EU; Ecogenomics Consortium of The Netherlands Genomics Initiative (NGI)	EU(European Commission); Ecogenomics Consortium of The Netherlands Genomics Initiative (NGI)	This work was supported by the EU FP6 framework programme NoMiracle(http://nomiracle.jrc.ec.europa.eu/default.aspx) and Ecogenomics Consortium of The Netherlands Genomics Initiative (NGI) (http://www.ecogenomics.nl/) to Dr. Vinuela and Dr. Snoek. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Antebi A., 2006, C ELEGANS RES COMMUN, DOI [DOI 10.1895/WORMBOOK.1.64.1, 10.1895/wormbook.1.64.1]; Bindesbol AM, 2009, ENVIRON TOXICOL CHEM, V28, P2341, DOI 10.1897/09-078.1; Boyd WA, 2010, NEUROTOXICOL TERATOL, V32, P68, DOI 10.1016/j.ntt.2008.12.004; Carlson M, 2007, GO DB SET ANNOTATION; Cui YX, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r122; De Silva PMCS, 2009, CHEMOSPHERE, V76, P1410, DOI 10.1016/j.chemosphere.2009.06.006; DREZINA B, 2007, INT J ENVIRON AN CH, V87, P1079; Eaton DL, 2008, CRIT REV TOXICOL, V38, P1, DOI 10.1080/10408440802272158 ; Fang H, 2008, B ENVIRON CONTAM TOX, V81, P397, DOI 10.1007/s00128-008-9514-6; GENTLEMAN R, 2003, ANNOTATE ANNOTATION; Gentry J., 2010, RGRAPHVIZ PROVIDES P; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Holmstrup M, 2010, SCI TOTAL ENVIRON, V408, P3746, DOI 10.1016/j.scitotenv.2009.10.067; Hook SE, 2008, TOXICOL SCI, V102, P42, DOI 10.1093/toxsci/kfm293; Jonker MJ, 2005, ENVIRON TOXICOL CHEM, V24, P2701, DOI 10.1897/04-431R.1; Jonker MJ, 2004, ENVIRON TOXICOL CHEM, V23, P1529, DOI 10.1897/03-49; Jonker MJ, 2004, ENVIRON TOXICOL CHEM, V23, P480, DOI 10.1897/03-29; Kammenga JE, 2007, PLOS GENET, V3, P358, DOI 10.1371/journal.pgen.0030034; Kulas J, 2008, ARCH BIOCHEM BIOPHYS, V472, P65, DOI 10.1016/j.abb.2008.02.002; Lee SJ, 2009, CURR BIOL, V19, P715, DOI 10.1016/j.cub.2009.03.041; Lewis JA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-202; Li Y, 2006, PLOS GENET, V2, P2155, DOI 10.1371/journal.pgen.0020222; Lindblom TH, 2006, J EXP ZOOL PART A, V305A, P720, DOI 10.1002/jez.a.324; Lydy MJ, 1999, ARCH ENVIRON CON TOX, V37, P542, DOI 10.1007/s002449900550; Martin HL, 2009, ENVIRON TOXICOL CHEM, V28, P97, DOI 10.1897/07-215.1; Menzel R, 2005, ARCH BIOCHEM BIOPHYS, V438, P93, DOI 10.1016/j.abb.2005.03.020; Mumtaz MM, 2002, ENVIRON HEALTH PERSP, V110, P947, DOI 10.1289/ehp.02110s6947; Nota B, 2010, INSECT MOL BIOL, V19, P315, DOI 10.1111/j.1365-2583.2009.00990.x; Osterauer R, 2008, AQUAT TOXICOL, V86, P485, DOI 10.1016/j.aquatox.2007.12.013; Poet TS, 2003, TOXICOL SCI, V72, P193, DOI 10.1093/toxsci/kfg035; Pope CN, 1999, J TOXICOL ENV HEAL B, V2, P161, DOI 10.1080/109374099281205; Rajini PS, 2008, J TOXICOL ENV HEAL A, V71, P1043, DOI 10.1080/15287390801989002; Reichert K, 2005, CHEMOSPHERE, V61, P229, DOI 10.1016/j.chemosphere.2005.01.077; Roh JY, 2007, TOXICOLOGY, V237, P126, DOI 10.1016/j.tox.2007.05.008; Scheil V, 2009, ARCH ENVIRON CON TOX, V56, P238, DOI 10.1007/s00244-008-9192-8; Slotkin TA, 2007, BRAIN RES BULL, V72, P232, DOI 10.1016/j.brainresbull.2007.01.005; Slotkin TA, 2007, ENVIRON HEALTH PERSP, V115, P93, DOI 10.1289/ehp.9527; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; SMYTH GK, 2005, LIMMA LINEAR MODELS, P397; Sorensen JG, 2005, CELL STRESS CHAPERON, V10, P312, DOI 10.1379/CSC-128R1.1; Spurgeon DJ, 2010, SCI TOTAL ENVIRON, V408, P3725, DOI 10.1016/j.scitotenv.2010.02.038; Spurgeon DJ, 2003, ENVIRON TOXICOL CHEM, V22, P1465, DOI [10.1897/1551-5028(2003)22&lt;1465:QCACIO&gt;2.0.CO;2, 10.1002/etc.5620220707]; Stein L, 2001, NUCLEIC ACIDS RES, V29, P82, DOI 10.1093/nar/29.1.82; Svendsen C, 2010, ENVIRON TOXICOL CHEM, V29, P1182, DOI 10.1002/etc.140; Team RDC, 2011, COMP RFFS; Vinuela A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012145; Vinuela A, 2010, GENOME RES, V20, P929, DOI 10.1101/gr.102160.109; Yang YH, 2003, INST MATH S, V40, P403	49	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2011	6	9							e24676	10.1371/journal.pone.0024676	http://dx.doi.org/10.1371/journal.pone.0024676			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CN	21931806	gold, Green Submitted, Green Published			2022-12-25	WOS:000294803100054
J	Brunskill, EW; Georgas, K; Rumballe, B; Little, MH; Potter, SS				Brunskill, Eric W.; Georgas, Kylie; Rumballe, Bree; Little, Melissa H.; Potter, S. Steven			Defining the Molecular Character of the Developing and Adult Kidney Podocyte	PLOS ONE			English	Article							GLOMERULAR-BASEMENT-MEMBRANE; FATE DETERMINATION FACTOR; GENE-EXPRESSION PATTERNS; CELL FATE; EPITHELIAL-CELLS; MESSENGER-RNA; UP-REGULATION; E-CADHERIN; C-JUN; DIFFERENTIATION	Background: The podocyte is a remarkable cell type, which encases the capillaries of the kidney glomerulus. Although mesodermal in origin it sends out axonal like projections that wrap around the capillaries. These extend yet finer projections, the foot processes, which interdigitate, leaving between them the slit diaphragms, through which the glomerular filtrate must pass. The podocytes are a subject of keen interest because of their key roles in kidney development and disease. Methodology/Principal Findings: In this report we identified and characterized a novel transgenic mouse line, MafB-GFP, which specifically marked the kidney podocytes from a very early stage of development. These mice were then used to facilitate the fluorescent activated cell sorting based purification of podocytes from embryos at E13.5 and E15.5, as well as adults. Microarrays were then used to globally define the gene expression states of podocytes at these different developmental stages. A remarkable picture emerged, identifying the multiple sets of genes that establish the neuronal, muscle, and phagocytic properties of podocytes. The complete combinatorial code of transcription factors that create the podocyte was characterized, and the global lists of growth factors and receptors they express were defined. Conclusions/Significance: The complete molecular character of the in vivo podocyte is established for the first time. The active molecular functions and biological processes further define their unique combination of features. The results provide a resource atlas of gene expression patterns of developing and adult podocytes that will help to guide further research of these incredible cells.	[Brunskill, Eric W.; Potter, S. Steven] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA; [Brunskill, Eric W.; Potter, S. Steven] Univ Cincinnati, Sch Med, Cincinnati, OH USA; [Georgas, Kylie; Rumballe, Bree; Little, Melissa H.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Queensland	Brunskill, EW (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA.	steve.potter@cchmc.org	Little, Melissa H/A-6170-2010	Little, Melissa H/0000-0003-0380-2263	National Institutes of Health [UO1DK070251]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK070251] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a grant from the National Institutes of Health UO1DK070251. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAMSON DR, 1985, J CELL BIOL, V100, P1988, DOI 10.1083/jcb.100.6.1988; Akilesh S, 2008, P NATL ACAD SCI USA, V105, P967, DOI 10.1073/pnas.0711515105; ANDREWS PM, 1983, FED PROC, V42, P3046; BAUDEAU C, 1994, EXP NEPHROL, V2, P306; Brunskill EW, 2008, DEV CELL, V15, P781, DOI 10.1016/j.devcel.2008.09.007; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Cohen CD, 2002, KIDNEY INT, V61, P133, DOI 10.1046/j.1523-1755.2002.00113.x; Cohen CD, 2002, KIDNEY INT, V61, P125, DOI 10.1046/j.1523-1755.2002.00112.x; Cohen DE, 2011, NAT REV GENET, V12, P243, DOI 10.1038/nrg2938; Costantini F, 2010, DEV CELL, V18, P698, DOI 10.1016/j.devcel.2010.04.008; Davis RJ, 2001, MOL CELL BIOL, V21, P1484, DOI 10.1128/MCB.21.5.1484-1490.2001; Dijkman H, 2005, KIDNEY INT, V68, P1562, DOI 10.1111/j.1523-1755.2005.00568.x; Endlich N, 2002, FASEB J, V16, P1850, DOI 10.1096/fj.02-0125fje; Feng W, 2002, J BIOL CHEM, V277, P17016, DOI 10.1074/jbc.M107876200; Georgas K, 2008, HISTOCHEM CELL BIOL, V130, P927, DOI 10.1007/s00418-008-0454-3; Georgas K, 2009, DEV BIOL, V332, P273, DOI 10.1016/j.ydbio.2009.05.578; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Guan F, 2006, KIDNEY INT, V69, P1564, DOI 10.1038/sj.ki.5000313; Han SH, 2008, BIOCHEM BIOPH RES CO, V370, P514, DOI 10.1016/j.bbrc.2008.03.121; Hatini V, 1996, GENE DEV, V10, P1467, DOI 10.1101/gad.10.12.1467; Jang S, 2009, J BIOL CHEM, V284, P3956, DOI 10.1074/jbc.M807477200; Kaimal V, 2010, NUCLEIC ACIDS RES, V38, pW96, DOI 10.1093/nar/gkq418; KELES GE, 1992, ONCOL RES, V4, P431; Knirsh R, 2009, MOL BIOL CELL, V20, P2121, DOI 10.1091/mbc.E08-12-1196; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; Levinson RS, 2005, DEVELOPMENT, V132, P529, DOI 10.1242/dev.01604; Li JJ, 2007, KIDNEY INT, V72, pS36, DOI 10.1038/sj.ki.5002384; Matsukawa N, 1999, P NATL ACAD SCI USA, V96, P7403, DOI 10.1073/pnas.96.13.7403; McCabe CD, 2008, CANCER RES, V68, P1988, DOI 10.1158/0008-5472.CAN-07-5843; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Nakamura K, 2006, J NEUROSCI RES, V84, P874, DOI 10.1002/jnr.20992; Pache G, 2006, AM J PHYSIOL-RENAL, V291, pF654, DOI 10.1152/ajprenal.00214.2004; Pavenstadt H, 2003, PHYSIOL REV, V83, P253, DOI 10.1152/physrev.00020.2002; Reidy KJ, 2009, DEVELOPMENT, V136, P3979, DOI 10.1242/dev.037267; Sadl VS, 2002, DEV BIOL, V249, P16, DOI 10.1006/dbio.2002.0751; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Saleem MA, 2008, AM J PHYSIOL-RENAL, V295, pF959, DOI 10.1152/ajprenal.00559.2007; Sampogna RV, 2004, PHYSIOLOGY, V19, P339, DOI 10.1152/physiol.00025.2004; Sanchez-Tillo E, 2010, ONCOGENE, V29, P3490, DOI 10.1038/onc.2010.102; Schroppel B, 1998, KIDNEY INT, V53, P119, DOI 10.1046/j.1523-1755.1998.00742.x; Shankland SJ, 2007, KIDNEY INT, V72, P26, DOI 10.1038/sj.ki.5002291; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takemoto M, 2006, EMBO J, V25, P1160, DOI 10.1038/sj.emboj.7601014; White JT, 2010, DEVELOPMENT, V137, P1863, DOI 10.1242/dev.042887; Wu KM, 2007, MOL BIOL CELL, V18, P755, DOI 10.1091/mbc.E06-09-0793; Wu KM, 2006, MOL CELL BIOL, V26, P7116, DOI 10.1128/MCB.00268-06	47	94	96	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e24640	10.1371/journal.pone.0024640	http://dx.doi.org/10.1371/journal.pone.0024640			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CK	21931791	Green Published, gold			2022-12-25	WOS:000294802800079
J	Improgo, MRD; Johnson, CW; Tapper, AR; Gardner, PD				Improgo, Ma. Reina D.; Johnson, Christopher W.; Tapper, Andrew R.; Gardner, Paul D.			Bioluminescence-Based High-Throughput Screen Identifies Pharmacological Agents That Target Neurotransmitter Signaling in Small Cell Lung Carcinoma	PLOS ONE			English	Article							HUMAN CANCER; ASSAYS; GROWTH; PROLIFERATION; EXPRESSION; RECEPTORS; SEROTONIN; PROBES	Background: Frontline treatment of small cell lung carcinoma (SCLC) relies heavily on chemotherapeutic agents and radiation therapy. Though SCLC patients respond well to initial cycles of chemotherapy, they eventually develop resistance. Identification of novel therapies against SCLC is therefore imperative. Methods and Findings: We have designed a bioluminescence-based cell viability assay for high-throughput screening of anti-SCLC agents. The assay was first validated via standard pharmacological agents and RNA interference using two human SCLC cell lines. We then utilized the assay in a high-throughput screen using the LOPAC(1280) compound library. The screening identified several drugs that target classic cancer signaling pathways as well as neuroendocrine markers in SCLC. In particular, perturbation of dopaminergic and serotonergic signaling inhibits SCLC cell viability. Conclusions: The convergence of our pharmacological data with key SCLC pathway components reiterates the importance of neurotransmitter signaling in SCLC etiology and points to possible leads for drug development.	[Improgo, Ma. Reina D.; Johnson, Christopher W.; Tapper, Andrew R.; Gardner, Paul D.] Univ Massachusetts, Sch Med, Dept Psychiat, Brudnick Neuropsychiat Res Inst, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester	Improgo, MRD (corresponding author), Univ Massachusetts, Sch Med, Dept Psychiat, Brudnick Neuropsychiat Res Inst, Worcester, MA 01655 USA.	paul.gardner@umassmed.edu			University of Massachusetts Medical School	University of Massachusetts Medical School	The work was supported by internal funds from the University of Massachusetts Medical School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*ACS, 2009, CANC STAT 2009; CATTANEO MG, 1994, EUR J PHARM-MOLEC PH, V268, P425, DOI 10.1016/0922-4106(94)90068-X; CATTANEO MG, 1995, EUR J PHARM-MOLEC PH, V291, P209, DOI 10.1016/0014-2999(95)90106-X; DELUCA M, 1974, BIOCHEMISTRY-US, V13, P921, DOI 10.1021/bi00702a015; Fan F, 2007, ASSAY DRUG DEV TECHN, V5, P127, DOI 10.1089/adt.2006.053; Govindan R, 2006, J CLIN ONCOL, V24, P4539, DOI 10.1200/JCO.2005.04.4859; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Heasley LE, 2001, ONCOGENE, V20, P1563, DOI 10.1038/sj.onc.1204183; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Hynes J, 2003, J BIOMOL SCREEN, V8, P264, DOI 10.1177/1087057103008003004; Inglese J, 2007, NAT CHEM BIOL, V3, P466, DOI 10.1038/nchembio.2007.17; ISHIBASHI M, 1994, CANCER RES, V54, P3442; Julien SG, 2011, NAT REV CANCER, V11, P35, DOI 10.1038/nrc2980; Jull BA, 2001, J CANCER RES CLIN, V127, P707; Junker K, 2000, J CANCER RES CLIN, V126, P361, DOI 10.1007/PL00008483; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mailman RB, 2010, NEUROPSYCHOPHARMACOL, V35, P345, DOI 10.1038/npp.2009.117; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; NAKANISHI S, 1986, J ANTIBIOT, V39, P1066; NRC [National Research Council], 1996, GUID CAR US LAB AN; Onganer PU, 2005, BRIT J CANCER, V93, P1197, DOI 10.1038/sj.bjc.6602857; PETTENGILL OS, 1980, CANCER-AM CANCER SOC, V45, P906, DOI 10.1002/1097-0142(19800301)45:5<906::AID-CNCR2820450513>3.0.CO;2-H; ROSENBERG B, 1979, CANCER TREAT REP, V63, P1433; Sandler AB, 2003, SEMIN ONCOL, V30, P9, DOI 10.1053/sonc.2003.50012; Schuller HM, 2008, ANTI-CANCER DRUG, V19, P655, DOI 10.1097/CAD.0b013e3283025b58; Senogles SE, 2007, ANTI-CANCER DRUG, V18, P801, DOI 10.1097/CAD.0b013e3280b10d36; Vila MR, 2000, CANCER, V89, P152; World Health Organization, 2011, CANC FACT SHEET; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	29	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e24132	10.1371/journal.pone.0024132	http://dx.doi.org/10.1371/journal.pone.0024132			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CK	21931655	Green Published, gold, Green Submitted			2022-12-25	WOS:000294802800027
J	Kondgen, S; Leider, M; Lankester, F; Bethe, A; Lubke-Becker, A; Leendertz, FH; Ewers, C				Koendgen, Sophie; Leider, Michaela; Lankester, Felix; Bethe, Astrid; Luebke-Becker, Antina; Leendertz, Fabian H.; Ewers, Christa			Pasteurella multocida Involved in Respiratory Disease of Wild Chimpanzees	PLOS ONE			English	Article							PHENOTYPIC CHARACTERIZATION; GREAT APES; STRAINS; IDENTIFICATION; AIRSACCULITIS; INFECTIONS; MANAGEMENT; DIVERSITY; PATHOGENS; SURVIVAL	Pasteurella multocida can cause a variety of diseases in various species of mammals and birds throughout the world but nothing is known about its importance for wild great apes. In this study we isolated P. multocida from wild living, habituated chimpanzees from Tai National Park, Cote d'Ivoire. Isolates originated from two chimpanzees that died during a respiratory disease outbreak in 2004 as well as from one individual that developed chronic air-sacculitis following this outbreak. Four isolates were subjected to a full phenotypic and molecular characterisation. Two different clones were identified using pulsed field gel electrophoresis. Multi Locus Sequence Typing (MLST) enabled the identification of previous unknown alleles and two new sequence types, ST68 and ST69, were assigned. Phylogenetic analysis of the superoxide dismutase (sodA) gene and concatenated sequences from seven MLST-housekeeping genes showed close clustering within known P. multocida isolated from various hosts and geographic locations. Due to the clinical relevance of the strains described here, these results make an important contribution to our knowledge of pathogens involved in lethal disease outbreaks among endangered great apes.	[Koendgen, Sophie; Leider, Michaela; Leendertz, Fabian H.] Robert Koch Inst, Res Grp Emerging Zoonoses, D-1000 Berlin, Germany; [Lankester, Felix] Lincoln Pk Zoo, Conservat & Sci Dept, Chicago, IL USA; [Bethe, Astrid; Luebke-Becker, Antina; Ewers, Christa] Free Univ Berlin, Fac Vet, Inst Microbiol & Epizoot, D-1000 Berlin, Germany; [Koendgen, Sophie] Max Planck Inst Evolutionary Anthropol, Dept Primatol, Leipzig, Germany	Robert Koch Institute; Free University of Berlin; Max Planck Society	Kondgen, S (corresponding author), Robert Koch Inst, Res Grp Emerging Zoonoses, D-1000 Berlin, Germany.	KoendgenS@rki.de	Leendertz, Fabian Hubertus/H-8902-2019; Ewers, Christa/AAL-9186-2020	Lankester, Felix/0000-0002-0802-0693; Ewers, Christa/0000-0001-6167-1340	Robert Koch Institute; Max Planck Insitute; Ministry of the Environment and Forests; Ministry of Research; Tai National Park; Swiss Research Centre in Abidjan; Ivorian authorities	Robert Koch Institute; Max Planck Insitute(Max Planck Society); Ministry of the Environment and Forests; Ministry of Research(Ministry of Research and Technology of the Republic of Indonesia (RISTEK)); Tai National Park; Swiss Research Centre in Abidjan; Ivorian authorities	The work was funded by the Robert Koch Institute and the Max Planck Insitute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Ivorian authorities for long-term support, especially the Ministry of the Environment and Forests as well as the Ministry of Research, the directorship of the Tai National Park, and the Swiss Research Centre in Abidjan. We are grateful to Prof. C. Boesch for providing infrastructure and logistic support. We thank S. Schenk for performing the necropsies and S. Metzger for assistance during surgery. For field observations and assistance in sample collection the field assistants and students of the Tai Chimpanzee Project are gratefully acknowledged. We thank I. Diehl, M. Kuhl, C. Simon, A. Schellin and A. Schmidt for technical support in the laboratory. For sequencing, we thank J. Tesch.	BACKSTRAND JM, 1986, J WILDLIFE DIS, V22, P257, DOI 10.7589/0090-3558-22.2.257; BENJAMIN SA, 1971, LAB ANIM SCI, V21, P258; Bethe A, 2009, VET MICROBIOL, V139, P97, DOI 10.1016/j.vetmic.2009.04.027; Blackall PJ, 1997, VET MICROBIOL, V57, P355, DOI 10.1016/S0378-1135(97)00111-9; Boesch C, 2000, CHIMPANZEES TAI FORE; Breen D, 2000, PATHOLOGY, V32, P152, DOI 10.1080/003130200104448; BRONSDON MA, 1993, PRIMATES, V34, P205, DOI 10.1007/BF02381391; CARTER G. R., 1962, CANADIAN JOUR PUBL HEALTH, V53, P158; Carter GR, 1984, BERGEY MANUAL SYSTEM, P554; CHENGAPPA MM, 1982, CAN J COMP MED, V46, P437; Chi F, 2007, J BACTERIOL, V189, P6085, DOI 10.1128/JB.00468-07; Clarkson TB, 1968, ANIMAL MODELS BIOMED, P64; Clinical and Laboratory Standards Institute, 2008, M100S18 CLSI; DANIEL MD, 1976, LAB ANIM SCI, V26, P1073; Davies RL, 2004, VET MICROBIOL, V99, P145, DOI 10.1016/j.vetmic.2003.11.013; Davies RL, 2003, VET MICROBIOL, V91, P169, DOI 10.1016/S0378-1135(02)00300-0; Donnio PY, 2004, J COMP PATHOL, V130, P137, DOI 10.1016/j.jcpa.2003.10.002; Ewers C, 2004, BERL MUNCH TIERARZTL, V117, P367; Ewers C, 2006, VET MICROBIOL, V114, P304, DOI 10.1016/j.vetmic.2005.12.012; Fegan N, 1995, VET MICROBIOL, V47, P281, DOI 10.1016/0378-1135(95)00119-0; Frank GH, 1989, PASTEURELLA PASTEURE, P197; FREDERIKSEN W, 1993, ZBL BAKT-INT J MED M, V279, P27; Gautier AL, 2005, J CLIN MICROBIOL, V43, P2307, DOI 10.1128/JCM.43.5.2307-2314.2005; Gerardo SH, 1999, ANTIMICROBIAL, P326; Gibson S, 1998, AM COLL LAB, P59; Goldberg TL, 2007, BIOL CONSERV, V135, P511, DOI 10.1016/j.biocon.2006.10.048; GOLDSTEIN EJC, 1988, ANTIMICROB AGENTS CH, V32, P213, DOI 10.1128/AAC.32.2.213; GOOD RC, 1971, INFECT IMMUN, V3, P87, DOI 10.1128/IAI.3.1.87-93.1971; GREENSTEIN ET, 1965, LAB ANIM CARE, V15, P74; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; HASTINGS BE, 1991, J MED PRIMATOL, V20, P361; Hill LR, 2001, COMPARATIVE MED, V51, P80; HOLST E, 1992, J CLIN MICROBIOL, V30, P2984, DOI 10.1128/JCM.30.11.2984-2987.1992; Jolley KA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-86; KALTER SS, 1989, ZOO BIOL, P61, DOI 10.1002/zoo.1430080508; Kehrenberg C, 2005, ANTIMICROB AGENTS CH, V49, P414, DOI 10.1128/AAC.49.1.414-417.2005; Klein N C, 1997, Semin Respir Infect, V12, P54; Kobayaa H, 2009, PEDIATR INFECT DIS J, V28, P928, DOI 10.1097/INF.0b013e3181a81f0f; Kondgen S, 2008, CURR BIOL, V18, P260, DOI 10.1016/j.cub.2008.01.012; Lawson B, 2006, J MED PRIMATOL, V35, P149, DOI 10.1111/j.1600-0684.2006.00153.x; Leendertz FH, 2006, BIOL CONSERV, V131, P325, DOI 10.1016/j.biocon.2006.05.002; Lewis P, 1975, CONT PRIMATOLOGY, P487; MCCLURE H M, 1986, P531; MUTTERS R, 1985, INT J SYST BACTERIOL, V35, P309, DOI 10.1099/00207713-35-3-309; Mutters R, 1989, TAXONOMY GROUP PASTE, P3; Petersen KD, 2001, MICROBIOL-SGM, V147, P2739, DOI 10.1099/00221287-147-10-2739; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rietschel W., 1989, Tieraerztliche Praxis, V17, P323; ROSE HD, 1977, BRIT J DIS CHEST, V71, P123, DOI 10.1016/0007-0971(77)90093-6; Rwego IB, 2008, CONSERV BIOL, V22, P1600, DOI 10.1111/j.1523-1739.2008.01018.x; Schwarz Stefan, 2008, P197; STROBERT EA, 1979, LAB ANIM SCI, V29, P387; Subaaharan S, 2010, VET MICROBIOL, V141, P354, DOI 10.1016/j.vetmic.2010.01.017; Talan DA, 1999, NEW ENGL J MED, V340, P85, DOI 10.1056/NEJM199901143400202; THOMSON CMA, 1992, APPL ENVIRON MICROB, V58, P932, DOI 10.1128/AEM.58.3.932-936.1992; Townsend KM, 1998, J CLIN MICROBIOL, V36, P1096, DOI 10.1128/JCM.36.4.1096-1100.1998; Townsend KM, 2001, J CLIN MICROBIOL, V39, P924, DOI 10.1128/JCM.39.3.924-929.2001; Villesen P, 2007, MOL ECOL NOTES, V7, P965, DOI 10.1111/j.1471-8286.2007.01821.x; Wallis J, 1999, INT J PRIMATOL, V20, P803, DOI 10.1023/A:1020879700286; WEBER DJ, 1984, MEDICINE, V63, P133, DOI 10.1097/00005792-198405000-00001; Woodford MH, 2002, ORYX, V36, P153, DOI 10.1017/S0030605302000224	63	27	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e24236	10.1371/journal.pone.0024236	http://dx.doi.org/10.1371/journal.pone.0024236			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CK	21931664	Green Published, gold, Green Submitted			2022-12-25	WOS:000294802800034
J	Reineke, LC; Cao, Y; Baus, D; Hossain, NM; Merrick, WC				Reineke, Lucas C.; Cao, Yu; Baus, Diane; Hossain, Nasheed M.; Merrick, William C.			Insights into the Role of Yeast eIF2A in IRES-Mediated Translation	PLOS ONE			English	Article							RIBOSOME ENTRY SITE; SACCHAROMYCES-CEREVISIAE; PROTEIN-SYNTHESIS; INTERNAL INITIATION; MESSENGER-RNA; ACTIN CYTOSKELETON; COMPLEX; DOMAIN; CELL; HOMOLOG	Eukaryotic initiation factor 2A is a single polypeptide that acts to negatively regulate IRES-mediated translation during normal cellular conditions. We have found that eIF2A (encoded by YGR054w) abundance is reduced at both the mRNA and protein level during 6% ethanol stress (or 37 degrees C heat shock) under conditions that mimic the diauxic shift in the yeast Saccharomyces cerevisiae. Furthermore, eIF2A protein is posttranslationally modified during ethanol stress. Unlike ethanol and heat shock stress, H(2)O(2) and sorbitol treatment induce the loss of eIF2A mRNA, but not protein and without protein modification. To investigate the mechanism of eIF2A function we employed immunoprecipitation-mass spectrometry and identified an interaction between eIF2A and eEF1A. The interaction between eIF2A and eEF1A increases during ethanol stress, which correlates with an increase in IRES-mediated translation from the URE2 IRES element. These data suggest that eIF2A acts as a switch to regulate IRES-mediated translation, and eEF1A may be an important mediator of translational activation during ethanol stress.	[Reineke, Lucas C.; Cao, Yu; Baus, Diane; Hossain, Nasheed M.; Merrick, William C.] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA; [Reineke, Lucas C.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Cao, Yu] So Methodist Univ, Dept Engn Management Informat & Syst, Dallas, TX 75275 USA; [Hossain, Nasheed M.] Univ Chicago, Med Ctr, Dept Med, Chicago, IL 60637 USA	Case Western Reserve University; Baylor College of Medicine; Southern Methodist University; University of Chicago; University of Chicago Medical Center	Reineke, LC (corresponding author), Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA.	wcm2@cwru.edu			National Institutes of Health [GM-68079, T32 GM-08056]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008056, R01GM068079] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (GM-68079 to WM and T32 GM-08056 to LR). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS SL, 1975, J BIOL CHEM, V250, P9083; ALTMANN M, 1993, EMBO J, V12, P3997, DOI 10.1002/j.1460-2075.1993.tb06077.x; Anand M, 2006, J BIOL CHEM, V281, P32318, DOI 10.1074/jbc.M601899200; Choi SK, 1998, SCIENCE, V280, P1757, DOI 10.1126/science.280.5370.1757; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; Dmitriev SE, 2010, J BIOL CHEM, V285, P26779, DOI 10.1074/jbc.M110.119693; FUGE EK, 1994, J BACTERIOL, V176, P5802, DOI 10.1128/JB.176.18.5802-5813.1994; GONEN H, 1994, P NATL ACAD SCI USA, V91, P7648, DOI 10.1073/pnas.91.16.7648; Gromadski KB, 2007, J BIOL CHEM, V282, P35629, DOI 10.1074/jbc.M707245200; Gross SR, 2005, NAT STRUCT MOL BIOL, V12, P772, DOI 10.1038/nsmb979; Gross SR, 2007, MOL CELL BIOL, V27, P1974, DOI 10.1128/MCB.00832-06; Hussey GS, 2011, MOL CELL, V41, P419, DOI 10.1016/j.molcel.2011.02.003; Kaake RM, 2010, J PROTEOME RES, V9, P2016, DOI 10.1021/pr1000175; Kim JH, 2011, EMBO J, V30, P2454, DOI 10.1038/emboj.2011.146; Komar AA, 2003, EMBO J, V22, P1199, DOI 10.1093/emboj/cdg103; Komar AA, 2005, J BIOL CHEM, V280, P15601, DOI 10.1074/jbc.M413728200; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Krogan NJ, 2004, MOL CELL, V13, P225, DOI 10.1016/S1097-2765(04)00003-6; Kubota S, 2004, BIOSCI BIOTECH BIOCH, V68, P968, DOI 10.1271/bbb.68.968; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; MERRICK WC, 1975, J BIOL CHEM, V250, P1197; Pestova TV, 2008, EMBO J, V27, P1060, DOI 10.1038/emboj.2008.49; RAMIREZ M, 1992, MOL CELL BIOL, V12, P5801, DOI 10.1128/MCB.12.12.5801; Reineke EL, 2008, MOL CELL BIOL, V28, P997, DOI 10.1128/MCB.01848-07; Reineke LC, 2008, J BIOL CHEM, V283, P19011, DOI 10.1074/jbc.M803109200; Reineke LC, 2009, RNA, V15, P2264, DOI 10.1261/rna.1722809; Robert F, 2006, MOL BIOL CELL, V17, P4632, DOI 10.1091/mbc.E06-06-0478; SAFER B, 1975, J BIOL CHEM, V250, P9076; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Terenin IM, 2008, NAT STRUCT MOL BIOL, V15, P836, DOI 10.1038/nsmb.1445; Thompson SR, 2001, P NATL ACAD SCI USA, V98, P12972, DOI 10.1073/pnas.241286698; Turk EM, 2010, J BIOL CHEM, V285, P8585, DOI 10.1074/jbc.M109.090761; Ventoso I, 2006, GENE DEV, V20, P87, DOI 10.1101/gad.357006; WHITE JP, 2011, J VIROL; Wilmes GM, 2008, MOL CELL, V32, P735, DOI 10.1016/j.molcel.2008.11.012; Zoll WL, 2002, J BIOL CHEM, V277, P37079, DOI 10.1074/jbc.M207109200; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	39	17	17	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2011	6	9							e24492	10.1371/journal.pone.0024492	http://dx.doi.org/10.1371/journal.pone.0024492			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CH	21915340	Green Submitted, Green Published, gold			2022-12-25	WOS:000294802500055
J	Kuriakose, JA; Miyashiro, S; Luo, T; Zhu, B; McBride, JW				Kuriakose, Jeeba A.; Miyashiro, Simone; Luo, Tian; Zhu, Bing; McBride, Jere W.			Ehrlichia chaffeensis Transcriptome in Mammalian and Arthropod Hosts Reveals Differential Gene Expression and Post Transcriptional Regulation	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; TICK CELL-CULTURE; ANAPLASMA-PHAGOCYTOPHILUM; DEVELOPMENTAL CYCLE; ANTIBODY EPITOPES; MULTIGENE FAMILY; TANDEM REPEATS; SCID MICE; CANIS; MACROPHAGE	Background: Human monocytotropic ehrlichiosis is an emerging life-threatening zoonosis caused by obligately intracellular bacterium, Ehrlichia chaffeensis. E. chaffeensis is transmitted by the lone star tick, Amblyomma americanum, and replicates in mononuclear phagocytes in mammalian hosts. Differences in the E. chaffeensis transcriptome in mammalian and arthropod hosts are unknown. Thus, we determined host-specific E. chaffeensis gene expression in human monocyte (THP-1) and in Amblyomma and Ixodes tick cell lines (AAE2 and ISE6) using a whole genome microarray. Methodology/Principal Findings: The majority (similar to 80%) of E. chaffeensis genes were expressed during infection in human and tick cells. There were few differences observed in E. chaffeensis gene expression between the vector Amblyomma and non-vector Ixodes tick cells, but extensive host-specific and differential gene expression profiles were detected between human and tick cells, including higher transcriptional activity in tick cells and identification of gene subsets that were differentially expressed in the two hosts. Differentially and host-specifically expressed ehrlichial genes encoded major immunoreactive tandem repeat proteins (TRP), the outer membrane protein (OMP-1) family, and hypothetical proteins that were 30-80 amino acids in length. Consistent with previous observations, high expression of p28 and OMP-1B genes was detected in human and tick cells, respectively. Notably, E. chaffeensis genes encoding TRP32 and TRP47 were highly upregulated in the human monocytes and expressed as proteins; however, although TRP transcripts were expressed in tick cells, the proteins were not detected in whole cell lysates demonstrating that TRP expression was post transcriptionally regulated. Conclusions/Significance: Ehrlichia gene expression is highly active in tick cells, and differential gene expression among a wide variety of host-pathogen associated genes occurs. Furthermore, we demonstrate that genes associated with host-pathogen interactions are differentially expressed and regulated by post transcriptional mechanisms.	[Kuriakose, Jeeba A.; Miyashiro, Simone; Luo, Tian; Zhu, Bing; McBride, Jere W.] Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Dept Pathol, Galveston, TX 77555 USA; [McBride, Jere W.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX USA; [McBride, Jere W.] Univ Texas Med Branch, Sealy Ctr Vaccine Dev, Galveston, TX USA; [McBride, Jere W.] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Kuriakose, JA (corresponding author), Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Dept Pathol, Galveston, TX 77555 USA.	jemcbrid@utmb.edu	Miyashiro, Simone/D-8326-2013	Luo, Tian/0000-0003-4360-3429; Miyashiro, Simone/0000-0003-0623-1128	National Institute of Allergy and Infectious Diseases (NIAID) [R01 AI 071145, T32 AI060549]; Clayton Foundation for Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060549, R01AI071145] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Clayton Foundation for Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grant R01 AI 071145 from the National Institute of Allergy and Infectious Diseases (NIAID) and by the Clayton Foundation for Research. Jeeba Kuriakose was supported by NIAID Biodefense Training grant T32 AI060549. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arraiano CM, 2010, FEMS MICROBIOL REV, V34, P883, DOI 10.1111/j.1574-6976.2010.00242.x; Babitzke P, 2009, ANNU REV MICROBIOL, V63, P27, DOI 10.1146/annurev.micro.091208.073514; Bell-Sakyi L, 2007, TRENDS PARASITOL, V23, P450, DOI 10.1016/j.pt.2007.07.009; Belland RJ, 2003, P NATL ACAD SCI USA, V100, P8478, DOI 10.1073/pnas.1331135100; Buttner D, 2010, FEMS MICROBIOL REV, V34, P107, DOI 10.1111/j.1574-6976.2009.00192.x; Doyle CK, 2006, INFECT IMMUN, V74, P711, DOI 10.1128/IAI.74.1.711-720.2006; Hotopp JCD, 2006, PLOS GENET, V2, P208, DOI 10.1371/journal.pgen.0020021; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ellison DW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005612; Ganta RR, 2007, INFECT IMMUN, V75, P135, DOI 10.1128/IAI.01127-06; Ge Y, 2007, INFECT IMMUN, V75, P3833, DOI 10.1128/IAI.00188-07; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ismail N, 2010, CLIN LAB MED, V30, P261, DOI 10.1016/j.cll.2009.10.004; Jansen A, 2006, CURR OPIN MICROBIOL, V9, P138, DOI 10.1016/j.mib.2006.01.003; Konig J, 2002, J MOL MICROB BIOTECH, V4, P197; Konkel ME, 2000, MICROBES INFECT, V2, P157, DOI 10.1016/S1286-4579(00)00272-0; Kumagai Y, 2008, J BACTERIOL, V190, P3597, DOI 10.1128/JB.02017-07; Kumagai Y, 2010, J BACTERIOL, V192, P4122, DOI 10.1128/JB.00132-10; La MV, 2007, J MICROBIOL METH, V71, P292, DOI 10.1016/j.mimet.2007.09.017; Li JSY, 2002, J IMMUNOL, V169, P1419, DOI 10.4049/jimmunol.169.3.1419; Li JSY, 2001, J IMMUNOL, V166, P1855; Lin MQ, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00024; Lin MQ, 2003, INFECT IMMUN, V71, P5324, DOI 10.1128/IAI.71.9.5324-5331.2003; Long SW, 2002, INFECT IMMUN, V70, P1824, DOI 10.1128/IAI.70.4.1824-1831.2002; LUO T, 2011, INFECT IMMU IN PRESS; LUO T, 2011, 6 INT M RICK RICK DI; Luo T, 2008, INFECT IMMUN, V76, P1572, DOI 10.1128/IAI.01466-07; Luo T, 2010, CLIN VACCINE IMMUNOL, V17, P87, DOI 10.1128/CVI.00331-09; Luo T, 2009, CLIN VACCINE IMMUNOL, V16, P982, DOI 10.1128/CVI.00048-09; Mavromatis K, 2006, J BACTERIOL, V188, P4015, DOI 10.1128/JB.01837-05; McBride JW, 2003, INFECT IMMUN, V71, P2516, DOI 10.1128/IAI.71.5.2516-2524.2003; MUNDERLOH UG, 1989, EXP APPL ACAROL, V7, P219, DOI 10.1007/BF01194061; Munderloh UG, 1999, J CLIN MICROBIOL, V37, P2518, DOI 10.1128/JCM.37.8.2518-2524.1999; Nelson CM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-364; Nogueira T, 2000, CURR OPIN MICROBIOL, V3, P154, DOI 10.1016/S1369-5274(00)00068-0; Ohashi N, 2001, INFECT IMMUN, V69, P2083, DOI 10.1128/IAI.69.4.2083-2091.2001; Paddock CD, 2003, CLIN MICROBIOL REV, V16, P37, DOI 10.1128/CMR.16.1.37-64.2003; Picard F, 2009, CR BIOL, V332, P958, DOI 10.1016/j.crvi.2009.09.005; Popov VL, 2000, MICROB PATHOGENESIS, V28, P71, DOI 10.1006/mpat.1999.0327; Revel AT, 2002, P NATL ACAD SCI USA, V99, P1562, DOI 10.1073/pnas.032667699; Romby P, 2006, CURR OPIN MICROBIOL, V9, P229, DOI 10.1016/j.mib.2006.02.005; Seo GM, 2008, INFECT IMMUN, V76, P4823, DOI 10.1128/IAI.00484-08; Singu V, 2005, INFECT IMMUN, V73, P79, DOI 10.1128/IAI.73.1.79-87.2005; Singu V, 2006, CELL MICROBIOL, V8, P1475, DOI 10.1111/j.1462-5822.2006.00727.x; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Unver A, 2002, INFECT IMMUN, V70, P4701, DOI 10.1128/IAI.70.8.4701-4704.2002; Wakeel A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009552; Wakeel A, 2009, INFECT IMMUN, V77, P1734, DOI 10.1128/IAI.00027-09; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Yu CS, 2006, PROTEINS, V64, P643, DOI 10.1002/prot.21018; Zhang HZ, 2004, INFECT IMMUN, V72, P498, DOI 10.1128/IAI.72.1.498-507.2004; Zhang JZ, 2007, CELL MICROBIOL, V9, P610, DOI 10.1111/j.1462-5822.2006.00812.x; ZHU B, 2011, INFECT IMMU IN PRESS; Zhu B, 2009, INFECT IMMUN, V77, P4243, DOI 10.1128/IAI.00376-09	54	44	47	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2011	6	9							e24136	10.1371/journal.pone.0024136	http://dx.doi.org/10.1371/journal.pone.0024136			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817QP	21915290	Green Submitted, Green Published, gold			2022-12-25	WOS:000294689200022
J	Akimova, T; Beier, UH; Wang, LQ; Levine, MH; Hancock, WW				Akimova, Tatiana; Beier, Ulf H.; Wang, Liqing; Levine, Matthew H.; Hancock, Wayne W.			Helios Expression Is a Marker of T Cell Activation and Proliferation	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; SUPPRESSIVE FUNCTION; FOXP3 LOCUS; IKAROS; TNFR2; DIFFERENTIATION; SPECIFICATION; GENERATION; INHIBITION; PROMOTES	Foxp3+ T-regulatory cells (Tregs) normally serve to attenuate immune responses and are key to maintenance of immune homeostasis. Over the past decade, Treg cells have become a major focus of research for many groups, and various functional subsets have been characterized. Recently, the Ikaros family member, Helios, was reported as a marker to discriminate naturally occurring, thymic-derived Tregs from those peripherally induced from naive CD4+ T cells. We investigated Helios expression in murine and human T cells under resting or activating conditions, using well-characterized molecules of naive/effector/memory phenotypes, as well as a set of Treg-associated markers. We found that Helios-negative T cells are enriched for naive T cell phenotypes and vice versa. Moreover, Helios can be induced during T cell activation and proliferation, but regresses in the same cells under resting conditions. We demonstrated comparable findings using human and murine CD4+ Foxp3+ Tregs, as well as in CD4+ and CD8+ T cells. Since Helios expression is associated with T cell activation and cellular division, regardless of the cell subset involved, it does not appear suitable as a marker to distinguish natural and induced Treg cells.	[Akimova, Tatiana; Wang, Liqing; Hancock, Wayne W.] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Div Transplant Immunol, Philadelphia, PA 19104 USA; [Akimova, Tatiana; Beier, Ulf H.; Wang, Liqing; Levine, Matthew H.; Hancock, Wayne W.] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Beier, Ulf H.] Childrens Hosp Philadelphia, Dept Pediat, Div Nephrol, Philadelphia, PA 19104 USA; [Levine, Matthew H.] Hosp Univ Penn, Penn Transplant Inst, Dept Surg, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine	Akimova, T (corresponding author), Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Div Transplant Immunol, Philadelphia, PA 19104 USA.	whancock@mail.med.upenn.edu	Levine, Matthew/O-4809-2015; Akimova, Tatiana/I-7200-2012	Levine, Matthew/0000-0003-4525-5827; Akimova, Tatiana/0000-0003-2767-8762; Beier, Ulf/0000-0002-3672-572X	National Institutes of Health [DK087270-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC1DK087270, K08DK092282] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by a grant (DK087270-01) to WWH from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimova T, 2010, CLIN IMMUNOL, V136, P348, DOI 10.1016/j.clim.2010.04.018; Baron U, 2007, EUR J IMMUNOL, V37, P2378, DOI 10.1002/eji.200737594; Booth NJ, 2010, J IMMUNOL, V184, P4317, DOI 10.4049/jimmunol.0903781; Cai Q, 2009, J IMMUNOL, V183, P2303, DOI 10.4049/jimmunol.0901407; Chen GY, 2008, J IMMUNOL, V180, P5163, DOI 10.4049/jimmunol.180.8.5163; Chen X, 2008, J IMMUNOL, V180, P6467, DOI 10.4049/jimmunol.180.10.6467; Chen X, 2010, J IMMUNOL, V185, P174, DOI 10.4049/jimmunol.0903548; Chen X, 2010, EUR J IMMUNOL, V40, P1099, DOI 10.1002/eji.200940022; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; de Zoeten EF, 2010, GASTROENTEROLOGY, V138, P583, DOI 10.1053/j.gastro.2009.10.037; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Dovat S, 2005, J IMMUNOL, V175, P3508, DOI 10.4049/jimmunol.175.6.3508; Feuerer M, 2009, NAT IMMUNOL, V10, P689, DOI 10.1038/ni.1760; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Fornasa G, 2010, J IMMUNOL, V184, P5485, DOI 10.4049/jimmunol.0902219; Fujimoto M, 2011, J IMMUNOL, V186, P32, DOI 10.4049/jimmunol.0903314; GEORGOPOULOS K, 1992, SCIENCE, V258, P808, DOI 10.1126/science.1439790; Getnet D, 2010, MOL IMMUNOL, V47, P1595, DOI 10.1016/j.molimm.2010.02.001; Getnet D, 2009, J IMMUNOL, V182, P4675, DOI 10.4049/jimmunol.0803400; Golovina TN, 2008, J IMMUNOL, V181, P2855, DOI 10.4049/jimmunol.181.4.2855; Haas J, 2007, J IMMUNOL, V179, P1322, DOI 10.4049/jimmunol.179.2.1322; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hosokawa Y, 1999, IMMUNOGENETICS, V50, P106, DOI 10.1007/s002510050696; Kimmig S, 2002, J EXP MED, V195, P789, DOI 10.1084/jem.20011756; Le Campion A, 2002, P NATL ACAD SCI USA, V99, P4538, DOI 10.1073/pnas.062621699; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Lorenzi AR, 2009, ANN RHEUM DIS, V68, P983, DOI 10.1136/ard.2008.088112; Min BK, 2003, IMMUNITY, V18, P131, DOI 10.1016/S1074-7613(02)00508-3; Nakase K, 2002, EXP HEMATOL, V30, P313, DOI 10.1016/S0301-472X(01)00796-2; Pan F, 2009, SCIENCE, V325, P1142, DOI 10.1126/science.1176077; Pillai V, 2007, CLIN IMMUNOL, V123, P18, DOI 10.1016/j.clim.2006.10.014; Rolland JM, 2010, CURR OPIN ALLERGY CL, V10, P559, DOI 10.1097/ACI.0b013e32833ff2b2; Sakaguchi S, 2003, J CLIN INVEST, V112, P1310, DOI 10.1172/JCI200320274; Sbardella G, 2001, ANTIVIR CHEM CHEMOTH, V12, P37, DOI 10.1177/095632020101200102; Sugimoto N, 2006, INT IMMUNOL, V18, P1197, DOI 10.1093/intimm/dxl060; Tanaskovic S, 2010, IMMUNOL CELL BIOL, V88, P321, DOI 10.1038/icb.2009.108; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Tran DQ, 2007, BLOOD, V110, P2983, DOI 10.1182/blood-2007-06-094656; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Verhagen J, 2010, J IMMUNOL, V185, P7129, DOI 10.4049/jimmunol.1090105; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Wang R, 2009, P NATL ACAD SCI USA, V106, P13439, DOI 10.1073/pnas.0901965106; Wang R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002705; Zhang Z, 2007, BLOOD, V109, P2190, DOI 10.1182/blood-2005-01-031930; Zheng Y, 2008, J IMMUNOL, V181, P1683, DOI 10.4049/jimmunol.181.3.1683	48	265	269	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2011	6	8							e24226	10.1371/journal.pone.0024226	http://dx.doi.org/10.1371/journal.pone.0024226			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817MS	21918685	Green Published, gold, Green Submitted			2022-12-25	WOS:000294678300033
J	Sorbye, SW; Arbyn, M; Fismen, S; Gutteberg, TJ; Mortensen, ES				Sorbye, Sveinung Wergeland; Arbyn, Marc; Fismen, Silje; Gutteberg, Tore Jarl; Mortensen, Elin Synnove			Triage of Women with Low-Grade Cervical Lesions - HPV mRNA Testing versus Repeat Cytology	PLOS ONE			English	Article							2-YEAR FOLLOW-UP; HUMAN-PAPILLOMAVIRUS; INTRAEPITHELIAL NEOPLASIA; DNA DETECTION; CANCER; MANAGEMENT; AGE; METAANALYSIS; GUIDELINES; LSIL	Background: In Norway, women with low-grade squamous intraepithelial lesions (LSIL) are followed up after six months in order to decide whether they should undergo further follow-up or be referred back to the screening interval of three years. A high specificity and positive predictive value (PPV) of the triage test is important to avoid unnecessary diagnostic and therapeutic procedures. Materials and Methods: At the University Hospital of North Norway, repeat cytology and the HPV mRNA test PreTect HPV-Proofer, detecting E6/E7 mRNA from HPV types 16, 18, 31, 33 and 45, are used in triage of women with ASC-US and LSIL. In this study, women with LSIL cytology in the period 2005-2008 were included (n = 522). Two triage methods were evaluated in two separate groups: repeat cytology only (n = 225) and HPV mRNA testing in addition to repeat cytology (n = 297). Histologically confirmed cervical intraepithelial neoplasia of grade 2 or worse (CIN2+) was used as the study endpoint. Results: Of 522 women with LSIL, 207 had biopsies and 125 of them had CIN2+. The sensitivity and specificity of repeat cytology (ASC-US or worse) were 85.7% (95% confidence interval (CI): 72.1, 92.2) and 54.4% (95% CI: 46.9, 61.9), respectively. The sensitivity and specificity of the HPV mRNA test were 94.2% (95% CI: 88.7, 99.7) and 86.0% (95% CI: 81.5, 90.5), respectively. The PPV of repeat cytology was 38.4% (95% CI: 29.9, 46.9) compared to 67.0% (95% CI: 57.7, 76.4) of the HPV mRNA test. Conclusion: HPV mRNA testing was more sensitive and specific than repeat cytology in triage of women with LSIL cytology. In addition, the HPV mRNA test showed higher PPV. These data indicate that the HPV mRNA test is a better triage test for women with LSIL than repeat cytology.	[Sorbye, Sveinung Wergeland; Fismen, Silje; Mortensen, Elin Synnove] Univ Hosp N Norway, Dept Clin Pathol, Tromso, Norway; [Arbyn, Marc] Belgian Canc Ctr, Canc Epidemiol Unit, Sci Inst Publ Hlth, Brussels, Belgium; [Gutteberg, Tore Jarl] Univ Hosp N Norway, Dept Microbiol & Infect Control, Tromso, Norway; [Gutteberg, Tore Jarl; Mortensen, Elin Synnove] Univ Tromso, Fac Hlth Sci, Dept Med Biol, Tromso, Norway	UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso	Sorbye, SW (corresponding author), Univ Hosp N Norway, Dept Clin Pathol, Tromso, Norway.	sveinung.sorbye@unn.no	Sorbye, Sveinung Wergeland/AAE-7208-2020	Sorbye, Sveinung Wergeland/0000-0002-8250-3992; Arbyn, Marc/0000-0001-8434-8263	University Hospital of North Norway; European Commission [242061]; Belgian Foundation Against Cancer (Brussels, Belgium)	University Hospital of North Norway; European Commission(European CommissionEuropean Commission Joint Research Centre); Belgian Foundation Against Cancer (Brussels, Belgium)	This research was supported by the University Hospital of North Norway (http://www.unn.no/). M. Arbyn received financial support from: (1) the European Commission (Directorate of SANCO, Luxembourg, Grand-Duchy of Luxembourg), through the ECCG project (European Cooperation on development and implementation of Cancer screening and prevention Guidelines, IARC, Lyon, France) and the 7th Framework Programme of DG Research through the PREHDICT project (grant No. 242061, coordinated by the Vrije Universiteit Amsterdam, The Netherlands); (2) the Belgian Foundation Against Cancer (Brussels, Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*ACOG, 2008, OBSTET GYNECOL, V112, P1419; Arbyn M, 2005, GYNECOL ONCOL, V99, pS7, DOI 10.1016/j.ygyno.2005.07.033; Arbyn M, 2004, JNCI-J NATL CANCER I, V96, P280, DOI 10.1093/jnci/djh037; Arbyn Marc, 2010, Evid Based Med, V15, P13, DOI 10.1136/ebm.15.1.13; Arbyn M, 2009, J CELL MOL MED, V13, P648, DOI 10.1111/j.1582-4934.2008.00631.x; Bjerre P, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2007.11.053; Boardman LA, 2008, OBSTET GYN CLIN N AM, V35, P599, DOI 10.1016/j.ogc.2008.09.001; Brismar-Wendel S, 2009, BRIT J CANCER, V101, P511, DOI 10.1038/sj.bjc.6605165; Cattani P, 2009, J CLIN MICROBIOL, V47, P3895, DOI 10.1128/JCM.01275-09; Dillner L, 2011, INT J CANCER, V129, P151, DOI 10.1002/ijc.25649; Jordan J, 2008, CYTOPATHOLOGY, V19, P342, DOI 10.1111/j.1365-2303.2008.00623.x; Molden T, 2005, CANCER EPIDEM BIOMAR, V14, P367, DOI 10.1158/1055-9965.EPI-04-0410; Molden T, 2005, INT J CANCER, V114, P973, DOI 10.1002/ijc.20839; Richart R M, 1973, Pathol Annu, V8, P301; Ronco G, 2007, EUR J CANCER, V43, P476, DOI 10.1016/j.ejca.2006.11.013; Solomon D, 2003, AM J OBSTET GYNECOL, V188, P1393, DOI 10.1067/mob.2003.462; Solomon D, 2003, AM J OBSTET GYNECOL, V188, P1383, DOI 10.1067/mob.2003.457; Sorbye SW, 2010, J VIROL METHODS, V169, P219, DOI 10.1016/j.jviromet.2010.07.011; Sorbye SW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012724; Szarewski A, 2008, CANCER EPIDEM BIOMAR, V17, P3033, DOI 10.1158/1055-9965.EPI-08-0508; Thrall MJ, 2010, DIAGN CYTOPATHOL, V38, P407, DOI 10.1002/dc.21209; Trope A, 2009, J CLIN MICROBIOL, V47, P2458, DOI 10.1128/JCM.01863-08; Wright TC, 2007, AM J OBSTET GYNECOL, V197, P346, DOI 10.1016/j.ajog.2007.07.047; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798; [No title captured]	25	30	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2011	6	8							e24083	10.1371/journal.pone.0024083	http://dx.doi.org/10.1371/journal.pone.0024083			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817MS	21918682	Green Published, Green Submitted, gold			2022-12-25	WOS:000294678300020
J	Hanks, EM; Hooten, MB; Johnson, DS; Sterling, JT				Hanks, Ephraim M.; Hooten, Mevin B.; Johnson, Devin S.; Sterling, Jeremy T.			Velocity-Based Movement Modeling for Individual and Population Level Inference	PLOS ONE			English	Article							ANIMAL MOVEMENT; REVERSIBLE JUMP; RESOURCE SELECTION; HABITAT PREFERENCE; FRAMEWORK; ECOLOGY	Understanding animal movement and resource selection provides important information about the ecology of the animal, but an animal's movement and behavior are not typically constant in time. We present a velocity-based approach for modeling animal movement in space and time that allows for temporal heterogeneity in an animal's response to the environment, allows for temporal irregularity in telemetry data, and accounts for the uncertainty in the location information. Population-level inference on movement patterns and resource selection can then be made through cluster analysis of the parameters related to movement and behavior. We illustrate this approach through a study of northern fur seal (Callorhinus ursinus) movement in the Bering Sea, Alaska, USA. Results show sex differentiation, with female northern fur seals exhibiting stronger response to environmental variables.	[Hanks, Ephraim M.; Hooten, Mevin B.] Colorado State Univ, Dept Stat, Ft Collins, CO 80523 USA; [Hooten, Mevin B.] Colorado State Univ, US Geol Survey, Colorado Cooperat Fish & Wildlife Res Unit, Ft Collins, CO 80523 USA; [Hooten, Mevin B.] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA; [Johnson, Devin S.; Sterling, Jeremy T.] NOAA, Natl Marine Fisheries Serv, Natl Marine Mammal Lab, Alaska Fisheries Sci Ctr, Seattle, WA 98115 USA	Colorado State University; Colorado State University; United States Department of the Interior; United States Geological Survey; Colorado State University; National Oceanic Atmospheric Admin (NOAA) - USA	Hanks, EM (corresponding author), Colorado State Univ, Dept Stat, Ft Collins, CO 80523 USA.	hanks@stat.colostate.edu		Hanks, Ephraim/0000-0003-0345-7164	National Oceanic and Atmospheric Administration [AB133F-09-SE-4640]; U.S. Geological Survey [1434-06HQRU1555]	National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); U.S. Geological Survey(United States Geological Survey)	Funding for this study was provided by the National Oceanic and Atmospheric Administration AB133F-09-SE-4640 and the U.S. Geological Survey 1434-06HQRU1555. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts G, 2008, ECOGRAPHY, V31, P140, DOI 10.1111/j.2007.0906-7590.05236.x; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Beyer HL, 2010, PHILOS T R SOC B, V365, P2245, DOI 10.1098/rstb.2010.0083; Blewitt ME, 2008, NAT GENET, V40, P663, DOI 10.1038/ng.142; Brockwell P. J., 2002, INTRO TIME SERIES FO; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Cagnacci F, 2010, PHILOS T R SOC B, V365, P2157, DOI 10.1098/rstb.2010.0107; Cappe O, 2003, J R STAT SOC B, V65, P679, DOI 10.1111/1467-9868.00409; Celeux G, 2006, BAYESIAN ANAL, V1, P651, DOI 10.1214/06-BA122; Christ A, 2008, ENVIRON ECOL STAT, V15, P27, DOI 10.1007/s10651-007-0036-x; Cressie N, 2009, ECOL APPL, V19, P553, DOI 10.1890/07-0744.1; Dalziel BD, 2008, AM NAT, V172, P248, DOI 10.1086/589448; Duchon J., 1977, SPLINES MINIMIZING R; Forester JD, 2009, ECOLOGY, V90, P3554, DOI 10.1890/08-0874.1; Fraley C, 2006, MCLUST VERSION 3 R N; Furrer R., 2010, FIELDS TOOLS SPATIAL; Gelman A., 2004, BAYESIAN DATA ANAL; Gentry R.L., 1998, BEHAV ECOLOGY NO SEA; Getz WM, 2008, P NATL ACAD SCI USA, V105, P19066, DOI 10.1073/pnas.0801732105; Green PJ, 1995, BIOMETRIKA, V82, P711, DOI 10.2307/2337340; Gurarie E, 2009, ECOL LETT, V12, P395, DOI 10.1111/j.1461-0248.2009.01293.x; HASTIE T, 1993, J ROY STAT SOC B MET, V55, P757; Hooten MB, 2010, J AGR BIOL ENVIR ST, V15, P523, DOI 10.1007/s13253-010-0038-2; Hooten MB, 2010, J AM STAT ASSOC, V105, P236, DOI 10.1198/jasa.2009.tm09036; Izenman A. J., 2008, MODERN MULTIVARIATE; Johnson D, 2011, J AGR BIOL IN PRESS; Johnson DS, 2008, BIOMETRICS, V64, P968, DOI 10.1111/j.1541-0420.2007.00943.x; Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852; KENYON KW, 1953, J MAMMAL, V34, P86, DOI 10.2307/1375947; Kuhn CE, 2009, MAR ECOL PROG SER, V393, P97, DOI 10.3354/meps08229; Loughlin TR, 1994, STATUS NO SEAL POPUL; Manly B.F.J., 2002, RESOURCE SELECTION A; McClintock BT, 2011, ECOLOGICAL IN PRESS; Merrill E, 2010, PHILOS T R SOC B, V365, P2279, DOI 10.1098/rstb.2010.0077; Morales JM, 2004, ECOLOGY, V85, P2436, DOI 10.1890/03-0269; Morales JM, 2010, PHILOS T R SOC B, V365, P2289, DOI 10.1098/rstb.2010.0082; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; Polansky L, 2010, ECOLOGY, V91, P1506, DOI 10.1890/08-2159.1; R Development Core Team, 2009, R FDN STAT COMP; Rubin DB, 1996, J AM STAT ASSOC, V91, P473, DOI 10.1080/01621459.1996.10476908; Rubin DB, 2004, MULTIPLE IMPUTATION; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; SENFT RL, 1987, BIOSCIENCE, V37, P789, DOI 10.2307/1310545; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Steele Russell J, 2010, Stat Methodol, V7, P351; Stephens M, 2000, ANN STAT, V28, P40, DOI 10.1214/aos/1016120364; Sumner MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007324; Tomkiewicz SM, 2010, PHILOS T R SOC B, V365, P2163, DOI 10.1098/rstb.2010.0090; Tremblay Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004711; Turchin Peter, 1998; Ver Hoef JM, 2009, COMPUTATION STAT, V25, P39; Wheeler DC, 2007, J GEOGR SYST, V9, P145, DOI 10.1007/s10109-006-0040-y	52	45	45	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 11	2011	6	8							e22795	10.1371/journal.pone.0022795	http://dx.doi.org/10.1371/journal.pone.0022795			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	808CS	21931584	gold, Green Submitted, Green Published			2022-12-25	WOS:000293953400014
J	Amable, L; Grankvist, N; Largen, JW; Ortsater, H; Sjoholm, A; Honkanen, RE				Amable, Lauren; Grankvist, Nina; Largen, Jason W.; Ortsater, Henrik; Sjoholm, Ake; Honkanen, Richard E.			Disruption of Serine/Threonine Protein Phosphatase 5 (PP5: PPP5c) in Mice Reveals a Novel Role for PP5 in the Regulation of Ultraviolet Light-induced Phosphorylation of SerinefThreonine Protein Kinase Chk1 (CHEK1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE RESPONSE; CELL-CYCLE ARREST; CHECKPOINT ACTIVATION; 14-3-3 BINDING; GROWTH ARREST; ATR; PROTEIN-PHOSPHATASE-5; CDC25A; EXPRESSION; DEGRADATION	PPS is a ubiquitously expressed Ser/Thr protein phosphatase. High levels of PP5 have been observed in human cancers, and constitutive PP5 overexpression aids tumor progression in mouse models of tumor development. However, PP5 is highly conserved among species, and the roles of PP5 in normal tissues are not clear. Here, to help evaluate the biological actions of PP5, a CrelloxP-conditional mouse line was generated. In marked contrast to the early embryonic lethality associated with the genetic disruption of other PPP family phosphatases (e.g. PP2A and PP4), intercrosses with mouse lines that ubiquitously express Cre recombinase starting early in development (e.g. MeuCre40 and ACTB-Cre) produced viable and fertile PP5-deficient mice. Phenotypic differences caused by the total disruption of PP5 were minor, suggesting that small molecule inhibitors of PP5 will not have widespread systemic toxicity. Examination of roles for PP5 in fibroblasts generated from PP5, deficient embryos (PP5' mouse embryonic fibroblasts) confirmed some known roles and identified new actions for PP5. PP5(-/-) mouse embryonic fibroblasts demonstrated increased sensitivity to UV light, hydroxyurea, and camptothecin, which are known activators of ATR (ataxia-telangiectasia and Rad3-related) kinase. Further study revealed a previously unrecognized role for PP5 downstream of ATR activation in a UV light-induced response. The genetic disruption of PP5 is associated with enhanced and prolonged phosphorylation of a single senile (Ser-345) on Chk1, increased phosphorylation of the p53 tumor suppressor protein (p53) at serine 18, and increased p53 protein levels. A comparable role for PP5 in the regulation of Chk1 phosphorylation was also observed in human cells.	[Amable, Lauren; Largen, Jason W.; Honkanen, Richard E.] Univ S Alabama, Coll Med, Dept Biochem & Mol Biol, Mobile, AL 36688 USA; [Grankvist, Nina; Ortsater, Henrik; Sjoholm, Ake; Honkanen, Richard E.] Karolinska Inst, Sodersjukhuset, Dept Clin Sci & Educ, SE-11883 Stockholm, Sweden	University of South Alabama; Karolinska Institutet; Sodersjukhuset Hospital	Honkanen, RE (corresponding author), Univ S Alabama, Coll Med, Dept Biochem & Mol Biol, Mobile, AL 36688 USA.	richard.honkanen@ki.se		Grankvist, Nina/0000-0002-3111-4575	National Institutes of Health [CA60750, T32 HL076125]; Olle Engkvist Byggmastare Foundation; Diabetes Research and Wellness Foundation; Berth von Kantzow's Foundation; Golje's Memorial Foundation; Eva and Oscar Ahren's Foundation; Karolinska Institutet; Swedish Society for Medical Research; United States National Center for Research Resources [C06 RR11174]; NATIONAL CANCER INSTITUTE [R29CA060750, R01CA060750] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR011174] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL076125] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Olle Engkvist Byggmastare Foundation; Diabetes Research and Wellness Foundation; Berth von Kantzow's Foundation; Golje's Memorial Foundation; Eva and Oscar Ahren's Foundation; Karolinska Institutet(Karolinska Institutet); Swedish Society for Medical Research; United States National Center for Research Resources; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA60750 (to R. E. H.) and T32 HL076125 (to J. W. L.). This work was also supported by the Olle Engkvist Byggmastare Foundation, the Diabetes Research and Wellness Foundation, Berth von Kantzow's Foundation, Golje's Memorial Foundation, the Eva and Oscar Ahren's Foundation, and the Karolinska Institutet (to A. S.) and the Swedish Society for Medical Research (to H. O.). Some of the studies for this investigation were conducted in a facility constructed with support from Research Facilities Improvement Program Grant C06 RR11174 from the United States National Center for Research Resources.	Ali A, 2004, GENE DEV, V18, P249, DOI 10.1101/gad.1176004; Amable L, 2009, THESIS U S ALABAMA; Ben Mkaddem S, 2009, J BIOL CHEM, V284, P12541, DOI 10.1074/jbc.M808376200; Brown EJ, 2000, GENE DEV, V14, P397; Brown EJ, 2003, GENE DEV, V17, P615, DOI 10.1101/gad.1067403; Chen MS, 2003, MOL CELL BIOL, V23, P7488, DOI 10.1128/MCB.23.21.7488-7497.2003; Chen YH, 2004, DNA REPAIR, V3, P1025, DOI 10.1016/j.dnarep.2004.03.003; Cheng AY, 2000, J BIOL CHEM, V275, P1846, DOI 10.1074/jbc.275.3.1846; Fukuda H, 2007, J CELL BIOCHEM, V101, P321, DOI 10.1002/jcb.21178; Ghobrial IM, 2005, BLOOD, V105, P3722, DOI 10.1182/blood-2004-10-3999; Golden T, 2004, CANCER LETT, V215, P95, DOI 10.1016/j.canlet.2004.03.027; Golden TA, 2003, METHOD ENZYMOL, V366, P372; Golden T, 2008, CANCER METAST REV, V27, P169, DOI 10.1007/s10555-008-9125-z; Golden T, 2008, BBA-MOL BASIS DIS, V1782, P259, DOI 10.1016/j.bbadis.2008.01.004; Huang SL, 2004, J BIOL CHEM, V279, P36490, DOI 10.1074/jbc.M401208200; Jiang KC, 2003, J BIOL CHEM, V278, P25207, DOI 10.1074/jbc.M300070200; Kang N, BIOCH BIOPHYS RES CO, V404, P476; Kutuzov MA, 2005, J BIOL CHEM, V280, P25388, DOI 10.1074/jbc.M413202200; Leneuve P, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng021; Leung-Pineda V, 2006, MOL CELL BIOL, V26, P7529, DOI 10.1128/MCB.00447-06; Lewandoski M, 1997, COLD SPRING HARB SYM, V62, P159; Liu QH, 2000, GENE DEV, V14, P1448; Lovejoy CA, 2009, DNA REPAIR, V8, P1004, DOI 10.1016/j.dnarep.2009.04.006; Lubert EJ, 2001, J BIOL CHEM, V276, P38582, DOI 10.1074/jbc.M106906200; Morita K, 2001, EMBO J, V20, P6028, DOI 10.1093/emboj/20.21.6028; Post S, 2001, P NATL ACAD SCI USA, V98, P13102, DOI 10.1073/pnas.231364598; Reinhardt HC, 2009, CURR OPIN CELL BIOL, V21, P245, DOI 10.1016/j.ceb.2009.01.018; Shao J, 2002, BIOCHEMISTRY-US, V41, P6770, DOI 10.1021/bi025737a; Shimuta K, 2002, EMBO J, V21, P3694, DOI 10.1093/emboj/cdf357; Shirato H, 2000, INT J ONCOL, V17, P909; Skarra DV, 2011, PROTEOMICS, V11, P1508, DOI 10.1002/pmic.201000770; Smits VAJ, 2010, FRONT BIOSCI-LANDMRK, V15, P840, DOI 10.2741/3649; Sorensen CS, 2003, CANCER CELL, V3, P247, DOI 10.1016/S1535-6108(03)00048-5; Swingle Mark, 2007, V365, P23; Swingle MR, 2009, J PHARMACOL EXP THER, V331, P45, DOI 10.1124/jpet.109.155630; Swingle MR, 2004, J BIOL CHEM, V279, P33992, DOI 10.1074/jbc.M402855200; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Vaughan CK, 2008, MOL CELL, V31, P886, DOI 10.1016/j.molcel.2008.07.021; von Kriegsheim A, 2006, NAT CELL BIOL, V8, P1011, DOI 10.1038/ncb1465; Wechsler T, 2004, P NATL ACAD SCI USA, V101, P1247, DOI 10.1073/pnas.0307765100; Xiao Z, 2003, J BIOL CHEM, V278, P21767, DOI 10.1074/jbc.M300229200; Xu Y, 1996, GENE DEV, V10, P2401, DOI 10.1101/gad.10.19.2401; Yong WD, 2007, J BIOL CHEM, V282, P14690, DOI 10.1074/jbc.C700019200; Zhang J, 2005, MOL CELL BIOL, V25, P9910, DOI 10.1128/MCB.25.22.9910-9919.2005; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zhou GF, 2004, J BIOL CHEM, V279, P46595, DOI 10.1074/jbc.M408320200; Zuo Z, 1999, BIOCHEMISTRY-US, V38, P8849, DOI 10.1021/bi990842e; Zuo Z, 1998, J BIOL CHEM, V273, P12250, DOI 10.1074/jbc.273.20.12250	49	30	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40413	40422		10.1074/jbc.M111.244053	http://dx.doi.org/10.1074/jbc.M111.244053			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21921034	hybrid, Green Published			2022-12-25	WOS:000297315400001
J	Farkas, T; Daugaard, M; Jaattela, M				Farkas, Thomas; Daugaard, Mads; Jaattela, Marja			Identification of Small Molecule Inhibitors of Phosphatidylinositol 3-Kinase and Autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; CELL-DEATH; MAMMALIAN DEVELOPMENT; TARGETING AUTOPHAGY; CANCER; MACROAUTOPHAGY; APOPTOSIS; 3-PHOSPHATE; SELECTIVITY; NECROSIS	Macroautophagy (hereafter autophagy) is a lysosomal catabolic pathway that controls cellular homeostasis and survival. It has recently emerged as an attractive target for the treatment of a variety of degenerative diseases and cancer. The targeting of autophagy has, however, been hampered by the lack of specific small molecule inhibitors. Thus, we screened two small molecule kinase inhibitor libraries for inhibitors of rapamycin-induced autophagic flux. The three most potent inhibitors identified conferred profound inhibition of autophagic flux by inhibiting the formation of autophagosomes. Notably, the autophagy inhibitory effects of all three compounds were independent of their established kinase targets, i.e. ataxia telangiectasia mutated for KU55933, protein kinase C for Go6976, and Janus kinase 3 for Jak3 inhibitor VI. Instead, we identified phosphatidylinositol 3-kinase (PtdIns3K) as a direct target of KU55933 and Go6976. Importantly, and in contrast to the currently available inhibitors of autophagosome formation (e.g. 3-methyladenine), none of the three compounds inhibited the cell survival promoting class I phosphoinositide 3-kinase-Akt signaling at the concentrations required for effective autophagy inhibition. Accordingly, they proved to be valuable tools for investigations of autophagy-associated cell death and survival. Employing KU55399, we demonstrated that autophagy protects amino acid-starved cells against both apoptosis and necroptosis. Taken together, our data introduce new possibilities for the experimental study of autophagy and can form a basis for the development of clinically relevant autophagy inhibitors.	Danish Canc Soc, Apoptosis Dept, DK-2100 Copenhagen, Denmark; Danish Canc Soc, Ctr Genotox Stress Res, Inst Canc Biol, DK-2100 Copenhagen, Denmark	Danish Cancer Society; Danish Cancer Society	Jaattela, M (corresponding author), Strandboulevarden 49, DK-2100 Copenhagen, Denmark.	mj@cancer.dk	Jäättelä, Marja/AAT-7932-2021; Daugaard, Mads/Y-6483-2018	Jäättelä, Marja/0000-0001-5950-7111; Farkas, Thomas/0000-0003-1903-6081; Daugaard, Mads/0000-0001-8383-055X	Danish National Research Foundation,; Danish Cancer Society; European Commission; Lundbeck Foundation; Meyer Foundation; Novo Nordisk Foundation	Danish National Research Foundation,(Danmarks Grundforskningsfond); Danish Cancer Society(Danish Cancer Society); European Commission(European CommissionEuropean Commission Joint Research Centre); Lundbeck Foundation(Lundbeckfonden); Meyer Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	This work was supported by grants from the Danish National Research Foundation, the Danish Cancer Society, the European Commission FP7 (APO-SYS), the Lundbeck Foundation, the Meyer Foundation, and the Novo Nordisk Foundation (to M. J.).	Adams C, 2003, BIOORG MED CHEM LETT, V13, P3105, DOI 10.1016/S0960-894X(03)00657-7; Amaravadi RK, 2011, CLIN CANCER RES, V17, P654, DOI 10.1158/1078-0432.CCR-10-2634; Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Cao Y, 2009, P NATL ACAD SCI USA, V106, P21819, DOI 10.1073/pnas.0911987106; Cecconi F, 2008, DEV CELL, V15, P344, DOI 10.1016/j.devcel.2008.08.012; Chan EY, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.284pe51; Chrencik JE, 2010, J MOL BIOL, V400, P413, DOI 10.1016/j.jmb.2010.05.020; Corcelle EA, 2009, FEBS J, V276, P6084, DOI 10.1111/j.1742-4658.2009.07332.x; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Dietrich N, 2004, CELL DEATH DIFFER, V11, P301, DOI 10.1038/sj.cdd.4401353; Farkas T, 2009, AUTOPHAGY, V5, P1018, DOI 10.4161/auto.5.7.9443; Foghsgaard L, 2001, J CELL BIOL, V153, P999, DOI 10.1083/jcb.153.5.999; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Hoyer-Hansen M, 2008, AUTOPHAGY, V4, P574, DOI 10.4161/auto.5921; Hoyer-Hansen M, 2007, AUTOPHAGY, V3, P381, DOI 10.4161/auto.4240; Hoyer-Hansen M, 2007, MOL CELL, V25, P193, DOI 10.1016/j.molcel.2006.12.009; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Knight ZA, 2007, BIOCHEM SOC T, V35, P245, DOI 10.1042/BST0350245; Knight ZA, 2007, NAT PROTOC, V2, P2459, DOI 10.1038/nprot.2007.361; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Mathew R, 2011, CURR OPIN GENET DEV, V21, P113, DOI 10.1016/j.gde.2010.12.008; Matsunaga K, 2010, J CELL BIOL, V190, P511, DOI 10.1083/jcb.200911141; Miller S, 2010, SCIENCE, V327, P1638, DOI 10.1126/science.1184429; Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Rainey MD, 2008, CANCER RES, V68, P7466, DOI 10.1158/0008-5472.CAN-08-0763; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Saiki S, 2011, AUTOPHAGY, V7, P176, DOI 10.4161/auto.7.2.14074; Sarkaria JN, 1999, CANCER RES, V59, P4375; Simonsen A, 2009, J CELL BIOL, V186, P773, DOI 10.1083/jcb.200907014; Szyniarowski P, 2011, AUTOPHAGY, V7, P892, DOI 10.4161/auto.7.8.15770; Vanden Berghe T, 2010, CELL DEATH DIFFER, V17, P922, DOI 10.1038/cdd.2009.184; Weidberg H, 2011, ANNU REV BIOCHEM, V80, P125, DOI 10.1146/annurev-biochem-052709-094552; Wu YT, 2010, J BIOL CHEM, V285, P10850, DOI 10.1074/jbc.M109.080796; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	46	74	78	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					38904	38912		10.1074/jbc.M111.269134	http://dx.doi.org/10.1074/jbc.M111.269134			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21930714	Green Published, hybrid			2022-12-25	WOS:000296759800009
J	Fenner, D; Odili, S; Hong, HK; Kobayashi, Y; Kohsaka, A; Siepka, SM; Vitaterna, MH; Chen, P; Zelent, B; Grimsby, J; Takahashi, JS; Matschinsky, FM; Bass, J				Fenner, Deborah; Odili, Stella; Hong, Hee-Kyung; Kobayashi, Yumiko; Kohsaka, Akira; Siepka, Sandra M.; Vitaterna, Martha H.; Chen, Pan; Zelent, Bogumil; Grimsby, Joseph; Takahashi, Joseph S.; Matschinsky, Franz M.; Bass, Joseph			Generation of N-Ethyl-N-nitrosourea (ENU) Diabetes Models in Mice Demonstrates Genotype-specific Action of Glucokinase Activators	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENOME-WIDE ASSOCIATION; BETA-CELL GLUCOKINASE; HIGH-FAT DIET; REGULATORY PROTEIN; GLUCOSE-HOMEOSTASIS; SUSCEPTIBILITY LOCI; ANIMAL-MODEL; ALPHA-GENE; RISK LOCI; YOUNG	We performed genome-wide mutagenesis in C57BL/6J mice using N-ethyl-N-nitrosourea to identify mutations causing high blood glucose early in life and to produce new animal models of diabetes. Of a total of 13 new lines confirmed by heritability testing, we identified two semi-dominant pedigrees with novel missense mutations (Gck(K140E) and Gck(P417R)) in the gene encoding glucokinase (Gck), the mammalian glucose sensor that is mutated in human maturity onset diabetes of the young type 2 and the target of emerging anti-hyperglycemic agents that function as glucokinase activators (GKAs). Diabetes phenotype corresponded with genotype (mild-to-severe: Gck(+/+) < Gck(P417R/+), Gck(K140E/+) < Gck(P417R/P417R), Gck(P417R/K140E), and Gck(K140E/K140E)) and with the level of expression of GCK in liver. Each mutant was produced as the recombinant enzyme in Escherichia coli, and analysis of k(cat) and tryptophan fluorescence (I-320/360) during thermal shift unfolding revealed a correlation between thermostability and the severity of hyperglycemia in the whole animal. Disruption of the glucokinase regulatory protein-binding site (GCK(K140E)), but not the ATP binding cassette (GCK(P417R)), prevented inhibition of enzyme activity by glucokinase regulatory protein and corresponded with reduced responsiveness to the GKA drug. Surprisingly, extracts from liver of diabetic GCK mutants inhibited activity of the recombinant enzyme, a property that was also observed in liver extracts from mice with streptozotocin-induced diabetes. These results indicate a relationship between genotype, phenotype, and GKA efficacy. The integration of forward genetic screening and bio-chemical profiling opens a pathway for preclinical development of mechanism-based diabetes therapies.	[Fenner, Deborah; Kobayashi, Yumiko; Bass, Joseph] Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA; [Fenner, Deborah; Hong, Hee-Kyung; Kobayashi, Yumiko; Kohsaka, Akira; Siepka, Sandra M.; Vitaterna, Martha H.; Takahashi, Joseph S.; Bass, Joseph] Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; [Hong, Hee-Kyung; Siepka, Sandra M.; Vitaterna, Martha H.; Bass, Joseph] Northwestern Univ, Ctr Sleep & Circadian Biol, Evanston, IL 60208 USA; [Odili, Stella; Chen, Pan; Zelent, Bogumil; Matschinsky, Franz M.] Univ Penn, Sch Med, Dept Biochem & Biophys, Childrens Hosp Penn, Philadelphia, PA 19104 USA; [Odili, Stella; Chen, Pan; Zelent, Bogumil; Matschinsky, Franz M.] Univ Penn, Sch Med, Ctr Diabet, Philadelphia, PA 19104 USA; [Grimsby, Joseph] Hoffmann La Roche, Dept Metab Dis, Nutley, NJ 07110 USA; [Takahashi, Joseph S.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Takahashi, Joseph S.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Kohsaka, Akira] Wakayama Med Univ, Dept Med, Wakayama 6408265, Japan; [Kohsaka, Akira] Wakayama Med Univ, Dept Physiol 2, Wakayama 6408265, Japan	Northwestern University; Feinberg School of Medicine; Northwestern University; Northwestern University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Roche Holding; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Wakayama Medical University; Wakayama Medical University	Bass, J (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Med, 303 E Super St, Chicago, IL 60611 USA.	j-bass@northwestern.edu	Takahashi, Joseph S/E-8482-2012; Takahashi, Joseph S./Y-2781-2019	Takahashi, Joseph S/0000-0003-0384-8878; Takahashi, Joseph S./0000-0003-0384-8878; Fenner, Deborah/0000-0002-3193-2084	National Institutes of Health, NIMH [U01 MH61915]; National Institutes of Health, NIDDK [R01 DK022122]; University of Chicago Diabetes Research and Training Center [DK-20595]; Chicago Biomedical Consortium [C-007]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090625, P60DK020595, R01DK022122, P30DK020595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH061915] Funding Source: NIH RePORTER	National Institutes of Health, NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institutes of Health, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); University of Chicago Diabetes Research and Training Center(University of Chicago); Chicago Biomedical Consortium; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported, in whole or in part, by National Institutes of Health Grants U01 MH61915 from NIMH (to J. S. T.) and R01 DK022122 from NIDDK (to F. M. M.). This work was also supported by the University of Chicago Diabetes Research and Training Center Grant DK-20595 (to J. B.) and the Chicago Biomedical Consortium with support from The Searle Funds at the Chicago Community Trust Grant C-007 (to J. B.).	Augustin M, 2005, MAMM GENOME, V16, P405, DOI 10.1007/s00335-004-3028-2; BALI D, 1995, J BIOL CHEM, V270, P21464, DOI 10.1074/jbc.270.37.21464; BEDOYA FJ, 1986, J BIOL CHEM, V261, P760; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Boles MK, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000759; Burke CV, 1999, BIOCHEM J, V342, P345, DOI 10.1042/0264-6021:3420345; Concepcion D, 2004, GENETICS, V168, P953, DOI 10.1534/genetics.104.029843; de la Iglesia N, 1999, FEBS LETT, V456, P332, DOI 10.1016/S0014-5793(99)00971-0; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Farrelly D, 1999, P NATL ACAD SCI USA, V96, P14511, DOI 10.1073/pnas.96.25.14511; FROGUEL P, 1992, NATURE, V356, P162, DOI 10.1038/356162a0; Gloyn AL, 2003, HUM MUTAT, V22, P353, DOI 10.1002/humu.10277; Gloyn AL, 2004, FRONT DIABETES, V16, P92; Gloyn AL, 2005, J BIOL CHEM, V280, P14105, DOI 10.1074/jbc.M413146200; Gorman T, 2008, DIABETES OBES METAB, V10, P885, DOI 10.1111/j.1463-1326.2007.00819.x; Grimsby J, 2000, J BIOL CHEM, V275, P7826, DOI 10.1074/jbc.275.11.7826; Grimsby J, 2003, SCIENCE, V301, P370, DOI 10.1126/science.1084073; GRUPE A, 1995, CELL, V83, P69, DOI 10.1016/0092-8674(95)90235-X; HATTERSLEY AT, 1992, LANCET, V339, P1307, DOI 10.1016/0140-6736(92)91958-B; Herbach N, 2007, DIABETES, V56, P1268, DOI 10.2337/db06-0658; Kamata K, 2004, STRUCTURE, V12, P429, DOI 10.1016/j.str.2004.02.005; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LIANG Y, 1995, BIOCHEM J, V309, P167, DOI 10.1042/bj3090167; Marotta DE, 2005, ARCH BIOCHEM BIOPHYS, V436, P23, DOI 10.1016/j.abb.2005.01.018; Michaud EJ, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-164; Nakamura A, 2009, ENDOCRINOLOGY, V150, P1147, DOI 10.1210/en.2008-1183; NISHI S, 1992, DIABETOLOGIA, V35, P743; Patrucco E, 2004, CELL, V118, P375, DOI 10.1016/j.cell.2004.07.017; Pino MF, 2007, J BIOL CHEM, V282, P13906, DOI 10.1074/jbc.M610094200; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Rozen S, 2000, Methods Mol Biol, V132, P365; Sagen JV, 2006, DIABETES, V55, P1713, DOI 10.2337/db05-1513; Sakuraba Y, 2005, BIOCHEM BIOPH RES CO, V336, P609, DOI 10.1016/j.bbrc.2005.08.134; Salpeter SJ, 2010, DEVELOPMENT, V137, P3205, DOI 10.1242/dev.054304; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Stoy J, 2007, P NATL ACAD SCI USA, V104, P15040, DOI 10.1073/pnas.0707291104; Takahasi KR, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-52; Terauchi Y, 1995, J BIOL CHEM, V270, P30253, DOI 10.1074/jbc.270.51.30253; Terauchi Y, 2007, J CLIN INVEST, V117, P246, DOI 10.1172/JCI17645; Vanhaesebroeck B, 2004, CELL, V118, P274, DOI 10.1016/j.cell.2004.07.018; VeigadaCunha M, 1996, J BIOL CHEM, V271, P6292, DOI 10.1074/jbc.271.11.6292; VIONNET N, 1992, NATURE, V356, P721, DOI 10.1038/356721a0; Vitaterna MH, 2006, TRENDS NEUROSCI, V29, P233, DOI 10.1016/j.tins.2006.02.006; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Yamagata K, 1996, NATURE, V384, P458, DOI 10.1038/384458a0; Yamagata K, 1996, NATURE, V384, P455, DOI 10.1038/384455a0; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zelent B, 2011, BIOCHEM J, V440, P203, DOI 10.1042/BJ20110440; Zhang YL, 2004, ACTA PHARMACOL SIN, V25, P1659	53	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39560	39572		10.1074/jbc.M111.269100	http://dx.doi.org/10.1074/jbc.M111.269100			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21921030	Green Published, hybrid			2022-12-25	WOS:000296759800073
J	Lee, KH; Hsu, EC; Guh, JH; Yang, HC; Wang, DS; Kulp, SK; Shapiro, CL; Chen, CS				Lee, Kuen-Haur; Hsu, En-Chi; Guh, Jih-Hwa; Yang, Hsiao-Ching; Wang, Dasheng; Kulp, Samuel K.; Shapiro, Charles L.; Chen, Ching-Shih			Targeting Energy Metabolic and Oncogenic Signaling Pathways in Triple-negative Breast Cancer by a Novel Adenosine Monophosphate-activated Protein Kinase (AMPK) Activator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CADHERIN GENE-EXPRESSION; MESENCHYMAL TRANSITION; METFORMIN; GROWTH; STAT3; RISK; PHOSPHORYLATION; TRANSLATION; METASTASIS; MECHANISM	The antitumor activities of the novel adenosine monophosphate-activated protein kinase (AMPK) activator, OSU-53, were assessed in in vitro and in vivo models of triple-negative breast cancer. OSU-53 directly stimulated recombinant AMPK kinase activity (EC50, 0.3 mu M) and inhibited the viability and clonogenic growth of MDA-MB-231 and MDA-MB-468 cells with equal potency (IC50, 5 and 2 mu M, respectively) despite lack of LKB1 expression in MDA-MB-231 cells. Nonmalignant MCF-10A cells, however, were unaffected. Beyond AMPK-mediated effects on mammalian target of rapamycin signaling and lipogenesis, OSU-53 also targeted multiple AMPK downstream pathways. Among these, the protein phosphatase 2A-dependent dephosphorylation of Akt is noteworthy because it circumvents the feedback activation of Akt that results from mammalian target of rapamycin inhibition. OSU-53 also modulated energy homeostasis by suppressing fatty acid biosynthesis and shifting the metabolism to oxidation by up-regulating the expression of key regulators of mitochondrial biogenesis, such as a peroxisome proliferator-activated receptor gamma coactivator 1 alpha and the transcription factor nuclear respiratory factor 1. Moreover, OSU-53 suppressed LPS-induced IL-6 production, thereby blocking subsequent Stat3 activation, and inhibited hypoxia-induced epithelial-mesenchymal transition in association with the silencing of hypoxia-inducible factor 1a and the E-cadherin repressor Snail. In MDA-MB-231 tumor-bearing mice, daily oral administration of OSU-53 (50 and 100 mg/kg) suppressed tumor growth by 47-49% and modulated relevant intratumoral biomarkers of drug activity. However, OSU-53 also induced protective autophagy that attenuated its antiproliferative potency. Accordingly, cotreatment with the autophagy inhibitor chloroquine increased the in vivo tumor-suppressive activity of OSU-53. OSU-53 is a potent, orally bioavailable AMPK activator that acts through a broad spectrum of antitumor activities.	[Lee, Kuen-Haur; Hsu, En-Chi; Wang, Dasheng; Kulp, Samuel K.; Chen, Ching-Shih] Ohio State Univ, Coll Pharm, Div Med Chem, Columbus, OH 43210 USA; [Shapiro, Charles L.] Ohio State Univ, Coll Med, Div Med Oncol, Columbus, OH 43210 USA; [Guh, Jih-Hwa] Natl Taiwan Univ, Coll Med, Sch Pharm, Taipei 10051, Taiwan; [Yang, Hsiao-Ching] Fu Jen Catholic Univ, Dept Chem, New Taipei City 24205, Taiwan	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; National Taiwan University; Fu Jen Catholic University	Chen, CS (corresponding author), Ohio State Univ, Coll Pharm, Div Med Chem, 336 Pk Hall,500 W 12th Ave, Columbus, OH 43210 USA.	chen.844@osu.edu	Hsu, En-Chi/AAH-4589-2021	Hsu, En-Chi/0000-0002-5671-6169; GUH, JIH-HWA/0000-0002-6738-6054; Yang, Hsiao-Ching/0000-0002-7970-1357	National Institutes of Health (USPHS) from NCI [R01CA112250, R21CA158807]; NATIONAL CANCER INSTITUTE [R01CA112250, R21CA158807] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025755] Funding Source: NIH RePORTER	National Institutes of Health (USPHS) from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)United States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA112250 and R21CA158807 (USPHS) from NCI (to C. S. C.).	Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Bayascas JR, 2005, MOL CELL, V18, P143, DOI 10.1016/j.molcel.2005.03.020; Berishaj M, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1680; Bernardi R, 2006, NATURE, V442, P779, DOI 10.1038/nature05029; Bodmer M, 2010, DIABETES CARE, V33, P1304, DOI 10.2337/dc09-1791; Bromberg J, 2009, CANCER CELL, V15, P79, DOI 10.1016/j.ccr.2009.01.009; Carey LA, 2007, CLIN CANCER RES, V13, P2329, DOI 10.1158/1078-0432.CCR-06-1109; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Diaz N, 2006, CLIN CANCER RES, V12, P20, DOI 10.1158/1078-0432.CCR-04-1749; Dowling RJO, 2007, CANCER RES, V67, P10804, DOI 10.1158/0008-5472.CAN-07-2310; Dyck JRB, 1996, J BIOL CHEM, V271, P17798, DOI 10.1074/jbc.271.30.17798; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Fan QW, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001017; Flugel D, 2007, MOL CELL BIOL, V27, P3253, DOI 10.1128/MCB.00015-07; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Foubert E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2585; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Goodwin PJ, 2009, J CLIN ONCOL, V27, P3271, DOI 10.1200/JCO.2009.22.1630; Guh JH, 2010, J MED CHEM, V53, P2552, DOI 10.1021/jm901773d; Guo DL, 2009, P NATL ACAD SCI USA, V106, P12932, DOI 10.1073/pnas.0906606106; Hadad SM, 2008, CRIT REV ONCOL HEMAT, V67, P1, DOI 10.1016/j.critrevonc.2008.01.007; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hardie DG, 2007, ANNU REV PHARMACOL, V47, P185, DOI 10.1146/annurev.pharmtox.47.120505.105304; Hardie DG, 2006, PHYSIOLOGY, V21, P48, DOI 10.1152/physiol.00044.2005; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jiralerspong S, 2009, J CLIN ONCOL, V27, P3297, DOI 10.1200/JCO.2009.19.6410; Jornayvaz FR, 2010, ESSAYS BIOCHEM, V47, P69, DOI [10.1042/BSE0470069, 10.1042/bse0470069]; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kim KY, 2009, CANCER RES, V69, P4018, DOI 10.1158/0008-5472.CAN-08-2641; Kuznetsov JN, 2011, MOL CANCER THER, V10, P437, DOI 10.1158/1535-7163.MCT-10-0777; Leclerc Gilles M, 2010, J Mol Signal, V5, P15, DOI 10.1186/1750-2187-5-15; Lihn AS, 2008, MOL CELL ENDOCRINOL, V292, P36, DOI 10.1016/j.mce.2008.06.004; Ma YW, 2010, BBA-BIOENERGETICS, V1797, P29, DOI 10.1016/j.bbabio.2009.07.008; Mbalaviele G, 1996, CANCER RES, V56, P4063; Meijer AJ, 2007, AUTOPHAGY, V3, P238, DOI 10.4161/auto.3710; Memmott RM, 2010, CANCER PREV RES, V3, P1066, DOI 10.1158/1940-6207.CAPR-10-0055; Memmott RM, 2009, J CLIN ONCOL, V27, pE226, DOI 10.1200/JCO.2009.25.3963; Nerstedt A, 2010, DIABETOLOGIA, V53, P2406, DOI 10.1007/s00125-010-1856-z; Pang T, 2008, J BIOL CHEM, V283, P16051, DOI 10.1074/jbc.M710114200; Reis-Filho JS, 2008, HISTOPATHOLOGY, V52, P108, DOI 10.1111/j.1365-2559.2007.02889.x; Sag D, 2008, J IMMUNOL, V181, P8633, DOI 10.4049/jimmunol.181.12.8633; Sanders MJ, 2007, J BIOL CHEM, V282, P32539, DOI 10.1074/jbc.M706543200; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shen Z, 2002, CLIN CANCER RES, V8, P2085; Sullivan NJ, 2009, ONCOGENE, V28, P2940, DOI 10.1038/onc.2009.180; Sun Y, 2007, MOL CELL BIOCHEM, V306, P239, DOI 10.1007/s11010-007-9575-6; Thomson DM, 2009, ACTA PHYSIOL, V196, P147, DOI 10.1111/j.1748-1716.2009.01973.x; Tse JC, 2007, J CELL BIOCHEM, V101, P816, DOI 10.1002/jcb.21215; Vesuna F, 2008, BIOCHEM BIOPH RES CO, V367, P235, DOI 10.1016/j.bbrc.2007.11.151; Vilar E, 2011, MOL CANCER THER, V10, P395, DOI 10.1158/1535-7163.MCT-10-0905; Weinstein IB, 2008, CANCER RES, V68, P3077, DOI 10.1158/0008-5472.CAN-07-3293; Xie Z, 2008, CIRCULATION, V117, P952, DOI 10.1161/CIRCULATIONAHA.107.744490; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Yu L, 2010, NEUROSCIENCE, V169, P23, DOI 10.1016/j.neuroscience.2010.04.063; Zadra G, 2010, CLIN CANCER RES, V16, P3322, DOI 10.1158/1078-0432.CCR-09-1955; Zakikhani M, 2010, BREAST CANCER RES TR, V123, P271, DOI 10.1007/s10549-010-0763-9; Zang Y, 2008, J BIOL CHEM, V283, P6201, DOI 10.1074/jbc.M708619200; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012; Zhang L, 2007, AM J PHYSIOL-HEART C, V293, pH457, DOI 10.1152/ajpheart.00002.2007; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zhou WB, 2003, CANCER RES, V63, P7330	62	87	93	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39247	39258		10.1074/jbc.M111.264598	http://dx.doi.org/10.1074/jbc.M111.264598			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21917926	Green Published, hybrid			2022-12-25	WOS:000296759800043
J	Yang, DL; Fan, TX; Zhou, H; Ding, J; Zhang, D				Yang, Dalong; Fan, Tongxiang; Zhou, Han; Ding, Jian; Zhang, Di			Biogenic Hierarchical TiO2/SiO2 Derived from Rice Husk and Enhanced Photocatalytic Properties for Dye Degradation	PLOS ONE			English	Article							DOPED TITANIUM-DIOXIDE; TIO2 THIN-FILMS; VISIBLE-LIGHT; SURFACE-AREA; RUTILE PHASE; SILICA; NANOPARTICLES; BIOMASS; PRETREATMENT; FABRICATION	Background: Rice husk, an agricultural bioresource, is utilized as a non-metallic bio-precursor to synthesize biogenic hierarchical TiO2/SiO2 (BH-TiO2/SiO2) and the products are applied to dye degradation. Methodology/Principal Findings: The as-prepared BH-TiO2/SiO2 samples are characterized by X-ray diffraction(XRD), X-ray photoelectron spectroscopy(XPS), nitrogen-adsorption measurement, UV-vis spectroscopy and electronic paramagnetic resonance (EPR). The results show that BH-TiO2/SiO2 possesses both anatase and rutile phases with amorphous SiO2 as background, which contains mesopore structure, and nitrogen derived from original rice husk is self-doped into the lattice. Besides, the light-harvesting within the visible-light range of BH-TiO2/SiO2 has been enhanced. Moreover, the catalytic activity of BH-TiO2/SiO2 has been proven by EPR, and both the photocatalytic activity and stability of BH-TiO2/SiO2 are improved as well, which has been illustrated by cycled degradation of methylene blue dye under irradiation. Conclusions/Significance: This work provides a good way to combine natural hierarchical porous structure with synthetic material chemistry based on available biomass in the vast natural environment for the sustainable development of human society, and extends potentials of biomass in applications such as photocatalysts, sunlight splitting water and so forth.	[Yang, Dalong; Fan, Tongxiang; Zhou, Han; Ding, Jian; Zhang, Di] Shanghai Jiao Tong Univ, State Key Lab Composites, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Yang, DL (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Composites, Shanghai 200030, Peoples R China.	txfan@sjtu.edu.cn	Zhang, Di/AAA-5463-2021		National Natural Science Foundation of China [50972090]; Shanghai Education Commission [08SG15]; Shanghai Rising-star Program [10Qh1401300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Education Commission; Shanghai Rising-star Program	The authors are grateful for financial support by the National Natural Science Foundation of China (No. 50972090), Dawn Program of Shanghai Education Commission (No. 08SG15) and Shanghai Rising-star Program (No. 10Qh1401300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson C, 1997, J PHYS CHEM B, V101, P2611, DOI 10.1021/jp9626982; Bacsa RR, 1998, APPL CATAL B-ENVIRON, V16, P19, DOI 10.1016/S0926-3373(97)00058-1; Bansal V, 2005, J MATER CHEM, V15, P2583, DOI 10.1039/b503008k; Bansal V, 2005, ADV MATER, V17, P889, DOI 10.1002/adma.200401176; Bansal V, 2006, J AM CHEM SOC, V128, P14059, DOI 10.1021/ja062113+; Behnajady MA, 2007, CHEM ENG J, V127, P167, DOI 10.1016/j.cej.2006.09.013; Behnajady MA, 2006, J HAZARD MATER, V133, P226, DOI 10.1016/j.jhazmat.2005.10.022; BROW RK, 1987, J AM CERAM SOC, V70, P9, DOI 10.1111/j.1151-2916.1987.tb04845.x; Burda C, 2003, NANO LETT, V3, P1049, DOI 10.1021/nl034332o; Chen XB, 2004, J PHYS CHEM B, V108, P15446, DOI 10.1021/jp0469160; Choi Y, 2004, J MATER SCI, V39, P1837, DOI 10.1023/B:JMSC.0000016198.73153.31; Coronado JM, 2001, LANGMUIR, V17, P5368, DOI 10.1021/la010153f; Fan TX, 2009, PROG MATER SCI, V54, P542, DOI 10.1016/j.pmatsci.2009.02.001; Fritz SE, 2004, J AM CHEM SOC, V126, P4084, DOI 10.1021/ja049726b; Gao YF, 2004, LANGMUIR, V20, P3188, DOI 10.1021/la0303207; Gartner M, 2008, THIN SOLID FILMS, V516, P8184, DOI 10.1016/j.tsf.2008.04.027; Hashimoto K, 2005, JPN J APPL PHYS 1, V44, P8269, DOI 10.1143/JJAP.44.8269; Hurum DC, 2006, J ELECTRON SPECTROSC, V150, P155, DOI 10.1016/j.elspec.2005.01.294; Jagadale TC, 2008, J PHYS CHEM C, V112, P14595, DOI 10.1021/jp803567f; Jayakumar OD, 2006, NANOTECHNOLOGY, V17, P1278, DOI 10.1088/0957-4484/17/5/020; Kim Y, 2005, ENERG FUEL, V19, P2189, DOI 10.1021/ef050106l; Kurosaki F, 2008, CARBON, V46, P850, DOI 10.1016/j.carbon.2008.02.014; Li XF, 2009, ADV FUNCT MATER, V19, P45, DOI 10.1002/adfm.200800519; Livraghi S, 2006, J AM CHEM SOC, V128, P15666, DOI 10.1021/ja064164c; Mosier N, 2005, BIORESOURCE TECHNOL, V96, P673, DOI 10.1016/j.biortech.2004.06.025; Nosaka Y, 2005, SCI TECHNOL ADV MAT, V6, P143, DOI 10.1016/j.stam.2004.11.006; Okada K, 2001, J AM CERAM SOC, V84, P1591, DOI 10.1111/j.1151-2916.2001.tb00882.x; Sakthivel S, 2004, J PHYS CHEM B, V108, P19384, DOI 10.1021/jp046857q; SAMUNEVA B, 1993, J MATER SCI, V28, P2353, DOI 10.1007/BF01151665; SING KSW, 1985, PURE APPL CHEM, V57, P603, DOI 10.1351/pac198557040603; STATHIS JH, 1984, PHYS REV B, V29, P7079, DOI 10.1103/PhysRevB.29.7079; Subramanian V, 2004, J AM CHEM SOC, V126, P4943, DOI 10.1021/ja0315199; Tsai WT, 2007, BIORESOURCE TECHNOL, V98, P22, DOI 10.1016/j.biortech.2005.12.005; Wang Y, 2006, J MOL CATAL A-CHEM, V260, P1, DOI 10.1016/j.molcata.2006.06.044; Weil JR, 2002, IND ENG CHEM RES, V41, P6132, DOI 10.1021/ie0201056; WILLNER I, 1994, J AM CHEM SOC, V116, P1428, DOI 10.1021/ja00083a031; Xing Y, 2009, ENVIRON ENG SCI, V26, P551, DOI 10.1089/ees.2007.0346; Yalcin N, 2000, CARBON, V38, P1943, DOI 10.1016/S0008-6223(00)00029-4; Yalcin N, 2001, CERAM INT, V27, P219, DOI 10.1016/S0272-8842(00)00068-7; Yang GD, 2010, J MATER CHEM, V20, P5301, DOI 10.1039/c0jm00376j; Yu JG, 2007, ADV FUNCT MATER, V17, P1984, DOI 10.1002/adfm.200600933; Zhou H, 2010, ADV MATER, V22, P951, DOI 10.1002/adma.200902039; Zhu XY, 2000, LANGMUIR, V16, P6766, DOI 10.1021/la9915264	43	50	50	3	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2011	6	9							e24788	10.1371/journal.pone.0024788	http://dx.doi.org/10.1371/journal.pone.0024788			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CN	21931853	Green Published, Green Submitted, gold			2022-12-25	WOS:000294803100068
J	Browning, S; Baker, CA; Smith, E; Mahal, SP; Herva, ME; Demczyk, CA; Li, JL; Weissmann, C				Browning, Shawn; Baker, Christopher A.; Smith, Emery; Mahal, Sukhvir P.; Herva, Maria E.; Demczyk, Cheryl A.; Li, Jiali; Weissmann, Charles			Abrogation of Complex Glycosylation by Swainsonine Results in Strain- and Cell-specific Inhibition of Prion Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE NEUROBLASTOMA-CELLS; PROTEIN ACCUMULATION; DISEASE; INFECTION; PRPSC; CULTURES; RELEASE; AUTOPHAGOSOMES; GLYCOPROTEINS; CONFORMATION	Neuroblastoma-derived N2a-PK1 cells, fibroblastic LD9 cells, and CNS-derived CAD5 cells can be infected efficiently and pertly by various prion strains, as measured by the standard scrapie cell assay. Swainsonine, an inhibitor of Golgi alpha-mannosidase II that causes abnormal N-glycosylation, strongly inhibits infection of PK1 cells by RML, 79A and 22F, less so by 139A, and not at all by 221, prions, and it does not diminish propagation of any of these strains in LD9 or CADS cells. Misglycosylated PrPC formed in the presence of swainsonine is a good substrate for conversion to PrPSc, and misglycosylated PrPSc is fully able to trigger infection and seed the protein misfolding cyclic amplification reaction. Distinct subdones of PK1 cells mediate swainsonine inhibition to very different degrees, implicating misglycosylation of one or more host proteins in the inhibitory process. The use of swainsonine and other glycosylation inhibitors described herein enhances the ability of the cell panel assay to differentiate between prion strains. Moreover, as shown elsewhere, the susceptibility of prions to inhibition by swainsonine in PK1 cells is a mutable trait.	[Browning, Shawn; Baker, Christopher A.; Smith, Emery; Mahal, Sukhvir P.; Herva, Maria E.; Demczyk, Cheryl A.; Li, Jiali; Weissmann, Charles] Scripps Florida, Dept Infectol, Jupiter, FL 33458 USA	State University System of Florida; University of Florida	Weissmann, C (corresponding author), Scripps Florida, Dept Infectol, 130 Scripps Way, Jupiter, FL 33458 USA.	charlesw@scripps.edu	li, Jiali/HGF-2395-2022	li, Jiali/0000-0001-6202-7741	National Institutes of Health [1RO1NSO59543, 1RO1NS067214]; Alafi Family Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067214] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alafi Family Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1RO1NSO59543 and 1RO1NS067214. This work was also supported by The Alafi Family Foundation (to C. W.).	Aguib Y, 2009, AUTOPHAGY, V5, P361, DOI 10.4161/auto.5.3.7662; Alais S, 2008, BIOL CELL, V100, P603, DOI 10.1042/BC20080025; BESSEN RA, 1992, J VIROL, V66, P2096, DOI 10.1128/JVI.66.4.2096-2101.1992; BRUCE ME, 1992, E H S NEURO, P497; BUTLER DA, 1988, J VIROL, V62, P1558, DOI 10.1128/JVI.62.5.1558-1564.1988; Caughey B, 2003, J VIROL, V77, P5499, DOI 10.1128/JVI.77.9.5499-5502.2003; CAUGHEY B, 1993, J VIROL, V67, P643, DOI 10.1128/JVI.67.2.643-650.1993; Caughey WS, 1998, P NATL ACAD SCI USA, V95, P12117, DOI 10.1073/pnas.95.21.12117; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Crispin M, 2007, FEBS LETT, V581, P1963, DOI 10.1016/j.febslet.2007.04.020; Cronier S, 2008, BIOCHEM J, V416, P297, DOI 10.1042/BJ20081235; D'Castro L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015679; DeArmond SJ, 1999, J NEUROPATH EXP NEUR, V58, P1000, DOI 10.1097/00005072-199909000-00010; Demaimay R, 1998, J NEUROCHEM, V71, P2534; Enari M, 2001, P NATL ACAD SCI USA, V98, P9295, DOI 10.1073/pnas.151242598; ENDO T, 1989, BIOCHEMISTRY-US, V28, P8380, DOI 10.1021/bi00447a017; Feng BY, 2008, NAT CHEM BIOL, V4, P197, DOI 10.1038/nchembio.65; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; GAJDUSEK DC, 1988, J NEUROIMMUNOL, V20, P95; Gambetti P, 2008, ANN NEUROL, V63, P697, DOI 10.1002/ana.21420; Groschup MH, 2007, PRIONS IN HUMANS AND ANIMALS, P166; Heiseke A, 2010, CURR ISSUES MOL BIOL, V12, P87; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Klohn PC, 2003, P NATL ACAD SCI USA, V100, P11666, DOI 10.1073/pnas.1834432100; Kocisko DA, 2005, NEUROSCI LETT, V388, P106, DOI 10.1016/j.neulet.2005.06.053; Leblanc P, 2006, EMBO J, V25, P2674, DOI 10.1038/sj.emboj.7601162; Lehmann Sylvain, 2004, V299, P227; Li JL, 2010, SCIENCE, V327, P869, DOI 10.1126/science.1183218; Magalhaes AC, 2005, J NEUROSCI, V25, P5207, DOI 10.1523/JNEUROSCI.0653-05.2005; Mahal S. P, 2008, METHODS MOL BIOL PRI; Mahal SP, 2007, P NATL ACAD SCI USA, V104, P20908, DOI 10.1073/pnas.0710054104; Mahal SP, 2010, P NATL ACAD SCI USA, V107, P22653, DOI 10.1073/pnas.1013014108; Marijanovic Z, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000426; Mays CE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018047; Moravec RA, 2009, ANAL BIOCHEM, V387, P294, DOI 10.1016/j.ab.2009.01.016; Nazor KE, 2005, EMBO J, V24, P2472, DOI 10.1038/sj.emboj.7600717; Nicoll AJ, 2010, P NATL ACAD SCI USA, V107, P17610, DOI 10.1073/pnas.1009062107; Peretz D, 2001, NATURE, V412, P739, DOI 10.1038/35089090; Peretz D, 2001, PROTEIN SCI, V10, P854, DOI 10.1110/ps.39201; Perrier V, 2004, J NEUROCHEM, V89, P454, DOI 10.1111/j.1471-4159.2004.02356.x; RACE RE, 1987, J GEN VIROL, V68, P1391, DOI 10.1099/0022-1317-68-5-1391; Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823; Rudd PM, 2001, BIOCHEMISTRY-US, V40, P3759, DOI 10.1021/bi002625f; Saa Paula, 2004, V299, P53; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; TARENTINO AL, 1994, METHOD ENZYMOL, V230, P44; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; Thackray AM, 2007, BIOCHEM J, V401, P475, DOI 10.1042/BJ20061264; TULSIANI DRP, 1983, J BIOL CHEM, V258, P7578; TULSIANI DRP, 1982, J BIOL CHEM, V257, P7936; Tzaban S, 2002, BIOCHEMISTRY-US, V41, P12868, DOI 10.1021/bi025958g; Veith NM, 2009, EUR J CELL BIOL, V88, P45, DOI 10.1016/j.ejcb.2008.08.001; Vella LJ, 2007, J PATHOL, V211, P582, DOI 10.1002/path.2145; Vincent B, 2000, J BIOL CHEM, V275, P35612, DOI 10.1074/jbc.M004628200; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4; Weissmann C, 2009, FOLIA NEUROPATHOL, V47, P104; Williamson RA, 1998, J VIROL, V72, P9413, DOI 10.1128/JVI.72.11.9413-9418.1998; Winklhofer KF, 2003, TRAFFIC, V4, P313, DOI 10.1034/j.1600-0854.2003.00088.x; Yadavalli R, 2004, J BIOL CHEM, V279, P21948, DOI 10.1074/jbc.M400793200; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33	63	23	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40962	40973		10.1074/jbc.M111.283978	http://dx.doi.org/10.1074/jbc.M111.283978			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21930694	Green Published, hybrid			2022-12-25	WOS:000297315400056
J	Bosch, DE; Wittchen, ES; Qiu, CN; Burridge, K; Siderovski, DP				Bosch, Dustin E.; Wittchen, Erika S.; Qiu, Connie; Burridge, Keith; Siderovski, David P.			Unique Structural and Nucleotide Exchange Features of the Rho1 GTPase of Entamoeba histolytica	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; RAS-SUPERFAMILY; ONCOGENIC MUTANT; FAMILY; CDC42; COMPLEX; PHAGOCYTOSIS; CYTOSKELETON; ACTIVATION; PROTEINS	The single-celled human parasite Entamoeba histolytica possesses a dynamic actin cytoskeleton vital for its intestinal and systemic pathogenicity. The E. histolytica genome encodes several Rho family GTPases known to regulate cytoskeletal dynamics. EhRho1, the first family member identified, was reported to be insensitive to the Rho GTPase-specific Clostridium botulinum C3 exoenzyme, raising the possibility that it may be a misclassified Ras family member. Here, we report the crystal structures of EhRho1 in both active and inactive states. EhRho1 is activated by a conserved switch mechanism, but diverges from mammalian Rho GTPases in lacking a signature Rho insert helix. EhRho1 engages a homolog of mDia, EhFormin1, suggesting a role in mediating serum-stimulated actin reorganization and microtubule formation during mitosis. EhRho1, but not a constitutively active mutant, interacts with a newly identified EhRhoGDI in a prenylation-dependent manner. Furthermore, constitutively active EhRho1 induces actin stress fiber formation in mammalian fibroblasts, thereby identifying it as a functional Rho family GTPase. EhRho1 exhibits a fast rate of nucleotide exchange relative to mammalian Rho GTPases due to a distinctive switch one isoleucine residue reminiscent of the constitutively active F28L mutation in human Cdc42, which for the latter protein, is sufficient for cellular transformation. Nonconserved, nucleotide-interacting residues within EhRho1, revealed by the crystal structure models, were observed to contribute a moderating influence on fast spontaneous nucleotide exchange. Collectively, these observations indicate that EhRho1 is a bona fide member of the Rho GTPase family, albeit with unique structural and functional aspects compared with mammalian Rho GTPases.	[Bosch, Dustin E.; Qiu, Connie; Siderovski, David P.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Siderovski, David P.] Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA; [Burridge, Keith; Siderovski, David P.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Wittchen, Erika S.; Burridge, Keith] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; [Burridge, Keith] Univ N Carolina, McAllister Heart Inst, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Siderovski, DP (corresponding author), 4073 Genet Med Bldg,120 Mason Farm Rd,CB 7365, Chapel Hill, NC 27599 USA.	dsiderov@med.unc.edu	Siderovski, David Peter/AAA-9603-2019; , PEP-MX Core/AGV-4051-2022	Siderovski, David Peter/0000-0002-0688-8210; Bosch, Dustin/0000-0002-7430-2939	National Institutes of Health [R01GM082892, R01GM029860, T32GM008719, T32GM007040]; NIDDK [F30DK091978]; American Heart Association [10SDG3430042]; American Society of Pharmacology and Experimental Therapeutics (ASPET); Carolina Summer Fellows program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK091978] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029860, T32GM008719, R01GM082892, T32GM007040] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Heart Association(American Heart Association); American Society of Pharmacology and Experimental Therapeutics (ASPET); Carolina Summer Fellows program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM082892 (to D. P. S.) and R01GM029860 (to K. B.).; Supported by National Institutes of Health institutional training grants T32GM008719 and T32GM007040 and an independent F30 NRSA Grant F30DK091978 from the NIDDK.; Supported by American Heart Association Scientist Development Grant 10SDG3430042.; Supported by the Carolina Summer Fellows program funded in part by the American Society of Pharmacology and Experimental Therapeutics (ASPET).	Abdul-Manan N, 1999, NATURE, V399, P379, DOI 10.1038/20726; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adams PD, 2004, BIOCHEMISTRY-US, V43, P9968, DOI 10.1021/bi0490901; Adams PD, 2006, BIOCHEMISTRY-US, V45, P2577, DOI 10.1021/bi051686g; Aguilar-Rojas A, 2005, EXP PARASITOL, V109, P150, DOI 10.1016/j.exppara.2004.12.013; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 1997, Epidemiol Bull, V18, P13; Arias-Romero LE, 2007, CELL MOTIL CYTOSKEL, V64, P390, DOI 10.1002/cm.20191; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Freeman JL, 1996, J BIOL CHEM, V271, P19794, DOI 10.1074/jbc.271.33.19794; Garcia-Mata R, 2011, NAT REV MOL CELL BIO, V12, P493, DOI 10.1038/nrm3153; Ghosh SK, 1997, INFECT IMMUN, V65, P4243, DOI 10.1128/IAI.65.10.4243-4249.1997; Gilchrist CA, 2010, MBIO, V1, DOI 10.1128/mBio.00057-10; Godbold GD, 2002, EXP PARASITOL, V101, P107, DOI 10.1016/S0014-4894(02)00101-7; Guillen N, 1996, TRENDS MICROBIOL, V4, P191, DOI 10.1016/0966-842X(96)10033-0; Guillen N, 1998, J CELL SCI, V111, P1729; Haque R, 2003, NEW ENGL J MED, V348, P1565, DOI 10.1056/NEJMra022710; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hoffman GR, 2000, CELL, V102, P403, DOI 10.1016/S0092-8674(00)00045-3; Ihara K, 1998, J BIOL CHEM, V273, P9656, DOI 10.1074/jbc.273.16.9656; Kimple AJ, 2010, METHODS MOL BIOL, V627, P91, DOI 10.1007/978-1-60761-670-2_5; Kimple RJ, 2004, BIOCHEM J, V378, P801, DOI 10.1042/BJ20031686; Labruyere E, 2003, J CELL SCI, V116, P61, DOI 10.1242/jcs.00190; Lapouge K, 2000, MOL CELL, V6, P899, DOI 10.1016/S1097-2765(00)00087-3; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lin R, 1999, J BIOL CHEM, V274, P23633, DOI 10.1074/jbc.274.33.23633; Lin R, 1997, CURR BIOL, V7, P794, DOI 10.1016/S0960-9822(06)00338-1; Loftus B, 2005, NATURE, V433, P865, DOI 10.1038/nature03291; LOHIA A, 1993, MOL BIOCHEM PARASIT, V58, P177, DOI 10.1016/0166-6851(93)90104-6; Lohia A, 1996, GENE, V173, P205, DOI 10.1016/0378-1119(96)00232-6; Machacek M, 2009, NATURE, V461, P99, DOI 10.1038/nature08242; Majumder S, 2008, INFECT IMMUN, V76, P2368, DOI 10.1128/IAI.01449-07; Markiewicz JM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001002; Maugis B, 2010, J CELL SCI, V123, P3884, DOI 10.1242/jcs.065672; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meza I, 2006, ARCH MED RES, V37, P234, DOI 10.1016/j.arcmed.2005.09.008; Narumiya S, 2009, CANCER METAST REV, V28, P65, DOI 10.1007/s10555-008-9170-7; Nassar N, 1998, NAT STRUCT BIOL, V5, P1047, DOI 10.1038/4156; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PAI EF, 1990, EMBO J, V9, P2351, DOI 10.1002/j.1460-2075.1990.tb07409.x; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Perriere G, 1996, BIOCHIMIE, V78, P364, DOI 10.1016/0300-9084(96)84768-7; Raines KW, 2007, CARDIOVASC RES, V75, P229, DOI 10.1016/j.cardiores.2007.04.013; Ravdin J. I., 2000, AMOEBIASIS; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Rojas RJ, 2003, COMB CHEM HIGH T SCR, V6, P409; Scheffzek K, 2000, NAT STRUCT BIOL, V7, P122, DOI 10.1038/72392; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Voigt H, 1999, CELL MICROBIOL, V1, P195, DOI 10.1046/j.1462-5822.1999.00021.x; Walker SJ, 2000, J BIOL CHEM, V275, P15665, DOI 10.1074/jbc.M000076200; Wei YY, 1997, NAT STRUCT BIOL, V4, P699, DOI 10.1038/nsb0997-699; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Wennerberg K, 2004, J CELL SCI, V117, P1301, DOI 10.1242/jcs.01118; Willard MD, 2007, EMBO J, V26, P2029, DOI 10.1038/sj.emboj.7601659	55	13	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39236	39246		10.1074/jbc.M111.253898	http://dx.doi.org/10.1074/jbc.M111.253898			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21930699	Green Published, hybrid			2022-12-25	WOS:000296759800042
J	Lyons, PJ; Fricker, LD				Lyons, Peter J.; Fricker, Lloyd D.			Carboxypeptidase O Is a Glycosylphosphatidylinositol-anchored Intestinal Peptidase with Acidic Amino Acid Specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PURKINJE-CELL DEGENERATION; METALLOCARBOXYPEPTIDASE GENE FAMILY; CYTOSOLIC CARBOXYPEPTIDASES; PANCREATIC CARBOXYPEPTIDASE; 3-DIMENSIONAL STRUCTURE; EMBRYONIC-DEVELOPMENT; CRYSTAL-STRUCTURE; CANAVAN-DISEASE; MOUSE; ENZYME	The first metallocarboxypeptidase (CP) was identified in pancreatic extracts more than 80 years ago and named carboxypeptidase A (CPA; now known as CPA1). Since that time, seven additional mammalian members of the CPA subfamily have been described, all of which are initially produced as proenzymes, are activated by endoproteases, and remove either C-terminal hydrophobic or basic amino acids from peptides. Here we describe the enzymatic and structural properties of carboxypeptidase O (CPO), a previously uncharacterized and unique member of the CPA subfamily. Whereas all other members of the CPA subfamily contain an N-terminal prodomain necessary for folding, bioinformatics and expression of both human and zebrafish CPO orthologs revealed that CPO does not require a prodomain. CPO was purified by affinity chromatography, and the purified enzyme was able to cleave proteins and synthetic peptides with greatest activity toward acidic C-terminal amino acids unlike other CPA-like enzymes. CPO displayed a neutral pH optimum and was inhibited by common metallo carboxypeptidase inhibitors as well as citrate. CPO was modified by attachment of a glycosylphosphatidylinositol membrane anchor to the C terminus of the protein. Immunocytochemistry of Madin-Darby canine kidney cells stably expressing CPO showed localization to vesicular membranes in subconfluent cells and to the plasma membrane in differentiated cells. CPO is highly expressed in intestinal epithelial cells in both zebrafish and human. These results suggest that CPO cleaves acidic amino acids from dietary proteins and peptides, thus complementing the actions of well known digestive carboxypeptidases CPA and CPB.	[Lyons, Peter J.; Fricker, Lloyd D.] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Fricker, LD (corresponding author), Albert Einstein Coll Med, Dept Mol Pharmacol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	lloyd.fricker@einstein.yu.edu		Lyons, Peter/0000-0001-5214-5445	National Institutes of Health [DA-004494, EY-194332]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004494] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DA-004494 (to L. D. F.) and EY-194332 (to P. J. L.).	ADIBI SA, 1973, J CLIN INVEST, V52, P1586, DOI 10.1172/JCI107335; Alonso-del-Rivero M, 2009, FEBS J, V276, P4875, DOI 10.1111/j.1742-4658.2009.07187.x; Arolas JL, 2007, CURR PHARM DESIGN, V13, P349, DOI 10.2174/138161207780162980; BECK IT, 1973, AM J CLIN NUTR, V26, P311, DOI 10.1093/ajcn/26.3.311; Benjamin MA, 2000, GUT, V47, P112, DOI 10.1136/gut.47.1.112; Bitto E, 2007, P NATL ACAD SCI USA, V104, P456, DOI 10.1073/pnas.0607817104; Bown DP, 2004, EUR J BIOCHEM, V271, P2000, DOI 10.1111/j.1432-1033.2004.04113.x; COLL M, 1991, EMBO J, V10, P1; de la Vega MR, 2007, FASEB J, V21, P851, DOI 10.1096/fj.06-7330com; DEDDISH PA, 1990, J BIOL CHEM, V265, P15083; Drozdowski L, 2009, WORLD J GASTROENTERO, V15, P385, DOI 10.3748/wjg.15.385; Drucker DJ, 1996, P NATL ACAD SCI USA, V93, P7911, DOI 10.1073/pnas.93.15.7911; ERDOS EG, 1962, BIOCHEM PHARMACOL, V11, P585, DOI 10.1016/0006-2952(62)90119-3; FACER P, 1985, GASTROENTEROLOGY, V89, P1366, DOI 10.1016/0016-5085(85)90657-2; Fernandez D., 2011, ENZYME RES, V2011; Fernandez D, 2010, BIOCHIMIE, V92, P1484, DOI 10.1016/j.biochi.2010.05.002; Fernandez-Gonzalez A, 2002, SCIENCE, V295, P1904, DOI 10.1126/science.1068912; FOLK JE, 1956, J AM CHEM SOC, V78, P3541, DOI 10.1021/ja01595a077; FRICKER LD, 1988, ANNU REV PHYSIOL, V50, P309, DOI 10.1146/annurev.ph.50.030188.001521; FRICKER LD, 1982, P NATL ACAD SCI-BIOL, V79, P3886, DOI 10.1073/pnas.79.12.3886; GARDELL SJ, 1988, J BIOL CHEM, V263, P17828; Gomis-Ruth FX, 1999, EMBO J, V18, P5817, DOI 10.1093/emboj/18.21.5817; GUASCH A, 1992, J MOL BIOL, V224, P141, DOI 10.1016/0022-2836(92)90581-4; Hsieh JM, 2010, P NATL ACAD SCI USA, V107, P17962, DOI 10.1073/pnas.1006687107; Isoe J, 2009, INSECT BIOCHEM MOLEC, V39, P68, DOI 10.1016/j.ibmb.2008.09.006; Kalinina E, 2007, FASEB J, V21, P836, DOI 10.1096/fj.06-7329com; Kalinina EV, 2003, J BIOL CHEM, V278, P9244, DOI 10.1074/jbc.M209379200; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kimura Y, 2010, J BIOL CHEM, V285, P22934, DOI 10.1074/jbc.C110.128280; Lei YH, 1999, DNA CELL BIOL, V18, P175, DOI 10.1089/104454999315565; MULLEN RJ, 1976, P NATL ACAD SCI USA, V73, P208, DOI 10.1073/pnas.73.1.208; Nagell CF, 2004, SCAND J GASTROENTERO, V39, P353, DOI 10.1080/00365520410004424; Namboodiri AMA, 2006, MOL CELL ENDOCRINOL, V252, P216, DOI 10.1016/j.mce.2006.03.016; Phillips MA, 1996, BIOCHEMISTRY-US, V35, P6771, DOI 10.1021/bi960113o; Reverter D, 2004, J MOL BIOL, V338, P257, DOI 10.1016/j.jmb.2004.02.058; Reznik SE, 2001, CELL MOL LIFE SCI, V58, P1790, DOI 10.1007/PL00000819; Rogowski K, 2010, CELL, V143, P564, DOI 10.1016/j.cell.2010.10.014; Rosenberg I. M., 2005, PROTEIN ANAL PURIFIC, P308; Schneider E, 2006, CLIN CHIM ACTA, V374, P25, DOI 10.1016/j.cca.2006.05.044; Song LX, 1997, J BIOL CHEM, V272, P10543; SONG LX, 1995, J BIOL CHEM, V270, P25007, DOI 10.1074/jbc.270.42.25007; Stoll B, 1999, AM J PHYSIOL-ENDOC M, V277, pE168, DOI 10.1152/ajpendo.1999.277.1.E168; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Thomas AG, 2006, ADV EXP MED BIOL, V576, P327; Vendrell J, 2000, BBA-PROTEIN STRUCT M, V1477, P284, DOI 10.1016/S0167-4838(99)00280-0; Waldschmidt-Leitz E, 1929, BER DTSCH CHEM GES, V62, P2217, DOI 10.1002/cber.19290620857; Wallace KN, 2005, MECH DEVELOP, V122, P157, DOI 10.1016/j.mod.2004.10.009; Wang TY, 2006, MOL CELL NEUROSCI, V33, P200, DOI 10.1016/j.mcn.2006.07.009; Wei SW, 2002, J BIOL CHEM, V277, P14954, DOI 10.1074/jbc.M112254200; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; WOLFF A, 1992, EUR J CELL BIOL, V59, P425; Gomis-Ruth FX, 2008, CRIT REV BIOCHEM MOL, V43, P319, DOI 10.1080/10409230802376375 ; Zhang X, 2008, J NEUROCHEM, V107, P1596, DOI 10.1111/j.1471-4159.2008.05722.x	53	21	23	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39023	39032		10.1074/jbc.M111.265819	http://dx.doi.org/10.1074/jbc.M111.265819			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21921028	hybrid, Green Published			2022-12-25	WOS:000296759800021
J	Kubo, A; Stull, R; Takeuchi, M; Bonham, K; Gouon-Evans, V; Sho, M; Iwano, M; Saito, Y; Keller, G; Snodgrass, R				Kubo, Atsushi; Stull, Robert; Takeuchi, Mitsuaki; Bonham, Kristina; Gouon-Evans, Valerie; Sho, Masayuki; Iwano, Masayuki; Saito, Yoshihiko; Keller, Gordon; Snodgrass, Ralph			Pdx1 and Ngn3 Overexpression Enhances Pancreatic Differentiation of Mouse ES Cell-Derived Endoderm Population	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; BETA-CELLS; DEFINITIVE ENDODERM; INSULIN GENE; TRANSCRIPTIONAL REGULATION; ISLET TRANSPLANTATION; IN-VIVO; PROGENITORS; EXPRESSION; MICE	In order to define the molecular mechanisms regulating the specification and differentiation of pancreatic beta-islet cells, we investigated the effect of upregulating Pdx1 and Ngn3 during the differentiation of the beta-islet-like cells from murine embryonic stem (ES) cell-derived activin induced-endoderm. Induced overexpression of Pdx1 resulted in a significant upregulation of insulin (Ins1 and Ins2), and other pancreas-related genes. To enhance the developmental progression from the pancreatic bud to the formation of the endocrine lineages, we induced the overexpression express of Ngn3 together with Pdx1. This combination dramatically increased the level and timing of maximal Ins1 mRNA expression to approximately 100% of that found in the beta TC6 insulinoma cell line. Insulin protein and C-peptide expression was confirmed by immunohistochemistry staining. These inductive effects were restricted to c-kit(+) endoderm enriched EB-derived populations suggesting that Pdx1/Ngn3 functions after the specification of pancreatic endoderm. Although insulin secretion was stimulated by various insulin secretagogues, these cells had only limited glucose response. Microarray analysis was used to evaluate the expression of a broad spectrum of pancreatic endocrine cell-related genes as well as genes associated with glucose responses. Taken together, these findings demonstrate the utility of manipulating Pdx1 and Ngn3 expression in a stage-specific manner as an important new strategy for the efficient generation of functionally immature insulin-producing beta-islet cells from ES cells.	[Kubo, Atsushi; Takeuchi, Mitsuaki; Iwano, Masayuki; Saito, Yoshihiko] Nara Med Univ, Dept Internal Med 1, Nara, Japan; [Stull, Robert; Bonham, Kristina; Snodgrass, Ralph] VistaGen Therapeut Inc, San Francisco, CA USA; [Gouon-Evans, Valerie] Mt Sinai Sch Med, Dept Gene & Cell Med, New York, NY USA; [Sho, Masayuki] Nara Med Univ, Dept Surg 1, Nara, Japan; [Keller, Gordon] McEwen Ctr Regenerat Med, Toronto, ON, Canada	Nara Medical University; Icahn School of Medicine at Mount Sinai; Nara Medical University	Kubo, A (corresponding author), Nara Med Univ, Dept Internal Med 1, Nara, Japan.	akubo@naramed-u.ac.jp		Keller, Gordon/0000-0001-9309-9297; Gouon-Evans, Valerie/0000-0001-5424-6573	VistaGen Therapeutics, Inc.; Ministry of Education, Sports, Science and Technology of Japan [17790197]; Grants-in-Aid for Scientific Research [21591036] Funding Source: KAKEN	VistaGen Therapeutics, Inc.; Ministry of Education, Sports, Science and Technology of Japan(Core Research for Evolutional Science and Technology (CREST)Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	These studies have been supported by funding from VistaGen Therapeutics, Inc., and in part from the Ministry of Education, Sports, Science and Technology of Japan (17790197). VistaGen scientists helped in the design, analyses, interpretation of the data, and in the preparation of this manuscript.	Bernardo AS, 2009, STEM CELLS, V27, P341, DOI 10.1634/stemcells.2008-0310; Bonner-Weir S, 2000, P NATL ACAD SCI USA, V97, P7999, DOI 10.1073/pnas.97.14.7999; BOROVJAGIN AV, 1991, NUCLEIC ACIDS RES, V19, P4999, DOI 10.1093/nar/19.18.4999; Cissell MA, 2003, J BIOL CHEM, V278, P751, DOI 10.1074/jbc.M205905200; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; DELTOUR L, 1993, P NATL ACAD SCI USA, V90, P527, DOI 10.1073/pnas.90.2.527; Gershengorn MC, 2004, SCIENCE, V306, P2261, DOI 10.1126/science.1101968; Gouon-Evans V, 2006, NAT BIOTECHNOL, V24, P1402, DOI 10.1038/nbt1258; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Grapin-Botton A, 2001, GENE DEV, V15, P444, DOI 10.1101/gad.846001; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Gu GQ, 2003, MECH DEVELOP, V120, P35, DOI 10.1016/S0925-4773(02)00330-1; Habener JF, 2005, ENDOCRINOLOGY, V146, P1025, DOI 10.1210/en.2004-1576; Hua H, 2006, J BIOL CHEM, V281, P13574, DOI 10.1074/jbc.M600526200; Jiang FX, 2002, J CELL SCI, V115, P753; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; KELLER GM, 1995, CURR OPIN CELL BIOL, V7, P862, DOI 10.1016/0955-0674(95)80071-9; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Kubo A, 2004, DEVELOPMENT, V131, P1651, DOI 10.1242/dev.01044; Kubo A, 2010, HEPATOLOGY, V51, P633, DOI 10.1002/hep.23293; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; Lamotte L, 2004, TRANSGENIC RES, V13, P463, DOI 10.1007/s11248-004-9587-x; LEONARD J, 1993, MOL ENDOCRINOL, V7, P1275, DOI 10.1210/me.7.10.1275; Lumelsky N, 2001, SCIENCE, V292, P1389, DOI 10.1126/science.1058866; MILLER CP, 1994, EMBO J, V13, P1145, DOI 10.1002/j.1460-2075.1994.tb06363.x; Murtaugh LC, 2003, ANNU REV CELL DEV BI, V19, P71, DOI 10.1146/annurev.cellbio.19.111301.144752; Naya FJ, 1997, GENE DEV, V11, P2323, DOI 10.1101/gad.11.18.2323; OHLSSON H, 1993, EMBO J, V12, P4251, DOI 10.1002/j.1460-2075.1993.tb06109.x; PETERSEN HV, 1994, P NATL ACAD SCI USA, V91, P10465, DOI 10.1073/pnas.91.22.10465; Ramakrishnan R, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.7.e30; Sander M, 2000, DEVELOPMENT, V127, P5533; Seaberg RM, 2004, NAT BIOTECHNOL, V22, P1115, DOI 10.1038/nbt1004; Serafimidis I, 2008, STEM CELLS, V26, P3, DOI 10.1634/stemcells.2007-0194; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; SosaPineda B, 1997, NATURE, V386, P399, DOI 10.1038/386399a0; Sussel L, 1998, DEVELOPMENT, V125, P2213; Wandzioch E, 2009, SCIENCE, V324, P1707, DOI 10.1126/science.1174497; Wierup N, 2006, DIABETES, V55, P305, DOI 10.2337/diabetes.55.02.06.db04-1383; Wierup N, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-51; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Zhang G, 2007, J ENDOCRINOL, V195, P313, DOI 10.1677/JOE-07-0252	44	36	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2011	6	9							e24058	10.1371/journal.pone.0024058	http://dx.doi.org/10.1371/journal.pone.0024058			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZV	21931641	Green Submitted, Green Published, gold			2022-12-25	WOS:000295321800016
J	Noury-Desvaux, B; Abraham, P; Mahe, G; Sauvaget, T; Leftheriotis, G; Le Faucheur, A				Noury-Desvaux, Benedicte; Abraham, Pierre; Mahe, Guillaume; Sauvaget, Thomas; Leftheriotis, Georges; Le Faucheur, Alexis			The Accuracy of a Simple, Low-Cost GPS Data Logger/Receiver to Study Outdoor Human Walking in View of Health and Clinical Studies	PLOS ONE			English	Article							GLOBAL POSITIONING SYSTEM; PERIPHERAL ARTERIAL-DISEASE; CORONARY-HEART-DISEASE; PHYSICAL-ACTIVITY; HUMAN LOCOMOTION; NONDIFFERENTIAL GPS; VIGOROUS EXERCISE; SPEED; WOMEN; RELIABILITY	Introduction: Accurate and objective measurements of physical activity and lower-extremity function are important in health and disease monitoring, particularly given the current epidemic of chronic diseases and their related functional impairment. Purpose: The aim of the present study was to determine the accuracy of a handy (lightweight, small, only one stop/start button) and low-cost (similar to$75 with its external antenna) Global Positioning System (GPS) data logger/receiver (the DG100) as a tool to study outdoor human walking in perspective of health and clinical research studies. Methods. Healthy subjects performed two experiments that consisted of different prescribed outdoor walking protocols. Experiment 1. We studied the accuracy of the DG100 for detecting bouts of walking and resting. Experiment 2. We studied the accuracy of the DG100 for estimating distances and speeds of walking. Results: Experiment 1. The performance in the detection of bouts, expressed as the percentage of walking and resting bouts that were correctly detected, was 92.4% [95% Confidence Interval: 90.6-94.3]. Experiment 2. The coefficients of variation [95% Confidence Interval] for the accuracy of estimating the distances and speeds of walking were low: 3.1% [2.9-3.3] and 2.8% [2.6-3.1], respectively. Conclusion: The DG100 produces acceptable accuracy both in detecting bouts of walking and resting and in estimating distances and speeds of walking during the detected walking bouts. However, before we can confirm that the DG100 can be used to study walking with respect to health and clinical studies, the inter-and intra-DG100 variability should be studied.	[Noury-Desvaux, Benedicte; Sauvaget, Thomas; Le Faucheur, Alexis] UCO, APCoSS, Inst Phys Educ & Sports Sci IFEPSA, Les Ponts De Ce, France; [Noury-Desvaux, Benedicte; Abraham, Pierre; Mahe, Guillaume; Leftheriotis, Georges; Le Faucheur, Alexis] Univ Angers, INSERM, U771, Sch Med,CNRS,UMR6214, Angers, France; [Abraham, Pierre; Mahe, Guillaume; Sauvaget, Thomas; Leftheriotis, Georges] Univ Hosp, Lab Vasc Invest & Sports Med, Angers, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Universite de Franche-Comte; Universite d'Angers; Centre Hospitalier Universitaire d'Angers	Noury-Desvaux, B (corresponding author), UCO, APCoSS, Inst Phys Educ & Sports Sci IFEPSA, Les Ponts De Ce, France.	alexislefaucheur@hotmail.com	, Mahe/AAF-7983-2020; LE FAUCHEUR, Alexis/AAK-3232-2021	LE FAUCHEUR, Alexis/0000-0002-3688-6574	GENESI foundation; Direction Regionale de la Recherche Clinique	GENESI foundation; Direction Regionale de la Recherche Clinique	This work was supported by the GENESI foundation and the Direction Regionale de la Recherche Clinique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bland M., 2000, INTRO MED STAT, V3rd; Bouchard C., 2007, PHYS ACTIVITY HLTH; Creange A, 2007, MULT SCLER, V13, P220, DOI 10.1177/1352458506070667; Dobkin BH, 2005, NEW ENGL J MED, V352, P1677, DOI 10.1056/NEJMcp043511; Dobkin BH, 2011, STROKE; Duncan MJ, 2007, MED SCI SPORT EXER, V39, P1851, DOI 10.1249/mss.0b013e31811ff31e; *EUR GNSS AG, 2009, US GUID EGNOS APPL D; Gray AJ, 2010, J SPORTS SCI, P1; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; Hakim AA, 1998, NEW ENGL J MED, V338, P94, DOI 10.1056/NEJM199801083380204; Hopkins W., 2000, RELIABILITY CONSECUT; Hopkins WG, 2000, SPORTS MED, V30, P1, DOI 10.2165/00007256-200030010-00001; Hopkins WG., NEW VIEW STAT; Jennings Denise, 2010, Int J Sports Physiol Perform, V5, P328; Le Faucheur A, 2008, CIRCULATION, V117, P897, DOI 10.1161/CIRCULATIONAHA.107.725994; Le Faucheur A, 2007, MED SCI SPORT EXER, V39, P1570, DOI 10.1249/mss.0b013e3180cc20c7; Le Faucheur A, 2010, J VASC SURG, V51, P886, DOI 10.1016/j.jvs.2009.10.120; Lee IM, 2001, JAMA-J AM MED ASSOC, V285, P1447, DOI 10.1001/jama.285.11.1447; Maddison R, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-73; Manson JE, 1999, NEW ENGL J MED, V341, P650, DOI 10.1056/NEJM199908263410904; Manson JE, 2002, NEW ENGL J MED, V347, P716, DOI 10.1056/NEJMoa021067; McDermott MM, 2001, JAMA-J AM MED ASSOC, V286, P1599; Petersen C, 2009, INTJ SPORT PHYSIOL, V4, P381, DOI 10.1123/ijspp.4.3.381; RINGBAEK T, J CARDIOPULM REHABIL, V30, P409; Schutz Y, 1997, EUR J CLIN NUTR, V51, P338, DOI 10.1038/sj.ejcn.1600403; Schutz Y, 2000, MED SCI SPORT EXER, V32, P642, DOI 10.1097/00005768-200003000-00014; Terrier P, 2000, J BIOMECH, V33, P1717, DOI 10.1016/S0021-9290(00)00133-0; Terrier Philippe, 2005, J Neuroeng Rehabil, V2, P28, DOI 10.1186/1743-0003-2-28; Townshend AD, 2008, MED SCI SPORT EXER, V40, P124, DOI 10.1249/mss.0b013e3181590bc2; Troped PJ, 2008, MED SCI SPORT EXER, V40, P972, DOI 10.1249/MSS.0b013e318164c407; Witte TH, 2005, J BIOMECH, V38, P1717, DOI 10.1016/j.jbiomech.2004.07.028; Witte TH, 2004, J BIOMECH, V37, P1891, DOI 10.1016/j.jbiomech.2004.02.031; YAIR B, 2010, SPINE PHILA PA  1211	33	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2011	6	9							e23027	10.1371/journal.pone.0023027	http://dx.doi.org/10.1371/journal.pone.0023027			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZV	21931593	Green Submitted, Green Published, gold			2022-12-25	WOS:000295321800002
J	Redeker, V; Hughes, C; Savistchenko, J; Vissers, JPC; Melki, R				Redeker, Virginie; Hughes, Chris; Savistchenko, Jimmy; Vissers, Johannes P. C.; Melki, Ronald			Qualitative and Quantitative Multiplexed Proteomic Analysis of Complex Yeast Protein Fractions That Modulate the Assembly of the Yeast Prion Sup35p	PLOS ONE			English	Article							ESCHERICHIA-COLI RIBOSOME; SACCHAROMYCES-CEREVISIAE; IN-VITRO; MASS-SPECTROMETRY; MOLECULAR CHAPERONES; ALZHEIMERS-DISEASE; CELL-GROWTH; 50S SUBUNIT; PROPAGATION; HSP70	Background: The aggregation of the baker's yeast prion Sup35p is at the origin of the transmissible [PSI(+)] trait. We and others have shown that molecular chaperones modulate Sup35p aggregation. However, other protein classes might be involved in [PSI(+)] formation. Results: We designed a functional proteomic study that combines two techniques to identify modulators of Sup35p aggregation and describe the changes associated to [PSI(+)] formation. The first allows measuring the effect of fractionated Saccharomyces cerevisiae cytosolic extracts from [PSI(+)] and [psi(-)] yeast cells on Sup35p assembly. The second is a multiplex qualitative and quantitative comparison of protein composition of active and inactive fractions using a gel-free and labelfree LC-MS approach. We identify changes in proteins involved in translation, folding, degradation, oxido-reduction and metabolic processes. Conclusion: Our functional proteomic study provides the first inventory list of over 300 proteins that directly or indirectly affect Sup35p aggregation and [PSI(+)] formation. Our results highlight the complexity of the cellular changes accompanying [PSI(+)] formation and pave the way for in vitro studies aimed to document the effect of individual and/or combinations of proteins identified here, susceptible of affecting Sup35p assembly.	[Redeker, Virginie; Savistchenko, Jimmy; Melki, Ronald] CNRS, Lab Enzymol & Biochim Struct, Gif Sur Yvette, France; [Hughes, Chris; Vissers, Johannes P. C.] Waters Corp, Manchester, Lancs, England	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Waters UK	Redeker, V (corresponding author), CNRS, Lab Enzymol & Biochim Struct, Gif Sur Yvette, France.	redeker@lebs.cnrs-gif.fr; melki@lebs.cnrs-gif.fr	Redeker, Virginie/L-8929-2018	Redeker, Virginie/0000-0003-2694-8388	Agence Nationale de la Recherche [ANR-06-BLAN-0266]; Era-Net Neuron [ANR-08-NEUR-001-03]; CNRS; INSERM	Agence Nationale de la Recherche(French National Research Agency (ANR)); Era-Net Neuron; CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work was supported by Agence Nationale de la Recherche (ANR-06-BLAN-0266), Era-Net Neuron (ANR-08-NEUR-001-03), CNRS and INSERM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu A, 2008, BIOCHEM BIOPH RES CO, V366, P598, DOI 10.1016/j.bbrc.2007.11.143; Basu A, 2008, BIOCHEM BIOPH RES CO, V366, P592, DOI 10.1016/j.bbrc.2007.11.142; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brundin P, 2010, NAT REV MOL CELL BIO, V11, P301, DOI 10.1038/nrm2873; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Castilla J, 2006, METHOD ENZYMOL, V412, P3, DOI 10.1016/s0076-6879(06)12001-7; Chernoff YO, 1999, MOL CELL BIOL, V19, P8103; CHERNOFF YO, 1995, SCIENCE, V268, P880, DOI 10.1126/science.7754373; Chich JF, 2007, BBA-PROTEINS PROTEOM, V1774, P154, DOI 10.1016/j.bbapap.2006.10.016; Cosson B, 2002, MOL CELL BIOL, V22, P3301, DOI 10.1128/MCB.22.10.3301-3315.2002; Cottrell BA, 2005, ANN NEUROL, V58, P277, DOI 10.1002/ana.20554; COX BS, 1988, YEAST, V4, P159, DOI 10.1002/yea.320040302; De Iuliis A, 2005, CLIN CHIM ACTA, V357, P202, DOI 10.1016/j.cccn.2005.03.028; Geromanos SJ, 2009, PROTEOMICS, V9, P1683, DOI 10.1002/pmic.200800562; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Huang P, 2005, NAT STRUCT MOL BIOL, V12, P497, DOI 10.1038/nsmb942; Jones GW, 2005, BIOESSAYS, V27, P823, DOI 10.1002/bies.20267; Jones GW, 2003, GENETICS, V163, P495; Krzewska J, 2006, EMBO J, V25, P822, DOI 10.1038/sj.emboj.7600985; Krzewska J, 2007, J BIOL CHEM, V282, P1679, DOI 10.1074/jbc.M608110200; Kushnirov VV, 2000, CURR BIOL, V10, P1443, DOI 10.1016/S0960-9822(00)00802-2; Li GZ, 2009, PROTEOMICS, V9, P1696, DOI 10.1002/pmic.200800564; McParland VJ, 2000, BIOCHEMISTRY-US, V39, P8735, DOI 10.1021/bi000276j; Mitsui K, 2006, METHOD ENZYMOL, V412, P63, DOI 10.1016/S0076-6879(06)12005-4; Nesvizhskii AI, 2007, NAT METHODS, V4, P787, DOI 10.1038/NMETH1088; Old WM, 2005, MOL CELL PROTEOMICS, V4, P1487, DOI 10.1074/mcp.M500084-MCP200; Patel BK, 2007, J MOL BIOL, V365, P773, DOI 10.1016/j.jmb.2006.10.069; Paushkin SV, 1997, MOL CELL BIOL, V17, P2798, DOI 10.1128/MCB.17.5.2798; Peisker K, 2008, MOL BIOL CELL, V19, P5279, DOI 10.1091/mbc.E08-06-0661; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Schonberger SJ, 2001, PROTEOMICS, V1, P1519, DOI 10.1002/1615-9861(200111)1:12<1519::AID-PROT1519>3.0.CO;2-L; Sharma D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006644; Shorter J, 2008, EMBO J, V27, P2712, DOI 10.1038/emboj.2008.194; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P589, DOI 10.1074/mcp.M500321-MCP200; Silva JC, 2005, ANAL CHEM, V77, P2187, DOI 10.1021/ac048455k; Simpson KL, 2009, J CHROMATOGR B, V877, P1240, DOI 10.1016/j.jchromb.2008.11.023; Singh R, 2002, FEBS LETT, V527, P234, DOI 10.1016/S0014-5793(02)03243-X; Sorolla MA, 2008, FREE RADICAL BIO MED, V45, P667, DOI 10.1016/j.freeradbiomed.2008.05.014; Thual C, 1999, J BIOL CHEM, V274, P13666, DOI 10.1074/jbc.274.19.13666; Tribouillard-Tanvier D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002174; Tuite MF, 2003, NAT REV MOL CELL BIO, V4, P878, DOI 10.1038/nrm1247; Vissers JPC, 2009, J CHROMATOGR B, V877, P1317, DOI 10.1016/j.jchromb.2008.10.024; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Xun ZY, 2008, MOL CELL PROTEOMICS, V7, P1191, DOI 10.1074/mcp.M700467-MCP200; Yu YQ, 2003, ANAL CHEM, V75, P6023, DOI 10.1021/ac0346196	50	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2011	6	9							e23659	10.1371/journal.pone.0023659	http://dx.doi.org/10.1371/journal.pone.0023659			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZV	21931608	Green Submitted, gold, Green Published			2022-12-25	WOS:000295321800006
J	Chibnik, LB; Keenan, BT; Cui, J; Liao, KP; Costenbader, KH; Plenge, RM; Karlson, EW				Chibnik, Lori B.; Keenan, Brendan T.; Cui, Jing; Liao, Katherine P.; Costenbader, Karen H.; Plenge, Robert M.; Karlson, Elizabeth W.			Genetic Risk Score Predicting Risk of Rheumatoid Arthritis Phenotypes and Age of Symptom Onset	PLOS ONE			English	Article							CYCLIC CITRULLINATED PEPTIDE; HLA-DRB1 SHARED EPITOPE; RADIOGRAPHIC JOINT DAMAGE; RADIOLOGICAL PROGRESSION; FOLLOW-UP; ANTIBODIES; ASSOCIATION; ALLELES; DISABILITY; EROSIONS	Background: Cumulative genetic profiles can help identify individuals at high-risk for developing RA. We examined the impact of 39 validated genetic risk alleles on the risk of RA phenotypes characterized by serologic and erosive status. Methods/Principal Findings: We evaluated single nucleotide polymorphisms at 31 validated RA risk loci and 8 Human Leukocyte Antigen alleles among 542 Caucasian RA cases and 551 Caucasian controls from Nurses' Health Study and Nurses' Health Study II. We created a weighted genetic risk score (GRS) and evaluated it as 7 ordinal groups using logistic regression (adjusting for age and smoking) to assess the relationship between GRS group and odds of developing seronegative (RF- and CCP-), seropositive (RF+ or CCP+), erosive, and seropositive, erosive RA phenotypes. In separate case only analyses, we assessed the relationships between GRS and age of symptom onset. In 542 RA cases, 317 (58%) were seropositive, 163 (30%) had erosions and 105 (19%) were seropositive with erosions. Comparing the highest GRS risk group to the median group, we found an OR of 1.2 (95% CI = 0.8-2.1) for seronegative RA, 3.0 (95% CI = 1.9-4.7) for seropositive RA, 3.2 (95% CI = 1.8-5.6) for erosive RA, and 7.6 (95% CI = 3.6-16.3) for seropositive, erosive RA. No significant relationship was seen between GRS and age of onset. Conclusions/Significance: Results suggest that seronegative and seropositive/erosive RA have different genetic architecture and support the importance of considering RA phenotypes in RA genetic studies.	[Chibnik, Lori B.; Keenan, Brendan T.] Brigham & Womens Hosp, Program Translat NeuroPsychiat Genom, Dept Neurol, Boston, MA 02115 USA; [Cui, Jing; Liao, Katherine P.; Costenbader, Karen H.; Karlson, Elizabeth W.] Brigham & Womens Hosp, Dept Med, Clin Sci Sect, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA; [Plenge, Robert M.] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Chibnik, LB (corresponding author), Brigham & Womens Hosp, Program Translat NeuroPsychiat Genom, Dept Neurol, 75 Francis St, Boston, MA 02115 USA.	lchibnik@rics.bwh.harvard.edu		Chibnik, Lori/0000-0001-6293-806X	National Institutes of Health [CA87969, CA49449, CA67262, CA50385, R049880, AR47782, AR0524]; NATIONAL CANCER INSTITUTE [U01CA067262, R01CA050385, R01CA067262, R01CA049449, U01CA049449, P01CA087969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K24AR052403, T32AR055885, P60AR047782] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the National Institutes of Health (grants CA87969, CA49449, CA67262, CA50385, R049880, AR47782, AR0524). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajocchi G, 2000, CLIN EXP RHEUMATOL, V18, pS49; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Bukhari M, 2002, ARTHRITIS RHEUM-US, V46, P906, DOI 10.1002/art.10167; Bukhari M, 2007, ANN RHEUM DIS, V66, P389, DOI 10.1136/ard.2006.055657; Campbell CD, 2005, NAT GENET, V37, P868, DOI 10.1038/ng1607; Clarke AE, 2001, J RHEUMATOL, V28, P2416; Costenbader KH, 2006, AM J MED, V119, P503, DOI 10.1016/j.amjmed.2005.09.053; Costenbader KH, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2421; De Jager PL, 2009, LANCET NEUROL, V8, P1111, DOI 10.1016/S1474-4422(09)70275-3; De Rycke L, 2004, ANN RHEUM DIS, V63, P1587, DOI 10.1136/ard.2003.017574; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Ding B, 2009, ARTHRITIS RHEUM, V60, P30, DOI 10.1002/art.24135; Fernando MMA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000024; Finckh A, 2006, ANN RHEUM DIS, V65, P1192, DOI 10.1136/ard.2005.049338; Finckh A, 2006, ARTHRIT RHEUM-ARTHR, V55, P864, DOI 10.1002/art.22353; Gorman JD, 2004, ARTHRITIS RHEUM-US, V50, P3476, DOI 10.1002/art.20588; HAZES JMW, 1989, ANN RHEUM DIS, V48, P406, DOI 10.1136/ard.48.5.406; Huizinga TWJ, 2005, ARTHRITIS RHEUM, V52, P3433, DOI 10.1002/art.21385; Jansen LMA, 2001, ANN RHEUM DIS, V60, P924, DOI 10.1136/ard.60.10.924; JARAQUEMADA D, 1986, ANN RHEUM DIS, V45, P627, DOI 10.1136/ard.45.8.627; Kaarela K, 1985, Scand J Rheumatol Suppl, V57, P1; Kallberg H, 2010, ANN RHEUM DIS; Karlson EW, 2008, ANN RHEUM DIS, V67, P358, DOI 10.1136/ard.2007.071662; Karlson EW, 2010, ANN RHEUM DIS, V69, P1077, DOI 10.1136/ard.2009.120170; Karlson EW, 2009, ARTHRITIS RHEUM-US, V60, P641, DOI 10.1002/art.24350; Karlson EW, 2010, ANN RHEUM D IN PRESS; Kirwan JR, 2001, J RHEUMATOL, V28, P881; Klareskog L, 2009, LANCET, V373, P659, DOI 10.1016/S0140-6736(09)60008-8; Klareskog L, 2009, J MOL MED-JMM, V87, P357, DOI 10.1007/s00109-008-0437-9; Kurreeman F, 2011, AM J HUM GENET, V88, P57, DOI 10.1016/j.ajhg.2010.12.007; Lee DM, 2001, LANCET, V358, P903, DOI 10.1016/S0140-6736(01)06075-5; LIANG MH, 1980, ARTHRITIS RHEUM-US, V23, P153, DOI 10.1002/art.1780230204; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Lorentzen JC, 2007, ARTHRITIS RHEUM-US, V56, P2620, DOI 10.1002/art.22813; Lundstrom E, 2009, ARTHRITIS RHEUM-US, V60, P924, DOI 10.1002/art.24410; LUUKKAINEN R, 1983, CLIN EXP RHEUMATOL, V1, P295; Mikuls TR, 2001, RHEUM DIS CLIN N AM, V27, P283, DOI 10.1016/S0889-857X(05)70202-7; Pease CT, 1999, RHEUMATOLOGY, V38, P228, DOI 10.1093/rheumatology/38.3.228; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Plenge RM, 2007, NEW ENGL J MED, V357, P1199, DOI 10.1056/NEJMoa073491; Rantapaa-Dahlqvist S, 2003, ARTHRITIS RHEUM, V48, P2741, DOI 10.1002/art.11223; Raychaudhuri S, 2008, NAT GENET, V40, P1216, DOI 10.1038/ng.233; Raychaudhuri S, 2009, NAT GENET, V41, P1313, DOI 10.1038/ng.479; Remmers EF, 2007, NEW ENGL J MED, V357, P977, DOI 10.1056/NEJMoa073003; Reneses S, 2009, J RHEUMATOL, V36, P1143, DOI 10.3899/jrheum.081075; Ronnelid J, 2005, ANN RHEUM DIS, V64, P1744, DOI 10.1136/ard.2004.033571; Sigurdsson S, 2007, ARTHRITIS RHEUM-US, V56, P2202, DOI 10.1002/art.22704; Sokka T, 2001, J RHEUMATOL, V28, P1718; Stahl EA, 2010, NATURE GENE IN PRESS; Stolt P, 2003, ANN RHEUM DIS, V62, P835, DOI 10.1136/ard.62.9.835; TERKELTAUB R, 1983, J RHEUMATOL, V10, P418; van der Helm-van Mil AHM, 2006, ARTHRITIS RHEUM-US, V54, P1117, DOI 10.1002/art.21739; VANDERHEIJDE DMFM, 1991, J RHEUMATOL, V18, P1285; VANLEEUWEN MA, 1995, SCAND J RHEUMATOL, V24, P146, DOI 10.3109/03009749509099303; Verpoort KN, 2005, ARTHRITIS RHEUM, V52, P3058, DOI 10.1002/art.21302; Vittecoq O, 2003, RHEUMATOLOGY, V42, P939, DOI 10.1093/rheumatology/keg257; Yukioka M, 1998, BRIT J RHEUMATOL, V37, P98	58	38	40	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2011	6	9							e24380	10.1371/journal.pone.0024380	http://dx.doi.org/10.1371/journal.pone.0024380			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CO	21931699	Green Published, gold			2022-12-25	WOS:000294803200017
J	Nishino, T; Wang, CS; Mochizuki-Kashio, M; Osawa, M; Nakauchi, H; Iwama, A				Nishino, Taito; Wang, Changshan; Mochizuki-Kashio, Makiko; Osawa, Mitsujiro; Nakauchi, Hiromitsu; Iwama, Atsushi			Ex Vivo Expansion of Human Hematopoietic Stem Cells by Garcinol, a Potent Inhibitor of Histone Acetyltransferase	PLOS ONE			English	Article							COMBINED IMMUNODEFICIENCY MICE; POLYCOMB GROUP PROTEINS; PROGENITOR CELLS; GENE-EXPRESSION; SELF-RENEWAL; IN-VITRO; TRANSPLANTATION; BIOLOGY; REGENERATION; ACETYLATION	Background: Human cord blood (hCB) is the main source of hematopoietic stem and progenitor cells (HSCs/PCs) for transplantation. Efforts to overcome relative shortages of HSCs/PCs have led to technologies to expand HSCs/PCs ex vivo. However, methods suitable for clinical practice have yet to be fully established. Methodology/Principal Findings: In this study, we screened biologically active natural products for activity to promote expansion of hCB HSCs/PCs ex vivo, and identified Garcinol, a plant-derived histone acetyltransferase (HAT) inhibitor, as a novel stimulator of hCB HSC/PC expansion. During a 7-day culture of CD34(+)CD38(-) HSCs supplemented with stem cell factor and thrombopoietin, Garcinol increased numbers of CD34(+)CD38(-) HSCs/PCs more than 4.5-fold and Isogarcinol, a derivative of Garcinol, 7.4-fold. Furthermore, during a 7-day culture of CD34(+) HSCs/PCs, Garcinol expanded the number of SCID-repopulating cells (SRCs) 2.5-fold. We also demonstrated that the capacity of Garcinol and its derivatives to expand HSCs/PCs was closely correlated with their inhibitory effect on HAT. The Garcinol derivatives which expanded HSCs/PCs inhibited the HAT activity and acetylation of histones, while inactive derivatives did not. Conclusions/Significance: Our findings identify Garcinol as the first natural product acting on HSCs/PCs and suggest the inhibition of HAT to be an alternative approach for manipulating HSCs/PCs.	[Nishino, Taito] Nissan Chem Ind Co Ltd, Res Planning Dept, Tokyo, Japan; [Wang, Changshan; Mochizuki-Kashio, Makiko; Osawa, Mitsujiro; Iwama, Atsushi] Chiba Univ, Dept Cellular & Mol Med, Grad Sch Med, Chiba, Japan; [Nakauchi, Hiromitsu] Univ Tokyo, Inst Med Sci, Div Stem Cell Therapy, Ctr Stem Cell Biol & Regenerat Med, Tokyo, Japan; [Wang, Changshan; Mochizuki-Kashio, Makiko; Osawa, Mitsujiro; Iwama, Atsushi] Japan Sci & Technol Agcy, CREST, Tokyo, Japan; [Nakauchi, Hiromitsu] ERATO, Tokyo, Japan	Nissan Chemical Corporation; Chiba University; University of Tokyo; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST)	Nishino, T (corresponding author), Nissan Chem Ind Co Ltd, Res Planning Dept, Tokyo, Japan.	aiwama@faculty.chiba-u.jp		Nishino, Taito/0000-0001-5298-4353	Nissan Chemical Industries, LTD.; Grants-in-Aid for Scientific Research [21390289] Funding Source: KAKEN	Nissan Chemical Industries, LTD.; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was financially supported by Nissan Chemical Industries, LTD. The funders had a role in study design, data collection and analysis, and decision to publish.	Akala OO, 2006, CURR OPIN GENET DEV, V16, P496, DOI 10.1016/j.gde.2006.08.011; Araki H, 2007, BLOOD, V109, P3570, DOI 10.1182/blood-2006-07-035287; Araki H, 2009, EXP HEMATOL, V37, P1084, DOI 10.1016/j.exphem.2009.05.012; Balasubramanyam K, 2004, J BIOL CHEM, V279, P51163, DOI 10.1074/jbc.M409024200; Balasubramanyam K, 2003, J BIOL CHEM, V278, P19134, DOI 10.1074/jbc.M301580200; Bhatia M, 1997, P NATL ACAD SCI USA, V94, P5320, DOI 10.1073/pnas.94.10.5320; Boitano AE, 2010, SCIENCE, V329, P1345, DOI 10.1126/science.1191536; de Lima M, 2008, BONE MARROW TRANSPL, V41, P771, DOI 10.1038/sj.bmt.1705979; Delaney C, 2010, NAT MED, V16, P232, DOI 10.1038/nm.2080; Ding S, 2004, NAT BIOTECHNOL, V22, P833, DOI 10.1038/nbt987; Foeken LM, 2010, BONE MARROW TRANSPL, V45, P811, DOI 10.1038/bmt.2010.9; GEY GO, 1952, CANCER RES, V12, P264; Himburg HA, 2010, NAT MED, V16, P475, DOI 10.1038/nm.2119; Hofmeister CC, 2007, BONE MARROW TRANSPL, V39, P11, DOI 10.1038/sj.bmt.1705538; Iwama A, 2004, IMMUNITY, V21, P843, DOI 10.1016/j.immuni.2004.11.004; Ko KH, 2011, STEM CELLS, V29, P108, DOI 10.1002/stem.551; Kollet O, 1999, BLOOD, V94, P923, DOI 10.1182/blood.V94.3.923.415k08_923_931; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Konuma T, 2010, DEV GROWTH DIFFER, V52, P505, DOI 10.1111/j.1440-169X.2010.01191.x; KRISHNAMURTHY N, 1981, TETRAHEDRON LETT, V22, P793, DOI 10.1016/0040-4039(81)80154-2; Larochelle A, 1996, NAT MED, V2, P1329, DOI 10.1038/nm1296-1329; Mantelingu K, 2007, CHEM BIOL, V14, P645, DOI 10.1016/j.chembiol.2007.04.011; MATSUOKA Y, 1967, P SOC EXP BIOL MED, V125, P1246; MCNIECE IK, 1989, BLOOD, V74, P609; Nishino T, 2009, EXP HEMATOL, V37, P1364, DOI 10.1016/j.exphem.2009.09.001; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Pflumio F, 1996, BLOOD, V88, P3731, DOI 10.1182/blood.V88.10.3731.bloodjournal88103731; Rocha V, 2008, BONE MARROW TRANSPL, V41, P207, DOI 10.1038/sj.bmt.1705963; Rodriguez-Paredes M, 2011, NAT MED, V17, P330, DOI 10.1038/nm.2305; Sakaguchi K, 1998, GENE DEV, V12, P2831, DOI 10.1101/gad.12.18.2831; Sangeetha VM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012221; Sauvageau G, 2004, ONCOGENE, V23, P7223, DOI 10.1038/sj.onc.1207942; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; Shizuru JA, 2005, ANNU REV MED, V56, P509, DOI 10.1146/annurev.med.54.101601.152334; Shojaei F, 2005, DEV CELL, V8, P651, DOI 10.1016/j.devcel.2005.03.004; TeKippe M, 2003, EXP HEMATOL, V31, P521, DOI 10.1016/S0301-472X(03)00072-9; Verma IM, 2005, ANNU REV BIOCHEM, V74, P711, DOI 10.1146/annurev.biochem.74.050304.091637; Wang JF, 2003, BLOOD, V101, P2924, DOI 10.1182/blood-2002-09-2782; Zhang CC, 2008, BLOOD, V111, P3415, DOI 10.1182/blood-2007-11-122119	39	39	42	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2011	6	9							e24298	10.1371/journal.pone.0024298	http://dx.doi.org/10.1371/journal.pone.0024298			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CO	21931675	gold, Green Submitted, Green Published			2022-12-25	WOS:000294803200012
J	Johansson, US; Pasquet, E; Irestedt, M				Johansson, Ulf S.; Pasquet, Eric; Irestedt, Martin			The New Zealand Thrush: An Extinct Oriole	PLOS ONE			English	Article							MITOCHONDRIAL SEQUENCE DATA; OLD-WORLD SUBOSCINES; PASSERINE BIRDS; NUCLEAR-DNA; SONGBIRD RADIATION; AVES PASSERIFORMES; CORE CORVOIDEA; PHYLOGENY; ORIGIN; HISTORY	The New Zealand Thrush, or Piopio, is an extinct passerine that was endemic to New Zealand. It has often been placed in its own family (Turnagridae), unresolved relative to other passerines, but affinities with thrushes, Australaian magpies, manucodes, whistlers, birds-of-paradise and bowerbirds has been suggested based on morphological data. An affinity with the bowerbirds was also indicated in an early molecular study, but low statistical support make this association uncertain. In this study we use sequence data from three nuclear introns to examine the phylogenetic relationships of the piopios. All three genes independently indicate an oriole (Oriolidae) affinity of the piopios, and the monophyly of the typical orioles (Oriolus), figbirds (Sphecotheres), and the piopios is strongly supported in the Bayesian analysis of the concatenated data set (posterior probability = 1.0). The exact placement of the piopios within Oriolidae is, however, more uncertain but in the combined analysis and in two of the gene trees the piopios are placed basal to the typical orioles while the third gene suggest a sister relationship with the figbirds. This is the first time an oriole affinity has been proposed for the piopios. Divergence time estimates for the orioles suggest that the clade originated ca 20 million years ago, and based on these estimates it is evident that the piopios must have arrived on New Zealand by dispersal across the Tasman Sea and not as a result of vicariance when New Zealand separated from Gondwana in the late Cretaceous.	[Johansson, Ulf S.] Swedish Museum Nat Hist, Dept Vertebrate Zool, S-10405 Stockholm, Sweden; [Pasquet, Eric] Museum Natl Hist Nat, CNRS, UMR7205, Dept Systemat & Evolut, F-75231 Paris, France; [Irestedt, Martin] Swedish Museum Nat Hist, Mol Systemat Lab, S-10405 Stockholm, Sweden	Swedish Museum of Natural History; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Swedish Museum of Natural History	Johansson, US (corresponding author), Swedish Museum Nat Hist, Dept Vertebrate Zool, S-10405 Stockholm, Sweden.	ulf.johansson@nrm.se	Irestedt, Martin/AAF-2525-2019	Johansson, Ulf/0000-0002-2544-8528	Swedish Research Council [621-2010-5321]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This research was supported by the Swedish Research Council (Grant No. 621-2010-5321; www.vr.se) to Per Ericson. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker FK, 2004, P NATL ACAD SCI USA, V101, P11040, DOI 10.1073/pnas.0401892101; BULLER WL, 1869, IBIS, V5, P37; Buller WL., 1888, HIST BIRDS NZ, V2; BULLER WL, 1882, MANUAL BIREDS NZ; Christidis L, 1996, P NATL ACAD SCI USA, V93, P3898, DOI 10.1073/pnas.93.9.3898; Cooper A, 2001, NATURE, V409, P704, DOI 10.1038/35055536; Edwards SV, 2002, TRENDS ECOL EVOL, V17, P347, DOI 10.1016/S0169-5347(02)02543-0; Ericson PGP, 2003, MOL PHYLOGENET EVOL, V29, P126, DOI 10.1016/S1055-7903(03)00067-8; Ericson PGP, 2003, J AVIAN BIOL, V34, P3, DOI 10.1034/j.1600-048X.2003.03121.x; Ericson PGP, 2002, MOL PHYLOGENET EVOL, V25, P53, DOI 10.1016/S1055-7903(02)00215-4; Ericson PGP, 2002, P ROY SOC LOND B BIO, V269, P435; Filardi CE, 2005, NATURE, V438, P216, DOI 10.1038/nature04057; Fjeldsa J, 2003, P ROY SOC B-BIOL SCI, V270, pS238, DOI 10.1098/rsbl.2003.0075; Fuchs J, 2004, MOL PHYLOGENET EVOL, V33, P428, DOI 10.1016/j.ympev.2004.06.014; Fuchs J, 2007, MOL PHYLOGENET EVOL, V44, P138, DOI 10.1016/j.ympev.2006.10.014; Fuchs J, 2006, ZOOL SCR, V35, P375, DOI 10.1111/j.1463-6409.2006.00238.x; Gaina C, 1999, J GEOPHYS RES-SOL EA, V104, P12927, DOI 10.1029/1999JB900038; Gaina C, 1998, J GEOPHYS RES-SOL EA, V103, P12413, DOI 10.1029/98JB00386; GIBB GC, 2010, BIRDS TREE JOURNEY A; GILL BJ, 2010, CHECKLIST BIRDS NZ M; Heslewood MM, 1998, ELECTROPHORESIS, V19, P142, DOI 10.1002/elps.1150190203; Irestedt M, 2008, ZOOL SCR, V37, P305, DOI 10.1111/j.1463-6409.2007.00321.x; Irestedt M, 2008, MOL PHYLOGENET EVOL, V48, P1218, DOI 10.1016/j.ympev.2008.05.038; Irestedt M, 2006, ZOOL SCR, V35, P567, DOI 10.1111/j.1463-6409.2006.00249.x; Jonsson KA, 2008, MOL PHYLOGENET EVOL, V47, P221, DOI 10.1016/j.ympev.2008.01.017; Jonsson KA, 2008, BIOL LETTERS, V4, P71, DOI 10.1098/rsbl.2007.0464; Jonsson KA, 2007, BIOLOGY LETT, V3, P323, DOI 10.1098/rsbl.2007.0054; Jonsson KA, 2010, ECOGRAPHY, V33, P232, DOI 10.1111/j.1600-0587.2010.06167.x; Ladiges PY, 2007, AUST SYST BOT, V20, P383, DOI 10.1071/SB07018; LANDIS CA, 2006, GEOLOGICAL SOC NZ MI; MAYR ERNST, 1951, AMER MUS NOVITATES, V1496, P1; Neall VE, 2008, PHILOS T R SOC B, V363, P3293, DOI 10.1098/rstb.2008.0119; Newton I., 2003, SPECIATION BIOGEOGRA; Norman JA, 2009, J AVIAN BIOL, V40, P640, DOI 10.1111/j.1600-048X.2009.04722.x; Norman JA, 2009, MOL PHYLOGENET EVOL, V52, P488, DOI 10.1016/j.ympev.2009.03.019; NYLANDER JAA, 2004, MRMODEITESET V2; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Oliver W.R.B., 1945, EMU, V45, P119; OLIVER WRB, 1955, NZ BIRDS; OLSON S L, 1983, Notornis, V30, P319; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schellart WP, 2006, EARTH-SCI REV, V76, P191, DOI 10.1016/j.earscirev.2006.01.002; Shepherd LD, 2007, MOL PHYLOGENET EVOL, V43, P480, DOI 10.1016/j.ympev.2006.12.008; SLADE RW, 1993, MOL ECOL, V2, P359, DOI 10.1111/j.1365-294X.1993.tb00029.x; Spellman GM, 2008, MOL PHYLOGENET EVOL, V49, P1036, DOI 10.1016/j.ympev.2008.09.006; Swofford D.L., 2001, PAUP PHYLOGENETIC AN; Tennyson A.J.D., 2006, EXTINCT BIRDS NZ; Tennyson AJD, 2010, NEW ZEAL J ECOL, V34, P6; Trewick SA, 2007, J BIOGEOGR, V34, P1, DOI 10.1111/j.1365-2699.2006.01643.x; Trewick SA, 2010, IBIS, V152, P226, DOI 10.1111/j.1474-919X.2010.01018.x; WALTHER B, 2008, HDB BIRDS WORLD BARC; Wright TF, 2008, MOL BIOL EVOL, V25, P2141, DOI 10.1093/molbev/msn160; Zuccon D, 2006, MOL PHYLOGENET EVOL, V41, P333, DOI 10.1016/j.ympev.2006.05.007; Zuccon D, 2010, ZOOL SCR, V39, P213, DOI 10.1111/j.1463-6409.2010.00423.x	54	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2011	6	9							e24317	10.1371/journal.pone.0024317	http://dx.doi.org/10.1371/journal.pone.0024317			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CN	21931679	Green Published, gold, Green Submitted			2022-12-25	WOS:000294803100018
J	Robanus-Maandag, E; Bosch, C; Amini-Nik, S; Knijnenburg, J; Szuhai, K; Cervera, P; Poon, R; Eccles, D; Radice, P; Giovannini, M; Alman, BA; Tejpar, S; Devilee, P; Fodde, R				Robanus-Maandag, Els; Bosch, Cathy; Amini-Nik, Saeid; Knijnenburg, Jeroen; Szuhai, Karoly; Cervera, Pascale; Poon, Raymond; Eccles, Diana; Radice, Paolo; Giovannini, Marco; Alman, Benjamin A.; Tejpar, Sabine; Devilee, Peter; Fodde, Riccardo			Familial Adenomatous Polyposis-Associated Desmoids Display Significantly More Genetic Changes than Sporadic Desmoids	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; DEPENDENT PROBE AMPLIFICATION; TUMOR-SUPPRESSOR GENE; BETA-CATENIN; COLORECTAL-CANCER; APC GENE; TYROSINE KINASE; FIBROMATOSIS; MUTATIONS; EXPRESSION	Desmoid tumours (also called deep or aggressive fibromatoses) are potentially life-threatening fibromatous lesions. Hereditary desmoid tumours arise in individuals affected by either familial adenomatous polyposis (FAP) or hereditary desmoid disease (HDD) carrying germline mutations in APC. Most sporadic desmoids carry somatic mutations in CTNNB1. Previous studies identified losses on 5q and 6q, and gains on 8q and 20q as recurrent genetic changes in desmoids. However, virtually all genetic changes were derived from sporadic tumours. To investigate the somatic alterations in FAP-associated desmoids and to compare them with changes occurring in sporadic tumours, we analysed 17 FAP-associated and 38 sporadic desmoids by array comparative genomic hybridisation and multiple ligation-dependent probe amplification. Overall, the desmoids displayed only a limited number of genetic changes, occurring in 44% of cases. Recurrent gains at 8q (7%) and 20q (5%) were almost exclusively found in sporadic tumours. Recurrent losses were observed for a 700 kb region at 5q22.2, comprising the APC gene (11%), a 2 Mb region at 6p21.2-p21.1 (15%), and a relatively large region at 6q15-q23.3 (20%). The FAP-associated desmoids displayed a significantly higher frequency of copy number abnormalities (59%) than the sporadic tumours (37%). As predicted by the APC germline mutations among these patients, a high percentage (29%) of FAP-associated desmoids showed loss of the APC region at 5q22.2, which was infrequently (3%) seen among sporadic tumours. Our data suggest that loss of region 6q15-q16.2 is an important event in FAP-associated as well as sporadic desmoids, most likely of relevance for desmoid tumour progression.	[Robanus-Maandag, Els; Bosch, Cathy; Devilee, Peter] Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands; [Amini-Nik, Saeid; Tejpar, Sabine] Univ Louvain, Ctr Human Genet, Louvain, Belgium; [Knijnenburg, Jeroen; Szuhai, Karoly] Leiden Univ, Med Ctr, Dept Mol Cellular Biol, Leiden, Netherlands; [Cervera, Pascale; Giovannini, Marco] Fondat Jean Dausset CEPH, INSERM U674, Paris, France; [Amini-Nik, Saeid; Poon, Raymond; Alman, Benjamin A.] Univ Toronto, Div Orthopaed Surg, Toronto, ON, Canada; [Amini-Nik, Saeid; Poon, Raymond; Alman, Benjamin A.] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Amini-Nik, Saeid; Poon, Raymond; Alman, Benjamin A.] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Eccles, Diana] Southampton Univ Hosp Trust, Wessex Clin Genet Serv, Southampton, Hants, England; [Radice, Paolo] Fdn IRCCS Ist Nazl Tumori, Dept Prevent & Predict Med, Milan, Italy; [Fodde, Riccardo] Erasmus Univ, Dept Pathol, Med Ctr, Josephine Nefkens Inst, NL-3000 DR Rotterdam, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Southampton; University Hospital Southampton NHS Foundation Trust; Fondazione IRCCS Istituto Nazionale Tumori Milan; Erasmus University Rotterdam; Erasmus MC	Robanus-Maandag, E (corresponding author), Leiden Univ, Med Ctr, Dept Human Genet, Leiden, Netherlands.	e.c.robanus@lumc.nl	Nik, Saeid Amini/B-6640-2014; Knijnenburg, Jeroen/AAC-1663-2022; Fodde, Riccardo/AAW-9394-2021; Devilee, Peter/GXV-8005-2022; DEVILEE, PETER/ABR-2140-2022; Eccles, Diana/K-6327-2019; Szuhai, Karoly/A-1100-2008; Radice, Paolo/O-3119-2013	Nik, Saeid Amini/0000-0002-9185-9456; Knijnenburg, Jeroen/0000-0001-5662-7054; Fodde, Riccardo/0000-0001-9839-4324; Eccles, Diana/0000-0002-9935-3169; Szuhai, Karoly/0000-0002-1228-4245; Radice, Paolo/0000-0001-6298-4111	Association for International Cancer Research [04-354]; Canadian Cancer Society Research Institute	Association for International Cancer Research; Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS))	This work was supported by a Grant from the Association for International Cancer Research (04-354, awarded to E.R.-M. and R.F.). B.A.A. is supported by the Canadian Cancer Society Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brandal P, 2003, CANCER GENET CYTOGEN, V146, P1, DOI 10.1016/S0165-4608(03)00122-5; Bridge JA, 1999, AM J PATHOL, V154, P729, DOI 10.1016/S0002-9440(10)65319-9; Buffart TE, 2009, VIRCHOWS ARCH, V455, P213, DOI 10.1007/s00428-009-0814-y; Clark SK, 1996, BRIT J SURG, V83, P1494, DOI 10.1002/bjs.1800831105; De Angelis PM, 2007, INT J CANCER, V120, P2734, DOI 10.1002/ijc.22537; De Wever I, 2000, MODERN PATHOL, V13, P1080, DOI 10.1038/modpathol.3880200; Depaepe V, 2005, NATURE, V435, P1244, DOI 10.1038/nature03651; Eccles DM, 1996, AM J HUM GENET, V59, P1193; Fallen T, 2006, FAM CANCER, V5, P191, DOI 10.1007/s10689-005-5959-5; FLETCHER JA, 1995, CANCER GENET CYTOGEN, V79, P139, DOI 10.1016/0165-4608(94)00134-W; Fodde R, 2001, NAT CELL BIOL, V3, P433, DOI 10.1038/35070129; Fodde R, 2001, NAT REV CANCER, V1, P55, DOI 10.1038/35094067; Fodde Riccardo, 1995, Critical Reviews in Oncogenesis, V6, P291; Jong K, 2004, BIOINFORMATICS, V20, P3636, DOI 10.1093/bioinformatics/bth355; Knijnenburg J, 2005, AM J MED GENET A, V132A, P36, DOI 10.1002/ajmg.a.30378; Kresse SH, 2009, GENE CHROMOSOME CANC, V48, P679, DOI 10.1002/gcc.20675; Kwon J, 2010, J BIOL CHEM, V285, P12232, DOI 10.1074/jbc.M109.065920; Larramendy ML, 1998, GENE CHROMOSOME CANC, V23, P183, DOI 10.1002/(SICI)1098-2264(199810)23:2<183::AID-GCC12>3.0.CO;2-P; Latchford A, 2007, HUM MOL GENET, V16, P78, DOI 10.1093/hmg/ddl442; Lips DJ, 2009, EJSO-EUR J SURG ONC, V35, P3, DOI 10.1016/j.ejso.2008.07.003; Liu W, 2007, CLIN CANCER RES, V13, P5028, DOI 10.1158/1078-0432.CCR-07-0300; MIYAKI M, 1993, CANCER RES, V53, P5079; Postma C, 2007, CELL ONCOL, V29, P73; Putzke AP, 2010, P NATL ACAD SCI USA, V107, P16154, DOI 10.1073/pnas.1006600107; Qi H, 1996, CANCER GENET CYTOGEN, V92, P147, DOI 10.1016/S0165-4608(96)00170-7; Remke M, 2009, BLOOD, V114, P1053, DOI 10.1182/blood-2008-10-186536; Rosato R, 1998, MOL CELL BIOL, V18, P5762, DOI 10.1128/MCB.18.10.5762; Salas S, 2010, GENE CHROMOSOME CANC, V49, P560, DOI 10.1002/gcc.20766; Sasaki S, 2000, ONCOGENE, V19, P3739, DOI 10.1038/sj.onc.1203716; Schoch C, 2006, GENE CHROMOSOME CANC, V45, P1164, DOI 10.1002/gcc.20380; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Schwarz-Romond T, 2002, GENE DEV, V16, P2073, DOI 10.1101/gad.230402; SENGUPTA S, 1993, LANCET, V342, P552, DOI 10.1016/0140-6736(93)91677-E; Sparks AB, 1998, CANCER RES, V58, P1130; Tejpar S, 1999, ONCOGENE, V18, P6615, DOI 10.1038/sj.onc.1203041; Tejpar S, 2001, BRIT J CANCER, V85, P98, DOI 10.1054/bjoc.2001.1857; van Eijk R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-67; vanderLuijt RB, 1996, HUM GENET, V98, P727, DOI 10.1007/s004390050293; White SJ, 2004, HUM MUTAT, V24, P86, DOI 10.1002/humu.20054; Wu C, 2010, CANCER RES, V70, P7690, DOI 10.1158/0008-5472.CAN-10-1656	40	17	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2011	6	9							e24354	10.1371/journal.pone.0024354	http://dx.doi.org/10.1371/journal.pone.0024354			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CN	21931686	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000294803100021
J	Yang, DC; Yang, MH; Tsai, CC; Huang, TF; Chen, YH; Hung, SC				Yang, Der-Chih; Yang, Muh-Hwa; Tsai, Chih-Chien; Huang, Tung-Fu; Chen, Yau-Hung; Hung, Shih-Chieh			Hypoxia Inhibits Osteogenesis in Human Mesenchymal Stem Cells through Direct Regulation of RUNX2 by TWIST	PLOS ONE			English	Article							SAETHRE-CHOTZEN-SYNDROME; OSTEOBLAST DIFFERENTIATION; MASTER REGULATOR; INDUCIBLE FACTOR; STROMAL CELLS; EXPRESSION; PATHWAY; PROTEIN; GROWTH; METASTASIS	Background: Bone loss induced by hypoxia is associated with various pathophysiological conditions, however, little is known about the effects of hypoxia and related signaling pathways on osteoblast differentiation and bone formation. Because bone marrow-derived mesenchymal stem cells (MSCs) survive under hypoxic conditions and readily differentiate into osteoblasts by standard induction protocols, they are a good in vitro model to study the effects of hypoxia on osteoblast differentiation. Methodology/Principle Findings: Using human MSCs, we discovered TWIST, a downstream target of HIF-1 alpha, was induced under hypoxia and acted as a transcription repressor of RUNX2 through binding to the E-box located on the promoter of type 1 RUNX2. Suppression of type 1 RUNX2 by TWIST under hypoxia further inhibited the expression of BMP2, type 2 RUNX2 and downstream targets of RUNX2 in MSCs. Conclusions/Significance: Our findings point to the important role of hypoxia-mediated signalling in osteogenic differentiation in MSCs through direct regulation of RUNX2 by TWIST, and provide a method for modifying MSC osteogenesis upon application of these cells in fracture healing and bone reconstruction.	[Yang, Der-Chih; Yang, Muh-Hwa; Hung, Shih-Chieh] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Huang, Tung-Fu] Natl Yang Ming Univ, Dept Surg, Taipei 112, Taiwan; [Chen, Yau-Hung] Tamkang Univ, Dept Chem, Taipei, Taiwan; [Yang, Der-Chih; Tsai, Chih-Chien; Hung, Shih-Chieh] Vet Gen Hosp Taipei, Dept Med Res & Educ, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Tamkang University	Yang, DC (corresponding author), Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan.	yauhung@mail.tku.edu.tw; hungsc@vghtpe.gov.tw	Yang, Muh-Hwa/AAE-4691-2020		National Science Council [97-3111-B-010-001, 97-2313-B-032-001-MY3, 98-3111-B-010-001-, 98-2628-B-010-001-MY3]; Taipei Veterans General Hospital [V98C1-009, V98E1-002, V99E1-011]; National Yang-Ming University; Ministry of Education	National Science Council(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital(Taipei Veterans General Hospital); National Yang-Ming University; Ministry of Education	This study was supported in part by grants from the National Science Council (97-3111-B-010-001, 97-2313-B-032-001-MY3, 98-3111-B-010-001-, 98-2628-B-010-001-MY3), the Taipei Veterans General Hospital (V98C1-009, V98E1-002, V99E1-011), and National Yang-Ming University, Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Alagiakrishnan K, 2003, J GERONTOL A-BIOL, V58, P362; Bialek P, 2004, DEV CELL, V6, P423, DOI 10.1016/S1534-5807(04)00058-9; Bozec A, 2008, NATURE, V454, P221, DOI 10.1038/nature07019; Caplan AI, 2005, TISSUE ENG, V11, P1198, DOI 10.1089/ten.2005.11.1198; Chung UI, 2004, J ORTHOP SCI, V9, P410, DOI 10.1007/s00776-004-0786-3; COFFIN JD, 1995, MOL BIOL CELL, V6, P1861, DOI 10.1091/mbc.6.12.1861; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Fehrer C, 2007, AGING CELL, V6, P745, DOI 10.1111/j.1474-9726.2007.00336.x; Firulli BA, 2005, NAT GENET, V37, P373, DOI 10.1038/ng1525; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; GOLDBERG MA, 1988, SCIENCE, V242, P1412, DOI 10.1126/science.2849206; Guenou H, 2005, HUM MOL GENET, V14, P1429, DOI 10.1093/hmg/ddi152; Hiraga T, 2007, CANCER RES, V67, P4157, DOI 10.1158/0008-5472.CAN-06-2355; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529; Hsieh PC, 2007, ONCOGENE, V26, P4928, DOI 10.1038/sj.onc.1210304; Hung SC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000416; Isenmann S, 2009, STEM CELLS, V27, P2457, DOI 10.1002/stem.181; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Laroche M, 2003, CLIN EXP RHEUMATOL, V21, P103; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; SAITO T, NAT MED, V16, P678; Sekiya I, 2002, STEM CELLS, V20, P530, DOI 10.1634/stemcells.20-6-530; Semenza GL, 1998, CURR OPIN GENET DEV, V8, P588, DOI 10.1016/S0959-437X(98)80016-6; Sudhakar S, 2001, BIOCHEM BIOPH RES CO, V286, P74, DOI 10.1006/bbrc.2001.5363; TSAI CC, BLOOD; Tsai CC, 2011, BLOOD, V117, P459, DOI 10.1182/blood-2010-05-287508; Utting JC, 2006, EXP CELL RES, V312, P1693, DOI 10.1016/j.yexcr.2006.02.007; Vogt MT, 1997, J BONE MINER RES, V12, P283, DOI 10.1359/jbmr.1997.12.2.283; Wan C, 2008, P NATL ACAD SCI USA, V105, P686, DOI 10.1073/pnas.0708474105; Wang Y, 2007, J CLIN INVEST, V117, P1616, DOI 10.1172/JCI31581; Webster William S., 2007, Birth Defects Research, V81, P215, DOI 10.1002/bdrc.20102; Xiao ZS, 1998, GENE, V214, P187, DOI 10.1016/S0378-1119(98)00227-3; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691	35	120	128	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2011	6	9							e23965	10.1371/journal.pone.0023965	http://dx.doi.org/10.1371/journal.pone.0023965			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CN	21931630	Green Published, Green Submitted, gold			2022-12-25	WOS:000294803100010
J	McCrone, P; Payan, CAM; Knapp, M; Ludolph, A; Agid, Y; Leigh, PN; Bensimon, G				McCrone, Paul; Payan, Christine Anne Mary; Knapp, Martin; Ludolph, Albert; Agid, Yves; Leigh, P. Nigel; Bensimon, Gilbert		NNIPPS Study Grp	The Economic Costs of Progressive Supranuclear Palsy and Multiple System Atrophy in France, Germany and the United Kingdom	PLOS ONE			English	Article							RICHARDSON-OLSZEWSKI-SYNDROME; NATURAL-HISTORY; SELF-REPORT; SERVICE USE; OF-LIFE; SURVIVAL; EPIDEMIOLOGY; PREVALENCE; CARE; SCLEROSIS	Progressive supranuclear palsy (PSP) and multiple system atrophy (MSA) are progressive disabling neurological conditions usually fatal within 10 years of onset. Little is known about the economic costs of these conditions. This paper reports service use and costs from France, Germany and the UK and identifies patient characteristics that are associated with cost. 767 patients were recruited, and 760 included in the study, from 44 centres as part of the NNIPPS trial. Service use during the previous six months was measured at entry to the study and costs calculated. Mean six-month costs were calculated for 742 patients. Data on patient sociodemographic and clinical characteristics were recorded and used in regression models to identify predictors of service costs and unpaid care costs (i.e., care from family and friends). The mean six-month service costs of PSP were (sic)24,491 in France, (sic)30,643 in Germany and (sic)25,655 in the UK. The costs for MSA were (sic)28,924, (sic)25,645 and (sic)J19,103 respectively. Unpaid care accounted for 68-76%. Formal and unpaid costs were significantly higher the more severe the illness, as indicated by the Parkinson's Plus Symptom scale. There was a significant inverse relationship between service and unpaid care costs.	[McCrone, Paul; Knapp, Martin] Kings Coll London, Hlth Serv & Populat Res Dept, Inst Psychiat, London WC2R 2LS, England; [Payan, Christine Anne Mary; Bensimon, Gilbert] UPMC Pharmacol, Hop La Pitie Salpetriere, APHP, Dept Clin Pharmacol,UMR 7211, Paris, France; [Knapp, Martin] London Sch Econ, Personal Social Serv Res Unit, London WC2A 2AE, England; [Ludolph, Albert] Univ Ulm, Dept Neurol, D-7900 Ulm, Germany; [Agid, Yves] Hop La Pitie Salpetriere, AP HP, Brain & Spine Inst, ICM, Paris, France; [Agid, Yves] Univ Paris 06, Paris, France; [Leigh, P. Nigel] Univ Sussex, Brighton & Sussex Med Sch, Trafford Ctr Biomed Res, Brighton, E Sussex, England	University of London; King's College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of London; London School Economics & Political Science; Ulm University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; University of Brighton; University of Sussex	McCrone, P (corresponding author), Kings Coll London, Hlth Serv & Populat Res Dept, Inst Psychiat, London WC2R 2LS, England.	paul.mccrone@kcl.ac.uk	Landwehrmeyer, Georg Bernhard/AHB-4443-2022; PHAM, Hang-Phuong/E-1479-2012; Winner, Beate/O-8213-2019; Schulz, Jörg B/D-9786-2012; Knapp, Martin RJ/G-3011-2011; Broussolle, Emmanuel/H-1592-2017; Brown, Richard G/A-9599-2010; Gröschel, Klaus/ABC-4777-2021; Gasser, Thomas/GNH-5293-2022; Leigh, Peter/AAD-5638-2019; Winner, Beate/K-3730-2012; Fressinaud, Catherine/K-4393-2015	Landwehrmeyer, Georg Bernhard/0000-0003-3375-790X; Winner, Beate/0000-0002-6909-0564; Schulz, Jörg B/0000-0002-8903-0593; Broussolle, Emmanuel/0000-0002-0410-9519; Brown, Richard G/0000-0001-9021-0172; Gröschel, Klaus/0000-0002-0244-6116; Gasser, Thomas/0000-0002-1069-1146; Winner, Beate/0000-0002-6909-0564; Verny, Marc/0000-0001-7960-9705; Knapp, Martin/0000-0003-1427-0215; Schrader, Christoph/0000-0001-5323-8299; McCrone, Paul/0000-0001-7001-4502	European Union [QLG1-CT-2000-01262]; French Health Ministry; Programme Hospitalier de Recherche Clinique [AOM97073, AOM01125]; Sanofi-Aventis; Institute of Psychiatry, King's College London; Assistance Publique-Hopitaux de Paris; University of Ulm	European Union(European Commission); French Health Ministry; Programme Hospitalier de Recherche Clinique; Sanofi-Aventis(Sanofi-Aventis); Institute of Psychiatry, King's College London; Assistance Publique-Hopitaux de Paris; University of Ulm	NNIPPS was an academic-led study with core funding from the European Union 5th Framework programme (QLG1-CT-2000-01262); support from French Health Ministry, Programme Hospitalier de Recherche Clinique (AOM97073, AOM01125) and from Sanofi-Aventis affiliates in the UK, France and Germany providing an unconditional research grant and drug supply throughout the study. Sanofi Aventis provided an unconditional research grant to fund the drug supply and data entry and to help with miscellaneous and travel expenses. Three academic institutions (Institute of Psychiatry, King's College London; Assistance Publique-Hopitaux de Paris; and University of Ulm) were sponsors of the study in each country and jointly own the data. Dr. C.A.M. Payan was funded by EU-FP5-grant QLG1-CT-2000-01262 and by the French Health Ministry, Programme Hospitalier de Recherche Clinique (AOM97073 and AOM01125). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN R, 1973, MILBANK FUND Q, V51, P95, DOI 10.2307/3349613; [Anonymous], 2010, EUR; Beecham J., 2001, MEASURING MENTAL HLT, P200; BenShlomo Y, 1997, NEUROLOGY, V48, P384, DOI 10.1212/WNL.48.2.384; Bensimon G, 2009, BRAIN, V132, P156, DOI 10.1093/brain/awn291; Bower JH, 1997, NEUROLOGY, V49, P1284, DOI 10.1212/WNL.49.5.1284; CALSYN RJ, 1993, EVALUATION REV, V17, P353, DOI 10.1177/0193841X9301700306; Curtis, 2003, UNIT COSTS HLTH SOCI; Golbe LI, 2007, BRAIN, V130, P1552, DOI 10.1093/brain/awm032; GOLBE LI, 1988, NEUROLOGY, V38, P1031, DOI 10.1212/WNL.38.7.1031; Goldberg RW, 2002, PSYCHIATR SERV, V53, P879, DOI 10.1176/appi.ps.53.7.879; Guy W., 1976, ECDEU ASSESSMENT PSY; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Hutton J, 2001, UNIT COSTS HLTH SOCI, P31; Kennedy ADM, 2002, BMC HEALTH SERV RES, V2, DOI 10.1186/1472-6963-2-2; Knapp M, 2002, ACTA PSYCHIAT SCAND, V105, P42, DOI 10.1034/j.1600-0447.2002._10310.x; Kobelt G, 2000, COSTS QUALITY LIFE M; Litvan I, 2003, MOVEMENT DISORD, V18, pS43, DOI 10.1002/mds.10562; Litvan I, 1996, J NEUROL NEUROSUR PS, V60, P615, DOI 10.1136/jnnp.60.6.615; Lowin A, 2001, INT J GERIATR PSYCH, V16, P1143, DOI 10.1002/gps.499; McCrone P, 2008, PHARMACOECONOMICS, V26, P847, DOI 10.2165/00019053-200826100-00005; McCrone P, 2009, J PAIN SYMPTOM MANAG, V38, P62, DOI 10.1016/j.jpainsymman.2009.04.006; Mirandola M, 1999, SOC PSYCH PSYCH EPID, V34, P541, DOI 10.1007/s001270050173; Nath U, 2001, BRAIN, V124, P1438, DOI 10.1093/brain/124.7.1438; Nath U, 2000, PARKINSONISM RELAT D, V6, P145, DOI 10.1016/S1353-8020(00)00011-0; O'Hagan A, 2003, HEALTH ECON, V12, P33, DOI 10.1002/hec.699; OECD, STAT PORT; Patel A, 2005, FAM PRACT, V22, P323, DOI 10.1093/fampra/cmi027; Payan CAM, 2011, PLOS ONE, V6; Schrag A, 1999, LANCET, V354, P1771, DOI 10.1016/S0140-6736(99)04137-9; Schrag A, 2008, MOVEMENT DISORD, V23, P294, DOI 10.1002/mds.21839; Testa D, 1996, J NEUROL, V243, P401, DOI 10.1007/BF00868999; Testa D, 2001, NEUROL SCI, V22, P247, DOI 10.1007/s100720100021; Vanacore N, 2001, NEUROL SCI, V22, P97, DOI 10.1007/s100720170064; Vanacore N, 2001, NEUROL SCI, V22, P101, DOI 10.1007/s100720170065; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Watanabe H, 2002, BRAIN, V125, P1070, DOI 10.1093/brain/awf117	37	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e24369	10.1371/journal.pone.0024369	http://dx.doi.org/10.1371/journal.pone.0024369			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	819CK	21931694	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000294802800043
J	Jager, E; van der Velden, VHJ; te Marvelde, JG; Walter, RB; Agur, Z; Vainstein, V				Jager, Eva; van der Velden, Vincent H. J.; te Marvelde, Jeroen G.; Walter, Roland B.; Agur, Zvia; Vainstein, Vladimir			Targeted Drug Delivery by Gemtuzumab Ozogamicin: Mechanism-Based Mathematical Model for Treatment Strategy Improvement and Therapy Individualization	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; CD33 EXPRESSION; INTERNALIZATION; EFFICACY; MYLOTARG; PHARMACOKINETICS; IMMUNOCONJUGATE; CYTOTOXICITY; CHEMOTHERAPY; ENDOCYTOSIS	Gemtuzumab ozogamicin (GO) is a chemotherapy-conjugated anti-CD33 monoclonal antibody effective in some patients with acute myeloid leukemia (AML). The optimal treatment schedule and optimal timing of GO administration relative to other agents remains unknown. Conventional pharmacokinetic analysis has been of limited insight for the schedule optimization. We developed a mechanism-based mathematical model and employed it to analyze the time-course of free and GO-bound CD33 molecules on the lekemic blasts in individual AML patients treated with GO. We calculated expected intravascular drug exposure (I-AUC) as a surrogate marker for the response to the drug. A high CD33 production rate and low drug efflux were the most important determinants of high I-AUC, characterizing patients with favorable pharmacokinetic profile and, hence, improved response. I-AUC was insensitive to other studied parameters within biologically relevant ranges, including internalization rate and dissociation constant. Our computations suggested that even moderate blast burden reduction prior to drug administration enables lowering of GO doses without significantly compromising intracellular drug exposure. These findings indicate that GO may optimally be used after cyto-reductive chemotherapy, rather than before, or concomitantly with it, and that GO efficacy can be maintained by dose reduction to 6 mg/m(2) and a dosing interval of 7 days. Model predictions are validated by comparison with the results of EORTC-GIMEMA AML19 clinical trial, where two different GO schedules were administered. We suggest that incorporation of our results in clinical practice can serve identification of the subpopulation of elderly patients who can benefit most of the GO treatment and enable return of the currently suspended drug to clinic.	[Jager, Eva; Agur, Zvia; Vainstein, Vladimir] Inst Med Biomath, Bene Ataroth, Israel; [van der Velden, Vincent H. J.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Immunol, Rotterdam, Netherlands; [Walter, Roland B.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Walter, Roland B.] Univ Washington, Dept Med, Div Hematol, Seattle, WA 98195 USA; [Agur, Zvia] Optimata Ltd, Ramat Gan, Israel	Erasmus University Rotterdam; Erasmus MC; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Jager, E (corresponding author), Inst Med Biomath, Bene Ataroth, Israel.	vladimir.dr@gmail.com	Walter, Roland/C-1064-2008; te Marvelde, Jeroen/CAH-0770-2022	Walter, Roland/0000-0002-9268-3341; 	Chai Foundation, Israel; EU NEST [012930]; Leukemia & Lymphoma Society [3588-07]	Chai Foundation, Israel; EU NEST(European Commission); Leukemia & Lymphoma Society(Leukemia and Lymphoma Society)	EJ, ZA and VV were supported by the Chai Foundation, Israel, and by the EU NEST grant: 012930. RBW is the recipient of a Leukemia & Lymphoma Society 'Special Fellow' Award (#3588-07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burnett AK, 2006, BLOOD, V108, p8A, DOI 10.1182/blood.V108.11.18.18; Dowell JA, 2001, J CLIN PHARMACOL, V41, P1206, DOI 10.1177/00912700122012751; Gleissner B, 2007, ONKOLOGIE, V30, P657, DOI 10.1159/000109956; HIDDEMANN W, 1982, BLOOD, V59, P216; ICRP, 1975, 23 ICRP; Jedema I, 2004, LEUKEMIA, V18, P316, DOI 10.1038/sj.leu.2403205; Larson RA, 2005, CANCER, V104, P1442, DOI 10.1002/cncr.21326; Linenberger ML, 2005, LEUKEMIA, V19, P176, DOI 10.1038/sj.leu.2403598; Lobo ED, 2004, J PHARM SCI-US, V93, P2645, DOI 10.1002/jps.20178; Mager DE, 2001, J PHARMACOKINET PHAR, V28, P507, DOI 10.1023/A:1014414520282; Ng CM, 2005, PHARM RES-DORDR, V22, P1088, DOI 10.1007/s11095-005-5642-4; Ng CM, 2006, PHARM RES-DORDR, V23, P95, DOI 10.1007/s11095-005-8814-3; Pagano L, 2007, ONCOGENE, V26, P3679, DOI 10.1038/sj.onc.1210364; Resat H, 2003, BIOPHYS J, V85, P730, DOI 10.1016/S0006-3495(03)74516-0; Sato H, 1996, ADV DRUG DELIVER REV, V19, P445, DOI 10.1016/0169-409X(96)00013-0; Sergio A, 2008, PHASE 2 3 STUDY GEMT; Sievers EL, 1999, BLOOD, V93, P3678, DOI 10.1182/blood.V93.11.3678; Tzafriri AR, 2004, J THEOR BIOL, V229, P127, DOI 10.1016/j.jtbi.2004.03.009; van der Velden VHJ, 2004, LEUKEMIA, V18, P983, DOI 10.1038/sj.leu.2403350; van der Velden VHJ, 2001, BLOOD, V97, P3197, DOI 10.1182/blood.V97.10.3197; Walter RB, 2005, BLOOD, V105, P1295, DOI 10.1182/blood-2004-07-2784; Walter RB, 2007, BLOOD, V109, P4168, DOI 10.1182/blood-2006-09-047399; WILEY HS, 1981, CELL, V25, P433, DOI 10.1016/0092-8674(81)90061-1	23	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2011	6	9							e24265	10.1371/journal.pone.0024265	http://dx.doi.org/10.1371/journal.pone.0024265			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CH	21915304	Green Published, Green Submitted, gold			2022-12-25	WOS:000294802500036
J	Klaiman, JM; Fenna, AJ; Shiels, HA; Macri, J; Gillis, TE				Klaiman, Jordan M.; Fenna, Andrew J.; Shiels, Holly A.; Macri, Joseph; Gillis, Todd E.			Cardiac Remodeling in Fish: Strategies to Maintain Heart Function during Temperature Change	PLOS ONE			English	Article							BINDING-PROTEIN-C; TROUT ONCORHYNCHUS-MYKISS; RAINBOW-TROUT; PRESSURE-OVERLOAD; TROPONIN-I; HYPERTROPHY; PHOSPHORYLATION; MYOSIN; ACCLIMATION; FIBROSIS	Rainbow trout remain active in waters that seasonally change between 4 degrees C and 20 degrees C. To explore how these fish are able to maintain cardiac function over this temperature range we characterized changes in cardiac morphology, contractile function, and the expression of contractile proteins in trout following acclimation to 4 degrees C (cold), 12 degrees C (control), and 17 degrees C (warm). The relative ventricular mass (RVM) of the cold acclimated male fish was significantly greater than that of males in the control group. In addition, the compact myocardium of the cold acclimated male hearts was thinner compared to controls while the amount of spongy myocardium was found to have increased. Cold acclimation also caused an increase in connective tissue content, as well as muscle bundle area in the spongy myocardium of the male fish. Conversely, warm acclimation of male fish caused an increase in the thickness of the compact myocardium and a decrease in the amount of spongy myocardium. There was also a decrease in connective tissue content in both myocardial layers. In contrast, there was no change in the RVM or connective tissue content in the hearts of female trout with warm or cold acclimation. Cold acclimation also caused a 50% increase in the maximal rate of cardiac AM Mg2+-ATPase but did not influence the Ca2+ sensitivity of this enzyme. To identify a mechanism for this change we utilized two-dimensional difference gel electrophoresis to characterize changes in the cardiac contractile proteins. Cold acclimation caused subtle changes in the phosphorylation state of the slow skeletal isoform of troponin T found in the heart, as well as of myosin binding protein C. These results demonstrate that acclimation of trout to warm and cold temperatures has opposing effects on cardiac morphology and tissue composition and that this results in distinct warm and cold cardiac phenotypes.	[Klaiman, Jordan M.; Gillis, Todd E.] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; [Fenna, Andrew J.; Shiels, Holly A.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Macri, Joseph] Hamilton Hlth Sci, Hamilton Reg Lab Med Program, Dept Lab Med, Hamilton, ON, Canada; [Macri, Joseph] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada	University of Guelph; University of Manchester; McMaster University; McMaster University	Klaiman, JM (corresponding author), Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada.	tgillis@uoguelph.ca			Ontario Graduate Scholarship; Natural Sciences and Engineering Research Council (NSERC); Biotechnology and Biological Sciences Research Council, UK; NSERC; Canadian Foundation for Innovation (CFI)	Ontario Graduate Scholarship(Ontario Graduate Scholarship); Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation)	JMK was supported by an Ontario Graduate Scholarship and a Natural Sciences and Engineering Research Council (NSERC)-Canadian Graduate Scholarship. AJF and HAS are supported by the Biotechnology and Biological Sciences Research Council, UK. JM is supported by a NSERC Discovery Grant and a Canadian Foundation for Innovation (CFI) equipment grant. TEG is supported by a NSERC Discovery Grant and equipment grants from NSERC and CFI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGNISOLA C, 1994, CARDIOSCIENCE, V5, P145; Aho E, 1999, J EXP BIOL, V202, P2663; Babiker FA, 2002, CARDIOVASC RES, V53, P709, DOI 10.1016/S0008-6363(01)00526-0; BEHRENDT H, 1977, CELL TISSUE RES, V180, P303; Bercik P, 2010, GASTROENTEROLOGY, V139, P2102, DOI 10.1053/j.gastro.2010.06.063; Bernardo BC, 2010, PHARMACOL THERAPEUT, V128, P191, DOI 10.1016/j.pharmthera.2010.04.005; BERS DM, 1994, METHOD CELL BIOL, V40, P3; CHURCOTT CS, 1994, AM J PHYSIOL, V267, pR62, DOI 10.1152/ajpregu.1994.267.1.R62; Cox J, 2007, CELL, V130, P395, DOI 10.1016/j.cell.2007.07.032; Davie PS, 1997, COMP BIOCHEM PHYS A, V117, P227, DOI 10.1016/S0300-9629(96)00236-8; DOERING CW, 1988, CARDIOVASC RES, V22, P686, DOI 10.1093/cvr/22.10.686; Farrell AP, 1996, J EXP BIOL, V199, P663; FARRELL AP, 1987, J EXP BIOL, V129, P107; FARRELL AP, 1988, CAN J ZOOL, V66, P2368, DOI 10.1139/z88-351; Geng J, 2010, PHARMACOL RES, V61, P40, DOI 10.1016/j.phrs.2009.08.004; Gillis TE, 2000, AM J PHYSIOL-REG I, V279, pR1707, DOI 10.1152/ajpregu.2000.279.5.R1707; Gillis TE, 2007, J PHYSIOL-LONDON, V580, P561, DOI 10.1113/jphysiol.2007.128975; Gillis TE, 2011, J EXP BIOL, V214, P1989, DOI 10.1242/jeb.052084; GOOLISH EM, 1987, J THERM BIOL, V12, P203, DOI 10.1016/0306-4565(87)90005-2; GRAHAM MS, 1989, PHYSIOL ZOOL, V62, P38, DOI 10.1086/physzool.62.1.30159997; Grobe JL, 2006, AM J PHYSIOL-HEART C, V290, pH2417, DOI 10.1152/ajpheart.01170.2005; Huang XR, 2010, HYPERTENSION, V55, P1165, DOI 10.1161/HYPERTENSIONAHA.109.147611; JALIL JE, 1989, CIRC RES, V64, P1041, DOI 10.1161/01.RES.64.6.1041; KENT J, 1988, J COMP PHYSIOL B, V158, P185, DOI 10.1007/BF01075832; KENT JD, 1985, AM ZOOL, V25, pA29; McMullen JR, 2007, CLIN EXP PHARMACOL P, V34, P255, DOI 10.1111/j.1440-1681.2007.04585.x; NOLAND TA, 1991, J BIOL CHEM, V266, P4974; Pelzer T, 1997, ADV EXP MED BIOL, V432, P83; Pieperhoff S, 2009, J ANAT, V215, P536, DOI 10.1111/j.1469-7580.2009.01129.x; RUPP H, 1981, BASIC RES CARDIOL, V76, P79, DOI 10.1007/BF01908164; Sadayappan S, 2005, CIRC RES, V97, P1156, DOI 10.1161/01.RES.0000190605.79013.4d; Sadayappan S, 2006, P NATL ACAD SCI USA, V103, P16918, DOI 10.1073/pnas.0607069103; Salameh A, 2010, CIRC RES, V106, P1592, DOI 10.1161/CIRCRESAHA.109.214429; SCHAIBLE TF, 1984, CIRC RES, V54, P38, DOI 10.1161/01.RES.54.1.38; Scruggs SB, 2009, J BIOL CHEM, V284, P5097, DOI 10.1074/jbc.M807414200; Shaffer JF, 2010, PHYSIOL GENOMICS, V42, P406, DOI 10.1152/physiolgenomics.00055.2010; TSUKUDA H, 1985, COMP BIOCHEM PHYS A, V82, P281; van Eickels M, 2001, CIRCULATION, V104, P1419, DOI 10.1161/hc3601.095577; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; VENEMA RC, 1993, J BIOL CHEM, V268, P2705; VILLARREAL FJ, 1992, AM J PHYSIOL, V262, pH1861, DOI 10.1152/ajpheart.1992.262.6.H1861; VOLLMER RT, 1983, JAMA-J AM MED ASSOC, V250, P1909, DOI 10.1001/jama.1983.03340140079044; Vornanen M, 2005, AM J PHYSIOL-REG I, V289, pR1177, DOI 10.1152/ajpregu.00157.2005; Weber KT, 2000, CURR OPIN CARDIOL, V15, P264, DOI 10.1097/00001573-200007000-00010; WEBER KT, 1991, CIRCULATION, V83, P1849, DOI 10.1161/01.CIR.83.6.1849; WIKMANCOFFELT J, 1979, CIRC RES, V45, P697, DOI 10.1161/01.RES.45.6.697; Yang F, 2008, BIOCHEM CELL BIOL, V86, P70, DOI [10.1139/O07-150, 10.1139/o07-150]; Yang H, 2000, PHYSIOL BIOCHEM ZOOL, V73, P841, DOI 10.1086/318095; Yuan C, 2008, AM J PHYSIOL-HEART C, V295, pH647, DOI 10.1152/ajpheart.00357.2008; Yuan C, 2006, PROTEOMICS, V6, P4176, DOI 10.1002/pmic.200500894; ZUMMO G, 1995, BRAZ J MED BIOL RES, V28, P1265	51	80	83	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2011	6	9							e24464	10.1371/journal.pone.0024464	http://dx.doi.org/10.1371/journal.pone.0024464			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CH	21915331	Green Published, Green Submitted, gold			2022-12-25	WOS:000294802500049
J	Quan, RC; Ren, GP; Behm, JE; Wang, L; Huang, Y; Long, YC; Zhu, JG				Quan, Rui-Chang; Ren, Guopeng; Behm, Jocelyn E.; Wang, Lin; Huang, Yong; Long, Yongcheng; Zhu, Jianguo			Why Does Rhinopithecus bieti Prefer the Highest Elevation Range in Winter? A Test of the Sunshine Hypothesis	PLOS ONE			English	Article							HABITAT SELECTION; SAMAGE FOREST; MIGRATION; DEER; YUNNAN; CONSERVATION; MOUNTAINS; ENERGY; BIRDS	Environmental factors that affect spatiotemporal distribution patterns of animals usually include resource availability, temperature, and the risk of predation. However, they do not explain the counterintuitive preference of high elevation range in winter by the black-and-white snub-nosed monkey (Rhinopithecus bieti). We asked whether variation of sunshine along with elevations is the key driving force. To test this hypothesis, we conducted field surveys to demonstrate that there was a statistically significant pattern of high elevation use during winter. We then asked whether this pattern can be explained by certain environmental factors, namely temperature, sunshine duration and solar radiation. Finally, we concluded with a possible ecological mechanism for this pattern. In this study, we employed GIS technology to quantify solar radiation and sunshine duration across the monkey's range. Our results showed that: 1) R. bieti used the high altitude range between 4100-4400 m in winter although the yearly home range spanned from 3500-4500 m; 2) both solar radiation and sunshine duration increased with elevation while temperature decreased with elevation; 3) within the winter range, the use of range was significantly correlated with solar radiation and sunshine duration; 4) monkeys moved to the areas with high solar radiation and duration following a snowfall, where the snow melts faster and food is exposed earlier. We concluded that sunshine was the main factor that influences selection of high elevation habitat for R. bieti in winter. Since some other endotherms in the area exhibit similar winter distributional patterns, we developed a sunshine hypothesis to explain this phenomenon. In addition, our work also represented a new method of integrating GIS models into traditional field ecology research to study spatiotemporal distribution pattern of wildlife. We suggest that further theoretical and empirical studies are necessary for better understanding of sunshine influence on wildlife range use.	[Quan, Rui-Chang] Chinese Acad Sci, XTBG, CAS Key Lab Trop Forest Ecol, Mengla, Yunnan, Peoples R China; [Ren, Guopeng; Wang, Lin; Huang, Yong; Zhu, Jianguo] Chinese Acad Sci, KIZ, ECEC, Kunming, Yunnan, Peoples R China; [Behm, Jocelyn E.] Univ Wisconsin, Dept Zool, Madison, WI 53706 USA	Chinese Academy of Sciences; Chinese Academy of Sciences; University of Wisconsin System; University of Wisconsin Madison	Quan, RC (corresponding author), Chinese Acad Sci, XTBG, CAS Key Lab Trop Forest Ecol, Mengla, Yunnan, Peoples R China.	zhu@mail.kiz.ac.cn	Wang, Lin/ABF-8028-2021; Ren, Guo-Peng/ABA-2138-2021; Wang, Lin/AAA-2163-2022	Wang, Lin/0000-0001-5645-8991; Ren, Guo-Peng/0000-0003-3381-3166; 	Committee for Research and Exploration, National Geographic Society of U.S. [7962-05]; Nature Conservancy, National Nature Science Foundation of China [30770308]; Kunming Institute of Zoology [Y106521131]; Chinese Academy of Sciences [INFO-115-C01-SDB3-06-02]	Committee for Research and Exploration, National Geographic Society of U.S.(National Geographic Society); Nature Conservancy, National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Kunming Institute of Zoology(Chinese Academy of Sciences); Chinese Academy of Sciences(Chinese Academy of Sciences)	The study was supported by funding from the Committee for Research and Exploration, National Geographic Society of U.S. (grant #7962-05), The Nature Conservancy, National Nature Science Foundation of China (grant #30770308), Kunming Institute of Zoology (grant #Y106521131), and the Chinese Academy of Sciences (INFO-115-C01-SDB3-06-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBON SD, 1992, OIKOS, V65, P502, DOI 10.2307/3545568; Berthold P, 2001, AUK, V2nd; BLEM CR, 1993, CONDOR, V95, P728, DOI 10.2307/1369619; Boyle WA, 2008, OECOLOGIA, V155, P397, DOI 10.1007/s00442-007-0897-6; Boyle WA, 2007, AM NAT, V169, P344, DOI 10.1086/511335; Brinkman TJ, 2005, J WILDLIFE MANAGE, V69, P1099, DOI 10.2193/0022-541X(2005)069[1099:MOFWDE]2.0.CO;2; C?lix M., 2018, EUROPEAN RED LIST SA; Canterbury G, 2002, ECOLOGY, V83, P946, DOI 10.2307/3071904; Carrascal LM, 2001, ECOLOGY, V82, P1642, DOI 10.1890/0012-9658(2001)082[1642:BTBTTO]2.0.CO;2; Chaves-Campos J, 2003, BIRD CONSERV INT, V13, P45, DOI 10.1017/S0959270903003046; Chesser RT, 1998, AM NAT, V152, P311, DOI 10.1086/286171; Cottle HJ, 1932, ECOLOGY, V13, P121, DOI 10.2307/1931063; Cristobal J, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD010616; Cui LW, 2003, FOLIA PRIMATOL, V74, P51, DOI 10.1159/000068393; Ding W, 2003, FEEDING ECOLOGY SOCI; Fu PD, 2002, COMPUT ELECTRON AGR, V37, P25, DOI 10.1016/S0168-1699(02)00115-1; Grueter CC, 2008, INT J PRIMATOL, V29, P1121, DOI 10.1007/s10764-008-9299-9; HAMILTON WJ, 1967, SCIENCE, V155, P196, DOI 10.1126/science.155.3759.196; Harris RB, 2004, WILDLIFE BIOL, V10, P91, DOI 10.2981/wlb.2004.013; HAYES JP, 1989, PHYSIOL ZOOL, V62, P732, DOI 10.1086/physzool.62.3.30157924; Holch AE, 1931, ECOLOGY, V12, P259, DOI 10.2307/1931633; Huertas DL, 2001, CAN J ZOOL, V79, P279, DOI 10.1139/cjz-79-2-279; Huo S, 2005, DIET HABITAT USE RHI; Igota H, 2004, ECOL RES, V19, P169, DOI 10.1111/j.1440-1703.2003.00621.x; JING Y, 2005, LIFE HIST COOPERATIV; Kirkpatrick RC, 1998, INT J PRIMATOL, V19, P13, DOI 10.1023/A:1020302809584; Li DY, 2008, INT J PRIMATOL, V29, P1147, DOI 10.1007/s10764-008-9298-x; Liu XD, 2009, GLOBAL PLANET CHANGE, V68, P164, DOI 10.1016/j.gloplacha.2009.03.017; Liu ZH, 2004, PRIMATES, V45, P241, DOI 10.1007/s10329-004-0091-y; LOISELLE BA, 1991, ECOLOGY, V72, P180, DOI 10.2307/1938913; LONG YC, 1994, PRIMATES, V35, P241, DOI 10.1007/BF02382060; LUSTICK S, 1971, CONDOR, V73, P121, DOI 10.2307/1366139; [麻应太 Ma Yingtai], 2002, [兽类学报, Acta Theriologica Sinica], V22, P248; Messerli B., 1997, MOUNTAINS WORLD GLOB; Moyer BR, 1995, AUK, V112, P1073, DOI 10.2307/4089047; Nicholson MC, 1997, J MAMMAL, V78, P483, DOI 10.2307/1382900; Panah SKA, 2008, J AGR SCI TECH-IRAN, V10, P439; Schaller GB, 1996, BIOL CONSERV, V76, P1, DOI 10.1016/0006-3207(96)85972-6; Tibet Forestry Survey and Planning Institute, 2000, COMPR PROGR HONGL NA; Wachob DG, 1996, CONDOR, V98, P114, DOI 10.2307/1369514; Xiang ZF, 2005, ECOLOGY BEHAV BLACK; Xiao W, 2003, INT J PRIMATOL, V24, P389, DOI 10.1023/A:1023009518806; Zar JH, 1974, BIOSTATISTICAL ANAL; Zhang J, 2007, INT J REMOTE SENS, V28, P2383, DOI 10.1080/01431160701236811; ZHAO QK, 1988, AM J PRIMATOL, V16, P275, DOI 10.1002/ajp.1350160309	45	8	12	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2011	6	9							e24449	10.1371/journal.pone.0024449	http://dx.doi.org/10.1371/journal.pone.0024449			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CH	21915329	Green Submitted, Green Published, gold			2022-12-25	WOS:000294802500047
J	Ithoi, I; Ahmad, AF; Nissapatorn, V; Lau, YL; Mahmud, R; Mak, JW				Ithoi, Init; Ahmad, Arine Fadzlun; Nissapatorn, Veeranoot; Lau, Yee Ling; Mahmud, Rohela; Mak, Joon Wah			Detection of Naegleria Species in Environmental Samples from Peninsular Malaysia	PLOS ONE			English	Article							PRIMARY AMEBIC MENINGOENCEPHALITIS; INTERNAL TRANSCRIBED SPACERS; FREE-LIVING AMEBAS; GENUS NAEGLERIA; FOWLERI; SEQUENCES; ALIGNMENT; PCR	Background: In Malaysia, researchers and medical practitioners are unfamiliar with Naegleria infections. Thus little is known about the existence of pathogenic Naegleria fowleri, and the resultant primary amoebic meningoencephalitis (PAM) is seldom included in the differential diagnosis of central nervous system infections. This study was conducted to detect the presence of Naegleria species in various environmental samples. Methods/Findings: A total of 41 Naegleria-like isolates were isolated from water and dust samples. All these isolates were subjected to PCR using two primer sets designed from the ITS1-ITS2 regions. The N. fowleri species-specific primer set failed to produce the expected amplicon. The Naegleria genus-specific primers produced amplicons of 408 bp (35), 450 bp (2), 457 bp (2) or 381 bp (2) from all 41 isolates isolated from aquatic (33) and dust (8) samples. Analysis of the sequences from 10 representative isolates revealed that amplicons with fragments 408, 450 and 457 bp showed homology with nonpathogenic Naegleria species, and 381 bp showed homology with Vahlkampfia species. These results concurred with the morphological observation that all 39 isolates which exhibited flagella were Naegleria, while 2 isolates (AC7, JN034055 and AC8, JN034056) that did not exhibit flagella were Vahlkampfia species. Conclusion: To date, pathogenic species of N. fowleri have not been isolated from Malaysia. All 39 isolates that produced amplicons (408, 450 and 457 bp) from the genus-specific primers were identified as being similar to nonpathogenic Naegleria. Amplicon 408 bp from 5 representative isolates showed 100% and 99.7% identity to Naegleria philippinensis isolate RJTM (AM167890) and is thus believed to be the most common species in our environment. Amplicons 450 bp and 457 bp were respectively believed to be from 2 new species of Naegleria, since representative isolates showed lower homology and had a longer base pair length when compared to the reference species in the Genbank, Naegleria schusteri (AJ566626) and Naegleria laresi (AJ566630), respectively.	[Ithoi, Init; Ahmad, Arine Fadzlun; Nissapatorn, Veeranoot; Lau, Yee Ling; Mahmud, Rohela] Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia; [Mak, Joon Wah] Int Med Univ, Sch Postgrad Studies & Res, Kuala Lumpur 57000, Malaysia	Universiti Malaya; International Medical University Malaysia	Ithoi, I (corresponding author), Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia.	init@um.edu.my	Ithoi, Init/B-8660-2010; Lau, Yee Ling/C-6996-2009; Mak, Joon Wah/C-9174-2011; MAHMUD, ROHELA/B-9593-2010	Ithoi, Init/0000-0001-8698-4546; Lau, Yee Ling/0000-0002-2037-2165; Mak, Joon Wah/0000-0002-2538-0797; 	University of Malaya (UM) [RG187/10HTM]	University of Malaya (UM)(Universiti Malaya)	This research was funded by the University of Malaya Research Grant (UMRG) No. RG187/10HTM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Carraway M, 1996, APPL ENVIRON MICROB, V62, P712, DOI 10.1128/AEM.62.2.712-716.1996; CARTER RF, 1970, J PATHOL, V100, P217, DOI 10.1002/path.1711000402; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; De Jonckheere JF, 2004, PROTIST, V155, P89, DOI 10.1078/1434461000167; De Jonckheere JF, 2002, ACTA PROTOZOOL, V41, P309; De Jonckheere JF, 2001, PROTIST, V152, P115, DOI 10.1078/1434-4610-00049; De Jonckheere JF, 1998, PROTIST, V149, P221, DOI 10.1016/S1434-4610(98)70030-6; DEJONCKHEERE JF, 1994, EUR J PROTISTOL, V30, P333, DOI 10.1016/S0932-4739(11)80080-5; Diaz J.H., 2010, J NEUROPARASITOL, V1, P76, DOI DOI 10.4303/JNP/N100801; Felleisen RSJ, 1997, PARASITOLOGY, V115, P111, DOI 10.1017/S0031182097001212; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Garstecki T, 2005, EUR J PROTISTOL, V41, P119, DOI 10.1016/j.ejop.2005.01.003; GRIFFIN JL, 1972, SCIENCE, V178, P869, DOI 10.1126/science.178.4063.869; Init I, 2010, TROP BIOMED, V27, P566; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kumar SS, 2001, J MED MICROBIOL, V50, P602, DOI 10.1099/0022-1317-50-7-602; LAWANDE RV, 1980, AM J TROP MED HYG, V29, P21, DOI 10.4269/ajtmh.1980.29.21; MACARTHY C, 1998, CHROMAS 1 45; Pelandakis M, 2002, APPL ENVIRON MICROB, V68, P2061, DOI 10.1128/AEM.68.4.2061-2065.2002; Pelandakis M, 2000, J EUKARYOT MICROBIOL, V47, P116, DOI 10.1111/j.1550-7408.2000.tb00020.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Shakoor S, 2011, EMERG INFECT DIS, V17, P258, DOI 10.3201/eid1702.100442; Sheehan KB, 2003, APPL ENVIRON MICROB, V69, P5914, DOI 10.1128/AEM.69.10.5914-5918.2003; Sugita Y, 1999, PATHOL INT, V49, P468, DOI 10.1046/j.1440-1827.1999.00893.x; Tiewcharoen S, 2004, SE ASIAN J TROP MED, V35, P24; TYNDALL RL, 1989, APPL ENVIRON MICROB, V55, P722, DOI 10.1128/AEM.55.3.722-732.1989; WARHURST D C, 1985, Parasitology Today, V1, P24, DOI 10.1016/0169-4758(85)90102-4; WELLING FM, 1979, US EPA PUBLICATION; WIWANITKIT V, 2004, MEDSCAPE GEN MED, V6, P1	30	29	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2011	6	9							e24327	10.1371/journal.pone.0024327	http://dx.doi.org/10.1371/journal.pone.0024327			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817QP	21915311	gold, Green Published			2022-12-25	WOS:000294689200034
J	Schikora, A; Virlogeux-Payant, I; Bueso, E; Garcia, AV; Nilau, T; Charrier, A; Pelletier, S; Menanteau, P; Baccarini, M; Velge, P; Hirt, H				Schikora, Adam; Virlogeux-Payant, Isabelle; Bueso, Eduardo; Garcia, Ana V.; Nilau, Theodora; Charrier, Amelie; Pelletier, Sandra; Menanteau, Pierrette; Baccarini, Manuela; Velge, Philippe; Hirt, Heribert			Conservation of Salmonella Infection Mechanisms in Plants and Animals	PLOS ONE			English	Article							III SECRETION SYSTEM; ESCHERICHIA-COLI O157-H7; PV. TOMATO DC3000; PSEUDOMONAS-SYRINGAE; LISTERIA-MONOCYTOGENES; ARABIDOPSIS-THALIANA; ENTERICA; PROTEIN; PATHOGENICITY; COLONIZATION	Salmonella virulence in animals depends on effectors injected by Type III Secretion Systems (T3SSs). In this report we demonstrate that Salmonella mutants that are unable to deliver effectors are also compromised in infection of Arabidopsis thaliana plants. Transcriptome analysis revealed that in contrast to wild type bacteria, T3SS mutants of Salmonella are compromised in suppressing highly conserved Arabidopsis genes that play a prominent role during Salmonella infection of animals. We also found that Salmonella originating from infected plants are equally virulent for human cells and mice. These results indicate a high degree of conservation in the defense and infection mechanism of animal and plant hosts during Salmonella infection.	[Schikora, Adam; Bueso, Eduardo; Garcia, Ana V.; Charrier, Amelie; Pelletier, Sandra; Hirt, Heribert] Univ Evry, INRA, URGV Plant Genom, Evry, France; [Virlogeux-Payant, Isabelle; Menanteau, Pierrette; Velge, Philippe] INRA Tours, Infectiol Anim & Sante Publ UR1282, Nouzilly, France; [Nilau, Theodora; Baccarini, Manuela; Hirt, Heribert] Univ Vienna, Max F Perutz Labs, Vienna, Austria	INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Schikora, A (corresponding author), Univ Giessen, Inst Phytopathol & Appl Zool, IFZ, Giessen, Germany.	adam.schikora@agrar.uni-giessen.de	Virlogeux-Payant, Isabelle/H-5800-2013; velge, philippe/AAK-4165-2021; Hirt, Heribert/A-2061-2013; Pelletier, Sandra/A-3852-2013; Baccarini, Manuela/B-6481-2014; Schikora, Adam/B-4842-2014	Pelletier, Sandra/0000-0001-7582-2939; Baccarini, Manuela/0000-0002-3033-391X; Schikora, Adam/0000-0002-0869-6423; Bueso, Eduardo/0000-0002-0828-121X; Virlogeux-Payant, Isabelle/0000-0003-4149-0168; Velge, Philippe/0000-0002-8201-0194	CNRS; Ecole Doctorale Des Genomes Aux Organismes (G.A.O) at University Evry-Val d'Essone; Spanish Ministry of Science and Technology; INRA-ANR	CNRS(Centre National de la Recherche Scientifique (CNRS)); Ecole Doctorale Des Genomes Aux Organismes (G.A.O) at University Evry-Val d'Essone; Spanish Ministry of Science and Technology(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); INRA-ANR(French National Research Agency (ANR))	AS was supported by the CNRS post-doc fellowship. AC was supported by the grant from Ecole Doctorale Des Genomes Aux Organismes (G.A.O) at University Evry-Val d'Essone. EB was founded by Spanish Ministry of Science and Technology. AVG was founded by the INRA-ANR Project ERASYSBIO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfano JR, 2004, ANNU REV PHYTOPATHOL, V42, P385, DOI 10.1146/annurev.phyto.42.040103.110731; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Barak JD, 2005, APPL ENVIRON MICROB, V71, P5685, DOI 10.1128/AEM.71.10.5685-5691.2005; Barak JD, 2011, APPL ENVIRON MICROB, V77, P498, DOI 10.1128/AEM.01661-10; Barak JD, 2009, MICROBIOL-SGM, V155, P3701, DOI 10.1099/mic.0.032029-0; BEHLAU I, 1993, J BACTERIOL, V175, P4475, DOI 10.1128/JB.175.14.4475-4484.1993; BERGER CN, 2011, ENV MICROBIOL; Boureau T, 2002, MOL PLANT PATHOL, V3, P451, DOI 10.1046/j.1364-3703.2002.00139.x; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Collazo CM, 1997, GENE, V192, P51, DOI 10.1016/S0378-1119(96)00825-6; Craig A, 2009, J EXP BOT, V60, P1123, DOI 10.1093/jxb/erp059; Crowe ML, 2003, NUCLEIC ACIDS RES, V31, P156, DOI 10.1093/nar/gkg071; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dong YM, 2003, APPL ENVIRON MICROB, V69, P1783, DOI 10.1128/AEM.69.3.1783-1790.2003; Fisher IST, 2005, EPIDEMIOL INFECT, V133, P1, DOI 10.1017/S095026880400305X; GALAN JE, 1992, J BACTERIOL, V174, P4338; Golberg D, 2011, INT J FOOD MICROBIOL, V145, P250, DOI 10.1016/j.ijfoodmicro.2010.12.031; Haapalainen M, 2009, MOL PLANT MICROBE IN, V22, P282, DOI 10.1094/MPMI-22-3-0282; Hensel M, 2000, MOL MICROBIOL, V36, P1015, DOI 10.1046/j.1365-2958.2000.01935.x; Hensel M, 1997, MOL MICROBIOL, V24, P155, DOI 10.1046/j.1365-2958.1997.3271699.x; Holden N, 2009, FEMS MICROBIOL REV, V33, P689, DOI 10.1111/j.1574-6976.2008.00153.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iniguez AL, 2005, MOL PLANT MICROBE IN, V18, P169, DOI 10.1094/MPMI-18-0169; Klerks MM, 2007, ISME J, V1, P620, DOI 10.1038/ismej.2007.82; Kroupitski Y, 2009, APPL ENVIRON MICROB, V75, P6076, DOI 10.1128/AEM.01084-09; Kubori T, 2000, P NATL ACAD SCI USA, V97, P10225, DOI 10.1073/pnas.170128997; Kuhle V, 2004, CELL MOL LIFE SCI, V61, P2812, DOI 10.1007/s00018-004-4248-z; Lang MM, 2004, J FOOD PROTECT, V67, P1092, DOI 10.4315/0362-028X-67.6.1092; Lara-Tejero M, 2009, INFECT IMMUN, V77, P2635, DOI 10.1128/IAI.00077-09; Li J, 2009, P NATL ACAD SCI USA, V106, P15973, DOI 10.1073/pnas.0905532106; Lu DP, 2008, MOL GENET GENOMICS, V280, P199, DOI 10.1007/s00438-008-0356-z; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Marlovits TC, 2006, NATURE, V441, P637, DOI 10.1038/nature04822; McGhie EJ, 2009, CURR OPIN MICROBIOL, V12, P117, DOI 10.1016/j.mib.2008.12.001; Milillo SR, 2008, FOOD MICROBIOL, V25, P698, DOI 10.1016/j.fm.2008.03.003; Murray SL, 2007, MOL PLANT MICROBE IN, V20, P1431, DOI 10.1094/MPMI-20-11-1431; Patel JC, 2005, TRENDS PHARMACOL SCI, V26, P564, DOI 10.1016/j.tips.2005.09.005; Prithiviraj B, 2005, PLANT J, V42, P417, DOI 10.1111/j.1365-313X.2005.02385.x; Prithiviraj B, 2005, CELL MICROBIOL, V7, P315, DOI 10.1111/j.1462-5822.2005.00494.x; Rangel JM, 2005, EMERG INFECT DIS, V11, P603, DOI 10.3201/eid1104.040739; Saggers EJ, 2008, J APPL MICROBIOL, V105, P1239, DOI 10.1111/j.1365-2672.2008.03795.x; Schikora A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002279; SCHIKORA M, 2010, 5 IEEE ISIF WORKSH S; Sclep G, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-400; Shirron N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018855; Takeuchi K, 2000, J FOOD PROTECT, V63, P1433, DOI 10.4315/0362-028X-63.10.1433; Thilmony R, 2006, PLANT J, V46, P34, DOI 10.1111/j.1365-313X.2006.02725.x; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Wang D, 2005, SCIENCE, V308, P1036, DOI 10.1126/science.1108791; Waterman SR, 2003, CELL MICROBIOL, V5, P501, DOI 10.1046/j.1462-5822.2003.00294.x; Xu XP, 2006, PLANT CELL, V18, P1310, DOI 10.1105/tpc.105.037523	52	90	91	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2011	6	9							e24112	10.1371/journal.pone.0024112	http://dx.doi.org/10.1371/journal.pone.0024112			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817QP	21915285	Green Published, gold			2022-12-25	WOS:000294689200021
J	Duran-Prado, M; Gahete, MD; Hergueta-Redondo, M; Martinez-Fuentes, AJ; Cordoba-Chacon, J; Palacios, J; Gracia-Navarro, F; Moreno-Bueno, G; Malagon, MM; Luque, RM; Castano, JP				Duran-Prado, M.; Gahete, M. D.; Hergueta-Redondo, M.; Martinez-Fuentes, A. J.; Cordoba-Chacon, J.; Palacios, J.; Gracia-Navarro, F.; Moreno-Bueno, G.; Malagon, M. M.; Luque, R. M.; Castano, J. P.			The new truncated somatostatin receptor variant sst5TMD4 is associated to poor prognosis in breast cancer and increases malignancy in MCF-7 cells	ONCOGENE			English	Article						somatostatin receptors; sst5TMD4; sst2; breast cancer; poor prognosis	PROTEIN MAP KINASE; SUBTYPE 2; PATHWAY; ACTIVATION; ANALOG; PHOSPHORYLATION; GROWTH; AKT; INHIBITION; EXPRESSION	Somatostatin receptors (sst1-5) are present in different types of tumors, where they inhibit key cellular processes such as proliferation and invasion. Although ssts are densely expressed in breast cancer, especially sst2, their role and therapeutic potential remain uncertain. Recently, we identified a new truncated sst5 variant, sst5TMD4, which is related to the abnormal response of certain pituitary tumors to treatment with somatostatin analogs. Here, we investigated the possible role of sst5TMD4 in breast cancer. This study revealed that sst5TMD4 is absent in normal mammary gland, but is abundant in a subset of poorly differentiated human breast tumors, where its expression correlated to that of sst2. Moreover, in the MCF-7 breast cancer model cell, sst5TMD4 expression increased malignancy features such as invasion and proliferation abilities (both in cell cultures and nude mice). This was likely mediated by sst5TMD4-induced increase in phosphorylated extracellular signal-regulated kinases 1 and 2 and p-Akt levels, and cyclin D3 and Arp2/3 complex expression, which also led to mesenchymal-like phenotype. Interestingly, sst5TMD4 interacts physically with sst2 and thereby alters its signaling, enabling disruption of sst2 inhibitory feedback and providing a plausible basis for our findings. These results suggest that sst5TMD4 could be involved in the pathophysiology of certain types of breast tumors. Oncogene (2012) 31, 2049-2061; doi: 10.1038/onc.2011.389; published online 19 September 2011	[Duran-Prado, M.; Gahete, M. D.; Martinez-Fuentes, A. J.; Cordoba-Chacon, J.; Gracia-Navarro, F.; Malagon, M. M.; Luque, R. M.; Castano, J. P.] Univ Cordoba, Dept Cell Biol Physiol & Immunol, Reina Sofia Univ Hosp, Inst Maimonides Invest Biomed Cordoba IMIBIC, Cordoba 14014, Spain; [Duran-Prado, M.; Gahete, M. D.; Martinez-Fuentes, A. J.; Cordoba-Chacon, J.; Gracia-Navarro, F.; Malagon, M. M.; Luque, R. M.; Castano, J. P.] CIBER Fisiopatol Obesidad & Nutr CIBERobn, Cordoba, Spain; [Hergueta-Redondo, M.; Moreno-Bueno, G.] UAM, Inst Invest Biomed Alberto Sols, CSIC UAM, IdiPAZ Inst Invest Sanitaria La Paz,Dept Bioquim, Madrid, Spain; [Hergueta-Redondo, M.; Moreno-Bueno, G.] Fdn MD Anderson Int, Madrid, Spain; [Palacios, J.] Hosp Univ Virgen del Rocio, Inst Biomed Sevilla IBIS, Serv Anat Patol, Seville, Spain	Universidad de Cordoba; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); University of Texas System; UTMD Anderson Cancer Center; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital	Castano, JP (corresponding author), Univ Cordoba, Dept Cell Biol Physiol & Immunol, Edificio Severo Ochoa,Planta 3,Campus Rabanales, Cordoba 14014, Spain.	justo@uco.es	Romo, José A./J-3024-2012; Gahete, Manuel D./C-4969-2009; Palacios, Jose/AAV-3765-2020; duran-prado, mario/M-6545-2014; Martinez-Fuentes, Antonio J/F-8198-2016; Moreno-Bueno, Gema/K-9354-2016; Raul, Luque Huertas/M-6948-2018; Cordoba-Chacon, Jose/AAH-5753-2019; Castaño, Justo P/A-7124-2010; Malagon, Maria M/L-5386-2014	Romo, José A./0000-0003-2907-580X; Gahete, Manuel D./0000-0002-4578-2179; duran-prado, mario/0000-0001-9652-5765; Moreno-Bueno, Gema/0000-0002-5030-6687; Cordoba-Chacon, Jose/0000-0001-8787-2706; Castaño, Justo P/0000-0002-3145-7287; Malagon, Maria M/0000-0002-2419-2727; Gracia Navarro, Francisco/0000-0003-2128-4228; Luque, Raul M./0000-0002-7585-1913	IPSEN;  [BIO-0139];  [CTS-01705];  [CTS-5051];  [BFU2004-03883];  [BFU2007-60180/BFI];  [BFU2008-01136-BFI];  [BFU2010-19300];  [FPU-AP20052473];  [FI06-00804];  [SAF2007-63075];  [SAF2007-63075/FMM07];  [SAF2010-201075];  [CD07/00246];  [RYC-2007-00186]	IPSEN(Ipsen); ; ; ; ; ; ; ; ; ; ; ; ; ; 	This work was supported by BIO-0139, CTS-01705, CTS-5051, BFU2004-03883, BFU2007-60180/BFI, BFU2008-01136-BFI, BFU2010-19300, FPU-AP20052473, FI06-00804, SAF2007-63075, SAF2007-63075/FMM07, SAF2010-201075, CD07/00246, RYC-2007-00186 and IPSEN. Ciber is an initiative of the Instituto de Salud Carlos III.	Ben-Shlomo A, 2010, TRENDS ENDOCRIN MET, V21, P123, DOI 10.1016/j.tem.2009.12.003; Benali N, 2000, P NATL ACAD SCI USA, V97, P9180, DOI 10.1073/pnas.130196697; Charland S, 2001, ENDOCRINOLOGY, V142, P121, DOI 10.1210/en.142.1.121; Cordoba-Chacon J, 2010, CELL MOL LIFE SCI, V67, P1147, DOI 10.1007/s00018-009-0240-y; Donovan JCH, 2001, J BIOL CHEM, V276, P40888, DOI 10.1074/jbc.M106448200; Duran-Prado M, 2007, ENDOCRINOLOGY, V148, P411, DOI 10.1210/en.2006-0920; Duran-Prado M, 2010, J CLIN ENDOCR METAB, V95, P2497, DOI 10.1210/jc.2009-2247; Duran-Prado M, 2009, J CLIN ENDOCR METAB, V94, P2634, DOI 10.1210/jc.2008-2564; Eralp Y, 2008, ANN ONCOL, V19, P669, DOI 10.1093/annonc/mdm522; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; He Y, 2009, ACTA PHARMACOL SIN, V30, P1053, DOI 10.1038/aps.2009.59; Hubina E, 2006, EUR J ENDOCRINOL, V155, P371, DOI 10.1530/eje.1.02213; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kahan Z, 1999, INT J CANCER, V82, P592, DOI 10.1002/(SICI)1097-0215(19990812)82:4<592::AID-IJC20>3.0.CO;2-0; Keri G, 1996, P NATL ACAD SCI USA, V93, P12513, DOI 10.1073/pnas.93.22.12513; Lee JF, 2006, HISTOCHEM CELL BIOL, V126, P297, DOI 10.1007/s00418-006-0143-z; Leu FP, 2008, MOL CANCER RES, V6, P1029, DOI 10.1158/1541-7786.MCR-07-2073; Liu W, 2007, FRONT BIOSCI-LANDMRK, V12, P4011, DOI 10.2741/2367; Moller LN, 2003, BBA-BIOMEMBRANES, V1616, P1, DOI 10.1016/S0005-2736(03)00235-9; Moreno-Bueno G, 2011, EMBO MOL MED, V3, P528, DOI 10.1002/emmm.201100156; Nakanishi O, 2007, J BIOCHEM, V141, P319, DOI 10.1093/jb/mvm034; Orlando C, 2004, ENDOCR-RELAT CANCER, V11, P323, DOI 10.1677/erc.0.0110323; Perez-Tenorio G, 2002, BRIT J CANCER, V86, P540, DOI 10.1038/sj.bjc.6600126; Pola S, 2003, J BIOL CHEM, V278, P40601, DOI 10.1074/jbc.M306510200; PREVOST G, 1993, EUR J CANCER, V29A, P1589, DOI 10.1016/0959-8049(93)90300-5; Rinke A, 2009, J CLIN ONCOL, V27, P4656, DOI 10.1200/JCO.2009.22.8510; Rommel C, 1999, SCIENCE, V286, P1738, DOI 10.1126/science.286.5445.1738; Santen RJ, 2002, J STEROID BIOCHEM, V80, P239, DOI 10.1016/S0960-0760(01)00189-3; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Sawai H, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-37; Schulz S, 1998, CLIN CANCER RES, V4, P2047; SETYONOHAN B, 1987, CANCER RES, V47, P1566; Sun LC, 2007, CANCER LETT, V246, P157, DOI 10.1016/j.canlet.2006.02.016; Umemura S, 2007, CANCER SCI, V98, P1889, DOI 10.1111/j.1349-7006.2007.00622.x; VANEIJCK CHJ, 1994, LANCET, V343, P640, DOI 10.1016/S0140-6736(94)92637-9; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wang WG, 2005, TRENDS CELL BIOL, V15, P138, DOI 10.1016/j.tcb.2005.01.003; Watt HL, 2008, MOL CELL ENDOCRINOL, V286, P251, DOI 10.1016/j.mce.2008.01.006; Xu Y, 1996, ENDOCRINOLOGY, V137, P5634, DOI 10.1210/en.137.12.5634; Yamaguchi H, 2005, J CELL BIOL, V168, P441, DOI 10.1083/jcb.200407076; Zimmermann S, 1999, SCIENCE, V286, P1741, DOI 10.1126/science.286.5445.1741	41	57	57	0	11	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2012	31	16					2049	2061		10.1038/onc.2011.389	http://dx.doi.org/10.1038/onc.2011.389			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	928TP	21927030				2022-12-25	WOS:000303008600006
J	Ponts, N; Saraf, A; Chung, DWD; Harris, A; Prudhomme, J; Washburn, MP; Florens, L; Le Roch, KG				Ponts, Nadia; Saraf, Anita; Chung, Duk-Won D.; Harris, Alona; Prudhomme, Jacques; Washburn, Michael P.; Florens, Laurence; Le Roch, Karine G.			Unraveling the Ubiquitome of the Human Malaria Parasite	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMODIUM-FALCIPARUM; UBIQUITINATED PROTEINS; FOOD VACUOLE; IDENTIFICATION; GENE; PLASMEPSINS; REVEALS; COMPLEX; PURIFICATION; QUANTITATION	Malaria is one of the deadliest infectious diseases worldwide. The most severe form is caused by the eukaryotic protozoan parasite Plasmodium falciparum. Recent studies have highlighted the importance of post-translational regulations for the parasite's progression throughout its life cycle, protein ubiquitylation being certainly one of the most abundant. The specificity of its components and the wide range of biological processes in which it is involved make the ubiquitylation pathway a promising source of suitable targets for anti-malarial drug development. Here, we combined immunofluorescent microscopy, biochemical assays, in silico prediction, and mass spectrometry analysis using the multidimensional protein identification technology, or MudPIT, to describe the P. falciparum ubiquitome. We found that ubiquitin conjugates are detected at every morphological stage of the parasite erythrocytic cycle. Furthermore, we detected that more than half of the parasite's proteome represents possible targets for ubiquitylation, especially proteins found to be present at the most replicative stage of the asexual cycle, the trophozoite stage. A large proportion of ubiquitin conjugates were also detected at the schizont stage, consistent with a cell activity slowdown to prepare for merozoite differentiation and invasion. Finally, for the first time in the human malaria parasite, our results strongly indicate the presence of heterologous mixed conjugations, SUMO/UB. This discovery suggests that sumoylated proteins may be regulated by ubiquitylation in P. falciparum. Altogether, our results present the first stepping stone toward a better understanding of ubiquitylation and its role(s) in the biology of the human malaria parasite.	[Ponts, Nadia; Chung, Duk-Won D.; Harris, Alona; Prudhomme, Jacques; Le Roch, Karine G.] Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA; [Saraf, Anita; Washburn, Michael P.; Florens, Laurence] Stowers Inst Med Res, Kansas City, MO 64110 USA	University of California System; University of California Riverside; Stowers Institute for Medical Research	Le Roch, KG (corresponding author), Univ Calif Riverside, Dept Cell Biol & Neurosci, 900 Univ Ave, Riverside, CA 92521 USA.	karine.leroch@ucr.edu		Washburn, Michael/0000-0001-7568-2585; Florens, Laurence/0000-0002-9310-6650	University of California, Riverside; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI085077] Funding Source: NIH RePORTER	University of California, Riverside(University of California System); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by University of California, Riverside, start-up funds (to K. L. R.).	Banerjee R, 2003, MOL BIOCHEM PARASIT, V129, P157, DOI 10.1016/S0166-6851(03)00119-1; Banerjee R, 2002, P NATL ACAD SCI USA, V99, P990, DOI 10.1073/pnas.022630099; Berkers CR, 2010, BIOCHEM SOC T, V38, P14, DOI 10.1042/BST0380014; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chung DWD, 2009, MOL BIOCHEM PARASIT, V168, P123, DOI 10.1016/j.molbiopara.2009.08.001; D'Alessandro A, 2010, J PROTEOME RES, V9, P144, DOI 10.1021/pr900831f; Daulny A, 2009, DNA REPAIR, V8, P444, DOI 10.1016/j.dnarep.2009.01.017; Edelmann MJ, 2008, BBA-MOL BASIS DIS, V1782, P809, DOI 10.1016/j.bbadis.2008.08.010; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; FIELD SJ, 1993, CELL MOTIL CYTOSKEL, V25, P43, DOI 10.1002/cm.970250106; Foth BJ, 2003, SCIENCE, V299, P705, DOI 10.1126/science.1078599; Francis SE, 1997, ANNU REV MICROBIOL, V51, P97, DOI 10.1146/annurev.micro.51.1.97; Francis SE, 1997, J BIOL CHEM, V272, P14961, DOI 10.1074/jbc.272.23.14961; Golebiowski F, 2010, NAT PROTOC, V5, P873, DOI 10.1038/nprot.2010.40; Goodman SR, 2007, EXP BIOL MED, V232, P1391, DOI 10.3181/0706-MR-156; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Hjerpe R, 2009, EMBO REP, V10, P1250, DOI 10.1038/embor.2009.192; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Issar N, 2008, CELL MICROBIOL, V10, P1999, DOI 10.1111/j.1462-5822.2008.01183.x; Kirkpatrick DS, 2005, NAT CELL BIOL, V7, P750, DOI 10.1038/ncb0805-750; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Le Roch KG, 2004, GENOME RES, V14, P2308, DOI 10.1101/gr.2523904; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Lindenthal C, 2005, PARASITOLOGY, V131, P37, DOI 10.1017/S003118200500747X; Manzano C, 2008, PLANT MOL BIOL, V68, P145, DOI 10.1007/s11103-008-9358-9; Marti M, 2005, J CELL BIOL, V171, P587, DOI 10.1083/jcb.200508051; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Matsumoto M, 2005, PROTEOMICS, V5, P4145, DOI 10.1002/pmic.200401280; Matsumoto ML, 2010, MOL CELL, V39, P477, DOI 10.1016/j.molcel.2010.07.001; McDonald WH, 2004, RAPID COMMUN MASS SP, V18, P2162, DOI 10.1002/rcm.1603; McDonald WH, 2002, INT J MASS SPECTROM, V219, P245, DOI 10.1016/S1387-3806(02)00563-8; McFadden G. I, 2011, PROTOPLASMA IN PRESS; Pavelka N, 2008, MOL CELL PROTEOMICS, V7, P631, DOI 10.1074/mcp.M700240-MCP200; Petroski MD, 2008, BMC BIOCHEM, V9, DOI 10.1186/1471-2091-9-S1-S7; Ponder EL, 2007, EUKARYOT CELL, V6, P1943, DOI 10.1128/EC.00282-07; Ponts N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002386; Prudhomme J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002335; Qin F, 2008, PLANT CELL, V20, P1693, DOI 10.1105/tpc.107.057380; Radivojac P, 2010, PROTEINS, V78, P365, DOI 10.1002/prot.22555; Reynolds Jennifer M, 2007, BMC Clin Pharmacol, V7, P13, DOI 10.1186/1472-6904-7-13; Sommer MS, 2007, MOL BIOL EVOL, V24, P918, DOI 10.1093/molbev/msm008; Spallek T, 2009, CELL MICROBIOL, V11, P1425, DOI 10.1111/j.1462-5822.2009.01346.x; Spence J, 2000, CELL, V102, P67, DOI 10.1016/S0092-8674(00)00011-8; Spork S, 2009, EUKARYOT CELL, V8, P1134, DOI 10.1128/EC.00083-09; Svejstrup JQ, 2007, TRENDS BIOCHEM SCI, V32, P165, DOI 10.1016/j.tibs.2007.02.005; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Tan FW, 2008, PROTEOMICS, V8, P2885, DOI 10.1002/pmic.200700887; Tomlinson E, 2007, PROTEOMICS, V7, P1016, DOI 10.1002/pmic.200601008; Tonkin CJ, 2008, P NATL ACAD SCI USA, V105, P4781, DOI 10.1073/pnas.0707827105; Tonkin CJ, 2004, MOL BIOCHEM PARASIT, V137, P13, DOI 10.1016/j.molbiopara.2004.05.009; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Trelle MB, 2009, J PROTEOME RES, V8, P3439, DOI 10.1021/pr9000898; Tung J, 2009, NATURE, V460, P388, DOI 10.1038/nature08149; Venable JD, 2004, NAT METHODS, V1, P39, DOI 10.1038/NMETH705; Weake VM, 2008, MOL CELL, V29, P653, DOI 10.1016/j.molcel.2008.02.014; Xiang Y, 2007, PLOS BIOL, V5, P2831, DOI 10.1371/journal.pbio.0050323; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Zhang Y, 2010, ANAL CHEM, V82, P2272, DOI 10.1021/ac9023999	60	52	53	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40320	40330		10.1074/jbc.M111.238790	http://dx.doi.org/10.1074/jbc.M111.238790			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21930698	hybrid, Green Published			2022-12-25	WOS:000296925700063
J	Chruszcz, M; Maleki, SJ; Majorek, KA; Demas, M; Bublin, M; Solberg, R; Hurlburt, BK; Ruan, SB; Mattisohn, CP; Breiteneder, H; Minor, W				Chruszcz, Maksymilian; Maleki, Soheila J.; Majorek, Karolina A.; Demas, Matthew; Bublin, Merima; Solberg, Robert; Hurlburt, Barry K.; Ruan, Sanbao; Mattisohn, Christopher P.; Breiteneder, Heimo; Minor, Wladek			Structural and Immunologic Characterization of Ara h 1, a Major Peanut Allergen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IGE-BINDING EPITOPES; X-RAY-DIFFRACTION; MACROMOLECULAR STRUCTURES; STRUCTURE VALIDATION; MOLECULAR-WEIGHT; NATURAL-HISTORY; PSI-BLAST; IN-VITRO; PROTEIN; SCATTERING	Allergic reactions to peanuts and tree nuts are major causes of anaphylaxis in the United States. We compare different properties of natural and recombinant versions of Ara h 1, a major peanut allergen, through structural, immunologic, and bioinformatics analyses. Small angle x-ray scattering studies show that natural Ara h 1 forms higher molecular weight aggregates in solution. In contrast, the full-length recombinant protein is partially unfolded and exists as a monomer. The crystal structure of the Ara h 1 core (residues 170-586) shows that the central part of the allergen has a bicupin fold, which is in agreement with our bioinformatics analysis. In its crystalline state, the core region of Ara h 1 forms trimeric assemblies, while in solution the protein exists as higher molecular weight assemblies. This finding reveals that the residues forming the core region of the protein are sufficient for formation of Ara h 1 trimers and higher order oligomers. Natural and recombinant variants of proteins tested in in vitro gastric and duodenal digestion assays show that the natural protein is the most stable form, followed by the recombinant Ara h 1 core fragment and the full-length recombinant protein. Additionally, IgE binding studies reveal that the natural and recombinant allergens have different patterns of interaction with IgE antibodies. The molecular basis of cross-reactivity between vicilin allergens is also elucidated.	[Chruszcz, Maksymilian; Majorek, Karolina A.; Demas, Matthew; Solberg, Robert; Minor, Wladek] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; [Maleki, Soheila J.; Hurlburt, Barry K.; Ruan, Sanbao; Mattisohn, Christopher P.] ARS, So Reg Res Ctr, USDA, New Orleans, LA 70124 USA; [Bublin, Merima; Breiteneder, Heimo] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Dept Pathophysiol & Allergy Res, A-1090 Vienna, Austria	University of Virginia; United States Department of Agriculture (USDA); Medical University of Vienna	Chruszcz, M (corresponding author), Univ Virginia, Dept Mol Physiol & Biol Phys, 1340 Jefferson Pk Ave, Charlottesville, VA 22908 USA.	maks@iwonka.med.virginia.edu; wladek@iwonka.med.virginia.edu	Chruszcz, Maksymilian/E-6407-2011; Minor, Wladek/F-3096-2014	Chruszcz, Maksymilian/0000-0001-7521-5485; Minor, Wladek/0000-0001-7075-7090; Bublin, Merima/0000-0002-7191-9431	Austrian Research Promotion Agency (FFG) [820127]; US Dept. of Agriculture-Agricultural Research Service; New York Structural Genomics Consortium [GM094662]; U.S. Dept. of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357];  [GM53163]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053163, U54GM094662] Funding Source: NIH RePORTER	Austrian Research Promotion Agency (FFG); US Dept. of Agriculture-Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); New York Structural Genomics Consortium; U.S. Dept. of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Grant GM53163, the Austrian Research Promotion Agency (FFG) BRIDGE Grant 820127, and the US Dept. of Agriculture-Agricultural Research Service.; We thank Steve Almo and Alexander Wlodawer for valuable comments on the manuscript and Michal Sabat for help with SAXS experiments. Some of the methodology used in this publication was developed for the New York Structural Genomics Consortium supported by Grant GM094662. The structural results shown in this report are derived from work performed at Argonne National Laboratory, at the Structural Biology Center of the Advanced Photon Source. Argonne is operated by University of Chicago Argonne, LLC, for the U.S. Dept. of Energy, Office of Biological and Environmental Research under Contract DE-AC02-06CH11357.	Agarwal G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005736; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Altschul SF, 1998, TRENDS BIOCHEM SCI, V23, P444, DOI 10.1016/S0968-0004(98)01298-5; Anand R, 2002, BIOCHEMISTRY-US, V41, P7659, DOI 10.1021/bi0200965; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barre A, 2005, BIOCHIMIE, V87, P499, DOI 10.1016/j.biochi.2005.02.011; Barre A, 2008, MOL IMMUNOL, V45, P1231, DOI 10.1016/j.molimm.2007.09.014; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Burks AW, 1997, EUR J BIOCHEM, V245, P334, DOI 10.1111/j.1432-1033.1997.t01-1-00334.x; BURKS AW, 1995, J CLIN INVEST, V96, P1715, DOI 10.1172/JCI118216; Cabanos C, 2010, ACTA CRYSTALLOGR F, V66, P1071, DOI 10.1107/S1744309110029040; Chung SY, 2007, J AGR FOOD CHEM, V55, P9054, DOI 10.1021/jf071213b; Cong YJ, 2008, FOOD AGR IMMUNOL, V19, P175, DOI 10.1080/09540100802172599; Cymborowski M., 2010, Journal of Structural and Functional Genomics, V11, P211, DOI 10.1007/s10969-010-9092-9; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; de Leon Maria P., 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S1462399407000208; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dooper MMBW, 2009, J INVEST ALLERG CLIN, V19, P283; Dunwell JM, 2004, PHYTOCHEMISTRY, V65, P7, DOI 10.1016/j.phytochem.2003.08.016; Dunwell JM, 2001, TRENDS BIOCHEM SCI, V26, P740, DOI 10.1016/S0968-0004(01)01981-8; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076; Fleischer DM, 2007, CURR ALLERGY ASTHM R, V7, P175, DOI 10.1007/s11882-007-0018-y; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Keet CA, 2007, IMMUNOL ALLERGY CLIN, V27, P193, DOI 10.1016/j.iac.2007.03.005; Khodoun M, 2009, J ALLERGY CLIN IMMUN, V123, P342, DOI 10.1016/j.jaci.2008.11.004; Kolarich D, 2000, ANAL BIOCHEM, V285, P64, DOI 10.1006/abio.2000.4737; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Koppelman SJ, 1999, J BIOL CHEM, V274, P4770, DOI 10.1074/jbc.274.8.4770; Koppelman SJ, 2010, MOL NUTR FOOD RES, V54, P1711, DOI 10.1002/mnfr.201000011; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pW89, DOI 10.1093/nar/gki414; Li JX, 2010, PROTEIN SCI, V19, P174, DOI 10.1002/pro.295; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Maleki SJ, 2000, J IMMUNOL, V164, P5844, DOI 10.4049/jimmunol.164.11.5844; Mills ENC, 2002, BIOCHEM SOC T, V30, P925, DOI 10.1042/BST0300925; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Mondoulet L, 2005, J AGR FOOD CHEM, V53, P4547, DOI 10.1021/jf050091p; Moreno FJ, 2005, FEBS J, V272, P341, DOI 10.1111/j.1742-4658.2004.04472.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neugut AI, 2001, ARCH INTERN MED, V161, P15, DOI 10.1001/archinte.161.1.15; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Rosenbaum G, 2006, J SYNCHROTRON RADIAT, V13, P30, DOI 10.1107/S0909049505036721; Schmitt DA, 2010, J AGR FOOD CHEM, V58, P1138, DOI 10.1021/jf902694j; Shin DS, 1998, J BIOL CHEM, V273, P13753, DOI 10.1074/jbc.273.22.13753; Shinmoto Hiroshi, 2010, Human Antibodies, V19, P101, DOI 10.3233/HAB-2010-0233; Sicherer SH, 2007, J ALLERGY CLIN IMMUN, V120, P491, DOI 10.1016/j.jaci.2007.07.015; Skolnick HS, 2001, J ALLERGY CLIN IMMUN, V107, P367, DOI 10.1067/mai.2001.112129; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Teuber SS, 2004, CURR OPIN ALLERGY CL, V4, P201, DOI 10.1097/01.all.0000129451.19469.e2; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; van Boxtel EL, 2008, J AGR FOOD CHEM, V56, P2223, DOI 10.1021/jf072907n; van Boxtel EL, 2007, J AGR FOOD CHEM, V55, P8772, DOI 10.1021/jf071585k; Van Boxtel EL, 2006, J AGR FOOD CHEM, V54, P7180, DOI 10.1021/jf061433+; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wensing M, 2003, J ALLERGY CLIN IMMUN, V111, P420, DOI 10.1067/mai.2003.61; Willison LN, 2008, CLIN EXP ALLERGY, V38, P1229, DOI 10.1111/j.1365-2222.2008.02998.x; Yang HW, 2004, ACTA CRYSTALLOGR D, V60, P1833, DOI 10.1107/S0907444904019419; Zimmerman M, 2005, ACTA CRYSTALLOGR A, V61, pC178, DOI 10.1107/S0108767305092391	67	73	83	3	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39318	39327		10.1074/jbc.M111.270132	http://dx.doi.org/10.1074/jbc.M111.270132			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21917921	hybrid, Green Published			2022-12-25	WOS:000296759800050
J	Karena, E; Frillingos, S				Karena, Ekaterini; Frillingos, Stathis			The Role of Transmembrane Segment TM3 in the Xanthine Permease XanQ of Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-SCANNING ANALYSIS; TRANSPORTER SIGNATURE MOTIF; FUNCTIONAL-CHARACTERIZATION; SUBSTRATE RECOGNITION; PURINE TRANSPORTERS; NAT/NCS2 FAMILY; BACTERIAL; SPECIFICITY; MECHANISM; PLASMIDS	The xanthine permease XanQ of Escherichia coli is used as a study prototype for function-structure analysis of the ubiquitous nucleobase-ascorbate transporter (NAT/NCS2) family. Our previous mutagenesis study of polar residues of XanQ has shown that Asn-93 at the middle of putative TM3 is a determinant of substrate affinity and specificity. To study the role of TM3 in detail we employed Cys-scanning mutagenesis. Using a functional mutant devoid of Cys residues (C-less), each amino acid residue in sequence 79-107 (YGIVGSGLL-SIQSVNFSFVTVMIALGSSM) including TM3 (underlined) and flanking sequences was replaced individually with Cys. Of 29 single-Cys mutants, 20 accumulate xanthine to 40-110% of the steady state observed with C-less, six (S88C, F94C, A102C, G104C, S106C) accumulate to low levels (10-30%) and three (G83C, G85C, N93C) are inactive. Extensive mutagenesis reveals that Gly-83 and, to a lesser extent, Gly-85, are crucial for expression in the membrane. Replacements of Asn-93 disrupt affinity (Thr) or permit recognition of 8-methylxanthine which is not a wild-type ligand (Ala, Ser, Asp) and utilization of uric acid which is not a wild-type substrate (Ala, Ser). Replacements of Phe-94 impair affinity for 2-thio and 6-thioxanthine (Tyr) or 3-methylxanthine (Ile). Single-Cys mutants S84C, L86C, L87C, and S95C are highly sensitive to inactivation by N-ethylmaleimide. Our data reveal that key residues of TM3 cluster in two conserved sequence motifs, 83GSGLL87 and 93NFS95, and highlight the importance of Asn-93 and Phe-94 in substrate recognition and specificity; these findings are supported by structural modeling on the recently described x-ray structure of the uracil- transporting homolog UraA.	[Karena, Ekaterini; Frillingos, Stathis] Univ Ioannina, Sch Med, Biol Chem Lab, GR-45110 Ioannina, Greece	University of Ioannina	Frillingos, S (corresponding author), Univ Ioannina, Sch Med, Biol Chem Lab, GR-45110 Ioannina, Greece.	efriligo@cc.uoi.gr	Frillingos, Stathis/AAQ-3148-2021		European Union; European Social Fund (ESF); National Sources; Hellenic Ministry of Education, Lifelong Learning and Religious Affairs	European Union(European Commission); European Social Fund (ESF)(European Social Fund (ESF)); National Sources; Hellenic Ministry of Education, Lifelong Learning and Religious Affairs	This report is part of a research project co-funded by the European Union, European Social Fund (ESF) and National Sources, in the framework of program "Hraklitos II" through the Operational Program "Education and Lifelong Learning" of the Hellenic Ministry of Education, Lifelong Learning and Religious Affairs, in the context of the National Strategic Reference Framework (NSRF).	Amillis S, 2011, J MOL BIOL, V411, P567, DOI 10.1016/j.jmb.2011.06.024; Diallinas G, 1998, EMBO J, V17, P3827, DOI 10.1093/emboj/17.14.3827; Georgopoulou E, 2010, J BIOL CHEM, V285, P19422, DOI 10.1074/jbc.M110.120543; Goudela S, 2005, MOL MEMBR BIOL, V22, P263, DOI 10.1080/09687860500093016; Granseth E, 2005, J MOL BIOL, V352, P489, DOI 10.1016/j.jmb.2005.07.053; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Jiang XX, 2011, BIOCHEMISTRY-US, V50, P1634, DOI 10.1021/bi101988s; Kaback HR, 2007, P NATL ACAD SCI USA, V104, P491, DOI 10.1073/pnas.0609968104; Karatza P, 2005, MOL MEMBR BIOL, V22, P251, DOI 10.1080/09687860500092927; Karatza P, 2006, J BIOL CHEM, V281, P39881, DOI 10.1074/jbc.M605748200; Karena E, 2009, J BIOL CHEM, V284, P24257, DOI 10.1074/jbc.M109.030734; Kosti V, 2010, J MOL BIOL, V397, P1132, DOI 10.1016/j.jmb.2010.02.037; Koukaki M, 2005, J MOL BIOL, V350, P499, DOI 10.1016/j.jmb.2005.04.076; Lu FR, 2011, NATURE, V472, P243, DOI 10.1038/nature09885; Mermelekas G, 2010, J BIOL CHEM, V285, P35011, DOI 10.1074/jbc.M110.170415; Papageorgiou L, 2008, J MOL BIOL, V382, P1121, DOI 10.1016/j.jmb.2008.08.005; Papakostas K, 2008, J BIOL CHEM, V283, P13666, DOI 10.1074/jbc.M800261200; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Tavoulari S, 2008, J MOL BIOL, V376, P681, DOI 10.1016/j.jmb.2007.12.015; TEATHER RM, 1980, EUR J BIOCHEM, V108, P223, DOI 10.1111/j.1432-1033.1980.tb04715.x; Tsukaguchi H, 1999, NATURE, V399, P70, DOI 10.1038/19986; Yamamoto S, 2010, J BIOL CHEM, V285, P6522, DOI 10.1074/jbc.M109.032961	23	19	19	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39595	39605		10.1074/jbc.M111.299164	http://dx.doi.org/10.1074/jbc.M111.299164			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21917919	hybrid, Green Published			2022-12-25	WOS:000296759800076
J	Schrader, EK; Harstad, KG; Holmgren, RA; Matouschek, A				Schrader, Erin K.; Harstad, Kristine G.; Holmgren, Robert A.; Matouschek, Andreas			A Three-part Signal Governs Differential Processing of Gli1 and Gli3 Proteins by the Proteasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; GLYCINE-RICH REGION; SCF-BETA-TRCP; CUBITUS-INTERRUPTUS; TRANSCRIPTION FACTOR; DEGRADATION SIGNAL; UBIQUITIN LIGASE; VERTEBRATE LIMB; P50 SUBUNIT; KINASE-A	The Gli proteins are the transcriptional effectors of the mammalian Hedgehog signaling pathway. In an unusual mechanism, the proteasome partially degrades or processes Gli3 in the absence of Hedgehog pathway stimulation to create a Gli3 fragment that opposes the activity of the full-length protein. In contrast, Gli1 is not processed but degraded completely, despite considerable homology with Gli3. We found that these differences in processing can be described by defining a processing signal that is composed of three parts: the zinc finger domain, an adjacent linker sequence, and a degron. Gli3 processing is inhibited when any one component of the processing signal is disrupted. We show that the zinc fingers are required for processing only as a folded structure and that the location but not the identity of the processing degron is critical. Within the linker sequence, regions of low sequence complexity play a crucial role, but other sequence features are also important. Gli1 is not processed because two components of the processing signal, the linker sequence and the degron, are ineffective. These findings provide new insights into the molecular elements that regulate Gli protein processing by the proteasome.	Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA; Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL 60208 USA	Northwestern University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center	Matouschek, A (corresponding author), 2205 Tech Dr,Hogan 2-100, Evanston, IL 60208 USA.	matouschek@northwestern.edu	Matouschek, Andreas/L-9379-2013	Matouschek, Andreas/0000-0001-6016-2341	National Institutes of Health [R01GM63004, U54 CA143869, P50CA090386]; Oncogenesis and Developmental Biology NIH [T32 CA080621]; Robert H. Lurie Comprehensive Cancer Center at Northwestern University; NATIONAL CANCER INSTITUTE [T32CA080621, U54CA143869, P50CA090386] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063004] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Oncogenesis and Developmental Biology NIH; Robert H. Lurie Comprehensive Cancer Center at Northwestern University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM63004 and U54 CA143869 (to A. M.), by NIH Grant P50CA090386 (to R. H.), by Oncogenesis and Developmental Biology NIH training grant T32 CA080621 (to E. K. S.). This work was also supported by the Robert H. Lurie Comprehensive Cancer Center at Northwestern University (to R. A. H. and A. M.).	AzaBlanc P, 1997, CELL, V89, P1043, DOI 10.1016/S0092-8674(00)80292-5; BACHMAIR A, 1989, CELL, V56, P1019, DOI 10.1016/0092-8674(89)90635-1; Brown K, 1997, MOL CELL BIOL, V17, P3021, DOI 10.1128/MCB.17.6.3021; Chen MH, 2009, GENE DEV, V23, P1910, DOI 10.1101/gad.1794109; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Di Marcotullio L, 2011, ONCOGENE, V30, P65, DOI 10.1038/onc.2010.394; Di Marcotullio L, 2006, NAT CELL BIOL, V8, P1415, DOI 10.1038/ncb1510; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; FAN CM, 1991, NATURE, V354, P395, DOI 10.1038/354395a0; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Hoppe T, 2000, CELL, V102, P577, DOI 10.1016/S0092-8674(00)00080-5; Hoyt MA, 2006, EMBO J, V25, P1720, DOI 10.1038/sj.emboj.7601058; Huntzicker EG, 2006, GENE DEV, V20, P276, DOI 10.1101/gad.1380906; Inobe T, 2011, NAT CHEM BIOL, V7, P161, DOI 10.1038/NCHEMBIO.521; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Kaesler S, 2000, BIOL CHEM, V381, P545, DOI 10.1515/BC.2000.070; Kanarek N, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000166; Kent D, 2006, DEVELOPMENT, V133, P2001, DOI 10.1242/dev.02370; Kraut DA, 2011, ACS CHEM BIOL, V6, P1087, DOI 10.1021/cb2002285; Laney JD, 1999, CELL, V97, P427, DOI 10.1016/S0092-8674(00)80752-7; Lee C, 2001, MOL CELL, V7, P627, DOI 10.1016/S1097-2765(01)00209-X; Lin L, 2000, EMBO J, V19, P4712, DOI 10.1093/emboj/19.17.4712; Lin L, 1996, MOL CELL BIOL, V16, P2248; Lin L, 1998, CELL, V92, P819, DOI 10.1016/S0092-8674(00)81409-9; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Methot N, 1999, CELL, V96, P819, DOI 10.1016/S0092-8674(00)80592-9; Moorthy AK, 2006, EMBO J, V25, P1945, DOI 10.1038/sj.emboj.7601081; Orian A, 1999, MOL CELL BIOL, V19, P3664; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Pan Y, 2006, MOL CELL BIOL, V26, P3365, DOI 10.1128/MCB.26.9.3365-3377.2006; Pan Y, 2007, J BIOL CHEM, V282, P10846, DOI 10.1074/jbc.M608599200; Park HL, 2000, DEVELOPMENT, V127, P1593; Piwko W, 2006, NAT STRUCT MOL BIOL, V13, P691, DOI 10.1038/nsmb1122; Rape M, 2002, NAT CELL BIOL, V4, pE113, DOI 10.1038/ncb0502-e113; Sadowski M, 2010, MOL CELL BIOL, V30, P2316, DOI 10.1128/MCB.01094-09; Sears C, 1998, J BIOL CHEM, V273, P1409, DOI 10.1074/jbc.273.3.1409; Spencer E, 1999, GENE DEV, V13, P284, DOI 10.1101/gad.13.3.284; Tempe D, 2006, MOL CELL BIOL, V26, P4316, DOI 10.1128/MCB.02183-05; Tian L, 2005, NAT STRUCT MOL BIOL, V12, P1045, DOI 10.1038/nsmb1018; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Wang BW, 2006, P NATL ACAD SCI USA, V103, P33, DOI 10.1073/pnas.0509927103; Wang CB, 2007, DEV BIOL, V305, P460, DOI 10.1016/j.ydbio.2007.02.029; Wang CB, 2007, DEV DYNAM, V236, P769, DOI 10.1002/dvdy.21082; Wang CB, 2010, DEVELOPMENT, V137, P2001, DOI 10.1242/dev.052126; Wang YF, 2008, MOL CELL BIOL, V28, P5555, DOI 10.1128/MCB.00524-08; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Wulczyn FG, 1998, NUCLEIC ACIDS RES, V26, P1724, DOI 10.1093/nar/26.7.1724; Zhang MS, 2004, J BIOL CHEM, V279, P8635, DOI 10.1074/jbc.M310449200; Zhang Q, 2006, DEV CELL, V10, P719, DOI 10.1016/j.devcel.2006.05.004; Zhang Q, 2009, P NATL ACAD SCI USA, V106, P21191, DOI 10.1073/pnas.0912008106	52	27	28	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39051	39058		10.1074/jbc.M111.274993	http://dx.doi.org/10.1074/jbc.M111.274993			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21921029	Green Published, hybrid			2022-12-25	WOS:000296759800024
J	Chung, E; Prelli, F; Dealler, S; Lee, WS; Chang, YT; Wisniewski, T				Chung, Erika; Prelli, Frances; Dealler, Stephen; Lee, Woo Sirl; Chang, Young-Tae; Wisniewski, Thomas			Styryl-Based and Tricyclic Compounds as Potential Anti-Prion Agents	PLOS ONE			English	Article							SCRAPIE-INFECTED HAMSTERS; CHRONIC WASTING DISEASE; BETA-AMYLOID PLAQUES; ALZHEIMERS-DISEASE; PRP ANTIBODIES; CONGO-RED; IN-VIVO; DERIVATIVES; THERAPEUTICS; QUINACRINE	Prion diseases currently have no effective therapy. These illnesses affect both animal and human populations, and are characterized by the conformational change of a normal self protein PrPC (C for cellular) to a pathological and infectious conformer, PrPSc (Sc for scrapie). We used a well characterized tissue culture model of prion infection, where mouse neuroblastoma cells (N2a) were infected with 22L PrPSc, to screen compounds for anti-prion activity. In a prior study we designed a library of styryl based, potential imaging compounds which were selected for high affinity binding to Alzheimer's disease beta-amyloid plaques and good blood-brain barrier permeability. In the current study we screened this library for activity in the N2a/22L tissue culture system. We also tested the anti-prion activity of two clinically used drugs, trimipramine and fluphenazine, in the N2a/22L system. These were selected based on their structural similarity to quinacrine, which was previously reported to have anti-prion activity. All the compounds were also screened for toxicity in tissue culture and their ability to disaggregate amyloid fibrils composed of PrP and beta-amyloid synthetic peptides in vitro. Two of the imaging agents, 23I and 59, were found to be both effective at inhibiting prion infection in N2a/22L tissue culture and to be non-toxic. These two compounds, as well as trimipramine and fluphenazine were evaluated in vivo using wild-type CD-1 mice infected peripherally with 139A PrPSc. All four agents significantly prolonged the asymptomatic incubation period of prion infection (p<0.0001 log-rank test), as well as significantly reducing the degree of spongiform change, astrocytosis and PrPSc levels in the brains of treated mice. These four compounds can be considered, with further development, as candidates for prion therapy.	[Chung, Erika; Prelli, Frances; Wisniewski, Thomas] NYU, Sch Med, Dept Neurol, New York, NY 10003 USA; [Dealler, Stephen] Microsens Biotechnol Ltd, Camden, NJ USA; [Lee, Woo Sirl; Chang, Young-Tae] Natl Univ Singapore, Dept Chem, Singapore 117548, Singapore; [Lee, Woo Sirl; Chang, Young-Tae] Natl Univ Singapore, Inst Life Sci, MedChem Program, Singapore 117548, Singapore; [Chang, Young-Tae] ASTAR, Singapore Bioimaging Consortium, Lab Bioimaging Probe Dev, Singapore, Singapore; [Wisniewski, Thomas] NYU, Sch Med, Dept Pathol, New York, NY USA; [Wisniewski, Thomas] NYU, Sch Med, Dept Psychiat, New York, NY USA	New York University; National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Singapore Bioimaging Consortium (SBIC); New York University; New York University	Chung, E (corresponding author), NYU, Sch Med, Dept Neurol, New York, NY 10003 USA.	Thomas.wisniewski@nyumc.org	Wisniewski, Thomas/Q-6525-2019; Chang, Young-Tae/B-2780-2010	Wisniewski, Thomas/0000-0002-3379-8966; Chang, Young-Tae/0000-0002-1927-3688; Prelli, Frances/0000-0002-8744-4151	National Institutes of Health [NS047433, NS073502]; Robert Alvo; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073502, R01NS047433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG008051] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Alvo; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This manuscript was supported by National Institutes of Health grants NS047433 and NS073502, and by funding from Robert Alvo (www.babina.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2008, ANNU REV PATHOL-MECH, V3, P11, DOI 10.1146/annurev.pathmechdis.3.121806.154326; Appleby BS, 2009, CNS NEUROL DISORD-DR, V8, P353, DOI 10.2174/187152709789541961; Barret A, 2003, J VIROL, V77, P8462, DOI 10.1128/JVI.77.15.8462-8469.2003; Brazier MW, 2009, EXPERT REV ANTI-INFE, V7, P83, DOI 10.1586/14787210.7.1.83; Brown P, 2008, NEUROLOGY, V70, P713, DOI 10.1212/01.wnl.0000302186.10596.f6; Chung E, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-130; Cobb NJ, 2009, BIOCHEMISTRY-US, V48, P2574, DOI 10.1021/bi900108v; Collins SJ, 2002, ANN NEUROL, V52, P503, DOI 10.1002/ana.10336; Follette P, 2003, SCIENCE, V299, P191, DOI 10.1126/science.299.5604.191; Gambetti P, 2008, ANN NEUROL, V63, P697, DOI 10.1002/ana.21420; Goni F, 2008, NEUROSCIENCE, V153, P679, DOI 10.1016/j.neuroscience.2008.02.051; INGROSSO L, 1995, J VIROL, V69, P506, DOI 10.1128/JVI.69.1.506-508.1995; Ishikawa K, 2006, J NEUROCHEM, V99, P198, DOI 10.1111/j.1471-4159.2006.04035.x; Kawasaki Y, 2007, J VIROL, V81, P12889, DOI 10.1128/JVI.01563-07; Kocisko DA, 2003, J VIROL, V77, P10288, DOI 10.1128/JVI.77.19.10288-10294.2003; Korth C, 2001, P NATL ACAD SCI USA, V98, P9836, DOI 10.1073/pnas.161274798; Li L, 2010, IMMUNOTHERAPY-UK, V2, P269, DOI 10.2217/IMT.10.3; Li Q, 2007, CHEMBIOCHEM, V8, P1679, DOI 10.1002/cbic.200700154; Marsh RF, 2005, J VIROL, V79, P13794, DOI 10.1128/JVI.79.21.13794-13796.2005; NORRBY E, 2011, J INTERN ME IN PRESS; Pankiewicz J, 2006, EUR J NEUROSCI, V23, P2635, DOI 10.1111/j.1460-9568.2006.04805.x; Poli G, 2004, ARZNEIMITTEL-FORSCH, V54, P406; Prusiner SB, 2001, NEW ENGL J MED, V344, P1516, DOI 10.1056/NEJM200105173442006; Race B, 2009, EMERG INFECT DIS, V15, P1366, DOI 10.3201/eid1509.090253; Sadowski M, 2004, AM J PATHOL, V165, P937, DOI 10.1016/S0002-9440(10)63355-X; Sadowski MJ, 2006, P NATL ACAD SCI USA, V103, P18787, DOI 10.1073/pnas.0604011103; Sadowski MJ, 2009, NEUROBIOL DIS, V34, P267, DOI 10.1016/j.nbd.2009.01.013; Sigurdson CJ, 2008, VET RES, V39, DOI 10.1051/vetres:2008018; SPINNER DS, 2007, J LEUKOCYTE BIOL, V14, P36; Trevitt CR, 2006, BRAIN, V129, P2241, DOI 10.1093/brain/awl150; Webb S, 2007, J VIROL, V81, P10729, DOI 10.1128/JVI.01075-07; Wisniewski T, 2010, EXPERT REV VACCINES, V9, P1441, DOI [10.1586/erv.10.131, 10.1586/ERV.10.131]; Ye XM, 1998, BRAIN RES, V809, P277, DOI 10.1016/S0006-8993(98)00833-6	33	13	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2011	6	9							e24844	10.1371/journal.pone.0024844	http://dx.doi.org/10.1371/journal.pone.0024844			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZV	21931860	Green Published, gold, Green Submitted			2022-12-25	WOS:000295321800070
J	Rottner, M; Tual-Chalot, S; Mostefai, HA; Andriantsitohaina, R; Freyssinet, JM; Martinez, MC				Rottner, Mathilde; Tual-Chalot, Simon; Mostefai, H. Ahmed; Andriantsitohaina, Ramaroson; Freyssinet, Jean-Marie; Martinez, Maria Carmen			Increased Oxidative Stress Induces Apoptosis in Human Cystic Fibrosis Cells	PLOS ONE			English	Article							EXTRACELLULAR-SUPEROXIDE DISMUTASE; NITRIC-OXIDE; REACTIVE NITROGEN; KAPPA-B; LUNG; MECHANISMS; CFTR; INFECTION; GENE	Oxidative stress results in deleterious cell function in pathologies associated with inflammation. Here, we investigated the generation of superoxide anion as well as the anti-oxidant defense systems related to the isoforms of superoxide dismutases (SOD) in cystic fibrosis (CF) cells. Pro-apoptotic agents induced apoptosis in CF but not in control cells that was reduced by treatment with SOD mimetic. These effects were associated with increased superoxide anion production, sensitive to the inhibition of I kappa B-alpha phosphorylation, in pancreatic but not tracheal CF cells, and reduced upon inhibition of either mitochondrial complex I or NADPH oxidase. CF cells exhibited reduced expression, but not activity, of both Mn-SOD and Cu/Zn-SOD when compared to control cells. Although, expression of EC-SOD was similar in normal and CF cells, its activity was reduced in CF cells. We provide evidence that high levels of oxidative stress are associated with increased apoptosis in CFTR-mutated cells, the sources being different depending on the cell type. These observations underscore a reduced anti-oxidant defense mechanism, at least in part, via diminished EC-SOD activity and regulation of Cu/Zn-SOD and Mn-SOD expressions. These data point to new therapeutic possibilities in targeting anti-oxidant pathways to reduce oxidative stress and apoptosis in CF cells.	[Rottner, Mathilde; Freyssinet, Jean-Marie] INSERM, U770, F-94275 Le Kremlin Bicetre, France; [Rottner, Mathilde; Freyssinet, Jean-Marie] Univ Strasbourg, Fac Med, Strasbourg, France; [Tual-Chalot, Simon; Mostefai, H. Ahmed; Andriantsitohaina, Ramaroson; Martinez, Maria Carmen] Univ Angers, INSERM, U694, Angers, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers	Rottner, M (corresponding author), INSERM, U770, F-94275 Le Kremlin Bicetre, France.	carmen.martinez@univ-angers.fr	Freyssinet, Jean-Marie/G-2719-2013; ANDRIANTSITOHAINA, Ramaroson/H-5286-2018	andriantsitohaina, ramaroson/0000-0002-4770-3585; Tual-Chalot, Simon/0000-0002-9307-7175; Martinez, M Carmen/0000-0003-3897-7397	French Association "Vaincre la Mucoviscidose" [II0532]; Fondation pour la Recherche Medicale; GEHT doctoral fellowship; Ministere de l'Enseignement Superieur et de la Recherche (France)	French Association "Vaincre la Mucoviscidose"; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); GEHT doctoral fellowship; Ministere de l'Enseignement Superieur et de la Recherche (France)	This work was supported by the French Association "Vaincre la Mucoviscidose" (AVL n II0532). MR was supported by a fellowship from the Fondation pour la Recherche Medicale and from GEHT doctoral fellowship, and STC by a fellowship from the Ministere de l'Enseignement Superieur et de la Recherche (France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], CYSTIC FIBROSIS MUTA; Ashcroft FM, 1999, ION CHANNELS DIS, V12, P211; Boucher RC, 2007, TRENDS MOL MED, V13, P231, DOI 10.1016/j.molmed.2007.05.001; Bowler RP, 2004, AM J RESP CELL MOL, V31, P432, DOI 10.1165/rcmb.2004-0057OC; Bowler RP, 2003, AM J PHYSIOL-LUNG C, V284, pL680, DOI 10.1152/ajplung.00191.2002; Darling KEA, 2003, INFECT IMMUN, V71, P2341, DOI 10.1128/IAI.71.5.2341-2349.2003; Dotsch J, 2002, EUR ARCH OTO-RHINO-L, V259, P222, DOI 10.1007/s00405-001-0436-8; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Folkerts G, 2001, EUR J PHARMACOL, V429, P251, DOI 10.1016/S0014-2999(01)01324-3; Gao L, 1999, AM J PHYSIOL-LUNG C, V277, pL113, DOI 10.1152/ajplung.1999.277.1.L113; Gomes-Alves P, 2010, EXPERT REV PROTEOMIC, V7, P487, DOI 10.1586/EPR.10.37; Hassett P, 2011, INTENS CARE MED, V37, P1680, DOI 10.1007/s00134-011-2309-y; Hoshino T, 2008, ANTIOXID REDOX SIGN, V10, P769, DOI 10.1089/ars.2007.1936; Joseph A, 2008, FREE RADICAL BIO MED, V45, P1143, DOI 10.1016/j.freeradbiomed.2008.07.006; Keen C, 2007, CHEST, V131, P1857, DOI 10.1378/chest.06-2635; Kreindler JL, 2010, PHARMACOL THERAPEUT, V125, P219, DOI 10.1016/j.pharmthera.2009.10.006; Kuo WW, 2011, J CELL PHYSL, DOI [10.1002/jcp.22847, DOI 10.1002/JCP.22847]; Lee CW, 2011, J CELL PHYSIOL, V226, P2103, DOI 10.1002/jcp.22537; Leung PS, 2009, ANTIOXID REDOX SIGN, V11, P135, DOI 10.1089/ars.2008.2109; Luciani A, 2010, NAT CELL BIOL, V12, P863, DOI 10.1038/ncb2090; Madarasi A, 2000, ANN NUTR METAB, V44, P207, DOI 10.1159/000046685; Madesh M, 2009, MOL CELL BIOL, V29, P3099, DOI 10.1128/MCB.01845-08; Manni ML, 2011, AM J PATHOL, V178, P2752, DOI 10.1016/j.ajpath.2011.02.007; Martinez MC, 2009, ANTIOXID REDOX SIGN, V11, P669, DOI 10.1089/ars.2007.1993; PERCIVAL SS, 1995, AM J CLIN NUTR, V62, P633, DOI 10.1093/ajcn/62.3.633; Percival SS, 1999, J AM COLL NUTR, V18, P614, DOI 10.1080/07315724.1999.10718896; Pramanik KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020151; RIORDAN JR, 1992, BIOCHIM BIOPHYS ACTA, V1101, P221, DOI 10.1016/0005-2728(92)90230-Y; Rottner M, 2007, FASEB J, V21, P2939, DOI 10.1096/fj.06-7614com; Rottner M, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-23; Talbot S, 2011, PEPTIDES, V32, P1447, DOI 10.1016/j.peptides.2011.05.005; Taylor C J, 2002, Paediatr Respir Rev, V3, P77, DOI 10.1053/prrv.2002.0183; Texereau J, 2004, THORAX, V59, P156, DOI 10.1136/thorax.2003.006718; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; Trudel S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006075; Tual-Chalot S, 2010, AM J RESP CRIT CARE, V182, P261, DOI 10.1164/rccm.200909-1347OC; Velsor LW, 2006, AM J RESP CELL MOL, V35, P579, DOI 10.1165/rcmb.2005-0473OC; Wullaert A, 2007, ENDOCR REV, V28, P365, DOI 10.1210/er.2006-0031; Yasui K, 2006, INFLAMM RES, V55, P359, DOI 10.1007/s00011-006-5195-y	39	35	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2011	6	9							e24880	10.1371/journal.pone.0024880	http://dx.doi.org/10.1371/journal.pone.0024880			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CO	21931865	Green Published, gold, Green Submitted			2022-12-25	WOS:000294803200055
J	Petersen, LK; Stowers, RS				Petersen, Lena K.; Stowers, R. Steven			A Gateway MultiSite Recombination Cloning Toolkit	PLOS ONE			English	Article							MECHANOSENSORY TRANSDUCTION; DROSOPHILA; EXPRESSION; SYNAPTOJANIN; SYSTEM	The generation of DNA constructs is often a rate-limiting step in conducting biological experiments. Recombination cloning of single DNA fragments using the Gateway system provided an advance over traditional restriction enzyme cloning due to increases in efficiency and reliability. Here we introduce a series of entry clones and a destination vector for use in two, three, and four fragment Gateway MultiSite recombination cloning whose advantages include increased flexibility and versatility. In contrast to Gateway single-fragment cloning approaches where variations are typically incorporated into model system-specific destination vectors, our Gateway MultiSite cloning strategy incorporates variations in easily generated entry clones that are model system-independent. In particular, we present entry clones containing insertions of GAL4, QF, UAS, QUAS, eGFP, and mCherry, among others, and demonstrate their in vivo functionality in Drosophila by using them to generate expression clones including GAL4 and QF drivers for various trp ion channel family members, UAS and QUAS excitatory and inhibitory light-gated ion channels, and QUAS red and green fluorescent synaptic vesicle markers. We thus establish a starter toolkit of modular Gateway MultiSite entry clones potentially adaptable to any model system. An inventory of entry clones and destination vectors for Gateway MultiSite cloning has also been established (www.gatewaymultisite.org).	[Petersen, Lena K.; Stowers, R. Steven] Montana State Univ, Dept Cell Biol & Neurosci, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman	Petersen, LK (corresponding author), Montana State Univ, Dept Cell Biol & Neurosci, Bozeman, MT 59717 USA.	sstowers@montana.edu			Montana State University	Montana State University	Start-up funds were provided by Montana State University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Alberti S, 2007, YEAST, V24, P913, DOI 10.1002/yea.1502; Cheo DL, 2004, GENOME RES, V14, P2111, DOI 10.1101/gr.2512204; DIANTONIO A, 1993, J NEUROSCI, V13, P4924; Dickman DK, 2005, CELL, V123, P521, DOI 10.1016/j.cell.2005.09.026; Gong W, 2004, PLANT PHYSIOL, V135, P773, DOI 10.1104/pp.104.042176; Gong ZF, 2004, J NEUROSCI, V24, P9059, DOI 10.1523/JNEUROSCI.1645-04.2004; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Grueber WB, 2002, DEVELOPMENT, V129, P2867; Grueber WB, 2007, DEVELOPMENT, V134, P55, DOI 10.1242/dev.02666; Gunaydin LA, 2010, NAT NEUROSCI, V13, P387, DOI 10.1038/nn.2495; Hartley JL, 2000, GENOME RES, V10, P1788, DOI 10.1101/gr.143000; Hughes CL, 2007, MOL CELL NEUROSCI, V35, P383, DOI 10.1016/j.mcn.2007.04.001; KERNAN M, 1994, NEURON, V12, P1195, DOI 10.1016/0896-6273(94)90437-5; Kim SK, 2004, NATURE, V431, P316, DOI 10.1038/nature02897; LANDAU NR, 1988, NATURE, V334, P159, DOI 10.1038/334159a0; Le T, 2007, BIOTECHNIQUES, V42, P162, DOI 10.2144/000112386; Luan CH, 2004, GENOME RES, V14, P2102, DOI 10.1101/gr.2520504; Markstein M, 2008, NAT GENET, V40, P476, DOI 10.1038/ng.101; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; Montell C, 2005, J PHYSIOL-LONDON, V567, P45, DOI 10.1113/jphysiol.2005.092551; Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; Pfeiffer BD, 2010, GENETICS, V186, P735, DOI 10.1534/genetics.110.119917; Potter CJ, 2010, CELL, V141, P536, DOI 10.1016/j.cell.2010.02.025; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Tahayato A, 2003, DEV CELL, V5, P391, DOI 10.1016/S1534-5807(03)00239-9; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Verstreken P, 2003, NEURON, V40, P733, DOI 10.1016/S0896-6273(03)00644-5; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Walker RG, 2000, SCIENCE, V287, P2229, DOI 10.1126/science.287.5461.2229; Xiang Y, 2010, NATURE, V468, P921, DOI 10.1038/nature09576; Zhang YQ, 2002, GENESIS, V34, P142, DOI 10.1002/gene.10144	32	64	65	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2011	6	9							e24531	10.1371/journal.pone.0024531	http://dx.doi.org/10.1371/journal.pone.0024531			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CN	21931740	Green Published, Green Submitted, gold			2022-12-25	WOS:000294803100040
J	Xue, SW; Yao, X; Luo, W; Jha, D; Tester, M; Horie, T; Schroeder, JI				Xue, Shaowu; Yao, Xuan; Luo, Wei; Jha, Deepa; Tester, Mark; Horie, Tomoaki; Schroeder, Julian I.			AtHKT1;1 Mediates Nernstian Sodium Channel Transport Properties in Arabidopsis Root Stelar Cells	PLOS ONE			English	Article							HIGH-AFFINITY POTASSIUM; XYLEM-PARENCHYMA CELLS; SALT TOLERANCE; HKT TRANSPORTERS; K+ TRANSPORTER; NA+ TRANSPORT; DURUM-WHEAT; SALINITY TOLERANCE; PATCH-CLAMP; VOLTAGE-DEPENDENCE	The Arabidopsis AtHKT1;1 protein was identified as a sodium (Na(+)) transporter by heterologous expression in Xenopus laevis oocytes and Saccharomyces cerevisiae. However, direct comparative in vivo electrophysiological analyses of a plant HKT transporter in wild-type and hkt loss-of-function mutants has not yet been reported and it has been recently argued that heterologous expression systems may alter properties of plant transporters, including HKT transporters. In this report, we analyze several key functions of AtHKT1;1-mediated ion currents in their native root stelar cells, including Na(+) and K(+) conductances, AtHKT1;1-mediated outward currents, and shifts in reversal potentials in the presence of defined intracellular and extracellular salt concentrations. Enhancer trap Arabidopsis plants with GFP-labeled root stelar cells were used to investigate AtHKT1;1-dependent ion transport properties using patch clamp electrophysiology in wild-type and athkt1;1 mutant plants. AtHKT1;1-dependent currents were carried by sodium ions and these currents were not observed in athkt1;1 mutant stelar cells. However, K(+) currents in wild-type and athkt1;1 root stelar cell protoplasts were indistinguishable correlating with the Na(+) over K(+) selectivity of AtHKT1;1-mediated transport. Moreover, AtHKT1;1-mediated currents did not show a strong voltage dependence in vivo. Unexpectedly, removal of extracellular Na(+) caused a reduction in AtHKT1;1-mediated outward currents in Columbia root stelar cells and Xenopus oocytes, indicating a role for external Na(+) in regulation of AtHKT1;1 activity. Shifting the NaCl gradient in root stelar cells showed a Nernstian shift in the reversal potential providing biophysical evidence for the model that AtHKT1;1 mediates passive Na(+) channel transport properties.	[Jha, Deepa; Tester, Mark] Univ Adelaide, Australian Ctr Plant Funct Genom, Adelaide, SA 5005, Australia; [Luo, Wei] Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, Coll Resources & Environm Sci, Nanjing, Peoples R China; [Xue, Shaowu; Yao, Xuan; Luo, Wei; Horie, Tomoaki; Schroeder, Julian I.] Univ Calif San Diego, Div Biol Sci, Cell & Dev Biol Sect, La Jolla, CA 92093 USA	University of Adelaide; Nanjing Agricultural University; University of California System; University of California San Diego	Xue, SW (corresponding author), Shanxi Univ, Inst Mol Sci, Taiyuan, Peoples R China.	jischroeder@ucsd.edu	Tester, Mark/J-2368-2017; Xue, Shaowu/O-8678-2019; Xue, Shaowu/D-5400-2011	Tester, Mark/0000-0002-5085-8801; Xue, Shaowu/0000-0002-8838-3362; Xue, Shaowu/0000-0002-8838-3362; Schroeder, Julian/0000-0002-3283-5972	Chemical Sciences, Geosciences, and Biosciences Division of the Office of Basic Energy Sciences at the US Department of Energy [DE-FG02-03ER15449]; National Institute of Environmental Health Sciences [P42 ES010337]; Australian Research Council; China Scholarship Council; University of California, San Diego; National Science Foundation of China [20701028]; Shanxi Scholarship Council of China [2011-012]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010337] Funding Source: NIH RePORTER	Chemical Sciences, Geosciences, and Biosciences Division of the Office of Basic Energy Sciences at the US Department of Energy(United States Department of Energy (DOE)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Australian Research Council(Australian Research Council); China Scholarship Council(China Scholarship Council); University of California, San Diego(University of California System); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanxi Scholarship Council of China; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by a grant from the Chemical Sciences, Geosciences, and Biosciences Division of the Office of Basic Energy Sciences at the US Department of Energy (DE-FG02-03ER15449) and in part from the National Institute of Environmental Health Sciences (P42 ES010337) to JIS and from the Australian Research Council to MT. XY and WL received support from the China Scholarship Council, at the University of California, San Diego. SX was in part supported by the National Science Foundation of China (20701028) and the Shanxi Scholarship Council of China (2011-012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apse MP, 2007, FEBS LETT, V581, P2247, DOI 10.1016/j.febslet.2007.04.014; Banuelos MA, 2008, PLANT CELL PHYSIOL, V49, P1128, DOI 10.1093/pcp/pcn088; Baxter I, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001193; Berthomieu Pierre, 2003, EMBO (European Molecular Biology Organization) Journal, V22, P2004, DOI 10.1093/emboj/cdg207; BLUMWALD E, 1985, PLANT PHYSIOL, V78, P163, DOI 10.1104/pp.78.1.163; Buschmann PH, 2000, PLANT PHYSIOL, V122, P1387, DOI 10.1104/pp.122.4.1387; Byrt CS, 2007, PLANT PHYSIOL, V143, P1918, DOI 10.1104/pp.106.093476; Cao Y, 2011, NATURE, V471, P336, DOI 10.1038/nature09731; Corratge C, 2007, J BIOL CHEM, V282, P26057, DOI 10.1074/jbc.M611613200; Davenport R, 2005, PLANT PHYSIOL, V137, P807, DOI 10.1104/pp.104.057307; Davenport RJ, 2007, PLANT CELL ENVIRON, V30, P497, DOI 10.1111/j.1365-3040.2007.01637.x; Demidchik V, 2002, PLANT PHYSIOL, V128, P379, DOI 10.1104/pp.010524; Diatloff E, 1998, FEBS LETT, V432, P31, DOI 10.1016/S0014-5793(98)00833-3; DUBCOVSKY J., 1996, GENETICS, V92, P448; DVORAK J, 1994, THEOR APPL GENET, V87, P872, DOI 10.1007/BF00221141; Essah PA, 2003, PLANT PHYSIOL, V133, P307, DOI 10.1104/pp.103.022178; Flowers TJ, 1999, SCI HORTIC-AMSTERDAM, V78, P1; Garciadeblas B, 2003, PLANT J, V34, P788, DOI 10.1046/j.1365-313X.2003.01764.x; Gassmann W, 1996, PLANT J, V10, P869, DOI 10.1046/j.1365-313X.1996.10050869.x; Gierth M, 2005, PLANT PHYSIOL, V137, P1105, DOI 10.1104/pp.104.057216; Gong JM, 2004, P NATL ACAD SCI USA, V101, P15404, DOI 10.1073/pnas.0404780101; GREENWAY H, 1980, ANNU REV PLANT PHYS, V31, P149, DOI 10.1146/annurev.pp.31.060180.001053; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Haro R, 2005, PLANT PHYSIOL, V139, P1495, DOI 10.1104/pp.105.067553; Hauser F, 2010, PLANT CELL ENVIRON, V33, P552, DOI 10.1111/j.1365-3040.2009.02056.x; Horie T, 2001, PLANT J, V27, P129, DOI 10.1046/j.1365-313x.2001.01077.x; Horie T, 2004, PLANT PHYSIOL, V136, P2457, DOI 10.1104/pp.104.046664; Horie T, 2007, EMBO J, V26, P3003, DOI 10.1038/sj.emboj.7601732; Horie T, 2006, PLANT CELL PHYSIOL, V47, P622, DOI 10.1093/pcp/pcj029; Horie T, 2011, PLANT PHYSIOL, V156, P1493, DOI 10.1104/pp.110.168047; Horie T, 2009, TRENDS PLANT SCI, V14, P660, DOI 10.1016/j.tplants.2009.08.009; Huang SB, 2006, PLANT PHYSIOL, V142, P1718, DOI 10.1104/pp.106.088864; Jabnoune M, 2009, PLANT PHYSIOL, V150, P1955, DOI 10.1104/pp.109.138008; James RA, 2006, PLANT PHYSIOL, V142, P1537, DOI 10.1104/pp.106.086538; Jha D, 2010, PLANT CELL ENVIRON, V33, P793, DOI 10.1111/j.1365-3040.2009.02105.x; Kato Y, 2001, P NATL ACAD SCI USA, V98, P6488, DOI 10.1073/pnas.101556598; Kiegle E, 2000, PLANT J, V21, P225, DOI 10.1046/j.1365-313x.2000.00659.x; Kielland J, 1937, J AM CHEM SOC, V59, P1675, DOI 10.1021/ja01288a032; Kohler B, 2002, PLANT J, V30, P133, DOI 10.1046/j.1365-313X.2002.01269.x; KWAK JM, 2001, PLANT PHYSIOL, V127, P1; Lan WZ, 2010, P NATL ACAD SCI USA, V107, P7089, DOI 10.1073/pnas.1000698107; Liu WH, 2000, J BIOL CHEM, V275, P27924; LUO MC, 1996, GENETICS, V93, P1180; Maathuis FJM, 1998, PLANT J, V15, P843, DOI 10.1046/j.1365-313X.1998.00256.x; Maser P, 2002, P NATL ACAD SCI USA, V99, P6428, DOI 10.1073/pnas.082123799; Maser P, 2002, FEBS LETT, V531, P157, DOI 10.1016/S0014-5793(02)03488-9; Mason MG, 2010, PLANT J, V64, P753, DOI 10.1111/j.1365-313X.2010.04366.x; Moller IS, 2009, PLANT CELL, V21, P2163, DOI 10.1105/tpc.108.064568; Munns R, 2003, AUST J AGR RES, V54, P627, DOI 10.1071/AR03027; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; NIEVESCORDONES M, 2010, ARABIDOPSIS, V3, P326; Pei ZM, 1997, PLANT CELL, V9, P409, DOI 10.1105/tpc.9.3.409; PUSCH M, 1988, PFLUG ARCH EUR J PHY, V411, P204, DOI 10.1007/BF00582316; Pyo YJ, 2010, PLANT PHYSIOL, V153, P863, DOI 10.1104/pp.110.154369; Ren ZH, 2005, NAT GENET, V37, P1141, DOI 10.1038/ng1643; Roberts SK, 1995, PLANT J, V8, P811, DOI 10.1046/j.1365-313X.1995.8060811.x; Rubio F, 1999, J BIOL CHEM, V274, P6839, DOI 10.1074/jbc.274.11.6839; RUBIO F, 1995, SCIENCE, V270, P1660, DOI 10.1126/science.270.5242.1660; SCHACHTMAN DP, 1994, NATURE, V370, P655, DOI 10.1038/370655a0; SCHROEDER JI, 1987, P NATL ACAD SCI USA, V84, P4108, DOI 10.1073/pnas.84.12.4108; SCHROEDER JI, 1995, PLANT MOL BIOL, V28, P353, DOI 10.1007/BF00020385; SCHROEDER JI, 1989, J MEMBRANE BIOL, V107, P229, DOI 10.1007/BF01871938; Senn ME, 2001, J BIOL CHEM, V276, P44563, DOI 10.1074/jbc.M108129200; SHI H, 2000, ARABIDOPSIS, V97, P6896; Su H, 2003, PLANT MOL BIOL, V52, P967, DOI 10.1023/A:1025445612244; Sunarpi, 2005, PLANT J, V44, P928, DOI 10.1111/j.1365-313X.2005.02595.x; Tester M, 2003, ANN BOT-LONDON, V91, P503, DOI 10.1093/aob/mcg058; Tholema N, 2005, J BIOL CHEM, V280, P41146, DOI 10.1074/jbc.M507647200; Uozumi N, 2000, PLANT PHYSIOL, V122, P1249, DOI 10.1104/pp.122.4.1249; Wang TB, 1998, PLANT PHYSIOL, V118, P651, DOI 10.1104/pp.118.2.651; WEGNER LH, 1994, PLANT PHYSIOL, V105, P799, DOI 10.1104/pp.105.3.799; Wegner LH, 1997, PLANT PHYSIOL, V115, P1707, DOI 10.1104/pp.115.4.1707; Yao X, 2010, PLANT PHYSIOL, V152, P341, DOI 10.1104/pp.109.145722; ZHU JK, 2002, NATURE, V53, P247	74	44	46	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2011	6	9							e24725	10.1371/journal.pone.0024725	http://dx.doi.org/10.1371/journal.pone.0024725			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CN	21931830	Green Published, Green Submitted, gold			2022-12-25	WOS:000294803100061
J	Bidet, M; Joubert, O; Lacombe, B; Ciantar, M; Nehme, R; Mollat, P; Bretillon, L; Faure, H; Bittman, R; Ruat, M; Mus-Veteau, I				Bidet, Michel; Joubert, Olivier; Lacombe, Benoit; Ciantar, Marine; Nehme, Rony; Mollat, Patrick; Bretillon, Lionel; Faure, Helene; Bittman, Robert; Ruat, Martial; Mus-Veteau, Isabelle			The Hedgehog Receptor Patched Is Involved in Cholesterol Transport	PLOS ONE			English	Article							STEROL-SENSING DOMAIN; SONIC HEDGEHOG; SIGNAL-TRANSDUCTION; PRIMARY CILIUM; VESICULAR TRAFFICKING; PATHWAY ACTIVATION; PROTEIN SIGNALS; CELLS; DROSOPHILA; YEAST	Background: Sonic hedgehog (Shh) signaling plays a crucial role in growth and patterning during embryonic development, and also in stem cell maintenance and tissue regeneration in adults. Aberrant Shh pathway activation is involved in the development of many tumors, and one of the most affected Shh signaling steps found in these tumors is the regulation of the signaling receptor Smoothened by the Shh receptor Patched. In the present work, we investigated Patched activity and the mechanism by which Patched inhibits Smoothened. Methodology/Principal Findings: Using the well-known Shh-responding cell line of mouse fibroblasts NIH 3T3, we first observed that enhancement of the intracellular cholesterol concentration induces Smoothened enrichment in the plasma membrane, which is a crucial step for the signaling activation. We found that binding of Shh protein to its receptor Patched, which involves Patched internalization, increases the intracellular concentration of cholesterol and decreases the efflux of a fluorescent cholesterol derivative (BODIPY-cholesterol) from these cells. Treatment of fibroblasts with cyclopamine, an antagonist of Shh signaling, inhibits Patched expression and reduces BODIPY-cholesterol efflux, while treatment with the Shh pathway agonist SAG enhances Patched protein expression and BODIPY-cholesterol efflux. We also show that overexpression of human Patched in the yeast S. cerevisiae results in a significant boost of BODIPY-cholesterol efflux. Furthermore, we demonstrate that purified Patched binds to cholesterol, and that the interaction of Shh with Patched inhibits the binding of Patched to cholesterol. Conclusion/Significance: Our results suggest that Patched may contribute to cholesterol efflux from cells, and to modulation of the intracellular cholesterol concentration. This activity is likely responsible for the inhibition of the enrichment of Smoothened in the plasma membrane, which is an important step in Shh pathway activation.	[Bidet, Michel; Joubert, Olivier; Lacombe, Benoit; Ciantar, Marine; Nehme, Rony; Mus-Veteau, Isabelle] Univ Nice Sophia Antipolis, CNRS UMR 6543, Inst Dev Biol & Canc, Nice, France; [Joubert, Olivier] Univ Nancy 1, EA 3452, Fac Pharm, Nancy, France; [Nehme, Rony] MRC, Mol Biol Lab, Cambridge CB2 2QH, England; [Mollat, Patrick] Galapagos SASU, Romainville, France; [Bretillon, Lionel] Univ Bourgogne, CNRS INRA, Ctr Sci Gout & Alimentat, Dijon, France; [Faure, Helene; Ruat, Martial] CNRS, Lab Neurobiol & Dev, Inst Neurobiol Alfred Fessard IFR2118, UPR 3294, Gif Sur Yvette, France; [Bittman, Robert] CUNY Queens Coll, Dept Chem & Biochem, Flushing, NY 11367 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Universite de Lorraine; MRC Laboratory Molecular Biology; Galapagos NV; INRAE; Institut Agro; AgroSup Dijon; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; City University of New York (CUNY) System; Queens College NY (CUNY)	Bidet, M (corresponding author), Univ Nice Sophia Antipolis, CNRS UMR 6543, Inst Dev Biol & Canc, Nice, France.	isabelle.mus-veteau@unice.fr	Joubert, Olivier/C-5705-2011; Ruat, Martial/E-5544-2016; Joubert, Olivier/A-7713-2015; Michel, BIDET/B-6966-2009	Joubert, Olivier/0000-0001-6440-191X; Mus-Veteau, Isabelle/0000-0001-5739-7684; Bretillon, Lionel/0000-0002-6957-100X; FAURE, Helene/0000-0002-0005-9331	CNRS; University of Nice-Sophia Antipolis; foundations France Cancer 06 and InnerWheel (Grasse); Conseil General des Alpes Maritimes	CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Nice-Sophia Antipolis; foundations France Cancer 06 and InnerWheel (Grasse); Conseil General des Alpes Maritimes(Region Provence-Alpes-Cote d'Azur)	This work was supported by the CNRS and the University of Nice-Sophia Antipolis, and by research grants from the foundations France Cancer 06 and InnerWheel (Grasse), and from the Conseil General des Alpes Maritimes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann SW, 2004, SCIENCE, V303, P1201, DOI 10.1126/science.1093131; Bale AE, 2002, ANNU REV GENOM HUM G, V3, P47, DOI 10.1146/annurev.genom.3.022502.103031; Beachy PA, 2004, NATURE, V432, P324, DOI 10.1038/nature03100; Bijlsma MF, 2006, PLOS BIOL, V4, P1397, DOI 10.1371/journal.pbio.0040232; Brown MS, 2009, J LIPID RES, V50, pS15, DOI 10.1194/jlr.R800054-JLR200; Cooper MK, 2003, NAT GENET, V33, P508, DOI 10.1038/ng1134; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Corcoran RB, 2006, P NATL ACAD SCI USA, V103, P8408, DOI 10.1073/pnas.0602852103; Davis HR, 2004, J BIOL CHEM, V279, P33586, DOI 10.1074/jbc.M405817200; De Rivoyre M, 2005, FEBS LETT, V579, P1529, DOI 10.1016/j.febslet.2005.01.054; De Rivoyre M, 2006, J BIOL CHEM, V281, P28584, DOI 10.1074/jbc.M512986200; Dellovade T, 2006, ANNU REV NEUROSCI, V29, P539, DOI 10.1146/annurev.neuro.29.051605.112858; Denef N, 2000, CELL, V102, P521, DOI 10.1016/S0092-8674(00)00056-8; Dwyer JR, 2007, J BIOL CHEM, V282, P8959, DOI 10.1074/jbc.M611741200; Fuse N, 1999, P NATL ACAD SCI USA, V96, P10992, DOI 10.1073/pnas.96.20.10992; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Grandgirard A, 2004, J CHROMATOGR A, V1040, P239, DOI 10.1016/j.chroma.2004.04.008; Haas D, 2010, AM J MED GENET C, V154C, P102, DOI 10.1002/ajmg.c.30243; Holtta-Vuori M, 2008, TRAFFIC, V9, P1839, DOI 10.1111/j.1600-0854.2008.00801.x; Huangfu D, 2006, DEVELOPMENT, V133, P3, DOI 10.1242/dev.02169; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Incardona JP, 2002, CURR BIOL, V12, P983, DOI 10.1016/S0960-9822(02)00895-3; Infante RE, 2008, J BIOL CHEM, V283, P1052, DOI 10.1074/jbc.M707943200; Jia JH, 2004, NATURE, V432, P1045, DOI 10.1038/nature03179; Joubert O, 2010, METHODS MOL BIOL, V601, P87, DOI 10.1007/978-1-60761-344-2_6; Joubert O, 2009, BBA-BIOMEMBRANES, V1788, P1813, DOI 10.1016/j.bbamem.2009.05.009; Khaliullina H, 2009, DEVELOPMENT, V136, P4111, DOI 10.1242/dev.041392; Kovacs JJ, 2008, SCIENCE, V320, P1777, DOI 10.1126/science.1157983; Kuwabara PE, 2002, TRENDS GENET, V18, P193, DOI 10.1016/S0168-9525(02)02640-9; Lee SW, 2007, INT J MOL MED, V19, P445; Li ZG, 2006, J ORG CHEM, V71, P1718, DOI 10.1021/jo052029x; Liu RH, 2009, J BIOL CHEM, V284, P1840, DOI 10.1074/jbc.M803741200; Low JA, 2010, J CLIN ONCOL, V28, P5321, DOI 10.1200/JCO.2010.27.9943; Mann RK, 2004, ANNU REV BIOCHEM, V73, P891, DOI 10.1146/annurev.biochem.73.011303.073933; Martin V, 2001, CURR BIOL, V11, P601, DOI 10.1016/S0960-9822(01)00178-6; Martirosyan A, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-103; Minogue S, 2010, J LIPID RES, V51, P2314, DOI 10.1194/jlr.M005751; Nehme R, 2010, EXPERT REV PROTEOMIC, V7, P601, DOI 10.1586/EPR.10.39; Nehme R, 2010, BBA-BIOMEMBRANES, V1798, P1100, DOI 10.1016/j.bbamem.2010.02.015; Nieuwenhuis E, 2005, CLIN GENET, V67, P193, DOI 10.1111/j.1399-0004.2004.00360.x; Parhami F, 2002, J BONE MINER RES, V17, P1997, DOI 10.1359/jbmr.2002.17.11.1997; Petrel C, 2003, J BIOL CHEM, V278, P49487, DOI 10.1074/jbc.M308010200; Pisani DF, 2005, BIOCHEM BIOPH RES CO, V331, P552, DOI 10.1016/j.bbrc.2005.04.008; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Rohatgi R, 2009, P NATL ACAD SCI USA, V106, P3196, DOI 10.1073/pnas.0813373106; Scales SJ, 2009, TRENDS PHARMACOL SCI, V30, P303, DOI 10.1016/j.tips.2009.03.007; Schoenheimer R, 1933, J BIOL CHEM, V103, P439; Stone DM, 1996, NATURE, V384, P129, DOI 10.1038/384129a0; Strutt H, 2001, CURR BIOL, V11, P608, DOI 10.1016/S0960-9822(01)00179-8; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Taipale J, 2002, NATURE, V418, P892, DOI 10.1038/nature00989; Traiffort E, 2010, J NEUROCHEM, V113, P576, DOI 10.1111/j.1471-4159.2010.06642.x; Varjosalo M, 2006, DEV CELL, V10, P177, DOI 10.1016/j.devcel.2005.12.014; Varjosalo M, 2008, GENE DEV, V22, P2454, DOI 10.1101/gad.1693608; Weaver DD, 2010, AM J MED GENET C, V154C, P142, DOI 10.1002/ajmg.c.30241; Yavan A, 2010, DEV CELL, V19, P54, DOI 10.1016/j.devcel.2010.06.007; Zhang C, 2004, P NATL ACAD SCI USA, V101, P17900, DOI 10.1073/pnas.0408093101; Zhu AJ, 2003, GENE DEV, V17, P1240, DOI 10.1101/gad.1080803	58	85	86	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e23834	10.1371/journal.pone.0023834	http://dx.doi.org/10.1371/journal.pone.0023834			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CK	21931618	gold, Green Published			2022-12-25	WOS:000294802800010
J	Li, WH; Ahn, AC				Li, Weihui; Ahn, Andrew C.			Subcutaneous Fascial Bands-A Qualitative and Morphometric Analysis	PLOS ONE			English	Article							CONNECTIVE-TISSUE; NETWORK; BODY	Background: Although fascial bands within the subcutaneous (SQ) layer are commonly seen in ultrasound images, little is known about their functional role, much less their structural characteristics. This study's objective is to describe the morphological features of SQ fascial bands and to systematically evaluate the bands using image analyses tools and morphometric measures. Methods: In 28 healthy volunteers, ultrasound images were obtained at three body locations: the lateral aspect of the upper arm, medial aspect of the thigh and posterior aspect of lower leg. Using image analytical techniques, the total SQ band area, fascial band number, fascial band thickness, and SQ zone (layer) thickness were determined. In addition, the SQ spatial coherence was calculated based on the eigenvalues associated with the largest and smallest eigenvectors of the images. Results: Fascial bands at these sites were contiguous with the dermis and the epimysium forming an interconnected network within the subcutaneous tissue. Subcutaneous blood vessels were also frequently encased by these fascial bands. The total SQ fascial band area was greater at the thigh and calf compared to the arm and was unrelated to SQ layer (zone) thickness. The thigh was associated with highest average number of fascial bands while calf was associated with the greatest average fascial band thickness. Across body regions, greater SQ zone thickness was associated with thinner fascial bands. SQ coherence was significantly associated with SQ zone thickness and body location (calf with statistically greater coherence compared to arm). Conclusion: Fascial bands are structural bridges that mechanically link the skin, subcutaneous layer, and deeper muscle layers. This cohesive network also encases subcutaneous vessels and may indirectly mediate blood flow. The quantity and morphological characteristics of the SQ fascial band may reflect the composite mechanical forces experienced by the body part.	[Li, Weihui; Ahn, Andrew C.] Massachusetts Gen Hosp, Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA; [Ahn, Andrew C.] Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Boston, MA 02215 USA	Harvard University; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center	Li, WH (corresponding author), Massachusetts Gen Hosp, Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA.	weihuil@gmail.com			National Center for Complementary Alternative Medicine (NCCAM) [K23-AT003238, P30AT005895, K24-AT004095]; Bernard Osher Foundation; National Center for Research Resources [UL1RR025758]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [P30AT005895, K23AT003238] Funding Source: NIH RePORTER; National Center for Complementary & Integrative Health [K24AT004095] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER	National Center for Complementary Alternative Medicine (NCCAM)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); Bernard Osher Foundation; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was supported by grant number K23-AT003238, P30AT005895, and K24-AT004095 of the National Center for Complementary Alternative Medicine (NCCAM) and supported in part by a gift from The Bernard Osher Foundation. The project described was supported by Clinical Translational Science Award UL1RR025758 to Harvard University and Beth Israel Deaconess Medical Center from the National Center for Research Resources. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Complementary Alternative Medicine or the National Center for Research Resources or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Hijleh MF, 2006, SURG RADIOL ANAT, V28, P606, DOI 10.1007/s00276-006-0142-8; Ahn AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011907; Caggiati A, 2000, SURG RADIOL ANAT, V22, P191, DOI 10.1007/s00276-000-0191-3; Caggiati A, 2001, J VASC SURG, V34, P241, DOI 10.1067/mva.2001.116972; Hollinshead W.H., 1985, TXB ANATOMY; Hsu C J, 1992, J COMPUTATIONAL GRAP, V1, P151; Jahne B, 1993, SPATIAL TEMPORAL IMA; Johnson D, 1996, Clin Anat, V9, P19, DOI 10.1002/(SICI)1098-2353(1996)9:1<19::AID-CA4>3.0.CO;2-V; Langevin HM, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-25; Langevin HM, 2006, MED HYPOTHESES, V66, P1074, DOI 10.1016/j.mehy.2005.12.032; LOCKWOOD TE, 1991, PLAST RECONSTR SURG, V87, P1009, DOI 10.1097/00006534-199106000-00001; Nash LG, 2004, CLIN ANAT, V17, P287, DOI 10.1002/ca.10203; Vader D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005902	13	1	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e23987	10.1371/journal.pone.0023987	http://dx.doi.org/10.1371/journal.pone.0023987			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CK	21931632	Green Submitted, Green Published, gold			2022-12-25	WOS:000294802800017
J	Spivak, DI; Giesa, T; Wood, E; Buehler, MJ				Spivak, David I.; Giesa, Tristan; Wood, Elizabeth; Buehler, Markus J.			Category Theoretic Analysis of Hierarchical Protein Materials and Social Networks	PLOS ONE			English	Article							PREDICTION; MECHANICS; EVOLUTION; LANGUAGE; FRACTURE; BIOLOGY	Materials in biology span all the scales from Angstroms to meters and typically consist of complex hierarchical assemblies of simple building blocks. Here we describe an application of category theory to describe structural and resulting functional properties of biological protein materials by developing so-called ologs. An olog is like a "concept web'' or "semantic network'' except that it follows a rigorous mathematical formulation based on category theory. This key difference ensures that an olog is unambiguous, highly adaptable to evolution and change, and suitable for sharing concepts with other olog. We consider simple cases of beta-helical and amyloid-like protein filaments subjected to axial extension and develop an olog representation of their structural and resulting mechanical properties. We also construct a representation of a social network in which people send text-messages to their nearest neighbors and act as a team to perform a task. We show that the olog for the protein and the olog for the social network feature identical category-theoretic representations, and we proceed to precisely explicate the analogy or isomorphism between them. The examples presented here demonstrate that the intrinsic nature of a complex system, which in particular includes a precise relationship between structure and function at different hierarchical levels, can be effectively represented by an olog. This, in turn, allows for comparative studies between disparate materials or fields of application, and results in novel approaches to derive functionality in the design of de novo hierarchical systems. We discuss opportunities and challenges associated with the description of complex biological materials by using ologs as a powerful tool for analysis and design in the context of materiomics, and we present the potential impact of this approach for engineering, life sciences, and medicine.	[Spivak, David I.] MIT, Dept Math, Cambridge, MA 02139 USA; [Giesa, Tristan; Wood, Elizabeth; Buehler, Markus J.] MIT, Dept Civil & Environm Engn, Lab Atomist & Mol Mech, Cambridge, MA 02139 USA; [Giesa, Tristan] Rhein Westfal TH Aachen, Dept Mech Engn, Aachen, Germany; [Buehler, Markus J.] MIT, Ctr Mat Sci & Engn, Cambridge, MA 02139 USA; [Buehler, Markus J.] MIT, Ctr Computat Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); RWTH Aachen University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Spivak, DI (corresponding author), MIT, Dept Math, Cambridge, MA 02139 USA.	mbuehler@MIT.EDU	Buehler, Markus J./C-4580-2008	Buehler, Markus J./0000-0002-4173-9659; Wood, Elizabeth/0000-0002-6766-6865	DOD-PECASE award [N000141010562]; DOD-MURI [W911NF0910541]; Office of Naval Research [N000141010841]; German Academic Foundation (Studienstiftung des deutschen Volkes)	DOD-PECASE award; DOD-MURI(MURIUnited States Department of Defense); Office of Naval Research(Office of Naval Research); German Academic Foundation (Studienstiftung des deutschen Volkes)	MJB and TG acknowledge support from a DOD-PECASE award (N000141010562) and DOD-MURI (W911NF0910541). DIS acknowledges support from Office of Naval Research grant (N000141010841) as well as generous support from Clark Barwick, Jacob Lurie, and the Massachusetts Institute of Technology Department of Mathematics. TG acknowledges support from the German Academic Foundation (Studienstiftung des deutschen Volkes). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackbarow T, 2007, P NATL ACAD SCI USA, V104, P16410, DOI 10.1073/pnas.0705759104; Aizenberg J, 2005, SCIENCE, V309, P275, DOI 10.1126/science.1112255; Alberts B, 2002, MOL BIOL CELL; [Anonymous], 2010, CATEGORY THEORY; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barr M, 1995, CATEGORY THEORY COMP; Brown R, 2006, WHAT IS CATEGORY THE; Buehler MJ, 2010, NANO TODAY, V5, P379, DOI 10.1016/j.nantod.2010.08.001; Buehler MJ, 2009, NAT MATER, V8, P175, DOI 10.1038/nmat2387; Chomsky N., 1957, SYNTACTIC STRUCTURES; Cranford S, 2010, NANOTECHNOL SCI APPL, V3, P127, DOI 10.2147/NSA.S9037; Csermely P, 2008, TRENDS BIOCHEM SCI, V33, P569, DOI 10.1016/j.tibs.2008.09.006; Currey JD, 2005, SCIENCE, V309, P253, DOI 10.1126/science.1113954; EILENBERG S, 1945, T AM MATH SOC, V58, P231, DOI 10.2307/1990284; Eisenberg D, 2000, NATURE, V405, P823, DOI 10.1038/35015694; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; Fratzl P, 2009, NATURE, V462, P442, DOI 10.1038/nature08603; Fritsch A, 2007, J THEOR BIOL, V244, P597, DOI 10.1016/j.jtbi.2006.09.013; Hauser MD, 2002, SCIENCE, V298, P1569, DOI 10.1126/science.298.5598.1569; Hofstetter K, 2005, EUR J MECH A-SOLID, V24, P1030, DOI 10.1016/j.euromechsol.2005.05.006; Huebsch N, 2009, NATURE, V462, P426, DOI 10.1038/nature08601; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Keten S, 2010, NAT MATER, V9, P359, DOI [10.1038/nmat2704, 10.1038/NMAT2704]; LAKES R, 1993, NATURE, V361, P511, DOI 10.1038/361511a0; Lawvere F.W., 2009, CONCEPTUAL MATH 1 IN; Lawvere FW, 1965, CATEGORY CATEGORIES; Lee I, 2004, SCIENCE, V306, P1555, DOI 10.1126/science.1099511; Mac Lane S., 1998, CATEGORIES WORKING M, V5; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; Mason O, 2007, IET SYST BIOL, V1, P89, DOI 10.1049/iet-syb:20060038; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Moggi E, 1989, P CATEGORY THEORY CO; Moortgat M., 1988, CATEGORIAL INVESTIGA, DOI 10.1515/9783112329580; Nurse P, 1998, REDUCTIONISM EXPLANA; Oehrle RT, 1988, CATEGORIAL GRAMMARS; Olson GB, 2000, SCIENCE, V288, P993, DOI 10.1126/science.288.5468.993; Paparcone R, 2011, BIOMATERIALS, V32, P3367, DOI 10.1016/j.biomaterials.2010.11.066; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Peterlik H, 2006, NAT MATER, V5, P52, DOI 10.1038/nmat1545; Pierce BC, 1996, BASIC CATEGORY THEOR; Powell WW, 2005, AM J SOCIOL, V110, P1132, DOI 10.1086/421508; Pugno NM, 2007, MED HYPOTHESES, V69, P441, DOI 10.1016/j.mehy.2006.10.067; Rodriguez E, 1999, NATURE, V397, P430, DOI 10.1038/17120; Schneider CM, 2011, EPL-EUROPHYS LETT, V95, DOI 10.1209/0295-5075/95/16001; Searls DB, 2002, NATURE, V420, P211, DOI 10.1038/nature01255; Sica G., 2006, WHAT IS CATEGORY THE; Spivak DI, 2011, ARXIV11021889V2; Strohman RC, 1997, NAT BIOTECHNOL, V15, P194, DOI 10.1038/nbt0397-194; Szalay MS, 2007, FEBS LETT, V581, P3675, DOI 10.1016/j.febslet.2007.03.083; Taylor D, 2007, NAT MATER, V6, P263, DOI 10.1038/nmat1866; Verdasca J, 2005, J THEOR BIOL, V233, P553, DOI 10.1016/j.jtbi.2004.10.031; Wadler P, 1992, MATH STRUCTURES COMP, V2, P461	55	34	35	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e23911	10.1371/journal.pone.0023911	http://dx.doi.org/10.1371/journal.pone.0023911			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CK	21931622	Green Published, Green Submitted, gold			2022-12-25	WOS:000294802800014
J	Myrden, AJB; Kushki, A; Sejdic, E; Guerguerian, AM; Chau, T				Myrden, Andrew J. B.; Kushki, Azadeh; Sejdic, Ervin; Guerguerian, Anne-Marie; Chau, Tom			A Brain-Computer Interface Based on Bilateral Transcranial Doppler Ultrasound	PLOS ONE			English	Article							BLOOD-FLOW-VELOCITY; MIDDLE CEREBRAL-ARTERY; COGNITIVE TASKS; ULTRASONOGRAPHY; LATERALIZATION; SONOGRAPHY; SIGNALS	In this study, we investigate the feasibility of a BCI based on transcranial Doppler ultrasound (TCD), a medical imaging technique used to monitor cerebral blood flow velocity. We classified the cerebral blood flow velocity changes associated with two mental tasks - a word generation task, and a mental rotation task. Cerebral blood flow velocity was measured simultaneously within the left and right middle cerebral arteries while nine able-bodied adults alternated between mental activity (i.e. word generation or mental rotation) and relaxation. Using linear discriminant analysis and a set of time-domain features, word generation and mental rotation were classified with respective average accuracies of 82.9% +/- 10.5 and 85.7% +/- 10.0 across all participants. Accuracies for all participants significantly exceeded chance. These results indicate that TCD is a promising measurement modality for BCI research.	[Myrden, Andrew J. B.; Kushki, Azadeh; Sejdic, Ervin; Chau, Tom] Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Toronto, ON, Canada; [Myrden, Andrew J. B.; Chau, Tom] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [Sejdic, Ervin] Univ Pittsburgh, Dept Elect & Comp Engn, Pittsburgh, PA USA; [Guerguerian, Anne-Marie] Hosp Sick Children, Dept Crit Care Med, Toronto, ON M5G 1X8, Canada; [Guerguerian, Anne-Marie] Hosp Sick Children, Dept Pediat, Toronto, ON M5G 1X8, Canada; [Guerguerian, Anne-Marie] Hosp Sick Children, Res Inst, Neurosci & Mental Hlth Res Program, Toronto, ON M5G 1X8, Canada; [Guerguerian, Anne-Marie] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A1, Canada	University of Toronto; University Toronto Affiliates; Holland Bloorview Kids Rehabilitation Hospital; University of Toronto; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Myrden, AJB (corresponding author), Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Toronto, ON, Canada.	andrew.myrden@utoronto.ca	Chau, Tom TK/C-8426-2009	Chau, Tom TK/0000-0002-7486-0316; Sejdic, Ervin/0000-0003-4987-8298	Canada Research Chairs program; Canada Foundation for Innovation; Ontario Centres of Excellence; Natural Sciences and Engineering Research Council of Canada; Bloorview Research Institute	Canada Research Chairs program(Canada Research Chairs); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ontario Centres of Excellence; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Bloorview Research Institute	This study was supported by funding from the Canada Research Chairs program, the Canada Foundation for Innovation, the Ontario Centres of Excellence, the Natural Sciences and Engineering Research Council of Canada, and the Bloorview Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASLID R, 1987, STROKE, V18, P771, DOI 10.1161/01.STR.18.4.771; AASLID R, 1982, J NEUROSURG, V57, P769, DOI 10.3171/jns.1982.57.6.0769; Alexandrov AV, 2007, J NEUROIMAGING, V17, P11, DOI 10.1111/j.1552-6569.2006.00088.x; Allison BZ, 2007, EXPERT REV MED DEVIC, V4, P463, DOI 10.1586/17434440.4.4.463; Birbaumer N, 2008, CURR OPIN NEUROL, V21, P634, DOI 10.1097/WCO.0b013e328315ee2d; BullaHellwig M, 1996, NEUROPSYCHOLOGIA, V34, P987, DOI 10.1016/0028-3932(96)00021-8; Duschek S, 2003, PSYCHOPHYSIOLOGY, V40, P436, DOI 10.1111/1469-8986.00046; FARWELL LA, 1988, ELECTROEN CLIN NEURO, V70, P510, DOI 10.1016/0013-4694(88)90149-6; FOLEY DH, 1975, IEEE T COMPUT, VC 24, P281, DOI 10.1109/T-C.1975.224208; GUR RC, 1980, BRAIN LANG, V9, P78, DOI 10.1016/0093-934X(80)90073-5; Haag A, 2010, DEV MED CHILD NEUROL, V52, P331, DOI 10.1111/j.1469-8749.2009.03362.x; HARDERS AG, 1989, INT J NEUROSCI, V47, P91, DOI 10.3109/00207458908987421; HARTJE W, 1994, NEUROPSYCHOLOGIA, V32, P1443, DOI 10.1016/0028-3932(94)90116-3; Kubler A, 2001, PSYCHOL BULL, V127, P358, DOI 10.1037//0033-2909.127.3.358; Lecuyer A, 2008, COMPUTER, V41, P66, DOI 10.1109/MC.2008.410; Leeb Robert, 2007, Comput Intell Neurosci, P79642, DOI 10.1155/2007/79642; Lowe LH, 2005, PEDIATR RADIOL, V35, P54, DOI 10.1007/s00247-004-1257-x; Lule D, 2009, PROG BRAIN RES, V177, P339, DOI 10.1016/S0079-6123(09)17723-3; MARKWALDER TM, 1984, J CEREBR BLOOD F MET, V4, P368, DOI 10.1038/jcbfm.1984.54; Mellinger J, 2007, NEUROIMAGE, V36, P581, DOI 10.1016/j.neuroimage.2007.03.019; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Panerai RB, 2009, CLIN AUTON RES, V19, P197, DOI 10.1007/s10286-009-0011-8; PETERS M, 1995, BRAIN COGNITION, V28, P39, DOI 10.1006/brcg.1995.1032; Peters M, 2008, BRAIN COGNITION, V66, P260, DOI 10.1016/j.bandc.2007.09.003; Peters M, 2007, ARCH SEX BEHAV, V36, P251, DOI 10.1007/s10508-006-9166-8; Power SD, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/2/026002; RINGELSTEIN EB, 1990, ULTRASOUND MED BIOL, V16, P745, DOI 10.1016/0301-5629(90)90039-F; Safety Grp British Med Ultrasound, 2010, ULTRASOUND, V18, P52, DOI 10.1258/ult.2010.100003; Saqqur M, 2007, CRIT CARE MED, V35, pS216, DOI 10.1097/01.CCM.0000260633.66384.FB; Sarkar S, 2007, POSTGRAD MED J, V83, P683, DOI 10.1136/pgmj.2007.058602; Sellers EW, 2006, CLIN NEUROPHYSIOL, V117, P538, DOI 10.1016/j.clinph.2005.06.027; Sitaram R, 2007, NEUROIMAGE, V34, P1416, DOI 10.1016/j.neuroimage.2006.11.005; Stroobant N, 2000, NEUROPSYCHOL REV, V10, P213, DOI 10.1023/A:1026412811036; Szirmai I, 2005, COGNITIVE BRAIN RES, V24, P33, DOI 10.1016/j.cogbrainres.2004.12.011; Tai K, 2008, ASSIST TECHNOL, V20, P204, DOI 10.1080/10400435.2008.10131947; Tegeler C., 1999, TRANSCRANIAL DOPPLER, P3; Tsivgoulis G, 2009, CURR NEUROL NEUROSCI, V9, P46, DOI 10.1007/s11910-009-0008-7; Vingerhoets G, 1999, STROKE, V30, P2152, DOI 10.1161/01.STR.30.10.2152; Weiskopf N, 2004, IEEE T BIO-MED ENG, V51, P966, DOI 10.1109/TBME.2004.827063; Wessels T, 2006, ULTRASOUND MED BIOL, V32, P1845, DOI 10.1016/j.ultrasmedbio.2006.06.023; Whitehouse AJO, 2009, J INT NEUROPSYCH SOC, V15, P1028, DOI 10.1017/S1355617709990555; Wolpaw JR, 2006, IEEE T NEUR SYS REH, V14, P138, DOI 10.1109/TNSRE.2006.875583; Wolpaw JR, 2000, IEEE T REHABIL ENG, V8, P164, DOI 10.1109/TRE.2000.847807; Wolpaw JR, 2004, P NATL ACAD SCI USA, V101, P17849, DOI 10.1073/pnas.0403504101	44	34	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2011	6	9							e24170	10.1371/journal.pone.0024170	http://dx.doi.org/10.1371/journal.pone.0024170			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CH	21915292	Green Published, gold, Green Accepted			2022-12-25	WOS:000294802500031
J	Risberg, K; Fodstad, O; Andersson, Y				Risberg, Karianne; Fodstad, Oystein; Andersson, Yvonne			Synergistic Anticancer Effects of the 9.2.27PE Immunotoxin and ABT-737 in Melanoma	PLOS ONE			English	Article							EFFICIENTLY INDUCES APOPTOSIS; ENDOPLASMIC-RETICULUM; BCL-2 FAMILY; PSEUDOMONAS EXOTOXIN; CELL-DEATH; MCL-1; RECEPTOR; PROTEIN; EXPRESSION; INHIBITOR	In cancer, combinations of drugs targeting different cellular functions is well accepted to improve tumor control. We studied the effects of a Pseudomonas exotoxin A (PE) -based immunotoxin, the 9.2.27PE, and the BH-3 mimetic compound ABT-737 in a panel of melanoma cell lines. The drug combination resulted in synergistic cytotoxicity, and the cell death observed was associated with apoptosis, as activation of caspase-3, inactivation of Poly (ADP-ribose) polymerase (PARP) and increased DNA fragmentation could be prevented by pre-treatment with caspase and cathepsin inhibitors. We further show that ABT-737 caused endoplasmic reticulum (ER) stress with increased GRP78 and phosphorylated eIF2 alpha protein levels. Moreover, treatment with ABT-737 increased the intracellular calcium levels, an effect which was enhanced by 9.2.27PE, which as a single entity drug had minimal effect on calcium release from the ER. In addition, silencing of Mcl-1 by short hairpin RNA (shRNA) enhanced the intracellular calcium levels and cytotoxicity caused by ABT-737. Notably, the combination of 9.2.27PE and ABT-737 caused growth delay in a human melanoma xenograft mice model, supporting further investigations of this particular drug combination.	[Risberg, Karianne; Fodstad, Oystein; Andersson, Yvonne] Oslo Univ Hosp Radiumhosp, Inst Canc Res, Dept Tumor Biol, Oslo, Norway	University of Oslo	Risberg, K (corresponding author), Oslo Univ Hosp Radiumhosp, Inst Canc Res, Dept Tumor Biol, Oslo, Norway.	Karianne.Risberg@rr-research.no			Norwegian Extra Foundation for Health and Rehabilitation [2008/2/0054]; South-Eastern Norway Regional Health Authority [32254/6051]	Norwegian Extra Foundation for Health and Rehabilitation; South-Eastern Norway Regional Health Authority	This work was supported by Norwegian Extra Foundation for Health and Rehabilitation (project number 2008/2/0054) and South-Eastern Norway Regional Health Authority (32254/6051). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson Y, 2004, INT J CANCER, V112, P475, DOI 10.1002/ijc.20371; Andersson Y, 2009, BRIT J CANCER, V101, P1307, DOI 10.1038/sj.bjc.6605312; Bollag G, 2010, NATURE, V467, P596, DOI 10.1038/nature09454; Chang CC, 2004, ANN NY ACAD SCI, V1028, P340, DOI 10.1196/annals.1322.040; Chou TC, 2006, PHARMACOL REV, V58, P621, DOI 10.1124/pr.58.3.10; Cummins DL, 2006, MAYO CLIN PROC, V81, P500, DOI 10.4065/81.4.500; Curry BJ, 1996, MELANOMA RES, V6, P45, DOI 10.1097/00008390-199602000-00007; Decuypere J.-P., 2011, J AGING RES, DOI [10.4061/2011/920178, DOI 10.4061/2011/920178]; Distelhorst CW, 2010, CELL CALCIUM; Eckenrode EF, 2010, J BIOL CHEM, V285, P13678, DOI 10.1074/jbc.M109.096040; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; FODSTAD O, 1994, J CELL BIOCHEM, V56, P23, DOI 10.1002/jcb.240560106; Han ZY, 1997, J BIOL CHEM, V272, P13432, DOI 10.1074/jbc.272.20.13432; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Hermanson D, 2009, MOL PHARMACOL, V76, P667, DOI 10.1124/mol.109.055830; Hikita H, 2010, HEPATOLOGY, V52, P1310, DOI 10.1002/hep.23836; Inuzuka H, 2011, ONCOTARGET, V2, P239; Joseph SK, 2007, APOPTOSIS, V12, P951, DOI 10.1007/s10495-007-0719-7; Mason KD, 2008, P NATL ACAD SCI USA, V105, P17961, DOI 10.1073/pnas.0809957105; Mihic LL, 2010, COLLEGIUM ANTROPOL, V34, P303; NATALI PG, 1983, J CUTAN PATHOL, V10, P225, DOI 10.1111/j.1600-0560.1983.tb01489.x; Norberg E, 2010, BIOCHEM BIOPH RES CO, V396, P95, DOI 10.1016/j.bbrc.2010.02.163; Oakes SA, 2005, P NATL ACAD SCI USA, V102, P105, DOI 10.1073/pnas.0408352102; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Risberg K, 2010, J IMMUNOTHER, V33, P272, DOI 10.1097/CJI.0b013e3181c54991; Risberg K, 2009, INT J CANCER, V125, P23, DOI 10.1002/ijc.24317; Rong YP, 2009, BBA-MOL CELL RES, V1793, P971, DOI 10.1016/j.bbamcr.2008.10.015; Satyamoorthy K, 2003, CANCER RES, V63, P756; Smalley KSM, 2009, BRIT J CANCER, V100, P431, DOI 10.1038/sj.bjc.6604891; Soengas MS, 2003, ONCOGENE, V22, P3138, DOI 10.1038/sj.onc.1206454; Straten PT, 2010, ONCOTARGET, V1, P239; Szegezdi E, 2009, AM J PHYSIOL-CELL PH, V296, pC941, DOI 10.1152/ajpcell.00612.2008; Tao WK, 2007, MOL CELL BIOL, V27, P689, DOI 10.1128/MCB.01505-06; Traini R, 2010, MOL CANCER THER, V9, P2007, DOI 10.1158/1535-7163.MCT-10-0257; Tsai Yien Che, 2010, Genes Cancer, V1, P764; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; White C, 2005, NAT CELL BIOL, V7, P1021, DOI 10.1038/ncb1302; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Xu HS, 2010, CLIN CANCER RES, V16, P4392, DOI 10.1158/1078-0432.CCR-10-0640; Yecies D, 2010, BLOOD, V115, P3304, DOI 10.1182/blood-2009-07-233304; Zhang XD, 1999, CANCER RES, V59, P2747	41	33	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2011	6	9							e24012	10.1371/journal.pone.0024012	http://dx.doi.org/10.1371/journal.pone.0024012			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CH	21915275	Green Submitted, Green Published, gold			2022-12-25	WOS:000294802500022
J	Astikainen, P; Stefanics, G; Nokia, M; Lipponen, A; Cong, FY; Penttonen, M; Ruusuvirta, T				Astikainen, Piia; Stefanics, Gabor; Nokia, Miriam; Lipponen, Arto; Cong, Fengyu; Penttonen, Markku; Ruusuvirta, Timo			Memory-Based Mismatch Response to Frequency Changes in Rats	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; STIMULUS-SPECIFIC ADAPTATION; ANESTHETIZED RATS; NEGATIVITY MMN; AUDITORY THALAMUS; PROPOFOL SEDATION; CORTICAL-NEURONS; SENSORY MEMORY; PITCH CHANGE; BRAIN	Any occasional changes in the acoustic environment are of potential importance for survival. In humans, the preattentive detection of such changes generates the mismatch negativity (MMN) component of event-related brain potentials. MMN is elicited to rare changes ('deviants') in a series of otherwise regularly repeating stimuli ('standards'). Deviant stimuli are detected on the basis of a neural comparison process between the input from the current stimulus and the sensory memory trace of the standard stimuli. It is, however, unclear to what extent animals show a similar comparison process in response to auditory changes. To resolve this issue, epidural potentials were recorded above the primary auditory cortex of urethane-anesthetized rats. In an oddball condition, tone frequency was used to differentiate deviants interspersed randomly among a standard tone. Mismatch responses were observed at 60-100 ms after stimulus onset for frequency increases of 5% and 12.5% but not for similarly descending deviants. The response diminished when the silent inter-stimulus interval was increased from 375 ms to 600 ms for +5% deviants and from 600 ms to 1000 ms for +12.5% deviants. In comparison to the oddball condition the response also diminished in a control condition in which no repetitive standards were presented (equiprobable condition). These findings suggest that the rat mismatch response is similar to the human MMN and indicate that anesthetized rats provide a valuable model for studies of central auditory processing.	[Astikainen, Piia; Nokia, Miriam; Penttonen, Markku; Ruusuvirta, Timo] Univ Jyvaskyla, Dept Psychol, Jyvaskyla, Finland; [Stefanics, Gabor] Hungarian Acad Sci, Inst Psychol, Budapest, Hungary; [Stefanics, Gabor] Univ Zurich, Inst Empir Res Econ, Zurich, Switzerland; [Lipponen, Arto] Univ Eastern Finland, Dept Neurobiol, AI Virtanen Inst, Kuopio, Finland; [Cong, Fengyu] Univ Jyvaskyla, Dept Math Informat Technol, Jyvaskyla, Finland; [Ruusuvirta, Timo] Univ Turku, Dept Psychol, Turku Inst Adv Studies, Turku, Finland	University of Jyvaskyla; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; University of Zurich; University of Eastern Finland; University of Jyvaskyla; University of Turku	Astikainen, P (corresponding author), Univ Jyvaskyla, Dept Psychol, Jyvaskyla, Finland.	piia.astikainen@jyu.fi	Nokia, Miriam/AAL-7599-2021; Stefanics, Gabor/M-9955-2019; Penttonen, Markku/B-8348-2013; Astikainen, Piia/ABE-4699-2020	Stefanics, Gabor/0000-0002-0324-0996; Penttonen, Markku/0000-0002-1033-7286; Astikainen, Piia/0000-0003-4842-7460; Nokia, Miriam/0000-0003-2222-6118; Cong, Fengyu/0000-0003-0058-2429; Lipponen, Arto/0000-0001-6201-6647	Academy of Finland [127595]	Academy of Finland(Academy of Finland)	The study was supported by the Academy of Finland (project no. 127595 to PA; http://www.aka.fi/en-GB/A/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALHO K, 1990, ELECTROEN CLIN NEURO, V77, P151, DOI 10.1016/0168-5597(90)90031-8; Anderson LA, 2009, J NEUROSCI, V29, P7359, DOI 10.1523/JNEUROSCI.0793-09.2009; Antunes FM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014071; Astikainen P, 2005, EXP BRAIN RES, V160, P189, DOI 10.1007/s00221-004-1999-6; Astikainen P, 2006, NEUROREPORT, V17, P1561, DOI 10.1097/01.wnr.0000233097.13032.7d; BOTTCHERGANDOR C, 1992, PSYCHOPHYSIOLOGY, V29, P546, DOI 10.1111/j.1469-8986.1992.tb02028.x; COWAN N, 1984, PSYCHOL BULL, V96, P341, DOI 10.1037/0033-2909.96.2.341; CSEPE V, 1987, ELECTROEN CLIN NEURO, V66, P571, DOI 10.1016/0013-4694(87)90103-9; CSEPE V, 1989, SLEEP 88, P210; DARWIN CJ, 1972, COGNITIVE PSYCHOL, V3, P255, DOI 10.1016/0010-0285(72)90007-2; Heinke W, 2004, ANESTHESIOLOGY, V100, P617, DOI 10.1097/00000542-200403000-00023; Jacobsen T, 2001, PSYCHOPHYSIOLOGY, V38, P723, DOI 10.1017/S0048577201000993; Jacobsen T, 2003, NEUROSCI LETT, V344, P79, DOI 10.1016/S0304-3940(03)00408-7; JAVITT DC, 1992, ELECTROEN CLIN NEURO, V83, P87, DOI 10.1016/0013-4694(92)90137-7; KELLY JB, 1977, J COMP PHYSIOL PSYCH, V91, P930, DOI 10.1037/h0077356; KING C, 1995, HEARING RES, V85, P45, DOI 10.1016/0378-5955(95)00028-3; Kishon-Rabin Liat, 2004, Journal of Basic and Clinical Physiology and Pharmacology, V15, P29; Koelsch S, 2006, CLIN NEUROPHYSIOL, V117, P1746, DOI 10.1016/j.clinph.2006.05.009; KRAUS N, 1994, J ACOUST SOC AM, V96, P2758, DOI 10.1121/1.411282; Lazar R, 2003, HEARING RES, V181, P51, DOI 10.1016/S0378-5955(03)00166-7; Malmierca MS, 2009, J NEUROSCI, V29, P5483, DOI 10.1523/JNEUROSCI.4153-08.2009; MANTYSALO S, 1987, BIOL PSYCHOL, V24, P183, DOI 10.1016/0301-0511(87)90001-9; May PJC, 2010, PSYCHOPHYSIOLOGY, V47, P66, DOI 10.1111/j.1469-8986.2009.00856.x; Naatanen R, 2005, PSYCHOPHYSIOLOGY, V42, P25, DOI 10.1111/j.1469-8986.2005.00256.x; NAATANEN R, 1978, ACTA PSYCHOL, V42, P313, DOI 10.1016/0001-6918(78)90006-9; NAATANEN R, 1990, BEHAV BRAIN SCI, V13, P201, DOI 10.1017/S0140525X00078407; Naatanen R, 1999, PSYCHOL BULL, V125, P826, DOI 10.1037/0033-2909.125.6.826; Nelken I, 2007, J PSYCHOPHYSIOL, V21, P214, DOI 10.1027/0269-8803.21.34.214; Peter V, 2010, NEUROSCI LETT, V482, P71, DOI 10.1016/j.neulet.2010.07.010; Pratt H, 2009, CLIN NEUROPHYSIOL, V120, P360, DOI 10.1016/j.clinph.2008.10.158; Ruusuvirta T, 1998, NEUROSCI LETT, V248, P45, DOI 10.1016/S0304-3940(98)00330-9; Ruusuvirta T, 1996, NEUROREPORT, V7, P413, DOI 10.1097/00001756-199601310-00009; Ruusuvirta T, 2010, NEUROSCIENCE, V170, P232, DOI 10.1016/j.neuroscience.2010.06.062; Ruusuvirta T, 2007, EUR J NEUROSCI, V26, P701, DOI 10.1111/j.1460-9568.2007.05687.x; SAMS M, 1993, J COGNITIVE NEUROSCI, V5, P363, DOI 10.1162/jocn.1993.5.3.363; Schroger E, 1996, NEUROREPORT, V7, P3005, DOI 10.1097/00001756-199611250-00041; Syka J, 1996, HEARING RES, V100, P107, DOI 10.1016/0378-5955(96)00101-3; TIITINEN H, 1994, NATURE, V372, P90, DOI 10.1038/372090a0; Tikhonravov D, 2010, NEUROSCIENCE, V167, P1175, DOI 10.1016/j.neuroscience.2010.03.014; Tikhonravov D, 2008, BRAIN RES, V1203, P97, DOI 10.1016/j.brainres.2008.02.006; Ulanovsky N, 2003, NAT NEUROSCI, V6, P391, DOI 10.1038/nn1032; Umbricht D, 2005, CLIN NEUROPHYSIOL, V116, P353, DOI 10.1016/j.clinph.2004.08.015; von der Behrens W, 2009, J NEUROSCI, V29, P13837, DOI 10.1523/JNEUROSCI.3475-09.2009	43	51	52	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2011	6	9							e24208	10.1371/journal.pone.0024208	http://dx.doi.org/10.1371/journal.pone.0024208			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817QP	21915297	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000294689200025
J	Dossena, S; Gandini, R; Tamma, G; Vezzoli, V; Nofziger, C; Tamplenizza, M; Salvioni, E; Bernardinelli, E; Meyer, G; Valenti, G; Wolf-Watz, M; Furst, J; Paulmichl, M				Dossena, Silvia; Gandini, Rosaria; Tamma, Grazia; Vezzoli, Valeria; Nofziger, Charity; Tamplenizza, Margherita; Salvioni, Elisabetta; Bernardinelli, Emanuele; Meyer, Giuliano; Valenti, Giovanna; Wolf-Watz, Magnus; Fuerst, Johannes; Paulmichl, Markus			The Molecular and Functional Interaction between ICln and HSPC038 Proteins Modulates the Regulation of Cell Volume	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAENORHABDITIS-ELEGANS OPERONS; MEMBRANE TRANSPOSITION; CHLORIDE CHANNELS; ANION CHANNEL; I-CLN; TRANSLOCATION; ACTIVATION; CYTOSOL; PICLN; CONDUCTANCE	Identifying functional partners for protein/protein interactions can be a difficult challenge. We proposed the use of the operon structure of the Caenorhabditis elegans genome as a "new gene-finding tool" (Eichmuller, S., Vezzoli, V., Bazzini, C., Ritter, M., Furst, J., Jakab, M., Ravasio, A., Chwatal, S., Dossena, S., Botta, G., Meyer, G., Maier, B., Valenti, G., Lang, F., and Paulmichl, M. (2004) J. Biol. Chem. 279, 7136 7146) that could be functionally translated to the human system. Here we show the validity of this approach by studying the predicted functional interaction between ICln and HSPC038. In C. elegans, the gene encoding for the ICln homolog (icln-1) is embedded in an operon with two other genes, Nx (the human homolog of Nx is HSPC038) and Ny. ICln is a highly conserved, ubiquitously expressed multifunctional protein that plays a critical role in the regulatory volume decrease after cell swelling. Following hypotonic stress, ICln translocates from the cytosol to the plasma membrane, where it has been proposed to participate in the activation of the swelling-induced chloride current (IClswell). Here we show that the interaction between human ICln and HSPC038 plays a role in volume regulation after cell swelling and that HSPC038 acts as an escort, directing ICln to the cell membrane after cell swelling and facilitating the activation of IClswell. Assessment of the NMR structure of HSPC038 showed the presence of a zinc finger motif. Moreover, NMR and additional biochemical techniques enabled us to identify the putative ICln/HSPC038 interacting sites, thereby explaining the functional interaction of both proteins on a molecular level.	[Dossena, Silvia; Nofziger, Charity; Tamplenizza, Margherita; Salvioni, Elisabetta; Bernardinelli, Emanuele; Paulmichl, Markus] Paracelsus Med Univ, Inst Pharmacol & Toxicol, A-5020 Salzburg, Austria; [Gandini, Rosaria; Fuerst, Johannes] Innsbruck Med Univ, Dept Physiol & Med Phys, A-6020 Innsbruck, Austria; [Gandini, Rosaria] Karolinska Inst, Dept Med Biochem & Biophys, SE-17177 Stockholm, Sweden; [Tamma, Grazia; Valenti, Giovanna] Univ Bari, Dept Gen & Environm Physiol, I-70125 Bari, Italy; [Vezzoli, Valeria; Tamplenizza, Margherita; Salvioni, Elisabetta; Meyer, Giuliano] Univ Milan, Dept Biomol Sci & Biotechnol, I-20133 Milan, Italy; [Wolf-Watz, Magnus] Umea Univ, Dept Chem, Chem Biol Ctr, SE-90187 Umea, Sweden	Paracelsus Private Medical University; Medical University of Innsbruck; Karolinska Institutet; Universita degli Studi di Bari Aldo Moro; University of Milan; Umea University	Dossena, S (corresponding author), Paracelsus Med Univ, Inst Pharmacol & Toxicol, A-5020 Salzburg, Austria.	silvia.dossena@pmu.ac.at	Dossena, Silvia/G-1437-2018; Salvioni, Elisabetta/ABD-9775-2020; Meyer, Giuliano/G-8062-2011; Tamma, Grazia/F-8823-2016	Tamma, Grazia/0000-0002-8890-0278; Salvioni, Elisabetta/0000-0002-8448-7551; Gandini, Rosaria/0000-0003-4171-0693; BERNARDINELLI, EMANUELE/0000-0002-6119-3067; Vezzoli, Valeria/0000-0001-6396-7284; VALENTI, GIOVANNA/0000-0003-0233-0778	Fonds zur Forderung der Wissenschaftlichen Forschung [P18608, P17119, M11108-B11]; Swedish Research Council [621-2010-5247]	Fonds zur Forderung der Wissenschaftlichen Forschung(Austrian Science Fund (FWF)); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported in part by Fonds zur Forderung der Wissenschaftlichen Forschung Grants P18608 (to M.P.) and P17119 (to J.F.).; Supported by the Lise Meitner stipend of Fonds zur Forderung der Wissenschaftlichen Forschung Grant M11108-B11.; Supported by Swedish Research Council Grant 621-2010-5247.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Blumenthal T, 2002, NATURE, V417, P851, DOI 10.1038/nature00831; CHEN BPC, 1994, GENE, V139, P73, DOI 10.1016/0378-1119(94)90525-8; Chen LX, 1999, AM J PHYSIOL-CELL PH, V276, pC182, DOI 10.1152/ajpcell.1999.276.1.C182; Choi JW, 1996, SCIENCE, V273, P239, DOI 10.1126/science.273.5272.239; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Eichmuller S, 2004, J BIOL CHEM, V279, P7136, DOI 10.1074/jbc.M307347200; Furst J, 2006, ACTA PHYSIOL, V187, P43, DOI 10.1111/j.1748-1716.2006.01549.x; Furst J, 2002, PFLUG ARCH EUR J PHY, V444, P1, DOI 10.1007/s00424-002-0805-1; Furst J, 2005, J BIOL CHEM, V280, P31276, DOI 10.1074/jbc.M500541200; Furst J, 2002, J BIOL CHEM, V277, P4435, DOI 10.1074/jbc.M107372200; Furst J, 2000, PFLUG ARCH EUR J PHY, V440, P100; Gandini R, 2008, CELL PHYSIOL BIOCHEM, V22, P579, DOI 10.1159/000185542; Garavaglia M, 2004, CELL PHYSIOL BIOCHEM, V14, P231, DOI 10.1159/000080332; Garavaglia ML, 2002, PFLUG ARCH EUR J PHY, V443, P748, DOI 10.1007/s00424-001-0772-y; Gschwentner M, 1996, J ALLERGY CLIN IMMUN, V98, pS98, DOI 10.1016/S0091-6749(96)80135-7; Gschwentner M, 1999, EXP PHYSIOL, V84, P1023; GSCHWENTNER M, 1995, MOL MED, V1, P407, DOI 10.1007/BF03401578; GSCHWENTNER M, 1995, PFLUG ARCH EUR J PHY, V430, P464, DOI 10.1007/BF00373882; Helgstrand M, 2000, J BIOMOL NMR, V18, P329, DOI 10.1023/A:1026729404698; Ho SN, 1996, NATURE, V382, P822, DOI 10.1038/382822a0; HOFFMANN EK, 1989, PHYSIOL REV, V69, P315, DOI 10.1152/physrev.1989.69.2.315; Hubert MD, 2000, BBA-BIOMEMBRANES, V1466, P105, DOI 10.1016/S0005-2736(00)00177-2; Jakab M, 2006, CONTRIB NEPHROL, V152, P161, DOI 10.1159/000096322; Jakab M, 2002, CELL PHYSIOL BIOCHEM, V12, P235, DOI 10.1159/000067895; Jakab M, 2006, CELL PHYSIOL BIOCHEM, V18, P21, DOI 10.1159/000095131; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Krapivinsky G, 1998, J BIOL CHEM, V273, P10811, DOI 10.1074/jbc.273.18.10811; KRAPIVINSKY GB, 1994, CELL, V76, P439, DOI 10.1016/0092-8674(94)90109-0; Larkin D, 2004, J BIOL CHEM, V279, P27286, DOI 10.1074/jbc.M402159200; Li CH, 1998, J GEN PHYSIOL, V112, P727, DOI 10.1085/jgp.112.6.727; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Meyer G, 2004, FEBS LETT, V559, P45, DOI 10.1016/S0014-5793(04)00020-1; MORGAN RA, 1992, NUCLEIC ACIDS RES, V20, P1293, DOI 10.1093/nar/20.6.1293; Musch MW, 1997, J EXP ZOOL, V277, P460, DOI 10.1002/(SICI)1097-010X(19970415)277:6<460::AID-JEZ6>3.0.CO;2-M; Musch MW, 1998, PFLUG ARCH EUR J PHY, V436, P415, DOI 10.1007/s004240050651; Okada Y, 1997, AM J PHYSIOL-CELL PH, V273, pC755, DOI 10.1152/ajpcell.1997.273.3.C755; Okada Y, 2009, J PHYSIOL-LONDON, V587, P2141, DOI 10.1113/jphysiol.2008.165076; Paulmichl M., 1992, NATURE, V356, P238; Pu WT, 1999, MOL CELL BIOL, V19, P4113; Ritter M, 2003, J BIOL CHEM, V278, P50163, DOI 10.1074/jbc.M300374200; Schedlbauer A, 2003, J BIOMOL NMR, V27, P399, DOI 10.1023/A:1025809828637; Strange K, 1998, J GEN PHYSIOL, V111, P617, DOI 10.1085/jgp.111.5.617; Tamma G, 2007, ENDOCRINOLOGY, V148, P1118, DOI 10.1210/en.2006-1277; Wienk H, 2009, BIOCHEMISTRY-US, V48, P4431, DOI 10.1021/bi9001997; Zhang QH, 2000, GENOME RES, V10, P1546, DOI 10.1101/gr.140200	46	15	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40659	40670		10.1074/jbc.M111.260430	http://dx.doi.org/10.1074/jbc.M111.260430			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21917931	Green Published, hybrid			2022-12-25	WOS:000297315400027
J	Bodon, G; Chassefeyre, R; Pernet-Gallay, K; Martinelli, N; Effantin, G; Hulsik, DL; Belly, A; Goldberg, Y; Chatellard-Causse, C; Blot, B; Schoehn, G; Weissenhorn, W; Sadoul, R				Bodon, Gilles; Chassefeyre, Romain; Pernet-Gallay, Karin; Martinelli, Nicolas; Effantin, Gregory; Hulsik, David Lutje; Belly, Agnes; Goldberg, Yves; Chatellard-Causse, Christine; Blot, Beatrice; Schoehn, Guy; Weissenhorn, Winfried; Sadoul, Remy			Charged Multivesicular Body Protein 2B (CHMP2B) of the Endosomal Sorting Complex Required for Transport-III (ESCRT-III) Polymerizes into Helical Structures Deforming the Plasma Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRONTOTEMPORAL DEMENTIA; FILAMENTS; ATPASE; VPS4; AUTOINHIBITION; CYTOKINESIS; MACHINERY; DYNAMICS; CARGO; ALIX	The endosomal sorting complexes required for transport (ESCRT-0-III) allow membrane budding and fission away from the cytosol. This machinery is used during multivesicular endosome biogenesis, cytokinesis, and budding of some enveloped viruses. Membrane fission is catalyzed by ESCRT-III complexes made of polymers of charged multivesicular body proteins (CHMPs) and by the AAA-type ATPase VPS4. How and which of the ESCRT-III subunits sustain membrane fission from the cytoplasmic surface remain uncertain. In vitro, CHMP2 and CHMP3 recombinant proteins polymerize into tubular helical structures, which were hypothesized to drive vesicle fission. However, this model awaits the demonstration that such structures exist and can deform membranes in cellulo. Here, we show that depletion of VPS4 induces specific accumulation of endogenous CHMP2B at the plasma membrane. Unlike other CHMPs, overexpressed full-length CHMP2B polymerizes into long, rigid tubes that protrude out of the cell. CHMP4s relocalize at the base of the tubes, the formation of which depends on VPS4. Cryo-EM of the CHMP2B membrane tubes demonstrates that CHMP2B polymerizes into a tightly packed helical lattice, in close association with the inner leaflet of the membrane tube. This association is tight enough to deform the lipid bilayer in cases where the tubular CHMP2B helix varies in diameter or is closed by domes. Thus, our observation that CHMP2B polymerization scaffolds membranes in vivo represents a first step toward demonstrating its structural role during outward membrane deformation.	[Bodon, Gilles; Chassefeyre, Romain; Pernet-Gallay, Karin; Belly, Agnes; Goldberg, Yves; Chatellard-Causse, Christine; Blot, Beatrice; Sadoul, Remy] Univ Grenoble 1, Grenoble Inst Neurosci, F-38042 Grenoble, France; [Bodon, Gilles; Chassefeyre, Romain; Belly, Agnes; Goldberg, Yves; Chatellard-Causse, Christine; Blot, Beatrice; Sadoul, Remy] INSERM, Equipe 2, U836, F-38042 Grenoble, France; [Martinelli, Nicolas; Effantin, Gregory; Hulsik, David Lutje; Schoehn, Guy; Weissenhorn, Winfried] Univ Grenoble 1, EMBL, CNRS, UVHCI,UMI 3265, F-38042 Grenoble, France; [Schoehn, Guy] CEA, Inst Biol Struct Jean Pierre Ebel, UMR 5075, F-38027 Grenoble, France; [Schoehn, Guy] CNRS, Inst Biol Struct Jean Pierre Ebel, UMR 5075, F-38027 Grenoble, France; [Schoehn, Guy] Univ Grenoble 1, Inst Biol Struct Jean Pierre Ebel, UMR 5075, F-38027 Grenoble, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA	Sadoul, R (corresponding author), Univ Grenoble 1, Grenoble Inst Neurosci, Chemin Fortune Ferrini,BP 170, F-38042 Grenoble, France.	remy.sadoul@ujf-grenoble.fr		Goldberg, Yves/0000-0001-7446-8595; Schoehn, Guy/0000-0002-1459-3201; SADOUL, Remy/0000-0002-4763-0320; PERNET GALLAY, Karin/0000-0003-3468-3316	INSERM; CNRS; Universite Joseph Fourier; Fondation France Alzheimer; ANR [08-Blanc-0271]; Region Rhone-Alpes	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Joseph Fourier; Fondation France Alzheimer; ANR(French National Research Agency (ANR)); Region Rhone-Alpes(Region Auvergne-Rhone-Alpes)	This work was supported by INSERM, CNRS, Universite Joseph Fourier, Fondation France Alzheimer, and ANR(Grant 08-Blanc-0271, to W. W., R. S., and G. S.).; Supported by the Region Rhone-Alpes (Cluster 10 Infectiologie).	Agromayor M, 2006, J BIOL CHEM, V281, P23083, DOI 10.1074/jbc.M513803200; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Babst M, 2002, DEV CELL, V3, P283, DOI 10.1016/S1534-5807(02)00219-8; Babst M, 2002, DEV CELL, V3, P271, DOI 10.1016/S1534-5807(02)00220-4; Babst M, 1997, EMBO J, V16, P1820, DOI 10.1093/emboj/16.8.1820; Bajorek M, 2009, NAT STRUCT MOL BIOL, V16, P754, DOI 10.1038/nsmb.1621; Baumgartel V, 2011, NAT CELL BIOL, V13, P469, DOI 10.1038/ncb2215; Belly A, 2010, J CELL SCI, V123, P2943, DOI 10.1242/jcs.068817; Bieniasz PD, 2009, CELL HOST MICROBE, V5, P550, DOI 10.1016/j.chom.2009.05.015; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Conway JF, 1999, J STRUCT BIOL, V128, P106, DOI 10.1006/jsbi.1999.4168; Demirov DG, 2004, VIRUS RES, V106, P87, DOI 10.1016/j.virusres.2004.08.007; Elia N, 2011, P NATL ACAD SCI USA, V108, P4846, DOI 10.1073/pnas.1102714108; Fabrikant G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000575; Filimonenko M, 2007, J CELL BIOL, V179, P485, DOI 10.1083/jcb.200702115; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Guizetti J, 2011, SCIENCE, V331, P1616, DOI 10.1126/science.1201847; Hanson PI, 2008, J CELL BIOL, V180, P389, DOI 10.1083/jcb.200707031; Hurley J. H., 2010, NAT REV MOL CELL BIO; Hurley JH, 2010, CRIT REV BIOCHEM MOL, V45, P463, DOI 10.3109/10409238.2010.502516; Jouvenet N, 2011, NAT CELL BIOL, V13, P394, DOI 10.1038/ncb2207; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Lata S, 2008, SCIENCE, V321, P1354, DOI 10.1126/science.1161070; Lata S, 2008, J MOL BIOL, V378, P818, DOI 10.1016/j.jmb.2008.03.030; Lee JA, 2007, CURR BIOL, V17, P1561, DOI 10.1016/j.cub.2007.07.029; Lenz M, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.038101; Lin Y, 2005, J BIOL CHEM, V280, P12799, DOI 10.1074/jbc.M413968200; Liou W, 1996, HISTOCHEM CELL BIOL, V106, P41, DOI 10.1007/BF02473201; Mahul-Mellier AL, 2009, BIOCHEM SOC T, V37, P200, DOI 10.1042/BST0370200; Martin-Serrano J, 2003, J VIROL, V77, P4794, DOI 10.1128/JVI.77.8.4794-4804.2003; Martin-Serrano J, 2011, NAT REV MICROBIOL, V9, P519, DOI 10.1038/nrmicro2596; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; Morita E, 2011, CELL HOST MICROBE, V9, P235, DOI 10.1016/j.chom.2011.02.004; Morita E, 2010, P NATL ACAD SCI USA, V107, P12889, DOI 10.1073/pnas.1005938107; Muziol T, 2006, DEV CELL, V10, P821, DOI 10.1016/j.devcel.2006.03.013; Obita T, 2007, NATURE, V449, P735, DOI 10.1038/nature06171; Peel S, 2011, TRENDS BIOCHEM SCI, V36, P199, DOI 10.1016/j.tibs.2010.09.004; Pires R, 2009, STRUCTURE, V17, P843, DOI 10.1016/j.str.2009.04.007; Saksena S, 2009, CELL, V136, P97, DOI 10.1016/j.cell.2008.11.013; Shestakova A, 2010, MOL BIOL CELL, V21, P1059, DOI 10.1091/mbc.E09-07-0572; Shim S, 2007, TRAFFIC, V8, P1068, DOI 10.1111/j.1600-0854.2007.00584.x; Skibinski G, 2005, NAT GENET, V37, P806, DOI 10.1038/ng1609; Stuchell-Brereton MD, 2007, NATURE, V449, P740, DOI 10.1038/nature06172; Teis D, 2008, DEV CELL, V15, P578, DOI 10.1016/j.devcel.2008.08.013; Teis D, 2010, EMBO J, V29, P871, DOI 10.1038/emboj.2009.408; Usami Y, 2009, BIOCHEM SOC T, V37, P181, DOI 10.1042/BST0370181; Wollert T, 2010, NATURE, V464, P864, DOI 10.1038/nature08849; Zamborlini A, 2006, P NATL ACAD SCI USA, V103, P19140, DOI 10.1073/pnas.0603788103	49	76	76	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40276	40286		10.1074/jbc.M111.283671	http://dx.doi.org/10.1074/jbc.M111.283671			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21926173	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000296925700059
J	Song, MH; Cho, HJ; Lee, HK; Kwon, TJ; Lee, WS; Oh, S; Bok, J; Choi, JY; Kim, UK				Song, Mee Hyun; Cho, Hyun-Ju; Lee, Hee Keun; Kwon, Tae Jun; Lee, Won-Sang; Oh, Sanghee; Bok, Jinwoong; Choi, Jae Young; Kim, Un-Kyung			CHD7 Mutational Analysis and Clinical Considerations for Auditory Rehabilitation in Deaf Patients with CHARGE Syndrome	PLOS ONE			English	Article							COCHLEAR NERVE; PHENOTYPIC SPECTRUM; MULTIPLE ANOMALIES; CHOANAL ATRESIA; HEART-DISEASE; CHILDREN; IMPLANTATION; GENE; ASSOCIATION; COLOBOMA	Background: Otologic manifestations are one of the most consistent findings of CHARGE syndrome found in more than 90%. Since genetic analysis of the CHD7 gene has rarely been performed in previous reports dealing with ear abnormalities, the genotypic spectrum of CHD7 mutations was analyzed in deaf patients with CHARGE syndrome, and the clinical considerations concerning auditory rehabilitation were investigated. Methods: Nine Korean patients with CHARGE syndrome showing profound hearing loss and semicircular canal aplasia were included. All 38 exons of CHD7 were analyzed by direct sequencing. For splice site variations, in silico and exon-trapping analyses were performed to verify the pathogenicity of nucleotide variations. Clinical features and the outcome of auditory rehabilitation were also analyzed. Results: Eight of 9 patients revealed alterations of the CHD7 gene including 3 frameshift, 2 nonsense, 2 splice site, and 1 missense mutations. Five of 9 patients were clinically diagnosed as atypical CHARGE syndrome but demonstrated various mutations of the CHD7 gene. One familial case showed intra-familial variability. Radiologic findings suggesting cochleovestibular nerve deficiency were identified in most of the patients. Of the 8 patients who underwent cochlear implantation, 5 patients demonstrated favorable outcome. Larger diameter of the cochleovestibular nerve on imaging and absence of severe mental retardation were factors related to better outcome after cochlear implantation rather than the type of CHD7 mutations. Auditory brainstem implantation was performed in two patients who did not benefit from cochlear implantation. Conclusions: Genetic analysis of the CHD7 gene should be performed in cases with semicircular canal aplasia even when other typical features of CHARGE syndrome are absent. For auditory rehabilitation in CHARGE syndrome, cochlear implantation should be strongly recommended in selected cases with favorable prognostic factors. Auditory brainstem implantation may be a viable option in patients with CHARGE syndrome who have failed to benefit from cochlear implantation.	[Song, Mee Hyun] Kwandong Univ, Dept Otorhinolaryngol, Coll Med, Goyang, South Korea; [Cho, Hyun-Ju; Lee, Hee Keun; Kwon, Tae Jun; Kim, Un-Kyung] Kyungpook Natl Univ, Coll Nat Sci, Dept Biol, Taegu, South Korea; [Lee, Won-Sang; Oh, Sanghee; Choi, Jae Young] Yonsei Univ, Coll Med, Dept Otorhinolaryngol, Seoul, South Korea; [Bok, Jinwoong] Yonsei Univ, Coll Med, BK Project Med Sci 21, Dept Anat, Seoul, South Korea	Catholic Kwandong University; Kyungpook National University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Song, MH (corresponding author), Kwandong Univ, Dept Otorhinolaryngol, Coll Med, Goyang, South Korea.	kimuk@knu.ac.kr	Bok, Jinwoong/M-2834-2019	Bok, Jinwoong/0000-0003-1958-1872; choi, jae young/0000-0001-9493-3458	Ministry of Health & Welfare, Republic of Korea [A100367]	Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This study was supported by a grant of the Korea Healthcare Technology Research and Development Project, Ministry of Health & Welfare, Republic of Korea (A100367). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aramaki M, 2006, J PEDIATR-US, V148, P410, DOI 10.1016/j.jpeds.2005.10.044; Archbold S, 1995, Ann Otol Rhinol Laryngol Suppl, V166, P312; Arndt S, 2010, OTOL NEUROTOL, V31, P67, DOI 10.1097/MAO.0b013e3181c0e972; Bergman JEH, 2011, J MED GENET; Berrettini S, 2008, INT J AUDIOL, V47, P199, DOI 10.1080/14992020701870197; Blake KD, 1998, CLIN PEDIATR, V37, P159, DOI 10.1177/000992289803700302; Colletti V, 2005, OTOLARYNG HEAD NECK, V133, P126, DOI 10.1016/j.otohns.2005.03.022; Glastonbury CM, 2002, AM J NEURORADIOL, V23, P635; HALL BD, 1979, J PEDIATR-US, V95, P395, DOI 10.1016/S0022-3476(79)80513-2; HITTNER HM, 1979, J PEDIAT OPHTH STRAB, V16, P122; Jongmans M, 2005, AM J MED GENET A, V134A, P165, DOI 10.1002/ajmg.a.30598; Jongmans MCJ, 2006, J MED GENET, V43, P306, DOI 10.1136/jmg.2005.036061; Jyonouchi S, 2009, PEDIATRICS, V123, pE871, DOI 10.1542/peds.2008-3400; Lanson BG, 2007, LARYNGOSCOPE, V117, P1260, DOI 10.1097/MLG.0b013e31806009c9; Lee YW, 2009, CLIN GENET, V75, P290, DOI 10.1111/j.1399-0004.2008.01127.x; Morimoto AK, 2006, AM J NEURORADIOL, V27, P1663; PAGON RA, 1981, J PEDIATR-US, V99, P223, DOI 10.1016/S0022-3476(81)80454-4; Papsin Blake C, 2005, Laryngoscope, V115, P1, DOI 10.1097/00005537-200501001-00001; Sanlaville D, 2007, EUR J HUM GENET, V15, P389, DOI 10.1038/sj.ejhg.5201778; Sennaroglu L, 2009, OTOL NEUROTOL, V30, P708, DOI 10.1097/MAO.0b013e3181b07d41; SHELTON C, 1989, OTOLARYNG HEAD NECK, V100, P227, DOI 10.1177/019459988910000310; Verloes A, 2005, AM J MED GENET A, V133A, P306, DOI 10.1002/ajmg.a.30559; Vissers LELM, 2004, NAT GENET, V36, P955, DOI 10.1038/ng1407; Warren FM, 2010, OTOL NEUROTOL, V31, P1088, DOI 10.1097/MAO.0b013e3181eb3272; Zentner GE, 2010, AM J MED GENET A, V152A, P674, DOI 10.1002/ajmg.a.33323	25	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2011	6	9							e24511	10.1371/journal.pone.0024511	http://dx.doi.org/10.1371/journal.pone.0024511			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZV	21931733	gold, Green Published, Green Submitted			2022-12-25	WOS:000295321800028
J	Zhou, XM; Chan, PKS; Tam, JS; Tang, JW				Zhou, Xiaoming; Chan, Paul K. S.; Tam, John S.; Tang, Julian W.			A Possible Geographic Origin of Endemic Hepatitis C Virus 6a in Hong Kong: Evidences for the Association with Vietnamese Immigration	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; GENOTYPE DISTRIBUTION; HIGH PREVALENCE; POPULATION; INFECTION; RATES	Background: Hepatitis C virus (HCV) 6a accounts for 23.6% of all HCV infections of the general population and 58.5% of intravenous drug users in Hong Kong. However, the geographical origin of this highly predominant HCV subgenotype is largely unknown. This study explores a hypothesis for one possible transmission route of HCV 6a to Hong Kong. Methods: NSSA sequences derived from 26 HCV 6a samples were chosen from a five year period (1999-2004) from epidemiologically unrelated patients from Hong Kong. Partial-NS5A sequences (513-bp from nt 6728 to 7240) were adopted for Bayesian coalescent analysis to reconstruct the evolutionary history of HCV infections in Hong Kong using the BEAST v1.3 program. A rooted phylogenetic tree was drawn for these sequences by alignment with reference Vietnamese sequences. Demographic data were accessed from "The Statistic Yearbooks of Hong Kong". Results: Bayesian coalescent analysis showed that the rapid increase in 6a infections, which had increased more than 90-fold in Hong Kong from 1986 to 1994 correlated to two peaks of Vietnamese immigration to Hong Kong from 1978 to 1997. The second peak, which occurred from 1987 through 1997, overlapped with the rapid increase of HCV 6a occurrence in Hong Kong. Phylogenetic analyses have further revealed that HCV 6a strains from Vietnam may be ancestral to Hong Kong counterparts. Conclusions: The high predominance of HCV 6a infections in Hong Kong was possibly associated with Vietnamese immigration during 1987-1997.	[Zhou, Xiaoming] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Dept Epidemiol, Shanghai 200433, Peoples R China; [Chan, Paul K. S.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Microbiol, Shatin, Hong Kong, Peoples R China; [Tam, John S.] WHO, CH-1211 Geneva, Switzerland; [Tang, Julian W.] Natl Univ Singapore Hosp, Dept Lab Med, Singapore 117548, Singapore	Fudan University; Chinese University of Hong Kong; Prince of Wales Hospital; World Health Organization; National University of Singapore	Zhou, XM (corresponding author), Fudan Univ, Shanghai Publ Hlth Clin Ctr, Dept Epidemiol, Shanghai 200433, Peoples R China.	xmzhou@shmu.edu.cn	, Julian W Tang/H-2348-2014; Chan, Paul KS/J-9360-2013	Chan, Paul KS/0000-0002-6360-4608; Tang, Julian/0000-0002-4963-1028	Chinese National Key Technologies Research and Development Program [2009ZX10004-104]	Chinese National Key Technologies Research and Development Program	The funding for this work was provided by the Chinese National Key Technologies Research and Development Program (No. 2009ZX10004-104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Drummond A, 2003, ADV PARASIT, V54, P331, DOI 10.1016/S0065-308X(03)54008-8; Drummond AJ, 2002, GENETICS, V161, P1307; Drummond AJ, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-114; ENOMOTO N, 1990, BIOCHEM BIOPH RES CO, V170, P1021, DOI 10.1016/0006-291X(90)90494-8; HUDSON RR, 1995, PHILOS T R SOC B, V349, P19, DOI 10.1098/rstb.1995.0086; *INF SERV DEP HG, 2006, HONG KONG YB; Jenkins GM, 2002, J MOL EVOL, V54, P156, DOI 10.1007/s00239-001-0064-3; Lemey P, 2004, GENETICS, V167, P1059, DOI 10.1534/genetics.104.026666; Lu L, 2005, J MED VIROL, V75, P538, DOI 10.1002/jmv.20307; MCOMISH F, 1994, J CLIN MICROBIOL, V32, P884, DOI 10.1128/JCM.32.4.884-892.1994; Mellor J, 1996, J CLIN MICROBIOL, V34, P417, DOI 10.1128/JCM.34.2.417-423.1996; Naoumov NV, 1997, J HEPATOL, V27, P331, DOI 10.1016/S0168-8278(97)80179-1; PAWLOTSKY JM, 1995, J INFECT DIS, V171, P1607, DOI 10.1093/infdis/171.6.1607; Pham DA, 2009, ASIAN PAC J ALLERGY, V27, P153; Pybus Oliver G, 2005, Infect Genet Evol, V5, P131, DOI 10.1016/j.meegid.2004.08.001; Pybus OG, 2009, NAT REV GENET, V10, P540, DOI 10.1038/nrg2583; Shapiro B, 2011, MOL BIOL EVOL, V28, P879, DOI 10.1093/molbev/msq262; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Tanaka Y, 2006, GASTROENTEROLOGY, V130, P703, DOI 10.1053/j.gastro.2006.01.032; Wong DA, 1998, EUR J EPIDEMIOL, V14, P421, DOI 10.1023/A:1007400304726; Zhou DXM, 2006, J MED VIROL, V78, P574, DOI 10.1002/jmv.20578	21	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2011	6	9							e24889	10.1371/journal.pone.0024889	http://dx.doi.org/10.1371/journal.pone.0024889			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZV	21931867	Green Submitted, gold, Green Published			2022-12-25	WOS:000295321800075
J	Heger, CD; Wrann, CD; Collins, RN				Heger, Christopher D.; Wrann, Christiane D.; Collins, Ruth N.			Phosphorylation Provides a Negative Mode of Regulation for the Yeast Rab GTPase Sec4p	PLOS ONE			English	Article							TYPE-1 PROTEIN PHOSPHATASE; CELL-CYCLE PROGRESSION; SACCHAROMYCES-CEREVISIAE; ISOCITRATE DEHYDROGENASE; NUCLEOTIDE EXCHANGE; VESICULAR TRANSPORT; GOLGI FRAGMENTATION; SECRETORY VESICLES; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE	The Rab family of Ras-related GTPases are part of a complex signaling circuitry in eukaryotic cells, yet we understand little about the mechanisms that underlie Rab protein participation in such signal transduction networks, or how these networks are integrated at the physiological level. Reversible protein phosphorylation is widely used by cells as a signaling mechanism. Several phospho-Rabs have been identified, however the functional consequences of the modification appear to be diverse and need to be evaluated on an individual basis. In this study we demonstrate a role for phosphorylation as a negative regulatory event for the action of the yeast Rab GTPase Sec4p in regulating polarized growth. Our data suggest that the phosphorylation of the Rab Sec4p prevents interactions with its effector, the exocyst component Sec15p, and that the inhibition may be relieved by a PP2A phosphatase complex containing the regulatory subunit Cdc55p.	[Heger, Christopher D.] Cornell Univ, Grad Program Pharmacol, Ithaca, NY 14853 USA; [Wrann, Christiane D.] Cornell Univ, Coll Vet Med, Leadership Program Vet Students, Ithaca, NY 14853 USA; [Heger, Christopher D.; Collins, Ruth N.] Cornell Univ, Dept Mol Med, Ithaca, NY USA	Cornell University; Cornell University; Cornell University	Heger, CD (corresponding author), Cornell Univ, Grad Program Pharmacol, Ithaca, NY 14853 USA.	rnc8@cornell.edu			National Institutes of Health [5R01GM069596]; NIH [5T32GM008210-18]; College of Veterinary Medicine, Cornell University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069596, R01GM087812, T32GM008210] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); College of Veterinary Medicine, Cornell University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant No. 5R01GM069596 to R. Collins. Christopher Heger was supported by NIH training grant (5T32GM008210-18) and Christiane Wrann was supported by the Leadership Program for Veterinary Students, College of Veterinary Medicine, Cornell University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya U, 1998, CELL, V92, P183, DOI 10.1016/S0092-8674(00)80913-7; Aivazian D, 2006, J CELL BIOL, V173, P917, DOI 10.1083/jcb.200510010; An Y, 2003, STRUCTURE, V11, P347, DOI 10.1016/S0969-2126(03)00034-0; Andrews PD, 2000, J CELL SCI, V113, P507; Ayad N, 1997, EMBO J, V16, P4497, DOI 10.1093/emboj/16.15.4497; BAILLY E, 1991, NATURE, V350, P715, DOI 10.1038/350715a0; Bao Y, 2008, J BIOL CHEM, V283, P324, DOI 10.1074/jbc.M706873200; Bard F, 2006, NATURE, V439, P604, DOI 10.1038/nature04377; Bard F, 2003, J BIOL CHEM, V278, P46601, DOI 10.1074/jbc.M302221200; Blankenship JT, 2007, J CELL SCI, V120, P3099, DOI 10.1242/jcs.004770; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; BODENMILLER B, SCI SIGNAL, V3, pRS4; BRENNWALD P, 1993, NATURE, V362, P560, DOI 10.1038/362560a0; Burguete AS, 2008, CELL, V132, P286, DOI 10.1016/j.cell.2007.11.048; Chang JS, 2002, J BIOL CHEM, V277, P48002, DOI 10.1074/jbc.M208471200; Chang L, 2004, MOL MED, V10, P65, DOI 10.2119/2005-00029.Saltiel; CHAVRIER P, 1991, NATURE, V353, P769, DOI 10.1038/353769a0; Chi A, 2007, P NATL ACAD SCI USA, V104, P2193, DOI 10.1073/pnas.0607084104; Chiariello M, 1999, FEBS LETT, V453, P20, DOI 10.1016/S0014-5793(99)00686-9; Chien YC, 2006, CELL, V127, P157, DOI 10.1016/j.cell.2006.08.034; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; Cohen P, 2000, TRENDS BIOCHEM SCI, V25, P596, DOI 10.1016/S0968-0004(00)01712-6; COHEN P, 1989, J BIOL CHEM, V264, P21435; Colanzi A, 2000, J CELL BIOL, V149, P331, DOI 10.1083/jcb.149.2.331; Colanzi A, 2003, J CELL BIOL, V161, P27, DOI 10.1083/jcb.200208099; Collins RN, 2005, METHOD ENZYMOL, V403, P19, DOI 10.1016/S0076-6879(05)03003-X; DEAN AM, 1989, J BIOL CHEM, V264, P20482; DeRegis CJ, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-3; Dong G, 2007, MOL CELL, V25, P455, DOI 10.1016/j.molcel.2007.01.013; Ficarro SB, 2002, NAT BIOTECHNOL, V20, P301, DOI 10.1038/nbt0302-301; Finger FP, 2000, GENETICS, V156, P943; Forsburg SL, 2001, NAT REV GENET, V2, P659, DOI 10.1038/35088500; France YE, 2006, J CELL SCI, V119, P876, DOI 10.1242/jcs.02849; Gentry MS, 2002, MOL BIOL CELL, V13, P3477, DOI 10.1091/mbc.02-05-0065; Goehring AS, 2007, J BIOL CHEM, V282, P33155, DOI 10.1074/jbc.M705167200; GOUD B, 1988, CELL, V53, P753, DOI 10.1016/0092-8674(88)90093-1; GOVINDAN B, 1995, J CELL BIOL, V128, P1055, DOI 10.1083/jcb.128.6.1055; Gromley A, 2005, CELL, V123, P75, DOI 10.1016/j.cell.2005.07.027; Grosshans BL, 2006, J CELL BIOL, V172, P55, DOI 10.1083/jcb.200510016; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Gruhler A, 2005, MOL CELL PROTEOMICS, V4, P310, DOI 10.1074/mcp.M400219-MCP200; GUARENTE L, 1993, TRENDS GENET, V9, P362, DOI 10.1016/0168-9525(93)90042-G; Guo W, 1999, J BIOL CHEM, V274, P23558, DOI 10.1074/jbc.274.33.23558; Guo W, 1999, EMBO J, V18, P1071, DOI 10.1093/emboj/18.4.1071; He B, 2007, EMBO J, V26, P4053, DOI 10.1038/sj.emboj.7601834; HISAMOTO N, 1994, MOL CELL BIOL, V14, P3158, DOI 10.1128/MCB.14.5.3158; INGRELL CB, 2007, BIOINFORMATICS; Itzen A, 2006, EMBO J, V25, P1445, DOI 10.1038/sj.emboj.7601044; JIANG L, 2007, DEV BIOL; Jiang Y, 2006, MICROBIOL MOL BIOL R, V70, P440, DOI 10.1128/MMBR.00049-05; KARNIGUIAN A, 1993, P NATL ACAD SCI USA, V90, P7647, DOI 10.1073/pnas.90.16.7647; Lee J, 1998, CURR BIOL, V8, P1310, DOI 10.1016/S0960-9822(07)00561-1; Li X, 2007, J PROTEOME RES, V6, P1190, DOI 10.1021/pr060559j; Lillie SH, 1998, J CELL BIOL, V140, P873, DOI 10.1083/jcb.140.4.873; Lin CY, 2000, P NATL ACAD SCI USA, V97, P12589, DOI 10.1073/pnas.220423497; LORD C, NATURE, V473, P181; Merithew E, 2001, J BIOL CHEM, V276, P13982, DOI 10.1074/jbc.M009771200; MUMBY MC, 1993, PHYSIOL REV, V73, P673, DOI 10.1152/physrev.1993.73.4.673; Nejsum LN, 2007, J CELL BIOL, V178, P323, DOI 10.1083/jcb.200705094; NOVICK P, 1993, CELL, V75, P597, DOI 10.1016/0092-8674(93)90478-9; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Ooi SL, 2006, TRENDS GENET, V22, P56, DOI 10.1016/j.tig.2005.11.003; Ostermeier C, 1999, CELL, V96, P363, DOI 10.1016/S0092-8674(00)80549-8; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Preisinger C, 2005, BIOCHEM SOC SYMP, V72, P15, DOI 10.1042/bss0720015; Pulvirenti T, 2008, NAT CELL BIOL, V10, P912, DOI 10.1038/ncb1751; Pylypenko O, 2006, EMBO J, V25, P13, DOI 10.1038/sj.emboj.7600921; Rak A, 2003, SCIENCE, V302, P646, DOI 10.1126/science.1087761; ROACH PJ, 1991, J BIOL CHEM, V266, P14139; SALMINEN A, 1987, CELL, V49, P527, DOI 10.1016/0092-8674(87)90455-7; SALMINEN A, 1989, J CELL BIOL, V109, P1023, DOI 10.1083/jcb.109.3.1023; Sato Y, 2007, P NATL ACAD SCI USA, V104, P8305, DOI 10.1073/pnas.0701550104; Schott D, 1999, J CELL BIOL, V147, P791, DOI 10.1083/jcb.147.4.791; Sieczkarski SB, 2003, J VIROL, V77, P460, DOI 10.1128/JVI.77.1.460-469.2003; STENMARK H, 1994, EMBO J, V13, P575, DOI 10.1002/j.1460-2075.1994.tb06295.x; Stroupe C, 2000, J MOL BIOL, V304, P585, DOI 10.1006/jmbi.2000.4236; Stuart LM, 2007, NATURE, V445, P95, DOI 10.1038/nature05380; TAKIZAWA PA, 1993, CELL, V73, P1079, DOI 10.1016/0092-8674(93)90638-7; Tarrant MK, 2009, ANNU REV BIOCHEM, V78, P797, DOI 10.1146/annurev.biochem.78.070907.103047; TerBush DR, 1996, EMBO J, V15, P6483, DOI 10.1002/j.1460-2075.1996.tb01039.x; THORSNESS PE, 1987, J BIOL CHEM, V262, P10422; VANDERSLUIJS P, 1992, EMBO J, V11, P4379, DOI 10.1002/j.1460-2075.1992.tb05538.x; VANZYL W, 1992, MOL CELL BIOL, V12, P4946, DOI 10.1128/MCB.12.11.4946; Wagner W, 2002, EMBO J, V21, P6397, DOI 10.1093/emboj/cdf650; WalchSolimena C, 1997, J CELL BIOL, V137, P1495, DOI 10.1083/jcb.137.7.1495; WALWORTH NC, 1992, MOL CELL BIOL, V12, P2017, DOI 10.1128/MCB.12.5.2017; WELLER SG, P NATL ACAD SCI US, V107, P5863; WERA S, 1995, BIOCHEM J, V311, P17, DOI 10.1042/bj3110017	88	12	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2011	6	9							e24332	10.1371/journal.pone.0024332	http://dx.doi.org/10.1371/journal.pone.0024332			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CO	21931684	Green Submitted, Green Published, gold			2022-12-25	WOS:000294803200014
J	Shi, JT; Yang, WT; Chen, MJ; Du, YZ; Zhang, J; Wang, KK				Shi, Jiantao; Yang, Wentao; Chen, Mingjie; Du, Yanzhi; Zhang, Ji; Wang, Kankan			AMD, an Automated Motif Discovery Tool Using Stepwise Refinement of Gapped Consensuses	PLOS ONE			English	Article							CIS-REGULATORY ELEMENTS; FACTOR-BINDING SITES; TRANSCRIPTION FACTOR; CHROMATIN-IMMUNOPRECIPITATION; COMPUTATIONAL IDENTIFICATION; SACCHAROMYCES-CEREVISIAE; SYSTEMATIC DISCOVERY; HUMAN GENOME; CHIP-CHIP; DNA	Motif discovery is essential for deciphering regulatory codes from high throughput genomic data, such as those from ChIP-chip/seq experiments. However, there remains a lack of effective and efficient methods for the identification of long and gapped motifs in many relevant tools reported to date. We describe here an automated tool that allows for de novo discovery of transcription factor binding sites, regardless of whether the motifs are long or short, gapped or contiguous.	[Shi, Jiantao; Du, Yanzhi; Zhang, Ji] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai, Peoples R China; [Yang, Wentao; Chen, Mingjie; Zhang, Ji; Wang, Kankan] Shanghai Jiao Tong Univ, Rui Jin Hosp, Sch Med, Shanghai Inst Hematol, Shanghai 200030, Peoples R China; [Yang, Wentao; Chen, Mingjie; Zhang, Ji; Wang, Kankan] Shanghai Jiao Tong Univ, Rui Jin Hosp, Sinofrench Ctr Life Sci & Genom, Sch Med, Shanghai 200030, Peoples R China; [Shi, Jiantao] Chinese Acad Sci, Grad Sch, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences	Shi, JT (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai, Peoples R China.	jizhang@sibs.ac.cn			Ministry of Science and Technology of China [2009CB825607, 2011CB910202]; National Natural Science Foundation [90919059, 30730033]; Chinese Academy of Sciences [KSCX1-YW-22-01]; Shanghai Commission of Science and Technology [09410706500]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai Commission of Science and Technology(Shanghai Science & Technology Committee)	This work was supported in part by grants from Ministry of Science and Technology of China (2009CB825607 and 2011CB910202), the National Natural Science Foundation (90919059 and 30730033), Chinese Academy of Sciences (KSCX1-YW-22-01) and the Shanghai Commission of Science and Technology (09410706500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bi CP, 2004, NUCLEIC ACIDS RES, V32, P4979, DOI 10.1093/nar/gkh825; Bussemaker HJ, 2001, NAT GENET, V27, P167, DOI 10.1038/84792; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Chakravarty A, 2007, BIOINFORMATICS, V23, P1029, DOI 10.1093/bioinformatics/btm041; Elemento O, 2007, MOL CELL, V28, P337, DOI 10.1016/j.molcel.2007.09.027; Ettwiller L, 2007, NAT METHODS, V4, P563, DOI 10.1038/NMETH1061; Frith MC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000071; GuhaThakurta D, 2006, NUCLEIC ACIDS RES, V34, P3585, DOI 10.1093/nar/gkl372; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hughes JD, 2000, J MOL BIOL, V296, P1205, DOI 10.1006/jmbi.2000.3519; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; LAUX G, 1994, EMBO J, V13, P5624, DOI 10.1002/j.1460-2075.1994.tb06900.x; Linhart C, 2008, GENOME RES, V18, P1180, DOI 10.1101/gr.076117.108; Liu XS, 2002, NAT BIOTECHNOL, V20, P835, DOI 10.1038/nbt717; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; MacIsaac KD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-113; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Pavesi G, 2004, NUCLEIC ACIDS RES, V32, pW199, DOI 10.1093/nar/gkh465; Pevzner P A, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P269; Prabhakar S, 2006, GENOME RES, V16, P855, DOI 10.1101/gr.4717506; Redhead E, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-385; Roth FP, 1998, NAT BIOTECHNOL, V16, P939, DOI 10.1038/nbt1098-939; Sinha S, 2003, NUCLEIC ACIDS RES, V31, P3586, DOI 10.1093/nar/gkg618; Smith AD, 2005, P NATL ACAD SCI USA, V102, P1560, DOI 10.1073/pnas.0406123102; Smith AD, 2005, BIOINFORMATICS, V21, pI403, DOI 10.1093/bioinformatics/bti1043; Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Tompa M, 2005, NAT BIOTECHNOL, V23, P137, DOI 10.1038/nbt1053; Valen E, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000562; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Vokes SA, 2008, GENE DEV, V22, P2651, DOI 10.1101/gad.1693008; Weigelt K, 2009, BIOCHEM BIOPH RES CO, V380, P308, DOI 10.1016/j.bbrc.2009.01.067; Wijaya E, 2007, BIOINFORMATICS, V23, P1476, DOI 10.1093/bioinformatics/btm118; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Xie XH, 2007, P NATL ACAD SCI USA, V104, P7145, DOI 10.1073/pnas.0701811104; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; AFFYMETRIX HUMAN PRO; WEBSITE AMD SOFTWARE	43	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2011	6	9							e24576	10.1371/journal.pone.0024576	http://dx.doi.org/10.1371/journal.pone.0024576			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CO	21931761	gold, Green Submitted, Green Published			2022-12-25	WOS:000294803200029
J	Tai, V; Poon, AFY; Paulsen, IT; Palenik, B				Tai, Vera; Poon, Art F. Y.; Paulsen, Ian T.; Palenik, Brian			Selection in Coastal Synechococcus (Cyanobacteria) Populations Evaluated from Environmental Metagenomes	PLOS ONE			English	Article							CLOSELY-RELATED BACTERIAL; NUCLEOTIDE SUBSTITUTION; MARINE SYNECHOCOCCUS; RIBOSOMAL-PROTEINS; POSITIVE SELECTION; MUTATION-RATE; GENES; EVOLUTION; ADAPTATION; LIKELIHOOD	Environmental metagenomics provides snippets of genomic sequences from all organisms in an environmental sample and are an unprecedented resource of information for investigating microbial population genetics. Current analytical methods, however, are poorly equipped to handle metagenomic data, particularly of short, unlinked sequences. A custom analytical pipeline was developed to calculate dN/dS ratios, a common metric to evaluate the role of selection in the evolution of a gene, from environmental metagenomes sequenced using 454 technology of flow-sorted populations of marine Synechococcus, the dominant cyanobacteria in coastal environments. The large majority of genes (98%) have evolved under purifying selection (dN/dS < 1). The metagenome sequence coverage of the reference genomes was not uniform and genes that were highly represented in the environment (i.e. high read coverage) tended to be more evolutionarily conserved. Of the genes that may have evolved under positive selection (dN/dS > 1), 77 out of 83 (93%) were hypothetical. Notable among annotated genes, ribosomal protein L35 appears to be under positive selection in one Synechococcus population. Other annotated genes, in particular a possible porin, a large-conductance mechanosensitive channel, an ATP binding component of an ABC transporter, and a homologue of a pilus retraction protein had regions of the gene with elevated dN/dS. With the increasing use of next-generation sequencing in metagenomic investigations of microbial diversity and ecology, analytical methods need to accommodate the peculiarities of these data streams. By developing a means to analyze population diversity data from these environmental metagenomes, we have provided the first insight into the role of selection in the evolution of Synechococcus, a globally significant primary producer.	[Tai, Vera; Palenik, Brian] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Poon, Art F. Y.] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Paulsen, Ian T.] Macquarie Univ, Dept Chem & Biomol Sci, Sydney, NSW 2109, Australia	University of California System; University of California San Diego; Scripps Institution of Oceanography; B.C. Centre for Excellence in HIV/AIDS; Macquarie University	Tai, V (corresponding author), Univ British Columbia, Dept Bot, Vancouver, BC, Canada.	bpalenik@ucsd.edu	Paulsen, Ian T/K-3832-2012; Palenik, Brian/AAA-1822-2020; Poon, Art/W-9811-2019	Paulsen, Ian T/0000-0001-9015-9418; Palenik, Brian/0000-0002-3717-9046; Poon, Art/0000-0003-3779-154X	National Science Foundation [MCB0731771, DBI-0542119]	National Science Foundation(National Science Foundation (NSF))	This study was supported by a National Science Foundation grant (MCB0731771 and DBI-0542119). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen EE, 2007, P NATL ACAD SCI USA, V104, P1883, DOI 10.1073/pnas.0604851104; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aukema KG, 2005, J BACTERIOL, V187, P611, DOI 10.1128/JB.187.2.611-618.2005; Chen K, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-179; Daubin V, 2004, SCIENCE, V306; Dufresne A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r90; Eyre-Walker A, 1999, NATURE, V397, P344, DOI 10.1038/16915; FRANKHAM R, 1995, GENET RES, V66, P95, DOI 10.1017/S0016672300034455; Gianoulis TA, 2009, P NATL ACAD SCI USA, V106, P1374, DOI 10.1073/pnas.0808022106; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Glover HE., 1985, ADV AQUATIC MICROB, V3, P49; Gomez-Alvarez V, 2009, ISME J, V3, P1314, DOI 10.1038/ismej.2009.72; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Haentjens-Sitri J, 2008, J MOL BIOL, V375, P612, DOI 10.1016/j.jmb.2007.10.058; Hansel A, 1998, CURR MICROBIOL, V36, P321, DOI 10.1007/s002849900316; Hansel A, 1998, BBA-GENE STRUCT EXPR, V1399, P31, DOI 10.1016/S0167-4781(98)00090-6; Harismendy O, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r32; Hewson I, 2009, LIMNOL OCEANOGR, V54, P1981, DOI 10.4319/lo.2009.54.6.1981; Hu JH, 2009, MOL BIOL EVOL, V26, P5, DOI 10.1093/molbev/msn217; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; KIMURA M, 1974, P NATL ACAD SCI USA, V71, P2848, DOI 10.1073/pnas.71.7.2848; Klein DJ, 2004, J MOL BIOL, V340, P141, DOI 10.1016/j.jmb.2004.03.076; Konstantinidis KT, 2009, APPL ENVIRON MICROB, V75, P5345, DOI 10.1128/AEM.00473-09; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LI WH, 1985, MOL BIOL EVOL, V2, P150; LI WKW, 1994, LIMNOL OCEANOGR, V39, P169, DOI 10.4319/lo.1994.39.1.0169; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; LOI, 2007, NATURE, V446, P537; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; LYNCH M, 2004, SCIENCE, V306, pB978; Mes THM, 2008, ENVIRON MICROBIOL, V10, P251, DOI 10.1111/j.1462-2920.2007.01449.x; Mes THM, 2006, ENVIRON MICROBIOL, V8, P1534, DOI 10.1111/j.1462-2920.2006.01044.x; MUKAI T, 1972, GENETICS, V72, P335; MUKAI T, 1964, GENETICS, V50, P1; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nielsen R, 1998, GENETICS, V148, P929; Novichkov PS, 2009, J BACTERIOL, V191, P65, DOI 10.1128/JB.01237-08; OHTA T, 1976, THEOR POPUL BIOL, V10, P254, DOI 10.1016/0040-5809(76)90019-8; Ohta T, 1996, THEOR POPUL BIOL, V49, P128, DOI 10.1006/tpbi.1996.0007; Palenik B, 2009, ENVIRON MICROBIOL, V11, P349, DOI 10.1111/j.1462-2920.2008.01772.x; Palenik B, 2006, P NATL ACAD SCI USA, V103, P13555, DOI 10.1073/pnas.0602963103; PERLER F, 1980, CELL, V20, P555, DOI 10.1016/0092-8674(80)90641-8; Petersen L, 2007, GENOME RES, V17, P1336, DOI 10.1101/gr.6254707; Pinard R, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-216; Pond SLK, 2005, MOL BIOL EVOL, V22, P478, DOI 10.1093/molbev/msi031; Richardson TL, 2007, SCIENCE, V315, P838, DOI 10.1126/science.1133471; Richter DC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003373; Rocha EPC, 2006, J THEOR BIOL, V239, P226, DOI 10.1016/j.jtbi.2005.08.037; Rodrigue S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006864; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Simmons SL, 2008, PLOS BIOL, V6, P1427, DOI 10.1371/journal.pbio.0060177; Smith EM, 2001, LIMNOL OCEANOGR, V46, P473, DOI 10.4319/lo.2001.46.3.0473; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Stuart RK, 2009, APPL ENVIRON MICROB, V75, P5047, DOI 10.1128/AEM.00271-09; Tai V, 2009, ISME J, V3, P903, DOI 10.1038/ismej.2009.35; Tetu SG, 2009, ISME J, V3, P835, DOI 10.1038/ismej.2009.31; Toledo G, 1997, APPL ENVIRON MICROB, V63, P4298, DOI 10.1128/AEM.63.11.4298-4303.1997; Wang J, 2011, APPL ENVIRON MICROB, V77, P4241, DOI 10.1128/AEM.01834-10; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhaxybayeva O, 2009, GENOME BIOL EVOL, V1, P325, DOI 10.1093/gbe/evp032	65	15	16	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2011	6	9							e24249	10.1371/journal.pone.0024249	http://dx.doi.org/10.1371/journal.pone.0024249			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CN	21931665	gold, Green Published, Green Submitted			2022-12-25	WOS:000294803100015
J	Huang, DC; Haack, RA; Zhang, RZ				Huang, Dingcheng; Haack, Robert A.; Zhang, Runzhi			Does Global Warming Increase Establishment Rates of Invasive Alien Species? A Centurial Time Series Analysis	PLOS ONE			English	Article							BIOLOGICAL INVASIONS; CLIMATE-CHANGE; PROPAGULE PRESSURE; INSECT; TEMPERATURE; RESPONSES; COLONIZATION; LEPIDOPTERA; MIGRATION; PATHWAYS	Background: The establishment rate of invasive alien insect species has been increasing worldwide during the past century. This trend has been widely attributed to increased rates of international trade and associated species introductions, but rarely linked to environmental change. To better understand and manage the bioinvasion process, it is crucial to understand the relationship between global warming and establishment rate of invasive alien species, especially for poikilothermic invaders such as insects. Methodology/Principal Findings: We present data that demonstrate a significant positive relationship between the change in average annual surface air temperature and the establishment rate of invasive alien insects in mainland China during 1900-2005. This relationship was modeled by regression analysis, and indicated that a 1 degrees C increase in average annual surface temperature in mainland China was associated with an increase in the establishment rate of invasive alien insects of about 0.5 species year(-1). The relationship between rising surface air temperature and increasing establishment rate remained significant even after accounting for increases in international trade during the period 1950-2005. Moreover, similar relationships were detected using additional data from the United Kingdom and the contiguous United States. Conclusions/Significance: These findings suggest that the perceived increase in establishments of invasive alien insects can be explained only in part by an increase in introduction rate or propagule pressure. Besides increasing propagule pressure, global warming is another driver that could favor worldwide bioinvasions. Our study highlights the need to consider global warming when designing strategies and policies to deal with bioinvasions.	[Huang, Dingcheng; Zhang, Runzhi] Chinese Acad Sci, Inst Zool, CAS Key Lab Zool Systemat & Evolut, Beijing, Peoples R China; [Huang, Dingcheng] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Haack, Robert A.] US Forest Serv, USDA, No Res Stn, E Lansing, MI USA; [Zhang, Runzhi] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; United States Department of Agriculture (USDA); United States Forest Service; Chinese Academy of Sciences; Institute of Zoology, CAS	Huang, DC (corresponding author), Chinese Acad Sci, Inst Zool, CAS Key Lab Zool Systemat & Evolut, Beijing, Peoples R China.	zhangrz@ioz.ac.cn			Chinese Academy of Sciences; Ministry of Science and Technology [2009CB119204]; Ministry of Agriculture [200903042]; National Natural Science Foundation of China [30525039, J0930004]	Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Agriculture(Gida Tarim Ve Hayvancilik Bakanligi); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the Chinese Academy of Sciences (Hundred Talents in 2010), Ministry of Science and Technology (2009CB119204), the Ministry of Agriculture (200903042), and the National Natural Science Foundation of China (30525039, J0930004) programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert Peter, 2000, Perspectives in Plant Ecology Evolution and Systematics, V3, P52, DOI 10.1078/1433-8319-00004; Andrew NR, 2007, GLOBAL CHANGE BIOL, V13, P1539, DOI 10.1111/j.1365-2486.2007.01393.x; Aukema JE, 2010, BIOSCIENCE, V60, P886, DOI 10.1525/bio.2010.60.11.5; Bale JS, 2010, J EXP BIOL, V213, P980, DOI 10.1242/jeb.037911; Battisti A, 2006, GLOBAL CHANGE BIOL, V12, P662, DOI 10.1111/j.1365-2486.2006.01124.x; Brohan P, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006548; Cannon RJC, 1998, GLOBAL CHANGE BIOL, V4, P785, DOI 10.1046/j.1365-2486.1998.00190.x; Costello CJ, 2003, P NATL ACAD SCI USA, V100, P3321, DOI 10.1073/pnas.0636536100; DAISIE, 2008, HDB AL SPEC EUR; Dukes JS, 1999, TRENDS ECOL EVOL, V14, P135, DOI 10.1016/S0169-5347(98)01554-7; Hansen J, 1999, J GEOPHYS RES-ATMOS, V104, P30997, DOI 10.1029/1999JD900835; Hellmann JJ, 2008, CONSERV BIOL, V22, P534, DOI 10.1111/j.1523-1739.2008.00951.x; Hickling R, 2006, GLOBAL CHANGE BIOL, V12, P450, DOI 10.1111/j.1365-2486.2006.01116.x; Hill M, 2005, ENGLISH NATURE RES R; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Johnson DM, 2010, P NATL ACAD SCI USA, V107, P20576, DOI 10.1073/pnas.1010270107; Kobelt M, 2008, DIVERS DISTRIB, V14, P273, DOI 10.1111/j.1472-4642.2007.00426.x; Levine JM, 2003, CONSERV BIOL, V17, P322, DOI 10.1046/j.1523-1739.2003.02038.x; Lin E., 2007, PHYS SCI BASIS WORKI, V3, P6; Lin W, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001208; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; Lockwood JL, 2009, DIVERS DISTRIB, V15, P904, DOI 10.1111/j.1472-4642.2009.00594.x; Luedeling E, 2011, GLOBAL CHANGE BIOL, V17, P228, DOI 10.1111/j.1365-2486.2010.02227.x; Mainka SA, 2010, INTEGR ZOOL, V5, P102, DOI 10.1111/j.1749-4877.2010.00193.x; MATTSON WJ, 1987, BIOSCIENCE, V37, P110, DOI 10.2307/1310365; Musolin DL, 2007, GLOBAL CHANGE BIOL, V13, P1565, DOI 10.1111/j.1365-2486.2007.01395.x; PARKER DE, 1992, INT J CLIMATOL, V12, P317, DOI 10.1002/joc.3370120402; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Pelini SL, 2010, GLOBAL CHANGE BIOL, V16, P2923, DOI 10.1111/j.1365-2486.2010.02177.x; Poyry J, 2011, GLOBAL ECOL BIOGEOGR, V20, P289, DOI 10.1111/j.1466-8238.2010.00597.x; Pysek P, 2010, P NATL ACAD SCI USA, V107, P12157, DOI 10.1073/pnas.1002314107; Pysek P, 2009, ECOLOGY, V90, P2734, DOI 10.1890/08-0857.1; Robinet C, 2010, INTEGR ZOOL, V5, P132, DOI 10.1111/j.1749-4877.2010.00196.x; Simberloff D, 2009, ANNU REV ECOL EVOL S, V40, P81, DOI 10.1146/annurev.ecolsys.110308.120304; Smith RM, 2007, AGR FOREST ENTOMOL, V9, P307, DOI 10.1111/j.1461-9563.2007.00349.x; Sparks TH, 2005, GLOBAL CHANGE BIOL, V11, P507, DOI 10.1111/j.1365-2486.2005.00910.x; Sparks TH, 2007, EUR J ENTOMOL, V104, P139, DOI 10.14411/eje.2007.019; Tanentzap AJ, 2010, BIOL INVASIONS, V12, P2105, DOI 10.1007/s10530-009-9612-3; [唐国利 Tang Guoli], 2009, [气候变化研究进展, Advances in Climate Change Research], V5, P71; Waage JK, 2008, AGR SYST, V99, P1, DOI 10.1016/j.agsy.2008.08.001; Walther GR, 2007, GLOBAL ECOL BIOGEOGR, V16, P801, DOI 10.1111/j.1466-8238.2007.00328.x; Walther GR, 2009, TRENDS ECOL EVOL, V24, P686, DOI 10.1016/j.tree.2009.06.008; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wan FH, 2009, RES BIOL INVASIONS C; Westphal MI, 2008, BIOL INVASIONS, V10, P391, DOI 10.1007/s10530-007-9138-5; Wonham MJ, 2006, ECOL LETT, V9, P663, DOI 10.1111/j.1461-0248.2006.00913.x; Work TT, 2005, BIOL INVASIONS, V7, P323, DOI 10.1007/s10530-004-1663-x	47	77	81	2	108	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e24733	10.1371/journal.pone.0024733	http://dx.doi.org/10.1371/journal.pone.0024733			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CK	21931837	Green Published, Green Submitted, gold			2022-12-25	WOS:000294802800088
J	Chen, SH; Wang, JM; Irwin, RW; Yao, J; Liu, LF; Brinton, RD				Chen, Shuhua; Wang, Jun Ming; Irwin, Ronald W.; Yao, Jia; Liu, Lifei; Brinton, Roberta Diaz			Allopregnanolone Promotes Regeneration and Reduces beta-Amyloid Burden in a Preclinical Model of Alzheimer's Disease	PLOS ONE			English	Article							TRIPLE-TRANSGENIC MODEL; X RECEPTOR ACTIVATION; A-BETA; MOUSE MODEL; NEUROSTEROID ALLOPREGNANOLONE; COGNITIVE DEFICITS; NERVOUS-SYSTEM; C DISEASE; IN-VIVO; PROTEIN	Previously, we demonstrated that allopregnanolone (AP alpha) promoted proliferation of rodent and human neural progenitor cells in vitro. Further, we demonstrated that AP alpha promoted neurogenesis in the hippocampal subgranular zone (SGZ) and reversed learning and memory deficits in the male triple transgenic mouse model of Alzheimer's (3xTgAD). In the current study, we determined the efficacy of AP alpha to promote the survival of newly generated neural cells while simultaneously reducing Alzheimer's disease (AD) pathology in the 3xTgAD male mouse model. Comparative analyses between three different AP alpha treatment regimens indicated that AP alpha administered 1/week for 6 months was maximally efficacious for simultaneous promotion of neurogenesis and survival of newly generated cells and reduction of AD pathology. We further investigated the efficacy of AP alpha to impact A beta burden. Treatment was initiated either prior to or post intraneuronal A beta accumulation. Results indicated that AP alpha administered 1/week for 6 months significantly increased survival of newly generated neurons and simultaneously reduced A beta pathology with greatest efficacy in the pre-pathology treatment group. AP alpha significantly reduced A beta generation in hippocampus, cortex, and amygdala, which was paralleled by decreased expression of A beta-binding-alcohol-dehydrogenase. In addition, AP alpha significantly reduced microglia activation as indicated by reduced expression of OX42 while increasing CNPase, an oligodendrocyte myelin marker. Mechanistic analyses indicated that pre-pathology treatment with AP alpha increased expression of liver-X-receptor, pregnane-X-receptor, and 3-hydroxy-3-methyl-glutaryl-CoA-reductase (HMG-CoA-R), three proteins that regulate cholesterol homeostasis and clearance from brain. Together these findings provide preclinical evidence for the optimal treatment regimen of AP alpha to achieve efficacy as a disease modifying therapeutic to promote regeneration while simultaneously decreasing the pathology associated with Alzheimer's disease.	[Chen, Shuhua; Irwin, Ronald W.; Yao, Jia; Brinton, Roberta Diaz] Univ So Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90007 USA; [Wang, Jun Ming] Univ Mississippi, Med Ctr, Dept Pathol, Jackson, MS 39216 USA; [Liu, Lifei; Brinton, Roberta Diaz] Univ So Calif, Neurosci Program, Los Angeles, CA 90089 USA	University of Southern California; University of Mississippi; University of Mississippi Medical Center; University of Southern California	Chen, SH (corresponding author), Univ So Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90007 USA.	rbrinton@usc.edu	Irwin, Ronald W./N-8686-2013	Irwin, Ronald W./0000-0002-6969-6021; Brinton, Roberta/0000-0001-8450-772X	National Institute on Aging [U01 AG031115]; Kenneth T. and Eileen L. Norris Foundation; Alzheimer's Drug Discovery Foundation; NATIONAL INSTITUTE ON AGING [U01AG031115] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Kenneth T. and Eileen L. Norris Foundation; Alzheimer's Drug Discovery Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by grants from Alzheimer's Drug Discovery Foundation, National Institute on Aging U01 AG031115, and the Kenneth T. and Eileen L. Norris Foundation to RDB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad I, 2005, J NEUROSCI RES, V82, P811, DOI 10.1002/jnr.20685; Ahmed Z, 2007, J HISTOCHEM CYTOCHEM, V55, P687, DOI 10.1369/jhc.6A7156.2007; Bartzokis G, 2004, NEUROBIOL AGING, V25, P5, DOI 10.1016/j.neurobiolaging.2003.03.001; Bartzokis G, 2003, ARCH NEUROL-CHICAGO, V60, P393, DOI 10.1001/archneur.60.3.393; Bartzokis G, 2010, NEUROBIOL AGING, V31, P1554, DOI 10.1016/j.neurobiolaging.2008.08.015; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Bilsland JG, 2006, J NEUROSCI METH, V157, P54, DOI 10.1016/j.jneumeth.2006.03.026; Brinton RD, 2008, TRENDS NEUROSCI, V31, P529, DOI 10.1016/j.tins.2008.07.003; Davidson CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006951; Desai MK, 2009, GLIA, V57, P54, DOI 10.1002/glia.20734; Donkin JJ, 2010, J BIOL CHEM; Griffin LD, 2004, NAT MED, V10, P704, DOI 10.1038/nm1073; Henry S, 2009, BIOSCI TRENDS, V3, P233; Jacobs H.I.L., 2010, NEUROBIOL AGING; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Klein WL, 2004, NEUROBIOL AGING, V25, P569, DOI 10.1016/j.neurobiolaging.2004.02.010; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; Klyubin I, 2005, NAT MED, V11, P556, DOI 10.1038/nm1234; Koldamova T, 2005, J BIOL CHEM, V280, P4079, DOI 10.1074/jbc.M411420200; Kuczynski B, 2008, ARCH NEUROL-CHICAGO, V65, P650, DOI 10.1001/archneur.65.5.650; Kuczynski B, 2010, ALZHEIMERS DEMENT, V6, P54, DOI 10.1016/j.jalz.2009.04.1228; Lamba V, 2004, TOXICOL APPL PHARM, V199, P251, DOI 10.1016/j.taap.2003.12.027; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Langmade SJ, 2006, P NATL ACAD SCI USA, V103, P13807, DOI 10.1073/pnas.0606218103; Leduc V., 2010, TRENDS MOL MED; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Li R, 2000, J NEUROCHEM, V75, P1447, DOI 10.1046/j.1471-4159.2000.0751447.x; Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230; Marx CE, 2006, BIOL PSYCHIAT, V60, P1287, DOI 10.1016/j.biopsych.2006.06.017; Mellon S, 2004, ENDOCR RES, V30, P727, DOI 10.1081/ERC-200044016; Mellon SH, 2008, BRAIN RES REV, V57, P410, DOI 10.1016/j.brainresrev.2007.05.012; Mika J, 2009, EUR J PHARMACOL, V623, P65, DOI 10.1016/j.ejphar.2009.09.030; Naylor JC, 2010, BBA-MOL CELL BIOL L, V1801, P951, DOI 10.1016/j.bbalip.2010.05.006; ODA T, 1995, EXP NEUROL, V136, P22, DOI 10.1006/exnr.1995.1080; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Oddo S, 2004, NEURON, V43, P321, DOI 10.1016/j.neuron.2004.07.003; Oddo S, 2003, NEUROBIOL AGING, V24, P1063, DOI 10.1016/j.neurobiolaging.2003.08.012; Oosterveer MH, 2010, EUR J CLIN INVEST, V40, P64; Repa JJ, 2007, J NEUROSCI, V27, P14470, DOI 10.1523/JNEUROSCI.4823-07.2007; Riddell DR, 2007, MOL CELL NEUROSCI, V34, P621, DOI 10.1016/j.mcn.2007.01.011; Rosenbaum AI, 2010, P NATL ACAD SCI USA, V107, P5477, DOI 10.1073/pnas.0914309107; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Schumacher M, 2004, GROWTH HORM IGF RES, V14, pS18, DOI 10.1016/j.ghir.2004.03.007; Selkoe DJ, 2001, J ALZHEIMERS DIS, V3, P75, DOI 10.3233/JAD-2001-3111; Shenoy SD, 2004, DRUG METAB DISPOS, V32, P66, DOI 10.1124/dmd.32.1.66; Singh C, 2011, NEUROBIOL AGING 0729; Sonoda J, 2002, P NATL ACAD SCI USA, V99, P13801, DOI 10.1073/pnas.212494599; Sun Y, 2003, J BIOL CHEM, V278, P27688, DOI 10.1074/jbc.M300760200; Takuma K, 2005, FASEB J, V19, P597, DOI 10.1096/fj.04-2582fje; Wang JM, 2005, J NEUROSCI, V25, P4706, DOI 10.1523/JNEUROSCI.4520-04.2005; Wang JM, 2010, P NATL ACAD SCI USA, V107, P6498, DOI 10.1073/pnas.1001422107; Whitney KD, 2002, MOL ENDOCRINOL, V16, P1378, DOI 10.1210/me.16.6.1378; Xie Z, 2005, J NEUROCHEM, V93, P1038, DOI 10.1111/j.1471-4159.2005.03065.x; Xie Z, 2002, J NEUROSCI, V22, P3484; Xiong HQ, 2008, NEUROBIOL DIS, V29, P422, DOI 10.1016/j.nbd.2007.10.005; Yan SD, 2005, INT J EXP PATHOL, V86, P161, DOI 10.1111/j.0959-9673.2005.00427.x; Yao J, 2009, P NATL ACAD SCI USA, V106, P14670, DOI 10.1073/pnas.0903563106; Zhou HW, 2006, BBA-MOL CELL BIOL L, V1761, P1482, DOI 10.1016/j.bbalip.2006.09.008	58	88	92	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2011	6	8							e24293	10.1371/journal.pone.0024293	http://dx.doi.org/10.1371/journal.pone.0024293			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817MS	21918687	Green Published, gold, Green Submitted			2022-12-25	WOS:000294678300036
J	Zhang, RP; Shao, JZ; Xiang, LX				Zhang, Rui-peng; Shao, Jian-zhong; Xiang, Li-xin			GADD45A Protein Plays an Essential Role in Active DNA Demethylation during Terminal Osteogenic Differentiation of Adipose-derived Mesenchymal Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTIDINE DEAMINASE AID; PRIMORDIAL GERM-CELLS; ZYGOTIC PATERNAL GENOME; CPG ISLAND SHORES; EMBRYONIC STEM; STRESS-PROTEIN; MAMMALIAN DNA; GROWTH ARREST; PROMOTER DNA; METHYLATION	Methylation and demethylation of DNA are the complementary processes of epigenetic regulation. These two types of regulation influence a diverse array of cellular activities, including the maintenance of pluripotency and self-renewal in embryonic stem cells. It was generally believed that DNA demethylation occurs passively over several cycles of DNA replication and that active DNA demethylation is rare. Recently, evidence for active DNA demethylation has been obtained in several cancer, neuronal, and embryonic stem cell lines. Studies in embryonic stem cell models, however, suggested that active DNA demethylation might be restricted to the early development of progenitor cells. Whether active demethylation is involved in terminal differentiation of adult stem cells is poorly understood. We provide evidence that active DNA demethylation does occur during terminal specification of stem cells in an adipose-derived mesenchymal stern cell-derived osteogenic differentiation model. The medium CpG regions in promoters of the Dlx5, Runx2, Bglap, and Osterix osteogenic lineage-specific genes were demethylated during the increase in gene expression associated with osteogenic differentiation. The growth arrest and DNA damage-inducible protein GADD45A was up-regulated in these processes. Knockdown of GADD45A led to hypermethylation of Dlx5, Runx2, Bglap, and Osterix promoters, followed by suppression of the expression of these genes and interruption of osteogenic differentiation. These results reveal that GADD45A plays an essential role in gene-specific active DNA demethylation during adult stem cell differentiation. They enhance the current knowledge of osteogenic specification and may also lead to a better understanding of the common mechanisms underlying epigenetic regulation in adult stern cell differentiation.	[Zhang, Rui-peng; Shao, Jian-zhong; Xiang, Li-xin] Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Zhang, Rui-peng; Shao, Jian-zhong; Xiang, Li-xin] Key Lab Cell & Gene Engn, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University	Shao, JZ (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou 310058, Zhejiang, Peoples R China.	shaojz@zju.edu.cn; xianglx@zju.edu.cn			National Basic Research Program of China [973 2012CB114404]; Science and Technology Foundation of Ministry of Health of the People's Republic of China [WKJ2007-2-037]	National Basic Research Program of China(National Basic Research Program of China); Science and Technology Foundation of Ministry of Health of the People's Republic of China	This work was supported by National Basic Research Program of China Grant 973 2012CB114404 and Science and Technology Foundation of Ministry of Health of the People's Republic of China Grant WKJ2007-2-037.	Abdalla H, 2009, J REPROD DEVELOP, V55, P356, DOI 10.1262/jrd.20234; Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Bruniquel D, 2003, NAT IMMUNOL, V4, P235, DOI 10.1038/ni887; Bunnell BA, 2008, METHODS, V45, P115, DOI 10.1016/j.ymeth.2008.03.006; Carrier F, 1999, MOL CELL BIOL, V19, P1673; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Cowan CM, 2004, NAT BIOTECHNOL, V22, P560, DOI 10.1038/nbt958; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Engel N, 2009, EPIGENETICS-US, V4, P98, DOI 10.4161/epi.4.2.7858; Fitzpatrick DR, 2003, CLIN IMMUNOL, V109, P37, DOI 10.1016/S1521-6616(03)00205-5; Fulka H, 2004, REPRODUCTION, V128, P703, DOI 10.1530/rep.1.00217; Gan Q, 2007, STEM CELLS, V25, P2, DOI 10.1634/stemcells.2006-0383; Gidekel S, 2002, J BIOL CHEM, V277, P34521, DOI 10.1074/jbc.M203338200; Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09; Haines TR, 2001, DEV BIOL, V240, P585, DOI 10.1006/dbio.2001.0504; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Hattori N, 2004, J BIOL CHEM, V279, P17063, DOI 10.1074/jbc.M309002200; Hattori N, 2007, GENES CELLS, V12, P387, DOI 10.1111/j.1365-2443.2007.01058.x; Hollander MC, 2005, CELL CYCLE, V4, P704, DOI 10.4161/cc.4.5.1675; IMRE R, 1983, ACTA HISTOCHEM, V73, P17, DOI 10.1016/S0065-1281(83)80067-1; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jackson M, 2004, MOL CELL BIOL, V24, P8862, DOI 10.1128/MCB.24.20.8862-8871.2004; Jin SG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000013; Jiricny J, 2008, CELL, V135, P1167, DOI 10.1016/j.cell.2008.12.008; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640; Kress C, 2001, FEBS LETT, V494, P135, DOI 10.1016/S0014-5793(01)02328-6; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Latham T, 2008, CELL TISSUE RES, V331, P31, DOI 10.1007/s00441-007-0537-9; Lee J, 2002, DEVELOPMENT, V129, P1807; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Miller CA, 2007, NEURON, V53, P857, DOI 10.1016/j.neuron.2007.02.022; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Morgan HD, 2004, J BIOL CHEM, V279, P52353, DOI 10.1074/jbc.M407695200; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Muto T, 2000, GENOMICS, V68, P85, DOI 10.1006/geno.2000.6268; Okada Y, 2010, NATURE, V463, P554, DOI 10.1038/nature08732; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sanchez R, 2010, J BIOL CHEM, V285, P22196, DOI 10.1074/jbc.M109.069344; Schmitz KM, 2009, MOL CELL, V33, P344, DOI 10.1016/j.molcel.2009.01.015; Siafakas AR, 2009, INT J BIOCHEM CELL B, V41, P986, DOI 10.1016/j.biocel.2008.06.018; Sorensen A. L., 2010, CELL, V21, P2066; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Takekawa M, 1998, CELL, V95, P521, DOI 10.1016/S0092-8674(00)81619-0; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Wu SC, 2010, NAT REV MOL CELL BIO, V11, P607, DOI 10.1038/nrm2950; Yeo S, 2007, BIOCHEM BIOPH RES CO, V359, P536, DOI 10.1016/j.bbrc.2007.05.120; Zhan QM, 2005, MUTAT RES-FUND MOL M, V569, P133, DOI 10.1016/j.mrfmmm.2004.06.055; Zhang SJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000604; Zhou GS, 2009, CYTOTECHNOLOGY, V60, P11, DOI 10.1007/s10616-009-9203-2; Zuk PA, 2010, MOL BIOL CELL, V21, P1783, DOI 10.1091/mbc.E09-07-0589	62	84	93	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					41083	41094		10.1074/jbc.M111.258715	http://dx.doi.org/10.1074/jbc.M111.258715			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21917922	Green Published, hybrid			2022-12-25	WOS:000297315400067
J	Ryuda, M; Tsuzuki, S; Matsumoto, H; Oda, Y; Tanimura, T; Hayakawa, Y				Ryuda, Masasuke; Tsuzuki, Seiji; Matsumoto, Hitoshi; Oda, Yasunori; Tanimura, Teiichi; Hayakawa, Yoichi			Identification of a Novel Gene, Anorexia, Regulating Feeding Activity via Insulin Signaling in Drosophila melanogaster	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANDIDATE TASTE RECEPTORS; CENTRAL-NERVOUS-SYSTEM; PEPTIDE; FAMILY; EXPRESSION; PROTEIN; BEHAVIOR; NEURONS; TARGET	Feeding activities of animals, including insects, are influenced by various signals from the external environment, internal energy status, and physiological conditions. Full understanding of how such signals are integrated to regulate feeding activities has, however, been hampered by a lack of knowledge about the genes involved. Here, we identified an anorexic Drosophila melanogaster mutant (GS1189) in which the expression of a newly identified gene, Anorexia (Anox), is mutated. In Drosophila larvae, Anox encodes an acyl-CoA binding protein with an ankyrin repeat domain that is expressed in the cephalic chemosensory organs and various neurons in the central nervous system (CNS). Loss of its expression or disturbance of neural transmission in Anox-expressing cells decreased feeding activity. Conversely, overexpression of Anox in the CNS increased food intake. We further found that Anox regulates expression of the insulin receptor gene (dInR); overexpression and knockdown of Anox in the CNS, respectively, elevated and repressed dInR expression, which altered larval feeding activity in parallel with Anox expression levels. Anox mutant adults also showed significant repression of sugar-induced nerve responses and feeding potencies. Although Anox expression levels did not depend on the fasting and feeding states cycle, stressors such as high temperature and desiccation significantly repressed its expression levels. These results strongly suggest that Anox is essential for gustatory sensation and food intake of Drosophila through regulation of the insulin signaling activity that is directly regulated by internal nutrition status. Therefore, the mutant strain lacking Anox expression cannot enhance feeding potencies even under starvation.	[Ryuda, Masasuke; Tsuzuki, Seiji; Matsumoto, Hitoshi; Oda, Yasunori; Hayakawa, Yoichi] Saga Univ, Dept Appl Biol Sci, Saga 8408502, Japan; [Tanimura, Teiichi] Kyushu Univ, Grad Sch Sci, Dept Biol, Hakozaki 8128581, Japan	Saga University; Kyushu University	Hayakawa, Y (corresponding author), Honjo 1, Saga 8408502, Japan.	hayakayo@cc.saga-u.ac.jp			Grants-in-Aid for Scientific Research [21370003] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Adler E, 2000, CELL, V100, P693, DOI 10.1016/S0092-8674(00)80705-9; Amrein H, 2005, CURR BIOL, V15, pR673, DOI 10.1016/j.cub.2005.08.021; Breitling Rainer, 2004, BMC Pediatr, V4, P5, DOI 10.1186/1471-2431-4-5; Buch S, 2008, CELL METAB, V7, P321, DOI 10.1016/j.cmet.2008.02.012; Cao C, 2001, CELL TISSUE RES, V304, P317, DOI 10.1007/s004410100367; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830; Dunipace L, 2001, CURR BIOL, V11, P822, DOI 10.1016/S0960-9822(01)00258-5; EDGECOMB RS, 1994, J EXP BIOL, V197, P215; Hiroi M, 2002, ZOOL SCI, V19, P1009, DOI 10.2108/zsj.19.1009; Hoon MA, 1999, CELL, V96, P541, DOI 10.1016/S0092-8674(00)80658-3; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Inoshita T, 2006, P NATL ACAD SCI USA, V103, P1094, DOI 10.1073/pnas.0502376103; Ja WW, 2007, P NATL ACAD SCI USA, V104, P8253, DOI 10.1073/pnas.0702726104; Junger Martin A, 2003, J Biol, V2, P20, DOI 10.1186/1475-4924-2-20; Luquet S, 2005, SCIENCE, V310, P683, DOI 10.1126/science.1115524; Matsumoto Y, 2003, J BIOL CHEM, V278, P38579, DOI 10.1074/jbc.M305986200; Matsunami H, 2000, NATURE, V404, P601, DOI 10.1038/35007072; Mikhailov AT, 2008, INT J DEV BIOL, V52, P811, DOI 10.1387/ijdb.082655am; Mosavi LK, 2002, P NATL ACAD SCI USA, V99, P16029, DOI 10.1073/pnas.252537899; Ninomiya Y, 2008, FEBS J, V275, P894, DOI 10.1111/j.1742-4658.2008.06252.x; NOVICK P, 1981, CELL, V25, P461, DOI 10.1016/0092-8674(81)90064-7; Oda Y, 2010, P NATL ACAD SCI USA, V107, P15862, DOI 10.1073/pnas.1003785107; Partridge L, 2005, MECH AGEING DEV, V126, P938, DOI 10.1016/j.mad.2005.03.023; Puig O, 2005, GENE DEV, V19, P2435, DOI 10.1101/gad.1340505; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; Ryuda M, 2008, J INSECT PHYSIOL, V54, P1440, DOI 10.1016/j.jinsphys.2008.08.006; Ryuda M, 2008, ZOOL SCI, V25, P746, DOI 10.2108/zsj.25.746; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; TANIMURA T, 1982, J COMP PHYSIOL, V147, P433, DOI 10.1007/BF00612007; Toba G, 1999, GENETICS, V151, P725; Voie A. M., 1998, CELL BIOL LAB HDB, V275, P3; Voie A. M., 1998, CELL BIOL LAB HDB, V3, P3; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Zhang AH, 2004, J BIOL CHEM, V279, P33799, DOI 10.1074/jbc.M403997200	36	26	26	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38417	38426		10.1074/jbc.M111.267344	http://dx.doi.org/10.1074/jbc.M111.267344			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21917925	Green Published, hybrid			2022-12-25	WOS:000296594200056
J	Gao, X; Deng, P; Xu, ZC; Chen, JH				Gao, Xiang; Deng, Ping; Xu, Zao C.; Chen, Jinhui			Moderate Traumatic Brain Injury Causes Acute Dendritic and Synaptic Degeneration in the Hippocampal Dentate Gyrus	PLOS ONE			English	Article							CONTROLLED CORTICAL IMPACT; FLUID PERCUSSION INJURY; INDUCED AXONAL INJURY; STEREOLOGICAL ESTIMATION; CHOLINERGIC INNERVATION; ALZHEIMERS-DISEASE; MEMORY DYSFUNCTION; PYRAMIDAL NEURONS; IMMATURE RAT; TIME-COURSE	Hippocampal injury-associated learning and memory deficits are frequent hallmarks of brain trauma and are the most enduring and devastating consequences following traumatic brain injury (TBI). Several reports, including our recent paper, showed that TBI brought on by a moderate level of controlled cortical impact (CCI) induces immature newborn neuron death in the hippocampal dentate gyrus. In contrast, the majority of mature neurons are spared. Less research has been focused on these spared neurons, which may also be injured or compromised by TBI. Here we examined the dendrite morphologies, dendritic spines, and synaptic structures using a genetic approach in combination with immunohistochemistry and Golgi staining. We found that although most of the mature granular neurons were spared following TBI at a moderate level of impact, they exhibited dramatic dendritic beading and fragmentation, decreased number of dendritic branches, and a lower density of dendritic spines, particularly the mushroom-shaped mature spines. Further studies showed that the density of synapses in the molecular layer of the hippocampal dentate gyrus was significantly reduced. The electrophysiological activity of neurons was impaired as well. These results indicate that TBI not only induces cell death in immature granular neurons, it also causes significant dendritic and synaptic degeneration in pathohistology. TBI also impairs the function of the spared mature granular neurons in the hippocampal dentate gyrus. These observations point to a potential anatomic substrate to explain, in part, the development of posttraumatic memory deficits. They also indicate that dendritic damage in the hippocampal dentate gyrus may serve as a therapeutic target following TBI.	[Gao, Xiang; Xu, Zao C.; Chen, Jinhui] Stark Neurosci Res Inst, Dept Neurosurg, Spinal Cord & Brain Injury Res Grp, Indianapolis, IN USA; [Deng, Ping] Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN USA	Indiana University System; Indiana University Bloomington	Gao, X (corresponding author), Stark Neurosci Res Inst, Dept Neurosurg, Spinal Cord & Brain Injury Res Grp, Indianapolis, IN USA.	chen204@iupui.edu			Indiana Spinal Cord & Brain Injury Research Fund (SCBI) [200-12]; Ralph W. and Grace M. Showalter Research Award; Indiana University; Showalter award; biomedical research award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS075733, R21NS072631] Funding Source: NIH RePORTER	Indiana Spinal Cord & Brain Injury Research Fund (SCBI); Ralph W. and Grace M. Showalter Research Award; Indiana University; Showalter award; biomedical research award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the Indiana Spinal Cord & Brain Injury Research Fund (SCBI 200-12)(http://www.in.gov/isdh/23657.htm); the Ralph W. and Grace M. Showalter Research Award, and the Indiana University Biological Research Grant to J. Chen. Both the Showalter award and the biomedical research award are internal funding, and do not have grant numbers and specific websites. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelson PD, 1997, J NEUROTRAUM, V14, P99, DOI 10.1089/neu.1997.14.99; Adelson PD, 2000, J NEUROTRAUM, V17, P273, DOI 10.1089/neu.2000.17.273; Balthasar N, 2004, NEURON, V42, P983, DOI 10.1016/j.neuron.2004.06.004; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Calhoun ME, 1996, J NEUROCYTOL, V25, P821, DOI 10.1007/BF02284844; Chen LJ, 2010, J NEUROTRAUM, V27, P1657, DOI 10.1089/neu.2010.1308; Ciallella JR, 1998, EXP NEUROL, V152, P11, DOI 10.1006/exnr.1998.6831; DIXON CE, 1995, BEHAV BRAIN RES, V70, P125, DOI 10.1016/0166-4328(95)80002-6; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Ehlers MD, 2005, J CELL BIOL, V170, P517, DOI 10.1083/jcb.200507096; EMERY DG, 1995, BRAIN RES, V692, P161, DOI 10.1016/0006-8993(95)00726-7; FELDMAN ML, 1979, J COMP NEUROL, V188, P527, DOI 10.1002/cne.901880403; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Gao X., 2009, J NEUROTRAUMA; Gao X, 2008, J NEUROTRAUM, V25, P985, DOI 10.1089/neu.2008.0460; Gao X, 2008, J NEUROSCI RES, V86, P2258, DOI 10.1002/jnr.21677; Gao X, 2007, J NEUROSCI, V27, P14317, DOI 10.1523/JNEUROSCI.3206-07.2007; Gao X, 2009, EXP NEUROL, V219, P516, DOI 10.1016/j.expneurol.2009.07.007; Gao X, 2009, EXP NEUROL, V215, P178, DOI 10.1016/j.expneurol.2008.10.009; Geula C, 1998, NEUROLOGY, V51, pS18, DOI 10.1212/WNL.51.1_Suppl_1.S18; Grady MS, 2003, J NEUROTRAUM, V20, P929, DOI 10.1089/089771503770195786; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; HARRIS KM, 1992, J NEUROSCI, V12, P2685; Hellmich HL, 2005, BRAIN RES, V1044, P144, DOI 10.1016/j.brainres.2005.02.054; Hoskison MM, 2009, NEUROSCIENCE, V159, P483, DOI 10.1016/j.neuroscience.2008.12.050; Hunt RF, 2010, J NEUROPHYSIOL, V103, P1490, DOI 10.1152/jn.00957.2009; Isoniemi H, 2006, NEUROLOGY, V67, P756, DOI 10.1212/01.wnl.0000234140.64954.12; Jan YN, 2001, GENE DEV, V15, P2627, DOI 10.1101/gad.916501; Kelly Kevin M, 2004, Epilepsy Curr, V4, P160, DOI 10.1111/j.1535-7597.2004.44015.x; Leuner B, 2010, ANNU REV PSYCHOL, V61, P111, DOI 10.1146/annurev.psych.093008.100359; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; LINDROOS OFC, 1983, STAIN TECHNOL, V58, P240, DOI 10.3109/10520298309066795; Lister JP, 2009, ARCH NEUROL-CHICAGO, V66, P829, DOI 10.1001/archneurol.2009.125; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Markgraf CG, 2001, J NEUROTRAUM, V18, P175, DOI 10.1089/08977150150502604; McCarthy MM, 2003, EXP NEUROL, V184, P40, DOI 10.1016/j.expneurol.2003.08.020; Monnerie H, 2010, EXP NEUROL, V224, P415, DOI 10.1016/j.expneurol.2010.05.001; NORRIS CM, 2009, J NEUROTRAUMA; Novak K, 2000, NAT MED, V6, P864, DOI 10.1038/78615; Petrak LJ, 2005, J COMP NEUROL, V484, P183, DOI 10.1002/cne.20468; Polydoro M, 2009, J NEUROSCI, V29, P10741, DOI 10.1523/JNEUROSCI.1065-09.2009; Portera-Cailliau C, 2003, J NEUROSCI, V23, P7129, DOI 10.1523/JNEUROSCI.23-18-07129.2003; Posmantur RM, 1996, J NEUROTRAUM, V13, P125, DOI 10.1089/neu.1996.13.125; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Pruss H, 2005, MOL BRAIN RES, V139, P63, DOI 10.1016/j.molbrainres.2005.05.006; Pullela R, 2006, DEV NEUROSCI-BASEL, V28, P396, DOI 10.1159/000094166; REISINE TD, 1978, BRAIN RES, V159, P477, DOI 10.1016/0006-8993(78)90562-0; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; Santhakumar V, 2005, J NEUROPHYSIOL, V93, P437, DOI 10.1152/jn.00777.2004; SAUER B, 1988, P NATL ACAD SCI USA, V85, P5166, DOI 10.1073/pnas.85.14.5166; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Schmidt RH, 1999, J NEUROTRAUM, V16, P1139, DOI 10.1089/neu.1999.16.1139; Selkoe Dennis, 2002, Harv Health Lett, V27, P5; SERESS L, 1981, J ANAT, V133, P181; SHOLL D A, 1956, Prog Neurobiol, P324; SMITH DH, 1994, NEUROSCI LETT, V168, P151, DOI 10.1016/0304-3940(94)90438-3; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; SOTREL A, 1993, NEUROLOGY, V43, P2088, DOI 10.1212/WNL.43.10.2088; Stewart TH, 2010, J NEUROPHYSIOL, V104, P3345, DOI 10.1152/jn.00398.2010; SUETSUGU M, 1980, ACTA NEUROPATHOL, V50, P207, DOI 10.1007/BF00688755; Swann JW, 2000, HIPPOCAMPUS, V10, P617, DOI 10.1002/1098-1063(2000)10:5<617::AID-HIPO13>3.0.CO;2-R; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Tong W, 2002, EXP NEUROL, V176, P105, DOI 10.1006/exnr.2002.7941; Travis K, 2005, DEV NEUROSCI-BASEL, V27, P277, DOI 10.1159/000086707; UYLINGS HBM, 1986, J NEUROSCI METH, V18, P127, DOI 10.1016/0165-0270(86)90116-0; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Young CC, 2009, J PHYSIOL-LONDON, V587, P4213, DOI 10.1113/jphysiol.2009.170746; Zeng LH, 2007, J NEUROSCI, V27, P11604, DOI 10.1523/JNEUROSCI.0983-07.2007	74	145	147	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2011	6	9							e24566	10.1371/journal.pone.0024566	http://dx.doi.org/10.1371/journal.pone.0024566			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZV	21931758	Green Published, gold, Green Submitted			2022-12-25	WOS:000295321800033
J	Madan, LL; Veeranna, S; Shameer, K; Reddy, CCS; Sowdhamini, R; Gopal, B				Madan, Lalima L.; Veeranna, S.; Shameer, Khader; Reddy, Chilamakuri C. S.; Sowdhamini, R.; Gopal, B.			Modulation of Catalytic Activity in Multi-Domain Protein Tyrosine Phosphatases	PLOS ONE			English	Article							SUBSTRATE-SPECIFICITY; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; AXON GUIDANCE; DOMAINS; DROSOPHILA; PEPTIDE; REQUIREMENTS; EXPRESSION	Signaling mechanisms involving protein tyrosine phosphatases govern several cellular and developmental processes. These enzymes are regulated by several mechanisms which include variation in the catalytic turnover rate based on redox stimuli, subcellular localization or protein-protein interactions. In the case of Receptor Protein Tyrosine Phosphatases (RPTPs) containing two PTP domains, phosphatase activity is localized in their membrane-proximal (D1) domains, while the membrane-distal (D2) domain is believed to play a modulatory role. Here we report our analysis of the influence of the D2 domain on the catalytic activity and substrate specificity of the D1 domain using two Drosophila melanogaster RPTPs as a model system. Biochemical studies reveal contrasting roles for the D2 domain of Drosophila Leukocyte antigen Related (DLAR) and Protein Tyrosine Phosphatase on Drosophila chromosome band 99A (PTP99A). While D2 lowers the catalytic activity of the D1 domain in DLAR, the D2 domain of PTP99A leads to an increase in the catalytic activity of its D1 domain. Substrate specificity, on the other hand, is cumulative, whereby the individual specificities of the D1 and D2 domains contribute to the substrate specificity of these two-domain enzymes. Molecular dynamics simulations on structural models of DLAR and PTP99A reveal a conformational rationale for the experimental observations. These studies reveal that concerted structural changes mediate inter-domain communication resulting in either inhibitory or activating effects of the membrane distal PTP domain on the catalytic activity of the membrane proximal PTP domain.	[Madan, Lalima L.; Veeranna, S.; Gopal, B.] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India; [Shameer, Khader; Reddy, Chilamakuri C. S.; Sowdhamini, R.] Natl Ctr Biol Sci TIFR, Bangalore, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Madan, LL (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.	mini@ncbs.res.in; bgopal@mbu.iisc.ernet.in	Gopal, Balasubramanian/ABG-3754-2021; Khader, Shameer/J-2564-2016	Khader, Shameer/0000-0002-9982-1911	Department of Science and Technology, Government of India [SR/SO/BB-30/2005]; NCBS (TIFR)	Department of Science and Technology, Government of India(Department of Science & Technology (India)); NCBS (TIFR)	This study was supported by a grant from the Department of Science and Technology, Government of India, grant number SR/SO/BB-30/2005 (http://www.serc-dst.org/). LLM is a Senior Research Fellow of the CSIR, India. RS thanks NCBS (TIFR) for financial and infrastructural support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersen JN, 2001, MOL CELL BIOL, V21, P7117, DOI 10.1128/MCB.21.21.7117-7136.2001; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Desai CJ, 1997, DEVELOPMENT, V124, P1941; Webb Benjamin, 2016, Curr Protoc Bioinformatics, V54, DOI [10.1002/0471140864.ps0209s50, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/cpbi.3]; Gago Federico, 2004, Current Medicinal Chemistry - Anti-Cancer Agents, V4, P401, DOI 10.2174/1568011043352786; Garrity PA, 1999, NEURON, V22, P707, DOI 10.1016/S0896-6273(00)80730-8; GELADOPOULOS TP, 1991, ANAL BIOCHEM, V192, P112, DOI 10.1016/0003-2697(91)90194-X; Johnson KG, 2003, PHYSIOL REV, V83, P1, DOI 10.1152/physrev.00016.2002; Kamerlin SCL, 2006, BIOCHEM BIOPH RES CO, V345, P1161, DOI 10.1016/j.bbrc.2006.04.181; Kashio N, 1998, J BIOL CHEM, V273, P33856, DOI 10.1074/jbc.273.50.33856; Khajehpour M, 2007, BIOCHEMISTRY-US, V46, P4370, DOI 10.1021/bi602335x; Krueger NX, 2003, MOL CELL BIOL, V23, P6909, DOI 10.1128/MCB.23.19.6909-6921.2003; Krueger NX, 1996, CELL, V84, P611, DOI 10.1016/S0092-8674(00)81036-3; Kumar R, 2010, J CHEM INF MODEL, V50, P1147, DOI 10.1021/ci900484g; Kamerlin SCL, 2007, BIOCHEM BIOPH RES CO, V356, P1011, DOI 10.1016/j.bbrc.2007.03.093; Madan LL, 2008, PROTEIN EXPRES PURIF, V57, P234, DOI 10.1016/j.pep.2007.10.002; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Nam HJ, 1999, CELL, V97, P449, DOI 10.1016/S0092-8674(00)80755-2; Pils B, 2004, MOL BIOL EVOL, V21, P625, DOI 10.1093/molbev/msh055; Romsicki Y, 2003, J BIOL CHEM, V278, P29009, DOI 10.1074/jbc.M303817200; Shameer K, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-473; STREULI M, 1990, EMBO J, V9, P2399, DOI 10.1002/j.1460-2075.1990.tb07415.x; Sun Q, 2000, DEVELOPMENT, V127, P801; Tamamura H, 1996, BIOCHEM BIOPH RES CO, V219, P555, DOI 10.1006/bbrc.1996.0272; Taylor NR, 1996, J MOL GRAPH MODEL, V14, P291, DOI 10.1016/S0263-7855(96)00077-X; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Tsujikawa K, 2001, MOL ENDOCRINOL, V15, P271, DOI 10.1210/me.15.2.271; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wiesmann C, 2004, NAT STRUCT MOL BIOL, V11, P730, DOI 10.1038/nsmb803; Wu L, 1997, J BIOL CHEM, V272, P6994, DOI 10.1074/jbc.272.11.6994; Zhang ZY, 1997, CURR TOP CELL REGUL, V35, P21, DOI 10.1016/S0070-2137(97)80002-7; ZHANG ZY, 1994, BIOCHEMISTRY-US, V33, P2285, DOI 10.1021/bi00174a040	35	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2011	6	9							e24766	10.1371/journal.pone.0024766	http://dx.doi.org/10.1371/journal.pone.0024766			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZV	21931847	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000295321800062
J	Bar-Joseph, H; Ben-Aharon, I; Tzabari, M; Tsarfaty, G; Stemmer, SM; Shalgi, R				Bar-Joseph, Hadas; Ben-Aharon, Irit; Tzabari, Moran; Tsarfaty, Galia; Stemmer, Salomon M.; Shalgi, Ruth			In vivo Bioimaging as a Novel Strategy to Detect Doxorubicin-Induced Damage to Gonadal Blood Vessels	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; CONFOCAL FLUORESCENCE MICROSCOPY; ENDOTHELIAL DYSFUNCTION; CARDIOMYOCYTE APOPTOSIS; ADRIAMYCIN; TOXICITY; CELLS; FLOW; CANCER; CARDIOTOXICITY	In Introduction: Chemotherapy may induce deleterious effects in normal tissues, leading to organ damage. Direct vascular injury is the least characterized side effect. Our aim was to establish a real-time, in vivo molecular imaging platform for evaluating the potential vascular toxicity of doxorubicin in mice. Methods: Mice gonads served as reference organs. Mouse ovarian or testicular blood volume and femoral arterial blood flow were measured in real-time during and after doxorubicin (8 mg/kg intravenously) or paclitaxel (1.2 mg/kg) administration. Ovarian blood volume was imaged by ultrasound biomicroscopy (Vevo2100) with microbubbles as a contrast agent whereas testicular blood volume and blood flow as well as femoral arterial blood flow was imaged by pulse wave Doppler ultrasound. Visualization of ovarian and femoral microvasculature was obtained by fluorescence optical imaging system, equipped with a confocal fiber microscope (Cell-viZio). Results: Using microbubbles as a contrast agent revealed a 33% (P < 0.01) decrease in ovarian blood volume already 3 minutes after doxorubicin injection. Doppler ultrasound depicted the same phenomenon in testicular blood volume and blood flow. The femoral arterial blood flow was impaired in the same fashion. Cell-viZio imaging depicted a pattern of vessels' injury at around the same time after doxorubicin injection: the wall of the blood vessels became irregular and the fluorescence signal displayed in the small vessels was gradually diminished. Paclitaxel had no vascular effect. Conclusion: We have established a platform of innovative high-resolution molecular imaging, suitable for in vivo imaging of vessels' characteristics, arterial blood flow and organs blood volume that enable prolonged real-time detection of chemotherapy-induced effects in the same individuals. The acute reduction in gonadal and femoral blood flow and the impairment of the blood vessels wall may represent an acute universal doxorubicin-related vascular toxicity, an initial event in organ injury.	[Bar-Joseph, Hadas; Tzabari, Moran; Shalgi, Ruth] Tel Aviv Univ, Sackler Fac Med, Dept Cell & Dev Biol, Tel Aviv, Israel; [Ben-Aharon, Irit; Stemmer, Salomon M.] Rabin Med Ctr, Inst Oncol, Davidoff Ctr, Petah Tiqwa, Israel; [Tsarfaty, Galia] Chaim Sheba Med Ctr, Dept Diagnost Imaging, IL-52621 Tel Hashomer, Israel	Tel Aviv University; Sackler Faculty of Medicine; Rabin Medical Center; Chaim Sheba Medical Center	Bar-Joseph, H (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Cell & Dev Biol, Tel Aviv, Israel.	iritbenaharon@gmail.com			Israel Cancer Research Fund (ICRF); Israel Ministry of Health	Israel Cancer Research Fund (ICRF); Israel Ministry of Health	This work was partially supported by a grant from the Israel Cancer Research Fund (ICRF) and the Israel Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Gubory KH, 2006, EUR J CELL BIOL, V85, P837, DOI 10.1016/j.ejcb.2006.03.007; Arola OJ, 2000, CANCER RES, V60, P1789; Auner HW, 2001, CANCER RES, V61, P2335; Baltabaeva A, 2009, J HYPERTENS, V27, P2086, DOI 10.1097/HJH.0b013e32832f4f3d; Beinert T, 1999, Eur J Med Res, V4, P43; Ben-Aharon I, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-20; Bollmann A, 2007, ECHOCARDIOGR-J CARD, V24, P430, DOI 10.1111/j.1540-8175.2006.00411.x; Caretta N, 2010, J UROLOGY, V183, P263, DOI 10.1016/j.juro.2009.08.140; Chaosuwannakit N, 2010, J CLIN ONCOL, V28, P166, DOI 10.1200/JCO.2009.23.8527; Chow AY, 2006, J CLIN ONCOL, V24, P925, DOI 10.1200/JCO.2005.03.5956; Coveney D, 2008, P NATL ACAD SCI USA, V105, P7212, DOI 10.1073/pnas.0707674105; Duquaine D, 2003, VASC MED, V8, P101, DOI 10.1191/1358863x03vm476oa; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Grant DS, 2003, INT J CANCER, V104, P121, DOI 10.1002/ijc.10907; Kaushal V, 2004, ENDOTHELIUM-J ENDOTH, V11, P253, DOI 10.1080/10623320490904124; Keefe DL, 2001, SEMIN ONCOL, V28, P2, DOI 10.1053/sonc.2001.26431; Kotamraju S, 2000, J BIOL CHEM, V275, P33585, DOI 10.1074/jbc.M003890200; Laemmel E, 2004, J VASC RES, V41, P400, DOI 10.1159/000081209; Lindner JR, 2002, J AM SOC ECHOCARDIOG, V15, P396, DOI 10.1067/mje.2002.117290; Murata T, 2001, BRIT J PHARMACOL, V132, P1365, DOI 10.1038/sj.bjp.0703959; Nuver J, 2005, J CLIN ONCOL, V23, P9130, DOI 10.1200/JCO.2005.01.4092; Olukman M, 2009, ANATOL J CARDIOL, V9, P260; Outomuro D, 2007, INT J CARDIOL, V117, P6, DOI 10.1016/j.ijcard.2006.05.005; Singal PK, 1998, NEW ENGL J MED, V339, P900, DOI 10.1056/NEJM199809243391307; Sohn S, 2002, ECHOCARDIOGR-J CARD, V19, P207, DOI 10.1046/j.1540-8175.2002.00207.x; Sullivan JC, 2009, AM J PHYSIOL-RENAL, V297, pF228, DOI 10.1152/ajprenal.00016.2009; Tsarfaty G, 2006, NEOPLASIA, V8, P344, DOI 10.1593/neo.05685; VasquezVivar J, 1997, BIOCHEMISTRY-US, V36, P11293, DOI 10.1021/bi971475e; Wang L, 1998, ENDOCRINOLOGY, V139, P1354, DOI 10.1210/en.139.3.1354; Wolf MB, 2006, BBA-GEN SUBJECTS, V1760, P267, DOI 10.1016/j.bbagen.2005.10.012; Wu S, 2002, J MOL CELL CARDIOL, V34, P1595, DOI 10.1006/jmcc.2002.2110; Yamac D, 2006, ULTRASTRUCT PATHOL, V30, P103, DOI 10.1080/01913120500406335; Yatsu Y, 2008, ANESTH ANALG, V106, P530, DOI 10.1213/ane.0b013e31816071b0	33	56	62	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2011	6	9							e23492	10.1371/journal.pone.0023492	http://dx.doi.org/10.1371/journal.pone.0023492			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CN	21931602	Green Submitted, Green Published, gold			2022-12-25	WOS:000294803100002
J	Culbertson, MD; Lewis, ZR; Nechiporuk, AV				Culbertson, Maya D.; Lewis, Zachary R.; Nechiporuk, Alexei V.			Chondrogenic and Gliogenic Subpopulations of Neural Crest Play Distinct Roles during the Assembly of Epibranchial Ganglia	PLOS ONE			English	Article							ZEBRAFISH FOXD3; EXPRESSION; PLACODES; GENES; SPECIFICATION; NEUROGENESIS; MIGRATION; ENDODERM; SYSTEM	In vertebrates, the sensory neurons of the epibranchial (EB) ganglia transmit somatosensory signals from the periphery to the CNS. These ganglia are formed during embryogenesis by the convergence and condensation of two distinct populations of precursors: placode-derived neuroblasts and neural crest- (NC) derived glial precursors. In addition to the gliogenic crest, chondrogenic NC migrates into the pharyngeal arches, which lie in close proximity to the EB placodes and ganglia. Here, we examine the respective roles of these two distinct NC-derived populations during development of the EB ganglia using zebrafish morphant and mutants that lack one or both of these NC populations. Our analyses of mutant and morphant zebrafish that exhibit deficiencies in chondrogenic NC at early stages reveal a distinct requirement for this NC subpopulation during early EB ganglion assembly and segmentation. Furthermore, restoration of wildtype chondrogenic NC in one of these mutants, prdm1a, is sufficient to restore ganglion formation, indicating a specific requirement of the chondrogenic NC for EB ganglia assembly. By contrast, analysis of the sox10 mutant, which lacks gliogenic NC, reveals that the initial assembly of ganglia is not affected. However, during later stages of development, EB ganglia are dispersed in the sox10 mutant, suggesting that glia are required to maintain normal EB ganglion morphology. These results highlight novel roles for two subpopulations of NC cells in the formation and maintenance of EB ganglia: chondrogenic NC promotes the early-stage formation of the developing EB ganglia while glial NC is required for the late-stage maintenance of ganglion morphology.	[Culbertson, Maya D.; Lewis, Zachary R.; Nechiporuk, Alexei V.] Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Portland, OR 97201 USA	Oregon Health & Science University	Culbertson, MD (corresponding author), Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Portland, OR 97201 USA.	nechipor@ohsu.edu		Lewis, Zachary/0000-0003-0160-4722	National Institute of Child Health and Human Development [HD055303]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R00HD055303, K99HD055303] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This article was supported by the National Institute of Child Health and Human Development, HD055303. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; AKIMENKO MA, 1994, J NEUROSCI, V14, P3475; Andermann P, 2002, DEV BIOL, V251, P45, DOI 10.1006/dbio.2002.0820; Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Artinger KB, 1999, DEVELOPMENT, V126, P3969; Begbie J, 2001, SCIENCE, V294, P595, DOI 10.1126/science.1062028; Birkholz DA, 2009, DEV DYNAM, V238, P2575, DOI 10.1002/dvdy.22090; Coppola E, 2010, P NATL ACAD SCI USA, V107, P2066, DOI 10.1073/pnas.0910213107; Drerup CM, 2009, DEVELOPMENT, V136, P2623, DOI 10.1242/dev.030577; Hernandez-Lagunas L, 2005, DEV BIOL, V278, P347, DOI 10.1016/j.ydbio.2004.11.014; Holzschuh J, 2005, DEVELOPMENT, V132, P3731, DOI 10.1242/dev.01936; KELLER AD, 1992, MOL CELL BIOL, V12, P1940, DOI 10.1128/MCB.12.5.1940; Kelsh RN, 2000, DEVELOPMENT, V127, P515; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Knight RD, 2006, ADV EXP MED BIOL, V589, P120; Lee KH, 1996, DEV BIOL, V180, P722, DOI 10.1006/dbio.1996.0341; Lister JA, 2006, DEV BIOL, V290, P92, DOI 10.1016/j.ydbio.2005.11.014; Montero-Balaguer M, 2006, DEV DYNAM, V235, P3199, DOI 10.1002/dvdy.20959; MULLINS MC, 1993, CURR OPIN GENET DEV, V3, P648, DOI 10.1016/0959-437X(93)90102-U; MULLINS MC, 1994, CURR BIOL, V4, P189, DOI 10.1016/S0960-9822(00)00048-8; Nechiporuk A, 2005, DEVELOPMENT, V132, P3717, DOI 10.1242/dev.01876; Nechiporuk A, 2007, DEVELOPMENT, V134, P611, DOI 10.1242/dev.02749; Nusslein-Volhard C., 2002, ZEBRAFISH PRACTICAL; Obholzer N, 2008, J NEUROSCI, V28, P2110, DOI 10.1523/JNEUROSCI.5230-07.2008; Odenthal J, 1998, DEV GENES EVOL, V208, P245, DOI 10.1007/s004270050179; Raible DW, 2000, J COMP NEUROL, V421, P189, DOI 10.1002/(SICI)1096-9861(20000529)421:2<189::AID-CNE5>3.0.CO;2-K; Shepherd IT, 2004, DEVELOPMENT, V131, P241, DOI 10.1242/dev.00912; Shiau CE, 2008, NAT NEUROSCI, V11, P269, DOI 10.1038/nn2051; Shiau CE, 2009, DEVELOPMENT, V136, P4155, DOI 10.1242/dev.034355; Stewart RA, 2006, DEV BIOL, V292, P174, DOI 10.1016/j.ydbio.2005.12.035; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Westerfield M, 1993, ZEBRAFISH BOOK	32	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2011	6	9							e24443	10.1371/journal.pone.0024443	http://dx.doi.org/10.1371/journal.pone.0024443			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CN	21931719	Green Submitted, gold, Green Published			2022-12-25	WOS:000294803100032
J	Stoll, M; Kollan, C; Bergmann, F; Bogner, J; Faetkenheuer, G; Fritzsche, C; Hoeper, K; Horst, HA; van Lunzen, J; Plettenberg, A; Reuter, S; Rockstroh, J; Stellbrink, HJ; Hamouda, O; Bartmeyer, B				Stoll, Matthias; Kollan, Christian; Bergmann, Frank; Bogner, Johannes; Faetkenheuer, Gerd; Fritzsche, Carlos; Hoeper, Kirsten; Horst, Heinz-August; van Lunzen, Jan; Plettenberg, Andreas; Reuter, Stefan; Rockstroh, Juergen; Stellbrink, Hans-Juergen; Hamouda, Osamah; Bartmeyer, Barbara		ClinSurv Study Grp	Calculation of Direct Antiretroviral Treatment Costs and Potential Cost Savings by Using Generics in the German HIV ClinSurv Cohort	PLOS ONE			English	Article							THERAPY; DRUGS; EMTRICITABINE; INDIVIDUALS; STRATEGIES; INFECTION; REDUCE; PRICE; LIFE	Background/Aim of the Study: The study aimed to determine the cost impacts of antiretroviral drugs by analysing a long-term follow-up of direct costs for combined antiretroviral therapy,cART,-regimens in the nationwide long-term observational multi-centre German HIV ClinSurv Cohort. The second aim was to develop potential cost saving strategies by modelling different treatment scenarios. Methods: Antiretroviral regimens (ART) from 10,190 HIV-infected patients from 11 participating ClinSurv study centres have been investigated since 1996. Biannual data cART,-initiation, cART-changes, surrogate markers, clinical events and the Centre of Disease Control-(CDC)-stage of HIV disease are reported. Treatment duration was calculated on a daily basis via the documented dates for the beginning and end of each antiretroviral drug treatment. Prices were calculated for each individual regimen based on actual office sales prices of the branded pharmaceuticals distributed by the license holder including German taxes. Results: During the 13-year follow-up period, 21,387,427 treatment days were covered. Cumulative direct costs for antiretroviral drugs of (sic)812,877,356 were determined according to an average of (sic)42.08 per day (sic)7.52 to (sic)217.70). Since cART is widely used in Germany, the costs for an entire regimen increased by 13.5%. Regimens are more expensive in the advanced stages of HIV disease. The potential for cost savings was calculated using non-nucleotide-reverse-transcriptase-inhibitor, NNRTI, more frequently instead of ritonavir-boosted protease inhibitor, PI/r, in first line therapy. This calculation revealed cumulative savings of 10.9% to 19.8% of daily treatment costs (50% and 90% substitution of PI/r, respectively). Substituting certain branded drugs by generic drugs showed potential cost savings of between 1.6% and 31.8%. Conclusions: Analysis of the data of this nationwide study reflects disease-specific health services research and will give insights into the cost impacts of antiretroviral therapy, and might allow a more rational allocation of resources within the German health care system.	[Stoll, Matthias; Hoeper, Kirsten] Med Univ, Infect Dis Unit, Hannover, Germany; [Kollan, Christian; Hamouda, Osamah; Bartmeyer, Barbara] Robert Koch Inst, D-1000 Berlin, Germany; [Bergmann, Frank] Charite, D-13353 Berlin, Germany; [Bogner, Johannes] Univ Munich, Univ Hosp, Munich, Germany; [Faetkenheuer, Gerd] Univ Hosp Cologne, Cologne, Germany; [Fritzsche, Carlos] Univ Hosp, Rostock, Germany; [Horst, Heinz-August] Univ Schleswig Holstein, Kiel, Germany; [van Lunzen, Jan] Univ Hosp Eppendorf, Hamburg, Germany; [Plettenberg, Andreas] Ifi Inst Interdisciplinary Med, Hamburg, Germany; [Reuter, Stefan] Univ Hosp, Dusseldorf, Germany; [Rockstroh, Juergen] Univ Hosp, Bonn, Germany; [Stellbrink, Hans-Juergen] ICH Studyctr, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Robert Koch Institute; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Munich; University of Cologne; University of Rostock; University of Kiel; Schleswig Holstein University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Bonn	Stoll, M (corresponding author), Med Univ, Infect Dis Unit, Hannover, Germany.	Stoll.Matthias@mh-hannover.de	Reuter, Stefan/F-5895-2011		Robert Koch Institute, Germany; Boehringer-Ingelheim; Glaxo-Smith-Kline; Roche; Tibotec	Robert Koch Institute, Germany; Boehringer-Ingelheim(Boehringer Ingelheim); Glaxo-Smith-Kline(GlaxoSmithKline); Roche(Roche Holding); Tibotec	The ClinSurv Study was funded by the Robert Koch Institute which is the competent Body for Public health in Germany. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; The first author Matthias Stoll received honoraria as a lecturer by Abbott, Bristol-Myers-Squibb, Boehringer, Ingelheim, Glaxo-Smith-Kline, Roche, Gilead, Tibotec, Pfizer, Merck, Sharp & Dohme, and ViiV. He had served as a scientific advisor for Glaxo-Smith-Kline, Gilead, DuPont, Merck, Sharp & Dohme, Abbott, Roche, Solvay, Tibotec and ViiV. He received funding for scientific projects by Boehringer-Ingelheim, Glaxo-Smith-Kline, Roche, and Tibotec This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Augurzky B, 2009, HEALTH ECON, V18, P421, DOI 10.1002/hec.1376; BARTMEYER B, 2010, INT AIDS C 2010 VIEN; Borroto-Esoda Katyna, 2007, Antiviral Chemistry & Chemotherapy, V18, P297; Borroto-Esoda K, 2006, ANTIVIR THER, V11, P377; Chowers M, 2010, EUR J CLIN MICROBIOL, V29, P779, DOI 10.1007/s10096-010-0926-y; *DAIG, 2010, GERM AUSTR TREATM GU; Davidson I, 2010, ANTIVIR RES, V86, P227, DOI 10.1016/j.antiviral.2010.03.001; DHHS, 2011, GUID US ANT AG HIV 1; European AIDS Clinical Society (EACS), 2009, GUID CLIN MAN TREATM; FEIGENBAUM JB, 2010, COH PROF GERM CLIN S; Green CJ, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008654; HELLSTRO MJ, 2004, EUR J HEALTH ECON, V5, P203; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Kingham R, 2009, FOOD DRUG LAW J, V64, P101; Ledergerber B, 2011, HIV MED, V12, P279, DOI 10.1111/j.1468-1293.2010.00880.x; Levy AR, 2006, LANCET INFECT DIS, V6, P171, DOI 10.1016/S1473-3099(06)70413-3; Mannheimer SB, 2005, AIDS CARE, V17, P10, DOI 10.1080/09540120412331305098; McKinnon JE, 2009, ANTIVIR THER, V14, P1; Metzner KJ, 2010, J INFECT DIS, V201, P1063, DOI 10.1086/651136; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Rizzo JA, 2009, INT J HEALTH CARE FI, V9, P291, DOI 10.1007/s10754-008-9052-0; Roebuck MC, 2009, HEALTH SERV RES, V44, P988, DOI 10.1111/j.1475-6773.2008.00943.x; Shimatani T, 2009, DIGEST DIS SCI, V54, P2385, DOI 10.1007/s10620-008-0634-y; Stargardt T, 2007, HEALTH POLICY, V84, P30, DOI 10.1016/j.healthpol.2007.04.006; TOMECZKOWSKI JGH, 2010, ESTIMATION PATIENTS; von der Schulenburg J-Matthias Graf, 2005, Eur J Health Econ, V6, P183; Walensky RP, 2006, J INFECT DIS, V194, P11, DOI 10.1086/505147; Waning B, 2009, B WORLD HEALTH ORGAN, V87, P520, DOI 10.2471/BLT.08.058925	28	32	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2011	6	9							e23946	10.1371/journal.pone.0023946	http://dx.doi.org/10.1371/journal.pone.0023946			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	819CN	21931626	Green Published, gold, Green Submitted			2022-12-25	WOS:000294803100007
J	Wang, L; Chen, HM; Pourgholami, MH; Beretov, J; Hao, JL; Chao, HT; Perkins, AC; Kearsley, JH; Li, Y				Wang, Li; Chen, Hongmin; Pourgholami, Mohammad H.; Beretov, Julia; Hao, Jingli; Chao, Hongtu; Perkins, Alan C.; Kearsley, John H.; Li, Yong			Anti-MUC1 Monoclonal Antibody (C595) and Docetaxel Markedly Reduce Tumor Burden and Ascites, and Prolong Survival in an in vivo Ovarian Cancer Model	PLOS ONE			English	Article							ENDOTHELIAL-GROWTH-FACTOR; TARGETED ALPHA-THERAPY; MUC1; CHEMOTHERAPY; CARCINOMA; EXPRESSION; PACLITAXEL; CYTOTOXICITY; PROGRESSION; INHIBITION	MUC1 is associated with cellular transformation and tumorigenicity and is considered as an important tumor-associated antigen (TAA) for cancer therapy. We previously reported that anti-MUC1 monoclonal antibody C595 (MAb C595) plus docetaxel (DTX) increased efficacy of DTX alone and caused cultured human epithelial ovarian cancer (EOC) cells to undergo apoptosis. To further study the mechanisms of this combination-mediated apoptosis, we investigated the effectiveness of this combination therapy in vivo in an intraperitoneal (i.p.) EOC mouse model. OVCAR-3 cells were implanted intraperitoneally in female athymic nude mice and allowed to grow tumor and ascites. Mice were then treated with single MAb C595, DTX, combination test (MAb C595 and DTX), combination control (negative MAb IgG(3) and DTX) or vehicle control i.p for 3 weeks. Treated mice were killed 4 weeks post-treatment. Ascites volume, tumor weight, CA125 levels from ascites and survival of animals were assessed. The expression of MUC1, CD31, Ki-67, TUNEL and apoptotic proteins in tumor xenografts was evaluated by immunohistochemistry. MAb C595 alone inhibited i.p. tumor growth and ascites production in a dose-dependent manner but did not obviously prevent tumor development. However, combination test significantly reduced ascites volume, tumor growth and metastases, CA125 levels in ascites and improved survival of treated mice compared with single agent-treated mice, combination control or vehicle control-treated mice (P<0.05). The data was in a good agreement with that from cultured cells in vitro. The mechanisms behind the observed effects could be through targeting MUC1 antigens, inhibition of tumor angiogenesis, and induction of apoptosis. Our results suggest that this combination approach can effectively reduce tumor burden and ascites, prolong survival of animals through induction of tumor apoptosis and necrosis, and may provide a potential therapy for advanced metastatic EOC.	[Wang, Li; Chen, Hongmin; Chao, Hongtu] Henan Canc Hosp, Dept Gynecol Oncol, Zhengzhou, Henan, Peoples R China; [Wang, Li; Chen, Hongmin; Pourgholami, Mohammad H.; Beretov, Julia; Hao, Jingli; Chao, Hongtu; Kearsley, John H.; Li, Yong] Univ New S Wales, Fac Med, Sydney, NSW, Australia; [Pourgholami, Mohammad H.] St George Hosp, Dept Surg, Sydney, NSW, Australia; [Beretov, Julia; Hao, Jingli; Kearsley, John H.; Li, Yong] St George Hosp, Canc Care Ctr, Sydney, NSW, Australia; [Perkins, Alan C.] Queens Med Ctr, Sch Med, Nottingham NG7 2UH, England	Zhengzhou University; University of New South Wales Sydney; St George Hospital; St George Hospital; University of Nottingham	Wang, L (corresponding author), Henan Canc Hosp, Dept Gynecol Oncol, Zhengzhou, Henan, Peoples R China.	wangli1672003@yahoo.com.cn; y.li@unsw.edu.au	Pourgholami, Mohammad Hossein/AAA-3474-2020	Beretov, Julia/0000-0001-5582-0020; Pourgholami, Mohammad Hossein/0000-0002-1158-801X; Li, Yong/0000-0002-8910-9787; Perkins, Alan/0000-0002-1054-8200	Henan Health Board, China; Cancer Institute NSW; St George Hospital	Henan Health Board, China; Cancer Institute NSW; St George Hospital	This study was partially supported by an International Collaborative Grant from Henan Health Board, China (LW, HMC and HTC), a Cancer Institute NSW Career Development Fellowship (YL) and St George Hospital Ovarian Cancer Research Trust Fund (YL and JK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong DK, 2006, NEW ENGL J MED, V354, P34, DOI 10.1056/NEJMoa052985; BAST RC, 1983, NEW ENGL J MED, V309, P883, DOI 10.1056/NEJM198310133091503; Bouchard WJ, 2003, EXP HEMATOL, V31, P446, DOI 10.1016/S0301-472X(03)00083-3; Budiu RA, 2011, CANC IMMUNOL IM 0402; Carraway KL, 2007, CURR TOP DEV BIOL, V78, P1, DOI 10.1016/S0070-2153(06)78001-2; de Bree E, 2006, CANCER TREAT REV, V32, P471, DOI 10.1016/j.ctrv.2006.07.006; De Souza R, 2010, MOL CANCER THER, V9, P1820, DOI 10.1158/1535-7163.MCT-10-0249; GENDLER S, 1988, J BIOL CHEM, V263, P12820; GERDES J, 1983, INT J CANCER, V31, P13, DOI 10.1002/ijc.2910310104; Gulley JL, 2008, CLIN CANCER RES, V14, P3060, DOI 10.1158/1078-0432.CCR-08-0126; Harries M, 2002, LANCET ONCOL, V3, P537, DOI 10.1016/S1470-2045(02)00847-1; Harries M, 2001, EXPERT OPIN INV DRUG, V10, P1715, DOI 10.1517/13543784.10.9.1715; Hu XF, 2006, EXPERT REV ANTICANC, V6, P1261, DOI 10.1586/14737140.6.8.1261; Hughes ODM, 2000, J UROL PATHOL, V12, P179; Jang SH, 2003, PHARM RES-DORDR, V20, P1337, DOI 10.1023/A:1025785505977; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Li Y, 2004, INT J RADIAT ONCOL, V60, P896, DOI 10.1016/j.ijrobp.2004.04.035; Li Y, 2010, MED RES REV, V30, P67, DOI 10.1002/med.20165; Liu H, 1998, CANCER RES, V58, P4055; Mesiano S, 1998, AM J PATHOL, V153, P1249, DOI 10.1016/S0002-9440(10)65669-6; Mollinedo F, 2003, APOPTOSIS, V8, P413, DOI 10.1023/A:1025513106330; Moreno M, 2007, CANCER LETT, V257, P47, DOI 10.1016/j.canlet.2007.06.016; Naora H, 2005, NAT REV CANCER, V5, P355, DOI 10.1038/nrc1611; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Nishida N, 2004, CANCER-AM CANCER SOC, V101, P1364, DOI 10.1002/cncr.20449; Oei ALM, 2008, INT J CANCER, V123, P1848, DOI 10.1002/ijc.23725; PERKINS AC, 1993, NUCL MED COMMUN, V14, P578, DOI 10.1097/00006231-199307000-00011; Perry MC, 2001, CHEMOTHERAPY SOURCE; Pourgholami MH, 2006, CLIN CANCER RES, V12, P1928, DOI 10.1158/1078-0432.CCR-05-1181; PRICE MR, 1990, BRIT J CANCER, V61, P681, DOI 10.1038/bjc.1990.154; Qu CF, 2005, CANCER BIOL THER, V4, P848, DOI 10.4161/cbt.4.8.1892; Qu CF, 2004, BRIT J CANCER, V91, P2086, DOI 10.1038/sj.bjc.6602232; Rahn JJ, 2001, CANCER, V91, P1973, DOI 10.1002/1097-0142(20010601)91:11<1973::AID-CNCR1222>3.0.CO;2-A; Rose PG, 2003, GYNECOL ONCOL, V88, P130, DOI 10.1016/S0090-8258(02)00091-4; Rustin GJS, 2006, J CLIN ONCOL, V24, P45, DOI 10.1200/JCO.2005.01.2757; Rustin GJS, 2001, J CLIN ONCOL, V19, P4054, DOI 10.1200/JCO.2001.19.20.4054; Shimizu M, 2008, BIOL PHARM BULL, V31, P2288, DOI 10.1248/bpb.31.2288; Smith JA, 2005, GYNECOL ONCOL, V98, P141, DOI 10.1016/j.ygyno.2005.02.006; Song YJ, 2006, CANCER LETT, V234, P176, DOI 10.1016/j.canlet.2005.03.060; Stordal B, 2007, CANCER TREAT REV, V33, P688, DOI 10.1016/j.ctrv.2007.07.013; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; Thie H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015921; Van Elssen CHMJ, 2010, HISTOPATHOLOGY, V57, P597, DOI 10.1111/j.1365-2559.2010.03667.x; Vasey PA, 2004, JNCI-J NATL CANCER I, V96, P1682, DOI 10.1093/jnci/djh323; Wang L, 2007, GYNECOL ONCOL, V105, P695, DOI 10.1016/j.ygyno.2007.02.004; Wang L, 2011, CANCER LETT, V300, P122, DOI 10.1016/j.canlet.2010.09.013; Yap TA, 2009, NAT REV CANCER, V9, P167, DOI 10.1038/nrc2583; Zamboni WC, 2008, CANCER CHEMOTH PHARM, V62, P417, DOI 10.1007/s00280-007-0620-7	49	92	98	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2011	6	9							e24405	10.1371/journal.pone.0024405	http://dx.doi.org/10.1371/journal.pone.0024405			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CN	21931707	gold, Green Published, Green Submitted			2022-12-25	WOS:000294803100027
J	Wilson, JJ				Wilson, John James			Assessing the Value of DNA Barcodes for Molecular Phylogenetics: Effect of Increased Taxon Sampling in Lepidoptera	PLOS ONE			English	Article							NOCTUOIDEA INSECTA; EVOLUTION; SEQUENCES; UTILITY; GENE; BUTTERFLIES; SYSTEMATICS; CHARACTERS; PARSIMONY; DITRYSIA	Background: A common perception is that DNA barcode datamatrices have limited phylogenetic signal due to the small number of characters available per taxon. However, another school of thought suggests that the massively increased taxon sampling afforded through the use of DNA barcodes may considerably increase the phylogenetic signal present in a datamatrix. Here I test this hypothesis using a large dataset of macrolepidopteran DNA barcodes. Methodology/Principal Findings: Taxon sampling was systematically increased in datamatrices containing macrolepidopteran DNA barcodes. Sixteen family groups were designated as concordance groups and two quantitative measures; the taxon consistency index and the taxon retention index, were used to assess any changes in phylogenetic signal as a result of the increase in taxon sampling. DNA barcodes alone, even with maximal taxon sampling (500 species per family), were not sufficient to reconstruct monophyly of families and increased taxon sampling generally increased the number of clades formed per family. However, the scores indicated a similar level of taxon retention (species from a family clustering together) in the cladograms as the number of species included in the datamatrix was increased, suggesting substantial phylogenetic signal below the 'family' branch. Conclusions/Significance: The development of supermatrix, supertree or constrained tree approaches could enable the exploitation of the massive taxon sampling afforded through DNA barcodes for phylogenetics, connecting the twigs resolved by barcodes to the deep branches resolved through phylogenomics.	Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Wilson, JJ (corresponding author), Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada.	wilso04@gmail.com	Wilson, John-James/C-4656-2012	Wilson, John-James/0000-0002-3583-3550	Natural Sciences and Engineering Research Council of Canada; Genome Canada through the Ontario Genomics Institute	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Genome Canada through the Ontario Genomics Institute(Genome Canada)	This study was funded by grants from The Natural Sciences and Engineering Research Council of Canada and Genome Canada through the Ontario Genomics Institute to Paul D. N. Hebert. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazin E, 2006, SCIENCE, V312, P570, DOI 10.1126/science.1122033; Brower AVZ, 1996, ANNU REV ECOL SYST, V27, P423, DOI 10.1146/annurev.ecolsys.27.1.423; Brower AVZ, 2000, P ROY SOC B-BIOL SCI, V267, P1201, DOI 10.1098/rspb.2000.1129; Bucheli SR, 2005, MOL PHYLOGENET EVOL, V35, P380, DOI 10.1016/j.ympev.2005.02.003; DeSaille R, 2007, BIOESSAYS, V29, P1289, DOI 10.1002/bies.20667; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; Feil EJ, 2004, NAT REV MICROBIOL, V2, P483, DOI 10.1038/nrmicro904; Fibiger Michael, 2005, Esperiana, V11, P7; Floyd Robin M., 2009, P417, DOI 10.1002/9781444308211.ch17; Franz NM, 2005, CLADISTICS, V21, P495, DOI 10.1111/j.1096-0031.2005.00080.x; Goloboff P, 2008, CLADISTICS, V24, P91; Goloboff PA, 2009, CLADISTICS, V25, P211, DOI 10.1111/j.1096-0031.2009.00255.x; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; HEBERT PDN, 2009, BIOL LETTERS, DOI DOI 10.1098/RSPB.2009.0848; Hedtke SM, 2006, SYST BIOL, V55, P522, DOI 10.1080/10635150600697358; Hillis DM, 2003, SYST BIOL, V52, P124, DOI 10.1080/10635150390132911; Hillis DM, 1998, SYST BIOL, V47, P3, DOI 10.1080/106351598260987; Kaila L, 2004, CLADISTICS, V20, P303, DOI 10.1111/j.1096-0031.2004.00027.x; Kallersjo M, 1998, PLANT SYST EVOL, V213, P259, DOI 10.1007/BF00985205; Kawahara AY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005719; Kolaczkowski B, 2004, NATURE, V431, P980, DOI 10.1038/nature02917; Kress WJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015409; Kristensen NP, 2007, ZOOTAXA, P699, DOI 10.11646/zootaxa.1668.1.30; Mitchell A, 2000, SYST BIOL, V49, P202, DOI 10.1093/sysbio/49.2.202; Mitchell A, 1997, MOL BIOL EVOL, V14, P381, DOI 10.1093/oxfordjournals.molbev.a025774; Monaghan MT, 2007, MOL PHYLOGENET EVOL, V45, P674, DOI 10.1016/j.ympev.2007.06.009; Mutanen M, 2010, P ROY SOC B-BIOL SCI, V277, P2839, DOI 10.1098/rspb.2010.0392; Phillips AJ, 2006, J BIOMED INFORM, V39, P18, DOI 10.1016/j.jbi.2005.11.005; POGUE MG, 2009, INSECT BIODIVERSITY, P263; Pollock DD, 2002, SYST BIOL, V51, P664, DOI 10.1080/10635150290102357; Purvis A, 1997, TRENDS ECOL EVOL, V12, P49, DOI 10.1016/S0169-5347(96)30066-9; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Regier JC, 2008, SYST ENTOMOL, V33, P175, DOI 10.1111/j.1365-3113.2007.00409.x; Regier JC, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-280; Salisbury BA, 1999, SYST BIOL, V48, P153, DOI 10.1080/106351599260508; Savolainen V, 2005, PHILOS T R SOC B, V360, P1805, DOI 10.1098/rstb.2005.1730; Scoble MJ, 1992, LEPIDOPTERA FORM FUN; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tautz D, 2003, TRENDS ECOL EVOL, V18, P70, DOI 10.1016/S0169-5347(02)00041-1; Vane-Wright Richard I., 2003, P477; Wahlberg N, 2005, P ROY SOC B-BIOL SCI, V272, P1577, DOI 10.1098/rspb.2005.3124; Wahlberg N, 2008, SYST BIOL, V57, P231, DOI 10.1080/10635150802033006; Warren AD, 2008, CLADISTICS, V24, P642, DOI 10.1111/j.1096-0031.2008.00218.x; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Wilson JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010525; Wortley AH, 2006, TAXON, V55, P431, DOI 10.2307/25065589; Yang ZH, 1998, SYST BIOL, V47, P125, DOI 10.1080/106351598261067; Zwick A, 2008, SYST ENTOMOL, V33, P190, DOI 10.1111/j.1365-3113.2007.00410.x	53	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2011	6	9							e24769	10.1371/journal.pone.0024769	http://dx.doi.org/10.1371/journal.pone.0024769			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CN	21931848	Green Published, gold			2022-12-25	WOS:000294803100067
J	Bocanegra, R; Nevot, M; Domenech, R; Lopez, I; Abian, O; Rodriguez-Huete, A; Cavasotto, CN; Velazquez-Campoy, A; Gomez, J; Martinez, MA; Neira, JL; Mateu, MG				Bocanegra, Rebeca; Nevot, Maria; Domenech, Rosa; Lopez, Inmaculada; Abian, Olga; Rodriguez-Huete, Alicia; Cavasotto, Claudio N.; Velazquez-Campoy, Adrian; Gomez, Javier; Angel Martinez, Miguel; Luis Neira, Jose; Mateu, Mauricio G.			Rationally Designed Interfacial Peptides Are Efficient In Vitro Inhibitors of HIV-1 Capsid Assembly with Antiviral Activity	PLOS ONE			English	Article							C-TERMINAL DOMAIN; INTERSUBUNIT INTERACTIONS; DIMERIZATION DOMAIN; PROTEIN; NMR; COMPLEX; REPLICATION; MATURATION; BINDING; PHASE	Virus capsid assembly constitutes an attractive target for the development of antiviral therapies; a few experimental inhibitors of this process for HIV-1 and other viruses have been identified by screening compounds or by selection from chemical libraries. As a different, novel approach we have undertaken the rational design of peptides that could act as competitive assembly inhibitors by mimicking capsid structural elements involved in intersubunit interfaces. Several discrete interfaces involved in formation of the mature HIV-1 capsid through polymerization of the capsid protein CA were targeted. We had previously designed a peptide, CAC1, that represents CA helix 9 (a major part of the dimerization interface) and binds the CA C-terminal domain in solution. Here we have mapped the binding site of CAC1, and shown that it substantially overlaps with the CA dimerization interface. We have also rationally modified CAC1 to increase its solubility and CA-binding affinity, and designed four additional peptides that represent CA helical segments involved in other CA interfaces. We found that peptides CAC1, its derivative CAC1M, and H8 (representing CA helix 8) were able to efficiently inhibit the in vitro assembly of the mature HIV-1 capsid. Cocktails of several peptides, including CAC1 or CAC1M plus H8 or CAI (a previously discovered inhibitor of CA polymerization), or CAC1M+H8+CAI, also abolished capsid assembly, even when every peptide was used at lower, sub-inhibitory doses. To provide a preliminary proof that these designed capsid assembly inhibitors could eventually serve as lead compounds for development of anti-HIV-1 agents, they were transported into cultured cells using a cell-penetrating peptide, and tested for antiviral activity. Peptide cocktails that drastically inhibited capsid assembly in vitro were also able to efficiently inhibit HIV-1 infection ex vivo. This study validates a novel, entirely rational approach for the design of capsid assembly interfacial inhibitors that show antiviral activity.	[Bocanegra, Rebeca; Lopez, Inmaculada; Rodriguez-Huete, Alicia; Mateu, Mauricio G.] Univ Autonoma Madrid, CSIC, Centro Biol Mol Severo Ochoa, Madrid, Spain; [Nevot, Maria; Angel Martinez, Miguel] Hosp Badalona Germans Trias & Pujol, Fundacio IrsiCaixa, Barcelona, Spain; [Domenech, Rosa; Gomez, Javier; Luis Neira, Jose] Univ Miguel Hernandez, Ctr Biol Mol & Celular, Alicante, Spain; [Abian, Olga; Velazquez-Campoy, Adrian; Luis Neira, Jose] Inst Biocomputat & Phys Complex Syst, Zaragoza, Spain; [Abian, Olga] CIBERed, Aragon Hlth Sci Inst, Zaragoza, Spain; [Cavasotto, Claudio N.] Univ Texas Hlth Sci Ctr, Sch Hlth Informat Sci, Houston, TX USA; [Velazquez-Campoy, Adrian] Fdn ARAID, Zaragoza, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Hospital Germans Trias i Pujol; Institut de Recerca de la Sida - IrsiCaixa; Universidad Miguel Hernandez de Elche; University of Texas System; University of Texas Health Science Center Houston	Bocanegra, R (corresponding author), Univ Autonoma Madrid, CSIC, Centro Biol Mol Severo Ochoa, Madrid, Spain.	mgarcia@cbm.uam.es	Mateu, Mauricio/ABF-2146-2021; Bocanegra, Rebeca/AAO-3887-2020; Neira, Jose/ABF-4210-2021; Velazquez-Campoy, Adrian/E-7946-2012; Gomez, Javier/N-9820-2013; Martinez, Miguel Angel/K-6435-2014; Nevot, Maria/AAC-7839-2022; Cavasotto, Claudio/GQY-7627-2022; ABIAN, OLGA/K-8935-2014; DOMÉNECH, ROSA/F-8930-2012; Nevot, Maria/E-6187-2016	Mateu, Mauricio/0000-0002-2915-1529; Velazquez-Campoy, Adrian/0000-0001-5702-4538; Gomez, Javier/0000-0001-9612-5075; Martinez, Miguel Angel/0000-0002-6681-4950; Nevot, Maria/0000-0003-4947-4648; ABIAN, OLGA/0000-0001-5664-1729; Nevot, Maria/0000-0003-4947-4648; Bocanegra, Rebeca/0000-0002-9024-9365; Neira, Jose Luis/0000-0002-4933-0428; Cavasotto, Claudio/0000-0002-1372-0379	Fundacion para la Investigacion y Prevencion del SIDA en ESpana (FIPSE) [Exp: 36557/06]; Spain's Ministerio de Ciencia e Innovacion [BIO2009-10072, SAF2008-05742-C02-01, CSD20008-00005]; Comunidad de Madrid [S-2009/MAT/1467]; Generalitat Valenciana [ACOMP2010/114]; Ministerio de Ciencia e Innovacion [BFU2008-02302-BMC]	Fundacion para la Investigacion y Prevencion del SIDA en ESpana (FIPSE); Spain's Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Comunidad de Madrid(Comunidad de Madrid); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was supported by grants from Fundacion para la Investigacion y Prevencion del SIDA en ESpana (FIPSE Exp: 36557/06) to MGM, JLN and MAM, Spain's Ministerio de Ciencia e Innovacion (BIO2009-10072 to MGM and SAF2008-05742-C02-01 and CSD20008-00005 to JLN and JG), Comunidad de Madrid (S-2009/MAT/1467 to MGM), Generalitat Valenciana (ACOMP2010/114 to JLN and JG). Short-term research of RD in AVC's laboratory was supported by Ministerio de Ciencia e Innovacion (BFU2008-02302-BMC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdurahman S, 2008, ANTIMICROB AGENTS CH, V52, P3737, DOI 10.1128/AAC.00265-08; Adamson CS, 2009, EXPERT OPIN THER TAR, V13, P895, DOI 10.1517/14728220903039714; Adamson CS, 2004, REV MED VIROL, V14, P107, DOI 10.1002/rmv.418; Alcaraz LA, 2007, BIOPHYS J, V93, P1264, DOI 10.1529/biophysj.106.101089; Andersson E, 2005, ANTIMICROB AGENTS CH, V49, P40, DOI 10.1128/AAC.49.1.40-44.2005; ANGLISTER J, 1993, J BIOMOL NMR, V3, P121; Barklis E, 2009, J MOL BIOL, V387, P376, DOI 10.1016/j.jmb.2009.01.058; Bartonova V, 2008, J BIOL CHEM, V283, P32024, DOI 10.1074/jbc.M804230200; Bhattacharya S, 2008, J BIOL CHEM, V283, P16274, DOI 10.1074/jbc.C800048200; Blair WS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001220; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Braun Klaus, 2008, Int J Med Sci, V5, P230; Byeon IJL, 2009, CELL, V139, P780, DOI 10.1016/j.cell.2009.10.010; Czypionka A, 2007, BIOCHEMISTRY-US, V46, P12764, DOI 10.1021/bi701343q; del Alamo M, 2005, J VIROL, V79, P14271, DOI 10.1128/JVI.79.22.14271-14281.2005; del Alamo M, 2005, J MOL BIOL, V345, P893, DOI 10.1016/j.jmb.2004.10.086; del Alamo M, 2003, J BIOL CHEM, V278, P27923, DOI 10.1074/jbc.M304466200; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Deres K, 2003, SCIENCE, V299, P893, DOI 10.1126/science.1077215; Domenech R, 2010, BIOMACROMOLECULES, V11, P2069, DOI 10.1021/bm100432x; EHRLICH LS, 1992, J VIROL, V66, P4874, DOI 10.1128/JVI.66.8.4874-4883.1992; Gamble TR, 1997, SCIENCE, V278, P849, DOI 10.1126/science.278.5339.849; Ganser-Pornillos BK, 2008, CURR OPIN STRUC BIOL, V18, P203, DOI 10.1016/j.sbi.2008.02.001; Ganser-Pornillos BK, 2007, CELL, V131, P70, DOI 10.1016/j.cell.2007.08.018; Ganser-Pornillos BK, 2004, J VIROL, V78, P2545, DOI 10.1128/JVI.78.5.2545-2552.2004; Garzon MT, 2004, PROTEIN SCI, V13, P1512, DOI 10.1110/ps.03555304; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; Greene WC, 2008, ANTIVIR RES, V80, P251, DOI 10.1016/j.antiviral.2008.08.003; Gross I, 1997, EUR J BIOCHEM, V249, P592, DOI 10.1111/j.1432-1033.1997.t01-1-00592.x; Hoglund S, 2002, ANTIMICROB AGENTS CH, V46, P3597, DOI 10.1128/AAC.46.11.3597-3605.2002; Ivanov D, 2007, P NATL ACAD SCI USA, V104, P4353, DOI 10.1073/pnas.0609477104; Kelly BN, 2007, J MOL BIOL, V373, P355, DOI 10.1016/j.jmb.2007.07.070; Kota S, 2009, J GEN VIROL, V90, P1319, DOI 10.1099/vir.0.008565-0; Lanman J, 2003, J MOL BIOL, V325, P759, DOI 10.1016/S0022-2836(02)01245-7; Lanman J, 2002, J VIROL, V76, P6900, DOI 10.1128/JVI.76.14.6900-6908.2002; Lee KK, 2004, J VIROL, V78, P7208, DOI 10.1128/JVI.78.13.7208-7216.2004; Li S, 2000, NATURE, V407, P409, DOI 10.1038/35030177; Mascarenhas AP, 2009, FEBS J, V276, P6118, DOI 10.1111/j.1742-4658.2009.07315.x; Mateu MG, 2009, FEBS J, V276, P6098, DOI 10.1111/j.1742-4658.2009.07313.x; Mateu MG, 2002, J MOL BIOL, V318, P519, DOI 10.1016/S0022-2836(02)00091-8; Mokhtarzada S, 2011, BIOCHEMISTRY-US, V50, P715, DOI 10.1021/bi101236z; Neira JL, 2009, SCI WORLD J, V9, P409; Neira JL, 2009, FEBS J, V276, P6110, DOI 10.1111/j.1742-4658.2009.07314.x; Noviello CM, 2011, J VIROL IN PRESS; Pannecouque C, 2008, NAT PROTOC, V3, P427, DOI 10.1038/nprot.2007.517; Pantoliano MW, 2001, J BIOMOL SCREEN, V6, P429, DOI 10.1089/108705701753364922; Pawlicki S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-273; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Pornillos O, 2009, CELL, V137, P1282, DOI 10.1016/j.cell.2009.04.063; Rincon V, 2011, BIOPHYS J, V100, P738, DOI 10.1016/j.bpj.2010.12.3714; Royer C, METHODS MOL BIOL, V40, P65; SAYLE RA, 1995, TRENDS BIOCHEM SCI, V20, P374, DOI 10.1016/S0968-0004(00)89080-5; Shi J, 2011, J VIROL, V85, P542, DOI 10.1128/JVI.01406-10; SKLENAR V, 1987, J MAGN RESON, V74, P469, DOI 10.1016/0022-2364(87)90269-1; STATES DJ, 1982, J MAGN RESON, V48, P286, DOI 10.1016/0022-2364(82)90279-7; Sticht J, 2005, NAT STRUCT MOL BIOL, V12, P671, DOI 10.1038/nsmb964; Tang C, 2003, J MOL BIOL, V327, P1013, DOI 10.1016/S0022-2836(03)00289-4; Ternois F, 2005, NAT STRUCT MOL BIOL, V12, P678, DOI 10.1038/nsmb967; Vogt VM, 2005, NAT STRUCT MOL BIOL, V12, P638, DOI 10.1038/nsmb0805-638; von Schwedler UK, 2003, J VIROL, V77, P5439, DOI 10.1128/JVI.77.9.5439-5450.2003; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Waldron TT, 2003, BIOCHEMISTRY-US, V42, P5058, DOI 10.1021/bi034212v; Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q; Wong HC, 2008, BIOCHEMISTRY-US, V47, P2289, DOI 10.1021/bi7022128; Worthylake DK, 1999, ACTA CRYSTALLOGR D, V55, P85, DOI 10.1107/S0907444998007689; Zhang H, 2008, J MOL BIOL, V378, P565, DOI 10.1016/j.jmb.2008.02.066; Zhang JY, 2009, MINI-REV MED CHEM, V9, P510, DOI 10.2174/138955709787847958; Zhu XJ, 2010, BIOORG MED CHEM LETT, V20, P299, DOI 10.1016/j.bmcl.2009.10.119	70	20	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e23877	10.1371/journal.pone.0023877	http://dx.doi.org/10.1371/journal.pone.0023877			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CK	21931621	Green Published, gold			2022-12-25	WOS:000294802800013
J	Gonin, J; Larousserie, F; Bastard, C; Picquenot, JM; Couturier, J; Radford-Weiss, I; Dietrich, C; Brousse, N; Vacher-Lavenu, MC; Devergne, O				Gonin, Julie; Larousserie, Frederique; Bastard, Christian; Picquenot, Jean-Michel; Couturier, Jerome; Radford-Weiss, Isabelle; Dietrich, Celine; Brousse, Nicole; Vacher-Lavenu, Marie-Cecile; Devergne, Odile			Epstein-Barr Virus-Induced Gene 3 (EBI3): A Novel Diagnosis Marker in Burkitt Lymphoma and Diffuse Large B-Cell Lymphoma	PLOS ONE			English	Article							NF-KAPPA-B; CHEMOTHERAPY PLUS RITUXIMAB; EXPRESSION; PROTEIN; APOPTOSIS; CYTOKINE; PROGNOSIS; MOLECULE; LEUKEMIA; SUBUNIT	The distinction between Burkitt lymphoma (BL) and diffuse large B-cell lymphoma (DLBCL), two types of mature aggressive B-cell lymphomas that require distinct treatments, can be difficult because of forms showing features intermediate between DLBCL and BL (here called BL/DLBCL). They can be discriminated by the presence of c-myc translocations characteristic of BL. However, these are not exclusive of BL and when present in DLBCL are associated with lower survival. In this study, we show that Epstein-Barr virus-induced gene 3 (EBI3) is differentially expressed among BL and DLBCL. Analysis of gene expression data from 502 cases of aggressive mature B-cell lymphomas available on Gene Expression Omnibus and immunohistochemical analysis of 184 cases of BL, BL/DLBCL or DLBCL, showed that EBI3 was not expressed in EBV-positive or -negative BL cases, whereas it was expressed by over 30% of tumoral cells in nearly 80% of DLBCL cases, independently of their subtypes. In addition, we show that c-myc overexpression represses EBI3 expression, and that DLBCL or BL/DLBCL cases with c-myc translocations have lower expression of EBI3. Thus, EBI3 immunohistochemistry could be useful to discriminate BL from DLBCL, and to identify cases of BL/DLBCL or DLBCL with potential c-myc translocations.	[Gonin, Julie; Larousserie, Frederique; Dietrich, Celine; Devergne, Odile] Univ Paris 05, CNRS, UMR 8147, Paris, France; [Gonin, Julie; Larousserie, Frederique; Vacher-Lavenu, Marie-Cecile] Hop Cochin, AP HP, Serv Anat Pathol, F-75674 Paris, France; [Bastard, Christian] Ctr Henri Becquerel, Lab Genet Oncol, F-76038 Rouen, France; [Picquenot, Jean-Michel] Ctr Henri Becquerel, Anat Pathol Lab, F-76038 Rouen, France; [Couturier, Jerome] Inst Curie, Serv Genet Oncol, Paris, France; [Radford-Weiss, Isabelle] Hop Necker Enfants Malad, AP HP, Lab Cytogenet, Paris, France; [Brousse, Nicole] Hop Necker Enfants Malad, AP HP, Serv Anat Pathol, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Centre Henri Becquerel; UNICANCER; Centre Henri Becquerel; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Gonin, J (corresponding author), Univ Paris 05, CNRS, UMR 8147, Paris, France.	odile.devergne@inserm.fr	Devergne, Odile/M-6633-2017	Devergne, Odile/0000-0002-2838-7564	CNRS; Universite Paris Descartes; Academie de Medecine	CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Paris Descartes; Academie de Medecine	This study was funded by institutional funds from the CNRS and Universite Paris Descartes. JG was supported by a fellowship from the Academie de Medecine. These funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Armitage JO, 2007, BLOOD, V110, P29, DOI 10.1182/blood-2007-01-041871; Blum KA, 2004, BLOOD, V104, P3009, DOI 10.1182/blood-2004-02-0405; Caron G, 2009, J IMMUNOL, V182, P7595, DOI 10.4049/jimmunol.0804272; Coiffier B, 2002, NEW ENGL J MED, V346, P235, DOI 10.1056/NEJMoa011795; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Collison LW, 2010, NAT IMMUNOL, V11, P1093, DOI 10.1038/ni.1952; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Dang CV, 1999, MOL CELL BIOL, V19, P1; Dave SS, 2006, NEW ENGL J MED, V354, P2431, DOI 10.1056/NEJMoa055759; Devergne O, 1996, J VIROL, V70, P1143, DOI 10.1128/JVI.70.2.1143-1153.1996; Devergne O, 1997, P NATL ACAD SCI USA, V94, P12041, DOI 10.1073/pnas.94.22.12041; Devergne O, 1998, J VIROL, V72, P7900, DOI 10.1128/JVI.72.10.7900-7908.1998; Devergne O, 2001, AM J PATHOL, V159, P1763, DOI 10.1016/S0002-9440(10)63023-4; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; Hummel M, 2006, NEW ENGL J MED, V354, P2419, DOI 10.1056/NEJMoa055351; Johnson NA, 2009, BLOOD, V114, P2273, DOI 10.1182/blood-2009-03-212191; Klapper W, 2008, BLOOD, V112, P1374, DOI 10.1182/blood-2008-01-136465; Lam LT, 2005, CLIN CANCER RES, V11, P28; Larousserie F, 2006, J PATHOL, V209, P360, DOI 10.1002/path.1995; Larousserie F, 2005, AM J PATHOL, V166, P1217, DOI 10.1016/S0002-9440(10)62340-1; McClure RE, 2005, AM J SURG PATHOL, V29, P1652, DOI 10.1097/01.pas.0000180442.87022.08; Monti S, 2005, BLOOD, V105, P1851, DOI 10.1182/blood-2004-07-2947; Niedobitek G, 2002, J PATHOL, V198, P310, DOI 10.1002/path.1217; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Pfreundschuh M, 2006, LANCET ONCOL, V7, P379, DOI 10.1016/S1470-2045(06)70664-7; Rimsza LM, 2008, BLOOD, V112, P3425, DOI 10.1182/blood-2008-02-137372; Ruzinova MB, 2010, AM J SURG PATHOL, V34, P882, DOI 10.1097/PAS.0b013e3181db83af; Savage K, 2003, J EXP MED, V198, P851; Savage KJ, 2009, BLOOD, V114, P3533, DOI 10.1182/blood-2009-05-220095; Staudt LM, 2005, ADV IMMUNOL, V87, P163, DOI 10.1016/S0065-2776(05)87005-1; Swerdlow SH, 2008, WHO CLASSIFICATION T, P265; Tanaka H, 2002, MOL CELL, V9, P1017, DOI 10.1016/S1097-2765(02)00522-1; Yoon SO, 2008, HISTOPATHOLOGY, V53, P205, DOI 10.1111/j.1365-2559.2008.03076.x; Yoshida H, 2008, IMMUNOL REV, V226, P234, DOI 10.1111/j.1600-065X.2008.00710.x; You ZB, 2002, J BIOL CHEM, V277, P36671, DOI 10.1074/jbc.M203213200	36	19	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e24617	10.1371/journal.pone.0024617	http://dx.doi.org/10.1371/journal.pone.0024617			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CK	21931777	Green Published, gold, Green Submitted			2022-12-25	WOS:000294802800071
J	Krishnan, N; Malaga, W; Constant, P; Caws, M; Tran, THC; Salmons, J; Nguyen, TNL; Bang, ND; Daffe, M; Young, DB; Robertson, BD; Guilhot, C; Thwaites, GE				Krishnan, Nitya; Malaga, Wladimir; Constant, Patricia; Caws, Maxine; Tran Thi Hoang Chau; Salmons, Jenifer; Nguyen Thi Ngoc Lan; Nguyen Duc Bang; Daffe, Mamadou; Young, Douglas B.; Robertson, Brian D.; Guilhot, Christophe; Thwaites, Guy E.			Mycobacterium tuberculosis Lineage Influences Innate Immune Response and Virulence and Is Associated with Distinct Cell Envelope Lipid Profiles	PLOS ONE			English	Article							HUMAN MACROPHAGES; PHTHIOCEROL DIMYCOCEROSATE; LUNG PATHOLOGY; IN-VITRO; INFECTION; DISSEMINATION; DIVERSITY; STRAINS; COMPLEX; H37RV	The six major genetic lineages of Mycobacterium tuberculosis are strongly associated with specific geographical regions, but their relevance to bacterial virulence and the clinical consequences of infection are unclear. Previously, we found that in Vietnam, East Asian/Beijing and Indo-Oceanic strains were significantly more likely to cause disseminated tuberculosis with meningitis than those from the Euro-American lineage. To investigate this observation we characterised 7 East Asian/Beijing, 5 Indo-Oceanic and 6 Euro-American Vietnamese strains in bone-marrow-derived macrophages, dendritic cells and mice. East Asian/Beijing and Indo-Oceanic strains induced significantly more TNF-alpha and IL-1 beta from macrophages than the Euro-American strains, and East Asian/Beijing strains were detectable earlier in the blood of infected mice and grew faster in the lungs. We hypothesised that these differences were induced by lineage-specific variation in cell envelope lipids. Whole lipid extracts from East Asian/Beijing and Indo-Oceanic strains induced higher concentrations of TNF-a from macrophages than Euro-American lipids. The lipid extracts were fractionated and compared by thin layer chromatography to reveal a distinct pattern of lineage-associated profiles. A phthiotriol dimycocerosate was exclusively produced by East Asian/Beijing strains, but not the phenolic glycolipid previously associated with the hyper-virulent phenotype of some isolates of this lineage. All Indo-Oceanic strains produced a unique unidentified lipid, shown to be a phenolphthiocerol dimycocerosate dependent upon an intact pks15/1 for its production. This was described by Goren as the 'attenuation indictor lipid' more than 40 years ago, due to its association with less virulent strains from southern India. Mutation of pks15/1 in a representative Indo-Oceanic strain prevented phenolphthiocerol dimycocerosate synthesis, but did not alter macrophage cytokine induction. Our findings suggest that the early interactions between M. tuberculosis and host are determined by the lineage of the infecting strain; but we were unable to show these differences are driven by lineage-specific cell-surface expressed lipids.	[Krishnan, Nitya; Salmons, Jenifer; Young, Douglas B.; Robertson, Brian D.; Thwaites, Guy E.] Univ London Imperial Coll Sci Technol & Med, Ctr Mol Microbiol & Infect, London, England; [Malaga, Wladimir; Constant, Patricia; Daffe, Mamadou; Guilhot, Christophe] CNRS, IPBS, Toulouse, France; [Malaga, Wladimir; Constant, Patricia; Daffe, Mamadou; Guilhot, Christophe] Univ Toulouse, UPS, IPBS, Toulouse, France; [Caws, Maxine] Univ Oxford, Clin Res Unit, Ho Chi Minh City, Vietnam; [Tran Thi Hoang Chau] Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Nguyen Thi Ngoc Lan; Nguyen Duc Bang] Pham Ngoc Thach Hosp TB & Lung Dis, Ho Chi Minh City, Vietnam; [Young, Douglas B.] Natl Inst Med Res, London NW7 1AA, England	Imperial College London; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Oxford; MRC National Institute for Medical Research	Krishnan, N (corresponding author), Univ London Imperial Coll Sci Technol & Med, Ctr Mol Microbiol & Infect, London, England.	guy.thwaites@btinternet.com	Thwaites, Guy E/R-4993-2019	Thwaites, Guy E/0000-0002-2858-2087; Caws, Maxine/0000-0002-9109-350X; Robertson, Brian D./0000-0001-5785-5307	Wellcome Trust, UK; MRC [MC_U117581288] Funding Source: UKRI; Medical Research Council [MC_U117581288] Funding Source: researchfish	Wellcome Trust, UK(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was funded by the Wellcome Trust, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar D, 2010, TUBERCULOSIS, V90, P319, DOI 10.1016/j.tube.2010.08.004; Alland D, 2007, J CLIN MICROBIOL, V45, P39, DOI 10.1128/JCM.02483-05; Andreu N, 2008, TUBERCULOSIS, V88, P553, DOI 10.1016/j.tube.2008.03.005; Bardarov S, 2002, MICROBIOL-SGM, V148, P3007, DOI 10.1099/00221287-148-10-3007; Bishai WR, 1999, INFECT IMMUN, V67, P4931, DOI 10.1128/IAI.67.9.4931-4934.1999; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Caws M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000034; Chackerian AA, 2002, INFECT IMMUN, V70, P4501, DOI 10.1128/IAI.70.8.4501-4509.2002; Chacon-Salinas R, 2005, CLIN EXP IMMUNOL, V140, P443, DOI 10.1111/j.1365-2249.2005.02797.x; Clay H, 2007, CELL HOST MICROBE, V2, P29, DOI 10.1016/j.chom.2007.06.004; Constant P, 2002, J BIOL CHEM, V277, P38148, DOI 10.1074/jbc.M206538200; Dale JW, 2001, INT J TUBERC LUNG D, V5, P216; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; Domenech P, 2009, MICROBIOL-SGM, V155, P3532, DOI 10.1099/mic.0.029199-0; Dormans J, 2004, CLIN EXP IMMUNOL, V137, P460, DOI 10.1111/j.1365-2249.2004.02551.x; DUNN PL, 1995, INFECT IMMUN, V63, P3428, DOI 10.1128/IAI.63.9.3428-3437.1995; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; GOREN MB, 1972, BACTERIOL REV, V36, P33, DOI 10.1128/MMBR.36.1.33-64.1972; GOREN MB, 1974, INFECT IMMUN, V9, P150, DOI 10.1128/IAI.9.1.150-158.1974; Guenin-Mace L, 2009, TRANSBOUND EMERG DIS, V56, P255, DOI 10.1111/j.1865-1682.2009.01072.x; Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311; Huet G, 2009, J BIOL CHEM, V284, P27101, DOI 10.1074/jbc.M109.041939; Humphreys IR, 2006, MICROBES INFECT, V8, P1339, DOI 10.1016/j.micinf.2005.12.023; Ioerger TR, 2010, J BACTERIOL, V192, P3645, DOI 10.1128/JB.00166-10; Kleinnijenhuis J, 2009, EUR J IMMUNOL, V39, P1914, DOI 10.1002/eji.200839115; Korbel DS, 2008, MICROBES INFECT, V10, P995, DOI 10.1016/j.micinf.2008.07.039; Krishnan N, 2010, TUBERCULOSIS, V90, P361, DOI 10.1016/j.tube.2010.08.005; Laval F, 2001, ANAL CHEM, V73, P4537, DOI 10.1021/ac0105181; Lin PL, 2010, ARTHRITIS RHEUM-US, V62, P340, DOI 10.1002/art.27271; Lopez B, 2003, CLIN EXP IMMUNOL, V133, P30, DOI 10.1046/j.1365-2249.2003.02171.x; Maartens G, 2007, LANCET, V370, P2030, DOI 10.1016/S0140-6736(07)61262-8; Manca C, 2004, INFECT IMMUN, V72, P5511, DOI 10.1128/IAI.72.9.5511-5514.2004; Manca C, 2001, P NATL ACAD SCI USA, V98, P5752, DOI 10.1073/pnas.091096998; MITCHISON D A, 1960, Tubercle, V41, P1, DOI 10.1016/S0041-3879(60)80019-0; Netea MG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000661; Newton SM, 2006, P NATL ACAD SCI USA, V103, P15594, DOI 10.1073/pnas.0604283103; Nicol MP, 2008, T ROY SOC TROP MED H, V102, P955, DOI 10.1016/j.trstmh.2008.03.025; Perez E, 2004, J BIOL CHEM, V279, P42574, DOI 10.1074/jbc.M406246200; Portevin D, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001307; Reed MB, 2004, NATURE, V431, P84, DOI 10.1038/nature02837; Rich AR, 1933, B JOHNS HOPKINS HOSP, V52, P5; Rocha-Ramirez LM, 2008, TUBERCULOSIS, V88, P212, DOI 10.1016/j.tube.2007.10.003; Sinsimer D, 2008, INFECT IMMUN, V76, P3027, DOI 10.1128/IAI.01663-07; Sohn H, 2009, SCAND J IMMUNOL, V69, P43, DOI 10.1111/j.1365-3083.2008.02188.x; Supply P, 2001, J CLIN MICROBIOL, V39, P3563, DOI 10.1128/JCM.39.10.3563-3571.2001; Tanveer M, 2009, T ROY SOC TROP MED H, V103, P581, DOI 10.1016/j.trstmh.2009.03.014; Tsenova L, 2005, J INFECT DIS, V192, P98, DOI 10.1086/430614; Wong KC, 2007, CLIN VACCINE IMMUNOL, V14, P1279, DOI 10.1128/CVI.00190-07	49	92	92	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e23870	10.1371/journal.pone.0023870	http://dx.doi.org/10.1371/journal.pone.0023870			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CK	21931620	Green Published, gold, Green Submitted			2022-12-25	WOS:000294802800012
J	Lee, JS; Ward, WO; Liu, J; Ren, HZ; Vallanat, B; Delker, D; Corton, JC				Lee, Janice S.; Ward, William O.; Liu, Jie; Ren, Hongzu; Vallanat, Beena; Delker, Don; Corton, J. Christopher			Hepatic Xenobiotic Metabolizing Enzyme and Transporter Gene Expression through the Life Stages of the Mouse	PLOS ONE			English	Article							DRUG-METABOLISM; LYMPHOID NEOGENESIS; MICROARRAY ANALYSIS; MAMMALIAN LIVER; RAT-LIVER; PHASE-II; MICE; AGE; PROFILES; ONTOGENY	Background: Differences in responses to environmental chemicals and drugs between life stages are likely due in part to differences in the expression of xenobiotic metabolizing enzymes and transporters (XMETs). No comprehensive analysis of the mRNA expression of XMETs has been carried out through life stages in any species. Results: Using full-genome arrays, the mRNA expression of all XMETs and their regulatory proteins was examined during fetal (gestation day (GD) 19), neonatal (postnatal day (PND) 7), prepubescent (PND32), middle age (12 months), and old age (18 and 24 months) in the C57BL/6J (C57) mouse liver and compared to adults. Fetal and neonatal life stages exhibited dramatic differences in XMET mRNA expression compared to the relatively minor effects of old age. The total number of XMET probe sets that differed from adults was 636, 500, 84, 5, 43, and 102 for GD19, PND7, PND32, 12 months, 18 months and 24 months, respectively. At all life stages except PND32, under-expressed genes outnumbered over-expressed genes. The altered XMETs included those in all of the major metabolic and transport phases including introduction of reactive or polar groups (Phase I), conjugation (Phase II) and excretion (Phase III). In the fetus and neonate, parallel increases in expression were noted in the dioxin receptor, Nrf2 components and their regulated genes while nuclear receptors and regulated genes were generally down-regulated. Suppression of male-specific XMETs was observed at early (GD19, PND7) and to a lesser extent, later life stages (18 and 24 months). A number of female-specific XMETs exhibited a spike in expression centered at PND7. Conclusions: The analysis revealed dramatic differences in the expression of the XMETs, especially in the fetus and neonate that are partially dependent on gender-dependent factors. XMET expression can be used to predict life stage-specific responses to environmental chemicals and drugs.	[Lee, Janice S.; Ward, William O.; Ren, Hongzu; Vallanat, Beena; Delker, Don; Corton, J. Christopher] US EPA, Natl Hlth & Environm Effects Res Lab, Res Triangle Pk, NC 27711 USA; [Liu, Jie] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA	United States Environmental Protection Agency; University of Kansas; University of Kansas Medical Center	Lee, JS (corresponding author), US EPA, Natl Ctr Environm Assessment, Res Triangle Pk, NC 27711 USA.	lee.janices@epa.gov		Lee, Janice/0000-0002-4331-8452	United States Environmental Protection Agency	United States Environmental Protection Agency(United States Environmental Protection Agency)	Work funded by the United States Environmental Protection Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlborn GJ, 2009, TOXICOLOGY, V262, P106, DOI 10.1016/j.tox.2009.05.003; Akhtar RA, 2002, CURR BIOL, V12, P540, DOI 10.1016/S0960-9822(02)00759-5; Amador-Noguez D, 2005, BIOCHEM BIOPH RES CO, V332, P1086, DOI 10.1016/j.bbrc.2005.05.063; [Anonymous], 2005, GUID CARC RISK ASS; Barski OA, 2008, DRUG METAB REV, V40, P553, DOI [10.1080/03602530802431439, 10.1080/03602530802431439 ]; Bleasby K, 2006, XENOBIOTICA, V36, P963, DOI 10.1080/00498250600861751; BORLAKOGLU JT, 1993, BIOCHEM PHARMACOL, V46, P29, DOI 10.1016/0006-2952(93)90344-V; Broccardo C, 2001, CYTOGENET CELL GENET, V92, P264, DOI 10.1159/000056914; Choudhary D, 2003, ARCH BIOCHEM BIOPHYS, V414, P91, DOI 10.1016/S0003-9861(03)00174-7; Clodfelter KH, 2007, PHYSIOL GENOMICS, V31, P63, DOI 10.1152/physiolgenomics.00055.2007; Clodfelter KH, 2006, MOL ENDOCRINOL, V20, P1333, DOI 10.1210/me.2005-0489; Czekaj P, 2005, ARCH TOXICOL, V79, P13, DOI 10.1007/s00204-004-0607-7; DRINKWATER NR, 1986, CARCINOGENESIS, V7, P1701, DOI 10.1093/carcin/7.10.1701; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Endo S, 2006, BIOL PHARM BULL, V29, P2488, DOI 10.1248/bpb.29.2488; Francis GA, 2003, ANNU REV PHYSIOL, V65, P261, DOI 10.1146/annurev.physiol.65.092101.142528; Fujimori K, 2010, J BIOL CHEM, V285, P8880, DOI 10.1074/jbc.M109.077164; FUJITA S, 1990, J PHARMACOL EXP THER, V253, P369; Guo Minglei, 2009, Adv Stud Biol, V1, P61; Hakkola J, 1998, CRIT REV TOXICOL, V28, P35, DOI 10.1080/10408449891344173; He XJ, 2007, EXP MOL PATHOL, V83, P428, DOI 10.1016/j.yexmp.2006.05.002; Hines RN, 2008, PHARMACOL THERAPEUT, V118, P250, DOI 10.1016/j.pharmthera.2008.02.005; Hjelmstrom P, 2001, J LEUKOCYTE BIOL, V69, P331; Huang HZ, 2005, CHEM RES TOXICOL, V18, P1371, DOI 10.1021/tx050072+; IMAOKA S, 1991, BIOCHIM BIOPHYS ACTA, V1097, P187, DOI 10.1016/0925-4439(91)90034-7; Karanth S, 2000, TOXICOL SCI, V58, P282, DOI 10.1093/toxsci/58.2.282; Kensler TW, 2010, CARCINOGENESIS, V31, P90, DOI 10.1093/carcin/bgp231; Kohle C, 2007, BIOCHEM PHARMACOL, V73, P1853, DOI 10.1016/j.bcp.2007.01.009; Lee JS, 2008, TOXICOL SCI, V106, P263, DOI 10.1093/toxsci/kfn144; McGlynn KA, 2003, CANCER RES, V63, P4594; McGrath K, 2008, CURR TOP DEV BIOL, V82, P1, DOI 10.1016/S0070-2153(07)00001-4; Mickley L, 2001, MAMM GENOME, V12, P86, DOI 10.1007/s003350010237; Mori K, 2007, TOXICOL PATHOL, V35, P242, DOI 10.1080/01926230601156286; Nakata K, 2006, DRUG METAB PHARMACOK, V21, P437, DOI 10.2133/dmpk.21.437; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Rich KJ, 1997, MICROSC RES TECHNIQ, V39, P424, DOI 10.1002/(SICI)1097-0029(19971201)39:5<424::AID-JEMT5>3.0.CO;2-G; Schmucker DL, 2005, EXP GERONTOL, V40, P650, DOI 10.1016/j.exger.2005.06.009; Schroder O, 2005, CELL MOL LIFE SCI, V62, P87, DOI 10.1007/s00018-004-4366-7; Singh P, 2008, HEPATOLOGY, V47, P1680, DOI 10.1002/hep.22224; Slatter JG, 2006, XENOBIOTICA, V36, P902, DOI 10.1080/00498250600861694; Spear BT, 2006, CELL MOL LIFE SCI, V63, P2922, DOI 10.1007/s00018-006-6258-5; U.S. EPA, 2005, SUPPL GUID ASS CANC; Wang T, 2010, J BIOL CHEM, V285, P7670, DOI 10.1074/jbc.M109.090175; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016	45	146	147	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e24381	10.1371/journal.pone.0024381	http://dx.doi.org/10.1371/journal.pone.0024381			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CK	21931700	Green Published, Green Submitted, gold			2022-12-25	WOS:000294802800046
J	Paulo, AC; Sampaio, A; Santos, NC; Costa, PS; Cunha, P; Zihl, J; Cerqueira, J; Palha, JA; Sousa, N				Paulo, Ana Cristina; Sampaio, Adriana; Santos, Nadine Correia; Costa, Patricio Soares; Cunha, Pedro; Zihl, Joseph; Cerqueira, Joao; Palha, Joana Almeida; Sousa, Nuno			Patterns of Cognitive Performance in Healthy Ageing in Northern Portugal: A Cross-Sectional Analysis	PLOS ONE			English	Article							MINI-MENTAL-STATE; EXECUTIVE FUNCTIONS; OLDER-ADULTS; LIFE-SPAN; EDUCATION; MEMORY; POPULATION; DECLINE; AGE; INTERFERENCE	Background: The Minho Integrative Neuroscience Database (MIND)-Ageing project aims to identify predictors of healthy cognitive ageing, including socio-demographic factors. In this exploratory analysis we sought to establish baseline cohorts for longitudinal assessment of age-related changes in cognition. Methods: The population sample (472 individuals) was strictly a convenient one, but similar to the Portuguese population in the age profile. Participants older than 55 years of age were included if they did not present defined disabling pathologies or dementia. A standardized clinical interview was conducted to assess medical history and a battery of neuropsychological tests was administered to characterize global cognition (Mini Mental State Examination), memory and executive functions (Selective Reminding Test; Stroop Color and Word Test; and Block Design subtest of the Wechsler Adult Intelligence Scale). Cross-sectional analysis of the neuropsychological performance with individual characteristics such as age, gender, educational level and setting (retirement home, senior university, day care center or community), allowed the establishment of baseline clusters for subsequent longitudinal studies. Results: Based on different socio-demographic characteristics, four main clusters that group distinctive patterns of cognitive performance were identified. The type of institution where the elders were sampled from, together with the level of formal education, were the major hierarchal factors for individual distribution in the four clusters. Of notice, education seems to delay the cognitive decline that is associated with age in all clusters. Conclusions: Social-inclusion/engagement and education seem to have a protective effect on mental ageing, although this effect may not be effective in the eldest elders.	[Paulo, Ana Cristina; Sampaio, Adriana; Santos, Nadine Correia; Costa, Patricio Soares; Cunha, Pedro; Cerqueira, Joao; Palha, Joana Almeida; Sousa, Nuno] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal; [Paulo, Ana Cristina; Sampaio, Adriana; Santos, Nadine Correia; Costa, Patricio Soares; Cunha, Pedro; Cerqueira, Joao; Palha, Joana Almeida; Sousa, Nuno] PT Govt Associate Lab, ICVS 3Bs, Braga, Portugal; [Cunha, Pedro] Ctr Hosp Alto Ave EPE, Guimaraes, Portugal; [Zihl, Joseph] Univ Munich, Dept Psychol Neuropsychol, Munich, Germany	Universidade do Minho; University of Munich	Paulo, AC (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal.	njcsousa@ecsaude.uminho.pt	Sampaio, Adriana/C-8361-2011; Santos, Nadine Correia/AAC-2873-2019; Santos, Nadine/K-7431-2015; Cunha, Pedro/AAE-6732-2019; Cerqueira, Joao J/B-4579-2008; Sousa, Nuno/C-2782-2009; Palha, Joana Almeida/C-2745-2009; Sousa, Nuno JC/N-9137-2017; Cunha, Pedro G/K-6743-2014; Sampaio, Adriana/AAI-9641-2021; Costa, Patrício/A-3072-2013	Sampaio, Adriana/0000-0001-7347-1282; Santos, Nadine/0000-0001-8110-7173; Cunha, Pedro/0000-0002-8518-4130; Cerqueira, Joao J/0000-0003-3155-2775; Palha, Joana Almeida/0000-0002-8866-368X; Sousa, Nuno JC/0000-0002-8755-5126; Cunha, Pedro G/0000-0002-8518-4130; Costa, Patrício/0000-0002-1201-9177; PAULO, Ana Cristina/0000-0002-9249-2609	European Commission [HEALTH-F2-2010-259772]; Calouste Gulbenkian Foundation [JG0495]; Compromisso com a Ciencia; NCS [SFRH/BPD/51057/2010]; Fundacao para a Ciencia e Tecnologia (FCT), Portugal	European Commission(European CommissionEuropean Commission Joint Research Centre); Calouste Gulbenkian Foundation; Compromisso com a Ciencia; NCS; Fundacao para a Ciencia e Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology)	This study is integrated in the "Maintaining health in old age through homeostasis (SWITCHBOX)" collaborative project funded by the European Commission FP7 initiative (grant HEALTH-F2-2010-259772). NS, JAP and JC are main team members of the European consortium SWITCHBOX (http://www.switchbox-online.eu/). The study was also supported by the Calouste Gulbenkian Foundation (grant JG0495). ACP and AS were supported by "Compromisso com a Ciencia 2007" and NCS by SFRH/BPD/51057/2010, post-doctoral fellowships, funded by the Fundacao para a Ciencia e Tecnologia (FCT), Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ardila A, 2000, ARCH CLIN NEUROPSYCH, V15, P495, DOI 10.1016/S0887-6177(99)00040-2; Ardila A, 2007, ARCH CLIN NEUROPSYCH, V22, P1003, DOI 10.1016/j.acn.2007.08.004; Bielak AAM, 2010, GERONTOLOGY, V56, P507, DOI 10.1159/000264918; Brickman AM, 2005, ARCH CLIN NEUROPSYCH, V20, P561, DOI 10.1016/j.acn.2004.12.006; Busch RM, 2008, CLIN NEUROPSYCHOL, V22, P620, DOI 10.1080/13854040701448793; Buschke H, 1995, J Int Neuropsychol Soc, V1, P483; Capitani E, 1996, DEV NEUROPSYCHOL, V12, P231, DOI 10.1080/87565649609540648; Carlesimo GA, 2010, NEUROLOGY, V74, P194, DOI 10.1212/WNL.0b013e3181cb3e39; Carlson MC, 2008, GERONTOLOGIST, V48, P793, DOI 10.1093/geront/48.6.793; Christensen H, 2001, AUST NZ J PSYCHIAT, V35, P768, DOI 10.1046/j.1440-1614.2001.00966.x; COOPER PV, 1990, J GERONTOL, V45, pP210, DOI 10.1093/geronj/45.5.P210; Davidson DJ, 2003, AGING NEUROPSYCHOL C, V10, P85, DOI 10.1076/anec.10.2.85.14463; De'Ath G, 2002, ECOLOGY, V83, P1105, DOI 10.2307/3071917; DESA United Nations, 2001, WORLD POP AG 1950 20; Eggermont LHP, 2009, J AM GERIATR SOC, V57, P1750, DOI 10.1111/j.1532-5415.2009.02441.x; Evans DA, 1997, ARCH NEUROL-CHICAGO, V54, P1399, DOI 10.1001/archneur.1997.00550230066019; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fornito A, 2004, CEREB CORTEX, V14, P424, DOI 10.1093/cercor/bhh004; Glei DA, 2005, INT J EPIDEMIOL, V34, P864, DOI 10.1093/ije/dyi049; Golden C.J., 1978, STROOP COLOR WORD TE; Grigoletto F, 1999, NEUROLOGY, V53, P315, DOI 10.1212/WNL.53.2.315; Guerreiro M. P., 1994, REV PORTUGUESA NEURO, V1, P9, DOI DOI 10.1017/CB09781107415324.004; Gunstad J, 2006, J GERIATR PSYCH NEUR, V19, P59, DOI 10.1177/0891988705284738; Hedden T, 2004, NAT REV NEUROSCI, V5, P87, DOI 10.1038/nrn1323; Hertzog Christopher, 2008, Psychol Sci Public Interest, V9, P1, DOI 10.1111/j.1539-6053.2009.01034.x; Hilborn JV, 2009, J CLIN EXP NEUROPSYC, V31, P412, DOI 10.1080/13803390802232659; INE Demographic statistics - provisional estimates of resident population: the people 2009, 2009, INE DEM STAT PROV ES; Jokela M, 2010, PSYCHOL MED, V40, P837, DOI 10.1017/S0033291709991024; Jurado MB, 2007, NEUROPSYCHOL REV, V17, P213, DOI 10.1007/s11065-007-9040-z; MacDonald SWS, 2003, PSYCHOL AGING, V18, P510, DOI 10.1037/0882-7974.18.3.510; Morgado J, 2010, EUR J NEUROL, V17, P692, DOI 10.1111/j.1468-1331.2009.02907.x; Nagel IE, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.001.2008; Ngandu T, 2007, NEUROLOGY, V69, P1442, DOI 10.1212/01.wnl.0000277456.29440.16; Park DC, 2002, NEUROSCI BIOBEHAV R, V26, P859, DOI 10.1016/S0149-7634(02)00072-6; Park DC, 2002, PSYCHOL AGING, V17, P299, DOI 10.1037//0882-7974.17.2.299; PLASSMAN BL, 1995, NEUROLOGY, V45, P1446, DOI 10.1212/WNL.45.8.1446; Potter GG, 2006, NEUROLOGY, V67, P1377, DOI 10.1212/01.wnl.0000240061.51215.ed; Proust-Lima C, 2007, AM J EPIDEMIOL, V165, P344, DOI 10.1093/aje/kwk017; *R DEV COR TEAM, 2004, R LANG ENV STAT COMP; Reynolds CR, 2008, PSYCHOL SCHOOLS, V45, P875, DOI 10.1002/pits.20332; Rosselli M, 2006, ARCH CLIN NEUROPSYCH, V21, P677, DOI 10.1016/j.acn.2006.08.001; Salthouse TA, 2004, CURR DIR PSYCHOL SCI, V13, P140, DOI 10.1111/j.0963-7214.2004.00293.x; Salthouse TA, 2006, PERSPECT PSYCHOL SCI, V1, P68, DOI 10.1111/j.1745-6916.2006.00005.x; Small GW, 2008, LANCET NEUROL, V7, P161, DOI 10.1016/S1474-4422(08)70019-X; Spencer WD, 1995, PSYCHOL AGING, V10, P527, DOI 10.1037/0882-7974.10.4.527; STERN Y, 1994, JAMA-J AM MED ASSOC, V271, P1004, DOI 10.1001/jama.271.13.1004; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Strauss E, 2006, COMPENDIUM NEUROPSYC; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; van Boxtel MPJ, 1998, J GERONTOL A-BIOL, V53, pM147; Verghese J, 2006, NEUROLOGY, V66, P821, DOI 10.1212/01.wnl.0000202520.68987.48; Wechsler D., 1997, WAIS 3 WECHSLER ADUL, V3rd, DOI 10.1111/j.1749-6632.1989.tb21005.x; Wilson RS, 2009, NEUROLOGY, V72, P460, DOI 10.1212/01.wnl.0000341782.71418.6c; Yassuda MS, 2009, ARCH CLIN NEUROPSYCH, V24, P71, DOI 10.1093/arclin/acp009	55	29	31	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e24553	10.1371/journal.pone.0024553	http://dx.doi.org/10.1371/journal.pone.0024553			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	819CK	21931752	Green Submitted, Green Published, gold			2022-12-25	WOS:000294802800066
J	Sanada, Y; Mizushima, T; Kai, Y; Nishimura, J; Hagiya, H; Kurata, H; Mizuno, H; Uejima, E; Ito, T				Sanada, Yasuaki; Mizushima, Tsunekazu; Kai, Yasuyuki; Nishimura, Junichi; Hagiya, Hiroshi; Kurata, Haruto; Mizuno, Hirotaka; Uejima, Etsuko; Ito, Toshinori			Therapeutic Effects of Novel Sphingosine-1-Phosphate Receptor Agonist W-061 in Murine DSS Colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; REGULATORY T-CELLS; RELAPSING MULTIPLE-SCLEROSIS; GENE-DEFICIENT MICE; INTESTINAL INFLAMMATION; RHEUMATOID-ARTHRITIS; ULCERATIVE-COLITIS; LYMPHOID ORGANS; ORAL FINGOLIMOD; CROHNS-DISEASE	Although IL-17 is a pro-inflammatory cytokine reportedly involved in various autoimmune inflammatory disorders, its role remains unclear in murine models of colitis. Acute colitis was induced by 2.5% dextran sodium sulfate (DSS) treatment for 5 days. A novel sphingosine-1-phosphate receptor agonist W-061, a prototype of ONO-4641, was orally administered daily, and histopathological analysis was performed on the colon. The number of lymphocytes and their cytokine production were also evaluated in spleen, mesenteric lymph node, Peyer's patch and lamina propria of the colon. Daily administration of W-061 resulted in improvement of DSS-induced colitis, and significantly reduced the number of CD4+ T cells in the colonic lamina propria. Numbers of both Th17 and Th1 cells were reduced by W-061 treatment. W-061, however, had no influence on the number of Treg cells in lamina propria. Thus, Th17 and Th1 cells in lamina propria were thought to be the key subsets in the pathogenesis of DSS-induced colitis. In conclusion, W-061 may be a novel therapeutic strategy to ameliorate acute aggravation of inflammatory bowel diseases.	[Sanada, Yasuaki; Ito, Toshinori] Osaka Univ, Grad Sch Med, Dept Complementary, Osaka, Japan; [Sanada, Yasuaki; Ito, Toshinori] Osaka Univ, Grad Sch Med, Dept Alternat Med, Osaka, Japan; [Sanada, Yasuaki; Uejima, Etsuko] Osaka Univ, Grad Sch Pharmaceut Sci, Dept Hosp Pharm Educ, Osaka, Japan; [Mizushima, Tsunekazu; Kai, Yasuyuki; Nishimura, Junichi] Osaka Univ, Grad Sch Med, Dept Surg, Osaka, Japan; [Hagiya, Hiroshi; Kurata, Haruto] Ono Pharmaceut Co Ltd, Minase Res Inst, Osaka, Japan; [Mizuno, Hirotaka] Ono Pharmaceut Co Ltd, Tsukuba Res Inst, Ibaraki, Japan	Osaka University; Osaka University; Osaka University; Osaka University; Ono Pharmaceutical Co Ltd; Ono Pharmaceutical Co Ltd	Sanada, Y (corresponding author), Osaka Univ, Grad Sch Med, Dept Complementary, Osaka, Japan.	juki@cam.med.osaka-u.ac.jp	Mizushima, Tsunekazu/AAS-7245-2020	Mizushima, Tsunekazu/0000-0002-0825-6823; Kurata, Haruto/0000-0002-9009-3428	Ono Pharmaceutical Co., Ltd.	Ono Pharmaceutical Co., Ltd.(Ono Pharmaceutical Co Ltd)	YS, TM, YK, JN, EU and TI have declared that no competing interests exist. HH, HK, and HM are employers of Ono Pharmaceutical Co., Ltd. This company did not provide direct financial support, it can be considered to be as an indirect funder for this study. This company provided us a base powder of W-061 free of charge and some in vitro pharmacological data. There are no patents, products in development or marketed products to declare. The authors confirm that this does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Alex P, 2009, INFLAMM BOWEL DIS, V15, P341, DOI 10.1002/ibd.20753; Asseman C, 1999, J EXP MED, V190, P995, DOI 10.1084/jem.190.7.995; Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Baumgart DC, 2007, LANCET, V369, P1627, DOI 10.1016/S0140-6736(07)60750-8; Bongartz T, 2006, JAMA-J AM MED ASSOC, V295, P2275, DOI 10.1001/jama.295.19.2275; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Colombel JF, 2010, NEW ENGL J MED, V362, P1383, DOI 10.1056/NEJMoa0904492; Deguchi Y, 2006, ONCOL REP, V16, P699; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Fuss IJ, 1996, J IMMUNOL, V157, P1261; Goverman J, 2009, NAT REV IMMUNOL, V9, P393, DOI 10.1038/nri2550; Inoue S, 1999, AM J GASTROENTEROL, V94, P2441; Ito R, 2008, BIOCHEM BIOPH RES CO, V377, P12, DOI 10.1016/j.bbrc.2008.09.019; Kappos L, 2006, NEW ENGL J MED, V355, P1124, DOI 10.1056/NEJMoa052643; Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494; Lee TK, 2005, CARCINOGENESIS, V26, P681, DOI 10.1093/carcin/bgi002; Lee TK, 2004, CARCINOGENESIS, V25, P2397, DOI 10.1093/carcin/bgh250; Leppkes M, 2009, GASTROENTEROLOGY, V136, P257, DOI 10.1053/j.gastro.2008.10.018; Makita S, 2007, J IMMUNOL, V178, P4937, DOI 10.4049/jimmunol.178.8.4937; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; McGeachy MJ, 2008, IMMUNITY, V28, P445, DOI 10.1016/j.immuni.2008.03.001; Menning A, 2007, EUR J IMMUNOL, V37, P1575, DOI 10.1002/eji.200737201; Mizushima T, 2004, INFLAMM BOWEL DIS, V10, P182, DOI 10.1097/00054725-200405000-00002; Neurath MF, 1996, J EXP MED, V183, P2605, DOI 10.1084/jem.183.6.2605; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; Ogawa A, 2004, CLIN IMMUNOL, V110, P55, DOI 10.1016/j.clim.2003.09.013; Ohno T, 2010, BIOPHARM DRUG DISPOS, V31, P396, DOI 10.1002/bdd.719; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Pinschewer DD, 2000, J IMMUNOL, V164, P5761, DOI 10.4049/jimmunol.164.11.5761; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sanna MG, 2004, J BIOL CHEM, V279, P13839, DOI 10.1074/jbc.M311743200; Song J, 2008, J PHARMACOL EXP THER, V324, P276, DOI 10.1124/jpet.106.119172; Tesmer LA, 2008, IMMUNOL REV, V223, P87, DOI 10.1111/j.1600-065X.2008.00628.x; van den Berg WB, 2009, NAT REV RHEUMATOL, V5, P549, DOI 10.1038/nrrheum.2009.179	36	40	42	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e23933	10.1371/journal.pone.0023933	http://dx.doi.org/10.1371/journal.pone.0023933			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CK	21931623	Green Published, Green Submitted, gold			2022-12-25	WOS:000294802800015
J	Morton, NM; Nelson, YB; Michailidou, Z; Di Rollo, EM; Ramage, L; Hadoke, PWF; Seckl, JR; Bunger, L; Horvat, S; Kenyon, CJ; Dunbar, DR				Morton, Nicholas M.; Nelson, Yvonne B.; Michailidou, Zoi; Di Rollo, Emma M.; Ramage, Lynne; Hadoke, Patrick W. F.; Seckl, Jonathan R.; Bunger, Lutz; Horvat, Simon; Kenyon, Christopher J.; Dunbar, Donald R.			A Stratified Transcriptomics Analysis of Polygenic Fat and Lean Mouse Adipose Tissues Identifies Novel Candidate Obesity Genes	PLOS ONE			English	Article							INSULIN-RESISTANCE; MACROPHAGE INFILTRATION; EXPRESSION ANALYSIS; CRUCIAL ROLE; CELLS; THROMBOSPONDIN-1; INFLAMMATION; ANGIOGENESIS; INDIVIDUALS; MECHANISMS	Background: Obesity and metabolic syndrome results from a complex interaction between genetic and environmental factors. In addition to brain-regulated processes, recent genome wide association studies have indicated that genes highly expressed in adipose tissue affect the distribution and function of fat and thus contribute to obesity. Using a stratified transcriptome gene enrichment approach we attempted to identify adipose tissue-specific obesity genes in the unique polygenic Fat (F) mouse strain generated by selective breeding over 60 generations for divergent adiposity from a comparator Lean (L) strain. Results: To enrich for adipose tissue obesity genes a 'snap-shot' pooled-sample transcriptome comparison of key fat depots and non adipose tissues (muscle, liver, kidney) was performed. Known obesity quantitative trait loci (QTL) information for the model allowed us to further filter genes for increased likelihood of being causal or secondary for obesity. This successfully identified several genes previously linked to obesity (C1qr1, and Np3r) as positional QTL candidate genes elevated specifically in F line adipose tissue. A number of novel obesity candidate genes were also identified (Thbs1, Ppp1r3d, Tmepai, Trp53inp2, Ttc7b, Tuba1a, Fgf13, Fmr) that have inferred roles in fat cell function. Quantitative microarray analysis was then applied to the most phenotypically divergent adipose depot after exaggerating F and L strain differences with chronic high fat feeding which revealed a distinct gene expression profile of line, fat depot and diet-responsive inflammatory, angiogenic and metabolic pathways. Selected candidate genes Npr3 and Thbs1, as well as Gys2, a non-QTL gene that otherwise passed our enrichment criteria were characterised, revealing novel functional effects consistent with a contribution to obesity. Conclusions: A focussed candidate gene enrichment strategy in the unique F and L model has identified novel adipose tissue-enriched genes contributing to obesity.	[Morton, Nicholas M.; Nelson, Yvonne B.; Di Rollo, Emma M.; Ramage, Lynne] Univ Edinburgh, Queens Med Res Inst, BHF Univ Ctr Cardiovasc Sci, Mol Metab Grp, Edinburgh, Midlothian, Scotland; [Michailidou, Zoi] Queens Med Res Inst, Ctr Inflammat Res, Tissue Remodelling & Regenerat Grp, Edinburgh, Midlothian, Scotland; [Hadoke, Patrick W. F.; Seckl, Jonathan R.; Kenyon, Christopher J.] Univ Edinburgh, Queens Med Res Inst, BHF Univ Ctr Cardiovasc Sci, Endocrinol Unit, Edinburgh, Midlothian, Scotland; [Bunger, Lutz] SAC, Anim Breeding & Dev Team, Penicuik, Midlothian, Scotland; [Horvat, Simon] Univ Ljubljana, Dept Anim Sci, Biotech Fac, Ljubljana, Slovenia; [Horvat, Simon] Natl Inst Chem, Ljubljana, Slovenia	University of Edinburgh; University of Edinburgh; University of Edinburgh; Scottish Agricultural College; University of Ljubljana; National Institute of Chemistry - Slovenia	Morton, NM (corresponding author), Univ Edinburgh, Queens Med Res Inst, BHF Univ Ctr Cardiovasc Sci, Mol Metab Grp, Edinburgh, Midlothian, Scotland.	nik.morton@ed.ac.uk	Bunger, Lutz/T-5647-2019; Morton, NICHOLAS/ABF-3774-2020; Dunbar, Donald R/A-7093-2012; Seckl, Jonathan R/C-3555-2013; Bunger, Lutz/A-8751-2014	Bunger, Lutz/0000-0003-4457-8288; Bunger, Lutz/0000-0003-4457-8288	Wellcome Trust [WT 079660/z/06/z]; RCUK; Wellcome Trust Cardiovascular Research Initiative; British Heart Foundation Centre; Slovenian Research Agency [P4-0220]; MRC [G0701528] Funding Source: UKRI; Medical Research Council [G0701528] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); RCUK(UK Research & Innovation (UKRI)); Wellcome Trust Cardiovascular Research Initiative(Wellcome Trust); British Heart Foundation Centre(British Heart Foundation); Slovenian Research Agency(Slovenian Research Agency - Slovenia); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by a Wellcome Trust Career Development fellowship (WT 079660/z/06/z) and an RCUK Fellowship to NMM (http://www.wellcome.ac.uk/). DRD was funded by the Wellcome Trust Cardiovascular Research Initiative and by a British Heart Foundation Centre of Research Excellence Award. The Slovenian Research Agency co-financed part of this work through projects P4-0220 and project Syntol to SH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JC, 2011, CSH PERSPECT BIOL, V3, DOI [10.1101/cshperspect.a009712, 10.1016/j.biocel.2004.01.004]; Aitman TJ, 1999, NAT GENET, V21, P76, DOI 10.1038/5013; Bourdon C, 2009, PHYSIOL GENOMICS, V38, P63, DOI 10.1152/physiolgenomics.90209.2008; Brasaemle DL, 2004, J BIOL CHEM, V279, P46835, DOI 10.1074/jbc.M409340200; Bruun JM, 2004, AM J PHYSIOL-ENDOC M, V286, pE8, DOI 10.1152/ajpendo.00269.2003; Bunger L, 1999, MAMM GENOME, V10, P645, DOI 10.1007/s003359901063; Cao YH, 2010, NAT REV DRUG DISCOV, V9, P107, DOI 10.1038/nrd3055; Chiu S, 2007, PHYSIOL GENOMICS, V31, P75, DOI 10.1152/physiolgenomics.00267.2006; Collier A, 2011, AM J CLIN ONCOL; Dankel SN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011033; Delibegovic M, 2003, DIABETES, V52, P596, DOI 10.2337/diabetes.52.3.596; DEVRIES BBA, 1993, J MED GENET, V30, P761, DOI 10.1136/jmg.30.9.761; Ferretti G, 2010, OBESITY, V18, P1079, DOI 10.1038/oby.2009.338; Franks PW, 2010, CURR VASC PHARM 1214, P14; Gauss KA, 2003, FASEB J, V17, pC97; GREEN H, 1974, CELL, V3, P127, DOI 10.1016/0092-8674(74)90116-0; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Grove KL, 2010, INT J OBESITY, V34, P989, DOI 10.1038/ijo.2010.12; Hader T, 2003, EMBO REP, V4, P511, DOI 10.1038/sj.embor.embor837; Han CY, 2007, DIABETES, V56, P2260, DOI 10.2337/db07-0218; Haviv F, 2005, J MED CHEM, V48, P2838, DOI 10.1021/jm0401560; Herrera BM, 2010, CURR DIABETES REP, V10, P498, DOI 10.1007/s11892-010-0153-z; Horvat S, 2000, MAMM GENOME, V11, P2, DOI 10.1007/s003350010002; Jaworski K, 2009, NAT MED, V15, P159, DOI 10.1038/nm.1904; Keller MP, 2010, ANNU REV NUTR, V30, P341, DOI 10.1146/annurev.nutr.012809.104747; Kim YJ, 2008, NUTR RES, V28, P414, DOI 10.1016/j.nutres.2008.03.015; Kleemann R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008817; Kliewer SA, 2010, AM J CLIN NUTR, V91, p254S, DOI 10.3945/ajcn.2009.28449B; KOCH AE, 1992, SCIENCE, V258, P1798, DOI 10.1126/science.1281554; Koppo K, 2010, AM J PHYSIOL-ENDOC M, V299, pE258, DOI 10.1152/ajpendo.00767.2009; Kozak LP, 2008, INT J OBESITY, V32, pS32, DOI 10.1038/ijo.2008.236; Lindgren CM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000508; Mamane Y, 2009, DIABETES, V58, P2006, DOI 10.2337/db09-0323; McCarthy MI, 2010, NEW ENGL J MED, V363, P2339, DOI 10.1056/NEJMra0906948; Mejhert N, 2010, J CLIN ENDOCR METAB, V95, P2451, DOI 10.1210/jc.2009-2049; Minamino T, 2009, NAT MED, V15, P1082, DOI 10.1038/nm.2014; Morton NM, 2005, DIABETES, V54, P3371, DOI 10.2337/diabetes.54.12.3371; Naggert J, 2011, DIET EFFECTS BONE MI; Nomiyama T, 2007, J CLIN INVEST, V117, P2877, DOI 10.1172/JCI31986; O'Hara A, 2009, PFLUG ARCH EUR J PHY, V458, P1103, DOI 10.1007/s00424-009-0693-8; PASSONNEAU JV, 1974, ANAL BIOCHEM, V60, P405, DOI 10.1016/0003-2697(74)90248-6; Perrini Sebastio, 2009, Archives of Physiology and Biochemistry, V115, P218, DOI 10.1080/13813450903260864; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Roozendaal R, 2007, IMMUNOL REV, V219, P157, DOI 10.1111/j.1600-065X.2007.00556.x; Rutkowski JM, 2009, FEBS J, V276, P5738, DOI 10.1111/j.1742-4658.2009.07303.x; Sabbatini ME, 2003, AM J PHYSIOL-GASTR L, V285, pG929, DOI 10.1152/ajpgi.00010.2003; Sartipy P, 2003, P NATL ACAD SCI USA, V100, P7265, DOI 10.1073/pnas.1133870100; Schaffler A, 2007, TRENDS IMMUNOL, V28, P393, DOI 10.1016/j.it.2007.07.003; SCHRANDERSTUMPEL C, 1994, CLIN GENET, V45, P175; Sengenes C, 2002, AM J PHYSIOL-REG I, V283, pR257, DOI 10.1152/ajpregu.00453.2001; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Simoncic M, 2008, BEHAV GENET, V38, P292, DOI 10.1007/s10519-008-9199-y; Simoncic M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-96; Speakman JR, 2007, CELL METAB, V6, P5, DOI 10.1016/j.cmet.2007.06.004; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Stylianou IM, 2005, PHYSIOL GENOMICS, V20, P224, DOI 10.1152/physiolgenomics.00183.2004; Stylianou IM, 2004, MAMM GENOME, V15, P472, DOI 10.1007/s00335-004-3039-z; Tabeta K, 2004, P NATL ACAD SCI USA, V101, P3516, DOI 10.1073/pnas.0400525101; Varma V, 2008, DIABETES, V57, P432, DOI 10.2337/db07-0840; Wallingford N, 2009, J CLIN INVEST, V119, P2291, DOI 10.1172/JCI37209; Weedon MN, 2008, TRENDS GENET, V24, P595, DOI 10.1016/j.tig.2008.09.006; Wolfs MGM, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-34; Wood IS, 2009, P NUTR SOC, V68, P370, DOI 10.1017/S0029665109990206; Wu HZ, 2007, CIRCULATION, V115, P1029, DOI 10.1161/CIRCULATIONAHA.106.638379; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Xu J, 2006, DIABETES, V55, P3429, DOI 10.2337/db06-0260; Yalcin B, 2004, NAT GENET, V36, P1197, DOI 10.1038/ng1450; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Zhang XM, 2010, J BIOL CHEM, V285, P32869, DOI 10.1074/jbc.M110.135509; Ziouzenkova O, 2007, NAT MED, V13, P695, DOI 10.1038/nm1587	70	37	38	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2011	6	9							e23944	10.1371/journal.pone.0023944	http://dx.doi.org/10.1371/journal.pone.0023944			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CH	21915269	Green Published, Green Submitted, gold			2022-12-25	WOS:000294802500019
J	Xie, XW; Liu, JX; Hu, B; Xiao, WH				Xie, Xun-wei; Liu, Jing-Xia; Hu, Bo; Xiao, Wuhan			Zebrafish foxo3b Negatively Regulates Canonical Wnt Signaling to Affect Early Embryogenesis	PLOS ONE			English	Article							FORKHEAD TRANSCRIPTION FACTOR; POSTERIOR MESODERM FORMATION; BETA-CATENIN; HOMEOBOX GENE; ORGANIZER FORMATION; XENOPUS MESODERM; DORSAL ORGANIZER; EXPRESSION; PROTEINS; PATHWAYS	FOXO genes are involved in many aspects of development and vascular homeostasis by regulating cell apoptosis, proliferation, and the control of oxidative stress. In addition, FOXO genes have been showed to inhibit Wnt/beta-catenin signaling by competing with T cell factor to bind to beta-catenin. However, how important of this inhibition in vivo, particularly in embryogenesis is still unknown. To demonstrate the roles of FOXO genes in embryogenesis will help us to further understand their relevant physiological functions. Zebrafish foxo3b gene, an orthologue of mammalian FOXO3, was expressed maternally and distributed ubiquitously during early embryogenesis and later restricted to brain. After morpholino-mediated knockdown of foxo3b, the zebrafish embryos exhibited defects in axis and neuroectoderm formation, suggesting its critical role in early embryogenesis. The embryo-developmental marker gene staining at different stages, phenotype analysis and rescue assays revealed that foxo3b acted its role through negatively regulating both maternal and zygotic Wnt/beta-catenin signaling. Moreover, we found that foxo3b could interact with zebrafish beta-catenin1 and beta-catenin2 to suppress their transactivation in vitro and in vivo, further confirming its role relevant to the inhibition of Wnt/beta-catenin signaling. Taken together, we revealed that foxo3b played a very important role in embryogenesis and negatively regulated maternal and zygotic Wnt/beta-catenin signaling by directly interacting with both beta-catenin1 and beta-catenin2. Our studies provide an in vivo model for illustrating function of FOXO transcription factors in embryogenesis.	[Xie, Xun-wei; Liu, Jing-Xia; Hu, Bo; Xiao, Wuhan] Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan, Peoples R China	Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Xiao, WH (corresponding author), Chinese Acad Sci, Inst Hydrobiol, Key Lab Aquat Biodivers & Conservat, Wuhan, Peoples R China.	w-xiao@ihb.ac.cn	hu, bo/ABC-3810-2021; Xiao, Wuhan/GLU-7352-2022	hu, bo/0000-0001-5656-9632; 	"973" grant [2010CB126306, 2007CB815705]; NSFC [91019008, 31071212, 30971667, 20890113]; National Transgene Project [2009ZX08010-021B]; Chinese Academy of Science [KSCX2-Y-W-N-020, KSCX2-EW-Q-12]	"973" grant(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC)); National Transgene Project; Chinese Academy of Science(Chinese Academy of Sciences)	W.X. is supported by "973" grant 2010CB126306, 2007CB815705, NSFC grant 91019008, 31071212, 30971667 and National Transgene Project 2009ZX08010-021B. CAS grant KSCX2-Y-W-N-020. J.L. is supported by innovation project of Chinese Academy of Science KSCX2-EW-Q-12 and NSFC grant 20890113. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Begemann G, 2000, MECH DEVELOP, V90, P299, DOI 10.1016/S0925-4773(99)00246-4; Bellipanni G, 2006, DEVELOPMENT, V133, P1299, DOI 10.1242/dev.02295; Biggs WH, 2001, MAMM GENOME, V12, P416, DOI 10.1007/s003350020002; Bouwmeester T, 1996, NATURE, V382, P595, DOI 10.1038/382595a0; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Carter ME, 2007, CURR BIOL, V17, pR113, DOI 10.1016/j.cub.2007.01.008; Cavodeassi F, 2005, NEURON, V47, P43, DOI 10.1016/j.neuron.2005.05.026; Christian M, 2002, J BIOL CHEM, V277, P20825, DOI 10.1074/jbc.M201018200; Dorsky RI, 2003, DEVELOPMENT, V130, P1937, DOI 10.1242/dev.00402; Dosch R, 1997, DEVELOPMENT, V124, P2325; Erter CE, 2001, DEVELOPMENT, V128, P3571; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Fekany-Lee K, 2000, DEVELOPMENT, V127, P2333; Flores MVC, 2008, NAT CELL BIOL, V10, P346, DOI 10.1038/ncb1697; Gawantka V, 1995, EMBO J, V14, P6268, DOI 10.1002/j.1460-2075.1995.tb00317.x; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Heisenberg CP, 2001, GENE DEV, V15, P1427, DOI 10.1101/gad.194301; Hoogeboom D, 2008, J BIOL CHEM, V283, P9224, DOI 10.1074/jbc.M706638200; Hoppler S, 1998, MECH DEVELOP, V71, P119, DOI 10.1016/S0925-4773(98)00004-5; Hoppler S, 1996, GENE DEV, V10, P2805, DOI 10.1101/gad.10.21.2805; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Imai Y, 2001, DEVELOPMENT, V128, P2407; Kawahara A, 2000, P NATL ACAD SCI USA, V97, P12121, DOI 10.1073/pnas.97.22.12121; Kelly C, 2000, DEVELOPMENT, V127, P3899; KELLY GM, 1995, DEVELOPMENT, V121, P1787; KELLY GM, 1995, DEV GENET, V17, P129, DOI 10.1002/dvg.1020170205; KEYNES R, 1990, NEURON, V4, P1, DOI 10.1016/0896-6273(90)90438-L; Kim CH, 2000, NATURE, V407, P913, DOI 10.1038/35038097; Kim SH, 2002, DEVELOPMENT, V129, P4443; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kishimoto Y, 1997, DEVELOPMENT, V124, P4457; Lekven AC, 2001, DEV CELL, V1, P103, DOI 10.1016/S1534-5807(01)00007-7; Leyns L, 1997, CELL, V88, P747, DOI 10.1016/S0092-8674(00)81921-2; Liu JX, 2009, J BIOL CHEM, V284, P16679, DOI 10.1074/jbc.M109.009654; Martin BL, 2008, DEV BIOL, V319, P581, DOI 10.1016/j.ydbio.2008.05.403; Moon RT, 1998, BIOESSAYS, V20, P536, DOI 10.1002/(SICI)1521-1878(199807)20:7<536::AID-BIES4>3.3.CO;2-U; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Onichtchouk D, 1998, DEVELOPMENT, V125, P1447; Onichtchouk D, 1996, DEVELOPMENT, V122, P3045; Pelegri F, 1998, MECH DEVELOP, V77, P63, DOI 10.1016/S0925-4773(98)00132-4; Ramel MC, 2005, DEV BIOL, V287, P237, DOI 10.1016/j.ydbio.2005.08.012; Ramel MC, 2004, DEVELOPMENT, V131, P3991, DOI 10.1242/dev.01277; Reim G, 2006, DEVELOPMENT, V133, P2757, DOI 10.1242/dev.02391; Seiliez I, 2006, DEV BIOL, V290, P152, DOI 10.1016/j.ydbio.2005.11.021; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Shimizu T, 2005, DEV BIOL, V279, P125, DOI 10.1016/j.ydbio.2004.12.007; Shimizu T, 2000, MECH DEVELOP, V91, P293, DOI 10.1016/S0925-4773(99)00319-6; Shimizu T, 2002, MECH DEVELOP, V118, P125, DOI 10.1016/S0925-4773(02)00243-5; Stahl M, 2002, J IMMUNOL, V168, P5024, DOI 10.4049/jimmunol.168.10.5024; STEWARD R, 1993, CURR OPIN GENET DEV, V3, P556, DOI 10.1016/0959-437X(93)90090-C; Szeto DR, 2004, DEVELOPMENT, V131, P3751, DOI 10.1242/dev.01236; Tago K, 2000, GENE DEV, V14, P1741; Van Raay TJ, 2007, DEV BIOL, V309, P151, DOI 10.1016/j.ydbio.2007.04.018; Westerfield M, 1999, TRENDS GENET, V15, P248, DOI 10.1016/S0168-9525(99)01741-2; Wilm TP, 2005, DEVELOPMENT, V132, P393, DOI 10.1242/dev.01572; Yang ZG, 2001, DEV BIOL, V231, P138, DOI 10.1006/dbio.2000.0139; Zhou JG, 2009, J BIOL CHEM, V284, P19142, DOI 10.1074/jbc.M109.010439	58	23	24	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2011	6	9							e24469	10.1371/journal.pone.0024469	http://dx.doi.org/10.1371/journal.pone.0024469			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CH	21915332	Green Published, gold, Green Submitted			2022-12-25	WOS:000294802500050
J	Gao, JB; Hu, J; Tung, WW				Gao, Jianbo; Hu, Jing; Tung, Wen-wen			Facilitating Joint Chaos and Fractal Analysis of Biosignals through Nonlinear Adaptive Filtering	PLOS ONE			English	Article							LONG-RANGE CORRELATION; TIME-SERIES; 1/F NOISE; DYNAMICS; SPECTRA; IMAGES	Background: Chaos and random fractal theories are among the most important for fully characterizing nonlinear dynamics of complicated multiscale biosignals. Chaos analysis requires that signals be relatively noise-free and stationary, while fractal analysis demands signals to be non-rhythmic and scale-free. Methodology/Principal Findings: To facilitate joint chaos and fractal analysis of biosignals, we present an adaptive algorithm, which: (1) can readily remove nonstationarities from the signal, (2) can more effectively reduce noise in the signals than linear filters, wavelet denoising, and chaos-based noise reduction techniques; (3) can readily decompose a multiscale biosignal into a series of intrinsically bandlimited functions; and (4) offers a new formulation of fractal and multifractal analysis that is better than existing methods when a biosignal contains a strong oscillatory component. Conclusions: The presented approach is a valuable, versatile tool for the analysis of various types of biological signals. Its effectiveness is demonstrated by offering new important insights into brainwave dynamics and the very high accuracy in automatically detecting epileptic seizures from EEG signals.	[Gao, Jianbo] PMB Intelligence LLC, W Lafayette, IN USA; [Gao, Jianbo] Wright State Univ, Dept Mech & Mat Engn, Dayton, OH 45435 USA; [Hu, Jing] Affymetrix Inc, Santa Clara, CA USA; [Tung, Wen-wen] Purdue Univ, Dept Earth & Atmospher Sci, W Lafayette, IN 47907 USA	University System of Ohio; Wright State University Dayton; Affymetrix; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Gao, JB (corresponding author), PMB Intelligence LLC, W Lafayette, IN USA.	jbgao@pmbintelligence.com			Directorate For Engineering [1031958] Funding Source: National Science Foundation	Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))		Adeli H, 2007, IEEE T BIO-MED ENG, V54, P205, DOI 10.1109/TBME.2006.886855; Andrzejak RG, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.061907; Bak P., 1996, NATURE WORKS SCI SEL; Billock VA, 2000, PHYSICA D, V137, P379, DOI 10.1016/S0167-2789(99)00197-9; Billock VA, 2001, PHYSICA D, V148, P136, DOI 10.1016/S0167-2789(00)00174-3; Chen YQ, 1997, PHYS REV LETT, V79, P4501, DOI 10.1103/PhysRevLett.79.4501; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; COLLINS JJ, 1994, PHYS REV LETT, V73, P764, DOI 10.1103/PhysRevLett.73.764; Furstenau N, 2010, BIOL CYBERN, V103, P175, DOI 10.1007/s00422-010-0388-4; Gao J., 2007, MULTISCALE ANAL COMP; Gao J B, 2006, Cogn Process, V7, P105, DOI 10.1007/s10339-006-0030-5; Gao JB, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.016117; Gao JB, 2003, PHYS LETT A, V314, P392, DOI 10.1016/S0375-9601(03)00938-1; Gao JB, 2011, COGN NEURODYNAMICS, V5, P171, DOI 10.1007/s11571-011-9151-3; Gao JB, 2010, IEEE SIGNAL PROC LET, V17, P237, DOI 10.1109/LSP.2009.2037773; GILDEN DL, 1995, SCIENCE, V267, P1837, DOI 10.1126/science.7892611; Hu J, 2006, IEEE T ANTENN PROPAG, V54, P136, DOI 10.1109/TAP.2005.861541; Hu J, 2006, FRACTALS, V14, P187, DOI 10.1142/S0218348X06003210; Hu J, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/02/P02066; Hwa RC, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.021901; Kantz H., 2004, NONLINEAR TIME SERIE; Kodba S, 2005, EUR J PHYS, V26, P205, DOI 10.1088/0143-0807/26/1/021; LELAND WE, 1994, IEEE ACM T NETWORK, V2, P1, DOI 10.1109/90.282603; LI W, 1992, EUROPHYS LETT, V17, P655, DOI 10.1209/0295-5075/17/7/014; Movahed MS, 2006, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2006/02/P02003; PENG CK, 1994, PHYS REV E, V49, P1685, DOI 10.1103/PhysRevE.49.1685; Perc M, 2005, EUR J PHYS, V26, P757, DOI 10.1088/0143-0807/26/5/008; Perc M, 2005, EUR J PHYS, V26, P525, DOI 10.1088/0143-0807/26/3/017; Press W. H., 1978, Comments on Astrophysics. Comments on Modern Physics: Part C, V7, P103; Robinson PA, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.032902; Tung WW, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.046210; Wolf M, 1997, PHYSICA A, V241, P493, DOI 10.1016/S0378-4371(97)00251-3; Wornell G.W., 1996, SIGNAL PROCESSING FR; Zhou Y, 2010, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2010/12/P12006	34	65	68	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2011	6	9							e24331	10.1371/journal.pone.0024331	http://dx.doi.org/10.1371/journal.pone.0024331			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817QP	21915312	gold, Green Published, Green Submitted			2022-12-25	WOS:000294689200035
J	Lindquist, S; Karitkina, D; Langnaese, K; Posevitz-Fejfar, A; Schraven, B; Xavier, R; Seed, B; Lindquist, JA				Lindquist, Sabine; Karitkina, Diana; Langnaese, Kristina; Posevitz-Fejfar, Anita; Schraven, Burkhart; Xavier, Ramnik; Seed, Brian; Lindquist, Jonathan A.			Phosphoprotein Associated with Glycosphingolipid-Enriched Microdomains Differentially Modulates Src Kinase Activity in Brain Maturation	PLOS ONE			English	Article							FAMILY TYROSINE KINASES; TRANSMEMBRANE ADAPTER PROTEIN; DOWN-REGULATION; NEGATIVE REGULATION; CSK; FYN; ACTIVATION; CBP; LYN; PAG	Src family kinases (SFK) control multiple processes during brain development and function. We show here that the phosphoprotein associated with glycosphigolipid-enriched microdomains (PAG)/Csk binding protein (Cbp) modulates SFK activity in the brain. The timing and localization of PAG expression overlap with Fyn and Src, both of which we find associated to PAG. We demonstrate in newborn (P1) mice that PAG negatively regulates Src family kinases (SFK). P1 Pag1(-/-)mouse brains show decreased recruitment of Csk into lipid rafts, reduced phosphorylation of the inhibitory tyrosines within SFKs, and an increase in SFK activity of >/= 50%. While in brain of P1 mice, PAG and Csk are highly and ubiquitously expressed, little Csk is found in adult brain suggesting altered modes of SFK regulation. In adult brain Pag1-deficiency has no effect upon Csk-distribution or inhibitory tyrosine phosphorylation, but kinase activity is now reduced (-20-30%), pointing to the development of a compensatory mechanism that may involve PSD93. The distribution of the Csk-homologous kinase CHK is not altered. Importantly, since the activities of Fyn and Src are decreased in adult Pag1(-/-)mice, thus presenting the reversed phenotype of P1, this provides the first in vivo evidence for a Csk-independent positive regulatory function for PAG in the brain.	[Lindquist, Sabine] Hannover Med Sch, Dept Neurol, D-3000 Hannover, Germany; [Lindquist, Sabine; Karitkina, Diana] Leibniz Inst Neurobiol, Magdeburg, Germany; [Langnaese, Kristina] Otto Von Guericke Univ, Inst Biochem & Cell Biol, Magdeburg, Germany; [Posevitz-Fejfar, Anita; Schraven, Burkhart; Lindquist, Jonathan A.] Otto Von Guericke Univ, Inst Mol & Clin Immunol, Magdeburg, Germany; [Schraven, Burkhart] Helmholtz Ctr Infect Res, Dept Immune Control, Braunschweig, Germany; [Xavier, Ramnik; Seed, Brian] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Computat & Integrat Biol, Boston, MA USA	Hannover Medical School; Leibniz Institut fur Neurobiologie (LIN); Otto von Guericke University; Otto von Guericke University; Helmholtz Association; Helmholtz-Center for Infection Research; Harvard University; Harvard Medical School; Massachusetts General Hospital	Lindquist, S (corresponding author), Hannover Med Sch, Dept Neurol, D-3000 Hannover, Germany.	lindquist.sabine@mh-hannover.de	Lindquist, Jonathan/AAB-8526-2021	Lindquist, Jonathan/0000-0001-6846-5056	German Ministry for Education and Research (Bundesministerium fur Bildung und Forschung (BMBF)) [FKZ 01ZZ0407]; German Research Society (DFG) [1031/1-3]	German Ministry for Education and Research (Bundesministerium fur Bildung und Forschung (BMBF))(Federal Ministry of Education & Research (BMBF)); German Research Society (DFG)(German Research Foundation (DFG))	B.S. and J.L. are members of the Magdeburg Center for Systems Biology (MACS) and the SYBILLA consortium [European Union 7th Frame Program]. This work was supported by the German Ministry for Education and Research (Bundesministerium fur Bildung und Forschung (BMBF)) NBL3 program- FKZ 01ZZ0407, Startup grant to S. L. and in part by the German Research Society (DFG)[JL 1031/1-3] to J.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben Fredj N, 2004, J CELL SCI, V117, P1079, DOI 10.1242/jcs.00927; Brdicka T, 2000, J EXP MED, V191, P1591, DOI 10.1084/jem.191.9.1591; Brdickova N, 2003, J EXP MED, V198, P1453, DOI 10.1084/jem.20031484; Chong YP, 2005, GROWTH FACTORS, V23, P233, DOI 10.1080/08977190500178877; Davidson D, 2003, MOL CELL BIOL, V23, P2017, DOI 10.1128/MCB.23.6.2017-2028.2003; Davidson D, 2007, MOL CELL BIOL, V27, P1960, DOI 10.1128/MCB.01983-06; Dobenecker MW, 2005, MOL CELL BIOL, V25, P10533, DOI 10.1128/MCB.25.23.10533-10542.2005; GRANT SGN, 1992, SCIENCE, V258, P1903, DOI 10.1126/science.1361685; GRANT SGN, 1995, GENE DEV, V9, P1909, DOI 10.1101/gad.9.15.1909; Hermiston ML, 2002, J CLIN INVEST, V109, P9; Hirao A, 1997, EMBO J, V16, P2342, DOI 10.1093/emboj/16.9.2342; Hur EM, 2003, J EXP MED, V198, P1463, DOI 10.1084/jem.20030232; IMAMOTO A, 1993, CELL, V73, P1117, DOI 10.1016/0092-8674(93)90641-3; Ingley E, 2006, J BIOL CHEM, V281, P31920, DOI 10.1074/jbc.M602637200; Kasai A, 2005, GENES CELLS, V10, P1175, DOI 10.1111/j.1365-2443.2005.00909.x; Kawabuchi M, 2000, NATURE, V404, P999, DOI 10.1038/35010121; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Kuo SS, 1997, EUR J NEUROSCI, V9, P2383, DOI 10.1111/j.1460-9568.1997.tb01655.x; Lindquist JA, 2003, IMMUNOL REV, V191, P165, DOI 10.1034/j.1600-065X.2003.00007.x; Lu TL, 2006, CELL SIGNAL, V18, P1977, DOI 10.1016/j.cellsig.2006.03.002; Matsuoka H, 2004, J BIOL CHEM, V279, P5975, DOI 10.1074/jbc.M311278200; MIYAKAWA T, 1994, MOL BRAIN RES, V27, P179, DOI 10.1016/0169-328X(94)90201-1; Miyakawa T, 1997, SCIENCE, V278, P698, DOI 10.1126/science.278.5338.698; Nada S, 2003, J BIOL CHEM, V278, P47610, DOI 10.1074/jbc.M303873200; NADA S, 1993, CELL, V73, P1125, DOI 10.1016/0092-8674(93)90642-4; Odom S, 2004, J EXP MED, V199, P1491, DOI 10.1084/jem.20040382; Ohtake H, 2002, J IMMUNOL, V168, P2087, DOI 10.4049/jimmunol.168.5.2087; OKADA M, 1989, J BIOL CHEM, V264, P20886; Oneyama C, 2008, MOL CELL, V30, P426, DOI 10.1016/j.molcel.2008.03.026; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; Ponniah S, 1999, CURR BIOL, V9, P535, DOI 10.1016/S0960-9822(99)80238-3; Posevitz-Fejfar A, 2008, EUR J IMMUNOL, V38, P250, DOI 10.1002/eji.200636664; Rathore VB, 2007, BIOCHEM J, V403, P275, DOI 10.1042/BJ20061618; Relucio J, 2009, J NEUROSCI, V29, P11794, DOI 10.1523/JNEUROSCI.0888-09.2009; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V331, P1, DOI 10.1016/j.bbrc.2005.03.012; ROSS CA, 1988, P NATL ACAD SCI USA, V85, P9831, DOI 10.1073/pnas.85.24.9831; Saito K, 2008, BIOCHEM BIOPH RES CO, V366, P969, DOI 10.1016/j.bbrc.2007.12.055; SCHAFER MKH, 1995, METH NEUROSCI, V23, P16; Seidel B, 1998, DNA CELL BIOL, V17, P1017, DOI 10.1089/dna.1998.17.1017; Shima T, 2003, P NATL ACAD SCI USA, V100, P14897, DOI 10.1073/pnas.2432139100; Simarro M, 2004, INT IMMUNOL, V16, P727, DOI 10.1093/intimm/dxh074; Skelton MR, 2003, BRAIN RES, V984, P1, DOI 10.1016/S0006-8993(03)02839-7; Smida M, 2007, BLOOD, V110, P596, DOI 10.1182/blood-2006-07-038752; Solheim SA, 2008, FEBS J, V275, P4863, DOI 10.1111/j.1742-4658.2008.06626.x; Solheim SA, 2008, J BIOL CHEM, V283, P2773, DOI 10.1074/jbc.M705215200; Sperber BR, 2001, J NEUROSCI, V21, P2039, DOI 10.1523/JNEUROSCI.21-06-02039.2001; STEIN PL, 1994, GENE DEV, V8, P1999, DOI 10.1101/gad.8.17.1999; Takeuchi S, 2000, J BIOL CHEM, V275, P29183, DOI 10.1074/jbc.C000326200; Tauzin S, 2008, BLOOD, V111, P2310, DOI 10.1182/blood-2007-05-090985; UMEMORI H, 1994, NATURE, V367, P572, DOI 10.1038/367572a0; Vacaresse N, 2008, J BIOL CHEM, V283, P35815, DOI 10.1074/jbc.M807964200; Vang T, 2001, J EXP MED, V193, P497, DOI 10.1084/jem.193.4.497; Veracini L, 2008, J CELL BIOL, V182, P603, DOI 10.1083/jcb.200705102; Xu SL, 2005, MOL CELL BIOL, V25, P8486, DOI 10.1128/MCB.25.19.8486-8495.2005; Yang Y, 2003, NAT BIOTECHNOL, V21, P447, DOI 10.1038/nbt803	55	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2011	6	9							e23978	10.1371/journal.pone.0023978	http://dx.doi.org/10.1371/journal.pone.0023978			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817QP	21915273	Green Submitted, Green Published, gold			2022-12-25	WOS:000294689200014
J	Darini, CY; Pisani, DF; Hofman, P; Pedeutour, F; Sudaka, I; Chomienne, C; Dani, C; Ladoux, A				Darini, C. Y.; Pisani, D. F.; Hofman, P.; Pedeutour, F.; Sudaka, I.; Chomienne, C.; Dani, C.; Ladoux, A.			Self-renewal gene tracking to identify tumour-initiating cells associated with metastatic potential	ONCOGENE			English	Article						tumour-initiating cells; Oct-4; metastasis; gene tracking	CANCER STEM-CELLS; MYELOID-LEUKEMIA; BONE-MARROW; EXPRESSION; GROWTH; DIFFERENTIATION; IDENTIFICATION; OCT-3/4; CXCR4; HETEROGENEITY	Tumour-initiating cells (TICs) are rare cancer cells isolated from tumours of different origins including high-grade tumours that sustain neoplasic progression and development of metastatic disease. They harbour deregulated stem cells pathways and exhibit an unchecked ability to self-renew, a property essential for tumour progression. Among the essential factors maintaining embryonic stem (ES) cells properties, OCT-4 (also known as POU5F1) has been detected in tumours of different origins. Although ectopic expression results in dysplasic growth restricted to epithelial tissues, overexpression expands the proportion of immature cells in teratomas. However, OCT-4-expressing cells have not been purified from spontaneously occurring tumours, thus information concerning their properties is rather scant. Here, using p53-/- mice expressing green fluorescent protein and the puromycin resistance gene under the control of the Oct-4 promoter, we show that OCT-4 is expressed in 5% onwards of the undifferentiated tumour cell populations derived from different organs. OCT-4 expression was low as compared with ES cells, but was associated with a 'stemness' signature and expression of the chemokine receptor CXCR4. These cells displayed cancer stem cell features, including increased self-renewal and differentiation ability in vitro and in vivo. They not only formed allografts containing immature bone regions but also disseminated into different organs, including lung, liver and bone. Experiments based on RNA interference revealed that Oct-4 expression drives both their engraftment and metastasis formation. This work points out the crucial contribution of Oct-4-expressing TICs in the hierarchical organization of the malignant potential, leading to metastasis formation. Consequently, it provides an appropriate model to develop novel therapies aiming to strike down TICs by targeting self-renewal genes, therefore efficient to reduce tumour growth and metastatic disease. Oncogene (2012) 31, 2438-2449; doi: 10.1038/onc.2011.421; published online 19 September 2011	[Darini, C. Y.; Pisani, D. F.; Pedeutour, F.; Dani, C.; Ladoux, A.] Univ Nice Sophia Antipolis, CNRS, Inst Biol Dev & Canc, F-06107 Nice 2, France; [Hofman, P.] Univ Nice Sophia Antipolis, Fac Med, INSERM, ERI 21,EA 4319, F-06107 Nice 2, France; [Hofman, P.] Univ Nice Sophia Antipolis, Fac Med, Human Biobank, F-06107 Nice 2, France; [Hofman, P.] Univ Nice Sophia Antipolis, CHU Nice, Pasteur Hosp, F-06107 Nice 2, France; [Pedeutour, F.] Univ Nice Sophia Antipolis, Nice Univ Hosp, Fac Med, F-06107 Nice 2, France; [Sudaka, I.] Cimiez Hosp, CHU Nice, Haematol Lab, Nice, France; [Chomienne, C.] Paris Diderot Univ, Hop St Louis, INSERM, UMRS 940, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Ladoux, A (corresponding author), Univ Nice Sophia Antipolis, CNRS, Inst Biol Dev & Canc, 28 Ave Valombrose, F-06107 Nice 2, France.	ladoux@unice.fr	DANI, Christian/G-3639-2014; Hofman, Paul/P-7654-2018; LADOUX, ANNIE/O-4267-2016; LADOUX, ANNIE/S-2077-2019; Pisani, Didier/AAC-2997-2019	DANI, Christian/0000-0003-3228-0230; Hofman, Paul/0000-0003-0431-9353; LADOUX, ANNIE/0000-0003-3857-2621; LADOUX, ANNIE/0000-0003-3857-2621; Pisani, Didier/0000-0001-5879-8527; CHOMIENNE, Christine/0000-0001-5513-5752	Association pour la Recherche contre le Cancer; Institut National du Cancer [CT 30008187, PL-96-007]; Conseil General des Alpes-Maritimes	Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Institut National du Cancer(Institut National du Cancer (INCA) France); Conseil General des Alpes-Maritimes(Region Provence-Alpes-Cote d'Azur)	We are grateful to Professor Austin Smith and Dr Jenny Nichols for generously providing Oct-4-GiP mice and for useful comments. The contributions of Drs Ez-Zoubir Amri and Gilles Pages for in vivo imaging analyses are appreciated. We thank our colleagues, Dr Katrina Podsypanina and Dr Alain Aurias, for helpful suggestions and discussions. We are indebted to Drs Pascal Peraldi, Nathalie Mazure, Jean-Francois Peyron, Marie-Christine De Vernejoul and Minoo Rassoulzadegan for a careful reading of this manuscript, and to Drs Amanda Patel and Eric Lingueglia for valuable help in editing this manuscript. We acknowledge expert technical assistance of Katia Havet with histology; Agnes Loubat with flow cytometry; Mansour Djedaini with in vivo imaging; Thibault Fabas and Annie-Claude Peyron with genetic analysis; and Franck Paput, Cendrine Dubaud and Jacky Paput with animal care. Our lab receives financial support from Association pour la Recherche contre le Cancer and Institut National du Cancer (grant numbers: CT 30008187 and PL-96-007). We thank Conseil General des Alpes-Maritimes for financial support for the animal imaging equipment (SkyScan).	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Altaba ARI, 2009, EMBO REP, V10, P832, DOI 10.1038/embor.2009.169; Beier D, 2007, CANCER RES, V67, P4010, DOI 10.1158/0008-5472.CAN-06-4180; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Carlisle AJ, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-126; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Charrad RS, 1999, NAT MED, V5, P669, DOI 10.1038/9518; Chiou SH, 2010, CANCER RES, V70, P10433, DOI 10.1158/0008-5472.CAN-10-2638; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; Diehn M, 2009, SEMIN RADIAT ONCOL, V19, P78, DOI 10.1016/j.semradonc.2008.11.002; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Felsher DW, 2004, CURR OPIN GENET DEV, V14, P37, DOI 10.1016/j.gde.2003.12.008; Gassmann P, 2009, NEOPLASIA, V11, P651, DOI 10.1593/neo.09272; Gidekel S, 2003, CANCER CELL, V4, P361, DOI 10.1016/S1535-6108(03)00270-8; Harris MA, 2008, CANCER RES, V68, P10051, DOI 10.1158/0008-5472.CAN-08-0786; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Hochedlinger K, 2009, DEVELOPMENT, V136, P509, DOI 10.1242/dev.020867; Huang CY, 2009, J CELL PHYSIOL, V221, P204, DOI 10.1002/jcp.21846; Hutchin ME, 2005, GENE DEV, V19, P214, DOI 10.1101/gad.1258705; Kaufman DS, 2006, ANN ONCOL, V17, pV106, DOI 10.1093/annonc/mdj963; Kucia M, 2005, BIOL CELL, V97, P133, DOI 10.1042/BC20040069; le Viseur C, 2008, CANCER CELL, V14, P47, DOI 10.1016/j.ccr.2008.05.015; Lee J, 2007, BIOCHEM J, V406, P519, DOI 10.1042/BJ20070243; Lengner CJ, 2007, CELL STEM CELL, V1, P403, DOI 10.1016/j.stem.2007.07.020; Levings PP, 2009, CANCER RES, V69, P5648, DOI 10.1158/0008-5472.CAN-08-3580; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Marangoni E, 2009, BRIT J CANCER, V100, P918, DOI 10.1038/sj.bjc.6604953; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Monteiro J, 2010, EUR J CANCER, V46, P1198, DOI 10.1016/j.ejca.2010.02.030; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; O'Brien CA, 2009, SEMIN RADIAT ONCOL, V19, P71, DOI 10.1016/j.semradonc.2008.11.001; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Rajagopalan V, 2005, J NEURO-ONCOL, V72, P157, DOI 10.1007/s11060-004-3346-y; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rodriguez AM, 2005, J EXP MED, V201, P1397, DOI 10.1084/jem.20042224; Santagata S, 2007, AM J SURG PATHOL, V31, P836, DOI 10.1097/PAS.0b013e31802e708a; Shachaf CM, 2004, NATURE, V431, P1112, DOI 10.1038/nature03043; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Somervaille TCP, 2009, CELL STEM CELL, V4, P129, DOI 10.1016/j.stem.2008.11.015; Wang JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003769; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729; Zeelenberg IS, 2001, J CLIN INVEST, V108, P269, DOI 10.1172/JCI200111330; Zeineddine D, 2006, DEV CELL, V11, P535, DOI 10.1016/j.devcel.2006.07.013; Zhang YF, 2010, CANCER LETT, V292, P1, DOI 10.1016/j.canlet.2009.11.003	53	17	18	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2012	31	19					2438	2449		10.1038/onc.2011.421	http://dx.doi.org/10.1038/onc.2011.421			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	941SP	21927026				2022-12-25	WOS:000303985300006
J	Wang, H; Shi, BZ; Zhang, QL; Jiang, H; Hu, SW; Kong, J; Yao, M; Yang, SL; Li, ZH				Wang, Hai; Shi, Bizhi; Zhang, Qingli; Jiang, Hua; Hu, Suwen; Kong, Juan; Yao, Ming; Yang, Shengli; Li, Zonghai			Growth and metastasis suppression of glioma xenografts expressing exon 4-deletion variant of epidermal growth factor receptor by monoclonal antibody CH12-mediated receptor degradation	FASEB JOURNAL			English	Article						target therapy; C225; LAMP-1	INTRACELLULAR TRAFFICKING; KINASE-ACTIVITY; CANCER-CELLS; EGFR; MONOCLONAL-ANTIBODY-806; IDENTIFICATION; PROLIFERATION; CARCINOMA; APOPTOSIS; CETUXIMAB	We recently isolated an exon-4-deleted epidermal growth factor receptor (EGFR) variant, termed de4 EGFR. Because the extracellular domain alteration of receptors often influences the antitumor effect of therapeutic antibodies, it is essential to test the sensitivity of de4 EGFR(+) tumors to anti-EGFR antibodies. Therefore, in this study, the antitumor activities of mAb CH12, an anti-EGFRvIII antibody developed in our laboratory, as well as a U. S. Food and Drug Administration-approved anti-EGFR antibody, cetuximab (C225), were characterized on de4 EGFR(+) models. The results of FACS assays showed that CH12 bound to de4 EGFR with a higher avidity than did C225. Interestingly, CH12, but not C225, significantly inhibited the metastasis and growth of U87MG-de4 EGFR xenografts, with a growth-inhibition ratio of 46.48% in vivo, and prolonged the survival of the tumor-bearing mice by 37.2%. Treatment with CH12 significantly suppressed tumor proliferation and angiogenesis with increased tumor apoptosis. Mechanistically, de4 EGFR protein expression was virtually undetectable in the U87MG-de4 EGFR xenografts treated with CH12. This may account for the observed reduction of Akt and Erk phosphorylation, cyclin D1, Bcl-2, and Bcl-x(L) expression and the increase of p27 and E-cadherin expression. Intriguingly, LAMP-1, a major component of the lysosome, was significantly up-regulated in the CH12-treated group but not in the C225-treated group, suggesting its contribution to the degradation of de4 EGFR. Taken together, our data demonstrated that mAb CH12 is a promising therapeutic agent for treating de4 EGFR(+) gliomas.-Wang, H., Shi, B., Zhang, Q., Jiang, H., Hu, S., Kong, J., Yao, M., Yang, S., Li, Z. Growth and metastasis suppression of glioma xenografts expressing exon 4-deletion variant of epidermal growth factor receptor by monoclonal antibody CH12-mediated receptor degradation. FASEB J. 26, 73-80 (2012). www.fasebj.org	[Wang, Hai; Shi, Bizhi; Jiang, Hua; Hu, Suwen; Kong, Juan; Yao, Ming; Yang, Shengli; Li, Zonghai] Shanghai Jiao Tong Univ, Key Lab Oncogenes & Related Genes, Renji Hosp, Sch Med,Shanghai Canc Inst, Shanghai 200032, Peoples R China; [Zhang, Qingli] Univ S China, Sch Med, Canc Res Inst, Hengyang City, Peoples R China	Shanghai Jiao Tong University; University of South China	Li, ZH (corresponding author), Shanghai Jiao Tong Univ, Key Lab Oncogenes & Related Genes, Renji Hosp, Sch Med,Shanghai Canc Inst, Shanghai 200032, Peoples R China.	zonghaili@shsmu.edu.cn			National Basic Research Program [2010CB529902]; National Natural Science Foundation of China [81071746]; Shanghai Science and Technology Committee [10431903700]; State Key Laboratory of Oncogenes and Related Genes [91-10-06]	National Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee); State Key Laboratory of Oncogenes and Related Genes	This study was supported by the National Basic Research Program (grant 2010CB529902), the National Natural Science Foundation of China (81071746), the Key Program Project of the Shanghai Science and Technology Committee (10431903700), and the research fund of the State Key Laboratory of Oncogenes and Related Genes (91-10-06).	Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Doody JF, 2007, MOL CANCER THER, V6, P2642, DOI 10.1158/1535-7163.MCT-06-0506; Eskelinen Eeva-Liisa, 2006, Molecular Aspects of Medicine, V27, P495, DOI 10.1016/j.mam.2006.08.005; Gladden AB, 2005, J CELL BIOCHEM, V96, P906, DOI 10.1002/jcb.20613; Ho R, 2005, CANCER RES, V65, P9868, DOI 10.1158/0008-5472.CAN-04-2426; Huang SM, 1999, CANCER RES, V59, P1935; Huang ZQ, 2003, J SURG RES, V111, P274, DOI 10.1016/S0022-4804(03)00076-3; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Jiang H, 2011, J BIOL CHEM, V286, P5913, DOI 10.1074/jbc.M110.192252; Johns TG, 2007, CLIN CANCER RES, V13, P1911, DOI 10.1158/1078-0432.CCR-06-1453; Johns TG, 2004, J BIOL CHEM, V279, P30375, DOI 10.1074/jbc.M401218200; Liao HJ, 2009, CANCER RES, V69, P6179, DOI 10.1158/0008-5472.CAN-09-0049; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luwor RB, 2001, CANCER RES, V61, P5355; Margineanu Eliana, 2008, Rev Med Chir Soc Med Nat Iasi, V112, P432; Pedersen MW, 2001, ANN ONCOL, V12, P745, DOI 10.1023/A:1011177318162; Perera RM, 2007, NEOPLASIA, V9, P1099, DOI 10.1593/neo.07721; Sclabas GM, 2003, J GASTROINTEST SURG, V7, P37, DOI 10.1016/S1091-255X(02)00088-4; Scott AM, 2007, P NATL ACAD SCI USA, V104, P4071, DOI 10.1073/pnas.0611693104; SUNADA H, 1986, P NATL ACAD SCI USA, V83, P3825, DOI 10.1073/pnas.83.11.3825; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; Vermorken JB, 2008, CANCER-AM CANCER SOC, V112, P2710, DOI 10.1002/cncr.23442; Wang H, 2011, NEOPLASIA, V13, P461, DOI 10.1593/neo.101744; Weihua Z, 2008, CANCER CELL, V13, P385, DOI 10.1016/j.ccr.2008.03.015; Xue CS, 2006, CANCER RES, V66, P192, DOI 10.1158/0008-5472.CAN-05-1242	25	10	12	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2012	26	1					73	80		10.1096/fj.11-191064	http://dx.doi.org/10.1096/fj.11-191064			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	877SF	21917986				2022-12-25	WOS:000299202200009
J	De Stefano, S; Pusch, M; Zifarelli, G				De Stefano, Silvia; Pusch, Michael; Zifarelli, Giovanni			Extracellular Determinants of Anion Discrimination of the Cl-/H+ Antiporter Protein CLC-5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLORIDE-CHANNELS; CYSTEINE ACCESSIBILITY; NITRATE ACCUMULATION; PROKARYOTIC HOMOLOG; SELECTIVITY FILTER; MOLECULAR-BASIS; ION PERMEATION; BINDING-SITE; PORE; TRANSPORTER	Mammalian CLC proteins comprise both Cl- channels and Cl-/H+ antiporters that carry out fundamental physiological tasks by transporting Cl- across plasma membrane and intracellular compartments. TheNO(3)(-) over Cl- preference of a plant CLC transporter has been pinpointed to a conserved serine residue located at S-cen and it is generally assumed that the other two binding sites of CLCs, S-ext and S-in, do not substantially contribute to anion selectivity. Here we show for the Cl-/H+ antiporter CLC-5 that the conserved and extracellularly exposed Lys(210) residue is critical to determine the anion specificity for transport activity. In particular, mutations that neutralize or invert the charge at this position reverse the NO3- over Cl- preference of WT CLC-5 at a concentration of 100 mM, but do not modify the coupling stoichiometry with H+. The importance of the electrical charge is shown by chemical modification of K210C with positively charged cysteine-reactive compounds that reintroduce the WT preference for Cl-. At saturating extracellular anion concentrations, neutralization of Lys(210) is of little impact on the anion preference, suggesting an important role of Lys(210) on the association rate of extracellular anions to S-ext.	[De Stefano, Silvia; Pusch, Michael; Zifarelli, Giovanni] CNR, Ist Biofis, I-16149 Genoa, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR)	Zifarelli, G (corresponding author), CNR, Ist Biofis, Via De Marini 6, I-16149 Genoa, Italy.	zifarelli@ge.ibf.cnr.it		Pusch, Michael/0000-0002-8644-8847	Telethon Italy [GGP08064]; Italian Institute of Technology (Progetto SEED); Compagnia San Paolo	Telethon Italy(Fondazione Telethon); Italian Institute of Technology (Progetto SEED); Compagnia San Paolo(Compagnia di San Paolo)	This work was supported by Telethon Italy Grant GGP08064, the Italian Institute of Technology (Progetto SEED), and the Compagnia San Paolo.	Accardi A, 2004, J GEN PHYSIOL, V123, P109, DOI 10.1085/jgp.200308935; Accardi A, 2003, J GEN PHYSIOL, V122, P277, DOI 10.1085/jgp.200308834; Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Accardi A, 2006, J MOL BIOL, V362, P691, DOI 10.1016/j.jmb.2006.07.081; Accardi A, 2010, BBA-BIOMEMBRANES, V1798, P1457, DOI 10.1016/j.bbamem.2010.02.022; Bergsdorf EY, 2009, J BIOL CHEM, V284, P11184, DOI 10.1074/jbc.M901170200; De Angeli A, 2006, NATURE, V442, P939, DOI 10.1038/nature05013; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Dutzler R, 2003, SCIENCE, V300, P108, DOI 10.1126/science.1082708; EISENMAN G, 1983, J MEMBRANE BIOL, V76, P197, DOI 10.1007/BF01870364; Engh AM, 2005, J GEN PHYSIOL, V125, P601, DOI 10.1085/jgp.200509258; Estevez R, 2003, NEURON, V38, P47, DOI 10.1016/S0896-6273(03)00168-5; Fahlke C, 1997, NATURE, V390, P529, DOI 10.1038/37391; Feng LA, 2010, SCIENCE, V330, P635, DOI 10.1126/science.1195230; Friedrich T, 1999, J BIOL CHEM, V274, P896, DOI 10.1074/jbc.274.2.896; Gradogna A, 2010, J GEN PHYSIOL, V136, P311, DOI 10.1085/jgp.201010455; Graves AR, 2008, NATURE, V453, P788, DOI 10.1038/nature06907; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Jayaram H, 2008, P NATL ACAD SCI USA, V105, P11194, DOI 10.1073/pnas.0804503105; Jentsch TJ, 2005, ANNU REV PHYSIOL, V67, P779, DOI 10.1146/annurev.physiol.67.032003.153245; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; Jossier M, 2010, PLANT J, V64, P563, DOI 10.1111/j.1365-313X.2010.04352.x; Lin CW, 2000, J GEN PHYSIOL, V116, P535, DOI 10.1085/jgp.116.4.535; Lin CW, 2003, J GEN PHYSIOL, V122, P147, DOI 10.1085/jgp.200308845; Lorenz L, 1996, P NATL ACAD SCI USA, V93, P13362, DOI 10.1073/pnas.93.23.13362; Ludewig U, 1997, J GEN PHYSIOL, V110, P165, DOI 10.1085/jgp.110.2.165; NEYTON J, 1988, J GEN PHYSIOL, V92, P569, DOI 10.1085/jgp.92.5.569; Nguitragool W, 2006, J MOL BIOL, V362, P682, DOI 10.1016/j.jmb.2006.07.006; Novarino G, 2010, SCIENCE, V328, P1398, DOI 10.1126/science.1188070; Picollo A, 2005, NATURE, V436, P420, DOI 10.1038/nature03720; Picollo A, 2009, NAT STRUCT MOL BIOL, V16, P1294, DOI 10.1038/nsmb.1704; PUSCH M, 1995, NATURE, V373, P527, DOI 10.1038/373527a0; Rosental N, 2010, J BIOL CHEM, V285, P21241, DOI 10.1074/jbc.M109.087163; Rychkov GY, 1998, J GEN PHYSIOL, V111, P653, DOI 10.1085/jgp.111.5.653; Steinberg BE, 2010, J CELL BIOL, V189, P1171, DOI 10.1083/jcb.200911083; Steinmeyer K, 1995, J BIOL CHEM, V270, P31172, DOI 10.1074/jbc.270.52.31172; Traverso S, 2003, J GEN PHYSIOL, V122, P295, DOI 10.1085/jgp.200308784; Vandenberg RJ, 2007, J BIOL CHEM, V282, P14447, DOI 10.1074/jbc.M609158200; Wege S, 2010, PLANT J, V63, P861, DOI 10.1111/j.1365-313X.2010.04288.x; Weinert S, 2010, SCIENCE, V328, P1401, DOI 10.1126/science.1188072; WOODHULL AM, 1973, J GEN PHYSIOL, V61, P687, DOI 10.1085/jgp.61.6.687; Zdebik AA, 2008, J BIOL CHEM, V283, P4219, DOI 10.1074/jbc.M708368200; Zifarelli G, 2007, REV PHYSIOL BIOCH P, V158, P23, DOI 10.1007/112_2006_0605; Zifarelli G, 2009, EMBO J, V28, P175, DOI 10.1038/emboj.2008.284	44	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 23	2011	286	51					44134	44144		10.1074/jbc.M111.272815	http://dx.doi.org/10.1074/jbc.M111.272815			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	866SH	21921031	Green Published, hybrid			2022-12-25	WOS:000298402300054
J	Zhang, Y; Liu, LL; Wu, XR; An, XX; Stubbe, J; Huang, MX				Zhang, Yan; Liu, Lili; Wu, Xiaorong; An, Xiuxiang; Stubbe, JoAnne; Huang, Mingxia			Investigation of in Vivo Diferric Tyrosyl Radical Formation in Saccharomyces cerevisiae Rnr2 Protein REQUIREMENT OF Rnr4 AND CONTRIBUTION OF Grx3/4 AND Dre2 PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-SULFUR CLUSTER; YEAST RIBONUCLEOTIDE REDUCTASE; COUPLED ELECTRON-TRANSFER; ESCHERICHIA-COLI; SMALL-SUBUNIT; 2FE-2S CLUSTER; MONOTHIOL GLUTAREDOXINS; ALLOSTERIC REGULATION; SUPEROXIDE-DISMUTASE; KINETIC-ANALYSIS	The beta(2) subunit of class La ribonucleotide reductase (RNR) contains a diferric tyrosyl radical cofactor (Fe-2(III)-Tyr) that is essential for nucleotide reduction. The beta(2) subunit of Saccharomyces cerevisiae is a heterodimer of Rnr2 (beta) and Rnr4 (beta'). Although only beta is capable of iron binding and Tyr formation, cells lacking beta' are either dead or exhibit extremely low Tyr levels and RNR activity depending on genetic backgrounds. Here, we present evidence supporting the model that beta' is required for iron loading and Tyr' formation in beta in vivo via a pathway that is likely dependent on the cytosolic monothiol glutaredoxins Grx3/Grx4 and the Fe-S duster protein Dre2. rnr4 mutants are defective in iron loading into nascent beta and are hypersensitive to iron depletion and the Tyr'-reducing agent hydroxyurea. transient induction of beta' in a GaIRNR4 strain leads to a concomitant increase in iron loading and Tyr' levels in beta. Tyr' can also be rapidly generated using endogenous iron when permeabilized Delta rnr4 spheroplasts are supplemented with recombinant beta' and is inhibited by adding an iron chelator prior to, but not after, beta' supplementation. The growth defects of rnr4 mutants are enhanced by deficiencies in grx3/grx4 and dre2. Moreover, depletion of Dre2 in Gal-DRE2 cells leads to a decrease in both Tyr' levels and beta beta' activity. This result, in combination with previous findings that a low level of Gnc3/4 impairs RNR function, strongly suggests that Grx3/4 and Dre2 serve in the assembly of the deferric Tyr' cofactor in RNR.	[Zhang, Yan; Stubbe, JoAnne] MIT, Dept Chem, Cambridge, MA 02139 USA; [Stubbe, JoAnne] MIT, Dept Biol, Cambridge, MA 02139 USA; [Liu, Lili; Wu, Xiaorong; An, Xiuxiang; Huang, Mingxia] Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Colorado System; University of Colorado Anschutz Medical Campus	Stubbe, J (corresponding author), MIT, Dept Chem, 77 Mass Ave, Cambridge, MA 02139 USA.	stubbe@mit.edu; mingxia.huang@ucdenver.edu	Zhang, Yan/K-1638-2015	Zhang, Yan/0000-0003-2031-0631	National Institutes of Health [GM81393]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081393] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM81393 (to J. S. and M. H.).	ACHLEITNER G, 1995, J BIOL CHEM, V270, P29836; Alves R, 2004, PROTEINS, V56, P354, DOI 10.1002/prot.20110; An XX, 2006, GENETICS, V173, P63, DOI 10.1534/genetics.105.055236; ATKIN CL, 1973, J BIOL CHEM, V248, P7464; Banci L, 2011, CHEM BIOL, V18, P794, DOI 10.1016/j.chembiol.2011.03.015; Chabes A, 2000, P NATL ACAD SCI USA, V97, P2474, DOI 10.1073/pnas.97.6.2474; Cotruvo JA, 2011, ANNU REV BIOCHEM, V80, P733, DOI 10.1146/annurev-biochem-061408-095817; CRICHTON RR, 1987, EUR J BIOCHEM, V164, P485, DOI 10.1111/j.1432-1033.1987.tb11155.x; Culotta VC, 1997, J BIOL CHEM, V272, P23469, DOI 10.1074/jbc.272.38.23469; ELLEDGE SJ, 1987, MOL CELL BIOL, V7, P2783, DOI 10.1128/MCB.7.8.2783; Fairman JW, 2011, NAT STRUCT MOL BIOL, V18, P316, DOI 10.1038/nsmb.2007; FLICK JS, 1990, MOL CELL BIOL, V10, P4757, DOI 10.1128/MCB.10.9.4757; Ge H, 2001, P NATL ACAD SCI USA, V98, P10067, DOI 10.1073/pnas.181336498; Ge J, 2003, BIOCHEMISTRY-US, V42, P10071, DOI 10.1021/bi034374r; HARDER J, 1990, FREE RADICAL RES COM, V10, P281, DOI 10.3109/10715769009149896; Hartman JL, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-r49; Hristova D, 2008, BIOCHEMISTRY-US, V47, P3989, DOI 10.1021/bi702408k; Huang MX, 1997, MOL CELL BIOL, V17, P6105, DOI 10.1128/MCB.17.10.6105; Huang MX, 1998, CELL, V94, P595, DOI 10.1016/S0092-8674(00)81601-3; Kashlan OB, 2003, BIOCHEMISTRY-US, V42, P1696, DOI 10.1021/bi020634d; Kumanovics A, 2008, J BIOL CHEM, V283, P10276, DOI 10.1074/jbc.M801160200; Lamb AL, 2001, NAT STRUCT BIOL, V8, P751, DOI 10.1038/nsb0901-751; Lange H, 2000, P NATL ACAD SCI USA, V97, P1050, DOI 10.1073/pnas.97.3.1050; Li HR, 2009, BIOCHEMISTRY-US, V48, P9569, DOI 10.1021/bi901182w; Li J, 2001, J BIOL CHEM, V276, P1503, DOI 10.1074/jbc.M007198200; Licht S., 1999, COMPREHENSIVE NATURA, P163; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; MANN GJ, 1991, BIOCHEMISTRY-US, V30, P1939, DOI 10.1021/bi00221a030; Martin JE, 2011, MOL MICROBIOL, V80, P319, DOI 10.1111/j.1365-2958.2011.07593.x; Muhlenhoff U, 2010, CELL METAB, V12, P373, DOI 10.1016/j.cmet.2010.08.001; Netz DJA, 2010, NAT CHEM BIOL, V6, P758, DOI [10.1038/NCHEMBIO.432, 10.1038/nchembio.432]; Nguyen HHT, 1999, P NATL ACAD SCI USA, V96, P12339, DOI 10.1073/pnas.96.22.12339; NORDLUND P, 1993, J MOL BIOL, V232, P123, DOI 10.1006/jmbi.1993.1374; NORDLUND P, 1990, NATURE, V345, P593, DOI 10.1038/345593a0; Ortigosa AD, 2006, BIOCHEMISTRY-US, V45, P12282, DOI 10.1021/bi0610404; Perlstein DL, 2005, BIOCHEMISTRY-US, V44, P15366, DOI 10.1021/bi051616+; Picciocchi A, 2007, BIOCHEMISTRY-US, V46, P15018, DOI 10.1021/bi7013272; Ravi N., 1995, METHOD ENZYMOL, V258, P278; Reece SY, 2006, PHILOS T R SOC B, V361, P1351, DOI 10.1098/rstb.2006.1874; Rofougaran R, 2006, J BIOL CHEM, V281, P27705, DOI 10.1074/jbc.M605573200; Rofougaran R, 2008, J BIOL CHEM, V283, P35310, DOI 10.1074/jbc.M806738200; Saito Y, 2011, BIOCHEM BIOPH RES CO, V408, P329, DOI 10.1016/j.bbrc.2011.04.033; Sommerhalter M, 2004, BIOCHEMISTRY-US, V43, P7736, DOI 10.1021/bi049510m; Stearman R, 1996, SCIENCE, V271, P1552, DOI 10.1126/science.271.5255.1552; STEEPER JR, 1970, ANAL BIOCHEM, V34, P123, DOI 10.1016/0003-2697(70)90092-8; Stehling Oliver, 2007, Methods Mol Biol, V372, P325, DOI 10.1007/978-1-59745-365-3_24; Stubbe J, 2003, CHEM REV, V103, P2167, DOI 10.1021/cr020421u; Stubbe J, 1998, CHEM REV, V98, P705, DOI 10.1021/cr9400875; Stubbe J, 2011, CURR OPIN CHEM BIOL, V15, P284, DOI 10.1016/j.cbpa.2010.12.001; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; THELANDER L, 1983, BIOCHEM BIOPH RES CO, V110, P859, DOI 10.1016/0006-291X(83)91040-9; THELANDER L, 1979, ANNU REV BIOCHEM, V48, P133, DOI 10.1146/annurev.bi.48.070179.001025; Voegtli WC, 2001, P NATL ACAD SCI USA, V98, P10073, DOI 10.1073/pnas.181336398; Wang J, 2009, BIOCHEMISTRY-US, V48, P11612, DOI 10.1021/bi901588z; Wang PJ, 1997, MOL CELL BIOL, V17, P6114, DOI 10.1128/MCB.17.10.6114; Wu CH, 2007, BIOCHEMISTRY-US, V46, P11577, DOI 10.1021/bi7012454; Wu G, 2002, BIOCHEMISTRY-US, V41, P5024, DOI 10.1021/bi016073s; Wu SP, 2002, BIOCHEMISTRY-US, V41, P8876, DOI 10.1021/bi0256781; Yu Y, 2006, CLIN CANCER RES, V12, P6876, DOI 10.1158/1078-0432.CCR-06-1954; Zhang Y, 2005, J BIOL CHEM, V280, P19794, DOI 10.1074/jbc.M500397200; Zhang Y, 2008, MOL CELL BIOL, V28, P5569, DOI 10.1128/MCB.00642-08	63	42	44	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41499	41509		10.1074/jbc.M111.294074	http://dx.doi.org/10.1074/jbc.M111.294074			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21931161	Green Published, hybrid			2022-12-25	WOS:000298057500036
J	Bernabe-Ortiz, A; Carcamo, CP; Scott, JD; Hughes, JP; Garcia, PJ; Holmes, KK				Bernabe-Ortiz, Antonio; Carcamo, Cesar P.; Scott, John D.; Hughes, James P.; Garcia, Patricia J.; Holmes, King K.			HBV Infection in Relation to Consistent Condom Use: A Population-Based Study in Peru	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; SEXUALLY-TRANSMITTED INFECTIONS; FEMALE SEX WORKERS; RISK-FACTORS; PREVALENCE; TRANSMISSION; WOMEN; HIV; MEN; DISEASES	Background: Data on hepatitis B virus (HBV) prevalence are limited in developing countries. There is also limited information of consistent condom use efficacy for reducing HBV transmission at the population level. The study goal was to evaluate the prevalence and factors associated with HBV infection in Peru, and the relationship between anti-HBc positivity and consistent condom use. Methods and Findings: Data from two different surveys performed in 28 mid-sized Peruvian cities were analyzed. Participants aged 18-29 years were selected using a multistage cluster sampling. Information was collected through a validated two-part questionnaire. The first part (face-to-face) concerned demographic data, while the second part (self-administered using handheld computers) concerned sexual behavior. Hepatitis B core antibody (anti-HBc) was tested in 7,000 blood samples. Prevalences and associations were adjusted for sample strata, primary sampling units and population weights. Anti-HBc prevalence was 5.0% (95% CI 4.1%-5.9%), with the highest prevalence among jungle cities: 16.3% (95% CI 13.8%-19.1%). In the multivariable analysis, Anti-HBc positivity was directly associated with geographic region (highlands OR = 2.05; 95% CI 1.28-3.27, and jungle OR = 4.86; 95% CI 3.05-7.74; compared to coastal region); and inversely associated with age at sexual debut (OR = 0.90; 95% CI 0.85-0.97). Consistent condom use, evaluated in about 40% of participants, was associated with reduced prevalence (OR = 0.34; 95% CI 0.15-0.79) after adjusting for gender, geographic region, education level, lifetime number of sex partners, age at sexual debut and year of survey. Conclusion: Residence in highlands or jungle cities is associated with higher anti-HBc prevalences, whereas increasing age at sexual debut were associated with lower prevalences. Consistent condom use was associated with decreased risk of anti-HBc. Findings from this study emphasize the need of primary prevention programs (vaccination) especially in the jungle population, and imply that condom use promotion might be a potential strategy to prevent HBV infection.	[Bernabe-Ortiz, Antonio; Carcamo, Cesar P.; Garcia, Patricia J.] Univ Peruana Cayetano Heredia, Sch Publ Hlth & Adm, Lima, Peru; [Scott, John D.; Holmes, King K.] Univ Washington, Dept Med, Seattle, WA USA; [Hughes, James P.; Holmes, King K.] Univ Washington, Ctr AIDS & STD, Seattle, WA 98195 USA; [Holmes, King K.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA	Universidad Peruana Cayetano Heredia; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Bernabe-Ortiz, A (corresponding author), Univ Peruana Cayetano Heredia, Sch Publ Hlth & Adm, Lima, Peru.	antonio.bernabe@upch.pe	, Holmes/K-6215-2019	Bernabe-Ortiz, Antonio/0000-0002-6834-1376	Joint International Infectious Disease Initiative of the Wellcome Trust; Burroughs-Wellcome Foundation [059131/Z/99/A]; Comprehensive International Program of Research on AIDS [5U19AI053218]; University of Washington Center for AIDS Research [AI 27757]; STI-TM Cooperation Research Center AI; National Institutes of Health Fogarty International Center [D43-TW00007]; Department of Global Health at University of Washington; FOGARTY INTERNATIONAL CENTER [D43TW000007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI053218, P30AI027757] Funding Source: NIH RePORTER	Joint International Infectious Disease Initiative of the Wellcome Trust; Burroughs-Wellcome Foundation(Burroughs Wellcome Fund); Comprehensive International Program of Research on AIDS; University of Washington Center for AIDS Research; STI-TM Cooperation Research Center AI; National Institutes of Health Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Department of Global Health at University of Washington; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by the Joint International Infectious Disease Initiative of the Wellcome Trust and the Burroughs-Wellcome Foundation (059131/Z/99/A), by the Comprehensive International Program of Research on AIDS Grant 5U19AI053218, by the University of Washington Center for AIDS Research Grant AI 27757, and STI-TM Cooperation Research Center AI by the National Institutes of Health Fogarty International Center AIDS International Training and Research Program Grant D43-TW00007, and the Department of Global Health at University of Washington. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal R, 2004, BMJ-BRIT MED J, V329, P1080, DOI 10.1136/bmj.329.7474.1080; ALI MM, 2001, AIDS BEHAV, V5, P343, DOI DOI 10.1023/A:1013186806939; Bernabe-Ortiz A, 2009, CAN MED ASSOC J, V180, P298, DOI 10.1503/cmaj.071399; BHAVE G, 1995, AIDS, V9, pS21; Brook MG, 2002, SEX TRANSM INFECT, V78, P235, DOI 10.1136/sti.78.4.235; Cabezas César, 2007, Rev. perú. med. exp. salud publica, V24, P378; CARCAMO C, 2009, GASTROENTEROLOGY, DOI DOI 10.1016/S0016-5085(09)63987-1; Colin JF, 1999, HEPATOLOGY, V29, P1306, DOI 10.1002/hep.510290447; Custer B, 2004, J CLIN GASTROENTEROL, V38, pS158, DOI 10.1097/00004836-200411003-00008; Davis KR, 1999, FAM PLANN PERSPECT, V31, P272, DOI 10.2307/2991537; Diamond C, 2003, SEX TRANSM DIS, V30, P425, DOI 10.1097/00007435-200305000-00009; Dienstag JL, 2008, NEW ENGL J MED, V359, P1486, DOI 10.1056/NEJMra0801644; Garcia PJ, 2004, B WORLD HEALTH ORGAN, V82, P483; GERLICH WH, 1991, BIOTEST B, V4, P283; Gilson R, 2006, SEX TRANSM INFECT, V82, P35, DOI 10.1136/sti.2006.023218; Gilson RJC, 1998, SEX TRANSM INFECT, V74, P110, DOI 10.1136/sti.74.2.110; GILSON RJC, 1992, GENITOURIN MED, V68, P123; Holmes KK, 2004, B WORLD HEALTH ORGAN, V82, P454; HOOPER RR, 1978, AM J EPIDEMIOL, V108, P136, DOI 10.1093/oxfordjournals.aje.a112597; Jiang J, 2006, SEX TRANSM DIS, V33, P118, DOI 10.1097/01.olq.0000199763.14766.2b; Koepsell T. D, 2003, EPIDEMIOLOGIC METHOD; Kurien T, 2005, INDIAN J MED RES, V121, P670; Lama JR, 2006, JAIDS-J ACQ IMM DEF, V42, P501, DOI 10.1097/01.qai.0000221677.29693.dd; Madalengoitia J, 1975, Bull Pan Am Health Organ, V9, P142; Mast Eric E., 2006, Morbidity and Mortality Weekly Report, V55, P1; Matos MA, 2008, SEX TRANSM INFECT, V84, P386, DOI 10.1136/sti.2008.030205; *NAC UN, 2007, DROG DEL PER SIT ACT; Pando MA, 2006, AM J TROP MED HYG, V74, P233, DOI 10.4269/ajtmh.2006.74.233; Parish WL, 2003, JAMA-J AM MED ASSOC, V289, P1265, DOI 10.1001/jama.289.10.1265; Sanchez J, 1998, SEX TRANSM DIS, V25, P82, DOI 10.1097/00007435-199802000-00005; Sanchez J, 2003, SEX TRANSM DIS, V30, P273, DOI 10.1097/00007435-200304000-00001; Soldan VAP, 2008, INT J EPIDEMIOL, V37, P862, DOI 10.1093/ije/dyn118; Vildosola H, 1990, Rev Gastroenterol Peru, V10, P96; Vildózola Herman, 2006, Rev. gastroenterol. Perú, V26, P242; Wald A, 2005, ANN INTERN MED, V143, P707, DOI 10.7326/0003-4819-143-10-200511150-00007; Warner L, 2006, SEX TRANSM DIS, V33, P36, DOI 10.1097/01.olq.0000187908.42622.fd; Winer RL, 2006, NEW ENGL J MED, V354, P2645, DOI 10.1056/NEJMoa053284	37	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2011	6	9							e24721	10.1371/journal.pone.0024721	http://dx.doi.org/10.1371/journal.pone.0024721			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZV	21931828	Green Submitted, gold, Green Published			2022-12-25	WOS:000295321800054
J	Chen, F; Zhang, XL; Sun, S; Zara, JN; Zou, X; Chiu, R; Culiat, CT; Ting, K; Soo, C				Chen, Feng; Zhang, Xinli; Sun, Shan; Zara, Janette N.; Zou, Xuan; Chiu, Robert; Culiat, Cymbelin T.; Ting, Kang; Soo, Chia			NELL-1, an Osteoinductive Factor, Is a Direct Transcriptional Target of Osterix	PLOS ONE			English	Article							OSTEOBLAST DIFFERENTIATION; BONE-FORMATION; GENE; EXPRESSION; FAMILY; MICE; CRANIOSYNOSTOSIS; PROTEINS; SP1	NELL-1 is a novel secreted protein associated with premature fusion of cranial sutures in craniosynostosis that has been found to promote osteoblast cell differentiation and mineralization. Our previous study showed that Runx2, the key transcription factor in osteoblast differentiation, transactivates the NELL-1 promoter. In this study, we evaluated the regulatory involvement and mechanisms of Osterix, an essential transcription factor of osteoblasts, in NELL-1 gene expression and function. Promoter analysis showed a cluster of potential Sp1 sites (Sp1/Osterix binding sites) within approximately 70 bp (from 271 to 2142) of the 59 flanking region of the human NELL-1 transcriptional start site. Luciferase activity in our NELL-1 promoter reporter systems was significantly decreased in Saos-2 cells when Osterix was overexpressed. Mutagenesis study demonstrated that this suppression is mediated by the Sp1 sites. The binding specificity of Osterix to these Sp1 sites was confirmed in Saos-2 cells and primary human osteoblasts by EMSA in vitro and ChIP assay in vivo. ChIP assay also showed that Osterix downregulated NELL-1 by affecting binding of RNA polymerase II to the NELL-1 promoter, but not by competing with Runx2 binding to the OSE2 sites. Moreover, NELL-1 mRNA levels were significantly decreased when Osterix was overexpressed in Saos-2, U2OS, Hela and Glioma cells. Correspondingly, knockdown of Osterix increased NELL-1 transcription and osteoblastic differentiation in both Saos-2 cells and primary human osteoblasts. These results suggest that Osterix is a direct transcriptional regulator with repressive effect on NELL-1 gene expression, contributing to a delicate balance of regulatory effects on NELL-1 transcription with Runx2, and may play a crucial role in osteoblast differentiation and mineralization. These findings also extend our understanding of the molecular mechanism of Runx2, Osterix, and NELL-1 and demonstrate their crosstalk during osteogenesis.	[Chen, Feng; Zhang, Xinli; Zou, Xuan; Ting, Kang] Univ Calif Los Angeles, Dent & Craniofacial Res Inst, Los Angeles, CA 90024 USA; [Zara, Janette N.] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA USA; [Sun, Shan; Chiu, Robert; Ting, Kang] Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90024 USA; [Culiat, Cymbelin T.] Oak Ridge Natl Lab, Oak Ridge, TN USA; [Soo, Chia] Univ Calif Los Angeles, Orthopaed Hosp, Dept Orthopaed Surg, Los Angeles, CA USA; [Soo, Chia] Univ Calif Los Angeles, Orthopaed Hosp Res Ctr, Los Angeles, CA USA; [Chen, Feng] Peking Univ, Sch & Hosp Stomatol, Beijing 100871, Peoples R China	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Peking University	Chen, F (corresponding author), Univ Calif Los Angeles, Dent & Craniofacial Res Inst, Los Angeles, CA 90024 USA.	bsoo@ucla.edu	Zou, Xuan/A-6452-2015	CULIAT, CYMBELINE/0000-0003-1644-7168	NIH/NIDCR [R21 DE0177711, RO1 DE01607]; UC [07-10677]; Thomas R. Bales Endowed Chair	NIH/NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); UC; Thomas R. Bales Endowed Chair	This work was supported by the NIH/NIDCR (grants R21 DE0177711 and RO1 DE01607), UC Discovery Grant 07-10677 and the Thomas R. Bales Endowed Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghaloo T, 2006, AM J PATHOL, V169, P903, DOI 10.2353/ajpath.2006.051210; Cao Y, 2008, MOL CANCER RES, V6, P119, DOI 10.1158/1541-7786.MCR-07-0090; Cook T, 1999, ANN NY ACAD SCI, V880, P94, DOI 10.1111/j.1749-6632.1999.tb09513.x; Cowan CM, 2006, BONE, V38, P48, DOI 10.1016/j.bone.2005.06.023; Deng ZL, 2008, FRONT BIOSCI-LANDMRK, V13, P2001, DOI 10.2741/2819; Desai J, 2006, HUM MOL GENET, V15, P1329, DOI 10.1093/hmg/ddl053; Goto T, 2006, J BONE MINER RES, V21, P661, DOI 10.1359/JBMR.020605; Kaback LA, 2008, J CELL PHYSIOL, V214, P173, DOI 10.1002/jcp.21176; Karsenty G, 2008, ANNU REV GENOM HUM G, V9, P183, DOI 10.1146/annurev.genom.9.081307.164437; Koga T, 2005, NAT MED, V11, P880, DOI 10.1038/nm1270; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Komori T, 2006, J CELL BIOCHEM, V99, P1233, DOI 10.1002/jcb.20958; Lemon B, 2000, GENE DEV, V14, P2551, DOI 10.1101/gad.831000; MATSUHASHI S, 1995, DEV DYNAM, V203, P212, DOI 10.1002/aja.1002030209; MCQUILLAN DJ, 1995, BONE, V16, P415; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Nakashima K, 2003, TRENDS GENET, V19, P458, DOI 10.1016/S0168-9525(03)00176-8; Nishio Y, 2006, GENE, V372, P62, DOI 10.1016/j.gene.2005.12.022; Rao LG, 2003, BIOL PHARM BULL, V26, P936, DOI 10.1248/bpb.26.936; Sinha KM, 2010, EMBO J, V29, P68, DOI 10.1038/emboj.2009.332; Ting K, 1999, J BONE MINER RES, V14, P80, DOI 10.1359/jbmr.1999.14.1.80; Truong T, 2007, J BONE MINER RES, V22, P7, DOI 10.1359/JBMR.061012; Ulsamer A, 2008, J BIOL CHEM, V283, P3816, DOI 10.1074/jbc.M704724200; Watanabe TK, 1996, GENOMICS, V38, P273, DOI 10.1006/geno.1996.0628; Zhang C, 2008, P NATL ACAD SCI USA, V105, P6936, DOI 10.1073/pnas.0710831105; Zhang X, 2008, J BONE MINER RES, V23, pS99; Zhang XL, 2011, J BONE MINER RES, V26, P777, DOI 10.1002/jbmr.267; Zhang XL, 2002, J CLIN INVEST, V110, P861, DOI 10.1172/JCI200215375	28	21	24	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2011	6	9							e24638	10.1371/journal.pone.0024638	http://dx.doi.org/10.1371/journal.pone.0024638			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZV	21931789	Green Submitted, Green Published, gold			2022-12-25	WOS:000295321800041
J	Li, L; Li, H; Li, Q; Yang, XH; Zheng, DB; Warburton, M; Chai, YC; Zhang, P; Guo, YQ; Yan, JB; Li, JS				Li, Lin; Li, Hui; Li, Qing; Yang, Xiaohong; Zheng, Debo; Warburton, Marilyn; Chai, Yuchao; Zhang, Pan; Guo, Yuqiu; Yan, Jianbing; Li, Jiansheng			An 11-bp Insertion in Zea mays fatb Reduces the Palmitic Acid Content of Fatty Acids in Maize Grain	PLOS ONE			English	Article							ACYL-ACP THIOESTERASE; OIL CONCENTRATION; SUBSTRATE-SPECIFICITY; GENETIC-VARIATION; INBRED LINES; EXPRESSION; SELECTION; ORIGIN; MODEL; POLYMORPHISMS	The ratio of saturated to unsaturated fatty acids in maize kernels strongly impacts human and livestock health, but is a complex trait that is difficult to select based on phenotype. Map-based cloning of quantitative trait loci (QTL) is a powerful but time-consuming method for the dissection of complex traits. Here, we combine linkage and association analyses to fine map QTL-Pal9, a QTL influencing levels of palmitic acid, an important class of saturated fatty acid. QTL-Pal9 was mapped to a 90-kb region, in which we identified a candidate gene, Zea mays fatb (Zmfatb), which encodes acyl-ACP thioesterase. An 11-bp insertion in the last exon of Zmfatb decreases palmitic acid content and concentration, leading to an optimization of the ratio of saturated to unsaturated fatty acids while having no effect on total oil content. We used three-dimensional structure analysis to explain the functional mechanism of the ZmFATB protein and confirmed the proposed model in vitro and in vivo. We measured the genetic effect of the functional site in 15 different genetic backgrounds and found a maximum change of 4.57 mg/g palmitic acid content, which accounts for similar to 20-60% of the variation in the ratio of saturated to unsaturated fatty acids. A PCR-based marker for QTL-Pal9 was developed for marker-assisted selection of nutritionally healthier maize lines. The method presented here provides a new, efficient way to clone QTL, and the cloned palmitic acid QTL sheds lights on the genetic mechanism of oil biosynthesis and targeted maize molecular breeding.	[Li, Lin; Li, Hui; Li, Qing; Yang, Xiaohong; Zheng, Debo; Chai, Yuchao; Zhang, Pan; Guo, Yuqiu; Yan, Jianbing; Li, Jiansheng] China Agr Univ, Natl Maize Improvement Ctr China, Beijing 100094, Peoples R China; [Warburton, Marilyn] ARS, Corn Host Plant Resistance Res Unit, USDA, Starkville, MS USA; [Yan, Jianbing] Int Maize & Wheat Improvement Ctr, Genet Resources Program, Mexico City, DF, Mexico	China Agricultural University; United States Department of Agriculture (USDA); CGIAR; International Maize & Wheat Improvement Center (CIMMYT)	Li, L (corresponding author), China Agr Univ, Natl Maize Improvement Ctr China, Beijing 100094, Peoples R China.	yjianbing@gmail.com; lijiansheng@cau.edu.cn	, 李会/AAO-7674-2020; Warburton, Marilyn/J-2250-2017	Warburton, Marilyn/0000-0002-9542-9912	National Natural Science Foundation of China; National Hi-Tech Research and Development Program of China; Genetically Modified Varieties Breeding Science and Technology Projects of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); Genetically Modified Varieties Breeding Science and Technology Projects of China	This research was supported by the National Natural Science Foundation of China, the National Hi-Tech Research and Development Program of China and the Genetically Modified Varieties Breeding Science and Technology Projects of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bonaventure G, 2003, PLANT CELL, V15, P1020, DOI 10.1105/tpc.008946; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Buckler ES, 2006, CURR OPIN PLANT BIOL, V9, P172, DOI 10.1016/j.pbi.2006.01.013; Buhr T, 2002, PLANT J, V30, P155, DOI 10.1046/j.1365-313X.2002.01283.x; Burlingame B, 2009, ANN NUTR METAB, V55, P5, DOI 10.1159/000228993; Dani KGS, 2011, PLANT BIOLOGY, V13, P453, DOI 10.1111/j.1438-8677.2010.00410.x; Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0; DOEBLEY J, 1995, GENETICS, V141, P333; Dooner HK, 2008, PLANT CELL, V20, P249, DOI 10.1105/tpc.107.057596; Dormann P, 2000, PLANT PHYSIOL, V123, P637, DOI 10.1104/pp.123.2.637; Dudley J. W., 2004, Plant Breeding Reviews, V24, P79; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Esch E, 2007, GENETICS, V177, P1851, DOI 10.1534/genetics.107.080622; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fu Y, 2010, PLANT J, V62, P898, DOI 10.1111/j.1365-313X.2010.04196.x; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Harjes CE, 2008, SCIENCE, V319, P330, DOI 10.1126/science.1150255; Hill WG, 2005, SCIENCE, V307, P683, DOI 10.1126/science.1105459; Jha JK, 2006, PLANT PHYSIOL BIOCH, V44, P645, DOI 10.1016/j.plaphy.2006.09.017; JONES A, 1995, PLANT CELL, V7, P359, DOI 10.1105/tpc.7.3.359; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Laurie CC, 2004, GENETICS, V168, P2141, DOI 10.1534/genetics.104.029686; Li L, 2010, SCI CHINA LIFE SCI, V53, P690, DOI 10.1007/s11427-010-4007-3; Liu ZJ, 2009, MOL BIOL REP, V36, P813, DOI 10.1007/s11033-008-9250-3; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mayer KM, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-1; Mayer KM, 2005, J BIOL CHEM, V280, P3621, DOI 10.1074/jbc.M411351200; Moose SP, 2004, TRENDS PLANT SCI, V9, P358, DOI 10.1016/j.tplants.2004.05.005; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Pathak MK, 2004, PLANT SCI, V166, P191, DOI 10.1016/j.plantsci.2003.09.005; Remington DL, 2001, P NATL ACAD SCI USA, V98, P11479, DOI 10.1073/pnas.201394398; Rosegrant M. W., 2001, Global food projections to 2020: emerging trends and alternative futures; Salas JJ, 2002, ARCH BIOCHEM BIOPHYS, V403, P25, DOI 10.1016/S0003-9861(02)00017-6; Salvi S, 2007, P NATL ACAD SCI USA, V104, P11376, DOI 10.1073/pnas.0704145104; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Schuster SC, 2008, NAT METHODS, V5, P16, DOI 10.1038/NMETH1156; Song TM, 2004, MAYDICA, V49, P9; Thornsberry JM, 2001, NAT GENET, V28, P286, DOI 10.1038/90135; TOPFER R, 1994, J PLANT PHYSIOL, V143, P416; VOELKER TA, 1992, SCIENCE, V257, P72, DOI 10.1126/science.1621095; Wang H, 2005, NATURE, V436, P714, DOI 10.1038/nature03863; Wilson RF, 2001, J AM OIL CHEM SOC, V78, P335, DOI 10.1007/s11746-001-0265-4; Yan JB, 2011, CROP SCI, V51, P433, DOI 10.2135/cropsci2010.04.0233; Yan JB, 2010, NAT GENET, V42, P322, DOI 10.1038/ng.551; Yan JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008451; Yang XH, 2011, MOL BREEDING, V28, P511, DOI 10.1007/s11032-010-9500-7; Yang XH, 2010, THEOR APPL GENET, V121, P417, DOI 10.1007/s00122-010-1320-y; Yang XH, 2010, THEOR APPL GENET, V120, P665, DOI 10.1007/s00122-009-1184-1; Yu JM, 2009, PLANT GENOME-US, V2, P63, DOI 10.3835/plantgenome2008.09.0009; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zheng P, 2008, NAT GENET, V40, P367, DOI 10.1038/ng.85	55	29	29	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2011	6	9							e24699	10.1371/journal.pone.0024699	http://dx.doi.org/10.1371/journal.pone.0024699			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZV	21931818	Green Submitted, Green Published, gold			2022-12-25	WOS:000295321800050
J	Paszcuk, AF; Dutra, RC; da Silva, KABS; Quintao, NLM; Campos, MM; Calixto, JB				Paszcuk, Ana F.; Dutra, Rafael C.; da Silva, Kathryn A. B. S.; Quintao, Nara L. M.; Campos, Maria M.; Calixto, Joao B.			Cannabinoid Agonists Inhibit Neuropathic Pain Induced by Brachial Plexus Avulsion in Mice by Affecting Glial Cells and MAP Kinases	PLOS ONE			English	Article							PERIPHERAL-NERVE INJURY; SPINAL-CORD-INJURY; ANTISENSE OLIGONUCLEOTIDES; MECHANICAL ALLODYNIA; CB2 RECEPTOR; DORSAL-HORN; KAPPA-B; RATS; HYPERSENSITIVITY; ACTIVATION	Background: Many studies have shown the antinociceptive effects of cannabinoid (CB) agonists in different models of pain. Herein, we have investigated their relevance in neuropathic pain induced by brachial plexus avulsion (BPA) in mice. Methodology/Principal Findings: Mice underwent BPA or sham surgery. The mRNA levels and protein expression of CB(1) and CB(2) receptors were assessed by RT-PCR and immunohistochemistry, respectively. The activation of glial cells, MAP kinases and transcription factors were evaluated by immunohistochemistry. The antinociceptive properties induced by cannabinoid agonists were assessed on the 5(th) and 30(th) days after surgery. We observed a marked increase in CB(1) and CB(2) receptor mRNA and protein expression in the spinal cord and dorsal root ganglion, either at the 5(th) or 30(th) day after surgery. BPA also induced a marked activation of p38 and JNK MAP kinases (on the 30(th) day), glial cells, such as microglia and astrocytes, and the transcription factors CREB and NF-kappa B (at the 5(th) and 30(th) days) in the spinal cord. Systemic treatment with cannabinoid agonists reduced mechanical allodynia on both the 5(th) and 30(th) days after surgery, but the greatest results were observed by using central routes of administration, especially at the 30(th) day. Treatment with WIN 55,212-2 prevented the activation of both glial cells and MAP kinases, associated with an enhancement of CREB and NF-kB activation. Conclusions/Significance: Our results indicate a relevant role for cannabinoid agonists in BPA, reinforcing their potential therapeutic relevance for the management of chronic pain states.	[Paszcuk, Ana F.; Dutra, Rafael C.; da Silva, Kathryn A. B. S.; Calixto, Joao B.] Univ Fed Santa Catarina, Dept Pharmacol, Ctr Biol Sci, Florianopolis, SC, Brazil; [Quintao, Nara L. M.] Univ Vale Itajai, Programa Mestrado Ciencias Farmaceut, Itajai, Brazil; [Campos, Maria M.] Pontificia Univ Catolica Rio de Janeiro, Sch Dent, Porto Alegre, RS, Brazil; [Campos, Maria M.] Pontificia Univ Catolica Rio de Janeiro, Inst Toxicol, Porto Alegre, RS, Brazil	Universidade Federal de Santa Catarina (UFSC); Universidade do Vale do Itajai	Paszcuk, AF (corresponding author), Univ Fed Santa Catarina, Dept Pharmacol, Ctr Biol Sci, Florianopolis, SC, Brazil.	calixto@farmaco.ufsc.br	Quintão, Nara NL/G-1472-2012; Campos, Maria Martha M/J-8829-2015; Dutra, Rafael C/F-8452-2012	Quintão, Nara NL/0000-0001-8305-9339; Campos, Maria Martha M/0000-0002-1153-3633; Dutra, Rafael C/0000-0002-6938-2161; calixto, joao Batista/0000-0003-4041-7153; Campos, Maria/0000-0001-7738-9892	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Apoio a Pesquisa Cientifica e Tecnologica do Estado de Santa Catarina; Programa de Apoio aos Nucleos de Excelencia	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Apoio a Pesquisa Cientifica e Tecnologica do Estado de Santa Catarina; Programa de Apoio aos Nucleos de Excelencia	This work was supported by a grant from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); the Fundacao de Apoio a Pesquisa Cientifica e Tecnologica do Estado de Santa Catarina; and the Programa de Apoio aos Nucleos de Excelencia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal N, 2007, NAT NEUROSCI, V10, P870, DOI 10.1038/nn1916; Amaya F, 2006, PAIN, V124, P175, DOI 10.1016/j.pain.2006.04.001; Bahremand A, 2008, EPILEPSY RES, V81, P44, DOI 10.1016/j.eplepsyres.2008.04.010; Bromberg KD, 2008, SCIENCE, V320, P903, DOI 10.1126/science.1152662; Chang YW, 2010, J PAIN, V11, P1146, DOI 10.1016/j.jpain.2010.02.010; Dogrul A, 2004, NEUROSCI LETT, V368, P82, DOI 10.1016/j.neulet.2004.06.060; Dogrul A, 2002, PAIN, V100, P203, DOI 10.1016/S0304-3959(02)00302-0; Dray A, 2008, BRIT J ANAESTH, V101, P48, DOI 10.1093/bja/aen107; Eder P S, 1991, Antisense Res Dev, V1, P141; Fernandez-Ruiz J, 2008, MOL CELL ENDOCRINOL, V286, pS91, DOI 10.1016/j.mce.2008.01.001; Garcia-Ovejero D, 2009, NEUROBIOL DIS, V33, P57, DOI 10.1016/j.nbd.2008.09.015; Gutierrez H, 2008, J NEUROSCI, V28, P8246, DOI 10.1523/JNEUROSCI.1941-08.2008; Hama A, 2007, EXP NEUROL, V204, P454, DOI 10.1016/j.expneurol.2006.09.002; Hegyi Z, 2009, EUR J NEUROSCI, V30, P251, DOI 10.1111/j.1460-9568.2009.06816.x; Howlett AC, 2005, HANDB EXP PHARMACOL, V168, P53; Hsieh GC, 2011, BRIT J PHARMACOL, V162, P428, DOI 10.1111/j.1476-5381.2010.01046.x; HYLDEN JLK, 1980, EUR J PHARMACOL, V67, P313, DOI 10.1016/0014-2999(80)90515-4; Kanaya S, 1995, Subcell Biochem, V24, P377; Kurreck J, 2004, CURR OPIN DRUG DISC, V7, P179; LAURSEN SE, 1986, J PHARMACOL METHOD, V16, P355, DOI 10.1016/0160-5402(86)90038-0; Lim G, 2003, PAIN, V105, P275, DOI 10.1016/S0304-3959(03)00242-2; Loeser JD, 2008, PAIN, V137, P473, DOI 10.1016/j.pain.2008.04.025; Ma WY, 2001, PAIN, V93, P295, DOI 10.1016/S0304-3959(01)00335-9; Milligan ED, 2009, NAT REV NEUROSCI, V10, P23, DOI 10.1038/nrn2533; Myers KJ, 2000, TRENDS PHARMACOL SCI, V21, P19, DOI 10.1016/S0165-6147(99)01420-0; Potenzieri C, 2008, J NEUROPHYSIOL, V100, P2794, DOI 10.1152/jn.90809.2008; Qin ZH, 2007, ACTA PHARMACOL SIN, V28, P1859, DOI 10.1111/j.1745-7254.2007.00741.x; Quintao NLM, 2008, J NEUROSCI, V28, P2856, DOI 10.1523/JNEUROSCI.4389-07.2008; Quintao NLM, 2008, PAIN, V136, P125, DOI 10.1016/j.pain.2007.06.027; Rahn EJ, 2009, NEUROTHERAPEUTICS, V6, P713, DOI 10.1016/j.nurt.2009.08.002; Richardson JD, 1998, J NEUROSCI, V18, P451; Romero-Sandoval A, 2008, ANESTHESIOLOGY, V108, P722, DOI 10.1097/ALN.0b013e318167af74; Sanson M, 2006, NEUROGASTROENT MOTIL, V18, P949, DOI 10.1111/j.1365-2982.2006.00819.x; Sheng WS, 2005, GLIA, V49, P211, DOI 10.1002/glia.20108; Songcharoen P, 2008, SCAND J SURG, V97, P317, DOI 10.1177/145749690809700408; Stella N, 2010, GLIA, V58, P1017, DOI 10.1002/glia.20983; Stone LS, 2003, ADV DRUG DELIVER REV, V55, P1081, DOI 10.1016/S0169-409X(03)00105-4; Tsuda M, 2004, GLIA, V45, P89, DOI 10.1002/glia.10308; WALDER RY, 1988, P NATL ACAD SCI USA, V85, P5011, DOI 10.1073/pnas.85.14.5011; Wen AY, 2010, J IMMUNOL, V185, P6413, DOI 10.4049/jimmunol.1001829; Yamamoto W, 2008, EUR J PHARMACOL, V583, P56, DOI 10.1016/j.ejphar.2008.01.010; Yoon MH, 2003, ANESTHESIOLOGY, V99, P701, DOI 10.1097/00000542-200309000-00027; Zhuang ZY, 2006, J NEUROSCI, V26, P3551, DOI 10.1523/JNEUROSCI.5290-05.2006; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4; Zorina Y, 2010, J BIOL CHEM, V285, P1358, DOI 10.1074/jbc.M109.049841	45	45	48	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2011	6	9							e24034	10.1371/journal.pone.0024034	http://dx.doi.org/10.1371/journal.pone.0024034			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZV	21931637	gold, Green Published, Green Submitted			2022-12-25	WOS:000295321800014
J	Rajith, B; Doss, CGP				Rajith, B.; Doss, George Priya C.			Path to Facilitate the Prediction of Functional Amino Acid Substitutions in Red Blood Cell Disorders - A Computational Approach	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; PYRUVATE-KINASE-DEFICIENCY; NON-SYNONYMOUS SNPS; POINT MUTATIONS; MOLECULAR-BASIS; RNA-BINDING; GENE; PROTEIN; VARIANTS; REGIONS	Background: A major area of effort in current genomics is to distinguish mutations that are functionally neutral from those that contribute to disease. Single Nucleotide Polymorphisms (SNPs) are amino acid substitutions that currently account for approximately half of the known gene lesions responsible for human inherited diseases. As a result, the prediction of non-synonymous SNPs (nsSNPs) that affect protein functions and relate to disease is an important task. Principal Findings: In this study, we performed a comprehensive analysis of deleterious SNPs at both functional and structural level in the respective genes associated with red blood cell metabolism disorders using bioinformatics tools. We analyzed the variants in Glucose-6-phosphate dehydrogenase (G6PD) and isoforms of Pyruvate Kinase (PKLR & PKM2) genes responsible for major red blood cell disorders. Deleterious nsSNPs were categorized based on empirical rule and support vector machine based methods to predict the impact on protein functions. Furthermore, we modeled mutant proteins and compared them with the native protein for evaluation of protein structure stability. Significance: We argue here that bioinformatics tools can play an important role in addressing the complexity of the underlying genetic basis of Red Blood Cell disorders. Based on our investigation, we report here the potential candidate SNPs, for future studies in human Red Blood Cell disorders. Current study also demonstrates the presence of other deleterious mutations and also endorses with in vivo experimental studies. Our approach will present the application of computational tools in understanding functional variation from the perspective of structure, expression, evolution and phenotype.	[Rajith, B.; Doss, George Priya C.] Vellore Inst Technol Univ, Sch Biosci & Technol, Med Biotechnol Div, Ctr Nanobiotechnol, Vellore, Tamil Nadu, India	Vellore Institute of Technology	Rajith, B (corresponding author), Vellore Inst Technol Univ, Sch Biosci & Technol, Med Biotechnol Div, Ctr Nanobiotechnol, Vellore, Tamil Nadu, India.	georgepriyadoss@vit.ac.in	C, George/ABE-4676-2021; Alizadeh/AAK-1398-2021	C, George Priya Doss/0000-0002-5971-8290				Amberger J, 2009, NUCLEIC ACIDS RES, V37, pD793, DOI 10.1093/nar/gkn665; Arbiza L, 2006, J MOL BIOL, V358, P1390, DOI 10.1016/j.jmb.2006.02.067; Avni D, 1997, NUCLEIC ACIDS RES, V25, P995, DOI 10.1093/nar/25.5.995; Bairoch A, 1996, NUCLEIC ACIDS RES, V24, P21, DOI 10.1093/nar/24.1.21; BALINSKY D, 1973, BIOCHEMISTRY-US, V12, P863, DOI 10.1021/bi00729a013; BARONCIANI L, 1993, P NATL ACAD SCI USA, V90, P4324, DOI 10.1073/pnas.90.9.4324; Bava KA, 2004, NUCLEIC ACIDS RES, V32, pD120, DOI 10.1093/nar/gkh082; Beutler E, 1997, HUM MUTAT, V9, P282, DOI 10.1002/(SICI)1098-1004(1997)9:3<282::AID-HUMU13>3.0.CO;2-Z; BEUTLER E, 1994, BLOOD, V84, P3613, DOI 10.1182/blood.V84.11.3613.bloodjournal84113613; Beutler E, 2002, BLOOD CELL MOL DIS, V28, P93, DOI 10.1006/bcmd.2002.0490; Bromberg Y, 2007, NUCLEIC ACIDS RES, V35, P3823, DOI 10.1093/nar/gkm238; Brooks-Wilson AR, 2004, J MED GENET, V41, P508, DOI 10.1136/jmg.2004.018275; Burke DF, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-301; Capriotti E, 2005, NUCLEIC ACIDS RES, V33, pW306, DOI 10.1093/nar/gki375; Capriotti E, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S4-S3; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Chang TC, 2004, GENE DEV, V18, P2010, DOI 10.1101/gad.1219104; Chasman D, 2001, J MOL BIOL, V307, P683, DOI 10.1006/jmbi.2001.4510; Chen JJ, 2009, CURR PROTEOMICS, V6, P228, DOI 10.2174/157016409789973734; Cohen-Solal M, 1998, BRIT J HAEMATOL, V103, P950, DOI 10.1046/j.1365-2141.1998.01094.x; Conde L, 2006, NUCLEIC ACIDS RES, V34, pW621, DOI 10.1093/nar/gkl071; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Delarue M, 2004, P NATL ACAD SCI USA, V101, P6957, DOI 10.1073/pnas.0400301101; Doss CGP, 2008, FUNCT INTEGR GENOMIC, V8, P309, DOI 10.1007/s10142-008-0086-7; Doss CGP, 2009, ADV SCI LETT, V2, P364, DOI 10.1166/asl.2009.1066; Doss CGP, 2009, NEW BIOTECHNOL, V25, P214, DOI 10.1016/j.nbt.2009.01.004; Doss CGP, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-42; FOTHERGILLGILMORE LA, 1993, PROG BIOPHYS MOL BIO, V59, P105, DOI 10.1016/0079-6107(93)90001-Z; Frederic MY, 2009, HUM MUTAT, V30, P952, DOI 10.1002/humu.20970; FUJII H, 1998, CLIN CHEM, V33, P1; George Priya Doss C, 2008, Genomic Med, V2, P23, DOI 10.1007/s11568-008-9019-8; Gerhard DS, 2004, GENOME RES, V14, P2121, DOI 10.1101/gr.2596504; Good P, 1998, GENOMICS, V52, P382, DOI 10.1006/geno.1998.5456; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Grillo G, 2010, NUCLEIC ACIDS RES, V38, pD75, DOI 10.1093/nar/gkp902; Han JH, 2006, STRUCTURE, V14, P935, DOI 10.1016/j.str.2006.01.016; Hernan D., 2008, ENCY LIFE SCI, DOI [10.1002/9780470015902.a002076, DOI 10.1002/9780470015902.A002076]; Hurst JM, 2009, HUM MUTAT, V30, P616, DOI 10.1002/humu.20898; Jamshidi N, 2002, GENOME RES, V12, P1687, DOI 10.1101/gr.329302; KAEDA JS, 1995, AM J HUM GENET, V57, P1335; Kanetsky PA, 2004, CANCER EPIDEM BIOMAR, V13, P808; KANNO H, 1992, BLOOD, V79, P1347, DOI 10.1182/blood.V79.5.1347.bloodjournal7951347; KANNO H, 1994, BLOOD, V83, P2311; Karchin R, 2005, BIOINFORMATICS, V21, P2814, DOI 10.1093/bioinformatics/bti442; Kimura MA, 1985, NEUTRAL THEORY MOL E; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lee JE, 2005, MUTAT RES-FUND MOL M, V573, P195, DOI 10.1016/j.mrfmmm.2004.08.018; Lindahl E, 2006, NUCLEIC ACIDS RES, V34, pW52, DOI 10.1093/nar/gkl082; Lo KS, 2011, HUM GENET, V129, P307, DOI 10.1007/s00439-010-0925-1; Magyar C, 2005, NUCLEIC ACIDS RES, V33, pW303, DOI 10.1093/nar/gki409; Mi HY, 2007, NUCLEIC ACIDS RES, V35, pD247, DOI 10.1093/nar/gkl869; NAFA K, 1993, HUM MOL GENET, V2, P81, DOI 10.1093/hmg/2.1.81; NEUBAUER B, 1991, BLOOD, V77, P1871; Ng PC, 2002, GENOME RES, V12, P436, DOI 10.1101/gr.212802; Okano H, 2002, J CELL SCI, V115, P1355; Palmer JS, 2000, AM J HUM GENET, V66, P176, DOI 10.1086/302711; Pastore L, 1998, HUM MUTAT, V11, P127, DOI 10.1002/(SICI)1098-1004(1998)11:2<127::AID-HUMU5>3.3.CO;2-P; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Reumers J, 2006, BIOINFORMATICS, V22, P2183, DOI 10.1093/bioinformatics/btl348; ROVIRA A, 1994, HUM MOL GENET, V3, P833; SAMUELS ME, 1994, MOL CELL BIOL, V14, P4975, DOI 10.1128/MCB.14.7.4975; SATOH H, 1988, CYTOGENET CELL GENET, V47, P132, DOI 10.1159/000132530; Savas S, 2004, CANCER EPIDEM BIOMAR, V13, P801; Sayers EW, 2011, NUCLEIC ACIDS RES, V39, pD38, DOI 10.1093/nar/gkq1172; SCHNEIDER TD, 1986, J MOL BIOL, V188, P415, DOI 10.1016/0022-2836(86)90165-8; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; TANI K, 1988, GENE, V73, P509; Taylor KH, 2006, MAMM GENOME, V17, P892, DOI 10.1007/s00335-005-0148-2; Valentini G, 2002, J BIOL CHEM, V277, P23807, DOI 10.1074/jbc.M202107200; Varfolomeev SD, 2002, BIOCHEMISTRY-MOSCOW+, V67, P1099, DOI 10.1023/A:1020907122341; VULLIAMY TJ, 1988, P NATL ACAD SCI USA, V85, P5171, DOI 10.1073/pnas.85.14.5171; Walczak R, 1996, RNA, V2, P367; Wang PL, 2006, BIOINFORMATICS, V22, pE523, DOI 10.1093/bioinformatics/btl241; Wang Z, 2001, HUM MUTAT, V17, P263, DOI 10.1002/humu.22; Xi T, 2004, GENOMICS, V83, P970, DOI 10.1016/j.ygeno.2003.12.016; Yuan HY, 2006, NUCLEIC ACIDS RES, V34, pW635, DOI 10.1093/nar/gkl236; Yue P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-166; Zhang EY, 2004, J PHARMACOL EXP THER, V310, P437, DOI 10.1124/jpet.104.065912; Zhu Y, 2004, CANCER RES, V64, P2251, DOI 10.1158/0008-5472.CAN-03-2800; Zhu Y, 2008, MUTAT RES-FUND MOL M, V639, P80, DOI 10.1016/j.mrfmmm.2007.11.005	80	28	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2011	6	9							e24607	10.1371/journal.pone.0024607	http://dx.doi.org/10.1371/journal.pone.0024607			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZV	21931771	Green Published, gold			2022-12-25	WOS:000295321800037
J	Wang, Y; Lu, JJ; He, L; Yu, Q				Wang, Ying; Lu, Jin-jian; He, Li; Yu, Qiang			Triptolide (TPL) Inhibits Global Transcription by Inducing Proteasome-Dependent Degradation of RNA Polymerase II (Pol II)	PLOS ONE			English	Article							CARBOXYL-TERMINAL DOMAIN; KAPPA-B ACTIVATION; COUPLED DNA-REPAIR; CELL-DEATH; INDUCED UBIQUITINATION; LARGE SUBUNIT; COMET ASSAY; IN-VITRO; PHOSPHORYLATION; ELONGATION	Triptolide (TPL), a key biologically active component of the Chinese medicinal herb Tripterygium wilfordii Hook. f., has potent anti-inflammation and anti-cancer activities. Its anti-proliferative and pro-apoptotic effects have been reported to be related to the inhibition of Nuclear Factor kappa B (NF-kappa B) and Nuclear Factor of Activated T-cells (NFAT) mediated transcription and suppression of HSP70 expression. The direct targets and precise mechanisms that are responsible for the gene expression inhibition, however, remain unknown. Here, we report that TPL inhibits global gene transcription by inducing proteasome-dependent degradation of the largest subunit of RNA polymerase II (Rpb1) in cancer cells. In the presence of proteosome inhibitor MG132, TPL treatment causes hyperphosphorylation of Rpb1 by activation of upstream protein kinases such as Positive Transcription Elongation Factor b (P-TEFb) in a time and dose dependent manner. Also, we observe that short time incubation of TPL with cancer cells induces DNA damage. In conclusion, we propose a new mechanism of how TPL works in killing cancer. TPL inhibits global transcription in cancer cells by induction of phosphorylation and subsequent proteasome dependent degradation of Rpb1 resulting in global gene transcription, which may explain the high potency of TPL in killing cancer.	[Wang, Ying; Lu, Jin-jian; He, Li; Yu, Qiang] Chinese Acad Sci, Shanghai Inst Mat Med, Dept Pharmacol, Shanghai 200031, Peoples R China; [Lu, Jin-jian] Zhejiang Chinese Med Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Zhejiang Chinese Medical University	Wang, Y (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Dept Pharmacol, Shanghai 200031, Peoples R China.	qyu@sibs.ac.cn	Lu, Jinjian/X-2083-2019; Lu, Jinjian/R-6207-2019	Lu, Jinjian/0000-0001-6703-3120; 	China National Natural Science Foundation [31129004, 31000619]; National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program" China [2009ZX09301-001, 2009ZX09103-064]; Shanghai Science and Technology Research grants [08DZ1971403, 09JC1416700]	China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program" China; Shanghai Science and Technology Research grants	This work was supported by the China National Natural Science Foundation, grant 31129004 and 31000619; the National Science & Technology Major Project "Key New Drug Creation and Manufacturing Program" China (numbers 2009ZX09301-001 and 2009ZX09103-064); and the Shanghai Science and Technology Research grants 08DZ1971403 and 09JC1416700. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao XF, 2007, J MOL MED, V85, P85, DOI 10.1007/s00109-006-0113-x; Bregman DB, 1996, P NATL ACAD SCI USA, V93, P11586, DOI 10.1073/pnas.93.21.11586; Carter BZ, 2006, BLOOD, V108, P630, DOI 10.1182/blood-2005-09-3898; Choi YJ, 2003, BIOCHEM PHARMACOL, V66, P273, DOI 10.1016/S0006-2952(03)00282-X; CHRISTIANS FC, 1992, MUTAT RES, V274, P93, DOI 10.1016/0921-8777(92)90056-9; Corson TW, 2007, CELL, V130, P769, DOI 10.1016/j.cell.2007.08.021; DUBOIS MF, 1994, J BIOL CHEM, V269, P13331; Efferth T, 2007, TRENDS MOL MED, V13, P353, DOI 10.1016/j.molmed.2007.07.001; Fidler JM, 2003, MOL CANCER THER, V2, P855; Hartley JA, 1999, BRIT J CANCER, V79, P264, DOI 10.1038/sj.bjc.6690043; Huang M, 2007, CLIN CANCER RES, V13, P1298, DOI 10.1158/1078-0432.CCR-06-1277; Inukai N, 2004, J BIOL CHEM, V279, P8190, DOI 10.1074/jbc.M311412200; Jiang XH, 2001, ONCOGENE, V20, P8009, DOI 10.1038/sj.onc.1204981; Jung Y, 2006, J BIOL CHEM, V281, P1361, DOI 10.1074/jbc.M509688200; KANG ME, 1993, J BIOL CHEM, V268, P25033; Kiviharju TM, 2002, CLIN CANCER RES, V8, P2666; Kobor MS, 2002, BBA-GENE STRUCT EXPR, V1577, P261, DOI 10.1016/S0167-4781(02)00457-8; Lee KB, 2002, P NATL ACAD SCI USA, V99, P4239, DOI 10.1073/pnas.072068399; Leuenroth SJ, 2005, CHEM BIOL, V12, P1259, DOI 10.1016/j.chembiol.2005.09.009; Leuenroth SJ, 2008, CANCER RES, V68, P5257, DOI 10.1158/0008-5472.CAN-07-6207; Marshall NF, 1996, J BIOL CHEM, V271, P27176, DOI 10.1074/jbc.271.43.27176; Matsui Y, 2008, ONCOGENE, V27, P4603, DOI 10.1038/onc.2008.89; McCallum C, 2007, IMMUNOBIOLOGY, V212, P549, DOI 10.1016/j.imbio.2007.02.002; Mitsui A, 1999, P NATL ACAD SCI USA, V96, P6054, DOI 10.1073/pnas.96.11.6054; Oelgeschlager T, 2002, J CELL PHYSIOL, V190, P160, DOI 10.1002/JCP.10058; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; OLIVE PL, 1990, RADIAT RES, V122, P86, DOI 10.2307/3577587; Peng J, 1998, COLD SPRING HARB SYM, V63, P365, DOI 10.1101/sqb.1998.63.365; Phillips PA, 2007, CANCER RES, V67, P9407, DOI 10.1158/0008-5472.CAN-07-1077; Qiu DM, 1999, J BIOL CHEM, V274, P13443, DOI 10.1074/jbc.274.19.13443; Radhakrishnan SK, 2006, CANCER RES, V66, P3264, DOI 10.1158/0008-5472.CAN-05-3940; Ratner JN, 1998, J BIOL CHEM, V273, P5184, DOI 10.1074/jbc.273.9.5184; Shilatifard A, 2003, ANNU REV BIOCHEM, V72, P693, DOI 10.1146/annurev.biochem.72.121801.161551; SOBELL HM, 1985, P NATL ACAD SCI USA, V82, P5328, DOI 10.1073/pnas.82.16.5328; Svejstrup JQ, 2002, NAT REV MOL CELL BIO, V3, P21, DOI 10.1038/nrm703; Vispe S, 2009, MOL CANCER THER, V8, P2780, DOI 10.1158/1535-7163.MCT-09-0549; Wang Y, 2009, CANCER RES, V69, P7302, DOI 10.1158/0008-5472.CAN-09-0462; Westerheide SD, 2006, J BIOL CHEM, V281, P9616, DOI 10.1074/jbc.M512044200; Wu YY, 2006, INT J MOL MED, V17, P141; Yang SM, 2003, MOL CANCER THER, V2, P65	40	45	49	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2011	6	9							e23993	10.1371/journal.pone.0023993	http://dx.doi.org/10.1371/journal.pone.0023993			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZV	21931633	Green Published, gold, Green Submitted			2022-12-25	WOS:000295321800011
J	Croix, JA; Carbonero, F; Nava, GM; Russell, M; Greenberg, E; Gaskins, HR				Croix, Jennifer A.; Carbonero, Franck; Nava, Gerardo M.; Russell, Mark; Greenberg, Eugene; Gaskins, H. Rex			On the Relationship between Sialomucin and Sulfomucin Expression and Hydrogenotrophic Microbes in the Human Colonic Mucosa	PLOS ONE			English	Article							SULFATE-REDUCING BACTERIA; ULCERATIVE-COLITIS; INTESTINAL MUCINS; DIVERSITY; SULFIDE; DIETS; IDENTIFICATION; POPULATIONS; SEQUENCE; HEALTHY	The colonic mucus layer is comprised primarily of acidomucins, which provide viscous properties and can be broadly classified into sialomucins or sulfomucins based on the presence of terminating sialic acid or sulfate groups. Differences in acidomucin chemotypes have been observed in diseases such as colorectal cancer and inflammatory bowel disease, and variation in sialo-and sulfomucin content may influence microbial colonization. For example, sulfate derived from sulfomucin degradation may promote the colonization of sulfate-reducing bacteria (SRB), which through sulfate respiration generate the genotoxic gas hydrogen sulfide. Here, paired biopsies from right colon, left colon, and rectum of 20 subjects undergoing routine screening colonoscopies were collected to enable parallel histochemical and microbiological studies. Goblet cell sialo-and sulfomucins in each biopsy were distinguished histochemically and quantified. Quantitative PCR and multivariate analyses were used to examine the abundance of hydrogenotrophic microbial groups and SRB genera relative to acidomucin profiles. Regional variation was observed in sialomucins and sulfomucins with the greatest abundance of each found in the rectum. Mucin composition did not appear to influence the abundance of SRB or other hydrogenotrophic microbiota but correlated with the composition of different SRB genera. A higher sulfomucin proportion correlated with higher quantities of Desulfobacter, Desulfobulbus and Desulfotomaculum, relative to the predominant Desulfovibrio genus. Thus, acidomucin composition may influence bacterial sulfate respiration in the human colon, which may in turn impact mucosal homeostasis. These results stress the need to consider mucus characteristics in the context of studies of the microbiome that target intestinal diseases.	[Croix, Jennifer A.; Nava, Gerardo M.; Gaskins, H. Rex] Univ Illinois, Div Nutr Sci, Urbana, IL 61801 USA; [Carbonero, Franck; Russell, Mark; Gaskins, H. Rex] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Greenberg, Eugene] Univ Illinois, Dept Internal Med, Urbana, IL 61801 USA; [Gaskins, H. Rex] Univ Illinois, Dept Pathobiol, Urbana, IL 61801 USA; [Gaskins, H. Rex] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Greenberg, Eugene] Carle Fdn Hosp, Inst Digest Hlth, Urbana, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Croix, JA (corresponding author), Univ Illinois, Div Nutr Sci, Urbana, IL 61801 USA.	hgaskins@illinois.edu	Carbonero, Franck/AAF-9523-2019; Carbonero, Franck/L-2292-2019; Nava, Gerardo M/J-9138-2015	Carbonero, Franck/0000-0003-3389-3725; Nava, Gerardo/0000-0003-4689-0419; Gaskins, H. Rex/0000-0002-1249-535X	Carle Foundation	Carle Foundation	This study was supported by a grant from the Carle Foundation awarded to Dr. Gaskins. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amerongen AVN, 1998, BIOL CHEM, V379, P1; Attene-Ramos MS, 2006, MOL CANCER RES, V4, P9, DOI 10.1158/1541-7786.MCR-05-0126; Byrd JC, 2004, CANCER METAST REV, V23, P77, DOI 10.1023/A:1025815113599; Conour JE, 2002, AM J PHYSIOL-GASTR L, V283, pG1185, DOI 10.1152/ajpgi.00097.2002; Corfield AP, 1999, GLYCOCONJUGATE J, V16, P307, DOI 10.1023/A:1007026314792; Daly K, 2000, MICROBIOL-UK, V146, P1693, DOI 10.1099/00221287-146-7-1693; DePlancke B, 2003, EXP BIOL MED, V228, P424, DOI 10.1177/153537020322800413; Deplancke B, 2001, AM J CLIN NUTR, V73, p1131S; Deplancke B, 2000, APPL ENVIRON MICROB, V66, P2166, DOI 10.1128/AEM.66.5.2166-2174.2000; FILIPE MI, 1979, INVEST CELL PATHOL, V2, P195; Fite A, 2004, GUT, V53, P523, DOI 10.1136/gut.2003.031245; Gagen EJ, 2010, APPL ENVIRON MICROB, V76, P7785, DOI 10.1128/AEM.01679-10; GIBSON GR, 1991, FEMS MICROBIOL ECOL, V86, P103, DOI 10.1111/j.1574-6968.1991.tb04799.x; Hales BA, 1996, APPL ENVIRON MICROB, V62, P668, DOI 10.1128/AEM.62.2.668-675.1996; Kuever J, 2005, BERGEYS MANUAL SYSTE, V2, P988; Leaphart AB, 2001, APPL ENVIRON MICROB, V67, P1392, DOI 10.1128/AEM.67.3.1392-1395.2001; Leloup J, 2007, ENVIRON MICROBIOL, V9, P131, DOI 10.1111/j.1462-2920.2006.01122.x; Levine J, 1998, AM J GASTROENTEROL, V93, P83, DOI 10.1111/j.1572-0241.1998.083_c.x; Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5; Loubinoux J, 2002, INT J SYST EVOL MICR, V52, P1305, DOI 10.1099/ijs.0.02175-0; MACFARLANE GT, 1992, J APPL BACTERIOL, V72, P57, DOI 10.1111/j.1365-2672.1992.tb05187.x; Matsuo K, 1997, GUT, V40, P782, DOI 10.1136/gut.40.6.782; Moncada D, 2002, INFECT GASTROINTEST, V1, P57; MORE J, 1987, HISTOCHEMISTRY, V87, P189, DOI 10.1007/BF00533405; Muyzer G, 2008, NAT REV MICROBIOL, V6, P441, DOI 10.1038/nrmicro1892; Nava GM, 2011, ISME J IN PRESS; Plugge CM, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00081; Rameshkumar Karuna, 1997, Indian Journal of Cancer, V34, P107; Robbe C, 2004, BIOCHEM J, V384, P307, DOI 10.1042/BJ20040605; Roediger WEW, 1997, DIGEST DIS SCI, V42, P1571, DOI 10.1023/A:1018851723920; RYAN P. D., 2001, PALAEONT ELEC, V4; SHARMA R, 1995, LAB INVEST, V73, P558; Sharma R, 1995, DIGEST DIS SCI, V40, P2532, DOI 10.1007/BF02220438; Yang K, 1996, CANCER RES, V56, P4644; Zinkevich V, 2000, FEMS MICROBIOL ECOL, V34, P147, DOI 10.1111/j.1574-6941.2000.tb00764.x	35	62	63	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2011	6	9							e24447	10.1371/journal.pone.0024447	http://dx.doi.org/10.1371/journal.pone.0024447			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CN	21931721	Green Submitted, Green Published, gold			2022-12-25	WOS:000294803100034
J	Kumar, D; Patro, S; Ranjan, R; Sahoo, DK; Maiti, IB; Dey, N				Kumar, Deepak; Patro, Sunita; Ranjan, Rajiv; Sahoo, Dipak K.; Maiti, Indu B.; Dey, Nrisingha			Development of Useful Recombinant Promoter and Its Expression Analysis in Different Plant Cells Using Confocal Laser Scanning Microscopy	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; INHIBITS GENE-EXPRESSION; CIS-REGULATORY ELEMENTS; HIGH-LEVEL EXPRESSION; MOSAIC-VIRUS; TRANSCRIPT PROMOTER; DNA METHYLATION; CPG METHYLATION; COMBINATORIAL; TRANSGENES	Background: Designing functionally efficient recombinant promoters having reduced sequence homology and enhanced promoter activity will be an important step toward successful stacking or pyramiding of genes in a plant cell for developing transgenic plants expressing desired traits(s). Also basic knowledge regarding plant cell specific expression of a transgene under control of a promoter is crucial to assess the promoter's efficacy. Methodology/Principal Findings: We have constructed a set of 10 recombinant promoters incorporating different upstream activation sequences (UAS) of Mirabilis mosaic virus sub-genomic transcript (MS8, -306 to +27) and TATA containing core domains of Figwort mosaic virus sub-genomic transcript promoter (FS3, -271 to +31). Efficacies of recombinant promoters coupled to GUS and GFP reporter genes were tested in tobacco protoplasts. Among these, a 369-bp long hybrid sub-genomic transcript promoter (MSgt-FSgt) showed the highest activity in both transient and transgenic systems. In a transient system, MSgt-FSgt was 10.31, 2.86 and 2.18 times more active compared to the CaMV35S, MS8 and FS3 promoters, respectively. In transgenic tobacco (Nicotiana tabaccum, var. Samsun NN) and Arabidopsis plants, the MSgt-FSgt hybrid promoter showed 14.22 and 7.16 times stronger activity compared to CaMV35S promoter respectively. The correlation between GUS activity and uidA-mRNA levels in transgenic tobacco plants were identified by qRT-PCR. Both CaMV35S and MSgt-FSgt promoters caused gene silencing but the degree of silencing are less in the case of the MSgt-FSgt promoter compared to CaMV35S. Quantification of GUS activity in individual plant cells driven by the MSgt-FSgt and the CaMV35S promoter were estimated using confocal laser scanning microscopy and compared. Conclusion and Significance: We propose strong recombinant promoter MSgt-FSgt, developed in this study, could be very useful for high-level constitutive expression of transgenes in a wide variety of plant cells.	[Kumar, Deepak; Patro, Sunita; Ranjan, Rajiv; Sahoo, Dipak K.; Dey, Nrisingha] Govt India, Dept Biotechnol, Inst Life Sci, Dept Gene Funct & Regulat, Bhubaneswar, Orissa, India; [Sahoo, Dipak K.; Maiti, Indu B.] Univ Kentucky, Coll Agr, KTRDC, Lexington, KY USA	Department of Biotechnology (DBT) India; Institute of Life Sciences India (ILS); University of Kentucky	Kumar, D (corresponding author), Govt India, Dept Biotechnol, Inst Life Sci, Dept Gene Funct & Regulat, Bhubaneswar, Orissa, India.	dey@ils.res.in	kumar, Deepak/P-6773-2016; Sahoo, Dipak Kumar/M-8818-2013	kumar, Deepak/0000-0002-3072-7994; Sahoo, Dipak Kumar/0000-0003-3748-3395	Department of Biotechnology, Govt. of India [BT/PR6805/PBD/16/622/2005]; Council for Scientific and Industrial Research, Govt. of India [38(1147)/07/EMR-II]	Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India); Council for Scientific and Industrial Research, Govt. of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by the Department of Biotechnology, Govt. of India [Project No. BT/PR6805/PBD/16/622/2005 to ND] and the Council for Scientific and Industrial Research, Govt. of India [Project No. 38(1147)/07/EMR-II to ND]. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of manuscript.	Allen GC, 2006, NAT PROTOC, V1, P2320, DOI 10.1038/nprot.2006.384; ATCHISON ML, 1988, ANNU REV CELL BIOL, V4, P127, DOI 10.1146/annurev.cellbio.4.1.127; BENFEY PN, 1989, EMBO J, V8, P2195, DOI 10.1002/j.1460-2075.1989.tb08342.x; BENFEY PN, 1990, EMBO J, V9, P1685, DOI 10.1002/j.1460-2075.1990.tb08292.x; BENFEY PN, 1990, SCIENCE, V250, P959, DOI 10.1126/science.250.4983.959; Bestwick RK, 2000, Synthetic Hybrid Tomato E4/E8 Plant Promoter-Patent, Patent No. 6118049; Bhasin M, 2005, FEBS LETT, V579, P4302, DOI 10.1016/j.febslet.2005.07.002; Bhattacharyya S, 2002, VIRUS RES, V90, P47, DOI 10.1016/S0166-0934(02)00146-5; Bhullar S, 2003, PLANT PHYSIOL, V132, P988, DOI 10.1104/pp.103.020602; BIENZ M, 1986, CELL, V45, P753, DOI 10.1016/0092-8674(86)90789-0; Bongaerts RJM, 2002, METHOD ENZYMOL, V358, P43; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chang WC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-561; Chaturvedi CP, 2006, J BIOTECHNOL, V123, P1, DOI 10.1016/j.jbiotec.2005.10.014; COMAI L, 1990, PLANT MOL BIOL, V15, P373, DOI 10.1007/BF00019155; DEBOER HA, 1983, P NATL ACAD SCI-BIOL, V80, P21; Dey N, 1999, PLANT MOL BIOL, V40, P771, DOI 10.1023/A:1006285426523; Dey N, 2003, TRANSGENICS, V4, P35; Dieguez MJ, 1997, MOL GEN GENET, V253, P581, DOI 10.1007/s004380050360; DYNAN WS, 1989, CELL, V58, P1, DOI 10.1016/0092-8674(89)90393-0; Escobar C, 2001, PLANT MOL BIOL REP, V19, p375a; FANG RX, 1989, PLANT CELL, V1, P141, DOI 10.1105/tpc.1.1.141; GOTZ F, 1990, BIOCHIM BIOPHYS ACTA, V1087, P323, DOI 10.1016/0167-4781(90)90006-N; GUARENTE L, 1984, CELL, V36, P799, DOI 10.1016/0092-8674(84)90028-X; GUARENTE L, 1982, P NATL ACAD SCI-BIOL, V79, P7410, DOI 10.1073/pnas.79.23.7410; HERSHKOVITZ M, 1990, GENE, V94, P189, DOI 10.1016/0378-1119(90)90386-6; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; HOFGEN R, 1988, NUCLEIC ACIDS RES, V16, P9877, DOI 10.1093/nar/16.20.9877; Hohn T, 1996, P NATL ACAD SCI USA, V93, P8334, DOI 10.1073/pnas.93.16.8334; HSIEH CL, 1994, MOL CELL BIOL, V14, P5487, DOI 10.1128/MCB.14.8.5487; INGELBRECHT I, 1994, P NATL ACAD SCI USA, V91, P10502, DOI 10.1073/pnas.91.22.10502; JEFFERSON RA, 1987, EMBO J, V6, P3901; KESHET I, 1985, P NATL ACAD SCI USA, V82, P2560, DOI 10.1073/pnas.82.9.2560; Klucher KM, 1996, PLANT CELL, V8, P137, DOI 10.1105/tpc.8.2.137; Konishi M, 2007, PLANT PHYSIOL BIOCH, V45, P623, DOI 10.1016/j.plaphy.2007.05.001; LAM E, 1989, P NATL ACAD SCI USA, V86, P7890, DOI 10.1073/pnas.86.20.7890; LANG M, 1991, RADIAT ENVIRON BIOPH, V30, P333, DOI 10.1007/BF01210517; LAST DI, 1991, THEOR APPL GENET, V81, P581, DOI 10.1007/BF00226722; Lee LY, 2007, PLANT PHYSIOL, V145, P1294, DOI 10.1104/pp.107.106633; LEISNER SM, 1988, P NATL ACAD SCI USA, V85, P2553, DOI 10.1073/pnas.85.8.2553; LEVINE A, 1991, P NATL ACAD SCI USA, V88, P6515, DOI 10.1073/pnas.88.15.6515; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MAITI IB, 1993, P NATL ACAD SCI USA, V90, P6110, DOI 10.1073/pnas.90.13.6110; Meyer P, 1996, ANNU REV PLANT PHYS, V47, P23, DOI 10.1146/annurev.arplant.47.1.23; MOL JNM, 1989, PLANT MOL BIOL, V13, P287, DOI 10.1007/BF00025316; NI M, 1995, PLANT J, V7, P661, DOI 10.1046/j.1365-313X.1995.7040661.x; ODELL JT, 1985, NATURE, V313, P810, DOI 10.1038/313810a0; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pradhan S, 1999, BIOCHEM J, V341, P473, DOI 10.1042/0264-6021:3410473; Rushton PJ, 2002, PLANT CELL, V14, P749, DOI 10.1105/tpc.010412; Sahoo DK, 2009, J VIROL METHODS, V161, P114, DOI 10.1016/j.jviromet.2009.06.011; Sakai H, 2000, PLANT J, V24, P703, DOI 10.1046/j.1365-313x.2000.00909.x; Sawant S, 2001, THEOR APPL GENET, V102, P635, DOI 10.1007/s001220051691; SCHARDL CL, 1987, GENE, V61, P1, DOI 10.1016/0378-1119(87)90359-3; STRUHL K, 1985, P NATL ACAD SCI USA, V82, P8419, DOI 10.1073/pnas.82.24.8419; Vaucheret H, 2001, TRENDS GENET, V17, P29, DOI 10.1016/S0168-9525(00)02166-1; WEBER H, 1990, EMBO J, V9, P4409, DOI 10.1002/j.1460-2075.1990.tb07891.x; Wu LG, 2003, J VIROL METHODS, V111, P101, DOI 10.1016/S0166-0934(03)00153-8; Yanagisawa S, 2004, PLANT CELL PHYSIOL, V45, P386, DOI 10.1093/pcp/pch055; Yanagisawa S, 2002, TRENDS PLANT SCI, V7, P555, DOI 10.1016/S1360-1385(02)02362-2; Ye XD, 2000, SCIENCE, V287, P303, DOI 10.1126/science.287.5451.303; Zhang XR, 2006, NAT PROTOC, V1, P641, DOI 10.1038/nprot.2006.97; Zimmer M, 2002, CHEM REV, V102, P759, DOI 10.1021/cr010142r	63	29	31	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2011	6	9							e24627	10.1371/journal.pone.0024627	http://dx.doi.org/10.1371/journal.pone.0024627			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CN	21931783	Green Published, Green Submitted, gold			2022-12-25	WOS:000294803100049
J	Kim, Y; Tesar, C; Mire, J; Jedrzejczak, R; Binkowski, A; Babnigg, G; Sacchettini, J; Joachimiak, A				Kim, Youngchang; Tesar, Christine; Mire, Joseph; Jedrzejczak, Robert; Binkowski, Andrew; Babnigg, Gyorgy; Sacchettini, James; Joachimiak, Andrzej			Structure of Apo- and Monometalated Forms of NDM-1-A Highly Potent Carbapenem-Hydrolyzing Metallo-beta-Lactamase	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; PSEUDOMONAS-AERUGINOSA; ANTIBIOTIC-RESISTANCE; BACILLUS-CEREUS; 3-DIMENSIONAL STRUCTURE; MOLECULAR-REPLACEMENT; BACTEROIDES-FRAGILIS; ZINC; SUBCLASS; PROTEIN	The New Delhi Metallo-beta-lactamase (NDM-1) gene makes multiple pathogenic microorganisms resistant to all known beta-lactam antibiotics. The rapid emergence of NDM-1 has been linked to mobile plasmids that move between different strains resulting in world-wide dissemination. Biochemical studies revealed that NDM-1 is capable of efficiently hydrolyzing a wide range of beta-lactams, including many carbapenems considered as "last resort" antibiotics. The crystal structures of metal-free apo- and monozinc forms of NDM-1 presented here revealed an enlarged and flexible active site of class B1 metallo-beta-lactamase. This site is capable of accommodating many beta-lactam substrates by having many of the catalytic residues on flexible loops, which explains the observed extended spectrum activity of this zinc dependent beta-lactamase. Indeed, five loops contribute "keg" residues in the active site including side chains involved in metal binding. Loop 1 in particular, shows conformational flexibility, apparently related to the acceptance and positioning of substrates for cleavage by a zinc-activated water molecule.	[Kim, Youngchang; Jedrzejczak, Robert; Binkowski, Andrew; Babnigg, Gyorgy; Joachimiak, Andrzej] Argonne Natl Lab, Midwest Ctr Struct Genom, Argonne, IL 60439 USA; [Kim, Youngchang; Jedrzejczak, Robert; Binkowski, Andrew; Babnigg, Gyorgy; Joachimiak, Andrzej] Argonne Natl Lab, Struct Biol Ctr, Argonne, IL 60439 USA; [Mire, Joseph; Sacchettini, James] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Joachimiak, Andrzej] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA	United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory; Texas A&M University System; Texas A&M University College Station; University of Chicago	Kim, Y (corresponding author), Argonne Natl Lab, Midwest Ctr Struct Genom, 9700 S Cass Ave, Argonne, IL 60439 USA.	jim.sacchettini@gmail.com; andrzejj@anl.gov		Kim, Youngchang/0000-0002-1610-4889; Joachimiak, Andrzej/0000-0003-2535-6209	National Institutes of Health [GM094585, GM094568]; U. S. Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM094568, U54GM094585] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U. S. Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant GM094585 (AJ), GM094568 (JS) and by the U. S. Department of Energy, Office of Biological and Environmental Research, under contract DE-AC02-06CH11357. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alkire RW, 2010, NUCL INSTRUMENTS M A; Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P750; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Bebrone C, 2007, BIOCHEM PHARMACOL, V74, P1686, DOI 10.1016/j.bcp.2007.05.021; Bebrone C, 2009, ANTIMICROB AGENTS CH, V53, P4464, DOI 10.1128/AAC.00288-09; Bush K, 2010, ANTIMICROB AGENTS CH, V54, P969, DOI 10.1128/AAC.01009-09; Bush K, 2010, CURR OPIN MICROBIOL, V13, P558, DOI 10.1016/j.mib.2010.09.006; CARFI A, 1995, EMBO J, V14, P4914, DOI 10.1002/j.1460-2075.1995.tb00174.x; Castanheira M, 2004, ANTIMICROB AGENTS CH, V48, P4654, DOI 10.1128/AAC.48.12.4654-4661.2004; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen Y, 2011, J ANTIMICROB CHEMOTH, V66, P1255, DOI 10.1093/jac/dkr082; CLARKE AM, 1993, EUR J CLIN MICROBIOL, V12, P377, DOI 10.1007/BF01964438; Concha NO, 1996, STRUCTURE, V4, P823, DOI 10.1016/S0969-2126(96)00089-5; Concha NO, 2000, BIOCHEMISTRY-US, V39, P4288, DOI 10.1021/bi992569m; Cornaglia G., 2011, Lancet Infectious Diseases, V11, P381, DOI 10.1016/S1473-3099(11)70056-1; Crowder MW, 2006, ACCOUNTS CHEM RES, V39, P721, DOI 10.1021/ar0400241; Docquier JD, 2003, J ANTIMICROB CHEMOTH, V51, P257, DOI 10.1093/jac/dkg067; Docquier JD, 2002, ANTIMICROB AGENTS CH, V46, P1823, DOI 10.1128/AAC.46.6.1823-1830.2002; Docquier JD, 2010, ANTIMICROB AGENTS CH, V54, P4343, DOI 10.1128/AAC.00409-10; Donnelly MI, 2006, PROTEIN EXPRES PURIF, V47, P446, DOI 10.1016/j.pep.2005.12.011; Drawz SM, 2010, CLIN MICROBIOL REV, V23, P160, DOI 10.1128/CMR.00037-09; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eschenfeldt William H., 2009, V498, P105, DOI 10.1007/978-1-59745-196-3_7; Fabiane SM, 1998, BIOCHEMISTRY-US, V37, P12404, DOI 10.1021/bi980506i; Feldman C, 2011, DRUGS, V71, P131, DOI 10.2165/11585310-000000000-00000; Fitzgerald PMD, 1998, BIOCHEMISTRY-US, V37, P6791, DOI 10.1021/bi9730339; Garau G, 2005, J MOL BIOL, V345, P785, DOI 10.1016/j.jmb.2004.10.070; Garcia-Saez I, 2008, J MOL BIOL, V375, P604, DOI 10.1016/j.jmb.2007.11.012; Garcia-Saez I, 2003, J BIOL CHEM, V278, P23868, DOI 10.1074/jbc.M301062200; Garcia-Saez I, 2003, J MOL BIOL, V325, P651, DOI 10.1016/S0022-2836(02)01271-8; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gillespie Stephen H, 2011, Recent Pat Antiinfect Drug Discov, V6, P77; Guo Y, 2011, PROTEIN CELL, V2, P384, DOI 10.1007/s13238-011-1055-9; Harada S, 2008, KOREAN J LAB MED, V28, P401, DOI 10.3343/kjlm.2008.28.6.401; Ho PL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017989; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jacquin O, 2009, J MOL BIOL, V392, P1278, DOI 10.1016/j.jmb.2009.07.092; Jaroszewski L, 2005, NUCLEIC ACIDS RES, V33, pW284, DOI 10.1093/nar/gki418; Jean SS, 2011, INT J ANTIMICROB AG, V37, P291, DOI 10.1016/j.ijantimicag.2011.01.009; Jin WC, 2004, BIOL PHARM BULL, V27, P851, DOI 10.1248/bpb.27.851; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kozawa O, 1998, ANTIMICROB AGENTS CH, V42, P1433, DOI 10.1128/AAC.42.6.1433; Kumarasamy KK, 2010, LANCET INFECT DIS, V10, P597, DOI 10.1016/S1473-3099(10)70143-2; Laraki N, 1999, ANTIMICROB AGENTS CH, V43, P902, DOI 10.1128/AAC.43.4.902; Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pW89, DOI 10.1093/nar/gki414; Lassaux P, 2011, ANTIMICROB AGENTS CH, V55, P1248, DOI 10.1128/AAC.01486-09; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lisa MN, 2010, J BIOL CHEM, V285, P4570, DOI 10.1074/jbc.M109.063743; Llarrull LI, 2010, CURR OPIN MICROBIOL, V13, P551, DOI 10.1016/j.mib.2010.09.008; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; MALANOSKI GJ, 1993, ANTIMICROB AGENTS CH, V37, P2009, DOI 10.1128/AAC.37.9.2009; Marra A, 2011, FUTURE MICROBIOL, V6, P137, DOI 10.2217/FMB.10.171; McManus-Munoz S, 1999, BIOCHEMISTRY-US, V38, P1547, DOI 10.1021/bi9826512; Mercuri PS, 2004, J BIOL CHEM, V279, P33630, DOI 10.1074/jbc.M403671200; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Moellering RC, 2010, NEW ENGL J MED, V363, P2377, DOI 10.1056/NEJMp1011715; Moran-Barrio J, 2007, J BIOL CHEM, V282, P18286, DOI 10.1074/jbc.M700467200; Mori M, 1996, J ANTIMICROB CHEMOTH, V37, P1034, DOI 10.1093/jac/37.5.1034; Mulvey MR, 2011, EMERG INFECT DIS, V17, P103, DOI 10.3201/eid1701.101358; Nathwani Dilip, 2010, BMJ Clin Evid, V2010; Nocek BP, 2010, J MOL BIOL, V397, P617, DOI 10.1016/j.jmb.2010.01.062; Oelschlaeger P, 2003, PROTEIN ENG, V16, P341, DOI 10.1093/protein/gzg049; Page MI, 2008, BIOINORG CHEM APPL, V2008, DOI 10.1155/2008/576297; Peirano G, 2011, ANTIMICROB AGENTS CH, V55, P2986, DOI 10.1128/AAC.01763-10; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07; RASMUSSEN BA, 1994, ANTIMICROB AGENTS CH, V38, P2116, DOI 10.1128/AAC.38.9.2116; Rosenbaum G, 2006, J SYNCHROTRON RADIAT, V13, P30, DOI 10.1107/S0909049505036721; Rossolini GM, 2001, ANTIMICROB AGENTS CH, V45, P837, DOI 10.1128/AAC.45.3.837-844.2001; Saavedra MJ, 2003, ANTIMICROB AGENTS CH, V47, P2330, DOI 10.1128/AAC.47.7.2330-2333.2003; Sarma JB, 2011, INDIAN J MED MICROBI, V29, P22, DOI 10.4103/0255-0857.76519; Siemann S, 2003, BIOCHEMISTRY-US, V42, P1673, DOI 10.1021/bi027072i; Tamilselvi A, 2008, J BIOL INORG CHEM, V13, P1039, DOI 10.1007/s00775-008-0407-2; Tomatis PE, 2008, P NATL ACAD SCI USA, V105, P20605, DOI 10.1073/pnas.0807989106; Ullah JH, 1998, J MOL BIOL, V284, P125, DOI 10.1006/jmbi.1998.2148; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Walsh TR, 2011, LANCET INFECT DIS, V11, P355, DOI 10.1016/S1473-3099(11)70059-7; Walsh TR, 2010, INT J ANTIMICROB AG, V36, pS8, DOI 10.1016/S0924-8579(10)70004-2; Walsh TR, 1998, ANTIMICROB AGENTS CH, V42, P436; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Xu D, 2007, J AM CHEM SOC, V129, P10814, DOI 10.1021/ja072532m; Yamaguchi Y, 2007, J MED CHEM, V50, P6647, DOI 10.1021/jm701031n; Yamamoto T, 2011, J INFECT CHEMOTHER, V17, P435, DOI 10.1007/s10156-011-0232-3; Yong Dongeun, 2009, Antimicrob Agents Chemother, V53, P5046, DOI 10.1128/AAC.00774-09; Yu NY, 2011, NUCLEIC ACIDS RES, V39, pD241, DOI 10.1093/nar/gkq1093; Zhang HM, 2011, FASEB J, V25, P2574, DOI 10.1096/fj.11-184036; Zheng BW, 2011, PROTEIN CELL, V2, P250, DOI 10.1007/s13238-011-1027-0	88	73	83	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e24621	10.1371/journal.pone.0024621	http://dx.doi.org/10.1371/journal.pone.0024621			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CK	21931780	gold, Green Published, Green Submitted			2022-12-25	WOS:000294802800073
J	Lim, HH; Fang, YL; Williams, C				Lim, Hyun-Ho; Fang, Yiling; Williams, Carole			High-Efficiency Screening of Monoclonal Antibodies for Membrane Protein Crystallography	PLOS ONE			English	Article							COUPLED RECEPTOR; RESOLUTION; CRYSTALLIZATION	Determination of crystal structures of membrane proteins is often limited by difficulties obtaining crystals diffracting to high resolution. Co-crystallization with Fab fragments of monoclonal antibodies has been reported to improve diffraction of membrane proteins crystals. However, it is not simple to generate useful monoclonal antibodies for membrane protein crystallography. In this report, we present an optimized process for efficient screening from immunization to final validation of monoclonal antibody for membrane protein crystallography.	[Lim, Hyun-Ho; Fang, Yiling; Williams, Carole] Brandeis Univ, Dept Biochem, Howard Hughes Med Inst, Waltham, MA 02254 USA	Brandeis University; Howard Hughes Medical Institute	Lim, HH (corresponding author), Brandeis Univ, Dept Biochem, Howard Hughes Med Inst, Waltham, MA 02254 USA.	hhlim@brandeis.edu			National Institutes of Health (NIH) [RO1-GM089688]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089688] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) RO1-GM089688 (to Dr. Christopher Miller). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Day PW, 2007, NAT METHODS, V4, P927, DOI 10.1038/NMETH1112; DEISENHOFER J, 1985, NATURE, V318, P618, DOI 10.1038/318618a0; Dow SW, 1998, J CLIN INVEST, V101, P2406, DOI 10.1172/JCI510; Dutzler R, 2003, SCIENCE, V300, P108, DOI 10.1126/science.1082708; Fang YL, 2009, NATURE, V460, P1040, DOI 10.1038/nature08201; Fellouse FA, 2007, J MOL BIOL, V373, P924, DOI 10.1016/j.jmb.2007.08.005; Harlow E., 1988, ANTIBODIES LAB MANUA; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hunte C, 2002, CURR OPIN STRUC BIOL, V12, P503, DOI 10.1016/S0959-440X(02)00354-8; OSTERMEIER C, 1995, NAT STRUCT BIOL, V2, P842, DOI 10.1038/nsb1095-842; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Sennhauser G, 2008, STRUCTURE, V16, P1443, DOI 10.1016/j.str.2008.08.010; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; Templeton NS, 1997, NAT BIOTECHNOL, V15, P647, DOI 10.1038/nbt0797-647; Wassef N M, 1994, Immunomethods, V4, P217, DOI 10.1006/immu.1994.1023; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009; Zhou YH, 2007, IMMUNOL CELL BIOL, V85, P73, DOI 10.1038/sj.icb.7100004	17	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e24653	10.1371/journal.pone.0024653	http://dx.doi.org/10.1371/journal.pone.0024653			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CK	21931797	Green Published, gold, Green Submitted			2022-12-25	WOS:000294802800082
J	Wang, Y; Yu, CC; Pan, Y; Li, JL; Zhang, YL; Ye, FQ; Yang, SL; Zhang, H; Li, XK; Liang, G				Wang, Yi; Yu, Congcong; Pan, Yong; Li, Jianling; Zhang, Yali; Ye, Faqing; Yang, Shulin; Zhang, Hui; Li, Xiaokun; Liang, Guang			A Novel Compound C12 Inhibits Inflammatory Cytokine Production and Protects from Inflammatory Injury In Vivo	PLOS ONE			English	Article							NF-KAPPA-B; GENE-EXPRESSION; NITRIC-OXIDE; CELLS; RECEPTOR; MACROPHAGES; ACTIVATION; CURCUMIN; ADHESION; RELEASE	Inflammation is a hallmark of many diseases. Although steroids and cyclooxygenase inhibitors are main anti-inflammatory therapeutical agents, they may cause serious side effects. Therefore, developing non-steroid anti-inflammatory agents is urgently needed. A novel hydrosoluble compound, C12 (2,6-bis(4-(3-(dimethylamino)-propoxy)benzylidene)cyclohexanone), has been designed and synthesized as an anti-inflammatory agent in our previous study. In the present study, we investigated whether C12 can affect inflammatory processes in vitro and in vivo. In mouse primary peritoneal macrophages, C12 potently inhibited the production of the proinflammatory gene expression including TNF-alpha, IL-1 beta, IL-6, iNOS, COX-2 and PGE synthase. The activity of C12 was partly dependent on inhibition of ERK/JNK (but p38) phosphorylation and NF-kappa B activation. In vivo, C12 suppressed proinflammatory cytokine production in plasma and liver, attenuated lung histopathology, and significantly reduced mortality in endotoxemic mice. In addition, the pre-treatment with C12 reduced the inflammatory pain in the acetic acid and formalin models and reduced the carrageenan-induced paw oedema and acetic acid-increased vascular permeability. Taken together, C12 has multiple anti-inflammatory effects. These findings, coupled with the low toxicity and hydrosolubility of C12, suggests that this agent may be useful in the treatment of inflammatory diseases.	[Wang, Yi; Yu, Congcong; Pan, Yong; Li, Jianling; Ye, Faqing; Li, Xiaokun; Liang, Guang] Wenzhou Med Coll, Bioorgan & Med Chem Res Ctr, Sch Pharmaceut Sci, Wenzhou, Peoples R China; [Zhang, Yali; Yang, Shulin; Liang, Guang] Nanjing Univ Sci & Technol, Inst Bioengn, Nanjing, Peoples R China; [Zhang, Hui] Wenzhou Med Coll, Dept Pharm, Affiliated Hosp 1, Wenzhou, Peoples R China; [Li, Xiaokun] Jilin Univ, Norman Bethune Coll Med Sci, Changchun 130023, Peoples R China	Wenzhou Medical University; Nanjing University of Science & Technology; Wenzhou Medical University; Jilin University	Wang, Y (corresponding author), Wenzhou Med Coll, Bioorgan & Med Chem Res Ctr, Sch Pharmaceut Sci, Wenzhou, Peoples R China.	wzmcliangguang@163.com			National Natural Science Funding of China [20802054, 30872308, 30871434]; Zhejiang Department of Health; Wenzhou SciTech Bureau [Y20090009, Y20100006, Y20100078]; Zhejiang Natural Science Funding [Y2090680, Y20101108, Y2090358]; China Postdoctoral Science Foundation [20090461121, 201003591]	National Natural Science Funding of China(National Natural Science Foundation of China (NSFC)); Zhejiang Department of Health; Wenzhou SciTech Bureau; Zhejiang Natural Science Funding; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	Financial support was provided by the National Natural Science Funding of China (20802054 & 30872308 & 30871434), High-level Innovative Talent Funding of Zhejiang Department of Health (G.L.), Project of Wenzhou Sci&Tech Bureau (Y20090009 & Y20100006 & Y20100078), Zhejiang Natural Science Funding (Y2090680 & Y20101108 & Y2090358) and China Postdoctoral Science Foundation funded project (20090461121 & 201003591). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouffi C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014247; Brevetti G, 2010, CIRCULATION, V122, P1862, DOI 10.1161/CIRCULATIONAHA.109.918417; Chiu J, 2009, NUTRITION, V25, P964, DOI 10.1016/j.nut.2008.12.007; Christaki E, 2010, J INFECT DIS, V201, P1250, DOI 10.1086/651276; CORREA CR, 1993, BRIT J PHARMACOL, V110, P193, DOI 10.1111/j.1476-5381.1993.tb13791.x; Dai RJ, 2009, J IMMUNOL, V183, P6998, DOI 10.4049/jimmunol.0901737; Duffield JS, 2010, SEMIN NEPHROL, V30, P234, DOI 10.1016/j.semnephrol.2010.03.003; Duran WN, 2010, CARDIOVASC RES, V87, P254, DOI 10.1093/cvr/cvq139; Edirisinghe I, 2008, FASEB J, V22, P2297, DOI 10.1096/fj.07-099481; Fiorino G, 2010, CURR MED CHEM, V17, P1851, DOI 10.2174/092986710791111170; Garrido-Suarez BB, 2009, BRAIN RES BULL, V79, P339, DOI 10.1016/j.brainresbull.2009.04.014; Ghosh SS, 2009, AM J PHYSIOL-RENAL, V296, pF1146, DOI 10.1152/ajprenal.90732.2008; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Hiransai P, 2010, J CELL BIOCHEM, V109, P1057, DOI 10.1002/jcb.22535; Hummasti S, 2010, CIRC RES, V107, P579, DOI 10.1161/CIRCRESAHA.110.225698; Jeon KI, 2010, P NATL ACAD SCI USA, V107, P9795, DOI 10.1073/pnas.0914414107; Jeong HW, 2009, AM J PHYSIOL-ENDOC M, V296, P10; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; Lambrecht BN, 2010, LANCET, V376, P835, DOI 10.1016/S0140-6736(10)61226-3; Lee CH, 2008, MOL IMMUNOL, V45, P3693, DOI 10.1016/j.molimm.2008.06.007; Li Y, 2008, EUR J PHARMACOL, V590, P417, DOI 10.1016/j.ejphar.2008.06.047; Liang G, 2008, BIOORG MED CHEM LETT, V18, P1525, DOI 10.1016/j.bmcl.2007.12.068; Liu XJ, 2001, EUR J PHARMACOL, V429, P147, DOI 10.1016/S0014-2999(01)01316-4; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Moreau ME, 2007, MOL PHARMACOL, V71, P949, DOI 10.1124/mol.106.030684; Musa H, 2006, J CELL SCI, V119, P4322, DOI 10.1242/jcs.03198; Olajide Olumayokun A., 2003, Inflammopharmacology, V11, P293, DOI 10.1163/156856003322315631; Oliveira C, 2010, BRIT J PHARMACOL, V161, P899, DOI 10.1111/j.1476-5381.2010.00924.x; Panayiotou CM, 2010, BRIT J PHARMACOL, V160, P2045, DOI 10.1111/j.1476-5381.2010.00830.x; Paulino N, 2009, BIOORGAN MED CHEM, V17, P4290, DOI 10.1016/j.bmc.2009.05.034; Ren GW, 2010, J IMMUNOL, V184, P2321, DOI 10.4049/jimmunol.0902023; Rittirsch D, 2008, J IMMUNOL, V180, P7664, DOI 10.4049/jimmunol.180.11.7664; Vaickus LJ, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-160; Voilley Nicolas, 2004, Current Drug Targets - Inflammation and Allergy, V3, P71, DOI 10.2174/1568010043483980; Zhang ZJ, 2011, INT J MOL MED, V27, P195, DOI 10.3892/ijmm.2010.571; Zhao CG, 2010, BIOORGAN MED CHEM, V18, P2388, DOI 10.1016/j.bmc.2010.03.001	36	19	19	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e24377	10.1371/journal.pone.0024377	http://dx.doi.org/10.1371/journal.pone.0024377			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CK	21931698	Green Published, gold			2022-12-25	WOS:000294802800045
J	Garcia-Rodas, R; Casadevall, A; Rodriguez-Tudela, JL; Cuenca-Estrella, M; Zaragoza, O				Garcia-Rodas, Rocio; Casadevall, Arturo; Luis Rodriguez-Tudela, Juan; Cuenca-Estrella, Manuel; Zaragoza, Oscar			Cryptococcus neoformans Capsular Enlargement and Cellular Gigantism during Galleria mellonella Infection	PLOS ONE			English	Article							FUNGAL PATHOGEN CRYPTOCOCCUS; POLYSACCHARIDE CAPSULE; MODEL HOST; VIRULENCE; GLUCURONOXYLOMANNAN; PHAGOCYTOSIS; EXPRESSION; SYSTEM; LARVAE; YEAST	We have studied infection of Cryptococcus neoformans in the non-vertebrate host Galleria mellonella with particular interest in the morphological response of the yeast. Inoculation of C. neoformans in caterpillars induced a capsule-independent increase in haemocyte density 2 h after infection. C. neoformans manifested a significant increase in capsule size after inoculation into the caterpillar. The magnitude of capsule increase depended on the temperature, being more pronounced at 37 degrees C than at 30 degrees C, which correlated with an increased virulence of the fungus and reduced phagocytosis at 37 degrees C. Capsule enlargement impaired phagocytosis by haemocytes. Incubation of the yeast in G. mellonella extracts also resulted in capsule enlargement, with the polar lipidic fraction having a prominent role in this effect. During infection, the capsule decreased in permeability. A low proportion of the cells (<5%) recovered from caterpillars measured more than 30 mm and were considered giant cells. Giant cells recovered from mice were able to kill the caterpillars in a manner similar to regular cells obtained from in vivo or grown in vitro, establishing their capacity to cause disease. Our results indicate that the morphological transitions exhibited by C. neoformans in mammals also occur in a non-vertebrate host system. The similarities in morphological transitions observed in different animal hosts and in their triggers are consistent with the hypothesis that the cell body and capsular responses represent an adaptation of environmental survival strategies to pathogenesis.	[Garcia-Rodas, Rocio; Luis Rodriguez-Tudela, Juan; Cuenca-Estrella, Manuel; Zaragoza, Oscar] Inst Salud Carlos III, Mycol Reference Lab, Natl Ctr Microbiol, Madrid, Spain; [Casadevall, Arturo] Albert Einstein Coll Med, Dept Microbiol & Immunol & Med, Bronx, NY 10467 USA	Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); Yeshiva University; Albert Einstein College of Medicine	Garcia-Rodas, R (corresponding author), Inst Salud Carlos III, Mycol Reference Lab, Natl Ctr Microbiol, Madrid, Spain.	ozaragoza@isciii.es		Garcia-Rodas, Rocio/0000-0002-3759-2412; Zaragoza, Oscar/0000-0002-1581-0845	FPI [BES-2009-015913]; NIH [AI033774, HL059842, AI033142]; Spanish Ministry of Science and Innovation [SAF2008-03761]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033142, R01AI033774, R37AI033142] Funding Source: NIH RePORTER	FPI(Spanish Government); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	R.G.R. is supported by a FPI fellowship (reference BES-2009-015913), which funded her stay in Dr. Casadevall's laboratory during three months. A.C. was supported by NIH awards AI033774, HL059842, and AI033142. O.Z. is funded by grant SAF2008-03761 from the Spanish Ministry of Science and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apidianakis Y, 2004, EUKARYOT CELL, V3, P413, DOI 10.1128/EC.3.2.413-419.2004; Bergin D, 2005, INFECT IMMUN, V73, P4161, DOI 10.1128/IAI.73.7.4161-4170.2005; Bergin D, 2003, MICROBES INFECT, V5, P1389, DOI 10.1016/j.micinf.2003.09.019; Botts MR, 2010, CURR OPIN MICROBIOL, V13, P437, DOI 10.1016/j.mib.2010.05.003; Brennan M, 2002, FEMS IMMUNOL MED MIC, V34, P153, DOI 10.1111/j.1574-695X.2002.tb00617.x; Brivio MF, 2010, DEV COMP IMMUNOL, V34, P991, DOI 10.1016/j.dci.2010.05.002; CASADEVALL A, 1992, J INFECT DIS, V165, P1086, DOI 10.1093/infdis/165.6.1086; Casadevall A, 1998, CRYPTOCOCCUS NEOFORM; Cerenius L, 2008, TRENDS IMMUNOL, V29, P263, DOI 10.1016/j.it.2008.02.009; Chaka W, 1997, INFECT IMMUN, V65, P272, DOI 10.1128/IAI.65.1.272-278.1997; Chang YC, 1995, GENE, V167, P179, DOI 10.1016/0378-1119(95)00640-0; Charlier C, 2005, AM J PATHOL, V166, P421, DOI 10.1016/S0002-9440(10)62265-1; Chrisman CJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002047; Cytrynska M, 2007, ACTA BIOCHIM POL, V54, P167; Dong ZM, 1997, INFECT IMMUN, V65, P557, DOI 10.1128/IAI.65.2.557-563.1997; Dubovskiy IM, 2008, J INVERTEBR PATHOL, V98, P360, DOI 10.1016/j.jip.2008.03.011; Feldmesser M, 2001, MICROBIOL-SGM, V147, P2355, DOI 10.1099/00221287-147-8-2355; Feldmesser M, 2000, INFECT IMMUN, V68, P4225, DOI 10.1128/IAI.68.7.4225-4237.2000; Fonseca FL, INFECT IMMUN, V3861-3870; Fuchs BB, 2006, CURR OPIN MICROBIOL, V9, P346, DOI 10.1016/j.mib.2006.06.004; Fuchs BB, 2010, VIRULENCE, V1, P475, DOI 10.4161/viru.1.6.12985; Gates MA, 2004, MOL MICROBIOL, V52, P13, DOI 10.1111/j.1365-2958.2003.03957.x; Goldman DL, 1998, P NATL ACAD SCI USA, V95, P14967, DOI 10.1073/pnas.95.25.14967; Goldman DL, 2000, INFECT IMMUN, V68, P832, DOI 10.1128/IAI.68.2.832-838.2000; Grijpstra J, 2009, FEMS IMMUNOL MED MIC, V57, P142, DOI 10.1111/j.1574-695X.2009.00587.x; Heitman J, 2011, CRYPTOCOCCUS: FROM HUMAN PATHOGEN TO MODEL YEAST, P1; Hu KJ, 2006, BIOORGAN MED CHEM, V14, P4677, DOI 10.1016/j.bmc.2006.01.025; Jander G, 2000, J BACTERIOL, V182, P3843, DOI 10.1128/JB.182.13.3843-3845.2000; KOZEL TR, 1988, REV INFECT DIS, V10, pS436; KOZEL TR, 1982, J IMMUNOL, V129, P1675; KWONCHUNG KJ, 1976, MYCOLOGIA, V68, P821, DOI 10.2307/3758800; Leger RJS, 2000, APPL ENVIRON MICROB, V66, P320, DOI 10.1128/AEM.66.1.320-324.2000; London R, 2006, FEMS YEAST RES, V6, P567, DOI 10.1111/j.1567-1364.2006.00056.x; Maxson ME, 2007, EUKARYOT CELL, V6, P95, DOI 10.1128/EC.00306-06; McClelland EE, 2006, INFECT IMMUN, V74, P1500, DOI 10.1128/IAI.74.3.1500-1504.2006; Miyata S, 2003, INFECT IMMUN, V71, P2404, DOI 10.1128/IAI.71.5.2404-2413.2003; Monari C, 2005, J IMMUNOL, V174, P3461, DOI 10.4049/jimmunol.174.6.3461; Monari C, 2006, FEMS YEAST RES, V6, P537, DOI 10.1111/j.1567-1364.2006.00072.x; MORTON DB, 1984, MICROBIOS, V39, P177; Mylonakis E, 2005, INFECT IMMUN, V73, P3842, DOI 10.1128/IAI.73.7.3842-3850.2005; Mylonakis E, 2002, P NATL ACAD SCI USA, V99, P15675, DOI 10.1073/pnas.232568599; Okagaki LH, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000953; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; PERFECT JR, 1980, AM J PATHOL, V101, P177; Pierini LM, 2001, MOL MICROBIOL, V41, P105, DOI 10.1046/j.1365-2958.2001.02504.x; Reeves EP, 2004, MYCOPATHOLOGIA, V158, P73, DOI 10.1023/B:MYCO.0000038434.55764.16; Retini C, 1996, INFECT IMMUN, V64, P2897, DOI 10.1128/IAI.64.8.2897-2903.1996; Rodrigues ML, 2008, EUKARYOT CELL, V7, P602, DOI 10.1128/EC.00307-07; Steenbergen JN, 2004, INFECT IMMUN, V72, P3478, DOI 10.1128/IAI.72.6.3478-3488.2004; Steenbergen JN, 2003, INFECT IMMUN, V71, P4862, DOI 10.1128/IAI.71.9.4862-4872.2003; Steenbergen JN, 2003, MICROBES INFECT, V5, P667, DOI 10.1016/S1286-4579(03)00092-3; Steenbergen JN, 2001, P NATL ACAD SCI USA, V98, P15245, DOI 10.1073/pnas.261418798; TOFFALETTI DL, 1993, J BACTERIOL, V175, P1405, DOI 10.1128/JB.175.5.1405-1411.1993; Tojo S, 2000, J INSECT PHYSIOL, V46, P1129, DOI 10.1016/S0022-1910(99)00223-1; Vecchiarelli A, 2003, J LEUKOCYTE BIOL, V74, P370, DOI 10.1189/jlb.1002476; Vecchiarelli A, 2005, CURR MOL MED, V5, P413, DOI 10.2174/1566524054022585; Velagapudi R, 2009, INFECT IMMUN, V77, P4345, DOI 10.1128/IAI.00542-09; Xue CY, 2007, CELL HOST MICROBE, V1, P263, DOI 10.1016/j.chom.2007.05.005; Zaragoza O, 2003, EUR J IMMUNOL, V33, P1957, DOI 10.1002/eji.200323848; Zaragoza O, 2006, MOL MICROBIOL, V59, P67, DOI 10.1111/j.1365-2958.2005.04928.x; Zaragoza O, 2007, INFECT IMMUN, V75, P2729, DOI 10.1128/IAI.00094-07; Zaragoza O, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000945; Zaragoza Oscar, 2004, Biol Proced Online, V6, P10, DOI 10.1251/bpo68; Zaragoza O, 2009, ADV APPL MICROBIOL, V68, P133, DOI 10.1016/S0065-2164(09)01204-0	64	73	75	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2011	6	9							e24485	10.1371/journal.pone.0024485	http://dx.doi.org/10.1371/journal.pone.0024485			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CH	21915338	Green Published, Green Submitted, gold			2022-12-25	WOS:000294802500053
J	Pasieka, TJ; Collins, L; O'Connor, MA; Chen, YF; Parker, ZM; Berwin, BL; Piwnica-Worms, DR; Leib, DA				Pasieka, Tracy Jo; Collins, Lynne; O'Connor, Megan A.; Chen, Yufei; Parker, Zachary M.; Berwin, Brent L.; Piwnica-Worms, David R.; Leib, David A.			Bioluminescent Imaging Reveals Divergent Viral Pathogenesis in Two Strains of Stat1-Deficient Mice, and in alpha beta gamma Interferon Receptor-Deficient Mice	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; INNATE IMMUNITY; SYSTEMIC DISSEMINATION; PERSISTENT INFECTION; TARGETED DISRUPTION; DENDRITIC CELLS; WILD-TYPE; TYPE-1; RESISTANCE; HEPATITIS	Pivotal components of the IFN response to virus infection include the IFN receptors (IFNR), and the downstream factor signal transducer and activator of transcription 1 (Stat1). Mice deficient for Stat1 and IFNR (Stat1(-/-) and IFN alpha beta gamma R-/- mice) lack responsiveness to IFN and exhibit high sensitivity to various pathogens. Here we examined herpes simplex virus type 1 (HSV-1) pathogenesis in Stat1(-/-) mice and in IFN alpha beta gamma R-/- mice following corneal infection and bioluminescent imaging. Two divergent and paradoxical patterns of infection were observed. Mice with an N-terminal deletion in Stat1 (129Stat1(-/-) (N-term)) had transient infection of the liver and spleen, but succumbed to encephalitis by day 10 post-infection. In stark contrast, infection of IFN alpha beta gamma R-/- mice was rapidly fatal, with associated viremia and fulminant infection of the liver and spleen, with infected infiltrating cells being primarily of the monocyte/macrophage lineage. To resolve the surprising difference between Stat1(-/-) and IFN alpha beta gamma R-/- mice, we infected an additional Stat1(-/-) strain deleted in the DNA-binding domain (129Stat1(-/-) (DBD)). These 129Stat1(-/-) (DBD) mice recapitulated the lethal pattern of liver and spleen infection seen following infection of IFN alpha beta gamma R-/- mice. This lethal pattern was also observed when 129Stat1(-/-) (N-term) mice were infected and treated with a Type I IFN-blocking antibody, and immune cells derived from 129Stat1(-/-) (N-term) mice were shown to be responsive to Type I IFN. These data therefore show significant differences in viral pathogenesis between two commonly-used Stat1(-/-) mouse strains. The data are consistent with the hypothesis that Stat1 2/2 (N-term) mice have residual Type I IFN receptor-dependent IFN responses. Complete loss of IFN signaling pathways allows viremia and rapid viral spread with a fatal infection of the liver. This study underscores the importance of careful comparisons between knockout mouse strains in viral pathogenesis, and may also be relevant to the causation of HSV hepatitis in humans, a rare but frequently fatal infection.	[Pasieka, Tracy Jo] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; [Collins, Lynne; Piwnica-Worms, David R.] Washington Univ, Sch Med, Mallinckrodt Inst Radiol, BRIGHT Inst,Mol Imaging Ctr, St Louis, MO 63110 USA; [O'Connor, Megan A.; Chen, Yufei; Parker, Zachary M.; Berwin, Brent L.; Leib, David A.] Dartmouth Med Sch, Dept Microbiol & Immunol, Lebanon, NH USA	Washington University (WUSTL); Washington University (WUSTL); Dartmouth College	Pasieka, TJ (corresponding author), Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA.	david.a.leib@dartmouth.edu		Berwin, Brent/0000-0001-9196-3256; O'Connor, Megan/0000-0003-2127-5073	National Institutes of Health [RO1 EY09083, P50-CA94056]; Department of Ophthalmology and Visual Sciences [P30-EY02687, P20RR16437-S1]; NATIONAL CANCER INSTITUTE [P50CA094056] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016437] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY002687, R01EY009083] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Ophthalmology and Visual Sciences; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	National Institutes of Health grants: RO1 EY09083 to David Leib, P50-CA94056 to David Piwinica-Worms, P30-EY02687 to the Department of Ophthalmology and Visual Sciences, P20RR16437-S1 to James Gorham. Research to Prevent Blindness Award (USA) to David Leib and The Department of Ophthalmology and Visual Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Casrouge A, 2006, SCIENCE, V314, P308, DOI 10.1126/science.1128346; Davido DJ, 2002, J VIROL, V76, P1077, DOI 10.1128/JVI.76.3.1077-1088.2002; Duerst RJ, 2004, VIROLOGY, V322, P158, DOI 10.1016/j.virol.2004.01.019; Dupuis S, 2003, NAT GENET, V33, P388, DOI 10.1038/ng1097; Durbin JE, 2002, J IMMUNOL, V168, P2944, DOI 10.4049/jimmunol.168.6.2944; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Gil MP, 2001, P NATL ACAD SCI USA, V98, P6680, DOI 10.1073/pnas.111163898; Grob P, 1999, J VIROL, V73, P4748, DOI 10.1128/JVI.73.6.4748-4754.1999; Halford WP, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-44; Halford WP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012251; Hofer MJ, J NEUROSCI, V1149-1157; Johnson KE, 2008, VIROLOGY, V374, P487, DOI 10.1016/j.virol.2008.01.001; Johnson KE, 2010, VIROLOGY, V396, P21, DOI 10.1016/j.virol.2009.09.021; Jouanguy E, 2007, BIOCHIMIE, V89, P878, DOI 10.1016/j.biochi.2007.04.016; Kao YS, 1999, AM J HEMATOL, V62, P93, DOI 10.1002/(SICI)1096-8652(199910)62:2<93::AID-AJH5>3.3.CO;2-Z; Karst SM, 2003, SCIENCE, V299, P1575, DOI 10.1126/science.1077905; Kato A, 2007, J VIROL, V81, P3264, DOI 10.1128/JVI.02590-06; Kimberlin David W, 2005, Semin Pediatr Infect Dis, V16, P7, DOI 10.1053/j.spid.2004.09.006; Kyle JL, 2007, J INFECT DIS, V195, P1808, DOI 10.1086/518007; Leib DA, 2002, CURR TOP MICROBIOL, V269, P171; Leib DA, 1999, J EXP MED, V189, P663, DOI 10.1084/jem.189.4.663; Luker GD, 2003, J VIROL, V77, P11082, DOI 10.1128/JVI.77.20.11082-11093.2003; Luker GD, 2002, J VIROL, V76, P12149, DOI 10.1128/JVI.76.23.12149-12161.2002; Lundberg P, 2003, J VIROL, V77, P11661, DOI 10.1128/JVI.77.21.11661-11673.2003; Meier KC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000614; Menachery VD, 2009, J VIROL, V83, P12399, DOI 10.1128/JVI.00888-09; Meraz MA, 1996, CELL, V84, P431, DOI 10.1016/S0092-8674(00)81288-X; MOGENSEN SC, 1977, INFECT IMMUN, V17, P268, DOI 10.1128/IAI.17.2.268-273.1977; Mott KR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-56; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Mumphrey SM, 2007, J VIROL, V81, P3251, DOI 10.1128/JVI.02096-06; Norvell JP, 2007, LIVER TRANSPLANT, V13, P1428, DOI 10.1002/lt.21250; Pasieka TJ, 2008, J VIROL, V82, P6052, DOI 10.1128/JVI.00297-08; Pasieka TJ, 2009, J VIROL, V83, P2075, DOI 10.1128/JVI.02007-08; Perry ST, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001297; RADER KA, 1993, J GEN VIROL, V74, P1859, DOI 10.1099/0022-1317-74-9-1859; Ramana CV, 2001, P NATL ACAD SCI USA, V98, P6674, DOI 10.1073/pnas.111164198; Ramana CV, 2000, ONCOGENE, V19, P2619, DOI 10.1038/sj.onc.1203525; Ryman KD, 2007, VIROLOGY, V368, P273, DOI 10.1016/j.virol.2007.06.039; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Seksik P, 1999, INTENS CARE MED, V25, P415, DOI 10.1007/s001340050869; Sheehan KCF, 2006, J INTERF CYTOK RES, V26, P804, DOI 10.1089/jir.2006.26.804; Shresta S, 2005, J IMMUNOL, V175, P3946, DOI 10.4049/jimmunol.175.6.3946; Shresta S, 2004, J VIROL, V78, P2701, DOI 10.1128/JVI.78.6.2701-2710.2004; SMITH KO, 1964, P SOC EXP BIOL MED, V115, P814, DOI 10.3181/00379727-115-29045; Spath GF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000381; SULLENDER WM, 1987, J INFECT DIS, V155, P28, DOI 10.1093/infdis/155.1.28; Summers BC, 2002, J VIROL, V76, P7020, DOI 10.1128/JVI.76.14.7020-7029.2002; Tanaka N, 1998, GENES CELLS, V3, P29, DOI 10.1046/j.1365-2443.1998.00164.x; TANG JL, 1988, MICROBIOL IMMUNOL, V32, P363, DOI 10.1111/j.1348-0421.1988.tb01396.x; TENNEY DJ, 1987, J IMMUNOL, V139, P3076; Toi M, 2001, PATHOL INT, V51, P288, DOI 10.1046/j.1440-1827.2001.01191.x; VANDENBROEK MF, 1995, J VIROL, V69, P4792, DOI 10.1128/JVI.69.8.4792-4796.1995; vandenBroek MF, 1995, IMMUNOL REV, V148, P5; Vollstedt S, 2004, J VIROL, V78, P3846, DOI 10.1128/JVI.78.8.3846-3850.2004; Vollstedt S, 2003, J EXP MED, V197, P575, DOI 10.1084/jem.20021900; ZAWATZKY R, 1982, J INFECT DIS, V146, P405, DOI 10.1093/infdis/146.3.405; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522	58	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2011	6	9							e24018	10.1371/journal.pone.0024018	http://dx.doi.org/10.1371/journal.pone.0024018			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CH	21915277	Green Published, gold			2022-12-25	WOS:000294802500023
J	Yang, MH; Lin, BR; Chang, CH; Chen, ST; Lin, SK; Kuo, MYP; Jeng, YM; Kuo, ML; Chang, CC				Yang, M-H; Lin, B-R; Chang, C-H; Chen, S-T; Lin, S-K; Kuo, M. Y-P; Jeng, Y-M; Kuo, M-L; Chang, C-C			Connective tissue growth factor modulates oral squamous cell carcinoma invasion by activating a miR-504/FOXP1 signalling	ONCOGENE			English	Article						connective tissue growth factor; microRNA-504; forkhead box P1; oral squamous cell carcinoma; invasion	TUMOR-SUPPRESSOR; FACTOR CTGF; CCN FAMILY; CANCER CELLS; GENE FAMILY; LUNG; METASTASIS; EXPRESSION; MOTILITY; OVEREXPRESSION	Connective tissue growth factor (CTGF) is a multifunctional secreted protein, and it has been shown either to promote or suppress tumor progression among different kinds of cancers. Here, we investigated the role of CTGF in oral squamous cell carcinoma (OSCC) invasion and metastasis. In five OSCC cell lines, endogenous CTGF negatively correlated with invasiveness. Exogenous CTGF protein or forced expression of CTGF gene in the oral cancer cell line SAS significantly decreased their invasive and migratory abilities. MicroRNA (miRNA) microarray analysis was performed in CTGF-overexpressed SAS cells (SAS/CTGF-M3) versus control cells to investigate the mechanism of CTGF-mediated inhibition of OSCC invasion. Among the miRNAs regulated by CTGF, miR-504 and miR-346 were the top two miRNAs downregulated in CTGF transfectants, and the result was confirmed by quantitative reverse transcriptase-PCR. Ectopic miR-504 increased migration and invasion in SAS/CTGF-M3, however, miR-346 did not have such impact on migration/invasion. Furthermore, we identified FOXP1, a member of forkhead transcription factors, as a target gene that takes part in the miR-504-induced cellular invasion. Knockdown of FOXP1 increased invasiveness in SAS/CTGF-M3, confirming the signal axis of CTGF/miR-504/FOXP1 in OSCC. Animal experiments showed that SAS/CTGF-M3-formed orthotopic tumors were associated with a lesser invasive phenotype than control cells. Expression of miR-504 in SAS/CTGF-M3 increased lymph node metastasis, and co-expression of FOXP1 in miR-504-transfected SAS/CTGF-M3 alleviated miR-504-induced metastasis. In OSCC samples, high CTGF was associated with a lower clinical stage and a better outcome. A reverse correlation between CTGF and miR-504, miR-504 and FOXP1, and a positive correlation between CTGF and FOXP1 were shown. Our study discovers a novel signal pathway involving the regulation of miRNA machinery by a secreted cytokine, which will be beneficial for developing therapeutic strategy against advanced OSCC. Oncogene (2012) 31, 2401-2411; doi: 10.1038/onc.2011.423; published online 19 September 2011	[Chang, C-H; Chang, C-C] Natl Taiwan Univ, Sch Dent, Grad Inst Oral Biol, Taipei 100, Taiwan; [Yang, M-H] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Yang, M-H] Taipei Vet Gen Hosp, Dept Med, Div Hematol Oncol, Taipei, Taiwan; [Lin, B-R] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Chen, S-T] Natl Taiwan Univ Hosp, Dept Pediat, Yun Lin Branch, Taipei 10016, Taiwan; [Lin, S-K; Kuo, M. Y-P] Natl Taiwan Univ, Sch Dent, Grad Inst Clin Dent, Taipei 100, Taiwan; [Jeng, Y-M] Natl Taiwan Univ Hosp, Dept Pathol, Taipei 100, Taiwan; [Kuo, M-L] Natl Taiwan Univ, Coll Med, Inst Toxicol, Taipei 100, Taiwan	National Taiwan University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Chang, CC (corresponding author), Natl Taiwan Univ, Sch Dent, Grad Inst Oral Biol, Taipei 100, Taiwan.	ccclrc@gmail.com	Yang, Muh-Hwa/AAE-4691-2020	LIN, BEEN-REN/0000-0001-8354-1758; JENG, YUNG-MING/0000-0002-3878-4491; LIN, SZE-KWAN/0000-0002-7969-0280; KUO, MIN-LIANG/0000-0002-7139-0144; CHANG, CHIA-HSUIN/0000-0003-0024-6177; Chen, Szu-Ta/0000-0002-9715-1221	National Science Council, Taiwan [NSC-97-2314-B-002-031-MY2, NSC-98-2320-B-002-003, NSC-99-2314-B-010-007-MY3]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants from National Science Council, Taiwan NSC-97-2314-B-002-031-MY2, NSC-98-2320-B-002-003 (to CCC) and NSC-99-2314-B-010-007-MY3 (to MHY).	Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; Banham AH, 2001, CANCER RES, V61, P8820; Brigstock DR, 1999, ENDOCR REV, V20, P189, DOI 10.1210/er.20.2.189; Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780; Chan CS, 2005, PLOS COMPUT BIOL, V1, P564, DOI 10.1371/journal.pcbi.0010069; Chang CC, 2004, JNCI-J NATL CANCER I, V96, P364, DOI 10.1093/jnci/djh059; Chen PS, 2007, J CELL SCI, V120, P2053, DOI 10.1242/jcs.03460; Chu CY, 2008, J BIOMED SCI, V15, P675, DOI 10.1007/s11373-008-9264-9; Chu YW, 1997, AM J RESP CELL MOL, V17, P353, DOI 10.1165/ajrcmb.17.3.2837; Chuang JY, 2011, INT IMMUNOPHARMACOL, V11, P948, DOI 10.1016/j.intimp.2011.02.008; Haddad RI, 2008, NEW ENGL J MED, V359, P1143, DOI 10.1056/NEJMra0707975; Hashimoto Y, 1998, J EXP MED, V187, P289, DOI 10.1084/jem.187.3.289; Hu WW, 2010, MOL CELL, V38, P689, DOI 10.1016/j.molcel.2010.05.027; Huebner K, 2001, P NATL ACAD SCI USA, V98, P14763, DOI 10.1073/pnas.261586598; Jerjes W, 2010, HEAD NECK ONCOL, V2, DOI 10.1186/1758-3284-2-9; JOLIOT V, 1992, MOL CELL BIOL, V12, P10, DOI 10.1128/MCB.12.1.10; Kademani D, 2007, MAYO CLIN PROC, V82, P878, DOI 10.4065/82.7.878; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Katoh M, 2004, INT J ONCOL, V25, P1495; Koliopanos A, 2002, WORLD J SURG, V26, P420, DOI 10.1007/s00268-001-0242-x; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Lau LF, 1999, EXP CELL RES, V248, P44, DOI 10.1006/excr.1999.4456; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lin BR, 2005, GASTROENTEROLOGY, V128, P9, DOI 10.1053/j.gastro.2004.10.007; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Moritani NH, 2003, CANCER LETT, V192, P205, DOI 10.1016/S0304-3835(02)00718-8; OBRIEN TP, 1990, MOL CELL BIOL, V10, P3569, DOI 10.1128/MCB.10.7.3569; Pan LH, 2002, NEUROL RES, V24, P677, DOI 10.1179/016164102101200573; Perbal B, 2001, J CLIN PATHOL-MOL PA, V54, P103, DOI 10.1136/mp.54.2.103; Planque N, 2003, CANCER CELL INT, V3, DOI 10.1186/1475-2867-3-15; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Scott GK, 2006, CANCER RES, V66, P1277, DOI 10.1158/0008-5472.CAN-05-3632; Shimo T, 2008, ANTICANCER RES, V28, P2343; Soon LL, 2003, J BIOL CHEM, V278, P11465, DOI 10.1074/jbc.M210945200; Tong XJ, 2001, J BIOL CHEM, V276, P47709, DOI 10.1074/jbc.M107878200; VOKES EE, 1993, NEW ENGL J MED, V328, P184, DOI 10.1056/NEJM199301213280306; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Wutzl A, 2007, J ORAL MAXIL SURG, V65, P255, DOI 10.1016/j.joms.2006.09.007; Xue ZH, 2010, J IMMUNOL, V184, P3697, DOI 10.4049/jimmunol.0903316; Yosimichi G, 2001, EUR J BIOCHEM, V268, P6058, DOI 10.1046/j.0014-2956.2001.02553.x; Zabarovsky ER, 2002, ONCOGENE, V21, P6915, DOI 10.1038/sj.onc.1205835	41	67	69	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2012	31	19					2401	2411		10.1038/onc.2011.423	http://dx.doi.org/10.1038/onc.2011.423			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	941SP	21927029	Green Submitted			2022-12-25	WOS:000303985300003
J	Agarwal, S; Agarwal, S; Pancholi, P; Pancholi, V				Agarwal, Shivani; Agarwal, Shivangi; Pancholi, Preeti; Pancholi, Vijay			Role of Serine/Threonine Phosphatase (SP-STP) in Streptococcus pyogenes Physiology and Virulence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-A STREPTOCOCCUS; FATTY-ACID BIOSYNTHESIS; GRAM-POSITIVE BACTERIA; STAPHYLOCOCCUS-AUREUS; EUKARYOTIC-TYPE; REGULATORY NETWORKS; SIGNAL-TRANSDUCTION; GENE-REGULATION; PROTEIN-KINASE; CELL-SHAPE	Reversible phosphorylation is the key mechanism regulating several cellular events in prokaryotes and eukaryotes. In prokaryotes, signal transduction is perceived to occur primarily via the two-component signaling system involving histidine kinases and cognate response regulators. Although an alternative regulatory pathway controlled by the eukaryote-type serine/threonine kinase (Streptococcus pyogenes serine/threonine kinase; SP-STK) has been shown to modulate bacterial growth, division, adherence, invasion, and virulence in group A Streptococcus (GAS; S. pyogenes), the precise role of the co-transcribing serine/threonine phosphatase (SP-STP) has remained enigmatic. In this context, this is the first report describing the construction and characterization of non-polar SP-STP mutants in two different strains of Type M1 GAS. The STP knock-out mutants displayed increased bacterial chain lengths in conjunction with thickened cell walls, significantly reduced capsule and hemolysin production, and restoration of the phenotypes postcomplementation. The present study also reveals important contribution of cognately regulated-reversible phosphorylation by SP-STK/SP-STP on two major response regulators of two-component systems, WalRK and CovRS. We also demonstrate a distinct role of SP-STP in terms of expression of surface proteins and SpeB in a strain-specific manner. Further, the attenuation of virulence in the absence of SIP and its restoration only in the complemented strains that were generated by the use of a low copy plasmid and not by a high copy one emphasize not only the essential role of STP in virulence but also highlight the tightly regulated SP-STP/SP-STK-mediated cognate functions. SP-STP thus is an important regulator of GAS virulence and plays a critical role in GAS pathogenesis.	[Agarwal, Shivani; Agarwal, Shivangi; Pancholi, Preeti; Pancholi, Vijay] Ohio State Univ, Coll Med, Dept Pathol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Pancholi, V (corresponding author), 420 W 12th Ave,TMRF 288A, Columbus, OH 43210 USA.	Vijay.Pancholi@osumc.edu	Pancholi, Vijay/E-3810-2011	Agarwal, Shivangi/0000-0002-2406-7678	National Institutes of Health [AI-64912, AI-76889]; Ohio State University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI076889, R21AI064912] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ohio State University(Ohio State University); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI-64912 and AI-76889 (to V. P.). This work was also supported by Ohio State University departmental funds (to P. P.).	Aziz RK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009798; Balemans W, 2010, NATURE, V463, pE3, DOI 10.1038/nature08667; Banu LD, 2010, INFECT IMMUN, V78, P2209, DOI 10.1128/IAI.01167-09; Barendt SM, 2009, J BACTERIOL, V191, P3024, DOI 10.1128/JB.01505-08; Barnett TC, 2007, J BACTERIOL, V189, P1866, DOI 10.1128/JB.01658-06; Beltramini AM, 2009, INFECT IMMUN, V77, P1406, DOI 10.1128/IAI.01499-08; Biswas I, 2008, MICROBIOL-SGM, V154, P2275, DOI 10.1099/mic.0.2008/019265-0; Bugrysheva J, 2011, INFECT IMMUN, V79, P4201, DOI 10.1128/IAI.05360-11; Burnside K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011071; Cabeen MT, 2005, NAT REV MICROBIOL, V3, P601, DOI 10.1038/nrmicro1205; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Chaffin DO, 1998, GENE, V219, P91, DOI 10.1016/S0378-1119(98)00396-5; Chatellier S, 2000, INFECT IMMUN, V68, P3523, DOI 10.1128/IAI.68.6.3523-3534.2000; Choi KH, 2000, J BACTERIOL, V182, P365, DOI 10.1128/JB.182.2.365-370.2000; Churchward G, 2007, MOL MICROBIOL, V64, P34, DOI 10.1111/j.1365-2958.2007.05649.x; de Hoon MJL, 2005, PLOS COMPUT BIOL, V1, P212, DOI 10.1371/journal.pcbi.0010025; Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398; Fozo EA, 2004, APPL ENVIRON MICROB, V70, P929, DOI 10.1128/AEM.70.2.929-936.2004; Fozo EM, 2007, INFECT IMMUN, V75, P1537, DOI 10.1128/IAI.01938-06; Fujita Y, 2007, MOL MICROBIOL, V66, P829, DOI 10.1111/j.1365-2958.2007.05947.x; Grady R, 2003, MOL MICROBIOL, V47, P1419, DOI 10.1046/j.1365-2958.2003.03387.x; Hollands A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004102; Jin H, 2006, J MOL BIOL, V357, P1351, DOI 10.1016/j.jmb.2006.01.020; Jin H, 2011, MBIO, V2, DOI 10.1128/mBio.00068-11; Kreikemeyer B, 2003, TRENDS MICROBIOL, V11, P224, DOI 10.1016/S0966-842X(03)00098-2; Lu YJ, 2006, MOL MICROBIOL, V59, P551, DOI 10.1111/j.1365-2958.2005.04951.x; Madec E, 2002, MOL MICROBIOL, V46, P571, DOI 10.1046/j.1365-2958.2002.03178.x; McIver KS, 2009, CONTRIB MICROBIOL, V16, P103, DOI 10.1159/000219375; Musser JM, 2009, J CLIN INVEST, V119, P2455, DOI 10.1172/JCI38095; Ng WL, 2003, MOL MICROBIOL, V50, P1647, DOI 10.1046/j.1365-2958.2003.03806.x; PANCHOLI V, 1992, J EXP MED, V176, P415, DOI 10.1084/jem.176.2.415; Pancholi V, 2010, J BIOL CHEM, V285, P30861, DOI 10.1074/jbc.M110.153825; Pereira SFF, 2011, MICROBIOL MOL BIOL R, V75, P192, DOI 10.1128/MMBR.00042-10; Podbielski A, 1996, GENE, V177, P137, DOI 10.1016/0378-1119(96)84178-3; Rajagopal L, 2003, J BIOL CHEM, V278, P14429, DOI 10.1074/jbc.M212747200; Rajagopal L, 2006, MOL MICROBIOL, V62, P941, DOI 10.1111/j.1365-2958.2006.05431.x; Ravins M, 2000, J INFECT DIS, V182, P1702, DOI 10.1086/317635; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Singh VK, 2008, APPL ENVIRON MICROB, V74, P5882, DOI 10.1128/AEM.00882-08; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Sumby P, 2005, J INFECT DIS, V192, P771, DOI 10.1086/432514; Sun Y, 2010, INFECT IMMUN, V78, P4667, DOI 10.1128/IAI.00546-10; Treuner-Lange A, 2001, MOL MICROBIOL, V40, P126, DOI 10.1046/j.1365-2958.2001.02362.x; Ulijasz AT, 2009, MOL MICROBIOL, V71, P382, DOI 10.1111/j.1365-2958.2008.06532.x; Ulrich LE, 2007, NUCLEIC ACIDS RES, V35, pD386, DOI 10.1093/nar/gkl932; Wehenkel A, 2007, J MOL BIOL, V374, P890, DOI 10.1016/j.jmb.2007.09.076; Winkler ME, 2008, J BACTERIOL, V190, P2645, DOI 10.1128/JB.01682-07; Zapun A, 2008, FEMS MICROBIOL REV, V32, P361, DOI 10.1111/j.1574-6976.2007.00095.x	48	35	37	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 2	2011	286	48					41368	41380		10.1074/jbc.M111.286690	http://dx.doi.org/10.1074/jbc.M111.286690			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	861YR	21917918	Green Published, hybrid			2022-12-25	WOS:000298057500024
J	Bedekovics, T; Li, HQ; Gajdos, GB; Isaya, G				Bedekovics, Tibor; Li, Hongqiao; Gajdos, Gabriella B.; Isaya, Grazia			Leucine Biosynthesis Regulates Cytoplasmic Iron-Sulfur Enzyme Biogenesis in an Atm1p-independent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABC TRANSPORTER ATM1P; CYTOSOLIC FE/S PROTEINS; SACCHAROMYCES-CEREVISIAE; YEAST FRATAXIN; CLUSTER BIOGENESIS; IN-VITRO; EXPRESSION; MATURATION; MITOCHONDRIA; ACONITASE	Fe-S clusters (ISCs) are versatile cofactors utilized by many mitochondrial, cytoplasmic, and nuclear enzymes. Whereas mitochondria can independently initiate and complete ISC synthesis, other cellular compartments are believed to assemble ISCs from putative precursors exported from the mitochondria via an ATP binding cassette (ABC) transporter conserved from yeast (Atm1p) to humans (ABCB7). However, the regulatory interactions between mitochondrial and extramitochondrial ISC synthesis are largely unknown. In yeast, we found that mitochondrial ISC synthesis is regulated by the leucine biosynthetic pathway, which among other proteins involves an abundant cytoplasmic [4Fe-4S] enzyme, Leu1p. Enzymatic blocks in the pathway (i.e. leu1 Delta or leu2 Delta gene deletion mutations) induced post-transcriptional up-regulation of core components of mitochondrial ISC biosynthesis (i.e. the sulfur donor Nfs1p, the iron donor Yfh1p, and the ISC scaffold Isu1p). In leu2 Delta cells, transcriptional mechanisms also led to dramatic up-regulation of Leu1p with concomitant down-regulation of mitochondrial aconitase (Aco1p), a [4Fe-4S] enzyme in the tricarboxylic acid cycle. Accordingly, the leu2 Delta deletion mutation exacerbated Aco1p inactivation in cells with mutations in Yfh1p. These data indicate that defects in leucine biosynthesis promote the biogenesis of enzymatically active Leu1p at the expense of Aco1p activity. Surprisingly, this effect is independent of Atm1p; previous reports linking the loss of Leu1p activity to Atm1p depletion were confounded by the fact that LEU2 was used as a selectable marker to create Atm1p-depleted cells, whereas a leu2 Delta allele was present in Atm1p-repleted controls. Thus, still largely unknown transcriptional and post-transcriptional mechanisms control ISC distribution between mitochondria and other cellular compartments.	[Bedekovics, Tibor; Li, Hongqiao; Isaya, Grazia] Mayo Clin, Dept Pediat & Adolescent Med, Rochester, MN 55905 USA; [Bedekovics, Tibor; Li, Hongqiao; Isaya, Grazia] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Gajdos, Gabriella B.] Mayo Clin, Ctr Basic Res Digest Dis, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Isaya, G (corresponding author), Mayo Clin, Dept Pediat & Adolescent Med, 200 1st St SW,Stabile 7-52, Rochester, MN 55905 USA.	isaya@mayo.edu			National Institutes of Health [AG15709]; Friedreich Ataxia Research Alliance and Muscular Dystrophy Association; Mayo Clinic Department of Pediatric and Adolescent Medicine; NATIONAL INSTITUTE ON AGING [R01AG015709] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Friedreich Ataxia Research Alliance and Muscular Dystrophy Association; Mayo Clinic Department of Pediatric and Adolescent Medicine; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG15709 (to G. I.). This work was also supported by grants from the Friedreich Ataxia Research Alliance and Muscular Dystrophy Association (to G. I.) and the Mayo Clinic Department of Pediatric and Adolescent Medicine (to T. B. and H. L).	Andrew AJ, 2008, MOL BIOL CELL, V19, P5259, DOI 10.1091/mbc.E08-06-0622; Balk J, 2005, MOL CELL BIOL, V25, P10833, DOI 10.1128/MCB.25.24.10833-10841.2005; BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; Boer VM, 2005, FEMS YEAST RES, V5, P885, DOI 10.1016/j.femsyr.2005.04.003; Campanella A, 2004, HUM MOL GENET, V13, P2279, DOI 10.1093/hmg/ddh232; CARLSON M, 1982, CELL, V28, P145, DOI 10.1016/0092-8674(82)90384-1; Cavadini P, 2007, BLOOD, V109, P3552, DOI 10.1182/blood-2006-08-041632; Chen OS, 2000, J BIOL CHEM, V275, P7626, DOI 10.1074/jbc.275.11.7626; Chen XJ, 2005, SCIENCE, V307, P714, DOI 10.1126/science.1106391; Chloupkova M, 2004, FEBS LETT, V569, P65, DOI 10.1016/j.febslet.2004.05.051; DAUM G, 1982, J BIOL CHEM, V257, P3028; Desmyter L, 2004, EXP GERONTOL, V39, P707, DOI 10.1016/j.exger.2004.01.008; Fabrizio Paola, 2007, Methods Mol Biol, V371, P89; Fansler B., 1969, METHODS ENZYMOL, V13, P26; Fontecave M, 2008, ARCH BIOCHEM BIOPHYS, V474, P226, DOI 10.1016/j.abb.2007.12.014; Foury F, 2002, J BIOL CHEM, V277, P24475, DOI 10.1074/jbc.M111789200; Foury F, 2007, EMBO REP, V8, P194, DOI 10.1038/sj.embor.7400881; Gakh O, 2006, HUM MOL GENET, V15, P467, DOI 10.1093/hmg/ddi461; Gakh O, 2008, J BIOL CHEM, V283, P31500, DOI 10.1074/jbc.M805415200; Gakh O, 2010, J BIOL CHEM, V285, P38486, DOI 10.1074/jbc.M110.145144; Gardner PR, 2002, METHOD ENZYMOL, V349, P9, DOI 10.1016/S0076-6879(02)49317-2; GARDNER PR, 1994, P NATL ACAD SCI USA, V91, P12248, DOI 10.1073/pnas.91.25.12248; Gerber J, 2004, MOL CELL BIOL, V24, P4848, DOI 10.1128/MCB.24.11.4848-4857.2004; Gerber J, 2003, EMBO REP, V4, P906, DOI 10.1038/sj.embor.embor918; GUARENTE L, 1983, METHOD ENZYMOL, V101, P181; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Hellauer K, 1996, MOL CELL BIOL, V16, P6096; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Kispal G, 1997, FEBS LETT, V418, P346, DOI 10.1016/S0014-5793(97)01414-2; Kispal G, 1999, EMBO J, V18, P3981, DOI 10.1093/emboj/18.14.3981; KOHLHAW GB, 1988, METHOD ENZYMOL, V166, P429; Kohlhaw GB, 2003, MICROBIOL MOL BIOL R, V67, P1, DOI 10.1128/MMBR.67.1.1-15.2003; Kuhnke G, 2006, MOL MEMBR BIOL, V23, P173, DOI 10.1080/09687860500473630; Lange H, 2000, P NATL ACAD SCI USA, V97, P1050, DOI 10.1073/pnas.97.3.1050; LEIGHTON J, 1995, EMBO J, V14, P188, DOI 10.1002/j.1460-2075.1995.tb06989.x; Li HQ, 2009, J BIOL CHEM, V284, P21971, DOI 10.1074/jbc.M109.011197; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Lill R, 2009, NATURE, V460, P831, DOI 10.1038/nature08301; Liu X, 2006, GENOME RES, V16, P1517, DOI 10.1101/gr.5655606; Miao R, 2009, BIOCHEMISTRY-US, V48, P9556, DOI 10.1021/bi901110n; Muhlenhoff U, 2003, EMBO J, V22, P4815, DOI 10.1093/emboj/cdg446; Muhlenhoff U, 2002, HUM MOL GENET, V11, P2025, DOI 10.1093/hmg/11.17.2025; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; Prohl C, 2000, METHOD ENZYMOL, V324, P365; Rouault TA, 2008, TRENDS GENET, V24, P398, DOI 10.1016/j.tig.2008.05.008; Schilke B, 1999, P NATL ACAD SCI USA, V96, P10206, DOI 10.1073/pnas.96.18.10206; SIKORSKI RS, 1989, GENETICS, V122, P19; Sipos K, 2002, J BIOL CHEM, V277, P26944, DOI 10.1074/jbc.M200677200; SZE JY, 1992, SCIENCE, V258, P1143, DOI 10.1126/science.1439822; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Ye H, 2010, BIOCHEMISTRY-US, V49, P4945, DOI 10.1021/bi1004798	51	17	19	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40878	40888		10.1074/jbc.M111.270082	http://dx.doi.org/10.1074/jbc.M111.270082			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21926174	hybrid, Green Published			2022-12-25	WOS:000297315400048
J	Lorda-Diez, CI; Montero, JA; Diaz-Mendoza, MJ; Garcia-Porrero, JA; Hurle, JM				Lorda-Diez, Carlos I.; Montero, Juan A.; Diaz-Mendoza, Manuel J.; Garcia-Porrero, Juan A.; Hurle, Juan M.			Defining the Earliest Transcriptional Steps of Chondrogenic Progenitor Specification during the Formation of the Digits in the Embryonic Limb	PLOS ONE			English	Article							IN-VITRO CHONDROGENESIS; N-CADHERIN; CHONDROCYTE DIFFERENTIATION; SKELETAL DEVELOPMENT; CARTILAGE FORMATION; MESENCHYMAL CHONDROGENESIS; CELL CONDENSATION; HOMEOBOX GENE; BONE-MARROW; CCN FAMILY	The characterization of genes involved in the formation of cartilage is of key importance to improve cell-based cartilage regenerative therapies. Here, we have developed a suitable experimental model to identify precocious chondrogenic events in vivo by inducing an ectopic digit in the developing embryo. In this model, only 12 hr after the implantation of a Tgf beta bead, in the absence of increased cell proliferation, cartilage forms in undifferentiated interdigital mesoderm and in the course of development, becomes a structurally and morphologically normal digit. Systematic quantitative PCR expression analysis, together with other experimental approaches allowed us to establish 3 successive periods preceding the formation of cartilage. The "pre-condensation stage", occurring within the first 3 hr of treatment, is characterized by the activation of connective tissue identity transcriptional factors (such as Sox9 and Scleraxis) and secreted factors (such as Activin A and the matricellular proteins CCN-1 and CCN-2) and the downregulation of the galectin CG-8. Next, the "condensation stage" is characterized by intense activation of Smad 1/5/8 BMP-signaling and increased expression of extracellular matrix components. During this period, the CCN matricellular proteins promote the expression of extracellular matrix and cell adhesion components. The third period, designated the "pre-cartilage period", precedes the formation of molecularly identifiable cartilage by 2-3 hr and is characterized by the intensification of Sox 9 gene expression, along with the stimulation of other pro-chondrogenic transcription factors, such as HifIa. In summary, this work establishes a temporal hierarchy in the regulation of pro-chondrogenic genes preceding cartilage differentiation and provides new insights into the relative roles of secreted factors and cytoskeletal regulators that direct the first steps of this process in vivo.	[Lorda-Diez, Carlos I.] Univ Cantabria, Dept Anat & Biol Celular, E-39005 Santander, Spain; Univ Cantabria, Inst Formac & Invest Marques de Valdecilla, E-39005 Santander, Spain	Universidad de Cantabria; Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria	Lorda-Diez, CI (corresponding author), Univ Cantabria, Dept Anat & Biol Celular, E-39005 Santander, Spain.	hurlej@unican.es	Montero, Juan A/K-4395-2014; Lorda-Diez, Carlos I./J-7990-2019	Montero, Juan A/0000-0001-9099-5344; Lorda-Diez, Carlos I./0000-0002-3248-9918; Hurle, Juan M/0000-0002-4685-025X	Spanish Science and Innovation Ministry [BFU2008-03930]; Science and Innovation Spanish Ministry (MICINN);  [FMV-UC 09/01]	Spanish Science and Innovation Ministry(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Science and Innovation Spanish Ministry (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); 	This work was supported by a grant from the Spanish Science and Innovation Ministry to JMH (BFU2008-03930) and FMV-UC 09/01. MJDM is a recipient of a predoctoral FPI fellowship from the Science and Innovation Spanish Ministry (MICINN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrovich A, 2008, DEV BIOL, V314, P457, DOI 10.1016/j.ydbio.2007.12.001; Amarilio R, 2007, DEVELOPMENT, V134, P3917, DOI 10.1242/dev.008441; Arikawa T, 2009, BONE, V44, P849, DOI 10.1016/j.bone.2009.01.365; Bai XH, 2009, CELL MOL LIFE SCI, V66, P667, DOI 10.1007/s00018-008-8633-x; Bandyopadhyay A, 2006, PLOS GENET, V2, P2116, DOI 10.1371/journal.pgen.0020216; Barna M, 2007, DEV CELL, V12, P931, DOI 10.1016/j.devcel.2007.04.016; Bhat R, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-6; Brigstock DR, 2003, J ENDOCRINOL, V178, P169, DOI 10.1677/joe.0.1780169; Buchberger A, 1998, DEV DYNAM, V212, P94, DOI 10.1002/(SICI)1097-0177(199805)212:1<94::AID-AJA9>3.3.CO;2-Q; Cameron TL, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-20; Chen CC, 2009, INT J BIOCHEM CELL B, V41, P771, DOI 10.1016/j.biocel.2008.07.025; Chimal-Monroy J, 2003, DEV BIOL, V257, P292, DOI 10.1016/S0012-1606(03)00066-6; Choocheep K, 2010, J BIOL CHEM, V285, P21114, DOI 10.1074/jbc.M109.096479; Church V, 2005, ANAT EMBRYOL, V209, P461, DOI 10.1007/s00429-005-0464-z; Connors SA, 1999, DEVELOPMENT, V126, P3119; Delise AM, 2002, DEV DYNAM, V225, P195, DOI 10.1002/dvdy.10151; Djouad F, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2153; Dudics V, 2009, CELLS TISSUES ORGANS, V189, P307, DOI 10.1159/000140679; Fell HB, 1925, J MORPHOL PHYSIOL, V40, P417, DOI 10.1002/jmor.1050400302; Furumatsu T, 2010, INT J BIOCHEM CELL B, V42, P148, DOI 10.1016/j.biocel.2009.10.003; Furumatsu T, 2010, BIOCHEM BIOPH RES CO, V391, P1142, DOI 10.1016/j.bbrc.2009.12.044; Ganan Y, 1996, DEVELOPMENT, V122, P2349; Gehris AL, 1997, DEV BIOL, V190, P191, DOI 10.1006/dbio.1997.8693; Gong GC, 2010, J CELL PHYSIOL, V224, P664, DOI 10.1002/jcp.22166; Hall BK, 2000, BIOESSAYS, V22, P138, DOI 10.1002/(SICI)1521-1878(200002)22:2<138::AID-BIES5>3.3.CO;2-W; Heath E, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-18; Hellingman CA, 2010, TISSUE ENG PT A, V16, P545, DOI [10.1089/ten.tea.2008.0551, 10.1089/ten.TEA.2008.0551]; Huang AH, 2010, TISSUE ENG PT A, V16, P2699, DOI [10.1089/ten.tea.2010.0042, 10.1089/ten.TEA.2010.0042]; Hudson KS, 2010, ANAT REC, V293, P1669, DOI 10.1002/ar.21235; HURLE JM, 1990, CELL DIFFER DEV, V30, P97, DOI 10.1016/0922-3371(90)90078-B; Ivkovic S, 2003, DEVELOPMENT, V130, P2779, DOI 10.1242/dev.00505; Jahchan NS, 2010, CURR OPIN PHARMACOL, V10, P670, DOI 10.1016/j.coph.2010.08.006; Jin EJ, 2007, DEV BIOL, V308, P474, DOI 10.1016/j.ydbio.2007.06.003; Karamboulas K, 2010, J CELL SCI, V123, P2067, DOI 10.1242/jcs.062901; Katsube K, 2009, DEV GROWTH DIFFER, V51, P55, DOI 10.1111/j.1440-169X.2009.01077.x; Keller B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016421; Kim D, 2009, J CELL PHYSIOL, V221, P161, DOI 10.1002/jcp.21840; Kitzing TM, 2010, ONCOGENE, V29, P2441, DOI 10.1038/onc.2009.515; Knudson CB, 2001, SEMIN CELL DEV BIOL, V12, P69, DOI 10.1006/scdb.2000.0243; Kular L, 2011, BIOCHIMIE, V93, P377, DOI 10.1016/j.biochi.2010.11.010; Lafont J, 2005, J BONE MINER RES, V20, P2213, DOI 10.1359/JBMR.050818; Lefebvre Veronique, 2005, Birth Defects Research, V75, P200, DOI 10.1002/bdrc.20048; Lengner CJ, 2005, J BIOL CHEM, V280, P15872, DOI 10.1074/jbc.M411144200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorda-Diez CI, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-69; Lorda-Diez CI, 2009, J BIOL CHEM, V284, P29988, DOI 10.1074/jbc.M109.014811; Lu MF, 1999, DEV BIOL, V205, P145, DOI 10.1006/dbio.1998.9116; Luo Y, 2005, DEV DYNAM, V232, P336, DOI 10.1002/dvdy.20241; Marcon P, 2005, BIOMATERIALS, V26, P4975, DOI 10.1016/j.biomaterials.2005.01.044; Marsich E, 2008, MATRIX BIOL, V27, P513, DOI 10.1016/j.matbio.2008.04.003; Merino R, 1999, DEVELOPMENT, V126, P2161; MONTERO JA, 2011, J TISSUE EN IN PRESS; Montero JA, 2008, DEV BIOL, V321, P343, DOI 10.1016/j.ydbio.2008.06.022; Montero JA, 2007, DEV BIOL, V303, P325, DOI 10.1016/j.ydbio.2006.11.019; Murchison ND, 2007, DEVELOPMENT, V134, P2697, DOI 10.1242/DEV.001933; Ohno S, 2002, BBA-GEN SUBJECTS, V1572, P114, DOI 10.1016/S0304-4165(02)00286-6; Pala D, 2008, J BIOL CHEM, V283, P9239, DOI 10.1074/jbc.M705175200; Perbal B, 2001, J CLIN PATHOL-MOL PA, V54, P57, DOI 10.1136/mp.54.2.57; Peterson RE, 2005, DEV DYNAM, V233, P811, DOI 10.1002/dvdy.20412; Provot S, 2007, J CELL BIOL, V177, P451, DOI 10.1083/jcb.200612023; Rich JT, 2008, BIOCHEM BIOPH RES CO, V372, P230, DOI 10.1016/j.bbrc.2008.05.022; Rodrigo I, 2003, DEVELOPMENT, V130, P473, DOI 10.1242/dev.00240; ROS MA, 1995, ANAT EMBRYOL, V192, P483; Schweitzer R, 2001, DEVELOPMENT, V128, P3855; Sekiya I, 2002, P NATL ACAD SCI USA, V99, P4397, DOI 10.1073/pnas.052716199; Song JJ, 2007, J CELL PHYSIOL, V210, P398, DOI 10.1002/jcp.20850; Sperber SM, 2008, DEV BIOL, V321, P101, DOI 10.1016/j.ydbio.2008.06.004; Stadler HS, 2001, DEVELOPMENT, V128, P4177; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; TAVELLA S, 1994, EXP CELL RES, V215, P354, DOI 10.1006/excr.1994.1352; Tribioli C, 2006, DEV DYNAM, V235, P2483, DOI 10.1002/dvdy.20867; Tuli R, 2003, J BIOL CHEM, V278, P41227, DOI 10.1074/jbc.M305312200; VONDERMARK K, 1977, NATURE, V267, P531, DOI 10.1038/267531a0; Wada N, 2003, DEV BIOL, V264, P550, DOI 10.1016/j.ydbio.2003.08.019; WIDELITZ RB, 1993, J CELL PHYSIOL, V156, P399, DOI 10.1002/jcp.1041560224; Wilkinson DG, 2001, NAT REV NEUROSCI, V2, P155, DOI 10.1038/35058515; Wong M, 1997, DEV BIOL, V192, P492, DOI 10.1006/dbio.1997.8766; Woods A, 2007, J CELL PHYSIOL, V213, P1, DOI 10.1002/jcp.21110; Wozney J M, 1989, Prog Growth Factor Res, V1, P267, DOI 10.1016/0955-2235(89)90015-X; Xu DL, 2006, GROWTH FACTORS, V24, P268, DOI 10.1080/08977190601075865; Yang M, 2008, CELL TISSUE RES, V333, P81, DOI 10.1007/s00441-008-0619-3; Yates KE, 2006, GENE, V377, P77, DOI 10.1016/j.gene.2006.03.005; Yoon BS, 2005, P NATL ACAD SCI USA, V102, P5062, DOI 10.1073/pnas.0500031102; Zeng LP, 2006, STEM CELLS, V24, P2355, DOI 10.1634/stemcells.2005-0551; Zhou Z, 2010, DEV CELL, V19, P90, DOI 10.1016/j.devcel.2010.06.016; Zuzarte-Luis V, 2005, SEMIN CELL DEV BIOL, V16, P261, DOI 10.1016/j.semcdb.2004.12.004	86	45	47	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2011	6	9							e24546	10.1371/journal.pone.0024546	http://dx.doi.org/10.1371/journal.pone.0024546			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZV	21931747	Green Published, gold, Green Submitted			2022-12-25	WOS:000295321800030
J	Sun, J; Fu, FQ; Gu, WC; Yan, RH; Zhang, GB; Shen, ZY; Zhou, YH; Wang, H; Shen, BR; Zhang, XG				Sun, Jing; Fu, Fengqing; Gu, Wenchao; Yan, Ruhong; Zhang, Guangbo; Shen, Zhiyong; Zhou, Yinghui; Wang, Han; Shen, Bairong; Zhang, Xueguang			Origination of New Immunological Functions in the Costimulatory Molecule B7-H3: The Role of Exon Duplication in Evolution of the Immune System	PLOS ONE			English	Article							T-CELL-ACTIVATION; B7 FAMILY; COUNTER-RECEPTOR; IN-VIVO; RESPONSES; DOMAINS; MEMBER; MOUSE; MODEL	B7-H3, a recently identified B7 family member, has different isoforms in human and mouse. Mouse B7-H3 gene has only one isoform (2IgB7-H3) with two Ig-like domains, whereas human B7-H3 has two isoforms (2IgB7-H3 and 4IgB7-H3). In this study a systematic genomic survey across various species from teleost fishes to mammals revealed that 4IgB7-H3 isoform also appeared in pigs, guinea pigs, cows, dogs, African elephants, pandas, megabats and higher primate animals, which resulted from tandem exon duplication. Further sequence analysis indicated that this duplication generated a new conserved region in the first IgC domain, which might disable 4IgB7-H3 from releasing soluble form, while 2IgB7-H3 presented both membrane and soluble forms. Through three-dimensional (3D) structure modeling and fusion-protein binding assays, we discovered that the duplicated isoform had a different structure and might bind to another potential receptor on activated T cells. In T cell proliferation assay, human 2IgB7-H3 (h2IgB7-H3) and mouse B7-H3 (mB7-H3) both increased T cell proliferation and IL-2, IFN-gamma production, whereas human 4IgB7-H3 (h4IgB7-H3) reduced cytokine production and T cell proliferation compared to control. Furthermore, both h2IgB7-H3 and mB7-H3 upregulated the function of lipopolysacharide (LPS)-activated monocyte in vitro. Taken together, our data implied that during the evolution of vertebrates, B7-H3 exon duplication contributed to the generation of a new 4IgB7-H3 isoform in many mammalian species, which have carried out distinct functions in the immune responses.	[Sun, Jing] Suzhou Hlth Technol Coll, Suzhou, Peoples R China; [Fu, Fengqing; Gu, Wenchao; Yan, Ruhong; Shen, Zhiyong; Zhou, Yinghui; Zhang, Xueguang] Soochow Univ, Inst Med Biotechnol, Suzhou, Peoples R China; [Gu, Wenchao; Zhang, Guangbo; Zhang, Xueguang] Stem Cell Res Lab Jiangsu Prov, Suzhou, Peoples R China; [Fu, Fengqing; Yan, Ruhong; Zhang, Guangbo; Zhang, Xueguang] Affiliated Hosp 1, Clin Immunol Lab, Suzhou, Peoples R China; [Wang, Han] Soochow Univ, Lab Dev Genet, Suzhou, Peoples R China; [Wang, Han] Soochow Univ, Genom Med Coll, Suzhou, Peoples R China; [Shen, Bairong] Soochow Univ, Ctr Syst Biol, Suzhou, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China; Soochow University - China	Sun, J (corresponding author), Suzhou Hlth Technol Coll, Suzhou, Peoples R China.	bairong.shen@suda.edu.cn; xueguangzh@yahoo.com.cn	Shen, Bairong/E-6431-2012; Wang, Han/A-9774-2008; Shen, Bairong/W-1254-2019	Shen, Bairong/0000-0003-2899-1531; Wang, Han/0000-0003-2420-3147; Shen, Bairong/0000-0003-2899-1531	National Natural Science Foundation of China [31040022, 30901313, 30801023, 30930085]; National Basic Research Development Program of China (973 Program) [2007CB512402]; Changjiang Scholars and Innovative Research Team in University [IRT0849]; Soochow University [Q4134918]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Development Program of China (973 Program)(National Basic Research Program of China); Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Soochow University	This work was supported by grants from the National Natural Science Foundation of China (no. 31040022, no. 30901313, no. 30801023), the Key Program of National Natural Science Foundation of China (no. 30930085), the National Basic Research Development Program of China (973 Program, no. 2007CB512402), Changjiang Scholars and Innovative Research Team in University (IRT0849) and the Soochow University Start-up Fund (grant no. Q4134918). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chapoval AI, 2001, NAT IMMUNOL, V2, P269, DOI 10.1038/85339; Chen XQ, 2009, J MOL NEUROSCI, V37, P86, DOI 10.1007/s12031-008-9133-z; Combet C, 2002, BIOINFORMATICS, V18, P213, DOI 10.1093/bioinformatics/18.1.213; Coyle AJ, 2001, NAT IMMUNOL, V2, P203, DOI 10.1038/85251; Haack M, 2008, J AM CHEM SOC, V130, P8326, DOI 10.1021/ja8004495; Hashiguchi M, 2008, P NATL ACAD SCI USA, V105, P10495, DOI 10.1073/pnas.0802423105; Kakoulidou M, 2007, J NEUROIMMUNOL, V185, P150, DOI 10.1016/j.jneuroim.2007.01.007; Kobori H, 2010, IMMUNOLOGY, V130, P363, DOI 10.1111/j.1365-2567.2009.03236.x; Lai SW, 2000, INORG CHEM, V39, P255, DOI 10.1021/ic991089g; Leitner J, 2009, EUR J IMMUNOL, V39, P1754, DOI 10.1002/eji.200839028; Ling V, 2003, GENOMICS, V82, P365, DOI 10.1016/S0888-7543(03)00126-5; Logue EC, 2006, J IMMUNOL, V177, P2356, DOI 10.4049/jimmunol.177.4.2356; Luo LQ, 2004, J IMMUNOL, V173, P5445, DOI 10.4049/jimmunol.173.9.5445; Lupu CM, 2006, J GASTROINTEST SURG, V10, P635, DOI 10.1016/j.gassur.2006.02.001; Magistrelli G, 1999, EUR J IMMUNOL, V29, P3596, DOI 10.1002/(SICI)1521-4141(199911)29:11<3596::AID-IMMU3596>3.0.CO;2-Y; Nagashima O, 2008, J IMMUNOL, V181, P4062, DOI 10.4049/jimmunol.181.6.4062; Nei M, 2001, P NATL ACAD SCI USA, V98, P2497, DOI 10.1073/pnas.051611498; Nielsen C, 2005, CELL IMMUNOL, V235, P109, DOI 10.1016/j.cellimm.2005.07.007; Prasad DVR, 2004, J IMMUNOL, V173, P2500, DOI 10.4049/jimmunol.173.4.2500; Steinberger P, 2004, J IMMUNOL, V172, P2352, DOI 10.4049/jimmunol.172.4.2352; Suh WK, 2003, NAT IMMUNOL, V4, P899, DOI 10.1038/ni967; Sun MY, 2002, J IMMUNOL, V168, P6294, DOI 10.4049/jimmunol.168.12.6294; Sun X, 2003, GENE THER, V10, P1728, DOI 10.1038/sj.gt.3302070; Tran CN, 2008, J IMMUNOL, V180, P2989, DOI 10.4049/jimmunol.180.5.2989; Wang LQ, 2005, EUR J IMMUNOL, V35, P428, DOI 10.1002/eji.200425518; Yan Ru-hong, 2010, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V26, P1067; ZHANG G, J IMMUNOL, V185, P3677; Zhang GB, 2004, ACTA BIOCH BIOPH SIN, V36, P430, DOI 10.1093/abbs/36.6.430; ZHANG GB, 2004, MOD IMMUNOL, V24, P455; Zhang GB, 2008, IMMUNOLOGY, V123, P538, DOI 10.1111/j.1365-2567.2007.02723.x; Zhang GB, 2010, J IMMUNOL, V185, P3677, DOI 10.4049/jimmunol.0904020; Zhang GB, 2009, LUNG CANCER, V66, P245, DOI 10.1016/j.lungcan.2009.01.017; Zhou YH, 2007, TISSUE ANTIGENS, V70, P96, DOI 10.1111/j.1399-0039.2007.00853.x	33	20	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2011	6	9							e24751	10.1371/journal.pone.0024751	http://dx.doi.org/10.1371/journal.pone.0024751			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZV	21931843	Green Published, gold, Green Submitted			2022-12-25	WOS:000295321800059
J	Bertrand, MJM; Lippens, S; Staes, A; Gilbert, B; Roelandt, R; De Medts, J; Gevaert, K; Declercq, W; Vandenabeele, P				Bertrand, Mathieu J. M.; Lippens, Saskia; Staes, An; Gilbert, Barbara; Roelandt, Ria; De Medts, Jelle; Gevaert, Kris; Declercq, Wim; Vandenabeele, Peter			cIAP1/2 Are Direct E3 Ligases Conjugating Diverse Types of Ubiquitin Chains to Receptor Interacting Proteins Kinases 1 to 4 (RIP1-4)	PLOS ONE			English	Article							NF-KAPPA-B; C-ASSOCIATED KINASE; TNF-ALPHA; CELL-DEATH; APOPTOSIS PROTEINS; SIGNALING COMPLEX; IMMUNE-RESPONSES; ACTIVATION; NECROSIS; C-IAP1	The RIP kinases have emerged as essential mediators of cellular stress that integrate both extracellular stimuli emanating from various cell-surface receptors and signals coming from intracellular pattern recognition receptors. The molecular mechanisms regulating the ability of the RIP proteins to transduce the stress signals remain poorly understood, but seem to rely only partially on their kinase activities. Recent studies on RIP1 and RIP2 have highlighted the importance of ubiquitination as a key process regulating their capacity to activate downstream signaling pathways. In this study, we found that XIAP, cIAP1 and cIAP2 not only directly bind to RIP1 and RIP2 but also to RIP3 and RIP4. We show that cIAP1 and cIAP2 are direct E3 ubiquitin ligases for all four RIP proteins and that cIAP1 is capable of conjugating the RIPs with diverse types of ubiquitin chains, including linear chains. Consistently, we show that repressing cIAP1/2 levels affects the activation of NF-kappa B that is dependent on RIP1, -2, -3 and -4. Finally, we identified Lys51 and Lys145 of RIP4 as two critical residues for cIAP1-mediated ubiquitination and NF-kB activation.	[Bertrand, Mathieu J. M.; Lippens, Saskia; Gilbert, Barbara; Roelandt, Ria; De Medts, Jelle; Declercq, Wim; Vandenabeele, Peter] VIB, Dept Mol Biomed Res, Ghent, Belgium; [Bertrand, Mathieu J. M.; Lippens, Saskia; Gilbert, Barbara; Roelandt, Ria; Declercq, Wim; Vandenabeele, Peter] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium; [Staes, An; Gevaert, Kris] VIB, Dept Med Prot Res, Ghent, Belgium; [Staes, An; Gevaert, Kris] Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University	Bertrand, MJM (corresponding author), VIB, Dept Mol Biomed Res, Ghent, Belgium.	mathieu.bertrand@dmbr.vib-ugent.be	Bertrand, Mathieu J/P-6465-2016; Gevaert, Kris/AAE-4212-2019; Vandenabeele, Peter/AAD-5793-2022; Vandenabeele, Peter/C-8597-2009; Gevaert, Kris/H-3637-2013; Gevaert, Kris/D-6489-2017; Bertrand, Mathieu JM/AAD-2653-2019	Bertrand, Mathieu J/0000-0001-9000-0626; Gevaert, Kris/0000-0002-4237-0283; Vandenabeele, Peter/0000-0002-6669-8822; Gevaert, Kris/0000-0002-4237-0283; Gevaert, Kris/0000-0002-4237-0283; Bertrand, Mathieu JM/0000-0001-9000-0626; Staes, An/0000-0001-8767-8508; Lippens, Saskia/0000-0002-8261-3462	Flemish Government [BOF09/01M00709]; Flanders Institute for Biotechnology (VIB); Interuniversity Poles of Attraction-Belgian Science Policy [IAP6/18]; Fonds voor Wetenschappelijk Onderzoek - Vlaanderen (FWO) [G.0226.09]; European Commission (EU) [MRTN-CT-035624, LSHB-CT-2005-019067, BM0903, HEALTH-F4-2007-200767]	Flemish Government(European Commission); Flanders Institute for Biotechnology (VIB); Interuniversity Poles of Attraction-Belgian Science Policy; Fonds voor Wetenschappelijk Onderzoek - Vlaanderen (FWO)(FWO); European Commission (EU)(European CommissionEuropean Commission Joint Research Centre)	MB and SL are holders of a postdoc mandate from the FWO. PV holds a Methusalem grant from the Flemish Government (BOF09/01M00709) and is supported by Flanders Institute for Biotechnology (VIB), Interuniversity Poles of Attraction-Belgian Science Policy (IAP6/18), Fonds voor Wetenschappelijk Onderzoek - Vlaanderen (FWO, G.0226.09), and European Commission (EU Marie Curie Training and Mobility Program, ApopTrain, MRTN-CT-035624; FP6 Integrated Project Epistem LSHB-CT-2005-019067; COST action SKINBAD BM0903; EU FP7 Integrated Project, APO-SYS, HEALTH-F4-2007-200767). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahr C, 2000, J BIOL CHEM, V275, P36350, DOI 10.1074/jbc.M004771200; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Bertrand MJM, 2009, IMMUNITY, V30, P789, DOI 10.1016/j.immuni.2009.04.011; Blankenship JW, 2009, BIOCHEM J, V417, P149, DOI 10.1042/BJ20081885; Chen LJ, 2001, J BIOL CHEM, V276, P21737, DOI 10.1074/jbc.M008069200; Chin AI, 2002, NATURE, V416, P190, DOI 10.1038/416190a; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Conze DB, 2005, MOL CELL BIOL, V25, P3348, DOI 10.1128/MCB.25.8.3348-3356.2005; Correia JD, 2007, CELL DEATH DIFFER, V14, P830, DOI 10.1038/sj.cdd.4402070; Csomos RA, 2009, J BIOL CHEM, V284, P20531, DOI 10.1074/jbc.M109.029983; Cusson-Hermance N, 2005, J BIOL CHEM, V280, P36560, DOI 10.1074/jbc.M506831200; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Dynek JN, EMBO J; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; Geserick P, 2009, J CELL BIOL, V187, P1037, DOI 10.1083/jcb.200904158; Gyrd-Hansen M, NAT REV CANC, V10, P561; Haas TL, 2009, MOL CELL, V36, P831, DOI 10.1016/j.molcel.2009.10.013; Hasegawa M, 2008, EMBO J, V27, P373, DOI 10.1038/sj.emboj.7601962; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Holland PM, 2002, CURR BIOL, V12, P1424, DOI 10.1016/S0960-9822(02)01075-8; Janssens S, 2005, CELL, V123, P1079, DOI 10.1016/j.cell.2005.09.036; Kasof GM, 2000, FEBS LETT, V473, P285, DOI 10.1016/S0014-5793(00)01473-3; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Komander D, 2009, BIOCHEM SOC T, V37, P937, DOI 10.1042/BST0370937; Komander D, 2009, EMBO REP, V10, P466, DOI 10.1038/embor.2009.55; Krieg A, 2009, P NATL ACAD SCI USA, V106, P14524, DOI 10.1073/pnas.0907131106; Lee TH, 2004, J BIOL CHEM, V279, P33185, DOI 10.1074/jbc.M404206200; Li S, 2009, MOL CELL, V33, P30, DOI 10.1016/j.molcel.2008.11.023; Li XM, 2002, NATURE, V416, P345, DOI 10.1038/416345a; Lu CF, 2005, J BIOL CHEM, V280, P16278, DOI 10.1074/jbc.M410114200; Mahoney DJ, 2008, P NATL ACAD SCI USA, V105, P11778, DOI 10.1073/pnas.0711122105; Meylan E, 2005, TRENDS BIOCHEM SCI, V30, P151, DOI 10.1016/j.tibs.2005.01.003; Meylan E, 2002, EMBO REP, V3, P1201, DOI 10.1093/embo-reports/kvf236; Meylan E, 2004, NAT IMMUNOL, V5, P503, DOI 10.1038/ni1061; Mollah S, 2007, RAPID COMMUN MASS SP, V21, P3357, DOI 10.1002/rcm.3227; Moran ST, 2003, J BIOL CHEM, V278, P21526, DOI 10.1074/jbc.M301575200; Nembrini C, 2009, J BIOL CHEM; Newton K, 2004, MOL CELL BIOL, V24, P1464, DOI 10.1128/MCB.24.4.1464-1469.2004; O'Donnell MA, 2007, CURR BIOL, V17, P418, DOI 10.1016/j.cub.2007.01.027; Park JH, 2007, J IMMUNOL, V178, P2380, DOI 10.4049/jimmunol.178.4.2380; Park SM, 2004, FEBS LETT, V566, P151, DOI 10.1016/j.feblset.2004.04.021; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; Rountree RB, 2010, J INVEST DERMATOL, V130, P102, DOI 10.1038/jid.2009.223; Sun XQ, 1999, J BIOL CHEM, V274, P16871, DOI 10.1074/jbc.274.24.16871; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Upton JW, 2010, CELL HOST MICROBE, V7, P302, DOI 10.1016/j.chom.2010.03.006; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Vanlangenakker N, CELL DEATH DIFFER; Varfolomeev E, 2008, J BIOL CHEM, V283, P24295, DOI 10.1074/jbc.C800128200; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vince JE, 2009, J BIOL CHEM, V284, P35906, DOI 10.1074/jbc.M109.072256; Vischioni B, 2004, EXP CELL RES, V298, P535, DOI 10.1016/j.yexcr.2004.04.040; Wu CJ, 2005, EMBO J, V24, P1886, DOI 10.1038/sj.emboj.7600649; Xu M, 2009, MOL CELL, V36, P302, DOI 10.1016/j.molcel.2009.10.002; Yu PW, 1999, CURR BIOL, V9, P539, DOI 10.1016/S0960-9822(99)80239-5; Zhang D, MOL IMMUNOL, V7, P243; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308	59	76	87	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2011	6	9							e22356	10.1371/journal.pone.0022356	http://dx.doi.org/10.1371/journal.pone.0022356			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CO	21931591	gold, Green Published			2022-12-25	WOS:000294803200001
J	Costa, MW; Lee, S; Furtado, MB; Xin, L; Sparrow, DB; Martinez, CG; Dunwoodie, SL; Kurtenbach, E; Mohun, T; Rosenthal, N; Harvey, RP				Costa, Mauro W.; Lee, Stella; Furtado, Milena B.; Xin, Li; Sparrow, Duncan B.; Martinez, Camila G.; Dunwoodie, Sally L.; Kurtenbach, Eleonora; Mohun, Tim; Rosenthal, Nadia; Harvey, Richard P.			Complex SUMO-1 Regulation of Cardiac Transcription Factor Nkx2-5	PLOS ONE			English	Article							CONGENITAL HEART-DISEASE; SERUM RESPONSE FACTOR; CSX/NKX2.5 HOMEOPROTEIN; CONDUCTION SYSTEM; INTERACTING MOTIF; CHAMBER FORMATION; GENE-EXPRESSION; SUMOYLATION; CONJUGATION; PROTEIN	Reversible post-translational protein modifications such as SUMOylation add complexity to cardiac transcriptional regulation. The homeodomain transcription factor Nkx2-5/Csx is essential for heart specification and morphogenesis. It has been previously suggested that SUMOylation of lysine 51 (K51) of Nkx2-5 is essential for its DNA binding and transcriptional activation. Here, we confirm that SUMOylation strongly enhances Nkx2-5 transcriptional activity and that residue K51 of Nkx2-5 is a SUMOylation target. However, in a range of cultured cell lines we find that a point mutation of K51 to arginine (K51R) does not affect Nkx2-5 activity or DNA binding, suggesting the existence of additional Nkx2-5 SUMOylated residues. Using biochemical assays, we demonstrate that Nkx2-5 is SUMOylated on at least one additional site, and this is the predominant site in cardiac cells. The second site is either non-canonical or a "shifting" site, as mutation of predicted consensus sites and indeed every individual lysine in the context of the K51R mutation failed to impair Nkx2-5 transcriptional synergism with SUMO, or its nuclear localization and DNA binding. We also observe SUMOylation of Nkx2-5 cofactors, which may be critical to Nkx2-5 regulation. Our data reveal highly complex regulatory mechanisms driven by SUMOylation to modulate Nkx2-5 activity.	[Costa, Mauro W.; Lee, Stella; Furtado, Milena B.; Xin, Li; Sparrow, Duncan B.; Dunwoodie, Sally L.; Harvey, Richard P.] Victor Chang Cardiac Res Inst, Dev & Stem Cell Biol Div, Darlinghurst, NSW, Australia; [Costa, Mauro W.; Furtado, Milena B.; Rosenthal, Nadia] Monash Univ, Australian Regenerat Med Inst, Clayton, Vic, Australia; [Costa, Mauro W.; Martinez, Camila G.; Kurtenbach, Eleonora] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil; [Sparrow, Duncan B.; Dunwoodie, Sally L.; Harvey, Richard P.] Univ New S Wales, Fac Med, St Vincents Clin Sch, Kensington, NSW 2033, Australia; [Mohun, Tim] MRC Natl Inst Med Res, Div Dev Biol, London, England	Victor Chang Cardiac Research Institute; Australian Regenerative Medicine Institute; Monash University; Universidade Federal do Rio de Janeiro; University of New South Wales Sydney; MRC National Institute for Medical Research	Costa, MW (corresponding author), Victor Chang Cardiac Res Inst, Dev & Stem Cell Biol Div, Darlinghurst, NSW, Australia.	r.harvey@victorchang.edu.au	Kurtenbach, Eleonora/L-4148-2016; Neurociencia, Inct/I-1011-2013; Costa, Mauro W/S-9219-2018; Sparrow, Duncan/B-3994-2008; Dunwoodie, Sally L/M-4019-2018; Martinez, Camila G/S-4666-2018	Kurtenbach, Eleonora/0000-0002-2141-518X; Costa, Mauro W/0000-0003-3579-8625; Sparrow, Duncan/0000-0002-1141-6613; Dunwoodie, Sally L/0000-0002-2069-7349; Martinez, Camila G/0000-0001-6116-9182; Rosenthal, Nadia/0000-0002-7599-7365; Harvey, Richard/0000-0002-9950-9792	NHMRC, Australia [354400, 573703, 514900, 546133]; ARC-SRI, Australia; FAPERJ; CNPq, Brazil; MRC [MC_U117562103] Funding Source: UKRI; Medical Research Council [MC_U117562103] Funding Source: researchfish	NHMRC, Australia(National Health and Medical Research Council (NHMRC) of Australia); ARC-SRI, Australia(Australian Research Council); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from NHMRC, Australia to RH (354400; 573703; 514900); NHRMC Australia Fellowship (546133) and ARC-SRI, Australia to NR; FAPERJ and CNPq, Brazil to MWC. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkuraya FS, 2006, SCIENCE, V313, P1751, DOI 10.1126/science.1128406; Barolo S, 2002, GENE DEV, V16, P1167, DOI 10.1101/gad.976502; Bauer DC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-366; Benson MD, 2007, P NATL ACAD SCI USA, V104, P1805, DOI 10.1073/pnas.0606702104; Biben C, 1997, GENE DEV, V11, P1357, DOI 10.1101/gad.11.11.1357; BODMER R, 1993, DEVELOPMENT, V118, P719; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Caprioli A, 2011, CIRCULATION, V123, P1633, DOI 10.1161/CIRCULATIONAHA.110.008185; Christoffels VM, 2004, DEV DYNAM, V229, P763, DOI 10.1002/dvdy.10487; Christoffels VM, 2000, DEV BIOL, V223, P266, DOI 10.1006/dbio.2000.9753; Chun TH, 2003, CIRC RES, V92, P1201, DOI 10.1161/01.RES.0000076893.70898.36; Clark KL, 2006, ANNU REV PHYSIOL, V68, P97, DOI 10.1146/annurev.physiol.68.040104.113828; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Collavin L, 2004, P NATL ACAD SCI USA, V101, P8870, DOI 10.1073/pnas.0308605101; Dohmen RJ, 2004, BBA-MOL CELL RES, V1695, P113, DOI 10.1016/j.bbamcr.2004.09.021; Du JX, 2010, J BIOL CHEM, V285, P28298, DOI 10.1074/jbc.M110.101717; Durocher D, 1997, EMBO J, V16, P5687, DOI 10.1093/emboj/16.18.5687; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Girdwood DWH, 2004, SEMIN CELL DEV BIOL, V15, P201, DOI 10.1016/j.semcdb.2003.12.001; Guo B, 2007, BIOCHEM SOC T, V35, P1414, DOI 10.1042/BST0351414; Habets PEMH, 2002, GENE DEV, V16, P1234, DOI 10.1101/gad.222902; Harvey RP, 2002, NAT REV GENET, V3, P544, DOI 10.1038/nrg843; Harvey RP, 1996, DEV BIOL, V178, P203, DOI 10.1006/dbio.1996.0212; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hoogaars WMH, 2004, CARDIOVASC RES, V62, P489, DOI 10.1016/j.cardiores.2004.01.030; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; Jay PY, 2004, J CLIN INVEST, V113, P1130, DOI 10.1172/JCI200419846; Jian Ouyang, 2009, V497, P141, DOI 10.1007/978-1-59745-566-4_9; Kang XL, 2010, MOL CELL, V38, P191, DOI 10.1016/j.molcel.2010.03.005; Kasahara H, 2001, J CLIN INVEST, V108, P189, DOI 10.1172/JCI200112694; Kasahara H, 1999, MOL CELL BIOL, V19, P526; Kasahara H, 2000, J CLIN INVEST, V106, P299, DOI 10.1172/JCI9860; Kim EY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020803; Kim S, 1997, MOL CELL BIOL, V17, P2266, DOI 10.1128/MCB.17.4.2266; Kioussi C, 2002, CELL, V111, P673, DOI 10.1016/S0092-8674(02)01084-X; Kuo HY, 2005, P NATL ACAD SCI USA, V102, P16973, DOI 10.1073/pnas.0504460102; Lai D, 2010, CIRC RES, V107, P715, DOI 10.1161/CIRCRESAHA.110.218693; Li T, 2007, J MOL BIOL, V370, P976, DOI 10.1016/j.jmb.2007.05.033; Lickert H, 2004, NATURE, V432, P107, DOI 10.1038/nature03071; Lin LZ, 2007, P NATL ACAD SCI USA, V104, P9313, DOI 10.1073/pnas.0700923104; Linhares VLF, 2004, CARDIOVASC RES, V64, P402, DOI 10.1016/j.cardiores.2004.09.021; LYONS I, 1995, GENE DEV, V9, P1654, DOI 10.1101/gad.9.13.1654; Matsuzaki K, 2003, BIOCHEM BIOPH RES CO, V306, P32, DOI 10.1016/S0006-291X(03)00910-0; Meulmeester E, 2008, NATURE, V452, P709, DOI 10.1038/452709a; Oka T, 2007, SEMIN CELL DEV BIOL, V18, P117, DOI 10.1016/j.semcdb.2006.11.012; Onishi A, 2009, NEURON, V61, P234, DOI 10.1016/j.neuron.2008.12.006; Pashmforoush M, 2004, CELL, V117, P373, DOI 10.1016/S0092-8674(04)00405-2; Perdomo J, 2005, MOL CELL BIOL, V25, P1549, DOI 10.1128/MCB.25.4.1549-1559.2005; Prall OWJ, 2007, CELL, V128, P947, DOI 10.1016/j.cell.2007.01.042; Ren J, 2009, PROTEOMICS, V9, P3409, DOI 10.1002/pmic.200800646; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Ross S, 2002, MOL CELL, V10, P831, DOI 10.1016/S1097-2765(02)00682-2; Rytinki MM, 2009, CELL MOL LIFE SCI, V66, P3029, DOI 10.1007/s00018-009-0061-z; Saether T, 2011, ONCOGENE, V30, P212, DOI 10.1038/onc.2010.397; Saitoh H, 1998, CURR BIOL, V8, P121, DOI 10.1016/S0960-9822(98)70044-2; Sebban H, 2006, TRENDS CELL BIOL, V16, P569, DOI 10.1016/j.tcb.2006.09.004; Shishido T, 2008, CIRC RES, V102, P1416, DOI 10.1161/CIRCRESAHA.107.168138; Stennard FA, 2003, DEV BIOL, V262, P206, DOI 10.1016/S0012-1606(03)00385-3; Stennard FA, 2005, DEVELOPMENT, V132, P4897, DOI 10.1242/dev.02099; Sydorskyy Y, 2010, MOL CELL BIOL, V30, P4452, DOI 10.1128/MCB.00335-10; Verger A, 2003, EMBO REP, V4, P137, DOI 10.1038/sj.embor.embor738; Wakimoto H, 2002, J CARDIOVASC ELECTR, V13, P682, DOI 10.1046/j.1540-8167.2002.00682.x; Wang J, 2004, J BIOL CHEM, V279, P49091, DOI 10.1074/jbc.M407494200; Wang J, 2008, J BIOL CHEM, V283, P23235, DOI 10.1074/jbc.M709748200; Wang J, 2007, MOL CELL BIOL, V27, P622, DOI 10.1128/MCB.01160-06; Wang J, 2009, FRONT BIOSCI-LANDMRK, V14, P1219, DOI 10.2741/3304; Watada H, 2000, P NATL ACAD SCI USA, V97, P9443, DOI 10.1073/pnas.97.17.9443; Winston JB, 2010, CIRCULATION, V121, P1313, DOI 10.1161/CIRCULATIONAHA.109.887687; Yang SH, 2004, MOL CELL, V13, P611, DOI 10.1016/S1097-2765(04)00060-7; Zhang FP, 2008, MOL CELL BIOL, V28, P5381, DOI 10.1128/MCB.00651-08; Zhao J, 2007, CELL MOL LIFE SCI, V64, P3017, DOI 10.1007/s00018-007-7137-4	72	32	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2011	6	9							e24812	10.1371/journal.pone.0024812	http://dx.doi.org/10.1371/journal.pone.0024812			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CO	21931855	Green Published, Green Submitted, gold			2022-12-25	WOS:000294803200051
J	Ahmed, SSU; Ersboll, AK; Biswas, PK; Christensen, JP; Toft, N				Ahmed, Syed S. U.; Ersboll, Annette K.; Biswas, Paritosh K.; Christensen, Jens P.; Toft, Nils			Spatio-Temporal Magnitude and Direction of Highly Pathogenic Avian Influenza (H5N1) Outbreaks in Bangladesh	PLOS ONE			English	Article							A VIRUS H5N1; RISK-FACTORS; MIGRATORY WATERFOWL; SUBTYPE H5N1; INFECTION; CLUSTERS; THAILAND; PATTERNS; EAST	Background: The number of outbreaks of HPAI-H5N1 reported by Bangladesh from 2007 through 2011 placed the country among the highest reported numbers worldwide. However, so far, the understanding of the epidemic progression, direction, intensity, persistence and risk variation of HPAI-H5N1 outbreaks over space and time in Bangladesh remains limited. Methodology/Principal Findings: To determine the magnitude and spatial pattern of the highly pathogenic avian influenza A subtype H5N1 virus outbreaks over space and time in poultry from 2007 to 2009 in Bangladesh, we applied descriptive and analytical spatial statistics. Temporal distribution of the outbreaks revealed three independent waves of outbreaks that were clustered during winter and spring. The descriptive analyses revealed that the magnitude of the second wave was the highest as compared to the first and third waves. Exploratory mapping of the infected flocks revealed that the highest intensity and magnitude of the outbreaks was systematic and persistent in an oblique line that connects south-east to north-west through the central part of the country. The line follows the Brahmaputra-Meghna river system, the junction between Central Asian and East Asian flyways, and the major poultry trading route in Bangladesh. Moreover, several important migratory bird areas were identified along the line. Geostatistical analysis revealed significant latitudinal directions of outbreak progressions that have similarity to the detected line of intensity and magnitude. Conclusion/Significance: The line of magnitude and direction indicate the necessity of mobilizing maximum resources on this line to strengthen the existing surveillance.	[Ahmed, Syed S. U.; Toft, Nils] Univ Copenhagen, Fac Life Sci, Dept Large Anim Sci, Copenhagen, Denmark; [Ahmed, Syed S. U.] Chittagong Vet & Anim Sci Univ, Fac Vet Med, Dept Med & Surg, Chittagong, Bangladesh; [Ersboll, Annette K.] Univ So Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark; [Biswas, Paritosh K.] Chittagong Vet & Anim Sci Univ, Fac Vet Med, Dept Microbiol, Chittagong, Bangladesh; [Christensen, Jens P.] Univ Copenhagen, Fac Life Sci, Dept Vet Dis Biol, Copenhagen, Denmark	University of Copenhagen; University of Southern Denmark; University of Copenhagen	Ahmed, SSU (corresponding author), Univ Copenhagen, Fac Life Sci, Dept Large Anim Sci, Copenhagen, Denmark.	ssua@life.ku.dk	Ahmed, Syed Sayeem Uddin/AAL-5160-2021; Syed, Ahmed/B-5030-2009	Syed, Ahmed/0000-0002-5394-3227; Toft, Nils/0000-0002-0265-3764; Christensen, Jens Peter/0000-0002-6430-9010; Ersboll, Annette Kjaer/0000-0002-9407-3387				Ahmed SSU, 2010, EPIDEMIOL INFECT, V138, P843, DOI 10.1017/S0950268810000178; Alam J, 2008, BANGLADESH J LIVESTO, V15, P13; Bailey T, 1995, INTERACTIVE SPATIAL; *BANGL, 2011, NAT ENCY BANGL BIRD; *BIRD LIF INT, 2010, IMP BIRD AR FACTSH; Biswas PK, 2009, VET REC, V164, P743, DOI 10.1136/vr.164.24.743; Biswas PK, 2009, EMERG INFECT DIS, V15, P1931, DOI 10.3201/eid1512.090643; Bivand RS, 2000, COMPUT GEOSCI-UK, V26, P1043, DOI 10.1016/S0098-3004(00)00057-1; Brooker S, 2000, ADV PARASIT, V47, P245, DOI 10.1016/S0065-308X(00)47011-9; Chen H, 2005, NATURE, V436, P191, DOI 10.1038/nature03974; Chen HL, 2006, J VIROL, V80, P5976, DOI 10.1128/JVI.00110-06; CLAYTON D, 1987, BIOMETRICS, V43, P671, DOI 10.2307/2532003; DOLBERG F, 2009, POLUTRY SECTOR COUNT; Gilbert M, 2010, ECOHEALTH, V7, P448, DOI 10.1007/s10393-010-0672-8; Islam M.R., 2008, BANGLADESH J LIVESTO, V15, P1; JACQUEZ GM, USER MANUAL STAT STA; Lebarbenchon C, 2010, EMERG INFECT DIS, V16, P1057, DOI 10.3201/eid1607.090389; Liu J, 2005, SCIENCE, V309, P1206, DOI 10.1126/science.1115273; Loth L, 2010, PREV VET MED, V96, P104, DOI 10.1016/j.prevetmed.2010.05.013; *MOFL, 2010, MIN FISH LIV; Muzaffar Sabir Bin, 2008, Forktail, V24, P100; OIE, 2011, WORLD ORG AN HLTH; Park AW, 2007, LANCET INFECT DIS, V7, P543, DOI 10.1016/S1473-3099(07)70186-X; Paul M, 2010, VET RES, V41, DOI 10.1051/vetres/2009076; Pfeiffer DU, 2007, VET J, V174, P302, DOI 10.1016/j.tvjl.2007.05.010; Prosser DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017622; Rivas AL, 2010, EPIDEMIOL INFECT, V138, P192, DOI 10.1017/S0950268809990495; STEVENSON M, 2002, GEOHEALTH 2002 SUPP, P167; Suarez David L., 2010, Animal Health Research Reviews, V11, P19, DOI 10.1017/S1466252310000095; Takekawa JY, 2010, AVIAN DIS, V54, P466, DOI 10.1637/8914-043009-Reg.1; Tiensin T, 2007, AVIAN DIS, V51, P182, DOI 10.1637/7635-042806R.1; Tiensin T, 2009, J INFECT DIS, V199, P1735, DOI 10.1086/599207; *USGS, 2011, BANGL SOURC HIGHL PA; Ward MP, 2008, VET RES, V39, DOI 10.1051/vetres:2007063; Ward M, 2008, VET RES COMMUN, V32, P627, DOI 10.1007/s11259-008-9064-8; WHO, 2011, WHO CUM NUMB CONF HU; Wint W., 2007, GRIDDED LIVESTOCK WO	37	21	21	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2011	6	9							e24324	10.1371/journal.pone.0024324	http://dx.doi.org/10.1371/journal.pone.0024324			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CN	21931683	Green Published, gold			2022-12-25	WOS:000294803100020
J	Hildebrandt, A; Bickmeyer, I; Kuhnlein, RP				Hildebrandt, Anja; Bickmeyer, Iris; Kuehnlein, Ronald P.			Reliable Drosophila Body Fat Quantification by a Coupled Colorimetric Assay	PLOS ONE			English	Article							OBESITY; STORAGE; MELANOGASTER; HOMEOSTASIS; MODEL; METABOLISM; REGULATOR; HEDGEHOG; BIOLOGY; PROTEIN	Factors and mechanisms controlling lipometabolism homeostasis share a remarkable evolutionary conservation between humans and Drosophila flies. Accordingly, the Drosophila model has been successfully used to understand the pathophysiology of human metabolic diseases such as obesity. Body fat stores in species as different as humans and flies consist of neutral lipids, mainly triacylglycerols. Changes in body fat storage are a diagnostic phenotype of lipometabolism imbalances of genetic or environmental origin. Various methods have been developed to quantify Drosophila body fat storage. The most widely used method adopts a commercial coupled colorimetric assay designed for human serum triacylglycerol quantification, which is based on glycerol content determination after enzymatic conversion of glycerides into glycerol. The coupled colorimetric assay is compatible with large-scale genetic screen approaches and has been successfully applied to characterize central regulators of Drosophila lipometabolism. Recently, the applicability of the coupled colorimetric assay for Drosophila storage fat quantification has been questioned in principle. Here we compare the performance of the coupled colorimetric assay on Drosophila samples with thin layer chromatography, the "gold standard'' in storage lipid analysis. Our data show that the presented variant of the coupled colorimetric assay reliably discriminates between lean and fat flies and allows robust, quick and cost-effective quantification of Drosophila body fat stores.	[Hildebrandt, Anja; Bickmeyer, Iris; Kuehnlein, Ronald P.] Max Planck Inst Biophys Chem, Abt Mol Entwicklungsbiol, Forschungsgrp Mol, Gottingen, Germany	Max Planck Society	Hildebrandt, A (corresponding author), Max Planck Inst Biophys Chem, Abt Mol Entwicklungsbiol, Forschungsgrp Mol, Gottingen, Germany.	rkuehnl@gwdg.de			Max Planck Society (MPS)	Max Planck Society (MPS)(Max Planck Society)	This study was supported by the Max Planck Society (MPS). The MPS had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Anzi B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012353; Al-Anzi B, 2009, NEURON, V63, P329, DOI 10.1016/j.neuron.2009.07.021; Barsh GS, 2002, NAT REV GENET, V3, P589, DOI [10.1038/nrn902, 10.1038/nrg862]; Bauer R, 2009, EMBO J, V28, P3706, DOI 10.1038/emboj.2009.305; Beller M, 2010, CELL METAB, V12, P521, DOI 10.1016/j.cmet.2010.10.001; Beller M, 2008, PLOS BIOL, V6, P2530, DOI 10.1371/journal.pbio.0060292; Bharucha KN, 2009, PEDIATR RES, V65, P132, DOI 10.1203/PDR.0b013e318191fc68; Birse RT, 2010, CELL METAB, V12, P533, DOI 10.1016/j.cmet.2010.09.014; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Daum G, 2007, BIOCHIMIE, V89, P243, DOI 10.1016/j.biochi.2006.06.018; DiAngelo JR, 2009, MOL CELL BIOL, V29, P6341, DOI 10.1128/MCB.00675-09; Dixon JB, 2010, MOL CELL ENDOCRINOL, V316, P104, DOI 10.1016/j.mce.2009.07.008; Gilbert LI, 2008, MOL CELL ENDOCRINOL, V293, P25, DOI 10.1016/j.mce.2008.02.009; Gronke S, 2005, CELL METAB, V1, P323, DOI 10.1016/j.cmet.2005.04.003; Gronke S, 2003, CURR BIOL, V13, P603, DOI 10.1016/S0960-9822(03)00175-1; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; Hader T, 2003, EMBO REP, V4, P511, DOI 10.1038/sj.embor.embor837; Harbison ST, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006211; Holtta-Vuori M, 2010, BIOCHEM J, V429, P235, DOI 10.1042/BJ20100293; Hong JW, 2010, EXP MOL MED, V42, P12, DOI 10.3858/emm.2010.42.1.007; Jones KT, 2009, DIS MODEL MECH, V2, P224, DOI 10.1242/dmm.001933; Kohler K, 2009, AUTOPHAGY, V5, P980; Kohlwein SD, 2010, J BIOL CHEM, V285, P15663, DOI 10.1074/jbc.R110.118356; Kuhnlein RP, 2010, RESULTS PROBL CELL D, V52, P159, DOI 10.1007/978-3-642-14426-4_13; Kuhnlein RP, 2010, BBA-MOL CELL BIOL L, V1801, P215, DOI 10.1016/j.bbalip.2009.09.006; Nielsen J, 2009, FEBS LETT, V583, P3905, DOI 10.1016/j.febslet.2009.10.054; Pospisilik JA, 2010, CELL, V140, P148, DOI 10.1016/j.cell.2009.12.027; Reis T, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001206; Sieber MH, 2009, CELL METAB, V10, P481, DOI 10.1016/j.cmet.2009.10.010; *SIGM ALDR SER TRI, T2449 SIGM ALDR SER; *SIGM FREE GLYC RE, F6428 SIGM FREE GLYC; Skorupa DA, 2008, AGING CELL, V7, P478, DOI 10.1111/j.1474-9726.2008.00400.x; Suh JM, 2006, CELL METAB, V3, P25, DOI 10.1016/j.cmet.2005.11.012; Warden CH, 2010, PROG MOL BIOL TRANSL, V94, P373, DOI 10.1016/S1877-1173(10)94013-1; Xu PZ, 2003, CURR BIOL, V13, P790, DOI 10.1016/S0960-9822(03)00250-1	35	62	64	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2011	6	9							e23796	10.1371/journal.pone.0023796	http://dx.doi.org/10.1371/journal.pone.0023796			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CN	21931614	gold, Green Published, Green Submitted			2022-12-25	WOS:000294803100005
J	Loucoubar, C; Paul, R; Bar-Hen, A; Huret, A; Tall, A; Sokhna, C; Trape, JF; Ly, AB; Faye, J; Badiane, A; Diakhaby, G; Sarr, FD; Diop, A; Sakuntabhai, A; Bureau, JF				Loucoubar, Cheikh; Paul, Richard; Bar-Hen, Avner; Huret, Augustin; Tall, Adama; Sokhna, Cheikh; Trape, Jean-Francois; Ly, Alioune Badara; Faye, Joseph; Badiane, Abdoulaye; Diakhaby, Gaoussou; Sarr, Fatoumata Diene; Diop, Aliou; Sakuntabhai, Anavaj; Bureau, Jean-Francois			An Exhaustive, Non-Euclidean, Non-Parametric Data Mining Tool for Unraveling the Complexity of Biological Systems - Novel Insights into Malaria	PLOS ONE			English	Article							BLOOD INFECTION LEVELS; PLASMODIUM-FALCIPARUM; MIXED INFECTIONS; LINKAGE	Complex, high-dimensional data sets pose significant analytical challenges in the post-genomic era. Such data sets are not exclusive to genetic analyses and are also pertinent to epidemiology. There has been considerable effort to develop hypothesis-free data mining and machine learning methodologies. However, current methodologies lack exhaustivity and general applicability. Here we use a novel non-parametric, non-euclidean data mining tool, HyperCube (R), to explore exhaustively a complex epidemiological malaria data set by searching for over density of events in m-dimensional space. Hotspots of over density correspond to strings of variables, rules, that determine, in this case, the occurrence of Plasmodium falciparum clinical malaria episodes. The data set contained 46,837 outcome events from 1,653 individuals and 34 explanatory variables. The best predictive rule contained 1,689 events from 148 individuals and was defined as: individuals present during 1992-2003, aged 1-5 years old, having hemoglobin AA, and having had previous Plasmodium malariae malaria parasite infection <= 10 times. These individuals had 3.71 times more P. falciparum clinical malaria episodes than the general population. We validated the rule in two different cohorts. We compared and contrasted the HyperCube (R) rule with the rules using variables identified by both traditional statistical methods and non-parametric regression tree methods. In addition, we tried all possible sub-stratified quantitative variables. No other model with equal or greater representativity gave a higher Relative Risk. Although three of the four variables in the rule were intuitive, the effect of number of P. malariae episodes was not. HyperCube (R) efficiently sub-stratified quantitative variables to optimize the rule and was able to identify interactions among the variables, tasks not easy to perform using standard data mining methods. Search of local over density in m-dimensional space, explained by easily interpretable rules, is thus seemingly ideal for generating hypotheses for large datasets to unravel the complexity inherent in biological systems.	[Loucoubar, Cheikh; Paul, Richard; Sakuntabhai, Anavaj; Bureau, Jean-Francois] Inst Pasteur, Unite Pathogenie Virale, Paris, France; [Loucoubar, Cheikh; Bar-Hen, Avner] Univ Paris 05, UMR 8145, Lab Math Appl Paris 5, Paris, France; [Loucoubar, Cheikh; Tall, Adama; Ly, Alioune Badara; Faye, Joseph; Badiane, Abdoulaye; Diakhaby, Gaoussou; Sarr, Fatoumata Diene] Inst Pasteur, UR 172, Unite Epidemiol Malad Infectieuses, Dakar, Senegal; [Bar-Hen, Avner] Ecole Hautes Etud Sante Publ, Rennes, France; [Huret, Augustin] Inst Hlth & Sci, Paris, France; [Sokhna, Cheikh; Trape, Jean-Francois] Inst Rech Dev, UMR 198, Unite Paludol Afrotrop, Dakar, Senegal; [Diop, Aliou] UGB, Lab Etud & Rech Stat & Dev, St Louis, Senegal; [Sakuntabhai, Anavaj] Mahidol Univ, Fac Sci, Ctr Excellence Vectors & Vector Borne Dis, Bangkok 10400, Thailand	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; Institut de Recherche pour le Developpement (IRD); Mahidol University	Loucoubar, C (corresponding author), Inst Pasteur, Unite Pathogenie Virale, Paris, France.	anavaj@pasteur.fr		Paul, Richard/0000-0002-0665-5089; Bureau, Jean-Francois/0000-0003-1945-1883; DIOP, Aliou/0000-0002-0808-5622	Institut Pasteur; Ecole des Hautes Etudes en Sante Publique	Institut Pasteur(European Commission); Ecole des Hautes Etudes en Sante Publique	Funding was provided by Institut Pasteur and the Ecole des Hautes Etudes en Sante Publique. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; BLACK J, 1994, LANCET, V343, P1095, DOI 10.1016/S0140-6736(94)90203-8; Bousema JT, 2008, AM J TROP MED HYG, V78, P442, DOI 10.4269/ajtmh.2008.78.442; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; Bruce MC, 2000, SCIENCE, V287, P845, DOI 10.1126/science.287.5454.845; Calcagno V, 2010, J STAT SOFTW, V34, P1; Collins WE, 1999, AM J TROP MED HYG, V61, P36, DOI 10.4269/tropmed.1999.61-036; Cordell HJ, 2009, NAT REV GENET, V10, P392, DOI 10.1038/nrg2579; Cox DR, 1969, ANAL BINARY DATA; Domarle O, 2002, AM J TROP MED HYG, V66, P124, DOI 10.4269/ajtmh.2002.66.124; Domarle O, 1999, AM J TROP MED HYG, V61, P926, DOI 10.4269/ajtmh.1999.61.926; Falconer DS, 1996, INTRO QUANTITATIVE G, V4; Flori L, 2003, GENES IMMUN, V4, P265, DOI 10.1038/sj.gene.6363960; Garcia A, 1998, AM J TROP MED HYG, V58, P705, DOI 10.4269/ajtmh.1998.58.705; Lawaly YR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011358; Lemeshow, 2000, APPL LOGISTIC REGRES, P375, DOI [10.1002/0471722146, DOI 10.1002/0471722146]; Mackinnon MJ, 2005, PLOS MED, V2, P1253, DOI 10.1371/journal.pmed.0020340; McCulloch C. E., 2008, GEN LINEAR MIXED MOD; McKenzie FE, 2002, AM J TROP MED HYG, V67, P411, DOI 10.4269/ajtmh.2002.67.411; McKenzie FE, 1999, J PARASITOL, V85, P12, DOI 10.2307/3285692; McKinney Brett A, 2006, Appl Bioinformatics, V5, P77, DOI 10.2165/00822942-200605020-00002; MOLINEAUX L, 1980, AM J TROP MED HYG, V29, P725, DOI 10.4269/ajtmh.1980.29.725; MOLINEAUX L., 1980, The Garki project. Research on the epidemiology and control of malaria in the Sudan savanna of West Africa.; Muller I, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-158; Nelson MR, 2001, GENOME RES, V11, P458, DOI 10.1101/gr.172901; Rihet P, 1998, AM J HUM GENET, V63, P498, DOI 10.1086/301967; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Rogier C, 1996, AM J TROP MED HYG, V54, P613, DOI 10.4269/ajtmh.1996.54.613; Rogier C, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P255; Sakuntabhai A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002000; Sokhna CS, 2001, AM J TROP MED HYG, V65, P167, DOI 10.4269/ajtmh.2001.65.167; TRAPE JF, 1994, AM J TROP MED HYG, V51, P123, DOI 10.4269/ajtmh.1994.51.123; YAMAMOTO F, 1995, GLYCOBIOLOGY, V5, P51, DOI 10.1093/glycob/5.1.51; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	35	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2011	6	9							e24085	10.1371/journal.pone.0024085	http://dx.doi.org/10.1371/journal.pone.0024085			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CN	21931645	Green Published, gold			2022-12-25	WOS:000294803100011
J	Schafer, B; Holzer, GW; Joachimsthaler, A; Coulibaly, S; Schwendinger, M; Crowe, BA; Kreil, TR; Barrett, PN; Falkner, FG				Schaefer, Birgit; Holzer, Georg W.; Joachimsthaler, Alexandra; Coulibaly, Sogue; Schwendinger, Michael; Crowe, Brian A.; Kreil, Thomas R.; Barrett, P. Noel; Falkner, Falko G.			Pre-Clinical Efficacy and Safety of Experimental Vaccines Based on Non-Replicating Vaccinia Vectors against Yellow Fever	PLOS ONE			English	Article							COLORECTAL-CANCER PATIENTS; VIRUS ANKARA RECOMBINANT; ATTENUATED MVA STRAIN; HOST-RANGE SELECTION; T-CELL RESPONSE; IMMUNE-RESPONSES; IN-VITRO; NONSTRUCTURAL PROTEINS; MICE; IMMUNIZATION	Background: Currently existing yellow fever (YF) vaccines are based on the live attenuated yellow fever virus 17D strain (YFV-17D). Although, a good safety profile was historically attributed to the 17D vaccine, serious adverse events have been reported, making the development of a safer, more modern vaccine desirable. Methodology/Principal Findings: A gene encoding the precursor of the membrane and envelope (prME) protein of the YFV-17D strain was inserted into the non-replicating modified vaccinia virus Ankara and into the D4R-defective vaccinia virus. Candidate vaccines based on the recombinant vaccinia viruses were assessed for immunogenicity and protection in a mouse model and compared to the commercial YFV-17D vaccine. The recombinant live vaccines induced gamma-interferon-secreting CD4- and functionally active CD8-T cells, and conferred full protection against lethal challenge already after a single low immunization dose of 10(5) TCID50. Surprisingly, pre-existing immunity against wild-type vaccinia virus did not negatively influence protection. Unlike the classical 17D vaccine, the vaccinia virus-based vaccines did not cause mortality following intracerebral administration in mice, demonstrating better safety profiles. Conclusions/Significance: The non-replicating recombinant YF candidate live vaccines induced a broad immune response after single dose administration, were effective even in the presence of a pre-existing immunity against vaccinia virus and demonstrated an excellent safety profile in mice.	[Schaefer, Birgit; Holzer, Georg W.; Joachimsthaler, Alexandra; Falkner, Falko G.] Biomed Res Ctr, Dept Virol, Orth, Austria; [Coulibaly, Sogue] Biomed Res Ctr, Dept Anim Housing, Orth, Austria; [Schwendinger, Michael; Crowe, Brian A.] Biomed Res Ctr, Dept Immunol, Orth, Austria		Schafer, B (corresponding author), Biomed Res Ctr, Dept Virol, Orth, Austria.	falknef@baxter.com			Baxter Bioscience	Baxter Bioscience	This study was funded by Baxter Bioscience. The funders were involved in study design, data collection and analysis, decision to publish and preparation of the manuscript.	Aberle JH, 1999, J IMMUNOL, V163, P6756; Akondy RS, 2009, J IMMUNOL, V183, P7919, DOI 10.4049/jimmunol.0803903; BARRETT ADT, 1986, J GEN VIROL, V67, P631, DOI 10.1099/0022-1317-67-4-631; Barrett ADT, 1997, BIOLOGICALS, V25, P17, DOI 10.1006/biol.1997.0056; Bejon P, 2006, CLIN INFECT DIS, V42, P1102, DOI 10.1086/501459; Bejon P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000707; Belsher JL, 2007, VACCINE, V25, P8480, DOI 10.1016/j.vaccine.2007.08.061; BENDER BS, 1993, J INFECT DIS, V168, P873, DOI 10.1093/infdis/168.4.873; BRANDRISS MW, 1986, J GEN VIROL, V67, P229, DOI 10.1099/0022-1317-67-2-229; BRANDRISS MW, 1990, J INFECT DIS, V161, P1134, DOI 10.1093/infdis/161.6.1134; Brookes RH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002921; Carroll MW, 1997, VIROLOGY, V238, P198, DOI 10.1006/viro.1997.8845; Cebere I, 2006, VACCINE, V24, P417, DOI 10.1016/j.vaccine.2005.08.041; Chan RC, 2001, LANCET, V358, P121, DOI 10.1016/S0140-6736(01)05341-7; Co MDT, 2002, VIROLOGY, V293, P151, DOI 10.1006/viro.2001.1255; COONEY EL, 1991, LANCET, V337, P567, DOI 10.1016/0140-6736(91)91636-9; Cosma A, 2007, AIDS RES HUM RETROV, V23, P782, DOI 10.1089/aid.2006.0226; De Beeck AO, 2003, J VIROL, V77, P813, DOI 10.1128/JVI.77.2.813-820.2003; Doblas A, 2006, J CLIN VIROL, V36, P156, DOI 10.1016/j.jcv.2006.02.005; Drexler I, 2004, CURR OPIN BIOTECH, V15, P506, DOI 10.1016/j.copbio.2004.09.001; Drexler I, 1998, J GEN VIROL, V79, P347, DOI 10.1099/0022-1317-79-2-347; Garg M, 1996, INFECT IMMUN, V64, P4456, DOI 10.1128/IAI.64.11.4456-4462.1996; Gerasimon G, 2005, SOUTH MED J, V98, P653, DOI 10.1097/01.SMJ.0000157537.11806.DC; Gubler D.J., 2007, FIELDS VIROLOGY, VVolume 1; Harrop R, 2008, CANCER IMMUNOL IMMUN, V57, P977, DOI 10.1007/s00262-007-0428-7; Harrop R, 2006, CLIN CANCER RES, V12, P3416, DOI 10.1158/1078-0432.CCR-05-2732; Hermans IF, 2004, J IMMUNOL METHODS, V285, P25, DOI 10.1016/j.jim.2003.10.017; Holzer GW, 2011, VACCINE, V29, P4132, DOI 10.1016/j.vaccine.2011.03.089; Holzer GW, 1998, VIROLOGY, V249, P160, DOI 10.1006/viro.1998.9307; Holzer GW, 1997, J VIROL, V71, P4997, DOI 10.1128/JVI.71.7.4997-5002.1997; Kaufman HL, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-2; Kengsakul Kitisak, 2002, J Med Assoc Thai, V85, P131; Klinman DM, 1998, J GERONTOL A-BIOL, V53, pB281, DOI 10.1093/gerona/53A.4.B281; Lindenbach BD, 2007, FIELDS VIROLOGY, P1101; Lindsey NP, 2008, VACCINE, V26, P6077, DOI 10.1016/j.vaccine.2008.09.009; Liu T, 2001, J VIROL, V75, P2107, DOI 10.1128/JVI.75.5.2107-2118.2001; Maciel M, 2008, VIROLOGY, V378, P105, DOI 10.1016/j.virol.2008.04.043; Martin M, 2001, LANCET, V358, P98, DOI 10.1016/S0140-6736(01)05327-2; MAYR A, 1978, ZBL BAKT MIK HYG B, V167, P375; Mayr A, 1975, INFECTION, V3; Mayrhofer J, 2009, J VIROL, V83, P5192, DOI 10.1128/JVI.02081-08; Meier KC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000614; Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020; Monath T P, 2001, Lancet Infect Dis, V1, P11, DOI 10.1016/S1473-3099(01)00016-0; Monath TP, 2007, NEW ENGL J MED, V357, P2222, DOI 10.1056/NEJMp0707161; Monath TP, 2010, VACCINE, V28, P3827, DOI 10.1016/j.vaccine.2010.03.023; Monath TP, 2003, ADV VIRUS RES, V60, P343, DOI 10.1016/S0065-3527(03)60009-6; MONATH TP, 1986, PATHOBIOLOGY FLAVIVI, P375; MONATH TP, 2004, VACCINES, P1095; Nam JH, 1999, VACCINE, V17, P261, DOI 10.1016/S0264-410X(98)00156-X; Ober BT, 2002, J VIROL, V76, P7713, DOI 10.1128/JVI.76.15.7713-7723.2002; PERKUS ME, 1985, SCIENCE, V229, P981, DOI 10.1126/science.2992092; PINCUS S, 1992, VIROLOGY, V187, P290, DOI 10.1016/0042-6822(92)90317-I; PUTNAK JR, 1990, J GEN VIROL, V71, P1697, DOI 10.1099/0022-1317-71-8-1697; Ramirez JC, 2000, J VIROL, V74, P7651, DOI 10.1128/JVI.74.16.7651-7655.2000; Ramirez JC, 2000, J VIROL, V74, P923, DOI 10.1128/JVI.74.2.923-933.2000; RICE CM, 1985, SCIENCE, V229, P726, DOI 10.1126/science.4023707; ROONEY JF, 1988, J VIROL, V62, P1530, DOI 10.1128/JVI.62.5.1530-1534.1988; Scheiflinger F, 1998, ARCH VIROL, V143, P467, DOI 10.1007/s007050050303; Staib C, 2000, BIOTECHNIQUES, V28, P1137, DOI 10.2144/00286st04; STICKL H, 1974, DEUT MED WOCHENSCHR, V99, P2386, DOI 10.1055/s-0028-1108143; Stokes A, 2001, REV MED VIROL, V11, P141, DOI 10.1002/rmv.311; Tesh RB, 2001, J INFECT DIS, V183, P1431, DOI 10.1086/320199; Theiler M, 1937, J EXP MED, V65, P787, DOI 10.1084/jem.65.6.787; Tykodi SS, 2008, EXPERT OPIN BIOL TH, V8, P1947, DOI [10.1517/14712590802567298, 10.1517/14712590802567298 ]; van der Most RG, 2002, VIROLOGY, V296, P117, DOI 10.1006/viro.2002.1432; Vasconcelos PFC, 2001, LANCET, V358, P91, DOI 10.1016/S0140-6736(01)05326-0; WHO, 2009, YELL FEV YELL FEV FA; Wyatt LS, 2008, VACCINE, V26, P486, DOI 10.1016/j.vaccine.2007.11.036; Wyatt LS, 1998, VIROLOGY, V251, P334, DOI 10.1006/viro.1998.9397; Wyatt LS, 1996, VACCINE, V14, P1451, DOI 10.1016/S0264-410X(96)00072-2	71	20	23	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2011	6	9							e24505	10.1371/journal.pone.0024505	http://dx.doi.org/10.1371/journal.pone.0024505			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CN	21931732	Green Submitted, Green Published, gold			2022-12-25	WOS:000294803100037
J	Wendling, BM; Galbreath, KE; DeChaine, EG				Wendling, Barry M.; Galbreath, Kurt E.; DeChaine, Eric G.			Resolving the Evolutionary History of Campanula (Campanulaceae) in Western North America	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; RECOMBINATION; BIOGEOGRAPHY; SEQUENCES; INFERENCE; PATTERNS; UTILITY; TAXA	Recent phylogenetic works have begun to address long-standing questions regarding the systematics of Campanula (Campanulaceae). Yet, aspects of the evolutionary history, particularly in northwestern North America, remain unresolved. Thus, our primary goal in this study was to infer the phylogenetic positions of northwestern Campanula species within the greater Campanuloideae tree. We combined new sequence data from 5 markers (atpB, rbcL, matK, and trnL-F regions of the chloroplast and the nuclear ITS) representing 12 species of Campanula with previously published datasets for worldwide campanuloids, allowing us to include approximately 75% of North American Campanuleae in a phylogenetic analysis of the Campanuloideae. Because all but one of North American Campanula species are nested within a single campanuloid subclade (the Rapunculus clade), we conducted a separate set of analyses focused specifically on this group. Our findings show that i) the campanuloids have colonized North America at least 6 times, 4 of which led to radiations, ii) all but one North American campanuloid are nested within the Rapunculus clade, iii) in northwestern North America, a C. piperi - C. lasiocarpa ancestor gave rise to a monophyletic Cordilleran clade that is sister to a clade containing C. rotundifolia, iv) within the Cordilleran clade, C. parryi var. parryi and C. parryi var. idahoensis exhibit a deep, species-level genetic divergence, and v) C. rotundifolia is genetically diverse across its range and polyphyletic. Potential causes of diversification and endemism in northwestern North America are discussed.	[Wendling, Barry M.; Galbreath, Kurt E.; DeChaine, Eric G.] Western Washington Univ, Dept Biol, Bellingham, WA 98225 USA	Western Washington University	Wendling, BM (corresponding author), Western Washington Univ, Dept Biol, Bellingham, WA 98225 USA.	dechainelab@gmail.com			National Science Foundation [ARC-0714232]; Washington Native Plant Society; RSP; Biology Department Research Funds; Biology Chair Funds; Microsoft Corporation	National Science Foundation(National Science Foundation (NSF)); Washington Native Plant Society; RSP; Biology Department Research Funds; Biology Chair Funds; Microsoft Corporation(Microsoft)	Financial support was provided by the National Science Foundation (ARC-0714232), the Washington Native Plant Society, an RSP Fund for the Enhancement of Graduate Research grant, Biology Department Research Funds, and Biology Chair Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank thesis committee members A. Singh-Cundy and E. Binney, Michael Knapp, and two anonymous reviewers for valuable feedback. Collecting permits were provided by the Gates of the Arctic National Park (GAAR-2008-SCI-0001), the Noatak National Preserve (NOAT-2008-SCI-0003), Mt. Baker-Snoqualmie National Forest (2201), Olympic National Park (OLYM-2007-SCI-0055), Olympic National Forest (11403), Okanogan and Wenatchee National Forest (07-02), Wallowa Whitman National Forests/Hells Canyon National Recreation area-Seven Devils Mountains and Wallowa Mountains (2007-0X), Nez Perce National Forest, Beaverhead-Deerlodge National Forest, Lolo National Forest, and the Bitterroot National Forest. Herbarium specimens were generously loaned from the Rancho Santa Ana Botanic Garden Herbarium; University of Arizona Herbarium; Biological Sciences Herbarium, California State University, Chico; University Herbarium and Jepson Herbarium, University of California, Berkeley; University of Montana Herbarium; Rocky Mountain Herbarium, Wyoming; Arizona State University Vascular Plant Herbarium; University of Idaho Herbarium; Herbarium of the University of Alaska Museum; Montana State University Herbarium; and the Marion Ownbey Herbarium of Washington State University. We thank Julie K. Nelson at the Shasta-Trinity National Forest for her help in collecting plant material. Plant material was also provided by the Royal Botanic Garden Edinburgh. Some analyses were performed using the resources of the Computational Biology Service Unit at Cornell University, which is partially funded by Microsoft Corporation.	Abbott RJ, 2003, MOL ECOL, V12, P299, DOI 10.1046/j.1365-294X.2003.01731.x; Boissier E., 1875, FLORA ORIENTALIS, V3, P884, DOI [10.5962/bhl.title.20323, DOI 10.5962/BHL.TITLE.20323]; Borsch Thomas, 2009, Willdenowia, V39, P7, DOI 10.3372/wi.39.39101; Buckingham N. M., 1995, FLORA OLYMPIC PENINS; Campbell V, 2009, SYST BIOL, V58, P560, DOI 10.1093/sysbio/syp056; Cellinese N, 2009, J BIOGEOGR, V36, P1253, DOI 10.1111/j.1365-2699.2008.02077.x; Cosner ME, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-27; DAMBOLDT J, 1976, Notes from the Royal Botanic Garden Edinburgh, V35, P39; DAMBOLDT JURGEN, 1965, OESTERR BOT Z, V112, P392, DOI 10.1007/BF01372959; DeChaine EG, 2005, AM J BOT, V92, P477, DOI 10.3732/ajb.92.3.477; DECONDOLLE AP, 1830, MONOGRAPHIE CAMPANUL, P444; Eddie WMM, 2003, ANN MO BOT GARD, V90, P554, DOI 10.2307/3298542; EDDIE WMM, 1984, THESIS U READING ENG; FEDOROV AA, 1957, FLORA SSSR, V24, P92; Galbreath KE, 2009, EVOLUTION, V63, P2848, DOI 10.1111/j.1558-5646.2009.00803.x; Grant V., 1981, PLANT SPECIATION, DOI [10.7312/gran92318, DOI 10.7312/GRAN92318]; Haberle RC, 2009, TAXON, V58, P715, DOI 10.1002/tax.583003; HITCHCOCK CL, 1973, FLORA PACIFIC NORTHW; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kovacic Sanja, 2004, Acta Botanica Croatica, V63, P171; Kovanda M., 1978, FLOWERING PLANTS WOR, P254; Linder CR, 2004, AM J BOT, V91, P1700, DOI 10.3732/ajb.91.10.1700; Lmmers TG, 2007, WORLD CHECKLIST BIBL; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Martin DP, 2005, BIOINFORMATICS, V21, P260, DOI 10.1093/bioinformatics/bth490; MCLAUGHLIN SP, 1989, J BIOGEOGR, V16, P239, DOI 10.2307/2845260; McVaugh Rogers, 1945, WRIGHTIA, V1, P13; Milne RI, 2004, MOL PHYLOGENET EVOL, V33, P389, DOI 10.1016/j.ympev.2004.06.009; Minin V, 2003, SYST BIOL, V52, P674, DOI 10.1080/10635150390235494; MORIN N, 1983, SYST BOT, V8, P436, DOI 10.2307/2418363; Muller K, 2006, MOL PHYLOGENET EVOL, V38, P667, DOI 10.1016/j.ympev.2005.07.011; Muller Kai, 2005, Appl Bioinformatics, V4, P65; Nylander JAA, 2008, BIOINFORMATICS, V24, P581, DOI 10.1093/bioinformatics/btm388; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Park JM, 2006, SYST BOT, V31, P862, DOI 10.1600/036364406779695924; PIPER CV, 1896, BOT GAZETT, V22, P488; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; Qian H, 2007, AM NAT, V170, P690, DOI 10.1086/521960; Rambaut A., 2007, TRACER V1 5; Rieseberg LH, 1997, ANNU REV ECOL SYST, V28, P359, DOI 10.1146/annurev.ecolsys.28.1.359; Roquet C, 2008, SYST BOT, V33, P203, DOI 10.1600/036364408783887465; Roquet C, 2009, MOL PHYLOGENET EVOL, V52, P575, DOI 10.1016/j.ympev.2009.05.014; SHETLER S G, 1967, ASB Bulletin, V14, P40; SHETLER SG, 1979, TAXON, V28, P205, DOI 10.2307/1219578; SHETLER SG, 1986, ANN MO BOT GARD, V73, P653, DOI 10.2307/2399199; Shetler SG, 1982, VARIATION EVOLUTION; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; Stebbins G. L., 1959, Proceedings of the American Philosophical Society, V103, P231; SUN Y, 1994, THEOR APPL GENET, V89, P26, DOI 10.1007/BF00226978; Swofford DL, 2001, PAUP PHYLOGENETIC AN; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Takhtajan A, 1986, FLORISTIC REGIONS WO, P522; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tremblay NO, 1999, MOL ECOL, V8, P1187, DOI 10.1046/j.1365-294x.1999.00680.x; *WASH NAT HER PROG, 1981, ILL GUID END THREAT; Westergaard KB, 2010, J BIOGEOGR, V37, P1262, DOI 10.1111/j.1365-2699.2010.02278.x; YEO PF, 1993, PLANT SYST EVOL, V6, P111; ZHARKIKH A, 1994, J MOL EVOL, V39, P315, DOI 10.1007/BF00160155; Zwickl D. J, 2010, GARLI PART V0 97; Zwickl D. J., 2006, THESIS TEXAS AUSTIN	60	20	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2011	6	9							e23559	10.1371/journal.pone.0023559	http://dx.doi.org/10.1371/journal.pone.0023559			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CN	21931605	Green Published, gold, Green Submitted			2022-12-25	WOS:000294803100003
J	Puig, B; Altmeppen, HC; Thurm, D; Geissen, M; Conrad, C; Braulke, T; Glatzel, M				Puig, Berta; Altmeppen, Hermann C.; Thurm, Dana; Geissen, Markus; Conrad, Catharina; Braulke, Thomas; Glatzel, Markus			N-Glycans and Glycosylphosphatidylinositol-Anchor Act on Polarized Sorting of Mouse PrPC in Madin-Darby Canine Kidney Cells	PLOS ONE			English	Article							PRION PROTEIN; GLYCOSYLATION SITES; GPI-ANCHOR; MEMBRANE; SCRAPIE; HETEROGENEITY; SURFACE; OLIGOMERIZATION; TRAFFICKING; MUTATION	The cellular prion protein (PrPC) plays a fundamental role in prion disease. PrPC is a glycosylphosphatidylinositol (GPI)-anchored protein with two variably occupied N-glycosylation sites. In general, GPI-anchor and N-glycosylation direct proteins to apical membranes in polarized cells whereas the majority of mouse PrPC is found in basolateral membranes in polarized Madin-Darby canine kidney (MDCK) cells. In this study we have mutated the first, the second, and both N-glycosylation sites of PrPC and also replaced the GPI-anchor of PrPC by the Thy-1 GPI-anchor in order to investigate the role of these signals in sorting of PrPC in MDCK cells. Cell surface biotinylation experiments and confocal microscopy showed that lack of one N-linked oligosaccharide leads to loss of polarized sorting of PrPC. Exchange of the PrPC GPI-anchor for the one of Thy-1 redirects PrPC to the apical membrane. In conclusion, both N-glycosylation and GPI-anchor act on polarized sorting of PrPC, with the GPI-anchor being dominant over N-glycans.	[Puig, Berta; Altmeppen, Hermann C.; Thurm, Dana; Geissen, Markus; Conrad, Catharina; Glatzel, Markus] Univ Med Ctr Hamburg Eppendorf, Inst Neuropathol, Hamburg, Germany; [Braulke, Thomas] Childrens Hosp, Univ Med Ctr Hamburg Eppendorf, Dept Biochem, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Puig, B (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Neuropathol, Hamburg, Germany.	m.glatzel@uke.de	Puig, Berta/AAS-2110-2021; Glatzel, Markus/G-3356-2011; Braulke, Thomas/AAV-9121-2020; Puig, Berta/AAD-7982-2020; Glatzel, Markus/V-8844-2019	Puig, Berta/0000-0002-2255-8393; Glatzel, Markus/0000-0002-7720-8817; Braulke, Thomas/0000-0002-2336-8532; Glatzel, Markus/0000-0002-7720-8817; Altmeppen, Hermann/0000-0001-9439-6533	Deutsche Forschungsgemeinschaft [GRK1459, GI589/2-1]; Leibniz Center Infection (LCI) graduate school (Model systems for infectious diseases); Landesexzellenzinitiative of Hamburg (SDI-LEXI)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Leibniz Center Infection (LCI) graduate school (Model systems for infectious diseases); Landesexzellenzinitiative of Hamburg (SDI-LEXI)	This research was supported by grants from the Deutsche Forschungsgemeinschaft (GRK1459, GI589/2-1), Leibniz Center Infection (LCI) graduate school (Model systems for infectious diseases), and the Landesexzellenzinitiative of Hamburg (SDI-LEXI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmeppen HC, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-36; Benting JH, 1999, J CELL BIOL, V146, P313, DOI 10.1083/jcb.146.2.313; Beringue V, 2003, BRAIN, V126, P2065, DOI 10.1093/brain/awg205; Bremer J, 2010, NAT NEUROSCI, V13, P310, DOI 10.1038/nn.2483; Breuer P, 1997, MOL BIOL CELL, V8, P567, DOI 10.1091/mbc.8.4.567; BROWN DA, 1989, SCIENCE, V245, P1499, DOI 10.1126/science.2571189; Brugger B, 2004, J BIOL CHEM, V279, P7530, DOI 10.1074/jbc.M310207200; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Cancellotti E, 2005, J BIOL CHEM, V280, P42909, DOI 10.1074/jbc.M509557200; CAUGHEY B, 1991, J BIOL CHEM, V266, P18217; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Chesebro B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000800; COHEN FE, 1994, SCIENCE, V264, P530, DOI 10.1126/science.7909169; De Keukeleire B, 2007, BIOCHEM BIOPH RES CO, V354, P949, DOI 10.1016/j.bbrc.2007.01.096; DeArmond SJ, 1999, J NEUROPATH EXP NEUR, V58, P1000, DOI 10.1097/00005072-199909000-00010; Delacour D, 2007, TRAFFIC, V8, P379, DOI 10.1111/j.1600-0854.2007.00539.x; Geissen M, 2007, VACCINE, V25, P5631, DOI 10.1016/j.vaccine.2007.02.041; Glatzel M, 2001, NEURON, V31, P25, DOI 10.1016/S0896-6273(01)00331-2; Goubaeva F, 2005, BIOCHEM BIOPH RES CO, V329, P624, DOI 10.1016/j.bbrc.2005.02.020; Grasbon-Frodl E, 2004, ACTA NEUROPATHOL, V108, P476, DOI 10.1007/s00401-004-0913-4; Gravotta D, 2007, P NATL ACAD SCI USA, V104, P1564, DOI 10.1073/pnas.0610700104; Hooper NM, 2006, MOL MEMBR BIOL, V23, P1, DOI 10.1080/09687860500500879; Ikeda S, 2008, BIOCHEM BIOPH RES CO, V369, P1195, DOI 10.1016/j.bbrc.2008.03.014; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Korth C, 2000, J GEN VIROL, V81, P2555, DOI 10.1099/0022-1317-81-10-2555; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Le Pichon CE, 2009, NAT NEUROSCI, V12, P60, DOI 10.1038/nn.2238; Lehmann S, 1997, J BIOL CHEM, V272, P21479, DOI 10.1074/jbc.272.34.21479; Linden R, 2008, PHYSIOL REV, V88, P673, DOI 10.1152/physrev.00007.2007; Lipschutz Joshua H, 2001, Curr Protoc Cell Biol, VChapter 15, DOI 10.1002/0471143030.cb1505s12; LISANTI MP, 1990, J MEMBRANE BIOL, V113, P155, DOI 10.1007/BF01872889; Madore N, 1999, EMBO J, V18, P6917, DOI 10.1093/emboj/18.24.6917; Mishra R, 2010, P NATL ACAD SCI USA, V107, P17633, DOI 10.1073/pnas.1012424107; Monnet C, 2003, EUR J NEUROSCI, V18, P542, DOI 10.1046/j.1460-9568.2003.02777.x; Nisbet RM, 2010, J VIROL, V84, P6678, DOI 10.1128/JVI.02709-09; Paladino S, 2006, J CELL BIOL, V172, P1023, DOI 10.1083/jcb.200507116; Paladino S, 2004, J CELL BIOL, V167, P699, DOI 10.1083/jcb.200407094; Paladino S, 2007, TRAFFIC, V8, P251, DOI 10.1111/j.1600-0854.2006.00522.x; Paladino S, 2008, J CELL SCI, V121, P4001, DOI 10.1242/jcs.036038; Pan T, 2002, J NEUROCHEM, V81, P1092, DOI 10.1046/j.1471-4159.2002.00909.x; Pang S, 2004, J CELL SCI, V117, P5079, DOI 10.1242/jcs.01386; Paquet S, 2007, J VIROL, V81, P10786, DOI 10.1128/JVI.01137-07; Paulick MG, 2008, BIOCHEMISTRY-US, V47, P6991, DOI 10.1021/bi8006324; RADEMACHER T W, 1991, Current Biology, V1, P41, DOI 10.1016/0960-9822(91)90123-E; ROGERS M, 1990, Glycobiology, V1, P101, DOI 10.1093/glycob/1.1.101; Rudd PM, 2002, CURR OPIN STRUC BIOL, V12, P578, DOI 10.1016/S0959-440X(02)00377-9; Russelakis-Carneiro M, 2002, J BIOL CHEM, V277, P36872, DOI 10.1074/jbc.M202229200; Salamat MK, 2011, J VIROL, V85, P3077, DOI 10.1128/JVI.02257-10; Sarnataro D, 2002, TRAFFIC, V3, P810, DOI 10.1034/j.1600-0854.2002.31106.x; SCHEIFFELE P, 1995, NATURE, V378, P96, DOI 10.1038/378096a0; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755; Stimson E, 1999, BIOCHEMISTRY-US, V38, P4885, DOI 10.1021/bi982330q; Tuzi NL, 2008, PLOS BIOL, V6, P872, DOI 10.1371/journal.pbio.0060100; Uelhoff A, 2005, J BIOL CHEM, V280, P5137, DOI 10.1074/jbc.C400560200; Vagin O, 2005, J BIOL CHEM, V280, P43159, DOI 10.1074/jbc.M508262200; XUE GP, 1991, DEVELOPMENT, V112, P161; Zaidi SIA, 2005, J ALZHEIMERS DIS, V7, P159; Zuegg J, 2000, GLYCOBIOLOGY, V10, P959, DOI 10.1093/glycob/10.10.959	58	19	19	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e24624	10.1371/journal.pone.0024624	http://dx.doi.org/10.1371/journal.pone.0024624			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CK	21931781	Green Published, gold, Green Submitted			2022-12-25	WOS:000294802800075
J	Sun, JH; Li, XB; Feng, HQ; Gu, HD; Blair, T; Li, JK; Soriano, S; Meng, YF; Zhang, F; Feng, QH; Yang, XM				Sun, Jihong; Li, Xubin; Feng, Hongqing; Gu, Huidong; Blair, Tiffany; Li, Jiakai; Soriano, Stephanie; Meng, Yanfeng; Zhang, Feng; Feng, Qinghua; Yang, Xiaoming			Magnetic Resonance Imaging of Bone Marrow Cell-Mediated Interleukin-10 Gene Therapy of Atherosclerosis	PLOS ONE			English	Article							IN-VIVO; STEM-CELLS; PROGENITOR CELLS; MICE; MRI; OVEREXPRESSION; MACROPHAGES; RECEPTOR; DISEASE; PLAQUES	Background: A characteristic feature of atherosclerosis is its diffuse involvement of arteries across the entire human body. Bone marrow cells (BMC) can be simultaneously transferred with therapeutic genes and magnetic resonance (MR) contrast agents prior to their transplantation. Via systemic transplantation, these dual-transferred BMCs can circulate through the entire body and thus function as vehicles to carry genes/contrast agents to multiple atherosclerosis. This study was to evaluate the feasibility of using in vivo MR imaging (MRI) to monitor BMC-mediated interleukin-10 (IL-10) gene therapy of atherosclerosis. Methodology: For in vitro confirmation, donor mouse BMCs were transduced by IL-10/lentivirus, and then labeled with a T2-MR contrast agent (Feridex). For in vivo validation, atherosclerotic apoE 2/2 mice were intravenously transplanted with IL-10/Feridex-BMCs (Group I, n = 5) and Feridex-BMCs (Group II, n = 5), compared to controls without BMC transplantation (Group III, n = 5). The cell migration to aortic atherosclerotic lesions was monitored in vivo using 3.0T MRI with subsequent histology correlation. To evaluate the therapeutic effect of BMC-mediated IL-10 gene therapy, we statistically compared the normalized wall indexes (NWI) of ascending aortas amongst different mouse groups with various treatments. Principal Findings: Of in vitro experiments, simultaneous IL-10 transduction and Feridex labeling of BMCs were successfully achieved, with high cell viability and cell labeling efficiency, as well as IL-10 expression efficiency (>= 90%). Of in vivo experiments, MRI of animal groups I and II showed signal voids within the aortic walls due to Feridex-created artifacts from the migrated BMCs in the atherosclerotic plaques, which were confirmed by histology. Histological quantification showed that the mean NWI of group I was significantly lower than those of group II and group III (P < 0.05). Conclusion: This study has confirmed the possibility of using MRI to track, in vivo, IL-10/Feridex-BMCs recruited to atherosclerotic lesions, where IL-10 genes function to prevent the progression of atherosclerosis.	[Sun, Jihong] Zhejiang Univ, Sch Med, Dept Radiol, Sir Run Run Shaw Hosp, Hangzhou 310003, Zhejiang, Peoples R China; [Sun, Jihong; Li, Xubin; Feng, Hongqing; Gu, Huidong; Blair, Tiffany; Li, Jiakai; Soriano, Stephanie; Meng, Yanfeng; Zhang, Feng; Yang, Xiaoming] Univ Washington, Sch Med, Dept Radiol, Image Guided Biomol Intervent Sect, Seattle, WA 98195 USA; [Feng, Qinghua] Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA	Zhejiang University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Sun, JH (corresponding author), Zhejiang Univ, Sch Med, Dept Radiol, Sir Run Run Shaw Hosp, Hangzhou 310003, Zhejiang, Peoples R China.	xmyang@u.washington.edu	Meng, Yanfeng/AAS-4532-2021; Meng, Yanfeng/D-1804-2013; Sun, Jihong/AGN-2573-2022; Feng, Hongqing/I-5222-2019	Feng, Hongqing/0000-0003-2767-3080	National Institutes of Health [R01 HL078672]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078672] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by a National Institutes of Health R01 HL078672 grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanco E, 2008, HUM IMMUNOL, V69, P651, DOI 10.1016/j.humimm.2008.07.005; Bos C, 2004, RADIOLOGY, V233, P781, DOI 10.1148/radiol.2333031714; Bulte JWM, 2001, NAT BIOTECHNOL, V19, P1141, DOI 10.1038/nbt1201-1141; Chae EY, 2010, RADIOLOGY, V256, P847, DOI 10.1148/radiol.10091732; Gao FB, 2007, NMR BIOMED, V20, P673, DOI 10.1002/nbm.1128; Han XB, 2010, FASEB J, V24, P2869, DOI 10.1096/fj.09-148155; Kleemann R, 2008, CARDIOVASC RES, V79, P360, DOI 10.1093/cvr/cvn120; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; LACRAZ S, 1995, J CLIN INVEST, V96, P2304, DOI 10.1172/JCI118286; Mallat Z, 1999, CIRC RES, V85, pE17, DOI 10.1161/01.RES.85.8.e17; Mallat Z, 1999, ARTERIOSCL THROM VAS, V19, P611, DOI 10.1161/01.ATV.19.3.611; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; NABEL EG, 1995, CIRCULATION, V91, P541, DOI 10.1161/01.CIR.91.2.541; Namiki M, 2004, ATHEROSCLEROSIS, V172, P21, DOI 10.1016/j.atherosclerosis.2003.08.032; *NIH, NIH PUBL, V8623; Orlic D, 2003, PEDIATR TRANSPLANT, V7, P86, DOI 10.1034/j.1399-3046.7.s3.13.x; Oslund LJP, 1999, ARTERIOSCL THROM VAS, V19, P2847, DOI 10.1161/01.ATV.19.12.2847; Pinderski LJ, 2002, CIRC RES, V90, P1064, DOI 10.1161/01.RES.0000018941.10726.FA; Qiu BS, 2008, NAT CLIN PRACT CARD, V5, P396, DOI 10.1038/ncpcardio1217; Qiu BS, 2007, J MAGN RESON IMAGING, V26, P339, DOI 10.1002/jmri.21016; Qiu BS, 2010, ACAD RADIOL, V17, P547, DOI 10.1016/j.acra.2010.02.004; Rubic T, 2006, CARDIOVASC RES, V69, P527, DOI 10.1016/j.cardiores.2005.10.018; Russell JC, 2003, CARDIOVASC RES, V59, P810, DOI 10.1016/S0008-6363(03)00530-3; Sata M, 2002, NAT MED, V8, P403, DOI 10.1038/nm0402-403; Shapiro EM, 2006, MAGN RESON MED, V55, P242, DOI 10.1002/mrm.20718; Sinnaeve P, 1999, CARDIOVASC RES, V44, P498, DOI 10.1016/S0008-6363(99)00259-X; Tang TY, 2008, STROKE, V39, P2144, DOI 10.1161/STROKEAHA.107.504753; Xu Y, 2004, ARTERIOSCL THROM VAS, V24, P477, DOI 10.1161/01.ATV.0000118016.94368.35; Yang XM, 2003, RADIOLOGY, V228, P36, DOI 10.1148/radiol.2281020307	29	6	7	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2011	6	9							e24529	10.1371/journal.pone.0024529	http://dx.doi.org/10.1371/journal.pone.0024529			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CH	21915349	Green Published, gold, Green Submitted			2022-12-25	WOS:000294802500058
J	Chen, L; Li, W; Zhang, LC; Wang, H; He, WM; Tai, JX; Li, X; Li, X				Chen, Lina; Li, Wan; Zhang, Liangcai; Wang, Hong; He, Weiming; Tai, Jingxie; Li, Xu; Li, Xia			Disease Gene Interaction Pathways: A Potential Framework for How Disease Genes Associate by Disease-Risk Modules	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; PROTEIN-INTERACTION; HIERARCHICAL ORGANIZATION; NETWORK; IDENTIFICATION; PLASMINOGEN; COAGULATION; DISCOVERY; ONTOLOGY; MUTATION	Background: Disease genes that interact cooperatively play crucial roles in the process of complex diseases, yet how to analyze and represent their associations is still an open problem. Traditional methods have failed to represent direct biological evidences that disease genes associate with each other in the pathogenesis of complex diseases. Molecular networks, assumed as 'a form of biological systems', consist of a set of interacting biological modules (functional modules or pathways) and this notion could provide a promising insight into deciphering this topic. Methodology/Principal Findings: In this paper, we hypothesized that disease genes might associate by virtue of the associations between biological modules in molecular networks. Then we introduced a novel disease gene interaction pathway representation and analysis paradigm, and managed to identify the disease gene interaction pathway for 61 known disease genes of coronary artery disease (CAD), which contained 46 disease-risk modules and 182 interaction relationships. As demonstrated, disease genes associate through prescribed communication protocols of common biological functions and pathways. Conclusions/Significance: Our analysis was proved to be coincident with our primary hypothesis that disease genes of complex diseases interact with their neighbors in a cooperative manner, associate with each other through shared biological functions and pathways of disease-risk modules, and finally cause dysfunctions of a series of biological processes in molecular networks. We hope our paradigm could be a promising method to identify disease gene interaction pathways for other types of complex diseases, affording additional clues in the pathogenesis of complex diseases.	[Chen, Lina; Li, Wan; Zhang, Liangcai; Wang, Hong; Tai, Jingxie; Li, Xu; Li, Xia] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Hei Longjiang, Peoples R China; [He, Weiming] Harbin Inst Technol, Inst Optoelect, Harbin 150006, Hei Longjiang, Peoples R China	Harbin Medical University; Harbin Institute of Technology	Chen, L (corresponding author), Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Hei Longjiang, Peoples R China.	chenlina@ems.hrbmu.edu.cn; zhangliangcai@ems.hrbmu.edu.cn; lixia@hrbmu.edu.cn	Zhang, Liang/GWM-6088-2022; Zhang, Liangcai/AAD-4415-2020; li, xia/HHZ-7468-2022	Li, Wan/0000-0002-9797-0315; Chen, Lina/0000-0002-4576-6814	National Science Foundation of Heilongjiang Province [D2007-48]; Harbin Medical University [HCXS2010006]; National High Tech Development Project of China; 863 (National High Technology Research and Development Program) Program [2007AA02Z329]	National Science Foundation of Heilongjiang Province; Harbin Medical University; National High Tech Development Project of China(National High Technology Research and Development Program of China); 863 (National High Technology Research and Development Program) Program(National High Technology Research and Development Program of China)	This work was supported by the National Science Foundation of Heilongjiang Province (grant no. D2007-48), the Master Innovation Funds of Harbin Medical University (grant no. HCXS2010006), the National High Tech Development Project of China, and the 863 (National High Technology Research and Development Program) Program (grant no. 2007AA02Z329). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Bazrgar M, 2008, MOL BIOL REP, V35, P495, DOI 10.1007/s11033-007-9113-3; Bebek G, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-335; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; Berger SI, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-372; Bertram L, 2008, NAT REV NEUROSCI, V9, P768, DOI 10.1038/nrn2494; Borinskaia S A, 2007, Genetika, V43, P1434; Brazionis L, 2008, ARTERIOSCL THROM VAS, V28, P786, DOI 10.1161/ATVBAHA.107.160168; Campbell IG, 2004, CANCER RES, V64, P7678, DOI 10.1158/0008-5472.CAN-04-2933; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Clement K, 2010, BIOINFORMATICS, V26, P423, DOI 10.1093/bioinformatics/btp661; Dale JM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-15; DAVIES JA, 1980, ACTA MED SCAND, P141; Deftereos S, 2010, AM J CARDIOL, V105, P54, DOI 10.1016/j.amjcard.2009.08.648; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dezso Z, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-36; Du P, 2009, BIOINFORMATICS, V25, pI63, DOI 10.1093/bioinformatics/btp193; Faust K, 2010, BIOINFORMATICS, V26, P1211, DOI 10.1093/bioinformatics/btq105; Frisch M, 2009, NUCLEIC ACIDS RES, V37, pW135, DOI 10.1093/nar/gkp303; Frost G, 1999, NUTRITION, V15, P183, DOI 10.1016/S0899-9007(98)00177-4; Gerlee P, 2009, BIOINFORMATICS, V25, P3282, DOI 10.1093/bioinformatics/btp575; Gu J, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-47; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang X, 2010, TOHOKU J EXP MED, V220, P157, DOI 10.1620/tjem.220.157; Huffner F, 2007, BIOINFORMATICS, V23, P1708, DOI 10.1093/bioinformatics/btm160; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kelley R, 2005, NAT BIOTECHNOL, V23, P561, DOI 10.1038/nbt1096; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; Kind T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005440; Li A, 2007, BIOINFORMATICS, V23, P222, DOI 10.1093/bioinformatics/btl581; Li H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006410; Lu LY, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.046122; Martins IJ, 2009, J NEUROCHEM, V111, P1275, DOI 10.1111/j.1471-4159.2009.06408.x; McCarthy JJ, 2004, J MED GENET, V41, P334, DOI 10.1136/jmg.2003.016584; McCarthy JJ, 2003, HUM GENET, V114, P87, DOI 10.1007/s00439-003-1026-1; McGeachie M, 2009, CIRCULATION, V120, P2448, DOI 10.1161/CIRCULATIONAHA.109.865501; McKusick VA, 2007, AM J HUM GENET, V80, P588, DOI 10.1086/514346; MERSKEY C, 1960, BRIT MED J, V1, P219, DOI 10.1136/bmj.1.5168.219; Mithani A, 2009, BIOINFORMATICS, V25, P1831, DOI 10.1093/bioinformatics/btp269; Mocellin S, 2004, TRENDS MOL MED, V10, P24, DOI 10.1016/j.molmed.2003.11.001; Nelson MR, 2001, GENOME RES, V11, P458, DOI 10.1101/gr.172901; Ostlund G, 2010, MOL CELL PROTEOMICS, V9, P648, DOI 10.1074/mcp.M900227-MCP200; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Qian XN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008070; Qian XN, 2009, J COMPUT BIOL, V16, P145, DOI 10.1089/cmb.2008.02TT; Qiu YQ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-26; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Rives AW, 2003, P NATL ACAD SCI USA, V100, P1128, DOI 10.1073/pnas.0237338100; Sales-Pardo M, 2007, P NATL ACAD SCI USA, V104, P15224, DOI 10.1073/pnas.0703740104; Scott J, 2006, J COMPUT BIOL, V13, P133, DOI 10.1089/cmb.2006.13.133; Segal E, 2003, BIOINFORMATICS, V19, pi264, DOI 10.1093/bioinformatics/btg1037; Segev A, 2004, CARDIOVASC RES, V63, P603, DOI 10.1016/j.cardiores.2004.03.028; Shimizu A, 2010, INT J COMPUT ASS RAD, V5, P85, DOI 10.1007/s11548-009-0384-0; Shlomi T, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-199; Steffen M, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-34; Supper J, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-67; Thomas P, 2007, MUTAGENESIS, V22, P15, DOI 10.1093/mutage/gel055; Wilensky RL, 2009, CURR OPIN LIPIDOL, V20, P415, DOI 10.1097/MOL.0b013e3283307c16; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Yamagishi K, 2010, J ATHEROSCLER THROMB, V17, P402, DOI 10.5551/jat.3673; YU X, 2009, MOL BIOL REP; Zeng Y, 2007, J ALZHEIMERS DIS, V12, P357; Zhang KX, 2010, BIOINFORMATICS, V26, P529, DOI 10.1093/bioinformatics/btp701	66	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2011	6	9							e24495	10.1371/journal.pone.0024495	http://dx.doi.org/10.1371/journal.pone.0024495			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817QP	21915342	Green Submitted, gold, Green Published			2022-12-25	WOS:000294689200049
J	Dawson, JC; Timpson, P; Kalna, G; Machesky, LM				Dawson, J. C.; Timpson, P.; Kalna, G.; Machesky, L. M.			Mtss1 regulates epidermal growth factor signaling in head and neck squamous carcinoma cells	ONCOGENE			English	Article						Mtss1; HNSCC; epidermal growth factor receptor	HEDGEHOG-RESPONSIVE GENE; MISSING-IN-METASTASIS; SUPPRESSOR 1 MTSS1; FACTOR RECEPTOR; CANCER-CELLS; COPY NUMBER; DIFFERENTIAL REGULATION; ADHERENS JUNCTIONS; SURFACE DYNAMICS; DOWN-REGULATION	Mtss1 is located within chromosomal region 8q23-24, which is one of the three most commonly amplified regions in head and neck squamous cell carcinoma (HNSCC). Mtss1 is lost in metastatic cells, but confusingly is commonly overexpressed in primary tumors. Here we address possible reasons why Mtss1 is positively selected for in primary tumors. We find that Mtss1 enhances the localization of the epidermal growth factor (EGF) receptor to the plasma membrane, prolonging EGF signaling and resulting in enhanced proliferation in HNSCC. Depletion of Mtss1 results in decreased EGF receptor levels and decreased phosphorylation of Erk1/2 and Akt. However, when cells are at high density and adherent to each other, analogous to conditions in a solid tumor, Mtss1 does not confer any growth advantage, either in basal conditions or following EGF stimulation. This could indicate why Mtss1 might be lost in metastases, but preserved in early primary tumors. This is supported by an organotypic assay showing that Mtss1-expressing cells display a less proliferative more epithelial-like morphology on top of a collagen matrix. Furthermore, xenograft tumors expressing Mtss1 initially grow more rapidly, but later show less proliferation and more differentiation. Mtss1 positively modulates EGF signaling at low cell densities to promote proliferation and, therefore, may be beneficial for the early stages of primary HNSCC tumor growth. However, at high cell densities, Mtss1 impacts negatively on EGF signaling and this suggests why it inhibits metastasis. Oncogene (2012) 31, 1781-1793; doi: 10.1038/onc.2011.376; published online 19 September 2011	[Dawson, J. C.; Timpson, P.; Kalna, G.; Machesky, L. M.] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland	Beatson Institute	Dawson, JC (corresponding author), Beatson Inst Canc Res, Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.	j.dawson@beatson.gla.ac.uk; l.machesky@beatson.gla.ac.uk	Timpson, Paul/A-9429-2016; Dawson, John/HDM-6702-2022; Machesky, Laura/Z-4554-2019	Machesky, Laura/0000-0002-7592-9856; Dawson, John/0000-0001-5713-1026; Timpson, Paul/0000-0002-5514-7080	AICR [07-0438]; MRC [G117/569]; CRUK; Cancer Research UK [15673] Funding Source: researchfish; Medical Research Council [G117/569] Funding Source: researchfish	AICR; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); CRUK(Cancer Research UK); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	JD was funded by an AICR Grant to LMM (07-0438). LMM received funding from an MRC Senior Research fellowship (G117/569) and a CRUK core grant. We thank Roger Daly for HNSCC cell lines and Heather Spence for technical help.	Basu D, 2010, ONCOGENE, V29, P4170, DOI 10.1038/onc.2010.170; Bershteyn M, 2010, DEV CELL, V19, P270, DOI 10.1016/j.devcel.2010.07.009; Betson M, 2002, J BIOL CHEM, V277, P36962, DOI 10.1074/jbc.M207358200; Boissan M, 2010, CANCER RES, V70, P7710, DOI 10.1158/0008-5472.CAN-10-1887; Bompard G, 2005, J CELL SCI, V118, P5393, DOI 10.1242/jcs.02640; Bremm A, 2008, CANCER RES, V68, P707, DOI 10.1158/0008-5472.CAN-07-1588; Callahan CA, 2004, GENE DEV, V18, P2724, DOI 10.1101/gad.1221804; Canel M, 2006, CLIN CANCER RES, V12, P3272, DOI 10.1158/1078-0432.CCR-05-1583; Cheng GZ, 2007, CANCER RES, V67, P1979, DOI 10.1158/0008-5472.CAN-06-1479; Chung CH, 2006, J CLIN ONCOL, V24, P4170, DOI 10.1200/JCO.2006.07.2587; Cooper JB, 2009, HEAD NECK-J SCI SPEC, V31, P1086, DOI 10.1002/hed.21109; Danglot L, 2010, J CELL SCI, V123, P723, DOI 10.1242/jcs.062497; Donev IS, 2011, CLIN CANCER RES, V17, P2260, DOI 10.1158/1078-0432.CCR-10-1993; Edward M, 2005, CARCINOGENESIS, V26, P1215, DOI 10.1093/carcin/bgi064; Gan Y, 2010, ONCOGENE, V29, P4947, DOI 10.1038/onc.2010.240; Goh LK, 2010, J CELL BIOL, V189, P871, DOI 10.1083/jcb.201001008; Gonzalez-Quevedo R, 2005, J CELL BIOL, V168, P453, DOI 10.1083/jcb.200409078; Hsia DA, 2003, J CELL BIOL, V160, P753, DOI 10.1083/jcb.200212114; Irie HY, 2005, J CELL BIOL, V171, P1023, DOI 10.1083/jcb.200505087; Kelley LC, 2008, CLIN EXP METASTAS, V25, P289, DOI 10.1007/s10585-008-9154-6; Lee SH, 2007, STRUCTURE, V15, P145, DOI 10.1016/j.str.2006.12.005; Lee YG, 2002, NEOPLASIA, V4, P291, DOI 10.1038/sj.neo.7900231; Lin JX, 2005, ONCOGENE, V24, P2059, DOI 10.1038/sj.onc.1208412; Lin M, 2006, ONCOGENE, V25, P1424, DOI 10.1038/sj.onc.1209166; Liu K, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-428; Loberg RD, 2005, INT J ONCOL, V26, P1699; Ma S, 2007, HUM PATHOL, V38, P1201, DOI 10.1016/j.humpath.2007.01.004; Machesky LM, 2007, J MOL MED-JMM, V85, P569, DOI 10.1007/s00109-007-0207-0; Mattila PK, 2007, J CELL BIOL, V176, P953, DOI 10.1083/jcb.200609176; Mattila PK, 2003, J BIOL CHEM, V278, P8452, DOI 10.1074/jbc.M212113200; Miranti CK, 2009, CELL SIGNAL, V21, P196, DOI 10.1016/j.cellsig.2008.08.023; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; Parr C, 2009, EUR J CANCER, V45, P1673, DOI 10.1016/j.ejca.2009.02.019; Qian XL, 2004, EMBO J, V23, P1739, DOI 10.1038/sj.emboj.7600136; Quinones GA, 2010, J CELL BIOL, V189, P353, DOI 10.1083/jcb.200910136; Sigismund S, 2008, DEV CELL, V15, P209, DOI 10.1016/j.devcel.2008.06.012; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Thurlow JK, 2010, J CLIN ONCOL, V28, P2881, DOI 10.1200/JCO.2009.24.8724; Timpson P, 2005, CANCER RES, V65, P3273, DOI 10.1158/0008-5472.CAN-04-2118; Timpson P, 2007, CANCER RES, V67, P9304, DOI 10.1158/0008-5472.CAN-07-0798; Uhlenbrock K, 2004, J CELL SCI, V117, P4863, DOI 10.1242/jcs.01367; Woodcock SA, 2009, MOL CELL, V33, P639, DOI 10.1016/j.molcel.2009.02.012; Woodings JA, 2003, BIOCHEM J, V371, P463, DOI 10.1042/BJ20021962; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691	44	34	36	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2012	31	14					1781	1793		10.1038/onc.2011.376	http://dx.doi.org/10.1038/onc.2011.376			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	925TT	21927027	Green Accepted			2022-12-25	WOS:000302785200004
J	Kim, WY; Lee, SY; Jung, YJ; Chae, HB; Nawkar, GM; Shin, MR; Kim, SY; Park, JH; Kang, CH; Chi, YH; Ahn, IP; Yun, DJ; Lee, KO; Kim, YM; Kim, MG; Lee, SY				Kim, Woe Yeon; Lee, Sun Yong; Jung, Young Jun; Chae, Ho Byoung; Nawkar, Ganesh M.; Shin, Mi Rim; Kim, Sun Young; Park, Jin Ho; Kang, Chang Ho; Chi, Yong Hun; Ahn, Il Pyung; Yun, Dae Jin; Lee, Kyun Oh; Kim, Young-Myeong; Kim, Min Gab; Lee, Sang Yeol			Inhibitor of Apoptosis (IAP)-like Protein Lacks a Baculovirus IAP Repeat (BIR) Domain and Attenuates Cell Death in Plant and Animal Systems	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINAL MUSCULAR-ATROPHY; UBIQUITIN LIGASE; HYPERSENSITIVE RESPONSE; PSEUDOMONAS-SYRINGAE; ANTIAPOPTOTIC GENES; CYSTEINE PROTEASES; EMERGING ROLE; NAIP GENES; ARABIDOPSIS; DROSOPHILA	A novel Arabidopsis thaliana inhibitor of apoptosis was identified by sequence homology to other known inhibitor of apoptosis (IAP) proteins. Arabidopsis IAP-like protein (AtILP) contained a C-terminal RING finger domain but lacked a baculovirus IAP repeat (BIR) domain, which is essential for antiapoptotic activity in other IAP family members. The expression of AtILP in HeLa cells conferred resistance against tumor necrosis factor (TNF)-alpha/ActD-induced apoptosis through the inactivation of caspase activity. In contrast to the C-terminal RING domain of AtILP, which did not inhibit the activity of caspase-3, the N-terminal region, despite displaying no homology to known BIR domains, potently inhibited the activity of caspase-3 in vitro and blocked TNF-alpha/ActD-induced apoptosis. The antiapoptotic activity of the AtILP N-terminal domain observed in plants was reproduced in an animal system. Transgenic Arabidopsis lines overexpressing AtILP exhibited anti-apoptotic activity when challenged with the fungal toxin fumonisin B1, an agent that induces apoptosis-like cell death in plants. In AtIPL transgenic plants, suppression of cell death was accompanied by inhibition of caspase activation and DNA fragmentation. Overexpression of AtILP also attenuated effector protein-induced cell death and increased the growth of an avirulent bacterial pathogen. The current results demonstrated the existence of a novel plant IAP-like protein that prevents caspase activation in Arabidopsis and showed that a plant anti-apoptosis gene functions similarly in plant and animal systems.	[Ahn, Il Pyung; Kim, Min Gab] RDA, Natl Acad Agr Sci, Suwon 441856, South Korea; [Kim, Woe Yeon; Lee, Sun Yong; Jung, Young Jun; Chae, Ho Byoung; Nawkar, Ganesh M.; Shin, Mi Rim; Kim, Sun Young; Park, Jin Ho; Kang, Chang Ho; Chi, Yong Hun; Yun, Dae Jin; Lee, Kyun Oh; Lee, Sang Yeol] Gyeongsang Natl Univ, Div Appl Life Sci, Program BK21, Jinju 660701, South Korea; [Kim, Young-Myeong] Kangwon Natl Univ, Coll Med, Dept Mol & Cellular Biochem, Chunchon, South Korea; [Kim, Min Gab] Gyeongsang Natl Univ, Coll Pharm, Jinju 660751, South Korea	Rural Development Administration (RDA); Gyeongsang National University; Kangwon National University; Gyeongsang National University	Kim, MG (corresponding author), RDA, Natl Acad Agr Sci, Suwon 441856, South Korea.	mgk1284@gnu.ac.kr; sylee@gnu.ac.kr	Kim, Sun/GSN-4867-2022; Nawkar, Ganesh Mahadeo/AAT-3117-2020	Nawkar, Ganesh Mahadeo/0000-0002-1693-097X; Kang, Chang Ho/0000-0003-4342-5247; Yun, Dae-Jin/0000-0002-3638-6043	RDA [PJ008109]; Cooperative Research Program for Agriculture Science and Technology Development Project [PJ007850]; MOEST [R32-10148]; BK21 Program, Korea	RDA(Rural Development Administration (RDA), Republic of Korea); Cooperative Research Program for Agriculture Science and Technology Development Project; MOEST; BK21 Program, Korea(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This work was supported by the RDA for the Next-Generation BioGreen Program (SSAC; Grant PJ008109), by Cooperative Research Program for Agriculture Science and Technology Development Project PJ007850, and by MOEST for the WCU Program R32-10148.; Supported by the BK21 Program, Korea.	Ali S, 2010, BIOCHEM BIOPH RES CO, V391, P1512, DOI 10.1016/j.bbrc.2009.12.107; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Asai T, 2000, PLANT CELL, V12, P1823, DOI 10.1105/tpc.12.10.1823; Basnayake BMVS, 2011, PLANT CELL REP, V30, P37, DOI 10.1007/s00299-010-0941-6; Beers EP, 2001, CURR OPIN PLANT BIOL, V4, P561, DOI 10.1016/S1369-5266(00)00216-8; Behjati R, 2011, CANCER SCI, V102, P267, DOI 10.1111/j.1349-7006.2010.01750.x; Benard G, 2010, EMBO J, V29, P1458, DOI 10.1038/emboj.2010.39; Bonneau L, 2008, J EXP BOT, V59, P491, DOI 10.1093/jxb/erm352; Borden KLB, 2000, J MOL BIOL, V295, P1103, DOI 10.1006/jmbi.1999.3429; Boyce M, 2004, CELL DEATH DIFFER, V11, P29, DOI 10.1038/sj.cdd.4401339; Broemer M, 2009, TRENDS CELL BIOL, V19, P130, DOI 10.1016/j.tcb.2009.01.004; BUMP NJ, 1995, SCIENCE, V269, P1885, DOI 10.1126/science.7569933; Burguillos MA, 2011, NEUROBIOL DIS, V41, P177, DOI 10.1016/j.nbd.2010.09.005; Chang JH, 2005, P NATL ACAD SCI USA, V102, P2549, DOI 10.1073/pnas.0409660102; CLEM RJ, 1994, MOL CELL BIOL, V14, P5212, DOI 10.1128/MCB.14.8.5212; Collmer A, 2002, TRENDS MICROBIOL, V10, P462, DOI 10.1016/S0966-842X(02)02451-4; Conus S, 2008, J EXP MED, V205, P685, DOI 10.1084/jem.20072152; Crack PJ, 2001, J NEUROCHEM, V78, P1389, DOI 10.1046/j.1471-4159.2001.00535.x; CROOK NE, 1993, J VIROL, V67, P2168, DOI 10.1128/JVI.67.4.2168-2174.1993; De Jong AJ, 2000, PLANTA, V211, P656, DOI 10.1007/s004250000341; del Pozo O, 1998, CURR BIOL, V8, P1129, DOI 10.1016/S0960-9822(98)70469-5; Dickman MB, 2001, P NATL ACAD SCI USA, V98, P6957, DOI 10.1073/pnas.091108998; Duckett CS, 1996, EMBO J, V15, P2685, DOI 10.1002/j.1460-2075.1996.tb00629.x; Eichmann R, 2004, MOL PLANT MICROBE IN, V17, P484, DOI 10.1094/MPMI.2004.17.5.484; Gechev TS, 2006, BIOESSAYS, V28, P1091, DOI 10.1002/bies.20493; Goyal L, 2000, EMBO J, V19, P589, DOI 10.1093/emboj/19.4.589; Harvey HA, 1998, ONCOLOGY-NY, V12, P32; Hay BA, 2000, CELL DEATH DIFFER, V7, P1045, DOI 10.1038/sj.cdd.4400765; Hay BA, 1995, CELL, V83, P1253, DOI 10.1016/0092-8674(95)90150-7; He X, 2003, PLANT MOL BIOL, V52, P729, DOI 10.1023/A:1025008117046; Hengartner MO, 1998, NATURE, V391, P441, DOI 10.1038/35036; Herman MD, 2009, ACTA CRYSTALLOGR F, V65, P1091, DOI 10.1107/S1744309109038597; Higashi K, 2005, APOPTOSIS, V10, P471, DOI 10.1007/s10495-005-1876-1; Hornle M, 2011, ONCOGENE, V30, P575, DOI 10.1038/onc.2010.434; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Jones G, 2000, J BIOL CHEM, V275, P22157, DOI 10.1074/jbc.M000369200; Kim YM, 1997, J BIOL CHEM, V272, P31138, DOI 10.1074/jbc.272.49.31138; Kimchi A, 2007, CYTOKINE GROWTH F R, V18, P435, DOI 10.1016/j.cytogfr.2007.06.004; Korthout HAAJ, 2000, FEBS LETT, V475, P139, DOI 10.1016/S0014-5793(00)01643-4; LaCasse EC, 1998, ONCOGENE, V17, P3247, DOI 10.1038/sj.onc.1202569; Lacomme C, 1999, P NATL ACAD SCI USA, V96, P7956, DOI 10.1073/pnas.96.14.7956; Lam E, 2000, PLANT MOL BIOL, V44, P417, DOI 10.1023/A:1026509012695; Leong WF, 2005, MICROBES INFECT, V7, P248, DOI 10.1016/j.micinf.2004.11.004; Lin SS, 2008, PLANT J, V56, P550, DOI 10.1111/j.1365-313X.2008.03625.x; Lincoln JE, 2002, P NATL ACAD SCI USA, V99, P15217, DOI 10.1073/pnas.232579799; LINDGREN PB, 1986, J BACTERIOL, V168, P512, DOI 10.1128/jb.168.2.512-522.1986; Liston P, 2003, ONCOGENE, V22, P8568, DOI 10.1038/sj.onc.1207101; Lorrain S, 2003, TRENDS PLANT SCI, V8, P263, DOI 10.1016/S1360-1385(03)00108-0; Mackey D, 2003, CELL, V112, P379, DOI 10.1016/S0092-8674(03)00040-0; MacNeill AL, 2009, VIROLOGY, V384, P151, DOI 10.1016/j.virol.2008.10.041; Malladi S, 2009, EMBO J, V28, P1916, DOI 10.1038/emboj.2009.152; Matsumura H, 2003, PLANT J, V33, P425, DOI 10.1046/j.1365-313X.2003.01639.x; Morel JB, 1997, CELL DEATH DIFFER, V4, P671, DOI 10.1038/sj.cdd.4400309; Morizane Y, 2005, J BIOCHEM, V137, P125, DOI 10.1093/jb/mvi029; Muzio M, 1998, J BIOL CHEM, V273, P2926, DOI 10.1074/jbc.273.5.2926; Ni T, 2005, IUBMB LIFE, V57, P779, DOI 10.1080/15216540500389013; Pereira WF, 2008, AN ACAD BRAS CIENC, V80, P129, DOI 10.1590/S0001-37652008000100008; Peter ME, 2011, NATURE, V471, P310, DOI 10.1038/471310a; Rohmer L, 2003, MOL MICROBIOL, V47, P1545, DOI 10.1046/j.1365-2958.2003.03402.x; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; ROY N, 1995, CELL, V80, P167, DOI 10.1016/0092-8674(95)90461-1; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Solomon M, 1999, PLANT CELL, V11, P431, DOI 10.1105/tpc.11.3.431; STELLER H, 1995, SCIENCE, V267, P1445, DOI 10.1126/science.7878463; Stone JM, 2000, PLANT CELL, V12, P1811, DOI 10.1105/tpc.12.10.1811; Stone SL, 2005, PLANT PHYSIOL, V137, P13, DOI 10.1104/pp.104.052423; Sung JH, 2007, NEUROSCIENCE, V149, P804, DOI 10.1016/j.neuroscience.2007.07.030; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Thornberry NA, 1997, BRIT MED BULL, V53, P478; Tripathy MK, 2010, APOPTOSIS, V15, P1453, DOI 10.1007/s10495-010-0527-3; Vaux DL, 2005, NAT REV MOL CELL BIO, V6, P287, DOI 10.1038/nrm1621; Vaux DL, 1999, CELL, V96, P245, DOI 10.1016/S0092-8674(00)80564-4; Vucic D, 2005, BIOCHEM J, V385, P11, DOI 10.1042/BJ20041108; Watanabe N, 2006, PLANT J, V45, P884, DOI 10.1111/j.1365-313X.2006.02654.x; Watihayati MS, 2007, PEDIATR INT, V49, P11, DOI 10.1111/j.1442-200X.2007.02302.x; Wei YB, 2008, ACTA BIOCH BIOPH SIN, V40, P278, DOI 10.1111/j.1745-7270.2008.00407.x; Williams B, 2008, MOL PLANT PATHOL, V9, P531, DOI [10.1111/j.1364-3703.2008.00473.x, 10.1111/J.1364-3703.2008.00473.X]; Woo CH, 2010, FASEB J, V24, P4917, DOI 10.1096/fj.10-162636; Xu M, 2002, BBA-GENE STRUCT EXPR, V1574, P35, DOI 10.1016/S0167-4781(01)00343-8; Xu P, 2004, P NATL ACAD SCI USA, V101, P15805, DOI 10.1073/pnas.0407094101; XUE D, 1995, NATURE, V377, P248, DOI 10.1038/377248a0; Yu D, 2010, ENDOCR J, V57, P825, DOI 10.1507/endocrj.K10E-085; Yu IC, 1998, P NATL ACAD SCI USA, V95, P7819, DOI 10.1073/pnas.95.13.7819; Zhou Q, 1997, J BIOL CHEM, V272, P7797, DOI 10.1074/jbc.272.12.7797	84	15	16	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42670	42678		10.1074/jbc.M111.262204	http://dx.doi.org/10.1074/jbc.M111.262204			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21926169	Green Published, hybrid			2022-12-25	WOS:000298180900074
J	Wada, S; Kato, Y; Okutsu, M; Miyaki, S; Suzuki, K; Yan, Z; Schiaffino, S; Asahara, H; Ushida, T; Akimoto, T				Wada, Shogo; Kato, Yoshio; Okutsu, Mitsuharu; Miyaki, Shigeru; Suzuki, Katsuhiko; Yan, Zhen; Schiaffino, Stefano; Asahara, Hiroshi; Ushida, Takashi; Akimoto, Takayuki			Translational Suppression of Atrophic Regulators by MicroRNA-23a Integrates Resistance to Skeletal Muscle Atrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TARGET MESSENGER-RNAS; CARDIAC-HYPERTROPHY; GENE-REGULATION; IN-VIVO; EXPRESSION; PROTEIN; TRANSCRIPTION; MICE; DIFFERENTIATION; ACTIVATION	Muscle atrophy is caused by accelerated protein degradation and occurs in many pathological states. Two muscle-specific ubiquitin ligases, MAFbx/atrogin-1 and muscle RING-finger 1 (MuRF1), are prominently induced during muscle atrophy and mediate atrophy-associated protein degradation. Blocking the expression of these two ubiquitin ligases provides protection against muscle atrophy. Here we report that miR-23a suppresses the translation of both MAFbx/atrogin-1 and MuRF1 in a 3'-UTR-dependent manner. Ectopic expression of miR-23a is sufficient to protect muscles from atrophy in vitro and in vivo. Furthermore, miR-23a transgenic mice showed resistance against glucocorticoid-induced skeletal muscle atrophy. These data suggest that suppression of multiple regulators by a single miRNA can have significant consequences in adult tissues.	[Wada, Shogo; Ushida, Takashi; Akimoto, Takayuki] Univ Tokyo, Div Regenerat Med Engn, Ctr Dis Biol & Integrat Med, Grad Sch Med,Bunkyo Ku, Tokyo 1130033, Japan; [Okutsu, Mitsuharu; Suzuki, Katsuhiko; Akimoto, Takayuki] Waseda Univ, Inst Biomed Engn Consolidated Res Inst Adv Sci &, Shinjuku Ku, Tokyo 1620041, Japan; [Kato, Yoshio] Natl Inst Adv Ind Sci & Technol, Res Inst Cell Engn, Tsukuba, Ibaraki 3058562, Japan; [Okutsu, Mitsuharu; Yan, Zhen] Univ Virginia, Sch Med, Robert M Berne Cardiovasc Res Ctr, Charlottesville, VA 22908 USA; [Miyaki, Shigeru; Asahara, Hiroshi] Natl Res Inst Child Hlth & Dev, Dept Regenerat Biol & Med, Setagaya Ku, Tokyo 1578535, Japan; [Suzuki, Katsuhiko] Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama 3591192, Japan; [Schiaffino, Stefano; Akimoto, Takayuki] Venetian Inst Mol Med, I-35129 Padua, Italy	University of Tokyo; Waseda University; National Institute of Advanced Industrial Science & Technology (AIST); University of Virginia; National Center for Child Health & Development - Japan; Waseda University; Veneto Institute Molecular Medicine	Akimoto, T (corresponding author), Univ Tokyo, Div Regenerat Med Engn, Ctr Dis Biol & Integrat Med, Grad Sch Med,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	akimoto@m.u-tokyo.ac.jp	Miyaki, Shigeru/E-4293-2013; Akimoto, Takayuki/H-6704-2012; Kato, Yoshio/M-1093-2018; Suzuki, Katsuhiko/AAI-2197-2019	Miyaki, Shigeru/0000-0002-1602-5777; Akimoto, Takayuki/0000-0002-8874-7779; Kato, Yoshio/0000-0001-8584-367X; Suzuki, Katsuhiko/0000-0002-6572-5809; Yan, Zhen/0000-0002-4826-9813; Schiaffino, Stefano/0000-0002-5607-6421	Ministry of Education, Culture, Sports, Science, and Technology, Japan [18680047, 21680049]; Takeda Science Foundation; Suzuken Memorial Foundation; Japan Society for the Promotion of Science; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050429] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [10J05580] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Suzuken Memorial Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-aid for Young Investigators (A) 18680047 and 21680049 (to T. A.) and in part by the "Establishment of Consolidated Research Institute for Advanced Science and Medical Care," Encouraging Development Strategic Research Centers Program, the Special Coordination Funds for Promoting Science and Technology, Ministry of Education, Culture, Sports, Science, and Technology, Japan, and the Takeda Science Foundation (2009) and Suzuken Memorial Foundation (2009).; Supported by Japan Society for the Promotion of Science.	Akimoto T, 2005, J BIOL CHEM, V280, P19587, DOI 10.1074/jbc.M408862200; Akimoto T, 2004, AM J PHYSIOL-CELL PH, V287, pC790, DOI 10.1152/ajpcell.00425.2003; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Clarke BA, 2007, CELL METAB, V6, P376, DOI 10.1016/j.cmet.2007.09.009; Cohen S, 2009, J CELL BIOL, V185, P1083, DOI 10.1083/jcb.200901052; Djuranovic S, 2011, SCIENCE, V331, P550, DOI 10.1126/science.1191138; Dona M, 2003, BIOCHEM BIOPH RES CO, V312, P1132, DOI 10.1016/j.bbrc.2003.11.032; Elmen J, 2008, NUCLEIC ACIDS RES, V36, P1153, DOI 10.1093/nar/gkm1113; Fielitz J, 2007, J CLIN INVEST, V117, P2486, DOI 10.1172/JCI32827; Glass DJ, 2010, CURR OPIN CLIN NUTR, V13, P225, DOI 10.1097/MCO.0b013e32833862df; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Hill JA, 2000, CIRCULATION, V101, P2863, DOI 10.1161/01.CIR.101.24.2863; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Jiang JM, 2005, NUCLEIC ACIDS RES, V33, P5394, DOI 10.1093/nar/gki863; Kalsotra A, 2010, GENE DEV, V24, P653, DOI 10.1101/gad.1894310; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Lagirand-Cantaloube J, 2008, EMBO J, V27, P1266, DOI 10.1038/emboj.2008.52; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lin ZQ, 2009, P NATL ACAD SCI USA, V106, P12103, DOI 10.1073/pnas.0811371106; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Rana ZA, 2004, ACTA PHYSIOL SCAND, V181, P233, DOI 10.1111/j.1365-201X.2004.01282.x; Rosenberg MI, 2006, J CELL BIOL, V175, P77, DOI 10.1083/jcb.200603039; Sacheck JM, 2007, FASEB J, V21, P140, DOI 10.1096/fj.06-6604com; Schakman O, 2008, J ENDOCRINOL, V197, P1, DOI 10.1677/JOE-07-0606; SCHIAFFINO S, 1989, J MUSCLE RES CELL M, V10, P197, DOI 10.1007/BF01739810; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Tintignac LA, 2005, J BIOL CHEM, V280, P2847, DOI 10.1074/jbc.M411346200; Van Rooij E, 2007, J CLIN INVEST, V117, P2369, DOI 10.1172/JCI33099; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; Witt CC, 2008, EMBO J, V27, P350, DOI 10.1038/sj.emboj.7601952	40	140	149	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38456	38465		10.1074/jbc.M111.271270	http://dx.doi.org/10.1074/jbc.M111.271270			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21926429	Green Published, hybrid			2022-12-25	WOS:000296594200060
J	Villar, J; Cabrera, NE; Valladares, F; Casula, M; Flores, C; Blanch, L; Quilez, ME; Santana-Rodriguez, N; Kacmarek, RM; Slutsky, AS				Villar, Jesus; Cabrera, Nuria E.; Valladares, Francisco; Casula, Milena; Flores, Carlos; Blanch, Lluis; Elisa Quilez, Maria; Santana-Rodriguez, Norberto; Kacmarek, Robert M.; Slutsky, Arthur S.			Activation of the Wnt/beta-Catenin Signaling Pathway by Mechanical Ventilation Is Associated with Ventilator-Induced Pulmonary Fibrosis in Healthy Lungs	PLOS ONE			English	Article							END-EXPIRATORY PRESSURE; RESPIRATORY-DISTRESS-SYNDROME; GENE-EXPRESSION; PHOSPHOINOSITIDE 3-KINASE; INFLAMMATORY RESPONSES; TIDAL VOLUME; BETA-CATENIN; INJURY MODEL; CELL FACTOR; MICE	Background: Mechanical ventilation (MV) with high tidal volumes (V(T)) can cause or aggravate lung damage, so-called ventilator induced lung injury (VILI). The relationship between specific mechanical events in the lung and the cellular responses that result in VILI remains incomplete. Since activation of Wnt/beta-catenin signaling has been suggested to be central to mechanisms of lung healing and fibrosis, we hypothesized that the Wnt/beta-catenin signaling plays a role during VILI. Methodology/Principal Findings: Prospective, randomized, controlled animal study using adult, healthy, male Sprague-Dawley rats. Animals (n = 6/group) were randomized to spontaneous breathing or two strategies of MV for 4 hours: low tidal volume (V(T)) (6 mL/kg) or high V(T) (20 mL/kg). Histological evaluation of lung tissue, measurements of WNT5A, total beta-catenin, non-phospho (Ser33/37/Thr41) beta-catenin, matrix metalloproteinase-7 (MMP-7), cyclin D1, vascular endothelial growth factor (VEGF), and axis inhibition protein 2 (AXIN2) protein levels by Western blot, and WNT5A, non-phospho (Ser33/37/Thr41) beta-catenin, MMP-7, and AXIN2 immunohistochemical localization in the lungs were analyzed. High-V(T) MV caused lung inflammation and perivascular edema with cellular infiltrates and collagen deposition. Protein levels of WNT5A, non-phospho (Ser33/37/Thr41) beta-catenin, MMP-7, cyclin D1, VEGF, and AXIN2 in the lungs were increased in all ventilated animals although high-V(T) MV was associated with significantly higher levels of WNT5A, non-phospho (Ser33/37/Thr41) beta-catenin, MMP-7, cyclin D1, VEGF, and AXIN2 levels. Conclusions/Significance: Our findings demonstrate that the Wnt/beta-catenin signaling pathway is modulated very early by MV in lungs without preexistent lung disease, suggesting that activation of this pathway could play an important role in both VILI and lung repair. Modulation of this pathway might represent a therapeutic option for prevention and/or management of VILI.	[Villar, Jesus; Cabrera, Nuria E.; Valladares, Francisco; Casula, Milena; Flores, Carlos; Blanch, Lluis; Elisa Quilez, Maria] Inst Salud Carlos III, CIBER Enfermedades Resp, Madrid, Spain; [Villar, Jesus; Cabrera, Nuria E.; Casula, Milena; Santana-Rodriguez, Norberto] Hosp Univ Dr Negrin, Res Unit, Las Palmas Gran Canaria, Spain; [Villar, Jesus; Slutsky, Arthur S.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada; [Valladares, Francisco] Univ La Laguna, Dept Anat Pathol & Histol, Tenerife, Spain; [Flores, Carlos] Hosp Univ NS Candelaria, Res Unit, Santa Cruz De Tenerife, Spain; [Blanch, Lluis; Elisa Quilez, Maria] Corp Sanitaria Parc Tauli, Crit Care Ctr, Barcelona, Spain; [Santana-Rodriguez, Norberto] Hosp Univ Dr Negrin, Dept Thorac Surg, Las Palmas Gran Canaria, Spain; [Kacmarek, Robert M.] Massachusetts Gen Hosp, Dept Resp Care, Boston, MA 02114 USA; [Kacmarek, Robert M.] Harvard Univ, Dept Anesthesia, Boston, MA 02115 USA; [Slutsky, Arthur S.] Univ Toronto, Interdept Div Crit Care Med, Toronto, ON, Canada; [Slutsky, Arthur S.] King Saud Univ, Riyadh, Saudi Arabia	CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; Universidad de la Laguna; Autonomous University of Barcelona; Parc Tauli Hospital Universitari; Harvard University; Massachusetts General Hospital; Harvard University; University of Toronto; King Saud University	Villar, J (corresponding author), Inst Salud Carlos III, CIBER Enfermedades Resp, Madrid, Spain.	jesus.villar54@gmail.com	Santana Rodriguez, Norberto/ABA-5291-2021; Villar, Jesús/R-4526-2019; Slutsky, Arthur/M-3325-2019; Casula, Milena/AAA-7461-2019; Flores, Carlos/R-1159-2019; Santana-Rodriguez, Norberto/H-6079-2015	Villar, Jesús/0000-0001-5687-3562; CASULA, Milena/0000-0002-5079-9864; Santana-Rodriguez, Norberto/0000-0003-3524-5991; Flores, Carlos/0000-0001-5352-069X	Ministry of Science, Spain [SAF 2004-06833, PI10/0393]	Ministry of Science, Spain	This work was supported by grants from the Ministry of Science, Spain (SAF 2004-06833 and PI10/0393). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2000, AM J RESP CELL MOL, V22, P401, DOI 10.1165/ajrcmb.22.4.f184; Adachi K, 2003, TOXICOL PATHOL, V31, P665, DOI 10.1080/01926230390244924; ASHCROFT T, 1988, J CLIN PATHOL, V41, P467, DOI 10.1136/jcp.41.4.467; Blumenthal A, 2006, BLOOD, V108, P965, DOI 10.1182/blood-2005-12-5046; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Caruso P, 2003, INTENS CARE MED, V29, P1808, DOI 10.1007/s00134-003-1908-7; Copland IB, 2003, AM J RESP CRIT CARE, V168, P1051, DOI 10.1164/rccm.200208-964OC; Cosgrove GP, 2008, CHEST, V133, P1058, DOI 10.1378/chest.07-2882; Crosby LM, 2010, AM J PHYSIOL-LUNG C, V298, pL715, DOI 10.1152/ajplung.00361.2009; dos Santos CC, 2004, CRIT CARE, V8, P145, DOI 10.1186/cc2849; Dreyfuss D, 1998, AM J RESP CRIT CARE, V157, P294, DOI 10.1164/ajrccm.157.1.9604014; Eisner MD, 2003, THORAX, V58, P983, DOI 10.1136/thorax.58.11.983; Flozak AS, 2010, J BIOL CHEM, V285, P3157, DOI 10.1074/jbc.M109.070326; Grigoryev DN, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-r34; Henderson WR, 2010, P NATL ACAD SCI USA, V107, P14309, DOI 10.1073/pnas.1001520107; Herrera MT, 2003, INTENS CARE MED, V29, P1345, DOI 10.1007/s00134-003-1756-5; Konigshoff M, 2010, AM J RESP CELL MOL, V42, P21, DOI 10.1165/rcmb.2008-0485TR; Konigshoff M, 2009, J CLIN INVEST, V119, P772, DOI 10.1172/JCI33950; Konigshoff M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002142; Leung JY, 2002, J BIOL CHEM, V277, P21657, DOI 10.1074/jbc.M200139200; Li LF, 2008, CRIT CARE, V12, DOI 10.1186/cc6983; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MALKUSCH W, 1995, EXP LUNG RES, V21, P67, DOI 10.3109/01902149509031745; Martinez-Galan L, 2010, ARCH BRONCONEUMOL, V46, P20, DOI 10.1016/j.arbres.2009.10.006; Miyahara T, 2007, AM J PHYSIOL-LUNG C, V293, pL11, DOI 10.1152/ajplung.00279.2005; Moriondo A, 2007, J APPL PHYSIOL, V103, P747, DOI 10.1152/japplphysiol.00056.2007; Morrisey EE, 2003, AM J PATHOL, V162, P1393, DOI 10.1016/S0002-9440(10)64271-X; Negrini D, 2006, AM J PHYSIOL-LUNG C, V290, pL470, DOI 10.1152/ajplung.00310.2005; Pelosi P, 2008, INTENS CARE MED, V34, P631, DOI 10.1007/s00134-007-0964-9; Pereira C, 2008, ARTERIOSCL THROM VAS, V28, P504, DOI 10.1161/ATVBAHA.107.157438; Pongracz JE, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-15; Staal FJT, 2002, EMBO REP, V3, P63, DOI 10.1093/embo-reports/kvf002; Stockmann C, 2010, P NATL ACAD SCI USA, V107, P4329, DOI 10.1073/pnas.0912766107; TOKICS L, 1987, ANESTHESIOLOGY, V66, P157, DOI 10.1097/00000542-198702000-00009; Tremblay LN, 2002, CRIT CARE MED, V30, P1693, DOI 10.1097/00003246-200208000-00003; Vaneker M, 2007, ANESTHESIOLOGY, V107, P419, DOI 10.1097/01.anes.0000278908.22686.01; Villar J, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-27; Villar J, 2009, ANESTHESIOLOGY, V110, P1341, DOI 10.1097/ALN.0b013e31819fcba9; Vuga LJ, 2009, AM J RESP CELL MOL, V41, P583, DOI 10.1165/rcmb.2008-0201OC; Wolthuis EK, 2009, CRIT CARE, V13, DOI 10.1186/cc7688; Zuo FR, 2002, P NATL ACAD SCI USA, V99, P6292, DOI 10.1073/pnas.092134099	42	52	56	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e23914	10.1371/journal.pone.0023914	http://dx.doi.org/10.1371/journal.pone.0023914			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21935365	Green Published, gold, Green Submitted			2022-12-25	WOS:000295041700002
J	Beltran, AS; Russo, A; Lara, H; Fan, C; Lizardi, PM; Blancafort, P				Beltran, Adriana S.; Russo, Angela; Lara, Haydee; Fan, Cheng; Lizardi, Paul M.; Blancafort, Pilar			Suppression of Breast Tumor Growth and Metastasis by an Engineered Transcription Factor	PLOS ONE			English	Article							PROSTATE-CANCER; GENE-EXPRESSION; MASPIN EXPRESSION; CLINICAL-SIGNIFICANCE; CARNOSINE; METHYLATION; CARCINOMA; PROTEIN; CELLS; LOCALIZATION	Maspin is a tumor and metastasis suppressor playing an essential role as gatekeeper of tumor progression. It is highly expressed in epithelial cells but is silenced in the onset of metastatic disease by epigenetic mechanisms. Reprogramming of Maspin epigenetic silencing offers a therapeutic potential to lock metastatic progression. Herein we have investigated the ability of the Artificial Transcription Factor 126 (ATF-126) designed to upregulate the Maspin promoter to inhibit tumor progression in pre-established breast tumors in immunodeficient mice. ATF-126 was transduced in the aggressive, mesenchymal-like and triple negative breast cancer line, MDA-MB-231. Induction of ATF expression in vivo by Doxycycline resulted in 50% reduction in tumor growth and totally abolished tumor cell colonization. Genome-wide transcriptional profiles of ATF-induced cells revealed a gene signature that was found over-represented in estrogen receptor positive (ER+) "Normal-like" intrinsic subtype of breast cancer and in poorly aggressive, ER+ luminal A breast cancer cell lines. The comparison transcriptional profiles of ATF-126 and Maspin cDNA defined an overlapping 19-gene signature, comprising novel targets downstream the Maspin signaling cascade. Our data suggest that Maspin up-regulates downstream tumor and metastasis suppressor genes that are silenced in breast cancers, and are normally expressed in the neural system, including CARNS1, SLC8A2 and DACT3. In addition, ATF-126 and Maspin cDNA induction led to the re-activation of tumor suppressive miRNAs also expressed in neural cells, such as miR-1 and miR-34, and to the down-regulation of potential oncogenic miRNAs, such as miR-10b, miR-124, and miR-363. As expected from its over-representation in ER+ tumors, the ATF-126-gene signature predicted favorable prognosis for breast cancer patients. Our results describe for the first time an ATF able to reduce tumor growth and metastatic colonization by epigenetic reactivation of a dormant, normal-like, and more differentiated gene program.	[Beltran, Adriana S.; Lara, Haydee; Blancafort, Pilar] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27515 USA; [Fan, Cheng; Blancafort, Pilar] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Russo, Angela] Univ Illinois, Dept Pharmacol, Chicago, IL USA; [Lizardi, Paul M.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Lara, Haydee] CICESE Res Inst, Dept Marine Biotechnol, Ensenada, Baja California, Mexico	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Yale University; CICESE - Centro de Investigacion Cientifica y de Educacion Superior de Ensenada	Beltran, AS (corresponding author), Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27515 USA.	pilar_blancafort@med.unc.edu	Blancafort, Pilar/K-9029-2012	Blancafort, Pilar/0000-0002-3881-7396	National Cancer Institute/National Institutes of Health [1R01CA125273, 3R01CA125273-03S1]; Department of Defense (DoD) [W81XWH-10-1-0265]; NATIONAL CANCER INSTITUTE [R01CA125273] Funding Source: NIH RePORTER	National Cancer Institute/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense (DoD)(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported from National Cancer Institute/National Institutes of Health grants 1R01CA125273, 3R01CA125273-03S1 and Department of Defense (DoD) W81XWH-10-1-0265 (PB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambasudhan R, 2011, CELL STEM CELL, V9, P113, DOI 10.1016/j.stem.2011.07.002; Bailey CM, 2006, J CELL PHYSIOL, V209, P617, DOI 10.1002/jcp.20782; Bastian I, 2011, HISTOCHEM CELL BIOL, V135, P37, DOI 10.1007/s00418-010-0772-0; Beltran A, 2007, ONCOGENE, V26, P2791, DOI 10.1038/sj.onc.1210072; Beltran A, 2006, ASSAY DRUG DEV TECHN, V4, P317, DOI 10.1089/adt.2006.4.317; Beltran AS, 2008, MOL CANCER THER, V7, P1080, DOI 10.1158/1535-7163.MCT-07-0526; Beltran AS, 2010, METHODS MOL BIOL, V649, P163, DOI 10.1007/978-1-60761-753-2_10; BELTRAN AS, 2011, EPIGENETICS, V6; Cher ML, 2003, P NATL ACAD SCI USA, V100, P7847, DOI 10.1073/pnas.1331360100; Damiano L, 2010, ONCOGENE, V29, P3677, DOI 10.1038/onc.2010.128; Domann FE, 2000, INT J CANCER, V85, P805, DOI 10.1002/(SICI)1097-0215(20000315)85:6<805::AID-IJC12>3.0.CO;2-5; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fan C, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-3; Futscher BW, 2002, NAT GENET, V31, P175, DOI 10.1038/ng886; Ghosh T, 2008, NUCLEIC ACIDS RES, V36, P6318, DOI 10.1093/nar/gkn624; Goulet B, 2011, LAB INVEST, V91, P1181, DOI 10.1038/labinvest.2011.66; Guiotto A, 2005, CURR MED CHEM, V12, P2293, DOI 10.2174/0929867054864796; Hennessy BT, 2009, CANCER RES, V69, P4116, DOI 10.1158/0008-5472.CAN-08-3441; Hipkiss AR, 2007, J ALZHEIMERS DIS, V11, P229; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Jaworski J, 2009, NEURON, V61, P85, DOI 10.1016/j.neuron.2008.11.013; Jiang X, 2008, CANCER CELL, V13, P529, DOI 10.1016/j.ccr.2008.04.019; Kalyanaraman S, 1998, GENOMICS, V49, P147, DOI 10.1006/geno.1998.5223; Leone V, 2011, J CLIN ENDOCRINOL ME; Li XH, 2006, CANCER RES, V66, P9323, DOI 10.1158/0008-5472.CAN-06-1578; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Machtens S, 2001, INT J CANCER, V95, P337, DOI 10.1002/1097-0215(20010920)95:5<337::AID-IJC1059>3.0.CO;2-1; Maina EN, 2005, ONCOGENE, V24, P4549, DOI 10.1038/sj.onc.1208649; McKenzie S, 2008, ONCOGENE, V27, P7171, DOI 10.1038/onc.2008.321; Nakagawa M, 2006, ANN SURG ONCOL, V13, P1517, DOI 10.1245/s10434-006-9030-z; Nam E, 2010, CANCER RES TREAT, V42, P42, DOI 10.4143/crt.2010.42.1.42; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nohata N, 2011, ONCOTARGET, V2, P29; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Qu M, 2010, NEUROPATH APPL NEURO, V36, P198, DOI 10.1111/j.1365-2990.2010.01070.x; Renner C, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-2; Renner C, 2010, NEUROL RES, V32, P101, DOI 10.1179/016164109X12518779082237; Romani AA, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-255; Sager R, 1997, ADV EXP MED BIOL, V425, P77; Schaefer JS, 2006, EXPERT OPIN THER TAR, V10, P401, DOI 10.1517/14728222.10.3.401; Seftor REB, 1998, CANCER RES, V58, P5681; Sharma G, 2011, TUMOR BIOL, V32, P23, DOI 10.1007/s13277-010-0087-8; Takebe N, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2876; Tomomura M, 2007, NEUROSCIENCE, V148, P510, DOI 10.1016/j.neuroscience.2007.05.048; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wozniak RJ, 2007, ONCOGENE, V26, P77, DOI 10.1038/sj.onc.1209763; Zhang M, 2000, NAT MED, V6, P196, DOI 10.1038/72303; Zhang M, 1997, CELL GROWTH DIFFER, V8, P179	50	42	45	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2011	6	9							e24595	10.1371/journal.pone.0024595	http://dx.doi.org/10.1371/journal.pone.0024595			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZV	21931769	Green Published, gold			2022-12-25	WOS:000295321800036
J	Brown, JE; Chatterjee, N; Younger, J; Mackey, S				Brown, Justin E.; Chatterjee, Neil; Younger, Jarred; Mackey, Sean			Towards a Physiology-Based Measure of Pain: Patterns of Human Brain Activity Distinguish Painful from Non-Painful Thermal Stimulation	PLOS ONE			English	Article							FUNCTIONAL MRI; HEART-RATE; CEREBRAL ACTIVATION; SKIN-CONDUCTANCE; ADULT PATIENTS; FMRI ACTIVITY; PERCEPTION; INTENSITY; RESPONSES; CORTEX	Pain often exists in the absence of observable injury; therefore, the gold standard for pain assessment has long been self-report. Because the inability to verbally communicate can prevent effective pain management, research efforts have focused on the development of a tool that accurately assesses pain without depending on self-report. Those previous efforts have not proven successful at substituting self-report with a clinically valid, physiology-based measure of pain. Recent neuroimaging data suggest that functional magnetic resonance imaging (fMRI) and support vector machine (SVM) learning can be jointly used to accurately assess cognitive states. Therefore, we hypothesized that an SVM trained on fMRI data can assess pain in the absence of self-report. In fMRI experiments, 24 individuals were presented painful and nonpainful thermal stimuli. Using eight individuals, we trained a linear SVM to distinguish these stimuli using whole-brain patterns of activity. We assessed the performance of this trained SVM model by testing it on 16 individuals whose data were not used for training. The whole-brain SVM was 81% accurate at distinguishing painful from non-painful stimuli (p<0.0000001). Using distance from the SVM hyperplane as a confidence measure, accuracy was further increased to 84%, albeit at the expense of excluding 15% of the stimuli that were the most difficult to classify. Overall performance of the SVM was primarily affected by activity in pain-processing regions of the brain including the primary somatosensory cortex, secondary somatosensory cortex, insular cortex, primary motor cortex, and cingulate cortex. Region of interest (ROI) analyses revealed that whole-brain patterns of activity led to more accurate classification than localized activity from individual brain regions. Our findings demonstrate that fMRI with SVM learning can assess pain without requiring any communication from the person being tested. We outline tasks that should be completed to advance this approach toward use in clinical settings.	[Brown, Justin E.; Chatterjee, Neil; Younger, Jarred; Mackey, Sean] Stanford Univ, Dept Anesthesia, Palo Alto, CA 94304 USA; [Brown, Justin E.; Mackey, Sean] Stanford Univ, Neurosci Program, Palo Alto, CA 94304 USA; [Brown, Justin E.] Simpson Coll, Dept Biol & Environm Sci, Indianola, IA USA; [Chatterjee, Neil] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	Stanford University; Stanford University; Northwestern University; Feinberg School of Medicine	Brown, JE (corresponding author), Stanford Univ, Dept Anesthesia, Palo Alto, CA 94304 USA.	smackey@pain.stanford.edu	Mackey, Sean/AAF-3314-2019	Mackey, Sean/0000-0001-7744-5348	National Institutes of Health (NIH) [1R21DA026092, K24DA029262, 1F31GM08361]; Chris Redlich Pain Research Fund; NATIONAL INSTITUTE ON DRUG ABUSE [K24DA029262, R21DA026092] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chris Redlich Pain Research Fund; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was funded by the National Institutes of Health (NIH) [1R21DA026092, K24DA029262 and 1F31GM08361] and the Chris Redlich Pain Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apkarian AV, 2005, EUR J PAIN, V9, P463, DOI 10.1016/j.ejpain.2004.11.001; Becerra L, 2001, NEURON, V32, P927, DOI 10.1016/S0896-6273(01)00533-5; Borsook D, 2010, NEUROSCIENTIST, V16, P171, DOI 10.1177/1073858409349902; Bossart P, 2007, J EMERG MED, V32, P19, DOI 10.1016/j.jemermed.2006.05.029; Brooks J, 2005, J ANAT, V207, P19, DOI 10.1111/j.1469-7580.2005.00428.x; Chapman CR, 1999, PSYCHOPHYSIOLOGY, V36, P44, DOI 10.1017/S0048577299970373; Coghill RC, 1999, J NEUROPHYSIOL, V82, P1934, DOI 10.1152/jn.1999.82.4.1934; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cox DD, 2003, NEUROIMAGE, V19, P261, DOI 10.1016/S1053-8119(03)00049-1; deCharms RC, 2005, P NATL ACAD SCI USA, V102, P18626, DOI 10.1073/pnas.0505210102; Derbyshire SWG, 2004, NEUROIMAGE, V23, P392, DOI 10.1016/j.neuroimage.2004.04.033; Eisenberger NI, 2003, SCIENCE, V302, P290, DOI 10.1126/science.1089134; Faye PM, 2010, CLIN J PAIN, V26, P777, DOI 10.1097/AJP.0b013e3181ed1058; Formisano E, 2008, SCIENCE, V322, P970, DOI 10.1126/science.1164318; Frot M, 2007, CEREB CORTEX, V17, P610, DOI 10.1093/cercor/bhk007; Gelinas C, 2006, AM J CRIT CARE, V15, P420; Glover GH, 2001, MAGNET RESON MED, V46, P515, DOI 10.1002/mrm.1222; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.0.CO;2-E; Harrison D, 2006, EARLY HUM DEV, V82, P603, DOI 10.1016/j.earlhumdev.2005.12.008; Hellerud BC, 2002, EARLY HUM DEV, V70, P35, DOI 10.1016/S0378-3782(02)00070-1; Herr K, 2006, J PAIN SYMPTOM MANAG, V31, P170, DOI 10.1016/j.jpainsymman.2005.07.001; Kim DH, 2002, MAGNET RESON MED, V48, P715, DOI 10.1002/mrm.10267; Li D, 2008, J PAIN, V9, P2, DOI 10.1016/j.jpain.2007.08.009; Lui F, 2008, PAIN, V138, P362, DOI 10.1016/j.pain.2008.01.010; Marquand A, 2010, NEUROIMAGE, V49, P2178, DOI 10.1016/j.neuroimage.2009.10.072; Merskey H, 1994, CLASSIFICATION CHRON, DOI DOI 10.1016/0304-3959(86)90113-2; Miller G, 2009, SCIENCE, V323, P195, DOI 10.1126/science.323.5911.195; Miyawaki Y, 2008, NEURON, V60, P915, DOI 10.1016/j.neuron.2008.11.004; Moulton EA, 2005, J NEUROPHYSIOL, V93, P2183, DOI 10.1152/jn.01025.2004; Mourao-Miranda J, 2005, NEUROIMAGE, V28, P980, DOI 10.1016/j.neuroimage.2005.06.070; Mouraux A, 2011, NEUROIMAGE, V54, P2237, DOI 10.1016/j.neuroimage.2010.09.084; Naliboff BD, 2003, GASTROENTEROLOGY, V124, P1738, DOI 10.1016/S0016-5085(03)00400-1; Nir RR, 2010, BRAIN RES, V1344, P77, DOI 10.1016/j.brainres.2010.05.004; Ochsner KN, 2006, PAIN, V120, P69, DOI 10.1016/j.pain.2005.10.014; Paulson PE, 1998, PAIN, V76, P223, DOI 10.1016/S0304-3959(98)00048-7; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Ploghaus A, 1999, SCIENCE, V284, P1979, DOI 10.1126/science.284.5422.1979; Ploner M, 2010, P NATL ACAD SCI USA, V107, P355, DOI 10.1073/pnas.0906186106; Puntillo KA, 2004, CRIT CARE MED, V32, P421, DOI 10.1097/01.CCM.0000108875.35298.D2; Seminowicz DA, 2006, PAIN, V120, P297, DOI 10.1016/j.pain.2005.11.008; Shankar K, 2009, IFMBE PROC, V23, P678; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Storm H, 2000, ARCH DIS CHILD-FETAL, V83, pF143, DOI 10.1136/fn.83.2.F143; Taylor KS, 2009, HUM BRAIN MAPP, V30, P1947, DOI 10.1002/hbm.20641; Timmermann L, 2001, J NEUROPHYSIOL, V86, P1499, DOI 10.1152/jn.2001.86.3.1499; Tousignant-Laflamme Y, 2005, J PAIN, V6, P341, DOI 10.1016/j.jpain.2005.01.351; Treede RD, 2000, PAIN, V87, P113, DOI 10.1016/S0304-3959(00)00350-X; Veldhuijzen DS, 2009, PAIN, V141, P104, DOI 10.1016/j.pain.2008.10.027; Vogt BA, 2003, EUR J NEUROSCI, V18, P3134, DOI 10.1111/j.1460-9568.2003.03034.x; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065; Young Jeanne, 2006, Intensive Crit Care Nurs, V22, P32, DOI 10.1016/j.iccn.2005.04.004; Zubieta JK, 2003, SCIENCE, V299, P1240, DOI 10.1126/science.1078546	52	124	133	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2011	6	9							e24124	10.1371/journal.pone.0024124	http://dx.doi.org/10.1371/journal.pone.0024124			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZV	21931652	Green Published, Green Submitted, gold			2022-12-25	WOS:000295321800020
J	Liu, X; Wang, JM				Liu, Xin; Wang, Jian Ming			Iridoid Glycosides Fraction of Folium syringae Leaves Modulates NF-kappa B Signal Pathway and Intestinal Epithelial Cells Apoptosis in Experimental Colitis	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; ACUTE MURINE COLITIS; ULCERATIVE-COLITIS; FAS-LIGAND; IKK-BETA; TRANSFORMING GROWTH-FACTOR-BETA-1; GENE-EXPRESSION; IN-VITRO; KINASE; ACTIVATION	Background and Aims: Iridoid glycosides (IG), the major active fraction of F. syringae leaves has been demonstrated to have strong anti-inflammatory properties to ulcerative colitis (UC) in our previous study. The aim of this study was to investigate whether IG modulates the inflammatory response in experimental colitis at the level of NF-kappa B signal pathway and epithelial cell apoptosis. Methods: UC in rats was induced by administration with dextran sulfate sodium (DSS) in drinking water. The inflammatory damage was assessed by disease activity index (DAI), macroscopic findings, histology and myeloperoxidase (MPO) activity. The effect of IG on pro-inflammatory cytokines TNF-alpha, IL-8, COX-2 and regulatory peptide TGF-beta 1 was measured. Epithelial cell apoptosis and the protein and mRNA expressions of Fas/FasL, Bcl-2/Bax, caspase-3, NF-kappa B p65, I kappa B alpha, p-I kappa B alpha and IKK beta were detected by TUNEL method, immunohistochemistry, Western blotting and real-time quantitative PCR, respectively. Results: IG significantly ameliorated macroscopic damage and histological changes, reduced the activity of MPO, and strongly inhibited epithelial cell apoptosis. Moreover, IG markedly depressed TNF-alpha, IL-8, COX-2 and TGF-beta 1 levels in the colon tissues in a dose-dependent manner. Furthermore, IG significantly blocked of NF-kappa B signaling by inhibiting I kappa B alpha phosphorylation/degradation and IKK beta activity, down-regulated the protein and mRNA expressions of Fas/FasL, Bax and caspase-3, and activated Bcl-2 in intestinal epithelial cells. Conclusions: These results demonstrated for the first time that IG possessed marked protective effects on experimental colitis through inhibition of epithelial cell apoptosis and blockade of NF-kappa B signal pathway.	[Liu, Xin] Zhejiang Univ, Coll Pharmaceut Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Jian Ming] Heilongjiang Univ Chinese Med, Acad Tradit Chinese Med, Harbin, Peoples R China	Zhejiang University; Heilongjiang University of Chinese Medicine	Liu, X (corresponding author), Zhejiang Univ, Coll Pharmaceut Sci, Hangzhou 310003, Zhejiang, Peoples R China.	xinliu98@126.com			Specialized Research Foundation for the Doctoral Program of Ministry of Education of China (SRFDP) [20060228005]	Specialized Research Foundation for the Doctoral Program of Ministry of Education of China (SRFDP)(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by a grant from the Specialized Research Foundation for the Doctoral Program of Ministry of Education of China (SRFDP) (No. 20060228005). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atreya I, 2008, J INTERN MED, V263, P591, DOI 10.1111/j.1365-2796.2008.01953.x; Barnhart BC, 2005, CELL DEATH DIFFER, V12, P25, DOI 10.1038/sj.cdd.4401509; Beck PL, 2003, AM J PATHOL, V162, P597, DOI 10.1016/S0002-9440(10)63853-9; Bobin-Dubigeon C, 2001, EUR J PHARMACOL, V431, P103, DOI 10.1016/S0014-2999(01)01410-8; Chae S, 2006, J IMMUNOL, V177, P1214, DOI 10.4049/jimmunol.177.2.1214; Cheon JH, 2006, INFLAMM BOWEL DIS, V12, P1152, DOI 10.1097/01.mib.0000235830.94057.c6; Clovel T, 2007, INFLAMM BOWEL DIS, V13, P1153, DOI 10.1002/ibd.20174; COOPER HS, 1993, LAB INVEST, V69, P238; da Silva MS, 2010, J ETHNOPHARMACOL, V128, P467, DOI 10.1016/j.jep.2010.01.024; Eckmann L, 2008, P NATL ACAD SCI USA, V105, P15058, DOI 10.1073/pnas.0808216105; Fiocchi C, 1998, GASTROENTEROLOGY, V115, P182, DOI 10.1016/S0016-5085(98)70381-6; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Gorina R, 2011, GLIA, V59, P242, DOI 10.1002/glia.21094; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Ina K, 1999, J IMMUNOL, V163, P1081; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Jobin C, 1999, J IMMUNOL, V163, P3474; Jun CD, 2006, INFLAMM BOWEL DIS, V12, P619, DOI 10.1097/01.ibd.0000225340.99108.8a; Kilic ZMY, 2009, TURK J GASTROENTEROL, V20, P165, DOI 10.4318/tjg.2009.0002; Koelink PJ, 2010, CANCER LETT, V287, P82, DOI 10.1016/j.canlet.2009.05.033; Kozuch PL, 2008, WORLD J GASTROENTERO, V14, P354, DOI 10.3748/wjg.14.354; KRAWISZ JE, 1984, GASTROENTEROLOGY, V87, P1344; Kucharczak J, 2003, ONCOGENE, V22, P8961, DOI 10.1038/sj.onc.1207230; Lammers KM, 2005, INFLAMM BOWEL DIS, V11, P447, DOI 10.1097/01.mpa.0000160302.40931.7b; Lee JY, 2007, INT IMMUNOPHARMACOL, V7, P241, DOI 10.1016/j.intimp.2006.10.013; Lee KY, 2006, J IMMUNOL, V176, P603, DOI 10.4049/jimmunol.176.1.603; Liu X, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/572570; Liu X, 2011, J ETHNOPHARMACOL, V133, P780, DOI 10.1016/j.jep.2010.11.010; Luo JL, 2005, J CLIN INVEST, V115, P2625, DOI 10.1172/JCI26322; Malek R, 2007, PHARMACOL REP, V59, P25; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Martin AR, 2006, BRIT J PHARMACOL, V147, P873, DOI 10.1038/sj.bjp.0706469; Mazzon E, 2006, J PINEAL RES, V41, P363, DOI 10.1111/j.1600-079X.2006.00378.x; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Nam SY, 2008, EXP BIOL MED, V233, P180, DOI 10.3181/0707-RM-186; Neurath MF, 1996, NAT MED, V2, P998, DOI 10.1038/nm0996-998; O'Shea JJ, 2002, NAT REV IMMUNOL, V2, P37, DOI 10.1038/nri702; Sakuraba H, 2007, BIOCHEM BIOPH RES CO, V359, P406, DOI 10.1016/j.bbrc.2007.05.117; Sayani FA, 2004, NEUROGASTROENT MOTIL, V16, P61, DOI 10.1046/j.1365-2982.2003.00457.x; Scorrano L, 2003, BIOCHEM BIOPH RES CO, V304, P437, DOI 10.1016/S0006-291X(03)00615-6; Seidelin JB, 2008, INFLAMM BOWEL DIS, V14, P1623, DOI 10.1002/ibd.20629; Seidelin Jakob Benedict, 2003, Ugeskr Laeger, V165, P790; Shanahan F, 2009, CURR OPIN GASTROEN, V25, P301, DOI 10.1097/MOG.0b013e32832b12ef; Singer II, 1998, GASTROENTEROLOGY, V115, P297, DOI 10.1016/S0016-5085(98)70196-9; Stadnicki A, 2009, INT IMMUNOPHARMACOL, V9, P761, DOI 10.1016/j.intimp.2009.02.014; Strater J, 1997, GASTROENTEROLOGY, V113, P160, DOI 10.1016/S0016-5085(97)70091-X; Talero E, 2008, PEPTIDES, V29, P2001, DOI 10.1016/j.peptides.2008.07.013; Ueyama H, 1998, GUT, V43, P48, DOI 10.1136/gut.43.1.48; WALLACE JL, 1992, GASTROENTEROLOGY, V102, P18, DOI 10.1016/0016-5085(92)91779-4; Weber CK, 2000, GASTROENTEROLOGY, V119, P1209, DOI 10.1053/gast.2000.19458; Wiercinska-Drapalo A, 2003, REGUL PEPTIDES, V113, P57, DOI 10.1016/S0167-0115(02)00300-2; Yang F, 2003, J IMMUNOL, V170, P5630, DOI 10.4049/jimmunol.170.11.5630; Yao J, 2010, ARCH MED RES, V41, P288, DOI 10.1016/j.arcmed.2010.05.002; Zhang DK, 2010, J PATHOL, V222, P213, DOI 10.1002/path.2749; ZHANG LX, 2009, STRAIT PHARM J, V21, P20	57	25	26	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2011	6	9							e24740	10.1371/journal.pone.0024740	http://dx.doi.org/10.1371/journal.pone.0024740			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZV	21931839	gold, Green Submitted, Green Published			2022-12-25	WOS:000295321800058
J	Rivera, CG; Mellberg, S; Claesson-Welsh, L; Bader, JS; Popel, AS				Rivera, Corban G.; Mellberg, Sofie; Claesson-Welsh, Lena; Bader, Joel S.; Popel, Aleksander S.			Analysis of VEGF-A Regulated Gene Expression in Endothelial Cells to Identify Genes Linked to Angiogenesis	PLOS ONE			English	Article							SET ENRICHMENT ANALYSIS; FUNCTION PREDICTION; IN-VITRO; ALZHEIMERS-DISEASE; NETWORK; MORPHOGENESIS; INFLAMMATION; DISCOVERY; FRAMEWORK; DATABASE	Angiogenesis is important for many physiological processes, diseases, and also regenerative medicine. Therapies that inhibit the vascular endothelial growth factor (VEGF) pathway have been used in the clinic for cancer and macular degeneration. In cancer applications, these treatments suffer from a "tumor escape phenomenon'' where alternative pathways are upregulated and angiogenesis continues. The redundancy of angiogenesis regulation indicates the need for additional studies and new drug targets. We aimed to (i) identify novel and missing angiogenesis annotations and (ii) verify their significance to angiogenesis. To achieve these goals, we integrated the human interactome with known angiogenesis-annotated proteins to identify a set of 202 angiogenesis-associated proteins. Across endothelial cell lines, we found that a significant fraction of these proteins had highly perturbed gene expression during angiogenesis. After treatment with VEGF-A, we found increasing expression of HIF-1 alpha, APP, HIV-1 tat interactive protein 2, and MEF2C, while endoglin, liprin beta 1 and HIF-2 alpha had decreasing expression across three endothelial cell lines. The analysis showed differential regulation of HIF-1 alpha and HIF-2 alpha. The data also provided additional evidence for the role of endothelial cells in Alzheimer's disease.	[Rivera, Corban G.; Bader, Joel S.; Popel, Aleksander S.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA; [Rivera, Corban G.; Bader, Joel S.] Johns Hopkins Sch Med, High Throughput Biol Ctr, Baltimore, MD USA; [Mellberg, Sofie; Claesson-Welsh, Lena] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Uppsala University	Rivera, CG (corresponding author), Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA.	cgrivera@jhu.edu	Bader, Joel/A-1818-2009; Popel, Aleksander S/A-6724-2009	Bader, Joel/0000-0002-6020-4625; Popel, Aleksander/0000-0002-6706-9235	National Institutes of Health [R01 HL101200, R01 CA138264]; NATIONAL CANCER INSTITUTE [R01CA138264] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL101200] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work was supported by National Institutes of Health grants R01 HL101200 and R01 CA138264. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Breitkreutz BJ, 2008, NUCLEIC ACIDS RES, V36, pD637, DOI 10.1093/nar/gkm1001; Browder T, 2000, J BIOL CHEM, V275, P1521, DOI 10.1074/jbc.275.3.1521; Chen YF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-264; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Garber K, 2002, NAT BIOTECHNOL, V20, P1067, DOI 10.1038/nbt1102-1067; Glesne DA, 2006, CANCER RES, V66, P4030, DOI 10.1158/0008-5472.CAN-05-3294; Grammas P, 1999, AM J PATHOL, V154, P337, DOI 10.1016/S0002-9440(10)65280-7; Gu J, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-47; Huang YZ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S32; Jayapandian M, 2007, NUCLEIC ACIDS RES, V35, pD566, DOI 10.1093/nar/gkl859; Koukourakis MI, 2001, CANCER RES, V61, P1830; Lanckriet GRG, 2004, BIOINFORMATICS, V20, P2626, DOI 10.1093/bioinformatics/bth294; Lee SH, 2000, NEW ENGL J MED, V342, P626, DOI 10.1056/NEJM200003023420904; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Maiti D, 2008, INVEST OPHTH VIS SCI, V49, P3640, DOI 10.1167/iovs.08-1760; Mellberg S, 2009, FASEB J, V23, P1490, DOI 10.1096/fj.08-123810; Murali TM, 2006, NAT BIOTECHNOL, V24, P1474, DOI 10.1038/nbt1206-1474; NicAmhlaoibh R, 2001, ONCOGENE, V20, P270, DOI 10.1038/sj.onc.1204075; Pena-Castillo L, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s2; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Rehn M, 2001, P NATL ACAD SCI USA, V98, P1024, DOI 10.1073/pnas.031564998; Rivera CG, 2011, ANN BIOMED ENG, V39, P2213, DOI 10.1007/s10439-011-0325-2; Schweighofer B, 2009, THROMB HAEMOSTASIS, V102, P544, DOI 10.1160/TH08-12-0830; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Talks KL, 2000, AM J PATHOL, V157, P411, DOI 10.1016/S0002-9440(10)64554-3; ten Dijke P, 2008, ANGIOGENESIS, V11, P79, DOI 10.1007/s10456-008-9101-9; Troyanskaya OG, 2003, P NATL ACAD SCI USA, V100, P8348, DOI 10.1073/pnas.0832373100; Vagnucci AH, 2003, LANCET, V361, P605, DOI 10.1016/S0140-6736(03)12521-4; Vastrik I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r39; Zhou XH, 2002, P NATL ACAD SCI USA, V99, P12783, DOI 10.1073/pnas.192159399	35	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2011	6	9							e24887	10.1371/journal.pone.0024887	http://dx.doi.org/10.1371/journal.pone.0024887			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZV	21931866	Green Published, gold, Green Submitted			2022-12-25	WOS:000295321800074
J	Petit, A; Sanders, AD; Kennedy, TE; Tetzlaff, W; Glattfelder, KJ; Dalley, RA; Puchalski, RB; Jones, AR; Roskams, AJ				Petit, Audrey; Sanders, Ashley D.; Kennedy, Timothy E.; Tetzlaff, Wolfram; Glattfelder, Katie J.; Dalley, Rachel A.; Puchalski, Ralph B.; Jones, Allan R.; Roskams, A. Jane			Adult Spinal Cord Radial Glia Display a Unique Progenitor Phenotype	PLOS ONE			English	Article							IN-VIVO; INJURY; CELLS; EXPRESSION; PROLIFERATION; DIFFERENTIATION; INDUCTION; INCREASE; LINEAGE; PROTEIN	Radial glia (RG) are primarily embryonic neuroglial progenitors that express Brain Lipid Binding Protein (Blbp a.k.a. Fabp7) and Glial Fibrillary Acidic Protein (Gfap). We used these transcripts to demarcate the distribution of spinal cord radial glia (SCRG) and screen for SCRG gene expression in the Allen Spinal Cord Atlas (ASCA). We reveal that neonatal and adult SCRG are anchored in a non-ventricular niche at the spinal cord (SC) pial boundary, and express a "signature" subset of 122 genes, many of which are shared with "classic" neural stem cells (NSCs) of the subventricular zone (SVZ) and SC central canal (CC). A core expressed gene set shared between SCRG and progenitors of the SVZ and CC is particularly enriched in genes associated with human disease. Visualizing SCRG in a Fabp7-EGFP reporter mouse reveals an extensive population of SCRG that extend processes around the SC boundary and inwardly (through) the SC white matter (WM), whose abundance increases in a gradient from cervical to lumbar SC. Confocal analysis of multiple NSC-enriched proteins reveals that postnatal SCRG are a discrete and heterogeneous potential progenitor population that become activated by multiple SC lesions, and that CC progenitors are also more heterogeneous than previously appreciated. Gene ontology analysis highlights potentially unique regulatory pathways that may be further manipulated in SCRG to enhance repair in the context of injury and SC disease.	[Petit, Audrey; Sanders, Ashley D.; Tetzlaff, Wolfram; Roskams, A. Jane] Univ British Columbia, Dept Zool, Inst Life Sci, Vancouver, BC, Canada; [Petit, Audrey; Sanders, Ashley D.; Tetzlaff, Wolfram; Roskams, A. Jane] Univ British Columbia, Int Collaborat Repair Discoveries iCORD, Vancouver, BC, Canada; [Kennedy, Timothy E.] McGill Univ, Montreal Neurol Inst, Dept Neurol & Neurosurg, Montreal, PQ H3A 2B4, Canada; [Glattfelder, Katie J.; Dalley, Rachel A.; Puchalski, Ralph B.; Jones, Allan R.] Allen Inst Brain Sci, Seattle, WA USA	University of British Columbia; University of British Columbia; McGill University; Allen Institute for Brain Science	Petit, A (corresponding author), Univ British Columbia, Dept Zool, Inst Life Sci, Vancouver, BC, Canada.	roskams@zoology.ubc.ca	Tetzlaff, Wolfram/AAY-4430-2020	Sanders, Ashley/0000-0003-3945-0677	Canadian Institutes of Health Research [MOP-89739]; Michael Smith Foundation for Health Research; Natural Sciences and Engineering Research Council of Canada; ALS Association; Wyeth Research; PVA Research Foundation [2525]; National Multiple Sclerosis Society; International Spinal Research Trust; PEMCO Insurance; Philanthropist Paul G. Allen	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); ALS Association; Wyeth Research(Wyeth); PVA Research Foundation; National Multiple Sclerosis Society(National Multiple Sclerosis Society); International Spinal Research Trust; PEMCO Insurance; Philanthropist Paul G. Allen	This work was funded by Canadian Institutes of Health Research (MOP-89739 to AJR; also to TK and WT), the Michael Smith Foundation for Health Research (Senior Scholar award, JR) and Natural Sciences and Engineering Research Council of Canada (ADS studentship), and the consortium of funding organizations that supported the production of the Spinal Cord Map: ALS Association, Wyeth Research, PVA Research Foundation (#2525), National Multiple Sclerosis Society, International Spinal Research Trust, PEMCO Insurance, Philanthropist Paul G. Allen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony TE, 2004, NEURON, V41, P881, DOI 10.1016/S0896-6273(04)00140-0; Anthony TE, 2005, GENE DEV, V19, P1028, DOI 10.1101/gad.1302105; Au E, 2003, GLIA, V41, P224, DOI 10.1002/glia.10160; Bannerman P, 2007, GLIA, V55, P57, DOI 10.1002/glia.20437; Barry D, 2005, GLIA, V50, P187, DOI 10.1002/glia.20166; Barry D, 2004, J ANATOMY; Boor PKI, 2006, HUM MUTAT, V27, P505, DOI 10.1002/humu.20332; Bordet R, 2006, BIOCHEM SOC T, V34, P1341, DOI 10.1042/BST0341341; Brown KM, 2005, J NEUROTRAUM, V22, P559, DOI 10.1089/neu.2005.22.559; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Devaux B, 1997, J NEUROIMMUNOL, V75, P169, DOI 10.1016/S0165-5728(97)00019-2; Gregg CT, 2002, J NEUROSCI RES, V69, P708, DOI 10.1002/jnr.10340; Ihrie RA, 2008, CELL TISSUE RES, V331, P179, DOI 10.1007/s00441-007-0461-z; Knerlich-Lukoschus F, 2010, GLIA, V58, P916, DOI 10.1002/glia.20974; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Kulbatski I, 2007, J HISTOCHEM CYTOCHEM, V55, P209, DOI 10.1369/jhc.6A7020.2006; Liang Y, 2008, EXP CELL RES, V314, P1962, DOI 10.1016/j.yexcr.2008.01.032; MacDonald JL, 2005, DEV BIOL, V288, P461, DOI 10.1016/j.ydbio.2005.09.048; Marin-Husstege M, 2006, GLIA, V54, P285, DOI 10.1002/glia.20385; Martens DJ, 2002, EUR J NEUROSCI, V16, P1045, DOI 10.1046/j.1460-9568.2002.02181.x; McDermott KW, 2005, J ANAT, V207, P241, DOI 10.1111/j.1469-7580.2005.00462.x; McMahon SS, 2002, J COMP NEUROL, V454, P263, DOI 10.1002/cne.10427; Mctigue DM, 2008, POTENTIAL THERAPEUTI, P1; Mothe AJ, 2005, NEUROSCIENCE, V131, P177, DOI 10.1016/j.neuroscience.2004.10.011; OUDEGA M, 1991, J ANAT, V179, P97; Plemel JR, 2008, J NEUROTRAUM, V25, P350, DOI 10.1089/neu.2007.0426; Sabourin JC, 2009, STEM CELLS, V27, P2722, DOI 10.1002/stem.226; Shibata T, 1997, J NEUROSCI, V17, P9212; Shibuya S, 2003, GLIA, V42, P172, DOI 10.1002/glia.10203; Shibuya S, 2002, NEUROSCIENCE, V114, P905, DOI 10.1016/S0306-4522(02)00323-8; Shibuya S, 2009, CELL ADHES MIGR, V3, P99, DOI 10.4161/cam.3.1.7372; Sottile V, 2006, BRAIN RES, V1099, P8, DOI 10.1016/j.brainres.2006.04.127; White RE, 2010, J COMP NEUROL, V518, P1370, DOI 10.1002/cne.22282; Wu D, 2005, J NEUROCYTOL, V34, P459, DOI 10.1007/s11068-006-8998-4; Yun K, 2004, DEVELOPMENT, V131, P5441, DOI 10.1242/dev.01430	35	36	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2011	6	9							e24538	10.1371/journal.pone.0024538	http://dx.doi.org/10.1371/journal.pone.0024538			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CO	21931744	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000294803200026
J	Wang, PH; Gu, ZH; Wan, DH; Zhang, MY; Weng, SP; Yu, XQ; He, JG				Wang, Pei-Hui; Gu, Zhi-Hua; Wan, Ding-Hui; Zhang, Ming-Yan; Weng, Shao-Ping; Yu, Xiao-Qiang; He, Jian-Guo			The Shrimp NF-kappa B Pathway Is Activated by White Spot Syndrome Virus (WSSV) 449 to Facilitate the Expression of WSSV069 (ie1), WSSV303 and WSSV371	PLOS ONE			English	Article							DEATH DOMAIN; FUNCTIONAL INTERACTIONS; LITOPENAEUS-VANNAMEI; VACCINIA VIRUS; TOLL RECEPTOR; CUTTING EDGE; PELLE KINASE; IRAK FAMILY; GENE FAMILY; HOMOLOG	The Toll-like receptor (TLR)-mediated NF-kappa B pathway is essential for defending against viruses in insects and mammals. Viruses also develop strategies to utilize this pathway to benefit their infection and replication in mammal hosts. In invertebrates, the TLR-mediated NF-kappa B pathway has only been well-studied in insects and has been demonstrated to be important in antiviral responses. However, there are few reports of interactions between viruses and the TLR-mediated NF kappa B pathway in invertebrate hosts. Here, we studied Litopenaeus vannamei Pelle, which is the central regulator of the Toll pathway, and proposed that a similar TLR/MyD88/Tube/Pelle/TRAF6/NF-kappa B cascade may exist in shrimp for immune gene regulation. After performing genome-wild analysis of white spot syndrome virus (WSSV) encoded proteins, we found that WSSV449 shows 15.7- 19.4% identity to Tube, which is an important component of the insect Toll pathway. We further found that WSSV449 activated promoters of Toll pathway-controlled antimicrobial peptide genes, indicating WSSV449 has a similar function to host Tube in activating the NF-kappa B pathway. We suspected that WSSV449 activated the Toll-mediated NF kappa B pathway for regulating viral gene expression. To test this hypothesis, we analyzed the promoters of viral genes and found 40 promoters that possess NF-kappa B binding sites. A promoter screen showed that the promoter activities of WSSV069 (ie1), WSSV303 and WSSV371 can be highly induced by the shrimp NF-kappa B family protein LvDorsal. WSSV449 also induced these three viral promoter activities by activating the NF-kappa B pathway. To our knowledge, this is the first report of a virus that encodes a protein similar to the Toll pathway component Tube to upregulate gene expression in the invertebrate host.	[Wang, Pei-Hui; Gu, Zhi-Hua; Wan, Ding-Hui; Zhang, Ming-Yan; Weng, Shao-Ping; He, Jian-Guo] Sun Yat Sen Univ, MOE Key Lab Aquat Prod Safety, State Key Lab Biocontrol, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [He, Jian-Guo] Sun Yat Sen Univ, Sch Marine Sci, Guangzhou 510275, Guangdong, Peoples R China; [Yu, Xiao-Qiang] Univ Missouri, Sch Biol Sci, Div Cell Biol & Biophys, Kansas City, MO 64110 USA	Sun Yat Sen University; Sun Yat Sen University; University of Missouri System; University of Missouri Kansas City	Wang, PH (corresponding author), Sun Yat Sen Univ, MOE Key Lab Aquat Prod Safety, State Key Lab Biocontrol, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China.	lsshjg@mail.sysu.edu.cn	YU, XIAO-QIANG/AAL-1797-2021; YU, XiaoQiang/GRJ-1077-2022; Wang, Pei-Hui/F-7682-2014	YU, XIAO-QIANG/0000-0003-1419-9009; Wang, Pei-Hui/0000-0001-6853-2423	National Key Technology R&D Program in the 11th Five-year Plan of China [2007BAD29B01]; China Agriculture Research system-47; Special Fund for Agro-scientific Research in the Public Interest [201103034]; State Key Laboratory of Biocontrol [SKLBC09K04]; Foundation from Science and Technology Bureau of Guangdong Province [2008A020100004, 2009A020102002]	National Key Technology R&D Program in the 11th Five-year Plan of China(National Key Technology R&D Program); China Agriculture Research system-47; Special Fund for Agro-scientific Research in the Public Interest; State Key Laboratory of Biocontrol; Foundation from Science and Technology Bureau of Guangdong Province	This research was supported by National Key Technology R&D Program in the 11th Five-year Plan of China under grant no. 2007BAD29B01; China Agriculture Research system-47; Special Fund for Agro-scientific Research in the Public Interest (201103034); the Open Project of the State Key Laboratory of Biocontrol (SKLBC09K04), and Foundation from Science and Technology Bureau of Guangdong Province under grant no. 2008A020100004 and 2009A020102002. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal K, 2008, BMB REP, V41, P267, DOI 10.5483/BMBRep.2008.41.4.267; Bowie A, 2000, P NATL ACAD SCI USA, V97, P10162, DOI 10.1073/pnas.160027697; Falabella P, 2007, J GEN VIROL, V88, P92, DOI 10.1099/vir.0.82306-0; Fan ZH, 2008, INFECT IMMUN, V76, P664, DOI 10.1128/IAI.00948-07; Geleziunas R, 1998, MOL CELL BIOL, V18, P5157, DOI 10.1128/MCB.18.9.5157; GRIFFIN GE, 1989, NATURE, V339, P70, DOI 10.1038/339070a0; Harte MT, 2003, J EXP MED, V197, P343, DOI 10.1084/jem.20021652; Hiscott J, 2001, J CLIN INVEST, V107, P143, DOI 10.1172/JCI11918; Hiscott J, 2006, ONCOGENE, V25, P6844, DOI 10.1038/sj.onc.1209941; Ho SH, 2009, FISH SHELLFISH IMMUN, V27, P73, DOI 10.1016/j.fsi.2009.05.001; Huang XD, 2010, DEV COMP IMMUNOL, V34, P107, DOI 10.1016/j.dci.2009.08.009; Janssens S, 2003, MOL CELL, V11, P293, DOI 10.1016/S1097-2765(03)00053-4; Kuglstatter A, 2007, J IMMUNOL, V178, P2641, DOI 10.4049/jimmunol.178.5.2641; Lasker MV, 2005, J IMMUNOL, V175, P4175, DOI 10.4049/jimmunol.175.7.4175; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Leu JH, 2010, DEV COMP IMMUNOL, V34, P1068, DOI 10.1016/j.dci.2010.05.010; Leulier F, 2008, NAT REV GENET, V9, P165, DOI 10.1038/nrg2303; Li FH, 2010, DEV COMP IMMUNOL, V34, P874, DOI 10.1016/j.dci.2010.03.008; Li SY, 2002, P NATL ACAD SCI USA, V99, P5567, DOI 10.1073/pnas.082100399; Lin YR, 2011, J VIROL, V85, P3517, DOI 10.1128/JVI.01973-10; Liu WJ, 2008, J VIROL, V82, P11362, DOI 10.1128/JVI.01244-08; Liu WJ, 2007, J VIROL, V81, P1461, DOI 10.1128/JVI.01880-06; Lye E, 2004, J BIOL CHEM, V279, P40653, DOI 10.1074/jbc.M402666200; Mohamed MR, 2009, J VIROL, V83, P9223, DOI 10.1128/JVI.00861-09; Mohamed MR, 2009, P NATL ACAD SCI USA, V106, P9045, DOI 10.1073/pnas.0900452106; Moncrieffe MC, 2008, J BIOL CHEM, V283, P33447, DOI 10.1074/jbc.M805427200; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; Norris JL, 1996, GENE DEV, V10, P862, DOI 10.1101/gad.10.7.862; Nupan B, 2011, DEV COMP IMMUNOL, V35, P469, DOI 10.1016/j.dci.2010.11.016; O'Leary NA, 2006, GENE, V371, P75, DOI 10.1016/j.gene.2005.11.028; Powell PP, 1996, J VIROL, V70, P8527, DOI 10.1128/JVI.70.12.8527-8533.1996; Qian YC, 2001, J BIOL CHEM, V276, P41661, DOI 10.1074/jbc.M102262200; Sabin LR, 2010, CURR OPIN IMMUNOL, V22, P4, DOI 10.1016/j.coi.2010.01.007; Sakakibara S, 2011, J VIROL, V85, P3179, DOI 10.1128/JVI.02333-10; Santoro MG, 2003, EMBO J, V22, P2552, DOI 10.1093/emboj/cdg267; Shen BH, 2001, P NATL ACAD SCI USA, V98, P8596, DOI 10.1073/pnas.141235698; Staal J, 2011, CELL RES, V21, P40, DOI 10.1038/cr.2010.168; Stack J, 2005, J EXP MED, V201, P1007, DOI 10.1084/jem.20041442; Sun HY, 2002, P NATL ACAD SCI USA, V99, P12871, DOI 10.1073/pnas.202396399; Tait SWG, 2000, J BIOL CHEM, V275, P34656, DOI 10.1074/jbc.M000320200; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Thoetkiattikul H, 2005, P NATL ACAD SCI USA, V102, P11426, DOI 10.1073/pnas.0505240102; Towb P, 2009, J INNATE IMMUN, V1, P309, DOI 10.1159/000200773; Valanne S, 2011, J IMMUNOL, V186, P649, DOI 10.4049/jimmunol.1002302; Wang PH, 2012, DEV COMP IMMUNOL, V36, P359, DOI 10.1016/j.dci.2011.07.007; Wang PH, 2012, DEV COMP IMMUNOL, V36, P39, DOI 10.1016/j.dci.2011.06.002; Wang PH, 2011, DEV COMP IMMUNOL, V35, P105, DOI 10.1016/j.dci.2010.08.013; Wang PH, 2009, MOL IMMUNOL, V46, P1897, DOI 10.1016/j.molimm.2009.01.005; Yang F, 2001, J VIROL, V75, P11811, DOI 10.1128/JVI.75.23.11811-11820.2001; Zambon RA, 2005, P NATL ACAD SCI USA, V102, P7257, DOI 10.1073/pnas.0409181102; [No title captured]	52	97	99	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2011	6	9							e24773	10.1371/journal.pone.0024773	http://dx.doi.org/10.1371/journal.pone.0024773			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CO	21931849	Green Submitted, Green Published, gold			2022-12-25	WOS:000294803200048
J	Claerhout, S; Lim, JY; Choi, W; Park, YY; Kim, K; Kim, SB; Lee, JS; Mills, GB; Cho, JY				Claerhout, Sofie; Lim, Jae Yun; Choi, Woonyoung; Park, Yun-Yong; Kim, KyoungHyun; Kim, Sang-Bae; Lee, Ju-Seog; Mills, Gordon B.; Cho, Jae Yong			Gene Expression Signature Analysis Identifies Vorinostat as a Candidate Therapy for Gastric Cancer	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; CONNECTIVITY MAP; SERIAL ANALYSIS; HUMAN COLON; CELL-DEATH; PHASE-II; CARCINOMA; GROWTH; AUTOPHAGY; RISK	Background: Gastric cancer continues to be one of the deadliest cancers in the world and therefore identification of new drugs targeting this type of cancer is thus of significant importance. The purpose of this study was to identify and validate a therapeutic agent which might improve the outcomes for gastric cancer patients in the future. Methodology/Principal Findings: Using microarray technology, we generated a gene expression profile of human gastric cancer-specific genes from human gastric cancer tissue samples. We used this profile in the Broad Institute's Connectivity Map analysis to identify candidate therapeutic compounds for gastric cancer. We found the histone deacetylase inhibitor vorinostat as the lead compound and thus a potential therapeutic drug for gastric cancer. Vorinostat induced both apoptosis and autophagy in gastric cancer cell lines. Pharmacological and genetic inhibition of autophagy however, increased the therapeutic efficacy of vorinostat, indicating that a combination of vorinostat with autophagy inhibitors may therapeutically be more beneficial. Moreover, gene expression analysis of gastric cancer identified a collection of genes (ITGB5, TYMS, MYB, APOC1, CBX5, PLA2G2A, and KIF20A) whose expression was elevated in gastric tumor tissue and downregulated more than 2-fold by vorinostat treatment in gastric cancer cell lines. In contrast, SCGB2A1, TCN1, CFD, APLP1, and NQO1 manifested a reversed pattern. Conclusions/Significance: We showed that analysis of gene expression signature may represent an emerging approach to discover therapeutic agents for gastric cancer, such as vorinostat. The observation of altered gene expression after vorinostat treatment may provide the clue to identify the molecular mechanism of vorinostat and those patients likely to benefit from vorinostat treatment.	[Claerhout, Sofie; Lim, Jae Yun; Park, Yun-Yong; Kim, Sang-Bae; Lee, Ju-Seog; Mills, Gordon B.; Cho, Jae Yong] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Div Canc Med, Houston, TX 77030 USA; [Lim, Jae Yun; Cho, Jae Yong] Yonsei Univ, Coll Med, Dept Med Oncol, Gangnam Severance Hosp, Seoul, South Korea; [Choi, Woonyoung] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Kim, KyoungHyun] Texas A&M Univ, Dept Vet Physiol & Pharmacol, College Stn, TX 77843 USA	University of Texas System; UTMD Anderson Cancer Center; Yonsei University; Yonsei University Health System; University of Texas System; UTMD Anderson Cancer Center; Texas A&M University System; Texas A&M University College Station	Claerhout, S (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Div Canc Med, Houston, TX 77030 USA.	chojy@yuhs.ac	Lee, Ju-Seog/X-1786-2018	Lee, Ju-Seog/0000-0002-5666-9753; Claerhout, Sofie/0000-0003-0857-0211; Cho, Jae Yong/0000-0002-0926-1819; Kim, Kyounghyun/0000-0002-7240-2768	Odyssey Program; University of Texas MD Anderson Cancer Center; National Research Foundation of Korea; Ministry of Education, Science and Technology [2010-0024248]; NATIONAL CANCER INSTITUTE [P50CA098258, P30CA016672] Funding Source: NIH RePORTER	Odyssey Program; University of Texas MD Anderson Cancer Center; National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding to SC as an Odyssey Fellow was supported by the Odyssey Program and the Theodore N. Law Endowment for Scientific Achievement at the University of Texas MD Anderson Cancer Center. This work was also supported by funds from the 2009 Internal Medicine Academic Research Fund and Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (No. 2010-0024248). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajani JA, 2005, J CLIN ONCOL, V23, P1237, DOI 10.1200/JCO.2005.01.305; Amaravadi RK, 2007, CLIN CANCER RES, V13, P7271, DOI 10.1158/1078-0432.CCR-07-1595; Bang YJ, 2010, LANCET, V376, P1302; Begleiter A, 2006, CANCER EPIDEM BIOMAR, V15, P2422, DOI 10.1158/1055-9965.EPI-06-0661; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brabender J, 2001, J SURG RES, V99, P301, DOI 10.1006/jsre.2001.6186; Butler LM, 2002, P NATL ACAD SCI USA, V99, P11700, DOI 10.1073/pnas.182372299; Carew JS, 2007, AUTOPHAGY, V3, P464, DOI 10.4161/auto.4311; Chang H, 2010, J CANCER RES CLIN, V136, P1901, DOI 10.1007/s00432-010-0849-0; Chang TH, 2002, CLIN CANCER RES, V8, P1206; Cho JY, 2011, CLIN CANCER RES, V17, P1850, DOI 10.1158/1078-0432.CCR-10-2180; Choi JH, 2001, JPN J CANCER RES, V92, P1300, DOI 10.1111/j.1349-7006.2001.tb02153.x; COLTEN HR, 1992, J APPL PHYSIOL, V72, P1; Cunningham D, 2008, NEW ENGL J MED, V358, P36, DOI 10.1056/NEJMoa073149; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Deroanne CF, 2002, ONCOGENE, V21, P427, DOI 10.1038/sj.onc.1205108; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ganter B, 2005, J BIOTECHNOL, V119, P219, DOI 10.1016/j.jbiotec.2005.03.022; Glaser KB, 2003, MOL CANCER THER, V2, P151; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Hlavata I, 2010, ONCOL REP, V24, P1347, DOI 10.3892/or_0000992; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Iskander K, 2005, CANCER RES, V65, P2054, DOI 10.1158/0008-5472.CAN-04-3157; Jeong JW, 2002, CELL, V111, P709, DOI 10.1016/S0092-8674(02)01085-1; Kanai T, 1998, INT J CANCER, V77, P933, DOI 10.1002/(SICI)1097-0215(19980911)77:6<933::AID-IJC23>3.0.CO;2-0; Kauraniemi P, 2000, CANCER RES, V60, P5323; Kitano E, 2002, INT IMMUNOPHARMACOL, V2, P843, DOI 10.1016/S1567-5769(02)00028-0; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Lamb J, 2007, NAT REV CANCER, V7, P54, DOI 10.1038/nrc2044; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lee JH, 2010, MOL CELLS, V30, P107, DOI 10.1007/s10059-010-0094-z; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Ooyama A, 2007, CANCER SCI, V98, P577, DOI 10.1111/j.1349-7006.2007.00424.x; Oue N, 2004, CANCER RES, V64, P2397, DOI 10.1158/0008-5472.CAN-03-3514; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Peart MJ, 2005, P NATL ACAD SCI USA, V102, P3697, DOI 10.1073/pnas.0500369102; Pinto C, 2007, ANN ONCOL, V18, P510, DOI 10.1093/annonc/mdl459; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Prince HM, 2009, CLIN CANCER RES, V15, P3958, DOI 10.1158/1078-0432.CCR-08-2785; Retterspitz MF, 2010, ANTICANCER RES, V30, P4635; Shah MA, 2006, J CLIN ONCOL, V24, P5201, DOI 10.1200/JCO.2006.08.0887; Shao YF, 2004, P NATL ACAD SCI USA, V101, P18030, DOI 10.1073/pnas.0408345102; Tang X, 2007, ONCOGENE, V26, P7302, DOI 10.1038/sj.onc.1210542; Taniuchi K, 2005, CANCER RES, V65, P105; Tanner M, 2005, ANN ONCOL, V16, P273, DOI 10.1093/annonc/mdi064; Tomita A, 1998, LEUKEMIA, V12, P1422, DOI 10.1038/sj.leu.2401113; TORELLI G, 1987, CANCER RES, V47, P5266; Van Cutsem E, 2006, J CLIN ONCOL, V24, P4991, DOI 10.1200/JCO.2006.06.8429; Yasui W, 2004, CANCER SCI, V95, P385, DOI 10.1111/j.1349-7006.2004.tb03220.x; Yoon SN, 2010, HEPATO-GASTROENTEROL, V57, P657; Zhang Y, 2006, CELL DEATH DIFFER, V13, P129, DOI 10.1038/sj.cdd.4401686; Zhao Y, 2005, P NATL ACAD SCI USA, V102, P16090, DOI 10.1073/pnas.0505585102	53	89	94	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2011	6	9							e24662	10.1371/journal.pone.0024662	http://dx.doi.org/10.1371/journal.pone.0024662			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CN	21931799	gold, Green Published, Green Submitted			2022-12-25	WOS:000294803100051
J	Gao, JH; Hu, J; Buckley, T; White, K; Hass, C				Gao, Jianbo; Hu, Jing; Buckley, Thomas; White, Keith; Hass, Chris			Shannon and Renyi Entropies to Classify Effects of Mild Traumatic Brain Injury on Postural Sway	PLOS ONE			English	Article							COLLEGIATE FOOTBALL PLAYERS; CONCUSSION ASSESSMENT; TIME-SERIES; HEAD-INJURY; STABILITY; ENCEPHALOPATHY; COMPLEXITY; DEFICITS; IMPACT	Background: Mild Traumatic Brain Injury (mTBI) has been identified as a major public and military health concern both in the United States and worldwide. Characterizing the effects of mTBI on postural sway could be an important tool for assessing recovery from the injury. Methodology/Principal Findings: We assess postural sway by motion of the center of pressure (COP). Methods for data reduction include calculation of area of COP and fractal analysis of COP motion time courses. We found that fractal scaling appears applicable to sway power above about 0.5 Hz, thus fractal characterization is only quantifying the secondary effects (a small fraction of total power) in the sway time series, and is not effective in quantifying long-term effects of mTBI on postural sway. We also found that the area of COP sensitively depends on the length of data series over which the COP is obtained. These weaknesses motivated us to use instead Shannon and Renyi entropies to assess postural instability following mTBI. These entropy measures have a number of appealing properties, including capacity for determination of the optimal length of the time series for analysis and a new interpretation of the area of COP. Conclusions: Entropy analysis can readily detect postural instability in athletes at least 10 days post-concussion so that it appears promising as a sensitive measure of effects of mTBI on postural sway. Availability: The programs for analyses may be obtained from the authors.	[Gao, Jianbo] PMB Intelligence LLC, W Lafayette, IN USA; [Hu, Jing] Affymetrix Inc, Santa Clara, CA USA; [Buckley, Thomas] Georgia So Univ, Grad Athlet Training Program, Statesboro, GA 30460 USA; [White, Keith] Univ Florida, Dept Psychol, Gainesville, FL 32611 USA; [Hass, Chris] Univ Florida, Dept Appl Physiol & Kinesiol, Gainesville, FL USA	Affymetrix; University System of Georgia; Georgia Southern University; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Gao, JH (corresponding author), PMB Intelligence LLC, W Lafayette, IN USA.	jbgao@pmbintelligence.com	Buckley, Thomas/HGD-4732-2022; Buckley, Thomas A/B-7525-2016	Buckley, Thomas A/0000-0002-0515-0150; White, Keith/0000-0002-4442-5743	Army Research Office [56382LSJDO, W911NF-10-1-0425]; Div Of Civil, Mechanical, & Manufact Inn [1031958] Funding Source: National Science Foundation	Army Research Office; Div Of Civil, Mechanical, & Manufact Inn(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported in part by Army Research Office grants #56382LSJDO and #W911NF-10-1-0425. The views expressed herein are those of the authors and do not reflect the views of the Army Research Office. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoud H, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-12; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Broglio SP, 2007, NEUROSURGERY, V60, P1050, DOI 10.1227/01.NEU.0000255479.90999.C0; Cantu R., 2009, J ATHL TRAINING, V44, P434, DOI [DOI 10.4085/1062-6050-44.4.434, 10.4085/1062-6050-44.4.434]; Cantu RC, 1998, CLIN SPORT MED, V17, P37, DOI 10.1016/S0278-5919(05)70059-4; Cantu RC, 2001, J ATHL TRAINING, V36, P244; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Duarte M, 2008, EXP BRAIN RES, V191, P265, DOI 10.1007/s00221-008-1521-7; Finkelstein E., 2006, INCIDENCE EC BURDEN, DOI [10.1093/acprof:oso/9780195179484.001.0001, DOI 10.1093/ACPROF:OSO/9780195179484.001.0001]; Gao J., 2007, MULTISCALE ANAL COMP; Gao JB, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.016117; Gao JB, 2011, PLOS ONE IN PRESS; Gao JB, 2010, IEEE SIGNAL PROC LET, V17, P237, DOI 10.1109/LSP.2009.2037773; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Guskiewicz KM, 1996, J ATHL TRAINING, V31, P300; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hu J, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/02/P02066; Hunt T, 2010, CLIN SPORT MED, V29, P5, DOI 10.1016/j.csm.2009.09.002; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Mandelbrot B.B, 1982, FRACTAL GEOMETRY NAT; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mrazik M, 2000, BRAIN INJURY, V14, P921, DOI 10.1080/026990500445736; National Center for Injury Prevention and Control, 2003, REP C MILD TRAUM BRA; PENG CK, 1994, PHYS REV E, V49, P1685, DOI 10.1103/PhysRevE.49.1685; Riley MA, 2002, J MOTOR BEHAV, V34, P99, DOI 10.1080/00222890209601934; Slobounov S, 2008, CLIN NEUROPHYSIOL, V119, P281, DOI 10.1016/j.clinph.2007.10.006; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Thurner S, 2002, AUDIOL NEURO-OTOL, V7, P240, DOI 10.1159/000063740; Tung WW, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.046210; Valovich TC, 2003, J ATHL TRAINING, V38, P51	37	45	46	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2011	6	9							e24446	10.1371/journal.pone.0024446	http://dx.doi.org/10.1371/journal.pone.0024446			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CN	21931720	Green Published, Green Submitted, gold			2022-12-25	WOS:000294803100033
J	Henry, M; Stoner, KE				Henry, Mickael; Stoner, Kathryn E.			Relationship between Spatial Working Memory Performance and Diet Specialization in Two Sympatric Nectar Bats	PLOS ONE			English	Article							LONG-NOSED BAT; LEPTONYCTERIS-CURASOAE CHIROPTERA; MUSONYCTERIS-HARRISONI; REPRODUCTIVE SUCCESS; FOREST FRAGMENTATION; POPULATION-DYNAMICS; FEEDING BAT; JALISCO; PHYLLOSTOMIDAE; CONSEQUENCES	Behavioural ecologists increasingly recognise spatial memory as one the most influential cognitive traits involved in evolutionary processes. In particular, spatial working memory (SWM), i.e. the ability of animals to store temporarily useful information for current foraging tasks, determines the foraging efficiency of individuals. As a consequence, SWM also has the potential to influence competitive abilities and to affect patterns of sympatric occurrence among closely related species. The present study aims at comparing the efficiency of SWM between generalist (Glossophaga soricina) and specialist (Leptonycteris yerbabuenae) nectarivorous bats at flowering patches. The two species differ in diet - the generalist diet including seasonally fruits and insects with nectar and pollen while the specialist diet is dominated by nectar and pollen yearlong - and in some morphological traits - the specialist being heavier and with proportionally longer rostrum than the generalist. These bats are found sympatrically within part of their range in the Neotropics. We habituated captive individuals to feed on artificial flower patches and we used infrared video recordings to monitor their ability to remember and avoid the spatial location of flowers they emptied in previous visits in the course of 15-min foraging sequences. Experiments revealed that both species rely on SWM as their foraging success attained significantly greater values than random expectations. However, the nectar specialist L. yerbabuenae was significantly more efficient at extracting nectar (+28% in foraging success), and sustained longer foraging bouts (+27% in length of efficient foraging sequences) than the generalist G. soricina. These contrasting SWM performances are discussed in relation to diet specialization and other life history traits.	[Henry, Mickael] INRA, UMR Abeilles & Environm 406, Avignon, France; [Henry, Mickael; Stoner, Kathryn E.] Univ Nacl Autonoma Mexico, Ctr Invest Ecosistemas, Morelia, Michoacan, Mexico; [Stoner, Kathryn E.] Texas A&M Univ, Dept Biol & Hlth Sci, Kingsville, TX USA	INRAE; Universidad Nacional Autonoma de Mexico; Texas A&M University System; Texas A&M University Kingsville	Henry, M (corresponding author), INRA, UMR Abeilles & Environm 406, Site Agroparc, Avignon, France.	mickael.henry@avignon.inra.fr	Stoner, Kathryn E/E-1510-2015	Stoner, Kathryn E/0000-0002-9964-1697	Universidad Nacional Autonoma de Mexico [IN226007]; Fondation Fyssen, Paris, France	Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico); Fondation Fyssen, Paris, France	This research was funded by a grant to KES from the Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPITT IN226007), Universidad Nacional Autonoma de Mexico, and by a post-doctoral grant to MH from the Fondation Fyssen, Paris, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Bates D., 2008, LME4 LINEAR MIXED EF; Brown C, 2005, BEHAV ECOL, V16, P482, DOI 10.1093/beheco/ari016; Brown MF, 1997, ANIM LEARN BEHAV, V25, P473, DOI 10.3758/BF03209853; Carter GG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010808; Ceballos G, 1997, J MAMMAL, V78, P1220, DOI 10.2307/1383065; Datzmann T, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-165; Dukas R, 2004, ANNU REV ECOL EVOL S, V35, P347, DOI 10.1146/annurev.ecolsys.35.112202.130152; Dukas R, 1998, COGNITIVE ECOLOGY EV; Herrera LG, 2001, J MAMMAL, V82, P352, DOI 10.1644/1545-1542(2001)082&lt;0352:SOPITS&gt;2.0.CO;2; Horner MA, 1998, J ZOOL, V244, P575, DOI 10.1111/j.1469-7998.1998.tb00062.x; Jensen ME, 2005, J EXP BIOL, V208, P4399, DOI 10.1242/jeb.01901; LEMKE TO, 1984, ECOLOGY, V65, P538, DOI 10.2307/1941416; Lott EJ, 1993, OCCASIONAL PAPERS CA, V148, P1; Miron MLL, 2006, J EXP BIOL, V209, P541, DOI 10.1242/jeb.02016; Noguera FA, 2002, HIST NATURAL CHAMELA, P379; Normand E, 2009, ANIM COGN, V12, P797, DOI 10.1007/s10071-009-0239-7; Odling-Smee LC, 2008, BEHAV ECOL SOCIOBIOL, V62, P1935, DOI 10.1007/s00265-008-0625-1; OLTON DS, 1976, J EXP PSYCHOL-ANIM B, V2, P97, DOI 10.1037/0097-7403.2.2.97; Pravosudov VV, 2002, BEHAV NEUROSCI, V116, P515, DOI 10.1037//0735-7044.116.4.515; Quesada M, 2004, BIOTROPICA, V36, P131, DOI 10.1111/j.1744-7429.2004.tb00305.x; Quesada M, 2003, OECOLOGIA, V135, P400, DOI 10.1007/s00442-003-1234-3; R Core Team, 2022, R LANG ENV STAT COMP; Ratcliffe JM, 2009, BEHAV PROCESS, V80, P247, DOI 10.1016/j.beproc.2008.12.010; Rodriguez-Pena N, 2007, J MAMMAL, V88, P1466, DOI 10.1644/06-MAMM-A-353R1.1; Schlumpberger BO, 2009, ANN BOT-LONDON, V103, P1489, DOI 10.1093/aob/mcp075; Stoner KE, 2003, BIODIVERS CONSERV, V12, P357, DOI 10.1023/A:1021963819751; Stoner KE, 2002, BIOTROPICA, V34, P462, DOI 10.1111/j.1744-7429.2002.tb00562.x; Sulikowski D, 2010, BEHAV PROCESS, V83, P31, DOI 10.1016/j.beproc.2009.09.002; Thiele J, 2005, ANIM BEHAV, V69, P315, DOI 10.1016/j.anbehav.2004.05.012; Tschapka M, 2008, J MAMMAL, V89, P924, DOI 10.1644/07-MAMM-A-038.1; VANHELVERSEN O, 1984, OECOLOGIA, V63, P178, DOI 10.1007/BF00379875; Winter Y, 2005, J EXP BIOL, V208, P539, DOI 10.1242/jeb.01416; Winter Y, 2005, J NEUROSCI METH, V141, P283, DOI 10.1016/j.jneumeth.2004.07.002	34	13	13	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2011	6	9							e23773	10.1371/journal.pone.0023773	http://dx.doi.org/10.1371/journal.pone.0023773			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CN	21931612	Green Submitted, gold, Green Published			2022-12-25	WOS:000294803100004
J	Hung, SC; Seitz, AR				Hung, Shao-Chin; Seitz, Aaron R.			Retrograde Interference in Perceptual Learning of a Peripheral Hyperacuity Task	PLOS ONE			English	Article							CONSOLIDATION; DISCRIMINATION	Consolidation, a process that stabilizes memory trace after initial acquisition, has been studied for over a century. A number of studies have shown that a skill or memory must be consolidated after acquisition so that it becomes resistant to interference from new information. Previous research found that training on a peripheral 3-dot hyperacuity task could retrogradely interfere with earlier training on the same task but with a mirrored stimulus configuration. However, a recent study failed to replicate this finding. Here we address the controversy by replicating both patterns of results, however, under different experimental settings. We find that retrograde interference occurs when eye-movements are tightly controlled, using a gaze-contingent display, where the peripheral stimuli were only presented when subjects maintained fixation. On the other hand, no retrograde interference was found in a group of subjects who performed the task without this fixation control. Our results provide a plausible explanation of why divergent results were found for retrograde interference in perceptual learning on the 3-dot hyperacuity task and confirm that retrograde interference can occur in this type of low-level perceptual learning. Furthermore, our results demonstrate the importance of eye-movement controls in studies of perceptual learning in the peripheral visual field.	[Hung, Shao-Chin; Seitz, Aaron R.] Univ Calif Riverside, Dept Psychol, Riverside, CA 92521 USA	University of California System; University of California Riverside	Hung, SC (corresponding author), Univ Calif Riverside, Dept Psychol, Riverside, CA 92521 USA.	aseitz@ucr.edu						Aberg KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014161; Been M, 2010, PERCEPTION, V39, P39; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BrashersKrug T, 1996, NATURE, V382, P252, DOI 10.1038/382252a0; Caithness G, 2004, J NEUROSCI, V24, P8662, DOI 10.1523/JNEUROSCI.2214-04.2004; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; KARNI A, 1991, P NATL ACAD SCI USA, V88, P4966, DOI 10.1073/pnas.88.11.4966; Kuai SG, 2005, NAT NEUROSCI, V8, P1497, DOI 10.1038/nn1546; Mednick S, 2010, J VISION, V10, P1122; Muller G. E., 1900, Z PSYCHOLOGIE, V1, P1; Osu R, 2004, NAT NEUROSCI, V7, P111, DOI 10.1038/nn1184; Otto TU, 2006, VISION RES, V46, P3223, DOI 10.1016/j.visres.2006.03.021; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Petrov AA, 2005, PSYCHOL REV, V112, P715, DOI 10.1037/0033-295X.112.4.715; Seitzt AR, 2005, P NATL ACAD SCI USA, V102, P14895, DOI 10.1073/pnas.0505765102; Shadmehr R, 1997, J NEUROSCI, V17, P409, DOI 10.1523/JNEUROSCI.17-01-00409.1997; Sotiropoulos G, 2011, VISION RES, V51, P585, DOI 10.1016/j.visres.2011.02.004; Tartaglia EM, 2009, VISION RES, V49, P1420, DOI 10.1016/j.visres.2009.02.013; Walker MP, 2003, NATURE, V425, P616, DOI 10.1038/nature01930; Yotsumoto Y, 2009, VISION RES, V49, P2611, DOI 10.1016/j.visres.2009.08.001; Yu C, 2004, J VISION, V4, P169, DOI 10.1167/4.3.4; Zhang JY, 2008, PLOS BIOL, V6, P1651, DOI 10.1371/journal.pbio.0060197	22	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2011	6	9							e24556	10.1371/journal.pone.0024556	http://dx.doi.org/10.1371/journal.pone.0024556			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	819CN	21931753	Green Published, gold			2022-12-25	WOS:000294803100041
J	Higuchi, MKK; Fornari, J; Del Ben, CM; Graeff, FG; Leite, JP				Kodama Higuchi, Marcia K.; Fornari, Jose; Del Ben, Cristina M.; Graeff, Frederico G.; Leite, Joao Pereira			Reciprocal Modulation of Cognitive and Emotional Aspects in Pianistic Performances	PLOS ONE			English	Article							MUSIC PERFORMANCE; NEGATIVE EMOTION; COMMUNICATION; AMYGDALA; ACQUISITION; SUPPRESSION; PERCEPTION; ATTENTION; RESPONSES; SYSTEMS	Background: High level piano performance requires complex integration of perceptual, motor, cognitive and emotive skills. Observations in psychology and neuroscience studies have suggested reciprocal inhibitory modulation of the cognition by emotion and emotion by cognition. However, it is still unclear how cognitive states may influence the pianistic performance. The aim of the present study is to verify the influence of cognitive and affective attention in the piano performances. Methods and Findings: Nine pianists were instructed to play the same piece of music, firstly focusing only on cognitive aspects of musical structure (cognitive performances), and secondly, paying attention solely on affective aspects (affective performances). Audio files from pianistic performances were examined using a computational model that retrieves nine specific musical features (descriptors) - loudness, articulation, brightness, harmonic complexity, event detection, key clarity, mode detection, pulse clarity and repetition. In addition, the number of volunteers' errors in the recording sessions was counted. Comments from pianists about their thoughts during performances were also evaluated. The analyses of audio files throughout musical descriptors indicated that the affective performances have more: agogics, legatos, pianos phrasing, and less perception of event density when compared to the cognitive ones. Error analysis demonstrated that volunteers misplayed more left hand notes in the cognitive performances than in the affective ones. Volunteers also played more wrong notes in affective than in cognitive performances. These results correspond to the volunteers' comments that in the affective performances, the cognitive aspects of piano execution are inhibited, whereas in the cognitive performances, the expressiveness is inhibited. Conclusions: Therefore, the present results indicate that attention to the emotional aspects of performance enhances expressiveness, but constrains cognitive and motor skills in the piano execution. In contrast, attention to the cognitive aspects may constrain the expressivity and automatism of piano performances.	[Kodama Higuchi, Marcia K.; Del Ben, Cristina M.; Graeff, Frederico G.; Leite, Joao Pereira] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Neurosci & Behav, BR-14049 Ribeirao Preto, Brazil; [Fornari, Jose] Univ Estadual Campinas, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas	Higuchi, MKK (corresponding author), Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Neurosci & Behav, BR-14049 Ribeirao Preto, Brazil.	jpleite@fmrp.usp.br	Leite, Joao/B-9070-2012; Del-Ben, Cristina M/F-1817-2012; Fornari, José E/R-7163-2018	Leite, Joao/0000-0003-0558-3519; Del-Ben, Cristina M/0000-0003-0145-9975; Graeff, Frederico/0000-0002-0746-3118	Brazilian government research agency: Fundacao de Apoio a Pesquisa do Estado de Sao Paulo (FAPESP) [08/54844-7, 07/59826-4]	Brazilian government research agency: Fundacao de Apoio a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	The authors would like to emphasize that this study was conducted in the University of Sao Paulo School of Medicine at Ribeirao Preto, and received funding for research from Brazilian government research agency: Fundacao de Apoio a Pesquisa do Estado de Sao Paulo (FAPESP), grant numbers 08/54844-7, 07/59826-4. Fapesp URL: http://www.fapesp.br/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bharucha JJ, 2006, COGNITION, V100, P131, DOI 10.1016/j.cognition.2005.11.008; Blair KS, 2007, NEUROIMAGE, V35, P430, DOI 10.1016/j.neuroimage.2006.11.048; BRATTICO E, BIOL PSYCHOL, V85, P393; Chaffin R, 2010, PSYCHOL MUSIC, V38, P3, DOI 10.1177/0305735608100377; Darwin Ch, 2000, EXPRESSAO EMOCOES HO; Drake C, 2000, COGNITION, V74, P1, DOI 10.1016/S0010-0277(99)00061-X; Droit-Volet S, 2007, TRENDS COGN SCI, V11, P504, DOI 10.1016/j.tics.2007.09.008; Eigeldinger Jacques, 1986, CHOPIN PIANIST TEACH; Ekman Paul, 1973, DARWIN FACIAL EXPRES; FORNARI J, 2009, PURSUIT HAPPINESS MU; FORNARI J, 2008, 10 INT C MUS PERC CO; GAINZA VH, ESTUDOS PSICOLOGIA M; Goleman D., 2012, INTELIGENCIA EMOCION; GRINDEA C, 2001, EUROPEAN J PIANISTS, P29; HIGUCHI MKK, 2007, 17 C ANPPOM 2007 SAO; JUSLIN JNL, 2010, HDB MUSIC EMOTION; JUSLIN Patrik, 2005, MUSIC EMOTION THEORY; Juslin PN, 2008, BEHAV BRAIN SCI, V31, P559, DOI 10.1017/S0140525X08005293; Juslin PN, 2006, J EXP PSYCHOL-APPL, V12, P79, DOI 10.1037/1076-898X.12.2.79; Juslin PN, 2000, J EXP PSYCHOL HUMAN, V26, P1797, DOI 10.1037//0096-1523.26.6.1797; Juslin PN, 1997, MUSIC PERCEPT, V14, P383; Karlsson J, 2008, PSYCHOL MUSIC, V36, P309, DOI 10.1177/0305735607086040; Kompus K, 2009, NEUROSCI LETT, V467, P76, DOI 10.1016/j.neulet.2009.10.005; Lartillot O., 2008, INT C MUS INF; LARTILLOT O, 2008, 9 INT C MUS INF RETR; LeDoux J. E., 1996, EMOTIONAL BRAIN MYST; Levesque J, 2003, BIOL PSYCHIAT, V53, P502, DOI 10.1016/S0006-3223(02)01817-6; McNevin NH, 2003, PSYCHOL RES-PSYCH FO, V67, P22, DOI 10.1007/s00426-002-0093-6; Meyer L., 1956, EMOTION MEANING MUSI; Northoff G, 2004, HUM BRAIN MAPP, V21, P202, DOI 10.1002/hbm.20002; Ochsner KN, 2008, CURR DIR PSYCHOL SCI, V17, P153, DOI 10.1111/j.1467-8721.2008.00566.x; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; Ohira H, 2006, NEUROIMAGE, V29, P721, DOI 10.1016/j.neuroimage.2005.08.047; Packard MG, 2004, NEUROBIOL LEARN MEM, V82, P243, DOI 10.1016/j.nlm.2004.06.008; Pallesen KJ, 2005, ANN NY ACAD SCI, V1060, P450, DOI 10.1196/annals.1360.047; Pallesen KJ, 2009, J COGNITIVE NEUROSCI, V21, P1065, DOI 10.1162/jocn.2009.21086; Palmer C, 1997, ANNU REV PSYCHOL, V48, P115, DOI 10.1146/annurev.psych.48.1.115; Palmer C, 1997, CAN J EXP PSYCHOL, V51, P369, DOI 10.1037/1196-1961.51.4.369; Palmer C, 2000, PSYCHOL SCI, V11, P63, DOI 10.1111/1467-9280.00216; Parsons LM, 2005, NEUROPSYCHOLOGIA, V43, P199, DOI 10.1016/j.neuropsychologia.2004.11.007; Pereira MG, 2010, COGN AFFECT BEHAV NE, V10, P94, DOI 10.3758/CABN.10.1.94; Peretz I, 2003, NAT NEUROSCI, V6, P688, DOI 10.1038/nn1083; Pessoa L, 2005, NEUROIMAGE, V28, P249, DOI 10.1016/j.neuroimage.2005.05.048; SLOBODA J, 2003, MUSICAL BEGINNINGS O; Sloboda JA, 2000, TRENDS COGN SCI, V4, P397, DOI 10.1016/S1364-6613(00)01531-X; Sloboda John, 2004, MUSICAL MIND COGNITI; Sloboda John A., 2005, EXPLORING MUSICAL MI; Snyder B, 2000, MUSIC AND MEMORY; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Wingard JC, 2008, BEHAV BRAIN RES, V193, P126, DOI 10.1016/j.bbr.2008.05.002; Wulf G, 2001, Q J EXP PSYCHOL-A, V54, P1143, DOI 10.1080/02724980143000118	51	3	3	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2011	6	9							e24437	10.1371/journal.pone.0024437	http://dx.doi.org/10.1371/journal.pone.0024437			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	819CN	21931716	Green Published, gold, Green Submitted			2022-12-25	WOS:000294803100031
J	Pietsch, SJ; Hobson, KA; Wassenaar, LI; Tutken, T				Pietsch, Stephanie J.; Hobson, Keith A.; Wassenaar, Leonard I.; Tuetken, Thomas			Tracking Cats: Problems with Placing Feline Carnivores on delta O-18, delta D Isoscapes	PLOS ONE			English	Article							STABLE-ISOTOPE RATIOS; OXYGEN ISOTOPES; BONE PHOSPHATE; AMINO-ACIDS; HUMAN HAIR; HYDROGEN ISOTOPES; BODY-WATER; MIGRATORY CONNECTIVITY; SPATIAL-DISTRIBUTION; DRINKING-WATER	Background: Several felids are endangered and threatened by the illegal wildlife trade. Establishing geographic origin of tissues of endangered species is thus crucial for wildlife crime investigations and effective conservation strategies. As shown in other species, stable isotope analysis of hydrogen and oxygen in hair (delta D-h, delta O-18(h)) can be used as a tool for provenance determination. However, reliably predicting the spatial distribution of delta D-h and delta O-18(h) requires confirmation from animal tissues of known origin and a detailed understanding of the isotopic routing of dietary nutrients into felid hair. Methodology/Findings: We used coupled delta D-h and delta O-18(h) measurements from the North American bobcat (Lynx rufus) and puma (Puma concolor) with precipitation-based assignment isoscapes to test the feasibility of isotopic geo-location of felidae. Hairs of felid and rabbit museum specimens from 75 sites across the United States and Canada were analyzed. Bobcat and puma lacked a significant correlation between H/O isotopes in hair and local waters, and also exhibited an isotopic decoupling of delta O-18(h) and delta D-h. Conversely, strong delta D and delta O-18 coupling was found for key prey, eastern cottontail rabbit (Sylvilagus floridanus; hair) and white-tailed deer (Odocoileus virginianus; collagen, bone phosphate). Conclusions/Significance: Puma and bobcat hairs do not adhere to expected pattern of H and O isotopic variation predicted by precipitation isoscapes for North America. Thus, using bulk hair, felids cannot be placed on delta O-18 and delta D isoscapes for use in forensic investigations. The effective application of isotopes to trace the provenance of feline carnivores is likely compromised by major controls of their diet, physiology and metabolism on hair delta O-18 and delta D related to body water budgets. Controlled feeding experiments, combined with single amino acid isotope analysis of diets and hair, are needed to reveal mechanisms and physiological traits explaining why felid hair does not follow isotopic patterns demonstrated in many other taxa.	[Pietsch, Stephanie J.] Univ Bonn, Zool Forschungsmuseum Alexander Koenig, D-5300 Bonn, Germany; [Hobson, Keith A.; Wassenaar, Leonard I.] Environm Canada, Saskatoon, SK, Canada; [Tuetken, Thomas] Univ Bonn, Steinmann Inst Geol Mineral & Palaontol, D-5300 Bonn, Germany	University of Bonn; Zoologisches Forschungsmuseum Alexander Koenig (ZFMK); Environment & Climate Change Canada; University of Bonn	Pietsch, SJ (corresponding author), Univ Bonn, Zool Forschungsmuseum Alexander Koenig, D-5300 Bonn, Germany.	feliden.zfmk@googlemail.com	Wassenaar, Leonard/AAY-7081-2020; Hobson, Keith/Q-9306-2019; Tütken, Thomas/E-4988-2010; Wassenaar, Leonard I/B-5996-2013	Wassenaar, Leonard/0000-0001-5532-0771; Tutken, Thomas/0000-0002-2590-8600	Deutsche Forschungsgemeinschaft [TU 148/2-1]; Deutscher Akademischer Austausch Dienst	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutscher Akademischer Austausch Dienst(Deutscher Akademischer Austausch Dienst (DAAD))	This study was funded by the Deutsche Forschungsgemeinschaft grant TU 148/2-1 Emmy Noether-Group Bone Geochemistry to TT and by a Deutscher Akademischer Austausch Dienst PROMOS Foreign Exchange Grant to SP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS T, 1966, J APPL PHYSIOL, V21, P1004, DOI 10.1152/jappl.1966.21.3.1004; ANDERSON RS, 1982, J SMALL ANIM PRACT, V23, P588, DOI 10.1111/j.1748-5827.1982.tb02519.x; Arnay-De-La-Rosa M, 2010, J ARCHAEOL SCI, V37, P1490, DOI 10.1016/j.jas.2010.01.009; AYLIFFE LK, 1990, GEOCHIM COSMOCHIM AC, V54, P2603, DOI 10.1016/0016-7037(90)90246-H; Baillie J.E.M., 2004, IUCN RED LIST THREAT; BAKER KP, 1974, BRIT VET J, V130, P327, DOI 10.1016/S0007-1935(17)35835-9; Birchall J, 2005, J ANIM ECOL, V74, P877, DOI 10.1111/j.1365-2656.2005.00979.x; Bowen GJ, 2007, WATER RESOUR RES, V43, DOI 10.1029/2006WR005186; Bowen GJ, 2009, AM J PHYS ANTHROPOL, V139, P494, DOI 10.1002/ajpa.21008; Bowen GJ, 2005, OECOLOGIA, V143, P337, DOI 10.1007/s00442-004-1813-y; Bowen GJ, 2003, WATER RESOUR RES, V39, DOI 10.1029/2003WR002086; Bowen GJ, 2002, GEOLOGY, V30, P315, DOI 10.1130/0091-7613(2002)030<0315:SDOOIM>2.0.CO;2; Bryant JD, 1996, GEOCHIM COSMOCHIM AC, V60, P5145; BRYANT JD, 1995, GEOCHIM COSMOCHIM AC, V59, P4523; Buchardt B, 2007, CHEM GEOL, V244, P316, DOI 10.1016/j.chemgeo.2007.06.022; Chesson LA, 2008, J AGR FOOD CHEM, V56, P4084, DOI 10.1021/jf0733618; Chesson LA, 2010, J AGR FOOD CHEM, V58, P7311, DOI 10.1021/jf1003539; Chew R. M., 1965, PHYSL MAMMALOGY, V2, P43; COHEN JE, 1994, PHILOS T R SOC B, V343, P57, DOI 10.1098/rstb.1994.0008; COMMERFORD SL, 1983, RADIAT RES, V94, P151, DOI 10.2307/3575870; Coplen T, 2000, STABLE HYDROGEN OXYG, DOI [10.3133/ofr00160, DOI 10.3133/OFR00160]; CORMIE AB, 1994, GEOCHIM COSMOCHIM AC, V58, P3439, DOI 10.1016/0016-7037(94)90097-3; Covington AD, 1997, CHEM SOC REV, V26, P111, DOI 10.1039/cs9972600111; Cryan PM, 2004, J MAMMAL, V85, P995, DOI 10.1644/BRG-202; DANGELA D, 1990, CHEM GEOL, V86, P75, DOI 10.1016/0168-9622(90)90007-Y; DANSGAARD W, 1964, TELLUS, V16, P436; Daux V, 2008, J HUM EVOL, V55, P1138, DOI 10.1016/j.jhevol.2008.06.006; del Rio CM, 2009, BIOL REV, V84, P91, DOI 10.1111/j.1469-185X.2008.00064.x; DENIRO MJ, 1981, SCIENCE, V214, P1374, DOI 10.1126/science.7313700; DORIS PA, 1981, J APPL PHYSIOL, V51, P46, DOI 10.1152/jappl.1981.51.1.46; Dutton A, 2005, HYDROL PROCESS, V19, P4121, DOI 10.1002/hyp.5876; Ehleringer JR, 2008, P NATL ACAD SCI USA, V105, P2788, DOI 10.1073/pnas.0712228105; EPSTEIN S, 1977, SCIENCE, V198, P1209, DOI 10.1126/science.198.4323.1209; ESTEP MF, 1980, GEOCHIM COSMOCHIM AC, V44, P1197, DOI 10.1016/0016-7037(80)90073-3; FARQUHAR GD, 1993, NATURE, V363, P439, DOI 10.1038/363439a0; Fraser I, 2006, RAPID COMMUN MASS SP, V20, P1109, DOI 10.1002/rcm.2424; Frasert I, 2007, RAPID COMMUN MASS SP, V21, P3279, DOI 10.1002/rcm.3209; GAEBLER OH, 1966, CAN J BIOCHEM CELL B, V44, P1249, DOI 10.1139/o66-142; Galbraith H, 1998, P NUTR SOC, V57, P195, DOI 10.1079/PNS19980032; GIBSON RA, 1981, LANCET, V1, P1100; Gretebeck RJ, 1997, J APPL PHYSIOL, V82, P563, DOI 10.1152/jappl.1997.82.2.563; HARE PE, 1991, J ARCHAEOL SCI, V18, P277; Henaux V, 2011, METHODS ECOLOGY EVOL, V2; Hendriks WH, 1999, J ANIM PHYSIOL AN N, V82, P94, DOI 10.1111/j.1439-0396.1999.00214.x; Hendriks WH, 1998, ANIM SCI, V67, P165, DOI 10.1017/S1357729800009905; Hobson KA, 2005, AUK, V122, P1037, DOI 10.1642/0004-8038(2005)122[1037:SIATDO]2.0.CO;2; Hobson KA, 2004, OECOLOGIA, V141, P477, DOI 10.1007/s00442-004-1671-7; Hobson KA, 2008, TERR ECOL SER, V2, P1; Hobson KA, 1999, P NATL ACAD SCI USA, V96, P8003, DOI 10.1073/pnas.96.14.8003; Hobson KA, 1999, OECOLOGIA, V120, P314, DOI 10.1007/s004420050865; Homberger DG, 2009, J ANAT, V214, P620, DOI 10.1111/j.1469-7580.2009.01068.x; HUERTAS AD, 1995, GEOCHIM COSMOCHIM AC, V59, P4299; IRIARTE JA, 1990, OECOLOGIA, V85, P185, DOI 10.1007/BF00319400; Jackson P., 1996, BIOL CONSERVATION; JOHNSON CN, 1986, OECOLOGIA, V69, P626, DOI 10.1007/BF00410373; Kane E., 1981, Nutrition Research, V1, P499, DOI 10.1016/S0271-5317(81)80053-X; Karasov W. H., 2007, PHYSL ECOLOGY ANIMAL; Kennedy CD, 2011, FORENSIC SCI INT, V208, P156, DOI 10.1016/j.forsciint.2010.11.021; KIENZLE E, 1993, J ANIM PHYSIOL AN N, V69, P92, DOI 10.1111/j.1439-0396.1993.tb00793.x; KIRK CA, 2000, SMALL ANIMAL CLIN NU, P291; Kirsanow K, 2011, PALAEOGEOGR IN PRESS; KITCHENER A., 1991, NATURAL HIST WILD CA; Kohn MJ, 1996, GEOCHIM COSMOCHIM AC, V60, P4811, DOI 10.1016/S0016-7037(96)00240-2; KROMHOUT D, 2005, CORONARY HEART DIS E, P264; Lariviere Serge, 1997, Mammalian Species, V563, P1, DOI 10.2307/3504533; LEES S, 1986, INT J BIOL MACROMOL, V8, P66, DOI 10.1016/0141-8130(86)90001-2; LEGRANDDEFRETIN V, 1994, P NUTR SOC, V53, P15, DOI 10.1079/PNS19940004; Levin NE, 2006, P NATL ACAD SCI USA, V103, P11201, DOI 10.1073/pnas.0604719103; Levinson A.A., 1987, APPL GEOCHEM, V2, P367, DOI DOI 10.1016/0883-2927(87)90021-7; Lindzey F., 1987, P656; LONGINELLI A, 1984, GEOCHIM COSMOCHIM AC, V48, P385, DOI 10.1016/0016-7037(84)90259-X; Lott CA, 2003, OECOLOGIA, V134, P505, DOI 10.1007/s00442-002-1153-8; LUZ B, 1990, GEOCHIM COSMOCHIM AC, V54, P1723, DOI 10.1016/0016-7037(90)90403-8; LUZ B, 1985, EARTH PLANET SC LETT, V75, P29, DOI 10.1016/0012-821X(85)90047-0; LUZ B, 1984, GEOCHIM COSMOCHIM AC, V48, P1689, DOI 10.1016/0016-7037(84)90338-7; Luz B., 1989, Applied Geochemistry, V4, P317, DOI 10.1016/0883-2927(89)90035-8; MACDONALD ML, 1984, ANNU REV NUTR, V4, P521, DOI 10.1146/annurev.nu.04.070184.002513; MACKO SA, 1987, CHEM GEOL, V65, P79, DOI 10.1016/0168-9622(87)90064-9; Masud Z, 1999, J AGR FOOD CHEM, V47, P4693, DOI 10.1021/jf9900027; McCullagh JSO, 2005, RAPID COMMUN MASS SP, V19, P3227, DOI 10.1002/rcm.2150; McKechnie AE, 2004, OECOLOGIA, V140, P191, DOI 10.1007/s00442-004-1564-9; McNab BK, 2000, CAN J ZOOL, V78, P2227, DOI 10.1139/cjz-78-12-2227; MCNAB BK, 1986, ECOL MONOGR, V56, P1, DOI 10.2307/2937268; Meehan TD, 2003, CONDOR, V105, P567, DOI 10.1650/7283; Mellanby K, 1942, NATURE, V150, P21, DOI 10.1038/150021a0; MORRIS JG, 1985, J NUTR, V115, P524, DOI 10.1093/jn/115.4.524; Nielson KE, 2010, GEOCHIM COSMOCHIM AC, V74, P1812, DOI 10.1016/j.gca.2009.12.025; O'Brien DM, 2007, RAPID COMMUN MASS SP, V21, P2422, DOI 10.1002/rcm.3108; O'Connell TC, 2001, J ARCHAEOL SCI, V28, P1247, DOI 10.1006/jasc.2001.0698; O'Grady SP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011699; Pecquerie L, 2010, PHILOS T R SOC B, V365, P3455, DOI 10.1098/rstb.2010.0097; Pequignot A, 2006, COLLECTION FORUM, V21; Petzke KJ, 2010, CURR OPIN CLIN NUTR, V13, P532, DOI 10.1097/MCO.0b013e32833c3c84; Podlesak DW, 2008, GEOCHIM COSMOCHIM AC, V72, P19, DOI 10.1016/j.gca.2007.10.003; Raghavan M, 2010, RAPID COMMUN MASS SP, V24, P541, DOI 10.1002/rcm.4398; Reynard LM, 2008, J ARCHAEOL SCI, V35, P1934, DOI 10.1016/j.jas.2007.12.004; Rozanski K., 1993, CLIMATE CHANGE CONTI, V78, P1, DOI DOI 10.1029/GM078P0001; RYDER ML, 1976, RES VET SCI, V21, P280, DOI 10.1016/S0034-5288(18)33336-8; Sandell M., 1989, P164; SCHIMMELMANN A, 1986, GEOCHIM COSMOCHIM AC, V50, P1485, DOI 10.1016/0016-7037(86)90322-4; SCHMIDTNIELSEN K, 1952, PHYSIOL REV, V32, P135, DOI 10.1152/physrev.1952.32.2.135; SCHOELLER DA, 1986, AM J PHYSIOL, V251, pR1137, DOI 10.1152/ajpregu.1986.251.6.R1137; Sharp ZD, 2003, J ARCHAEOL SCI, V30, P1709, DOI 10.1016/S0305-4403(03)00071-2; Smith AD, 2008, CONDOR, V110, P500, DOI 10.1525/cond.2008.8515; SMITH BN, 1970, PLANT PHYSIOL, V46, P738, DOI 10.1104/pp.46.5.738; Symes CT, 2010, BIRD CONSERV INT, V20, P134, DOI 10.1017/S0959270910000237; Takeda H, 2001, INT J RADIAT BIOL, V77, P375, DOI 10.1080/09553000010017117; TATNER P, 1988, J THEOR BIOL, V133, P267, DOI 10.1016/S0022-5193(88)80321-7; Thompson AH, 2010, AM J PHYS ANTHROPOL, V141, P440, DOI 10.1002/ajpa.21162; Tuross N, 2008, RAPID COMMUN MASS SP, V22, P1741, DOI 10.1002/rcm.3556; Wallach AD, 2007, CAN J ZOOL, V85, P1182, DOI 10.1139/Z07-098; Wang YV, 2009, OECOLOGIA, V160, P225, DOI 10.1007/s00442-009-1303-3; Warinner C, 2010, AM J PHYS ANTHROPOL, V141, P486, DOI 10.1002/ajpa.21222; Wassenaar LI, 2003, ISOT ENVIRON HEALT S, V39, P211, DOI 10.1080/1025601031000096781; West JB, 2010, ISOSCAPES: UNDERSTANDING MOVEMENT, PATTERN, AND PROCESS ON EARTH THROUGH ISOTOPE MAPPING, P1, DOI 10.1007/978-90-481-3354-3; Wolf N, 2011, J EXP BIOL, V214, P98, DOI 10.1242/jeb.050211; WONG WW, 1988, AM J CLIN NUTR, V47, P1; Zoran DL, 2002, J AM VET MED ASSOC, V221, P1559, DOI 10.2460/javma.2002.221.1559	118	46	46	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2011	6	9							e24601	10.1371/journal.pone.0024601	http://dx.doi.org/10.1371/journal.pone.0024601			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CN	21931770	Green Published, gold, Green Submitted			2022-12-25	WOS:000294803100046
J	Rotundo, IL; Faraso, S; De Leonibus, E; Nigro, G; Vitiello, C; Lancioni, A; Di Napoli, D; Castaldo, S; Russo, V; Russo, F; Piluso, G; Auricchio, A; Nigro, V				Rotundo, Ida Luisa; Faraso, Stefania; De Leonibus, Elvira; Nigro, Gerardo; Vitiello, Carmen; Lancioni, Alessio; Di Napoli, Daniele; Castaldo, Sigismondo; Russo, Vincenzo; Russo, Fabio; Piluso, Giulio; Auricchio, Alberto; Nigro, Vincenzo			Worsening of Cardiomyopathy Using Deflazacort in an Animal Model Rescued by Gene Therapy	PLOS ONE			English	Article							GIRDLE MUSCULAR-DYSTROPHY; DELTA-SARCOGLYCAN GENE; DUCHENNE DYSTROPHY; PREDNISONE; MUTATION; IDENTIFICATION; EXPRESSION; HAMSTERS; VECTORS; DISEASE	We have previously demonstrated that gene therapy can rescue the phenotype and extend lifespan in the delta-sarcoglycan deficient cardiomyopathic hamster. In patients with similar genetic defects, steroids have been largely used to slow down disease progression. Aim of our study was to evaluate the combined effects of steroid treatment and gene therapy on cardiac function. We injected the human delta-sarcoglycan cDNA by adeno-associated virus (AAV) 2/8 by a single intraperitoneal injection into BIO14.6 Syrian hamsters at ten days of age to rescue the phenotype. We then treated the hamsters with deflazacort. Treatment was administered to half of the hamsters that had received the AAV and the other hamsters without AAV, as well as to normal hamsters. Both horizontal and vertical activities were greatly enhanced by deflazacort in all groups. As in previous experiments, the AAV treatment alone was able to preserve the ejection fraction (70 +/- 7% EF). However, the EF value declined (52 +/- 14%) with a combination of AAV and deflazacort. This was similar with all the other groups of affected animals. We confirm that gene therapy improves cardiac function in the BIO14.6 hamsters. Our results suggest that deflazacort is ineffective and may also have a negative impact on the cardiomyopathy rescue, possibly by boosting motor activity. This is unexpected and may have significance in terms of the lifestyle recommendations for patients.	[Rotundo, Ida Luisa; Faraso, Stefania; De Leonibus, Elvira; Vitiello, Carmen; Lancioni, Alessio; Russo, Fabio; Auricchio, Alberto; Nigro, Vincenzo] Telethon Inst Genet & Med, Naples, Italy; [De Leonibus, Elvira] CNR, Inst Genet & Biophys, I-80125 Naples, Italy; [Nigro, Gerardo; Russo, Vincenzo] Univ Naples 2, AO Monaldi, Naples, Italy; [Di Napoli, Daniele; Castaldo, Sigismondo] Osped A Cardarelli, Ctr Biotechnol, Naples, Italy; [Piluso, Giulio; Nigro, Vincenzo] Univ Naples 2, Med Genet Lab, Dipartimento Patol Gen, Naples, Italy; [Piluso, Giulio; Nigro, Vincenzo] Univ Naples 2, CIRM, Naples, Italy; [Auricchio, Alberto] Univ Naples Federico II, Dipartimento Pediat, Naples, Italy	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); Universita della Campania Vanvitelli; Antonio Cardarelli Hospital; Universita della Campania Vanvitelli; Universita della Campania Vanvitelli; University of Naples Federico II	Rotundo, IL (corresponding author), Telethon Inst Genet & Med, Naples, Italy.	nigro@tigem.it	PILUSO, Giulio/AAA-3400-2019; AURICCHIO, Alberto/AHE-7979-2022; De Leonibus, Elvira/AAY-5411-2020; Piluso, Giulio/AAA-3661-2019; Nigro, Vincenzo/AAB-2274-2022; Russo, Vincenzo/ABH-1766-2020	PILUSO, Giulio/0000-0001-9418-125X; AURICCHIO, Alberto/0000-0002-0832-2472; Russo, Vincenzo/0000-0002-9227-0360; Nigro, Vincenzo/0000-0002-3378-5006	Telethon, Italy [TIGEM-TNP42TELC, GTB07001]; TECHGENE [FP7/2007-2013, 223143]; Ministero della Salute [RF-MUL-2007-666195]	Telethon, Italy(Fondazione Telethon); TECHGENE; Ministero della Salute(Ministry of Health, Italy)	This study was supported by grants from Telethon, Italy (TIGEM-TNP42TELC and GTB07001), from FP7/2007-2013 under grant agreement nu 223143 (project acronym: TECHGENE), and from Ministero della Salute (Ricerca Finalizzata RF-MUL-2007-666195). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JE, 2000, CELL TRANSPLANT, V9, P551, DOI 10.1177/096368970000900411; ANGELINI C, 1994, MUSCLE NERVE, V17, P386, DOI 10.1002/mus.880170405; Angelini C, 2007, MUSCLE NERVE, V36, P424, DOI 10.1002/mus.20812; Bauer R, 2008, CARDIOVASC RES, V79, P652, DOI 10.1093/cvr/cvn131; Bauer R, 2010, NEUROMUSCULAR DISORD, V20, P21, DOI 10.1016/j.nmd.2009.10.003; Bonifati MD, 2000, MUSCLE NERVE, V23, P1344, DOI 10.1002/1097-4598(200009)23:9<1344::AID-MUS4>3.3.CO;2-6; Bushby K, 2010, LANCET NEUROL, V9, P77, DOI 10.1016/S1474-4422(09)70271-6; Chao HJ, 2000, MOL THER, V2, P619, DOI 10.1006/mthe.2000.0219; Frosk P, 2004, NEUROMUSCULAR DISORD, V14, P579; Gao GP, 2000, HUM GENE THER, V11, P2079, DOI 10.1089/104303400750001390; Gao GP, 2002, P NATL ACAD SCI USA, V99, P11854, DOI 10.1073/pnas.182412299; GRIGGS RC, 1991, ARCH NEUROL-CHICAGO, V48, P383, DOI 10.1001/archneur.1991.00530160047012; Heydemann A, 2007, TRENDS CARDIOVAS MED, V17, P55, DOI 10.1016/j.tcm.2006.12.002; HOMBURGER F, 1962, ARCH INTERN MED, V110, P660, DOI 10.1001/archinte.1962.03620230106015; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; Jacobs SCJM, 1996, J NEUROL, V243, P410, DOI 10.1007/BF00869001; Judge L M, 2005, Acta Myol, V24, P184; Karkkainen S, 2003, J MOL MED-JMM, V81, P795, DOI 10.1007/s00109-003-0480-5; KISSEL JT, 1991, NEUROLOGY, V41, P667, DOI 10.1212/WNL.41.5.667; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Manzur AY, 2009, J NEUROL NEUROSUR PS, V80, P706, DOI 10.1136/jnnp.2008.158329; Markham LW, 2005, PEDIATR CARDIOL, V26, P768, DOI 10.1007/s00246-005-0909-4; Marques MJ, 2009, MUSCLE NERVE, V40, P466, DOI 10.1002/mus.21341; Mendell JR, 2010, ANN NEUROL, V68, P629, DOI 10.1002/ana.22251; Moreira ES, 1998, J MED GENET, V35, P951, DOI 10.1136/jmg.35.11.951; Muntoni F, 2002, NEUROMUSCULAR DISORD, V12, pS162, DOI 10.1016/S0960-8966(02)00101-3; NIGRO G, 1990, INT J CARDIOL, V26, P271, DOI 10.1016/0167-5273(90)90082-G; Nigro V, 1996, HUM MOL GENET, V5, P1179, DOI 10.1093/hmg/5.8.1179; Nigro V, 1997, HUM MOL GENET, V6, P601, DOI 10.1093/hmg/6.4.601; Nigro V, 1996, NAT GENET, V14, P195, DOI 10.1038/ng1096-195; Ozawa E, 2005, MUSCLE NERVE, V32, P563, DOI 10.1002/mus.20349; PASQUINI F, 1995, NEUROMUSCULAR DISORD, V5, P105, DOI 10.1016/0960-8966(94)00042-8; Politano L, 1996, JAMA-J AM MED ASSOC, V275, P1335, DOI 10.1001/jama.275.17.1335; Politano L, 2001, NEUROMUSCULAR DISORD, V11, P178, DOI 10.1016/S0960-8966(00)00174-7; RIFAI Z, 1995, AM J PHYSIOL-ENDOC M, V268, pE67, DOI 10.1152/ajpendo.1995.268.1.E67; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; Sandona D, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001203; Silversides CK, 2003, AM J CARDIOL, V91, P769, DOI 10.1016/S0002-9149(02)03429-X; Tsubata S, 2000, J CLIN INVEST, V106, P655, DOI 10.1172/JCI9224; Vainzof M, 1996, HUM MOL GENET, V5, P1963, DOI 10.1093/hmg/5.12.1963; Vandebrouck C, 1999, NEUROSCI LETT, V269, P110, DOI 10.1016/S0304-3940(99)00418-8; Vitiello C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005051; Yiu EM, 2008, NEUROL INDIA, V56, P236; Yoshida M, 1997, FEBS LETT, V403, P143, DOI 10.1016/S0014-5793(97)00040-9; Zhu T, 2005, CIRCULATION, V112, P2650, DOI 10.1161/CIRCULATIONAHA.105.565598	45	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2011	6	9							e24729	10.1371/journal.pone.0024729	http://dx.doi.org/10.1371/journal.pone.0024729			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CN	21931833	Green Submitted, gold, Green Published			2022-12-25	WOS:000294803100062
J	Zhendre, V; Grelard, A; Garnier-LHomme, M; Buchoux, S; Larijani, B; Dufourc, EJ				Zhendre, Vanessa; Grelard, Axelle; Garnier-LHomme, Marie; Buchoux, Sebastien; Larijani, Banafshe; Dufourc, Erick J.			Key Role of Polyphosphoinositides in Dynamics of Fusogenic Nuclear Membrane Vesicles	PLOS ONE			English	Article							SOLID-STATE H-2-NMR; MAGNETIC-RESONANCE; NMR; FUSION; PHOSPHATIDYLINOSITOL; BINDING; PIP2; PHOSPHOLIPIDS; BIOMEMBRANES; CHOLESTEROL	The role of phosphoinositides has been thoroughly described in many signalling and membrane trafficking events but their function as modulators of membrane structure and dynamics in membrane fusion has not been investigated. We have reconstructed models that mimic the composition of nuclear envelope precursor membranes with naturally elevated amounts of phosphoinositides. These fusogenic membranes (membrane vesicle 1(MV1) and nuclear envelope remnants (NER) are critical for the assembly of the nuclear envelope. Phospholipids, cholesterol, and polyphosphoinositides, with polyunsaturated fatty acid chains that were identified in the natural nuclear membranes by lipid mass spectrometry, have been used to reconstruct complex model membranes mimicking nuclear envelope precursor membranes. Structural and dynamic events occurring in the membrane core and at the membrane surface were monitored by solid-state deuterium and phosphorus NMR. "MV1-like'' (PC: PI: PIP: PIP2, 30: 20: 18: 12, mol%) membranes that exhibited high levels of PtdIns, PtdInsP and PtdInsP(2) had an unusually fluid membrane core (up to 20% increase, compared to membranes with low amounts of phosphoinositides to mimic the endoplasmic reticulum). "NER-like'' (PC: CH: PI: PIP: PIP2, 28: 42: 16: 7: 7, mol%) membranes containing high amounts of both cholesterol and phosphoinositides exhibited liquid-ordered phase properties, but with markedly lower rigidity (10-15% decrease). Phosphoinositides are the first lipids reported to counterbalance the ordering effect of cholesterol. At the membrane surface, phosphoinositides control the orientation dynamics of other lipids in the model membranes, while remaining unchanged themselves. This is an important finding as it provides unprecedented mechanistic insight into the role of phosphoinositides in membrane dynamics. Biological implications of our findings and a model describing the roles of fusogenic membrane vesicles are proposed.	[Zhendre, Vanessa; Grelard, Axelle; Garnier-LHomme, Marie; Dufourc, Erick J.] Univ Bordeaux, CNRS, Inst Polytech Bordeaux, UMR5248, Pessac, France; [Zhendre, Vanessa; Garnier-LHomme, Marie; Larijani, Banafshe] Canc Res UK, Lincolns Inn Fields Labs, Cell Biophys Lab, London, England; [Buchoux, Sebastien] UPJV, UMR Genie Enzymat & Cellulaire 6022, Amiens, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite de Bordeaux; Cancer Research UK; Picardie Universites; Universite de Picardie Jules Verne (UPJV)	Zhendre, V (corresponding author), Univ Bordeaux, CNRS, Inst Polytech Bordeaux, UMR5248, Pessac, France.	banafshe.larijani@cancer.org.uk; e.dufourc@iecb.u-bordeaux.fr	Buchoux, Sébastien/B-1822-2010; DUFOURC, Erick Joel/AAA-4992-2020; Larijani, Banafshe/H-3909-2015	Buchoux, Sébastien/0000-0002-1544-2093; DUFOURC, Erick Joel/0000-0002-8221-9326; Larijani, Banafshe/0000-0003-4735-1169; GRELARD, Axelle/0000-0002-6708-2253; LHOMME, MARIE/0000-0002-6335-4506	Cancer Research UK [TGE RMN THC FR3050]; Acquitaine government	Cancer Research UK(Cancer Research UK); Acquitaine government	Cancer Research UK Core funding TGE RMN THC FR3050 and the Acquitaine government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbuzova A, 2000, BBA-BIOMEMBRANES, V1464, P35, DOI 10.1016/S0005-2736(99)00243-6; Arbuzova A, 2000, BIOCHEMISTRY-US, V39, P10330, DOI 10.1021/bi001039j; Aussenac F, 2003, LANGMUIR, V19, P10468, DOI 10.1021/la034268q; Barona T, 2005, J BIOL CHEM, V280, P41171, DOI 10.1074/jbc.M412863200; Beck JG, 2007, FASEB J, V21, P1714, DOI 10.1096/fj.06-7809com; BLOOM M, 1981, CHEM PHYS LETT, V80, P198, DOI 10.1016/0009-2614(81)80089-9; BURNETT LJ, 1971, J CHEM PHYS, V55, P5829, DOI 10.1063/1.1675758; Byrne RD, 2007, CELL SIGNAL, V19, P913, DOI 10.1016/j.cellsig.2006.10.011; Collas P, 1996, EUR J CELL BIOL, V71, P22; DAVIS JH, 1976, CHEM PHYS LETT, V42, P390, DOI 10.1016/0009-2614(76)80392-2; DAVIS JH, 1988, BIOCHEMISTRY-US, V27, P428, DOI 10.1021/bi00401a064; Douliez JP, 1996, J PHYS CHEM-US, V100, P18450, DOI 10.1021/jp961220v; Dufourc E.J., 2006, CHEM BIOL, P113, DOI [10.1002/9780470319253.ch8, DOI 10.1002/9780470319253.CH8]; DUFOURC EJ, 1992, BIOPHYS J, V61, P42, DOI 10.1016/S0006-3495(92)81814-3; Dufourc EJ, 2009, WILEY ENCY CHEM BIOL, DOI [10.1002/9780470048672.wecb9780470048389, DOI 10.1002/9780470048672.WECB9780470048389]; Dufourc EJ, 2008, PLANT SIGNAL BEHAV, V3, P133, DOI 10.4161/psb.3.2.5051; Dufourc Erick J, 2008, J Chem Biol, V1, P63, DOI 10.1007/s12154-008-0010-6; Fabrice Dumas RDB, 2010, PLOS ONE IN PRESS; Gambhir A, 2004, BIOPHYS J, V86, P2188, DOI 10.1016/S0006-3495(04)74278-2; Gamier-Lhomme M, 2007, BBA-BIOMEMBRANES, V1768, P2516, DOI 10.1016/j.bbamem.2007.06.004; Garnier-Lhomme M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004255; Garnier-Lhomme Marie, 2009, V462, P89, DOI 10.1007/978-1-60327-115-8_6; Golebiewska U, 2006, BIOPHYS J, V91, P588, DOI 10.1529/biophysj.106.081562; Grelard Axelle, 2009, V462, P111, DOI 10.1007/978-1-60327-115-8_7; James DJ, 2008, J CELL BIOL, V182, P355, DOI 10.1083/jcb.200801056; Knight JD, 2009, BIOPHYS J, V96, P566, DOI 10.1016/j.bpj.2008.10.020; Landgraf KE, 2008, BIOCHEMISTRY-US, V47, P12260, DOI 10.1021/bi801683k; Larijani B, 2000, LIPIDS, V35, P1289, DOI 10.1007/s11745-000-0645-4; Larijani B, 2006, LIPIDS, V41, P925, DOI 10.1007/s11745-006-5045-2; Larijani B, 2009, ANNU REV BIOPHYS, V38, P107, DOI 10.1146/annurev.biophys.050708.133625; LEONARD A, 1991, BIOCHIMIE, V73, P1295, DOI 10.1016/0300-9084(91)90092-F; Li Z, 2009, BIOPHYS J, V97, P155, DOI 10.1016/j.bpj.2009.04.037; Lynch KL, 2008, MOL BIOL CELL, V19, P5093, DOI 10.1091/mbc.E08-03-0235; Martin TFJ, 1997, BIOCHEM SOC T, V25, P1137, DOI 10.1042/bst0251137; Mima J, 2008, EMBO J, V27, P2031, DOI 10.1038/emboj.2008.139; Mima J, 2009, J BIOL CHEM, V284, P27114, DOI 10.1074/jbc.M109.010223; Poccia D, 2009, BIOCHEM J, V418, P233, DOI 10.1042/BJ20082105; POTT T, 1995, BIOPHYS J, V68, P965, DOI 10.1016/S0006-3495(95)80272-9; RANCE M, 1983, J MAGN RESON, V52, P221, DOI 10.1016/0022-2364(83)90190-7; SEELIG J, 1978, BIOCHIM BIOPHYS ACTA, V515, P105, DOI 10.1016/0304-4157(78)90001-1; STERNIN E, 1983, J MAGN RESON, V55, P274, DOI 10.1016/0022-2364(83)90239-1; Stroupe C, 2009, P NATL ACAD SCI USA, V106, P17626, DOI 10.1073/pnas.0903801106; Wang L, 2002, CELL, V108, P357, DOI 10.1016/S0092-8674(02)00632-3; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451	44	29	29	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e23859	10.1371/journal.pone.0023859	http://dx.doi.org/10.1371/journal.pone.0023859			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CK	21931619	Green Published, gold, Green Submitted			2022-12-25	WOS:000294802800011
J	Zinger, L; Amaral-Zettler, LA; Fuhrman, JA; Horner-Devine, MC; Huse, SM; Welch, DBM; Martiny, JBH; Sogin, M; Boetius, A; Ramette, A				Zinger, Lucie; Amaral-Zettler, Linda A.; Fuhrman, Jed A.; Horner-Devine, M. Claire; Huse, Susan M.; Welch, David B. Mark; Martiny, Jennifer B. H.; Sogin, Mitchell; Boetius, Antje; Ramette, Alban			Global Patterns of Bacterial Beta-Diversity in Seafloor and Seawater Ecosystems	PLOS ONE			English	Article							SEDIMENT-WATER INTERFACE; DEEP-SEA; RIBOSOMAL-RNA; OCEAN; COMMUNITY; BIOGEOGRAPHY; MICROORGANISMS; BIODIVERSITY; ECOLOGY; LIFE	Background: Marine microbial communities have been essential contributors to global biomass, nutrient cycling, and biodiversity since the early history of Earth, but so far their community distribution patterns remain unknown in most marine ecosystems. Methodology/Principal Findings: The synthesis of 9.6 million bacterial V6-rRNA amplicons for 509 samples that span the global ocean's surface to the deep-sea floor shows that pelagic and benthic communities greatly differ, at all taxonomic levels, and share <10% bacterial types defined at 3% sequence similarity level. Surface and deep water, coastal and open ocean, and anoxic and oxic ecosystems host distinct communities that reflect productivity, land influences and other environmental constraints such as oxygen availability. The high variability of bacterial community composition specific to vent and coastal ecosystems reflects the heterogeneity and dynamic nature of these habitats. Both pelagic and benthic bacterial community distributions correlate with surface water productivity, reflecting the coupling between both realms by particle export. Also, differences in physical mixing may play a fundamental role in the distribution patterns of marine bacteria, as benthic communities showed a higher dissimilarity with increasing distance than pelagic communities. Conclusions/Significance: This first synthesis of global bacterial distribution across different ecosystems of the World's oceans shows remarkable horizontal and vertical large-scale patterns in bacterial communities. This opens interesting perspectives for the definition of biogeographical biomes for bacteria of ocean waters and the seabed.	[Zinger, Lucie; Boetius, Antje; Ramette, Alban] Max Planck Inst Marine Microbiol, Microbial Habitat Grp, Bremen, Germany; [Amaral-Zettler, Linda A.; Huse, Susan M.; Welch, David B. Mark; Sogin, Mitchell] Josephine Bay Paul Ctr, Marine Biol Lab, Woods Hole, MA USA; [Fuhrman, Jed A.] Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; [Horner-Devine, M. Claire] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Martiny, Jennifer B. H.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA; [Boetius, Antje; Ramette, Alban] Alfred Wegener Inst Polar & Marine Res, HGF MPG Joint Res Grp Deep Sea Ecol & Technol, D-2850 Bremerhaven, Germany	Max Planck Society; Marine Biological Laboratory - Woods Hole; University of Southern California; University of Washington; University of Washington Seattle; University of California System; University of California Irvine; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Zinger, L (corresponding author), Max Planck Inst Marine Microbiol, Microbial Habitat Grp, Bremen, Germany.	aramette@mpi-bremen.de	Sogin, Mitchell/AAE-7186-2019; Zinger, Lucie/D-2527-2010; Fuhrman, Jed A/C-6461-2013; Martiny, Jennifer/AAB-9323-2019; Boetius, Antje/D-5459-2013; Ramette, Alban/E-9197-2016	Zinger, Lucie/0000-0002-3400-5825; Fuhrman, Jed A/0000-0002-2361-1985; Boetius, Antje/0000-0003-2117-4176; Ramette, Alban/0000-0002-3437-4639; Martiny, Jennifer/0000-0002-2415-1247	Alfred P. Sloan Foundation; W.M. Keck Foundation; DFG; Max Planck Society; Helmholtz Association	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); W.M. Keck Foundation(W.M. Keck Foundation); DFG(German Research Foundation (DFG)); Max Planck Society(Max Planck SocietyFoundation CELLEX); Helmholtz Association(Helmholtz Association)	This study has been funded by the Alfred P. Sloan (MLS and LAAZ) and W.M. Keck Foundations (MLS) and by the Leibniz programme of the DFG to AB. The work of AR and AB was financially supported by the Max Planck Society and the Helmholtz Association. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral-Zettler Linda, 2010, P223; Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; Aristegui J, 2009, LIMNOL OCEANOGR, V54, P1501, DOI 10.4319/lo.2009.54.5.1501; Austen MC, 2002, BIODIVERS CONSERV, V11, P113, DOI 10.1023/A:1014098917535; Azam F, 2007, NAT REV MICROBIOL, V5, P782, DOI 10.1038/nrmicro1747; Barberan A, 2010, AQUAT MICROB ECOL, V59, P1, DOI 10.3354/ame01389; Baumann KH, 2000, DEEP-SEA RES PT II, V47, P1743, DOI 10.1016/S0967-0645(00)00005-9; Beaugrand G, 2002, MAR ECOL PROG SER, V232, P179, DOI 10.3354/meps232179; Biers EJ, 2009, APPL ENVIRON MICROB, V75, P2221, DOI 10.1128/AEM.02118-08; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Campbell BJ, 2006, NAT REV MICROBIOL, V4, P458, DOI 10.1038/nrmicro1414; Coddington JA, 2009, J ANIM ECOL, V78, P573, DOI 10.1111/j.1365-2656.2009.01525.x; Corliss BH, 2009, DEEP-SEA RES PT I, V56, P835, DOI 10.1016/j.dsr.2008.12.009; Curtis TP, 2002, P NATL ACAD SCI USA, V99, P10494, DOI 10.1073/pnas.142680199; de Wit R, 2006, ENVIRON MICROBIOL, V8, P755, DOI 10.1111/j.1462-2920.2006.01017.x; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Field KG, 1997, APPL ENVIRON MICROB, V63, P63, DOI 10.1128/AEM.63.1.63-70.1997; Finlay BJ, 2002, SCIENCE, V296, P1061, DOI 10.1126/science.1070710; Fisher CR, 2007, OCEANOGRAPHY, V20, P14, DOI 10.5670/oceanog.2007.75; Fry JC, 2008, FEMS MICROBIOL ECOL, V66, P181, DOI 10.1111/j.1574-6941.2008.00566.x; Galand PE, 2010, ISME J, V4, P564, DOI 10.1038/ismej.2009.134; Giovannoni SJ, 2005, NATURE, V437, P343, DOI 10.1038/nature04158; Gobet A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq545; Goericke R, 2002, LIMNOL OCEANOGR, V47, P1307, DOI 10.4319/lo.2002.47.5.1307; Green J, 2006, TRENDS ECOL EVOL, V21, P501, DOI 10.1016/j.tree.2006.06.012; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Horner-Devine MC, 2004, NATURE, V432, P750, DOI 10.1038/nature03073; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Inagaki F, 2006, P NATL ACAD SCI USA, V103, P14164, DOI 10.1073/pnas.0606083103; Janssen PH, 2006, APPL ENVIRON MICROB, V72, P1719, DOI 10.1128/AEM.72.3.1719-1728.2006; Jorgensen BB, 2007, NAT REV MICROBIOL, V5, P770, DOI 10.1038/nrmicro1745; Kirchman DL, 2002, FEMS MICROBIOL ECOL, V39, P91, DOI 10.1111/j.1574-6941.2002.tb00910.x; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Li HR, 2009, EXTREMOPHILES, V13, P233, DOI 10.1007/s00792-009-0225-7; LOCHTE K, 1988, NATURE, V333, P67, DOI 10.1038/333067a0; LONGHURST A, 1995, J PLANKTON RES, V17, P1245, DOI 10.1093/plankt/17.6.1245; Lozupone CA, 2007, P NATL ACAD SCI USA, V104, P11436, DOI 10.1073/pnas.0611525104; Madrid VM, 2001, APPL ENVIRON MICROB, V67, P1663, DOI 10.1128/AEM.67.4.1663-1674.2001; Magnusson A, 2010, GMT INTERFACE GMT MA; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Martiny AC, 2009, ENVIRON MICROBIOL, V11, P823, DOI 10.1111/j.1462-2920.2008.01803.x; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Novotny V, 2000, OIKOS, V89, P564, DOI 10.1034/j.1600-0706.2000.890316.x; Oksanen J., 2013, R PACKAGE VERSION 2, P292; Orcutt BN, 2011, MICROBIOL MOL BIOL R, V75, P361, DOI 10.1128/MMBR.00039-10; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; Philippot L, 2010, NAT REV MICROBIOL, V8, P523, DOI 10.1038/nrmicro2367; Pinhassi J, 2004, APPL ENVIRON MICROB, V70, P6753, DOI 10.1128/AEM.70.11.6753-6766.2004; Pinhassi J, 1999, AQUAT MICROB ECOL, V17, P13, DOI 10.3354/ame017013; Pommier T, 2007, MOL ECOL, V16, P867, DOI 10.1111/j.1365-294X.2006.03189.x; Qian H, 2009, J SYST EVOL, V47, P509, DOI 10.1111/j.1759-6831.2009.00043.x; Quaiser A, 2011, ISME J, V5, P285, DOI 10.1038/ismej.2010.113; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; R Development Core Team, 2009, R FDN STAT COMP; Ramette A, 2007, MICROB ECOL, V53, P197, DOI 10.1007/s00248-005-5010-2; Rappe MS, 2000, FEMS MICROBIOL ECOL, V33, P219, DOI 10.1016/S0168-6496(00)00064-7; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Sapp M, 2010, FEMS MICROBIOL ECOL, V74, P410, DOI 10.1111/j.1574-6941.2010.00957.x; Silvertown J, 2004, TRENDS ECOL EVOL, V19, P605, DOI 10.1016/j.tree.2004.09.003; SMETACEK VS, 1985, MAR BIOL, V84, P239, DOI 10.1007/BF00392493; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Soininen J, 2007, ECOLOGY, V88, P2830, DOI 10.1890/06-1730.1; Turley C, 2000, FEMS MICROBIOL ECOL, V33, P89, DOI 10.1111/j.1574-6941.2000.tb00731.x; Turley C, 2002, MICROBIOL TODAY, V29, P177; Varela MM, 2008, ENVIRON MICROBIOL, V10, P110, DOI 10.1111/j.1462-2920.2007.01437.x; Ward JV, 1998, FRESHWATER BIOL, V40, P531, DOI 10.1046/j.1365-2427.1998.00368.x; Wei CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015323; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Williams KP, 2010, J BACTERIOL, V192, P2305, DOI 10.1128/JB.01480-09; Wu CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011285; Yooseph S, 2010, NATURE, V468, P60, DOI 10.1038/nature09530	74	397	413	1	194	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e24570	10.1371/journal.pone.0024570	http://dx.doi.org/10.1371/journal.pone.0024570			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CK	21931760	Green Published, gold			2022-12-25	WOS:000294802800068
J	Tadema, H; Abdulahad, WH; Stegeman, CA; Kallenberg, CGM; Heeringa, P				Tadema, Henko; Abdulahad, Wayel H.; Stegeman, Coen A.; Kallenberg, Cees G. M.; Heeringa, Peter			Increased Expression of Toll-Like Receptors by Monocytes and Natural Killer Cells in ANCA-Associated Vasculitis	PLOS ONE			English	Article							ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES; PATTERN-RECOGNITION RECEPTORS; NAIVE B-CELLS; WEGENERS-GRANULOMATOSIS; STAPHYLOCOCCUS-AUREUS; AUTOANTIBODY PRODUCTION; MONONUCLEAR-CELLS; NASAL CARRIAGE; BACTERIAL-DNA; ACTIVATION	Introduction: Toll-like receptors (TLRs) are a family of receptors that sense pathogen associated patterns such as bacterial cell wall proteins. Bacterial infections are associated with anti-neutrophil cytoplasmic antibodies (ANCA)-associated vasculitis (AAV). Here, we assessed the expression of TLRs 2, 4, and 9 by peripheral blood leukocytes from patients with AAV, and investigated TLR mediated responses ex vivo. Methods: Expression of TLRs was determined in 38 AAV patients (32 remission, 6 active disease), and 20 healthy controls (HC). Membrane expression of TLRs 2, 4, and 9, and intracellular expression of TLR9 by B lymphocytes, T lymphocytes, NK cells, monocytes and granulocytes was assessed using 9-color flowcytometry. Whole blood from 13 patients and 7 HC was stimulated ex vivo with TLR 2, 4 and 9 ligands and production of cytokines was analyzed. Results: In patients, we observed increased proportions of TLR expressing NK cells. Furthermore, patient monocytes expressed higher levels of TLR2 compared to HC, and in a subset of patients an increased proportion of TLR4(+) monocytes was observed. Monocytes from nasal carriers of Staphylococcus aureus expressed increased levels of intracellular TLR9. Membrane expression of TLRs by B lymphocytes, T lymphocytes, and granulocytes was comparable between AAV patients and HC. Patients with active disease did not show differential TLR expression compared to patients in remission. Ex vivo responses to TLR ligands did not differ significantly between patients and HC. Conclusions: In AAV, monocytes and NK cells display increased TLR expression. Increased TLR expression by these leukocytes, probably resulting from increased activation, could play a role in disease (re) activation.	[Tadema, Henko; Abdulahad, Wayel H.; Kallenberg, Cees G. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, Groningen, Netherlands; [Stegeman, Coen A.] Univ Groningen, Univ Med Ctr Groningen, Dept Nephrol, Groningen, Netherlands; [Heeringa, Peter] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Tadema, H (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, Groningen, Netherlands.	h.tadema@reuma.umcg.nl	Heeringa, Peter/A-6008-2009	Heeringa, Peter/0000-0001-8684-763X; Stegeman, Coen/0000-0002-0224-0927; /0000-0003-3109-4487	Dutch Arthritis Association [06-1-401]	Dutch Arthritis Association	This work was supported by the Dutch Arthritis Association (06-1-401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi-Roodsaz S, 2007, ARTHRITIS RHEUM, V56, P2957, DOI 10.1002/art.22848; Abdulahad WH, 2006, KIDNEY INT, V70, P938, DOI 10.1038/sj.ki.5001670; Barrat FJ, 2007, EUR J IMMUNOL, V37, P3582, DOI 10.1002/eji.200737815; Belge KU, 2002, J IMMUNOL, V168, P3536, DOI 10.4049/jimmunol.168.7.3536; Bernasconi NL, 2003, BLOOD, V101, P4500, DOI 10.1182/blood-2002-11-3569; Capolunghi F, 2010, RHEUMATOLOGY, V49, P2281, DOI 10.1093/rheumatology/keq226; Csernok E, 2010, CURR OPIN RHEUMATOL, V22, P43, DOI 10.1097/BOR.0b013e3283323538; Deng JS, 2009, CIRC RES, V104, P488, DOI 10.1161/CIRCRESAHA.108.185777; FALK RJ, 1990, P NATL ACAD SCI USA, V87, P4115, DOI 10.1073/pnas.87.11.4115; Farag SS, 2006, BLOOD REV, V20, P123, DOI 10.1016/j.blre.2005.10.001; Gollapudi P, 2010, AM J NEPHROL, V31, P247, DOI 10.1159/000276764; Hadley JS, 2005, INFECT IMMUN, V73, P7613, DOI 10.1128/IAI.73.11.7613-7619.2005; Harter L, 2004, SHOCK, V22, P403, DOI 10.1097/01.shk.0000142256.23382.5d; Hattar K, 2005, J LEUKOCYTE BIOL, V78, P992, DOI 10.1189/jlb.0902442; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Huggins J, 2007, BLOOD, V109, P1611, DOI 10.1182/blood-2006-03-008441; Hurtado PR, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-34; Huugen D, 2005, AM J PATHOL, V167, P47, DOI 10.1016/S0002-9440(10)62952-5; Isnardi I, 2008, IMMUNITY, V29, P746, DOI 10.1016/j.immuni.2008.09.015; JENNETTE JC, 1994, ARTHRITIS RHEUM-US, V37, P187, DOI 10.1002/art.1780370206; Jiang W, 2007, EUR J IMMUNOL, V37, P2205, DOI 10.1002/eji.200636984; Kallenberg CGM, 2008, AUTOIMMUN REV, V8, P29, DOI 10.1016/j.autrev.2008.07.020; Kallenberg CGM, 2006, NAT CLIN PRACT RHEUM, V2, P661, DOI 10.1038/ncprheum0355; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kobold ACM, 1999, ANN RHEUM DIS, V58, P237, DOI 10.1136/ard.58.4.237; Lampropoulou V, 2008, J IMMUNOL, V180, P4763, DOI 10.4049/jimmunol.180.7.4763; Lauzon NM, 2006, CELL IMMUNOL, V241, P102, DOI 10.1016/j.cellimm.2006.08.004; Lidar M, 2009, AUTOIMMUNITY, V42, P432, DOI 10.1080/08916930802613210; Myles A, 2011, RHEUMATOLOGY, V50, P481, DOI 10.1093/rheumatology/keq362; Ospelt C, 2008, ARTHRITIS RHEUM-US, V58, P3684, DOI 10.1002/art.24140; Papadimitraki ED, 2006, ARTHRITIS RHEUM-US, V54, P3601, DOI 10.1002/art.22197; Pegu A, 2008, J IMMUNOL, V180, P3399, DOI 10.4049/jimmunol.180.5.3399; Ralston DR, 1997, J CLIN INVEST, V100, P1416, DOI 10.1172/JCI119662; Sabroe I, 2005, CLIN INFECT DIS, V41, pS421, DOI 10.1086/431992; Salomao R, 2008, SHOCK, V30, P1, DOI 10.1097/SHK.0b013e318181837f; Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406; Small CL, 2008, J IMMUNOL, V180, P5558, DOI 10.4049/jimmunol.180.8.5558; STEGEMAN CA, 1994, ANN INTERN MED, V120, P12, DOI 10.7326/0003-4819-120-1-199401010-00003; Stegeman CA, 1996, NEW ENGL J MED, V335, P16, DOI 10.1056/NEJM199607043350103; Stegeman CA, 1997, NEPHROL DIAL TRANSPL, V12, P652, DOI 10.1093/ndt/12.4.652; Stenzel W, 2008, AM J PATHOL, V172, P132, DOI 10.2353/ajpath.2008.070567; Summers SA, 2011, ARTHRITIS RHEUM-US, V63, P1124, DOI 10.1002/art.30208; Summers SA, 2010, KIDNEY INT, V78, P1263, DOI 10.1038/ki.2010.327; Tadema H, 2011, RHEUMATOLOGY, V50, P689, DOI 10.1093/rheumatology/keq375; Takeuchi O, 2000, J IMMUNOL, V165, P5392, DOI 10.4049/jimmunol.165.10.5392; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; TERVAERT JWC, 1993, ANN RHEUM DIS, V52, P115, DOI 10.1136/ard.52.2.115; Uehara A, 2009, DIAGN PATHOL, V4, DOI 10.1186/1746-1596-4-23; Wikman A, 2008, INFLAMMATION, V31, P384, DOI 10.1007/s10753-008-9089-8; Zycinska K, 2008, J PHYSIOL PHARMACOL, V59, P825	51	47	49	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2011	6	9							e24315	10.1371/journal.pone.0024315	http://dx.doi.org/10.1371/journal.pone.0024315			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817QP	21915309	Green Submitted, Green Published, gold			2022-12-25	WOS:000294689200033
J	Cho, S; Park, JS; Kang, YK				Cho, Sunwha; Park, Jung Sun; Kang, Yong-Kook			Dual Functions of Histone-Lysine N-Methyltransferase Setdb1 Protein at Promyelocytic Leukemia-Nuclear Body (PML-NB) MAINTAINING PML-NB STRUCTURE AND REGULATING THE EXPRESSION OF ITS ASSOCIATED GENES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; BODIES; CHROMATIN; H3; HETEROCHROMATIN; METHYLATION; DNA; TRANSCRIPTION; DOMAIN; INTERACTS	Setdb1/Eset is a histone H3 lysine 9 (H3K9)-specific methyltransferase that associates with various transcription factors to regulate gene expression via chromatin remodeling. Here, we report that Setdb1 associates with promyelocytic leukemia (Pm1) protein from the early stage of mouse development and is a constitutive member of promyelocytic leukemia (PML)-nuclear bodies (PML-NBs) that have been linked to many cellular processes such as apoptosis, DNA damage responses, and transcriptional regulation. Arsenic treatment, which induces Pm1 degradation, caused Setdb1 signals to disappear. Setdb1 knockdown resulted in dismantlement of PML-NBs. Immunoprecipitation results demonstrated physical interactions between Setdb1 and Pm1. Chromatin immunoprecipitation revealed that, within the frame of PML-NBs, Setdb1 binds the promoter of Id2 and suppresses its expression through installing H3K9 methylation. Our findings suggest that Setdb1 performs dual, but inseparable, functions at PML-NBs to maintain the structural integrity of PML-NBs and to control PML-NB-associated genes transcriptionally.	[Cho, Sunwha; Park, Jung Sun; Kang, Yong-Kook] Korea Res Inst Biosci & Biotechnol, Dev & Differentiat Res Ctr, Taejon 305806, South Korea; [Cho, Sunwha; Kang, Yong-Kook] Univ Sci & Technol, Dept Funct Genom, Taejon 305806, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Kang, YK (corresponding author), 111 Gwahangno, Taejon 305806, South Korea.	ykkang@kribb.re.kr			National Research Foundation of Korea [2011-0027808, 2011-0030769]; Next-generation BioGreen21 Grant [PJ008002]; KRIBB initiative	National Research Foundation of Korea(National Research Foundation of Korea); Next-generation BioGreen21 Grant; KRIBB initiative	This work was supported by National Research Foundation of Korea Grants 2011-0027808 and 2011-0030769, Next-generation BioGreen21 Grant PJ008002, and KRIBB initiative program.	Aagaard L, 1999, EMBO J, V18, P1923, DOI 10.1093/emboj/18.7.1923; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bernardi R, 2007, NAT REV MOL CELL BIO, V8, P1006, DOI 10.1038/nrm2277; Cairo S, 2005, ONCOGENE, V24, P2195, DOI 10.1038/sj.onc.1208338; Chen GQ, 1997, BLOOD, V89, P3345; Dellaire G, 2004, BIOESSAYS, V26, P963, DOI 10.1002/bies.20089; DETHE H, 1990, NATURE, V347, P558, DOI 10.1038/347558a0; Dodge JE, 2004, MOL CELL BIOL, V24, P2478, DOI 10.1128/MCB.24.6.2478-2486.2004; Duan Q, 2008, J BIOL CHEM, V283, P33585, DOI 10.1074/jbc.M803312200; Ebrahimian M, 2010, CELLS TISSUES ORGANS, V192, P374, DOI 10.1159/000319466; Eskiw CH, 2004, J BIOL CHEM, V279, P9577, DOI 10.1074/jbc.M312580200; Eskiw CH, 2003, J CELL SCI, V116, P4455, DOI 10.1242/jcs.00758; Everett RD, 1999, J CELL SCI, V112, P3443; Everett RD, 1999, J CELL SCI, V112, P4581; GODDARD AD, 1995, MAMM GENOME, V6, P732, DOI 10.1007/BF00354296; Gratze P, 2008, CIRCULATION, V117, P2645, DOI 10.1161/CIRCULATIONAHA.107.760116; Hofmann TG, 2003, CELL DEATH DIFFER, V10, P1290, DOI 10.1038/sj.cdd.4401313; Ishov AM, 1999, J CELL BIOL, V147, P221, DOI 10.1083/jcb.147.2.221; Ito K, 2008, NATURE, V453, P1072, DOI 10.1038/nature07016; Ivanov AV, 2007, MOL CELL, V28, P823, DOI 10.1016/j.molcel.2007.11.012; Jeong YS, 2007, DEV DYNAM, V236, P1509, DOI 10.1002/dvdy.21150; Jeong YS, 2010, GENES CELLS, V15, P181, DOI 10.1111/j.1365-2443.2009.01375.x; Jia ST, 2004, CELL, V119, P469, DOI 10.1016/j.cell.2004.10.020; Kang YK, 1999, J BIOL CHEM, V274, P36585, DOI 10.1074/jbc.274.51.36585; Kumar P, 2007, NAT CELL BIOL, V9, P45, DOI 10.1038/ncb1516; Kurowska-Stolarska M, 2009, ARTHRITIS RHEUM-US, V60, P3663, DOI 10.1002/art.25001; Li YH, 2003, DEVELOPMENT, V130, P1817, DOI 10.1242/dev.00405; Luciani JJ, 2006, J CELL SCI, V119, P2518, DOI 10.1242/jcs.02965; Ma DK, 2008, STEM CELLS, V26, P2131, DOI 10.1634/stemcells.2008-0388; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Melnick A, 1999, BLOOD, V93, P3167, DOI 10.1182/blood.V93.10.3167.410k44_3167_3215; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Pidoux AL, 2005, PHILOS T R SOC B, V360, P569, DOI 10.1098/rstb.2004.1611; Ruzinova MB, 2003, TRENDS CELL BIOL, V13, P410, DOI 10.1016/S0962-8924(03)00147-8; Sarraf SA, 2004, MOL CELL, V15, P595, DOI 10.1016/j.molcel.2004.06.043; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Seeler JS, 1998, P NATL ACAD SCI USA, V95, P7316, DOI 10.1073/pnas.95.13.7316; Shiels C, 2001, J CELL SCI, V114, P3705; Stielow B, 2008, EMBO REP, V9, P899, DOI 10.1038/embor.2008.127; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Urrutia R, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-231; Yang L, 2002, ONCOGENE, V21, P148, DOI 10.1038/sj.onc.1204998; Yang L, 2003, BIOCHEM J, V369, P651, DOI 10.1042/BJ20020854; Yeap LS, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-12; Yeo S, 2005, MOL CELLS, V20, P423; Yoon J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002234; Zhong S, 2000, NAT CELL BIOL, V2, pE85, DOI 10.1038/35010583; Zhong S, 2000, BLOOD, V95, P2748, DOI 10.1182/blood.V95.9.2748.009k31a_2748_2752; Zong S, 1999, ONCOGENE, V18, P7941, DOI 10.1038/sj.onc.1203367	51	41	41	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					41115	41124		10.1074/jbc.M111.248534	http://dx.doi.org/10.1074/jbc.M111.248534			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21921037	hybrid, Green Published			2022-12-25	WOS:000297315400070
J	Hall, BM; Owens, KM; Singh, KK				Hall, Brandon M.; Owens, Kjerstin M.; Singh, Keshav K.			Distinct Functions of Evolutionary Conserved MSF1 and Late Embryogenesis Abundant (LEA)-like Domains in Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERMEMBRANE SPACE; RESPIRATORY-CHAIN; GENE DELETION; DNA DAMAGE; PRELI-LIKE; CARDIOLIPIN; PROTEINS; LEA; PHOSPHOLIPIDS; VECTORS	PRELID1, the only late embryogenesis abundant (LEA) domain-containing protein in humans, exerts cytoprotective effects through its LEA domain within the mitochondria. Although PRELID1 homologs in vertebrates contain the LEA domain, homologs in lower eukaryotes are thought to lack this domain. In this study, we identify a novel LEA-like domain in a yeast PRELID1 homolog, Ups2p, which contains sequence conservation with the LEA domain of human PRELID1. PRELID1 homologs, including Ups2p, are known to contain the PRELI/MSF1 domain. Our study reveals that the MSF1 domain of Ups2p maintains proper mitochondrial electron transport chain function, respiratory competency, and mitochondrial phosphatidylethanolamine metabolism. The Ups2p MSF1 domain mediates cardiolipin depletion in the absence of Ups1p. However, the Ups2p LEA-like domain is responsible for cardiolipin depletion resulting from UPS2 overexpression. The regulation of phosphatidylethanolamine levels by the MSF1 domain is antagonized by the Ups2p LEA-like domain. We demonstrate that the yeast LEA-like domain protects cells from oxidative stress and can be functionally replaced by the human LEA domain. Together our studies suggest distinct roles of MSF1 and LEA-like domains in mitochondrial function and resistance to oxidative stress.	[Singh, Keshav K.] Univ Alabama Birmingham, Dept Genet, Ctr Aging, Ctr Free Rad Biol, Birmingham, AL 35294 USA; [Hall, Brandon M.; Owens, Kjerstin M.; Singh, Keshav K.] Roswell Pk Canc Inst, Dept Canc Genet, Buffalo, NY 14263 USA; [Singh, Keshav K.] Univ Alabama Birmingham, Ctr Comprehens Canc, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; Roswell Park Cancer Institute; University of Alabama System; University of Alabama Birmingham	Singh, KK (corresponding author), Univ Alabama Birmingham, Dept Genet, Ctr Aging, Ctr Free Rad Biol, KAUL 620,720 S 20th St, Birmingham, AL 35294 USA.	kksingh@uab.edu		Owens, Kjerstin/0000-0001-5210-319X	National Institutes of Health [R01 CA116430, 121904, 113655]; NATIONAL CANCER INSTITUTE [R01CA113655, R01CA116430, R01CA121904] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA116430, 121904, and 113655 (to K. K. S.).	Alvaro D, 2007, PLOS GENET, V3, P2439, DOI 10.1371/journal.pgen.0030228; Anantharaman V, 2002, GENOME BIOL, V3; Barrientos A, 1998, J BIOL CHEM, V273, P14210, DOI 10.1074/jbc.273.23.14210; BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; BIRCHMACHIN MA, 1994, BIOCHEM MED METAB B, V51, P35, DOI 10.1006/bmmb.1994.1004; Birner R, 2001, MOL BIOL CELL, V12, P997, DOI 10.1091/mbc.12.4.997; Brachmann CB, 1998, YEAST, V14, P115; Carhan A, 2004, INVERTEBR NEUROSCI, V5, P65, DOI 10.1007/s10158-003-0028-y; Choi SY, 2007, CELL DEATH DIFFER, V14, P597, DOI 10.1038/sj.cdd.4402020; Claypool SM, 2006, J CELL BIOL, V174, P379, DOI 10.1083/jcb.200605043; Contamine V, 2000, MICROBIOL MOL BIOL R, V64, P281, DOI 10.1128/MMBR.64.2.281-315.2000; Dee CT, 2005, DEV GENES EVOL, V215, P248, DOI 10.1007/s00427-005-0470-4; Diekert K, 2001, METHOD CELL BIOL, V65, P37, DOI 10.1016/S0091-679X(01)65003-9; Fox EJ, 2004, BIOCHEM J, V378, P817, DOI 10.1042/BJ20031504; Gohil VM, 2004, J BIOL CHEM, V279, P42612, DOI 10.1074/jbc.M402545200; Grelet J, 2005, PLANT PHYSIOL, V137, P157, DOI 10.1104/pp.104.052480; Guzman-Rojas L, 2000, INT IMMUNOL, V12, P607, DOI 10.1093/intimm/12.5.607; Hand SC, 2007, J EXP ZOOL PART A, V307A, P62, DOI 10.1002/jez.a.343; Hand SC, 2011, ANNU REV PHYSIOL, V73, P115, DOI 10.1146/annurev-physiol-012110-142203; HUGHES DW, 1991, PLANT CELL, V3, P605, DOI 10.1105/tpc.3.6.605; IMAI Y, 1991, NUCLEIC ACIDS RES, V19, P2785, DOI 10.1093/nar/19.10.2785; Kim IS, 2007, J MICROBIOL, V45, P326; Leister D., 2007, METHODS MOL BIOL MIT, V372, P87; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; McKeller MR, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.19; Menze MA, 2009, J BIOL CHEM, V284, P10714, DOI 10.1074/jbc.C900001200; Merz S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r95; MITCHELL DA, 1993, YEAST, V9, P715, DOI 10.1002/yea.320090705; Mowla SB, 2006, PLANT J, V48, P743, DOI 10.1111/j.1365-313X.2006.02911.x; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; NAKAI M, 1993, BIOCHIM BIOPHYS ACTA, V1174, P282, DOI 10.1016/0167-4781(93)90198-M; Niu S, 1996, GENE, V175, P187, DOI 10.1016/0378-1119(96)00146-1; O'Rourke TW, 2002, MOL CELL BIOL, V22, P4086, DOI 10.1128/MCB.22.12.4086-4093.2002; OHTSUKA T, 1993, J BIOL CHEM, V268, P22914; OHTSUKA T, 1993, J BIOL CHEM, V268, P22908; Osman C., 2008, CHARACTERIZATION GEN; Osman C, 2009, J CELL BIOL, V184, P583, DOI 10.1083/jcb.200810189; Potting C, 2010, EMBO J, V29, P2888, DOI 10.1038/emboj.2010.169; Powers WJ, 2007, NEUROBIOL DIS, V27, P99, DOI 10.1016/j.nbd.2007.04.008; Reeve S, 2007, GENESIS, V45, P66, DOI 10.1002/dvg.20265; Sesaki H, 2006, J CELL BIOL, V173, P651, DOI 10.1083/jcb.200603092; SIKORSKI RS, 1989, GENETICS, V122, P19; STEWART JCM, 1980, ANAL BIOCHEM, V104, P10, DOI 10.1016/0003-2697(80)90269-9; Tahvanainen J, 2009, BLOOD, V113, P1268, DOI 10.1182/blood-2008-07-166553; Tamura Y, 2010, EMBO J, V29, P2875, DOI 10.1038/emboj.2010.149; Tamura Y, 2009, J CELL BIOL, V185, P1029, DOI 10.1083/jcb.200812018; Tolleter D, 2010, BBA-BIOMEMBRANES, V1798, P1926, DOI 10.1016/j.bbamem.2010.06.029; TREGER JM, 1990, MOL CELL BIOL, V10, P3174, DOI 10.1128/MCB.10.6.3174; Tsubouchi A, 2009, DEVELOPMENT, V136, P3757, DOI 10.1242/dev.042135; Vaden DL, 2005, ANAL BIOCHEM, V338, P162, DOI 10.1016/j.ab.2004.11.020; Wise MJ, 2004, TRENDS PLANT SCI, V9, P13, DOI 10.1016/j.tplants.2003.10.012; Wise MJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-52; Zhang M, 2005, J BIOL CHEM, V280, P29403, DOI 10.1074/jbc.M504955200; Zhang M, 2003, J BIOL CHEM, V278, P35204, DOI 10.1074/jbc.M306729200; Zhong Q, 2004, J BIOL CHEM, V279, P32294, DOI 10.1074/jbc.M403275200; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191	56	13	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39141	39152		10.1074/jbc.M111.259853	http://dx.doi.org/10.1074/jbc.M111.259853			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21930701	Green Published, hybrid			2022-12-25	WOS:000296759800033
J	Hsieh, CH; Shyu, WC; Chiang, CY; Kuo, JW; Shen, WC; Liu, RS				Hsieh, Chia-Hung; Shyu, Woei-Cherng; Chiang, Chien-Yi; Kuo, Jung-Wen; Shen, Wu-Chung; Liu, Ren-Shyan			NADPH Oxidase Subunit 4-Mediated Reactive Oxygen Species Contribute to Cycling Hypoxia-Promoted Tumor Progression in Glioblastoma Multiforme	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION ACTIVITY; INTERMITTENT HYPOXIA; INDUCIBLE-FACTOR; FREE-RADICALS; GROWTH-FACTOR; TRANSCRIPTIONAL ACTIVITY; REGULATE ANGIOGENESIS; CANCER; CELL; HIF-1	Background: Cycling and chronic tumor hypoxia are involved in tumor development and growth. However, the impact of cycling hypoxia and its molecular mechanism on glioblastoma multiforme (GBM) progression remain unclear. Methodology: Glioblastoma cell lines, GBM8401 and U87, and their xenografts were exposed to cycling hypoxic stress in vitro and in vivo. Reactive oxygen species (ROS) production in glioblastoma cells and xenografts was assayed by in vitro ROS analysis and in vivo molecular imaging studies. NADPH oxidase subunit 4 (Nox4) RNAi-knockdown technology was utilized to study the role of Nox4 in cycling hypoxia-mediated ROS production and tumor progression. Furthermore, glioblastoma cells were stably transfected with a retroviral vector bearing a dual reporter gene cassette that allowed for dynamic monitoring of HIF-1 signal transduction and tumor cell growth in vitro and in vivo, using optical and nuclear imaging. Tempol, an antioxidant compound, was used to investigate the impact of ROS on cycling hypoxia-mediated HIF-1 activation and tumor progression. Principal Findings: Glioblastoma cells and xenografts were compared under cycling hypoxic and normoxic conditions; upregulation of NOX4 expression and ROS levels were observed under cycling hypoxia in glioblastoma cells and xenografts, concomitant with increased tumor cell growth in vitro and in vivo. However, knockdown of Nox4 inhibited these effects. Moreover, in vivo molecular imaging studies demonstrated that Tempol is a good antioxidant compound for inhibiting cycling hypoxia-mediated ROS production, HIF-1 activation, and tumor growth. Immunofluorescence imaging and flow cytometric analysis for NOX4, HIF-1 activation, and Hoechst 3342 in glioblastoma also revealed high localized NOX4 expression predominantly in potentially cycling hypoxic areas with HIF-1 activation and blood perfusion within the endogenous solid tumor microenvironment. Conclusions: Cycling hypoxia-induced ROS via Nox4 is a critical aspect of cancer biology to consider for therapeutic targeting of cycling hypoxia-promoted HIF-1 activation and tumor progression in GBM.	[Hsieh, Chia-Hung] China Med Univ & Hosp, Grad Inst Basic Med Sci, Taichung, Taiwan; [Shyu, Woei-Cherng] China Med Univ & Hosp, Dept Neurol, Ctr Neuropsychiat, Taichung, Taiwan; [Shyu, Woei-Cherng] China Med Univ & Hosp, Grad Inst Immunol, Taichung, Taiwan; [Chiang, Chien-Yi] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Kuo, Jung-Wen; Liu, Ren-Shyan] Natl Yang Ming Univ, Dept Nucl Med, Sch Med, Sch Biomed Sci & Engn, Taipei 112, Taiwan; [Shen, Wu-Chung] China Med Univ & Hosp, Dept Radiol, Taichung, Taiwan; [Liu, Ren-Shyan] Taipei Vet Gen Hosp, Dept Nucl Med, Natl PET Cyclotron Ctr, Taipei, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; National Yang Ming Chiao Tung University; China Medical University Taiwan; China Medical University Hospital - Taiwan; Taipei Veterans General Hospital	Hsieh, CH (corresponding author), China Med Univ & Hosp, Grad Inst Basic Med Sci, Taichung, Taiwan.	chhsiehcmu@mail.cmu.edu.tw			National Science Council, Taiwan (NSC) [97-2314-B-039-033-MY3]; China Medical University, Taichung, Taiwan [CMU98-N1-06, CMU98-BC-02]	National Science Council, Taiwan (NSC)(Ministry of Science and Technology, Taiwan); China Medical University, Taichung, Taiwan(China Medical University)	This study was supported by grant NSC 97-2314-B-039-033-MY3 from the National Science Council, Taiwan and grant CMU98-N1-06 and CMU98-BC-02 from China Medical University, Taichung, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramov AY, 2007, J NEUROSCI, V27, P1129, DOI 10.1523/JNEUROSCI.4468-06.2007; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Brat DJ, 2003, ANN INTERN MED, V138, P659, DOI 10.7326/0003-4819-138-8-200304150-00014; Brown DI, 2009, FREE RADICAL BIO MED, V47, P1239, DOI 10.1016/j.freeradbiomed.2009.07.023; Cairns RA, 2004, CANCER RES, V64, P2054, DOI 10.1158/0008-5472.CAN-03-3196; Cairns RA, 2001, CANCER RES, V61, P8903; CHAPLIN DJ, 1985, BRIT J CANCER, V51, P569, DOI 10.1038/bjc.1985.79; CHAPLIN DJ, 1986, INT J RADIAT ONCOL, V12, P1279, DOI 10.1016/0360-3016(86)90153-7; COLEMAN CN, 1988, J NATL CANCER I, V80, P310, DOI 10.1093/jnci/80.5.310; Dewhirst MW, 2008, NAT REV CANCER, V8, P425, DOI 10.1038/nrc2397; Dewhirst MW, 2009, RADIAT RES, V172, P653, DOI 10.1667/RR1926.1; Graham KA, 2010, CANCER BIOL THER, V10, DOI 10.4161/cbt.10.3.12207; Griguer CE, 2006, CANCER RES, V66, P2257, DOI 10.1158/0008-5472.CAN-05-3364; Hamanaka RB, 2009, CURR OPIN CELL BIOL, V21, P894, DOI 10.1016/j.ceb.2009.08.005; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hsieh CH, 2010, ONCOL REP, V24, P1629, DOI 10.3892/or_00001027; Hsieh CH, 2009, J NUCL MED, V50, P2049, DOI 10.2967/jnumed.108.061234; Jensen RL, 2009, J NEURO-ONCOL, V92, P317, DOI 10.1007/s11060-009-9827-2; Kamata T, 2009, CANCER SCI, V100, P1382, DOI 10.1111/j.1349-7006.2009.01207.x; Kaur B, 2005, NEURO-ONCOLOGY, V7, P134, DOI 10.1215/S1152851704001115; Kielland A, 2009, FREE RADICAL BIO MED, V47, P760, DOI 10.1016/j.freeradbiomed.2009.06.013; Lee YM, 2006, CELL SIGNAL, V18, P499, DOI 10.1016/j.cellsig.2005.05.025; Liou GY, 2010, FREE RADICAL RES, V44, P479, DOI 10.3109/10715761003667554; Lu JP, 2010, PROSTATE CANCER P D, V13, P39, DOI 10.1038/pcan.2009.24; Maranchie JK, 2005, CANCER RES, V65, P9190, DOI 10.1158/0008-5472.CAN-05-2105; Martinive P, 2006, CANCER RES, V66, P11736, DOI 10.1158/0008-5472.CAN-06-2056; Moeller BJ, 2004, CANCER CELL, V5, P429, DOI 10.1016/S1535-6108(04)00115-1; Nauseef WM, 2008, J BIOL CHEM, V283, P16961, DOI 10.1074/jbc.R700045200; Sarkaria JN, 2006, CLIN CANCER RES, V12, P2264, DOI 10.1158/1078-0432.CCR-05-2510; Semenza GL, 2002, TRENDS MOL MED, V8, pS62, DOI 10.1016/S1471-4914(02)02317-1; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Senturk S, 2010, HEPATOLOGY, V52, P966, DOI 10.1002/hep.23769; Serganova I, 2004, CANCER RES, V64, P6101, DOI 10.1158/0008-5472.CAN-04-0842; Shono T, 2008, INT J CANCER, V123, P787, DOI 10.1002/ijc.23569; Simon MC, 2006, ADV EXP MED BIOL, V588, P165; Szulc Jolanta, 2008, V434, P291, DOI 10.1007/978-1-60327-248-3_18; Toffoli S, 2008, FEBS J, V275, P2991, DOI 10.1111/j.1742-4658.2008.06454.x; Xia C, 2007, CANCER RES, V67, P10823, DOI 10.1158/0008-5472.CAN-07-0783; Yamaura M, 2009, CANCER RES, V69, P2647, DOI 10.1158/0008-5472.CAN-08-3745; Yuan GX, 2005, J BIOL CHEM, V280, P4321, DOI 10.1074/jbc.M407706200	40	77	79	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e23945	10.1371/journal.pone.0023945	http://dx.doi.org/10.1371/journal.pone.0023945			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21935366	Green Published, gold, Green Submitted			2022-12-25	WOS:000295041700003
J	Aalberse, JA; Kapitein, B; de Roock, S; Klein, MR; de Jager, W; van der Zee, R; Hoekstra, MO; van Wijk, F; Prakken, BJ				Aalberse, Joost A.; Kapitein, Berber; de Roock, Sytze; Klein, Mark R.; de Jager, Wilco; van der Zee, Ruurd; Hoekstra, Maarten O.; van Wijk, Femke; Prakken, Berent J.			Cord Blood CD4(+) T Cells Respond to Self Heat Shock Protein 60 (HSP60)	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; JUVENILE IDIOPATHIC ARTHRITIS; EPITOPE-SPECIFIC IMMUNOTHERAPY; PHASE-II TRIAL; RHEUMATOID-ARTHRITIS; IMMUNE DEVIATION; SYNOVIAL-FLUID; DOUBLE-BLIND; INFLAMMATION; TOLERANCE	Background: To prevent harmful autoimmunity most immune responses to self proteins are controlled by central and peripheral tolerance. T cells specific for a limited set of self-proteins such as human heat shock protein 60 (HSP60) may contribute to peripheral tolerance. It is not known whether HSP60-specific T cells are present at birth and thus may play a role in neonatal tolerance. We studied whether self-HSP60 reactive T cells are present in cord blood, and if so, what phenotype these cells have. Methodology/Principal Findings: Cord blood mononuclear cells (CBMC) of healthy, full term neonates (n = 21), were cultured with HSP60 and Tetanus Toxoid (TT) to study antigen specific proliferation, cytokine secretion and up-regulation of surface markers. The functional capacity of HSP60-induced T cells was determined with in vitro suppression assays. Stimulation of CBMC with HSP60 led to CD4(+) T cell proliferation and the production of various cytokines, most notably IL-10, Interferon-gamma, and IL-6. HSP60-induced T cells expressed FOXP3 and suppressed effector T cell responses in vitro. Conclusion: Self-reactive HSP60 specific T cells are already present at birth. Upon stimulation with self-HSP60 these cells proliferate, produce cytokines and express FOXP3. These cells function as suppressor cells in vitro and thus they may be involved in the regulation of neonatal immune responses.	[Aalberse, Joost A.; Kapitein, Berber; de Roock, Sytze; Klein, Mark R.; de Jager, Wilco; van Wijk, Femke; Prakken, Berent J.] Wilhelmina Childrens Hosp, Dept Pediat Immunol, Utrecht, Netherlands; [van der Zee, Ruurd] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Utrecht, Netherlands; [Hoekstra, Maarten O.] Radboud Univ Nijmegen, Med Ctr, Dept Pediat, NL-6525 ED Nijmegen, Netherlands	Wilhelmina Kinderziekenhuis; Utrecht University; Radboud University Nijmegen	Aalberse, JA (corresponding author), Wilhelmina Childrens Hosp, Dept Pediat Immunol, Utrecht, Netherlands.	jaalber2@umcutrecht.nl	van der Zee, Ruurd/O-5256-2015	van der Zee, Ruurd/0000-0002-4331-2755; de Jager, Wilco/0000-0002-0014-0682				ANDERTON SM, 1993, EUR J IMMUNOL, V23, P33, DOI 10.1002/eji.1830230107; ANDERTON SM, 1995, J EXP MED, V181, P943, DOI 10.1084/jem.181.3.943; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; COHEN IR, 1991, IMMUNOL TODAY, V12, P105, DOI 10.1016/0167-5699(91)90093-9; d'Hennezel E, 2009, NEW ENGL J MED, V361, P1710, DOI 10.1056/NEJMc0907093; de Jager W, 2005, J IMMUNOL METHODS, V300, P124, DOI 10.1016/j.jim.2005.03.009; de Kleer IM, 2004, J IMMUNOL, V172, P6435, DOI 10.4049/jimmunol.172.10.6435; de Kleer IM, 2003, ARTHRITIS RHEUM, V48, P2001, DOI 10.1002/art.11174; de Kleer I, 2010, J IMMUNOL, V185, P2071, DOI 10.4049/jimmunol.0901901; FISCHER HP, 1991, EUR J IMMUNOL, V21, P2937, DOI 10.1002/eji.1830211207; JANEWAY C, 2005, IMMUNOBIOLOGY IMMUNE, P12; Kamphuis S, 2005, LANCET, V366, P50, DOI 10.1016/S0140-6736(05)66827-4; KAUFMANN SHE, 1990, IMMUNOL TODAY, V11, P129, DOI 10.1016/0167-5699(90)90050-J; Koffeman EC, 2009, ARTHRITIS RHEUM-US, V60, P3207, DOI 10.1002/art.24916; Lacroix-Desmazes S, 1998, J IMMUNOL METHODS, V216, P117, DOI 10.1016/S0022-1759(98)00074-X; Levy O, 2006, J IMMUNOL, V177, P1956, DOI 10.4049/jimmunol.177.3.1956; Lillicrap MS, 2004, INT IMMUNOL, V16, P405, DOI 10.1093/intimm/dxh032; Merbl Y, 2007, J CLIN INVEST, V117, P712, DOI 10.1172/JCI29943; Prakken BJ, 2004, P NATL ACAD SCI USA, V101, P4228, DOI 10.1073/pnas.0400061101; Quintana FJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004026; Quintana Francisco J, 2008, Novartis Found Symp, V291, P101; Ramage JM, 1999, J IMMUNOL, V162, P704; Raz I, 2001, LANCET, V358, P1749, DOI 10.1016/S0140-6736(01)06801-5; Romagnoli P, 2002, J IMMUNOL, V168, P1644, DOI 10.4049/jimmunol.168.4.1644; Sakaguchi S, 2000, CELL, V101, P455, DOI 10.1016/S0092-8674(00)80856-9; Thornton CA, 2004, J IMMUNOL, V173, P3084, DOI 10.4049/jimmunol.173.5.3084; Tsan MF, 2004, CELL MOL IMMUNOL, V1, P274; van Eden W, 2005, NAT REV IMMUNOL, V5, P318, DOI 10.1038/nri1593; van Wijk F, 2010, J LEUKOCYTE BIOL, V88, P431, DOI 10.1189/jlb.0410236; VANEDEN W, 1988, NATURE, V331, P171, DOI 10.1038/331171a0; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707	31	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2011	6	9							e24119	10.1371/journal.pone.0024119	http://dx.doi.org/10.1371/journal.pone.0024119			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZV	21931651	Green Submitted, Green Published, gold			2022-12-25	WOS:000295321800019
J	Pusic, KM; Hashimoto, CN; Lehrer, A; Aniya, C; Clements, DE; Hui, GS				Pusic, Kae M.; Hashimoto, Caryn N.; Lehrer, Axel; Aniya, Charmaine; Clements, David E.; Hui, George S.			T Cell Epitope Regions of the P. falciparum MSP1-33 Critically Influence Immune Responses and In Vitro Efficacy of MSP1-42 Vaccines	PLOS ONE			English	Article							MEROZOITE SURFACE PROTEIN-1; CARBOXYL-TERMINAL FRAGMENT; PROTECTS AOTUS MONKEYS; PLASMODIUM-FALCIPARUM; INHIBITORY ANTIBODIES; ADJUVANT FORMULATIONS; PROCESSING FRAGMENT; MALARIA-NAIVE; ANTIGEN; IMMUNIZATION	The C-terminal 42 kDa fragments of the P. falciparum Merozoite Surface Protein 1, MSP1-42 is a leading malaria vaccine candidate. MSP1-33, the N-terminal processed fragment of MSP1-42, is rich in T cell epitopes and it is hypothesized that they enhance antibody response toward MSP1-19. Here, we gave in vivo evidence that T cell epitope regions of MSP1-33 provide functional help in inducing anti-MSP1-19 antibodies. Eleven truncated MSP1-33 segments were expressed in tandem with MSP1-19, and immunogenicity was evaluated in Swiss Webster mice and New Zealand White rabbits. Analyses of anti-MSP119 antibody responses revealed striking differences in these segments' helper function despite that they all possess T cell epitopes. Only a few fragments induced a generalized response (100%) in outbred mice. These were comparable to or surpassed the responses observed with the full length MSP1-42. In rabbits, only a subset of truncated antigens induced potent parasite growth inhibitory antibodies. Notably, two constructs were more efficacious than MSP1-42, with one containing only conserved T cell epitopes. Moreover, another T cell epitope region induced high titers of non-inhibitory antibodies and they interfered with the inhibitory activities of anti-MSP1-42 antibodies. In mice, this region also induced a skewed TH2 cellular response. This is the first demonstration that T cell epitope regions of MSP1-33 positively or negatively influenced antibody responses. Differential recognition of these regions by humans may play critical roles in vaccine induced and/or natural immunity to MSP1-42. This study provides the rational basis to re-engineer more efficacious MSP1-42 vaccines by selective inclusion and exclusion of MSP1-33 specific T cell epitopes.	[Pusic, Kae M.; Hashimoto, Caryn N.; Hui, George S.] Univ Hawaii, John A Burns Sch Med, Dept Trop Med Med Microbiol & Pharmacol, Honolulu, HI 96822 USA; [Lehrer, Axel; Aniya, Charmaine; Clements, David E.] Hawaii Biotech Inc, Aiea, HI USA	University of Hawaii System	Pusic, KM (corresponding author), Univ Hawaii, John A Burns Sch Med, Dept Trop Med Med Microbiol & Pharmacol, Honolulu, HI 96822 USA.	kae@hawaii.edu			National Institute of Allergies and Infectious Diseases [AI051021, AI045768, AI076955]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045768, R21AI076955, R43AI051021] Funding Source: NIH RePORTER	National Institute of Allergies and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was funded by the National Institute of Allergies and Infectious Diseases. Grant number #AI051021, AI045768, AI076955. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Axel Lehrer and Charmaine Anya were employed by Hawaii Biotech Incat the time of the study, and David E. Clements is employed by Hawaii Biotech Inc. These authors helped design and perform the experiments and with the analysis of the data. Axel Lehrer is currently employed by PantheraBioPharma.	Ahlborg N, 2000, INFECT IMMUN, V68, P2102, DOI 10.1128/IAI.68.4.2102-2109.2000; AlYaman F, 1996, AM J TROP MED HYG, V54, P443, DOI 10.4269/ajtmh.1996.54.443; ANGOV E, 2007, AM J TROPICAL MED HY, V77; BLACKMAN MJ, 1991, MOL BIOCHEM PARASIT, V49, P29, DOI 10.1016/0166-6851(91)90127-R; BOUHAROUNTAYOUN H, 1995, J EXP MED, V182, P409, DOI 10.1084/jem.182.2.409; BURNS JM, 1988, P NATL ACAD SCI USA, V85, P602, DOI 10.1073/pnas.85.2.602; BURNS JM, 1989, J IMMUNOL, V142, P2835; Chang SP, 1996, INFECT IMMUN, V64, P253, DOI 10.1128/IAI.64.1.253-261.1996; CHANG SP, 1992, J IMMUNOL, V149, P548; CHANG SP, 1989, P NATL ACAD SCI USA, V86, P6343, DOI 10.1073/pnas.86.16.6343; CULP JS, 1991, BIO-TECHNOL, V9, P173, DOI 10.1038/nbt0291-173; DALY TM, 1995, J IMMUNOL, V155, P236; Datta SK, 1998, LUPUS, V7, P591, DOI 10.1191/096120398678920703; Draper SJ, 2009, CELL HOST MICROBE, V5, P95, DOI 10.1016/j.chom.2008.12.004; Egan AF, 2000, INFECT IMMUN, V68, P1418, DOI 10.1128/IAI.68.3.1418-1427.2000; Egan AF, 1999, PARASITE IMMUNOL, V21, P133, DOI 10.1046/j.1365-3024.1999.00209.x; Ellis RD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008787; Eslava I, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-46; Goodman AL, 2010, INFECT IMMUN, V78, P4601, DOI 10.1128/IAI.00315-10; Guevara-Patino JA, 1997, J EXP MED, V186, P1689, DOI 10.1084/jem.186.10.1689; Hirunpetcharat C, 1997, J IMMUNOL, V159, P3400; HOLDER AA, 1984, J EXP MED, V160, P624, DOI 10.1084/jem.160.2.624; HOLDER AA, 1985, NATURE, V317, P270, DOI 10.1038/317270a0; Holder AA, 1999, PARASSITOLOGIA, VOL 41, NOS 1-3, SEPTEMBER 1999, P409; Hui G, 2008, CLIN VACCINE IMMUNOL, V15, P1145, DOI 10.1128/CVI.00058-08; Hui G, 2007, VACCINE, V25, P8549, DOI 10.1016/j.vaccine.2007.10.010; Hui G, 2007, VACCINE, V25, P948, DOI 10.1016/j.vaccine.2006.08.041; HUI GSN, 1994, J IMMUNOL, V153, P2544; HUI GSN, 1994, J IMMUNOL, V153, P1195; HUI GSN, 1987, EXP PARASITOL, V64, P519, DOI 10.1016/0014-4894(87)90068-3; John CC, 2004, J IMMUNOL, V173, P666, DOI 10.4049/jimmunol.173.1.666; Kumar S, 2000, INFECT IMMUN, V68, P2215, DOI 10.1128/IAI.68.4.2215-2223.2000; LANZAVECCHIA A, 1985, NATURE, V314, P537, DOI 10.1038/314537a0; Lee EAM, 2001, AM J TROP MED HYG, V64, P194, DOI 10.4269/ajtmh.2001.64.194; Lee EAM, 2006, EUR J IMMUNOL, V36, P1168, DOI 10.1002/eji.200526010; Leung WH, 2004, BBA-GEN SUBJECTS, V1675, P62, DOI 10.1016/j.bbagen.2004.08.005; Malhotra I, 2008, J IMMUNOL, V180, P3383, DOI 10.4049/jimmunol.180.5.3383; MALKIN E, 2007, PLOS CLIN TRIALS, V2, pC12; MCBRIDE JS, 1987, MOL BIOCHEM PARASIT, V23, P71, DOI 10.1016/0166-6851(87)90189-7; McIntosh RS, 2007, PLOS PATHOG, V3, P647, DOI 10.1371/journal.ppat.0030072; MCKEAN PG, 1993, MOL BIOCHEM PARASIT, V62, P199, DOI 10.1016/0166-6851(93)90109-B; MILICH DR, 1987, J IMMUNOL, V138, P4457; MILICH DR, 1988, IMMUNOL TODAY, V9, P380, DOI 10.1016/0167-5699(88)91239-X; Murhandarwati EEH, 2010, INFECT IMMUN, V78, P680, DOI 10.1128/IAI.00939-09; Murhandarwati EEH, 2009, INFECT IMMUN, V77, P4510, DOI 10.1128/IAI.00360-09; Nagata M, 2007, EXP PARASITOL, V115, P403, DOI 10.1016/j.exppara.2006.10.005; O'Donnell RA, 2001, J EXP MED, V193, P1403, DOI 10.1084/jem.193.12.1403; Ogutu BR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004708; Pang ALY, 2002, INFECT IMMUN, V70, P2772, DOI 10.1128/IAI.70.6.2772-2779.2002; Perraut R, 2005, J INFECT DIS, V191, P264, DOI 10.1086/426398; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; Sette A, 2008, IMMUNITY, V28, P847, DOI 10.1016/j.immuni.2008.04.018; SIDDIQUI WA, 1987, P NATL ACAD SCI USA, V84, P3014, DOI 10.1073/pnas.84.9.3014; Singh H, 2001, BIOINFORMATICS, V17, P1236, DOI 10.1093/bioinformatics/17.12.1236; Singh S, 2006, INFECT IMMUN, V74, P4573, DOI 10.1128/IAI.01679-05; Stanisic DI, 2003, J IMMUNOL, V171, P5461, DOI 10.4049/jimmunol.171.10.5461; Stoute JA, 2007, VACCINE, V25, P176, DOI 10.1016/j.vaccine.2005.11.037; Stowers AW, 2001, INFECT IMMUN, V69, P1536, DOI 10.1128/IAI.69.3.1536-1546.2001; Tian JH, 1998, PARASITE IMMUNOL, V20, P263, DOI 10.1046/j.1365-3024.1998.00138.x; Tian JH, 1996, J IMMUNOL, V157, P1176; UDHAYAKUMAR V, 1995, J IMMUNOL, V154, P6022; Valero LMS, 1998, INFECT IMMUN, V66, P3925, DOI 10.1128/IAI.66.8.3925-3930.1998; Wipasa J, 2002, J IMMUNOL, V169, P944, DOI 10.4049/jimmunol.169.2.944; Yuen D, 2007, VACCINE, V25, P490, DOI 10.1016/j.vaccine.2006.07.053	64	11	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2011	6	9							e24782	10.1371/journal.pone.0024782	http://dx.doi.org/10.1371/journal.pone.0024782			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZV	21931852	Green Published, gold, Green Submitted			2022-12-25	WOS:000295321800063
J	Tucker, JD; Peng, H; Wang, KD; Chang, H; Zhang, SM; Yang, LG; Yang, B				Tucker, Joseph D.; Peng, Hua; Wang, Kaidi; Chang, Helena; Zhang, Sen-Miao; Yang, Li-Gang; Yang, Bin			Female Sex Worker Social Networks and STI/HIV Prevention in South China	PLOS ONE			English	Article							HIV PREVENTION; ENTERTAINMENT WORKERS; RISK-FACTORS; YUNNAN PROVINCE; MIGRANT WORKERS; KAIYUAN CITY; INFECTION; BEHAVIOR; INTERVENTION; HEALTH	Background: Reducing harm associated with selling and purchasing sex is an important public health priority in China, yet there are few examples of sustainable, successful programs to promote sexual health among female sex workers. The limited civil society and scope of nongovernmental organizations circumscribe the local capacity of female sex workers to collectively organize, advocate for their rights, and implement STI/HIV prevention programs. The purpose of this study was to examine social networks among low-income female sex workers in South China to determine their potential for sexual health promotion. Methods/Principal Findings: Semi-structured interviews with 34 low-income female sex workers and 28 health outreach members were used to examine how social relationships affected condom use and negotiation, STI/HIV testing and health-seeking behaviors, and dealing with violent clients. These data suggested that sex worker's laoxiang (hometown social connections) were more powerful than relationships between women selling sex at the same venue in establishing the terms and risk of commercial sex. Female sex workers from the same hometown often migrated to the city with their laoxiang and these social connections fulfilled many of the functions of nongovernmental organizations, including collective mobilization, condom promotion, violence mitigation, and promotion of health-seeking behaviors. Outreach members observed that sex workers accompanied by their laoxiang were often more willing to accept STI/HIV testing and trust local sexual health services. Conclusions/Significance: Organizing STI/HIV prevention services around an explicitly defined laoxiang social network may provide a strong foundation for sex worker health programs. Further research on dyadic interpersonal relationships between female sex workers, group dynamics and norm establishment, and the social network characteristics are needed.	[Tucker, Joseph D.] Massachusetts Gen Hosp, Infect Dis Unit, Boston, MA 02114 USA; [Tucker, Joseph D.; Peng, Hua; Zhang, Sen-Miao; Yang, Li-Gang; Yang, Bin] Guangdong Prov STD Control Ctr, Guangzhou, Guangdong, Peoples R China; [Wang, Kaidi] Harvard Univ, Sch Med, Boston, MA USA; [Chang, Helena] Univ Calif San Francisco, Dept Urol, San Francisco, CA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of California System; University of California San Francisco	Tucker, JD (corresponding author), Massachusetts Gen Hosp, Infect Dis Unit, Boston, MA 02114 USA.	jtucker4@partners.org		Tucker, Joseph/0000-0003-2804-1181	National Institutes of Health [US NIH 1K01TW008200-01A1]; Harvard Institute for Global Health; FOGARTY INTERNATIONAL CENTER [K01TW008200] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Institute for Global Health; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Support for this research came from an National Institutes of Health Fogarty K01 Award (US NIH 1K01TW008200-01A1) and the Harvard Institute for Global Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern J, 2008, AM J EPIDEMIOL, V167, P1041, DOI 10.1093/aje/kwn022; Alagappa Muthiah, 2004, CIVIL SOC POLITICAL; [Anonymous], 2010, B WORLD HEALTH ORGAN, V88, P5, DOI 10.2471/BLT.10.010110; Biradavolu MR, 2009, SOC SCI MED, V68, P1541, DOI 10.1016/j.socscimed.2009.01.040; BOOTH RE, 2010, AM J PUBLIC HLTH; Bun Chan Kwok, 2000, CHINESE BUSINESS NET; Chen XS, 2007, J INFECT DIS, V196, P1654, DOI 10.1086/522008; Chen ZQ, 2007, LANCET, V369, P132, DOI 10.1016/S0140-6736(07)60074-9; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Cornish F, 2007, SOC SCI MED, V64, P496, DOI 10.1016/j.socscimed.2006.09.009; Dedobbeleer N, 2005, WOMEN HEALTH, V41, P63, DOI 10.1300/J013v41n03_04; Entwisle Barbara., 2000, REDRAWING BOUNDARIES; Evans C, 2008, SOC SCI MED, V66, P467, DOI 10.1016/j.socscimed.2007.08.030; Glasier A, 2006, LANCET, V368, P1595, DOI 10.1016/S0140-6736(06)69478-6; Hankins CA, 2010, AIDS, V24, pS70, DOI 10.1097/01.aids.0000390709.04255.fd; Hiltunen-Back E, 2001, SEX TRANSM DIS, V28, P252, DOI 10.1097/00007435-200105000-00002; Hong Y, 2008, AIDS BEHAV, V12, P623, DOI 10.1007/s10461-007-9287-7; Huang YY, 2004, SEX TRANSM DIS, V31, P695, DOI 10.1097/01.olq.0000143107.06988.ea; Jacka T., 2005, RURAL WOMEN URBAN CH; KAUFMAN J, 2011, J INFECT DIS; Li SH, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-195; Li XM, 2007, AIDS EDUC PREV, V19, P396, DOI 10.1521/aeap.2007.19.5.396; Li Y, 2010, HEALTH PROMOT INT, V25, P371, DOI 10.1093/heapro/daq020; Lin P., 2009, Morbidity and Mortality Weekly Report, V58, P396; Lippman SA, 2010, AM J PUBLIC HEALTH, V100, pS216, DOI 10.2105/AJPH.2008.147462; Lu L, 2008, NATURE, V455, P609, DOI 10.1038/455609a; MA LJC, 1998, CHINA QUART, V155, P546, DOI DOI 10.2307/655950; Mantell JE, 2011, HEALTH EDUC RES, V26, P283, DOI 10.1093/her/cyr002; Mobrand E., 2007, J COMP ASIAN DEV, V6, P337; Mou J, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-214; Murray LR, 2010, CULT HEALTH SEX, V12, P293, DOI 10.1080/13691050903450122; Padian NS, 2008, LANCET, V372, P585, DOI 10.1016/S0140-6736(08)60885-5; Parish WL, 2003, JAMA-J AM MED ASSOC, V289, P1265, DOI 10.1001/jama.289.10.1265; Peng YC, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-69; Perry ElizabethJ., 2002, CHANGING MEANINGS CI; Pirkle C, 2007, SEX TRANSM DIS, V34, P695, DOI 10.1097/01.olq.0000260989.70866.94; Rekart ML, 2005, LANCET, V366, P2123, DOI 10.1016/S0140-6736(05)67732-X; Shahmanesh M, 2009, SOC SCI MED, V69, P604, DOI 10.1016/j.socscimed.2009.06.020; Sherman SG, 2009, SOC SCI MED, V68, P69, DOI 10.1016/j.socscimed.2008.09.061; SOLINGER DJ, 2005, NARRATIVES CHINESE E; Swendeman D, 2009, SOC SCI MED, V69, P1157, DOI 10.1016/j.socscimed.2009.07.035; Tucker J. D., 2009, GENDER POLICY HIV CH; Tucker JD, 2005, AIDS, V19, P539, DOI 10.1097/01.aids.0000163929.84154.87; TUCKER JD, 2011, INT J EPIDEMIOLOGY; TUCKER JD, 2011, JAIDS; TUCKER JD, 2011, J INFECT DI IN PRESS; TUCKER JD, 2010, NEW ENGLAND J MED; Tucker JD, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-58; Vargo S, 2004, AM J PUBLIC HEALTH, V94, P29, DOI 10.2105/AJPH.94.1.29; WANG B, 2009, SEX TRANSM DIS; Wang H, 2009, SEX TRANSM INFECT, V85, P290, DOI 10.1136/sti.2008.033100; Wang HB, 2009, INT J INFECT DIS, V13, P162, DOI 10.1016/j.ijid.2008.05.1229; Wang Q, 2009, CHIN J AIDS STDS, V15, P398; Weeks MR, 2010, AIDS EDUC PREV, V22, P252, DOI 10.1521/aeap.2010.22.3.252; WOODHOUSE DE, 1994, AIDS, V8, P1331, DOI 10.1097/00002030-199409000-00018; Xia GM, 2005, AIDS EDUC PREV, V17, P143, DOI 10.1521/aeap.17.3.143.62904; Yamazaki M, 2010, SEX TRANSM INFECT, V86, P548, DOI 10.1136/sti.2009.040626; Yang C, 2010, J URBAN HEALTH, V87, P292, DOI 10.1007/s11524-009-9431-y; Yang XS, 2006, AIDS EDUC PREV, V18, P333, DOI 10.1521/aeap.2006.18.4.333; Yang XS, 2010, AIDS EDUC PREV, V22, P69, DOI 10.1521/aeap.2010.22.1.69; Yi HS, 2010, PSYCHOL HEALTH MED, V15, P172, DOI 10.1080/13548501003623914; 2010, CHINA 2010 UNGASS CO	63	35	38	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2011	6	9							e24816	10.1371/journal.pone.0024816	http://dx.doi.org/10.1371/journal.pone.0024816			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	825ZV	21931856	gold, Green Published, Green Submitted			2022-12-25	WOS:000295321800067
J	Li, LF; Chen, BX; Tsai, YH; Kao, WWY; Yang, CT; Chu, PH				Li, Li-Fu; Chen, Bao-Xiang; Tsai, Ying-Huang; Kao, Winston W. -Y.; Yang, Cheng-Ta; Chu, Pao-Hsien			Lumican Expression in Diaphragm Induced by Mechanical Ventilation	PLOS ONE			English	Article							ACUTE LUNG INJURY; RESPIRATORY-DISTRESS-SYNDROME; INDUCED PULMONARY-FIBROSIS; GROWTH-FACTOR-BETA; OXIDATIVE STRESS; TISSUE-REPAIR; TGF-BETA; DYSFUNCTION; PROTEOGLYCANS; ACTIVATION	Background: Diaphragmatic dysfunction found in the patients with acute lung injury required prolonged mechanical ventilation. Mechanical ventilation can induce production of inflammatory cytokines and excess deposition of extracellular matrix proteins via up-regulation of transforming growth factor (TGF)-beta 1. Lumican is known to participate in TGF-beta 1 signaling during wound healing. The mechanisms regulating interactions between mechanical ventilation and diaphragmatic injury are unclear. We hypothesized that diaphragmatic damage by short duration of mechanical stretch caused up-regulation of lumican that modulated TGF-beta 1 signaling. Methods: Male C57BL/6 mice, either wild-type or lumican-null, aged 3 months, weighing between 25 and 30 g, were exposed to normal tidal volume (10 ml/kg) or high tidal volume (30 ml/kg) mechanical ventilation with room air for 2 to 8 hours. Nonventilated mice served as control groups. Results: High tidal volume mechanical ventilation induced interfibrillar disassembly of diaphragmatic collagen fiber, lumican activation, type I and III procollagen, fibronectin, and alpha-smooth muscle actin (alpha-SMA) mRNA, production of free radical and TGF-beta 1 protein, and positive staining of lumican in diaphragmatic fiber. Mechanical ventilation of lumican deficient mice attenuated diaphragmatic injury, type I and III procollagen, fibronectin, and alpha-SMA mRNA, and production of free radical and TGF-beta 1 protein. No significant diaphragmatic injury was found in mice subjected to normal tidal volume mechanical ventilation. Conclusion: Our data showed that high tidal volume mechanical ventilation induced TGF-beta 1 production, TGF-beta 1-inducible genes, e. g., collagen, and diaphragmatic dysfunction through activation of the lumican.	[Li, Li-Fu; Tsai, Ying-Huang; Yang, Cheng-Ta] Chang Gung Mem Hosp, Div Pulm & Crit Care Med, Dept Internal Med, Taipei 10591, Taiwan; [Li, Li-Fu; Yang, Cheng-Ta; Chu, Pao-Hsien] Chang Gung Univ, Dept Med, Coll Med, Tao Yuan, Taiwan; [Chen, Bao-Xiang] Chang Gung Univ, Grad Inst Clin Med Sci, Coll Med, Tao Yuan, Taiwan; [Chen, Bao-Xiang; Tsai, Ying-Huang] Chang Gung Univ, Dept Resp Care, Coll Med, Tao Yuan, Taiwan; [Chen, Bao-Xiang] Natl Taiwan Univ Hosp, Sect Resp Care, Dept Integrated Diagnotherapeut, Taipei, Taiwan; [Kao, Winston W. -Y.] Univ Cincinnati, Coll Med, Dept Ophthalmol, Crawley Vis Res Ctr, Cincinnati, OH USA; [Chu, Pao-Hsien] Chang Gung Mem Hosp, Cardiovasc Div 1, Dept Internal Med, Taipei 10591, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung University; National Taiwan University; National Taiwan University Hospital; University System of Ohio; University of Cincinnati; Chang Gung Memorial Hospital	Li, LF (corresponding author), Chang Gung Mem Hosp, Div Pulm & Crit Care Med, Dept Internal Med, 199 Tung Hwa N Rd, Taipei 10591, Taiwan.	yang1946@adm.cgmh.org.tw; pchu@adm.cgmh.org.tw	Chu, Pao-Hsien/P-5249-2019; Chu, Pao-Hsien/G-3685-2010	Chu, Pao-Hsien/0000-0003-0361-6348; Yang, Cheng-Ta/0000-0003-1846-1027	National Science Council, Taiwan [98-2314-B-182A-084-MY3, 96-2314-B-182-026-, 97-2314-B-182-028-MY2, 99-2314-B-182-042-MY3]; NIH/NEI [EY011845]; Research to Prevent Blindness; Ohio Lions Eye Research Foundations; NATIONAL EYE INSTITUTE [R01EY011845] Funding Source: NIH RePORTER	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); NIH/NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Ohio Lions Eye Research Foundations; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The work was supported by National Science Council, Taiwan 98-2314-B-182A-084-MY3 (L.-F.Li); 96-2314-B-182-026-, 97-2314-B-182-028-MY2, and 99-2314-B-182-042-MY3 (P.-H. Chu); and NIH/NEI grant EY011845, Research to Prevent Blindness and Ohio Lions Eye Research Foundations (W.W.Y. Kao). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostini Carlo, 2006, Proc Am Thorac Soc, V3, P357, DOI 10.1513/pats.200601-010TK; Al-Jamal R, 2001, AM J PHYSIOL-LUNG C, V281, pL1078, DOI 10.1152/ajplung.2001.281.5.L1078; Bai KJ, 2005, AM J RESP CRIT CARE, V172, P92, DOI 10.1164/rccm.200405-652OC; Bartram U, 2004, CHEST, V125, P754, DOI 10.1378/chest.125.2.754; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Chakravarti S, 2006, DEV DYNAM, V235, P2493, DOI 10.1002/dvdy.20868; Chaudhary NI, 2006, AM J RESP CRIT CARE, V173, P769, DOI 10.1164/rccm.200505-717OC; Chen J, 2005, DIABETES, V54, P2143, DOI 10.2337/diabetes.54.7.2143; de Carvalho MEP, 2007, CRIT CARE, V11, DOI 10.1186/cc5702; Dolhnikoff M, 1998, AM J RESP CELL MOL, V19, P582, DOI 10.1165/ajrcmb.19.4.2979; Dreyfuss D, 1998, AM J RESP CRIT CARE, V157, P294, DOI 10.1164/ajrccm.157.1.9604014; Fahy RJ, 2003, AM J RESP CELL MOL, V28, P499, DOI 10.1165/rcmb.2002-0092OC; Held HD, 2001, AM J RESP CRIT CARE, V163, P711, DOI 10.1164/ajrccm.163.3.2003001; Higashiyama H, 2007, EXP MOL PATHOL, V83, P39, DOI 10.1016/j.yexmp.2006.12.003; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Jubran A, 2006, RESPIR CARE, V51, P1054; Kao WWY, 2006, EXP EYE RES, V82, P3, DOI 10.1016/j.exer.2005.08.012; Levine S, 2008, NEW ENGL J MED, V358, P1327, DOI 10.1056/NEJMoa070447; Li LF, 2004, AM J RESP CRIT CARE, V169, P518, DOI 10.1164/rccm.200305-660OC; Li LF, 2011, TRANSL RES, V157, P293, DOI 10.1016/j.trsl.2010.12.009; Li LF, 2008, CRIT CARE, V12, DOI 10.1186/cc6983; Ludwig MS, 2007, J APPL PHYSIOL, V103, P735, DOI 10.1152/japplphysiol.00751.2007; Matthay MA, 2003, AM J RESP CRIT CARE, V167, P1027, DOI 10.1164/rccm.200208-966WS; McClung JM, 2009, CRIT CARE MED, V37, P1373, DOI 10.1097/CCM.0b013e31819cef63; Moriondo A, 2007, J APPL PHYSIOL, V103, P747, DOI 10.1152/japplphysiol.00056.2007; Petrof BJ, 2010, CURR OPIN CRIT CARE, V16, P19, DOI 10.1097/MCC.0b013e328334b166; Pittet JF, 2001, J CLIN INVEST, V107, P1537, DOI 10.1172/JCI11963; Saika S, 2000, J BIOL CHEM, V275, P2607, DOI 10.1074/jbc.275.4.2607; Takala TE, 2000, SCAND J MED SCI SPOR, V10, P321, DOI 10.1034/j.1600-0838.2000.010006321.x; VARGA J, 1987, BIOCHEM J, V247, P597, DOI 10.1042/bj2470597; Vassilakopoulos T, 2008, INTENS CARE MED, V34, P7, DOI 10.1007/s00134-007-0866-x; Whidden MA, 2009, J APPL PHYSIOL, V106, P385, DOI 10.1152/japplphysiol.91106.2008; Ying SX, 1997, J BIOL CHEM, V272, P30306, DOI 10.1074/jbc.272.48.30306; Zergeroglu MA, 2003, J APPL PHYSIOL, V95, P1116, DOI 10.1152/japplphysiol.00824.2002	34	27	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2011	6	9							e24692	10.1371/journal.pone.0024692	http://dx.doi.org/10.1371/journal.pone.0024692			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CN	21931815	Green Published, Green Submitted, gold			2022-12-25	WOS:000294803100057
J	Goncalves, A; Burckstummer, T; Dixit, E; Scheicher, R; Gorna, MW; Karayel, E; Sugar, C; Stukalov, A; Berg, T; Kralovics, R; Planyavsky, M; Bennett, KL; Colinge, J; Superti-Furga, G				Goncalves, Adriana; Buerckstuemmer, Tilmann; Dixit, Evelyn; Scheicher, Ruth; Gorna, Maria W.; Karayel, Evren; Sugar, Cristina; Stukalov, Alexey; Berg, Tiina; Kralovics, Robert; Planyavsky, Melanie; Bennett, Keiryn L.; Colinge, Jacques; Superti-Furga, Giulio			Functional Dissection of the TBK1 Molecular Network	PLOS ONE			English	Article							INTERFERON ANTIVIRAL RESPONSE; INNATE IMMUNE-RESPONSE; KINASE-RELATED KINASES; TANK-BINDING KINASE-1; KAPPA-B ACTIVATION; IKK-EPSILON; SIGNALING PATHWAYS; CYTOPLASMIC DNA; VIRAL-INFECTION; ADAPTER	TANK-binding kinase 1 (TBK1) and inducible I kappa B-kinase (IKK-i) are central regulators of type-I interferon induction. They are associated with three adaptor proteins called TANK, Sintbad (or TBKBP1) and NAP1 (or TBKBP2, AZI2) whose functional relationship to TBK1 and IKK-i is poorly understood. We performed a systematic affinity purification-mass spectrometry approach to derive a comprehensive TBK1/IKK-i molecular network. The most salient feature of the network is the mutual exclusive interaction of the adaptors with the kinases, suggesting distinct alternative complexes. Immunofluorescence data indicated that the individual adaptors reside in different subcellular locations. TANK, Sintbad and NAP1 competed for binding of TBK1. The binding site for all three adaptors was mapped to the C-terminal coiled-coil 2 region of TBK1. Point mutants that affect binding of individual adaptors were used to reconstitute TBK1/IKK-i-deficient cells and dissect the functional relevance of the individual kinase-adaptor edges within the network. Using a microarray-derived gene expression signature of TBK1 in response virus infection or poly(I: C) stimulation, we found that TBK1 activation was strictly dependent on the integrity of the TBK1/TANK interaction.	[Goncalves, Adriana; Buerckstuemmer, Tilmann; Dixit, Evelyn; Scheicher, Ruth; Gorna, Maria W.; Karayel, Evren; Sugar, Cristina; Stukalov, Alexey; Berg, Tiina; Kralovics, Robert; Planyavsky, Melanie; Bennett, Keiryn L.; Colinge, Jacques; Superti-Furga, Giulio] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1010 Vienna, Austria	Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences	Goncalves, A (corresponding author), Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1010 Vienna, Austria.	tbuerckstuemmer@cemm.oeaw.ac.at; gsuperti@cemm.oeaw.ac.at	Górna, Maria/F-4269-2014; Stukalov, Alexey/AAS-3208-2021; Superti-Furga, Giulio/F-4755-2015; Superti-Furga, Giulio/AAE-5681-2019; Colinge, Jacques/Z-2613-2019; Colinge, Jacques/D-1578-2017	Górna, Maria/0000-0002-1769-4542; Stukalov, Alexey/0000-0002-4981-8124; Superti-Furga, Giulio/0000-0002-0570-1768; Colinge, Jacques/0000-0003-2466-4824; Colinge, Jacques/0000-0003-2466-4824; Burckstummer, Tilmann/0000-0001-5681-8045; Bennett, Keiryn L./0000-0001-9356-7708; Buerckstuemmer, Tilmann/0000-0002-5961-0829; Kralovics, Robert/0000-0002-6997-8539	GEN-AU consortium [820962, 820965]; ERC [250179]	GEN-AU consortium; ERC(European Research Council (ERC)European Commission)	The work presented here was supported by the GEN-AU consortium (BIN-III grant (820962) to J.C.; APP-III grant (820965) to K. L. B.) and an ERC Advanced Investigator Grant (I-FIVE grant (250179) to G. S. F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett KL, 2011, J PROTEOMICS, V74, P151, DOI 10.1016/j.jprot.2010.10.002; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Burckstummer T, 2006, NAT METHODS, V3, P1013, DOI 10.1038/nmeth968; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Chariot A, 2002, J BIOL CHEM, V277, P37029, DOI 10.1074/jbc.M205069200; Chau TL, 2008, TRENDS BIOCHEM SCI, V33, P171, DOI 10.1016/j.tibs.2008.01.002; Cheng GH, 1996, GENE DEV, V10, P963, DOI 10.1101/gad.10.8.963; Chien YC, 2006, CELL, V127, P157, DOI 10.1016/j.cell.2006.08.034; Clark K, 2009, J BIOL CHEM, V284, P14136, DOI 10.1074/jbc.M109.000414; Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Fujita F, 2003, MOL CELL BIOL, V23, P7780, DOI 10.1128/MCB.23.21.7780-7793.2003; Guo BC, 2007, J BIOL CHEM, V282, P11817, DOI 10.1074/jbc.M700017200; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; HACKER H, 2006, SCI STKE, DOI DOI 10.1126/STKE.3572006RE13; Haura EB, 2011, J PROTEOME RES, V10, P182, DOI 10.1021/pr100863f; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Ikeda F, 2007, EMBO J, V26, P3451, DOI 10.1038/sj.emboj.7601773; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kawagoe T, 2009, NAT IMMUNOL, V10, P965, DOI 10.1038/ni.1771; Mao AP, 2010, J BIOL CHEM, V285, P9470, DOI 10.1074/jbc.M109.071043; Mason JM, 2004, CHEMBIOCHEM, V5, P170, DOI 10.1002/cbic.200300781; Miyahira AK, 2009, J IMMUNOL, V182, P2248, DOI 10.4049/jimmunol.0802466; Ou YH, 2011, MOL CELL, V41, P458, DOI 10.1016/j.molcel.2011.01.019; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Parvatiyar K, 2010, J BIOL CHEM, V285, P14999, DOI 10.1074/jbc.M110.109819; Perry AK, 2004, J EXP MED, V199, P1651, DOI 10.1084/jem.20040528; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012; Pomerantz JL, 1999, EMBO J, V18, P6694, DOI 10.1093/emboj/18.23.6694; Radtke AL, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030029; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; RYZHAKOV G, 2007, EMBO J; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; Sasai M, 2006, J IMMUNOL, V177, P8676, DOI 10.4049/jimmunol.177.12.8676; Schroder M, 2008, EMBO J, V27, P2147, DOI 10.1038/emboj.2008.143; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Shembade N, 2008, NAT IMMUNOL, V9, P254, DOI 10.1038/ni1563; Soulat D, 2008, EMBO J, V27, P2135, DOI 10.1038/emboj.2008.126; Thurston TLM, 2009, NAT IMMUNOL, V10, P1215, DOI 10.1038/ni.1800; Tojima Y, 2000, NATURE, V404, P778, DOI 10.1038/35008109; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Zhao TJ, 2007, NAT IMMUNOL, V8, P592, DOI 10.1038/ni1465	45	90	95	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e23971	10.1371/journal.pone.0023971	http://dx.doi.org/10.1371/journal.pone.0023971			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CK	21931631	Green Submitted, gold, Green Published			2022-12-25	WOS:000294802800016
J	Yao, L; Zhang, Y; Chen, KY; Hu, XF; Xu, LSX				Yao, Ling; Zhang, Yan; Chen, Keying; Hu, Xiaofang; Xu, Lisa X.			Discovery of IL-18 As a Novel Secreted Protein Contributing to Doxorubicin Resistance by Comparative Secretome Analysis of MCF-7 and MCF-7/Dox	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; BREAST-CANCER CELLS; DRUG-RESISTANCE; AUTOCRINE PRODUCTION; CARCINOMA CELLS; UP-REGULATION; PREDICTION; INTERLEUKIN-18; CHEMOTHERAPY; MECHANISM	Background: Resistance to chemotherapy is the major cause of failure in breast cancer treatment. Recent studies suggest that secreted proteins may play important roles in chemoresistance. We sought to systematically characterize secreted proteins associated with drug resistance, which may represent potential serum biomarkers or novel drug targets. Methodology/Principal Findings: In the present work, we adopted the proteomic strategy of one-dimensional gel electrophoresis followed by liquid chromatography-tandem mass spectrometry to compare the secretome of MCF-7 and doxorubicin-resistant MCF-7/Dox. A total of 2,084 proteins were identified with at least two unique peptides in the conditioned media of two cell lines. By quantification with label-free spectral counting, 89 differentially expressed secreted proteins (DESPs) between the two cell lines were found. Among them, 57 DESPs were first found to be related to doxorubicin resistance in this work, including 24 extracellular matrix related proteins, 2 cytokines and 31 unclassified proteins. We focused on 13 novel DESPs with confirmed roles in tumor metastasis. Among them, the elevated expression of IL-18 in doxorubicin-resistant cell lines and breast tumor tissues was validated and its role in doxorubicin resistance was further confirmed by cell viability experiments in the presence or absence of this protein. Conclusions/Significance: Comparative analysis of the secretome of MCF-7 and MCF-7/Dox identified novel secreted proteins related to chemotherapy resistance. IL-18 was further validated to contribute to doxorubicin resistance, in addition to its confirmed role in breast cancer metastasis. Due to its dual roles in both drug resistance and tumor metastasis, IL-18 may represent a useful drug target for breast cancer therapy.	[Yao, Ling; Zhang, Yan; Chen, Keying; Hu, Xiaofang; Xu, Lisa X.] Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China; [Yao, Ling; Zhang, Yan; Chen, Keying; Hu, Xiaofang; Xu, Lisa X.] Shanghai Jiao Tong Univ, Med X Res Inst, Shanghai 200030, Peoples R China; [Zhang, Yan] Shanghai Jiao Tong Univ, Minist Educ, Shanghai Ctr Syst Biomed, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Yao, L (corresponding author), Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China.	xfhu@sjtu.edu.cn; lisaxu@sjtu.edu.cn	Zhang, Yan/S-3703-2017	Zhang, Yan/0000-0003-1233-3219	Ministry of Science and Technology of China [2010CB834300]; National Natural Science Foundation of China [50725622, 81071792]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Ministry of Science and Technology of China (973 Program, 2010CB834300), National Natural Science Foundation of China (50725622, 81071792). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn Myung-Ju, 2004, Cancer Res Treat, V36, P43, DOI 10.4143/crt.2004.36.1.43; Arlt A, 2002, CANCER RES, V62, P910; Ayers M, 2004, J CLIN ONCOL, V22, P2284, DOI 10.1200/JCO.2004.05.166; Folgueira MAAK, 2009, ONCOL REP, V22, P805, DOI 10.3892/or_00000503; Bantscheff M, 2007, ANAL BIOANAL CHEM, V389, P1017, DOI 10.1007/s00216-007-1486-6; Beissbarth T, 2004, BIOINFORMATICS, V20, P31, DOI 10.1093/bioinformatics/bth924; Bendtsen JD, 2004, PROTEIN ENG DES SEL, V17, P349, DOI 10.1093/protein/gzh037; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Boivin M, 2009, GYNECOL ONCOL, V115, P407, DOI 10.1016/j.ygyno.2009.08.007; BORSELLINO N, 1995, CANCER RES, V55, P4633; Cao QZ, 2008, CLIN CANCER RES, V14, P6137, DOI 10.1158/1078-0432.CCR-08-0049; Chang PMH, 2008, INT J ONCOL, V33, P549, DOI 10.3892/ijo_00000039; Chen CC, 2009, INT J BIOCHEM CELL B, V41, P771, DOI 10.1016/j.biocel.2008.07.025; Chen PS, 2007, J CELL SCI, V120, P2053, DOI 10.1242/jcs.03460; Chuthapisith S, 2007, INT J ONCOL, V30, P1545; Conze D, 2001, CANCER RES, V61, P8851; Cortesi L, 2009, J PROTEOME RES, V8, P4916, DOI 10.1021/pr900239h; Dinarello CA, 1999, J ALLERGY CLIN IMMUN, V103, P11, DOI 10.1016/S0091-6749(99)70518-X; Dorff TB, 2010, CLIN CANCER RES, V16, P3028, DOI 10.1158/1078-0432.CCR-09-3122; Dressman HK, 2006, CLIN CANCER RES, V12, P819, DOI 10.1158/1078-0432.CCR-05-1447; Fomarini B, 2000, BLOOD, V96, P3282, DOI 10.1182/blood.V96.9.3282.h8003282_3282_3285; Fu ZM, 2005, J PROTEOME RES, V4, P1583, DOI 10.1021/pr0501158; Furukawa T, 2000, ANTICANCER RES, V20, P3657; Gehrmann ML, 2004, J PROTEOME RES, V3, P1063, DOI 10.1021/pr049906k; Gewirtz DA, 1999, BIOCHEM PHARMACOL, V57, P727, DOI 10.1016/S0006-2952(98)00307-4; Gianni L, 2005, J CLIN ONCOL, V23, P7265, DOI 10.1200/JCO.2005.02.0818; Gottesman MM, 2002, ANNU REV MED, V53, P615, DOI 10.1146/annurev.med.53.082901.103929; Gronborg M, 2006, MOL CELL PROTEOMICS, V5, P157, DOI 10.1074/mcp.M500178-MCP200; Gunel N, 2002, CANCER-AM CANCER SOC, V95, P663, DOI 10.1002/cncr.10705; Gyorffy B, 2005, ONCOGENE, V24, P7542, DOI 10.1038/sj.onc.1208908; Gyorffy B, 2006, INT J CANCER, V118, P1699, DOI 10.1002/ijc.21570; Haga A, 1997, CANCER BIOCHEM BIOPH, V15, P275; HARDIN J, 1994, BLOOD, V84, P3063; Hathout Y, 2007, EXPERT REV PROTEOMIC, V4, P239, DOI 10.1586/14789450.4.2.239; HAYWARD JL, 1977, BRIT J CANCER, V35, P292, DOI 10.1038/bjc.1977.42; Hess KR, 2006, J CLIN ONCOL, V24, P4236, DOI 10.1200/JCO.2006.05.6861; Hodgkinson VC, 2010, CANCER LETT, V294, P13, DOI 10.1016/j.canlet.2010.01.036; Hoyt DG, 1996, CANCER RES, V56, P4146; Hu HD, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/571343; Iseri OD, 2010, CANCER CHEMOTH PHARM, V65, P447, DOI 10.1007/s00280-009-1048-z; Jung MK, 2006, IMMUNOL LETT, V107, P125, DOI 10.1016/j.imlet.2006.08.004; Kim KE, 2007, ONCOGENE, V26, P1468, DOI 10.1038/sj.onc.1209926; Kudoh K, 2000, CANCER RES, V60, P4161; Kulasingam V, 2007, MOL CELL PROTEOMICS, V6, P1997, DOI 10.1074/mcp.M600465-MCP200; Liang YH, 2004, INT J CANCER, V111, P484, DOI 10.1002/ijc.20230; Lin MT, 2005, CLIN CANCER RES, V11, P5809, DOI 10.1158/1078-0432.CCR-04-2639; Lin MT, 2004, J BIOL CHEM, V279, P24015, DOI 10.1074/jbc.M402305200; Liu Y, 2006, CANCER RES, V66, P3248, DOI 10.1158/0008-5472.CAN-05-3801; Mina L, 2007, BREAST CANCER RES TR, V103, P197, DOI 10.1007/s10549-006-9366-x; Nielsen H, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P122; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Old WM, 2005, MOL CELL PROTEOMICS, V4, P1487, DOI 10.1074/mcp.M500084-MCP200; Park S, 2007, CELL MOL IMMUNOL, V4, P329; Perbal B, 2008, CLIN CANCER RES, V14, P701, DOI 10.1158/1078-0432.CCR-07-0806; Potti A, 2006, NAT MED, V12, P1294, DOI 10.1038/nm1491; RIVOLTINI L, 1991, INT J CANCER, V47, P746, DOI 10.1002/ijc.2910470521; Rouzier R, 2005, CLIN CANCER RES, V11, P5678, DOI 10.1158/1078-0432.CCR-04-2421; Salter KH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001908; Sethi T, 1999, NAT MED, V5, P662, DOI 10.1038/9511; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Smalley KSM, 2006, MOL CANCER THER, V5, P1136, DOI 10.1158/1535-7163.MCT-06-0084; Staunton JE, 2001, P NATL ACAD SCI USA, V98, P10787, DOI 10.1073/pnas.191368598; Strong R, 2006, J PROTEOME RES, V5, P2389, DOI 10.1021/pr060207c; Tang XR, 2009, NUCL SCI TECH, V20, P286; Turton NJ, 2001, ONCOGENE, V20, P1300, DOI 10.1038/sj.onc.1204235; Vallacchi V, 2009, CELL ADHES MIGR, V3, P7, DOI 10.4161/cam.3.1.6836; Vidal-Vanaclocha F, 2006, CANCER METAST REV, V25, P417, DOI 10.1007/s10555-006-9013-3; Wang CL, 2009, J PROTEOME RES, V8, P4428, DOI 10.1021/pr900160h; Wang MY, 2009, CANCER RES, V69, P3482, DOI 10.1158/0008-5472.CAN-08-2524; Wang Y, 2010, CANCER LETT, V295, P110, DOI 10.1016/j.canlet.2010.02.019; Wu CC, 2010, MOL CELL PROTEOMICS, V9, P1100, DOI 10.1074/mcp.M900398-MCP200; Xie D, 2001, J BIOL CHEM, V276, P14187, DOI 10.1074/jbc.M009755200; Zhang B, 2004, LEUKEMIA RES, V28, P91, DOI 10.1016/S0145-2126(03)00121-8	73	38	39	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e24684	10.1371/journal.pone.0024684	http://dx.doi.org/10.1371/journal.pone.0024684			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CK	21931812	Green Published, Green Submitted, gold			2022-12-25	WOS:000294802800083
J	Chen, JY; Liu, DJ; Jiang, YM; Zhao, ML; Shan, W; Kuang, JF; Lu, WJ				Chen, Jian-ye; Liu, Du-juan; Jiang, Yue-ming; Zhao, Ming-lei; Shan, Wei; Kuang, Jian-fei; Lu, Wang-jin			Molecular Characterization of a Strawberry FaASR Gene in Relation to Fruit Ripening	PLOS ONE			English	Article							ABSCISIC-ACID; ASR GENE; EXPRESSION ANALYSIS; WATER-DEFICIT; ETHYLENE BIOSYNTHESIS; RESPONSIVE GENE; LILY POLLEN; GRAPE; PROTEIN; STRESS	Background: ABA-, stress- and ripening-induced (ASR) proteins have been reported to act as a downstream component involved in ABA signal transduction. Although much attention has been paid to the roles of ASR in plant development and stress responses, the mechanisms by which ABA regulate fruit ripening at the molecular level are not fully understood. In the present work, a strawberry ASR gene was isolated and characterized (FaASR), and a polyclonal antibody against FaASR protein was prepared. Furthermore, the effects of ABA, applied to two different developmental stages of strawberry, on fruit ripening and the expression of FaASR at transcriptional and translational levels were investigated. Methodology/Principal Findings: FaASR, localized in the cytoplasm and nucleus, contained 193 amino acids and shared common features with other plant ASRs. It also functioned as a transcriptional activator in yeast with trans-activation activity in the N-terminus. During strawberry fruit development, endogenous ABA content, levels of FaASR mRNA and protein increased significantly at the initiation of ripening at a white (W) fruit developmental stage. More importantly, application of exogenous ABA to large green (LG) fruit and W fruit markedly increased endogenous ABA content, accelerated fruit ripening, and greatly enhanced the expression of FaASR transcripts and the accumulation of FaASR protein simultaneously. Conclusions: These results indicate that FaASR may be involved in strawberry fruit ripening. The observed increase in endogenous ABA content, and enhanced FaASR expression at transcriptional and translational levels in response to ABA treatment might partially contribute to the acceleration of strawberry fruit ripening.	[Chen, Jian-ye; Liu, Du-juan; Zhao, Ming-lei; Shan, Wei; Kuang, Jian-fei; Lu, Wang-jin] S China Agr Univ, Coll Hort Sci, Guangdong Key Lab Postharvest Sci, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou, Guangdong, Peoples R China; [Jiang, Yue-ming] Chinese Acad Sci, S China Bot Garden, Guangzhou, Guangdong, Peoples R China	South China Agricultural University; Chinese Academy of Sciences; South China Botanical Garden, CAS	Chen, JY (corresponding author), S China Agr Univ, Coll Hort Sci, Guangdong Key Lab Postharvest Sci, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou, Guangdong, Peoples R China.	wjlu@scau.edu.cn	Zhao, Minglei/V-3884-2018; Jiang, Yueming/AAJ-5538-2020; Chen, Jian-ye/V-8278-2019	Zhao, Minglei/0000-0002-2763-4180; Jiang, Yueming/0000-0002-4648-9572; Chen, Jian-ye/0000-0002-8975-6941; Kuang, Jianfei/0000-0001-9192-2155	National Key Technology R&D Program of China [2011BAD24B02]; Guangdong Science Foundation [06200670]	National Key Technology R&D Program of China(National Key Technology R&D Program); Guangdong Science Foundation	This project was supported in part by the National Key Technology R&D Program of China (grant No. 2011BAD24B02) and Guangdong Science Foundation (grant No. 06200670). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2003, PLANT CELL, V15, P63, DOI 10.1105/tpc.006130; ABEL S, 1994, PLANT J, V5, P421, DOI 10.1111/j.1365-313X.1994.00421.x; Aharoni A, 2002, PLANT PHYSIOL, V129, P1019, DOI 10.1104/pp.003558; Aharoni A, 2002, J EXP BOT, V53, P2073, DOI 10.1093/jxb/erf026; Alexander L, 2002, J EXP BOT, V53, P2039, DOI 10.1093/jxb/erf072; ARCHBOLD DD, 1988, HORTSCIENCE, V23, P880; ARCHBOLD DD, 1984, J AM SOC HORTIC SCI, V109, P330; Ban T, 2003, J HORTIC SCI BIOTECH, V78, P586, DOI 10.1080/14620316.2003.11511668; Bustamante CA, 2009, PLANT SCI, V177, P49, DOI 10.1016/j.plantsci.2009.03.015; Cakir B, 2003, PLANT CELL, V15, P2165, DOI 10.1105/tpc.013854; CANEL C, 1995, PLANT PHYSIOL, V108, P1323, DOI 10.1104/pp.108.3.1323; Chernys JT, 2000, PLANT PHYSIOL, V124, P343, DOI 10.1104/pp.124.1.343; Chervin C, 2004, PLANT SCI, V167, P1301, DOI 10.1016/j.plantsci.2004.06.026; Civello PM, 1999, PLANT PHYSIOL, V121, P1273, DOI 10.1104/pp.121.4.1273; Csukasi F, 2011, NEW PHYTOL, V191, P376, DOI 10.1111/j.1469-8137.2011.03700.x; Davies C, 1997, PLANT PHYSIOL, V115, P1155, DOI 10.1104/pp.115.3.1155; Fait A, 2008, PLANT PHYSIOL, V148, P730, DOI 10.1104/pp.108.120691; Fei ZJ, 2004, PLANT J, V40, P47, DOI 10.1111/j.1365-313X.2004.02188.x; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Frankel N, 2007, PLANT MOL BIOL, V63, P719, DOI 10.1007/s11103-006-9120-0; Frankel N, 2006, GENE, V378, P74, DOI 10.1016/j.gene.2006.05.010; Fu FQ, 2008, J EXP BOT, V59, P2299, DOI 10.1093/jxb/ern093; Gambetta GA, 2010, PLANTA, V232, P219, DOI 10.1007/s00425-010-1165-2; Giovannoni J, 2001, ANNU REV PLANT PHYS, V52, P725, DOI 10.1146/annurev.arplant.52.1.725; Giovannoni JJ, 2004, PLANT CELL, V16, pS170, DOI 10.1105/tpc.019158; Giribaldi M, 2010, J EXP BOT, V61, P2447, DOI 10.1093/jxb/erq079; GIVEN NK, 1988, PLANTA, V174, P402, DOI 10.1007/BF00959527; Gonzalez-Garcia MP, 2003, PLANT PHYSIOL, V133, P135, DOI 10.1104/pp.103.025569; Griesser M, 2008, J EXP BOT, V59, P2611, DOI 10.1093/jxb/ern117; Harpster MH, 1998, PLANT PHYSIOL, V118, P1307, DOI 10.1104/pp.118.4.1307; Hong SH, 2002, J EXP BOT, V53, P2271, DOI 10.1093/jxb/erf075; HOUDE M, 1995, PLANT J, V8, P583, DOI 10.1046/j.1365-313X.1995.8040583.x; Huang JC, 2000, PLANT CELL PHYSIOL, V41, P477, DOI 10.1093/pcp/41.4.477; Iannetta PPM, 2006, PHYSIOL PLANTARUM, V127, P247, DOI 10.1111/j.1399-3054.2006.00656.x; IUSEM ND, 1993, PLANT PHYSIOL, V102, P1353, DOI 10.1104/pp.102.4.1353; Jeanneau M, 2002, BIOCHIMIE, V84, P1127, DOI 10.1016/S0300-9084(02)00024-X; Jeong ST, 2004, PLANT SCI, V167, P247, DOI 10.1016/j.plantsci.2004.03.021; Jiang YM, 2003, PLANT GROWTH REGUL, V39, P171, DOI 10.1023/A:1022539901044; Kalifa Y, 2004, PLANT CELL ENVIRON, V27, P1459, DOI 10.1111/j.1365-3040.2004.01251.x; Kalifa Y, 2004, BIOCHEM J, V381, P373, DOI 10.1042/BJ20031800; KANO Y, 1981, J JPN SOC HORTIC SCI, V50, P31, DOI 10.2503/jjshs.50.31; Kojima K., 1996, Chemical Regulation of Plants, V31, P68; Kondo S, 1998, J HORTIC SCI BIOTECH, V73, P467, DOI 10.1080/14620316.1998.11511000; Kondo S, 1997, J HORTIC SCI BIOTECH, V72, P221, DOI 10.1080/14620316.1997.11515509; Konrad Z, 2008, PLANTA, V227, P1213, DOI 10.1007/s00425-008-0693-5; Lacampagne S, 2010, J PLANT GROWTH REGUL, V29, P81, DOI 10.1007/s00344-009-9115-6; Lee S, 2010, FUNCT INTEGR GENOMIC, V10, P135, DOI 10.1007/s10142-009-0136-9; Li X, 2010, CRIT REV PLANT SCI, V29, P222, DOI 10.1080/07352689.2010.487776; Lin ZF, 2009, J EXP BOT, V60, P3311, DOI 10.1093/jxb/erp204; Liu DJ, 2011, MOL BIOL REP, V38, P1187, DOI 10.1007/s11033-010-0216-x; Liu HY, 2010, J INTEGR PLANT BIOL, V52, P315, DOI 10.1111/j.1744-7909.2010.00912.x; Mahdieh M, 2009, J PLANT PHYSIOL, V166, P1993, DOI 10.1016/j.jplph.2009.06.001; MANNING K, 1994, PLANTA, V194, P62, DOI 10.1007/BF00201035; Manning K, 1998, PLANTA, V205, P622, DOI 10.1007/s004250050365; MARTINEZ GA, 1994, J PLANT GROWTH REGUL, V13, P87, DOI 10.1007/BF00210952; Maskin L, 2001, PLANT SCI, V161, P739, DOI 10.1016/S0168-9452(01)00464-2; Mukkun L, 2009, SCI HORTIC-AMSTERDAM, V123, P5, DOI 10.1016/j.scienta.2009.07.006; Nam YW, 1999, PLANT MOL BIOL, V39, P629, DOI 10.1023/A:1006179928312; Padmanabhan V, 1997, PLANT MOL BIOL, V35, P801, DOI 10.1023/A:1005897921567; Perkins-Veazie P., 1995, Horticultural Reviews, V17, P267, DOI 10.1002/9780470650585.ch8; Pimentel P, 2010, J PLANT PHYSIOL, V167, P1179, DOI 10.1016/j.jplph.2010.03.006; Riccardi F, 1998, PLANT PHYSIOL, V117, P1253, DOI 10.1104/pp.117.4.1253; Saravanan RS, 2004, PROTEOMICS, V4, P2522, DOI 10.1002/pmic.200300789; Saumonneau A, 2008, FEBS LETT, V582, P3281, DOI 10.1016/j.febslet.2008.09.015; Schneider A, 1997, PLANT PHYSIOL, V113, P335, DOI 10.1104/pp.113.2.335; Shen G, 2005, PLANT PHYSIOL BIOCH, V43, P836, DOI 10.1016/j.plaphy.2005.06.010; Shkolnik D, 2008, PLANT BIOTECHNOL J, V6, P368, DOI 10.1111/j.1467-7652.2008.00328.x; SILHAVY D, 1995, PLANT MOL BIOL, V27, P587, DOI 10.1007/BF00019324; Symons GM, 2006, PLANT PHYSIOL, V140, P150, DOI 10.1104/pp.105.070706; Tian L, 2006, PROTEIN EXPRES PURIF, V50, P223, DOI 10.1016/j.pep.2006.06.003; Tisza V, 2010, PLANT PHYSIOL BIOCH, V48, P822, DOI 10.1016/j.plaphy.2010.08.001; Trainotti L, 2005, J EXP BOT, V56, P2037, DOI 10.1093/jxb/eri202; Urtasun Nicolas, 2010, Open Biochem J, V4, P68, DOI 10.2174/1874091X01004010068; Vaidyanathan R, 1999, PLANT SCI, V140, P21, DOI 10.1016/S0168-9452(98)00194-0; WAN CY, 1994, ANAL BIOCHEM, V223, P7, DOI 10.1006/abio.1994.1538; Wang CS, 1998, PLANT CELL PHYSIOL, V39, P1307, DOI 10.1093/oxfordjournals.pcp.a029335; Wang HJ, 2005, PHYSIOL PLANTARUM, V123, P314, DOI 10.1111/j.1399-3054.2005.00454.x; Wheeler S, 2009, AUST J GRAPE WINE R, V15, P195, DOI 10.1111/j.1755-0238.2008.00045.x; Yang CY, 2005, PLANT PHYSIOL, V139, P836, DOI 10.1104/pp.105.065458; Yoneda Y, 2000, GENES CELLS, V5, P777, DOI 10.1046/j.1365-2443.2000.00366.x; Zhang FJ, 2008, PHYTOCHEM ANALYSIS, V19, P560, DOI 10.1002/pca.1085; Zhang JJ, 2011, J EXP BOT, V62, P1103, DOI 10.1093/jxb/erq343; Zhang M, 2009, J PLANT PHYSIOL, V166, P1241, DOI 10.1016/j.jplph.2009.01.013; Zhang M, 2009, J EXP BOT, V60, P1579, DOI 10.1093/jxb/erp026; Zhu SH, 2007, FOOD CHEM, V100, P1517, DOI 10.1016/j.foodchem.2005.12.022	85	48	61	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2011	6	9							e24649	10.1371/journal.pone.0024649	http://dx.doi.org/10.1371/journal.pone.0024649			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817QP	21915355	Green Published, Green Submitted, gold			2022-12-25	WOS:000294689200055
J	Chen, YJ; Tian, X; Kim, WY; Snider, WD				Chen, Youjun; Tian, Xu; Kim, Woo-Yang; Snider, William D.			Adenomatous Polyposis Coli Regulates Axon Arborization and Cytoskeleton Organization via Its N-Terminus	PLOS ONE			English	Article							TUMOR-SUPPRESSOR APC; BETA-CATENIN; NEURONAL POLARITY; CELL POLARIZATION; EPITHELIAL-CELLS; ACTIN-FILAMENTS; PLASMA-MEMBRANE; CEREBRAL-CORTEX; EXCHANGE FACTOR; PROTEIN	Conditional deletion of APC leads to marked disruption of cortical development and to excessive axonal branching of cortical neurons. However, little is known about the cell biological basis of this neuronal morphological regulation. Here we show that APC deficient cortical neuronal growth cones exhibit marked disruption of both microtubule and actin cytoskeleton. Functional analysis of the different APC domains revealed that axonal branches do not result from stabilized beta-catenin, and that the C-terminus of APC containing microtubule regulatory domains only partially rescues the branching phenotype. Surprisingly, the N-terminus of APC containing the oligomerization domain and the armadillo repeats completely rescues the branching and cytoskeletal abnormalities. Our data indicate that APC is required for appropriate axon morphological development and that the N-terminus of APC is important for regulation of the neuronal cytoskeleton.	[Chen, Youjun; Snider, William D.] Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27515 USA; [Chen, Youjun; Snider, William D.] Univ N Carolina, Sch Med, Ctr Neurosci, Chapel Hill, NC USA; [Tian, Xu] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Anhui, Peoples R China; [Tian, Xu] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China; [Kim, Woo-Yang] Univ Nebraska Med Ctr, Munroe Meyer Inst, Dept Dev Neurosci, Omaha, NE USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of Nebraska System; University of Nebraska Medical Center	Chen, YJ (corresponding author), Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27515 USA.	william_snider@med.unc.edu	Tian, Xu/A-3951-2015; Chen, Youjun/G-4066-2015; Chen, Youjun/N-2571-2014; , UNC Neuroscience Microscopy Core/AAE-8305-2022	Tian, Xu/0000-0001-8174-5669; Chen, Youjun/0000-0003-4162-6897; Chen, Youjun/0000-0003-4162-6897; 	National Institutes of Health [RO1 NS050968, P30 NS045892]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045892, R01NS050968] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grant RO1 NS050968. Imaging was done in the Confocal and Multiphoton Imaging Core supported by National Institutes of Health grant P30 NS045892 (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki K, 2007, J CELL SCI, V120, P3327, DOI 10.1242/jcs.03485; Barth AIM, 2002, J CELL SCI, V115, P1583; Barth AIM, 2008, SEMIN CELL DEV BIOL, V19, P245, DOI 10.1016/j.semcdb.2008.02.003; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Brocardo M, 2005, EMBO REP, V6, P184, DOI 10.1038/sj.embor.7400329; Dent EW, 2004, J NEUROSCI, V24, P3002, DOI 10.1523/JNEUROSCI.4963-03.2004; Dent EW, 2001, J NEUROSCI, V21, P9757, DOI 10.1523/JNEUROSCI.21-24-09757.2001; Etienne-Manneville S, 2005, J CELL BIOL, V170, P895, DOI 10.1083/jcb.200412172; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; Geraldo S, 2009, J CELL SCI, V122, P3595, DOI 10.1242/jcs.042309; Hamann MJ, 2007, MOL CELL BIOL, V27, P1380, DOI 10.1128/MCB.01608-06; Iizuka-Kogo A, 2005, HISTOCHEM CELL BIOL, V123, P67, DOI 10.1007/s00418-004-0729-2; Ishidate T, 2000, ONCOGENE, V19, P365, DOI 10.1038/sj.onc.1203309; Ivaniutsin U, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-3; Jimbo T, 2002, NAT CELL BIOL, V4, P323, DOI 10.1038/ncb779; Kawasaki Y, 2007, ONCOGENE, V26, P7620, DOI 10.1038/sj.onc.1210574; Kawasaki Y, 2003, NAT CELL BIOL, V5, P211, DOI 10.1038/ncb937; Kawasaki Y, 2000, SCIENCE, V289, P1194, DOI 10.1126/science.289.5482.1194; Kennell J, 2009, ADV EXP MED BIOL, V656, P1, DOI 10.1007/978-1-4419-1145-2_1; Kita K, 2006, MOL BIOL CELL, V17, P2331, DOI 10.1091/mbc.E05-06-0498; Koester MP, 2007, J NEUROSCI, V27, P12590, DOI 10.1523/JNEUROSCI.2250-07.2007; Li ZY, 2005, CANCER RES, V65, P5195, DOI 10.1158/0008-5472.CAN-04-4609; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Lowery LA, 2009, NAT REV MOL CELL BIO, V10, P332, DOI 10.1038/nrm2679; Mattie FJ, 2010, CURR BIOL, V20, P2169, DOI 10.1016/j.cub.2010.11.050; Mimori-Kiyosue Y, 2000, J CELL BIOL, V148, P505, DOI 10.1083/jcb.148.3.505; Nakagawa H, 1998, CANCER RES, V58, P5176; Nakamura M, 2001, CURR BIOL, V11, P1062, DOI 10.1016/S0960-9822(01)00297-4; Nathke IS, 1996, J CELL BIOL, V134, P165, DOI 10.1083/jcb.134.1.165; Ouch Y, 2005, J CELL SCI, V118, P4473, DOI 10.1242/jcs.02575; Purro SA, 2008, J NEUROSCI, V28, P8644, DOI 10.1523/JNEUROSCI.2320-08.2008; Rusan NM, 2008, J CELL BIOL, V183, P203, DOI 10.1083/jcb.200807079; Shi SH, 2004, CURR BIOL, V14, P2025, DOI 10.1016/j.cub.2004.11.009; Shibata H, 1997, SCIENCE, V278, P120, DOI 10.1126/science.278.5335.120; Smits R, 1999, GENE DEV, V13, P1309, DOI 10.1101/gad.13.10.1309; Tago K, 2000, GENE DEV, V14, P1741; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Votin V, 2005, J CELL SCI, V118, P5699, DOI 10.1242/jcs.02679; Wang J, 2008, J BIOL CHEM, V283, P21668, DOI 10.1074/jbc.M709939200; Watanabe T, 2004, DEV CELL, V7, P871, DOI 10.1016/j.devcel.2004.10.017; Wrobel CN, 2007, DEV BIOL, V309, P285, DOI 10.1016/j.ydbio.2007.07.013; Yamana N, 2006, MOL CELL BIOL, V26, P6844, DOI 10.1128/MCB.00283-06; Yokota Y, 2009, NEURON, V61, P42, DOI 10.1016/j.neuron.2008.10.053; Yu X, 2003, NAT NEUROSCI, V6, P1169, DOI 10.1038/nn1132; Zhou FQ, 2004, NEURON, V42, P897, DOI 10.1016/j.neuron.2004.05.011	45	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2011	6	9							e24335	10.1371/journal.pone.0024335	http://dx.doi.org/10.1371/journal.pone.0024335			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817QP	21915313	Green Published, Green Submitted, gold			2022-12-25	WOS:000294689200036
J	Harel, E; Rubinstein, A; Nissan, A; Khazanov, E; Milbauer, MN; Barenholz, Y; Tirosh, B				Harel, Efrat; Rubinstein, Abraham; Nissan, Aviram; Khazanov, Elena; Milbauer, Mirela Nadler; Barenholz, Yechezkel; Tirosh, Boaz			Enhanced Transferrin Receptor Expression by Proinflammatory Cytokines in Enterocytes as a Means for Local Delivery of Drugs to Inflamed Gut Mucosa	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; NEGATIVELY CHARGED LIPOSOMES; LAMINA PROPRIA LYMPHOCYTES; COLONIC EPITHELIAL-CELLS; ACTIVATION; IRON; RAT; INDUCTION; COLITIS; NANOPARTICLES	Therapeutic intervention in inflammatory bowel diseases (IBDs) is often associated with adverse effects related to drug distribution into non-diseased tissues, a situation which attracts a rational design of a targeted treatment confined to the inflamed mucosa. Upon activation of immune cells, transferrin receptor (TfR) expression increases at their surface. Because TfR is expressed in all cell types we hypothesized that its cell surface levels are regulated also in enterocytes. We, therefore, compared TfR expression in healthy and inflamed human colonic mucosa, as well as healthy and inflamed colonic mucosa of the DNBS-induced rat model. TfR expression was elevated in the colonic mucosa of IBD patients in both the basolateral and apical membranes of the enterocytes. Increased TfR expression was also observed in colonocytes of the induced colitis rats. To explore the underlying mechanism CaCo-2 cells were treated with various proinflammatory cytokines, which increased both TfR expression and transferrin cellular uptake in a mechanism that did not involve hyper proliferation. These findings were then exploited for the design of targetable carrier towards inflamed regions of the colon. Anti-TfR antibodies were conjugated to nano-liposomes. As expected, iron-starved Caco-2 cells internalized anti-TfR immunoliposomes better than controls. Ex vivo binding studies to inflamed mucosa showed that the anti-TfR immunoliposomes accumulated significantly better in the mucosa of DNBS-induced rats than the accumulation of non-specific immunoliposomes. It is concluded that targeting mucosal inflammation can be accomplished by nano-liposomes decorated with anti-TfR due to inflammation-dependent, apical, elevated expression of the receptor.	[Harel, Efrat; Rubinstein, Abraham; Khazanov, Elena; Milbauer, Mirela Nadler; Tirosh, Boaz] Hebrew Univ Jerusalem, Inst Drug Res, Jerusalem, Israel; [Nissan, Aviram] Hadassah Hebrew Univ, Med Ctr, Dept Surg, Jerusalem, Israel; [Barenholz, Yechezkel] Hebrew Univ Jerusalem, Lab Membrane & Liposome Res, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem	Harel, E (corresponding author), Hebrew Univ Jerusalem, Inst Drug Res, Jerusalem, Israel.	boazt@ekmd.huji.ac.il		Rubinstein, Abraham/0000-0001-6212-3725	Chief Scientist Office of the Israeli Ministry of Health [01797]	Chief Scientist Office of the Israeli Ministry of Health	The study was supported in part by research grant number 01797 from the Chief Scientist Office of the Israeli Ministry of Health (AR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study. BT and AR are affiliated with the David R. Bloom Center of Pharmacy. BT is affiliated with the Dr. Adolf and Klara Brettler Centre for Research in Molecular Pharmacology and Therapeutics at the Hebrew University.	Barenholz Y., 1993, LIPOSOME TECHNOLOGY, P527; Barth BM, 2010, ACS NANO, V4, P1279, DOI 10.1021/nn901297q; Baumgart DC, 2007, LANCET, V369, P1641, DOI 10.1016/S0140-6736(07)60751-X; Campieri M, 2002, GUT, V50, P43; CANO E, 1990, EUR J IMMUNOL, V20, P765, DOI 10.1002/eji.1830200409; Carter MJ, 2004, GUT, V53, DOI 10.1136/gut.2004.043372; Cu Y, 2009, NAT MATER, V8, P11, DOI 10.1038/nmat2347; Daniels TR, 2006, CLIN IMMUNOL, V121, P144, DOI 10.1016/j.clim.2006.06.010; Daniels TR, 2006, CLIN IMMUNOL, V121, P159, DOI 10.1016/j.clim.2006.06.006; Erichsen K, 2005, SCAND J GASTROENTERO, V40, P1058, DOI 10.1080/00365520510023198; FAIS S, 1989, GASTROENTEROLOGY, V97, P1435, DOI 10.1016/0016-5085(89)90387-9; FAIS S, 1991, J CLIN PATHOL, V44, P290, DOI 10.1136/jcp.44.4.290; FAIS S, 1987, CLIN EXP IMMUNOL, V68, P605; Faraji AH, 2009, BIOORGAN MED CHEM, V17, P2950, DOI 10.1016/j.bmc.2009.02.043; Fiocchi C, 1998, GASTROENTEROLOGY, V115, P182, DOI 10.1016/S0016-5085(98)70381-6; Forster C, 2008, HISTOCHEM CELL BIOL, V130, P55, DOI 10.1007/s00418-008-0424-9; Gravotta D, 2007, P NATL ACAD SCI USA, V104, P1564, DOI 10.1073/pnas.0610700104; Han O, 1997, J NUTR BIOCHEM, V8, P585, DOI 10.1016/S0955-2863(97)00111-3; Hanauer SB, 2008, ALIMENT PHARM THER, V27, P15, DOI 10.1111/j.1365-2036.2008.03606.x; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; HUEBERS HA, 1987, PHYSIOL REV, V67, P520, DOI 10.1152/physrev.1987.67.2.520; Jubeh TT, 2006, J DRUG TARGET, V14, P155, DOI 10.1080/10611860600648429; Jubeh TT, 2005, MOL PHARMACEUT, V2, P2, DOI 10.1021/mp0499095; Jubeh TT, 2004, PHARM RES-DORDR, V21, P447, DOI 10.1023/B:PHAM.0000019298.29561.cd; Kawabata H, 1999, J BIOL CHEM, V274, P20826, DOI 10.1074/jbc.274.30.20826; Kesisoglou Filippos, 2005, Expert Opin Drug Deliv, V2, P451, DOI 10.1517/17425247.2.3.451; Kim S, 2000, J BIOL CHEM, V275, P6220, DOI 10.1074/jbc.275.9.6220; KOHEN R, 1992, J BIOL CHEM, V267, P21349; Korzenik JR, 2006, NAT REV DRUG DISCOV, V5, P197, DOI 10.1038/nrd1986; Krishna ADS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007240; Kucharzik T, 2005, LAB INVEST, V85, P932, DOI 10.1038/labinvest.3700289; Kurtovic Jelica, 2004, Trop Gastroenterol, V25, P9; Lai SK, 2009, ADV DRUG DELIVER REV, V61, P158, DOI 10.1016/j.addr.2008.11.002; Levy JE, 1999, NAT GENET, V21, P396, DOI 10.1038/7727; MANGER B, 1986, J IMMUNOL, V136, P532; Odorizzi G, 1997, J CELL BIOL, V137, P1255, DOI 10.1083/jcb.137.6.1255; PALLONE F, 1988, CLIN EXP IMMUNOL, V74, P75; PALLONE F, 1987, GUT, V28, P745, DOI 10.1136/gut.28.6.745; Rodriguez JA, 2007, J CONTROL RELEASE, V124, P35, DOI 10.1016/j.jconrel.2007.08.020; Scholmerich J, 2003, DIGEST DIS, V21, P180, DOI 10.1159/000073249; SHAH D, 1994, J DRUG TARGET, V2, P93, DOI 10.3109/10611869409015897; SHANKARAN RR, 2007, J PHYS D, V40, P7187; Steidler L, 2000, SCIENCE, V289, P1352, DOI 10.1126/science.289.5483.1352; Tacchini L, 2008, J BIOL CHEM, V283, P20674, DOI 10.1074/jbc.M800365200; TAETLE R, 1988, BLOOD, V71, P1590; Tang BC, 2009, P NATL ACAD SCI USA, V106, P19268, DOI 10.1073/pnas.0905998106; TARGAN SR, 2005, INFLAMMATORY BOWEL D; Tirosh B, 2009, MOL PHARMACEUT, V6, P1083, DOI 10.1021/mp9000926; WALLACE JL, 1995, J PHARMACOL TOXICOL, V33, P237, DOI 10.1016/1056-8719(95)00001-X; Widera A, 2003, ADV DRUG DELIVER REV, V55, P1439, DOI 10.1016/j.addr.2003.07.004	50	46	50	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2011	6	9							e24202	10.1371/journal.pone.0024202	http://dx.doi.org/10.1371/journal.pone.0024202			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817QP	21915296	gold, Green Submitted, Green Published			2022-12-25	WOS:000294689200024
J	Choi, HJ; Fukui, M; Zhu, BT				Choi, Hye Joung; Fukui, Masayuki; Zhu, Bao Ting			Role of Cyclin B1/Cdc2 Up-Regulation in the Development of Mitotic Prometaphase Arrest in Human Breast Cancer Cells Treated with Nocodazole	PLOS ONE			English	Article							KINASE; APOPTOSIS; ACTIVATION; CHECKPOINT; DEATH; PHOSPHORYLATION; ACCUMULATION; MICROTUBULES; COMPLEX; AGENTS	Background: During a normal cell cycle, the transition from G(2) phase to mitotic phase is triggered by the activation of the cyclin B1-dependent Cdc2 kinase. Here we report our finding that treatment of MCF-7 human breast cancer cells with nocodazole, a prototypic microtubule inhibitor, results in strong up-regulation of cyclin B1 and Cdc2 levels, and their increases are required for the development of mitotic prometaphase arrest and characteristic phenotypes. Methodology/Principal Findings: It was observed that there was a time-dependent early increase in cyclin B1 and Cdc2 protein levels (peaking between 12 and 24 h post treatment), and their levels started to decline after the initial increase. This early up-regulation of cyclin B1 and Cdc2 closely matched in timing the nocodazole-induced mitotic prometaphase arrest. Selective knockdown of cyclin B1or Cdc2 each abrogated nocodazole-induced accumulation of prometaphase cells. The nocodazole-induced prometaphase arrest was also abrogated by pre-treatment of cells with roscovitine, an inhibitor of cyclin-dependent kinases, or with cycloheximide, a protein synthesis inhibitor that was found to suppress cyclin B1 and Cdc2 up-regulation. In addition, we found that MAD2 knockdown abrogated nocodazole-induced accumulation of cyclin B1 and Cdc2 proteins, which was accompanied by an attenuation of nocodazole-induced prometaphase arrest. Conclusions/Significance: These observations demonstrate that the strong early up-regulation of cyclin B1 and Cdc2 contributes critically to the rapid and selective accumulation of prometaphase-arrested cells, a phenomenon associated with exposure to microtubule inhibitors.	[Choi, Hye Joung; Fukui, Masayuki; Zhu, Bao Ting] Univ Kansas, Med Ctr, Sch Med, Dept Pharm Toxicol & Therapeut, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center	Choi, HJ (corresponding author), Univ Kansas, Med Ctr, Sch Med, Dept Pharm Toxicol & Therapeut, Kansas City, KS 66103 USA.	BTZhu@kumc.edu			National Institutes of Health (NIH) [ES15242]; National Center for Research Resources [P20RR021940]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015242] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by a grant from the National Institutes of Health (NIH) (grant no. ES15242). Some of the analytical and imaging instruments employed in this study are part of the COBRE core facility that is supported by the NIH grant P20RR021940 from the National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALDIN V, 1995, J CELL SCI, V108, P2425; Blajeski AL, 2002, J CLIN INVEST, V110, P91, DOI 10.1172/JCI200213275; FOTEDAR R, 1995, MOL CELL BIOL, V15, P932; GILLIES RJ, 1986, ANAL BIOCHEM, V159, P109, DOI 10.1016/0003-2697(86)90314-3; Harley ME, 2010, EMBO J, V29, P2407, DOI 10.1038/emboj.2010.112; Harper Jane V., 2004, V296, P157; HEALD R, 1993, CELL, V74, P463, DOI 10.1016/0092-8674(93)80048-J; Ibrado AM, 1998, LEUKEMIA, V12, P1930, DOI 10.1038/sj.leu.2401218; Jordan MA, 1998, CURR OPIN CELL BIOL, V10, P123, DOI 10.1016/S0955-0674(98)80095-1; Lanni JS, 1998, MOL CELL BIOL, V18, P1055, DOI 10.1128/MCB.18.2.1055; Lew DJ, 1996, CURR OPIN CELL BIOL, V8, P795, DOI 10.1016/S0955-0674(96)80080-9; Li FZ, 1998, NATURE, V396, P580, DOI 10.1038/25141; Li Y, 1996, SCIENCE, V274, P246, DOI 10.1126/science.274.5285.246; Li Y, 1997, P NATL ACAD SCI USA, V94, P12431, DOI 10.1073/pnas.94.23.12431; Ling YH, 1998, INT J CANCER, V75, P925, DOI 10.1002/(SICI)1097-0215(19980316)75:6<925::AID-IJC16>3.0.CO;2-1; Maurer M, 2009, ANN NY ACAD SCI, V1171, P250, DOI 10.1111/j.1749-6632.2009.04717.x; MCGOWAN CH, 1995, EMBO J, V14, P2166, DOI 10.1002/j.1460-2075.1995.tb07210.x; Michel L, 2004, P NATL ACAD SCI USA, V101, P4459, DOI 10.1073/pnas.0306069101; Mollinedo F, 2003, APOPTOSIS, V8, P413, DOI 10.1023/A:1025513106330; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; MUELLER PR, 1995, SCIENCE, V270, P86, DOI 10.1126/science.270.5233.86; Nguyen VQ, 2001, NATURE, V411, P1068, DOI 10.1038/35082600; Ohi R, 1999, CURR OPIN CELL BIOL, V11, P267, DOI 10.1016/S0955-0674(99)80036-2; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Poxleitner MK, 2008, EUKARYOT CELL, V7, P569, DOI 10.1128/EC.00415-07; Vitrat N, 1998, BLOOD, V91, P3711; Wang TH, 2000, CANCER, V88, P2619, DOI 10.1002/1097-0142(20000601)88:11<2619::AID-CNCR26>3.0.CO;2-J; Wang TH, 1999, J BIOL CHEM, V274, P8208, DOI 10.1074/jbc.274.12.8208; Wassmann K, 1998, P NATL ACAD SCI USA, V95, P11193, DOI 10.1073/pnas.95.19.11193; WENDELL KL, 1993, J CELL SCI, V104, P261; Wesierska-Gadek J, 2009, J CELL BIOCHEM, V106, P937, DOI 10.1002/jcb.22074; Whang YM, 2009, CANCER-AM CANCER SOC, V115, P1253, DOI 10.1002/cncr.24113; Zhang H, 2002, J BIOL CHEM, V277, P43648, DOI 10.1074/jbc.M203214200	34	65	69	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2011	6	8							e24312	10.1371/journal.pone.0024312	http://dx.doi.org/10.1371/journal.pone.0024312			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817MS	21918689	Green Submitted, gold, Green Published			2022-12-25	WOS:000294678300038
J	Geng, H; Harvey, CT; Pittsenbarger, J; Liu, Q; Beer, TM; Xue, CH; Qian, DZ				Geng, Hao; Harvey, Chris T.; Pittsenbarger, Janet; Liu, Qiong; Beer, Tomasz M.; Xue, Changhui; Qian, David Z.			HDAC4 Protein Regulates HIF1 alpha Protein Lysine Acetylation and Cancer Cell Response to Hypoxia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE INHIBITORS; INDUCIBLE FACTOR-I; TUMOR-GROWTH; HIF-1-ALPHA; ANGIOGENESIS; DEGRADATION; STABILITY; VHL; HYPOXIA-INDUCIBLE-FACTOR-1-ALPHA; FACTOR-1-ALPHA	Hypoxia-inducible factor 1 alpha (HIF1 alpha) is an essential part of the HIF-1 transcriptional complex that regulates angiogenesis, cellular metabolism, and cancer development. In von Hippel-Lindau (VHL)-null kidney cancer cell lines, we reported previously that HIF1 alpha proteins can be acetylated and inhibited by histone deacetylase (HDAC) inhibitors or specific siRNA against HDAC4. To investigate the mechanism and biological consequence of the inhibition, we have generated stableHDAC4 knockdown via shRNA in VHL-positive normal and cancer cell lines. We report that HDAC4 regulates HIF1 alpha protein acetylation and stability. Specifically, the HIF1 alpha protein acetylation can be increased by HDAC4 shRNA and decreased by HDAC4 overexpression. HDAC4 shRNA inhibits HIF1 alpha protein stability. In contrast, HDAC1 or HDAC3 shRNA has no such inhibitory effect. Mutations of the first five lysine residues (lysine 10, 11, 12, 19, and 21) to arginine within the HIF1 alpha N terminus reduce protein acetylation but render the mutant HIF1 alpha protein resistant to HDAC4 and HDACi-mediated inhibition. Functionally, in VHL-positive cancer cell lines, stable inhibition of HDAC4 decreases both the HIF-1 transcriptional activity and a subset of HIF-1 hypoxia target gene expression. On the cellular level, HDAC4 inhibition reduces the hypoxia-related increase of glycolysis and resistance to docetaxel chemotherapy. Taken together, the novel biological relationship between HDAC4 and HIF1 alpha presented here suggests a potential role for the deacetylase enzyme in regulating HIF-1 cancer cell response to hypoxia and presents a more specific molecular target of inhibition.	[Geng, Hao; Harvey, Chris T.; Pittsenbarger, Janet; Liu, Qiong; Beer, Tomasz M.; Xue, Changhui; Qian, David Z.] OHSU, Knight Canc Inst, Portland, OR 97239 USA	Oregon Health & Science University	Qian, DZ (corresponding author), OHSU, Knight Canc Inst, 3303 SW Bond Ave,CH14R, Portland, OR 97239 USA.	qianzh@ohsu.edu	Liu, Qiong/G-8666-2014; Qian, David Z/AAL-3441-2021	Liu, Qiong/0000-0003-4114-5540; 	National Institutes of Health NCI [R01CA149253 01]; Department of Defense; NATIONAL CANCER INSTITUTE [R01CA149253] Funding Source: NIH RePORTER	National Institutes of Health NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported, in whole or in part, by National Institutes of Health NCI Grant R01CA149253 01 (to D. Z. Q.). This work was also supported by a New Investigator Award from the Department of Defense Prostate Cancer Research Program (to D. Z. Q.).	Arany Z, 1996, P NATL ACAD SCI USA, V93, P12969, DOI 10.1073/pnas.93.23.12969; Backs J, 2006, J CLIN INVEST, V116, P1853, DOI 10.1172/JCI27438; Chen B, 2009, SCIENCE, V323, P256, DOI 10.1126/science.1166226; Ellis L, 2009, CANCER LETT, V280, P145, DOI 10.1016/j.canlet.2008.11.012; Geng H, 2010, CANCER RES, V70, P3239, DOI 10.1158/0008-5472.CAN-09-3186; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Isaacs JS, 2002, J BIOL CHEM, V277, P29936, DOI 10.1074/jbc.M204733200; Jeong JW, 2002, CELL, V111, P709, DOI 10.1016/S0092-8674(02)01085-1; Jiang BH, 1996, J BIOL CHEM, V271, P17771, DOI 10.1074/jbc.271.30.17771; Kato H, 2004, J BIOL CHEM, V279, P41966, DOI 10.1074/jbc.M406320200; Kim MS, 2001, NAT MED, V7, P437, DOI 10.1038/86507; Kim SH, 2007, ONCOL REP, V17, P647; Kong XG, 2006, MOL CELL BIOL, V26, P2019, DOI 10.1128/MCB.26.6.2019-2028.2006; Kung AL, 2000, NAT MED, V6, P1335, DOI 10.1038/82146; Lee Ji-Won, 2004, Experimental & Molecular Medicine, V36, P1; Lim JH, 2010, MOL CELL, V38, P864, DOI 10.1016/j.molcel.2010.05.023; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Luo WB, 2010, J BIOL CHEM, V285, P3651, DOI 10.1074/jbc.M109.068577; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Miska EA, 2001, NUCLEIC ACIDS RES, V29, P3439, DOI 10.1093/nar/29.16.3439; Qian DZ, 2006, CANCER RES, V66, P8814, DOI 10.1158/0008-5472.CAN-05-4598; Qian DZ, 2004, CANCER RES, V64, P6626, DOI 10.1158/0008-5472.CAN-04-0540; Semenza GL, 2004, CANCER CELL, V5, P405, DOI 10.1016/S1535-6108(04)00118-7; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; SEMENZA GL, 2007, SCI STKE, pCM8, DOI DOI 10.1126/STKE.4072007CM8; Semenza GL, 2007, SCIENCE, V318, P62, DOI 10.1126/science.1147949; Semenza GL, 2009, SEMIN CANCER BIOL, V19, P12, DOI 10.1016/j.semcancer.2008.11.009; Sullivan R, 2008, MOL CANCER THER, V7, P1961, DOI 10.1158/1535-7163.MCT-08-0198; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Wang AH, 1999, MOL CELL BIOL, V19, P7816; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; Yoo YG, 2006, EMBO J, V25, P1231, DOI 10.1038/sj.emboj.7601025; Yuan Zhigang, 2009, V523, P279, DOI 10.1007/978-1-59745-190-1_19; Zhang HF, 2008, P NATL ACAD SCI USA, V105, P19579, DOI 10.1073/pnas.0809763105; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033	35	139	147	2	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38095	38102		10.1074/jbc.M111.257055	http://dx.doi.org/10.1074/jbc.M111.257055			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21917920	Green Published, hybrid			2022-12-25	WOS:000296594200022
J	Germain, C; Meier, A; Jensen, T; Knapnougel, P; Poupon, G; Lazzari, A; Neisig, A; Hakansson, K; Dong, T; Wagtmann, N; Galsgaard, ED; Spee, P; Braud, VM				Germain, Claire; Meier, Anders; Jensen, Teis; Knapnougel, Perrine; Poupon, Gwenola; Lazzari, Anne; Neisig, Anne; Hakansson, Katarina; Dong, Tao; Wagtmann, Nicolai; Galsgaard, Elizabeth D.; Spee, Pieter; Braud, Veronique M.			Induction of Lectin-like Transcript 1 (LLT1) Protein Cell Surface Expression by Pathogens and Interferon-gamma Contributes to Modulate Immune Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN NKR-P1A; T-CELLS; NK CELLS; DENDRITIC CELLS; UP-REGULATION; CUTTING EDGE; ACTIVATION; CD161; LIGAND; MOUSE	CD161 is a C-type lectin-like receptor expressed on human natural killer (NK) cells and subsets of T cells. CD161 has been described as an inhibitory receptor that regulates NK cell-mediated cytotoxicity and IFN-gamma production. Its role on T cells has remained unclear. Studies have shown that triggering of CD161 enhances NK T cell proliferation and T cell-IFN-gamma production while inhibiting TNF-alpha production by CD8(+) T cells. Lectin-like transcript 1 (LLT1), the ligand of CD161, was found to be expressed on Toll-like receptor (TLR)-activated plasmacytoid and monocyte-derived dendritic cells (DC) and on activated B cells. Using newly developed anti-LLT1 mAbs, we show that LLT1 is not expressed on the surface of circulating B and T lymphocytes, NK cells, monocytes, and dendritic cells but that LLT1 is up-regulated upon activation. Not only TLR-stimulated dendritic cells and B cells but also T cell receptor-activated T cells and activated NK cells up-regulate LLT1. Interestingly, IFN-gamma increases LLT1 expression level on antigen-presenting cells. LLT1 is also induced on B cells upon viral infection such as Epstein-Barr virus or HIV infection and in inflamed tonsils. Finally, expression of LLT1 on B cells inhibits NK cell function but costimulates T cell proliferation or IFN-gamma production, and coengagement of CD161 with CD3 increases IL-17 secretion. Altogether, our results point toward a role for LLT1/CD161 in modulating immune responses to pathogens.	[Germain, Claire; Knapnougel, Perrine; Poupon, Gwenola; Lazzari, Anne; Braud, Veronique M.] CNRS UNSA UMR6097, Inst Pharmacol Mol & Cellulaire, F-06560 Valbonne, France; [Meier, Anders; Jensen, Teis; Neisig, Anne; Hakansson, Katarina; Wagtmann, Nicolai; Galsgaard, Elizabeth D.; Spee, Pieter] Novo Nordisk AS, Biopharmaceut Res Unit, DK-2760 Malov, Denmark; [Dong, Tao] John Radcliffe Hosp, Weatherall Inst Mol Med, Med Res Council Human Immunol Unit, Oxford OX3 9DU, England	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Novo Nordisk; University of Oxford	Braud, VM (corresponding author), CNRS UNSA UMR6097, Inst Pharmacol Mol & Cellulaire, 660 Route Lucioles, F-06560 Valbonne, France.	braud@ipmc.cnrs.fr	POUPON, Gwénola/M-4632-2016; braud, veronique M/I-4597-2013	POUPON, Gwénola/0000-0001-5772-2539; braud, veronique M/0000-0001-8213-3947; Dong, Tao/0000-0003-3545-3758	Novo Nordisk S/A; Agence Nationale de Recherches sur le Syndrome de l'Immunodeficience Acquise (SIDA); Ensemble contre le SIDA; Centre National de la Recherche Scientifique; Medical Research Council [G0600520, G1001046] Funding Source: researchfish; MRC [G1001046, G0600520] Funding Source: UKRI	Novo Nordisk S/A; Agence Nationale de Recherches sur le Syndrome de l'Immunodeficience Acquise (SIDA)(French National Research Agency (ANR)); Ensemble contre le SIDA; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Novo Nordisk S/A, Agence Nationale de Recherches sur le Syndrome de l'Immunodeficience Acquise (SIDA), Ensemble contre le SIDA, and the Centre National de la Recherche Scientifique. A. M., T. J., A. N., K. H., N. W., E. D. G., and P. S. are employees of Novo Nordisk, which has developed products related to this work.	Aldemir H, 2005, J IMMUNOL, V175, P7791, DOI 10.4049/jimmunol.175.12.7791; Annibali V, 2011, BRAIN, V134, P542, DOI 10.1093/brain/awq354; Aust JG, 2009, J IMMUNOL, V183, P106, DOI 10.4049/jimmunol.0804281; Bajenoff M, 2006, J EXP MED, V203, P619, DOI 10.1084/jem.20051474; Beuneu H, 2009, BLOOD, V114, P3227, DOI 10.1182/blood-2009-06-228759; Bihl F, 2010, J IMMUNOL, V185, P2174, DOI 10.4049/jimmunol.1001486; Bryceson YT, 2006, BLOOD, V107, P159, DOI 10.1182/blood-2005-04-1351; Burshtyn DN, 1997, J BIOL CHEM, V272, P13066, DOI 10.1074/jbc.272.20.13066; Carlyle JR, 2004, P NATL ACAD SCI USA, V101, P3527, DOI 10.1073/pnas.0308304101; Carlyle JR, 1999, J IMMUNOL, V162, P5917; CHAMBERS WH, 1989, J EXP MED, V169, P1373, DOI 10.1084/jem.169.4.1373; Cosmi L, 2008, J EXP MED, V205, P1903, DOI 10.1084/jem.20080397; Dusseaux M, 2011, BLOOD, V117, P1250, DOI 10.1182/blood-2010-08-303339; Exley M, 1998, J EXP MED, V188, P867, DOI 10.1084/jem.188.5.867; Germain C, 2010, J BIOL CHEM, V285, P36207, DOI 10.1074/jbc.M110.179622; GIORDA R, 1991, J IMMUNOL, V147, P1701; GIORDA R, 1990, SCIENCE, V249, P1298, DOI 10.1126/science.2399464; GIORDA R, 1992, J IMMUNOL, V149, P1957; Holmes S, 2005, P NATL ACAD SCI USA, V102, P5519, DOI 10.1073/pnas.0501437102; Iizuka K, 2003, NAT IMMUNOL, V4, P801, DOI 10.1038/ni954; Kalinski P, 1999, IMMUNOL TODAY, V20, P561, DOI 10.1016/S0167-5699(99)01547-9; Kalinski P, 2010, METHODS MOL BIOL, V595, P117, DOI 10.1007/978-1-60761-421-0_7; Kamishikiryo J, 2011, J BIOL CHEM, V286, P23823, DOI 10.1074/jbc.M110.214254; Kveberg L, 2009, EUR J IMMUNOL, V39, P541, DOI 10.1002/eji.200838891; LANIER LL, 1994, J IMMUNOL, V153, P2417; Lund FE, 2008, CURR OPIN IMMUNOL, V20, P332, DOI 10.1016/j.coi.2008.03.003; Maggi L, 2010, EUR J IMMUNOL, V40, P2174, DOI 10.1002/eji.200940257; Martin E, 2009, PLOS BIOL, V7, P525, DOI 10.1371/journal.pbio.1000054; Nish S, 2011, IMMUNITY, V34, P629, DOI 10.1016/j.immuni.2011.05.009; Palm NW, 2009, IMMUNOL REV, V227, P221, DOI 10.1111/j.1600-065X.2008.00731.x; Plougastel B, 2001, IMMUNOGENETICS, V53, P592, DOI 10.1007/s002510100367; Poggi A, 1998, EUR J IMMUNOL, V28, P1611, DOI 10.1002/(SICI)1521-4141(199805)28:05<1611::AID-IMMU1611>3.0.CO;2-6; Poggi A, 1997, IMMUNOL LETT, V57, P121, DOI 10.1016/S0165-2478(97)00050-3; Poggi A, 1999, J IMMUNOL, V162, P4349; Pozo D, 2006, J IMMUNOL, V176, P2397, DOI 10.4049/jimmunol.176.4.2397; Robbins SH, 2004, J IMMUNOL, V173, P259, DOI 10.4049/jimmunol.173.1.259; Rosen DB, 2008, J IMMUNOL, V180, P6508, DOI 10.4049/jimmunol.180.10.6508; Rosen DB, 2005, J IMMUNOL, V175, P7796, DOI 10.4049/jimmunol.175.12.7796; Rudd CE, 2009, IMMUNOL REV, V229, P12, DOI 10.1111/j.1600-065X.2009.00770.x; Sharpe AH, 2009, IMMUNOL REV, V229, P5, DOI 10.1111/j.1600-065X.2009.00784.x; Takahashi T, 2006, J IMMUNOL, V176, P211, DOI 10.4049/jimmunol.176.1.211	41	85	85	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					37964	37975		10.1074/jbc.M111.285312	http://dx.doi.org/10.1074/jbc.M111.285312			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21930700	Green Published, hybrid			2022-12-25	WOS:000296594200009
J	Ivanov, AV; Smirnova, OA; Ivanova, ON; Masalova, OV; Kochetkov, SN; Isaguliants, MG				Ivanov, Alexander V.; Smirnova, Olga A.; Ivanova, Olga N.; Masalova, Olga V.; Kochetkov, Sergey N.; Isaguliants, Maria G.			Hepatitis C Virus Proteins Activate NRF2/ARE Pathway by Distinct ROS-Dependent and Independent Mechanisms in HUH7 Cells	PLOS ONE			English	Article							OXIDATIVE STRESS; GENE-EXPRESSION; ANTIOXIDANT RESPONSE; MOLECULAR-MECHANISM; INSULIN-RESISTANCE; LIVER-DISEASES; CORE; INFECTION; NS5A; TRANSCRIPTION	Hepatitis C virus (HCV) is a highly pathogenic human virus associated with liver fibrosis, steatosis, and cancer. In infected cells HCV induces oxidative stress. Here, we show that HCV proteins core, E1, E2, NS4B, and NS5A activate antioxidant defense Nrf2/ARE pathway via several independent mechanisms. This was demonstrated by the analysis of transient co-expression in Huh7 cells of HCV proteins and luciferase reporters. Expression, controlled by the promoters of stress-response genes or their minimal Nrf2-responsive elements, was studied using luminescence assay, RT-qPCR and/or Western-blot analysis. All five proteins induced Nrf2 activation by protein kinase C in response to accumulation of reactive oxygen species (ROS). In addition, expression of core, E1, E2, NS4B, and NS5A proteins resulted in the activation of Nrf2 in a ROS-independent manner. The effect of core and NS5A was mediated through casein kinase 2 and phosphoinositide-3 kinase, whereas those of NS4B, E1, and E2, were not mediated by either PKC, CK2, PI3K, p38, or ERK. Altogether, on the earliest stage of expression HCV proteins induced a strong up-regulation of the antioxidant defense system. These events may underlie the harmful effects of HCV-induced oxidative stress during acute stage of hepatitis C.	[Ivanov, Alexander V.; Smirnova, Olga A.; Ivanova, Olga N.; Kochetkov, Sergey N.] Russian Acad Sci, VA Engelhardt Mol Biol Inst, Moscow, Russia; [Smirnova, Olga A.; Isaguliants, Maria G.] Karolinska Inst, Dept Mol Biol Tumor & Cell Biol, Stockholm, Sweden; [Masalova, Olga V.; Isaguliants, Maria G.] DI Ivanovskii Inst Virol, Moscow 123098, Russia	Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Karolinska Institutet; Russian Academy of Medical Sciences; Gamaleya National Research Center for Epidemiology & Microbiology, RAMS	Ivanov, AV (corresponding author), Russian Acad Sci, VA Engelhardt Mol Biol Inst, Moscow, Russia.	aivanov@yandex.ru	Ivanov, Alexander/A-7700-2012; Masalova, Olga V./P-3620-2015; Kochetkov, Sergey N./O-1065-2013; , ISSAGOULIANTIS/AAI-3148-2021; masalova, olga/ABB-9750-2021; Ivanova, Olga/J-5667-2015	Ivanov, Alexander/0000-0002-5659-9679; Masalova, Olga V./0000-0001-5571-5669; , ISSAGOULIANTIS/0000-0001-9382-2254; masalova, olga/0000-0001-5571-5669; Kochetkov, Sergey/0000-0002-7443-6961; Ivanova, Olga/0000-0002-3673-4714	Russian Foundation for Basic Research [10-04-00047, 10-04-01402]; Ministry of Education and Science [02.740.11.5134]; Presidium of the Russian Academy of Sciences; Russian Federation [MK-5035.2011.4]; Swedish Research Council [K2009-66X-21053-01-3]; Swedish Institute	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Ministry of Education and Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Presidium of the Russian Academy of Sciences(Russian Academy of Sciences); Russian Federation(Russian Federation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Institute	This work was supported by the Russian Foundation for Basic Research (grants 10-04-00047 and 10-04-01402), Ministry of Education and Science (state contract No. 02.740.11.5134), Program of the Presidium of the Russian Academy of Sciences "Molecular and Cellular Biology", grant of the President of the Russian Federation (MK-5035.2011.4), grant "Genetic design of microbial vaccines" (#K2009-66X-21053-01-3) of the Swedish Research Council, and the New Visby Program of the Swedish Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleksunes LM, 2007, TOXICOL PATHOL, V35, P459, DOI 10.1080/01926230701311344; [Anonymous], 2002, NIH Consens State Sci Statements, V19, P1; Apopa PL, 2008, J BIOCHEM MOL TOXIC, V22, P63, DOI 10.1002/jbt.20212; Bataller R, 2004, GASTROENTEROLOGY, V126, P529, DOI 10.1053/j.gastro.2003.11.018; Blackham S, 2010, J VIROL, V84, P5404, DOI 10.1128/JVI.02529-09; Boudreau HE, 2009, J VIROL, V83, P12934, DOI 10.1128/JVI.01059-09; Burdette D, 2010, J GEN VIROL, V91, P681, DOI 10.1099/vir.0.014340-0; Carvajal-Yepes M, 2011, J BIOL CHEM, V286, P8941, DOI 10.1074/jbc.M110.186684; Chan SW, 2005, FASEB J, V19, P1510, DOI 10.1096/fj.04-3455fje; Choi JN, 2004, HEPATOLOGY, V39, P81, DOI 10.1002/hep.20001; Clement S, 2009, VIRUSES-BASEL, V1, P126, DOI 10.3390/v1020126; Cullinan SB, 2003, MOL CELL BIOL, V23, P7198, DOI 10.1128/MCB.23.20.7198-7209.2003; de Mochel NSR, 2010, HEPATOLOGY, V52, P47, DOI 10.1002/hep.23671; Di Bona D, 2006, J HEPATOL, V45, P271, DOI 10.1016/j.jhep.2006.01.037; Diamond DL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000719; Ding B, 2007, J CELL SCI, V120, P2284, DOI 10.1242/jcs.002345; Dionisio N, 2009, J HEPATOL, V50, P872, DOI 10.1016/j.jhep.2008.12.026; Faraonio R, 2006, J BIOL CHEM, V281, P39776, DOI 10.1074/jbc.M605707200; Gong GZ, 2001, P NATL ACAD SCI USA, V98, P9599, DOI 10.1073/pnas.171311298; Hinoshita E, 2001, J HEPATOL, V35, P765, DOI 10.1016/S0168-8278(01)00216-1; Jacobson IM, 2010, CLIN GASTROENTEROL H, V8, P924, DOI 10.1016/j.cgh.2010.06.032; Kamisako T, 2000, J GASTROENTEROL, V35, P659, DOI 10.1007/s005350070044; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; Koike Kazuhiko, 2005, Clin Gastroenterol Hepatol, V3, pS132, DOI 10.1016/S1542-3565(05)00700-7; Levent G, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-25; Levrero M, 2006, ONCOGENE, V25, P3834, DOI 10.1038/sj.onc.1209562; Li K, 2002, HEPATOLOGY, V35, P1237, DOI 10.1053/jhep.2002.32968; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Masalova O, 2002, IMMUNOL LETT, V83, P187, DOI 10.1016/S0165-2478(02)00081-0; Matsuo K, 2004, CANCER SCI, V95, P745, DOI 10.1111/j.1349-7006.2004.tb03256.x; Melhem A, 2005, J CLIN GASTROENTEROL, V39, P737, DOI 10.1097/01.mcg.0000174023.73472.29; Mitsuyoshi H, 2008, HEPATOL RES, V38, P348, DOI 10.1111/j.1872-034X.2007.00280.x; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Nishina S, 2008, GASTROENTEROLOGY, V134, P226, DOI 10.1053/j.gastro.2007.10.011; Niture SK, 2009, J CELL SCI, V122, P4452, DOI 10.1242/jcs.058537; Nocente R, 2003, HEPATO-GASTROENTEROL, V50, P1149; Numazawa S, 2003, AM J PHYSIOL-CELL PH, V285, pC334, DOI 10.1152/ajpcell.00043.2003; Okuda M, 2002, GASTROENTEROLOGY, V122, P366, DOI 10.1053/gast.2002.30983; Osman H G, 2007, Indian J Med Microbiol, V25, P323; Pi JB, 2007, FREE RADICAL BIO MED, V42, P1797, DOI 10.1016/j.freeradbiomed.2007.03.001; Qadri I, 2002, BBA-MOL CELL RES, V1592, P193, DOI 10.1016/S0167-4889(02)00315-4; RAY RB, 1995, VIRUS RES, V37, P209, DOI 10.1016/0168-1702(95)00034-N; Rechkina EA, 2006, MOL BIOL+, V40, P357; Reichard JF, 2006, ARCH BIOCHEM BIOPHYS, V446, P111, DOI 10.1016/j.abb.2005.12.011; RUSHMORE TH, 1991, J BIOL CHEM, V266, P11632; Santos CXC, 2009, ANTIOXID REDOX SIGN, V11, P2409, DOI 10.1089/ARS.2009.2625; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Smirnova IS, 2006, CELL BIOL INT, V30, P915, DOI 10.1016/j.cellbi.2006.06.020; Sonoda Y, 1999, J BIOL CHEM, V274, P10566, DOI 10.1074/jbc.274.15.10566; Street A, 2004, J BIOL CHEM, V279, P12232, DOI 10.1074/jbc.M312245200; Tanikawa K, 2006, MED MOL MORPHOL, V39, P22, DOI 10.1007/s00795-006-0313-z; Tong WY, 2002, BIOCHEM BIOPH RES CO, V299, P366, DOI 10.1016/S0006-291X(02)02638-4; Traylor A, 2007, AM J PHYSIOL-RENAL, V293, pF885, DOI 10.1152/ajprenal.00519.2006; Vidali M, 2008, J HEPATOL, V48, P399, DOI 10.1016/j.jhep.2007.10.011	54	115	119	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2011	6	9							e24957	10.1371/journal.pone.0024957	http://dx.doi.org/10.1371/journal.pone.0024957			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZV	21931870	Green Published, Green Submitted, gold			2022-12-25	WOS:000295321800078
J	Binnenkade, L; Lassak, J; Thormann, KM				Binnenkade, Lucas; Lassak, Juergen; Thormann, Kai M.			Analysis of the BarA/UvrY Two-Component System in Shewanella oneidensis MR-1	PLOS ONE			English	Article							CAROTOVORA SUBSP CAROTOVORA; PSEUDOMONAS-FLUORESCENS CHA0; CAMP RECEPTOR PROTEIN; MICROBIAL FUEL-CELLS; BARA SENSOR KINASE; ESCHERICHIA-COLI; SMALL RNAS; SIGNAL-TRANSDUCTION; ANAEROBIC RESPIRATION; GLYCOGEN BIOSYNTHESIS	The BarA/UvrY two-component system is well conserved in species of the gamma-proteobacteria and regulates numerous processes predominantly by controlling the expression of a subset of noncoding small RNAs. In this study, we identified and characterized the BarA/UvrY two-component system in the gammaproteobacterium Shewanella oneidensis MR-1. Functional interaction of sensor kinase BarA and the cognate response regulator UvrY was indicated by in vitro phosphotransfer studies. The expression of two predicted small regulatory RNAs (sRNAs), CsrB1 and CsrB2, was dependent on UvrY. Transcriptomic analysis by microarrays revealed that UvrY is a global regulator and directly or indirectly affects transcript levels of more than 200 genes in S. oneidensis. Among these are genes encoding key enzymes of central carbon metabolism such as ackA, aceAB, and pflAB. As predicted of a signal transduction pathway that controls aspects of central metabolism, mutants lacking UvrY reach a significantly higher OD than the wild type during aerobic growth on N-acetylglucosamine (NAG) while under anaerobic conditions the mutant grew more slowly. A shorter lag phase occurred with lactate as carbon source. In contrast, significant growth phenotypes were absent in complex medium. Based on these studies we hypothesize that, in S. oneidensis MR-1, the global BarA/UvrY/Csr regulatory pathway is involved in central carbon metabolism processes.	[Binnenkade, Lucas; Lassak, Juergen; Thormann, Kai M.] Max Planck Inst Terr Mikrobiol, Dept Ecophysiol, Marburg, Germany	Max Planck Society	Binnenkade, L (corresponding author), Max Planck Inst Terr Mikrobiol, Dept Ecophysiol, Marburg, Germany.	thormann@mpi-marburg.mpg.de	Lassak, Jürgen Michael/Q-2128-2019	Lassak, Jürgen Michael/0000-0003-3936-3389	Max-Planck-Gesellschaft; Deutsche Forschungsgemeinschaft [TH 831/3-1]	Max-Planck-Gesellschaft(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by the Max-Planck-Gesellschaft and the Deutsche Forschungsgemeinschaft (TH 831/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIBA H, 1981, J BIOL CHEM, V256, P1905; Aiyar A, 1996, Methods Mol Biol, V57, P177; Baker CS, 2002, MOL MICROBIOL, V44, P1599, DOI 10.1046/j.1365-2958.2002.02982.x; BALCH WE, 1976, APPL ENVIRON MICROB, V32, P781, DOI 10.1128/AEM.32.6.781-791.1976; Beliaev AS, 2002, J BACTERIOL, V184, P4612, DOI 10.1128/JB.184.16.4612-4616.2002; Brencic A, 2009, MOL MICROBIOL, V73, P434, DOI 10.1111/j.1365-2958.2009.06782.x; Bretschger O, 2007, APPL ENVIRON MICROB, V73, P7003, DOI 10.1128/AEM.01087-07; Bull CT, 2001, ANTON LEEUW INT J G, V79, P327, DOI 10.1023/A:1012061014717; Charania MA, 2009, J BACTERIOL, V191, P4298, DOI 10.1128/JB.01829-08; Choi KH, 2005, NAT METHODS, V2, P443, DOI 10.1038/NMETH765; Cui Y, 1999, J BACTERIOL, V181, P6042, DOI 10.1128/JB.181.19.6042-6052.1999; Cui Y, 2001, MOL PLANT MICROBE IN, V14, P516, DOI 10.1094/MPMI.2001.14.4.516; Daraselia N., 2003, OMICS A Journal of Integrative Biology, V7, P171, DOI 10.1089/153623103322246566; Eriksson ARB, 1998, MOL PLANT MICROBE IN, V11, P743, DOI 10.1094/MPMI.1998.11.8.743; Fic E, 2009, J MOL MICROB BIOTECH, V17, P1, DOI 10.1159/000178014; Gao HC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-42; Gardner PP, 2009, NUCLEIC ACIDS RES, V37, pD136, DOI 10.1093/nar/gkn766; Godeke J, 2011, ISME J, V5, P613, DOI 10.1038/ismej.2010.153; Chavez RG, 2010, J BACTERIOL, V192, P2009, DOI 10.1128/JB.01685-09; Goodman AL, 2009, GENE DEV, V23, P249, DOI 10.1101/gad.1739009; Gralnick JA, 2005, MOL MICROBIOL, V56, P1347, DOI 10.1111/j.1365-2958.2005.04628.x; Green J, 2009, CURR OPIN MICROBIOL, V12, P145, DOI 10.1016/j.mib.2009.01.008; Gudapaty S, 2001, J BACTERIOL, V183, P6017, DOI 10.1128/JB.183.20.6017-6027.2001; Hassan KA, 2010, ENVIRON MICROBIOL, V12, P899, DOI 10.1111/j.1462-2920.2009.02134.x; Hau HH, 2007, ANNU REV MICROBIOL, V61, P237, DOI 10.1146/annurev.micro.61.080706.093257; Heidelberg JF, 2002, NAT BIOTECHNOL, V20, P1118, DOI 10.1038/nbt749; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.2307/2336325; Humair B, 2010, APPL ENVIRON MICROB, V76, P1497, DOI 10.1128/AEM.02014-09; Hunt KA, 2010, J BACTERIOL, V192, P3345, DOI 10.1128/JB.00090-10; Jagadeesan S, 2009, J BIOL CHEM, V284, P21435, DOI 10.1074/jbc.M109.033415; Jonas K, 2009, FEMS MICROBIOL LETT, V297, P80, DOI 10.1111/j.1574-6968.2009.01661.x; Kay E, 2005, P NATL ACAD SCI USA, V102, P17136, DOI 10.1073/pnas.0505673102; Kiley PJ, 1998, FEMS MICROBIOL REV, V22, P341, DOI 10.1111/j.1574-6976.1998.tb00375.x; KLIPPERAURBACH Y, 1995, MED HYPOTHESES, V45, P486, DOI 10.1016/0306-9877(95)90228-7; Kouzuma A, 2010, APPL ENVIRON MICROB, V76, P4151, DOI 10.1128/AEM.00117-10; Krin E, 2008, ENVIRON MICROBIOL, V10, P1118, DOI 10.1111/j.1462-2920.2007.01528.x; Kulkarni PR, 2006, NUCLEIC ACIDS RES, V34, P3361, DOI 10.1093/nar/gkl439; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lapouge K, 2008, MOL MICROBIOL, V67, P241, DOI 10.1111/j.1365-2958.2007.06042.x; Lassak J, 2010, APPL ENVIRON MICROB, V76, P3263, DOI 10.1128/AEM.00512-10; Leaphart AB, 2006, J BACTERIOL, V188, P1633, DOI 10.1128/JB.188.4.1633-1642.2006; Lenz DH, 2005, MOL MICROBIOL, V58, P1186, DOI 10.1111/j.1365-2958.2005.04902.x; Liu Y, 1999, J BACTERIOL, V181, P2411, DOI 10.1128/JB.181.8.2411-2421.1999; Logan BE, 2009, NAT REV MICROBIOL, V7, P375, DOI 10.1038/nrmicro2113; Maier TM, 2001, J BACTERIOL, V183, P4918, DOI 10.1128/JB.183.16.4918-4926.2001; Malpica R, 2006, ANTIOXID REDOX SIGN, V8, P781, DOI 10.1089/ars.2006.8.781; MILLER VL, 1988, J BACTERIOL, V170, P2575, DOI 10.1128/JB.170.6.2575-2583.1988; Mukherjee A, 2000, ENVIRON MICROBIOL, V2, P203, DOI 10.1046/j.1462-2920.2000.00093.x; MYERS CR, 1988, SCIENCE, V240, P1319, DOI 10.1126/science.240.4857.1319; NEALSON KH, 2003, PROKARYOTES EVOLVING, P1133; Pernestig AK, 2003, J BACTERIOL, V185, P843, DOI 10.1128/JB.185.3.843-853.2003; Pernestig AK, 2001, J BIOL CHEM, V276, P225, DOI 10.1074/jbc.M001550200; Pinchuk GE, 2009, P NATL ACAD SCI USA, V106, P2874, DOI 10.1073/pnas.0806798106; POSPIECH A, 1995, TRENDS GENET, V11, P217, DOI 10.1016/S0168-9525(00)89052-6; Romeo T, 1998, MOL MICROBIOL, V29, P1321, DOI 10.1046/j.1365-2958.1998.01021.x; ROMEO T, 1993, J BACTERIOL, V175, P4744, DOI 10.1128/JB.175.15.4744-4755.1993; SABNIS NA, 1995, J BIOL CHEM, V270, P29096, DOI 10.1074/jbc.270.49.29096; Saffarini DA, 2003, J BACTERIOL, V185, P3668, DOI 10.1128/JB.185.12.3668-3671.2003; Sahr T, 2009, MOL MICROBIOL, V72, P741, DOI 10.1111/j.1365-2958.2009.06677.x; Sambrook KJ, 1989, MOL CLONING LAB MANU; SCOTT JH, 1994, J BACTERIOL, V176, P3408, DOI 10.1128/jb.176.11.3408-3411.1994; Shi XY, 2009, APPL ENVIRON MICROB, V75, P2275, DOI 10.1128/AEM.01964-08; Suzuki K, 2006, GENE DEV, V20, P2605, DOI 10.1101/gad.1461606; Takeuchi K, 2009, J BIOL CHEM, V284, P34976, DOI 10.1074/jbc.M109.052571; Tang YJJ, 2007, APPL ENVIRON MICROB, V73, P718, DOI 10.1128/AEM.01532-06; Tang YJ, 2007, J BACTERIOL, V189, P894, DOI 10.1128/JB.00926-06; Teplitski M, 2003, J BACTERIOL, V185, P7257, DOI 10.1128/JB.185.24.7257-7265.2003; Teplitski M, 2006, MICROBIOL-SGM, V152, P3411, DOI 10.1099/mic.0.29118-0; Thormann KM, 2006, J BACTERIOL, V188, P2681, DOI 10.1128/JB.188.7.2681-2691.2006; Valverde C, 2003, MOL MICROBIOL, V50, P1361, DOI 10.1046/j.1365-2958.2003.03774.x; Venkateswaran K, 1999, INT J SYST BACTERIOL, V49, P705, DOI 10.1099/00207713-49-2-705; Wang X, 2005, MOL MICROBIOL, V56, P1648, DOI 10.1111/j.1365-2958.2005.04648.x; Weilbacher T, 2003, MOL MICROBIOL, V48, P657, DOI 10.1046/j.1365-2958.2003.03459.x; Yang C, 2006, J BIOL CHEM, V281, P29872, DOI 10.1074/jbc.M605052200; Ziemke F, 1997, AQUAT MICROB ECOL, V13, P63, DOI 10.3354/ame013063	75	12	12	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2011	6	9							e23440	10.1371/journal.pone.0023440	http://dx.doi.org/10.1371/journal.pone.0023440			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CO	21931597	gold, Green Submitted, Green Published			2022-12-25	WOS:000294803200002
J	Feng, B; Jiao, P; Nie, YH; Kim, T; Jun, DL; van Rooijen, N; Yang, ZQ; Xu, HY				Feng, Bin; Jiao, Ping; Nie, Yaohui; Kim, Thomas; Jun, Dale; van Rooijen, Nico; Yang, Zaiqing; Xu, Haiyan			Clodronate Liposomes Improve Metabolic Profile and Reduce Visceral Adipose Macrophage Content in Diet-Induced Obese Mice	PLOS ONE			English	Article							INSULIN-RESISTANCE ATHEROSCLEROSIS; NECROSIS-FACTOR-ALPHA; FATTY LIVER; ADIPONECTIN EXPRESSION; HEPATIC STEATOSIS; 3T3-L1 ADIPOCYTES; IMMUNE-RESPONSE; PROTEIN-KINASE; TNF-ALPHA; T-CELLS	Background: Obesity-related adipose inflammation has been thought to be a causal factor for the development of insulin resistance and type 2 diabetes. Infiltrated macrophages in adipose tissue of obese animals and humans are an important source for inflammatory cytokines. Clodronate liposomes can ablate macrophages by inducing apoptosis. In this study, we aim to determine whether peritoneal injection of clodronate liposomes has any beneficial effect on systemic glucose homeostasis/insulin sensitivity and whether macrophage content in visceral adipose tissue will be reduced in diet-induced obese (DIO) mice. Methodology/Principal Findings: Clodronate liposomes were used to deplete macrophages in lean and DIO mice. Macrophage content in visceral adipose tissue, metabolic parameters, glucose and insulin tolerance, adipose and liver histology, adipokine and cytokine production were examined. Hyperinsulinemic-euglycemic clamp study was also performed to assess systemic insulin sensitivity. Peritoneal injection of clodronate liposomes significantly reduced blood glucose and insulin levels in DIO mice. Systemic glucose tolerance and insulin sensitivity were mildly improved in both lean and DIO mice treated with clodronate liposomes by intraperitoneal (ip) injection. Hepatosteatosis was dramatically alleviated and suppression of hepatic glucose output was markedly increased in DIO mice treated with clodronate liposomes. Macrophage content in visceral adipose tissue of DIO mice was effectively decreased without affecting subcutaneous adipose tissue. Interestingly, levels of insulin sensitizing hormone adiponectin, including the high molecular weight form, were significantly elevated in circulation. Conclusions/Significance: Intraperitoneal injection of clodronate liposomes reduces visceral adipose tissue macrophages, improves systemic glucose homeostasis and insulin sensitivity in DIO mice, which can be partially attributable to increased adiponectin levels.	[Feng, Bin; Yang, Zaiqing] Huazhong Agr Univ, Key Lab Agr Anim Genet Breeding & Reprod, Minist Educ, Coll Life Sci & Technol, Wuhan, Peoples R China; [van Rooijen, Nico] Vrije Univ Amsterdam, Dept Mol Cell Biol, Fac Med, Amsterdam, Netherlands; [Feng, Bin; Jiao, Ping; Nie, Yaohui; Kim, Thomas; Jun, Dale; Xu, Haiyan] Brown Univ, Alpert Med Sch, Hallett Ctr Diabet & Endocrinol, Providence, RI 02912 USA	Huazhong Agricultural University; Vrije Universiteit Amsterdam; Brown University	Feng, B (corresponding author), Huazhong Agr Univ, Key Lab Agr Anim Genet Breeding & Reprod, Minist Educ, Coll Life Sci & Technol, Wuhan, Peoples R China.	HXu@Lifespan.org	Van Rooijen, Nico/Z-1578-2019		American Heart Association; China Scholarship Council	American Heart Association(American Heart Association); China Scholarship Council(China Scholarship Council)	Dr. Xu received a scientist development grant from the American Heart Association. Dr. Feng received a scholarship from China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano T, 2009, J GASTROEN HEPATOL, V24, P1669, DOI 10.1111/j.1440-1746.2009.06039.x; Bennett CL, 2007, TRENDS IMMUNOL, V28, P525, DOI 10.1016/j.it.2007.08.011; Clementi AH, 2009, BBA-MOL BASIS DIS, V1792, P1062, DOI 10.1016/j.bbadis.2009.08.007; Elgazar-Carmon V, 2008, J LIPID RES, V49, P1894, DOI 10.1194/jlr.M800132-JLR200; Festa A, 2002, DIABETES, V51, P1131, DOI 10.2337/diabetes.51.4.1131; Festa A, 2000, CIRCULATION, V102, P42, DOI 10.1161/01.CIR.102.1.42; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Ghanim H, 2004, CIRCULATION, V110, P1564, DOI 10.1161/01.CIR.0000142055.53122.FA; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Hajri T, 2011, AM J PHYSIOL-ENDOC M, V300, pE350, DOI 10.1152/ajpendo.00307.2010; Hirasaka K, 2007, DIABETES, V56, P2511, DOI 10.2337/db06-1768; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kim K, 2005, BIOCHEM BIOPH RES CO, V327, P460, DOI 10.1016/j.bbrc.2004.12.026; Komai Norio, 2007, Mod Rheumatol, V17, P385; Kosteli A, 2010, J CLIN INVEST, V120, P3466, DOI 10.1172/JCI42845; Lanthier N, 2010, AM J PHYSIOL-GASTR L, V298, pG107, DOI 10.1152/ajpgi.00391.2009; Lim JY, 2008, FEBS LETT, V582, P3473, DOI 10.1016/j.febslet.2008.09.012; Liu J, 2009, NAT MED, V15, P940, DOI 10.1038/nm.1994; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Nara N, 2007, J BIOL CHEM, V282, P30794, DOI 10.1074/jbc.M700412200; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Nomiyama T, 2007, J CLIN INVEST, V117, P2877, DOI 10.1172/JCI31986; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Pickup JC, 1997, DIABETOLOGIA, V40, P1286, DOI 10.1007/s001250050822; Polyzos SA, 2010, DIABETES OBES METAB, V12, P365, DOI 10.1111/j.1463-1326.2009.01176.x; Pradhan AD, 2001, JAMA-J AM MED ASSOC, V286, P327, DOI 10.1001/jama.286.3.327; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Shen Z, 2010, AM J PHYSIOL-GASTR L, V298, pG364, DOI 10.1152/ajpgi.00456.2009; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Stienstra R, 2010, HEPATOLOGY, V51, P511, DOI 10.1002/hep.23337; Stofkova A, 2009, Endocr Regul, V43, P157; SU D, 1989, IMMUNOLOGY, V66, P466; van Rooijen N, 2003, METHOD ENZYMOL, V373, P3; VanRooijen N, 1996, HEPATOLOGY, V23, P1239; Vozarova B, 2002, DIABETES, V51, P455, DOI 10.2337/diabetes.51.2.455; Wang Y, 2009, ARQ BRAS ENDOCRINOL, V53, P201, DOI 10.1590/S0004-27302009000200012; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Zhang HR, 2010, ARTERIOSCL THROM VAS, V30, P2156, DOI 10.1161/ATVBAHA.110.214700	44	85	87	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2011	6	9							e24358	10.1371/journal.pone.0024358	http://dx.doi.org/10.1371/journal.pone.0024358			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CO	21931688	Green Published, Green Submitted, gold			2022-12-25	WOS:000294803200015
J	Carre, GA; Couty, I; Hennequet-Antier, C; Govoroun, MS				Carre, Gwenn-Ael; Couty, Isabelle; Hennequet-Antier, Christelle; Govoroun, Marina S.			Gene Expression Profiling Reveals New Potential Players of Gonad Differentiation in the Chicken Embryo	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; FOLLICLE-STIMULATING-HORMONE; PRIMORDIAL GERM-CELLS; BONE MORPHOGENETIC PROTEIN-15; OVARIAN DEVELOPMENT; SEX DETERMINATION; MAMMALIAN OVARY; DEVELOPMENTAL EXPRESSION; IMMUNOACTIVE INHIBIN; ACTIVIN RECEPTORS	Background: In birds as in mammals, a genetic switch determines whether the undifferentiated gonad develops into an ovary or a testis. However, understanding of the molecular pathway(s) involved in gonad differentiation is still incomplete. Methodology/Principal Findings: With the aim of improving characterization of the molecular pathway(s) involved in gonad differentiation in the chicken embryo, we developed a large scale real time reverse transcription polymerase chain reaction approach on 110 selected genes for evaluation of their expression profiles during chicken gonad differentiation between days 5.5 and 19 of incubation. Hierarchical clustering analysis of the resulting datasets discriminated gene clusters expressed preferentially in the ovary or the testis, and/or at early or later periods of embryonic gonad development. Fitting a linear model and testing the comparisons of interest allowed the identification of new potential actors of gonad differentiation, such as Z-linked ADAMTS12, LOC427192 (corresponding to NIM1 protein) and CFC1, that are upregulated in the developing testis, and BMP3 and Z-linked ADAMTSL1, that are preferentially expressed in the developing ovary. Interestingly, the expression patterns of several members of the transforming growth factor beta family were sexually dimorphic, with inhibin subunits upregulated in the testis, and bone morphogenetic protein subfamily members including BMP2, BMP3, BMP4 and BMP7, upregulated in the ovary. This study also highlighted several genes displaying asymmetric expression profiles such as GREM1 and BMP3 that are potentially involved in different aspects of gonad left-right asymmetry. Conclusion/Significance: This study supports the overall conservation of vertebrate sex differentiation pathways but also reveals some particular feature of gene expression patterns during gonad development in the chicken. In particular, our study revealed new candidate genes which may be potential actors of chicken gonad differentiation and provides evidence of the preferential expression of BMPs in the developing ovary and Inhibin/Activin subunits in the developing testis.	[Carre, Gwenn-Ael; Couty, Isabelle; Govoroun, Marina S.] Univ Tours, CNRS, INRA, Physiol Reprod & Comportements UMR 6175, Nouzilly, France; [Hennequet-Antier, Christelle] INRA, Unite Rech Avicole, F-37380 Nouzilly, France	Centre National de la Recherche Scientifique (CNRS); Universite de Tours; INRAE; INRAE	Carre, GA (corresponding author), Univ Tours, CNRS, INRA, Physiol Reprod & Comportements UMR 6175, Nouzilly, France.	Marina.Govoroun@tours.inra.fr			INRA; Region Centre	INRA; Region Centre(Region Centre-Val de Loire)	This work was funded by INRA, so there are not current external funding sources for this study. Gwenn-Ael Carre's fellowship was supported by Region Centre. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ABINAWANTO SK, 1996, GEN COMP ENDOCR, V102, P241, DOI DOI 10.1006/GCEN.1996.0065; ABINAWANTO SKS, 1997, POULTRY SCI, V34, P158; Abir R, 2005, MOL HUM REPROD, V11, P229, DOI 10.1093/molehr/gah164; ACKLAND JF, 1991, BIOL REPROD, V45, P295, DOI 10.1095/biolreprod45.2.295; Acloque H, 2008, METHOD CELL BIOL, V87, P169, DOI 10.1016/S0091-679X(08)00209-4; ALBERS N, 1989, ENDOCRINOLOGY, V125, P675, DOI 10.1210/endo-125-2-675; Anderson RA, 2002, J CLIN ENDOCR METAB, V87, P890, DOI 10.1210/jc.87.2.890; Apte SS, 2009, J BIOL CHEM, V284, P31493, DOI 10.1074/jbc.R109.052340; Bai XH, 2009, CELL MOL LIFE SCI, V66, P667, DOI 10.1007/s00018-008-8633-x; Balemans W, 2002, DEV BIOL, V250, P231, DOI 10.1006/dbio.2002.0779; Baron D, 2005, BIOL REPROD, V73, P959, DOI 10.1095/biolreprod.105.041830; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cederroth CR, 2007, MOL CELL ENDOCRINOL, V265, P3, DOI 10.1016/j.mce.2006.12.029; CIVININI A, 1986, EXP CELL BIOL, V54, P94; Clinton M, 2001, BRIT POULTRY SCI, V42, P134, DOI 10.1080/713655025; Dissen GA, 2001, ENDOCRINOLOGY, V142, P2078, DOI 10.1210/en.142.5.2078; DISSEN GA, 1995, ENDOCRINOLOGY, V136, P4681, DOI 10.1210/en.136.10.4681; Dissen GA, 2009, SEMIN REPROD MED, V27, P24, DOI 10.1055/s-0028-1108007; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; ELBRECHT A, 1992, SCIENCE, V255, P467, DOI 10.1126/science.1734525; Elis S, 2007, J ENDOCRINOL, V194, P485, DOI 10.1677/JOE-07-0143; ETCHES R, 1997, GENOTYPIC PHENOTYPIC, P57; ETSOUP APE, 1996, MOL MAR BIOL BIOTECH, V5, P295; FEIJEN A, 1994, DEVELOPMENT, V120, P3621; GASC JM, 1980, J EMBRYOL EXP MORPH, V55, P331; Govoroun MS, 2004, DEV DYNAM, V231, P859, DOI 10.1002/dvdy.20189; Gray PC, 2003, P NATL ACAD SCI USA, V100, P5193, DOI 10.1073/pnas.0531290100; GUICHARD A, 1973, GEN COMP ENDOCR, V20, P16, DOI 10.1016/0016-6480(73)90126-3; GUICHARD A, 1979, GEN COMP ENDOCR, V39, P9, DOI 10.1016/0016-6480(79)90187-4; Guioli S, 2007, DEVELOPMENT, V134, P4199, DOI 10.1242/dev.010249; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Hellani A, 2000, ENDOCRINOLOGY, V141, P3012, DOI 10.1210/en.141.8.3012; Hoshino A, 2005, DEV GROWTH DIFFER, V47, P65, DOI 10.1111/j.1440-169x.2004.00783.x; Hudson QJ, 2005, DEV DYNAM, V233, P1052, DOI 10.1002/dvdy.20388; HUGHES GC, 1963, J EMBRYOL EXP MORPH, V11, P513; Iemura S, 1998, P NATL ACAD SCI USA, V95, P9337, DOI 10.1073/pnas.95.16.9337; Ishimaru Y, 2008, DEVELOPMENT, V135, P677, DOI 10.1242/dev.012856; Jakob S, 2011, FEBS J, V278, P1002, DOI 10.1111/j.1742-4658.2011.08029.x; Jaleel M, 2005, FEBS LETT, V579, P1417, DOI 10.1016/j.febslet.2005.01.042; Knight PG, 2006, REPRODUCTION, V132, P191, DOI 10.1530/rep.1.01074; Mattioli M, 1999, DOMEST ANIM ENDOCRIN, V17, P361, DOI 10.1016/S0739-7240(99)00056-9; MAZAUDGUITTOT S, BIOL REPROD, V82, P202; Menke Douglas B., 2002, Gene Expression Patterns, V2, P359, DOI 10.1016/S1567-133X(02)00022-4; MOORE A, 1994, MOL CELL ENDOCRINOL, V100, P81, DOI 10.1016/0303-7207(94)90283-6; Moore RK, 2003, J BIOL CHEM, V278, P304, DOI 10.1074/jbc.M207362200; Nadler JJ, 2000, GENESIS, V27, P117, DOI 10.1002/1526-968X(200007)27:3<117::AID-GENE40>3.0.CO;2-7; Nakabayashi O, 1998, J MOL ENDOCRINOL, V20, P193, DOI 10.1677/jme.0.0200193; Nakamura Y, 2007, POULTRY SCI, V86, P2182, DOI 10.1093/ps/86.10.2182; Oreal E, 2002, DEV DYNAM, V225, P221, DOI 10.1002/dvdy.10153; Oreal E, 1998, DEV DYNAM, V212, P522, DOI 10.1002/(SICI)1097-0177(199808)212:4<522::AID-AJA5>3.0.CO;2-J; Paredes A, 2004, DEV BIOL, V267, P430, DOI 10.1016/j.ydbio.2003.12.001; Pellegrini M, 2003, J CELL SCI, V116, P3363, DOI 10.1242/jcs.00650; Porter S, 2005, BIOCHEM J, V386, P15, DOI 10.1042/BJ20040424; Puglisi R, 2004, EUR J ENDOCRINOL, V151, P511, DOI 10.1530/eje.0.1510511; RABINOVICI J, 1991, J CLIN ENDOCR METAB, V73, P1141, DOI 10.1210/jcem-73-5-1141; Raymond CS, 2000, GENE DEV, V14, P2587, DOI 10.1101/gad.834100; Raymond CS, 1999, DEV BIOL, V215, P208, DOI 10.1006/dbio.1999.9461; Rombauts L, 1996, BIOL REPROD, V54, P1229, DOI 10.1095/biolreprod54.6.1229; ROMBAUTS L, 1994, BIOL REPROD, V51, P926, DOI 10.1095/biolreprod51.5.926; Romero C, 2002, ENDOCRINOLOGY, V143, P1485, DOI 10.1210/en.143.4.1485; Ross A, 2007, SEX DEV, V1, P127, DOI 10.1159/000100034; Safi M, 2001, GEN COMP ENDOCR, V122, P304, DOI 10.1006/gcen.2000.7546; Salas C, 2006, J CLIN ENDOCR METAB, V91, P2396, DOI 10.1210/jc.2005-1925; SCHEIB D, 1983, DIFFERENTIATION, V23, pS87; Smith CA, 2004, BIOESSAYS, V26, P120, DOI 10.1002/bies.10400; Smith CA, 2009, NATURE, V461, P267, DOI 10.1038/nature08298; Smith CA, 2009, INT J DEV BIOL, V53, P59, DOI 10.1387/ijdb.082742cs; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sotomayor-Zarate R, 2008, BIOL REPROD, V78, P673, DOI 10.1095/biolreprod.107.063974; Spears N, 2003, DEVELOPMENT, V130, P5481, DOI 10.1242/dev.00707; Tian T, 2006, CELL MOL LIFE SCI, V63, P672, DOI 10.1007/s00018-005-5503-7; TORNEY AH, 1990, ENDOCRINOLOGY, V127, P2938, DOI 10.1210/endo-127-6-2938; Tsunekawa N, 2000, DEVELOPMENT, V127, P2741; UKESHIMA A, 1991, ANAT REC, V230, P378, DOI 10.1002/ar.1092300311; Vaillant S, 2003, MOL REPROD DEV, V65, P420, DOI 10.1002/mrd.10318; Yao HHC, 2004, DEV DYNAM, V230, P210, DOI 10.1002/dvdy.20042; Yao HHC, 2006, BIOL REPROD, V74, P978, DOI 10.1095/biolreprod.105.050286	77	28	28	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2011	6	9							e23959	10.1371/journal.pone.0023959	http://dx.doi.org/10.1371/journal.pone.0023959			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CN	21931629	Green Published, Green Submitted, gold			2022-12-25	WOS:000294803100009
J	Ramkisoensing, AA; Pijnappels, DA; Askar, SFA; Passier, R; Swildens, J; Goumans, MJ; Schutte, CI; de Vries, AAF; Scherjon, S; Mummery, CL; Schalij, MJ; Atsma, DE				Ramkisoensing, Arti A.; Pijnappels, Daniel A.; Askar, Said F. A.; Passier, Robert; Swildens, Jim; Goumans, Marie Jose; Schutte, Cindy I.; de Vries, Antoine A. F.; Scherjon, Sicco; Mummery, Christine L.; Schalij, Martin J.; Atsma, Douwe E.			Human Embryonic and Fetal Mesenchymal Stem Cells Differentiate toward Three Different Cardiac Lineages in Contrast to Their Adult Counterparts	PLOS ONE			English	Article							HEART-FAILURE; REGENERATION; DERIVATION	Mesenchymal stem cells (MSCs) show unexplained differences in differentiation potential. In this study, differentiation of human (h) MSCs derived from embryonic, fetal and adult sources toward cardiomyocytes, endothelial and smooth muscle cells was investigated. Labeled hMSCs derived from embryonic stem cells (hESC-MSCs), fetal umbilical cord, bone marrow, amniotic membrane and adult bone marrow and adipose tissue were co-cultured with neonatal rat cardiomyocytes (nrCMCs) or cardiac fibroblasts (nrCFBs) for 10 days, and also cultured under angiogenic conditions. Cardiomyogenesis was assessed by human-specific immunocytological analysis, whole-cell current-clamp recordings, human-specific qRT-PCR and optical mapping. After co-culture with nrCMCs, significantly more hESC-MSCs than fetal hMSCs stained positive for a-actinin, whereas adult hMSCs stained negative. Furthermore, functional cardiomyogenic differentiation, based on action potential recordings, was shown to occur, but not in adult hMSCs. Of all sources, hESC-MSCs expressed most cardiac-specific genes. hESC-MSCs and fetal hMSCs contained significantly higher basal levels of connexin43 than adult hMSCs and co-culture with nrCMCs increased expression. After co-culture with nrCFBs, hESC-MSCs and fetal hMSCs did not express a-actinin and connexin43 expression was decreased. Conduction velocity (CV) in co-cultures of nrCMCs and hESC-MSCs was significantly higher than in co-cultures with fetal or adult hMSCs. In angiogenesis bioassays, only hESC-MSCs and fetal hMSCs were able to form capillary-like structures, which stained for smooth muscle and endothelial cell markers. Human embryonic and fetal MSCs differentiate toward three different cardiac lineages, in contrast to adult MSCs. Cardiomyogenesis is determined by stimuli from the cellular microenvironment, where connexin43 may play an important role.	[Ramkisoensing, Arti A.; Pijnappels, Daniel A.; Askar, Said F. A.; Swildens, Jim; Schutte, Cindy I.; de Vries, Antoine A. F.; Schalij, Martin J.; Atsma, Douwe E.] Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands; [Passier, Robert; Mummery, Christine L.] Leiden Univ, Med Ctr, Dept Anat & Embryol, Leiden, Netherlands; [Swildens, Jim; Goumans, Marie Jose] Leiden Univ, Med Ctr, Dept Mol Cell Biol, Leiden, Netherlands; [Scherjon, Sicco] Leiden Univ, Med Ctr, Dept Obstet & Gynaecol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Ramkisoensing, AA (corresponding author), Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands.	d.e.atsma@lumc.nl	Goumans, Marie Jose/U-1455-2019; Pijnappels, Daniël/AAA-2304-2022; de Vries, Antoine/ABG-5787-2021; Goumans, Marie-José/AAG-4994-2021	Goumans, Marie Jose/0000-0001-9344-6746; Pijnappels, Daniël/0000-0001-6731-4125; Mummery, Christine/0000-0002-4549-6535	Dutch Ministry of Economic Affairs, Agriculture and Innovation [P1.04]; Nederlandse Hartstichting; Netherlands Ministry of Economic Affairs; Netherlands Ministry of Education, Culture and Science; Netherlands Organisation for Scientific Research (NWO) [91611070]	Dutch Ministry of Economic Affairs, Agriculture and Innovation; Nederlandse Hartstichting; Netherlands Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); Netherlands Ministry of Education, Culture and Science; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This research forms part of the Project P1.04 SMARTCARE of the research program of the BioMedical Materials Institute, co-funded by the Dutch Ministry of Economic Affairs, Agriculture and Innovation. The financial contribution of the Nederlandse Hartstichting is gratefully acknowledged. DEA is funded by the Smart Mix Program of the Netherlands Ministry of Economic Affairs and the Netherlands Ministry of Education, Culture and Science. DAP is a recipient of a Netherlands Organisation for Scientific Research (NWO) Veni grant (91611070). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Dolado M, 2007, FRONT BIOSCI-LANDMRK, V12, P1, DOI 10.2741/2044; Bai DL, 2006, J PHARMACOL EXP THER, V319, P1452, DOI 10.1124/jpet.106.112045; Ballard VLT, 2007, CIRC RES, V100, P1116, DOI 10.1161/01.RES.0000261964.19115.e3; Ballard VLT, 2010, HEART FAIL REV, V15, P447, DOI 10.1007/s10741-010-9160-z; Barberi T, 2005, PLOS MED, V2, P554, DOI 10.1371/journal.pmed.0020161; Bellantuono Ilaria, 2007, Expert Reviews in Molecular Medicine, V9, DOI 10.1017/S146239940700049X; Chambers SM, 2007, STEM CELL REV, V3, P201, DOI 10.1007/s12015-007-0027-1; Chen MY, 2009, EXP HEMATOL, V37, P629, DOI 10.1016/j.exphem.2009.02.003; Hare JM, 2009, J AM COLL CARDIOL, V54, P2277, DOI 10.1016/j.jacc.2009.06.055; Harks EGA, 2003, FASEB J, V17, P941, DOI 10.1096/fj.02-0786fje; Hwang NS, 2008, P NATL ACAD SCI USA, V105, P20641, DOI 10.1073/pnas.0809680106; in't Anker PS, 2004, STEM CELLS, V22, P1338, DOI 10.1634/stemcells.2004-0058; Jo CH, 2008, CELL TISSUE RES, V334, P423, DOI 10.1007/s00441-008-0696-3; Karlsson C, 2009, STEM CELL RES, V3, P39, DOI 10.1016/j.scr.2009.05.002; Kleber AG, 2004, PHYSIOL REV, V84, P431, DOI 10.1152/physrev.00025.2003; Lian QZ, 2007, STEM CELLS, V25, P425, DOI 10.1634/stemcells.2006-0420; Liechty KW, 2000, NAT MED, V6, P1282, DOI 10.1038/81395; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Miao ZN, 2006, CELL BIOL INT, V30, P681, DOI 10.1016/j.cellbi.2006.03.009; Nishiyama N, 2007, STEM CELLS, V25, P2017, DOI 10.1634/stemcells.2006-0662; O'Donoghue K, 2004, BEST PRACT RES CL OB, V18, P853, DOI 10.1016/j.bpobgyn.2004.06.010; Olivier EN, 2006, STEM CELLS, V24, P1914, DOI 10.1634/stemcells.2005-0648; Oswald J, 2004, STEM CELLS, V22, P377, DOI 10.1634/stemcells.22-3-377; Passier R, 2008, NATURE, V453, P322, DOI 10.1038/nature07040; Pijnappels DA, 2008, CIRC RES, V103, P167, DOI 10.1161/CIRCRESAHA.108.176131; Pijnappels DA, 2006, CARDIOVASC RES, V72, P282, DOI 10.1016/j.cardiores.2006.07.016; Roobrouck VD, 2008, EXP CELL RES, V314, P1937, DOI 10.1016/j.yexcr.2008.03.006; Roubelakis MG, 2007, STEM CELLS DEV, V16, P931, DOI 10.1089/scd.2007.0036; Semenov OV, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.10.869; Torella D, 2004, CIRC RES, V94, P514, DOI 10.1161/01.RES.0000117306.10142.50; Trivedi P, 2008, EXP HEMATOL, V36, P350, DOI 10.1016/j.exphem.2007.10.007; van Vliet P, 2010, STEM CELL REV REP, V6, P178, DOI 10.1007/s12015-010-9142-5; Yoo KH, 2009, CELL IMMUNOL, V259, P150, DOI 10.1016/j.cellimm.2009.06.010	33	56	60	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2011	6	9							e24164	10.1371/journal.pone.0024164	http://dx.doi.org/10.1371/journal.pone.0024164			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CN	21931658	Green Published, gold, Green Submitted			2022-12-25	WOS:000294803100014
J	Barakat, A; Ihazmad, H; Benkaroum, S; Cherkaoui, I; Benmamoun, A; Youbi, M; El Aouad, R				Barakat, Amal; Ihazmad, Hassan; Benkaroum, Samira; Cherkaoui, Imad; Benmamoun, Abderahman; Youbi, Mohammed; El Aouad, Rajae			Influenza Surveillance among Outpatients and Inpatients in Morocco, 1996-2009	PLOS ONE			English	Article							INTERRUPTED TIME-SERIES; SEASONAL INFLUENZA; EPIDEMIOLOGY; BURDEN; IMPACT; MORTALITY; CHILDREN; DISEASE	Background: There is limited information about the epidemiology of influenza in Africa. We describe the epidemiology and seasonality of influenza in Morocco from 1996 to 2009 with particular emphasis on the 2007-2008 and 2008-2009 influenza seasons. Successes and challenges of the enhanced surveillance system introduced in 2007 are also discussed. Methods: Virologic sentinel surveillance for influenza virus was initiated in Morocco in 1996 using a network of private practitioners that collected oro-pharyngeal and naso-pharyngeal swabs from outpatients presenting with influenza-like-illness (ILI). The surveillance network expanded over the years to include inpatients presenting with severe acute respiratory illness (SARI) at hospitals and syndromic surveillance for ILI and acute respiratory infection (ARI). Respiratory samples and structured questionnaires were collected from eligible patients, and samples were tested by immunofluorescence assays and by viral isolation for influenza viruses. Results: We obtained a total of 6465 respiratory specimens during 1996 to 2009, of which, 3102 were collected during 2007-2009. Of those, 2249 (72%) were from patients with ILI, and 853 (27%) were from patients with SARI. Among the 3,102 patients, 98 (3%) had laboratory-confirmed influenza, of whom, 85 (87%) had ILI and 13 (13%) had SARI. Among ILI patients, the highest proportion of laboratory-confirmed influenza occurred in children less than 5 years of age (3/169; 2% during 2007-2008 and 23/271; 9% during 2008-2009) and patients 25-59 years of age (8/440; 2% during 2007-2009 and 21/483; 4% during 2008-2009). All SARI patients with influenza were less than 14 years of age. During all surveillance years, influenza virus circulation was seasonal with peak circulation during the winter months of October through April. Conclusion: Influenza results in both mild and severe respiratory infections in Morocco, and accounted for a large proportion of all hospitalizations for severe respiratory illness among children 5 years of age and younger.	[Barakat, Amal; Ihazmad, Hassan; Benkaroum, Samira] Minist Sante, Natl Inst Hyg, Ctr Natl Reference Grippe, Rabat, Morocco; Minist Sante, Direct Epidemiol & Lutte Malad, Rabat, Morocco		Barakat, A (corresponding author), Minist Sante, Natl Inst Hyg, Ctr Natl Reference Grippe, Rabat, Morocco.	amal.barakat@yahoo.fr		EL AOUAD, Rajae/0000-0002-2686-6924	Ministry of Health, Morocco; Centers for Disease Control and Prevention (CDC) [5U51CI000469]; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [U51CI000469] Funding Source: NIH RePORTER	Ministry of Health, Morocco; Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by the Ministry of Health, Morocco and through funding by the Centers for Disease Control and Prevention (CDC) grant no. 5U51CI000469. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barakat A, 2011, J INFECT DEV COUNTR, V5, P270, DOI 10.3855/jidc.1065; Cox JN, 1996, OPTIONS CONTROL INFU, P59; Cox NJ, 2000, ANNU REV MED, V51, P407, DOI 10.1146/annurev.med.51.1.407; Finkelman BS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001296; Gessner BD, 2011, LANCET INFECT DIS, V11, P223, DOI 10.1016/S1473-3099(11)70008-1; Jennings JC, 1999, VACCINE, V17, pS115, DOI 10.1016/S0264-410X(99)00260-1; Klimov A, 1999, VACCINE, V17, pS42, DOI 10.1016/S0264-410X(99)00104-8; Li C, 2009, J SCH NURS, V25, p4S, DOI 10.1177/1059840508330066; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Monto AS, 2006, J INFECT DIS, V194, pS92, DOI 10.1086/507559; Morgan OW, 2007, PLOS MED, V4, P654, DOI 10.1371/journal.pmed.0040105; NAIR H, 2011, 2010 OPT CONTR INFL; Neuzil KM, 2002, J INFECT DIS, V185, P147, DOI 10.1086/338363; Schanzer DL, 2006, PEDIATR INFECT DIS J, V25, P795, DOI 10.1097/01.inf.0000232632.86800.8c; Simmerman JM, 2009, PLOS ONE, V4, pA107, DOI 10.1371/journal.pone.0007776; Simonsen L, 1997, AM J PUBLIC HEALTH, V87, P1944, DOI 10.2105/AJPH.87.12.1944; Stohr K, 2003, VACCINE, V21, P1744, DOI 10.1016/S0264-410X(03)00065-3; Thompson WW, 2006, J INFECT DIS, V194, pS82, DOI 10.1086/507558; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Yazdanbakhsh M, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000182; Zambon MC, 2001, LANCET, V358, P1410, DOI 10.1016/S0140-6736(01)06528-X	21	32	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e24579	10.1371/journal.pone.0024579	http://dx.doi.org/10.1371/journal.pone.0024579			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CK	21931764	gold, Green Published, Green Submitted			2022-12-25	WOS:000294802800069
J	Boehnisch, C; Wong, D; Habig, M; Isermann, K; Michiels, NK; Roeder, T; May, RC; Schulenburg, H				Boehnisch, Claudia; Wong, Daniel; Habig, Michael; Isermann, Kerstin; Michiels, Nicolaas K.; Roeder, Thomas; May, Robin C.; Schulenburg, Hinrich			Protist-Type Lysozymes of the Nematode Caenorhabditis elegans Contribute to Resistance against Pathogenic Bacillus thuringiensis	PLOS ONE			English	Article							FREE-LIVING NEMATODES; EXPERIMENTAL COEVOLUTION; STATISTICAL TESTS; QUANTITATIVE PCR; GENE-EXPRESSION; INNATE IMMUNITY; BACTERIAL TOXIN; PROTEIN; HOST; SPECIFICITY	Pathogens represent a universal threat to other living organisms. Most organisms express antimicrobial proteins and peptides, such as lysozymes, as a protection against these challenges. The nematode Caenorhabditis elegans harbours 15 phylogenetically diverse lysozyme genes, belonging to two distinct types, the protist-or Entamoeba-type (lys genes) and the invertebrate-type (ilys genes) lysozymes. In the present study we characterized the role of several protist-type lysozyme genes in defence against a nematocidal strain of the Gram-positive bacterium Bacillus thuringiensis. Based on microarray and subsequent qRT-PCR gene expression analysis, we identified protist-type lysozyme genes as one of the differentially transcribed gene classes after infection. A functional genetic analysis was performed for three of these genes, each belonging to a distinct evolutionary lineage within the protist-type lysozymes (lys-2, lys-5, and lys-7). Their knock-out led to decreased pathogen resistance in all three cases, while an increase in resistance was observed when two out of three tested genes were overexpressed in transgenic lines (lys-5, lys-7, but not lys-2). We conclude that the lysozyme genes lys-5, lys-7, and possibly lys-2 contribute to resistance against B. thuringiensis, thus highlighting the particular role of lysozymes in the nematode's defence against pathogens.	[Boehnisch, Claudia; Michiels, Nicolaas K.; Schulenburg, Hinrich] Univ Munster, Inst Evolut & Biodivers, Munster, Germany; [Boehnisch, Claudia; Michiels, Nicolaas K.; Schulenburg, Hinrich] Univ Tubingen, Dept Anim Evolutionary Ecol, Tubingen, Germany; [Boehnisch, Claudia; May, Robin C.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Wong, Daniel] Univ Mediterranee, Ctr Immunol Marseille Luminy, Marseille, France; [Wong, Daniel] INSERM, F-13258 Marseille, France; [Wong, Daniel] CNRS, Marseille, France; [Wong, Daniel] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Habig, Michael; Schulenburg, Hinrich] Univ Kiel, Dept Evolutionary Ecol & Genet, Kiel, Germany; [Isermann, Kerstin; Roeder, Thomas] Univ Kiel, Dept Zoophysiol, Kiel, Germany	University of Munster; Eberhard Karls University of Tubingen; University of Birmingham; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); University of Oxford; Wellcome Centre for Human Genetics; University of Kiel; University of Kiel	Boehnisch, C (corresponding author), Univ Munster, Inst Evolut & Biodivers, Munster, Germany.	claudia_boehnisch@web.de; hschulenburg@zoologie.uni-kiel.de	Schulenburg, Hinrich/A-3886-2009; Michiels, Nico K/A-2045-2009; Roeder, Thomas/B-9016-2011; May, Robin Charles/ABA-9266-2021	Michiels, Nico K/0000-0001-9873-3111; Roeder, Thomas/0000-0002-3489-3834; May, Robin Charles/0000-0001-5364-1838; Habig, Michael/0000-0002-8059-806X	BBSRC [BB/F000138/1]; German Science Foundation [SCHU 1415/3]; Biotechnology and Biological Sciences Research Council [BB/F000138/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); German Science Foundation(German Research Foundation (DFG)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	RCM acknowledges financial support from the BBSRC (grant BB/F000138/1); HS from the German Science Foundation (grant SCHU 1415/3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrows BD, 2006, METHOD ENZYMOL, V417, P340, DOI 10.1016/S0076-6879(06)17021-4; Barrows BD, 2007, J BIOL CHEM, V282, P3302, DOI 10.1074/jbc.M606621200; Beintema J J, 1996, EXS, V75, P75; Bellier A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000689; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BORGONIE G, 1995, J INVERTEBR PATHOL, V65, P61, DOI 10.1006/jipa.1995.1008; Borgonie G, 1996, FUND APPL NEMATOL, V19, P391; Borgonie G, 1996, FUND APPL NEMATOL, V19, P407; Chen CS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009494; Cui X, 2003, STAT APPL GENET MOL, V2; Cui XG, 2005, BIOSTATISTICS, V6, P59, DOI 10.1093/biostatistics/kxh018; Cui XQ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-210; de Maagd RA, 2001, TRENDS GENET, V17, P193, DOI 10.1016/S0168-9525(01)02237-5; Evans EA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000175; Fastrez J, 1996, EXS, V75, P35; Griffitts JS, 2005, BIOESSAYS, V27, P614, DOI 10.1002/bies.20239; Griffitts JS, 2001, SCIENCE, V293, P860, DOI 10.1126/science.1062441; Griffitts JS, 2005, SCIENCE, V307, P922, DOI 10.1126/science.1104444; Griffitts JS, 2003, J BIOL CHEM, V278, P45594, DOI 10.1074/jbc.M308142200; Haber M, 2005, MOL BIOL EVOL, V22, P160, DOI 10.1093/molbev/msh264; Hahm JH, 2011, AGING CELL, V10, P208, DOI 10.1111/j.1474-9726.2010.00655.x; Hasshoff M, 2007, FASEB J, V21, P1801, DOI 10.1096/fj.06-6551com; Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01; Holtje J V, 1996, EXS, V75, P65; Huffman DL, 2004, P NATL ACAD SCI USA, V101, P10995, DOI 10.1073/pnas.0404073101; Hultmark D., 1996, Experientia Supplementum (Basel), V75, P87; Ideo H, 2009, J BIOL CHEM, V284, P26493, DOI 10.1074/jbc.M109.038257; Irazoqui JE, 2008, P NATL ACAD SCI USA, V105, P17469, DOI 10.1073/pnas.0809527105; Irazoqui JE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000982; Irwin D.M., 1996, Experientia Supplementum (Basel), V75, P347; Irwin DM, 2004, GENOME, V47, P1082, DOI 10.1139/G04-075; JACOBS T, 1995, EUR J BIOCHEM, V231, P831, DOI 10.1111/j.1432-1033.1995.0831d.x; Jensen VL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015902; JOLLES J, 1975, EUR J BIOCHEM, V54, P19, DOI 10.1111/j.1432-1033.1975.tb04108.x; Kao CY, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001314; Kawli T, 2008, NAT IMMUNOL, V9, P1415, DOI 10.1038/ni.1672; Leippe M, 1999, DEV COMP IMMUNOL, V23, P267, DOI 10.1016/S0145-305X(99)00010-5; LEYNS F, 1995, FUND APPL NEMATOL, V18, P211; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Los FCO, 2011, CELL HOST MICROBE, V9, P147, DOI 10.1016/j.chom.2011.01.005; Mallo GV, 2002, CURR BIOL, V12, P1209, DOI 10.1016/S0960-9822(02)00928-4; Marsh EK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016839; Mello C, 1995, METHOD CELL BIOL, V48, P451; Mysliwy J, 2010, DEV COMP IMMUNOL, V34, P323, DOI 10.1016/j.dci.2009.11.003; Nandakumar M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000273; O'Rourke D, 2006, GENOME RES, V16, P1005, DOI 10.1101/gr.50823006; Payne J. M., 1993, US patent, Patent No. 5424410; Payne J. M., 1992, US patent, Patent No. 5151363; Prager E.M., 1996, Experientia Supplementum (Basel), V75, P9; Pujol N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000105; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; RASBAND W, 2007, IMAGEJ; Regel R, 1998, INSECT BIOCHEM MOLEC, V28, P309, DOI 10.1016/S0965-1748(97)00108-2; Roeder T, 2010, DEV COMP IMMUNOL, V34, P203, DOI 10.1016/j.dci.2009.09.010; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Schmid-Hempel P, 2008, TRENDS ECOL EVOL, V23, P318, DOI 10.1016/j.tree.2008.02.011; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; Schnepf E., 2001, US patent, Patent No. 20010010932; Schulenburg H, 2004, PARASITOLOGY, V128, P433, DOI 10.1017/S003118200300461X; Schulenburg H, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-114; Schulenburg H, 2008, IMMUNOBIOLOGY, V213, P237, DOI 10.1016/j.imbio.2007.12.004; Schulenburg H, 2007, MOL MICROBIOL, V66, P563, DOI 10.1111/j.1365-2958.2007.05946.x; Schulte RD, 2011, P ROY SOC B-BIOL SCI, V278, P2832, DOI 10.1098/rspb.2011.0019; Schulte RD, 2010, P NATL ACAD SCI USA, V107, P7359, DOI 10.1073/pnas.1003113107; Sicard M, 2007, ENVIRON MICROBIOL, V9, P12, DOI 10.1111/j.1462-2920.2006.01099.x; Simonsen KT, 2011, VIRULENCE, V2, P120, DOI 10.4161/viru.2.2.15270; Stiernagle Theresa, 2006, WormBook, P1; Sun JR, 2011, SCIENCE, V332, P729, DOI 10.1126/science.1203411; Troemel ER, 2006, PLOS GENET, V2, P1725, DOI 10.1371/journal.pgen.0020183; Wei JZ, 2003, P NATL ACAD SCI USA, V100, P2760, DOI 10.1073/pnas.0538072100; Wong D, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r194; WU H, 2008, R MAANOVA EXTENSIVE	72	40	48	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e24619	10.1371/journal.pone.0024619	http://dx.doi.org/10.1371/journal.pone.0024619			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CK	21931778	Green Published, gold, Green Submitted			2022-12-25	WOS:000294802800072
J	Gross, SM; Williamson, VM				Gross, Stephen M.; Williamson, Valerie M.			Tm1: A Mutator/Foldback Transposable Element Family in Root-Knot Nematodes	PLOS ONE			English	Article							RESISTANCE GENE MI; MELOIDOGYNE-INCOGNITA; HORIZONTAL TRANSFER; CHROMOSOME REARRANGEMENTS; DNA TRANSPOSONS; EVOLUTION; SEQUENCE; GENOME; DROSOPHILA; TOMATO	Three closely related parthenogenetic species of root-knot nematodes, collectively termed the Meloidogyne incognita-group, are economically significant pathogens of diverse crop species. Remarkably, these asexual root-knot nematodes are capable of acquiring heritable changes in virulence even though they lack sexual reproduction and meiotic recombination. Characterization of a near isogenic pair of M. javanica strains differing in response to tomato with the nematode resistance gene Mi-1 showed that the virulent strain carried a deletion spanning a gene called Cg-1. Herein, we present evidence that the Cg-1 gene lies within a member of a novel transposable element family (Tm1; Transposon in Meloidogyne-1). This element family is defined by composite terminal inverted repeats of variable lengths similar to those of Foldback (FB) transposable elements and by 9 bp target site duplications. In M. incognita, Tm1 elements can be classified into three general groups: 1) histone-hairpin motif elements; 2) MITE-like elements; 3) elements encoding a putative transposase. The predicted transposase shows highest similarity to gene products encoded by aphids and mosquitoes and resembles those of the Phantom subclass of the Mutator transposon superfamily. Interestingly, the meiotic, sexually-reproducing root-knot nematode species M. hapla has Tm1 elements with similar inverted repeat termini, but lacks elements with histone hairpin motifs and contains no elements encoding an intact transposase. These Tm1 elements may have impacts on root-knot nematode genomes and contribute to genetic diversity of the asexual species.	[Gross, Stephen M.; Williamson, Valerie M.] Univ Calif Davis, Dept Nematol, Davis, CA 95616 USA	University of California System; University of California Davis	Gross, SM (corresponding author), Dept Energy Joint Genome Inst, Walnut Creek, CA 94598 USA.	vmwilliamson@ucdavis.edu		Shah, Rushi/0000-0001-5421-2402; Gross, Stephen/0000-0003-0711-787X	USDA, Cooperative State Research, Education, and Extension Service (CSREES) [2008-35302-18802]	USDA, Cooperative State Research, Education, and Extension Service (CSREES)(United States Department of Agriculture (USDA)National Institute of Food and Agriculture)	This work was funded by the USDA, Cooperative State Research, Education, and Extension Service (CSREES), grant no. 2008-35302-18802. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad P, 2008, NAT BIOTECHNOL, V26, P909, DOI 10.1038/nbt.1482; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arnold DL, 2007, TRENDS GENET, V23, P293, DOI 10.1016/j.tig.2007.03.017; Arnold DL, 2003, MOL PLANT PATHOL, V4, P407, DOI [10.1046/j.1364-3703.2003.00187.x, 10.1046/J.1364-3703.2003.00187.X]; Babu MM, 2006, NUCLEIC ACIDS RES, V34, P6505, DOI 10.1093/nar/gkl888; BARHAM WARREN S., 1957, PROC AMER SOC HORT SCI, V69, P372; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; BENNETZEN JL, 1984, P NATL ACAD SCI-BIOL, V81, P4125, DOI 10.1073/pnas.81.13.4125; Besemer J, 2005, NUCLEIC ACIDS RES, V33, pW451, DOI 10.1093/nar/gki487; BIRD AF, 1975, J NEMATOL, V7, P111; Bird DM, 2009, ANNU REV PHYTOPATHOL, V47, P333, DOI 10.1146/annurev-phyto-080508-081839; Blumenthal Thomas, 1997, Cold Spring Harbor Monograph Series, V33, P117; BOST SC, 1982, J NEMATOL, V14, P540; Branch C, 2004, MOL PLANT MICROBE IN, V17, P351, DOI 10.1094/MPMI.2004.17.4.351; Caceres M, 1999, SCIENCE, V285, P415, DOI 10.1126/science.285.5426.415; Casals F, 2003, MOL BIOL EVOL, V20, P674, DOI 10.1093/molbev/msg070; Castagnone-Sereno P, 2006, HEREDITY, V96, P282, DOI 10.1038/sj.hdy.6800794; CASTAGNONESERENO P, 1994, THEOR APPL GENET, V88, P749, DOI 10.1007/BF01253980; Chalvet F, 2003, MOL BIOL EVOL, V20, P1362, DOI 10.1093/molbev/msg155; Chandler M, 2002, MOBILE DNA, P306; Cheng CY, 2000, GENES GENET SYST, V75, P327, DOI 10.1266/ggs.75.327; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Diao XM, 2006, PLOS BIOL, V4, P119, DOI 10.1371/journal.pbio.0040005; Dorn R, 2003, GENETICA, V117, P165, DOI 10.1023/A:1022983810016; DRUMMOND AJ, 2008, GENEIOUS V4 0; EISEN JA, 1994, NUCLEIC ACIDS RES, V22, P2634, DOI 10.1093/nar/22.13.2634; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Feschotte C, 2007, ANNU REV GENET, V41, P331, DOI 10.1146/annurev.genet.40.110405.090448; FINNEGAN DJ, 1989, TRENDS GENET, V5, P103, DOI 10.1016/0168-9525(89)90039-5; Gause M, 2001, MOL CELL BIOL, V21, P4807, DOI 10.1128/MCB.21.14.4807-4817.2001; Ghosh D, 2001, EMBO J, V20, P2518, DOI 10.1093/emboj/20.10.2518; Gilbert JC, 1956, P AM SOC HORTIC SCI, V63, P437; Gleason CA, 2008, MOL PLANT MICROBE IN, V21, P576, DOI 10.1094/MPMI-21-5-0576; Haren L, 1999, ANNU REV MICROBIOL, V53, P245, DOI 10.1146/annurev.micro.53.1.245; Hicks GR, 1995, ANNU REV CELL DEV BI, V11, P155, DOI 10.1146/annurev.cb.11.110195.001103; Hua-Van A, 2008, J MOL EVOL; Hugall A, 1999, MOL BIOL EVOL, V16, P157, DOI 10.1093/oxfordjournals.molbev.a026098; Jiang N, 2004, NATURE, V431, P569, DOI 10.1038/nature02953; Kaloshian I, 2004, J CHEM ECOL, V30, P2419, DOI 10.1007/s10886-004-7943-1; KAPLAN N, 1985, GENETICS, V109, P459; Keall R, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-51; Kidwell MG, 1992, CURR OPIN GENET DEV, V2, P868, DOI 10.1016/S0959-437X(05)80109-1; Kidwell MG, 2001, EVOLUTION, V55, P1, DOI 10.1111/j.0014-3820.2001.tb01268.x; Kidwell MG, 1997, P NATL ACAD SCI USA, V94, P7704, DOI 10.1073/pnas.94.15.7704; Lampe DJ, 2003, MOL BIOL EVOL, V20, P554, DOI 10.1093/molbev/msg069; Leroy H, 2003, GENE, V304, P35, DOI 10.1016/S0378-1119(02)01144-7; LIM JK, 1994, BIOESSAYS, V16, P269, DOI 10.1002/bies.950160410; Lisch D, 2005, BIOESSAYS, V27, P353, DOI 10.1002/bies.20219; Lisch D, 2002, TRENDS PLANT SCI, V7, P498, DOI 10.1016/S1360-1385(02)02347-6; Lisch D, 2008, P NATL ACAD SCI USA, V105, P16827, DOI 10.1073/pnas.0809525105; Liu QL, 2006, J NEMATOL, V38, P279; Liu QLL, 2007, GENETICS, V176, P1483, DOI 10.1534/genetics.107.071134; Lomsadze A, 2005, NUCLEIC ACIDS RES, V33, P6494, DOI 10.1093/nar/gki937; Lunt DH, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-194; Marquez CP, 2010, GENETICS, V185, P1507, DOI 10.1534/genetics.110.116673; Marzluff WF, 2005, CURR OPIN CELL BIOL, V17, P274, DOI 10.1016/j.ceb.2005.04.010; Marzo M, 2008, P NATL ACAD SCI USA, V105, P2957, DOI 10.1073/pnas.0712110105; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; MCCLURE MA, 1977, J NEMATOL, V9, P88; Mieczkowski PA, 2006, DNA REPAIR, V5, P1010, DOI 10.1016/j.dnarep.2006.05.027; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Nombela G, 2003, MOL PLANT MICROBE IN, V16, P645, DOI 10.1094/MPMI.2003.16.7.645; Opperman CH, 2008, P NATL ACAD SCI USA, V105, P14802, DOI 10.1073/pnas.0805946105; Pace JK, 2008, P NATL ACAD SCI USA, V105, P17023, DOI 10.1073/pnas.0806548105; POTTER SS, 1982, NATURE, V297, P201, DOI 10.1038/297201a0; POWERS TO, 1993, J NEMATOL, V25, P1; Quintiliani R, 1996, GENE, V172, P1, DOI 10.1016/0378-1119(96)00110-2; Rebatchouk D, 1997, PLANT MOL BIOL, V34, P831, DOI 10.1023/A:1005855008823; Rossi M, 1998, P NATL ACAD SCI USA, V95, P9750, DOI 10.1073/pnas.95.17.9750; Sambrook J, 2001, MOL CLONING LAB MANU; Sasser J. N., 1987, Vistas on Nematology: A Commemoration of the Twenty-fifth Anniversary of the Society of Nematologists, P7; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Semblat JP, 2001, MOL PLANT MICROBE IN, V14, P72, DOI 10.1094/MPMI.2001.14.1.72; Silva JC, 2004, CURR ISSUES MOL BIOL, V6, P57; Silva JC, 2000, MOL BIOL EVOL, V17, P1542, DOI 10.1093/oxfordjournals.molbev.a026253; Sinzelle L, 2009, CELL MOL LIFE SCI, V66, P1073, DOI 10.1007/s00018-009-8376-3; TAILLIEZ P, 1994, GENE, V145, P75, DOI 10.1016/0378-1119(94)90325-5; Takami H, 2001, J BACTERIOL, V183, P4345, DOI 10.1128/JB.183.14.4345-4356.2001; Takumi Toru, 2002, Methods Mol Biol, V192, P385; Triantaphyllou A. C., 1962, Nematologica, V7, P105; TRIANTAPHYLLOU AC, 1966, J MORPHOL, V118, P403, DOI 10.1002/jmor.1051180308; TRIANTAPHYLLOU AC, 1981, J NEMATOL, V13, P95; Trudgill DL, 2001, ANNU REV PHYTOPATHOL, V39, P53, DOI 10.1146/annurev.phyto.39.1.53; Wang CL, 2009, J CHEM ECOL, V35, P1242, DOI 10.1007/s10886-009-9703-8; WESSLER SR, 1995, CURR OPIN GENET DEV, V5, P814, DOI 10.1016/0959-437X(95)80016-X; Williamson VM, 2003, CURR OPIN PLANT BIOL, V6, P327, DOI 10.1016/S1369-5266(03)00059-1; Windsor AJ, 2000, GENETICS, V156, P1983; Wright S, 2001, CURR BIOL, V11, pR296, DOI 10.1016/S0960-9822(01)00168-3; Xu J, 2001, PHYTOPATHOLOGY, V91, P377, DOI 10.1094/PHYTO.2001.91.4.377; Xu Jian-Hua, 2002, Acta Genetica Sinica, V29, P212; Xu ZN, 2004, PLANT CELL, V16, P1105, DOI 10.1105/tpc.019802; Zijlstra C, 2000, NEMATOLOGY, V2, P847, DOI 10.1163/156854100750112798	94	17	18	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e24534	10.1371/journal.pone.0024534	http://dx.doi.org/10.1371/journal.pone.0024534			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CK	21931741	Green Published, Green Submitted, gold			2022-12-25	WOS:000294802800060
J	Membrino, A; Cogoi, S; Pedersen, EB; Xodo, LE				Membrino, Alexandro; Cogoi, Susanna; Pedersen, Erik B.; Xodo, Luigi E.			G4-DNA Formation in the HRAS Promoter and Rational Design of Decoy Oligonucleotides for Cancer Therapy	PLOS ONE			English	Article							ZINC-FINGER PROTEIN; G-QUADRUPLEX; C-MYC; ANTIPROLIFERATIVE ACTIVITY; MODIFIED PHTHALOCYANINES; SMALL-MOLECULE; RAS ONCOGENES; KRAS PROMOTER; HUMAN GENOME; BINDING	HRAS is a proto-oncogene involved in the tumorigenesis of urinary bladder cancer. In the HRAS promoter we identified two G-rich elements, hras-1 and hras-2, that fold, respectively, into an antiparallel and a parallel quadruplex (qhras-1, qhras-2). When we introduced in sequence hras-1 or hras-2 two point mutations that block quadruplex formation, transcription increased 5-fold, but when we stabilized the G-quadruplexes by guanidinium phthalocyanines, transcription decreased to 20% of control. By ChIP we found that sequence hras-1 is bound only by MAZ, while hras-2 is bound by MAZ and Sp1: two transcription factors recognizing guanine boxes. We also discovered by EMSA that recombinant MAZ-GST binds to both HRAS quadruplexes, while Sp1-GST only binds to qhras-1. The over-expression of MAZ and Sp1 synergistically activates HRAS transcription, while silencing each gene by RNAi results in a strong down-regulation of transcription. All these data indicate that the HRAS G-quadruplexes behave as transcription repressors. Finally, we designed decoy oligonucleotides mimicking the HRAS quadruplexes, bearing (R)-1-O-[4-(1-Pyrenylethynyl) phenylmethyl] glycerol and LNA modifications to increase their stability and nuclease resistance (G4-decoys). The G4-decoys repressed HRAS transcription and caused a strong antiproliferative effect, mediated by apoptosis, in T24 bladder cancer cells where HRAS is mutated.	[Membrino, Alexandro; Cogoi, Susanna; Xodo, Luigi E.] Sch Med, Dept Med & Biol Sci, Udine, Italy; [Pedersen, Erik B.] Univ So Denmark, Nucle Acid Ctr, Inst Chem & Phys, Odense, Denmark	University of Southern Denmark	Membrino, A (corresponding author), Sch Med, Dept Med & Biol Sci, Udine, Italy.	luigi.xodo@uniud.it	Xodo, Luigi/W-6350-2019; Pedersen, Erik B./M-4573-2017	Xodo, Luigi/0000-0003-3344-7207; Pedersen, Erik B./0000-0002-7917-2379	AIRC (Associazione Italiana per la Ricerca sul Cancro)	AIRC (Associazione Italiana per la Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro)	AIRC 2010, "Associazione Italiana per la Ricerca sul Cancro". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscruipt.	Alzeer J, 2009, ANGEW CHEM INT EDIT, V48, P9362, DOI 10.1002/anie.200903685; Alzeer J, 2009, CHEM COMMUN, P1970, DOI 10.1039/b822985f; Bates PJ, 2009, EXP MOL PATHOL, V86, P151, DOI 10.1016/j.yexmp.2009.01.004; Bates PJ, 1999, J BIOL CHEM, V274, P26369, DOI 10.1074/jbc.274.37.26369; Bejugam M, 2007, J AM CHEM SOC, V129, P12926, DOI 10.1021/ja075881p; BOS JL, 1989, CANCER RES, V49, P4682; BOSSONE SA, 1992, P NATL ACAD SCI USA, V89, P7452, DOI 10.1073/pnas.89.16.7452; Brooks TA, 2009, NAT REV CANCER, V9, P849, DOI 10.1038/nrc2733; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Choi EW, 2010, NUCLEIC ACIDS RES, V38, P1623, DOI 10.1093/nar/gkp1088; CLARKE S, 1992, ANNU REV BIOCHEM, V61, P355, DOI 10.1146/annurev.bi.61.070192.002035; Cogoi S, 2006, NUCLEIC ACIDS RES, V34, P2536, DOI 10.1093/nar/gkl286; Cogoi S, 2010, J BIOL CHEM, V285, P22003, DOI 10.1074/jbc.M110.101923; Cogoi S, 2009, J MED CHEM, V52, P564, DOI 10.1021/jm800874t; Dai JX, 2006, J AM CHEM SOC, V128, P1096, DOI 10.1021/ja055636a; Dinney CPN, 2004, CANCER CELL, V6, P111, DOI 10.1016/j.ccr.2004.08.002; Downward J, 1998, CURR OPIN GENET DEV, V8, P49, DOI 10.1016/S0959-437X(98)80061-0; Eddy J, 2006, NUCLEIC ACIDS RES, V34, P3887, DOI 10.1093/nar/gkl529; Federici L, 2010, J BIOL CHEM, V285, P37138, DOI 10.1074/jbc.M110.166736; FUJITA J, 1984, NATURE, V309, P464, DOI 10.1038/309464a0; Gonzalez V, 2009, J BIOL CHEM, V284, P23622, DOI 10.1074/jbc.M109.018028; Han HY, 2001, J AM CHEM SOC, V123, P8902, DOI 10.1021/ja002179j; Her S, 2003, MOL PHARMACOL, V64, P1180, DOI 10.1124/mol.64.5.1180; Himeda CL, 2008, MOL CELL BIOL, V28, P6521, DOI 10.1128/MCB.00306-08; Huppert JL, 2007, NUCLEIC ACIDS RES, V35, P406, DOI 10.1093/nar/gkl1057; ISHII S, 1985, SCIENCE, V230, P1378, DOI 10.1126/science.2999983; ISHII S, 1986, SCIENCE, V232, P1410, DOI 10.1126/science.3012774; Karantzoulis-Fegaras F, 1999, J BIOL CHEM, V274, P3076, DOI 10.1074/jbc.274.5.3076; Komatsu M, 1997, ONCOGENE, V15, P1123, DOI 10.1038/sj.onc.1201283; Leroy C, 2004, J MOL ENDOCRINOL, V32, P99, DOI 10.1677/jme.0.0320099; Lew A, 2000, P NATL ACAD SCI USA, V97, P12508, DOI 10.1073/pnas.97.23.12508; LOWY DR, 1993, ANNU REV BIOCHEM, V62, P851, DOI 10.1146/annurev.bi.62.070193.004223; Membrino A, 2010, CHEM COMMUN, V46, P625, DOI 10.1039/b918964e; Mo L, 2007, J CLIN INVEST, V117, P314, DOI 10.1172/JCI30062; Palumbo SL, 2008, NUCLEIC ACIDS RES, V36, P1755, DOI 10.1093/nar/gkm1069; Paramasivan S, 2007, METHODS, V43, P324, DOI 10.1016/j.ymeth.2007.02.009; Parks CL, 1997, J VIROL, V71, P9600, DOI 10.1128/JVI.71.12.9600-9607.1997; Parks CL, 1996, J BIOL CHEM, V271, P4417; Porter AC, 1998, ONCOGENE, V17, P1343, DOI 10.1038/sj.onc.1202171; Rebollo A, 1999, BLOOD, V94, P2971, DOI 10.1182/blood.V94.9.2971.421k43_2971_2980; REDDY EP, 1982, NATURE, V300, P149, DOI 10.1038/300149a0; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; SCHLESSINGER J, 1993, TRENDS BIOCHEM SCI, V18, P273, DOI 10.1016/0968-0004(93)90031-H; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; SEN D, 1988, NATURE, V334, P364, DOI 10.1038/334364a0; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Song J, 2001, J BIOL CHEM, V276, P19897, DOI 10.1074/jbc.M010658200; Todd AK, 2008, NUCLEIC ACIDS RES, V36, P2700, DOI 10.1093/nar/gkn078; Vageli D, 1996, CANCER LETT, V107, P241, DOI 10.1016/0304-3835(96)04372-8; Weisman-Shomer P, 2000, J BIOL CHEM, V275, P2231, DOI 10.1074/jbc.275.3.2231; Weisman-Shomer P, 2002, NUCLEIC ACIDS RES, V30, P3672, DOI 10.1093/nar/gkf506; Zhao YQ, 2007, FEBS LETT, V581, P1951, DOI 10.1016/j.febslet.2007.04.017	52	85	85	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e24421	10.1371/journal.pone.0024421	http://dx.doi.org/10.1371/journal.pone.0024421			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CK	21931711	Green Published, Green Submitted, gold			2022-12-25	WOS:000294802800049
J	Grigorov, B; Rabilloud, J; Lawrence, P; Gerlier, D				Grigorov, Boyan; Rabilloud, Jessica; Lawrence, Philip; Gerlier, Denis			Rapid Titration of Measles and Other Viruses: Optimization with Determination of Replication Cycle Length	PLOS ONE			English	Article							VESICULAR STOMATITIS-VIRUS; FLOW-CYTOMETRY; CELLULAR RECEPTOR; ASSAY; INFECTION; VACCINES; CELLS; GLYCOPROTEIN; FIBROBLASTS; VECTORS	Background: Measles virus (MV) is a member of the Paramyxoviridae family and an important human pathogen causing strong immunosuppression in affected individuals and a considerable number of deaths worldwide. Currently, measles is a re-emerging disease in developed countries. MV is usually quantified in infectious units as determined by limiting dilution and counting of plaque forming unit either directly (PFU method) or indirectly from random distribution in microwells (TCID50 method). Both methods are time-consuming (up to several days), cumbersome and, in the case of the PFU assay, possibly operator dependent. Methods/Findings: A rapid, optimized, accurate, and reliable technique for titration of measles virus was developed based on the detection of virus infected cells by flow cytometry, single round of infection and titer calculation according to the Poisson's law. The kinetics follow up of the number of infected cells after infection with serial dilutions of a virus allowed estimation of the duration of the replication cycle, and consequently, the optimal infection time. The assay was set up to quantify measles virus, vesicular stomatitis virus (VSV), and human immunodeficiency virus type 1 (HIV-1) using antibody labeling of viral glycoprotein, virus encoded fluorescent reporter protein and an inducible fluorescent-reporter cell line, respectively. Conclusion: Overall, performing the assay takes only 24-30 hours for MV strains, 12 hours for VSV, and 52 hours for HIV-1. The step-by-step procedure we have set up can be, in principle, applicable to accurately quantify any virus including lentiviral vectors, provided that a virus encoded gene product can be detected by flow cytometry.	[Grigorov, Boyan] Ecole Normale Super Lyon, INSERM, U758, F-69364 Lyon, France; Univ Lyon, Lyon, France	Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm)	Grigorov, B (corresponding author), Ecole Normale Super Lyon, INSERM, U758, F-69364 Lyon, France.	boyan.grigorov@inserm.fr	Grigorov, Boyan/AFT-7687-2022; Lawrence, Philip/M-7897-2014; Gerlier, Denis/L-6094-2014	Grigorov, Boyan/0000-0003-0376-7779; Gerlier, Denis/0000-0001-5539-456X; Lawrence, Philip/0000-0002-7637-045X	Sanofi Pasteur, Agence Nationale de la Recherche [ANR-08-PCVI-0020-03, AFF-IDP]; Recherche sur le SIDA et les Hepatites Virales - ANRS [AO 2009-2]	Sanofi Pasteur, Agence Nationale de la Recherche(French National Research Agency (ANR)); Recherche sur le SIDA et les Hepatites Virales - ANRS(French National Research Agency (ANR))	This work was supported by Sanofi Pasteur, Agence Nationale de la Recherche (ANR-08-PCVI-0020-03, AFF-IDP) and Recherche sur le SIDA et les Hepatites Virales - ANRS, through fellowship support (Sanofi Pasteur to BG and JR; ANRS to PL). (AO 2009-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arfi V, 2009, J VIROL, V83, P7524, DOI 10.1128/JVI.00429-09; Drayman Nir, 2011, Curr Protoc Cell Biol, VChapter 26, DOI 10.1002/0471143030.cb2611s51; Drayman N, 2010, J VIROL METHODS, V164, P145, DOI 10.1016/j.jviromet.2009.12.003; DULBECCO R, 1954, J EXP MED, V99, P167, DOI 10.1084/jem.99.2.167; Escoffier C, 1999, J VIROL, V73, P5220, DOI 10.1128/JVI.73.6.5220-5224.1999; FORSEY T, 1993, BIOLOGICALS, V21, P239, DOI 10.1006/biol.1993.1081; Gao Yong, 2009, V485, P27, DOI 10.1007/978-1-59745-170-3_3; Gates IV, 2009, APPL ENVIRON MICROB, V75, P2027, DOI 10.1128/AEM.02006-08; GERLIER D, 1994, J EXP MED, V179, P353, DOI 10.1084/jem.179.1.353; GERLIER D, 1995, TRENDS MICROBIOL, V3, P338, DOI 10.1016/S0966-842X(00)88972-6; Goujon C, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-2; Grigorov B, 2011, NUCL ACIDS RES; Gueret V, 2002, CYTOTECHNOLOGY, V38, P87, DOI 10.1023/A:1021106116887; Huang TG, 2003, MOL THER, V8, P434, DOI 10.1016/S1525-0016(03)00204-1; Konduru K, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-155; Kutner RH, 2009, NAT PROTOC, V4, P495, DOI 10.1038/nprot.2009.22; LaBarre DD, 2001, J VIROL METHODS, V96, P107, DOI 10.1016/S0166-0934(01)00316-0; Lambert Francine, 2008, V454, P93, DOI 10.1007/978-1-59745-181-9_8; Lecouturier V, 1996, J VIROL, V70, P4200, DOI 10.1128/JVI.70.7.4200-4204.1996; Li ZJ, 2010, J VIROL METHODS, V169, P87, DOI 10.1016/j.jviromet.2010.07.003; Lonsdale R, 2003, J VIROL METHODS, V110, P67, DOI 10.1016/S0166-0934(03)00102-2; Morner A, 1999, J VIROL, V73, P2343; REED L. J., 1938, AMER JOUR HYG, V27, P493; Roldao A, 2009, J VIROL METHODS, V159, P69, DOI 10.1016/j.jviromet.2009.03.007; Romanutti C, 2009, VET J, V182, P327, DOI 10.1016/j.tvjl.2008.06.015; Schalk JAC, 2005, BIOLOGICALS, V33, P71, DOI 10.1016/j.biologicals.2005.01.001; Schalk JAC, 2004, J VIROL METHODS, V117, P179, DOI 10.1016/j.jviromet.2004.01.009; SCOTTI PD, 1977, J GEN VIROL, V35, P393, DOI 10.1099/0022-1317-35-2-393; Tatsuo H, 2000, NATURE, V406, P893, DOI 10.1038/35022579; Vincent S, 1999, VIROLOGY, V265, P185, DOI 10.1006/viro.1999.0064; Wickersham IR, 2010, NAT PROTOC, V5, P595, DOI 10.1038/nprot.2009.248	31	41	45	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2011	6	9							e24135	10.1371/journal.pone.0024135	http://dx.doi.org/10.1371/journal.pone.0024135			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CH	21915289	Green Published, gold, Green Submitted			2022-12-25	WOS:000294802500029
J	Chen, Y; Yang, D; Li, S; Gao, Y; Jiang, R; Deng, L; Frankel, FR; Sun, B				Chen, Y.; Yang, D.; Li, S.; Gao, Y.; Jiang, R.; Deng, L.; Frankel, F. R.; Sun, B.			Development of a Listeria monocytogenes-based vaccine against hepatocellular carcinoma	ONCOGENE			English	Article						Listeria monocytogenes; hepatocellular carcinoma; immunotherapy; epitope; cancer vaccines	T-CELL RESPONSES; ALPHA-FETOPROTEIN; IMMUNE-RESPONSES; CANCER-IMMUNOTHERAPY; ANTITUMOR IMMUNITY; DENDRITIC CELLS; TRANSGENIC MICE; PEPTIDE ELISA; IN-VIVO; PROTEIN	Live attenuated Listeria monocytogenes (LM) is a promising bacterial vector able to induce a T-cell response to tumor-associated antigens and demonstrates great potential for use in vaccine development. A novel recombinant LM-based vaccine (Lmdd (LM Delta dal Delta dat)-MPFG (multiple peptide fusing genes)) was developed with the ability to express and secrete hepatocellular carcinoma (HCC)-related tumor-associated antigens fragments due to the insertion of hepatitis B virus (HBV)-X protein (HBx)-derived epitopes HBx(52-60) and HBx(140-148), the universal T-helper epitope, alpha-fetoprotein (AFP) epitope AFP(158-166), and melanoma antigen gene (MAGE)-3(271-279) into the HBV core protein. Following immunization with the Lmdd-MPFG vaccine, macrophages exhibited uptake of the bacteria; the vaccine was then nearly cleared 3 days after the first administration. It disappeared even more quickly following subsequent vaccinations. However, recombinant Lmdd-MPFG allowed for the full development of an antitumor response towards the human leukocyte antigen (HLA)-A0201 epitopes of MPFG. Each epitope stimulated an augmented T-cell proliferation and enhanced the supernatant level of interferon (IFN)-gamma in vitro. In addition, IFN-gamma-producing CD8(+) T cells as well as in vivo cytolytic activity were significantly increased in HLA-A2 transgenic mice. Additionally, the Lmdd-MPFG developed a strong antitumor response, as indicated by the significant resistance of immunized mice to MPFG-positive Hepa1-6 cell challenge in both a prophylactic and therapeutic setting. Tumor regression was accompanied by an enhanced cytotoxic T lymphocyte response and a decrease of regulatory T cells in the tumor. Collectively, these results suggest that utilizing attenuated LM as a vaccine vector, able to carry the MPFG gene, presents a potentially feasible strategy for prevention of HCC. Oncogene (2012) 31, 2140-2152; doi:10.1038/onc.2011.395; published online 19 September 2011	[Chen, Y.; Yang, D.; Gao, Y.; Jiang, R.; Deng, L.; Sun, B.] Nanjing Med Univ, Affiliated Hosp 1, Liver Transplantat Ctr, Nanjing, Jiangsu, Peoples R China; [Li, S.; Frankel, F. R.] Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA	Nanjing Medical University; University of Pennsylvania	Sun, B (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Liver Transplantat Ctr, 300 Guangzhou Rd, Nanjing, Jiangsu, Peoples R China.	sunbc@njmu.edu.cn	Jiang, Runqiu/T-8844-2018	Jiang, Runqiu/0000-0003-2720-1366	National Basic Research Program of China [2012CB910800]; National Natural Science Foundation [81072029, 30901750]; Major Research Plan of the National Natural Science Foundation [91029721]; New Century Excellent Talents in University, Ministry of Education [NCET-09-0160]; Natural Science Foundation of Jiangsu Province [BK201 0532]; Ministry of Health, China [W201001]; National Institutes of Health [R21-AI-071774]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI071774] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Major Research Plan of the National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); New Century Excellent Talents in University, Ministry of Education(Program for New Century Excellent Talents in University (NCET)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Ministry of Health, China; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from National Basic Research Program of China (2012CB910800 to BS), the National Natural Science Foundation (81072029 to BS and 30901750 to YC), Major Research Plan of the National Natural Science Foundation (91029721 to BS), the New Century Excellent Talents in University, Ministry of Education (NCET-09-0160 to BS), Natural Science Foundation of Jiangsu Province (BK201 0532 to YC), Ministry of Health, China (W201001 to LD), and National Institutes of Health grant (R21-AI-071774 to FRF).	Alouf JE, 2000, INT J MED MICROBIOL, V290, P351; Badvie S, 2000, POSTGRAD MED J, V76, P4, DOI 10.1136/pmj.76.891.4; Bai X, 2011, CARCINOGENESIS, V32, P63, DOI 10.1093/carcin/bgq195; BERTOLETTI A, 1993, J VIROL, V67, P2376, DOI 10.1128/JVI.67.4.2376-2380.1993; Blasco H, 2007, J IMMUNOL METHODS, V325, P127, DOI 10.1016/j.jim.2007.06.011; Butterfield LH, 2001, J IMMUNOL, V166, P5300, DOI 10.4049/jimmunol.166.8.5300; Butterfield LH, 1999, CANCER RES, V59, P3134; Chen Y, 2009, CELL MOL IMMUNOL, V6, P269, DOI 10.1038/cmi.2009.36; Cheng ZQ, 1997, HEPATOLOGY, V26, P1351; Ding FX, 2009, HEPATOLOGY, V49, P1492, DOI 10.1002/hep.22816; Duvoux C, 1998, ANN CHIR, V52, P511; FRANKEL FR, 1995, J IMMUNOL, V155, P4775; Friedman RS, 2000, J VIROL, V74, P9987, DOI 10.1128/JVI.74.21.9987-9993.2000; Furukawa S, 2004, IMMUNOBIOLOGY, V209, P551, DOI 10.1016/j.imbio.2004.07.001; Gedde MM, 2000, INFECT IMMUN, V68, P999, DOI 10.1128/IAI.68.2.999-1003.2000; Greten TF, 2010, J IMMUNOTHER, V33, P211, DOI 10.1097/CJI.0b013e3181bb499f; Hussain SA, 2001, ANN ONCOL, V12, P161, DOI 10.1023/A:1008370324827; KIM CM, 1991, NATURE, V351, P317, DOI 10.1038/351317a0; Kong J, 2007, ONCOL REP, V18, P279; Kursar M, 2002, J IMMUNOL, V168, P6382, DOI 10.4049/jimmunol.168.12.6382; Li ZX, 2008, J IMMUNOL, V180, P2504, DOI 10.4049/jimmunol.180.4.2504; Lin SM, 2005, GUT, V54, P1151, DOI 10.1136/gut.2004.045203; MACKANESS GB, 1969, J EXP MED, V129, P973, DOI 10.1084/jem.129.5.973; Menetrier-Caux C, 2009, CANCER RES, V69, P7895, DOI 10.1158/0008-5472.CAN-09-1642; Nieters A, 2005, CANCER, V103, P740, DOI 10.1002/cncr.20842; Olkhanud PB, 2009, CANCER RES, V69, P5996, DOI 10.1158/0008-5472.CAN-08-4619; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; Pamer EG, 1997, IMMUNOL REV, V158, P129, DOI 10.1111/j.1600-065X.1997.tb00999.x; Peters C, 2003, VACCINE, V21, P1187, DOI 10.1016/S0264-410X(02)00554-6; Ritter M, 2004, J HEPATOL, V41, P999, DOI 10.1016/j.jhep.2004.08.013; Sanyal AJ, 2010, ONCOLOGIST, V15, P14, DOI 10.1634/theoncologist.2010-S4-14; Sciaranghella G, 2011, VACCINE, V29, P476, DOI 10.1016/j.vaccine.2010.10.072; Seavey MM, 2009, CLIN CANCER RES, V15, P924, DOI 10.1158/1078-0432.CCR-08-2283; Shedlock DJ, 2003, J IMMUNOL, V170, P2053, DOI 10.4049/jimmunol.170.4.2053; Shen F, 1999, VACCINE, V17, P3039, DOI 10.1016/S0264-410X(99)00148-6; Shen XH, 2010, J CANCER RES CLIN, V136, P1745, DOI 10.1007/s00432-010-0833-8; Shen YN, 2010, INFECT IMMUN, V78, P2857, DOI 10.1128/IAI.01138-09; Singh R, 2006, EXPERT REV VACCINES, V5, P541, DOI 10.1586/14760584.5.4.541; Skoberne M, 2008, J CLIN INVEST, V118, P3990, DOI 10.1172/JCI31350; SMITH K, 1992, BIOCHIMIE, V74, P705, DOI 10.1016/0300-9084(92)90143-3; Song SX, 2007, VACCINE, V25, P4853, DOI 10.1016/j.vaccine.2006.12.029; Souders NC, 2006, DNA CELL BIOL, V25, P142, DOI 10.1089/dna.2006.25.142; Spears PA, 2008, INFECT IMMUN, V76, P4046, DOI 10.1128/IAI.00283-08; Su F, 1997, P NATL ACAD SCI USA, V94, P8744, DOI 10.1073/pnas.94.16.8744; Su Q, 1998, HEPATOLOGY, V27, P1109, DOI 10.1002/hep.510270428; Thompson RJ, 1998, INFECT IMMUN, V66, P3552, DOI 10.1128/IAI.66.8.3552-3561.1998; Vollmer CM, 1999, CANCER RES, V59, P3064; Wallecha A, 2009, CLIN VACCINE IMMUNOL, V16, P96, DOI 10.1128/CVI.00274-08; Williams JC, 2010, J IMMUNOL, V184, P6637, DOI 10.4049/jimmunol.0902784; Yamamoto K, 2006, CLIN EXP IMMUNOL, V144, P475, DOI 10.1111/j.1365-2249.2006.03092.x; Yoshimura K, 2006, CANCER RES, V66, P1096, DOI 10.1158/0008-5472.CAN-05-2307; Yoshimura K, 2007, CANCER RES, V67, P10058, DOI 10.1158/0008-5472.CAN-07-0573; Zerbini A, 2004, J HEPATOL, V40, P102, DOI 10.1016/S0168-8278(03)00484-7; Zhao XY, 2005, INFECT IMMUN, V73, P5789, DOI 10.1128/IAI.73.9.5789-5798.2005; Zhou L, 2010, J GASTROENTEROL, V45, P968, DOI 10.1007/s00535-010-0243-3; Zhou M, 2005, IMMUNOL LETT, V99, P113, DOI 10.1016/j.imlet.2005.02.007	56	28	30	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	APR	2012	31	17					2140	2152		10.1038/onc.2011.395	http://dx.doi.org/10.1038/onc.2011.395			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	934BS	21927025				2022-12-25	WOS:000303415900003
J	Levav-Cohen, Y; Wolyniec, K; Alsheich-Bartok, O; Chan, AL; Woods, SJ; Jiang, YH; Haupt, S; Haupt, Y				Levav-Cohen, Y.; Wolyniec, K.; Alsheich-Bartok, O.; Chan, A-L; Woods, S. J.; Jiang, Y-H; Haupt, S.; Haupt, Y.			E6AP is required for replicative and oncogene-induced senescence in mouse embryo fibroblasts	ONCOGENE			English	Article						E6AP; cellular senescence; stress; p53; Ras	UBIQUITIN-PROTEIN LIGASE; HUMAN-PAPILLOMAVIRUS TYPE-16; CELLULAR SENESCENCE; TUMOR SUPPRESSION; G(1) CONTROL; P53; GROWTH; CELLS; ANGELMAN; E6-AP	Cellular senescence is important for the maintenance of tissue homeostasis, and has recently been shown to pose a natural barrier to tumorigenesis. The E3 ubiquitin ligase, E6AP, has been linked to a number of protein regulators of the cell cycle as well as the cellular stress response. We therefore explored the role of E6AP in the cellular response to stress. We found that mouse embryo fibroblasts (MEFs) lacking E6AP escape replicative senescence, as well as Ras-induced senescence associated with impaired markers. E6AP-deficient MEFs exhibit a range of transformed phenotypes: these include the ability to grow under stress conditions (such as low serum and DNA damage), enhanced proliferation, anchorage independent growth and enhanced growth of xenografts in mice. The transformed phenotype of E6AP-deficient MEFs is associated with lower basal and stress-induced accumulation of p53. Overall, our study implicates E6AP as an important regulator of the cellular response to stress, in particular through the regulation of replicative and oncogene-induced senescence. Oncogene (2012) 31, 2199-2209; doi:10.1038/onc.2011.402; published online 19 September 2011	[Wolyniec, K.; Chan, A-L; Woods, S. J.; Haupt, S.; Haupt, Y.] Peter MacCallum Canc Ctr, Div Res, Melbourne, Vic 3002, Australia; [Levav-Cohen, Y.; Alsheich-Bartok, O.] Hebrew Univ Jerusalem, Hadassah Med Sch, Lautenberg Ctr Gen & Tumor Immunol, IL-91010 Jerusalem, Israel; [Jiang, Y-H] Duke Univ, Sch Med, Dept Pediat & Neurobiol, Div Med Genet, Durham, NC USA	Peter Maccallum Cancer Center; Hebrew University of Jerusalem; Duke University	Haupt, Y (corresponding author), Peter MacCallum Canc Ctr, Div Res, St Andrews Pl, Melbourne, Vic 3002, Australia.	ygal.haupt@petermac.org		Chan, Ai-Leen/0000-0003-3553-7249; Haupt, Ygal/0000-0001-5925-0096	NHMRC [509196]; Cancer Council Victoria; VESKI; European commission [503576]	NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); VESKI; European commission(European CommissionEuropean Commission Joint Research Centre)	We express our thanks to Scott Lowe and Martin Scheffner for the generous gifts of expression plasmids, and to Mariam Mansour for critical comments on the manuscript. Work in the authors laboratory is supported by an NHMRC project grant (grant No. 509196), by a grant from the Cancer Council Victoria, by the VESKI award and by the EC FP6 funding of the European commission (contract 503576). This publication reflects only the authors' views. The European commission is not liable for any use that may be made of the information herein.	Bar-Or RL, 2000, P NATL ACAD SCI USA, V97, P11250, DOI 10.1073/pnas.210171597; Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Beaudenon S, 2008, BMC BIOCHEM, V9, DOI 10.1186/1471-2091-9-S1-S4; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Ciechanover A, 2006, NEUROLOGY, V66, pS7, DOI 10.1212/01.wnl.0000192261.02023.b8; Collado M, 2006, NAT REV CANCER, V6, P472, DOI 10.1038/nrc1884; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Dannenberg JH, 2000, GENE DEV, V14, P3051, DOI 10.1101/gad.847700; Di Micco R, 2008, CELL CYCLE, V7, P3601, DOI 10.4161/cc.7.22.7152; Di Micco R, 2007, TRENDS CELL BIOL, V17, P529, DOI 10.1016/j.tcb.2007.07.012; Dimri GP, 2005, CANCER CELL, V7, P505, DOI 10.1016/j.ccr.2005.05.025; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Ferbeyre G, 2002, MOL CELL BIOL, V22, P3497, DOI 10.1128/MCB.22.10.3497-3508.2002; Frank KM, 2000, MOL CELL, V5, P993, DOI 10.1016/S1097-2765(00)80264-6; Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; HARVEY M, 1993, FASEB J, V7, P938, DOI 10.1096/fasebj.7.10.8344491; Haupt S, 2009, CANCER RES, V69, P4818, DOI 10.1158/0008-5472.CAN-08-4010; Haupt Y, 1996, EMBO J, V15, P1596, DOI 10.1002/j.1460-2075.1996.tb00504.x; Howley Peter M, 2006, Trans Am Clin Climatol Assoc, V117, P113; Howley PM., 2006, T AM CLIN CLIMAT ASS, V117, P126; HUIBREGTSE JM, 1991, EMBO J, V10, P4129, DOI 10.1002/j.1460-2075.1991.tb04990.x; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Jiang YH, 1998, CURR OPIN GENET DEV, V8, P334, DOI 10.1016/S0959-437X(98)80091-9; Khan OY, 2006, MOL ENDOCRINOL, V20, P544, DOI 10.1210/me.2005-0110; Kortlever RM, 2006, NAT CELL BIOL, V8, P877, DOI 10.1038/ncb1448; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Longworth MS, 2004, MICROBIOL MOL BIOL R, V68, P362, DOI 10.1128/MMBR.68.2.362-372.2004; Louria-Hayon I, 2009, CELL DEATH DIFFER, V16, P1156, DOI 10.1038/cdd.2009.31; Maezawa Y, 2006, DIABETES-METAB RES, V22, P313, DOI 10.1002/dmrr.612; Matentzoglu K, 2008, BIOCHEM SOC T, V36, P797, DOI 10.1042/BST0360797; Matsuura T, 1997, NAT GENET, V15, P74, DOI 10.1038/ng0197-74; Mishra A, 2008, CELL MOL LIFE SCI, V65, P656, DOI 10.1007/s00018-007-7476-1; Mishra A, 2009, NEUROBIOL DIS, V36, P26, DOI 10.1016/j.nbd.2009.06.010; MU XC, 1995, J CELL PHYSIOL, V165, P647, DOI 10.1002/jcp.1041650324; Papazoglu C, 2007, J PATHOL, V211, P124, DOI 10.1002/path.2086; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Rodier F, 2007, NUCLEIC ACIDS RES, V35, P7475, DOI 10.1093/nar/gkm744; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Sage J, 2003, NATURE, V424, P223, DOI 10.1038/nature01764; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sherman M, 2007, FEBS LETT, V581, P3711, DOI 10.1016/j.febslet.2007.05.036; Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5; SMITH JR, 1984, INT REV CYTOL, V89, P151, DOI 10.1016/S0074-7696(08)61303-0; Talis AL, 1998, J BIOL CHEM, V273, P6439, DOI 10.1074/jbc.273.11.6439; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Wolyniec K, 2009, ONCOGENE, V28, P2502, DOI 10.1038/onc.2009.101; Zuckerman V, 2009, J PATHOL, V219, P3, DOI 10.1002/path.2584; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	57	17	17	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2012	31	17					2199	2209		10.1038/onc.2011.402	http://dx.doi.org/10.1038/onc.2011.402			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	934BS	21927031				2022-12-25	WOS:000303415900008
J	Ulucan, O; Keskin, O; Erman, B; Gursoy, A				Ulucan, Ozlem; Keskin, Ozlem; Erman, Burak; Gursoy, Attila			A Comparative Molecular Dynamics Study of Methylation State Specificity of JMJD2A	PLOS ONE			English	Article							FREE-ENERGIES; RECOGNITION; SIMULATION; MECHANICS; CHROMATIN; PROTEINS; INSIGHTS; RECEPTOR; BINDING; QUANTUM	Histone modifications have great importance in epigenetic regulation. JMJD2A is a histone demethylase which is selective for di- and trimethyl forms of residues Lys9 and Lys36 of Histone 3 tail (H3K9 and H3K36). We present a molecular dynamics simulations of mono-, di- and trimethylated histone tails in complex with JMJD2A catalytic domain to gain insight into how JMJD2A discriminates between the methylation states of H3K9. The methyl groups are located at specific distances and orientations with respect to Fe(II) in methylammonium binding pocket. For the trimethyllysine the mechanism which provides the effectual orientation of methyl groups is the symmetry, whereas for the dimethyllysine case the determining factors are the interactions between methyllysine head and its environment and subsequently the restriction on angular motion. The occurrence frequency of methyl groups in a certain proximity of Fe(II) comes out as the explanation of the enzyme activity difference on di-and tri-methylated peptides. Energy analysis suggests that recognition is mostly driven by van der Waals and followed by Coulombic interactions in the enzyme-substrate interface. The number (mono, di or tri) and orientations of methyl groups and water molecules significantly affect the extent of van der Waals interaction strengths. Hydrogen bonding analysis suggests that the interaction between JMJD2A and its substrates mainly comes from main chain-side chain interactions. Binding free energy analysis points out Arg8 as an important residue forming an intra-substrate hydrogen bond with tri and dimethylated Lys9 of the H3 chain. Our study provides new insights into how JMJD2A discriminates between its substrates from both a structural and dynamical point of view.	Koc Univ, Ctr Computat Biol & Bioinformat, Istanbul, Turkey; Koc Univ, Coll Engn, Istanbul, Turkey	Koc University; Koc University	Ulucan, O (corresponding author), Univ Saarland, Ctr Bioinformat, D-6600 Saarbrucken, Germany.	agursoy@ku.edu.tr	Ulucan, Ozlem/K-8410-2018; Gursoy, Attila/Z-4394-2019; erman, burak/F-5900-2015; Gursoy, Attila/E-9565-2015	Ulucan, Ozlem/0000-0002-7442-5728; Gursoy, Attila/0000-0002-2297-2113; erman, burak/0000-0002-2496-6059; Gursoy, Attila/0000-0002-2297-2113				[Anonymous], 2008, AMBER 10; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chen ZZ, 2006, CELL, V125, P691, DOI 10.1016/j.cell.2006.04.024; Chen ZZ, 2007, P NATL ACAD SCI USA, V104, P10818, DOI 10.1073/pnas.0704525104; Cortez CC, 2008, MUTAT RES-FUND MOL M, V647, P44, DOI 10.1016/j.mrfmmm.2008.07.006; Couture JF, 2007, NAT STRUCT MOL BIOL, V14, P689, DOI 10.1038/nsmb1273; Couture JF, 2006, J BIOL CHEM, V281, P19280, DOI 10.1074/jbc.M602257200; Dal Peraro MD, 2007, J STRUCT BIOL, V157, P444, DOI 10.1016/j.jsb.2006.10.019; DEREWENDA ZS, 1995, J MOL BIOL, V252, P248, DOI 10.1006/jmbi.1995.0492; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Gohlke H, 2003, J MOL BIOL, V330, P891, DOI 10.1016/S0022-2836(03)00610-7; JORGENSEN WL, 1981, J AM CHEM SOC, V103, P335, DOI 10.1021/ja00392a016; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Karlin S, 1997, P NATL ACAD SCI USA, V94, P14225, DOI 10.1073/pnas.94.26.14225; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Moss TJ, 2007, MUTAT RES-FUND MOL M, V618, P163, DOI 10.1016/j.mrfmmm.2006.05.038; Ng SS, 2007, NATURE, V448, P87, DOI 10.1038/nature05971; Ozboyaci M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014765; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Shao JY, 2007, J CHEM THEORY COMPUT, V3, P2312, DOI 10.1021/ct700119m; Shin S, 2007, BIOCHEM BIOPH RES CO, V359, P742, DOI 10.1016/j.bbrc.2007.05.179; Simmons JM, 2008, DALTON T, P5132, DOI 10.1039/b803512a; Wan SZ, 2005, PHILOS T R SOC A, V363, P2037, DOI 10.1098/rsta.2005.1627; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028	28	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2011	6	9							e24664	10.1371/journal.pone.0024664	http://dx.doi.org/10.1371/journal.pone.0024664			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZV	21931800	Green Published, gold, Green Submitted			2022-12-25	WOS:000295321800045
J	Crisci, C; Bensoussan, N; Romano, JC; Garrabou, J				Crisci, Carolina; Bensoussan, Nathaniel; Romano, Jean-Claude; Garrabou, Joaquim			Temperature Anomalies and Mortality Events in Marine Communities: Insights on Factors behind Differential Mortality Impacts in the NW Mediterranean	PLOS ONE			English	Article							ROCKY BENTHIC COMMUNITIES; MASS-MORTALITY; CLIMATE-CHANGE; CORAL; POPULATIONS; COASTAL; BIODIVERSITY; RESILIENCE; ESTUARINE; DYNAMICS	Two large-scale mass mortality events (MMEs) of unprecedented extent and severity affecting rocky benthic communities occurred during the summers of 1999 and 2003 along the coasts of the NW Mediterranean Sea. These mortality outbreaks were associated with positive thermal anomalies. In this study, we performed an analysis of inter-regional and inter-annual differences in temperature (T) conditions associated with MMEs of the red gorgonian Paramuricea clavata by analyzing high resolution T time series (hourly records for 3 to 8 years) from four regions of the NW Mediterranean with differing hydrological conditions and biological impacts. High resolution records allowed a detailed analysis using classical and new descriptors to characterize T anomalies. We were able to determine that the MMEs were triggered by two main types of positive thermal anomalies, with the first type being characterized by short periods (2 to 5 days) with high Mean T reaching more than 27 degrees C in some regions and being associated with high intra-day and intra-period variability, while the second type of anomaly presented long duration (near one month) at warm T (24 degrees C) with low intra-period variability. Inter-regional patterns arose; some regions displayed both types of anomalies, while others exhibited only one type. The results showed that T conditions should be considered as the main factor that explains the observed inter-regional and inter-annual differences in mortality impacts. In explaining these differences, the late timing of T anomalies, in addition to their magnitude was found to be determinant. Finally, by combining thermotolerance experimental data with the maximal T stress conditions observed in the four regions, we were able to determine the differential risk of mass mortality across regions. We conclude that expanding high resolution T series is important for the development of sound management and conservation plans to protect Mediterranean marine biodiversity in the face of climate change.	[Crisci, Carolina; Garrabou, Joaquim] Univ Mediterranee, Ctr Oceanol Marseille, Stn Marine Endoume, DIMAR,CNRS,UMR 6540, Marseille, France; [Bensoussan, Nathaniel] SARL, FACTO, IPSO, Marseille, France; [Romano, Jean-Claude] Univ Corse, UMR 6134, CNRS, Lab Syst Phys Environm, Ajaccio, France; [Garrabou, Joaquim] ICM CSIC, Inst Ciencies Mar, Barcelona, Catalonia, Spain	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM)	Crisci, C (corresponding author), Univ Mediterranee, Ctr Oceanol Marseille, Stn Marine Endoume, DIMAR,CNRS,UMR 6540, Marseille, France.	Carolina.CRISCI@univmed.fr			Alban Program [E06D103213UY]; Parc National de Port-Cros; IFB Foundation (Institut Francais de la Biodiversite); Agence Nationale pour la Recherche (ANR); Ministry of Science and Innovation [CTM2009-08045]	Alban Program; Parc National de Port-Cros; IFB Foundation (Institut Francais de la Biodiversite); Agence Nationale pour la Recherche (ANR)(French National Research Agency (ANR)); Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by the Alban Program (C. Crisci doctoral fellowship, fellowship code: E06D103213UY; www.programalban.org); Parc National de Port-Cros; The IFB Foundation (Institut Francais de la Biodiversite); Agence Nationale pour la Recherche (ANR) (MEDCHANGE Project) (http://www.agence-nationale-recherche.fr; http://sudek.esil.univmed.fr/medchange/spip); Ministry of Science and Innovation (Biorock project ref. CTM2009-08045). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dr. Nathaniel Bensoussan is employed by IPSO-FACTO SARL; he contributed to the analysis of the data and the writing of the manuscript.	Antonov J, 1998, NOAA ATLAS NESDIS, V1, P27; Bally M, 2007, GLOBAL CHANGE BIOL, V13, P2078, DOI 10.1111/j.1365-2486.2007.01423.x; Baums IB, 2008, MOL ECOL, V17, P2796, DOI 10.1111/j.1365-294X.2008.03787.x; Bensoussan N, 2009, P 1 MED S CONS COR O, P167; Bensoussan N, 2010, ESTUAR COAST SHELF S, V87, P431, DOI 10.1016/j.ecss.2010.01.008; Bianchi CN, 2007, HYDROBIOLOGIA, V580, P7, DOI 10.1007/s10750-006-0469-5; Cerrano C, 2000, ECOL LETT, V3, P284, DOI 10.1046/j.1461-0248.2000.00152.x; COLES SL, 1975, PAC SCI, V29, P15; Coll M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011842; Coma R, 2003, OIKOS, V101, P205, DOI 10.1034/j.1600-0706.2003.12028.x; Coma R, 2009, P NATL ACAD SCI USA, V106, P6176, DOI 10.1073/pnas.0805801106; COSTANZA R, 1993, AMBIO, V22, P88; DAYTON PK, 1995, AQUAT CONSERV, V5, P205, DOI 10.1002/aqc.3270050305; Duran S, 2004, MOL ECOL, V13, P109, DOI 10.1046/j.1365-294X.2003.02022.x; Ferrier-Pages C, 2009, J EXP BIOL, V212, P3007, DOI 10.1242/jeb.031823; FRANCOUR P, 1994, MAR POLLUT BULL, V28, P523, DOI 10.1016/0025-326X(94)90071-X; Garrabou J, 2002, ESTUAR COAST SHELF S, V55, P493, DOI 10.1006/ecss.2001.0920; Garrabou J, 2009, GLOBAL CHANGE BIOL, V15, P1090, DOI 10.1111/j.1365-2486.2008.01823.x; Garrabou J, 2001, MAR ECOL PROG SER, V217, P263, DOI 10.3354/meps217263; Gili Josep-Maria, 1992, Oecologia Aquatica, V10, P243; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Harmelin JG, 2004, SCI REP PORT CROS NA, V20, P173; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Hendry AP, 1999, EVOLUTION, V53, P1637, DOI 10.1111/j.1558-5646.1999.tb04550.x; Huete-Stauffer C, 2011, MAR ECOL-EVOL PERSP, V32, P107, DOI 10.1111/j.1439-0485.2011.00429.x; Hughes TP, 2005, TRENDS ECOL EVOL, V20, P380, DOI 10.1016/j.tree.2005.03.022; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Kappel CV, 2005, FRONT ECOL ENVIRON, V3, P275, DOI 10.2307/3868490; Kawecki TJ, 2004, ECOLOGY LETT, P7; Ledoux JB, 2010, MOL ECOL, V19, P675, DOI 10.1111/j.1365-294X.2009.04516.x; Linares C, 2005, MAR ECOL PROG SER, V305, P127, DOI 10.3354/meps305127; Margalef R., 1985, W MEDITERRANEAN; McClanahan TR, 2007, ECOL MONOGR, V77, P503, DOI 10.1890/06-1182.1; MILLOT C, 1979, OCEANOL ACTA, V2, P261; Oliver TA, 2011, CORAL REEFS; Perez T, 2000, CR ACAD SCI III-VIE, V323, P853, DOI 10.1016/S0764-4469(00)01237-3; Previati M, 2010, J EXP MAR BIOL ECOL, V390, P39, DOI 10.1016/j.jembe.2010.04.025; Rebetez M, 2009, THEOR APPL CLIMATOL, V95, P1, DOI 10.1007/s00704-007-0370-9; Rodolfo-Metalpa R, 2006, J EXP BIOL, V209, P4546, DOI 10.1242/jeb.02550; Romano JC, 2007, CR GEOSCI, V339, P57, DOI 10.1016/j.crte.2006.10.003; Sammarco PW, 2006, MAR BIOL, V149, P1337, DOI 10.1007/s00227-006-0318-0; Schar C, 2004, NATURE, V427, P332, DOI 10.1038/nature02300; Smith-Keune C, 2006, CORAL REEFS, V25, P493, DOI 10.1007/s00338-006-0129-2; Somot S, 2008, GLOBAL PLANET CHANGE, V63, P112, DOI 10.1016/j.gloplacha.2007.10.003; Steneck RS, 2001, MARINE COMMUNITY ECOLOGY, P445; Torrents O, 2008, J EXP MAR BIOL ECOL, V357, P7, DOI 10.1016/j.jembe.2007.12.006; TRUE M A, 1970, Bulletin de l'Institut Oceanographique (Monaco), V69, P1; Vargas-Yanez M, 2010, J MARINE SYST, V82, P171, DOI 10.1016/j.jmarsys.2010.04.013; Vezzulli L, 2010, ENVIRON MICROBIOL, V12, P2007, DOI 10.1111/j.1462-2920.2010.02209.x; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Williams G. C., 1966, P307; Wilson RS, 2002, TRENDS ECOL EVOL, V17, P66, DOI 10.1016/S0169-5347(01)02384-9; WONG P. P, 2007, CLIMATE CHANGE, P315, DOI DOI 10.1017/CB09781107415379; ZABALA M, 1989, Scientia Marina, V53, P3	57	63	65	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2011	6	9							e23814	10.1371/journal.pone.0023814	http://dx.doi.org/10.1371/journal.pone.0023814			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CO	21931615	Green Submitted, gold, Green Published			2022-12-25	WOS:000294803200005
J	Kawabe-Yako, R; Ii, M; Masuo, O; Asahara, T; Itakura, T				Kawabe-Yako, Rie; Ii, Masaaki; Masuo, Osamu; Asahara, Takayuki; Itakura, Toru			Cilostazol Activates Function of Bone Marrow-Derived Endothelial Progenitor Cell for Re-endothelialization in a Carotid Balloon Injury Model	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; NITRIC-OXIDE SYNTHASE; VIVO REENDOTHELIALIZATION CAPACITY; CYTOKINE-INDUCED MOBILIZATION; ELUTING STENT IMPLANTATION; E-DEFICIENT MICE; NEOINTIMA FORMATION; VASCULAR REPAIR; PHOSPHODIESTERASE INHIBITOR; ARTERIAL INJURY	Background: Cilostazol(CLZ) has been used as a vasodilating anti-platelet drug clinically and demonstrated to inhibit proliferation of smooth muscle cells and effect on endothelial cells. However, the effect of CLZ on re-endothelialization including bone marrow (BM)-derived endothelial progenitor cell (EPC) contribution is unclear. We have investigated the hypothesis that CLZ might accelerate re-endothelialization with EPCs. Methodology/Principal Findings: Balloon carotid denudation was performed in male Sprague-Dawley rats. CLZ group was given CLZ mixed feed from 2weeks before carotid injury. Control group was fed normal diet. CLZ accelerated re-endothelialization at 2 weeks after surgery and resulted in a significant reduction of neointima formation 4 weeks after surgery compared with that in control group. CLZ also increased the number of circulating EPCs throughout the time course. We examined the contribution of BM-derived EPCs to re-endothelialization by BM transplantation from Tie2/lacZ mice to nude rats. The number of Tie2-regulated X-gal positive cells on injured arterial luminal surface was increased at 2 weeks after surgery in CLZ group compared with that in control group. In vitro, CLZ enhanced proliferation, adhesion and migration activity, and differentiation with mRNA upregulation of adhesion molecule integrin alpha nu beta 3, chemokine receptor CXCR4 and growth factor VEGF assessed by real-time RT-PCR in rat BM-derived cultured EPCs. In addition, CLZ markedly increased the expression of SDF-1a that is a ligand of CXCR4 receptor in EPCs, in the media following vascular injury. Conclusions/Significance: CLZ promotes EPC mobilization from BM and EPC recruitment to sites of arterial injury, and thereby inhibited neointima formation with acceleration of re-endothelialization with EPCs as well as pre-existing endothelial cells in a rat carotid balloon injury model. CLZ could be not only an anti-platelet agent but also a promising tool for endothelial regeneration, which is a key event for preventing atherosclerosis or restenosis after vascular intervention.	[Kawabe-Yako, Rie; Ii, Masaaki; Asahara, Takayuki] RIKEN, Grp Vasc Regenerat Res, Inst Biomed Res & Innovat, Ctr Dev Biol, Kobe, Hyogo, Japan; [Kawabe-Yako, Rie; Masuo, Osamu; Itakura, Toru] Wakayama Med Univ, Dept Neurosurg, Wakayama, Japan; [Ii, Masaaki] Osaka Med Coll, Dept Pharmacol, Grp Translat Stem Cell Res, Osaka, Japan; [Asahara, Takayuki] Tokai Univ, Sch Med Kanagawa, Dept Regenerat Med Sci, Hiratsuka, Kanagawa 25912, Japan	Institute for Biomedical Research & Innovation (IBRI); RIKEN; Wakayama Medical University; Osaka Medical College; Tokai University	Kawabe-Yako, R (corresponding author), RIKEN, Grp Vasc Regenerat Res, Inst Biomed Res & Innovat, Ctr Dev Biol, Kobe, Hyogo, Japan.	masaii@art.osaka-med.ac.jp; asa777@is.icc.u-tokai.ac.jp			Ministry of Health, Labor and Welfare Organization in Japan; Foundation of Biomedical Research and Innovation of Kobe	Ministry of Health, Labor and Welfare Organization in Japan; Foundation of Biomedical Research and Innovation of Kobe	This work was supported by research funding from the Ministry of Health, Labor and Welfare Organization in Japan, and the Foundation of Biomedical Research and Innovation of Kobe. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aicher A, 2003, NAT MED, V9, P1370, DOI 10.1038/nm948; AKIYAMA H, 1985, J CHROMATOGR, V338, P456, DOI 10.1016/0378-4347(85)80121-3; Aoki M, 2001, DIABETOLOGIA, V44, P1034, DOI 10.1007/s001250100593; Asahara T, 2002, J HEMATOTH STEM CELL, V11, P171, DOI 10.1089/152581602753658385; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, EMBO J, V18, P3964, DOI 10.1093/emboj/18.14.3964; Chavakis E, 2005, J EXP MED, V201, P63, DOI 10.1084/jem.20041402; Chavakis E, 2007, CIRC RES, V100, P204, DOI 10.1161/01.RES.0000257774.55970.f4; Chen L, 2010, CARDIOVASC RES, V88, P462, DOI 10.1093/cvr/cvq207; Cho HJ, 2003, CIRCULATION, V108, P2918, DOI 10.1161/01.CIR.0000097001.79750.78; Dimmeler S, 2004, J MOL MED, V82, P671, DOI 10.1007/s00109-004-0580-x; Dimmeler S, 2001, J CLIN INVEST, V108, P391, DOI 10.1172/JCI200113152; Douglas JS, 2005, CIRCULATION, V112, P2826, DOI 10.1161/CIRCULATIONAHA.104.530097; Dufourcq P, 2002, CARDIOVASC RES, V53, P952, DOI 10.1016/S0008-6363(01)00547-8; Dzau VJ, 2005, HYPERTENSION, V46, P7, DOI 10.1161/01.HYP.0000168923.92885.f7; Fukuda D, 2005, CIRCULATION, V111, P926, DOI 10.1161/01.CIR.0000155612.47040.17; Giannotti G, 2010, HYPERTENSION, V55, P1389, DOI 10.1161/HYPERTENSIONAHA.109.141614; Hashimoto A, 2006, ATHEROSCLEROSIS, V189, P350, DOI 10.1016/j.atherosclerosis.2006.01.022; Hiatt WR, 2002, J VASC SURG, V36, P1283, DOI 10.1067/mva.2002.129654; Hofma SH, 2006, EUR HEART J, V27, P166, DOI 10.1093/eurheartj/ehi571; Hristov M, 2004, J CELL MOL MED, V8, P498, DOI 10.1111/j.1582-4934.2004.tb00474.x; Hristov M, 2007, CIRC RES, V100, P590, DOI 10.1161/01.RES.0000259043.42571.68; Imanishi T, 2006, ATHEROSCLEROSIS, V189, P288, DOI 10.1016/j.atherosclerosis.2005.12.031; Ishizaka N, 1999, ATHEROSCLEROSIS, V142, P41, DOI 10.1016/S0021-9150(98)00147-6; Iwakura A, 2003, CIRCULATION, V108, P3115, DOI 10.1161/01.CIR.0000106906.56972.83; Kambayashi J, 2003, CURR PHARM DESIGN, V9, P2289, DOI 10.2174/1381612033453910; Karshovska E, 2007, ARTERIOSCL THROM VAS, V27, P2540, DOI 10.1161/ATVBAHA.107.151050; Kim KY, 2002, J PHARMACOL EXP THER, V300, P709, DOI 10.1124/jpet.300.2.709; KIMURA Y, 1985, ARZNEIMITTEL-FORSCH, V35-2, P1144; Kong DL, 2004, CIRCULATION, V110, P2039, DOI 10.1161/01.CIR.0000143161.01901.BD; Lamping K, 2007, CIRC RES, V100, P1243, DOI 10.1161/01.RES.0000268193.46418.d1; Laufs U, 2004, CIRCULATION, V109, P220, DOI 10.1161/01.CIR.0000109141.48980.37; Leone AM, 2009, EUR HEART J, V30, P890, DOI 10.1093/eurheartj/ehp078; Liistro F, 2001, HEART, V86, P262, DOI 10.1136/heart.86.3.262; Matsumoto M, 2005, ATHEROSCLEROSIS SUPP, V6, P33, DOI 10.1016/j.atherosclerosissup.2005.09.003; Miyamoto N, 2010, J CEREBR BLOOD F MET, V30, P299, DOI 10.1038/jcbfm.2009.210; Morishita R, 1997, DIABETOLOGIA, V40, P1053, DOI 10.1007/s001250050787; Nishio Y, 1997, HORM METAB RES, V29, P491, DOI 10.1055/s-2007-979086; Omi H, 2004, MICROVASC RES, V68, P119, DOI 10.1016/j.mvr.2004.05.002; Otsuki M, 2001, ATHEROSCLEROSIS, V158, P121, DOI 10.1016/S0021-9150(01)00431-2; Rahman S, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-8; Sainz J, 2007, ARTERIOSCL THROM VAS, V27, P263, DOI 10.1161/01.ATV.0000256727.34148.e2; Sanada F, 2009, HYPERTENSION, V53, P77, DOI 10.1161/HYPERTENSIONAHA.108.120725; Schober A, 2003, CIRCULATION, V108, P2491, DOI 10.1161/01.CIR.0000099508.76665.9A; Shin HK, 2004, CIRCULATION, V109, P1022, DOI 10.1161/01.CIR.0000117403.64398.53; Shin HK, 2010, J NEUROSCI RES, V88, P2228, DOI 10.1002/jnr.22376; Sorrentino SA, 2007, CIRCULATION, V116, P163, DOI 10.1161/CIRCULATIONAHA.106.684381; Strehlow K, 2003, CIRCULATION, V107, P3059, DOI 10.1161/01.CIR.0000077911.81151.30; TAKAHASHI S, 1992, J CARDIOVASC PHARM, V20, P900, DOI 10.1097/00005344-199212000-00009; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Takigawa T, 2010, J VASC SURG, V51, P51, DOI 10.1016/j.jvs.2009.08.040; Tsuchikane E, 1999, CIRCULATION, V100, P21, DOI 10.1161/01.CIR.100.1.21; Tsuruta W, 2007, NEUROL MED-CHIR, V47, P525, DOI 10.2176/nmc.47.525; Urbich C, 2005, J MOL CELL CARDIOL, V39, P733, DOI 10.1016/j.yjmcc.2005.07.003; Walter DH, 2002, CIRCULATION, V105, P3017, DOI 10.1161/01.CIR.0000018166.84319.55; Werner N, 2002, ARTERIOSCL THROM VAS, V22, P1567, DOI 10.1161/01.ATV.0000036417.43987.D8; Yin YG, 2010, CARDIOVASC PATHOL, V19, P218, DOI 10.1016/j.carpath.2009.04.002; Zampetaki A, 2008, CARDIOVASC RES, V78, P413, DOI 10.1093/cvr/cvn081; Zernecke A, 2005, CIRC RES, V96, P784, DOI 10.1161/01.RES.0000162100.52009.38; Zhang Po, 2006, Zhonghua Xinxueguanbing Zazhi, V34, P1021; Zhang ZF, 2006, AM HEART J, V152, P770, DOI 10.1016/j.ahj.2006.03.018	61	43	43	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2011	6	9							e24646	10.1371/journal.pone.0024646	http://dx.doi.org/10.1371/journal.pone.0024646			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CO	21931795	Green Published, gold, Green Submitted			2022-12-25	WOS:000294803200035
J	Aukema, JE; Leung, B; Kovacs, K; Chivers, C; Britton, KO; Englin, J; Frankel, SJ; Haight, RG; Holmes, TP; Liebhold, AM; McCullough, DG; Von Holle, B				Aukema, Juliann E.; Leung, Brian; Kovacs, Kent; Chivers, Corey; Britton, Kerry O.; Englin, Jeffrey; Frankel, Susan J.; Haight, Robert G.; Holmes, Thomas P.; Liebhold, Andrew M.; McCullough, Deborah G.; Von Holle, Betsy			Economic Impacts of Non-Native Forest Insects in the Continental United States	PLOS ONE			English	Article							BIOLOGICAL INVASIONS; COSTS; MANAGEMENT; THREATS; PESTS; PRICE	Reliable estimates of the impacts and costs of biological invasions are critical to developing credible management, trade and regulatory policies. Worldwide, forests and urban trees provide important ecosystem services as well as economic and social benefits, but are threatened by non-native insects. More than 450 non-native forest insects are established in the United States but estimates of broad-scale economic impacts associated with these species are largely unavailable. We developed a novel modeling approach that maximizes the use of available data, accounts for multiple sources of uncertainty, and provides cost estimates for three major feeding guilds of non-native forest insects. For each guild, we calculated the economic damages for five cost categories and we estimated the probability of future introductions of damaging pests. We found that costs are largely borne by homeowners and municipal governments. Wood-and phloem-boring insects are anticipated to cause the largest economic impacts by annually inducing nearly $1.7 billion in local government expenditures and approximately $830 million in lost residential property values. Given observations of new species, there is a 32% chance that another highly destructive borer species will invade the U. S. in the next 10 years. Our damage estimates provide a crucial but previously missing component of cost-benefit analyses to evaluate policies and management options intended to reduce species introductions. The modeling approach we developed is highly flexible and could be similarly employed to estimate damages in other countries or natural resource sectors.	[Aukema, Juliann E.] Natl Ctr Ecol Anal & Synth, Santa Barbara, CA USA; [Leung, Brian; Chivers, Corey] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; [Leung, Brian] McGill Univ, Sch Environm, Montreal, PQ, Canada; [Kovacs, Kent] Univ Minnesota, Dept Appl Econ, St Paul, MN 55108 USA; [Kovacs, Kent] Univ Minnesota, Inst Environm, St Paul, MN 55108 USA; [Britton, Kerry O.] US Forest Serv, Arlington, VA USA; [Englin, Jeffrey] Arizona State Univ, Morrison Sch Agribusiness & Resource Management, Mesa, AZ USA; [Frankel, Susan J.] US Forest Serv, Pacific SW Res Stn, Albany, CA USA; [Haight, Robert G.] US Forest Serv, No Res Stn, St Paul, MN USA; [Holmes, Thomas P.] US Forest Serv, So Res Stn, Res Triangle Pk, NC USA; [Liebhold, Andrew M.] US Forest Serv, No Res Stn, Morgantown, WV USA; [McCullough, Deborah G.] Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA; [McCullough, Deborah G.] Michigan State Univ, Dept Forestry, E Lansing, MI 48824 USA; [Von Holle, Betsy] Univ Cent Florida, Dept Biol, Orlando, FL 32816 USA	National Center for Ecological Analysis & Synthesis; McGill University; McGill University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; United States Department of Agriculture (USDA); United States Forest Service; Arizona State University; United States Department of Agriculture (USDA); United States Forest Service; United States Department of Agriculture (USDA); United States Forest Service; United States Department of Agriculture (USDA); United States Forest Service; United States Department of Agriculture (USDA); United States Forest Service; Michigan State University; Michigan State University; State University System of Florida; University of Central Florida	Aukema, JE (corresponding author), Natl Ctr Ecol Anal & Synth, Santa Barbara, CA USA.	aukema@nceas.ucsb.edu	Liebhold, Andrew M./C-1423-2008; Englin, Jeff/AAN-2322-2020; Von Holle, Betsy/GZG-5112-2022; Frankel, Susan/AAQ-7781-2021	Liebhold, Andrew M./0000-0001-7427-6534; Von Holle, Betsy/0000-0002-3116-3027; 	Nature Conservancy; NCEAS; National Science Foundation [DEB-0553768]; University of California Santa Barbara; State of California	Nature Conservancy; NCEAS; National Science Foundation(National Science Foundation (NSF)); University of California Santa Barbara(University of California System); State of California	This work is the product of a National Center for Ecological Analysis and Synthesis (NCEAS) Working Group supported by The Nature Conservancy and NCEAS, which is funded by the National Science Foundation (Grant #DEB-0553768), the University of California Santa Barbara, and the State of California. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aukema JE, 2010, BIOSCIENCE, V60, P886, DOI 10.1525/bio.2010.60.11.5; Born W, 2005, ECOL ECON, V55, P321, DOI 10.1016/j.ecolecon.2005.08.014; BRIGHT C, 1998, LIFE OUT BOUNDS BIOI, P287; Chornesky EA, 2005, BIOSCIENCE, V55, P335, DOI 10.1641/0006-3568(2005)055[0335:SPFRTT]2.0.CO;2; Colautti RI, 2006, BIOL INVASIONS, V8, P45, DOI 10.1007/s10530-005-0236-y; Evans M., 1993, STAT DISTRIBUTIONS, V2nd; Everett RA, 2000, TRENDS ECOL EVOL, V15, P177, DOI 10.1016/S0169-5347(00)01835-8; *FAO, 2006, INT STAND PHYT MEAS, P189; Fraedrich SW, 2008, PLANT DIS, V92, P215, DOI 10.1094/PDIS-92-2-0215; Gandhi KJK, 2010, BIOL INVASIONS, V12, P389, DOI 10.1007/s10530-009-9627-9; Gren IM, 2009, AMBIO, V38, P135, DOI 10.1579/0044-7447-38.3.135; Haack RA, 2006, CAN J FOREST RES, V36, P269, DOI 10.1139/x05-249; Holmes TP, 2009, ANN NY ACAD SCI, V1162, P18, DOI 10.1111/j.1749-6632.2009.04446.x; HOLMES TP, 1991, FOREST SCI, V37, P500; Jenkins PT, 2002, ISSUES SCI TECHNOL, V19, P67; Jones CG, 1998, SCIENCE, V279, P1023, DOI 10.1126/science.279.5353.1023; Kenis M, 2007, B ENTOMOL RES, V97, P489, DOI 10.1017/S0007485307005184; Leuschner William A., 1996, Southern Journal of Applied Forestry, V20, P65; Lodge DM, 2006, ECOL APPL, V16, P2035, DOI 10.1890/1051-0761(2006)016[2035:BIRFUP]2.0.CO;2; Lovett GM, 2006, BIOSCIENCE, V56, P395, DOI 10.1641/0006-3568(2006)056[0395:FERTEP]2.0.CO;2; Lovett GM, 2002, BIOSCIENCE, V52, P335, DOI 10.1641/0006-3568(2002)052[0335:IDANCI]2.0.CO;2; Ludwig D, 1999, ECOLOGY, V80, P298, DOI 10.1890/0012-9658(1999)080[0298:IIMTEA]2.0.CO;2; Perrings C, 2005, TRENDS ECOL EVOL, V20, P212, DOI 10.1016/j.tree.2005.02.011; Peterson GD, 2003, ECOLOGY, V84, P1403, DOI 10.1890/0012-9658(2003)084[1403:UATMOM]2.0.CO;2; Pimentel D, 2001, AGR ECOSYST ENVIRON, V84, P1, DOI 10.1016/S0167-8809(00)00178-X; Pimentel D, 2000, BIOSCIENCE, V50, P53, DOI 10.1641/0006-3568(2000)050[0053:EAECON]2.3.CO;2; Prestemon JP, 2000, AM J AGR ECON, V82, P145, DOI 10.1111/0002-9092.00012; Sharov AA, 1998, ECOL APPL, V8, P833, DOI 10.1890/1051-0761(1998)008[0833:BOMTSO]2.0.CO;2; Simberloff Daniel, 2000, P325; SIMON HA, 1961, ECONOMETRICA, V29, P111, DOI 10.2307/1909285; Wagner DL, 2010, ANNU REV ENTOMOL, V55, P547, DOI 10.1146/annurev-ento-112408-085516; WARD JD, 2002, SRS53 USDA FOR SERV; Wilcove DS, 1998, CONSERV BIOL, V12, P1405, DOI 10.1046/j.1523-1739.1998.97451.x; Williamson M, 1996, ECOLOGY, V77, P1661, DOI 10.2307/2265769	34	378	401	3	179	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2011	6	9							e24587	10.1371/journal.pone.0024587	http://dx.doi.org/10.1371/journal.pone.0024587			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	819CN	21931766	Green Published, Green Submitted, gold			2022-12-25	WOS:000294803100045
J	Choi, M; Kim, H; Qian, H; Palepu, A				Choi, Mark; Kim, Haerin; Qian, Hong; Palepu, Anita			Readmission Rates of Patients Discharged against Medical Advice: A Matched Cohort Study	PLOS ONE			English	Article							LEAVE; HOSPITALS	Objective: We compared the readmission rates and the pattern of readmission among patients discharged against medical advice (AMA) to control patients discharged with approval over a one-year follow-up period. Methods: A retrospective matched-cohort study of 656 patients(328 were discharged AMA) who were followed for one year after their initial hospitalization at an urban university-affiliated teaching hospital in Vancouver, Canada that serves a population with high prevalence of addiction and psychiatric disorders. Multivariate conditional logistic regression was used to examine the independent association of discharge AMA on 14-day related diagnosis hospital readmission. We fit a multivariate conditional negative binomial regression model to examine the readmission frequency ratio between the AMA and non-AMA group. Principal Findings: AMA patients were more likely to be homeless (32.3% vs. 11%) and have co-morbid conditions such as psychiatric illnesses, injection drug use, HIV, hepatitis C and previous gastrointestinal bleeding. Patients discharged AMA were more likely to be readmitted: 25.6% vs. 3.4%, p<0.001 by day 14. The AMA group were more likely to be readmitted within 14 days with a related diagnosis than the non-AMA group (Adjusted Odds Ratio 12.0; 95% Confidence Interval [CI]: 3.7-38.9). Patients who left AMA were more likely to be readmitted multiple times at one year compared to the non-AMA group (adjusted frequency ratio 1.6; 95% CI: 1.3-2.0). There was also higher all-cause in-hospital mortality during the 12-month follow-up in the AMA group compared to non-AMA group (6.7% vs. 2.4%, p = 0.01). Conclusions: Patients discharged AMA were more likely to be homeless and have multiple co-morbid conditions. At one year follow-up, the AMA group had higher readmission rates, were predisposed to multiple readmissions and had a higher in-hospital mortality. Interventions to reduce discharges AMA in high-risk groups need to be developed and tested.	[Choi, Mark; Kim, Haerin; Palepu, Anita] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Qian, Hong; Palepu, Anita] St Pauls Hosp, Ctr Hlth Evaluat & Outcome Sci, Vancouver, BC, Canada	University of British Columbia; St. Paul's Hospital; University of Saskatchewan	Choi, M (corresponding author), Univ British Columbia, Dept Med, Vancouver, BC, Canada.	anita@hivnet.ubc.ca		Palepu, Anita/0000-0002-7881-4800				Alfandre DJ, 2009, MAYO CLIN PROC, V84, P255, DOI 10.1016/S0025-6196(11)61143-9; Aliyu Z, 2002, INT J CLIN PRACT, V56, P325; Anis AH, 2002, CAN MED ASSOC J, V167, P633; [Anonymous], 2010, J GEN INTERN MED, V26, P926; Baptist AP, 2007, J ALLERGY CLIN IMMUN, V119, P924, DOI 10.1016/j.jaci.2006.11.695; Brook M, 2006, PSYCHIAT SERV, V57, P1192, DOI 10.1176/appi.ps.57.8.1192; Chan ACH, 2004, JAIDS-J ACQ IMM DEF, V35, P56, DOI 10.1097/00126334-200401010-00008; COOK CAL, 1994, J SUBST ABUSE TREAT, V11, P239; DUBOW D, 1992, Journal of Emergency Medicine, V10, P513, DOI 10.1016/0736-4679(92)90289-6; Hwang SW, 2003, CAN MED ASSOC J, V168, P417; Ibrahim SA, 2007, AM J PUBLIC HEALTH, V97, P2204, DOI 10.2105/AJPH.2006.100164; JEREMIAH J, 1995, J GEN INTERN MED, V10, P403, DOI 10.1007/BF02599843; Kuo CJ, 2010, J CLIN PSYCHIAT, V71, P808, DOI 10.4088/JCP.09l05404blu; Maas B, 2007, HEALTH PLACE, V13, P432, DOI 10.1016/j.healthplace.2006.05.005; *NAT CTR HLTH STAT, 2001, HLTH US; Onukwugha E, 2010, QUAL SAF HEALTH CARE, V19, P420, DOI 10.1136/qshc.2009.036269; Pages KP, 1998, PSYCHIATR SERV, V49, P1187, DOI 10.1176/ps.49.9.1187; Perry S, 2009, ST HEAL T, V143, P496, DOI 10.3233/978-1-58603-979-0-496; Reinke DA, 2009, CLIN PEDIATR, V48, P263, DOI 10.1177/0009922808323109; Saitz R, 1999, AM J MED, V107, P507, DOI 10.1016/S0002-9343(99)00262-4; Saitz R, 2000, J GEN INTERN MED, V15, P103, DOI 10.1046/j.1525-1497.2000.12068.x; Sclar David A, 2010, Prim Care Companion J Clin Psychiatry, V12, DOI 10.4088/PCC.09m00827yel; Seaborn Moyse Heidi, 2004, Can J Rural Med, V9, P148; Shepperd S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000313.pub3; SMITH DB, 1991, AM J PUBLIC HEALTH, V81, P210, DOI 10.2105/AJPH.81.2.212; Valevski A, 2012, EUR PSYCHIAT, V27, P496, DOI 10.1016/j.eurpsy.2011.04.009; Weingart SN, 1998, J GEN INTERN MED, V13, P568, DOI 10.1046/j.1525-1497.1998.00169.x; Windish DM, 2008, J GEN INTERN MED, V23, P1698, DOI 10.1007/s11606-008-0728-4	28	87	88	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e24459	10.1371/journal.pone.0024459	http://dx.doi.org/10.1371/journal.pone.0024459			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	819CK	21931723	gold, Green Published, Green Submitted			2022-12-25	WOS:000294802800054
J	Remenant, B; de Cambiaire, JC; Cellier, G; Jacobs, JM; Mangenot, S; Barbe, V; Lajus, A; Vallenet, D; Medigue, C; Fegan, M; Allen, C; Prior, P				Remenant, Benoit; de Cambiaire, Jean-Charles; Cellier, Gilles; Jacobs, Jonathan M.; Mangenot, Sophie; Barbe, Valerie; Lajus, Aurelie; Vallenet, David; Medigue, Claudine; Fegan, Mark; Allen, Caitilyn; Prior, Philippe			Ralstonia syzygii, the Blood Disease Bacterium and Some Asian R. solanacearum Strains Form a Single Genomic Species Despite Divergent Lifestyles	PLOS ONE			English	Article							CAMPESTRIS-PV.-MUSACEARUM; XYLEM-LIMITED BACTERIUM; BANANA XANTHOMONAS WILT; DNA-DNA HYBRIDIZATION; SUMATRA DISEASE; PSEUDOMONAS-SOLANACEARUM; BIOFILM FORMATION; SP-NOV; TOMATO; SEQUENCE	The Ralstonia solanacearum species complex includes R. solanacearum, R. syzygii, and the Blood Disease Bacterium (BDB). All colonize plant xylem vessels and cause wilt diseases, but with significant biological differences. R. solanacearum is a soilborne bacterium that infects the roots of a broad range of plants. R. syzygii causes Sumatra disease of clove trees and is actively transmitted by cercopoid insects. BDB is also pathogenic to a single host, banana, and is transmitted by pollinating insects. Sequencing and DNA-DNA hybridization studies indicated that despite their phenotypic differences, these three plant pathogens are actually very closely related, falling into the Phylotype IV subgroup of the R. solanacearum species complex. To better understand the relationships among these bacteria, we sequenced and annotated the genomes of R. syzygii strain R24 and BDB strain R229. These genomes were compared to strain PSI07, a closely related Phylotype IV tomato isolate of R. solanacearum, and to five additional R. solanacearum genomes. Whole-genome comparisons confirmed previous phylogenetic results: the three phylotype IV strains share more and larger syntenic regions with each other than with other R. solanacearum strains. Furthermore, the genetic distances between strains, assessed by an in-silico equivalent of DNA-DNA hybridization, unambiguously showed that phylotype IV strains of BDB, R. syzygii and R. solanacearum form one genomic species. Based on these comprehensive data we propose a revision of the taxonomy of the R. solanacearum species complex. The BDB and R. syzygii genomes encoded no obvious unique metabolic capacities and contained no evidence of horizontal gene transfer from bacteria occupying similar niches. Genes specific to R. syzygii and BDB were almost all of unknown function or extrachromosomal origin. Thus, the pathogenic life-styles of these organisms are more probably due to ecological adaptation and genomic convergence during vertical evolution than to the acquisition of DNA by horizontal transfer.	[Remenant, Benoit; Prior, Philippe] INRA CIRAD, Peuplements Vegetaux & Bioagresseurs Milieu Trop, St Pierre, Reunion, France; [de Cambiaire, Jean-Charles; Cellier, Gilles] CIRAD, Peuplements Vegetaux & Bioagresseurs Milieu Trop, St Pierre, Reunion, France; [Cellier, Gilles] Agence Natl Secur Sanit, Unite Ravageurs & Agents Pathogenes Trop, Lab Sante Vegetaux, St Pierre, Reunion, France; [Jacobs, Jonathan M.; Allen, Caitilyn] Univ Wisconsin, Dept Plant Pathol, Madison, WI 53706 USA; [Lajus, Aurelie; Vallenet, David; Medigue, Claudine] CNRS UMR 8030, Lab Anal Bioinformat Genom & Metab, Evry, France; [Mangenot, Sophie; Barbe, Valerie; Lajus, Aurelie; Vallenet, David; Medigue, Claudine] CEA, Direct Sci Vivant, Inst Genom, Evry, France; [Fegan, Mark] Dept Primary Ind, Biosci Res Div, Attwood, Vic, Australia	CIRAD; INRAE; CIRAD; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de la Sante des Vegetaux; University of Wisconsin System; University of Wisconsin Madison; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; CEA; UDICE-French Research Universities; Universite Paris Saclay	Remenant, B (corresponding author), Univ Wisconsin, Dept Plant Pathol, Madison, WI 53706 USA.	philippe.prior@cirad.fr	Cellier, Gilles/B-5891-2015	Cellier, Gilles/0000-0003-2587-3169; Vallenet, David/0000-0001-6648-0332; Jacobs, Jonathan Michael/0000-0002-1553-2013	Federation Nationale des Producteurs de Plants de Pommes de Terre, Mission-DAR, French Ministry of Food, Agriculture and Fisheries [7124]; European Union; Conseil Regional de La Reunion; "Agence Nationale de la Recherche" Plates-Formes Technologiques du Vivant MicroScope and the GIS Infrastructures Biologie Sante et Agronomie; Federation Nationale des Producteurs de Plants de Pommes de Terre, Mission-DAR, French Ministry of Food, Agriculture and Fisheries [7124]; European Union; Conseil Regional de La Reunion; "Agence Nationale de la Recherche" Plates-Formes Technologiques du Vivant MicroScope and the GIS Infrastructures Biologie Sante et Agronomie	Federation Nationale des Producteurs de Plants de Pommes de Terre, Mission-DAR, French Ministry of Food, Agriculture and Fisheries; European Union(European Commission); Conseil Regional de La Reunion; "Agence Nationale de la Recherche" Plates-Formes Technologiques du Vivant MicroScope and the GIS Infrastructures Biologie Sante et Agronomie(French National Research Agency (ANR)); Federation Nationale des Producteurs de Plants de Pommes de Terre, Mission-DAR, French Ministry of Food, Agriculture and Fisheries; European Union(European Commission); Conseil Regional de La Reunion; "Agence Nationale de la Recherche" Plates-Formes Technologiques du Vivant MicroScope and the GIS Infrastructures Biologie Sante et Agronomie(French National Research Agency (ANR))	This work was funded by the Federation Nationale des Producteurs de Plants de Pommes de Terre, Mission-DAR, Grant-7124 of the French Ministry of Food, Agriculture and Fisheries. The European Regional Development Fund of the European Union, Conseil Regional de La Reunion also provided financial support as part of Biorisk programme. This work was supported by the "Agence Nationale de la Recherche" Plates-Formes Technologiques du Vivant MicroScope and the GIS Infrastructures Biologie Sante et Agronomie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aritua V, 2008, PLANT PATHOL, V57, P170, DOI 10.1111/j.1365-3059.2007.01687.x; Aury JM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-603; BENNETT CPA, 1987, PLANT PATHOL, V36, P45, DOI 10.1111/j.1365-3059.1987.tb02176.x; BENNETT CPA, 1985, PLANT PATHOL, V34, P487, DOI 10.1111/j.1365-3059.1985.tb01398.x; Bertolla F, 1999, MOL PLANT MICROBE IN, V12, P467, DOI 10.1094/MPMI.1999.12.5.467; BOUCHER CA, 1985, J GEN MICROBIOL, V131, P2449; Brown DG, 2007, APPL ENVIRON MICROB, V73, P2777, DOI 10.1128/AEM.00984-06; Brown DG, 2004, MOL MICROBIOL, V53, P1641, DOI 10.1111/j.1365-2958.2004.04237.x; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Caserta R, 2010, APPL ENVIRON MICROB, V76, P4250, DOI 10.1128/AEM.02114-09; Cellier G, 2010, PHYTOPATHOLOGY, V100, P1250, DOI 10.1094/PHYTO-02-10-0059; Cho JC, 2001, APPL ENVIRON MICROB, V67, P3677, DOI 10.1128/AEM.67.8.3677-3682.2001; Colburn-Clifford J, 2010, MOL PLANT MICROBE IN, V23, P1042, DOI 10.1094/MPMI-23-8-1042; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Costechareyre D, 2009, MOL BIOL EVOL, V26, P167, DOI 10.1093/molbev/msn236; Coupat B, 2008, FEMS MICROBIOL ECOL, V66, P14, DOI 10.1111/j.1574-6941.2008.00552.x; Cunnac S, 2004, MOL MICROBIOL, V53, P115, DOI 10.1111/j.1365-2958.2004.04118.x; De Baere T, 2001, INT J SYST EVOL MICR, V51, P547, DOI 10.1099/00207713-51-2-547; Dow JM, 2000, YEAST, V17, P263, DOI 10.1002/1097-0061(200012)17:4&lt;263::AID-YEA44&gt;3.0.CO;2-G; Eden-Green S, 1994, BANANA BLOOD DIS; EDENGREEN SJ, 1994, COLLOQ INRA, V66, P51; EDENGREEN SJ, 1992, PLANT PATHOL, V41, P702, DOI 10.1111/j.1365-3059.1992.tb02553.x; Fegan M, 2006, AUSTRALAS PLANT PATH, V35, P93, DOI 10.1071/AP05105; Fegan M, 2005, BACTERIAL WILT DIS R; Gabriel DW, 2006, MOL PLANT MICROBE IN, V19, P69, DOI 10.1094/MPMI-19-0069; Gaumann E, 1921, MEDEDELINGEN I PLANT, V50, P47; GILLINGS MR, 1994, BACTERIAL WILT, P95; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; GRIMAULT V, 1994, PLANT PATHOL, V43, P663, DOI 10.1111/j.1365-3059.1994.tb01604.x; Guidot A, 2009, PHYTOPATHOLOGY, V99, P1105, DOI 10.1094/PHYTO-99-9-1105; Guidot A, 2007, J BACTERIOL, V189, P377, DOI 10.1128/JB.00999-06; HAYWARD AC, 1990, J APPL BACTERIOL, V69, P269, DOI 10.1111/j.1365-2672.1990.tb01518.x; HAYWARD AC, 1991, ANNU REV PHYTOPATHOL, V29, P65, DOI 10.1146/annurev.py.29.090191.000433; Jacobs JM, 2009, PHYTOPATHOLOGY, V99, pS57; KELMAN A, 1954, PHYTOPATHOLOGY, V44, P693; Killiny N, 2010, APPL ENVIRON MICROB, V76, P6134, DOI 10.1128/AEM.01036-10; Killiny N, 2009, APPL ENVIRON MICROB, V75, P521, DOI 10.1128/AEM.01921-08; Konstantinidis KT, 2005, P NATL ACAD SCI USA, V102, P2567, DOI 10.1073/pnas.0409727102; Kuhnert P, 2006, MICROBIOL-SGM, V152, P2537, DOI 10.1099/mic.0.28991-0; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lawrence JG, 1997, TRENDS MICROBIOL, V5, P355, DOI 10.1016/S0966-842X(97)01110-4; Lin YM, 2008, MOL PLANT MICROBE IN, V21, P1261, DOI 10.1094/MPMI-21-9-1261; Luo CW, 2011, P NATL ACAD SCI USA, V108, P7200, DOI 10.1073/pnas.1015622108; Mackie A, 2007, FOODDOAA; McClelland M, 2004, NAT GENET, V36, P1268, DOI 10.1038/ng1470; Mira A, 2001, TRENDS GENET, V17, P589, DOI 10.1016/S0168-9525(01)02447-7; Moran NA, 2002, CELL, V108, P583, DOI 10.1016/S0092-8674(02)00665-7; Ndungo V, 2006, PLANT PATHOL, V55, P294, DOI 10.1111/j.1365-3059.2005.01258.x; Pallen MJ, 2007, NATURE, V449, P835, DOI 10.1038/nature06248; Pieretti I, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-616; Prior P, 2005, ACTA HORTIC, P127, DOI 10.17660/ActaHortic.2005.695.14; Purcell AH, 1996, ANNU REV PHYTOPATHOL, V34, P131, DOI 10.1146/annurev.phyto.34.1.131; Remenant B, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-379; Rich RL, 1998, BIOCHEMISTRY-US, V37, P15423, DOI 10.1021/bi981773r; ROBERTS SJ, 1990, SYST APPL MICROBIOL, V13, P34, DOI 10.1016/S0723-2020(11)80178-5; Salanoubat M, 2002, NATURE, V415, P497, DOI 10.1038/415497a; Schembri MA, 2000, INFECT IMMUN, V68, P2638, DOI 10.1128/IAI.68.5.2638-2646.2000; Song H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000922; Stackebrandt E, 2002, INT J SYST EVOL MICR, V52, P1043, DOI 10.1099/00207713-52-3-1043; Stothard P, 2005, BIOINFORMATICS, V21, P537, DOI 10.1093/bioinformatics/bti054; Stover R. H., 1992, Fruits (Paris), V47, P611; Studholme DJ, 2010, FEMS MICROBIOL LETT, V310, P182, DOI 10.1111/j.1574-6968.2010.02065.x; Subandiyah S., 2005, Bacterial wilt disease and the Ralstonia solanacearum species complex, P415; Supriadi, 2005, Bacterial wilt disease and the Ralstonia solanacearum species complex, P395; Taghavi M, 1996, INT J SYST BACTERIOL, V46, P10, DOI 10.1099/00207713-46-1-10; Tushemereirwe W, 2004, PLANT PATHOL, V53, P802, DOI 10.1111/j.1365-3059.2004.01090.x; Vallenet D, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap021; Vaneechoutte M, 2004, INT J SYST EVOL MICR, V54, P317, DOI 10.1099/ijs.0.02754-0; Vasse J, 2000, MOL PLANT MICROBE IN, V13, P259, DOI 10.1094/MPMI.2000.13.3.259; Voegel TM, 2010, MICROBIOL-SGM, V156, P2172, DOI 10.1099/mic.0.037564-0; Yao J, 2007, J BACTERIOL, V189, P6415, DOI 10.1128/JB.00398-07	72	85	90	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e24356	10.1371/journal.pone.0024356	http://dx.doi.org/10.1371/journal.pone.0024356			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CK	21931687	gold, Green Submitted, Green Published			2022-12-25	WOS:000294802800040
J	Virreira Winter, S; Niedelman, W; Jensen, KD; Rosowski, EE; Julien, L; Spooner, E; Caradonna, K; Burleigh, BA; Saeij, JPJ; Ploegh, HL; Frickel, EM				Virreira Winter, Sebastian; Niedelman, Wendy; Jensen, Kirk D.; Rosowski, Emily E.; Julien, Lindsay; Spooner, Eric; Caradonna, Kacey; Burleigh, Barbara A.; Saeij, Jeroen P. J.; Ploegh, Hidde L.; Frickel, Eva-Maria			Determinants of GBP Recruitment to Toxoplasma gondii Vacuoles and the Parasitic Factors That Control It	PLOS ONE			English	Article							GUANYLATE-BINDING PROTEIN-1; IRG RESISTANCE GTPASES; INTERFERON-GAMMA; NUCLEOTIDE-BINDING; PARASITOPHOROUS VACUOLE; INTRACELLULAR PATHOGENS; IMMUNITY; CELL; MACROPHAGES; INHIBITION	IFN-gamma is a major cytokine that mediates resistance against the intracellular parasite Toxoplasma gondii. The p65 guanylate-binding proteins (GBPs) are strongly induced by IFN-gamma. We studied the behavior of murine GBP1 (mGBP1) upon infection with T. gondii in vitro and confirmed that IFN-gamma-dependent re-localization of mGBP1 to the parasitophorous vacuole (PV) correlates with the virulence type of the parasite. We identified three parasitic factors, ROP16, ROP18, and GRA15 that determine strain-specific accumulation of mGBP1 on the PV. These highly polymorphic proteins are held responsible for a large part of the strain-specific differences in virulence. Therefore, our data suggest that virulence of T. gondii in animals may rely in part on recognition by GBPs. However, phagosomes or vacuoles containing Trypanosoma cruzi did not recruit mGBP1. Co-immunoprecipitation revealed mGBP2, mGBP4, and mGBP5 as binding partners of mGBP1. Indeed, mGBP2 and mGBP5 co-localize with mGBP1 in T. gondii-infected cells. T. gondii thus elicits a cell-autonomous immune response in mice with GBPs involved. Three parasitic virulence factors and unknown IFN-gamma-dependent host factors regulate this complex process. Depending on the virulence of the strains involved, numerous GBPs are brought to the PV as part of a large, multimeric structure to combat T. gondii.	[Virreira Winter, Sebastian; Spooner, Eric; Ploegh, Hidde L.; Frickel, Eva-Maria] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Niedelman, Wendy; Jensen, Kirk D.; Rosowski, Emily E.; Julien, Lindsay; Saeij, Jeroen P. J.; Ploegh, Hidde L.] MIT, Dept Biol, Cambridge, MA USA; [Caradonna, Kacey; Burleigh, Barbara A.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard T.H. Chan School of Public Health	Virreira Winter, S (corresponding author), Max Planck Inst Infect Biol, Dept Cellular Microbiol, Berlin, Germany.	ploegh@wi.mit.edu; eva.frickel@nimr.mrc.ac.uk	Rosowski, Emily E./U-9654-2019	Rosowski, Emily E./0000-0002-6761-1098; Virreira Winter, Sebastian/0000-0002-2299-8110; Saeij, Jeroen/0000-0003-0289-7109	NIH; Massachusetts Life Sciences Center; Pre-Doctoral Grant in the Biological Sciences [5-T32-GM007287-33]; German National Academic Foundation; Cancer Research Institute; Cleo and Paul Schimmel Fund; Bayer HealthCare; Human Frontier Science Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007287] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Massachusetts Life Sciences Center; Pre-Doctoral Grant in the Biological Sciences; German National Academic Foundation; Cancer Research Institute; Cleo and Paul Schimmel Fund; Bayer HealthCare(Bayer AGBayer Healthcare Pharmaceuticals); Human Frontier Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by grants from the NIH (to JPJS & HLP), a Massachusetts Life Sciences Center New Investigator Award (to JPJS), a Pre-Doctoral Grant in the Biological Sciences (5-T32-GM007287-33) (to EER) and by stipends from the German National Academic Foundation (to SVW), the Cancer Research Institute (to KDJ), the Cleo and Paul Schimmel Fund (to EER), Bayer HealthCare (to KC), and the Human Frontier Science Program (to EMF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SL, 1999, VIROLOGY, V256, P8, DOI 10.1006/viro.1999.9614; Bekpen C, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r92; BONNER WM, 1974, EUR J BIOCHEM, V46, P83, DOI 10.1111/j.1432-1033.1974.tb03599.x; Britzen-Laurent N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014246; Butcher BA, 2005, INFECT IMMUN, V73, P3278, DOI 10.1128/IAI.73.6.3278-3286.2005; Carter CC, 2005, ARCH VIROL, V150, P1213, DOI 10.1007/s00705-004-0489-2; de Veer MJ, 2001, J LEUKOCYTE BIOL, V69, P912; Degrandi D, 2007, J IMMUNOL, V179, P7729, DOI 10.4049/jimmunol.179.11.7729; Donald RGK, 1998, MOL BIOCHEM PARASIT, V91, P295, DOI 10.1016/S0166-6851(97)00210-7; Egan CE, 2009, CLIN EXP IMMUNOL, V156, P17, DOI 10.1111/j.1365-2249.2009.03876.x; Ehrt S, 2001, J EXP MED, V194, P1123, DOI 10.1084/jem.194.8.1123; Fentress SJ, 2010, CELL HOST MICROBE, V8, P484, DOI 10.1016/j.chom.2010.11.005; Gorbacheva VY, 2002, J BIOL CHEM, V277, P6080, DOI 10.1074/jbc.M110542200; Guenzi E, 2003, EMBO J, V22, P3772, DOI 10.1093/emboj/cdg382; Guenzi E, 2001, EMBO J, V20, P5568, DOI 10.1093/emboj/20.20.5568; Hakansson S, 2001, EMBO J, V20, P3132, DOI 10.1093/emboj/20.12.3132; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hunn JP, 2008, EMBO J, V27, P2495, DOI 10.1038/emboj.2008.176; Khaminets A, 2010, CELL MICROBIOL, V12, P939, DOI 10.1111/j.1462-5822.2010.01443.x; Kim SK, 2007, INFECT IMMUN, V75, P1626, DOI 10.1128/IAI.01862-06; Kresse A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-158; Lecordier L, 1999, MOL BIOL CELL, V10, P1277, DOI 10.1091/mbc.10.4.1277; Ling YM, 2006, J EXP MED, V203, P2063, DOI 10.1084/jem.20061318; Luan ZD, 2002, FEBS LETT, V530, P233, DOI 10.1016/S0014-5793(02)03467-1; MacMicking JD, 2004, TRENDS IMMUNOL, V25, P601, DOI 10.1016/j.it.2004.08.010; Martens S, 2005, PLOS PATHOG, V1, P187, DOI 10.1371/journal.ppat.0010024; Melo MB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001071; Messmer-Blust AF, 2010, MOL BIOL CELL, V21, P2514, DOI 10.1091/mbc.E09-04-0344; Minns LA, 2006, J IMMUNOL, V176, P7589, DOI 10.4049/jimmunol.176.12.7589; Modiano N, 2005, P NATL ACAD SCI USA, V102, P8680, DOI 10.1073/pnas.0503227102; Praefcke GJK, 2004, J MOL BIOL, V344, P257, DOI 10.1016/j.jmb.2004.09.026; Prakash B, 2000, EMBO J, V19, P4555, DOI 10.1093/emboj/19.17.4555; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; Rosowski EE, 2011, J EXP MED, V208, P195, DOI 10.1084/jem.20100717; Saeij JPJ, 2007, NATURE, V445, P324, DOI 10.1038/nature05395; Saeij JPJ, 2006, SCIENCE, V314, P1780, DOI 10.1126/science.1133690; STAEHELI P, 1986, MOL CELL BIOL, V6, P4770, DOI 10.1128/MCB.6.12.4770; Steinfeldt T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000576; Stickney JT, 2000, MOL BIOL CELL, V11, P2191, DOI 10.1091/mbc.11.7.2191; SUZUKI Y, 1988, SCIENCE, V240, P516, DOI 10.1126/science.3128869; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Taylor GA, 2007, CELL MICROBIOL, V9, P1099, DOI 10.1111/j.1462-5822.2007.00916.x; Tietzel I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006499; Vestal DJ, 2000, J INTERF CYTOK RES, V20, P991, DOI 10.1089/10799900050198435; Zhao YO, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000288; Zhao YO, 2009, MEM I OSWALDO CRUZ, V104, P234, DOI 10.1590/S0074-02762009000200016; Zhao Y, 2009, J IMMUNOL, V182, P3775, DOI 10.4049/jimmunol.0804190	47	89	89	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e24434	10.1371/journal.pone.0024434	http://dx.doi.org/10.1371/journal.pone.0024434			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CK	21931713	Green Published, Green Submitted, gold			2022-12-25	WOS:000294802800051
J	Carlson, MA; Chakkalakal, D				Carlson, Mark A.; Chakkalakal, Dennis			Tensile Properties of the Murine Ventral Vertical Midline Incision	PLOS ONE			English	Article							AGE-RELATED-CHANGES; GROWTH-FACTOR-BETA; TISSUE STRENGTH; RAT SKIN; MECHANICAL-PROPERTIES; ARTICULAR-CARTILAGE; CONNECTIVE-TISSUE; WOUND CLOSURE; LINEA ALBA; MICE	Background: In clinical surgery, the vertical midline abdominal incision is popular but associated with healing failures. A murine model of the ventral vertical midline incision was developed in order to study the healing of this incision type. Methodology/Principal Findings: The strength of the wild type murine ventral abdominal wall in the midline was contained within the dermis; the linea alba made a negligible contribution. Unwounded abdominal wall had a downward trend (nonsignificant) in maximal tension between 12 and 29 weeks of age. The incision attained 50% of its final strength by postoperative day 40. The maximal tension of the ventral vertical midline incision was nearly that of unwounded abdominal wall by postwounding day 60; there was no difference in unwounded vs. wounded maximal tension at postwounding day 120. Conclusions/Significance: After 120 days of healing, the ventral vertical midline incision in the wild type mouse was not significantly different from age-matched nonwounded controls. About half of the final incisional strength was attained after 6 weeks of healing. The significance of this work was to establish the kinetics of wild type incisional healing in a model for which numerous genotypes and genetic tools would be available for subsequent study.	[Carlson, Mark A.] Univ Nebraska Med Ctr, Dept Surg, Omaha, NE USA; [Chakkalakal, Dennis] Omaha Vet Affairs Med Ctr, Orthoped Res Lab, Omaha, NE USA; [Chakkalakal, Dennis] Creighton Univ, Med Ctr, Dept Surg, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Nebraska-Western Iowa Health Care System; Creighton University	Carlson, MA (corresponding author), Univ Nebraska Med Ctr, Dept Surg, Omaha, NE USA.	macarlso@unmc.edu			National Institutes of Health [K08 GM00703]; University of Nebraska Medical Center; Creighton University Medical Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K08GM000703] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Nebraska Medical Center; Creighton University Medical Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	MC was supported by grants from the National Institutes of Health (K08 GM00703; www.nih.gov) and University of Nebraska Medical Center (www.unmc.edu). DC received partial salary support from Creighton University Medical Center (www.cumc.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMSONS RJ, 1970, SURG GYNECOL OBSTETR, V130, P837; Ailawadi M, 2002, SURGERY, V131, P219, DOI 10.1067/msy.2002.118709; AVMA, 2007, AM VET MED ASS GUID; Benn SI, 1996, J CLIN INVEST, V98, P2894, DOI 10.1172/JCI119118; BLEVINS FT, 1994, AM J SPORT MED, V22, P328, DOI 10.1177/036354659402200306; Botsford T., 1941, SURG GYNECOL OBSTET, V72, P690; BROWN GL, 1988, ANN SURG, V208, P788, DOI 10.1097/00000658-198812000-00019; BURSTEIN AH, 1976, J BONE JOINT SURG AM, V58, P82, DOI 10.2106/00004623-197658010-00015; CAMPBELL JA, 1989, SURGERY, V106, P888; CARLSON MA, 1995, SOUTHERN MED J, V88, P450, DOI 10.1097/00007611-199504000-00013; Carlson MA, 1997, SURG CLIN N AM, V77, P607, DOI 10.1016/S0039-6109(05)70571-5; Chism PN, 2000, VET SURG, V29, P145, DOI 10.1111/j.1532-950X.2000.00145.x; Cool T, 1997, MAT SCI ENG A-STRUCT, V223, P186, DOI 10.1016/S0921-5093(96)10513-X; Cunniff P.M., 1994, POLYM ADVAN TECHNOL, V5, P401; Currey JD, 1998, P I MECH ENG H, V212, P399, DOI 10.1243/0954411981534178; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; Delaney CP, 2008, ANN SURG, V247, P819, DOI 10.1097/SLA.0b013e31816d950e; DOUGLAS DM, 1952, BRIT J SURG, V40, P79, DOI 10.1002/bjs.18004015918; Dovi JV, 2003, J LEUKOCYTE BIOL, V73, P448, DOI 10.1189/jlb.0802406; Eberl T, 2008, AM J SURG, V196, P592, DOI 10.1016/j.amjsurg.2007.10.023; FAST J, 1947, SURG GYNECOL OBSTET, V84, P685; FOGDESTAM I, 1981, SURG GYNECOL OBSTET, V153, P191; FORRESTER JC, 1970, BRIT J SURG, V57, P729, DOI 10.1002/bjs.1800571009; Franz MG, 2001, SURGERY, V129, P203, DOI 10.1067/msy.2001.110220; Franz MG, 2000, WOUND REPAIR REGEN, V8, P511, DOI 10.1046/j.1524-475x.2000.00511.x; Fu SY, 2000, COMPOS PART A-APPL S, V31, P1117, DOI 10.1016/S1359-835X(00)00068-3; GREENALL MJ, 1980, BRIT J SURG, V67, P188, DOI 10.1002/bjs.1800670308; HARTZELL J. B., 1942, Surgery, Gynecology and Obstetrics, V75, P1; HAXTON H, 1964, BRIT J SURG, V52, P372; HOLM-PEDERSEN P, 1971, Scandinavian Journal of Plastic and Reconstructive Surgery, V5, P7; Howes EL, 1929, J AMER MED ASSOC, V92, P42, DOI 10.1001/jama.1929.02700270046011; KEMPSON GE, 1982, ANN RHEUM DIS, V41, P508, DOI 10.1136/ard.41.5.508; KEMPSON GE, 1991, BIOCHIM BIOPHYS ACTA, V1075, P223, DOI 10.1016/0304-4165(91)90270-Q; LEAPER DJ, 1977, BRIT J SURG, V64, P603, DOI 10.1002/bjs.1800640822; Lee PC, 1999, AM J PHYSIOL-HEART C, V277, pH1600, DOI 10.1152/ajpheart.1999.277.4.H1600; LEVENSON SM, 1965, ANN SURG, V161, P293, DOI 10.1097/00000658-196502000-00019; Liaw L, 1998, J CLIN INVEST, V101, P1468; LICHTENSTEIN IL, 1970, SURG GYNECOL OBSTETR, V130, P685; Mack JA, 2003, FASEB J, V17, P1352, DOI 10.1096/fj.02-0959fje; MILTHORPE BK, 1994, BIOMATERIALS, V15, P745, DOI 10.1016/0142-9612(94)90027-2; MUDGE M, 1985, BRIT J SURG, V72, P70, DOI 10.1002/bjs.1800720127; Muehlberger T, 2005, J AM ACAD DERMATOL, V52, P583, DOI 10.1016/j.jaad.2004.08.059; Muller-Decker K, 2002, J INVEST DERMATOL, V119, P1189, DOI 10.1046/j.1523-1747.2002.19501.x; MUSTOE TA, 1987, SCIENCE, V237, P1333, DOI 10.1126/science.2442813; NELSON CA, 1951, SURG GYNECOL OBSTET, V93, P461; OXLUND H, 1979, SURG GYNECOL OBSTET, V148, P876; REEVES B, 1968, Journal of Bone and Joint Surgery British Volume, V50-B, P858; Seiler CM, 2009, ANN SURG, V249, P913, DOI 10.1097/SLA.0b013e3181a77c92; TERA H, 1976, ACTA CHIR SCAND, V142, P349; Thomay AA, 2009, AM J PATHOL, V174, P2129, DOI 10.2353/ajpath.2009.080765; VOGEL HG, 1980, MECH AGEING DEV, V14, P283, DOI 10.1016/0047-6374(80)90002-0; WALL JC, 1979, CALCIFIED TISSUE INT, V27, P105, DOI 10.1007/BF02441170; WHITE WL, 1971, ANN SURG, V173, P19, DOI 10.1097/00000658-197101000-00003; Wickens JC, 1998, SURG ENDOSC-ULTRAS, V12, P1166, DOI 10.1007/s004649900808; Wu NJ, 2003, J INVEST DERMATOL, V121, P926, DOI 10.1046/j.1523-1747.2003.12497.x	56	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2011	6	9							e24212	10.1371/journal.pone.0024212	http://dx.doi.org/10.1371/journal.pone.0024212			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CH	21915298	Green Submitted, Green Published, gold			2022-12-25	WOS:000294802500034
J	Liu, EB; Ferreyra, L; Fischer, SL; Pavan, JV; Nates, SV; Hudson, NR; Tirado, D; Dyer, DW; Chodosh, J; Seto, D; Jones, MS				Liu, Elizabeth B.; Ferreyra, Leonardo; Fischer, Stephen L.; Pavan, Jorge V.; Nates, Silvia V.; Hudson, Nolan Ryan; Tirado, Damaris; Dyer, David W.; Chodosh, James; Seto, Donald; Jones, Morris S.			Genetic Analysis of a Novel Human Adenovirus with a Serologically Unique Hexon and a Recombinant Fiber Gene	PLOS ONE			English	Article							KERATOCONJUNCTIVITIS; PROTEINS; EVASION; AGENT	In February of 1996 a human adenovirus (formerly known as Ad-Cor-96-487) was isolated from the stool of an AIDS patient who presented with severe chronic diarrhea. To characterize this apparently novel pathogen of potential public health significance, the complete genome of this adenovirus was sequenced to elucidate its origin. Bioinformatic and phylogenetic analyses of this genome demonstrate that this virus, heretofore referred to as HAdV-D58, contains a novel hexon gene as well as a recombinant fiber gene. In addition, serological analysis demonstrated that HAdV-D58 has a different neutralization profile than all previously characterized HAdVs. Bootscan analysis of the HAdV-D58 fiber gene strongly suggests one recombination event.	[Liu, Elizabeth B.; Seto, Donald] George Mason Univ, Dept Bioinformat & Computat Biol, Manassas, VA USA; [Liu, Elizabeth B.; Seto, Donald] George Mason Univ, Dept Syst Biol, Manassas, VA USA; [Ferreyra, Leonardo; Pavan, Jorge V.; Nates, Silvia V.] Natl Univ Cordoba, Inst Virol, Sch Med Sci, Cordoba, Argentina; [Fischer, Stephen L.] USN, Hosp Camp Pendleton, Camp Pendleton, CA USA; [Hudson, Nolan Ryan; Tirado, Damaris] David Grant USAF Med Ctr, Clin Invest Facil, Fairfield, CA USA; [Dyer, David W.] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73190 USA; [Chodosh, James] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Howe Lab,Dept Ophthalmol, Boston, MA USA; [Jones, Morris S.] Calif Dept Publ Hlth, Viral & Rickettsial Dis Lab, Richmond, CA USA	George Mason University; George Mason University; Instituto Nacional de Tecnologia Agropecuaria (INTA); National University of Cordoba; United States Department of Defense; United States Navy; University of Oklahoma System; University of Oklahoma Health Sciences Center; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; California Department of Public Health	Liu, EB (corresponding author), George Mason Univ, Dept Bioinformat & Computat Biol, Manassas, VA USA.	morris.jones@cdph.ca.gov	Pavan, Jorge Victorio/AAG-5741-2019; Pavan, Jorge/AAJ-8300-2020	Pavan, Jorge Victorio/0000-0003-1308-5261; 	United States Air Force Surgeon General [FDG20040024E]; Research to Prevent Blindness, Inc.;  [R01EY013124];  [P30EY014104]; NATIONAL EYE INSTITUTE [R01EY013124, P30EY014104] Funding Source: NIH RePORTER	United States Air Force Surgeon General; Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); ; ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by R01EY013124 (DS, MSJ and JC) and P30EY014104 (JC). MSJ was also funded by the United States Air Force Surgeon General-approved Clinical Investigation No. FDG20040024E. JC was also funded by an unrestricted grant to the Department of Ophthalmology, Harvard Medical School, from Research to Prevent Blindness, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Darr S, 2009, J GEN VIROL, V90, P2849, DOI 10.1099/vir.0.014514-0; Echavarria M., 2009, Principles and practice of clinical virology, P463, DOI 10.1002/9780470741405.ch19; Elsing A, 1998, P NATL ACAD SCI USA, V95, P10072, DOI 10.1073/pnas.95.17.10072; Ferreyra L, 2010, ARCH VIROL, V155, P27, DOI 10.1007/s00705-009-0539-x; Frenzen PD, 2003, J INFECT DIS, V187, P441, DOI 10.1086/368097; HIERHOLZER JC, 1991, ARCH VIROL, V121, P179, DOI 10.1007/BF01316753; HILLEMAN M R, 1953, Bull World Health Organ, V8, P613; Ishiko H, 2009, J CLIN MICROBIOL, V47, P2678, DOI 10.1128/JCM.r00313-09; Jones MS, 2007, J VIROL, V81, P5978, DOI 10.1128/JVI.02650-06; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li HT, 2009, VACCINE, V27, P116, DOI 10.1016/j.vaccine.2008.10.032; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Madisch I, 2005, J VIROL, V79, P15265, DOI 10.1128/JVI.79.24.15265-15276.2005; McSharry BP, 2008, J VIROL, V82, P4585, DOI 10.1128/JVI.02251-07; Metzgar D, 2010, J CLIN MICROBIOL, V48, P1397, DOI 10.1128/JCM.01600-09; Robinson CM, 2011, VIROLOGY, V409, P141, DOI 10.1016/j.virol.2010.10.020; Robinson CM, 2009, VIRUS RES, V139, P122, DOI 10.1016/j.virusres.2008.10.001; ROWE WP, 1953, P SOC EXP BIOL MED, V84, P570, DOI 10.3181/00379727-84-20714; Schneider-Brachert W, 2006, J CLIN INVEST, V116, P2901, DOI 10.1172/JCI23771; Sester M, 2010, J IMMUNOL, V184, P255, DOI 10.4049/jimmunol.0902343; Torres S, 2010, VIRUSES-BASEL, V2, P1367, DOI 10.3390/v2071367; Walsh MP, 2010, J CLIN MICROBIOL, V48, P991, DOI 10.1128/JCM.01694-09; Walsh MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005635; Windheim M, 2004, CURR TOP MICROBIOL, V273, P29	24	41	50	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2011	6	9							e24491	10.1371/journal.pone.0024491	http://dx.doi.org/10.1371/journal.pone.0024491			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CH	21915339	Green Published, gold, Green Submitted			2022-12-25	WOS:000294802500054
J	Ong, SA; Tan, JJ; Tew, WL; Chen, KS				Ong, Shufen Angeline; Tan, Jen Jen; Tew, Wai Loon; Chen, Ken-Shiung			Rasd1 Modulates the Coactivator Function of NonO in the Cyclic AMP Pathway	PLOS ONE			English	Article							ORPHAN NUCLEAR RECEPTOR; NGFI-B; ANDROGEN RECEPTOR; CIRCADIAN CLOCK; BINDING PROTEIN; GENE-EXPRESSION; H-RAS; CREB; TRANSCRIPTION; DEXRAS1	All living organisms exhibit autonomous daily physiological and behavioural rhythms to help them synchronize with the environment. Entrainment of circadian rhythm is achieved via activation of cyclic AMP (cAMP) and mitogen-activated protein kinase signaling pathways. NonO (p54nrb) is a multifunctional protein involved in transcriptional activation of the cAMP pathway and is involved in circadian rhythm control. Rasd1 is a monomeric G protein implicated to play a pivotal role in potentiating both photic and nonphotic responses of the circadian rhythm. In this study, we have identified and validated NonO as an interacting partner of Rasd1 via affinity pulldown, co-immunoprecipitation and indirect immunofluorescence studies. The GTP-hydrolysis activity of Rasd1 is required for the functional interaction. Functional interaction of Rasd1-NonO in the cAMP pathway was investigated via reporter gene assays, chromatin immunoprecipitation and gene knockdown. We showed that Rasd1 and NonO interact at the CRE-site of specific target genes. These findings reveal a novel mechanism by which the coregulator activity of NonO can be modulated.	[Ong, Shufen Angeline; Tan, Jen Jen; Tew, Wai Loon; Chen, Ken-Shiung] Nanyang Technol Univ, Dept Genom & Genet, Sch Biol Sci, Singapore, Singapore; [Tan, Jen Jen] Agcy Sci Technol & Res, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Agency for Science Technology & Research (A*STAR)	Ong, SA (corresponding author), Nanyang Technol Univ, Dept Genom & Genet, Sch Biol Sci, Singapore, Singapore.	kschen@ntu.edu.sg			Singapore Ministry of Education [ARC 3/04, M45080000]	Singapore Ministry of Education(Ministry of Education, Singapore)	This work was supported by a grant from the Singapore Ministry of Education, Academic Research Fund Tier 2 (ARC 3/04, M45080000) awarded to Ken-Shiung Chen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aherne CM, 2009, MOL IMMUNOL, V46, P3345, DOI 10.1016/j.molimm.2009.07.019; Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; Allen TD, 2000, J CELL SCI, V113, P1651; Amelio AL, 2007, P NATL ACAD SCI USA, V104, P20314, DOI 10.1073/pnas.0707999105; Auboeuf D, 2004, MOL CELL BIOL, V24, P442, DOI 10.1128/MCB.24.1.442-453.2004; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Benito E, 2010, TRENDS NEUROSCI, V33, P230, DOI 10.1016/j.tins.2010.02.001; Bittinger MA, 2004, CURR BIOL, V14, P2156, DOI 10.1016/j.cub.2004.11.002; Blask DE, 2009, SLEEP MED REV, V13, P257, DOI 10.1016/j.smrv.2008.07.007; Boethel CD, 2002, CURR OPIN PULM MED, V8, P502, DOI 10.1097/00063198-200211000-00003; Brown SA, 2005, SCIENCE, V308, P693, DOI 10.1126/science.1107373; Buervenich S, 2000, AM J MED GENET, V96, P808, DOI 10.1002/1096-8628(20001204)96:6<808::AID-AJMG23>3.0.CO;2-E; Cha-Molstad H, 2004, P NATL ACAD SCI USA, V101, P13572, DOI 10.1073/pnas.0405587101; Cheah JH, 2006, NEURON, V51, P431, DOI 10.1016/j.neuron.2006.07.011; CHEN SY, 1994, ONCOGENE, V9, P2691; Chen YH, 2001, AM J MED GENET, V105, P753, DOI 10.1002/ajmg.10036; Cheng HYM, 2004, NEURON, V43, P715, DOI 10.1016/j.neuron.2004.08.021; Chuderland D, 2008, MOL CELL, V31, P850, DOI 10.1016/j.molcel.2008.08.007; Cismowski MJ, 2000, J BIOL CHEM, V275, P23421, DOI 10.1074/jbc.C000322200; Colicelli J., 2004, SCI STKE, V250, P1; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Crosio C, 2000, NAT NEUROSCI, V3, P1241, DOI 10.1038/81767; de Urquiza AM, 2000, SCIENCE, V290, P2140, DOI 10.1126/science.290.5499.2140; Dentin R, 2007, NATURE, V449, P366, DOI 10.1038/nature06128; Dong XS, 2007, MOL CELL BIOL, V27, P4863, DOI 10.1128/MCB.02144-06; Dowhan DH, 2005, MOL CELL, V17, P429, DOI 10.1016/j.molcel.2004.12.025; Emili A, 2002, RNA, V8, P1102, DOI 10.1017/S1355838202025037; Fang M, 2000, NEURON, V28, P183, DOI 10.1016/S0896-6273(00)00095-7; FEIG LA, 1988, MOL CELL BIOL, V8, P2472, DOI 10.1128/MCB.8.6.2472; Foulkes NS, 1997, TRENDS NEUROSCI, V20, P487, DOI 10.1016/S0166-2236(97)01109-0; Fox AH, 2005, MOL BIOL CELL, V16, P5304, DOI 10.1091/mbc.E05-06-0587; Giordano A, 1999, J CELL PHYSIOL, V181, P218, DOI 10.1002/(SICI)1097-4652(199911)181:2<218::AID-JCP4>3.0.CO;2-5; Graham TE, 2001, ENDOCRINOLOGY, V142, P2631, DOI 10.1210/en.142.6.2631; Graham TE, 2004, BIOCHEM BIOPH RES CO, V316, P307, DOI 10.1016/j.bbrc.2004.02.049; Graham TE, 2002, J BIOL CHEM, V277, P10876, DOI 10.1074/jbc.M110397200; Green CB, 2003, SCIENCE, V301, P319, DOI 10.1126/science.1087824; Hansen J, 2001, JNCI-J NATL CANCER I, V93, P1513, DOI 10.1093/jnci/93.20.1513; Hirota T, 2004, ZOOL SCI, V21, P359, DOI 10.2108/zsj.21.359; Holla VR, 2006, J BIOL CHEM, V281, P2676, DOI 10.1074/jbc.M507752200; Humphries A, 2004, J NEUROCHEM, V91, P946, DOI 10.1111/j.1471-4159.2004.02777.x; Hwang MCC, 1996, J BIOL CHEM, V271, P8196, DOI 10.1074/jbc.271.14.8196; Ke N, 2004, CANCER RES, V64, P8208, DOI 10.1158/0008-5472.CAN-04-2134; Kemppainen RJ, 1998, J BIOL CHEM, V273, P3129, DOI 10.1074/jbc.273.6.3129; Kuwahara S, 2006, BIOL REPROD, V75, P352, DOI 10.1095/biolreprod.106.051136; Lau KF, 2008, J BIOL CHEM, V283, P34728, DOI 10.1074/jbc.M801874200; Le Minh N, 2001, EMBO J, V20, P7128, DOI 10.1093/emboj/20.24.7128; Le WD, 2003, NAT GENET, V33, P85, DOI 10.1038/ng1066; Maruyama K, 1997, BIOCHEM BIOPH RES CO, V231, P417, DOI 10.1006/bbrc.1997.6122; Mathur M, 2001, MOL CELL BIOL, V21, P2298, DOI 10.1128/MCB.21.7.2298-2311.2001; MECHTI N, 1991, MOL CELL BIOL, V11, P2832, DOI 10.1128/MCB.11.5.2832; Monsalve M, 2000, MOL CELL, V6, P307, DOI 10.1016/S1097-2765(00)00031-9; Murphy EP, 2001, ARTHRITIS RHEUM-US, V44, P782, DOI 10.1002/1529-0131(200104)44:4<782::AID-ANR134>3.3.CO;2-8; Newman SJ, 2000, BRAIN RES, V857, P131, DOI 10.1016/S0006-8993(99)02417-8; Nguyen CH, 2005, BIOCHEM BIOPH RES CO, V332, P913, DOI 10.1016/j.bbrc.2005.05.041; Okada T, 1996, J BIOL CHEM, V271, P4671; Pearen MA, 2010, MOL ENDOCRINOL, V24, P1891, DOI 10.1210/me.2010-0015; PERLMANN T, 1995, GENE DEV, V9, P769, DOI 10.1101/gad.9.7.769; Pinaud S, 1998, J MOL BIOL, V280, P785, DOI 10.1006/jmbi.1998.1905; Ren MD, 1998, P NATL ACAD SCI USA, V95, P6187, DOI 10.1073/pnas.95.11.6187; RUSAK B, 1990, SCIENCE, V248, P1237, DOI 10.1126/science.2112267; Rutter J, 2002, ANNU REV BIOCHEM, V71, P307, DOI 10.1146/annurev.biochem.71.090501.142857; Schibler U, 2003, J BIOL RHYTHM, V18, P250, DOI 10.1177/0748730403018003007; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Sewer MB, 2002, ENDOCRINOLOGY, V143, P1280, DOI 10.1210/en.143.4.1280; Shav-Tal Y, 2002, FEBS LETT, V531, P109, DOI 10.1016/S0014-5793(02)03447-6; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Smith AG, 2008, J BIOL CHEM, V283, P12564, DOI 10.1074/jbc.M800480200; Tan JJ, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-4; Travnickova-Bendova Z, 2002, P NATL ACAD SCI USA, V99, P7728, DOI 10.1073/pnas.102075599; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Vallejo M, 2009, MOL NEUROBIOL, V39, P90, DOI 10.1007/s12035-009-8055-2; Volakakis N, 2010, P NATL ACAD SCI USA, V107, P12317, DOI 10.1073/pnas.1007088107; WILSON TE, 1993, MOL CELL BIOL, V13, P5794, DOI 10.1128/MCB.13.9.5794; WILSON TE, 1991, SCIENCE, V252, P1296, DOI 10.1126/science.1925541; XIAO JH, 1991, CELL, V65, P551, DOI 10.1016/0092-8674(91)90088-G; Xu J, 2005, HUM MOL GENET, V14, P1231, DOI 10.1093/hmg/ddi134; Xu W, 2007, EMBO J, V26, P2890, DOI 10.1038/sj.emboj.7601734; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Yang YS, 1997, NUCLEIC ACIDS RES, V25, P2284, DOI 10.1093/nar/25.12.2284; YANG YS, 1993, MOL CELL BIOL, V13, P5593, DOI 10.1128/MCB.13.9.5593; Zehorai E, 2010, MOL CELL ENDOCRINOL, V314, P213, DOI 10.1016/j.mce.2009.04.008; Zhang C, 2008, BBA-MOL CELL RES, V1783, P1517, DOI 10.1016/j.bbamcr.2008.03.011	83	12	16	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2011	6	9							e24401	10.1371/journal.pone.0024401	http://dx.doi.org/10.1371/journal.pone.0024401			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CH	21915321	Green Published, gold			2022-12-25	WOS:000294802500041
J	Steenhard, BM; Zelenchuk, A; Stroganova, L; Isom, K; St John, PL; Andrews, GK; Peterson, KR; Abrahamson, DR				Steenhard, Brooke M.; Zelenchuk, Adrian; Stroganova, Larysa; Isom, Kathryn; St John, Patricia L.; Andrews, Glen K.; Peterson, Kenneth R.; Abrahamson, Dale R.			Transgenic Expression of Human LAMA5 Suppresses Murine Lama5 mRNA and Laminin alpha 5 Protein Deposition	PLOS ONE			English	Article							GLOMERULAR ENDOTHELIAL-CELLS; MICE LACKING; MOUSE MODEL; KIDNEY; PODOCIN; GENE; DEFECTS; NEPHRIN; BARRIER; COL4A3	Laminin alpha 5 is required for kidney glomerular basement membrane (GBM) assembly, and mice with targeted deletions of the Lama5 gene fail to form glomeruli. As a tool to begin to understand factors regulating the expression of the LAMA5 gene, we generated transgenic mice carrying the human LAMA5 locus in a bacterial artificial chromosome. These mice deposited human laminin alpha 5 protein into basement membranes in heart, liver, spleen and kidney. Here, we characterized two lines of transgenics; Line 13 expressed similar to 6 times more LAMA5 than Line 25. Mice from both lines were healthy, and kidney function and morphology were normal. Examination of developing glomeruli from fetal LAMA5 transgenics showed that the human transgene was expressed at the correct stage of glomerular development, and deposited into the nascent GBM simultaneously with mouse laminin alpha 5. Expression of human LAMA5 did not affect the timing of the mouse laminin alpha 1-alpha 5 isoform switch, or that for mouse laminin beta 1-beta 2. Immunoelectron microscopy showed that human laminin alpha 5 originated in both glomerular endothelial cells and podocytes, known to be origins for mouse laminin alpha 5 normally. Notably, in neonatal transgenics expressing the highest levels of human LAMA5, there was a striking reduction of mouse laminin alpha 5 protein in kidney basement membranes compared to wildtype, and significantly lower levels of mouse Lama5 mRNA. This suggests the presence in kidney of a laminin expression monitor, which may be important for regulating the overall production of basement membrane protein.	[Steenhard, Brooke M.; Zelenchuk, Adrian; Stroganova, Larysa; Isom, Kathryn; St John, Patricia L.; Andrews, Glen K.; Peterson, Kenneth R.; Abrahamson, Dale R.] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66103 USA; [Andrews, Glen K.; Peterson, Kenneth R.] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS USA; [Steenhard, Brooke M.; Zelenchuk, Adrian; Stroganova, Larysa; Isom, Kathryn; St John, Patricia L.; Peterson, Kenneth R.; Abrahamson, Dale R.] Univ Kansas, Med Ctr, Kidney Inst, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Steenhard, BM (corresponding author), Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66103 USA.	dabrahamson@kumc.edu			National Institutes of Health (NIH) [5P01DK065123, 5P20RR024214, 1S10RR027564]; University of Kansas Medical Center Research Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR024214, S10RR027564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK065123] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Kansas Medical Center Research Institute; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funds came from National Institutes of Health (NIH) grants 5P01DK065123 and 5P20RR024214, and a Lied Pilot grant from the University of Kansas Medical Center Research Institute. The JEOL JEM-1400 transmission electron microscope was purchased with funds from NIH grant 1S10RR027564. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamson DR, 2007, J AM SOC NEPHROL, V18, P2465, DOI 10.1681/ASN.2007030328; Abrahamson DR, 2007, J AM SOC NEPHROL, V18, P2285, DOI 10.1681/ASN.2007020207; Abrahamson DR, 2009, ORGANOGENESIS, V5, P275; Abrahamson DR, 2009, J AM SOC NEPHROL, V20, P1471, DOI 10.1681/ASN.2008101086; ABRAHAMSON DR, 1992, J HISTOCHEM CYTOCHEM, V40, P1943, DOI 10.1177/40.12.1280666; ABRAHAMSON DR, 1989, J CELL BIOL, V109, P3477, DOI 10.1083/jcb.109.6.3477; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; Cosgrove D, 1996, GENE DEV, V10, P2981, DOI 10.1101/gad.10.23.2981; Eremina V, 2003, J CLIN INVEST, V111, P707, DOI 10.1172/JCI200317423; Eremina V, 2008, NEW ENGL J MED, V358, P1129, DOI 10.1056/NEJMoa0707330; Goldberg S, 2010, J AM SOC NEPHROL, V21, P579, DOI 10.1681/ASN.2009091004; Haraldsson B, 2008, PHYSIOL REV, V88, P451, DOI 10.1152/physrev.00055.2006; Haraldsson B, 2009, CURR OPIN NEPHROL HY, V18, P331, DOI 10.1097/MNH.0b013e32832c9dba; Heidet L, 2003, AM J PATHOL, V163, P1633, DOI 10.1016/S0002-9440(10)63520-1; Hudson BG, 2003, NEW ENGL J MED, V348, P2543, DOI 10.1056/NEJMra022296; Hudson BG, 2004, J AM SOC NEPHROL, V15, P2514, DOI 10.1097/01.ASN.0000141462.00630.76; Jeansson M, 2006, AM J PHYSIOL-RENAL, V290, pF111, DOI 10.1152/ajprenal.00173.2005; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu W, 1999, GENOMICS, V61, P113, DOI 10.1006/geno.1999.5943; Miner JH, 2011, PEDIATR NEPHROL, V26, P1413, DOI 10.1007/s00467-011-1785-1; Miner JH, 2006, DEVELOPMENT, V133, P967, DOI 10.1242/dev.02270; Miner JH, 2005, J AM SOC NEPHROL, V16, P857, DOI 10.1681/ASN.2004121139; Miner JH, 1998, CURR OPIN NEPHROL HY, V7, P13; Miner JH, 1996, J CELL BIOL, V135, P1403, DOI 10.1083/jcb.135.5.1403; Miner JH, 2000, DEV BIOL, V217, P278, DOI 10.1006/dbio.1999.9546; Miner JH, 1998, J CELL BIOL, V143, P1713, DOI 10.1083/jcb.143.6.1713; NOAKES PG, 1995, NAT GENET, V10, P400, DOI 10.1038/ng0895-400; Patrakka J, 2010, BIOCHEM BIOPH RES CO, V396, P164, DOI 10.1016/j.bbrc.2010.04.069; Putaala H, 2001, HUM MOL GENET, V10, P1, DOI 10.1093/hmg/10.1.1; Roselli S, 2004, MOL CELL BIOL, V24, P550, DOI 10.1128/MCB.24.2.550-560.2004; Schwarz K, 2001, J CLIN INVEST, V108, P1621, DOI 10.1172/JCI200112849; Shih NY, 1999, SCIENCE, V286, P312, DOI 10.1126/science.286.5438.312; St John PL, 2001, KIDNEY INT, V60, P1037, DOI 10.1046/j.1523-1755.2001.0600031037.x; Yurchenco PD, 1997, P NATL ACAD SCI USA, V94, P10189, DOI 10.1073/pnas.94.19.10189	35	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2011	6	9							e23926	10.1371/journal.pone.0023926	http://dx.doi.org/10.1371/journal.pone.0023926			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CH	21915268	Green Published, Green Submitted, gold			2022-12-25	WOS:000294802500018
J	Basu-Roy, U; Seo, E; Ramanathapuram, L; Rapp, TB; Perry, JA; Orkin, SH; Mansukhani, A; Basilico, C				Basu-Roy, U.; Seo, E.; Ramanathapuram, L.; Rapp, T. B.; Perry, J. A.; Orkin, S. H.; Mansukhani, A.; Basilico, C.			Sox2 maintains self renewal of tumor-initiating cells in osteosarcomas	ONCOGENE			English	Article						osteosarcoma; wnt signaling; cancer stem cell; mesenchymal tumors; differentiation; sarcosphere	CANCER STEM-CELLS; TRANSCRIPTION FACTOR SOX2; OSTEOBLAST DIFFERENTIATION; PROGENITOR CELLS; BETA-CATENIN; MOUSE MODEL; WNT; GROWTH; SARCOMA; LINEAGE	Tumors are thought to be sustained by a reservoir of self-renewing cells, termed tumor-initiating cells or cancer stem cells. Osteosarcomas are high-grade sarcomas derived from osteoblast progenitor cells and are the most common pediatric bone malignancy. In this report we show that the stem cell transcription factor Sox2 is highly expressed in human and murine osteosarcoma (mOS) cell lines as well as in the tumor samples. Osteosarcoma cells have increased ability to grow in suspension as osteospheres, that are greatly enriched in expression of Sox2 and the stem cell marker, Sca-1. Depletion of Sox2 by short-hairpin RNAs in independent mOS-derived cells drastically reduces their transformed properties in vitro and their ability to form tumors. Sox2-depleted osteosarcoma cells can no longer form osteospheres and differentiate into mature osteoblasts. Concomitantly, they exhibit decreased Sca-1 expression and upregulation of the Wnt signaling pathway. Thus, despite other mutations, these cells maintain a requirement for Sox2 for tumorigenicity. Our data indicate that Sox2 is required for osteosarcoma cell self renewal, and that Sox2 antagonizes the pro-differentiation Wnt pathway that can in turn reduce Sox2 expression. These studies define Sox2 as a survival factor and a novel biomarker of self renewal in osteosarcomas, and support a tumor suppressive role for the Wnt pathway in tumors of mesenchymal origin. Our findings could provide the basis for novel therapeutic strategies based on inhibiting Sox2 or enhancing Wnt signaling for the treatment of osteosarcomas. Oncogene (2012) 31, 2270-2282; doi:10.1038/onc.2011.405; published online 19 September 2011	[Basu-Roy, U.; Seo, E.; Mansukhani, A.; Basilico, C.] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Ramanathapuram, L.] NYU, Coll Dent, New York, NY 10016 USA; [Rapp, T. B.] NYU, Sch Med, Dept Orthoped Surg, New York, NY 10016 USA; [Perry, J. A.; Orkin, S. H.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Harvard Stem Cell Inst, Boston, MA 02115 USA; [Perry, J. A.; Orkin, S. H.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Perry, J. A.; Orkin, S. H.] Harvard Univ, Sch Med, Div Hematol Oncol, Childrens Hosp Boston, Boston, MA USA	New York University; New York University; New York University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Harvard Medical School	Mansukhani, A (corresponding author), NYU, Sch Med, Dept Microbiol, 550 1st Ave, New York, NY 10016 USA.	Alka.Mansukhani@med.nyu.edu; Claudio.Basilico@med.nyu.edu		Mansukhani, Alka/0000-0003-1020-3242; , Tim/0000-0002-1444-0803	PHS from the NIAMS [AR051358]; NIDCR [DE013745]; NCI; Children's Cancer Research Fund; St Baldrick's Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051358] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013745] Funding Source: NIH RePORTER	PHS from the NIAMS; NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Children's Cancer Research Fund; St Baldrick's Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank Dr E De Stanchina (Antitumor Assessment Facility, Memorial Sloan Kettering Cancer Center, New York, NY) for excellent services and advice with the xenograft assays. Thanks to Dr J Durbin, NYU TABS, for help with tissue acquisition. This investigation was supported by PHS Grants AR051358 from the NIAMS and DE013745 from the NIDCR, and by an NCI UO1 award (to SHO). UBR is a recipient of a fellowship from The Children's Cancer Research Fund in memory of Dr A Rausen. AM is a recipient of a research grant from St Baldrick's Foundation. JAP is a postdoctoral fellow of the American Cancer Society. SHO is an Investigator of the Howard Hughes Medical Institute.	Adams JM, 2008, COLD SH Q B, V73, P451, DOI 10.1101/sqb.2008.73.004; Ambrosetti D, 2008, MOL CELL BIOL, V28, P4759, DOI 10.1128/MCB.01849-07; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Basu-Roy U, 2010, CELL DEATH DIFFER, V17, P1345, DOI 10.1038/cdd.2010.57; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Berman SD, 2008, P NATL ACAD SCI USA, V105, P11851, DOI 10.1073/pnas.0805462105; Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161; Buzzeo MP, 2007, LEUKEMIA, V21, P1619, DOI 10.1038/sj.leu.2404768; Cai YP, 2010, J PATHOL, V220, P24, DOI 10.1002/path.2628; Calo E, 2010, NATURE, V466, P1110, DOI 10.1038/nature09264; Cantiani L, 2007, CANCER RES, V67, P7675, DOI 10.1158/0008-5472.CAN-06-4697; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Cleton-Jansen AM, 2009, BRIT J CANCER, V101, P1909, DOI 10.1038/sj.bjc.6605405; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cormier JN, 2004, CA-CANCER J CLIN, V54, P94, DOI 10.3322/canjclin.54.2.94; Douglas D, 2008, CANCER RES, V68, P6507, DOI 10.1158/0008-5472.CAN-07-6152; Fujii H, 2009, INT J ONCOL, V34, P1381, DOI 10.3892/ijo_00000265; Gangemi RMR, 2009, STEM CELLS, V27, P40, DOI 10.1634/stemcells.2008-0493; Gibbs CP, 2005, NEOPLASIA, V7, P967, DOI 10.1593/neo.05394; Gillette JM, 2008, IN VITRO CELL DEV-AN, V44, P87, DOI 10.1007/s11626-007-9075-8; Gong C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015630; Gutierrez GM, 2008, P NATL ACAD SCI USA, V105, P18402, DOI 10.1073/pnas.0805925105; Heare T, 2009, CURR OPIN PEDIATR, V21, P365, DOI 10.1097/MOP.0b013e32832b1111; Helman LJ, 2003, NAT REV CANCER, V3, P685, DOI 10.1038/nrc1168; Hong JH, 2006, CELL CYCLE, V5, P176, DOI 10.4161/cc.5.2.2362; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Jia SF, 1999, CLIN EXP METASTAS, V17, P501, DOI 10.1023/A:1006623001465; Kansara M, 2009, J CLIN INVEST, V119, P837, DOI 10.1172/JCI37175; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Kim CF, 2008, CELL STEM CELL, V3, P147, DOI 10.1016/j.stem.2008.07.012; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Lefebvre V, 2007, INT J BIOCHEM CELL B, V39, P2195, DOI 10.1016/j.biocel.2007.05.019; Levings PP, 2009, CANCER RES, V69, P5648, DOI 10.1158/0008-5472.CAN-08-3580; Mansukhani A, 2000, J CELL BIOL, V149, P1297, DOI 10.1083/jcb.149.6.1297; Mansukhani A, 2005, J CELL BIOL, V168, P1065, DOI 10.1083/jcb.200409182; Marie PJ, 2003, GENE, V316, P23, DOI 10.1016/S0378-1119(03)00748-0; Matushansky I, 2007, J CLIN INVEST, V117, P3248, DOI 10.1172/JCI31377; Milat F, 2009, MOL CELL ENDOCRINOL, V310, P52, DOI 10.1016/j.mce.2009.06.002; Morikawa S, 2009, J EXP MED, V206, P2483, DOI 10.1084/jem.20091046; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Pevny LH, 2010, INT J BIOCHEM CELL B, V42, P421, DOI 10.1016/j.biocel.2009.08.018; Que JW, 2009, DEVELOPMENT, V136, P1899, DOI 10.1242/dev.034629; Rainusso N, 2011, CANCER BIOL THER, V12, P278, DOI 10.4161/cbt.12.4.15951; Riggi N, 2010, GENE DEV, V24, P916, DOI 10.1101/gad.1899710; Rosen JM, 2009, SCIENCE, V324, P1670, DOI 10.1126/science.1171837; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; TABONE MD, 1994, J CLIN ONCOL, V12, P2614, DOI 10.1200/JCO.1994.12.12.2614; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Takada I, 2009, NAT REV RHEUMATOL, V5, P442, DOI 10.1038/nrrheum.2009.137; Takenobu H, 2011, ONCOGENE, V30, P97, DOI 10.1038/onc.2010.383; Tang N, 2008, CLIN ORTHOP RELAT R, V466, P2114, DOI 10.1007/s11999-008-0335-z; Thomas DM, 2004, J CELL BIOL, V167, P925, DOI 10.1083/jcb.200409187; Tirino V, 2011, FASEB J, V25, P2022, DOI 10.1096/fj.10-179036; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; WADAYAMA B, 1994, CANCER RES, V54, P3042; Walkley CR, 2008, GENE DEV, V22, P1662, DOI 10.1101/gad.1656808; Xiang R, 2011, BRIT J CANCER, V104, P1410, DOI 10.1038/bjc.2011.94; YUAN HB, 1995, GENE DEV, V9, P2635, DOI 10.1101/gad.9.21.2635	59	177	187	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY	2012	31	18					2270	2282		10.1038/onc.2011.405	http://dx.doi.org/10.1038/onc.2011.405			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	936SR	21927024	Green Submitted, Green Accepted			2022-12-25	WOS:000303610800003
J	Motallebzadeh, R; Rehakova, S; Conlon, TM; Win, TS; Callaghan, CJ; Goddard, M; Bolton, EM; Ruddle, NH; Bradley, JA; Pettigrew, GJ				Motallebzadeh, Reza; Rehakova, Sylvia; Conlon, Thomas M.; Win, Thet Su; Callaghan, Chris J.; Goddard, Martin; Bolton, Eleanor M.; Ruddle, Nancy H.; Bradley, J. Andrew; Pettigrew, Gavin J.			Blocking lymphotoxin signaling abrogates the development of ectopic lymphoid tissue within cardiac allografts and inhibits effector antibody responses	FASEB JOURNAL			English	Article						chronic rejection; vasculopathy	TUMOR-NECROSIS-FACTOR; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FOLLICULAR DENDRITIC CELLS; NONOBESE DIABETIC MICE; B-CELLS; GERMINAL-CENTERS; BETA-RECEPTOR; CHRONIC REJECTION; SURFACE LYMPHOTOXIN; SJOGRENS-SYNDROME	Tertiary lymphoid organs (TLOs) may develop within allografts, but their contribution to graft rejection remains unclear. Here, we study a mouse model of autoantibody-mediated cardiac allograft vasculopathy to clarify the alloimmune responses mediated by intragraft TLOs and whether blocking lymphotoxin-beta-receptor (LT beta R) signaling, a pathway essential for lymphoid organogenesis, abrogates TLO development. TLOs (defined as discrete lymphoid aggregates associated with high endothelial venules) were detectable in 9 of 13 heart allografts studied and were predominantly B cell in composition, harboring germinal-center activity. These are most likely manifestations of the humoral autoimmunity triggered in this model after transplantation; TLOs did not develop if autoantibody production was prevented. Treatment with inhibitory LT beta R-Ig fusion protein virtually abolished allograft TLO formation (mean TLOs/heart: 0.2 vs. 2.2 in control recipients; P = 0.02), with marked attenuation of the autoantibody response. Recipients primed for autoantibody before transplantation rejected grafts rapidly, but this accelerated rejection was prevented by postoperative administration of LT beta R-Ig (median survival time: 18 vs. > 50 d, respectively, P = 0.003). Our results provide the first demonstration that TLOs develop within chronically rejecting heart allografts, are predominantly B cell in origin, and can be targeted pharmacologically to inhibit effector humoral responses.-Motallebzadeh, R., Rehakova, S., Conlon, T. M., Win, T. S., Callaghan, C. J., Goddard, M., Bolton, E. M., Ruddle, N. H., Bradley, J. A., Pettigrew, G. J. Blocking lymphotoxin signaling abrogates the development of ectopic lymphoid tissue within cardiac allografts and inhibits effector antibody responses. FASEB J. 26, 51-62 (2012). www.fasebj.org	[Motallebzadeh, Reza; Rehakova, Sylvia; Conlon, Thomas M.; Win, Thet Su; Callaghan, Chris J.; Bolton, Eleanor M.; Bradley, J. Andrew; Pettigrew, Gavin J.] Univ Cambridge, Dept Surg, Natl Inst Hlth Res, Cambridge Biomed Res Ctr, Cambridge, England; [Ruddle, Nancy H.] Yale Univ, Dept Epidemiol & Publ Hlth, New Haven, CT 06520 USA	University of Cambridge; Yale University	Pettigrew, GJ (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Surg, Hills Rd, Cambridge CB2 2QQ, England.	gjp25@cam.ac.uk	Motallebzadeh, Reza/AAF-5515-2021	Motallebzadeh, Reza/0000-0002-5399-9546; Conlon, Thomas/0000-0002-4316-6612; pettigrew, gavin/0000-0003-3724-9945; Bolton, Eleanor/0000-0002-7253-6045	Wellcome Trust; Raymond and Beverly Sackler Scholarship; British Heart Foundation [PG/10/002/28143] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Raymond and Beverly Sackler Scholarship; British Heart Foundation(British Heart Foundation)	The authors thank Dr. J. Browning (Biogen Idec, Cambridge, MA, USA) for providing LT beta R-Ig and MOPC-21 fusion proteins. R.M. was suported by a clinical research fellowship from the Wellcome Trust and the Raymond and Beverly Sackler Scholarship.	Allen CDC, 2008, SEMIN IMMUNOL, V20, P14, DOI 10.1016/j.smim.2007.12.001; Angeli V, 2006, IMMUNITY, V24, P203, DOI 10.1016/j.immuni.2006.01.003; Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Armengol MP, 2001, AM J PATHOL, V159, P861, DOI 10.1016/S0002-9440(10)61762-2; Baddoura FK, 2005, AM J TRANSPLANT, V5, P510, DOI 10.1111/j.1600-6143.2004.00714.x; BRADLEY DS, 1994, J IMMUNOL, V152, P1960; Browning JL, 2005, IMMUNITY, V23, P539, DOI 10.1016/j.immuni.2005.10.002; Cassese G, 2001, EUR J IMMUNOL, V31, P2726, DOI 10.1002/1521-4141(200109)31:9<2726::AID-IMMU2726>3.0.CO;2-H; CLAUSELL N, 1994, CIRCULATION, V89, P2768, DOI 10.1161/01.CIR.89.6.2768; Columba-Cabezas S, 2006, J NEUROIMMUNOL, V179, P76, DOI 10.1016/j.jneuroim.2006.06.015; Cuff CA, 1998, J IMMUNOL, V161, P6853; Cyster JG, 2000, IMMUNOL REV, V176, P181; Deteix C, 2010, J IMMUNOL, V184, P5344, DOI 10.4049/jimmunol.0902999; Dohi T, 2001, J IMMUNOL, V167, P2781, DOI 10.4049/jimmunol.167.5.2781; Drayton DL, 2006, NAT IMMUNOL, V7, P344, DOI 10.1038/ni1330; Drayton DL, 2003, J EXP MED, V197, P1153, DOI 10.1084/jem.20021761; Endres R, 1999, J EXP MED, V189, P159, DOI 10.1084/jem.189.1.159; Fava RA, 2003, J IMMUNOL, V171, P115, DOI 10.4049/jimmunol.171.1.115; Fu YX, 1999, ANNU REV IMMUNOL, V17, P399, DOI 10.1146/annurev.immunol.17.1.399; Gatumu MK, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2617; Gommerman JL, 2003, J CLIN INVEST, V112, P755, DOI 10.1172/JCI200318648; Gommerman JL, 2002, J CLIN INVEST, V110, P1359, DOI 10.1172/JCI200215975; Humby F, 2009, PLOS MED, V6, P59, DOI 10.1371/journal.pmed.0060001; Kim HJ, 1999, J IMMUNOL, V162, P3053; Kranich J, 2008, J EXP MED, V205, P1293, DOI 10.1084/jem.20071019; Kratz A, 1996, J EXP MED, V183, P1461, DOI 10.1084/jem.183.4.1461; Legler DF, 1998, J EXP MED, V187, P655, DOI 10.1084/jem.187.4.655; Liao S, 2006, J IMMUNOL, V177, P3369, DOI 10.4049/jimmunol.177.5.3369; Luther SA, 2003, J EXP MED, V197, P1191, DOI 10.1084/jem.20021294; Mackay F, 1997, EUR J IMMUNOL, V27, P2033, DOI 10.1002/eji.1830270830; Mackay F, 1998, NATURE, V395, P26, DOI 10.1038/25630; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.iy.12.040194.001001; Mauri DN, 1998, IMMUNITY, V8, P21, DOI 10.1016/S1074-7613(00)80455-0; Motallebzadeh R, 2008, TRANSPLANTATION, V85, P309, DOI 10.1097/TP.0b013e318162d2d0; Mounzer RH, 2010, BLOOD, V116, P2173, DOI 10.1182/blood-2009-12-256065; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Ngo VN, 1999, J EXP MED, V189, P403, DOI 10.1084/jem.189.2.403; Podgrabinska S, 2002, P NATL ACAD SCI USA, V99, P16069, DOI 10.1073/pnas.242401399; RADIO SJ, 1991, MODERN PATHOL, V4, P654; RANDEN I, 1992, J IMMUNOL, V148, P3296; Rennert PD, 1996, J EXP MED, V184, P1999, DOI 10.1084/jem.184.5.1999; Sims GP, 2001, J IMMUNOL, V167, P1935, DOI 10.4049/jimmunol.167.4.1935; Stewart S, 2005, J HEART LUNG TRANSPL, V24, P1710, DOI 10.1016/j.healun.2005.03.019; Stott DI, 1998, J CLIN INVEST, V102, P938, DOI 10.1172/JCI3234; STREETER PR, 1988, J CELL BIOL, V107, P1853, DOI 10.1083/jcb.107.5.1853; Stuht S, 2007, AM J TRANSPLANT, V7, P377, DOI 10.1111/j.1600-6143.2006.01638.x; Suzuki J, 2003, AM J TRANSPLANT, V3, P968, DOI 10.1034/j.1600-6143.2003.00164.x; Thaunat O, 2005, P NATL ACAD SCI USA, V102, P14723, DOI 10.1073/pnas.0507223102; Ware CF, 2008, IMMUNOL REV, V223, P186, DOI 10.1111/j.1600-065X.2008.00629.x; Win TS, 2009, CIRC-HEART FAIL, V2, P361, DOI 10.1161/CIRCHEARTFAILURE.108.827139; Wu Q, 2001, J EXP MED, V193, P1327, DOI 10.1084/jem.193.11.1327; Zarkhin V, 2008, KIDNEY INT, V74, P664, DOI 10.1038/ki.2008.249	52	50	51	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2012	26	1					51	62		10.1096/fj.11-186973	http://dx.doi.org/10.1096/fj.11-186973			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	877SF	21926237				2022-12-25	WOS:000299202200007
J	Na, GN; Salt, DE				Na, GunNam; Salt, David E.			Differential Regulation of Serine Acetyltransferase Is Involved in Nickel Hyperaccumulation in Thlaspi goesingense	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE BIOSYNTHESIS; ESCHERICHIA-COLI; MOLECULAR-CLONING; SUBCELLULAR-LOCALIZATION; SULFUR ASSIMILATION; KINETIC-PROPERTIES; HIGHER-PLANTS; SYNTHASE; GENE; EXPRESSION	When growing in its native habitat, Thlaspi goesingense can hyperaccumulate 1.2% of its shoot dry weight as nickel We reported previously that both constitutively elevated activity of serine acetyltransferase (SAT) and concentration of glutathione (GSH) are involved in the ability of T. goesingense to tolerate nickel. A feature of SAT is its feedback inhibition by L-cysteine. To understand the role of this regulation of SAT by Cys on GSH-mediated nickel tolerance in T. goesingense, we characterized the enzymatic properties of SATs from T. goesingense. We demonstrate that all three isoforms of SAT in T. goesingense are insensitive to inhibition by Cys. Further, two amino acids (proline and alanine) in the C-terminal region of the cytosolic SAT (SAT-c) from T. goesingense are responsible for converting the enzyme from a Cys-sensitive to a Cys-insensitive form. Furthermore, the Cys-insensitive isoform of SAT-c confers elevated resistance to nickel when expressed in Escherichia colt and Arabidopsis thaliana, supporting a role for altered regulation of SAT by Cys in nickel tolerance in T. goesingense.	[Na, GunNam; Salt, David E.] Purdue Univ, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Salt, DE (corresponding author), Univ Aberdeen, Inst Biol & Environm Sci, Cruickshank Bldg,St Machar Dr, Aberdeen AB24 3UU, Scotland.	david.salt@abdn.ac.uk			National Science Foundation [IOS-0419695]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant IOS-0419695 (to D. E. S).	BROOKS RR, 1977, J GEOCHEM EXPLOR, V7, P49, DOI 10.1016/0375-6742(77)90074-7; BROOKS SPJ, 1992, BIOTECHNIQUES, V13, P906; Chronis D, 2004, PLANTA, V218, P417, DOI 10.1007/s00425-003-1123-3; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; DENK D, 1987, J GEN MICROBIOL, V133, P515; Droux M, 1998, EUR J BIOCHEM, V255, P235, DOI 10.1046/j.1432-1327.1998.2550235.x; Feldman-Salit A, 2009, J MOL BIOL, V386, P37, DOI 10.1016/j.jmb.2008.08.075; Francois JA, 2006, PLANT CELL, V18, P3647, DOI 10.1105/tpc.106.047316; Freeman JL, 2005, APPL ENVIRON MICROB, V71, P8627, DOI 10.1128/AEM.71.12.8627-8633.2005; Freeman JL, 2005, PLANT PHYSIOL, V137, P1082, DOI 10.1104/pp.104.055293; Freeman JL, 2004, PLANT CELL, V16, P2176, DOI 10.1105/tpc.104.023036; Haas FH, 2008, PLANT PHYSIOL, V148, P1055, DOI 10.1104/pp.108.125237; Howarth JR, 1997, BBA-GENE STRUCT EXPR, V1350, P123, DOI 10.1016/S0167-4781(96)00213-8; Inoue K, 1999, EUR J BIOCHEM, V266, P220, DOI 10.1046/j.1432-1327.1999.00847.x; Jin JB, 2001, PLANT CELL, V13, P1511, DOI 10.1105/tpc.13.7.1511; Kawashima CG, 2005, PLANT PHYSIOL, V137, P220, DOI 10.1104/pp.104.045377; Kramer U, 2010, ANNU REV PLANT BIOL, V61, P517, DOI 10.1146/annurev-arplant-042809-112156; Kramer U, 2000, PLANT PHYSIOL, V122, P1343, DOI 10.1104/pp.122.4.1343; Kramer U, 1997, PLANT PHYSIOL, V115, P1641, DOI 10.1104/pp.115.4.1641; Kredich N. M, 1971, BIOL CHEM, V246, P3474; Krueger S, 2009, PLANT CELL ENVIRON, V32, P349, DOI [10.1111/j.1365-3040.2009.01928.x, 10.1111/j.1365-3040.2008.01928.x]; Liszewska F, 2001, ACTA BIOCHIM POL, V48, P647; Mino K, 1999, BIOSCI BIOTECH BIOCH, V63, P168, DOI 10.1271/bbb.63.168; Mino K, 2000, BIOSCI BIOTECH BIOCH, V64, P1874, DOI 10.1271/bbb.64.1874; Nakamori S, 1998, APPL ENVIRON MICROB, V64, P1607; Noji M, 1998, J BIOL CHEM, V273, P32739, DOI 10.1074/jbc.273.49.32739; Noji M, 2002, AMINO ACIDS, V22, P231, DOI 10.1007/s007260200011; Peer WA, 2003, NEW PHYTOL, V159, P421, DOI 10.1046/j.1469-8137.2003.00822.x; Peer WA, 2006, NEW PHYTOL, V172, P248, DOI 10.1111/j.1469-8137.2006.01820.x; Rausch T, 2007, PLANT BIOLOGY, V9, P565, DOI 10.1055/s-2007-965580; REEVES RD, 1983, J GEOCHEM EXPLOR, V18, P275, DOI 10.1016/0375-6742(83)90073-0; RUFFET ML, 1994, PLANT PHYSIOL, V104, P597, DOI 10.1104/pp.104.2.597; RUFFET ML, 1995, EUR J BIOCHEM, V227, P500, DOI 10.1111/j.1432-1033.1995.tb20416.x; Saby S, 1999, APPL ENVIRON MICROB, V65, P5600; SAITO K, 1995, J BIOL CHEM, V270, P16321, DOI 10.1074/jbc.270.27.16321; SAITO K, 1994, PLANT PHYSIOL, V106, P887, DOI 10.1104/pp.106.3.887; Saito K, 1997, GENE, V189, P57, DOI 10.1016/S0378-1119(96)00833-5; Tsakraklides G, 2002, PLANT J, V32, P879, DOI 10.1046/j.1365-313X.2002.01477.x; Urano Y, 2000, GENE, V257, P269, DOI 10.1016/S0378-1119(00)00399-1; Wirtz M, 2006, J PLANT PHYSIOL, V163, P273, DOI 10.1016/j.jplph.2005.11.013; Wirtz M, 2005, PHOTOSYNTH RES, V86, P345, DOI 10.1007/s11120-005-8810-9; Zubieta C, 2008, J BIOL CHEM, V283, P7561, DOI 10.1074/jbc.M709283200	42	12	12	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40423	40432		10.1074/jbc.M111.247411	http://dx.doi.org/10.1074/jbc.M111.247411			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21930704	Green Published, hybrid			2022-12-25	WOS:000297315400002
J	Neuss, S; Denecke, B; Gan, L; Lin, Q; Bovi, M; Apel, C; Woltje, M; Dhanasingh, A; Salber, J; Knuchel, R; Zenke, M				Neuss, Sabine; Denecke, Bernd; Gan, Lin; Lin, Qiong; Bovi, Manfred; Apel, Christian; Woeltje, Michael; Dhanasingh, Anandhan; Salber, Jochen; Knuechel, Ruth; Zenke, Martin			Transcriptome Analysis of MSC and MSC-Derived Osteoblasts on Resomer (R) LT706 and PCL: Impact of Biomaterial Substrate on Osteogenic Differentiation	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; SKIN SUBSTITUTE; TISSUE; EXPRESSION; PROTEIN; DEGRADATION; COPOLYMERS; SCAFFOLDS	Background: Mesenchymal stem cells (MSC) represent a particularly attractive cell type for bone tissue engineering because of their ex vivo expansion potential and multipotent differentiation capacity. MSC are readily differentiated towards mature osteoblasts with well-established protocols. However, tissue engineering frequently involves three-dimensional scaffolds which (i) allow for cell adhesion in a spatial environment and (ii) meet application-specific criteria, such as stiffness, degradability and biocompatibility. Methodology/Principal Findings: In the present study, we analysed two synthetic, long-term degradable polymers for their impact on MSC-based bone tissue engineering: PLLA-co-TMC (Resomer (R) LT706) and poly(epsilon-caprolactone) (PCL). Both polymers enhance the osteogenic differentiation compared to tissue culture polystyrene (TCPS) as determined by Alizarin red stainings, scanning electron microscopy, PCR and whole genome expression analysis. Resomer (R) LT706 and PCL differ in their influence on gene expression, with Resomer (R) LT706 being more potent in supporting osteogenic differentiation of MSC. The major trigger on the osteogenic fate, however, is from osteogenic induction medium. Conclusion: This study demonstrates an enhanced osteogenic differentiation of MSC on Resome (R) LT706 and PCL compared to TCPS. MSC cultured on Resomer (R) LT706 showed higher numbers of genes involved in skeletal development and bone formation. This identifies Resomer (R) LT706 as particularly attractive scaffold material for bone tissue engineering.	[Neuss, Sabine; Knuechel, Ruth] Rhein Westfal TH Aachen Univ, Inst Pathol, Aachen, Germany; [Neuss, Sabine] Rhein Westfal TH Aachen Univ, Biointerface Grp, Inst Biomed Engn, Aachen, Germany; [Neuss, Sabine; Lin, Qiong; Zenke, Martin] Rhein Westfal TH Aachen Univ, Helmholtz Inst Biomed Engn, Aachen, Germany; [Denecke, Bernd; Gan, Lin; Woeltje, Michael] Rhein Westfal TH Aachen Univ, Interdisciplinary Ctr Clin Res, IZKF Aachen, Aachen, Germany; [Lin, Qiong; Zenke, Martin] Rhein Westfal TH Aachen Univ, Dept Cell Biol, Inst Biomed Engn, Aachen, Germany; [Bovi, Manfred] Univ Clin Aachen, Electron Microscop Facil, Aachen, Germany; [Apel, Christian] Rhein Westfal TH Aachen Univ, Dept Conservat Dent Periodontol & Prevent Dent, Aachen, Germany; [Dhanasingh, Anandhan; Salber, Jochen] Rhein Westfal TH Aachen Univ, DWI eV, Aachen, Germany; [Dhanasingh, Anandhan; Salber, Jochen] Rhein Westfal TH Aachen Univ, Inst Tech & Macromol Chem, Aachen, Germany; [Salber, Jochen] Ruhr Univ Bochum, Chirurg Klin & Poliklin, BG Univ Klinikum Bergmannsheil, Bochum, Germany	RWTH Aachen University; RWTH Aachen University; Helmholtz Association; RWTH Aachen University; RWTH Aachen University; RWTH Aachen University; RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University; RWTH Aachen University; Ruhr University Bochum	Neuss, S (corresponding author), Rhein Westfal TH Aachen Univ, Inst Pathol, Aachen, Germany.	sneuss-stein@ukaachen.de	Salber, Jochen/ABD-5182-2020; Lin, Qiong/J-6880-2015	Salber, Jochen/0000-0001-9738-2305; Lin, Qiong/0000-0002-7964-6191; Apel, Christian/0000-0002-1339-1990; Woltje, Michael/0000-0002-5405-0981	Interdisciplinary Centre for Clinical Research (IZKF) Aachen from the faculty of Medicine at RWTH Aachen University [VVB-110]	Interdisciplinary Centre for Clinical Research (IZKF) Aachen from the faculty of Medicine at RWTH Aachen University	This work was supported by a grant from the Interdisciplinary Centre for Clinical Research (IZKF) Aachen from the faculty of Medicine at RWTH Aachen University (VVB-110). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artham T, 2008, MACROMOL BIOSCI, V8, P14, DOI 10.1002/mabi.200700106; BENGTSSON E, 1995, J BIOL CHEM, V270, P25639, DOI 10.1074/jbc.270.43.25639; BREITLING R, 2004, FEBS LETT, P57383; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; Cappi B, 2010, J BIOMED MATER RES A, V93A, P67, DOI 10.1002/jbm.a.32527; Chandra R, 1998, PROG POLYM SCI, V23, P1273, DOI 10.1016/S0079-6700(97)00039-7; Costa-Pinto AR, 2009, BIOMACROMOLECULES, V10, P2067, DOI 10.1021/bm9000102; Di Cesare PE, 2000, J ORTHOPAED RES, V18, P713, DOI 10.1002/jor.1100180506; Fabbri P, 2010, J MATER SCI-MATER M, V21, P343, DOI 10.1007/s10856-009-3839-5; Garlet TP, 2008, CYTOKINE, V42, P330, DOI 10.1016/j.cyto.2008.03.003; Gunatillake Pathiraja A., 2003, European Cells & Materials, V5, P1; HAYMAN EG, 1985, EXP CELL RES, V160, P245, DOI 10.1016/0014-4827(85)90173-9; Hofmann A, 2008, J TRAUMA, V65, P1402, DOI 10.1097/TA.0b013e318173e7c2; HOLLAND SJ, 1992, ADV PHARM SCI, V6, P101; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hutmacher D, 1996, Int J Oral Maxillofac Implants, V11, P667; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Ji LJ, 2010, BIOMED MATER, V5, DOI 10.1088/1748-6041/5/4/045009; Kahler RA, 2008, MATRIX BIOL, V27, P330, DOI 10.1016/j.matbio.2008.01.002; Kronenthal R.L., 1975, POLYM MED SURG, P119, DOI DOI 10.1007/978-1-4684-7744-3_9; Lee K, 2009, J BIOMED MATER RES B, V89B, P252, DOI 10.1002/jbm.b.31199; Li XM, 2006, J BIOMED MATER RES B, V77B, P219, DOI 10.1002/jbm.b.30425; Mavis B, 2009, ACTA BIOMATER, V5, P3098, DOI 10.1016/j.actbio.2009.04.037; Mei Y, 2010, NAT MATER, V9, P768, DOI [10.1038/NMAT2812, 10.1038/nmat2812]; Meirelles LD, 2008, STEM CELLS, V26, P2287, DOI 10.1634/stemcells.2007-1122; Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0; Nakanishi R, 2008, J BONE MINER RES, V23, P271, DOI 10.1359/JBMR.071007; Neuss S, 2004, STEM CELLS, V22, P405, DOI 10.1634/stemcells.22-3-405; Neuss S, 2008, CELL TRANSPLANT, V17, P977, DOI 10.3727/096368908786576462; Neuss S, 2008, BIOMATERIALS, V29, P302, DOI 10.1016/j.biomaterials.2007.09.022; Neuss S, 2010, CELLS TISSUES ORGANS, V191, P36, DOI 10.1159/000215579; Neuss S, 2009, BIOMATERIALS, V30, P1697, DOI 10.1016/j.biomaterials.2008.12.027; Ohgushi H, 1999, J BIOMED MATER RES, V48, P913, DOI 10.1002/(SICI)1097-4636(1999)48:6<913::AID-JBM22>3.0.CO;2-0; Patlolla A, 2010, ACTA BIOMATER, V6, P90, DOI 10.1016/j.actbio.2009.07.028; Pego AP, 2003, J BIOMED MATER RES A, V67A, P1044, DOI 10.1002/jbm.a.10121; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Porter JR, 2009, BIOMATERIALS, V30, P780, DOI 10.1016/j.biomaterials.2008.10.022; Pospiech D, 2005, BIOMACROMOLECULES, V6, P439, DOI 10.1021/bm049393a; R Development Core Team, 2005, R LANG ENV STAT COMP; Rezwan K, 2006, BIOMATERIALS, V27, P3413, DOI 10.1016/j.biomaterials.2006.01.039; Rim NG, 2009, MACROMOL BIOSCI, V9, P795, DOI 10.1002/mabi.200800358; Schwarze H, 2008, ANN PLAS SURG, V60, P181, DOI 10.1097/SAP.0b013e318056bbf6; Simionescu A, 2007, AM J PATHOL, V171, P116, DOI 10.2353/ajpath.2007.060930; Tae SK, 2006, BIOMED MATER, V1, P63, DOI 10.1088/1748-6041/1/2/003; TANZI MC, 2006, BASIC APPL MYOL, V16, P117; Uhlig C, 2007, BURNS, V33, P221, DOI 10.1016/j.burns.2006.04.024; Wang JP, 2010, J BIOMED MATER RES A, V93A, P753, DOI 10.1002/jbm.a.32591; Weinand C, 2007, TISSUE ENG, V13, P757, DOI 10.1089/ten.2006.0083; Yang J, 2010, EUR POLYM J, V46, P783, DOI 10.1016/j.eurpolymj.2009.12.017; Yoshimoto H, 2003, BIOMATERIALS, V24, P2077, DOI 10.1016/S0142-9612(02)00635-X; Zhang HN, 2009, BIOMATERIALS, V30, P4063, DOI 10.1016/j.biomaterials.2009.04.015	51	19	21	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2011	6	9							e23195	10.1371/journal.pone.0023195	http://dx.doi.org/10.1371/journal.pone.0023195			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JC	21935359	Green Published, gold, Green Submitted			2022-12-25	WOS:000295039700001
J	Wilcox, BR; Knutsen, GA; Berdeen, J; Goekjian, V; Poulson, R; Goyal, S; Sreevatsan, S; Cardona, C; Berghaus, RD; Swayne, DE; Yabsley, MJ; Stallknecht, DE				Wilcox, Benjamin R.; Knutsen, Gregory A.; Berdeen, James; Goekjian, Virginia; Poulson, Rebecca; Goyal, Sagar; Sreevatsan, Srinand; Cardona, Carol; Berghaus, Roy D.; Swayne, David E.; Yabsley, Michael J.; Stallknecht, David E.			Influenza-A Viruses in Ducks in Northwestern Minnesota: Fine Scale Spatial and Temporal Variation in Prevalence and Subtype Diversity	PLOS ONE			English	Article							AVIAN INFLUENZA; NORTH-AMERICA; AQUATIC BIRDS; WILD BIRDS; PARAMYXOVIRUSES; WATERFOWL; AMPLIFICATION; PATTERNS; FLYWAY	Waterfowl from northwestern Minnesota were sampled by cloacal swabbing for Avian Influenza Virus (AIV) from July - October in 2007 and 2008. AIV was detected in 222 (9.1%) of 2,441 ducks in 2007 and in 438 (17.9%) of 2,452 ducks in 2008. Prevalence of AIV peaked in late summer. We detected 27 AIV subtypes during 2007 and 31 during 2008. Ten hemagglutinin (HA) subtypes were detected each year (i.e., H1, 3-8, and 10-12 during 2007; H1-8, 10 and 11 during 2008). All neuraminidase (NA) subtypes were detected during each year of the study. Subtype diversity varied between years and increased with prevalence into September. Predominant subtypes during 2007 (comprising >= 5% of subtype diversity) included H1N1, H3N6, H3N8, H4N6, H7N3, H10N7, and H11N9. Predominant subtypes during 2008 included H3N6, H3N8, H4N6, H4N8, H6N1, and H10N7. Additionally, within each HA subtype, the same predominant HA/NA subtype combinations were detected each year and included H1N1, H3N8, H4N6, H5N2, H6N1, H7N3, H8N4, H10N7, and H11N9. The H2N3 and H12N5 viruses also predominated within the H2 and H12 subtypes, respectively, but only were detected during a single year (H2 and H12 viruses were not detected during 2007 and 2008, respectively). Mallards were the predominant species sampled (63.7% of the total), and 531 AIV were isolated from this species (80.5% of the total isolates). Mallard data collected during both years adequately described the observed temporal and spatial prevalence from the total sample and also adequately represented subtype diversity. Juvenile mallards also were adequate in describing the temporal and spatial prevalence of AIV as well as subtype diversity.	[Wilcox, Benjamin R.; Goekjian, Virginia; Poulson, Rebecca; Yabsley, Michael J.; Stallknecht, David E.] Univ Georgia, Coll Vet Med, Dept Populat Hlth, SE Cooperat Wildlife Dis Study, Athens, GA 30602 USA; [Wilcox, Benjamin R.; Yabsley, Michael J.] Univ Georgia, Daniel B Warnell Sch Forestry & Nat Resources, Athens, GA 30602 USA; [Knutsen, Gregory A.] US Fish & Wildlife Serv, Middle River, MN USA; [Berdeen, James] Minnesota Dept Nat Resources, Wetland Wildlife Populat & Res Grp, Bemidji, MN 56601 USA; [Goyal, Sagar; Sreevatsan, Srinand] Univ Minnesota, Dept Vet Populat Med, St Paul, MN 55108 USA; [Sreevatsan, Srinand; Cardona, Carol] Univ Minnesota, Dept Vet Biomed Sci, St Paul, MN 55108 USA; [Swayne, David E.] ARS, SE Poultry Res Lab, USDA, Athens, GA USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; United States Department of the Interior; US Fish & Wildlife Service; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; United States Department of Agriculture (USDA)	Wilcox, BR (corresponding author), Univ Georgia, Coll Vet Med, Dept Populat Hlth, SE Cooperat Wildlife Dis Study, Athens, GA 30602 USA.	myabsley@uga.edu	Berghaus, Roy/GPX-7566-2022; Sreevatsan, Srinand/V-6808-2019; Poulson, Rebecca/K-4014-2019; Poulson, Rebecca/AAD-2231-2021; Swayne, David/AAP-7166-2020	Berghaus, Roy/0000-0002-8813-3056; Sreevatsan, Srinand/0000-0002-5162-2403; Poulson, Rebecca/0000-0002-8087-3295; Yabsley, Michael/0000-0003-2452-5015; Swayne, David/0000-0001-7472-1992	Southeast Poultry Research Laboratory [58-612-0220]; SCWDS [58-612-0220]; National Institutes of Health (NIH) and Department of Health and Human Services [HHSN266200700007C]	Southeast Poultry Research Laboratory; SCWDS; National Institutes of Health (NIH) and Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding was provided through Specific Cooperative Agreement 58-612-0220 between the Southeast Poultry Research Laboratory and SCWDS, and by the National Institutes of Health (NIH) and Department of Health and Human Services under Contract No. HHSN266200700007C. Contents are solely the responsibility of the authors and do not necessarily represent the official views of NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAHL A K, 1975, Journal of Wildlife Diseases, V11, P360; Brown JD, 2007, AVIAN DIS, V51, P285, DOI 10.1637/7636-042806R.1; Carney S.M., 1992, SPECIES AGE SEX IDEN; Chander Y, 2010, J VIROL METHODS, V165, P116, DOI 10.1016/j.jviromet.2010.01.002; DEIBEL R, 1985, AVIAN DIS, V29, P970, DOI 10.2307/1590450; Fouchier RAM, 2000, J CLIN MICROBIOL, V38, P4096, DOI 10.1128/JCM.38.11.4096-4101.2000; Garamszegi LZ, 2007, P ROY SOC B-BIOL SCI, V274, P2003, DOI 10.1098/rspb.2007.0124; HALVORSON D, 1983, AVIAN DIS, V27, P77, DOI 10.2307/1590374; Hanson BA, 2003, AVIAN DIS, V47, P867, DOI 10.1637/0005-2086-47.s3.867; HINSHAW VS, 1980, CAN J MICROBIOL, V26, P622, DOI 10.1139/m80-108; HINSHAW VS, 1985, B WORLD HEALTH ORGAN, V63, P711; HINSHAW VS, 1979, INTERVIROLOGY, V11, P66, DOI 10.1159/000149014; HINSHAW VS, 1982, BASIC APPLIED INFLUE, P79; Hirst GK, 1941, SCIENCE, V94, P22, DOI 10.1126/science.94.2427.22; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Krauss S, 2004, VECTOR-BORNE ZOONOT, V4, P177, DOI 10.1089/vbz.2004.4.177; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Pearce JM, 2009, EVOL APPL, V2, P457, DOI 10.1111/j.1752-4571.2009.00071.x; Sharp GB, 1997, J VIROL, V71, P6128, DOI 10.1128/JVI.71.8.6128-6135.1997; Siembieda JL, 2010, VECTOR-BORNE ZOONOT, V10, P793, DOI 10.1089/vbz.2009.0095; Spackman E., 2008, METHODS MOL BIOL, V436; STALLKNECHT DE, 1988, VET RES COMMUN, V12, P125, DOI 10.1007/BF00362792; STALLKNECHT DE, 1990, AVIAN DIS, V34, P398, DOI 10.2307/1591427; SUSS J, 1994, ARCH VIROL, V135, P101, DOI 10.1007/BF01309768; Wallensten A, 2007, EMERG INFECT DIS, V13, P404, DOI 10.3201/eid1303.061130	26	79	80	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2011	6	9							e24010	10.1371/journal.pone.0024010	http://dx.doi.org/10.1371/journal.pone.0024010			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZV	21931636	gold, Green Published			2022-12-25	WOS:000295321800013
J	Bessaud, M; Joffret, ML; Holmblat, B; Razafindratsimandresy, R; Delpeyroux, F				Bessaud, Mael; Joffret, Marie-Line; Holmblat, Barbara; Razafindratsimandresy, Richter; Delpeyroux, Francis			Genetic Relationship between Cocirculating Human Enteroviruses Species C	PLOS ONE			English	Article							VACCINE-DERIVED POLIOVIRUS; MOLECULAR EVOLUTION; RNA RECOMBINATION; CROSSOVER REGIONS; IDENTIFICATION; CIRCULATION; VP1; POLIOMYELITIS; AMPLIFICATION; REEMERGENCE	Recombination events between human enteroviruses (HEV) are known to occur frequently and to participate in the evolution of these viruses. In a previous study, we reported the isolation of a panel of viruses belonging to the Human enterovirus species C (HEV-C) that had been cocirculating in a small geographic area of Madagascar in 2002. This panel included type 2 vaccine-derived polioviruses (PV) that had caused several cases of acute flaccid paralysis in humans. Previous partial sequencing of the genome of these HEV-C isolates revealed considerable genetic diversity, mostly due to recombination. In the work presented herein, we carried out a more detailed characterization of the genomes of viruses from this collection. First, we determined the full VP1 sequence of 41 of these isolates of different types. These sequences were compared with those of HEV-C isolates obtained from other countries or in other contexts. The sequences of the Madagascan isolates of a given type formed specific clusters clearly differentiated from those formed by other strains of the same type isolated elsewhere. Second, we sequenced the entire genome of 10 viruses representing most of the lineages present in this panel. All but one of the genomes appeared to be mosaic assemblies of different genomic fragments generated by intra-and intertypic recombination. The location of the breakpoints suggested potential preferred genomic regions for recombination. Our results also suggest that recombination between type HEV-99 and other HEV-C may be quite rare. This first exhaustive genomic analysis of a panel of non-PV HEV-C cocirculating in a small human population highlights the high frequency of inter and intra-typic genetic recombination, constituting a widespread mechanism of genetic plasticity and continually shifting the HEV-C biodiversity.	[Bessaud, Mael; Joffret, Marie-Line; Holmblat, Barbara; Delpeyroux, Francis] Inst Pasteur, Unite Postulante Biol Virus Enter, Paris, France; [Bessaud, Mael; Joffret, Marie-Line; Holmblat, Barbara; Delpeyroux, Francis] INSERM, U994, Paris, France; [Razafindratsimandresy, Richter] Inst Pasteur Madagascar, Unite Virol, Antananarivo, Madagascar	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar	Bessaud, M (corresponding author), Inst Pasteur, Unite Postulante Biol Virus Enter, Paris, France.	mael.bessaud@ird.fr	Bessaud, Maël/J-3961-2019; DELPEYROUX, Francis/ABA-5429-2021; Delpeyroux, Francis/H-8838-2016; Razafindratsimandresy, Richter/H-9881-2014	Bessaud, Maël/0000-0001-6758-9591; DELPEYROUX, Francis/0000-0002-4895-823X; Delpeyroux, Francis/0000-0002-4895-823X; JOFFRET, Marie-Line/0000-0002-5244-5429	ANR [09 MIEN 019];  [PTR 276]	ANR(French National Research Agency (ANR)); 	PTR 276 (www.pasteur.fr). ANR 09 MIEN 019 (www.agence-nationale-recherche.fr;www.aird.fr). www.iledefrance.fr. FRM DMI20091117313 (www.frm.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adu F, 2007, VIRUS RES, V127, P17, DOI 10.1016/j.virusres.2007.03.009; Arita M, 2005, J VIROL, V79, P12650, DOI 10.1128/JVI.79.20.12650-12657.2005; Bessaud M, 2008, J VIROL METHODS, V149, P277, DOI 10.1016/j.jviromet.2008.01.027; Blomqvist S, 2003, J GEN VIROL, V84, P573, DOI 10.1099/vir.0.18708-0; Blomqvist S, 2010, VIRUS RES, V151, P246, DOI 10.1016/j.virusres.2010.05.006; Bouslama L, 2007, J VIROL, V81, P8944, DOI 10.1128/JVI.00180-07; Brown BA, 2009, J GEN VIROL, V90, P1713, DOI 10.1099/vir.0.008540-0; Caro V, 2001, J GEN VIROL, V82, P79, DOI 10.1099/0022-1317-82-1-79; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P874; Combelas N, 2011, VIRUSES-BASEL, V3, P1460, DOI 10.3390/v3081460; Dedepsidis E, 2008, FEMS IMMUNOL MED MIC, V52, P343, DOI 10.1111/j.1574-695X.2008.00381.x; Dedepsidis E, 2007, APPL ENVIRON MICROB, V73, P6697, DOI 10.1128/AEM.00535-07; Dedepsidis E, 2010, VIRUS GENES, V41, P181, DOI 10.1007/s11262-010-0512-5; HAMMING RW, 1950, BELL SYST TECH J, V29, P147, DOI 10.1002/j.1538-7305.1950.tb00463.x; Huang SW, 2009, J CLIN MICROBIOL, V47, P3653, DOI 10.1128/JCM.00630-09; Huang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006355; Jegouic S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000412; Joffret ML, J INFECT DI IN PRESS; Junttila N, 2007, J MED VIROL, V79, P393, DOI 10.1002/jmv.20825; Kew O, 2002, SCIENCE, V296, P356, DOI 10.1126/science.1068284; Kew OM, 2005, ANNU REV MICROBIOL, V59, P587, DOI 10.1146/annurev.micro.58.030603.123625; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KIRKEGAARD K, 1986, CELL, V47, P433, DOI 10.1016/0092-8674(86)90600-8; Lin KH, 2006, J MED VIROL, V78, P254, DOI 10.1002/jmv.20534; Liu HM, 2000, J VIROL, V74, P11153, DOI 10.1128/JVI.74.23.11153-11161.2000; Liu Y, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001066; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Lukashev AN, 2010, REV MED VIROL, V20, P327, DOI 10.1002/rmv.660; Lukashev AN, 2005, J GEN VIROL, V86, P3281, DOI 10.1099/vir.0.81264-0; Lukashev AN, 2005, REV MED VIROL, V15, P157, DOI 10.1002/rmv.457; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; Martin J, 2002, J VIROL, V76, P10921, DOI 10.1128/JVI.76.21.10921-10928.2002; Minor P, 2009, VACCINE, V27, P2649, DOI 10.1016/j.vaccine.2009.02.071; Mueller JE, 2009, APPL ENVIRON MICROB, V75, P1395, DOI 10.1128/AEM.02201-08; Nix WA, 2006, J CLIN MICROBIOL, V44, P2698, DOI 10.1128/JCM.00542-06; Oberste MS, 2004, J VIROL, V78, P2948, DOI 10.1128/JVI.78.6.2948-2955.2004; Oberste MS, 1999, J CLIN MICROBIOL, V37, P1288, DOI 10.1128/JCM.37.5.1288-1293.1999; Oberste MS, 1999, J VIROL, V73, P1941, DOI 10.1128/JVI.73.3.1941-1948.1999; Racaniello VR, 2007, FIELDS VIROLOGY, P795; Rakoto-Andrianarivelo M, 2005, J CLIN MICROBIOL, V43, P242, DOI 10.1128/JCM.43.1.242-249.2005; Rakoto-Andrianarivelo M, 2008, J INFECT DIS, V197, P1427, DOI 10.1086/587694; Rakoto-Andrianarivelo M, 2007, PLOS PATHOG, V3, P1950, DOI 10.1371/journal.ppat.0030191; ROMANOVA LI, 1986, VIROLOGY, V155, P202, DOI 10.1016/0042-6822(86)90180-7; Rousset D, 2003, EMERG INFECT DIS, V9, P885; Santti J, 1999, J VIROL, V73, P8741, DOI 10.1128/JVI.73.10.8741-8749.1999; Savolainen-Kopra C, 2010, REV MED VIROL, V20, P358, DOI 10.1002/rmv.663; Simmonds P, 2006, J VIROL, V80, P483, DOI 10.1128/JVI.80.1.483-493.2006; Simmonds P, 2006, J VIROL, V80, P11124, DOI 10.1128/JVI.01076-06; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TOLSKAYA EA, 1987, VIROLOGY, V161, P54, DOI 10.1016/0042-6822(87)90170-X; Wisdom A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008518; Worobey M, 1999, J GEN VIROL, V80, P2535, DOI 10.1099/0022-1317-80-10-2535; Zhang Y, 2010, ARCH VIROL, V155, P197, DOI 10.1007/s00705-009-0564-9	53	37	38	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2011	6	9							e24823	10.1371/journal.pone.0024823	http://dx.doi.org/10.1371/journal.pone.0024823			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CO	21931857	Green Published, gold			2022-12-25	WOS:000294803200052
J	de Antonellis, P; Medaglia, C; Cusanelli, E; Andolfo, I; Liguori, L; De Vita, G; Carotenuto, M; Bello, A; Formiggini, F; Galeone, A; De Rosa, G; Virgilio, A; Scognamiglio, I; Sciro, M; Basso, G; Schulte, JH; Cinalli, G; Iolascon, A; Zollo, M				de Antonellis, Pasqualino; Medaglia, Chiara; Cusanelli, Emilio; Andolfo, Immacolata; Liguori, Lucia; De Vita, Gennaro; Carotenuto, Marianeve; Bello, Annamaria; Formiggini, Fabio; Galeone, Aldo; De Rosa, Giuseppe; Virgilio, Antonella; Scognamiglio, Immacolata; Sciro, Manuela; Basso, Giuseppe; Schulte, Johannes H.; Cinalli, Giuseppe; Iolascon, Achille; Zollo, Massimo			MiR-34a Targeting of Notch Ligand Delta-Like 1 Impairs CD15(+)/CD133(+) Tumor-Propagating Cells and Supports Neural Differentiation in Medulloblastoma	PLOS ONE			English	Article							CANCER STEM-CELLS; PERIVASCULAR NICHE; INITIATING CELLS; MOUSE MODEL; IN-VITRO; MICRORNA; P53; ACTIVATION; PROLIFERATION; EXPRESSION	Background: Through negative regulation of gene expression, microRNAs (miRNAs) can function as oncosuppressors in cancers, and can themselves show altered expression in various tumor types. Here, we have investigated medulloblastoma tumors (MBs), which arise from an early impairment of developmental processes in the cerebellum, where Notch signaling is involved in many of the cell-fate-determining stages. Notch regulates a subset of MB cells that have stem-cell-like properties and can promote tumor growth. On the basis of this evidence, we hypothesized that miRNAs targeting the Notch pathway can regulate these phenomena, and can be used in anti-cancer therapies. Methodology/Principal Findings: In a screening of potential targets within Notch signaling, miR-34a was seen to be a regulator of the Notch pathway through its targeting of Notch ligand Delta-like 1 (Dll1). Down-regulation of Dll1 expression by miR-34a negatively regulates cell proliferation, and induces apoptosis and neural differentiation in MB cells. Using an inducible tetracycline on-off model of miR-34a expression, we show that in Daoy MB cells, Dll1 is the first target that is regulated in MB, as compared to the other targets analyzed here: Cyclin D1, cMyc and CDK4. MiR-34a expression negatively affects CD133(+)/CD15(+) tumor-propagating cells, then we assay through reverse-phase proteomic arrays, Akt and Stat3 signaling hypo-phosphorylation. Adenoviruses carrying the precursor miR-34a induce neurogenesis of tumor spheres derived from a genetic animal model of MB (Patch1(+/-)p53(-/-)), thus providing further evidence that the miR-34a/Dll1 axis controls both autonomous and non autonomous signaling of Notch. In vivo, miR-34a overexpression carried by adenoviruses reduces tumor burden in cerebellum xenografts of athymic mice, thus demonstrating an anti-tumorigenic role of miR-34a in vivo. Conclusions/Significance: Despite advances in our understanding of the pathogenesis of MB, one-third of patients with MB remain incurable. Here, we show that stable nucleic-acid-lipid particles carrying mature miR-34a can target Dll1 in vitro and show equal effects to those of adenovirus miR-34a cell infection. Thus, this technology forms the basis for their therapeutic use for the delivery of miR-34a in brain-tumor treatment, with no signs of toxicity described to date in non-human primate trials.	[de Antonellis, Pasqualino; Medaglia, Chiara; Cusanelli, Emilio; Andolfo, Immacolata; Liguori, Lucia; De Vita, Gennaro; Carotenuto, Marianeve; Bello, Annamaria; Formiggini, Fabio; Zollo, Massimo] Ctr Ingn Genet & Biotecnol Avanzate CEINGE, Naples, Italy; [Sciro, Manuela; Basso, Giuseppe] Univ Padua, Dept Pediat, Lab Hematol Oncol, Padua, Italy; [Schulte, Johannes H.] Univ Childrens Hosp Essen, Essen, Germany; [Galeone, Aldo; Virgilio, Antonella] Univ Naples Federico 2, Dipartimento Chim Sostanze Nat, Naples, Italy; [De Rosa, Giuseppe; Scognamiglio, Immacolata] Univ Naples Federico 2, Dipartimento Chim Farmaceut & Tossicol, Naples, Italy; [Cinalli, Giuseppe] Osped Pediat Santobono Pausilipon, Naples, Italy; [Iolascon, Achille; Zollo, Massimo] Univ Naples Federico 2, Dipartimento Biochim & Biotecnol Med DBBM, Naples, Italy	CEINGE Biotecnologie Avanzate; University of Padua; University of Duisburg Essen; University of Naples Federico II; University of Naples Federico II; University of Naples Federico II	de Antonellis, P (corresponding author), Ctr Ingn Genet & Biotecnol Avanzate CEINGE, Naples, Italy.	massimo.zollo@unina.it	Bello, Anna Maria/AAA-9139-2020; Andolfo, Immacolata/Q-4012-2019; Schulte, Johannes H./V-2474-2018; Zollo, Massimo/K-5857-2016; Schulte, Johannes H/G-3981-2010; Galeone, Aldo/H-7248-2019; Liguori, Lucia/ABG-2034-2021; De Rosa, Giuseppe/G-6343-2012; Iolascon, Achille/A-4461-2014; cinalli, giuseppe/AAC-3889-2022; de Antonellis, Pasqualino/AAT-1233-2020; Liguori, Lucia/AAB-8911-2022; Andolfo, Immacolata/K-7381-2016; Carotenuto, Marianeve/AAA-6250-2021; Cusanelli, Emilio/G-6092-2015	Bello, Anna Maria/0000-0001-6975-3340; Andolfo, Immacolata/0000-0003-0493-812X; Zollo, Massimo/0000-0002-0970-7243; Galeone, Aldo/0000-0001-8805-6348; De Rosa, Giuseppe/0000-0002-1210-1269; cinalli, giuseppe/0000-0002-7797-8483; de Antonellis, Pasqualino/0000-0001-8551-9431; Liguori, Lucia/0000-0001-7784-1172; Andolfo, Immacolata/0000-0003-0493-812X; Cusanelli, Emilio/0000-0002-7683-8542; Schulte, Johannes Hubertus/0000-0003-0671-1201; iolascon, achille/0000-0002-9558-0356; Formiggini, Fabio/0000-0002-3547-4500; BASSO, GIUSEPPE/0000-0002-2634-9302	European School of Molecular Medicine (SEMM) "Federico II" University of Naples, Naples, Italy [LSH-CT-2006-037260, HEALTH-F2-2008-201662]; Associazione Italiana per la Ricerca sul Cancro AIRC; Associazione Italiana della Lotta al Neuroblastoma	European School of Molecular Medicine (SEMM) "Federico II" University of Naples, Naples, Italy; Associazione Italiana per la Ricerca sul Cancro AIRC(Fondazione AIRC per la ricerca sul cancro); Associazione Italiana della Lotta al Neuroblastoma	This work was supported by the European School of Molecular Medicine (SEMM) "Federico II" University of Naples, Naples, Italy, FP6-E.E.T pipeline LSH-CT-2006-037260 and FP7-Tumic HEALTH-F2-2008-201662 grants (MZ), an Associazione Italiana per la Ricerca sul Cancro AIRC 2007-2009 grant (MZ), a 2006/08 Associazione Italiana della Lotta al Neuroblastoma "Progetto Pensiero" grant (MZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Cole KA, 2008, MOL CANCER RES, V6, P735, DOI 10.1158/1541-7786.MCR-07-2102; Cordle J, 2008, NAT STRUCT MOL BIOL, V15, P849, DOI 10.1038/nsmb.1457; Corney DC, 2007, CANCER RES, V67, P8433, DOI 10.1158/0008-5472.CAN-07-1585; Crawford JR, 2007, LANCET NEUROL, V6, P1073, DOI 10.1016/S1474-4422(07)70289-2; Dutta KK, 2007, CANCER SCI, V98, P1845, DOI 10.1111/j.1349-7006.2007.00619.x; Fan X, 2004, CANCER RES, V64, P7787, DOI 10.1158/0008-5472.CAN-04-1446; Fan X, 2008, J CLIN ONCOL, V26, P2821, DOI 10.1200/JCO.2007.15.2264; Ferretti E, 2008, EMBO J, V27, P2616, DOI 10.1038/emboj.2008.172; Gartel AL, 2003, ONCOL RES, V13, P405; Garzia L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004998; Gilbertson RJ, 2008, ANNU REV PATHOL-MECH, V3, P341, DOI 10.1146/annurev.pathmechdis.3.121806.151518; Hallahan AR, 2004, CANCER RES, V64, P7794, DOI 10.1158/0008-5472.CAN-04-1813; Hambardzumyan D, 2008, GENE DEV, V22, P436, DOI 10.1101/gad.1627008; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Hermeking H, 2007, CANCER CELL, V12, P414, DOI 10.1016/j.ccr.2007.10.028; Jeffs LB, 2005, PHARM RES-DORDR, V22, P362, DOI 10.1007/s11095-004-1873-z; Ji Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006816; Kabos P, 2002, J BIOL CHEM, V277, P8763, DOI 10.1074/jbc.C100758200; Kato M, 2009, ONCOGENE, V28, P2419, DOI 10.1038/onc.2009.106; Kawaguchi D, 2008, DEVELOPMENT, V135, P3849, DOI 10.1242/dev.024570; Kim JY, 2004, INT J RADIAT ONCOL, V58, P376, DOI 10.1016/j.ijrobp.2003.09.040; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Laws AM, 2004, EUR J IMMUNOL, V34, P726, DOI 10.1002/eji.200324772; Li YQ, 2009, CANCER RES, V69, P7569, DOI 10.1158/0008-5472.CAN-09-0529; Liotta LA, 2003, CANCER CELL, V3, P317, DOI 10.1016/S1535-6108(03)00086-2; Mathonnet G, 2007, SCIENCE, V317, P1764, DOI 10.1126/science.1146067; Miceli-Libby L, 2008, J VASC RES, V45, P1, DOI 10.1159/000109072; Murata K, 2005, MOL CELL BIOL, V25, P4262, DOI 10.1128/MCB.25.10.4262-4271.2005; QIAN CF, 2009, INT J MOL MED; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Read TA, 2009, CANCER CELL, V15, P135, DOI 10.1016/j.ccr.2008.12.016; Shimizu K, 2000, BIOCHEM BIOPH RES CO, V276, P385, DOI 10.1006/bbrc.2000.3469; Shimojo H, 2008, NEURON, V58, P52, DOI 10.1016/j.neuron.2008.02.014; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sprinzak D, 2010, NATURE, V465, P86, DOI 10.1038/nature08959; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Uziel T, 2009, P NATL ACAD SCI USA, V106, P2812, DOI 10.1073/pnas.0809579106; Wang Q, 2008, NEUROSCI LETT, V438, P168, DOI 10.1016/j.neulet.2008.04.012; Yang ZJ, 2008, CANCER CELL, V14, P135, DOI 10.1016/j.ccr.2008.07.003; Zhang BH, 2007, DEV BIOL, V302, P1, DOI 10.1016/j.ydbio.2006.08.028; Zimmermann TS, 2006, NATURE, V441, P111, DOI 10.1038/nature04688	45	125	126	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2011	6	9							e24584	10.1371/journal.pone.0024584	http://dx.doi.org/10.1371/journal.pone.0024584			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CO	21931765	Green Submitted, Green Published, gold			2022-12-25	WOS:000294803200030
J	Saberianfar, R; Cunningham-Dunlop, S; Karagiannis, J				Saberianfar, Reza; Cunningham-Dunlop, Stephen; Karagiannis, Jim			Global Gene Expression Analysis of Fission Yeast Mutants Impaired in Ser-2 Phosphorylation of the RNA Pol II Carboxy Terminal Domain	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASE; SEPTATION INITIATION NETWORK; POLYMERASE-II; SCHIZOSACCHAROMYCES-POMBE; CTDK-I; CELL-DIVISION; BUDDING YEAST; CYTOKINESIS; SIN; PHOSPHATASE	In Schizosaccharomyces pombe the nuclear-localized Lsk1p-Lsc1p cyclin dependent kinase complex promotes Ser-2 phosphorylation of the heptad repeats found within the RNA pol II carboxy terminal domain (CTD). Here, we first provide evidence supporting the existence of a third previously uncharacterized Ser-2 CTD kinase subunit, Lsg1p. As expected for a component of the complex, Lsg1p localizes to the nucleus, promotes Ser-2 phosphorylation of the CTD, and physically interacts with both Lsk1p and Lsc1p in vivo. Interestingly, we also demonstrate that lsg1 Delta mutants - just like lsk1 Delta and lsc1 Delta strains - are compromised in their ability to faithfully and reliably complete cytokinesis. Next, to address whether kinase mediated alterations in CTD phosphorylation might selectively alter the expression of genes with roles in cytokinesis and/or the cytoskeleton, global gene expression profiles were analyzed. Mutants impaired in Ser-2 phosphorylation display little change with respect to the level of transcription of most genes. However, genes affecting cytokinesis - including the actin interacting protein gene, aip1 - as well as genes with roles in meiosis, are included in a small subset that are differentially regulated. Significantly, genetic analysis of lsk1 Delta aip1 Delta double mutants is consistent with Lsk1p and Aip1p acting in a linear pathway with respect to the regulation of cytokinesis.	[Saberianfar, Reza; Cunningham-Dunlop, Stephen; Karagiannis, Jim] Univ Western Ontario, Dept Biol, London, ON, Canada	Western University (University of Western Ontario)	Saberianfar, R (corresponding author), Univ Western Ontario, Dept Biol, London, ON, Canada.	jkaragia@uwo.com		Karagiannis, Jim/0000-0002-7901-1815	National Sciences and Engineering Research Council [341494]	National Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding was provided by the National Sciences and Engineering Research Council, Grant #341494 (http://www.nserc-crsng.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayscough KR, 1997, J CELL BIOL, V137, P399, DOI 10.1083/jcb.137.2.399; Balasubramanian MK, 2000, J CELL SCI, V113, P1503; Balasubramanian MK, 2004, CURR BIOL, V14, pR806, DOI 10.1016/j.cub.2004.09.022; Bathe M, 2010, TRENDS MICROBIOL, V18, P38, DOI 10.1016/j.tim.2009.10.002; Bridge AJ, 1998, GENE DEV, V12, P927, DOI 10.1101/gad.12.7.927; Buratowski S, 2003, NAT STRUCT BIOL, V10, P679, DOI 10.1038/nsb0903-679; Carlson M, 1997, ANNU REV CELL DEV BI, V13, P1, DOI 10.1146/annurev.cellbio.13.1.1; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Cho EJ, 2001, GENE DEV, V15, P3319, DOI 10.1101/gad.935901; Coudreuse D, 2010, CURR BIOL, V20, P1053, DOI 10.1016/j.cub.2010.04.054; Egloff S, 2008, TRENDS GENET, V24, P280, DOI 10.1016/j.tig.2008.03.008; FANKHAUSER C, 1993, EMBO J, V12, P2697, DOI 10.1002/j.1460-2075.1993.tb05931.x; Forsburg SL, 2006, YEAST, V23, P173, DOI 10.1002/yea.1347; Hautbergue G, 2001, J BIOL CHEM, V276, P8005, DOI 10.1074/jbc.M010162200; Howe KJ, 2002, BBA-GENE STRUCT EXPR, V1577, P308, DOI 10.1016/S0167-4781(02)00460-8; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jeong SJ, 2005, J MICROBIOL, V43, P516; Karagiannis J, 2005, MOL BIOL CELL, V16, P358, DOI 10.1091/mbc.E04-06-0502; Karagiannis J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000433; Kato A, 2008, BIOCHEM J, V414, P261, DOI 10.1042/BJ20071655; Krapp A, 2004, CURR BIOL, V14, pR722, DOI 10.1016/j.cub.2004.08.049; Krapp A, 2008, BIOCHEM SOC T, V36, P411, DOI 10.1042/BST0360411; Larochelle S, 2001, EMBO J, V20, P3749, DOI 10.1093/emboj/20.14.3749; Lattmann E, 2009, CURR BIOL, V19, pR1040, DOI 10.1016/j.cub.2009.10.012; Lee BN, 1999, P NATL ACAD SCI USA, V96, P12679, DOI 10.1073/pnas.96.22.12679; Lee KM, 2005, MOL BIOL CELL, V16, P2734, DOI 10.1091/mbc.E04-11-0982; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; McCollum D, 2001, TRENDS CELL BIOL, V11, P89, DOI 10.1016/S0962-8924(00)01901-2; Meinhart A, 2005, GENE DEV, V19, P1401, DOI 10.1101/gad.1318105; Mishra M, 2005, CURR BIOL, V15, P1376, DOI 10.1016/j.cub.2005.06.070; Mishra M, 2004, J CELL SCI, V117, P3897, DOI 10.1242/jcs.01244; Mulvihill DP, 1999, MOL BIOL CELL, V10, P2771, DOI 10.1091/mbc.10.8.2771; Oliferenko S, 2009, GENE DEV, V23, P660, DOI 10.1101/gad.1772009; Ostapenko D, 2003, EUKARYOT CELL, V2, P274, DOI 10.1128/EC.2.2.274-283.2003; Patturajan M, 1998, J BIOL CHEM, V273, P4689, DOI 10.1074/jbc.273.8.4689; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Prelich G, 2002, EUKARYOT CELL, V1, P153, DOI 10.1128/EC.1.2.153-162.2002; Rajagopalan S, 2003, TRENDS GENET, V19, P403, DOI 10.1016/S0168-9525(03)00149-5; Roberts-Galbraith RH, 2008, GENE DEV, V22, P3082, DOI 10.1101/gad.1748908; STERNER DE, 1995, MOL CELL BIOL, V15, P5716; Tallada VA, 2009, J CELL BIOL, V185, P875, DOI 10.1083/jcb.200812108	42	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2011	6	9							e24694	10.1371/journal.pone.0024694	http://dx.doi.org/10.1371/journal.pone.0024694			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CO	21931816	gold, Green Submitted, Green Published			2022-12-25	WOS:000294803200039
J	Yokoi, F; Dang, MT; Li, JY; Standaert, DG; Li, YQ				Yokoi, Fumiaki; Dang, Mai Tu; Li, Jianyong; Standaert, David G.; Li, Yuqing			Motor Deficits and Decreased Striatal Dopamine Receptor 2 Binding Activity in the Striatum-Specific Dyt1 Conditional Knockout Mice	PLOS ONE			English	Article							DYSTONIA-ASSOCIATED PROTEIN; EARLY-ONSET DYSTONIA; TORSION DYSTONIA; NUCLEAR-ENVELOPE; MOUSE MODEL; GENE; HYPERACTIVITY; DEPRESSION; MYOCLONUS; RESPONSES	DYT1 early-onset generalized dystonia is a hyperkinetic movement disorder caused by mutations in DYT1 (TOR1A), which codes for torsinA. Recently, significant progress has been made in studying pathophysiology of DYT1 dystonia using targeted mouse models. Dyt1 DGAG heterozygous knock-in (KI) and Dyt1 knock-down (KD) mice exhibit motor deficits and alterations of striatal dopamine metabolisms, while Dyt1 knockout (KO) and Dyt1 DGAG homozygous KI mice show abnormal nuclear envelopes and neonatal lethality. However, it has not been clear whether motor deficits and striatal abnormality are caused by Dyt1 mutation in the striatum itself or the end results of abnormal signals from other brain regions. To identify the brain region that contributes to these phenotypes, we made a striatum-specific Dyt1 conditional knockout (Dyt1 sKO) mouse. Dyt1 sKO mice exhibited motor deficits and reduced striatal dopamine receptor 2 (D2R) binding activity, whereas they did not exhibit significant alteration of striatal monoamine contents. Furthermore, we also found normal nuclear envelope structure in striatal medium spiny neurons (MSNs) of an adult Dyt1 sKO mouse and cerebral cortical neurons in cerebral cortex-specific Dyt1 conditional knockout (Dyt1 cKO) mice. The results suggest that the loss of striatal torsinA alone is sufficient to produce motor deficits, and that this effect may be mediated, at least in part, through changes in D2R function in the basal ganglia circuit.	[Yokoi, Fumiaki; Li, Yuqing] Univ Florida, Coll Med, Dept Neurol, Gainesville, FL 32611 USA; [Dang, Mai Tu] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Li, Jianyong] Virginia Tech, Dept Biochem, Blacksburg, VA USA; [Standaert, David G.] Univ Alabama Birmingham, Dept Neurol, Sch Med, Ctr Neurodegenerat & Expt Therapeut, Birmingham, AL 35294 USA	State University System of Florida; University of Florida; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Virginia Polytechnic Institute & State University; University of Alabama System; University of Alabama Birmingham	Li, YQ (corresponding author), Univ Florida, Coll Med, Dept Neurol, Gainesville, FL 32611 USA.	yuqing.li@neurology.ufl.edu	Li, Yuqing/AAR-9383-2021; Li, Yuqing/G-1596-2011	Li, Yuqing/0000-0003-1211-5529; Li, Yuqing/0000-0003-1211-5529; Standaert, David/0000-0003-2921-8348	National Institutes of Health [NS37409, NS47466, NS47692, NS54246, NS57098, NS65273, NS72782, NS74423]; Lucille P. Markey Charitable Trust; Beckman Institute (UIUC); Department of Neurology (UAB); Tyler's Hope for a Dystonia Cure, Inc. (UF); University of Florida; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R03NS074423, P01NS037409, R21NS065273, R01NS054246, R21NS047692, P50NS037409, P30NS057098, P30NS047466] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lucille P. Markey Charitable Trust; Beckman Institute (UIUC); Department of Neurology (UAB); Tyler's Hope for a Dystonia Cure, Inc. (UF); University of Florida(University of Florida); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grants (NS37409, NS47466, NS47692, NS54246, NS57098, NS65273, NS72782, and NS74423) and startup funds from the Lucille P. Markey Charitable Trust and Beckman Institute (UIUC), Department of Neurology (UAB), and Tyler's Hope for a Dystonia Cure, Inc. (UF). Publication of this article was funded in part by the University of Florida Open-Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asanuma K, 2005, NEUROLOGY, V64, P347, DOI 10.1212/01.WNL.0000149764.34953.BF; Augood SJ, 2002, NEUROLOGY, V59, P445, DOI 10.1212/WNL.59.3.445; Breakefield XO, 2008, NAT REV NEUROSCI, V9, P222, DOI 10.1038/nrn2337; Burdette AJ, 2010, CELL STRESS CHAPERON, V15, P605, DOI 10.1007/s12192-010-0173-2; Campos VE, 2004, BIOCHEM BIOPH RES CO, V320, P606, DOI 10.1016/j.bbrc.2004.05.204; Cao BJ, 2002, BRAIN RES, V937, P32, DOI 10.1016/S0006-8993(02)02461-7; Cao SS, 2010, DIS MODEL MECH, V3, P386, DOI 10.1242/dmm.003715; Dang MT, 2006, NEUROSCI RES, V56, P470, DOI 10.1016/j.neures.2006.09.005; Dang MT, 2006, P NATL ACAD SCI USA, V103, P15254, DOI 10.1073/pnas.0601758103; Dang MT, 2005, EXP NEUROL, V196, P452, DOI 10.1016/j.expneurol.2005.08.025; DeAndrade MP, 2011, BEHAV BRAIN RES, V216, P659, DOI 10.1016/j.bbr.2010.09.009; Fernagut PO, 2002, NEUROSCIENCE, V114, P1005, DOI 10.1016/S0306-4522(02)00205-1; Furukawa Y, 2000, NEUROLOGY, V54, P1193, DOI 10.1212/WNL.54.5.1193; Gonzalez-Alegre P, 2004, J NEUROSCI, V24, P2593, DOI 10.1523/JNEUROSCI.4461-03.2004; Goodchild RE, 2005, NEURON, V48, P923, DOI 10.1016/j.neuron.2005.11.010; Goodchild RE, 2004, P NATL ACAD SCI USA, V101, P847, DOI 10.1073/pnas.0304375101; Grundmann K, 2007, NEUROBIOL DIS, V27, P190, DOI 10.1016/j.nbd.2007.04.015; Hewett JW, 2007, P NATL ACAD SCI USA, V104, P7271, DOI 10.1073/pnas.0701185104; Kim CE, 2010, P NATL ACAD SCI USA, V107, P9861, DOI 10.1073/pnas.0912877107; Konakova M, 2005, J MOL NEUROSCI, V25, P105, DOI 10.1385/JMN:25:1:105; Kustedjo K, 2003, BIOCHEMISTRY-US, V42, P15333, DOI 10.1021/bi0349569; Leung JC, 2001, NEUROGENETICS, V3, P133, DOI 10.1007/s100480100111; MCBRIDE WJ, 1993, ALCOHOL, V10, P387, DOI 10.1016/0741-8329(93)90025-J; Muller U, 2009, BRAIN, V132, P2005, DOI 10.1093/brain/awp172; Naismith TV, 2004, P NATL ACAD SCI USA, V101, P7612, DOI 10.1073/pnas.0308760101; Napolitano F, 2010, NEUROBIOL DIS, V38, P434, DOI 10.1016/j.nbd.2010.03.003; Ozelius LJ, 1997, NAT GENET, V17, P40, DOI 10.1038/ng0997-40; Pisani A, 2006, NEUROBIOL DIS, V24, P318, DOI 10.1016/j.nbd.2006.07.006; Ritz K, 2009, J NEUROL NEUROSUR PS, V80, P653, DOI 10.1136/jnnp.2008.162099; SAUER B, 1988, P NATL ACAD SCI USA, V85, P5166, DOI 10.1073/pnas.85.14.5166; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Shen WX, 2008, SCIENCE, V321, P848, DOI 10.1126/science.1160575; TERAI M, 1989, EUR J PHARMACOL, V173, P177, DOI 10.1016/0014-2999(89)90516-5; Torres GE, 2004, P NATL ACAD SCI USA, V101, P15650, DOI 10.1073/pnas.0308088101; Vidailhet M, 2007, LANCET NEUROL, V6, P223, DOI 10.1016/S1474-4422(07)70035-2; Wang YY, 2000, J NEUROSCI, V20, P8305, DOI 10.1523/JNEUROSCI.20-22-08305.2000; Wang ZF, 2006, NEURON, V50, P443, DOI 10.1016/j.neuron.2006.04.010; Yokoi F, 2008, J BIOCHEM, V143, P39, DOI 10.1093/jb/mvm191; Yokoi F, 2006, J BIOCHEM, V140, P141, DOI 10.1093/jb/mvj138; Yokoi F, 2010, J BIOCHEM, V148, P459, DOI 10.1093/jb/mvq078; Yokoi F, 2009, NEUROSCI RES, V65, P228, DOI 10.1016/j.neures.2009.07.004; Zhang L, 2011, PLOS ONE, V6, DOI DOI 10.1371/J0URNAL.P0NE.0018357.PUBMED:21479250; Zim B, 2008, J NEUROL NEUROSUR PS, V79, P1327, DOI 10.1136/jnnp.2008.148270	43	50	51	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2011	6	9							e24539	10.1371/journal.pone.0024539	http://dx.doi.org/10.1371/journal.pone.0024539			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CO	21931745	Green Published, gold			2022-12-25	WOS:000294803200027
J	Chen, LL; He, ZX; Qin, L; Li, QY; Shi, XB; Zhao, ST; Chen, L; Zhong, NS; Chen, XP				Chen, Lili; He, Zhengxiang; Qin, Li; Li, Qinyan; Shi, Xibao; Zhao, Siting; Chen, Ling; Zhong, Nanshan; Chen, Xiaoping			Antitumor Effect of Malaria Parasite Infection in a Murine Lewis Lung Cancer Model through Induction of Innate and Adaptive Immunity	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; DENDRITIC CELLS; LISTERIA-MONOCYTOGENES; BLOOD-STAGE; PLASMODIUM-FALCIPARUM; VACCINE THERAPIES; TUMOR; IMMUNOTHERAPY; HYPERTHERMIA; RESPONSES	Background: Lung cancer is the most common malignancy in humans and its high fatality means that no effective treatment is available. Developing new therapeutic strategies for lung cancer is urgently needed. Malaria has been reported to stimulate host immune responses, which are believed to be efficacious for combating some clinical cancers. This study is aimed to provide evidence that malaria parasite infection is therapeutic for lung cancer. Methodology/Principal Findings: Antitumor effect of malaria infection was examined in both subcutaneously and intravenously implanted murine Lewis lung cancer (LLC) model. The results showed that malaria infection inhibited LLC growth and metastasis and prolonged the survival of tumor-bearing mice. Histological analysis of tumors from mice infected with malaria revealed that angiogenesis was inhibited, which correlated with increased terminal deoxynucleotidyl transferase-mediated (TUNEL) staining and decreased Ki-67 expression in tumors. Through natural killer (NK) cell cytotoxicity activity, cytokine assays, enzyme-linked immunospot assay, lymphocyte proliferation, and flow cytometry, we demonstrated that malaria infection provided anti-tumor effects by inducing both a potent anti-tumor innate immune response, including the secretion of IFN-gamma and TNF-alpha and the activation of NK cells as well as adaptive anti-tumor immunity with increasing tumor-specific T-cell proliferation and cytolytic activity of CD8(+) T cells. Notably, tumor-bearing mice infected with the parasite developed long-lasting and effective tumor-specific immunity. Consequently, we found that malaria parasite infection could enhance the immune response of lung cancer DNA vaccine pcDNA3.1-hMUC1 and the combination produced a synergistic antitumor effect. Conclusions/Significance: Malaria infection significantly suppresses LLC growth via induction of innate and adaptive antitumor responses in a mouse model. These data suggest that the malaria parasite may provide a novel strategy or therapeutic vaccine vector for anti-lung cancer immune-based therapy.	[Chen, Lili; He, Zhengxiang; Qin, Li; Li, Qinyan; Shi, Xibao; Zhao, Siting; Chen, Ling; Chen, Xiaoping] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, State Key Lab Resp Dis, Ctr Infect & Immun, Guangzhou, Guangdong, Peoples R China; [Zhong, Nanshan] Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou Inst Resp Dis, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China; [Chen, Lili; He, Zhengxiang; Qin, Li; Li, Qinyan; Chen, Xiaoping] Chinese Acad Sci, CAS FS Biotech & Pharmaceut Ctr, Foshan, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; State Key Laboratory of Respiratory Disease; Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Chinese Academy of Sciences	Chen, LL (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, State Key Lab Resp Dis, Ctr Infect & Immun, Guangzhou, Guangdong, Peoples R China.	nanshan@vip.163.com; chen_xiaoping@gibh.ac.cn	Chen, Lili/AAC-8411-2020; He, Zhengxiang/I-2035-2019	Chen, Lili/0000-0003-0026-4877; He, Zhengxiang/0000-0002-8961-859X	National Natural Sciences Foundation of China [81001022]; State Key Laboratory of Respiratory Disease; CAS-FS Biotech and Pharmaceutical Center	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Respiratory Disease; CAS-FS Biotech and Pharmaceutical Center	Grant support from the National Natural Sciences Foundation of China (No. 81001022 to ZH), a grant from the State Key Laboratory of Respiratory Disease to XC, and a grant from the CAS-FS Biotech and Pharmaceutical Center to XC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandroff AB, 1999, LANCET, V353, P1689, DOI 10.1016/S0140-6736(98)07422-4; Berhanu A, 2006, CANCER RES, V66, P4895, DOI 10.1158/0008-5472.CAN-05-2384; Blattman JN, 2004, SCIENCE, V305, P200, DOI 10.1126/science.1100369; Boissonnas A, 2010, IMMUNITY, V32, P266, DOI 10.1016/j.immuni.2009.11.015; Bulk E, 2008, CANCER RES, V68, P1896, DOI 10.1158/0008-5472.CAN-07-2390; Choudhury HR, 2000, INFECT IMMUN, V68, P6127, DOI 10.1128/IAI.68.11.6127-6132.2000; Chung MA, 2003, CANCER RES, V63, P1280; Coban C, 2010, EXPERT REV VACCINES, V9, P775, DOI 10.1586/ERV.10.60; Coban C, 2010, CELL HOST MICROBE, V7, P50, DOI 10.1016/j.chom.2009.12.003; Cockburn IA, 2007, CURR OPIN IMMUNOL, V19, P424, DOI 10.1016/j.coi.2007.05.008; CORDEIRO RSB, 1983, ANN TROP MED PARASIT, V77, P455, DOI 10.1080/00034983.1983.11811739; DAY JF, 1984, COMP BIOCHEM PHYS A, V77, P447, DOI 10.1016/0300-9629(84)90210-X; DICKSON JA, 1979, LANCET, V1, P202, DOI 10.1016/S0140-6736(79)90594-4; Donati D, 2004, INFECT IMMUN, V72, P5412, DOI 10.1128/IAI.72.9.5412-5418.2004; FULTON AM, 1979, INFECT IMMUN, V25, P708, DOI 10.1128/IAI.25.2.708-716.1979; Gowda DC, 2007, TRENDS PARASITOL, V23, P596, DOI 10.1016/j.pt.2007.09.003; GREENTREE LB, 1981, MED HYPOTHESES, V7, P43, DOI 10.1016/0306-9877(81)90019-0; Gridelli C, 2009, ONCOLOGIST, V14, P909, DOI 10.1634/theoncologist.2009-0017; HIBBS JB, 1971, J INFECT DIS, V124, P587, DOI 10.1093/infdis/124.6.587; Ho C, 2008, CLIN LUNG CANCER, V9, pS20, DOI 10.3816/CLC.2008.s.004; Ing R, 2006, J IMMUNOL, V176, P441, DOI 10.4049/jimmunol.176.1.441; ISSELL BF, 1978, CANCER TREAT REP, V62, P1059; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jeon YH, 2007, INT J CANCER, V121, P1593, DOI 10.1002/ijc.22837; JONES KR, 1990, EUR J IMMUNOL, V20, P307, DOI 10.1002/eji.1830200212; Jorritsma A, 2008, CANCER RES, V68, P2455, DOI 10.1158/0008-5472.CAN-07-5254; KAFUKO GW, 1970, INT J CANCER, V6, P1, DOI 10.1002/ijc.2910060102; Kakimi K, 2009, LUNG CANCER, V65, P1, DOI 10.1016/j.lungcan.2008.10.018; Kalinski P, 2005, EXPERT OPIN BIOL TH, V5, P1303, DOI 10.1517/14712598.5.10.1303; Kamoun WS, 2009, J CLIN ONCOL, V27, P2542, DOI 10.1200/JCO.2008.19.9356; Kelly RJ, 2010, CLIN LUNG CANCER, V11, P228, DOI 10.3816/CLC.2010.n.029; Kurts C, 2010, NAT REV IMMUNOL, V10, P403, DOI 10.1038/nri2780; Lamb TJ, 2010, FUTURE MICROBIOL, V5, P1167, DOI 10.2217/FMB.10.85; LIMA MRD, 1991, INT IMMUNOL, V3, P1207, DOI 10.1093/intimm/3.12.1207; Liu FY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016241; Miyakoda M, 2008, J IMMUNOL, V181, P1420, DOI 10.4049/jimmunol.181.2.1420; Odida M, 2002, INT J CANCER, V99, P737, DOI 10.1002/ijc.10384; Oh MD, 2001, AM J TROP MED HYG, V65, P143, DOI 10.4269/ajtmh.2001.65.143; Paulides MM, 2010, PHYS MED BIOL, V55, P2465, DOI 10.1088/0031-9155/55/9/003; Qiao J, 2008, NAT MED, V14, P37, DOI 10.1038/nm1681; Roetynck S, 2006, IMMUNOL REV, V214, P251, DOI 10.1111/j.1600-065X.2006.00446.x; Romero P, 2008, CLIN LUNG CANCER, V9, pS28, DOI 10.3816/CLC.2008.s.005; Sardinha LR, 2002, SCAND J IMMUNOL, V56, P408, DOI 10.1046/j.1365-3083.2002.01146.x; Shafer-Weaver KA, 2009, CANCER RES, V69, P6256, DOI 10.1158/0008-5472.CAN-08-4516; Song Hun Ho, 2003, Korean Journal of Internal Medicine, V18, P220; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Tanaka H, 1999, J IMMUNOL, V162, P3574; Tangney M, 2010, CURR GENE THER, V10, P46, DOI 10.2174/156652310790945539; Ullrich E, 2008, CYTOKINE GROWTH F R, V19, P79, DOI 10.1016/j.cytogfr.2007.10.009; Van den Heuvel MM, 2009, CLIN LUNG CANCER, V10, P99, DOI 10.3816/CLC.2009.n.012; Woan K, 2007, EXPERT OPIN BIOL TH, V7, P17, DOI 10.1517/14712598.7.1.17; Wood LM, 2008, IMMUNOL RES, V42, P233, DOI 10.1007/s12026-008-8087-0; Wykes MN, 2007, J IMMUNOL, V179, P3982, DOI 10.4049/jimmunol.179.6.3982; Xu M, 1998, INT J HYPERTHER, V14, P211, DOI 10.3109/02656739809018226; Yasumoto K, 2009, GEN THORAC CARDIOVAS, V57, P449, DOI 10.1007/s11748-008-0433-6; Yoshimoto T, 2009, IMMUNOTHERAPY-UK, V1, P825, DOI [10.2217/imt.09.46, 10.2217/IMT.09.46]; You JL, 2010, CANCER SCI, V101, P2644, DOI 10.1111/j.1349-7006.2010.01724.x; Zhang HG, 2008, CANCER LETT, V271, P191, DOI 10.1016/j.canlet.2008.05.026; Zimmermann VS, 2004, J IMMUNOL, V172, P2643, DOI 10.4049/jimmunol.172.4.2643	59	66	77	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2011	6	9							e24407	10.1371/journal.pone.0024407	http://dx.doi.org/10.1371/journal.pone.0024407			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CN	21931708	gold, Green Published, Green Submitted			2022-12-25	WOS:000294803100028
J	Kohara, K; Ochi, M; Tabara, Y; Nagai, T; Igase, M; Miki, T				Kohara, Katsuhiko; Ochi, Masayuki; Tabara, Yasuharu; Nagai, Tokihisa; Igase, Michiya; Miki, Tetsuro			Leptin in Sarcopenic Visceral Obesity: Possible Link between Adipocytes and Myocytes	PLOS ONE			English	Article							SKELETAL-MUSCLE MASS; BODY-COMPOSITION; METABOLISM; RESISTANCE; DISEASE; INFLAMMATION; ASSOCIATION; EXPRESSION; HEALTH; MEN	The combination of sarcopenia, age-related loss of muscle strength and mass, and obesity has been recognized as a new category of obesity among the elderly. Given that leptin has been hypothesized to be involved in the pathogenesis of sarcopenic obesity, we investigated the relationship between plasma leptin levels and thigh muscle sarcopenia and visceral obesity. Thigh muscle cross-sectional area (CSA) and visceral fat area were measured using computed tomography as indices for muscle mass and visceral fat, respectively, in 782 middle-aged to elderly subjects (303 men and 479 women), participating in a medical check-up program. Visceral obesity was defined as visceral fat area > 100 cm(2), and sarcopenia was defined as < (one standard deviation - mean of thigh muscle CSA/body weight of young subjects [aged <50 years]). Thigh muscle CSA was significantly and negatively associated with plasma levels of leptin in both men (beta = -0.28, p<0.0001) and women (beta = -0.20, p<0.0001), even after correcting for other confounding parameters, including age, body weight, body height, visceral fat area, blood pressure, homeostatic model assessment index, and high sensitive C reactive protein. Subjects were divided into four groups based on presence or absence of sarcopenia or visceral obesity. Plasma levels of leptin were higher in subjects with sarcopenic visceral obesity than in those with either sarcopenia or visceral obesity alone. These findings indicate that sarcopenic visceral obesity is a more advanced, and suggest that leptin may link visceral obesity and sarcopenia.	[Kohara, Katsuhiko; Ochi, Masayuki; Nagai, Tokihisa; Igase, Michiya; Miki, Tetsuro] Ehime Univ, Dept Geriatr Med, Grad Sch Med, Matsuyama, Ehime 790, Japan; [Tabara, Yasuharu] Ehime Univ, Dept Basic Med Res & Educ, Grad Sch Med, Matsuyama, Ehime 790, Japan; [Kohara, Katsuhiko; Tabara, Yasuharu; Miki, Tetsuro] Ehime Univ, Proteomed Res Ctr, Grad Sch Med, Matsuyama, Ehime 790, Japan	Ehime University; Ehime University; Ehime University	Kohara, K (corresponding author), Ehime Univ, Dept Geriatr Med, Grad Sch Med, Matsuyama, Ehime 790, Japan.	koharak@m.ehime-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor and Welfare of Japan; Japan Arteriosclerosis Prevention Fund; Ehime University; Grants-in-Aid for Scientific Research [23390188] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Arteriosclerosis Prevention Fund; Ehime University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in-Aid for Scientific Research from The Ministry of Education, Culture, Sports, Science and Technology of Japan; The Ministry of Health, Labor and Welfare of Japan; The Japan Arteriosclerosis Prevention Fund; and a Research Promotion Award from Ehime University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argiles JM, 2005, MED RES REV, V25, P49, DOI 10.1002/med.20010; Dominguez Ligia J, 2007, J Cardiometab Syndr, V2, P183, DOI 10.1111/j.1559-4564.2007.06673.x; Dutta C, 1997, J NUTR, V127, pS992, DOI 10.1093/jn/127.5.992S; Dyck DJ, 2009, APPL PHYSIOL NUTR ME, V34, P396, DOI 10.1139/H09-037; Fuentes T, 2010, EXP PHYSIOL, V95, P160, DOI 10.1113/expphysiol.2009.049270; Gomez JM, 2003, CLIN ENDOCRINOL, V58, P213, DOI 10.1046/j.1365-2265.2003.01698.x; Hamrick MW, 2010, BIOCHEM BIOPH RES CO, V400, P379, DOI 10.1016/j.bbrc.2010.08.079; Hubbard RE, 2008, J AM GERIATR SOC, V56, P279, DOI 10.1111/j.1532-5415.2007.01548.x; Jalbert F, 2008, REV STOMATOL CHIR, V109, P53, DOI 10.1016/j.stomax.2007.07.007; Janssen I, 2002, J AM GERIATR SOC, V50, P889, DOI 10.1046/j.1532-5415.2002.50216.x; Lim S, 2010, DIABETES CARE, V33, P1652, DOI 10.2337/dc10-0107; Martin SS, 2008, J AM COLL CARDIOL, V52, P1201, DOI 10.1016/j.jacc.2008.05.060; Matsuzawa Y, 2002, CIRC J, V66, P987, DOI 10.1253/circj.66.987; Ochi M, 2010, ATHEROSCLEROSIS, V212, P327, DOI 10.1016/j.atherosclerosis.2010.05.026; Ochi N, 2010, AM J HYPERTENS, V23, P889, DOI 10.1038/ajh.2010.60; Proctor DN, 1998, J NUTR, V128, p351S, DOI 10.1093/jn/128.2.351S; Rahmouni K, 2010, HYPERTENSION, V55, P844, DOI 10.1161/HYPERTENSIONAHA.109.148932; Sell H, 2006, TRENDS ENDOCRIN MET, V17, P416, DOI 10.1016/j.tem.2006.10.010; Stenholm S, 2008, CURR OPIN CLIN NUTR, V11, P693, DOI 10.1097/MCO.0b013e328312c37d; Sweeney G, 2010, NAT REV CARDIOL, V7, P22, DOI 10.1038/nrcardio.2009.224; Villareal DT, 2008, J CLIN ENDOCR METAB, V93, P2181, DOI 10.1210/jc.2007-1473; Visser M, 2002, J AM GERIATR SOC, V50, P897, DOI 10.1046/j.1532-5415.2002.50217.x; Waters DL, 2008, J GERONTOL A-BIOL, V63, P536, DOI 10.1093/gerona/63.5.536; Zamboni M, 2008, NUTR METAB CARDIOVAS, V18, P388, DOI 10.1016/j.numecd.2007.10.002	24	61	62	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2011	6	9							e24633	10.1371/journal.pone.0024633	http://dx.doi.org/10.1371/journal.pone.0024633			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CN	21931785	Green Published, gold, Green Submitted			2022-12-25	WOS:000294803100050
J	Matthiesen, K; Nielsen, J				Matthiesen, Karina; Nielsen, Jacob			Cyclic AMP Control Measured in Two Compartments in HEK293 Cells: Phosphodiesterase K-M Is More Important than Phosphodiesterase Localization	PLOS ONE			English	Article							NUCLEOTIDE PHOSPHODIESTERASE; GENE FAMILY; CAMP; CGMP; PURIFICATION; RECEPTOR; CILOSTAMIDE; ACTIVATION; DYNAMICS; ISOFORMS	The intracellular second messenger cyclic AMP (cAMP) is degraded by phosphodiesterases (PDE). The knowledge of individual families and subtypes of PDEs is considerable, but how the different PDEs collaborate in the cell to control a cAMP signal is still not fully understood. In order to investigate compartmentalized cAMP signaling, we have generated a membrane-targeted variant of the cAMP Bioluminiscence Resonance Energy Transfer (BRET) sensor CAMYEL and have compared intracellular cAMP measurements with it to measurements with the cytosolic BRET sensor CAMYEL in HEK293 cells. With these sensors we observed a slightly higher cAMP response to adenylyl cyclase activation at the plasma membrane compared to the cytosol, which is in accordance with earlier results from Fluorescence Resonance Energy Transfer (FRET) sensors. We have analyzed PDE activity in fractionated lysates from HEK293 cells using selective PDE inhibitors and have identified PDE3 and PDE10A as the major membrane-bound PDEs and PDE4 as the major cytosolic PDE. Inhibition of membrane-bound or cytosolic PDEs can potentiate the cAMP response to adenylyl cyclase activation, but we see no significant difference between the potentiation of the cAMP response at the plasma membrane and in cytosol when membrane-bound and cytosolic PDEs are inhibited. When different levels of stimulation were tested, we found that PDEs 3 and 10 are mainly responsible for cAMP degradation at low intracellular cAMP concentrations, whereas PDE4 is more important for control of cAMP at higher concentrations.	[Matthiesen, Karina; Nielsen, Jacob] H Lundbeck & Co AS, Copenhagen, Denmark	Lundbeck Corporation	Matthiesen, K (corresponding author), H Lundbeck & Co AS, Synapt Transmiss 2, Copenhagen, Denmark.	jcni@lundbeck.com		Nielsen, Jacob/0000-0001-9842-2276	Danish Ministry of Science, Technology and Innovation; H. Lundbeck A/S	Danish Ministry of Science, Technology and Innovation; H. Lundbeck A/S	KM was supported by the Danish Ministry of Science, Technology and Innovation as part of the Industrial PhD program. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The work was funded by H. Lundbeck A/S. The company had a role in this study due to employment of JN and KM.	Baillie GS, 2009, FEBS J, V276, P1790, DOI 10.1111/j.1742-4658.2009.06926.x; Barak LS, 2008, MOL PHARMACOL, V74, P585, DOI 10.1124/mol.108.048884; Beavo JA, 2002, NAT REV MOL CELL BIO, V3, P710, DOI 10.1038/nrm911; BEAVO JA, 1995, PHYSIOL REV, V75, P725, DOI 10.1152/physrev.1995.75.4.725; BELL AS, 2002, Patent No. 911333; Boess FG, 2004, NEUROPHARMACOLOGY, V47, P1081, DOI 10.1016/j.neuropharm.2004.07.040; Chin KV, 2002, ANN NY ACAD SCI, V968, P49, DOI 10.1111/j.1749-6632.2002.tb04326.x; Cooper DMF, 2005, BIOCHEM SOC T, V33, P1319, DOI 10.1042/BST0331319; DEGERMAN E, 1987, J BIOL CHEM, V262, P5797; DiPilato LM, 2004, P NATL ACAD SCI USA, V101, P16513, DOI 10.1073/pnas.0405973101; Fawcett L, 2000, P NATL ACAD SCI USA, V97, P3702, DOI 10.1073/pnas.050585197; Fujishige K, 1999, J BIOL CHEM, V274, P18438, DOI 10.1074/jbc.274.26.18438; Goraya TA, 2008, CELL SIGNAL, V20, P359, DOI 10.1016/j.cellsig.2007.10.024; GRANT PG, 1984, BIOCHEMISTRY-US, V23, P1801, DOI 10.1021/bi00303a034; HARRISON SA, 1986, MOL PHARMACOL, V29, P506; Hatzelmann A, 2001, J PHARMACOL EXP THER, V297, P267; Jiang LI, 2007, J BIOL CHEM, V282, P10576, DOI 10.1074/jbc.M609695200; Lynch MJ, 2005, J BIOL CHEM, V280, P33178, DOI 10.1074/jbc.M414316200; Matthiesen K, 2009, BIOCHEM J, V423, P401, DOI 10.1042/BJ20090982; McKnight GS, 1991, CURR OPIN CELL BIOL, V3, P213; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Oliveira RF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011725; Russwurm C, 2009, J BIOL CHEM, V284, P25782, DOI 10.1074/jbc.M109.017194; Schmidt CJ, 2008, J PHARMACOL EXP THER, V325, P681, DOI 10.1124/jpet.107.132910; Shelly M, 2010, SCIENCE, V327, P547, DOI 10.1126/science.1179735; Soderling SH, 1999, P NATL ACAD SCI USA, V96, P7071, DOI 10.1073/pnas.96.12.7071; Soderling SH, 2000, CURR OPIN CELL BIOL, V12, P174, DOI 10.1016/S0955-0674(99)00073-3; Sudo T, 2000, BIOCHEM PHARMACOL, V59, P347, DOI 10.1016/S0006-2952(99)00346-9; Terrin A, 2006, J CELL BIOL, V175, P441, DOI 10.1083/jcb.200605050; Tsai LCL, 2011, MOL PHARMACOL, V79, P639, DOI 10.1124/mol.110.069104; Wang P, 1997, BIOCHEM BIOPH RES CO, V234, P320, DOI 10.1006/bbrc.1997.6636; Zaccolo M, 2002, SCIENCE, V295, P1711, DOI 10.1126/science.1069982; Zaccolo M, 2000, NAT CELL BIOL, V2, P25, DOI 10.1038/71345; Zaccolo M, 2009, BRIT J PHARMACOL, V158, P50, DOI 10.1111/j.1476-5381.2009.00185.x	34	29	30	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e24392	10.1371/journal.pone.0024392	http://dx.doi.org/10.1371/journal.pone.0024392			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CK	21931705	Green Published, Green Submitted, gold			2022-12-25	WOS:000294802800047
J	Pujolar, JM; Vincenzi, S; Zane, L; Jesensek, D; De Leo, GA; Crivelli, AJ				Pujolar, Jose Martin; Vincenzi, Simone; Zane, Lorenzo; Jesensek, Dusan; De Leo, Giulio A.; Crivelli, Alain J.			The Effect of Recurrent Floods on Genetic Composition of Marble Trout Populations	PLOS ONE			English	Article							SALMON SALMO-SALAR; SALVELINUS CONFLUENTUS; FRESH-WATER; TRUTTA; CONSERVATION; MICROSATELLITES; DIFFERENTIATION; BOTTLENECKS; MARKERS; DENSITY	A changing global climate can threaten the diversity of species and ecosystems. We explore the consequences of catastrophic disturbances in determining the evolutionary and demographic histories of secluded marble trout populations in Slovenian streams subjected to weather extremes, in particular recurrent flash floods and debris flows causing massive mortalities. Using microsatellite data, a pattern of extreme genetic differentiation was found among populations (global F-ST of 0.716), which exceeds the highest values reported in freshwater fish. All locations showed low levels of genetic diversity as evidenced by low heterozygosities and a mean of only 2 alleles per locus, with few or no rare alleles. Many loci showed a discontinuous allele distribution, with missing alleles across the allele size range, suggestive of a population contraction. Accordingly, bottleneck episodes were inferred for all samples with a reduction in population size of 3-4 orders of magnitude. The reduced level of genetic diversity observed in all populations implies a strong impact of genetic drift, and suggests that along with limited gene flow, genetic differentiation might have been exacerbated by recurrent mortalities likely caused by flash flood and debris flows. Due to its low evolutionary potential the species might fail to cope with an intensification and altered frequency of flash flood events predicted to occur with climate change.	[Pujolar, Jose Martin; Zane, Lorenzo] Univ Padua, Dept Biol, Padua, Italy; [Vincenzi, Simone; De Leo, Giulio A.] Univ Parma, Dept Environm Sci, I-43100 Parma, Italy; [Jesensek, Dusan] Tolmin Angling Assoc, Most Na Soci, Slovenia; [Crivelli, Alain J.] Stn Biol Tour Valat, F-13200 Arles, France	University of Padua; University of Parma	Pujolar, JM (corresponding author), Univ Padua, Dept Biol, Padua, Italy.	martipujolar@gmail.com	De Leo, Giulio/AAC-5098-2019; Vincenzi, Simone/D-9547-2012; Zane, Lorenzo/G-6249-2010	De Leo, Giulio/0000-0002-4186-3369; Vincenzi, Simone/0000-0002-8436-8608; Zane, Lorenzo/0000-0002-6963-2132; pujolar, marti/0000-0002-5037-8840	Fondation Tour du Valat	Fondation Tour du Valat	This work has been funded by a contract by Fondation Tour du Valat to LZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angers B, 1998, MOL BIOL EVOL, V15, P143, DOI 10.1093/oxfordjournals.molbev.a025911; [Anonymous], 2002, FSTAT VERSION 2 9 3; Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Balloux F, 2002, MOL ECOL, V11, P155, DOI 10.1046/j.0962-1083.2001.01436.x; Beaumont MA, 1999, GENETICS, V153, P2013; BELKHIR K, 2005, GENETIX 4 05 LOGICIE; Berrebi P, 2000, HEREDITY, V85, P277, DOI 10.1046/j.1365-2540.2000.00753.x; Bouzat JL, 2010, CONSERV GENET, V11, P463, DOI 10.1007/s10592-010-0049-0; Carroll SP, 2008, MOL ECOL, V17, P361, DOI 10.1111/j.1365-294X.2007.03484.x; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Cornuet JM, 1996, GENETICS, V144, P2001; Crivelli A, 2000, CYBIUM, V24, P211; DIRIENZO A, 1994, P NATL ACAD SCI USA, V91, P3166, DOI 10.1073/pnas.91.8.3166; Ellegren H, 2000, TRENDS GENET, V16, P551, DOI 10.1016/S0168-9525(00)02139-9; Elliott JM, 1997, J APPL ECOL, V34, P1229, DOI 10.2307/2405234; ESTOUP A, 1993, HEREDITY, V71, P488, DOI 10.1038/hdy.1993.167; Estoup A, 1998, CAN J FISH AQUAT SCI, V55, P715, DOI 10.1139/cjfas-55-3-715; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Frankham R, 1995, ANNU REV GENET, V29, P305, DOI 10.1146/annurev.ge.29.120195.001513; Fraser DJ, 2007, MOL ECOL, V16, P3866, DOI 10.1111/j.1365-294X.2007.03453.x; Fumagalli L, 2002, MOL ECOL, V11, P2711, DOI 10.1046/j.1365-294X.2002.01648.x; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Giuffra E, 1996, MOL ECOL, V5, P207, DOI 10.1111/j.1365-294X.1996.tb00308.x; GIUFFRA E, 1994, MOL ECOL, V3, P161, DOI 10.1111/j.1365-294X.1994.tb00117.x; Grossman GD, 1998, ECOL MONOGR, V68, P395, DOI 10.1890/0012-9615(1998)068[0395:AOISFE]2.0.CO;2; Hedrick P. W., 2011, GENETICS POPULATIONS; IPCC, 2007, CLIM CHANG 2007 PHYS; Jensen AJ, 1999, FUNCT ECOL, V13, P778, DOI 10.1046/j.1365-2435.1999.00358.x; Jentsch A, 2007, FRONT ECOL ENVIRON, V5, P365, DOI 10.1890/1540-9295(2007)5[365:ANGOCE]2.0.CO;2; Katz RW, 2002, ADV WATER RESOUR, V25, P1287, DOI 10.1016/S0309-1708(02)00056-8; LAKE PS, 2000, J N AMER BENTHOL SOC, V49, P210; Lehner B, 2006, CLIMATIC CHANGE, V75, P273, DOI 10.1007/s10584-006-6338-4; Luikart G, 1998, MOL ECOL, V7, P963, DOI 10.1046/j.1365-294x.1998.00414.x; LYTLE DA, 2004, OECOLOGIA, V140, P639; Meeuwig MH, 2010, MOL ECOL, V19, P3620, DOI 10.1111/j.1365-294X.2010.04655.x; Meldgaard T, 2007, BIOL CONSERV, V136, P602, DOI 10.1016/j.biocon.2007.01.004; Meraner A, 2007, HYDROBIOLOGIA, V579, P337, DOI 10.1007/s10750-006-0479-3; Meraner A, 2010, CONSERV GENET, V11, P985, DOI 10.1007/s10592-009-9942-9; Min SK, 2011, NATURE, V470, P378, DOI 10.1038/nature09763; Ng SHS, 2005, MOL ECOL NOTES, V5, P762, DOI 10.1111/j.1471-8286.2005.01056.x; OReilly PT, 1996, CAN J FISH AQUAT SCI, V53, P2292, DOI 10.1139/cjfas-53-10-2292; Pall P, 2011, NATURE, V470, P382, DOI 10.1038/nature09762; Picket S. T. A, 1985, ECOLOGY NATURAL DIST; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Poteaux C, 1999, HEREDITY, V82, P645, DOI 10.1046/j.1365-2540.1999.00519.x; Presa P, 1996, J FISH BIOL, V49, P1326, DOI 10.1111/j.1095-8649.1996.tb01800.x; Pritchard JK, 2000, GENETICS, V155, P945; Pritchard VL, 2009, CONSERV GENET, V10, P1209, DOI 10.1007/s10592-008-9652-8; Pujolar JM, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-7; Rambaut A, 2007, TRACER 1 4; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Sato T, 2006, J FISH BIOL, V69, P1849, DOI 10.1111/j.1095-8649.2006.01222.x; Schneider S., 2000, ARLEQUIN SOFTWARE PO, V2, P2496; Snoj A, 1997, J ANIM SCI, V75, P1983; Snoj A, 2000, J FRESHW BIOL, V29, P5; Taylor EB, 2003, MOL ECOL, V12, P2609, DOI 10.1046/j.1365-294X.2003.01937.x; Taylor EB, 2006, CAN J FISH AQUAT SCI, V63, P1157, DOI 10.1139/F06-026; Turner WR, 2010, CONSERV LETT, V3, P304, DOI 10.1111/j.1755-263X.2010.00128.x; van Oosterhout C, 2006, EVOLUTION, V60, P2562, DOI 10.1111/j.0014-3820.2006.tb01890.x; Vasemagi A, 2005, MOL ECOL NOTES, V5, P282, DOI 10.1111/j.1471-8286.2005.00902.x; Vincenzi S, 2008, ECOL FRESHW FISH, V17, P515, DOI 10.1111/j.1600-0633.2008.00309.x; Vincenzi S, 2008, OECOLOGIA, V156, P523, DOI 10.1007/s00442-008-1012-3; Vincenzi S, 2008, BIOL CONSERV, V141, P198, DOI 10.1016/j.biocon.2007.09.013; Volckaert FAM, 2002, J EVOLUTION BIOL, V15, P930, DOI 10.1046/j.1420-9101.2002.00469.x; Wagner A, 2003, J THEOR BIOL, V225, P45, DOI 10.1016/S0022-5193(03)00219-4; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; WARD RD, 1994, J FISH BIOL, V44, P213, DOI 10.1111/j.1095-8649.1994.tb01200.x; Warnock WG, 2010, CONSERV GENET, V11, P1421, DOI 10.1007/s10592-009-9969-y; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Zorn M, 2006, STUDIA GEOMORPHOLOGI, VXL, P127	71	21	21	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e23822	10.1371/journal.pone.0023822	http://dx.doi.org/10.1371/journal.pone.0023822			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CK	21931617	Green Submitted, Green Published, gold			2022-12-25	WOS:000294802800009
J	Sarfstein, R; Bruchim, I; Fishman, A; Werner, H				Sarfstein, Rive; Bruchim, Ilan; Fishman, Ami; Werner, Haim			The Mechanism of Action of the Histone Deacetylase Inhibitor Vorinostat Involves Interaction with the Insulin-Like Growth Factor Signaling Pathway	PLOS ONE			English	Article							FACTOR-I RECEPTOR; SUBEROYLANILIDE HYDROXAMIC ACID; CELL-PROLIFERATION; TRICHOSTATIN-A; CLINICAL-TRIAL; PHASE-I; GENE; EXPRESSION; CANCER; P53	A correlation between components of the insulin-like growth factor (IGF) system and endometrial cancer risk has been shown in recent studies. The antitumor action of vorinostat, a histone deacetylase inhibitor, involves changes in the expression of specific genes via acetylation of histones and transcription factors. The aim of this study was to establish whether vorinostat can modify the expression of specific genes related to the IGF-I receptor (IGF-IR) signaling pathway and revert the transformed phenotype. Human endometrioid (Type I, Ishikawa) and uterine serous papillary (Type II, USPC-2) endometrial cancer cell lines were treated with vorinostat in the presence or absence of IGF-I. Vorinostat increased IGF-IR phosphorylation, produced acetylation of histone H3, up-regulated pTEN and p21 expression, and reduced p53 and cyclin D1 levels in Ishikawa cells. Vorinostat up-regulated IGF-IR and p21 expression, produced acetylation of histone H3, and down-regulated the expression of total AKT, pTEN and cyclin D1 in USPC-2 cells. Of interest, IGF-IR activation was associated with a major elevation in IGF-IR promoter activity. In addition, vorinostat treatment induced apoptosis in both cell lines and abolished the anti-apoptotic activity of IGF-I both in the absence or presence of a humanized monoclonal IGF-IR antibody, MK-0646. Finally, vorinostat treatment led to a significant decrease in proliferation and colony forming capability in both cell lines. In summary, our studies demonstrate that vorinostat exhibits a potent apoptotic and anti-proliferative effect in both Type I and II endometrial cancer cells, thus suggesting that endometrial cancer may be therapeutically targeted by vorinostat.	[Sarfstein, Rive; Werner, Haim] Tel Aviv Univ, Sackler Sch Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel; [Bruchim, Ilan; Fishman, Ami] Meir Med Ctr, Dept Obstet & Gynecol, Gynecol Oncol Unit, Kefar Sava, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine	Sarfstein, R (corresponding author), Tel Aviv Univ, Sackler Sch Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel.	hwerner@post.tau.ac.il			Merck; Sharp; Dohme (MSD, Israel)	Merck(Merck & Company); Sharp; Dohme (MSD, Israel)	This study was supported by a grant from Merck, Sharp and Dohme (MSD, Israel) to H.W., A.F., and I.B. None of the authors has received any payment or royalty from MSD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashkenazi A, 2002, NAT REV CANCER, V2, P420, DOI 10.1038/nrc821; Baserga R, 1997, BBA-REV CANCER, V1332, pF105, DOI 10.1016/S0304-419X(97)00007-3; BOKHMAN JV, 1983, GYNECOL ONCOL, V15, P10, DOI 10.1016/0090-8258(83)90111-7; BRASAEMLE DL, 1988, BIOTECHNIQUES, V6, P418; Duriez PJ, 1997, BIOCHEM CELL BIOL, V75, P337, DOI 10.1139/bcb-75-4-337; Esteller M, 2007, HUM MOL GENET, V16, pR50, DOI 10.1093/hmg/ddm018; Fulda S, 2005, CANCER BIOL THER, V4, P1113, DOI 10.4161/cbt.4.10.2100; GOFF BA, 1994, GYNECOL ONCOL, V54, P264, DOI 10.1006/gyno.1994.1208; Gridelli C, 2008, CRIT REV ONCOL HEMAT, V68, P29, DOI 10.1016/j.critrevonc.2008.03.002; Gualberto A, 2009, ONCOGENE, V28, P3009, DOI 10.1038/onc.2009.172; Gunter MJ, 2008, CANCER EPIDEM BIOMAR, V17, P921, DOI 10.1158/1055-9965.EPI-07-2686; Hamilton CA, 2006, BRIT J CANCER, V94, P642, DOI 10.1038/sj.bjc.6603012; HATA H, 1992, J STEROID BIOCHEM, V42, P201, DOI 10.1016/0960-0760(92)90029-I; Henderson C, 2003, J BIOL CHEM, V278, P12579, DOI 10.1074/jbc.M213093200; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Honda H, 1999, BIOCHEM BIOPH RES CO, V262, P25, DOI 10.1006/bbrc.1999.1162; Idrees MT, 2006, HISTOPATHOLOGY, V49, P75, DOI 10.1111/j.1365-2559.2006.02447.x; Ito A, 2002, EMBO J, V21, P6236, DOI 10.1093/emboj/cdf616; Juan LJ, 2000, J BIOL CHEM, V275, P20436, DOI 10.1074/jbc.M000202200; Kang-Park S, 2003, FEBS LETT, V545, P203, DOI 10.1016/S0014-5793(03)00535-0; Kelly WK, 2005, J CLIN ONCOL, V23, P3923, DOI 10.1200/JCO.2005.14.167; Kelly WK, 2003, CLIN CANCER RES, V9, P3578; Lax SF, 2004, VIRCHOWS ARCH, V444, P213, DOI 10.1007/s00428-003-0947-3; LEROITH D, 1995, ENDOCR REV, V16, P143, DOI 10.1210/er.16.2.143; Lu KH, 2008, CLIN CANCER RES, V14, P2543, DOI 10.1158/1078-0432.CCR-07-0321; Marks PA, 2007, NAT BIOTECHNOL, V25, P84, DOI 10.1038/nbt1272; Mitsiades CS, 2004, P NATL ACAD SCI USA, V101, P540, DOI 10.1073/pnas.2536759100; Nayak NR, 2003, PLACENTA, V24, P281, DOI 10.1053/plac.2002.0906; Okamoto H, 2006, J ATHEROSCLER THROMB, V13, P183, DOI 10.5551/jat.13.183; Pallares J, 2004, J PATHOL, V204, P569, DOI 10.1002/path.1666; Quesnel B, 1996, BRIT J HAEMATOL, V95, P291, DOI 10.1046/j.1365-2141.1996.d01-1913.x; Reynolds RK, 1998, GYNECOL ONCOL, V70, P202, DOI 10.1006/gyno.1998.5089; Richon VM, 2000, P NATL ACAD SCI USA, V97, P10014, DOI 10.1073/pnas.180316197; Risinger JI, 2003, ANN NY ACAD SCI, V983, P208, DOI 10.1111/j.1749-6632.2003.tb05975.x; Rutanen EM, 1998, GYNECOL ENDOCRINOL, V12, P399, DOI 10.3109/09513599809012842; Sarfstein R, 2006, MOL CELL ENDOCRINOL, V252, P241, DOI 10.1016/j.mce.2006.03.018; Siegel D, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-31; Stimson L, 2009, CANCER LETT, V280, P177, DOI 10.1016/j.canlet.2009.03.016; WERNER H, 1994, J BIOL CHEM, V269, P12577; WERNER H, 1992, MOL ENDOCRINOL, V6, P1545, DOI 10.1210/me.6.10.1545; Werner H, 2003, MED INTELL UNIT, P346; Werner Haim, 2009, Archives of Physiology and Biochemistry, V115, P58, DOI 10.1080/13813450902783106; Wozniak MB, 2010, HAEMATOL-HEMATOL J, V95, P613, DOI 10.3324/haematol.2009.013870; Zhao H, 2004, ONCOGENE, V23, P786, DOI 10.1038/sj.onc.1207162	44	30	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e24468	10.1371/journal.pone.0024468	http://dx.doi.org/10.1371/journal.pone.0024468			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CK	21931726	Green Published, Green Submitted, gold			2022-12-25	WOS:000294802800055
J	Jones, DD				Jones, D. Dafydd			Recombining Low Homology, Functionally Rich Regions of Bacterial Subtilisins by Combinatorial Fragment Exchange	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; SUBSTRATE-SPECIFICITY; ANGSTROM RESOLUTION; DIRECTED EVOLUTION; PROTEIN EVOLUTION; ESCHERICHIA-COLI; 1.4-A RESOLUTION; SERINE PROTEASES; SEQUENCE SPACE; AK.1 PROTEASE	Combinatorial fragment exchange was utilised to recombine key structural and functional low homology regions of bacilli subtilisins to generate new active hybrid proteases with altered substrate profiles. Up to six different regions comprising mostly of loop residues from the commercially important subtilisin Savinase were exchanged with the structurally equivalent regions of six other subtilisins. The six additional subtilisins derive from diverse origins and included thermophilic and intracellular subtilisins as well as other academically and commercially relevant subtilisins. Savinase was largely tolerant to fragment exchange; rational replacement of all six regions with 5 of 6 donating subtilisin sequences preserved activity, albeit reduced compared to Savinase. A combinatorial approach was used to generate hybrid Savinase variants in which the sequences derived from all seven subtilisins at each region were recombined to generate new region combinations. Variants with different substrate profiles and with greater apparent activity compared to Savinase and the rational fragment exchange variants were generated with the substrate profile exhibited by variants dependent on the sequence combination at each region.	[Jones, D. Dafydd] Cardiff Univ, Sch Biosci, Cardiff, S Glam, Wales; [Jones, D. Dafydd] Novozymes AS, Bagsvaerd, Denmark	Cardiff University; Novozymes	Jones, DD (corresponding author), Cardiff Univ, Sch Biosci, Cardiff, S Glam, Wales.	jonesdd@cf.ac.uk	Jones, Dafydd/A-4330-2010		EU at Novozymes A/S; Biotechnology and Biological Sciences Research Council [BB/E007384/1] Funding Source: researchfish; BBSRC [BB/E007384/1] Funding Source: UKRI	EU at Novozymes A/S; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	EU Marie Curie Industrial Fellowship undertaken at Novozymes A/S. The EU had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Novozymes A/S provided the infrastructure required to support the project.	Andreeva A, 2006, CURR OPIN STRUC BIOL, V16, P399, DOI 10.1016/j.sbi.2006.04.003; Bershtein S, 2008, J MOL BIOL, V379, P1029, DOI 10.1016/j.jmb.2008.04.024; BETZEL C, 1992, J MOL BIOL, V223, P427, DOI 10.1016/0022-2836(92)90662-4; BOTT R, 1988, J BIOL CHEM, V263, P7895; Bryan PN, 2002, CHEM REV, V102, P4805, DOI 10.1021/cr010190b; Bryan PN, 2000, BBA-PROTEIN STRUCT M, V1543, P203, DOI 10.1016/S0167-4838(00)00235-1; CARTER P, 1987, SCIENCE, V237, P394, DOI 10.1126/science.3299704; CARTER P, 1988, NATURE, V332, P564, DOI 10.1038/332564a0; Chothia C, 2003, SCIENCE, V300, P1701, DOI 10.1126/science.1085371; DePristo MA, 2005, NAT REV GENET, V6, P678, DOI 10.1038/nrg1672; EDER J, 1995, MOL MICROBIOL, V16, P609, DOI 10.1111/j.1365-2958.1995.tb02423.x; Ewert S, 2004, METHODS, V34, P184, DOI 10.1016/j.ymeth.2004.04.007; Glasner ME, 2006, CURR OPIN CHEM BIOL, V10, P492, DOI 10.1016/j.cbpa.2006.08.012; GRON H, 1992, BIOCHEMISTRY-US, V31, P6011, DOI 10.1021/bi00141a008; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Gupta R, 2002, APPL MICROBIOL BIOT, V59, P15, DOI 10.1007/s00253-002-0975-y; Jain SC, 1998, J MOL BIOL, V284, P137, DOI 10.1006/jmbi.1998.2161; Jones DD, 2008, BIOCHEM J, V409, P357, DOI 10.1042/BJ20071119; Jones DD, 2000, J MOL BIOL, V295, P289, DOI 10.1006/jmbi.1999.3335; Lee AY, 2004, PROTEOMICS, V4, P3437, DOI 10.1002/pmic.200400997; Meyer MM, 2006, PROTEIN ENG DES SEL, V19, P563, DOI 10.1093/protein/gzl045; Minshull J, 1999, CURR OPIN CHEM BIOL, V3, P284, DOI 10.1016/S1367-5931(99)80044-1; NEIDHART DJ, 1988, PROTEIN ENG, V2, P271, DOI 10.1093/protein/2.4.271; Ness JE, 1999, NAT BIOTECHNOL, V17, P893, DOI 10.1038/12884; Neylon C, 2004, NUCLEIC ACIDS RES, V32, P1448, DOI 10.1093/nar/gkh315; PERONA JJ, 1995, PROTEIN SCI, V4, P337; Povolotskaya IS, 2010, NATURE, V465, P922, DOI 10.1038/nature09105; Rockwell NC, 2002, CHEM REV, V102, P4525, DOI 10.1021/cr010168i; Siezen RJ, 1997, PROTEIN SCI, V6, P501; Simm AM, 2007, FEBS LETT, V581, P3904, DOI 10.1016/j.febslet.2007.07.018; Smith CA, 1999, J MOL BIOL, V294, P1027, DOI 10.1006/jmbi.1999.3291; Stemmer W, 2003, AM SCI, V91, P526, DOI 10.1511/2003.6.526; Stott KM, 2009, STRUCTURE, V17, P1117, DOI 10.1016/j.str.2009.07.001; TEPLYAKOV AV, 1990, J MOL BIOL, V214, P261, DOI 10.1016/0022-2836(90)90160-N; Tindbaek N, 2004, PROTEIN ENG DES SEL, V17, P149, DOI 10.1093/protein/gzh019; Tokuriki N, 2009, SCIENCE, V324, P203, DOI 10.1126/science.1169375; Toogood HS, 2000, BIOCHEM J, V350, P321, DOI 10.1042/0264-6021:3500321; Vevodova J, 2010, STRUCTURE, V18, P744, DOI 10.1016/j.str.2010.03.008; WELLS JA, 1987, P NATL ACAD SCI USA, V84, P1219, DOI 10.1073/pnas.84.5.1219; WELLS JA, 1988, TRENDS BIOCHEM SCI, V13, P291, DOI 10.1016/0968-0004(88)90121-1; WRIGHT CS, 1969, NATURE, V221, P235, DOI 10.1038/221235a0; Zhao HM, 1999, PROTEIN ENG, V12, P47, DOI 10.1093/protein/12.1.47	42	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2011	6	9							e24319	10.1371/journal.pone.0024319	http://dx.doi.org/10.1371/journal.pone.0024319			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CH	21915310	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000294802500038
J	Marino, L; Frohoff, T				Marino, Lori; Frohoff, Toni			Towards a New Paradigm of Non-Captive Research on Cetacean Cognition	PLOS ONE			English	Review							BOTTLE-NOSED DOLPHINS; WHALES ORCINUS-ORCA; STRESS; TRANSMISSION; COMPLEX; SOUND	Contemporary knowledge of impressive neurophysiology and behavior in cetaceans, combined with increasing opportunities for studying free-ranging cetaceans who initiate sociable interaction with humans, are converging to highlight serious ethical considerations and emerging opportunities for a new era of progressive and less-invasive cetacean research. Most research on cetacean cognition has taken place in controlled captive settings, e. g., research labs, marine parks. While these environments afford a certain amount of experimental rigor and logistical control they are fraught with limitations in external validity, impose tremendous stress on the part of the captive animals, and place burdens on populations from which they are often captured. Alternatively, over the past three decades, some researchers have sought to focus their attention on the presence of free-ranging cetacean individuals and groups who have initiated, or chosen to participate in, sociable interactions with humans in the wild. This new approach, defined as Interspecies Collaborative Research between cetacean and human, involves developing novel ways to address research questions under natural conditions and respecting the individual cetacean's autonomy. It also offers a range of potential direct benefits to the cetaceans studied, as well as allowing for unprecedented cognitive and psychological research on sociable mysticetes. Yet stringent precautions are warranted so as to not increase their vulnerability to human activities or pathogens. When conducted in its best and most responsible form, collaborative research with free-ranging cetaceans can deliver methodological innovation and invaluable new insights while not necessitating the ethical and scientific compromises that characterize research in captivity. Further, it is representative of a new epoch in science in which research is designed so that the participating cetaceans are the direct recipients of the benefits.	[Marino, Lori] Emory Univ, Dept Psychol, Atlanta, GA 30322 USA; [Marino, Lori] Emory Univ, Emory Ctr Eth, Atlanta, GA 30322 USA; [Frohoff, Toni] TerraMar Res & Learning Inst, Santa Barbara, CA USA	Emory University; Emory University	Marino, L (corresponding author), Emory Univ, Dept Psychol, Atlanta, GA 30322 USA.	lmarino@emory.edu			TerraMar Research & Learning Institute; Whale Stewardship Project	TerraMar Research & Learning Institute; Whale Stewardship Project	The authors would like to thank Catherine Kinsman and Ken Petersen, Ann Smith, Wildquest, Tom Conlin of Aquatic Adventures, Ute Margreff, Baja Discovery, Baja Expeditions and all of the supporters of TerraMar Research & Learning Institute and Whale Stewardship Project.	[Anonymous], ENCY ANIMAL BEHAV; CARTER N, 1982, INT J STUD ANIM PROB, V3, P193; Connor RC, 1999, NATURE, V397, P571, DOI 10.1038/17501; Connor RC, 2007, PHILOS T R SOC B, V362, P587, DOI 10.1098/rstb.2006.1997; Couquiaud Laurence, 2005, Aquatic Mammals, V31, P279; Defran RH., 1980, CETACEAN BEHAV MECH, P319; DEMASTER DP, 1988, MAR MAMMAL SCI, V4, P297, DOI 10.1111/j.1748-7692.1988.tb00539.x; Dudzinski K., 2008, DOLPHIN MYSTERIES UN; Ford J. K., 1994, KILLER WHALES; FORD JKB, 1991, CAN J ZOOL, V69, P1454, DOI 10.1139/z91-206; Ford JKB, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P650; Fowler M. E., 1978, ZOO WILD ANIMAL MED, P33; FROHOFF T, 2010, P 12 INT C AM CET SO; FROHOFF T, 1996, THESIS UNION I CINCI; FROHOFF T, 2006, PREL P WORKSH RES MA; FROHOFF T, 1993, THESIS TEXAS A M U C; FROHOFF T, 2010, TEDGLOBAL JUL 15 OXF; Frohoff T., 2008, ENCY TOURISM RECREAT, P515; Frohoff T. G, 2000, SC52WW2 INT WHAL COM; FROHOFF TG, 1995, ANTHROZOOS, V8, P44, DOI 10.2752/089279395787156527; FROHOFF TG, 1996, P 21 INT M STUD MAR; FROHOFF TG, 2000, SC52WW3 IWC; FROHOFF TG, 2005, WORKSH RES MAN UNPUB, P50; Frohoff Toni, 2011, P135; GERACI JR, 1991, MAR MAMMAL SCI, V7, P191, DOI 10.1111/j.1748-7692.1991.tb00565.x; Greenwood A. G., 1977, Aquatic Mamm., V5, P15; HERMAN LM, 1993, J EXP PSYCHOL GEN, V122, P184, DOI 10.1037/0096-3445.122.2.184; Herzing Denise L., 2006, Aquatic Mammals, V32, P554, DOI 10.1578/AM.32.4.2006.554; HERZING DL, 1995, 11 BIENN C BIOL MAR; Hobaiter C, 2011, ANIM COGN, V14, P827, DOI 10.1007/s10071-011-0416-3; Hoelzel A., 1991, GENETIC ECOLOGY WHAL, P155; Hoyt E, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P1223; Hunt TD, 2008, DIS AQUAT ORGAN, V81, P81, DOI 10.3354/dao01942; Janik VM, 2006, P NATL ACAD SCI USA, V103, P8293, DOI 10.1073/pnas.0509918103; Jones M.L., 1984, GRAY WHALE ESCHRICHT; KINSMAN CK, 2005, WORKSH RES MAN SOL S, P26; Krutzen M, 2005, P NATL ACAD SCI USA, V102, P8939, DOI 10.1073/pnas.0500232102; Lavigne D., 1997, 9301 INT MAR MAMM AS; Lockyer C., 2003, SPECIES CELEBRATING, P138; Lusseau D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000348; Lusseau D, 2007, EVOL ECOL, V21, P357, DOI 10.1007/s10682-006-9105-0; Mann J., 2000, CETACEAN SOC FIELD S; Mann J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003868; Marino L, 2004, CURR BIOL, V14, pR910, DOI 10.1016/j.cub.2004.10.010; Marino L, 2008, BIOL REV, V83, P417, DOI 10.1111/j.1469-185X.2008.00049.x; Marino L, 2007, PLOS BIOL, V5, P966, DOI 10.1371/journal.pbio.0050139; Marino Lori, 2011, P115; Matkin CO, 2008, MAR ECOL PROG SER, V356, P269, DOI 10.3354/meps07273; Mazet JAK, 2004, ASSESSMENT RISK ZOON; MOONEY J, 2006, CAPTIVE CETACEANS A; *NAT MAR FISH SERV, 2010, US MAR MAMM INV REP; Noda K, 2007, J VET MED SCI, V69, P379, DOI 10.1292/jvms.69.379; Olesiuk P.F., 1990, Reports of the International Whaling Commission Special Issue, P209; Peterson B., 2003, SPECIES CELEBRATING; Pliny the Elder, 1940, NATURAL HIST, V3; PRYOR K, 1990, MAR MAMMAL SCI, V6, P77, DOI 10.1111/j.1748-7692.1990.tb00228.x; Reeves R. R., 2003, 2002 2010 CONSERVATI; REISS D, 1993, J COMP PSYCHOL, V107, P301, DOI 10.1037/0735-7036.107.3.301; RUSSEL D, EYE WHALE EPIC PASSA; SCHNEIDER M, 2010, HUFFINGTON POST 0224; SHANE SH, 1986, MAR MAMMAL SCI, V2, P34, DOI 10.1111/j.1748-7692.1986.tb00026.x; Simmonds MP, 2006, APPL ANIM BEHAV SCI, V100, P103, DOI 10.1016/j.applanim.2006.04.015; SMALL RJ, 1995, MAR MAMMAL SCI, V11, P209, DOI 10.1111/j.1748-7692.1995.tb00519.x; Smolker R, 1997, ETHOLOGY, V103, P454, DOI 10.1111/j.1439-0310.1997.tb00160.x; STEWART KL, 2009, DOLPHIN HUMAN INTERA; Sweeney Jay C., 1990, P53; SWEENEY JC, 1988, SOUNDINGS NEWSLETTER, V13, P7; Visser IN, 2008, MAR MAMMAL SCI, V24, P225, DOI 10.1111/j.1748-7692.2007.00163.x; Visser Ingrid N., 1998, Aquatic Mammals, V24, P71; Waples KA, 2002, ZOO BIOL, V21, P5, DOI 10.1002/zoo.10004; Wells R.S., 1990, Reports of the International Whaling Commission Special Issue, P407; Wells RS, 2009, ZOO BIOL, V28, P635, DOI 10.1002/zoo.20252; Whale and Dolphin Conservation Society The Humane Society of the United States, 2003, BIT HAND FEEDS CAS D; Whitehead H, 2004, BIOL CONSERV, V120, P427, DOI 10.1016/j.biocon.2004.03.017; Whitehead Hal, 2011, P149; Wilke Monika, 2005, Aquatic Mammals, V31, P427, DOI 10.1578/AM.31.4.2005.427; Williams V., 2001, CAPTIVE ORCAS DYING; WOODLEY TH, 1997, 9702 IMMA, P30	78	21	21	3	133	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2011	6	9							e24121	10.1371/journal.pone.0024121	http://dx.doi.org/10.1371/journal.pone.0024121			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	819CH	21915286	Green Submitted, gold, Green Published			2022-12-25	WOS:000294802500026
J	Pedersen, C; Mihranyan, A; Stromme, M				Pedersen, Christian; Mihranyan, Albert; Stromme, Maria			Surface Transition on Ice Induced by the Formation of a Grain Boundary	PLOS ONE			English	Article							NITRIC-ACID; PHYSICS; GROWTH; SNOW; PRESSURE; WATER	Interfaces between individual ice crystals, usually referred to as grain boundaries, play an important part in many processes in nature. Grain boundary properties are, for example, governing the sintering processes in snow and ice which transform a snowpack into a glacier. In the case of snow sintering, it has been assumed that there are no variations in surface roughness and surface melting, when considering the ice-air interface of an individual crystal. In contrast to that assumption, the present work suggests that there is an increased probability of molecular surface disorder in the vicinity of a grain boundary. The conclusion is based on the first detailed visualization of the formation of an ice grain boundary. The visualization is enabled by studying ice crystals growing into contact, at temperatures between -20 degrees C and -15 degrees C and pressures of 1-2 Torr, using Environmental Scanning Electron Microscopy. It is observed that the formation of a grain boundary induces a surface transition on the facets in contact. The transition does not propagate across facet edges. The surface transition is interpreted as the spreading of crystal dislocations away from the grain boundary. The observation constitutes a qualitatively new finding, and can potentially increase the understanding of specific processes in nature where ice grain boundaries are involved.	[Pedersen, Christian; Mihranyan, Albert; Stromme, Maria] Uppsala Univ, Dept Engn Sci, Uppsala, Sweden	Uppsala University	Pedersen, C (corresponding author), Uppsala Univ, Dept Engn Sci, Uppsala, Sweden.	Christian.Pedersen@angstrom.uu.se; Maria.Stromme@angstrom.uu.se		Mihranyan, Albert/0000-0002-8105-2317	Swedish Science Council (VR); Carl Trygger Research Foundation [CTS 09:248]; Uppsala University	Swedish Science Council (VR)(Swedish Research Council); Carl Trygger Research Foundation; Uppsala University	The work was financially supported by the Swedish Science Council (VR), the Carl Trygger Research Foundation (CTS 09:248) and faculty funding from Uppsala University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blackford JR, 2007, J PHYS D APPL PHYS, V40, pR355, DOI 10.1088/0022-3727/40/21/R02; BRYANT GW, 1959, J PHYS CHEM SOLIDS, V12, P189; Dash JG, 2006, REV MOD PHYS, V78, P695, DOI 10.1103/RevModPhys.78.695; Dash JG, 1999, REV MOD PHYS, V71, P1737, DOI 10.1103/RevModPhys.71.1737; Dash JG, 2003, CAN J PHYS, V81, P201, DOI 10.1139/P03-011; Goldstein J., 2018, SCANNING ELECT MICRO, V4th ed.; GUBLER H, 1982, J GLACIOL, V28, P457, DOI 10.3189/S0022143000005050; HALLETT J, 1961, PHILOS MAG, V6, P1073, DOI 10.1080/14786436108239669; Hobbs P. V, 1974, ICE PHYS; HOBBS PV, 1964, PHILOS MAG, V9, P181, DOI 10.1080/14786436408229184; JANCSO G, 1970, J PHYS CHEM-US, V74, P2984, DOI 10.1021/j100709a025; KEYSER LF, 1993, MICROSC RES TECHNIQ, V25, P434, DOI 10.1002/jemt.1070250514; Leu MT, 2009, INT REV PHYS CHEM, V28, P53, DOI 10.1080/01442350802617129; Libbrecht KG, 2005, REP PROG PHYS, V68, P855, DOI 10.1088/0034-4885/68/4/R03; Lock G.S.H., 1990, GROWTH DECAY ICE; MAENO N, 1983, J PHYS CHEM-US, V87, P4103, DOI 10.1021/j100244a023; MASON BJ, 1963, PHILOS MAG, V8, P505, DOI 10.1080/14786436308211150; Miller DA, 2003, COLD REG SCI TECHNOL, V37, P213, DOI 10.1016/j.coldregions.2003.07.001; Petrenko VF, 1999, PHYS ICE; Szabo D, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2721391; Tanaka H, 1996, CHEM PHYS LETT, V259, P593, DOI 10.1016/0009-2614(96)00824-X; Thomson ES, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3249562	22	11	11	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2011	6	9							e24373	10.1371/journal.pone.0024373	http://dx.doi.org/10.1371/journal.pone.0024373			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CH	21915317	Green Published, Green Submitted, gold			2022-12-25	WOS:000294802500040
J	Srivastava, A; Garg, N; Mittal, T; Khanna, R; Gupta, S; Seth, PK; Mittal, B				Srivastava, Anshika; Garg, Naveen; Mittal, Tulika; Khanna, Roopali; Gupta, Shipra; Seth, Prahlad Kishore; Mittal, Balraj			Association of 25 bp Deletion in MYBPC3 Gene with Left Ventricle Dysfunction in Coronary Artery Disease Patients	PLOS ONE			English	Article							BINDING-PROTEIN-C; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; DILATED CARDIOMYOPATHY; MUTATIONS; PHOSPHORYLATION; IDENTIFICATION; IMPAIRMENT; MUTANTS; FAILURE; VARIANT	Rationale: Mutations in MYBPC3 encoding cardiac myosin binding protein C are common genetic cause of hereditary cardiac myopathies. An intronic 25-bp deletion in MYBPC3 at 39 region is associated with dilated (DCM) and hypertrophic (HCM) cardiomyopathies in Southeast Asia. However, the frequency of MYBPC3 25 bp deletion and associated clinical presentation has not been established in an unrelated cohort of left ventricular dysfunction (LVD) secondary to coronary artery disease (CAD) patients. Objective: We sought to determine the role of MYBPC3 25 bp polymorphism on LVD in two cohorts of CAD patients. Methods and Results: The study included 265 consecutive patients with angiographically confirmed CAD and 220 controls. MYBPC3 25 bp polymorphism was determined by polymerase chain reaction. Our results showed that carrier status of MYBPC3 25 bp deletion was associated with significant compromised left ventricle ejection fraction (LVEF <= 45) in CAD patients (p value = <0.001; OR = 4.49). To validate our results, we performed a replication study in additional 140 cases with similar clinical characteristics and results again confirmed consistent findings (p = 0.029; OR = 3.3). Also, presence of the gene deletion did not have significant association in CAD patients with preserved ejection fraction (LVEF >45) (p value = 0.1; OR = 2.3). Conclusion: The frequency of MYBPC3 DW genotype and D allele was associated with compromised LVEF implying that genetic variants of MYBPC3 encoding mutant structural sarcomere protein could increase susceptibility to left ventricular dysfunction. Therefore, 25 bp deletion in MYBPC3 may represent a genetic marker for cardiac failure in CAD patients from Southeast Asia.	[Srivastava, Anshika; Mittal, Tulika; Mittal, Balraj] Sanjay Gandhi Post Grad Inst Med Sci Lucknow UP, Dept Genet, Lucknow, Uttar Pradesh, India; [Garg, Naveen; Khanna, Roopali] Sanjay Gandhi Post Grad Inst Med Sci Lucknow UP, Dept Cardiol, Lucknow, Uttar Pradesh, India; [Gupta, Shipra; Seth, Prahlad Kishore] Biotech Pk Lucknow UP, Bioinformat Ctr, Lucknow, Uttar Pradesh, India	Sanjay Gandhi Postgraduate Institute of Medical Sciences; Sanjay Gandhi Postgraduate Institute of Medical Sciences	Srivastava, A (corresponding author), Sanjay Gandhi Post Grad Inst Med Sci Lucknow UP, Dept Genet, Lucknow, Uttar Pradesh, India.	bml_pgi@yahoo.com			Indian Council of Medical Research New Delhi; Department of Biotechnology (DBT), India	Indian Council of Medical Research New Delhi(Indian Council of Medical Research (ICMR)); Department of Biotechnology (DBT), India(Department of Biotechnology (DBT) India)	This study was supported by research and fellowship grants from the Indian Council of Medical Research New Delhi and Department of Biotechnology (DBT), India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bienengraeber M, 2004, NAT GENET, V36, P382, DOI 10.1038/ng1329; Bulteau AL, 2002, ARCH BIOCHEM BIOPHYS, V397, P298, DOI 10.1006/abbi.2001.2663; Chahal NS, 2010, HEART, V96, P466, DOI 10.1136/hrt.2009.173153; Dellefave LM, 2009, CIRC-CARDIOVASC GENE, V2, P442, DOI 10.1161/CIRCGENETICS.109.861955; Dhandapany PS, 2009, NAT GENET, V41, P187, DOI 10.1038/ng.309; EMIGH JF, 1980, AM PHARM, V11, P35; Flavigny J, 2003, CARDIOVASC RES, V60, P388, DOI 10.1016/j.cardiores.2003.07.001; Flavigny J, 1999, J MOL BIOL, V294, P443, DOI 10.1006/jmbi.1999.3276; Freiburg A, 1996, EUR J BIOCHEM, V235, P317, DOI 10.1111/j.1432-1033.1996.00317.x; Galasko GIW, 2005, HEART, V91, P595, DOI 10.1136/hrt.2003.029959; Gruen M, 1999, J MOL BIOL, V286, P933, DOI 10.1006/jmbi.1998.2522; HITOMI N, 2010, J CARDIOL; Johnson R, 1997, CLIN CHEM, V43, P2183; Kimura A, 2010, J HUM GENET, V55, P81, DOI 10.1038/jhg.2009.138; McClellan G, 2001, BIOPHYS J, V81, P1083, DOI 10.1016/S0006-3495(01)75765-7; McNair WP, 2004, CIRCULATION, V110, P2163, DOI 10.1161/01.CIR.0000144458.58660.BB; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Murphy RT, 2004, LANCET, V363, P371, DOI 10.1016/S0140-6736(04)15468-8; Niimura H, 2002, CIRCULATION, V105, P446, DOI 10.1161/hc0402.102990; Okada K, 1999, J BIOL CHEM, V274, P23787, DOI 10.1074/jbc.274.34.23787; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Sadayappan S, 2006, P NATL ACAD SCI USA, V103, P16918, DOI 10.1073/pnas.0607069103; Sarikas A, 2005, CARDIOVASC RES, V66, P33, DOI 10.1016/j.cardiores.2005.01.004; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; Simonson TS, 2010, ANN HUM GENET, V74, P184, DOI 10.1111/j.1469-1809.2010.00561.x; Squire JM, 2003, J MOL BIOL, V331, P713, DOI 10.1016/S0022-2836(03)00781-2; Takai E, 2002, HEART, V88, P649, DOI 10.1136/heart.88.6.649; Tanjore RR, 2008, CAN J CARDIOL, V24, P127, DOI 10.1016/S0828-282X(08)70568-3; Van Driest SL, 2005, MAYO CLIN PROC, V80, P463, DOI 10.4065/80.4.463; Waldmuller S, 2003, J MOL CELL CARDIOL, V35, P623, DOI 10.1016/S0022-2828(03)00050-6; Yang QL, 2001, J MOL CELL CARDIOL, V33, P1649, DOI 10.1006/jmcc.2001.1417	31	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2011	6	9							e24123	10.1371/journal.pone.0024123	http://dx.doi.org/10.1371/journal.pone.0024123			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CH	21915287	Green Published, Green Submitted, gold			2022-12-25	WOS:000294802500027
J	Woo, JK; Choi, Y; Oh, SH; Jeong, JH; Choi, DH; Seo, HS; Kim, CW				Woo, J. K.; Choi, Y.; Oh, S-H; Jeong, J-H; Choi, D-H; Seo, H-S; Kim, C-W			Mucin 1 enhances the tumor angiogenic response by activation of the AKT signaling pathway	ONCOGENE			English	Article						breast cancer; angiogenesis; MUC1; PI3K/AKT; VEGF	ENDOTHELIAL-GROWTH-FACTOR; FACTOR EXPRESSION; ANTIGEN-EXPRESSION; FACTOR RECEPTOR; FACTOR-I; INDUCTION; PHOSPHORYLATION; METASTASIS; INHIBITION; SUGGESTS	Although the hyper-glycosylated transmembrane protein Mucin 1 (MUC1) is aberrantly overexpressed in human breast carcinoma, the biological significance of MUC1 overexpression is unclear. This study showed that MUC1 expression promoted the synthesis and secretion of vascular endothelial growth factor (VEGF) through the AKT signaling pathway. Increase VEGF production through MUC1 expression had a number of effect. First, MUC1 transfection increased expression of VEGF in breast cancer cells. Second, MUC1-mediated VEGF induction was attenuated by a chemical inhibitor of AKT or MUC1 knock-down by MUC1 siRNA. Third, MUC1 expression led to the activation of insulin-like growth factor-1 receptor, which correlated with VEGF expression. In addition, when MDA-MB-231 human breast cancer cells were directly injected into NOD/SCID mice, MUC1 expression accelerated xenograft tumor growth in vivo. Finally, MUC1 expression enhanced tumor growth and angiogenesis in a PyMT-MMTV/hMUC1 transgenic mouse model. Concurrent with these results, analysis of a human tissue microarray identified a high correlation between MUC1 and VEGF expression in human breast carcinoma. The current report is the first to demonstrate that MUC1 expression promotes angiogenesis in human breast cancer in vivo and in vitro. Oncogene (2012) 31, 2187-2198; doi:10.1038/onc.2011.410; published online 19 September 2011	[Woo, J. K.; Kim, C-W] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 110799, South Korea; [Woo, J. K.; Choi, Y.; Choi, D-H; Kim, C-W] Seoul Natl Univ, Coll Med, Tumor Immun Med Res Ctr, Seoul 110799, South Korea; [Woo, J. K.; Choi, Y.; Choi, D-H; Kim, C-W] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul 110799, South Korea; [Oh, S-H] Gachon Univ Med & Sci, Coll Pharm, Inchon, South Korea; [Jeong, J-H] Korea Inst Radiol & Med Sci, Res Ctr Radiotherapy, Seoul, South Korea; [Seo, H-S] Kyung Hee Univ, Dept Oriental Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Gachon University; Korea Institute of Radiological & Medical Sciences; Kyung Hee University	Kim, CW (corresponding author), Seoul Natl Univ, Coll Med, Dept Pathol, 28 Yeongeon Dong, Seoul 110799, South Korea.	cwkim@snu.ac.kr	Kim, Chul-Woo/F-7008-2011	Woo, Jong Kyu/0000-0002-3374-6488	Ministry of Knowledge Economy (MOST) [10035353]; Korean Science and Engineering Foundation (KOSEF) through the Tumor Immunity Medical Research Center at Seoul National University college of Medicine, Republic of Korea	Ministry of Knowledge Economy (MOST)(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea); Korean Science and Engineering Foundation (KOSEF) through the Tumor Immunity Medical Research Center at Seoul National University college of Medicine, Republic of Korea(Korea Science and Engineering Foundation)	We are grateful to Drs Dong-Young Noh and Hyeong-Gon Moon for providing the human breast cancer tissues microarray. This work was supported in part by grants from the R&D Project, the Ministry of Knowledge Economy (MOST, 10035353) and the Korean Science and Engineering Foundation (KOSEF) through the Tumor Immunity Medical Research Center at Seoul National University college of Medicine, Republic of Korea	BENAV P, 1995, FEBS LETT, V372, P83, DOI 10.1016/0014-5793(95)00956-A; Borgstrom P, 1996, CANCER RES, V56, P4032; Brayman Melissa, 2004, Reprod Biol Endocrinol, V2, P4, DOI 10.1186/1477-7827-2-4; Cho JA, 2005, INT J CANCER, V114, P613, DOI 10.1002/ijc.20757; Cohen T, 1996, J BIOL CHEM, V271, P736, DOI 10.1074/jbc.271.2.736; Duffy MJ, 2000, INT J BIOL MARKER, V15, P330, DOI 10.1177/172460080001500410; Duraisamy S, 2007, INT J ONCOL, V31, P671; Dvorak HF, 1999, CURR TOP MICROBIOL, V237, P97; Feldkamp MM, 1999, INT J CANCER, V81, P118, DOI 10.1002/(SICI)1097-0215(19990331)81:1<118::AID-IJC20>3.3.CO;2-X; Ferrara N, 2002, SEMIN ONCOL, V29, P10, DOI 10.1053/sonc.2002.37264; Fessler SP, 2009, BREAST CANCER RES TR, V118, P113, DOI 10.1007/s10549-009-0412-3; Fontana J, 2002, CIRC RES, V90, P866, DOI 10.1161/01.RES.0000016837.26733.BE; FRANK S, 1995, J BIOL CHEM, V270, P12607, DOI 10.1074/jbc.270.21.12607; Geddis AE, 2006, EXP HEMATOL, V34, P82, DOI 10.1016/j.exphem.2005.09.008; GENDLER SJ, 1990, J BIOL CHEM, V265, P15286; Gendler SJ, 2001, J MAMMARY GLAND BIOL, V6, P339, DOI 10.1023/A:1011379725811; Giatromanolaki A, 2000, CLIN CANCER RES, V6, P1917; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hattrup CL, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1515; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kim B, 1997, J BIOL CHEM, V272, P21268, DOI 10.1074/jbc.272.34.21268; Kimura T, 2000, INT J ONCOL, V16, P55; KOHNO N, 1992, CHEST, V102, P117, DOI 10.1378/chest.102.1.117; Kucab Jill E, 2003, Breast Dis, V17, P41; Kurmasheva RT, 2009, CANCER RES, V69, P7662, DOI 10.1158/0008-5472.CAN-09-1693; Lee HY, 2005, J NATL CANCER I, V97, P1695, DOI 10.1093/jnci/dji377; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; LI J, 1995, J BIOL CHEM, V270, P308, DOI 10.1074/jbc.270.1.308; Mikami Y, 2009, BIOCHEM BIOPH RES CO, V379, P1060, DOI 10.1016/j.bbrc.2009.01.002; Milanini-Mongiat J, 2002, J BIOL CHEM, V277, P20631, DOI 10.1074/jbc.M201753200; Morgillo F, 2006, CANCER RES, V66, P10100, DOI 10.1158/0008-5472.CAN-06-1684; Okajima E, 2000, BIOCHEM BIOPH RES CO, V270, P108, DOI 10.1006/bbrc.2000.2386; Papadopoulos I, 2001, CLIN CANCER RES, V7, P1533; Parrizas M, 1997, J BIOL CHEM, V272, P154; Peruzzi F, 1999, MOL CELL BIOL, V19, P7203, DOI 10.1128/mcb.19.10.7203; Pochampalli MR, 2007, ONCOGENE, V26, P1693, DOI 10.1038/sj.onc.1209976; Pochampalli MR, 2007, CANCER RES, V67, P6591, DOI 10.1158/0008-5472.CAN-06-4518; Pollak MN, 2004, NAT REV CANCER, V4, P505, DOI 10.1038/nrc1387; Pollak MN, 2004, NOVART FDN SYMP, V262, P265, DOI DOI 10.1002/0470869976.CH6; Pore N, 2004, MOL BIOL CELL, V15, P4841, DOI 10.1091/mbc.E04-05-0374; Poulaki V, 2003, J CLIN ENDOCR METAB, V88, P5392, DOI 10.1210/jc.2003-030389; Raina D, 2004, J BIOL CHEM, V279, P20607, DOI 10.1074/jbc.M310538200; Ren J, 2006, MOL CANCER RES, V4, P873, DOI 10.1158/1541-7786.MCR-06-0204; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Sachdeva M, 2010, CANCER RES, V70, P378, DOI 10.1158/0008-5472.CAN-09-2021; Sakamoto H, 1997, HUM PATHOL, V28, P1056, DOI 10.1016/S0046-8177(97)90059-9; Sorokin LM, 1997, DEV BIOL, V189, P285, DOI 10.1006/dbio.1997.8668; Tang YC, 2003, CANCER RES, V63, P1166; Wang Bao-Feng, 2009, Zhongguo Zhong Xi Yi Jie He Za Zhi, V29, P425; Wei XL, 2006, MOL CELL, V21, P295, DOI 10.1016/j.molcel.2005.11.030; Werner H, 2000, CELL MOL LIFE SCI, V57, P932, DOI 10.1007/PL00000735; Yin L, 2007, J BIOL CHEM, V282, P257, DOI 10.1074/jbc.M610156200; Yoshiji H, 1997, CANCER RES, V57, P3924; Yu H, 2007, BIOCHEM BIOPH RES CO, V361, P946, DOI 10.1016/j.bbrc.2007.07.114; Yuen JSP, 2007, ONCOGENE, V26, P6499, DOI 10.1038/sj.onc.1210474	55	48	50	0	9	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2012	31	17					2187	2198		10.1038/onc.2011.410	http://dx.doi.org/10.1038/onc.2011.410			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	934BS	21927028				2022-12-25	WOS:000303415900007
J	Araki, M; Shima, F; Yoshikawa, Y; Muraoka, S; Ijiri, Y; Nagahara, Y; Shirono, T; Kataoka, T; Tamura, A				Araki, Mitsugu; Shima, Fumi; Yoshikawa, Yoko; Muraoka, Shin; Ijiri, Yuichi; Nagahara, Yuka; Shirono, Tomoya; Kataoka, Tohru; Tamura, Atsuo			Solution Structure of the State 1 Conformer of GTP-bound H-Ras Protein and Distinct Dynamic Properties between the State 1 and State 2 Conformers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIDE-CHAIN ENTROPY; NMR-SPECTROSCOPY; CONFORMATIONAL DYNAMICS; CRYSTAL-STRUCTURE; SIGNAL-TRANSDUCTION; BACKBONE DYNAMICS; BINDING PROTEINS; CHEMICAL-SHIFT; GAMMA-S; ACTIVATION	Ras small GTPases undergo dynamic equilibrium of two interconverting conformations, state 1 and state 2, in the GTP-bound forms, where state 2 is recognized by effectors, whereas physiological functions of state 1 have been unknown. Limited information, such as static crystal structures and P-31 NMR spectra, was available for the study of the conformational dynamics. Here we determine the solution structure and dynamics of state 1 by multidimensional heteronuclear NMR analysis of an H-RasT35S mutant in complex with guanosine 5'-(beta, gamma-imido)triphosphate (GppNHp). The state 1 structure shows that the switch I loop fluctuates extensively compared with that in state 2 or H-Ras-GDP. Also, backbone H-1, N-15 signals for state 2 are identified, and their dynamics are studied by utilizing a complex with c-Raf-1. Furthermore, the signals for almost all the residues of H-Ras.GppNHp are identified by measurement at low temperature, and the signals for multiple residues are found split into two peaks corresponding to the signals for state 1 and state 2. Intriguingly, these residues are located not only in the switch regions and their neighbors but also in the rigidly structured regions, suggesting that global structural rearrangements occur during the state interconversion. The backbone dynamics of each state show that the switch loops in state 1 are dynamically mobile on the picosecond to nanosecond time scale, and these mobilities are significantly reduced in state 2. These results suggest that multiconformations existing in state 1 are mostly deselected upon the transition toward state 2 induced by the effector binding.	[Shima, Fumi; Yoshikawa, Yoko; Muraoka, Shin; Ijiri, Yuichi; Shirono, Tomoya; Kataoka, Tohru] Kobe Univ, Grad Sch Med, Div Mol Biol, Dept Biochem & Mol Biol,Chuo Ku, Kobe, Hyogo 6500017, Japan; [Araki, Mitsugu; Nagahara, Yuka; Tamura, Atsuo] Kobe Univ, Grad Sch Sci, Dept Chem, Nada Ku, Kobe, Hyogo 6578501, Japan	Kobe University; Kobe University	Kataoka, T (corresponding author), Kobe Univ, Grad Sch Med, Div Mol Biol, Dept Biochem & Mol Biol,Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	kataoka@people.kobe-u.ac.jp; tamuatsu@kobe-u.ac.jp	Araki, Mitsugu/C-7470-2016	Tamura, Atsuo/0000-0001-8238-8851	Ministry of Education, Science, Sports, and Culture of Japan [17014061, 18057014, A08]; National Institute of Biomedical Innovation [06-3]; Grants-in-Aid for Scientific Research [23390071] Funding Source: KAKEN	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid for Scientific Research in Priority Areas 17014061 and 18057014 and Global COE Program A08 from the Ministry of Education, Science, Sports, and Culture of Japan and by Grant for the Program for Promotion of Fundamental Studies of Health Sciences 06-3 from the National Institute of Biomedical Innovation.	Boriack-Sjodin PA, 1998, NATURE, V394, P337, DOI 10.1038/28548; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cavanagh J., 1996, PROTEIN NMR SPECTROS; Cherfils J, 1999, TRENDS BIOCHEM SCI, V24, P306, DOI 10.1016/S0968-0004(99)01429-2; Corbett KD, 2001, TRENDS BIOCHEM SCI, V26, P710, DOI 10.1016/S0968-0004(01)01974-0; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Fenwick RB, 2009, BIOCHEMISTRY-US, V48, P2192, DOI 10.1021/bi802129d; Ford B, 2005, J BIOL CHEM, V280, P25697, DOI 10.1074/jbc.M502240200; Geyer M, 1996, BIOCHEMISTRY-US, V35, P10308, DOI 10.1021/bi952858k; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hu JS, 1997, BIOCHEMISTRY-US, V36, P5045, DOI 10.1021/bi963010e; Huang L, 1998, NAT STRUCT BIOL, V5, P422, DOI 10.1038/nsb0698-422; Kalbitzer HR, 2009, J AM CHEM SOC, V131, P16714, DOI 10.1021/ja904314q; KAY LE, 1992, J MAGN RESON, V97, P359, DOI 10.1016/0022-2364(92)90320-7; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Kern D, 1999, NATURE, V402, P894, DOI 10.1038/47273; Kobayashi C, 2010, BIOPHYS J, V99, P3726, DOI 10.1016/j.bpj.2010.09.063; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; KRAULIS PJ, 1994, BIOCHEMISTRY-US, V33, P3515, DOI 10.1021/bi00178a008; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee AL, 2000, NAT STRUCT BIOL, V7, P72; Liao JL, 2008, BIOCHEM BIOPH RES CO, V369, P327, DOI 10.1016/j.bbrc.2008.01.169; Loh AP, 2001, BIOCHEMISTRY-US, V40, P4590, DOI 10.1021/bi002418f; Matsumoto K, 2011, J BIOL CHEM, V286, P15403, DOI 10.1074/jbc.M110.204933; O'Connor C, 2008, BIOCHEMISTRY-US, V47, P10244, DOI 10.1021/bi801076c; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; PAI EF, 1990, EMBO J, V9, P2351, DOI 10.1002/j.1460-2075.1990.tb07409.x; Shima F, 2010, J BIOL CHEM, V285, P22696, DOI 10.1074/jbc.M110.125161; Spoerner M, 2004, FEBS LETT, V578, P305, DOI 10.1016/j.febslet.2004.11.020; Spoerner M, 2001, P NATL ACAD SCI USA, V98, P4944, DOI 10.1073/pnas.081441398; Spoerner M, 2007, FEBS J, V274, P1419, DOI 10.1111/j.1742-4658.2007.05681.x; Spoerner M, 2010, J BIOL CHEM, V285, P39768, DOI 10.1074/jbc.M110.145235; Tamura A, 1997, J MOL BIOL, V273, P1048, DOI 10.1006/jmbi.1997.1368; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Wand AJ, 2001, NAT STRUCT BIOL, V8, P926, DOI 10.1038/nsb1101-926; Wohlgemuth S, 2005, J MOL BIOL, V348, P741, DOI 10.1016/j.jmb.2005.02.048; Ye M, 2005, J BIOL CHEM, V280, P31267, DOI 10.1074/jbc.M505503200	40	72	75	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39644	39653		10.1074/jbc.M111.227074	http://dx.doi.org/10.1074/jbc.M111.227074			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21930707	hybrid, Green Published			2022-12-25	WOS:000296759800081
J	Zanzoni, S; Assfalg, M; Giorgetti, A; D'Onofrio, M; Molinari, H				Zanzoni, Serena; Assfalg, Michael; Giorgetti, Alejandro; D'Onofrio, Mariapina; Molinari, Henriette			Structural Requirements for Cooperativity in Ileal Bile Acid-binding Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING; SITE SELECTIVITY; NMR; DETERMINANTS; CRYSTALLOGRAPHY; IDENTIFICATION; ACTIVATION; EVOLUTION; ALLOSTERY; DYNAMICS	Ileal bile acid-binding proteins (I-BABP), belonging to the family of intracellular lipid-binding proteins, control bile acid trafficking in enterocytes and participate in regulating the homeostasis of these cholesterol-derived metabolites. I-BABP orthologues share the same structural fold and are able to host up to two ligands in their large internal cavities. However variations in the primary sequences determine differences in binding properties such as the degree of binding cooperativity. To investigate the molecular requirements for cooperativity we adopted a gain-of-function approach, exploring the possibility to turn the noncooperative chicken I-BABP (cI-BABP) into a cooperative mutant protein. To this aim we first solved the solution structure of cI-BABP in complex with two molecules of the physiological ligand glycochenodeoxycholate. A comparative structural analysis with closely related members of the same protein family provided the basis to design a double mutant (H99Q/A101S cI-BABP) capable of establishing a cooperative binding mechanism. Molecular dynamics simulation studies of the wild type and mutant complexes and essential dynamics analysis of the trajectories supported the role of the identified amino acid residues as hot spot mediators of communication between binding sites. The emerging picture is consistent with a binding mechanism that can be described as an extended conformational selection model.	[Zanzoni, Serena; Assfalg, Michael; Giorgetti, Alejandro; D'Onofrio, Mariapina; Molinari, Henriette] Univ Verona, Dept Biotechnol, I-37134 Verona, Italy; [Giorgetti, Alejandro] FZ Julich, German Res Sch Simulat Sci, D-52428 Julich, Germany; [Giorgetti, Alejandro] Rhein Westfal TH Aachen, D-52428 Julich, Germany	University of Verona; RWTH Aachen University	Molinari, H (corresponding author), Univ Verona, Dept Biotechnol, Str Le Grazie 15, I-37134 Verona, Italy.	henriette.molinari@univr.it	molinari, henriette/ABE-9775-2021; Molinari, Henriette/A-1695-2008	Molinari, Henriette/0000-0002-3678-130X; D'ONOFRIO, Mariapina/0000-0002-8699-0847; Giorgetti, Alejandro/0000-0001-8738-6150; Assfalg, Michael/0000-0001-9331-3169	Ministero dell'Istruzione, dell'Universita e della Ricerca (Fondo per gli Investimenti della Ricerca di Base, Futuro in Ricerca) [RBFR08R7OU]; European Community [RII3-026145]; University of Verona; Cariverona Foundation; Netherlands Organization for Scientific Research [213010]	Ministero dell'Istruzione, dell'Universita e della Ricerca (Fondo per gli Investimenti della Ricerca di Base, Futuro in Ricerca); European Community(European Commission); University of Verona; Cariverona Foundation(Fondazione Cariverona); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Ministero dell'Istruzione, dell'Universita e della Ricerca (Fondo per gli Investimenti della Ricerca di Base, Futuro in Ricerca 2008, Grant RBFR08R7OU).; We thank Simona Tomaselli for help with structure calculations. We thank the European Community (EU-NMR Contract RII3-026145) for access to the HWB-NMR facility at Birmingham, United Kingdom; the Consorzio Interuniversitario di Risonanze Magnetiche di Metalloproteine Paramagnetiche (CIRMMP) for access to high field spectrometers; the e-NMR project (a European FP7 e-Infrastructure grant, Contract 213010), supported by the national GRID Initiatives of Italy, Germany, and the Dutch BiG Grid project (Netherlands Organization for Scientific Research) for the use of Web server facilities; and the University of Verona and the Cariverona Foundation for financial support for the acquisition of anNMR spectrometer and cryoprobe.	Argmann Carmen A, 2006, Curr Protoc Mol Biol, VChapter 29, DOI 10.1002/0471142727.mb29a03s75; Ayers SD, 2007, BIOCHEMISTRY-US, V46, P6744, DOI 10.1021/bi700047a; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Capaldi S, 2009, J MOL BIOL, V385, P99, DOI 10.1016/j.jmb.2008.10.007; Chau CD, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.016701; Cogliati C, 2010, CHEM-EUR J, V16, P11300, DOI 10.1002/chem.201000498; Csermely P, 2010, TRENDS BIOCHEM SCI, V35, P539, DOI 10.1016/j.tibs.2010.04.009; Cui Q, 2008, PROTEIN SCI, V17, P1295, DOI 10.1110/ps.03259908; DARDEN TA, 1993, ENVIRON HEALTH PERSP, V101, P410, DOI 10.2307/3431897; Daura X, 1999, PROTEINS, V36, P542, DOI 10.1002/(SICI)1097-0134(19990901)36:4<542::AID-PROT17>3.0.CO;2-M; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Eliseo T, 2007, BIOCHEMISTRY-US, V46, P12557, DOI 10.1021/bi7013085; ELKIN RG, 1990, COMP BIOCHEM PHYS B, V96, P157, DOI 10.1016/0305-0491(90)90356-X; EUFRI D, 1989, J MOL GRAPHICS, V7, P165, DOI 10.1016/0263-7855(89)80021-9; Eufri D., 1989, J MOL GRAPHICS, V7, P158; Guariento M, 2008, PROTEINS, V70, P462, DOI 10.1002/prot.21518; Guariento M, 2010, BIOCHEM J, V425, P413, DOI 10.1042/BJ20091209; Guntert Peter, 2004, Methods Mol Biol, V278, P353; HAGEY LR, 1994, J LIPID RES, V35, P2041; Hamilton JA, 2004, PROG LIPID RES, V43, P177, DOI 10.1016/j.plipres.2003.09.002; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Houten SM, 2006, CELL METAB, V4, P423, DOI 10.1016/j.cmet.2006.11.006; Houten SM, 2006, EMBO J, V25, P1419, DOI 10.1038/sj.emboj.7601049; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ijare OB, 2005, LIPIDS, V40, P1031, DOI 10.1007/s11745-005-1466-1; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kouvatsos N, 2007, J MOL BIOL, V371, P1365, DOI 10.1016/j.jmb.2007.06.024; Kouvatsos N, 2006, CHEM COMMUN, P4623, DOI 10.1039/b610130e; Kramer W, 2001, J BIOL CHEM, V276, P7291, DOI 10.1074/jbc.M006877200; Kurz M, 2003, PROTEINS, V50, P312, DOI 10.1002/prot.10289; Lew JL, 2004, J BIOL CHEM, V279, P8856, DOI 10.1074/jbc.M306422200; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Nei M, 2000, MOL EVOLUTION PHYLOG; Nunez S, 2006, J PHYS CHEM A, V110, P463, DOI 10.1021/jp051277u; Pedo M, 2009, PROTEINS, V77, P718, DOI 10.1002/prot.22496; Ragona L, 2006, J BIOL CHEM, V281, P9697, DOI 10.1074/jbc.M513003200; Reichheld SE, 2009, P NATL ACAD SCI USA, V106, P22263, DOI 10.1073/pnas.0911566106; RZHETSKY A, 1992, MOL BIOL EVOL, V9, P945; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schaap FG, 2002, MOL CELL BIOCHEM, V239, P69, DOI 10.1023/A:1020519011939; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Smock RG, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.65; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tochtrop GP, 2004, J AM CHEM SOC, V126, P11024, DOI 10.1021/ja047589c; Tochtrop GP, 2003, BIOCHEMISTRY-US, V42, P11561, DOI 10.1021/bi0346502; Tochtrop GP, 2002, P NATL ACAD SCI USA, V99, P1847, DOI 10.1073/pnas.012379199; Toke O, 2006, BIOCHEMISTRY-US, V45, P727, DOI 10.1021/bi051781p; Toke O, 2007, BIOCHEMISTRY-US, V46, P5427, DOI 10.1021/bi700030r; Tornaselli S, 2008, J MED CHEM, V51, P6782, DOI 10.1021/jm800820b; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; van Dijk ADJ, 2006, BIOINFORMATICS, V22, P2340, DOI 10.1093/bioinformatics/btl395; VEERKAMP JH, 1995, PROG LIPID RES, V34, P17, DOI 10.1016/0163-7827(94)00005-7; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Zuckerkandl E., 1965, EVOLVING GENES PROTE, P97, DOI DOI 10.1016/B978-1-4832-2734-4.50017-6	57	16	16	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39307	39317		10.1074/jbc.M111.261099	http://dx.doi.org/10.1074/jbc.M111.261099			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21917914	Green Published, hybrid			2022-12-25	WOS:000296759800049
J	Zierler, S; Yao, GM; Zhang, Z; Kuo, WC; Porzgen, P; Penner, R; Horgen, FD; Fleig, A				Zierler, Susanna; Yao, Guangmin; Zhang, Zheng; Kuo, W. Cedric; Poerzgen, Peter; Penner, Reinhold; Horgen, F. David; Fleig, Andrea			Waixenicin A Inhibits Cell Proliferation through Magnesium-dependent Block of Transient Receptor Potential Melastatin 7 (TRPM7) Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANOXIC NEURONAL DEATH; NORDIHYDROGUAIARETIC ACID; ION-CHANNEL; ATRIAL-FIBRILLATION; MG2+ HOMEOSTASIS; CALCIUM; CURRENTS; ENTRY; CRAC; LIPOXYGENASE	Transient receptor potential melastatin 7 (TRPM7) channels represent the major magnesium-uptake mechanism in mammalian cells and are key regulators of cell growth and proliferation. They are expressed abundantly in a variety of human carcinoma cells controlling survival, growth, and migration. These characteristics are the basis for recent interest in the channel as a target for cancer therapeutics. We screened a chemical library of marine organism-derived extracts and identified waixenicin A from the soft coral Sarcothelia edmondsoni as a strong inhibitor of overexpressed and native TRPM7. Waixenicin A activity was cytosolic and potentiated by intracellular free magnesium (Mg2+) concentration. Mutating a Mg2+ binding site on the TRPM7 kinase domain reduced the potency of the compound, whereas kinase deletion enhanced its efficacy independent of Mg2+. Waixenicin A failed to inhibit the closely homologous TRPM6 channel and did not significantly affect TRPM2, TRPM4, and Ca2+ release-activated Ca2+ current channels. Therefore, waixenicin A represents the first potent and relatively specific inhibitor of TRPM7 ion channels. Consistent with TRPM7 inhibition, the compound blocked cell proliferation in human Jurkat T-cells and rat basophilic leukemia cells. Based on the ability of the compound to inhibit cell proliferation through Mg2+-dependent block of TRPM7, waixenicin A, or structural analogs may have cancer-specific therapeutic potential, particularly because certain cancers accumulate cytosolic Mg2+.	[Zierler, Susanna; Zhang, Zheng; Penner, Reinhold; Fleig, Andrea] Univ Hawaii, Queens Med Ctr, Ctr Biomed Res, Honolulu, HI 96813 USA; [Zierler, Susanna; Zhang, Zheng; Penner, Reinhold; Fleig, Andrea] Univ Hawaii, John A Burns Sch Med, Honolulu, HI 96813 USA; [Yao, Guangmin; Kuo, W. Cedric; Poerzgen, Peter; Horgen, F. David] Hawaii Pacific Univ, Dept Nat Sci, Lab Marine Biol Chem, Kaneohe, HI 96744 USA	The Queen's Medical Center; University of Hawaii System; University of Hawaii System	Fleig, A (corresponding author), Univ Hawaii, Queens Med Ctr, Ctr Biomed Res, Honolulu, HI 96813 USA.	afleig@hawaii.edu	Zierler, Susanna/E-2070-2012; Horgen, David/N-1393-2016	Zierler, Susanna/0000-0002-4684-0385; Horgen, David/0000-0001-9409-3030; Penner, Reinhold/0000-0002-5366-1537	National Institutes of Health [P01GM078195, P20 RR-016467]; University of Hawaii [5G12 RR003061-22]; American Society of Pharmacognosy; Austrian Science Fund [J2784]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003061, P20RR016467] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM078195] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Hawaii; American Society of Pharmacognosy; Austrian Science Fund(Austrian Science Fund (FWF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P01GM078195 (to A. F.), P20 RR-016467 (to F. D. H.), and 5G12 RR003061-22 (University of Hawaii Imaging Core). This work was also supported by an American Society of Pharmacognosy Undergraduate Research Award (to W. C. K.) and Austrian Science Fund Grant J2784 (to S. Z.).	Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; Abed E, 2007, CELL PROLIFERAT, V40, P849, DOI 10.1111/j.1365-2184.2007.00476.x; Abed E, 2009, AM J PHYSIOL-CELL PH, V297, pC360, DOI 10.1152/ajpcell.00614.2008; Cao G, 2008, CURR OPIN NEPHROL HY, V17, P373, DOI 10.1097/MNH.0b013e328303e184; Castillo B, 2010, J BIOMOL SCREEN, V15, P498, DOI 10.1177/1087057110368294; Chen HC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011161; Chen JP, 2010, CELL CALCIUM, V47, P425, DOI 10.1016/j.ceca.2010.03.003; Chubanov V, 2005, PFLUG ARCH EUR J PHY, V451, P228, DOI 10.1007/s00424-005-1470-y; Coburn RF, 2009, J CELL PHYSIOL, V221, P544, DOI 10.1002/jcp.21899; COVAL SJ, 1984, TETRAHEDRON, V40, P3823, DOI 10.1016/S0040-4020(01)88813-X; DeHaven WI, 2008, J BIOL CHEM, V283, P19265, DOI 10.1074/jbc.M801535200; Demeuse P, 2006, J GEN PHYSIOL, V127, P421, DOI 10.1085/jgp.200509410; Du JY, 2010, CIRC RES, V106, P992, DOI 10.1161/CIRCRESAHA.109.206771; Gong YZ, 2008, EUR J PHARMACOL, V600, P18, DOI 10.1016/j.ejphar.2008.10.010; Guilbert A, 2009, AM J PHYSIOL-CELL PH, V297, pC493, DOI 10.1152/ajpcell.00624.2008; Hatton CJ, 1997, BRIT J PHARMACOL, V122, P923, DOI 10.1038/sj.bjp.0701452; Hermosura MC, 2002, J PHYSIOL-LONDON, V539, P445, DOI 10.1113/jphysiol.2001.013361; Inoue K, 2010, J BIOL CHEM, V285, P7430, DOI 10.1074/jbc.M109.040485; Jiang J, 2007, CANCER RES, V67, P10929, DOI 10.1158/0008-5472.CAN-07-1121; Jin J, 2008, SCIENCE, V322, P756, DOI 10.1126/science.1163493; Kerschbaum HH, 2003, BIOPHYS J, V84, P2293, DOI 10.1016/S0006-3495(03)75035-8; Kim BJ, 2008, CANCER SCI, V99, P2502, DOI 10.1111/j.1349-7006.2008.00982.x; KORN SJ, 1990, MOL PHARMACOL, V38, P524; Kozak JA, 2002, J GEN PHYSIOL, V120, P221, DOI 10.1085/jgp.20028601; Kucherenko YV, 2010, J MEMBRANE BIOL, V237, P93, DOI 10.1007/s00232-010-9310-1; Lang G, 2006, J NAT PROD, V69, P621, DOI 10.1021/np0504917; Lange I, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000278; Launay P, 2002, CELL, V109, P397, DOI 10.1016/S0092-8674(02)00719-5; Li M, 2006, J GEN PHYSIOL, V127, P525, DOI 10.1085/jgp.200609502; Li MK, 2009, AM J PHYSIOL-CELL PH, V297, pC1445, DOI 10.1152/ajpcell.00259.2009; Liang JY, 2003, CELL CYCLE, V2, P339, DOI 10.4161/cc.2.4.433; MASTROCOLA T, 1991, BIOCHIM BIOPHYS ACTA, V1097, P275, DOI 10.1016/0925-4439(91)90081-J; Matsuda H, 2010, J PHYSIOL-LONDON, V588, P4673, DOI 10.1113/jphysiol.2010.194480; Monteilh-Zoller MK, 2003, J GEN PHYSIOL, V121, P49, DOI 10.1085/jgp.20028740; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Nicotera P, 2003, CELL, V115, P768, DOI 10.1016/S0092-8674(03)01019-5; Parnas M, 2009, CELL CALCIUM, V45, P300, DOI 10.1016/j.ceca.2008.11.009; Peinelt C, 2008, J PHYSIOL-LONDON, V586, P3061, DOI 10.1113/jphysiol.2008.151365; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; Ryazanova LV, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1108; Ryazanova LV, 2004, J BIOL CHEM, V279, P3708, DOI 10.1074/jbc.M308820200; Sahni J, 2008, CELL METAB, V8, P84, DOI 10.1016/j.cmet.2008.06.002; Schmitz C, 2003, CELL, V114, P191, DOI 10.1016/S0092-8674(03)00556-7; Shtivelman E, 2002, CURR BIOL, V12, P919, DOI 10.1016/S0960-9822(02)00843-6; Sontia B, 2008, HYPERTENSION, V51, P915, DOI 10.1161/HYPERTENSIONAHA.107.100339; Starkus JG, 2010, J PHYSIOL-LONDON, V588, P1227, DOI 10.1113/jphysiol.2010.187476; Sun HS, 2009, NAT NEUROSCI, V12, P1300, DOI 10.1038/nn.2395; Szydlowska K, 2010, CELL CALCIUM, V47, P122, DOI 10.1016/j.ceca.2010.01.003; Tani D, 2007, CELL CALCIUM, V41, P249, DOI 10.1016/j.ceca.2006.07.004; Tseveleki V, 2010, GENOMICS, V96, P82, DOI 10.1016/j.ygeno.2010.04.004; Voets T, 2004, J BIOL CHEM, V279, P19, DOI 10.1074/jbc.M311201200; Wolf FI, 2008, MAGNESIUM RES, V21, P83; Wolf FI, 2009, CANCER TREAT REV, V35, P378, DOI 10.1016/j.ctrv.2009.01.003; Wykes RCE, 2007, J IMMUNOL, V179, P4045, DOI 10.4049/jimmunol.179.6.4045; Yamamoto S, 2008, NAT MED, V14, P738, DOI 10.1038/nm1758; Yue LX, 2011, CARDIOVASC RES, V89, P744, DOI 10.1093/cvr/cvq329; Zhang SYL, 2008, J BIOL CHEM, V283, P17662, DOI 10.1074/jbc.M801536200	57	110	114	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39328	39335		10.1074/jbc.M111.264341	http://dx.doi.org/10.1074/jbc.M111.264341			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21926172	Green Published, hybrid			2022-12-25	WOS:000296759800051
J	Aboulwafa, M; Saier, MH				Aboulwafa, Mohammad; Saier, Milton H., Jr.			Biophysical Studies of the Membrane-Embedded and Cytoplasmic Forms of the Glucose-Specific Enzyme II of the E. coli Phosphotransferase System (PTS)	PLOS ONE			English	Article							PHOSPHATE SUGAR TRANSPHOSPHORYLATION; RECOGNITION PARTICLE RECEPTOR; DYNAMIC LIGHT-SCATTERING; ESCHERICHIA-COLI; ANIONIC PHOSPHOLIPIDS; IN-VIVO; VECTORIAL TRANSPHOSPHORYLATION; SPIROCHAETA-AURANTIA; PROTEIN-PROTEIN; PHOSPHOENOLPYRUVATE	The glucose Enzyme II transporter complex of the Escherichia coli phosphotransferase system (PTS) exists in at least two physically distinct forms: a membrane-integrated dimeric form, and a cytoplasmic monomeric form, but little is known about the physical states of these enzyme forms. Six approaches were used to evaluate protein-protein and protein-lipid interactions in this system. Fluorescence energy transfer (FRET) using MBP-II(Glc)-YFP and MBP-II(Glc)-CFP revealed that the homodimeric Enzyme II complex in cell membranes is stable (FRET(-)) but can be dissociated and reassociated to the heterodimer only in the presence of Triton X100 (FRET(+)). The monomeric species could form a heterodimeric species (FRET(+)) by incubation and purification without detergent exposure. Formaldehyde cross linking studies, conducted both in vivo and in vitro, revealed that the dimeric MBP-II(Glc) activity decreased dramatically with increasing formaldehyde concentrations due to both aggregation and activity loss, but that the monomeric MBP-II(Glc) retained activity more effectively in response to the same formaldehyde treatments, and little or no aggregation was observed. Electron microscopy of MBP-II(Glc) indicated that the dimeric form is larger than the monomeric form. Dynamic light scattering confirmed this conclusion and provided quantitation. NMR analyses provided strong evidence that the dimeric form is present primarily in a lipid bilayer while the monomeric form is present as micelles. Finally, lipid analyses of the different fractions revealed that the three lipid species (PE, PG and CL) are present in all fractions, but the monomeric micellar structure contains a higher percentage of anionic lipids (PG & CL) while the dimeric bilayer form has a higher percentage of zwitterion lipids (PE). Additionally, evidence for a minor dimeric micellar species, possibly an intermediate between the monomeric micellar and the dimeric bilayer forms, is presented. These results provide convincing evidence for interconvertible physical forms of Enzyme-II(Glc)	[Aboulwafa, Mohammad; Saier, Milton H., Jr.] Univ Calif San Diego, Dept Mol Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Aboulwafa, M (corresponding author), Ain Shams Univ, Dept Microbiol & Immunol, Fac Pharm, Cairo, Egypt.	msaier@ucsd.edu	Aboulwafa, Mohammad/V-5498-2018	Aboulwafa, Mohammad/0000-0002-0828-1420	Institute of General Medical Services [GM077402]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077402] Funding Source: NIH RePORTER	Institute of General Medical Services; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by NIH grant GM077402 from the Institute of General Medical Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboulwafa M, 2004, J BACTERIOL, V186, P8453, DOI 10.1128/JB.186.24.8453-8462.2004; Aboulwafa M, 2003, MOL MICROBIOL, V48, P131, DOI 10.1046/j.1365-2958.2003.03394.x; Aboulwafa M, 2002, RES MICROBIOL, V153, P667, DOI 10.1016/S0923-2508(02)01376-1; Aboulwafa M, 2008, J BASIC MICROB, V48, P3, DOI 10.1002/jobm.200700263; Aboulwafa M, 2007, J MOL MICROB BIOTECH, V12, P263, DOI 10.1159/000099647; Albertazzi L, 2009, PHOTOCHEM PHOTOBIOL, V85, P287, DOI 10.1111/j.1751-1097.2008.00435.x; Angelini S, 2006, J CELL BIOL, V174, P715, DOI 10.1083/jcb.200606093; Clegg R. M, 1996, FLUORESCENCE IMAGING, V137, P179; Crawford R, 2011, INT J PHARMACEUT, V403, P237, DOI 10.1016/j.ijpharm.2010.10.025; CULLIS PR, 1979, BIOCHIM BIOPHYS ACTA, V559, P399, DOI 10.1016/0304-4157(79)90012-1; Dahneke B.E., 1983, MEASUREMENT SUSPENDE; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; de Leeuw E, 2000, EMBO J, V19, P531, DOI 10.1093/emboj/19.4.531; DELEIJ L, 1977, BIOCHIM BIOPHYS ACTA, V471, P92, DOI 10.1016/0005-2736(77)90396-0; Diller A, 2009, BIOCHIMIE, V91, P744, DOI 10.1016/j.biochi.2009.02.003; Dowhan W, 1997, ANNU REV BIOCHEM, V66, P199, DOI 10.1146/annurev.biochem.66.1.199; Fankhauser F, 2010, KLIN MONATSBL AUGENH, V227, P194, DOI 10.1055/s-0028-1109740; FOLCH J, 1957, J BIOL CHEM, V226, P497; Goedhart J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001011; Herzberg C, 2007, PROTEOMICS, V7, P4032, DOI 10.1002/pmic.200700491; HITCHCOCK PB, 1974, P NATL ACAD SCI USA, V71, P3036, DOI 10.1073/pnas.71.8.3036; ISO, 1996, ISO13321; Kaszuba M, 2008, J NANOPART RES, V10, P823, DOI 10.1007/s11051-007-9317-4; Kitchen JL, 1999, BIOCHEMISTRY-US, V38, P6213, DOI 10.1021/bi982733q; Kleinschmidt JH, 2002, BIOPHYS J, V83, P994, DOI 10.1016/S0006-3495(02)75225-9; Kurdistani SK, 2003, METHODS, V31, P90, DOI 10.1016/S1046-2023(03)00092-6; KUSTERS R, 1991, J BIOL CHEM, V266, P8659; LEONARD JE, 1983, J BIOL CHEM, V258, P757; Leong PA, 2010, METHOD ENZYMOL, V482, P369, DOI 10.1016/S0076-6879(10)82015-4; LILL R, 1990, CELL, V60, P271, DOI 10.1016/0092-8674(90)90742-W; Luckham PF, 1999, J COLLOID INTERF SCI, V220, P347, DOI 10.1006/jcis.1999.6515; Luirink J, 2005, ANNU REV MICROBIOL, V59, P329, DOI 10.1146/annurev.micro.59.030804.121246; Matsumoto K, 2001, MOL MICROBIOL, V39, P1427, DOI 10.1046/j.1365-2958.2001.02320.x; Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200; Mircheva M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-76; Orlova EV, 2010, METHOD ENZYMOL, V482, P321, DOI [10.1016/S0076-6879(10)82013_0, 10.1016/S0076-6879(10)82013-0]; Pecora R, 1985, BER BUNSEN PHYS CHEM, DOI DOI 10.1002/BBPC.19870910455; REPHAELI AW, 1978, J BIOL CHEM, V253, P7595; ROEPE PD, 1990, BIOCHEMISTRY-US, V29, P2572, DOI 10.1021/bi00462a020; SAIER MH, 1981, J BACTERIOL, V145, P391, DOI 10.1128/JB.145.1.391-397.1981; SAIER MH, 1976, J BIOL CHEM, V251, P3834; SAIER MH, 1977, J BIOL CHEM, V252, P8908; SAIER MH, 1977, J BIOL CHEM, V252, P8899; SAIER MH, 1977, J BIOL CHEM, V252, P8890; Sambrook J., 2002, MOL CLONING LAB MANU; SEN A, 1988, CHEM PHYS LIPIDS, V47, P109, DOI 10.1016/0009-3084(88)90079-5; SHIBUYA I, 1992, PROG LIPID RES, V31, P245, DOI 10.1016/0163-7827(92)90010-G; SHIN TB, 1991, BIOCHEMISTRY-US, V30, P7491, DOI 10.1021/bi00244a018; SLATER SJ, 1993, BIOCHEMISTRY-US, V32, P3714, DOI 10.1021/bi00065a025; ULBRANDT ND, 1992, J BIOL CHEM, V267, P15184; Valianpour F, 2002, CLIN CHEM, V48, P1390; Zhang YP, 1997, BIOPHYS J, V72, P779, DOI 10.1016/S0006-3495(97)78712-5	52	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24088	10.1371/journal.pone.0024088	http://dx.doi.org/10.1371/journal.pone.0024088			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21935376	gold, Green Published, Green Submitted			2022-12-25	WOS:000295041700011
J	Goldshmit, Y; Spanevello, MD; Tajouri, S; Li, L; Rogers, F; Pearse, M; Galea, M; Bartlett, PF; Boyd, AW; Turnley, AM				Goldshmit, Yona; Spanevello, Mark D.; Tajouri, Sophie; Li, Li; Rogers, Fiona; Pearse, Martin; Galea, Mary; Bartlett, Perry F.; Boyd, Andrew W.; Turnley, Ann M.			EphA4 Blockers Promote Axonal Regeneration and Functional Recovery Following Spinal Cord Injury in Mice	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; RECEPTOR TYROSINE KINASES; NEURITE OUTGROWTH; EPHA4-DEFICIENT MICE; UP-REGULATION; RHO KINASE; GROWTH; EXPRESSION; INHIBITION; CNS	Upregulation and activation of developmental axon guidance molecules, such as semaphorins and members of the Eph receptor tyrosine kinase family and their ligands, the ephrins, play a role in the inhibition of axonal regeneration following injury to the central nervous system. Previously we have demonstrated in a knockout model that axonal regeneration following spinal cord injury is promoted in the absence of the axon guidance protein EphA4. Antagonism of EphA4 was therefore proposed as a potential therapy to promote recovery from spinal cord injury. To further assess this potential, two soluble recombinant blockers of EphA4, unclustered ephrin-A5-Fc and EphA4-Fc, were examined for their ability to promote axonal regeneration and to improve functional outcome following spinal cord hemisection in wildtype mice. A 2-week administration of either of these blockers following spinal cord injury was sufficient to promote substantial axonal regeneration and functional recovery by 5 weeks following injury. Both inhibitors produced a moderate reduction in astrocytic gliosis, indicating that much of the effect of the blockers may be due to promotion of axon growth. These studies provide definitive evidence that soluble inhibitors of EphA4 function offer considerable therapeutic potential for the treatment of spinal cord injury and may have broader potential for the treatment of other central nervous system injuries.	[Goldshmit, Yona; Turnley, Ann M.] Univ Melbourne, Ctr Neurosci, Parkville, Vic 3052, Australia; [Spanevello, Mark D.; Boyd, Andrew W.] Queensland Inst Med Res, Herston, Qld 4006, Australia; [Spanevello, Mark D.; Tajouri, Sophie; Li, Li; Rogers, Fiona; Bartlett, Perry F.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Boyd, Andrew W.] Univ Queensland, Dept Med, Brisbane, Qld 4000, Australia; [Pearse, Martin] CSL Ltd, Parkville, Vic, Australia; [Galea, Mary] Univ Melbourne, Physiotherapy Dept, Parkville, Vic 3052, Australia	University of Melbourne; QIMR Berghofer Medical Research Institute; University of Queensland; University of Queensland; CSL; University of Melbourne	Goldshmit, Y (corresponding author), Monash Univ, Australian Regenerat Med Inst, Melbourne, Vic 3004, Australia.	p.bartlett@uq.edu.au; Andrew.Boyd@qimr.edu.au; turnley@unimelb.edu.au	Galea, Mary/F-4242-2010; Bartlett, Perry/F-3813-2012; Li, Li/D-3641-2016	Galea, Mary/0000-0003-0045-7978; Li, Li/0000-0001-6545-858X; Turnley, Ann/0000-0002-8442-127X	National Health and Medical Research Council of Australia [ID 351479, 511212]; SpinalCure Australia (Lisa Palmer Spinal Research Consortium); CSL Ltd. [PCT/AU2005/001363]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); SpinalCure Australia (Lisa Palmer Spinal Research Consortium); CSL Ltd.	National Health and Medical Research Council of Australia (ID 351479 and 511212), SpinalCure Australia (Lisa Palmer Spinal Research Consortium) and CSL Ltd. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Martin Pearse is an employee of CSL Limited who, for the studies described in this manuscript, coordinated the production and quality control of gram quantities of the EphA4-Fc blocker from the EphA4-Fc expression construct as detailed in the methods.; The authors have read the journal's policy and have the following conflicts: Martin Pearse is an employee of CSL Limited and who, for the studies described in this manuscript, coordinated the production and quality control of gram quantities of the EphA4-Fc blocker from the EphA4-Fc expression construct as detailed in the methods and provided by Andrew Boyd. Yona Goldshmit, Ann Turnley, Mary Galea, Andrew Boyd and Perry Bartlett have submitted a patent application regarding the use of EphA4 blockers in neural injury, which was sponsored by CSL Ltd (PCT/AU2005/001363). This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Adams RH, 2000, TRENDS CARDIOVAS MED, V10, P183, DOI 10.1016/S1050-1738(00)00046-3; Benson MD, 2005, P NATL ACAD SCI USA, V102, P10694, DOI 10.1073/pnas.0504021102; Bowden TA, 2009, STRUCTURE, V17, P1386, DOI 10.1016/j.str.2009.07.018; Brantley DM, 2002, ONCOGENE, V21, P7011, DOI 10.1038/sj.onc.1205679; Brosamle C, 2000, J NEUROSCI, V20, P8061; Bundesen LQ, 2003, J NEUROSCI, V23, P7789; Cai D, 2001, J NEUROSCI, V21, P4731, DOI 10.1523/JNEUROSCI.21-13-04731.2001; Case LC, 2005, CURR BIOL, V15, pR749, DOI 10.1016/j.cub.2005.09.008; Cruz-Orengo L, 2007, NEUROSCI LETT, V418, P49, DOI 10.1016/j.neulet.2007.03.015; Cruz-Orengo L, 2006, EXP NEUROL, V202, P421, DOI 10.1016/j.expneurol.2006.07.005; DAVIS S, 1994, SCIENCE, V266, P816, DOI 10.1126/science.7973638; Day BW, 2006, PROTEIN PEPTIDE LETT, V13, P193, DOI 10.2174/092986606775101625; De Winter F, 2002, EXP NEUROL, V175, P61, DOI 10.1006/exnr.2002.7884; Dergham P, 2002, J NEUROSCI, V22, P6570; Dubreuil CI, 2003, J CELL BIOL, V162, P233, DOI 10.1083/jcb.200301080; Ellezam B, 2002, PROG BRAIN RES, V137, P371; Fabes J, 2006, EUR J NEUROSCI, V23, P1721, DOI 10.1111/j.1460-9568.2006.04704.x; Fabes J, 2007, EUR J NEUROSCI, V26, P2496, DOI 10.1111/j.1460-9568.2007.05859.x; Fawcett JW, 2006, J NEUROTRAUM, V23, P371, DOI 10.1089/neu.2006.23.371; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Fournier AE, 2003, J NEUROSCI, V23, P1416, DOI 10.1523/JNEUROSCI.23-04-01416.2003; Fu Q, 2007, J NEUROSCI, V27, P4154, DOI 10.1523/JNEUROSCI.4353-06.2007; Goldshmit Y, 2004, J NEUROSCI, V24, P10064, DOI 10.1523/JNEUROSCI.2981-04.2004; Goldshmit Y, 2008, J NEUROTRAUM, V25, P449, DOI 10.1089/neu.2007.0392; Goldshmit Y, 2006, BRAIN RES REV, V52, P327, DOI 10.1016/j.brainresrev.2006.04.006; Goldshmit Y, 2006, J COMP NEUROL, V497, P864, DOI 10.1002/cne.21029; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; Herrmann JE, 2010, EXP NEUROL, V223, P582, DOI 10.1016/j.expneurol.2010.02.005; Himanen JP, 2004, NAT NEUROSCI, V7, P501, DOI 10.1038/nn1237; Himanen JP, 2003, TRENDS NEUROSCI, V26, P46, DOI 10.1016/S0166-2236(02)00005-X; Kaneko S, 2006, NAT MED, V12, P1380, DOI 10.1038/nm1505; Kuijper S, 2007, TRENDS CARDIOVAS MED, V17, P145, DOI 10.1016/j.tcm.2007.03.003; Lehmann M, 1999, J NEUROSCI, V19, P7537, DOI 10.1523/JNEUROSCI.19-17-07537.1999; Li JS, 2006, J NEUROSURG-SPINE, V4, P165, DOI 10.3171/spi.2006.4.2.165; Mautes AEM, 2000, PHYS THER, V80, P673, DOI 10.1093/ptj/80.7.673; Miranda JD, 1999, EXP NEUROL, V156, P218, DOI 10.1006/exnr.1998.7012; Miyashita T, 2009, J NEUROTRAUM, V26, P955, DOI 10.1089/neu.2008.0776; Munoz JJ, 2006, J IMMUNOL, V177, P804, DOI 10.4049/jimmunol.177.2.804; Murai KK, 2003, MOL CELL NEUROSCI, V24, P1000, DOI 10.1016/j.mcn.2003.08.006; Murai KK, 2003, J CELL SCI, V116, P2823, DOI 10.1242/jcs.00625; Niclou SP, 2006, J NEUROTRAUM, V23, P409, DOI 10.1089/neu.2006.23.409; Nikolic M, 2002, INT J BIOCHEM CELL B, V34, P731, DOI 10.1016/S1357-2725(01)00167-4; Ohta K, 1997, MECH DEVELOP, V64, P127, DOI 10.1016/S0925-4773(97)00056-7; Petros TJ, 2006, MOL CELL NEUROSCI, V32, P49, DOI 10.1016/j.mcn.2006.02.002; Puschmann TB, 2010, J NEUROCHEM, V113, P881, DOI 10.1111/j.1471-4159.2010.06655.x; Qin HN, 2010, J BIOL CHEM, V285, P644, DOI 10.1074/jbc.M109.064824; Sahin M, 2005, NEURON, V46, P191, DOI 10.1016/j.neuron.2005.01.030; Sandvig A, 2004, GLIA, V46, P225, DOI 10.1002/glia.10315; Shamah SM, 2001, CELL, V105, P233, DOI 10.1016/S0092-8674(01)00314-2; Stein E, 1998, GENE DEV, V12, P667, DOI 10.1101/gad.12.5.667; Steward O, 2003, J COMP NEUROL, V459, P1, DOI 10.1002/cne.10593; Vearing C, 2005, CANCER RES, V65, P6745, DOI 10.1158/0008-5472.CAN-05-0758; Wahl S, 2000, J CELL BIOL, V149, P263, DOI 10.1083/jcb.149.2.263; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Wang XX, 2009, J NEUROTRAUM, V26, P81, DOI 10.1089/neu.2007.0464; Willson CA, 2002, CELL TRANSPLANT, V11, P229; Wimmer-Kleikamp SH, 2004, J CELL BIOL, V164, P661, DOI 10.1083/jcb.200312001	57	93	103	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2011	6	9							e24636	10.1371/journal.pone.0024636	http://dx.doi.org/10.1371/journal.pone.0024636			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZV	21931787	Green Published, gold			2022-12-25	WOS:000295321800040
J	Hwang, CS; Sukalo, M; Batygin, O; Addor, MC; Brunner, H; Aytes, AP; Mayerle, J; Song, HK; Varshavsky, A; Zenker, M				Hwang, Cheol-Sang; Sukalo, Maja; Batygin, Olga; Addor, Marie-Claude; Brunner, Han; Perez Aytes, Antonio; Mayerle, Julia; Song, Hyun Kyu; Varshavsky, Alexander; Zenker, Martin			Ubiquitin Ligases of the N-End Rule Pathway: Assessment of Mutations in UBR1 That Cause the Johanson-Blizzard Syndrome	PLOS ONE			English	Article							TERMINAL ACETYLTRANSFERASE; DEGRADATION SIGNALS; CARDIOVASCULAR DEVELOPMENT; RECOGNITION COMPONENT; CYTOSOLIC PROTEINS; PROTEASOME SYSTEM; STRUCTURAL BASIS; MICE LACKING; DNA-REPAIR; E3	Background: Johanson-Blizzard syndrome (JBS; OMIM 243800) is an autosomal recessive disorder that includes congenital exocrine pancreatic insufficiency, facial dysmorphism with the characteristic nasal wing hypoplasia, multiple malformations, and frequent mental retardation. Our previous work has shown that JBS is caused by mutations in human UBR1, which encodes one of the E3 ubiquitin ligases of the N-end rule pathway. The N-end rule relates the regulation of the in vivo half-life of a protein to the identity of its N-terminal residue. One class of degradation signals (degrons) recognized by UBR1 are destabilizing N-terminal residues of protein substrates. Methodology/Principal Findings: Most JBS-causing alterations of UBR1 are nonsense, frameshift or splice-site mutations that abolish UBR1 activity. We report here missense mutations of human UBR1 in patients with milder variants of JBS. These single-residue changes, including a previously reported missense mutation, involve positions in the RING-H2 and UBR domains of UBR1 that are conserved among eukaryotes. Taking advantage of this conservation, we constructed alleles of the yeast Saccharomyces cerevisiae UBR1 that were counterparts of missense JBS-UBR1 alleles. Among these yeast Ubr1 mutants, one of them (H160R) was inactive in yeast-based activity assays, the other one (Q1224E) had a detectable but weak activity, and the third one (V146L) exhibited a decreased but significant activity, in agreement with manifestations of JBS in the corresponding JBS patients. Conclusions/Significance: These results, made possible by modeling defects of a human ubiquitin ligase in its yeast counterpart, verified and confirmed the relevance of specific missense UBR1 alleles to JBS, and suggested that a residual activity of a missense allele is causally associated with milder variants of JBS.	[Hwang, Cheol-Sang; Batygin, Olga; Varshavsky, Alexander] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Sukalo, Maja; Zenker, Martin] Univ Hosp, Inst Human Genet, Magdeburg, Germany; [Addor, Marie-Claude] CHU Vaudois, Serv Genet Med, Lausanne, Switzerland; [Brunner, Han] Univ Med Ctr Nijmegen, Dept Human Genet, Nijmegen, Netherlands; [Perez Aytes, Antonio] Fdn Hosp La Fe, Grp Invest Perinatol, Inst Invest Sanitari, Valencia, Spain; [Mayerle, Julia] Univ Hosp, Dept Gastroenterol & Nutr, Greifswald, Germany; [Song, Hyun Kyu] Korea Univ, Sch Life Sci & Biotechnol, Seoul, South Korea; [Zenker, Martin] Univ Erlangen Nurnberg, Inst Human Genet, Univ Hosp Erlangen, D-8520 Erlangen, Germany	California Institute of Technology; University Hospital Magdeburg; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Radboud University Nijmegen; Korea University; University of Erlangen Nuremberg	Hwang, CS (corresponding author), Pohang Univ Sci & Technol, Dept Life Sci, Pohang, South Korea.	avarsh@caltech.edu; martin.zenker@med.ovgu.de	Brunner, Han/C-9928-2013; Mayerle, Julia/W-7907-2019; Song, Hyun Kyu/D-6763-2016; Hwang, Cheol-Sang/Q-7391-2019	Song, Hyun Kyu/0000-0001-5684-4059; Hwang, Cheol-Sang/0000-0002-0105-5957; Perez-Aytes, Antonio/0000-0003-3401-6943; Mayerle, Julia/0000-0002-3666-6459	German Research Foundation (DFG) [ZE 5242-3, MA 4115/1-3]; Korea Research Foundation [2008-313-C00521]; March of Dimes Foundation; National Institutes of Health (NIH) [GM031530, DK039520]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039520, R37DK039520, R56DK039520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031530] Funding Source: NIH RePORTER	German Research Foundation (DFG)(German Research Foundation (DFG)); Korea Research Foundation(National Research Foundation of Korea); March of Dimes Foundation(March of Dimes); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the German Research Foundation (DFG) grant ZE 5242-3 to M.Z. and grant MA 4115/1-3 to J.M.; by the Korea Research Foundation grant 2008-313-C00521 to H.K.S.; by a grant from the March of Dimes Foundation to A.V.; and by the National Institutes of Health (NIH) grants GM031530 and DK039520 to A.V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Dosari MS, 2008, AM J MED GENET A, V146A, P1875, DOI 10.1002/ajmg.a.32401; Alkhouri N, 2008, WORLD J GASTROENTERO, V14, P6863, DOI 10.3748/wjg.14.6863; An JY, 2006, P NATL ACAD SCI USA, V103, P6212, DOI 10.1073/pnas.0601700103; Arnesen T, 2009, P NATL ACAD SCI USA, V106, P8157, DOI 10.1073/pnas.0901931106; Ausubel F.M., 2006, CURRENT PROTOCOLS MO; BACHMAIR A, 1989, CELL, V56, P1019, DOI 10.1016/0092-8674(89)90635-1; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; BARTEL B, 1990, EMBO J, V9, P3179, DOI 10.1002/j.1460-2075.1990.tb07516.x; Bosu DR, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-7; Brower CS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007757; Cai HJ, 2006, GENETICS, V172, P1459, DOI 10.1534/genetics.105.053041; Choi WS, 2010, NAT STRUCT MOL BIOL, V17, P1175, DOI 10.1038/nsmb.1907; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; DOHMEN RJ, 1991, P NATL ACAD SCI USA, V88, P7351, DOI 10.1073/pnas.88.16.7351; DOUGAN DMD, 2011, BIOCH BIOPH IN PRESS; Du FY, 2002, P NATL ACAD SCI USA, V99, P14110, DOI 10.1073/pnas.172527399; Dye BT, 2007, ANNU REV BIOPH BIOM, V36, P131, DOI 10.1146/annurev.biophys.36.040306.132820; Eisele F, 2008, FEBS LETT, V582, P4143, DOI 10.1016/j.febslet.2008.11.015; Elting M, 2008, AM J MED GENET A, V146A, P3058, DOI 10.1002/ajmg.a.32566; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Foerster F, 2010, MOL CELL PROTEOMICS, V9, P1666, DOI 10.1074/mcp.R000002-MCP201; Gautschi M, 2003, MOL CELL BIOL, V23, P7403, DOI 10.1128/MCB.23.20.7403-7414.2003; Goetze S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000236; GONDA DK, 1989, J BIOL CHEM, V264, P16700; Heck JW, 2010, P NATL ACAD SCI USA, V107, P1106, DOI 10.1073/pnas.0910591107; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; Hu RG, 2005, NATURE, V437, P981, DOI 10.1038/nature04027; Hu RG, 2008, P NATL ACAD SCI USA, V105, P76, DOI 10.1073/pnas.0710568105; HURST JA, 1989, J MED GENET, V26, P45, DOI 10.1136/jmg.26.1.45; Hwang CS, 2010, NAT CELL BIOL, V12, P1177, DOI 10.1038/ncb2121; Hwang CS, 2010, SCIENCE, V327, P973, DOI 10.1126/science.1183147; Hwang CS, 2009, P NATL ACAD SCI USA, V106, P2142, DOI 10.1073/pnas.0812316106; Hwang CS, 2008, P NATL ACAD SCI USA, V105, P19188, DOI 10.1073/pnas.0808891105; JOHANSON A, 1971, J PEDIATR-US, V79, P982, DOI 10.1016/S0022-3476(71)80194-4; JONES NL, 1994, J PEDIATR-US, V125, P406, DOI 10.1016/S0022-3476(05)83286-X; JORNVALL H, 1975, J THEOR BIOL, V55, P1, DOI 10.1016/S0022-5193(75)80105-6; Kwon YT, 1998, P NATL ACAD SCI USA, V95, P7898, DOI 10.1073/pnas.95.14.7898; Kwon YT, 2003, MOL CELL BIOL, V23, P8255, DOI 10.1128/MCB.23.22.8255-8271.2003; Kwon YT, 2002, SCIENCE, V297, P96, DOI 10.1126/science.1069531; Kwon YT, 2001, MOL CELL BIOL, V21, P8007, DOI 10.1128/MCB.21.23.8007-8021.2001; Lee MJ, 2005, P NATL ACAD SCI USA, V102, P15030, DOI 10.1073/pnas.0507533102; Matta-Camacho E, 2010, NAT STRUCT MOL BIOL, V17, P1182, DOI 10.1038/nsmb.1894; Metzger MB, 2010, NAT CELL BIOL, V12, P1124, DOI 10.1038/ncb1210-1124; Mogk A, 2007, TRENDS CELL BIOL, V17, P165, DOI 10.1016/j.tcb.2007.02.001; MULLEN JR, 1989, EMBO J, V8, P2067, DOI 10.1002/j.1460-2075.1989.tb03615.x; Nillegoda NB, 2010, MOL BIOL CELL, V21, P2102, DOI 10.1091/mbc.E10-02-0098; O'Connell BC, 2007, CURR OPIN CELL BIOL, V19, P206, DOI 10.1016/j.ceb.2007.02.014; PARK EC, 1992, EMBO J, V11, P2087, DOI 10.1002/j.1460-2075.1992.tb05267.x; Polevoda B, 2003, J MOL BIOL, V325, P595, DOI 10.1016/S0022-2836(02)01269-X; Prasad R, 2010, MOL BIOL CELL, V21, P2117, DOI 10.1091/mbc.E10-02-0111; Rao H, 2001, NATURE, V410, P955, DOI 10.1038/35073627; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Roest HP, 2004, MOL CELL BIOL, V24, P5485, DOI 10.1128/MCB.24.12.5485-5495.2004; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Song OK, 2003, J BIOL CHEM, V278, P38109, DOI 10.1074/jbc.C300355200; Sriram SM, 2010, NAT STRUCT MOL BIOL, V17, P1164, DOI 10.1038/nsmb1010-1164; Starheim KK, 2009, MOL CELL BIOL, V29, P3569, DOI 10.1128/MCB.01909-08; Suzuki T, 1999, EMBO J, V18, P6017, DOI 10.1093/emboj/18.21.6017; Tasaki T, 2005, MOL CELL BIOL, V25, P7120, DOI 10.1128/MCB.25.16.7120-7136.2005; Tasaki T, 2007, TRENDS BIOCHEM SCI, V32, P520, DOI 10.1016/j.tibs.2007.08.010; Tasaki T, 2009, J BIOL CHEM, V284, P1884, DOI 10.1074/jbc.M803641200; Turner GC, 2000, NATURE, V405, P579, DOI 10.1038/35014629; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; Varshavsky A, 2005, METHOD ENZYMOL, V399, P777, DOI 10.1016/S0076-6879(05)99051-4; Varshavsky A, 2004, CURR BIOL, V14, pR181, DOI 10.1016/j.cub.2004.02.014; Varshavsky A, 2011, PROTEIN SCI, V20, P1298, DOI 10.1002/pro.666; Varshavsky A, 2008, J BIOL CHEM, V283, P34469, DOI 10.1074/jbc.X800009200; Wang HQ, 2009, MOL CELL, V34, P686, DOI 10.1016/j.molcel.2009.04.032; Xia ZX, 2008, J BIOL CHEM, V283, P28958, DOI 10.1074/jbc.M803980200; Xia ZX, 2008, J BIOL CHEM, V283, P24011, DOI 10.1074/jbc.M802583200; Xie YM, 1999, EMBO J, V18, P6832, DOI 10.1093/emboj/18.23.6832; Yang F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014017; Zenker M, 2006, ENDOCRIN METAB CLIN, V35, P243, DOI 10.1016/j.ecl.2006.02.013; Zenker M, 2005, NAT GENET, V37, P1345, DOI 10.1038/ng1681; ZENKER M, 2008, INBORN ERRORS DEV, P1190	75	31	32	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2011	6	9							e24925	10.1371/journal.pone.0024925	http://dx.doi.org/10.1371/journal.pone.0024925			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZV	21931868	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000295321800076
J	Nair, DR; Ghosh, R; Manocha, A; Mohanty, D; Saran, S; Gokhale, RS				Nair, Divya R.; Ghosh, Ratna; Manocha, Alzu; Mohanty, Debasisa; Saran, Shweta; Gokhale, Rajesh S.			Two Functionally Distinctive Phosphopantetheinyl Transferases from Amoeba Dictyostelium discoideum	PLOS ONE			English	Article							ACYL-CARRIER PROTEIN; FATTY-ACID; 4'-PHOSPHOPANTETHEINYL TRANSFERASES; SECONDARY METABOLISM; POLYKETIDE SYNTHASE; DIFFERENTIATION; STREPTOMYCES; SFP; BIOSYNTHESIS; SUPERFAMILY	The life cycle of Dictyostelium discoideum is proposed to be regulated by expression of small metabolites. Genome sequencing studies have revealed a remarkable array of genes homologous to polyketide synthases (PKSs) that are known to synthesize secondary metabolites in bacteria and fungi. A crucial step in functional activation of PKSs involves their post-translational modification catalyzed by phosphopantetheinyl transferases (PPTases). PPTases have been recently characterized from several bacteria; however, their relevance in complex life cycle of protozoa remains largely unexplored. Here we have identified and characterized two phosphopantetheinyl transferases from D. discoideum that exhibit distinct functional specificity. DiAcpS specifically modifies a stand-alone acyl carrier protein (ACP) that possesses a mitochondrial import signal. DiSfp in contrast is specific to Type I multifunctional PKS/fatty acid synthase proteins and cannot modify the stand-alone ACP. The mRNA of two PPTases can be detected during the vegetative as well as starvation-induced developmental pathway and the disruption of either of these genes results in non-viable amoebae. Our studies show that both PPTases play an important role in Dictyostelium biology and provide insight into the importance of PPTases in lower eukaryotes.	[Nair, Divya R.; Ghosh, Ratna; Manocha, Alzu; Mohanty, Debasisa; Gokhale, Rajesh S.] Natl Inst Immunol, New Delhi 110067, India; [Saran, Shweta] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India; [Gokhale, Rajesh S.] CSIR, Inst Genom & Integrat Biol, Delhi, India; [Gokhale, Rajesh S.] Indian Inst Sci, Jawaharlal Nehru Ctr Adv Sci Res, Bangalore 560012, Karnataka, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Jawaharlal Nehru University, New Delhi; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Indian Institute of Science (IISC) - Bangalore	Nair, DR (corresponding author), Natl Inst Immunol, New Delhi 110067, India.	rsg@igib.res.in	Mohanty, Debasisa/A-1428-2009	MOHANTY, DEBASISA/0000-0002-3374-0588	DBT, India; Council of Scientific and Industrial Research, India	DBT, India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	DBT's National Bioscience Award for Career Development, India. Council of Scientific and Industrial Research, India (http://rdpp.csir.res.in/csir_acsir/Home.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anjard C, 1998, DEVELOPMENT, V125, P4067; Ansari MZ, 2004, NUCLEIC ACIDS RES, V32, pW405, DOI 10.1093/nar/gkh359; Austin MB, 2006, NAT CHEM BIOL, V2, P494, DOI 10.1038/nchembio811; Barekzi N, 2004, MICROBIOL-SGM, V150, P795, DOI 10.1099/mic.0.26823-0; Brody S, 1997, FEBS LETT, V408, P217, DOI 10.1016/S0014-5793(97)00428-6; Byers DM, 2007, BIOCHEM CELL BIOL, V85, P649, DOI 10.1139/O07-109; Cai XM, 2005, EUKARYOT CELL, V4, P1211, DOI 10.1128/EC.4.7.1211-1220.2005; Carreras CW, 1997, BIOCHEMISTRY-US, V36, P11757, DOI 10.1021/bi971350+; Chalut C, 2006, P NATL ACAD SCI USA, V103, P8511, DOI 10.1073/pnas.0511129103; Chopra T, 2008, PLOS BIOL, V6, P1584, DOI 10.1371/journal.pbio.0060163; Copp JN, 2007, J BACTERIOL, V189, P3133, DOI 10.1128/JB.01850-06; Copp JN, 2006, APPL ENVIRON MICROB, V72, P2298, DOI 10.1128/AEM.72.4.2298-2305.2006; Donato H, 2007, J BIOL CHEM, V282, P34159, DOI 10.1074/jbc.M707627200; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Finking R, 2002, J BIOL CHEM, V277, P50293, DOI 10.1074/jbc.M205042200; Gehring AM, 1997, CHEM BIOL, V4, P17, DOI 10.1016/S1074-5521(97)90233-7; Ghosh R, 2008, J BIOL CHEM, V283, P11348, DOI 10.1074/jbc.M709588200; Huang Y, 2006, J BIOL CHEM, V281, P29660, DOI 10.1074/jbc.M604895200; Kuwayama H, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e2; Lambalot RH, 1996, CHEM BIOL, V3, P923, DOI 10.1016/S1074-5521(96)90181-7; Marquez-Fernandez O, 2007, EUKARYOT CELL, V6, P710, DOI 10.1128/EC.00362-06; McAllister KA, 2000, J BIOL CHEM, V275, P30864, DOI 10.1074/jbc.M004475200; McAllister KA, 2006, J BACTERIOL, V188, P4737, DOI 10.1128/JB.01917-05; Meiser P, 2008, CHEMBIOCHEM, V9, P1549, DOI 10.1002/cbic.200800077; Mootz HD, 2001, J BIOL CHEM, V276, P37289, DOI 10.1074/jbc.M103556200; Parris KD, 2000, STRUCT FOLD DES, V8, P883, DOI 10.1016/S0969-2126(00)00178-7; Quadri LEN, 1998, BIOCHEMISTRY-US, V37, P1585, DOI 10.1021/bi9719861; Reed MAC, 2003, ORG BIOMOL CHEM, V1, P463, DOI 10.1039/b208941f; Reuter K, 1999, EMBO J, V18, P6823, DOI 10.1093/emboj/18.23.6823; SACKMANN U, 1991, EUR J BIOCHEM, V200, P463, DOI 10.1111/j.1432-1033.1991.tb16205.x; Saito T, 2006, BBA-GEN SUBJECTS, V1760, P754, DOI 10.1016/j.bbagen.2005.12.006; Saito T, 2008, DEV BIOL, V317, P444, DOI 10.1016/j.ydbio.2008.02.036; Sanchez C, 2001, CHEM BIOL, V8, P725, DOI 10.1016/S1074-5521(01)00047-3; Serafimidis I, 2005, DEV BIOL, V282, P432, DOI 10.1016/j.ydbio.2005.03.023; STERNFELD J, 1979, J CELL SCI, V38, P181; Stuible HP, 1998, J BIOL CHEM, V273, P22334, DOI 10.1074/jbc.273.35.22334; Walsh CT, 1997, CURR OPIN CHEM BIOL, V1, P309, DOI 10.1016/S1367-5931(97)80067-1; Zucko J, 2007, BIOINFORMATICS, V23, P2543, DOI 10.1093/bioinformatics/btm381	39	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2011	6	9							e24262	10.1371/journal.pone.0024262	http://dx.doi.org/10.1371/journal.pone.0024262			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CO	21931666	Green Submitted, Green Published, gold			2022-12-25	WOS:000294803200009
J	Carvajal-Rodriguez, A; de Una-Alvarez, J				Carvajal-Rodriguez, Antonio; de Una-Alvarez, Jacobo			Assessing Significance in High-Throughput Experiments by Sequential Goodness of Fit and q-Value Estimation	PLOS ONE			English	Article							FALSE DISCOVERY RATE; DEPENDENCE; NUMBER; RATES	We developed a new multiple hypothesis testing adjustment called SGoF+ implemented as a sequential goodness of fit metatest which is a modification of a previous algorithm, SGoF, taking advantage of the information of the distribution of p-values in order to fix the rejection region. The new method uses a discriminant rule based on the maximum distance between the uniform distribution of p-values and the observed one, to set the null for a binomial test. This new approach shows a better power/pFDR ratio than SGoF. In fact SGoF+ automatically sets the threshold leading to the maximum power and the minimum false non-discovery rate inside the SGoF' family of algorithms. Additionally, we suggest combining the information provided by SGoF+ with the estimate of the FDR that has been committed when rejecting a given set of nulls. We study different positive false discovery rate, pFDR, estimation methods to combine q-value estimates jointly with the information provided by the SGoF+ method. Simulations suggest that the combination of SGoF+ metatest with the q-value information is an interesting strategy to deal with multiple testing issues. These techniques are provided in the latest version of the SGoF+ software freely available at http://webs.uvigo.es/acraaj/SGoF.htm.	[Carvajal-Rodriguez, Antonio] Univ Vigo, Dept Bioquim Genet & Inmunol, Fac Biol, Vigo 36310, Spain; [de Una-Alvarez, Jacobo] Univ Vigo, Dept Estadist & Invest Operat, Fac Ciencias Econ & Empresariales, Vigo 36310, Spain	Universidade de Vigo; Universidade de Vigo	Carvajal-Rodriguez, A (corresponding author), Univ Vigo, Dept Bioquim Genet & Inmunol, Fac Biol, Vigo 36310, Spain.	acraaj@uvigo.es	de Uña-Álvarez, Jacobo/K-5667-2014; , ACR/A-7676-2012	de Uña-Álvarez, Jacobo/0000-0002-4686-8417; , ACR/0000-0002-6242-3581	Ministerio de Ciencia e Innovacion [CGL2008-00135/BOS, CGL2009-13278/C02-01, MTM2008-03129]; Xunta de Galicia (Grupo de Referencia Competitiva) [2010/80, 10 PXIB 300 068 PR]; Xunta de Galicia (Spain); Xunta de Galicia [2009/063]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Xunta de Galicia (Grupo de Referencia Competitiva)(Xunta de Galicia); Xunta de Galicia (Spain)(Xunta de Galicia); Xunta de Galicia(Xunta de GaliciaEuropean Commission)	This work was supported by Ministerio de Ciencia e Innovacion (CGL2008-00135/BOS, CGL2009-13278/C02-01 and MTM2008-03129), Xunta de Galicia (Grupo de Referencia Competitiva 2010/80 and fondos FEDER and 10 PXIB 300 068 PR). ACR is currently funded by an Isidro Parga Pondal research fellowship from Xunta de Galicia (Spain). JdUA is also grateful to the Xunta de Galicia for financial support under the INBIOMED project (DXPCTSUG, Ref. 2009/063). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamini Y, 2001, ANN STAT, V29, P1165; Benjamini Y, 2005, GENETICS, V171, P783, DOI 10.1534/genetics.104.036699; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brown BW, 1997, STAT MED, V16, P2511, DOI 10.1002/(SICI)1097-0258(19971130)16:22<2511::AID-SIM693>3.0.CO;2-4; Carvajal-Rodriguez A, 2008, SGOF SEQUENTIAL GOOD; Carvajal-Rodriguez A, 2011, ADV INTEL SOFT COMPU, V93, P241; Carvajal-Rodriguez A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-209; Dalmasso C, 2005, BIOINFORMATICS, V21, P660, DOI 10.1093/bioinformatics/bti063; de Una-Alvarez J, 2011, STAT APPL GENET MOL, V10, DOI 10.2202/1544-6115.1659; de Una-Alvarez J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015930; Diz AP, 2009, MOL CELL PROTEOMICS, V8, P132, DOI 10.1074/mcp.M800237-MCP200; Efron B, 2007, J AM STAT ASSOC, V102, P93, DOI 10.1198/016214506000001211; Farcomeni A, 2008, STAT METHODS MED RES, V17, P347, DOI 10.1177/0962280206079046; Kim KI, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-114; Meinshausen N, 2006, ANN STAT, V34, P373, DOI 10.1214/009053605000000741; Pounds SB, 2006, BRIEF BIOINFORM, V7, P25, DOI 10.1093/bib/bbk002; Press WH, 2002, NUMERICAL RECIPES C, VXXVIII; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Storey JD, 2004, J R STAT SOC B, V66, P187, DOI 10.1111/j.1467-9868.2004.00439.x; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Zaykin DV, 2000, GENETICS, V154, P1917	22	65	66	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2011	6	9							e24700	10.1371/journal.pone.0024700	http://dx.doi.org/10.1371/journal.pone.0024700			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CN	21931819	Green Submitted, gold, Green Published			2022-12-25	WOS:000294803100059
J	Hambardzumyan, D; Cheng, YK; Haeno, H; Holland, EC; Michor, F				Hambardzumyan, Dolores; Cheng, Yu-Kang; Haeno, Hiroshi; Holland, Eric C.; Michor, Franziska			The Probable Cell of Origin of NF1-and PDGF-Driven Glioblastomas	PLOS ONE			English	Article							NEURAL STEM-CELLS; SELF-RENEWAL; NEUROEPITHELIAL CELLS; GLIAL PROGENITORS; MOUSE MODELS; ADULT BRAIN; GLIOMA; PATHWAYS; CANCER; NF1	Primary glioblastomas are subdivided into several molecular subtypes. There is an ongoing debate over the cell of origin for these tumor types where some suggest a progenitor while others argue for a stem cell origin. Even within the same molecular subgroup, and using lineage tracing in mouse models, different groups have reached different conclusions. We addressed this problem from a combined mathematical modeling and experimental standpoint. We designed a novel mathematical framework to identify the most likely cells of origin of two glioma subtypes. Our mathematical model of the unperturbed in vivo system predicts that if a genetic event contributing to tumor initiation imparts symmetric self-renewing cell division (such as PDGF overexpression), then the cell of origin is a transit amplifier. Otherwise, the initiating mutations arise in stem cells. The mathematical framework was validated with the RCAS/tv-a system of somatic gene transfer in mice. We demonstrated that PDGF-induced gliomas can be derived from GFAP-expressing cells of the subventricular zone or the cortex (reactive astrocytes), thus validating the predictions of our mathematical model. This interdisciplinary approach allowed us to determine the likelihood that individual cell types serve as the cells of origin of gliomas in an unperturbed system.	[Hambardzumyan, Dolores] Cleveland Clin, Dept Regenerat Med, Cleveland, OH 44106 USA; [Cheng, Yu-Kang; Haeno, Hiroshi; Michor, Franziska] Harvard Univ, Sch Publ Hlth, Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Cheng, Yu-Kang; Haeno, Hiroshi; Michor, Franziska] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Cheng, Yu-Kang] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10021 USA; [Cheng, Yu-Kang] Weill Cornell Med Coll, Triinst Training Program Computat Biol & Med, New York, NY USA; [Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Dept Neurosurg, Brain Tumor Ctr, New York, NY 10021 USA; [Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, New York, NY 10021 USA; [Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Dept Neurol, New York, NY 10021 USA; [Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10021 USA	Cleveland Clinic Foundation; Harvard University; Dana-Farber Cancer Institute; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Hambardzumyan, D (corresponding author), Cleveland Clin, Dept Regenerat Med, Cleveland, OH 44106 USA.	michor@jimmy.harvard.edu			National Institutes of Health [U54CA143798]; NATIONAL CANCER INSTITUTE [U54CA143798] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health U54CA143798. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers AC, 2009, EXPERT REV NEUROTHER, V9, P535, DOI [10.1586/ern.09.4, 10.1586/ERN.09.4]; Araten DJ, 2005, CANCER RES, V65, P8111, DOI 10.1158/0008-5472.CAN-04-1198; Assanah MC, 2009, GLIA, V57, P1835, DOI 10.1002/glia.20895; Assanah M, 2006, J NEUROSCI, V26, P6781, DOI 10.1523/JNEUROSCI.0514-06.2006; Bachoo RM, 2002, CANCER CELL, V1, P269, DOI 10.1016/S1535-6108(02)00046-6; Boucher K, 1999, MATH BIOSCI, V159, P47, DOI 10.1016/S0025-5564(99)00010-3; Brennan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007752; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chow LML, 2011, CANCER CELL, V19, P305, DOI 10.1016/j.ccr.2011.01.039; Dai C, 2001, GENE DEV, V15, P1913, DOI 10.1101/gad.903001; FIALKOW PJ, 1981, BLOOD, V58, P916; FRANKLIN KBJ, 1997, MOUSE BRAIN STERIOTA; GRIFFIN JD, 1986, BLOOD, V68, P1185; Hambardzumyan D, 2009, TRANSL ONCOL, V2, P89, DOI 10.1593/tlo.09100; Holland EC, 2001, NAT REV GENET, V2, P120, DOI 10.1038/35052535; Huttner WB, 1997, CURR OPIN NEUROBIOL, V7, P29, DOI 10.1016/S0959-4388(97)80117-1; Ivanchuk SM, 2001, J NEURO-ONCOL, V51, P219, DOI 10.1023/A:1010632309113; Jackson EL, 2006, NEURON, V51, P187, DOI 10.1016/j.neuron.2006.06.012; Johnston MD, 2007, P NATL ACAD SCI USA, V104, P4008, DOI 10.1073/pnas.0611179104; Joseph NM, 2008, CANCER CELL, V13, P129, DOI 10.1016/j.ccr.2008.01.003; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; Kosodo Y, 2004, EMBO J, V23, P2314, DOI 10.1038/sj.emboj.7600223; Lindberg N, 2009, ONCOGENE, V28, P2266, DOI 10.1038/onc.2009.76; Liu C, 2011, CELL; Llaguno SA, 2009, CANCER CELL, V15, P45, DOI 10.1016/j.ccr.2008.12.006; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; Moran P., 1962, STAT PROCESSES EVOLU; Morrison SJ, 1997, CELL, V88, P287, DOI 10.1016/S0092-8674(00)81867-X; OLLER AR, 1989, MUTAT RES, V216, P149, DOI 10.1016/0165-1161(89)90001-0; Pardal R, 2005, COLD SH Q B, V70, P177, DOI 10.1101/sqb.2005.70.057; Persson AI, 2010, CANCER CELL, V18, P669, DOI 10.1016/j.ccr.2010.10.033; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; POTTEN CS, 1990, DEVELOPMENT, V110, P1001; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Simons BD, 2011, CELL, V145, P851, DOI 10.1016/j.cell.2011.05.033; Stiles CD, 2008, NEURON, V58, P832, DOI 10.1016/j.neuron.2008.05.031; Temple S, 1999, CURR OPIN NEUROBIOL, V9, P135, DOI 10.1016/S0959-4388(99)80017-8; TOMLINSON IPM, 1995, P NATL ACAD SCI USA, V92, P11130, DOI 10.1073/pnas.92.24.11130; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Zhang RL, 2004, J NEUROSCI, V24, P5810, DOI 10.1523/JNEUROSCI.1109-04.2004; Zhu H, 2009, P NATL ACAD SCI USA, V106, P2712, DOI 10.1073/pnas.0813314106; Zhu Y, 2005, DEVELOPMENT, V132, P5577, DOI 10.1242/dev.02162; Zhu Y, 2005, CANCER CELL, V8, P119, DOI 10.1016/j.ccr.2005.07.004	47	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2011	6	9							e24454	10.1371/journal.pone.0024454	http://dx.doi.org/10.1371/journal.pone.0024454			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CN	21931722	Green Published, Green Submitted, gold			2022-12-25	WOS:000294803100035
J	Oliva, CR; Moellering, DR; Gillespie, GY; Griguer, CE				Oliva, Claudia R.; Moellering, Douglas R.; Gillespie, G. Yancey; Griguer, Corinne E.			Acquisition of Chemoresistance in Gliomas Is Associated with Increased Mitochondrial Coupling and Decreased ROS Production	PLOS ONE			English	Article							PERSISTENT OXIDATIVE STRESS; ELECTRON-TRANSPORT CHAIN; CANCER-CELLS; CYTOCHROME-C; GLIOBLASTOMA-MULTIFORME; SUPEROXIDE-DISMUTASE; GLUCOSE-METABOLISM; HYDROGEN-PEROXIDE; OVARIAN-CANCER; TEMOZOLOMIDE	Temozolomide (TMZ) is an alkylating agent used for treating gliomas. Chemoresistance is a severe limitation to TMZ therapy; there is a critical need to understand the underlying mechanisms that determine tumor response to TMZ. We recently reported that chemoresistance to TMZ is related to a remodeling of the entire electron transport chain, with significant increases in the activity of complexes II/III and cytochrome c oxidase (CcO). Moreover, pharmacologic and genetic manipulation of CcO reverses chemoresistance. Therefore, to test the hypothesis that TMZ-resistance arises from tighter mitochondrial coupling and decreased production of reactive oxygen species (ROS), we have assessed mitochondrial function in TMZ-sensitive and -resistant glioma cells, and in TMZ-resistant glioblastoma multiform (GBM) xenograft lines (xenolines). Maximum ADP-stimulated (state 3) rates of mitochondrial oxygen consumption were greater in TMZ-resistant cells and xenolines, and basal respiration (state 2), proton leak (state 4), and mitochondrial ROS production were significantly lower in TMZ-resistant cells. Furthermore, TMZ-resistant cells consumed less glucose and produced less lactic acid. Chemoresistant cells were insensitive to the oxidative stress induced by TMZ and hydrogen peroxide challenges, but treatment with the oxidant L-buthionine-S,R-sulfoximine increased TMZ-dependent ROS generation and reversed chemoresistance. Importantly, treatment with the antioxidant N-acetyl-cysteine inhibited TMZ-dependent ROS generation in chemosensitive cells, preventing TMZ toxicity. Finally, we found that mitochondrial DNA-depleted cells (rho degrees) were resistant to TMZ and had lower intracellular ROS levels after TMZ exposure compared with parental cells. Repopulation of rho degrees cells with mitochondria restored ROS production and sensitivity to TMZ. Taken together, our results indicate that chemoresistance to TMZ is linked to tighter mitochondrial coupling and low ROS production, and suggest a novel mitochondrial ROS-dependent mechanism underlying TMZ-chemoresistance in glioma. Thus, perturbation of mitochondrial functions and changes in redox status might constitute a novel strategy for sensitizing glioma cells to therapeutic approaches.	[Oliva, Claudia R.; Gillespie, G. Yancey; Griguer, Corinne E.] Univ Alabama, Dept Surg, Div Neurosurg, Birmingham, AL 35294 USA; [Moellering, Douglas R.] Univ Alabama, Dept Nutr Sci, Birmingham, AL 35294 USA; [Griguer, Corinne E.] Univ Alabama, Ctr Free Rad Biol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Oliva, CR (corresponding author), Univ Alabama, Dept Surg, Div Neurosurg, Birmingham, AL 35294 USA.	cgriguer@uab.edu		Gillespie, George/0000-0001-6436-9542; , Corinne/0000-0003-3877-5031; Moellering, Douglas/0000-0003-2040-4187; Oliva, Claudia/0000-0003-0624-5490	National Institutes of Health (National Cancer Institute (NCI) [P30 CA13148-35]; NCI [R21 CA139290]; UCDC DRTC BARB Core [P60 DK079626]; NATIONAL CANCER INSTITUTE [P20CA151129, R01CA160821, P30CA013148, R21CA139290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK079626] Funding Source: NIH RePORTER	National Institutes of Health (National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); UCDC DRTC BARB Core; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole, by National Institutes of Health Grants P30 CA13148-35 (National Cancer Institute (NCI), to the University of Alabama Comprehensive Cancer Center Collaborative Programmatic Development Grant Program from the USPHS), R21 CA139290 (NCI) and UCDC DRTC BARB Core (P60 DK079626). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atamna H, 2000, P NATL ACAD SCI USA, V97, P686, DOI 10.1073/pnas.97.2.686; Boushel R, 2007, DIABETOLOGIA, V50, P790, DOI 10.1007/s00125-007-0594-3; Bouzier AK, 1998, J BIOL CHEM, V273, P27162, DOI 10.1074/jbc.273.42.27162; Bouzier AK, 1998, DEV NEUROSCI-BASEL, V20, P331, DOI 10.1159/000017328; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; Campian JL, 2007, J BIOL CHEM, V282, P12430, DOI 10.1074/jbc.M604547200; Carlson BL, 2009, INT J RADIAT ONCOL, V75, P212, DOI 10.1016/j.ijrobp.2009.04.026; Chandra J, 2000, FREE RADICAL BIO MED, V29, P323, DOI 10.1016/S0891-5849(00)00302-6; Devi GS, 2000, CLIN CHIM ACTA, V293, P53, DOI 10.1016/S0009-8981(99)00222-3; Ferraresi R, 2008, CYTOM PART A, V73A, P528, DOI 10.1002/cyto.a.20544; Giannini C, 2005, NEURO-ONCOLOGY, V7, P164, DOI 10.1215/S1152851704000821; Gnaiger E, 2002, BIOCHEM SOC T, V30, P252, DOI 10.1042/BST0300252; Griguer CE, 2005, J NEURO-ONCOL, V74, P123, DOI 10.1007/s11060-004-6404-6; Griguer CE, 2006, CANCER RES, V66, P2257, DOI 10.1158/0008-5472.CAN-05-3364; Griguer CE, 2007, J NEURO-ONCOL, V81, P9, DOI 10.1007/s11060-006-9201-6; Griguer CE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003655; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Hileman Elizabeth A, 2001, Expert Opin Ther Targets, V5, P697, DOI 10.1517/14728222.5.6.697; Hu YM, 2005, J BIOL CHEM, V280, P39485, DOI 10.1074/jbc.M503296200; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Kondo S, 1999, FREE RADICAL BIO MED, V27, P401, DOI 10.1016/S0891-5849(99)00087-8; KRZYWANSKI DM, 2011, LAB INVEST; LAI JCK, 1976, BIOCHEM J, V154, P423, DOI 10.1042/bj1540423; Landriscina M, 2009, ANTIOXID REDOX SIGN, V11, P2701, DOI 10.1089/ars.2009.2692; Lanza IR, 2009, METHOD ENZYMOL, V457, P349, DOI 10.1016/S0076-6879(09)05020-4; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Medina RA, 2004, J ENDOCRINOL, V182, P467, DOI 10.1677/joe.0.1820467; Mukhopadhyay P, 2007, NAT PROTOC, V2, P2295, DOI 10.1038/nprot.2007.327; Oliva CR, 2010, J BIOL CHEM, V285, P39759, DOI 10.1074/jbc.M110.147504; Park SY, 2004, J BIOL CHEM, V279, P7512, DOI 10.1074/jbc.M307677200; Pennington JD, 2005, DRUG RESIST UPDATE, V8, P322, DOI 10.1016/j.drup.2005.09.002; Pramanik KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020151; Puchowicz MA, 2004, MITOCHONDRION, V4, P377, DOI 10.1016/j.mito.2004.07.004; RICHTER C, 1995, BBA-MOL BASIS DIS, V1271, P67, DOI 10.1016/0925-4439(95)00012-S; Saybasili H, 2001, ANTIOXID REDOX SIGN, V3, P1099, DOI 10.1089/152308601317203602; Staniek K, 2002, FREE RADICAL RES, V36, P381, DOI 10.1080/10715760290021225; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Tiligada E, 2006, ENDOCR-RELAT CANCER, V13, pS115, DOI 10.1677/erc.1.01272; Toyokuni S, 1998, BIOTHERAPY, V11, P147, DOI 10.1023/A:1007934229968; TOYOKUNI S, 1995, FEBS LETT, V358, P1, DOI 10.1016/0014-5793(94)01368-B; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; Turcotte ML, 2002, BRIT J CANCER, V86, P619, DOI 10.1038/sj.bjc.6600087; WARBURG O, 1956, Oncologia, V9, P75; WARBURG O, 1956, SCIENCE, V124, P269; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Yu T, 2009, ULTRASOUND OBST GYN, V33, P355, DOI 10.1002/uog.6258; ZHANG WB, J BIOL CHEM, V285, P40461; Zhou M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-33	51	99	100	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2011	6	9							e24665	10.1371/journal.pone.0024665	http://dx.doi.org/10.1371/journal.pone.0024665			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CN	21931801	Green Published, Green Submitted, gold			2022-12-25	WOS:000294803100052
J	Cuny, C; Layer, F; Strommenger, B; Witte, W				Cuny, Christiane; Layer, Franziska; Strommenger, Birgit; Witte, Wolfgang			Rare Occurrence of Methicillin-Resistant Staphylococcus aureus CC130 with a Novel mecA Homologue in Humans in Germany	PLOS ONE			English	Article							GENETIC-VARIATION; BOVINE MASTITIS; STRAINS; SPECIFICITY; MICROARRAY; MILK	MRSA CC130 containing the mecA homologue mecA(LGA251) were reported from the UK and from Denmark so far from cattle and humans. Here we report on 11 MRSA CC130 among a sample of 12691 isolates of human origin collected from January 2006 until June 2011. MRSA CC130 grew insufficiently on chromogernic agar plates for detection of MRSA; the agglutination test for presence of PBP2a was negative. We designed primers for specific detection of mecA(LGA251) as well as for concomitant detection of both, mec(LGA251) and mecA. As already described, the isolates exhibited spa-types t843, t1736, and t1773. The ccrA homologue indicated the presence SCCmec(XI). When subjected to further characterization by means of a commercially available microarray the isolates were negative for sak chp, and scn, and as expected positive for hla, untruncated hlb, and hld. They furthermore contained edinB, aur, slpA, slpB, slpE. From genes coding for surface and cell wall associated products the ica-operon, cap8, clfA, clfF, ebpS, fnbA, fnbB, sdrC were detected but not cna. The isolates were negative for enterotoxin genes and tst, as well as for eta, and etb; agr-type was III.	[Cuny, Christiane; Layer, Franziska; Strommenger, Birgit; Witte, Wolfgang] Robert Koch Inst, Wernigerode Branch, Wernigerode, Germany	Robert Koch Institute	Cuny, C (corresponding author), Robert Koch Inst, Wernigerode Branch, Wernigerode, Germany.	wittew@rki.de		Layer, Franziska/0000-0002-4613-6478	German Federal Ministry of Education and Research [01KI1014G]	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This study was supported by grant 01KI1014G from the German Federal Ministry of Education and Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves PDD, 2009, VET MICROBIOL, V137, P190, DOI 10.1016/j.vetmic.2008.12.014; Catry B, 2010, EPIDEMIOL INFECT, V138, P626, DOI 10.1017/S0950268810000014; Cuny C, 1999, EUR J CLIN MICROBIOL, V18, P834, DOI 10.1007/s100960050413; Cuny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006800; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; DEVRIESE LA, 1984, J APPL BACTERIOL, V56, P215, DOI 10.1111/j.1365-2672.1984.tb01341.x; DEVRIESE LA, 1972, ZENTRALB VET RIEHE B, V19, P598; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; *EUR COMM ANT SUSC, BREAKP TABL INT MICS; Garcia-Alvarez L, 2011, LANCET INFECT DIS, V11, P595, DOI 10.1016/S1473-3099(11)70126-8; German Institute for Standardization, MED MICR IMM DIAGN P; Grundmann H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000215; Hasman H, 2010, VET MICROBIOL, V141, P326, DOI 10.1016/j.vetmic.2009.09.025; Hata E, 2010, J CLIN MICROBIOL, V48, P2130, DOI 10.1128/JCM.01940-09; Holtfreter S, 2007, J CLIN MICROBIOL, V45, P2669, DOI 10.1128/JCM.00204-07; Huber H, 2010, EURO SURVEILL, V15; Juhasz-Kaszanyitzky E, 2007, EMERG INFECT DIS, V13, P630, DOI 10.3201/eid1304.060833; Kampen AH, 2005, INFECT IMMUN, V73, P1578, DOI 10.1128/IAI.73.3.1578-1583.2005; McCarthy AJ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-173; Monecke S, 2008, CLIN MICROBIOL INFEC, V14, P534, DOI 10.1111/j.1469-0691.2008.01986.x; MURAKAMI K, 1991, J CLIN MICROBIOL, V29, P2240, DOI 10.1128/JCM.29.10.2240-2244.1991; Nam HM, 2011, FOODBORNE PATHOG DIS, V8, P231, DOI 10.1089/fpd.2010.0661; Shore AC, 2011, ANTIMICROB AGENTS CH, V55, P3765, DOI 10.1128/AAC.00187-11; Sibbald MJJB, 2006, MICROBIOL MOL BIOL R, V70, P755, DOI 10.1128/MMBR.00008-06; Smith EM, 2005, J CLIN MICROBIOL, V43, P4737, DOI 10.1128/JCM.43.9.4737-4743.2005; Spohr M, 2010, ZOONOSES PUBLIC 0711; Strommenger B, 2006, J CLIN MICROBIOL, V44, P2533, DOI 10.1128/JCM.00420-06; Sung JML, 2008, MICROBIOL-SGM, V154, P1949, DOI 10.1099/mic.0.2007/015289-0; Turkyilmaz S, 2010, ZOONOSES PUBLIC HLTH, V57, P197, DOI 10.1111/j.1863-2378.2009.01257.x; van Wamel WJB, 2006, J BACTERIOL, V188, P1310, DOI 10.1128/JB.188.4.1310-1315.2006; Vanderhaeghen W, 2010, VET MICROBIOL, V144, P166, DOI 10.1016/j.vetmic.2009.12.044; Watts A, 2005, INFECT IMMUN, V73, P3502, DOI 10.1128/IAI.73.6.3502-3511.2005	32	153	160	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e24360	10.1371/journal.pone.0024360	http://dx.doi.org/10.1371/journal.pone.0024360			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CK	21931689	Green Published, Green Submitted, gold			2022-12-25	WOS:000294802800041
J	Fitzgerald, DM; Charness, ME; Leite-Morris, KA; Chen, SZ				Fitzgerald, Devon M.; Charness, Michael E.; Leite-Morris, Kimberly A.; Chen, Suzhen			Effects of Ethanol and NAP on Cerebellar Expression of the Neural Cell Adhesion Molecule L1	PLOS ONE			English	Article							DEPENDENT NEUROPROTECTIVE PROTEIN; TIME PCR EXPERIMENTS; DENDRITIC MORPHOGENESIS; NEURITE OUTGROWTH; GRANULE NEURONS; BRAIN-STEM; ADULT RATS; ALCOHOL; ASTROCYTES; EXPOSURE	The neural cell adhesion molecule L1 is critical for brain development and plays a role in learning and memory in the adult. Ethanol inhibits L1-mediated cell adhesion and neurite outgrowth in cerebellar granule neurons (CGNs), and these actions might underlie the cerebellar dysmorphology of fetal alcohol spectrum disorders. The peptide NAP potently blocks ethanol inhibition of L1 adhesion and prevents ethanol teratogenesis. We used quantitative RT-PCR and Western blotting of extracts of cerebellar slices, CGNs, and astrocytes from postnatal day 7 (PD7) rats to investigate whether ethanol and NAP act in part by regulating the expression of L1. Treatment of cerebellar slices with 20 mM ethanol, 10(-12) M NAP, or both for 4 hours, 24 hours, and 10 days did not significantly affect L1 mRNA and protein levels. Similar treatment for 4 or 24 hours did not regulate L1 expression in primary cultures of CGNs and astrocytes, the predominant cerebellar cell types. Because ethanol also damages the adult cerebellum, we studied the effects of chronic ethanol exposure in adult rats. One year of binge drinking did not alter L1 gene and protein expression in extracts from whole cerebellum. Thus, ethanol does not alter L1 expression in the developing or adult cerebellum; more likely, ethanol disrupts L1 function by modifying its conformation and signaling. Likewise, NAP antagonizes the actions of ethanol without altering L1 expression.	[Fitzgerald, Devon M.; Charness, Michael E.; Leite-Morris, Kimberly A.] Vet Affairs Boston Healthcare Syst, Boston, MA 02301 USA; [Charness, Michael E.; Chen, Suzhen] Harvard Univ, Dept Neurol, Sch Med, W Roxbury, MA USA; [Leite-Morris, Kimberly A.] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [Leite-Morris, Kimberly A.] Boston Univ, Sch Med, Dept Pharmacol, Boston, MA 02118 USA; [Leite-Morris, Kimberly A.] Boston Univ, Sch Med, Dept Expt Therapeut, Boston, MA 02118 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Boston University; Boston University; Boston University	Fitzgerald, DM (corresponding author), Vet Affairs Boston Healthcare Syst, Boston, MA 02301 USA.	suzhen_chen@hms.harvard.edu	Fitzgerald, Devon M./E-2763-2018	Fitzgerald, Devon M./0000-0002-2480-7269; Leite-Morris, Kimberly/0000-0003-3407-7375; Charness, Michael/0000-0002-3301-8966	Foundation for Alcohol Research; Department of Veterans Affairs; National Institute on Alcohol Abuse and Alcoholism (NIAAA) [R37-AA12974, U24-AA014811, AA015194 9]; Canadian Incidence Study\Foetal Alcohol Spectrum Disorder; Department of Psychiatry, Boston University School of Medicine; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U24AA014811, K01AA015194, R37AA012974] Funding Source: NIH RePORTER	Foundation for Alcohol Research; Department of Veterans Affairs(US Department of Veterans Affairs); National Institute on Alcohol Abuse and Alcoholism (NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Canadian Incidence Study\Foetal Alcohol Spectrum Disorder; Department of Psychiatry, Boston University School of Medicine; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Funding for this work was provided by: The Foundation for Alcohol Research Award to SC (www.abmrf.org), Merit Review Award from Department of Veterans Affairs to MC (www.research.va.gov), National Institute on Alcohol Abuse and Alcoholism (NIAAA) R37-AA12974 to MC (www.niaaa.nih.gov), NIAAA U24-AA014811, Canadian Incidence Study vertical bar Foetal Alcohol Spectrum Disorder to MC (www.niaaa.nih.go), NIAAA AA015194 9 to KL-M, Research service, Department of Veterans Affairs, and Department of Psychiatry, Boston University School of Medicine to KL-M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquaah-Mensah GK, 2001, TOXICOL APPL PHARM, V175, P10, DOI 10.1006/taap.2001.9229; Arevalo E, 2008, P NATL ACAD SCI USA, V105, P371, DOI 10.1073/pnas.0707815105; BAYER SA, 1993, NEUROTOXICOLOGY, V14, P83; Bearer CF, 1999, J BIOL CHEM, V274, P13264, DOI 10.1074/jbc.274.19.13264; Birdsill AC, 2010, CELL TISSUE BAN 0812; Bustin SA, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-74; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chaisuksunt V, 2000, NEUROSCIENCE, V100, P87, DOI 10.1016/S0306-4522(00)00254-2; CHANG S, 1987, J CELL BIOL, V104, P355, DOI 10.1083/jcb.104.2.355; CHARNESS ME, 1994, J BIOL CHEM, V269, P9304; CHARNESS ME, 1989, NEW ENGL J MED, V321, P442, DOI 10.1056/NEJM198908173210706; Chen S, 1999, J NEUROBIOL, V38, P428, DOI 10.1002/(SICI)1097-4695(19990215)38:3<428::AID-NEU10>3.0.CO;2-6; Chen SZ, 2008, P NATL ACAD SCI USA, V105, P19962, DOI 10.1073/pnas.0807758105; Chen SY, 2005, DEV NEUROSCI-BASEL, V27, P13, DOI 10.1159/000084528; Chen SY, 2001, FASEB J, V15, P1649, DOI 10.1096/fj.00-0862fje; CLARREN SK, 1978, J PEDIATR-US, V92, P64, DOI 10.1016/S0022-3476(78)80072-9; Czachowski CL, 1999, ALCOHOL CLIN EXP RES, V23, P1331, DOI 10.1097/00000374-199908000-00006; Czachowski CL, 1999, ALCOHOL CLIN EXP RES, V23, P398, DOI 10.1097/00000374-199903000-00002; de la Monte SM, 2005, CELL MOL LIFE SCI, V62, P1131, DOI 10.1007/s00018-005-4571-z; Dikranian K, 2005, DEV BRAIN RES, V155, P1, DOI 10.1016/j.devbrainres.2004.11.005; Dou XW, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.209254; Farnell YZ, 2008, ALCOHOL CLIN EXP RES, V32, P544, DOI 10.1111/j.1530-0277.2007.00598.x; Fleige S, 2006, BIOTECHNOL LETT, V28, P1601, DOI 10.1007/s10529-006-9127-2; FRANSEN E, 1995, EUR J HUM GENET, V3, P273; Fransen E, 1998, HUM MOL GENET, V7, P999, DOI 10.1093/hmg/7.6.999; Gaudilliere B, 2004, NEURON, V41, P229, DOI 10.1016/S0896-6273(03)00841-9; Gozes I, 2007, PHARMACOL THERAPEUT, V114, P146, DOI 10.1016/j.pharmthera.2007.01.004; Heaton MB, 2004, DEV BRAIN RES, V150, P117, DOI 10.1016/j.devbrainres.2004.03.010; HOWERTON T C, 1984, Alcohol, V1, P471, DOI 10.1016/0741-8329(84)90024-7; Incerti M, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.03.050; Jaatinen P, 2008, CEREBELLUM, V7, P332, DOI 10.1007/s12311-008-0034-z; KEILHAUER G, 1985, NATURE, V316, P728, DOI 10.1038/316728a0; LILJELUND P, 1994, J BIOL CHEM, V269, P32886; LINDNER J, 1983, NATURE, V305, P427, DOI 10.1038/305427a0; LINDNER J, 1986, BRAIN RES, V377, P298, DOI 10.1016/0006-8993(86)90872-3; LUTHI A, 1994, NATURE, V372, P777, DOI 10.1038/372777a0; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; McCaffery P, 2004, DEV BRAIN RES, V153, P233, DOI 10.1016/j.devbrainres.2004.09.003; Miller MW, 2006, J NEUROCHEM, V97, P1182, DOI 10.1111/j.1471-4159.2006.03858.x; Nguon K, 2005, CEREBELLUM, V4, P112, DOI 10.1080/14734220510007860; Nicolas JM, 2000, QJM-MON J ASSOC PHYS, V93, P449, DOI 10.1093/qjmed/93.7.449; NYBROE O, 1990, INT J DEV NEUROSCI, V8, P273, DOI 10.1016/0736-5748(90)90033-X; Pabinger S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-268; Pickering C, 2010, BASIC CLIN PHARMACOL, V106, P472, DOI 10.1111/j.1742-7843.2009.00528.x; Ramanathan R, 1996, J CELL BIOL, V133, P381, DOI 10.1083/jcb.133.2.381; SAMSON HH, 1986, ALCOHOL CLIN EXP RES, V10, P436, DOI 10.1111/j.1530-0277.1986.tb05120.x; Shalizi A, 2007, J NEUROSCI, V27, P10037, DOI 10.1523/JNEUROSCI.0361-07.2007; Shtutman M, 2006, CANCER RES, V66, P11370, DOI 10.1158/0008-5472.CAN-06-2106; Sowell ER, 1996, ALCOHOL CLIN EXP RES, V20, P31, DOI 10.1111/j.1530-0277.1996.tb01039.x; Spong CY, 2001, J PHARMACOL EXP THER, V297, P774; Su LD, 2010, ALCOHOL CLIN EXP RES, V34, P1140, DOI 10.1111/j.1530-0277.2010.01190.x; Takeda Y, 1996, J NEUROCHEM, V66, P2338; Tang NF, 2006, J NEUROCHEM, V96, P1480, DOI 10.1111/j.1471-4159.2006.03649.x; TORVIK A, 1986, J NEUROL SCI, V75, P43, DOI 10.1016/0022-510X(86)90049-3; Vaudry D, 2002, P NATL ACAD SCI USA, V99, P6398, DOI 10.1073/pnas.082112699; Vink J, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2009.01.052; Wilkemeyer MF, 1999, ALCOHOL CLIN EXP RES, V23, P1711, DOI 10.1097/00000374-199911000-00002; Wilkemeyer MF, 2003, P NATL ACAD SCI USA, V100, P8543, DOI 10.1073/pnas.1331636100; Wilkemeyer MF, 2002, J PHARMACOL EXP THER, V303, P110, DOI 10.1124/jpet.102.036277; Wilkemeyer WF, 2000, P NATL ACAD SCI USA, V97, P3690, DOI 10.1073/pnas.97.7.3690; Wu JH, 2011, BIOCHEM BIOPH RES CO, V406, P47, DOI 10.1016/j.bbrc.2011.01.104; Wu JF, 2010, GLIA, V58, P315, DOI 10.1002/glia.20925; Yagle K, 1999, ALCOHOL CLIN EXP RES, V23, P446, DOI 10.1097/00000374-199903000-00010; Yazaki T, 1996, MOL BRAIN RES, V43, P311, DOI 10.1016/S0169-328X(96)00186-6; Yeaney NK, 2009, J NEUROCHEM, V110, P779, DOI 10.1111/j.1471-4159.2009.06143.x; Zhang Y, 2005, P NATL ACAD SCI USA, V102, P14883, DOI 10.1073/pnas.0505164102; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047; Zhou FC, 2004, J MOL NEUROSCI, V24, P189, DOI 10.1385/JMN:24:2:189	68	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e24364	10.1371/journal.pone.0024364	http://dx.doi.org/10.1371/journal.pone.0024364			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CK	21931691	Green Submitted, Green Published, gold			2022-12-25	WOS:000294802800042
J	Mellegard, H; Kovacs, AT; Lindback, T; Christensen, BE; Kuipers, OP; Granum, PE				Mellegard, Hilde; Kovacs, Akos T.; Lindback, Toril; Christensen, Bjorn E.; Kuipers, Oscar P.; Granum, Per E.			Transcriptional Responses of Bacillus cereus towards Challenges with the Polysaccharide Chitosan	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; ESCHERICHIA-COLI; POTASSIUM-TRANSPORT; MOLECULAR-WEIGHT; ANTIBACTERIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; CATION-TRANSPORT; LIGHT-SCATTERING; CHAIN STIFFNESS; EXPRESSION DATA	The antibacterial activity of the polysaccharide chitosan towards different bacterial species has been extensively documented. The response mechanisms of bacteria exposed to this biopolymer and the exact molecular mechanism of action, however, have hardly been investigated. This paper reports the transcriptome profiling using DNA microarrays of the type-strain of Bacillus cereus (ATCC 14579) exposed to subinhibitory concentrations of two water-soluble chitosan preparations with defined chemical characteristics (molecular weight and degree of acetylation (F-A)). The expression of 104 genes was significantly altered upon chitosan A (weight average molecular weight (M-w) 36.0 kDa, F-A = 0.01) exposure and 55 genes when treated with chitosan B (M-w 28.4 kDa, F-A = 0.16). Several of these genes are involved in ion transport, especially potassium influx (BC0753-BC0756). Upregulation of a potassium transporting system coincides with previous studies showing a permeabilizing effect on bacterial cells of this polymer with subsequent loss of potassium. Quantitative PCR confirmed the upregulation of the BC0753 gene encoding the K+-transporting ATPase subunit A. A markerless gene replacement method was used to construct a mutant strain deficient of genes encoding an ATP-driven K+ transport system (Kdp) and the KdpD sensor protein. Growth of this mutant strain in potassium limiting conditions and under salt stress did not affect the growth pattern or growth yield compared to the wild-type strain. The necessity of the Kdp system for potassium acquisition in B. cereus is therefore questionable. Genes involved in the metabolism of arginine, proline and other cellular constituents, in addition to genes involved in the gluconeogenesis, were also significantly affected. BC2798 encoding a chitin binding protein was significantly downregulated due to chitosan exposure. This study provides insight into the response mechanisms of B. cereus to chitosan treatment and the significance of the Kdp system in potassium influx under challenging conditions.	[Mellegard, Hilde; Lindback, Toril; Granum, Per E.] Norwegian Sch Vet Sci, Dept Food Safety & Infect Biol, Oslo, Norway; [Kovacs, Akos T.; Kuipers, Oscar P.] Univ Groningen, Mol Genet Grp, Groningen Biomol Sci & Biotechnol Inst, Groningen, Netherlands; [Christensen, Bjorn E.] Norwegian Univ Sci & Technol, NOBIPOL, Dept Biotechnol, N-7034 Trondheim, Norway	Norwegian University of Life Sciences; University of Groningen; Norwegian University of Science & Technology (NTNU)	Mellegard, H (corresponding author), Norwegian Sch Vet Sci, Dept Food Safety & Infect Biol, Oslo, Norway.	pereinar.granum@nvh.no	Kovács, Ákos T/A-9433-2015; Christensen, Bjørn E. E./G-6033-2015; Kuipers, Oscar/B-6752-2009; Lindbäck, Toril/AAZ-9278-2020	Kovács, Ákos T/0000-0002-4465-1636; Christensen, Bjørn E. E./0000-0002-1135-9815; Kuipers, Oscar/0000-0001-5596-7735; Lindback, Toril/0000-0002-5245-1087	Research Council of Norway [173243/I10]; Tine SA; ALW-NWO (Division for Earth and Life Sciences of The Netherlands Organisation for Scientific Research) [818.02.004]	Research Council of Norway(Research Council of Norway); Tine SA; ALW-NWO (Division for Earth and Life Sciences of The Netherlands Organisation for Scientific Research)(Netherlands Organization for Scientific Research (NWO))	HM was supported by the Research Council of Norway (grant no. 173243/I10) and by Tine SA (http://www.tine.no/). ATK was financially supported by grant 818.02.004 from ALW-NWO (Division for Earth and Life Sciences of The Netherlands Organisation for Scientific Research) Open Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGATA N, 1995, FEMS MICROBIOL LETT, V129, P17, DOI 10.1016/0378-1097(95)00119-P; Allan G., 1989, CHITIN CHITOSAN; Altendorf K, 1998, ACTA PHYSIOL SCAND, V163, P137; ANTHONSEN MW, 1993, CARBOHYD POLYM, V22, P193, DOI 10.1016/0144-8617(93)90140-Y; ANTHONSEN MW, 1995, CARBOHYD POLYM, V26, P303, DOI 10.1016/0144-8617(95)00010-5; Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Arnesen LPS, 2008, FEMS MICROBIOL REV, V32, P579, DOI 10.1111/j.1574-6976.2008.00112.x; Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; Ballal A, 2007, J BIOSCIENCES, V32, P559, DOI 10.1007/s12038-007-0055-7; Beales N, 2004, COMPR REV FOOD SCI F, V3, P1, DOI 10.1111/j.1541-4337.2004.tb00057.x; Blom EJ, 2007, BIOINFORMATICS, V23, P1161, DOI 10.1093/bioinformatics/btl658; BOOTH IR, 1985, MICROBIOL REV, V49, P359, DOI 10.1128/MMBR.49.4.359-378.1985; Boraston AB, 2006, J BIOL CHEM, V281, P35263, DOI 10.1074/jbc.M607620200; CarrenoGomez B, 1997, INT J PHARM, V148, P231, DOI 10.1016/S0378-5173(96)04847-8; Ceragioli M, 2010, APPL ENVIRON MICROB, V76, P3352, DOI 10.1128/AEM.03003-09; Christensen BE, 2008, CARBOHYD POLYM, V74, P559, DOI 10.1016/j.carbpol.2008.04.012; Chung YC, 2008, BIORESOURCE TECHNOL, V99, P2806, DOI 10.1016/j.biortech.2007.06.044; Clavel T, 2004, J APPL MICROBIOL, V97, P214, DOI 10.1111/j.1365-2672.2004.02292.x; Devcich DA, 2007, APPETITE, V48, P333, DOI 10.1016/j.appet.2006.09.014; Dierick K, 2005, J CLIN MICROBIOL, V43, P4277, DOI 10.1128/JCM.43.8.4277-4279.2005; DOMARD A, 1987, INT J BIOL MACROMOL, V9, P98, DOI 10.1016/0141-8130(87)90033-X; Ehling-Schulz M, 2004, MOL NUTR FOOD RES, V48, P479, DOI 10.1002/mnfr.200400055; Epstein W, 2003, PROG NUCLEIC ACID RE, V75, P293, DOI 10.1016/S0079-6603(03)75008-9; EPSTEIN W, 1971, J BACTERIOL, V108, P639, DOI 10.1128/JB.108.2.639-644.1971; EPSTEIN W, 1986, FEMS MICROBIOL LETT, V39, P73; Fernandes JC, 2009, ULTRAMICROSCOPY, V109, P854, DOI 10.1016/j.ultramic.2009.03.015; Ficko-Blean E, 2009, J MOL BIOL, V390, P208, DOI 10.1016/j.jmb.2009.04.066; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Gaserod O, 1998, BIOMATERIALS, V19, P1815, DOI 10.1016/S0142-9612(98)00073-8; Gerasimenko DV, 2004, APPL BIOCHEM MICRO+, V40, P253, DOI 10.1023/B:ABIM.0000025947.84650.b4; Burgos MJG, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-227; Granum P. E., 2005, Foodborne pathogens: microbiology and molecular biology, P409; GRANUM PE, 1993, NETH MILK DAIRY J, V47, P63; Granum PE, 2007, FOOD MICROBIOLOGY: FUNDAMENTALS AND FRONTIERS, THIRD EDITION, P445; Guillen D, 2010, APPL MICROBIOL BIOT, V85, P1241, DOI 10.1007/s00253-009-2331-y; Hamann K, 2008, J BACTERIOL, V190, P2360, DOI 10.1128/JB.01635-07; Han CS, 2006, J BACTERIOL, V188, P3382, DOI 10.1128/JB.188.9.3382-3390.2006; Harwood C.R., 1990, MOL BIOL METHODS BAC; Heermann R, 2010, FEMS MICROBIOL LETT, V304, P97, DOI 10.1111/j.1574-6968.2010.01906.x; Helander IM, 2001, INT J FOOD MICROBIOL, V71, P235, DOI 10.1016/S0168-1605(01)00609-2; HENRIKSEN I, 1994, INT J PHARMACEUT, V101, P227, DOI 10.1016/0378-5173(94)90218-6; Holtmann G, 2003, J BACTERIOL, V185, P1289, DOI 10.1128/JB.185.4.1289-1298.2003; Janes BK, 2006, INFECT IMMUN, V74, P1949, DOI 10.1128/IAI.74.3.1949-1953.2006; Jeon YJ, 2001, CARBOHYD POLYM, V44, P71, DOI 10.1016/S0144-8617(00)00200-9; Kuipers OP, 2002, ANTON LEEUW INT J G, V82, P113, DOI 10.1023/A:1020691801251; Kumar BAV, 2007, BIOMACROMOLECULES, V8, P566, DOI 10.1021/bm060753z; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079; Liu H, 2004, INT J FOOD MICROBIOL, V95, P147, DOI 10.1016/j.ijfoodmicro.2004.01.022; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lund T, 2000, MOL MICROBIOL, V38, P254, DOI 10.1046/j.1365-2958.2000.02147.x; MAHILLON J, 1989, FEMS MICROBIOL LETT, V60, P205, DOI [10.1111/j.1574-6968.1989.tb03447.x, 10.1016/S0378-1097(98)00032-9]; Mahler H, 1997, NEW ENGL J MED, V336, P1142, DOI 10.1056/NEJM199704173361604; Mao SR, 2010, ADV DRUG DELIVER REV, V62, P12, DOI 10.1016/j.addr.2009.08.004; Mao SR, 2004, INT J PHARMACEUT, V281, P45, DOI 10.1016/j.ijpharm.2004.05.019; Maqueda M, 2004, CURR PROTEIN PEPT SC, V5, P399, DOI 10.2174/1389203043379567; Mellegard H, 2011, INT J FOOD MICROBIOL, V148, P48, DOI 10.1016/j.ijfoodmicro.2011.04.023; Mellegard H, 2011, INT J FOOD MICROBIOL, V149, P218, DOI 10.1016/j.ijfoodmicro.2011.06.013; Mols M, 2010, ENVIRON MICROBIOL, V12, P873, DOI 10.1111/j.1462-2920.2009.02132.x; Mols M, 2010, INT J FOOD MICROBIOL, V137, P13, DOI 10.1016/j.ijfoodmicro.2009.09.027; Nakamura T, 1998, J BACTERIOL, V180, P3491, DOI 10.1128/JB.180.13.3491-3494.1998; No HK, 2007, J FOOD SCI, V72, pR87, DOI 10.1111/j.1750-3841.2007.00383.x; No HK, 2002, INT J FOOD MICROBIOL, V74, P65, DOI 10.1016/S0168-1605(01)00717-6; Park PJ, 2004, J MICROBIOL BIOTECHN, V14, P317; Raafat D, 2008, APPL ENVIRON MICROB, V74, P7455, DOI 10.1128/AEM.02290-08; Raafat D, 2008, APPL ENVIRON MICROB, V74, P3764, DOI 10.1128/AEM.00453-08; Rabea EI, 2003, BIOMACROMOLECULES, V4, P1457, DOI 10.1021/bm034130m; Rhoades J, 2000, APPL ENVIRON MICROB, V66, P80, DOI 10.1128/AEM.66.1.80-86.2000; RHOADS DB, 1976, J GEN PHYSIOL, V67, P325, DOI 10.1085/jgp.67.3.325; RHOADS DB, 1978, J GEN PHYSIOL, V72, P283, DOI 10.1085/jgp.72.3.283; Richardson SCW, 1999, INT J PHARMACEUT, V178, P231, DOI 10.1016/S0378-5173(98)00378-0; SABRY SA, 1992, J BASIC MICROB, V32, P107, DOI 10.1002/jobm.3620320207; SCHLEYER M, 1993, ARCH MICROBIOL, V160, P424, DOI 10.1007/BF00245302; SCHLEYER M, 1993, J BACTERIOL, V175, P6925, DOI 10.1128/jb.175.21.6925-6931.1993; Shahidi F, 1999, TRENDS FOOD SCI TECH, V10, P37, DOI 10.1016/S0924-2244(99)00017-5; Sorlier P, 2001, BIOMACROMOLECULES, V2, P765, DOI 10.1021/bm015531+; SPIZIZEN J, 1958, P NATL ACAD SCI USA, V44, P1072, DOI 10.1073/pnas.44.10.1072; Strand SP, 2001, BIOMACROMOLECULES, V2, P1310, DOI 10.1021/bm015598x; Stumpe S, 1996, TRANSPORT PROCESSES, P473; Sturr MG, 1997, GENE, V188, P91, DOI 10.1016/S0378-1119(96)00784-6; Tsai GJ, 2002, FISHERIES SCI, V68, P170, DOI 10.1046/j.1444-2906.2002.00404.x; van Bueren AL, 2007, NAT STRUCT MOL BIOL, V14, P76, DOI 10.1038/nsmb1187; van Hijum Sacha A F T, 2003, Appl Bioinformatics, V2, P241; van Hijum SAFT, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-77; van Hijum SAFT, 2003, BIOINFORMATICS, V19, P1580, DOI 10.1093/bioinformatics/btg203; Varum K.M., 2005, VERSATILITY, P625; Wang W, 2000, J BACTERIOL, V182, P2088, DOI 10.1128/JB.182.8.2088-2095.2000; WHATMORE AM, 1990, J GEN MICROBIOL, V136, P2527, DOI 10.1099/00221287-136-12-2527; Xiong ZH, 2009, J BACTERIOL, V191, P1120, DOI 10.1128/JB.01629-08	90	9	9	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e24304	10.1371/journal.pone.0024304	http://dx.doi.org/10.1371/journal.pone.0024304			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CK	21931677	gold, Green Submitted, Green Published, Green Accepted			2022-12-25	WOS:000294802800038
J	Qin, AP; Scott, DW; Rabideau, MM; Moore, EA; Mann, BJ				Qin, Aiping; Scott, David W.; Rabideau, Meaghan M.; Moore, Emily A.; Mann, Barbara J.			Requirement of the CXXC Motif of Novel Francisella Infectivity Potentiator Protein B FipB, and FipA in Virulence of F. tularensis subsp tularensis	PLOS ONE			English	Article							DISULFIDE-BOND FORMATION; LEGIONELLA-PNEUMOPHILA; INTRACELLULAR SURVIVAL; PHAGOSOMAL ESCAPE; CRYSTAL-STRUCTURE; DSBA; MIP; ISOMERASE; IDENTIFICATION; ACIDIFICATION	The lipoprotein encoded by the Francisella tularensis subsp. tularensis locus FTT1103 is essential for virulence; an FTT1103 deletion mutant is defective in uptake and intracellular survival, and mice survive high dose challenges of greater than 10(8) bacteria. This protein has two conserved domains; one is found in a class of virulence proteins called macrophage infectivity potentiator (Mip) proteins, and the other in oxidoreductase Disulfide Bond formation protein A (DsbA)-related proteins. We have designated the protein encoded by FTT1103 as FipB for Francisella infectivity potentiator protein B. The locus FTT1102 (fipA), which is upstream of fipB, also has similarity to same conserved Mip domain. Deletion and site-specific mutants of fipA and fipB were constructed in the Schu S4 strain, and characterized with respect to intracellular replication and in vivo virulence. A nonpolar fipA mutant demonstrated reduced survival in host cells, but was only slightly attenuated in vivo. Although FipB protein was present in a fipA mutant, the abundance of the three isoforms of FipB was altered, suggesting that FipA has a role in post-translational modification of FipB. Similar to many DsbA homologues, FipB contains a cysteine-any amino acid-any amino acid-cysteine (CXXC) motif. This motif was found to be important for FipB's role in virulence; a deletion mutant complemented with a gene encoding a FipB protein in which the first cysteine was changed to an alanine residue (AXXC) failed to restore intracellular survival or in vivo virulence. Complementation with a gene that encoded a CXXA containing FipB protein was significantly defective in intracellular growth; however, only slightly attenuated in vivo.	[Qin, Aiping; Scott, David W.; Rabideau, Meaghan M.; Moore, Emily A.; Mann, Barbara J.] Univ Virginia, Dept Med, Charlottesville, VA 22903 USA; [Mann, Barbara J.] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; [Qin, Aiping] Chinese Ctr Dis Control & Prevent, Off Lab Management, Beijing, Peoples R China	University of Virginia; University of Virginia; Chinese Center for Disease Control & Prevention	Qin, AP (corresponding author), Univ Virginia, Dept Med, Charlottesville, VA 22903 USA.	bjm2r@virginia.edu			NIH/NIAID [R56AI79035]; Middle Atlantic Regional Center of Excellence for Biodefense [U54 AI05716]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI079035, U54AI057168] Funding Source: NIH RePORTER	NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Middle Atlantic Regional Center of Excellence for Biodefense; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH/NIAID grants R56AI79035 to BJM and Middle Atlantic Regional Center of Excellence for Biodefense U54 AI05716. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibek Ken., 1999, BIOHAZARD; ANTHONY LSD, 1991, INFECT IMMUN, V59, P3291, DOI 10.1128/IAI.59.9.3291-3296.1991; Balonova L, 2010, J PROTEOME RES, V9, P1995, DOI 10.1021/pr9011602; Barker JR, 2009, MOL MICROBIOL, V74, P1459, DOI 10.1111/j.1365-2958.2009.06947.x; Bouwman CW, 2003, J BACTERIOL, V185, P991, DOI 10.1128/JB.185.3.991-1000.2003; Checroun C, 2006, P NATL ACAD SCI USA, V103, P14578, DOI 10.1073/pnas.0601838103; Chong A, 2008, INFECT IMMUN, V76, P5488, DOI 10.1128/IAI.00682-08; Clemens DL, 2009, INFECT IMMUN, V77, P1757, DOI 10.1128/IAI.01485-08; CONLAN JW, 1992, INFECT IMMUN, V60, P5164, DOI 10.1128/IAI.60.12.5164-5171.1992; DebRoy S, 2006, INFECT IMMUN, V74, P5152, DOI 10.1128/IAI.00484-06; Dennis DT, 2001, JAMA-J AM MED ASSOC, V285, P2763, DOI 10.1001/jama.285.21.2763; Ellermeier CD, 2004, J BACTERIOL, V186, P68, DOI 10.1128/JB.186.1.68-79.2004; Forestal CA, 2003, J IMMUNOL, V171, P2563, DOI 10.4049/jimmunol.171.5.2563; GUILHOT C, 1995, P NATL ACAD SCI USA, V92, P9895, DOI 10.1073/pnas.92.21.9895; Ha UH, 2003, INFECT IMMUN, V71, P1590, DOI 10.1128/IAI.71.3.1590-1595.2003; HENDRIX LR, 1993, INFECT IMMUN, V61, P470, DOI 10.1128/IAI.61.2.470-477.1993; Heras B, 2009, NAT REV MICROBIOL, V7, P215, DOI 10.1038/nrmicro2087; Horzempa J, 2010, INFECT IMMUN, V78, P2607, DOI 10.1128/IAI.00134-10; Jameson-Lee M, 2011, MOL MICROBIOL, V80, P835, DOI 10.1111/j.1365-2958.2011.07615.x; Kadokura H, 2010, ANTIOXID REDOX SIGN, V13, P1231, DOI 10.1089/ars.2010.3187; KISHIGAMI S, 1995, J BIOL CHEM, V270, P17072, DOI 10.1074/jbc.270.29.17072; Kohler R, 2003, INFECT IMMUN, V71, P4389, DOI 10.1128/IAI.71.8.4389-4397.2003; Leuzzi R, 2005, MOL MICROBIOL, V58, P669, DOI 10.1111/j.1365-2958.2005.04859.x; LoVullo ED, 2009, MICROBIOL-SGM, V155, P1152, DOI 10.1099/mic.0.022491-0; Maier TM, 2004, APPL ENVIRON MICROB, V70, P7511, DOI 10.1128/AEM.70.12.7511-7519.2004; MARTIN JL, 1993, NATURE, V365, P464, DOI 10.1038/365464a0; Miki T, 2004, J BIOL CHEM, V279, P34631, DOI 10.1074/jbc.M402760200; Nano FE, 2007, ANN NY ACAD SCI, V1105, P122, DOI 10.1196/annals.1409.000; Neff L, 2007, J BACTERIOL, V189, P4739, DOI 10.1128/JB.01889-06; Oyston PCF, 2009, VACCINE, V27, pD48, DOI 10.1016/j.vaccine.2009.07.090; Qin AP, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-69; Qin AP, 2009, INFECT IMMUN, V77, P152, DOI 10.1128/IAI.01113-08; Quan S, 2007, J BIOL CHEM, V282, P28823, DOI 10.1074/jbc.M705291200; Riboldi-Tunnicliffe A, 2001, NAT STRUCT BIOL, V8, P779, DOI 10.1038/nsb0901-779; Santic M, 2008, INFECT IMMUN, V76, P2671, DOI 10.1128/IAI.00185-08; Santic M, 2007, CELL MICROBIOL, V9, P2391, DOI 10.1111/j.1462-5822.2007.00968.x; SCHMIDT B, 1994, FEBS LETT, V352, P185, DOI 10.1016/0014-5793(94)00970-8; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Sinha S, 2004, MICROBIOL-SGM, V150, P2993, DOI 10.1099/mic.0.27216-0; Straskova A, 2009, J PROTEOME RES, V8, P5336, DOI 10.1021/pr900570b; Sullivan JT, 2006, J BACTERIOL, V188, P3785, DOI 10.1128/JB.00027-06; Thomas RM, 2011, J BACTERIOL; Wagner C, 2007, CELL MICROBIOL, V9, P450, DOI 10.1111/j.1462-5822.2006.00802.x; WINTERMEYER E, 1995, INFECT IMMUN, V63, P4576, DOI 10.1128/IAI.63.12.4576-4583.1995; Yu J, 1998, INFECT IMMUN, V66, P3909, DOI 10.1128/IAI.66.8.3909-3917.1998; Yu J, 1999, MICROBES INFECT, V1, P1221, DOI 10.1016/S1286-4579(99)00239-7	46	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e24611	10.1371/journal.pone.0024611	http://dx.doi.org/10.1371/journal.pone.0024611			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CK	21931773	Green Published, Green Submitted, gold			2022-12-25	WOS:000294802800070
J	Scheer, FAJL; Michelson, AD; Frelinger, AL; Evoniuk, H; Kelly, EE; McCarthy, M; Doamekpor, LA; Barnard, MR; Shea, SA				Scheer, Frank A. J. L.; Michelson, Alan D.; Frelinger, Andrew L., III; Evoniuk, Heather; Kelly, Erin E.; McCarthy, Mary; Doamekpor, Lauren A.; Barnard, Marc R.; Shea, Steven A.			The Human Endogenous Circadian System Causes Greatest Platelet Activation during the Biological Morning Independent of Behaviors	PLOS ONE			English	Article							FLOW-CYTOMETRY; MELATONIN; RHYTHM; AGGREGATION; FREQUENCY; EXERCISE; INCREASE; ONSET	Background: Platelets are involved in the thromboses that are central to myocardial infarctions and ischemic strokes. Such adverse cardiovascular events have day/night patterns with peaks in the morning (similar to 9AM), potentially related to endogenous circadian clock control of platelet activation. The objective was to test if the human endogenous circadian system influences (1) platelet function and (2) platelet response to standardized behavioral stressors. We also aimed to compare the magnitude of any effects on platelet function caused by the circadian system with that caused by varied standardized behavioral stressors, including mental arithmetic, passive postural tilt and mild cycling exercise. Methodology/Principal Findings: We studied 12 healthy adults (6 female) who lived in individual laboratory suites in dim light for 240 h, with all behaviors scheduled on a 20-h recurring cycle to permit assessment of endogenous circadian function independent from environmental and behavioral effects including the sleep/wake cycle. Circadian phase was assessed from core body temperature. There were highly significant endogenous circadian rhythms in platelet surface activated glycoprotein (GP) IIb-IIIa, GPIb and P-selectin (6-17% peak-trough amplitudes; p <= 0.01). These circadian peaks occurred at a circadian phase corresponding to 8-9AM. Platelet count, ATP release, aggregability, and plasma epinephrine also had significant circadian rhythms but with later peaks (corresponding to 3-8PM). The circadian effects on the platelet activation markers were always larger than that of any of the three behavioral stressors. Conclusions/Significance: These data demonstrate robust effects of the endogenous circadian system on platelet activation in humans-independent of the sleep/wake cycle, other behavioral influences and the environment. The similar to 9AM timing of the circadian peaks of the three platelet surface markers, including platelet surface activated GPIIb-IIIa, the final common pathway of platelet aggregation, suggests that endogenous circadian influences on platelet function could contribute to the morning peak in adverse cardiovascular events as seen in many epidemiological studies.	[Scheer, Frank A. J. L.; Evoniuk, Heather; Kelly, Erin E.; McCarthy, Mary; Doamekpor, Lauren A.; Shea, Steven A.] Brigham & Womens Hosp, Med Chronobiol Program, Div Sleep Med, Boston, MA 02115 USA; [Scheer, Frank A. J. L.; Shea, Steven A.] Harvard Univ, Sch Med, Div Sleep Med, Boston, MA USA; [Michelson, Alan D.; Frelinger, Andrew L., III; Barnard, Marc R.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Ctr Platelet Res Studies,Div Hematol Oncol,Childr, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Scheer, FAJL (corresponding author), Brigham & Womens Hosp, Med Chronobiol Program, Div Sleep Med, 75 Francis St, Boston, MA 02115 USA.	fscheer@rics.bwh.harvard.edu; sshea@hms.harvard.edu	Michelson, Alan/ABE-8487-2021; Scheer, Frank A.J.L./C-2795-2012	Michelson, Alan/0000-0002-1746-4819; Scheer, Frank A.J.L./0000-0002-2014-7582; Shea, Steven/0000-0003-1949-0954; Frelinger, Andrew/0000-0002-6871-7441	National Institutes of Health [NIH-R01-HL76409, NIH-K24-HL076446, NIH-P30-HL101299];  [NCRR-GCRC-M01-RR02635]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P30HL101299, R01HL076409, K24HL076446] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	National Institutes of Health: NIH-R01-HL76409; NIH-K24-HL076446 in support of SAS; NIH-P30-HL101299 in support of FAJLS; NCRR-GCRC-M01-RR02635. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews NP, 1996, J AM COLL CARDIOL, V28, P1789, DOI 10.1016/S0735-1097(96)00398-1; Bedard PW, 2008, J PHARMACOL EXP THER, V324, P497, DOI 10.1124/jpet.107.128124; Casetta I, 2002, ARCH NEUROL-CHICAGO, V59, P48, DOI 10.1001/archneur.59.1.48; Coller BS, 1997, J CLIN INVEST, V99, P1467, DOI 10.1172/JCI119307; CORNELISSEN G, 1991, JAMA-J AM MED ASSOC, V266, P3128, DOI 10.1001/jama.266.22.3128; Czeisler CA, 1999, SCIENCE, V284, P2177, DOI 10.1126/science.284.5423.2177; DELZAR MD, 1990, J CLIN ENDOCR METAB, V70, P246; Fontayne A, 2008, THROMB HAEMOSTASIS, V100, P670, DOI 10.1160/TH08-02-0073; HOLME S, 1988, J LAB CLIN MED, V112, P223; Hu K, 2011, CIRCULATION, V123, P961, DOI 10.1161/CIRCULATIONAHA.110.943019; IMADA T, 1983, THROMB RES, V31, P807, DOI 10.1016/0049-3848(83)90112-3; KESTIN AS, 1993, CIRCULATION, V88, P1502, DOI 10.1161/01.CIR.88.4.1502; KNUTSSON A, 1986, LANCET, V2, P89; KROLL MH, 1991, J CLIN INVEST, V88, P1568, DOI 10.1172/JCI115468; LIBRE EP, 1968, BLOOD, V31, P358, DOI 10.1182/blood.V31.3.358.358; Linden MD, 2004, SEMIN THROMB HEMOST, V30, P501, DOI 10.1055/s-2004-835671; McEver RP, 2007, PLATELETS; Michelson AD, 2009, AM J CARDIOL, V103, p20A, DOI 10.1016/j.amjcard.2008.11.019; MULLER JE, 1987, CIRCULATION, V75, P131, DOI 10.1161/01.CIR.75.1.131; MULLER JE, 1985, NEW ENGL J MED, V313, P1315, DOI 10.1056/NEJM198511213132103; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; Ohkura N, 2009, THROMB RES, V123, P523, DOI 10.1016/j.thromres.2008.03.009; RADHA E, 1985, THROMB RES, V40, P823, DOI 10.1016/0049-3848(85)90319-6; Reid KJ, 2009, SEMIN NEUROL, V29, P393, DOI 10.1055/s-0029-1237120; RODEN M, 1993, AM J PHYSIOL, V265, pR261, DOI 10.1152/ajpregu.1993.265.1.R261; Ruggeri ZM, 2002, NAT MED, V8, P1227, DOI 10.1038/nm1102-1227; SACK RL, 1992, SLEEP, V15, P434, DOI 10.1093/sleep/15.5.434; Scheer FA, 2005, SLEEP MED REV, V9, P5, DOI 10.1016/j.smrv.2004.11.004; Scheer FAJL, 2010, P NATL ACAD SCI USA, V107, P20541, DOI 10.1073/pnas.1006749107; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; SHATTIL SJ, 1985, J BIOL CHEM, V260, P1107; Shea SA, 2011, CIRC RES, V108, P980, DOI 10.1161/CIRCRESAHA.110.233668; Somanath PR, 2011, J CELL PHYSIOL, V226, P132, DOI 10.1002/jcp.22314; TOFLER GH, 1987, NEW ENGL J MED, V316, P1514, DOI 10.1056/NEJM198706113162405; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Zhao Y, 2011, THROMB RES, V127, P122, DOI 10.1016/j.thromres.2010.11.025	36	113	118	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e24549	10.1371/journal.pone.0024549	http://dx.doi.org/10.1371/journal.pone.0024549			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CK	21931750	Green Published, gold, Green Submitted			2022-12-25	WOS:000294802800064
J	Webb, TJ; Rolls, ET; Deco, G; Feng, JF				Webb, Tristan J.; Rolls, Edmund T.; Deco, Gustavo; Feng, Jianfeng			Noise in Attractor Networks in the Brain Produced by Graded Firing Rate Representations	PLOS ONE			English	Article							DECISION-MAKING; NEURONAL REPRESENTATIONS; ORBITOFRONTAL CORTEX; RECURRENT NETWORK; TASTE CORTEX; FAT TEXTURE; INFORMATION; GRITTINESS; VISCOSITY; DYNAMICS	Representations in the cortex are often distributed with graded firing rates in the neuronal populations. The firing rate probability distribution of each neuron to a set of stimuli is often exponential or gamma. In processes in the brain, such as decision-making, that are influenced by the noise produced by the close to random spike timings of each neuron for a given mean rate, the noise with this graded type of representation may be larger than with the binary firing rate distribution that is usually investigated. In integrate-and-fire simulations of an attractor decision-making network, we show that the noise is indeed greater for a given sparseness of the representation for graded, exponential, than for binary firing rate distributions. The greater noise was measured by faster escaping times from the spontaneous firing rate state when the decision cues are applied, and this corresponds to faster decision or reaction times. The greater noise was also evident as less stability of the spontaneous firing state before the decision cues are applied. The implication is that spiking-related noise will continue to be a factor that influences processes such as decision-making, signal detection, short-term memory, and memory recall even with the quite large networks found in the cerebral cortex. In these networks there are several thousand recurrent collateral synapses onto each neuron. The greater noise with graded firing rate distributions has the advantage that it can increase the speed of operation of cortical circuitry.	[Webb, Tristan J.; Rolls, Edmund T.; Feng, Jianfeng] Univ Warwick, Dept Comp Sci, Coventry CV4 7AL, W Midlands, England; [Webb, Tristan J.; Feng, Jianfeng] Univ Warwick, Complex Sci Ctr, Coventry CV4 7AL, W Midlands, England; [Rolls, Edmund T.] Oxford Ctr Computat Neurosci, Oxford, England; [Deco, Gustavo] Univ Pompeu Fabra, Barcelona, Spain	University of Warwick; University of Warwick; University of Oxford; Pompeu Fabra University	Webb, TJ (corresponding author), Univ Warwick, Dept Comp Sci, Coventry CV4 7AL, W Midlands, England.	Edmund.Rolls@oxcns.org	2010, BRAINGLOT Consolider Ingenio/D-1235-2009; DECO, GUSTAVO/A-6341-2008	DECO, GUSTAVO/0000-0002-8995-7583; Rolls, Edmund/0000-0003-3025-1292; feng, jianfeng/0000-0002-9328-5732	Oxford Centre for Computational Neuroscience; McDonnell Centre for Cognitive Neuroscience at Oxford University; Spanish Ministry of Science	Oxford Centre for Computational Neuroscience; McDonnell Centre for Cognitive Neuroscience at Oxford University; Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	The research was supported by the Oxford Centre for Computational Neuroscience. G. D. received support from the McDonnell Centre for Cognitive Neuroscience at Oxford University, and from grant CONSOLIDER Bilingualism and Cognitive Neuroscience and project BFU (Spanish Ministry of Science). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeles M, 1991, CORTICONICS NEURAL C, DOI DOI 10.1017/CBO9780511574566; Albantakis L, 2009, P NATL ACAD SCI USA, V106, P10308, DOI 10.1073/pnas.0901621106; Amit DJ, 1997, NETWORK-COMP NEURAL, V8, P373, DOI 10.1088/0954-898X/8/4/003; Amit DJ, 1989, MODELING BRAIN FUNCT, DOI 10.1017/CBO9780511623257; [Anonymous], 1998, NEURAL NETWORKS BRAI; Baddeley R, 1997, P ROY SOC B-BIOL SCI, V264, P1775, DOI 10.1098/rspb.1997.0246; Beamish D, 2006, J R SOC INTERFACE, V3, P649, DOI 10.1098/rsif.2006.0123; Braitenberg V, 1991, ANATOMY CORTEX; Brody CD, 2003, CURR OPIN NEUROBIOL, V13, P204, DOI 10.1016/S0959-4388(03)00050-3; Brunel N, 2001, J COMPUT NEUROSCI, V11, P63, DOI 10.1023/A:1011204814320; Buehlmann A, 2008, J NEUROSCI, V28, P7679, DOI 10.1523/JNEUROSCI.5640-07.2008; Burkitt AN, 2006, BIOL CYBERN, V95, P1, DOI 10.1007/s00422-006-0068-6; Churchland AK, 2008, NAT NEUROSCI, V11, P693, DOI 10.1038/nn.2123; De Polavieja GG, 2002, J THEOR BIOL, V214, P657, DOI 10.1006/jtbi.2001.2498; Deco G, 2005, CEREB CORTEX, V15, P15, DOI 10.1093/cercor/bhh103; Deco G, 2006, EUR J NEUROSCI, V24, P901, DOI 10.1111/j.1460-9568.2006.04940.x; Deco G, 2009, PROG NEUROBIOL, V88, P1, DOI 10.1016/j.pneurobio.2009.01.006; Elston GN, 2006, ANAT REC PART A, V288A, P26, DOI 10.1002/ar.a.20278; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; Franco L, 2007, BIOL CYBERN, V96, P547, DOI 10.1007/s00422-007-0149-1; Furman M, 2008, NEURON, V60, P1153, DOI 10.1016/j.neuron.2008.12.003; Hertz JA, 2018, INTRO THEORY NEURAL; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Kadohisa M, 2005, CHEM SENSES, V30, P401, DOI 10.1093/chemse/bji036; Kadohisa M, 2005, NEUROSCIENCE, V132, P33, DOI 10.1016/j.neuroscience.2004.12.005; Knight BW, 2000, NEURAL COMPUT, V12, P473, DOI 10.1162/089976600300015673; Levy WB, 1996, NEURAL COMPUT, V8, P531, DOI 10.1162/neco.1996.8.3.531; Liu F, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000253; Loh M, 2007, PHARMACOPSYCHIATRY, V40, pS78, DOI 10.1055/s-2007-990304; Loh M, 2007, PLOS COMPUT BIOL, V3, P2255, DOI 10.1371/journal.pcbi.0030228; Marti D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002534; Miller P, 2006, J NEUROPHYSIOL, V95, P1099, DOI 10.1152/jn.00491.2005; Nordlie E, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000456; Panzeri S, 2001, NETWORK-COMP NEURAL, V12, P423, DOI 10.1088/0954-898X/12/4/302; Panzeri S, 1996, NETWORK-COMP NEURAL, V7, P365, DOI 10.1088/0954-898X/7/2/018; Ratcliff R, 1999, PSYCHOL REV, V106, P261, DOI 10.1037/0033-295X.106.2.261; Ratcliff R, 1998, PSYCHOL SCI, V9, P347, DOI 10.1111/1467-9280.00067; Rolls E.T., 2010, NOISY BRAIN STOCHAST; Rolls E.T., 2008, MEMORY ATTENTION DEC; Rolls ET, 2008, NAT REV NEUROSCI, V9, P696, DOI 10.1038/nrn2462; Rolls ET, 2008, EUR J NEUROSCI, V28, P782, DOI 10.1111/j.1460-9568.2008.06379.x; Rolls ET, 2011, NEUROSCI BIOBEHAV R, V35, P1644, DOI 10.1016/j.neubiorev.2010.09.001; Rolls ET, 2010, J NEUROPHYSIOL, V104, P2359, DOI 10.1152/jn.00571.2010; Rolls ET, 2010, NEUROIMAGE, V53, P694, DOI 10.1016/j.neuroimage.2010.06.073; Rolls ET, 2010, CHEMOSENS PERCEPT, V3, P16, DOI 10.1007/s12078-009-9054-4; Rolls ET, 1990, NETWORK-COMP NEURAL, V1, P407, DOI 10.1088/0954-898X/1/4/002; ROLLS ET, 1995, J NEUROPHYSIOL, V73, P713, DOI 10.1152/jn.1995.73.2.713; Rolls ET, 1998, J NEUROPHYSIOL, V79, P1797, DOI 10.1152/jn.1998.79.4.1797; Rolls ET, 2003, PROG BRAIN RES, V144, P95, DOI 10.1016/S0079-6123(03)14400-6; Rolls ET, 1996, J NEUROPHYSIOL, V75, P1982, DOI 10.1152/jn.1996.75.5.1982; Rolls ET, 2003, J NEUROPHYSIOL, V90, P3711, DOI 10.1152/jn.00515.2003; Rolls ET, 1997, NEURAL NETWORKS, V10, P1559, DOI 10.1016/S0893-6080(97)00092-0; Rolls ET, 1999, J COGNITIVE NEUROSCI, V11, P300, DOI 10.1162/089892999563409; Rolls ET, 1997, J COMPUT NEUROSCI, V4, P309, DOI 10.1023/A:1008899916425; Rolls ET, 2011, PROGR NEURO IN PRESS; Rolls ET, 2011, BRAIN RES IN PRESS; Rolls ET, 2011, PHARM BIOCH BEHAV; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Smerieri A, 2010, J NEUROSCI, V30, P14173, DOI 10.1523/JNEUROSCI.0945-10.2010; SOFTKY WR, 1993, J NEUROSCI, V13, P334; TREVES A, 1991, NETWORK-COMP NEURAL, V2, P371, DOI 10.1088/0954-898X/2/4/004; Treves A, 1999, NEURAL COMPUT, V11, P601, DOI 10.1162/089976699300016593; Verhagen JV, 2004, J NEUROPHYSIOL, V92, P1685, DOI 10.1152/jn.00321.2004; Wang XJ, 2008, NEURON, V60, P215, DOI 10.1016/j.neuron.2008.09.034; Wang XJ, 2002, NEURON, V36, P955, DOI 10.1016/S0896-6273(02)01092-9	65	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e23630	10.1371/journal.pone.0023630	http://dx.doi.org/10.1371/journal.pone.0023630			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CK	21931607	gold, Green Published, Green Submitted			2022-12-25	WOS:000294802800007
J	Katahira, K; Suzuki, K; Okanoya, K; Okada, M				Katahira, Kentaro; Suzuki, Kenta; Okanoya, Kazuo; Okada, Masato			Complex Sequencing Rules of Birdsong Can be Explained by Simple Hidden Markov Processes	PLOS ONE			English	Article							NEURAL-NETWORK MODEL; AUDITORY-FEEDBACK; BENGALESE FINCH; SONG; GENERATION; PHONOLOGY; DYNAMICS; SPEECH	Complex sequencing rules observed in birdsongs provide an opportunity to investigate the neural mechanism for generating complex sequential behaviors. To relate the findings from studying birdsongs to other sequential behaviors such as human speech and musical performance, it is crucial to characterize the statistical properties of the sequencing rules in birdsongs. However, the properties of the sequencing rules in birdsongs have not yet been fully addressed. In this study, we investigate the statistical properties of the complex birdsong of the Bengalese finch (Lonchura striata var. domestica). Based on manual-annotated syllable labeles, we first show that there are significant higher-order context dependencies in Bengalese finch songs, that is, which syllable appears next depends on more than one previous syllable. We then analyze acoustic features of the song and show that higher-order context dependencies can be explained using first-order hidden state transition dynamics with redundant hidden states. This model corresponds to hidden Markov models (HMMs), well known statistical models with a large range of application for time series modeling. The song annotation with these models with first-order hidden state dynamics agreed well with manual annotation, the score was comparable to that of a second-order HMM, and surpassed the zeroth-order model (the Gaussian mixture model; GMM), which does not use context information. Our results imply that the hierarchical representation with hidden state dynamics may underlie the neural implementation for generating complex behavioral sequences with higher-order dependencies.	[Katahira, Kentaro; Suzuki, Kenta; Okanoya, Kazuo; Okada, Masato] Japan Sci & Technol Agcy, Okanoya Emot Informat Project, ERATO, Saitama, Japan; [Katahira, Kentaro; Okada, Masato] Univ Tokyo, Grad Sch Frontier Sci, Chiba, Japan; [Katahira, Kentaro; Suzuki, Kenta; Okanoya, Kazuo; Okada, Masato] RIKEN, Brain Sci Inst, Saitama, Japan; [Suzuki, Kenta] Saitama Univ, Grad Sch Sci & Engn, Saitama 3388570, Japan; [Okanoya, Kazuo] Univ Tokyo, Grad Sch Arts & Sci, Tokyo, Japan	Japan Science & Technology Agency (JST); University of Tokyo; RIKEN; Saitama University; University of Tokyo	Katahira, K (corresponding author), Japan Sci & Technol Agcy, Okanoya Emot Informat Project, ERATO, Saitama, Japan.	okada@k.u-tokyo.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [18079003, 20240020, 20650019]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was partially supported by Grants-in-Aid for Scientific Research (18079003, 20240020, 20650019) from the Ministry of Education, Culture, Sports, Science and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Attias H, 1999, UNCERTAINTY IN ARTIFICIAL INTELLIGENCE, PROCEEDINGS, P21; Beal M.J., 2003, VARIATIONAL ALGORITH; Bishop C.M., 2006, PATTERN RECOGNITION; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; FLEISS JL, 1971, PSYCHOL BULL, V76, P378, DOI 10.1037/h0031619; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Honda E, 1999, ZOOL SCI, V16, P319, DOI 10.2108/zsj.16.319; Hosino T, 2000, NEUROREPORT, V11, P2091, DOI 10.1097/00001756-200007140-00007; Jin DZ, 2007, J COMPUT NEUROSCI, V23, P283, DOI 10.1007/s10827-007-0032-z; Jin DZ, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001108; Jin DZ, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.051902; Katahira K, 2007, BIOL CYBERN, V97, P441, DOI 10.1007/s00422-007-0184-y; Katahira K, 2010, NEURAL COMPUT, V22, P2369, DOI 10.1162/neco.2010.08-08-838; Kogan JA, 1998, J ACOUST SOC AM, V103, P2185, DOI 10.1121/1.421364; Leonardo A, 2005, J NEUROSCI, V25, P652, DOI 10.1523/JNEUROSCI.3036-04.2005; Long MA, 2008, NATURE, V456, P189, DOI 10.1038/nature07448; MACKAY DJC, 1992, NEURAL COMPUT, V4, P415, DOI [10.1162/neco.1992.4.3.415, 10.1162/neco.1992.4.3.448]; Okanoya K, 2004, ADV STUD BEHAV, V34, P297, DOI 10.1016/S0065-3454(04)34008-8; Okanoya K, 1997, J NEUROBIOL, V33, P343; Okanoya K, 2006, ANN NY ACAD SCI, V1016, P724; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Sakata JT, 2006, J NEUROSCI, V26, P9619, DOI 10.1523/JNEUROSCI.2027-06.2006; Sakata JT, 2009, J NEUROPHYSIOL, V102, P2485, DOI 10.1152/jn.00340.2009; Sober SJ, 2008, J NEUROSCI, V28, P10370, DOI 10.1523/JNEUROSCI.2448-08.2008; Tchernichovski O, 2000, ANIM BEHAV, V59, P1167, DOI 10.1006/anbe.1999.1416; Wohlgemuth MJ, 2010, J NEUROSCI, V30, P12936, DOI 10.1523/JNEUROSCI.2690-10.2010; Wu W, 2008, J NEUROSCI METH, V174, P147, DOI 10.1016/j.jneumeth.2008.06.033; Yamashita Y, 2008, NEURAL NETWORKS, V21, P1224, DOI 10.1016/j.neunet.2008.03.003; Yu AC, 1996, SCIENCE, V273, P1871, DOI 10.1126/science.273.5283.1871	29	39	39	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2011	6	9							e24516	10.1371/journal.pone.0024516	http://dx.doi.org/10.1371/journal.pone.0024516			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CH	21915345	Green Submitted, Green Published, gold			2022-12-25	WOS:000294802500056
J	Lemaire, B; Vandamme, P; Merckx, V; Smets, E; Dessein, S				Lemaire, Benny; Vandamme, Peter; Merckx, Vincent; Smets, Erik; Dessein, Steven			Bacterial Leaf Symbiosis in Angiosperms: Host Specificity without Co-Speciation	PLOS ONE			English	Article							AZOLLA-ANABAENA SYMBIOSIS; FOSSIL FLOWERS; NORTH-AMERICA; ENDOPHYTE CONTINUITY; EPIDERMAL TRICHOMES; NONCODING REGIONS; LIFE-CYCLE; RUBIACEAE; EVOLUTION; ENDOSYMBIONTS	Bacterial leaf symbiosis is a unique and intimate interaction between bacteria and flowering plants, in which endosymbionts are organized in specialized leaf structures. Previously, bacterial leaf symbiosis has been described as a cyclic and obligate interaction in which the endosymbionts are vertically transmitted between plant generations and lack autonomous growth. Theoretically this allows for co-speciation between leaf nodulated plants and their endosymbionts. We sequenced the nodulated Burkholderia endosymbionts of 54 plant species from known leaf nodulated angiosperm genera, i.e. Ardisia, Pavetta, Psychotria and Sericanthe. Phylogenetic reconstruction of bacterial leaf symbionts and closely related free-living bacteria indicates the occurrence of multiple horizontal transfers of bacteria from the environment to leaf nodulated plant species. This rejects the hypothesis of a long co-speciation process between the bacterial endosymbionts and their host plants. Our results indicate a recent evolutionary process towards a stable and host specific interaction confirming the proposed maternal transmission mode of the endosymbionts through the seeds. Divergence estimates provide evidence for a relatively recent origin of bacterial leaf symbiosis, dating back to the Miocene (5-23 Mya). This geological epoch was characterized by cool and arid conditions, which may have triggered the origin of bacterial leaf symbiosis.	[Lemaire, Benny; Smets, Erik] Katholieke Univ Leuven, Lab Plant Systemat, Louvain, Belgium; [Vandamme, Peter] Univ Ghent, Microbiol Lab, B-9000 Ghent, Belgium; [Merckx, Vincent; Smets, Erik] Netherlands Ctr Biodivers Naturalis, Leiden, Netherlands; [Smets, Erik] Leiden Univ, Natl Herbarium Netherlands, Leiden, Netherlands; [Dessein, Steven] Natl Bot Garden Belgium, Meise, Belgium	KU Leuven; Ghent University; Naturalis Biodiversity Center; Leiden University; Leiden University - Excl LUMC	Lemaire, B (corresponding author), Katholieke Univ Leuven, Lab Plant Systemat, Louvain, Belgium.	benny.lemaire@bio.kuleuven.be	Merckx, Vincent/C-6025-2011; Vandamme, Peter/ABG-3431-2021; Dessein, Steven/I-9147-2014; Smets, Erik F/A-9875-2011; Vandamme, Peter AR/B-7967-2009	Merckx, Vincent/0000-0002-3959-8623; Vandamme, Peter/0000-0002-5581-7937; Dessein, Steven/0000-0002-3179-4005; Smets, Erik F/0000-0002-9416-983X; Vandamme, Peter AR/0000-0002-5581-7937	King Leopold III Fund; Fund for Scientific Research - Flanders (FWO - Vlaanderen) [G.0343.09N]; Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT Vlaanderen) [71488]; K.U.Leuven [OT/05/35]	King Leopold III Fund; Fund for Scientific Research - Flanders (FWO - Vlaanderen)(FWO); Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); K.U.Leuven(KU Leuven)	This work was supported by the King Leopold III Fund, the Fund for Scientific Research - Flanders (FWO - Vlaanderen, G.0343.09N), the Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT Vlaanderen, no. 71488) and the K.U.Leuven (OT/05/35). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An ZS, 2001, NATURE, V411, P62, DOI 10.1038/35075035; Andersson L, 2005, TAXON, V54, P17, DOI 10.2307/25065299; Andersson Lennart, 2002, Systematics and Geography of Plants, V72, P167; Andreasen K, 2000, AM J BOT, V87, P1731, DOI 10.2307/2656750; BASINGER JF, 1985, CAN J BOT, V63, P1825, DOI 10.1139/b85-258; Baumann P, 2005, ANNU REV MICROBIOL, V59, P155, DOI 10.1146/annurev.micro.59.030804.121041; Bremer B, 2002, MOL PHYLOGENET EVOL, V24, P274, DOI 10.1016/S1055-7903(02)00240-3; Bremer B, 2000, PLANT SYST EVOL, V225, P43, DOI 10.1007/BF00985458; Bremer B, 2009, INT J PLANT SCI, V170, P766, DOI 10.1086/599077; Bremer K, 2004, SYST BIOL, V53, P496, DOI 10.1080/10635150490445913; Charleston MA, 2002, SYST BIOL, V51, P528, DOI 10.1080/10635150290069940; Coenye T, 2003, ENVIRON MICROBIOL, V5, P719, DOI 10.1046/j.1462-2920.2003.00471.x; Compant S, 2010, FEMS MICROBIOL ECOL, V73, P197, DOI 10.1111/j.1574-6941.2010.00900.x; Corsaro D, 1999, CRIT REV MICROBIOL, V25, P39, DOI 10.1080/10408419991299167; Davis AP, 2007, AM J BOT, V94, P313, DOI 10.3732/ajb.94.3.313; Alguacil MD, 2009, MICROB ECOL, V58, P942, DOI 10.1007/s00248-009-9544-6; Drummond A, 2010, GENEIOUS V5 1; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FRIIS EM, 1985, REV PALAEOBOT PALYNO, V45, P171, DOI 10.1016/0034-6667(85)90001-6; Gandolfo MA, 1998, AM J BOT, V85, P376, DOI 10.2307/2446331; Gordon JF, 1963, THESIS U LONDON; Graham A, 2009, ANN MO BOT GARD, V96, P90, DOI 10.3417/2006165; Groeninckx I, 2009, INTEGRATED STUDY HER; GROTE PJ, 1989, BOT GAZ, V150, P190, DOI 10.1086/337764; Hayatsu M, 2000, APPL ENVIRON MICROB, V66, P1737, DOI 10.1128/AEM.66.4.1737-1740.2000; Hosokawa T, 2006, PLOS BIOL, V4, P1841, DOI 10.1371/journal.pbio.0040337; Janssens SB, 2009, MOL PHYLOGENET EVOL, V52, P806, DOI 10.1016/j.ympev.2009.04.013; Keller JA, 1996, AM J BOT, V83, P528, DOI 10.2307/2446221; Kikuchi Y, 2007, APPL ENVIRON MICROB, V73, P4308, DOI 10.1128/AEM.00067-07; Kikuchi Y, 2011, ISME J, V5, P446, DOI 10.1038/ismej.2010.150; Kikuchi Y, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-2; Kohler J, 2009, SOIL BIOL BIOCHEM, V41, P1710, DOI 10.1016/j.soilbio.2009.05.014; Lemaire B, 2011, INT J SYST MICROBIOL, DOI ijs. 0.028019-028010v028011; Lemaire B, 2011, J MICROBIOL, V49, P935, DOI 10.1007/s12275-011-1163-5; Lemaire B, 2011, RES MICROBIOL, V162, P528, DOI 10.1016/j.resmic.2011.04.003; Lohne C, 2005, MOL BIOL EVOL, V22, P317, DOI 10.1093/molbev/msi019; Martinez-Millan M, 2010, BOT REV, V76, P83, DOI 10.1007/s12229-010-9040-1; Martinez-Millan M, 2009, AM J BOT, V96, P933, DOI 10.3732/ajb.0800347; MILLER IM, 1990, ADV BOT RES, V17, P163, DOI 10.1016/S0065-2296(08)60134-2; Moran NA, 2000, CURR OPIN MICROBIOL, V3, P270, DOI 10.1016/S1369-5274(00)00088-6; Morley RJ, 2000, ORIGIN EVOLUTION TRO; Motley TJ, 2005, AM J BOT, V92, P316, DOI 10.3732/ajb.92.2.316; MURRAY RGE, 1995, INT J SYST BACTERIOL, V45, P186, DOI 10.1099/00207713-45-1-186; Near TJ, 2004, PHILOS T R SOC B, V359, P1477, DOI 10.1098/rstb.2004.1523; Nie ZL, 2005, AM J BOT, V92, P642, DOI 10.3732/ajb.92.4.642; NIXON KC, 1993, AM J BOT, V80, P616, DOI 10.2307/2445430; Oxelman B, 1997, PLANT SYST EVOL, V206, P393, DOI 10.1007/BF00987959; Paracer S, 2000, SYMBIOSIS INTRO BIOL, V2nd; PERKINS SK, 1993, NEW PHYTOL, V123, P53; PETERS GA, 1993, NEW PHYTOL, V123, P65; Petit E, 1966, B JARD BOT ETAT BRUX, V36, P65, DOI DOI 10.2307/3667246; Plana V, 2004, PHILOS T ROY SOC B, V359, P1585, DOI 10.1098/rstb.2004.1535; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rambaut A, TRACER V1 4; Ran LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011486; Razafimandimbison SG, 2008, MOL PHYLOGENET EVOL, V48, P207, DOI 10.1016/j.ympev.2008.03.034; Robbrecht Elmar, 2006, Systematics and Geography of Plants, V76, P85; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; ROTH JL, 1979, AM J BOT, V66, P1194, DOI 10.2307/2442218; Rutschmann F, 2006, DIVERS DISTRIB, V12, P35, DOI 10.1111/j.1366-9516.2006.00210.x; Schonenberger J, 2005, INT J PLANT SCI, V166, P265, DOI 10.1086/427198; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Spilker T, 2009, J CLIN MICROBIOL, V47, P2607, DOI 10.1128/JCM.00770-09; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stewart FJ, 2008, MOL BIOL EVOL, V25, P673, DOI 10.1093/molbev/msn010; Tabacchioni S, 2008, FEMS MICROBIOL LETT, V281, P175, DOI 10.1111/j.1574-6968.2008.01105.x; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Takahashi M, 2002, J PLANT RES, V115, P463, DOI 10.1007/s10265-002-0062-6; Takenaka S, 2003, APPL ENVIRON MICROB, V69, P5410, DOI 10.1128/AEM.69.9.5410-5413.2003; Taylor MW, 2007, MICROBIOL MOL BIOL R, V71, P295, DOI 10.1128/MMBR.00040-06; Taylor MJ, 2005, ADV PARASIT, V60, P245, DOI 10.1016/S0065-308X(05)60004-8; Tel-Zur N, 1999, PLANT MOL BIOL REP, V17, P249, DOI 10.1023/A:1007656315275; Tesfaye K, 2007, GENOME, V50, P1112, DOI 10.1139/G07-088; Tosh J, 2009, BIOGEOGRAPHY MADAGAS; Van Oevelen S, 2004, INT J SYST EVOL MICR, V54, P2237, DOI 10.1099/ijs.0.63188-0; Van Oevelen S, 2002, INT J SYST EVOL MICR, V52, P2023, DOI [10.1099/ijs.0.02103-0, 10.1099/00207713-52-6-2023]; Van Oevelen Sandra, 2001, Systematics and Geography of Plants, V71, P557, DOI 10.2307/3668700; Vandamme P, 2007, DIVERSITY ROLE BURKH; WERLE E, 1994, NUCLEIC ACIDS RES, V22, P4354, DOI 10.1093/nar/22.20.4354; Xu LingLing, 2009, Acta Horticulturae Sinica, V36, P1531; Yesson C, 2009, J BIOGEOGR, V36, P1234, DOI 10.1111/j.1365-2699.2008.01971.x; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	84	28	29	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2011	6	9							e24430	10.1371/journal.pone.0024430	http://dx.doi.org/10.1371/journal.pone.0024430			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CH	21915326	Green Published, Green Submitted, gold			2022-12-25	WOS:000294802500044
J	Agur, Z; Kirnasovsky, OU; Vasserman, G; Tencer-Hershkowicz, L; Kogan, Y; Harrison, H; Lamb, R; Clarke, RB				Agur, Zvia; Kirnasovsky, Oleg U.; Vasserman, Genadiy; Tencer-Hershkowicz, Lilach; Kogan, Yuri; Harrison, Hannah; Lamb, Rebecca; Clarke, Robert B.			Dickkopf1 Regulates Fate Decision and Drives Breast Cancer Stem Cells to Differentiation: An Experimentally Supported Mathematical Model	PLOS ONE			English	Article							IN-VITRO PROPAGATION; WNT; NOTCH; EXPRESSION; MECHANISM; DKK-1; GENE	Background: Modulation of cellular signaling pathways can change the replication/differentiation balance in cancer stem cells (CSCs), thus affecting tumor growth and recurrence. Analysis of a simple, experimentally verified, mathematical model suggests that this balance is maintained by quorum sensing (QS). Methodology/Principal Findings: To explore the mechanism by which putative QS cellular signals in mammary stem cells (SCs) may regulate SC fate decisions, we developed a multi-scale mathematical model, integrating extra-cellular and intracellular signal transduction within the mammary tissue dynamics. Preliminary model analysis of the single cell dynamics indicated that Dickkopf1 (Dkk1), a protein known to negatively regulate the Wnt pathway, can serve as anti-proliferation and pro-maturation signal to the cell. Simulations of the multi-scale tissue model suggested that Dkk1 may be a QS factor, regulating SC density on the level of the whole tissue: relatively low levels of exogenously applied Dkk1 have little effect on SC numbers, whereas high levels drive SCs into differentiation. To verify these model predictions, we treated the MCF-7 cell line and primary breast cancer (BC) cells from 3 patient samples with different concentrations and dosing regimens of Dkk1, and evaluated subsequent formation of mammospheres (MS) and the mammary SC marker CD44(+)CD24(lo). As predicted by the model, low concentrations of Dkk1 had no effect on primary BC cells, or even increased MS formation among MCF-7 cells, whereas high Dkk1 concentrations decreased MS formation among both primary BC cells and MCF-7 cells. Conclusions/Significance: Our study suggests that Dkk1 treatment may be more robust than other methods for eliminating CSCs, as it challenges a general cellular homeostasis mechanism, namely, fate decision by QS. The study also suggests that low dose Dkk1 administration may be counterproductive; we showed experimentally that in some cases it can stimulate CSC proliferation, although this needs validating in vivo.	[Agur, Zvia; Kirnasovsky, Oleg U.; Vasserman, Genadiy; Tencer-Hershkowicz, Lilach; Kogan, Yuri] Inst Med BioMath, Bene Ataroth, Israel; [Harrison, Hannah; Lamb, Rebecca; Clarke, Robert B.] Univ Manchester, Breast Biol Grp, Sch Canc & Enabling Sci, Paterson Inst Canc Res, Manchester, Lancs, England	Paterson Institute for Cancer Research; University of Manchester	Agur, Z (corresponding author), Inst Med BioMath, Bene Ataroth, Israel.	agur@imbm.org	Clarke, Robert/AAA-3442-2021	Clarke, Robert/0000-0001-5407-3123; Harrison, Hannah/0000-0002-0054-8047	Chai Foundation; European Union [012930]; Breast Cancer Campaign	Chai Foundation; European Union(European Commission); Breast Cancer Campaign	The work was partly supported by the Chai Foundation and partly by Contract no. 012930 from European Union FP6 'Developing a virtual and molecular normal board for diverting cancer stem cell to non-malignance'. RC is a Breast Cancer Campaign-funded Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera O, 2007, CARCINOGENESIS, V28, P1877, DOI 10.1093/carcin/bgm094; Agur Z, 2002, J MATH BIOL, V44, P79, DOI 10.1007/s002850100115; Agur Z, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-20; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Brennan KR, 2004, J MAMMARY GLAND BIOL, V9, P119, DOI 10.1023/B:JOMG.0000037157.94207.33; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Forget MA, 2007, BRIT J CANCER, V96, P646, DOI 10.1038/sj.bjc.6603579; Fujita K, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-71; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; HARRISON H, 2010, CANC RES; Kirnasovsky OU, 2008, MATH MODEL NAT PHENO, V3, P78, DOI 10.1051/mmnp:2008042; Kirnasovsky OU, 2008, DISCRETE CONT DYN-B, V10, P129; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; MAHLERARAUJO B, 2007, J CLIN PATHOL; Pannuti A, 2010, CLIN CANCER RES, V16, P3141, DOI 10.1158/1078-0432.CCR-09-2823; Pece S, 2004, J CELL BIOL, V167, P215, DOI 10.1083/jcb.200406140; Phillips TM, 2006, JNCI-J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Prockop DJ, 2003, P NATL ACAD SCI USA, V100, P11917, DOI 10.1073/pnas.1834138100; Qiao L, 2008, CANCER LETT, V269, P67, DOI 10.1016/j.canlet.2008.04.032; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Ribba B, 2004, LECT NOTES COMPUT SC, V3305, P444; Sell S, 2004, CRIT REV ONCOL HEMAT, V51, P1, DOI 10.1016/j.critrevonc.2004.04.007; Takahashi-Yanaga F, 2010, CLIN CANCER RES, V16, P3153, DOI 10.1158/1078-0432.CCR-09-2943; Takebe N, 2010, CLIN CANCER RES, V16, P3106, DOI 10.1158/1078-0432.CCR-09-2934; Veeck J, 2006, ONCOGENE, V25, P3479, DOI 10.1038/sj.onc.1209386; Verani R, 2007, J NEUROCHEM, V100, P242, DOI 10.1111/j.1471-4159.2006.04207.x; Voorzanger-Rousselot N, 2009, CALCIFIED TISSUE INT, V84, P348, DOI 10.1007/s00223-009-9225-y; Zardawi SJ, 2009, HISTOL HISTOPATHOL, V24, P385, DOI 10.14670/HH-24.385; Zhou XQ, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.216801	32	24	26	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2011	6	9							e24225	10.1371/journal.pone.0024225	http://dx.doi.org/10.1371/journal.pone.0024225			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817QP	21915302	Green Published, Green Submitted, gold			2022-12-25	WOS:000294689200028
J	Eidson, M; Wahlstrom, J; Beaulieu, AM; Zaidi, B; Carsons, SE; Crow, PK; Yuan, JD; Wolchok, JD; Horsthemke, B; Wieczorek, D; Sant'Angelo, DB				Eidson, Maggie; Wahlstrom, Justin; Beaulieu, Aimee M.; Zaidi, Bushra; Carsons, Steven E.; Crow, Peggy K.; Yuan, Jianda; Wolchok, Jedd D.; Horsthemke, Bernhard; Wieczorek, Dagmar; Sant'Angelo, Derek B.			Altered Development of NKT Cells, gamma delta T Cells, CD8 T Cells and NK Cells in a PLZF Deficient Patient	PLOS ONE			English	Article							GERMINAL CENTER FORMATION; ZINC-FINGER; CD1D TETRAMERS; LINEAGE FATE; IN-VIVO; EXPRESSION; REGULATOR; PHENOTYPE; RESPONSES; SUPPRESS	In mice, the transcription factor, PLZF, controls the development of effector functions in invariant NKT cells and a subset of NKT cell-like, gamma delta T cells. Here, we show that in human lymphocytes, in addition to invariant NKT cells, PLZF was also expressed in a large percentage of CD8+ and CD4+ T cells. Furthermore, PLZF was also found to be expressed in all gamma delta T cells and in all NK cells. Importantly, we show that in a donor lacking functional PLZF, all of these various lymphocyte populations were altered. Therefore, in contrast to mice, PLZF appears to control the development and/or function of a wide variety of human lymphocytes that represent more than 10% of the total PBMCs. Interestingly, the PLZF-expressing CD8+ T cell population was found to be expanded in the peripheral blood of patients with metastatic melanoma but was greatly diminished in patients with autoimmune disease.	[Eidson, Maggie; Wahlstrom, Justin] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10021 USA; [Beaulieu, Aimee M.; Sant'Angelo, Derek B.] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Program Immunol, New York, NY 10021 USA; [Zaidi, Bushra; Yuan, Jianda] Mem Sloan Kettering Canc Ctr, Ludwig Ctr Canc Immunotherapy, Program Immunol, New York, NY 10021 USA; [Carsons, Steven E.] Winthrop Univ Hosp, Dept Med, Div Rheumatol Allergy & Immunol, Mineola, NY 11501 USA; [Crow, Peggy K.] Hosp Special Surg, Mary Kirkland Ctr Lupus Res, Div Rheumatol, New York, NY 10021 USA; [Crow, Peggy K.; Sant'Angelo, Derek B.] Cornell Univ, Weill Grad Sch Med Sci, New York, NY 10021 USA; [Wolchok, Jedd D.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Horsthemke, Bernhard; Wieczorek, Dagmar] Univ Klinikum Essen, Inst Human Genet, Essen, Germany; [Sant'Angelo, Derek B.] Mem Sloan Kettering Canc Ctr, Gerstner Grad Sch Biomed Sci, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Winthrop University Hospital; Cornell University; Memorial Sloan Kettering Cancer Center; University of Duisburg Essen; Memorial Sloan Kettering Cancer Center	Eidson, M (corresponding author), Miami Childrens Hosp, Dept Pediat Hematol Oncol, Miami, FL 33155 USA.	santangd@mskcc.org	Wieczorek, Dagmar/AAU-6008-2021	Wieczorek, Dagmar/0000-0003-2812-6492; Wahlstrom, Justin/0000-0001-7998-8506	National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID) [R01 AI059739, R01 AI083988, T32 CA009149]; NATIONAL CANCER INSTITUTE [T32CA009149] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059739, R01AI083988] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIH/NIAID) R01s AI059739 and AI083988 (D. B. S.) and T32 CA009149 (A. M. B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonzo ES, 2010, J IMMUNOL, V184, P1268, DOI 10.4049/jimmunol.0903218; AVANTAGGIATO V, 1995, J NEUROSCI, V15, P4927; Baev DV, 2004, BLOOD, V104, P4150, DOI 10.1182/blood-2004-04-1629; Barna M, 2000, NAT GENET, V25, P166, DOI 10.1038/76014; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Benlagha K, 2000, J EXP MED, V191, P1895, DOI 10.1084/jem.191.11.1895; Berzins SP, 2005, EUR J IMMUNOL, V35, P1399, DOI 10.1002/eji.200425958; Berzofsky JA, 2009, CURR MOL MED, V9, P667, DOI 10.2174/156652409788970706; Billerbeck E, 2010, P NATL ACAD SCI USA, V107, P3006, DOI 10.1073/pnas.0914839107; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Doulatov S, 2009, GENE DEV, V23, P2076, DOI 10.1101/gad.1788109; Exley MA, 2001, J IMMUNOL, V167, P5531, DOI 10.4049/jimmunol.167.10.5531; Felices M, 2009, P NATL ACAD SCI USA, V106, P8308, DOI 10.1073/pnas.0808459106; Fischer S, 2008, J MED GENET, V45, P731, DOI 10.1136/jmg.2008.059451; Fukuda T, 1997, J EXP MED, V186, P439, DOI 10.1084/jem.186.3.439; Hammond KJL, 2001, J IMMUNOL, V167, P1164, DOI 10.4049/jimmunol.167.3.1164; He LZ, 1998, NAT GENET, V18, P126, DOI 10.1038/ng0298-126; He X, 2010, ANNU REV IMMUNOL, V28, P295, DOI 10.1146/annurev.immunol.25.022106.141715; Kelly KF, 2006, TRENDS CELL BIOL, V16, P578, DOI 10.1016/j.tcb.2006.09.003; Kosub DA, 2008, J VIROL, V82, P1155, DOI 10.1128/JVI.01275-07; Kovalovsky D, 2008, NAT IMMUNOL, V9, P1055, DOI 10.1038/ni.1641; Kovalovsky D, 2010, J IMMUNOL, V184, P6746, DOI 10.4049/jimmunol.1000776; Kreslavsky T, 2009, P NATL ACAD SCI USA, V106, P12453, DOI 10.1073/pnas.0903895106; Kronenberg M, 2002, NAT REV IMMUNOL, V2, P557, DOI 10.1038/nri854; Lee YJ, 2010, J EXP MED, V207, P237, DOI 10.1084/jem.20091519; Maeda T, 2007, SCIENCE, V316, P860, DOI 10.1126/science.1140881; Marsh RA, 2009, CLIN IMMUNOL, V132, P116, DOI 10.1016/j.clim.2009.03.517; Martin E, 2009, PLOS BIOL, V7, P525, DOI 10.1371/journal.pbio.1000054; Matsuda JL, 2000, J EXP MED, V192, P741, DOI 10.1084/jem.192.5.741; Mitsuo A, 2006, RHEUMATOLOGY, V45, P1477, DOI 10.1093/rheumatology/kel119; Motohashi S, 2009, IMMUNOTHERAPY-UK, V1, P73, DOI 10.2217/1750743X.1.1.73; Novak J, 2007, INT REV IMMUNOL, V26, P49, DOI 10.1080/08830180601070229; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Raberger J, 2008, P NATL ACAD SCI USA, V105, P17919, DOI 10.1073/pnas.0805733105; Renukaradhya GJ, 2008, BLOOD, V111, P5637, DOI 10.1182/blood-2007-05-092866; Sakaguchi S, 2010, NAT IMMUNOL, V11, P442, DOI 10.1038/ni.1860; Savage AK, 2008, IMMUNITY, V29, P391, DOI 10.1016/j.immuni.2008.07.011; Scaglioni PP, 2007, CURR TOP MICROBIOL, V313, P85; Swann JB, 2009, BLOOD, V113, P6382, DOI 10.1182/blood-2009-01-198564; Takahashi T, 2006, J IMMUNOL, V176, P211, DOI 10.4049/jimmunol.176.1.211; Teng MWL, 2009, J IMMUNOL, V183, P1911, DOI 10.4049/jimmunol.0900796; Teng MWL, 2009, J IMMUNOL, V182, P3366, DOI 10.4049/jimmunol.0802964; Turtle CJ, 2009, IMMUNITY, V31, P834, DOI 10.1016/j.immuni.2009.09.015; van der Vliet H, 2002, LANCET ONCOL, V3, P574, DOI 10.1016/S1470-2045(02)00850-1; Van Kaer Luc, 2006, Expert Rev Clin Immunol, V2, P745, DOI 10.1586/1744666X.2.5.745; Verykokakis M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009303; Weinreich MA, 2010, NAT IMMUNOL, V11, P709, DOI 10.1038/ni.1898; Wither J, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2505; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002	51	44	45	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2011	6	9							e24441	10.1371/journal.pone.0024441	http://dx.doi.org/10.1371/journal.pone.0024441			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817QP	21915328	Green Published			2022-12-25	WOS:000294689200044
J	Su, FY; Alam, R; Mei, Q; Tian, YQ; Meldrum, DR				Su, Fengyu; Alam, Ruhaniyah; Mei, Qian; Tian, Yanqing; Meldrum, Deirdre R.			Micelles as Delivery Vehicles for Oligofluorene for Bioimaging	PLOS ONE			English	Article							LIGHT-EMITTING-DIODES; CONJUGATED POLYELECTROLYTE; POLYMER NANOPARTICLES; COLORIMETRIC ASSAY; ENERGY-TRANSFER; IN-VITRO; TOXICITY; CELLS; DOTS; NANOSPHERES	With the successful development of organic/polymeric light emitting diodes, many organic and polymeric fluorophores with high quantum efficiencies and optical stability were synthesized. However, most of these materials which have excellent optical properties are insoluble in water, limiting their applications in biological fields. Herein, we used micelles formed from an amino-group-containing poly(epsilon-caprolactone)-block-poly(ethylene glycol) (PCL-b-PEG-NH2) to incorporate a hydrophobic blue emitter oligofluorene (OF) to enable its application in biological conditions. Although OF is completely insoluble in water, it was successfully transferred into aqueous solutions with a good retention of its photophysical properties. OF exhibited a high quantum efficiency of 0.84 in a typical organic solvent of tetrahydrofuran (THF). In addition, OF also showed a good quantum efficiency of 0.46 after being encapsulated into micelles. Two cells lines, human glioblastoma (U87MG) and esophagus premalignant (CP-A), were used to study the cellular internalization of the OF incorporated micelles. Results showed that the hydrophobic OF was located in the cytoplasm, which was confirmed by co-staining the cells with nucleic acid specific SYTO 9, lysosome specific LysoTracker Red (R), and mitochondria specific MitoTracker Red. MTT assay indicated non-toxicity of the OF-incorporated micelles. This study will broaden the application of hydrophobic functional organic compounds, oligomers, and polymers with good optical properties to enable their applications in biological research fields.	[Su, Fengyu; Alam, Ruhaniyah; Mei, Qian; Tian, Yanqing; Meldrum, Deirdre R.] Arizona State Univ, Ctr Biosignatures Discovery Automat, Biodesign Inst, Tempe, AZ 85069 USA	Arizona State University; Arizona State University-Tempe	Su, FY (corresponding author), Arizona State Univ, Ctr Biosignatures Discovery Automat, Biodesign Inst, Tempe, AZ 85069 USA.	yanqing.tian@asu.edu	Tian, Yanqing/N-1506-2019; Su, Fengyu/ABE-2523-2021; Tian, Yanqing/C-1423-2013; Su, Fengyu/V-1014-2018; MLSC, Colletion/B-3912-2013	Tian, Yanqing/0000-0002-1441-2431; Tian, Yanqing/0000-0002-1441-2431; Su, Fengyu/0000-0003-1922-9182; 	National Institutes of Health National Human Genome Research Institute, Centers of Excellence in Genomic Science [5 P50 HG002360]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002360] Funding Source: NIH RePORTER	National Institutes of Health National Human Genome Research Institute, Centers of Excellence in Genomic Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by the National Institutes of Health National Human Genome Research Institute, Centers of Excellence in Genomic Science, Grant Number 5 P50 HG002360. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, MOL PROBES HDB A GUI, P664; CARMICHAEL J, 1987, CANCER RES, V47, P936; Chatteriee DK, 2008, BIOMATERIALS, V29, P937, DOI 10.1016/j.biomaterials.2007.10.051; Chen CY, 2007, J AM CHEM SOC, V129, P7220, DOI 10.1021/ja071057p; DEMAS JN, 1971, J PHYS CHEM-US, V75, P991, DOI 10.1021/j100678a001; Feng XL, 2010, J MATER CHEM, V20, P1312, DOI 10.1039/b915112e; Feng XL, 2010, ACS APPL MATER INTER, V2, P2429, DOI 10.1021/am100435k; Fisslthaler E, 2008, SOFT MATTER, V4, P2448, DOI 10.1039/b812235k; Hameed S, 2010, REV ADV MATER SCI, V26, P30; Hardman R, 2006, ENVIRON HEALTH PERSP, V114, P165, DOI 10.1289/ehp.8284; Howes P, 2010, J AM CHEM SOC, V132, P9833, DOI 10.1021/ja1031634; Howes P, 2010, J AM CHEM SOC, V132, P3989, DOI 10.1021/ja1002179; Howes P, 2009, CHEM COMMUN, P2490, DOI 10.1039/b903405f; Joshi HS, 1999, ANGEW CHEM INT EDIT, V38, P2722; Kaeser A, 2010, ADV MATER, V22, P2985, DOI 10.1002/adma.201000427; KASHA M, 1963, RADIAT RES, V20, P55, DOI 10.2307/3571331; Kim IB, 2007, BIOCONJUGATE CHEM, V18, P815, DOI 10.1021/bc0603440; Li K, 2009, ADV FUNCT MATER, V19, P3535, DOI 10.1002/adfm.200901098; Mahendra S, 2008, ENVIRON SCI TECHNOL, V42, P9424, DOI 10.1021/es8023385; Moon JH, 2007, ANGEW CHEM INT EDIT, V46, P8223, DOI 10.1002/anie.200701991; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Pu KY, 2010, ADV FUNCT MATER, V20, P2770, DOI 10.1002/adfm.201000495; Pu KY, 2009, CHEM MATER, V21, P3816, DOI 10.1021/cm901197s; Savic R, 2003, SCIENCE, V300, P615, DOI 10.1126/science.1078192; Tian Y, 2007, ADV FUNCT MATER, V17, P1691, DOI 10.1002/adfm.200600916; Tian YQ, 2010, J BIOMED MATER RES A, V93A, P1068, DOI 10.1002/jbm.a.32607; Tian YQ, 2010, J MATER CHEM, V20, P1728, DOI 10.1039/b922435c; Tian YQ, 2010, MACROMOLECULES, V43, P282, DOI 10.1021/ma9019619; Tuncel D, 2010, NANOSCALE, V2, P484, DOI 10.1039/b9nr00374f; Vinegoni C, 2009, OPT LETT, V34, P2566, DOI 10.1364/OL.34.002566; Wang J, 2005, J DRUG TARGET, V13, P73, DOI 10.1080/10611860400011935; Wang YS, 2010, ADV MATER, V22, P656, DOI 10.1002/adma.200902675; Wu CF, 2007, J AM CHEM SOC, V129, P12904, DOI 10.1021/ja074590d; Wu CF, 2010, J AM CHEM SOC, V132, P15410, DOI 10.1021/ja107196s; Wu CF, 2009, ANGEW CHEM INT EDIT, V48, P2741, DOI 10.1002/anie.200805894; Xiong LQ, 2009, BIOMATERIALS, V30, P5592, DOI 10.1016/j.biomaterials.2009.06.015; Zhong CM, 2011, CHEM MATER, V23, P326, DOI 10.1021/cm101937p	37	7	7	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2011	6	9							e24425	10.1371/journal.pone.0024425	http://dx.doi.org/10.1371/journal.pone.0024425			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817QP	21915324	Green Published, Green Submitted, gold			2022-12-25	WOS:000294689200043
J	Brunotte, L; Kerber, R; Shang, WF; Hauer, F; Hass, M; Gabriel, M; Lelke, M; Busch, C; Stark, H; Svergun, DI; Betzel, C; Perbandt, M; Gunther, S				Brunotte, Linda; Kerber, Romy; Shang, Weifeng; Hauer, Florian; Hass, Meike; Gabriel, Martin; Lelke, Michaela; Busch, Carola; Stark, Holger; Svergun, Dmitri I.; Betzel, Christian; Perbandt, Markus; Guenther, Stephan			Structure of the Lassa Virus Nucleoprotein Revealed by X-ray Crystallography, Small-angle X-ray Scattering, and Electron Microscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							Z-PROTEIN; BIOLOGICAL MACROMOLECULES; RNA-POLYMERASE; CAP-BINDING; REPLICATION; TRANSCRIPTION; PROGRAM; SYSTEM; DOMAIN; FEVER	The nucleoprotein (NP) of Lassa virus (LASV) strain AV was expressed in a recombinant baculovirus system. The crystal structure of full-length NP was solved at a resolution of 2.45 angstrom. The overall fold corresponds to that of NP of LASV strain Josiah (Qi, X., Lan, S., Wang, W., Schelde, L. M., Dong, H., Wallat, G. D., Ly, H., Liang, Y., and Dong, C. (2010) Nature 468, 779-783) with a root mean square deviation of 0.67 angstrom for all atoms (6.3% difference in primary sequence). As the packing in the crystal offers two different trimer architectures for the biological assembly, the quaternary structure of NP in solution was determined by small-angle x-ray scattering and EM. After classification and averaging of >6000 EM raw images, trimeric centrosymmetric structures were obtained, which correspond in size and shape to one trimer in the crystal structure formed around a crystallographic 3-fold rotation axis (symmetric trimer). The symmetric trimer is also a good model for the small-angle x-ray scattering data and could be well embedded into the ab initio model. The N-terminal domain of NP contains a deep nucleotide-binding cavity that has been proposed to bind cellular cap structures for priming viral mRNA synthesis. All residues implicated in m(7)GpppN binding were exchanged, and the transcription/replication phenotype of the NP mutant was tested using a LASV replicon system. None of the mutants showed a specific defect in mRNA expression; most were globally defective in RNA synthesis. In conclusion, we describe the full-length crystal structure and the quaternary structure in solution of LASV NP. The nucleotide-binding pocket of NP could not be assigned a specific role in viral mRNA synthesis.	[Betzel, Christian; Perbandt, Markus] Univ Hamburg, Lab Struct Biol Infect & Inflammat, DESY, Dept Chem, D-22603 Hamburg, Germany; [Brunotte, Linda; Kerber, Romy; Hass, Meike; Gabriel, Martin; Lelke, Michaela; Busch, Carola; Guenther, Stephan] Bernhard Nocht Inst Trop Med, Dept Virol, D-20359 Hamburg, Germany; [Shang, Weifeng; Svergun, Dmitri I.] DESY, European Mol Biol Lab, Hamburg Outstn, D-22603 Hamburg, Germany; [Hauer, Florian; Stark, Holger] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany; [Hauer, Florian; Stark, Holger] Univ Gottingen, Gottingen Ctr Mol Biol, D-37077 Gottingen, Germany; [Perbandt, Markus] Univ Med Ctr Hamburg Eppendorf, Dept Med Microbiol Virol & Hyg, D-20246 Hamburg, Germany	Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of Hamburg; Bernhard Nocht Institut fur Tropenmedizin; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Max Planck Society; University of Gottingen; University of Hamburg; University Medical Center Hamburg-Eppendorf	Perbandt, M (corresponding author), Univ Hamburg, Lab Struct Biol Infect & Inflammat, DESY, Dept Chem, Bldg 22A,Notkestr 85, D-22603 Hamburg, Germany.	perbandt@chemie.uni-hamburg.de; guenther@bni.uni-hamburg.de	Perbandt, Markus/K-7603-2018; Betzel, Christian/G-8105-2018	Betzel, Christian/0000-0002-3879-5019; Gunther, Stephan/0000-0002-6562-0230; Svergun, Dmitri/0000-0003-0830-5696; Holger, Stark/0000-0002-6161-1118	Deutsche Forschungsgemeinschaft (DFG) [GU 883/1-1]; Bundesministerium fur Bildung und Forschung (BMBF) [05K10YEA]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by Deutsche Forschungsgemeinschaft (DFG) Grant GU 883/1-1 and Bundesministerium fur Bildung und Forschung (BMBF) Sync-Life Contract 05K10YEA.	Brunotte L, 2011, J VIROL, V85, P324, DOI 10.1128/JVI.00721-10; Buchholz UJ, 1999, J VIROL, V73, P251, DOI 10.1128/JVI.73.1.251-259.1999; Chen JZ, 2007, J STRUCT BIOL, V157, P168, DOI 10.1016/j.jsb.2006.06.001; Casabona JC, 2009, J VIROL, V83, P7029, DOI 10.1128/JVI.00329-09; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; DUBE P, 1993, EMBO J, V12, P1303, DOI 10.1002/j.1460-2075.1993.tb05775.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fechter P, 2003, J BIOL CHEM, V278, P20381, DOI 10.1074/jbc.M300130200; Ferron F, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002030; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Gunther S, 2000, EMERG INFECT DIS, V6, P466, DOI 10.3201/eid0605.000504; Gunther S, 2004, CRIT REV CL LAB SCI, V41, P339, DOI 10.1080/10408360490497456; Hass M, 2004, J VIROL, V78, P13793, DOI 10.1128/JVI.78.24.13793-13803.2004; Hass M, 2008, J VIROL, V82, P10207, DOI 10.1128/JVI.00220-08; Hass M, 2006, J VIROL, V80, P12414, DOI 10.1128/JVI.01374-06; Hastie KM, 2011, P NATL ACAD SCI USA, V108, P2396, DOI 10.1073/pnas.1016404108; Jacamo R, 2003, J VIROL, V77, P10383, DOI 10.1128/JVI.77.19.10383-10393.2003; Kastner B, 2008, NAT METHODS, V5, P53, DOI 10.1038/NMETH1139; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Kranzusch PJ, 2010, P NATL ACAD SCI USA, V107, P20069, DOI 10.1073/pnas.1007152107; Lee KJ, 2000, J VIROL, V74, P3470, DOI 10.1128/JVI.74.8.3470-3477.2000; Lelke M, 2010, J VIROL, V84, P1934, DOI 10.1128/JVI.01657-09; Macleod JML, 2011, J VIROL, V85, P2012, DOI 10.1128/JVI.01875-10; Lopez N, 2001, J VIROL, V75, P12241, DOI 10.1128/JVI.75.24.12241-12251.2001; Lukashevich IS, 1997, J GEN VIROL, V78, P547, DOI 10.1099/0022-1317-78-3-547; Martinez-Sobrido L, 2006, J VIROL, V80, P9192, DOI 10.1128/JVI.00555-06; Martinez-Sobrido L, 2009, J VIROL, V83, P11330, DOI 10.1128/JVI.00763-09; Morin B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001038; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Otwinowski Z., 1993, DATA COLLECTION PROC, P56; Perez M, 2003, P NATL ACAD SCI USA, V100, P12978, DOI 10.1073/pnas.2133782100; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Qi XX, 2010, NATURE, V468, P779, DOI 10.1038/nature09605; Raymond DD, 2010, P NATL ACAD SCI USA, V107, P11769, DOI 10.1073/pnas.1001760107; Roessle MW, 2007, J APPL CRYSTALLOGR, V40, pS190, DOI 10.1107/S0021889806055506; Round AR, 2008, J APPL CRYSTALLOGR, V41, P913, DOI 10.1107/S0021889808021018; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Shtanko O, 2011, J VIROL, V85, P3631, DOI 10.1128/JVI.01984-10; Shtanko O, 2010, J VIROL, V84, P5415, DOI 10.1128/JVI.02417-09; Strecker T, 2003, J VIROL, V77, P10700, DOI 10.1128/JVI.77.19.10700-10705.2003; SUTTER G, 1995, FEBS LETT, V371, P9, DOI 10.1016/0014-5793(95)00843-X; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Yuan PW, 2009, NATURE, V458, P909, DOI 10.1038/nature07720	50	42	42	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38748	38756		10.1074/jbc.M111.278838	http://dx.doi.org/10.1074/jbc.M111.278838			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21917929	Green Published, hybrid			2022-12-25	WOS:000296594200086
J	Nam, J; Perera, P; Liu, J; Rath, B; Deschner, J; Gassner, R; Butterfield, TA; Agarwal, S				Nam, Jin; Perera, Priyangi; Liu, Jie; Rath, Bjoern; Deschner, James; Gassner, Robert; Butterfield, Timothy A.; Agarwal, Sudha			Sequential Alterations in Catabolic and Anabolic Gene Expression Parallel Pathological Changes during Progression of Monoiodoacetate-Induced Arthritis	PLOS ONE			English	Article							ARTICULAR-CARTILAGE; CANDIDATE GENES; RHEUMATIC CONDITIONS; HUMAN OSTEOARTHRITIS; PROFILING REVEALS; PROSTAGLANDIN E-2; BONE; CELL; CHONDROCYTES; MODELS	Chronic inflammation is one of the major causes of cartilage destruction in osteoarthritis. Here, we systematically analyzed the changes in gene expression associated with the progression of cartilage destruction in monoiodoacetate-induced arthritis (MIA) of the rat knee. Sprague Dawley female rats were given intra-articular injection of monoiodoacetate in the knee. The progression of MIA was monitored macroscopically, microscopically and by micro-computed tomography. Grade 1 damage was observed by day 5 post-monoiodoacetate injection, progressively increasing to Grade 2 by day 9, and to Grade 3-3.5 by day 21. Affymetrix GeneChip was utilized to analyze the transcriptome-wide changes in gene expression, and the expression of salient genes was confirmed by real-time-PCR. Functional networks generated by Ingenuity Pathways Analysis (IPA) from the microarray data correlated the macroscopic/histologic findings with molecular interactions of genes/gene products. Temporal changes in gene expression during the progression of MIA were categorized into five major gene clusters. IPA revealed that Grade 1 damage was associated with upregulation of acute/innate inflammatory responsive genes (Cluster I) and suppression of genes associated with musculoskeletal development and function (Cluster IV). Grade 2 damage was associated with upregulation of chronic inflammatory and immune trafficking genes (Cluster II) and downregulation of genes associated with musculoskeletal disorders (Cluster IV). The Grade 3 to 3.5 cartilage damage was associated with chronic inflammatory and immune adaptation genes (Cluster III). These findings suggest that temporal regulation of discrete gene clusters involving inflammatory mediators, receptors, and proteases may control the progression of cartilage destruction. In this process, IL-1 beta, TNF-alpha, IL-15, IL-12, chemokines, and NF-kappa B act as central nodes of the inflammatory networks, regulating catabolic processes. Simultaneously, upregulation of asporin, and downregulation of TGF-beta complex, SOX-9, IGF and CTGF may be central to suppress matrix synthesis and chondrocytic anabolic activities, collectively contributing to the progression of cartilage destruction in MIA.	[Nam, Jin; Perera, Priyangi; Liu, Jie; Agarwal, Sudha] Ohio State Univ, Coll Dent, Biomech & Tissue Engn Lab, Columbus, OH 43210 USA; [Rath, Bjoern] Univ Aachen, Dept Orthoped Surg, D-5100 Aachen, Germany; [Deschner, James] Univ Cologne, Dept Periodont, Cologne, Germany; [Deschner, James] Univ Innsbruck, Coll Med, Dept Oral & Maxillofacial Surg, A-6020 Innsbruck, Austria; [Butterfield, Timothy A.] Univ Kentucky, Coll Hlth Sci, Lexington, KY USA; [Agarwal, Sudha] Ohio State Univ, Dept Orthoped, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; RWTH Aachen University; University of Cologne; University of Innsbruck; University of Kentucky; University System of Ohio; Ohio State University	Nam, J (corresponding author), Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA.	Agarwal.61@osu.edu	DESCHNER, JAMES/AAW-3998-2021; Rath, Björn/AAF-3938-2022; Butterfield, Tim/AGE-3904-2022; Rath, Björn/AFI-8239-2022	Nam, Jin/0000-0001-5117-8958; Butterfield, Timothy A/0000-0002-8787-2148	National Institute of Arthritis, Musculoskeletal and Skin Diseases at the National Institutes of Health, Bethesda, Maryland [AR048781]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048781] Funding Source: NIH RePORTER	National Institute of Arthritis, Musculoskeletal and Skin Diseases at the National Institutes of Health, Bethesda, Maryland; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grant number AR048781 from the National Institute of Arthritis, Musculoskeletal and Skin Diseases at the National Institutes of Health, Bethesda, Maryland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigner T, 2001, ARTHRITIS RHEUM-US, V44, P2777, DOI 10.1002/1529-0131(200112)44:12<2777::AID-ART465>3.0.CO;2-H; Aigner T, 2006, ARTHRITIS RHEUM-US, V54, P3533, DOI 10.1002/art.22174; Alaaeddine N, 2001, ARTHRITIS RHEUM-US, V44, P1633, DOI 10.1002/1529-0131(200107)44:7<1633::AID-ART286>3.0.CO;2-Z; Appleton CTG, 2007, ARTHRITIS RHEUM-US, V56, P1854, DOI 10.1002/art.22711; Attur MG, 1998, P ASSOC AM PHYSICIAN, V110, P65; Baragi VM, 2009, ARTHRITIS RHEUM-US, V60, P2008, DOI 10.1002/art.24629; Blumer MJF, 2006, J ANAT, V208, P695, DOI 10.1111/j.1469-7580.2006.00578.x; Bos SD, 2010, EUR J HUM GENET, V18, P953, DOI 10.1038/ejhg.2010.52; Bove SE, 2003, OSTEOARTHR CARTILAGE, V11, P821, DOI 10.1016/S1063-4584(03)00163-8; Bradley K, 1996, IMMUNOLOGY, V88, P648; Brew CJ, 2010, ANN RHEUM DIS, V69, P234, DOI 10.1136/ard.2008.097139; Brown DP, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-56; Chen Q., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P311; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; DAVIES DL, 1979, IEEE T PATTERN ANAL, V1, P224, DOI 10.1109/TPAMI.1979.4766909; Dell'Accio F, 2008, ARTHRITIS RHEUM-US, V58, P1410, DOI 10.1002/art.23444; Duan C, 2010, ARTHRITIS RHEUM-US, V62, P771, DOI 10.1002/art.27282; DUNHAM J, 1992, INT J EXP PATHOL, V73, P455; Fernihough J, 2004, PAIN, V112, P83, DOI 10.1016/j.pain.2004.08.004; Garvican ER, 2010, VET J, V185, P36, DOI 10.1016/j.tvjl.2010.04.011; Garvican ER, 2010, VET J, V185, P43, DOI 10.1016/j.tvjl.2010.04.012; Gebauer M, 2005, ARTHRITIS RES THER, V7, pR274, DOI 10.1186/ar1479; Geyer M, 2009, OSTEOARTHR CARTILAGE, V17, P328, DOI 10.1016/j.joca.2008.07.010; Gruber HE, 2005, BIOTECH HISTOCHEM, V80, P157, DOI 10.1080/10520290500387607; Gruber HE, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2660; Guingamp C, 1997, ARTHRITIS RHEUM, V40, P1670, DOI 10.1002/art.1780400917; Guzman RE, 2003, TOXICOL PATHOL, V31, P619, DOI 10.1080/01926230390241800; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Iannone F, 2001, CLIN EXP RHEUMATOL, V19, P139; Iliopoulos D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003740; Karlsson C, 2010, OSTEOARTHR CARTILAGE, V18, P581, DOI 10.1016/j.joca.2009.12.002; Kim JS, 2007, J BIOL CHEM, V282, P29359, DOI 10.1074/jbc.M700965200; Klooster AR, 2005, ARTHRITIS RES THER, V7, pR127, DOI 10.1186/ar1464; Kraus VB, 2010, OSTEOARTHR CARTILAGE, V18, P742, DOI 10.1016/j.joca.2010.02.014; Kraus VB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009739; Lapadula G, 2005, SEMIN ARTHRITIS RHEU, V34, P9, DOI 10.1016/j.semarthrit.2004.03.004; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303; Li X, 2009, ARTHRITIS RHEUM-US, V60, P513, DOI 10.1002/art.24258; Loeser R. F., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P301; Lorenzo P, 2004, MATRIX BIOL, V23, P381, DOI 10.1016/j.matbio.2004.07.007; Malemud CJ, 2010, DRUG AGING, V27, P95, DOI 10.2165/11319950-000000000-00000; MANKIN HJ, 1970, J BONE JOINT SURG AM, VA 52, P424, DOI 10.2106/00004623-197052030-00002; Min JL, 2007, EUR J HUM GENET, V15, P791, DOI 10.1038/sj.ejhg.5201829; Nakajima M, 2007, J BIOL CHEM, V282, P32185, DOI 10.1074/jbc.M700522200; Nakki A, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-50; NAM J, 2011, ARTHRITIS RHEUM; Nam J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005262; Piccinini AM, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/672395; Pleis J. R., 2009, VITAL HLTH STAT, V10; Pozgan U, 2010, BIOL CHEM, V391, P571, DOI 10.1515/BC.2010.035; Pritzker KPH, 2006, OSTEOARTHR CARTILAGE, V14, P13, DOI 10.1016/j.joca.2005.07.014; Raynauld JP, 2009, ANN RHEUM DIS, V68, P938, DOI 10.1136/ard.2008.088732; Roach HI, 2007, CURR DRUG TARGETS, V8, P271, DOI 10.2174/138945007779940160; Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034; Sandell LJ, 2007, ARTHRITIS RHEUM, V56, P2474, DOI 10.1002/art.22760; Sato T, 2006, ARTHRITIS RHEUM-US, V54, P808, DOI 10.1002/art.21638; Schett G, 2009, ARTHRITIS RHEUM-US, V60, P2381, DOI 10.1002/art.24757; van der Weyden L, 2006, AM J PATHOL, V169, P515, DOI 10.2353/ajpath.2006.050981; Vermeirsch H, 2007, PHARMACOL BIOCHEM BE, V87, P349, DOI 10.1016/j.pbb.2007.05.010; Vincent TL, 2008, ARTHRITIS RHEUM, V58, P1207, DOI 10.1002/art.23443; Wallin R, 2010, OSTEOARTHR CARTILAGE, V18, P1096, DOI 10.1016/j.joca.2010.05.013; Wang WZ, 2009, OSTEOARTHR CARTILAGE, V17, P83, DOI 10.1016/j.joca.2008.05.008; Yang S, 2010, NAT MED, V16, P687, DOI 10.1038/nm.2153; Yelin E, 2007, ARTHRITIS RHEUM-US, V56, P1397, DOI 10.1002/art.22565	65	36	38	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2011	6	9							e24320	10.1371/journal.pone.0024320	http://dx.doi.org/10.1371/journal.pone.0024320			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZV	21931681	Green Published, gold, Green Submitted			2022-12-25	WOS:000295321800023
J	Redmond, NE; Raleigh, J; van Soest, RWM; Kelly, M; Travers, SAA; Bradshaw, B; Vartia, S; Stephens, KM; McCormack, GP				Redmond, Niamh E.; Raleigh, Jean; van Soest, Rob W. M.; Kelly, Michelle; Travers, Simon A. A.; Bradshaw, Brian; Vartia, Salla; Stephens, Kelly M.; McCormack, Grace P.			Phylogenetic Relationships of the Marine Haplosclerida (Phylum Porifera) Employing Ribosomal (28S rRNA) and Mitochondrial (cox1, nad1) Gene Sequence Data	PLOS ONE			English	Article							CLASS DEMOSPONGIAE; SUPPORTS; RDNA; CLASSIFICATION; AMPLIFICATION; PERSPECTIVE; INFERENCE; ALIGNMENT; PRIMERS; SPONGES	The systematics of the poriferan Order Haplosclerida (Class Demospongiae) has been under scrutiny for a number of years without resolution. Molecular data suggests that the order needs revision at all taxonomic levels. Here, we provide a comprehensive view of the phylogenetic relationships of the marine Haplosclerida using many species from across the order, and three gene regions. Gene trees generated using 28S rRNA, nad1 and cox1 gene data, under maximum likelihood and Bayesian approaches, are highly congruent and suggest the presence of four clades. Clade A is comprised primarily of species of Haliclona and Callyspongia, and clade B is comprised of H. simulans and H. vansoesti (Family Chalinidae), Amphimedon queenslandica (Family Niphatidae) and Tabulocalyx (Family Phloeodictyidae), Clade C is comprised primarily of members of the Families Petrosiidae and Niphatidae, while Clade D is comprised of Aka species. The polyphletic nature of the suborders, families and genera described in other studies is also found here.	[Redmond, Niamh E.] Smithsonian Inst, Natl Museum Nat Hist, Dept Invertebrate Zool, Washington, DC 20560 USA; [Redmond, Niamh E.; Raleigh, Jean; Bradshaw, Brian; Vartia, Salla; Stephens, Kelly M.; McCormack, Grace P.] Natl Univ Ireland, Galway, Ireland; [van Soest, Rob W. M.] Univ Amsterdam, Zool Museum, Amsterdam, Netherlands; [Kelly, Michelle] Natl Inst Water & Atmospher Res, Natl Ctr Aquat Biodivers & Biosecur, Auckland, New Zealand; [Travers, Simon A. A.] Univ Western Cape, S African Natl Bioinformat Inst, ZA-7535 Bellville, South Africa	Smithsonian Institution; Smithsonian National Museum of Natural History; Ollscoil na Gaillimhe-University of Galway; University of Amsterdam; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; South African National Biodiversity Institute; University of the Western Cape	Redmond, NE (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Dept Invertebrate Zool, Washington, DC 20560 USA.	grace.mccormack@nuigalway.ie		McCormack, Grace/0000-0003-4960-5185; Bradshaw, Brian/0000-0003-2311-1021	Irish Research Council for Science, Engineering and Technology [EI/SC/2003432/Y]; U.S. National Science Foundation [0829986]; Division Of Environmental Biology [0829986] Funding Source: National Science Foundation	Irish Research Council for Science, Engineering and Technology(Irish Research Council for Science, Engineering and Technology); U.S. National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The Irish Research Council for Science, Engineering and Technology (http://www.ircset.ie/) primarily funded this work, Grant No. EI/SC/2003432/Y. The Porifera Tree of Life Project, which is funded by the U.S. National Science Foundation (http://www.nsf.gov/) Grant No. 0829986, to Robert W. Thacker and Allen G. Collins, provided sequences from specimens. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altekar G, 2004, BIOINFORMATICS, V20, P407, DOI 10.1093/bioinformatics/btg427; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Becking Leontine E., 2007, V28, P173; Bergquist P.R., 1979, Colloques Internationaux du Centre National de la Recherche Scientifique, P103; Bergquist P.R., 1980, NZ OCEANOGRAPHIC I M, V87, P1; Borchiellini C, 2004, MOL PHYLOGENET EVOL, V32, P823, DOI 10.1016/j.ympev.2004.02.021; Boury-Esnault N., 1982, CNFRA PUBLICATIONS C, V52, P1; de Laubenfels M. W., 1936, Papers from the Tortugas Laboratory of the Carnegie Institution of Washington, V30, P1; de Weerdt W.H., 1985, Beaufortia, V35, P61; de Weerdt W.H., 1986, Beaufortia, V36, P81; de Weerdt W.H., 1989, Beaufortia, V39, P55; DeBiasse MB, 2010, CORAL REEFS, V29, P47, DOI 10.1007/s00338-009-0554-0; Desqueyroux-Faundez R., 2002, SYSTEMA PORIFERA GUI, V1, P893, DOI DOI 10.1007/978-1-4615-0747-5_94; DEWEERDT WH, 1867, SYSTEMA PORIFERA GUI, P852; Erickson KL, 1997, J ORG CHEM, V62, P8188, DOI 10.1021/jo971556g; Erpenbeck D, 2007, MOL BIOL EVOL, V24, P19, DOI 10.1093/molbev/msl154; Erpenbeck D, 2006, MOL PHYLOGENET EVOL, V38, P293, DOI 10.1016/j.ympev.2005.11.001; Erpenbeck D, 2004, MOL PHYLOGENET EVOL, V32, P388, DOI 10.1016/j.ympev.2004.02.014; Erpenbeck D, 2007, J MAR BIOL ASSOC UK, V87, P1563, DOI 10.1017/S0025315407058195; Erpenbeck D, 2007, ZOOTAXA, P107, DOI 10.11646/zootaxa.1668.1.10; Erpenbeck D, 2007, MAR BIOTECHNOL, V9, P2, DOI 10.1007/s10126-005-6109-7; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fredslund J, 2005, NUCLEIC ACIDS RES, V33, pW516, DOI 10.1093/nar/gki425; FROMONT J, 1994, BIOCHEM SYST ECOL, V22, P735, DOI 10.1016/0305-1978(94)90059-0; Gray J. E., 1867, Proceedings Zoological Society, P492; Griessinger J.-M., 1971, Bulletin Mus Natn Hist Nat Paris (Zool), VNo. 3,1971, P97; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Harcet M, 2010, MOL PHYLOGENET EVOL, V54, P1021, DOI 10.1016/j.ympev.2009.12.019; Hu Jin-Feng, 2003, Alkaloids Chem Biol, V60, P207, DOI 10.1016/S0099-9598(03)60004-0; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; ITSKOVICH VB, 2007, PORIFERA RES BIODIVE, P1; Lavrov DV, 2008, MOL PHYLOGENET EVOL, V49, P111, DOI 10.1016/j.ympev.2008.05.014; Lendenfeld R. von, 1887, ZOOLOGISCHE JB, V2, P723; Levi C., 1956, Archives de Zoologie Experimentale et Generale, V93, P1; Liu H. W., 2004, MAR DRUGS, V2, P154; Lopez-Legentil S, 2010, SCI MAR, V74, P445, DOI 10.3989/scimar.2010.74n3445; MADDISON WP, 1998, MACCLADE VERSION 4 0; McCormack GP, 2002, J ZOOL SYST EVOL RES, V40, P237, DOI 10.1046/j.1439-0469.2002.00204.x; Nichols SA, 2005, MOL PHYLOGENET EVOL, V34, P81, DOI 10.1016/j.ympev.2004.08.019; Philippe H, 2009, CURR BIOL, V19, P706, DOI 10.1016/j.cub.2009.02.052; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Raleigh J, 2007, J MAR BIOL ASSOC UK, V87, P1577, DOI 10.1017/S0025315407058341; Redmond NE, 2007, MOL PHYLOGENET EVOL, V43, P344, DOI 10.1016/j.ympev.2006.10.021; Redmond NE, 2008, MOL PHYLOGENET EVOL, V47, P1090, DOI 10.1016/j.ympev.2008.02.018; Redmond NE, 2009, J MAR BIOL ASSOC UK, V89, P1251, DOI 10.1017/S0025315409000411; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rot C, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-71; Sperling EA, 2009, MOL BIOL EVOL, V26, P2261, DOI 10.1093/molbev/msp148; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Telford MJ, 2004, CURR BIOL, V14, pR274, DOI 10.1016/j.cub.2004.03.022; Topsent E., 1928, Resultats des Campagnes Scientifiques Albert I de Monaco Fasc, V74, P1; Urban S, 2000, CURR ORG CHEM, V4, P765, DOI 10.2174/1385272003376085; Van Soest, 2002, SYSTEMA PORIFERA GUI, V1, P921, DOI DOI 10.1007/978-1-4615-0747-5_97; van Soest R. W. M., 1999, Memoirs of the Queensland Museum, V44, P569; Van Soest R.W.M., 2002, SYSTEMA PORIFERA GUI, P831; van Soest Rob W.M., 1998, P3; van Soest RWM, 1980, STUD FAUNA CURACAO, V62, P1; VANSOEST RWM, 2002, SYSTEMA PORIFERA GUI, P833; Wang XJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002723; WEIDENMAYER F, 1977, MONOGRAPH SHALLOW WA, P78	60	45	45	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2011	6	9							e24344	10.1371/journal.pone.0024344	http://dx.doi.org/10.1371/journal.pone.0024344			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZV	21931685	Green Published, Green Submitted, gold			2022-12-25	WOS:000295321800024
J	Cummins, NW; Klicpera, A; Sainski, AM; Bren, GD; Khosla, S; Westendorf, JJ; Badley, AD				Cummins, Nathan W.; Klicpera, Anna; Sainski, Amy M.; Bren, Gary D.; Khosla, Sundeep; Westendorf, Jennifer J.; Badley, Andrew D.			Human Immunodeficiency Virus Envelope Protein Gp120 Induces Proliferation but Not Apoptosis in Osteoblasts at Physiologic Concentrations	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; NECROSIS-FACTOR-ALPHA; BONE; CELLS; EXPRESSION; OSTEOPOROSIS; INDIVIDUALS; PREVALENCE; MODULATION; INHIBITORS	Patients with HIV infection have decreased numbers of osteoblasts, decreased bone mineral density and increased risk of fracture compared to uninfected patients; however, the molecular mechanisms behind these associations remain unclear. We questioned whether Gp120, a component of the envelope protein of HIV capable of inducing apoptosis in many cell types, is able to induce cell death in bone-forming osteoblasts. We show that treatment of immortalized osteoblast-like cells and primary human osteoblasts with exogenous Gp120 in vitro at physiologic concentrations does not result in apoptosis. Instead, in the osteoblast-like U2OS cell line, cells expressing CXCR4, a receptor for Gp120, had increased proliferation when treated with Gp120 compared to control (P<0.05), which was inhibited by pretreatment with a CXCR4 inhibitor and a G-protein inhibitor. This suggests that Gp120 is not an inducer of apoptosis in human osteoblasts and likely does not directly contribute to osteoporosis in infected patients by this mechanism.	[Cummins, Nathan W.; Klicpera, Anna; Bren, Gary D.; Badley, Andrew D.] Mayo Clin, Div Infect Dis, Rochester, MN 55905 USA; [Cummins, Nathan W.; Badley, Andrew D.] Mayo Clin, Program Translat Immunovirol & Biodef, Rochester, MN USA; [Sainski, Amy M.] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN USA; [Khosla, Sundeep] Mayo Clin, Div Endocrinol Diabet Metab & Nutr, Rochester, MN USA; [Westendorf, Jennifer J.] Mayo Clin, Dept Orthoped Surg, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Cummins, NW (corresponding author), Mayo Clin, Div Infect Dis, Rochester, MN 55905 USA.	Cummins.nathan@mayo.edu	badley, andrew d/O-9022-2014; Khosla, Sundeep/AAE-6170-2020	Khosla, Sundeep/0000-0002-2936-4372; Badley, Andrew/0000-0001-7796-7680	National Institutes of Health (NIH) [AI 40384, AR 056950-02]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040384, R56AI040384, R21AI040384] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR056950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM072474] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was funded by National Institutes of Health (NIH) grants AI 40384 and AR 056950-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkins GJ, 2002, BONE, V31, P448, DOI 10.1016/S8756-3282(02)00858-X; Aukrust P, 1999, J CLIN ENDOCR METAB, V84, P145, DOI 10.1210/jc.84.1.145; Borderi M, 2009, AIDS, V23, P1297, DOI 10.1097/QAD.0b013e32832ce85a; Brown TT, 2006, AIDS, V20, P2165, DOI 10.1097/QAD.0b013e32801022eb; Bu RF, 2003, BONE, V33, P760, DOI 10.1016/j.bone.2003.07.006; Caetano-Lopes J, 2009, AUTOIMMUN REV, V8, P250, DOI 10.1016/j.autrev.2008.07.038; Cotter EJ, 2007, AIDS RES HUM RETROV, V23, P1521, DOI 10.1089/aid.2007.0112; Cotter EJ, 2011, AIDS RES HUM RETROV, V27, P187, DOI 10.1089/aid.2010.0114; Cummins NW, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.77; Cummins NW, 2010, J INFECT DIS, V201, P1273, DOI 10.1086/651434; De Clercq E, 2009, BIOCHEM PHARMACOL, V77, P1655, DOI 10.1016/j.bcp.2008.12.014; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; Fakruddin JM, 2003, J BIOL CHEM, V278, P48251, DOI 10.1074/jbc.M304676200; Gibellini D, 2008, J MED VIROL, V80, P1507, DOI 10.1002/jmv.21266; Grigsby IF, 2010, BIOCHEM BIOPH RES CO, V394, P48, DOI 10.1016/j.bbrc.2010.02.080; Iyengar S, 2011, AIDS RES HUM RETROV, V27, P519, DOI 10.1089/aid.2010.0131; Jain RG, 2002, J BIOL CHEM, V277, P19247, DOI 10.1074/jbc.C200069200; Kapasi AA, 2001, AM J PHYSIOL-RENAL, V280, pF333, DOI 10.1152/ajprenal.2001.280.2.F333; Kassem M, 2011, AGING CELL, V10, P191, DOI 10.1111/j.1474-9726.2011.00669.x; Khaitan Alka, 2011, Curr HIV/AIDS Rep, V8, P4, DOI 10.1007/s11904-010-0066-0; Khosla S, 2008, J CLIN INVEST, V118, P421, DOI 10.1172/JCI33612; Kim J, 1998, REGUL PEPTIDES, V75-6, P201, DOI 10.1016/S0167-0115(98)00069-X; Klasse PJ, 2004, VIROLOGY, V323, P1, DOI 10.1016/j.virol.2004.03.003; Lodowski DT, 2009, CURR OPIN HIV AIDS, V4, P88, DOI 10.1097/COH.0b013e3283223d8d; Lum JJ, 2005, AIDS, V19, P1125, DOI 10.1097/01.aids.0000176212.16205.23; Mallon PWG, 2010, CURR OPIN INFECT DIS, V23, P1, DOI 10.1097/QCO.0b013e328334fe9a; Monroe DG, 2003, J CELL BIOCHEM, V90, P315, DOI 10.1002/jcb.10633; Mora S, 2007, AIDS, V21, P1129, DOI 10.1097/QAD.0b013e32810c8ccf; Nacher M, 2001, AIDS, V15, P2239, DOI 10.1097/00002030-200111230-00004; OKAZAKI R, 1995, J BONE MINER RES, V10, P788; OYAIZU N, 1994, BLOOD, V84, P2622; Patke CL, 2000, J ALLERGY CLIN IMMUN, V105, P975, DOI 10.1067/mai.2000.105315; Richardson J, 2008, J BONE JOINT SURG BR, V90B, P988, DOI 10.1302/0301-620X.90B8.20861; Rickard DJ, 2003, J CELL BIOCHEM, V89, P633, DOI 10.1002/jcb.10539; Santosuosso M, 2009, J INFECT DIS, V200, P1050, DOI 10.1086/605695; SERRANO S, 1995, BONE, V16, P185, DOI 10.1016/8756-3282(94)00028-X; Singhal PC, 1998, J INVEST MED, V46, P243; Singhal PC, 2000, J CELL BIOCHEM, V76, P61, DOI 10.1002/(SICI)1097-4644(20000101)76:1<61::AID-JCB7>3.0.CO;2-F; Toneguzzi S., 1995, Bollettino Societa Italiana Biologia Sperimentale, V71, P275; Triant VA, 2008, J CLIN ENDOCR METAB, V93, P3499, DOI 10.1210/jc.2008-0828; Tsuboi M, 1999, J LAB CLIN MED, V134, P222, DOI 10.1016/S0022-2143(99)90201-9; VANCORVEN EJ, 1993, P NATL ACAD SCI USA, V90, P1257, DOI 10.1073/pnas.90.4.1257	42	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2011	6	9							e24876	10.1371/journal.pone.0024876	http://dx.doi.org/10.1371/journal.pone.0024876			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CO	21931863	Green Submitted, Green Published, gold			2022-12-25	WOS:000294803200054
J	Okada, Y; Nobori, H; Shimizu, M; Watanabe, M; Yonekura, M; Nakai, T; Kamikawa, Y; Wakimura, A; Funahashi, N; Naruse, H; Watanabe, A; Yamasaki, D; Fukada, S; Yasui, K; Matsumoto, K; Sato, T; Kitajima, K; Nakano, T; Aird, WC; Doi, T				Okada, Yoshiaki; Nobori, Haruaki; Shimizu, Mikiko; Watanabe, Miho; Yonekura, Masaaki; Nakai, Tomoko; Kamikawa, Yuko; Wakimura, Atsuko; Funahashi, Nobuaki; Naruse, Hiroki; Watanabe, Ayako; Yamasaki, Daisuke; Fukada, So-ichiro; Yasui, Kazuta; Matsumoto, Kayoko; Sato, Takahiro; Kitajima, Kenji; Nakano, Toru; Aird, William C.; Doi, Takefumi			Multiple ETS Family Proteins Regulate PF4 Gene Expression by Binding to the Same ETS Binding Site	PLOS ONE			English	Article							GENOME-WIDE ANALYSIS; TRANSCRIPTION FACTOR; DNA-BINDING; IN-VITRO; ERYTHROID-DIFFERENTIATION; PLATELET-FACTOR-4 GENE; ROBO4 PROMOTER; GATA-1; PU.1; CELLS	In previous studies on the mechanism underlying megakaryocyte-specific gene expression, several ETS motifs were found in each megakaryocyte-specific gene promoter. Although these studies suggested that several ETS family proteins regulate megakaryocyte-specific gene expression, only a few ETS family proteins have been identified. Platelet factor 4 (PF4) is a megakaryocyte-specific gene and its promoter includes multiple ETS motifs. We had previously shown that ETS-1 binds to an ETS motif in the PF4 promoter. However, the functions of the other ETS motifs are still unclear. The goal of this study was to investigate a novel functional ETS motif in the PF4 promoter and identify proteins binding to the motif. In electrophoretic mobility shift assays and a chromatin immunoprecipitation assay, FLI-1, ELF-1, and GABP bound to the 251 ETS site. Expression of FLI-1, ELF-1, and GABP activated the PF4 promoter in HepG2 cells. Mutation of a 251 ETS site attenuated FLI-1-, ELF-1-, and GABP-mediated transactivation of the promoter. siRNA analysis demonstrated that FLI-1, ELF-1, and GABP regulate PF4 gene expression in HEL cells. Among these three proteins, only FLI-1 synergistically activated the promoter with GATA-1. In addition, only FLI-1 expression was increased during megakaryocytic differentiation. Finally, the importance of the -51 ETS site for the activation of the PF4 promoter during physiological megakaryocytic differentiation was confirmed by a novel reporter gene assay using in vitro ES cell differentiation system. Together, these data suggest that FLI-1, ELF-1, and GABP regulate PF4 gene expression through the -51 ETS site in megakaryocytes and implicate the differentiation stage-specific regulation of PF4 gene expression by multiple ETS factors.	[Okada, Yoshiaki; Nobori, Haruaki; Shimizu, Mikiko; Yonekura, Masaaki; Nakai, Tomoko; Kamikawa, Yuko; Wakimura, Atsuko; Funahashi, Nobuaki; Naruse, Hiroki; Watanabe, Ayako; Yamasaki, Daisuke; Fukada, So-ichiro; Doi, Takefumi] Osaka Univ, Grad Sch Pharmaceut Sci, Osaka, Japan; [Watanabe, Miho; Doi, Takefumi] Osaka Univ, Grad Sch Frontier Biosci, Osaka, Japan; [Yasui, Kazuta] Osaka Red Cross Blood Ctr, Dept Res, Osaka, Japan; [Matsumoto, Kayoko] Osaka Red Cross Blood Ctr, Div Cord Blood Cell Proc, Osaka, Japan; [Sato, Takahiro] Tokyo Med & Dent Univ, Dept Cellular Physiol Chem, Tokyo, Japan; [Kitajima, Kenji; Nakano, Toru] Osaka Univ, Sch Med, Dept Pathol, Osaka 530, Japan; [Aird, William C.] Beth Israel Deaconess Med Ctr, Vasc Biol Res Ctr, Boston, MA 02215 USA; [Aird, William C.] Beth Israel Deaconess Med Ctr, Div Mol & Vasc Med, Boston, MA 02215 USA	Osaka University; Osaka University; Osaka Red Cross Hospital; Osaka Red Cross Hospital; Tokyo Medical & Dental University (TMDU); Osaka University; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center	Okada, Y (corresponding author), Osaka Univ, Grad Sch Pharmaceut Sci, Osaka, Japan.	okadabos@phs.osaka-u.ac.jp	Okada, Yoshiaki/M-8718-2017; Fukada, So-ichiro/AAI-9151-2020; Funahashi, Nobuaki/ABF-1529-2021	Fukada, So-ichiro/0000-0003-4051-5108; Funahashi, Nobuaki/0000-0003-0888-1060	Japan Society for the Promotion of Science [19390022]; Ministry of Education, Culture, Sports, Science and Technology [19890117, 20790064]; Takeda Science Foundation; Mitsubishi Pharma Research Foundation; Uehara Memorial Foundation; Suzuken Memorial Foundation; Senri Life Science Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Mitsubishi Pharma Research Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Suzuken Memorial Foundation; Senri Life Science Foundation	This work was supported by Japan Society for the Promotion of Science KAKENHI (19390022), The Ministry of Education, Culture, Sports, Science and Technology KAKENHI (19890117 and 20790064), Takeda Science Foundation, Mitsubishi Pharma Research Foundation, the Uehara Memorial Foundation, Senri Life Science Foundation and Suzuken Memorial Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Doubeikovski A, 1997, J BIOL CHEM, V272, P24300, DOI 10.1074/jbc.272.39.24300; Eisbacher M, 2003, MOL CELL BIOL, V23, P3427, DOI 10.1128/MCB.23.10.3427-3441.2003; Evans V, 2000, PHYSIOL GENOMICS, V2, P67, DOI 10.1152/physiolgenomics.2000.2.2.67; Fujimoto TT, 2003, BLOOD, V102, P4044, DOI 10.1182/blood-2003-06-1773; Gu TL, 2000, MOL CELL BIOL, V20, P91, DOI 10.1128/MCB.20.1.91-103.2000; Hollenhorst PC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000778; Hong W, 2002, MOL CELL BIOL, V22, P3729, DOI 10.1128/MCB.22.11.3729-3743.2002; Kamura T, 1997, J BIOL CHEM, V272, P11361; Matsumoto K, 2000, STEM CELLS, V18, P196, DOI 10.1634/stemcells.18-3-196; Minami T, 1998, EUR J BIOCHEM, V258, P879, DOI 10.1046/j.1432-1327.1998.2580879.x; Moussa O, 2010, MOL CELL BIOL, V30, P5194, DOI 10.1128/MCB.01112-09; Okada Y, 2004, BLOOD, V104, P2027, DOI 10.1182/blood-2003-09-3107; Okada Y, 2003, BLOOD, V101, P4748, DOI 10.1182/blood-2002-02-0380; Okada Y, 2003, BIOCHEM BIOPH RES CO, V305, P155, DOI 10.1016/S0006-291X(03)00718-6; Okada Y, 2008, BLOOD, V112, P2336, DOI 10.1182/blood-2008-01-135079; Okada Y, 2007, CIRC RES, V100, P1712, DOI 10.1161/01.RES.0000269779.10644.dc; Pang LY, 2006, BLOOD, V108, P2198, DOI 10.1182/blood-2006-04-019760; RAVID K, 1991, MOL CELL BIOL, V11, P6116, DOI 10.1128/MCB.11.12.6116; Rekhtman N, 1999, GENE DEV, V13, P1398, DOI 10.1101/gad.13.11.1398; Rekhtman N, 2003, MOL CELL BIOL, V23, P7460, DOI 10.1128/MCB.23.21.7460-7474.2003; Rosmarin  AG, 2004, BLOOD CELL MOL DIS, V32, P143, DOI 10.1016/j.bcmd.2003.09.005; Shivdasani RA, 2001, STEM CELLS, V19, P397, DOI 10.1634/stemcells.19-5-397; Starck J, 2010, BLOOD, V116, P4795, DOI 10.1182/blood-2010-02-270405; Stopka T, 2005, EMBO J, V24, P3712, DOI 10.1038/sj.emboj.7600834; Szalai G, 2006, CELL MOL LIFE SCI, V63, P2460, DOI 10.1007/s00018-006-6190-8; THOMPSON CB, 1992, MOL CELL BIOL, V12, P1043, DOI 10.1128/MCB.12.3.1043; Walters DK, 2006, LEUKEMIA RES, V30, P1097, DOI 10.1016/j.leukres.2006.01.001; WASYLYK B, 1993, EUR J BIOCHEM, V211, P7, DOI 10.1111/j.1432-1033.1993.tb19864.x; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Zhang CY, 1997, J BIOL CHEM, V272, P26236, DOI 10.1074/jbc.272.42.26236; Zhang P, 2000, BLOOD, V96, P2641; Zhang P, 1999, P NATL ACAD SCI USA, V96, P8705, DOI 10.1073/pnas.96.15.8705	33	12	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2011	6	9							e24837	10.1371/journal.pone.0024837	http://dx.doi.org/10.1371/journal.pone.0024837			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CO	21931859	Green Submitted, gold, Green Published			2022-12-25	WOS:000294803200053
J	Xu, W; Wang, YC; Taylor, E; Laujac, A; Gao, LY; Savikhin, S; Chitnis, PR				Xu, Wu; Wang, Yingchun; Taylor, Eric; Laujac, Amelie; Gao, Liyan; Savikhin, Sergei; Chitnis, Parag R.			Mutational Analysis of Photosystem I of Synechocystis sp PCC 6803: The Role of Four Conserved Aromatic Residues in the j-helix of PsaB	PLOS ONE			English	Article							PRIMARY ELECTRON-DONOR; SITE-DIRECTED MUTAGENESIS; CYTOCHROME C(6); CHLAMYDOMONAS-REINHARDTII; ANGSTROM RESOLUTION; AXIAL LIGANDS; REACTION-MECHANISM; CHARGE SEPARATION; REACTION CENTERS; KINETIC-ANALYSIS	Photosystem I is the light-driven plastocyanin-ferredoxin oxidoreductase in the photosynthetic electron transfer of cyanobacteria and plants. Two histidyl residues in the symmetric transmembrane helices A-j and B-j provide ligands for the P700 chlorophyll molecules of the reaction center of photosystem I. To determine the role of conserved aromatic residues adjacent to the histidyl molecule in the helix of B-j, we generated six site-directed mutants of the psaB gene in Synechocystis sp. PCC 6803. Three mutant strains with W645C, W643C/A644I and S641C/V642I substitutions could grow photoautotrophically and showed no obvious reduction in the photosystem I activity. Kinetics of P700 re-reduction by plastocyanin remained unaltered in these mutants. In contrast, the strains with H651C/L652M, F649C/G650I and F647C substitutions could not grow under photoautotrophic conditions because those mutants had low photosystem I activity, possibly due to low levels of proteins. A procedure to select spontaneous revertants from the mutants that are incapable to photoautotrophic growth resulted in three revertants that were used in this study. The molecular analysis of the spontaneous revertants suggested that an aromatic residue at F647 and a small residue at G650 may be necessary for maintaining the structural integrity of photosystem I. The (P700(+) - P700) steady-state absorption difference spectrum of the revertant F647Y has a similar to 5 nm narrower peak than the recovered wild-type, suggesting that additional hydroxyl group of this revertant may participate in the interaction with the special pair while the photosystem I complexes of the F649C/G650T and H651Q mutants closely resemble the wild-type spectrum. The results presented here demonstrate that the highly conserved residues W645, W643 and F649 are not critical for maintaining the integrity and in mediating electron transport from plastocyanin to photosystem I. Our data suggest that an aromatic residue is required at position of 647 for structural integrity and/or function of photosystem I.	[Xu, Wu; Taylor, Eric; Laujac, Amelie] Univ SW Louisiana, Dept Chem, Lafayette, LA 70504 USA; [Wang, Yingchun; Gao, Liyan] Chinese Acad Sci, Inst Genet & Dev Biol, Key Lab Mol & Dev Biol, Beijing, Peoples R China; [Savikhin, Sergei] Purdue Univ, Dept Phys, W Lafayette, IN 47907 USA; [Chitnis, Parag R.] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA USA	University of Louisiana Lafayette; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Iowa State University	Xu, W (corresponding author), Univ SW Louisiana, Dept Chem, Lafayette, LA 70504 USA.	wxx6941@louisiana.edu; ycwang@genetics.ac.cn		Xu, Wu/0000-0002-2982-3276	Iowa Sate University; National Science Foundation; LA Board of Regents; University of Louisiana at Lafayette; Chinese Academy of Sciences	Iowa Sate University; National Science Foundation(National Science Foundation (NSF)); LA Board of Regents; University of Louisiana at Lafayette; Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported in part by grants to PRC from Iowa Sate University. The authors thank National Science Foundation's EPSCoR grant, LA Board of Regents, awarded to WX from the University of Louisiana at Lafayette and the One Hundred Talents project of the Chinese Academy of Sciences awarded to YW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amunts A, 2007, NATURE, V447, P58, DOI 10.1038/nature05687; ANDERSON SL, 1991, J BACTERIOL, V173, P2761, DOI 10.1128/JB.173.9.2761-2767.1991; Ben-Shem A, 2003, NATURE, V426, P630, DOI 10.1038/nature02200; Breton J, 2002, BIOCHEMISTRY-US, V41, P11200, DOI 10.1021/bi0262404; Brettel K, 2001, BBA-BIOENERGETICS, V1507, P100, DOI 10.1016/S0005-2728(01)00202-X; Chen J, 2009, J PHYS CHEM B, V113, P11367, DOI 10.1021/jp906491r; Chitnis PR, 2001, ANNU REV PLANT PHYS, V52, P593, DOI 10.1146/annurev.arplant.52.1.593; CHITNIS VP, 1993, J BIOL CHEM, V268, P11678; Clarke AK, 1996, PLANT PHYSIOL, V112, P1551, DOI 10.1104/pp.112.4.1551; Cohen RO, 2004, BIOCHEMISTRY-US, V43, P4741, DOI 10.1021/bi035633f; Dashdorj N, 2005, BIOPHYS J, V88, P1238, DOI 10.1529/biophysj.104.050963; DelaCerda B, 1997, BIOCHEMISTRY-US, V36, P10125, DOI 10.1021/bi9708601; Dur n RV, 2004, J BIOL CHEM, V279, P7229, DOI 10.1074/jbc.M311565200; Duran RV, 2006, BIOCHEMISTRY-US, V45, P1054, DOI 10.1021/bi052090w; Duran RV, 2005, BIOCHEM BIOPH RES CO, V334, P170, DOI 10.1016/j.bbrc.2005.06.070; Finazzi G, 2005, P NATL ACAD SCI USA, V102, P7031, DOI 10.1073/pnas.0406288102; Fromme P, 2001, BBA-BIOENERGETICS, V1507, P5, DOI 10.1016/S0005-2728(01)00195-5; Grotjohann I, 2005, PHOTOSYNTH RES, V85, P51, DOI 10.1007/s11120-005-1440-4; Hervas M, 1996, BIOCHEMISTRY-US, V35, P2693, DOI 10.1021/bi951876z; HERVAS M, 1995, BIOCHEMISTRY-US, V34, P11321, DOI 10.1021/bi00036a004; Hippler M, 1997, BIOCHEMISTRY-US, V36, P6343, DOI 10.1021/bi970082c; HIYAMA T, 1972, BIOCHIM BIOPHYS ACTA, V267, P160, DOI 10.1016/0005-2728(72)90147-8; Holzwarth AR, 2006, BIOPHYS J, V90, P552, DOI 10.1529/biophysj.105.059824; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Krabben L, 2000, BIOCHEMISTRY-US, V39, P13012, DOI 10.1021/bi001200q; Mamedov MD, 2001, FEBS LETT, V500, P172, DOI 10.1016/S0014-5793(01)02615-1; Mary Mennes A, 1968, J PHYCOL, V4, P1; MEHLER AH, 1951, ARCH BIOCHEM BIOPHYS, V34, P339, DOI 10.1016/0003-9861(51)90012-4; MEHLER AH, 1951, ARCH BIOCHEM BIOPHYS, V33, P65, DOI 10.1016/0003-9861(51)90082-3; Muller MG, 2010, P NATL ACAD SCI USA, V107, P4123, DOI 10.1073/pnas.0905407107; Nishioka H, 2005, J PHYS CHEM B, V109, P1978, DOI 10.1021/jp046282x; PICARD V, 1994, NUCLEIC ACIDS RES, V22, P2587, DOI 10.1093/nar/22.13.2587; Redding K, 1998, EMBO J, V17, P50, DOI 10.1093/emboj/17.1.50; Santabarbara S, 2009, BIOCHEMISTRY-US, V48, P10457, DOI 10.1021/bi901052c; Savikhin S, 2001, BIOCHEMISTRY-US, V40, P9282, DOI 10.1021/bi0104165; Savikhin S, 2000, BIOPHYS J, V79, P1573, DOI 10.1016/S0006-3495(00)76408-3; SCHAFFERNICHT H, 1981, PHOTOCHEM PHOTOBIOL, V34, P223; Schubert WD, 1997, J MOL BIOL, V272, P741, DOI 10.1006/jmbi.1997.1269; SHEN GZ, 1995, PHOTOSYNTH RES, V44, P41, DOI 10.1007/BF00018295; Shih C, 2008, SCIENCE, V320, P1760, DOI 10.1126/science.1158241; Sigfridsson K, 1998, PHOTOSYNTH RES, V57, P1, DOI 10.1023/A:1006067631076; Sommer F, 2004, J BIOL CHEM, V279, P20009, DOI 10.1074/jbc.M313986200; Sommer F, 2002, J BIOL CHEM, V277, P6573, DOI 10.1074/jbc.M110633200; Sommer F, 2006, J BIOL CHEM, V281, P35097, DOI 10.1074/jbc.M607384200; Sun J, 1999, J BIOL CHEM, V274, P19048, DOI 10.1074/jbc.274.27.19048; Sun J, 1998, METHOD ENZYMOL, V297, P124; Sun J, 1997, J BIOL CHEM, V272, P21793, DOI 10.1074/jbc.272.35.21793; Webber AN, 1996, BIOCHEMISTRY-US, V35, P12857, DOI 10.1021/bi961198w; Webber AN, 2001, BBA-BIOENERGETICS, V1507, P61, DOI 10.1016/S0005-2728(01)00198-0; Weigel M, 2003, J BIOL CHEM, V278, P31286, DOI 10.1074/jbc.M302876200; WILLIAMS JGK, 1988, METHOD ENZYMOL, V167, P766; Witt H, 2003, J BIOL CHEM, V278, P46760, DOI 10.1074/jbc.M304776200; XU QA, 1994, J BIOL CHEM, V269, P3205; Xu W, 2003, J BIOL CHEM, V278, P27864, DOI 10.1074/jbc.M302962200; ZHANG L, 1992, J BIOL CHEM, V267, P19054	55	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2011	6	9							e24625	10.1371/journal.pone.0024625	http://dx.doi.org/10.1371/journal.pone.0024625			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CO	21931782	gold, Green Submitted, Green Published			2022-12-25	WOS:000294803200033
J	Casey, GJ; Sartori, D; Horton, SE; Phuc, TQ; Phu, LB; Thach, DT; Dai, TC; Fattore, G; Montresor, A; Biggs, BA				Casey, Gerard J.; Sartori, Davide; Horton, Susan E.; Phuc, Tran Q.; Phu, Luong B.; Thach, Dang T.; Dai, Tran C.; Fattore, Giovanni; Montresor, Antonio; Biggs, Beverley-A.			Weekly Iron-Folic Acid Supplementation with Regular Deworming Is Cost-Effective in Preventing Anaemia in Women of Reproductive Age in Vietnam	PLOS ONE			English	Article							PREGNANT-WOMEN; DEFICIENCY; PROGRAM; HOOKWORM; PROVINCE; REDUCE; RISK	Background: To estimate the cost and cost-effectiveness of a project administering de-worming and weekly iron-folic acid supplementation to control anaemia in women of reproductive age in Yen Bai province, Vietnam. Methods and Findings: Cost effectiveness was evaluated using data on programmatic costs based on two surveys in 2006 and 2009 and impact on anaemia and iron status collected in 2006, 2007, and 2008. Data on initial costs for training and educational materials were obtained from the records of the National Institute of Malariology, Parasitology and Entomology and the Yen Bai Malaria Control Program. Structured questionnaires for health workers at district, commune and village level were used to collect ongoing distribution and monitoring costs, and for participants to collect transport and loss of earnings costs. The cost per woman treated (defined as consuming at least 75% of the recommended intake) was USD0.76 per annum. This estimate includes financial costs (for supplies, training), and costs of health care workers' time. Prevalence of anaemia fell from 38% at baseline, to 20% after 12 months. Thus, the cost-effectiveness of the project is assessed at USD 4.24 per anaemia case prevented per year. Based on estimated productivity gains for adult women, the benefit: cost ratio is 6.7:1. Cost of the supplements and anthelminthics was 47% of the total, while costs of training, monitoring, and health workers' time accounted for 53%. Conclusion: The study shows that weekly iron-folic acid supplementation and regular de-worming is a low-cost and cost-effective intervention and would be appropriate for population-based introduction in settings with a high prevalence of anaemia and iron deficiency and low malaria infection rates.	[Casey, Gerard J.; Biggs, Beverley-A.] Univ Melbourne, Royal Melbourne Hosp, Dept Med RMH WH, Parkville, Vic, Australia; [Sartori, Davide] Univ Commerciale Luigi Bocconi, Milan, Italy; [Horton, Susan E.] Univ Waterloo, Balsillie Sch Int Affairs, Waterloo, ON N2L 3G1, Canada; [Phuc, Tran Q.; Thach, Dang T.] Natl Inst Malariol, Hanoi, Vietnam; [Phu, Luong B.] Yen Bai Med Coll, Yen Bai, Vietnam; [Dai, Tran C.] WHO, Hanoi, Vietnam; [Fattore, Giovanni] Bocconi Univ, Milan, Italy; [Montresor, Antonio] WHO, CH-1211 Geneva, Switzerland; [Biggs, Beverley-A.] Royal Melbourne Hosp, CCREID, Parkville, Vic 3050, Australia	Royal Melbourne Hospital; University of Melbourne; Bocconi University; University of Waterloo; World Health Organization; Bocconi University; World Health Organization; Royal Melbourne Hospital	Casey, GJ (corresponding author), Univ Melbourne, Royal Melbourne Hosp, Dept Med RMH WH, Parkville, Vic, Australia.	babiggs@unimelb.edu.au	Montresor, Antonio/J-3137-2019	Montresor, Antonio/0000-0003-3103-8872; Horton, Susan/0000-0002-9243-4767; Biggs, Beverley-Ann/0000-0002-2961-9793	Atlantic Philanthropies Incorporated; Yen Bai People's Committee	Atlantic Philanthropies Incorporated; Yen Bai People's Committee	The Atlantic Philanthropies Incorporated kindly funded the project (http://salmon.atlanticphilanthropies.org/help). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge the support of Yen Bai People's Committee, district and commune health staff, and village health workers. We are grateful to the staff of the local implementing agency, Yen Bai Malaria Control Centre, Pham Thi Xuyen, Beth Hilton-Thorp and Christalla Hajisava for invaluable contributions. Most importantly, we thank the women of Tran Yen and Yen Binh who participated in these surveys.	Aikawa R, 2006, PUBLIC HEALTH NUTR, V9, P443, DOI 10.1079/PHN2005851; Allen LH, 2000, AM J CLIN NUTR, V71, p1280S, DOI 10.1093/ajcn/71.5.1280s; [Anonymous], 2001, IRON DEFICIENCY ANAE; Baltussen R, 2004, J NUTR, V134, P2678, DOI 10.1093/jn/134.10.2678; Behrman J, 2004, GLOBAL CRISES GLOBAL; Berger J, 2005, NUTR REV, V63, pS95, DOI 10.1301/nr.2005.dec.S95-S108; Casey GJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015691; Casey GJ, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-261; Fiedler JL, 2008, INT J HEALTH PLAN M, V23, P373, DOI 10.1002/hpm.928; Hindmarsh PC, 2000, LANCET, V356, P719, DOI 10.1016/S0140-6736(00)02630-1; Horton S, 2003, FOOD POLICY, V28, P51, DOI 10.1016/S0306-9192(02)00070-2; Khoi HH, 2001, REPORT VIETNAM NATL; Margetts BM, 2007, WEEKLY IRON FOLIC SU, P25; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; Pasricha SR, 2008, AM J TROP MED HYG, V78, P375, DOI 10.4269/ajtmh.2008.78.375; Phuc TQ, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-266; Preziosi P, 1997, AM J CLIN NUTR, V66, P1178, DOI 10.1093/ajcn/66.5.1178; Sartori DA, 2007, COST EFFECTIVENESS A; SCHOLL TO, 1992, AM J CLIN NUTR, V55, P985, DOI 10.1093/ajcn/55.5.985; Stoltzfus RJ, 2005, COMP QUANTIFICATION; Trinh LTT, 2007, ASIA PAC J CLIN NUTR, V16, P310; UN, 2008, REV POP DAT; World Bank, 2020, WORLD DEV IND; World Health Organization (WHO), 2009, WEEKL IR FOL AC SUPP; Zeng LX, 2009, FOOD NUTR BULL, V30, pS480, DOI 10.1177/15648265090304S402	25	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e23723	10.1371/journal.pone.0023723	http://dx.doi.org/10.1371/journal.pone.0023723			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CK	21931611	Green Published, gold			2022-12-25	WOS:000294802800008
J	Xu, LL; Deng, YP; Feng, LX; Li, DF; Chen, XY; Ma, C; Liu, X; Yin, J; Yang, M; Teng, FK; Wu, WY; Guan, SH; Jiang, BH; Guo, DA				Xu, Lingling; Deng, Yanping; Feng, Lixin; Li, Defang; Chen, Xiaoyan; Ma, Chao; Liu, Xuan; Yin, Jun; Yang, Min; Teng, Fukang; Wu, Wanying; Guan, Shuhong; Jiang, Baohong; Guo, Dean			Cardio-Protection of Salvianolic Acid B through Inhibition of Apoptosis Network	PLOS ONE			English	Article							MOLECULAR NETWORKS; DRUG DISCOVERY; HEART-FAILURE; PATHWAY; DEATH; CELLS	Targeting cellular function as a system rather than on the level of the single target significantly increases therapeutic potency. In the present study, we detect the target pathway of salvianolic acid B (SalB) in vivo. Acute myocardial infarction (AMI) was induced in rats followed by the treatment with 10 mg/kg SalB. Hemodynamic detection and pathological stain, 2-dimensional electrophoresis, MALDI-TOF MS/MS, Western blot, pathway identification, apoptosis assay and transmission electron microscope were used to elucidate the effects and mechanism of SalB on cardioprotection. Higher SalB concentration was found in ischemic area compared to no-ischemic area of heart, correlating with improved heart function and histological structure. Thirty-three proteins regulated by SalB in AMI rats were identified by biochemical analysis and were classified as the components of metabolism and apoptosis networks. SalB protected cardiomyocytes from apoptosis, inhibited poly (ADP-ribose) polymerase-1 pathway, and improved the integrity of mitochondrial and nucleus of heart tissue during AMI. Furthermore, the protective effects of SalB against apoptosis were verified in H9c2 cells. Our results provide evidence that SalB regulates multi-targets involved in the apoptosis pathway during AMI and therefore may be a candidate for novel therapeutics of heart diseases.	[Xu, Lingling; Deng, Yanping; Feng, Lixin; Li, Defang; Chen, Xiaoyan; Ma, Chao; Liu, Xuan; Yang, Min; Teng, Fukang; Wu, Wanying; Guan, Shuhong; Jiang, Baohong; Guo, Dean] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 200031, Peoples R China; [Yin, Jun; Teng, Fukang] Shenyang Pharmaceut Univ, Shenyang, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Shenyang Pharmaceutical University	Xu, LL (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 200031, Peoples R China.	jiangbh@mail.shcnc.ac.cn; daguo@mail.shcnc.ac.cn	zhou, ju/M-3255-2017; ding, zuoqi/C-9271-2013	Li, Defang/0000-0003-4151-9151; Jiang, Baohong/0000-0002-8573-1536	National Science and Technology Major Project for "Key New Drug Creation and Manufacturing Program" [2009ZX09308-005, 2009ZX09102-122, 2009ZX090304-002, 2009ZX09311-001, 2009ZX09502-020]	National Science and Technology Major Project for "Key New Drug Creation and Manufacturing Program"	This work was supported by the National Science and Technology Major Project for "Key New Drug Creation and Manufacturing Program" (2009ZX09308-005; 2009ZX09102-122; 2009ZX090304-002; 2009ZX09311-001; 2009ZX09502-020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrabi SA, 2008, ANN NY ACAD SCI, V1147, P233, DOI 10.1196/annals.1427.014; Balakumar P, 2010, PHARMACOL RES, V62, P365, DOI 10.1016/j.phrs.2010.07.003; Bartha E, 2008, J CARDIOVASC PHARM, V52, P253, DOI 10.1097/FJC.0b013e3181855cef; Guo WZ, 2011, CHINESE MED J-PEKING, V124, P423, DOI 10.3760/cma.j.issn.0366-6999.2011.03.019; Jiang Baohong, 2010, BMC Pharmacology, V10, P10, DOI 10.1186/1471-2210-10-10; Jiang BH, 2009, PLANTA MED, V75, P1286, DOI 10.1055/s-0029-1185669; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Koh DW, 2005, CELL MOL LIFE SCI, V62, P760, DOI 10.1007/s00018-004-4508-y; Ma C, 2009, FOOD CHEM TOXICOL, V47, P1841, DOI 10.1016/j.fct.2009.04.041; Ma XH, 2010, PHARM RES-DORDR, V27, P739, DOI 10.1007/s11095-010-0065-2; Molnar A, 2006, MOL MED, V12, P143, DOI 10.2119/2006-00043.Molnar; Morrow John Kenneth, 2010, Critical Reviews in Biomedical Engineering, V38, P143, DOI 10.1615/CritRevBiomedEng.v38.i2.30; Shi CS, 2007, THROMB RES, V119, P769, DOI 10.1016/j.thromres.2006.06.008; Wang QL, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-31; Wang SX, 2010, NEUROCHEM RES, V35, P1029, DOI 10.1007/s11064-010-0151-1; Xu M, 2007, BIOMED CHROMATOGR, V21, P1052, DOI 10.1002/bmc.852; Yue QX, 2008, CANCER SCI, V99, P1461, DOI 10.1111/j.1349-7006.2008.00824.x; Zeng G, 2010, BIOL PHARM BULL, V33, P1337, DOI 10.1248/bpb.33.1337; Zhao Jun-Fang, 2004, Hepatobiliary Pancreat Dis Int, V3, P102; Zhou LM, 2009, INT J PHARMACEUT, V379, P109, DOI 10.1016/j.ijpharm.2009.06.016; Zhou LM, 2005, J CLIN PHARMACOL, V45, P1345, DOI 10.1177/0091270005282630	21	44	47	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2011	6	9							e24036	10.1371/journal.pone.0024036	http://dx.doi.org/10.1371/journal.pone.0024036			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817QP	21915278	gold, Green Published, Green Submitted			2022-12-25	WOS:000294689200016
J	Rosenberg, MF; O'Ryan, LP; Hughes, G; Zhao, ZF; Aleksandrov, LA; Riordan, JR; Ford, RC				Rosenberg, Mark F.; O'Ryan, Liam P.; Hughes, Guy; Zhao, Zhefeng; Aleksandrov, Luba A.; Riordan, John R.; Ford, Robert C.			The Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) THREE-DIMENSIONAL STRUCTURE AND LOCALIZATION OF A CHANNEL GATE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSPORTER P-GLYCOPROTEIN; NUCLEOTIDE-BINDING DOMAINS; MULTIDRUG ABC TRANSPORTER; MALTOSE TRANSPORTER; ELECTRON CRYSTALLOGRAPHY; DELTA-F508 MUTATION; ALTERNATING ACCESS; CRYSTAL-STRUCTURE; CHLORIDE CHANNEL; CL-CHANNELS	Cystic fibrosis affects about 1 in 2500 live births and involves loss of transmembrane chloride flux due to a lack of a membrane protein channel termed the cystic fibrosis transmembrane conductance regulator (CFTR). We have studied CFTR structure by electron crystallography. The data were compared with existing structures of other ATP-binding cassette transporters. The protein was crystallized in the outward facing state and resembled the well characterized Sav1866 transporter. We identified regions in the CFTR map, not accounted for by Sav1866, which were potential locations for the regulatory region as well as the channel gate. In this analysis, we were aided by the fact that the unit cell was composed of two molecules not related by crystallographic symmetry. We also identified regions in the fitted Sav1866 model that were missing from the map, hence regions that were either disordered in CFTR or differently organized compared with Sav1866. Apart from the N and C termini, this indicated that in CFTR, the cytoplasmic end of transmembrane helix 5/11 and its associated loop could be partly disordered (or alternatively located).	[Ford, Robert C.] Univ Manchester, Fac Life Sci, Manchester Interdisciplinary Bioctr, Manchester M1 7DN, Lancs, England; [Zhao, Zhefeng; Aleksandrov, Luba A.; Riordan, John R.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of Manchester; University of North Carolina; University of North Carolina Chapel Hill	Ford, RC (corresponding author), Univ Manchester, Fac Life Sci, Manchester Interdisciplinary Bioctr, Manchester M1 7DN, Lancs, England.	robert.ford@manchester.ac.uk		Ford, Robert/0000-0002-0958-1505	National Institutes of Health [DK051619]; Cystic Fibrosis Foundation [FORD08XX0, RIORDA06XX0]; Wellcome Trust; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051619] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK051619. This work was also supported by Cystic Fibrosis Foundation Grants FORD08XX0 and RIORDA06XX0. The Polara electron microscope was obtained with funding from the Wellcome Trust.	Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; AMOS LA, 1983, PROG BIOPHYS MOL BIO, V39, P183, DOI 10.1016/0079-6107(83)90017-2; Aubin CNS, 2006, J GEN PHYSIOL, V128, P535, DOI 10.1085/jgp.200609516; Baker JMR, 2007, NAT STRUCT MOL BIOL, V14, P738, DOI 10.1038/nsmb1278; Bobadilla JL, 2002, HUM MUTAT, V19, P575, DOI 10.1002/humu.10041; Cai ZW, 2003, J GEN PHYSIOL, V122, P605, DOI 10.1085/jgp.200308921; Chang XB, 1999, MOL CELL, V4, P137, DOI 10.1016/S1097-2765(00)80196-3; Cui G, 2008, J MEMBRANE BIOL, V222, P91, DOI 10.1007/s00232-008-9105-9; Da Paula AC, 2010, J BIOL CHEM, V285, P27033, DOI 10.1074/jbc.M110.120352; Davidson AL, 2007, TRENDS MICROBIOL, V15, P448, DOI 10.1016/j.tim.2007.09.005; Dawson RJP, 2007, MOL MICROBIOL, V65, P250, DOI 10.1111/j.1365-2958.2007.05792.x; Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Ford RC, 2008, TRENDS BIOCHEM SCI, V33, P38, DOI 10.1016/j.tibs.2007.10.002; Gabriel MP, 2003, BIOCHEMISTRY-US, V42, P7780, DOI 10.1021/bi0341049; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; Gipson B, 2007, J STRUCT BIOL, V160, P375, DOI 10.1016/j.jsb.2007.09.011; Gipson B, 2007, J STRUCT BIOL, V157, P64, DOI 10.1016/j.jsb.2006.07.020; He LH, 2010, FASEB J, V24, P3103, DOI 10.1096/fj.09-141788; Heikal A, 2009, CRYOBIOLOGY, V58, P37, DOI 10.1016/j.cryobiol.2008.10.125; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; Jiang QS, 1998, J CELL BIOL, V143, P645, DOI 10.1083/jcb.143.3.645; Jordan IK, 2008, P NATL ACAD SCI USA, V105, P18865, DOI 10.1073/pnas.0806306105; Khare D, 2009, MOL CELL, V33, P528, DOI 10.1016/j.molcel.2009.01.035; Kirk KL, 2011, J BIOL CHEM, V286, P12813, DOI 10.1074/jbc.R111.219634; Kos V, 2009, CELL MOL LIFE SCI, V66, P3111, DOI 10.1007/s00018-009-0064-9; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Lewis HA, 2005, J BIOL CHEM, V280, P1346, DOI 10.1074/jbc.M410968200; Li-Blatter X, 2009, BBA-BIOMEMBRANES, V1788, P2335, DOI 10.1016/j.bbamem.2009.07.010; Linsdell P, 1996, J PHYSIOL-LONDON, V496, P687, DOI 10.1113/jphysiol.1996.sp021719; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; McDevitt CA, 2008, FEBS LETT, V582, P2950, DOI 10.1016/j.febslet.2008.07.022; McIntosh R, 2005, TRENDS CELL BIOL, V15, P43, DOI 10.1016/j.tcb.2004.11.009; Mornon JP, 2008, CELL MOL LIFE SCI, V65, P2594, DOI 10.1007/s00018-008-8249-1; Mornon JP, 2009, CELL MOL LIFE SCI, V66, P3469, DOI 10.1007/s00018-009-0133-0; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Oldham ML, 2011, SCIENCE, V332, P1202, DOI 10.1126/science.1200767; Pagano MA, 2008, BIOCHEMISTRY-US, V47, P7925, DOI 10.1021/bi800316z; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pinkett HW, 2007, SCIENCE, V315, P373, DOI 10.1126/science.1133488; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Rosenberg MF, 2010, J STRUCT BIOL, V170, P540, DOI 10.1016/j.jsb.2010.01.011; Rosenberg MF, 2004, J BIOL CHEM, V279, P39051, DOI 10.1074/jbc.M407434200; SCARBOROUGH GA, 1994, ACTA CRYSTALLOGR D, V50, P643, DOI 10.1107/S0907444993014283; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Sheppard DN, 2004, J GEN PHYSIOL, V124, P109, DOI 10.1085/JGP.200409135; SHEPPARD DN, 1993, NATURE, V362, P160, DOI 10.1038/362160a0; Sheppard DN, 1999, PHYSIOL REV, V79, P23; Smith SS, 2001, J GEN PHYSIOL, V118, P407, DOI 10.1085/jgp.118.4.407; Stenham DR, 2003, FASEB J, V17, P2287, DOI 10.1096/fj.03-0107fje; Thibodeau PH, 2005, NAT STRUCT MOL BIOL, V12, P10, DOI 10.1038/nsmb881; Vankeerberghen A, 1998, FEBS LETT, V437, P1, DOI 10.1016/S0014-5793(98)01042-4; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhang LA, 2011, BBA-BIOMEMBRANES, V1808, P399, DOI 10.1016/j.bbamem.2010.08.012; Zhang L, 2009, J STRUCT BIOL, V167, P242, DOI 10.1016/j.jsb.2009.06.004; Zhang ZR, 2000, J MEMBRANE BIOL, V175, P35, DOI 10.1007/s002320001053; Zolnerciks JK, 2007, FASEB J, V21, P3937, DOI 10.1096/fj.07-8610com	61	57	58	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 9	2011	286	49					42647	42654		10.1074/jbc.M111.292268	http://dx.doi.org/10.1074/jbc.M111.292268			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	863QI	21931164	Green Published, hybrid			2022-12-25	WOS:000298180900072
J	Xu, LH; Huang, M; Fang, SG; Liu, DX				Xu, Ling Hui; Huang, Mei; Fang, Shou Guo; Liu, Ding Xiang			Coronavirus Infection Induces DNA Replication Stress Partly through Interaction of Its Nonstructural Protein 13 with the p125 Subunit of DNA Polymerase delta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; DOUBLE-STRAND BREAKS; ACUTE RESPIRATORY SYNDROME; TELANGIECTASIA MUTATED KINASE; S-PHASE CHECKPOINT; CELL-CYCLE ARREST; BRONCHITIS VIRUS; ATAXIA-TELANGIECTASIA; CULTURED-CELLS; VIRAL REPLICATION	Perturbation of cell cycle regulation is a characteristic feature of infection by many DNA and RNA viruses, including Coronavirus infectious bronchitis virus (IBV). IBV infection was shown to induce cell cycle arrest at both S and G(2)/M phases for the enhancement of viral replication and progeny production. However, the underlying mechanisms are not well explored. In this study we show that activation of cellular DNA damage response is one of the mechanisms exploited by Coronavirus to induce cell cycle arrest. An ATR-dependent cellular DNA damage response was shown to be activated by IBV infection. Suppression of the ATR kinase activity by chemical inhibitors and siRNA-mediated knockdown of ATR reduced the IBV-induced ATR signaling and inhibited the replication of IBV. Furthermore, yeast two-hybrid screens and subsequent biochemical and functional studies demonstrated that interaction between Coronavirus nsp13 and DNA polymerase delta induced DNA replication stress in IBV-infected cells. These findings indicate that the ATR signaling activated by IBV replication contributes to the IBV-induced S-phase arrest and is required for efficient IBV replication and progeny production.	[Xu, Ling Hui; Huang, Mei; Fang, Shou Guo; Liu, Ding Xiang] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Liu, DX (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.	dxliu@ntu.edu.sg	Liu, Ding Xiang/A-2226-2011					ABOUSSEKHRA A, 1995, EXP CELL RES, V221, P326, DOI 10.1006/excr.1995.1382; ABOUSSEKHRA A, 1995, CELL, V80, P859, DOI 10.1016/0092-8674(95)90289-9; Alderton GK, 2004, HUM MOL GENET, V13, P3127, DOI 10.1093/hmg/ddh335; Andegeko Y, 2001, J BIOL CHEM, V276, P38224; Ariumi Y, 2008, J VIROL, V82, P9639, DOI 10.1128/JVI.00351-08; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Brown EJ, 2003, GENE DEV, V17, P615, DOI 10.1101/gad.1067403; Burdak-Rothkamm S, 2008, CANCER RES, V68, P7059, DOI 10.1158/0008-5472.CAN-08-0545; Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; Casper AM, 2002, CELL, V111, P779, DOI 10.1016/S0092-8674(02)01113-3; Cavanagh D, 2007, VET RES, V38, P281, DOI 10.1051/vetres:2006055; Chanoux RA, 2009, J BIOL CHEM, V284, P5994, DOI 10.1074/jbc.M806739200; Chaurushiya MS, 2009, DNA REPAIR, V8, P1166, DOI 10.1016/j.dnarep.2009.04.016; Choudhuri T, 2007, J VIROL, V81, P6718, DOI 10.1128/JVI.00053-07; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Costanzo V, 2003, CELL CYCLE, V2, pA16, DOI 10.4161/cc.2.1.290; Digweed M, 2002, ONCOGENE, V21, P4873, DOI 10.1038/sj.onc.1205616; Dimitrova DS, 2000, NAT CELL BIOL, V2, P686, DOI 10.1038/35036309; Dove B, 2006, J VIROL, V80, P4147, DOI 10.1128/JVI.80.8.4147-4156.2006; Fang SG, 2005, BIOCHEM BIOPH RES CO, V336, P417, DOI 10.1016/j.bbrc.2005.08.105; Fang SG, 2008, VIROLOGY, V379, P175, DOI 10.1016/j.virol.2008.06.038; Fang SG, 2007, VIROLOGY, V358, P136, DOI 10.1016/j.virol.2006.08.020; Hagemeijer MC, 2010, J VIROL, V84, P2134, DOI 10.1128/JVI.01716-09; Halas A, 1997, CURR GENET, V31, P292, DOI 10.1007/s002940050208; Heffernan TP, 2002, MOL CELL BIOL, V22, P8552, DOI 10.1128/MCB.22.24.8552-8561.2002; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Iftode C, 1999, CRIT REV BIOCHEM MOL, V34, P141, DOI 10.1080/10409239991209255; Ivanov KA, 2004, J VIROL, V78, P5619, DOI 10.1128/JVI.78.11.5619-5632.2004; Kinner A, 2008, NUCLEIC ACIDS RES, V36, P5678, DOI 10.1093/nar/gkn550; Knoops K, 2008, PLOS BIOL, V6, P1957, DOI 10.1371/journal.pbio.0060226; Kozlov SV, 2006, EMBO J, V25, P3504, DOI 10.1038/sj.emboj.7601231; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Kudoh A, 2005, J BIOL CHEM, V280, P8156, DOI 10.1074/jbc.M411405200; Kudoh A, 2009, J VIROL, V83, P6641, DOI 10.1128/JVI.00049-09; Lai CK, 2008, VIROLOGY, V370, P295, DOI 10.1016/j.virol.2007.08.037; Larrea AA, 2010, P NATL ACAD SCI USA, V107, P17674, DOI 10.1073/pnas.1010178107; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Li FQS, 2005, FEBS LETT, V579, P2387, DOI 10.1016/j.febslet.2005.03.039; Li FQ, 2007, VIROLOGY, V365, P435, DOI 10.1016/j.virol.2007.04.015; Li H, 2006, J BIOL CHEM, V281, P14748, DOI 10.1074/jbc.M600322200; Lilley CE, 2007, TRENDS MICROBIOL, V15, P119, DOI 10.1016/j.tim.2007.01.003; Liu C, 2001, J VIROL, V75, P6402, DOI 10.1128/JVI.75.14.6402-6409.2001; Liu JS, 2006, J CELL BIOCHEM, V99, P1452, DOI 10.1002/jcb.21066; Longley MJ, 1997, J BIOL CHEM, V272, P10917; Lopes M, 2001, NATURE, V412, P557, DOI 10.1038/35087613; Manthey KC, 2007, J CELL SCI, V120, P4221, DOI 10.1242/jcs.004580; Marti TM, 2006, P NATL ACAD SCI USA, V103, P9891, DOI 10.1073/pnas.0603779103; Matsuoka S, 2000, P NATL ACAD SCI USA, V97, P10389, DOI 10.1073/pnas.190030497; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Murga M, 2009, NAT GENET, V41, P891, DOI 10.1038/ng.420; Nishida H, 2009, NUCLEIC ACIDS RES, V37, P5678, DOI 10.1093/nar/gkp593; Nyberg KA, 2002, ANNU REV GENET, V36, P617, DOI 10.1146/annurev.genet.36.060402.113540; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; Ogi T, 2010, MOL CELL, V37, P714, DOI 10.1016/j.molcel.2010.02.009; Olson E, 2006, J BIOL CHEM, V281, P39517, DOI 10.1074/jbc.M605121200; Overmeer RM, 2010, MOL CELL BIOL, V30, P4828, DOI 10.1128/MCB.00285-10; Paulsen RD, 2007, DNA REPAIR, V6, P953, DOI 10.1016/j.dnarep.2007.02.015; Podust VN, 2002, J BIOL CHEM, V277, P3894, DOI 10.1074/jbc.M109684200; Pohler JRG, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-17; Reinhardt HC, 2009, CURR OPIN CELL BIOL, V21, P245, DOI 10.1016/j.ceb.2009.01.018; Rohaly G, 2010, J VIROL, V84, P10727, DOI 10.1128/JVI.00122-10; Sarkaria JN, 1999, CANCER RES, V59, P4375; Schang Luis M, 2003, Prog Cell Cycle Res, V5, P103; Segurado M, 2009, BIOL CELL, V101, P617, DOI 10.1042/BC20090053; Shen HY, 2009, J VIROL METHODS, V160, P48, DOI 10.1016/j.jviromet.2009.04.023; Shi YL, 2005, J BIOL CHEM, V280, P40195, DOI 10.1074/jbc.C500400200; Spardy N, 2009, CANCER RES, V69, P7022, DOI 10.1158/0008-5472.CAN-09-0925; Stokes MP, 2007, P NATL ACAD SCI USA, V104, P19855, DOI 10.1073/pnas.0707579104; Syljuasen RG, 2005, MOL CELL BIOL, V25, P3553, DOI 10.1128/MCB.25.9.3553-3562.2005; Tercero JA, 2001, NATURE, V412, P553, DOI 10.1038/35087607; Toledo LI, 2008, GENE DEV, V22, P297, DOI 10.1101/gad.452308; Toledo LI, 2011, MOL ONCOL, V5, P368, DOI 10.1016/j.molonc.2011.07.002; Toledo LI, 2011, NAT STRUCT MOL BIOL, V18, P721, DOI 10.1038/nsmb.2076; Wang K, 2010, CANCER GENET CYTOGEN, V200, P40, DOI 10.1016/j.cancergencyto.2010.03.006; Wang XX, 2009, J VIROL, V83, P12462, DOI 10.1128/JVI.01546-09; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Willmore E, 2004, BLOOD, V103, P4659, DOI 10.1182/blood-2003-07-2527; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Won JJ, 2006, NAT CHEM BIOL, V2, P369, DOI 10.1038/nchembio800; Woo PCY, 2009, EXP BIOL MED, V234, P1117, DOI 10.3181/0903-MR-94; Xiao H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001494; Xu LH, 2010, J VIROL, V84, P8571, DOI 10.1128/JVI.00392-10; Yamada Y, 2009, J VIROL, V83, P8744, DOI 10.1128/JVI.00613-09; Zachos G, 2003, EMBO J, V22, P713, DOI 10.1093/emboj/cdg060; ZENG XR, 1994, J BIOL CHEM, V269, P13748; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zhao X, 2008, J VIROL, V82, P5316, DOI 10.1128/JVI.02677-07; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	89	60	62	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39546	39559		10.1074/jbc.M111.242206	http://dx.doi.org/10.1074/jbc.M111.242206			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21918226	hybrid, Green Published			2022-12-25	WOS:000296759800072
J	Kumar, KK; Jacques, DA; Pishchany, G; Caradoc-Davies, T; Spirig, T; Malmirchegini, GR; Langley, DB; Dickson, CF; Mackay, JP; Clubb, RT; Skaar, EP; Guss, JM; Gell, DA				Kumar, Kaavya Krishna; Jacques, David A.; Pishchany, Gleb; Caradoc-Davies, Tom; Spirig, Thomas; Malmirchegini, G. Reza; Langley, David B.; Dickson, Claire F.; Mackay, Joel P.; Clubb, Robert T.; Skaar, Eric P.; Guss, J. Mitchell; Gell, David A.			Structural Basis for Hemoglobin Capture by Staphylococcus aureus Cell-surface Protein, IsdH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEME-IRON; ALPHA-HEMOGLOBIN; UPTAKE SYSTEM; RECEPTOR; BINDING; NEAT; IDENTIFICATION; ACQUISITION; DOMAIN; STREPTOCOCCUS	Pathogens must steal iron from their hosts to establish infection. In mammals, hemoglobin (Hb) represents the largest reservoir of iron, and pathogens express Hb-binding proteins to access this source. Here, we show how one of the commonest and most significant human pathogens, Staphylococcus aureus, captures Hb as the first step of an iron-scavenging pathway. The x-ray crystal structure of Hb bound to a domain from the Isd (iron-regulated surface determinant) protein, IsdH, is the first structure of a Hb capture complex to be determined. Surface mutations in Hb that reduce binding to the Hb-receptor limit the capacity of S. aureus to utilize Hb as an iron source, suggesting that Hb sequence is a factor in host susceptibility to infection. The demonstration that pathogens make highly specific recognition complexes with Hb raises the possibility of developing inhibitors of Hb binding as antibacterial agents.	[Kumar, Kaavya Krishna; Jacques, David A.; Langley, David B.; Mackay, Joel P.; Guss, J. Mitchell] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Pishchany, Gleb; Skaar, Eric P.] Vanderbilt Univ, Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Caradoc-Davies, Tom] Australian Synchrotron, Clayton, Vic 3168, Australia; [Spirig, Thomas; Malmirchegini, G. Reza; Clubb, Robert T.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Dickson, Claire F.; Gell, David A.] Univ Tasmania, Menzies Res Inst, Hobart, Tas 7000, Australia	University of Sydney; Vanderbilt University; University of California System; University of California Los Angeles; University of Tasmania; Menzies Institute for Medical Research	Gell, DA (corresponding author), Menzies Res Inst Tasmania, 17 Liverpool St, Hobart, Tas 7000, Australia.	david.gell@utas.edu.au	Guss, Jules Mitchell/N-1387-2019; Langley, David B/B-1861-2009; Pishchany, Gleb/E-2016-2015; Mackay, Joel/D-6834-2011	Guss, Jules Mitchell/0000-0003-4259-6079; Langley, David B/0000-0003-2752-0041; Gell, David/0000-0003-0382-1181; Spirig, Thomas/0000-0001-8936-238X; Jacques, David/0000-0002-6426-4510; Pishchany, Gleb/0000-0001-9303-010X; Mackay, Joel/0000-0001-7508-8033	University of Sydney; Australian Institute of Nuclear Science and Engineering; Australia Research Council; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052217] Funding Source: NIH RePORTER	University of Sydney(University of Sydney); Australian Institute of Nuclear Science and Engineering; Australia Research Council(Australian Research Council); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by a University of Sydney international scholarship.; Supported by an Australian Institute of Nuclear Science and Engineering postgraduate research award.; Supported by an Australia Research Council research fellowship.	Alontaga AY, 2009, BIOCHEMISTRY-US, V48, P96, DOI 10.1021/bi801860g; Andrade MA, 2002, GENOME BIOL, V3; Bahrami F, 2005, MICROB PATHOGENESIS, V39, P45, DOI 10.1016/j.micpath.2005.03.002; Bates CS, 2003, INFECT IMMUN, V71, P1042, DOI 10.1128/IAI.71.3.1042-1055.2003; Calmettes C, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.206102; Carlson PE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006988; Clarke SR, 2006, J INFECT DIS, V193, P1098, DOI 10.1086/501471; Daou N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000675; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Di Iorio E E, 1981, Methods Enzymol, V76, P57; Drazek ES, 2000, MOL MICROBIOL, V36, P68, DOI 10.1046/j.1365-2958.2000.01818.x; Dryla A, 2003, MOL MICROBIOL, V49, P37, DOI 10.1046/j.1365-2958.2003.03542.x; Dryla A, 2007, J BACTERIOL, V189, P254, DOI 10.1128/JB.01366-06; DUTHIE ES, 1952, J GEN MICROBIOL, V6, P95, DOI 10.1099/00221287-6-1-2-95; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Eaton W A, 1981, Methods Enzymol, V76, P175; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fabian M, 2009, J BIOL CHEM, V284, P32138, DOI 10.1074/jbc.M109.040915; Ganz T, 2011, BLOOD, V117, P4425, DOI 10.1182/blood-2011-01-258467; Gaudin CFM, 2011, BIOCHEMISTRY-US, V50, P5443, DOI 10.1021/bi200369p; Gell D, 2002, J BIOL CHEM, V277, P40602, DOI 10.1074/jbc.M206084200; Gonzalez-Lopez MA, 2009, BIOMETALS, V22, P889, DOI 10.1007/s10534-009-9240-5; Graves PE, 2008, BBA-PROTEINS PROTEOM, V1784, P1471, DOI 10.1016/j.bbapap.2008.04.012; Grigg JC, 2007, MOL MICROBIOL, V63, P139, DOI 10.1111/j.1365-2958.2006.05502.x; Hempel K, 2011, J PROTEOME RES, V10, P1657, DOI 10.1021/pr1009838; JACOBSEN MP, 1995, BBA-PROTEIN STRUCT M, V1246, P17, DOI 10.1016/0167-4838(94)00174-F; Kim HK, 2010, VACCINE, V28, P6382, DOI 10.1016/j.vaccine.2010.02.097; Kuklin NA, 2006, INFECT IMMUN, V74, P2215, DOI 10.1128/IAI.74.4.2215-2223.2006; Kumar KK, 2010, BIOCHEM J, V432, P275, DOI 10.1042/BJ20100642; Legrand D, 2010, BIOMETALS, V23, P365, DOI 10.1007/s10534-010-9297-1; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Liu MY, 2008, J BIOL CHEM, V283, P6668, DOI 10.1074/jbc.M708372200; Maresso AW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000132; Mazmanian SK, 2003, SCIENCE, V299, P906, DOI 10.1126/science.1081147; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meehan M, 2010, MICROBIOL-SGM, V156, P1824, DOI 10.1099/mic.0.036087-0; Moraes TF, 2009, MOL CELL, V35, P523, DOI 10.1016/j.molcel.2009.06.029; Morrissey JA, 2002, INFECT IMMUN, V70, P2399, DOI 10.1128/IAI.70.5.2399-2407.2002; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Muryoi N, 2008, J BIOL CHEM, V283, P28125, DOI 10.1074/jbc.M802171200; Nairz M, 2010, CELL MICROBIOL, V12, P1691, DOI 10.1111/j.1462-5822.2010.01529.x; Nepluev I, 2009, INFECT IMMUN, V77, P3065, DOI 10.1128/IAI.00034-09; Nilsson IM, 1999, INFECT IMMUN, V67, P1045, DOI 10.1128/IAI.67.3.1045-1049.1999; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ouattara M, 2010, MOL MICROBIOL, V78, P739, DOI 10.1111/j.1365-2958.2010.07367.x; Pilpa RM, 2006, J MOL BIOL, V360, P435, DOI 10.1016/j.jmb.2006.05.019; Pilpa RM, 2009, J BIOL CHEM, V284, P1166, DOI 10.1074/jbc.M806007200; Pishchany G, 2010, CELL HOST MICROBE, V8, P544, DOI 10.1016/j.chom.2010.11.002; Pishchany G, 2009, INFECT IMMUN, V77, P2624, DOI 10.1128/IAI.01531-08; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; Raymond KN, 2003, P NATL ACAD SCI USA, V100, P3584, DOI 10.1073/pnas.0630018100; Reniere ML, 2008, MOL MICROBIOL, V69, P1304, DOI 10.1111/j.1365-2958.2008.06363.x; Rohde KH, 2004, INFECT IMMUN, V72, P2494, DOI 10.1128/IAI.72.5.2494-2506.2004; SAWATZKI G, 1983, INFECT IMMUN, V39, P659, DOI 10.1128/IAI.39.2.659-665.1983; Sharp KH, 2007, J BIOL CHEM, V282, P10625, DOI 10.1074/jbc.M700234200; Simpson W, 2000, J BACTERIOL, V182, P5737, DOI 10.1128/JB.182.20.5737-5748.2000; Skaar EP, 2004, MICROBES INFECT, V6, P390, DOI 10.1016/j.micinf.2003.12.008; Skaar EP, 2004, SCIENCE, V305, P1626, DOI 10.1126/science.1099930; Skaar EP, 2004, J BIOL CHEM, V279, P436, DOI 10.1074/jbc.M307952200; Ster C, 2010, VET IMMUNOL IMMUNOP, V136, P311, DOI 10.1016/j.vetimm.2010.03.010; Stranger-Jones YK, 2006, P NATL ACAD SCI USA, V103, P16942, DOI 10.1073/pnas.0606863103; Torres VJ, 2006, J BACTERIOL, V188, P8421, DOI 10.1128/JB.01335-06; Villareal VA, 2008, J BIOL CHEM, V283, P31591, DOI 10.1074/jbc.M801126200; Villarreal DM, 2008, APPL ENVIRON MICROB, V74, P5854, DOI 10.1128/AEM.01291-08; Visai L, 2009, MICROBIOL-SGM, V155, P667, DOI 10.1099/mic.0.025684-0; Wang Y, 2011, J BACTERIOL, V193, P3606, DOI 10.1128/JB.00396-11; Watanabe M, 2008, J BIOL CHEM, V283, P28649, DOI 10.1074/jbc.M803383200; Zhu H, 2008, J BIOL CHEM, V283, P18450, DOI 10.1074/jbc.M801466200	68	50	51	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38439	38447		10.1074/jbc.M111.287300	http://dx.doi.org/10.1074/jbc.M111.287300			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21917915	hybrid, Green Published			2022-12-25	WOS:000296594200058
J	Wentworth, CC; Alam, A; Jones, RM; Nusrat, A; Neish, AS				Wentworth, Christy C.; Alam, Ashfaqul; Jones, Rheinallt M.; Nusrat, Asma; Neish, Andrew S.			Enteric Commensal Bacteria Induce Extracellular Signal-regulated Kinase Pathway Signaling via Formyl Peptide Receptor-dependent Redox Modulation of Dual Specific Phosphatase 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REACTIVE OXYGEN; IN-VIVO; VACCINIA VIRUS; CELL-GROWTH; DISEASE; GUT; ACTIVATION; RESPONSES; RESTITUTION; GENERATION	The normal microbial occupants of the mammalian intestine are crucial for maintaining gut homeostasis, yet the mechanisms by which intestinal cells perceive and respond to the microbiota are largely unknown. Intestinal epithelial contact with commensal bacteria and/or their products has been shown to activate noninflammatory signaling pathways, such as extracellular signal-related kinase (ERK), thus influencing homeostatic processes. We previously demonstrated that commensal bacteria stimulate ERK pathway activity via interaction with formyl peptide receptors (FPRs). In the current study, we expand on these findings and show that commensal bacteria initiate ERK signaling through rapid FPR-dependent reactive oxygen species (ROS) generation and subsequent modulation of MAP kinase phosphatase redox status. ROS generation induced by the commensal bacteria Lactobacillus rhamnosus GG and the FPR peptide ligand, N-formyl-Met-Leu-Phe, was abolished in the presence of selective inhibitors for G protein-coupled signaling and FPR ligand interaction. In addition, pretreatment of cells with inhibitors of ROS generation attenuated commensal bacteria-induced ERK signaling, indicating that ROS generation is required for ERK pathway activation. Bacterial colonization also led to oxidative inactivation of the redox-sensitive and ERK-specific phosphatase, DUSP3/VHR, and consequent stimulation of ERK pathway signaling. Together, these data demonstrate that commensal bacteria and their products activate ROS signaling in an FPR-dependent manner and define a mechanism by which cellular ROS influences the ERK pathway through a redox-sensitive regulatory circuit.	[Wentworth, Christy C.; Alam, Ashfaqul; Jones, Rheinallt M.; Nusrat, Asma; Neish, Andrew S.] Emory Univ, Sch Med, Dept Pathol & Lab Med, Epithelial Pathobiol Unit, Atlanta, GA 30322 USA	Emory University	Neish, AS (corresponding author), Whitehead Bldg,Rm 105F,615 Michael St, Atlanta, GA 30322 USA.	aneish@emory.edu	Jones, Rheinallt/C-4611-2013	Jones, Rheinallt/0000-0002-0415-9487	National Institutes of Health [R01DK071604, DK089763, AI064462, K01DK081481]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064462, R56AI064462] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK089763, K01DK081481, R56DK089763, R01DK071604] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01DK071604, DK089763, and AI064462.; Supported by Grant K01DK081481 from the NIH.	Babbin BA, 2007, J IMMUNOL, V179, P8112, DOI 10.4049/jimmunol.179.12.8112; Babbin BA, 2006, J BIOL CHEM, V281, P19588, DOI 10.1074/jbc.M513025200; BOKOCH GM, 1984, CELL, V39, P301, DOI 10.1016/0092-8674(84)90008-4; Cerignoli F, 2006, CELL CYCLE, V5, P2210, DOI 10.4161/cc.5.19.3267; Collier-Hyams LS, 2002, J IMMUNOL, V169, P2846, DOI 10.4049/jimmunol.169.6.2846; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Forman HJ, 2010, BIOCHEMISTRY-US, V49, P835, DOI 10.1021/bi9020378; Gavins FNE, 2003, BLOOD, V101, P4140, DOI 10.1182/blood-2002-11-3411; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; GUAN KL, 1991, NATURE, V350, P359, DOI 10.1038/350359a0; Ha EM, 2005, DEV CELL, V8, P125, DOI 10.1016/j.devcel.2004.11.007; Hart AL, 2003, J CLIN GASTROENTEROL, V36, P111, DOI 10.1097/00004836-200302000-00005; Hooper LV, 1998, BIOESSAYS, V20, P336, DOI 10.1002/(SICI)1521-1878(199804)20:4&lt;336::AID-BIES10&gt;3.0.CO;2-3; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Janssen-Heininger YMW, 2008, FREE RADICAL BIO MED, V45, P1, DOI 10.1016/j.freeradbiomed.2008.03.011; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kotchoni SO, 2006, J BIOSCIENCES, V31, P389, DOI 10.1007/BF02704112; Kruis W, 2004, GUT, V53, P1617, DOI 10.1136/gut.2003.037747; Kumar A, 2007, EMBO J, V26, P4457, DOI 10.1038/sj.emboj.7601867; Kumar A, 2009, J IMMUNOL, V182, P538, DOI 10.4049/jimmunol.182.1.538; Kundu K, 2009, ANGEW CHEM INT EDIT, V48, P299, DOI 10.1002/anie.200804851; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lin PW, 2008, PEDIATR RES, V64, P511, DOI 10.1203/PDR.0b013e3181827c0f; Lin PW, 2009, FREE RADICAL BIO MED, V47, P1205, DOI 10.1016/j.freeradbiomed.2009.07.033; LIU K, 1995, J VIROL, V69, P7823, DOI 10.1128/JVI.69.12.7823-7834.1995; Migeotte I, 2006, CYTOKINE GROWTH F R, V17, P501, DOI 10.1016/j.cytogfr.2006.09.009; Neish AS, 2009, GASTROENTEROLOGY, V136, P65, DOI 10.1053/j.gastro.2008.10.080; Park J, 2007, GASTROENTEROL CLIN N, V36, P47, DOI 10.1016/j.gtc.2007.03.001; Pauly N, 2006, J EXP BOT, V57, P1769, DOI 10.1093/jxb/erj184; Pull SL, 2005, P NATL ACAD SCI USA, V102, P99, DOI 10.1073/pnas.0405979102; Rabiet MJ, 2007, BIOCHIMIE, V89, P1089, DOI 10.1016/j.biochi.2007.02.015; Rahmouni S, 2006, NAT CELL BIOL, V8, P524, DOI 10.1038/ncb1398; Reddie KG, 2008, CURR OPIN CHEM BIOL, V12, P746, DOI 10.1016/j.cbpa.2008.07.028; Swanson PA, 2011, P NATL ACAD SCI USA, V108, P8803, DOI 10.1073/pnas.1010042108; Tanaka A, 2006, PLANT CELL, V18, P1052, DOI 10.1105/tpc.105.039263; TORRES M, 1993, J IMMUNOL, V150, P1563; Wentworth CC, 2010, AM J PATHOL, V177, P2782, DOI 10.2353/ajpath.2010.100529; Xu J, 2007, PLOS BIOL, V5, P1574, DOI 10.1371/journal.pbio.0050156; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578	39	79	81	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38448	38455		10.1074/jbc.M111.268938	http://dx.doi.org/10.1074/jbc.M111.268938			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21921027	Green Published, hybrid			2022-12-25	WOS:000296594200059
J	Agarwal, S; Mishra, NK; Singh, H; Raghava, GPS				Agarwal, Sandhya; Mishra, Nitish Kumar; Singh, Harinder; Raghava, Gajendra P. S.			Identification of Mannose Interacting Residues Using Local Composition	PLOS ONE			English	Article							PREDICTING SUBCELLULAR-LOCALIZATION; DNA-BINDING SITES; PROTEIN; EVOLUTIONARY; LECTIN; INFORMATION; SEQUENCE; SEARCH; LEVEL	Background: Mannose binding proteins (MBPs) play a vital role in several biological functions such as defense mechanisms. These proteins bind to mannose on the surface of a wide range of pathogens and help in eliminating these pathogens from our body. Thus, it is important to identify mannose interacting residues (MIRs) in order to understand mechanism of recognition of pathogens by MBPs. Results: This paper describes modules developed for predicting MIRs in a protein. Support vector machine (SVM) based models have been developed on 120 mannose binding protein chains, where no two chains have more than 25% sequence similarity. SVM models were developed on two types of datasets: 1) main dataset consists of 1029 mannose interacting and 1029 non-interacting residues, 2) realistic dataset consists of 1029 mannose interacting and 10320 non-interacting residues. In this study, firstly, we developed standard modules using binary and PSSM profile of patterns and got maximum MCC around 0.32. Secondly, we developed SVM modules using composition profile of patterns and achieved maximum MCC around 0.74 with accuracy 86.64% on main dataset. Thirdly, we developed a model on a realistic dataset and achieved maximum MCC of 0.62 with accuracy 93.08%. Based on this study, a standalone program and web server have been developed for predicting mannose interacting residues in proteins (http://www.imtech.res.in/raghava/premier/). Conclusions: Compositional analysis of mannose interacting and non-interacting residues shows that certain types of residues are preferred in mannose interaction. It was also observed that residues around mannose interacting residues have a preference for certain types of residues. Composition of patterns/peptide/segment has been used for predicting MIRs and achieved reasonable high accuracy. It is possible that this novel strategy may be effective to predict other types of interacting residues. This study will be useful in annotating the function of protein as well as in understanding the role of mannose in the immune system.	[Agarwal, Sandhya; Mishra, Nitish Kumar; Singh, Harinder; Raghava, Gajendra P. S.] Inst Microbial Technol, Chandigarh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Agarwal, S (corresponding author), Inst Microbial Technol, Chandigarh, India.	raghava@imtech.res.in	Singh, Harinder/V-7699-2019; Raghava, Gajendra/B-1717-2009; Mishra, Nitish Kumar/D-5577-2009; Raghava, Gajendra P.S./AAA-2413-2022; Mishra, Nitish/AAR-3757-2021	Singh, Harinder/0000-0003-4897-9759; Raghava, Gajendra P.S./0000-0002-8902-2876; 	Council of Scientific and Industrial Research (CSIR); Department of Biotechnology (DBT), Government of India	Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India)	The authors are thankful to the Council of Scientific and Industrial Research (CSIR) and Department of Biotechnology (DBT), Government of India for financial assistance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2004, BIOINFORMATICS, V20, P477, DOI 10.1093/bioinformatics/btg432; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ansari Hifzur Rahman, 2010, Immunome Res, V6, P6, DOI 10.1186/1745-7580-6-6; Bauer RA, 2009, NUCLEIC ACIDS RES, V37, pD195, DOI 10.1093/nar/gkn618; Bhardwaj N, 2007, FEBS LETT, V581, P1058, DOI 10.1016/j.febslet.2007.01.086; Bouwman LH, 2006, HUM IMMUNOL, V67, P247, DOI 10.1016/j.humimm.2006.02.030; Chauhan JS, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-434; Garg A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-503; Gromiha MM, 1999, PROTEIN ENG, V12, P557, DOI 10.1093/protein/12.7.557; HAKOMORI S, 1991, CURR OPIN IMMUNOL, V3, P646, DOI 10.1016/0952-7915(91)90091-E; Jeong EN, 2006, LECT NOTES COMPUT SC, V3939, P123; Joachims T, 1999, ADVANCES IN KERNEL METHODS, P169; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Kaur H, 2004, BIOINFORMATICS, V20, P2751, DOI 10.1093/bioinformatics/bth322; Kaur H, 2003, PROTEIN SCI, V12, P627, DOI 10.1110/ps.0228903; Koch A, 2001, JAMA-J AM MED ASSOC, V285, P1316, DOI 10.1001/jama.285.10.1316; Kulharia M, 2009, J MOL GRAPH MODEL, V28, P297, DOI 10.1016/j.jmgm.2009.08.009; Kumar M, 2008, PROTEINS, V71, P189, DOI 10.1002/prot.21677; Kumar Manish, 2008, In Silico Biology, V8, P121; Kuznetsov IB, 2006, PROTEINS, V64, P19, DOI 10.1002/prot.20977; Larsen F, 2004, J BIOL CHEM, V279, P21302, DOI 10.1074/jbc.M400520200; Malik A, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-1; Malik Adeel, 2010, Advances in Bioinformatics, V2010, P436036, DOI 10.1155/2010/436036; Mishra NK, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S48; Muraki M, 2002, PROTEIN PEPTIDE LETT, V9, P195, DOI 10.2174/0929866023408751; Nassif H, 2009, PROTEINS, V77, P121, DOI 10.1002/prot.22424; Patra M, 2006, GLYCOBIOLOGY, V16, P959, DOI 10.1093/glycob/cwl021; QUIOCHO FA, 1989, PURE APPL CHEM, V61, P1293, DOI 10.1351/pac198961071293; Raghava GPS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-59; Rao VSR, 1998, INT J BIOL MACROMOL, V23, P295, DOI 10.1016/S0141-8130(98)00056-7; Rashid M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-337; Rashid M, 2010, CURR PROTEIN PEPT SC, V11, P589, DOI 10.2174/138920310794109120; Shionyu-Mitsuyama C, 2003, PROTEIN ENG, V16, P467, DOI 10.1093/protein/gzg065; Sobolev V, 1999, BIOINFORMATICS, V15, P327, DOI 10.1093/bioinformatics/15.4.327; Sompayrac L., 1999, IMMUNE SYSTEM WORKS, P17; Sujatha MS, 2004, PROTEINS, V55, P44, DOI 10.1002/prot.10612; Taroni C, 2000, PROTEIN ENG, V13, P89, DOI 10.1093/protein/13.2.89	37	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2011	6	9							e24039	10.1371/journal.pone.0024039	http://dx.doi.org/10.1371/journal.pone.0024039			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZV	21931639	Green Published, Green Submitted, gold			2022-12-25	WOS:000295321800015
J	Kim, PS; Woods, C; Dutcher, L; Georgoff, P; Rosenberg, A; Mican, JAM; Kopp, JB; Smith, MA; Hadigan, C				Kim, Peter S.; Woods, Christian; Dutcher, Lauren; Georgoff, Patrick; Rosenberg, Alice; Mican, Jo Ann M.; Kopp, Jeffrey B.; Smith, Margo A.; Hadigan, Colleen			Increased Prevalence of Albuminuria in HIV-Infected Adults with Diabetes	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; REVERSE-TRANSCRIPTASE INHIBITORS; MYOCARDIAL-INFARCTION; CARDIOVASCULAR-DISEASE; URINARY ALBUMIN; RISK-FACTORS; MICROALBUMINURIA; NEPHROPATHY; COHORT; ASSOCIATION	Objective: HIV and type 2 diabetes are known risk factors for albuminuria, but no previous reports have characterized albuminuria in HIV-infected patients with diabetes. Research Design and Methods: We performed a cross-sectional study including 73 HIV-infected adults with type 2 diabetes, 82 HIV-infected non-diabetics, and 61 diabetic control subjects without HIV. Serum creatinine > 1.5 mg/dL was exclusionary. Albuminuria was defined as urinary albumin/creatinine ratio > 30 mg/g. Results: The prevalence of albuminuria was significantly increased among HIV-infected diabetics (34% vs. 13% of HIV nondiabetic vs. 16% diabetic control, p = 0.005). HIV status and diabetes remained significant predictors of albuminuria after adjusting for age, race, BMI, and blood pressure. Albumin/creatinine ratio correlated significantly with HIV viral load (r = 0.28, p = 0.0005) and HIV-infected subjects with albuminuria had significantly greater cumulative exposure to abacavir (p = 0.01). In an adjusted multivariate regression analysis of HIV-infected subjects, the diagnosis of diabetes (p = 0.003), higher HIV viral load (p = 0.03) and cumulative exposure to abacavir (p = 0.0009) were significant independent predictors of albuminuria. Conclusions: HIV and diabetes appear to have additive effects on albuminuria which is also independently associated with increased exposure to abacavir and HIV viral load. Future research on the persistence, progression and management of albuminuria in this unique at-risk population is needed.	[Kim, Peter S.; Rosenberg, Alice; Mican, Jo Ann M.; Hadigan, Colleen] NIAID, NIH, Bethesda, MD 20892 USA; [Woods, Christian; Smith, Margo A.] Washington Hosp Ctr, Dept Infect Dis, Washington, DC 20010 USA; [Dutcher, Lauren; Georgoff, Patrick] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Kopp, Jeffrey B.] NIDDKD, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); MedStar Washington Hospital Center; University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Kim, PS (corresponding author), NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	hadiganc@niaid.nih.gov	Kopp, Jeffrey B/O-2681-2015	Kopp, Jeffrey B/0000-0001-9052-186X	National Institute of Allergy and Infectious Diseases; National Institute of Diabetes and Digestive and Kidney Diseases; Washington Hospital Center, Department of Infectious Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK043411] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Washington Hospital Center, Department of Infectious Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The study was funded and conducted by the National Institute of Allergy and Infectious Diseases and the National Institute of Diabetes and Digestive and Kidney Diseases Intramural Research Programs and the Washington Hospital Center, Department of Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler AI, 2003, KIDNEY INT, V63, P225, DOI 10.1046/j.1523-1755.2003.00712.x; Arnlov J, 2005, CIRCULATION, V112, P969, DOI 10.1161/CIRCULATIONAHA.105.538132; Aso Y, 2004, CLIN CHIM ACTA, V348, P139, DOI 10.1016/j.cccn.2004.05.006; Baekken M, 2008, NEPHROL DIAL TRANSPL, V23, P3130, DOI 10.1093/ndt/gfn236; Bedimo RJ, 2011, CLIN INFECT DIS, V53, P84, DOI 10.1093/cid/cir269; Brown TT, 2005, ARCH INTERN MED, V165, P1179, DOI 10.1001/archinte.165.10.1179; Cao JJ, 2006, ATHEROSCLEROSIS, V187, P372, DOI 10.1016/j.atherosclerosis.2005.09.015; De Wit S, 2008, DIABETES CARE, V31, P1224, DOI 10.2337/dc07-2013; Flandre P, 2011, CLIN J AM SOC NEPHRO, V6, P1700, DOI 10.2215/CJN.09191010; Glesby MJ, 2010, ANTIVIR THER, V15, P571, DOI 10.3851/IMP1557; Hallan S, 2007, ARCH INTERN MED, V167, P2490, DOI 10.1001/archinte.167.22.2490; Ho JE, 2009, AIDS; Izzedine H, 2007, AIDS, V21, P409, DOI 10.1097/QAD.0b013e328011ec40; Jones CA, 2002, AM J KIDNEY DIS, V39, P445, DOI 10.1053/ajkd.2002.31388; Kim PS, 2009, DIABETES CARE, V32, P1591, DOI 10.2337/dc09-0177; KIMMEL PL, 1993, CLIN NEPHROL, V39, P17; Ledergerber B, 2007, CLIN INFECT DIS, V45, P111, DOI 10.1086/518619; Lucas GM, 2004, AIDS, V18, P541, DOI 10.1097/00002030-200402200-00022; LUKE DR, 1992, CLIN NEPHROL, V38, P69; Lundgren JD, 2008, AIDS, V22, pF17, DOI 10.1097/QAD.0b013e32830fe35e; Navarro JF, 2003, AM J KIDNEY DIS, V42, P53, DOI 10.1016/S0272-6386(03)00408-6; Rossi MCE, 2008, NEPHROL DIAL TRANSPL, V23, P1278, DOI 10.1093/ndt/gfm798; Sabin CA, 2008, LANCET, V371, P1417, DOI 10.1016/S0140-6736(08)60423-7; Schwartz EJ, 2005, J AM SOC NEPHROL, V16, P2412, DOI 10.1681/ASN.2005040340; Stehouwer CDA, 2002, DIABETES, V51, P1157, DOI 10.2337/diabetes.51.4.1157; Szczech LA, 2007, AIDS, V21, P1003, DOI 10.1097/QAD.0b013e3280d3587f; Wyatt CM, 2007, AM J MED, V120, P488, DOI 10.1016/j.amjmed.2007.01.025	27	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2011	6	9							e24610	10.1371/journal.pone.0024610	http://dx.doi.org/10.1371/journal.pone.0024610			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZV	21931772	Green Published, gold, Green Submitted			2022-12-25	WOS:000295321800038
J	Shang, SB; Gibbs, S; Henao-Tamayo, M; Shanley, CA; McDonnell, G; Duarte, RS; Ordway, DJ; Jackson, M				Shang, Shaobin; Gibbs, Sara; Henao-Tamayo, Marcela; Shanley, Crystal A.; McDonnell, Gerald; Duarte, Rafael Silva; Ordway, Diane J.; Jackson, Mary			Increased Virulence of an Epidemic Strain of Mycobacterium massiliense in Mice	PLOS ONE			English	Article							RAPIDLY GROWING MYCOBACTERIA; REGULATORY T-CELLS; TUMOR-NECROSIS-FACTOR; NONTUBERCULOUS MYCOBACTERIA; TUBERCULOSIS INFECTION; IMMUNE-RESPONSE; LUNG-DISEASE; SP-NOV; ABSCESSUS; CHELONAE	Background: Chronic pulmonary disease and skin/soft tissue infections due to non-tuberculous mycobacteria (NTM) of the Mycobacterium chelonae-abscessus-massiliense group is an emerging health problem worldwide. Moreover, the cure rate for the infections this group causes is low despite aggressive treatment. Post-surgical outbreaks that reached epidemic proportions in Brazil recently were caused by M. massiliense isolates resistant to high-level disinfection with glutaraldehyde (GTA). Understanding the differences in the virulence and host immune responses induced by NTM differing in their sensitivity to disinfectants, and therefore their relative threat of causing outbreaks in hospitals, is an important issue. Methodology/Principal Finding: We compared the replication and survival inside macrophages of a GTA-susceptible reference Mycobacterium massiliense clinical isolate CIP 108297 and an epidemic strain from Brazil, CRM-0019, and characterized the immune responses of IFN gamma knockout mice exposed to a high dose aerosol with these two isolates. CRM-0019 replicated more efficiently than CIP 108297 inside mouse bone marrow macrophages. Moreover, the animals infected with CRM-0019 showed a progressive lung infection characterized by a delayed influx of CD4+ and CD8+ T cells, culminating in extensive lung consolidation and demonstrated increased numbers of pulmonary CD4+ Foxp3+ regulatory T cells compared to those infected with the reference strain. Immunosuppressive activity of regulatory T cells may contribute to the progression and worsening of NTM disease by preventing the induction of specific protective immune responses. Conclusions/Significance: These results provide the first direct evidence of the increased virulence in macrophages and mice and pathogenicity in vivo of the Brazilian epidemic isolate and the first observation that NTM infections can be associated with variable levels of regulatory T cells which may impact on their virulence and ability to persist in the host.	[Shang, Shaobin; Gibbs, Sara; Henao-Tamayo, Marcela; Shanley, Crystal A.; Ordway, Diane J.; Jackson, Mary] Colorado State Univ, Mycobacteria Res Labs, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [McDonnell, Gerald] STERIS Ltd, Basingstoke, Hants, England; [Duarte, Rafael Silva] Univ Fed Rio de Janeiro, Inst Microbiol, BR-21941 Rio De Janeiro, Brazil	Colorado State University; Universidade Federal do Rio de Janeiro	Shang, SB (corresponding author), Colorado State Univ, Mycobacteria Res Labs, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	D.Ordway-Rodriguez@colostate.edu; Mary.Jackson@colostate.edu	Jackson, Mary/D-5345-2017; Shang, Shaobin/K-5669-2015; Ordway, Diane/H-9732-2017; Henao-Tamayo, Marcela/D-8189-2017; Duarte, Rafael/AAK-7946-2020	Jackson, Mary/0000-0002-9212-0258; Shang, Shaobin/0000-0003-4407-1911; Ordway, Diane/0000-0003-0003-326X; Henao-Tamayo, Marcela/0000-0002-4249-9650; 	National Institutes of Health/National Institute of Allergy and Infectious Diseases [AI089718]; College of Veterinary Medicine; Biomedical Sciences Research Council (Colorado State University) [CRC 0014]; STERIS Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089718] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); College of Veterinary Medicine; Biomedical Sciences Research Council (Colorado State University); STERIS Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported in part by the National Institutes of Health/National Institute of Allergy and Infectious Diseases grant AI089718, the College of Veterinary Medicine and Biomedical Sciences Research Council CRC 0014 (Colorado State University) and the STERIS Foundation. The STERIS Foundation provided funds for equipment and materials purchased for the study. In addition, Dr. McDonnell, an employee of STERIS, assisted in the technical aspects of disinfectant-susceptibility testing and aided in the presentation of these results in the manuscript. The STERIS Foundation and the Research Council CRC 0014 had no role in the decision to publish.	Adekambi T, 2006, INT J SYST EVOL MICR, V56, P133, DOI 10.1099/ijs.0.63969-0; Adekambi T, 2004, J CLIN MICROBIOL, V42, P5493, DOI 10.1128/JCM.42.12.5493-5501.2004; Basu S, 2008, J INFECT DIS, V198, P1502, DOI 10.1086/592508; Behr MA, 1997, NATURE, V389, P133, DOI 10.1038/38151; Brown-Elliott BA, 2002, CLIN MICROBIOL REV, V15, P716, DOI 10.1128/CMR.15.4.716-746.2002; Byrd TF, 1999, INFECT IMMUN, V67, P4700, DOI 10.1128/IAI.67.9.4700-4707.1999; Cao W, 2009, AIDS RES HUM RETROV, V25, P183, DOI 10.1089/aid.2008.0140; Cardona PJ, 1999, SCAND J IMMUNOL, V49, P362; Cardoso AM, 2008, MICROBES INFECT, V10, P1552, DOI 10.1016/j.micinf.2008.09.008; Chan ED, 2010, AM J RESP CELL MOL, V43, P387, DOI 10.1165/rcmb.2009-0276TR; Chiacchio T, 2009, CLIN EXP IMMUNOL, V156, P463, DOI 10.1111/j.1365-2249.2009.03908.x; Cooper AM, 2009, CURR OPIN IMMUNOL, V21, P378, DOI 10.1016/j.coi.2009.06.004; De Groote MA, 2006, APPL ENVIRON MICROB, V72, P7602, DOI 10.1128/AEM.00930-06; Duarte RS, 2009, J CLIN MICROBIOL, V47, P2149, DOI 10.1128/JCM.00027-09; FINE PEM, 1995, LANCET, V346, P1339, DOI 10.1016/S0140-6736(95)92348-9; Garg A, 2008, EUR J IMMUNOL, V38, P459, DOI 10.1002/eji.200737268; Griffiths PA, 1997, J APPL MICROBIOL, V82, P519, DOI 10.1046/j.1365-2672.1997.00171.x; Higgins SC, 2003, J IMMUNOL, V171, P3119, DOI 10.4049/jimmunol.171.6.3119; Holland SM, 2001, AM J MED SCI, V321, P49, DOI 10.1097/00000441-200101000-00008; Kim HY, 2008, J CLIN MICROBIOL, V46, P3384, DOI 10.1128/JCM.00319-08; Kim HY, 2007, J CLIN MICROBIOL, V45, P3127, DOI 10.1128/JCM.00608-07; KINTER A, 2007, AIDS RES HUM RETROV, V23, P248; Leao SC, 2010, FUTURE MICROBIOL, V5, P971, DOI 10.2217/FMB.10.49; Lin PL, 2010, ARTHRITIS RHEUM-US, V62, P340, DOI 10.1002/art.27271; Matsumoto CK, 2011, J CLIN MICROBIOL, V49, P62, DOI 10.1128/JCM.01665-10; Moore JE, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-612; Ordway D, 2008, CLIN VACCINE IMMUNOL, V15, P1248, DOI 10.1128/CVI.00019-08; Ordway D, 2008, J LEUKOCYTE BIOL, V83, P1502, DOI 10.1189/jlb.1007696; Ordway D, 2007, J IMMUNOL, V179, P522, DOI 10.4049/jimmunol.179.1.522; ORDWAY DJ, 1995, INFECT IMMUN, V63, P741, DOI 10.1128/IAI.63.2.741-743.1995; Petrini B, 2006, APMIS, V114, P319, DOI 10.1111/j.1600-0463.2006.apm_390.x; Phillips MS, 2001, CLIN INFECT DIS, V33, P1363, DOI 10.1086/323126; Prevots DR, 2010, AM J RESP CRIT CARE, V182, P970, DOI 10.1164/rccm.201002-0310OC; Rottman M, 2007, INFECT IMMUN, V75, P5898, DOI 10.1128/IAI.00014-07; Seiler P, 2000, J INFECT DIS, V181, P671, DOI 10.1086/315278; Shafiani S, 2010, J EXP MED, V207, P1409, DOI 10.1084/jem.20091885; Sinsimer D, 2008, INFECT IMMUN, V76, P3027, DOI 10.1128/IAI.01663-07; SOUSA M, 2010, INFECT IMMUN, V78, P1571; Svetlikova Z, 2009, ANTIMICROB AGENTS CH, V53, P4015, DOI 10.1128/AAC.00590-09; Talati NJ, 2008, LANCET INFECT DIS, V8, P390, DOI 10.1016/S1473-3099(08)70127-0; Wallace RJ, 1998, ANNU REV MICROBIOL, V52, P453, DOI 10.1146/annurev.micro.52.1.453; Zelazny AM, 2009, J CLIN MICROBIOL, V47, P1985, DOI 10.1128/JCM.01688-08	42	32	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2011	6	9							e24726	10.1371/journal.pone.0024726	http://dx.doi.org/10.1371/journal.pone.0024726			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CO	21931831	gold, Green Submitted, Green Published			2022-12-25	WOS:000294803200043
J	Niewalda, T; Voller, T; Eschbach, C; Ehmer, J; Chou, WC; Timme, M; Fiala, A; Gerber, B				Niewalda, Thomas; Voeller, Thomas; Eschbach, Claire; Ehmer, Julia; Chou, Wen-Chuang; Timme, Marc; Fiala, Andre; Gerber, Bertram			A Combined Perceptual, Physico-Chemical, and Imaging Approach to 'Odour-Distances' Suggests a Categorizing Function of the Drosophila Antennal Lobe	PLOS ONE			English	Article							MUSHROOM BODY; SPATIAL REPRESENTATION; OLFACTORY INFORMATION; MELANOGASTER; REVEALS; NEURONS; MAP; ORGANIZATION; HONEYBEES; CAMELEON	How do physico-chemical stimulus features, perception, and physiology relate? Given the multi-layered and parallel architecture of brains, the question specifically is where physiological activity patterns correspond to stimulus features and/or perception. Perceived distances between six odour pairs are defined behaviourally from four independent odour recognition tasks. We find that, in register with the physico-chemical distances of these odours, perceived distances for 3octanol and n-amylacetate are consistently smallest in all four tasks, while the other five odour pairs are about equally distinct. Optical imaging in the antennal lobe, using a calcium sensor transgenically expressed in only first-order sensory or only second-order olfactory projection neurons, reveals that 3-octanol and n-amylacetate are distinctly represented in sensory neurons, but appear merged in projection neurons. These results may suggest that within-antennal lobe processing funnels sensory signals into behaviourally meaningful categories, in register with the physico-chemical relatedness of the odours.	[Niewalda, Thomas; Voeller, Thomas; Eschbach, Claire; Ehmer, Julia; Fiala, Andre; Gerber, Bertram] Univ Wurzburg, Biozentrum, Wurzburg, Germany; [Niewalda, Thomas; Gerber, Bertram] Univ Leipzig, Inst Biol, Leipzig, Germany; [Chou, Wen-Chuang; Timme, Marc] Max Planck Inst Dynam & Self Org, Network Dynam Grp, Gottingen, Germany; [Timme, Marc] Univ Gottingen, Fak Phys, Gottingen, Germany; [Timme, Marc; Fiala, Andre] Bernstein Ctr Computat Neurosci, Gottingen, Germany; [Fiala, Andre] Univ Gottingen, Johann Friedrich Blumenbach Inst Zool & Anthropol, Abt Mol Neurobiol Verhaltens, ENI G, Gottingen, Germany; [Gerber, Bertram] Leibniz Inst Neurobiol, Abt Genet Lernen & Gedachtnis, Magdeburg, Germany; [Gerber, Bertram] Otto VonGuericke Univ Magdegurg, Inst Biol, D-39016 Magdeburg, Germany	University of Wurzburg; Leipzig University; Max Planck Society; University of Gottingen; University of Gottingen; Leibniz Institut fur Neurobiologie (LIN); Otto von Guericke University	Niewalda, T (corresponding author), Univ Wurzburg, Biozentrum, Wurzburg, Germany.	bertram.gerber@uni-leipzig.de	Timme, Marc/G-6094-2011; Eschbach, Claire/AAA-9165-2022; Fiala, André/AAA-3852-2019	Fiala, André/0000-0002-9745-5145; Gerber, Bertram/0000-0003-3003-0051; Eschbach, Claire/0000-0002-8092-3440; Timme, Marc/0000-0002-5956-3137	German Science Foundation [PP 1392]; German Excellence Initiative via the Graduate School of Life Sciences, University of Wurzburg; Gottingen Graduate School for Neuroscience and Molecular Bioscience; German Federal Ministry for Education and Research via the BCCN Gottingen [01GQ1005A, 01GQ1005B]; Max Planck Society	German Science Foundation(German Research Foundation (DFG)); German Excellence Initiative via the Graduate School of Life Sciences, University of Wurzburg; Gottingen Graduate School for Neuroscience and Molecular Bioscience; German Federal Ministry for Education and Research via the BCCN Gottingen; Max Planck Society(Max Planck Society)	The work was supported by the German Science Foundation (PP 1392) to Dr. Gerber and Dr. Fiala, by the German Excellence Initiative via the Graduate School of Life Sciences, University of Wurzburg to Dr. Eschbach, by the Gottingen Graduate School for Neuroscience and Molecular Bioscience to Dr. Chou, by the German Federal Ministry for Education and Research via the BCCN Gottingen (01GQ1005A) to Dr. Timme and Dr. Fiala, and (01GQ1005B) to Dr. Timme, and by the Max Planck Society (Dr. Timme). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aso Y, 2009, J NEUROGENET, V23, P156, DOI 10.1080/01677060802471718; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Diegelmann S, 2002, GENESIS, V34, P95, DOI 10.1002/gene.10112; Estes PS, 1996, J NEUROSCI, V16, P5443; Fiala A, 2002, CURR BIOL, V12, P1877, DOI 10.1016/S0960-9822(02)01239-3; FIALA A, 2003, SCI STKE, V174, pPL6; Fiala A, 2007, CURR OPIN NEUROBIOL, V17, P720, DOI 10.1016/j.conb.2007.11.009; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Gerber B, 2009, RESULTS PROBL CELL D, V47, P139, DOI 10.1007/400_2008_9; Guerrieri F, 2005, PLOS BIOL, V3, P718, DOI 10.1371/journal.pbio.0030060; Haddad R, 2008, NAT METHODS, V5, P425, DOI [10.1038/nmeth.1197, 10.1038/NMETH.1197]; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2006, ANNU REV ENTOMOL, V51, P113, DOI 10.1146/annurev.ento.51.051705.113646; Heimbeck G, 2001, P NATL ACAD SCI USA, V98, P15336, DOI 10.1073/pnas.011314898; Ito K, 1998, LEARN MEMORY, V5, P52; Kreher SA, 2008, NEURON, V59, P110, DOI 10.1016/j.neuron.2008.06.010; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6; Miyawaki A, 1999, P NATL ACAD SCI USA, V96, P2135, DOI 10.1073/pnas.96.5.2135; Murthy M, 2008, NEURON, V59, P1009, DOI 10.1016/j.neuron.2008.07.040; Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3; Sachse S, 1999, EUR J NEUROSCI, V11, P3970, DOI 10.1046/j.1460-9568.1999.00826.x; Schmuker M, 2007, CHEM CENT J, V1, DOI 10.1186/1752-153X-1-11; Schmuker M, 2007, P NATL ACAD SCI USA, V104, P20285, DOI 10.1073/pnas.0705683104; Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5; Strausfeld NJ, 1999, CURR OPIN NEUROBIOL, V9, P634, DOI 10.1016/S0959-4388(99)00019-7; Tanaka NK, 2008, J COMP NEUROL, V508, P711, DOI 10.1002/cne.21692; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Tomer R, 2010, CELL, V142, P800, DOI 10.1016/j.cell.2010.07.043; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Wang JW, 2003, CELL, V112, P271, DOI 10.1016/S0092-8674(03)00004-7; Wilson RI, 2008, CURR OPIN NEUROBIOL, V18, P408, DOI 10.1016/j.conb.2008.08.015; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9	33	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2011	6	9							e24300	10.1371/journal.pone.0024300	http://dx.doi.org/10.1371/journal.pone.0024300			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CN	21931676	Green Published, gold			2022-12-25	WOS:000294803100017
J	Berg, L; Lopper, ME				Berg, Linda; Lopper, Matthew E.			The priB Gene of Klebsiella pneumoniae Encodes a 104-Amino Acid Protein That Is Similar in Structure and Function to Escherichia coli PriB	PLOS ONE			English	Article							STALLED REPLICATION FORKS; SINGLE-STRANDED-DNA; CRYSTAL-STRUCTURE; PRIMOSOME; RESTART; COMPONENT; HELICASE; REPAIR	Primosome protein PriB is a single-stranded DNA-binding protein that serves as an accessory factor for PriA helicase-catalyzed origin-independent reinitiation of DNA replication in bacteria. A recent report describes the identification of a novel PriB protein in Klebsiella pneumoniae that is significantly shorter than most sequenced PriB homologs. The K. pneumoniae PriB protein is proposed to comprise 55 amino acid residues, in contrast to E. coli PriB which comprises 104 amino acid residues and has a length that is typical of most sequenced PriB homologs. Here, we report results of a sequence analysis that suggests that the priB gene of K. pneumoniae encodes a 104-amino acid PriB protein, akin to its E. coli counterpart. Furthermore, we have cloned the K. pneumoniae priB gene and purified the 104-amino acid K. pneumoniae PriB protein. Gel filtration experiments reveal that the K. pneumoniae PriB protein is a dimer, and equilibrium DNA binding experiments demonstrate that K. pneumoniae PriB's single-stranded DNA-binding activity is similar to that of E. coli PriB. These results indicate that the PriB homolog of K. pneumoniae is similar in structure and in function to that of E. coli.	[Berg, Linda; Lopper, Matthew E.] Univ Dayton, Dept Chem, Dayton, OH 45469 USA	University of Dayton	Berg, L (corresponding author), Univ Dayton, Dept Chem, Dayton, OH 45469 USA.	matthew.lopper@notes.udayton.edu			Research Corporation for Science Advancement [19756]; University of Dayton Graduate School	Research Corporation for Science Advancement(Research Corporation for Science Advancement); University of Dayton Graduate School	This work was supported by a grant from Research Corporation for Science Advancement to MEL (grant #19756, http://www.rescorp.org/), and by a grant from the University of Dayton Graduate School to LB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN GC, 1993, J BIOL CHEM, V268, P19204; Cadman CJ, 2005, J BIOL CHEM, V280, P39693, DOI 10.1074/jbc.M508521200; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Cox MM, 2002, MUTAT RES-FUND MOL M, V510, P107, DOI 10.1016/S0027-5107(02)00256-7; Heller RC, 2006, NAT REV MOL CELL BIO, V7, P932, DOI 10.1038/nrm2058; Hsieh HC, 2011, BIOCHEM BIOPH RES CO, V404, P546, DOI 10.1016/j.bbrc.2010.12.023; LEE MS, 1987, P NATL ACAD SCI USA, V84, P8345, DOI 10.1073/pnas.84.23.8345; Liu JH, 2004, J BIOL CHEM, V279, P50465, DOI 10.1074/jbc.M406773200; Lopper M, 2004, STRUCTURE, V12, P1967, DOI 10.1016/j.str.2004.09.004; Lopper M, 2007, MOL CELL, V26, P781, DOI 10.1016/j.molcel.2007.05.012; LOW RL, 1982, J BIOL CHEM, V257, P6242; McGlynn P, 2002, NAT REV MOL CELL BIO, V3, P859, DOI 10.1038/nrm951; Ng JY, 1996, J BIOL CHEM, V271, P15642, DOI 10.1074/jbc.271.26.15642; Shioi S, 2005, BIOCHEM BIOPH RES CO, V326, P766, DOI 10.1016/j.bbrc.2004.11.104; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876	15	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e24494	10.1371/journal.pone.0024494	http://dx.doi.org/10.1371/journal.pone.0024494			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CK	21931731	Green Published, Green Submitted, gold			2022-12-25	WOS:000294802800058
J	Uawisetwathana, U; Leelatanawit, R; Klanchui, A; Prommoon, J; Klinbunga, S; Karoonuthaisiri, N				Uawisetwathana, Umaporn; Leelatanawit, Rungnapa; Klanchui, Amornpan; Prommoon, Juthatip; Klinbunga, Sirawut; Karoonuthaisiri, Nitsara			Insights into Eyestalk Ablation Mechanism to Induce Ovarian Maturation in the Black Tiger Shrimp	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; KURUMA PRAWN; MOLECULAR CHARACTERIZATION; OOCYTE MATURATION; PENAEUS-MONODON; LITOPENAEUS-VANNAMEI; COACTIVATOR COMPLEX; INHIBITING HORMONE; TRAP220 COMPONENT; NUCLEAR RECEPTORS	Eyestalk ablation is commonly practiced in crustacean to induce ovarian maturation in captivity. The molecular mechanism of the ablation has not been well understood, preventing a search for alternative measures to induce ovarian maturation in aquaculture. This is the first study to employ cDNA microarray to examine effects of eyestalk ablation at the transcriptomic level and pathway mapping analysis to identify potentially affected biological pathways in the black tiger shrimp (Penaeus monodon). Microarray analysis comparing between gene expression levels of ovaries from eyestalk-intact and eyestalk-ablated brooders revealed 682 differentially expressed transcripts. Based on Hierarchical clustering of gene expression patterns, Gene Ontology annotation, and relevant functions of these differentially expressed genes, several gene groups were further examined by pathway mapping analysis. Reverse-transcriptase quantitative PCR analysis for some representative transcripts confirmed microarray data. Known reproductive genes involved in vitellogenesis were dramatically increased during the ablation. Besides these transcripts expected to be induced by the ablation, transcripts whose functions involved in electron transfer mechanism, immune responses and calcium signal transduction were significantly altered following the ablation. Pathway mapping analysis revealed that the activation of gonadotropin-releasing hormone signaling, calcium signaling, and progesterone-mediated oocyte maturation pathways were putatively crucial to ovarian maturation induced by the ablation. These findings shed light on several possible molecular mechanisms of the eyestalk ablation effect and allow more focused investigation for an ultimate goal of finding alternative methods to replace the undesirable practice of the eyestalk ablation in the future.	[Uawisetwathana, Umaporn; Leelatanawit, Rungnapa; Klanchui, Amornpan; Prommoon, Juthatip; Klinbunga, Sirawut; Karoonuthaisiri, Nitsara] Natl Sci & Technol Dev Agcy, Natl Ctr Genet Engn & Biotechnol BIOTEC, Klongluang, Pathumthani, Thailand; [Klinbunga, Sirawut] Chulalongkorn Univ, Fac Sci, Ctr Excellence Marine Biotechnol, Bangkok, Thailand	National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Chulalongkorn University	Uawisetwathana, U (corresponding author), Natl Sci & Technol Dev Agcy, Natl Ctr Genet Engn & Biotechnol BIOTEC, Klongluang, Pathumthani, Thailand.	nitsara.kar@biotec.or.th	Uawisetwathana, Umaporn/E-8974-2011; Klinbunga, Sirawut/F-5307-2011		National Center for Genetic Engineering and Biotechnology (BIOTEC); National Science and Technology Development Agency (NSTDA)	National Center for Genetic Engineering and Biotechnology (BIOTEC); National Science and Technology Development Agency (NSTDA)	This research is supported by the National Center for Genetic Engineering and Biotechnology (BIOTEC) and National Science and Technology Development Agency (NSTDA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano M, 2009, ZOOL SCI, V26, P840, DOI 10.2108/zsj.26.840; Bauer R, 2004, MOL BIOL CELL, V15, P2992, DOI 10.1091/mbc.E04-01-0056; Beltz B.S., 1988, Invertebrate Endocrinology, V2, P235; Benninghoff AD, 2005, GEN COMP ENDOCR, V144, P211, DOI 10.1016/j.ygcen.2005.06.005; BENZIE JAH, 1997, P FISH SHELLF LARV S, P69; Bohrmann J, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-111; BRAY WA, 1992, REPROD PENAEUS SPECI, P93; Brothers SP, 2006, J MOL ENDOCRINOL, V37, P479, DOI 10.1677/jme.1.02142; BROWDY CL, 1985, AQUACULTURE, V49, P19, DOI 10.1016/0044-8486(85)90187-5; CAHU C, 1994, AQUACULTURE, V126, P159, DOI 10.1016/0044-8486(94)90257-7; CARNEGIE JA, 1984, BIOL REPROD, V30, P515, DOI 10.1095/biolreprod30.2.515; CHANG ES, 1992, ENDOCRINOLOGY, P53; CHU KH, 1993, FISH RES, V18, P187, DOI 10.1016/0165-7836(93)90152-W; CICIRELLI MF, 1987, DEV BIOL, V121, P48, DOI 10.1016/0012-1606(87)90137-0; Corbett EF, 2000, TRENDS BIOCHEM SCI, V25, P307, DOI 10.1016/S0968-0004(00)01588-7; CUMMINGS WILLIAM C., 1961, TRANS AMER FISH SOC, V90, P462, DOI 10.1577/1548-8659(1961)90[462:MASOTP]2.0.CO;2; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; FRANCISCO SKS, 1987, J EXP ZOOL, V244, P133, DOI 10.1002/jez.1402440116; Garrett R., 2010, BIOCHEMISTRY; HARRISON K E, 1990, Journal of Shellfish Research, V9, P1; Hoang T, 2002, AQUACULTURE, V208, P159, DOI 10.1016/S0044-8486(01)00713-X; Ito M, 1999, MOL CELL, V3, P361, DOI 10.1016/S1097-2765(00)80463-3; Ito M, 2000, MOL CELL, V5, P683, DOI 10.1016/S1097-2765(00)80247-6; Khayat M, 2001, BIOL REPROD, V64, P1090, DOI 10.1095/biolreprod64.4.1090; KING JE, 1948, BIOL BULL, V94, P244, DOI 10.2307/1538251; Kruevaisayawan H, 2010, AQUACULTURE, V301, P91, DOI 10.1016/j.aquaculture.2010.01.018; KUGU K, 1995, J REPROD FERTIL, V103, P273, DOI 10.1530/jrf.0.1030273; Lawniczak MKN, 2007, TRENDS ECOL EVOL, V22, P48, DOI 10.1016/j.tree.2006.09.012; Leelatanawit R, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-15; LYTLE JS, 1990, AQUACULTURE, V89, P287, DOI 10.1016/0044-8486(90)90133-8; Meunpol O, 2007, AQUACULTURE, V270, P485, DOI 10.1016/j.aquaculture.2007.05.031; MEUSY JJ, 1988, ZOOL SCI, V5, P217; Middleditch B.S., 1979, Proceedings of the Annual Meeting of the World Mariculture Society, V10, P472; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Muminjonov H, 2004, TURON GAHVORAI TAMAD; Nakatsuji T, 2009, COMP BIOCHEM PHYS A, V152, P139, DOI 10.1016/j.cbpa.2008.10.012; Ngernsoungnern A, 2008, AQUACULTURE, V279, P197, DOI 10.1016/j.aquaculture.2008.04.018; Ngernsoungnern P, 2008, GEN COMP ENDOCR, V155, P613, DOI 10.1016/j.ygcen.2007.08.012; Ngernsoungnern P, 2009, INVERTEBR REPROD DEV, V53, P125, DOI 10.1080/07924259.2009.9652298; Okazaki Y, 2000, J BIOL CHEM, V275, P35751, DOI 10.1074/jbc.M007476200; Okumura T, 2006, COMP BIOCHEM PHYS A, V143, P246, DOI 10.1016/j.cbpa.2005.12.002; OLEARY CD, 1990, AQUACULTURE, V89, P65, DOI 10.1016/0044-8486(90)90234-E; Preechaphol R, 2010, GEN COMP ENDOCR, V168, P440, DOI 10.1016/j.ygcen.2010.06.002; PRIMAVERA JH, 1983, BROODSTOCK SURGO PEN; Qiu GF, 2005, COMP BIOCHEM PHYS B, V140, P171, DOI 10.1016/j.cbpc.2004.09.027; QUACKENBUSH LS, 1981, COMP BIOCHEM PHYS A, V69, P523, DOI 10.1016/0300-9629(81)93014-0; QUACKENBUSH LS, 1991, REGULATION VITELLOGE, P125; Ravid T, 1999, J EXP BIOL, V202, P1819; RODRGUEZ A, 1996, AQUACULTURE, V148, P63; ROSAS C, 1993, COMP BIOCHEM PHYS A, V104, P183, DOI 10.1016/0300-9629(93)90027-2; Sainz-Hernandez JC, 2008, AQUACULTURE, V283, P188, DOI 10.1016/j.aquaculture.2008.07.002; Salomonis N, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-217; SANTIAGO AC, 1977, AQUACULTURE, V11, P185, DOI 10.1016/0044-8486(77)90111-9; Schmitt A, 2002, J CELL SCI, V115, P2457; Seachord CL, 2005, BIOL REPROD, V72, P1305, DOI 10.1095/biolreprod.104.037523; Subramoniam T, 2011, FISHERIES SCI, V77, P1, DOI 10.1007/s12562-010-0301-z; SUBRAMONIAM T, 1993, CURR SCI INDIA, V65, P619; TANFERMIN JD, 1989, AQUACULTURE, V77, P229, DOI 10.1016/0044-8486(89)90205-6; TESHIMA SI, 1983, AQUACULTURE, V31, P159, DOI 10.1016/0044-8486(83)90310-1; Treerattrakool S, 2008, FEBS J, V275, P970, DOI 10.1111/j.1742-4658.2008.06266.x; Tsutsui N, 2000, ZOOL SCI, V17, P651, DOI 10.2108/zsj.15.651; Verghese B, 2008, AQUAC RES, V39, P1009, DOI 10.1111/j.1365-2109.2008.01949.x; Wouters R, 2001, AQUACULTURE, V198, P307, DOI 10.1016/S0044-8486(01)00522-1; Yamano K, 2004, BIOL REPROD, V70, P1670, DOI 10.1095/biolreprod.103.025379; Yano I, 1995, J EXP MAR BIOL ECOL, V193, P113, DOI 10.1016/0022-0981(95)00113-1; Yepiz-Plascencia G, 2000, AQUACULTURE, V191, P177, DOI 10.1016/S0044-8486(00)00427-0; Yuan CX, 1998, P NATL ACAD SCI USA, V95, P7939, DOI 10.1073/pnas.95.14.7939; Zhu XG, 2010, CURR OPIN ENDOCRINOL, V17, P408, DOI 10.1097/MED.0b013e32833d6d46	70	70	86	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2011	6	9							e24427	10.1371/journal.pone.0024427	http://dx.doi.org/10.1371/journal.pone.0024427			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CH	21915325	Green Submitted, Green Published, gold			2022-12-25	WOS:000294802500043
J	Vinokurova, S; Doeberitz, MV				Vinokurova, Svetlana; Doeberitz, Magnus von Knebel			Differential Methylation of the HPV 16 Upstream Regulatory Region during Epithelial Differentiation and Neoplastic Transformation	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; CERVICAL INTRAEPITHELIAL NEOPLASIA; L1 CAPSID PROTEIN; DNA METHYLATION; CPG METHYLATION; GENE-EXPRESSION; CELLULAR-DIFFERENTIATION; P16 PROTEIN; E2 PROTEIN; IN-SITU	High risk human papillomaviruses are squamous epitheliotropic viruses that may cause cervical and other cancers. HPV replication depends on squamous epithelial differentiation. Transformation of HPV-infected cells goes along with substantial alteration of the viral gene expression profile and preferentially occurs at transformation zones usually at the uterine cervix. Methylation of the viral genome may affect regulatory features that control transcription and replication of the viral genome. Therefore, we analyzed the methylation pattern of the HPV16 upstream regulatory region (URR) during squamous epithelial differentiation and neoplastic transformation and analyzed how shifts in the HPV URR methylome may affect viral gene expression and replication. HPV 16 positive biopsy sections encompassing all stages of an HPV infection (latent, permissive and transforming) were micro-dissected and DNA was isolated from cell fractions representing the basal, intermediate, and superficial cell layers, each, as well as from transformed p16(INK4a)-positive cells. We observed fundamental changes in the methylation profile of transcription factor binding sites in the HPV16 upstream regulatory region linked to the squamous epithelial differentiation stage. Squamous epithelial transformation indicated by p16(INK4a) overexpression was associated with methylation of the distal E2 binding site 1 leading to hyper-activation of the HPV 16 URR. Adjacent normal but HPV 16-infected epithelial areas retained hyper-methylated HPV DNA suggesting that these viral genomes were inactivated. These data suggest that distinct shifts of the HPV 16 methylome are linked to differentiation dependent transcription and replication control and may trigger neoplastic transformation.	[Vinokurova, Svetlana; Doeberitz, Magnus von Knebel] Heidelberg Univ, Inst Pathol, Dept Appl Tumor Biol, D-6900 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Vinokurova, S (corresponding author), Heidelberg Univ, Inst Pathol, Dept Appl Tumor Biol, Neuenheimer Feld 220, D-6900 Heidelberg, Germany.	knebel@med.uni-heidelberg.de	von Knebel Doeberitz, Magnus/D-2372-2016	von Knebel Doeberitz, Magnus/0000-0002-0498-6781; Vinokurova, Svetlana/0000-0003-1615-3928				Arias-Pulido H, 2006, J CLIN MICROBIOL, V44, P1755, DOI 10.1128/JCM.44.5.1755-1762.2006; Badal S, 2004, VIROLOGY, V324, P483, DOI 10.1016/j.virol.2004.04.002; Badal V, 2003, J VIROL, V77, P6227, DOI 10.1128/JVI.77.11.6227-6234.2003; Balderas-Loaeza A, 2007, INT J CANCER, V120, P2165, DOI 10.1002/ijc.22563; Bhattacharjee B, 2006, VIROLOGY, V354, P280, DOI 10.1016/j.virol.2006.06.018; Bodily J, 2011, TRENDS MICROBIOL, V19, P33, DOI 10.1016/j.tim.2010.10.002; Brandsma JL, 2009, VIROLOGY, V389, P100, DOI 10.1016/j.virol.2009.03.029; Ding DC, 2009, EUR J OBSTET GYN R B, V147, P215, DOI 10.1016/j.ejogrb.2009.08.023; Doeberitz MV, 2009, ARCH MED RES, V40, P435, DOI 10.1016/j.arcmed.2009.06.002; Doeberitz MV, 2002, EUR J CANCER, V38, P2229, DOI 10.1016/S0959-8049(02)00462-8; Doerfler W, 2006, CURR TOP MICROBIOL, V301, P125; DONG G, 1994, J VIROL, V68, P1115, DOI 10.1128/JVI.68.2.1115-1127.1994; Doorbar J, 2007, DIS MARKERS, V23, P297, DOI 10.1155/2007/613150; DURST M, 1992, VIROLOGY, V189, P132, DOI 10.1016/0042-6822(92)90688-L; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; Fernandez AF, 2009, GENOME RES, V19, P438, DOI 10.1101/gr.083550.108; Gonzalo S, 2010, J APPL PHYSIOL, V109, P586, DOI 10.1152/japplphysiol.00238.2010; HAUSEN HZ, 1986, LANCET, V2, P489; Huang MZ, 2010, DIAGN CYTOPATHOL, V38, P573, DOI 10.1002/dc.21258; Hublarova P, 2009, INT J GYNECOL CANCER, V19, P321, DOI 10.1111/IGC.0b013e31819d8a5c; Ikegami K, 2009, INT J DEV BIOL, V53, P203, DOI 10.1387/ijdb.082741ki; Kalantari M, 2004, J VIROL, V78, P12762, DOI 10.1128/JVI.78.23.12762-12772.2004; Kalantari M, 2008, INT J CANCER, V123, P1832, DOI 10.1002/ijc.23707; Kalantari M, 2008, VIROLOGY, V374, P292, DOI 10.1016/j.virol.2007.12.016; Kalantari M, 2009, VIROLOGY, V390, P261, DOI 10.1016/j.virol.2009.05.006; Kim K, 2003, J VIROL, V77, P12450, DOI 10.1128/JVI.77.23.12450-12459.2003; Kines RC, 2009, P NATL ACAD SCI USA, V106, P20458, DOI 10.1073/pnas.0908502106; Klaes R, 2001, INT J CANCER, V92, P276, DOI 10.1002/ijc.1174; Klaes R, 1999, CANCER RES, V59, P6132; Kulis M, 2010, ADV GENET, V70, P27, DOI [10.1016/S0065-2660(10)70002-X, 10.1016/B978-0-12-380866-0.60002-2]; Melsheimer P, 2004, CLIN CANCER RES, V10, P3059, DOI 10.1158/1078-0432.CCR-03-0565; Middleton K, 2003, J VIROL, V77, P10186, DOI 10.1128/JVI.77.19.10186-10201.2003; Pett M, 2007, J PATHOL, V212, P356, DOI 10.1002/path.2192; Piyathilake CJ, 2010, CANCER; Rapp B, 1997, J VIROL, V71, P6956, DOI 10.1128/JVI.71.9.6956-6966.1997; Rishi V, 2010, P NATL ACAD SCI USA, V107, P20311, DOI 10.1073/pnas.1008688107; Sano T, 1998, AM J PATHOL, V153, P1741, DOI 10.1016/S0002-9440(10)65689-1; Schiffman M, 2007, LANCET, V370, P890, DOI 10.1016/S0140-6736(13)60022-7; Shiota K, 2004, CYTOGENET GENOME RES, V105, P325, DOI 10.1159/000078205; Steger G, 1997, J VIROL, V71, P50, DOI 10.1128/JVI.71.1.50-58.1997; STOLER MH, 1992, HUM PATHOL, V23, P117, DOI 10.1016/0046-8177(92)90232-R; Sun C, 2011, GYNECOL ONCOL; Taby R, 2010, CA-CANCER J CLIN, V60, P376, DOI 10.3322/caac.20085; Thain A, 1996, J VIROL, V70, P7233, DOI 10.1128/JVI.70.10.7233-7235.1996; Thierry F, 2009, VIROLOGY, V384, P375, DOI 10.1016/j.virol.2008.11.014; Turan T, 2007, VIROLOGY, V361, P185, DOI 10.1016/j.virol.2006.11.010; Turan T, 2006, VIROLOGY, V349, P175, DOI 10.1016/j.virol.2005.12.033; Van Tine BA, 2004, J VIROL, V78, P11172, DOI 10.1128/JVI.78.20.11172-11186.2004; Vinokurova S, 2008, CANCER RES, V68, P307, DOI 10.1158/0008-5472.CAN-07-2754; Wang HK, 2009, GENE DEV, V23, P181, DOI 10.1101/gad.1735109; Xiong ZG, 1997, NUCLEIC ACIDS RES, V25, P2532, DOI 10.1093/nar/25.12.2532; Yamada Y, 2010, ADV GENET, V70, P177, DOI [10.1016/B978-0-12-380866-0.60007-1, 10.1016/S0065-2660(10)70007-9]; Yoshida T, 2008, CANCER CYTOPATHOL, V114, P83, DOI 10.1002/cncr.23366; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798; zur Hausen H, 2000, JNCI-J NATL CANCER I, V92, P690, DOI 10.1093/jnci/92.9.690	55	81	83	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2011	6	9							e24451	10.1371/journal.pone.0024451	http://dx.doi.org/10.1371/journal.pone.0024451			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CH	21915330	Green Published, gold, Green Submitted			2022-12-25	WOS:000294802500048
J	Eltom, S; Stevenson, CS; Rastrick, J; Dale, N; Raemdonck, K; Wong, S; Catley, MC; Belvisi, MG; Birrell, MA				Eltom, Suffwan; Stevenson, Christopher S.; Rastrick, Joseph; Dale, Nicole; Raemdonck, Kristof; Wong, Sissie; Catley, Matthew C.; Belvisi, Maria G.; Birrell, Mark A.			P2X7 Receptor and Caspase 1 Activation Are Central to Airway Inflammation Observed after Exposure to Tobacco Smoke	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; P2X(7) RECEPTOR; KEY PLAYER; EMPHYSEMA; RELEASE; LUNG; ATP; ADENOSINE; IL-18; PATHOGENESIS	Chronic Obstructive Pulmonary Disease (COPD) is a cigarette smoke (CS)-driven inflammatory airway disease with an increasing global prevalence. Currently there is no effective medication to stop the relentless progression of this disease. It has recently been shown that an activator of the P2X7/inflammasome pathway, ATP, and the resultant products (IL-1 beta/IL-18) are increased in COPD patients. The aim of this study was to determine whether activation of the P2X7/caspase 1 pathway has a functional role in CS-induced airway inflammation. Mice were exposed to CS twice a day to induce COPD-like inflammation and the role of the P2X7 receptor was investigated. We have demonstrated that CS-induced neutrophilia in a pre-clinical model is temporally associated with markers of inflammasome activation, (increased caspase 1 activity and release of IL-1 beta/IL-18) in the lungs. A selective P2X7 receptor antagonist and mice genetically modified so that the P2X7 receptors were non-functional attenuated caspase 1 activation, IL-1 beta release and airway neutrophilia. Furthermore, we demonstrated that the role of this pathway was not restricted to early stages of disease development by showing increased caspase 1 activation in lungs from a more chronic exposure to CS and from patients with COPD. This translational data suggests the P2X7/Inflammasome pathway plays an ongoing role in disease pathogenesis. These results advocate the critical role of the P2X7/caspase 1 axis in CS-induced inflammation, highlighting this as a possible therapeutic target in combating COPD.	[Eltom, Suffwan; Stevenson, Christopher S.; Rastrick, Joseph; Dale, Nicole; Raemdonck, Kristof; Wong, Sissie; Belvisi, Maria G.; Birrell, Mark A.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Fac Med, Airway Dis Sect, London, England; [Eltom, Suffwan; Stevenson, Christopher S.; Belvisi, Maria G.; Birrell, Mark A.] Univ London Imperial Coll Sci Technol & Med, Ctr Integrat Mammalian Physiol & Pharmacol, London, England; [Catley, Matthew C.] Union Chim Belge Pharma Ltd, Union Chim Belge Celltech, Slough, Berkshire, Belgium	Imperial College London; Imperial College London; UCB Pharma SA	Eltom, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Fac Med, Airway Dis Sect, London, England.	m.birrell@imperial.ac.uk	Raemdonck, Kristof/Y-7125-2019; Raemdonck, Kristof/K-5554-2013	Raemdonck, Kristof/0000-0002-7073-7484	Medical Research Council (MRC), (United Kingdom) [G0800196]; Capacity Building Award in Integrative Mammalian Biology; Biotechnology and Biological Sciences Research Council; BPS; Higher Education Funding Council for England; KTN MRC; MRC; National Institute for Health Research (NIHR) Biomedical Research Unit; BBSRC [BB/E52708X/1] Funding Source: UKRI; MRC [G0800196] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E52708X/1] Funding Source: researchfish; Medical Research Council [G0800196] Funding Source: researchfish	Medical Research Council (MRC), (United Kingdom)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Capacity Building Award in Integrative Mammalian Biology; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BPS; Higher Education Funding Council for England(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); KTN MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research (NIHR) Biomedical Research Unit(National Institute for Health Research (NIHR)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	M. Birrell was funded by a project grant from the Medical Research Council (MRC), (United Kingdom) (MAB, G0800196). SE and CS were funded by a Capacity Building Award in Integrative Mammalian Biology funded by the Biotechnology and Biological Sciences Research Council, BPS, Higher Education Funding Council for England, KTN & MRC. JR and ND were funded by MRC studentships. The human tissue experiments in this manuscript were undertaken with the support of the National Institute for Health Research (NIHR) Biomedical Research Unit in Advanced Lung Disease at the Royal Brompton and Harefield National Health Service Foundation, Trust and Imperial College, London, and partly funded by the NIHR Biomedical Research Unit funding scheme. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Barnes PJ, 2005, EUR RESPIR J, V25, P1084, DOI 10.1183/09031936.05.00139104; Birrell MA, 2005, FASEB J, V19, P840, DOI 10.1096/fj.04-2691fje; Bours MJL, 2006, PHARMACOL THERAPEUT, V112, P358, DOI 10.1016/j.pharmthera.2005.04.013; Churg A, 2009, AM J RESP CELL MOL, V40, P482, DOI 10.1165/rcmb.2008-0038OC; Cicko S, 2010, J IMMUNOL, V185, P688, DOI 10.4049/jimmunol.0904042; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Donnelly-Roberts DL, 2007, BRIT J PHARMACOL, V151, P571, DOI 10.1038/sj.bjp.0707265; Ekberg-Jansson A, 2001, RESP MED, V95, P363, DOI 10.1053/rmed.2001.1050; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Grahames CBA, 1999, BRIT J PHARMACOL, V127, P1915, DOI 10.1038/sj.bjp.0702732; Grumelli S, 2004, PLOS MED, V1, P75, DOI 10.1371/journal.pmed.0010008; Hoshino T, 2007, AM J RESP CRIT CARE, V176, P49, DOI 10.1164/rccm.200603-316OC; Hoshino Y, 2007, AM J RESP CELL MOL, V37, P438, DOI 10.1165/rcmb.2006-0402OC; Imaoka H, 2008, EUR RESPIR J, V31, P287, DOI 10.1183/09031936.00019207; Kang MJ, 2007, J IMMUNOL, V178, P1948, DOI 10.4049/jimmunol.178.3.1948; Labasi JM, 2002, J IMMUNOL, V168, P6436, DOI 10.4049/jimmunol.168.12.6436; Lappalainen U, 2005, AM J RESP CELL MOL, V32, P311, DOI 10.1165/rcmb.2004-0309OC; Lazarowski ER, 2003, MOL PHARMACOL, V64, P785, DOI 10.1124/mol.64.4.785; Lommatzsch M, 2010, AM J RESP CRIT CARE, V181, P928, DOI 10.1164/rccm.200910-1506OC; Lopez AD, 1998, NAT MED, V4, P1241, DOI 10.1038/3218; Lucattelli M, 2011, AM J RESP CELL MOL, V44, P423, DOI 10.1165/rcmb.2010-0038OC; Lucey EC, 2002, LAB INVEST, V82, P79, DOI 10.1038/labinvest.3780397; MacNee William, 2005, Proc Am Thorac Soc, V2, P258, DOI 10.1513/pats.200504-045SR; Mariathasan S, 2007, NAT REV IMMUNOL, V7, P31, DOI 10.1038/nri1997; Mohsenin A, 2006, CURR OPIN PULM MED, V12, P54, DOI 10.1097/01.mcp.0000199002.46038.cb; Mortaz E, 2009, EUR J PHARMACOL, V619, P92, DOI 10.1016/j.ejphar.2009.07.022; PERREGAUX D, 1994, J BIOL CHEM, V269, P15195; Petersen AMW, 2007, LUNG, V185, P161, DOI 10.1007/s00408-007-9000-7; Polosa R, 2009, TRENDS PHARMACOL SCI, V30, P528, DOI 10.1016/j.tips.2009.07.005; Qu Y, 2007, J IMMUNOL, V179, P1913, DOI 10.4049/jimmunol.179.3.1913; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Robson SC, 1997, J EXP MED, V185, P153, DOI 10.1084/jem.185.1.153; Solle M, 2001, J BIOL CHEM, V276, P125, DOI 10.1074/jbc.M006781200; Sutterwala FS, 2006, J ENDOTOXIN RES, V12, P251, DOI 10.1179/096805106X118771; Zeidel A, 2002, ACTA ANAESTH SCAND, V46, P959, DOI 10.1034/j.1399-6576.2002.460806.x	35	90	101	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2011	6	9							e24097	10.1371/journal.pone.0024097	http://dx.doi.org/10.1371/journal.pone.0024097			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817QP	21915284	Green Published, gold, Green Submitted			2022-12-25	WOS:000294689200020
J	Kuruba, R; Hattiangady, B; Parihar, VK; Shuai, B; Shetty, AK				Kuruba, Ramkumar; Hattiangady, Bharathi; Parihar, Vipan K.; Shuai, Bing; Shetty, Ashok K.			Differential Susceptibility of Interneurons Expressing Neuropeptide Y or Parvalbumin in the Aged Hippocampus to Acute Seizure Activity	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; DENTATE GRANULE CELLS; RAT HIPPOCAMPUS; STATUS EPILEPTICUS; INHIBITORY INTERNEURONS; POSITIVE INTERNEURONS; PROTEIN PARVALBUMIN; NEUROTROPHIC FACTOR; EXCITOTOXIC INJURY; GABAERGIC NEURONS	Acute seizure (AS) activity in old age has an increased predisposition for evolving into temporal lobe epilepsy (TLE). Furthermore, spontaneous seizures and cognitive dysfunction after AS activity are often intense in the aged population than in young adults. This could be due to an increased vulnerability of inhibitory interneurons in the aged hippocampus to AS activity. We investigated this issue by comparing the survival of hippocampal GABA-ergic interneurons that contain the neuropeptide Y (NPY) or the calcium binding protein parvalbumin (PV) between young adult (5-months old) and aged (22-months old) F344 rats at 12 days after three-hours of AS activity. Graded intraperitoneal injections of the kainic acid (KA) induced AS activity and a diazepam injection at 3 hours after the onset terminated AS-activity. Measurement of interneuron numbers in different hippocampal subfields revealed that NPY+ interneurons were relatively resistant to AS activity in the aged hippocampus in comparison to the young adult hippocampus. Whereas, PV+ interneurons were highly susceptible to AS activity in both age groups. However, as aging alone substantially depleted these populations, the aged hippocampus after three-hours of AS activity exhibited 48% reductions in NPY+ interneurons and 70% reductions in PV+ interneurons, in comparison to the young hippocampus after similar AS activity. Thus, AS activity-induced TLE in old age is associated with far fewer hippocampal NPY+ and PV+ interneuron numbers than AS-induced TLE in the young adult age. This discrepancy likely underlies the severe spontaneous seizures and cognitive dysfunction observed in the aged people after AS activity.	[Kuruba, Ramkumar; Hattiangady, Bharathi; Parihar, Vipan K.; Shuai, Bing; Shetty, Ashok K.] Vet Affairs Med Ctr, Med Res Serv, Durham, NC USA; [Kuruba, Ramkumar; Hattiangady, Bharathi; Parihar, Vipan K.; Shuai, Bing; Shetty, Ashok K.] Vet Affairs Med Ctr, Surg Serv, Durham, NC USA; [Hattiangady, Bharathi; Shuai, Bing; Shetty, Ashok K.] Texas A&M Hlth Sci Ctr Scott & White, Inst Regenerat Med, Temple, TX USA; [Shetty, Ashok K.] Cent Texas Vet Hlth Care Syst, Res Serv, Temple, TX USA; [Kuruba, Ramkumar; Hattiangady, Bharathi; Parihar, Vipan K.; Shuai, Bing; Shetty, Ashok K.] Duke Univ, Med Ctr, Dept Surg, Div Neurosurg, Durham, NC 27710 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); US Department of Veterans Affairs; Veterans Health Administration (VHA); Duke University	Kuruba, R (corresponding author), Vet Affairs Med Ctr, Med Res Serv, Durham, NC USA.	Shetty@medicine.tamhsc.edu	Parihar, Vipan K/Z-1195-2018; Shetty, Ashok/AAT-7273-2020; Shetty, Ashok K/A-2428-2008	Parihar, Vipan K/0000-0003-4878-7386; Shetty, Ashok/0000-0001-5049-6671; Shetty, Ashok K/0000-0001-5049-6671; Hattiangady, Bharathi/0000-0002-0432-1894	Department of Veterans Affairs; National Institute of Neurological Disorders and Stroke [R01 NS 054780]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054780] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by grants from the Department of Veterans Affairs (VA Merit Review Award to A. K. S.), and the National Institute of Neurological Disorders and Stroke (R01 NS 054780 to A. K. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre V, 2001, HIPPOCAMPUS, V11, P452, DOI 10.1002/hipo.1060.abs; Andrioli A, 2007, NEUROSCIENCE, V149, P131, DOI 10.1016/j.neuroscience.2007.07.029; Baraban SC, 1997, J NEUROSCI, V17, P8927, DOI 10.1523/jneurosci.17-23-08927.1997; BARNES CA, 1987, J COMP NEUROL, V259, P549, DOI 10.1002/cne.902590405; BARNES CA, 1994, TRENDS NEUROSCI, V17, P13, DOI 10.1016/0166-2236(94)90029-9; BEKENSTEIN JW, 1993, SCIENCE, V259, P97, DOI 10.1126/science.8093417; Ben-Ari Yehezkel, 2006, Critical Reviews in Neurobiology, V18, P135; Buzsaki G, 2004, TRENDS NEUROSCI, V27, P186, DOI 10.1016/j.tins.2004.02.007; Cadiacio CL, 2003, EXP NEUROL, V183, P147, DOI 10.1016/S0014-4886(03)00126-2; CELIO MR, 1981, NATURE, V293, P300, DOI 10.1038/293300a0; COLMERS WF, 1994, TRENDS NEUROSCI, V17, P373, DOI 10.1016/0166-2236(94)90046-9; CORNISH SM, 1989, NEUROSCIENCE, V28, P563, DOI 10.1016/0306-4522(89)90005-5; Darbin O, 2004, EPILEPSIA, V45, P1219, DOI 10.1111/j.0013-9580.2004.66103.x; Doherty J, 2001, J NEUROSCI, V21, P2048, DOI 10.1523/JNEUROSCI.21-06-02048.2001; Engel J, 2001, NEUROSCIENTIST, V7, P340, DOI 10.1177/107385840100700410; Faught E, 1999, DRUG AGING, V15, P255, DOI 10.2165/00002512-199915040-00002; FRANCK JE, 1988, J NEUROSCI, V8, P1991; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Fu LY, 2007, J PHYSIOL-LONDON, V579, P445, DOI 10.1113/jphysiol.2002.019356; GRUBER B, 1994, HIPPOCAMPUS, V4, P474, DOI 10.1002/hipo.450040409; Hattiangady B, 2005, EXP NEUROL, V195, P353, DOI 10.1016/j.expneurol.2005.05.014; Hattiangady B, 2011, AGING DIS, V2, P1; HAUSER WA, 1993, EPILEPSIA, V34, P453, DOI 10.1111/j.1528-1157.1993.tb02586.x; HAUSER WA, 1992, EPILEPSIA, V33, pS6; Howell OW, 2005, J NEUROCHEM, V93, P560, DOI 10.1111/j.1471-4159.2005.03057.x; KERR DS, 1991, J NEUROSCI, V11, P1316; Kharlamov EA, 2007, BRAIN RES, V1127, P151, DOI 10.1016/j.brainres.2006.09.107; Klapstein GJ, 1997, J NEUROPHYSIOL, V78, P1651, DOI 10.1152/jn.1997.78.3.1651; Klausberger T, 2005, J NEUROSCI, V25, P9782, DOI 10.1523/JNEUROSCI.3269-05.2005; Kobayashi M, 2003, J NEUROSCI, V23, P2440; Korotkova T, 2010, NEURON, V68, P557, DOI 10.1016/j.neuron.2010.09.017; KOSAKA T, 1987, BRAIN RES, V419, P119, DOI 10.1016/0006-8993(87)90575-0; LANDFIELD PW, 1986, J NEUROPHYSIOL, V56, P797, DOI 10.1152/jn.1986.56.3.797; LaRoche SM, 2003, NEUROLOGIST, V9, P241, DOI 10.1097/01.nrl.0000087719.64343.be; Leppik IE, 2006, EPILEPSY RES, V68, pS21, DOI 10.1016/j.eplepsyres.2005.07.014; Liang LP, 2007, NEUROSCIENCE, V147, P1114, DOI 10.1016/j.neuroscience.2007.03.026; Luebke JI, 2003, J COMP NEUROL, V460, P573, DOI 10.1002/cne.10668; McCord MC, 2008, NEUROSCIENCE, V154, P1143, DOI 10.1016/j.neuroscience.2008.03.082; MILNER TA, 1992, HIPPOCAMPUS, V2, P107, DOI 10.1002/hipo.450020204; Murray AJ, 2011, NAT NEUROSCI, V14, P297, DOI 10.1038/nn.2751; Papatheodoropoulos C, 1996, EUR J NEUROSCI, V8, P510, DOI 10.1111/j.1460-9568.1996.tb01235.x; Patrylo PR, 2007, PROG BRAIN RES, V163, P679, DOI 10.1016/S0079-6123(07)63037-4; Patrylo PR, 1999, J NEUROPHYSIOL, V82, P478, DOI 10.1152/jn.1999.82.1.478; Potier B, 2006, NEUROSCIENCE, V142, P187, DOI 10.1016/j.neuroscience.2006.06.040; Redrobe JP, 1999, BRAIN RES, V848, P153, DOI 10.1016/S0006-8993(99)02119-8; Rodrigo C, 2010, J NEUROCHEM, V113, P615, DOI 10.1111/j.1471-4159.2010.06633.x; Scharfman HE, 2002, EXP NEUROL, V174, P201, DOI 10.1006/exnr.2002.7869; Schwaller B, 2004, MOL CELL NEUROSCI, V25, P650, DOI 10.1016/j.mcn.2003.12.006; Shetty AK, 1998, J COMP NEUROL, V394, P252; Shetty AK, 2009, J CELL MOL MED, V13, P2408, DOI 10.1111/j.1582-4934.2009.00675.x; Shi L, 2004, J COMP NEUROL, V478, P282, DOI 10.1002/cne.20303; Sloviter RS, 2003, J COMP NEUROL, V459, P44, DOI 10.1002/cne.10630; SLOVITER RS, 1987, SCIENCE, V235, P73, DOI 10.1126/science.2879352; SPERK G, 1994, PROG NEUROBIOL, V42, P1, DOI 10.1016/0301-0082(94)90019-1; Sperk G, 2007, PROG BRAIN RES, V163, P285, DOI 10.1016/S0079-6123(07)63017-9; Spreafico R, 2000, EPILEPSIA, V41, pS168, DOI 10.1111/j.1528-1157.2000.tb01576.x; Stanley DP, 2004, J NEUROCHEM, V89, P204, DOI 10.1111/j.1471-4159.2004.02318.x; Sundstrom LE, 2001, BRAIN, V124, P688, DOI 10.1093/brain/124.4.688; Treiman DM, 2001, EPILEPSIA, V42, P8, DOI 10.1046/j.1528-1157.2001.042suppl.3008.x; Vela J, 2003, J NEUROCHEM, V85, P368, DOI 10.1046/j.1471-4159.2003.01681.x; Vezzani A, 1999, TRENDS NEUROSCI, V22, P25, DOI 10.1016/S0166-2236(98)01284-3; Wallace H, 1998, LANCET, V352, P1970, DOI 10.1016/S0140-6736(98)04512-7; WEISS JH, 1990, NEUROLOGY, V40, P1288, DOI 10.1212/WNL.40.8.1288	63	53	55	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2011	6	9							e24493	10.1371/journal.pone.0024493	http://dx.doi.org/10.1371/journal.pone.0024493			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817QP	21915341	gold, Green Submitted, Green Published			2022-12-25	WOS:000294689200048
J	Llewellyn, AC; Jones, CL; Napier, BA; Bina, JE; Weiss, DS				Llewellyn, Anna C.; Jones, Crystal L.; Napier, Brooke A.; Bina, James E.; Weiss, David S.			Macrophage Replication Screen Identifies a Novel Francisella Hydroperoxide Resistance Protein Involved in Virulence	PLOS ONE			English	Article							TULARENSIS SCHU S4; VIVO-INDUCED GENE; OXIDATIVE STRESS; REACTIVE NITROGEN; NADPH OXIDASE; FUNCTIONAL-CHARACTERIZATION; INTRACELLULAR REPLICATION; INTRAMACROPHAGE GROWTH; ALLELIC REPLACEMENT; PROTECTIVE IMMUNITY	Francisella tularensis is a Gram-negative facultative intracellular pathogen and the causative agent of tularemia. Recently, genome-wide screens have identified Francisella genes required for virulence in mice. However, the mechanisms by which most of the corresponding proteins contribute to pathogenesis are still largely unknown. To further elucidate the roles of these virulence determinants in Francisella pathogenesis, we tested whether each gene was required for replication of the model pathogen F. novicida within macrophages, an important virulence trait. Fifty-three of the 224 genes tested were involved in intracellular replication, including many of those within the Francisella pathogenicity island (FPI), validating our results. Interestingly, over one third of the genes identified are annotated as hypothetical, indicating that F. novicida likely utilizes novel virulence factors for intracellular replication. To further characterize these virulence determinants, we selected two hypothetical genes to study in more detail. As predicted by our screen, deletion mutants of FTN_0096 and FTN_1133 were attenuated for replication in macrophages. The mutants displayed differing levels of attenuation in vivo, with the FTN_1133 mutant being the most attenuated. FTN_1133 has sequence similarity to the organic hydroperoxide resistance protein Ohr, an enzyme involved in the bacterial response to oxidative stress. We show that FTN_1133 is required for F. novicida resistance to, and degradation of, organic hydroperoxides as well as resistance to the action of the NADPH oxidase both in macrophages and mice. Furthermore, we demonstrate that F. holarctica LVS, a strain derived from a highly virulent human pathogenic species of Francisella, also requires this protein for organic hydroperoxide resistance as well as replication in macrophages and mice. This study expands our knowledge of Francisella's largely uncharacterized intracellular lifecycle and demonstrates that FTN_1133 is an important novel mediator of oxidative stress resistance.	[Llewellyn, Anna C.; Jones, Crystal L.; Napier, Brooke A.] Emory Univ, Dept Microbiol & Immunol, Microbiol & Mol Genet Program, Atlanta, GA 30322 USA; [Llewellyn, Anna C.; Jones, Crystal L.; Napier, Brooke A.; Weiss, David S.] Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Bina, James E.] Univ Tennessee, Ctr Hlth Sci, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA; [Weiss, David S.] Emory Univ, Dept Med, Div Infect Dis, Atlanta, GA 30322 USA	Emory University; Emory University; University of Tennessee System; University of Tennessee Health Science Center; Emory University	Llewellyn, AC (corresponding author), Emory Univ, Dept Microbiol & Immunol, Microbiol & Mol Genet Program, Atlanta, GA 30322 USA.	david.weiss@emory.edu	Napier, Brooke A/H-5600-2019	Llewellyn, Anna/0000-0001-6712-7477	NIH from the Southeastern Regional Center of Excellence for Emerging Infections and Biodefense [U54 AI057157]; NIH [5R21AI079482-02]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI079482, U54AI057157] Funding Source: NIH RePORTER	NIH from the Southeastern Regional Center of Excellence for Emerging Infections and Biodefense; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project described was supported by NIH grant #U54 AI057157 (to DSW) from the Southeastern Regional Center of Excellence for Emerging Infections and Biodefense. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. This work was also supported by NIH grant 5R21AI079482-02 (to JEB).	AHLUND MK, 2010, INFECT IMMUN; AKAIKE T, 1992, ARCH BIOCHEM BIOPHYS, V294, P55, DOI 10.1016/0003-9861(92)90136-K; Allen LAH, 2007, IMMUNOL REV, V219, P103, DOI 10.1111/j.1600-065X.2007.00544.x; ANTHONY LSD, 1991, J GEN MICROBIOL, V137, P2697, DOI 10.1099/00221287-137-12-2697; ASARE R, 2010, ENV MICROBIOL; Atichartpongkul S, 2001, MICROBIOL-SGM, V147, P1775, DOI 10.1099/00221287-147-7-1775; BAKER CN, 1985, J CLIN MICROBIOL, V22, P212, DOI 10.1128/JCM.22.2.212-215.1985; Bakshi CS, 2008, VACCINE, V26, P5276, DOI 10.1016/j.vaccine.2008.07.051; Bakshi CS, 2006, J BACTERIOL, V188, P6443, DOI 10.1128/JB.00266-06; Barker JR, 2009, MOL MICROBIOL, V74, P1459, DOI 10.1111/j.1365-2958.2009.06947.x; Baron GS, 1998, MOL MICROBIOL, V29, P247, DOI 10.1046/j.1365-2958.1998.00926.x; Beckett D, 2007, ANNU REV GENET, V41, P443, DOI 10.1146/annurev.genet.41.042007.170450; BELL BL, 2010, INFECT IMMUN; Bina XR, 2008, FEMS MICROBIOL LETT, V279, P226, DOI 10.1111/j.1574-6968.2007.01033.x; Brotcke A, 2006, INFECT IMMUN, V74, P6642, DOI 10.1128/IAI.01250-06; CHAMBERL.RE, 1965, APPL MICROBIOL, V13, P232, DOI 10.1128/AEM.13.2.232-235.1965; Chong A, 2008, INFECT IMMUN, V76, P5488, DOI 10.1128/IAI.00682-08; Chuchue T, 2006, J BACTERIOL, V188, P842, DOI 10.1128/JB.188.3.842-851.2006; Clarridge JE, 1996, J CLIN MICROBIOL, V34, P1995, DOI 10.1128/JCM.34.8.1995-2000.1996; Clemens DL, 2007, ANN NY ACAD SCI, V1105, P160, DOI 10.1196/annals.1409.001; Cong Y, 2009, VACCINE, V27, P5554, DOI 10.1016/j.vaccine.2009.07.034; Conlan JW, 2007, ANN NY ACAD SCI, V1105, P325, DOI 10.1196/annals.1409.012; Conlan JW, 2010, VACCINE, V28, P1824, DOI 10.1016/j.vaccine.2009.12.001; Craven RR, 2008, INFECT IMMUN, V76, P2833, DOI 10.1128/IAI.00043-08; Cussiol JRR, 2010, J BIOL CHEM, V285, P21943, DOI 10.1074/jbc.M110.117283; Darling RG, 2002, EMERG MED CLIN N AM, V20, P273, DOI 10.1016/S0733-8627(02)00005-6; de Bruin OM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-1; Deng K, 2006, INFECT IMMUN, V74, P4224, DOI 10.1128/IAI.01975-05; DIEPPEDALE J, 2011, INFECT IMMUN; Dorsey CW, 2006, PLASMID, V56, P112, DOI 10.1016/j.plasmid.2006.01.004; Dringen R, 1998, GLIA, V23, P139, DOI 10.1002/(SICI)1098-1136(199806)23:2<139::AID-GLIA5>3.0.CO;2-1; Dubbs James M., 2007, V44, P143; Frank DW, 2007, ANN NY ACAD SCI, V1105, P67, DOI 10.1196/annals.1409.008; Fuangthong M, 2001, J BACTERIOL, V183, P4134, DOI 10.1128/JB.183.14.4134-4141.2001; FUJITA H, 1993, MICROBIOL IMMUNOL, V37, P837, DOI 10.1111/j.1348-0421.1993.tb01713.x; Gallagher LA, 2008, J BACTERIOL, V190, P7830, DOI 10.1128/JB.01188-08; Gallagher LA, 2007, P NATL ACAD SCI USA, V104, P1009, DOI 10.1073/pnas.0606713104; Girotti AW, 1998, J LIPID RES, V39, P1529; Golovliov I, 2003, FEMS MICROBIOL LETT, V222, P273, DOI 10.1016/S0378-1097(03)00313-6; Gray CG, 2002, FEMS MICROBIOL LETT, V215, P53, DOI 10.1016/S0378-1097(02)00911-4; Guina T, 2007, J BACTERIOL, V189, P6580, DOI 10.1128/JB.00809-07; Hall JD, 2008, INFECT IMMUN, V76, P5843, DOI 10.1128/IAI.01176-08; Hall JD, 2007, INFECT IMMUN, V75, P1034, DOI 10.1128/IAI.01254-06; HALLIWELL B, 1984, LANCET, V1, P1396; HOLLIS DG, 1989, J CLIN MICROBIOL, V27, P1601, DOI 10.1128/JCM.27.7.1601-1608.1989; Horzempa J, 2010, INFECT IMMUN, V78, P2607, DOI 10.1128/IAI.00134-10; Jenkins C, 2008, J BACTERIOL, V190, P2206, DOI 10.1128/JB.01685-07; Kadzhaev K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005463; Kanistanon D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040024; Keim P, 2007, ANN NY ACAD SCI, V1105, P30, DOI 10.1196/annals.1409.011; Kiss K, 2008, FEMS MICROBIOL LETT, V285, P270, DOI 10.1111/j.1574-6968.2008.01237.x; Kraemer PS, 2009, INFECT IMMUN, V77, P232, DOI 10.1128/IAI.00978-08; KUOLEE R, 2011, MICROBES INFECT; Lai XH, 2004, MICROB PATHOGENESIS, V37, P225, DOI 10.1016/j.micpath.2004.07.002; Lauriano CM, 2004, P NATL ACAD SCI USA, V101, P4246, DOI 10.1073/pnas.0307690101; LEE RK, 2011, MICROBES INFECT; Lenco J, 2005, FEMS MICROBIOL LETT, V246, P47, DOI 10.1016/j.femsle.2005.03.040; Lesniak J, 2002, EMBO J, V21, P6649, DOI 10.1093/emboj/cdf670; Lindemann SR, 2011, INFECT IMMUN, V79, P581, DOI 10.1128/IAI.00863-10; Lindgren H, 2005, MICROBES INFECT, V7, P467, DOI 10.1016/j.micinf.2004.11.020; Lindgren H, 2004, INFECT IMMUN, V72, P7172, DOI 10.1128/IAI.72.12.7172-7182.2004; Lindgren H, 2007, INFECT IMMUN, V75, P1303, DOI 10.1128/IAI.01717-06; LoVullo ED, 2006, MICROBIOL-SGM, V152, P3425, DOI 10.1099/mic.0.29121-0; Ludu JS, 2008, J BACTERIOL, V190, P4584, DOI 10.1128/JB.00198-08; Lyons CR, 2007, ANN NY ACAD SCI, V1105, P238, DOI 10.1196/annals.1409.003; Maier TA, 2007, INFECT IMMUN, V75, P5376, DOI 10.1128/IAI.00238-07; Mariathasan S, 2005, J EXP MED, V202, P1043, DOI 10.1084/jem.20050977; McCaffrey RL, 2006, J LEUKOCYTE BIOL, V80, P1224, DOI 10.1189/jlb.0406287; McCaffrey RL, 2010, J LEUKOCYTE BIOL, V88, P791, DOI 10.1189/jlb.1209811; Meibom KL, 2008, MOL MICROBIOL, V67, P1384, DOI 10.1111/j.1365-2958.2008.06139.x; Melillo AA, 2009, J BACTERIOL, V191, P6447, DOI 10.1128/JB.00534-09; Mohapatra NP, 2010, J IMMUNOL, V184, P5141, DOI 10.4049/jimmunol.0903413; Mongkolsuk S, 1998, J BACTERIOL, V180, P2636, DOI 10.1128/JB.180.10.2636-2643.1998; MOSLEN MT, 1994, ADV EXP MED BIOL, V366, P17; Moule MG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001065; Nano FE, 2007, ANN NY ACAD SCI, V1105, P122, DOI 10.1196/annals.1409.000; Nigrovic LE, 2008, INFECT DIS CLIN N AM, V22, P489, DOI 10.1016/j.idc.2008.03.004; Ochsner UA, 2001, J BACTERIOL, V183, P773, DOI 10.1128/JB.183.2.773-778.2001; Ochsner UA, 2000, J BACTERIOL, V182, P4533, DOI 10.1128/JB.182.16.4533-4544.2000; Oliveira MA, 2006, J MOL BIOL, V359, P433, DOI 10.1016/j.jmb.2006.03.054; Oyston PCF, 2008, J MED MICROBIOL, V57, P921, DOI 10.1099/jmm.0.2008/000653-0; Parsonage D, 2008, P NATL ACAD SCI USA, V105, P8209, DOI 10.1073/pnas.0708308105; Payne Shelley M., 1993, Trends in Microbiology, V1, P66, DOI 10.1016/0966-842X(93)90036-Q; Pechous R, 2006, INFECT IMMUN, V74, P4452, DOI 10.1128/IAI.00666-06; Pelegrin P, 2008, J IMMUNOL, V180, P7147, DOI 10.4049/jimmunol.180.11.7147; Qin AP, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-69; Quarry JE, 2007, VACCINE, V25, P2011, DOI 10.1016/j.vaccine.2006.11.054; Ramakrishnan G, 2008, J BACTERIOL, V190, P5353, DOI 10.1128/JB.00181-08; Raynaud C, 2007, INFECT IMMUN, V75, P536, DOI 10.1128/IAI.01429-06; Read A, 2008, J MED ENTOMOL, V45, P1108, DOI 10.1603/0022-2585(2008)45[1108:FGRFRI]2.0.CO;2; Renato J, 2003, J BIOL CHEM, V278, P11570, DOI 10.1074/jbc.M300252200; Rengarajan J, 2008, P NATL ACAD SCI USA, V105, P264, DOI 10.1073/pnas.0710601105; Rince A, 2001, J BACTERIOL, V183, P1482, DOI 10.1128/JB.183.4.1482-1488.2001; Rodriguez SA, 2009, METHODS, V49, P270, DOI 10.1016/j.ymeth.2009.04.011; Rohmer L, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r102; Saikolappan S, 2009, J BACTERIOL, V191, P6675, DOI 10.1128/JB.01066-08; SANDSTROM G, 1988, INFECT IMMUN, V56, P1194; Santic M, 2005, CELL MICROBIOL, V7, P969, DOI 10.1111/j.1462-5822.2005.00526.x; Santic M, 2006, TRENDS MICROBIOL, V14, P37, DOI 10.1016/j.tim.2005.11.008; Santic M, 2007, CELL MICROBIOL, V9, P2391, DOI 10.1111/j.1462-5822.2007.00968.x; SASLAW S, 1961, ARCH INTERN MED, V107, P702, DOI 10.1001/archinte.1961.03620050068007; Sassetti CM, 2003, P NATL ACAD SCI USA, V100, P12989, DOI 10.1073/pnas.2134250100; Schaible ME, 2004, NAT REV MICROBIOL, V2, P946, DOI 10.1038/nrmicro1046; Schaible UE, 2002, METHOD MICROBIOL, V31, P343, DOI 10.1016/S0580-9517(02)31020-1; Schmerk CL, 2009, MICROBIOL-SGM, V155, P1498, DOI 10.1099/mic.0.025445-0; Schulert GS, 2009, INFECT IMMUN, V77, P1324, DOI 10.1128/IAI.01318-08; Shea RJ, 2002, INFECT IMMUN, V70, P794, DOI 10.1128/IAI.70.2.794-802.2002; Sjostedt A, 2007, ANN NY ACAD SCI, V1105, P1, DOI 10.1196/annals.1409.009; Splettstoesser WD, 2002, MICROSC RES TECHNIQ, V57, P441, DOI 10.1002/jemt.10098; Steele KH, 2010, J BACTERIOL, V192, P4912, DOI 10.1128/JB.00231-10; STORZ G, 1990, TRENDS GENET, V6, P363, DOI 10.1016/0168-9525(90)90278-E; Su JL, 2007, INFECT IMMUN, V75, P3089, DOI 10.1128/IAI.01865-06; Sullivan JT, 2006, J BACTERIOL, V188, P3785, DOI 10.1128/JB.00027-06; Tempel R, 2006, INFECT IMMUN, V74, P5095, DOI 10.1128/IAI.00598-06; Titball RW, 2007, ANN NY ACAD SCI, V1105, P98, DOI 10.1196/annals.1409.015; Wehrly TD, 2009, CELL MICROBIOL, V11, P1128, DOI 10.1111/j.1462-5822.2009.01316.x; Weiss DS, 2007, P NATL ACAD SCI USA, V104, P6037, DOI 10.1073/pnas.0609675104; Wolfram TJ, 2009, FEMS IMMUNOL MED MIC, V57, P59, DOI 10.1111/j.1574-695X.2009.00579.x	118	39	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2011	6	9							e24201	10.1371/journal.pone.0024201	http://dx.doi.org/10.1371/journal.pone.0024201			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817QP	21915295	Green Published, Green Submitted, gold			2022-12-25	WOS:000294689200023
J	Murrell, M; Kamm, R; Matsudaira, P				Murrell, Michael; Kamm, Roger; Matsudaira, Paul			Tension, Free Space, and Cell Damage in a Microfluidic Wound Healing Assay	PLOS ONE			English	Article							MAMMARY EPITHELIAL-CELLS; SHEAR-STRESS; E-CADHERIN; ENDOTHELIAL-CELLS; HYDROGEN-PEROXIDE; MIGRATION ASSAY; ADHESION; ACTIVATION; CLOSURE; SHEETS	We use a novel, microfluidics-based technique to deconstruct the classical wound healing scratch assay, decoupling the contribution of free space and cell damage on the migratory dynamics of an epithelial sheet. This method utilizes multiple laminar flows to selectively cleave cells enzymatically, and allows us to present a 'damage free' denudation. We therefore isolate the influence of free space on the onset of sheet migration. First, we observe denudation directly to measure the retraction in the cell sheet that occurs after cell-cell contact is broken, providing direct and quantitative evidence of strong tension within the sheet. We further probe the mechanical integrity of the sheet without denudation, instead using laminar flows to selectively inactivate actomyosin contractility. In both cases, retraction is observed over many cell diameters. We then extend this method and complement the enzymatic denudation with analogies to wounding, including gradients in signals associated with cell damage, such as reactive oxygen species, suspected to play a role in the induction of movement after wounding. These chemical factors are evaluated in combination with the enzymatic cleavage of cells, and are assessed for their influence on the collective migration of a non-abrasively denuded epithelial sheet. We conclude that free space alone is sufficient to induce movement, but this movement is predominantly limited to the leading edge, leaving cells further from the edge less able to move towards the wound. Surprisingly, when coupled with a gradient in ROS to simulate the chemical effects of abrasion however, motility was not restored, but further inhibited.	[Matsudaira, Paul] MIT, Dept Biol Engn, Whitehead Inst Biomed Res, Cambridge, MA 02139 USA; [Kamm, Roger] MIT, Dept Mech Engn, Cambridge, MA 02139 USA; [Matsudaira, Paul] MIT, Dept Biol, Whitehead Inst Biomed Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute	Murrell, M (corresponding author), Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA.	murrell@uchicago.edu	Kamm, Roger D/I-7630-2012; Matsudaira, Paul/H-1475-2012	Matsudaira, Paul/0000-0002-8399-3276; /0000-0002-7232-304X	MIT; NIH; MIT-Singapore Alliance (SMART); Massachusetts Institute of Biotechnology	MIT; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MIT-Singapore Alliance (SMART); Massachusetts Institute of Biotechnology	The authors thank the MIT Presidential Fellow program, the NIH Biotechnology Training Grant, MIT open-source funding, and the MIT-Singapore Alliance (SMART) for funding to MM. A Massachusetts Institute of Biotechnology Training Grant provided 2 years of tuition support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque MLC, 2000, AM J PHYSIOL-HEART C, V279, pH293, DOI 10.1152/ajpheart.2000.279.1.H293; ANDERSON LW, 1979, IN VITRO CELL DEV B, V15, P841, DOI 10.1007/BF02618037; ANDO J, 1987, MICROVASC RES, V33, P62, DOI 10.1016/0026-2862(87)90007-0; Angelini TE, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.168104; Block ER, 2004, J BIOL CHEM, V279, P24307, DOI 10.1074/jbc.M401058200; BRADLEY JR, 1993, AM J PATHOL, V142, P1598; BURK RR, 1973, P NATL ACAD SCI USA, V70, P369, DOI 10.1073/pnas.70.2.369; Cai H, 2005, CARDIOVASC RES, V68, P26, DOI 10.1016/j.cardiores.2005.06.021; Chien S, 2005, FRONT BIOSCI-LANDMRK, V10, P1985, DOI 10.2741/1673; Escaffit F, 2005, EXP CELL RES, V302, P206, DOI 10.1016/j.yexcr.2004.08.033; Farooqui R, 2005, J CELL SCI, V118, P51, DOI 10.1242/jcs.01577; Fenteany G, 2000, CURR BIOL, V10, P831, DOI 10.1016/S0960-9822(00)00579-0; FRIXEN UH, 1991, J CELL BIOL, V113, P173, DOI 10.1083/jcb.113.1.173; Gilles C, 1999, J CELL SCI, V112, P4615; Gordillo GM, 2003, AM J SURG, V186, P259, DOI 10.1016/S0002-9610(03)00211-3; Happel J., 1965, LOW REYNOLDS NUMBER; Heath JP, 1996, CELL BIOL INT, V20, P139, DOI 10.1006/cbir.1996.0018; Hermiston ML, 1996, GENE DEV, V10, P985, DOI 10.1101/gad.10.8.985; Hsu PP, 2001, BIOCHEM BIOPH RES CO, V285, P751, DOI 10.1006/bbrc.2001.5221; Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev; Jacinto A, 2002, DEV CELL, V3, P9, DOI 10.1016/S1534-5807(02)00208-3; Karuri NW, 2004, J CELL SCI, V117, P3153, DOI 10.1242/jcs.01146; Li S, 2005, J CELL BIOCHEM, V96, P1110, DOI 10.1002/jcb.20614; MASUDA M, 1993, BIOL CELL, V77, P237, DOI 10.1016/S0248-4900(05)80193-5; Matsubayashi Y, 2004, CURR BIOL, V14, P731, DOI 10.1016/j.cub.2004.03.060; Mege RM, 2006, CURR OPIN CELL BIOL, V18, P541, DOI 10.1016/j.ceb.2006.08.004; Mori K, 2004, CANCER RES, V64, P7464, DOI 10.1158/0008-5472.CAN-04-1725; Nguyen TD, 1999, J CLIN INVEST, V103, P261, DOI 10.1172/JCI2539; Nie FQ, 2007, BIOMATERIALS, V28, P4017, DOI 10.1016/j.biomaterials.2007.05.037; Nikolic DL, 2006, AM J PHYSIOL-CELL PH, V291, pC68, DOI 10.1152/ajpcell.00411.2005; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Omelchenko T, 2003, P NATL ACAD SCI USA, V100, P10788, DOI 10.1073/pnas.1834401100; Plomp M, 2001, J PHYS CHEM B, V105, P542, DOI 10.1021/jp003007b; Poujade M, 2007, P NATL ACAD SCI USA, V104, P15988, DOI 10.1073/pnas.0705062104; Ridge KM, 2005, J BIOL CHEM, V280, P30400, DOI 10.1074/jbc.M504239200; ROSEN P, 1980, P NATL ACAD SCI-BIOL, V77, P4760, DOI 10.1073/pnas.77.8.4760; Sen CK, 2003, WOUND REPAIR REGEN, V11, P431, DOI 10.1046/j.1524-475X.2003.11607.x; Sharma GD, 2003, J BIOL CHEM, V278, P21989, DOI 10.1074/jbc.M302650200; Sprague EA, 1997, J VASC INTERV RADIOL, V8, P83, DOI 10.1016/S1051-0443(97)70521-9; Stewart PS, 2003, J BACTERIOL, V185, P1485, DOI 10.1128/JB.185.5.1485-1491.2003; Takayama S, 1999, P NATL ACAD SCI USA, V96, P5545, DOI 10.1073/pnas.96.10.5545; Torres M, 2003, FRONT BIOSCI, V8, pD369, DOI 10.2741/999; Trepat X, 2009, NAT PHYS, V5, P426, DOI 10.1038/NPHYS1269; van der Meer AD, 2010, AM J PHYSIOL-HEART C, V298, pH719, DOI 10.1152/ajpheart.00933.2009; van Horssen R, 2006, J CELL BIOCHEM, V99, P1536, DOI 10.1002/jcb.20994; VANKOOTEN TG, 1994, MED ENG PHYS, V16, P506, DOI 10.1016/1350-4533(94)90077-9; Wechselberger C, 2001, EXP CELL RES, V266, P95, DOI 10.1006/excr.2001.5195; Yin J, 2007, J CELL SCI, V120, P815, DOI 10.1242/jcs.03389; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055; Yoon SO, 2002, J BIOL CHEM, V277, P30271, DOI 10.1074/jbc.M202647200	50	33	34	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2011	6	9							e24283	10.1371/journal.pone.0024283	http://dx.doi.org/10.1371/journal.pone.0024283			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817QP	21915305	Green Published, Green Submitted, gold			2022-12-25	WOS:000294689200030
J	Ponnusamy, L; Boroczky, K; Wesson, DM; Schal, C; Apperson, CS				Ponnusamy, Loganathan; Boeroeczky, Katalin; Wesson, Dawn M.; Schal, Coby; Apperson, Charles S.			Bacteria Stimulate Hatching of Yellow Fever Mosquito Eggs	PLOS ONE			English	Article							AEDES-AEGYPTI; DIPTERA; RESPONSES	Background: Aedes aegypti Linnaeus is a peridomestic mosquito that lays desiccation-resistant eggs in water-filled human-made containers. Previous investigations connected egg hatching with declining dissolved oxygen (DO) that is associated with bacterial growth. However, past studies failed to uncouple DO from other potential stimulatory factors and they contained little quantitative information about the microbial community; consequently, a direct role for bacteria or compounds associated with bacteria in stimulating egg hatching cannot be dismissed. Methodology/Principal Findings: Environmental factors stimulating hatch of Ae. aegypti eggs were investigated using non-sterile and sterile white oak leaf (WOL) infusions and a bacterial culture composed of a mix of 14 species originally isolated from bamboo leaf infusion. In WOL infusion with active microbes, 92.4% of eggs hatched in 2-h at an average DO concentration of 2.4 ppm. A 24-h old bacterial culture with a DO concentration of 0.73 ppm also stimulated 95.2% of eggs hatch within 1-h. In contrast, only 4.0% of eggs hatched in sterile infusion, whose DO averaged 7.4 ppm. Effects of bacteria were uncoupled from DO by exposing eggs to bacterial cells suspended in NaCl solution. Over a 4-h exposure period, 93.8% of eggs hatched while DO concentration changed minimally from 7.62 to 7.50 ppm. Removal of bacteria by ultra-filtration and cell-free filtrate resulted in only 52.0% of eggs hatching after 4-h at an average DO concentration of 5.5 ppm. Conclusions/Significance: Collectively, the results provide compelling evidence that bacteria or water-soluble compounds secreted by bacteria, not just low DO concentration, stimulate hatching of Ae. aegypti eggs. However, the specific cues involved remain to be identified. These research findings contribute new insight into an important aspect of the oviposition biology of Ae. aegypti, a virus vector of global importance, providing the basis for a new paradigm of environmental factors involved in egg hatching.	[Ponnusamy, Loganathan; Boeroeczky, Katalin; Schal, Coby; Apperson, Charles S.] N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA; [Wesson, Dawn M.] Tulane Univ, Dept Trop Med, New Orleans, LA 70118 USA	University of North Carolina; North Carolina State University; Tulane University	Ponnusamy, L (corresponding author), N Carolina State Univ, Dept Entomol, Raleigh, NC 27695 USA.	loganathan_ponnusamy@ncsu.edu	Schal, Coby/A-8717-2010	Schal, Coby/0000-0001-7195-6358; Ponnusamy, Loganathan/0000-0002-0700-4472	Bill and Melinda Gates Foundation	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Support for our research was provided by a grant to DMW, CSA and CS from the Bill and Melinda Gates Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDEL-MALEK ALBERT, 1948, ANN ENT SOC AMER, V41, P51, DOI 10.1093/aesa/41.1.51; Atkin E. E., 1917, Parasitology Cambridge, V9, DOI 10.1017/S0031182000006181; Clements AN., 1999, SENSORY RECEPTION BE; EDGERLY JS, 1992, ECOL ENTOMOL, V17, P28, DOI 10.1111/j.1365-2311.1992.tb01035.x; FALLIS SP, 1983, ECOL ENTOMOL, V8, P23, DOI 10.1111/j.1365-2311.1983.tb00478.x; Farrar J, 2007, TROP MED INT HEALTH, V12, P695, DOI [10.1111/j.1365-3156.2007.01838, 10.1111/j.1365-3156.2007.01838.x]; GILLETT JD, 1977, PROC R SOC SER B-BIO, V196, P223, DOI 10.1098/rspb.1977.0038; Gjullin CM, 1941, J CELL COMPAR PHYSL, V17, P193, DOI 10.1002/jcp.1030170205; Gjullin CM, 1939, SCIENCE, V89, P539, DOI 10.1126/science.89.2319.539-a; GUBLER DJ, 1989, AM J TROP MED HYG, V40, P571, DOI 10.4269/ajtmh.1989.40.571; Horsfall W. R., 1973, BIONOMICS EMBRYOLOGY; HORSFALL WR, 1949, SCIENCE, V110, P504, DOI 10.1126/science.110.2863.504; JUDSON CHARLES L., 1960, ANN ENT SOC AMER, V53, P688, DOI 10.1093/aesa/53.5.688; JUDSON CL, 1967, ENTOMOL EXP APPL, V10, P181, DOI 10.1007/BF00302240; LIVDAHL TP, 1984, ECOL ENTOMOL, V9, P437, DOI 10.1111/j.1365-2311.1984.tb00841.x; NOVAK RJ, 1978, MOSQ NEWS, V38, P515; Ponnusamy L, 2008, P NATL ACAD SCI USA, V105, P9262, DOI 10.1073/pnas.0802505105; Ponnusamy L, 2010, MICROB ECOL, V59, P158, DOI 10.1007/s00248-009-9565-1; REASONER DJ, 1985, APPL ENVIRON MICROB, V49, P1; ROUBAUD E, 1927, CR HEBD ACAD SCI, V184, P244; Russell BM, 2001, J MED ENTOMOL, V38, P441, DOI 10.1603/0022-2585-38.3.441; Trexler JD, 2003, J MED ENTOMOL, V40, P841, DOI 10.1603/0022-2585-40.6.841	22	52	53	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2011	6	9							e24409	10.1371/journal.pone.0024409	http://dx.doi.org/10.1371/journal.pone.0024409			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817QP	21915323	Green Submitted, gold, Green Published			2022-12-25	WOS:000294689200042
J	Kinnunen, PM; Inkeroinen, H; Ilander, M; Kallio, ER; Heikkila, HP; Koskela, E; Mappes, T; Palva, A; Vaheri, A; Kipar, A; Vapalahti, O				Kinnunen, Paula Maria; Inkeroinen, Hanna; Ilander, Mette; Kallio, Eva Riikka; Heikkila, Henna Pauliina; Koskela, Esa; Mappes, Tapio; Palva, Airi; Vaheri, Antti; Kipar, Anja; Vapalahti, Olli			Intracerebral Borna Disease Virus Infection of Bank Voles Leading to Peripheral Spread and Reverse Transcription of Viral RNA	PLOS ONE			English	Article							NERVOUS-SYSTEM; WILD RODENTS; RATS; PERSISTENT; ANTIGEN; MODEL; MICE; RESISTANCE; ANTIBODIES; APOPTOSIS	Bornaviruses, which chronically infect many species, can cause severe neurological diseases in some animal species; their association with human neuropsychiatric disorders is, however, debatable. The epidemiology of Borna disease virus (BDV), as for other members of the family Bornaviridae, is largely unknown, although evidence exists for a reservoir in small mammals, for example bank voles (Myodes glareolus). In addition to the current exogenous infections and despite the fact that bornaviruses have an RNA genome, bornavirus sequences integrated into the genomes of several vertebrates millions of years ago. Our hypothesis is that the bank vole, a common wild rodent species in traditional BDV-endemic areas, can serve as a viral host; we therefore explored whether this species can be infected with BDV, and if so, how the virus spreads and whether viral RNA is transcribed into DNA in vivo. We infected neonate bank voles intracerebrally with BDV and euthanized them 2 to 8 weeks post-infection. Specific Ig antibodies were detectable in 41%. Histological evaluation revealed no significant pathological alterations, but BDV RNA and antigen were detectable in all infected brains. Immunohistology demonstrated centrifugal spread throughout the nervous tissue, because viral antigen was widespread in peripheral nerves and ganglia, including the mediastinum, esophagus, and urinary bladder. This was associated with viral shedding in feces, of which 54% were BDV RNA-positive, and urine at 17%. BDV nucleocapsid gene DNA occurred in 66% of the infected voles, and, surprisingly, occasionally also phosphoprotein DNA. Thus, intracerebral BDV infection of bank vole led to systemic infection of the nervous tissue and viral excretion, as well as frequent reverse transcription of the BDV genome, enabling genomic integration. This first experimental bornavirus infection in wild mammals confirms the recent findings regarding bornavirus DNA, and suggests that bank voles are capable of bornavirus transmission.	[Kinnunen, Paula Maria; Inkeroinen, Hanna; Ilander, Mette; Heikkila, Henna Pauliina; Palva, Airi; Vapalahti, Olli] Univ Helsinki, Dept Vet Biosci, Fac Vet Med, Helsinki, Finland; [Kinnunen, Paula Maria; Ilander, Mette; Vaheri, Antti; Vapalahti, Olli] Univ Helsinki, Dept Virol, Haartman Inst, Helsinki, Finland; [Kallio, Eva Riikka; Koskela, Esa; Mappes, Tapio] Univ Jyvaskyla, Ctr Excellence Evolutionary Res, Jyvaskyla, Finland; [Kallio, Eva Riikka] Univ Liverpool, Dept Evolut Ecol & Behav, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England; [Vaheri, Antti; Vapalahti, Olli] Univ Helsinki, Cent Hosp, HUSLAB, Helsinki, Finland; [Kipar, Anja] Univ Helsinki, Finnish Ctr Lab Anim Pathol, Fac Vet Med, Helsinki, Finland; [Kipar, Anja] Univ Liverpool, Sch Vet Sci, Liverpool L69 3BX, Merseyside, England	University of Helsinki; University of Helsinki; University of Jyvaskyla; University of Liverpool; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Liverpool	Kinnunen, PM (corresponding author), Finnish Def Forces, Ctr Mil Med, Helsinki, Finland.	Paula.Kinnunen@helsinki.fi	Kipar, Anja/L-7214-2014; Mappes, Tapio/B-9780-2013; Vaheri, Antti/AAV-1523-2020	Kipar, Anja/0000-0001-7289-3459; Vapalahti, Olli/0000-0003-2270-6824; Mappes, Tapio/0000-0002-5936-7355; Koskela, Esa/0000-0002-9418-5733	University of Helsinki; Finnish Graduate School on Applied Bioscience; Finnish Veterinary Foundation; HUS-EVO grant [TYH2008309]; Research Foundation of the University of Helsinki [TA 715321, 2103039]; Finnish Foundation for Veterinary Sciences; Orion Farmos Foundation for Research and Science; Emil Aaltonen Foundation; Finnish Foundation for Research on Viral Diseases	University of Helsinki; Finnish Graduate School on Applied Bioscience; Finnish Veterinary Foundation; HUS-EVO grant; Research Foundation of the University of Helsinki; Finnish Foundation for Veterinary Sciences; Orion Farmos Foundation for Research and Science; Emil Aaltonen Foundation; Finnish Foundation for Research on Viral Diseases(Finnish IT center for science)	This project was funded by the University of Helsinki (www.helsinki.fi/university/index.html), the Finnish Graduate School on Applied Bioscience (www.vetmed.helsinki.fi/abs/), the Finnish Veterinary Foundation (www.etts.fi). The project was supported by the HUS-EVO grant TYH2008309 (www.hus.fi/default.asp?path = 1,28,2530,15595,2539), the Research Foundation of the University of Helsinki grant TA 715321 (project 2103039) (www.helsinki.fi/tiedesaatio/english/index.htm), the Finnish Foundation for Veterinary Sciences (www.sell.fi/elainlaakariliitto/linkkeja_ja_tietolahteita/suomen_elainlaaketieteen_saatio_/), the Orion Farmos Foundation for Research and Science (http://www.orion.fi/Tutkimus-ja-tuotekehitys/Orion-Farmos-Tutkimussaatio/),the Emil Aaltonen Foundation (www.emilaaltonen.fi/brieflyeng.html) and the Finnish Foundation for Research on Viral Diseases (www.virustauti.fi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann A, 2010, J VIROL, V84, P5438, DOI 10.1128/JVI.00098-10; Amori G., 2006, MYODES GLAREOLUS IUC, P5; ANZIL AP, 1973, ARCH GES VIRUSFORSCH, V40, P52, DOI 10.1007/BF01242635; BAUTISTA JR, 1994, BRAIN RES BULL, V34, P31, DOI 10.1016/0361-9230(94)90183-X; Belyi VA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001030; Berg AL, 1998, VET REC, V142, P715, DOI 10.1136/vr.142.26.715; Bode L, 2008, APMIS, V116, P21, DOI 10.1111/j.1600-0463.2008.000m3.x; Chalmers RM, 2005, QJM-INT J MED, V98, P255, DOI 10.1093/qjmed/hci039; CUBITT B, 1994, J VIROL, V68, P1382, DOI 10.1128/JVI.68.3.1382-1396.1994; Dauphin G, 2001, J GEN VIROL, V82, P2199, DOI 10.1099/0022-1317-82-9-2199; De Lahunta A., 2015, VET NEUROANATOMY CLI, P214; Dean AG, 2009, OPENEPI OPEN SOURCE; Degiorgis MP, 2000, J CLIN MICROBIOL, V38, P3087, DOI 10.1128/JCM.38.8.3087-3091.2000; DelaTorre JC, 1996, VIROLOGY, V223, P272, DOI 10.1006/viro.1996.0479; DELATORRE JC, 2002, INT COMMITTEE TAXONO; Durrwald R, 2007, REV MED VIROL, V17, P181, DOI 10.1002/rmv.530; Durrwald R, 2006, MICROBES INFECT, V8, P917, DOI 10.1016/j.micinf.2005.08.013; Durrwald R, 1997, J VET MED B, V44, P147, DOI 10.1111/j.1439-0450.1997.tb00962.x; Enbergs HK, 2001, J NEUROVIROL, V7, P272; Furrer E, 2001, J VIROL, V75, P11700, DOI 10.1128/JVI.75.23.11700-11708.2001; Grabner A, 1991, Tierarztl Prax, V19, P68; HAAS B, 1986, J GEN VIROL, V67, P235, DOI 10.1099/0022-1317-67-2-235; Hallensleben W, 1998, J VIROL, V72, P4379, DOI 10.1128/JVI.72.5.4379-4386.1998; Hardestam J, 2008, EMERG INFECT DIS, V14, P1209, DOI 10.3201/eid1408.080221; Heinrich A, 2010, PSYCHIAT CLIN NEUROS, V64, P255, DOI 10.1111/j.1440-1819.2010.02073.x; HERZOG S, 1991, J GEN VIROL, V72, P535, DOI 10.1099/0022-1317-72-3-535; Hilbe M, 2006, EMERG INFECT DIS, V12, P675, DOI 10.3201/eid1204.051418; HIRANO N, 1983, J GEN VIROL, V64, P1521, DOI 10.1099/0022-1317-64-7-1521; Horie M, 2010, NATURE, V463, P84, DOI 10.1038/nature08695; Hornig M, 1999, P NATL ACAD SCI USA, V96, P12102, DOI 10.1073/pnas.96.21.12102; Ikuta Kazuyoshi, 2002, P87; Jakob S, 2008, METHODS, V44, P255, DOI 10.1016/j.ymeth.2007.11.004; Johansson M, 2002, VET IMMUNOL IMMUNOP, V90, P23, DOI 10.1016/S0165-2427(02)00226-X; Kallio ER, 2009, EPIDEMICS-NETH, V1, P101, DOI 10.1016/j.epidem.2009.03.002; KAO M, 1984, J GEN VIROL, V65, P1845, DOI 10.1099/0022-1317-65-10-1845; Kinnunen PM, 2007, J CLIN VIROL, V38, P64, DOI 10.1016/j.jcv.2006.10.003; Kistler AL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-88; Kolodziejek J, 2005, J GEN VIROL, V86, P385, DOI 10.1099/vir.0.80587-0; Lancaster K, 2007, BEHAV BRAIN RES, V176, P141, DOI 10.1016/j.bbr.2006.06.013; Lebelt J, 1996, BERL MUNCH TIERARZTL, V109, P178; Lydersen S, 2009, STAT MED, V28, P1159, DOI 10.1002/sim.3531; Mavtchoutko V, 2000, J MED VIROL, V60, P216, DOI 10.1002/(SICI)1096-9071(200002)60:2&lt;216::AID-JMV18&gt;3.0.CO;2-Z; MORALES JA, 1988, MED MICROBIOL IMMUN, V177, P51; Moritoh K, 2009, JPN J VET RES, V57, P89; NARAYAN O, 1983, SCIENCE, V220, P1401, DOI 10.1126/science.6602380; Olsson GE, 2010, VECTOR-BORNE ZOONOT, V10, P549, DOI 10.1089/vbz.2009.0138; PASCALE E, 1993, J MOL EVOL, V36, P9, DOI 10.1007/BF02407302; Patti AM, 2008, APMIS, V116, P70, DOI 10.1111/j.1600-0463.2008.00m12.x; Planz O, 2009, CELL MICROBIOL, V11, P872, DOI 10.1111/j.1462-5822.2009.01310.x; Pletnikov Mikhail V., 2002, P125; Prat CMA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000425; Puorger ME, 2010, VET PATHOL, V47, P236, DOI 10.1177/0300985809351849; Ritter M, 2000, J GEN VIROL, V81, P2683, DOI 10.1099/0022-1317-81-11-2683; RUBIN SA, 1993, J VIROL, V67, P548, DOI 10.1128/JVI.67.1.548-552.1993; Sauder C, 2003, J VIROL, V77, P12886, DOI 10.1128/JVI.77.23.12886-12890.2003; SHANKAR V, 1992, J VIROL, V66, P992, DOI 10.1128/JVI.66.2.992-998.1992; SIERRAHONIGMANN AM, 1993, J NEUROIMMUNOL, V45, P31, DOI 10.1016/0165-5728(93)90160-Z; Staeheli P, 2000, J GEN VIROL, V81, P2123, DOI 10.1099/0022-1317-81-9-2123; Stitz L, 1998, J VIROL, V72, P8884, DOI 10.1128/JVI.72.11.8884-8892.1998; Thakur R, 2009, INDIAN J MED MICROBI, V27, P191, DOI 10.4103/0255-0857.53200; Tonteri E, 2011, EMERG INFECT DIS, V17, P72, DOI 10.3201/eid1701.100051; Vahlenkamp TW, 2002, J VIROL, V76, P9735, DOI 10.1128/JVI.76.19.9735-9743.2002; Volmer R, 2007, J VIROL, V81, P8833, DOI 10.1128/JVI.00612-07; Watanabe M, 2000, MICROBIOL IMMUNOL, V44, P765, DOI 10.1111/j.1348-0421.2000.tb02561.x; Watanabe M, 2001, VIROLOGY, V282, P65, DOI 10.1006/viro.2001.0813; Weissenbock H, 2000, BRAIN PATHOL, V10, P260, DOI 10.1111/j.1750-3639.2000.tb00259.x; Wensman JJ, 2007, J VIROL METHODS, V143, P1, DOI 10.1016/j.jviromet.2007.01.034; Williams BL, 2007, J VIROL, V81, P2675, DOI 10.1128/JVI.02245-06; Wolff T, 2006, J CLIN VIROL, V36, P309, DOI 10.1016/j.jcv.2006.05.005; Zocher M, 2000, J NEUROVIROL, V6, P462, DOI 10.3109/13550280009091947	70	17	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2011	6	8							e23622	10.1371/journal.pone.0023622	http://dx.doi.org/10.1371/journal.pone.0023622			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	811XK	21935357	Green Published, Green Submitted, gold			2022-12-25	WOS:000294251800017
J	Nguyen, TT; Stevens, MV; Kohr, M; Steenbergen, C; Sack, MN; Murphy, E				Nguyen, Tiffany T.; Stevens, Mark V.; Kohr, Mark; Steenbergen, Charles; Sack, Michael N.; Murphy, Elizabeth			Cysteine 203 of Cyclophilin D Is Critical for Cyclophilin D Activation of the Mitochondrial Permeability Transition Pore	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENINE-NUCLEOTIDE TRANSLOCASE; CYTOCHROME-C RELEASE; S-NITROSYLATION; NITRIC-OXIDE; CELL-DEATH; ISCHEMIA-REPERFUSION; OXIDATIVE STRESS; CARDIOPROTECTION; INJURY; RAT	The mitochondrial permeability transition pore (mPTP) opening plays a critical role in mediating cell death during ischemia/reperfusion (I/R) injury. Our previous studies have shown that cysteine 203 of cyclophilin D(CypD), a critical mPTP mediator, undergoes protein S-nitrosylation (SNO). To investigate the role of cysteine 203 in mPTP activation, we mutated cysteine 203 of CypD to a serine residue (C203S) and determined its effect on mPTP opening. Treatment of WT mouse embryonic fibroblasts (MEFs) with H2O2 resulted in an 50% loss of the mitochondrial calcein fluorescence, suggesting substantial activation of the mPTP. Consistent with the reported role of CypD in mPTP activation, CypD null (CypD(-/-)) MEFs exhibited significantly less mPTP opening. Addition of a nitric oxide donor, GSNO, to WT but not CypD(-/-) MEFs prior to H2O2 attenuated mPTP opening. To test whether Cys-203 is required for this protection, we infected CypD(-/-) MEFs with a C203S-CypD vector. Surprisingly, C203S-CypD reconstituted MEFs were resistant to mPTP opening in the presence or absence of GSNO, suggesting a crucial role for Cys-203 in mPTP activation. To determine whether mutation of C203S-CypD would alter mPTP in vivo, we injected a recombinant adenovirus encoding C203S-CypD or WT CypD into CypD(-/-) mice via tail vein. Mitochondria isolated from livers of CypD(-/-) mice or mice expressing C203S-CypD were resistant to Ca2+ -induced swelling as compared with WT CypD-reconstituted mice. Our results indicate that the Cys-203 residue of CypD is necessary for redox stress-induced activation of mPTP.	[Nguyen, Tiffany T.; Kohr, Mark; Murphy, Elizabeth] NHLBI, Syst Biol Ctr, NIH, Bethesda, MD 20892 USA; [Stevens, Mark V.; Sack, Michael N.] NHLBI, Ctr Mol Med, NIH, Bethesda, MD 20892 USA; [Kohr, Mark; Steenbergen, Charles] Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21257 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Johns Hopkins University	Murphy, E (corresponding author), NHLBI, Syst Biol Ctr, NIH, Bldg 10-8N202,10 Ctr Dr, Bethesda, MD 20892 USA.	murphy1@nhlbi.nih.gov	Nguyen, Tiffany/HGD-2431-2022		National Institutes of Health [Z01HL006059, Z01HL002066, 1F32HL096142, 5R01HL039752]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005102] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants Z01HL006059 and Z01HL002066 (to T. T. N. and E. M.), 1F32HL096142 (to M. K.) and 5R01HL039752 (to C. S.).	Atar S, 2006, AM J PHYSIOL-HEART C, V290, pH1960, DOI 10.1152/ajpheart.01137.2005; Baines CP, 2007, AM J PHYSIOL-HEART C, V293, pH903, DOI 10.1152/ajpheart.00575.2007; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Bernardi P, 1996, J BIOENERG BIOMEMBR, V28, P131, DOI 10.1007/BF02110643; Brookes PS, 2000, J BIOL CHEM, V275, P20474, DOI 10.1074/jbc.M001077200; Burwell LS, 2008, ANTIOXID REDOX SIGN, V10, P579, DOI 10.1089/ars.2007.1845; Burwell LS, 2006, BIOCHEM J, V394, P627, DOI 10.1042/BJ20051435; Chernyak BV, 1997, BIOSCIENCE REP, V17, P293, DOI 10.1023/A:1027384628678; Costantini P, 1996, J BIOL CHEM, V271, P6746, DOI 10.1074/jbc.271.12.6746; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Cruz TS, 2010, BIOCHEM PHARMACOL, V80, P1284, DOI 10.1016/j.bcp.2010.06.052; Devalaraja-Narashimha K, 2009, AM J PHYSIOL-RENAL, V297, pF749, DOI 10.1152/ajprenal.00239.2009; Feldkamp T, 2005, AM J PHYSIOL-RENAL, V288, pF1092, DOI 10.1152/ajprenal.00443.2004; GRIFFITHS EJ, 1993, J MOL CELL CARDIOL, V25, P1461, DOI 10.1006/jmcc.1993.1162; Halestrap AP, 2009, J MOL CELL CARDIOL, V46, P821, DOI 10.1016/j.yjmcc.2009.02.021; Halestrap AP, 1997, J BIOL CHEM, V272, P3346, DOI 10.1074/jbc.272.6.3346; Kohr MJ, 2011, AM J PHYSIOL-HEART C, V300, pH1327, DOI 10.1152/ajpheart.00997.2010; Kohr MJ, 2011, CIRC RES, V108, P418, DOI 10.1161/CIRCRESAHA.110.232173; Kowaltowski AJ, 1996, FEBS LETT, V378, P150, DOI 10.1016/0014-5793(95)01449-7; Lin J, 2009, CIRCULATION, V120, P245, DOI 10.1161/CIRCULATIONAHA.109.868729; Linard D, 2009, ARCH BIOCHEM BIOPHYS, V491, P39, DOI 10.1016/j.abb.2009.09.002; Maejima Y, 2005, J MOL CELL CARDIOL, V38, P163, DOI 10.1016/j.yjmcc.2004.10.012; Matsumoto S, 1999, J CEREBR BLOOD F MET, V19, P736, DOI 10.1097/00004647-199907000-00002; McStay GP, 2002, BIOCHEM J, V367, P541, DOI 10.1042/BJ20011672; Morin D, 2004, BIOCHEM PHARMACOL, V68, P2065, DOI 10.1016/j.bcp.2004.07.006; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Pagliaro P, 2011, ANTIOXID REDOX SIGN, V14, P833, DOI 10.1089/ars.2010.3245; Petronilli V, 2001, J BIOL CHEM, V276, P12030, DOI 10.1074/jbc.M010604200; PETRONILLI V, 1994, J BIOL CHEM, V269, P16638; Salet C, 1997, J BIOL CHEM, V272, P21938, DOI 10.1074/jbc.272.35.21938; Shiva S, 2007, J EXP MED, V204, P2089, DOI 10.1084/jem.20070198; Sun JH, 2007, CIRC RES, V101, P1155, DOI 10.1161/CIRCRESAHA.107.155879; Sun JH, 2006, ANTIOXID REDOX SIGN, V8, P1693, DOI 10.1089/ars.2006.8.1693; Sun JH, 2010, CIRC RES, V106, P285, DOI 10.1161/CIRCRESAHA.109.209452	34	141	143	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40184	40192		10.1074/jbc.M111.243469	http://dx.doi.org/10.1074/jbc.M111.243469			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21930693	Green Published, hybrid			2022-12-25	WOS:000296925700051
J	Klippel, S; Wieczorek, M; Schumann, M; Krause, E; Marg, B; Seidel, T; Meyer, T; Knapp, EW; Freund, C				Klippel, Stefan; Wieczorek, Marek; Schuemann, Michael; Krause, Eberhard; Marg, Berenice; Seidel, Thorsten; Meyer, Tim; Knapp, Ernst-Walter; Freund, Christian			Multivalent Binding of Formin-binding Protein 21 (FBP21)-Tandem-WW Domains Fosters Protein Recognition in the Pre-spliceosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TANDEM WW DOMAINS; LIGAND RECOGNITION; BACKBONE DYNAMICS; REDOX POTENTIALS; NMR-SPECTROSCOPY; SH3 DOMAINS; GYF DOMAIN; RNA; IDENTIFICATION; SPECIFICITY	The high abundance of repetitive but nonidentical proline-rich sequences in spliceosomal proteins raises the question of how these known interaction motifs recruit their interacting protein domains. Whereas complex formation of these adaptors with individual motifs has been studied in great detail, little is known about the binding mode of domains arranged in tandem repeats and long proline-rich sequences including multiple motifs. Here we studied the interaction of the two adjacent WW domains of spliceosomal protein FBP21 with several ligands of different lengths and composition to elucidate the hallmarks of multivalent binding for this class of recognition domains. First, we show that many of the proteins that define the cellular proteome interacting with FBP21-WW1-WW2 contain multiple proline-rich motifs. Among these is the newly identified binding partner SF3B4. Fluorescence resonance energy transfer (FRET) analysis reveals the tandem-WW domains of FBP21 to interact with splicing factor 3B4 (SF3B4) in nuclear speckles where splicing takes place. Isothermal titration calorimetry and NMR shows that the tandem arrangement of WW domains and the multivalency of the proline-rich ligands both contribute to affinity enhancement. However, ligand exchange remains fast compared with the NMR time scale. Surprisingly, a N-terminal spin label attached to a bivalent ligand induces NMR line broadening of signals corresponding to both WW domains of the FBP21-WW1-WW2 protein. This suggests that distinct orientations of the ligand contribute to a delocalized and semispecific binding mode that should facilitate search processes within the spliceosome.	[Klippel, Stefan; Wieczorek, Marek; Freund, Christian] Leibniz Inst Mol Pharmacol, Prot Engn Grp, D-13125 Berlin, Germany; [Klippel, Stefan; Wieczorek, Marek; Freund, Christian] Free Univ Berlin, D-13125 Berlin, Germany; [Schuemann, Michael; Krause, Eberhard] Leibniz Inst Mol Pharmacol, Mass Spectrometry Unit, D-13125 Berlin, Germany; [Marg, Berenice; Seidel, Thorsten] Univ Bielefeld, Dept Dynam Cell Imaging, D-33615 Bielefeld, Germany; [Meyer, Tim; Knapp, Ernst-Walter] Free Univ Berlin, Inst Chem, Theoret Chem Grp, D-14195 Berlin, Germany	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Free University of Berlin; Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); University of Bielefeld; Free University of Berlin	Freund, C (corresponding author), Leibniz Inst Mol Pharmacol, Prot Engn Grp, Robert Rossle Str 10, D-13125 Berlin, Germany.	freund@fmp-berlin.de	Knapp, Ernst-Walter/E-4493-2010; Knapp, Ernst-Walter/AAH-6720-2021	Knapp, Ernst-Walter/0000-0002-2858-0460; Knapp, Ernst-Walter/0000-0002-2858-0460	Deutsche Forschungsgemeinschaft [FG806, SFB765]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants FG806 and SFB765.	Ball LJ, 2005, ANGEW CHEM INT EDIT, V44, P2852, DOI 10.1002/anie.200400618; Bedford MT, 1998, P NATL ACAD SCI USA, V95, P10602, DOI 10.1073/pnas.95.18.10602; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Chan DC, 1996, EMBO J, V15, P1045, DOI 10.1002/j.1460-2075.1996.tb00442.x; Chong PA, 2010, P NATL ACAD SCI USA, V107, P18404, DOI 10.1073/pnas.1003023107; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Enkhmandakh B, 2006, P NATL ACAD SCI USA, V103, P11631, DOI 10.1073/pnas.0605209103; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Fogh Rasmus, 2002, Nature Structural Biology, V9, P416, DOI 10.1038/nsb0602-416; Furumai R, 2010, CANCER SCI, V101, P2483, DOI 10.1111/j.1349-7006.2010.01686.x; FUSHMAN D, 1994, J BIOMOL NMR, V4, P61, DOI 10.1007/BF00178336; Gamiz-Hernandez AP, 2010, CHEMPHYSCHEM, V11, P1196, DOI 10.1002/cphc.200900889; Huang X, 2000, NAT STRUCT BIOL, V7, P634, DOI 10.1038/77923; Huang XJ, 2009, J BIOL CHEM, V284, P25375, DOI 10.1074/jbc.M109.024828; Ingham RJ, 2005, MOL CELL BIOL, V25, P7092, DOI 10.1128/MCB.25.16.7092-7106.2005; Ishiyama A, 2011, J ANTIBIOT, V64, P381, DOI 10.1038/ja.2011.6; Iwahara J, 2006, NATURE, V440, P1227, DOI 10.1038/nature04673; Jennings MD, 2007, J BIOL CHEM, V282, P29032, DOI 10.1074/jbc.M703453200; Kofler M, 2004, J BIOL CHEM, V279, P28292, DOI 10.1074/jbc.M402008200; Kofler M, 2009, MOL CELL PROTEOMICS, V8, P2461, DOI 10.1074/mcp.M900191-MCP200; Kofler MM, 2006, FEBS J, V273, P245, DOI 10.1111/j.1742-4658.2005.05078.x; Lange S, 2010, J PROTEOME RES, V9, P4113, DOI 10.1021/pr1003054; Lardelli RM, 2010, RNA, V16, P516, DOI 10.1261/rna.2030510; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mayer BJ, 2001, J CELL SCI, V114, P1253; Otte L, 2003, PROTEIN SCI, V12, P491, DOI 10.1110/ps.0233203; Popovic DM, 2001, J AM CHEM SOC, V123, P6040, DOI 10.1021/ja003878z; Schanda P, 2005, J AM CHEM SOC, V127, P8014, DOI 10.1021/ja051306e; Schanda P, 2006, J AM CHEM SOC, V128, P9042, DOI 10.1021/ja062025p; Schlundt A, 2009, MOL CELL PROTEOMICS, V8, P2474, DOI 10.1074/mcp.M800337-MCP200; Seidel T, 2005, FEBS LETT, V579, P4374, DOI 10.1016/j.febslet.2005.06.077; Spadaccini R, 2006, RNA, V12, P410, DOI 10.1261/rna.2271406; Stark H, 2001, NATURE, V409, P539, DOI 10.1038/35054102; Sudol M, 1996, PROG BIOPHYS MOL BIO, V65, P113, DOI 10.1016/S0079-6107(96)00008-9; Verdecia MA, 2000, NAT STRUCT BIOL, V7, P639, DOI 10.1038/77929; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Webb C, 2011, BIOCHEMISTRY-US, V50, P3300, DOI 10.1021/bi2001888; Wiesner S, 2002, J MOL BIOL, V324, P807, DOI 10.1016/S0022-2836(02)01145-2; Zarrinpar Ali, 2003, Sci STKE, V2003, pRE8, DOI 10.1126/stke.2003.179.re8	39	20	20	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38478	38487		10.1074/jbc.M111.265710	http://dx.doi.org/10.1074/jbc.M111.265710			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21917930	Green Published, hybrid			2022-12-25	WOS:000296594200062
J	Jordan, TR; Fuggetta, G; Paterson, KB; Kurtev, S; Xu, MY				Jordan, Timothy R.; Fuggetta, Giorgio; Paterson, Kevin B.; Kurtev, Stoyan; Xu, Mengyun			An ERP Assessment of Hemispheric Projections in Foveal and Extrafoveal Word Recognition	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; NASO-TEMPORAL DIVISION; MONKEY MACACA-FUSCATA; SPLIT-FOVEA; EYE-MOVEMENTS; INTERHEMISPHERIC COMMUNICATION; NASOTEMPORAL OVERLAP; VISUAL-FIELD; TIME-COURSE; SUPERIOR COLLICULI	Background: The existence and function of unilateral hemispheric projections within foveal vision may substantially affect foveal word recognition. The purpose of this research was to reveal these projections and determine their functionality. Methodology: Single words (and pseudowords) were presented to the left or right of fixation, entirely within either foveal or extrafoveal vision. To maximize the likelihood of unilateral projections for foveal displays, stimuli in foveal vision were presented away from the midline. The processing of stimuli in each location was assessed by combining behavioural measures (reaction times, accuracy) with on-line monitoring of hemispheric activity using event-related potentials recorded over each hemisphere, and carefully-controlled presentation procedures using an eye-tracker linked to a fixation-contingent display. Principal Findings: Event-related potentials 100-150 ms and 150-200 ms after stimulus onset indicated that stimuli in extrafoveal and foveal locations were projected unilaterally to the hemisphere contralateral to the presentation hemifield with no concurrent projection to the ipsilateral hemisphere. These effects were similar for words and pseudowords, suggesting this early division occurred before word recognition. Indeed, event-related potentials revealed differences between words and pseudowords 300-350 ms after stimulus onset, for foveal and extrafoveal locations, indicating that word recognition had now occurred. However, these later event-related potentials also revealed that the hemispheric division observed previously was no longer present for foveal locations but remained for extrafoveal locations. These findings closely matched the behavioural finding that foveal locations produced similar performance each side of fixation but extrafoveal locations produced left-right asymmetries. Conclusions: These findings indicate that an initial division in unilateral hemispheric projections occurs in foveal vision away from the midline but is not apparent, or functional, when foveal word recognition actually occurs. In contrast, the division in unilateral hemispheric projections that occurs in extrafoveal locations is still apparent, and is functional, when extrafoveal word recognition takes place.	[Jordan, Timothy R.; Fuggetta, Giorgio; Paterson, Kevin B.; Kurtev, Stoyan; Xu, Mengyun] Univ Leicester, Fac Med & Biol Sci, Leicester, Leics, England	University of Leicester	Jordan, TR (corresponding author), Univ Leicester, Fac Med & Biol Sci, Leicester, Leics, England.	proftimjordan@gmail.com		Paterson, Kevin/0000-0002-8150-8628; Kurtev, Stoyan/0000-0002-2978-1408				Almabruk AAA, 2010, PLOS ONE IN PRESS; ANNETT M, 1970, BRIT J PSYCHOL, V61, P303, DOI 10.1111/j.2044-8295.1970.tb01248.x; Baayen R. H, 1995, CELEX LEXICAL DATABA; Binder JR, 2003, J COGNITIVE NEUROSCI, V15, P372, DOI 10.1162/089892903321593108; BLAKEMORE C, 1969, Journal of Physiology (Cambridge), V205, P471; Brandt T, 2000, NEUROREPORT, V11, P2803, DOI 10.1097/00001756-200008210-00039; Brysbaert M, 2004, BRAIN LANG, V88, P259, DOI 10.1016/S0093-934X(03)00279-7; BRYSBAERT M, 1994, BEHAV BRAIN RES, V64, P151, DOI 10.1016/0166-4328(94)90127-9; Cornelissen P, 2003, J COGNITIVE NEUROSCI, V15, P731, DOI 10.1162/jocn.2003.15.5.731; Dane A, 2004, PERCEPT MOTOR SKILL, V99, P519, DOI 10.2466/PMS.99.5.519-524; Dehaene S, 2005, TRENDS COGN SCI, V9, P335, DOI 10.1016/j.tics.2005.05.004; Dien J, 2009, BIOL PSYCHOL, V80, P10, DOI 10.1016/j.biopsycho.2008.04.013; Dragovic M, 2007, BRIT J PSYCHOL, V98, P375, DOI 10.1348/000712606X146197; DRASDO N, 1977, NATURE, V266, P554, DOI 10.1038/266554a0; Fendrich R, 1996, NEUROPSYCHOLOGIA, V34, P637, DOI 10.1016/0028-3932(95)00155-7; Friederici Angela D, 2004, Curr Neurol Neurosci Rep, V4, P466, DOI 10.1007/s11910-004-0070-0; Friedrich CK, 2004, J COGNITIVE NEUROSCI, V16, P541, DOI 10.1162/089892904323057281; Fuggetta G, 2009, J COGNITIVE NEUROSCI, V21, P403, DOI 10.1162/jocn.2008.21030; FUKUDA Y, 1989, J NEUROSCI, V9, P2353; Gazzaniga MS, 2000, BRAIN, V123, P1293, DOI 10.1093/brain/123.7.1293; Grainger J, 2009, LANG LINGUIST COMPAS, V3, P128, DOI 10.1111/j.1749-818x.2008.00121.x; Gray LG, 1997, ARCH NEUROL-CHICAGO, V54, P312, DOI 10.1001/archneur.1997.00550150068018; GROSSBERG S, 1987, COGNITIVE SCI, V11, P23, DOI 10.1111/j.1551-6708.1987.tb00862.x; Hauk O, 2006, NEUROIMAGE, V30, P1383, DOI 10.1016/j.neuroimage.2005.11.048; Hauk O, 2004, CLIN NEUROPHYSIOL, V115, P1090, DOI 10.1016/j.clinph.2003.12.020; Holcomb PJ, 2006, J COGNITIVE NEUROSCI, V18, P1631, DOI 10.1162/jocn.2006.18.10.1631; Hunter ZR, 2007, J COGNITIVE NEUROSCI, V19, P1373, DOI 10.1162/jocn.2007.19.8.1373; Johnson RL, 2007, J EXP PSYCHOL HUMAN, V33, P209, DOI 10.1037/0096-1523.33.1.209; Jordan TR, 2008, NEUROPSYCHOLOGY, V22, P738, DOI 10.1037/a0013140; Jordan TR, 2010, NEUROPSYCHOLOGIA, V48, P2782, DOI 10.1016/j.neuropsychologia.2010.04.029; Jordan TR, 2010, CORTEX, V46, P298, DOI 10.1016/j.cortex.2009.01.008; Jordan TR, 2010, CORTEX, V46, P100, DOI 10.1016/j.cortex.2008.10.008; Jordan TR, 2009, NEUROPSYCHOLOGIA, V47, P2341, DOI 10.1016/j.neuropsychologia.2008.07.020; Jordan TR, 2009, NEUROPSYCHOLOGIA, V47, P2004, DOI 10.1016/j.neuropsychologia.2008.12.014; Jordan TR, 2009, CORTEX, V45, P495, DOI 10.1016/j.cortex.2007.07.007; Jordan TR, 2009, COGN AFFECT BEHAV NE, V9, P113, DOI 10.3758/CABN.9.1.113; Jordan TR, 2011, EVALUATING IN PRESS; KONDO Y, 1994, J COMP NEUROL, V346, P119, DOI 10.1002/cne.903460108; KONDO Y, 1992, BRAIN RES, V597, P155, DOI 10.1016/0006-8993(92)91519-K; Lavidor M, 2004, NAT REV NEUROSCI, V5, P729, DOI 10.1038/nrn1498; Lavidor M, 2001, COGNITIVE BRAIN RES, V12, P265, DOI 10.1016/S0926-6410(01)00056-8; LEVENTHAL AG, 1988, SCIENCE, V240, P66, DOI 10.1126/science.3353708; Lindell AK, 2003, CORTEX, V39, P111, DOI 10.1016/S0010-9452(08)70079-0; Liversedge SP, 2006, VISION RES, V46, P2363, DOI 10.1016/j.visres.2006.01.013; MANGUN GR, 1991, J EXP PSYCHOL HUMAN, V17, P1057, DOI 10.1037/0096-1523.17.4.1057; Martin CD, 2007, BRAIN RES, V1185, P212, DOI 10.1016/j.brainres.2007.09.049; Marzi CA, 2009, NEUROPSYCHOLOGIA, V47, P3007, DOI 10.1016/j.neuropsychologia.2009.05.007; MISHKIN M, 1952, J EXP PSYCHOL, V43, P43, DOI 10.1037/h0061361; Paterson KB, 2009, J EXP PSYCHOL HUMAN, V35, P1961, DOI 10.1037/a0016889; Perea M, 1998, J EXP PSYCHOL HUMAN, V24, P767, DOI 10.1037/0096-1523.24.3.767; PORAC C, 1976, PSYCHOL BULL, V83, P880, DOI 10.1037/0033-2909.83.5.880; Pylkkanen L, 2002, BRAIN LANG, V81, P666, DOI 10.1006/brln.2001.2555; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; Reinhard J, 2003, INVEST OPHTH VIS SCI, V44, P1568, DOI 10.1167/iovs.02-0313; Rossion B, 2003, NEUROIMAGE, V20, P1609, DOI 10.1016/j.neuroimage.2003.07.010; SARON CD, 1989, BEHAV NEUROSCI, V103, P1115, DOI 10.1037/0735-7044.103.5.1115; Schendan HE, 1998, PSYCHOPHYSIOLOGY, V35, P240, DOI 10.1017/S004857729897010X; Sereno SC, 2003, TRENDS COGN SCI, V7, P489, DOI 10.1016/j.tics.2003.09.010; STONE J, 1966, J COMP NEUROL, V126, P585; STONE J, 1973, J COMP NEUROL, V150, P333, DOI 10.1002/cne.901500306; SUGISHITA M, 1994, NEUROPSYCHOLOGIA, V32, P399, DOI 10.1016/0028-3932(94)90086-8; Tarkiainen A, 2002, BRAIN, V125, P1125, DOI 10.1093/brain/awf112; Tootell RBH, 1998, P NATL ACAD SCI USA, V95, P818, DOI 10.1073/pnas.95.3.818; Trauzettel-Klosinski S, 1998, INVEST OPHTH VIS SCI, V39, P2177; Van der Haegen L, 2009, BRAIN LANG, V108, P112, DOI 10.1016/j.bandl.2008.06.005; VanRullen R, 2001, J COGNITIVE NEUROSCI, V13, P454, DOI 10.1162/08989290152001880; VICTOR JD, 1991, CLIN VISION SCI, V6, P261; Wessinger CM, 1996, NEUROPSYCHOLOGIA, V34, P1129, DOI 10.1016/0028-3932(96)00023-1; Whitney C, 2004, NEUROPSYCHOLOGIA, V42, P1680, DOI 10.1016/j.neuropsychologia.2004.04.007; Whitney C, 2001, PSYCHON B REV, V8, P221, DOI 10.3758/BF03196158	71	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e23957	10.1371/journal.pone.0023957	http://dx.doi.org/10.1371/journal.pone.0023957			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	822JR	21935368	gold, Green Published, Green Submitted			2022-12-25	WOS:000295041700004
J	Naidu, MD; Agarwal, R; Pena, LA; Cunha, L; Mezei, M; Shen, M; Wilson, DM; Liu, Y; Sanchez, Z; Chaudhary, P; Wilson, SH; Waring, MJ				Naidu, Mamta D.; Agarwal, Rakhi; Pena, Louis A.; Cunha, Luis; Mezei, Mihaly; Shen, Min; Wilson, David M., III; Liu, Yuan; Sanchez, Zina; Chaudhary, Pankaj; Wilson, Samuel H.; Waring, Michael J.			Lucanthone and Its Derivative Hycanthone Inhibit Apurinic Endonuclease-1 (APE1) by Direct Protein Binding	PLOS ONE			English	Article							RADIOTHERAPY IN-VITRO; DNA-POLYMERASE-BETA; BASE EXCISION; TOPOISOMERASE-II; CANCER CELLS; MIRACIL-D; ALKYLATING-AGENTS; AUTOMATED DOCKING; REPAIR ACTIVITY; ABASIC SITES	Lucanthone and hycanthone are thioxanthenone DNA intercalators used in the 1980s as antitumor agents. Lucanthone is in Phase I clinical trial, whereas hycanthone was pulled out of Phase II trials. Their potential mechanism of action includes DNA intercalation, inhibition of nucleic acid biosyntheses, and inhibition of enzymes like topoisomerases and the dual function base excision repair enzyme apurinic endonuclease 1 (APE1). Lucanthone inhibits the endonuclease activity of APE1, without affecting its redox activity. Our goal was to decipher the precise mechanism of APE1 inhibition as a prerequisite towards development of improved therapeutics that can counteract higher APE1 activity often seen in tumors. The IC50 values for inhibition of APE1 incision of depurinated plasmid DNA by lucanthone and hycanthone were 5 mu M and 80 nM, respectively. The KD values (affinity constants) for APE1, as determined by BIACORE binding studies, were 89 nM for lucanthone/10 nM for hycanthone. APE1 structures reveal a hydrophobic pocket where hydrophobic small molecules like thioxanthenones can bind, and our modeling studies confirmed such docking. Circular dichroism spectra uncovered change in the helical structure of APE1 in the presence of lucanthone/hycanthone, and notably, this effect was decreased (Phe266Ala or Phe266Cys or Trp280Leu) or abolished (Phe266Ala/Trp280Ala) when hydrophobic site mutants were employed. Reduced inhibition by lucanthone of the diminished endonuclease activity of hydrophobic mutant proteins (as compared to wild type APE1) supports that binding of lucanthone to the hydrophobic pocket dictates APE1 inhibition. The DNA binding capacity of APE1 was marginally inhibited by lucanthone, and not at all by hycanthone, supporting our hypothesis that thioxanthenones inhibit APE1, predominantly, by direct interaction. Finally, lucanthone-induced degradation was drastically reduced in the presence of short and long lived free radical scavengers, e.g., TRIS and DMSO, suggesting that the mechanism of APE1 breakdown may involve free radical-induced peptide bond cleavage.	[Naidu, Mamta D.; Agarwal, Rakhi; Chaudhary, Pankaj] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; [Pena, Louis A.] Brookhaven Natl Lab, Dept Med, Upton, NY 11973 USA; [Cunha, Luis] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA; [Mezei, Mihaly] Mt Sinai Sch Med, Dept Struct & Chem Biol, New York, NY USA; [Shen, Min] NIH, NIH Chem Genom Ctr, Rockville, MD USA; [Wilson, David M., III] NIA, Lab Mol Gerontol, Biomed Res Ctr, NIH, Baltimore, MD 21224 USA; [Liu, Yuan; Wilson, Samuel H.] Natl Inst Environm Hlth Sci, Struct Biol Lab, NIH, Res Triangle Pk, NC USA; [Sanchez, Zina] SUNY Stony Brook, Stony Brook, NY 11794 USA; [Waring, Michael J.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1QJ, England	United States Department of Energy (DOE); Brookhaven National Laboratory; United States Department of Energy (DOE); Brookhaven National Laboratory; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Cambridge	Naidu, MD (corresponding author), Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA.	mnaidu@bnl.gov	Wilson, Samuel H/E-6644-2019; Wilson, David M/AAK-5409-2021	Wilson, Samuel H/0000-0002-1702-5293; Wilson, David M/0000-0002-8945-0395; Chaudhary, Pankaj/0000-0002-0381-3635; Naidu, Mamta/0000-0002-2754-2470	DOE [KP-1401020/MO-079]; NIH [R01-CA86897]; National Institute on Aging; NIH, National Institutes of Environmental Health Sciences [Z01ES050158, Z01-ES050159]; U.S. Department of Energy [DE-AC02-98CH10886]; NATIONAL CANCER INSTITUTE [R01CA086897] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES050159, Z01ES050159, Z01ES050158, ZIAES050158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000750] Funding Source: NIH RePORTER	DOE(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH, National Institutes of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by DOE grant KP-1401020/MO-079, NIH grant R01-CA86897, the Intramural Research Program of the National Institute on Aging and the Intramural Research Program of the NIH, National Institutes of Environmental Health Sciences (Z01ES050158 & Z01-ES050159). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; BNL is managed by Brookhaven Science Associates, L.L.C. for the U.S. Department of Energy under Contract DE-AC02-98CH10886.	Agarwal R, 2004, PROTEIN EXPRES PURIF, V34, P95, DOI 10.1016/j.pep.2003.10.017; ARCHER S, 1982, J MED CHEM, V25, P220, DOI 10.1021/jm00345a006; BAILLY C, 1993, BIOCHEMISTRY-US, V32, P5985, DOI 10.1021/bi00074a009; BASES R, 1969, J CELL PHYSIOL, V74, P283, DOI 10.1002/jcp.1040740308; Bases RE, 1997, INT J RADIAT ONCOL, V37, P1133, DOI 10.1016/S0360-3016(97)00113-2; BERBERIAN DA, 1967, AM J TROP MED HYG, V16, P487, DOI 10.4269/ajtmh.1967.16.487; Bobola MS, 2005, CLIN CANCER RES, V11, P7405, DOI 10.1158/1078-0432.CCR-05-1068; Bobola MS, 2001, CLIN CANCER RES, V7, P3510; BULAY O, 1979, INT J CANCER, V23, P97, DOI 10.1002/ijc.2910230117; CHEN DS, 1991, NUCLEIC ACIDS RES, V19, P5907, DOI 10.1093/nar/19.21.5907; CIOLI D, 1995, PHARMACOL THERAPEUT, V68, P35, DOI 10.1016/0163-7258(95)00026-7; Dassonneville L, 1999, BIOCHEM PHARMACOL, V58, P1307, DOI 10.1016/S0006-2952(99)00221-X; Del Rowe JD, 1999, INT J RADIAT ONCOL, V43, P89, DOI 10.1016/S0360-3016(98)00374-5; EPIFANOVA OI, 1975, J CELL PHYSIOL, V86, P261, DOI 10.1002/jcp.1040860210; Erzberger JP, 1998, NUCLEIC ACIDS RES, V26, P2771, DOI 10.1093/nar/26.11.2771; Fishel ML, 2007, MOL ASPECTS MED, V28, P375, DOI 10.1016/j.mam.2007.04.005; Fishel ML, 2007, MUTAT RES-FUND MOL M, V614, P24, DOI 10.1016/j.mrfmmm.2006.06.007; FUTCHER AB, 1979, CAN J BIOCHEM CELL B, V57, P932, DOI 10.1139/o79-113; Goodsell DS, 1996, J MOL RECOGNIT, V9, P1, DOI 10.1002/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO;2-6; Guikema JEJ, 2007, J EXP MED, V204, P3017, DOI 10.1084/jem.20071289; Hadi MZ, 2002, J MOL BIOL, V316, P853, DOI 10.1006/jmbi.2001.5382; HARDGROVE GL, 1983, ACTA CRYSTALLOGR C, V39, P616, DOI 10.1107/S0108270183005673; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Horton JK, 2000, J BIOL CHEM, V275, P2211, DOI 10.1074/jbc.275.3.2211; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Izumi T, 2005, P NATL ACAD SCI USA, V102, P5739, DOI 10.1073/pnas.0500986102; Jiang YL, 2009, DNA REPAIR, V8, P1273, DOI 10.1016/j.dnarep.2009.08.003; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kelley MR, 2008, ANTI-CANCER AGENT ME, V8, P417, DOI 10.2174/187152008784220294; Kelley MR, 2010, FUNCTIONAL ANAL NOVE; KINGMA PS, 1995, J BIOL CHEM, V270, P21441, DOI 10.1074/jbc.270.37.21441; Koll TT, 2008, MOL CANCER THER, V7, P1985, DOI 10.1158/1535-7163.MCT-07-2104; Liu Y, 2005, J BIOL CHEM, V280, P3665, DOI 10.1074/jbc.M412922200; Liu YA, 2007, J BIOL CHEM, V282, P13532, DOI 10.1074/jbc.M611295200; Luo MH, 2004, ANTICANCER RES, V24, P2127; Madhusudan S, 2005, NUCLEIC ACIDS RES, V33, P4711, DOI 10.1093/nar/gki781; Mendez F, 2002, CANCER INVEST, V20, P983, DOI 10.1081/CNV-120005914; Mezei M, 2010, SOURCE CODE BIOL MED, V5, DOI 10.1186/1751-0473-5-2; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Naidu MD, 2010, J RADIAT RES, V51, P393, DOI 10.1269/jrr.09077; Nguyen C, 2003, P NATL ACAD SCI USA, V100, P1169, DOI 10.1073/pnas.0437889100; Nyland RL, 2010, J MED CHEM, V53, P1200, DOI 10.1021/jm9014857; ONO Y, 1995, J NEURO-ONCOL, V25, P183, DOI 10.1007/BF01053151; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Raffoul JJ, 2007, CANCER RES, V67, P2141, DOI 10.1158/0008-5472.CAN-06-2147; Robertson KA, 2001, CANCER RES, V61, P2220; ROSI D, 1965, NATURE, V208, P1005, DOI 10.1038/2081005a0; RUSSELL WL, 1975, J TOXICOL ENV HEALTH, V1, P301, DOI 10.1080/15287397509529329; Shimizu N, 2000, NAT BIOTECHNOL, V18, P877, DOI 10.1038/78496; Silber JR, 2002, CLIN CANCER RES, V8, P3008; Simeonov A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005740; SUTHERLAND JC, 1991, BIOTECHNIQUES, V10, P492; TURNER S, 1975, RADIOLOGY, V114, P729, DOI 10.1148/114.3.729; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Wilson DM, 2001, MUTAT RES-DNA REPAIR, V485, P283, DOI 10.1016/S0921-8777(01)00063-5; XANTHOUDAKIS S, 1994, P NATL ACAD SCI USA, V91, P23, DOI 10.1073/pnas.91.1.23; Xiang DB, 2008, CANCER GENE THER, V15, P625, DOI 10.1038/cgt.2008.30; Yang S, 2005, MOL CAN THERAP, V12, P1930; Zawahir Z, 2009, J MED CHEM, V52, P20, DOI 10.1021/jm800739m; ZILVERSMIT R, 1971, MOL PHARMACOL, V7, P674	63	36	37	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e23679	10.1371/journal.pone.0023679	http://dx.doi.org/10.1371/journal.pone.0023679			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21935361	Green Submitted, Green Published, gold			2022-12-25	WOS:000295041700001
J	Gjesing, AP; Vestmar, MA; Jorgensen, T; Heni, M; Holst, JJ; Witte, DR; Hansen, T; Pedersen, O				Gjesing, Anette P.; Vestmar, Marie A.; Jorgensen, Torben; Heni, Martin; Holst, Jens J.; Witte, Daniel R.; Hansen, Torben; Pedersen, Oluf			The Effect of PCSK1 Variants on Waist, Waist-Hip Ratio and Glucose Metabolism Is Modified by Sex and Glucose Tolerance Status	PLOS ONE			English	Article							INHIBITORY POLYPEPTIDE GIP; INSULIN SENSITIVITY; OBESITY; ASSOCIATION	Background: We aimed to evaluate the effects of the G-allele of rs6232 and the C-allele of rs6235 within PCSK1 on measures of body fat and glucose homeostasis in Danish individuals and to assess interactions of genotypes with age, sex and glucose tolerance status. Data were included in meta-analyses of additional Europeans. Methodology/Principal Findings: Rs6232 and rs6235 were genotyped in 6,164 Danes from the Inter99 study of middle-aged people. Results from these analyses were combined with previously published studies in meta-analyses of a total of 27,786 individuals. The impact of the variants was also investigated in a subset of 62 glucose-tolerant men during a meal challenge including measures of serum incretins. In men we found an effect on body composition in sex-stratified analyses where the rs6235 C-allele conferred an increased waist circumference of 0.8 cm per allele (0.2-1.5, p = 0.008) and increased waist-to-hip ratio of 0.004 (0.0005-0.008, p = 0.027). In the meta-analyses where men and women were combined, the rs6232 G-allele associated with increased waist-to-hip ratio (p = 0.02) and the rs6235 C-allele associated with increased waist circumference (p = 0.01). Furthermore, the rs6235 C-allele was associated nominally with a 0.6% (0.1-1%, p = 0.01) reduction in fasting glucose, it interacted with glucose tolerance status for traits related to glucose metabolism and analysis among individuals having abnormal glucose tolerance revealed a 5% (20.7-9%, p = 0.02) elevated level of acute insulin response for this variant. Finally, we found that the rs6232 G-allele associated with higher levels of GLP-1, GLP-2 and glucagon and that the rs6235 C-allele associated with higher levels of GIP and glucagon during a meal-test. Conclusions/Significance: PCSK1 rs6232 G-allele and rs6235 C-allele have an effect on body composition which may be modified by sex, whereas the effect of rs6235 C-allele on fasting and stimulated circulating plasma glucose and hormone levels may be influenced by glucose tolerance status.	[Gjesing, Anette P.; Vestmar, Marie A.; Witte, Daniel R.; Hansen, Torben; Pedersen, Oluf] Steno Diabet Ctr, Copenhagen, Denmark; [Gjesing, Anette P.; Vestmar, Marie A.; Witte, Daniel R.; Hansen, Torben; Pedersen, Oluf] Hagedorn Res Inst, Copenhagen, Denmark; [Gjesing, Anette P.; Vestmar, Marie A.; Hansen, Torben; Pedersen, Oluf] Univ Copenhagen, Fac Hlth Sci, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark; [Jorgensen, Torben] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, Glostrup, Denmark; [Heni, Martin] Univ Tubingen, Dept Internal Med, D-7400 Tubingen, Germany; [Hansen, Torben] Univ So Denmark, Fac Hlth Sci, Odense, Denmark; [Pedersen, Oluf] Aarhus Univ, Fac Hlth Sci, Aarhus, Denmark	Steno Diabetes Center; Novo Nordisk; Hagedorn Research Institute; Novo Nordisk Foundation; University of Copenhagen; University of Copenhagen; Eberhard Karls University of Tubingen; University of Southern Denmark; Aarhus University	Gjesing, AP (corresponding author), Steno Diabet Ctr, Copenhagen, Denmark.	anette.gjesing@sund.ku.dk	Jørgensen, Torben/Z-1335-2018; Witte, Daniel/AAF-9535-2019; Holst, Jens/AAA-8022-2022; Gjesing, Anette/ACC-7521-2022; Pedersen, Oluf/Z-1731-2019; Witte, Daniel R/C-1722-2008; Pedersen, Oluf/AAG-8015-2020	Witte, Daniel/0000-0002-0769-2922; Gjesing, Anette/0000-0003-4580-1576; Pedersen, Oluf/0000-0002-3321-3972; Witte, Daniel R/0000-0002-0769-2922; Hansen, Torben/0000-0001-8748-3831; Heni, Martin/0000-0002-8462-3832; Jorgensen, Torben/0000-0001-9453-2830; Holst, Jens Juul/0000-0001-6853-3805	Lundbeck Foundation Centre of Applied Medical Genomics for Personalized Disease Prediction, Prevention and Care (LUCAMP); Danish Medical Research Council; Novo Nordisk; University of Copenhagen; Danish Diabetes Association; FOOD Study Group/the Danish Ministry of Food, Agriculture and Fisheries; Ministry of Family and Consumer Affairs [2101-05-0044]; Novo Nordisk Foundation	Lundbeck Foundation Centre of Applied Medical Genomics for Personalized Disease Prediction, Prevention and Care (LUCAMP); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novo Nordisk(Novo Nordisk); University of Copenhagen; Danish Diabetes Association; FOOD Study Group/the Danish Ministry of Food, Agriculture and Fisheries; Ministry of Family and Consumer Affairs; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	The study was supported by grants from the Lundbeck Foundation Centre of Applied Medical Genomics for Personalized Disease Prediction, Prevention and Care (LUCAMP), the Danish Medical Research Council, Novo Nordisk, the University of Copenhagen, the Danish Diabetes Association, and the FOOD Study Group/the Danish Ministry of Food, Agriculture and Fisheries and Ministry of Family and Consumer Affairs, grant no. 2101-05-0044. The Novo Nordisk Foundation Center for Basic Metabolic Research is funded by the Novo Nordisk Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell CG, 2004, DIABETES, V53, P1857, DOI 10.2337/diabetes.53.7.1857; Benzinou M, 2008, NAT GENET, V40, P943, DOI 10.1038/ng.177; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Farooqi IS, 2007, J CLIN ENDOCR METAB, V92, P3369, DOI 10.1210/jc.2007-0687; Gjesing AP, 2011, DIABETOLOGIA, V54, P103, DOI 10.1007/s00125-010-1940-4; Grarup N, 2008, DIABETES, V57, P2534, DOI 10.2337/db08-0436; Hager J, 1998, NAT GENET, V20, P304, DOI 10.1038/3123; Hansen T, 2007, DIABETES CARE, V30, P257, DOI 10.2337/dc06-1240; HENI M, 2010, BMC MED GENET   0609, P11; Irwin N, 2009, DIABETOLOGIA, V52, P1724, DOI 10.1007/s00125-009-1422-8; Jackson RS, 2003, J CLIN INVEST, V112, P1550, DOI 10.1172/JCI18784; Jackson RS, 1997, NAT GENET, V16, P303, DOI 10.1038/ng0797-303; JANSEN E, 1995, J BIOL CHEM, V270, P15391, DOI 10.1074/jbc.270.25.15391; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Kilpelainen TO, 2009, HUM MOL GENET, V18, P3496, DOI 10.1093/hmg/ddp280; Lloyd DJ, 2006, HUM MOL GENET, V15, P1884, DOI 10.1093/hmg/ddl111; Meier JJ, 2003, DIABETOLOGIA, V46, P798, DOI 10.1007/s00125-003-1103-y; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; ORAHILLY S, 1995, NEW ENGL J MED, V333, P1386, DOI 10.1056/NEJM199511233332104; Renstrom F, 2009, HUM MOL GENET, V18, P1489, DOI 10.1093/hmg/ddp041; Sandholt CH, 2010, DIABETES, V59, P1667, DOI 10.2337/db09-1042; Seidah Nabil G., 1999, V885, P57; Ugleholdt R, 2006, J BIOL CHEM, V281, P11050, DOI 10.1074/jbc.M601203200; World Health Organization, 1999, WHO DIAGN CLASS DI 1	24	20	20	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2011	6	9							e23907	10.1371/journal.pone.0023907	http://dx.doi.org/10.1371/journal.pone.0023907			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JC	21935364	Green Published, gold, Green Submitted			2022-12-25	WOS:000295039700005
J	Arvizo, RR; Miranda, OR; Moyano, DF; Walden, CA; Giri, K; Bhattacharya, R; Robertson, JD; Rotello, VM; Reid, JM; Mukherjee, P				Arvizo, Rochelle R.; Miranda, Oscar R.; Moyano, Daniel F.; Walden, Chad A.; Giri, Karuna; Bhattacharya, Resham; Robertson, J. David; Rotello, Vincent M.; Reid, Joel M.; Mukherjee, Priyabrata			Modulating Pharmacokinetics, Tumor Uptake and Biodistribution by Engineered Nanoparticles	PLOS ONE			English	Article							GOLD NANOPARTICLES; CANCER-THERAPY; DELIVERY; THERAPEUTICS; SYSTEM; DRUG; NANOTECHNOLOGY; PROTEINS; DESIGN; AGENTS	Background: Inorganic nanoparticles provide promising tools for biomedical applications including detection, diagnosis and therapy. While surface properties such as charge are expected to play an important role in their in vivo behavior, very little is known how the surface chemistry of nanoparticles influences their pharmacokinetics, tumor uptake, and biodistribution. Method/Principal Findings: Using a family of structurally homologous nanoparticles we have investigated how pharmacological properties including tumor uptake and biodistribution are influenced by surface charge using neutral (TEGOH), zwitterionic (Tzwit), negative (TCOOH) and positive (TTMA) nanoparticles. Nanoparticles were injected into mice (normal and athymic) either in the tail vein or into the peritoneum. Conclusion: Neutral and zwitterionic nanoparticles demonstrated longer circulation time via both IP and IV administration, whereas negatively and positively charged nanoparticles possessed relatively short half-lives. These pharmacological characteristics were reflected on the tumor uptake and biodistribution of the respective nanoparticles, with enhanced tumor uptake by neutral and zwitterionic nanoparticles via passive targeting.	[Arvizo, Rochelle R.; Giri, Karuna; Bhattacharya, Resham; Mukherjee, Priyabrata] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Miranda, Oscar R.; Moyano, Daniel F.; Rotello, Vincent M.] Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA; [Walden, Chad A.; Reid, Joel M.] Mayo Clin, Dept Oncol, Rochester, MN USA; [Mukherjee, Priyabrata] Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN USA; [Robertson, J. David] Univ Missouri, Dept Chem, Columbia, MO 65211 USA; [Robertson, J. David] Univ Missouri, Univ Missouri Res Reactor, Columbia, MO USA; [Mukherjee, Priyabrata] Mayo Clin, Coll Med, Ctr Canc, Rochester, MN USA	Mayo Clinic; University of Massachusetts System; University of Massachusetts Amherst; Mayo Clinic; Mayo Clinic; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Mayo Clinic	Arvizo, RR (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA.	Mukherjee.priyabrata@mayo.edu	Moyano, Daniel/A-7306-2012; Miranda, Oscar/G-9183-2014	Moyano, Daniel/0000-0002-9213-5660; Miranda, Oscar/0000-0002-2500-2075; Robertson, John/0000-0002-6675-8469	National Institutes of Health [Ca135001, CA136494, GM077173]; NATIONAL CANCER INSTITUTE [R01CA136494] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077173] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Ca135001, CA136494 to PM and GM077173 to VR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agasti SS, 2009, J AM CHEM SOC, V131, P5728, DOI 10.1021/ja900591t; Arvizo RR, 2010, NANO LETT, V10, P2543, DOI 10.1021/nl101140t; BRUST M, 1994, J CHEM SOC CHEM COMM, P801, DOI 10.1039/c39940000801; Chanda N, 2010, NANOMED-NANOTECHNOL, V6, P201, DOI 10.1016/j.nano.2009.11.001; Choi HS, 2010, NAT NANOTECHNOL, V5, P42, DOI [10.1038/NNANO.2009.314, 10.1038/nnano.2009.314]; Davis Alison J, 2002, Cancer Treat Res, V112, P1; Davis ME, 2008, NAT REV DRUG DISCOV, V7, P771, DOI 10.1038/nrd2614; De M, 2009, NAT CHEM, V1, P461, DOI [10.1038/NCHEM.334, 10.1038/nchem.334]; Dobrovolskaia MA, 2007, NAT NANOTECHNOL, V2, P469, DOI 10.1038/nnano.2007.223; Fang J, 2011, ADV DRUG DELIVER REV, V63, P136, DOI 10.1016/j.addr.2010.04.009; Ferrari M, 2005, NAT REV CANCER, V5, P161, DOI 10.1038/nrc1566; Gao JH, 2007, J AM CHEM SOC, V129, P1428, DOI 10.1021/ja067785e; Gindy ME, 2009, EXPERT OPIN DRUG DEL, V6, P865, DOI 10.1517/17425240902932908; GROBMYER SR, METHODS MOL BIOL, V624, P1; Gwak HS, 2005, INT J PHARMACEUT, V297, P156, DOI 10.1016/j.ijpharm.2005.03.016; Hillyer JF, 2001, J PHARM SCI, V90, P1927, DOI 10.1002/jps.1143; Hong R, 2006, CHEM COMMUN, P2347, DOI 10.1039/b603988j; Jain RK, 2010, NAT REV CLIN ONCOL, V7, P653, DOI 10.1038/nrclinonc.2010.139; JAIN RK, 1990, CANCER METAST REV, V9, P253, DOI 10.1007/BF00046364; Kanaras AG, 2002, CHEM COMMUN, P2294, DOI 10.1039/b207838b; Katti KV, 2006, CZECH J PHYS, V56, pD23; Kim CK, 2009, NANOSCALE, V1, P61, DOI 10.1039/b9nr00112c; Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388; Medintz IL, 2005, NAT MATER, V4, P435, DOI 10.1038/nmat1390; Moghimi SM, 1999, ADV DRUG DELIVER REV, V37, P295, DOI 10.1016/S0169-409X(98)00099-4; MOYANO DF, 2011, LANGMUIR IN PRESS; Mukherjee P, 2005, J BIOMED NANOTECHNOL, V1, P224, DOI 10.1166/jbn.2005.016; Oh YK, 2009, ADV DRUG DELIVER REV, V61, P850, DOI 10.1016/j.addr.2009.04.018; Owens DE, 2006, INT J PHARMACEUT, V307, P93, DOI 10.1016/j.ijpharm.2005.10.010; Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387; Perrault SD, 2009, NANO LETT, V9, P1909, DOI 10.1021/nl900031y; Petros RA, 2010, NAT REV DRUG DISCOV, V9, P615, DOI 10.1038/nrd2591; Schluep T, 2009, P NATL ACAD SCI USA, V106, P11394, DOI 10.1073/pnas.0905487106; Simberg D, 2009, BIOMATERIALS, V30, P3926, DOI 10.1016/j.biomaterials.2009.03.056; Sinha R, 2006, MOL CANCER THER, V5, P1909, DOI 10.1158/1535-7163.MCT-06-0141; Templeton AC, 2000, ACCOUNTS CHEM RES, V33, P27, DOI 10.1021/ar9602664; von Maltzahn G, 2009, ADV MATER, V21, P3175, DOI 10.1002/adma.200803464; Wu W, 2005, ANGEW CHEM INT EDIT, V44, P6358, DOI 10.1002/anie.200501613; Yang XC, 2011, ANGEW CHEM INT EDIT, V50, P477, DOI 10.1002/anie.201005662; You CC, 2007, NAT NANOTECHNOL, V2, P318, DOI 10.1038/nnano.2007.99; Zhou ZK, 2010, ACS NANO, V4, P5003, DOI 10.1021/nn100578b; Zhu ZJ, 2008, J AM CHEM SOC, V130, P14139, DOI 10.1021/ja805392f; Zhu ZJ, 2010, SMALL, V6, P2261, DOI 10.1002/smll.201000989	43	264	281	2	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2011	6	9							e24374	10.1371/journal.pone.0024374	http://dx.doi.org/10.1371/journal.pone.0024374			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZV	21931696	gold, Green Published, Green Submitted			2022-12-25	WOS:000295321800025
J	Singhal, J; Nagaprashantha, L; Vatsyayan, R; Awasthi, S; Singhal, SS				Singhal, Jyotsana; Nagaprashantha, Lokesh; Vatsyayan, Rit; Awasthi, Sanjay; Singhal, Sharad S.			RLIP76, a Glutathione-Conjugate Transporter, Plays a Major Role in the Pathogenesis of Metabolic Syndrome	PLOS ONE			English	Article							ATP-DEPENDENT TRANSPORT; OXIDATIVE STRESS; FRUCTOSE 1,6-DIPHOSPHATASE; INSULIN-SECRETION; SKELETAL-MUSCLE; PROTEIN; LIVER; ENDOCYTOSIS; INHIBITION; EXPRESSION	Purpose: Characteristic hypoglycemia, hypotriglyceridemia, hypocholesterolemia, lower body mass, and fat as well as pronounced insulin-sensitivity of RLIP76(-/-) mice suggested to us the possibility that elevation of RLIP76 in response to stress could itself elicit metabolic syndrome (MSy). Indeed, if it were required for MSy, drugs used to treat MSy should have no effect on RLIP76(-/-) mice. Research Design and Methods: Blood glucose (BG) and lipid measurements were performed in RLIP76(+/+) and RLIP76(-/-) mice, using Ascensia Elite Glucometer (R) for glucose and ID Labs kits for cholesterol and triglycerides assays. The ultimate effectors of gluconeogenesis are the three enzymes: PEPCK, F-1,6-BPase, and G6Pase, and their expression is regulated by PPAR gamma and AMPK. The activity of these enzymes was tested by protocols standardized by us. Expressions of RLIP76, PPAR alpha, PPAR gamma, HMGCR, pJNK, pAkt, and AMPK were performed by Western-blot and tissue staining. Results: The concomitant activation of AMPK and PPAR gamma by inhibiting transport activity of RLIP76, despite inhibited activity of key glucocorticoid-regulated hepatic gluconeogenic enzymes like PEPCK, G6Pase and F-1,6-BP in RLIP76(-/-) mice, is a salient finding of our studies. The decrease in RLIP76 protein expression by rosiglitazone and metformin is associated with an up-regulation of PPAR gamma and AMPK. Conclusions/Significance: All four drugs, rosiglitazone, metformin, gemfibrozil and atorvastatin failed to affect glucose and lipid metabolism in RLIP76(-/-) mice. Studies confirmed a model in which RLIP76 plays a central role in the pathogenesis of MSy and RLIP76 loss causes profound and global alterations of MSy signaling functions. RLIP76 is a novel target for single-molecule therapeutics for metabolic syndrome.	[Singhal, Jyotsana; Nagaprashantha, Lokesh; Awasthi, Sanjay; Singhal, Sharad S.] Natl Med Ctr, Beckman Res Inst, Dept Diabet & Metab Dis Res, Duarte, CA USA; [Vatsyayan, Rit] Univ N Texas, Hlth Sci Ctr, Dept Mol Biol & Immunol, Ft Worth, TX USA	City of Hope; Beckman Research Institute of City of Hope; University of North Texas System; University of North Texas Health Science Center	Singhal, J (corresponding author), Natl Med Ctr, Beckman Res Inst, Dept Diabet & Metab Dis Res, Duarte, CA USA.	ssinghal@coh.org	Awasthi, Sanjay/R-4904-2019; Dalasanur Nagaprashantha, Lokesh/A-6661-2012	Dalasanur Nagaprashantha, Lokesh/0000-0001-7041-1970; Awasthi, Sanjay/0000-0002-5214-5717	National Institutes of Health [CA 77495]; Cancer Research Foundation of North Texas; NATIONAL CANCER INSTITUTE [R01CA077495] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Foundation of North Texas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health Grant CA 77495 and Cancer Research Foundation of North Texas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anisimov VN, 2010, AGING-US, V2, P945, DOI 10.18632/aging.100245; Anisimov VN, 2010, AGING-US, V2, P760, DOI 10.18632/aging.100230; Annaloro C, 2008, BONE MARROW TRANSPL, V41, P797, DOI 10.1038/sj.bmt.1705972; Awasthi S, 2000, BIOCHEMISTRY-US, V39, P9327, DOI 10.1021/bi992964c; Awasthi S, 2005, CANCER RES, V65, P6022, DOI 10.1158/0008-5472.CAN-05-0968; Awasthi S, 2003, INT J CANCER, V106, P635, DOI 10.1002/ijc.11260; Awasthi S, 2010, DIABETES, V59, P714, DOI 10.2337/db09-0911; Belgardt BF, 2010, AGING-US, V2, P621, DOI 10.18632/aging.100192; Belgardt BF, 2010, P NATL ACAD SCI USA, V107, P6028, DOI 10.1073/pnas.1001796107; Cefalu WT, 2008, DIABETES METAB SYND, V2, P208, DOI 10.1016/j.dsx.2008.04.001; Diehl AM, 2004, GUT, V53, P923, DOI 10.1136/gut.2003.037309; Ding QR, 2009, CELL RES, V19, P317, DOI 10.1038/cr.2008.299; Evans JL, 2003, DIABETES, V52, P1, DOI 10.2337/diabetes.52.1.1; Evans JL, 2005, ANTIOXID REDOX SIGN, V7, P1040, DOI 10.1089/ars.2005.7.1040; FONSECA MA, 2005, CLIN CORNERSTONE, V7, P61; GIEROW P, 1980, ANAL BIOCHEM, V101, P305, DOI 10.1016/0003-2697(80)90191-8; Ginsberg Henry N, 2009, J Cardiometab Syndr, V4, P113, DOI 10.1111/j.1559-4572.2008.00044.x; Han R, 2007, DIABETOLOGIA, V50, P1960, DOI 10.1007/s00125-007-0752-7; Hayes JD, 1995, CRIT REV BIOCHEM MOL, V30, P445, DOI 10.3109/10409239509083491; Ikeda M, 1998, J BIOL CHEM, V273, P814, DOI 10.1074/jbc.273.2.814; Jakoby W B, 1978, Adv Enzymol Relat Areas Mol Biol, V46, P383; Jones TH, 2010, J DIABETES, V2, P146, DOI 10.1111/j.1753-0407.2010.00085.x; JULLIENFLORES V, 1995, J BIOL CHEM, V270, P22473, DOI 10.1074/jbc.270.38.22473; Krishnaswami Ashok, 2010, Perm J, V14, P64; Kurucz I, 2002, DIABETES, V51, P1102, DOI 10.2337/diabetes.51.4.1102; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Maechler P, 1999, J BIOL CHEM, V274, P27905, DOI 10.1074/jbc.274.39.27905; Mauser W, 2007, EUR J PHARMACOL, V564, P37, DOI 10.1016/j.ejphar.2007.02.024; Nagaprashantha LD, 2011, CARCINOGENESIS, V32, P568, DOI 10.1093/carcin/bgr021; OPIE LH, 1967, BIOCHEM J, V104, P353, DOI 10.1042/bj1040353; Pessler D, 2001, DIABETOLOGIA, V44, P2156, DOI 10.1007/s001250100024; Pollak M, 2010, CANCER PREV RES, V3, P1060, DOI 10.1158/1940-6207.CAPR-10-0175; Puglianiello Antonella, 2006, Review of Diabetic Studies, V3, P54, DOI 10.1900/RDS.2006.3.54; Robertson RP, 2004, DIABETES, V53, pS119, DOI 10.2337/diabetes.53.2007.S119; Rosse C, 2003, J BIOL CHEM, V278, P30597, DOI 10.1074/jbc.M302191200; Sakai K, 2003, BIOCHEM BIOPH RES CO, V300, P216, DOI 10.1016/S0006-291X(02)02832-2; Sanguino E, 2004, BIOCHEM PHARMACOL, V67, P157, DOI 10.1016/j.bcp.2003.08.034; Sharma R, 2004, INT J CANCER, V112, P934, DOI 10.1002/ijc.20516; Singhal J, 2008, INT J RADIAT ONCOL, V72, P553, DOI 10.1016/j.ijrobp.2008.06.1497; Singhal SS, 2008, J BIOL CHEM, V283, P19714, DOI 10.1074/jbc.M708703200; Singhal SS, 2007, CANCER RES, V67, P4382, DOI 10.1158/0008-5472.CAN-06-4124; Singhal SS, 2011, MOL CANCER THER, V10, P16, DOI 10.1158/1535-7163.MCT-10-0699; Singhal SS, 2009, CANCER LETT, V283, P152, DOI 10.1016/j.canlet.2009.03.033; Singhal SS, 2009, CANCER RES, V69, P4244, DOI 10.1158/0008-5472.CAN-08-3521; Singhal SS, 2009, BIOCHEM PHARMACOL, V77, P761, DOI 10.1016/j.bcp.2008.10.006; Singhal SS, 2009, INT J ONCOL, V34, P191, DOI 10.3892/ijo_00000141; Singhal SS, 2006, CANCER RES, V66, P2354, DOI 10.1158/0008-5472.CAN-05-3534; TAKETA K, 1965, J BIOL CHEM, V240, P651; Talior I, 2003, AM J PHYSIOL-ENDOC M, V285, pE295, DOI 10.1152/ajpendo.00044.2003; Tenenbaum A, 2003, CARDIOVASC DIABETOL, V2, DOI 10.1186/1475-2840-2-4; Tiedge M, 1997, DIABETES, V46, P1733, DOI 10.2337/diabetes.46.11.1733; Tomkin GH, 2009, CURR OPIN LIPIDOL, V20, P10, DOI 10.1097/MOL.0b013e32831ac56c; Vatsyayan R, 2010, BIOCHEM PHARMACOL, V79, P1699, DOI 10.1016/j.bcp.2010.01.016; Vetterli L, 2011, AGING-US, V3, P444, DOI 10.18632/aging.100304	54	36	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2011	6	9							e24688	10.1371/journal.pone.0024688	http://dx.doi.org/10.1371/journal.pone.0024688			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZV	21931813	Green Published, gold, Green Submitted			2022-12-25	WOS:000295321800049
J	Di Marco, GS; Rustemeyer, P; Brand, M; Koch, R; Kentrup, D; Grabner, A; Greve, B; Wittkowski, W; Pavenstadt, H; Hausberg, M; Reuter, S; Lang, D				Di Marco, Giovana S.; Rustemeyer, Peter; Brand, Marcus; Koch, Raphael; Kentrup, Dominik; Grabner, Alexander; Greve, Burkhard; Wittkowski, Werner; Pavenstaedt, Hermann; Hausberg, Martin; Reuter, Stefan; Lang, Detlef			Circulating Endothelial Progenitor Cells in Kidney Transplant Patients	PLOS ONE			English	Article							STAGE RENAL-DISEASE; PERIPHERAL-BLOOD; DYSFUNCTION; RECIPIENTS; HEMODIALYSIS; MOBILIZATION; NEOVASCULARIZATION; HYPERTENSION; EXPRESSION; PREGNANCY	Background: Kidney transplantation (RTx) leads to amelioration of endothelial function in patients with advanced renal failure. Endothelial progenitor cells (EPCs) may play a key role in this repair process. The aim of this study was to determine the impact of RTx and immunosuppressive therapy on the number of circulating EPCs. Methods: We analyzed 52 RTx patients (58+/-13 years; 33 males, mean +/-SD) and 16 age- and gender-matched subjects with normal kidney function (57+/-17; 10 males). RTx patients received a calcineurin inhibitor (CNI)-based (65%) or a CNI-free therapy (35%) and steroids. EPC number was determined by double positive staining for CD133/VEGFR2 and CD34/VEGFR2 by flow cytometry. Stromal cell-derived factor 1 alpha (SDF-1) levels were assessed by ELISA. Experimentally, to dissociate the impact of RTx from the impact of immunosuppressants, we used the 5/6 nephrectomy model. The animals were treated with a CNI-based or a CNI-free therapy, and EPCs (Sca+cKit+) and CD26+ cells were determined by flow cytometry. Results: Compared to controls, circulating number of CD34+/VEGFR2+ and CD133+/VEGFR2+ EPCs increased in RTx patients. There were no correlations between EPC levels and statin, erythropoietin or use of renin angiotensin system blockers in our study. Indeed, multivariate analysis showed that SDF-1 - a cytokine responsible for EPC mobilization - is independently associated with the EPC number. 5/6 rats presented decreased EPC counts in comparison to control animals. Immunosuppressive therapy was able to restore normal EPC values in 5/6 rats. These effects on EPC number were associated with reduced number of CD26+ cells, which might be related to consequent accumulation of SDF-1. Conclusions: We conclude that kidney transplantation and its associated use of immunosuppressive drugs increases the number of circulating EPCs via the manipulation of the CD26/SDF-1 axis. Increased EPC count may be associated to endothelial repair and function in these patients.	[Di Marco, Giovana S.; Brand, Marcus; Kentrup, Dominik; Grabner, Alexander; Pavenstaedt, Hermann; Hausberg, Martin; Reuter, Stefan; Lang, Detlef] Univ Klinikum Munster, Med Klin & Poliklin D, Munster, Germany; [Rustemeyer, Peter; Wittkowski, Werner] Univ Klinikum Munster, Inst Anat, Munster, Germany; [Koch, Raphael] Univ Klinikum Munster, Inst Med Informat & Biomath, Munster, Germany; [Greve, Burkhard] Univ Klinikum Munster, Inst Strahlenbiol, Munster, Germany	University of Munster; University of Munster; University of Munster; University of Munster	Di Marco, GS (corresponding author), Univ Klinikum Munster, Med Klin & Poliklin D, Munster, Germany.	langd@uni-muenster.de	Koch, Raphael/A-7857-2013; Hausberg, Martin/AAE-5484-2019	Koch, Raphael/0000-0002-5581-5122; Kentrup, Dominik/0000-0003-3887-4304; Seno Di Marco, Giovana/0000-0002-1877-638X	Else-Kroener Fresenius Foundation, Germany [P37/2004]; Deutsche Forschungsgemeinschaft (DFG); University of Muenster	Else-Kroener Fresenius Foundation, Germany; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); University of Muenster	This study was supported by an unrestricted grant from the Else-Kroener Fresenius Foundation (P37/2004), Germany. The authors acknowledge support by Deutsche Forschungsgemeinschaft (DFG) and Open Access Publication Fund of University of Muenster. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Bahlmann FH, 2005, HYPERTENSION, V45, P526, DOI 10.1161/01.HYP.0000159191.98140.89; Buemi M, 2007, AM J OBSTET GYNECOL, V196, P68, DOI 10.1016/j.ajog.2006.08.032; Cassens U, 2002, VOX SANG, V82, P198, DOI 10.1046/j.1423-0410.2002.00176.x; Choi JH, 2004, ARTERIOSCL THROM VAS, V24, P1246, DOI 10.1161/01.ATV.0000133488.56221.4a; Coppolino G, 2008, HYPERTENS RES, V31, P717, DOI 10.1291/hypres.31.717; de Groot K, 2005, TRANSPLANTATION, V79, P941, DOI 10.1097/00007890-200504270-00012; de Groot K, 2004, KIDNEY INT, V66, P641, DOI 10.1111/j.1523-1755.2004.00784.x; DECKERT T, 1989, DIABETOLOGIA, V32, P219, DOI 10.1007/BF00285287; Delva P, 2007, J HYPERTENS, V25, P127, DOI 10.1097/HJH.0b013e3280109271; Di Marco GS, 2011, EUR HEART J, V32, P1935, DOI 10.1093/eurheartj/ehq436; Di Marco GS, 2009, J AM SOC NEPHROL, V20, P2235, DOI 10.1681/ASN.2009010061; Herbrig K, 2006, AM J TRANSPLANT, V6, P2922, DOI 10.1111/j.1600-6143.2006.01555.x; Horcicka V, 2009, TRANSPL P, V41, P1599, DOI 10.1016/j.transproceed.2008.10.100; Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150; Jie KE, 2010, NEPHROL DIAL TRANSPL, V25, P1875, DOI 10.1093/ndt/gfp749; Kocak H, 2006, TRANSPL P, V38, P416, DOI 10.1016/j.transproceed.2006.01.015; Korom S, 2003, ADV EXP MED BIOL, V524, P133; Korom S, 2002, TRANSPLANT P, V34, P1753, DOI 10.1016/S0041-1345(02)03054-3; Lorenzen J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011477; Metsuyanim S, 2009, PEDIATR RES, V65, P221, DOI 10.1203/PDR.0b013e3181903909; Nickel T, 2006, TRANSPLANTATION, V82, pS41, DOI 10.1097/01.tp.0000231505.91988.26; Ochodnicky P, 2006, J CARDIOVASC PHARM, V47, pS151, DOI 10.1097/00005344-200606001-00009; Patterson C, 2003, CIRCULATION, V107, P2995, DOI 10.1161/01.CIR.0000074241.91121.70; Peichev M, 2000, BLOOD, V95, P952, DOI 10.1182/blood.V95.3.952.003k27_952_958; Reuter S, 2009, NEPHROL DIAL TRANSPL, V24, P2838, DOI 10.1093/ndt/gfp142; Robb AO, 2007, REPRODUCTION, V133, P1, DOI 10.1530/REP-06-0219; Rustemeyer P, 2007, J IMMUNOASS IMMUNOCH, V28, P13, DOI 10.1080/15321810601025549; Rustemeyer P, 2006, J IMMUNOASS IMMUNOCH, V27, P77, DOI 10.1080/15321810500403789; Siddique Aurangzeb, 2010, J Angiogenes Res, V2, P6, DOI 10.1186/2040-2384-2-6; Soler MJ, 2005, AM J TRANSPLANT, V5, P2154, DOI 10.1111/j.1600-6143.2005.01010.x; Spiel AO, 2008, THROMB RES, V123, P108, DOI 10.1016/j.thromres.2008.03.007; Steiner S, 2006, TRANSPLANTATION, V81, P599, DOI 10.1097/01.tp.0000198418.06383.e8; Sturiale A, 2007, BLOOD PURIFICAT, V25, P242, DOI 10.1159/000101697; Szmitko PE, 2003, CIRCULATION, V107, P3093, DOI 10.1161/01.CIR.0000074242.66719.4A; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Togel F, 2005, KIDNEY INT, V67, P1772, DOI 10.1111/j.1523-1755.2005.00275.x; Tongers J, 2007, J AM SOC NEPHROL, V18, P2843, DOI 10.1681/ASN.2007050597; Trapp A, 2005, J CARDIOVASC PHARM, V45, P81, DOI 10.1097/00005344-200501000-00014; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; Urbich C, 2003, CIRCULATION, V108, P2511, DOI 10.1161/01.CIR.0000096483.29777.50; Wang CH, 2008, AM J PHYSIOL-REG I, V294, pR811, DOI 10.1152/ajpregu.00543.2007; Westerweel PE, 2007, AM J PHYSIOL-RENAL, V292, pF1132, DOI 10.1152/ajprenal.00163.2006; Wolfe RA, 1999, NEW ENGL J MED, V341, P1725, DOI 10.1056/NEJM199912023412303; Zemani F, 2008, ARTERIOSCL THROM VAS, V28, P644, DOI 10.1161/ATVBAHA.107.160044	45	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e24046	10.1371/journal.pone.0024046	http://dx.doi.org/10.1371/journal.pone.0024046			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CK	21931640	gold, Green Published, Green Submitted			2022-12-25	WOS:000294802800019
J	Hellman, AB; Shen, K				Hellman, Andrew B.; Shen, Kang			Sensory Transduction Channel Subunits, tax-4 and tax-2, Modify Presynaptic Molecular Architecture in C-elegans	PLOS ONE			English	Article							NUCLEOTIDE-GATED CHANNEL; CAENORHABDITIS-ELEGANS; THERMOSENSORY NEURON; SYNAPTIC ACTIVITY; THERMOTAXIS; PLASTICITY; CELLS	During development, neural activity is important for forming proper connections in neural networks. The effect of activity on the gross morphology and synaptic strength of neurons has been well documented, but little is known about how activity affects different molecular components during development. Here, we examine the localization of four fluorescently-tagged presynaptic proteins, RAB-3, SNG-1/synaptogyrin, SYD-2/Liprin-a, and SAD-1/SAD kinase, in the C. elegans thermosensory neuron AFD. We show that tax-4 and tax-2, two genes that encode the cyclic nucleotide-gated channel necessary for sensory transduction in AFD, disrupt the localization of all four proteins. In wild-type animals, the synaptic vesicle (SV) markers RAB-3 and SNG-1 and the active zone markers SYD-2 and SAD-1 localize in a stereotyped, punctate pattern in the AFD axon. In tax-4 and tax-2 mutants, SV and SYD-2 puncta are more numerous and less intense. Interestingly, SAD-1 puncta are also less intense but do not increase in number. The change in puncta number can be rescued cell-autonomously in AFD. These results suggest that sensory transduction genes tax-4 and tax-2 are necessary for the proper assembly of presynapses.	[Hellman, Andrew B.; Shen, Kang] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Shen, Kang] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Shen, Kang] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University	Shen, K (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	kangshen@stanford.edu		Hellman, Andrew/0000-0002-6208-0566	Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	Funding was provided by the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chi P, 2001, NAT NEUROSCI, V4, P1187, DOI 10.1038/nn756; Coburn CM, 1996, NEURON, V17, P695, DOI 10.1016/S0896-6273(00)80201-9; Craven KB, 2006, ANNU REV PHYSIOL, V68, P375, DOI 10.1146/annurev.physiol.68.040104.134728; Davis MW, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-118; Daw MI, 2007, MOL CELL NEUROSCI, V34, P493, DOI 10.1016/j.mcn.2007.01.001; HEDGECOCK EM, 1975, P NATL ACAD SCI USA, V72, P4061, DOI 10.1073/pnas.72.10.4061; Hopf FW, 2002, J NEUROSCI, V22, P775, DOI 10.1523/JNEUROSCI.22-03-00775.2002; Inada H, 2006, GENETICS, V172, P2239, DOI 10.1534/genetics.105.050013; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kimura KD, 2004, CURR BIOL, V14, P1291, DOI 10.1016/j.cub.2004.06.060; Komatsu H, 1999, BRAIN RES, V821, P160, DOI 10.1016/S0006-8993(99)01111-7; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Matulef K, 2003, ANNU REV CELL DEV BI, V19, P23, DOI 10.1146/annurev.cellbio.19.110701.154854; Mello C, 1995, METHOD CELL BIOL, V48, P451; MORI I, 1995, NATURE, V376, P344, DOI 10.1038/376344a0; Nguyen QT, 1996, CURR OPIN NEUROBIOL, V6, P104, DOI 10.1016/S0959-4388(96)80015-8; Ramot D, 2008, NAT NEUROSCI, V11, P908, DOI 10.1038/nn.2157; Spitzer NC, 2006, NATURE, V444, P707, DOI 10.1038/nature05300; Tsuriel S, 2006, PLOS BIOL, V4, P1572, DOI 10.1371/journal.pbio.0040271; WHITE JG, 1986, STRUCTURE NERVOUS SY; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P978, DOI 10.1152/jn.1963.26.6.978; Yu S, 1997, P NATL ACAD SCI USA, V94, P3384, DOI 10.1073/pnas.94.7.3384	24	5	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2011	6	9							e24562	10.1371/journal.pone.0024562	http://dx.doi.org/10.1371/journal.pone.0024562			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CH	21915351	Green Published, gold, Green Submitted			2022-12-25	WOS:000294802500060
J	Yadav, AK; Bhardwaj, G; Basak, T; Kumar, D; Ahmad, S; Priyadarshini, R; Singh, AK; Dash, D; Sengupta, S				Yadav, Amit Kumar; Bhardwaj, Gourav; Basak, Trayambak; Kumar, Dhirendra; Ahmad, Shadab; Priyadarshini, Ruby; Singh, Ashish Kumar; Dash, Debasis; Sengupta, Shantanu			A Systematic Analysis of Eluted Fraction of Plasma Post Immunoaffinity Depletion: Implications in Biomarker Discovery	PLOS ONE			English	Article							PROTEIN REFERENCE DATABASE; TANDEM MASS-SPECTROMETRY; HUMAN SERUM; PROTEOMIC ANALYSIS; IDENTIFICATIONS; INTERACTOME; STRATEGIES; ALBUMINOME; ALGORITHM; PEPTIDES	Plasma is the most easily accessible source for biomarker discovery in clinical proteomics. However, identifying potential biomarkers from plasma is a challenge given the large dynamic range of proteins. The potential biomarkers in plasma are generally present at very low abundance levels and hence identification of these low abundance proteins necessitates the depletion of highly abundant proteins. Sample pre-fractionation using immuno-depletion of high abundance proteins using multi-affinity removal system (MARS) has been a popular method to deplete multiple high abundance proteins. However, depletion of these abundant proteins can result in concomitant removal of low abundant proteins. Although there are some reports suggesting the removal of non-targeted proteins, the predominant view is that number of such proteins is small. In this study, we identified proteins that are removed along with the targeted high abundant proteins. Three plasma samples were depleted using each of the three MARS (Hu-6, Hu-14 and Proteoprep 20) cartridges. The affinity bound fractions were subjected to gelC-MS using an LTQ-Orbitrap instrument. Using four database search algorithms including MassWiz (developed in house), we selected the peptides identified at <1% FDR. Peptides identified by at least two algorithms were selected for protein identification. After this rigorous bioinformatics analysis, we identified 101 proteins with high confidence. Thus, we believe that for biomarker discovery and proper quantitation of proteins, it might be better to study both bound and depleted fractions from any MARS depleted plasma sample.	[Yadav, Amit Kumar; Kumar, Dhirendra; Singh, Ashish Kumar; Dash, Debasis] CSIR, Inst Genom & Integrat Biol, GN Ramachandran Knowledge Ctr Genome Informat, Delhi, India; [Bhardwaj, Gourav; Basak, Trayambak; Ahmad, Shadab; Priyadarshini, Ruby; Sengupta, Shantanu] CSIR, Inst Genom & Integrat Biol, Prote & Struct Biol Div, Delhi, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB)	Yadav, AK (corresponding author), CSIR, Inst Genom & Integrat Biol, GN Ramachandran Knowledge Ctr Genome Informat, Delhi, India.	ddash@igib.res.in; shantanus@igib.res.in	Basak, Trayambak/AAB-8534-2020; Yadav, Amit Kumar/AAR-3803-2021; Bhardwaj, Gourav/L-1746-2019; Yadav, Amit/B-9388-2011; Kumar, Dhirendra/AAE-7237-2021; Dash, Debasis/F-3137-2012	Yadav, Amit Kumar/0000-0002-9445-8156; Bhardwaj, Gourav/0000-0002-9543-8237; Yadav, Amit/0000-0002-9445-8156; Dash, Debasis/0000-0002-5647-3785; Basak, Trayambak/0000-0001-7683-3189; Kumar, Dhirendra/0000-0002-4349-3605	Council of Science & Industrial Research [NWP-04]	Council of Science & Industrial Research	This study was funded by Council of Science & Industrial Research network project entitled 'Plasma Proteomics: Health, Environment and Disease'(NWP-04). www.csir.res.in. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson NL, 2010, CLIN CHEM, V56, P1775, DOI 10.1373/clinchem.2010.146167; Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200; Anderson NL, 2004, MOL CELL PROTEOMICS, V3, P311, DOI 10.1074/mcp.M300127-MCP200; Bellei E, 2011, AMINO ACIDS, V40, P145, DOI 10.1007/s00726-010-0628-x; Bjorhall K, 2005, PROTEOMICS, V5, P307, DOI 10.1002/pmic.200400900; Cabre A, 2007, J INTERN MED, V262, P496, DOI 10.1111/j.1365-2796.2007.01849.x; Coombes KR, 2005, NAT BIOTECHNOL, V23, P291, DOI 10.1038/nbt0305-291; Costa LG, 2005, CLIN CHIM ACTA, V352, P37, DOI 10.1016/j.cccn.2004.09.019; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Dagda Ruben K, 2010, J Proteomics Bioinform, V3, P39; Derer W, 2009, CIRC-CARDIOVASC INTE, V2, P14, DOI 10.1161/CIRCINTERVENTIONS.108.795799; Echan LA, 2005, PROTEOMICS, V5, P3292, DOI 10.1002/pmic.200401228; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Faca V, 2007, J PROTEOME RES, V6, P3558, DOI 10.1021/pr070233q; Faca V, 2007, BIOTECHNIQUES, V43, P279, DOI 10.2144/000112541; Geer LY, 2004, J PROTEOME RES, V3, P958, DOI 10.1021/pr0499491; Gong Y, 2006, J PROTEOME RES, V5, P1379, DOI 10.1021/pr0600024; Gundry RL, 2007, PROTEOM CLIN APPL, V1, P73, DOI 10.1002/prca.200600276; Gundry RL, 2009, PROTEOMICS, V9, P2021, DOI 10.1002/pmic.200800686; Gupta N, 2009, J PROTEOME RES, V8, P4173, DOI 10.1021/pr9004794; Hernandez-Toro J, 2007, BIOINFORMATICS, V23, P2495, DOI 10.1093/bioinformatics/btm373; Huang L, 2005, PROTEOMICS, V5, P3314, DOI 10.1002/pmic.200401277; Juhasz P, 2011, J PROTEOME RES, V10, P34, DOI 10.1021/pr100659e; Kall L, 2008, J PROTEOME RES, V7, P29, DOI 10.1021/pr700600n; Kersey PJ, 2004, PROTEOMICS, V4, P1985, DOI 10.1002/pmic.200300721; Kessner D, 2008, BIOINFORMATICS, V24, P2534, DOI 10.1093/bioinformatics/btn323; Krasnoselsky AL, 2008, J PROTEOME RES, V7, P2546, DOI 10.1021/pr7007219; Liotta LA, 2003, NATURE, V425, P905, DOI 10.1038/425905a; Liu T, 2006, MOL CELL PROTEOMICS, V5, P2167, DOI 10.1074/mcp.T600039-MCP200; Lo WY, 2007, J PROTEOME RES, V6, P2143, DOI 10.1021/pr060551+; Mishra GR, 2006, NUCLEIC ACIDS RES, V34, pD411, DOI 10.1093/nar/gkj141; Muthusamy B, 2005, PROTEOMICS, V5, P3531, DOI 10.1002/pmic.200401335; Nesvizhskii AI, 2005, MOL CELL PROTEOMICS, V4, P1419, DOI 10.1074/mcp.R500012-MCP200; Nicholas BL, 2010, AM J RESP CRIT CARE, V181, P1049, DOI 10.1164/rccm.200906-0857OC; Omenn GS, 2005, PROTEOMICS, V5, P3226, DOI 10.1002/pmic.200500358; Peri S, 2003, GENOME RES, V13, P2363, DOI 10.1101/gr.1680803; Peri S, 2004, NUCLEIC ACIDS RES, V32, pD497, DOI 10.1093/nar/gkh070; Prasad TSK, 2009, METHODS MOL BIOL, V577, P67, DOI 10.1007/978-1-60761-232-2_6; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smith MPW, 2011, PROTEOMICS, V11, P2222, DOI 10.1002/pmic.201100005; States DJ, 2006, NAT BIOTECHNOL, V24, P333, DOI 10.1038/nbt1183; Stempfer R, 2008, ELECTROPHORESIS, V29, P4316, DOI 10.1002/elps.200800211; Sun RX, 2010, J PROTEOME RES, V9, P6354, DOI 10.1021/pr100648r; Taylor CF, 2007, NAT BIOTECHNOL, V25, P887, DOI 10.1038/nbt1329; Tu CJ, 2010, J PROTEOME RES, V9, P4982, DOI 10.1021/pr100646w; Yadav AK, 2011, J PROTEOME RES, V10, P2154, DOI 10.1021/pr200031z; Zhang Q, 2011, J PROTEOME RES, V10, P46, DOI 10.1021/pr101052y; Zhou M, 2004, ELECTROPHORESIS, V25, P1289, DOI 10.1002/elps.200405866	49	76	76	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2011	6	9							e24442	10.1371/journal.pone.0024442	http://dx.doi.org/10.1371/journal.pone.0024442			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CH	21931718	gold, Green Submitted, Green Published			2022-12-25	WOS:000294802500046
J	Chan, KMA; Hoshizaki, L; Klinkenberg, B				Chan, Kai M. A.; Hoshizaki, Lara; Klinkenberg, Brian			Ecosystem Services in Conservation Planning: Targeted Benefits vs. Co-Benefits or Costs?	PLOS ONE			English	Article							LAND-USE; CARBON SEQUESTRATION; POLLINATION SERVICES; TRADE-OFFS; BIODIVERSITY; LANDSCAPE; RECRUITMENT; WATERSHEDS; COLUMBIA; DESIGN	There is growing support for characterizing ecosystem services in order to link conservation and human well-being. However, few studies have explicitly included ecosystem services within systematic conservation planning, and those that have follow two fundamentally different approaches: ecosystem services as intrinsically-important targeted benefits vs. substitutable co-benefits. We present a first comparison of these two approaches in a case study in the Central Interior of British Columbia. We calculated and mapped economic values for carbon storage, timber production, and recreational angling using a geographical information system (GIS). These 'marginal' values represent the difference in service-provision between conservation and managed forestry as land uses. We compared two approaches to including ecosystem services in the site-selection software Marxan: as Targeted Benefits, and as Co-Benefits/Costs (in Marxan's cost function); we also compared these approaches with a Hybrid approach (carbon and angling as targeted benefits, timber as an opportunity cost). For this analysis, the Co-Benefit/Cost approach yielded a less costly reserve network than the Hybrid approach (1.6% cheaper). Including timber harvest as an opportunity cost in the cost function resulted in a reserve network that achieved targets equivalently, but at 15% lower total cost. We found counter-intuitive results for conservation: conservation-compatible services (carbon, angling) were positively correlated with each other and biodiversity, whereas the conservation-incompatible service (timber) was negatively correlated with all other networks. Our findings suggest that including ecosystem services within a conservation plan may be most cost-effective when they are represented as substitutable co-benefits/costs, rather than as targeted benefits. By explicitly valuing the costs and benefits associated with services, we may be able to achieve meaningful biodiversity conservation at lower cost and with greater co-benefits.	[Chan, Kai M. A.; Hoshizaki, Lara] Univ British Columbia, Inst Resources Environm & Sustainabil, Vancouver, BC V5Z 1M9, Canada; [Klinkenberg, Brian] Univ British Columbia, Dept Geog, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia	Chan, KMA (corresponding author), Univ British Columbia, Inst Resources Environm & Sustainabil, Vancouver, BC V5Z 1M9, Canada.	kaichan@ires.ubc.ca	Chan, Kai M A/C-1682-2009	Chan, Kai M A/0000-0002-7804-3276	Nature Conservancy of Canada (NCC) through UBC [07-4916]; UBC [J05-0035]; (Canadian) Social Sciences and Humanities Research Council [06-1860]; Canada Research Chairs program; Canadian Foundation for Innovation/B.C. Knowledge Development Leaders Opportunity Fund [F07-0010]	Nature Conservancy of Canada (NCC) through UBC; UBC; (Canadian) Social Sciences and Humanities Research Council(Social Sciences and Humanities Research Council of Canada (SSHRC)); Canada Research Chairs program(Canada Research Chairs); Canadian Foundation for Innovation/B.C. Knowledge Development Leaders Opportunity Fund(Canada Foundation for Innovation)	This work was funded by a contract with the Nature Conservancy of Canada (NCC, http://www.natureconservancy.ca/) through UBC (ORSIL # 07-4916), a UBC Hampton Fund Research Grant (ORSIL # J05-0035), a Research Development Initiatives grant from the (Canadian) Social Sciences and Humanities Research Council (www.sshrc-crsh.gc.ca/) (ORSIL # 06-1860), the Canada Research Chairs program, and a Canadian Foundation for Innovation/B.C. Knowledge Development Leaders Opportunity Fund grant (ORSIL # F07-0010). NCC supplied data and assistance with the biodiversity Marxan runs as described in the methods, but otherwise the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, THE FUTURE OF NATURE, DOI DOI 10.12987/9780300188479-039; Ardron J. A., 2010, MARXAN GOOD PRACTICE; Ardron J. A., 2008, MARXAN GOOD PRACTICE; Arroja L, 2006, CLIMATIC CHANGE, V74, P123, DOI 10.1007/s10584-006-3461-1; Assessment M.E., 2005, EC HUM WELL BEING SY, P534, DOI [10.1119/1.2344558, DOI 10.1119/1.2344558]; BALL IR, 2000, MARXAN  V1 8 2 MARIN; Ban NC, 2009, CONSERV LETT, V2, P206, DOI 10.1111/j.1755-263X.2009.00071.x; Bennett EM, 2009, ECOL LETT, V12, P1394, DOI 10.1111/j.1461-0248.2009.01387.x; BOCKSTAEL N, 1995, ECOL ECON, V14, P143, DOI 10.1016/0921-8009(95)00026-6; Bode M, 2008, P NATL ACAD SCI USA, V105, P6498, DOI 10.1073/pnas.0710705105; Carpenter SR, 2009, P NATL ACAD SCI USA, V106, P1305, DOI 10.1073/pnas.0808772106; Chan KMA, 2006, PLOS BIOL, V4, P2138, DOI 10.1371/journal.pbio.0040379; Chan KMA, 2007, CONSERV BIOL, V21, P59, DOI 10.1111/j.1523-1739.2006.00570.x; Chan KMA, 2011, NATURAL CAPITAL: THEORY & PRACTICE OF MAPPING ECOSYSTEM SERVICES, P206; Chan KMA, 2008, P NATL ACAD SCI USA, V105, P19342, DOI 10.1073/pnas.0810522105; CHAN KMA, ECOLOGICAL IN PRESS; Chape S., 2009, BIOSCIENCE, V59, P623; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Creedy J, 2001, ECOL ECON, V38, P71, DOI 10.1016/S0921-8009(01)00148-3; Daily GC, 2000, SCIENCE, V289, P395, DOI 10.1126/science.289.5478.395; Daily GC, 2009, FRONT ECOL ENVIRON, V7, P21, DOI 10.1890/080025; DEMARCHI DA, 1996, ECOLOGY INTRO ECOREG; Egoh B, 2009, BIOL CONSERV, V142, P553, DOI 10.1016/j.biocon.2008.11.009; Egoh B, 2007, ECOL ECON, V63, P714, DOI 10.1016/j.ecolecon.2007.04.007; Fishburn IS, 2009, CONSERV LETT, V2, P74, DOI 10.1111/j.1755-263X.2008.00045.x; Goldman RL, 2008, P NATL ACAD SCI USA, V105, P9445, DOI 10.1073/pnas.0800208105; *GOV CAN FAOSS, 2009, 2005 SURV RECR FISH; Jordan P, 2006, GEOMORPHOLOGY, V79, P27, DOI 10.1016/j.geomorph.2005.09.019; Knight AT, 2008, CONSERV BIOL, V22, P610, DOI 10.1111/j.1523-1739.2008.00914.x; Kurz W.A., 1998, MITIGATION ADAPTATIO, V2, P405, DOI [10.1023/B:MITI.0000004486.62808.29, DOI 10.1023/B:MITI.0000004486.62808.29]; Leslie H, 2003, ECOL APPL, V13, pS185; Lohse KA, 2008, ECOL APPL, V18, P467, DOI 10.1890/07-0354.1; Lonsdorf E, 2009, ANN BOT-LONDON, V103, P1589, DOI 10.1093/aob/mcp069; Luck GW, 2009, CONSERV LETT, V2, P179, DOI 10.1111/j.1755-263X.2009.00064.x; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; MATTHEWS E, 2000, PILOT ANAL GLOBAL EC; McLeod K., 2009, ECOSYSTEM BASED MANA; *MIN FOR RANG, 2010, LOG MARK REP WEBS; *MIN FOR RANG, 2008, TIMB SUPPL REV WEBS; *MIN FOR RANG, 2008, INT APPR MAN EFF JUL; Naidoo R, 2008, P NATL ACAD SCI USA, V105, P9495, DOI 10.1073/pnas.0707823105; Naidoo R, 2006, PLOS BIOL, V4, P2153, DOI 10.1371/journal.pbio.0040360; Naidoo R, 2006, TRENDS ECOL EVOL, V21, P681, DOI 10.1016/j.tree.2006.10.003; Nalle D. J., 2004, Journal of Environmental Economics and Management, V48, P997, DOI 10.1016/j.jeem.2004.01.001; *NATURESERVE, 2005, NATURESERVE CONS STA; *NCC, 2007, CENTR INT EC ASS; Nelson E, 2009, FRONT ECOL ENVIRON, V7, P4, DOI 10.1890/080023; Newburn D, 2005, CONSERV BIOL, V19, P1411, DOI 10.1111/j.1523-1739.2005.00199.x; Northcote T.G., 2004, FISHES FORESTRY WORL; Parkinson EA, 2004, CAN J FISH AQUAT SCI, V61, P1658, DOI 10.1139/F04-101; Polasky S, 2005, ECOL APPL, V15, P1387, DOI 10.1890/03-5423; Polasky S, 2008, BIOL CONSERV, V141, P1505, DOI 10.1016/j.biocon.2008.03.022; PRESSEY RL, 1994, BIODIVERS CONSERV, V3, P242, DOI 10.1007/BF00055941; Pressey RL, 2003, BIOL CONSERV, V112, P99, DOI 10.1016/S0006-3207(02)00424-X; Pressey RL, 2009, ORYX, V43, P464, DOI 10.1017/S0030605309990500; REESEHANSEN L, 2006, EVALUATING DESIGNATI; Regetz J, 2003, AQUAT CONSERV, V13, P35, DOI 10.1002/aqc.524; Ricketts TH, 2008, ECOL LETT, V11, P499, DOI 10.1111/j.1461-0248.2008.01157.x; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; Rodriguez JP, 2006, ECOL SOC, V11; Rosenzweig M. L., 2003, WIN WIN ECOLOGY EART; Stewart RR, 2005, ENVIRON MODEL ASSESS, V10, P203, DOI 10.1007/s10666-005-9001-y; TERBORGH J, 1999, REQUIEM NATURE; THOMAE O, 2008, E KOOTENAY TIMBER ME; Toman M, 1998, ECOL ECON, V25, P57, DOI 10.1016/S0921-8009(98)00017-2; Waltner-Toews D, 2008, ECOSYSTEM APPROACH C; Wilson K, 2005, ENVIRON MANAGE, V35, P527, DOI 10.1007/s00267-004-0095-9	67	67	75	5	143	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2011	6	9							e24378	10.1371/journal.pone.0024378	http://dx.doi.org/10.1371/journal.pone.0024378			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	817QP	21915318	Green Published, gold			2022-12-25	WOS:000294689200039
J	Zhao, YG; Thornton, AM; Kinney, MC; Ma, CA; Spinner, JJ; Fuss, IJ; Shevach, EM; Jain, A				Zhao, Yongge; Thornton, Angela M.; Kinney, Matthew C.; Ma, Chi A.; Spinner, Jacob J.; Fuss, Ivan J.; Shevach, Ethan M.; Jain, Ashish			The Deubiquitinase CYLD Targets Smad7 Protein to Regulate Transforming Growth Factor beta (TGF-beta) Signaling and the Development of Regulatory T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE TAK1; UBIQUITIN LIGASE; INDUCTION; RECEPTOR; ACTIVATION; ENZYME; BINDS; A20; JNK	CYLD is a lysine 63-deubiquitinating enzyme that inhibits NF-kappa B and JNK signaling. Here, we show that CYLD knock-out mice have markedly increased numbers of regulatory T cells (Tregs) in peripheral lymphoid organs but not in the thymus. In vitro stimulation of CYLD-deficient naive T cells with anti-CD3/28 in the presence of TGF-beta led to a marked increase in the number of Foxp3-expressing T cells when compared with stimulated naive control CD4(+) cells. Under endogenous conditions, CYLD formed a complex with Smad7 that facilitated CYLD deubiquitination of Smad7 at lysine 360 and 374 residues. Moreover, this site-specific ubiquitination of Smad7 was required for activation of TAK1 and p38 kinases. Finally, knockdown of Smad7 or inhibition of p38 activity in primary T cells impaired Treg differentiation. Together, our results show that CYLD regulates TGF-beta signaling function in T cells and the development of Tregs through deubiquitination of Smad7.	[Zhao, Yongge; Kinney, Matthew C.; Ma, Chi A.; Spinner, Jacob J.; Fuss, Ivan J.; Jain, Ashish] NIAID, Lab Host Def, NIH, Bethesda, MD 20892 USA; [Thornton, Angela M.; Shevach, Ethan M.] NIAID, Lab Immunol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Jain, A (corresponding author), Clin Res Ctr, Rm 5-W-3950,9000 Rockville Pike, Bethesda, MD 20892 USA.	ajain@niaid.nih.gov			National Institutes of Health through the NIAID; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000959] Funding Source: NIH RePORTER	National Institutes of Health through the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program of the National Institutes of Health through the NIAID.	Bignell GR, 2000, NAT GENET, V25, P160, DOI 10.1038/76006; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Cobbold SP, 2004, J IMMUNOL, V172, P6003, DOI 10.4049/jimmunol.172.10.6003; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Glittenberg M, 2007, FLY, V1, P330, DOI 10.4161/fly.5399; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hong S, 2007, NAT IMMUNOL, V8, P504, DOI 10.1038/ni1451; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; JENTSCH S, 1990, TRENDS BIOCHEM SCI, V15, P195, DOI 10.1016/0968-0004(90)90161-4; Juszczynski P, 2007, P NATL ACAD SCI USA, V104, P13134, DOI 10.1073/pnas.0706017104; Kavsak P, 2000, MOL CELL, V6, P1365, DOI 10.1016/S1097-2765(00)00134-9; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Lee AJ, 2010, J BIOL CHEM, V285, P15696, DOI 10.1074/jbc.M109.095190; Mantel PY, 2006, J IMMUNOL, V176, P3593, DOI 10.4049/jimmunol.176.6.3593; Maruyama T, 2011, NAT IMMUNOL, V12, P86, DOI 10.1038/ni.1965; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Prud'homme GJ, 2000, J AUTOIMMUN, V14, P23, DOI 10.1006/jaut.1999.0339; Reiley W, 2004, J BIOL CHEM, V279, P55161, DOI 10.1074/jbc.M411049200; Reiley WW, 2007, J EXP MED, V204, P1475, DOI 10.1084/jem.20062694; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sather BD, 2007, J EXP MED, V204, P1335, DOI 10.1084/jem.20070081; Sun SC, 2010, CELL DEATH DIFFER, V17, P25, DOI 10.1038/cdd.2009.43; Sun SC, 2008, NAT REV IMMUNOL, V8, P501, DOI 10.1038/nri2337; Tanaka K, 1998, MOL CELLS, V8, P503; Thornton AM, 2004, EUR J IMMUNOL, V34, P366, DOI 10.1002/eji.200324455; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Wan YSY, 2006, NAT IMMUNOL, V7, P851, DOI 10.1038/ni1355; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Yamashita M, 2008, MOL CELL, V31, P918, DOI 10.1016/j.molcel.2008.09.002; Zhang J, 2006, J CLIN INVEST, V116, P3042, DOI 10.1172/JCI28746	34	54	60	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40520	40530		10.1074/jbc.M111.292961	http://dx.doi.org/10.1074/jbc.M111.292961			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21931165	Green Published, hybrid			2022-12-25	WOS:000297315400011
J	Zhao, L; Yamaguchi, Y; Sharif, S; Du, XY; Song, JJ; Lee, DM; Recht, LD; Robinson, WH; Morser, J; Leung, LLK				Zhao, Lei; Yamaguchi, Yasuto; Sharif, Shadi; Du, Xiao-Yan; Song, Jason J.; Lee, David M.; Recht, Lawrence D.; Robinson, William H.; Morser, John; Leung, Lawrence L. K.			Chemerin158K Protein Is the Dominant Chemerin Isoform in Synovial and Cerebrospinal Fluids but Not in Plasma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIRCULATING LEVELS; DIABETES-MELLITUS; DENDRITIC CELLS; FATTY LIVER; INFLAMMATION; ACTIVATION; EXPRESSION; PROTEASES; LIGANDS; DISEASE	Chemerin is a chemoattractant involved in immunity that may also function as an adipokine. Chemerin circulates as an inactive precursor (chem163S), and its activation requires proteolytic cleavages at its C terminus, involving proteases involved in coagulation, fibrinolysis, and inflammation. However, the key proteolytic steps in prochemerin activation in vivo remain to be established. Previously, we have shown that C-terminal cleavage of chem163S by plasmin to chem158K, followed by a carboxypeptidase cleavage, leads to the most active isoform, chem157S. To identify and quantify the in vivo chemerin isoforms in biological specimens, we developed specific ELISAs for chem163S, chem158K, and chem157S, using antibodies raised against peptides from the C terminus of the different chemerin isoforms. We found that the mean plasma concentrations of chem163S, chem158K, and chem157S were 40 +/- 7.9, 8.1 +/- 2.9, and 0.7 +/- 0.8 ng/ml, respectively. The total level of cleaved and non-cleaved chemerins in cerebrospinal fluids was similar to 10% of plasma levels whereas it was elevated similar to 2-fold in synovial fluids from patients with arthritis. On the other hand, the fraction of cleaved chemerins was much higher in synovial fluid and cerebrospinal fluid samples than in plasma (similar to 75%, 50%, and 18% respectively). Chem158K was the dominant chemerin isoform, and it was not generated by ex vivo processing, indicating that cleavage of prochemerin at position Lys-158, whether by plasmin or another serine protease, represents a major step in prochemerin activation in vivo. Our study provides the first direct evidence that chemerin undergoes extensive proteolytic processing in vivo, underlining the importance of measuring individual isoforms.	[Zhao, Lei; Yamaguchi, Yasuto; Sharif, Shadi; Du, Xiao-Yan; Morser, John; Leung, Lawrence L. K.] Stanford Univ, Sch Med, Div Hematol, Dept Med, Stanford, CA 94305 USA; [Song, Jason J.; Robinson, William H.] Stanford Univ, Sch Med, Div Rheumatol & Immunol, Dept Med, Stanford, CA 94305 USA; [Recht, Lawrence D.] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Lee, David M.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Lee, David M.] Novartis Inst BioMed Res, CH-4002 Basel, Switzerland; [Robinson, William H.; Leung, Lawrence L. K.] Vet Affairs Palo Alto Hlth Care Syst, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Harvard University; Brigham & Women's Hospital; Novartis; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Morser, J (corresponding author), 269 Campus Dr,CCSR 1155,MC5156, Stanford, CA 94305 USA.	jmorser@stanford.edu; lawrence.leung@stanford.edu		Robinson, William/0000-0003-4385-704X	National Institutes of Health [HL057530, AI085268]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057530] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI085268] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants HL057530 and AI085268.	Berahovich RD, 2005, J IMMUNOL, V174, P7341, DOI 10.4049/jimmunol.174.11.7341; Dogru T, 2010, SCAND J GASTROENTERO, V45, P1000, DOI 10.3109/00365521003749826; Du XY, 2009, J BIOL CHEM, V284, P751, DOI 10.1074/jbc.M805000200; Ernst MC, 2010, TRENDS ENDOCRIN MET, V21, P660, DOI 10.1016/j.tem.2010.08.001; Guillabert A, 2008, J LEUKOCYTE BIOL, V84, P1530, DOI 10.1189/jlb.0508322; Hu WC, 2011, DIABETES RES CLIN PR, V91, P159, DOI 10.1016/j.diabres.2010.11.016; Kukla M, 2010, J VIRAL HEPATITIS, V17, P661, DOI 10.1111/j.1365-2893.2009.01224.x; Meder W, 2003, FEBS LETT, V555, P495, DOI 10.1016/S0014-5793(03)01312-7; Nagpal S, 1997, J INVEST DERMATOL, V109, P91, DOI 10.1111/1523-1747.ep12276660; Pfau D, 2010, HORM RES PAEDIAT, V74, P56, DOI 10.1159/000282114; Pfau D, 2010, DIABETES CARE, V33, P171, DOI 10.2337/dc09-1351; Sell H, 2010, J CLIN ENDOCR METAB, V95, P2892, DOI 10.1210/jc.2009-2374; Sharif SA, 2009, ARTHRITIS RHEUM-US, V60, P2902, DOI 10.1002/art.24814; Tonjes A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013911; Vermi W, 2005, J EXP MED, V201, P509, DOI 10.1084/jem.20041310; Weigert J, 2010, INFLAMM BOWEL DIS, V16, P630, DOI 10.1002/ibd.21091; Wittamer V, 2005, J IMMUNOL, V175, P487, DOI 10.4049/jimmunol.175.1.487; Wittamer V, 2003, J EXP MED, V198, P977, DOI 10.1084/jem.20030382; Yamaguchi Y, 2011, J BIOL CHEM, V286, P39510, DOI 10.1074/jbc.M111.258921; Yamamoto T, 2010, NEPHROL DIAL TRANSPL, V25, P4017, DOI 10.1093/ndt/gfq329; Yang ML, 2010, J INVEST MED, V58, P883, DOI 10.231/JIM.0b013e3181ec5db2; Zabel BA, 2005, J BIOL CHEM, V280, P34661, DOI 10.1074/jbc.M504868200; Zabel BA, 2005, J IMMUNOL, V174, P244, DOI 10.4049/jimmunol.174.1.244; Zabel BA, 2008, J EXP MED, V205, P2207, DOI 10.1084/jem.20080300; Zabel BA, 2006, EXP HEMATOL, V34, P1021, DOI 10.1016/j.exphem.2006.05.003; Zabel BA, 2006, EXP HEMATOL, V34, P1106, DOI 10.1016/j.exphem.2006.03.011	26	47	48	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39520	39527		10.1074/jbc.M111.258954	http://dx.doi.org/10.1074/jbc.M111.258954			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21930706	hybrid, Green Published			2022-12-25	WOS:000296759800069
J	Schichl, YM; Resch, U; Lemberger, CE; Stichlberger, D; de Martin, R				Schichl, Yvonne M.; Resch, Ulrike; Lemberger, Christof E.; Stichlberger, Dominik; de Martin, Rainer			Novel Phosphorylation-dependent Ubiquitination of Tristetraprolin by Mitogen-activated Protein Kinase/Extracellular Signal-regulated Kinase Kinase Kinase 1 (MEKK1) and Tumor Necrosis Factor Receptor-associated Factor 2 (TRAF2)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; MESSENGER-RNA TURNOVER; ENDOTHELIAL-CELLS; GENE-EXPRESSION; TNF-ALPHA; INDUCIBLE EXPRESSION; NEGATIVE REGULATION; RICH ELEMENT; PLASMID DNA; IN-VITRO	Acute versus chronic inflammation is controlled by the accurate activation and regulation of interdependent signaling cascades. TNF-receptor 1 engagement concomitantly activates NF-kappa B and JNK signaling. The correctly timed activation of these pathways is the key to account for the balance between NF-kappa B-mediated cell survival and cell death, the latter fostered by prolonged JNK activation. Tristetraprolin (TTP), initially described as an mRNA destabilizing protein, acts as negative feedback regulator of the inflammatory response: it destabilizes cytokine-mRNAs but also acts as an NF-kappa B inhibitor by interfering with the p65/RelA nuclear import pathway. Our biochemical studies provide evidence that TTP contributes to the NF-kappa B/JNK balance. We find that the MAP 3-kinase MEKK1 acts as a novel TTP kinase that, together with the TNF receptor-associated factor 2 (TRAF2), constitutes not only a main determinate of the NF-kappa B-JNK cross-talk but also facilitates "TTP hypermodification": MEKK1 triggers TTP phosphorylation as prerequisite for its Lys-63-linked, TRAF2-mediated ubiquitination. Consequently, TTP no longer affects NF-kappa B activity but promotes the activation of JNK. Based on our data, we suggest a model where upon TNF alpha induction, TTP transits a hypo-to hypermodified state, thereby contributing to the molecular regulation of NF-kappa B versus JNK signaling cascades.	[Schichl, Yvonne M.; Resch, Ulrike; Lemberger, Christof E.; Stichlberger, Dominik; de Martin, Rainer] Med Univ Vienna, Dept Vasc Biol & Thrombosis Res, Ctr Physiol & Pharmacol, A-1090 Vienna, Austria	Medical University of Vienna	Schichl, YM (corresponding author), Med Univ Vienna, Dept Vasc Biol & Thrombosis Res, Ctr Physiol & Pharmacol, Lazarettgasse 19, A-1090 Vienna, Austria.	Yvonne.Schichl@meduniwien.ac.at		Resch, Ulrike/0000-0002-8380-9555	Austrian Science Foundation [T511-B20, P19217-B13]; European Commission [LSHB-CT-2006-037377]; Austrian Science Fund (FWF) [T 511] Funding Source: researchfish	Austrian Science Foundation(Austrian Science Fund (FWF)); European Commission(European CommissionEuropean Commission Joint Research Centre); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was funded by Austrian Science Foundation Project T511-B20 (to Y. M. S.) and Project P19217-B13 (to R. d. M.) and European Commission XENOME Project LSHB-CT-2006-037377 (to R. d. M.).	Arlt A, 2008, BBA-MOL CELL RES, V1783, P941, DOI 10.1016/j.bbamcr.2007.12.010; Baker A, 1997, GENE THER, V4, P773, DOI 10.1038/sj.gt.3300471; Baud V, 1999, GENE DEV, V13, P1297, DOI 10.1101/gad.13.10.1297; Berenjian S, 2006, VIRUS RES, V115, P16, DOI 10.1016/j.virusres.2005.07.001; Blackshear PJ, 2002, BIOCHEM SOC T, V30, P945, DOI 10.1042/BST0300945; Boutaud O, 2003, ADV EXP MED BIOL, V525, P157; Cao HP, 2008, PROTEIN J, V27, P163, DOI 10.1007/s10930-007-9119-7; Cao HP, 2006, BIOCHEM J, V394, P285, DOI 10.1042/BJ20051316; Carballo E, 2001, J BIOL CHEM, V276, P42580, DOI 10.1074/jbc.M104953200; CHEN CA, 1988, BIOTECHNIQUES, V6, P632; Chrestensen CA, 2004, J BIOL CHEM, V279, P10176, DOI 10.1074/jbc.M310486200; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; De Smaele E, 2001, NATURE, V414, P308, DOI 10.1038/35104560; DEMARTIN R, 1993, EMBO J, V12, P2773, DOI 10.1002/j.1460-2075.1993.tb05938.x; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Divanovic S, 2005, NAT IMMUNOL, V6, P571, DOI 10.1038/ni1198; Gallagher E, 2007, NAT IMMUNOL, V8, P57, DOI 10.1038/ni1421; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Habelhah H, 2004, EMBO J, V23, P322, DOI 10.1038/sj.emboj.7600044; Harkin DP, 1999, CELL, V97, P575, DOI 10.1016/S0092-8674(00)80769-2; Heximer SP, 1998, DNA CELL BIOL, V17, P249, DOI 10.1089/dna.1998.17.249; Hitti E, 2006, MOL CELL BIOL, V26, P2399, DOI 10.1128/MCB.26.6.2399-2407.2006; Johnson BA, 2000, ONCOGENE, V19, P1657, DOI 10.1038/sj.onc.1203474; Johnson BA, 2002, ONCOGENE, V21, P4237, DOI 10.1038/sj.onc.1205526; KANEDA N, 1992, GENE, V118, P289, DOI 10.1016/0378-1119(92)90202-Z; KANOH J, 1995, MOL BIOL CELL, V6, P1185, DOI 10.1091/mbc.6.9.1185; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; LAI WS, 1990, J BIOL CHEM, V265, P16556; Lawrence T, 2001, NAT MED, V7, P1291, DOI 10.1038/nm1201-1291; Liang J, 2009, J BIOL CHEM, V284, P29383, DOI 10.1074/jbc.M109.024745; Lu ZM, 2002, MOL CELL, V9, P945, DOI 10.1016/S1097-2765(02)00519-1; MA QF, 1994, ONCOGENE, V9, P3329; Matsuzawa A, 2008, SCIENCE, V321, P663, DOI 10.1126/science.1157340; Mayer H, 2004, ARTERIOSCL THROM VAS, V24, P1192, DOI 10.1161/01.ATV.0000131263.06296.77; Mongan M, 2008, TOXICOL SCI, V104, P405, DOI 10.1093/toxsci/kfn089; Monteleone G, 2004, J BIOL CHEM, V279, P3925, DOI 10.1074/jbc.M303654200; Natoli G, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.11pe1; Neininger A, 2002, J BIOL CHEM, V277, P3065, DOI 10.1074/jbc.C100685200; Ogawa K, 2003, J BIOL CHEM, V278, P30373, DOI 10.1074/jbc.M304856200; Ogilvie RL, 2009, J BIOL CHEM, V284, P11216, DOI 10.1074/jbc.M901229200; Ogilvie RL, 2005, J IMMUNOL, V174, P953, DOI 10.4049/jimmunol.174.2.953; Pikarsky E, 2006, EUR J CANCER, V42, P779, DOI 10.1016/j.ejca.2006.01.011; Rao N, 2005, MOL CELL BIOL, V25, P6521, DOI 10.1128/MCB.25.15.6521-6532.2005; Renner F, 2009, TRENDS BIOCHEM SCI, V34, P128, DOI 10.1016/j.tibs.2008.12.003; Rigby WFC, 2005, J IMMUNOL, V174, P7883, DOI 10.4049/jimmunol.174.12.7883; Sabapathy K, 2004, MOL CELL, V15, P713, DOI 10.1016/j.molcel.2004.08.028; Sauer I, 2006, BLOOD, V107, P4790, DOI 10.1182/blood-2005-07-3058; Schaljo B, 2009, J IMMUNOL, V183, P1197, DOI 10.4049/jimmunol.0803883; Schichl YM, 2009, J BIOL CHEM, V284, P29571, DOI 10.1074/jbc.M109.031237; Schlesinger TK, 2002, J BIOL CHEM, V277, P10283, DOI 10.1074/jbc.M106885200; Stoecklin G, 2003, ONCOGENE, V22, P3554, DOI 10.1038/sj.onc.1206418; Stoecklin G, 2004, EMBO J, V23, P1313, DOI 10.1038/sj.emboj.7600163; Stoecklin G, 2008, J BIOL CHEM, V283, P11689, DOI 10.1074/jbc.M709657200; Sun L, 2007, J BIOL CHEM, V282, P3766, DOI 10.1074/jbc.M607347200; Taylor GA, 1996, IMMUNITY, V4, P445, DOI 10.1016/S1074-7613(00)80411-2; Tenenhaus C, 2001, GENE DEV, V15, P1031, DOI 10.1101/gad.876201; Tiedje C, 2010, BIOCHEM SOC T, V38, P1632, DOI 10.1042/BST0381632; Weston CR, 2002, CURR OPIN GENET DEV, V12, P14, DOI 10.1016/S0959-437X(01)00258-1; Widmann C, 1998, MOL CELL BIOL, V18, P2416, DOI 10.1128/MCB.18.4.2416; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025; Wrighton CJ, 1996, J EXP MED, V183, P1013, DOI 10.1084/jem.183.3.1013; Xia Y, 2000, P NATL ACAD SCI USA, V97, P5243, DOI 10.1073/pnas.97.10.5243; Yujiri T, 2000, P NATL ACAD SCI USA, V97, P7272, DOI 10.1073/pnas.130176697; Zhang WJ, 1997, ARTERIOSCL THROM VAS, V17, P465, DOI 10.1161/01.ATV.17.3.465; Zhu W, 2001, AM J PHYSIOL-LUNG C, V281, pL499, DOI 10.1152/ajplung.2001.281.2.L499	66	30	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38466	38477		10.1074/jbc.M111.254888	http://dx.doi.org/10.1074/jbc.M111.254888			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21921033	Green Published, hybrid			2022-12-25	WOS:000296594200061
J	Vogl, K; Bryant, DA				Vogl, Kajetan; Bryant, Donald A.			Elucidation of the Biosynthetic Pathway for Okenone in Thiodictyon sp CAD16 Leads to the Discovery of Two Novel Carotene Ketolases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PURPLE SULFUR BACTERIA; STRAIN PCC 7002; RUBRIVIVAX-GELATINOSUS; ESCHERICHIA-COLI; HAEMATOCOCCUS-PLUVIALIS; RHODOBACTER-CAPSULATUS; PHOTOTROPHIC BACTERIA; CHLOROBIUM-TEPIDUM; LYCOPENE CYCLASE; BETA-CAROTENE	Okenone is a unique ketocarotenoid found in many purple sulfur bacteria; it is important because of its unique light absorption and photoprotection properties. Okenane, a compound formed by diagenetic reduction of okenone, is an important biomarker in geochemical analyses of sedimentary rocks. Despite its ecological and biogeochemical importance, the biochemical pathway for okenone synthesis has not yet been fully described. The genome sequence of an okenone-producing organism, Thiodictyon sp. strain CAD16, revealed four genes whose predicted proteins had strong sequence similarity to enzymes known to produce psi-end group modifications of carotenoids in proteobacteria. These four genes encoded homologs of a 1,2-carotenoid hydratase (CrtC), an O-methyltransferase (CrtF), and two paralogs of carotenoid 3,4-desaturases (CrtD). Expression studies in lycopene-or neurosporene-producing strains of Escherichia coli confirmed the functions of crtC and crtF, but the crtD paralogs encoded enzymes with previously undescribed functions. One enzyme, CruS, was only distantly related to CrtD desaturases, was bifunctional, and performed a 3,4-desaturation and introduced a C-2 keto group into neurosporene derivatives in the presence of dioxygen. The enzyme encoded by the other crtD paralog also represents a new enzyme in carotenogenesis and was named cruO. CruO encodes the C-4/4' ketolase uniquely required for okenone biosynthesis. The identification of CruO and the demonstration of its biochemical activity complete the elucidation of the biosynthetic pathway for okenone and other related ketocarotenoids.	[Vogl, Kajetan; Bryant, Donald A.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Bryant, Donald A.] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Montana State University System; Montana State University Bozeman	Bryant, DA (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, S-235 Frear Bldg, University Pk, PA 16802 USA.	dab14@psu.edu			United States Department of Energy [DE-FG02-94ER20137]	United States Department of Energy(United States Department of Energy (DOE))	This work was supported by United States Department of Energy Grant DE-FG02-94ER20137 (to D. A. B.).	AASEN AJ, 1967, ACTA CHEM SCAND, V21, P970, DOI 10.3891/acta.chem.scand.21-0970; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANDREWES AG, 1972, ACTA CHEM SCAND, V26, P2194, DOI 10.3891/acta.chem.scand.26-2194; Badenhop F, 2003, FEMS MICROBIOL LETT, V222, P237, DOI 10.1016/S0378-1097(03)00302-1; BLANKENSHIP RE, 1994, ANTON LEEUW INT J G, V65, P311, DOI 10.1007/BF00872216; BRITTON G, 1985, METHOD ENZYMOL, V111, P113, DOI 10.1016/S0076-6879(85)11007-4; Britton G., 1995, SPECTROSCOPY-US, V1B, P13; Brocks JJ, 2005, NATURE, V437, P866, DOI 10.1038/nature04068; Brocks JJ, 2008, GEOCHIM COSMOCHIM AC, V72, P1396, DOI 10.1016/j.gca.2007.12.006; Brocks JJ, 2009, NAT REV MICROBIOL, V7, P601, DOI 10.1038/nrmicro2167; Bryant DA, 2012, ADV PHOTOSYNTH RESP, V33, P47, DOI 10.1007/978-94-007-1533-2_3; Caumette P, 2004, INT J SYST EVOL MICR, V54, P1031, DOI 10.1099/ijs.0.02964-0; CUNNINGHAM FX, 1994, PLANT CELL, V6, P1107, DOI 10.1105/tpc.6.8.1107; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; FernandezGonzalez B, 1997, J BIOL CHEM, V272, P9728; Fraser PD, 1997, J BIOL CHEM, V272, P6128, DOI 10.1074/jbc.272.10.6128; Frigaard NU, 2004, METH MOL B, V274, P325; Frigaard NU, 2004, J BACTERIOL, V186, P5210, DOI 10.1128/JB.186.16.5210-5220.2004; Garcia Costas AM, 2011, ENV MICROBI IN PRESS; Gerjets T, 2009, BBA-MOL CELL BIOL L, V1791, P125, DOI 10.1016/j.bbalip.2008.12.006; Graham JE, 2009, J BACTERIOL, V191, P3292, DOI 10.1128/JB.00050-09; Graham JE, 2008, J BACTERIOL, V190, P7966, DOI 10.1128/JB.00985-08; Hoff A. J., 1997, PHYS REP, V287, P2; Imhoff J, 2004, ANOXYGENIC PHOTOSYNT, P1; IMHOFF JF, 1980, ZBL BAKT MIK HYG I C, V1, P61; Imhoff JF, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 6, THIRD EDITION, P874, DOI 10.1007/0-387-30746-x_32; KAJIWARA S, 1995, PLANT MOL BIOL, V29, P343, DOI 10.1007/BF00043657; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee PC, 2010, APPL ENVIRON MICROB, V76, P7328, DOI 10.1128/AEM.01606-10; Liaaen-Jensen S., 1963, ACTA CHEM SCAND, V17, P303; LOTAN T, 1995, FEBS LETT, V364, P125, DOI 10.1016/0014-5793(95)00368-J; Madigan Michael T., 2009, V28, P1; Maresca JA, 2008, J BACTERIOL, V190, P6384, DOI 10.1128/JB.00758-08; Maresca JA, 2008, PHOTOSYNTH RES, V97, P121, DOI 10.1007/s11120-008-9312-3; Maresca JA, 2007, P NATL ACAD SCI USA, V104, P11784, DOI 10.1073/pnas.0702984104; Maresca JA, 2009, ENV MICROBIOL REP, V1, P524, DOI 10.1111/j.1758-2229.2009.00075.x; MCEWAN AG, 1994, ANTON LEEUW INT J G, V66, P151, DOI 10.1007/BF00871637; MISAWA N, 1995, J BACTERIOL, V177, P6575, DOI 10.1128/jb.177.22.6575-6584.1995; Mukoyama D, 2006, FEMS MICROBIOL LETT, V265, P69, DOI 10.1111/j.1574-6968.2006.00471.x; Peduzzi S, 2003, FEMS MICROBIOL ECOL, V45, P29, DOI 10.1016/S0168-6496(03)00107-7; Pinta V, 2003, ARCH MICROBIOL, V179, P354, DOI 10.1007/s00203-003-0538-3; Polli D, 2006, BIOPHYS J, V90, P2486, DOI 10.1529/biophysj.105.069286; SCHMIDT K, 1963, ARCH MIKROBIOL, V46, P117, DOI 10.1007/BF00408204; SCOLNIK PA, 1980, J BIOL CHEM, V255, P2427; Sestak Z., 2004, CAROTENOIDS, V42, DOI 10.1023/b:phot.0000040641.40049.19,2; SHNEOUR EA, 1962, BIOCHIM BIOPHYS ACTA, V65, P510, DOI 10.1016/0006-3002(62)90455-9; STACKEBRANDT E, 1988, INT J SYST BACTERIOL, V38, P321, DOI 10.1099/00207713-38-3-321; Steiger S, 2003, ARCH BIOCHEM BIOPHYS, V414, P51, DOI 10.1016/S0003-9861(03)00099-7; Steiger S, 2002, J BIOTECHNOL, V97, P51, DOI 10.1016/S0168-1656(02)00055-X; Steiger S, 2000, BIOCHEM J, V349, P635, DOI 10.1042/0264-6021:3490635; Sun ZT, 2009, MICROBIOL-SGM, V155, P2775, DOI 10.1099/mic.0.027623-0; Takaichi S, 2001, PHOTOSYNTH RES, V67, P207, DOI 10.1023/A:1010666406176; Takaichi Shinichi, 2009, V28, P97; Vogl K., 2011, GEOBIOLOGY IN PRESS; Willows Robert D., 2009, V28, P57; Yeliseev AA, 1997, FEBS LETT, V403, P10, DOI 10.1016/S0014-5793(97)00006-9; Yu QJ, 2010, J BIOL CHEM, V285, P12109, DOI 10.1074/jbc.M109.091843; Yurkov VV, 1998, MICROBIOL MOL BIOL R, V62, P695, DOI 10.1128/MMBR.62.3.695-724.1998; Zhu YH, 2010, ARCH BIOCHEM BIOPHYS, V504, P86, DOI 10.1016/j.abb.2010.07.007	59	12	14	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38521	38532		10.1074/jbc.M111.280131	http://dx.doi.org/10.1074/jbc.M111.280131			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21921032	hybrid, Green Published			2022-12-25	WOS:000296594200066
J	Wang, Q; Lynch, JW				Wang, Qian; Lynch, Joseph W.			Activation and Desensitization Induce Distinct Conformational Changes at the Extracellular-Transmembrane Domain Interface of the Glycine Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; LIGAND-BINDING DOMAIN; CYS-LOOP RECEPTORS; RAPID DESENSITIZATION; GLUTAMATE-RECEPTOR; GABA(A) RECEPTORS; AGONIST BINDING; BETA-2 SUBUNIT; ACH RECEPTORS; A RECEPTOR	Most ligand-gated channels exhibit desensitization, which is the progressive fading of ionic current in the prolonged presence of agonist. This process involves conformational changes that close the channel despite continued agonist binding. Despite the physiological and pathological importance of desensitization, little is known about the conformational changes that underlie this process in any Cys-loop ion channel receptor. Here we employed voltage clamp fluorometry to identify conformational changes that occur with a similar time course as the current desensitization rate in both slow-and fast-desensitizing alpha 1 glycine receptor chloride channels. Voltage clamp fluorometry provides a direct indication of conformational changes that occur in the immediate vicinity of residues labeled with environmentally sensitive fluorophores. We compared the rates of current desensitization and fluorescence changes at nine labeled extracellular sites in both wild type slow-desensitizing and mutated (A248L) fast-desensitizing glycine receptors. As labels attached to three sites at the interface between the ligand binding domain and transmembrane domain reported fluorescence responses that changed in parallel with the current desensitization rate, we concluded that they experienced local conformational changes associated with desensitization. These labeled sites included A52C in loop 2, Q219C in the pre-M1 domain, and M227C in the M1 domain. Activation and desensitization were accompanied by physically distinct conformational changes at each labeled site. Because activation is mediated by a specific reorganization of molecular interactions at the extracellular-transmembrane domain interface, we propose that desensitization is mediated by a distinct set of conformational changes that prevents this reorganization from occurring, thereby favoring channel closure.	[Lynch, Joseph W.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia	University of Queensland; University of Queensland	Lynch, JW (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia.	j.lynch@uq.edu.au	Lynch, Joseph/C-8636-2009		Australian Research Council; National Health and Medical Research Council of Australia; University of Queensland	Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); University of Queensland(University of Queensland)	This work was supported by the Australian Research Council and the National Health and Medical Research Council of Australia.; Supported by a University of Queensland Ph.D. Confirmation Scholarship.	Armstrong N, 2006, CELL, V127, P85, DOI 10.1016/j.cell.2006.08.037; Auerbach A, 2010, J PHYSIOL-LONDON, V588, P573, DOI 10.1113/jphysiol.2009.182774; Bianchi MT, 2001, J NEUROSCI, V21, P1127; Bohler S, 2001, BIOCHEMISTRY-US, V40, P2066, DOI 10.1021/bi0020022; Bouzat C, 2008, J NEUROSCI, V28, P7808, DOI 10.1523/JNEUROSCI.0448-08.2008; Bowser DN, 2002, P NATL ACAD SCI USA, V99, P15170, DOI 10.1073/pnas.212320199; Breitinger HG, 2004, CHEM BIOL, V11, P1339, DOI 10.1016/j.chembiol.2004.07.008; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Castaldo P, 2004, J BIOL CHEM, V279, P25598, DOI 10.1074/jbc.M311021200; Cederholm JME, 2009, EUR BIOPHYS J BIOPHY, V39, P37, DOI 10.1007/s00249-009-0452-y; Chang YC, 2002, NAT NEUROSCI, V5, P1163, DOI 10.1038/nn926; Dahan DS, 2004, P NATL ACAD SCI USA, V101, P10195, DOI 10.1073/pnas.0301885101; Edelstein SJ, 1996, BIOL CYBERN, V75, P361, DOI 10.1007/s004220050302; Engblom AC, 2002, J BIOL CHEM, V277, P17438, DOI 10.1074/jbc.M111215200; Gandhi CS, 2005, TRENDS NEUROSCI, V28, P472, DOI 10.1016/j.tins.2005.07.005; Gay EA, 2008, J PHYSIOL-LONDON, V586, P1105, DOI 10.1113/jphysiol.2007.149492; Giniatullin R, 2005, TRENDS NEUROSCI, V28, P371, DOI 10.1016/j.tins.2005.04.009; Goldschen-Ohm MP, 2010, MOL PHARMACOL, V77, P35, DOI 10.1124/mol.109.058289; Hansen KB, 2007, CURR OPIN NEUROBIOL, V17, P281, DOI 10.1016/j.conb.2007.03.014; Jones MV, 1996, TRENDS NEUROSCI, V19, P96, DOI 10.1016/S0166-2236(96)80037-3; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; Lewis TM, 2003, J PHYSIOL-LONDON, V549, P361, DOI 10.1113/jphysiol.2002.037796; Lynch JW, 2009, NEUROPHARMACOLOGY, V56, P303, DOI 10.1016/j.neuropharm.2008.07.034; Lynch JW, 1997, EMBO J, V16, P110, DOI 10.1093/emboj/16.1.110; McCormack TJ, 2010, J PHYSIOL-LONDON, V588, P4415, DOI 10.1113/jphysiol.2010.195495; Miller PS, 2010, TRENDS PHARMACOL SCI, V31, P161, DOI 10.1016/j.tips.2009.12.005; Pless SA, 2008, CLIN EXP PHARMACOL P, V35, P1137, DOI 10.1111/j.1440-1681.2008.04954.x; Pless SA, 2007, J BIOL CHEM, V282, P36057, DOI 10.1074/jbc.M706468200; Pless SA, 2009, J BIOL CHEM, V284, P27370, DOI 10.1074/jbc.M109.048405; Pless SA, 2009, J BIOL CHEM, V284, P15847, DOI 10.1074/jbc.M809343200; Pless SA, 2009, J NEUROCHEM, V108, P1585, DOI 10.1111/j.1471-4159.2009.05930.x; Price KL, 2007, J BIOL CHEM, V282, P25623, DOI 10.1074/jbc.M702524200; Purohit P, 2007, J GEN PHYSIOL, V130, P559, DOI 10.1085/jgp.200709857; Reeves DC, 2005, J NEUROSCI, V25, P9358, DOI 10.1523/JNEUROSCI.1045-05.2005; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Wang J, 2007, J BIOL CHEM, V282, P26210, DOI 10.1074/jbc.M702314200; Wang QA, 2010, J BIOL CHEM, V285, P40373, DOI 10.1074/jbc.M110.161513; Weiland S, 1996, FEBS LETT, V398, P91, DOI 10.1016/S0014-5793(96)01215-X; Wilson GG, 2001, P NATL ACAD SCI USA, V98, P1241, DOI 10.1073/pnas.031567798; Xiu XN, 2005, J BIOL CHEM, V280, P41655, DOI 10.1074/jbc.M508635200; Yakel JL, 2010, J PHYSIOL-LONDON, V588, P597, DOI 10.1113/jphysiol.2009.182691; Yamodo IH, 2010, BIOCHEMISTRY-US, V49, P156, DOI 10.1021/bi901550p	44	20	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38814	38824		10.1074/jbc.M111.273631	http://dx.doi.org/10.1074/jbc.M111.273631			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21917927	hybrid, Green Published			2022-12-25	WOS:000296594200092
J	Mukundan, B; Ansari, A				Mukundan, Banupriya; Ansari, Athar			Novel Role for Mediator Complex Subunit Srb5/Med18 in Termination of Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; SACCHAROMYCES-CEREVISIAE; PREINITIATION COMPLEX; HEAD MODULE; YEAST; COACTIVATOR; RECRUITMENT; ACTIVATION; ELONGATION; BINDING	Mediator complex functions at the recruitment as well as the post-recruitment steps of transcription. Here we provide evidence for a novel role of Mediator in termination of transcription. Mediator subunit Srb5/Med18 cross-links to the 5' and 3' ends of INO1 and CHA1. In srb5(-) cells, recruitment of TATA-binding protein (TBP) and transcription factor IIB (TFIIB) onto the promoter of these genes remained unaffected, but cross-linking of the cleavage-polyadenylation factors Rna15 and Pta1 toward the 3' end of genes was compromised. In these cells, RNA polymerase II accumulated near the 3' end of genes and beyond. Transcription run-on analysis confirmed a transcription readthrough phenotype in the absence of Srb5/Med18. These results strongly suggest that Mediator subunit Srb5/Med18 is required for proper termination of transcription of a subset of genes in budding yeast.	[Mukundan, Banupriya; Ansari, Athar] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA	Wayne State University	Ansari, A (corresponding author), Wayne State Univ, Dept Biol Sci, 5047 Gullen Mall, Detroit, MI 48202 USA.	bb2749@wayne.edu	Ansari, Athar/AEK-0223-2022	Ansari, Athar/0000-0003-2806-421X	National Science Foundation (NSF) [MCB1020911]	National Science Foundation (NSF)(National Science Foundation (NSF))	This work was supported by Grant MCB1020911 from the National Science Foundation (NSF) (to A. A.).	Ahn SH, 2004, MOL CELL, V13, P67, DOI 10.1016/S1097-2765(03)00492-1; Andrau JC, 2006, MOL CELL, V22, P179, DOI 10.1016/j.molcel.2006.03.023; Ansari SA, 2009, P NATL ACAD SCI USA, V106, P16734, DOI 10.1073/pnas.0905103106; Baek HJ, 2002, MOL CELL BIOL, V22, P2842, DOI 10.1128/MCB.22.8.2842-2852.2002; Baek HJ, 2006, J BIOL CHEM, V281, P15172, DOI 10.1074/jbc.M601983200; Birse CE, 1998, SCIENCE, V280, P298, DOI 10.1126/science.280.5361.298; Bjorklund S, 2005, TRENDS BIOCHEM SCI, V30, P240, DOI 10.1016/j.tibs.2005.03.008; Bourbon HM, 2008, NUCLEIC ACIDS RES, V36, P3993, DOI 10.1093/nar/gkn349; Cai G, 2010, NAT STRUCT MOL BIOL, V17, P273, DOI 10.1038/nsmb.1757; Casamassimi A, 2007, BIOCHIMIE, V89, P1439, DOI 10.1016/j.biochi.2007.08.002; Chadick JZ, 2005, TRENDS BIOCHEM SCI, V30, P264, DOI 10.1016/j.tibs.2005.03.001; Conaway R. C., 2011, SEMIN CELL IN PRESS; Dettmann A, 2010, MOL GENET GENOMICS, V283, P211, DOI 10.1007/s00438-009-0508-9; El Kaderi B, 2009, J BIOL CHEM, V284, P25015, DOI 10.1074/jbc.M109.007948; Esnault C, 2008, MOL CELL, V31, P337, DOI 10.1016/j.molcel.2008.06.021; FLANAGAN PM, 1991, NATURE, V350, P436, DOI 10.1038/350436a0; Guglielmi B, 2004, NUCLEIC ACIDS RES, V32, P5379, DOI 10.1093/nar/gkh878; Hirayoshi K, 1999, METHOD ENZYMOL, V304, P351; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Imasaki T, 2011, NATURE, V475, P240, DOI 10.1038/nature10162; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; Knuesel MT, 2009, GENE DEV, V23, P439, DOI 10.1101/gad.1767009; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Laine JP, 2009, GENE DEV, V23, P2604, DOI 10.1101/gad.1823609; Lariviere L, 2006, NAT STRUCT MOL BIOL, V13, P895, DOI 10.1038/nsmb1143; Malik S, 2002, MOL CELL BIOL, V22, P5626, DOI 10.1128/MCB.22.15.5626-5637.2002; Malik S, 2007, P NATL ACAD SCI USA, V104, P6182, DOI 10.1073/pnas.0608717104; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Mandel CR, 2008, CELL MOL LIFE SCI, V65, P1099, DOI 10.1007/s00018-007-7474-3; Medler S, 2011, J BIOL CHEM, V286, P33709, DOI 10.1074/jbc.M110.193870; Mittler G, 2001, EMBO REP, V2, P808, DOI 10.1093/embo-reports/kve186; Myers LC, 2000, ANNU REV BIOCHEM, V69, P729, DOI 10.1146/annurev.biochem.69.1.729; PETERSEN JGL, 1988, GENETICS, V119, P527; Proshkina G M, 2009, Bioorg Khim, V35, P572; Richard P, 2009, GENE DEV, V23, P1247, DOI 10.1101/gad.1792809; Runner VM, 2008, MOL CELL BIOL, V28, P1883, DOI 10.1128/MCB.01714-07; Singh BN, 2007, MOL CELL, V27, P806, DOI 10.1016/j.molcel.2007.07.013; Taatjes DJ, 2010, TRENDS BIOCHEM SCI, V35, P315, DOI 10.1016/j.tibs.2010.02.004; Takagi Y, 2006, J BIOL CHEM, V281, P80, DOI 10.1074/jbc.M508253200; Takahashi H, 2011, CELL, V146, P92, DOI 10.1016/j.cell.2011.06.005; THOMPSON CM, 1993, CELL, V73, P1361, DOI 10.1016/0092-8674(93)90362-T; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Wang G, 2005, MOL CELL, V17, P683, DOI 10.1016/j.molcel.2005.02.010; Yudkovsky N, 2000, NATURE, V408, P225, DOI 10.1038/35041603	44	41	44	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2011	286	43					37053	37057		10.1074/jbc.C111.295915	http://dx.doi.org/10.1074/jbc.C111.295915			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	841VD	21921038	hybrid, Green Published			2022-12-25	WOS:000296542400004
J	Aldhous, MC; Soo, K; Stark, LA; Ulanicka, AA; Easterbrook, JE; Dunlop, MG; Satsangi, J				Aldhous, Marian C.; Soo, Kimberley; Stark, Lesley A.; Ulanicka, Agata A.; Easterbrook, Jennifer E.; Dunlop, Malcolm G.; Satsangi, Jack			Cigarette Smoke Extract (CSE) Delays NOD2 Expression and Affects NOD2/RIPK2 Interactions in Intestinal Epithelial Cells	PLOS ONE			English	Article							PROINFLAMMATORY CYTOKINE RELEASE; INFLAMMATORY-BOWEL-DISEASE; KAPPA-B ACTIVATION; CROHNS-DISEASE; ULCERATIVE-COLITIS; OXIDATIVE STRESS; BARRIER FUNCTION; GENE-MUTATIONS; TOBACCO-SMOKE; CARD15 GENE	Background: Genetic and environmental factors influence susceptibility to Crohn's disease (CD): NOD2 is the strongest individual genetic determinant and smoking the best-characterised environmental factor. Carriage of NOD2 mutations predispose to small-intestinal, stricturing CD, a phenotype also associated with smoking. We hypothesised that cigarette smoke extract (CSE) altered NOD2 expression and function in intestinal epithelial cells. Methods and Findings: Intestinal epithelial cell-lines (SW480, HT29, HCT116) were stimulated with CSE and nicotine (to mimic smoking) +/- TNF alpha (to mimic inflammation). NOD2 expression was measured by qRT-PCR and western blotting; NOD2-RIPK2 interactions by co-immunoprecipitation (CoIP); nuclear NF kappa B-p65 by ELISA; NF kappa B activity by luciferase reporter assays and chemokines (CCL20, IL8) in culture supernatants by ELISA. In SW480 and HT29 cells the TNF alpha-induced NOD2 expression at 4 hours was reduced by CSE (p = 0.0226), a response that was dose-dependent (p = 0.003) and time-dependent (p = 0.0004). Similar effects of CSE on NOD2 expression were seen in cultured ileal biopsies from healthy individuals. In SW480 cells CSE reduced TNF alpha-induced NF kappa B-p65 translocation at 15 minutes post-stimulation, upstream of NOD2. Levels of the NOD2-RIPK2 complex were no different at 8 hours post-stimulation with combinations of CSE, nicotine and TNF alpha, but at 18 hours it was increased in cells stimulated with TNF alpha+CSE but decreased with TNF alpha alone (p = 0.0330); CSE reduced TNF alpha-induced NF kappa B activity (p = 0.0014) at the same time-point. At 24 hours, basal CCL20 and IL8 (p<0.001 for both) and TNF alpha-induced CCL20 (p = 0.0330) production were decreased by CSE. CSE also reduced NOD2 expression, CCL20 and IL8 production seen with MDP-stimulation of SW480 cells pre-treated with combinations of TNF alpha and CSE. Conclusions: CSE delayed TNF alpha-induced NOD2 mRNA expression and was associated with abnormal NOD2/RIPK2 interaction, reduced NF kappa B activity and decreased chemokine production. These effects may be involved in the pathogenesis of small-intestinal CD and may have wider implications for the effects of smoking in NOD2-mediated responses.	[Aldhous, Marian C.; Soo, Kimberley; Ulanicka, Agata A.; Easterbrook, Jennifer E.; Satsangi, Jack] Univ Edinburgh, Western Gen Hosp, Mol Med Ctr, Gastrointestinal Unit, Edinburgh, Midlothian, Scotland; [Stark, Lesley A.; Dunlop, Malcolm G.] Western Gen Hosp, Edinburgh Canc Ctr, Edinburgh EH4 2XU, Midlothian, Scotland; [Stark, Lesley A.; Dunlop, Malcolm G.] Western Gen Hosp, Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; University of Edinburgh	Aldhous, MC (corresponding author), Univ Edinburgh, Western Gen Hosp, Mol Med Ctr, Gastrointestinal Unit, Edinburgh, Midlothian, Scotland.	maldhous@ed.ac.uk	Dunlop, Malcolm G/F-1973-2011	Dunlop, Malcolm G/0000-0002-3033-5851	Chief Scientist's Office of the Scottish Government [CZB/4/68, CZB/4/638]; MRC [G0800675, MC_U127527198, MC_PC_U127527198, G1002033, G0600329] Funding Source: UKRI; Medical Research Council [G0800675, G1002033, G0600329, MC_U127527198, MC_PC_U127527198] Funding Source: researchfish; Chief Scientist Office [CZB/4/540, ETM/75, CZB/4/638] Funding Source: researchfish	Chief Scientist's Office of the Scottish Government; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office	Chief Scientist's Office of the Scottish Government, grant numbers CZB/4/68 and CZB/4/638. Website: http://www.cso.scot.nhs.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DW, 2004, CURR BIOL, V14, P2217, DOI 10.1016/j.cub.2004.12.032; Abraham N, 2003, J GASTROEN HEPATOL, V18, P139, DOI 10.1046/j.1440-1746.2003.02953.x; Abreu MT, 2002, GASTROENTEROLOGY, V123, P679, DOI 10.1053/gast.2002.35393; Ahmad T, 2001, ALIMENT PHARM THER, V15, P731, DOI 10.1046/j.1365-2036.2001.00981.x; Aldhous MC, 2007, AM J GASTROENTEROL, V102, P589, DOI 10.1111/j.1572-0241.2007.01065.x; Aldhous MC, 2007, AM J GASTROENTEROL, V102, P577, DOI 10.1111/j.1572-0241.2007.01064.x; Aldhous MC, 2010, FRONTLINE GASTROENTE, V1, P156, DOI 10.1136/fg.2010.001487; Aldhous MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006285; Artis D, 2008, NAT REV IMMUNOL, V8, P411, DOI 10.1038/nri2316; Barrett JC, 2009, NAT GENET, V41, P1330, DOI 10.1038/ng.483; Begue B, 2006, GASTROENTEROLOGY, V130, P1962, DOI 10.1053/j.gastro.2006.03.022; Berrebi D, 2003, GUT, V52, P840, DOI 10.1136/gut.52.6.840; Berrington WR, 2010, J INFECT DIS, V201, P1422, DOI 10.1086/651559; Beynon V, 2008, INFLAMM BOWEL DIS, V14, P1033, DOI 10.1002/ibd.20441; Biswas A, 2010, P NATL ACAD SCI USA, V107, P14739, DOI 10.1073/pnas.1003363107; Bonen DK, 2003, GASTROENTEROLOGY, V124, P140, DOI 10.1053/gast.2003.50019; Brant SR, 2003, INFLAMM BOWEL DIS, V9, P281, DOI 10.1097/00054725-200309000-00001; Brant SR, 2007, AM J GASTROENTEROL, V102, P313, DOI 10.1111/j.1572-0241.2006.00926.x; Bridger S, 2002, GUT, V51, P21, DOI 10.1136/gut.51.1.21; Bruewer M, 2003, J IMMUNOL, V171, P6164, DOI 10.4049/jimmunol.171.11.6164; Choi SC, 2006, WORLD J GASTROENTERO, V12, P4850; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Cosnes J, 2001, GASTROENTEROLOGY, V120, P1093, DOI 10.1053/gast.2001.23231; Cosnes J, 2004, CLIN GASTROENTEROL H, V2, P41, DOI 10.1016/S1542-3565(03)00290-8; Crane-Godreau Mardi A, 2009, Open Immunol J, V2, P86; Cuthbert AP, 2002, GASTROENTEROLOGY, V122, P867, DOI 10.1053/gast.2002.32415; Ekman AK, 2010, IMMUNOLOGY, V130, P55, DOI 10.1111/j.1365-2567.2009.03212.x; Eliakim R, 2002, EUR J GASTROEN HEPAT, V14, P607, DOI 10.1097/00042737-200206000-00005; Facchinetti F, 2007, AM J RESP CELL MOL, V37, P617, DOI 10.1165/rcmb.2007-0130OC; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Hasegawa M, 2008, EMBO J, V27, P373, DOI 10.1038/sj.emboj.7601962; Hedl M, 2007, P NATL ACAD SCI USA, V104, P19440, DOI 10.1073/pnas.0706097104; Hegazi RAF, 2005, J EXP MED, V202, P1703, DOI 10.1084/jem.20051047; Hirota K, 2007, J EXP MED, V204, P2803, DOI 10.1084/jem.20071397; Hisamatsu T, 2003, GASTROENTEROLOGY, V124, P993, DOI 10.1053/gast.2003.50153; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Ingram JR, 2008, GASTROENT RES PRACT, V2008, DOI 10.1155/2008/237185; Iwasaki A, 2000, J EXP MED, V191, P1381, DOI 10.1084/jem.191.8.1381; Kikuchi H, 2008, NEUROSCI LETT, V432, P217, DOI 10.1016/j.neulet.2007.12.027; Ko JKS, 2005, TOXICOL SCI, V87, P285, DOI 10.1093/toxsci/kfi238; Kobayashi T, 2008, GUT, V57, P1682, DOI 10.1136/gut.2007.135053; Kode A, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-132; Kucharzik T, 2005, GUT, V54, P1565, DOI 10.1136/gut.2004.061168; Kulkarni R, 2010, INFECT IMMUN, V78, P2146, DOI 10.1128/IAI.01410-09; La Rocca G, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-23; Lee JW, 2008, J IMMUNOL, V181, P6536, DOI 10.4049/jimmunol.181.9.6536; Li L, 1999, AM J PHYSIOL-LUNG C, V277, pL550, DOI 10.1152/ajplung.1999.277.3.L550; Li W, 2007, CHINESE MED J-PEKING, V120, P1075, DOI 10.1097/00029330-200706020-00009; Manzel LJ, 2011, AM J RESP CELL MOL, V44, P155, DOI 10.1165/rcmb.2009-0454OC; Marks DJB, 2006, LANCET, V367, P668, DOI 10.1016/S0140-6736(06)68265-2; MCCANN MF, 1992, CANCER EPIDEM BIOMAR, V1, P125; McGilligan VE, 2007, INFLAMM BOWEL DIS, V13, P108, DOI 10.1002/ibd.20020; McGuckin MA, 2009, INFLAMM BOWEL DIS, V15, P100, DOI 10.1002/ibd.20539; Meuronen A, 2008, RESPIRATION, V75, P450, DOI 10.1159/000114855; Moodie FM, 2004, FASEB J, V18, P1897, DOI 10.1096/fj.04-1506fje; Netea MG, 2005, J IMMUNOL, V174, P6518, DOI 10.4049/jimmunol.174.10.6518; Nielsen OH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006210; Noguchi E, 2009, NAT IMMUNOL, V10, P471, DOI 10.1038/ni.1722; Nyunoya T, 2006, AM J RESP CELL MOL, V35, P681, DOI 10.1165/rcmb.2006-0169OC; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Oltmanns U, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-74; Page S, 1999, J BIOL CHEM, V274, P11611, DOI 10.1074/jbc.274.17.11611; Paun BC, 2010, CANCER-AM CANCER SOC, V116, P4495, DOI 10.1002/cncr.25348; Penack O, 2010, BLOOD, V115, P1865, DOI 10.1182/blood-2009-09-242784; Petnicki-Ocwieja T, 2009, P NATL ACAD SCI USA, V106, P15813, DOI 10.1073/pnas.0907722106; Richardson CE, 2003, QJM-INT J MED, V96, P57, DOI 10.1093/qjmed/hcg007; Rodriguez MS, 1996, ONCOGENE, V12, P2425; Rolhion N, 2007, INFLAMM BOWEL DIS, V13, P1277, DOI 10.1002/ibd.20176; Rosenstiel P, 2003, GASTROENTEROLOGY, V124, P1001, DOI 10.1053/gast.2003.50157; Rubin GP, 2000, ALIMENT PHARM THER, V14, P1553, DOI 10.1046/j.1365-2036.2000.00886.x; Sabbah A, 2009, NAT IMMUNOL, V10, P1073, DOI 10.1038/ni.1782; Smith LA, 2010, IMMUNOL RES, V46, P94, DOI 10.1007/s12026-009-8133-6; Stringer KA, 2007, AM J PHYSIOL-LUNG C, V292, pL1572, DOI 10.1152/ajplung.00325.2006; Sykes AP, 2000, INFLAMM RES, V49, P311, DOI 10.1007/s000110050597; Thomas GAO, 2005, NAT CLIN PRACT GASTR, V2, P536, DOI 10.1038/ncpgasthep0316; Tian Y, 2010, INT J COLORECTAL DIS, V25, P161, DOI 10.1007/s00384-009-0809-9; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Uehara A, 2007, MOL IMMUNOL, V44, P3100, DOI 10.1016/j.molimm.2007.02.007; van der Toorn M, 2007, AM J PHYSIOL-LUNG C, V292, pL1211, DOI 10.1152/ajplung.00291.2006; Van Limbergen J, 2009, ANNU REV GENOM HUM G, V10, P89, DOI 10.1146/annurev-genom-082908-150013; Verschuere S, 2011, LAB INVEST, V91, P1056, DOI 10.1038/labinvest.2011.74; Wehkamp J, 2004, GUT, V53, P1658, DOI 10.1136/gut.2003.032805; Whittle BJR, 2010, PHARMACOL REP, V62, P548; Wu WKK, 2004, J PHARMACOL SCI, V94, P348, DOI 10.1254/jphs.94.348; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Zhang FR, 2009, NEW ENGL J MED, V361, P2609, DOI 10.1056/NEJMoa0903753	86	18	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2011	6	9							e24715	10.1371/journal.pone.0024715	http://dx.doi.org/10.1371/journal.pone.0024715			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CO	21931826	Green Submitted, Green Published, gold			2022-12-25	WOS:000294803200042
J	Munk, R; Ghosh, P; Ghosh, MC; Saito, T; Xu, M; Carter, A; Indig, F; Taub, DD; Longo, DL				Munk, Rachel; Ghosh, Paritosh; Ghosh, Manik C.; Saito, Takeshi; Xu, Mai; Carter, Arnell; Indig, Fred; Taub, Dennis D.; Longo, Dan L.			Involvement of mTOR in CXCL12 Mediated T Cell Signaling and Migration	PLOS ONE			English	Article							HEMATOPOIETIC PROGENITOR CELLS; MAMMALIAN TARGET; PROTEIN-KINASE; CHEMOKINE; PATHWAY; ACTIVATION; RECEPTOR; LYMPHOCYTES; SDF-1-ALPHA	Background: CXCL12 is a pleiotropic chemokine involved in multiple different processes such as immune regulation, inflammatory responses, and cancer development. CXCL12 is also a potent chemokine involved in chemoattraction of T cells to the site of infection or inflammation. Mammalian target of rapamycin (mTOR) is a serine-threonine kinase that modulates different cellular processes, such as metabolism, nutrient sensing, protein translation, and cell growth. The role of mTOR in CXCL12-mediated resting T cell migration has yet to be elucidated. Methodology/Principal Findings: Rapamycin, an inhibitor of mTOR, significantly inhibits CXCL12 mediated migration of both primary human resting T cells and human T cell leukemia cell line CEM. p70(S6K1), an effector molecule of mTOR signaling pathway, was knocked down by shRNA in CEM cells using a lentiviral gene transfer system. Using p70(S6K1) knock down cells, we demonstrate the role of mTOR signaling in T cell migration both in vitro and in vivo. Conclusions: Our data demonstrate a new role for mTOR in CXCL12-induced T cell migration, and enrich the current knowledge regarding the clinical use of rapamycin.	[Munk, Rachel; Ghosh, Paritosh; Ghosh, Manik C.; Saito, Takeshi; Longo, Dan L.] NIA, Lymphocyte Cell Biol Unit, NIH, Baltimore, MD 21224 USA; [Xu, Mai; Carter, Arnell; Taub, Dennis D.] NIA, Clin Immunol Sect, Lab Mol Biol & Immunol, NIH, Baltimore, MD 21224 USA; [Indig, Fred] NIA, Res Resources Branch, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Munk, R (corresponding author), NIA, Lymphocyte Cell Biol Unit, NIH, Baltimore, MD 21224 USA.	ghoshp@grc.nia.nih.gov	Longo, Dan L./F-6022-2011		National Institutes of Health (NIH), National Institute on Aging; NATIONAL INSTITUTE ON AGING [ZIAAG000764, ZICAG000615, ZIAAG000115, ZIAAG000758] Funding Source: NIH RePORTER	National Institutes of Health (NIH), National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the Intramural Research Program of the National Institutes of Health (NIH), National Institute on Aging. There is no current external funding source for this study. The research was conducted as a part of the official duty of an employee in the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cloughesy TF, 2008, PLOS MED, V5, P139, DOI 10.1371/journal.pmed.0050008; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Finlay D, 2010, ANN NY ACAD SCI, V1183, P149, DOI 10.1111/j.1749-6632.2009.05134.x; Garcia-Martinez JM, 2009, BIOCHEM J, V421, P29, DOI 10.1042/BJ20090489; Ghosh MC, 2009, BLOOD, V114, P1366, DOI 10.1182/blood-2008-08-175869; Ghosh MC, 2009, BLOOD, V113, P575, DOI 10.1182/blood-2008-04-151803; Harris Thurl E, 2003, Sci STKE, V2003, pre15; Hashimoto I, 2008, EUR J CANCER, V44, P1022, DOI 10.1016/j.ejca.2008.02.043; Karin N, 2010, J LEUKOCYTE BIOL, V88, P463, DOI 10.1189/jlb.0909602; Kremer KN, 2003, J IMMUNOL, V171, P360, DOI 10.4049/jimmunol.171.1.360; Kumar A, 2006, IMMUNITY, V25, P213, DOI 10.1016/j.immuni.2006.06.015; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Murooka TT, 2008, BLOOD, V111, P4892, DOI 10.1182/blood-2007-11-125039; NORMAN MR, 1977, CANCER RES, V37, P3785; Sallusto F, 1998, IMMUNOL TODAY, V19, P568, DOI 10.1016/S0167-5699(98)01346-2; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sinclair LV, 2008, NAT IMMUNOL, V9, P513, DOI 10.1038/ni.1603; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Tilton B, 2000, J EXP MED, V192, P313, DOI 10.1084/jem.192.3.313; Vicente-Manzanares M, 2005, BLOOD, V105, P3026, DOI 10.1182/blood-2004-07-2925; Vila-Coro AJ, 1999, FASEB J, V13, P1699, DOI 10.1096/fasebj.13.13.1699; Voermans C, 2001, EXP HEMATOL, V29, P1456, DOI 10.1016/S0301-472X(01)00740-8; Wang JH, 2008, CANCER RES, V68, P10367, DOI 10.1158/0008-5472.CAN-08-2780; Ward SG, 2006, TRENDS IMMUNOL, V27, P80, DOI 10.1016/j.it.2005.12.004; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; Zhang SL, 2011, BLOOD, V117, P1228, DOI 10.1182/blood-2010-05-287821; Zhang XF, 2001, BLOOD, V97, P3342, DOI 10.1182/blood.V97.11.3342	29	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2011	6	9							e24667	10.1371/journal.pone.0024667	http://dx.doi.org/10.1371/journal.pone.0024667			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CO	21931802	Green Published, Green Submitted, gold			2022-12-25	WOS:000294803200036
J	Wilming, N; Betz, T; Kietzmann, TC; Konig, P				Wilming, Niklas; Betz, Torsten; Kietzmann, Tim C.; Koenig, Peter			Measures and Limits of Models of Fixation Selection	PLOS ONE			English	Article							EYE-MOVEMENTS; ALLOCATION; CONTRAST; SCENES	Models of fixation selection are a central tool in the quest to understand how the human mind selects relevant information. Using this tool in the evaluation of competing claims often requires comparing different models' relative performance in predicting eye movements. However, studies use a wide variety of performance measures with markedly different properties, which makes a comparison difficult. We make three main contributions to this line of research: First we argue for a set of desirable properties, review commonly used measures, and conclude that no single measure unites all desirable properties. However the area under the ROC curve (a classification measure) and the KL-divergence (a distance measure of probability distributions) combine many desirable properties and allow a meaningful comparison of critical model performance. We give an analytical proof of the linearity of the ROC measure with respect to averaging over subjects and demonstrate an appropriate correction of entropy-based measures like KL-divergence for small sample sizes in the context of eye-tracking data. Second, we provide a lower bound and an upper bound of these measures, based on image-independent properties of fixation data and between subject consistency respectively. Based on these bounds it is possible to give a reference frame to judge the predictive power of a model of fixation selection. We provide open-source python code to compute the reference frame. Third, we show that the upper, between subject consistency bound holds only for models that predict averages of subject populations. Departing from this we show that incorporating subject-specific viewing behavior can generate predictions which surpass that upper bound. Taken together, these findings lay out the required information that allow a well-founded judgment of the quality of any model of fixation selection and should therefore be reported when a new model is introduced.	[Wilming, Niklas; Betz, Torsten; Kietzmann, Tim C.; Koenig, Peter] Univ Osnabruck, Inst Cognit Sci, Osnabruck, Germany	University Osnabruck	Wilming, N (corresponding author), Univ Osnabruck, Inst Cognit Sci, Osnabruck, Germany.	nwilming@uos.de	Kietzman, Tim/AAA-5771-2019; König, Peter/ABB-2380-2020	Kietzman, Tim/0000-0001-8076-6062; König, Peter/0000-0003-3654-5267; Wilming, Niklas/0000-0003-0663-9828	7th Framework Programe [270212]	7th Framework Programe	This work was funded by the 7th Framework Programe, Grant Agreement No 270212, Extending Sensorimotor Contingencies to Cognition. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acik A, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00207; Acik A, 2009, VISION RES, V49, P1541, DOI 10.1016/j.visres.2009.03.011; Baddeley RJ, 2006, VISION RES, V46, P2824, DOI 10.1016/j.visres.2006.02.024; Betz T, 2010, J VISION, V10, DOI 10.1167/10.3.15; Bruce NDB, 2009, J VISION, V9, DOI 10.1167/9.3.5; Butko NJ, 2008, INT C DEVEL LEARN, P139, DOI 10.1109/DEVLRN.2008.4640819; Cerf M., 2008, ADV NEURAL INFORM PR, V20, P241, DOI DOI 10.1145/2185520.2185525; Cerf M, 2009, J VISION, V9, DOI 10.1167/9.12.10; Chao A, 2003, ENVIRON ECOL STAT, V10, P429, DOI 10.1023/A:1026096204727; Ehinger KA, 2009, VIS COGN, V17, P945, DOI 10.1080/13506280902834720; Einhauser W, 2008, J VISION, V8, DOI 10.1167/8.2.2; Elazary L, 2008, J VISION, V8, DOI 10.1167/8.3.3; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Frey HP, 2008, J VISION, V8, DOI 10.1167/8.14.6; Gilland J, 2008, THESIS U S DAKOTA; Hausser J, 2009, J MACH LEARN RES, V10, P1469; Holste D, 1998, J PHYS A-MATH GEN, V31, P2551, DOI 10.1088/0305-4470/31/11/007; Hwang AD, 2009, J VISION, V9, DOI 10.1167/9.5.25; Itti L, 2005, PROC CVPR IEEE, P631; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Itti L, 2009, VISION RES, V49, P1295, DOI 10.1016/j.visres.2008.09.007; Kanan C, 2009, VIS COGN, V17, P979, DOI 10.1080/13506280902771138; Kienzle W, 2009, J VISION, V9, DOI 10.1167/9.5.7; Kootstra G, 2011, COGN COMPUT, V3, P223, DOI 10.1007/s12559-010-9089-5; Miller G., 1955, INFORM THEORY PSYCHO, P95; Nemenman I, 2002, ADV NEUR IN, V14, P471; Parikh N, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/1/016006; Parkhurst D, 2002, VISION RES, V42, P107, DOI 10.1016/S0042-6989(01)00250-4; Perona, 2007, ADV NEURAL INFORM PR, P545, DOI DOI 10.7551/MITPRESS/7503.003.0073; Peters RJ, 2005, VISION RES, V45, P2397, DOI 10.1016/j.visres.2005.03.019; Recarte MA, 2000, J EXP PSYCHOL-APPL, V6, P31, DOI 10.1037/1076-898X.6.1.31; Renninger LW, 2007, J VISION, V7, DOI 10.1167/7.3.6; Schurmann T, 1996, CHAOS, V6, P414, DOI 10.1063/1.166191; Tatler BW, 2009, VIS COGN, V17, P1029, DOI 10.1080/13506280902764539; Tatler BW, 2007, J VISION, V7, DOI 10.1167/7.14.4; Tatler BW, 2005, VISION RES, V45, P643, DOI 10.1016/j.visres.2004.09.017; Torralba A, 2006, PSYCHOL REV, V113, P766, DOI 10.1037/0033-295X.113.4.766; TRYBULA S, 1958, ANN MATH STAT, V29, P245, DOI 10.1214/aoms/1177706722; Yanulevskaya V, 2011, COGN COMPUT, V3, P94, DOI 10.1007/s12559-010-9087-7; Zhang LY, 2008, J VISION, V8, DOI 10.1167/8.7.32	41	44	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2011	6	9							e24038	10.1371/journal.pone.0024038	http://dx.doi.org/10.1371/journal.pone.0024038			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CO	21931638	gold, Green Submitted, Green Published			2022-12-25	WOS:000294803200007
J	Amtul, Z; Keet, M; Wang, L; Merrifield, P; Westaway, D; Rozmahel, RF				Amtul, Zareen; Keet, Mary; Wang, Lin; Merrifield, Peter; Westaway, David; Rozmahel, Richard F.			DHA Supplemented in Peptamen Diet Offers No Advantage in Pathways to Amyloidosis: Is It Time to Evaluate Composite Lipid Diet?	PLOS ONE			English	Article							DOCOSAHEXAENOIC ACID; ALZHEIMERS-DISEASE; TRANSGENIC MICE; NERVOUS-SYSTEM; ELEMENTAL DIET; PEPTIDE LEVELS; BETA-PROTEIN; MOUSE MODEL; IN-VIVO; HIV	Numerous reports have documented the beneficial effects of dietary docosahexaenoic acid (DHA) on beta-amyloid production and Alzheimer's disease (AD). However, none of these studies have examined and compared DHA, in combination with other dietary nutrients, for its effects on plaque pathogenesis. Potential interactions of DHA with other dietary nutrients and fatty acids are conventionally ignored. Here we investigated DHA with two dietary regimes; peptamen (pep+DHA) and low fat diet (low fat+DHA). Peptamen base liquid diet is a standard sole-source nutrition for patients with gastrointestinal dysfunction. Here we demonstrate that a robust AD transgenic mouse model shows an increased tendency to produce beta-amyloid peptides and amyloid plaques when fed a pep+DHA diet. The increase in beta-amyloid peptides was due to an elevated trend in the levels of beta-secretase amyloid precursor protein (APP) cleaving enzyme (BACE), the proteolytic C-terminal fragment beta of APP and reduced levels of insulin degrading enzyme that endoproteolyse beta-amyloid. On the contrary, TgCRND8 mice on low fat+DHA diet (based on an approximately 18% reduction of fat intake) ameliorate the production of abeta peptides and consequently amyloid plaques. Our work not only demonstrates that DHA when taken with peptamen may have a tendency to confer a detrimental affect on the amyloid plaque build up but also reinforces the importance of studying composite lipids or nutrients rather than single lipids or nutrients for their effects on pathways important to plaque development.	[Amtul, Zareen; Keet, Mary; Rozmahel, Richard F.] Univ Western Ontario, Dept Biochem, London, ON, Canada; [Amtul, Zareen; Keet, Mary; Wang, Lin; Rozmahel, Richard F.] Lawson Hlth Res Inst, London, ON, Canada; [Westaway, David] Univ Alberta, Ctr Prions & Prot Folding Dis, Edmonton, AB, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); University of Alberta	Amtul, Z (corresponding author), Univ Western Ontario, Dept Anat & Cell Biol, Schulich Sch Med & Dent, London, ON, Canada.	zamtul@uwo.ca	AMTUL, ZAREEN/Y-6364-2019		London and Middlesex Alzheimer's Association; Canadian Institutes of Health Research [MOP49546]; Ontario Mental Health Foundation	London and Middlesex Alzheimer's Association; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Mental Health Foundation	This research was funded by grants from the London and Middlesex Alzheimer's Association (Marion and Chester Fish Alzheimer's Disease Research Grant) and the Canadian Institutes of Health Research (MOP49546) to RFR and an Ontario Mental Health Foundation Award to ZA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alisky JM, 2007, MED HYPOTHESES, V69, P1140, DOI 10.1016/j.mehy.2007.02.030; AMTUL Z, 2011, NEUROBIOL AGING, P7, DOI DOI 10.1016/J.NEUROBIOLAGING.07.014; AMTUL Z, 2011, J BIOL CHEM, V86, P6100; Amtul Z, 2011, J NEUROSCI RES, V89, P1795, DOI 10.1002/jnr.22706; Amtul Z, 2011, BRAIN PATHOL, V21, P321, DOI 10.1111/j.1750-3639.2010.00449.x; Amtul Z, 2010, NEUROSCI LETT, V481, P73, DOI 10.1016/j.neulet.2010.06.046; Ando H, 2006, BIOCHEM J, V394, P43, DOI 10.1042/BJ20051419; Arendash GW, 2007, NEUROSCIENCE, V149, P286, DOI 10.1016/j.neuroscience.2007.08.018; Asberom T, 2007, BIOORG MED CHEM LETT, V17, P511, DOI 10.1016/j.bmcl.2006.10.011; BANG HO, 1980, DAN MED BULL, V27, P202; Bate C, 2008, NEUROPHARMACOLOGY, V54, P934, DOI 10.1016/j.neuropharm.2008.02.003; Brijbassi S, 2007, NEUROBIOL DIS, V25, P291, DOI 10.1016/j.nbd.2006.09.013; Calon F, 2004, NEURON, V43, P633, DOI 10.1016/j.neuron.2004.08.013; Chishti MA, 2001, J BIOL CHEM, V276, P21562, DOI 10.1074/jbc.M100710200; Christensen MA, 2004, MOL CELL BIOL, V24, P865, DOI 10.1128/MCB.24.2.865-874.2004; ECKMAN EA, 1995, AM J PHYSIOL-LUNG C, V269, pL625, DOI 10.1152/ajplung.1995.269.5.L625; Esiri MM, 1998, J NEUROL NEUROSUR PS, V65, P29, DOI 10.1136/jnnp.65.1.29; Everall IP, 2005, NEUROTOX RES, V8, P51, DOI 10.1007/BF03033819; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; Freund-Levi Y, 2006, ARCH NEUROL-CHICAGO, V63, P1402, DOI 10.1001/archneur.63.10.1402; Gamoh S, 2001, CLIN EXP PHARMACOL P, V28, P266, DOI 10.1046/j.1440-1681.2001.03437.x; Green DA, 2005, AIDS, V19, P407, DOI 10.1097/01.aids.0000161770.06158.5c; Green KN, 2007, J NEUROSCI, V27, P4385, DOI 10.1523/JNEUROSCI.0055-07.2007; Gu YA, 2010, ARCH NEUROL-CHICAGO, V67, P699, DOI 10.1001/archneurol.2010.84; HARMAN D, 1976, J AM GERIATR SOC, V24, P301, DOI 10.1111/j.1532-5415.1976.tb06800.x; Hashimoto M, 2005, BBA-MOL CELL BIOL L, V1738, P91, DOI 10.1016/j.bbalip.2005.11.011; Ikemoto A, 2001, J LIPID RES, V42, P1655; Inglis F, 2002, INT J CLIN PRACT, P45; Kosyns'kyi O V, 2004, Klin Khir, P25; KUEHL FA, 1980, SCIENCE, V210, P978, DOI 10.1126/science.6254151; Lim GP, 2005, J NEUROSCI, V25, P3032, DOI 10.1523/JNEUROSCI.4225-04.2005; Lykhach T V, 2004, Klin Khir, P5; Maev I V, 2003, Eksp Klin Gastroenterol, P100; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; MILLER DL, 1993, ARCH BIOCHEM BIOPHYS, V301, P41, DOI 10.1006/abbi.1993.1112; Moser HW, 1991, TECHNIQUES DIAGNOSTI, P177; Nath A, 2005, AIDS, V19, P203, DOI 10.1097/00002030-200501280-00013; QUINN J, 2009, INT C ALZH DIS 2009; Rempel HC, 2005, AIDS, V19, P127, DOI 10.1097/00002030-200501280-00004; Salem N, 2001, LIPIDS, V36, P945, DOI 10.1007/s11745-001-0805-6; Salomon SB, 1998, J AM DIET ASSOC, V98, P460, DOI 10.1016/S0002-8223(98)00104-7; Schaefer EJ, 2006, ARCH NEUROL-CHICAGO, V63, P1545, DOI 10.1001/archneur.63.11.1545; Shapshak P, 2004, FRONT BIOSCI-LANDMRK, V9, P1073, DOI 10.2741/1271; Sudoh S, 2002, BIOCHEMISTRY-US, V41, P1091, DOI 10.1021/bi011193l; Tiengou LE, 2006, JPEN-PARENTER ENTER, V30, P1, DOI 10.1177/014860710603000101; Weisinger HS, 2002, LIPIDS, V37, P759, DOI 10.1007/s11745-002-0958-3; YURKOMAURO K, 2009, RESULTS MIDAS TRIAL; Zoli G, 1997, ALIMENT PHARM THER, V11, P735, DOI 10.1046/j.1365-2036.1997.t01-1-00192.x	48	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e24094	10.1371/journal.pone.0024094	http://dx.doi.org/10.1371/journal.pone.0024094			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CK	21931647	gold, Green Published, Green Submitted			2022-12-25	WOS:000294802800023
J	Zou, ZC; Chastain, A; Moir, S; Ford, J; Trandem, K; Martinelli, E; Cicala, C; Crocker, P; Arthos, J; Sun, PD				Zou, Zhongcheng; Chastain, Ashley; Moir, Susan; Ford, Jennifer; Trandem, Kathryn; Martinelli, Elena; Cicala, Claudia; Crocker, Paul; Arthos, James; Sun, Peter D.			Siglecs Facilitate HIV-1 Infection of Macrophages through Adhesion with Viral Sialic Acids	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; GP120 ENVELOPE GLYCOPROTEIN; MYELIN-ASSOCIATED GLYCOPROTEIN; I-TYPE LECTINS; INFLUENZA HEMAGGLUTININ; MANNOSE RECEPTOR; DENDRITIC CELLS; B-LYMPHOCYTES; TYPE-1; PROTEIN	Background: Human immunodeficiency virus type 1 (HIV-1) infects macrophages effectively, despite relatively low levels of cell surface-expressed CD4. Although HIV-1 infections are defined by viral tropisms according to chemokine receptor usage (R5 and X4), variations in infection are common within both R5- and X4-tropic viruses, indicating additional factors may contribute to viral tropism. Methodology and Principal Findings: Using both solution and cell surface binding experiments, we showed that R5- and X4-tropic HIV-1 gp120 proteins recognized a family of I-type lectin receptors, the Sialic acid-binding immunoglobulin-like lectins (Siglec). The recognition was through envelope-associated sialic acids that promoted viral adhesion to macrophages. The sialic acid-mediated viral-host interaction facilitated both R5-tropic pseudovirus and HIV-1(BaL) infection of macrophages. The high affinity Siglec-1 contributed the most to HIV-1 infection and the variation in Siglec-1 expression on primary macrophages from different donors was associated statistically with sialic acid-facilitated viral infection. Furthermore, envelope-associated sialoglycan variations on various strains of R5-tropic viruses also affected infection. Conclusions and Significance of the Findings: Our study showed that sialic acids on the viral envelope facilitated HIV-1 infection of macrophages through interacting with Siglec receptors, and the expression of Siglec-1 correlated with viral sialic acid-mediated host attachment. This glycan-mediated viral adhesion underscores the importance of viral sialic acids in HIV infection and pathogenesis, and suggests a novel class of antiviral compounds targeting Siglec receptors.	[Zou, Zhongcheng; Chastain, Ashley; Ford, Jennifer; Trandem, Kathryn; Sun, Peter D.] NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA; [Moir, Susan; Martinelli, Elena; Cicala, Claudia; Arthos, James] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA; [Crocker, Paul] Univ Dundee, Coll Life Sci, Dundee, Scotland	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Dundee	Zou, ZC (corresponding author), NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA.	psun@nih.gov	Moir, Susan/AAC-3676-2020; Chastain, Ashley/B-8813-2019	Martinelli, Elena/0000-0002-3416-9627; Crocker, Paul/0000-0001-6230-0293; Chastain, Ashley/0000-0001-9642-9749	National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000883, ZIAAI000880, ZIAAI000887, ZIAAI000825] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The funding is provided by the National Institutes of Health Intramural research funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akagawa KS, 2002, INT J HEMATOL, V76, P27, DOI 10.1007/BF02982715; Angata T, 2002, BBA-GEN SUBJECTS, V1572, P294, DOI 10.1016/S0304-4165(02)00316-1; Balzarini J, 2007, NAT REV MICROBIOL, V5, P583, DOI 10.1038/nrmicro1707; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Blixt O, 2003, J BIOL CHEM, V278, P31007, DOI 10.1074/jbc.M304331200; Bozzacco L, 2007, P NATL ACAD SCI USA, V104, P1289, DOI 10.1073/pnas.0610383104; Cho MW, 1998, J VIROL, V72, P2509, DOI 10.1128/JVI.72.3.2509-2515.1998; Cicala C, 2006, P NATL ACAD SCI USA, V103, P3746, DOI 10.1073/pnas.0511237103; Collins BE, 1997, J BIOL CHEM, V272, P16889, DOI 10.1074/jbc.272.27.16889; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Doria-Rose NA, 2005, J VIROL, V79, P11214, DOI 10.1128/JVI.79.17.11214-11224.2005; FANTINI J, 1993, P NATL ACAD SCI USA, V90, P2700, DOI 10.1073/pnas.90.7.2700; Hartnell A, 2001, BLOOD, V97, P288, DOI 10.1182/blood.V97.1.288; Hatsukari I, 2007, J AM SOC NEPHROL, V18, P780, DOI 10.1681/ASN.2006121307; HE JL, 1995, J VIROL, V69, P6705, DOI 10.1128/JVI.69.11.6705-6711.1995; Hu HL, 1996, J VIROL, V70, P7462, DOI 10.1128/JVI.70.11.7462-7470.1996; Kazmierczak K, 2007, J NEUROVIROL, V13, P452, DOI 10.1080/13550280701510104; Kinter A, 2000, IMMUNOL REV, V177, P88, DOI 10.1034/j.1600-065X.2000.17708.x; Klatt NR, 2010, MUCOSAL IMMUNOL, V3, P387, DOI 10.1038/mi.2010.14; Kwong PD, 2000, J VIROL, V74, P1961, DOI 10.1128/JVI.74.4.1961-1972.2000; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; LEONARD CK, 1990, J BIOL CHEM, V265, P10373; Martinelli E, 2007, P NATL ACAD SCI USA, V104, P3396, DOI 10.1073/pnas.0611353104; Moir S, 1999, J VIROL, V73, P7972, DOI 10.1128/JVI.73.10.7972-7980.1999; Montaner LJ, 2006, J LEUKOCYTE BIOL, V80, P961, DOI 10.1189/jlb.0806488; Mori T, 1998, PROTEIN EXPRES PURIF, V12, P151, DOI 10.1006/prep.1997.0838; Nath D, 1999, IMMUNOLOGY, V98, P213; Nguyen DG, 2003, EUR J IMMUNOL, V33, P483, DOI 10.1002/immu.200310024; Patnaik SK, 2006, METHOD ENZYMOL, V416, P159, DOI 10.1016/S0076-6879(06)16011-5; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Quinones-Kochs MI, 2002, J VIROL, V76, P4199, DOI 10.1128/JVI.76.9.4199-4211.2002; Razi N, 1998, P NATL ACAD SCI USA, V95, P7469, DOI 10.1073/pnas.95.13.7469; Reitter JN, 1998, J VIROL, V72, P5399, DOI 10.1128/JVI.72.7.5399-5407.1998; Rempel H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001967; REUTER G, 1989, GLYCOCONJUGATE J, V6, P35, DOI 10.1007/BF01047888; ROGERS GN, 1983, NATURE, V304, P76, DOI 10.1038/304076a0; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Shen L, 2008, J ALLERGY CLIN IMMUN, V122, P22, DOI 10.1016/j.jaci.2008.05.033; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Stamatos NM, 2005, FEBS J, V272, P2545, DOI 10.1111/j.1742-4658.2005.04679.x; Sun JF, 2001, VIROLOGY, V284, P26, DOI 10.1006/viro.2001.0889; Trujillo JR, 2007, P NATL ACAD SCI USA, V104, P5097, DOI 10.1073/pnas.0611263104; van den Berg TK, 2001, J IMMUNOL, V166, P3637, DOI 10.4049/jimmunol.166.6.3637; van der Kuyl AC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000257; Vidricaire G, 2007, J INFECT DIS, V195, P1461, DOI 10.1086/515576; Wahl SM, 2006, J LEUKOCYTE BIOL, V80, P973, DOI 10.1189/jlb.0306130; Wolk T, 2006, MED MICROBIOL IMMUN, V195, P165, DOI 10.1007/s00430-006-0016-z; Wu LJ, 1996, NATURE, V384, P179, DOI 10.1038/384179a0; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Yang XZ, 2002, J VIROL, V76, P4634, DOI 10.1128/JVI.76.9.4634-4642.2002; York MR, 2007, ARTHRITIS RHEUM-US, V56, P1010, DOI 10.1002/art.22382	52	73	74	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e24559	10.1371/journal.pone.0024559	http://dx.doi.org/10.1371/journal.pone.0024559			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CK	21931755	Green Published, Green Submitted, gold			2022-12-25	WOS:000294802800067
J	Chanda, E; Hemingway, J; Kleinschmidt, I; Rehman, AM; Ramdeen, V; Phiri, FN; Coetzer, S; Mthembu, D; Shinondo, CJ; Chizema-Kawesha, E; Kamuliwo, M; Mukonka, V; Baboo, KS; Coleman, M				Chanda, Emmanuel; Hemingway, Janet; Kleinschmidt, Immo; Rehman, Andrea M.; Ramdeen, Varsha; Phiri, Faustina N.; Coetzer, Sarel; Mthembu, David; Shinondo, Cecilia J.; Chizema-Kawesha, Elizabeth; Kamuliwo, Mulakwa; Mukonka, Victor; Baboo, Kumar S.; Coleman, Michael			Insecticide Resistance and the Future of Malaria Control in Zambia	PLOS ONE			English	Article							ENTOMOLOGIC INOCULATION RATES; ANOPHELES-GAMBIAE; TREATED NETS; VECTOR CONTROL; PLASMODIUM-FALCIPARUM; IDENTIFICATION; IMPACT; FUNESTUS; TRANSMISSION; MANAGEMENT	Background: In line with the Global trend to improve malaria control efforts a major campaign of insecticide treated net distribution was initiated in 1999 and indoor residual spraying with DDT or pyrethroids was reintroduced in 2000 in Zambia. In 2006, these efforts were strengthened by the President's Malaria Initiative. This manuscript reports on the monitoring and evaluation of these activities and the potential impact of emerging insecticide resistance on disease transmission. Methods: Mosquitoes were captured daily through a series of 108 window exit traps located at 18 sentinel sites. Specimens were identified to species and analyzed for sporozoites. Adult Anopheles mosquitoes were collected resting indoors and larva collected in breeding sites were reared to F1 and F0 generations in the lab and tested for insecticide resistance following the standard WHO susceptibility assay protocol. Annual cross sectional household parasite surveys were carried out to monitor the impact of the control programme on prevalence of Plasmodium falciparum in children aged 1 to 14 years. Results: A total of 619 Anopheles gambiae s.l. and 228 Anopheles funestus s.l. were captured from window exit traps throughout the period, of which 203 were An. gambiae malaria vectors and 14 An. funestus s.s.. In 2010 resistance to DDT and the pyrethroids deltamethrin, lambda-cyhalothrin and permethrin was detected in both An. gambiae s.s. and An. funestus s.s.. No sporozoites were detected in either species. Prevalence of P. falciparum in the sentinel sites remained below 10% throughout the study period. Conclusion: Both An. gambiae s.s. and An. funestus s.s. were controlled effectively with the ITN and IRS programme in Zambia, maintaining a reduced disease transmission and burden. However, the discovery of DDT and pyrethroid resistance in the country threatens the sustainability of the vector control programme.	[Chanda, Emmanuel; Phiri, Faustina N.; Kamuliwo, Mulakwa] Natl Malaria Control Ctr, Minist Hlth, Lusaka, Zambia; [Hemingway, Janet; Coleman, Michael] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Kleinschmidt, Immo; Rehman, Andrea M.] London Sch Hyg & Trop Med, MRC, Trop Epidemiol Grp, London WC1, England; [Ramdeen, Varsha; Coetzer, Sarel; Mthembu, David] MRC, Malaria Res Programme, Durban, South Africa; [Shinondo, Cecilia J.; Baboo, Kumar S.] Univ Zambia, Sch Med, Lusaka, Zambia	Liverpool School of Tropical Medicine; University of Liverpool; University of London; London School of Hygiene & Tropical Medicine; University of Zambia	Chanda, E (corresponding author), Natl Malaria Control Ctr, Minist Hlth, Lusaka, Zambia.	mcoleman@liverpool.ac.uk	Rehman, Andrea/AAP-3172-2020; Rehman, Andrea M/H-1351-2015	Rehman, Andrea/0000-0001-9967-5822; Rehman, Andrea M/0000-0001-9967-5822; Coleman, Michael/0000-0003-4186-3526; Hemingway, Janet/0000-0002-3200-7173	Innovative Vector Control Consortium (IVCC); Health Services and Systems Programme, Zambia; MRC [G0700837] Funding Source: UKRI; Medical Research Council [G0700837] Funding Source: researchfish	Innovative Vector Control Consortium (IVCC); Health Services and Systems Programme, Zambia; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was financially supported by the Innovative Vector Control Consortium (IVCC) and the Health Services and Systems Programme, Zambia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000363.PUB2; [Anonymous], 1998, TEST PROC INS RES MO; [Anonymous], WORLD MAL REP 2009 W; [Anonymous], 1968, ANOPHELINAE AFR S SA; Barnes KI, 2005, PLOS MED, V2, P1123, DOI 10.1371/journal.pmed.0020330; Bass C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-111; Bass C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-177; Beier JC, 1999, AM J TROP MED HYG, V61, P109, DOI 10.4269/ajtmh.1999.61.109; BRANSBYWILLIAMS WR, 1979, E AFR MED J, V56, P557; Casimiro SLR, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-142; Chanda E, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-164; Chanda P, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-49; Chizema-Kawesha E, 2010, AM J TROP MED HYG, V83, P480, DOI 10.4269/ajtmh.2010.10-0035; Coleman M, 2006, J MED ENTOMOL, V43, P663, DOI 10.1093/jmedent/43.4.663; Cuamba N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011010; CURTIS CF, 1994, PARASITOL TODAY, V10, P371, DOI 10.1016/0169-4758(94)90222-4; EKUE JMK, 1983, BRIT MED J, V286, P1315, DOI 10.1136/bmj.286.6374.1315-a; Favia G, 1997, INSECT MOL BIOL, V6, P377, DOI 10.1046/j.1365-2583.1997.00189.x; Feachem R, 2008, LANCET, V371, P1633, DOI 10.1016/S0140-6736(08)60424-9; Fegan GW, 2007, LANCET, V370, P1035, DOI 10.1016/S0140-6736(07)61477-9; Gillies M, 1987, ANOPHELINAE AFRICA S; Guyatt HL, 2002, HEALTH POLICY PLANN, V17, P144, DOI 10.1093/heapol/17.2.144; Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018; Janeira F, 2008, J MED ENTOMOL, V45, P237, DOI 10.1603/0022-2585(2008)45[237:APRACR]2.0.CO;2; Kengne P, 2001, INSECT MOL BIOL, V10, P427, DOI 10.1046/j.0962-1075.2001.00281.x; Kent RJ, 2007, AM J TROP MED HYG, V76, P267, DOI 10.4269/ajtmh.2007.76.267; Killeen GF, 2000, AM J TROP MED HYG, V62, P535, DOI 10.4269/ajtmh.2000.62.535; Kleinschmidt I, 2009, AM J TROP MED HYG, V81, P519, DOI 10.4269/ajtmh.2009.81.519; Koekemoer LL, 2002, AM J TROP MED HYG, V66, P804, DOI 10.4269/ajtmh.2002.66.804; Komatsu R, 2007, B WORLD HEALTH ORGAN, V85, P805, DOI 10.2471/BLT.06.038315; Lengeler C, 2004, B WORLD HEALTH ORGAN, V82, P84; Maharaj R, 2005, SAMJ S AFR MED J, V95, P871; Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x; McClean KL, 2002, TROP DOCT, V32, P139, DOI 10.1177/004947550203200306; *MIN HLTH, 2000, MAL SIT AN NAT MAL C; N'Guessan R, 2007, EMERG INFECT DIS, V13, P199, DOI 10.3201/eid1302.060631; Protopopoff N, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-158; Ranson H, 2000, INSECT MOL BIOL, V9, P491, DOI 10.1046/j.1365-2583.2000.00209.x; ROBERTS JMD, 1964, J TROP MED HYG, V67, P191; Russell TL, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-80; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; Sharp B, 2002, TROP MED INT HEALTH, V7, P732, DOI 10.1046/j.1365-3156.2002.00928.x; Sharp BL, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-52; SHELLEY AJ, 1973, ANN TROP MED PARASIT, V67, P237, DOI 10.1080/00034983.1973.11686884; Spillings BL, 2009, AM J TROP MED HYG, V81, P510, DOI 10.4269/ajtmh.2009.81.510; WHO, 2006, PEST THEIR APPL	46	78	81	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2011	6	9							e24336	10.1371/journal.pone.0024336	http://dx.doi.org/10.1371/journal.pone.0024336			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817QP	21915314	Green Accepted, gold, Green Published			2022-12-25	WOS:000294689200037
J	Perez-Alvarez, A; Hernandez-Vivanco, A; McIntosh, JM; Albillos, A				Perez-Alvarez, Alberto; Hernandez-Vivanco, Alicia; McIntosh, J. Michael; Albillos, Almudena			Native alpha 6 beta 4* nicotinic receptors control exocytosis in human chromaffin cells of the adrenal gland	FASEB JOURNAL			English	Article						patch clamp; acetylcholine; adrenaline; secretion	ALPHA-CONOTOXIN-MII; 3 BETA 2; VENTRAL TEGMENTAL AREA; RAT MEDIAL HABENULA; ACETYLCHOLINE-RECEPTORS; NOREPINEPHRINE RELEASE; PARKINSONS-DISEASE; NIGROSTRIATAL DAMAGE; SUBUNIT COMPOSITION; DOPAMINE NEURONS	In the present study, we have electro-physiologically characterized native nicotinic acetylcholine receptors (nAChRs) in human chromaffin cells of the adrenal gland as well as their contribution to the exocytotic process. alpha-Conotoxin AuIB blocked by 14 +/- 1% the acetylcholine (ACh)-induced nicotinic current. alpha-Conotoxin MII (alpha-Ctx MII) exhibited an almost full blockade of the nicotinic current at nanomolar concentrations (IC(50) = 21.6 nM). The alpha 6*-preferring alpha-Ctx MII mutant analogs, alpha-Ctx MII[H9A,L15A] and alpha-Ctx MII[S4A,E11A,L15A], blocked nAChR currents with an IC(50) of 217.8 and 33 nM, respectively. These data reveal that nAChRs in these cells include the alpha 6* subtype. The washout of the blockade exerted by alpha-conotoxin BuIA (alpha-Ctx BuIA; 1 mu M) on ACh-evoked currents was slight and slow, arguing in favor of the presence of a beta 4 subunit in the nAChR composition. Exocytosis was almost fully blocked by 1 mu M alpha-Ctx MII, its mutant analogs, or alpha-Ctx BuIA. Finally, the fluorescent analog Alexa Fluor 546-BuIA showed distinct staining in these cells. Our results reveal that alpha 6 beta 4* nAChRs are expressed and contribute to exocytosis in human chromaffin cells of the adrenal gland, the main source of adrenaline under stressful situations.-Perez-Alvarez, A., Hernandez-Vivanco, A., McIntosh, J. M., Albillos, A. Native alpha 6 beta 4* nicotinic receptors control exocytosis in human chromaffin cells of the adrenal gland. FASEB J. 26, 346-354 (2012). www.fasebj.org	[Perez-Alvarez, Alberto; Hernandez-Vivanco, Alicia; Albillos, Almudena] Univ Autonoma Madrid, Fac Med, Dept Farmacol & Terapeut, E-28029 Madrid, Spain; [McIntosh, J. Michael] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [McIntosh, J. Michael] Univ Utah, Dept Psychiat, Salt Lake City, UT USA	Autonomous University of Madrid; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Perez-Alvarez, A (corresponding author), Univ Autonoma Madrid, Fac Med, Dept Farmacol & Terapeut, C Arzobispo Morcillo 4, E-28029 Madrid, Spain.	a.perez@uam.es; almudena.albillos@uam.es	Albillos, Almudena/AAA-9098-2019	Perez-Alvarez, Alberto/0000-0002-5586-0927; ALBILLOS, ALMUDENA/0000-0003-3315-9715; Hernandez Vivanco, Alicia/0000-0001-7920-3588	Universidad Autonoma de Madrid; Ministerio de Ciencia y Tecnologia [BFU2008-01382/BFI]; U.S. National Institutes of Health [MH53631, GM48677]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM048677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH053631, R01MH053631] Funding Source: NIH RePORTER	Universidad Autonoma de Madrid; Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors thank the donors of the human adrenal glands and their relatives. The authors also thank Dr. Agustin Albillos and the Transplant Team of the Hospital Ramon y Cajal (Madrid, Spain) for their excellent coordination in supplying the human adrenal glands. A.H.-V. holds a fellowship award from the Universidad Autonoma de Madrid. This work was supported by grants from the Ministerio de Ciencia y Tecnologia (BFU2008-01382/BFI to A. A.) and the U.S. National Institutes of Health (MH53631 and GM48677 to J.M.M.). The authors declare no conflicts of interest.	Albillos A, 1997, NATURE, V389, P509, DOI 10.1038/39081; ALMAZAN G, 1984, BRIT J PHARMACOL, V81, P599, DOI 10.1111/j.1476-5381.1984.tb16124.x; Azam L, 2005, J BIOL CHEM, V280, P80, DOI 10.1074/jbc.M406281200; Azam L, 2005, J PHARMACOL EXP THER, V312, P231, DOI 10.1124/jpet.104.071456; Azam L, 2002, J COMP NEUROL, V444, P260, DOI 10.1002/cne.10138; Azam L, 2008, J BIOL CHEM, V283, P11625, DOI 10.1074/jbc.M710288200; Azam L, 2006, MOL PHARMACOL, V70, P967, DOI 10.1124/mol.106.024513; Azam L, 2010, FASEB J, V24, P5113, DOI 10.1096/fj.10-166272; Bibevski S, 2000, J NEUROSCI, V20, P5076; Bordia T, 2007, MOL PHARMACOL, V72, P52, DOI 10.1124/mol.107.035998; CamposCaro A, 1997, J NEUROCHEM, V68, P488; Cartier GE, 1996, J BIOL CHEM, V271, P7522, DOI 10.1074/jbc.271.13.7522; Champtiaux N, 2002, J NEUROSCI, V22, P1208, DOI 10.1523/JNEUROSCI.22-04-01208.2002; ChavezNoriega LE, 1997, J PHARMACOL EXP THER, V280, P346; Colomer C, 2010, J NEUROSCI, V30, P6732, DOI 10.1523/JNEUROSCI.4997-09.2010; Colquhoun LM, 1997, J NEUROCHEM, V69, P2355; CONNOLLY JG, 1995, J PHYSIOL-LONDON, V484, P87, DOI 10.1113/jphysiol.1995.sp020650; CONROY WG, 1995, J BIOL CHEM, V270, P4424, DOI 10.1074/jbc.270.9.4424; CRIADO M, 1992, NEUROCHEM RES, V17, P281, DOI 10.1007/BF00966671; Di Angelantonio S, 2003, EUR J NEUROSCI, V17, P2313, DOI 10.1046/j.1460-9568.2003.02669.x; Dowell C, 2003, J NEUROSCI, V23, P8445; Fu YT, 1999, NEUROSCI LETT, V266, P113, DOI 10.1016/S0304-3940(99)00293-1; Fucile S, 1998, EUR J NEUROSCI, V10, P172, DOI 10.1046/j.1460-9568.1998.00001.x; Genzen JR, 2001, J NEUROPHYSIOL, V86, P1773, DOI 10.1152/jn.2001.86.4.1773; Gerzanich V, 1997, MOL PHARMACOL, V51, P320, DOI 10.1124/mol.51.2.320; Gillis Kevin D., 1995, P155; Goldner FM, 1997, NEUROREPORT, V8, P2739; Harvey SC, 1997, MOL PHARMACOL, V51, P336, DOI 10.1124/mol.51.2.336; Hone AJ, 2010, J NEUROCHEM, V114, P994, DOI 10.1111/j.1471-4159.2010.06819.x; Jackson KJ, 2009, J PHARMACOL EXP THER, V331, P547, DOI 10.1124/jpet.109.155457; Kuryatov A, 2000, NEUROPHARMACOLOGY, V39, P2570, DOI 10.1016/S0028-3908(00)00144-1; Lai A, 2005, MOL PHARMACOL, V67, P1639, DOI 10.1124/mol.104.006429; Lamar E., 1990, SOC NEUR ABSTR, V16, P2852; LANGE KW, 1993, J NEUROCHEM, V60, P197, DOI 10.1111/j.1471-4159.1993.tb05838.x; LeNovere N, 1996, EUR J NEUROSCI, V8, P2428; LINDAU M, 1988, PFLUG ARCH EUR J PHY, V411, P137, DOI 10.1007/BF00582306; LUETJE CW, 1991, J NEUROSCI, V11, P837; Luo SQ, 1998, J NEUROSCI, V18, P8571; McIntosh JM, 2004, MOL PHARMACOL, V65, P944, DOI 10.1124/mol.65.4.944; MOLLARD P, 1995, P NATL ACAD SCI USA, V92, P3065, DOI 10.1073/pnas.92.7.3065; Mousavi M, 2001, LIFE SCI, V70, P577, DOI 10.1016/S0024-3205(01)01427-8; Mugnaini M, 2006, NEUROSCIENCE, V137, P565, DOI 10.1016/j.neuroscience.2005.09.008; NEHER E, 1982, P NATL ACAD SCI-BIOL, V79, P6712, DOI 10.1073/pnas.79.21.6712; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Neher E, 2006, PFLUG ARCH EUR J PHY, V453, P261, DOI 10.1007/s00424-006-0143-9; PAPKE RL, 1994, MOL PHARMACOL, V45, P142; Perez-Alvarez A, 2008, PFLUG ARCH EUR J PHY, V456, P1149, DOI 10.1007/s00424-008-0492-7; Perez-Alvarez A, 2007, J NEUROCHEM, V103, P2281, DOI 10.1111/j.1471-4159.2007.04932.x; Perez-Alvarez A, 2012, BRIT J PHARMACOL, V165, P908, DOI 10.1111/j.1476-5381.2011.01596.x; Perez-Alvarez A, 2011, J NEUROCHEM, V116, P105, DOI 10.1111/j.1471-4159.2010.07089.x; Perez-Alvarez A, 2010, CELL MOL NEUROBIOL, V30, P1407, DOI 10.1007/s10571-010-9582-0; Perry DC, 2007, J PHARMACOL EXP THER, V322, P306, DOI 10.1124/jpet.107.121228; Quick MW, 1999, NEUROPHARMACOLOGY, V38, P769, DOI 10.1016/S0028-3908(99)00024-6; Quik M, 2006, J PHARMACOL EXP THER, V316, P481, DOI 10.1124/jpet.105.094375; Quik M, 2001, J NEUROSCI, V21, P5494, DOI 10.1523/JNEUROSCI.21-15-05494.2001; Sala F, 2008, ACTA PHYSIOL, V192, P203, DOI 10.1111/j.1748-1716.2007.01804.x; Salminen O, 2004, MOL PHARMACOL, V65, P1526, DOI 10.1124/mol.65.6.1526; TAKIYYUDDIN MA, 1994, J AUTON PHARMACOL, V14, P187, DOI 10.1111/j.1474-8673.1994.tb00601.x; Tumkosit P, 2006, MOL PHARMACOL, V70, P1358, DOI 10.1124/mol.106.027326; Vailati S, 1999, MOL PHARMACOL, V56, P11, DOI 10.1124/mol.56.1.11; Walsh H, 2008, J BIOL CHEM, V283, P6022, DOI 10.1074/jbc.M703432200; WHITEHOUSE PJ, 1988, ARCH NEUROL-CHICAGO, V45, P722, DOI 10.1001/archneur.1988.00520310028012; Wu PC, 2010, J NEUROCHEM, V112, P1210, DOI 10.1111/j.1471-4159.2009.06533.x; Xiao C, 2011, BIOCHEM PHARMACOL, V82, P852, DOI 10.1016/j.bcp.2011.05.005; Yang KC, 2011, J NEUROSCI, V31, P2537, DOI 10.1523/JNEUROSCI.3003-10.2011; ZHANG ZW, 1994, NEURON, V12, P167, DOI 10.1016/0896-6273(94)90161-9	66	23	23	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	JAN	2012	26	1					346	354		10.1096/fj.11-190223	http://dx.doi.org/10.1096/fj.11-190223			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	877SF	21917987	Green Published			2022-12-25	WOS:000299202200034
J	Giorgi, L; Bontems, F; Fromant, M; Aubard, C; Blanquet, S; Plateau, P				Giorgi, Laurent; Bontems, Francois; Fromant, Michel; Aubard, Caroline; Blanquet, Sylvain; Plateau, Pierre			RNA-binding Site of Escherichia coli Peptidyl-tRNA Hydrolase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENZYMATIC-HYDROLYSIS; CRYSTAL-STRUCTURE; PROTEIN; AMINOACYLATION; RIBOSOME; 5'-PHOSPHATE; GROWTH; YAEJ; NMR	In a cell, peptidyl-tRNA molecules that have prematurely dissociated from ribosomes need to be recycled. This work is achieved by an enzyme called peptidyl-tRNA hydrolase. To characterize the RNA-binding site of Escherichia coli peptidyl-tRNA hydrolase, minimalist substrates inspired from tRNA(His) have been designed and produced. Two minisubstrates consist of an N-blocked histidylated RNA minihelix or a small RNA duplex mimicking the acceptor and T psi C stem regions of tRNA(His). Catalytic efficiency of the hydrolase toward these two substrates is reduced by factors of 2 and 6, respectively, if compared with N-acetyl-histidyl-tRNA(His). In contrast, with an N-blocked histidylated microhelix or a tetraloop missing the T psi C arm, efficiency of the hydrolase is reduced 20-fold. NMR mapping of complex formation between the hydrolase and the small RNA duplex indicates amino acid residues sensitive to RNA binding in the following: (i) the enzyme active site region; (ii) the helix-loop covering the active site; (iii) the region including Leu-95 and the bordering residues 111-117, supposed to form the boundary between the tRNA core and the peptidyl-CCA moiety-binding sites; (iv) the region including Lys-105 and Arg-133, two residues that are considered able to clamp the 5'-phosphate of tRNA, and (v) the positively charged C-terminal helix (residues 180-193). Functional value of these interactions is assessed taking into account the catalytic properties of various engineered protein variants, including one in which the C-terminal helix was simply subtracted. A strong role of Lys-182 in helix binding to the substrate is indicated.	[Giorgi, Laurent; Fromant, Michel; Aubard, Caroline; Blanquet, Sylvain; Plateau, Pierre] Ecole Polytech, CNRS, Biochim Lab, F-91128 Palaiseau, France; [Bontems, Francois] CNRS UPR2301, Ctr Rech Gif, Inst Chim Subst Nat, F-91190 Gif Sur Yvette, France; [Bontems, Francois] Ecole Polytech, Antenne Inst Chim Subst Nat, F-91128 Palaiseau, France	Centre National de la Recherche Scientifique (CNRS); Institut Polytechnique de Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Institut Polytechnique de Paris	Plateau, P (corresponding author), Ecole Polytech, CNRS, Biochim Lab, F-91128 Palaiseau, France.	pierre.plateau@polytechnique.edu		launay, caroline/0000-0002-6587-6631				ATHERLY AG, 1972, NATURE-NEW BIOL, V240, P245, DOI 10.1038/newbio240245a0; Chadani Y, 2011, MOL MICROBIOL, V80, P772, DOI 10.1111/j.1365-2958.2011.07607.x; CUZIN F, 1967, P NATL ACAD SCI USA, V58, P2079, DOI 10.1073/pnas.58.5.2079; DARDEL F, 1994, COMPUT APPL BIOSCI, V10, P273; Das G, 2006, MICROBIOL-SGM, V152, P2191, DOI 10.1099/mic.0.29024-0; DUTKA S, 1993, NUCLEIC ACIDS RES, V21, P4025, DOI 10.1093/nar/21.17.4025; Ferri-Fioni ML, 2006, J BIOL CHEM, V281, P27575, DOI 10.1074/jbc.M605860200; Fisher CL, 1997, BIOTECHNIQUES, V23, P570, DOI 10.2144/97234bm01; FRANCKLYN C, 1992, SCIENCE, V255, P1121, DOI 10.1126/science.1546312; FRANCKLYN C, 1990, P NATL ACAD SCI USA, V87, P8655, DOI 10.1073/pnas.87.21.8655; Fromant M, 2003, NUCLEIC ACIDS RES, V31, P3227, DOI 10.1093/nar/gkg428; Fromant M, 2000, BIOCHEMISTRY-US, V39, P4062, DOI 10.1021/bi9923297; Fromant M, 1999, BIOCHEMISTRY-US, V38, P4982, DOI 10.1021/bi982657r; Giorgi L, 2011, J MOL BIOL, V412, P619, DOI 10.1016/j.jmb.2011.06.025; Goodall JJ, 2004, BIOCHEMISTRY-US, V43, P4583, DOI 10.1021/bi0302200; Guillon L, 2005, BIOCHEMISTRY-US, V44, P15594, DOI 10.1021/bi051514j; Handa Y, 2011, NUCLEIC ACIDS RES, V39, P1739, DOI 10.1093/nar/gkq1097; Jenkins BD, 2001, EMBO J, V20, P872, DOI 10.1093/emboj/20.4.872; Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234; Korostelev A, 2010, EMBO J, V29, P2577, DOI 10.1038/emboj.2010.139; KOSSEL H, 1968, J MOL BIOL, V35, P539, DOI 10.1016/S0022-2836(68)80013-0; Menez J, 2002, MOL MICROBIOL, V45, P123, DOI 10.1046/j.1365-2958.2002.02992.x; MILLIGAN JF, 1987, NUCLEIC ACIDS RES, V15, P8783, DOI 10.1093/nar/15.21.8783; MILLIGAN JF, 1989, METHOD ENZYMOL, V180, P51; MUSIERFORSYTH K, 1993, FASEB J, V7, P282, DOI 10.1096/fasebj.7.2.7680012; Ostheimer GJ, 2005, J MOL BIOL, V345, P51, DOI 10.1016/j.jmb.2004.10.032; PLATEAU P, 1982, J AM CHEM SOC, V104, P7310, DOI 10.1021/ja00389a067; Pulavarti SVSRK, 2008, J MOL BIOL, V378, P165, DOI 10.1016/j.jmb.2008.02.027; Rosas-Sandoval G, 2002, P NATL ACAD SCI USA, V99, P16707, DOI 10.1073/pnas.222659199; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Schmitt E, 1997, EMBO J, V16, P4760, DOI 10.1093/emboj/16.15.4760; Schmitt E, 1997, PROTEINS, V28, P135, DOI 10.1002/(SICI)1097-0134(199705)28:1<135::AID-PROT14>3.3.CO;2-0; SCHULMAN LH, 1975, J BIOL CHEM, V250, P542; Selvaraj M, 2007, J MOL BIOL, V372, P186, DOI 10.1016/j.jmb.2007.06.053; SHI JP, 1992, BIOCHEMISTRY-US, V31, P4931, DOI 10.1021/bi00136a002; Snoussi K, 2001, J MOL BIOL, V309, P139, DOI 10.1006/jmbi.2001.4618; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089	37	13	13	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39585	39594		10.1074/jbc.M111.281840	http://dx.doi.org/10.1074/jbc.M111.281840			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21930710	Green Published, hybrid			2022-12-25	WOS:000296759800075
J	Tang, YS; Khan, RA; Zhang, YH; Xiao, SH; Wang, M; Hansen, DK; Jayaram, HN; Antony, AC				Tang, Ying-Sheng; Khan, Rehana A.; Zhang, Yonghua; Xiao, Suhong; Wang, Mu; Hansen, Deborah K.; Jayaram, Hiremagalur N.; Antony, Asok C.			Incrimination of Heterogeneous Nuclear Ribonucleoprotein E1 (hnRNP-E1) as a Candidate Sensor of Physiological Folate Deficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA STABILITY; POLY(C) BINDING-PROTEIN; 3' UNTRANSLATED REGION; NEURAL-TUBE DEFECTS; KH-DOMAIN PROTEINS; UP-REGULATION; 3'-UNTRANSLATED REGION; IN-VITRO; RADIAL GROWTH; TRANS-FACTOR	The mechanism underlying the sensing of varying degrees of physiological folate deficiency, prior to adaptive optimization of cellular folate uptake through the translational up-regulation of folate receptors (FR) is unclear. Because homocysteine, which accumulates intracellularly during folate deficiency, stimulated interactions between heterogeneous nuclear ribonucleoprotein E1 (hnRNP-E1) and an 18-base FR-alpha mRNA cis-element that led to increased FR biosynthesis and net up-regulation of FR at cell surfaces, hnRNP-E1 was a plausible candidate sensor of folate deficiency. Accordingly, using purified components, we evaluated the physiological basis whereby L-homocysteine triggered these RNA-protein interactions to stimulate FR biosynthesis. L-Homocysteine induced a concentration-dependent increase in RNA-protein binding affinity throughout the range of physiological folate deficiency, which correlated with a proportionate increase in translation of FR in vitro and in cultured human cells. Targeted reduction of newly synthesized hnRNP-E1 proteins by siRNA to hnRNP-E1 mRNA reduced both constitutive and L-homocysteine-induced rates of FR biosynthesis. Furthermore, L-homocysteine covalently bound hnRNP-E1 via multiple protein-cysteine-S-S-homocysteine mixed disulfide bonds within K-homology domains known to interact with mRNA. These data suggest that a concentration-dependent, sequential disruption of critical cysteine-S-S-cysteine bonds by covalently bound L-homocysteine progressively unmasks an underlying RNA-binding pocket in hnRNP-E1 to optimize interaction with FR-alpha mRNA cis-element preparatory to FR up-regulation. Collectively, such data incriminate hnRNP-E1 as a physiologically relevant, sensitive, cellular sensor of folate deficiency. Because diverse mammalian and viral mRNAs also interact with this RNA-binding domain with functional consequences to their protein expression, homocysteinylated hnRNP-E1 also appears well positioned to orchestrate a novel, nutrition-sensitive (homocysteine-responsive), posttranscriptional RNA operon in folate-deficient cells.	[Tang, Ying-Sheng; Khan, Rehana A.; Zhang, Yonghua; Xiao, Suhong; Antony, Asok C.] Indiana Univ Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Wang, Mu; Jayaram, Hiremagalur N.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Hansen, Deborah K.] US FDA, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA; [Jayaram, Hiremagalur N.; Antony, Asok C.] Richard L Roudebush Vet Affairs Med Ctr, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; US Food & Drug Administration (FDA); US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center	Antony, AC (corresponding author), 980 W Walnut St,RIII C321B, Indianapolis, IN 46202 USA.	aantony@iupui.edu			National Institutes of Health [CA120843, HD39295]; Veterans Affairs Merit Review Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD039295] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA120843] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Review Award(US Department of Veterans Affairs); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA120843 and HD39295 (to A. C. A.). This work was also supported by a Veterans Affairs Merit Review Award (to A. C. A. and H. N. J.).	Antony A. C., 2009, HEMATOLOGY BASIC PRI, P491; Antony AC, 2004, J CLIN INVEST, V113, P285, DOI 10.1172/JCI200411548; Antony AC, 1996, ANNU REV NUTR, V16, P501, DOI 10.1146/annurev.nu.16.070196.002441; ANTONY AC, 1987, J CLIN INVEST, V80, P1618, DOI 10.1172/JCI113249; ANTONY AC, 1981, J BIOL CHEM, V256, P9684; Antony AC, 2000, TERATOLOGY, V62, P42, DOI 10.1002/1096-9926(200007)62:1&lt;42::AID-TERA9&gt;3.0.CO;2-U; Antony AC, 2007, AM J CLIN NUTR, V85, p598S, DOI 10.1093/ajcn/85.2.598S; Barbato JC, 2007, ARTERIOSCL THROM VAS, V27, P49, DOI 10.1161/01.ATV.0000251536.49581.8a; Barber RC, 1998, AM J MED GENET, V76, P310, DOI 10.1002/(SICI)1096-8628(19980401)76:4<310::AID-AJMG6>3.0.CO;2-T; Beaudin AE, 2009, BIRTH DEFECTS RES A, V85, P274, DOI 10.1002/bdra.20553; Blyn LB, 1997, J VIROL, V71, P6243, DOI 10.1128/JVI.71.8.6243-6246.1997; Bolton JA, 1999, GENE, V230, P215, DOI 10.1016/S0378-1119(99)00081-5; Budy B, 2006, ARCH BIOCHEM BIOPHYS, V446, P119, DOI 10.1016/j.abb.2005.12.014; BURD CG, 1994, EMBO J, V13, P1197, DOI 10.1002/j.1460-2075.1994.tb06369.x; Chappell SA, 2000, ONCOGENE, V19, P4437, DOI 10.1038/sj.onc.1203791; Chaudhury A, 2010, RNA, V16, P1449, DOI 10.1261/rna.2254110; Chaudhury A, 2010, NAT CELL BIOL, V12, P286, DOI 10.1038/ncb2029; Chkheidze AN, 1999, MOL CELL BIOL, V19, P4572; Collier B, 1998, J BIOL CHEM, V273, P22648, DOI 10.1074/jbc.273.35.22648; Czyzyk-Krzeska MF, 1999, BLOOD, V93, P2111, DOI 10.1182/blood.V93.6.2111.406k24_2111_2120; CzyzykKrzeska MF, 1996, J BIOL CHEM, V271, P3293, DOI 10.1074/jbc.271.6.3293; Dejgaard K, 1996, EUR J BIOCHEM, V241, P425, DOI 10.1111/j.1432-1033.1996.00425.x; Dobbyn HC, 2008, ONCOGENE, V27, P1167, DOI 10.1038/sj.onc.1210723; Ferguson SA, 2005, BIRTH DEFECTS RES A, V73, P249, DOI 10.1002/bdra.20111; Fujimura K, 2009, BBA-MOL CELL RES, V1793, P878, DOI 10.1016/j.bbamcr.2009.02.002; Garcia ML, 2003, J CELL BIOL, V163, P1011, DOI 10.1083/jcb.200308159; Giles KM, 2003, J BIOL CHEM, V278, P2937, DOI 10.1074/jbc.M208439200; Hajjar KA, 1998, J BIOL CHEM, V273, P9987, DOI 10.1074/jbc.273.16.9987; Hansen DK, 2003, BIRTH DEFECTS RES A, V67, P475, DOI 10.1002/bdra.10072; Heil SG, 1999, EUR J HUM GENET, V7, P393, DOI 10.1038/sj.ejhg.5200305; HENDERSON GI, 1995, J LAB CLIN MED, V126, P184; Holcik M, 2001, NAT REV MOL CELL BIO, V2, P550, DOI 10.1038/35080103; Jacobsen DW, 2005, CLIN CHEM LAB MED, V43, P1076, DOI 10.1515/CCLM.2005.188; Jiang Y, 2006, MOL CELL BIOL, V26, P2419, DOI 10.1128/MCB.26.6.2419-2429.2006; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Keene JD, 2002, MOL CELL, V9, P1161, DOI 10.1016/S1097-2765(02)00559-2; KILEDJIAN M, 1995, EMBO J, V14, P4357, DOI 10.1002/j.1460-2075.1995.tb00110.x; LEFFERS H, 1995, EUR J BIOCHEM, V230, P447, DOI 10.1111/j.1432-1033.1995.tb20581.x; Lewis SM, 2008, ONCOGENE, V27, P1033, DOI 10.1038/sj.onc.1210777; Lewis SM, 2007, MOL BIOL CELL, V18, P1302, DOI 10.1091/mbc.E06-06-0515; Majors AK, 2002, ARTERIOSCL THROM VAS, V22, P1354, DOI 10.1161/01.ATV.0000023899.93940.7C; Makeyev AV, 2002, RNA, V8, P265, DOI 10.1017/S1355838202024627; Makeyev AV, 1999, J BIOL CHEM, V274, P24849, DOI 10.1074/jbc.274.35.24849; Meng Q, 2007, P NATL ACAD SCI USA, V104, P5866, DOI 10.1073/pnas.0701065104; Motulsky H., 2004, FITTING MODELS BIOL, P296; MUMA NA, 1991, J NEUROCYTOL, V20, P844, DOI 10.1007/BF01191735; Ostareck DH, 1997, CELL, V89, P597, DOI 10.1016/S0092-8674(00)80241-X; Ostareck-Lederer A, 1998, TRENDS BIOCHEM SCI, V23, P409, DOI 10.1016/S0968-0004(98)01301-2; OSTARECKLEDERER A, 1994, EMBO J, V13, P1476, DOI 10.1002/j.1460-2075.1994.tb06402.x; Paulding WR, 1999, J BIOL CHEM, V274, P2532, DOI 10.1074/jbc.274.4.2532; Perla-Kajan J, 2007, AMINO ACIDS, V32, P561, DOI 10.1007/s00726-006-0432-9; Pickering BM, 2003, NUCLEIC ACIDS RES, V31, P639, DOI 10.1093/nar/gkg146; Piedrahita JA, 1999, NAT GENET, V23, P228, DOI 10.1038/13861; Ramaekers VT, 2005, NEW ENGL J MED, V352, P1985, DOI 10.1056/NEJMoa043160; Rao MV, 2003, J CELL BIOL, V163, P1021, DOI 10.1083/jcb.200308076; RONDON IJ, 1991, J BIOL CHEM, V266, P16594; Saitsu H, 2003, DEV DYNAM, V226, P112, DOI 10.1002/dvdy.10203; SCHLAEPFER WW, 1990, J NEUROSCI RES, V25, P39, DOI 10.1002/jnr.490250106; Schlotz W, 2010, J CHILD PSYCHOL PSYC, V51, P594, DOI 10.1111/j.1469-7610.2009.02182.x; Sengupta S, 2001, J BIOL CHEM, V276, P46896, DOI 10.1074/jbc.M108451200; Shi HF, 2008, SCIENCE, V320, P1207, DOI 10.1126/science.1157643; Stefanovic B, 1997, MOL CELL BIOL, V17, P5201, DOI 10.1128/MCB.17.9.5201; Stover PJ., 2010, FOLATE HLTH DIS, P49; SUN XL, 1995, J CLIN INVEST, V96, P1535, DOI 10.1172/JCI118192; Sun XL, 1996, J BIOL CHEM, V271, P25539; Thyagarajan A, 2004, J BIOL CHEM, V279, P49680, DOI 10.1074/jbc.M408915200; Thyagarajan A, 2008, BRAIN RES, V1189, P33, DOI 10.1016/j.brainres.2007.11.012; Ule J, 2005, METHODS, V37, P376, DOI 10.1016/j.ymeth.2005.07.018; Waggoner SA, 2003, MOL CELL BIOL, V23, P7055, DOI 10.1128/MCB.23.19.7055-7067.2003; WANG XM, 1995, MOL CELL BIOL, V15, P1769; Woolaway K, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-28; Xiao SH, 2005, BIRTH DEFECTS RES A, V73, P6, DOI 10.1002/bdra.20105; Xiao XL, 2001, J BIOL CHEM, V276, P41510, DOI 10.1074/jbc.M106824200; Yeap BB, 2002, J BIOL CHEM, V277, P27183, DOI 10.1074/jbc.M202883200; Yu J, 2001, MOL CELL BIOL, V21, P5879, DOI 10.1128/MCB.21.17.5879-5888.2001; Zhao RB, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409000969	76	22	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39100	39115		10.1074/jbc.M111.230938	http://dx.doi.org/10.1074/jbc.M111.230938			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21930702	Green Published, hybrid			2022-12-25	WOS:000296759800029
J	Ehira, S; Ohmori, M				Ehira, Shigeki; Ohmori, Masayuki			NrrA, a Nitrogen-regulated Response Regulator Protein, Controls Glycogen Catabolism in the Nitrogen-fixing Cyanobacterium Anabaena sp Strain PCC 7120	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGMA-FACTOR; HETEROCYST DIFFERENTIATION; PCC-7120; GENE; EXPRESSION; HETR; INDUCTION; FIXATION; PCC-6803	Anabaena sp. strain PCC 7120 is a filamentous cyanobacterium in which certain vegetative cells differentiate into heterocysts that are specialized cells for nitrogen fixation. Heterocysts are unable to carry out photosynthesis and depend on vegetative cells for carbohydrate to generate ATP and reductants required for nitrogen fixation. Thus, carbohydrate metabolism is very important for nitrogen fixation in the filamentous cyanobacteria; however, its regulatory mechanism remains unknown. In the present study, a nitrogen-regulated response regulator NrrA, which is a transcriptional regulator involved in heterocyst differentiation, was shown to control glycogen catabolism. The transcript levels of genes involved in glycogen catabolism, such as glgP1 and xfp-gap1-pyk1-talB operon, were decreased by the nrrA disruption. Moreover, glycogen accumulation and depression of nitrogenase activities were observed in this disruptant. NrrA bound specifically to the promoter region of glgP1, encoding a glycogen phosphorylase, and to the promoter region of sigE, encoding a group 2 sigma factor of RNA polymerase. SigE activated expression of the xfp operon, encoding enzymes of glycolysis and the pentose phosphate pathway. It is concluded that NrrA controls not only heterocyst differentiation but also glycogen catabolism in Anabaena sp. strain PCC 7120.	[Ehira, Shigeki; Ohmori, Masayuki] Chuo Univ, Dept Biol Sci, Fac Sci & Engn, Bunkyo Ku, Tokyo 1128551, Japan	Chuo University	Ohmori, M (corresponding author), Chuo Univ, Dept Biol Sci, Fac Sci & Engn, Bunkyo Ku, 1-13-27 Kasuga, Tokyo 1128551, Japan.	ohmori@bio.chuo-u.ac.jp	Ehira, Shigeki/D-6081-2013	Ehira, Shigeki/0000-0002-4121-7367	Japan Science and Technology Agency; Japan Society for the Promotion of Science [23603005]; Japan Science Society	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science Society	This work was supported by the Adaptable and Seamless Technology Transfer Program from the Japan Science and Technology Agency (to S. E.), Grant-in-aid for Scientific Research (B) 23603005 from the Japan Society for the Promotion of Science (to S. E.), and the Sasakawa Scientific Research Grant from the Japan Science Society (to S. E.).	Aldea MR, 2007, J BACTERIOL, V189, P8392, DOI 10.1128/JB.00821-07; Azuma M, 2011, PLANT CELL PHYSIOL, V52, P404, DOI 10.1093/pcp/pcq204; Ballicora MA, 2003, MICROBIOL MOL BIOL R, V67, P213, DOI 10.1128/MMBR.67.2.213-225.2003; BLACK TA, 1993, MOL MICROBIOL, V9, P77, DOI 10.1111/j.1365-2958.1993.tb01670.x; Buikema WJ, 2001, P NATL ACAD SCI USA, V98, P2729, DOI 10.1073/pnas.051624898; BUIKEMA WJ, 1991, GENE DEV, V5, P321, DOI 10.1101/gad.5.2.321; Cumino AC, 2007, PLANT PHYSIOL, V143, P1385, DOI 10.1104/pp.106.091736; Ehira S, 2006, MOL MICROBIOL, V59, P1692, DOI 10.1111/j.1365-2958.2006.05049.x; Ehira S, 2006, J BACTERIOL, V188, P8520, DOI 10.1128/JB.01314-06; ELHAI J, 1988, METHOD ENZYMOL, V167, P747; ELHAI J, 1988, GENE, V68, P119, DOI 10.1016/0378-1119(88)90605-1; ERNST A, 1990, J BACTERIOL, V172, P748, DOI 10.1128/jb.172.2.748-755.1990; FAY P, 1976, APPL ENVIRON MICROB, V31, P376, DOI 10.1128/AEM.31.3.376-379.1976; Flores E, 2010, NAT REV MICROBIOL, V8, P39, DOI 10.1038/nrmicro2242; FORCHHAMMER K, 1995, J BACTERIOL, V177, P2033, DOI 10.1128/jb.177.8.2033-2040.1995; Herrero A, 2004, FEMS MICROBIOL REV, V28, P469, DOI 10.1016/j.femsre.2004.04.003; Kumar K, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000315; Lopez-Igual R, 2010, J BACTERIOL, V192, P5526, DOI 10.1128/JB.00776-10; Marcozzi C, 2009, ARCH MICROBIOL, V191, P255, DOI 10.1007/s00203-008-0450-y; Mella-Herrera RA, 2011, J BACTERIOL, V193, P1823, DOI 10.1128/JB.01472-10; Muro-Pastor AM, 2006, FEMS MICROBIOL LETT, V256, P171, DOI 10.1111/j.1574-6968.2006.00136.x; Muro-Pastor AM, 2001, J BACTERIOL, V183, P1090, DOI 10.1128/JB.183.3.1090-1095.2001; Olmedo-Verd E, 2006, J BACTERIOL, V188, P6694, DOI 10.1128/JB.00509-06; Osanai T, 2006, DNA RES, V13, P185, DOI 10.1093/dnares/dsl010; Osanai T, 2009, P NATL ACAD SCI USA, V106, P6860, DOI 10.1073/pnas.0810040106; Pinto FL, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-79; Suzuki E, 2010, APPL ENVIRON MICROB, V76, P3153, DOI 10.1128/AEM.00397-08; Valladares A, 2007, J BACTERIOL, V189, P4425, DOI 10.1128/JB.00220-07; Vargas WA, 2011, PLANTA, V233, P153, DOI 10.1007/s00425-010-1288-5; Wolk C.P., 1994, MOL BIOL CYANOBACTER, P769, DOI DOI 10.1007/978-94-011-0227-8_27; Yoshimura H, 2007, DNA RES, V14, P13, DOI 10.1093/dnares/dsm003	31	22	25	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38109	38114		10.1074/jbc.M111.289124	http://dx.doi.org/10.1074/jbc.M111.289124			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21926170	Green Published, hybrid			2022-12-25	WOS:000296594200024
J	Liu, S; Yan, SJ; Lee, YF; Liu, NC; Ting, HJ; Li, GH; Wu, Q; Chen, LM; Chang, CS				Liu, Su; Yan, Shian-Jang; Lee, Yi-Fen; Liu, Ning-Chun; Ting, Huei-Ju; Li, Gonghui; Wu, Qiao; Chen, Lu-Min; Chang, Chawnshang			Testicular Nuclear Receptor 4 (TR4) Regulates UV Light-induced Responses via Cockayne Syndrome B Protein-mediated Transcription-coupled DNA Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCISION-REPAIR; ORPHAN RECEPTOR-4; CELLULAR REPAIR; GENE-EXPRESSION; MICE; INDUCTION; 8-HYDROXYADENINE; DEGENERATION; DEFICIENT; MUTATIONS	UV irradiation is one of the major external insults to cells and can cause skin aging and cancer. In response to UV light-induced DNA damage, the nucleotide excision repair (NER) pathways are activated to remove DNA lesions. We report here that testicular nuclear receptor 4 (TR4), a member of the nuclear receptor family, modulates DNA repair specifically through the transcription-coupled (TC) NER pathway but not the global genomic NER pathway. The level of Cockayne syndrome B protein (CSB), a member of the TC-NER pathway, is 10-fold reduced in TR4-deficient mouse tissues, and TR4 directly regulates CSB at the transcriptional level. Moreover, restored CSB expression rescues UV hypersensitivity of TR4-deficient cells. Together, these results indicate that TR4 modulates UV sensitivity by promoting the TC-NER DNA repair pathway through transcriptional regulation of CSB. These results may lead to the development of new treatments for UV light-sensitive syndromes, skin cancer, and aging.	[Liu, Su; Yan, Shian-Jang; Lee, Yi-Fen; Liu, Ning-Chun; Ting, Huei-Ju; Li, Gonghui; Chang, Chawnshang] Univ Rochester, Med Ctr, George Whipple Lab Canc Res, Dept Pathol, Rochester, NY 14642 USA; [Liu, Su; Yan, Shian-Jang; Lee, Yi-Fen; Liu, Ning-Chun; Ting, Huei-Ju; Li, Gonghui; Chang, Chawnshang] Univ Rochester, Med Ctr, George Whipple Lab Canc Res, Dept Urol, Rochester, NY 14642 USA; [Wu, Qiao] Xiamen Univ, Key Lab, Minist Educ Cell Biol & Tumor Cell Engn, Xiamen 361005, Peoples R China; [Chen, Lu-Min] China Med Univ Hosp, Sex Hormone Res Ctr, Taichung 404, Taiwan	University of Rochester; University of Rochester; Xiamen University; China Medical University Taiwan; China Medical University Hospital - Taiwan	Chang, CS (corresponding author), Univ Rochester, Med Ctr, George Whipple Lab Canc Res, Dept Pathol, Rochester, NY 14642 USA.	chang@urmc.rochester.edu	Wu, Q/G-4646-2010	Chang, Chawnshang/0000-0001-8510-3516; Ting, Huei-Ju/0000-0003-3709-5755	National Institutes of Health [DK073414, CA127548]; Taiwan Department of Health Clinical Trial and Research Center of Excellence [DOH99-TD-B-111-004]; NATIONAL CANCER INSTITUTE [R01CA127548] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073414] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Taiwan Department of Health Clinical Trial and Research Center of Excellence; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK073414 and CA127548. This work was also supported by the George Whipple Professorship Endowment and Taiwan Department of Health Clinical Trial and Research Center of Excellence Grant DOH99-TD-B-111-004 (to the China Medical University, Taiwan).	Anindya R, 2010, MOL CELL, V38, P637, DOI 10.1016/j.molcel.2010.04.017; Balajee AS, 2000, ONCOGENE, V19, P477, DOI 10.1038/sj.onc.1203372; Chen YT, 2005, MOL CELL BIOL, V25, P2722, DOI 10.1128/MCB.25.7.2722-2732.2005; Christmann M, 2006, NUCLEIC ACIDS RES, V34, P6530, DOI 10.1093/nar/gkl895; Cleaver JE, 2009, NAT REV GENET, V10, P756, DOI 10.1038/nrg2663; Collins LL, 2004, P NATL ACAD SCI USA, V101, P15058, DOI 10.1073/pnas.0405700101; Corona R, 1996, Ann Ist Super Sanita, V32, P37; Filippi S, 2008, EMBO J, V27, P2545, DOI 10.1038/emboj.2008.180; Fousteri M, 2008, CELL RES, V18, P73, DOI 10.1038/cr.2008.6; Gorgels TGMF, 2007, MOL CELL BIOL, V27, P1433, DOI 10.1128/MCB.01037-06; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Horibata K, 2004, P NATL ACAD SCI USA, V101, P15410, DOI 10.1073/pnas.0404587101; Kang HS, 2011, DIABETES, V60, P177, DOI 10.2337/db10-0628; Kim E, 2005, BIOCHEM BIOPH RES CO, V328, P85, DOI 10.1016/j.bbrc.2004.12.146; Kim E, 2007, BIOCHEM BIOPH RES CO, V361, P323, DOI 10.1016/j.bbrc.2007.06.168; Kim E, 2011, DIABETES, V60, P1493, DOI 10.2337/db10-0393; Laposa RR, 2007, P NATL ACAD SCI USA, V104, P1389, DOI 10.1073/pnas.0610619104; Lee YF, 2011, AM J PHYSIOL-ENDOC M, V301, pE91, DOI 10.1152/ajpendo.00701.2010; Li G, 2008, ENDOCRINOLOGY, V149, P3490, DOI 10.1210/en.2008-0121; Licht CL, 2003, AM J HUM GENET, V73, P1217, DOI 10.1086/380399; Liu NC, 2007, DIABETES, V56, P2901, DOI 10.2337/db07-0359; Liu NC, 2009, ENDOCRINE, V36, P211, DOI 10.1007/s12020-009-9220-0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mallery DL, 1998, AM J HUM GENET, V62, P77, DOI 10.1086/301686; Mellon I, 1996, SCIENCE, V272, P557, DOI 10.1126/science.272.5261.557; Newman JC, 2006, P NATL ACAD SCI USA, V103, P9613, DOI 10.1073/pnas.0510909103; Nouspikel T, 2009, CELL MOL LIFE SCI, V66, P994, DOI 10.1007/s00018-009-8737-y; Plosky B, 2002, DNA REPAIR, V1, P683, DOI 10.1016/S1568-7864(02)00075-7; Proietti-De-Santis L, 2006, EMBO J, V25, P1915, DOI 10.1038/sj.emboj.7601071; Selby CP, 1997, P NATL ACAD SCI USA, V94, P11205, DOI 10.1073/pnas.94.21.11205; Shaulian E, 2000, CELL, V103, P897, DOI 10.1016/S0092-8674(00)00193-8; Spivak G, 2006, METHOD ENZYMOL, V408, P223, DOI 10.1016/S0076-6879(06)08014-1; Stevnsner T, 2002, ONCOGENE, V21, P8675, DOI 10.1038/sj.onc.1205994; Tanabe O, 2007, GENE DEV, V21, P2832, DOI 10.1101/gad.1593307; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Tsai NP, 2009, BBA-GENE REGUL MECH, V1789, P734, DOI 10.1016/j.bbagrm.2009.09.010; Tuo JS, 2003, FASEB J, V17, P668, DOI 10.1096/fj.02-0851com; Tuo JS, 2002, J BIOL CHEM, V277, P30832, DOI 10.1074/jbc.M204814200; vanderHorst GTJ, 1997, CELL, V89, P425, DOI 10.1016/S0092-8674(00)80223-8; Xie S, 2009, P NATL ACAD SCI USA, V106, P13353, DOI 10.1073/pnas.0905724106; Yang Y, 2003, J BIOL CHEM, V278, P7709, DOI 10.1074/jbc.M207116200; Young WJ, 1997, J BIOL CHEM, V272, P3109, DOI 10.1074/jbc.272.5.3109; Zhang YQ, 2007, MOL ENDOCRINOL, V21, P908, DOI 10.1210/me.2006-0219; Zhou XE, 2011, J BIOL CHEM, V286, P2877, DOI 10.1074/jbc.M110.168740	44	11	12	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38103	38108		10.1074/jbc.M111.259523	http://dx.doi.org/10.1074/jbc.M111.259523			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21918225	hybrid, Green Published			2022-12-25	WOS:000296594200023
J	Du, QS; Fan, XW; Wang, CH; Huang, RB				Du, Qi-Shi; Fan, Xina-Wei; Wang, Cheng-Hua; Huang, Ri-Bo			A Possible CO2 Conducting and Concentrating Mechanism in Plant Stomata SLAC1 Channel	PLOS ONE			English	Article							AQUAPORIN WATER CHANNELS; KINASE-PHOSPHATASE PAIR; OST1 PROTEIN-KINASE; PLASMA-MEMBRANE; ANION CHANNEL; ABSCISIC-ACID; GUARD-CELL; ARABIDOPSIS-THALIANA; SIGNAL-TRANSDUCTION; PK(A) VALUES	Background: The plant SLAC1 is a slow anion channel in the membrane of stomatal guard cells, which controls the turgor pressure in the aperture-defining guard cells, thereby regulating the exchange of water vapour and photosynthetic gases in response to environmental signals such as drought, high levels of carbon dioxide, and bacterial invasion. Recent study demonstrated that bicarbonate is a small-molecule activator of SLAC1. Higher CO2 and HCO3- concentration activates Stype anion channel currents in wild-type Arabidopsis guard cells. Based on the SLAC1 structure a theoretical model is derived to illustrate the activation of bicarbonate to SLAC1 channel. Meanwhile a possible CO2 conducting and concentrating mechanism of the SLAC1 is proposed. Methodology: The homology structure of Arabidopsis thaliana SLAC1 (AtSLAC1) provides the structural basis for study of the conducting and concentrating mechanism of carbon dioxide in SLAC1 channels. The pK(a) values of ionizable amino acid side chains in AtSLAC1 are calculated using software PROPKA3.0, and the concentration of CO2 and anion HCO3- are computed based on the chemical equilibrium theory. Conclusions: The AtSLAC1 is modeled as a five-region channel with different pH values. The top and bottom layers of channel are the alkaline residue-dominated regions, and in the middle of channel there is the acidic region surrounding acidic residues His332. The CO2 concentration is enhanced around 10(4) times by the pH difference between these regions, and CO2 is stored in the hydrophobic region, which is a CO2 pool. The pH driven CO2 conduction from outside to inside balances the back electromotive force and maintain the influx of anions (e. g. Cl- and NO3-) from inside to outside. SLAC1 may be a pathway providing CO2 for photosynthesis in the guard cells.	[Du, Qi-Shi; Wang, Cheng-Hua; Huang, Ri-Bo] Guangxi Acad Sci, Natl Engn Res Ctr Nonfood Biorefinery, Nanning, Peoples R China; [Du, Qi-Shi; Fan, Xina-Wei; Huang, Ri-Bo] Guangxi Univ, Coll Life Sci & Technol, Nanning 530004, Peoples R China; [Wang, Cheng-Hua; Huang, Ri-Bo] Nanjing Univ Technol, Nanjing 210009, Peoples R China; [Du, Qi-Shi] Gordon Life Sci Inst, San Diego, CA USA	Guangxi University; Nanjing Tech University	Du, QS (corresponding author), Guangxi Acad Sci, Natl Engn Res Ctr Nonfood Biorefinery, Nanning, Peoples R China.	qishi_du@yahoo.com.cn			National Program on Key Basic Research Project (973 Program) of China [2009CB724703]; National Science Foundation of China (NSFC) [30970562]	National Program on Key Basic Research Project (973 Program) of China(National Basic Research Program of China); National Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work is financially supported by the National Program on Key Basic Research Project (973 Program) of China, under project 2009CB724703, and by the National Science Foundation of China (NSFC) under project 30970562. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agre P, 2003, FEBS LETT, V555, P72, DOI 10.1016/S0014-5793(03)01083-4; Agre Peter, 2006, Proc Am Thorac Soc, V3, P5, DOI 10.1513/pats.200510-109JH; BADGER MR, 1994, ANNU REV PLANT PHYS, V45, P369, DOI 10.1146/annurev.pp.45.060194.002101; Badger Murray R., 2000, Advances in Photosynthesis, V9, P369; Bas DC, 2008, PROTEINS, V73, P765, DOI 10.1002/prot.22102; Chen YH, 2010, NATURE, V467, P1074, DOI 10.1038/nature09487; Colcombet J, 2005, J EXP BOT, V56, P1897, DOI 10.1093/jxb/eri184; Dutzler R, 2003, SCIENCE, V300, P108, DOI 10.1126/science.1082708; Esau K., 1977, ANATOMY SEED PLANTS; Fujii H, 2009, NATURE, V462, P660, DOI 10.1038/nature08599; Geiger D, 2009, P NATL ACAD SCI USA, V106, P21425, DOI 10.1073/pnas.0912021106; Hanba YT, 2004, PLANT CELL PHYSIOL, V45, P521, DOI 10.1093/pcp/pch070; Hashimoto M, 2006, NAT CELL BIOL, V8, P391, DOI 10.1038/ncb1387; Hetherington AM, 2003, NATURE, V424, P901, DOI 10.1038/nature01843; Hu HH, 2010, NAT CELL BIOL, V12, P87, DOI 10.1038/ncb2009; Kaplan A, 1999, ANNU REV PLANT PHYS, V50, P539, DOI 10.1146/annurev.arplant.50.1.539; Knepper MA, 2004, J AM SOC NEPHROL, V15, P1093, DOI 10.1097/01.ASN.0000118814.47663.7D; Lee SC, 2009, P NATL ACAD SCI USA, V106, P21419, DOI 10.1073/pnas.0910601106; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Liu J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000139; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; Melcher K, 2009, NATURE, V462, P602, DOI 10.1038/nature08613; Melotto M, 2006, CELL, V126, P969, DOI 10.1016/j.cell.2006.06.054; MEYER K, 1994, SCIENCE, V264, P1452, DOI 10.1126/science.8197457; Moroney JV, 1999, PLANT PHYSIOL, V119, P9, DOI 10.1104/pp.119.1.9; Mustilli AC, 2002, PLANT CELL, V14, P3089, DOI 10.1105/tpc.007906; Nadeau JA, 2002, SCIENCE, V296, P1697, DOI 10.1126/science.1069596; Negi J, 2008, NATURE, V452, P483, DOI 10.1038/nature06720; Nurnberger T, 2006, TRENDS PLANT SCI, V11, P519, DOI 10.1016/j.tplants.2006.09.005; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Picollo A, 2009, NAT STRUCT MOL BIOL, V16, P1294, DOI 10.1038/nsmb.1704; Raven JA, 1997, PLANT CELL ENVIRON, V20, P147, DOI 10.1046/j.1365-3040.1997.d01-67.x; Schrier RW, 2007, DRUG NEWS PERSPECT, V20, P447, DOI 10.1358/dnp.2007.20.7.1138161; SCHROEDER JI, 1989, NATURE, V338, P427, DOI 10.1038/338427a0; Sellers PJ, 1997, SCIENCE, V275, P502, DOI 10.1126/science.275.5299.502; Shaw MR, 2002, SCIENCE, V298, P1987, DOI 10.1126/science.1075312; Sirichandra C, 2009, J EXP BOT, V60, P1439, DOI 10.1093/jxb/ern340; TAYLOR DE, 1994, J BACTERIOL, V176, P2740, DOI 10.1128/JB.176.9.2740-2742.1994; Terashima I, 2002, PLANT CELL PHYSIOL, V43, P70, DOI 10.1093/pcp/pcf001; Xue SW, 2011, EMBO J, V30, P1645, DOI 10.1038/emboj.2011.68	40	7	9	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2011	6	9							e24264	10.1371/journal.pone.0024264	http://dx.doi.org/10.1371/journal.pone.0024264			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZV	21931667	Green Published, Green Submitted, gold			2022-12-25	WOS:000295321800021
J	Potts, RC; Zhang, PS; Wurster, AL; Precht, P; Mughal, MR; Wood, WH; Zhang, YQ; Becker, KG; Mattson, MP; Pazin, MJ				Potts, Rebecca Casaday; Zhang, Peisu; Wurster, Andrea L.; Precht, Patricia; Mughal, Mohamed R.; Wood, William H., III; Zhang, Yonqing; Becker, Kevin G.; Mattson, Mark P.; Pazin, Michael J.			CHD5, a Brain-Specific Paralog of Mi2 Chromatin Remodeling Enzymes, Regulates Expression of Neuronal Genes	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; HISTONE DEACETYLASE; SYNAPTIC PLASTICITY; MI-2/NURD COMPLEX; CANCER; FAMILY; NEUROBLASTOMAS; DIVERSE; MEMORY; HYPERMETHYLATION	CHD5 is frequently deleted in neuroblastoma and is a tumor suppressor gene. However, little is known about the role of CHD5 other than it is homologous to chromatin remodeling ATPases. We found CHD5 mRNA was restricted to the brain; by contrast, most remodeling ATPases were broadly expressed. CHD5 protein isolated from mouse brain was associated with HDAC2, p66 beta, MTA3 and RbAp46 in a megadalton complex. CHD5 protein was detected in several rat brain regions and appeared to be enriched in neurons. CHD5 protein was predominantly nuclear in primary rat neurons and brain sections. Microarray analysis revealed genes that were upregulated and downregulated when CHD5 was depleted from primary neurons. CHD5 depletion altered expression of neuronal genes, transcription factors, and brain-specific subunits of the SWI/SNF remodeling enzyme. Expression of gene sets linked to aging and Alzheimer's disease were strongly altered by CHD5 depletion from primary neurons. Chromatin immunoprecipitation revealed CHD5 bound to these genes, suggesting the regulation was direct. Together, these results indicate that CHD5 protein is found in a NuRD-like multi-protein complex. CHD5 expression is restricted to the brain, unlike the closely related family members CHD3 and CHD4. CHD5 regulates expression of neuronal genes, cell cycle genes and remodeling genes. CHD5 is linked to regulation of genes implicated in aging and Alzheimer's disease.	[Potts, Rebecca Casaday; Wurster, Andrea L.; Precht, Patricia; Pazin, Michael J.] Natl Inst Aging Intramural Res Program, Lab Mol Biol & Immunol, NIH, Baltimore, MD USA; [Zhang, Peisu; Mughal, Mohamed R.; Mattson, Mark P.] Natl Inst Aging Intramural Res Program, Neurosci Lab, NIH, Baltimore, MD USA; [Wood, William H., III; Zhang, Yonqing; Becker, Kevin G.] Natl Inst Aging Intramural Res Program, Res Resources Branch, NIH, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Potts, RC (corresponding author), US Pharmacopeia, Rockville, MD USA.	pazinm@mail.nih.gov	Mattson, Mark P/F-6038-2012	Becker, Kevin/0000-0002-6794-6656; Pazin, Michael/0000-0002-7561-3640	National Institutes of Health (NIH), National Institute on Aging [Z01AG000378]; NATIONAL INSTITUTE ON AGING [ZIAAG000378, Z01AG000378, ZICAG000616] Funding Source: NIH RePORTER	National Institutes of Health (NIH), National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported entirely by the Intramural Research Program of the National Institutes of Health (NIH), National Institute on Aging (http://www.grc.nia.nih.gov/), grant Z01AG000378. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagchi A, 2008, CANCER RES, V68, P2551, DOI 10.1158/0008-5472.CAN-07-2095; Bagchi A, 2007, CELL, V128, P459, DOI 10.1016/j.cell.2006.11.052; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; BRODEUR GM, 1977, CANCER-AM CANCER SOC, V40, P2256, DOI 10.1002/1097-0142(197711)40:5<2256::AID-CNCR2820400536>3.0.CO;2-1; Brown E, 2007, BIOCHEM CELL BIOL, V85, P444, DOI 10.1139/O07-059; Chi TH, 2004, METHOD ENZYMOL, V377, P299; de la Torre-Ubieta L, 2008, TRENDS CELL BIOL, V18, P48, DOI 10.1016/j.tcb.2007.12.003; De S, 2011, MOL CELL BIOL, V31, P1512, DOI 10.1128/MCB.00920-10; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Fujita T, 2008, JNCI-J NATL CANCER I, V100, P940, DOI 10.1093/jnci/djn176; Gao H, 2009, P NATL ACAD SCI USA, V106, P11258, DOI 10.1073/pnas.0809485106; Garcia I, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-277; Gorringe KL, 2008, NEOPLASIA, V10, P1253, DOI 10.1593/neo.08718; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Hall JA, 2007, BIOCHEM CELL BIOL, V85, P463, DOI 10.1139/O07-063; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; Isidor B, 2008, EUR J MED GENET, V51, P679, DOI 10.1016/j.ejmg.2008.06.004; Jung M, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-47; Kharchenko PV, 2011, NATURE, V471, P480, DOI 10.1038/nature09725; Kunert N, 2009, EPIGENETICS-US, V4, P209, DOI 10.4161/epi.8933; Lai DZ, 2009, P NATL ACAD SCI USA, V106, P1169, DOI 10.1073/pnas.0811274106; Landry J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000241; Landry JW, 2011, GENE DEV, V25, P275, DOI 10.1101/gad.2007311; Law ME, 2005, CANCER GENET CYTOGEN, V160, P1, DOI 10.1016/j.cancergencyto.2004.11.012; Lessard J, 2007, NEURON, V55, P201, DOI 10.1016/j.neuron.2007.06.019; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; MacDonald JL, 2008, DEV DYNAM, V237, P2256, DOI 10.1002/dvdy.21626; Marfella CGA, 2007, MUTAT RES-FUND MOL M, V618, P30, DOI 10.1016/j.mrfmmm.2006.07.012; Maser RS, 2007, NATURE, V447, P966, DOI 10.1038/nature05886; MATTSON MP, 1989, J NEUROSCI, V9, P3728; Miccio A, 2010, EMBO J, V29, P442, DOI 10.1038/emboj.2009.336; Mokarram P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007012; Mulero-Navarro S, 2008, EPIGENETICS-US, V3, P210, DOI 10.4161/epi.3.4.6610; Ng David, 2008, BMC Res Notes, V1, P86, DOI 10.1186/1756-0500-1-86; Okawa ER, 2008, ONCOGENE, V27, P803, DOI 10.1038/sj.onc.1210675; Peleg S, 2010, SCIENCE, V328, P753, DOI 10.1126/science.1186088; Precht P, 2010, MOL IMMUNOL, V47, P2038, DOI 10.1016/j.molimm.2010.04.009; Ramirez J, 2009, EPIGENETICS-US, V4, P532, DOI 10.4161/epi.4.8.10108; Robbins CM, 2011, GENOME RES, V21, P47, DOI 10.1101/gr.107961.110; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sims RJ, 2007, MOL CELL, V28, P665, DOI 10.1016/j.molcel.2007.11.010; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thompson PM, 2003, ONCOGENE, V22, P1002, DOI 10.1038/sj.onc.1206211; Tong JK, 1998, NATURE, V395, P917, DOI 10.1038/27699; Traynor Jeff, 2002, BMC Med Genet, V3, P12, DOI 10.1186/1471-2350-3-12; Vecsey CG, 2007, J NEUROSCI, V27, P6128, DOI 10.1523/JNEUROSCI.0296-07.2007; Wade PA, 1998, CURR BIOL, V8, P843, DOI 10.1016/S0960-9822(98)70328-8; Wang X, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-95; Williams CJ, 2004, IMMUNITY, V20, P719, DOI 10.1016/j.immuni.2004.05.005; Wong YW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r72; Wu JI, 2007, NEURON, V56, P94, DOI 10.1016/j.neuron.2007.08.021; WURSTER AL, 2011, MOL IMMUNOL IN PRESS; Wurster AL, 2008, MOL CELL BIOL, V28, P7274, DOI 10.1128/MCB.00835-08; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Ye B, 2000, NEURON, V26, P603, DOI 10.1016/S0896-6273(00)81198-8; Yoo AS, 2009, CURR OPIN NEUROBIOL, V19, P120, DOI 10.1016/j.conb.2009.04.006; Yoshimura S, 2010, HYBRIDOMA, V29, P63, DOI 10.1089/hyb.2009.0069; Zhang P, 2008, CURR BIOL, V18, P1489, DOI 10.1016/j.cub.2008.08.048; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4	60	63	69	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2011	6	9							e24515	10.1371/journal.pone.0024515	http://dx.doi.org/10.1371/journal.pone.0024515			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZV	21931736	Green Published, Green Submitted, gold			2022-12-25	WOS:000295321800029
J	Zhou, M; Hu, Q; Li, ZG; Li, DY; Chen, CF; Luo, H				Zhou, Man; Hu, Qian; Li, Zhigang; Li, Dayong; Chen, Chin-Fu; Luo, Hong			Expression of a Novel Antimicrobial Peptide Penaeidin4-1 in Creeping Bentgrass (Agrostis stolonifera L.) Enhances Plant Fungal Disease Resistance	PLOS ONE			English	Article							PATHOGEN-INDUCED EXPRESSION; TRANSGENIC TOBACCO; CECROPIN-B; AGROBACTERIUM-TUMEFACIENS; CONFERS RESISTANCE; PROTEIN SECRETION; MOLECULAR-CLONING; CATIONIC PEPTIDE; BOTRYTIS-CINEREA; MAGAININ ANALOG	Background: Turfgrass species are agriculturally and economically important perennial crops. Turfgrass species are highly susceptible to a wide range of fungal pathogens. Dollar spot and brown patch, two important diseases caused by fungal pathogens Sclerotinia homoecarpa and Rhizoctonia solani, respectively, are among the most severe turfgrass diseases. Currently, turf fungal disease control mainly relies on fungicide treatments, which raises many concerns for human health and the environment. Antimicrobial peptides found in various organisms play an important role in innate immune response. Methodology/Principal Findings: The antimicrobial peptide - Penaeidin4-1 (Pen4-1) from the shrimp, Litopenaeus setiferus has been reported to possess in vitro antifungal and antibacterial activities against various economically important fungal and bacterial pathogens. In this study, we have studied the feasibility of using this novel peptide for engineering enhanced disease resistance into creeping bentgrass plants (Agrostis stolonifera L., cv. Penn A-4). Two DNA constructs were prepared containing either the coding sequence of a single peptide, Pen4-1 or the DNA sequence coding for the transit signal peptide of the secreted tobacco AP24 protein translationally fused to the Pen4-1 coding sequence. A maize ubiquitin promoter was used in both constructs to drive gene expression. Transgenic turfgrass plants containing different DNA constructs were generated by Agrobacterium-mediated transformation and analyzed for transgene insertion and expression. In replicated in vitro and in vivo experiments under controlled environments, transgenic plants exhibited significantly enhanced resistance to dollar spot and brown patch, the two major fungal diseases in turfgrass. The targeting of Pen4-1 to endoplasmic reticulum by the transit peptide of AP24 protein did not significantly impact disease resistance in transgenic plants. Conclusion/Significance: Our results demonstrate the effectiveness of Pen4-1 in a perennial species against fungal pathogens and suggest a potential strategy for engineering broad-spectrum fungal disease resistance in crop species.	[Zhou, Man; Hu, Qian; Li, Zhigang; Li, Dayong; Chen, Chin-Fu; Luo, Hong] Clemson Univ, Dept Biochem & Genet, Clemson, SC 29634 USA	Clemson University	Zhou, M (corresponding author), Clemson Univ, Dept Biochem & Genet, Clemson, SC 29634 USA.	hluo@clemson.edu	Hu, Qian/GWZ-7617-2022	Luo, Hong/0000-0001-9223-1786	Biotechnology Risk Assessment Program; USDA National Institute of Food and Agriculture [2005-39454-16551, 2007-33522-18489, 2010-33522-21656, SC-1700315]	Biotechnology Risk Assessment Program; USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	This project was supported by the Biotechnology Risk Assessment Program Competitive Grant no. 2005-39454-16551, 2007-33522-18489 and 2010-33522-21656 from the USDA National Institute of Food and Agriculture, as well as grant SC-1700315 from the USDA National Institute of Food and Agriculture. Dr. Chin-Fu Chen was at Clemson University when this work was accomplished. His current employer, Greenwood Genetic Center, did not provide funds nor did it play any role in this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alan AR, 2004, PLANT CELL REP, V22, P388, DOI 10.1007/s00299-003-0702-x; ALLEFS SJHM, 1995, AM POTATO J, V72, P437, DOI 10.1007/BF02851677; [Anonymous], 1995, FUNGICIDE RESISTANCE; Arce P, 1999, AM J POTATO RES, V76, P169, DOI 10.1007/BF02853582; Bartlett DW, 2002, PEST MANAG SCI, V58, P649, DOI 10.1002/ps.520; Bi YM, 1999, PLANT CELL REP, V18, P835, DOI 10.1007/s002990050670; BOMAN HG, 1995, ANNU REV IMMUNOL, V13, P61, DOI 10.1146/annurev.immunol.13.1.61; Broekaert WF, 1997, CRIT REV PLANT SCI, V16, P297, DOI 10.1080/713608148; Chai BL, 2002, PLANT SCI, V163, P183, DOI 10.1016/S0168-9452(02)00069-9; Chakrabarti A, 2003, PLANTA, V216, P587, DOI 10.1007/s00425-002-0918-y; CHANG CN, 1987, GENE, V55, P189, DOI 10.1016/0378-1119(87)90279-4; Chen JY, 2004, FISH SHELLFISH IMMUN, V16, P665, DOI 10.1016/j.fsi.2003.10.007; Coca M, 2006, PLANTA, V223, P392, DOI 10.1007/s00425-005-0069-z; Coca M, 2004, PLANT MOL BIOL, V54, P245, DOI 10.1023/B:PLAN.0000028791.34706.80; Couch H.B., 1962, DIS TURFGRASSES; Cuthbertson BJ, 2005, J BIOL CHEM, V280, P16009, DOI 10.1074/jbc.M412420200; Cuthbertson BJ, 2004, BIOCHEM J, V381, P79, DOI 10.1042/BJ20040330; Cuthbertson BJ, 2006, CHEM BIOL DRUG DES, V68, P120, DOI 10.1111/j.1747-0285.2006.00417.x; Damicone J. P., 2009, FUNGICIDE RESISTANCE; DeGray G, 2001, PLANT PHYSIOL, V127, P852, DOI 10.1104/pp.010233; Destoumieux D, 2000, J CELL SCI, V113, P461; Destoumieux D, 1999, EUR J BIOCHEM, V266, P335, DOI 10.1046/j.1432-1327.1999.00855.x; Destoumieux D, 2000, CELL MOL LIFE SCI, V57, P1260, DOI 10.1007/PL00000764; Dong S, 2008, TRANSGENIC RES, V17, P47, DOI 10.1007/s11248-007-9073-3; Dong S, 2007, PLANT SCI, V173, P501, DOI 10.1016/j.plantsci.2007.08.002; FLORACK D, 1995, TRANSGENIC RES, V4, P132, DOI 10.1007/BF01969415; Fu DL, 2007, PLANT CELL REP, V26, P467, DOI 10.1007/s00299-006-0258-7; Gao AG, 2000, NAT BIOTECHNOL, V18, P1307, DOI 10.1038/82436; Gueguen Y, 2006, DEV COMP IMMUNOL, V30, P283, DOI 10.1016/j.dci.2005.04.003; Guo ZF, 2003, MOL BREEDING, V11, P95, DOI 10.1023/A:1022458101221; Hancock REW, 1999, ANTIMICROB AGENTS CH, V43, P1317, DOI 10.1128/AAC.43.6.1317; Haydu JJ., 2006, FOOD RESOUR EC, V632, P1; Horsfall J, 1945, PHYTOPATHOLOGY, V35, P7; Huang Y, 1997, PHYTOPATHOLOGY, V87, P494, DOI 10.1094/PHYTO.1997.87.5.494; Imamura T, 2010, TRANSGENIC RES, V19, P415, DOI 10.1007/s11248-009-9320-x; JAYNES JM, 1993, PLANT SCI, V89, P43, DOI 10.1016/0168-9452(93)90169-Z; Jha S, 2010, TRANSGENIC RES, V19, P373, DOI 10.1007/s11248-009-9315-7; Kang CH, 2004, FISH SHELLFISH IMMUN, V16, P513, DOI 10.1016/j.fsi.2003.09.003; Kang CJ, 2007, MOL IMMUNOL, V44, P1535, DOI 10.1016/j.molimm.2006.08.025; Keymanesh K, 2009, WORLD J MICROB BIOT, V25, P933, DOI 10.1007/s11274-009-9984-7; Komari T, 1996, PLANT J, V10, P165, DOI 10.1046/j.1365-313X.1996.10010165.x; Lee SC, 2008, PLANT PHYSIOL, V148, P1004, DOI 10.1104/pp.108.123836; Li QS, 2001, PLANTA, V212, P635, DOI 10.1007/s004250000480; Li ZG, 2010, PLANT CELL ENVIRON, V33, P272, DOI 10.1111/j.1365-3040.2009.02080.x; Liang HY, 2002, BIOTECHNOL LETT, V24, P383, DOI 10.1023/A:1014552503140; Liu CA, 1998, WEED SCI, V46, P139, DOI 10.1017/S0043174500090305; Luck JE, 1995, MYCOL RES, V99, P1483, DOI 10.1016/S0953-7562(09)80797-1; Luo H, 2005, MOL BREEDING, V16, P185, DOI 10.1007/s11032-005-4784-8; Luo H, 2004, DEV PLANT BREED, V11, P245; Luo H, 2004, PLANT CELL REP, V22, P645, DOI 10.1007/s00299-003-0734-2; Ma ZH, 2005, CROP PROT, V24, P853, DOI 10.1016/j.cropro.2005.01.011; Ma ZH, 2003, APPL ENVIRON MICROB, V69, P7145, DOI 10.1128/AEM.69.12.7145-7152.2003; McKay GJ, 1997, FEMS MICROBIOL LETT, V152, P371, DOI 10.1111/j.1574-6968.1997.tb10454.x; MELCHERS LS, 1993, PLANT MOL BIOL, V21, P583, DOI 10.1007/BF00014542; Mentag R, 2003, TREE PHYSIOL, V23, P405, DOI 10.1093/treephys/23.6.405; Munoz M, 2002, EUR J BIOCHEM, V269, P2678, DOI 10.1046/j.1432-1033.2002.02934.x; Newhouse AE, 2007, PLANT CELL REP, V26, P977, DOI 10.1007/s00299-007-0313-z; Osusky M, 2000, NAT BIOTECHNOL, V18, P1162, DOI 10.1038/81145; Osusky M, 2005, THEOR APPL GENET, V111, P711, DOI 10.1007/s00122-005-2056-y; Osusky M, 2004, TRANSGENIC RES, V13, P181, DOI 10.1023/B:TRAG.0000026076.72779.60; Patkar RN, 2006, MOL BREEDING, V17, P159, DOI 10.1007/s11032-005-4736-3; Qu R, 2008, COMPENDIUM TRANSGENI, P177; Rajasekaran K, 2005, PLANT BIOTECHNOL J, V3, P545, DOI 10.1111/j.1467-7652.2005.00145.x; RAO AG, 1995, MOL PLANT MICROBE IN, V8, P6, DOI 10.1094/MPMI-8-0006; Rekha, 2006, J CHEM HEALTH SAF, V13, P12, DOI 10.1016/j.chs.2005.01.012; Reynoird JP, 1999, PLANT SCI, V149, P23, DOI 10.1016/S0168-9452(99)00139-9; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Schnabel G, 2001, PHYTOPATHOLOGY, V91, P102, DOI 10.1094/PHYTO.2001.91.1.102; Sharma A, 2000, FEBS LETT, V484, P7, DOI 10.1016/S0014-5793(00)02106-2; SMITH RA, 1985, SCIENCE, V229, P1219, DOI 10.1126/science.3939723; TERRAS FRG, 1995, PLANT CELL, V7, P573, DOI 10.1105/tpc.7.5.573; The national turfgrass research initiative, 2003, NAT TURFGR EV PROGR; VONHEIJNE G, 1989, FEBS LETT, V244, P439, DOI 10.1016/0014-5793(89)80579-4; Walsh B, 1999, HORTSCIENCE, V34, P13, DOI 10.21273/HORTSCI.34.1.13; Wang W, 2011, RICE SCI, V18, P10, DOI 10.1016/S1672-6308(11)60002-4; Wang YX, 2003, WEED SCI, V51, P130, DOI 10.1614/0043-1745(2003)051[0130:GRFDIT]2.0.CO;2; Williams B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002107; Yang L, 2008, PLANT MOL BIOL, V66, P329, DOI 10.1007/s11103-007-9267-3; Yang YS, 2003, J BIOL CHEM, V278, P36859, DOI 10.1074/jbc.M305450200; Yevtushenko DP, 2007, PLANT BIOTECHNOL J, V5, P720, DOI 10.1111/j.1467-7652.2007.00277.x; Yevtushenko DP, 2005, J EXP BOT, V56, P1685, DOI 10.1093/jxb/eri165; Yi JY, 2004, PLANTA, V220, P165, DOI 10.1007/s00425-004-1346-y; Young J, 2010, GUIDE FUNGICIDE RESI; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	85	21	22	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2011	6	9							e24677	10.1371/journal.pone.0024677	http://dx.doi.org/10.1371/journal.pone.0024677			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CO	21931807	Green Submitted, Green Published, gold			2022-12-25	WOS:000294803200037
J	Pekkala, N; Kotiaho, JS; Puurtinen, M				Pekkala, Nina; Kotiaho, Janne S.; Puurtinen, Mikael			Laboratory Relationships between Adult Lifetime Reproductive Success and Fitness Surrogates in a Drosophila littoralis Population	PLOS ONE			English	Article							NATURAL-POPULATIONS; INDIVIDUAL FITNESS; HISTORY EVOLUTION; SEXUAL SELECTION; SURVIVAL; CONSEQUENCES; DETERMINANTS; CHARACTERS; COMPONENTS; MALES	The difficulties in measuring total fitness of individuals necessitate the use of fitness surrogates in ecological and evolutionary studies. These surrogates can be different components of fitness (e. g. survival or fecundity), or proxies more uncertainly related to fitness (e. g. body size or growth rate). Ideally, fitness would be measured over the lifetime of individuals; however, more convenient short-time measures are often used. Adult lifetime reproductive success (adult LRS) is closely related to the total fitness of individuals, but it is difficult to measure and rarely included in fitness estimation in experimental studies. We explored phenotypic correlations between female adult LRS and various commonly used fitness components and proxies in a recently founded laboratory population of Drosophila littoralis. Noting that survival is usually higher in laboratory conditions than in nature, we also calculated adjusted adult LRS measures that give more weight to early reproduction. The lifetime measures of fecundity, longevity, and offspring viability were all relatively highly correlated with adult LRS. However, correlations with short-time measures of fecundity and offspring production varied greatly depending on the time of measurement, and the optimal time for measurement was different for unadjusted compared to adjusted adult LRS measures. Correlations between size measures and adult LRS varied from weak to modest, leg size and female weight having the highest correlations. Our results stress the importance of well-founded choice of fitness surrogates in empirical research.	[Pekkala, Nina; Kotiaho, Janne S.; Puurtinen, Mikael] Univ Jyvaskyla, Dept Biol & Environm Sci, Ctr Excellence Evolutionary Res, Jyvaskyla, Finland; [Kotiaho, Janne S.] Univ Jyvaskyla, Nat Hist Museum, Jyvaskyla, Finland	University of Jyvaskyla; University of Jyvaskyla	Pekkala, N (corresponding author), Univ Jyvaskyla, Dept Biol & Environm Sci, Ctr Excellence Evolutionary Res, Jyvaskyla, Finland.	nina.a.pekkala@jyu.fi	Puurtinen, Mikael/I-5993-2012; Puurtinen, Mikael/P-1549-2014	Puurtinen, Mikael/0000-0003-3340-2762; Puurtinen, Mikael/0000-0003-3340-2762; Kotiaho, Janne/0000-0002-4732-784X; Pekkala, Nina/0000-0003-4617-2900	Academy of Finland's Centre of Excellence in Evolutionary Research; Academy of Finland [7121616]	Academy of Finland's Centre of Excellence in Evolutionary Research(Academy of Finland); Academy of Finland(Academy of Finland)	The study was financed by Academy of Finland's Centre of Excellence in Evolutionary Research, and Academy of Finland's grant no. 7121616 to MP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASPI J, 1993, ECOGRAPHY, V16, P65, DOI 10.1111/j.1600-0587.1993.tb00059.x; ASPI J, 1995, J INSECT BEHAV, V8, P67, DOI 10.1007/BF01990970; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERCOVITCH FB, 1993, BEHAV ECOL SOCIOBIOL, V32, P103, DOI 10.1007/BF00164042; Brommer JE, 2004, AM NAT, V163, P505, DOI 10.1086/382547; Brommer JE, 2002, ECOL LETT, V5, P802, DOI 10.1046/j.1461-0248.2002.00369.x; Bryant D.M., 1988, P173; Cotton S, 2010, EVOL ECOL, V24, P83, DOI 10.1007/s10682-009-9292-6; Edward DA, 2011, EVOLUTION, V65, P564, DOI 10.1111/j.1558-5646.2010.01151.x; Endler J.A., 1986, Monographs in Population Biology, pviii; Falconer D. S, 1996, INTRO QUANTITATIVE G; Fincke OM, 2001, EVOLUTION, V55, P762, DOI 10.1554/0014-3820(2001)055[0762:UOSITD]2.0.CO;2; Hunt J, 2010, EVOLUTIONARY BEHAV E; Janicke T, 2009, J EVOLUTION BIOL, V22, P405, DOI 10.1111/j.1420-9101.2008.01660.x; Kern S, 2001, EVOLUTION, V55, P1822, DOI 10.1111/j.0014-3820.2001.tb00831.x; Kolss M, 2009, EVOLUTION, V63, P2389, DOI 10.1111/j.1558-5646.2009.00718.x; Kruuk LEB, 1999, P ROY SOC B-BIOL SCI, V266, P1655, DOI 10.1098/rspb.1999.0828; Lakovaara S., 1969, DROSOPH INF SERV, V44, P128; LeBas NR, 2004, EVOLUTION, V58, P1763; Maynard Smith, 1998, EVOL GENET; McGraw JB, 1996, AM NAT, V147, P47, DOI 10.1086/285839; Newton J., 1988, P201; PARTRIDGE L, 1986, J INSECT PHYSIOL, V32, P925, DOI 10.1016/0022-1910(86)90140-X; Partridge L., 1988, P11; Reed DH, 2004, J EVOLUTION BIOL, V17, P919, DOI 10.1111/j.1420-9101.2004.00718.x; REZNICK DA, 1990, NATURE, V346, P357, DOI 10.1038/346357a0; Reznick DN, 1996, EVOLUTION, V50, P1651, DOI 10.1111/j.1558-5646.1996.tb03937.x; RIBBLE DO, 1992, J ANIM ECOL, V61, P457, DOI 10.2307/5336; ROSEWELL J, 1987, BIOL J LINN SOC, V32, P373, DOI 10.1111/j.1095-8312.1987.tb00438.x; Routtu J, 2007, HEREDITAS, V144, P213, DOI 10.1111/j.2007.0018-0661.02021.x; Scott DK, 1988, REPROD SUCCESS STUDI, P221; Simmons LW, 2008, J EVOLUTION BIOL, V21, P1227, DOI 10.1111/j.1420-9101.2008.01575.x; Smith J.N.M., 1988, P154; Stearns S.C., 1992, pi; TANTAWY AO, 1964, GENETICS, V50, P1349; Urrutia MA, 2007, ENTOMOL EXP APPL, V123, P63, DOI 10.1111/j.1570-7458.2007.00526.x; WAUTERS L, 1989, J ANIM ECOL, V58, P637, DOI 10.2307/4853; Wolf JB, 2001, J EVOLUTION BIOL, V14, P347, DOI 10.1046/j.1420-9101.2001.00277.x; Zhou Y, 2007, BIOL CONTROL, V40, P273, DOI 10.1016/j.biocontrol.2006.11.002	39	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2011	6	9							e24560	10.1371/journal.pone.0024560	http://dx.doi.org/10.1371/journal.pone.0024560			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CN	21931756	gold, Green Published, Green Submitted			2022-12-25	WOS:000294803100042
J	Zhang, T; Dayanandan, B; Rouiller, I; Lawrence, EJ; Mandato, CA				Zhang, Tong; Dayanandan, Bama; Rouiller, Isabelle; Lawrence, Elizabeth J.; Mandato, Craig A.			Growth-Arrest-Specific Protein 2 Inhibits Cell Division in Xenopus Embryos	PLOS ONE			English	Article							HUMAN BREAST-CANCER; TUMOR SUSCEPTIBILITY GENE; MICROTUBULE; TSG101; REARRANGEMENTS; GAS2	Background: Growth-arrest-specific 2 gene was originally identified in murine fibroblasts under growth arrest conditions. Furthermore, serum stimulation of quiescent, non-dividing cells leads to the down-regulation of gas2 and results in re-entry into the cell cycle. Cytoskeleton rearrangements are critical for cell cycle progression and cell division and the Gas2 protein has been shown to co-localize with actin and microtubules in interphase mammalian cells. Despite these findings, direct evidence supporting a role for Gas2 in the mechanism of cell division has not been reported. Methodology and Principal Findings: To determine whether the Gas2 protein plays a role in cell division, we over-expressed the full-length Gas2 protein and Gas2 truncations containing either the actin-binding CH domain or the tubulin-binding Gas2 domain in Xenopus laevis embryos. We found that both the full-length Gas2 protein and the Gas2 domain, but not the CH domain, inhibited cell division and resulted in multinucleated cells. The observation that Gas2 domain alone can arrest cell division suggests that Gas2 function is mediated by microtubule binding. Gas2 co-localized with microtubules at the cell cortex of Gas2-injected Xenopus embryos using cryo-confocal microscopy and co-sedimented with microtubules in cytoskeleton co-sedimentation assays. To investigate the mechanism of Gas2-induced cell division arrest, we showed, using a wound-induced contractile array assay, that Gas2 stabilized microtubules. Finally, electron microscopy studies demonstrated that Gas2 bundled microtubules into higher-order structures. Conclusion and Significance: Our experiments show that Gas2 inhibits cell division in Xenopus embryos. We propose that Gas2 function is mediated by binding and bundling microtubules, leading to cell division arrest.	[Zhang, Tong; Mandato, Craig A.] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada; [Dayanandan, Bama; Rouiller, Isabelle; Lawrence, Elizabeth J.; Mandato, Craig A.] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ, Canada	McGill University; McGill University	Zhang, T (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.	tong.zhang1@mail.mcgill.ca; craig.mandato@mcgill.ca	Rouiller, Isabelle/AAE-9637-2019; rouiller, isabelle/K-7679-2012	rouiller, isabelle/0000-0002-1288-8575; Lawrence, Elizabeth/0000-0001-9543-8678	Canadian Institutes of Health Research (CIHR) [MOPS68970]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the Canadian Institutes of Health Research (CIHR). C. A. M. is supported by a CIHR grant MOPS68970. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bement WM, 1999, CURR BIOL, V9, P579, DOI 10.1016/S0960-9822(99)80261-9; BRANCOLINI C, 1992, J CELL BIOL, V117, P1251, DOI 10.1083/jcb.117.6.1251; Collavin L, 1998, GENOMICS, V48, P265, DOI 10.1006/geno.1997.5172; Grinnell F, 2010, ANNU REV CELL DEV BI, V26, P335, DOI 10.1146/annurev.cellbio.042308.113318; Heng YW, 2010, INT J BIOCHEM CELL B, V42, P1622, DOI 10.1016/j.biocel.2010.04.007; Kline-Smith SL, 2004, MOL CELL, V15, P317, DOI 10.1016/j.molcel.2004.07.012; Lee MP, 1997, CANCER RES, V57, P3131; Li LM, 1997, CELL, V88, P143, DOI 10.1016/S0092-8674(00)81866-8; Mandato CA, 2003, CURR BIOL, V13, P1096, DOI 10.1016/S0960-9822(03)00420-2; Mandato CA, 2001, J CELL BIOL, V154, P785, DOI 10.1083/jcb.200103105; MAZZONI I, 2005, CAN PROT IN C; Mitelman F, 1997, NAT GENET, V15, P417, DOI 10.1038/ng0497supp-417; PARDEE AB, 1978, ANNU REV BIOCHEM, V47, P715, DOI 10.1146/annurev.bi.47.070178.003435; Petroulakis E, 2009, CANCER CELL, V16, P439, DOI 10.1016/j.ccr.2009.09.025; Pines MK, 2010, DEVELOPMENT, V137, P913, DOI 10.1242/dev.043224; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Roper K, 2004, CURR BIOL, V14, P99, DOI 10.1016/j.cub.2003.12.056; SCHNEIDER C, 1988, CELL, V54, P787, DOI 10.1016/S0092-8674(88)91065-3; Steiner P, 1997, NAT GENET, V16, P332, DOI 10.1038/ng0897-332; Stroud MJ, 2011, J BIOL CHEM, V286, P24987, DOI 10.1074/jbc.M111.242263; Sun DM, 2001, J CELL SCI, V114, P161; ZHANG T, 2007, METHODS MOL MED MICR, P181	22	17	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2011	6	9							e24698	10.1371/journal.pone.0024698	http://dx.doi.org/10.1371/journal.pone.0024698			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CN	21931817	Green Published, gold			2022-12-25	WOS:000294803100058
J	Frey, O; Bruns, L; Morawietz, L; Dunussi-Joannopoulos, K; Kamradt, T				Frey, Oliver; Bruns, Lisa; Morawietz, Lars; Dunussi-Joannopoulos, Kyri; Kamradt, Thomas			B Cell Depletion Reduces the Number of Autoreactive T Helper Cells and Prevents Glucose-6-Phosphate Isomerase-Induced Arthritis	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; CD154 EXPRESSION; CRUCIAL ROLE; MICE; ANTIBODIES; INDUCTION; RESPONSES; IMMUNIZATION; SUPPRESSION; RECEPTOR	The therapeutic benefit of B cell depletion in patients with rheumatoid arthritis has provided proof of concept that B cells are relevant for the pathogenesis of arthritis. It remains unknown which B cell effector functions contribute to the induction or chronification of arthritis. We studied the clinical and immunological effects of B cell depletion in glucose-6-phosphate isomerase-induced arthritis. We targeted CD22 to deplete B cells. Mice were depleted of B cells before or after immunization with glucose-6-phosphate isomerase (G6PI). The clinical and histological effects were studied. G6PI-specific antibody responses were measured by ELISA. G6PI-specific T helper (Th) cell responses were assayed by polychromatic flow cytometry. B cell depletion prior to G6PI-immunization prevented arthritis. B cell depletion after immunization ameliorated arthritis, whereas B cell depletion in arthritic mice was ineffective. Transfer of antibodies from arthritic mice into B cell depleted recipients did not reconstitute arthritis. B cell depleted mice harbored much fewer G6PI-specific Th cells than control animals. B cell depletion prevents but does not cure G6PI-induced arthritis. Arthritis prevention upon B cell depletion is associated with a drastic reduction in the number of G6PI-specific effector Th cells.	[Frey, Oliver; Bruns, Lisa; Kamradt, Thomas] Jena Univ Hosp, Inst Immunol, Jena, Germany; [Frey, Oliver] Jena Univ Hosp, Inst Clin Chem & Lab Diagnost, Jena, Germany; [Morawietz, Lars] Charite, Inst Pathol, Berlin, Germany; [Dunussi-Joannopoulos, Kyri] Pfizer Res, Cambridge, MA USA	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Pfizer	Frey, O (corresponding author), Jena Univ Hosp, Inst Immunol, Jena, Germany.	immunologie@mti.uni-jena.de	Kamradt, Thomas/E-9971-2018	Kamradt, Thomas/0000-0001-8443-5893	Deutsche Forschungsgemeinschaft (DFG) [Ka-755/5-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG, grant Ka-755/5-1 to TK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bockermann R, 2005, ARTHRITIS RES THER, V7, pR1316, DOI 10.1186/ar1829; Bouaziz JD, 2007, P NATL ACAD SCI USA, V104, P20878, DOI 10.1073/pnas.0709205105; Bruns L, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2777; Chattopadhyay PK, 2005, NAT MED, V11, P1113, DOI 10.1038/nm1293; DIAZ DS, 2002, EUR J IMMUNOL, V32, P2915; Dunussi-Joannopoulos K, 2005, BLOOD, V106, P2235, DOI 10.1182/blood-2004-11-4547; Fiorina P, 2008, DIABETES, V57, P3013, DOI 10.2337/db08-0420; Frentsch M, 2005, NAT MED, V11, P1118, DOI 10.1038/nm1292; Frey O, 2010, ANN RHEUM DIS, V69, P1495, DOI 10.1136/ard.2009.119164; Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292; Hamel K, 2008, J IMMUNOL, V180, P4994, DOI 10.4049/jimmunol.180.7.4994; Hietala MA, 2002, J IMMUNOL, V169, P454, DOI 10.4049/jimmunol.169.1.454; Huang HC, 2010, P NATL ACAD SCI USA, V107, P4658, DOI 10.1073/pnas.1001074107; Iwanami K, 2008, ARTHRITIS RHEUM-US, V58, P754, DOI 10.1002/art.23222; Kirchhoff D, 2007, EUR J IMMUNOL, V37, P2370, DOI 10.1002/eji.200737322; Kleinau S, 2000, J EXP MED, V191, P1611, DOI 10.1084/jem.191.9.1611; LANZAVECCHIA A, 1990, ANNU REV IMMUNOL, V8, P773, DOI 10.1146/annurev.immunol.8.1.773; Maccioni M, 2002, J EXP MED, V195, P1071, DOI 10.1084/jem.20011941; Magnusson SE, 2008, CLIN IMMUNOL, V127, P225, DOI 10.1016/j.clim.2008.02.002; Matsumoto I, 1999, SCIENCE, V286, P1732, DOI 10.1126/science.286.5445.1732; Matsumoto I, 2002, NAT IMMUNOL, V3, P360, DOI 10.1038/ni772; Mittrucker HW, 2007, P NATL ACAD SCI USA, V104, P12434, DOI 10.1073/pnas.0703510104; Nandakumar KS, 2007, ARTHRITIS RHEUM-US, V56, P3253, DOI 10.1002/art.22930; Schubert D, 2004, J IMMUNOL, V172, P4503, DOI 10.4049/jimmunol.172.7.4503; Silverman GJ, 2008, IMMUNOL REV, V223, P175, DOI 10.1111/j.1600-065X.2008.00627.x; SYMINGTON FW, 1982, IMMUNOGENETICS, V16, P381, DOI 10.1007/BF00372098; Tanaka-Watanabe Y, 2009, CLIN EXP IMMUNOL, V155, P285, DOI 10.1111/j.1365-2249.2008.03816.x; Tedder TF, 2005, ADV IMMUNOL, V88, P1, DOI 10.1016/S0065-2776(05)88001-0; Tokoyoda K, 2009, IMMUNITY, V30, P721, DOI 10.1016/j.immuni.2009.03.015; WESTERMANN J, 1990, IMMUNOL TODAY, V11, P406, DOI 10.1016/0167-5699(90)90160-B	30	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e24718	10.1371/journal.pone.0024718	http://dx.doi.org/10.1371/journal.pone.0024718			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CK	21931827	Green Published, Green Submitted, gold			2022-12-25	WOS:000294802800086
J	Matulonis, UA; Hirsch, M; Palescandolo, E; Kim, E; Liu, J; van Hummelen, P; MacConaill, L; Drapkin, R; Hahn, WC				Matulonis, Ursula A.; Hirsch, Michelle; Palescandolo, Emanuele; Kim, Eejung; Liu, Joyce; van Hummelen, Paul; MacConaill, Laura; Drapkin, Ronny; Hahn, William C.			High Throughput Interrogation of Somatic Mutations in High Grade Serous Cancer of the Ovary	PLOS ONE			English	Article							PHASE-II; LUNG-CANCER; CARCINOMA; GEFITINIB; GENE	Background: Epithelial ovarian cancer is the most lethal of all gynecologic malignancies, and high grade serous ovarian cancer (HGSC) is the most common subtype of ovarian cancer. The objective of this study was to determine the frequency and types of point somatic mutations in HGSC using a mutation detection protocol called OncoMap that employs mass spectrometric-based genotyping technology. Methodology/Principal Findings: The Center for Cancer Genome Discovery (CCGD) Program at the Dana-Farber Cancer Institute (DFCI) has adapted a high-throughput genotyping platform to determine the mutation status of a large panel of known cancer genes. The mutation detection protocol, termed OncoMap has been expanded to detect more than 1000 mutations in 112 oncogenes in formalin-fixed paraffin-embedded (FFPE) tissue samples. We performed OncoMap on a set of 203 FFPE advanced staged HGSC specimens. We isolated genomic DNA from these samples, and after a battery of quality assurance tests, ran each of these samples on the OncoMap v3 platform. 56% (113/203) tumor samples harbored candidate mutations. Sixty-five samples had single mutations (32%) while the remaining samples had >= 2 mutations (24%). 196 candidate mutation calls were made in 50 genes. The most common somatic oncogene mutations were found in EGFR, KRAS, PDGRF alpha, KIT, and PIK3CA. Other mutations found in additional genes were found at lower frequencies (<3%). Conclusions/Significance: Sequenom analysis using OncoMap on DNA extracted from FFPE ovarian cancer samples is feasible and leads to the detection of potentially druggable mutations. Screening HGSC for somatic mutations in oncogenes may lead to additional therapies for this patient population.	[Matulonis, Ursula A.; Palescandolo, Emanuele; Kim, Eejung; Liu, Joyce; van Hummelen, Paul; MacConaill, Laura; Drapkin, Ronny; Hahn, William C.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Hirsch, Michelle; Drapkin, Ronny] Brigham & Womens Hosp, Dept Pathol, Womens & Perinatal Pathol Div, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital	Matulonis, UA (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	Ursula_matulonis@dfci.harvard.edu	Drapkin, Ronny/E-9944-2016	Drapkin, Ronny/0000-0002-6912-6977; van hummelen, paul/0000-0002-4801-8600	Ovarian Cancer Specialized Program of Research Excellence [P50CA105009]; Madeline Franchi Ovarian Cancer Fund; Women's Executive Council of the Dana-Farber Cancer Institute; Novartis Pharmaceuticals; NATIONAL CANCER INSTITUTE [P50CA105009] Funding Source: NIH RePORTER	Ovarian Cancer Specialized Program of Research Excellence; Madeline Franchi Ovarian Cancer Fund; Women's Executive Council of the Dana-Farber Cancer Institute; Novartis Pharmaceuticals(Novartis); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding was provided by the following sources: Ovarian Cancer Specialized Program of Research Excellence (P50CA105009), the Madeline Franchi Ovarian Cancer Fund, and the Women's Executive Council of the Dana-Farber Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Drs. Hahn and Drapkin both serve as consultants for and have received research grants from Novartis Pharmaceuticals. This did not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. The other authors have no conflicts of interest to report.	Ahmed AA, 2010, J PATHOL, V221, P49, DOI 10.1002/path.2696; [Anonymous], 2011, NATURE, V272, P609; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Bookman MA, 2009, J CLIN ONCOL, V27, P1419, DOI 10.1200/JCO.2008.19.1684; Bowtell DDL, 2010, NAT REV CANCER, V10, P803, DOI 10.1038/nrc2946; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Garnett MJ, 2004, CANCER CELL, V6, P313, DOI 10.1016/j.ccr.2004.09.022; Gordon AN, 2005, INT J GYNECOL CANCER, V15, P785, DOI 10.1111/j.1525-1438.2005.00137.x; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Liu J, 2010, ONCOLOGY-NY, V24, P721; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; MacConaill LE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007887; McGuire WP, 1996, NEW ENGL J MED, V334, P1, DOI 10.1056/NEJM199601043340101; Nakayama K, 2006, CANCER BIOL THER, V5, P779, DOI 10.4161/cbt.5.7.2751; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Posadas EM, 2007, CANCER-AM CANCER SOC, V109, P1323, DOI 10.1002/cncr.22545; Schilder RJ, 2005, CLIN CANCER RES, V11, P5539, DOI 10.1158/1078-0432.CCR-05-0462; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Tolcher AW, 2009, AM SOC CLIN ONC ANN; Von Hoff DD, 2010, AM SOC CLIN ONC ANN; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096	21	38	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e24433	10.1371/journal.pone.0024433	http://dx.doi.org/10.1371/journal.pone.0024433			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CK	21931712	gold, Green Published			2022-12-25	WOS:000294802800050
J	Nallar, SC; Lin, LM; Srivastava, V; Gade, P; Hofmann, ER; Ahmed, H; Reddy, SP; Kalvakolanu, DV				Nallar, Shreeram C.; Lin, Limei; Srivastava, Varsha; Gade, Padmaja; Hofmann, Edward R.; Ahmed, Hafiz; Reddy, Sekhar P.; Kalvakolanu, Dhananjaya V.			GRIM-1, a Novel Growth Suppressor, Inhibits rRNA Maturation by Suppressing Small Nucleolar RNAs	PLOS ONE			English	Article							H/ACA SMALL NUCLEOLAR; DYSKERATOSIS-CONGENITA; TRANSLATIONAL CONTROL; PRERIBOSOMAL RNA; GENE-EXPRESSION; PROTEIN-KINASE; 2-5A SYSTEM; INTERFERON; MUTATIONS; CANCER	We have recently isolated novel IFN-inducible gene, Gene associated with Retinoid-Interferon-induced Mortality-1 (GRIM-1), using a genetic technique. Moderate ectopic expression of GRIM-1 caused growth inhibition and sensitized cells to retinoic acid (RA)/IFN-induced cell death while high expression caused apoptosis. GRIM-1 depletion, using RNAi, conferred a growth advantage. Three protein isoforms (1 alpha, 1 beta and 1 gamma) with identical C-termini are produced from GRIM-1 mRNA. We show that GRIM-1 isoforms interact with NAF1 and DKC1, two essential proteins required for box H/ACA sno/sca RNP biogenesis and suppresses box H/ACA RNA levels in mammalian cells by delocalizing NAF1. Suppression of these small RNAs manifests as inefficient rRNA maturation and growth suppression. Interestingly, yeast Shq1p also caused growth suppression in mammalian cells. Consistent with its growth-suppressive property, GRIM-1 expression is lost in a number of human primary prostate tumors. Our observations support a recent study that GRIM-1 might act as a co-tumor suppressor in the prostate.	[Nallar, Shreeram C.; Srivastava, Varsha; Gade, Padmaja; Hofmann, Edward R.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Ahmed, Hafiz] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Lin, Limei; Kalvakolanu, Dhananjaya V.] Univ Maryland, Sch Med, Canc Biol track Grad Program Life Sci, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA; [Reddy, Sekhar P.] Univ Illinois, Dept Pediat, Chicago, IL USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Nallar, SC (corresponding author), Univ Maryland, Sch Med, Dept Microbiol & Immunol, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA.	dkalvako@umaryland.edu	Ahmed, Hafiz/GWR-3787-2022		NIH [CA105005, CA78282, HL66109, ES11863, CA133935-01]; NATIONAL CANCER INSTITUTE [R01CA078282, R03CA133935, R01CA105005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R56ES011863, R01ES011863] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	NIH grants CA105005 and CA78282 to DVK. SPR is supported by grants HL66109 and ES11863 from the National Institutes of Health. HA is supported by CA133935-01 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsterdam A, 2004, PLOS BIOL, V2, P690, DOI 10.1371/journal.pbio.0020139; Angell JE, 2000, J BIOL CHEM, V275, P33416, DOI 10.1074/jbc.M003929200; Arabi A, 2005, NAT CELL BIOL, V7, P303, DOI 10.1038/ncb1225; Belin S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007147; Campisi Judith, 2002, Sci Aging Knowledge Environ, V2002, ppe1, DOI 10.1126/sageke.2002.1.pe1; Castle JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011779; Cavaille J, 1996, NATURE, V383, P732, DOI 10.1038/383732a0; Clemens MJ, 1997, J INTERF CYTOK RES, V17, P503, DOI 10.1089/jir.1997.17.503; Darzacq X, 2006, J CELL BIOL, V173, P207, DOI 10.1083/jcb.200601105; DEPPERT W, 1994, SEMIN CANCER BIOL, V5, P187; Dez C, 2002, MOL CELL BIOL, V22, P7053, DOI 10.1128/MCB.22.20.7053-7065.2002; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Dokal I, 2001, Lancet, V358 Suppl, pS27, DOI 10.1016/S0140-6736(01)07040-4; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Ender C, 2008, MOL CELL, V32, P519, DOI 10.1016/j.molcel.2008.10.017; Gale M, 2000, MICROBIOL MOL BIOL R, V64, P239, DOI 10.1128/MMBR.64.2.239-280.2000; Ganot P, 1997, CELL, V89, P799, DOI 10.1016/S0092-8674(00)80263-9; Ge JP, 2010, MOL CELL BIOL, V30, P413, DOI 10.1128/MCB.01128-09; Gee HE, 2011, BRIT J CANCER, V104, P1168, DOI 10.1038/sj.bjc.6606076; Gongora C, 1997, J BIOL CHEM, V272, P19457, DOI 10.1074/jbc.272.31.19457; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Grozdanov PN, 2009, HUM MOL GENET, V18, P4546, DOI 10.1093/hmg/ddp416; Grozdanov PN, 2009, RNA, V15, P1188, DOI 10.1261/rna.1532109; Guo JJ, 2000, EMBO J, V19, P6891, DOI 10.1093/emboj/19.24.6891; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hoareau-Aveilla C, 2006, RNA, V12, P832, DOI 10.1261/rna.2344106; Hofman ER, 1998, MOL CELL BIOL, V18, P6493, DOI 10.1128/MCB.18.11.6493; Hofmann ER, 2010, J CELL SCI, V123, P2781, DOI 10.1242/jcs.070250; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Jiang HP, 1997, ONCOGENE, V14, P473, DOI 10.1038/sj.onc.1200858; Kalvakolanu DV, 2004, CYTOKINE GROWTH F R, V15, P169, DOI 10.1016/j.cytogfr.2004.01.002; Killian A, 2004, ONCOGENE, V23, P8597, DOI 10.1038/sj.onc.1207845; KissLaszlo Z, 1996, CELL, V85, P1077, DOI 10.1016/S0092-8674(00)81308-2; Kittur N, 2006, RNA, V12, P2057, DOI 10.1261/rna.249306; Kroczynska B, 2009, CYTOKINE, V48, P138, DOI 10.1016/j.cyto.2009.07.009; Leulliot N, 2007, J MOL BIOL, V371, P1338, DOI 10.1016/j.jmb.2007.06.031; Li XL, 2000, J BIOL CHEM, V275, P8880, DOI 10.1074/jbc.275.12.8880; Ni JW, 1997, CELL, V89, P565, DOI 10.1016/S0092-8674(00)80238-X; Ohene-Abuakwa Y, 2005, BLOOD, V105, P838, DOI 10.1182/blood-2004-03-1016; Player MR, 1998, PHARMACOL THERAPEUT, V78, P55, DOI 10.1016/S0163-7258(97)00167-8; Rebouillat D, 1999, J INTERF CYTOK RES, V19, P295, DOI 10.1089/107999099313992; Ruggero D, 2003, SCIENCE, V299, P259, DOI 10.1126/science.1079447; Scacheri PC, 2004, P NATL ACAD SCI USA, V101, P1892, DOI 10.1073/pnas.0308698100; Schippert R, 2008, MOL VIS, V14, P1589; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Singh M, 2009, J BIOL CHEM, V284, P1906, DOI 10.1074/jbc.M807337200; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Sun P, 2009, ONCOGENE, V28, P1339, DOI 10.1038/onc.2008.480; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; THOMIS DC, 1992, VIROLOGY, V188, P33, DOI 10.1016/0042-6822(92)90732-5; Trahan C, 2010, HUM MOL GENET, V19, P825, DOI 10.1093/hmg/ddp551; Trere D, 2004, J HISTOCHEM CYTOCHEM, V52, P1601, DOI 10.1369/jhc.4A6454.2004; Vulliamy T, 2008, P NATL ACAD SCI USA, V105, P8073, DOI 10.1073/pnas.0800042105; Walne AJ, 2007, HUM MOL GENET, V16, P1619, DOI 10.1093/hmg/ddm111; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Yang PK, 2002, J BIOL CHEM, V277, P45235, DOI 10.1074/jbc.M207669200; Yoon A, 2006, SCIENCE, V312, P902, DOI 10.1126/science.1123835; ZHOU AM, 1993, CELL, V72, P753, DOI 10.1016/0092-8674(93)90403-D	61	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e24082	10.1371/journal.pone.0024082	http://dx.doi.org/10.1371/journal.pone.0024082			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CK	21931644	Green Published, gold, Green Submitted			2022-12-25	WOS:000294802800022
J	Dang, RH; Torigoe, D; Suzuki, S; Kikkawa, Y; Moritoh, K; Sasaki, N; Agui, T				Dang, Ruihua; Torigoe, Daisuke; Suzuki, Sari; Kikkawa, Yoshiaki; Moritoh, Kanako; Sasaki, Nobuya; Agui, Takashi			Genetic Background Strongly Modifies the Severity of Symptoms of Hirschsprung Disease, but not Hearing Loss in Rats Carrying Ednrb(sl) Mutations	PLOS ONE			English	Article							ENDOTHELIN-B RECEPTOR; ENTERIC NERVOUS-SYSTEM; SHAH-WAARDENBURG-SYNDROME; NEURAL CREST DEVELOPMENT; WHITE FOAL SYNDROME; GERMLINE MUTATIONS; MISSENSE MUTATION; MICE LACKING; MOUSE MODEL; COAT COLOR	Hirschsprung disease (HSCR) is thought to result as a consequence of multiple gene interactions that modulate the ability of enteric neural crest cells to populate the developing gut. However, it remains unknown whether the single complete deletion of important HSCR-associated genes is sufficient to result in HSCR disease. In this study, we found that the null mutation of the Ednrb gene, thought indispensable for enteric neuron development, is insufficient to result in HSCR disease when bred onto a different genetic background in rats carrying Ednrb(sl) mutations. Moreover, we found that this mutation results in serious congenital sensorineural deafness, and these strains may be used as ideal models of Waardenburg Syndrome Type 4 (WS4). Furthermore, we evaluated how the same changed genetic background modifies three features of WS4 syndrome, aganglionosis, hearing loss, and pigment disorder in these congenic strains. We found that the same genetic background markedly changed the aganglionosis, but resulted in only slight changes to hearing loss and pigment disorder. This provided the important evidence, in support of previous studies, that different lineages of neural crest-derived cells migrating along with various pathways are regulated by different signal molecules. This study will help us to better understand complicated diseases such as HSCR and WS4 syndrome.	[Dang, Ruihua; Torigoe, Daisuke; Moritoh, Kanako; Sasaki, Nobuya; Agui, Takashi] Hokkaido Univ, Grad Sch Vet Med, Dept Dis Control, Lab Anim Sci & Med, Sapporo, Hokkaido 060, Japan; [Suzuki, Sari; Kikkawa, Yoshiaki] Tokyo Univ Agr, Dept Bioprod, Abashiri, Japan; [Kikkawa, Yoshiaki] Tokyo Metropolitan Inst Med Sci, Mammalian Genet Project, Tokyo 113, Japan	Hokkaido University; Tokyo University of Agriculture; Tokyo Metropolitan Institute of Medical Science	Dang, RH (corresponding author), Hokkaido Univ, Grad Sch Vet Med, Dept Dis Control, Lab Anim Sci & Med, Sapporo, Hokkaido 060, Japan.	agui@vetmed.hokudai.ac.jp	Kikkawa, Yoshiaki/AAI-7229-2020; Sasaki, Nobuya/F-6579-2012	Kikkawa, Yoshiaki/0000-0001-8859-4998; MORITOH, KANAKO/0000-0001-7501-6806				Amiel J, 2008, J MED GENET, V45, P1, DOI 10.1136/jmg.2007.053959; Amiel J, 1996, HUM MOL GENET, V5, P355, DOI 10.1093/hmg/5.3.355; Ando M, 1999, CELL TISSUE RES, V298, P179, DOI 10.1007/s004419900066; ANGRIST M, 1993, NAT GENET, V4, P351, DOI 10.1038/ng0893-351; Angrist M, 1996, NAT GENET, V14, P341, DOI 10.1038/ng1196-341; ATTIE T, 1995, HUM MOL GENET, V4, P2407, DOI 10.1093/hmg/4.12.2407; Auricchio A, 1996, HUM MOL GENET, V5, P351, DOI 10.1093/hmg/5.3.351; BADNER JA, 1990, AM J HUM GENET, V46, P568; BAYNASH AG, 1994, CELL, V79, P1277, DOI 10.1016/0092-8674(94)90018-3; Boardman JP, 2001, J MED GENET, V38, P646, DOI 10.1136/jmg.38.9.646; Brooks AS, 2005, CLIN GENET, V67, P6, DOI 10.1111/j.1399-0004.2004.00319.x; COHEN IT, 1982, J PEDIATR SURG, V17, P632, DOI 10.1016/S0022-3468(82)80124-3; Druckenbrod NR, 2008, GENESIS, V46, P396, DOI 10.1002/dvg.20415; Edery P, 1996, NAT GENET, V12, P442, DOI 10.1038/ng0496-442; Enomoto H, 1998, NEURON, V21, P317, DOI 10.1016/S0896-6273(00)80541-3; Gariepy CE, 1996, P NATL ACAD SCI USA, V93, P867, DOI 10.1073/pnas.93.2.867; Heanue TA, 2007, NAT REV NEUROSCI, V8, P466, DOI 10.1038/nrn2137; Hofstra RMW, 1996, NAT GENET, V12, P445, DOI 10.1038/ng0496-445; HOSODA K, 1994, CELL, V79, P1267, DOI 10.1016/0092-8674(94)90017-5; Ivanchuk SM, 1996, HUM MOL GENET, V5, P2023, DOI 10.1093/hmg/5.12.2023; Karaki H, 1996, BIOCHEM BIOPH RES CO, V222, P139, DOI 10.1006/bbrc.1996.0711; Kenny SE, 2010, SEMIN PEDIATR SURG, V19, P194, DOI 10.1053/j.sempedsurg.2010.03.004; Kuriyama S, 2008, PHILOS T R SOC B, V363, P1349, DOI 10.1098/rstb.2007.2252; Kusafuka T, 1996, HUM MOL GENET, V5, P347, DOI 10.1093/hmg/5.3.347; Lee HO, 2003, DEV BIOL, V259, P162, DOI 10.1016/S0012-1606(03)00160-X; LUO Y, 1993, HUM MOL GENET, V2, P1803, DOI 10.1093/hmg/2.11.1803; LYONNET S, 1993, NAT GENET, V4, P346, DOI 10.1038/ng0893-346; Matsushima Y, 2002, MAMM GENOME, V13, P30, DOI 10.1007/s00335-001-3038-2; McCallion AS, 2003, P NATL ACAD SCI USA, V100, P1826, DOI 10.1073/pnas.0337540100; Metallinos DL, 1998, MAMM GENOME, V9, P426, DOI 10.1007/s003359900790; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; Newgreen D, 2002, PEDIATR DEVEL PATHOL, V5, P329, DOI 10.1007/s10024-002-0002-4; Ohgami N, 2010, P NATL ACAD SCI USA, V107, P13051, DOI 10.1073/pnas.1004520107; Passarge E, 2002, NAT GENET, V31, P11, DOI 10.1038/ng878; Pingault V, 1998, NAT GENET, V18, P171, DOI 10.1038/ng0298-171; Pingault V, 2010, HUM MUTAT, V31, P391, DOI 10.1002/humu.21211; Price ER, 2001, NEURON, V30, P15, DOI 10.1016/S0896-6273(01)00259-8; PUFFENBERGER EG, 1994, CELL, V79, P1257, DOI 10.1016/0092-8674(94)90016-7; Salomon R, 1996, NAT GENET, V14, P345, DOI 10.1038/ng1196-345; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; Shin MK, 1999, NATURE, V402, P496, DOI 10.1038/990040; Skinner MA, 1996, CURR PROB SURG, V33, P394, DOI 10.1016/S0011-3840(96)80009-8; Southard-Smith EM, 1998, NAT GENET, V18, P60, DOI 10.1038/ng0198-60; Southard-Smith EM, 1999, GENOME RES, V9, P215; Stanchina L, 2006, DEV BIOL, V295, P232, DOI 10.1016/j.ydbio.2006.03.031; Syrris P, 1999, AM J MED GENET, V87, P69, DOI 10.1002/(SICI)1096-8628(19991105)87:1<69::AID-AJMG14>3.0.CO;2-R; Tanaka H, 1998, J BIOL CHEM, V273, P11378, DOI 10.1074/jbc.273.18.11378; Uesaka T, 2008, J CLIN INVEST, V118, P1890, DOI 10.1172/JCI34425; Walters LC, 2010, HUM MOL GENET, V19, P4353, DOI 10.1093/hmg/ddq357; Yang GC, 1998, HUM MOL GENET, V7, P1047, DOI 10.1093/hmg/7.6.1047; Young HM, 2008, NEUROGASTROENT MOTIL, V20, P20, DOI 10.1111/j.1365-2982.2008.01098.x	51	24	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2011	6	9							e24086	10.1371/journal.pone.0024086	http://dx.doi.org/10.1371/journal.pone.0024086			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CH	21915282	Green Published, gold			2022-12-25	WOS:000294802500025
J	Michon, A; Allou, N; Chau, F; Podglajen, I; Fantin, B; Cambau, E				Michon, Adrien; Allou, Nicolas; Chau, Francoise; Podglajen, Isabelle; Fantin, Bruno; Cambau, Emmanuelle			Plasmidic qnrA3 Enhances Escherichia coli Fitness in Absence of Antibiotic Exposure	PLOS ONE			English	Article							MEDIATED QUINOLONE RESISTANCE; FLUOROQUINOLONE RESISTANCE; KLEBSIELLA-PNEUMONIAE; BIOLOGICAL COST; TETRACYCLINE-RESISTANCE; ENTEROCOCCUS-FAECALIS; FLOW-CYTOMETRY; IN-VIVO; PROTEIN; MECHANISMS	The widespread presence of plasmid-mediated quinolone resistance determinants, particularly qnr genes, has become a current issue. By protecting DNA-gyrase from quinolones, Qnr proteins confer a low level quinolone resistance that is not sufficient to explain their emergence. Since Qnr proteins were hypothesized to act as DNA-binding protein regulators, qnr genes could have emerged by providing a selective advantage other than antibiotic resistance. We investigated host fitness of Escherichia coli isogenic strains after acquisition of the qnrA3 gene, inserted either alone onto a small plasmid (pBR322), or harbored on a large conjugative native plasmid, pHe96(qnrA3) found in a clinical isolate. The isogenic strains were derived from the susceptible E. coli CFT073, a virulent B2 group strain known to infect bladder and kidneys in a mouse model of pyelonephritis. In vitro experiments included growth analysis by automatic spectrophotometry and flow cytometry, and competitions with CFU enumeration. In vivo experiments included infection with each strain and pairwise competitions in absence of antimicrobial exposure. As controls for our experiments we used mutations known to reduce fitness (rpsL K42N mutation) or to enhance fitness (tetA deletion in pBR322). E. coli CFT073 transformed with pBRAM(PBR322-qnrA3) had significantly higher maximal OD than E. coli CFT073 transformed with pBR322 or pBR322 Delta tetA, and in vivo competitions were more often won by the qnrA3 carrying strain (24 victories vs. 9 loss among 42 competitions, p = 0.001). In contrast, when pHe96(qnrA3) was introduced by conjugation in E. coli CFT073, it exerted a fitness cost shown by an impaired growth observed in vitro and in vivo and a majority of lost competitions (33/35, p<0.0001). In conclusion, qnrA3 acquisition enhanced bacterial fitness, which may explain qnr emergence and suggests a regulation role of qnr. However, fitness was reduced when qnrA3 was inserted onto multidrug-resistant plasmids and this can slow down its dissemination without antibiotic exposure.	[Michon, Adrien; Allou, Nicolas; Chau, Francoise; Fantin, Bruno; Cambau, Emmanuelle] Univ Paris Diderot, EA 3964, Paris, France; [Podglajen, Isabelle] Microbiol Hop Europeen Georges Pompidou, APHP, Paris, France; [Fantin, Bruno] Med Interne Hop Beaujon, APHP, Clichy, France; [Cambau, Emmanuelle] Grp Hosp St Louis Lariboisiere Fernand Widal, APHP, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Europeen Georges-Pompidou - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Beaujon - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	Michon, A (corresponding author), Univ Paris Diderot, EA 3964, Paris, France.	emmanuelle.cambau@lrb.aphp.fr	Cambau, Emmanuelle/G-7385-2014	Cambau, Emmanuelle/0000-0001-5944-2530	University Paris [EA3964]	University Paris	The work was supported with an annual grant from the University Paris Diderot for the team EA3964. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allou N, 2009, ANTIMICROB AGENTS CH, V53, P4292, DOI 10.1128/AAC.01664-08; Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319; Arsene S, 2007, ANTIMICROB AGENTS CH, V51, P3254, DOI 10.1128/AAC.00274-07; Bagel S, 1999, ANTIMICROB AGENTS CH, V43, P868, DOI 10.1128/AAC.43.4.868; Balsalobre L, 2008, ANTIMICROB AGENTS CH, V52, P822, DOI 10.1128/AAC.00731-07; BEGOT CDI, 1996, J MICROBIOLOGICAL ME, P225; Bemer P, 2007, PATHOL BIOL, V55, P288, DOI 10.1016/j.patbio.2006.06.006; BOLIVAR F, 1977, GENE, V2, P95, DOI 10.1016/0378-1119(77)90000-2; Cambau E, 2006, CLIN MICROBIOL INFEC, V12, P1013, DOI 10.1111/j.1469-0691.2006.01529.x; Cattoir V, 2007, ANTIMICROB AGENTS CH, V51, P2650, DOI 10.1128/AAC.00070-07; Cavaco LM, 2009, ANTIMICROB AGENTS CH, V53, P603, DOI 10.1128/AAC.00997-08; Cesaro A, 2008, J ANTIMICROB CHEMOTH, V61, P1007, DOI 10.1093/jac/dkn077; Chau F, 2011, ANTIMICROB AGENTS CH, V55, P395, DOI 10.1128/AAC.00970-10; De Gelder L, 2007, MICROBIOL-SGM, V153, P452, DOI 10.1099/mic.0.2006/001784-0; Garau J, 1999, ANTIMICROB AGENTS CH, V43, P2736, DOI 10.1128/AAC.43.11.2736; Goossens H, 2009, CLIN MICROBIOL INFEC, V15, P12, DOI 10.1111/j.1469-0691.2009.02725.x; Hegde SS, 2005, SCIENCE, V308, P1480, DOI 10.1126/science.1110699; Hegde SS, 2011, ANTIMICROB AGENTS CH, V55, P110, DOI 10.1128/AAC.01158-10; HEISIG P, 1994, ANTIMICROB AGENTS CH, V38, P1284, DOI 10.1128/AAC.38.6.1284; Heisig P, 2009, MUTAGENESIS, V24, P465, DOI 10.1093/mutage/gep035; Hooper D.C., 2003, QUINOLONE ANTIMICROB, V3rd ed., P41, DOI [10.1128/9781555817817.ch3, DOI 10.1128/9781555817817.CH3]; Hooper DC, 2000, CLIN INFECT DIS, V31, pS24, DOI 10.1086/314056; Hurdle JG, 2004, J ANTIMICROB CHEMOTH, V53, P102, DOI 10.1093/jac/dkh020; Jacoby GA, 2005, NEW ENGL J MED, V352, P380, DOI 10.1056/NEJMra041359; Jacoby GA, 2005, CLIN INFECT DIS, V41, pS120, DOI 10.1086/428052; Johnson CN, 2005, EMERG INFECT DIS, V11, P814, DOI 10.3201/eid1106.040840; Kugelberg E, 2005, J ANTIMICROB CHEMOTH, V55, P22, DOI 10.1093/jac/dkh505; Labat F, 2005, FEMS IMMUNOL MED MIC, V44, P317, DOI 10.1016/j.femsim.2005.01.003; Lascols C, 2008, J BACTERIOL, V190, P5217, DOI 10.1128/JB.00243-08; LEE SW, 1985, GENE, V39, P173, DOI 10.1016/0378-1119(85)90311-7; Liassine N, 2008, J ANTIMICROB CHEMOTH, V62, P1151, DOI 10.1093/jac/dkn295; Lindgren PK, 2005, ANTIMICROB AGENTS CH, V49, P2343, DOI 10.1128/AAC.49.6.2343-2351.2005; Luo ND, 2005, P NATL ACAD SCI USA, V102, P541, DOI 10.1073/pnas.0408966102; Mammeri H, 2005, ANTIMICROB AGENTS CH, V49, P71, DOI 10.1128/AAC.49.1.71-76.2005; Marcusson LL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000541; Martinez-Martinez L, 1998, LANCET, V351, P797, DOI 10.1016/S0140-6736(97)07322-4; Merens A, 2009, J BACTERIOL, V191, P1587, DOI 10.1128/JB.01205-08; Mnif B, 2010, J ANTIMICROB CHEMOTH, V65, P1599, DOI 10.1093/jac/dkq181; Morosini MI, 2000, ANTIMICROB AGENTS CH, V44, P3137, DOI 10.1128/AAC.44.11.3137-3143.2000; NGUYEN TNM, 1989, MOL BIOL EVOL, V6, P213; Paulander W, 2009, GENETICS, V183, P539, DOI 10.1534/genetics.109.106104; Petersen A, 2009, FEMS MICROBIOL LETT, V299, P53, DOI 10.1111/j.1574-6968.2009.01734.x; PINDER AC, 1990, J APPL BACTERIOL, V69, P92, DOI 10.1111/j.1365-2672.1990.tb02916.x; Poirel L, 2005, J ANTIMICROB CHEMOTH, V56, P1118, DOI 10.1093/jac/dki371; Poirel L, 2005, ANTIMICROB AGENTS CH, V49, P3593, DOI 10.1128/AAC.49.8.3593-3597.2005; Poole K, 2005, J ANTIMICROB CHEMOTH, V56, P20, DOI 10.1093/jac/dki171; Robicsek A, 2006, NAT MED, V12, P83, DOI 10.1038/nm1347; Robicsek A, 2006, ANTIMICROB AGENTS CH, V50, P2872, DOI 10.1128/AAC.01647-05; Robicsek A, 2006, LANCET INFECT DIS, V6, P629, DOI 10.1016/S1473-3099(06)70599-0; Rodriguez-Martinez JM, 2008, CLIN MICROBIOL INFEC, V14, P691, DOI 10.1111/j.1469-0691.2008.02020.x; Rossolini GM, 2008, CLIN MICROBIOL INFEC, V14, P33, DOI 10.1111/j.1469-0691.2007.01867.x; Rozen DE, 2007, ANTIMICROB AGENTS CH, V51, P412, DOI 10.1128/AAC.01161-06; Schrag SJ, 1996, NATURE, V381, P120, DOI 10.1038/381120b0; SHAW KJ, 1993, MICROBIOL REV, V57, P138, DOI 10.1128/MMBR.57.1.138-163.1993; Skippington E, 2011, FEMS MICROBIOL REV, V35, P707, DOI 10.1111/j.1574-6976.2010.00261.x; Strahilevitz J, 2009, CLIN MICROBIOL REV, V22, P664, DOI 10.1128/CMR.00016-09; Tamtam F, 2008, SCI TOTAL ENVIRON, V393, P84, DOI 10.1016/j.scitotenv.2007.12.009; Tran JH, 2002, P NATL ACAD SCI USA, V99, P5638, DOI 10.1073/pnas.082092899; Tran JH, 2005, ANTIMICROB AGENTS CH, V49, P118, DOI 10.1128/AAC.49.1.118-125.2005; Tran JH, 2005, ANTIMICROB AGENTS CH, V49, P3050, DOI 10.1128/AAC.49.7.3050-3052.2005; Vetting MW, 2011, J BIOL CHEM, V286, P25265, DOI 10.1074/jbc.M111.226936; WANG G, 1993, NUCLEIC ACIDS RES, V21, P5930, DOI 10.1093/nar/21.25.5930; Wang MG, 2004, ANTIMICROB AGENTS CH, V48, P1400, DOI 10.1128/AAC.48.4.1400-1401.2004; Wang MG, 2004, ANTIMICROB AGENTS CH, V48, P1295, DOI 10.1128/AAC.48.4.1295-1299.2004; Wang MG, 2003, ANTIMICROB AGENTS CH, V47, P2242, DOI 10.1128/AAC.47.7.2242-2248.2003; Warringer J, 2003, YEAST, V20, P53, DOI 10.1002/yea.931; WATSON N, 1988, GENE, V70, P399, DOI 10.1016/0378-1119(88)90212-0; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; Xiong XL, 2011, NUCLEIC ACIDS RES, V39, P3917, DOI 10.1093/nar/gkq1296; Yamane K, 2007, ANTIMICROB AGENTS CH, V51, P3354, DOI 10.1128/AAC.00339-07	70	22	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2011	6	9							e24552	10.1371/journal.pone.0024552	http://dx.doi.org/10.1371/journal.pone.0024552			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CH	21915350	gold, Green Submitted, Green Published			2022-12-25	WOS:000294802500059
J	Hamilton, SL; Wilson, JR; Ben-Horin, T; Caselle, JE				Hamilton, Scott L.; Wilson, Jono R.; Ben-Horin, Tal; Caselle, Jennifer E.			Utilizing Spatial Demographic and Life History Variation to Optimize Sustainable Yield of a Temperate Sex-Changing Fish	PLOS ONE			English	Article							SEMICOSSYPHUS-PULCHER LABRIDAE; ROCKFISH SEBASTES-MYSTINUS; ADULT CALIFORNIA SHEEPHEAD; LIMITED LARVAL DISPERSAL; STOCK ASSESSMENT; STRONGYLOCENTROTUS-FRANCISCANUS; POPULATION-STRUCTURE; FISHERIES; GROWTH; SIZE	Fish populations vary geographically in demography and life history due to environmental and ecological processes and in response to exploitation. However, population dynamic models and stock assessments, used to manage fisheries, rarely explicitly incorporate spatial variation to inform management decisions. Here, we describe extensive geographic variation in several demographic and life history characteristics (e.g., size structure, growth, survivorship, maturation, and sex change) of California sheephead (Semicossyphus pulcher), a temperate rocky reef fish targeted by recreational and commercial fisheries. Fish were sampled from nine locations throughout southern California in 2007-2008. We developed a dynamic size and age-structured model, parameterized separately for each location, to assess the potential cost or benefit in terms of fisheries yield and conservation objectives of changing minimum size limits and/or fishing mortality rates (compared to the status quo). Results indicate that managing populations individually, with location-specific regulations, could increase yield by over 26% while maintaining conservative levels of spawning biomass. While this local management approach would be challenging to implement in practice, we found statistically similar increases in yield could be achieved by dividing southern California into two separate management regions, reflecting geographic similarities in demography. To maximize yield, size limits should be increased by 90 mm in the northern region and held at current levels in the south. We also found that managing the fishery as one single stock (the status quo), but with a size limit 50 mm greater than the current regulations, could increase overall fishery yield by 15%. Increases in size limits are predicted to enhance fishery yield and may also have important ecological consequences for the predatory role of sheephead in kelp forests. This framework for incorporating demographic variation into fisheries models can be exported generally to other species and may aid in identifying the appropriate spatial scales for fisheries management.	[Hamilton, Scott L.; Caselle, Jennifer E.] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; [Hamilton, Scott L.] Moss Landing Marine Labs, Moss Landing, CA 95039 USA; [Wilson, Jono R.; Ben-Horin, Tal] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; Moss Landing Marine Laboratories; University of California System; University of California Santa Barbara	Hamilton, SL (corresponding author), Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA.	shamilton@mlml.calstate.edu	Bizzarro, Joseph/A-2988-2012	Ben-Horin, Tal/0000-0001-5123-2643	NOAA [NA04OAR4170038]; U.S. Dept. of Commerce, and the Ocean Protection Council [R/OPC-FISH05]; California Ocean Protection Council [07-021]; California Sea Grant [NA10OAR4170060]; Sustainable Fisheries Group; Channel Islands National Marine Sanctuary; David and Lucille Packard Foundation; Gordon and Betty Moore Foundation	NOAA(National Oceanic Atmospheric Admin (NOAA) - USA); U.S. Dept. of Commerce, and the Ocean Protection Council; California Ocean Protection Council; California Sea Grant; Sustainable Fisheries Group; Channel Islands National Marine Sanctuary; David and Lucille Packard Foundation(The David & Lucile Packard Foundation); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	Funding was generously provided by NOAA (Grant #NA04OAR4170038), the California Sea Grant College Program (Project #R/OPC-FISH05) through NOAA's National Sea Grant College Program, U.S. Dept. of Commerce, and the Ocean Protection Council. JR Wilson was supported by the California Ocean Protection Council (Research Award #07-021), California Sea Grant (#NA10OAR4170060), and the Sustainable Fisheries Group. Additional funding was provided by the Channel Islands National Marine Sanctuary and the Partnership for Interdisciplinary Studies of Coastal Oceans, which is funded by the David and Lucille Packard Foundation and the Gordon and Betty Moore Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonzo SH, 2005, FISH B-NOAA, V103, P229; Alonzo SH, 2004, FISH B-NOAA, V102, P1; Alonzo SH, 2004, STATUS CALIFORNIA SH; Alonzo SH, 2008, B MAR SCI, V83, P163; [Anonymous], QUANTITATIVE FISHERI; Armsworth PR, 2001, CAN J FISH AQUAT SCI, V58, P568, DOI 10.1139/cjfas-58-3-568; Berkeley SA, 2004, FISHERIES, V29, P23, DOI 10.1577/1548-8446(2004)29[23:FSVPOA]2.0.CO;2; Bernardi G, 2003, EVOLUTION, V57, P1599; Beverton R.J., 1957, FISHERY INVESTIGAT 2, VXIX; Brodziak J, 2000, FISH B-NOAA, V98, P661; Brown J. H., 1995, MACROECOLOGY; Buonaccorsi VP, 2004, MAR BIOL, V145, P779, DOI 10.1007/s00227-004-1362-2; BUXTON CD, 1993, ENVIRON BIOL FISH, V36, P47, DOI 10.1007/BF00005979; Caselle JE, 2011, CAN J FISH AQUAT SCI, V68, P288, DOI 10.1139/F10-140; Conover DO, 2002, SCIENCE, V297, P94, DOI 10.1126/science.1074085; CONOVER DO, 1990, OECOLOGIA, V83, P316, DOI 10.1007/BF00317554; Cope JM, 2009, STATUS CABEZON SCORP; COWEN RK, 1983, OECOLOGIA, V58, P249, DOI 10.1007/BF00399225; COWEN RK, 1990, COPEIA, P787; COWEN RK, 1986, ENVIRON BIOL FISH, V16, P193, DOI 10.1007/BF00005171; DeMartini EE, 2008, MAR ECOL PROG SER, V365, P199, DOI 10.3354/meps07501; DeMartini EE, 2005, MAR ECOL PROG SER, V297, P259, DOI 10.3354/meps297259; DEMARTINI EE, 1994, B MAR SCI, V55, P484; FRANCIS RIC, 1992, CAN J FISH AQUAT SCI, V49, P922, DOI 10.1139/f92-102; Gelcich S, 2008, ECOL APPL, V18, P273, DOI 10.1890/06-1896.1; Gertseva VV, 2010, MAR ECOL PROG SER, V413, P125, DOI 10.3354/meps08719; Gunderson DR, 2008, FISHERIES, V33, P172, DOI 10.1577/1548-8446-33.4.172; Gust N, 2002, MAR BIOL, V140, P1039, DOI 10.1007/s00227-001-0773-6; Hamilton SL, 2007, ECOL APPL, V17, P2268, DOI 10.1890/06-1930.1; Hamilton SL, 2011, MAR ECOL PROG SER, V429, P227, DOI 10.3354/meps09086; Hilborn R, 2003, P NATL ACAD SCI USA, V100, P6564, DOI 10.1073/pnas.1037274100; Hilborn R, 2003, SCI MAR, V67, P15, DOI 10.3989/scimar.2003.67s115; Hilborn R, 2006, B MAR SCI, V78, P487; HUYER A, 1983, PROG OCEANOGR, V12, P259, DOI 10.1016/0079-6611(83)90010-1; Jennings S., 2001, MARINE FISHERIES ECO; Jorgensen SJ, 2006, MAR ECOL PROG SER, V327, P157, DOI 10.3354/meps327157; KIMURA DK, 1980, FISH B-NOAA, V77, P765; Laidig TE, 2003, FISH B-NOAA, V101, P800; Law R, 2000, ICES J MAR SCI, V57, P659, DOI 10.1006/jmsc.2000.0731; McGovern JC, 1998, FISH B-NOAA, V96, P797; Miller JA, 2004, CAN J FISH AQUAT SCI, V61, P1723, DOI 10.1139/F04-111; Murray S., 1980, CALIFORNIA ISLANDS, P325; Orensanz JM, 2005, B MAR SCI, V76, P527; Punt AE, 1997, REV FISH BIOL FISHER, V7, P35, DOI 10.1023/A:1018419207494; Punt AE, 2003, FISH RES, V65, P391, DOI 10.1016/j.fishres.2003.09.028; R Development Core Team, 2009, R FDN STAT COMP; RIJNSDORP AD, 1993, OECOLOGIA, V96, P391, DOI 10.1007/BF00317510; Robertson DR, 2005, MAR ECOL PROG SER, V295, P229, DOI 10.3354/meps295229; Rosales-Casian Jorge Adrian, 2003, Bulletin Southern California Academy of Sciences, V102, P51; ROSENBERG AA, 1994, CAN J FISH AQUAT SCI, V51, P2715, DOI 10.1139/f94-271; Ruttenberg BI, 2005, OECOLOGIA, V145, P394, DOI 10.1007/s00442-005-0150-0; Sundberg Michael A., 2009, Bulletin Southern California Academy of Sciences, V108, P16, DOI 10.3160/0038-3872-108.1.16; TEGNER MJ, 1981, MAR ECOL PROG SER, V5, P255, DOI 10.3354/meps005255; Tegner MJ, 2000, ICES J MAR SCI, V57, P579, DOI 10.1006/jmsc.2000.0715; Topping DT, 2006, MAR ECOL PROG SER, V326, P257, DOI 10.3354/meps326257; Topping DT, 2005, MAR BIOL, V147, P301, DOI 10.1007/s00227-005-1573-1; WARNER RR, 1975, FISH B-NOAA, V73, P262; Williams AJ, 2003, FISH B-NOAA, V101, P673; Worthington D. G., 1998, Canadian Special Publication of Fisheries and Aquatic Sciences, V125, P341; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	72	28	28	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2011	6	9							e24580	10.1371/journal.pone.0024580	http://dx.doi.org/10.1371/journal.pone.0024580			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817QP	21915353	gold, Green Published			2022-12-25	WOS:000294689200054
J	Liu, WW; Guan, M; Hu, TT; Gu, XY; Lu, Y				Liu, Weiwei; Guan, Ming; Hu, Tingting; Gu, Xiaoye; Lu, Yuan			Re-Expression of AKAP12 Inhibits Progression and Metastasis Potential of Colorectal Carcinoma In Vivo and In Vitro	PLOS ONE			English	Article							KINASE-C SUBSTRATE; PROMOTER METHYLATION; DNA METHYLATION; CANCER; EXPRESSION; SSECKS; BREAST; GROWTH; GENES; APOPTOSIS	Background: AKAP12/Gravin (A kinase anchor protein 12) is one of the A-kinase scaffold proteins and a potential tumor suppressor gene in human primary cancers. Our recent study demonstrated the highly recurrent loss of AKAP12 in colorectal cancer and AKAP12 reexpression inhibited proliferation and anchorage-independent growth in colorectal cancer cells, implicating AKAP12 in colorectal cancer pathogenesis. Methods: To evaluate the effect of this gene on the progression and metastasis of colorectal cancer, we examined the impact of overexpressing AKAP12 in the AKAP12-negative human colorectal cancer cell line LoVo, the single clone (LoVo-AKAP12) compared to mock-transfected cells (LoVo-CON). Results: pCMV6-AKAP12-mediated AKAP12 re-expression induced apoptosis (3% to 12.7%, p<0.01), migration (89.6 +/- 7.5 cells to 31.0 +/- 4.1 cells, p<0.01) and invasion (82.7 +/- 5.2 cells to 24.7 +/- 3.3 cells, p<0.01) of LoVo cells in vitro compared to control cells. Nude mice injected with LoVo-AKAP12 cells had both significantly reduced tumor volume (p<0.01) and increased apoptosis compared to mice given AKAP12-CON. The quantitative human-specific Alu PCR analysis showed overexpression of AKAP12 suppressed the number of intravasated cells in vivo (p<0.01). Conclusion: These results demonstrate that AKAP12 may play an important role in tumor growth suppression and the survival of human colorectal cancer.	[Liu, Weiwei; Guan, Ming; Hu, Tingting; Lu, Yuan] Fudan Univ, Shanghai Med Coll, Dept Lab Med, Huashan Hosp, Shanghai 200433, Peoples R China; [Guan, Ming; Gu, Xiaoye] Fudan Univ, Shanghai Med Coll, Huashan Hosp, Cent Lab, Shanghai 200433, Peoples R China	Fudan University; Fudan University	Liu, WW (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Lab Med, Huashan Hosp, Shanghai 200433, Peoples R China.	huashanvivian@yahoo.com.cn; yuanlu@hsh.stn.sh.cn			National Natural Science Foundation [81001059]; Natural Science Foundation of Shanghai [09ZR1405300]; Shanghai Medical Key Discipline	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanghai(Natural Science Foundation of Shanghai); Shanghai Medical Key Discipline	This study was supported by the National Natural Science Foundation (Grant No. 81001059), the Natural Science Foundation of Shanghai (Grant No. 09ZR1405300) and a grant from the Shanghai Medical Key Discipline. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal A, 2007, MODERN PATHOL, V20, P711, DOI 10.1038/modpathol.3800822; Choi MC, 2004, ONCOGENE, V23, P7095, DOI 10.1038/sj.onc.1207932; Flotho C, 2007, BRIT J HAEMATOL, V138, P644, DOI 10.1111/j.1365-2141.2007.06709.x; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; GORDON T, 1992, J CLIN INVEST, V90, P992, DOI 10.1172/JCI115976; Guan M, 2003, J CLIN PATHOL, V56, P277, DOI 10.1136/jcp.56.4.277; Heller G, 2008, CANCER RES, V68, P44, DOI 10.1158/0008-5472.CAN-07-2531; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Jin Z, 2008, CANCER EPIDEM BIOMAR, V17, P111, DOI 10.1158/1055-9965.EPI-07-0407; Lee WJ, 2008, TOXICOL APPL PHARM, V226, P178, DOI 10.1016/j.taap.2007.09.013; Li HZ, 2009, MOL CANCER RES, V7, P832, DOI 10.1158/1541-7786.MCR-08-0403; Li JS, 2009, CLIN CANCER RES, V15, P3998, DOI 10.1158/1078-0432.CCR-08-3053; Lin XY, 2000, MOL CELL BIOL, V20, P7259, DOI 10.1128/MCB.20.19.7259-7272.2000; Lin XY, 1997, CANCER RES, V57, P2304; Liotta LA, 2004, NATURE, V430, P973, DOI 10.1038/430973a; Liu WW, 2010, CANCER BIOL THER, V9, P862, DOI 10.4161/cbt.9.11.11633; Liu YZ, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-105; Lowe SW, 2000, CARCINOGENESIS, V21, P485, DOI 10.1093/carcin/21.3.485; Mori Y, 2006, GASTROENTEROLOGY, V131, P797, DOI 10.1053/j.gastro.2006.06.006; Nauert JB, 1997, CURR BIOL, V7, P52, DOI 10.1016/S0960-9822(06)00027-3; Su B, 2006, CANCER RES, V66, P5599, DOI 10.1158/0008-5472.CAN-05-4123; Su B, 2010, J BIOL CHEM, V285, P4578, DOI 10.1074/jbc.M109.073494; Tessema M, 2008, CANCER RES, V68, P1707, DOI 10.1158/0008-5472.CAN-07-6325; Wallner M, 2006, CLIN CANCER RES, V12, P7347, DOI 10.1158/1078-0432.CCR-06-1264; Wang HY, 2006, EUR J CELL BIOL, V85, P643, DOI 10.1016/j.ejcb.2005.12.003; Weiser DC, 2007, GENE DEV, V21, P1559, DOI 10.1101/gad.1535007; Xia W, 2001, CANCER RES, V61, P5644; Yoon DK, 2007, CANCER LETT, V254, P111, DOI 10.1016/j.canlet.2007.02.017	28	24	24	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2011	6	8							e24015	10.1371/journal.pone.0024015	http://dx.doi.org/10.1371/journal.pone.0024015			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817MS	21918680	Green Published, Green Submitted, gold			2022-12-25	WOS:000294678300017
J	Wever, KE; Wagener, FADTG; Frielink, C; Boerman, OC; Scheffer, GJ; Allison, A; Masereeuw, R; Rongen, GA				Wever, Kimberley E.; Wagener, Frank A. D. T. G.; Frielink, Cathelijne; Boerman, Otto C.; Scheffer, Gert J.; Allison, Anthony; Masereeuw, Rosalinde; Rongen, Gerard A.			Diannexin Protects against Renal Ischemia Reperfusion Injury and Targets Phosphatidylserines in Ischemic Tissue	PLOS ONE			English	Article							ANNEXIN-V HOMODIMER; RISK-FACTORS; T-CELLS; IN-VIVO; A5; IDENTIFICATION; MECHANISMS; CLEARANCE; BIOMARKER; RECEPTOR	Renal ischemia/reperfusion injury (IRI) frequently complicates shock, renal transplantation and cardiac and aortic surgery, and has prognostic significance. The translocation of phosphatidylserines to cell surfaces is an important pro-inflammatory signal for cell-stress after IRI. We hypothesized that shielding of exposed phosphatidylserines by the annexin A5 (ANXA5) homodimer Diannexin protects against renal IRI. Protective effects of Diannexin on the kidney were studied in a mouse model of mild renal IRI. Diannexin treatment before renal IRI decreased proximal tubule damage and leukocyte influx, decreased transcription and expression of renal injury markers Neutrophil Gelatinase Associated Lipocalin and Kidney Injury Molecule-1 and improved renal function. A mouse model of ischemic hind limb exercise was used to assess Diannexin biodistribution and targeting. When comparing its biodistribution and elimination to ANXA5, Diannexin was found to have a distinct distribution pattern and longer blood half-life. Diannexin targeted specifically to the ischemic muscle and its affinity exceeded that of ANXA5. Targeting of both proteins was inhibited by pre-treatment with unlabeled ANXA5, suggesting that Diannexin targets specifically to ischemic tissues via phosphatidylserine-binding. This study emphasizes the importance of phosphatidylserine translocation in the pathophysiology of IRI. We show for the first time that Diannexin protects against renal IRI, making it a promising therapeutic tool to prevent IRI in a clinical setting. Our results indicate that Diannexin is a potential new imaging agent for the study of phosphatidylserine-exposing organs in vivo.	[Wever, Kimberley E.; Wagener, Frank A. D. T. G.; Masereeuw, Rosalinde; Rongen, Gerard A.] Radboud Univ Nijmegen, Med Ctr, Dept Pharmacol & Toxicol, Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands; [Wever, Kimberley E.; Wagener, Frank A. D. T. G.; Frielink, Cathelijne; Boerman, Otto C.; Scheffer, Gert J.; Allison, Anthony; Masereeuw, Rosalinde; Rongen, Gerard A.] Nijmegen Ctr Evidence Based Practice, Nijmegen, Netherlands; [Wagener, Frank A. D. T. G.] Radboud Univ Nijmegen, Med Ctr, Dept Orthodont & Oral Biol, Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands; [Frielink, Cathelijne; Boerman, Otto C.] Radboud Univ Nijmegen, Med Ctr, Dept Nucl Med, Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands; [Scheffer, Gert J.] Radboud Univ Nijmegen, Med Ctr, Dept Anaesthesiol, Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands; [Rongen, Gerard A.] Radboud Univ Nijmegen, Med Ctr, Dept Gen Internal Med, Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands; [Allison, Anthony] Alavita Pharmaceut Inc, Mountain View, CA USA	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Wever, KE (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Pharmacol & Toxicol, Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands.	g.rongen@pharmtox.umcn.nl	Rongen, Gerard/AAJ-9694-2021; Wever, Kimberley E./D-9705-2016; Masereeuw, Roos/N-3582-2014; Masereeuw, Roos/I-5276-2016; Boerman, Otto C/A-8112-2014; Wagener, Frank/O-6225-2014; Rongen, Gerard A/C-1578-2018; Scheffer, G.J./H-8086-2014	Wever, Kimberley E./0000-0003-3635-3660; Masereeuw, Roos/0000-0002-1560-1074; Boerman, Otto C/0000-0001-6832-101X; Wagener, Frank/0000-0003-4837-1559; 	Dutch Heart Foundation [2006T035]	Dutch Heart Foundation(Netherlands Heart Foundation)	This work was partially funded by the Dutch Heart Foundation (Established Clinical Investigator grant #2006T035 to Dr. GA Rongen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	ANDREE HAM, 1990, J BIOL CHEM, V265, P4923; Blankenberg F, 2002, CLIN CANCER RES, V8, P2757; Blankenberg FG, 1999, J NUCL MED, V40; Boersma HH, 2005, J NUCL MED, V46, P2035; Bonventre JV, 2008, SCAND J CLIN LAB INV, V68, P78, DOI 10.1080/00365510802145059; Bonventre JV, 2004, KIDNEY INT, V66, P480, DOI 10.1111/j.1523-1755.2004.761_2.x; Cheng EY, 2010, TRANSPLANTATION, V90, P709, DOI 10.1097/TP.0b013e3181ed55d8; Eisner C, 2010, KIDNEY INT, V77, P519, DOI 10.1038/ki.2009.501; Facio FN, 2011, J MOL MED, V89, P51, DOI 10.1007/s00109-010-0684-4; Granger DN, 1999, MICROCIRCULATION, V6, P167; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hofstra L, 2000, LANCET, V356, P209, DOI 10.1016/S0140-6736(00)02482-X; Huls M, 2006, KIDNEY INT, V69, P2186, DOI 10.1038/sj.ki.5000407; Ichimura T, 2008, J CLIN INVEST, V118, P1657, DOI 10.1172/JCI34487; Kellum JA, 2008, CRIT CARE MED, V36, pS141, DOI 10.1097/CCM.0b013e318168c4a4; Kemerink GJ, 2003, J NUCL MED, V44; Kenis H, 2004, J BIOL CHEM, V279, P52623, DOI 10.1074/jbc.M409009200; Kuypers FA, 2007, THROMB HAEMOSTASIS, V97, P478, DOI 10.1160/TH06-08-0436; Legrand M, 2008, MOL MED, V14, P502, DOI 10.2119/2008-00006.Legrand; Lentz BR, 2003, PROG LIPID RES, V42, P423, DOI 10.1016/S0163-7827(03)00025-0; MEERS P, 1991, BIOCHEMISTRY-US, V30, P2903, DOI 10.1021/bi00225a025; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; Mold C, 2001, IMMUNOLOGY, V102, P359, DOI 10.1046/j.1365-2567.2001.01192.x; Molski M, 2009, ANN PLAS SURG, V63, P564, DOI 10.1097/SAP.0b013e3181935a4e; Nigwekar SU, 2009, AM J KIDNEY DIS, V54, P413, DOI 10.1053/j.ajkd.2009.01.267; Ojo AO, 1997, TRANSPLANTATION, V63, P968, DOI 10.1097/00007890-199704150-00011; Oling F, 2001, J STRUCT BIOL, V133, P55, DOI 10.1006/jsbi.2000.4337; Qu JM, 1996, BIOCHEM J, V317, P343, DOI 10.1042/bj3170343; RAMCHANDRAN T, 1980, J NUCL MED, V21, P13; Rongen GA, 2005, CIRCULATION, V111, P173, DOI 10.1161/01.CIR.0000151612.02223.F2; Safian RD, 2001, NEW ENGL J MED, V344, P431, DOI 10.1056/NEJM200102083440607; Schrier RW, 2004, NEW ENGL J MED, V351, P159, DOI 10.1056/NEJMra032401; Shen XD, 2007, AM J TRANSPLANT, V7, P2463, DOI 10.1111/j.1600-6143.2007.01967.x; TAIT JF, 1992, ARCH BIOCHEM BIOPHYS, V298, P187, DOI 10.1016/0003-9861(92)90111-9; Teoh NC, 2007, GASTROENTEROLOGY, V133, P632, DOI 10.1053/j.gastro.2007.05.027; Thiagarajan P, 1997, CIRCULATION, V96, P2339; Wolf A, 2007, EMBO REP, V8, P465, DOI 10.1038/sj.embor.7400956; Ysebaert DK, 2004, KIDNEY INT, V66, P491, DOI 10.1111/j.1523-1755.2004.761_4.x; Zhang R, 2011, J NUCL MED, V52, P958, DOI 10.2967/jnumed.110.083220	39	32	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2011	6	8							e24276	10.1371/journal.pone.0024276	http://dx.doi.org/10.1371/journal.pone.0024276			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817MS	21918686	Green Submitted, Green Published, gold			2022-12-25	WOS:000294678300034
J	Wang, S; Chuang, HH				Wang, Shu; Chuang, Huai-hu			C-terminal Dimerization Activates the Nociceptive Transduction Channel Transient Receptor Potential Vanilloid 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRIMARY SENSORY NEURONS; CAPSAICIN RECEPTOR; GATING RING; TRPV1; CYSTEINE; MECHANISM; PHOSPHORYLATION; THERMOSENSATION; DESENSITIZATION; DETERMINANT	Covalent modification of the specific cysteine residue(s) by oxidative stress robustly potentiates transient receptor potential vanilloid 1 (TRPV1) and sensitizes nociception. Here we provide biochemical evidence of dimerization of TRPV1 subunits upon exposure to phenylarsine oxide and hydrogen peroxide (H2O2), two chemical surrogates of oxidative stress. A disulfide bond formed between apposing cysteines ligates two C termini, serving as the structural basis of channel sensitization by oxidative covalent C-terminal modification. Systematic cysteine scanning of the C terminus of a cysteineless TRPV1 channel revealed a critical region within which any cysteine introduced phenylarsine oxide activation to mutant TRPV1. Oxidative sensitization persisted even when this region is substituted with a random peptide linker containing a single cysteine. So did insertion of this region to TRPV3, a homolog lacking the corresponding region and resistant to oxidative challenge. These results suggest that the non-conserved linker in the TRPV1 C terminus senses environmental oxidative stress and adjusts channel activity during cumulative oxidative damage by lowering the activation threshold of gating elements shared by TRPV channels.	[Wang, Shu; Chuang, Huai-hu] Cornell Univ, Dept Biomed Sci, Ithaca, NY 14853 USA	Cornell University	Chuang, HH (corresponding author), Cornell Univ, Dept Biomed Sci, Ithaca, NY 14853 USA.	huai-hu.chuang@cornell.edu			American Heart Association	American Heart Association(American Heart Association)	This work is supported by a Scientist Developmental Grant from the American Heart Association (to H. C.).	Ahern GP, 2005, J NEUROSCI, V25, P5109, DOI 10.1523/JNEUROSCI.0237-05.2005; Bhave G, 2003, P NATL ACAD SCI USA, V100, P12480, DOI 10.1073/pnas.2032100100; Bhave G, 2002, NEURON, V35, P721, DOI 10.1016/S0896-6273(02)00802-4; Brauchi S, 2006, J NEUROSCI, V26, P4835, DOI 10.1523/JNEUROSCI.5080-05.2006; Brauchi S, 2007, P NATL ACAD SCI USA, V104, P10246, DOI 10.1073/pnas.0703420104; Chuang HH, 2009, P NATL ACAD SCI USA, V106, P20097, DOI 10.1073/pnas.0902675106; Craven KB, 2006, ANNU REV PHYSIOL, V68, P375, DOI 10.1146/annurev.physiol.68.040104.134728; Drain P, 1998, P NATL ACAD SCI USA, V95, P13953, DOI 10.1073/pnas.95.23.13953; Garcia-Sanz N, 2004, J NEUROSCI, V24, P5307, DOI 10.1523/JNEUROSCI.0202-04.2004; Hu HZ, 2004, J BIOL CHEM, V279, P35741, DOI 10.1074/jbc.M404164200; Ji RR, 2002, NEURON, V36, P57, DOI 10.1016/S0896-6273(02)00908-X; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Johnson JP, 2005, P NATL ACAD SCI USA, V102, P2742, DOI 10.1073/pnas.0408323102; Jordt SE, 2000, P NATL ACAD SCI USA, V97, P8134, DOI 10.1073/pnas.100129497; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Jung JY, 2004, J BIOL CHEM, V279, P7048, DOI 10.1074/jbc.M311448200; Keeble JE, 2009, PAIN, V141, P135, DOI 10.1016/j.pain.2008.10.025; Kolbe K, 2010, J PHYSIOL-LONDON, V588, P2999, DOI 10.1113/jphysiol.2010.192468; Kwak J, 2000, J NEUROSCI, V20, P8298, DOI 10.1523/JNEUROSCI.20-22-08298.2000; Lishko PV, 2007, NEURON, V54, P905, DOI 10.1016/j.neuron.2007.05.027; Liu BY, 2004, J PHYSIOL-LONDON, V560, P627, DOI 10.1113/jphysiol.2004.069054; Numazaki M, 2003, P NATL ACAD SCI USA, V100, P8002, DOI 10.1073/pnas.1337252100; Premkumar LS, 2000, NATURE, V408, P985, DOI 10.1038/35050121; Prescott ED, 2003, SCIENCE, V300, P1284, DOI 10.1126/science.1083646; Rosenbaum T, 2004, J GEN PHYSIOL, V123, P53, DOI 10.1085/jgp.200308906; Salazar H, 2008, NAT NEUROSCI, V11, P255, DOI 10.1038/nn2056; Takano M, 1998, J PHYSIOL-LONDON, V512, P395, DOI 10.1111/j.1469-7793.1998.395be.x; Taraska JW, 2007, NAT STRUCT MOL BIOL, V14, P854, DOI 10.1038/nsmb1281; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Tominaga M, 2001, P NATL ACAD SCI USA, V98, P6951, DOI 10.1073/pnas.111025298; Tucker SJ, 1997, NATURE, V387, P179, DOI 10.1038/387179a0; Ufret-Vincenty CA, 2011, J BIOL CHEM, V286, P9688, DOI 10.1074/jbc.M110.192526; Vlachova V, 2003, J NEUROSCI, V23, P1340, DOI 10.1523/JNEUROSCI.23-04-01340.2003; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Wang S, 2010, J BIOL CHEM, V285, P11547, DOI 10.1074/jbc.M109.058727; Xue Q, 2007, J NEUROCHEM, V101, P212, DOI 10.1111/j.1471-4159.2006.04363.x; Ye S, 2006, CELL, V126, P1161, DOI 10.1016/j.cell.2006.08.029; Yoshida T, 2006, NAT CHEM BIOL, V2, P596, DOI 10.1038/nchembio821; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zhang N, 2005, P NATL ACAD SCI USA, V102, P4536, DOI 10.1073/pnas.0406030102; Zhang XM, 2005, EMBO J, V24, P4211, DOI 10.1038/sj.emboj.7600893; Zhuang ZY, 2004, J NEUROSCI, V24, P8300, DOI 10.1523/JNEUROSCI.2893-04.2004; Zygmunt PM, 1999, NATURE, V400, P452, DOI 10.1038/22761	43	24	24	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40601	40607		10.1074/jbc.M111.256669	http://dx.doi.org/10.1074/jbc.M111.256669			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21926175	hybrid, Green Published			2022-12-25	WOS:000297315400020
J	Vaubel, RA; Rustin, P; Isaya, G				Vaubel, Rachael A.; Rustin, Pierre; Isaya, Grazia			Mutations in the Dimer Interface of Dihydrolipoamide Dehydrogenase Promote Site-specific Oxidative Damages in Yeast and Human Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-KETOGLUTARATE DEHYDROGENASE; MITOCHONDRIAL IRON HOMEOSTASIS; DISEASE-CAUSING MUTATIONS; LIPOAMIDE DEHYDROGENASE; SACCHAROMYCES-CEREVISIAE; LIPOIC ACID; PYRUVATE-DEHYDROGENASE; SELECTIVE INACTIVATION; MOONLIGHTING PROTEINS; PROTEOLYTIC ACTIVITY	Dihydrolipoamide dehydrogenase (DLD) is a multifunctional protein well characterized as the E3 component of the pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase complexes. Previously, conditions predicted to destabilize the DLD dimer revealed that DLD could also function as a diaphorase and serine protease. However, the relevance of these cryptic activities remained undefined. We analyzed human DLD mutations linked to strikingly different clinical phenotypes, including E340K, D444V, R447G, and R460G in the dimer interface domain that are responsible for severe multisystem disorders of infancy and G194C in the NAD(+)-binding domain that is typically associated with milder presentations. In vitro, all of these mutations decreased to various degrees dihydrolipoamide dehydrogenase activity, whereas dimer interface mutations also enhanced proteolytic and/or diaphorase activity. Human DLD proteins carrying each individual mutation complemented fully the respiratory-deficient phenotype of yeast cells lacking endogenous DLD even when residual dihydrolipoamide dehydrogenase activity was as low as 21% of controls. However, under elevated oxidative stress, expression of DLD proteins with dimer interface mutations greatly accelerated the loss of respiratory function, resulting from enhanced oxidative damage to the lipoic acid cofactor of pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase and other mitochondrial targets. This effect was not observed with the G194C mutation or a mutation that disrupts the proteolytic active site of DLD. As in yeast, lipoic acid cofactor was damaged in human D444V-homozygous fibroblasts after exposure to oxidative stress. We conclude that the cryptic activities of DLD promote oxidative damage to neighboring molecules and thus contribute to the clinical severity of DLD mutations.	[Vaubel, Rachael A.; Isaya, Grazia] Mayo Clin, Dept Pediat, Rochester, MN 55905 USA; [Vaubel, Rachael A.; Isaya, Grazia] Mayo Clin, Dept Adolescent Med, Rochester, MN 55905 USA; [Vaubel, Rachael A.; Isaya, Grazia] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Rustin, Pierre] Hop Robert Debre, INSERM, U676, F-75019 Paris, France; [Rustin, Pierre] Univ Paris 07, Fac Med Denis Diderot, IFR02, Paris, France	Mayo Clinic; Mayo Clinic; Mayo Clinic; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Isaya, G (corresponding author), Mayo Clin, Dept Pediat, 200 1st St SW,Stabile 7-52, Rochester, MN 55905 USA.	isaya@mayo.edu			National Institutes of Health from NIA [AG15709]; National Institutes of Health from NHLBI [F30 HL099036]; National Institutes of Health from NIGMS [T32 GM 65841]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F30HL099036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM065841] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015709] Funding Source: NIH RePORTER	National Institutes of Health from NIA; National Institutes of Health from NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG15709 from NIA (to G. I.), Grant F30 HL099036 from NHLBI (to R. A. V.), and Grant T32 GM 65841 from NIGMS. A technology used in this study, "Recombinant Mature Form of Human Frataxin Protein," has been licensed to a commercial entity. Mayo Clinic, but not the investigators, has received royalties from the licensing of this technology.	Ambrus A, 2011, HUM MOL GENET, V20, P2984, DOI 10.1093/hmg/ddr202; Ambrus A, 2009, J NEUROCHEM, V109, P222, DOI 10.1111/j.1471-4159.2009.05942.x; Applegate MAB, 2008, BIOCHEMISTRY-US, V47, P473, DOI 10.1021/bi7017464; Argyrou A, 2003, BIOCHEMISTRY-US, V42, P2218, DOI 10.1021/bi020654f; Babady NE, 2007, P NATL ACAD SCI USA, V104, P6158, DOI 10.1073/pnas.0610618104; Branda SS, 1999, HUM MOL GENET, V8, P1099, DOI 10.1093/hmg/8.6.1099; Brautigam CA, 2006, STRUCTURE, V14, P611, DOI 10.1016/j.str.2006.01.001; Brautigam CA, 2005, J MOL BIOL, V350, P543, DOI 10.1016/j.jmb.2005.05.014; Bulteau AL, 2005, P NATL ACAD SCI USA, V102, P5987, DOI 10.1073/pnas.0501519102; Cabiscol E, 2000, J BIOL CHEM, V275, P27393; Cameron JM, 2006, AM J MED GENET A, V140A, P1542, DOI 10.1002/ajmg.a.31313; Cavadini P, 2000, HUM MOL GENET, V9, P2523, DOI 10.1093/hmg/9.17.2523; Chen XJ, 2007, P NATL ACAD SCI USA, V104, P13738, DOI 10.1073/pnas.0703078104; Chuang D.T., 2001, METABOLIC MOL BASES, P1971; DAUM G, 1982, J BIOL CHEM, V257, P3028; Gakh O, 2006, HUM MOL GENET, V15, P467, DOI 10.1093/hmg/ddi461; Gakh O, 2008, J BIOL CHEM, V283, P31500, DOI 10.1074/jbc.M805415200; Gakh O, 2010, J BIOL CHEM, V285, P38486, DOI 10.1074/jbc.M110.145144; Gazaryan IG, 2002, J BIOL CHEM, V277, P10064, DOI 10.1074/jbc.M108264200; Herman PK, 2002, CURR OPIN MICROBIOL, V5, P602, DOI 10.1016/S1369-5274(02)00377-6; Hong YS, 2003, J INHERIT METAB DIS, V26, P816, DOI 10.1023/B:BOLI.0000010004.12053.5b; Hong YS, 1997, BBA-MOL BASIS DIS, V1362, P160, DOI 10.1016/S0925-4439(97)00073-2; Hong YS, 1996, HUM MOL GENET, V5, P1925, DOI 10.1093/hmg/5.12.1925; Huberts DHEW, 2010, BBA-MOL CELL RES, V1803, P520, DOI 10.1016/j.bbamcr.2010.01.022; Humphries KM, 1998, BIOCHEMISTRY-US, V37, P15835, DOI 10.1021/bi981512h; Igamberdiev AU, 2004, FEBS LETT, V568, P146, DOI 10.1016/j.febslet.2004.05.024; Jeffery CJ, 2009, MOL BIOSYST, V5, P345, DOI 10.1039/b900658n; Jiang YF, 2005, J BIOL CHEM, V280, P2244, DOI 10.1074/jbc.M408612200; KAEBERLEIN M, 2001, SCI AGING KNOWLEDGE, pPE1; Kareyeva AV, 2011, FEBS LETT, V585, P385, DOI 10.1016/j.febslet.2010.12.019; Kaufman BA, 2000, P NATL ACAD SCI USA, V97, P7772, DOI 10.1073/pnas.140063197; Kim G, 2002, MUTAGENESIS, V17, P375, DOI 10.1093/mutage/17.5.375; KIM H, 1992, J BIOL CHEM, V267, P5128; Klyachko NL, 2005, J BIOL CHEM, V280, P16106, DOI 10.1074/jbc.M414285200; Lanterman MM, 1996, HUM MOL GENET, V5, P1643, DOI 10.1093/hmg/5.10.1643; MASSEY V, 1961, BIOCHIM BIOPHYS ACTA, V48, P33, DOI 10.1016/0006-3002(61)90512-1; McLain AL, 2011, FREE RADICAL RES, V45, P29, DOI 10.3109/10715762.2010.534163; MISAKA E, 1965, J BIOCHEM, V58, P436, DOI 10.1093/oxfordjournals.jbchem.a128223; Odievre MH, 2005, HUM MUTAT, V25, DOI 10.1002/humu.9319; Parrella E, 2008, METHODS, V46, P256, DOI 10.1016/j.ymeth.2008.10.004; Petrat F, 2003, J BIOL CHEM, V278, P46403, DOI 10.1074/jbc.M305291200; Quintana E., 2011, J INHERIT M IN PRESS; Reed LJ, 2001, J BIOL CHEM, V276, P38329, DOI 10.1074/jbc.R100026200; RINALDO P, 2005, TIETZ TXB CLIN CHEM, P2207; ROBINSON BH, 1992, BIOCHEM MED METAB B, V48, P122, DOI 10.1016/0885-4505(92)90056-5; Robinson BH, 2001, METABOLIC MOL BASES, P2275; Sadek HA, 2002, ARCH BIOCHEM BIOPHYS, V406, P222, DOI 10.1016/S0003-9861(02)00446-0; Schmucker S, 2008, HUM MOL GENET, V17, P3521, DOI 10.1093/hmg/ddn244; Schonauer MS, 2009, J BIOL CHEM, V284, P23234, DOI 10.1074/jbc.M109.015594; Shaag A, 1999, AM J MED GENET, V82, P177, DOI 10.1002/(SICI)1096-8628(19990115)82:2<177::AID-AJMG15>3.3.CO;2-0; Shany E, 1999, BIOCHEM BIOPH RES CO, V262, P163, DOI 10.1006/bbrc.1999.1133; SIKORSKI RS, 1989, GENETICS, V122, P19; SRERE PA, 1967, SCIENCE, V158, P936, DOI 10.1126/science.158.3803.936; Sriram G, 2005, AM J HUM GENET, V76, P911, DOI 10.1086/430799; Starkov AA, 2004, J NEUROSCI, V24, P7779, DOI 10.1523/JNEUROSCI.1899-04.2004; Tahara EB, 2007, FASEB J, V21, P274, DOI 10.1096/fj.06-6686com; Taylor NL, 2002, J BIOL CHEM, V277, P42663, DOI 10.1074/jbc.M204761200; Tretter L, 2005, PHILOS T R SOC B, V360, P2335, DOI 10.1098/rstb.2005.1764; Tretter L, 2004, J NEUROSCI, V24, P7771, DOI 10.1523/JNEUROSCI.1842-04.2004; TSAI CS, 1981, ARCH BIOCHEM BIOPHYS, V206, P77, DOI 10.1016/0003-9861(81)90068-0; Xia L, 2001, EUR J BIOCHEM, V268, P1486, DOI 10.1046/j.1432-1327.2001.02013.x; Youn H, 2000, FEBS LETT, V472, P57, DOI 10.1016/S0014-5793(00)01437-X; Zundorf G, 2009, NEUROSCIENCE, V158, P610, DOI 10.1016/j.neuroscience.2008.10.015	63	28	29	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40232	40245		10.1074/jbc.M111.274415	http://dx.doi.org/10.1074/jbc.M111.274415			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21930696	Green Published, hybrid			2022-12-25	WOS:000296925700055
J	Ye, F; Lemieux, H; Hoppel, CL; Hanson, RW; Hakimi, P; Croniger, CM; Puchowicz, M; Anderson, VE; Fujioka, H; Stavnezer, E				Ye, Fang; Lemieux, Helene; Hoppel, Charles L.; Hanson, Richard W.; Hakimi, Parvin; Croniger, Colleen M.; Puchowicz, Michelle; Anderson, Vernon E.; Fujioka, Hisashi; Stavnezer, Ed			Peroxisome Proliferator-activated Receptor gamma (PPAR gamma) Mediates a Ski Oncogene-induced Shift from Glycolysis to Oxidative Energy Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONTROLLING MITOCHONDRIAL BIOGENESIS; SKELETAL-MUSCLE; ADIPOSE-TISSUE; ALAMAR BLUE; TUMOR-GROWTH; DNA-BINDING; IN-VIVO; CELLS; DIFFERENTIATION; REPRESSION	Overexpression of the Ski oncogene induces oncogenic transformation of chicken embryo fibroblasts (CEFs). However, unlike most other oncogene-transformed cells, Ski-transformed CEFs (Ski-CEFs) do not display the classical Warburg effect. On the contrary, Ski transformation reduced lactate production and glucose utilization in CEFs. Compared with CEFs, Ski-CEFs exhibited enhanced TCA cycle activity, fatty acid catabolism through beta-oxidation, glutamate oxidation, oxygen consumption, as well as increased numbers and mass of mitochondria. Interestingly, expression of PPAR gamma, a key transcription factor that regulates adipogenesis and lipid metabolism, was dramatically elevated at both the mRNA and protein levels in Ski-CEFs. Accordingly, PPAR gamma target genes that are involved in lipid uptake, transport, and oxidation were also markedly up-regulated by Ski. Knocking down PPAR gamma in Ski-CEFs by RNA interference reversed the elevated expression of these PPAR gamma target genes, as well as the shift to oxidative metabolism and the increased mitochondrial biogenesis. Moreover, we found that Ski co-immunoprecipitates with PPAR gamma and co-activates PPAR gamma-driven transcription.	[Ye, Fang; Hanson, Richard W.; Hakimi, Parvin; Anderson, Vernon E.; Stavnezer, Ed] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA; [Hoppel, Charles L.] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Lemieux, Helene; Hoppel, Charles L.; Fujioka, Hisashi] Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44106 USA; [Croniger, Colleen M.; Puchowicz, Michelle] Case Western Reserve Univ, Sch Med, Dept Nutr, Cleveland, OH 44106 USA; [Hoppel, Charles L.] Case Western Reserve Univ, Sch Med, Ctr Mitochondrial Dis, Cleveland, OH 44106 USA; [Croniger, Colleen M.; Puchowicz, Michelle] Case Western Reserve Univ, Sch Med, Mouse Metab Phenotyping Ctr, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Stavnezer, E (corresponding author), Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA.	ed.stavnezer@case.edu	Hakimi, Parvin/AAB-1643-2021	Anderson, Vernon Emmett/0000-0002-1699-7621	National Institutes of Health from NCI [U54CA116867]; National Sciences and Engineering Research Council of Canada;  [U24 DK76169];  [DK58620]; NATIONAL CANCER INSTITUTE [U54CA116867] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058620, U24DK076169] Funding Source: NIH RePORTER	National Institutes of Health from NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant U54CA116867 (TREC grant) from NCI (to E. S.), Grant U24 DK76169 (to C. M. C.), and DK58620 (to R. W. H.). This work was also supported by the National Sciences and Engineering Research Council of Canada (to H. L.).	Al-Nasiry S, 2007, HUM REPROD, V22, P1304, DOI 10.1093/humrep/dem011; Bederman IR, 2009, J BIOL CHEM, V284, P6101, DOI 10.1074/jbc.M808668200; Berk M, 1997, GENE DEV, V11, P2029, DOI 10.1101/gad.11.16.2029; Bogacka I, 2005, DIABETES, V54, P1392, DOI 10.2337/diabetes.54.5.1392; Calvo JA, 2008, J APPL PHYSIOL, V104, P1304, DOI 10.1152/japplphysiol.01231.2007; CARROLL RC, 1978, P NATL ACAD SCI USA, V75, P5015, DOI 10.1073/pnas.75.10.5015; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Chen DH, 2009, PIGM CELL MELANOMA R, V22, P761, DOI 10.1111/j.1755-148X.2009.00603.x; COLMENARES C, 1989, CELL, V59, P293, DOI 10.1016/0092-8674(89)90291-2; Dahl R, 1998, P NATL ACAD SCI USA, V95, P11187, DOI 10.1073/pnas.95.19.11187; DEFRIES R, 1995, J CLIN LAB ANAL, V9, P89, DOI 10.1002/jcla.1860090203; Diraison F, 1997, J MASS SPECTROM, V32, P81, DOI 10.1002/(SICI)1096-9888(199701)32:1<81::AID-JMS454>3.0.CO;2-2; EVANS PR, 1981, PHILOS T ROY SOC B, V293, P53, DOI 10.1098/rstb.1981.0059; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Fugier C, 2006, J BIOL CHEM, V281, P11553, DOI 10.1074/jbc.M512554200; Gnaiger E., 2000, MITOCHONDRIA COLD, P431; Gnaiger E, 2007, MITOCHONDRIAL PATHWA; Gonzalez RJ, 2001, TOXICOL IN VITRO, V15, P257, DOI 10.1016/S0887-2333(01)00014-5; Guitart M, 2009, MITOCHONDRION, V9, P266, DOI 10.1016/j.mito.2009.03.007; Gutmann I, 1974, METHOD ENZYMAT AN, P1464; He J, 2003, J BIOL CHEM, V278, P30540, DOI 10.1074/jbc.M304016200; Heider TR, 2007, ANN SURG, V246, P61, DOI 10.1097/SLA.0b013e318070cafa; Holloway GP, 2007, AM J PHYSIOL-ENDOC M, V292, pE1782, DOI 10.1152/ajpendo.00639.2006; Hoppel CL, 1998, J BIOL CHEM, V273, P23495, DOI 10.1074/jbc.273.36.23495; JOMAIN M, 1969, J LIPID RES, V10, P674; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Lana DP, 1996, DEV DYNAM, V205, P13, DOI 10.1002/(SICI)1097-0177(199601)205:1<13::AID-AJA2>3.0.CO;2-8; LEE WNP, 1994, AM J PHYSIOL, V266, pE372, DOI 10.1152/ajpendo.1994.266.3.E372; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Leonardi R, 2005, PROG LIPID RES, V44, P125, DOI 10.1016/j.plipres.2005.04.001; Leong GM, 2010, INT J OBESITY, V34, P524, DOI 10.1038/ijo.2009.265; LEVINTOW L, 1961, ANNU REV BIOCHEM, V30, P605, DOI 10.1146/annurev.bi.30.070161.003133; LI Y, 1986, J VIROL, V57, P1065, DOI 10.1128/JVI.57.3.1065-1072.1986; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Liu XD, 2001, CYTOKINE GROWTH F R, V12, P1, DOI 10.1016/S1359-6101(00)00031-9; NAGASE T, 1990, NUCLEIC ACIDS RES, V18, P337, DOI 10.1093/nar/18.2.337; Nicol R, 1999, CELL GROWTH DIFFER, V10, P243; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Perera RJ, 2006, GENE, V369, P90, DOI 10.1016/j.gene.2005.10.021; Presley AD, 2003, J CHROMATOGR B, V793, P141, DOI 10.1016/S1570-0232(03)00371-4; Ritter M, 2006, LEUKEMIA, V20, P437, DOI 10.1038/sj.leu.2404093; Roche TE, 2007, CELL MOL LIFE SCI, V64, P830, DOI 10.1007/s00018-007-6380-z; SATOH M, 1991, EXP CELL RES, V196, P137, DOI 10.1016/0014-4827(91)90467-9; Savage David B., 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405008793; Sebastian D, 2009, J LIPID RES, V50, P1789, DOI 10.1194/jlr.M800535-JLR200; Shaw RJ, 2006, CURR OPIN CELL BIOL, V18, P598, DOI 10.1016/j.ceb.2006.10.005; Stavnezer E., 1988, ONCOGENE HDB, P393; SUTRAVE P, 1990, GENE DEV, V4, P1462, DOI 10.1101/gad.4.9.1462; Sutrave P, 2000, GENE, V241, P107, DOI 10.1016/S0378-1119(99)00461-8; Takahata M, 2009, J BIOL CHEM, V284, P3334, DOI 10.1074/jbc.M808989200; Ueki N, 2008, ONCOGENE, V27, P300, DOI 10.1038/sj.onc.1210654; Ueki N, 2004, MOL CELL BIOL, V24, P10118, DOI 10.1128/MCB.24.23.10118-10125.2004; Walczak R, 2002, J LIPID RES, V43, P177; Wang XL, 2008, AM J PATHOL, V173, P470, DOI 10.2353/ajpath.2008.071208; Warburg O, 1924, BIOCHEM Z, V152, P319; Way JM, 2001, ENDOCRINOLOGY, V142, P1269, DOI 10.1210/en.142.3.1269; Wilson-Fritch L, 2004, J CLIN INVEST, V114, P1281, DOI 10.1172/JCI200421752; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yoon JC, 2010, GENE DEV, V24, P1507, DOI 10.1101/gad.1924910; Zaripheh S, 2006, J NUTR, V136, P932, DOI 10.1093/jn/136.4.932; Zhang H., 2009, THESIS CASE W RESERV, P87; Zhang H, 2009, J BIOL CHEM, V284, P2867, DOI 10.1074/jbc.M807526200; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001; Zheng GX, 1997, ONCOGENE, V15, P459, DOI 10.1038/sj.onc.1201205	65	10	10	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40013	40024		10.1074/jbc.M111.292029	http://dx.doi.org/10.1074/jbc.M111.292029			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21917928	Green Published, hybrid			2022-12-25	WOS:000296925700034
J	Simmons, GS; McKemey, AR; Morrison, NI; O'Connell, S; Tabashnik, BE; Claus, J; Fu, GL; Tang, GL; Sledge, M; Walker, AS; Phillips, CE; Miller, ED; Rose, RI; Staten, RT; Donnelly, CA; Alphey, L				Simmons, Gregory S.; McKemey, Andrew R.; Morrison, Neil I.; O'Connell, Sinead; Tabashnik, Bruce E.; Claus, John; Fu, Guoliang; Tang, Guolei; Sledge, Mickey; Walker, Adam S.; Phillips, Caroline E.; Miller, Ernie D.; Rose, Robert I.; Staten, Robert T.; Donnelly, Christl A.; Alphey, Luke			Field Performance of a Genetically Engineered Strain of Pink Bollworm	PLOS ONE			English	Article							SEXING STRAINS; FITNESS; LEPIDOPTERA; DOMINANT; SYSTEMS	Pest insects harm crops, livestock and human health, either directly or by acting as vectors of disease. The Sterile Insect Technique (SIT) - mass-release of sterile insects to mate with, and thereby control, their wild counterparts - has been used successfully for decades to control several pest species, including pink bollworm, a lepidopteran pest of cotton. Although it has been suggested that genetic engineering of pest insects provides potential improvements, there is uncertainty regarding its impact on their field performance. Discrimination between released and wild moths caught in monitoring traps is essential for estimating wild population levels. To address concerns about the reliability of current marking methods, we developed a genetically engineered strain of pink bollworm with a heritable fluorescent marker, to improve discrimination of sterile from wild moths. Here, we report the results of field trials showing that this engineered strain performed well under field conditions. Our data show that attributes critical to SIT in the field - ability to find a mate and to initiate copulation, as well as dispersal and persistence in the release area - were comparable between the genetically engineered strain and a standard strain. To our knowledge, these represent the first open-field experiments with a genetically engineered insect. The results described here provide encouragement for the genetic control of insect pests.	[Simmons, Gregory S.; Claus, John; Tang, Guolei; Sledge, Mickey; Miller, Ernie D.; Staten, Robert T.] Anim Plant Hlth & Inspect Serv, Ctr Plant Hlth Sci, USDA, Phoenix, AZ USA; [Simmons, Gregory S.; Claus, John; Tang, Guolei; Sledge, Mickey; Miller, Ernie D.; Staten, Robert T.] Anim Plant Hlth & Inspect Serv, Ctr Technol, USDA, Phoenix, AZ USA; [Simmons, Gregory S.] Anim Plant Hlth & Inspect Serv, Ctr Plant Hlth Sci, USDA, Moss Landing, CA USA; [Simmons, Gregory S.] Anim Plant Hlth & Inspect Serv, Ctr Technol, USDA, Moss Landing, CA USA; [McKemey, Andrew R.; Morrison, Neil I.; O'Connell, Sinead; Fu, Guoliang; Walker, Adam S.; Phillips, Caroline E.; Alphey, Luke] Oxitec Ltd, Oxford, England; [Tabashnik, Bruce E.] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA; [Donnelly, Christl A.] Univ London Imperial Coll Sci Technol & Med, Med Res Council Ctr Outbreak Anal & Modelling, Dept Infect Dis Epidemiol, Fac Med, London, England; [Alphey, Luke] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); University of Arizona; Imperial College London; University of Oxford	Simmons, GS (corresponding author), Anim Plant Hlth & Inspect Serv, Ctr Plant Hlth Sci, USDA, Phoenix, AZ USA.	gregory.s.simmons@aphis.usda.gov	Tang, Guolei/H-7070-2017	Tang, Guolei/0000-0003-4565-0800; Alphey, Luke/0000-0002-2916-3802; Donnelly, Christl/0000-0002-0195-2463	United States Department of Agriculture; Oxitec Ltd.; Medical Research Council Centre for Outbreak Analysis and Modelling, Department of Infectious Disease Epidemiology, Faculty of Medicine, Imperial College London; Medical Research Council [G0600719B] Funding Source: researchfish	United States Department of Agriculture(United States Department of Agriculture (USDA)); Oxitec Ltd.; Medical Research Council Centre for Outbreak Analysis and Modelling, Department of Infectious Disease Epidemiology, Faculty of Medicine, Imperial College London; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	No external funder had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was funded by internal funds of the agencies conducting the work (United States Department of Agriculture and Oxitec Ltd.). Oxitec Ltd. provided salary and other support for the research program of those authors employed by the company. CD acknowledges the Medical Research Council Centre for Outbreak Analysis and Modelling, Department of Infectious Disease Epidemiology, Faculty of Medicine, Imperial College London for funding support.	Alphey L, 2002, SCIENCE, V298, P119, DOI 10.1126/science.1078278; Alphey L, 2008, ADV EXP MED BIOL, V627, P93, DOI 10.1007/978-0-387-78225-6_8; ANTILLA L, 2008, BELTW COTT C NASHV T; Buonaccorsi JP, 2003, J MED ENTOMOL, V40, P6, DOI 10.1603/0022-2585-40.1.6; Caceres C, 2002, GENETICA, V116, P107, DOI 10.1023/A:1020967810703; Carpenter JE, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P115, DOI 10.1007/1-4020-4051-2_5; Catteruccia F, 2003, SCIENCE, V299, P1225, DOI 10.1126/science.1081453; DYCK VA, STERILE INSECT TECHN, P801; Fu GL, 2007, NAT BIOTECHNOL, V25, P353, DOI 10.1038/nbt1283; Gong P, 2005, NAT BIOTECHNOL, V23, P453, DOI 10.1038/nbt1071; GRAHAM HM, 1971, J ECON ENTOMOL, V64, P376, DOI 10.1093/jee/64.2.376; Hagler JR, 2002, ENTOMOL EXP APPL, V103, P1, DOI 10.1023/A:1019803106330; Henneberry T. J., 1998, Integrated Pest Management Reviews, V3, P31, DOI 10.1023/A:1009673622862; Hight SD, 2005, ENVIRON ENTOMOL, V34, P850, DOI 10.1603/0046-225X-34.4.850; Irvin N, 2004, P NATL ACAD SCI USA, V101, P891, DOI 10.1073/pnas.0305511101; James AA, 2000, INSECT TRANSGENESIS, P319, DOI 10.1201/9781420039399.ch18; KEAVENY D, COMMUNICATION; KNIPLING EF, 1955, J ECON ENTOMOL, V48, P459, DOI 10.1093/jee/48.4.459; LaChance LE, 1985, GENETIC METHODS CONT; LILLIE TH, 1981, CAN ENTOMOL, V113, P419, DOI 10.4039/Ent113419-5; Lukyanov KA, 2000, J BIOL CHEM, V275, P25879, DOI 10.1074/jbc.C000338200; Marec F, 2005, J ECON ENTOMOL, V98, P248, DOI 10.1603/0022-0493-98.2.248; Marrelli MT, 2007, P NATL ACAD SCI USA, V104, P5580, DOI 10.1073/pnas.0609809104; Marrelli MT, 2006, TRENDS PARASITOL, V22, P197, DOI 10.1016/j.pt.2006.03.004; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; MORRIS CD, 1991, J AM MOSQUITO CONTR, V7, P608; Olson KE, 2006, WAG UR FRON, V11, P77, DOI 10.1007/1-4020-3799-6_7; Peloquin JJ, 2000, INSECT MOL BIOL, V9, P323, DOI 10.1046/j.1365-2583.2000.00194.x; Phuc HK, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-11; Simmons G. S., 2007, P119, DOI 10.1007/978-1-4020-6059-5_10; Sinkins SP, 2006, NAT REV GENET, V7, P427, DOI 10.1038/nrg1870; Stewart F.D., 1984, P176; TABASHNIK BE, 1980, OECOLOGIA, V47, P175, DOI 10.1007/BF00346817; Tabashnik BE, 2010, NAT BIOTECHNOL, V28, P1304, DOI 10.1038/nbt.1704; Thomas DD, 2000, SCIENCE, V287, P2474, DOI 10.1126/science.287.5462.2474; Wu HH, 2006, ENVIRON ENTOMOL, V35, P887, DOI 10.1603/0046-225X-35.4.887	36	47	55	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2011	6	9							e24110	10.1371/journal.pone.0024110	http://dx.doi.org/10.1371/journal.pone.0024110			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZV	21931649	Green Published, gold, Green Submitted			2022-12-25	WOS:000295321800017
J	Jarhult, JD; Muradrasoli, S; Wahlgren, J; Soderstrom, H; Orozovic, G; Gunnarsson, G; Brojer, C; Latorre-Margalef, N; Fick, J; Grabic, R; Lennerstrand, J; Waldenstrom, J; Lundkvist, A; Olsen, B				Jarhult, Josef D.; Muradrasoli, Shaman; Wahlgren, John; Soderstrom, Hanna; Orozovic, Goran; Gunnarsson, Gunnar; Brojer, Caroline; Latorre-Margalef, Neus; Fick, Jerker; Grabic, Roman; Lennerstrand, Johan; Waldenstrom, Jonas; Lundkvist, Ake; Olsen, Bjorn			Environmental Levels of the Antiviral Oseltamivir Induce Development of Resistance Mutation H274Y in Influenza A/H1N1 Virus in Mallards	PLOS ONE			English	Article							A VIRUS; NEURAMINIDASE; EMERGENCE	Oseltamivir (Tamiflu (R)) is the most widely used drug against influenza infections and is extensively stockpiled worldwide as part of pandemic preparedness plans. However, resistance is a growing problem and in 2008-2009, seasonal human influenza A/H1N1 virus strains in most parts of the world carried the mutation H274Y in the neuraminidase gene which causes resistance to the drug. The active metabolite of oseltamivir, oseltamivir carboxylate (OC), is poorly degraded in sewage treatment plants and surface water and has been detected in aquatic environments where the natural influenza reservoir, dabbling ducks, can be exposed to the substance. To assess if resistance can develop under these circumstances, we infected mallards with influenza A/H1N1 virus and exposed the birds to 80 ng/L, 1 mu g/L and 80 mu g/L of OC through their sole water source. By sequencing the neuraminidase gene from fecal samples, we found that H274Y occurred at 1 mu g/L of OC and rapidly dominated the viral population at 80 mu g/L. IC50 for OC was increased from 2-4 nM in wild-type viruses to 400-700 nM in H274Y mutants as measured by a neuraminidase inhibition assay. This is consistent with the decrease in sensitivity to OC that has been noted among human clinical isolates carrying H274Y. Environmental OC levels have been measured to 58-293 ng/L during seasonal outbreaks and are expected to reach mu g/L-levels during pandemics. Thus, resistance could be induced in influenza viruses circulating among wild ducks. As influenza viruses can cross species barriers, oseltamivir resistance could spread to human-adapted strains with pandemic potential disabling oseltamivir, a cornerstone in pandemic preparedness planning. We propose surveillance in wild birds as a measure to understand the resistance situation in nature and to monitor it over time. Strategies to lower environmental levels of OC include improved sewage treatment and, more importantly, a prudent use of antivirals.	[Jarhult, Josef D.; Olsen, Bjorn] Uppsala Univ, Dept Med Sci, Infect Dis Sect, Uppsala, Sweden; [Muradrasoli, Shaman] Swedish Univ Agr Sci, Dept Biomed Sci & Vet Publ Hlth, Sect Bacteriol & Food Safety, Uppsala, Sweden; [Wahlgren, John; Lundkvist, Ake] Karolinska Inst, Microbiol & Tumor Biol Ctr, Stockholm, Sweden; [Wahlgren, John; Lundkvist, Ake] Swedish Inst Infect Dis Control, Stockholm, Sweden; [Soderstrom, Hanna; Fick, Jerker; Grabic, Roman] Umea Univ, Dept Chem, Umea, Sweden; [Orozovic, Goran; Gunnarsson, Gunnar; Latorre-Margalef, Neus; Waldenstrom, Jonas; Olsen, Bjorn] Linnaeus Univ, Sch Nat Sci, Sect Zoonot Ecol & Epidemiol, Kalmar, Sweden; [Gunnarsson, Gunnar] Kristianstad Univ, Aquat Biol & Chem Grp, Kristianstad, Sweden; [Brojer, Caroline] Natl Vet Inst, S-75007 Uppsala, Sweden; [Brojer, Caroline] Swedish Univ Agr Sci, Sect Pathol Pharmacol & Toxicol, Dept Biomed Sci & Vet Publ Hlth, Uppsala, Sweden; [Grabic, Roman] Univ S Bohemia Ceske Budejovice, Fac Fisheries & Protect Waters, Res Inst Fish Culture & Hydrobiol, Vodnany, Czech Republic; [Lennerstrand, Johan] Uppsala Univ, Dept Med Sci, Sect Clin Virol, Uppsala, Sweden	Uppsala University; Swedish University of Agricultural Sciences; Karolinska Institutet; Swedish Institute for Infectious Disease Control; Umea University; Linnaeus University; Kristianstad University; National Veterinary Institute SVA; Swedish University of Agricultural Sciences; University of South Bohemia Ceske Budejovice; Uppsala University	Jarhult, JD (corresponding author), Uppsala Univ, Dept Med Sci, Infect Dis Sect, Uppsala, Sweden.	josef.jarhult@medsci.uu.se	Berglund Fick, Jerker/HDO-5788-2022; Grabic, Roman/B-1289-2013; Gunnarsson, Gunnar/G-8458-2014; Grabic, Roman/AAF-5412-2021; Waldenström, Jonas/E-4460-2013; Jarhult, Josef D./ABE-8149-2020	Grabic, Roman/0000-0002-0935-2075; Gunnarsson, Gunnar/0000-0003-2345-3953; Grabic, Roman/0000-0002-0935-2075; Waldenström, Jonas/0000-0002-1152-4235; Jarhult, Josef D./0000-0002-7075-1059; Fick, Jerker/0000-0002-3949-7371; Olsen, Bjorn/0000-0002-4646-691X; Soderstrom, Hanna/0000-0003-1341-7879	Swedish Research Council; Swedish Research Council FORMAS	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council FORMAS(Swedish Research CouncilSwedish Research Council Formas)	This study was funded by the Swedish Research Council (www.vr.se) and the Swedish Research Council FORMAS (www.formas.se). F. Hoffman - La Roche Ltd. (www.roche.com) provided deuterium-labeled OC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accinelli C, 2010, CHEMOSPHERE, V81, P436, DOI 10.1016/j.chemosphere.2010.06.074; Accinelli C, 2010, CHEMOSPHERE, V79, P891, DOI 10.1016/j.chemosphere.2010.02.022; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Bloom JD, 2010, SCIENCE, V328, P1272, DOI 10.1126/science.1187816; Duan SS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001022; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ghosh GC, 2010, ENVIRON HEALTH PERSP, V118, P103, DOI 10.1289/ehp.0900930; GOVORKOVA EA, 2010, COMBINATION CHEMOTHE, P1510; Guan Y, 2010, PROTEIN CELL, V1, P9, DOI 10.1007/s13238-010-0008-z; Gubareva LV, 2001, J INFECT DIS, V183, P523, DOI 10.1086/318537; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hamelin ME, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001015; Jourdain E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008935; Kiso M., 2010, PLOS PATHOG, V6; Kramarz P, 2009, EUROSURVEILLANCE, V14; Latorre-Margalef N, 2009, P ROY SOC B-BIOL SCI, V276, P1029, DOI 10.1098/rspb.2008.1501; LAUDERT EA, 1993, J WILDLIFE DIS, V29, P523, DOI 10.7589/0090-3558-29.4.523; Meijer A, 2009, EMERG INFECT DIS, V15, P552, DOI [10.3201/eid1504.081280, 10.3201/eid1504.181280]; Moscona A, 2009, NEW ENGL J MED, V360, P953, DOI 10.1056/NEJMp0900648; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Orozovic G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016028; Patel A, 2009, CLIN PHARMACOL THER, V86, P241, DOI 10.1038/clpt.2009.142; Po ALW, 2009, EMERG INFECT DIS, V15, P1686, DOI 10.3201/eid1510.090844; Poland GA, 2009, CLIN INFECT DIS, V48, P1254, DOI 10.1086/598989; POTIER M, 1979, ANAL BIOCHEM, V94, P287, DOI 10.1016/0003-2697(79)90362-2; Rameix-Welti MA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000103; REED L. J., 1938, AMER JOUR HYG, V27, P493; Sacca ML, 2009, CHEMOSPHERE, V75, P28, DOI 10.1016/j.chemosphere.2008.11.060; Soderstrom H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006064; Spackman Erica, 2008, V436, P19, DOI 10.1007/978-1-59745-279-3_4; Stoner TD, 2010, J VIROL, V84, P9800, DOI 10.1128/JVI.00296-10; SWEETMAN SC, MARTINDALE COMPLETE; Sy CL, 2010, EMERG INFECT DIS, V16, P723, DOI 10.3201/eid1604.091706; Tashiro M, 2009, ANTIVIR THER, V14, P751, DOI 10.3851/IMP1194; Ujike M, 2010, EMERG INFECT DIS, V16, P926, DOI 10.3201/eid1606.091623; Wallensten A, 2007, EMERG INFECT DIS, V13, P404, DOI 10.3201/eid1303.061130; WEBSTER RG, 1978, VIROLOGY, V84, P268, DOI 10.1016/0042-6822(78)90247-7	37	43	45	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2011	6	9							e24742	10.1371/journal.pone.0024742	http://dx.doi.org/10.1371/journal.pone.0024742			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CO	21931841	Green Published, gold			2022-12-25	WOS:000294803200047
J	Lim, S; Chesser, AS; Grima, JC; Rappold, PM; Blum, D; Przedborski, S; Tieu, K				Lim, Soyeon; Chesser, Adrianne S.; Grima, Jonathan C.; Rappold, Phillip M.; Blum, David; Przedborski, Serge; Tieu, Kim			D-beta-Hydroxybutyrate Is Protective in Mouse Models of Huntington's Disease	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; CREB-BINDING PROTEIN; PARKINSONS-DISEASE; 3-NITROPROPIONIC ACID; DIETARY RESTRICTION; MUTANT HUNTINGTIN; 3-HYDROXYBUTYRATE DEHYDROGENASE; MITOCHONDRIAL RESPIRATION; STRIATAL DEGENERATION; DIABETES-MELLITUS	Abnormalities in mitochondrial function and epigenetic regulation are thought to be instrumental in Huntington's disease (HD), a fatal genetic disorder caused by an expanded polyglutamine track in the protein huntingtin. Given the lack of effective therapies for HD, we sought to assess the neuroprotective properties of the mitochondrial energizing ketone body, D-beta-hydroxybutyrate (D beta HB), in the 3-nitropropionic acid (3-NP) toxic and the R6/2 genetic model of HD. In mice treated with 3-NP, a complex II inhibitor, infusion of D beta HB attenuates motor deficits, striatal lesions, and microgliosis in this model of toxin induced-striatal neurodegeneration. In transgenic R6/2 mice, infusion of D beta HB extends life span, attenuates motor deficits, and prevents striatal histone deacetylation. In PC12 cells with inducible expression of mutant huntingtin protein, we further demonstrate that D beta HB prevents histone deacetylation via a mechanism independent of its mitochondrial effects and independent of histone deacetylase inhibition. These pre-clinical findings suggest that by simultaneously targeting the mitochondrial and the epigenetic abnormalities associated with mutant huntingtin, D beta HB may be a valuable therapeutic agent for HD.	[Lim, Soyeon; Chesser, Adrianne S.; Grima, Jonathan C.; Rappold, Phillip M.; Tieu, Kim] Univ Rochester, Dept Neurol, Ctr Translat Neuromed, Rochester, NY 14627 USA; [Blum, David] Univ Lille Nord France, Jean Pierre Aubert Res Ctr, IMPRT, Lille, France; [Blum, David] INSERM, UMR U837, F-59045 Lille, France; [Blum, David] CHRU, Lille, France; [Przedborski, Serge] Columbia Univ, Ctr Motor Neuron Biol & Dis, New York, NY USA; [Przedborski, Serge] Columbia Univ, Dept Neurol, New York, NY USA; [Przedborski, Serge] Columbia Univ, Dept Pathol, New York, NY USA; [Przedborski, Serge] Columbia Univ, Dept Cell Biol, New York, NY USA	University of Rochester; Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Columbia University; Columbia University; Columbia University; Columbia University	Lim, S (corresponding author), Univ Rochester, Dept Neurol, Ctr Translat Neuromed, Rochester, NY 14627 USA.	sp30@columbia.edu; kim_tieu@urmc.rochester.edu	Blum, David/E-9901-2016; Blum, David/O-2924-2019; Tieu, Kim/AAG-7336-2019; Rappold, Phillip/F-9417-2012; Tieu, Kim/F-5426-2012	Blum, David/0000-0001-5691-431X; Blum, David/0000-0001-5691-431X; Tieu, Kim/0000-0001-6606-4371; Tieu, Kim/0000-0001-6606-4371	United States National Institutes of Health [ES014899, ES17470, F30-ES020081, TL1RR024135]; National Institutes of Health [T32 GM07356]; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR024135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES017470, F30ES020081, R01ES014899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007356] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by United States National Institutes of Health grants ES014899 and ES17470 (to K. T.), F30-ES020081 (to A.C.) and TL1RR024135 (to P.M.R.). A.C. and P.M.R. are trainees in the Medical Scientist Training Program funded by National Institutes of Health T32 GM07356. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken CT, 2004, NEUROBIOL DIS, V16, P546, DOI 10.1016/j.nbd.2004.04.001; Andreassen OA, 2002, NEUROBIOL DIS, V11, P410, DOI 10.1006/nbdi.2002.0562; Anson RM, 2003, P NATL ACAD SCI USA, V100, P6216, DOI 10.1073/pnas.1035720100; Bannister AJ, 1996, NATURE, V384, P641, DOI 10.1038/384641a0; Benchoua A, 2006, MOL BIOL CELL, V17, P1652, DOI 10.1091/mbc.E05-07-0607; Bjorkqvist M, 2005, HUM MOL GENET, V14, P565, DOI 10.1093/hmg/ddi053; BRENNAN WA, 1985, J NEUROCHEM, V44, P1948, DOI 10.1111/j.1471-4159.1985.tb07192.x; Brouillet E, 2005, J NEUROCHEM, V95, P1521, DOI 10.1111/j.1471-4159.2005.03515.x; Brouillet E, 1998, J NEUROCHEM, V70, P794; Browne SE, 1997, ANN NEUROL, V41, P646, DOI 10.1002/ana.410410514; Chai YH, 2001, J BIOL CHEM, V276, P44889, DOI 10.1074/jbc.M106575200; Dedeoglu A, 2002, EXP NEUROL, V176, P262, DOI 10.1006/exnr.2002.7933; Duan WZ, 1999, J NEUROSCI RES, V57, P195, DOI 10.1002/(SICI)1097-4547(19990715)57:2&lt;195::AID-JNR5&gt;3.0.CO;2-P; Ferrante RJ, 2004, J NEUROSCI, V24, P10335, DOI 10.1523/JNEUROSCI.2599-04.2004; Ferrante RJ, 2003, J NEUROSCI, V23, P9418; Gardian G, 2005, J BIOL CHEM, V280, P556, DOI 10.1074/jbc.M410210200; Hathorn T, 2011, NEUROBIOL DIS, V41, P43, DOI 10.1016/j.nbd.2010.08.017; HERZBERG GR, 1984, BIOCHIM BIOPHYS ACTA, V802, P67, DOI 10.1016/0304-4165(84)90034-5; Hockly E, 2003, P NATL ACAD SCI USA, V100, P2041, DOI 10.1073/pnas.0437870100; Holmer HK, 2005, SYNAPSE, V57, P100, DOI 10.1002/syn.20163; Hurlbert MS, 1999, DIABETES, V48, P649, DOI 10.2337/diabetes.48.3.649; Izumi Y, 1998, J CLIN INVEST, V101, P1121, DOI 10.1172/JCI1009; Kashiwaya Y, 2000, P NATL ACAD SCI USA, V97, P5440, DOI 10.1073/pnas.97.10.5440; Kazantsev AG, 2008, NAT REV DRUG DISCOV, V7, P854, DOI 10.1038/nrd2681; Kim J, 2010, HUM MOL GENET, V19, P3919, DOI 10.1093/hmg/ddq306; KUHL DE, 1982, ANN NEUROL, V12, P425, DOI 10.1002/ana.410120504; KUHL DE, 1984, ANN NEUROL, V15, pS119; Levine MS, 2004, TRENDS NEUROSCI, V27, P691, DOI 10.1016/j.tins.2004.08.008; Li Jia Yi, 2005, NeuroRx, V2, P447, DOI 10.1602/neurorx.2.3.447; Li SH, 2004, TRENDS GENET, V20, P146, DOI 10.1016/j.tig.2004.01.008; MANN VM, 1990, LANCET, V336, P749, DOI 10.1016/0140-6736(90)92242-A; Maswood N, 2004, P NATL ACAD SCI USA, V101, P18171, DOI 10.1073/pnas.0405831102; McCampbell A, 2000, HUM MOL GENET, V9, P2197, DOI 10.1093/hmg/9.14.2197; Milakovic T, 2005, J BIOL CHEM, V280, P30773, DOI 10.1074/jbc.M504749200; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Panov AV, 2002, NAT NEUROSCI, V5, P731, DOI 10.1038/nn884; PODOLSKY S, 1972, LANCET, V1, P1356; Prins ML, 2004, J NEUROCHEM, V90, P666, DOI 10.1111/j.1471-4159.2004.02542.x; Reger MA, 2004, NEUROBIOL AGING, V25, P311, DOI 10.1016/S0197-4580(03)00087-3; ROBINSON AM, 1980, PHYSIOL REV, V60, P143, DOI 10.1152/physrev.1980.60.1.143; Ross CA, 2011, LANCET NEUROL, V10, P83, DOI 10.1016/S1474-4422(10)70245-3; Seong IS, 2005, HUM MOL GENET, V14, P2871, DOI 10.1093/hmg/ddi319; Shirendeb U, 2011, HUM MOL GENET, V20, P1438, DOI 10.1093/hmg/ddr024; Smith R, 2005, CELL MOL LIFE SCI, V62, P1901, DOI 10.1007/s00018-005-5084-5; Smith SL, 2005, CNS DRUG REV, V11, P113; SOKOLOFF L, 1973, ANNU REV MED, V24, P271, DOI 10.1146/annurev.me.24.020173.001415; Song WJ, 2011, NAT MED, V17, P377, DOI 10.1038/nm.2313; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; Thomas EA, 2008, P NATL ACAD SCI USA, V105, P15564, DOI 10.1073/pnas.0804249105; Tieu K, 2003, J CLIN INVEST, V112, P892, DOI 10.1172/JCI200318797; Van der Auwera Ingrid, 2005, Nutr Metab (Lond), V2, P28, DOI 10.1186/1743-7075-2-28; VanItallie TB, 2005, NEUROLOGY, V64, P728, DOI 10.1212/01.WNL.0000152046.11390.45; Vonsattel Jean Paul G, 2011, Handb Clin Neurol, V100, P83, DOI 10.1016/B978-0-444-52014-2.00004-5; Wallace TM, 2001, DIABETIC MED, V18, P640, DOI 10.1046/j.1464-5491.2001.00550.x; WATSON HR, 1972, BIOCHEM J, V128, P53, DOI 10.1042/bj1280053; Williamson D. H., 1971, BIOCHEM J, V121, P571; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174; Zhao Z, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-29	59	71	77	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2011	6	9							e24620	10.1371/journal.pone.0024620	http://dx.doi.org/10.1371/journal.pone.0024620			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CO	21931779	Green Submitted, gold, Green Published			2022-12-25	WOS:000294803200032
J	Segata, N; Huttenhower, C				Segata, Nicola; Huttenhower, Curtis			Toward an Efficient Method of Identifying Core Genes for Evolutionary and Functional Microbial Phylogenies	PLOS ONE			English	Article							COMPARATIVE GENOMIC ANALYSIS; ESCHERICHIA-COLI; CELLULAR PATHWAYS; TREES; ARCHAEA; RECONSTRUCTION; IDENTIFICATION; SEQUENCES; PROTEINS; DATABASE	Microbial community metagenomes and individual microbial genomes are becoming increasingly accessible by means of high-throughput sequencing. Assessing organismal membership within a community is typically performed using one or a few taxonomic marker genes such as the 16S rDNA, and these same genes are also employed to reconstruct molecular phylogenies. There is thus a growing need to bioinformatically catalog strongly conserved core genes that can serve as effective taxonomic markers, to assess the agreement among phylogenies generated from different core gene, and to characterize the biological functions enriched within core genes and thus conserved throughout large microbial clades. We present a method to recursively identify core genes (i.e. genes ubiquitous within a microbial clade) in high-throughput from a large number of complete input genomes. We analyzed over 1,100 genomes to produce core gene sets spanning 2,861 bacterial and archaeal clades, ranging in size from one to >2,000 genes in inverse correlation with the alpha-diversity (total phylogenetic branch length) spanned by each clade. These cores are enriched as expected for housekeeping functions including translation, transcription, and replication, in addition to significant representations of regulatory, chaperone, and conserved uncharacterized proteins. In agreement with previous manually curated core gene sets, phylogenies constructed from one or more of these core genes agree with those built using 16S rDNA sequence similarity, suggesting that systematic core gene selection can be used to optimize both comparative genomics and determination of microbial community structure. Finally, we examine functional phylogenies constructed by clustering genomes by the presence or absence of orthologous gene families and show that they provide an informative complement to standard sequence-based molecular phylogenies.	[Segata, Nicola; Huttenhower, Curtis] Harvard Univ, Dept Biostat, Harvard Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Segata, N (corresponding author), Harvard Univ, Dept Biostat, Harvard Sch Publ Hlth, Boston, MA 02115 USA.	chuttenh@hsph.harvard.edu	Segata, Nicola/AAB-2980-2019; Segata, Nicola/K-7240-2016	Huttenhower, Curtis/0000-0002-1110-0096; Segata, Nicola/0000-0002-1583-5794	NIH [1R01HG005969]; NSF [DBI-1053486]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005969] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by NIH 1R01HG005969 and NSF DBI-1053486 to CH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Beiko RG, 2005, P NATL ACAD SCI USA, V102, P14332, DOI 10.1073/pnas.0504068102; Brochier C, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-36; Brown JR, 2001, NAT GENET, V28, P281, DOI 10.1038/90129; Charlebois RL, 2004, GENOME RES, V14, P2469, DOI 10.1101/gr.3024704; Charlesworth J, 2006, MOL BIOL EVOL, V23, P1348, DOI 10.1093/molbev/msk025; Chattopadhyay S, 2009, P NATL ACAD SCI USA, V106, P12412, DOI 10.1073/pnas.0906217106; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Daubin V, 2002, GENOME RES, V12, P1080, DOI 10.1101/gr.187002; David LA, 2011, NATURE, V469, P93, DOI 10.1038/nature09649; Davie JJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-70; Devulder G, 2005, INT J SYST EVOL MICR, V55, P293, DOI 10.1099/ijs.0.63222-0; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Donati C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r107; Eaton HE, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-11; Gil R, 2004, MICROBIOL MOL BIOL R, V68, P518, DOI 10.1128/MMBR.68.3.518-537.2004; Gil R, 2002, P NATL ACAD SCI USA, V99, P4454, DOI 10.1073/pnas.062067299; Glazko GV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-r32; Gribaldo S, 2006, PHILOS T R SOC B, V361, P1007, DOI 10.1098/rstb.2006.1841; Harris JK, 2003, GENOME RES, V13, P407, DOI 10.1101/gr.652803; Jothi R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-173; Knight R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r171; Konstantinidis KT, 2006, APPL ENVIRON MICROB, V72, P7286, DOI 10.1128/AEM.01398-06; Konstantinidis KT, 2005, J BACTERIOL, V187, P6258, DOI 10.1128/JB.187.18.6258-6264.2005; Koonin EV, 2008, NUCLEIC ACIDS RES, V36, P6688, DOI 10.1093/nar/gkn668; Koonin EV, 2003, NAT REV MICROBIOL, V1, P127, DOI 10.1038/nrmicro751; Kreimer A, 2008, P NATL ACAD SCI USA, V105, P6976, DOI 10.1073/pnas.0712149105; Lan RT, 2002, MICROBES INFECT, V4, P1125, DOI 10.1016/S1286-4579(02)01637-4; Lerat E, 2003, PLOS BIOL, V1, P101, DOI 10.1371/journal.pbio.0000019; Makarova KS, 2005, CURR OPIN MICROBIOL, V8, P586, DOI 10.1016/j.mib.2005.08.003; Mazumder R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-279; Nakayama K, 2010, DNA RES, V17, P281, DOI 10.1093/dnares/dsq018; OLSEN GJ, 1994, COMPUT APPL BIOSCI, V10, P41; Pace NR, 2009, MICROBIOL MOL BIOL R, V73, P565, DOI 10.1128/MMBR.00033-09; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Pupo GM, 2000, P NATL ACAD SCI USA, V97, P10567, DOI 10.1073/pnas.180094797; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; Schleifer KH, 2009, SYST APPL MICROBIOL, V32, P533, DOI 10.1016/j.syapm.2009.09.002; Segata N, 2011, GENOME BIOL IN PRESS; Shi T, 2008, P NATL ACAD SCI USA, V105, P2510, DOI 10.1073/pnas.0711165105; Sims GE, 2011, P NATL ACAD SCI; Snel B, 1999, NAT GENET, V21, P108, DOI 10.1038/5052; Snel B, 2002, GENOME RES, V12, P17, DOI 10.1101/gr.176501; Susko E, 2006, MOL BIOL EVOL, V23, P1019, DOI 10.1093/molbev/msj113; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; Wolf YI, 2002, TRENDS GENET, V18, P472, DOI 10.1016/S0168-9525(02)02744-0; Wolf YI, 2001, BMC EVOL BIOL, V1, DOI 10.1186/1471-2148-1-8; Wu J, 2003, BIOINFORMATICS, V19, P1524, DOI 10.1093/bioinformatics/btg187; Wu M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r151; Yarza P, 2008, SYST APPL MICROBIOL, V31, P241, DOI 10.1016/j.syapm.2008.07.001; Yooseph S, 2010, NATURE, V468, P60, DOI 10.1038/nature09530; Zafar N, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-12	58	68	68	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2011	6	9							e24704	10.1371/journal.pone.0024704	http://dx.doi.org/10.1371/journal.pone.0024704			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CO	21931822	Green Published, Green Submitted, gold			2022-12-25	WOS:000294803200041
J	Li, RW; Wu, ST; Li, WZ; Huang, Y; Gasbarre, LC				Li, Robert W.; Wu, Sitao; Li, Weizhong; Huang, Ying; Gasbarre, Louis C.			Metagenome Plasticity of the Bovine Abomasal Microbiota in Immune Animals in Response to Ostertagia Ostertagi Infection	PLOS ONE			English	Article							FAST PROGRAM; SEQUENCES; RESISTANCE; SECRETION; BACTERIA; GENOMES; PROTEIN; CALVES; HIT; PH	Infections in cattle by the abomasal nematode Ostertagia ostertagi result in impaired gastrointestinal function. Six partially immune animals were developed using multiple drug-attenuated infections, and these animals displayed reduced worm burdens and a slightly elevated abomasal pH upon reinfection. In this study, we characterized the abomasal microbiota in response to reinfection using metagenomic tools. Compared to uninfected controls, infection did not induce a significant change in the microbial community composition in immune animals. 16S rRNA gene-based phylogenetic analysis identified 15 phyla in the bovine abomasal microbiota with Bacteroidetes (60.5%), Firmicutes (27.1%), Proteobacteria (7.2%), Spirochates (2.9%), and Fibrobacteres (1.5%) being the most predominant. The number of prokaryotic genera and operational taxonomic units (OTU) identified in the abomasal microbial community was 70.8 +/- 19.8 (mean +/- SD) and 90.3 +/- 2.9, respectively. However, the core microbiome comprised of 32 genera and 72 OTU. Infection seemingly had a minimal impact on the abomasal microbial diversity at a genus level in immune animals. Proteins predicted from whole genome shotgun (WGS) DNA sequences were assigned to 5,408 Pfam and 3,381 COG families, demonstrating dazzling arrays of functional diversity in bovine abomasal microbial communities. However, none of COG functional classes were significantly impacted by infection. Our results demonstrate that immune animals may develop abilities to maintain proper stability of their abomasal microbial ecosystem. A minimal disruption in the bovine abomasal microbiota by reinfection may contribute equally to the restoration of gastric function in immune animals.	[Li, Robert W.; Wu, Sitao; Gasbarre, Louis C.] ARS, Anim & Nat Resources Inst, USDA, Beltsville, MD USA; [Li, Weizhong; Huang, Ying] Univ Calif San Diego, Ctr Res Biol Syst, La Jolla, CA 92093 USA	United States Department of Agriculture (USDA); University of California System; University of California San Diego	Li, RW (corresponding author), ARS, Anim & Nat Resources Inst, USDA, Beltsville, MD USA.	robert.li@ars.usda.gov	Li, Weizhong/A-9735-2008; Wu, Sitao/E-8098-2011	Li, Weizhong/0000-0003-1804-9403; 	National Center for Research Resources (NCRR) [R01RR025030]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR025030] Funding Source: NIH RePORTER	National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	SW and WL are supported by Award Number R01RR025030 from the National Center for Research Resources (NCRR). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NCRR or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amadesi S, 2004, CURR OPIN PHARMACOL, V4, P551, DOI 10.1016/j.coph.2004.08.004; Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Antalis TM, 2007, NAT CLIN PRACT GASTR, V4, P393, DOI 10.1038/ncpgasthep0846; Asanuma N, 2010, ANAEROBE, V16, P405, DOI 10.1016/j.anaerobe.2010.05.005; Bearson S, 1997, FEMS MICROBIOL LETT, V147, P173, DOI 10.1016/S0378-1097(96)00503-4; Bik EM, 2006, P NATL ACAD SCI USA, V103, P732, DOI 10.1073/pnas.0506655103; FOX MT, 1993, VET PARASITOL, V46, P143, DOI 10.1016/0304-4017(93)90055-R; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Hayes ET, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-89; Hertzberg H, 2000, VET J, V159, P238, DOI 10.1053/tvjl.1999.0475; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Ivanov D, 2006, J BIOL CHEM, V281, P17246, DOI 10.1074/jbc.M601678200; Kurpad AV, 2003, AM J CLIN NUTR, V78, P1145, DOI 10.1093/ajcn/78.6.1145; Li RW, 2007, VET PARASITOL, V145, P100, DOI 10.1016/j.vetpar.2006.11.015; Li RW, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-48; Li RW, 2010, VET PARASITOL, V174, P247, DOI 10.1016/j.vetpar.2010.08.037; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Mascher T, 2006, MICROBIOL MOL BIOL R, V70, P910, DOI 10.1128/MMBR.00020-06; MICHEL JF, 1973, EXP PARASITOL, V33, P179, DOI 10.1016/0014-4894(73)90023-4; Niu BF, 2011, BIOINFORMATICS, V27, P1704, DOI 10.1093/bioinformatics/btr252; Noguchi H, 2006, NUCLEIC ACIDS RES, V34, P5623, DOI 10.1093/nar/gkl723; Purewal A, 1997, J PHYSIOL-LONDON, V498, P809, DOI 10.1113/jphysiol.1997.sp021904; Rho MN, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq747; ROEDER BL, 1987, J AM VET MED ASSOC, V190, P1550; RW Li, 2011, METAGENOMICS ITS APP, P135; Sanduleanu S, 2001, ALIMENT PHARM THER, V15, P379, DOI 10.1046/j.1365-2036.2001.00888.x; Simcock DC, 2006, RES VET SCI, V81, P225, DOI 10.1016/j.rvsc.2006.01.005; Simcock DC, 1999, INT J PARASITOL, V29, P1053, DOI 10.1016/S0020-7519(99)00065-X; Sparks ME, 2011, METAGENOMICS ITS APP, P165; Stebbins CE, 2001, NATURE, V412, P701, DOI 10.1038/35089000; Tapley TL, 2010, P NATL ACAD SCI USA, V107, P1071, DOI 10.1073/pnas.0911610107; THOMAS JM, 1987, GUT, V28, P726, DOI 10.1136/gut.28.6.726; Vatn S, 2000, J COMP PATHOL, V122, P193, DOI 10.1053/jcpa.1999.0363; Wallace RJ, 1997, ANAEROBE, V3, P251, DOI 10.1006/anae.1997.0080; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352	36	73	74	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2011	6	9							e24417	10.1371/journal.pone.0024417	http://dx.doi.org/10.1371/journal.pone.0024417			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CN	21931709	gold, Green Published, Green Submitted			2022-12-25	WOS:000294803100029
J	Natarajan, JV; Chattopadhyay, S; Ang, M; Darwitan, A; Foo, S; Zhen, M; Koo, M; Wong, TT; Venkatraman, SS				Natarajan, Jayaganesh V.; Chattopadhyay, Sujay; Ang, Marcus; Darwitan, Anastasia; Foo, Selin; Zhen, Ma; Koo, Magdalene; Wong, Tina T.; Venkatraman, Subbu S.			Sustained Release of an Anti-Glaucoma Drug: Demonstration of Efficacy of a Liposomal Formulation in the Rabbit Eye	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; DELIVERY SYSTEMS; IN-VITRO; LATANOPROST; OPHTHALMOLOGY; CHOLESTEROL; PROGRESSION; STABILITY; BEHAVIOR; BILAYERS	Topical medication remains the first line treatment of glaucoma; however, sustained ocular drug delivery via topical administration is difficult to achieve. Most drugs have poor penetration due to the multiple physiological barriers of the eye and are rapidly cleared if applied topically. Currently, daily topical administration for lowering the intra-ocular pressure (IOP), has many limitations, such as poor patient compliance and ocular allergy from repeated drug administration. Poor compliance leads to suboptimal control of IOP and disease progression with eventual blindness. The delivery of drugs in a sustained manner could provide the patient with a more attractive alternative by providing optimal therapeutic dosing, with minimal local toxicity and inconvenience. To investigate this, we incorporated latanoprost into LUVs (large unilamellar vesicles) derived from the liposome of DPPC (di-palmitoyl-phosphatidyl-choline) by the film hydration technique. Relatively high amounts of drug could be incorporated into this vesicle, and the drug resides predominantly in the bilayer. Vesicle stability monitored by size measurement and DSC (differential scanning calorimetry) analysis showed that formulations with a drug/lipid mole ratio of about 10% have good physical stability during storage and release. This formulation demonstrated sustained release of latanoprost in vitro, and then tested for efficacy in 23 rabbits. Subconjunctival injection and topical eye drop administration of the latanoprost/liposomal formulation were compared with conventional daily administration of latanoprost eye drops. The IOP lowering effect with a single subconjunctival injection was shown to be sustained for up to 50 days, and the extent of IOP lowering was comparable to daily eye drop administration. Toxicity and localized inflammation were not observed in any treatment groups. We believe that this is the first demonstration, in vivo, of sustained delivery to the anterior segment of the eye that is safe and efficacious for 50 days.	[Natarajan, Jayaganesh V.; Chattopadhyay, Sujay; Darwitan, Anastasia; Zhen, Ma; Wong, Tina T.; Venkatraman, Subbu S.] Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore, Singapore; [Chattopadhyay, Sujay] Doctor Babasaheb Ambedkar Technol Univ, Dept Chem Engn, Lonere, Maharashtra, India; [Ang, Marcus; Foo, Selin; Koo, Magdalene; Wong, Tina T.] Singapore Natl Eye Ctr, Singapore, Singapore; [Wong, Tina T.] Singapore Eye Res Inst, Ocular Drug Delivery Grp, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Dr. Babasaheb Ambedkar Technological University; Singapore National Eye Center; National University of Singapore; Singapore National Eye Center	Natarajan, JV (corresponding author), Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore, Singapore.	tina.wong.t.l@snec.com.sg; assubbu@ntu.edu.sg	Venkatraman, Subramanian/A-2228-2011; CHATTOPADHYAY, SUJAY/U-8544-2019	Venkatraman, Subramanian/0000-0002-8693-1070; CHATTOPADHYAY, SUJAY/0000-0001-7837-5329	Singapore Eye Research Institute [NMRC/TCR/002-SERI/2008]	Singapore Eye Research Institute	This study was supported by the grant from Singapore Eye Research Institute (NMRC/TCR/002-SERI/2008) (http://www.seri.com.sg/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMOG R, 1991, CHEM PHYS LIPIDS, V60, P93, DOI 10.1016/0009-3084(91)90031-6; Amano S, 2008, JPN J OPHTHALMOL, V52, P334, DOI 10.1007/s10384-008-0554-6; Baker R., 1987, CONTROLLED RELEASE B; BARTLETT GR, 1959, J BIOL CHEM, V234, P466; Bito LZ, 1986, US Patent No, Patent No. [4,599, 353, 4599353]; Bolean M, 2010, BIOPHYS CHEM, V152, P74, DOI 10.1016/j.bpc.2010.08.002; Costas D, 2008, J LIPOSOME RES, V18, P159; Detoni CB, 2009, J MICROENCAPSUL, V26, P684, DOI [10.3109/02652040802661887, 10.1080/02652040802661887]; Ebrahim S, 2005, SURV OPHTHALMOL, V50, P167, DOI 10.1016/j.survophthal.2004.12.006; Halling KK, 2004, BBA-BIOMEMBRANES, V1664, P161, DOI 10.1016/j.bbamem.2004.05.006; Hathout RM, 2007, AAPS PHARMSCITECH, V8; HIRNLE E, 1991, J MICROENCAPSUL, V8, P391, DOI 10.3109/02652049109069566; Hironaka K, 2009, J CONTROL RELEASE, V136, P247, DOI 10.1016/j.jconrel.2009.02.020; Huq F., 2007, J PHARM TOXICOLOGY, V2, P359, DOI [10.3923/jpt.2007.359.365, DOI 10.3923/jpt.2007.359.365]; Jonescu-Cuypers CP, 2001, OPHTHALMOLOGY, V108, P254, DOI 10.1016/S0161-6420(00)00514-5; Kaur IP, 2002, DRUG DEV IND PHARM, V28, P473; LANG JC, 1995, ADV DRUG DELIVER REV, V16, P39, DOI 10.1016/0169-409X(95)00012-V; LEE VHL, 1985, SURV OPHTHALMOL, V29, P335, DOI 10.1016/0039-6257(85)90109-2; LEE VHL, 1984, CURR EYE RES, V3, P585, DOI 10.3109/02713688409003058; Lee VHL, 1990, J CONTROL RELEASE, V11, P79; Lewis T. L., 2002, OPTOMETRIC CLIN PRAC; Lin HH, 1996, J PHARM PHARMACOL, V48, P801, DOI 10.1111/j.2042-7158.1996.tb03977.x; Linden C, 1997, BRIT J OPHTHALMOL, V81, P370, DOI 10.1136/bjo.81.5.370; Liu JB, 2006, CANCER CHEMOTH PHARM, V58, P306, DOI 10.1007/s00280-005-0161-x; Mannock DA, 2010, BBA-BIOMEMBRANES, V1798, P376, DOI 10.1016/j.bbamem.2009.09.002; Mehnert W, 2001, ADV DRUG DELIVER REV, V47, P165, DOI 10.1016/S0169-409X(01)00105-3; MEISNER D, 1995, ADV DRUG DELIVER REV, V16, P75, DOI 10.1016/0169-409X(95)00016-Z; Mohammed AR, 2004, INT J PHARMACEUT, V285, P23, DOI 10.1016/j.ijpharm.2004.07.010; Nagle JF, 2000, BBA-REV BIOMEMBRANES, V1469, P159, DOI 10.1016/S0304-4157(00)00016-2; Netland PA, 2001, AM J OPHTHALMOL, V132, P472, DOI 10.1016/S0002-9394(01)01177-1; NIESMAN MR, 1992, CRIT REV THER DRUG, V9, P1; Nordmann JP, 2003, HLTH QUAL LIFE OUTCO; PEREZSOLER R, 1992, CANCER RES, V52, P6341; Quigley HA, 1996, AM J OPHTHALMOL, V122, P355, DOI 10.1016/S0002-9394(14)72062-8; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; Radhakrishnan S, 2008, GLAUCOMA MEDICATION; Ritch R, 2001, PRIMARY CARE GLAUCOM, P443; ROJANASAKUL Y, 1991, INT J PHARM, V68, P135, DOI 10.1016/0378-5173(91)90136-C; ROJANASAKUL YY, 1989, INT J PHARM, V55, P237, DOI 10.1016/0378-5173(89)90047-1; Russo A, 2008, CLIN OPHTHALMOL, V2, P897; SCHAEFFER HE, 1982, INVEST OPHTH VIS SCI, V22, P220; SHAH M, 1994, J CELL SCI, V107, P1137; Sila-On W, 2008, AAPS PHARMSCITECH, V9, P684, DOI 10.1208/s12249-008-9089-x; SMOLIN G, 1981, AM J OPHTHALMOL, V91, P220, DOI 10.1016/0002-9394(81)90177-X; Stratford Jr. RE, 1983, CURR EYE RES, V2, P377; Wells AP, 2004, J GLAUCOMA, V13, P454, DOI 10.1097/00061198-200412000-00005; Yasukawa T, 2004, PROG RETIN EYE RES, V23, P253, DOI 10.1016/j.preteyeres.2004.02.003; Yusuke S, 2005, INT J PHARMACEUT, V305, P176	48	64	65	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2011	6	9							e24513	10.1371/journal.pone.0024513	http://dx.doi.org/10.1371/journal.pone.0024513			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CN	21931735	Green Submitted, gold, Green Published			2022-12-25	WOS:000294803100038
J	Wang, WQ; Messing, J				Wang, Wenqin; Messing, Joachim			High-Throughput Sequencing of Three Lemnoideae (Duckweeds) Chloroplast Genomes from Total DNA	PLOS ONE			English	Article							PHYLOGENETIC-RELATIONSHIPS; NUCLEOTIDE; SUBSTITUTIONS; ORGANIZATION; LEMNACEAE; ALIGNMENT; TOOLS	Background: Chloroplast genomes provide a wealth of information for evolutionary and population genetic studies. Chloroplasts play a particularly important role in the adaption for aquatic plants because they float on water and their major surface is exposed continuously to sunlight. The subfamily of Lemnoideae represents such a collection of aquatic species that because of photosynthesis represents one of the fastest growing plant species on earth. Methods: We sequenced the chloroplast genomes from three different genera of Lemnoideae, Spirodela polyrhiza, Wolffiella lingulata and Wolffia australiana by high-throughput DNA sequencing of genomic DNA using the SOLiD platform. Unfractionated total DNA contains high copies of plastid DNA so that sequences from the nucleus and mitochondria can easily be filtered computationally. Remaining sequence reads were assembled into contiguous sequences (contigs) using SOLiD software tools. Contigs were mapped to a reference genome of Lemna minor and gaps, selected by PCR, were sequenced on the ABI3730xl platform. Conclusions: This combinatorial approach yielded whole genomic contiguous sequences in a cost-effective manner. Over 1,000-time coverage of chloroplast from total DNA were reached by the SOLiD platform in a single spot on a quadrant slide without purification. Comparative analysis indicated that the chloroplast genome was conserved in gene number and organization with respect to the reference genome of L. minor. However, higher nucleotide substitution, abundant deletions and insertions occurred in non-coding regions of these genomes, indicating a greater genomic dynamics than expected from the comparison of other related species in the Pooideae. Noticeably, there was no transition bias over transversion in Lemnoideae. The data should have immediate applications in evolutionary biology and plant taxonomy with increased resolution and statistical power.	[Wang, Wenqin; Messing, Joachim] Rutgers State Univ, Waksman Inst Microbiol, Piscataway, NJ 08855 USA	Rutgers State University New Brunswick	Wang, WQ (corresponding author), Rutgers State Univ, Waksman Inst Microbiol, Piscataway, NJ 08855 USA.	messing@waksman.rutgers.edu	Wang, Wenqin/AAR-2970-2021	Wang, Wenqin/0000-0001-6427-6338; Messing, Joachim/0000-0001-8260-2643				Atherton RA, 2010, PLANT METHODS, V6, DOI 10.1186/1746-4811-6-22; Bock R, 2007, CURR OPIN BIOTECH, V18, P100, DOI 10.1016/j.copbio.2006.12.001; Bortiri Esteban, 2008, BMC Res Notes, V1, P61, DOI 10.1186/1756-0500-1-61; Brudno M, 2003, GENOME RES, V13, P721, DOI 10.1101/gr.926603; Cabrera LI, 2008, AM J BOT, V95, P1153, DOI 10.3732/ajb.0800073; Cheng JJ, 2009, CLEAN-SOIL AIR WATER, V37, P17, DOI 10.1002/clen.200800210; Cronn R, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn502; Delwiche CF, 2011, CURR BIOL, V21, pR417, DOI 10.1016/j.cub.2011.04.021; den Bakker HC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-688; Diekmann K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002813; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Friedberg EC, 2003, NATURE, V421, P436, DOI 10.1038/nature01408; GARDNER RC, 1981, NUCLEIC ACIDS RES, V9, P2871, DOI 10.1093/nar/9.12.2871; GuhaMajumdar M, 2005, MOL GENET GENOMICS, V273, P177, DOI 10.1007/s00438-005-1121-1; Keller I, 2007, PLOS GENET, V3, P185, DOI 10.1371/journal.pgen.0030022; KOLODNER R, 1979, P NATL ACAD SCI USA, V76, P41, DOI 10.1073/pnas.76.1.41; Landolt E., 1986, BIOSYSTEMATIC INVEST; LARSON R, 1982, NUCLEIC ACIDS RES, V10, P39, DOI 10.1093/nar/10.1.39; Les DH, 2002, SYST BOT, V27, P221; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lutz KA, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-54; Magee Alan M, 2010, Genome Res, V20, P1700, DOI 10.1101/gr.111955.110; Mardanov AV, 2008, J MOL EVOL, V66, P555, DOI 10.1007/s00239-008-9091-7; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Nachman MW, 2000, GENETICS, V156, P297; Nock CJ, 2011, PLANT BIOTECHNOL J, V9, P328, DOI 10.1111/j.1467-7652.2010.00558.x; PALMER JD, 1985, ANNU REV GENET, V19, P325, DOI 10.1146/annurev.ge.19.120185.001545; Paszkiewicz K, 2010, BRIEF BIOINFORM, V11, P457, DOI 10.1093/bib/bbq020; Rothwell GW, 2004, MOL PHYLOGENET EVOL, V30, P378, DOI 10.1016/S1055-7903(03)00205-7; Sasson A, 2010, BIOINFORMATICS, V26, P849, DOI 10.1093/bioinformatics/btq045; Shaver JM, 2006, PLANTA, V224, P72, DOI 10.1007/s00425-005-0195-7; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; VIEIRA J, 1982, GENE, V19, P259, DOI 10.1016/0378-1119(82)90015-4; Wakeley J, 1996, TRENDS ECOL EVOL, V11, P158, DOI 10.1016/0169-5347(96)10009-4; Wang W. Q., 2011, Journal of Botany, V2011, P570319, DOI 10.1155/2011/570319; Wang WQ, 2010, BMC PLANT BIOL, V10, DOI [10.1186/1471-2229-10-205, 10.1186/1471-2229-10-14]; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yang M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012762; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	39	59	65	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2011	6	9							e24670	10.1371/journal.pone.0024670	http://dx.doi.org/10.1371/journal.pone.0024670			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CN	21931804	gold, Green Published, Green Submitted			2022-12-25	WOS:000294803100053
J	Lo, KH; Hui, MNY; Yu, RMK; Wu, RSS; Cheng, SH				Lo, Kwok Hong; Hui, Michelle Nga Yu; Yu, Richard Man Kit; Wu, Rudolf Shiu Sun; Cheng, Shuk Han			Hypoxia Impairs Primordial Germ Cell Migration in Zebrafish (Danio rerio) Embryos	PLOS ONE			English	Article							INDUCED GENE-EXPRESSION; SEX-DIFFERENTIATION; CHEMOKINE RECEPTOR; GROWTH-RETARDATION; BINDING PROTEIN-1; ESTUARINE FISH; UP-REGULATION; E-CADHERIN; CXCR4; SURVIVAL	Background: As a global environmental concern, hypoxia is known to be associated with many biological and physiological impairments in aquatic ecosystems. Previous studies have mainly focused on the effect of hypoxia in adult animals. However, the effect of hypoxia and the underlying mechanism of how hypoxia affects embryonic development of aquatic animals remain unclear. Methodology/Principal Findings: In the current study, the effect of hypoxia on primordial germ cell (PGC) migration in zebrafish embryos was investigated. Hypoxic embryos showed PGC migration defect as indicated by the presence of mis-migrated ectopic PGCs. Insulin-like growth factor (IGF) signaling is required for embryonic germ line development. Using real-time PCR, we found that the mRNA expression levels of insulin-like growth factor binding protein (IGFBP-1), an inhibitor of IGF bioactivity, were significantly increased in hypoxic embryos. Morpholino knockdown of IGFBP-1 rescued the PGC migration defect phenotype in hypoxic embryos, suggesting the role of IGFBP-1 in inducing PGC mis-migration. Conclusions/Significance: This study provides novel evidence that hypoxia disrupts PGC migration during embryonic development in fish. IGF signaling is shown to be one of the possible mechanisms for the causal link between hypoxia and PGC migration. We propose that hypoxia causes PGC migration defect by inhibiting IGF signaling through the induction of IGFBP-1.	[Lo, Kwok Hong; Hui, Michelle Nga Yu; Wu, Rudolf Shiu Sun; Cheng, Shuk Han] City Univ Hong Kong, Dept Biol & Chem, Kowloon, Hong Kong, Peoples R China; [Lo, Kwok Hong; Hui, Michelle Nga Yu; Wu, Rudolf Shiu Sun; Cheng, Shuk Han] City Univ Hong Kong, State Key Lab Marine Pollut, Dept Biol & Chem, Kowloon, Hong Kong, Peoples R China; [Yu, Richard Man Kit] Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW 2308, Australia	City University of Hong Kong; City University of Hong Kong; University of Newcastle	Lo, KH (corresponding author), City Univ Hong Kong, Dept Biol & Chem, Kowloon, Hong Kong, Peoples R China.	rudolfwu@hku.hk; bhcheng@cityu.edu.hk	YU, MAN KIT RICHARD/G-8085-2013	Yu, Richard Man Kit/0000-0003-1995-2880; Cheng, Shuk Han/0000-0002-5822-7238	University Grants Committee of the Hong Kong Special Administrative Region, China [AoE/P-04/04]	University Grants Committee of the Hong Kong Special Administrative Region, China	The work described in this paper was fully supported by a grant from the University Grants Committee of the Hong Kong Special Administrative Region, China (Project No. AoE/P-04/04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuzzahab MJ, 2003, NEW ENGL J MED, V349, P2211, DOI 10.1056/NEJMoa010107; Ara T, 2003, P NATL ACAD SCI USA, V100, P5319, DOI 10.1073/pnas.0730719100; Arimoto-Ishida E, 2009, ENDOCRINOLOGY, V150, P4306, DOI 10.1210/en.2008-1662; Blaser H, 2005, J CELL SCI, V118, P4027, DOI 10.1242/jcs.02522; Braat AK, 1999, INT J DEV BIOL, V43, P745; Brockhaus F, 1999, ONCOGENE, V18, P6403, DOI 10.1038/sj.onc.1203058; Cheng SH, 2000, ENVIRON TOXICOL CHEM, V19, P3024, DOI 10.1002/etc.5620191223; Christofori G, 2003, EMBO J, V22, P2318, DOI 10.1093/emboj/cdg228; Devreotes P, 2003, J BIOL CHEM, V278, P20445, DOI 10.1074/jbc.R300010200; Doitsidou M, 2002, SDF 1 CELL, V11, P647; Guillemin K, 1997, CELL, V89, P9, DOI 10.1016/S0092-8674(00)80176-2; HOCHACHKA PW, 1986, SCIENCE, V231, P234, DOI 10.1126/science.2417316; Hochachka PW, 1996, P NATL ACAD SCI USA, V93, P9493, DOI 10.1073/pnas.93.18.9493; Hoei-Hansen CE, 2006, J PATHOL, V209, P25, DOI 10.1002/path.1948; Iijima M, 2002, DEV CELL, V3, P469, DOI 10.1016/S1534-5807(02)00292-7; Imai T, 2003, AM J PATHOL, V163, P1437, DOI 10.1016/S0002-9440(10)63501-8; Kajimura S, 2006, MOL CELL BIOL, V26, P1142, DOI 10.1128/MCB.26.3.1142-1155.2006; Kajimura S, 2005, P NATL ACAD SCI USA, V102, P1240, DOI 10.1073/pnas.0407443102; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Knaut H, 2003, NATURE, V421, P279, DOI 10.1038/nature01338; Koprunner M, 2001, GENE DEV, V15, P2877; Kucia M, 2005, STEM CELLS, V23, P879, DOI 10.1634/stemcells.2004-0342; Landry CA, 2007, COMP BIOCHEM PHYS A, V148, P317, DOI 10.1016/j.cbpa.2007.04.023; Li J, 2004, J BIOL CHEM, V279, P41275, DOI 10.1074/jbc.C400297200; Liu HB, 2010, BIOCHEM BIOPH RES CO, V401, P509, DOI 10.1016/j.bbrc.2010.09.076; Matzuk MM, 2002, NAT CELL BIOL, V4, pS41; Maures TJ, 2002, ENDOCRINOLOGY, V143, P2722, DOI 10.1210/en.143.7.2722; Molyneaux KA, 2003, DEVELOPMENT, V130, P4279, DOI 10.1242/dev.00640; Moore LG, 2003, HIGH ALT MED BIOL, V4, P141, DOI 10.1089/152702903322022767; Raz E, 2003, NAT REV GENET, V4, P690, DOI 10.1038/nrg1154; Saito T, 2006, INT J DEV BIOL, V50, P691, DOI 10.1387/ijdb.062143ts; Sang XP, 2008, ENDOCRINOLOGY, V149, P5035, DOI 10.1210/en.2008-0534; Schioppa T, 2003, J EXP MED, V198, P1391, DOI 10.1084/jem.20030267; Schlueter PJ, 2007, DEV BIOL, V305, P377, DOI 10.1016/j.ydbio.2007.02.015; Schneider DT, 2001, CANCER RES, V61, P7268; Semenza GL, 2000, GENE DEV, V14, P1983; Shang EHH, 2006, ENVIRON SCI TECHNOL, V40, P3118, DOI 10.1021/es0522579; Slanchev K, 2005, P NATL ACAD SCI USA, V102, P4074, DOI 10.1073/pnas.0407475102; Stebler J, 2004, DEV BIOL, V272, P351, DOI 10.1016/j.ydbio.2004.05.009; Tazuke SI, 1998, P NATL ACAD SCI USA, V95, P10188, DOI 10.1073/pnas.95.17.10188; Thomas P, 2007, P ROY SOC B-BIOL SCI, V274, P2693, DOI 10.1098/rspb.2007.0921; Wang JZ, 2006, J AM SOC NEPHROL, V17, P1875, DOI 10.1681/ASN.2005121371; Weidinger G, 2003, CURR BIOL, V13, P1429, DOI 10.1016/S0960-9822(03)00537-2; Weidinger G, 2002, DEVELOPMENT, V129, P25; Weidinger G, 1999, DEVELOPMENT, V126, P5295; Wheelock MJ, 2003, ANNU REV CELL DEV BI, V19, P207, DOI 10.1146/annurev.cellbio.19.011102.111135; Wiesener MS, 1998, BLOOD, V92, P2260, DOI 10.1182/blood.V92.7.2260.2260_2260_2268; Wolke U, 2002, CURR BIOL, V12, P289, DOI 10.1016/S0960-9822(02)00679-6; Woods KA, 1996, NEW ENGL J MED, V335, P1363, DOI 10.1056/NEJM199610313351805; Wu RSS, 2003, ENVIRON SCI TECHNOL, V37, P1137, DOI 10.1021/es0258327; Yu RMK, 2008, AQUAT TOXICOL, V90, P235, DOI 10.1016/j.aquatox.2008.09.004	51	24	25	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e24540	10.1371/journal.pone.0024540	http://dx.doi.org/10.1371/journal.pone.0024540			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CK	21931746	Green Published, gold, Green Submitted			2022-12-25	WOS:000294802800062
J	Sidorenkov, G; Haaijer-Ruskamp, FM; de Zeeuw, D; Denig, P				Sidorenkov, Grigory; Haaijer-Ruskamp, Flora M.; de Zeeuw, Dick; Denig, Petra			A Longitudinal Study Examining Adherence to Guidelines in Diabetes Care According to Different Definitions of Adequacy and Timeliness	PLOS ONE			English	Article							QUALITY-OF-CARE; CLINICAL INERTIA; TREATMENT DECISIONS; TYPE-2; MEDICATION; INDICATORS; RECOMMENDATIONS; HYPERTENSION; IMPROVEMENT; MANAGEMENT	Background: Performance indicators assessing quality of diabetes care often look at single processes, e. g. whether an HbA1c test was conducted. Adequate care, however, consists of consecutive processes which should be taken in time (clinical pathways). We assessed quality of diabetes care by looking at single processes versus clinical pathways. In addition, we evaluated the impact of time period definitions on this quality assessment. Methodology: We conducted a cohort study in 2007-2008 using the GIANTT (Groningen Initiative to Analyse type 2 diabetes Treatment) database. Proportions of patients adequately managed for HbA1c, systolic blood pressure (SBP), LDL-cholesterol (LDL-C), and albumin/creatinin ratio (ACR) were calculated for the pathway of (1) risk factor level testing, (2) treatment intensification when indicated, (3) response to treatment evaluation. Strict and wide time periods for each step were defined. Proportions of patients adequately managed regarding the overall pathway and single steps, using strict or wide time periods were compared using odds ratios (OR) with 95% confidence intervals. Findings: Of 11176 patients diagnosed with type 2 diabetes, 9439 with complete follow-up were included. The majority received annual examination of HbA1c (86%) and SBP (86%), whereas this was 67% for LDL-C and 49% for ACR. Adequate management regarding the three-step pathway was observed in 73%, 53%, 46%, 41% of patients for HbA1c, SBP, LDL-C, and ACR respectively. Quality scores reduced significantly due to the second step (OR 0.43, 0.18, 0.44, 0.74), but were not much further reduced by the third step. Timely treatment evaluation occurred in 88% for HbA1c, 87% for SBP, 83% for LDL-C, and 76% for ACR. The overall score was not significantly changed by using strict time windows. Conclusion: Quality estimates of glycemic, blood pressure and cholesterol management are substantially reduced when looking at clinical pathways as compared to estimates based on commonly used simple process measures.	[Sidorenkov, Grigory; Haaijer-Ruskamp, Flora M.; de Zeeuw, Dick; Denig, Petra] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharmacol, Groningen, Netherlands; [Sidorenkov, Grigory; Haaijer-Ruskamp, Flora M.; Denig, Petra] Univ Groningen, Grad Sch Med Sci, Res Inst SHARE, Univ Med Ctr Groningen, Groningen, Netherlands	University of Groningen; University of Groningen	Sidorenkov, G (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharmacol, Groningen, Netherlands.	p.denig@med.umcg.nl	de Zeeuw, Dick/E-9080-2014; Denig, Petra/L-9865-2014	de Zeeuw, Dick/0000-0003-3434-7777; Denig, Petra/0000-0002-7929-4739; Sidorenkov, Grigory/0000-0002-1926-8862	Research Institute SHARE of the Groningen Graduate School of Medical Sciences, University Medical Center Groningen, The Netherlands	Research Institute SHARE of the Groningen Graduate School of Medical Sciences, University Medical Center Groningen, The Netherlands(Netherlands Government)	The study was funded by the Research Institute SHARE of the Groningen Graduate School of Medical Sciences, University Medical Center Groningen, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aakre KM, 2010, DIABETES RES CLIN PR, V89, P103, DOI 10.1016/j.diabres.2010.03.023; Ab E, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-24; [Anonymous], RES POLICY; Basevi V, 2011, DIABETES CARE, V34, P1887, DOI 10.2337/dc11-s011; Berlowitz DR, 2005, HEALTH SERV RES, V40, P1836, DOI 10.1111/j.1475-6773.2005.00436.x; British Medical Association (BMA) and NHS Employers, 2009, QUAL OUTC FRAM GUID, P162; Brook RH, 2000, INT J QUAL HEALTH C, V12, P281, DOI 10.1093/intqhc/12.4.281; Brown JB, 2004, DIABETES CARE, V27, P1535, DOI 10.2337/diacare.27.7.1535; CANADIAN DIABETES ASSOCIATION, 2008, CAN J DIAB S1, V32; Charpentier G, 2003, DIABETES METAB, V29, P152, DOI 10.1016/S1262-3636(07)70022-8; Colagiuri R, 2009, NAT EV BAS GUID PRIM; De Berardis G, 2008, NUTR METAB CARDIOVAS, V18, P57, DOI 10.1016/j.numecd.2006.04.009; DONABEDIAN A, 1988, JAMA-J AM MED ASSOC, V260, P1743, DOI 10.1001/jama.260.12.1743; Dutch Health Care Insurance Board (Commissie Farmaceutische Hulp van het College van Zorgverzekeringen), 2009, DUTCH PHARM COMP KOM; Ellrodt G, 1997, JAMA-J AM MED ASSOC, V278, P1687, DOI 10.1001/jama.278.20.1687; Gorter K, 2008, BRIT J GEN PRACT, V58, P339, DOI 10.3399/bjgp08X280209; Grant RW, 2004, DIABETIC MED, V21, P150, DOI 10.1111/j.1464-5491.2004.01095.x; Greving JP, 2007, CARDIOVASC DIABETOL, V6, DOI 10.1186/1475-2840-6-25; Home P, 2006, DIABETIC MED, V23, P579; Hoogwerf BJ, 2008, CLEV CLIN J MED, V75, P729, DOI 10.3949/ccjm.75.10.729; Kerr EA, 2008, ANN INTERN MED, V148, P717, DOI 10.7326/0003-4819-148-10-200805200-00004; Kuritzky L, 2010, POSTGRAD MED, V122, P33, DOI 10.3810/pgm.2010.05.2140; Martirosya L, 2010, PHARMACOEPIDEM DR S, V19, P319, DOI 10.1002/pds.1894; Massing MW, 2003, DIABETES CARE, V26, P1369, DOI 10.2337/diacare.26.5.1369; *NAT COLL CTR CHRO, 2008, TYP 2 DIAB NAT CLIN; National Cholesterol Education Program, 2001, EXP PAN DET EV TREAT; National Committee for Quality Assurance (NCQA), 2010, HEDIS 2011 HEALTHC E, V1; Nicolucci A, 2010, DIABETIC MED, V27, P1041, DOI 10.1111/j.1464-5491.2010.03055.x; Nicolucci A, 2006, INT J QUAL HEALTH C, V18, P26, DOI 10.1093/intqhc/mzl023; Office of Quality Performance, 2009, FY 2009 Q2 TECHN MAN; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Phillips LS, 2008, ANN INTERN MED, V148, P783, DOI 10.7326/0003-4819-148-10-200805200-00011; Phillips LS, 2001, ANN INTERN MED, V135, P825, DOI 10.7326/0003-4819-135-9-200111060-00012; Rodondi N, 2006, ANN INTERN MED, V144, P475, DOI 10.7326/0003-4819-144-7-200604040-00006; Rutten G.E.H.M., 2006, HUIS WETEN, V49, P137; Sacks DB, 2002, CLIN CHEM, V48, P436; Selbly JV, 2009, MED CARE, V47, P395, DOI 10.1097/MLR.0b013e31818d775c; Shekelle PG, 1999, BRIT MED J, V318, P593, DOI 10.1136/bmj.318.7183.593; Sidorenkov G, 2011, MED CARE RES REV, V68, P263, DOI 10.1177/1077558710394200; Sperl-Hillen JM, 2005, AM J MANAG CARE, V11, pS177; Triplitt C, 2010, AM J MANAG CARE, V16, pS195; Trivedi AN, 2011, HEALTH AFFAIR, V30, P707, DOI 10.1377/hlthaff.2011.0074; Turner BJ, 2008, ANN INTERN MED, V148, P578, DOI 10.7326/0003-4819-148-8-200804150-00002; van Bruggen R, 2009, FAM PRACT, V26, P428, DOI 10.1093/fampra/cmp053; Viera AJ, 2010, J AM SOC HYPERTENS, V4, P244, DOI 10.1016/j.jash.2010.07.003; Voorham J, 2010, QUAL SAF HEALTH CARE, V19, P411, DOI 10.1136/qshc.2008.030106; Voorham J, 2008, DIABETES CARE, V31, P501, DOI 10.2337/dc07-1043; Voorham J, 2007, J AM MED INFORM ASSN, V14, P349, DOI 10.1197/jamia.M2128; Voorham J, 2011, CLIN THER, V33, P121, DOI 10.1016/j.clinthera.2011.01.024; Voorham J, 2010, PHARMACOEPIDEM DR S, V19, P1078, DOI 10.1002/pds.2023; Wens Johan, 2007, Prim Care Diabetes, V1, P17, DOI 10.1016/j.pcd.2006.07.001; Zafar A, 2010, PRIM CARE DIABETES, V4, P203, DOI 10.1016/j.pcd.2010.07.003; Ziemer DC, 2005, DIABETES EDUCATOR, V31, P564, DOI 10.1177/0145721705279050	53	44	45	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e24278	10.1371/journal.pone.0024278	http://dx.doi.org/10.1371/journal.pone.0024278			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	819CK	21931669	Green Published, gold, Green Submitted			2022-12-25	WOS:000294802800035
J	Haiminen, N; Kuhn, DN; Parida, L; Rigoutsos, I				Haiminen, Niina; Kuhn, David N.; Parida, Laxmi; Rigoutsos, Isidore			Evaluation of Methods for De Novo Genome Assembly from High-Throughput Sequencing Reads Reveals Dependencies That Affect the Quality of the Results	PLOS ONE			English	Article								Recent developments in high-throughput sequencing technology have made low-cost sequencing an attractive approach for many genome analysis tasks. Increasing read lengths, improving quality and the production of increasingly larger numbers of usable sequences per instrument-run continue to make whole-genome assembly an appealing target application. In this paper we evaluate the feasibility of de novo genome assembly from short reads (<= 100 nucleotides) through a detailed study involving genomic sequences of various lengths and origin, in conjunction with several of the currently popular assembly programs. Our extensive analysis demonstrates that, in addition to sequencing coverage, attributes such as the architecture of the target genome, the identity of the used assembly program, the average read length and the observed sequencing error rates are powerful variables that affect the best achievable assembly of the target sequence in terms of size and correctness.	[Haiminen, Niina; Parida, Laxmi; Rigoutsos, Isidore] IBM Corp, Thomas J Watson Res Ctr, Computat Biol Ctr, Yorktown Hts, NY USA; [Kuhn, David N.] USDA, ARS, Subtrop Hort Res Stn, Miami, FL USA	International Business Machines (IBM); United States Department of Agriculture (USDA)	Haiminen, N (corresponding author), IBM Corp, Thomas J Watson Res Ctr, Computat Biol Ctr, Yorktown Hts, NY USA.	nhaimin@us.ibm.com; isidore.rigoutsos@jefferson.edu	Rigoutsos, Isidore/C-5381-2012; Haiminen, Niina/AAU-3068-2020	Haiminen, Niina/0000-0002-8663-1019; Rigoutsos, Isidore/0000-0003-1529-8631	IBM	IBM(International Business Machines (IBM))	IBM funded this study through the employment, at the time of the study, of Isidore Rigoutsos, Niina Haiminen, Laxmi Parida and David N. Kuhn. Between them they conceived, designed and performed the experiments, analyzed the data and designed the assembly evaluation protocol.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Blakesley RW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-21; Chaisson MJ, 2008, GENOME RES, V18, P324, DOI 10.1101/gr.7088808; Church DM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000112; Cronn R, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn502; DiGuistini S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r94; Dohm JC, 2007, GENOME RES, V17, P1697, DOI 10.1101/gr.6435207; Gnerre S., 2010, P NATL ACAD SCI; Gnerre S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r88; Hernandez D, 2008, GENOME RES, V18, P802, DOI 10.1101/gr.072033.107; Jeck WR, 2007, BIOINFORMATICS, V23, P2942, DOI 10.1093/bioinformatics/btm451; KEITH CS, 1993, PLANT PHYSIOL, V101, P329, DOI 10.1104/pp.101.1.329; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Mavromatis K, 2007, NAT METHODS, V4, P495, DOI 10.1038/nmeth1043; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Miller JR, 2008, BIOINFORMATICS, V24, P2818, DOI 10.1093/bioinformatics/btn548; Narzisi G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019175; Ossowski S, 2008, GENOME RES, V18, P2024, DOI 10.1101/gr.080200.108; Reinhardt JA, 2009, GENOME RES, V19, P294, DOI 10.1101/gr.083311.108; Rounsley S, 2009, RICE, V2, P35, DOI 10.1007/s12284-009-9025-z; Salzberg SL, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000186; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang WY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017915	28	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2011	6	9							e24182	10.1371/journal.pone.0024182	http://dx.doi.org/10.1371/journal.pone.0024182			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CH	21915294	Green Submitted, Green Published, gold			2022-12-25	WOS:000294802500033
J	Stamataki, D; Holder, M; Hodgetts, C; Jeffery, R; Nye, E; Spencer-Dene, B; Winton, DJ; Lewis, J				Stamataki, Despina; Holder, Maxine; Hodgetts, Christine; Jeffery, Rosemary; Nye, Emma; Spencer-Dene, Bradley; Winton, Douglas J.; Lewis, Julian			Delta1 Expression, Cell Cycle Exit, and Commitment to a Specific Secretory Fate Coincide within a Few Hours in the Mouse Intestinal Stem Cell System	PLOS ONE			English	Article							ATONAL HOMOLOG 1; INNER-EAR; IN-VIVO; EPITHELIAL-CELLS; PROGENITOR CELLS; GENE-EXPRESSION; NOTCH; DIFFERENTIATION; MATH1; INHIBITION	The stem cells of the small intestine are multipotent: they give rise, via transit-amplifying cell divisions, to large numbers of columnar absorptive cells mixed with much smaller numbers of three different classes of secretory cells - mucus-secreting goblet cells, hormone-secreting enteroendocrine cells, and bactericide-secreting Paneth cells. Notch signaling is known to control commitment to a secretory fate, but why are the secretory cells such a small fraction of the population, and how does the diversity of secretory cell types arise? Using the mouse as our model organism, we find that secretory cells, and only secretory cells, pass through a phase of strong expression of the Notch ligand Delta1 (Dll1). Onset of this Dll1 expression coincides with a block to further cell division and is followed in much less than a cell cycle time by expression of Neurog3 - a marker of enteroendocrine fate - or Gfi1 - a marker of goblet or Paneth cell fate. By conditional knock-out of Dll1, we confirm that Delta-Notch signaling controls secretory commitment through lateral inhibition. We infer that cells stop dividing as they become committed to a secretory fate, while their neighbors continue dividing, explaining the final excess of absorptive over secretory cells. Our data rule out schemes in which cells first become committed to be secretory, and then diversify through subsequent cell divisions. A simple mathematical model shows how, instead, Notch signaling may simultaneously govern the commitment to be secretory and the choice between alternative modes of secretory differentiation.	[Stamataki, Despina; Holder, Maxine; Hodgetts, Christine; Lewis, Julian] Canc Res United Kingdom London Res Inst, Vertebrate Dev Lab, London, England; [Stamataki, Despina] Natl Inst Med Res, Div Dev Biol, Mill Hill, England; [Jeffery, Rosemary] Canc Res United Kingdom London Res Inst, Histopathol Unit Lab, London, England; [Nye, Emma; Spencer-Dene, Bradley] Canc Res United Kingdom London Res Inst, Expt Histopathol Unit, London, England; [Winton, Douglas J.] Canc Res United Kingdom Cambridge Res Inst, Li Ka Shing Ctr, Cambridge, England	Cancer Research UK; MRC National Institute for Medical Research; Cancer Research UK; Cancer Research UK; Cancer Research UK; CRUK Cambridge Institute	Stamataki, D (corresponding author), Canc Res United Kingdom London Res Inst, Vertebrate Dev Lab, London, England.	julian.lewis@cancer.org.uk	Lewis, Julian H/E-8733-2010	Holder, Maxine/0000-0002-4613-2194	Cancer Research United Kingdom	Cancer Research United Kingdom(Cancer Research UK)	The work was funded by Cancer Research United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bjerknes M, 1999, GASTROENTEROLOGY, V116, P7, DOI 10.1016/S0016-5085(99)70222-2; Bjerknes M, 2006, DEV BIOL, V300, P722, DOI 10.1016/j.ydbio.2006.07.040; Bjerknes M, 2006, METHOD ENZYMOL, V419, P337, DOI 10.1016/S0076-6879(06)19014-X; Bjerknes M, 2010, DEV BIOL, V345, P49, DOI 10.1016/j.ydbio.2010.06.021; Bossuyt W, 2009, PLOS BIOL, V7, P311, DOI 10.1371/journal.pbio.1000039; Brooker R, 2006, DEVELOPMENT, V133, P1277, DOI 10.1242/dev.02284; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; Collier JR, 1996, J THEOR BIOL, V183, P429, DOI 10.1006/jtbi.1996.0233; Crosnier C, 2005, DEVELOPMENT, V132, P1093, DOI 10.1242/dev.01644; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; deAngelis MH, 1997, NATURE, V386, P717, DOI 10.1038/386717a0; Eddison M, 2000, P NATL ACAD SCI USA, V97, P11692, DOI 10.1073/pnas.97.22.11692; Fortini ME, 2009, DEV CELL, V16, P633, DOI 10.1016/j.devcel.2009.03.010; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; Fre S, 2009, P NATL ACAD SCI USA, V106, P6309, DOI 10.1073/pnas.0900427106; Giudicelli F, 2007, PLOS BIOL, V5, P1309, DOI 10.1371/journal.pbio.0050150; Gregorieff A, 2009, GASTROENTEROLOGY, V137, P1333, DOI 10.1053/j.gastro.2009.06.044; HARTENSTEIN V, 1990, DEV BIOL, V142, P13, DOI 10.1016/0012-1606(90)90147-B; Hirata H, 2004, NAT GENET, V36, P750, DOI 10.1038/ng1372; Hozumi K, 2004, NAT IMMUNOL, V5, P638, DOI 10.1038/ni1075; Ireland H, 2005, DEV DYNAM, V233, P1332, DOI 10.1002/dvdy.20446; Ireland H, 2004, GASTROENTEROLOGY, V126, P1236, DOI 10.1053/j.gastro.2004.03.020; Jeffery R, 2006, METH MOLEC MED, V120, P323; Jenny M, 2002, EMBO J, V21, P6338, DOI 10.1093/emboj/cdf649; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Kazanjian A, 2010, GASTROENTEROLOGY, V139, P918, DOI 10.1053/j.gastro.2010.05.081; Konietzko U, 2010, NEUROBIOL AGING, V31, P58, DOI 10.1016/j.neurobiolaging.2008.03.001; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Lai EC, 2004, DEVELOPMENT, V131, P965, DOI 10.1242/dev.01074; Lewis J, 2003, CURR BIOL, V13, P1398, DOI 10.1016/S0960-9822(03)00534-7; McCutcheon SC, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-89; Millimaki BB, 2007, DEVELOPMENT, V134, P295, DOI 10.1242/dev.02734; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Pellegrinet L, 2011, GASTROENTEROLOGY, V140, P1230, DOI 10.1053/j.gastro.2011.01.005; Raft S, 2007, DEVELOPMENT, V134, P4405, DOI 10.1242/dev.009118; Riccio O, 2008, EMBO REP, V9, P377, DOI 10.1038/embor.2008.7; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Sancho R, 2009, EMBO J, V28, P1843, DOI 10.1038/emboj.2009.153; Sander GR, 2004, J HISTOCHEM CYTOCHEM, V52, P509, DOI 10.1177/002215540405200409; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Schroeder Natalia, 2002, Gene Expression Patterns, V2, P247, DOI 10.1016/S1567-133X(02)00060-1; Shroyer NF, 2005, GENE DEV, V19, P2412, DOI 10.1101/gad.1353905; Shroyer NF, 2007, GASTROENTEROLOGY, V132, P2478, DOI 10.1053/j.gastro.2007.03.047; SMITH RL, 1995, J VIROL, V69, P4593, DOI 10.1128/JVI.69.8.4593-4599.1995; Sonoshita M, 2011, CANCER CELL, V19, P125, DOI 10.1016/j.ccr.2010.11.008; Van der Flier LG, 2009, GASTROENTEROLOGY, V137, P15, DOI 10.1053/j.gastro.2009.05.035; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; van Es JH, 2005, NAT CELL BIOL, V7, P381, DOI 10.1038/ncb1240; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; van Es JH, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1017; VanDussen KL, 2010, DEV BIOL, V346, P215, DOI 10.1016/j.ydbio.2010.07.026; Wright N, 1984, BIOL EPITHELIAL CELL; Yang Q, 2001, SCIENCE, V294, P2155, DOI 10.1126/science.1065718; Zecchini V, 2005, GENE DEV, V19, P1686, DOI 10.1101/gad.341705	56	66	67	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2011	6	9							e24484	10.1371/journal.pone.0024484	http://dx.doi.org/10.1371/journal.pone.0024484			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CH	21915337	Green Submitted, Green Published, gold			2022-12-25	WOS:000294802500052
J	Koster, S; Pavkov-Keller, T; Kuhlbrandt, W; Yildiz, O				Koester, Stefan; Pavkov-Keller, Tea; Kuehlbrandt, Werner; Yildiz, Oezkan			Structure of Human Na+/H+ Exchanger NHE1 Regulatory Region in Complex with Calmodulin and Ca2+	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOMATED STRUCTURE SOLUTION; TARGET RECOGNITION; DIFFRACTION DATA; HEART-FAILURE; H+ EXCHANGER; BINDING; ACTIVATION; DOMAIN; PH; KINASE	The ubiquitous mammalian Na+/H+ exchanger NHE1 has critical functions in regulating intracellular pH, salt concentration, and cellular volume. The regulatory C-terminal domain of NHE1 is linked to the ion-translocating N-terminal membrane domain and acts as a scaffold for signaling complexes. A major interaction partner is calmodulin (CaM), which binds to two neighboring regions of NHE1 in a strongly Ca2+-dependent manner. Upon CaM binding, NHE1 is activated by a shift in sensitivity toward alkaline intracellular pH. Here we report the 2.23 angstrom crystal structure of the NHE1 CaM binding region (NHE1(CaMBR)) in complex with CaM and Ca2+-F. The C- and N-lobes of CaM bind the first and second helix of NHE1(CaMBR), respectively. Both the NHE1 helices and the Ca2+-bound CaM are elongated, as confirmed by small angle x-ray scattering analysis. Our x-ray structure sheds new light on the molecular mechanisms of the phosphorylation-dependent regulation of NHE1 and enables us to propose a model of how Ca2+ regulates NHE1 activity.	[Koester, Stefan; Pavkov-Keller, Tea; Kuehlbrandt, Werner; Yildiz, Oezkan] Max Planck Inst Biophys, Dept Struct Biol, Max von Laue Str 3, D-60438 Frankfurt, Germany; [Pavkov-Keller, Tea] Graz Univ, Dept Struct Biol, Inst Mol Biosci, A-8010 Graz, Austria	Max Planck Society; University of Graz	Yildiz, O (corresponding author), Max Planck Inst Biophys, Dept Struct Biol, Max von Laue Str 3, D-60438 Frankfurt, Germany.	Oezkan.Yildiz@biophys.mpg.de	Pavkov-Keller, Tea/K-9234-2015; Yildiz, Ozkan/P-9207-2016	Pavkov-Keller, Tea/0000-0001-7871-6680; Kuhlbrandt, Werner/0000-0002-2013-4810; Yildiz, Ozkan/0000-0003-3659-2805				Allen DG, 2003, CARDIOVASC RES, V57, P934, DOI 10.1016/S0008-6363(02)00836-2; ARONSON PS, 1982, NATURE, V299, P161, DOI 10.1038/299161a0; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baumgartner M, 2004, AM J PHYSIOL-CELL PH, V287, pC844, DOI 10.1152/ajpcell.00094.2004; Ben Ammar Y, 2006, EMBO J, V25, P2315, DOI 10.1038/sj.emboj.7601145; BERTRAND B, 1994, J BIOL CHEM, V269, P13703; Brett CL, 2005, AM J PHYSIOL-CELL PH, V288, pC223, DOI 10.1152/ajpcell.00360.2004; Chen L, 2001, J PHARMACOL EXP THER, V298, P469; Counillon L, 2000, J BIOL CHEM, V275, P1, DOI 10.1074/jbc.275.1.1; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Drum CL, 2000, J BIOL CHEM, V275, P36334, DOI 10.1074/jbc.M004778200; Engelhardt S, 2002, CIRC RES, V90, P814, DOI 10.1161/01.RES.0000014966.97486.C0; Feldkamp MD, 2011, STRUCTURE, V19, P733, DOI 10.1016/j.str.2011.02.009; Fenn TD, 2003, J APPL CRYSTALLOGR, V36, P944, DOI 10.1107/S0021889803006721; Garnovskaya MN, 2003, J BIOL CHEM, V278, P16908, DOI 10.1074/jbc.M209883200; Goswami P, 2011, EMBO J, V30, P439, DOI 10.1038/emboj.2010.321; GRINSTEIN S, 1989, BIOCHIM BIOPHYS ACTA, V988, P73, DOI 10.1016/0304-4157(89)90004-X; Guinier A., 1939, ANN PHYS-LEIPZIG, DOI DOI 10.1051/ANPHYS/193911120161; Halling DB, 2009, J BIOL CHEM, V284, P20041, DOI 10.1074/jbc.M109.013326; Ikeda T, 1997, J BIOCHEM-TOKYO, V121, P295; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lacroix J, 2004, EMBO REP, V5, P91, DOI 10.1038/sj.embor.7400035; Lee SH, 2008, BIOCHEM BIOPH RES CO, V369, P320, DOI 10.1016/j.bbrc.2008.01.168; Lefler D, 2003, ASSAY DRUG DEV TECHN, V1, P281, DOI 10.1089/15406580360545099; Li XJ, 2004, BIOCHEMISTRY-US, V43, P16477, DOI 10.1021/bi048538v; Lin X, 1996, P NATL ACAD SCI USA, V93, P12631, DOI 10.1073/pnas.93.22.12631; Majava V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005402; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Mishima M, 2007, J BIOL CHEM, V282, P2741, DOI 10.1074/jbc.M604092200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; ONEIL KT, 1990, TRENDS BIOCHEM SCI, V15, P59, DOI 10.1016/0968-0004(90)90177-D; Orlowski J, 2004, PFLUG ARCH EUR J PHY, V447, P549, DOI 10.1007/s00424-003-1110-3; Osawa M, 1999, NAT STRUCT BIOL, V6, P819; Pang TX, 2002, J BIOL CHEM, V277, P43771, DOI 10.1074/jbc.M208313200; Phan VN, 1997, HYPERTENSION, V29, P1265, DOI 10.1161/01.HYP.29.6.1265; POUYSSEGUR J, 1985, FEBS LETT, V190, P115, DOI 10.1016/0014-5793(85)80439-7; SANYAL G, 1988, BIOCHEMISTRY-US, V27, P6229, DOI 10.1021/bi00417a006; SARDET C, 1989, CELL, V56, P271, DOI 10.1016/0092-8674(89)90901-X; Snabaitis AK, 2008, CIRC RES, V103, P881, DOI 10.1161/CIRCRESAHA.108.175877; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Turner JH, 2007, J PHARMACOL EXP THER, V320, P314, DOI 10.1124/jpet.106.112581; Vertessy BG, 1998, BIOCHEMISTRY-US, V37, P15300, DOI 10.1021/bi980795a; Vetter SW, 2003, EUR J BIOCHEM, V270, P404, DOI 10.1046/j.1432-1033.2003.03414.x; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wakabayashi S, 1997, BIOCHEMISTRY-US, V36, P12854, DOI 10.1021/bi9715472; WAKABAYASHI S, 1992, P NATL ACAD SCI USA, V89, P2424, DOI 10.1073/pnas.89.6.2424; WAKABAYASHI S, 1994, J BIOL CHEM, V269, P13710; Zaun HC, 2008, J BIOL CHEM, V283, P12456, DOI 10.1074/jbc.M800267200; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	55	44	45	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40954	40961		10.1074/jbc.M111.286906	http://dx.doi.org/10.1074/jbc.M111.286906			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21931166	hybrid, Green Published			2022-12-25	WOS:000297315400055
J	Hannibal, L; Somasundaram, R; Tejero, J; Wilson, A; Stuehr, DJ				Hannibal, Luciana; Somasundaram, Ramasamy; Tejero, Jesus; Wilson, Adjele; Stuehr, Dennis J.			Influence of Heme-Thiolate in Shaping the Catalytic Properties of a Bacterial Nitric-oxide Synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NOS-LIKE PROTEIN; DEINOCOCCUS-RADIODURANS; ELECTRON-TRANSFER; OXYGENASE DOMAIN; TRYPTOPHAN; INTERMEDIATE; PARAMETERS; REACTIVITY; NITRATION; OXIDATION	Nitric-oxide synthases (NOS) are heme-thiolate enzymes that generate nitric oxide (NO) from L-arginine. Mammalian and bacterial NOSs contain a conserved tryptophan (Trp) that hydrogen bonds with the heme-thiolate ligand. We mutated Trp(66) to His and Phe (W66H, W66F) in B. subtilis NOS to investigate how heme-thiolate electronic properties control enzyme catalysis. The mutations had opposite effects on heme midpoint potential (-302, -361, and -427 mV for W66H, wild-type (WT), and W66F, respectively). These changes were associated with rank order (W66H < WT < W66F) changes in the rates of oxygen activation and product formation in Arg hydroxylation and N-hydroxyarginine (NOHA) oxidation single turnover reactions, and in the O-2 reactivity of the ferrous heme-NO product complex. However, enzyme ferrous heme-O-2 autoxidation showed an opposite rank order. Tetrahydrofolate supported NO synthesis by WT and the mutant NOS. All three proteins showed similar extents of product formation (L-Arg -> NOHA or NOHA -> citrulline) in single turnover studies, but the W66F mutant showed a 2.5 times lower activity when the reactions were supported by flavoproteins and NADPH. We conclude that Trp(66) controls several catalytic parameters by tuning the electron density of the heme-thiolate bond. A greater electron density (as in W66F) improves oxygen activation and reactivity toward substrate, but decreases heme-dioxy stability and lowers the driving force for heme reduction. In the WT enzyme the Trp(66) residue balances these opposing effects for optimal catalysis.	[Hannibal, Luciana; Somasundaram, Ramasamy; Tejero, Jesus; Stuehr, Dennis J.] Cleveland Clin, Lerner Res Inst, Dept Pathobiol, Cleveland, OH 44195 USA; [Wilson, Adjele] CEA IBITEC S, LSOD, F-91191 Gif Sur Yvette, France	Cleveland Clinic Foundation; CEA; UDICE-French Research Universities; Universite Paris Saclay	Stuehr, DJ (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, NC 22,9500 Euclid Ave, Cleveland, OH 44195 USA.	stuehrd@ccf.org	Tejero, Jesus/G-3953-2017; Hannibal, Luciana/AAY-7689-2021	Tejero, Jesus/0000-0003-3245-9978; Hannibal, Luciana/0000-0002-0911-5758; Wilson, Adjele Flore/0000-0003-2622-3600	National Institutes of Health [CA53914, GM51491, HL76491]; American Heart Association [11POST650034]; NATIONAL CANCER INSTITUTE [R01CA053914, R29CA053914] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL076491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051491] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA53914, GM51491, and HL76491 (to D. J. S.) and American Heart Association Postdoctoral Fellowship Grant 11POST650034 (to L. H.).	Adak S, 1999, J BIOL CHEM, V274, P26907, DOI 10.1074/jbc.274.38.26907; Adak S, 2000, J BIOL CHEM, V275, P17434, DOI 10.1074/jbc.M000846200; Adak S, 2001, J INORG BIOCHEM, V83, P301, DOI 10.1016/S0162-0134(00)00176-8; Adak S, 2002, J BIOL CHEM, V277, P16167, DOI 10.1074/jbc.M201136200; Adak S, 2002, P NATL ACAD SCI USA, V99, P107, DOI 10.1073/pnas.012470099; ADMAN E, 1975, P NATL ACAD SCI USA, V72, P4854, DOI 10.1073/pnas.72.12.4854; Agapie T, 2009, P NATL ACAD SCI USA, V106, P16221, DOI 10.1073/pnas.0908443106; Bird LE, 2002, STRUCTURE, V10, P1687, DOI 10.1016/S0969-2126(02)00911-5; Brunel A, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.195446; Buddha MR, 2005, J BIOL CHEM, V280, P31965, DOI 10.1074/jbc.M501568200; Buddha MR, 2004, J BIOL CHEM, V279, P49567, DOI 10.1074/jbc.C400418200; Buddha MR, 2004, P NATL ACAD SCI USA, V101, P15881, DOI 10.1073/pnas.0405483101; CARTER CW, 1977, J BIOL CHEM, V252, P7802; CHANG CK, 1973, J AM CHEM SOC, V95, P8477, DOI 10.1021/ja00806a062; Chartier FJM, 2004, BIOPHYS J, V87, P1939, DOI 10.1529/biophysj.104.042119; Chartier FJM, 2007, J BIOL CHEM, V282, P20877, DOI 10.1074/jbc.M701800200; Chartier FJM, 2007, BIOCHEM J, V401, P235, DOI 10.1042/BJ20060913; CHOUDHURY K, 1994, J BIOL CHEM, V269, P20239; Clark JP, 2006, J INORG BIOCHEM, V100, P1075, DOI 10.1016/j.jinorgbio.2005.11.020; Couture M, 2001, J BIOL CHEM, V276, P38280; Crane BR, 1997, SCIENCE, V278, P425, DOI 10.1126/science.278.5337.425; Crane BR, 1998, SCIENCE, V279, P2121, DOI 10.1126/science.279.5359.2121; Crane BR, 2010, ANNU REV BIOCHEM, V79, P445, DOI 10.1146/annurev-biochem-062608-103436; Crane BR, 2008, BIOCHEM SOC T, V36, P1149, DOI 10.1042/BST0361149; Davydov R, 2009, J AM CHEM SOC, V131, P14493, DOI 10.1021/ja906133h; DEMONTIGNY P, 1987, ANAL CHEM, V59, P1096, DOI 10.1021/ac00135a007; Gautier C, 2006, NITRIC OXIDE-BIOL CH, V15, P312, DOI 10.1016/j.niox.2006.03.010; Griess P., 1879, BER DTSCH CHEM GES, V12, P426, DOI [DOI 10.2147/DDDT.S165440, 10.1002/cber.187901201117., DOI 10.1002/CBER.187901201117]; Gusarov I, 2005, P NATL ACAD SCI USA, V102, P13855, DOI 10.1073/pnas.0504307102; Gusarov I, 2008, J BIOL CHEM, V283, P13140, DOI 10.1074/jbc.M710178200; Gusarov I, 2009, SCIENCE, V325, P1380, DOI 10.1126/science.1175439; HANSON LK, 1979, INT J QUANTUM CHEM, V16, P73; Johnson EG, 2008, CHEM BIOL, V15, P43, DOI 10.1016/j.chembiol.2007.11.014; Kabir M, 2008, BIOCHEMISTRY-US, V47, P12389, DOI 10.1021/bi801491e; Kers JA, 2004, NATURE, V429, P79, DOI 10.1038/nature02504; Kinloch RD, 2010, J INORG BIOCHEM, V104, P357, DOI 10.1016/j.jinorgbio.2009.12.014; Lang J, 2009, J INORG BIOCHEM, V103, P1102, DOI 10.1016/j.jinorgbio.2009.05.011; Marechal A, 2010, FEBS J, V277, P3963, DOI 10.1111/j.1742-4658.2010.07786.x; Matsumura H, 2008, BIOCHEMISTRY-US, V47, P4834, DOI 10.1021/bi800142v; Montgomery HJ, 2010, BIOCHEM RES INT, V2010, DOI 10.1155/2010/489892; Ost TWB, 2003, J AM CHEM SOC, V125, P15010, DOI 10.1021/ja035731o; Ost TWB, 2001, BIOCHEMISTRY-US, V40, P13421, DOI 10.1021/bi010716m; Ost TWB, 2001, BIOCHEMISTRY-US, V40, P13430, DOI 10.1021/bi010717e; Pant K, 2006, BIOCHEMISTRY-US, V45, P2537, DOI 10.1021/bi0518848; Pant K, 2002, BIOCHEMISTRY-US, V41, P11071, DOI 10.1021/bi0263715; Pant K, 2005, J MOL BIOL, V352, P932, DOI 10.1016/j.jmb.2005.07.070; Ray SS, 2007, BIOCHEMISTRY-US, V46, P11857, DOI 10.1021/bi700803p; Reece SY, 2009, BIOCHEMISTRY-US, V48, P5483, DOI 10.1021/bi900385g; Santolini J, 2001, J BIOL CHEM, V276, P48887, DOI 10.1074/jbc.M108666200; Santolini J, 2001, J BIOL CHEM, V276, P1233, DOI 10.1074/jbc.M006858200; Santolini M, 2006, BIOCHEMISTRY-US, V45, P1480, DOI 10.1021/bi051710q; Sudhamsu J, 2006, J BIOL CHEM, V281, P9623, DOI 10.1074/jbc.M510062200; Sudhamsu J, 2009, TRENDS MICROBIOL, V17, P212, DOI 10.1016/j.tim.2009.02.003; Tejero JS, 2008, J BIOL CHEM, V283, P33498, DOI 10.1074/jbc.M806122200; Tejero J, 2011, BIOCHEM J, V433, P163, DOI 10.1042/BJ20101353; Ueyama N, 1996, INORG CHEM, V35, P6473, DOI 10.1021/ic9604324; VALENTINE JS, 1979, P NATL ACAD SCI USA, V76, P1009, DOI 10.1073/pnas.76.3.1009; Wang ZQ, 2007, J BIOL CHEM, V282, P2196, DOI 10.1074/jbc.M608206200; Wang ZQ, 2004, J BIOL CHEM, V279, P19018, DOI 10.1074/jbc.M311663200; Wang ZQ, 2002, J BIOL CHEM, V277, P12830, DOI 10.1074/jbc.M111967200; Wei CC, 2003, BIOCHEMISTRY-US, V42, P1969, DOI 10.1021/bi026898h; Wilson DJ, 2001, BIOCHEM BIOPH RES CO, V287, P126, DOI 10.1006/bbrc.2001.5559; Yoshioka S, 2000, J INORG BIOCHEM, V81, P141, DOI 10.1016/S0162-0134(00)00097-0	63	20	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39224	39235		10.1074/jbc.M111.286351	http://dx.doi.org/10.1074/jbc.M111.286351			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21921039	Green Published, hybrid			2022-12-25	WOS:000296759800041
J	Ramachandran, G; Udgaonkar, JB				Ramachandran, Gayathri; Udgaonkar, Jayant B.			Understanding the Kinetic Roles of the Inducer Heparin and of Rod-like Protofibrils during Amyloid Fibril Formation by Tau Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; THIOFLAVIN-T BINDING; FULL-LENGTH TAU; ALZHEIMERS-DISEASE; NEUROFIBRILLARY TANGLES; IN-VITRO; SULFATE PROTEOGLYCANS; MOLECULAR-MECHANISM; MICROTUBULE-BINDING; ALPHA-SYNUCLEIN	The aggregation of the natively disordered protein, Tau, to form lesions called neurofibrillary tangles is a characteristic feature of several neurodegenerative tauopathies. The polyanion, heparin, is commonly used as an inducer in studies of Tau aggregation in vitro, but there is surprisingly no comprehensive model describing, quantitatively, all aspects of the heparin-induced aggregation reaction. In this study, rate constants and extents of fibril formation by the four repeat domain of Tau (Tau4RD) have been reproducibly determined over a full range of heparin and protein concentrations. The kinetic role of heparin in the nucleation-dependent fibril formation reaction is shown to be limited to participation in the initial rate-limiting steps; a single heparin molecule binds two Tau4RD molecules, forming an aggregation-competent protein dimer, which then serves as a building block for further fibril growth. Importantly, the minimal kinetic model that is proposed can quantitatively account for the characteristic bell-shaped dependence of the aggregation kinetics on the stoichiometry of protein to heparin. Very importantly, this study also identifies for the first time short and thin, rod-like protofibrils that are populated transiently, early during the time course of fibril formation. The identification of these protofibrils as bona fide off-pathway species has implications for the development of therapies for tauopathies based on driving fibril formation as a means of protecting the cell from smaller, putatively toxic aggregates.	[Ramachandran, Gayathri; Udgaonkar, Jayant B.] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore 560065, Karnataka, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Udgaonkar, JB (corresponding author), Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore 560065, Karnataka, India.	jayant@ncbs.res.in			Tata Institute of Fundamental Research; Department of Biotechnology, Government of India; Council of Scientific and Industrial Research, Government of India; Government of India	Tata Institute of Fundamental Research(Tata Institute of Fundamental Research (TIFR)); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); Government of India	This work was funded by the Tata Institute of Fundamental Research and by the Department of Biotechnology, Government of India.; Recipient of the SP Mukherjee Fellowship from the Council of Scientific and Industrial Research, Government of India.; Recipient of the JC Bose National Fellowship from the Government of India.	Andorfer C, 2005, J NEUROSCI, V25, P5446, DOI 10.1523/JNEUROSCI.4637-04.2005; ARRIAGADA PV, 1992, NEUROLOGY, V42, P1681, DOI 10.1212/WNL.42.9.1681; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Barghorn S, 2004, BIOCHEMISTRY-US, V43, P1694, DOI 10.1021/bi0357006; Barghorn S, 2002, BIOCHEMISTRY-US, V41, P14885, DOI 10.1021/bi026469j; Barghorn Stefan, 2004, V299, P35; BARSHOP BA, 1983, ANAL BIOCHEM, V130, P134, DOI 10.1016/0003-2697(83)90660-7; Baskakov IV, 2002, J BIOL CHEM, V277, P21140, DOI 10.1074/jbc.M111402200; Bazar E, 2010, CHEMBIOCHEM, V11, P1997, DOI 10.1002/cbic.201000207; Berriman J, 2003, P NATL ACAD SCI USA, V100, P9034, DOI 10.1073/pnas.1530287100; Biancalana M, 2010, BBA-PROTEINS PROTEOM, V1804, P1405, DOI 10.1016/j.bbapap.2010.04.001; Biancalana M, 2009, J MOL BIOL, V385, P1052, DOI 10.1016/j.jmb.2008.11.006; BISHOP MF, 1984, BIOPHYS J, V46, P631, DOI 10.1016/S0006-3495(84)84062-X; Calamai M, 2006, BIOCHEMISTRY-US, V45, P12806, DOI 10.1021/bi0610653; Carlson SW, 2007, BIOCHEMISTRY-US, V46, P8838, DOI 10.1021/bi700403a; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Chang E, 2011, BBA-PROTEINS PROTEOM, V1814, P388, DOI 10.1016/j.bbapap.2010.10.005; Chirita CN, 2005, BIOCHEMISTRY-US, V44, P5862, DOI 10.1021/bi0500123; Chirita CN, 2004, BIOCHEMISTRY-US, V43, P1704, DOI 10.1021/bi036034b; Chirita CN, 2003, J BIOL CHEM, V278, P25644, DOI 10.1074/jbc.M301663200; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cohlberg JA, 2002, BIOCHEMISTRY-US, V41, P1502, DOI 10.1021/bi011711s; Collins SR, 2004, PLOS BIOL, V2, P1582, DOI 10.1371/journal.pbio.0020321; Congdon EE, 2008, J BIOL CHEM, V283, P13806, DOI 10.1074/jbc.M800247200; CROWTHER RA, 1991, P NATL ACAD SCI USA, V88, P2288, DOI 10.1073/pnas.88.6.2288; Csokova N, 2004, PROTEIN EXPRES PURIF, V35, P366, DOI 10.1016/j.pep.2004.01.012; DEWITT DA, 1993, EXP NEUROL, V121, P149, DOI 10.1006/exnr.1993.1081; Ferrone F, 1999, METHOD ENZYMOL, V309, P256; Fersht A., 1999, STRUCTURE MECH PROTE, P191; FRIEDEN C, 1983, BIOCHEMISTRY-US, V22, P5836, DOI 10.1021/bi00294a023; Frieden C, 2007, PROTEIN SCI, V16, P2334, DOI 10.1110/ps.073164107; Friedhoff P, 1998, P NATL ACAD SCI USA, V95, P15712, DOI 10.1073/pnas.95.26.15712; Friedhoff P, 1998, BIOCHEMISTRY-US, V37, P10223, DOI 10.1021/bi980537d; Garcia ML, 2001, CURR OPIN CELL BIOL, V13, P41, DOI 10.1016/S0955-0674(00)00172-1; Ginsberg SD, 1997, ANN NEUROL, V41, P200, DOI 10.1002/ana.410410211; Goedert M, 1999, AM J PATHOL, V154, P1, DOI 10.1016/S0002-9440(10)65242-X; Goedert M, 1998, CURR OPIN NEUROBIOL, V8, P619, DOI 10.1016/S0959-4388(98)80090-1; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Goldsbury C, 2005, J MOL BIOL, V352, P282, DOI 10.1016/j.jmb.2005.07.029; Gosal WS, 2005, J MOL BIOL, V351, P850, DOI 10.1016/j.jmb.2005.06.040; Goux WJ, 2004, J BIOL CHEM, V279, P26868, DOI 10.1074/jbc.M402379200; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; GUSTKE N, 1994, BIOCHEMISTRY-US, V33, P9511, DOI 10.1021/bi00198a017; Harper JD, 1997, CHEM BIOL, V4, P119, DOI 10.1016/S1074-5521(97)90255-6; Hasegawa M, 1997, J BIOL CHEM, V272, P33118, DOI 10.1074/jbc.272.52.33118; Horcas I, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2432410; Hoshino M, 2002, NAT STRUCT BIOL, V9, P332, DOI 10.1038/nsb792; Inouye H, 2006, BIOPHYS J, V90, P1774, DOI 10.1529/biophysj.105.070136; Jain S, 2008, J MOL BIOL, V382, P1228, DOI 10.1016/j.jmb.2008.07.052; Jeganathan S, 2008, BIOCHEMISTRY-US, V47, P10526, DOI 10.1021/bi800783d; Kar S, 2003, EMBO J, V22, P70, DOI 10.1093/emboj/cdg001; Kheterpal I, 2006, J MOL BIOL, V361, P785, DOI 10.1016/j.jmb.2006.06.066; King ME, 1999, BIOCHEMISTRY-US, V38, P14851, DOI 10.1021/bi9911839; King ME, 2000, J NEUROCHEM, V74, P1749, DOI 10.1046/j.1471-4159.2000.0741749.x; Konno T, 2004, BIOCHEMISTRY-US, V43, P13613, DOI 10.1021/bi048549o; Kumar S, 2010, CURR SCI INDIA, V98, P639; Kumar S, 2009, BIOCHEMISTRY-US, V48, P6441, DOI 10.1021/bi900682w; Lasagna-Reeves CA, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-39; LEE G, 1988, SCIENCE, V239, P285, DOI 10.1126/science.3122323; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Maeda S, 2007, BIOCHEMISTRY-US, V46, P3856, DOI 10.1021/bi061359o; MAGNUS JH, 1991, SCAND J IMMUNOL, V34, P63, DOI 10.1111/j.1365-3083.1991.tb01521.x; Motamedi-Shad N, 2009, J BIOL CHEM, V284, P29921, DOI 10.1074/jbc.M109.018747; Mukrasch MD, 2009, PLOS BIOL, V7, P399, DOI 10.1371/journal.pbio.1000034; Mukrasch MD, 2005, J BIOL CHEM, V280, P24978, DOI 10.1074/jbc.M501565200; Myers SL, 2006, BIOCHEMISTRY-US, V45, P2311, DOI 10.1021/bi052434i; Mylonas E, 2008, BIOCHEMISTRY-US, V47, P10345, DOI 10.1021/bi800900d; NAIKI H, 1989, ANAL BIOCHEM, V177, P244, DOI 10.1016/0003-2697(89)90046-8; Nichols MR, 2002, BIOCHEMISTRY-US, V41, P6115, DOI 10.1021/bi015985r; OOSAWA F, 1962, J MOL BIOL, V4, P10, DOI 10.1016/S0022-2836(62)80112-0; Paudel HK, 1999, J BIOL CHEM, V274, P8029, DOI 10.1074/jbc.274.12.8029; Perez M, 1996, J NEUROCHEM, V67, P1183; PERRY G, 1991, J NEUROSCI, V11, P3679; Peterson DW, 2008, BIOCHEMISTRY-US, V47, P7393, DOI 10.1021/bi702466a; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Pickhardt M, 2007, BIOCHEMISTRY-US, V46, P10016, DOI 10.1021/bi700878g; POLLANEN MS, 1994, AM J PATHOL, V144, P869; Rentzeperis D, 1999, NAT STRUCT BIOL, V6, P569; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; SCHWEERS O, 1995, P NATL ACAD SCI USA, V92, P8463, DOI 10.1073/pnas.92.18.8463; SCHWEERS O, 1994, J BIOL CHEM, V269, P24290; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Sibille N, 2006, BIOCHEMISTRY-US, V45, P12560, DOI 10.1021/bi060964o; SNOW AD, 1992, J HISTOCHEM CYTOCHEM, V40, P105, DOI 10.1177/40.1.1370306; Spillantini MG, 1999, ACTA NEUROPATHOL, V97, P585, DOI 10.1007/s004010051034; St George-Hyslop PH, 2005, CR BIOL, V328, P119, DOI 10.1016/j.crvi.2004.10.013; SU JH, 1992, NEUROSCIENCE, V51, P801, DOI 10.1016/0306-4522(92)90521-3; Suk JY, 2006, BIOCHEMISTRY-US, V45, P2234, DOI 10.1021/bi0519295; Taniguchi S, 2005, J BIOL CHEM, V280, P7614, DOI 10.1074/jbc.M408714200; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; von Bergen M, 2006, BIOCHEMISTRY-US, V45, P6446, DOI 10.1021/bi052530j; Wegmann S, 2010, J BIOL CHEM, V285, P27302, DOI 10.1074/jbc.M110.145318; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; WILCOCK GK, 1982, J NEUROL SCI, V56, P343, DOI 10.1016/0022-510X(82)90155-1; WILLE H, 1992, J CELL BIOL, V118, P573, DOI 10.1083/jcb.118.3.573; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4884, DOI 10.1073/pnas.85.13.4884; Wolfe LS, 2010, P NATL ACAD SCI USA, V107, P16863, DOI 10.1073/pnas.1002867107; Wyman J, 1990, BINDING LINKAGE FUNC; Xu SH, 2010, ALZHEIMERS DEMENT, V6, P110, DOI 10.1016/j.jalz.2009.06.002; Yao TM, 2003, J BIOCHEM, V134, P91, DOI 10.1093/jb/mvg116; Yin HS, 2006, FEBS LETT, V580, P211, DOI 10.1016/j.febslet.2005.11.077; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; YOUNG ID, 1992, ARCH PATHOL LAB MED, V116, P951; YOUNG ID, 1989, ACTA NEUROPATHOL, V78, P202, DOI 10.1007/BF00688210; Zhu HL, 2010, J BIOL CHEM, V285, P3592, DOI 10.1074/jbc.M109.035691	107	97	96	0	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					38948	38959		10.1074/jbc.M111.271874	http://dx.doi.org/10.1074/jbc.M111.271874			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21931162	Green Published, hybrid			2022-12-25	WOS:000296759800014
J	Shi, Q; Padmanabhan, R; Villegas, CJ; Gu, SM; Jiang, JX				Shi, Qian; Padmanabhan, Rugmani; Villegas, Carla J.; Gu, Sumin; Jiang, Jean X.			Membrane Topological Structure of Neutral System N/A Amino Acid Transporter 4 (SNAT4) Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOPOGENIC SIGNALS; MOLECULAR-BIOLOGY; HUMAN PLACENTA; EXPRESSION; IDENTIFICATION; SUPERFAMILY; PREDICTIONS; MECHANISM; SEQUENCE; ISOFORM	Members of system N/A amino acid transporter (SNAT) family mediate transport of neutral amino acids, including L-alanine, L-glutamine, and L-histidine, across the plasma membrane and are involved in a variety of cellular functions. By using chemical labeling, glycosylation, immunofluorescence combined with molecular modeling approaches, we resolved the membrane topological structure of SNAT4, a transporter expressed predominantly in liver. To analyze the orientation using the chemical labeling and biotinylation approach, the "Cys-null" mutant of SNAT4 was first generated by mutating all five endogenous cysteine residues. Based on predicted topological structures, a single cysteine residue was introduced individually into all possible nontransmembrane domains of the Cys-null mutant. The cells expressing these mutants were labeled with N-biotinylaminoethyl methanethiosulfonate, a membrane-impermeable cysteine-directed reagent. We mapped the orientations of N- and C-terminal domains. There are three extracellular loop domains, and among them, the second loop domain is the largest that spans from amino acid residue similar to 242 to similar to 335. The orientation of this domain was further confirmed by the identification of two N-glycosylated residues, Asn-260 and Asn-264. Together, we showed that SNAT4 contains 10 transmembrane domains with extracellular N and C termini and a large N-glycosylated, extracellular loop domain. This is the first report concerning membrane topological structure of mammalian SNAT transporters, which will provide important implications for our understanding of structure-function of the members in this amino acid transporter family.	[Shi, Qian; Padmanabhan, Rugmani; Villegas, Carla J.; Gu, Sumin; Jiang, Jean X.] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Jiang, JX (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	jiangj@uthscsa.edu	Shi, Qian/C-5962-2013	Jiang, Jean/0000-0002-2185-5716	National Institutes of Health [EY12085]; Welch Foundation [AQ-1507]; NATIONAL EYE INSTITUTE [R29EY012085, R01EY012085] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The work was supported, in whole or in part, by National Institutes of Health Grant EY12085. This work was also supported by Welch Foundation Grant AQ-1507.	Ahmed Rezwan, 2010, Journal of Bioinformatics and Computational Biology, V8, P39, DOI 10.1142/S0219720010004501; Blakeslee JJ, 2007, PLANT CELL, V19, P131, DOI 10.1105/tpc.106.040782; Broer S, 2009, J BIOL CHEM, V284, P25823, DOI 10.1074/jbc.M109.031013; Castagna M, 1997, J EXP BIOL, V200, P269; CHRISTENSEN HN, 1990, PHYSIOL REV, V70, P43, DOI 10.1152/physrev.1990.70.1.43; Desforges M, 2006, AM J PHYSIOL-CELL PH, V290, pC305, DOI 10.1152/ajpcell.00258.2005; Devoto A, 1999, J BIOL CHEM, V274, P34993, DOI 10.1074/jbc.274.49.34993; Gao X, 2009, SCIENCE, V324, P1565, DOI 10.1126/science.1173654; Gu SM, 2003, BIOCHEM J, V371, P721, DOI 10.1042/BJ20030049; Gu SM, 2001, GENOMICS, V74, P262, DOI 10.1006/geno.2001.6567; Gu SM, 2001, J BIOL CHEM, V276, P24137, DOI 10.1074/jbc.M009003200; Gu SM, 2000, P NATL ACAD SCI USA, V97, P3230, DOI 10.1073/pnas.050318197; Gupta Ramneek, 2002, Pac Symp Biocomput, P310; Hagglund MGA, 2011, J BIOL CHEM, V286, P20500, DOI 10.1074/jbc.M110.162404; Hatanaka T, 2001, BBA-BIOMEMBRANES, V1510, P10, DOI 10.1016/S0005-2736(00)00390-4; Holmgren M, 1996, NEUROPHARMACOLOGY, V35, P797, DOI 10.1016/0028-3908(96)00129-3; Hyde R, 2007, J BIOL CHEM, V282, P19788, DOI 10.1074/jbc.M611520200; Jack DL, 2000, MICROBIOL-SGM, V146, P1797, DOI 10.1099/00221287-146-8-1797; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lolkema JS, 2008, MOL MEMBR BIOL, V25, P567, DOI 10.1080/09687680802541177; LOO TW, 1995, J BIOL CHEM, V270, P19345, DOI 10.1074/jbc.270.33.19345; Mackenzie B, 2004, PFLUG ARCH EUR J PHY, V447, P784, DOI 10.1007/s00424-003-1117-9; Malandro MS, 1996, ANNU REV BIOCHEM, V65, P305; Nilsson J, 2000, FEBS LETT, V486, P267, DOI 10.1016/S0014-5793(00)02321-8; Novak D, 2006, BIOCHIMIE, V88, P39, DOI 10.1016/j.biochi.2005.07.002; Palacin M, 1998, PHYSIOL REV, V78, P969, DOI 10.1152/physrev.1998.78.4.969; Punta M, 2007, METHODS, V41, P460, DOI 10.1016/j.ymeth.2006.07.026; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; Snider C, 2009, PROTEIN SCI, V18, P2624, DOI 10.1002/pro.256; Sundberg BE, 2008, J MOL NEUROSCI, V35, P179, DOI 10.1007/s12031-008-9046-x; van Geest M, 2000, MICROBIOL MOL BIOL R, V64, P13, DOI 10.1128/MMBR.64.1.13-33.2000; Viklund H, 2004, PROTEIN SCI, V13, P1908, DOI 10.1110/ps.04625404; von Heijne G, 2006, NAT REV MOL CELL BIO, V7, P909, DOI 10.1038/nrm2063; VONHEIJNE G, 1988, EUR J BIOCHEM, V174, P671; Wang HP, 2000, BIOCHEM BIOPH RES CO, V273, P1175, DOI 10.1006/bbrc.2000.3061; White SH, 2009, NATURE, V459, P344, DOI [10.1038/nature08142, 10.1038/nature]; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yao DD, 2000, J BIOL CHEM, V275, P22790, DOI 10.1074/jbc.M002965200; Zhang H, 1997, BIOCHEMISTRY-US, V36, P15856, DOI 10.1021/bi972357u; Zhang Z, 2011, BIOCHEM J, V434, P287, DOI 10.1042/BJ20100507; Zhang Z, 2009, J BIOL CHEM, V284, P25314, DOI 10.1074/jbc.M109.038422; Zheng WJ, 2004, COMPUT BIOL CHEM, V28, P265, DOI 10.1016/j.compbiolchem.2004.07.002	43	9	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38086	38094		10.1074/jbc.M111.220277	http://dx.doi.org/10.1074/jbc.M111.220277			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21917917	Green Published, hybrid			2022-12-25	WOS:000296594200021
J	Lim, MSC; Murray, J; Dowdeswell, RJ; Glynn, JR; Sonnenberg, P				Lim, Megan S. C.; Murray, Jill; Dowdeswell, Robert J.; Glynn, Judith R.; Sonnenberg, Pam			Unnatural Deaths in South African Platinum Miners, 1992-2008	PLOS ONE			English	Article							ACCIDENTS; FATALITIES; INJURIES	Background: The mortality rate from unnatural deaths for South Africa is nearly double the world average. Reliable data are limited by inaccurate and incomplete ascertainment of specific causes of unnatural death. This study describes trends in causes of unnatural death between 1992 and 2008 in a cohort of South African miners. Methodology/Principal Findings: The study used routinely-collected retrospective data with cause of death determined from multiple sources including the mine's human resources database, medical records, death registration, and autopsy. Cause-specific mortality rates and Poisson regression coefficients were calculated by calendar year and age group. The cohort included 40,043 men. One quarter of all 2937 deaths were from unnatural causes (n = 805). Causes of unnatural deaths were road traffic accidents 38% (109/100,000 py), homicides 30% (88/100,000 py), occupational injuries 17% (50/100,000 py), suicides 8% (24/100,000 py), and other accidents 6% (19/100,000 py). Rates of unnatural deaths declined by 2% (95% CI -4%,-1%) per year over the study period, driven by declining rates of road traffic and other accidents. The rate of occupational injury mortality did not change significantly over time (-2% per year, 95% CI -5%,+ 2%). Unnatural deaths were less frequent in this cohort of workers than in the South African population (IRR 0.89, 95% CI 0.82-0.95), particularly homicides (IRR 0.48, 95% CI 0.42-0.55). Conclusions/Significance: Unnatural deaths were a common cause of preventable and premature death in this cohort of miners. While unnatural death rates declined between 1992 and 2008, occupational fatalities remained at a high level. Evidence-based prevention strategies to address these avoidable deaths are urgently needed.	[Lim, Megan S. C.; Sonnenberg, Pam] UCL, Res Dept Infect & Populat Hlth, London, England; [Murray, Jill] Natl Inst Occupat Hlth, Natl Hlth Lab Serv, Johannesburg, South Africa; [Murray, Jill] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa; [Dowdeswell, Robert J.] Rustenburg Platinum Mines Ltd Precious Met Refine, Rustenburg, South Africa; [Glynn, Judith R.] London Sch Hyg & Trop Med, London WC1, England	University of London; University College London; National Health Laboratory Service; University of Witwatersrand; University of London; London School of Hygiene & Tropical Medicine	Lim, MSC (corresponding author), UCL, Res Dept Infect & Populat Hlth, London, England.	p.sonnenberg@ucl.ac.uk		Sonnenberg, Pam/0000-0002-1067-1583	Colt Foundation [CF/04/08]; National Health and Medical Research Council [543158]	Colt Foundation; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Colt Foundation [CF/04/08 www.coltfoundation.org.uk] and a National Health and Medical Research Council Overseas Postdoctoral Training Fellowship [543158] to ML. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. RD is an employee of Rustenburg Platinum Mines Limited and a part-time consultant to Anglo Platinum Ltd. He played a role in study design, analysis and preparation of the manuscript.	ALTBEKER A, 2008, CRIME VIOLENCE INJUR; ANDERSON BA, 2006, 030905 STAT S AFR; Bah S, 2004, SAMJ S AFR MED J, V94, P442; Bradshaw D, 2003, INITIAL BURDEN DIS E; Bradshaw D, 2004, S AFRICAN NATL BURDE; Burger EH, 2007, SAMJ S AFR MED J, V97, P1077; Donson H., 2008, PROFILE FATAL INJURI; Gilbert L, 1996, SOC SCI MED, V43, P873, DOI 10.1016/0277-9536(96)00131-1; Jansen JC, 2005, J S AFR I MIN METALL, V105, P719; Kahn K., 2006, DYING MAKE FRESH STA; LEGER JP, 1991, SAFETY SCI, V14, P169, DOI 10.1016/0925-7535(91)90019-I; LOEWENSON R, 1999, OCCUPATIONAL HLTH SA; Meel BL, 2008, SAMJ S AFR MED J, V98, P716; Michelo P, 2009, OCCUP MED-OXFORD, V59, P191, DOI 10.1093/occmed/kqp009; Murray J, 2005, AIDS, V19, P2019, DOI 10.1097/01.aids.0000188424.79914.ad; Murray J, 2007, AIDS, V21, pS97, DOI 10.1097/01.aids.0000299416.61808.24; Norman R, 2007, B WORLD HEALTH ORGAN, V85, P695, DOI 10.2471/BLT.06.037184; Seedat M, 2009, LANCET, V374, P1011, DOI 10.1016/S0140-6736(09)60948-X; South African Police Service, 2010, CRIM SIT S AFR; *STAT S AFR, 2010, STATS ONL MID POP ES; Statistics South Africa, 2010, MORT CAUS DEATH S AF; *US BUR LAB STAT, 2011, CENS FAT OCC INJ CHA; Van Niekerk A, 2008, CRIME VIOLENCE INJUR; van Schoor O, 2001, ACCIDENT ANAL PREV, V33, P713, DOI 10.1016/S0001-4575(00)00083-X; Walker ARP, 2005, SAMJ S AFR MED J, V95, P482; Weber-Fahr M., 2001, MINING POVERTY REDUC; *WHO, 2004, DEATH DIS ADJ LIF YE; World Health Organization, 2008, The global burden of disease: 2004 update	28	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2011	6	9							e22807	10.1371/journal.pone.0022807	http://dx.doi.org/10.1371/journal.pone.0022807			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZV	21931592	Green Published, gold, Green Accepted			2022-12-25	WOS:000295321800001
J	Vulliamy, TJ; Kirwan, MJ; Beswick, R; Hossain, U; Baqai, C; Ratcliffe, A; Marsh, J; Walne, A; Dokal, I				Vulliamy, Tom J.; Kirwan, Michael J.; Beswick, Richard; Hossain, Upal; Baqai, Charlotte; Ratcliffe, Anna; Marsh, Judith; Walne, Amanda; Dokal, Inderjeet			Differences in Disease Severity but Similar Telomere Lengths in Genetic Subgroups of Patients with Telomerase and Shelterin Mutations	PLOS ONE			English	Article							LINKED DYSKERATOSIS-CONGENITA; APLASTIC-ANEMIA; REVERSE-TRANSCRIPTASE; PULMONARY-FIBROSIS; STEM-CELLS; RNA; COMPONENT; COMPLEX; CANCER; TERC	The bone marrow failure syndrome dyskeratosis congenita (DC) has been considered to be a disorder of telomere maintenance in which disease features arise due to accelerated shortening of telomeres. By screening core components of the telomerase and shelterin complexes in patients with DC and related bone marrow failure syndromes we have identified 24 novel mutations: 11 in the RNA component of telomerase (TERC), 8 in the reverse transcriptase component (TERT), 4 in dyskerin (DKC1) and 1 in TRF1-interacting nuclear factor 2 (TINF2). This has prompted us to review these genetic subtypes in terms of telomere length, telomerase activity and clinical presentation among 194 genetically characterised index cases recruited onto the registry in London. While those with DKC1 and TINF2 mutations present at a younger age and have more disease features than those with TERC or TERT mutations, there is no difference in telomere length between these groups. There is no difference in the age of onset and numbers of disease features seen in those with TERC and TERT mutations despite the fact that the latter show higher levels of telomerase activity in vitro. The incidence of aplastic anaemia is greater in patients with TERC or TINF2 mutations compared to patients with DKC1 mutations, and cancer incidence is highest in patients with TERC mutations. These data are the first to provide robust comparisons between different genetic subtypes of telomerase and shelterin mutations (the "telomereopathies") and clearly demonstrate that disease severity is not explained by telomere length alone.	[Vulliamy, Tom J.; Kirwan, Michael J.; Beswick, Richard; Hossain, Upal; Ratcliffe, Anna; Walne, Amanda; Dokal, Inderjeet] Queen Mary Univ London, Barts & London Sch Med & Dent, Ctr Paediat, London, England; [Baqai, Charlotte] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Haematol, London, England; [Marsh, Judith] Kings Coll Hosp, Dept Haematol Med, London, England	University of London; Queen Mary University London; Imperial College London; King's College Hospital NHS Foundation Trust; King's College Hospital	Vulliamy, TJ (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Ctr Paediat, London, England.	t.vulliamy@qmul.ac.uk		Dokal, Inderjeet/0000-0003-4462-4782	Wellcome Trust [085937/Z/08/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	The authors are grateful to The Wellcome Trust (http://www.wellcome.ac.uk/) for financial support, through project grant number 085937/Z/08/Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter BP, 2007, BLOOD, V110, P1439, DOI 10.1182/blood-2007-02-075598; Alter BP, 2009, BLOOD, V113, P6549, DOI 10.1182/blood-2008-12-192880; Armanios M, 2005, P NATL ACAD SCI USA, V102, P15960, DOI 10.1073/pnas.0508124102; Armanios M, 2009, ANNU REV GENOM HUM G, V10, P45, DOI 10.1146/annurev-genom-082908-150046; Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; Artandi SE, 2010, CARCINOGENESIS, V31, P9, DOI 10.1093/carcin/bgp268; Bessler M, 2010, FEBS LETT, V584, P3831, DOI 10.1016/j.febslet.2010.05.019; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Blackburn EH, 2006, NAT MED, V12, P1133, DOI 10.1038/nm1006-1133; Brummendorf TH, 2001, BLOOD, V97, P895, DOI 10.1182/blood.V97.4.895; Calado RT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007926; Calado RT, 2009, P NATL ACAD SCI USA, V106, P1187, DOI 10.1073/pnas.0807057106; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; Cohen SB, 2007, SCIENCE, V315, P1850, DOI 10.1126/science.1138596; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; de Leon AD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010680; Dokal I, 2000, BRIT J HAEMATOL, V110, P768, DOI 10.1046/j.1365-2141.2000.02109.x; Du HY, 2009, BLOOD, V113, P309, DOI 10.1182/blood-2008-07-166421; Goldman F, 2005, P NATL ACAD SCI USA, V102, P17119, DOI 10.1073/pnas.0505318102; Gu BW, 2008, P NATL ACAD SCI USA, V105, P10173, DOI 10.1073/pnas.0803559105; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; Kim SH, 1999, NAT GENET, V23, P405, DOI 10.1038/70508; Kirwan M, 2009, HUM MUTAT, V30, P1567, DOI 10.1002/humu.21115; Knight SW, 1999, BRIT J HAEMATOL, V107, P335, DOI 10.1046/j.1365-2141.1999.01690.x; Lafontaine DLJ, 1998, GENE DEV, V12, P527, DOI 10.1101/gad.12.4.527; Lansdorp PM, 2009, EMBO J, V28, P2532, DOI 10.1038/emboj.2009.172; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Mochizuki Y, 2004, P NATL ACAD SCI USA, V101, P10756, DOI 10.1073/pnas.0402560101; Olovnikov AM, 1996, EXP GERONTOL, V31, P443, DOI 10.1016/0531-5565(96)00005-8; Sahin E, 2010, NATURE, V464, P520, DOI 10.1038/nature08982; Sasa G., 2011, CLIN GENET IN PRESS; Savage SA, 2008, AM J HUM GENET, V82, P501, DOI 10.1016/j.ajhg.2007.10.004; Savage Sharon A, 2009, Pediatr Blood Cancer, V53, P520, DOI 10.1002/pbc.22061; Shay JW, 2005, CARCINOGENESIS, V26, P867, DOI 10.1093/carcin/bgh296; Tollervey D, 1997, CURR OPIN CELL BIOL, V9, P337, DOI 10.1016/S0955-0674(97)80005-1; Tsakiri KD, 2007, P NATL ACAD SCI USA, V104, P7552, DOI 10.1073/pnas.0701009104; VAZIRI H, 1994, P NATL ACAD SCI USA, V91, P9857, DOI 10.1073/pnas.91.21.9857; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; Vulliamy T, 2004, NAT GENET, V36, P447, DOI 10.1038/ng1346; Vulliamy T, 2002, LANCET, V359, P2168, DOI 10.1016/S0140-6736(02)09087-6; Vulliamy T, 2011, CLIN GENET IN PRESS; Vulliamy TJ, 2006, BLOOD, V107, P2680, DOI 10.1182/blood-2005-07-2622; Vulliamy TJ, 2001, BLOOD CELL MOL DIS, V27, P353, DOI 10.1006/bcmd.2001.0389; Vulliamy T, 2008, P NATL ACAD SCI USA, V105, P8073, DOI 10.1073/pnas.0800042105; Walne AJ, 2008, BLOOD, V112, P3594, DOI 10.1182/blood-2008-05-153445; Walne AJ, 2007, HUM MOL GENET, V16, P1619, DOI 10.1093/hmg/ddm111; Walne AJ, 2010, HUM MOL GENET, V19, P4453, DOI 10.1093/hmg/ddq371; Wong JMY, 2004, HUM GENET, V115, P448, DOI 10.1007/s00439-004-1178-7; Xin ZT, 2007, BLOOD, V109, P524, DOI 10.1182/blood-2006-07-035089; Yamaguchi H, 2005, NEW ENGL J MED, V352, P1413, DOI 10.1056/NEJMoa042980; Yamaguchi H, 2003, BLOOD, V102, P916, DOI 10.1182/blood-2003-01-0335; Ye JZS, 2004, NAT GENET, V36, P618, DOI 10.1038/ng1360; Yoon A, 2006, SCIENCE, V312, P902, DOI 10.1126/science.1123835; Zhong F, 2011, GENE DEV, V25, P11, DOI 10.1101/gad.2006411	55	66	69	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2011	6	9							e24383	10.1371/journal.pone.0024383	http://dx.doi.org/10.1371/journal.pone.0024383			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZV	21931702	Green Published, Green Submitted, gold			2022-12-25	WOS:000295321800026
J	Johannessen, M; Walquist, M; Gerits, N; Dragset, M; Spang, A; Moens, U				Johannessen, Mona; Walquist, Mari; Gerits, Nancy; Dragset, Marte; Spang, Anne; Moens, Ugo			BKV Agnoprotein Interacts with alpha-Soluble N-Ethylmaleimide-Sensitive Fusion Attachment Protein, and Negatively Influences Transport of VSVG-EGFP	PLOS ONE			English	Article							HUMAN POLYOMAVIRUS BK; JC VIRUS AGNOPROTEIN; MHC CLASS-I; ANTIGEN PRESENTATION; LIPID DROPLETS; PHOSPHORYLATION; IDENTIFICATION; TRANSCRIPTION; DISSOCIATION; SECRETION	Background: The human polyomavirus BK (BKV) infects humans worldwide and establishes a persistent infection in the kidney. The BK virus genome encodes three regulatory proteins, large and small tumor-antigen and the agnoprotein, as well as the capsid proteins VP1 to VP3. Agnoprotein is conserved among BKV, JC virus (JCV) and SV40, and agnoprotein-deficient mutants reveal reduced viral propagation. Studies with JCV and SV40 indicate that their agnoproteins may be involved in transcription, replication and/or nuclear and cellular release of the virus. However, the exact function(s) of agnoprotein of BK virus remains elusive. Principal Findings: As a strategy of exploring the functions of BKV agnoprotein, we decided to look for cellular interaction partners for the viral protein. Several partners were identified by yeast two-hybrid assay, among them alpha-SNAP which is involved in disassembly of vesicles during secretion. BKV agnoprotein and alpha-SNAP were found to partially co-localize in cells, and a complex consisting of agnoprotein and alpha-SNAP could be co-immunoprecipitated from cells ectopically expressing the proteins as well as from BKV-transfected cells. The N-terminal part of the agnoprotein was sufficient for the interaction with alpha-SNAP. Finally, we could show that BKV agnoprotein negatively interferes with secretion of VSVG-EGFP reporter suggesting that agnoprotein may modulate exocytosis. Conclusions: We have identified the first cellular interaction partner for BKV agnoprotein. The most N-terminal part of BKV agnoprotein is involved in the interaction with alpha-SNAP. Presence of BKV agnoprotein negatively interferes with secretion of VSVG-EGFP reporter.	[Johannessen, Mona; Walquist, Mari; Gerits, Nancy; Dragset, Marte; Moens, Ugo] Univ Tromso, Res Grp Host Microbe Interact, Dept Med Biol, Fac Hlth Sci, Tromso, Norway; [Spang, Anne] Univ Basel, Biozentrum, Basel, Switzerland	UiT The Arctic University of Tromso; University of Basel	Johannessen, M (corresponding author), Univ Tromso, Res Grp Host Microbe Interact, Dept Med Biol, Fac Hlth Sci, Tromso, Norway.	mona.johannessen@uit.no	Spang, Anne/A-7029-2008; Spang, Anne/M-7223-2019	Spang, Anne/0000-0002-2387-6203; Spang, Anne/0000-0002-2387-6203	Norwegian Cancer Society [A20240]; Aakre-Foundation [A20308]; Mohn-Foundation [A20242]	Norwegian Cancer Society(Norwegian Cancer Society); Aakre-Foundation; Mohn-Foundation	The work was supported by grants from the Norwegian Cancer Society (A20240), the Aakre-Foundation (A20308) and the Mohn-Foundation (A20242). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander T, 2007, J VIROL, V81, P4130, DOI 10.1128/JVI.00028-07; [Anonymous], 2004, NAT METHODS, V1, P275, DOI DOI 10.1038/NMETH1204-275; Blagoveshchenskaya AD, 2002, CELL, V111, P853, DOI 10.1016/S0092-8674(02)01162-5; Bostrom P, 2007, NAT CELL BIOL, V9, P1286, DOI 10.1038/ncb1648; Daniels R, 2007, PLOS PATHOG, V3, P928, DOI 10.1371/journal.ppat.0030098; Deitz SB, 2000, P NATL ACAD SCI USA, V97, P13790, DOI 10.1073/pnas.250483097; Delbue S, 2008, J CLIN MICROBIOL, V46, P2461, DOI 10.1128/JCM.00381-08; Dodd DA, 2001, J VIROL, V75, P8158, DOI 10.1128/JVI.75.17.8158-8165.2001; DOEDENS JR, 1995, EMBO J, V14, P894, DOI 10.1002/j.1460-2075.1995.tb07071.x; Donaldson JG, 2009, TRAFFIC, V10, P1745, DOI 10.1111/j.1600-0854.2009.00979.x; Easha S, 2006, CELL MOL LIFE SCI, V63, P865, DOI 10.1007/s00018-005-5454-z; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Gaynor AM, 2007, PLOS PATHOG, V3, P595, DOI 10.1371/journal.ppat.0030064; Grinde B, 2007, VIRUS RES, V123, P86, DOI 10.1016/j.virusres.2006.08.005; Hansen TH, 2009, NAT REV IMMUNOL, V9, P503, DOI 10.1038/nri2575; HEY AW, 1994, J IMMUNOL METHODS, V173, P149, DOI 10.1016/0022-1759(94)90294-1; Hirling H, 1996, P NATL ACAD SCI USA, V93, P11945, DOI 10.1073/pnas.93.21.11945; Hirsch HH, 2005, CLIN INFECT DIS, V41, P354, DOI 10.1086/431488; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jiang MX, 2009, VIROLOGY, V384, P266, DOI 10.1016/j.virol.2008.09.027; Johannessen M, 2008, VIROLOGY, V379, P97, DOI 10.1016/j.virol.2008.06.007; Johannessen M, 2007, J BIOL CHEM, V282, P14777, DOI 10.1074/jbc.M610669200; Kean JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000363; Khalili K, 2005, J CELL PHYSIOL, V204, P1, DOI 10.1002/jcp.20266; Khalili K, 2001, HUMAN POLYOMAVIRUSES, P359; Liu PS, 2004, J BIOL CHEM, V279, P3787, DOI 10.1074/jbc.M311945200; Matveeva EA, 2001, J BIOL CHEM, V276, P12174, DOI 10.1074/jbc.M007394200; Moens U., 2007, NEW RES ONCOGENIC VI, P1; Nakajima K, 2004, EMBO J, V23, P3216, DOI 10.1038/sj.emboj.7600333; Okada Y, 2005, EMBO REP, V6, P452, DOI 10.1038/sj.embor.7400406; Pamer E, 1998, ANNU REV IMMUNOL, V16, P323, DOI 10.1146/annurev.immunol.16.1.323; Park KJ, 2003, J BIOL CHEM, V278, P35272, DOI 10.1074/jbc.M305095200; Patel NC, 2008, J CLIN VIROL, V43, P66, DOI 10.1016/j.jcv.2008.04.011; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; RESNICK J, 1986, J VIROL, V60, P1098, DOI 10.1128/JVI.60.3.1098-1106.1986; Rinaldo CH, 2003, VIRUS RES, V93, P181, DOI 10.1016/S0168-1702(03)00096-0; Rinaldo CH, 1998, J VIROL, V72, P6233, DOI 10.1128/JVI.72.7.6233-6236.1998; Rinaldo CH, 2007, EXPERT REV ANTI-INFE, V5, P105, DOI 10.1586/14787210.5.1.105; Safak M, 2001, J VIROL, V75, P1476, DOI 10.1128/JVI.75.3.1476-1486.2001; Sariyer IK, 2006, J VIROL, V80, P3893, DOI 10.1128/JVI.80.8.3893-3903.2006; Schowalter RM, 2010, CELL HOST MICROBE, V7, P509, DOI 10.1016/j.chom.2010.05.006; Scuda N, 2011, J VIROL, V85, P4586, DOI 10.1128/JVI.02602-10; Suzuki T, 2005, J BIOL CHEM, V280, P24948, DOI 10.1074/jbc.M411499200; Suzuki T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000801; Unterstab G, 2010, VIROLOGY, V399, P322, DOI 10.1016/j.virol.2010.01.011; van der Meijden E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001024; Viscidi RP, 2008, SCIENCE, V319, P1049, DOI 10.1126/science.1155048; Zhao CX, 2007, FEBS LETT, V581, P2140, DOI 10.1016/j.febslet.2007.03.032	48	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2011	6	9							e24489	10.1371/journal.pone.0024489	http://dx.doi.org/10.1371/journal.pone.0024489			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CO	21931730	gold, Green Published, Green Accepted			2022-12-25	WOS:000294803200022
J	Einevoll, GT; Jurkus, P; Heggelund, P				Einevoll, Gaute T.; Jurkus, Paulius; Heggelund, Paul			Coarse-to-Fine Changes of Receptive Fields in Lateral Geniculate Nucleus Have a Transient and a Sustained Component That Depend on Distinct Mechanisms	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; SPATIAL-FREQUENCY; X-CELLS; RESPONSE PROPERTIES; TEMPORAL DYNAMICS; VISUAL RESPONSE; PSYCHOPHYSICAL EVIDENCE; NONLAGGED CELLS; GAP-JUNCTIONS; SINGLE UNITS	Visual processing in the brain seems to provide fast but coarse information before information about fine details. Such dynamics occur also in single neurons at several levels of the visual system. In the dorsal lateral geniculate nucleus (LGN), neurons have a receptive field (RF) with antagonistic center-surround organization, and temporal changes in center-surround organization are generally assumed to be due to a time-lag of the surround activity relative to center activity. Spatial resolution may be measured as the inverse of center size, and in LGN neurons RF-center width changes during static stimulation with durations in the range of normal fixation periods (250-500 ms) between saccadic eye-movements. The RF-center is initially large, but rapidly shrinks during the first similar to 100 ms to a rather sustained size. We studied such dynamics in anesthetized cats during presentation (250 ms) of static spots centered on the RF with main focus on the transition from the first transient and highly dynamic component to the second more sustained component. The results suggest that the two components depend on different neuronal mechanisms that operate in parallel and with partial temporal overlap rather than on a continuously changing center-surround balance. Results from mathematical modeling further supported this conclusion. We found that existing models for the spatiotemporal RF of LGN neurons failed to account for our experimental results. The modeling demonstrated that a new model, in which the response is given by a sum of an early transient component and a partially overlapping sustained component, adequately accounts for our experimental data.	[Einevoll, Gaute T.; Jurkus, Paulius] Norwegian Univ Life Sci, Dept Math Sci & Technol, As, Norway; [Jurkus, Paulius; Heggelund, Paul] Univ Oslo, Inst Basic Med Sci, Dept Physiol, Oslo, Norway	Norwegian University of Life Sciences; University of Oslo	Einevoll, GT (corresponding author), Norwegian Univ Life Sci, Dept Math Sci & Technol, As, Norway.	paul.heggelund@medisin.uio.no			Norwegian Research Council	Norwegian Research Council(Research Council of NorwayEuropean Commission)	The project was financially supported by the Norwegian Research Council (eVITA and FRIBIO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Allen EA, 2006, J NEUROSCI, V26, P11763, DOI 10.1523/JNEUROSCI.3297-06.2006; BARLOW HB, 1964, J PHYSIOL-LONDON, V173, P377, DOI 10.1113/jphysiol.1964.sp007463; Baumgartner G, 1961, NEUROPHYSIOLOGIE PSY, P296; BAYLOR DA, 1971, J PHYSIOL-LONDON, V214, P265, DOI 10.1113/jphysiol.1971.sp009432; Bloomfield SA, 2007, VISUAL NEUROSCI, V24, P459, DOI 10.1017/S0952523807070071; Bloomfield SA, 2009, NAT REV NEUROSCI, V10, P495, DOI 10.1038/nrn2636; Bredfeldt CE, 2002, J NEUROSCI, V22, P1976, DOI 10.1523/JNEUROSCI.22-05-01976.2002; BREITMEYER B, 1975, VISION RES, V15, P411, DOI 10.1016/0042-6989(75)90090-5; BREITMEYER BG, 1975, VISION RES, V15, P1411, DOI 10.1016/0042-6989(75)90200-X; Cai DQ, 1997, J NEUROPHYSIOL, V78, P1045, DOI 10.1152/jn.1997.78.2.1045; Carpenter RHS, 1991, EYE MOVEMENTS VISION, V8; CLELAND BG, 1971, J PHYSIOL-LONDON, V217, P473, DOI 10.1113/jphysiol.1971.sp009581; DAWIS S, 1984, VISION RES, V24, P549, DOI 10.1016/0042-6989(84)90109-3; Dayan P., 2001, THEORETICAL NEUROSCI; DERRINGTON AM, 1982, J PHYSIOL-LONDON, V333, P343, DOI 10.1113/jphysiol.1982.sp014457; DeVries SH, 2002, CURR BIOL, V12, P1900, DOI 10.1016/S0960-9822(02)01261-7; Einevoll GT, 2000, VISUAL NEUROSCI, V17, P871, DOI 10.1017/S0952523800176060; ENROTHCUGELL C, 1983, J PHYSIOL-LONDON, V341, P279, DOI 10.1113/jphysiol.1983.sp014806; FELIPE A, 1993, VISION RES, V33, P2461, DOI 10.1016/0042-6989(93)90126-H; Fjeld IT, 2002, J PHYSIOL-LONDON, V543, P541, DOI 10.1113/jphysiol.2002.021204; Frazor RA, 2004, J NEUROPHYSIOL, V91, P2607, DOI 10.1152/jn.00858.2003; FRISHMAN LJ, 1987, J GEN PHYSIOL, V89, P599, DOI 10.1085/jgp.89.4.599; Gershenfeld N, 1998, NATURE MATH MODELING; HARRIS MG, 1986, VISION RES, V26, P1779, DOI 10.1016/0042-6989(86)90128-8; HARTVEIT E, 1992, VISUAL NEUROSCI, V9, P515, DOI 10.1017/S0952523800011317; HARTVEIT E, 1993, VISUAL NEUROSCI, V10, P325, DOI 10.1017/S0952523800003722; HARWERTH RS, 1980, VISION RES, V20, P15, DOI 10.1016/0042-6989(80)90137-6; Hegde J, 2004, J NEUROPHYSIOL, V92, P3030, DOI 10.1152/jn.00822.2003; HEGGELUND P, 1990, J NEUROPHYSIOL, V63, P1347, DOI 10.1152/jn.1990.63.6.1347; Hornstein EP, 2004, NAT NEUROSCI, V7, P745, DOI 10.1038/nn1274; HUBEL DH, 1961, J PHYSIOL-LONDON, V155, P385, DOI 10.1113/jphysiol.1961.sp006635; HUMPHREY AL, 1988, J COMP NEUROL, V268, P429, DOI 10.1002/cne.902680311; KULIKOWSKI JJ, 1973, J PHYSIOL-LONDON, V232, P149, DOI 10.1113/jphysiol.1973.sp010261; LEVICK WR, 1972, MED BIOL ENG, V10, P510, DOI 10.1007/BF02474199; MARR D, 1979, PROC R SOC SER B-BIO, V204, P301, DOI 10.1098/rspb.1979.0029; MASTRONARDE DN, 1987, J NEUROPHYSIOL, V57, P357, DOI 10.1152/jn.1987.57.2.357; Menz MD, 2004, J NEUROPHYSIOL, V91, P1782, DOI 10.1152/jn.00571.2003; Menz MD, 2003, NAT NEUROSCI, V6, P59, DOI 10.1038/nn986; Muller JR, 2001, J NEUROSCI, V21, P6978, DOI 10.1523/JNEUROSCI.21-17-06978.2001; Nishimoto S, 2005, J NEUROPHYSIOL, V93, P3524, DOI 10.1152/jn.01169.2004; Passaglia CL, 2009, J NEUROSCI, V29, P2467, DOI 10.1523/JNEUROSCI.4110-08.2009; RAVIOLA E, 1973, P NATL ACAD SCI USA, V70, P1677, DOI 10.1073/pnas.70.6.1677; Ringach DL, 1997, NATURE, V387, P281, DOI 10.1038/387281a0; RODIECK R. W., 1965, VISION RES, V5, P583, DOI 10.1016/0042-6989(65)90033-7; RODIECK RW, 1965, J NEUROPHYSIOL, V28, P833, DOI 10.1152/jn.1965.28.5.833; RODIECK RW, 1967, VISION RES, V7, P107, DOI 10.1016/0042-6989(67)90031-4; Roska B, 2000, J NEUROSCI, V20, P1941; Ruksenas O, 2007, J NEUROPHYSIOL, V97, P1445, DOI 10.1152/jn.01338.2005; Ruksenas O, 2000, VISUAL NEUROSCI, V17, P855, DOI 10.1017/S0952523800176059; Suder K, 2002, EXP BRAIN RES, V144, P430, DOI 10.1007/s00221-002-1061-5; TOLHURST DJ, 1975, VISION RES, V15, P1151, DOI 10.1016/0042-6989(75)90014-0; TOLHURST DJ, 1975, VISION RES, V15, P1143, DOI 10.1016/0042-6989(75)90013-9; Victor JD, 1999, NETWORK-COMP NEURAL, V10, pR1, DOI 10.1088/0954-898X/10/4/201; Worgotter F, 1998, NATURE, V396, P165, DOI 10.1038/24157; WUTTKE W, 1968, PFLUG ARCH EUR J PHY, V304, P253, DOI 10.1007/BF00592128; Xing DJ, 2005, J NEUROPHYSIOL, V94, P799, DOI 10.1152/jn.01139.2004; ZOHARY E, 1990, BIOL CYBERN, V62, P475, DOI 10.1007/BF00205109	58	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2011	6	9							e24523	10.1371/journal.pone.0024523	http://dx.doi.org/10.1371/journal.pone.0024523			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CN	21931739	Green Published, Green Submitted, gold			2022-12-25	WOS:000294803100039
J	Kawada, H; Futami, K; Komagata, O; Kasai, S; Tomita, T; Sonye, G; Mwatele, C; Njenga, SM; Mwandawiro, C; Minakawa, N; Takagi, M				Kawada, Hitoshi; Futami, Kyoko; Komagata, Osamu; Kasai, Shinji; Tomita, Takashi; Sonye, George; Mwatele, Cassian; Njenga, Sammy M.; Mwandawiro, Charles; Minakawa, Noboru; Takagi, Masahiro			Distribution of a Knockdown Resistance Mutation (L1014S) in Anopheles gambiae s.s. and Anopheles arabiensis in Western and Southern Kenya	PLOS ONE			English	Article							INSECTICIDE RESISTANCE; DIPTERA-CULICIDAE; CENTRAL-AFRICA; COVERAGE; ALLELE; SUSCEPTIBILITY; INTROGRESSION; POPULATIONS; ETHIOPIA; COMPLEX	In Kenya, insecticide-treated mosquito nets (ITNs) distributed to pregnant women and children under 5 years old through various programs have resulted in a significant reduction in malaria deaths. All of the World Health Organization-recommended insecticides for mosquito nets are pyrethroids, and vector mosquito resistance to these insecticides is one of the major obstacles to an effective malaria control program. Anopheles gambiae s.s. and Anopheles arabiensis are major malaria vectors that are widely distributed in Kenya. Two point mutations in the voltage-gated sodium channel (L1014F and L1014S) are associated with knockdown resistance (kdr) to DDT and pyrethroids in An. gambiae s.s. While the same point mutations have been reported to be rare in An. arabiensis, some evidence of metabolic resistance has been reported in this species. In order to determine the distribution of the point mutation L1014S in An. gambiae s.s. and An. arabiensis in southern and western Kenya, we collected larvae and screened for the mutation by DNA sequencing. We found high allelic and homozygous frequencies of the L1014S mutation in An. gambiae s.s. The L1014S mutation was also widely distributed in An. arabiensis, although the allelic frequency was lower than in An. gambiae s.s. The same intron sequence (length: 57 base) found in both species indicated that the mutation was introgressed by hybridization. The allelic frequency of L1014S was higher in both species in western regions, demonstrating the strong selection pressure imposed by long-lasting insecticide-treated nets (LLITN)/ITN on the An. gambiae s.s. and An. arabiensis populations in those areas. The present contribution of the L1014S mutation to pyrethroid resistance in An. arabiensis may be negligible. However, the homozygous frequency could increase with continuing selection pressure due to expanded LLITN coverage in the future.	[Kawada, Hitoshi; Futami, Kyoko; Minakawa, Noboru; Takagi, Masahiro] Nagasaki Univ, Inst Trop Med, Dept Vector Ecol & Environm, Nagasaki 852, Japan; [Minakawa, Noboru] Nagasaki Univ, Global Ctr Excellence Program, Nagasaki 852, Japan; [Komagata, Osamu; Kasai, Shinji; Tomita, Takashi] Natl Inst Infect Dis, Tokyo, Japan; [Sonye, George] Springs Hope, Mbita, Kenya; [Mwatele, Cassian; Njenga, Sammy M.] Eastern & So Africa Ctr Int Parasite Control, Nairobi, Kenya; [Mwandawiro, Charles] Kenya Govt Med Res Ctr, Nairobi, Kenya	Nagasaki University; Nagasaki University; National Institute of Infectious Diseases (NIID); Kenya Medical Research Institute	Kawada, H (corresponding author), Nagasaki Univ, Inst Trop Med, Dept Vector Ecol & Environm, Nagasaki 852, Japan.	vergiss@nagasaki-u.ac.jp	Komagata, Osamu/J-2771-2013	Komagata, Osamu/0000-0002-8175-6402; , Noboru/0000-0003-3664-9605	Nagasaki University Institute of Tropical Medicine-Kenya Medical Research Institute (NUITM-KEMRI); JSPS	Nagasaki University Institute of Tropical Medicine-Kenya Medical Research Institute (NUITM-KEMRI); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was partly supported by the Nagasaki University Institute of Tropical Medicine-Kenya Medical Research Institute (NUITM-KEMRI) project and JSPS AA Science Platform Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balkew M, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-40; Bayoh MN, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-62; Chen H, 2008, J MED ENTOMOL, V45, P242, DOI 10.1603/0022-2585(2008)45[242:MLAKRK]2.0.CO;2; dellaTorre A, 1997, GENETICS, V146, P239; Fegan GW, 2007, LANCET, V370, P1035, DOI 10.1016/S0140-6736(07)61477-9; GILLIES MT, 1987, 55 S AFR I MED RES; Kawada H., 2011, PLOS ONE IN PRESS; Kerah-Hinzoumbe C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-192; Mathias DK, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-10; Munhenga G, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-247; Mzilahowa T, 2008, MED VET ENTOMOL, V22, P258, DOI 10.1111/j.1365-2915.2008.00736.x; Nabarro DN, 1998, SCIENCE, V280, P2067, DOI 10.1126/science.280.5372.2067; Noor AM, 2007, PLOS MED, V4, P1341, DOI 10.1371/journal.pmed.0040255; Noor AM, 2010, AM J TROP MED HYG, V83, P854, DOI 10.4269/ajtmh.2010.10-0331; Noor AM, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-180; Okara RM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-69; Ramphul U, 2009, T ROY SOC TROP MED H, V103, P1121, DOI 10.1016/j.trstmh.2009.02.014; Santolamazza F, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-74; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; Slotman M, 2004, GENETICS, V167, P275, DOI 10.1534/genetics.167.1.275; Slotman MA, 2005, AM J TROP MED HYG, V73, P326, DOI 10.4269/ajtmh.2005.73.326; Stump AD, 2004, AM J TROP MED HYG, V70, P591, DOI 10.4269/ajtmh.2004.70.591; Wacira DG, 2007, TROP MED INT HEALTH, V12, P140, DOI 10.1111/j.1365-3156.2006.01759.x; Yewhalaw D, 2010, AM J TROP MED HYG, V83, P122, DOI 10.4269/ajtmh.2010.09-0738; Zaim M., 2007, GLOBAL INSECTICIDE U	25	29	33	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2011	6	9							e24323	10.1371/journal.pone.0024323	http://dx.doi.org/10.1371/journal.pone.0024323			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CN	21931682	Green Published, gold			2022-12-25	WOS:000294803100019
J	Kwiecinski, M; Noetel, A; Elfimova, N; Trebicka, J; Schievenbusch, S; Strack, I; Molnar, L; von Brandenstein, M; Tox, U; Nischt, R; Coutelle, O; Dienes, HP; Odenthal, M				Kwiecinski, Monika; Noetel, Andrea; Elfimova, Natalia; Trebicka, Jonel; Schievenbusch, Stephanie; Strack, Ingo; Molnar, Levente; von Brandenstein, Melanie; Toex, Ulrich; Nischt, Roswitha; Coutelle, Oliver; Dienes, Hans Peter; Odenthal, Margarete			Hepatocyte Growth Factor (HGF) Inhibits Collagen I and IV Synthesis in Hepatic Stellate Cells by miRNA-29 Induction	PLOS ONE			English	Article							BETA GENE-EXPRESSION; FAT-STORING CELLS; RAT-LIVER; TRANSFORMING GROWTH-FACTOR-BETA-1; TGF-BETA; FACTOR SUPPRESSES; FIBROSIS; ACTIVATION; MICRORNAS; TRANSDIFFERENTIATION	Background: In chronic liver disease, hepatic stellate cells (HSC) transdifferentiate into myofibroblasts, promoting extracellular matrix (ECM) synthesis and deposition. Stimulation of HSC by transforming growth factor-beta (TGF-beta) is a crucial event in liver fibrogenesis due to its impact on myofibroblastic transition and ECM induction. In contrast, hepatocyte growth factor (HGF), exerts antifibrotic activities. Recently, miR-29 has been reported to be involved in ECM synthesis. We therefore studied the influence of HGF and TGF-beta on the miR-29 collagen axis in HSC. Methodology: HSC, isolated from rats, were characterized for HGF and Met receptor expression by Real-Time PCR and Western blotting during culture induced myofibroblastic transition. Then, the levels of TGF-beta, HGF, collagen-I and -IV mRNA, in addition to miR-29a and miR-29b were determined after HGF and TGF-beta stimulation of HSC or after experimental fibrosis induced by bile-duct obstruction in rats. The interaction of miR-29 with 3'-untranslated mRNA regions (UTR) was analyzed by reporter assays. The repressive effect of miR-29 on collagen synthesis was studied in HSC treated with miR-29-mimicks by Real-Time PCR and immunoblotting. Principal Findings: The 3'-UTR of the collagen-1 and -4 subtypes were identified to bind miR-29. Hence, miR-29a/b overexpression in HSC resulted in a marked reduction of collagen-I and -IV synthesis. Conversely, a decrease in miR-29 levels is observed during collagen accumulation upon experimental fibrosis, in vivo, and after TGF-beta stimulation of HSC, in vitro. Finally, we show that during myofibroblastic transition and TGF-beta exposure the HGF-receptor, Met, is upregulated in HSC. Thus, whereas TGF-beta stimulation leads to a reduction in miR-29 expression and de-repression of collagen synthesis, stimulation with HGF was definitely associated with highly elevated miR-29 levels and markedly repressed collagen-I and -IV synthesis. Conclusions: Upregulation of miRNA-29 by HGF and downregulation by TGF-beta take part in the anti-or profibrogenic response of HSC, respectively.	[Kwiecinski, Monika; Noetel, Andrea; Elfimova, Natalia; Schievenbusch, Stephanie; Strack, Ingo; Molnar, Levente; von Brandenstein, Melanie; Dienes, Hans Peter; Odenthal, Margarete] Univ Hosp Cologne, Inst Pathol, Cologne, Germany; [Trebicka, Jonel] Univ Bonn, Dept Internal Med 1, D-5300 Bonn, Germany; [Schievenbusch, Stephanie; Toex, Ulrich] Univ Hosp Cologne, Dept Gastroenterol & Hepatol, Cologne, Germany; [Nischt, Roswitha] Univ Hosp Cologne, Dept Dermatol, Cologne, Germany; [Coutelle, Oliver] Univ Hosp Cologne, Dept Internal Med, Cologne, Germany	University of Cologne; University of Bonn; University of Cologne; University of Cologne; University of Cologne	Kwiecinski, M (corresponding author), Univ Hosp Cologne, Inst Pathol, Cologne, Germany.	m.odenthal@uni-koeln.de		Trebicka, Jonel/0000-0002-7028-3881	Medical Faculty of the University Cologne; German Ministry of Education and Research (BMBF) [01KI0601]; German Competence Network for Viral Hepatitis (HepNet); German Liver Foundation	Medical Faculty of the University Cologne; German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Competence Network for Viral Hepatitis (HepNet); German Liver Foundation	This study was partly supported by the Research and Education program of the Medical Faculty of the University Cologne and by the German Competence Network for Viral Hepatitis (HepNet), funded by the German Ministry of Education and Research (BMBF), Grant No 01KI0601 (to HPD / MO) and the German Liver Foundation. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANNONI G, 1992, J HEPATOL, V14, P259, DOI 10.1016/0168-8278(92)90168-O; ARMENDARIZBORUNDA J, 1990, FASEB J, V4, P215, DOI 10.1096/fasebj.4.2.2298342; BARDELLI A, 1994, J BIOTECHNOL, V37, P109, DOI 10.1016/0168-1656(94)90002-7; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; CASTILLA A, 1991, NEW ENGL J MED, V324, P933, DOI 10.1056/NEJM199104043241401; Creighton CJ, 2008, RNA, V14, P2290, DOI 10.1261/rna.1188208; CZAJA MJ, 1989, J CELL BIOL, V108, P2477, DOI 10.1083/jcb.108.6.2477; DeBleser PJ, 1997, J HEPATOL, V26, P886, DOI 10.1016/S0168-8278(97)80257-7; Dooley S, 2000, HEPATOLOGY, V31, P1094, DOI 10.1053/he.2000.6126; Dooley S, 2001, FEBS LETT, V502, P4, DOI 10.1016/S0014-5793(01)02656-4; Du B, 2010, FEBS LETT, V584, P811, DOI 10.1016/j.febslet.2009.12.053; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Friedman SL, 1999, ALCOHOL CLIN EXP RES, V23, P904, DOI 10.1097/00000374-199905000-00020; GALIMI F, 1993, STEM CELLS, V11, P22; GEERTS A, 1990, HEPATOLOGY, V12, P233, DOI 10.1002/hep.1840120209; GEERTS A, 1989, J HEPATOL, V9, P59, DOI 10.1016/0168-8278(89)90076-7; Gerling B, 1996, J HEPATOL, V25, P79, DOI 10.1016/S0168-8278(96)80331-X; Gressner AM, 2006, J CELL MOL MED, V10, P76, DOI 10.1111/j.1582-4934.2006.tb00292.x; Gressner OA, 2008, J GASTROEN HEPATOL, V23, P1024, DOI 10.1111/j.1440-1746.2008.05345.x; Guo CJ, 2009, FEBS J, V276, P5163, DOI 10.1111/j.1742-4658.2009.07213.x; Hautekeete ML, 1997, VIRCHOWS ARCH, V430, P195, DOI 10.1007/BF01324802; Ji JL, 2009, FEBS LETT, V583, P759, DOI 10.1016/j.febslet.2009.01.034; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kisseleva T, 2006, J HEPATOL, V45, P429, DOI 10.1016/j.jhep.2006.04.014; Knittel T, 1999, GASTROENTEROLOGY, V117, P1205, DOI 10.1016/S0016-5085(99)70407-5; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Li ZY, 2009, J BIOL CHEM, V284, P15676, DOI 10.1074/jbc.M809787200; MATSUDA Y, 1995, J BIOCHEM-TOKYO, V118, P643, DOI 10.1093/oxfordjournals.jbchem.a124958; Matsuda Y, 1997, HEPATOLOGY, V26, P81; Maurer B, 2010, ARTHRITIS RHEUM-US, V62, P1733, DOI 10.1002/art.27443; MICHALOPOULOS GK, 1990, FASEB J, V4, P176, DOI 10.1096/fasebj.4.2.2404819; MILANI S, 1990, AM J PATHOL, V137, P59; Mott JL, 2010, J CELL BIOCHEM, V110, P1155, DOI 10.1002/jcb.22630; NAGY P, 1991, HEPATOLOGY, V14, P269, DOI 10.1002/hep.1840140211; Ogawa T, 2010, BIOCHEM BIOPH RES CO, V391, P316, DOI 10.1016/j.bbrc.2009.11.056; PINZANI M, 1989, J CLIN INVEST, V84, P1786, DOI 10.1172/JCI114363; PINZANI M, 1991, AM J PHYSIOL, V260, pC485, DOI 10.1152/ajpcell.1991.260.3.C485; RAMADORI G, 1992, BIOCHEM BIOPH RES CO, V183, P739, DOI 10.1016/0006-291X(92)90545-V; RAMADORI G, 1990, VIRCHOWS ARCH B, V59, P349, DOI 10.1007/BF02899424; Roderburg C, 2011, HEPATOLOGY; Sauvant P, 2002, INT J BIOCHEM CELL B, V34, P1017, DOI 10.1016/S1357-2725(02)00023-7; Schievenbusch S, 2009, BIOCHEM BIOPH RES CO, V385, P55, DOI 10.1016/j.bbrc.2009.05.010; Schuppan D, 2003, CELL DEATH DIFFER, V10, pS59, DOI 10.1038/sj.cdd.4401163; Tox U, 2007, DIGEST DIS SCI, V52, P1995, DOI 10.1007/s10620-006-9133-1; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Ueki T, 1999, NAT MED, V5, P226, DOI 10.1038/5593; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; Verrecchia F, 2007, WORLD J GASTROENTERO, V13, P3056, DOI 10.3748/wjg.v13.i22.3056; Vogel S, 2000, J LIPID RES, V41, P882; Wang H, 2008, CANCER CELL, V14, P369, DOI 10.1016/j.ccr.2008.10.006; Yang CQ, 2003, GASTROENTEROLOGY, V124, P147, DOI 10.1053/gast.2003.50012; Yang JW, 2003, AM J PATHOL, V163, P621, DOI 10.1016/S0002-9440(10)63689-9; Yasuda H, 1996, HEPATOLOGY, V24, P636, DOI 10.1002/hep.510240328	54	113	126	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2011	6	9							e24568	10.1371/journal.pone.0024568	http://dx.doi.org/10.1371/journal.pone.0024568			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CN	21931759	gold, Green Published, Green Submitted			2022-12-25	WOS:000294803100043
J	Silvotti, L; Cavalca, E; Gatti, R; Percudani, R; Tirindelli, R				Silvotti, Lucia; Cavalca, Eleonora; Gatti, Rita; Percudani, Riccardo; Tirindelli, Roberto			A Recent Class of Chemosensory Neurons Developed in Mouse and Rat	PLOS ONE			English	Article							PUTATIVE PHEROMONE RECEPTORS; VOMERONASAL SENSORY NEURONS; COMBINATORIAL COEXPRESSION; MULTIGENE FAMILY; GENE CHOICE; ORGAN; EXPRESSION; ACTIVATION; MAMMALS; PROJECTIONS	In most animal species, the vomeronasal organ ensures the individual recognition of conspecifics, a prerequisite for a successful reproduction. The vomeronasal organ expresses several receptors for pheromone detection. Mouse vomeronasal type-2 receptors (V2Rs) are restricted to the basal neurons of this organ and organized in four families. Family-A, B and D (family ABD) V2Rs are expressed monogenically (one receptor per neuron) and coexpress with either Vmn2r1 or Vmn2r2, two members of family-C V2Rs. Thus, basal neurons are characterized by specific combinations of two V2Rs. To investigate this issue, we raised antibodies against all family-C V2Rs and analyzed their expression pattern. We found that six out of seven family-C V2Rs (Vmn2r2-7) largely coexpressed and that none of the anti-Vmn2r2-7 antibodies significantly stained Vmn2r1 positive neurons. Thus, basal neurons are divided into two complementary subsets. The first subset (Vmn2r1-positive) preferentially coexpresses a distinct group of family-ABD V2Rs, whereas the second subset (Vmn2r2-7-positive) coexpresses the remaining group of V2Rs. Phylogenetic reconstruction and the analysis of genetic loci in various species reveal that receptors expressed by this second neuronal subset are recent branches of the V2R tree exclusively present in mouse and rat. Conversely, V2Rs expressed in Vmn2r1 positive neurons, are phylogenetically ancient and found in most vertebrates including rodents. Noticeably, the more recent neuronal subset expresses a type of Major Histocompatibility Complex genes only found in murine species. These results indicate that the expansion of the V2R repertoire in a murine ancestor occurred with the establishment of a new population of vomeronasal neurons in which coexists the polygenic expression of a recent group of family-C V2Rs (Vmn2r2-7) and the monogenic expression of a recent group of family-ABD V2Rs. This evolutionary innovation could provide a molecular rationale for the exquisite ability in individual recognition and mate choice of murine species.	[Silvotti, Lucia; Cavalca, Eleonora; Tirindelli, Roberto] Univ Parma, Dept Neurosci, I-43100 Parma, Italy; [Silvotti, Lucia; Cavalca, Eleonora; Tirindelli, Roberto] Univ Parma, IIT, BCSMC, I-43100 Parma, Italy; [Gatti, Rita] Univ Parma, Dept Expt Med, I-43100 Parma, Italy; [Percudani, Riccardo] Univ Parma, Dept Biochem, I-43100 Parma, Italy	University of Parma; Istituto Italiano di Tecnologia - IIT; University of Parma; University of Parma; University of Parma	Silvotti, L (corresponding author), Univ Parma, Dept Neurosci, I-43100 Parma, Italy.	robertin@unipr.it	percudani, riccardo/B-4872-2011; Cavalca, Eleonora/AAN-8070-2020	percudani, riccardo/0000-0001-8452-1062; Cavalca, Eleonora/0000-0002-0131-3223	Italian Ministry of Research (MIUR)	Italian Ministry of Research (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work is supported by the Italian Ministry of Research (MIUR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belluscio L, 1999, CELL, V97, P209, DOI 10.1016/S0092-8674(00)80731-X; Berghard A, 1996, J NEUROSCI, V16, P909; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Blanga-Kanfi S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-71; Boschat C, 2002, NAT NEUROSCI, V5, P1261, DOI 10.1038/nn978; Brennan PA, 2006, NATURE, V444, P308, DOI 10.1038/nature05404; Capello L, 2009, EUR J NEUROSCI, V29, P671, DOI 10.1111/j.1460-9568.2009.06630.x; Del Punta K, 2002, NATURE, V419, P70, DOI 10.1038/nature00955; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Haga S, 2010, NATURE, V466, P118, DOI 10.1038/nature09142; Herrada G, 1997, CELL, V90, P763, DOI 10.1016/S0092-8674(00)80536-X; Ishii T, 2003, CURR BIOL, V13, P394, DOI 10.1016/S0960-9822(03)00092-7; Ishii T, 2008, J NEUROSCI, V28, P2332, DOI 10.1523/JNEUROSCI.4807-07.2008; Ishii T, 2011, MOL CELL NEUROSCI, V46, P397, DOI 10.1016/j.mcn.2010.11.002; Jia CP, 1996, BRAIN RES, V719, P117, DOI 10.1016/0006-8993(96)00110-2; Krieger J, 1999, J BIOL CHEM, V274, P4655, DOI 10.1074/jbc.274.8.4655; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Leinders-Zufall T, 2004, SCIENCE, V306, P1033, DOI 10.1126/science.1102818; Leinders-Zufall T, 2009, NAT NEUROSCI, V12, P1551, DOI 10.1038/nn.2452; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; Liberles SD, 2009, P NATL ACAD SCI USA, V106, P9842, DOI 10.1073/pnas.0904464106; Loconto J, 2003, CELL, V112, P607, DOI 10.1016/S0092-8674(03)00153-3; Martini S, 2001, J NEUROSCI, V21, P843, DOI 10.1523/JNEUROSCI.21-03-00843.2001; Matsunami H, 1997, CELL, V90, P775, DOI 10.1016/S0092-8674(00)80537-1; Mombaerts P, 2004, CURR OPIN NEUROBIOL, V14, P31, DOI 10.1016/j.conb.2004.01.014; Olson R, 2005, PLOS BIOL, V3, P1436, DOI 10.1371/journal.pbio.0030257; Papes F, 2010, CELL, V141, P692, DOI 10.1016/j.cell.2010.03.037; Riviere S, 2009, NATURE, V459, P574, DOI 10.1038/nature08029; Rodriguez I, 1999, CELL, V97, P199, DOI 10.1016/S0092-8674(00)80730-8; Roppolo D, 2007, EMBO J, V26, P3423, DOI 10.1038/sj.emboj.7601782; Ryba NJP, 1997, NEURON, V19, P371, DOI 10.1016/S0896-6273(00)80946-0; Shi P, 2007, GENOME RES, V17, P166, DOI 10.1101/gr.6040007; Silvotti L, 2005, CHEM SENSES, V30, P1, DOI 10.1093/chemse/bjh250; Silvotti L, 2007, J NEUROCHEM, V103, P1753, DOI 10.1111/j.1471-4159.2007.04877.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tirindelli R, 2009, PHYSIOL REV, V89, P921, DOI 10.1152/physrev.00037.2008; Yang H, 2005, GENOMICS, V86, P306, DOI 10.1016/j.ygeno.2005.05.012; Young JM, 2007, TRENDS GENET, V23, P212, DOI 10.1016/j.tig.2007.03.004; Zufall F, 2007, CURR OPIN NEUROBIOL, V17, P483, DOI 10.1016/j.conb.2007.07.012	40	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2011	6	9							e24462	10.1371/journal.pone.0024462	http://dx.doi.org/10.1371/journal.pone.0024462			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CN	21931725	Green Submitted, Green Published, gold			2022-12-25	WOS:000294803100036
J	Corbett, JE; Carrasco, M				Corbett, Jennifer E.; Carrasco, Marisa			Visual Performance Fields: Frames of Reference	PLOS ONE			English	Article							CONTRAST SENSITIVITY; COVERT ATTENTION; SUSTAINED ATTENTION; TARGET ECCENTRICITY; SPATIAL-RESOLUTION; STRIATE CORTEX; MACAQUE MONKEY; ORIENTATION; REPRESENTATION; NEGLECT	Performance in most visual discrimination tasks is better along the horizontal than the vertical meridian (Horizontal-Vertical Anisotropy, HVA), and along the lower than the upper vertical meridian (Vertical Meridian Asymmetry, VMA), with intermediate performance at intercardinal locations. As these inhomogeneities are prevalent throughout visual tasks, it is important to understand the perceptual consequences of dissociating spatial reference frames. In all studies of performance fields so far, allocentric environmental references and egocentric observer reference frames were aligned. Here we quantified the effects of manipulating head-centric and retinotopic coordinates on the shape of visual performance fields. When observers viewed briefly presented radial arrays of Gabors and discriminated the tilt of a target relative to homogeneously oriented distractors, performance fields shifted with head tilt (Experiment 1), and fixation (Experiment 2). These results show that performance fields shift in-line with egocentric referents, corresponding to the retinal location of the stimulus.	[Corbett, Jennifer E.] NYU, Dept Psychol, New York, NY 10003 USA; NYU, Ctr Neural Sci, New York, NY 10003 USA	New York University; New York University	Corbett, JE (corresponding author), NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA.	jennifer.e.corbett@gmail.com		Lauwereyns, Jan/0000-0003-0551-2550	NIH [RO1 EY016200]; NATIONAL EYE INSTITUTE [R01EY016200] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by an NIH Grant RO1 EY016200 to MC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams J, 2011, F1000 RES 2011, V2, P53542; Altpeter E, 2000, VISION RES, V40, P1539, DOI 10.1016/S0042-6989(00)00059-6; APPELLE S, 1972, PSYCHOL BULL, V78, P266, DOI 10.1037/h0033117; BEHRMANN M, 1994, J COGNITIVE NEUROSCI, V6, P1, DOI 10.1162/jocn.1994.6.1.1; Bisiach E, 1988, HDB NEUROPSYCHOLOGY, V1, P195; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Cameron EL, 2002, VISION RES, V42, P949, DOI 10.1016/S0042-6989(02)00039-1; Carrasco M, 2004, VISION RES, V44, P1351, DOI 10.1016/j.visres.2003.11.026; Carrasco M, 2001, SPATIAL VISION, V15, P61, DOI 10.1163/15685680152692015; Carrasco M, 1998, VISION RES, V38, P347, DOI 10.1016/S0042-6989(97)00152-1; Carrasco M, 1998, PERCEPT PSYCHOPHYS, V60, P1243, DOI 10.3758/BF03206173; Carrasco M, 1998, J EXP PSYCHOL HUMAN, V24, P673, DOI 10.1037/0096-1523.24.2.673; CARRASCO M, 1995, PERCEPT PSYCHOPHYS, V57, P1241, DOI 10.3758/BF03208380; Carrasco M, 1997, VISION RES, V37, P63, DOI 10.1016/S0042-6989(96)00102-2; Carrasco M, 2003, NAT NEUROSCI, V6, P699, DOI 10.1038/nn1079; Carrasco M, 2006, VISION RES, V46, P2028, DOI 10.1016/j.visres.2005.12.015; Carrasco M, 2002, J VISION, V2, DOI 10.1167/2.6.4; Chakravarthi R, 2009, VISION RES, V49, P1638, DOI 10.1016/j.visres.2009.03.026; CONNOLLY M, 1984, J COMP NEUROL, V226, P544, DOI 10.1002/cne.902260408; CURCIO CA, 1987, SCIENCE, V236, P579, DOI 10.1126/science.3576186; CURCIO CA, 1990, J COMP NEUROL, V292, P497, DOI 10.1002/cne.902920402; CURCIO CA, 1990, J COMP NEUROL, V300, P5, DOI 10.1002/cne.903000103; DANIEL PM, 1961, J PHYSIOL-LONDON, V159, P203, DOI 10.1113/jphysiol.1961.sp006803; EDGAR GK, 1990, PERCEPTION, V19, P759, DOI 10.1068/p190759; Farah MJ, 1990, COGNITIVE NEUROPSYCH, V8, P335; FERRANTE D, 1995, ACTA PSYCHOL, V88, P25, DOI 10.1016/0001-6918(93)E0057-9; Fuller S, 2008, J VISION, V8, DOI 10.1167/8.1.16; Fuller S, 2009, J VISION, V9, DOI 10.1167/9.4.13; Galati G, 2000, EXP BRAIN RES, V133, P156, DOI 10.1007/s002210000375; GOLDMEIER E, 1972, PSYCHOL ISSUES, V8, P1; Gordon J., 1997, Investigative Ophthalmology and Visual Science, V38, pS898; HALLIGAN PW, 1991, NATURE, V350, P498, DOI 10.1038/350498a0; He S, 1996, NATURE, V383, P334, DOI 10.1038/383334a0; Howard I. P., 1966, HUMAN SPATIAL ORIENT; Howard I. P., 1982, HUMAN VISUAL ORIENTA; KARNATH HO, 1991, BRAIN, V114, P1997, DOI 10.1093/brain/114.4.1997; KEHRER L, 1989, Spatial Vision, V4, P45, DOI 10.1163/156856889X00040; KEHRER L, 1987, Spatial Vision, V2, P247, DOI 10.1163/156856887X00204; Kirk R.E., 1968, EXPT DESIGN PROCEDUR; Kristjansson A, 2008, PERCEPTION, V37, P747, DOI 10.1068/p5922; KROSE BJA, 1989, VISION RES, V29, P1607, DOI 10.1016/0042-6989(89)90142-9; Lennie P, 1998, PERCEPTION, V27, P889, DOI 10.1068/p270889; Levine MW, 2005, VISION RES, V45, P2820, DOI 10.1016/j.visres.2005.04.001; Ling S, 2006, NAT NEUROSCI, V9, P1243, DOI 10.1038/nn1761; Liu TH, 2006, J VISION, V6, P1294, DOI 10.1167/6.11.12; Luyat M, 2002, J EXP PSYCHOL HUMAN, V28, P1002, DOI 10.1037//0096-1523.28.4.1002; Mackeben M, 1999, SPATIAL VISION, V12, P51, DOI 10.1163/156856899X00030; MAUNSELL JHR, 1987, J COMP NEUROL, V266, P535, DOI 10.1002/cne.902660407; Montaser-Kouhsari L, 2009, ATTEN PERCEPT PSYCHO, V71, P1782, DOI 10.3758/APP.71.8.1782; Morgan MJ, 2006, VISION RES, V46, P1868, DOI 10.1016/j.visres.2005.11.026; Najemnik J, 2005, NATURE, V434, P387, DOI 10.1038/nature03390; NAZIR TA, 1992, VISION RES, V32, P771, DOI 10.1016/0042-6989(92)90192-L; Paillard J., 1991, BRAIN SPACE, P81; PELLI DG, 1991, VISION RES, V31, P1337, DOI 10.1016/0042-6989(91)90055-A; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; PERRY VH, 1985, VISION RES, V25, P1795, DOI 10.1016/0042-6989(85)90004-5; Popple AV, 2005, PERCEPTION, V34, P87, DOI 10.1068/p5345; Pretorius LL, 2006, HUM FACTORS, V48, P774, DOI 10.1518/001872006779166370; PREVIC FH, 1990, BEHAV BRAIN SCI, V13, P519, DOI 10.1017/S0140525X00080018; Rajimehr R, 2009, J NEUROSCI, V29, P11149, DOI 10.1523/JNEUROSCI.1835-09.2009; REGAN D, 1983, INVEST OPHTH VIS SCI, V24, P754; RIJSDIJK JP, 1980, VISION RES, V20, P235, DOI 10.1016/0042-6989(80)90108-X; ROCK I, 1973, ORIENTATION FORM; Rock I., 1990, LEGACY SOLOMON ASCH, P243; ROVAMO J, 1979, EXP BRAIN RES, V37, P495, DOI 10.1007/bf00236819; Rubin N, 1996, SCIENCE, V271, P651, DOI 10.1126/science.271.5249.651; Sayres R, 2008, J NEUROPHYSIOL, V100, P249, DOI 10.1152/jn.01383.2007; Silva MF, 2008, VISION RES, V48, P127, DOI 10.1016/j.visres.2007.10.018; Silva MF, 2010, J VISION, V10, DOI 10.1167/10.6.26; Talgar CP, 2002, PSYCHON B REV, V9, P714, DOI 10.3758/BF03196326; Talgar CP, 2004, J VISION, V4, P22, DOI 10.1167/4.1.3; TOOTELL RBH, 1988, J NEUROSCI, V8, P1531; VANDEGRIND WA, 1993, VISION RES, V33, P1089, DOI 10.1016/0042-6989(93)90242-O; VANESSEN DC, 1984, VISION RES, V24, P429, DOI 10.1016/0042-6989(84)90041-5; Vecera SP, 2006, PSYCHON B REV, V13, P563, DOI 10.3758/BF03193963; Vecera SP, 2004, PSYCHON B REV, V11, P909, DOI 10.3758/BF03196720; Vecera SP, 2002, J EXP PSYCHOL GEN, V131, P194, DOI 10.1037//0096-3445.131.2.194; WADE NJ, 1992, AUST J PSYCHOL, V44, P139, DOI 10.1080/00049539208259833; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; Yeshurun Y, 1999, VISION RES, V39, P293, DOI 10.1016/S0042-6989(98)00114-X; Yeshurun Y, 2008, VISION RES, V48, P80, DOI 10.1016/j.visres.2007.10.015	81	22	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e24470	10.1371/journal.pone.0024470	http://dx.doi.org/10.1371/journal.pone.0024470			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	819CK	21931727	Green Published, gold, Green Submitted			2022-12-25	WOS:000294802800056
J	Kumar, AMV; Gupta, D; Rewari, BB; Bachani, D; Mohammed, S; Sharma, V; Lal, K; Reddy, HRR; Naik, B; Prasad, R; Yaqoob, M; Deepak, KG; Shastri, S; Satyanarayana, S; Harries, AD; Chauhan, LS; Dewan, P				Kumar, Ajay M. V.; Gupta, Devesh; Rewari, B. B.; Bachani, Damodar; Mohammed, Suresh; Sharma, Vartika; Lal, Kumaraswamy; Reddy, H. R. Raveendra; Naik, Balaji; Prasad, Rita; Yaqoob, Mohammed; Deepak, K. G.; Shastri, Suresh; Satyanarayana, Srinath; Harries, Anthony David; Chauhan, Lakhbir Singh; Dewan, Puneet			Will Adoption of the 2010 WHO ART Guidelines for HIV-Infected TB Patients Increase the Demand for ART Services in India?	PLOS ONE			English	Article							CD4 LYMPHOCYTE COUNTS; TUBERCULOSIS	Background: In 2010, WHO expanded previously-recommended indications for anti-retroviral treatment to include all HIV-infected TB patients irrespective of CD4 count. India, however, still limits ART to those TB patients with CD4 counts <350/mm(3) or with extrapulmonary TB manifestations. We sought to evaluate the additional number of patients that would be initiated on ART if India adopted the current 2010 WHO ART guidelines for HIV-infected TB patients. Methods: We evaluated all TB patients recorded in treatment registers of the Revised National TB Control Programme in June 2010 in the high-HIV prevalence state of Karnataka, and cross-matched HIV-infected TB patients with ART programme records. Results: Of 6182 TB patients registered, HIV status was ascertained for 5761(93%) and 710(12%) were HIV-infected. 146(21%) HIV-infected TB patients were on ART prior to TB diagnosis. Of the remaining 564, 497(88%) were assessed for ART eligibility; of these, 436(88%) were eligible for ART according to 2006 WHO ART guidelines. Altogether, 487(69%) HIV-infected TB patients received ART during TB treatment. About 80% started ART within 8 weeks of TB treatment and 95% received an efavirenz based regimen. Conclusion: In Karnataka, India, about nine out of ten HIV-infected TB patients were eligible for ART according to 2006 WHO ART guidelines. The efficiency of HIV case finding, ART evaluation, and ART initiation was relatively high, with 78% of eligible HIV-infected patients actually initiated on ART, and 80% within 8 weeks of diagnosis. ART could be extended to all HIV-infected TB patients irrespective of CD4 count with relatively little additional burden on the national ART programme.	[Kumar, Ajay M. V.; Gupta, Devesh; Satyanarayana, Srinath; Chauhan, Lakhbir Singh] Govt India, Cent TB Div, Directorate Gen Hlth Serv, Minist Hlth & Family Welf, New Delhi, India; [Kumar, Ajay M. V.; Reddy, H. R. Raveendra; Naik, Balaji; Prasad, Rita; Yaqoob, Mohammed; Deepak, K. G.; Dewan, Puneet] Off World Hlth Org Representat India, New Delhi, India; [Rewari, B. B.; Bachani, Damodar; Mohammed, Suresh; Sharma, Vartika] Govt India, Minist Hlth & Family Welf, Natl AIDS Control Org, New Delhi, India; [Lal, Kumaraswamy] Govt Karnataka, State TB Cell, Directorate Gen Hlth Serv, Minist Hlth & Family Welf, Bangalore, Karnataka, India; [Shastri, Suresh] Govt Karnataka, Karnataka State AIDS Prevent & Control Soc, Minist Hlth & Family Welf, Bangalore, Karnataka, India; [Satyanarayana, Srinath] SE Asia Reg Off, Int Union TB & Lung Dis The Union, New Delhi, India; [Harries, Anthony David] Int Union TB & Lung Dis The Union, Paris, France; [Harries, Anthony David] London Sch Hyg & Trop Med, London WC1, England	World Health Organization; University of London; London School of Hygiene & Tropical Medicine	Kumar, AMV (corresponding author), Govt India, Cent TB Div, Directorate Gen Hlth Serv, Minist Hlth & Family Welf, New Delhi, India.	kumaramv@rntcp.org; sathyasaakshi@gmail.com		Madhugiri Venkatachalaiah, Ajay Kumar/0000-0003-1011-8531; Satyanarayana, Srinath/0000-0002-5420-2551	Centre for Operational Research, International Union Against Tuberculosis and Lung Disease; Operational Research Unit, Medecins sans Frontieres, Brussels	Centre for Operational Research, International Union Against Tuberculosis and Lung Disease; Operational Research Unit, Medecins sans Frontieres, Brussels	This research was supported through an operational research course, which was jointly developed and run by the Centre for Operational Research, International Union Against Tuberculosis and Lung Disease, and the Operational Research Unit, Medecins sans Frontieres, Brussels. The study itself was not funded. However, the publication fees is being funded by Centre for Operational Research, International Union Against Tuberculosis and Lung Disease. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKAH AN, 1995, LANCET, V345, P607, DOI 10.1016/S0140-6736(95)90519-7; [Anonymous], 2007, ANT THER GUID HIV IN; Central TB Division, 2005, TECHN OP GUID TUB CO; Central TB Division Ministry of Health and Family Welfare, 2011, REV NAT TB CONTR PRO; *EPIDATA ASSOCIATI, EPIDATA ENTR VERS 3; Harries AD, 2010, LANCET, V375, P1906, DOI 10.1016/S0140-6736(10)60409-6; Mukadi YD, 2001, AIDS, V15, P143, DOI 10.1097/00002030-200101260-00002; *NAT AIDS CONTR OR, 2010, HIV EST IND; *NAT AIDS CONTR OR, 2008, TECHN BRIEF; *NAT AIDS CONTR OR, 2010, MIN NAT TECHN WORK G; National AIDS Control Organization, 2008, OP GUID INT COUNS TE; National AIDS Control Organization and Central TB Division, 2009, NAT FRAM JOINT HIV T; *OF REG GEN CENS C, 2011, 1 OF REG GEN CENS CO; Teck R, 2005, INT J TUBERC LUNG D, V9, P258; Vijay S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007899; WHO, ANT THER HIV INF AD; World Health Organization, 2010, ROADM ROLL XPERT MTB; World Health Organization, 2006, ANT THER HIV INF AD	18	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e24297	10.1371/journal.pone.0024297	http://dx.doi.org/10.1371/journal.pone.0024297			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CK	21931674	Green Submitted, gold, Green Published, Green Accepted			2022-12-25	WOS:000294802800037
J	Kim, SY; Romero, R; Tarca, AL; Bhatti, G; Lee, J; Chaiworapongsa, T; Hassan, SS; Kim, CJ				Kim, Sun Young; Romero, Roberto; Tarca, Adi L.; Bhatti, Gaurav; Lee, JoonHo; Chaiworapongsa, Tinnakorn; Hassan, Sonia S.; Kim, Chong Jai			miR-143 Regulation of Prostaglandin-Endoperoxidase Synthase 2 in the Amnion: Implications for Human Parturition at Term	PLOS ONE			English	Article							HUMAN FETAL MEMBRANES; GENE-EXPRESSION; MESSENGER-RNA; MICRORNAS; CYCLOOXYGENASE-2; MYOFIBROBLAST; REPRESSION; RUPTURE; DISEASE; CELLS	Background: The human amnion plays a pivotal role in parturition. Two of its compartments, the placental amnion and the reflected amnion, have distinct transcriptome and are functionally coordinated for parturition. This study was conducted to determine the microRNA (miRNA) expression pattern and its significance in the placental amnion and the reflected amnion in association with labor at term. Methodology/Principal Findings: MicroRNA microarray, real-time quantitative RT-PCR (qRT-PCR), and miRNA in situ hybridization analyses of the placental amnion and the reflected amnion (n = 20) obtained at term were conducted. Luciferase assay, transfection, and qRT-PCR analyses of primary amnion epithelial cells (AECs) and amnion mesenchymal cells (AMCs) were performed. MicroRNA microarray analysis demonstrated differential expression of 32 miRNAs between the placental amnion and the reflected amnion after labor. Thirty-one (97%) miRNAs, which included miR-143 and miR-145, a cardiovascular-specific miRNA cluster, were down-regulated in the reflected amnion. Analyses of miR-143 and miR-145 by qRT-PCR confirmed microarray results, and further demonstrated their decreased expression in the reflected amnion with labor. Interestingly, expression of miR-143 and miR-145 was higher in AMCs than in AECs (p<0.05). Luciferase assay and transfection confirmed miR-143 binding to 3' UTR of prostaglandin-endoperoxidase synthase 2 (PTGS2) mRNA and miR-143 regulation of PTGS2 in AMCs. Conclusions: We report region-specific amniotic microRNAome and miR-143 regulation of PTGS2 in the context of human labor at term for the first time. The findings indicate that miRNA-mediated post-transcriptional regulation of gene expression machinery in the amnion plays an important role in the compartments (placental amnion vs reflected amnion) and in a cell type-specific manner (AECs vs AMCs) for parturition.	[Kim, Sun Young; Romero, Roberto; Tarca, Adi L.; Bhatti, Gaurav; Lee, JoonHo; Chaiworapongsa, Tinnakorn; Hassan, Sonia S.; Kim, Chong Jai] NICHHD, Perinatol Res Branch, Dept Hlth & Human Serv, NIH, Bethesda, MD 20892 USA; [Kim, Sun Young; Romero, Roberto; Tarca, Adi L.; Bhatti, Gaurav; Lee, JoonHo; Chaiworapongsa, Tinnakorn; Hassan, Sonia S.; Kim, Chong Jai] NICHHD, Perinatol Res Branch, Dept Hlth & Human Serv, NIH, Detroit, MI USA; [Chaiworapongsa, Tinnakorn; Hassan, Sonia S.] Wayne State Univ, Sch Med, Dept Obstet & Gynecol, Detroit, MI 48201 USA; [Tarca, Adi L.] Wayne State Univ, Dept Comp Sci, Detroit, MI 48202 USA; [Kim, Chong Jai] Wayne State Univ, Sch Med, Dept Pathol, Detroit, MI 48201 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Wayne State University; Wayne State University; Wayne State University	Kim, SY (corresponding author), NICHHD, Perinatol Res Branch, Dept Hlth & Human Serv, NIH, Bethesda, MD 20892 USA.	cjkim@med.wayne.edu	Romero, Roberto/A-5268-2019	Romero, Roberto/0000-0002-4448-5121; bhatti, gaurav/0000-0002-8557-3347	Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD002400] Funding Source: NIH RePORTER	Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported in part by the Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman WE, 2006, PLACENTA, V27, P919, DOI 10.1016/j.placenta.2005.06.009; Ackerman WE, 2008, BIOL REPROD, V78, P68, DOI 10.1095/biolreprod.107.061663; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Arikat S, 2006, AM J OBSTET GYNECOL, V194, P211, DOI 10.1016/j.ajog.2005.06.083; Chakrabarty A, 2007, P NATL ACAD SCI USA, V104, P15144, DOI 10.1073/pnas.0705917104; Chassin C, 2010, CELL HOST MICROBE, V8, P358, DOI 10.1016/j.chom.2010.09.005; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Dixon DA, 2000, J BIOL CHEM, V275, P11750, DOI 10.1074/jbc.275.16.11750; Ella L, 2009, CELL DEATH DIFFER, V16, P1590, DOI 10.1038/cdd.2009.153; Engels BM, 2006, ONCOGENE, V25, P6163, DOI 10.1038/sj.onc.1209909; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Funai EF, 2009, AM J PERINAT, V26, P93, DOI 10.1055/s-0028-1103028; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GERMAIN AM, 1992, J CLIN ENDOCR METAB, V75, P1173, DOI 10.1210/jc.75.4.1173; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Haddad R, 2006, AM J OBSTET GYNECOL, V195, P394, DOI 10.1016/j.ajog.2005.08.057; Han YM, 2008, BIOL REPROD, V79, P954, DOI 10.1095/biolreprod.108.069260; Harper KA, 2008, BIOCHEM SOC T, V36, P543, DOI 10.1042/BST0360543; Hieber AD, 1997, PLACENTA, V18, P301, DOI 10.1016/S0143-4004(97)80065-3; Kim SS, 2008, LAB INVEST, V88, P365, DOI 10.1038/labinvest.3700749; Lee DC, 2010, J CLIN ENDOCR METAB, V95, pE86, DOI 10.1210/jc.2010-0203; McParland PC, 2000, PLACENTA, V21, P44, DOI 10.1053/plac.1999.0439; Miki Toshio, 2010, Curr Protoc Stem Cell Biol, VChapter 1, DOI [10.1002/9780470151808.sc01e03s3, 10.1002/9780470151808.sc01e03s12]; Mohan AR, 2007, ENDOCRINOLOGY, V148, P1850, DOI 10.1210/en.2006-1289; Montenegro D, 2009, J PATHOL, V217, P113, DOI 10.1002/path.2463; Montenegro D, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.06.027; Mouillet JF, 2010, PLACENTA, V31, P781, DOI 10.1016/j.placenta.2010.07.001; Nahid MA, 2011, J IMMUNOL, V186, P1723, DOI 10.4049/jimmunol.1002311; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Pineles BL, 2007, AM J OBSTET GYNECOL, V196, P261, DOI 10.1016/j.ajog.2007.01.008; Saba R, 2010, BRAIN RES, V1338, P3, DOI 10.1016/j.brainres.2010.03.107; Sato T, 2010, AM J RESP CRIT CARE, V182, P1020, DOI 10.1164/rccm.201001-0055OC; Silver JD, 2009, BIOSTATISTICS, V10, P352, DOI 10.1093/biostatistics/kxn042; Smith R, 2007, NEW ENGL J MED, V356, P271, DOI 10.1056/NEJMra061360; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Strohl A, 2010, PLACENTA, V31, P18, DOI 10.1016/j.placenta.2009.10.012; Sun SG, 2011, EMBO REP, V12, P56, DOI 10.1038/embor.2010.172; Terzidou V, 2010, BIOL REPROD, DOI [10.1095/biolreprod.110.086785, DOI 10.1095/BIOLREPR0D.110.086785]; Whittle WL, 2000, PLACENTA, V21, P394, DOI 10.1053/plac.1999.0482; WOLF HJ, 1991, CELL TISSUE RES, V266, P385, DOI 10.1007/BF00318194; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030; Zhu XM, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.12.045	45	25	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2011	6	9							e24131	10.1371/journal.pone.0024131	http://dx.doi.org/10.1371/journal.pone.0024131			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CH	21915288	gold, Green Published, Green Submitted			2022-12-25	WOS:000294802500028
J	Esposito, CL; Passaro, D; Longobardo, I; Condorelli, G; Marotta, P; Affuso, A; de Franciscis, V; Cerchia, L				Esposito, Carla Lucia; Passaro, Diana; Longobardo, Immacolata; Condorelli, Gerolama; Marotta, Pina; Affuso, Andrea; de Franciscis, Vittorio; Cerchia, Laura			A Neutralizing RNA Aptamer against EGFR Causes Selective Apoptotic Cell Death	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; INDUCED ACTIVATION; TUMOR-CELLS; CANCER; RESISTANCE; CETUXIMAB; ERBB3; MECHANISMS; GEFITINIB; 3-KINASE	Nucleic acid aptamers have been developed as high-affinity ligands that may act as antagonists of disease-associated proteins. Aptamers are non immunogenic and characterised by high specificity and low toxicity thus representing a valid alternative to antibodies or soluble ligand receptor traps/decoys to target specific cancer cell surface proteins in clinical diagnosis and therapy. The epidermal growth factor receptor (EGFR) has been implicated in the development of a wide range of human cancers including breast, glioma and lung. The observation that its inhibition can interfere with the growth of such tumors has led to the design of new drugs including monoclonal antibodies and tyrosine kinase inhibitors currently used in clinic. However, some of these molecules can result in toxicity and acquired resistance, hence the need to develop novel kinds of EGFR-targeting drugs with high specificity and low toxicity. Here we generated, by a cell-Systematic Evolution of Ligands by EXponential enrichment (SELEX) approach, a nuclease resistant RNA-aptamer that specifically binds to EGFR with a binding constant of 10 nM. When applied to EGFR-expressing cancer cells the aptamer inhibits EGFR-mediated signal pathways causing selective cell death. Furthermore, at low doses it induces apoptosis even of cells that are resistant to the most frequently used EGFR-inhibitors, such as gefitinib and cetuximab, and inhibits tumor growth in a mouse xenograft model of human non-small-cell lung cancer (NSCLC). Interestingly, combined treatment with cetuximab and the aptamer shows clear synergy in inducing apoptosis in vitro and in vivo. In conclusion, we demonstrate that this neutralizing RNA-aptamer is a promising bio-molecule that can be developed as a more effective alternative to the repertoire of already existing EGFR-inhibitors.	[Esposito, Carla Lucia; Condorelli, Gerolama; de Franciscis, Vittorio; Cerchia, Laura] CNR G Salvatore, Ist Endocrinol & Oncol Sperimentale, Naples, Italy; [Passaro, Diana; Longobardo, Immacolata; Condorelli, Gerolama] Univ Naples Federico II, Dipartimento Biol & Patol Cellulare & Mol, Naples, Italy; [Condorelli, Gerolama] Univ Naples Federico II, Fac Sci Biotecnol, Naples, Italy; [Marotta, Pina; Affuso, Andrea] Biogem Scarl, Anim Model Facil, Avellino, Italy; [Affuso, Andrea] Stn Zool Anton Dohrn, Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Naples Federico II; University of Naples Federico II; Stazione Zoologica Anton Dohrn di Napoli	Esposito, CL (corresponding author), CNR G Salvatore, Ist Endocrinol & Oncol Sperimentale, Naples, Italy.	cerchia@unina.it	Condorelli, Gerolama/AAC-3472-2022; Marotta, Pina e/K-5785-2018; Esposito, Carla L/K-5246-2016; Marotta, Pina/W-5262-2019	Condorelli, Gerolama/0000-0003-0177-8829; Marotta, Pina e/0000-0001-6857-8325; Esposito, Carla L/0000-0003-0624-6821; Marotta, Pina/0000-0001-6857-8325; Cerchia, Laura/0000-0002-7633-7932; Passaro, Diana/0000-0002-2488-3755	Consiglio Nazionale delle Ricerche (C.N.R.); Association for International Cancer Research (AICR) [11-0075]; Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR); MEdical Research in ITaly (MERIT) [RBNE08YFN3_001]; Associazione Italiana per la Ricerca sul Cancro (AIRC) [4971, 10620]; EU [503569]; Worldwide Cancer Research [11-0075] Funding Source: researchfish	Consiglio Nazionale delle Ricerche (C.N.R.)(Consiglio Nazionale delle Ricerche (CNR)); Association for International Cancer Research (AICR); Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); MEdical Research in ITaly (MERIT); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); EU(European Commission); Worldwide Cancer Research	This work was supported by funds from Consiglio Nazionale delle Ricerche (C.N.R.), Association for International Cancer Research (AICR) No 11-0075 (L.C.), Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) grant, MEdical Research in ITaly (MERIT) RBNE08YFN3_001 (VdF), Associazione Italiana per la Ricerca sul Cancro (AIRC) No 4971 (L. C.) and AIRC No 10620 (G. C.), EU grant European Molecular Imaging Laboratories (EMIL) No 503569. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Andrea Affuso is employed by Biogem s.c.ar.l. and helped perform the experiments.	BUCKLEY MF, 1993, ONCOGENE, V8, P2127; Cardo-Vila M, 2010, P NATL ACAD SCI USA, V107, P5118, DOI 10.1073/pnas.0915146107; Cerchia L, 2010, TRENDS BIOTECHNOL, V28, P517, DOI 10.1016/j.tibtech.2010.07.005; Cerchia L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007971; Cerchia Laura, 2009, V535, P59, DOI 10.1007/978-1-59745-557-2_5; DIFIORE PP, 1987, CELL, V51, P1063, DOI 10.1016/0092-8674(87)90592-7; Engelman JA, 2005, P NATL ACAD SCI USA, V102, P3788, DOI 10.1073/pnas.0409773102; Esposito CL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001643; Famulok M, 2007, CHEM REV, V107, P3715, DOI 10.1021/cr0306743; Grandis JR, 1998, J CLIN INVEST, V102, P1385, DOI 10.1172/JCI3785; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Keefe AD, 2010, NAT REV DRUG DISCOV, V9, P537, DOI 10.1038/nrd3141; Kimura H, 2007, CANCER SCI, V98, P1275, DOI 10.1111/j.1349-7006.2007.00510.x; Kruser TJ, 2010, EXP CELL RES, V316, P1083, DOI 10.1016/j.yexcr.2010.01.009; Li N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020299; Li N, 2010, CHEM COMMUN, V46, P392, DOI 10.1039/b920865h; Li SQ, 2005, CANCER CELL, V7, P301, DOI 10.1016/j.ccr.2005.03.003; Lurje G, 2009, ONCOLOGY-BASEL, V77, P400, DOI 10.1159/000279388; Morgillo F, 2009, CLIN TRANSL ONCOL, V11, P270, DOI 10.1007/s12094-009-0354-6; Mukohara T, 2005, JNCI-J NATL CANCER I, V97, P1185, DOI 10.1093/jnci/dji238; Ng EWM, 2006, NAT REV DRUG DISCOV, V5, P123, DOI 10.1038/nrd1955; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Olayioye MA, 1999, J BIOL CHEM, V274, P17209, DOI 10.1074/jbc.274.24.17209; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Rouge TD, 2007, CANCER RES, V67, P6253, DOI 10.1158/0008-5472.CAN-07-0538; Schlessinger J, 2004, SCIENCE, V306, P1506, DOI 10.1126/science.1105396; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; Schoeberl B, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000352; Sioud M, 2006, EUR J IMMUNOL, V36, P1222, DOI 10.1002/eji.200535708; Sithanandam G, 2008, CANCER GENE THER, V15, P413, DOI 10.1038/cgt.2008.15; SOLTOFF SP, 1994, MOL CELL BIOL, V14, P3550, DOI 10.1128/MCB.14.6.3550; Spicer J, 2005, INT J CLIN PRACT, V59, P1055, DOI 10.1111/j.1742-1241.2005.00622.x; Wan YA, 2010, CANCER RES, V70, P9371, DOI 10.1158/0008-5472.CAN-10-0568; Wheeler DL, 2008, ONCOGENE, V27, P3944, DOI 10.1038/onc.2008.19; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zanca C, 2008, J CELL MOL MED, V12, P2416, DOI 10.1111/j.1582-4934.2008.00283.x; Zhou Jiehua, 2010, Silence, V1, P4, DOI 10.1186/1758-907X-1-4	37	108	122	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2011	6	9							e24071	10.1371/journal.pone.0024071	http://dx.doi.org/10.1371/journal.pone.0024071			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817QP	21915281	Green Published, Green Submitted, gold			2022-12-25	WOS:000294689200018
J	Johnson, AAT; Kyriacou, B; Callahan, DL; Carruthers, L; Stangoulis, J; Lombi, E; Tester, M				Johnson, Alexander A. T.; Kyriacou, Bianca; Callahan, Damien L.; Carruthers, Lorraine; Stangoulis, James; Lombi, Enzo; Tester, Mark			Constitutive Overexpression of the OsNAS Gene Family Reveals Single-Gene Strategies for Effective Iron- and Zinc-Biofortification of Rice Endosperm	PLOS ONE			English	Article							NICOTIANAMINE SYNTHASE GENES; TRACE-ELEMENT; FORTIFICATION; BIOSYNTHESIS; ACCUMULATION; PHOSPHORUS; TRANSPORT; FERRITIN; CLONING; METALS	Background: Rice is the primary source of food for billions of people in developing countries, yet the commonly consumed polished grain contains insufficient levels of the key micronutrients iron (Fe), zinc (Zn) and Vitamin A to meet daily dietary requirements. Experts estimate that a rice-based diet should contain 14.5 mu g g(-1) Fe in endosperm, the main constituent of polished grain, but breeding programs have failed to achieve even half of that value. Transgenic efforts to increase the Fe concentration of rice endosperm include expression of ferritin genes, nicotianamine synthase genes (NAS) or ferritin in conjunction with NAS genes, with results ranging from two-fold increases via single-gene approaches to six-fold increases via multi-gene approaches, yet no approach has reported 14.5 mu g g(-1) Fe in endosperm. Methodology/Principal Findings: Three populations of rice were generated to constitutively overexpress OsNAS1, OsNAS2 or OsNAS3, respectively. Nicotianamine, Fe and Zn concentrations were significantly increased in unpolished grain of all three of the overexpression populations, relative to controls, with the highest concentrations in the OsNAS2 and OsNAS3 overexpression populations. Selected lines from each population had at least 10 mu g g(-1) Fe in polished grain and two OsNAS2 overexpression lines had 14 and 19 mu g g(-1) Fe in polished grain, representing up to four-fold increases in Fe concentration. Two-fold increases of Zn concentration were also observed in the OsNAS2 population. Synchrotron X-ray fluorescence spectroscopy demonstrated that OsNAS2 overexpression leads to significant enrichment of Fe and Zn in phosphorus-free regions of rice endosperm. Conclusions: The OsNAS genes, particularly OsNAS2, show enormous potential for Fe and Zn biofortification of rice endosperm. The results demonstrate that rice cultivars overexpressing single rice OsNAS genes could provide a sustainable and genetically simple solution to Fe and Zn deficiency disorders affecting billions of people throughout the world.	[Johnson, Alexander A. T.; Callahan, Damien L.] Univ Melbourne, Sch Bot, Melbourne, Vic, Australia; [Johnson, Alexander A. T.; Kyriacou, Bianca; Carruthers, Lorraine; Tester, Mark] Univ Adelaide, Australian Ctr Plant Funct Genom, Glen Osmond, SA, Australia; [Kyriacou, Bianca; Stangoulis, James] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA, Australia; [Lombi, Enzo] Univ S Australia, Ctr Environm Risk Assessment & Remediat, Mawson Lakes, SA, Australia	University of Melbourne; University of Adelaide; Flinders University South Australia; University of South Australia	Johnson, AAT (corresponding author), Univ Melbourne, Sch Bot, Melbourne, Vic, Australia.	johnsa@unimelb.edu.au	Lombi, Enzo/F-3860-2013; Stangoulis, James/S-3549-2019; Stangoulis, James/A-8865-2010; Tester, Mark/J-2368-2017	Lombi, Enzo/0000-0003-3384-0375; Stangoulis, James/0000-0001-7778-7110; Tester, Mark/0000-0002-5085-8801; Callahan, Damien/0000-0002-6384-8717; JOHNSON, ALEXANDER/0000-0002-1209-6447	Australian Research Council; HarvestPlus	Australian Research Council(Australian Research Council); HarvestPlus	The Australian Research Council and the HarvestPlus Challenge Program have provided funding that supported the work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENES I, 1983, EXPERIENTIA, V39, P261, DOI 10.1007/BF01955293; Callahan DL, 2007, NEW PHYTOL, V176, P836, DOI 10.1111/j.1469-8137.2007.02216.x; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Higuchi K, 1999, PLANT PHYSIOL, V119, P471, DOI 10.1104/pp.119.2.471; Hotz C, 2007, FOOD NUTR BULL, V28, pS271, DOI 10.1177/15648265070282S206; Hurrell RF, 2003, J NUTR, V133, p2973S, DOI 10.1093/jn/133.9.2973S; Inoue H, 2003, PLANT J, V36, P366, DOI 10.1046/j.1365-313X.2003.01878.x; Kennedy G, 2003, FOOD CHEM, V80, P589, DOI 10.1016/S0308-8146(02)00507-1; Khush GS, 2005, PLANT MOL BIOL, V59, P1, DOI 10.1007/s11103-005-2159-5; Kim S, 2005, PLANT CELL PHYSIOL, V46, P1809, DOI 10.1093/pcp/pci196; Kirkham R, 2010, AIP CONF PROC, V1234, P240, DOI 10.1063/1.3463181; Klatte M, 2009, PLANT PHYSIOL, V150, P257, DOI 10.1104/pp.109.136374; Lee SB, 2011, PLANT BIOTECHNOL J, V9, P100, DOI 10.1111/j.1467-7652.2010.00538.x; Lee S, 2009, P NATL ACAD SCI USA, V106, P22014, DOI 10.1073/pnas.0910950106; Liu JC, 2004, SEED SCI RES, V14, P109, DOI 10.1079/SSR2004160; Loladze I, 2002, TRENDS ECOL EVOL, V17, P457, DOI 10.1016/S0169-5347(02)02587-9; Lombi E, 2009, NEW PHYTOL, V184, P193, DOI 10.1111/j.1469-8137.2009.02912.x; Lombi E, 2011, J EXP BOT, V62, P273, DOI 10.1093/jxb/erq270; Lucca P, 2002, J AM COLL NUTR, V21, p184S, DOI 10.1080/07315724.2002.10719264; Luh B. S., 1991, RICE, V2; Masuda H, 2009, RICE, V2, P155, DOI 10.1007/s12284-009-9031-1; Mayer JE, 2008, CURR OPIN PLANT BIOL, V11, P166, DOI 10.1016/j.pbi.2008.01.007; Mizuno D, 2003, PLANT PHYSIOL, V132, P1989, DOI 10.1104/pp.102.019869; OGAWA M, 1979, PLANT CELL PHYSIOL, V20, P19; Pfeiffer Wolfgang H., 2007, P61, DOI 10.1002/9780470376447.ch3; Qu LQ, 2005, PLANTA, V222, P225, DOI 10.1007/s00425-005-1530-8; Ramakrishnan U, 2002, NUTR REV, V60, pS46, DOI 10.1301/00296640260130731; Ryan CG, 2000, INT J IMAG SYST TECH, V11, P219, DOI 10.1002/ima.1007; RYAN CG, 1993, NUCL INSTRUM METH B, V77, P203, DOI 10.1016/0168-583X(93)95545-G; Sallaud C, 2003, THEOR APPL GENET, V106, P1396, DOI 10.1007/s00122-002-1184-x; Schouten HJ, 2006, EMBO REP, V7, P750, DOI 10.1038/sj.embor.7400769; Takahashi M, 2003, PLANT CELL, V15, P1263, DOI 10.1105/tpc.010256; Usuda K, 2009, PLANT BIOTECHNOL J, V7, P87, DOI 10.1111/j.1467-7652.2008.00374.x; von Wiren N, 1999, PLANT PHYSIOL, V119, P1107, DOI 10.1104/pp.119.3.1107; Wada Y, 2007, BIOSCI BIOTECH BIOCH, V71, P435, DOI 10.1271/bbb.60496; Wirth J, 2009, PLANT BIOTECHNOL J, V7, P631, DOI 10.1111/j.1467-7652.2009.00430.x; Zheng LQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010190	39	214	223	1	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2011	6	9							e24476	10.1371/journal.pone.0024476	http://dx.doi.org/10.1371/journal.pone.0024476			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817QP	21915334	Green Published, Green Accepted, gold			2022-12-25	WOS:000294689200046
J	Becker, C; Cameron, ID; Klenk, J; Lindemann, U; Heinrich, S; Konig, HH; Rapp, K				Becker, Clemens; Cameron, Ian D.; Klenk, Jochen; Lindemann, Ulrich; Heinrich, Sven; Koenig, Hans-Helmut; Rapp, Kilian			Reduction of Femoral Fractures in Long-Term Care Facilities: The Bavarian Fracture Prevention Study	PLOS ONE			English	Article							FALL PREVENTION; HIP FRACTURE; PEOPLE; HOMES	Background: Hip fractures are a major public health burden. In industrialized countries about 20% of all femoral fractures occur in care dependent persons living in nursing care and assisted living facilities. Preventive strategies for these groups are needed as the access to medical services differs from independent home dwelling older persons at risk of osteoporotic fractures. It was the objective of the study to evaluate the effect of a fall and fracture prevention program on the incidence of femoral fracture in nursing homes in Bavaria, Germany. Methods: In a translational intervention study a fall prevention program was introduced in 256 nursing homes with 13,653 residents. The control group consisted of 893 nursing homes with 31,668 residents. The intervention consisted of staff education on fall and fracture prevention strategies, progressive strength and balance training, and on institutional advice on environmental adaptations. Incident femoral fractures served as outcome measure. Results: In the years before the intervention risk of a femoral fracture did not differ between the intervention group (IG) and control group (CG). During the one-year intervention period femoral fracture rates were 33.6 (IG) and 41.0/1000 person years (CG), respectively. The adjusted relative risk of a femoral fracture was 0.82 (95% CI 0.72-0.93) in residents exposed to the fall and fracture prevention program compared to residents from CG. Conclusions: The state-wide dissemination of a multi-factorial fall and fracture prevention program was able to reduce femoral fractures in residents of nursing homes.	[Becker, Clemens; Klenk, Jochen; Lindemann, Ulrich; Rapp, Kilian] Robert Bosch Krankenhaus, Dept Clin Gerontol, Stuttgart, Germany; [Cameron, Ian D.] Univ Sydney, Sydney Med Sch, Rehabil Studies Unit, Ryde, Australia; [Klenk, Jochen; Rapp, Kilian] Univ Ulm, Inst Epidemiol & Med Biometry, Ulm, Germany; [Heinrich, Sven; Koenig, Hans-Helmut] Univ Med Ctr Hamburg Eppendorf, Dept Med Sociol & Hlth Econ, Hamburg, Germany	Bosch; Robert Bosch Krankenhaus; University of Sydney; Ulm University; University of Hamburg; University Medical Center Hamburg-Eppendorf	Becker, C (corresponding author), Robert Bosch Krankenhaus, Dept Clin Gerontol, Stuttgart, Germany.	clemens.becker@rbk.de	Rapp, Kilian/AAJ-3370-2020; Klenk, Jochen/R-3614-2019; Becker, Clemens/ABI-5405-2020; König, Hans-Helmut/P-1211-2018; Klenk, Jochen/C-2164-2012	Rapp, Kilian/0000-0003-1625-2571; Klenk, Jochen/0000-0002-5987-447X; König, Hans-Helmut/0000-0001-5711-6862; 	Robert Bosch Foundation, Stuttgart, Germany; Bundesministerium fur Bildung und Forschung (Forderkennzeichen) [01EL0702, 01EL0717, 01EL0718]; AOK	Robert Bosch Foundation, Stuttgart, Germany; Bundesministerium fur Bildung und Forschung (Forderkennzeichen)(Federal Ministry of Education & Research (BMBF)); AOK	Kilian Rapp is supported by a Forschungskolleg Geriatrie Grant from the Robert Bosch Foundation, Stuttgart, Germany. The evaluation of the study was funded by the Bundesministerium fur Bildung und Forschung (Forderkennzeichen: 01EL0702, 01EL0717, 01EL0718). The AOK funded the implementation of The Bavarian Fall and Fracture Prevention Study. The AOK had no influence on the intervention components but participated in the implementation process. The evaluation of the intervention was not funded and not influenced by the AOK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker C, 2003, J AM GERIATR SOC, V51, P306, DOI 10.1046/j.1532-5415.2003.51103.x; Becker C, 1998, FACT RES INTERV GER, P55; Becker C, 2006, STURZPROPHYLAXE; Becker C, 2010, CLIN GERIATR MED, V26, P693, DOI 10.1016/j.cger.2010.07.004; Butler M, 1996, AGE AGEING, V25, P381, DOI 10.1093/ageing/25.5.381; Cameron ID, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005465.pub2; CHAPUY MC, 1992, NEW ENGL J MED, V327, P1637, DOI 10.1056/NEJM199212033272305; Cox H, 2008, AGE AGEING, V37, P167, DOI 10.1093/ageing/afm168; Gillespie Lesley D, 2012, Cochrane Database Syst Rev, pCD007146, DOI 10.1002/14651858.CD007146.pub3; Glasgow RE, 2008, ANN BEHAV MED, V35, P19, DOI 10.1007/s12160-007-9008-5; Glasgow RE, 2007, ANNU REV PUBL HEALTH, V28, P413, DOI 10.1146/annurev.publhealth.28.021406.144145; Klenk J, 2011, OSTEOPOROSIS INT, V22, P1593, DOI 10.1007/s00198-010-1366-3; Marx L, 1994, BARRIEREFREIE WOHNUN, P11; Pocock NA, 1999, MED J AUSTRALIA, V170, P486, DOI 10.5694/j.1326-5377.1999.tb127851.x; Rapp K, 2009, OSTEOPOROSIS INT, V20, P1775, DOI 10.1007/s00198-009-0852-y; Rapp K, 2010, J AM GERIATR SOC, V58, P70, DOI 10.1111/j.1532-5415.2009.02630.x; RUBENSTEIN LZ, 1994, ANN INTERN MED, V121, P442, DOI 10.7326/0003-4819-121-6-199409150-00009; Ward JA, 2010, MED J AUSTRALIA, V192, P319, DOI 10.5694/j.1326-5377.2010.tb03530.x; Zermansky AG, 2006, AGE AGEING, V35, P586, DOI 10.1093/ageing/afl075	19	27	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2011	6	8							e24311	10.1371/journal.pone.0024311	http://dx.doi.org/10.1371/journal.pone.0024311			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	817MS	21918688	Green Published, gold, Green Submitted			2022-12-25	WOS:000294678300037
J	Tian, L; Sun, SSM				Tian, Li; Sun, Samuel S. M.			A Cost-Effective ELP-Intein Coupling System for Recombinant Protein Purification from Plant Production Platform	PLOS ONE			English	Article							ONE-STEP PURIFICATION; MANNOSE-BINDING LECTIN; TRANSGENIC PLANTS; POLYPEPTIDE FUSIONS; ANTITUMOR-ACTIVITY; EXPRESSION SYSTEM; ELASTIN; DEGRADATION; TOBACCO; CELLS	Background: Plant bioreactor offers an efficient and economical system for large-scale production of recombinant proteins. However, high cost and difficulty in scaling-up of downstream purification of the target protein, particularly the common involvement of affinity chromatography and protease in the purification process, has hampered its industrial scale application, therefore a cost-effective and easily scale-up purification method is highly desirable for further development of plant bioreactor. Methodology/Principal Findings: To tackle this problem, we investigated the ELP-intein coupling system for purification of recombinant proteins expressed in transgenic plants using a plant lectin (PAL) with anti-tumor bioactivity as example target protein and rice seeds as production platform. Results showed that ELP-intein-PAL (EiP) fusion protein formed novel irregular ER-derived protein bodies in endosperm cells by retention of endogenous prolamins. The fusion protein was partially self-cleaved in vivo, but only self-cleaved PAL protein was detected in total seed protein sample and deposited in protein storage vacuoles (PSV). The in vivo uncleaved EiP protein was accumulated up to 2-4.2% of the total seed protein. The target PAL protein could be purified by the ELP-intein system efficiently without using complicated instruments and expensive chemicals, and the yield of pure PAL protein by the current method was up to 1.1 mg/g total seed protein. Conclusion/Significance: This study successfully demonstrated the purification of an example recombinant protein from rice seeds by the ELP-intein system. The whole purification procedure can be easily scaled up for industrial production, providing the first evidence on applying the ELP-intein coupling system to achieve cost-effective purification of recombinant proteins expressed in plant bioreactors and its possible application in industry.	[Tian, Li] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Tian, Li; Sun, Samuel S. M.] Tsinghua Univ, Grad Sch Shenzhen, Div Life Sci, Shenzhen 518057, Peoples R China; [Tian, Li; Sun, Samuel S. M.] Chinese Univ Hong Kong, Sch Life Sci, Shatin, Hong Kong, Peoples R China	Tsinghua University; Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School; Chinese University of Hong Kong	Tian, L (corresponding author), Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China.	ssun@cuhk.edu.hk	Tian, Li/M-7364-2016	Tian, Li/0000-0003-1497-7923	Hong Kong RGC [CUHK4580/05M]; Hong Kong UGC-AoE [AoE-B-07/09]; State (China) Key Laboratory of Agrobiotechnology, The Chinese University of Hong Kong, Shatin, Hong Kong	Hong Kong RGC(Hong Kong Research Grants Council); Hong Kong UGC-AoE; State (China) Key Laboratory of Agrobiotechnology, The Chinese University of Hong Kong, Shatin, Hong Kong(Chinese University of Hong Kong)	This work was supported by Hong Kong RGC Earmarked Grant CUHK4580/05M (http://www.ugc.edu.hk/eng/rgc/index.htm), the Hong Kong UGC-AoE Plant and Agricultural Biotechnology Project AoE-B-07/09 (http://www.ugc.edu.hk/eng/ugc/activity/aoes/aoes.htm), and the State (China) Key Laboratory of Agrobiotechnology, The Chinese University of Hong Kong, Shatin, Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banki MR, 2005, NAT METHODS, V2, P659, DOI 10.1038/nmeth787; Bhatla SC, 2010, BIOTECHNOL ADV, V28, P293, DOI 10.1016/j.biotechadv.2010.01.001; Ceriotti A, 2006, PLANT CELL MONOGR, V4, P75, DOI 10.1007/7089_066; Chai YR, 2003, J PLANT PHYSIOL, V160, P913, DOI 10.1078/0176-1617-01115; Conley AJ, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-48; Conley AJ, 2009, BIOTECHNOL BIOENG, V103, P562, DOI 10.1002/bit.22278; De Mejia EG, 2005, CRIT REV FOOD SCI, V45, P425, DOI 10.1080/10408390591034445; Fischer R, 2004, CURR OPIN PLANT BIOL, V7, P152, DOI 10.1016/j.pbi.2004.01.007; Fischer R, 1999, BIOL CHEM, V380, P825, DOI 10.1515/BC.1999.102; Floss DM, 2008, PLANT BIOTECHNOL J, V6, P379, DOI 10.1111/j.1467-7652.2008.00326.x; Floss DM, 2010, TRENDS BIOTECHNOL, V28, P37, DOI 10.1016/j.tibtech.2009.10.004; Ge X, 2006, BIOTECHNOL BIOENG, V95, P424, DOI 10.1002/bit.21046; Gething MJ, 1999, SEMIN CELL DEV BIOL, V10, P465, DOI 10.1006/scdb.1999.0318; Giddings G, 2000, NAT BIOTECHNOL, V18, P1151, DOI 10.1038/81132; Gillies Alison R., 2009, V498, P173, DOI 10.1007/978-1-59745-196-3_12; Guo CY, 2004, PROTEIN EXPRES PURIF, V37, P361, DOI 10.1016/j.pep.2004.06.037; Hirsch C, 2004, BBA-MOL CELL RES, V1695, P215, DOI 10.1016/j.bbamcr.2004.10.006; Jarosch E, 2003, INT REV CYTOL, V223, P39; Karg SR, 2010, J BIOTECHNOL, V146, P54, DOI 10.1016/j.jbiotec.2010.01.005; Lahtinen T, 2008, PROTEIN EXPRES PURIF, V59, P18, DOI 10.1016/j.pep.2007.12.014; Lao UL, 2007, BIOTECHNOL BIOENG, V98, P349, DOI 10.1002/bit.21478; Lau OS, 2009, BIOTECHNOL ADV, V27, P1015, DOI 10.1016/j.biotechadv.2009.05.005; Lerouge P., 2000, Current Pharmaceutical Biotechnology, V1, P347, DOI 10.2174/1389201003378843; Lerouge P, 1998, PLANT MOL BIOL, V38, P31, DOI 10.1023/A:1006012005654; LI XX, 1993, SCIENCE, V262, P1054, DOI 10.1126/science.8235623; Liu QQ, 2002, THESIS YANGZHOU U YA; Liu XQ, 2000, ANNU REV GENET, V34, P61, DOI 10.1146/annurev.genet.34.1.61; Liu Z, 2008, PHYTOMEDICINE, V15, P867, DOI 10.1016/j.phymed.2008.02.025; Lord JM, 2000, SEMIN CELL DEV BIOL, V11, P159; Ma Y, 1999, P NATL ACAD SCI USA, V96, P371, DOI 10.1073/pnas.96.2.371; Meyer DE, 1999, NAT BIOTECHNOL, V17, P1112, DOI 10.1038/15100; Morassutti C, 2002, FEBS LETT, V519, P141, DOI 10.1016/S0014-5793(02)02741-2; MOREIRA RD, 1991, MEM I OSWALDO CRUZ, V86, P211; Nakagawa T, 2003, METHOD ENZYMOL, V363, P26; Patel J, 2007, TRANSGENIC RES, V16, P239, DOI 10.1007/s11248-006-9026-2; Perler FB, 1999, NUCLEIC ACIDS RES, V27, P346, DOI 10.1093/nar/27.1.346; Perler FB, 1998, CELL, V92, P1, DOI 10.1016/S0092-8674(00)80892-2; Saito Y, 2009, J EXP BOT, V60, P615, DOI 10.1093/jxb/ern311; Scheller J, 2006, PLANT BIOTECHNOL J, V4, P243, DOI 10.1111/j.1467-7652.2005.00176.x; Scheller J, 2004, TRANSGENIC RES, V13, P51, DOI 10.1023/B:TRAG.0000017175.78809.7a; Schillberg S, 2005, VACCINE, V23, P1764, DOI 10.1016/j.vaccine.2004.11.002; Sharma AK, 2009, BIOTECHNOL ADV, V27, P811, DOI 10.1016/j.biotechadv.2009.06.004; Takaiwa F, 2009, PLANTA, V229, P1147, DOI 10.1007/s00425-009-0905-7; Torrent Margarita, 2009, V483, P193, DOI 10.1007/978-1-59745-407-0_11; Valdez-Ortiz A, 2005, J BIOTECHNOL, V115, P413, DOI 10.1016/j.jbiotec.2004.09.013; Witte CP, 2004, PLANT MOL BIOL, V55, P135, DOI 10.1007/s11103-004-0501-y; Wu WY, 2006, NAT PROTOC, V1, P2257, DOI 10.1038/nprot.2006.314; Xu MQ, 1996, EMBO J, V15, P5146, DOI 10.1002/j.1460-2075.1996.tb00898.x	48	30	31	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2011	6	8							e24183	10.1371/journal.pone.0024183	http://dx.doi.org/10.1371/journal.pone.0024183			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817MS	21918684	gold, Green Published, Green Submitted			2022-12-25	WOS:000294678300028
J	Taketani, K; Kawauchi, J; Tanaka-Okamoto, M; Ishizaki, H; Tanaka, Y; Sakai, T; Miyoshi, J; Maehara, Y; Kitajima, S				Taketani, K.; Kawauchi, J.; Tanaka-Okamoto, M.; Ishizaki, H.; Tanaka, Y.; Sakai, T.; Miyoshi, J.; Maehara, Y.; Kitajima, S.			Key role of ATF3 in p53-dependent DR5 induction upon DNA damage of human colon cancer cells	ONCOGENE			English	Article						DR5; ATF3; p53; CPT; TRAIL	ACTIVATING TRANSCRIPTION FACTOR-3; NECROSIS-FACTOR-ALPHA; APOPTOSIS-INDUCING LIGAND; RESPONSE GENE ATF3; ENDOTHELIAL-CELLS; P53 TRANSCRIPTION; STRESS RESPONSES; GENOTOXIC STRESS; KILLER/DR5 GENE; DEATH LIGAND	Stress response gene ATF3 is one of the p53 target genes and has a tumor suppressor role in cancer. However, the biological role of p53-ATF3 pathway is not well understood. Death receptor 5 (DR5) is a death domain-containing transmembrane receptor that triggers cell death upon binding to its ligand TRAIL (tumor necrosis factor-related apoptosis-inducing ligand), and a combination of TRAIL and agents that increase the expression of DR5 is expected as a novel anticancer therapy. In this report, we demonstrate that ATF3 is required for efficient DR5 induction upon DNA damage by camptothecin (CPT) in colorectal cancer cells. In the absence of ATF3, induction of DR5 messenger RNA and protein is remarkably abrogated, and this is associated with reduced cell death by TRAIL and CPT. By contrast, exogenous expression of ATF3 causes more rapid and elevated expression of DR5, resulting in enhanced sensitivity to apoptotic cell death by TRAIL/CPT. Reporter assay and DNA affinity precipitation assay demonstrate that at least three ATF/CRE motifs at the proximal promoter of the human DR5 gene are involved in the activation of DNA damage-induced DR5 gene transcription. Furthermore, ATF3 is shown to interact with p53 to form a complex on the DR5 gene by Re-chromatin immunoprecipitation assay. Taken together, our results provide a novel insight into the role of ATF3 as an essential co-transcription factor for p53 upon DNA damage, and this may represent a useful biomarker for TRAIL-based anticancer therapy. Oncogene (2012) 31, 2210-2221; doi:10.1038/onc.2011.397; published online 19 September 2011	[Kitajima, S.] Tokyo Med & Dent Univ, Med Res Inst, Dept Biochem Genet, Bunkyo Ku, Tokyo 1138510, Japan; [Taketani, K.; Maehara, Y.] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 812, Japan; [Tanaka-Okamoto, M.; Ishizaki, H.; Miyoshi, J.] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Mol Biol, Osaka, Japan; [Sakai, T.] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Mol Targeting Canc Prevent, Kyoto, Japan	Tokyo Medical & Dental University (TMDU); Kyushu University; Osaka Medical Center for Cancer & Cardiovascular Diseases; Kyoto Prefectural University of Medicine	Kitajima, S (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Biochem Genet, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	kita.bgen@mri.tmd.ac.jp		Tanaka-Okamoto, Miki/0000-0002-6429-7662	Ministry of Education, Culture, Sports, Science, and Technology of Japan [18012015, 18055008, 21590302, 22300330]; Grants-in-Aid for Scientific Research [22700878] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Dr WS El-Deiry for a kind gift of valuable plasmid pGL2-Full. This work was supported in part by a grant-in-aid for Research on Priority Areas from the Ministry of Education, Culture, Sports, Science, and Technology of Japan [18012015, 18055008, 21590302] to SK and [22300330] to JM.	Amundson SA, 1999, ONCOGENE, V18, P3666, DOI 10.1038/sj.onc.1202676; Ashkenazi A, 2008, J CLIN INVEST, V118, P1979, DOI 10.1172/JCI34359; Cai Y, 2000, BLOOD, V96, P2140, DOI 10.1182/blood.V96.6.2140.h8002140_2140_2148; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Eskes R, 2000, MOL CELL BIOL, V20, P929, DOI 10.1128/MCB.20.3.929-935.2000; Fan FY, 2002, ONCOGENE, V21, P7488, DOI 10.1038/sj.onc.1205896; Farczadi E, 1999, NEOPLASMA, V46, P219; Fuchs C, 2006, CANCER TREAT REV, V32, P491, DOI 10.1016/j.ctrv.2006.07.001; Gliniak B, 1999, CANCER RES, V59, P6153; Green DR, 2002, CANCER CELL, V1, P19, DOI 10.1016/S1535-6108(02)00024-7; Hackl C, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-668; Hai T, 1999, GENE EXPRESSION, V7, P321; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HSU JC, 1991, P NATL ACAD SCI USA, V88, P3511, DOI 10.1073/pnas.88.9.3511; Janz M, 2006, BLOOD, V107, P2536, DOI 10.1182/blood-2005-07-2694; Kawauchi J, 2002, J BIOL CHEM, V277, P39025, DOI 10.1074/jbc.M202974200; Kischkel FC, 2000, IMMUNITY, V12, P611, DOI 10.1016/S1074-7613(00)80212-5; LeBlanc H, 2002, NAT MED, V8, P274, DOI 10.1038/nm0302-274; Legarza K, 2006, ANTICANCER RES, V26, P3301; Lu D, 2006, J BIOL CHEM, V281, P10473, DOI 10.1074/jbc.M509278200; Miyazaki K, 2009, NUCLEIC ACIDS RES, V37, P1438, DOI 10.1093/nar/gkn1082; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Naka T, 2002, CANCER RES, V62, P5800; Nesterov A, 2004, CANCER RES, V64, P3922, DOI 10.1158/0008-5472.CAN-03-2219; Nicholson DW, 2000, NATURE, V407, P810, DOI 10.1038/35037747; Nobori K, 2002, J MOL CELL CARDIOL, V34, P1387, DOI 10.1006/jmcc.2002.2091; PAN JL, 1993, J BIOL CHEM, V268, P22600; Pelzer AE, 2006, J UROLOGY, V175, P1517, DOI 10.1016/S0022-5347(05)00651-8; Pitt RM, 1996, J BIOL CHEM, V271, P12687, DOI 10.1074/jbc.271.22.12687; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Scott N, 1998, EUR J SURG ONCOL, V24, P169, DOI 10.1016/S0748-7983(98)92861-X; Sellers WR, 1999, J CLIN INVEST, V104, P1655, DOI 10.1172/JCI9053; Sheikh MS, 1998, CANCER RES, V58, P1593; Sprick MR, 2000, IMMUNITY, V12, P599, DOI 10.1016/S1074-7613(00)80211-3; Sussman RT, 2007, CANCER BIOL THER, V6, P1490, DOI 10.4161/cbt.6.9.4905; SUZUKI T, 1993, P NATL ACAD SCI USA, V90, P610, DOI 10.1073/pnas.90.2.610; Takimoto R, 2000, ONCOGENE, V19, P1735, DOI 10.1038/sj.onc.1203489; Tamura K, 2005, EMBO J, V24, P2590, DOI 10.1038/sj.emboj.7600742; Turchi L, 2008, CELL DEATH DIFFER, V15, P1472, DOI 10.1038/cdd.2008.74; Wang L, 2001, P NATL ACAD SCI USA, V98, P13884, DOI 10.1073/pnas.241358198; Wang SL, 2003, P NATL ACAD SCI USA, V100, P15095, DOI 10.1073/pnas.2435285100; Wang Y, 2004, CANCER CELL, V5, P501, DOI 10.1016/S1535-6108(04)00113-8; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Wei MC, 2000, GENE DEV, V14, P2060; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Wu GS, 1997, NAT GENET, V17, P141, DOI 10.1038/ng1097-141; Wu XW, 2010, NATURE, V465, P368, DOI 10.1038/nature08996; Xiang H, 2002, ONCOGENE, V21, P3611, DOI 10.1038/sj.onc.1205449; Yamaguchi H, 2004, J BIOL CHEM, V279, P45495, DOI 10.1074/jbc.M406933200; Yan CH, 2005, EMBO J, V24, P2425, DOI 10.1038/sj.emboj.7600712; Yin X, 2008, ONCOGENE, V27, P2118, DOI 10.1038/sj.onc.1210861; Yoon K, 2011, CARCINOGENESIS, V32, P836, DOI 10.1093/carcin/bgr040; Yoshida T, 2001, FEBS LETT, V507, P381, DOI 10.1016/S0014-5793(01)02947-7; Zhang C, 2002, BIOCHEM BIOPH RES CO, V297, P1302, DOI 10.1016/S0006-291X(02)02382-3	55	59	59	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR	2012	31	17					2210	2221		10.1038/onc.2011.397	http://dx.doi.org/10.1038/onc.2011.397			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	934BS	21927023	Bronze			2022-12-25	WOS:000303415900009
J	Eades, G; Yang, MH; Yao, Y; Zhang, YS; Zhou, Q				Eades, Gabriel; Yang, Muhua; Yao, Yuan; Zhang, Yongshu; Zhou, Qun			miR-200a Regulates Nrf2 Activation by Targeting Keap1 mRNA in Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESENCHYMAL TRANSITION; OXIDATIVE STRESS; POSTTRANSCRIPTIONAL REGULATION; DNA METHYLATION; FEEDBACK LOOP; EXPRESSION; MICRORNAS; PROLIFERATION; MECHANISMS; CARCINOGENESIS	NE-E2-related factor 2 (Nrf2) is an important transcription factor that activates the expression of cellular detoxifying enzymes. Nrf2 expression is largely regulated through the association of Nrf2 with Kelch-like ECH-associated protein 1 (Keap1), which results in cytoplasmic Nrf2 degradation. Conversely, little is known concerning the regulation of Keap1 expression. Until now, a regulatory role for microRNAs (miRs) in controlling Keap1 gene expression had not been characterized. By using miR array-based screening, we observed miR-200a silencing in breast cancer cells and demonstrated that upon re-expression, miR-200a targets the Keap1 3'-untranslated region (3'-UTR), leading to Keap1 mRNA degradation. Loss of this regulatory mechanism may contribute to the dysregulation of Nrf2 activity in breast cancer. Previously, we have identified epigenetic repression of miR-200a in breast cancer cells. Here, we find that treatment with epigenetic therapy, the histone deacetylase inhibitor suberoylanilide hydroxamic acid, restored miR-200a expression and reduced Keap1 levels. This reduction in Keap1 levels corresponded with Nrf2 nuclear translocation and activation of Nrf2-dependent NAD(P)H-quinone oxidoreductase 1 (NQO1) gene transcription. Moreover, we found that Nrf2 activation inhibited the anchorage-independent growth of breast cancer cells. Finally, our in vitro observations were confirmed in a model of carcinogen-induced mammary hyperplasia in vivo. In conclusion, our study demonstrates that miR-200a regulates the Keap1/Nrf2 pathway in mammary epithelium, and we find that epigenetic therapy can restore miR-200a regulation of Keap1 expression, therefore reactivating the Nrf2-dependent antioxidant pathway in breast cancer.	[Eades, Gabriel; Yang, Muhua; Yao, Yuan; Zhang, Yongshu; Zhou, Qun] Univ Maryland, Dept Biochem & Mol Biol, Sch Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Zhou, Q (corresponding author), Univ Maryland, Dept Biochem & Mol Biol, Sch Med, Baltimore, MD 21201 USA.	qzhou@som.umaryland.edu			National Institutes of Health, NCI [NCI T32]; FAMRI; Maryland Stem Cell Fund; NATIONAL CANCER INSTITUTE [P30CA134274, T32CA154274] Funding Source: NIH RePORTER	National Institutes of Health, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); FAMRI; Maryland Stem Cell Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health, NCI, Training Grant NCI T32 in cancer biology (to G. E.). This work was also supported by grants from FAMRI (to Q. Z.) and the Maryland Stem Cell Fund (to Q. Z.).	Acharya A, 2010, OXID MED CELL LONGEV, V3, P23, DOI 10.4161/oxim.3.1.10095; Ahmad A, 2011, CANCER RES, V71, P3400, DOI 10.1158/0008-5472.CAN-10-0965; Aoki Y, 2007, CANCER RES, V67, P5643, DOI 10.1158/0008-5472.CAN-06-3355; Bagchi A, 2008, CANCER RES, V68, P2551, DOI 10.1158/0008-5472.CAN-07-2095; Bandres E, 2009, INT J CANCER, V125, P2737, DOI 10.1002/ijc.24638; Bolton JL, 2008, CHEM RES TOXICOL, V21, P93, DOI 10.1021/tx700191p; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Dinkova-Kostova AT, 2002, P NATL ACAD SCI USA, V99, P11908, DOI 10.1073/pnas.172398899; Eades G, 2011, J BIOL CHEM, V286, P25992, DOI 10.1074/jbc.M111.229401; Fields WR, 1999, CARCINOGENESIS, V20, P1121, DOI 10.1093/carcin/20.6.1121; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Furukawa M, 2005, MOL CELL BIOL, V25, P162, DOI 10.1128/MCB.25.1.162-171.2005; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Havens CG, 2006, MOL CELL BIOL, V26, P4701, DOI 10.1128/MCB.00303-06; Hsieh TC, 2010, ANTICANCER RES, V30, P4169; Iida K, 2004, CANCER RES, V64, P6424, DOI 10.1158/0008-5472.CAN-04-1906; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; Kensler TW, 2010, CARCINOGENESIS, V31, P90, DOI 10.1093/carcin/bgp231; Khor TO, 2008, CANCER PREV RES, V1, P187, DOI 10.1158/1940-6207.CAPR-08-0028; Kobayashi M, 2006, ADV ENZYME REGUL, V46, P113, DOI 10.1016/j.advenzreg.2006.01.007; Kovalchuk O, 2007, CELL CYCLE, V6, P2010, DOI 10.4161/cc.6.16.4549; Lee S, 2011, CELL MOL LIFE SCI, V68, P325, DOI 10.1007/s00018-010-0457-9; Lehmann U, 2008, J PATHOL, V214, P17, DOI 10.1002/path.2251; Lister A, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-37; Loignon M, 2009, MOL CANCER THER, V8, P2432, DOI 10.1158/1535-7163.MCT-08-1186; Mense SM, 2008, TOXICOL APPL PHARM, V232, P78, DOI 10.1016/j.taap.2008.06.007; Muscarella LA, 2011, EPIGENETICS-US, V6, P317, DOI 10.4161/epi.6.3.14408; Niture SK, 2010, TOXICOL APPL PHARM, V244, P37, DOI 10.1016/j.taap.2009.06.009; O'Day E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2484; Ohtsuji M, 2008, J BIOL CHEM, V283, P33554, DOI 10.1074/jbc.M804597200; Rachakonda G, 2010, ONCOGENE, V29, P3703, DOI 10.1038/onc.2010.118; Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798; Santini V, 2007, CURR DRUG METAB, V8, P383, DOI 10.2174/138920007780655397; Sarkar S, 2011, ANTICANCER RES, V31, P2723; Sato Y, 2001, LEUKEMIA, V15, P1193, DOI 10.1038/sj.leu.2402188; Shin DH, 2010, FREE RADICAL BIO MED, V48, P1051, DOI 10.1016/j.freeradbiomed.2010.01.021; Simonini PDR, 2010, CANCER RES, V70, P9175, DOI 10.1158/0008-5472.CAN-10-1318; Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420; Tellez CS, 2011, CANCER RES, V71, P3087, DOI 10.1158/0008-5472.CAN-10-3035; Tsai KW, 2009, EPIGENETICS-US, V4, P587, DOI 10.4161/epi.4.8.10230; Uhlmann S, 2010, ONCOGENE, V29, P4297, DOI 10.1038/onc.2010.201; Voorhoeve PM, 2007, BBA-REV CANCER, V1775, P274, DOI 10.1016/j.bbcan.2006.11.003; Vrba L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008697; Wakabayashi N, 2004, P NATL ACAD SCI USA, V101, P2040, DOI 10.1073/pnas.0307301101; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Yang MH, 2011, BREAST CANCER RES TR, V129, P983, DOI 10.1007/s10549-011-1604-1; Yao YA, 2010, BREAST CANCER RES TR, V124, P585, DOI 10.1007/s10549-010-1023-8; Yao Y, 2010, CARCINOGENESIS, V31, P382, DOI 10.1093/carcin/bgp308; Yu SW, 2007, CURR CANCER DRUG TAR, V7, P416; Zhang P, 2010, MOL CANCER THER, V9, P336, DOI 10.1158/1535-7163.MCT-09-0589; Zhou H, 2010, NUCLEIC ACIDS RES, V38, P3619, DOI 10.1093/nar/gkq084; Zimmerman AL, 2011, CANCER LETT, V300, P10, DOI 10.1016/j.canlet.2010.09.019	52	224	237	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 25	2011	286	47					40725	40733		10.1074/jbc.M111.275495	http://dx.doi.org/10.1074/jbc.M111.275495			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	852AN	21926171	Green Published, hybrid			2022-12-25	WOS:000297315400033
J	Salussolia, CL; Corrales, A; Talukder, I; Kazi, R; Akgul, G; Bowen, M; Wollmuth, LP				Salussolia, Catherine L.; Corrales, Alexandra; Talukder, Iehab; Kazi, Rashek; Akgul, Gulcan; Bowen, Mark; Wollmuth, Lonnie P.			Interaction of the M4 Segment with Other Transmembrane Segments Is Required for Surface Expression of Mammalian alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-TERMINAL DOMAIN; PROTEIN-PROTEIN INTERACTIONS; LIGAND-BINDING DOMAINS; GATED ION CHANNELS; GLUTAMATE-RECEPTOR; NMDA RECEPTOR; ENDOPLASMIC-RETICULUM; KAINATE RECEPTORS; POINT MUTATION; SUBUNIT	Ionotropic glutamate receptors (GluRs) are ligand-gated ion channels with a modular structure. The ion channel itself shares structural similarity, albeit an inverted membrane topology, with P-loop channels. Like P-loop channels, prokaryotic GluR subunits (e. g. GluR0) have two transmembrane segments. In contrast, eukaryotic GluRs have an additional transmembrane segment (M4), located C-terminal to the ion channel core. However, the structural/functional significance of this additional transmembrane segment is poorly defined. Although topologically similar to GluR0, mammalian AMPA receptor (GluA1) subunits lacking the M4 segment do not display surface expression. This lack of expression is not due to the M4 segment serving as an anchor to the ligand-binding domain because insertion of an artificial polyleucine transmembrane segment does not rescue surface expression. Specific interactions between M4 and the ligand-binding domain are also unlikely because insertion of polyglycines into the linker connecting them has no deleterious effects on function or surface expression. However, tryptophan and cysteine scanning mutagenesis of the M4 segment, as well as recovery of function in the polyleucine background, defined a unique face of the M4 helix that is required for GluR surface expression. In the AMPA receptor structure, this face forms intersubunit contacts with the transmembrane helices of the ion channel core (M1 and M3) from another subunit within the homotetramer. Thus, our experiments show that a highly specific interaction of the M4 segment with an adjacent subunit is required for surface expression of AMPA receptors. This interaction may represent a mechanism for regulating AMPA receptor biogenesis.	[Wollmuth, Lonnie P.] SUNY Stony Brook, Dept Neurobiol & Behav, Ctr Mol Med, Stony Brook, NY 11794 USA; [Wollmuth, Lonnie P.] SUNY Stony Brook, Ctr Nervous Syst Disorders, Stony Brook, NY 11794 USA; [Kazi, Rashek; Bowen, Mark] SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA; [Salussolia, Catherine L.; Talukder, Iehab; Kazi, Rashek] SUNY Stony Brook, Grad Program Neurosci, Stony Brook, NY 11794 USA; [Corrales, Alexandra] SUNY Stony Brook, Grad Program Mol & Cellular Pharmacol, Stony Brook, NY 11794 USA; [Akgul, Gulcan] SUNY Stony Brook, Grad Program Mol & Cellular Biol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Wollmuth, LP (corresponding author), SUNY Stony Brook, Dept Neurobiol & Behav, Ctr Mol Med, Stony Brook, NY 11794 USA.	lwollmuth@notes.cc.sunysb.edu	Akgül, Gülcan/AAE-1418-2019	Akgül, Gülcan/0000-0003-1590-6350; Salussolia, Catherine/0000-0003-0168-3205; Wollmuth, Lonnie/0000-0002-8179-1259; Bowen, Mark/0000-0002-9525-6986	National Institutes of Health from NIMH [MH066892, MH081923]; National Institutes of Health from NEI [EY01697905]; NRSA [NS073382]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008444] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081923, R01MH066892] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS073382] Funding Source: NIH RePORTER	National Institutes of Health from NIMH; National Institutes of Health from NEI; NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health RO1 Grants MH066892 (to L. P. W.) and MH081923 (to M. B.) from NIMH, Grant EY01697905 (to L. P. W.) from NEI, and NRSA NS073382 (to C. L. S.).	Alabi AA, 2007, NATURE, V450, P370, DOI 10.1038/nature06266; Armstrong N, 1998, NATURE, V395, P913, DOI 10.1038/27692; Arvola M, 1996, J BIOL CHEM, V271, P15527, DOI 10.1074/jbc.271.26.15527; Ayalon G, 2001, NEURON, V31, P103, DOI 10.1016/S0896-6273(01)00333-6; Bjerrum O. J., 1986, ANAL ELECTROPHORESIS; BOULTER J, 1990, SCIENCE, V249, P1033, DOI 10.1126/science.2168579; Caputo GA, 2004, BIOCHEMISTRY-US, V43, P8794, DOI 10.1021/bi049696p; Chen GQ, 1999, NATURE, V402, P817, DOI 10.1038/45568; Collingridge GL, 2009, NEUROPHARMACOLOGY, V56, P2, DOI 10.1016/j.neuropharm.2008.06.063; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; Dingledine R, 1999, PHARMACOL REV, V51, P7; Farina AN, 2011, J NEUROSCI, V31, P3565, DOI 10.1523/JNEUROSCI.6041-10.2011; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Gielen M, 2009, NATURE, V459, P703, DOI 10.1038/nature07993; Gill MB, 2009, J BIOL CHEM, V284, P14503, DOI 10.1074/jbc.M900510200; Greger IH, 2007, TRENDS NEUROSCI, V30, P407, DOI 10.1016/j.tins.2007.06.005; Hansen KB, 2010, MOL PHARMACOL, V78, P535, DOI 10.1124/mol.110.067157; Horak M, 2008, J NEUROSCI, V28, P3500, DOI 10.1523/JNEUROSCI.5239-07.2008; Horning MS, 2004, NEURON, V41, P379, DOI 10.1016/S0896-6273(04)00018-2; Janovjak H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1231; Jin RS, 2009, EMBO J, V28, P1812, DOI 10.1038/emboj.2009.140; Karakas E, 2009, EMBO J, V28, P3910, DOI 10.1038/emboj.2009.338; KEINANEN K, 1990, SCIENCE, V249, P556, DOI 10.1126/science.2166337; Kumar J, 2009, NAT STRUCT MOL BIOL, V16, P631, DOI 10.1038/nsmb.1613; Liu W, 2004, J MOL BIOL, V337, P713, DOI 10.1016/j.jmb.2004.02.001; Ma BY, 2011, STRUCTURE, V19, P907, DOI 10.1016/j.str.2011.06.002; Mah SJ, 2005, J NEUROSCI, V25, P2215, DOI 10.1523/JNEUROSCI.4573-04.2005; Mayer ML, 2005, NEURON, V45, P539, DOI 10.1016/j.neuron.2005.01.031; Mayer ML, 2006, NATURE, V440, P456, DOI 10.1038/nature04709; Moore DT, 2008, STRUCTURE, V16, P991, DOI 10.1016/j.str.2008.05.007; Oswald RE, 2007, CURR DRUG TARGETS, V8, P573, DOI 10.2174/138945007780618526; Pasternack A, 2002, J BIOL CHEM, V277, P49662, DOI 10.1074/jbc.M208349200; Penn AC, 2008, EMBO J, V27, P3056, DOI 10.1038/emboj.2008.222; Ren H, 2003, J BIOL CHEM, V278, P276, DOI 10.1074/jbc.M209486200; Ren H, 2008, J BIOL CHEM, V283, P8250, DOI 10.1074/jbc.M705933200; Rossmann M, 2011, EMBO J, V30, P959, DOI 10.1038/emboj.2011.16; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Schmid SM, 2007, J NEUROSCI, V27, P12230, DOI 10.1523/JNEUROSCI.3175-07.2007; Schorge S, 2003, J NEUROSCI, V23, P1151, DOI 10.1523/JNEUROSCI.23-04-01151.2003; Senes A, 2004, CURR OPIN STRUC BIOL, V14, P465, DOI 10.1016/j.sbi.2004.07.007; Shanks NF, 2010, J NEUROSCI, V30, P2728, DOI 10.1523/JNEUROSCI.5146-09.2010; Sobolevsky AI, 2002, NEURON, V33, P75, DOI 10.1016/S0896-6273(01)00560-8; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Stern-Bach Y, 1998, NEURON, V21, P907, DOI 10.1016/S0896-6273(00)80605-4; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Suzuki E, 2005, MOL CELL NEUROSCI, V29, P1, DOI 10.1016/j.mcn.2005.01.004; Talukder I, 2010, J NEUROSCI, V30, P11792, DOI 10.1523/JNEUROSCI.5382-09.2010; Terhag J, 2010, FRONT MOL NEUROSCI, V3, DOI 10.3389/fnmol.2010.00117; Tomita S, 2005, NATURE, V435, P1052, DOI 10.1038/nature03624; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Valluru L, 2005, J BIOL CHEM, V280, P6085, DOI 10.1074/jbc.M411549200; WO ZG, 1995, TRENDS NEUROSCI, V18, P161; WOOD MW, 1995, P NATL ACAD SCI USA, V92, P4882, DOI 10.1073/pnas.92.11.4882; Yelshansky MV, 2004, J NEUROSCI, V24, P4728, DOI 10.1523/JNEUROSCI.0757-04.2004; Yuan HJ, 2009, J NEUROSCI, V29, P12045, DOI 10.1523/JNEUROSCI.1365-09.2009; Zhou FX, 2001, P NATL ACAD SCI USA, V98, P2250, DOI 10.1073/pnas.041593698	56	26	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					40205	40218		10.1074/jbc.M111.268839	http://dx.doi.org/10.1074/jbc.M111.268839			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21930708	Green Published, hybrid			2022-12-25	WOS:000296925700053
J	Liu, J; Liu, MY; Fu, L; Zhu, GA; Yan, ECY				Liu, Jian; Liu, Monica Yun; Fu, Li; Zhu, Gefei Alex; Yan, Elsa C. Y.			Chemical Kinetic Analysis of Thermal Decay of Rhodopsin Reveals Unusual Energetics of Thermal Isomerization and Hydrolysis of Schiff Base	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-BOND NETWORK; RETINITIS-PIGMENTOSA; MOLECULAR-MECHANISM; WATER-MOLECULES; DIM-LIGHT; ACTIVATION; STABILITY; EVOLUTION; ORIGIN; RODS	The thermal properties of rhodopsin, which set the threshold of our vision, have long been investigated, but the chemical kinetics of the thermal decay of rhodopsin has not been revealed in detail. To understand thermal decay quantitatively, we propose a kinetic model consisting of two pathways: 1) thermal isomerization of 11-cis-retinal followed by hydrolysis of Schiff base (SB) and 2) hydrolysis of SB in dark state rhodopsin followed by opsin-catalyzed isomerization of free 11-cis-retinal. We solve the kinetic model mathematically and use it to analyze kinetic data from four experiments that we designed to assay thermal decay, isomerization, hydrolysis of SB using dark state rhodopsin, and hydrolysis of SB using photoactivated rhodopsin. We apply the model to WT rhodopsin and E181Q and S186A mutants at 55 degrees C, as well as WT rhodopsin in H2O and D2O at 59 degrees C. The results show that the hydrogen-bonding network strongly restrains thermal isomerization but is less important in opsin and activated rhodopsin. Furthermore, the ability to obtain individual rate constants allows comparison of thermal processes under various conditions. Our kinetic model and experiments reveal two unusual energetic properties: the steep temperature dependence of the rates of thermal isomerization and SB hydrolysis in the dark state and a strong deuterium isotope effect on dark state SB hydrolysis. These findings can be applied to study pathogenic rhodopsin mutants and other visual pigments.	[Liu, Jian; Liu, Monica Yun; Fu, Li; Zhu, Gefei Alex; Yan, Elsa C. Y.] Yale Univ, Dept Chem, New Haven, CT 06520 USA	Yale University	Yan, ECY (corresponding author), 225 Prospect St, New Haven, CT 06520 USA.	elsa.yan@yale.edu	Liu, Jian/A-9302-2013	Zhu, Gefei/0000-0002-0255-2664; Yan, Elsa/0000-0002-3583-1627; Liu, Monica Yun/0000-0003-3936-9377	National Science Foundation [MCB-0955407]; Anderson Postdoctoral Fellowship; Yale College; Yale-HHMI	National Science Foundation(National Science Foundation (NSF)); Anderson Postdoctoral Fellowship; Yale College; Yale-HHMI	This work is supported by National Science Foundation Career Grant MCB-0955407.; Recipient of an Anderson Postdoctoral Fellowship.; Recipient of a Yale College Dean's Research Fellowship.; Recipient of a Yale-HHMI Future Scientists Fellowship.	Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; Angel TE, 2009, P NATL ACAD SCI USA, V106, P14367, DOI 10.1073/pnas.0901074106; Angel TE, 2009, P NATL ACAD SCI USA, V106, P8555, DOI 10.1073/pnas.0903545106; Banerjee S, 2008, J MOL BIOL, V377, P1067, DOI 10.1016/j.jmb.2008.01.066; Bayburt TH, 2007, J BIOL CHEM, V282, P14875, DOI 10.1074/jbc.M701433200; Bayburt TH, 2011, J BIOL CHEM, V286, P1420, DOI 10.1074/jbc.M110.151043; Baylor D, 1996, P NATL ACAD SCI USA, V93, P560, DOI 10.1073/pnas.93.2.560; BAYLOR DA, 1984, J PHYSIOL-LONDON, V357, P575, DOI 10.1113/jphysiol.1984.sp015518; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; BELL RP, 1974, CHEM SOC REV, V3, P513, DOI 10.1039/cs9740300513; Berson EL, 1996, P NATL ACAD SCI USA, V93, P4526, DOI 10.1073/pnas.93.10.4526; BIRGE RR, 1990, ANNU REV PHYS CHEM, V41, P683, DOI 10.1146/annurev.pc.41.100190.003343; Botelho AV, 2006, BIOPHYS J, V91, P4464, DOI 10.1529/biophysj.106.082776; Bowmaker JK, 2008, VISION RES, V48, P2022, DOI 10.1016/j.visres.2008.03.025; Bowmaker JK, 2006, CURR BIOL, V16, pR484, DOI 10.1016/j.cub.2006.06.016; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; COOPER A, 1987, J AM CHEM SOC, V109, P7254, DOI 10.1021/ja00258a002; Corley SC, 2011, BIOPHYS J, V100, P2946, DOI 10.1016/j.bpj.2011.05.015; Del Valle LJ, 2003, CELL MOL LIFE SCI, V60, P2532, DOI 10.1007/s00018-003-3113-9; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; HUBBARD R, 1958, J GEN PHYSIOL, V42, P259, DOI 10.1085/jgp.42.2.259; Janz JM, 2004, J BIOL CHEM, V279, P55886, DOI 10.1074/jbc.M408766200; Janz JM, 2003, J BIOL CHEM, V278, P16982, DOI 10.1074/jbc.M210567200; Jastrzebska B, 2011, J BIOL CHEM, V286, P18930, DOI 10.1074/jbc.M111.234583; Kalloniatis Michael, 2004, Clin Exp Optom, V87, P65; Kennan A, 2005, TRENDS GENET, V21, P103, DOI 10.1016/j.tig.2004.12.001; LAGNADO L, 1992, NEURON, V8, P995, DOI 10.1016/0896-6273(92)90122-T; Lamb TD, 1996, P NATL ACAD SCI USA, V93, P566, DOI 10.1073/pnas.93.2.566; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Liu J, 2011, J BIOL CHEM, V286, P27622, DOI 10.1074/jbc.M111.233312; Liu J, 2009, J AM CHEM SOC, V131, P8750, DOI 10.1021/ja903154u; Lorenz-Fonfria VA, 2010, J AM CHEM SOC, V132, P5693, DOI 10.1021/ja907756e; Mahalingam M, 2008, P NATL ACAD SCI USA, V105, P17795, DOI 10.1073/pnas.0804541105; McAlear SD, 2010, ADV EXP MED BIOL, V664, P263, DOI 10.1007/978-1-4419-1399-9_30; Menon ST, 2001, PHYSIOL REV, V81, P1659, DOI 10.1152/physrev.2001.81.4.1659; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Okada T, 2002, P NATL ACAD SCI USA, V99, P5982, DOI 10.1073/pnas.082666399; Okada T, 2001, TRENDS BIOCHEM SCI, V26, P318, DOI 10.1016/S0968-0004(01)01799-6; Orban T, 2010, BIOCHEMISTRY-US, V49, P827, DOI 10.1021/bi901889t; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; Rakoczy EP, 2011, J MOL BIOL, V405, P584, DOI 10.1016/j.jmb.2010.11.003; Ranaghan MJ, 2010, J PHYS CHEM B, V114, P14064, DOI 10.1021/jp106633w; RAO VR, 1994, NATURE, V367, P639, DOI 10.1038/367639a0; Salem N, 2001, LIPIDS, V36, P945, DOI 10.1007/s11745-001-0805-6; SHASTRY BS, 1994, AM J MED GENET, V52, P467, DOI 10.1002/ajmg.1320520413; Shintani K, 2009, OPTOMETRY, V80, P384, DOI 10.1016/j.optm.2008.01.026; Soubias O, 2006, J BIOL CHEM, V281, P33233, DOI 10.1074/jbc.M603059200; SREBRO R, 1972, J PHYSIOL-LONDON, V224, P349, DOI 10.1113/jphysiol.1972.sp009899; Tsutsui K, 2007, BIOCHEMISTRY-US, V46, P6437, DOI 10.1021/bi7003763; Yan ECY, 2007, J PHYS CHEM C, V111, P8843, DOI 10.1021/jp067172o; Yokoyama S, 2000, PROG RETIN EYE RES, V19, P385, DOI 10.1016/S1350-9462(00)00002-1; Yokoyama S, 2008, ANNU REV GENOM HUM G, V9, P259, DOI 10.1146/annurev.genom.9.081307.164228	53	10	10	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2011	286	44					38408	38416		10.1074/jbc.M111.280602	http://dx.doi.org/10.1074/jbc.M111.280602			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	842JD	21921035	hybrid, Green Published			2022-12-25	WOS:000296594200055
J	Brett, BT; Berquam-Vrieze, KE; Nannapaneni, K; Huang, J; Scheetz, TE; Dupuy, AJ				Brett, Benjamin T.; Berquam-Vrieze, Katherine E.; Nannapaneni, Kishore; Huang, Jian; Scheetz, Todd E.; Dupuy, Adam J.			Novel Molecular and Computational Methods Improve the Accuracy of Insertion Site Analysis in Sleeping Beauty-Induced Tumors	PLOS ONE			English	Article							CANCER GENE DISCOVERY; MUTAGENESIS SCREENS; GENOME; MICE; NETWORKS; SYSTEM; MOUSE; PCR	The recent development of the Sleeping Beauty (SB) system has led to the development of novel mouse models of cancer. Unlike spontaneous models, SB causes cancer through the action of mutagenic transposons that are mobilized in the genomes of somatic cells to induce mutations in cancer genes. While previous methods have successfully identified many transposon-tagged mutations in SB-induced tumors, limitations in DNA sequencing technology have prevented a comprehensive analysis of large tumor cohorts. Here we describe a novel method for producing genetic profiles of SB-induced tumors using Illumina sequencing. This method has dramatically increased the number of transposon-induced mutations identified in each tumor sample to reveal a level of genetic complexity much greater than previously appreciated. In addition, Illumina sequencing has allowed us to more precisely determine the depth of sequencing required to obtain a reproducible signature of transposon-induced mutations within tumor samples. The use of Illumina sequencing to characterize SB-induced tumors should significantly reduce sampling error that undoubtedly occurs using previous sequencing methods. As a consequence, the improved accuracy and precision provided by this method will allow candidate cancer genes to be identified with greater confidence. Overall, this method will facilitate ongoing efforts to decipher the genetic complexity of the human cancer genome by providing more accurate comparative information from Sleeping Beauty models of cancer.	[Brett, Benjamin T.; Nannapaneni, Kishore; Scheetz, Todd E.] Univ Iowa, Ctr Bioinformat & Computat Biol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Berquam-Vrieze, Katherine E.; Dupuy, Adam J.] Univ Iowa, Dept Anat & Cell Biol, Roy J & Lucille A Carver Coll Med, Iowa City, IA USA; [Nannapaneni, Kishore; Scheetz, Todd E.] Univ Iowa, Dept Biomed Engn, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Huang, Jian] Univ Iowa, Dept Stat & Actuarial Sci, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Huang, Jian] Univ Iowa, Dept Biostat, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Scheetz, Todd E.] Univ Iowa, Dept Ophthalmol & Visual Sci, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Dupuy, Adam J.] Univ Iowa, Dept Pathol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa	Brett, BT (corresponding author), Univ Iowa, Ctr Bioinformat & Computat Biol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.	adam-dupuy@uiowa.edu		Scheetz, Todd/0000-0002-1965-5811; Dupuy, Adam/0000-0002-8561-4911; Nannapaneni, Kishore/0000-0002-5559-9378	National Cancer Institute (NCI) at the National Institutes of Health [5R01CA130867-03]; NATIONAL CANCER INSTITUTE [R01CA130867] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008629] Funding Source: NIH RePORTER	National Cancer Institute (NCI) at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by grant number 5R01CA130867-03 from the National Cancer Institute (NCI) at the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERQUAMVRIEZE KE, 2011, BLOOD IN PRESS; Collier LS, 2009, CANCER RES, V69, P8429, DOI 10.1158/0008-5472.CAN-09-1760; Collier LS, 2005, NATURE, V436, P272, DOI 10.1038/nature03681; de Ridder J, 2006, PLOS COMPUT BIOL, V2, P1530, DOI 10.1371/journal.pcbi.0020166; Dupuy AJ, 2009, CANCER RES, V69, P8150, DOI 10.1158/0008-5472.CAN-09-1135; Dupuy AJ, 2005, NATURE, V436, P221, DOI 10.1038/nature03691; DUPUY AJ, 2010, SEMIN CANC BIOL; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Harkey MA, 2007, STEM CELLS DEV, V16, P381, DOI 10.1089/scd.2007.0015; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Keng VW, 2009, NAT BIOTECHNOL, V27, P264, DOI 10.1038/nbt.1526; Kool J, 2009, NAT REV CANCER, V9, P389, DOI 10.1038/nrc2647; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Largaespada David A., 2008, V435, P95, DOI 10.1007/978-1-59745-232-8_7; Lauchle JO, 2009, NATURE, V461, P411, DOI 10.1038/nature08279; Manfred S, 2007, NAT METHODS, V4, P1051, DOI 10.1038/nmeth1103; Mardis ER, 2009, HUM MOL GENET, V18, pR163, DOI 10.1093/hmg/ddp396; Paruzynski A, 2010, NAT PROTOC, V5, P1379, DOI 10.1038/nprot.2010.87; Rad R, 2010, SCIENCE, V330, P1104, DOI 10.1126/science.1193004; Starr TK, 2011, P NATL ACAD SCI USA, V108, P5765, DOI 10.1073/pnas.1018012108; Starr TK, 2009, SCIENCE, V323, P1747, DOI 10.1126/science.1163040; Uren AG, 2008, CELL, V133, P727, DOI 10.1016/j.cell.2008.03.021; VASSILIOU GS, 2011, NATURE GENETICS	25	59	60	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2011	6	9							e24668	10.1371/journal.pone.0024668	http://dx.doi.org/10.1371/journal.pone.0024668			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZV	21931803	Green Submitted, gold, Green Published			2022-12-25	WOS:000295321800046
J	Subbiahdoss, G; Fernandez, ICS; Domingues, JFD; Kuijer, R; van der Mei, HC; Busscher, HJ				Subbiahdoss, Guruprakash; Fernandez, Isabel C. Saldarriaga; Domingues, Joana F. da Silva; Kuijer, Roel; van der Mei, Henny C.; Busscher, Henk J.			In Vitro Interactions between Bacteria, Osteoblast-Like Cells and Macrophages in the Pathogenesis of Biomaterial-Associated Infections	PLOS ONE			English	Article							MICROBIAL BIOFILM GROWTH; STAPHYLOCOCCUS-AUREUS; TISSUE INTEGRATION; EPIDERMIDIS; PHAGOCYTOSIS; EVOLUTION; SURVIVAL; SEQUENCE	Biomaterial-associated infections constitute a major clinical problem that is difficult to treat and often necessitates implant replacement. Pathogens can be introduced on an implant surface during surgery and compete with host cells attempting to integrate the implant. The fate of a biomaterial implant depends on the outcome of this race for the surface. Here we studied the competition between different bacterial strains and human U2OS osteoblast-like cells (ATCC HTB-94) for a poly(methylmethacrylate) surface in the absence or presence of macrophages in vitro using a peri-operative contamination model. Bacteria were seeded on the surface at a shear rate of 11 1/s prior to adhesion of U2OS cells and macrophages. Next, bacteria, U2OS cells and macrophages were allowed to grow simultaneously under low shear conditions (0.14 1/s). The outcome of the competition between bacteria and U2OS cells for the surface critically depended on bacterial virulence. In absence of macrophages, highly virulent Staphylococcus aureus or Pseudomonas aeruginosa stimulated U2OS cell death within 18 h of simultaneous growth on a surface. Moreover, these strains also caused cell death despite phagocytosis of adhering bacteria in presence of murine macrophages. Thus U2OS cells are bound to loose the race for a biomaterial surface against S. aureus or P. aeruginosa, even in presence of macrophages. In contrast, low-virulent Staphylococcus epidermidis did not cause U2OS cell death even after 48 h, regardless of the absence or presence of macrophages. Clinically, S. aureus and P. aeruginosa are known to yield acute and severe biomaterial-associated infections in contrast to S. epidermidis, mostly known to cause more low-grade infection. Thus it can be concluded that the model described possesses features concurring with clinical observations and therewith has potential for further studies on the simultaneous competition for an implant surface between tissue cells and pathogenic bacteria in presence of immune system components.	[Subbiahdoss, Guruprakash] Univ Med Ctr Groningen, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands; Univ Groningen, Groningen, Netherlands	University of Groningen; University of Groningen	Subbiahdoss, G (corresponding author), Univ Med Ctr Groningen, Dept Biomed Engn, NL-9713 AV Groningen, Netherlands.	h.c.van.der.mei@med.umcg.nl	Kuijer, Roel/A-6690-2015; Subbiahdoss, Guruprakash/AAE-6612-2021; Busscher, Henk/AAU-2113-2020	Kuijer, Roel/0000-0002-7637-4944; Subbiahdoss, Guruprakash/0000-0002-6684-7322; Busscher, Henk/0000-0002-3644-5533	University of Medical Center Groningen	University of Medical Center Groningen	This work was funded by the University of Medical Center Groningen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Anderson JM., 2004, BIOMATER SCI-UK, P296; BABIOR BM, 1984, BLOOD, V64, P959; Boelens JJ, 2000, J INFECT DIS, V181, P1337, DOI 10.1086/315369; BONVENTRE P F, 1970, Infection and Immunity, V2, P89; BUCHHOLZ HW, 1981, J BONE JOINT SURG BR, V63, P342, DOI 10.1302/0301-620X.63B3.7021561; DOUGHERTY SH, 1988, REV INFECT DIS, V10, P1102; Fernandez ICS, 2011, EUR CELLS MATER, V21, P73, DOI 10.22203/eCM.v021a06; FITZGERALD RH, 1979, ARCH SURG-CHICAGO, V114, P772; FITZGERALD RH, 1985, AM J MED, V78, P225, DOI 10.1016/0002-9343(85)90389-4; Garzoni C, 2009, TRENDS MICROBIOL, V17, P59, DOI 10.1016/j.tim.2008.11.005; GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258; GRISTINA AG, 1994, CLIN ORTHOP RELAT R, P106; GRISTINA AG, 1985, J BONE JOINT SURG AM, V67A, P264, DOI 10.2106/00004623-198567020-00014; GRISTINA AG, 1989, MED PROG TECHNOL, V14, P205; Gunther F, 2009, MOL IMMUNOL, V46, P1805, DOI 10.1016/j.molimm.2009.01.020; JOHNSON GM, 1986, INFECT IMMUN, V54, P13, DOI 10.1128/IAI.54.1.13-20.1986; Kaplan SS, 1999, INFECT IMMUN, V67, P1640; Khalil H, 2007, MICROBES INFECT, V9, P460, DOI 10.1016/j.micinf.2007.01.002; Kubica M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001409; Leid JG, 2002, INFECT IMMUN, V70, P6339, DOI 10.1128/IAI.70.11.6339-6345.2002; LYNN M, 1984, BRIT J EXP PATHOL, V65, P275; Massey RC, 2006, NAT REV MICROBIOL, V4, P953, DOI 10.1038/nrmicro1551; MCKEVITT AI, 1990, INFECT IMMUN, V58, P1473, DOI 10.1128/IAI.58.5.1473-1475.1990; Myrvik Q N, 1989, J Invest Surg, V2, P381, DOI 10.3109/08941938909018263; PETERS G, 1987, PATHOGENICITY CLIN S, P15; Raad I, 1998, CLIN INFECT DIS, V26, P1182, DOI 10.1086/520285; Robinson DA, 2004, CLIN MICROBIOL INFEC, V10, P92, DOI 10.1111/j.1469-0691.2004.00768.x; SHANBHAG A, 1992, J BIOMED MATER RES, V26, P185, DOI 10.1002/jbm.820260205; Stuart LM, 2005, IMMUNITY, V22, P539, DOI 10.1016/j.immuni.2005.05.002; Subbiahdoss G, 2010, J BIOMED MATER RES A, V94A, P533, DOI 10.1002/jbm.a.32731; Subbiahdoss G, 2009, ACTA BIOMATER, V5, P1399, DOI 10.1016/j.actbio.2008.12.011; TOFTE RW, 1980, INFECT IMMUN, V27, P693, DOI 10.1128/IAI.27.2.693-696.1980; Trampuz Andrej, 2005, Curr Opin Investig Drugs, V6, P185; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; Van Delden C, 1998, EMERG INFECT DIS, V4, P551, DOI 10.3201/eid0404.980405; Verkkala K, 1998, EUR J CARDIO-THORAC, V14, P206, DOI 10.1016/S1010-7940(98)00150-X; Vuong C, 2002, MICROBES INFECT, V4, P481, DOI 10.1016/S1286-4579(02)01563-0; Watanabe I, 2007, J IMMUNOL, V178, P4917, DOI 10.4049/jimmunol.178.8.4917; Zimmerli W, 2004, NEW ENGL J MED, V351, P1645, DOI 10.1056/NEJMra040181; ZIMMERLI W, 1984, J CLIN INVEST, V73, P1191, DOI 10.1172/JCI111305	41	41	42	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2011	6	9							e24827	10.1371/journal.pone.0024827	http://dx.doi.org/10.1371/journal.pone.0024827			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZV	21931858	Green Published, Green Submitted, gold			2022-12-25	WOS:000295321800069
J	Bharatham, K; Zhang, ZH; Mihalek, I				Bharatham, Kavitha; Zhang, Zong Hong; Mihalek, Ivana			Determinants, Discriminants, Conserved Residues - A Heuristic Approach to Detection of Functional Divergence in Protein Families	PLOS ONE			English	Article							AMINO-ACID SUBSTITUTIONS; SPECIFICITY DETERMINANTS; EVOLUTIONARY CONSERVATION; STATISTICAL-METHODS; LAC REPRESSOR; PREDICTION; INFORMATION; SEQUENCES; POSITIONS; ENTROPY	In this work, belonging to the field of comparative analysis of protein sequences, we focus on detection of functional specialization on the residue level. As the input, we take a set of sequences divided into groups of orthologues, each group known to be responsible for a different function. This provides two independent pieces of information: within group conservation and overlap in amino acid type across groups. We build our discussion around the set of scoring functions that keep the two separated and the source of the signal easy to trace back to its source. We propose a heuristic description of functional divergence that includes residue type exchangeability, both in the conservation and in the overlap measure, and does not make any assumptions on the rate of evolution in the groups other than the one under consideration. Residue types acceptable at a certain position within an orthologous group are described as a distribution which evolves in time, starting from a single ancestral type, and is subject to constraints that can be inferred only indirectly. To estimate the strength of the constraints, we compare the observed degrees of conservation and overlap with those expected in the hypothetical case of a freely evolving distribution. Our description matches the experiment well, but we also conclude that any attempt to capture the evolutionary behavior of specificity determining residues in terms of a scalar function will be tentative, because no single model can cover the variety of evolutionary behavior such residues exhibit. Especially, models expecting the same type of evolutionary behavior across functionally divergent groups tend to miss a portion of information otherwise retrievable by the conservation and overlap measures they use.	[Bharatham, Kavitha; Zhang, Zong Hong; Mihalek, Ivana] Agcy Sci Technol & Res, Bioinformat Inst, Singapore, Singapore; [Mihalek, Ivana] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Bharatham, K (corresponding author), Res Hosp, Dept Chem Biol & Therapeut, Memphis, TN 38105 USA.	ivanam@bii.a-star.edu.sg	Zhang, Zong Hong/N-9126-2013	Zhang, Zong Hong/0000-0002-8056-891X	Biomedical Research Council, Agency for Science Technology and Research, Singapore	Biomedical Research Council, Agency for Science Technology and Research, Singapore(Agency for Science Technology & Research (A*STAR))	Funding was provided by the Biomedical Research Council, Agency for Science Technology and Research, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Capra JA, 2008, BIOINFORMATICS, V24, P1473, DOI 10.1093/bioinformatics/btn214; Capra JA, 2007, BIOINFORMATICS, V23, P1875, DOI 10.1093/bioinformatics/btm270; Chakrabarti S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-207; Chakrabarti S, 2009, PROTEINS, V75, P231, DOI 10.1002/prot.22239; Clemmons DR, 2001, ENDOCR REV, V22, P800, DOI 10.1210/er.22.6.800; de Vries SJ, 2006, PROTEINS, V63, P479, DOI 10.1002/prot.20842; Elcock AH, 2001, P NATL ACAD SCI USA, V98, P2990, DOI 10.1073/pnas.061411798; Engelen S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000267; Felsenstein J, 2004, INFERRING PHYLOGENIE, P205; Gribaldo S, 2003, MOL BIOL EVOL, V20, P1754, DOI 10.1093/molbev/msg171; Gu X, 1999, MOL BIOL EVOL, V16, P1664, DOI 10.1093/oxfordjournals.molbev.a026080; Gu X, 2002, BIOINFORMATICS, V18, P500, DOI 10.1093/bioinformatics/18.3.500; Gu X, 2001, MOL BIOL EVOL, V18, P453, DOI 10.1093/oxfordjournals.molbev.a003824; Hanna M, 1996, BIOCHEMISTRY-US, V35, P3625, DOI 10.1021/bi951333p; Hannenhalli SS, 2000, J MOL BIOL, V303, P61, DOI 10.1006/jmbi.2000.4036; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Innis CA, 2000, PROTEIN ENG, V13, P839, DOI 10.1093/protein/13.12.839; Kalinina OV, 2004, NUCLEIC ACIDS RES, V32, pW424, DOI 10.1093/nar/gkh391; Kalinina OV, 2004, PROTEIN SCI, V13, P443, DOI 10.1110/ps.03191704; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Lichtarge O, 1996, J MOL BIOL, V257, P342, DOI 10.1006/jmbi.1996.0167; LIVINGSTONE CD, 1993, COMPUT APPL BIOSCI, V9, P745; Lo SC, 2006, EMBO J, V25, P3605, DOI 10.1038/sj.emboj.7601243; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Lopez P, 2002, MOL BIOL EVOL, V19, P1; Madabushi S, 2002, J MOL BIOL, V316, P139, DOI 10.1006/jmbi.2001.5327; MARKIEWICZ P, 1994, J MOL BIOL, V240, P421, DOI 10.1006/jmbi.1994.1458; Marttinen P, 2006, BIOINFORMATICS, V22, P2466, DOI 10.1093/bioinformatics/btl411; Mihalek I, 2006, PROTEINS, V63, P87, DOI 10.1002/prot.20866; Mihalek I, 2004, J MOL BIOL, V336, P1265, DOI 10.1016/j.jmb.2003.12.078; Mihalek I, 2003, J MOL BIOL, V331, P263, DOI 10.1016/S0022-2836(03)00663-6; Mihalek I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-488; Mirny L, 2001, J MOL BIOL, V308, P123, DOI 10.1006/jmbi.2001.4602; Mirny LA, 2002, J MOL BIOL, V321, P7, DOI 10.1016/S0022-2836(02)00587-9; Mirny LA, 1999, J MOL BIOL, V291, P177, DOI 10.1006/jmbi.1999.2911; Nooren IMA, 2003, J MOL BIOL, V325, P991, DOI 10.1016/S0022-2836(02)01281-0; Pei JM, 2006, BIOINFORMATICS, V22, P164, DOI 10.1093/bioinformatics/bti766; Pirovano W, 2006, NUCLEIC ACIDS RES, V34, P6540, DOI 10.1093/nar/gkl901; Pupko T, 2002, BIOINFORMATICS, V18, P1116, DOI 10.1093/bioinformatics/18.8.1116; Ramakrishnan B, 2006, J MOL BIOL, V357, P1619, DOI 10.1016/j.jmb.2006.01.088; Reva B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r232; Rodriguez GJ, 2010, P NATL ACAD SCI USA, V107, P7787, DOI 10.1073/pnas.0914877107; Sankararaman S, 2008, BIOINFORMATICS, V24, P2445, DOI 10.1093/bioinformatics/btn474; SCHNEIDER TD, 1986, J MOL BIOL, V188, P415, DOI 10.1016/0022-2836(86)90165-8; Shannon C., 1964, MATH THEORY COMMUNIC; SHENKIN PS, 1991, PROTEINS, V11, P297, DOI 10.1002/prot.340110408; Suckow J, 1996, J MOL BIOL, V261, P509, DOI 10.1006/jmbi.1996.0479; Sunita S, 2007, NUCLEIC ACIDS RES, V35, P4264, DOI 10.1093/nar/gkm411; Tungtur S, 2010, J MOL BIOL, V395, P785, DOI 10.1016/j.jmb.2009.10.001; Valdar WSJ, 2002, PROTEINS, V48, P227, DOI 10.1002/prot.10146; Veerassamy S, 2003, J COMPUT BIOL, V10, P997, DOI 10.1089/106652703322756195; Wallace IM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-135; Wong WSW, 2004, GENETICS, V168, P1041, DOI 10.1534/genetics.104.031153; WU TT, 1970, J EXP MED, V132, P211, DOI 10.1084/jem.132.2.211; Xu H, 2005, J BIOL CHEM, V280, P7956, DOI 10.1074/jbc.M412869200; Ye K, 2006, PROTEINS, V63, P1018, DOI 10.1002/prot.20899; Yin Y, 2007, P NATL ACAD SCI USA, V104, P17353, DOI 10.1073/pnas.0708265104	58	12	12	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2011	6	9							e24382	10.1371/journal.pone.0024382	http://dx.doi.org/10.1371/journal.pone.0024382			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CO	21931701	Green Submitted, gold, Green Published			2022-12-25	WOS:000294803200018
J	Hussain, AR; Uddin, S; Bu, R; Khan, OS; Ahmed, SO; Ahmed, M; Al-Kuraya, KS				Hussain, Azhar R.; Uddin, Shahab; Bu, Rong; Khan, Omar S.; Ahmed, Saeeda O.; Ahmed, Maqbool; Al-Kuraya, Khawla S.			Resveratrol Suppresses Constitutive Activation of AKT via Generation of ROS and Induces Apoptosis in Diffuse Large B Cell Lymphoma Cell Lines	PLOS ONE			English	Article							TRAIL-INDUCED APOPTOSIS; NON-HODGKINS-LYMPHOMA; FATTY-ACID SYNTHASE; FACTOR-KAPPA-B; DOWN-REGULATION; UP-REGULATION; CANCER CELLS; IN-VIVO; INHIBITION; PATHWAY	Background: We have recently shown that deregulation PI3-kinase/AKT survival pathway plays an important role in pathogenesis of diffuse large B cell lymphoma (DLBCL). In an attempt to identify newer therapeutic agents, we investigated the role of Resveratrol (trans-3,49, 5-trihydroxystilbene), a naturally occurring polyphenolic compound on a panel of diffuse large B-cell lymphoma (DLBCL) cells in causing inhibition of cell viability and inducing apoptosis. Methodology/Principal Findings: We investigated the action of Resveratrol on DLBCL cells and found that Resveratrol inhibited cell viability and induced apoptosis by inhibition of constitutively activated AKT and its downstream targets via generation of reactive oxygen species (ROS). Simultaneously, Resveratrol treatment of DLBCL cell lines also caused ROS dependent upregulation of DR5; and interestingly, co-treatment of DLBCL with sub-toxic doses of TRAIL and Resveratrol synergistically induced apoptosis via utilizing DR5, on the other hand, gene silencing of DR5 abolished this effect. Conclusion/Significance: Altogether, these data suggest that Resveratrol acts as a suppressor of AKT/PKB pathway leading to apoptosis via generation of ROS and at the same time primes DLBCL cells via up-regulation of DR5 to TRAIL-mediated apoptosis. These data raise the possibility that Resveratrol may have a future therapeutic role in DLBCL and possibly other malignancies with constitutive activation of the AKT/PKB pathway.	[Hussain, Azhar R.; Uddin, Shahab; Bu, Rong; Khan, Omar S.; Ahmed, Saeeda O.; Ahmed, Maqbool; Al-Kuraya, Khawla S.] King Faisal Specialist Hosp & Res Ctr, Riyadh 11211, Saudi Arabia	King Faisal Specialist Hospital & Research Center	Hussain, AR (corresponding author), King Faisal Specialist Hosp & Res Ctr, Riyadh 11211, Saudi Arabia.	Kkuraya@kfshrc.edu.sa		Uddin, Shahab/0000-0003-1886-6710; Khan, Omar/0000-0002-4998-1693				Ashkenazi A, 1999, CURR OPIN CELL BIOL, V11, P255, DOI 10.1016/S0955-0674(99)80034-9; Bai Y, 2010, CANCER SCI, V101, P488, DOI 10.1111/j.1349-7006.2009.01415.x; Bremer E, 2006, TRENDS MOL MED, V12, P382, DOI 10.1016/j.molmed.2006.06.002; Chan WC, 1997, BLOOD, V89, P3909; Chandra J, 2009, ANTIOXID REDOX SIGN, V11, P1123, DOI [10.1089/ars.2008.2302, 10.1089/ARS.2008.2302]; Clodi K, 2000, BRIT J HAEMATOL, V111, P580, DOI 10.1046/j.1365-2141.2000.02404.x; Cuevas B, 1999, J BIOL CHEM, V274, P27583, DOI 10.1074/jbc.274.39.27583; Escalon MP, 2008, EXPERT OPIN PHARMACO, V9, P2247, DOI 10.1517/14656566.9.13.2247 ; Fisher RI, 2003, LEUKEMIA, V17, P1948, DOI 10.1038/sj.leu.2403096; Fisher RI, 1997, CANCER CHEMOTH PHARM, V40, pS42, DOI 10.1007/s002800051060; Fu Z, 2008, ONCOGENE, V27, P2312, DOI 10.1038/onc.2008.24; Galati G, 2002, TOXICOLOGY, V177, P91, DOI 10.1016/S0300-483X(02)00198-1; Horndasch M, 2011, PROSTATE, V71, P1357, DOI 10.1002/pros.21353; Hsieh TC, 2010, BIOFACTORS, V36, P360, DOI 10.1002/biof.105; Hudson TS, 2007, CANCER RES, V67, P8396, DOI 10.1158/0008-5472.CAN-06-4069; Hussain AR, 2010, CELL PROLIFERAT, V43, P170, DOI 10.1111/j.1365-2184.2009.00662.x; Hussain AR, 2006, APOPTOSIS, V11, P245, DOI 10.1007/s10495-006-3392-3; Hussain AR, 2008, MOL CANCER THER, V7, P3318, DOI 10.1158/1535-7163.MCT-08-0541; Hussain AR, 2007, CANCER RES, V67, P3888, DOI 10.1158/0008-5472.CAN-06-3764; Hussain AR, 2011, FREE RADICAL BIO MED, V50, P978, DOI 10.1016/j.freeradbiomed.2010.12.034; Hussain AR, 2010, J PATHOL, V222, P180, DOI 10.1002/path.2747; Inoue A, 2004, FREE RADICAL BIO MED, V37, P1290, DOI 10.1016/j.freeradbiomed.2004.07.003; Kotliarova S, 2008, CANCER RES, V68, P6643, DOI 10.1158/0008-5472.CAN-08-0850; Kwon D, 2008, BIOCHEM BIOPH RES CO, V372, P870, DOI 10.1016/j.bbrc.2008.05.148; Le Corre L, 2005, MOL NUTR FOOD RES, V49, P462, DOI 10.1002/mnfr.200400094; Lee TJ, 2009, FREE RADICAL BIO MED, V46, P1639, DOI 10.1016/j.freeradbiomed.2009.03.022; Li Y, 2006, APPL BIOCHEM BIOTECH, V135, P181, DOI 10.1385/ABAB:135:3:181; Liu KW, 2011, J CLIN INVEST, V121, P905, DOI 10.1172/JCI43690; Low ICC, 2010, ANTIOXID REDOX SIGN, V13, P807, DOI 10.1089/ars.2009.3050; Mustafi SB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008719; Paraiso KHT, 2011, CANCER RES, V71, P2750, DOI 10.1158/0008-5472.CAN-10-2954; Pervaiz S, 2009, ANTIOXID REDOX SIGN, V11, P2851, DOI [10.1089/ars.2008.2412, 10.1089/ARS.2008.2412]; Prasad S, 2011, J BIOL CHEM, V286, P5546, DOI 10.1074/jbc.M110.183699; Prasad S, 2011, CANCER RES, V71, P538, DOI 10.1158/0008-5472.CAN-10-3121; Roccaro AM, 2008, CLIN CANCER RES, V14, P1849, DOI 10.1158/1078-0432.CCR-07-1750; Samovski D, 2010, J BIOL CHEM, V285, P6879, DOI 10.1074/jbc.M109.080416; Schilder YDC, 2009, FREE RADICAL BIO MED, V46, P1598, DOI 10.1016/j.freeradbiomed.2009.03.013; Schultz J, 2004, J NATL CANCER I, V96, P1497, DOI 10.1093/jnci/96.20.1497; Stowe DF, 2009, ANTIOXID REDOX SIGN, V11, P1373, DOI 10.1089/ARS.2008.2331; Terragni J, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-6; Trachootham D, 2008, ANTIOXID REDOX SIGN, V10, P1343, DOI 10.1089/ars.2007.1957; Uddin S, 2005, CLIN CANCER RES, V11, P3102, DOI 10.1158/1078-0432.CCR-04-1857; Uddin S, 2008, J CLIN ENDOCR METAB, V93, P4088, DOI 10.1210/jc.2008-0503; Uddin S, 2006, BLOOD, V108, P4178, DOI 10.1182/blood-2006-04-016907; Uddin S, 2010, LAB INVEST, V90, P1346, DOI 10.1038/labinvest.2010.108; Uddin S, 2009, AM J GASTROENTEROL, V104, P1790, DOI 10.1038/ajg.2009.230; Vanamala J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-238	47	58	63	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2011	6	9							e24703	10.1371/journal.pone.0024703	http://dx.doi.org/10.1371/journal.pone.0024703			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CO	21931821	gold, Green Published, Green Submitted			2022-12-25	WOS:000294803200040
J	Saito, T; Goto-Kazeto, R; Kawakami, Y; Nomura, K; Tanaka, H; Adachi, S; Arai, K; Yamaha, E				Saito, Taiju; Goto-Kazeto, Rie; Kawakami, Yutaka; Nomura, Kazuharu; Tanaka, Hideki; Adachi, Shinji; Arai, Katsutoshi; Yamaha, Etsuro			The Mechanism for Primordial Germ-Cell Migration Is Conserved between Japanese Eel and Zebrafish	PLOS ONE			English	Article							TRANSEPITHELIAL MIGRATION; GONAD MORPHOGENESIS; MESSENGER-RNAS; E-CADHERIN; DROSOPHILA; TRANSPLANTATION; RECEPTOR; ORIGIN; FISH; VISUALIZATION	Primordial germ cells (PGCs) are segregated and specified from somatic cells during early development. These cells arise elsewhere and have to migrate across the embryo to reach developing gonadal precursors. Several molecules associated with PGC migration (i.e. dead-end, nanos1, and cxcr4) are highly conserved across phylum boundaries. However, since cell migration is a complicated process that is regulated spatially and temporally by multiple adaptors and signal effectors, the process is unlikely to be explained by these known genes only. Indeed, it has been shown that there are variations in PGC migration pattern during development among teleost species. However, it is still unclear whether the actual mechanism of PGC migration is conserved among species. In this study, we studied the migration of PGCs in Japanese eel (Anguilla japonica) embryos and tested the migration mechanism between Japanese eel and zebrafish (Danio rerio) for conservation, by transplanting eel PGCs into zebrafish embryos. The experiments showed that eel PGCs can migrate toward the gonadal region of zebrafish embryos along with endogenous PGCs, even though the migration patterns, behaviors, and settlements of PGCs are somewhat different between these species. Our results demonstrate that the migration mechanism of PGCs during embryonic development is highly conserved between these two distantly related species (belonging to different teleost orders).	[Saito, Taiju; Goto-Kazeto, Rie; Kawakami, Yutaka; Yamaha, Etsuro] Hokkaido Univ, Nanae Fresh Water Lab, Field Sci Ctr No Biosphere, Nanae, Japan; [Saito, Taiju; Arai, Katsutoshi] Hokkaido Univ, Fac Fisheries Sci, Lab Aquaculture Genet & Genom, Hakodate, Hokkaido, Japan; [Nomura, Kazuharu; Tanaka, Hideki] Natl Res Inst Aquaculture, Minamiise, Mie, Japan; [Adachi, Shinji] Hokkaido Univ, Fac Fisheries Sci, Lab Aquaculture Biol, Hakodate, Hokkaido, Japan	Hokkaido University; Hokkaido University; Japan Fisheries Research & Education Agency (FRA); Hokkaido University	Saito, T (corresponding author), Hokkaido Univ, Nanae Fresh Water Lab, Field Sci Ctr No Biosphere, Nanae, Japan.	taiju@hokudai-nanae.jp	Arai, Katsutoshi/A-8480-2012; Saito, Taiju/A-3171-2013	Saito, Taiju/0000-0003-0029-2173	Bio-oriented Technology Research Advancement Institution	Bio-oriented Technology Research Advancement Institution	This work was supported by Grants-in-Aid for Promotion of Basic Research Activities for Innovative Biosciences from the Bio-oriented Technology Research Advancement Institution. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blaser H, 2005, J CELL SCI, V118, P4027, DOI 10.1242/jcs.02522; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; Doitsidou M, 2002, CELL, V111, P647, DOI 10.1016/S0092-8674(02)01135-2; Erwin DH, 1999, AM ZOOL, V39, P617; GILBERT SF, 2006, DEV BIOL, P144; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602; Inoue JG, 2005, GENE, V349, P227, DOI 10.1016/j.gene.2005.01.008; Inoue JG, 2010, BIOL LETTERS, V6, P363, DOI 10.1098/rsbl.2009.0989; Jenkins AB, 2003, DEVELOPMENT, V130, P4417, DOI 10.1242/dev.00639; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Knaut H, 2003, NATURE, V421, P279, DOI 10.1038/nature01338; Kunwar PS, 2008, J CELL BIOL, V183, P157, DOI 10.1083/jcb.200807049; Kunwar PS, 2003, PLOS BIOL, V1, P372, DOI 10.1371/journal.pbio.0000080; Kurokawa H, 2006, DEV GROWTH DIFFER, V48, P209, DOI 10.1111/j.1440-169x.2006.00858.x; Majhi SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006132; Mishima Y, 2006, CURR BIOL, V16, P2135, DOI 10.1016/j.cub.2006.08.086; Molyneaux KA, 2003, DEVELOPMENT, V130, P4279, DOI 10.1242/dev.00640; Ohta H, 1997, FISH PHYSIOL BIOCHEM, V17, P163, DOI 10.1023/A:1007720600588; Okutsu T, 2006, J REPROD DEVELOP, V52, P685, DOI 10.1262/jrd.18096; Peng ZG, 2006, GENE, V370, P113, DOI 10.1016/j.gene.2005.11.024; Richardson BE, 2010, NAT REV MOL CELL BIO, V11, P37, DOI 10.1038/nrm2815; Saito T, 2008, BIOL REPROD, V78, P159, DOI 10.1095/biolreprod.107.060038; Saito T, 2006, INT J DEV BIOL, V50, P691, DOI 10.1387/ijdb.062143ts; Saito T, 2010, INT J DEV BIOL, V54, P1481, DOI 10.1387/ijdb.103111ts; Stebler J, 2004, DEV BIOL, V272, P351, DOI 10.1016/j.ydbio.2004.05.009; Takeuchi T, 2010, MECH DEVELOP, V127, P146, DOI 10.1016/j.mod.2009.09.005; Takeuchi Y, 2004, NATURE, V430, P629, DOI 10.1038/430629a; Van Doren M, 2003, DEVELOPMENT, V130, P2355, DOI 10.1242/dev.00454; Weidinger G, 2002, DEVELOPMENT, V129, P25; Weidinger G, 1999, DEVELOPMENT, V126, P5295; Yamaha E, 2003, GENETICA, V119, P121, DOI 10.1023/A:1026061828744; Yamaha E, 2007, J SEA RES, V58, P8, DOI 10.1016/j.seares.2007.02.003	33	32	39	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2011	6	9							e24460	10.1371/journal.pone.0024460	http://dx.doi.org/10.1371/journal.pone.0024460			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CO	21931724	Green Submitted, Green Published, gold			2022-12-25	WOS:000294803200020
J	Golding, AE; Paliulis, LV				Golding, Adriana E.; Paliulis, Leocadia V.			Karyotype, Sex Determination, and Meiotic Chromosome Behavior in Two Pholcid (Araneomorphae, Pholcidae) Spiders: Implications for Karyotype Evolution	PLOS ONE			English	Article							ARANEAE	There are 1,111 species of pholcid spiders, of which less than 2% have published karyotypes. Our aim in this study was to determine the karyotypes and sex determination mechanisms of two species of pholcids: Physocyclus mexicanus (Banks, 1898) and Holocnemus pluchei (Scopoli, 1763), and to observe sex chromosome behavior during meiosis. We constructed karyotypes for P. mexicanus and H. pluchei using information from both living and fixed cells. We found that P. mexicanus has a chromosome number of 2n = 15 in males and 2n = 16 in females with X0-XX sex determination, like other members of the genus Physocyclus. H. pluchei has a chromosome number of 2n = 28 in males and 2n = 28 in females with XY-XX sex determination, which is substantially different from its closest relatives. These data contribute to our knowledge of the evolution of this large and geographically ubiquitous family, and are the first evidence of XY-XX sex determination in pholcids.	[Golding, Adriana E.; Paliulis, Leocadia V.] Bucknell Univ, Dept Biol, Lewisburg, PA 17837 USA	Bucknell University	Golding, AE (corresponding author), Bucknell Univ, Dept Biol, Lewisburg, PA 17837 USA.	le.paliulis@bucknell.edu			Biology Department, Bucknell University	Biology Department, Bucknell University	The Biology Department, Bucknell University funded this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARAUJO D, 2005, J ARACHNOL, V33, P591, DOI DOI 10.1636/04-105.1; Astrin JJ, 2006, ZOOL SCR, V35, P441, DOI 10.1111/j.1463-6409.2006.00239.x; BOLE-GOWDA B. N., 1958, PROC ZOOL SOC, V11, P69; Bruvo-Madaric B, 2005, MOL PHYLOGENET EVOL, V37, P661, DOI 10.1016/j.ympev.2005.08.016; COKENDOLPHER JC, 1989, J NEW YORK ENTOMOL S, V97, P475; DATTA SN, 1988, GENETICA, V76, P91, DOI 10.1007/BF00058807; Doan RN, 2009, HEREDITAS, V146, P180, DOI 10.1111/j.1601-5223.2009.02123.x; Kral J, 2006, CHROMOSOME RES, V14, P859, DOI 10.1007/s10577-006-1095-9; MADDISON WP, 1982, CHROMOSOMA, V85, P23, DOI 10.1007/BF00344592; Oliveira RM, 2007, J ARACHNOL, V35, P293; Painter T. S., 1914, Zoologische Jahrbuecher Jena Abteilungen fur Anatomie, V38; PARIDA BB, 1987, CHROMOSOME INF SERV, V43, P11; Platnick NI, 2011, WORLD SPIDER CATALOG; Ramlho MO, 2008, J ARACHNOL, V36, P453; SHARMA GP, 1959, PHOLCIDAE RES B PANJ, V10, P49; SHARMA GP, 1987, PRANIKEE, V8, P71; SRIVASTAVA MDL, 1986, CHROMOSOME INFORM SE, V41, P23; Suzuki S., 1954, Journal of Science of the Hiroshima University Zoology, V15, P23; Wang Xiuzhen, 1997, Acta Arachnologica Sinica, V6, P19; WHITE MJD, 1973, CHROMOSOMES	20	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2011	6	9							e24748	10.1371/journal.pone.0024748	http://dx.doi.org/10.1371/journal.pone.0024748			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CN	21931842	Green Published, gold, Green Submitted			2022-12-25	WOS:000294803100064
J	Ueno, K; Matsumoto, Y; Uno, J; Sasamoto, K; Sekimizu, K; Kinjo, Y; Chibana, H				Ueno, Keigo; Matsumoto, Yasuhiko; Uno, Jun; Sasamoto, Kaname; Sekimizu, Kazuhisa; Kinjo, Yuki; Chibana, Hiroji			Intestinal Resident Yeast Candida glabrata Requires Cyb2p-Mediated Lactate Assimilation to Adapt in Mouse Intestine	PLOS ONE			English	Article							TRANSCRIPTIONAL REGULATION; GLYOXYLATE CYCLE; BETA-OXIDATION; ALBICANS; EPIDEMIOLOGY; METABOLISM; EXPRESSION; INFECTION; TRANSPORT; VIRULENCE	The intestinal resident Candida glabrata opportunistically infects humans. However few genetic factors for adaptation in the intestine are identified in this fungus. Here we describe the C. glabrata CYB2 gene encoding lactate dehydrogenase as an adaptation factor for survival in the intestine. CYB2 was identified as a virulence factor by a silkworm infection study. To determine the function of CYB2, we analysed in vitro phenotypes of the mutant Delta cyb2. The Delta cyb2 mutant grew well in glucose medium under aerobic and anaerobic conditions, was not supersensitive to nitric oxide which has fungicidal-effect in phagocytes, and had normal levels of general virulence factors protease, lipase and adherence activities. A previous report suggested that Cyb2p is responsible for lactate assimilation. Additionally, it was speculated that lactate assimilation was required for Candida virulence because Candida must synthesize glucose via gluconeogenesis under glucose-limited conditions such as in the host. Indeed, the Delta cyb2 mutant could not grow on lactate medium in which lactate is the sole carbon source in the absence of glucose, indicating that Cyb2p plays a role in lactate assimilation. We hypothesized that Cyb2p-mediated lactate assimilation is necessary for proliferation in the intestinal tract, as the intestine is rich in lactate produced by bacteria flora, but not glucose. The Delta cyb2 mutant showed 100-fold decreased adaptation and few cells of Saccharomyces cerevisiae can adapt in mouse ceca. Interestingly, C. glabrata could assimilate lactate under hypoxic conditions, dependent on CYB2, but not yeast S. cerevisiae. Because accessible oxygen is limited in the intestine, the ability for lactate assimilation in hypoxic conditions may provide an advantage for a pathogenic yeast. From those results, we conclude that Cyb2p-mediated lactate assimilation is an intestinal adaptation factor of C. glabrata.	[Ueno, Keigo; Uno, Jun; Sasamoto, Kaname; Chibana, Hiroji] Chiba Univ, MMRC, Chiba, Japan; [Matsumoto, Yasuhiko; Sekimizu, Kazuhisa] Univ Tokyo, Microbiol Lab, Grad Sch Pharmaceut Sci, Tokyo, Japan; [Ueno, Keigo; Kinjo, Yuki] Natl Inst Infect Dis, Lab Immune Regulat, Dept Chemotherapy & Mycoses, Tokyo, Japan	Chiba University; University of Tokyo; National Institute of Infectious Diseases (NIID)	Ueno, K (corresponding author), Chiba Univ, MMRC, Chiba, Japan.	chibana@faculty.chiba-u.jp	Matsumoto, Yasuhiko/H-5767-2019	Matsumoto, Yasuhiko/0000-0002-0796-2304; Ueno, Keigo/0000-0003-0671-0049	Ministry of Education, Culture, Sports, Science and Technology, Japan [21022011]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (No. 21022011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almirante B, 2005, J CLIN MICROBIOL, V43, P1829, DOI 10.1128/JCM.43.4.1829-1835.2005; BARCHIESI F, 1994, J CLIN MICROBIOL, V32, P2494, DOI 10.1128/JCM.32.10.2494-2500.1994; Burke D., 2000, METHODS YEAST GENETI; Cant JP, 1996, J ANIM SCI, V74, P2541; Casal M, 2008, FEMS MICROBIOL REV, V32, P974, DOI 10.1111/j.1574-6976.2008.00128.x; CASSIO F, 1987, APPL ENVIRON MICROB, V53, P509; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Ernst JF, 2009, CELL MICROBIOL, V11, P183, DOI 10.1111/j.1462-5822.2008.01259.x; Fang FC, 2004, NAT REV MICROBIOL, V2, P820, DOI 10.1038/nrmicro1004; Fidel PL, 1999, CLIN MICROBIOL REV, V12, P80, DOI 10.1128/CMR.12.1.80; Fidel PL, 1996, J INFECT DIS, V173, P425, DOI 10.1093/infdis/173.2.425; Ganong WF, 1999, REV MED PHYSL; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Gumru B, 2006, MYCOPATHOLOGIA, V162, P389, DOI 10.1007/s11046-006-0074-1; Hamamoto H, 2004, ANTIMICROB AGENTS CH, V48, P774, DOI 10.1128/AAC.48.3.774-779.2004; Hanaoka N, 2008, EUKARYOT CELL, V7, P1640, DOI 10.1128/EC.00129-08; Harris AD, 1999, CLIN INFECT DIS, V29, P926, DOI 10.1086/520460; Iraqui I, 2005, MOL MICROBIOL, V55, P1259, DOI 10.1111/j.1365-2958.2004.04475.x; Jones T, 2004, P NATL ACAD SCI USA, V101, P7329, DOI 10.1073/pnas.0401648101; Kaito C, 2005, MOL MICROBIOL, V56, P934, DOI 10.1111/j.1365-2958.2005.04596.x; Kao AS, 1999, CLIN INFECT DIS, V29, P1164, DOI 10.1086/313450; KINNEY JM, 1960, ANESTHESIOLOGY, V21, P615, DOI 10.1097/00000542-196011000-00005; KUSNE S, 1994, TRANSPLANTATION, V57, P398, DOI 10.1097/00007890-199402150-00014; Leturque A, 2009, AM J PHYSIOL-ENDOC M, V296, pE985, DOI 10.1152/ajpendo.00004.2009; LODI T, 1991, MOL CELL BIOL, V11, P3762, DOI 10.1128/MCB.11.7.3762; Lorenz MC, 2004, EUKARYOT CELL, V3, P1076, DOI 10.1128/EC.3.5.1076-1087.2004; Lorenz MC, 2001, NATURE, V412, P83, DOI 10.1038/35083594; Matsumoto Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018292; Mellado E, 2000, DIAGN MICR INFEC DIS, V38, P21, DOI 10.1016/S0732-8893(00)00165-6; MENCACCI A, 1993, CELL IMMUNOL, V150, P36, DOI 10.1006/cimm.1993.1176; MOSCI P, 1993, CELL IMMUNOL, V150, P27, DOI 10.1006/cimm.1993.1175; Naglik JR, 2008, FEMS MICROBIOL LETT, V283, P129, DOI 10.1111/j.1574-6968.2008.01160.x; PAQUIN CE, 1986, MOL CELL BIOL, V6, P70, DOI 10.1128/MCB.6.1.70; Parvez S, 2006, J APPL MICROBIOL, V100, P1171, DOI 10.1111/j.1365-2672.2006.02963.x; Perlin DS, 2007, DRUG RESIST UPDATE, V10, P121, DOI 10.1016/j.drup.2007.04.002; Piekarska K, 2006, EUKARYOT CELL, V5, P1847, DOI 10.1128/EC.00093-06; Prigneau O, 2003, YEAST, V20, P723, DOI 10.1002/yea.998; Ramil E, 2000, MOL MICROBIOL, V37, P1116, DOI 10.1046/j.1365-2958.2000.02065.x; Richardson AR, 2008, SCIENCE, V319, P1672, DOI 10.1126/science.1155207; RYDEN AC, 1973, J BACTERIOL, V116, P25; Schuller HJ, 2003, CURR GENET, V43, P139, DOI 10.1007/s00294-003-0381-8; Segireddy M, 2011, MYCOSES, V54, pE39, DOI 10.1111/j.1439-0507.2009.01824.x; Turcotte B, 2010, FEMS YEAST RES, V10, P2, DOI 10.1111/j.1567-1364.2009.00555.x; Ueno K, 2007, EUKARYOT CELL, V6, P1239, DOI 10.1128/EC.00414-06; Vieira N, 2010, MOL MICROBIOL, V75, P1337, DOI 10.1111/j.1365-2958.2009.07003.x; Wells CL, 2007, J MED MICROBIOL, V56, P688, DOI 10.1099/jmm.0.47049-0; White SJ, 2007, PLOS PATHOG, V3, P1866, DOI 10.1371/journal.ppat.0030184; Yamaguchi N, 2005, J NUTR, V135, P109, DOI 10.1093/jn/135.1.109	48	74	81	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2011	6	9							e24759	10.1371/journal.pone.0024759	http://dx.doi.org/10.1371/journal.pone.0024759			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CN	21931845	gold, Green Published, Green Submitted			2022-12-25	WOS:000294803100065
J	Vandersteegen, K; Mattheus, W; Ceyssens, PJ; Bilocq, F; De Vos, D; Pirnay, JP; Noben, JP; Merabishvili, M; Lipinska, U; Hermans, K; Lavigne, R				Vandersteegen, Katrien; Mattheus, Wesley; Ceyssens, Pieter-Jan; Bilocq, Florence; De Vos, Daniel; Pirnay, Jean-Paul; Noben, Jean-Paul; Merabishvili, Maia; Lipinska, Urszula; Hermans, Katleen; Lavigne, Rob			Microbiological and Molecular Assessment of Bacteriophage ISP for the Control of Staphylococcus aureus	PLOS ONE			English	Article							TRANSFER-RNA GENES; PSEUDOMONAS-AERUGINOSA; PHI-KMV; PROGRAM; SERVER	The increasing antibiotic resistance in bacterial populations requires alternatives for classical treatment of infectious diseases and therefore drives the renewed interest in phage therapy. Methicillin resistant Staphylococcus aureus (MRSA) is a major problem in health care settings and live-stock breeding across the world. This research aims at a thorough microbiological, genomic, and proteomic characterization of S. aureus phage ISP, required for therapeutic applications. Host range screening of a large batch of S. aureus isolates and subsequent fingerprint and DNA microarray analysis of the isolates revealed a substantial activity of ISP against 86% of the isolates, including relevant MRSA strains. From a phage therapy perspective, the infection parameters and the frequency of bacterial mutations conferring ISP resistance were determined. Further, ISP was proven to be stable in relevant in vivo conditions and subcutaneous as well as nasal and oral ISP administration to rabbits appeared to cause no adverse effects. ISP encodes 215 gene products on its 138,339 bp genome, 22 of which were confirmed as structural proteins using tandem electrospray ionization-mass spectrometry (ESI-MS/MS), and shares strong sequence homology with the 'Twort-like viruses'. No toxic or virulence-associated proteins were observed. The microbiological and molecular characterization of ISP supports its application in a phage cocktail for therapeutic purposes.	[Vandersteegen, Katrien; Mattheus, Wesley; Ceyssens, Pieter-Jan; Lavigne, Rob] Katholieke Univ Leuven, Div Gene Technol, B-3001 Heverlee, Belgium; [Lipinska, Urszula; Hermans, Katleen] Univ Ghent, Dept Pathol Bacteriol & Poultry Dis, Merelbeke, Belgium; [Noben, Jean-Paul] Hasselt Univ, Biomed Res Inst, Diepenbeek, Belgium; [Noben, Jean-Paul] Transnat Univ Limburg, Sch Life Sci, Diepenbeek, Belgium; [Bilocq, Florence; De Vos, Daniel; Pirnay, Jean-Paul; Merabishvili, Maia] Queen Astrid Mil Hosp, Burn Ctr, Lab Mol & Cellular Technol, Brussels, Belgium; [Merabishvili, Maia] Eliava Inst Bacteriophage Microbiol & Virol, Tbilisi, Georgia	KU Leuven; Ghent University; Hasselt University; Hasselt University; Queen Astrid Military Hospital	Vandersteegen, K (corresponding author), Katholieke Univ Leuven, Div Gene Technol, B-3001 Heverlee, Belgium.	rob.lavigne@biw.kuleuven.be	Merabishvili, Maia/GLU-4387-2022; Noben, Jean-Paul/E-8066-2011	Merabishvili, Maia/0000-0002-2566-0772; Noben, Jean-Paul/0000-0003-3368-5686; Lavigne, Rob/0000-0001-7377-1314; Pirnay, Jean-Paul/0000-0002-6863-5219; Ceyssens, Pieter-Jan/0000-0001-7735-8316	'Fonds voor Wetenschappelijk Onderzoek-Vlaanderen' (FWO-Vlaanderen, Belgium); Federal Public Service of Health, Food Chain Safety and Environment, Belgium [RT 08/6 PHAGE]; Royal High Institute for Defence, Belgium [MED 19]	'Fonds voor Wetenschappelijk Onderzoek-Vlaanderen' (FWO-Vlaanderen, Belgium)(FWO); Federal Public Service of Health, Food Chain Safety and Environment, Belgium; Royal High Institute for Defence, Belgium	PC holds a postdoctoral fellowship of the 'Fonds voor Wetenschappelijk Onderzoek-Vlaanderen' (FWO-Vlaanderen, Belgium). This study was performed by members of the research community 'PhageBiotics' and was funded by the Federal Public Service of Health, Food Chain Safety and Environment, Belgium (contract RT 08/6 PHAGE). DNA fingerprinting and hybridization experiments were supported by grant MED 19 of the Royal High Institute for Defence, Belgium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MH, 1959, BACTERIOPHAGES; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Beale GH, 1949, MICROBIOL, V2, P131; Binetti AG, 2007, INT DAIRY J, V17, P343, DOI 10.1016/j.idairyj.2006.05.002; Ceyssens PJ, 2006, J BACTERIOL, V188, P6924, DOI 10.1128/JB.00831-06; Ceyssens PJ, 2009, ENVIRON MICROBIOL, V11, P1303, DOI 10.1111/j.1462-2920.2008.01862.x; Chibani-Chennoufi S, 2004, J BACTERIOL, V186, P7069, DOI 10.1128/JB.186.21.7069-7083.2004; Chibeu A, 2009, FEMS MICROBIOL LETT, V296, P210, DOI 10.1111/j.1574-6968.2009.01640.x; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dehbi M, 2009, J BACTERIOL, V191, P3763, DOI 10.1128/JB.00241-09; DONADIO S, 1986, J BACTERIOL, V166, P1055, DOI 10.1128/jb.166.3.1055-1060.1986; Eyer L, 2007, PROTEOMICS, V7, P64, DOI 10.1002/pmic.200600280; Gordon L, 2003, BIOINFORMATICS, V19, P1964, DOI 10.1093/bioinformatics/btg265; Kwan T, 2005, P NATL ACAD SCI USA, V102, P5174, DOI 10.1073/pnas.0501140102; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; Lavigne R, 2006, MICROBIOL-SGM, V152, P529, DOI 10.1099/mic.0.28431-0; Lavigne R, 2004, BIOINFORMATICS, V20, P629, DOI 10.1093/bioinformatics/btg456; Lavigne R, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-224; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; Merabishvili M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004944; Miller ES, 2003, MICROBIOL MOL BIOL R, V67, P86, DOI 10.1128/MMBR.67.1.86-156.2003; Monecke S, 2008, CLIN MICROBIOL INFEC, V14, P534, DOI 10.1111/j.1469-0691.2008.01986.x; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; MYERS EW, 1988, COMPUT APPL BIOSCI, V4, P11, DOI 10.1093/bioinformatics/4.1.11; O'Flaherty S, 2004, J BACTERIOL, V186, P2862, DOI 10.1128/JB.186.9.2862-2871.2004; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sambrook J, 2001, MOL CLONING LAB MANU; Smith TC, 2011, VECTOR-BORNE ZOONOT, V11, P327, DOI 10.1089/vbz.2010.0072; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Sulakvelidze A, 2005, BACTERIOPHAGE: BIOLOGY AND APPLICATIONS, P381; Vanderhaeghen W, 2010, EPIDEMIOL INFECT, V138, P606, DOI 10.1017/S0950268809991567; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	34	70	70	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2011	6	9							e24418	10.1371/journal.pone.0024418	http://dx.doi.org/10.1371/journal.pone.0024418			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CN	21931710	gold, Green Published			2022-12-25	WOS:000294803100030
J	Zhu, ZZ; Kremer, P; Tadmori, I; Ren, Y; Sun, DM; He, XJ; Young, WS				Zhu, Zhenzhong; Kremer, Penny; Tadmori, Iman; Ren, Yi; Sun, Dongming; He, Xijing; Young, Wise			Lithium Suppresses Astrogliogenesis by Neural Stem and Progenitor Cells by Inhibiting STAT3 Pathway Independently of Glycogen Synthase Kinase 3 Beta	PLOS ONE			English	Article							SPINAL-CORD-INJURY; CILIARY NEUROTROPHIC FACTOR; NERVE GROWTH-FACTOR; GRAY-MATTER VOLUME; BIPOLAR DISORDER; IN-VITRO; NEURONAL DIFFERENTIATION; SIGNALING PATHWAY; MICROGLIAL CELLS; ANIMAL-MODEL	Transplanted neural stem and progenitor cells (NSCs) produce mostly astrocytes in injured spinal cords. Lithium stimulates neurogenesis by inhibiting GSK3 beta (glycogen synthetase kinase 3-beta) and increasing WNT/beta catenin. Lithium suppresses astrogliogenesis but the mechanisms were unclear. We cultured NSCs from subventricular zone of neonatal rats and showed that lithium reduced NSC production of astrocytes as well as proliferation of glia restricted progenitor (GRP) cells. Lithium strongly inhibited STAT3 (signal transducer and activator of transcription 3) activation, a messenger system known to promote astrogliogenesis and cancer. Lithium abolished STAT3 activation and astrogliogenesis induced by a STAT3 agonist AICAR (5-aminoimidazole-4-carboxamide 1-beta-D-ribofuranoside), suggesting that lithium suppresses astrogliogenesis by inhibiting STAT3. GSK3 beta inhibition either by a specific GSK3 beta inhibitor SB216763 or overexpression of GID5-6 (GSK3 beta Interaction Domain aa380 to 404) did not suppress astrogliogenesis and GRP proliferation. GSK3 beta inhibition also did not suppress STAT3 activation. Together, these results indicate that lithium inhibits astrogliogenesis through non-GSK3 beta-mediated inhibition of STAT. Lithium may increase efficacy of NSC transplants by increasing neurogenesis and reducing astrogliogenesis. Our results also may explain the strong safety record of lithium treatment of manic depression. Millions of people take high-dose (> 1 gram/day) lithium carbonate for a lifetime. GSK3b inhibition increases WNT/beta catenin, associated with colon and other cancers. STAT3 inhibition may reduce risk for cancer.	[Zhu, Zhenzhong; He, Xijing] Xi An Jiao Tong Univ, Dept Orthoped Surg 2, Hosp 2, Xian 710049, Shaanxi Prov, Peoples R China; [Zhu, Zhenzhong; Kremer, Penny; Tadmori, Iman; Ren, Yi; Sun, Dongming; Young, Wise] Rutgers State Univ, WM Keck Ctr Collaborat Neurosci, Piscataway, NJ USA	Xi'an Jiaotong University; Rutgers State University New Brunswick	Zhu, ZZ (corresponding author), Xi An Jiao Tong Univ, Dept Orthoped Surg 2, Hosp 2, Xian 710049, Shaanxi Prov, Peoples R China.	wisey@pipeline.com	He, Xijing/AAE-7424-2021	He, Xijing/0000-0002-0465-5376	New Jersey Commission on Spinal Cord Research; China Scholarship Council	New Jersey Commission on Spinal Cord Research; China Scholarship Council(China Scholarship Council)	This study was sponsored in part by New Jersey Commission on Spinal Cord Research (http://www.state.nj.us/health/spinalcord/). Zhenzhong Zhu was supported in part by a fellowship from the China Scholarship Council (http://www.csc.edu.cn/). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acarin L, 2000, J NEUROPATH EXP NEUR, V59, P151, DOI 10.1093/jnen/59.2.151; Angelucci F, 2003, INT J NEUROPSYCHOPH, V6, P225, DOI 10.1017/S1461145703003468; Bearden CE, 2008, NEUROPSYCHOPHARMACOL, V33, P1229, DOI 10.1038/sj.npp.1301507; Beurel E, 2008, J BIOL CHEM, V283, P21934, DOI 10.1074/jbc.M802481200; Beurel E, 2009, CELL SIGNAL, V21, P978, DOI 10.1016/j.cellsig.2009.02.019; Beurel E, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-9; Boku S, 2009, NEUROPSYCHOPHARMACOL, V34, P805, DOI 10.1038/npp.2008.198; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Bordonaro M, 2004, ONCOL RES, V14, P427, DOI 10.3727/0965040041791428; Caldwell GM, 2008, BRIT J CANCER, V98, P1437, DOI 10.1038/sj.bjc.6604327; Cao F, 2010, BIOCH BIOPHYS RES CO; Cao F, 2010, BIOCHEM BIOPH RES CO, V394, P843, DOI 10.1016/j.bbrc.2010.03.092; Cao QL, 2001, EXP NEUROL, V167, P48, DOI 10.1006/exnr.2000.7536; Chalecka-Franaszek E, 1999, P NATL ACAD SCI USA, V96, P8745, DOI 10.1073/pnas.96.15.8745; Chen G, 2000, J NEUROCHEM, V75, P1729, DOI 10.1046/j.1471-4159.2000.0751729.x; Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102; Dill J, 2008, J NEUROSCI, V28, P8914, DOI 10.1523/JNEUROSCI.1178-08.2008; Edwards CM, 2008, BLOOD, V111, P2833, DOI 10.1182/blood-2007-03-077685; Endl E, 2000, EXP CELL RES, V257, P231, DOI 10.1006/excr.2000.4888; Erdal E, 2005, INT J CANCER, V115, P903, DOI 10.1002/ijc.20972; Farr GH, 2000, J CELL BIOL, V148, P691, DOI 10.1083/jcb.148.4.691; Fernando P, 2005, FASEB J, V19, P1671, DOI 10.1096/fj.04-2981fje; Frey BN, 2006, BEHAV PHARMACOL, V17, P311, DOI 10.1097/01.fbp.0000205013.59455.09; GERDES J, 1984, J IMMUNOL, V133, P1710; Ghosh MK, 2005, ONCOGENE, V24, P7290, DOI 10.1038/sj.onc.1208894; Gould TD, 2003, PHARMACOL RES, V48, P49, DOI 10.1016/S0143-6618(03)00096-3; Hacker G, 2000, CELL TISSUE RES, V301, P5, DOI 10.1007/s004410000193; HALLCHER LM, 1980, J BIOL CHEM, V255, P896; He B, 2003, BIOCHEM BIOPH RES CO, V301, P386, DOI 10.1016/S0006-291X(02)03071-1; He Biao, 2004, Clin Lung Cancer, V5, P366, DOI 10.3816/CLC.2004.n.015; Hedgepeth CM, 1997, DEV BIOL, V185, P82, DOI 10.1006/dbio.1997.8552; Hedgepeth CM, 1999, MECH DEVELOP, V80, P147, DOI 10.1016/S0925-4773(98)00203-2; Hedgepeth CM, 1999, MOL CELL BIOL, V19, P7147; Huang CF, 2008, J NEUROIMMUNOL, V204, P118, DOI 10.1016/j.jneuroim.2008.07.004; Jope RS, 2003, TRENDS PHARMACOL SCI, V24, P441, DOI 10.1016/S0165-6147(03)00206-2; Justicia C, 2000, GLIA, V30, P253, DOI 10.1002/(SICI)1098-1136(200005)30:3<253::AID-GLIA5>3.0.CO;2-O; Kempton MJ, 2008, ARCH GEN PSYCHIAT, V65, P1017, DOI 10.1001/archpsyc.65.9.1017; Kim JS, 2004, J NEUROCHEM, V89, P324, DOI 10.1046/j.1471-4159.2004.02329.x; Kim OS, 2002, J BIOL CHEM, V277, P40594, DOI 10.1074/jbc.M203885200; Kurek JB, 1998, NEUROSCI LETT, V249, P1, DOI 10.1016/S0304-3940(98)00360-7; Le Floch N, 2004, FASEB J, V18, P144, DOI 10.1096/fj.04-2373fje; Lee MY, 1998, NEUROSCI LETT, V255, P79, DOI 10.1016/S0304-3940(98)00710-1; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Lenox RH, 2003, MOL PSYCHIATR, V8, P135, DOI 10.1038/sj.mp.4001306; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Lucas FR, 1997, DEV BIOL, V192, P31, DOI 10.1006/dbio.1997.8734; Lyoo IK, 2010, NEUROPSYCHOPHARMACOL, V35, P1743, DOI 10.1038/npp.2010.41; Ma J, 2003, J BIOL CHEM, V278, P29252, DOI 10.1074/jbc.M304196200; Machado-Vieira R, 2009, BIPOLAR DISORD, V11, P92, DOI 10.1111/j.1399-5618.2009.00714.x; MayerProschel M, 1997, NEURON, V19, P773, DOI 10.1016/S0896-6273(00)80960-5; Merdek KD, 2004, MOL CELL BIOL, V24, P2410, DOI 10.1128/MCB.24.6.2410-2422.2004; Mukaino Masahiko, 2008, Nihon Rinsho Meneki Gakkai Kaishi, V31, P93; Nakamura M, 2005, CLIN REV ALLERG IMMU, V28, P197, DOI 10.1385/CRIAI:28:3:197; Ni CW, 2003, J BIOL CHEM, V278, P19702, DOI 10.1074/jbc.M300893200; Ogawa Y, 2002, J NEUROSCI RES, V69, P925, DOI 10.1002/jnr.10341; Okada S, 2005, FASEB J, V19, P1839, DOI 10.1096/fj.05-4082fje; Okano H, 2003, SEMIN CELL DEV BIOL, V14, P191, DOI 10.1016/S1084-9521(03)00011-9; Orre K, 2009, PROG NEURO-PSYCHOPH, V33, P503, DOI 10.1016/j.pnpbp.2009.01.015; Park DS, 2009, ACTA OTO-LARYNGOL, V129, P166, DOI 10.1080/00016480802163358; Parr AM, 2007, J NEUROTRAUM, V24, P835, DOI 10.1089/neu.2006.3771; Phiel CJ, 2001, ANNU REV PHARMACOL, V41, P789, DOI 10.1146/annurev.pharmtox.41.1.789; Rao MS, 1997, DEV BIOL, V188, P48, DOI 10.1006/dbio.1997.8597; Sahni V, 2010, NAT REV NEUROL, V6, P363, DOI 10.1038/nrneurol.2010.73; Sassi RB, 2002, NEUROSCI LETT, V329, P243, DOI 10.1016/S0304-3940(02)00615-8; SHERMAN WR, 1986, FASEB J, V45, P2639; Su HX, 2007, EXP NEUROL, V206, P296, DOI 10.1016/j.expneurol.2007.05.018; Su HX, 2009, J NEUROCHEM, V108, P1385, DOI 10.1111/j.1471-4159.2009.05902.x; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tripathi RB, 2008, J COMP NEUROL, V510, P129, DOI 10.1002/cne.21787; Vazey EM, 2009, EXP NEUROL, V216, P520, DOI 10.1016/j.expneurol.2008.12.023; Walz JC, 2008, J PSYCHIATR RES, V42, P416, DOI 10.1016/j.jpsychires.2007.03.005; Weible MW, 2007, GLIA, V55, P1156, DOI 10.1002/glia.20539; Wexler EM, 2008, MOL PSYCHIATR, V13, P285, DOI 10.1038/sj.mp.4002093; Yick LW, 2004, J NEUROTRAUM, V21, P932, DOI 10.1089/neu.2004.21.932; YORK JD, 1995, P NATL ACAD SCI USA, V92, P5149, DOI 10.1073/pnas.92.11.5149; Young W, 2009, CELL TRANSPLANT, V18, P951, DOI 10.3727/096368909X471251; Zang Y, 2008, J BIOL CHEM, V283, P6201, DOI 10.1074/jbc.M708619200; Zhang F, 2003, J BIOL CHEM, V278, P33067, DOI 10.1074/jbc.M212635200; Zhu PX, 2008, FASEB J, V22, P3866, DOI 10.1096/fj.08-105908	79	33	35	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2011	6	9							e23341	10.1371/journal.pone.0023341	http://dx.doi.org/10.1371/journal.pone.0023341			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CN	21931595	Green Submitted, Green Published, gold			2022-12-25	WOS:000294803100001
J	Bjorklund, E; Forsgren, S; Alfredson, H; Fowler, CJ				Bjorklund, Emmelie; Forsgren, Sture; Alfredson, Hakan; Fowler, Christopher J.			Increased Expression of Cannabinoid CB1 Receptors in Achilles Tendinosis	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; ENDOCANNABINOID SYSTEM; NEUROTROPHIN RECEPTORS; ULCERATIVE-COLITIS; NEUROPATHIC PAIN; TENDINOPATHY; TENDON; MODEL; CANCER; IMMUNOHISTOCHEMISTRY	Background: The endogenous cannabinoid system is involved in the control of pain. However, little is known as to the integrity of the cannabinoid system in human pain syndromes. Here we investigate the expression of the cannabinoid receptor 1 (CB1) in human Achilles tendons from healthy volunteers and from patients with Achilles tendinosis. Methodology: Cannabinoid CB1 receptor immunoreactivity (CB1IR) was evaluated in formalin-fixed biopsies from individuals suffering from painful Achilles tendinosis in comparison with healthy human Achilles tendons. Principal Findings: CB1IR was seen as a granular pattern in the tenocytes. CB1IR was also observed in the blood vessel wall and in the perineurium of the nerve. Quantification of the immunoreactivity in tenocytes showed an increase of CB1 receptor expression in tendinosis tissue compared to control tissue. Conclusion: Expression of cannabinoid receptor 1 is increased in human Achilles tendinosis suggesting that the cannabinoid system may be dysregulated in this disorder.	[Bjorklund, Emmelie; Fowler, Christopher J.] Umea Univ, Pharmacol Unit, Dept Pharmacol & Clin Neurosci, Umea, Sweden; [Forsgren, Sture] Umea Univ, Sect Anat, Dept Integrat Med Biol, Umea, Sweden; [Alfredson, Hakan] Umea Univ, Sports Med Unit, Dept Surg & Perioperat Sci, Umea, Sweden	Umea University; Umea University; Umea University	Bjorklund, E (corresponding author), Umea Univ, Pharmacol Unit, Dept Pharmacol & Clin Neurosci, Umea, Sweden.	emmelie.bjorklund@pharm.umu.se	Fowler, Christopher J./M-6313-2019	Fowler, Christopher J./0000-0002-6658-7874	Swedish Science Council [12158]; Medical Faculty, Umea University; Faculty of Medicine at Umea University; Swedish National Centre for Research in Sports; J.C. Kempe and Seth M. Kempe Memorial Foundations, Ornskoldsvik	Swedish Science Council; Medical Faculty, Umea University; Faculty of Medicine at Umea University; Swedish National Centre for Research in Sports; J.C. Kempe and Seth M. Kempe Memorial Foundations, Ornskoldsvik	The authors thank the Swedish Science Council (Grant no. 12158, medicine, to C.J. Fowler); the Research Funds of the Medical Faculty, Umea University (to C.J. Fowler); the Faculty of Medicine at Umea University, the Swedish National Centre for Research in Sports and the J.C. Kempe and Seth M. Kempe Memorial Foundations, Ornskoldsvik for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfredson H, 2005, SCAND J MED SCI SPOR, V15, P252, DOI 10.1111/j.1600-0838.2005.00466.x; Alfredson H, 2005, KNEE SURG SPORT TR A, V13, P338, DOI 10.1007/s00167-004-0585-6; Alfredson H, 2003, KNEE SURG SPORT TR A, V11, P334, DOI 10.1007/s00167-003-0391-6; Alfredson H, 2011, BRIT J SPORT MED, V45, P407, DOI 10.1136/bjsm.2010.081216; Andersson G, 2008, REGUL PEPTIDES, V150, P81, DOI 10.1016/j.regpep.2008.02.005; Andersson G, 2007, KNEE SURG SPORT TR A, V15, P1272, DOI 10.1007/s00167-007-0364-2; Andersson G, 2011, BRIT J SPORT MED, V45, P399, DOI 10.1136/bjsm.2009.068122; ASTROM M, 1995, CLIN ORTHOP RELAT R, P151; Bishay P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010628; Bjur D, 2005, CELL TISSUE RES, V320, P201, DOI 10.1007/s00441-004-1014-3; Bjur D, 2009, BRIT J SPORT MED, V43, P1136, DOI 10.1136/bjsm.2008.055780; Bjur D, 2008, CELL TISSUE RES, V331, P385, DOI 10.1007/s00441-007-0524-1; Bjur D, 2008, HISTOL HISTOPATHOL, V23, P197, DOI 10.14670/HH-23.197; Borner C, 2008, NEUROIMMUNOMODULAT, V14, P281, DOI 10.1159/000117809; Borner C, 2008, MOL PHARMACOL, V73, P1013, DOI 10.1124/mol.107.042945; BRAILOIU GC, 2011, JBC         IN PRESS; Bridges D, 2003, NEUROSCIENCE, V119, P803, DOI 10.1016/S0306-4522(03)00200-8; Chung SC, 2009, EUR J CANCER, V45, P174, DOI 10.1016/j.ejca.2008.10.010; Courneya JP, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-9; Danielson P, 2009, BRIT J SPORT MED, V43, P265, DOI 10.1136/bjsm.2008.054593; Frank B, 2008, BRIT MED J, V336, P199, DOI 10.1136/bmj.39429.619653.80; Grimsholm O, 2008, CELLS TISSUES ORGANS, V188, P299, DOI 10.1159/000121432; Guindon J, 2009, CNS NEUROL DISORD-DR, V8, P403, DOI 10.2174/187152709789824660; GUSTAFSSON SB, 2011, PLOS ONE    IN PRESS; HANSSON M, 1995, HISTOCHEM J, V27, P222; Hong S, 2009, GUT, V58, P202, DOI 10.1136/gut.2008.157594; Hoot MR, 2010, BRAIN RES, V1339, P18, DOI 10.1016/j.brainres.2010.03.105; Horne AW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003969; Izzo AA, 2001, BRIT J PHARMACOL, V134, P563, DOI 10.1038/sj.bjp.0704293; Jean-Gilles L, 2010, IMMUNOBIOLOGY, V215, P606, DOI 10.1016/j.imbio.2009.12.006; Johansson M, 2007, INFLAMM BOWEL DIS, V13, P398, DOI 10.1002/ibd.20072; Kaufmann I, 2009, EUR SURG RES, V43, P325, DOI 10.1159/000235870; Khan KM, 2000, BRIT J SPORT MED, V34, P81, DOI 10.1136/bjsm.34.2.81; Khan KM, 1999, SPORTS MED, V27, P393, DOI 10.2165/00007256-199927060-00004; Khasabova IA, 2008, J NEUROSCI, V28, P11141, DOI 10.1523/JNEUROSCI.2847-08.2008; Maffulli N, 2004, MED SCI SPORT EXER, V36, P1470, DOI 10.1249/01.MSS.0000139895.94846.8D; Maida Vincent, 2008, J Support Oncol, V6, P119; Marquez L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006893; McIntosh HH, 1998, MOL BRAIN RES, V53, P163, DOI 10.1016/S0169-328X(97)00294-5; Merriam FV, 2008, NEUROSCI LETT, V445, P130, DOI 10.1016/j.neulet.2008.08.076; Michalski CW, 2008, INT J CANCER, V122, P742, DOI 10.1002/ijc.23114; Mitrirattanakul S, 2006, PAIN, V126, P102, DOI 10.1016/j.pain.2006.06.016; Movin T, 1997, ACTA ORTHOP SCAND, V68, P170, DOI 10.3109/17453679709004002; Mukerji G, 2010, UROLOGY, V75, DOI 10.1016/j.urology.2009.12.051; Ong WY, 1999, NEUROSCIENCE, V92, P1177, DOI 10.1016/S0306-4522(99)00025-1; Reynolds J.R., 1890, LANCET, V135, P637, DOI [10.1016/S0140-6736(02)18723-X, DOI 10.1016/S0140-6736(02)18723-X]; Riley G, 2008, NAT CLIN PRACT RHEUM, V4, P82, DOI 10.1038/ncprheum0700; Rozenfeld R, 2008, FASEB J, V22, P2311, DOI 10.1096/fj.07-102731; Scavone JL, 2010, BRAIN RES, V1312, P18, DOI 10.1016/j.brainres.2009.11.023; Scott A, 2008, J ORTHOP RES, V26, P685, DOI 10.1002/jor.20536; Shalabi A, 2005, KNEE SURG SPORT TR A, V13, P492, DOI 10.1007/s00167-004-0546-0; Skrabek RQ, 2008, J PAIN, V9, P164, DOI 10.1016/j.jpain.2007.09.002; Tyagi V, 2009, J UROLOGY, V181, P1932, DOI 10.1016/j.juro.2008.11.078	53	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e24731	10.1371/journal.pone.0024731	http://dx.doi.org/10.1371/journal.pone.0024731			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CK	21931835	Green Submitted, gold, Green Published			2022-12-25	WOS:000294802800087
J	Celis-Morales, CA; Perez-Bravo, F; Ibanes, L; Sanzana, R; Hormazabal, E; Ulloa, N; Calvo, C; Bailey, MES; Gill, JMR				Celis-Morales, Carlos A.; Perez-Bravo, Francisco; Ibanes, Luis; Sanzana, Ruth; Hormazabal, Edison; Ulloa, Natalia; Calvo, Carlos; Bailey, Mark E. S.; Gill, Jason M. R.			Insulin Resistance in Chileans of European and Indigenous Descent: Evidence for an Ethnicity x Environment Interaction	PLOS ONE			English	Article							TYPE-2 DIABETES-MELLITUS; PHYSICAL-ACTIVITY; ABORIGINAL POPULATIONS; PIMA-INDIANS; CARDIORESPIRATORY FITNESS; CARDIOVASCULAR RISK; PREVALENCE; GLUCOSE; OBESITY; TIME	Background: Effects of urbanisation on diabetes risk appear to be greater in indigenous populations worldwide than in populations of European origin, but the reasons are unclear. This cross-sectional study aimed to determine whether the effects of environment (Rural vs. Urban), adiposity, fitness and lifestyle variables on insulin resistance differed between individuals of indigenous Mapuche origin compared to those of European origin in Chile. Methodology/Principal Findings: 123 Rural Mapuche, 124 Urban Mapuche, 91 Rural European and 134 Urban European Chilean adults had blood taken for determination of HOMA-estimated insulin resistance (HOMA(IR)) and underwent assessment of physical activity/sedentary behaviour (using accelerometry), cardiorespiratory fitness, dietary intake and body composition. General linear models were used to determine interactions with ethnicity for key variables. There was a significant "ethnicity x environment" interaction for HOMA(IR) (Mean +/- SD; Rural Mapuche: 1.65 +/- 2.03, Urban Mapuche: 4.90 +/- 3.05, Rural European: 0.82 +/- 0.61, Urban European: 1.55 +/- 1.34, p((interaction)) = 0.0003), such that the effect of urbanisation on HOMA(IR) was greater in Mapuches than Europeans. In addition, there were significant interactions (all p<0.004) with ethnicity for effects of adiposity, sedentary time and physical activity on HOMA(IR), with greater effects seen in Mapuches compared to Europeans, an observation that persisted after adjustment for potential confounders. Conclusions/Significance: Urbanisation, adiposity, physical activity and sedentary behaviour influence insulin resistance to a greater extent in Chilean Mapuches than Chileans of European descent. These findings have implications for the design and implementation of lifestyle strategies to reduce metabolic risk in different ethnic groups, and for understanding of the mechanisms underpinning human insulin resistance.	[Celis-Morales, Carlos A.; Gill, Jason M. R.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Celis-Morales, Carlos A.; Bailey, Mark E. S.] Univ Glasgow, Coll Med Vet & Life Sci, Sch Life Sci, Glasgow, Lanark, Scotland; [Perez-Bravo, Francisco] Univ Chile, Fac Med, Lab Nutr Genom, Dept Nutr, Santiago 7, Chile; [Ulloa, Natalia; Calvo, Carlos] Univ Concepcion, Dept Clin Biochem & Immunol, Concepcion, Chile; [Ibanes, Luis; Sanzana, Ruth; Hormazabal, Edison] Ctr Nutr Metab & Phys Act CNEF, Concepcion, Chile	University of Glasgow; University of Glasgow; Universidad de Chile; Universidad de Concepcion	Celis-Morales, CA (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland.	jason.gill@glasgow.ac.uk	Celis-Morales, Carlos/AAJ-5103-2020	Bailey, Mark E. S./0000-0002-9788-2278; Celis-Morales, Carlos/0000-0003-2612-3917	Chilean Government	Chilean Government	The study was funded by a PhD studentship from the Chilean Government to CACM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta AM, 2002, REV MED CHILE, V130, P1227; Amigo H, 2010, BMC PUBLIC HEALTH, V10, P1, DOI 10.1186/1471-2458-10-392; Baechler R, 2002, REV MED CHILE, V130, P1257; Black AE, 2001, J AM DIET ASSOC, V101, P70, DOI 10.1016/S0002-8223(01)00018-9; Buckley JP, 2004, BRIT J SPORT MED, V38, P197, DOI 10.1136/bjsm.2003.005389; Carrasco E, 2004, REV MED CHILE, V132, P1189; COLLINS VR, 1994, DIABETES CARE, V17, P288, DOI 10.2337/diacare.17.4.288; Dunstan DW, 2004, DIABETES CARE, V27, P2603, DOI 10.2337/diacare.27.11.2603; DURNIN JVGA, 1974, BRIT J NUTR, V32, P77, DOI 10.1079/BJN19740060; El Assaad MA, 2003, BLOOD PRESS MONIT, V8, P127, DOI 10.1097/00126097-200306000-00006; Esparza-Romero J, 2010, J CLIN ENDOCR METAB, V95, pE358, DOI 10.1210/jc.2010-0297; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gill JMR, 2008, SPORTS MED, V38, P807, DOI 10.2165/00007256-200838100-00002; Gill JMR, 2011, DIABETES CARE, V34, P1214, DOI 10.2337/dc10-2313; Gill JMR, 2006, CLIN SCI, V110, P409, DOI 10.1042/CS20050207; Hagstromer M, 2007, MED SCI SPORT EXER, V39, P1502, DOI 10.1249/mss.0b013e3180a76de5; Healy GN, 2008, MED SCI SPORT EXER, V40, P639, DOI 10.1249/MSS.0b013e3181607421; Hu FB, 2003, JAMA-J AM MED ASSOC, V289, P1785, DOI 10.1001/jama.289.14.1785; *I NAC EST CHIL, 2004, RES OF CENS POBL 200; International Diabetes Federation, 2009, IDF DIAB ATL; Jebb SA, 2010, AM J CLIN NUTR, V92, P748, DOI 10.3945/ajcn.2009.29096; KING H, 1984, DIABETES CARE, V7, P409, DOI 10.2337/diacare.7.5.409; Kriska AM, 2001, DIABETES CARE, V24, P1787, DOI 10.2337/diacare.24.10.1787; Laaksonen DE, 2003, DIABETES CARE, V26, P2156, DOI 10.2337/diacare.26.7.2156; LARENAS G, 1985, REV MED CHILE, V113, P1121; Marfell-Jones M, 2006, INT STANDARDS ANTHRO; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mendez R, 1997, SANT 7 C CHIL MARK I; MIDEPLAN G.d.C.M.d.P. Nacional, 2006, ENC CAR SOC NAC CASE; Perez-Bravo F, 2006, ACTA DIABETOL, V43, P93, DOI 10.1007/s00592-006-0221-7; Perez-Bravo F, 2001, NUTRITION, V17, P236, DOI 10.1016/S0899-9007(00)00550-5; Schulz LO, 2006, DIABETES CARE, V29, P1866, DOI 10.2337/dc06-0138; Schulze MB, 2004, AM J CLIN NUTR, V80, P348, DOI 10.1093/ajcn/80.2.348; Shephard RJ, 2003, BRIT J SPORT MED, V37, P197, DOI 10.1136/bjsm.37.3.197; Stefan N, 2004, DIABETIC MED, V21, P1090, DOI 10.1111/j.1464-5491.2004.01290.x; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; van Dam RM, 2002, DIABETES CARE, V25, P417, DOI 10.2337/diacare.25.3.417; Wadhwa PD, 2009, SEMIN REPROD MED, V27, P358, DOI 10.1055/s-0029-1237424; Wei M, 1999, ANN INTERN MED, V130, P89, DOI 10.7326/0003-4819-130-2-199901190-00002; Westerterp KR, 2002, CURR OPIN CLIN NUTR, V5, P489, DOI 10.1097/00075197-200209000-00006; Whincup PH, 2002, BRIT MED J, V324, P635, DOI 10.1136/bmj.324.7338.635; Yu CHY, 2007, DIABETES RES CLIN PR, V78, P159, DOI 10.1016/j.diabres.2007.03.022; Zimmet P, 2000, J INTERN MED, V247, P301, DOI 10.1046/j.1365-2796.2000.00625.x	44	58	61	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e24690	10.1371/journal.pone.0024690	http://dx.doi.org/10.1371/journal.pone.0024690			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CK	21931814	gold, Green Published, Green Accepted, Green Submitted			2022-12-25	WOS:000294802800084
J	Korenko, S; Pekar, S				Korenko, Stanislav; Pekar, Stano			A Parasitoid Wasp Induces Overwintering Behaviour in Its Spider Host	PLOS ONE			English	Article							NEPHILA-CLAVIPES ARANEAE; COTESIA-GLOMERATA L.; HYMENOPTERA; MANIPULATION; ICHNEUMONIDAE; CATERPILLARS; PIMPLINAE; WEBS; TETRAGNATHIDAE; USURPATION	Parasites and parasitoids control behaviors of their hosts. However, the origin of the behavior evoked by the parasitic organism has been rarely identified. It is also not known whether the manipulation is universal or host-specific. Polysphinctine wasps, koinobiont ectoparasitoids of several spider species that manipulate host web-spinning activity for their own protection during pupation, provide an ideal system to reveal the origin of the evoked behavior. Larva of Zatypota percontatoria performed species-specific manipulation of theridiid spiders, Neottiura bimaculata and Theridion varians, shortly before pupation. Parasitized N. bimaculata produced a dense web, whereas parasitized T. varians built a cupola-like structure. The larva pupated inside of either the dense web or the cupola-like structure. We discovered that unparasitized N. bimaculata produce an analogous dense web around their eggsacs and for themselves during winter, while T. varians construct an analogous 'cupola' only for overwintering. We induced analogous manipulation in unparasitized hosts by altering ambient conditions. We discovered that the behavior evoked by larvae in two hosts was functionally similar. The larva evoked protective behaviors that occur in unparasitized hosts only during specific life-history periods.	[Korenko, Stanislav] Czech Univ Life Sci, Fac Agrobiol Food & Nat Resources, Dept Agroecol & Biometeorol, Prague, Suchdol, Czech Republic; [Korenko, Stanislav; Pekar, Stano] Masaryk Univ, Fac Sci, Dept Bot & Zool, CS-61137 Brno, Czech Republic	Czech University of Life Sciences Prague; Masaryk University Brno	Korenko, S (corresponding author), Czech Univ Life Sci, Fac Agrobiol Food & Nat Resources, Dept Agroecol & Biometeorol, Prague, Suchdol, Czech Republic.	korenko.stanislav@yahoo.com	Korenko, Stanislav/U-5334-2019; Pekar, Stano/F-4148-2010	Korenko, Stanislav/0000-0001-8079-3618; Pekar, Stano/0000-0002-0197-5040	Ministry of Education, Youth and Sports of the Czech Republic [MSM0021622416];  [MSM6046070901]	Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); 	The study was supported by grant no. MSM0021622416 provided by the Ministry of Education, Youth and Sports of the Czech Republic. SK was also supported by project no. MSM6046070901. URL: http://www.isvav.cz/researchPlanDetail.do?rowId = MSM0021622416 and http://www.isvav.cz/researchPlanDetail.do?rowId = MSM6046070901. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Althoff DM, 2003, ECOL ENTOMOL, V28, P500, DOI 10.1046/j.1365-2311.2003.00533.x; Arnedo MA, 2007, ZOOL SCR, V36, P337, DOI 10.1111/j.1463-6409.2007.00280.x; Beckage NE, 1985, PARASITES PATHOGENS, P3; BETHEL WM, 1977, CAN J ZOOL, V55, P110, DOI 10.1139/z77-013; BRODEUR J, 1989, SCIENCE, V244, P226, DOI 10.1126/science.244.4901.226; BRODEUR J, 1994, ANIM BEHAV, V48, P187, DOI 10.1006/anbe.1994.1225; CARNEY WP, 1969, AM MIDL NAT, V82, P605, DOI 10.2307/2423801; Eberhard WG, 2000, NATURE, V406, P255, DOI 10.1038/35018636; Eberhard WG, 2001, J ARACHNOL, V29, P354, DOI 10.1636/0161-8202(2001)029[0354:UTIWAB]2.0.CO;2; Eberhard William G., 2010, Psyche (Cambridge), V2010, P1, DOI 10.1155/2010/950614; Eberhard William G., 2000, Journal of Hymenoptera Research, V9, P220; Eberhard WG, 2008, SYST BIODIVERS, V6, P415, DOI 10.1017/S1477200008002855; FINCKE OM, 1990, J ARACHNOL, V18, P321; FITTON MG, 1987, ZOOL J LINN SOC-LOND, V90, P65, DOI 10.1111/j.1096-3642.1987.tb01348.x; Gal R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010019; Gauld ID, 2006, SYST ENTOMOL, V31, P529, DOI 10.1111/j.1365-3113.2006.00334.x; Gauld ID, 2002, ZOOL J LINN SOC-LOND, V136, P421, DOI 10.1046/j.1096-3642.2002.00031.x; Gonzaga MO, 2010, ETHOL ECOL EVOL, V22, P151, DOI 10.1080/03949371003707836; Gonzaga MO, 2007, NATURWISSENSCHAFTEN, V94, P223, DOI 10.1007/s00114-006-0177-z; Grosman AH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002276; HARRISWARRICK RM, 1991, ANNU REV NEUROSCI, V14, P39, DOI 10.1146/annurev.ne.14.030191.000351; Harvey JA, 2008, ANIM BEHAV, V76, P701, DOI 10.1016/j.anbehav.2008.03.016; Harvey JA, 2011, ANIM BEHAV, V81, P1281, DOI 10.1016/j.anbehav.2011.03.019; Heimer S., 1991, SPINNEN MITTELEUROPA; Korenko S, 2011, J INSECT SC IN PRESS; Libersat F, 2009, ANNU REV ENTOMOL, V54, P189, DOI 10.1146/annurev.ento.54.110807.090556; Matsumoto R, 2007, ENTOMOL SCI, V10, P267, DOI 10.1111/j.1479-8298.2007.00223.x; Matsumoto R, 2009, J INSECT BEHAV, V22, P39, DOI 10.1007/s10905-008-9152-1; Maure F, 2011, BIOL LETTERS, V7, P843, DOI 10.1098/rsbl.2011.0415; Moore J., 2002, PARASITES BEHAV ANIM; Nielsen E., 1923, Entomologiske Meddelelser, V14, P137; Poulin R, 2000, P ROY SOC B-BIOL SCI, V267, P787, DOI 10.1098/rspb.2000.1072; Schlinger E.I., 1987, P319; Sobczak JF, 2009, J NAT HIST, V43, P2691, DOI 10.1080/00222930903244010; Tanaka S, 2006, ECOL RES, V21, P570, DOI 10.1007/s11284-006-0153-2; Tanaka S, 2009, ETHOLOGY, V115, P781, DOI 10.1111/j.1439-0310.2009.01667.x; Thomas F, 2002, J EVOLUTION BIOL, V15, P356, DOI 10.1046/j.1420-9101.2002.00410.x; Thomas F, 2005, BEHAV PROCESS, V68, P185, DOI 10.1016/j.beproc.2004.06.010; Vyas A, 2007, P NATL ACAD SCI USA, V104, P6442, DOI 10.1073/pnas.0608310104; Weng JL, 2007, J HYMENOPT RES, V16, P326	40	33	35	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e24628	10.1371/journal.pone.0024628	http://dx.doi.org/10.1371/journal.pone.0024628			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CK	21931784	gold, Green Published, Green Submitted			2022-12-25	WOS:000294802800076
J	Tumminello, M; Micciche, S; Dominguez, LJ; Lamura, G; Melchiorre, MG; Barbagallo, M; Mantegna, RN				Tumminello, Michele; Micciche, Salvatore; Dominguez, Ligia J.; Lamura, Giovanni; Melchiorre, Maria Gabriella; Barbagallo, Mario; Mantegna, Rosario N.			Happy Aged People Are All Alike, While Every Unhappy Aged Person Is Unhappy in Its Own Way	PLOS ONE			English	Article							COMPLEX NETWORKS; SOCIAL NETWORKS; CHALLENGES; LIFE; DEPRESSION; DISABILITY; LONGEVITY	Aging of the world's population represents one of the most remarkable success stories of medicine and of humankind, but it is also a source of various challenges. The aim of the collaborative cross-cultural European study of adult well being (ESAW) is to frame the concept of aging successfully within a causal model that embraces physical health and functional status, cognitive efficacy, material security, social support resources, and life activity. Within the framework of this project, we show here that the degree of heterogeneity among people who view aging in a positive light is significantly lower than the degree of heterogeneity of those who hold a negative perception of aging. We base this conclusion on our analysis of a survey involving 12,478 people aged 50 to 90 from six West European countries. We treat the survey database as a bipartite network in which individual respondents are linked to the actual answers they provide. Taking this perspective allows us to construct a projected network of respondents in which each link indicates a statistically validated similarity of answers profile between the connected respondents, and to identify clusters of individuals independently of demographics. We show that mental and physical well-being are key factors determining a positive perception of aging. We further observe that psychological aspects, like self-esteem and resilience, and the nationality of respondents are relevant aspects to discriminate among participants who indicate positive perception of aging.	[Tumminello, Michele] Carnegie Mellon Univ, Dept Social & Decis Sci, Pittsburgh, PA 15213 USA; [Tumminello, Michele; Micciche, Salvatore; Mantegna, Rosario N.] Univ Palermo, Dipartimento Fis, Palermo, Italy; [Dominguez, Ligia J.; Barbagallo, Mario] Univ Palermo, Dept Internal Med & Geriatr, Palermo, Italy; [Lamura, Giovanni; Melchiorre, Maria Gabriella] Natl Inst Hlth & Sci Aging INRCA, Socio Econ Res Ctr, Ancona, Italy	Carnegie Mellon University; University of Palermo; University of Palermo; IRCCS INRCA	Tumminello, M (corresponding author), Carnegie Mellon Univ, Dept Social & Decis Sci, Pittsburgh, PA 15213 USA.	rn.mantegna@gmail.com	Miccichè, Salvatore/B-6575-2008; Melchiorre, Maria Gabriella/K-4625-2016; Tumminello, Michele/G-4492-2011; BARBAGALLO, MARIO/K-4794-2017; Mantegna, Rosario N/H-3652-2014	Miccichè, Salvatore/0000-0003-3779-592X; Melchiorre, Maria Gabriella/0000-0002-4428-3749; Tumminello, Michele/0000-0001-6045-6761; BARBAGALLO, MARIO/0000-0002-1349-6530; Mantegna, Rosario N/0000-0003-4177-171X; dominguez, ligia j/0000-0003-1466-8610	European Union [QLRT-2001-00280]; Complex World Network [10-220210-C3]	European Union(European Commission); Complex World Network	The ESAW Project was designed as part of the Global Ageing Initiative, originated at the Indiana University Center on Aging and Aged, under the directorship of Dr. Barbara Hawkins. ESAW, funded by the European Union (QLRT-2001-00280), is a European subgroup of the larger global study. The ESAW group consists of following research teams: Austria - G. Weber (Principal Investigator, PI), J. Gluck, C. Heiss, S. Sassenrath; Italy - G. Lamura (PI), M. G. Melchiorre, S. Quattrini, C. Balducci, L. Spazzafumo, M. Barbabagallo, L. Dominguez; Luxembourg - D. Ferring (PI), M. Hoffman, C. Petit; The Netherlands - F. Thissen (PI), J. D. Fortujin, M. van der Meer, T. Scharf; Sweden - I. R. Hallberg (PI), C. Borg, C. Paulsson; United Kingdom - G. C. Wenger (Project Coordinator), V. Burholt (PI), G. Windle, B. Woods. SM and RNM acknowledge partial support from the Complex World Network co-funded by EUROCONTROL under the SESAR Work Package E framework, Contract Ref. 10-220210-C3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akincigil A, 2011, J AM GERIATR SOC, V59, P1042, DOI 10.1111/j.1532-5415.2011.03447.x; Barabasi AL, 2002, PHYSICA A, V311, P590, DOI 10.1016/S0378-4371(02)00736-7; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Bascompte J, 2003, P NATL ACAD SCI USA, V100, P9383, DOI 10.1073/pnas.1633576100; Berlau DJ, 2009, INT J GERIATR PSYCH, V24, P1217, DOI 10.1002/gps.2248; Blazer DG, 2003, J GERONTOL A-BIOL, V58, P249; Butler K., 1993, DISTRIBUTION SUM BIN; Cheng ST, 2009, AM J COMMUN PSYCHOL, V44, P161, DOI 10.1007/s10464-009-9244-x; Christensen K, 2006, NAT REV GENET, V7, P436, DOI 10.1038/nrg1871; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Colizza V, 2006, NAT PHYS, V2, P110, DOI 10.1038/nphys209; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Fuller-Thomson E, 2009, J GERONTOL A-BIOL, V64, P1333, DOI 10.1093/gerona/glp130; Guimera R, 2005, SCIENCE, V308, P697, DOI 10.1126/science.1106340; Inui TS, 2003, ANN INTERN MED, V139, P391, DOI 10.7326/0003-4819-139-5_Part_2-200309021-00002; Kinugasa T, 2007, WORLD DEV, V35, P1, DOI 10.1016/j.worlddev.2006.09.002; Kirkwood TBL, 2008, NATURE, V451, P644, DOI 10.1038/451644a; Knoops KTB, 2004, JAMA-J AM MED ASSOC, V292, P1433, DOI 10.1001/jama.292.12.1433; Manton KG, 2006, P NATL ACAD SCI USA, V103, P18374, DOI 10.1073/pnas.0608483103; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; McCallum A, 2007, J ARTIF INTELL RES, V30, P249, DOI 10.1613/jair.2229; Miller Rupert G., 1981, SIMULTANEOUS STAT IN, V2nd, DOI [DOI 10.1007/978-1-4613-8122-8, 10.1007/978-1-4613-8122-8_1]; Morley JE, 2009, J AM MED DIR ASSOC, V10, P85, DOI 10.1016/j.jamda.2008.12.001; Mortimer PM, 2008, AUSTRALAS J AGEING, V27, P200, DOI 10.1111/j.1741-6612.2008.00305.x; NEUGARTEN BL, 1961, J GERONTOL, V16, P134, DOI 10.1093/geronj/16.2.134; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Newman MEJ, 2002, P NATL ACAD SCI USA, V99, P2566, DOI 10.1073/pnas.012582999; Nolte E, 2000, J EPIDEMIOL COMMUN H, V54, P899, DOI 10.1136/jech.54.12.899; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Rowe JW, 1997, GERONTOLOGIST, V37, P433, DOI 10.1093/geront/37.4.433; Saavedra S, 2009, NATURE, V457, P463, DOI 10.1038/nature07532; Schweitzer F, 2009, SCIENCE, V325, P422, DOI 10.1126/science.1173644; Song CM, 2005, NATURE, V433, P392, DOI 10.1038/nature03248; Tumminello M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017994; Tumminello M, 2011, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2011/01/P01019; van der Meer M, 2003, COMP REPORT SOCIAL S; Veenhoven R, 1996, SOC INDIC RES, V39, P1, DOI 10.1007/BF00300831; Veenhoven R, 2010, SOC INDIC RES, V97, P105, DOI 10.1007/s11205-009-9556-0; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Windle G, 2008, AGING MENT HEALTH, V12, P285, DOI 10.1080/13607860802120763; Young Y, 2009, J AM MED DIR ASSOC, V10, P314, DOI 10.1016/j.jamda.2009.01.003; Young Y, 2009, J AM MED DIR ASSOC, V10, P87, DOI 10.1016/j.jamda.2008.11.003	42	19	21	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e23377	10.1371/journal.pone.0023377	http://dx.doi.org/10.1371/journal.pone.0023377			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	819CK	21931596	Green Published, Green Submitted, gold			2022-12-25	WOS:000294802800002
J	Cheng, L; Smith, DJ; Anderson, RL; Nagley, P				Cheng, Lesley; Smith, Danielle J.; Anderson, Robin L.; Nagley, Phillip			Modulation of Cellular Hsp72 Levels in Undifferentiated and Neuron-Like SH-SY5Y Cells Determines Resistance to Staurosporine-Induced Apoptosis	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; HYPERTHERMIC PRECONDITIONING PROTECTS; STRESS-INDUCED APOPTOSIS; CYTOCHROME-C; INHIBITS APOPTOSIS; APAF-1 APOPTOSOME; MITOCHONDRIA; THERMOTOLERANCE; HEAT-SHOCK-PROTEIN-70; EXPRESSION	Increased expression of Hsp72 accompanies differentiation of human neuroblastoma SH-SY5Y cells to neuron-like cells. By modulating cellular levels of Hsp72, we demonstrate here its anti-apoptotic activity both in undifferentiated and neuron-like cells. Thermal preconditioning (43 degrees C for 30 min) induced Hsp72, leading to cellular protection against apoptosis induced by a subsequent treatment with staurosporine. Preconditioned staurosporine-treated cells displayed decreased Bax recruitment to mitochondria and subsequent activation, as well as reduced cytochrome c redistribution from mitochondria. The data are consistent with Hsp72 blocking apoptosis upstream of Bax recruitment to mitochondria. Neuron-like cells (with elevated Hsp72) were more resistant to staurosporine by all measured indices of apoptotic signaling. Use of stable transfectants ectopically expressing moderately elevated levels of Hsp72 revealed that such cells in the undifferentiated state showed enhanced resistance to staurosporine-induced apoptosis, which was even more robust after differentiation to neuron-like cells. Overall, the protective effects of differentiation, thermal preconditioning and ectopic Hsp72 expression were additive. The strong inverse correlation between cellular Hsp72 levels and susceptibility to apoptosis support the notion that Hsp72 acts as a significant neuroprotective factor, enabling post-mitotic neurons to withstand potentially lethal stress that induces apoptosis.	[Cheng, Lesley; Smith, Danielle J.; Nagley, Phillip] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Smith, Danielle J.; Nagley, Phillip] Monash Univ, Australian Res Council, Ctr Excellence Struct & Funct Microbial Genom, Clayton, Vic, Australia; [Anderson, Robin L.] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Anderson, Robin L.] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia	Monash University; Monash University; Peter Maccallum Cancer Center; University of Melbourne	Cheng, L (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia.	phillip.nagley@monash.edu	Anderson, Robin/I-2306-2013; Anderson, Robin/K-6966-2019; Anderson, Robin/S-1005-2017	Anderson, Robin/0000-0002-6841-7422; Cheng, Lesley/0000-0002-8075-6144	National Health and Medical Research Council of Australia (NHMRC) [ID 236805]; Australian Research Council (ARC), Centre of Excellence in Structural and Functional Microbial Genomics [CE034819]; National Institutes of Health/National Cancer Institute [CA81421]; Neurosciences Victoria; National Breast Cancer Foundation of Australia; NATIONAL CANCER INSTITUTE [R01CA081421] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC), Centre of Excellence in Structural and Functional Microbial Genomics(Australian Research Council); National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Neurosciences Victoria; National Breast Cancer Foundation of Australia; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding was obtained from grants from the National Health and Medical Research Council of Australia (NHMRC), www.nhmrc.gov.au, Program Grant on Brain Injury and Repair (Grant ID 236805); the Australian Research Council (ARC), www.arc.gov.au, Centre of Excellence in Structural and Functional Microbial Genomics (Grant CE034819) to P. Nagley; and the National Institutes of Health/National Cancer Institute, www.cancer.gov, (Grant CA81421) to R. Anderson. L. Cheng was supported by a Ph.D. training scholarship from Neurosciences Victoria, www.neurosciencesvic.com.au. R. Anderson was supported by a fellowship from the National Breast Cancer Foundation of Australia, www.nbcf.org.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMIN V, 1995, NEUROSCI LETT, V200, P85, DOI 10.1016/0304-3940(95)12074-E; Beere HM, 2000, NAT CELL BIOL, V2, P469, DOI 10.1038/35019501; Benjamin IJ, 1998, CIRC RES, V83, P117, DOI 10.1161/01.RES.83.2.117; BERTRAND R, 1994, EXP CELL RES, V211, P314, DOI 10.1006/excr.1994.1093; Bettaieb A, 2005, J CELL PHYSIOL, V205, P47, DOI 10.1002/jcp.20386; Bossy-Wetzel E, 1998, EMBO J, V17, P37, DOI 10.1093/emboj/17.1.37; Chen L, 2004, ACTA PHARMACOL SIN, V25, P458; Chen S, 2007, CELL STRESS CHAPERON, V12, P51, DOI 10.1379/CSC-236R.1; Cheng L, 2011, INT J HYPERTHER, V27, P415, DOI 10.3109/02656736.2010.531075; Clemons NJ, 2005, J BIOL CHEM, V280, P9005, DOI 10.1074/jbc.M414165200; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Dwyer DS, 1996, NEUROCHEM RES, V21, P659, DOI 10.1007/BF02527722; Gabai VL, 1997, J BIOL CHEM, V272, P18033, DOI 10.1074/jbc.272.29.18033; Gotoh T, 2004, CELL DEATH DIFFER, V11, P390, DOI 10.1038/sj.cdd.4401369; HAMOS JE, 1991, NEUROLOGY, V41, P345, DOI 10.1212/WNL.41.3.345; Hansen T, 2006, CELL DEATH DIFFER, V13, P1181, DOI 10.1038/sj.cdd.4401795; HARMON BV, 1990, INT J RADIAT BIOL, V58, P845, DOI 10.1080/09553009014552221; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; Jiang BM, 2005, CELL STRESS CHAPERON, V10, P252, DOI 10.1379/CSC-124R.1; KELLY S, 2002, CURR MED RES OPIN, V18, P55; Koishi M, 2001, CLIN CANCER RES, V7, P215; Kwong JMK, 2003, BRAIN RES, V970, P119, DOI 10.1016/S0006-8993(03)02298-4; Li H, 2010, FEBS LETT, V584, P4672, DOI 10.1016/j.febslet.2010.10.050; Lim MLR, 2006, EXP CELL RES, V312, P1174, DOI 10.1016/j.yexcr.2006.01.026; Lukiw WJ, 2004, NEUROCHEM RES, V29, P1287, DOI 10.1023/B:NERE.0000023615.89699.63; Magrane J, 2004, J NEUROSCI, V24, P1700, DOI 10.1523/JNEUROSCI.4330-03.2004; MOSSER DD, 1992, J CELL PHYSIOL, V151, P561, DOI 10.1002/jcp.1041510316; Mosser DD, 2000, MOL CELL BIOL, V20, P7146, DOI 10.1128/MCB.20.19.7146-7159.2000; Mosser DD, 1997, MOL CELL BIOL, V17, P5317, DOI 10.1128/MCB.17.9.5317; Nagley P, 2010, BBA-MOL BASIS DIS, V1802, P167, DOI 10.1016/j.bbadis.2009.09.004; Narasimhan P, 1996, GLIA, V17, P147; Novoselova TV, 2005, J NEUROCHEM, V94, P597, DOI 10.1111/j.1471-4159.2005.03119.x; Oh J, 2005, NEUROCHEM RES, V30, P333, DOI 10.1007/s11064-005-2607-2; Ohnishi K, 2004, INT J RADIAT BIOL, V80, P607, DOI 10.1080/09553000412331283470; Poe BS, 1997, APOPTOSIS, V2, P510, DOI 10.1023/A:1026486531021; Saleh A, 2000, NAT CELL BIOL, V2, P476, DOI 10.1038/35019510; Sato K, 1996, BRAIN RES, V740, P117, DOI 10.1016/S0006-8993(96)00846-3; Sharp FR, 1999, TRENDS NEUROSCI, V22, P97, DOI 10.1016/S0166-2236(98)01392-7; Stankiewicz AR, 2009, CELL DEATH DIFFER, V16, P638, DOI 10.1038/cdd.2008.189; Stankiewicz AR, 2005, J BIOL CHEM, V280, P38729, DOI 10.1074/jbc.M509497200; Steel R, 2004, J BIOL CHEM, V279, P51490, DOI 10.1074/jbc.M401314200; Yenari MA, 1999, MOL MED TODAY, V5, P525, DOI 10.1016/S1357-4310(99)01599-3; Yokota S, 2000, CANCER RES, V60, P2942; Zhang P, 2000, ANN THORAC SURG, V70, P1490, DOI 10.1016/S0003-4975(00)01851-8; Zimmermann KC, 2001, PHARMACOL THERAPEUT, V92, P57, DOI 10.1016/S0163-7258(01)00159-0	46	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2011	6	9							e24473	10.1371/journal.pone.0024473	http://dx.doi.org/10.1371/journal.pone.0024473			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817QP	21915333	Green Submitted, Green Published, gold			2022-12-25	WOS:000294689200045
J	Xie, WD; Gu, DY; Li, JN; Cui, K; Zhang, YO				Xie, Weidong; Gu, Dayong; Li, Jianna; Cui, Kai; Zhang, Yaou			Effects and Action Mechanisms of Berberine and Rhizoma coptidis on Gut Microbes and Obesity in High-Fat Diet-Fed C57BL/6J Mice	PLOS ONE			English	Article							METABOLISM; HYPERGLYCEMIA; EXPRESSION; RESISTANCE; OXIDATION	Gut microbes play important roles in regulating fat storage and metabolism. Rhizoma coptidis (RC) and its main active compound, berberine, have either antimicrobial or anti-obesity activities. In the present study, we hypothesize that RC exerts anti-obesity effects that are likely mediated by mechanisms of regulating gut microbes and berberine may be a key compound of RC. Gut microbes and glucose and lipid metabolism in high-fat diet-fed C57BL/6J (HFD) mice in vivo are investigated after RC and berberine treatments. The results show that RC (200 mg/kg) and berberine (200 mg/kg) significantly lower both body and visceral adipose weights, and reduce blood glucose and lipid levels, and decrease degradation of dietary polysaccharides in HFD mice. Both RC and berberine significantly reduce the proportions of fecal Firmicutes and Bacteroidetes to total bacteria in HFD mice. In the trial ex vivo, both RC and berberine significantly inhibit the growth of gut bacteria under aerobic and anaerobic conditions. In in vitro trials, both RC and berberine significantly inhibit the growth of Lactobacillus (a classical type of Firmicutes) under anaerobic conditions. Furthermore, both RC and berberine significantly increase fasting-induced adipose factor (Fiaf, a key protein negatively regulated by intestinal microbes) expressions in either intestinal or visceral adipose tissues. Both RC and berberine significantly increase mRNA expressions of AMPK, PGC1 alpha, UCP2, CPT1 alpha, and Hadhb related to mitochondrial energy metabolism, which may be driven by increased Fiaf expression. These results firstly suggest that antimicrobial activities of RC and berberine may result in decreasing degradation of dietary polysaccharides, lowering potential calorie intake, and then systemically activating Fiaf protein and related gene expressions of mitochondrial energy metabolism in visceral adipose tissues. Taken together, these action mechanisms may contribute to significant anti-obesity effects. Findings in the present study also indicate that pharmacological regulation on gut microbes can develop an anti-obesity strategy.	[Xie, Weidong; Li, Jianna; Cui, Kai; Zhang, Yaou] Tsinghua Univ, Grad Sch Shenzhen, Div Life Sci, Shenzhen 518057, Peoples R China; [Gu, Dayong] Shenzhen Entry Exit Inspect & Quarantine Bur, Shenzhen Int Travel Hlth Care Ctr, Inst Dis Control & Prevent, Shenzhen, Peoples R China	Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School	Xie, WD (corresponding author), Tsinghua Univ, Grad Sch Shenzhen, Div Life Sci, Shenzhen 518057, Peoples R China.	zhangyo@sz.tsinghua.edu.cn		gu, dayong/0000-0002-9547-8474	National Natural Science Foundation of China [81072680]; Natural Science Foundation of Guangdong Province [10151805702000002]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20100002120017]; China Postdoctoral Science Foundation [20060390460]; Tertiary College Science Foundation of Nanshan, Shenzhen [2008028]; Science Seed Foundation of the Graduate School at Shenzhen, Tsinghua University, China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Tertiary College Science Foundation of Nanshan, Shenzhen; Science Seed Foundation of the Graduate School at Shenzhen, Tsinghua University, China	This study was supported by the National Natural Science Foundation of China (81072680), the Natural Science Foundation of Guangdong Province (10151805702000002), the Specialized Research Fund for the Doctoral Program of Higher Education of China (20100002120017), the China Postdoctoral Science Foundation (20060390460), and the Tertiary College Science Foundation of Nanshan, Shenzhen (2008028), the Science Seed Foundation (2008) of the Graduate School at Shenzhen, Tsinghua University, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAIN CC, 1974, CLIN CHEM, V20, P470; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Boss O, 2000, DIABETES, V49, P143, DOI 10.2337/diabetes.49.2.143; Brunani A, 2008, DIABETES OBES METAB, V10, P460, DOI 10.1111/j.1463-1326.2007.00728.x; Canto C, 2010, CELL MOL LIFE SCI, V67, P3407, DOI 10.1007/s00018-010-0454-z; de Sousa ULJ, 2005, BIOCHEM BIOPH RES CO, V338, P757, DOI 10.1016/j.bbrc.2005.10.016; DiBaise JK, 2008, MAYO CLIN PROC, V83, P460, DOI 10.4065/83.4.460; Fielding BA, 1998, BRIT J NUTR, V80, P495, DOI 10.1017/S0007114598001585; FOSSATI P, 1982, CLIN CHEM, V28, P2077; Freile ML, 2003, FITOTERAPIA, V74, P702, DOI 10.1016/S0367-326X(03)00156-4; Guo X, 2008, LETT APPL MICROBIOL, V47, P367, DOI 10.1111/j.1472-765X.2008.02408.x; Hu YS, 2010, FITOTERAPIA, V81, P358, DOI 10.1016/j.fitote.2009.10.010; Iwazaki RS, 2010, ANTON LEEUW INT J G, V97, P201, DOI 10.1007/s10482-009-9394-8; Kong WJ, 2004, NAT MED, V10, P1344, DOI 10.1038/nm1135; Lee YS, 2006, DIABETES, V55, P2256, DOI 10.2337/db06-0006; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; [李艺 LI Yi], 2008, [中国新药杂志, Chinese Journal New Drugs], V17, P733; LI ZX, 2001, ZHONG CAO YAO, V32, P337; Powell Tiffany M, 2010, Curr Treat Options Cardiovasc Med, V12, P381, DOI 10.1007/s11936-010-0080-y; Rokholm B, 2010, OBES REV, V11, P835, DOI 10.1111/j.1467-789X.2010.00810.x; SHI QM, 2003, ZHONG GUO DONG WU BA, V9, P29; SHI QM, 2003, ZHONG GUO DONG WU BA, V9, P22; Siersbaek R, 2010, FEBS LETT, V584, P3242, DOI 10.1016/j.febslet.2010.06.010; Spiegelman Bruce M, 2007, Novartis Found Symp, V287, P60; Spiekerkoetter U, 2003, HUM MUTAT, V21, P598, DOI 10.1002/humu.10211; Tennyson CA, 2008, CURR OPIN ENDOCRINOL, V15, P422, DOI 10.1097/MED.0b013e328308dbfb; Trinder P., 1969, ANN CLIN BIOCHEM, V6, P24, DOI DOI 10.1177/000456326900600108; WANG L, 2008, ZHONG GUO PI FU XING, V22, P498; WANG XJ, 2003, ZHONG GUO YAO SHI, V6, P370; Xie W, 2011, DIABETES OBES METAB, V13, P289, DOI 10.1111/j.1463-1326.2010.01336.x; Xie W., 2011, EVID-BASED COMPL ALT, V2011, DOI DOI 10.1155/2011/726723; Xie WD, 2005, LIFE SCI, V77, P481, DOI 10.1016/j.lfs.2004.08.044; Xie WD, 2011, EXP THER MED, V2, P309, DOI 10.3892/etm.2011.208; Xie WD, 2010, MOL MED REP, V3, P1047, DOI 10.3892/mmr.2010.354; Xie WD, 2007, PHARMACOL RES, V55, P392, DOI 10.1016/j.phrs.2007.01.014; Xie WD, 2008, EUR J PHARMACOL, V599, P159, DOI 10.1016/j.ejphar.2008.09.042; Yan D, 2008, J BIOCHEM BIOPH METH, V70, P845, DOI 10.1016/j.jbbm.2007.07.009; Yin Jun, 2008, Endocrine Metabolic & Immune Disorders-Drug Targets, V8, P99, DOI 10.2174/187153008784534330; Zhang Q, 2011, EVID BASED COMPLEMEN, V2011; Zhou JY, 2010, EUR J PHARMACOL, V649, P390, DOI 10.1016/j.ejphar.2010.09.030	41	125	154	6	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2011	6	9							e24520	10.1371/journal.pone.0024520	http://dx.doi.org/10.1371/journal.pone.0024520			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817QP	21915347	gold, Green Published, Green Submitted			2022-12-25	WOS:000294689200053
J	Kwak, H; Park, MW; Jeong, S				Kwak, Hoyun; Park, Min Woo; Jeong, Sunjoo			Annexin A2 Binds RNA and Reduces the Frameshifting Efficiency of Infectious Bronchitis Virus	PLOS ONE			English	Article							MYC MESSENGER-RNA; GENE-EXPRESSION; LOCALIZATION SIGNAL; PSEUDOKNOT; CORONAVIRUS; PROTEIN; REPLICATION; TRANSLATION; REGION; APTAMER	Annexin A2 (ANXA2) is a protein implicated in diverse cellular functions, including exocytosis, DNA synthesis and cell proliferation. It was recently proposed to be involved in RNA metabolism because it was shown to associate with some cellular mRNA. Here, we identified ANXA2 as a RNA binding protein (RBP) that binds IBV (Infectious Bronchitis Virus) pseudoknot RNA. We first confirmed the binding of ANXA2 to IBV pseudoknot RNA by ultraviolet crosslinking and showed its binding to RNA pseudoknot with ANXA2 protein in vitro and in the cells. Since the RNA pseudoknot located in the frameshifting region of IBV was used as bait for cellular RBPs, we tested whether ANXA2 could regulate the frameshfting of IBV pseudoknot RNA by dual luciferase assay. Overexpression of ANXA2 significantly reduced the frameshifting efficiency from IBV pseudoknot RNA and knockdown of the protein strikingly increased the frameshifting efficiency. The results suggest that ANXA2 is a cellular RBP that can modulate the frameshifting efficiency of viral RNA, enabling it to act as an antiviral cellular protein, and hinting at roles in RNA metabolism for other cellular mRNAs.	[Kwak, Hoyun; Park, Min Woo; Jeong, Sunjoo] Dankook Univ, Dept Mol Biol, Inst Nanosensor & Biotechnol, Natl Res Lab RNA Cell Biol,BK21 Grad Program RNA, Gyeonggi Do, South Korea	Dankook University	Kwak, H (corresponding author), Dankook Univ, Dept Mol Biol, Inst Nanosensor & Biotechnol, Natl Res Lab RNA Cell Biol,BK21 Grad Program RNA, Gyeonggi Do, South Korea.	sjsj@dankook.ac.kr			National Research Foundation of Korea (NRF); Korean government (MEST) [2011-0018634, 2011-0002169, 2011-0006428]; Korea Research foundation [KRF-2008-314-C00299]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Korea Research foundation(National Research Foundation of Korea)	This work was supported by the National Research Foundation of Korea (NRF) grants funded by the Korean government (MEST) (2011-0018634, 2011-0002169, 2011-0006428) and the Korea Research foundation (KRF-2008-314-C00299). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaza I, 2008, RNA, V14, P404, DOI 10.1261/rna.848208; Aranda-Orgilles B, 2008, HUM GENET, V123, P163, DOI 10.1007/s00439-007-0456-6; Aukrust I, 2007, J MOL BIOL, V368, P1367, DOI 10.1016/j.jmb.2007.02.094; BRIERLEY I, 1987, EMBO J, V6, P3779, DOI 10.1002/j.1460-2075.1987.tb02713.x; BRIERLEY I, 1989, CELL, V57, P537, DOI 10.1016/0092-8674(89)90124-4; BRIERLEY I, 1992, J MOL BIOL, V227, P463, DOI 10.1016/0022-2836(92)90901-U; Brierley I, 2007, NAT REV MICROBIOL, V5, P598, DOI 10.1038/nrmicro1704; Brierley I, 2006, VIRUS RES, V119, P29, DOI 10.1016/j.virusres.2005.10.008; Chabanon H, 2005, BIOCHEM J, V392, P475, DOI 10.1042/BJ20050812; Chaloin L, 2002, NUCLEIC ACIDS RES, V30, P4001, DOI 10.1093/nar/gkf522; Chetcuti A, 2001, CANCER RES, V61, P6331; Dulude D, 2006, VIROLOGY, V345, P127, DOI 10.1016/j.virol.2005.08.048; Fahling M, 2006, J BIOL CHEM, V281, P26089, DOI 10.1074/jbc.M604939200; Filipenko NR, 2004, J BIOL CHEM, V279, P8723, DOI 10.1074/jbc.M311951200; Giedroc DP, 2000, J MOL BIOL, V298, P167, DOI 10.1006/jmbi.2000.3668; Hansen TM, 2007, P NATL ACAD SCI USA, V104, P5830, DOI 10.1073/pnas.0608668104; Heppell B, 2008, BIOCHEMISTRY-US, V47, P1490, DOI 10.1021/bi701164y; Hollas H, 2006, BBA-MOL CELL RES, V1763, P1325, DOI 10.1016/j.bbamcr.2006.08.043; Kim MY, 2003, MOL CELLS, V16, P413; Kim YC, 1999, P NATL ACAD SCI USA, V96, P14234, DOI 10.1073/pnas.96.25.14234; Kim YG, 2000, RNA, V6, P1157, DOI 10.1017/S1355838200000510; Kontos H, 2001, MOL CELL BIOL, V21, P8657, DOI 10.1128/MCB.21.24.8657-8670.2001; Lee HK, 2006, NUCLEIC ACIDS RES, V34, P5705, DOI 10.1093/nar/gkl698; Liu Jie, 2003, BMC Biochem, V4, P10, DOI 10.1186/1471-2091-4-10; Marszalkowski M, 2008, RNA, V14, P127, DOI 10.1261/rna.762508; Mickleburgh I, 2005, FEBS J, V272, P413, DOI 10.1111/j.1742-4658.2004.04481.x; Namy O, 2006, NATURE, V441, P244, DOI 10.1038/nature04735; Nilsson J, 2004, EMBO REP, V5, P1137, DOI 10.1038/sj.embor.7400291; Parisien M, 2008, NATURE, V452, P51, DOI 10.1038/nature06684; Park SJ, 2008, BIOORGAN MED CHEM, V16, P4676, DOI 10.1016/j.bmc.2008.02.025; Plant EP, 2005, PLOS BIOL, V3, P1012, DOI 10.1371/journal.pbio.0030172; Plant EP, 2003, RNA, V9, P168, DOI 10.1261/rna.2132503; Rand JH, 2000, BBA-MOL CELL RES, V1498, P169, DOI 10.1016/S0167-4889(00)00093-8; Reeder J, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-104; Reeder J, 2007, NUCLEIC ACIDS RES, V35, pW320, DOI 10.1093/nar/gkm258; Reeder J, 2006, J BIOTECHNOL, V124, P41, DOI 10.1016/j.jbiotec.2006.01.034; Rescher U, 2004, J CELL SCI, V117, P2631, DOI 10.1242/jcs.01245; Scheper GC, 2007, NAT REV GENET, V8, P711, DOI 10.1038/nrg2142; Sharma MC, 2007, CURR PHARM DESIGN, V13, P3568, DOI 10.2174/138161207782794167; Sperschneider J, 2008, RNA, V14, P630, DOI 10.1261/rna.968808; Tanguay RL, 1996, J BIOL CHEM, V271, P14316, DOI 10.1074/jbc.271.24.14316; Theimer CA, 2006, CURR OPIN STRUC BIOL, V16, P307, DOI 10.1016/j.sbi.2006.05.005; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865; Vedeler A, 2000, BIOCHEM J, V348, P565, DOI 10.1042/0264-6021:3480565; Weiss SR, 2005, MICROBIOL MOL BIOL R, V69, P635, DOI 10.1128/MMBR.69.4.635-664.2005; Zeenko VV, 2002, J VIROL, V76, P5678, DOI 10.1128/JVI.76.11.5678-5691.2002; Zust R, 2008, J VIROL, V82, P1214, DOI 10.1128/JVI.01690-07	47	30	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2011	6	8							e24067	10.1371/journal.pone.0024067	http://dx.doi.org/10.1371/journal.pone.0024067			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817MS	21918681	gold, Green Published, Green Submitted			2022-12-25	WOS:000294678300019
J	Aranda-Orgilles, B; Rutschow, D; Zeller, R; Karagiannidis, AI; Kohler, A; Chen, CW; Wilson, T; Krause, S; Roepcke, S; Lilley, D; Schneider, R; Schweiger, S				Aranda-Orgilles, Beatriz; Rutschow, Desiree; Zeller, Raphael; Karagiannidis, Antonios I.; Koehler, Andrea; Chen, Changwei; Wilson, Timothy; Krause, Sven; Roepcke, Stefan; Lilley, David; Schneider, Rainer; Schweiger, Susann			Protein Phosphatase 2A (PP2A)-specific Ubiquitin Ligase MID1 Is a Sequence-dependent Regulator of Translation Efficiency Controlling 3-Phosphoinositide-dependent Protein Kinase-1 (PDPK-1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPITZ-SYNDROME GENE; MESSENGER-RNA; GBBB SYNDROME; EXPRESSION; ALPHA-4; PHOSPHORYLATION; SUBUNIT; TARGETS; BINDING; MTOR	We have shown previously that the ubiquitin ligase MID1, mutations of which cause the midline malformation Opitz BBB/G syndrome (OS), serves as scaffold for a microtubule-associated protein complex that regulates protein phosphatase 2A (PP2A) activity in a ubiquitin-dependent manner. Here, we show that the MID1 protein complex associates with mRNAs via a purine-rich sequence motif called MIDAS (MID1 association sequence) and thereby increases stability and translational efficiency of these mRNAs. Strikingly, inclusion of multiple copies of the MIDAS motif into mammalian mRNAs increases production of the encoded proteins up to 20-fold. Mutated MID1, as found in OS patients, loses its influence on MIDAS-containing mRNAs, suggesting that the malformations in OS patients could be caused by failures in the regulation of cytoskeleton-bound protein translation. This is supported by the observation that the majority of mRNAs that carry MIDAS motifs is involved in developmental processes and/or energy homeostasis. Further analysis of one of the proteins encoded by a MIDAS-containing mRNA, namely PDPK-1 (3-phosphoinositide dependent protein kinase-1), which is an important regulator of mammalian target of rapamycin/PP2A signaling, showed that PDPK-1 protein synthesis is significantly reduced in cells from an OS patient compared with an age-matched control and can be rescued by functional MID1. Together, our data uncover a novel messenger ribonucleoprotein complex that regulates microtubule-associated protein translation. They suggest a novel mechanism underlying OS and point at an enormous potential of the MIDAS motif to increase the efficiency of biotechnological protein production in mammalian cells.	[Karagiannidis, Antonios I.; Koehler, Andrea; Schneider, Rainer] Univ Innsbruck, Inst Biochem, Ctr Mol Biosci Innsbruck, A-6020 Innsbruck, Austria; [Aranda-Orgilles, Beatriz; Krause, Sven; Roepcke, Stefan; Schneider, Rainer; Schweiger, Susann] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Rutschow, Desiree; Zeller, Raphael; Chen, Changwei; Schweiger, Susann] Univ Dundee, Div Med Sci, Ninewells Hosp, Dundee DD1 9SY, Scotland; [Wilson, Timothy; Lilley, David] Univ Dundee, Coll Life Sci, Dundee DD1 5EH, Scotland	University of Innsbruck; Max Planck Society; University of Dundee; University of Dundee	Schneider, R (corresponding author), Univ Innsbruck, Inst Biochem, Ctr Mol Biosci Innsbruck, Peter Mayr Str 1A, A-6020 Innsbruck, Austria.	rainer.schneider@uibk.ac.at			Deutsche Forschungsgemeinschaft [SFB 577, A6]; Austrian Science Fund [FWF-SFB021, 03, TRP233-B18]; Tyrolean Future Foundation; Tenovus Scotland; AtaxiaUK; Austrian Science Fund (FWF) [TRP 233] Funding Source: researchfish; Cancer Research UK [11722] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Austrian Science Fund(Austrian Science Fund (FWF)); Tyrolean Future Foundation; Tenovus Scotland; AtaxiaUK; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Cancer Research UK(Cancer Research UK)	This work was supported in part by Deutsche Forschungsgemeinschaft Grant SFB 577 (Project A6, to S. S.), Austrian Science Fund Grants FWF-SFB021 (Project 03) and TRP233-B18 (to R. S.), the Tyrolean Future Foundation (to R. S.), Tenovus Scotland (to S. S.), and AtaxiaUK (to S. S.). Patent application pending (EP 07015280.6).	Aranda-Orgilles B, 2008, HUM GENET, V123, P163, DOI 10.1007/s00439-007-0456-6; Ashique AM, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000602; Averous J, 2006, ONCOGENE, V25, P6423, DOI 10.1038/sj.onc.1209887; Berthier CC, 2008, NEPHROL DIAL TRANSPL, V23, P880, DOI 10.1093/ndt/gfm697; Berti C, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-9; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Canedo CS, 2010, AM J PHYSIOL-ENDOC M, V298, pE761, DOI 10.1152/ajpendo.00421.2009; Cao WL, 2009, BIOL REPROD, V80, P124, DOI 10.1095/biolreprod.108.068882; Chen SA, 2011, CELL METAB, V13, P68, DOI 10.1016/j.cmet.2010.12.005; Clark MR, 2011, MOL IMMUNOL, V48, P1281, DOI 10.1016/j.molimm.2010.10.024; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; Dhakshinamoorthy S, 2000, J BIOL CHEM, V275, P40134, DOI 10.1074/jbc.M003531200; Dowling RJO, 2010, BBA-PROTEINS PROTEOM, V1804, P433, DOI 10.1016/j.bbapap.2009.12.001; Felschow DM, 2000, BIOCHEM BIOPH RES CO, V273, P294, DOI 10.1006/bbrc.2000.2887; Grech G, 2008, BLOOD, V112, P2750, DOI 10.1182/blood-2008-01-133140; HERRLICH P, 1974, P NATL ACAD SCI USA, V71, P1088, DOI 10.1073/pnas.71.4.1088; Huang JS, 2010, AM J PHYSIOL-GASTR L, V299, pG1211, DOI 10.1152/ajpgi.00322.2010; Iden S, 2008, NAT REV MOL CELL BIO, V9, P846, DOI 10.1038/nrm2521; Inui S, 1998, BLOOD, V92, P539, DOI 10.1182/blood.V92.2.539.414k23_539_546; Iskandar K, 2010, AM J PHYSIOL-ENDOC M, V298, pE787, DOI 10.1152/ajpendo.00512.2009; Jacinto E, 2003, NAT REV MOL CELL BIO, V4, P117, DOI 10.1038/nrm1018; Kickstein E, 2010, P NATL ACAD SCI USA, V107, P21830, DOI 10.1073/pnas.0912793107; Kim CW, 2010, P NATL ACAD SCI USA, V107, P9626, DOI 10.1073/pnas.1001292107; Kong M, 2004, SCIENCE, V306, P695, DOI 10.1126/science.1100537; Krauss S, 2008, CANCER RES, V68, P4658, DOI 10.1158/0008-5472.CAN-07-6174; Lancioni A, 2010, J NEUROSCI, V30, P2880, DOI 10.1523/JNEUROSCI.4196-09.2010; Landgren S, 2009, BRAIN RES, V1305, pS72, DOI 10.1016/j.brainres.2009.08.026; Lijnen HR, 2011, J PHARMACOL EXP THER, V337, P457, DOI 10.1124/jpet.110.178046; Liu EB, 2011, P NATL ACAD SCI USA, V108, P8680, DOI 10.1073/pnas.1100131108; Liu J, 2001, P NATL ACAD SCI USA, V98, P6650, DOI 10.1073/pnas.111154698; Lonyai A, 2008, IMMUNOL CELL BIOL, V86, P301, DOI 10.1038/icb.2008.6; Luo T, 2007, DEVELOPMENT, V134, P1279, DOI 10.1242/dev.02813; McDonald WJ, 2010, J CELL BIOCHEM, V110, P1123, DOI 10.1002/jcb.22624; Muller YL, 2010, DIABETES, V59, P2080, DOI 10.2337/db09-1593; Noble EE, 2011, AM J PHYSIOL-REG I, V300, pR1053, DOI 10.1152/ajpregu.00776.2010; Oganesian L, 2007, BIOESSAYS, V29, P155, DOI 10.1002/bies.20523; Quaderi NA, 1997, NAT GENET, V17, P285, DOI 10.1038/ng1197-285; ROBIN NH, 1995, NAT GENET, V11, P459, DOI 10.1038/ng1295-459; Saemann MD, 2009, AM J TRANSPLANT, V9, P2655, DOI 10.1111/j.1600-6143.2009.02832.x; Sakamoto T, 2010, J BIOL CHEM, V285, P29951, DOI 10.1074/jbc.M110.132704; Schaeffer C, 2001, EMBO J, V20, P4803, DOI 10.1093/emboj/20.17.4803; Schram K, 2011, ENDOCRINOLOGY, V152, P2037, DOI 10.1210/en.2010-1166; Schweiger S, 2003, BIOESSAYS, V25, P356, DOI 10.1002/bies.10256; Short KM, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-1; So J, 2005, AM J MED GENET A, V132A, P1, DOI 10.1002/ajmg.a.30407; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Trockenbacher A, 2001, NAT GENET, V29, P287, DOI 10.1038/ng762; Tsatsos NG, 2008, ENDOCRINOLOGY, V149, P5155, DOI 10.1210/en.2008-0215; Wauman J, 2008, MOL ENDOCRINOL, V22, P965, DOI 10.1210/me.2007-0414; Wilhelm JE, 2005, BIOL CELL, V97, P235, DOI 10.1042/BC20040097; WILLIAMSON JR, 1994, ANNU REV BIOPH BIOM, V23, P703, DOI 10.1146/annurev.bb.23.060194.003415; Wu HJ, 2009, J CLIN IMMUNOL, V29, P12, DOI 10.1007/s10875-008-9264-6	52	26	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 18	2011	286	46					39945	39957		10.1074/jbc.M111.224451	http://dx.doi.org/10.1074/jbc.M111.224451			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	846TI	21930711	hybrid, Green Published			2022-12-25	WOS:000296925700028
J	Patel, M; Chiang, TC; Tran, V; Lee, FJS; Cote, JF				Patel, Manishha; Chiang, Tsai-Chen; Tran, Viviane; Lee, Fang-Jen S.; Cote, Jean-Francois			The Arf Family GTPase Arl4A Complexes with ELMO Proteins to Promote Actin Cytoskeleton Remodeling and Reveals a Versatile Ras-binding Domain in the ELMO Proteins Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT CELL-MIGRATION; DOWNSTREAM ACTIVATION; NUCLEOTIDE EXCHANGE; APOPTOTIC CELLS; PLASMA-MEMBRANE; DOCK180; RAC1; RHOG; PATHWAY; FUSION	The prototypical DOCK protein, DOCK180, is an evolutionarily conserved Rac regulator and is indispensable during processes such as cell migration and myoblast fusion. The biological activity of DOCK180 is tightly linked to its binding partner ELMO. We previously reported that autoinhibited ELMO proteins regulate signaling from this pathway. One mechanism to activate the ELMO-DOCK180 complex appears to be the recruitment of this complex to the membrane via the Ras-binding domain (RBD) of ELMO. In the present study, we aimed to identify novel ELMO-interacting proteins to further define the molecular events capable of controlling ELMO recruitment to the membrane. To do so, we performed two independent interaction screens: one specifically interrogated an active GTPase library while the other probed a brain cDNA library. Both methods converged on Arl4A, an Arf-related GTPase, as a specific ELMO interactor. Biochemically, Arl4A is constitutively GTP-loaded, and our binding assays confirm that both wild-type and constitutively active forms of the GTPase associate with ELMO. Mechanistically, we report that Arl4A binds the ELMO RBD and acts as a membrane localization signal for ELMO. In addition, we report that membrane targeting of ELMO via Arl4A promotes cytoskeletal reorganization including membrane ruffling and stress fiber disassembly via an ELMO-DOCK1800-Rac signaling pathway. We conclude that ELMO is capable of interacting with GTPases from Rho and Arf families, leading to the conclusion that ELMO contains a versatile RBD. Furthermore, via binding of an Arf family GTPase, the ELMO-DOCK180 is uniquely positioned at the membrane to activate Rac signaling and remodel the actin cytoskeleton.	[Chiang, Tsai-Chen; Lee, Fang-Jen S.] Natl Taiwan Univ, Inst Mol Med, Coll Med, Taipei 100, Taiwan; [Patel, Manishha; Tran, Viviane; Cote, Jean-Francois] Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada; [Patel, Manishha; Cote, Jean-Francois] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; [Chiang, Tsai-Chen; Lee, Fang-Jen S.] Natl Taiwan Univ Hosp, Dept Med Res, Taipei 100, Taiwan; [Cote, Jean-Francois] McGill Univ, Div Expt Med, Montreal, PQ H3A 1A3, Canada	National Taiwan University; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Universite de Montreal; National Taiwan University; National Taiwan University Hospital; McGill University	Lee, FJS (corresponding author), Natl Taiwan Univ, Inst Mol Med, Coll Med, 7 Chung Shan S Rd, Taipei 100, Taiwan.	fangjen@ntu.edu.tw; jean-francois.cote@ircm.qc.ca		LEE, FANG-JEN/0000-0002-2167-2426	Canadian Institutes of Health Research; National Science Council, Taiwan [NSC-100 2325-B-022-028]; National Taiwan University Hospital [99P21-1]; Canadian Institutes of Health Research-Institut de Recherches Cliniques de Montreal; Universite de Montreal-Comite d'Organisation du Programme des Stagiaires d'Ete; Pfizer Canada; Fonds de la Recherches en Sante du Quebec	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Taiwan University Hospital(National Taiwan University); Canadian Institutes of Health Research-Institut de Recherches Cliniques de Montreal(Canadian Institutes of Health Research (CIHR)); Universite de Montreal-Comite d'Organisation du Programme des Stagiaires d'Ete; Pfizer Canada(Pfizer); Fonds de la Recherches en Sante du Quebec	This work was funded by a Canadian Institutes of Health Research operating grant (to J.-F.C.). This work was also supported by grants from the National Science Council, Taiwan, (NSC-100 2325-B-022-028), and National Taiwan University Hospital (99P21-1, to F.-J.S.L.).; Recipient of a Canadian Institutes of Health Research-Institut de Recherches Cliniques de Montreal training studentship.; Recipient of a Universite de Montreal-Comite d'Organisation du Programme des Stagiaires d'Ete undergraduate studentship funded by Pfizer Canada.; Recipient of a Canadian Institutes of Health Research New Investigator Award and currently holds a Fonds de la Recherches en Sante du Quebec Junior 2 career award.	Bartel P. L., 1993, CELLULAR INTERACTION, P153; Bowzard JB, 2007, J BIOL CHEM, V282, P17568, DOI 10.1074/jbc.M701347200; Cote JF, 2007, TRENDS CELL BIOL, V17, P383, DOI 10.1016/j.tcb.2007.05.001; Cote JF, 2005, NAT CELL BIOL, V7, P797, DOI 10.1038/ncb1280; Cote JF, 2002, J CELL SCI, V115, P4901, DOI 10.1242/jcs.00219; Cotton M, 2007, MOL BIOL CELL, V18, P501, DOI 10.1091/mbc.E06-06-0567; DeBakker CD, 2004, CURR BIOL, V14, P2208, DOI 10.1016/j.cub.2004.12.029; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Grimsley CM, 2006, J BIOL CHEM, V281, P5928, DOI 10.1074/jbc.M510647200; Grimsley CM, 2004, J BIOL CHEM, V279, P6087, DOI 10.1074/jbc.M307087200; Handa Y, 2007, NAT CELL BIOL, V9, P121, DOI 10.1038/ncb1526; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Hiramoto K, 2006, EXP CELL RES, V312, P4205, DOI 10.1016/j.yexcr.2006.09.006; Hofmann I, 2007, CURR BIOL, V17, P711, DOI 10.1016/j.cub.2007.03.007; Hu B, 2009, CANCER RES, V69, P794, DOI 10.1158/0008-5472.CAN-08-2110; Jacobs S, 1999, FEBS LETT, V456, P384, DOI 10.1016/S0014-5793(99)00759-0; Kahn RA, 2006, J CELL BIOL, V172, P645, DOI 10.1083/jcb.200512057; Katoh H, 2003, NATURE, V424, P461, DOI 10.1038/nature01817; Katoh H, 2000, MOL CELL BIOL, V20, P7378, DOI 10.1128/MCB.20.19.7378-7387.2000; Katoh H, 2006, J CELL SCI, V119, P56, DOI 10.1242/jcs.02720; Komander D, 2008, MOL BIOL CELL, V19, P4837, DOI 10.1091/mbc.E08-04-0345; Laurin M, 2008, P NATL ACAD SCI USA, V105, P15446, DOI 10.1073/pnas.0805546105; Li CC, 2007, MOL BIOL CELL, V18, P4420, DOI 10.1091/mbc.E07-02-0149; Meller J, 2008, J CELL SCI, V121, P1981, DOI 10.1242/jcs.025130; Meller N, 2005, J CELL SCI, V118, P4937, DOI 10.1242/jcs.02671; Nishikimi A, 2009, SCIENCE, V324, P384, DOI 10.1126/science.1170179; Pajcini KV, 2008, J CELL BIOL, V180, P1005, DOI 10.1083/jcb.200707191; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Patel M, 2010, CURR BIOL, V20, P2021, DOI 10.1016/j.cub.2010.10.028; Sanematsu F, 2010, CIRC RES, V107, P1102, DOI 10.1161/CIRCRESAHA.110.223388; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; Santy LC, 2005, CURR BIOL, V15, P1749, DOI 10.1016/j.cub.2005.08.052; Vives V, 2011, J BONE MINER RES, V26, P1099, DOI 10.1002/jbmr.282; VOJTEK AB, 1995, METHOD ENZYMOL, V255, P331; White DT, 2010, MOL BIOL CELL, V21, P562, DOI 10.1091/mbc.E09-03-0217; Yang J, 2009, SCIENCE, V325, P1398, DOI 10.1126/science.1174468; Zhou Z, 2001, DEV CELL, V1, P477, DOI 10.1016/S1534-5807(01)00058-2	39	30	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					38969	38979		10.1074/jbc.M111.274191	http://dx.doi.org/10.1074/jbc.M111.274191			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21930703	Green Published, hybrid			2022-12-25	WOS:000296759800016
J	Lee, BY; Assi, TM; Rookkapan, K; Wateska, AR; Rajgopal, J; Sornsrivichai, V; Chen, SI; Brown, ST; Welling, J; Norman, BA; Connor, DL; Bailey, RR; Jana, A; Van Panhuis, WG; Burke, DS				Lee, Bruce Y.; Assi, Tina-Marie; Rookkapan, Korngamon; Wateska, Angela R.; Rajgopal, Jayant; Sornsrivichai, Vorasith; Chen, Sheng-I; Brown, Shawn T.; Welling, Joel; Norman, Bryan A.; Connor, Diana L.; Bailey, Rachel R.; Jana, Anirban; Van Panhuis, Willem G.; Burke, Donald S.			Maintaining Vaccine Delivery Following the Introduction of the Rotavirus and Pneumococcal Vaccines in Thailand	PLOS ONE			English	Article							SYSTEMS THINKING; PUBLIC-HEALTH; INFLUENZA; STRATEGIES; SIMULATION; DYNAMICS; MODEL	Although the substantial burdens of rotavirus and pneumococcal disease have motivated many countries to consider introducing the rotavirus vaccine (RV) and heptavalent pneumococcal conjugate vaccine (PCV-7) to their National Immunization Programs (EPIs), these new vaccines could affect the countries' vaccine supply chains (i.e., the series of steps required to get a vaccine from their manufacturers to patients). We developed detailed computational models of the Trang Province, Thailand, vaccine supply chain to simulate introducing various RV and PCV-7 vaccine presentations and their combinations. Our results showed that the volumes of these new vaccines in addition to current routine vaccines could meet and even exceed (1) the refrigerator space at the provincial district and sub-district levels and (2) the transport cold space at district and sub-district levels preventing other vaccines from being available to patients who arrive to be immunized. Besides the smallest RV presentation (17.1 cm(3)/dose), all other vaccine introduction scenarios required added storage capacity at the provincial level (range: 20 L-1151 L per month) for the three largest formulations, and district level (range: 1 L-124 L per month) across all introduction scenarios. Similarly, with the exception of the two smallest RV presentation (17.1 cm(3)/dose), added transport capacity was required at both district and sub-district levels. Added transport capacity required across introduction scenarios from the provincial to district levels ranged from 1 L-187 L, and district to sub-district levels ranged from 1 L-13 L per shipment. Finally, only the smallest RV vaccine presentation (17.1 cm(3)/dose) had no appreciable effect on vaccine availability at sub-districts. All other RV and PCV-7 vaccines were too large for the current supply chain to handle without modifications such as increasing storage or transport capacity. Introducing these new vaccines to Thailand could have dynamic effects on the availability of all vaccines that may not be initially apparent to decision-makers.	[Lee, Bruce Y.; Assi, Tina-Marie; Wateska, Angela R.; Rajgopal, Jayant; Chen, Sheng-I; Brown, Shawn T.; Norman, Bryan A.; Connor, Diana L.; Bailey, Rachel R.; Van Panhuis, Willem G.; Burke, Donald S.] Univ Pittsburgh, Pittsburgh, PA 15260 USA; [Rookkapan, Korngamon; Sornsrivichai, Vorasith] Prince Songkla Univ, Hat Yai, Songkhla, Thailand; [Brown, Shawn T.; Welling, Joel; Jana, Anirban] Pittsburgh Supercomp Ctr, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Prince of Songkla University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lee, BY (corresponding author), Univ Pittsburgh, Pittsburgh, PA 15260 USA.	BYL1@pitt.edu	Van Panhuis, Willem/S-5495-2019	Van Panhuis, Willem/0000-0002-7278-9982; Brown, Shawn/0000-0001-6980-8372; Slayton, Rachel/0000-0003-4699-8040; Norman, Bryan/0000-0001-6488-7788; Rajgopal, Jayant/0000-0001-7730-8749; /0000-0002-5704-8094	Vaccine Modeling Initiative (VMI); Bill and Melinda Gates Foundation; National Institute of General Medical Sciences Models of Infectious Disease Agent Study (MIDAS) [1U54GM088491-0109]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088491] Funding Source: NIH RePORTER	Vaccine Modeling Initiative (VMI); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institute of General Medical Sciences Models of Infectious Disease Agent Study (MIDAS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the Vaccine Modeling Initiative (VMI), funded by the Bill and Melinda Gates Foundation (http://www.gatesfoundation.org/Pages/home.aspx) and the National Institute of General Medical Sciences Models of Infectious Disease Agent Study (MIDAS) (http://www.nigms.nih.gov/Initiatives/MIDAS/) grant 1U54GM088491-0109. The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Borndorfer R, 2008, LECT NOTES ECON MATH, V600, P3; Cooley P, 2010, INFLUENZA OTHER RESP, V4, P61, DOI 10.1111/j.1750-2659.2009.00122.x; de Oliveira LH, 2008, EXPERT REV VACCINES, V7, P345, DOI 10.1586/14760584.7.3.345; DeStefano F, 2008, B WORLD HEALTH ORGAN, V86, P373, DOI 10.2471/BLT.07.048025; Epstein J.M., 2006, GENERATIVE SOCIAL SC; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Halloran ME, 2008, P NATL ACAD SCI USA, V105, P4639, DOI 10.1073/pnas.0706849105; Holmes EC, 2005, SCIENCE, V309, P989, DOI 10.1126/science.1117128; *IBM, 2010, C C COMP, P24585; ILACHINSKI A, 1997, CTR NAVAL ANAL RES M, V10, P97; Lee BY, 2008, CLIN INFECT DIS, V46, P1139, DOI 10.1086/529441; Lee BY, 2010, AM J PREV MED, V39, pE21, DOI 10.1016/j.amepre.2010.07.014; Lee BY, 2010, VACCINE, V28, P5292, DOI 10.1016/j.vaccine.2010.05.048; Lee BY, 2010, VACCINE, V28, P4875, DOI 10.1016/j.vaccine.2010.05.002; Lee BY, 2010, J PUBLIC HEALTH MAN, V16, P252, DOI 10.1097/PHH.0b013e3181ce594e; Lee BY, 2010, AM J PREV MED, V38, P247, DOI 10.1016/j.amepre.2009.11.009; Lee BY, 2009, OBSTET GYNECOL, V114, P971, DOI 10.1097/AOG.0b013e3181bdbfed; Lee BY, 2006, PLOS MED, V3, P168, DOI 10.1371/journal.pmed.0030099; LEE JH, 2008, MULTIAGENT SYSTEMS A, P24585; Leischow SJ, 2006, AM J PUBLIC HEALTH, V96, P403, DOI 10.2105/AJPH.2005.082842; MOORMANN D, 1999, OBJECT ORIENTED COMP, P24585; *NAT STAT OFF THAI, 2000, POP HOUS CENS; *OPTIMIZE, 2009, OPT VACC SUPPL CHAIN; *PATH, 2009, PATH ROT VACC PROGR, P1; Pitzer VE, 2009, SCIENCE, V325, P290, DOI 10.1126/science.1172330; Setia S, 2002, VACCINE, V20, P1148, DOI 10.1016/S0264-410X(01)00433-9; Shepard DS, 2004, VACCINE, V22, P1275, DOI 10.1016/j.vaccine.2003.09.019; Tildesley MJ, 2006, NATURE, V440, P83, DOI 10.1038/nature04324; Trochim WM, 2006, AM J PUBLIC HEALTH, V96, P538, DOI 10.2105/AJPH.2005.066001; WHO, 2010, WHO PREQ VACC; *WHO, 2000, WHO POL STAT US OP M; *WHO, 2009, WEEKLY EPIDEMIOLOGIC, V51, P533; *WHO, 2011, IMM MON; WHO, 2009, VACC VOL CALC; World Health Organization, 2006, B WHO; Xia B, 2002, COMPUT ELECTRON AGR, V34, P5, DOI 10.1016/S0168-1699(01)00177-6	37	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2011	6	9							e24673	10.1371/journal.pone.0024673	http://dx.doi.org/10.1371/journal.pone.0024673			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZV	21931805	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000295321800047
J	Stewart, R; Flechner, L; Montminy, M; Berdeaux, R				Stewart, Randi; Flechner, Lawrence; Montminy, Marc; Berdeaux, Rebecca			CREB Is Activated by Muscle Injury and Promotes Muscle Regeneration	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; TARGET GENE ACTIVATION; GENOME-WIDE ANALYSIS; SKELETAL-MUSCLE; TRANSDUCTION PATHWAY; SATELLITE CELLS; CYCLIC-AMP; IN-VIVO; TRANSCRIPTION; EXPRESSION	The cAMP response element binding protein (CREB) plays key roles in differentiation of embryonic skeletal muscle progenitors and survival of adult skeletal muscle. However, little is known about the physiologic signals that activate CREB in normal muscle. Here we show that CREB phosphorylation and target genes are induced after acute muscle injury and during regeneration due to genetic mutation. Activated CREB localizes to both myogenic precursor cells and newly regenerating myofibers within regenerating areas. Moreover, we found that signals from damaged skeletal muscle tissue induce CREB phosphorylation and target gene expression in primary mouse myoblasts. An activated CREB mutant (CREBY134F) potentiates myoblast proliferation as well as expression of early myogenic transcription factors in cultured primary myocytes. Consistently, activated CREB-YF promotes myoblast proliferation after acute muscle injury in vivo and enhances muscle regeneration in dystrophic mdx mice. Our findings reveal a new physiologic function for CREB in contributing to skeletal muscle regeneration.	[Stewart, Randi; Berdeaux, Rebecca] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX USA; [Flechner, Lawrence; Montminy, Marc] Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, San Diego, CA 92138 USA	University of Texas System; University of Texas Health Science Center Houston; Salk Institute	Stewart, R (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX USA.	Rebecca.berdeaux@uth.tmc.edu		Berdeaux, Rebecca/0000-0002-9929-1711; Fitzgibbon, Randi/0000-0001-8766-4309	Muscular Dystrophy Association [MDA68640]; NIH National Institute of Diabetes and Digestive and Kidney Diseases [R01 DK049777, DK083834, DK58337]; NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01 AR059847]; University of Texas Health Science Center at Houston; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059847] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083834, R37DK083834, R01DK049777] Funding Source: NIH RePORTER	Muscular Dystrophy Association(Muscular Dystrophy Association); NIH National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); University of Texas Health Science Center at Houston; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding was provided by the Muscular Dystrophy Association (MDA68640, RB), the NIH National Institute of Diabetes and Digestive and Kidney Diseases (R01 DK049777 and DK083834, MM; DK58337 Texas Medical Center Digestive Diseases Center, RB), the NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01 AR059847, RB) and the University of Texas Health Science Center at Houston. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; Akimoto T, 2004, AM J PHYSIOL-CELL PH, V287, pC790, DOI 10.1152/ajpcell.00425.2003; BADER D, 1982, J CELL BIOL, V95, P763, DOI 10.1083/jcb.95.3.763; Berdeaux R, 2007, NAT MED, V13, P597, DOI 10.1038/nm1573; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Chen AE, 2005, NATURE, V433, P317, DOI 10.1038/nature03126; CHEN G, 1992, J CELL PHYSIOL, V153, P563, DOI 10.1002/jcp.1041530318; Conkright MD, 2003, MOL CELL, V11, P1101, DOI 10.1016/S1097-2765(03)00134-5; Cox LJ, 2008, NAT CELL BIOL, V10, P149, DOI 10.1038/ncb1677; Du KY, 2000, MOL CELL BIOL, V20, P4320, DOI 10.1128/MCB.20.12.4320-4327.2000; ELLIS JM, 1990, LANCET, V336, P881, DOI 10.1016/0140-6736(90)92392-U; Gao Y, 2004, NEURON, V44, P609, DOI 10.1016/j.neuron.2004.10.030; Garat CV, 2006, MOL CELL BIOL, V26, P4934, DOI 10.1128/MCB.02477-05; GOPALAKRISHNAN L, 1994, J BIOL CHEM, V269, P105; GRATZNER HG, 1982, SCIENCE, V218, P474, DOI 10.1126/science.7123245; Griffin CA, 2009, DEV CELL, V17, P649, DOI 10.1016/j.devcel.2009.09.004; Han JH, 2007, SCIENCE, V316, P457, DOI [10.1126/science.1139438, 10.1126/science.1134697]; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; HOFFMAN EP, 1987, NATURE, V330, P754, DOI 10.1038/330754a0; Iezzi S, 2004, DEV CELL, V6, P673, DOI 10.1016/S1534-5807(04)00107-8; Jagasia R, 2009, J NEUROSCI, V29, P7966, DOI 10.1523/JNEUROSCI.1054-09.2009; Karasseva N, 2003, MOL CELL BIOL, V23, P5143, DOI 10.1128/MCB.23.15.5143-5164.2003; Keren A, 2008, DEV BIOL, V322, P86, DOI 10.1016/j.ydbio.2008.07.010; LEFRANCOISMARTI.AM, 2011, J BIOL CHEM; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lepper C, 2009, NATURE, V460, P627, DOI 10.1038/nature08209; Liu HJ, 2010, J CELL SCI, V123, P2914, DOI 10.1242/jcs.057620; Lynch GS, 2008, PHYSIOL REV, V88, P729, DOI 10.1152/physrev.00028.2007; Magenta A, 2003, MOL CELL BIOL, V23, P2893, DOI 10.1128/MCB.23.8.2893-2906.2003; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Mayr BM, 2001, P NATL ACAD SCI USA, V98, P10936, DOI 10.1073/pnas.191152098; Pearen MA, 2010, MOL ENDOCRINOL, V24, P1891, DOI 10.1210/me.2010-0015; Ravnskjaer K, 2007, EMBO J, V26, P2880, DOI 10.1038/sj.emboj.7601715; Shi XZ, 2006, GENE DEV, V20, P1692, DOI 10.1101/gad.1419406; Song WJ, 2008, DIABETES, V57, P2371, DOI 10.2337/db07-1541; Tatsumi R, 1998, DEV BIOL, V194, P114, DOI 10.1006/dbio.1997.8803; Teng SC, 2004, J BIOL CHEM, V279, P14649, DOI 10.1074/jbc.M308842200; TIDBALL JG, 1995, MED SCI SPORT EXER, V27, P1022, DOI 10.1249/00005768-199507000-00011; WEBSTER C, 1988, CELL, V52, P503, DOI 10.1016/0092-8674(88)90463-1; Wen AY, 2010, J IMMUNOL, V185, P6413, DOI 10.4049/jimmunol.1001829; WHALEN RG, 1990, DEV BIOL, V141, P24, DOI 10.1016/0012-1606(90)90099-5; WRIGHT WE, 1991, MOL CELL BIOL, V11, P4104, DOI 10.1128/MCB.11.8.4104; Wu ZD, 2006, P NATL ACAD SCI USA, V103, P14379, DOI 10.1073/pnas.0606714103; Yan Z, 2003, J BIOL CHEM, V278, P8826, DOI 10.1074/jbc.M209879200; Yaylaoglu MB, 2005, DEV DYNAM, V234, P371, DOI 10.1002/dvdy.20441; ZALIN RJ, 1975, EXP CELL RES, V93, P55, DOI 10.1016/0014-4827(75)90422-X; Zhang XM, 2005, P NATL ACAD SCI USA, V102, P4459, DOI 10.1073/pnas.0501076102	49	52	52	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2011	6	9							e24714	10.1371/journal.pone.0024714	http://dx.doi.org/10.1371/journal.pone.0024714			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZV	21931825	Green Published, gold, Green Submitted			2022-12-25	WOS:000295321800052
J	Ang, SF; Moochhala, SM; MacAry, PA; Bhatia, M				Ang, Seah-Fang; Moochhala, Shabbir M.; MacAry, Paul A.; Bhatia, Madhav			Hydrogen Sulfide and Neurogenic Inflammation in Polymicrobial Sepsis: Involvement of Substance P and ERK-NF-kappa B Signaling	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASES; PUNCTURE-INDUCED SEPSIS; NITRIC-OXIDE PRODUCTION; ACUTE-PANCREATITIS; CECAL LIGATION; GENE-PRODUCTS; SEPTIC SHOCK; LUNG INJURY; IN-VITRO; RECEPTOR	Hydrogen sulfide (H2S) has been shown to induce transient receptor potential vanilloid 1 (TRPV1)-mediated neurogenic inflammation in polymicrobial sepsis. However, endogenous neural factors that modulate this event and the molecular mechanism by which this occurs remain unclear. Therefore, this study tested the hypothesis that whether substance P (SP) is one important neural element that implicates in H2S-induced neurogenic inflammation in sepsis in a TRPV1-dependent manner, and if so, whether H2S regulates this response through activation of the extracellular signal-regulated kinase-nuclear factor-kappa B (ERK-NF-kappa B) pathway. Male Swiss mice were subjected to cecal ligation and puncture (CLP)-induced sepsis and treated with TRPV1 antagonist capsazepine 30 minutes before CLP. DL-propargylglycine (PAG), an inhibitor of H2S formation, was administrated 1 hour before or 1 hour after sepsis, whereas sodium hydrosulfide (NaHS), an H2S donor, was given at the same time as CLP. Capsazepine significantly attenuated H2S-induced SP production, inflammatory cytokines, chemokines, and adhesion molecules levels, and protected against lung and liver dysfunction in sepsis. In the absence of H2S, capsazepine caused no significant changes to the PAG-mediated attenuation of lung and plasma SP levels, sepsis-associated systemic inflammatory response and multiple organ dysfunction. In addition, capsazepine greatly inhibited phosphorylation of ERK1/2 and inhibitory kappa B alpha, concurrent with suppression of NF-kappa B activation even in the presence of NaHS. Furthermore, capsazepine had no effect on PAG-mediated abrogation of these levels in sepsis. Taken together, the present findings show that H2S regulates TRPV1-mediated neurogenic inflammation in polymicrobial sepsis through enhancement of SP production and activation of the ERK-NF-kappa B pathway.	[Ang, Seah-Fang; MacAry, Paul A.] Natl Univ Singapore, Program Immunol, Singapore 117548, Singapore; [Ang, Seah-Fang; MacAry, Paul A.] Natl Univ Singapore, Dept Microbiol, Ctr Life Sci, Singapore 117548, Singapore; [Ang, Seah-Fang; MacAry, Paul A.] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore; [Moochhala, Shabbir M.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117595, Singapore; [Moochhala, Shabbir M.] Def Med & Environm Res Inst, DSO Natl Labs, Singapore, Singapore; [Bhatia, Madhav] Univ Otago, Dept Pathol, Christchurch, New Zealand	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; University of Otago	Ang, SF (corresponding author), Natl Univ Singapore, Program Immunol, Singapore 117548, Singapore.	madhav.bhatia@otago.ac.nz		MacAry, Paul/0000-0002-1139-8996; MOOCHHALA, SHABBIR/0000-0003-4521-3192	National Medical Research Council [R-184-000-111-213, R-184-000-156-213]	National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by National Medical Research Council grants R-184-000-111-213 and R-184-000-156-213. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; Ang SF, 2010, CRIT CARE MED, V38, P619, DOI 10.1097/CCM.0b013e3181c0df00; Beer S, 2002, CRIT CARE MED, V30, P1794, DOI 10.1097/00003246-200208000-00020; BERESFORD IJM, 1995, EUR J PHARMACOL, V272, P241, DOI 10.1016/0014-2999(94)00655-Q; Bhatia M, 2005, IUBMB LIFE, V57, P603, DOI 10.1080/15216540500217875; Bhatia M, 2005, BRIT J PHARMACOL, V145, P141, DOI 10.1038/sj.bjp.0706186; Bhatia M, 2008, J CELL MOL MED, V12, P580, DOI 10.1111/j.1582-4934.2007.00131.x; Bhatia M, 2006, AM J PHYSIOL-LUNG C, V291, pL896, DOI 10.1152/ajplung.00053.2006; Brown MA, 2004, FRONT BIOSCI-LANDMRK, V9, P1201, DOI 10.2741/1304; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Choi MS, 2007, EUR J PHARMACOL, V556, P181, DOI 10.1016/j.ejphar.2006.10.054; Clemons AP, 2002, PANCREAS, V25, P251, DOI 10.1097/00006676-200210000-00007; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Dakhama A, 2005, AM J PHYSIOL-LUNG C, V288, pL761, DOI 10.1152/ajplung.00143.2004; Di Paola R, 2009, INT J IMMUNOPATH PH, V22, P937, DOI 10.1177/039463200902200409; Di Paola R, 2010, PHARMACOL RES, V61, P175, DOI 10.1016/j.phrs.2009.09.008; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; Hui Y, 2003, J INFECTION, V47, P155, DOI 10.1016/S0163-4453(03)00043-4; Jarrar D, 2002, AM J PHYSIOL-LUNG C, V283, pL799, DOI 10.1152/ajplung.00465.2001; Jeong SO, 2006, BIOCHEM BIOPH RES CO, V345, P938, DOI 10.1016/j.bbrc.2006.05.002; Jiang BB, 2004, J BIOL CHEM, V279, P1323, DOI 10.1074/jbc.M307521200; Kew MC, 2000, LANCET, V355, P591, DOI 10.1016/S0140-6736(99)00219-6; LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7; Lau HY, 2005, BIOCHEM BIOPH RES CO, V327, P509, DOI 10.1016/j.bbrc.2004.12.030; Lee SW, 2006, GLIA, V54, P116, DOI 10.1002/glia.20362; Li L, 2008, TRENDS PHARMACOL SCI, V29, P84, DOI 10.1016/j.tips.2007.11.003; Medhurst AD, 1997, BRIT J PHARMACOL, V122, P469, DOI 10.1038/sj.bjp.0701406; Minutoli L, 2005, BIOL REPROD, V73, P730, DOI 10.1095/biolreprod.105.040741; Mok YYP, 2004, BRIT J PHARMACOL, V143, P881, DOI 10.1038/sj.bjp.0706014; MUDD SH, 1965, J BIOL CHEM, V240, P4382; Ng SW, 2008, J LEUKOCYTE BIOL, V83, P288, DOI 10.1189/jlb.0807575; O'Connor TM, 2004, J CELL PHYSIOL, V201, P167, DOI 10.1002/jcp.20061; Okajima K, 2004, J PHARMACOL EXP THER, V309, P684, DOI 10.1124/jpet.103.061150; Patacchini R, 2005, EUR J PHARMACOL, V509, P171, DOI 10.1016/j.ejphar.2005.01.005; Patacchini R, 2004, BRIT J PHARMACOL, V142, P31, DOI 10.1038/sj.bjp.0705764; Pittet JF, 2001, J CLIN INVEST, V107, P1537, DOI 10.1172/JCI11963; PITTET JF, 1994, J CLIN INVEST, V94, P663, DOI 10.1172/JCI117383; Puneet P, 2006, J IMMUNOL, V176, P3813, DOI 10.4049/jimmunol.176.6.3813; Remick DG, 2007, AM J PATHOL, V170, P1435, DOI 10.2353/ajpath.2007.060872; Richardson JD, 2002, J PHARMACOL EXP THER, V302, P839, DOI 10.1124/jpet.102.032797; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Spiller F, 2010, AM J RESP CRIT CARE, V182, P360, DOI 10.1164/rccm.200907-1145OC; Sternberg EM, 2006, NAT REV IMMUNOL, V6, P318, DOI 10.1038/nri1810; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P917, DOI 10.1038/nrd2425; Tamaoki J, 2004, CHEST, V126, P205, DOI 10.1378/chest.126.1.205; Tamizhselvi R, 2009, J PHARMACOL EXP THER, V329, P1166, DOI 10.1124/jpet.109.150532; Trevisani M, 2005, BRIT J PHARMACOL, V145, P1123, DOI 10.1038/sj.bjp.0706277; Veronesi B, 2006, TOXICOL SCI, V89, P1, DOI 10.1093/toxsci/kfj034; Wang P, 1996, AM J PHYSIOL-REG I, V270, pR927, DOI 10.1152/ajpregu.1996.270.5.R927; Yang GD, 2004, FASEB J, V18, P1782, DOI 10.1096/fj.04-2279fje; Yong QC, 2010, NEUROCHEM INT, V56, P508, DOI 10.1016/j.neuint.2009.12.011; Zhang HL, 2006, AM J PHYSIOL-LUNG C, V290, pL1193, DOI 10.1152/ajplung.00489.2005; Zhang HL, 2008, J IMMUNOL, V181, P4320, DOI 10.4049/jimmunol.181.6.4320; Zhang HL, 2007, J IMMUNOL, V179, P4153, DOI 10.4049/jimmunol.179.6.4153; Zhang HL, 2007, AM J PHYSIOL-LUNG C, V292, pL960, DOI 10.1152/ajplung.00388.2006; Zhang L, 2010, MOL MED, V16, P417, DOI 10.2119/molmed.2010.00027; Zhi L, 2007, J LEUKOCYTE BIOL, V81, P1322, DOI 10.1189/jlb.1006599; Zuege D, 1996, AM J PHYSIOL-LUNG C, V271, pL896, DOI 10.1152/ajplung.1996.271.6.L896	59	66	70	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2011	6	9							e24535	10.1371/journal.pone.0024535	http://dx.doi.org/10.1371/journal.pone.0024535			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CO	21931742	Green Published, Green Submitted, gold			2022-12-25	WOS:000294803200025
J	Lin, ACC; Dissanayake, D; Dhanji, S; Elford, AR; Ohashi, PS				Lin, Albert C. C.; Dissanayake, Dilan; Dhanji, Salim; Elford, Alisha R.; Ohashi, Pamela S.			Different Toll-Like Receptor Stimuli Have a Profound Impact on Cytokines Required to Break Tolerance and Induce Autoimmunity	PLOS ONE			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; DENDRITIC CELL ACTIVATION; ANTIGEN-PRESENTING CELLS; NECROSIS-FACTOR-ALPHA; IFN-GAMMA PRODUCTION; CD8 T-CELLS; NF-KAPPA-B; I INTERFERON; IL-12; INTERLEUKIN-12	Although toll-like receptor (TLR) signals are critical for promoting antigen presenting cell maturation, it remains unclear how stimulation via different TLRs influence dendritic cell (DC) function and the subsequent adaptive response in vivo. Furthermore, the relationship between TLR-induced cytokine production by DCs and the consequences on the induction of a functional immune response is not clear. We have established a murine model to examine whether TLR3 or TLR4 mediated DC maturation has an impact on the cytokines required to break tolerance and induce T-cell-mediated autoimmunity. Our study demonstrates that IL-12 is not absolutely required for the induction of a CD8 T-cell-mediated tissue specific immune response, but rather the requirement for IL-12 is determined by the stimuli used to mature the DCs. Furthermore, we found that IFN alpha is a critical pathogenic component of the cytokine milieu that circumvents the requirement for IL-12 in the induction of autoimmunity. These studies illustrate how different TLR stimuli have an impact on DC function and the induction of immunity.	[Lin, Albert C. C.; Dissanayake, Dilan; Dhanji, Salim; Elford, Alisha R.; Ohashi, Pamela S.] Ontario Canc Inst, Campbell Family Inst Breast Canc Res, Toronto, ON M4X 1K9, Canada; [Lin, Albert C. C.; Dissanayake, Dilan; Ohashi, Pamela S.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Ohashi, Pamela S.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto	Lin, ACC (corresponding author), Ontario Canc Inst, Campbell Family Inst Breast Canc Res, 500 Sherbourne St, Toronto, ON M4X 1K9, Canada.	pohashi@uhnres.utoronto.ca		Ohashi, Pamela S./0000-0003-2915-9317; Dissanayake, Dilan/0000-0003-4270-7015	Canadian Institute for Heath Research (CIHR) [FRN 79434]; Ontario Ministry of Health and Long Term Care (OMOHLTC)	Canadian Institute for Heath Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Health and Long Term Care (OMOHLTC)(Ministry of Health and Long-Term Care, Ontario)	This work was supported by the Canadian Institute for Heath Research (CIHR)(grant FRN 79434 http://www.cihr-irsc.gc.ca/e/193.html) to PO. DD is supported by a CIHR studentship. PO holds a Canada Research Chair in Autoimmunity and Tumor Immunity. This research was supported in part by the Ontario Ministry of Health and Long Term Care (OMOHLTC). The views expressed do not necessarily reflect those of the OMOHLTC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aichele P, 2006, J IMMUNOL, V176, P4525, DOI 10.4049/jimmunol.176.8.4525; Akira S, 2003, IMMUNOL LETT, V85, P85, DOI 10.1016/S0165-2478(02)00228-6; Alleva DG, 2000, DIABETES, V49, P1106, DOI 10.2337/diabetes.49.7.1106; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Barrat FJ, 2008, IMMUNOL REV, V223, P271, DOI 10.1111/j.1600-065X.2008.00630.x; BATTEGAY M, 1991, J VIROL METHODS, V33, P191, DOI 10.1016/0166-0934(91)90018-U; Blanco P, 2001, SCIENCE, V294, P1540, DOI 10.1126/science.1064890; Blanco P, 2008, CYTOKINE GROWTH F R, V19, P41, DOI 10.1016/j.cytogfr.2007.10.004; Boonstra A, 2006, J IMMUNOL, V177, P7551, DOI 10.4049/jimmunol.177.11.7551; Collison LW, 2007, NATURE, V450, P566, DOI 10.1038/nature06306; Cousens LP, 1999, J EXP MED, V189, P1315, DOI 10.1084/jem.189.8.1315; Cousens LP, 1997, P NATL ACAD SCI USA, V94, P634, DOI 10.1073/pnas.94.2.634; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Devendra D, 2005, DIABETES, V54, P2549, DOI 10.2337/diabetes.54.9.2549; Eriksson U, 2003, NAT MED, V9, P1484, DOI 10.1038/nm960; Garza KM, 2000, J EXP MED, V191, P2021, DOI 10.1084/jem.191.11.2021; Ghilardi N, 2004, J IMMUNOL, V172, P2827, DOI 10.4049/jimmunol.172.5.2827; Gonnella PA, 2008, J AUTOIMMUN, V31, P180, DOI 10.1016/j.jaut.2008.06.002; Grabie N, 2003, J CLIN INVEST, V111, P671, DOI 10.1172/JCI200316867; Guiducci C, 2006, J EXP MED, V203, P1999, DOI 10.1084/jem.20060401; Haddad W, 2003, J EXP MED, V198, P369, DOI 10.1084/jem.20020691; Hirschfeld M, 2001, INFECT IMMUN, V69, P1477, DOI 10.1128/IAI.69.3.1477-1482.2001; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021; Jiang A, 2007, IMMUNITY, V27, P610, DOI 10.1016/j.immuni.2007.08.015; Joffre O, 2009, IMMUNOL REV, V227, P234, DOI 10.1111/j.1600-065X.2008.00718.x; Kaka AS, 2008, J IMMUNOTHER, V31, P359, DOI 10.1097/CJI.0b013e318165f5d2; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Knippertz I, 2009, J IMMUNOTHER, V32, P524, DOI 10.1097/CJI.0b013e3181a28422; Kolumam GA, 2005, J EXP MED, V202, P637, DOI 10.1084/jem.20050821; Kono DH, 2003, AUTOIMMUNITY, V36, P503, DOI 10.1080/08916930310001624665; Lang KS, 2006, J CLIN INVEST, V116, P2456, DOI 10.1172/JCI28349; Lang KS, 2005, NAT MED, V11, P138, DOI 10.1038/nm1176; Lang PA, 2009, BLOOD, V113, P1045, DOI 10.1182/blood-2007-10-117861; Liu JJ, 2003, J IMMUNOL, V170, P4489, DOI 10.4049/jimmunol.170.9.4489; Longhi MP, 2009, J EXP MED, V206, P1589, DOI 10.1084/jem.20090247; Ma XJ, 2001, ADV IMMUNOL, V79, P55; Magram J, 1996, IMMUNITY, V4, P471, DOI 10.1016/S1074-7613(00)80413-6; Mannon PJ, 2004, NEW ENGL J MED, V351, P2069, DOI 10.1056/NEJMoa033402; Mattner F, 1996, EUR J IMMUNOL, V26, P1553, DOI 10.1002/eji.1830260722; Menges M, 2002, J EXP MED, V195, P15, DOI 10.1084/jem.20011341; Mescher MF, 2007, SEMIN IMMUNOL, V19, P153, DOI 10.1016/j.smim.2007.02.007; Mescher MF, 2006, IMMUNOL REV, V211, P81, DOI 10.1111/j.0105-2896.2006.00382.x; Monteiro JM, 1998, J VIROL, V72, P4825, DOI 10.1128/JVI.72.6.4825-4831.1998; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Nguyen LT, 2002, J EXP MED, V195, P423, DOI 10.1084/jem.20010032; Nitta Y, 2001, J AUTOIMMUN, V16, P97, DOI 10.1006/jaut.2000.0469; OHASHI PS, 1991, CELL, V65, P305, DOI 10.1016/0092-8674(91)90164-T; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Orange JS, 1996, J IMMUNOL, V156, P1138; Oxenius A, 1999, J IMMUNOL, V162, P965; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Re F, 2001, J BIOL CHEM, V276, P37692, DOI 10.1074/jbc.M105927200; Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038/nri1845; Rifkin IR, 2005, IMMUNOL REV, V204, P27, DOI 10.1111/j.0105-2896.2005.00239.x; Schijns VECJ, 1998, J IMMUNOL, V160, P3958; Skokos D, 2007, J EXP MED, V204, P1525, DOI 10.1084/jem.20062305; Sporri R, 2005, NAT IMMUNOL, V6, P163, DOI 10.1038/ni1162; Su Z, 2008, CLIN CANCER RES, V14, P6207, DOI 10.1158/1078-0432.CCR-08-0309; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Trembleau S, 2003, J IMMUNOL, V170, P5491, DOI 10.4049/jimmunol.170.11.5491; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Wakkach A, 2003, IMMUNITY, V18, P605, DOI 10.1016/S1074-7613(03)00113-4; Waldner H, 2004, J CLIN INVEST, V113, P990, DOI 10.1172/JCI200419388; WEIDT G, 1995, J VIROL, V69, P7147, DOI 10.1128/JVI.69.11.7147-7151.1995; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yang ZD, 2003, ANN NY ACAD SCI, V1005, P409, DOI 10.1196/annals.1288.069	70	16	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2011	6	9							e23940	10.1371/journal.pone.0023940	http://dx.doi.org/10.1371/journal.pone.0023940			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CO	21931625	Green Published, gold, Green Submitted			2022-12-25	WOS:000294803200006
J	Sack, I; Streitberger, KJ; Krefting, D; Paul, F; Braun, J				Sack, Ingolf; Streitberger, Kaspar-Josche; Krefting, Dagmar; Paul, Friedemann; Braun, Juergen			The Influence of Physiological Aging and Atrophy on Brain Viscoelastic Properties in Humans	PLOS ONE			English	Article							MAGNETIC-RESONANCE ELASTOGRAPHY; IN-VIVO; RECONSTRUCTION; BEHAVIOR; NEURONS	Physiological aging of the brain is accompanied by ubiquitous degeneration of neurons and oligodendrocytes. An alteration of the cellular matrix of an organ impacts its macroscopic viscoelastic properties which can be detected by magnetic resonance elastography (MRE) - to date the only method for measuring brain mechanical parameters without intervention. However, the wave patterns detected by MRE are affected by atrophic changes in brain geometry occurring in an individual's life span. Moreover, regional variability in MRE-detected age effects is expected corresponding to the regional variation in atrophy. Therefore, the sensitivity of brain MRE to brain volume and aging was investigated in 66 healthy volunteers aged 18-72. A linear decline in whole-brain elasticity was observed (-0.75%/year, R-square = 0.59, p<0.001); the rate is three times that determined by volume measurements (-0.23%/year, R-square = 0.4, p<0.001). The highest decline in elasticity (-0.92%/year, R-square = 0.43, p<0.001) was observed in a region of interest placed in the frontal lobe with minimal age-related shrinkage (-0.1%, R-square = 0.06, p = 0.043). Our results suggest that cerebral MRE can measure geometry-independent viscoelastic parameters related to intrinsic tissue structure and altered by age.	[Sack, Ingolf; Streitberger, Kaspar-Josche] Charite, Dept Radiol, D-13353 Berlin, Germany; [Krefting, Dagmar; Braun, Juergen] Charite, Inst Med Informat, D-13353 Berlin, Germany; [Paul, Friedemann] Charite, NeuroCure Clin Res Ctr, D-13353 Berlin, Germany; [Paul, Friedemann] Charite, Expt & Clin Res Ctr, D-13353 Berlin, Germany; [Paul, Friedemann] Max Delbruck Ctr Mol Med, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Sack, I (corresponding author), Charite, Dept Radiol, Campus Mitte, D-13353 Berlin, Germany.	ingolf.sack@charite.de	Paul, Friedemann/ABF-9415-2020	Braun, Jurgen/0000-0001-5183-7546; Krefting, Dagmar/0000-0002-7238-5339; paul, friedemann/0000-0002-6378-0070	German Research Foundation DFG [Sa901/3, Br2235/3, Exc. 257]	German Research Foundation DFG(German Research Foundation (DFG))	This work was supported by the German Research Foundation DFG (Sa901/3 to I.S., Br2235/3 to J.B., Exc. 257 to F.P.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atay SM, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2899575; Courchesne E, 2000, RADIOLOGY, V216, P672, DOI 10.1148/radiology.216.3.r00au37672; Green MA, 2008, NMR BIOMED, V21, P755, DOI 10.1002/nbm.1254; Gurtovenko AA, 2005, ADV POLYM SCI, V182, P171, DOI 10.1007/b135561; Hamhaber U, 2007, ACTA BIOMATER, V3, P127, DOI 10.1016/j.actbio.2006.08.007; Klatt D, 2007, PHYS MED BIOL, V52, P7281, DOI 10.1088/0031-9155/52/24/006; Klatt D, 2010, PHYS MED BIOL, V55, P6445, DOI 10.1088/0031-9155/55/21/007; Kochunov P, 2005, HUM BRAIN MAPP, V26, P210, DOI 10.1002/hbm.20198; Kruse SA, 2008, NEUROIMAGE, V39, P231, DOI 10.1016/j.neuroimage.2007.08.030; Lemaitre H, 2005, NEUROIMAGE, V26, P900, DOI 10.1016/j.neuroimage.2005.02.042; Lu YB, 2006, P NATL ACAD SCI USA, V103, P17759, DOI 10.1073/pnas.0606150103; Morrison JH, 1997, SCIENCE, V278, P412, DOI 10.1126/science.278.5337.412; Murphy MC, 2010, MAGN RESON IMAGING; Muthupillai R, 1996, NAT MED, V2, P601, DOI 10.1038/nm0596-601; Oliphant TE, 2001, MAGNET RESON MED, V45, P299, DOI 10.1002/1522-2594(200102)45:2<299::AID-MRM1039>3.0.CO;2-O; Papazoglou S, 2009, PHYS MED BIOL, V54, P2229, DOI 10.1088/0031-9155/54/7/025; Park E, 2006, PHYS MED BIOL, V51, P3697, DOI 10.1088/0031-9155/51/15/007; Pattison AJ, 2010, J BIOMECH; Perrinez PR, 2009, IEEE T BIO-MED ENG, V56, P598, DOI 10.1109/TBME.2008.2009928; Resnick SM, 2003, J NEUROSCI, V23, P3295; Romano AJ, 2005, MAGN RESON MED, V54, P893, DOI 10.1002/mrm.20607; Sack I, 2008, NMR BIOMED, V21, P265, DOI 10.1002/nbm.1189; Sack I, 2009, NEUROIMAGE, V46, P652, DOI 10.1016/j.neuroimage.2009.02.040; Streitberger KJ, 2011, NMR BIOMED, V24, P385, DOI 10.1002/nbm.1602; Vappou J, 2008, J BIOMECH, V41, P2954, DOI 10.1016/j.jbiomech.2008.07.034; Wuerfel J, 2010, NEUROIMAGE, V49, P2520, DOI 10.1016/j.neuroimage.2009.06.018; Xu L, 2007, ACTA RADIOL, V48, P327, DOI 10.1080/02841850701199967	27	108	108	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2011	6	9							e23451	10.1371/journal.pone.0023451	http://dx.doi.org/10.1371/journal.pone.0023451			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CO	21931599	Green Published, Green Accepted, gold			2022-12-25	WOS:000294803200003
J	Centeno-Cuadros, A; Roman, J; Delibes, M; Godoy, JA				Centeno-Cuadros, Alejandro; Roman, Jacinto; Delibes, Miguel; Antonio Godoy, Jose			Prisoners in Their Habitat? Generalist Dispersal by Habitat Specialists: A Case Study in Southern Water Vole (Arvicola sapidus)	PLOS ONE			English	Article							GENETIC-STRUCTURE; POPULATION-STRUCTURE; DISTANCE; INDIVIDUALS; TERRESTRIS; FLOW; LANDSCAPE; DIFFERENTIATION; METAPOPULATION; CONNECTIVITY	Habitat specialists inhabiting scarce and scattered habitat patches pose interesting questions related to dispersal such as how specialized terrestrial mammals do to colonize distant patches crossing hostile matrices. We assess dispersal patterns of the southern water vole (Arvicola sapidus), a habitat specialist whose habitat patches are distributed through less than 2% of the study area (overall 600 km(2)) and whose populations form a dynamic metapopulational network. We predict that individuals will require a high ability to move through the inhospitable matrix in order to avoid genetic and demographic isolations. Genotypes (N = 142) for 10 microsatellites and sequences of the whole mitochondrial Control Region (N = 47) from seven localities revealed a weak but significant genetic structure partially explained by geographic distance. None of the landscape models had a significant effect on genetic structure over that of the Euclidean distance alone and no evidence for efficient barriers to dispersal was found. Contemporary gene flow was not severely limited for A. sapidus as shown by high migration rates estimates (>10%) between non-neighbouring areas. Sex-biased dispersal tests did not support differences in dispersal rates, as shown by similar average axial parent-offspring distances, in close agreement with capture-mark-recapture estimates. As predicted, our results do not support any preferences of the species for specific landscape attributes on their dispersal pathways. Here, we combine field and molecular data to illustrate how a habitat specialist mammal might disperse like a habitat generalist, acquiring specific long-distance dispersal strategies as an adaptation to patchy, naturally fragmented, heterogeneous and unstable habitats.	[Centeno-Cuadros, Alejandro; Roman, Jacinto; Delibes, Miguel] CSIC, Dept Conservat Biol, Estn Biol Donana, E-41080 Seville, Spain; [Antonio Godoy, Jose] CSIC, Dept Integrat Ecol, Estn Biol Donana, E-41080 Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Centeno-Cuadros, A (corresponding author), CSIC, Dept Conservat Biol, Estn Biol Donana, E-41080 Seville, Spain.	acenteno@cc.huji.ac.il	Delibes, Miguel/K-2744-2014; Godoy, José Antonio/B-9288-2008; Centeno-Cuadros, Alejandro/H-1057-2016	Delibes, Miguel/0000-0002-3569-567X; Godoy, José Antonio/0000-0001-7502-9471; Centeno-Cuadros, Alejandro/0000-0003-4210-1128	Direccion General de Investigacion [BOS2001-2391-C02-01]; Ministerio de Educacion y Ciencia	Direccion General de Investigacion(Spanish Government); Ministerio de Educacion y Ciencia(Spanish Government)	This work has been funded by the Direccion General de Investigacion (project BOS2001-2391-C02-01). ACC benefited from a FPU fellowship from the Ministerio de Educacion y Ciencia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aars J, 2006, MOL ECOL, V15, P1455, DOI 10.1111/j.1365-294X.2006.02889.x; Belkhir K, 1996, 5171 CNRS UMR U MONT; Berthier K, 2006, MOL ECOL, V15, P2665, DOI 10.1111/j.1365-294X.2006.02959.x; Berthier K, 2005, MOL ECOL, V14, P2861, DOI 10.1111/j.1365-294X.2005.02636.x; Broquet T, 2006, MOL ECOL, V15, P1689, DOI 10.1111/j.1365-294X.2006.02878.x; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Centeno-Cuadros A, 2009, J ZOOL, V279, P404, DOI 10.1111/j.1469-7998.2009.00632.x; Centeno-Cuadros A, 2009, MOL ECOL, V18, P3652, DOI 10.1111/j.1365-294X.2009.04297.x; Centeno-Cuadros A, 2010, MITOCHONDR DNA, V21, P48, DOI 10.3109/19401731003681103; Corander J, 2006, MOL ECOL, V15, P2833, DOI 10.1111/j.1365-294X.2006.02994.x; Crochet PA, 2000, MOL ECOL, V9, P1463, DOI 10.1046/j.1365-294x.2000.01026.x; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fedriani JM, 2002, ECOSCIENCE, V9, P12, DOI 10.1080/11956860.2002.11682685; Figuerola J, 2002, FRESHWATER BIOL, V47, P483, DOI 10.1046/j.1365-2427.2002.00829.x; Fisher DO, 2009, POPUL ECOL, V51, P289, DOI 10.1007/s10144-008-0122-4; Fortuna MA, 2009, P NATL ACAD SCI USA, V106, P19044, DOI 10.1073/pnas.0907704106; Goudet J, 2002, MOL ECOL, V11, P1103, DOI 10.1046/j.1365-294X.2002.01496.x; Goudet J., 2001, FSTAT PROGRAM ESTIMA; Guillot G, 2009, MOL ECOL, V18, P4734, DOI 10.1111/j.1365-294X.2009.04410.x; Hansen MM, 1997, MOL ECOL, V6, P469, DOI 10.1046/j.1365-294X.1997.t01-1-00202.x; HANSSON L, 1991, BIOL J LINN SOC, V42, P89, DOI 10.1111/j.1095-8312.1991.tb00553.x; Hedrick PW, 1999, EVOLUTION, V53, P313, DOI 10.1111/j.1558-5646.1999.tb03767.x; HELLBERG ME, 1994, EVOLUTION, V48, P1829, DOI 10.1111/j.1558-5646.1994.tb02218.x; Hubbell Stephen P., 2001, V32, pi; HUDSON RR, 1992, GENETICS, V132, P583; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Koenig WD, 1996, TRENDS ECOL EVOL, V11, P514, DOI 10.1016/S0169-5347(96)20074-6; LAMBIN X, 1994, ECOLOGY, V75, P224, DOI 10.2307/1939396; Lambin X, 2001, DISPERSAL; Lambin Xavier, 2004, P515, DOI 10.1016/B978-012323448-3/50023-4; Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9; Nathan R, 2008, TRENDS ECOL EVOL, V23, P638, DOI 10.1016/j.tree.2008.08.003; NEI M, 1978, GENETICS, V89, P583; Palomares F, 2000, CONSERV BIOL, V14, P809, DOI 10.1046/j.1523-1739.2000.98539.x; Piertney SB, 2005, MOL ECOL, V14, P1435, DOI 10.1111/j.1365-294X.2005.02496.x; Pinto SM, 2010, AM NAT, V175, P675, DOI 10.1086/652467; Pocock MJO, 2005, BIOL J LINN SOC, V84, P565, DOI 10.1111/j.1095-8312.2005.00455.x; Pritchard JK, 2000, GENETICS, V155, P945; Ray N, 2005, MOL ECOL NOTES, V5, P177, DOI 10.1111/j.1471-8286.2004.00843.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Roman J, 2007, THESIS U AUTONOMA MA, P192; Ronce O, 2007, ANNU REV ECOL EVOL S, V38, P231, DOI 10.1146/annurev.ecolsys.38.091206.095611; Rousset F, 1997, GENETICS, V145, P1219; Rousset F, 2000, J EVOLUTION BIOL, V13, P58; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sacks BN, 2008, MOL BIOL EVOL, V25, P1384, DOI 10.1093/molbev/msn082; Schadt S, 2002, ECOL APPL, V12, P1469; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Schwartz MK, 2009, CONSERV GENET, V10, P441, DOI 10.1007/s10592-008-9622-1; Schweizer M, 2007, MOL ECOL, V16, P2463, DOI 10.1111/j.1365-294X.2007.03284.x; Snyder RE, 2004, AM NAT, V164, P633, DOI 10.1086/424969; Spiegel O, 2007, ECOL LETT, V10, P718, DOI 10.1111/j.1461-0248.2007.01062.x; Stacy JE, 1997, MOL ECOL, V6, P751, DOI 10.1046/j.1365-294X.1997.d01-470.x; Stenseth NC, 1992, ANIMAL DISPERSAL SMA; Stewart WA, 1999, BIOL J LINN SOC, V68, P159, DOI 10.1111/j.1095-8312.1999.tb01164.x; Stewart WA, 1998, MOL ECOL, V7, P1258; Telfer S, 2003, MOL ECOL, V12, P1939, DOI 10.1046/j.1365-294X.2003.01859.x; Telfer S, 2001, OIKOS, V95, P31, DOI 10.1034/j.1600-0706.2001.950104.x; Van de Zande L, 2000, MOL ECOL, V9, P1651, DOI 10.1046/j.1365-294x.2000.01051.x; Wilson GA, 2003, GENETICS, V163, P1177	62	29	31	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2011	6	9							e24613	10.1371/journal.pone.0024613	http://dx.doi.org/10.1371/journal.pone.0024613			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CN	21931775	Green Published, gold			2022-12-25	WOS:000294803100047
J	Judkowski, V; Bunying, A; Ge, F; Appel, JR; Law, K; Sharma, A; Raja-Gabaglia, C; Norori, P; Santos, RG; Giulianotti, MA; Slifka, MK; Douek, DC; Graham, BS; Pinilla, C				Judkowski, Valeria; Bunying, Alcinette; Ge, Feng; Appel, Jon R.; Law, Kingyee; Sharma, Atima; Raja-Gabaglia, Claudia; Norori, Patricia; Santos, Radleigh G.; Giulianotti, Marc A.; Slifka, Mark K.; Douek, Daniel C.; Graham, Barney S.; Pinilla, Clemencia			GM-CSF Production Allows the Identification of Immunoprevalent Antigens Recognized by Human CD4+T Cells Following Smallpox Vaccination	PLOS ONE			English	Article							CD4(+) T-CELLS; CYTOKINE EXPRESSION PATTERNS; VACCINIA VIRUS; IMMUNE-RESPONSE; IMMUNOLOGICAL MEMORY; ANTIVIRAL IMMUNITY; ANTIBODY-RESPONSES; BINDING PROTEIN; PEPTIDE LIGANDS; INFECTION	The threat of bioterrorism with smallpox and the broad use of vaccinia vectors for other vaccines have led to the resurgence in the study of vaccinia immunological memory. The importance of the role of CD4+ T cells in the control of vaccinia infection is well known. However, more CD8+ than CD4+ T cell epitopes recognized by human subjects immunized with vaccinia virus have been reported. This could be, in part, due to the fact that most of the studies that have identified human CD4+ specific protein-derived fragments or peptides have used IFN-gamma production to evaluate vaccinia specific T cell responses. Based on these findings, we reasoned that analyzing a large panel of cytokines would permit us to generate a more complete analysis of the CD4 T cell responses. The results presented provide clear evidence that TNF-alpha is an excellent readout of vaccinia specificity and that other cytokines such as GM-CSF can be used to evaluate the reactivity of CD4+ T cells in response to vaccinia antigens. Furthermore, using these cytokines as readout of vaccinia specificity, we present the identification of novel peptides from immunoprevalent vaccinia proteins recognized by CD4+ T cells derived from smallpox vaccinated human subjects. In conclusion, we describe a "T cell- driven'' methodology that can be implemented to determine the specificity of the T cell response upon vaccination or infection. Together, the single pathogen in vitro stimulation, the selection of CD4+ T cells specific to the pathogen by limiting dilution, the evaluation of pathogen specificity by detecting multiple cytokines, and the screening of the clones with synthetic combinatorial libraries, constitutes a novel and valuable approach for the elucidation of human CD4+ T cell specificity in response to large pathogens.	[Judkowski, Valeria; Bunying, Alcinette; Ge, Feng; Appel, Jon R.; Law, Kingyee; Sharma, Atima; Raja-Gabaglia, Claudia; Norori, Patricia; Pinilla, Clemencia] Torrey Pines Inst Mol Studies, San Diego, CA USA; [Santos, Radleigh G.; Giulianotti, Marc A.] Torrey Pines Inst Mol Studies, Port St Lucie, FL USA; [Slifka, Mark K.] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR USA; [Douek, Daniel C.; Graham, Barney S.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA	Torrey Pines Institute for Molecular Studies, California; Torrey Pines Institute for Molecular Studies, Florida; Oregon Health & Science University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Judkowski, V (corresponding author), Torrey Pines Inst Mol Studies, San Diego, CA USA.	pinilla@tpims.org	Graham, Barney S./AAC-5898-2019	Graham, Barney S./0000-0001-8112-0853; Giulianotti, Marc/0000-0002-2232-3789	National Institute of Allergy and Immunology [HHSN266200400080C/N01-AI-40080]; State of Florida, Executive Office of the Governor's Office of Tourism, Trade, and Economic Development; Multiple Sclerosis National Research Institute [UO1 AI082196, R44 AI079898]; Oregon National Primate Research Center [RR00163]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000163, K01RR000163] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI082196, R44AI079898] Funding Source: NIH RePORTER	National Institute of Allergy and Immunology; State of Florida, Executive Office of the Governor's Office of Tourism, Trade, and Economic Development; Multiple Sclerosis National Research Institute; Oregon National Primate Research Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was supported by National Institute of Allergy and Immunology HHSN266200400080C/N01-AI-40080 (C.P.) as well as the State of Florida, Executive Office of the Governor's Office of Tourism, Trade, and Economic Development (M.G. and R.S.); Multiple Sclerosis National Research Institute (C.P. and V.J.), UO1 AI082196 (M.K.S.), R44 AI079898 (M.K.S.); and Oregon National Primate Research Center grant RR00163 (M.K.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla AO, 2003, SCAND J IMMUNOL, V58, P601, DOI 10.1111/j.1365-3083.2003.01348.x; Amanna IJ, 2006, IMMUNOL REV, V211, P320, DOI 10.1111/j.0105-2896.2006.00392.x; Amanna IJ, 2011, VIROLOGY, V411, P206, DOI 10.1016/j.virol.2010.12.016; Amara RR, 2004, J VIROL, V78, P3811, DOI 10.1128/JVI.78.8.3811-3816.2004; Assarsson E, 2008, P NATL ACAD SCI USA, V105, P2140, DOI 10.1073/pnas.0711573105; Barsov EV, 2006, IMMUNOL LETT, V105, P26, DOI 10.1016/j.imlet.2005.11.028; Benhnia MREI, 2008, J VIROL, V82, P3751, DOI 10.1128/JVI.02244-07; Billiau A, 2009, CYTOKINE GROWTH F R, V20, P97, DOI 10.1016/j.cytogfr.2009.02.004; Borras-Cuesta F, 2000, HUM IMMUNOL, V61, P266, DOI 10.1016/S0198-8859(99)00153-6; Calvo-Calle JM, 2007, PLOS PATHOG, V3, P1511, DOI 10.1371/journal.ppat.0030144; Crotty S, 2003, J IMMUNOL, V171, P4969, DOI 10.4049/jimmunol.171.10.4969; Davies DH, 2008, J VIROL, V82, P652, DOI 10.1128/JVI.01706-07; Davies DH, 2005, P NATL ACAD SCI USA, V102, P547, DOI 10.1073/pnas.0408782102; Faist B, 2010, CLIN VACCINE IMMUNOL, V17, P986, DOI 10.1128/CVI.00455-09; Hammarlund E, 2003, NAT MED, V9, P1131, DOI 10.1038/nm917; Hammarlund E, 2010, J VIROL, V84, P12754, DOI 10.1128/JVI.01763-10; Hemmer B, 1999, NAT MED, V5, P1375; HOUGHTEN RA, 1985, P NATL ACAD SCI USA, V82, P5131, DOI 10.1073/pnas.82.15.5131; Howell MD, 2006, IMMUNITY, V24, P341, DOI 10.1016/j.immuni.2006.02.006; Huaman MC, 2008, J IMMUNOL, V180, P1451, DOI 10.4049/jimmunol.180.3.1451; Davies DH, 2007, PROTEOMICS, V7, P1678, DOI 10.1002/pmic.200600926; Jing L, 2008, J VIROL, V82, P7120, DOI 10.1128/JVI.00453-08; Jing L, 2007, J IMMUNOL, V178, P6374, DOI 10.4049/jimmunol.178.10.6374; Jing LC, 2009, J IMMUNOL METHODS, V347, P36, DOI 10.1016/j.jim.2009.05.011; Kennedy RB, 2010, VIROLOGY, V408, P232, DOI 10.1016/j.virol.2010.09.013; Lewinsohn DA, 2007, PLOS PATHOG, V3, P1240, DOI 10.1371/journal.ppat.0030127; LITTAURA RA, 1992, J VIROL, V66, P2274, DOI 10.1128/JVI.66.4.2274-2280.1992; Liu LZ, 2005, J VIROL, V79, P7363, DOI 10.1128/JVI.79.12.7363-7370.2005; Mangada MM, 2005, J IMMUNOL, V175, P2676, DOI 10.4049/jimmunol.175.4.2676; Markovic-Plese S, 2005, J NEUROIMMUNOL, V169, P31, DOI 10.1016/j.jneuroim.2005.07.014; McKinney BA, 2006, J INFECT DIS, V194, P444, DOI 10.1086/505503; MILLER G, 1973, P NATL ACAD SCI USA, V70, P190, DOI 10.1073/pnas.70.1.190; Mitra-Kaushik S, 2007, J IMMUNOL, V179, P1303, DOI 10.4049/jimmunol.179.2.1303; Moise L, 2009, VACCINE, V27, P6471, DOI 10.1016/j.vaccine.2009.06.018; Mueller H, 2008, CYTOKINE, V43, P143, DOI 10.1016/j.cyto.2008.05.002; Nino-Vasquez JJ, 2004, MOL IMMUNOL, V40, P1063, DOI 10.1016/j.molimm.2003.11.005; Nuara AA, 2008, P NATL ACAD SCI USA, V105, P1861, DOI 10.1073/pnas.0705753105; Parrino J, 2007, VACCINE, V25, P1513, DOI 10.1016/j.vaccine.2006.10.047; PINILLA C, 1994, BIOCHEM J, V301, P847, DOI 10.1042/bj3010847; PUISSANTLUBRANO B, 2010, J CLIN INVEST; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Reif DM, 2009, GENES IMMUN, V10, P112, DOI 10.1038/gene.2008.80; Rock MT, 2005, J IMMUNOL, V174, P3757, DOI 10.4049/jimmunol.174.6.3757; Rosenthal SR, 2001, EMERG INFECT DIS, V7, P920, DOI 10.3201/eid0706.010602; Rubio-Godoy V, 2002, EUR J IMMUNOL, V32, P2292, DOI 10.1002/1521-4141(200208)32:8<2292::AID-IMMU2292>3.0.CO;2-K; Ryan JE, 2009, J IMMUNOL METHODS, V341, P97, DOI 10.1016/j.jim.2008.11.001; Sakala IG, 2007, J VIROL, V81, P3346, DOI 10.1128/JVI.01927-06; Scriba TJ, 2010, EUR J IMMUNOL, V40, P279, DOI 10.1002/eji.200939754; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Sette A, 2008, IMMUNITY, V28, P847, DOI 10.1016/j.immuni.2008.04.018; Shi YF, 2006, CELL RES, V16, P126, DOI 10.1038/sj.cr.7310017; Sivapalasingam S, 2007, J INFECT DIS, V195, P1151, DOI 10.1086/512161; Sorkness RL, 2002, J ALLERGY CLIN IMMUN, V110, P607, DOI 10.1067/mai.2002.128241; Sospedra Mireia, 2005, PLoS Pathog, V1, pe41; Strug I, 2008, J PROTEOME RES, V7, P2703, DOI 10.1021/pr700780x; Tang J, 2006, J VIROL, V80, P10010, DOI 10.1128/JVI.00601-06; TOPALIAN SL, 1994, P NATL ACAD SCI USA, V91, P9461, DOI 10.1073/pnas.91.20.9461; Ullenhag GJ, 2006, CLIN CANCER RES, V12, P7389, DOI 10.1158/1078-0432.CCR-06-1003; Venturini S, 2006, EUR J IMMUNOL, V36, P27, DOI 10.1002/eji.200425767; Zaunders JJ, 2006, J VIROL, V80, P10151, DOI 10.1128/JVI.02670-05; ZHAO Y, 2001, TEST WEB BASED T CEL, P493; Zhao YD, 2001, J IMMUNOL, V167, P2130, DOI 10.4049/jimmunol.167.4.2130	62	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2011	6	9							e24091	10.1371/journal.pone.0024091	http://dx.doi.org/10.1371/journal.pone.0024091			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CN	21931646	Green Published, Green Submitted, gold			2022-12-25	WOS:000294803100012
J	Oksanen, T; Kawachi, I; Kouvonen, A; Suzuki, E; Takao, S; Sjosten, N; Virtanen, M; Pentti, J; Vahtera, J; Kivimaki, M				Oksanen, Tuula; Kawachi, Ichiro; Kouvonen, Anne; Suzuki, Etsuji; Takao, Soshi; Sjosten, Noora; Virtanen, Marianna; Pentti, Jaana; Vahtera, Jussi; Kivimaki, Mika			Workplace Social Capital and Adherence to Antihypertensive Medication: A Cohort Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; TIME PHYSICAL-ACTIVITY; DRUG-THERAPY; MULTILEVEL ANALYSIS; PHARMACY RECORDS; BLOOD-PRESSURE; HEALTH; PARTICIPATION; PREDICTOR; HYPERTENSION	Background: While hypertension is a common and treatable health problem, adherence to antihypertensive medication remains a challenge. This study examines the hypothesis that workplace social capital may influence adherence to antihypertensive medication among hypertensive employees. Methodology/Principal Findings: We linked survey responses to nationwide pharmacy records for a cohort of 3515 hypertensive employees (mean age 53.9 years, 76% women) who required continuous antihypertensive drug therapy (the Finnish Public Sector study). A standard scale was used to measure workplace social capital from co-workers' assessments and self-reports in 2000-2004. Non-adherence to antihypertensive medication was determined based on the number of days-not-treated at the year following the survey using comprehensive prescription records. Negative binomial regression models were conducted adjusting for socio-demographic characteristics, duration of hypertension, behaviour-related risk factors, and co-morbid conditions. The overall rate of days-not-treated was 20.7 per person-year (78% had no days-not-treated). Higher age, obesity, and presence of somatic co-morbidities were all associated with better adherence, but this was not the case for co-worker-assessed or self-reported workplace social capital. The rate of days-not-treated was 19.7 per person-year in the bottom fourth of co-worker-assessed workplace social capital, compared to 20.4 in the top fourth. The corresponding rate ratio from the fully-adjusted model was 0.95 (95% confidence interval (CI) 0.58-1.56). In a subgroup of 907 new users of antihypertensive medication this rate ratio was 0.98 (95% CI 0.42-2.29). Conclusions/Significance: We found no consistent evidence to support the hypothesized effect of workplace social capital on adherence to drug therapy among employees with chronic hypertension.	[Oksanen, Tuula; Sjosten, Noora; Virtanen, Marianna; Pentti, Jaana; Vahtera, Jussi; Kivimaki, Mika] Finnish Inst Occupat Hlth, Helsinki, Finland; [Oksanen, Tuula; Kawachi, Ichiro] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA; [Kouvonen, Anne] Wroclaw Fac, Warsaw Sch Social Sci & Humanities, Wroclaw, Poland; [Suzuki, Etsuji; Takao, Soshi] Okayama Univ, Dept Epidemiol, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan; [Vahtera, Jussi] Univ Turku, Dept Publ Hlth, Turku, Finland; [Vahtera, Jussi] Turku Univ Hosp, FIN-20520 Turku, Finland; [Kivimaki, Mika] UCL, Dept Epidemiol & Publ Hlth, Sch Med, London, England; [Kivimaki, Mika] Univ Helsinki, Dept Behav Sci, Helsinki, Finland	Finnish Institute of Occupational Health; Harvard University; Harvard T.H. Chan School of Public Health; SWPS University of Social Sciences & Humanities; Okayama University; University of Turku; University of Turku; University of London; University College London; UCL Medical School; University of Helsinki	Oksanen, T (corresponding author), Finnish Inst Occupat Hlth, Helsinki, Finland.	tuula.oksanen@ttl.fi	Vahtera, Jussi/J-3271-2013; Kivimaki, Mika/B-3607-2012; Suzuki, Etsuji/B-2342-2011; Oksanen, Tuula/AAK-5599-2021	Kivimaki, Mika/0000-0002-4699-5627; Suzuki, Etsuji/0000-0002-1290-5793; Kouvonen, Anne/0000-0001-6997-8312	Academy of Finland [124271, 124322, 126602 129262, 132944]; municipalities of Vantaa; Espoo; Turku; Tampere; Oulu; Raisio; Naantali; Valkeakoski; Nokia; Virrat; Hospital Districts of Southwest Finland; Pirkanmaa; Vaasa; Kanta-Hame; Pohjois-Pohjanmaa; Helsinki and Uusimaa; Otto A Malm Foundation; Finnish Medical Foundation; National Heart, Lung, and Blood Institute [R01HL03610]; National Institute on Aging at the National Institutes of Health [R01AG034454]; BUPA Foundation, UK; European Union; ESRC [ES/G007438/1] Funding Source: UKRI; MRC [G0902037] Funding Source: UKRI; British Heart Foundation [RG/07/008/23674] Funding Source: researchfish; Economic and Social Research Council [ES/G007438/1] Funding Source: researchfish; Medical Research Council [G19/35, G0902037, G0100222, G8802774] Funding Source: researchfish; NATIONAL INSTITUTE ON AGING [R01AG034454] Funding Source: NIH RePORTER	Academy of Finland(Academy of Finland); municipalities of Vantaa; Espoo; Turku; Tampere; Oulu; Raisio; Naantali; Valkeakoski; Nokia(Nokia Corporation); Virrat; Hospital Districts of Southwest Finland; Pirkanmaa; Vaasa; Kanta-Hame; Pohjois-Pohjanmaa; Helsinki and Uusimaa; Otto A Malm Foundation; Finnish Medical Foundation; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); BUPA Foundation, UK; European Union(European Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Academy of Finland http://www.aka.fi/(grant numbers 124271, 124322, 126602 129262, and 132944) and the participating organizations (municipalities of Vantaa (http://www.vantaa.fi/), Espoo (http://www.espoo.fi/), Turku (http://www.turku.fi/), Tampere (http://www.tampere.fi/), Oulu (http://www.oulu.fi/), Raisio (http://www.raisio.fi/), Naantali (http://www.naantali.fi/), Valkeakoski (http://www.valkeakoski.fi/), Nokia (www.nokiankaupunki.fi), Virrat (http://www.virrat.fi/), and Hospital Districts of Southwest Finland (http://www.vsshp.fi/), Pirkanmaa (http://www.pshp.fi/), Vaasa (http://www.vshp.fi/), Kanta-Hame (http://www.khshp.fi/), Pohjois-Pohjanmaa (http://www.ppshp.fi/), and Helsinki and Uusimaa (http://www.hus.fi/). Tuula Oksanen is supported by the Otto A Malm Foundation http://www.ottomalm.fi/ and the Finnish Medical Foundation http://www.suomenlaaketieteensaatio.fi/. Mika Kivimaki is supported by the National Heart, Lung, and Blood Institute http://www.nhlbi.nih.gov/(R01HL03610); National Institute on Aging at the National Institutes of Health http://www.nia.nih.gov/(R01AG034454); the BUPA Foundation, UK, http://www.bupafoundation.com/ and the European Union NEW OSH ERA research programme http://www.newoshera.eu/ The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baum FE, 2003, J EPIDEMIOL COMMUN H, V57, P320, DOI 10.1136/jech.57.5.320; Berkman LF, 2000, SOC SCI MED, V51, P843, DOI 10.1016/S0277-9536(00)00065-4; Luz TCB, 2011, CAD SAUDE PUBLICA, V27, P269, DOI 10.1590/S0102-311X2011000200008; Briesacher BA, 2009, AM J MANAG CARE, V15, P450; Burnier M, 2006, AM J HYPERTENS, V19, P1190, DOI 10.1016/j.amjhyper.2006.04.006; Caetano PA, 2006, CLIN THER, V28, P1411, DOI 10.1016/j.clinthera.2006.09.021; Chapman RH, 2005, ARCH INTERN MED, V165, P1147, DOI 10.1001/archinte.165.10.1147; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Choo PW, 1999, MED CARE, V37, P846, DOI 10.1097/00005650-199909000-00002; Furu K, 2010, BASIC CLIN PHARMACOL, V106, P86, DOI 10.1111/j.1742-7843.2009.00494.x; Hashmi SK, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000280; Hill MN, 2010, J CLIN HYPERTENS, V12, P757, DOI 10.1111/j.1751-7176.2010.00356.x; Johnell K, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-17; Kawachi I, 1999, AM J PUBLIC HEALTH, V89, P1187, DOI 10.2105/AJPH.89.8.1187; Kawachi I, 2001, J URBAN HEALTH, V78, P458, DOI 10.1093/jurban/78.3.458; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Kidd KE, 2000, CONTROL CLIN TRIALS, V21, p184S, DOI 10.1016/S0197-2456(00)00076-3; Kouvonen A, 2008, ADDICTION, V103, P1857, DOI 10.1111/j.1360-0443.2008.02315.x; Kouvonen A, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-251; Kouvonen A, 2008, AM J EPIDEMIOL, V167, P1143, DOI 10.1093/aje/kwn067; Krousel-Wood M, 2009, AM J MANAG CARE, V15, P59; Kujala UM, 1998, JAMA-J AM MED ASSOC, V279, P440, DOI 10.1001/jama.279.6.440; Li CY, 1999, OCCUP MED-OXFORD, V49, P225, DOI 10.1093/occmed/49.4.225; Lindstrom M, 2001, SOC SCI MED, V52, P441, DOI 10.1016/S0277-9536(00)00153-2; Lindstrom M, 2008, AM J EPIDEMIOL, V167, P1152, DOI 10.1093/aje/kwn070; Merlo J, 2003, AM J EPIDEMIOL, V157, P774, DOI 10.1093/aje/kwg053; Nabia H, 2008, J HYPERTENS, V26, P2236, DOI 10.1097/HJH.0b013e32830dfe5f; Nice, 1984, DISTINCTION SOCIAL C; Nielsen LH, 2008, PHARMACOEPIDEM DR S, V17, P384, DOI 10.1002/pds.1549; Oksanen T, 2008, SOC SCI MED, V66, P637, DOI 10.1016/j.socscimed.2007.10.013; Oksanen T, 2010, J EPIDEMIOL COMMUN H, V64, P684, DOI 10.1136/jech.2008.086074; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Pladevall M, 2010, CIRCULATION, V122, P1183, DOI 10.1161/CIRCULATIONAHA.109.892778; Putnam R.D., 1994, MAKING DEMOCRACY WOR, DOI DOI 10.2307/206637; Rimm EB, 1999, BMJ-BRIT MED J, V319, P1523, DOI 10.1136/bmj.319.7224.1523; Rogers E.M., 2010, DIFFUSION INNOVATION, V4th ed; Rose AJ, 2009, HYPERTENSION, V54, P524, DOI 10.1161/HYPERTENSIONAHA.109.133389; Salo P, 2010, SLEEP, V33, P1323, DOI 10.1093/sleep/33.10.1323; Sapp AL, 2010, J OCCUP ENVIRON MED, V52, P740, DOI 10.1097/JOM.0b013e3181e80842; Schneeweiss S, 2005, J CLIN EPIDEMIOL, V58, P323, DOI 10.1016/j.jclinepi.2004.10.012; Schroeder K, 2006, J HUM HYPERTENS, V20, P625, DOI 10.1038/sj.jhh.1002011; Schroeder K, 2005, FAM PRACT, V22, P144, DOI 10.1093/fampra/cmh717; Siegel D, 2007, AM J MED, V120, P26, DOI 10.1016/j.amjmed.2006.06.028; Simpson SH, 2006, BMJ-BRIT MED J, V333, P15, DOI 10.1136/bmj.38875.675486.55; STANTON AL, 1987, J BEHAV MED, V10, P377, DOI 10.1007/BF00846477; Steiner JF, 1997, J CLIN EPIDEMIOL, V50, P105, DOI 10.1016/S0895-4356(96)00268-5; Sundquist J, 2006, SOC SCI MED, V62, P954, DOI 10.1016/j.socscimed.2005.06.049; Sundquist K, 2004, SOC SCI MED, V58, P615, DOI 10.1016/S0277-9536(03)00229-6; Suzuki E, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-489; *WHO, 2006, GUID ATC CLASS DDD A; World Health Organization, 2003, ADHERENCE LONG TERM	51	14	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2011	6	9							e24732	10.1371/journal.pone.0024732	http://dx.doi.org/10.1371/journal.pone.0024732			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	819CN	21931836	gold, Green Published, Green Submitted			2022-12-25	WOS:000294803100063
J	Meurs, L; Labuda, L; Amoah, AS; Mbow, M; Ngoa, UA; Boakye, DA; Mboup, S; Dieye, TN; Mountford, AP; Turner, JD; Kremsner, PG; Polman, K; Yazdanbakhsh, M; Adegnika, AA				Meurs, Lynn; Labuda, Lucja; Amoah, Abena Serwaa; Mbow, Moustapha; Ngoa, Ulysse Ateba; Boakye, Daniel Adjei; Mboup, Souleymane; Dieye, Tandakha Ndiaye; Mountford, Adrian P.; Turner, Joseph D.; Kremsner, Peter Gottfried; Polman, Katja; Yazdanbakhsh, Maria; Adegnika, Ayola Akim			Enhanced Pro-Inflammatory Cytokine Responses following Toll-Like-Receptor Ligation in Schistosoma haematobium-Infected Schoolchildren from Rural Gabon	PLOS ONE			English	Article							ADAPTIVE IMMUNE-RESPONSES; TUMOR-NECROSIS-FACTOR; MANSONI INFECTION; DENDRITIC CELLS; LYMPHATIC FILARIASIS; TETANUS VACCINATION; SIGNALING PATHWAYS; HELMINTH-PARASITES; INTERFERON-GAMMA; NORTHERN TOGO	Background: Schistosoma infection is thought to lead to down-regulation of the host's immune response. This has been shown for adaptive immune responses, but the effect on innate immunity, that initiates and shapes the adaptive response, has not been extensively studied. In a first study to characterize these responses, we investigated the effect of Schistosoma haematobium infection on cytokine responses of Gabonese schoolchildren to a number of Toll-like receptor (TLR) ligands. Methodology: Peripheral blood mononuclear cells (PBMCs) were collected from S. haematobium-infected and uninfected schoolchildren from the rural area of Zile in Gabon. PBMCs were incubated for 24 h and 72 h with various TLR ligands, as well as schistosomal egg antigen (SEA) and adult worm antigen (AWA). Pro-inflammatory TNF-alpha and anti-inflammatory/regulatory IL-10 cytokine concentrations were determined in culture supernatants. Principal Findings: Infected children produced higher adaptive IL-10 responses than uninfected children against schistosomal antigens (72 h incubation). On the other hand, infected children had higher TNF-alpha responses than uninfected children and significantly higher TNF-alpha to IL-10 ratios in response to FSL-1 and Pam3, ligands of TLR2/6 and TLR2/1 respectively. A similar trend was observed for the TLR4 ligand LPS while Poly(I:C) (Mda5/TLR3 ligand) did not induce substantial cytokine responses (24 h incubation). Conclusions: This pilot study shows that Schistosoma-infected children develop a more pro-inflammatory TLR2-mediated response in the face of a more anti-inflammatory adaptive immune response. This suggests that S. haematobium infection does not suppress the host's innate immune system in the context of single TLR ligation.	[Meurs, Lynn; Polman, Katja] Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium; [Labuda, Lucja; Yazdanbakhsh, Maria; Adegnika, Ayola Akim] Leiden Univ Med Ctr, Dept Parasitol, Leiden, Netherlands; [Labuda, Lucja; Ngoa, Ulysse Ateba; Kremsner, Peter Gottfried; Adegnika, Ayola Akim] Albert Schweitzer Hosp, Med Res Unit, Lambarene, Gabon; [Labuda, Lucja; Ngoa, Ulysse Ateba; Kremsner, Peter Gottfried; Adegnika, Ayola Akim] Univ Tubingen, Inst Trop Med, Tubingen, Germany; [Amoah, Abena Serwaa; Boakye, Daniel Adjei] Noguchi Mem Inst Med Res, Dept Parasitol, Accra, Ghana; [Mbow, Moustapha; Mboup, Souleymane; Dieye, Tandakha Ndiaye] CHU Le Dantec, Immunol Lab, Dakar, Senegal; [Mountford, Adrian P.; Turner, Joseph D.] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England	Institute of Tropical Medicine (ITM); Leiden University; Leiden University Medical Center (LUMC); Eberhard Karls University of Tubingen; University of Ghana; University of York - UK	Meurs, L (corresponding author), Inst Trop Med, Dept Biomed Sci, B-2000 Antwerp, Belgium.	lemurs@itg.be	Yazdanbakhsh, Maria/AAI-3996-2020; Meurs, Lynn/AAF-8916-2019; ADEGNIKA, Ayola Akim/AAK-7307-2020; Meurs, Lynn/J-8661-2016	Yazdanbakhsh, Maria/0000-0002-7666-1441; Meurs, Lynn/0000-0002-6973-1237; Meurs, Lynn/0000-0002-6973-1237; Turner, Joseph/0000-0002-2185-5476; Amoah, Abena/0000-0003-2270-1871	European Union [INCO-CT-2006-032405]	European Union(European Commission)	This work was supported by the European Union's sixth framework programme (INCO-CT-2006-032405). Website: http://cordis.europa.eu/fp6/dc/index. cfm?fuseaction = UserSite.FP6HomePage. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 1998, LANCET, V351, P929; Aksoy E, 2005, J BIOL CHEM, V280, P277, DOI 10.1074/jbc.M411223200; Babu S, 2005, J IMMUNOL, V175, P1170, DOI 10.4049/jimmunol.175.2.1170; Babu S, 2006, J IMMUNOL, V176, P3885, DOI 10.4049/jimmunol.176.7.3885; Babu S, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000489; Booth M, 2004, J IMMUNOL, V172, P1295, DOI 10.4049/jimmunol.172.2.1295; Burke ML, 2009, PARASITE IMMUNOL, V31, P163, DOI 10.1111/j.1365-3024.2009.01098.x; Caldas IR, 2008, ACTA TROP, V108, P109, DOI 10.1016/j.actatropica.2008.05.027; Carvalho L, 2009, IMMUNOLOGY, V126, P28, DOI 10.1111/j.1365-2567.2008.03008.x; Chang ZL, 2010, INFLAMM RES, V59, P791, DOI 10.1007/s00011-010-0208-2; Chitsulo L, 2000, ACTA TROP, V77, P41, DOI 10.1016/S0001-706X(00)00122-4; Cooper PJ, 1998, J INFECT DIS, V178, P1133, DOI 10.1086/515661; DEVRIES JE, 1995, ANN MED, V27, P537, DOI 10.3109/07853899509002465; Diaz A, 2007, EUR J IMMUNOL, V37, P3319, DOI 10.1002/eji.200737765; Feldmann M, 1996, ANNU REV IMMUNOL, V14, P397, DOI 10.1146/annurev.immunol.14.1.397; Geijtenbeek TBH, 2009, NAT REV IMMUNOL, V9, P465, DOI 10.1038/nri2569; Grant AV, 2011, GENES IMMUN, V12, P46, DOI 10.1038/gene.2010.50; Grogan JL, 1998, J INFECT DIS, V177, P1433, DOI 10.1086/517832; Gryseels B, 2006, LANCET, V368, P1106, DOI 10.1016/S0140-6736(06)69440-3; Hartgers FC, 2006, PARASITE IMMUNOL, V28, P497, DOI 10.1111/j.1365-3024.2006.00901.x; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jackson JA, 2006, MICROBES INFECT, V8, P487, DOI 10.1016/j.micinf.2005.07.025; Joshi AD, 2008, J LEUKOCYTE BIOL, V83, P314, DOI 10.1189/jlb.1007689; Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397; King CH, 2008, CHRONIC ILLN, V4, P65, DOI 10.1177/1742395307084407; King CL, 1996, J IMMUNOL, V156, P4715; KREPEL HP, 1992, ANN TROP MED PARASIT, V86, P289, DOI 10.1080/00034983.1992.11812666; Lee MS, 2007, ANNU REV BIOCHEM, V76, P447, DOI 10.1146/annurev.biochem.76.060605.122847; Maizels RM, 2003, NAT REV IMMUNOL, V3, P733, DOI 10.1038/nri1183; MARTICH GD, 1993, IMMUNOBIOLOGY, V187, P403, DOI 10.1016/S0171-2985(11)80353-0; Montenegro SML, 1999, J INFECT DIS, V179, P1502, DOI 10.1086/314748; Montenegro SML, 2002, INFECT IMMUN, V70, P5903, DOI 10.1128/IAI.70.11.5903-5912.2002; Montresor A., 1998, WORLD HLTH ORG; Mwatha JK, 1998, J IMMUNOL, V160, P1992; Nookala S, 2004, INFECT IMMUN, V72, P2598, DOI 10.1128/IAI.72.5.2598-2604.2004; Papadakis KA, 2000, ANNU REV MED, V51, P289, DOI 10.1146/annurev.med.51.1.289; Planche T, 2001, AM J TROP MED HYG, V65, P599, DOI 10.4269/ajtmh.2001.65.599; POLDERMAN AM, 1991, AM J TROP MED HYG, V44, P336, DOI 10.4269/ajtmh.1991.44.336; Reiss D, 2007, AM J TROP MED HYG, V77, P1087, DOI 10.4269/ajtmh.2007.77.1087; Retra K, 2008, PARASITE IMMUNOL, V30, P39, DOI 10.1111/j.1365-3024.2007.01000.x; Ritter M, 2010, P NATL ACAD SCI USA, V107, P20459, DOI 10.1073/pnas.1010337107; ROCKLIN RE, 1980, J IMMUNOL, V125, P1916; Sabin EA, 1996, J INFECT DIS, V173, P269, DOI 10.1093/infdis/173.1.269; Smits HH, 2007, J ALLERGY CLIN IMMUN, V120, P932, DOI 10.1016/j.jaci.2007.06.009; SPITS H, 1992, INT ARCH ALLERGY IMM, V99, P8, DOI 10.1159/000236329; Thomas PG, 2003, J IMMUNOL, V171, P5837, DOI 10.4049/jimmunol.171.11.5837; van den Biggelaar AHJ, 2000, LANCET, V356, P1723, DOI 10.1016/S0140-6736(00)03206-2; van der Kleij D, 2004, J INFECT DIS, V189, P1044, DOI 10.1086/382089; van der Kleij D, 2002, J BIOL CHEM, V277, P48122, DOI 10.1074/jbc.M206941200; van Die I, 2003, GLYCOBIOLOGY, V13, P471, DOI 10.1093/glycob/cwg052; van Liempt E, 2007, MOL IMMUNOL, V44, P2605, DOI 10.1016/j.molimm.2006.12.012; van Vliet SJ, 2005, INT IMMUNOL, V17, P661, DOI 10.1093/intimm/dxh246; Wamachi AN, 2004, J INFECT DIS, V190, P2020, DOI 10.1086/425579; WILDLING E, 1995, TROP MED PARASITOL, V46, P77	54	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e24393	10.1371/journal.pone.0024393	http://dx.doi.org/10.1371/journal.pone.0024393			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CK	21931706	Green Published, gold			2022-12-25	WOS:000294802800048
J	Jijiwa, M; Demir, H; Gupta, S; Leung, C; Joshi, K; Orozco, N; Huang, T; Yildiz, VO; Shibahara, I; de Jesus, JA; Yong, WH; Mischel, PS; Fernandez, S; Kornblum, HI; Nakano, I				Jijiwa, Mayumi; Demir, Habibe; Gupta, Snehalata; Leung, Crystal; Joshi, Kaushal; Orozco, Nicholas; Huang, Tiffany; Yildiz, Vedat O.; Shibahara, Ichiyo; de Jesus, Jason A.; Yong, William H.; Mischel, Paul S.; Fernandez, Soledad; Kornblum, Harley I.; Nakano, Ichiro			CD44v6 Regulates Growth of Brain Tumor Stem Cells Partially through the AKT-Mediated Pathway	PLOS ONE			English	Article							CANCER INITIATING CELLS; LEUCINE-ZIPPER KINASE; ADHESION MOLECULE; ACTIVATION; SURVIVAL; GLIOBLASTOMA; EXPRESSION; IDENTIFICATION; 3-KINASE/AKT; OSTEOPONTIN	Identification of stem cell-like brain tumor cells (brain tumor stem-like cells; BTSC) has gained substantial attention by scientists and physicians. However, the mechanism of tumor initiation and proliferation is still poorly understood. CD44 is a cell surface protein linked to tumorigenesis in various cancers. In particular, one of its variant isoforms, CD44v6, is associated with several cancer types. To date its expression and function in BTSC is yet to be identified. Here, we demonstrate the presence and function of the variant form 6 of CD44 (CD44v6) in BTSC of a subset of glioblastoma multiforme (GBM). Patients with CD44(high) GBM exhibited significantly poorer prognoses. Among various variant forms, CD44v6 was the only isoform that was detected in BTSC and its knockdown inhibited in vitro growth of BTSC from CD44(high) GBM but not from CD44(low) GBM. In contrast, this siRNA-mediated growth inhibition was not apparent in the matched GBM sample that does not possess stem-like properties. Stimulation with a CD44v6 ligand, osteopontin (OPN), increased expression of phosphorylated AKT in CD44(high) GBM, but not in CD44(low) GBM. Lastly, in a mouse spontaneous intracranial tumor model, CD44v6 was abundantly expressed by tumor precursors, in contrast to no detectable CD44v6 expression in normal neural precursors. Furthermore, overexpression of mouse CD44v6 or OPN, but not its dominant negative form, resulted in enhanced growth of the mouse tumor stem-like cells in vitro. Collectively, these data indicate that a subset of GBM expresses high CD44 in BTSC, and its growth may depend on CD44v6/AKTpathway.	[Jijiwa, Mayumi; Demir, Habibe; Gupta, Snehalata; Joshi, Kaushal; Nakano, Ichiro] Ohio State Univ, Dept Neurol Surg, Columbus, OH 43210 USA; [Leung, Crystal; Kornblum, Harley I.] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Orozco, Nicholas; Shibahara, Ichiyo; Kornblum, Harley I.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Huang, Tiffany; de Jesus, Jason A.; Yong, William H.; Mischel, Paul S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol, Los Angeles, CA 90095 USA; [Yildiz, Vedat O.; Fernandez, Soledad] Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA; [Nakano, Ichiro] Ohio State Univ, James Comprehens Canc Ctr, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Jijiwa, M (corresponding author), Ohio State Univ, Dept Neurol Surg, Columbus, OH 43210 USA.	ichiro.nakano@osumc.edu	Nakano, Ichiro/AAR-9562-2020; KURT, HABIBE/GVU-6234-2022; kurt, habibe/AAB-8257-2020; Nakano, Ichiro/F-2076-2014	Nakano, Ichiro/0000-0002-0916-3207; kurt, habibe/0000-0002-4579-3003; Nakano, Ichiro/0000-0002-6734-3468	American Cancer Society [MRSG-08-108-01]; Vincent J. Sgro/The American Brain Tumor Association; National Institutes of Health (NIH) [1R21CA135013-01A1, R01: NS052563]; NATIONAL CANCER INSTITUTE [R21CA135013] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS052563, R01NS052563] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Vincent J. Sgro/The American Brain Tumor Association; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was financially supported by the American Cancer Society (MRSG-08-108-01), Vincent J. Sgro/The American Brain Tumor Association, National Institutes of Health (NIH) grant (1R21CA135013-01A1) for IN, and NIH grant (R01: NS052563) for HK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akisik Elif, 2002, Pathology and Oncology Research, V8, P36; Anido J, 2010, CANCER CELL, V18, P655, DOI 10.1016/j.ccr.2010.10.023; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bates RC, 2001, CANCER RES, V61, P5275; Beier D, 2008, CANCER RES, V68, P5706, DOI 10.1158/0008-5472.CAN-07-6878; Boudreau CR, 2005, SURG NEUROL, V64, P286, DOI 10.1016/j.surneu.2005.03.033; Chakravarti A, 2004, J CLIN ONCOL, V22, P1926, DOI 10.1200/JCO.2004.07.193; Christofori G, 2003, EMBO J, V22, P2318, DOI 10.1093/emboj/cdg228; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; Diamandis P, 2007, NAT CHEM BIOL, V3, P268, DOI 10.1038/nchembio873; Dirks P, 2010, NATURE, V466, P40, DOI 10.1038/466040a; Dirks PB, 2010, MOL ONCOL, V4, P420, DOI 10.1016/j.molonc.2010.08.001; Dontu G, 2005, STEM CELL REV, V1, P207, DOI 10.1385/SCR:1:3:207; Eyler CE, 2008, STEM CELLS, V26, P3027, DOI 10.1634/stemcells.2007-1073; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gallia GL, 2009, MOL CANCER THER, V8, P386, DOI 10.1158/1535-7163.MCT-08-0680; Georgolios A., 2006, Experimental Oncology, V28, P94; Gladson CL, 1999, J NEUROPATH EXP NEUR, V58, P1029, DOI 10.1097/00005072-199910000-00001; Goodison S, 1999, J CLIN PATHOL-MOL PA, V52, P189; Gotte M, 2006, CANCER RES, V66, P10233, DOI 10.1158/0008-5472.CAN-06-1464; Hovinga KE, 2010, STEM CELLS, V28, P1019, DOI 10.1002/stem.429; Iczkowski KA, 2003, ANTICANCER RES, V23, P3129; Jin LQ, 2006, NAT MED, V12, P1167, DOI 10.1038/nm1483; Katoh S, 2003, J CLIN INVEST, V111, P1563, DOI 10.1172/JCI200316583; Khan SA, 2005, CLIN EXP METASTAS, V22, P663, DOI 10.1007/s10585-006-9007-0; Lagadec C, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2479; Laks DR, 2009, STEM CELLS, V27, P980, DOI 10.1002/stem.15; Lee CJ, 2008, J CLIN ONCOL, V26, P2806, DOI 10.1200/JCO.2008.16.6702; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Lee JL, 2007, CANCER RES, V67, P2089, DOI 10.1158/0008-5472.CAN-06-3625; Lin YH, 2001, J BIOL CHEM, V276, P46024, DOI 10.1074/jbc.M105132200; Marhaba R, 2004, J MOL HISTOL, V35, P211; Nakano I, 2005, J CELL BIOL, V170, P413, DOI 10.1083/jcb.200412115; Nakano I, 2008, J NEUROSCI RES, V86, P48, DOI 10.1002/jnr.21471; Nakano I, 2008, CANCER CELL, V13, P3, DOI 10.1016/j.ccr.2007.12.018; Nakano I, 2011, NEURO-ONCOLOGY, V13, P622, DOI 10.1093/neuonc/nor023; Naor D, 1997, ADV CANCER RES, V71, P241, DOI 10.1016/S0065-230X(08)60101-3; Ranuncolo SM, 2002, J SURG ONCOL, V79, P30, DOI 10.1002/jso.10045; Saleh F, 2008, NEOPLASMA, V55, P246; Sathornsumetee S, 2006, EXPERT REV ANTICANC, V6, P1087, DOI 10.1586/14737140.6.7.1087; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sonoda Y, 2001, CANCER RES, V61, P6674; Vescovi AL, 2006, NAT REV CANCER, V6, P425, DOI 10.1038/nrc1889; Wiranowska M, 2010, INT J CANCER, V127, P532, DOI 10.1002/ijc.25085; Xu Y, 2010, CANCER RES, V70, P2455, DOI 10.1158/0008-5472.CAN-09-2505; Yang YM, 2008, CANCER INVEST, V26, P725, DOI 10.1080/07357900801941845; Ylagan LR, 1997, MODERN PATHOL, V10, P1239	48	96	100	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2011	6	9							e24217	10.1371/journal.pone.0024217	http://dx.doi.org/10.1371/journal.pone.0024217			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817QP	21915300	Green Submitted, Green Published, gold			2022-12-25	WOS:000294689200026
J	Yavari, R; McEntee, E; McEntee, M; Brines, M				Yavari, Reza; McEntee, Erin; McEntee, Michael; Brines, Michael			Anthropometric Variables Accurately Predict Dual Energy X-Ray Absorptiometric-Derived Body Composition and Can Be Used to Screen for Diabetes	PLOS ONE			English	Article							LIFE-STYLE INTERVENTION; METABOLIC SYNDROME; GENERALIZED EQUATIONS; RISK; FAT; NUTRITION; DENSITY; ADULTS; MASS	The current world-wide epidemic of obesity has stimulated interest in developing simple screening methods to identify individuals with undiagnosed diabetes mellitus type 2 (DM2) or metabolic syndrome (MS). Prior work utilizing body composition obtained by sophisticated technology has shown that the ratio of abdominal fat to total fat is a good predictor for DM2 or MS. The goals of this study were to determine how well simple anthropometric variables predict the fat mass distribution as determined by dual energy x-ray absorptometry (DXA), and whether these are useful to screen for DM2 or MS within a population. To accomplish this, the body composition of 341 females spanning a wide range of body mass indices and with a 23% prevalence of DM2 and MS was determined using DXA. Stepwise linear regression models incorporating age, weight, height, waistline, and hipline predicted DXA body composition (i.e., fat mass, trunk fat, fat free mass, and total mass) with good accuracy. Using body composition as independent variables, nominal logistic regression was then performed to estimate the probability of DM2. The results show good discrimination with the receiver operating characteristic (ROC) having an area under the curve (AUC) of 0.78. The anthropometrically-derived body composition equations derived from the full DXA study group were then applied to a group of 1153 female patients selected from a general endocrinology practice. Similar to the smaller study group, the ROC from logistical regression using body composition had an AUC of 0.81 for the detection of DM2. These results are superior to screening based on questionnaires and compare favorably with published data derived from invasive testing, e. g., hemoglobin A1c. This anthropometric approach offers promise for the development of simple, inexpensive, non-invasive screening to identify individuals with metabolic dysfunction within large populations.	[Yavari, Reza] Beyond Care LLC, Guilford, CT USA; [Yavari, Reza] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [McEntee, Erin] George Washington Univ, Sch Med & Hlth Sci, Phys Assistant Program, Washington, DC 20052 USA; [McEntee, Michael] Impact Hlth Biometr Testing Inc, King Of Prussia, PA USA; [Brines, Michael] Kenneth S Warren Inst, Ossining, NY USA	Yale University; George Washington University	Yavari, R (corresponding author), Beyond Care LLC, Guilford, CT USA.	mbrines@kswi.org	Brinesd, Michael/AAE-6072-2020	Brines, Michael/0000-0003-4151-4449				Albanese CV, 2003, J CLIN DENSITOM, V6, P75, DOI 10.1385/JCD:6:2:75; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; Andreoli A, 2009, RADIOL MED, V114, P286, DOI 10.1007/s11547-009-0369-7; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bray GA, 2008, AM J CLIN NUTR, V87, P1212, DOI 10.1093/ajcn/87.5.1212; Diabet Prevention Program Res Grp, 2006, OBESITY, V14, P2107; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Fonseca Vivian A, 2008, Clin Cornerstone, V9, P51; Forbes GB, 2003, ACTA DIABETOL, V40, pS238, DOI 10.1007/s00592-003-0075-1; Forbes GB, 2002, CURR OPIN CLIN NUTR, V5, P25, DOI 10.1097/00075197-200201000-00005; Forbes GB, 2000, ANN NY ACAD SCI, V904, P359; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; FOSTER C, 1984, AM HEART J, V107, P1229, DOI 10.1016/0002-8703(84)90282-5; Han TS, 1998, DIABETIC MED, V15, P129, DOI 10.1002/(SICI)1096-9136(199802)15:2<129::AID-DIA535>3.3.CO;2-U; Ilanne-Parikka P, 2008, DIABETES CARE, V31, P805, DOI 10.2337/dc07-1117; JACKSON AS, 1980, MED SCI SPORT EXER, V12, P175; JACKSON AS, 1984, MED SCI SPORT EXER, V16, P616; Leslie WD, 2010, J CLIN ENDOCR METAB, V95, P3272, DOI 10.1210/jc.2009-2794; Lindstrom J, 2008, DIABETES CARE, V31, P857, DOI 10.2337/dc07-2162; Lipska KJ, 2010, J CLIN ENDOCR METAB, V95, P5289, DOI 10.1210/jc.2010-1171; Matsuo T, 2003, J BONE MINER METAB, V21, P179, DOI 10.1007/s007740300028; Minderico CS, 2008, BRIT J NUTR, V99, P432, DOI 10.1017/S0007114507815789; Mingrone G, 2001, METABOLISM, V50, P1004, DOI 10.1053/meta.2001.25650; Mottillo S, 2010, J AM COLL CARDIOL, V56, P1113, DOI 10.1016/j.jacc.2010.05.034; Rathmann W, 2005, ARCH INTERN MED, V165, P436, DOI 10.1001/archinte.165.4.436; Stern MP, 2002, ANN INTERN MED, V136, P575, DOI 10.7326/0003-4819-136-8-200204160-00006; Stolar Mark W, 2010, Mayo Clin Proc, V85, pS50, DOI 10.4065/mcp.2010.0471; TRAN ZV, 1989, MED SCI SPORT EXER, V21, P101, DOI 10.1249/00005768-198902000-00018; WELTMAN A, 1987, HUM BIOL, V59, P523; WELTMAN A, 1988, AM J CLIN NUTR, V48, P1179, DOI 10.1093/ajcn/48.5.1179	30	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2011	6	9							e24017	10.1371/journal.pone.0024017	http://dx.doi.org/10.1371/journal.pone.0024017			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817QP	21915276	Green Published, gold, Green Submitted			2022-12-25	WOS:000294689200015
J	Jenei, ZA; Warren, GZL; Hasan, M; Zammit, VA; Dixon, AM				Jenei, Zsuzsanna A.; Warren, Gemma Z. L.; Hasan, Muhammad; Zammit, Victor A.; Dixon, Ann M.			Packing of transmembrane domain 2 of carnitine palmitoyltransferase-1A affects oligomerization and malonyl-CoA sensitivity of the mitochondrial outer membrane protein	FASEB JOURNAL			English	Article						fatty acid metabolism; diabetes; GXXXG motif; analytical ultracentrifugation; GALLEX assay	C-TERMINAL DOMAIN; CONTACT SITES; CARNITINE-PALMITOYLTRANSFERASE-1; ULTRACENTRIFUGATION; ASSOCIATION	The purpose of this study was to investigate the sequence-dependence of oligomerization of transmembrane domain 2 (TM2) of rat carnitine palmitoyltransferase 1A (rCPT1A), to elucidate the role of this domain in the function of the full-length enzyme. Oligomerization of TM2 was studied qualitatively using complementary genetic assays that facilitate measurement of helix-helix interactions in the Escherichia coli inner membrane, and multiple quantitative biophysical methods. The effects of TM2-mutations on oligomerization and malonyl-CoA inhibition of the full-length enzyme (expressed in the yeast Pichia pastoris) were quantified. Changes designed to disrupt close-packing of the GXXXG(A) motifs reduced the oligomeric state of the corresponding TM2 peptides from hexamer to trimer (or lower), a reduction also observed on mutation of the TM2 sequence in the full-length enzyme. Disruption of these GXXXG(A) motifs had a parallel effect on the malonyl-CoA sensitivity of rCPT1A, reducing the IC50 from 30.3 +/- 5.0 to 3.0 +/- 0.6 mu M. For all measurements, wild-type rCPT1A was used as a control alongside various appropriate (e. g., molecular mass) standards. Our results suggest that sequence-determined, TM2-mediated oligomerization is likely to be involved in the modulation of malonyl-CoA inhibition of CPT1A in response to short-and long-term changes in protein-protein and protein-lipid interactions that occur in vivo. -Jenei, Z. A., Warren, G. Z. L., Hasan, M., Zammit, V. A., Dixon, A. M. Packing of transmembrane domain 2 of carnitine palmitoyltransferase-1A affects oligomerization and malonyl-CoA sensitivity of the mitochondrial outer membrane protein. FASEB J. 25, 4522-4530 (2011). www.fasebj.org	[Jenei, Zsuzsanna A.; Dixon, Ann M.] Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England; [Warren, Gemma Z. L.; Zammit, Victor A.] Univ Warwick, Div Metab & Vasc Hlth, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [Hasan, Muhammad] Univ Warwick, MOAC Doctoral Training Ctr, Coventry CV4 7AL, W Midlands, England	University of Warwick; University of Warwick; University of Warwick	Dixon, AM (corresponding author), Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England.	ann.dixon@warwick.ac.uk	Hasan, Muhammad/AAQ-4243-2020; Dixon, Ann M/I-3696-2012	Hasan, Muhammad/0000-0003-3201-7184; Dixon, Ann M/0000-0002-5261-304X	Diabetes UK; British Heart Foundation [PG/08/087/25872]; Warwick University	Diabetes UK(Diabetes UK); British Heart Foundation(British Heart Foundation); Warwick University	The authors thank J. Crawford (HHMI Keck Facility, Yale University, New Haven, CT, USA) for peptide synthesis, R. Parslow (University of Birmingham, Birmingham, UK) and Dr. D. Staunton (Oxford University, Oxford, UK) for assistance with analytical ultracentrifugation, and Prof. A. Rodger (University of Warwick, Coventry, UK) for access to CD instrumentation. This work was supported by a Diabetes UK grant to V.A.Z. and A. M. D., a British Heart Foundation grant (PG/08/087/25872) to V.A.Z. and A. M. D. to support G.Z.L.W., and a Warwick University Postgraduate Research Fellowship to support Z.A.J.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; ADAMS PD, 1995, NAT STRUCT BIOL, V2, P154, DOI 10.1038/nsb0295-154; BRDICZKA D, 1991, BIOCHIM BIOPHYS ACTA, V1071, P291, DOI 10.1016/0304-4157(91)90018-R; Cohen I, 2001, J BIOL CHEM, V276, P5403, DOI 10.1074/jbc.M009555200; Dixon AM, 2006, BIOCHEMISTRY-US, V45, P5228, DOI 10.1021/bi052112e; Faye A, 2005, BIOCHEM J, V387, P67, DOI 10.1042/BJ20041533; Faye A, 2007, J BIOL CHEM, V282, P26908, DOI 10.1074/jbc.M705418200; Fraser F, 2001, J BIOL CHEM, V276, P20182, DOI 10.1074/jbc.M101078200; Jackson VN, 2000, J BIOL CHEM, V275, P38410, DOI 10.1074/jbc.M007722200; Jackson VN, 1999, BIOCHEM J, V341, P483, DOI 10.1042/0264-6021:3410483; Jenei ZA, 2009, J BIOL CHEM, V284, P6988, DOI 10.1074/jbc.M808487200; King G, 2010, MOL BIOSYST, V6, P1650, DOI 10.1039/c002241a; Kochendoerfer GG, 1999, BIOCHEMISTRY-US, V38, P11905, DOI 10.1021/bi990720m; KOLODZIEJ MP, 1990, BIOCHEM J, V272, P421, DOI 10.1042/bj2720421; KOLODZIEJ MP, 1992, BIOCHEM J, V282, P415, DOI 10.1042/bj2820415; LAUTERWEIN J, 1979, BIOCHIM BIOPHYS ACTA, V556, P244, DOI 10.1016/0005-2736(79)90046-4; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Lee KK, 2011, J BIOL CHEM; Lopez-Vinas E, 2007, J BIOL CHEM, V282, P18212, DOI 10.1074/jbc.M700885200; Oates J, 2008, BIOCHEMISTRY-US, V47, P8985, DOI 10.1021/bi8006252; Russ WP, 1999, P NATL ACAD SCI USA, V96, P863, DOI 10.1073/pnas.96.3.863; Schneider D, 2003, J BIOL CHEM, V278, P3105, DOI 10.1074/jbc.M206287200; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Zammit VA, 1998, LIPIDS, V33, P371, DOI 10.1007/s11745-998-0217-7; Zammit VA, 1999, BIOCHEM J, V343, P505, DOI 10.1042/0264-6021:3430505; Zammit VA, 2008, IUBMB LIFE, V60, P347, DOI 10.1002/iub.78	26	9	10	0	29	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2011	25	12					4522	4530		10.1096/fj.11-192005	http://dx.doi.org/10.1096/fj.11-192005			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	863BP	21917985				2022-12-25	WOS:000298138100042
J	Rubinsten, O; Sury, D				Rubinsten, Orly; Sury, Dana			Processing Ordinality and Quantity: The Case of Developmental Dyscalculia	PLOS ONE			English	Article							NUMERICAL COMPETENCE; NUMBER; MAGNITUDE; CHILDREN; REPRESENTATION; DISSOCIATION; DISTANCE; HUMANS; SPACE; ORDER	In contrast to quantity processing, up to date, the nature of ordinality has received little attention from researchers despite the fact that both quantity and ordinality are embodied in numerical information. Here we ask if there are two separate core systems that lie at the foundations of numerical cognition: (1) the traditionally and well accepted numerical magnitude system but also (2) core system for representing ordinal information. We report two novel experiments of ordinal processing that explored the relation between ordinal and numerical information processing in typically developing adults and adults with developmental dyscalculia (DD). Participants made "ordered'' or "non-ordered'' judgments about 3 groups of dots (non-symbolic numerical stimuli; in Experiment 1) and 3 numbers (symbolic task: Experiment 2). In contrast to previous findings and arguments about quantity deficit in DD participants, when quantity and ordinality are dissociated (as in the current tasks), DD participants exhibited a normal ratio effect in the non-symbolic ordinal task. They did not show, however, the ordinality effect. Ordinality effect in DD appeared only when area and density were randomized, but only in the descending direction. In the symbolic task, the ordinality effect was modulated by ratio and direction in both groups. These findings suggest that there might be two separate cognitive representations of ordinal and quantity information and that linguistic knowledge may facilitate estimation of ordinal information.	[Rubinsten, Orly; Sury, Dana] Univ Haifa, Edmond J Safra Brain Res Ctr Study Learning Disab, Dept Learning Disabil, IL-31999 Haifa, Israel; [Rubinsten, Orly] Israel Sci Fdn, Ctr Neurocognit Basis Numer Cognit, Jerusalem, Israel	University of Haifa	Rubinsten, O (corresponding author), Univ Haifa, Edmond J Safra Brain Res Ctr Study Learning Disab, Dept Learning Disabil, IL-31999 Haifa, Israel.	orly.rubinsten@gmail.com	Rubinsten, Orly/AAB-3694-2020					Ansari D, 2008, NAT REV NEUROSCI, V9, P278, DOI 10.1038/nrn2334; Bachot J., 2005, PSYCHOL SCI, V47, P172, DOI DOI 10.1016/0010-0277(92)90049-N; Barth H, 2006, COGNITION, V98, P199, DOI 10.1016/j.cognition.2004.09.011; Barth H, 2005, P NATL ACAD SCI USA, V102, P14116, DOI 10.1073/pnas.0505512102; Brannon EM, 2002, COGNITION, V83, P223, DOI 10.1016/S0010-0277(02)00005-7; Brannon EM, 2001, COGNITIVE PSYCHOL, V43, P53, DOI 10.1006/cogp.2001.0756; Brannon EM, 1998, SCIENCE, V282, P746, DOI 10.1126/science.282.5389.746; Butterworth B., 2008, HDB MATH COGNITION; Cantlon JF, 2009, TRENDS COGN SCI, V13, P83, DOI 10.1016/j.tics.2008.11.007; Cantlon JF, 2006, PSYCHOL SCI, V17, P401, DOI 10.1111/j.1467-9280.2006.01719.x; Carey S., 2009, ORIGIN CONCEPTS; DEHAENE S, 1993, J EXP PSYCHOL GEN, V122, P371, DOI 10.1037/0278-7393.21.2.314; Dehaene S., 2011, NUMBER SENSE MIND CR; Dehaene S, 1992, COGNITIO, V44; Dehaene S, 2009, ANN NY ACAD SCI, V1156, P232, DOI 10.1111/j.1749-6632.2009.04469.x; Delazer M, 1997, COGN NEUROPSYCHOL, V14, P613; Feigenson L, 2004, TRENDS COGN SCI, V8, P307, DOI 10.1016/j.tics.2004.05.002; Feigenson L, 2007, TRENDS COGN SCI, V11, P185, DOI 10.1016/j.tics.2007.01.006; Fias W, 2007, J NEUROSCI, V27, P8952, DOI 10.1523/JNEUROSCI.2076-07.2007; Fulbright RK, 2003, AM J NEURORADIOL, V24, P193; Hermer-Vazquez L, 2001, COGNITION, V79, P263, DOI 10.1016/S0010-0277(00)00120-7; Isaacs EB, 2001, BRAIN, V124, P1701, DOI 10.1093/brain/124.9.1701; Ischebeck A, 2008, HUM BRAIN MAPP, V29, P894, DOI 10.1002/hbm.20433; Jacob SN, 2008, TRENDS COGN SCI, V12, P41, DOI 10.1016/j.tics.2007.11.006; Kadosh RC, 2007, CURR BIOL, V17, P689, DOI 10.1016/j.cub.2007.02.056; Kaufmann L, 2009, COGNITIVE DEV, V24, P486, DOI 10.1016/j.cogdev.2009.09.001; KAUFMANN L, COGNITIVE D IN PRESS; Kaufmann L, 2009, BEHAV BRAIN FUNCT, V5, DOI 10.1186/1744-9081-5-35; Kennet-Cohen T., 2008, DIFFERENT APPROACHES; Kucian K, NEUROIMAGE IN PRESS; Kucian Karin, 2006, Behav Brain Funct, V2, P31; Landerl K, 2004, COGNITION, V93, P99, DOI 10.1016/j.cognition.2003.11.004; Landerl K, 2009, J EXP CHILD PSYCHOL, V103, P546, DOI 10.1016/j.jecp.2008.12.006; Landerl K, 2009, J EXP CHILD PSYCHOL, V103, P309, DOI 10.1016/j.jecp.2009.03.006; Mussolin C, 2010, COGNITION, V115, P10, DOI 10.1016/j.cognition.2009.10.006; Mussolin C, 2010, J COGNITIVE NEUROSCI, V22, P860, DOI 10.1162/jocn.2009.21237; Nieder A, 2005, NAT REV NEUROSCI, V6, P177, DOI 10.1038/nrn1626; Nuerk H.-C., 2005, PSYCHOL SCI, V47, P142; Pavese A, 1998, J EXP PSYCHOL HUMAN, V24, P1535, DOI 10.1037/0096-1523.24.5.1535; Platt ML, 2009, CURR OPIN NEUROBIOL, V19, P1, DOI 10.1016/j.conb.2009.06.002; Price GR, 2007, CURR BIOL, V17, pR1042, DOI 10.1016/j.cub.2007.10.013; Rotzer S, 2008, NEUROIMAGE, V39, P417, DOI 10.1016/j.neuroimage.2007.08.045; Rousselle L, 2007, COGNITION, V102, P361, DOI 10.1016/j.cognition.2006.01.005; Rubinsten O, 2005, NEUROPSYCHOLOGY, V19, P641, DOI 10.1037/0894-4105.19.5.641; Rubinsten O, 2009, COGNITIVE DEV, V24, P362, DOI 10.1016/j.cogdev.2009.09.008; Rubinsten O, 2009, TRENDS COGN SCI, V13, P92, DOI 10.1016/j.tics.2008.11.002; Rugani R, 2007, J EXP PSYCHOL ANIM B, V33, P21, DOI 10.1037/0097-7403.33.1.21; Rugani R, 2010, BIOL LETTERS, V6, P290, DOI 10.1098/rsbl.2009.0960; Shaki S, 2009, PSYCHON B REV, V16, P328, DOI 10.3758/PBR.16.2.328; Shepard RN, 2001, BEHAV BRAIN SCI, V24, P581, DOI 10.1017/S0140525X01000012; Spelke ES, 2003, BRADFORD BOOKS, P277; Suanda SH, 2008, INFANCY, V13, P308, DOI 10.1080/15250000802188800; Sury D, READING WRITING MATH; Turconi E, 2006, COGNITION, V98, P273, DOI 10.1016/j.cognition.2004.12.002; Turconi E, 2002, CORTEX, V38, P911, DOI 10.1016/S0010-9452(08)70069-8; VANOEFFELEN MP, 1982, PERCEPT PSYCHOPHYS, V32, P163, DOI 10.3758/BF03204275; Walsh V, 2003, TRENDS COGN SCI, V7, P483, DOI 10.1016/j.tics.2003.09.002; Wilson A.J., 2007, HUMAN BEHAV LEARNING; Wood G., 2008, PSYCHOL SCI Q, V50, P489; Zorzi M, NEUROIMAGE IN PRESS	60	40	40	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24079	10.1371/journal.pone.0024079	http://dx.doi.org/10.1371/journal.pone.0024079			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	822JR	21935374	Green Published, gold, Green Submitted			2022-12-25	WOS:000295041700009
J	Wang, J; Fan, YY; Wang, SJ; Liang, PF; Wang, JL; Qiu, JH				Wang Jian; Fan Ying-ying; Wang Shu-juan; Liang Peng-fei; Wang Jin-ling; Qiu Jian-hua			Variants of OTOF and PJVK Genes in Chinese Patients with Auditory Neuropathy Spectrum Disorder	PLOS ONE			English	Article							NONSYNDROMIC HEARING IMPAIRMENT; COCHLEAR IMPLANTATION; ENCODING OTOFERLIN; MUTATIONS; CHILDREN; DEAFNESS; SYNCHRONY; DFNB9; EXOCYTOSIS; FREQUENCY	Background: Mutations in OTOF and PJVK genes cause DFNB9 and DFNB59 types of hearing loss, respectively. The patients carrying pathogenic mutations in either of these genes may show the typical phenotype of auditory neuropathy spectrum disorder (ANSD). The aim of the present study was to identify OTOF and PJVK mutations in sporadic ANSD patients. Methods and Findings: A total of 76 unrelated Chinese non-syndromic ANSD patients were sequenced on the gene OTOF and PJVK exon by exon. Variants were valued in 105 controls with normal hearing to verify the carrying rate. We identified one pathogenic mutation (c.1194T>A) and three novel, possibly pathogenic, variants (c.3570+2T>C, c.4023+1 G>A, and c.1102G>A) in the OTOF gene, and one novel, possibly pathogenic, variant (c.548G>A) in PJVK. Moreover, we found three novel missense mutations within the exons of OTOF. Conclusions: As we identified 4 and 1 possible pathogenic variants of the OTOF gene and the PJVK gene, respectively, we believe that screening in these genes are important in sporadic ANSD patients. The pathogenicity of these novel mutations needs further study because of their single heterozygous nature. Knowledge on the mutation spectra of these genes in Chinese would be beneficial in understanding the genetic character of this worldwide disease.	[Wang Jian; Wang Shu-juan; Liang Peng-fei; Wang Jin-ling; Qiu Jian-hua] Fourth Mil Med Univ, PLA Otolaryngol Head & Neck Surg Ctr, Xijing Hosp, Xian 710032, Shannxi, Peoples R China; [Fan Ying-ying] Fourth Mil Med Univ, Dept Anesthesiol, Stomatol Coll, Xian 710032, Shannxi, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Wang, J (corresponding author), Fourth Mil Med Univ, PLA Otolaryngol Head & Neck Surg Ctr, Xijing Hosp, Xian 710032, Shannxi, Peoples R China.	qiujh@fmmu.edu.cn						Berlin CI, 2003, MENT RETARD DEV D R, V9, P225, DOI 10.1002/mrdd.10084; Beurg M, 2008, J NEUROSCI, V28, P1798, DOI 10.1523/JNEUROSCI.4653-07.2008; Cacace AT, 2011, AUDIOL NEURO-OTOL, V16, P398, DOI 10.1159/000323276; Chaleshtori MH, 2007, CLIN GENET, V72, P261, DOI 10.1111/j.1399-0004.2007.00852.x; Cheng X, 2005, AM J MED GENET A, V139A, P13, DOI 10.1002/ajmg.a.30929; Chiu YH, 2010, AUDIOL NEURO-OTOL, V15, P364, DOI 10.1159/000293992; Choi BY, 2009, CLIN GENET, V75, P237, DOI 10.1111/j.1399-0004.2008.01128.x; Collin RWJ, 2007, HUM MUTAT, V28, P718, DOI 10.1002/humu.20510; Delmaghani S, 2006, NAT GENET, V38, P770, DOI 10.1038/ng1829; Ebermann I, 2007, HUM MUTAT, V28, P571, DOI 10.1002/humu.20478; Gibson William P R, 2008, Cochlear Implants Int, V9, P1, DOI 10.1179/cim.2008.9.1.1; Hilgert N, 2009, MUTAT RES-REV MUTAT, V681, P189, DOI 10.1016/j.mrrev.2008.08.002; Jimenez JL, 2007, J NEUROL SCI, V260, P114, DOI 10.1016/j.jns.2007.04.016; Kirkim G, 2008, INT J PEDIATR OTORHI, V72, P1461, DOI 10.1016/j.ijporl.2008.06.010; Manchaiah VK, 2010, INT J PEDIAT OTORHIN; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; Migliosi V, 2002, J MED GENET, V39, P502, DOI 10.1136/jmg.39.7.502; Miyamoto RT, 1999, LARYNGOSCOPE, V109, P181, DOI 10.1097/00005537-199902000-00002; Piatto VB, 2004, HEARING RES, V196, P87, DOI 10.1016/j.heares.2004.05.007; Pollak A, 2007, AM J MED GENET A, V143A, P2534, DOI 10.1002/ajmg.a.31982; Rance G, 1999, EAR HEARING, V20, P238, DOI 10.1097/00003446-199906000-00006; Rance G, 2008, OTOL NEUROTOL, V29, P179, DOI 10.1097/mao.0b013e31815e92fd; Robertson CMT, 2009, PEDIATRICS, V123, pE797, DOI 10.1542/peds.2008-2531; Rodriguez-Ballesteros M, 2003, HUM MUTAT, V22, P451, DOI 10.1002/humu.10274; Rodriguez-Ballesteros M, 2008, HUM MUTAT, V29, P823, DOI 10.1002/humu.20708; Romanos J, 2009, J HUM GENET, V54, P382, DOI 10.1038/jhg.2009.45; Rouillon I, 2006, INT J PEDIATR OTORHI, V70, P689, DOI 10.1016/j.ijporl.2005.09.006; Roux I, 2006, CELL, V127, P277, DOI 10.1016/j.cell.2006.08.040; Schwander M, 2007, J NEUROSCI, V27, P2163, DOI 10.1523/JNEUROSCI.4975-06.2007; Starr A., 2000, Journal of Basic and Clinical Physiology and Pharmacology, V11, P215; Starr A, 1996, BRAIN, V119, P741, DOI 10.1093/brain/119.3.741; Tang TPY, 2004, INT J PEDIATR OTORHI, V68, P175, DOI 10.1016/j.ijporl.2003.10.004; Varga R, 2003, J MED GENET, V40, P45, DOI 10.1136/jmg.40.1.45; Wang DY, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-79; Wang Jinling, 2002, Lin Chuang Er Bi Yan Hou Ke Za Zhi, V16, P518; [王锦玲 Wang Jinling], 2007, [听力学及言语疾病杂志, Journal of Audiology and Speech Pathology], V15, P89; Wang QJ, 2005, AM J MED GENET A, V133A, P27, DOI 10.1002/ajmg.a.30424; Yang T, 2009, AM J HUM GENET, V84, P651, DOI 10.1016/j.ajhg.2009.04.014; Yasunaga S, 2000, AM J HUM GENET, V67, P591, DOI 10.1086/303049; Yasunaga S, 1999, NAT GENET, V21, P363, DOI 10.1038/7693; Zadro C, 2010, INT J PEDIATR OTORHI, V74, P494, DOI 10.1016/j.ijporl.2010.02.004	42	14	18	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24000	10.1371/journal.pone.0024000	http://dx.doi.org/10.1371/journal.pone.0024000			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21935370	Green Published, gold			2022-12-25	WOS:000295041700005
J	Yin, H; Glass, J				Yin, Hong; Glass, Jonathan			The Phenotypic Radiation Resistance of CD44(+)/CD24(-or) (low) Breast Cancer Cells Is Mediated through the Enhanced Activation of ATM Signaling	PLOS ONE			English	Article							MAMMARY STEM-CELLS; ATAXIA-TELANGIECTASIA; INITIATING CELLS; DNA-DAMAGE; TUMOR; LINES; IDENTIFICATION; RECEPTOR; RADIORESISTANCE; EXPRESSION	Cancer initiating cells (CIC) are stem-like cells. CIC may contribute not only to the initiation of cancer but also to cancer recurrence because of the resistance of CIC both to chemotherapy and radiation therapy. From the MCF-7 and MDA-MB231 breast cancer cell lines and primary culture of patient breast cancer cells, we isolated by flow cytometry a CIC subset of cells with the CD44(+)/CD24(-or) (low) phenotype. The CD44(+)/CD24(-or) (low) subset showed increased sphere formation and resistance to radiation compared to the non-CD44(+)/CD24(-or) (low) subset. The increased radiation resistance was not dependent on the result of altered non-homologous end joining (NHEJ) DNA repair activity as both NHEJ activity and expression of the various proteins involved in NHEJ were not significantly different between the CD44(+)/CD24(-or) (low) and non-CD44(+)/CD24(-or) (low) subsets. However, activation of ATM signaling was significantly increased in CD44(+)/CD24(-or) (low) cells compared to nonCD44(+)/CD24(-or) (low) cells in both from breast cancer cell lines and primary human breast cancer cells. Application of an ATM inhibitor effectively decreased the radiation resistance of CD44(+)/CD24(-or) (low) subset, suggesting that targeting ATM signaling may provide a new tool to eradicate stem-like CIC and abolish the radiation resistance of breast cancer.	[Yin, Hong] Louisiana State Univ, Hlth Sci Ctr, Feist Weiller Canc Ctr, Shreveport, LA 71105 USA; Louisiana State Univ, Hlth Sci Ctr, Dept Med, Shreveport, LA 71105 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport	Yin, H (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Feist Weiller Canc Ctr, Shreveport, LA 71105 USA.	hyin@lsuhsc.edu			U.S. Department of Defense [W81XWH-06-1-0578]; Feist-Weiller Cancer Center of the Louisiana State University Health Sciences Center in Shreveport	U.S. Department of Defense(United States Department of Defense); Feist-Weiller Cancer Center of the Louisiana State University Health Sciences Center in Shreveport	This work was supported by the W81XWH-06-1-0578 Concept Award, U.S. Department of Defense Breast Cancer Research Program and by the Feist-Weiller Cancer Center of the Louisiana State University Health Sciences Center in Shreveport. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Assar O, 2009, INT J RADIAT ONCOL, V75, P1216, DOI 10.1016/j.ijrobp.2009.07.001; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Blick T, 2008, CLIN EXP METASTAS, V25, P629, DOI 10.1007/s10585-008-9170-6; Chiou SH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002090; Chuthapisith S, 2010, SURG ONCOL, V19, P27, DOI 10.1016/j.suronc.2009.01.004; Dave B, 2009, J MAMMARY GLAND BIOL, V14, P79, DOI 10.1007/s10911-009-9117-9; Diehn M, 2006, J NATL CANCER I, V98, P1755, DOI 10.1093/jnci/djj505; Diehn M, 2009, SEMIN RADIAT ONCOL, V19, P78, DOI 10.1016/j.semradonc.2008.11.002; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Giatromanolaki A, 2011, MED ONCOL, V28, P745, DOI 10.1007/s12032-010-9530-3; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Golding SE, 2009, MOL CANCER THER, V8, P2894, DOI 10.1158/1535-7163.MCT-09-0519; Haince JF, 2007, J BIOL CHEM, V282, P16441, DOI 10.1074/jbc.M608406200; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Jo M, 2009, J BIOL CHEM, V284, P22825, DOI 10.1074/jbc.M109.023960; Karimi-Busheri F, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2583; Lagadec C, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2479; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Lavin MF, 2005, ADV EXP MED BIOL, V570, P457, DOI 10.1007/1-4020-3764-3_16; Li Y, 2010, MOL CANCER THER, V9, P113, DOI 10.1158/1535-7163.MCT-08-1189; Lou H, 2007, ONCOGENE, V26, P1357, DOI 10.1038/sj.onc.1210200; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Milas L, 2009, SEMIN RADIAT ONCOL, V19, P96, DOI 10.1016/j.semradonc.2008.11.004; Morimoto K, 2009, CANCER SCI, V100, P1062, DOI 10.1111/j.1349-7006.2009.01151.x; Murat A, 2008, J CLIN ONCOL, V26, P3015, DOI 10.1200/JCO.2007.15.7164; Nakshatri H, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2559; Patrawala L, 2005, CANCER RES, V65, P6207, DOI 10.1158/0008-5472.CAN-05-0592; Phillips TM, 2006, JNCI-J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Ponti D, 2006, EUR J CANCER, V42, P1219, DOI 10.1016/j.ejca.2006.01.031; Rainey MD, 2008, CANCER RES, V68, P7466, DOI 10.1158/0008-5472.CAN-08-0763; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Sajithlal GB, 2010, STEM CELLS, V28, P1008, DOI 10.1002/stem.424; Sheridan C, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1610; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Tian B, 2009, NAT CELL BIOL, V11, P211, DOI 10.1038/ncb1829; Trosko JE, 2006, ANN NY ACAD SCI, V1089, P36, DOI 10.1196/annals.1386.018; Woodward WA, 2005, J CELL SCI, V118, P3585, DOI 10.1242/jcs.02532; Woodward WA, 2007, P NATL ACAD SCI USA, V104, P618, DOI 10.1073/pnas.0606599104; ZOU L, 2009, CELL MOTIL CYTOSKELE	43	83	86	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2011	6	9							e24080	10.1371/journal.pone.0024080	http://dx.doi.org/10.1371/journal.pone.0024080			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JR	21935375	Green Published, Green Submitted, gold			2022-12-25	WOS:000295041700010
J	Ahammer, H				Ahammer, Helmut			Higuchi Dimension of Digital Images	PLOS ONE			English	Article							FRACTAL DIMENSION; FREQUENCY-ANALYSIS; TIME-SERIES; TEXTURE; RESOLUTION	There exist several methods for calculating the fractal dimension of objects represented as 2D digital images. For example, Box counting, Minkowski dilation or Fourier analysis can be employed. However, there appear to be some limitations. It is not possible to calculate only the fractal dimension of an irregular region of interest in an image or to perform the calculations in a particular direction along a line on an arbitrary angle through the image. The calculations must be made for the whole image. In this paper, a new method to overcome these limitations is proposed. 2D images are appropriately prepared in order to apply 1D signal analyses, originally developed to investigate nonlinear time series. The Higuchi dimension of these 1D signals is calculated using Higuchi's algorithm, and it is shown that both regions of interests and directional dependencies can be evaluated independently of the whole picture. A thorough validation of the proposed technique and a comparison of the new method to the Fourier dimension, a common two dimensional method for digital images, are given. The main result is that Higuchi's algorithm allows a direction dependent as well as direction independent analysis. Actual values for the fractal dimensions are reliable and an effective treatment of regions of interests is possible. Moreover, the proposed method is not restricted to Higuchi's algorithm, as any 1D method of analysis, can be applied.	Med Univ Graz, Ctr Physiol Med, Inst Biophys, Graz, Austria	Medical University of Graz	Ahammer, H (corresponding author), Med Univ Graz, Ctr Physiol Med, Inst Biophys, Graz, Austria.	helmut.ahammer@medunigraz.at		Ahammer, Helmut/0000-0001-5400-294X				AGUILAR M, 1993, J MICROSC-OXFORD, V172, P233, DOI 10.1111/j.1365-2818.1993.tb03417.x; Ahammer H, 2008, PHYSICA D, V237, P446, DOI 10.1016/j.physd.2007.09.016; Ahammer H, 2005, CHAOS SOLITON FRACT, V26, P707, DOI 10.1016/j.chaos.2005.01.050; Ahammer H, 2004, CHAOS, V14, P183, DOI 10.1063/1.1638947; Ahammer H, 2011, CHAOS SOLITON FRACT, V44, P86, DOI 10.1016/j.chaos.2010.12.004; Ahammer H, 2003, PHYSICA D, V181, P147, DOI 10.1016/S0167-2789(03)00099-X; Ahammer H, 2001, EUR BIOPHYS J BIOPHY, V30, P494, DOI 10.1007/s002490100173; Ahammer H, 2001, FRACTALS, V9, P61, DOI 10.1142/S0218348X01000488; ANGUIANO E, 1993, J MICROSC-OXFORD, V172, P223, DOI 10.1111/j.1365-2818.1993.tb03416.x; BROOMHEAD DS, 1986, PHYSICA D, V20, P217, DOI 10.1016/0167-2789(86)90031-X; CHAUDHURI BB, 1995, IEEE T PATTERN ANAL, V17, P72, DOI 10.1109/34.368149; Dubuc B., 1987, Proceedings of the SPIE - The International Society for Optical Engineering, V845, P241, DOI 10.1117/12.976511; Falconer K. J., 2003, FRACTAL GEOMETRY MAT; FRASER AM, 1989, PHYSICA D, V34, P391, DOI 10.1016/0167-2789(89)90263-7; Fuseler JW, 2010, MICROSC MICROANAL, V16, P73, DOI 10.1017/S143192760999119X; GRASSBERGER P, 1983, PHYS REV LETT, V50, P346, DOI 10.1103/PhysRevLett.50.346; HIGUCHI T, 1988, PHYSICA D, V31, P277, DOI 10.1016/0167-2789(88)90081-4; Klonowski W, 2005, MATER SCI-POLAND, V23, P607; Mattfeldt T, 1997, J MICROSC-OXFORD, V185, P47, DOI 10.1046/j.1365-2818.1997.1440701.x; Peleg S, 1984, IEEE Trans Pattern Anal Mach Intell, V6, P518, DOI 10.1109/TPAMI.1984.4767557; PENTLAND AP, 1984, IEEE T PATTERN ANAL, V6, P661, DOI 10.1109/TPAMI.1984.4767591; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; SULLIVAN R, 2010, INT J BIOL LIFE SCI, V6, P170; Turner MJ., 1998, FRACTAL GEOMETRY DIG; Xia Y, 2010, PATTERN RECOGN LETT, V31, P163, DOI 10.1016/j.patrec.2009.09.028; Yalcinkaya T, 1997, PHYS REV E, V56, P1623, DOI 10.1103/PhysRevE.56.1623	26	27	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2011	6	9							e24796	10.1371/journal.pone.0024796	http://dx.doi.org/10.1371/journal.pone.0024796			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZV	21931854	Green Published, gold, Green Submitted			2022-12-25	WOS:000295321800064
J	Ayoola, OO; Gemmell, I; Omotade, OO; Adeyanju, OA; Cruickshank, JK; Clayton, PE				Ayoola, Omolola O.; Gemmell, Isla; Omotade, Olayemi O.; Adeyanju, Olusoji A.; Cruickshank, J. Kennedy; Clayton, Peter Ellis			Maternal Malaria, Birth Size and Blood Pressure in Nigerian Newborns: Insights into the Developmental Origins of Hypertension from the Ibadan Growth Cohort	PLOS ONE			English	Article							INTERMITTENT PREVENTIVE TREATMENT; PLACENTAL MALARIA; GESTATIONAL-AGE; PREGNANT-WOMEN; IN-UTERO; WEIGHT; INFECTION; PREVALENCE; INFANTS; IMPACT	Background: Hypertension is an increasing health issue in sub-Saharan Africa where malaria remains common in pregnancy. We established a birth cohort in Nigeria to evaluate the early impact of maternal malaria on newborn blood pressure (BP). Methods: Anthropometric measurements, BP, blood films for malaria parasites and haematocrit were obtained in 436 mother-baby pairs. Women were grouped to distinguish between the timing of malaria parasitaemia as 'No Malaria', 'Malaria during pregnancy only' or 'Malaria at delivery', and parasite density as low (< 1000 parasites/mu l of blood) and high (>= 1000/mu l). Results: Prevalence of maternal malaria parasitaemia was 48%, associated with younger maternal age (p < 0.001), being primigravid (p = 0.022), lower haematocrit (p = 0.028). High parasite density through pregnancy had the largest effect on mean birth indices so that weight, length, head and mid-upper arm circumferences were smaller by 300 g, 1.1 cm, 0.7 cm and 0.4 cm respectively compared with 'No malaria' (all p (<=) under bar 0.005). In babies of mothers who had 'malaria at delivery', their SBPs adjusted for other confounders were lower respectively by 4.3 and 5.7 mmHg/kg compared with 'malaria during pregnancy only' or 'none'. In contrast the mean newborn systolic (SBP) and diastolic BPs (DBP) adjusted for birth weight were higher by 1.7 and 1.4 mmHg/kg respectively in babies whose mothers had high compared with low parasitaemia. Conclusions: As expected, prenatal malarial exposure had a significant impact on fetal growth rates. Malaria at delivery was associated with the lowest newborn BPs while malaria through pregnancy, which may attenuate growth of the vascular network, generated higher newborn BPs adjusted for size. These neonatal findings have potential implications for cardiovascular health in sub-Saharan Africa.	[Ayoola, Omolola O.; Gemmell, Isla; Cruickshank, J. Kennedy; Clayton, Peter Ellis] Univ Manchester, Endocrine & Cardiovasc Sci Grp, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England; [Ayoola, Omolola O.; Omotade, Olayemi O.] Univ Ibadan, Coll Med, Ibadan, Nigeria; [Adeyanju, Olusoji A.] Adeoyo Matern Hosp, Dept Obstet & Gynecol, Ibadan, Nigeria	University of Manchester; University of Ibadan	Ayoola, OO (corresponding author), Univ Manchester, Endocrine & Cardiovasc Sci Grp, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England.	ooayoola@yahoo.com		Clayton, Peter/0000-0003-1225-4537	Wellcome Trust, United Kingdom [080723/Z/06/Z]	Wellcome Trust, United Kingdom(Wellcome Trust)	This project was supported by a Research Training Fellowship to OA by Wellcome Trust, United Kingdom, Reference: 080723/Z/06/Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adedoyin RA, 2008, EUR J CARDIOV PREV R, V15, P683, DOI 10.1097/HJR.0b013e32830edc32; Aimakhu C O, 2003, West Afr J Med, V22, P18; Aleyamma TK, 2007, INT J GYNECOL OBSTET, V97, P48, DOI 10.1016/j.ijgo.2006.12.012; Alves J G, 1999, J Perinatol, V19, P593; Amodu OK, 2006, ACTA TROP, V97, P370, DOI 10.1016/j.actatropica.2005.09.009; Anorlu R I, 2001, Afr J Med Med Sci, V30 Suppl, P39; Bansal N, 2008, J HYPERTENS, V26, P412, DOI 10.1097/HJH.0b013e3282f3168e; Baragatti M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-13; Barker DJP, 2006, NAT CLIN PRACT NEPHR, V2, P700, DOI 10.1038/ncpneph0344; Bhargava SK, 2004, NEW ENGL J MED, V350, P865, DOI 10.1056/NEJMoa035698; Bouvier P, 1997, AM J TROP MED HYG, V56, P384, DOI 10.4269/ajtmh.1997.56.384; Bouyou-Akotet MK, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-18; Cot M, 2003, Med Trop (Mars), V63, P369; Cottrell G, 2005, AM J TROP MED HYG, V73, P1112, DOI 10.4269/ajtmh.2005.73.1112; Cottrell G, 2007, AM J TROP MED HYG, V76, P849, DOI 10.4269/ajtmh.2007.76.849; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; Duffy PE, 1999, BIOCHEM SOC T, V27, P478, DOI 10.1042/bst0270478; Ekejindu I M, 2006, Afr J Med Med Sci, V35, P1; Ezeaka V C, 2003, Niger Postgrad Med J, V10, P168; Falade CO, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-88; Gillman MW, 2004, J PEDIATR-US, V144, P240, DOI 10.1016/j.jpeds.2003.10.064; GODFREY KM, 1994, BRIT J OBSTET GYNAEC, V101, P398, DOI 10.1111/j.1471-0528.1994.tb11911.x; Guyatt HL, 2004, CLIN MICROBIOL REV, V17, P760, DOI 10.1128/CMR.17.4.760-769.2004; Hulman S, 1991, J Perinatol, V11, P231; Kalanda BF, 2005, ARCH DIS CHILD-FETAL, V90, P161, DOI 10.1136/adc.2004.054650; Kayentao K, 2005, J INFECT DIS, V191, P109, DOI 10.1086/426400; Komolafe MA, 2007, TROP DOCT, V37, P186, DOI 10.1258/004947507781524557; Koudsi A, 2007, HYPERTENSION, V49, P225, DOI 10.1161/01.HYP.0000250434.73119.7a; LAUNER LJ, 1993, BMJ-BRIT MED J, V307, P1451, DOI 10.1136/bmj.307.6917.1451; Lewis RM, 2001, PLACENTA, V22, P534, DOI 10.1053/plac.2001.0679; MARTYN CN, 1995, BRIT HEART J, V73, P116; Matteelli A, 1996, ANN TROP MED PARASIT, V90, P125, DOI 10.1080/00034983.1996.11813036; Menendez C, 2000, J INFECT DIS, V181, P1740, DOI 10.1086/315449; Mockenhaupt FP, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-119; Oboro V O, 2002, J Obstet Gynaecol, V22, P610, DOI 10.1080/0144361021000020367; Olatunbosun ST, 2000, J HUM HYPERTENS, V14, P249, DOI 10.1038/sj.jhh.1000975; Ouma P, 2007, TROP MED INT HEALTH, V12, P1515, DOI 10.1111/j.1365-3156.2007.01960.x; Oyedeji G.A., 1985, NIG J PAEDIAT, V12, P111; PRUDHOMME O, 2006, PARASITO RES, V99, P500; Rogerson SJ, 2000, AM J TROP MED HYG, V62, P335, DOI 10.4269/ajtmh.2000.62.335; Rogerson Stephen J, 2006, Expert Rev Anti Infect Ther, V4, P687, DOI 10.1586/14787210.4.4.687; Sadoh WE, 2009, CARDIOVASC J AFR, V20, P344; Smal JC, 2009, NEONATOLOGY, V96, P86, DOI 10.1159/000203338; Srivastava H C, 2007, J Indian Med Assoc, V105, P304; Staalsoe T, 2004, LANCET, V363, P283, DOI 10.1016/S0140-6736(03)15386-X; Tian JY, 2006, EUR J ENDOCRINOL, V155, P601, DOI 10.1530/eje.1.02265; Ukoh V A, 2007, East Afr Med J, V84, P329; Wagbatsoma V A, 2008, Afr J Reprod Health, V12, P49; World Health Organization, 2010, GLOB REC PHYS ACT HL, P10; WRIGHT EA, 1990, E AFR MED J, V67, P894; Yakoob Mohammad Yawar, 2005, JPMA Journal of the Pakistan Medical Association, V55, P543; Zubrow A B, 1995, J Perinatol, V15, P470	52	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2011	6	9							e24548	10.1371/journal.pone.0024548	http://dx.doi.org/10.1371/journal.pone.0024548			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZV	21931749	Green Published, Green Submitted, gold			2022-12-25	WOS:000295321800031
J	Snigdha, S; Berchtold, N; Astarita, G; Saing, T; Piomelli, D; Cotman, CW				Snigdha, Shikha; Berchtold, Nicole; Astarita, Giuseppe; Saing, Tommy; Piomelli, Daniele; Cotman, Carl W.			Dietary and Behavioral Interventions Protect against Age Related Activation of Caspase Cascades in the Canine Brain	PLOS ONE			English	Article							BETA-AMYLOID ACCUMULATION; ALZHEIMERS-DISEASE; COGNITIVE DYSFUNCTION; NEURAL PLASTICITY; LEARNING-ABILITY; OXIDATIVE STRESS; CELL-DEATH; CERAMIDE; ENRICHMENT; APOPTOSIS	Lifestyle interventions such as diet, exercise, and cognitive training represent a quietly emerging revolution in the modern approach to counteracting age-related declines in brain health. Previous studies in our laboratory have shown that long-term dietary supplementation with antioxidants and mitochondrial cofactors (AOX) or behavioral enrichment with social, cognitive, and exercise components (ENR), can effectively improve cognitive performance and reduce brain pathology of aged canines, including oxidative damage and A beta accumulation. In this study, we build on and extend our previous findings by investigating if the interventions reduce caspase activation and ceramide accumulation in the aged frontal cortex, since caspase activation and ceramide accumulation are common convergence points for oxidative damage and A beta, among other factors associated with the aged and AD brain. Aged beagles were placed into one of four treatment groups: CON - control environment/control diet, AOX-control environment/antioxidant diet, ENR - enriched environment/control diet, AOX/ENR-enriched environment/antioxidant diet for 2.8 years. Following behavioral testing, brains were removed and frontal cortices were analyzed to monitor levels of active caspase 3, active caspase 9 and their respective cleavage products such as tau and semaphorin7a, and ceramides. Our results show that levels of activated caspase-3 were reduced by ENR and AOX interventions with the largest reduction occurring with combined AOX/ENR group. Further, reductions in caspase-3 correlated with reduced errors in a reversal learning task, which depends on frontal cortex function. In addition, animals treated with an AOX arm showed reduced numbers of cells expressing active caspase 9 or its cleavage product semaphorin 7A, while ENR (but not AOX) reduced ceramide levels. Overall, these data demonstrate that lifestyle interventions curtail activation of pro-degenerative pathways to improve cellular health and are the first to show that lifestyle interventions can regulate caspase pathways in a higher animal model of aging.	[Snigdha, Shikha; Berchtold, Nicole; Saing, Tommy; Cotman, Carl W.] Univ Calif Irvine, Inst Memory Impairments & Neurol Disorders, Irvine, CA 92717 USA; [Astarita, Giuseppe; Piomelli, Daniele] Univ Calif Irvine, Dept Pharmacol, Irvine, CA 92717 USA; [Astarita, Giuseppe; Piomelli, Daniele] Italian Inst Technol, Unit Drug Discovery & Dev, Genoa, Italy	University of California System; University of California Irvine; University of California System; University of California Irvine; Istituto Italiano di Tecnologia - IIT	Snigdha, S (corresponding author), Univ Calif Irvine, Inst Memory Impairments & Neurol Disorders, Irvine, CA 92717 USA.	ssnigdha@uci.edu	Astarita, Giuseppe/AAD-1239-2019; Astarita, Giuseppe/N-7346-2014	Astarita, Giuseppe/0000-0001-6700-301X	National Institutes of Health/National Institute on Aging [AG12694]; NATIONAL INSTITUTE ON AGING [R37AG012694, R01AG012694] Funding Source: NIH RePORTER	National Institutes of Health/National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded by the National Institutes of Health/National Institute on Aging AG12694. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrieu-Abadie N, 2001, FREE RADICAL BIO MED, V31, P717, DOI 10.1016/S0891-5849(01)00655-4; Astarita G, 2009, METHODS MOL BIOL, V579, P201, DOI 10.1007/978-1-60761-322-0_10; Billis W, 1998, RECENT PROG HORM RES, V53, P85; Burke SN, 2006, NAT REV NEUROSCI, V7, P30, DOI 10.1038/nrn1809; Canu N, 1998, J NEUROSCI, V18, P7061; Chan C, 2000, AM J RESP CELL MOL, V22, P460, DOI 10.1165/ajrcmb.22.4.3376; Chou YY, 2010, NEUROBIOL AGING, V31, P1386, DOI 10.1016/j.neurobiolaging.2010.05.001; Cotman CW, 2007, TRENDS NEUROSCI, V30, P464, DOI 10.1016/j.tins.2007.06.011; Cotman CW, 2008, J ALZHEIMERS DIS, V15, P685; Cotman CW, 2002, NEUROBIOL AGING, V23, P809, DOI 10.1016/S0197-4580(02)00073-8; Cummings BJ, 1996, NEUROBIOL LEARN MEM, V66, P11, DOI 10.1006/nlme.1996.0039; Cutler RG, 2004, P NATL ACAD SCI USA, V101, P2070, DOI 10.1073/pnas.0305799101; D'Amelio M, 2011, NAT NEUROSCI, V14, P69, DOI 10.1038/nn.2709; Erickson KI, 2009, BRIT J SPORT MED, V43, P22, DOI 10.1136/bjsm.2008.052498; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; FAHNESTOCK M, 2010, NEUROBIOL AGING; Fasulo L., 1996, ALZHEIMERS RES, V2, P195; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Han XL, 2002, J NEUROCHEM, V82, P809, DOI 10.1046/j.1471-4159.2002.00997.x; Head E, 1998, NEUROBIOL AGING, V19, P415, DOI 10.1016/S0197-4580(98)00084-0; Head E, 2009, EXP NEUROL, V220, P171, DOI 10.1016/j.expneurol.2009.08.014; HEAD E, 2011, AGE DORDR; Jo J, 2011, NAT NEUROSCI, V14, P545, DOI 10.1038/nn.2785; Kim DH, 2005, NEUROCRIT CARE, V3, P71, DOI 10.1385/NCC:3:1:071; Kirkland RA, 2010, J NEUROSCI, V30, P16114, DOI 10.1523/JNEUROSCI.2862-10.2010; Kronke M, 1999, CHEM PHYS LIPIDS, V102, P157, DOI 10.1016/S0009-3084(99)00084-5; Li Z, 2010, CELL, V141, P859, DOI 10.1016/j.cell.2010.03.053; Mancuso M, 2009, INT J ALZHEIMERS DIS; Mielke MM, 2010, NEUROMOL MED, V12, P331, DOI 10.1007/s12017-010-8121-y; Mielke MM, 2010, ALZHEIMERS DEMENT, V6, P378, DOI 10.1016/j.jalz.2010.03.014; Milgram NW, 2002, NEUROBIOL AGING, V23, P737, DOI 10.1016/S0197-4580(02)00020-9; MILGRAM NW, 1994, BEHAV NEUROSCI, V108, P57, DOI 10.1037/0735-7044.108.1.57; Milgram NW, 2005, NEUROBIOL AGING, V26, P77, DOI 10.1016/j.neurobiolaging.2004.02.014; Ohsawa S, 2010, P NATL ACAD SCI USA, V107, P13366, DOI 10.1073/pnas.0910488107; Opii W, 2008, NEUROBIOL AGING, V29, P51, DOI 10.1016/j.neurobiolaging.2006.09.012; Pettus BJ, 2002, BBA-MOL CELL BIOL L, V1585, P114, DOI 10.1016/S1388-1981(02)00331-1; Pop V, 2010, J NEUROSCI, V30, P9831, DOI 10.1523/JNEUROSCI.6194-09.2010; Ravid T, 2003, AM J PHYSIOL-LUNG C, V284, pL1082, DOI 10.1152/ajplung.00172.2002; Siwak CT, 2005, PROG NEURO-PSYCHOPH, V29, P461, DOI 10.1016/j.pnpbp.2004.12.011; Siwak-Tapp CT, 2007, NEUROBIOL LEARN MEM, V88, P249, DOI 10.1016/j.nlm.2007.05.001; Sperling RA, 2010, NEUROMOL MED, V12, P27, DOI 10.1007/s12017-009-8109-7; Spires-Jones TL, 2008, J NEUROSCI, V28, P862, DOI 10.1523/JNEUROSCI.3072-08.2008	42	9	9	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2011	6	9							e24652	10.1371/journal.pone.0024652	http://dx.doi.org/10.1371/journal.pone.0024652			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	825ZV	21931796	Green Published, gold			2022-12-25	WOS:000295321800043
J	Echenique, P; Cavasotto, CN; De Marco, M; Garca-Risueno, P; Alonso, JL				Echenique, Pablo; Cavasotto, Claudio N.; De Marco, Monica; Garca-Risueno, Pablo; Alonso, J. L.			An Exact Expression to Calculate the Derivatives of Position-Dependent Observables in Molecular Simulations with Flexible Constraints	PLOS ONE			English	Article							FREE-ENERGY CALCULATIONS; STATISTICAL-MECHANICS; RIGID CONSTRAINTS; FORCE-FIELD; DYNAMICS SIMULATIONS; PROTEINS; MODELS	In this work, we introduce an algorithm to compute the derivatives of physical observables along the constrained subspace when flexible constraints are imposed on the system (i.e., constraints in which the constrained coordinates are fixed to configuration-dependent values). The presented scheme is exact, it does not contain any tunable parameter, and it only requires the calculation and inversion of a sub-block of the Hessian matrix of second derivatives of the function through which the constraints are defined. We also present a practical application to the case in which the sought observables are the Euclidean coordinates of complex molecular systems, and the function whose minimization defines the flexible constraints is the potential energy. Finally, and in order to validate the method, which, as far as we are aware, is the first of its kind in the literature, we compare it to the natural and straightforward finite-differences approach in a toy system and in three molecules of biological relevance: methanol, N-methyl-acetamide and a tri-glycine peptide.	[Echenique, Pablo; Garca-Risueno, Pablo] Consejo Super Invest Cient CSIC, Inst Quim Fis Rocasolano, Madrid, Spain; [Echenique, Pablo; Garca-Risueno, Pablo; Alonso, J. L.] Univ Zaragoza, Inst Biocomp & Fis Sistemas Complejos BIFI, Zaragoza, Spain; [Echenique, Pablo; De Marco, Monica; Garca-Risueno, Pablo; Alonso, J. L.] Univ Zaragoza, Dept Fis Teor, E-50009 Zaragoza, Spain; [Echenique, Pablo; Alonso, J. L.] Unidad Asociada IQFR BIFI, Zaragoza, Spain; [Cavasotto, Claudio N.] Univ Texas Hlth Sci Ctr Houston, Sch Biomed Informat, Houston, TX USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); University of Zaragoza; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - UAM - Institut de Fisica Teorica (IFT); University of Zaragoza; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); University of Texas System; University of Texas Health Science Center Houston	Echenique, P (corresponding author), Consejo Super Invest Cient CSIC, Inst Quim Fis Rocasolano, Madrid, Spain.	echenique.p@gmail.com	Echenique, Pablo/A-9484-2008; Cavasotto, Claudio/GQY-7627-2022	Cavasotto, Claudio/0000-0002-1372-0379; Echenique-Robba, Pablo/0000-0001-8549-3139; Alonso, Jose Luis/0000-0002-3146-8250	MICINN, Spain [FIS2009-13364-C02-01]; Grupo de Excelencia "Biocomputacion y Fisica de Sistemas Complejos" (DGA, Spain) [E24/3]; ARAID; Ibercaja, Spain; CSIC, Spain	MICINN, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Grupo de Excelencia "Biocomputacion y Fisica de Sistemas Complejos" (DGA, Spain); ARAID; Ibercaja, Spain; CSIC, Spain	This work was funded by FIS2009-13364-C02-01 (MICINN, Spain), Grupo de Excelencia "Biocomputacion y Fisica de Sistemas Complejos", E24/3 (DGA, Spain), and ARAID and Ibercaja grant for young researchers (DGA and Ibercaja, Spain). P.G.-R. is supported by a JAE-Predoc scholarship (CSIC, Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen M. P., 2005, COMPUTER SIMULATION; Alonso JL, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.096403; Andrade X, 2009, J CHEM THEORY COMPUT, V5, P728, DOI 10.1021/ct800518j; [Anonymous], 2008, AMBER 10; BELONGIE S, RODRIGUES ROTATION F; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; CAR R, 1985, PHYS REV LETT, V55, P2471, DOI 10.1103/PhysRevLett.55.2471; CARTER EA, 1989, CHEM PHYS LETT, V156, P472, DOI 10.1016/S0009-2614(89)87314-2; Christen M, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1872792; Christen M, 2007, CHEMPHYSCHEM, V8, P1557, DOI 10.1002/cphc.200700176; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Cotter CJ, 2004, BIT, V44, P439, DOI 10.1023/B:BITN.0000046816.68632.49; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dubrovin B.A., 1992, MODERN GEOMETRY METH, V2nd ed, DOI DOI 10.1007/978-1-4612-1100-6; EASTWOOD JW, 1974, J COMP PHYSIOL, V16, P342, DOI 10.1016/0021-9991(74)90044-8; ECHENIQUE P, 2011, CANONICAL E IN PRESS; Echenique P, 2007, MOL PHYS, V105, P3057, DOI 10.1080/00268970701757875; Echenique P, 2007, CONTEMP PHYS, V48, P81, DOI 10.1080/00107510701520843; Echenique P, 2006, J COMPUT CHEM, V27, P1748, DOI 10.1002/jcc.20499; Echenique P, 2006, J COMPUT CHEM, V27, P1733, DOI 10.1002/jcc.20467; Echenique P, 2006, J COMPUT CHEM, V27, P1076, DOI 10.1002/jcc.20424; Frenkel D., 2000, UNDERSTANDING MOL SI; Frisch M.J., 2007, GAUSSIAN 03 REVISION; GO N, 1976, MACROMOLECULES, V9, P535, DOI 10.1021/ma60052a001; Goldstein H, 2002, CLASSICAL MECH; GREENGARD L, 1987, J COMPUT PHYS, V73, P325, DOI 10.1016/0021-9991(87)90140-9; HELFAND E, 1979, J CHEM PHYS, V71, P5000, DOI 10.1063/1.438314; Hess B, 2002, J CHEM PHYS, V116, P9602, DOI 10.1063/1.1478056; Hutter J, 2005, CHEMPHYSCHEM, V6, P1788, DOI 10.1002/cphc.200500059; Jensen F, 1998, INTRO COMPUTATIONAL; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; KOLLMAN P, 1997, COMP SIM BIOMOL SYST, V3, P83; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; PECHUKAS P, 1980, J CHEM PHYS, V72, P6320, DOI 10.1063/1.439055; Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27; Rapaport D.C., 2004, ART MOL DYNAMICS SIM, DOI 10.1017/CBO9780511816581; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schlick T, 1997, ANNU REV BIOPH BIOM, V26, P181, DOI 10.1146/annurev.biophys.26.1.181; VANKAMPEN NG, 1984, AM J PHYS, V52, P419, DOI 10.1119/1.13647; Weisstein E.W., ORDINARY DIFFERENTIA; Zhou J, 2000, J CHEM PHYS, V112, P7919, DOI 10.1063/1.481393	43	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2011	6	9							e24563	10.1371/journal.pone.0024563	http://dx.doi.org/10.1371/journal.pone.0024563			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CO	21931757	Green Submitted, gold, Green Published			2022-12-25	WOS:000294803200028
J	Guo, YZ; Li, JN; Hagstrom, E; Ny, T				Guo, Yongzhi; Li, Jinan; Hagstrom, Elin; Ny, Tor			Beneficial and Detrimental Effects of Plasmin(ogen) during Infection and Sepsis in Mice	PLOS ONE			English	Article							VENOUS IL-6 LEVELS; PLASMINOGEN-ACTIVATOR; CYTOKINE STORM; COMPLEMENT ACTIVATION; DEFICIENT MICE; EXPRESSION; RECEPTOR; SYSTEM; C5A; INTERLEUKIN-6	Plasmin has been proposed to be an important mediator during inflammation/infection. In this study, by using mice lacking genes for plasminogen, tissue-type plasminogen activator (tPA), and urokinase-type PA (uPA), we have investigated the functional roles of active plasmin in infection and sepsis. Two models were used: an infection model by intravenous injection of 1x10(7) CFU of S. aureus, and a sepsis model by intravenous injection of 1.6x10(8) CFU of S. aureus. We found that in the infection model, wild-type (WT) mice showed significantly higher survival rates than plasminogen-deficient (plg(-/-)) mice. However, in the sepsis model, plg(-/-) or tPA(-/-)/uPA(-/-) mice showed the highest survival rate whereas WT and tPA(+/-)/uPA(+/-) mice showed the lowest survival rate, and plg(+/-), tPA(-/-), and uPA(-/-) mice had an intermediate survival rate. These results indicate that the levels of active plasmin are critical in determining the survival rate in the sepsis, partly through high levels of inflammatory cytokines and enhanced STAT3 activation. We conclude that plasmin is beneficial in infection but promotes the production of inflammatory cytokines in sepsis that may cause tissue destruction, diminished neutrophil function, and an impaired capacity to kill bacteria which eventually causes death of these mice.	[Guo, Yongzhi; Li, Jinan; Hagstrom, Elin; Ny, Tor] Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden	Umea University	Guo, YZ (corresponding author), Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden.	tor.ny@medchem.umu.se	Li, Jinan/ABC-3182-2020		Swedish Research Council; Medical Faculty of Umea University	Swedish Research Council(Swedish Research CouncilEuropean Commission); Medical Faculty of Umea University	This study was supported by the Swedish Research Council and the Medical Faculty of Umea University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral A, 2004, INTENS CARE MED, V30, P1032, DOI 10.1007/s00134-004-2291-8; Beck JM, 1999, INFECT IMMUN, V67, P879, DOI 10.1128/IAI.67.2.879-884.1999; BEHRENDTSEN O, 1992, DEVELOPMENT, V114, P447; Burysek L, 2002, J BIOL CHEM, V277, P33509, DOI 10.1074/jbc.M201941200; Busuttil SJ, 2004, J THROMB HAEMOST, V2, P1798, DOI 10.1111/j.1538-7836.2004.00916.x; Capsoni F, 1997, SCAND J IMMUNOL, V45, P269, DOI 10.1046/j.1365-3083.1997.d01-393.x; CARMELIET P, 1994, NATURE, V368, P419, DOI 10.1038/368419a0; Circolo A, 1999, IMMUNOPHARMACOLOGY, V42, P135, DOI 10.1016/S0162-3109(99)00021-1; Collen D, 1999, THROMB HAEMOSTASIS, V82, P259; Cunnion KM, 2004, J LAB CLIN MED, V143, P358, DOI 10.1016/j.lab.2004.03.005; Czermak BJ, 1999, NAT MED, V5, P788, DOI 10.1038/10512; Dinarello CA, 2002, AM J RESP CRIT CARE, V166, P1156, DOI 10.1164/rccm.2208006; Geppert A, 2002, CRIT CARE MED, V30, P1987, DOI 10.1097/00003246-200209000-00007; Giamarellos-Bourboulis EJ, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-51; Hinshaw LB, 1996, CRIT CARE MED, V24, P1072, DOI 10.1097/00003246-199606000-00031; Hopken UE, 1996, NATURE, V383, P86, DOI 10.1038/383086a0; Huang SH, 2000, MICROBES INFECT, V2, P1237, DOI 10.1016/S1286-4579(00)01277-6; Huber-Lang MS, 2002, J IMMUNOL, V169, P3223, DOI 10.4049/jimmunol.169.6.3223; LACHMANN PJ, 1982, J EXP MED, V156, P205, DOI 10.1084/jem.156.1.205; Lahteenmaki K, 2005, TRENDS MICROBIOL, V13, P79, DOI 10.1016/j.tim.2004.12.003; Leon LR, 1998, AM J PHYSIOL-REG I, V275, pR269, DOI 10.1152/ajpregu.1998.275.1.R269; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Li JN, 2005, AM J PATHOL, V166, P783, DOI 10.1016/S0002-9440(10)62299-7; Magudumana MO, 2000, J TROP PEDIATRICS, V46, P267, DOI 10.1093/tropej/46.5.267; Muhl H, 2006, CRIT CARE MED, V34, P1567, DOI 10.1097/01.CCM.0000216192.11019.46; Ny A, 1999, ENDOCRINOLOGY, V140, P5030, DOI 10.1210/en.140.11.5030; Paul R, 2005, J INFECT DIS, V191, P776, DOI 10.1086/427829; Persaud DR, 2003, PROTEIN EXPRES PURIF, V32, P260, DOI 10.1016/S1046-5928(03)00236-5; PLOPLIS VA, 1995, CIRCULATION, V92, P2585, DOI 10.1161/01.CIR.92.9.2585; Remick DG, 2005, INFECT IMMUN, V73, P2751, DOI 10.1128/IAI.73.5.2751-2757.2005; Riedemann NC, 2003, IMMUNITY, V19, P193, DOI 10.1016/S1074-7613(03)00206-1; Riedemann NC, 2002, J CLIN INVEST, V110, P101, DOI 10.1172/JCI200215409; Russell JA, 2006, NEW ENGL J MED, V355, P1699, DOI 10.1056/NEJMra043632; Schaiff WT, 1997, CORONARY ARTERY DIS, V8, P9, DOI 10.1097/00019501-199701000-00002; Shuck JM, 2001, SURGERY, V130, P751; Syrovets T, 2001, BLOOD, V97, P3941, DOI 10.1182/blood.V97.12.3941; Tyburski JG, 2001, SURGERY, V130, P748, DOI 10.1067/msy.2001.118094; WESSELS MR, 1995, P NATL ACAD SCI USA, V92, P11490, DOI 10.1073/pnas.92.25.11490; Winkler F, 2002, NEUROLOGY, V59, P1350, DOI 10.1212/01.WNL.0000031427.81898.96; Zhang JH, 2005, CELL MOL IMMUNOL, V2, P271	40	33	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2011	6	9							e24774	10.1371/journal.pone.0024774	http://dx.doi.org/10.1371/journal.pone.0024774			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CO	21931850	Green Published, gold, Green Submitted			2022-12-25	WOS:000294803200049
J	Zerbini, LF; Tamura, RE; Correa, RG; Czibere, A; Cordeiro, J; Bhasin, M; Simabuco, FM; Wang, YH; Gu, XS; Li, LL; Sarkar, D; Zhou, JR; Fisher, PB; Libermann, TA				Zerbini, Luiz F.; Tamura, Rodrigo E.; Correa, Ricardo G.; Czibere, Akos; Cordeiro, Jason; Bhasin, Manoj; Simabuco, Fernando M.; Wang, Yihong; Gu, Xuesong; Li, Linglin; Sarkar, Devanand; Zhou, Jin-Rong; Fisher, Paul B.; Libermann, Towia A.			Combinatorial Effect of Non-Steroidal Anti-inflammatory Drugs and NF-kappa B Inhibitors in Ovarian Cancer Therapy	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; EXPRESSING MDA-7/IL-24-MEDIATED APOPTOSIS; SELECTIVELY INDUCES APOPTOSIS; VASCULAR-PERMEABILITY FACTOR; CARCINOMA CELL-LINES; MELANOMA DIFFERENTIATION; BREAST-CANCER; CLINICAL PHARMACOKINETICS; TUMOR-GROWTH; HUMAN-PLASMA	Several epidemiological studies have correlated the use of non-steroidal anti-inflammatory drugs (NSAID) with reduced risk of ovarian cancer, the most lethal gynecological cancer, diagnosed usually in late stages of the disease. We have previously established that the pro-apoptotic cytokine melanoma differentiation associated gene-7/Interleukin-24 (mda-7/IL-24) is a crucial mediator of NSAID-induced apoptosis in prostate, breast, renal and stomach cancer cells. In this report we evaluated various structurally different NSAIDs for their efficacies to induce apoptosis and mda-7/IL-24 expression in ovarian cancer cells. While several NSAIDs induced apoptosis, Sulindac Sulfide and Diclofenac most potently induced apoptosis and reduced tumor growth. A combination of these agents results in a synergistic effect. Furthermore, mda-7/IL-24 induction by NSAIDs is essential for programmed cell death, since inhibition of mda-7/IL-24 by small interfering RNA abrogates apoptosis. mda-7/IL-24 activation leads to upregulation of growth arrest and DNA damage inducible (GADD) 45 alpha and gamma and JNK activation. The NF-kappa B family of transcription factors has been implicated in ovarian cancer development. We previously established NF-kappa B/I kappa B signaling as an essential step for cell survival in cancer cells and hypothesized that targeting NF-kB could potentiate NSAID-mediated apoptosis induction in ovarian cancer cells. Indeed, combining NSAID treatment with NFkB inhibitors led to enhanced apoptosis induction. Our results indicate that inhibition of NF-kB in combination with activation of mda-7/IL-24 expression may lead to a new combinatorial therapy for ovarian cancer.	[Zerbini, Luiz F.; Tamura, Rodrigo E.] Univ Cape Town, Med Biochem Div, Fac Hlth Sci, ICGEB, ZA-7925 Cape Town, South Africa; [Correa, Ricardo G.] Sanford Burnham Inst Med Res, La Jolla, CA USA; [Czibere, Akos] Univ Dusseldorf, Dept Haematol Oncol & Clin Immunol, Dusseldorf, Germany; [Zerbini, Luiz F.; Cordeiro, Jason; Bhasin, Manoj; Simabuco, Fernando M.; Wang, Yihong; Gu, Xuesong; Libermann, Towia A.] Beth Israel Deaconess Med Ctr, BIDMC Genom & Prote Ctr, Boston, MA 02215 USA; [Zerbini, Luiz F.; Cordeiro, Jason; Bhasin, Manoj; Simabuco, Fernando M.; Wang, Yihong; Gu, Xuesong; Li, Linglin; Zhou, Jin-Rong; Libermann, Towia A.] Harvard Univ, Sch Med, Boston, MA USA; [Li, Linglin; Zhou, Jin-Rong] Beth Israel Deaconess Med Ctr, Dept Surg, Boston, MA 02215 USA; [Sarkar, Devanand; Fisher, Paul B.] Virginia Commonwealth Univ, Dept Human & Mol Genet, Sch Med, VCU Inst Mol Med,VCU Massey Canc Ctr, Richmond, VA USA	International Center for Genetic Engineering & Biotechnology (ICGEB); ICGEB Cape Town; University of Cape Town; Sanford Burnham Prebys Medical Discovery Institute; Heinrich Heine University Dusseldorf; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Virginia Commonwealth University	Zerbini, LF (corresponding author), Univ Cape Town, Med Biochem Div, Fac Hlth Sci, ICGEB, ZA-7925 Cape Town, South Africa.	luiz.zerbini@uct.ac.za	Simabuco, Fernando M/G-8421-2017; Zerbini, Luiz/B-7720-2015; tamura, rodrigo/C-3085-2012; tamura, rodrigo e/O-9846-2014; Correa, Ricardo G/G-7613-2012; Simabuco, Fernando M/GQA-4176-2022	Simabuco, Fernando M/0000-0002-1672-9686; Zerbini, Luiz/0000-0003-0736-9508; tamura, rodrigo e/0000-0001-7767-0887; Correa, Ricardo G/0000-0001-6940-7034; Simabuco, Fernando M/0000-0002-1672-9686; Libermann, Towia/0000-0002-4006-8179; Bhasin, Manoj/0000-0001-5172-420X	ICGEB; National Institutes of Health [1R01 CA85467, P50 CA090381, P50 CA105009, 1R01 CA097318, 1R01 CA127641, P01 CA104177]; Hershey Foundation; Samuel Waxman Cancer Research Foundation; Department of Defense [PC051217, OC0060439]; NATIONAL CANCER INSTITUTE [P50CA090381, P50CA105009, R01CA127641, P01CA104177, R01CA097318, R01CA085467] Funding Source: NIH RePORTER	ICGEB; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hershey Foundation; Samuel Waxman Cancer Research Foundation; Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	RET is a recipient of the ICGEB post-doctoral fellowship. This research was supported by National Institutes of Health grants 1R01 CA85467, P50 CA090381, P50 CA105009 and the Hershey Foundation (TAL), NIH grants 1R01 CA097318, 1R01 CA127641, P01 CA104177, the Samuel Waxman Cancer Research Foundation (PBF) and Department of Defense grants PC051217 and OC0060439 (LFZ). DS is a Harrison Scholar in Cancer Research and a Blick Scholar in the VCU Massey Cancer Center and the VCU School of Medicine. PBF holds the Thelma Newmeyer Corman Chair in Cancer Research in the VCU Massey Cancer Center and is a SWCRF Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuJawdeh GM, 1996, LAB INVEST, V74, P1105; Baldwin AS, 2001, J CLIN INVEST, V107, P241, DOI 10.1172/JCI11991; Berkel HJ, 1996, EPIDEMIOL REV, V18, P205, DOI 10.1093/oxfordjournals.epirev.a017926; BOOCOCK CA, 1995, JNCI-J NATL CANCER I, V87, P506, DOI 10.1093/jnci/87.7.506; Byrne AT, 2003, CLIN CANCER RES, V9, P5721; CARLIN JR, 1992, DRUG METAB DISPOS, V20, P148; Coogan PF, 1999, PREV MED, V29, P72, DOI 10.1006/pmed.1999.0518; Cramer DW, 1998, LANCET, V351, P104, DOI 10.1016/S0140-6736(97)08064-1; Dash R, 2010, CYTOKINE GROWTH F R, V21, P381, DOI 10.1016/j.cytogfr.2010.08.004; Davies NM, 2000, CLIN PHARMACOKINET, V38, P225, DOI 10.2165/00003088-200038030-00003; Dore M, 1998, J HISTOCHEM CYTOCHEM, V46, P77, DOI 10.1177/002215549804600110; Emdad L, 2009, CANCER BIOL THER, V8, P402, DOI 10.4161/cbt.8.5.7581; Emdad L, 2006, J CELL PHYSIOL, V208, P298, DOI 10.1002/jcp.20663; Fecker LF, 2010, J INVEST DERMATOL, V130, P2098, DOI 10.1038/jid.2010.40; Gopalan B, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-11; Gupta RA, 2003, CANCER RES, V63, P906; Holmes MD, 2010, J CLIN ONCOL, V28, P1467, DOI 10.1200/JCO.2009.22.7918; Huang EY, 2001, ONCOGENE, V20, P7051, DOI 10.1038/sj.onc.1204897; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jiang HP, 1995, ONCOGENE, V11, P2477; Karin M, 2000, SEMIN IMMUNOL, V12, P85, DOI 10.1006/smim.2000.0210; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Kaur J, 2010, J ENVIRON PATHOL TOX, V29, P41, DOI 10.1615/JEnvironPatholToxicolOncol.v29.i1.70; Kennedy JM, 2006, BRIT J ANAESTH, V97, P171, DOI 10.1093/bja/ael117; Khosravan R, 2006, J CLIN PHARMACOL, V46, P855, DOI 10.1177/0091270006289848; Kishore N, 2003, J BIOL CHEM, V278, P32861, DOI 10.1074/jbc.M211439200; Klimp AH, 2001, CANCER RES, V61, P7305; Kobori M, 2004, CELL DEATH DIFFER, V11, P123, DOI 10.1038/sj.cdd.4401325; Lacey JV, 2004, INT J CANCER, V108, P281, DOI 10.1002/ijc.11538; Lebedeva IV, 2005, ONCOGENE, V24, P585, DOI 10.1038/sj.onc.1208183; LENTJES EGWM, 1987, INT J CLIN PHARM TH, V25, P185; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Liu XH, 1998, CANCER RES, V58, P4245; LOCKWOOD GF, 1983, CLIN PHARMACOL THER, V34, P97, DOI 10.1038/clpt.1983.136; Lynch ED, 2005, ANTI-CANCER DRUG, V16, P569, DOI 10.1097/00001813-200506000-00013; Lyss G, 1998, J BIOL CHEM, V273, P33508, DOI 10.1074/jbc.273.50.33508; Mackenzie GG, 2010, GASTROENTEROLOGY, V139, P1320, DOI 10.1053/j.gastro.2010.06.044; Matsumoto Y, 2001, INT J MOL MED, V8, P31; Mesiano S, 1998, AM J PATHOL, V153, P1249, DOI 10.1016/S0002-9440(10)65669-6; Mita H, 2002, MOL CELL BIOL, V22, P4544, DOI 10.1128/MCB.22.13.4544-4555.2002; NAGY JA, 1995, CANCER RES, V55, P360; Oida Y, 2005, MOL CANCER THER, V4, P291; Paley PJ, 1997, CANCER, V80, P98, DOI 10.1002/(SICI)1097-0142(19970701)80:1<98::AID-CNCR13>3.0.CO;2-A; Pinheiro SP, 2009, AM J EPIDEMIOL, V169, P1378, DOI 10.1093/aje/kwp062; RAVIS WR, 1993, J CLIN PHARMACOL, V33, P527, DOI 10.1002/j.1552-4604.1993.tb04699.x; Ray GF, 1995, J PHARMACEUT BIOMED, V14, P213, DOI 10.1016/0731-7085(95)01631-7; ROBERTS DG, 1985, CLIN PHARMACOL THER, V38, P258, DOI 10.1038/clpt.1985.168; Rodriguez-Burford C, 2002, CLIN CANCER RES, V8, P202; Skjodt NM, 1999, CLIN PHARMACOKINET, V36, P399, DOI 10.2165/00003088-199936060-00002; Steele VE, 2009, CANCER PREV RES, V2, P951, DOI 10.1158/1940-6207.CAPR-09-0080; Su SF, 2003, INT J PHARM, V260, P39, DOI 10.1016/S0378-5173(03)00237-0; Su ZZ, 1998, P NATL ACAD SCI USA, V95, P14400, DOI 10.1073/pnas.95.24.14400; SWANSON BN, 1982, CLIN PHARMACOL THER, V32, P397, DOI 10.1038/clpt.1982.178; Takada Y, 2004, ONCOGENE, V23, P9247, DOI 10.1038/sj.onc.1208169; TERLINDEN R, 1988, J CHROMATOGR-BIOMED, V430, P438, DOI 10.1016/S0378-4347(00)83183-7; Tingulstad S, 2003, OBSTET GYNECOL, V101, P885, DOI 10.1016/S0029-7844(03)00123-6; Tobe M, 2003, BIOORGAN MED CHEM, V11, P3869, DOI 10.1016/S0968-0896(03)00438-3; Urick ME, 2008, GYNECOL ONCOL, V110, P418, DOI 10.1016/j.ygyno.2008.05.018; Vairapandi M, 2002, J CELL PHYSIOL, V192, P327, DOI 10.1002/jcp.10140; Vane JR, 1998, INT J TISSUE REACT, V20, P3; Wang CJ, 2010, ONCOL RES, V18, P561, DOI 10.3727/096504010X12767359113929; Wernli KJ, 2008, BRIT J CANCER, V98, P1781, DOI 10.1038/sj.bjc.6604392; Yacoub A, 2010, MOL PHARMACOL, V77, P298, DOI 10.1124/mol.109.061820; Yin MJ, 1998, NATURE, V396, P77, DOI 10.1038/23948; Zerbini LF, 2004, P NATL ACAD SCI USA, V101, P13618, DOI 10.1073/pnas.0402069101; Zerbini LF, 2003, CANCER RES, V63, P2206; Zerbini LF, 2006, CANCER RES, V66, P11922, DOI 10.1158/0008-5472.CAN-06-2068	67	41	45	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2011	6	9							e24285	10.1371/journal.pone.0024285	http://dx.doi.org/10.1371/journal.pone.0024285			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CO	21931671	Green Published, gold			2022-12-25	WOS:000294803200010
J	Kurashige, H; Cateau, H				Kurashige, Hiroki; Cateau, Hideyuki			Dendritic Slow Dynamics Enables Localized Cortical Activity to Switch between Mobile and Immobile Modes with Noisy Background Input	PLOS ONE			English	Article							SPATIAL WORKING-MEMORY; BASAL DENDRITES; PYRAMIDAL NEURONS; CALCIUM DYNAMICS; PREFRONTAL CORTEX; ACTION-POTENTIALS; APICAL DENDRITES; NETWORK; BUMPS; VOLTAGE	Mounting lines of evidence suggest the significant computational ability of a single neuron empowered by active dendritic dynamics. This motivates us to study what functionality can be acquired by a network of such neurons. The present paper studies how such rich single-neuron dendritic dynamics affects the network dynamics, a question which has scarcely been specifically studied to date. We simulate neurons with active dendrites networked locally like cortical pyramidal neurons, and find that naturally arising localized activity - called a bump - can be in two distinct modes, mobile or immobile. The mode can be switched back and forth by transient input to the cortical network. Interestingly, this functionality arises only if each neuron is equipped with the observed slow dendritic dynamics and with in vivo-like noisy background input. If the bump activity is considered to indicate a point of attention in the sensory areas or to indicate a representation of memory in the storage areas of the cortex, this would imply that the flexible mode switching would be of great potential use for the brain as an information processing device. We derive these conclusions using a natural extension of the conventional field model, which is defined by combining two distinct fields, one representing the somatic population and the other representing the dendritic population. With this tool, we analyze the spatial distribution of the degree of after-spike adaptation and explain how we can understand the presence of the two distinct modes and switching between the modes. We also discuss the possible functional impact of this mode-switching ability.	[Kurashige, Hiroki; Cateau, Hideyuki] RIKEN, RIKEN BSI TOYOTA Collaborat Ctr, Wako, Saitama, Japan	RIKEN	Kurashige, H (corresponding author), RIKEN, RIKEN BSI TOYOTA Collaborat Ctr, Wako, Saitama, Japan.	cateau@brain.riken.jp	Cateau, Hideyuki/R-9446-2016	Cateau, Hideyuki/0000-0002-8861-0916	RIKEN BSI	RIKEN BSI	This work was supported by RIKEN BSI (internal fund). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMARI SI, 1977, BIOL CYBERN, V27, P77, DOI 10.1007/BF00337259; Amit DJ, 1997, CEREB CORTEX, V7, P237, DOI 10.1093/cercor/7.3.237; Archie KA, 2000, NAT NEUROSCI, V3, P54, DOI 10.1038/71125; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Cai X, 2004, NEURON, V44, P351, DOI 10.1016/j.neuron.2004.09.026; Camperi M, 1998, J COMPUT NEUROSCI, V5, P383, DOI 10.1023/A:1008837311948; Chow CC, 2006, SIAM J APPL DYN SYST, V5, P552, DOI 10.1137/060654347; Compte A, 2000, CEREB CORTEX, V10, P910, DOI 10.1093/cercor/10.9.910; Coombes S, 2005, BIOL CYBERN, V93, P91, DOI 10.1007/s00422-005-0574-y; Ferezou I, 2006, NEURON, V50, P617, DOI 10.1016/j.neuron.2006.03.043; Fortin MJ., 2005, SPATIAL ANAL GUIDE E, V1, P30, DOI [10.1017/CBO9780511542039, DOI 10.1017/CBO9780511542039]; Fukuda T, 2006, J NEUROSCI, V26, P3434, DOI 10.1523/JNEUROSCI.4076-05.2006; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Gias C, 2005, NEUROIMAGE, V24, P200, DOI 10.1016/j.neuroimage.2004.08.015; Golding NL, 1998, NEURON, V21, P1189, DOI 10.1016/S0896-6273(00)80635-2; Goldman MS, 2003, CEREB CORTEX, V13, P1185, DOI 10.1093/cercor/bhg095; Gordon U, 2006, J NEUROSCI, V26, P12717, DOI 10.1523/JNEUROSCI.3502-06.2006; Han F, 2008, NEURON, V60, P321, DOI 10.1016/j.neuron.2008.08.026; Hansel D., 1998, METHODS NEURONAL MOD, P499; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Hausser M, 2003, CURR OPIN NEUROBIOL, V13, P372, DOI 10.1016/S0959-4388(03)00075-8; Hausser M, 2001, SCIENCE, V291, P138, DOI 10.1126/science.291.5501.138; Hellwig B, 2000, BIOL CYBERN, V82, P111, DOI 10.1007/PL00007964; Helmchen F, 1999, NAT NEUROSCI, V2, P989, DOI 10.1038/14788; Holmgren C, 2003, J PHYSIOL-LONDON, V551, P139, DOI 10.1113/jphysiol.2003.044784; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Koulakov AA, 2002, NAT NEUROSCI, V5, P775, DOI 10.1038/nn893; Laing CR, 2001, PHYSICA D, V160, P149, DOI 10.1016/S0167-2789(01)00351-7; Laing CR, 2001, NEURAL COMPUT, V13, P1473, DOI 10.1162/089976601750264974; Larkum ME, 2008, CURR OPIN NEUROBIOL, V18, P321, DOI 10.1016/j.conb.2008.08.013; Larkum ME, 2009, SCIENCE, V325, P756, DOI 10.1126/science.1171958; Larkum ME, 2007, J NEUROSCI, V27, P8999, DOI 10.1523/JNEUROSCI.1717-07.2007; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Larkum ME, 2004, CEREB CORTEX, V14, P1059, DOI 10.1093/cercor/bhh065; Loewenstein Y, 2003, NAT NEUROSCI, V6, P961, DOI 10.1038/nn1109; Losonczy A, 2006, NEURON, V50, P291, DOI 10.1016/j.neuron.2006.03.016; Luczak A, 2007, P NATL ACAD SCI USA, V104, P347, DOI 10.1073/pnas.0605643104; Major G, 2008, J NEUROPHYSIOL, V99, P2584, DOI 10.1152/jn.00011.2008; Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519; MEL BW, 1992, ADV NEUR IN, V4, P35; MEL BW, 1992, NEURAL COMPUT, V4, P502, DOI 10.1162/neco.1992.4.4.502; Memmesheimer RM, 2010, P NATL ACAD SCI USA, V107, P11092, DOI 10.1073/pnas.0909615107; Milojkovic BA, 2005, J NEUROSCI, V25, P3940, DOI 10.1523/JNEUROSCI.5314-04.2005; Milojkovic BA, 2007, J PHYSIOL-LONDON, V585, P447, DOI 10.1113/jphysiol.2007.142315; Morita K, 2008, J NEUROSCI, V28, P7699, DOI 10.1523/JNEUROSCI.0059-08.2008; MORRIS C, 1981, BIOPHYS J, V35, P193, DOI 10.1016/S0006-3495(81)84782-0; Murayama M, 2009, NATURE, V457, P1137, DOI 10.1038/nature07663; Nevian T, 2007, NAT NEUROSCI, V10, P206, DOI 10.1038/nn1826; O'Herron P, 2009, NEURON, V61, P801, DOI 10.1016/j.neuron.2009.01.014; Pearson J, 2008, TRENDS COGN SCI, V12, P334, DOI 10.1016/j.tics.2008.05.006; Petersen CCH, 2003, P NATL ACAD SCI USA, V100, P13638, DOI 10.1073/pnas.2235811100; Poirazi P, 2003, NEURON, V37, P977, DOI 10.1016/S0896-6273(03)00148-X; Poirazi P, 2003, NEURON, V37, P989, DOI 10.1016/S0896-6273(03)00149-1; Poirazi P, 2000, NEURAL COMPUT, V12, P1189, DOI 10.1162/089976600300015556; Polsky A, 2004, NAT NEUROSCI, V7, P621, DOI 10.1038/nn1253; Redish AD, 1996, NETWORK-COMP NEURAL, V7, P671, DOI 10.1088/0954-898X/7/4/004; Remme MWH, 2010, NEURON, V66, P429, DOI 10.1016/j.neuron.2010.04.027; Remme MWH, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000493; Renart A, 2003, NEURON, V38, P473, DOI 10.1016/S0896-6273(03)00255-1; Salinas E, 2002, NEURAL COMPUT, V14, P2111, DOI 10.1162/089976602320264024; Schiller J, 2000, NATURE, V404, P285, DOI 10.1038/35005094; Schiller J, 1997, J PHYSIOL-LONDON, V505, P605, DOI 10.1111/j.1469-7793.1997.605ba.x; Skaggs W E, 1995, Adv Neural Inf Process Syst, V7, P173; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Svoboda K, 1999, NAT NEUROSCI, V2, P65, DOI 10.1038/4569; Svoboda K, 1997, NATURE, V385, P161, DOI 10.1038/385161a0; TSO DY, 1988, J NEUROSCI, V8, P1712; TSO DY, 1986, J NEUROSCI, V6, P1160; Wei DS, 2001, SCIENCE, V293, P2272, DOI 10.1126/science.1061198; WILSON HR, 1973, KYBERNETIK, V13, P55, DOI 10.1007/BF00288786; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252; ZADOR AM, 1992, ADV NEUR IN, V4, P51; Zhang K, 1996, J NEUROSCI, V16, P2112	75	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e24007	10.1371/journal.pone.0024007	http://dx.doi.org/10.1371/journal.pone.0024007			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CK	21931635	gold, Green Published, Green Submitted			2022-12-25	WOS:000294802800018
J	Burgess, STG; McNeilly, TN; Watkins, CA; Nisbet, AJ; Huntley, JF				Burgess, Stewart T. G.; McNeilly, Tom N.; Watkins, Craig A.; Nisbet, Alasdair J.; Huntley, John F.			Host Transcription Factors in the Immediate Pro-Inflammatory Response to the Parasitic Mite Psoroptes ovis	PLOS ONE			English	Article							SHEEP SCAB MITE; NF-KAPPA-B; KERATINOCYTE TERMINAL DIFFERENTIATION; DUST-MITE; ADHESION MOLECULES; ECTOPARASITIC MITE; EXPRESSION; ACTIVATION; CELLS; ACARI	Background: Sheep scab, caused by infestation with the ectoparasitic mite Psoroptes ovis, results in the rapid development of cutaneous inflammation and leads to the crusted skin lesions characteristic of the disease. We described previously the global host transcriptional response to infestation with P. ovis, elucidating elements of the inflammatory processes which lead to the development of a rapid and profound immune response. However, the mechanisms by which this response is instigated remain unclear. To identify novel methods of intervention a better understanding of the early events involved in triggering the immune response is essential. The objective of this study was to gain a clearer understanding of the mechanisms and signaling pathways involved in the instigation of the immediate pro-inflammatory response. Results: Through a combination of transcription factor binding site enrichment and pathway analysis we identified key roles for a number of transcription factors in the instigation of cutaneous inflammation. In particular, defined roles were elucidated for the transcription factors NF-kB and AP-1 in the orchestration of the early pro-inflammatory response, with these factors being implicated in the activation of a suite of inflammatory mediators. Conclusions: Interrogation of the host temporal response to P. ovis infestation has enabled the further identification of the mechanisms underlying the development of the immediate host pro-inflammatory response. This response involves key regulatory roles for the transcription factors NF-kB and AP-1. Pathway analysis demonstrated that the activation of these transcription factors may be triggered following a host LPS-type response, potentially involving TLR4-signalling and also lead to the intriguing possibility that this could be triggered by a P. ovis allergen.	[Burgess, Stewart T. G.; McNeilly, Tom N.; Watkins, Craig A.; Nisbet, Alasdair J.; Huntley, John F.] Moredun Res Inst, Edinburgh, Midlothian, Scotland	Moredun Research Institute	Burgess, STG (corresponding author), Moredun Res Inst, Pentlands Sci Pk, Edinburgh, Midlothian, Scotland.	stewart.burgess@moredun.ac.uk	McNeilly, Tom/AAC-8264-2019	McNeilly, Tom/0000-0001-6469-0512; burgess, stewart/0000-0002-9268-7641; Nisbet, Alasdair/0000-0002-4965-5396	Department for Environment, Food and Rural Affairs (Defra), UK [OD0553]	Department for Environment, Food and Rural Affairs (Defra), UK(Department for Environment, Food & Rural Affairs (DEFRA))	This study was funded by the Department for Environment, Food and Rural Affairs (Defra), UK under grant OD0553. http://www.defra.gov.uk/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlian LG, 2009, J MED ENTOMOL, V46, P595, DOI 10.1603/033.046.0326; BAGGIOLINI M, 1992, FEBS LETT, V307, P97, DOI 10.1016/0014-5793(92)80909-Z; Burgess STG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-624; Dai X, 2004, CURR OPIN GENET DEV, V14, P485, DOI 10.1016/j.gde.2004.07.002; DELOACH JR, 1981, J MED ENTOMOL, V18, P345, DOI 10.1093/jmedent/18.4.345; Eisenbarth SC, 2002, J EXP MED, V196, P1645, DOI 10.1084/jem.20021340; Eto A, 2003, BIOCHEM BIOPH RES CO, V301, P495, DOI 10.1016/S0006-291X(02)03082-6; Foell D, 2004, ARTHRITIS RHEUM-US, V50, P3762, DOI 10.1002/art.20631; Foell D, 2003, RHEUMATOLOGY, V42, P1383, DOI 10.1093/rheumatology/keg385; Friedman AD, 2007, ONCOGENE, V26, P6816, DOI 10.1038/sj.onc.1210764; Fukata M, 2006, GASTROENTEROLOGY, V131, P862, DOI 10.1053/j.gastro.2006.06.017; Gangnuss S, 2004, J INVEST DERMATOL, V122, P791, DOI 10.1111/j.0022-202X.2004.22319.x; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Ginsberg D, 2002, FEBS LETT, V529, P122, DOI 10.1016/S0014-5793(02)03270-2; Goodridge HS, 2005, J IMMUNOL, V174, P284, DOI 10.4049/jimmunol.174.1.284; Gruber A, 2004, J BIOL CHEM, V279, P28475, DOI 10.1074/jbc.M400993200; Hai T, 1999, GENE EXPRESSION, V7, P321; Hamilton KA, 2003, INT J PARASITOL, V33, P773, DOI 10.1016/S0020-7519(03)00089-4; Hammad H, 2009, NAT MED, V15, P410, DOI 10.1038/nm.1946; Hogg JC, 2001, PARASITOLOGY, V123, P441, DOI 10.1017/S0031182001008642; Hudson LG, 2010, MOL CARCINOGEN, V49, P619, DOI 10.1002/mc.20636; Huntley JF, 2005, VET PARASITOL, V127, P323, DOI 10.1016/j.vetpar.2004.10.021; Jang SI, 2000, J BIOL CHEM, V275, P15295, DOI 10.1074/jbc.275.20.15295; KIRKWOOD AC, 1986, PARASITOL TODAY, V2, P302, DOI 10.1016/0169-4758(86)90124-9; Kudo T, 2005, INFECT IMMUN, V73, P7602, DOI 10.1128/IAi.73.11.7602-7612.2005; Litvak V, 2009, NAT IMMUNOL, V10, P437, DOI 10.1038/ni.1721; Liu JG, 2006, J BIOL CHEM, V281, P19188, DOI 10.1074/jbc.M602059200; Mao-Qiang M, 2004, J INVEST DERMATOL, V123, P305, DOI 10.1111/j.0022-202X.2004.23235.x; Mathieson BRF, 2002, VET PARASITOL, V104, P151, DOI 10.1016/S0304-4017(01)00620-3; Matsuo S, 2007, BIOCHEM J, V405, P605, DOI 10.1042/BJ20061797; Mattiuzzo NR, 2011, EXP DERMATOL, V20, P113, DOI 10.1111/j.1600-0625.2010.01188.x; May MJ, 1997, SEMIN CANCER BIOL, V8, P63, DOI 10.1006/scbi.1997.0057; MCMAHON SB, 1992, FASEB J, V6, P2707, DOI 10.1096/fasebj.6.9.1612295; McNeilly TN, 2010, PARASITE IMMUNOL, V32, P361, DOI 10.1111/j.1365-3024.2009.01196.x; MEADE EA, 1993, J BIOL CHEM, V268, P6610; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; MORRONE G, 1988, J BIOL CHEM, V263, P12554; Nagarajan P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004179; Nauta AJ, 2003, EUR J IMMUNOL, V33, P465, DOI 10.1002/immu.200310022; Nisbet AJ, 2006, PARASITE IMMUNOL, V28, P165, DOI 10.1111/j.1365-3024.2006.00803.x; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Pensa S, 2009, J MAMMARY GLAND BIOL, V14, P121, DOI 10.1007/s10911-009-9124-x; Pruett JH, 1999, J MED ENTOMOL, V36, P544, DOI 10.1093/jmedent/36.5.544; Sark MWJ, 1998, J BIOL CHEM, V273, P24683, DOI 10.1074/jbc.273.38.24683; Schreiber J, 2006, P NATL ACAD SCI USA, V103, P5899, DOI 10.1073/pnas.0510996103; SEIBERT K, 1994, RECEPTOR, V4, P17; Shiina T, 2004, J BIOL CHEM, V279, P55493, DOI 10.1074/jbc.M409770200; SINCLAIR AN, 1991, VET REC, V129, P492, DOI 10.1136/vr.129.22.492; SMITH CH, 1993, AM REV RESPIR DIS, V148, pS75, DOI 10.1164/ajrccm/148.6_Pt_2.S75; Stelnicki EJ, 1998, J INVEST DERMATOL, V111, P57, DOI 10.1046/j.1523-1747.1998.00238.x; Sui SJH, 2005, NUCLEIC ACIDS RES, V33, P3154, DOI 10.1093/nar/gki624; SWEATMAN GORDON K., 1958, CANADIAN JOUR ZOOL, V36, P849, DOI 10.1139/z58-072; Temeyer KB, 2002, J MED ENTOMOL, V39, P384, DOI 10.1603/0022-2585-39.2.384; Thomas PG, 2003, J IMMUNOL, V171, P5837, DOI 10.4049/jimmunol.171.11.5837; Tian B, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-137; Totzke G, 2006, J BIOL CHEM, V281, P12645, DOI 10.1074/jbc.M511956200; Trompette A, 2009, NATURE, V457, P585, DOI 10.1038/nature07548; Valledor AF, 1998, J LEUKOCYTE BIOL, V63, P405, DOI 10.1002/jlb.63.4.405; van den Broek AH, 2003, J COMP PATHOL, V128, P79, DOI 10.1053/jcpa.2002.0627; van den Broek AHM, 2004, J COMP PATHOL, V131, P318, DOI 10.1016/j.jcpa.2004.05.005; van den Broek AHM, 2000, PARASITE IMMUNOL, V22, P407, DOI 10.1046/j.1365-3024.2000.00318.x; Visintin A, 2006, IMMUNOBIOLOGY, V211, P437, DOI 10.1016/j.imbio.2006.05.010; Vroling AB, 2008, ALLERGY, V63, P461, DOI 10.1111/j.1398-9995.2007.01621.x; Wang YF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-437; Watkins CA, 2009, PARASITE IMMUNOL, V31, P304, DOI 10.1111/j.1365-3024.2009.01103.x; Wen AY, 2010, J IMMUNOL, V185, P6413, DOI 10.4049/jimmunol.1001829; Xia LX, 2008, CHINESE MED J-PEKING, V121, P730, DOI 10.1097/00029330-200804020-00014; Zenz R, 2006, INT J BIOCHEM CELL B, V38, P1043, DOI 10.1016/j.biocel.2005.11.011	68	12	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2011	6	9							e24402	10.1371/journal.pone.0024402	http://dx.doi.org/10.1371/journal.pone.0024402			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CH	21915322	gold, Green Submitted, Green Published			2022-12-25	WOS:000294802500042
J	Cho, HJ; Joo, NS; Wine, JJ				Cho, Hyung-Ju; Joo, Nam Soo; Wine, Jeffrey J.			Defective Fluid Secretion from Submucosal Glands of Nasal Turbinates from CFTR-/- and CFTR Delta F508/Delta F508 Pigs	PLOS ONE			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; CYSTIC-FIBROSIS PATIENTS; AIRWAY SURFACE LIQUID; MUCUS SECRETION; PSEUDOMONAS-AERUGINOSA; CHRONIC RHINOSINUSITIS; BIOELECTRIC PROPERTIES; POTENTIAL DIFFERENCE; REGIONAL DIFFERENCES; SINUS SURGERY	Background: Cystic fibrosis (CF), caused by reduced CFTR function, includes severe sinonasal disease which may predispose to lung disease. Newly developed CF pigs provide models to study the onset of CF pathophysiology. We asked if glands from pig nasal turbinates have secretory responses similar to those of tracheal glands and if CF nasal glands show reduced fluid secretion. Methodology/Principal Findings: Unexpectedly, we found that nasal glands differed from tracheal glands in five ways, being smaller, more numerous (density per airway surface area), more sensitive to carbachol, more sensitive to forskolin, and nonresponsive to Substance P (a potent agonist for pig tracheal glands). Nasal gland fluid secretion from newborn piglets (12 CF and 12 controls) in response to agonists was measured using digital imaging of mucus bubbles formed under oil. Secretion rates were significantly reduced in all conditions tested. Fluid secretory rates (Controls vs. CF, in pl/min/gland) were as follows: 3 mu M forskolin: 9.2 +/- 2.2 vs. 0.6 +/- 0.3; 1 mu M carbachol: 143.5 +/- 35.5 vs. 52.2 +/- 10.3; 3 mu M forskolin + 0.1 mu M carbachol: 25.8 +/- 5.8 vs. CF 4.5 +/- 0.9. We also compared CF Delta F508/Delta F508 with CFTR-/- piglets and found significantly greater forskolin-stimulated secretion rates in the Delta F508 vs. the null piglets (1.460.8, n = 4 vs. 0.2 +/- 0.1, n = 7). An unexpected age effect was also discovered: the ratio of secretion to 3 mu M forskolin vs. 1 mu M carbachol was similar to 4 times greater in adult than in neonatal nasal glands. Conclusions/Significance: These findings reveal differences between nasal and tracheal glands, show defective fluid secretion in nasal glands of CF pigs, reveal some spared function in the Delta F508 vs. null piglets, and show unexpected age-dependent differences. Reduced nasal gland fluid secretion may predispose to sinonasal and lung infections.	[Cho, Hyung-Ju; Joo, Nam Soo; Wine, Jeffrey J.] Stanford Univ, Cyst Fibrosis Res Lab, Dept Psychol, Stanford, CA 94305 USA	Stanford University	Cho, HJ (corresponding author), Stanford Univ, Cyst Fibrosis Res Lab, Dept Psychol, Stanford, CA 94305 USA.	hyungjuc@stanford.edu			National Institute for Digestive and Kidney Diseases [R01 DK051817]; Cystic Fibrosis Foundation Therapeutics; National Heart Lung and Blood Institute [HL51670]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL051670] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051817] Funding Source: NIH RePORTER	National Institute for Digestive and Kidney Diseases; Cystic Fibrosis Foundation Therapeutics(Italian Cystic Fibrosis Research Foundation); National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	These studies were supported by National Institute for Digestive and Kidney Diseases research grant R01 DK051817 to J.J. Wine and by an award from Cystic Fibrosis Foundation Therapeutics. The CF piglet tissues used in this work were made possible by research supported by National Heart Lung and Blood Institute grant HL51670 to M. J. Welsh. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accurso FJ, 2010, NEW ENGL J MED, V363, P1991, DOI 10.1056/NEJMoa0909825; BALLARD ST, 1995, AM J PHYSIOL-LUNG C, V268, pL526, DOI 10.1152/ajplung.1995.268.3.L526; Ballard ST, 2004, J PHYSIOL-LONDON, V556, P1, DOI 10.1113/jphysiol.2003.052779; BALLARD ST, 1992, J APPL PHYSIOL, V73, P2021, DOI 10.1152/jappl.1992.73.5.2021; Ballard ST, 2007, RESP PHYSIOL NEUROBI, V159, P271, DOI 10.1016/j.resp.2007.06.017; Baraniuk JN, 1999, AM J RESP CRIT CARE, V160, P655, DOI 10.1164/ajrccm.160.2.9805081; Bonestroo HJC, 2010, J CYST FIBROS, V9, P130, DOI 10.1016/j.jcf.2010.01.001; BOUCHER RC, 1980, J APPL PHYSIOL, V48, P169, DOI 10.1152/jappl.1980.48.1.169; BOUCHER RC, 1981, J APPL PHYSIOL, V50, P613, DOI 10.1152/jappl.1981.50.3.613; BOUCHER RC, 1981, J APPL PHYSIOL, V51, P706, DOI 10.1152/jappl.1981.51.3.706; CHINET TC, 1993, AM J PHYSIOL, V265, pC1050, DOI 10.1152/ajpcell.1993.265.4.C1050; Cho HJ, 2010, AM J PHYSIOL-LUNG C, V299, pL124, DOI 10.1152/ajplung.00049.2010; Choi HK, 2000, J ANAT, V197, P361, DOI 10.1046/j.1469-7580.2000.19730361.x; Choi JY, 2007, J CLIN INVEST, V117, P3118, DOI 10.1172/JCI31992; Choi JY, 2009, J CLIN INVEST, V119, P1189, DOI 10.1172/JCI37284; CLARKE LL, 1992, AM J PHYSIOL, V263, pC348, DOI 10.1152/ajpcell.1992.263.2.C348; Cramer N, 2010, INT J MED MICROBIOL, V300, P526, DOI 10.1016/j.ijmm.2010.08.004; Dajani R, 2005, AM J RESP CELL MOL, V32, P548, DOI 10.1165/rcmb.2005-0059OC; ENGELHARDT JF, 1992, NAT GENET, V2, P240, DOI 10.1038/ng1192-240; Grubb BR, 2006, AM J PHYSIOL-LUNG C, V290, pL270, DOI 10.1152/ajplung.00249.2005; Harvey RJ, 2007, RHINOLOGY, V45, P3; Ianowski JP, 2007, J PHYSIOL-LONDON, V580, P301, DOI 10.1113/jphysiol.2006.123653; Jayaraman S, 2001, P NATL ACAD SCI USA, V98, P8119, DOI 10.1073/pnas.131087598; Joo N S, 2001, JOP, V2, P280; Joo NS, 2010, J CLIN INVEST, V120, P3161, DOI 10.1172/JCI43466; Joo NS, 2006, J BIOL CHEM, V281, P7392, DOI 10.1074/jbc.M512766200; Joo NS, 2002, J BIOL CHEM, V277, P50710, DOI 10.1074/jbc.M208826200; Joo NS, 2001, AM J PHYSIOL-LUNG C, V281, pL458, DOI 10.1152/ajplung.2001.281.2.L458; Khansaheb M, 2011, AM J PHYSIOL-LUNG C, V300, pL370, DOI 10.1152/ajplung.00372.2010; Kim HJ, 1997, AM J RHINOL, V11, P275, DOI 10.2500/105065897781446676; KNOWLES M, 1981, NEW ENGL J MED, V305, P1489, DOI 10.1056/NEJM198112173052502; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; Lee RJ, 2010, J CLIN INVEST, V120, P3137, DOI 10.1172/JCI42992; Leung MK, 2008, AM J RHINOL, V22, P192, DOI 10.2500/ajr.2008.22.3146; Loebinger MR, 2009, THORAX, V64, P1096, DOI 10.1136/thx.2008.112870; Mainz JG, 2009, THORAX, V64, P535, DOI 10.1136/thx.2008.104711; Mainz JG, 2009, J CYST FIBROS, V8, pS69; Mainz Jochen G, 2009, J Cyst Fibros, V8 Suppl 1, pS10, DOI 10.1016/S1569-1993(09)60005-9; Meyerholz DK, 2010, AM J RESP CRIT CARE, V182, P1251, DOI 10.1164/rccm.201004-0643OC; Meyerholz DK, 2010, AM J PATHOL, V176, P1377, DOI 10.2353/ajpath.2010.090849; Ostedgaard LS, 2007, P NATL ACAD SCI USA, V104, P15370, DOI 10.1073/pnas.0706974104; Ostedgaard LS, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001868; Roby BB, 2008, INT J PEDIATR OTORHI, V72, P1365, DOI 10.1016/j.ijporl.2008.05.011; Rogers CS, 2008, SCIENCE, V321, P1837, DOI 10.1126/science.1163600; Rogers CS, 2008, AM J PHYSIOL-LUNG C, V295, pL240, DOI 10.1152/ajplung.90203.2008; Rogers CS, 2008, J CLIN INVEST, V118, P1571, DOI 10.1172/JCI34773; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Salinas D, 2004, FASEB J, V18, P431, DOI 10.1096/fj.04-2879fje; Song YL, 2006, AM J PHYSIOL-CELL PH, V290, pC741, DOI 10.1152/ajpcell.00379.2005; Standaert TA, 2004, PEDIATR PULM, V37, P385, DOI 10.1002/ppul.10448; Stoltz DA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000928; Sun XS, 2010, J CLIN INVEST, V120, P3149, DOI 10.1172/JCI43052; Tai CF, 2002, CURR OPIN ALLERGY CL, V2, P11, DOI 10.1097/00130832-200202000-00003; TAYLOR RFH, 1992, THORAX, V47, P426, DOI 10.1136/thx.47.6.426; Thiagarajah JR, 2004, FASEB J, V18, P875, DOI 10.1096/fj.03-1248fje; TOS M, 1976, ACTA OTO-LARYNGOL, V82, P249, DOI 10.3109/00016487609120896; TOS M, 1975, ARCH OTOLARYNGOL, V101, P367; Trout L, 2001, AM J PHYSIOL-LUNG C, V281, pL639, DOI 10.1152/ajplung.2001.281.3.L639; Verkman AS, 2003, AM J PHYSIOL-CELL PH, V284, pC2, DOI 10.1152/ajpcell.00417.2002; Wagner JA, 1999, J GENE MED, V1, P13, DOI 10.1002/(SICI)1521-2254(199901/02)1:1<13::AID-JGM6>3.3.CO;2-7; Wang XJ, 2000, JAMA-J AM MED ASSOC, V284, P1814, DOI 10.1001/jama.284.14.1814; WHIMSTER W F, 1986, Applied Pathology, V4, P24; Widdicombe JH, 2002, EQUINE VET J, V34, P630, DOI 10.2746/042516402776180151; Wine Jeffrey J, 2004, Proc Am Thorac Soc, V1, P47, DOI 10.1513/pats.2306015; WINE JJ, 1991, AM J PHYSIOL, V261, pL218, DOI 10.1152/ajplung.1991.261.2.L218	65	27	27	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2011	6	8							e24424	10.1371/journal.pone.0024424	http://dx.doi.org/10.1371/journal.pone.0024424			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817NM	21935358	Green Published, gold, Green Submitted			2022-12-25	WOS:000294680800088
J	Molinari, P; Crespo, MI; Gravisaco, MJ; Taboga, O; Moron, G				Molinari, Paula; Crespo, Maria I.; Gravisaco, Maria J.; Taboga, Oscar; Moron, Gabriel			Baculovirus Capsid Display Potentiates OVA Cytotoxic and Innate Immune Responses	PLOS ONE			English	Article							NUCLEAR POLYHEDROSIS-VIRUS; PLASMACYTOID DENDRITIC CELLS; LYMPHOCYTE-MEDIATED CYTOTOXICITY; CD8(+) T-CELLS; IN-VIVO; CIRCUMSPOROZOITE PROTEIN; ANTIGEN; MICE; EXPRESSION; INFECTION	Baculoviruses (BV) are DNA viruses that are pathogenic for insects. Although BV infect a range of mammalian cell types, they do not replicate in these cells. Indeed, the potential effects of these insect viruses on the immune responses of mammals are only just beginning to be studied. We show in this paper that a recombinant Autographa californica multiple nuclear polyhedrosis virus carrying a fragment of ovalbumin (OVA) on the VP39 capsid protein (BV-OVA) has the capacity to act as an adjuvant and vector of antigens in mice, thereby promoting specific CD4 and cytotoxic T cell responses against OVA. BV also induced in vivo maturation of dendritic cells and the production of inflammatory cytokines, thus promoting innate and adaptive immune responses. The OVA-specific response induced by BV-OVA was strong enough to reject a challenge with OVA-expressing melanoma cells (MO5 cells) and effectively prolonged survival of MO5 bearing mice. All these findings, together with the absence of pre-existing immunity to BV in humans and the lack of viral gene expression in mammalian cells, make BV a candidate for vaccination.	[Molinari, Paula; Gravisaco, Maria J.; Taboga, Oscar] Ctr Nacl Invest Agropecuarias CNIA, INTA Castelar, Inst Biotecnol, Buenos Aires, DF, Argentina; [Crespo, Maria I.; Moron, Gabriel] Univ Nacl Cordoba, Fac Ciencias Quim, Ctr Invest Bioquim Clin & Inmunol CIBICI CONICET, RA-5000 Cordoba, Argentina	Instituto Nacional de Tecnologia Agropecuaria (INTA); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Molinari, P (corresponding author), Ctr Nacl Invest Agropecuarias CNIA, INTA Castelar, Inst Biotecnol, Buenos Aires, DF, Argentina.	gmoron@fcq.unc.edu.ar		, Oscar/0000-0001-9575-3045	Fondo para la Investigacion Cientifica y Tecnologica-Agencia Nacional de Promocion Cientifica y Tecnologica (FONCyT-ANPCyT) [PICT 2004-26339, PICT 2007-475]; Consejo Nacional de Investigacion Cientifica y Tecnologica (CONICET) [PIP 11220090100109]; Secretaria de Ciencia Y Tecnica de la Universidad Nacional de Cordoba (SECyT-UNC); Proyecto Estrategico-Instituto Nacional de Tecnologia Agropecuaria (PE-INTA [2009 232161]	Fondo para la Investigacion Cientifica y Tecnologica-Agencia Nacional de Promocion Cientifica y Tecnologica (FONCyT-ANPCyT)(ANPCyTFONCyT); Consejo Nacional de Investigacion Cientifica y Tecnologica (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Secretaria de Ciencia Y Tecnica de la Universidad Nacional de Cordoba (SECyT-UNC)(Secretaria de Ciencia y Tecnologia (SECYT)); Proyecto Estrategico-Instituto Nacional de Tecnologia Agropecuaria (PE-INTA	This work was supported by grants to GM from Fondo para la Investigacion Cientifica y Tecnologica-Agencia Nacional de Promocion Cientifica y Tecnologica (FONCyT-ANPCyT (PICT 2004-26339)), Consejo Nacional de Investigacion Cientifica y Tecnologica (CONICET, PIP 11220090100109) and Secretaria de Ciencia Y Tecnica de la Universidad Nacional de Cordoba (SECyT-UNC) and grants to OT from FonCyT-ANPCyT (PICT 2007-475) and Proyecto Estrategico-Instituto Nacional de Tecnologia Agropecuaria (PE-INTA 2009 232161). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2005, J VIROL, V79, P2847, DOI 10.1128/JVI.79.5.2847-2858.2005; Abe T, 2003, J IMMUNOL, V171, P1133, DOI 10.4049/jimmunol.171.3.1133; Abe T, 2009, J VIROL, V83, P7629, DOI 10.1128/JVI.00679-09; Andreasson K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011580; Blagborough AM, 2010, VACCINE, V28, P6014, DOI 10.1016/j.vaccine.2010.06.100; BLISSARD GW, 1992, J VIROL, V66, P6829, DOI 10.1128/JVI.66.11.6829-6835.1992; BOUBLIK Y, 1995, BIO-TECHNOL, V13, P1079, DOI 10.1038/nbt1095-1079; de Mare A, 2008, GENE THER, V15, P393, DOI 10.1038/sj.gt.3303060; Di Pucchio T, 2008, NAT IMMUNOL, V9, P551, DOI 10.1038/ni.1602; Facciabene A, 2004, J VIROL, V78, P8663, DOI 10.1128/JVI.78.16.8663-8672.2004; FALO LD, 1995, NAT MED, V1, P649, DOI 10.1038/nm0795-649; Federici BA, 1986, BIOL BACULOVIRUSES, VI, P61; Fujii SI, 2004, J EXP MED, V199, P1607, DOI 10.1084/jem.20040317; Goldberger O, 2008, CANCER RES, V68, P3450, DOI 10.1158/0008-5472.CAN-07-5006; Grabherr R, 2001, TRENDS BIOTECHNOL, V19, P231, DOI 10.1016/S0167-7799(01)01610-9; Hermans IF, 2003, J IMMUNOL, V171, P5140, DOI 10.4049/jimmunol.171.10.5140; Hervas-Stubbs S, 2007, J IMMUNOL, V178, P2361, DOI 10.4049/jimmunol.178.4.2361; Hoeffel G, 2007, IMMUNITY, V27, P481, DOI 10.1016/j.immuni.2007.07.021; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Jongbloed SL, 2010, J EXP MED, V207, P1247, DOI 10.1084/jem.20092140; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Kagi D, 1996, ANNU REV IMMUNOL, V14, P207, DOI 10.1146/annurev.immunol.14.1.207; KARTTUNEN J, 1992, P NATL ACAD SCI USA, V89, P6020, DOI 10.1073/pnas.89.13.6020; Kedl RM, 2003, CURR OPIN IMMUNOL, V15, P120, DOI 10.1016/S0952-7915(02)00009-2; Kitajima M, 2008, CLIN VACCINE IMMUNOL, V15, P376, DOI 10.1128/CVI.00285-07; Kitajima M, 2008, MOL THER, V16, P261, DOI 10.1038/sj.mt.6300364; Kukkonen SP, 2003, MOL THER, V8, P853, DOI 10.1016/j.ymthe.2003.07.009; Kuwajima S, 2006, NAT IMMUNOL, V7, P740, DOI 10.1038/ni1348; Maletto BA, 2005, CLIN IMMUNOL, V117, P251, DOI 10.1016/j.clim.2005.08.016; Moron G, 2002, J EXP MED, V195, P1233, DOI 10.1084/jem.20011930; Mottershead D, 1997, BIOCHEM BIOPH RES CO, V238, P717, DOI 10.1006/bbrc.1997.7372; Mouries J, 2008, BLOOD, V112, P3713, DOI 10.1182/blood-2008-03-146290; Naslund TI, 2007, J IMMUNOL, V178, P6761, DOI 10.4049/jimmunol.178.11.6761; Nowak AK, 2006, ADV DRUG DELIVER REV, V58, P975, DOI 10.1016/j.addr.2006.04.002; O'Reilly D.R., 1994, BACULOVIRUS EXPRESSI; Peralta A, 2007, APPL MICROBIOL BIOT, V75, P407, DOI 10.1007/s00253-006-0825-4; Rajagopal D, 2010, BLOOD, V115, P1949, DOI 10.1182/blood-2009-08-238543; Reschner A, 2008, CLIN EXP IMMUNOL, V152, P219, DOI 10.1111/j.1365-2249.2008.03624.x; Russell JH, 2002, ANNU REV IMMUNOL, V20, P323, DOI 10.1146/annurev.immunol.20.100201.131730; Rutigliano JA, 2007, VIROLOGY, V362, P314, DOI 10.1016/j.virol.2006.12.023; Salminen M, 2005, J VIROL, V79, P2720, DOI 10.1128/JVI.79.5.2720-2728.2005; Schirmbeck R, 2008, MOL THER, V16, P1609, DOI 10.1038/mt.2008.141; SETTE A, 1994, J IMMUNOL, V153, P5586; Shen CF, 2002, J VIROL METHODS, V105, P321, DOI 10.1016/S0166-0934(02)00128-3; Silk JD, 2004, J CLIN INVEST, V114, P1800, DOI 10.1172/JCI200422046; Sorensen MR, 2009, EUR J IMMUNOL, V39, P2725, DOI 10.1002/eji.200939543; Strauss R, 2007, MOL THER, V15, P193, DOI 10.1038/sj.mt.6300008; Suzuki T, 2010, CELL IMMUNOL, V262, P35, DOI 10.1016/j.cellimm.2009.12.005; Tami C, 2000, ARCH VIROL, V145, P1815, DOI 10.1007/s007050070058; TJIA ST, 1983, VIROLOGY, V125, P107; VOLKMAN LE, 1983, APPL ENVIRON MICROB, V45, P1085, DOI 10.1128/AEM.45.3.1085-1093.1983; Wang P, 1997, J GEN VIROL, V78, P3081, DOI 10.1099/0022-1317-78-12-3081; Wei J, 2010, J IMMUNOL, V185, P6013, DOI 10.4049/jimmunol.1002129; Whittaker GR, 1998, VIROLOGY, V246, P1, DOI 10.1006/viro.1998.9165; Yewdell JW, 2004, IMMUNITY, V21, P149, DOI 10.1016/j.immuni.2004.06.015; Yoshida S, 2003, VIROLOGY, V316, P161, DOI 10.1016/j.virol.2003.08.003; Yoshida S, 2009, INFECT IMMUN, V77, P1782, DOI 10.1128/IAI.01226-08	59	31	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	AUG 30	2011	6	8							e24108	10.1371/journal.pone.0024108	http://dx.doi.org/10.1371/journal.pone.0024108			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817MS	21918683	Green Submitted, Green Published, gold			2022-12-25	WOS:000294678300023
J	Stiehl, DP; Bordoli, MR; Abreu-Rodriguez, I; Wollenick, K; Schraml, P; Gradin, K; Poellinger, L; Kristiansen, G; Wenger, RH				Stiehl, D. P.; Bordoli, M. R.; Abreu-Rodriguez, I.; Wollenick, K.; Schraml, P.; Gradin, K.; Poellinger, L.; Kristiansen, G.; Wenger, R. H.			Non-canonical HIF-2 alpha function drives autonomous breast cancer cell growth via an AREG-EGFR/ErbB4 autocrine loop	ONCOGENE			English	Article						hypoxic expression profiles; luminal breast cancer; growth factors; HIF target genes; EGF signaling	HYPOXIA-INDUCIBLE FACTOR-2-ALPHA; TRANSCRIPTIONAL REGULATION; FACTOR (HIF)-1-ALPHA; GENE-EXPRESSION; TARGET GENES; DNA-BINDING; IN-VIVO; HIF-1-ALPHA; CARCINOMA; TUMORIGENESIS	Tumor progression is intrinsically tied to the clonal selection of tumor cells with acquired phenotypes allowing to cope with a hostile microenvironment. Hypoxia-inducible factors (HIFs) master the transcriptional response to local tissue hypoxia, a hallmark of solid tumors. Here, we report significantly longer patient survival in breast cancer with high levels of HIF-2 alpha. Amphiregulin (AREG) and WNT1-inducible signaling pathway protein-2 (WISP2) expression was strongly HIF-2 alpha-dependent and their promoters were particularly responsive to HIF-2 alpha. The endogenous AREG promoter recruited HIF-2 alpha in the absence of a classical HIF-DNA interaction motif, revealing a novel mechanism of gene regulation. Loss of AREG expression in HIF-2 alpha-depleted cells was accompanied by reduced activation of epidermal growth factor (EGF) receptor family members. Apparently opposing results from patient and in vitro data point to an HIF-2 alpha-dependent auto-stimulatory tumor phenotype that, while promoting EGF signaling in cellular models, increased the survival of diagnosed and treated human patients. Our findings suggest a model where HIF-2 alpha-mediated autocrine growth signaling in breast cancer sustains a state of cellular self-sufficiency, thereby masking unfavorable microenvironmental growth conditions, limiting adverse selection and improving therapy efficacy. Importantly, HIF-2 alpha/AREG/WISP2-expressing tumors were associated with luminal tumor differentiation, indicative of a better response to classical treatments. Shifting the HIF-1/2 alpha balance toward an HIF-2-dominated phenotype could thus offer a novel approach in breast cancer therapy. Oncogene (2012) 31, 2283-2297; doi:10.1038/onc.2011.417; published online 19 September 2011	[Stiehl, D. P.; Bordoli, M. R.; Abreu-Rodriguez, I.; Wollenick, K.; Wenger, R. H.] Univ Zurich, Inst Physiol, CH-8057 Zurich, Switzerland; [Stiehl, D. P.; Bordoli, M. R.; Abreu-Rodriguez, I.; Wollenick, K.; Wenger, R. H.] Univ Zurich, Zurich Ctr Human Physiol ZIHP, CH-8057 Zurich, Switzerland; [Schraml, P.] Univ Zurich Hosp, Dept Surg Pathol, CH-8091 Zurich, Switzerland; [Gradin, K.; Poellinger, L.] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden; [Poellinger, L.] Natl Univ Singapore, Canc Sci Inst, Singapore 117548, Singapore; [Kristiansen, G.] Univ Hosp Bonn, Inst Pathol, Bonn, Germany	University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP); University of Zurich; University Zurich Hospital; Karolinska Institutet; National University of Singapore; University of Bonn	Stiehl, DP (corresponding author), Univ Zurich, Inst Physiol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	daniel.stiehl@uzh.ch	Wenger, Roland H./B-7953-2009; Stiehl, Daniel/A-3622-2008	Wenger, Roland H./0000-0001-7592-4839; Stiehl, Daniel/0000-0002-0076-4874; Bordoli, Mattia/0000-0001-6917-8753	Swiss National Science Foundation [31003A_129962/1]; Swedish Cancer Society; European Union, Metoxia; COST Action [TD0901 HypoxiaNet]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swedish Cancer Society(Swedish Cancer Society); European Union, Metoxia; COST Action(European Cooperation in Science and Technology (COST))	We thank M Sabbah, SB Lee, S Pastorekova, C Pugh and PJ Ratcliffe for providing materials and primer information. This work was supported by the Swiss National Science Foundation grant 31003A_129962/1 (to RHW and DPS), the Swedish Cancer Society and European Union, Metoxia (to LP), and the COST Action TD0901 HypoxiaNet.	Aprelikova O, 2006, CANCER RES, V66, P5641, DOI 10.1158/0008-5472.CAN-05-3345; Banerjee S, 2008, CANCER RES, V68, P7606, DOI 10.1158/0008-5472.CAN-08-1461; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Bordoli MR, 2011, ONCOGENE, V30, P548, DOI 10.1038/onc.2010.433; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Cummins EP, 2005, PFLUG ARCH EUR J PHY, V450, P363, DOI 10.1007/s00424-005-1413-7; Dewhirst MW, 2008, NAT REV CANCER, V8, P425, DOI 10.1038/nrc2397; Elvert G, 2003, J BIOL CHEM, V278, P7520, DOI 10.1074/jbc.M211298200; Elvidge GP, 2006, J BIOL CHEM, V281, P15215, DOI 10.1074/jbc.M511408200; Franovic A, 2009, P NATL ACAD SCI USA, V106, P21306, DOI 10.1073/pnas.0906432106; Fritah A, 2008, MOL CELL BIOL, V28, P1114, DOI 10.1128/MCB.01335-07; Gatenby RA, 2007, BRIT J CANCER, V97, P646, DOI 10.1038/sj.bjc.6603922; Gatenby RA, 2009, CANCER RES, V69, P4894, DOI 10.1158/0008-5472.CAN-08-3658; Gordan JD, 2007, CANCER CELL, V11, P335, DOI 10.1016/j.ccr.2007.02.006; Gordan JD, 2008, CANCER CELL, V14, P435, DOI 10.1016/j.ccr.2008.10.016; Helczynska K, 2008, CANCER RES, V68, P9212, DOI 10.1158/0008-5472.CAN-08-1135; Holmquist-Mengelbier L, 2006, CANCER CELL, V10, P413, DOI 10.1016/j.ccr.2006.08.026; Hu CJ, 2007, MOL BIOL CELL, V18, P4528, DOI 10.1091/mbc.E06-05-0419; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Kim HS, 2007, J BIOL CHEM, V282, P16278, DOI 10.1074/jbc.M700215200; Kim WY, 2009, J CLIN INVEST, V119, P2160, DOI 10.1172/JCI38443; Lau KW, 2007, BRIT J CANCER, V96, P1284, DOI 10.1038/sj.bjc.6603675; Le Bras A, 2007, ONCOGENE, V26, P7480, DOI 10.1038/sj.onc.1210566; Lee SB, 1999, CELL, V98, P663, DOI 10.1016/S0092-8674(00)80053-7; Lehmann S, 2009, P NATL ACAD SCI USA, V106, P14004, DOI 10.1073/pnas.0901194106; Liao D, 2007, CANCER RES, V67, P563, DOI 10.1158/0008-5472.CAN-06-2701; Loeb DM, 2001, CANCER RES, V61, P921; Mazumdar J, 2010, P NATL ACAD SCI USA, V107, P14182, DOI 10.1073/pnas.1001296107; Minamishima YA, 2009, MOL CELL BIOL, V29, P5729, DOI 10.1128/MCB.00331-09; Mole DR, 2009, J BIOL CHEM, V284, P16767, DOI 10.1074/jbc.M901790200; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; Park SK, 2003, MOL CELL BIOL, V23, P4959, DOI 10.1128/MCB.23.14.4959-4971.2003; Patel SA, 2008, CELL DEATH DIFFER, V15, P628, DOI 10.1038/cdd.2008.17; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Saito T, 2010, NAT MED, V16, P678, DOI 10.1038/nm.2146; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; SEMENZA GL, 1994, J BIOL CHEM, V269, P23757; Sowter HM, 2003, CANCER RES, V63, P6130; Stiehl DP, 2006, J BIOL CHEM, V281, P23482, DOI 10.1074/jbc.M601719200; Tomes L, 2003, BREAST CANCER RES TR, V81, P61, DOI 10.1023/A:1025476722493; Wang V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009641; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Wykoff CC, 2000, CANCER RES, V60, P7075; Yamashita T, 2008, J BIOL CHEM, V283, P18926, DOI 10.1074/jbc.M709133200; Yan Q, 2007, MOL CELL BIOL, V27, P2092, DOI 10.1128/MCB.01514-06; Yang S, 2010, NAT MED, V16, P687, DOI 10.1038/nm.2153; Yu P, 2007, J BIOL CHEM, V282, P35035, DOI 10.1074/jbc.M707557200	52	55	56	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY	2012	31	18					2283	2297		10.1038/onc.2011.417	http://dx.doi.org/10.1038/onc.2011.417			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	936SR	21927022				2022-12-25	WOS:000303610800004
J	Atianand, MK; Duffy, EB; Shah, A; Kar, S; Malik, M; Harton, JA				Atianand, Maninjay K.; Duffy, Ellen B.; Shah, Aaloki; Kar, Supriya; Malik, Meenakshi; Harton, Jonathan A.			Francisella tularensis Reveals a Disparity between Human and Mouse NLRP3 Inflammasome Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVE VACCINE STRAIN; NF-KAPPA-B; INNATE IMMUNE RECOGNITION; LISTERIA-MONOCYTOGENES; NALP3 INFLAMMASOME; CASPASE-1 ACTIVATION; MURINE MACROPHAGES; SIGNALING PATHWAYS; AIM2 INFLAMMASOME; VIRULENT-STRAINS	Pathogen-triggered activation of the inflammasome complex leading to caspase-1 activation and IL-1 beta production involves similar sensor proteins between mouse and human. However, the specific sensors used may differ between infectious agents and host species. In mice, Francisella infection leads to seemingly exclusive activation of the Aim2 inflammasome with no apparent role for Nlrp3. Here we examine the IL-1 beta response of human cells to Francisella infection. Francisella strains exhibit differences in IL-1 beta production by influencing induction of IL-1 beta and ASC transcripts. Unexpectedly, our results demonstrate that Francisella activates the NLRP3 inflammasome in human cells. Francisella infection of THP-1 cells elicits IL-1 beta production, which is reduced by siRNA targeting of NLRP3. Moreover, in reconstituted 293T cells, Francisella triggers assembly of the NLRP3 inflammasome complex. In addition, inhibitors of reactive oxygen species, cathepsin B, and K+ efflux pathways, known to specifically influence NLRP3, substantially but not completely impair the Francisella-elicited IL-1 beta response, suggesting the involvement of another inflammasome pathway. Finally, shRNA targeting of NLRP3 and AIM2 reveals that both pathways contribute to the inflammasome response. Together these results establish NLRP3 as a cytosolic sensor for Francisella in human cells, a role not observed in mouse.	[Atianand, Maninjay K.; Duffy, Ellen B.; Shah, Aaloki; Kar, Supriya; Malik, Meenakshi; Harton, Jonathan A.] Albany Med Coll, Ctr Immunol & Microbial Dis, Albany, NY 12208 USA; [Malik, Meenakshi] Albany Coll Pharm & Hlth Sci, Dept Arts & Sci, Albany, NY 12208 USA	Albany Medical College; Albany College of Pharmacy & Health Sciences	Harton, JA (corresponding author), 47 New Scotland Ave,MC-151, Albany, NY 12208 USA.	hartonj@mail.amc.edu	Atianand, Maninjay/AAF-7823-2019; Harton, Jonathan/F-2848-2010; Harton, Jonathan A/AAW-5283-2021; Malik, Meenakshi/F-1501-2015	Atianand, Maninjay/0000-0003-4135-2515; Harton, Jonathan/0000-0002-0350-1877; Harton, Jonathan A/0000-0002-0350-1877; Malik, Meenakshi/0000-0003-0051-4485	National Institutes of Health [R21AI075250, P01AI056320, R01AI072259]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI075250, P01AI056320, R01AI072259] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants R21AI075250 (to M. M.) and P01AI056320 and R01AI072259 (J. A. H.).	Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Barlan AU, 2011, J VIROL, V85, P146, DOI 10.1128/JVI.01265-10; Bedoya F, 2007, J IMMUNOL, V178, P3837, DOI 10.4049/jimmunol.178.6.3837; Bolger CE, 2005, J LEUKOCYTE BIOL, V77, P893, DOI 10.1189/jlb.1104637; Bryan NB, 2009, J IMMUNOL, V182, P3173, DOI 10.4049/jimmunol.0802367; Burckstummer T, 2009, NAT IMMUNOL, V10, P266, DOI 10.1038/ni.1702; Butchar JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002924; Carta S, 2011, J BIOL CHEM, V286, P27069, DOI 10.1074/jbc.M110.203398; Choubey D, 2010, J INTERF CYTOK RES, V30, P371, DOI 10.1089/jir.2009.0096; Church LD, 2008, NAT CLIN PRACT RHEUM, V4, P34, DOI 10.1038/ncprheum0681; Cole LE, 2008, J IMMUNOL, V180, P6885, DOI 10.4049/jimmunol.180.10.6885; Cole LE, 2007, INFECT IMMUN, V75, P4127, DOI 10.1128/IAI.01868-06; Conlan JW, 2003, MICROB PATHOGENESIS, V34, P39, DOI 10.1016/S0882-4010(02)00194-8; Conlan JW, 2003, MICROB PATHOGENESIS, V34, P239, DOI 10.1016/S0882-4010(03)00046-9; Corr SC, 2009, CELL MICROBIOL, V11, P703, DOI 10.1111/j.1462-5822.2009.01294.x; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; Fernandes-Alnemri T, 2010, NAT IMMUNOL, V11, P385, DOI 10.1038/ni.1859; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Gavrilin MA, 2006, P NATL ACAD SCI USA, V103, P141, DOI 10.1073/pnas.0504271103; GAVRILIN MA, 2011, FRONT MICROBIOL, V2, P1; Gavrilin MA, 2009, J IMMUNOL, V182, P7982, DOI 10.4049/jimmunol.0803073; Golovliov I, 2003, INFECT IMMUN, V71, P5940, DOI 10.1128/IAI.71.10.5940-5950.2003; Hall JD, 2007, INFECT IMMUN, V75, P1034, DOI 10.1128/IAI.01254-06; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Harton JA, 2002, HUM IMMUNOL, V63, P588, DOI 10.1016/S0198-8859(02)00400-7; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jiang ZF, 2004, P NATL ACAD SCI USA, V101, P3533, DOI 10.1073/pnas.0308496101; Jones JW, 2010, P NATL ACAD SCI USA, V107, P9771, DOI 10.1073/pnas.1003738107; Kahlenberg JM, 2004, J LEUKOCYTE BIOL, V76, P676, DOI 10.1189/jlb.0404221; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Kanneganti TD, 2007, IMMUNITY, V26, P433, DOI 10.1016/j.immuni.2007.03.008; Kopp EB, 1999, CURR OPIN IMMUNOL, V11, P13, DOI 10.1016/S0952-7915(99)80003-X; Malik M, 2006, INFECT IMMUN, V74, P3657, DOI 10.1128/IAI.02030-05; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Mariathasan S, 2005, J EXP MED, V202, P1043, DOI 10.1084/jem.20050977; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Meixenberger K, 2010, J IMMUNOL, V184, P922, DOI 10.4049/jimmunol.0901346; Mohapatra NP, 2010, J IMMUNOL, V184, P5141, DOI 10.4049/jimmunol.0903413; Noah CE, 2010, INFECT IMMUN, V78, P1797, DOI 10.1128/IAI.01135-09; O'Connor W, 2003, J IMMUNOL, V171, P6329, DOI 10.4049/jimmunol.171.12.6329; Oyston PCF, 2004, NAT REV MICROBIOL, V2, P967, DOI 10.1038/nrmicro1045; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Santic M, 2010, CELL MICROBIOL, V12, P129, DOI 10.1111/j.1462-5822.2009.01400.x; Schneemann M, 2007, J LEUKOCYTE BIOL, V81, P579, DOI 10.1189/jlb.1106702; Schwende H, 1996, J LEUKOCYTE BIOL, V59, P555, DOI 10.1002/jlb.59.4.555; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shen H, 2004, VACCINE, V22, P2116, DOI 10.1016/j.vaccine.2003.12.003; Srinivasula SM, 2002, J BIOL CHEM, V277, P21119, DOI 10.1074/jbc.C200179200; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Ting JPY, 2005, ANNU REV IMMUNOL, V23, P387, DOI 10.1146/annurev.immunol.23.021704.115616; Williams KL, 2003, J IMMUNOL, V170, P5354, DOI 10.4049/jimmunol.170.11.5354; Wu JH, 2010, J CLIN IMMUNOL, V30, P693, DOI 10.1007/s10875-010-9425-2; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	62	54	55	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2011	286	45					39033	39042		10.1074/jbc.M111.244079	http://dx.doi.org/10.1074/jbc.M111.244079			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	844PO	21930705	Green Published, hybrid			2022-12-25	WOS:000296759800022
J	Lu, JW; Aggarwal, R; Kanji, S; Das, M; Joseph, M; Pompili, V; Das, H				Lu, Jingwei; Aggarwal, Reeva; Kanji, Suman; Das, Manjusri; Joseph, Matthew; Pompili, Vincent; Das, Hiranmoy			Human Ovarian Tumor Cells Escape gamma delta T Cell Recognition Partly by Down Regulating Surface Expression of MICA and Limiting Cell Cycle Related Molecules	PLOS ONE			English	Article							CARCINOMA CELLS; MULTIPLE-MYELOMA; INNATE IMMUNITY; BREAST-CANCER; NK CELLS; IN-VIVO; ACTIVATION; NKG2D; RECEPTOR; P53	Background: Mechanisms of human V gamma 2V delta 2 T cell-mediated tumor immunity have yet to be fully elucidated. Methods and Findings: At least some tumor cell recognition is mediated by NKG2D-MICA interactions. Herein, by using MTT assay and PI-BrdU co-staining and Western-blot, we show that these V gamma 2V delta 2 T cells can limit the proliferation of ovarian tumor cells by down regulation of apoptosis and cell cycle related molecules in tumor cells. Cell-to-cell contact is critical. gamma delta T cell-resistant, but not susceptible ovarian tumor cells escape gamma delta T cell-mediated immune recognition by up-regulating pErk1/2, thereby decreasing surface MICA levels. Erk1/2 inhibitor pretreatment or incubation prevents this MICA decrease, while up-regulating key cell cycle related molecules such as CDK2, CDK4 and Cyclin D1, as well as apoptosis related molecules making resistant tumor cells now vulnerable to gamma delta T cell-mediated lysis. Conclusion: These findings demonstrate novel effects of gamma delta T cells on ovarian tumor cells.	[Lu, Jingwei; Aggarwal, Reeva; Kanji, Suman; Das, Manjusri; Joseph, Matthew; Pompili, Vincent; Das, Hiranmoy] Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Das, Hiranmoy] Ohio State Univ, Ctr Comprehens Canc, Richard J Solove Res Inst, Arthur G James Canc Hosp, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Lu, JW (corresponding author), Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA.	hiranmoy.das@osumc.edu	Das, Hiranmoy/R-7452-2019	Das, Hiranmoy/0000-0002-3343-0096	National Institutes of Health; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [K01 AR054114]; National Heart, Lung, and Blood Institute (NHLBI) [SBIR R44 HL092706-01]; National Cancer Institute (NCI) [R21 CA143787]; The Ohio State University; NATIONAL CANCER INSTITUTE [R21CA143787] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R44HL092706] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR054114] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); The Ohio State University(Ohio State University); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part by National Institutes of Health grants, K01 AR054114 National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), SBIR R44 HL092706-01 National Heart, Lung, and Blood Institute (NHLBI), R21 CA143787 National Cancer Institute (NCI) and The Ohio State University start-up fund. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Austrup F, 1997, NATURE, V385, P81, DOI 10.1038/385081a0; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Bellacosa A, 2005, ADV CANCER RES, V94, P29, DOI 10.1016/S0065-230X(05)94002-5; Bukowski JF, 1999, IMMUNITY, V11, P57, DOI 10.1016/S1074-7613(00)80081-3; Champsaur M, 2010, IMMUNOL REV, V235, P267, DOI 10.1111/j.0105-2896.2010.00893.x; Chatterjee M, 2007, BLOOD, V109, P720, DOI 10.1182/blood-2006-05-024372; Das H, 2004, J IMMUNOL, V172, P6578, DOI 10.4049/jimmunol.172.11.6578; Das H, 2001, BLOOD, V98, P1616, DOI 10.1182/blood.V98.5.1616; Das H, 2001, IMMUNITY, V15, P83, DOI 10.1016/S1074-7613(01)00168-6; DeHaan RD, 2001, CANCER CHEMOTH PHARM, V48, P383, DOI 10.1007/s002800100318; Denkert C, 2003, ONCOGENE, V22, P8653, DOI 10.1038/sj.onc.1206920; Eleme K, 2004, J EXP MED, V199, P1005, DOI 10.1084/jem.20032194; Fang L, 2001, EMBO J, V20, P1931, DOI 10.1093/emboj/20.8.1931; Friese MA, 2003, CANCER RES, V63, P8996; Goping IS, 2003, IMMUNITY, V18, P355, DOI 10.1016/S1074-7613(03)00032-3; Groh V, 1999, P NATL ACAD SCI USA, V96, P6879, DOI 10.1073/pnas.96.12.6879; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; HARA T, 1992, J CLIN INVEST, V90, P204, DOI 10.1172/JCI115837; Hortobagyi GN, 1996, NEW ENGL J MED, V335, P1785, DOI 10.1056/NEJM199612123352401; HUTCHINS D, 1994, INT J CANCER, V58, P80, DOI 10.1002/ijc.2910580114; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kaiser BK, 2007, NATURE, V447, P482, DOI 10.1038/nature05768; Kajiyama H, 2003, CANCER RES, V63, P2278; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Kunzmann V, 2000, BLOOD, V96, P384; Kyriazi S, 2010, NAT REV CLIN ONCOL, V7, P381, DOI 10.1038/nrclinonc.2010.47; Morita CT, 2007, IMMUNOL REV, V215, P59, DOI 10.1111/j.1600-065X.2006.00479.x; MORITA CT, 1994, J IMMUNOL, V153, P3979; Oppenheim DE, 2005, NAT IMMUNOL, V6, P928, DOI 10.1038/ni1239; Pietenpol JA, 2002, TOXICOLOGY, V181, P475, DOI 10.1016/S0300-483X(02)00460-2; PORCELLI S, 1991, IMMUNOL REV, V120, P137, DOI 10.1111/j.1600-065X.1991.tb00591.x; Raspollini MR, 2005, ANN ONCOL, V16, P590, DOI 10.1093/annonc/mdi112; Roth SJ, 1998, EUR J IMMUNOL, V28, P104, DOI 10.1002/(SICI)1521-4141(199801)28:01<104::AID-IMMU104>3.0.CO;2-F; Russell RGG, 1999, BONE, V25, P97, DOI 10.1016/S8756-3282(99)00116-7; Salih HR, 2002, J IMMUNOL, V169, P4098, DOI 10.4049/jimmunol.169.8.4098; Sapino A, 2001, J PATHOL, V194, P254, DOI 10.1002/1096-9896(200106)194:2<254::AID-PATH880>3.0.CO;2-2; Sengupta TK, 1998, P NATL ACAD SCI USA, V95, P11107, DOI 10.1073/pnas.95.19.11107; Spada FM, 2000, J EXP MED, V191, P937, DOI 10.1084/jem.191.6.937; Syed V, 2002, JNCI-J NATL CANCER I, V94, P617; Tang DM, 2002, J BIOL CHEM, V277, P12710, DOI 10.1074/jbc.M111598200; Vermijlen D, 2001, CANCER IMMUNOL IMMUN, V50, P212, DOI 10.1007/s002620100191; Wisel S, 2009, J PHARMACOL EXP THER, V329, P543, DOI 10.1124/jpet.109.150839; Wu J, 2002, J IMMUNOL, V169, P1236, DOI 10.4049/jimmunol.169.3.1236; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730; Xu GX, 2001, BIOCHEM BIOPH RES CO, V287, P47, DOI 10.1006/bbrc.2001.5533; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yazlovitskaya EM, 2001, BIOCHEM BIOPH RES CO, V283, P732, DOI 10.1006/bbrc.2001.4849; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177	48	20	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2011	6	9							e23348	10.1371/journal.pone.0023348	http://dx.doi.org/10.1371/journal.pone.0023348			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	822JC	21935360	gold, Green Published, Green Submitted			2022-12-25	WOS:000295039700002
J	Gast, A; Bermejo, JL; Claus, R; Brandt, A; Weires, M; Weber, A; Plass, C; Sucker, A; Hemminki, K; Schadendorf, D; Kumar, R				Gast, Andreas; Bermejo, Justo Lorenzo; Claus, Rainer; Brandt, Andreas; Weires, Marianne; Weber, Alexander; Plass, Christoph; Sucker, Antje; Hemminki, Kari; Schadendorf, Dirk; Kumar, Rajiv			Association of Inherited Variation in Toll-Like Receptor Genes with Malignant Melanoma Susceptibility and Survival	PLOS ONE			English	Article							PROSTATE-CANCER; LINKING INNATE; METASTATIC MELANOMA; HUMAN-DISEASE; POLYMORPHISMS; VARIANTS; TLR2; IMMUNITY; THERAPY; INTERLEUKIN-2	The family of Toll-like receptors (TLRs) is critical in linking innate and acquired immunity. Polymorphisms in the genes encoding TLRs have been associated with autoimmune diseases and cancer. We investigated the genetic variation of TLR genes and its potential impact on melanoma susceptibility and patient survival. The study included 763 cutaneous melanoma cases recruited in Germany and 736 matched controls that were genotyped for 47 single nucleotide polymorphisms (SNPs) in 8 TLR genes. The relationship between genotype, disease status and survival was investigated taking into account patient and tumor characteristics, and melanoma treatment. Analysis of 7 SNPs in TLR2, 7 SNPs in TLR3 and 8 SNPs in TLR4 showed statistically significant differences in distribution of inferred haplotypes between cases and controls. No individual polymorphism was associated with disease susceptibility except for the observed tendency for TLR2-rs3804099 (odds ratio OR = 1.15, 95% CI 0.99-1.34, p = 0.07) and TLR4-rs2149356 (OR = 0.85, 95% CI 0.73-1.00, p = 0.06). Both polymorphisms were part of the haplotypes associated with risk modulation. An improved overall survival (Hazard ratio HR 0.53, 95% CI 0.32-0.88) and survival following metastasis (HR 0.55, 95% CI 0.34-0.91) were observed in carriers of the variant allele (D299G) of TLR4-rs4986790. In addition various TLR2, TLR4 and TLR5 haplotypes were associated with increased overall survival. Our results point to a novel association between TLR gene variants and haplotypes with melanoma survival. Our data suggest a role for the D299G polymorphism in the TLR4 gene in overall survival and a potential link with systemic treatment at stage IV of the disease. The polymorphic amino acid residue, located in the ectodomain of TLR4, can have functional consequences.	[Gast, Andreas; Brandt, Andreas; Weires, Marianne; Hemminki, Kari; Kumar, Rajiv] German Canc Res Ctr, Div Mol Genet Epidemiol, D-6900 Heidelberg, Germany; [Bermejo, Justo Lorenzo] Univ Heidelberg, Inst Med Biometry & Informat, Heidelberg, Germany; [Claus, Rainer; Plass, Christoph] German Canc Res Ctr, Dept Epigenom & Canc Risk Factors, D-6900 Heidelberg, Germany; [Weber, Alexander] German Canc Res Ctr, Jr Res Grp Toll Like Receptors & Canc, D-6900 Heidelberg, Germany; [Gast, Andreas; Sucker, Antje; Schadendorf, Dirk] Univ Hosp Essen, Dept Dermatol, Essen, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); University of Duisburg Essen	Gast, A (corresponding author), German Canc Res Ctr, Div Mol Genet Epidemiol, D-6900 Heidelberg, Germany.	r.kumar@dkfz.de	Kumar, Rajiv/H-6431-2019; Plass, Christoph/H-7192-2014; Schadendorf, Dirk/AAE-8206-2019; Claus, Rainer/AAZ-5606-2020	Kumar, Rajiv/0000-0002-6093-0395; Claus, Rainer/0000-0003-2617-8766; Weber, Alexander/0000-0002-8627-7056; Lorenzo Bermejo, Justo/0000-0002-6568-5333	Helmholtz Association within the Helmholtz Alliance on Immunotherapy of Cancer	Helmholtz Association within the Helmholtz Alliance on Immunotherapy of Cancer	This work was supported by the Initiative and Networking Fund of the Helmholtz Association within the Helmholtz Alliance on Immunotherapy of Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABUMAZIAD A, 2010, PEDIAT RES; Agarwala SS, 2009, EXPERT REV ANTICANC, V9, P587, DOI [10.1586/era.09.25, 10.1586/ERA.09.25]; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Apetoh L, 2007, IMMUNOL REV, V220, P47, DOI 10.1111/j.1600-065X.2007.00573.x; ATKINS MB, 1988, NEW ENGL J MED, V318, P1557, DOI 10.1056/NEJM198806163182401; Bochud PY, 2008, J INFECT DIS, V197, P253, DOI 10.1086/524688; Chen YC, 2005, CANCER RES, V65, P11771, DOI 10.1158/0008-5472.CAN-05-2078; Cheng I, 2007, CANCER EPIDEM BIOMAR, V16, P352, DOI 10.1158/1055-9965.EPI-06-0429; Eder W, 2004, J ALLERGY CLIN IMMUN, V113, P482, DOI 10.1016/j.jaci.2003.12.374; Eigentler TK, 2003, LANCET ONCOL, V4, P748, DOI 10.1016/S1470-2045(03)01280-4; El-Omar EM, 2008, ONCOGENE, V27, P244, DOI 10.1038/sj.onc.1210912; Gogas H, 2006, NEW ENGL J MED, V354, P709, DOI 10.1056/NEJMoa053007; Kalialis LV, 2009, MELANOMA RES, V19, P275, DOI 10.1097/CMR.0b013e32832eabd5; Kormann MSD, 2008, J ALLERGY CLIN IMMUN, V122, P86, DOI 10.1016/j.jaci.2008.04.039; Krieg AM, 2007, IMMUNOL REV, V220, P251, DOI 10.1111/j.1600-065X.2007.00572.x; Kumar H, 2009, BIOCHEM BIOPH RES CO, V388, P621, DOI 10.1016/j.bbrc.2009.08.062; Malhotra D, 2005, HUM GENET, V116, P413, DOI 10.1007/s00439-004-1249-9; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Misch EA, 2008, CLIN SCI, V114, P347, DOI 10.1042/CS20070214; Nakamura J, 2009, MOL VIS, V15, P2905; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Pasare C, 2005, ADV EXP MED BIOL, V560, P11; Phan GQ, 2001, J CLIN ONCOL, V19, P3477, DOI 10.1200/JCO.2001.19.15.3477; Rallabhandi P, 2006, J IMMUNOL, V177, P322, DOI 10.4049/jimmunol.177.1.322; Santin I, 2006, ANN NY ACAD SCI, V1079, P268, DOI 10.1196/annals.1375.040; Schwartz DA, 2005, CLIN INFECT DIS, V41, pS403, DOI 10.1086/431985; Stark JR, 2009, CANCER EPIDEM BIOMAR, V18, P1859, DOI 10.1158/1055-9965.EPI-08-0981; Tesniere A, 2010, ONCOGENE, V29, P482, DOI 10.1038/onc.2009.356; Thuong NTT, 2007, GENES IMMUN, V8, P422, DOI 10.1038/sj.gene.6364405; Wang MH, 2009, PROSTATE, V69, P874, DOI 10.1002/pros.20933; Wang RF, 2008, ONCOGENE, V27, P181, DOI 10.1038/sj.onc.1210906	31	50	51	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2011	6	9							e24370	10.1371/journal.pone.0024370	http://dx.doi.org/10.1371/journal.pone.0024370			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CN	21931695	Green Published, Green Submitted, gold			2022-12-25	WOS:000294803100024
J	Jheon, AH; Li, CY; Wen, T; Michon, F; Klein, OD				Jheon, Andrew H.; Li, Chun-Ying; Wen, Timothy; Michon, Frederic; Klein, Ophir D.			Expression of MicroRNAs in the Stem Cell Niche of the Adult Mouse Incisor	PLOS ONE			English	Article							MOLAR TOOTH GERM; MORPHOGENETIC PROTEIN; NUCLEAR EXPORT; DIFFERENTIATION; GENERATION; SKIN; LOCALIZATION; RECOGNITION; TRANSLATION; FOLLISTATIN	The mouse incisor is a valuable but under-utilized model organ for studying the behavior of adult stem cells. This remarkable tooth grows continuously throughout the animal's lifetime and houses two distinct epithelial stem cell niches called the labial and lingual cervical loop (laCL and liCL, respectively). These stem cells produce progeny that undergo a series of well-defined differentiation events en route to becoming enamel-producing ameloblasts. During this differentiation process, the progeny move out of the stem cell niche and migrate toward the distal tip of the tooth. Although the molecular pathways involved in tooth development are well documented, little is known about the roles of miRNAs in this process. We used microarray technology to compare the expression of miRNAs in three regions of the adult mouse incisor: the laCL, liCL, and ameloblasts. We identified 26 and 35 differentially expressed miRNAs from laCL/liCL and laCL/ameloblast comparisons, respectively. Out of 10 miRNAs selected for validation by qPCR, all transcripts were confirmed to be differentially expressed. In situ hybridization and target prediction analyses further supported the reliability of our microarray results. These studies point to miRNAs that likely play a role in the renewal and differentiation of adult stem cells during stem cell-fueled incisor growth.	[Jheon, Andrew H.; Li, Chun-Ying; Wen, Timothy; Klein, Ophir D.] Univ Calif San Francisco, Program Craniofacial & Mesenchymal Biol, Dept Orofacial Sci, San Francisco, CA 94143 USA; [Michon, Frederic] Univ Helsinki, Inst Biotechnol, Dev Biol Program, Helsinki, Finland; [Klein, Ophir D.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA; [Klein, Ophir D.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of Helsinki; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Jheon, AH (corresponding author), Univ Calif San Francisco, Program Craniofacial & Mesenchymal Biol, Dept Orofacial Sci, San Francisco, CA 94143 USA.	ophir.klein@ucsf.edu	MICHON, Frédéric/ABH-6712-2020	Michon, Frederic/0000-0003-4305-305X; Klein, Ophir/0000-0002-6254-7082	National Institute of Dental and Craniofacial Research (NIDCR) [R21-DE29977, R01-DE021420]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE021420] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The work was funded by R21-DE29977 and R01-DE021420 from the National Institute of Dental and Craniofacial Research (NIDCR) to O. D. Klein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andl T, 2006, CURR BIOL, V16, P1041, DOI 10.1016/j.cub.2006.04.005; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Cao H, 2010, J DENT RES, V89, P779, DOI 10.1177/0022034510369304; Chekulaeva M, 2009, CURR OPIN CELL BIOL, V21, P452, DOI 10.1016/j.ceb.2009.04.009; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Doi N, 2003, CURR BIOL, V13, P41, DOI 10.1016/S0960-9822(02)01394-5; Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Harada H, 1999, J CELL BIOL, V147, P105, DOI 10.1083/jcb.147.1.105; Harada H, 2002, CONNECT TISSUE RES, V43, P201, DOI 10.1080/030082002900000989; Harada H, 2002, DEVELOPMENT, V129, P1533; HOLM S, 1979, SCAND J STAT, V6, P65; Hu JCC, 2007, CELLS TISSUES ORGANS, V186, P78, DOI 10.1159/000102683; Huang X, 2011, INT J MOL MED; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Jarvinen E, 2006, P NATL ACAD SCI USA, V103, P18627, DOI 10.1073/pnas.0607289103; Jevnaker AM, 2008, ARCH ORAL BIOL, V53, P629, DOI 10.1016/j.archoralbio.2008.01.014; Jiang BZ, 2010, ARCH ORAL BIOL, V55, P995, DOI 10.1016/j.archoralbio.2010.07.021; Kassai Y, 2005, SCIENCE, V309, P2067, DOI 10.1126/science.1116848; Kettunen P, 2000, DEV DYNAM, V219, P322, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1062>3.0.CO;2-J; Klein OD, 2008, DEVELOPMENT, V135, P377, DOI 10.1242/dev.015081; Klein OD, 2006, DEV CELL, V11, P181, DOI 10.1016/j.devcel.2006.05.014; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lewis MA, 2010, SEMIN CELL DEV BIOL, V21, P774, DOI 10.1016/j.semcdb.2010.02.004; Lund E, 2006, COLD SPRING HARB SYM, V71, P59, DOI 10.1101/sqb.2006.71.050; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Ma I, 2011, STEM CELL REV REP, V7, P292, DOI 10.1007/s12015-010-9208-4; Mardaryev AN, 2010, FASEB J, V24, P3869, DOI 10.1096/fj.10-160663; Michon F, 2011, BIRTH DEFECTS RES A; Michon F, 2010, DEV BIOL, V340, P355, DOI 10.1016/j.ydbio.2010.01.019; Mitsiadis TA, 2007, EXP CELL RES, V313, P3377, DOI 10.1016/j.yexcr.2007.07.027; Morton SU, 2008, P NATL ACAD SCI USA, V105, P17830, DOI 10.1073/pnas.0804673105; Munne PM, 2010, EVOL DEV, V12, P383, DOI 10.1111/j.1525-142X.2010.00425.x; Munne PM, 2009, DEVELOPMENT, V136, P393, DOI 10.1242/dev.025064; Park CY, 2010, HUM MOL GENET, V19, pR169, DOI 10.1093/hmg/ddq367; Pirvola U, 2000, J NEUROSCI, V20, P6125, DOI 10.1523/JNEUROSCI.20-16-06125.2000; Seidel K, 2010, DEVELOPMENT, V137, P3753, DOI 10.1242/dev.056358; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Stephanopoulos G, 2005, J DENT RES, V84, P1117, DOI 10.1177/154405910508401206; Tummers M, 2009, J EXP ZOOL PART B, V312B, P309, DOI 10.1002/jez.b.21280; Wang XP, 2007, PLOS BIOL, V5, P1324, DOI 10.1371/journal.pbio.0050159; Wang XP, 2004, DEV CELL, V7, P719, DOI 10.1016/j.devcel.2004.09.012; Wang XP, 2004, DEV DYNAM, V231, P98, DOI 10.1002/dvdy.20118; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Yang JS, 2011, RNA, V17, P312, DOI 10.1261/rna.2537911; Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642; Yi R, 2011, J CELL SCI, V124, P1775, DOI 10.1242/jcs.069104	53	29	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e24536	10.1371/journal.pone.0024536	http://dx.doi.org/10.1371/journal.pone.0024536			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CK	21931743	Green Published, Green Submitted, gold			2022-12-25	WOS:000294802800061
J	Pang, K; Ryan, JF; Baxevanis, AD; Martindale, MQ				Pang, Kevin; Ryan, Joseph F.; Baxevanis, Andreas D.; Martindale, Mark Q.			Evolution of the TGF-beta Signaling Pathway and Its Potential Role in the Ctenophore, Mnemiopsis leidyi	PLOS ONE			English	Article							AMPHIMEDON-QUEENSLANDICA; EXPRESSION; SUPERFAMILY; RECEPTORS; INDUCTION; METAZOAN; ACTIVIN; PATTERN; CHORDIN; PROTEIN	The TGF-beta signaling pathway is a metazoan-specific intercellular signaling pathway known to be important in many developmental and cellular processes in a wide variety of animals. We investigated the complexity and possible functions of this pathway in a member of one of the earliest branching metazoan phyla, the ctenophore Mnemiopsis leidyi. A search of the recently sequenced Mnemiopsis genome revealed an inventory of genes encoding ligands and the rest of the components of the TGF-beta superfamily signaling pathway. The Mnemiopsis genome contains nine TGF-beta ligands, two TGF-beta-like family members, two BMP-like family members, and five gene products that were unable to be classified with certainty. We also identified four TGF-beta receptors: three Type I and a single Type II receptor. There are five genes encoding Smad proteins (Smad2, Smad4, Smad6, and two Smad1s). While we have identified many of the other components of this pathway, including Tolloid, SMURF, and Nomo, notably absent are SARA and all of the known antagonists belonging to the Chordin, Follistatin, Noggin, and CAN families. This pathway likely evolved early in metazoan evolution as nearly all components of this pathway have yet to be identified in any non-metazoan. The complement of TGF-beta signaling pathway components of ctenophores is more similar to that of the sponge, Amphimedon, than to cnidarians, Trichoplax, or bilaterians. The mRNA expression patterns of key genes revealed by in situ hybridization suggests that TGF-beta signaling is not involved in ctenophore early axis specification. Four ligands are expressed during gastrulation in ectodermal micromeres along all three body axes, suggesting a role in transducing earlier maternal signals. Later expression patterns and experiments with the TGF-beta inhibitor SB432542 suggest roles in pharyngeal morphogenesis and comb row organization.	[Pang, Kevin; Martindale, Mark Q.] Univ Hawaii Manoa, Kewalo Marine Lab, Pacific Biomed Res Ctr, Honolulu, HI 96822 USA; [Ryan, Joseph F.; Baxevanis, Andreas D.] NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA	University of Hawaii System; University of Hawaii Manoa; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Pang, K (corresponding author), Univ Hawaii Manoa, Kewalo Marine Lab, Pacific Biomed Res Ctr, Honolulu, HI 96822 USA.	mqmartin@hawaii.edu		Ryan, Joseph/0000-0001-5478-0522	National Science Foundation (NSF); National Human Genome Research Institute, National Institutes of Health (NIH); NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000140] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)); National Human Genome Research Institute, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	KP was funded by a National Science Foundation (NSF) Graduate Research Fellowship. This work was also supported in part by the Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamska M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001031; [Anonymous], SMAD SIGNAL TRANSDUC; Attisano L, 2000, GENOME BIOL, V2; Balemans W, 2002, DEV BIOL, V250, P231, DOI 10.1006/dbio.2002.0779; Chen YG, 1997, EMBO J, V16, P3866, DOI 10.1093/emboj/16.13.3866; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; DeRobertis EM, 1996, NATURE, V380, P37, DOI 10.1038/380037a0; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; DERYNCK R, 1985, NATURE, V316, P701, DOI 10.1038/316701a0; Descargues P, 2008, P NATL ACAD SCI USA, V105, P2487, DOI 10.1073/pnas.0712044105; DUBOIS CM, 1995, J BIOL CHEM, V270, P10618, DOI 10.1074/jbc.270.18.10618; Finnerty JR, 2004, SCIENCE, V304, P1335, DOI 10.1126/science.1091946; FREEMAN G, 1976, DEV BIOL, V49, P143, DOI 10.1016/0012-1606(76)90264-5; FREEMAN G, 1977, J EMBRYOL EXP MORPH, V42, P237; Ge GX, 2005, MOL CELL BIOL, V25, P5846, DOI 10.1128/MCB.25.14.5846-5858.2005; Hayward DC, 2002, P NATL ACAD SCI USA, V99, P8106, DOI 10.1073/pnas.112021499; He W, 2006, CELL, V125, P929, DOI 10.1016/j.cell.2006.03.045; Herpin A, 2004, DEV COMP IMMUNOL, V28, P461, DOI 10.1016/j.dci.2003.09.007; Huminiecki L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-28; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Kessler E, 1996, SCIENCE, V271, P360, DOI 10.1126/science.271.5247.360; KINGSLEY DM, 1994, GENE DEV, V8, P133, DOI 10.1101/gad.8.2.133; KISPERT A, 1995, DEV BIOL, V168, P406, DOI 10.1006/dbio.1995.1090; Latinkic BV, 1997, GENE DEV, V11, P3265, DOI 10.1101/gad.11.23.3265; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Liu XD, 2001, CYTOKINE GROWTH F R, V12, P1, DOI 10.1016/S1359-6101(00)00031-9; Lonn P, 2009, CELL RES, V19, P21, DOI 10.1038/cr.2008.308; Marques G, 1997, CELL, V91, P417, DOI 10.1016/S0092-8674(00)80425-0; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2000, GENE DEV, V14, P627; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Matus DQ, 2006, P NATL ACAD SCI USA, V103, P11195, DOI 10.1073/pnas.0601257103; Matus DQ, 2006, CURR BIOL, V16, P499, DOI 10.1016/j.cub.2006.01.052; Onichtchouk D, 1999, NATURE, V401, P480, DOI 10.1038/46794; Pang K, 2009, EMERGING MODEL ORGAN, P167; Pang K, 2010, EVODEVO, V1, DOI 10.1186/2041-9139-1-10; Reinhardt B, 2004, DEV BIOL, V267, P43, DOI 10.1016/j.ydbio.2003.10.031; Rentzsch F, 2006, DEV BIOL, V296, P375, DOI 10.1016/j.ydbio.2006.06.003; Richards GS, 2009, COLD SH Q B, V74, P81, DOI 10.1101/sqb.2009.74.028; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Runyan CE, 2005, J BIOL CHEM, V280, P8300, DOI 10.1074/jbc.M407939200; Ryan JF, 2010, EVODEVO, V1, DOI 10.1186/2041-9139-1-9; Saina M, 2009, P NATL ACAD SCI USA, V106, P18592, DOI 10.1073/pnas.0900151106; Saina M, 2009, J EXP ZOOL PART B, V312B, P780, DOI 10.1002/jez.b.21304; Serpe M, 2006, DEVELOPMENT, V133, P4969, DOI 10.1242/dev.02711; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; von Marschall Z, 2010, BIOCHEM BIOPH RES CO, V391, P1374, DOI 10.1016/j.bbrc.2009.12.067; Wolfman NM, 2003, P NATL ACAD SCI USA, V100, P15842, DOI 10.1073/pnas.2534946100; Wotton D, 2001, CELL GROWTH DIFFER, V12, P457; Yamada A, 2010, DEV BIOL, V339, P212, DOI 10.1016/j.ydbio.2009.12.019; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293	53	69	70	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e24152	10.1371/journal.pone.0024152	http://dx.doi.org/10.1371/journal.pone.0024152			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CK	21931657	Green Submitted, Green Published, gold			2022-12-25	WOS:000294802800029
J	Siebold, A; van Zoest, W; Donk, M				Siebold, Alisha; van Zoest, Wieske; Donk, Mieke			Oculomotor Evidence for Top-Down Control following the Initial Saccade	PLOS ONE			English	Article							EYE-MOVEMENTS; TARGET SELECTION; VISUAL EXAMINATION; STIMULUS-DRIVEN; GUIDED SEARCH; SALIENCY MAP; BOTTOM-UP; INFORMATION; CAPTURE; GOAL	The goal of the current study was to investigate how salience-driven and goal-driven processes unfold during visual search over multiple eye movements. Eye movements were recorded while observers searched for a target, which was located on (Experiment 1) or defined as (Experiment 2) a specific orientation singleton. This singleton could either be the most, medium, or least salient element in the display. Results were analyzed as a function of response time separately for initial and second eye movements. Irrespective of the search task, initial saccades elicited shortly after the onset of the search display were primarily salience-driven whereas initial saccades elicited after approximately 250 ms were completely unaffected by salience. Initial saccades were increasingly guided in line with task requirements with increasing response times. Second saccades were completely unaffected by salience and were consistently goal-driven, irrespective of response time. These results suggest that stimulus-salience affects the visual system only briefly after a visual image enters the brain and has no effect thereafter.	[Siebold, Alisha; van Zoest, Wieske; Donk, Mieke] Vrije Univ Amsterdam, Dept Cognit Psychol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Siebold, A (corresponding author), Vrije Univ Amsterdam, Dept Cognit Psychol, Amsterdam, Netherlands.	a.siebold@vu.nl	van Zoest, Wieske/L-2166-2019	van Zoest, Wieske/0000-0001-6760-2346; Donk, Mieke/0000-0001-9310-8210	Netherlands Organization for Scientific Research	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	WvZ is supported by a VENI grant from the Netherlands Organization for Scientific Research.	Belopolsky AV, 2010, VISION RES, V50, P2543, DOI 10.1016/j.visres.2010.08.023; Betz T, 2010, J VISION, V10, DOI 10.1167/10.3.15; Buswell Guy Thomas, 1935, PEOPLE LOOK PICTURES; Carlson-Radvansky LA, 1999, PERCEPT PSYCHOPHYS, V61, P919, DOI 10.3758/BF03206906; Chen X, 2006, VISION RES, V46, P4118, DOI 10.1016/j.visres.2006.08.008; Donk M, 2008, PSYCHOL SCI, V19, P733, DOI 10.1111/j.1467-9280.2008.02149.x; Donk M, 2010, J EXP PSYCHOL HUMAN, V36, P286, DOI 10.1037/a0017605; Einhauser W, 2008, J VISION, V8, DOI 10.1167/8.2.2; Elazary L, 2008, J VISION, V8, DOI 10.1167/8.3.3; Findlay JM, 1997, VISION RES, V37, P617, DOI 10.1016/S0042-6989(96)00218-0; Findlay JM, 2001, VISION RES, V41, P87, DOI 10.1016/S0042-6989(00)00236-4; Foulsham T, 2009, Q J EXP PSYCHOL, V62, P1088, DOI 10.1080/17470210802602433; Hunt AR, 2007, J EXP PSYCHOL HUMAN, V33, P271, DOI 10.1037/0096-1523.33.2.271; Itti L, 2005, VIS COGN, V12, P1093, DOI 10.1080/13506280444000661; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; KOCH C, 1985, HUM NEUROBIOL, V4, P219; Li ZP, 2002, TRENDS COGN SCI, V6, P9, DOI 10.1016/S1364-6613(00)01817-9; Ludwig CJH, 2006, VISION RES, V46, P2743, DOI 10.1016/j.visres.2006.02.012; Malcolm GL, 2010, J VISION, V10, DOI 10.1167/10.2.4; Mannan S, 1995, SPATIAL VISION, V9, P363, DOI 10.1163/156856895X00052; Mannan SK, 1997, SPATIAL VISION, V11, P157, DOI 10.1163/156856897X00177; Mannan SK, 1996, SPATIAL VISION, V10, P165, DOI 10.1163/156856896X00123; Neider MB, 2006, VISION RES, V46, P614, DOI 10.1016/j.visres.2005.08.025; Noudoost B, 2010, CURR OPIN NEUROBIOL, V20, P183, DOI 10.1016/j.conb.2010.02.003; Nuthmann A, 2010, J VISION, V10, DOI 10.1167/10.8.20; Parkhurst D, 2002, VISION RES, V42, P107, DOI 10.1016/S0042-6989(01)00250-4; Parkhurst DJ, 2003, SPATIAL VISION, V16, P125, DOI 10.1163/15685680360511645; Peters RJ, 2005, VISION RES, V45, P2397, DOI 10.1016/j.visres.2005.03.019; POLLATSEK A, 1984, J EXP PSYCHOL GEN, V113, P426, DOI 10.1037/0096-3445.113.3.426; POSNER MI, 1984, J NEUROSCI, V4, P1863; RAYNER K, 1980, COGNITIVE PSYCHOL, V12, P206, DOI 10.1016/0010-0285(80)90009-2; Roos JCP, 2008, EXP BRAIN RES, V187, P283, DOI 10.1007/s00221-008-1304-1; STAMPE DM, 1993, BEHAV RES METH INSTR, V25, P137, DOI 10.3758/BF03204486; Tatler BW, 2005, VISION RES, V45, P643, DOI 10.1016/j.visres.2004.09.017; Theeuwes J, 2004, PSYCHON B REV, V11, P65, DOI 10.3758/BF03206462; THEEUWES J, 1992, PERCEPT PSYCHOPHYS, V51, P599, DOI 10.3758/BF03211656; THEEUWES J, 1994, J EXP PSYCHOL HUMAN, V20, P799, DOI 10.1037/0096-1523.20.4.799; Theeuwes J, 2008, PSYCHON B REV, V15, P555, DOI 10.3758/PBR.15.3.555; Theeuwes Jan, 2005, P418, DOI 10.1016/B978-012375731-9/50073-2; TREISMAN A, 1990, J EXP PSYCHOL HUMAN, V16, P459, DOI 10.1037/0096-1523.16.3.459; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Underwood G, 2006, EUR J COGN PSYCHOL, V18, P321, DOI 10.1080/09541440500236661; Van Zoest W, 2006, SPATIAL VISION, V19, P61, DOI 10.1163/156856806775009205; van Zoest W, 2005, VIS COGN, V12, P353, DOI 10.1080/13506280444000229; van Zoest W, 2004, PERCEPTION, V33, P927, DOI 10.1068/p5158; van Zoest W, 2004, J EXP PSYCHOL HUMAN, V30, P746, DOI 10.1037/0096-1523.30.4.749; van Zoest W, 2008, Q J EXP PSYCHOL, V61, P1553, DOI 10.1080/17470210701595555; van Zoest W, 2010, CONSCIOUS COGN, V19, P861, DOI 10.1016/j.concog.2010.04.001; Verfaillie K, 2000, J EXP PSYCHOL HUMAN, V26, P1243, DOI 10.1037//0096-1523.26.4.1243; WOLFE JM, 1989, J EXP PSYCHOL HUMAN, V15, P419, DOI 10.1037/0096-1523.15.3.419; WOLFE JM, 1994, PSYCHON B REV, V1, P202, DOI 10.3758/BF03200774; Zelinsky Gregory, 2006, ADV NEURAL INFORM PR, P5	52	28	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2011	6	9							e23552	10.1371/journal.pone.0023552	http://dx.doi.org/10.1371/journal.pone.0023552			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	819CK	21931603	Green Published, Green Submitted, gold			2022-12-25	WOS:000294802800006
J	Lumbiganon, P; Festin, M; Ho, J; Mohammad, H; Henderson-Smart, D; Green, S; Crowther, C; McDonald, S; Laopaiboon, M; Murano, M; Narash, N; Poombankor, R; Laopaiboon, M; Pattanittum, P; Short, J; Turner, T; Martis, R; Buppasiri, P; Komvilaisak, P; Deesrikaew, JTS; Pattanittum, P; Ussahgij, B; Khianman, B; Suwannachat, B; Siriwachirachai, T; Swadpanich, U; Chang, A; Koh, CW; Peter, J; Sidi, ZM; Subramaniam, S; Anuar, C; Geok, TB; Hassan, N; Van Rostenberghe, H; Bautista, R; Torralba, GC; Guinto, V; Crisologo, C; Andal, ML; Anzures, C; Canceran, G; Nurdiati, D; Emilia, O; Hadiati, DR; Wibowo, T; Wandita, S; Basuki, F; Purwanti, N; Swadpanich, U; Thinkhamrop, J; Suwannachat, B; Numwanul, P; Issarawong, L; Khundom, C; Saenrian, B; Khunamas, N; Choonnapran, S; Thippawat, S; Haoboon, J; Noanbuddee, S; Chanwirat, S; Supasud, J; Oadpim, T; Hempira, A; Tharnprisan, P; Laurit, J; Phanphen, N; Nanudon, U; Prapapa, U; Doweragul, O; Tongsata, P; Khianman, B; Narash, N; Poombankor, R; Subramaniam, S; Peter, JR; Van Rostenberghe, H; Karuppiah, R; Jusoh, WPW; Ismail, NEB; Andal, ML; Pelaez-Crisologo, C; Ayapana, EM; Olivaros, R; Medina, P; Canete, L; Eugogco, E; Torralba, E; Binas, B; Binas, P; Nurdiati, D; Supiyah; Amanah, L; Sari, DL; Astuti, D				Lumbiganon, Pisake; Festin, Mario; Ho, Jacqueline; Mohammad, Hakimi; Henderson-Smart, David; Green, Sally; Crowther, Caroline; McDonald, Steve; Laopaiboon, Malinee; Murano, Melissa; Narash, Natthaleeya; Poombankor, Rabieb; Laopaiboon, Malinee; Pattanittum, Porjai; Short, Jacki; Turner, Tari; Martis, Ruth; Buppasiri, Pranom; Komvilaisak, Patcharee; Deesrikaew, Jadsada Thinkhamrop Songsri; Pattanittum, Porjai; Ussahgij, Butsakorn; Khianman, Bussarin; Suwannachat, Bunpode; Siriwachirachai, Thitiporn; Swadpanich, Ussanee; Chang, Alvin; Koh, Chun Wearn; Peter, Japaraj; Sidi, Zabidah Mat; Subramaniam, Sivasangari; Anuar, Che; Geok, Tan Beng; Hassan, Noraida; Van Rostenberghe, Hans; Bautista, Resti; Torralba, Geraldine Castillo; Guinto, Valerie; Crisologo, Cristina; Andal, Maria Lu; Anzures, Cynthia; Canceran, Gina; Nurdiati, Detty; Emilia, Ova; Hadiati, Diah Rumekti; Wibowo, Tunjung; Wandita, Setya; Basuki, Fauziah; Purwanti, Nawang; Swadpanich, Ussanee; Thinkhamrop, Jadsada; Suwannachat, Bunpode; Numwanul, Pranee; Issarawong, Laaeid; Khundom, Chaywadsan; Saenrian, Banyen; Khunamas, Nattaya; Choonnapran, Supaporn; Thippawat, Savanee; Haoboon, Julaluk; Noanbuddee, Siripan; Chanwirat, Sukulrat; Supasud, Jumrad; Oadpim, Tussanewan; Hempira, Anong; Tharnprisan, Piangjit; Laurit, Jiraporn; Phanphen, Nittaya; Nanudon, Urairat; Prapapa, Umaporn; Doweragul, Orawan; Tongsata, Phechalakorn; Khianman, Bussarin; Narash, Natthaleeya; Poombankor, Rabiab; Subramaniam, Sivasangari; Peter, Japaraj R.; Van Rostenberghe, Hans; Karuppiah, Rajaywari; Jusoh, Wan Paizah Wan; Ismail, Noor Elani Bte; Andal, Maria Lu; Pelaez-Crisologo, Cristina; Ayapana, Ella Marie; Olivaros, Rosette; Medina, Paolo; Canete, Lester; Eugogco, Elizabeth; Torralba, Ermie; Binas, Brian; Binas, Paul; Nurdiati, Detty; Supiyah; Amanah, Latifatun; Sari, Dany Lukita; Astuti, Dwi		SEA-ORCHID Study Grp	Impact of Increasing Capacity for Generating and Using Research on Maternal and Perinatal Health Practices in South East Asia (SEA-ORCHID Project)	PLOS ONE			English	Article							MAGNESIUM-SULFATE; CHILD HEALTH; TRENDS; BIRTH	Background: Maternal and neonatal mortality and morbidity remain unacceptably high in many low and middle income countries. SEA-ORCHID was a five year international collaborative project in South East Asia which aimed to determine whether health care and health outcomes for mothers and babies could be improved by developing capacity for research generation, synthesis and use. Methods: Nine hospitals in Indonesia, Malaysia, the Philippines and Thailand participated in SEA-ORCHID. These hospitals were supported by researchers from three Australian centres. Health care practices and outcomes were assessed for 1000 women at each hospital both before and after the intervention. The capacity development intervention was tailored to the needs and context of each hospital and delivered over an 18 month period. Main outcomes included adherence to forms of care likely to be beneficial and avoidance of forms of care likely to be ineffective or harmful. Results: We observed substantial variation in clinical practice change between sites. The capacity development intervention had a positive impact on some care practices across all countries, including increased family support during labour and decreased perineal shaving before birth, but in some areas there was no significant change in practice and a few beneficial practices were followed less often. Conclusion: The results of SEA-ORCHID demonstrate that investing in developing capacity for research use, synthesis and generation can lead to improvements in maternal and neonatal health practice and highlight the difficulty of implementing evidence-based practice change.	[Lumbiganon, Pisake; Laopaiboon, Malinee; Narash, Natthaleeya; Poombankor, Rabieb; Pattanittum, Porjai; Buppasiri, Pranom; Komvilaisak, Patcharee; Deesrikaew, Jadsada Thinkhamrop Songsri; Pattanittum, Porjai; Ussahgij, Butsakorn] Khon Kaen Univ, Khon Kaen, Thailand; [Festin, Mario; Canceran, Gina] Univ Philippines Manila, Manila, Philippines; [Ho, Jacqueline] Penang Med Coll, George Town, Malaysia; [Mohammad, Hakimi] Gadja Mada Univ, Jakarta, Indonesia; [Henderson-Smart, David; Murano, Melissa; Short, Jacki] Univ Sydney, Sydney, NSW 2006, Australia; [Green, Sally; McDonald, Steve; Turner, Tari] Monash Univ, Clayton, Vic 3800, Australia; [Crowther, Caroline; Martis, Ruth] Univ Adelaide, Adelaide, SA 5005, Australia; [Siriwachirachai, Thitiporn; Swadpanich, Ussanee] Khon Kaen Hosp, Khon Kaen, Thailand; [Chang, Alvin; Koh, Chun Wearn; Peter, Japaraj; Sidi, Zabidah Mat; Subramaniam, Sivasangari] Ipoh Hosp, Ipoh, Malaysia; [Anuar, Che; Geok, Tan Beng; Hassan, Noraida; Van Rostenberghe, Hans] Univ Sains Malaysia, George Town, Malaysia; [Bautista, Resti; Torralba, Geraldine Castillo; Guinto, Valerie; Crisologo, Cristina] Philippine Gen Hosp, Manila, Philippines; [Andal, Maria Lu; Anzures, Cynthia] Jose Fabella Hosp, Manila, Philippines	Khon Kaen University; University of the Philippines System; University of the Philippines Manila; Gadjah Mada University; University of Sydney; Monash University; University of Adelaide; Universiti Sains Malaysia; University of the Philippines System; University of the Philippines Manila	Lumbiganon, P (corresponding author), Khon Kaen Univ, Khon Kaen, Thailand.	pisake@kku.ac.th	McDonald, Steve/AAE-1613-2020; Festin, Mario Philip/GQQ-9749-2022; Lumbiganon, Pisake/E-8634-2010; Van Rostenberghe, Hans/AAD-8096-2019; Wibowo, Tunjung/AAC-6949-2021; Martis, Ruth/AAD-2267-2022; Pattanittum, Porjai/N-1480-2016; Van Rostenberghe, Hans/B-4989-2012; WANDITA, SETYA/GLV-5077-2022	McDonald, Steve/0000-0003-2832-5205; Lumbiganon, Pisake/0000-0001-9372-0071; Van Rostenberghe, Hans/0000-0002-7908-8994; Wibowo, Tunjung/0000-0002-2655-4306; Martis, Ruth/0000-0003-1900-0038; WANDITA, SETYA/0000-0001-7264-3767; Green, Sally Elizabeth/0000-0002-9564-9050	National Health and Medical Research Council of Australia [307703]; Wellcome Trust, United Kingdom [071672/Z/03/Z]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Wellcome Trust, United Kingdom(Wellcome Trust)	SEA-ORCHID was jointly funded by an International Collaborative Research Grant from the National Health and Medical Research Council of Australia (No. 307703) and Wellcome Trust, United Kingdom (071672/Z/03/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, MILL DEV GOALS REP; Basevi V, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001236; Carroli G, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000081.pub2; Cuervo L, 1999, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000330; Duley L, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000127; Duley L, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000128; Duley L, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002960.pub2; Global Forum for Health Research, 2008, FOST INN GLOB HLTH F; Henderson-Smart DJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-43; Hill K, 2007, LANCET, V370, P1311, DOI 10.1016/S0140-6736(07)61572-4; Hoddnet E, 2007, COCHRANE DB SYST REV; Hofmeyr GJ, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000184.PUB2; Johanson RBMB., 2000, COCHRANE DB SYST REV, V2, DOI 10.1002/14651858.CD000224; Kenyon S, 2013, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001058; Kettle C, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000947.pub2; Kettle C, 2000, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000006; Laopaiboon M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002646; Lee C, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004790.pub2; McDonald S, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-61; NSW Health Department, 2001, FRAM BUILD CAP IMPR; PRENDIVILLE WJ, 2000, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000007, DOI 10.1002/14651858.CD000007]; Qian X, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-29; Razmjou H, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-66; Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2; Sauvarin J, 2006, MATERNAL NEONATAL HL; Save the Children, 2006, STAT WORLDS NEWB REP; Shaban IA, 2011, INT J EVID-BASED HEA, V9, P25, DOI 10.1111/j.1744-1609.2010.00197.x; Short J, 2010, BMC MED EDUC, V10, DOI 10.1186/1472-6920-10-37; Smaill Fiona M, 2019, Cochrane Database Syst Rev, V2019, DOI 10.1002/14651858.CD000490.pub4; Stanton CK, 2006, STUD FAMILY PLANN, V37, P41, DOI 10.1111/j.1728-4465.2006.00082.x; Suwannachat B, 2011, BJOG; Suwannachat B, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006636.pub2	32	1	1	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2011	6	9							e23994	10.1371/journal.pone.0023994	http://dx.doi.org/10.1371/journal.pone.0023994			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CH	21915274	Green Published, Green Submitted, gold			2022-12-25	WOS:000294802500021
J	Sengupta, A; Baba, K; Mazzoni, F; Pozdeyev, NV; Strettoi, E; Iuvone, PM; Tosini, G				Sengupta, Anamika; Baba, Kenkichi; Mazzoni, Francesca; Pozdeyev, Nikita V.; Strettoi, Enrica; Iuvone, P. Michael; Tosini, Gianluca			Localization of Melatonin Receptor 1 in Mouse Retina and Its Role in the Circadian Regulation of the Electroretinogram and Dopamine Levels	PLOS ONE			English	Article							MAMMALIAN RETINA; RAT RETINA; CLOCK; RHYTHMS; MICE	Melatonin modulates many important functions within the eye by interacting with a family of G-protein-coupled receptors that are negatively coupled with adenylate cyclase. In the mouse, Melatonin Receptors type 1 (MT1) mRNAs have been localized to photoreceptors, inner retinal neurons, and ganglion cells, thus suggesting that MT1 receptors may play an important role in retinal physiology. Indeed, we have recently reported that absence of the MT1 receptors has a dramatic effect on the regulation of the daily rhythm in visual processing, and on retinal cell viability during aging. We have also shown that removal of MT1 receptors leads to a small (3-4 mmHg) increase in the level of the intraocular pressure during the night and to a significant loss (25-30%) in the number of cells within the retinal ganglion cell layer during aging. In the present study we investigated the cellular distribution in the C3H/f(+/+) mouse retina of MT1 receptors using a newly developed MT1 receptor antibody, and then we determined the role that MT1 signaling plays in the circadian regulation of the mouse electroretinogram, and in the retinal dopaminergic system. Our data indicate that MT1 receptor immunoreactivity is present in many retinal cell types, and in particular, on rod and cone photoreceptors and on intrinsically photosensitive ganglion cells (ipRGCs). MT1 signaling is necessary for the circadian rhythm in the photopic ERG, but not for the circadian rhythm in the retinal dopaminergic system. Finally our data suggest that the circadian regulation of dopamine turnover does not drive the photopic ERG rhythm.	[Sengupta, Anamika; Baba, Kenkichi; Tosini, Gianluca] Morehouse Sch Med, Inst Neurosci, Circadian Rhythms & Sleep Disorders Program, Atlanta, GA 30310 USA; [Sengupta, Anamika; Baba, Kenkichi; Tosini, Gianluca] Morehouse Sch Med, Dept Pharmacol & Toxicol, Atlanta, GA 30310 USA; [Pozdeyev, Nikita V.; Iuvone, P. Michael] Emory Univ, Sch Med, Dept Ophthalmol, Atlanta, GA 30322 USA; [Pozdeyev, Nikita V.; Iuvone, P. Michael] Emory Univ, Sch Med, Dept Pharmacol, Atlanta, GA 30322 USA; [Mazzoni, Francesca; Strettoi, Enrica] CNR, Ist Neurosci, I-56100 Pisa, Italy	Morehouse School of Medicine; Morehouse School of Medicine; Emory University; Emory University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Neuroscienze (IN-CNR)	Sengupta, A (corresponding author), Morehouse Sch Med, Inst Neurosci, Circadian Rhythms & Sleep Disorders Program, Atlanta, GA 30310 USA.	gtosini@msm.edu	Mazzoni, Francesca/T-9044-2019	Mazzoni, Francesca/0000-0002-7826-2786; tosini, gianluca/0000-0003-3645-4533; Strettoi, Enrica/0000-0002-6101-599X	National Institutes of Health [NS43459, EY28821, 5S21MD000101, 5U54NS060659, S21MD000101, G12-RR03034]; Georgia Research Alliance [EY004864, EY006360, EY12654]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003034] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY012654, P30EY006360, R01EY004864] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS043459, U54NS060659, R01NS043459] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [S21MD000101] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Research Alliance; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by National Institutes of Health Grants NS43459, EY28821, 5S21MD000101, 5U54NS060659, S21MD000101, G12-RR03034, the Georgia Research Alliance (to G. T.), EY004864 and EY006360 (to P. M. I.) and EY12654 (to E. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcantara-Contreras S, 2011, NEUROSCI LETT, V494, P61, DOI 10.1016/j.neulet.2011.02.056; Baba K, 2009, P NATL ACAD SCI USA, V106, P15043, DOI 10.1073/pnas.0904400106; Barnard AR, 2006, CURR BIOL, V16, P389, DOI 10.1016/j.cub.2005.12.045; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brydon L, 1999, MOL ENDOCRINOL, V13, P2025, DOI 10.1210/me.13.12.2025; Cameron MA, 2008, J BIOL RHYTHM, V23, P489, DOI 10.1177/0748730408325874; Chen W, 2000, MOL BRAIN RES, V81, P43, DOI 10.1016/S0169-328X(00)00160-1; Doyle SE, 2002, VISUAL NEUROSCI, V19, P593, DOI 10.1017/S0952523802195058; DUBOCOVICH ML, 1983, NATURE, V306, P782, DOI 10.1038/306782a0; Fujieda H, 1999, NEUROSCIENCE, V93, P793, DOI 10.1016/S0306-4522(99)00111-6; GOTO M, 1989, J PINEAL RES, V7, P195, DOI 10.1111/j.1600-079X.1989.tb00667.x; Jockers R, 2008, BRIT J PHARMACOL, V154, P1182, DOI 10.1038/bjp.2008.184; Liu C, 1997, NEURON, V19, P91, DOI 10.1016/S0896-6273(00)80350-5; Liu CM, 2004, CELL TISSUE RES, V315, P197, DOI 10.1007/s00441-003-0822-1; Meyer P, 2002, BRIT J OPHTHALMOL, V86, P1053, DOI 10.1136/bjo.86.9.1053; Nir I, 2000, BRAIN RES, V870, P118, DOI 10.1016/S0006-8993(00)02409-4; Pozdeyev N, 2008, EUR J NEUROSCI, V27, P2691, DOI 10.1111/j.1460-9568.2008.06224.x; Provencio I, 2002, NATURE, V415, P493, DOI 10.1038/415493a; Rada JAS, 2006, INVEST OPHTH VIS SCI, V47, P25, DOI 10.1167/iovs.05-0195; Sakamoto K, 2005, EUR J NEUROSCI, V22, P3536; Storch KF, 2007, CELL, V130, P730, DOI 10.1016/j.cell.2007.06.045; Tosini G, 1998, BRAIN RES, V789, P221, DOI 10.1016/S0006-8993(97)01446-7; Tosini G, 2008, BIOESSAYS, V30, P624, DOI 10.1002/bies.20777; Tosini G, 2007, FASEB J, V21, P3866, DOI 10.1096/fj.07-8371com; Wiechmann AF, 2008, PROG RETIN EYE RES, V27, P137, DOI 10.1016/j.preteyeres.2007.10.001	25	61	64	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2011	6	9							e24483	10.1371/journal.pone.0024483	http://dx.doi.org/10.1371/journal.pone.0024483			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CH	21915336	gold, Green Published, Green Submitted			2022-12-25	WOS:000294802500051
J	Bokenkamp, R; Raz, V; Venema, A; DeRuiter, MC; van Munsteren, C; Olive, M; Nabel, EG; Gittenberger-de Groot, AC				Bokenkamp, Regina; Raz, Vered; Venema, Andrea; DeRuiter, Marco C.; van Munsteren, Conny; Olive, Michelle; Nabel, Elizabeth G.; Gittenberger-de Groot, Adriana C.			Differential Temporal and Spatial Progerin Expression during Closure of the Ductus Arteriosus in Neonates	PLOS ONE			English	Article							HUTCHINSON-GILFORD-PROGERIA; MOUSE MODEL; LAMIN; APOPTOSIS; MUSCLE; DISEASE; PROGRESSION; BIOMARKER; DEFECTS	Closure of the ductus arteriosus (DA) at birth is essential for the transition from fetal to postnatal life. Before birth the DA bypasses the uninflated lungs by shunting blood from the pulmonary trunk into the systemic circulation. The molecular mechanism underlying DA closure and degeneration has not been fully elucidated, but is associated with apoptosis and cytolytic necrosis in the inner media and intima. We detected features of histology during DA degeneration that are comparable to Hutchinson Gilford Progeria syndrome and ageing. Immunohistochemistry on human fetal and neonatal DA, and aorta showed that lamin A/C was expressed in all layers of the vessel wall. As a novel finding we report that progerin, a splicing variant of lamin A/C was expressed almost selectively in the normal closing neonatal DA, from which we hypothesized that progerin is involved in DA closure. Progerin was detected in 16.2% +/- 7.2 cells of the DA. Progerin-expressing cells were predominantly located in intima and inner media where cytolytic necrosis accompanied by apoptosis will develop. Concomitantly we found loss of a-smooth muscle actin as well as reduced lamin A/C expression compared to the fetal and non-closing DA. In cells of the adjacent aorta, that remains patent, progerin expression was only sporadically detected in 2.5%+/- 1.5 of the cells. Data were substantiated by the detection of mRNA of progerin in the neonatal DA but not in the aorta, by PCR and sequencing analysis. The fetal DA and the non-closing persistent DA did not present with progerin expressing cells. Our analysis revealed that the spatiotemporal expression of lamin A/C and progerin in the neonatal DA was mutually exclusive. We suggest that activation of LMNA alternative splicing is involved in vascular remodeling in the circulatory system during normal neonatal DA closure.	[Bokenkamp, Regina] Leiden Univ Med Ctr, Dept Pediat Cardiol, Leiden, Netherlands; [Raz, Vered; Venema, Andrea] Leiden Univ Med Ctr, Dept Human Genet, Leiden, Netherlands; [Bokenkamp, Regina; DeRuiter, Marco C.; van Munsteren, Conny; Gittenberger-de Groot, Adriana C.] Leiden Univ Med Ctr, Dept Anat & Embryol, Leiden, Netherlands; [Olive, Michelle] NHLBI, Bethesda, MD 20892 USA; [Nabel, Elizabeth G.] Brigham & Womens Hosp, Boston, MA 02115 USA	Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Harvard University; Brigham & Women's Hospital	Bokenkamp, R (corresponding author), Leiden Univ Med Ctr, Dept Pediat Cardiol, Leiden, Netherlands.	r.bokenkamp@lumc.nl			Landspitali University Hospital; University of Iceland; Science and Technology Policy Council; European Science Foundation	Landspitali University Hospital; University of Iceland; Science and Technology Policy Council; European Science Foundation(European Science Foundation (ESF)European Commission)	This work was supported by grants from Landspitali University Hospital Research Fund, University of Iceland Research Fund (www.hi.is/research_degrees), Science and Technology Policy Council-Thematic program in postgenomic biomedicine (www.rannis.is), Science and Technology Policy Council Research fund (TG, MKM), European Science Foundation (EuroCORES program, EuroSTELLS) (TG). "Gongum saman", a supporting group for breast cancer research in Iceland (www.gongumsaman.is) (VS). Nordforsk, the Nordic Research Board (www.nordforsk.org), Nordic Stem Cell Mobility Program (HS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bokenkamp R, 2010, NEONATOLOGY, V98, P6, DOI 10.1159/000262481; Bridger JM, 2004, EXP GERONTOL, V39, P717, DOI 10.1016/j.exger.2004.02.002; Brown-Bryan TA, 2008, MOL CANCER RES, V6, P1293, DOI 10.1158/1541-7786.MCR-08-0125; Capell BC, 2008, P NATL ACAD SCI USA, V105, P15902, DOI 10.1073/pnas.0807840105; Dahl KN, 2006, P NATL ACAD SCI USA, V103, P10271, DOI 10.1073/pnas.0601058103; Dechat T, 2007, P NATL ACAD SCI USA, V104, P4955, DOI 10.1073/pnas.0700854104; ELLIOTT RB, 1975, LANCET, V1, P140; GITTENBERGERDEGROOT AC, 1988, INT J CARDIOL, V19, P153, DOI 10.1016/0167-5273(88)90076-9; GITTENBERGERDEGROOT AC, 1980, J PEDIATR-US, V96, P88, DOI 10.1016/S0022-3476(80)80337-4; GITTENBERGERDEGROOT AC, 1977, BRIT HEART J, V39, P610; Goldman RD, 2004, P NATL ACAD SCI USA, V101, P8963, DOI 10.1073/pnas.0402943101; HEYMANN MA, 1975, PHYSIOL REV, V55, P62, DOI 10.1152/physrev.1975.55.1.62; Hoffman JIE, 2002, J AM COLL CARDIOL, V39, P1890, DOI 10.1016/S0735-1097(02)01886-7; Kajimoto H, 2007, CIRCULATION, V115, P1777, DOI 10.1161/CIRCULATIONAHA.106.649566; Martinet W, 2002, CIRCULATION, V106, P927, DOI 10.1161/01.CIR.0000026393.47805.21; McClintock D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001269; Mehta IS, 2010, BIOCHEM SOC T, V38, P287, DOI 10.1042/BST0380287; Olive M, 2010, ARTERIOSCL THROM VAS, V30, P2301, DOI 10.1161/ATVBAHA.110.209460; Ragnauth CD, 2010, CIRCULATION, V121, P2200, DOI 10.1161/CIRCULATIONAHA.109.902056; Salomonis N, 2010, P NATL ACAD SCI USA, V107, P10514, DOI 10.1073/pnas.0912260107; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Slomp J, 1997, ARTERIOSCL THROM VAS, V17, P1003, DOI 10.1161/01.ATV.17.5.1003; SLOMP J, 1992, ATHEROSCLEROSIS, V93, P25, DOI 10.1016/0021-9150(92)90197-O; Stehbens WE, 1999, CARDIOVASC PATHOL, V8, P29, DOI 10.1016/S1054-8807(98)00023-4; Tananari Y, 2000, JPN CIRC J, V64, P684, DOI 10.1253/jcj.64.684; Valente V, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-17; Varga R, 2006, P NATL ACAD SCI USA, V103, P3250, DOI 10.1073/pnas.0600012103; Wolf CM, 2008, J MOL CELL CARDIOL, V44, P293, DOI 10.1016/j.yjmcc.2007.11.008; Xu XD, 2005, CELL, V120, P59, DOI 10.1016/j.cell.2004.11.036; Yokoyama U, 2006, J CLIN INVEST, V116, P3026, DOI 10.1172/JCI28639; Yokoyama Utako, 2010, Journal of Smooth Muscle Research, V46, P77	31	21	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2011	6	9							e23975	10.1371/journal.pone.0023975	http://dx.doi.org/10.1371/journal.pone.0023975			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817QP	21915271	Green Published, Green Submitted, gold			2022-12-25	WOS:000294689200012
J	Wang, J; Li, CH; Wang, EK; Wang, XD				Wang, Jin; Li, Chunhe; Wang, Erkang; Wang, Xidi			An FPT Approach for Predicting Protein Localization from Yeast Genomic Data	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; BAYESIAN NETWORKS; DATA INTEGRATION; GENE-EXPRESSION; CLASSIFICATION; IDENTIFICATION; GENERATION; SEQUENCES; PATTERNS; SYSTEM	Accurately predicting the localization of proteins is of paramount importance in the quest to determine their respective functions within the cellular compartment. Because of the continuous and rapid progress in the fields of genomics and proteomics, more data are available now than ever before. Coincidentally, data mining methods been developed and refined in order to handle this experimental windfall, thus allowing the scientific community to quantitatively address long-standing questions such as that of protein localization. Here, we develop a frequent pattern tree (FPT) approach to generate a minimum set of rules (mFPT) for predicting protein localization. We acquire a series of rules according to the features of yeast genomic data. The mFPT prediction accuracy is benchmarked against other commonly used methods such as Bayesian networks and logistic regression under various statistical measures. Our results show that mFPT gave better performance than other approaches in predicting protein localization. Meanwhile, setting 0.65 as the minimum hit-rate, we obtained 138 proteins that mFPT predicted differently than the simple naive bayesian method (SNB). In our analysis of these 138 proteins, we present novel predictions for the location for 17 proteins, which currently do not have any defined localization. These predictions can serve as putative annotations and should provide preliminary clues for experimentalists. We also compared our predictions against the eukaryotic subcellular localization database and related predictions by others on protein localization. Our method is quite generalized and can thus be applied to discover the underlying rules for protein-protein interactions, genomic interactions, and structure-function relationships, as well as those of other fields of research.	[Wang, Jin; Li, Chunhe; Wang, Erkang] Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Elect Chem, Changchun 130022, Jilin, Peoples R China; [Wang, Jin] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA; [Wang, Jin] SUNY Stony Brook, Dept Phys, Stony Brook, NY 11794 USA; [Wang, Jin] SUNY Stony Brook, Dept Astron, Stony Brook, NY 11794 USA; [Li, Chunhe] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Wang, Xidi] Citibank NA, Sao Paulo, Brazil	Chinese Academy of Sciences; Changchun Institute of Applied Chemistry, CAS; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Wang, J (corresponding author), Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Elect Chem, Changchun 130022, Jilin, Peoples R China.	jin.wang.1@stonybrook.edu; ekwang@ciac.jl.cn	Wang, Jiabo/B-6681-2015; xiao, xiang/GWU-6035-2022; , 汪尔康/P-1748-2019; Li, Chunhe/C-8132-2011	Li, Chunhe/0000-0002-9127-3930	National Science Foundation; National Natural Science Foundation of China [90713022, 20735003]; 973 project [2009CB930100, 2010CB833600]	National Science Foundation(National Science Foundation (NSF)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 project(National Basic Research Program of China)	JW acknowledges support from the National Science Foundation. CHL and EKW are supported by the National Natural Science Foundation of China (grants 90713022 and 20735003) and the 973 project (grants 2009CB930100 and 2010CB833600). The funder of XW from a commercial company had a role in preparation of the manuscript. Otherwise, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal RC, 2001, J PARALLEL DISTR COM, V61, P350, DOI 10.1006/jpdc.2000.1693; Agrawal R., 1994, P 20 INT C VER LARG, P487; ALEXANDROV V, 2001, INT J QUANTUM CHEM, V4, P188; Andrade MA, 1998, J MOL BIOL, V276, P517, DOI 10.1006/jmbi.1997.1498; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P45, DOI 10.1093/nar/28.1.45; Boyd D, 1998, PROTEIN SCI, V7, P201, DOI 10.1002/pro.5560070121; Brown MPS, 2000, P NATL ACAD SCI USA, V97, P262, DOI 10.1073/pnas.97.1.262; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Drawid A, 2000, TRENDS GENET, V16, P426, DOI 10.1016/S0168-9525(00)02108-9; Drawid A, 2000, J MOL BIOL, V301, P1059, DOI 10.1006/jmbi.2000.3968; ENGELMAN DM, 1986, ANNU REV BIOPHYS BIO, V15, P321, DOI 10.1146/annurev.bb.15.060186.001541; Friedman N, 2004, SCIENCE, V303, P799, DOI 10.1126/science.1094068; Friedman N, 2003, MACH LEARN, V50, P95, DOI 10.1023/A:1020249912095; Friedman N, 2000, J COMPUT BIOL, V7, P601, DOI 10.1089/106652700750050961; Frishman D, 1998, BIOINFORMATICS, V14, P551, DOI 10.1093/bioinformatics/14.7.551; Frishman D, 1997, TRENDS GENET, V13, P415, DOI 10.1016/S0168-9525(97)01224-9; GERSTEIN M, 2000, PAC S BIOCOMP, V5, P30; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; HAN J, 2000, SIGKDD EXPLORATIONS, V2, P14; Han JW, 2004, DATA MIN KNOWL DISC, V8, P53, DOI 10.1023/B:DAMI.0000005258.31418.83; HAN JW, 2006, DATA MINING CONCEPTS, P475; Hodges PE, 1999, NUCLEIC ACIDS RES, V27, P69, DOI 10.1093/nar/27.1.69; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Huang WL, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-80; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumar A, 2002, GENE DEV, V16, P707, DOI 10.1101/gad.970902; Lin N, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-154; Lu LJ, 2005, GENOME RES, V15, P945, DOI 10.1101/gr.3610305; Mewes HW, 1998, NUCLEIC ACIDS RES, V26, P33, DOI 10.1093/nar/26.1.33; NACHMAN I, 2004, THESIS HEBREW U; NAKAI K, 1991, PROTEINS, V11, P95, DOI 10.1002/prot.340110203; NAKAI K, 1992, GENOMICS, V14, P897, DOI 10.1016/S0888-7543(05)80111-9; NAKAI K, 1996, INTELL SYS MOL BIOL, V4, P109; NAKAI K, 1997, INTELL SYS MOL BIOL, V5, P147; Nielsen H, 1997, Int J Neural Syst, V8, P581, DOI 10.1142/S0129065797000537; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Nielsen H, 1999, PROTEIN ENG, V12, P3, DOI 10.1093/protein/12.1.3; Paulsen IT, 1998, FEBS LETT, V430, P116, DOI 10.1016/S0014-5793(98)00629-2; Pierleoni A, 2007, NUCLEIC ACIDS RES, V35, pD208, DOI 10.1093/nar/gkl775; Reinhardt A, 1998, NUCLEIC ACIDS RES, V26, P2230, DOI 10.1093/nar/26.9.2230; Riffle M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-263; Shiratori A, 1999, YEAST, V15, P219, DOI 10.1002/(SICI)1097-0061(199902)15:3<219::AID-YEA349>3.3.CO;2-V; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Stephenson T. A., 2000, INTRO BAYESIAN NETWO; Stryer L, 1996, BIOCHEMISTRY; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; VERHASSELT P, 1995, YEAST, V11, P961, DOI 10.1002/yea.320111007; Wang J, 2009, P NATL ACAD SCI USA, V106, P3752, DOI 10.1073/pnas.0806427106; Zhang LV, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-38	53	114	143	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 19	2011	6	1							e14449	10.1371/journal.pone.0014449	http://dx.doi.org/10.1371/journal.pone.0014449			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	710OH	21915343	Green Submitted, Green Published, gold			2022-12-25	WOS:000286520600001
J	Clark, JM; Aleksiyadis, K; Martin, A; McNamee, K; Tharmalingam, T; Williams, RO; Memet, S; Cope, AP				Clark, Joanna M.; Aleksiyadis, Karolina; Martin, Alex; McNamee, Kay; Tharmalingam, Tharsana; Williams, Richard O.; Memet, Sylvie; Cope, Andrew P.			Inhibitor of Kappa B Epsilon (I kappa B epsilon) Is a Non-Redundant Regulator of c-Rel-Dependent Gene Expression in Murine T and B Cells	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; RHEUMATOID-ARTHRITIS; TRANSCRIPTION FACTOR; SIGNALING PATHWAY; IMMUNE-SYSTEM; NEGATIVE FEEDBACK; IL-2 PROMOTER; ACTIVATION; BETA; PROLIFERATION	Inhibitors of kappa B (I kappa Bs) -alpha, -beta and -epsilon effect selective regulation of specific nuclear factor of kappa B (NF-kappa B) dimers according to cell lineage, differentiation state or stimulus, in a manner that is not yet precisely defined. Lymphocyte antigen receptor ligation leads to degradation of all three I kappa Bs but activation only of subsets of NF-kappa B-dependent genes, including those regulated by c-Rel, such as anti-apoptotic CD40 and BAFF-R on B cells, and interleukin-2 (IL-2) in T cells. We report that pre-culture of a mouse T cell line with tumour necrosis factor-alpha (TNF) inhibits IL-2 gene expression at the level of transcription through suppressive effects on NF-kappa B, AP-1 and NFAT transcription factor expression and function. Selective upregulation of I kappa B epsilon and suppressed nuclear translocation of c-Rel were very marked in TNF-treated, compared to control cells, whether activated via T cell receptor (TCR) pathway or TNF receptor. I kappa B epsilon associated with newly synthesised c-Rel in activated cells and, in contrast to I kappa B alpha and -beta, showed enhanced association with p65/c-Rel in TNF-treated cells relative to controls. Studies in I kappa B epsilon-deficient mice revealed that basal nuclear expression and nuclear translocation of c-Rel at early time-points of receptor ligation were higher in I kappa B epsilon-/- T and B cells, compared to wild-type. I kappa B epsilon-/- mice exhibited increased lymph node cellularity and enhanced basal thymidine incorporation by lymphoid cells ex vivo. I kappa B epsilon-/- T cell blasts were primed for IL-2 expression, relative to wild-type. I kappa B epsilon-/- splenic B cells showed enhanced survival ex vivo, compared to wild-type, and survival correlated with basal expression of CD40 and induced expression of CD40 and BAFF-R. Enhanced basal nuclear translocation of c-Rel, and upregulation of BAFF-R and CD40 occurred despite increased I kappa B alpha expression in I kappa B epsilon-/- B cells. The data imply that regulation of these c-Rel-dependent lymphoid responses is a non-redundant function of I kappa B epsilon.	[Clark, Joanna M.; Tharmalingam, Tharsana; Cope, Andrew P.] Kings Coll London, Acad Dept Rheumatol, Div Immunol Infect & Inflammatory Dis, Sch Med,Ctr Mol & Cellular Biol Inflammat, London WC2R 2LS, England; [Aleksiyadis, Karolina; Martin, Alex; McNamee, Kay; Williams, Richard O.] Univ London Imperial Coll Sci Technol & Med, Kennedy Inst, Div Rheumatol, London, England; [Memet, Sylvie] Inst Pasteur, Unite Mycol Mol, Paris, France; [Memet, Sylvie] CNRS, Unite Rech Associee 3012, Paris, France	University of London; King's College London; Imperial College London; University of Oxford; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS)	Clark, JM (corresponding author), Kings Coll London, Acad Dept Rheumatol, Div Immunol Infect & Inflammatory Dis, Sch Med,Ctr Mol & Cellular Biol Inflammat, London WC2R 2LS, England.	andrew.cope@kcl.ac.uk	Emery, Sean/J-3825-2017; Emery, Sean/O-9122-2019	Emery, Sean/0000-0001-6072-8309; Emery, Sean/0000-0001-6072-8309; Amin, Janaki/0000-0003-2161-9366; Memet, Sylvie/0000-0001-6571-4192; Cope, Andrew/0000-0001-6735-5496; Boyd, Mark/0000-0002-6848-3307; Medland, Nicholas Andrew/0000-0003-0403-8930; Martin, Allison/0000-0001-6065-1188	Wellcome Trust; Arthritis Research UK; European Community [HEALTH-F2-2008-223404]	Wellcome Trust(Wellcome TrustEuropean Commission); Arthritis Research UK(Versus Arthritis); European Community(European Commission)	This work was funded by (1) The Wellcome Trust: http://www.wellcome.ac.uk/ (2) Arthritis Research UK: http://www.arthritisresearchuk.org/ (3) The European Community's Seventh Framework Programme FP7 under grant agreement no. HEALTH-F2-2008-223404 (http://www.Masterswitchproject.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu JRF, 2009, J IMMUNOL, V183, P621, DOI 10.4049/jimmunol.0803278; Attema JL, 2002, J IMMUNOL, V169, P2466, DOI 10.4049/jimmunol.169.5.2466; Banerjee D, 2005, IMMUNITY, V23, P445, DOI 10.1016/j.immuni.2005.09.012; Batten M, 2000, J EXP MED, V192, P1453, DOI 10.1084/jem.192.10.1453; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Bunting K, 2007, J IMMUNOL, V178, P7097, DOI 10.4049/jimmunol.178.11.7097; Castro I, 2009, J IMMUNOL, V182, P7729, DOI 10.4049/jimmunol.0803281; Clark JM, 2004, P NATL ACAD SCI USA, V101, P1696, DOI 10.1073/pnas.0308231100; Cope AP, 2002, ARTHRITIS RES THER, V4; COPE AP, 1994, J CLIN INVEST, V94, P749, DOI 10.1172/JCI117394; Cope AP, 1999, ARTHRITIS RHEUM, V42, P1497, DOI 10.1002/1529-0131(199907)42:7<1497::AID-ANR25>3.0.CO;2-#; Criswell LA, 2010, IMMUNOL REV, V233, P55, DOI 10.1111/j.0105-2896.2009.00862.x; Dean JLE, 2001, MOL CELL BIOL, V21, P721, DOI 10.1128/MCB.21.3.721-730.2001; Doerre S, 1999, J IMMUNOL, V163, P269; Doerre S, 2005, J IMMUNOL, V174, P983, DOI 10.4049/jimmunol.174.2.983; Elgueta R, 2009, IMMUNOL REV, V229, P152, DOI 10.1111/j.1600-065X.2009.00782.x; Fu LC, 2009, BLOOD, V113, P4627, DOI 10.1182/blood-2008-10-183467; Gerondakis S, 2006, ONCOGENE, V25, P6781, DOI 10.1038/sj.onc.1209944; Gilmore TD, 2004, ONCOGENE, V23, P2275, DOI 10.1038/sj.onc.1207410; Goudeau B, 2003, P NATL ACAD SCI USA, V100, P15800, DOI 10.1073/pnas.2535880100; GREGERSEN PK, 2009, NAT GENET; Grumont R, 2004, IMMUNITY, V21, P19, DOI 10.1016/j.immuni.2004.06.004; GRUMONT RJ, 1993, CELL GROWTH DIFFER, V4, P731; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Huxford T, 1998, CELL, V95, P759, DOI 10.1016/S0092-8674(00)81699-2; Isomaki P, 2001, J IMMUNOL, V166, P5495, DOI 10.4049/jimmunol.166.9.5495; Kearns JD, 2006, J CELL BIOL, V173, P659, DOI 10.1083/jcb.200510155; Kim D, 2009, FASEB J, V23, P2796, DOI 10.1096/fj.09-130369; Laskov R, 2005, EUR CYTOKINE NETW, V16, P267; Lee SH, 2002, J BIOL CHEM, V277, P23358, DOI 10.1074/jbc.M111559200; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Li Z, 1997, MOL CELL BIOL, V17, P6184, DOI 10.1128/MCB.17.10.6184; Liou HC, 2003, BIOESSAYS, V25, P767, DOI 10.1002/bies.10306; Liou HC, 1999, INT IMMUNOL, V11, P361, DOI 10.1093/intimm/11.3.361; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; Malek S, 2001, J BIOL CHEM, V276, P45225, DOI 10.1074/jbc.M105865200; McGuire KL, 1997, J IMMUNOL, V159, P1319; Memet S, 1999, J IMMUNOL, V163, P5994; Olave IA, 2002, ANNU REV BIOCHEM, V71, P755, DOI 10.1146/annurev.biochem.71.110601.135507; Quezada SA, 2004, ANNU REV IMMUNOL, V22, P307, DOI 10.1146/annurev.immunol.22.012703.104533; Rao S, 2003, J IMMUNOL, V170, P3724, DOI 10.4049/jimmunol.170.7.3724; Shapiro VS, 1997, MOL CELL BIOL, V17, P4051, DOI 10.1128/MCB.17.7.4051; Shirane M, 1999, J BIOL CHEM, V274, P28169, DOI 10.1074/jbc.274.40.28169; Simeonidis S, 1997, P NATL ACAD SCI USA, V94, P14372, DOI 10.1073/pnas.94.26.14372; Stefansson B, 2008, BIOCHEMISTRY-US, V47, P1442, DOI 10.1021/bi7022877; Stefansson B, 2006, J BIOL CHEM, V281, P22624, DOI 10.1074/jbc.M601772200; Suyang H, 1996, MOL CELL BIOL, V16, P5444; Tam WF, 2001, J BIOL CHEM, V276, P7701, DOI 10.1074/jbc.C000916200; Tian B, 2005, J BIOL CHEM, V280, P17435, DOI 10.1074/jbc.M500437200; Tran K, 1997, MOL CELL BIOL, V17, P5386, DOI 10.1128/MCB.17.9.5386; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; van Kooten C, 2000, J LEUKOCYTE BIOL, V67, P2, DOI 10.1002/jlb.67.1.2; Venkataraman L, 1996, J IMMUNOL, V157, P1149; VISA N, COLD SPRING HARB PER, V2; Wang JM, 2007, J IMMUNOL, V178, P6777, DOI 10.4049/jimmunol.178.11.6777; Whiteside ST, 1997, EMBO J, V16, P1413, DOI 10.1093/emboj/16.6.1413; Zhernakova A, 2009, NAT REV GENET, V10, P43, DOI 10.1038/nrg2489; Zhou HJ, 2007, BLOOD, V110, P2121, DOI 10.1182/blood-2007-02-073080	59	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2011	6	9							e24504	10.1371/journal.pone.0024504	http://dx.doi.org/10.1371/journal.pone.0024504			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817QP	21915344	Green Submitted, Green Published, gold			2022-12-25	WOS:000294689200051
J	Charland, KM; Brownstein, JS; Verma, A; Brien, S; Buckeridge, DL				Charland, Katia M.; Brownstein, John S.; Verma, Aman; Brien, Stephanie; Buckeridge, David L.			Socio-Economic Disparities in the Burden of Seasonal Influenza: The Effect of Social and Material Deprivation on Rates of Influenza Infection	PLOS ONE			English	Article							ACUTE RESPIRATORY-INFECTIONS; HOSPITAL ADMISSION; HEALTH; CHILDREN; DISEASE; SURVEILLANCE; MORTALITY; SYSTEM; AGE	Background: There is little empirical evidence in support of a relationship between rates of influenza infection and level of material deprivation (i.e., lack of access to goods and services) and social deprivation (i.e. lack of social cohesion and support). Method: Using validated population-level indices of material and social deprivation and medical billing claims for outpatient clinic and emergency department visits for influenza from 1996 to 2006, we assessed the relationship between neighbourhood rates of influenza and neighbourhood levels of deprivation using Bayesian ecological regression models. Then, by pooling data from neighbourhoods in the top decile (i.e., most deprived) and the bottom decile, we compared rates in the most deprived populations to the least deprived populations using age-and sex-standardized rate ratios. Results: Deprivation scores ranged from one to five with five representing the highest level of deprivation. We found a 21% reduction in rates for every 1 unit increase in social deprivation score (rate ratio [RR] 0.79, 95% Credible Interval [CrI] 0.66, 0.97). There was little evidence of a meaningful linear relationship with material deprivation (RR 1.06, 95% CrI 0.93, 1.24). However, relative to neighbourhoods with deprivation scores in the bottom decile, those in the top decile (i. e., most materially deprived) had substantially higher rates (RR 2.02, 95% Confidence Interval 1.99, 2.05). Conclusion: Though it is hypothesized that social and material deprivation increase risk of acute respiratory infection, we found decreasing healthcare utilization rates for influenza with increasing social deprivation. This finding may be explained by the fewer social contacts and, thus, fewer influenza exposure opportunities of the socially deprived. Though there was no evidence of a linear relationship with material deprivation, when comparing the least to the most materially deprived populations, we observed higher rates in the most materially deprived populations.	[Charland, Katia M.; Brownstein, John S.] Childrens Hosp, Childrens Hosp Informat Program, Boston, MA 02115 USA; [Charland, Katia M.; Brownstein, John S.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Charland, Katia M.; Brownstein, John S.; Verma, Aman; Brien, Stephanie; Buckeridge, David L.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Buckeridge, David L.] Montreal Publ Hlth Dept, Off Surveillance & Epidemiol, Montreal, PQ, Canada	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; McGill University	Charland, KM (corresponding author), Childrens Hosp, Childrens Hosp Informat Program, 300 Longwood Ave, Boston, MA 02115 USA.	katia.charland@mcgill.ca	Verma, Aman/D-5550-2014; Thompson, Ross/D-7996-2013; Austin, Jeremy/F-8729-2010; Owen, Kylie/K-9400-2015; Gershwin, Lisa-ann/N-6392-2015	Verma, Aman/0000-0001-7436-1325; Thompson, Ross/0000-0002-5287-2455; Robb, Kate/0000-0002-7038-3612; Austin, Jeremy/0000-0003-4244-2942; Owen, Kylie/0000-0002-8986-482X; Gershwin, Lisa-ann/0000-0003-1254-725X	National Institute of Allergy and Infectious Diseases [R21AI073591-01]; National Library of Medicine, National Institutes of Health [R21LM009263-01]; Canadian Institutes of Health Research [PAN-83152, CAT 86857]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI073591] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R21LM009263] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Library of Medicine, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by the National Institute of Allergy and Infectious Diseases [R21AI073591-01], the National Library of Medicine, National Institutes of Health [R21LM009263-01], and the Canadian Institutes of Health Research [PAN-83152, CAT 86857]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern J, 2008, SOC SCI MED, V66, P691, DOI 10.1016/j.socscimed.2007.10.011; BERKMAN LF, 1995, PSYCHOSOM MED, V57, P245, DOI 10.1097/00006842-199505000-00006; Brownstein JS, 2005, AM J EPIDEMIOL, V162, P686, DOI 10.1093/aje/kwi257; Cadieux G, 2008, HEALTH SERV RES, V43, P2223, DOI 10.1111/j.1475-6773.2008.00873.x; Cardoso MRA, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-19; Carpenter KM, 2010, ANN BEHAV MED, V39, P79, DOI 10.1007/s12160-010-9160-1; Christakis N. A., 2010, PLOS ONE, V5; Cohen F, 2007, PSYCHOSOM MED, V69, P225, DOI 10.1097/PSY.0b013e31803139a6; Crighton EJ, 2007, SOC SCI MED, V64, P1636, DOI 10.1016/j.socscimed.2006.12.001; Feldman PJ, 2004, ANN BEHAV MED, V27, P91, DOI 10.1207/s15324796abm2702_3; Glynn AN, 2008, J ROY STAT SOC A STA, V171, P179; GRAHAM NMH, 1990, EPIDEMIOL REV, V12, P149, DOI 10.1093/oxfordjournals.epirev.a036050; Hawker JI, 2003, RESP MED, V97, P1219, DOI 10.1016/S0954-6111(03)00252-X; Jackson C, 2006, STAT MED, V25, P2136, DOI 10.1002/sim.2370; Jackson CH, 2008, SOC SCI MED, V67, P1995, DOI 10.1016/j.socscimed.2008.09.041; Jordan R, 2006, RESP MED, V100, P1282, DOI 10.1016/j.rmed.2005.10.014; Jordan RE, 2008, BRIT J GEN PRACT, V58, P400, DOI 10.3399/bjgp08X302682; Kaler SG, 2008, ANN NY ACAD SCI, V1136, P28, DOI 10.1196/annals.1425.035; Marmot M, 2001, NEW ENGL J MED, V345, P134, DOI 10.1056/NEJM200107123450210; Marsden-Haug N, 2007, EMERG INFECT DIS, V13, P207, DOI 10.3201/eid1302.060557; Olson DR, 2007, PLOS MED, V4, P1349, DOI 10.1371/journal.pmed.0040247; Pampalon R, 2000, Chronic Dis Can, V21, P104; Philibert MD, 2007, SOC SCI MED, V64, P1651, DOI 10.1016/j.socscimed.2006.12.010; Reichert TA, 2001, NEW ENGL J MED, V344, P889, DOI 10.1056/NEJM200103223441204; SPIEGELHELTER DJ, 2002, WINBUGS BAYESIAN INF; STONE AA, ARCH INTERN MED, V170, P570; TOWNSEND P, 1987, J SOC POLICY, V16, P125, DOI 10.1017/S0047279400020341; Wakefield J, 2007, BIOSTATISTICS, V8, P158, DOI 10.1093/biostatistics/kxl008	28	40	44	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	FEB 17	2011	6	2							e17207	10.1371/journal.pone.0017207	http://dx.doi.org/10.1371/journal.pone.0017207			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	723BX	21359150	Green Published, Green Submitted, gold			2022-12-25	WOS:000287482300040
J	Wang, YL; An, LL; Jiang, YD; Hang, HY				Wang, Yulan; An, Lili; Jiang, Yuanda; Hang, Haiying			Effects of Simulated Microgravity on Embryonic Stem Cells	PLOS ONE			English	Article							MODELED MICROGRAVITY; DNA-DAMAGE; HUMAN-LYMPHOCYTES; NUCLEAR ANTIGEN; DIFFERENTIATION; PROLIFERATION; CULTURE; REPAIR; ESTABLISHMENT; SPACEFLIGHT	There have been many studies on the biological effects of simulated microgravity (SMG) on differentiated cells or adult stem cells. However, there has been no systematic study on the effects of SMG on embryonic stem (ES) cells. In this study, we investigated various effects (including cell proliferation, cell cycle distribution, cell differentiation, cell adhesion, apoptosis, genomic integrity and DNA damage repair) of SMG on mouse embryonic stem (mES) cells. Mouse ES cells cultured under SMG condition had a significantly reduced total cell number compared with cells cultured under 1 g gravity (1G) condition. However, there was no significant difference in cell cycle distribution between SMG and 1G culture conditions, indicating that cell proliferation was not impaired significantly by SMG and was not a major factor contributing to the total cell number reduction. In contrast, a lower adhesion rate cultured under SMG condition contributed to the lower cell number in SMG. Our results also revealed that SMG alone could not induce DNA damage in mES cells while it could affect the repair of radiation-induced DNA lesions of mES cells. Taken together, mES cells were sensitive to SMG and the major alterations in cellular events were cell number expansion, adhesion rate decrease, increased apoptosis and delayed DNA repair progression, which are distinct from the responses of other types of cells to SMG.	[Wang, Yulan; An, Lili; Hang, Haiying] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China; [Wang, Yulan; An, Lili; Hang, Haiying] Chinese Acad Sci, Inst Biophys, Ctr Computat & Syst Biol, Beijing 100080, Peoples R China; [Jiang, Yuanda] Chinese Acad Sci, Ctr Space Sci & Appl Res, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences	Wang, YL (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China.	hh91@sun5.ibp.ac.cn	jiang, anyi/GPT-0379-2022	Huang, Yelin/0000-0002-2514-0144	Chinese Academy of Sciences [KSCX2-YW-R63]	Chinese Academy of Sciences(Chinese Academy of Sciences)	The study is supported by grants from Knowledge Innovation Program of Chinese Academy of Sciences (KSCX2-YW-R63). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DL, 2009, J APPL PHYSIOL, V106, P582, DOI 10.1152/japplphysiol.90780.2008; Auerbach W, 2000, BIOTECHNIQUES, V29, P1024, DOI 10.2144/00295st04; Coinu R, 2006, FEBS LETT, V580, P2465, DOI 10.1016/j.febslet.2006.03.078; Crucian B, 2009, J LEUKOCYTE BIOL, V86, P1017, DOI 10.1189/jlb.0709500; Degan P, 2005, J CELL BIOCHEM, V94, P460, DOI 10.1002/jcb.20302; Estrov Z, 2009, CLIN LYMPHOMA MYELOM, V9, pS319, DOI 10.3816/CLM.2009.s.031; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fridley KM, 2010, TISSUE ENG PT A, V16, P3285, DOI [10.1089/ten.tea.2010.0166, 10.1089/ten.TEA.2010.0166]; Guignandon A, 2001, FASEB J, V15, P2036, DOI 10.1096/fj.00-0837fje; Gundel A, 1997, J SLEEP RES, V6, P1, DOI 10.1046/j.1365-2869.1997.00028.x; Hammond TG, 2000, PHYSIOL GENOMICS, V3, P163, DOI 10.1152/physiolgenomics.2000.3.3.163; HANG HY, 2003, METH MOL B, V241, P23; Hatton DC, 2002, J APPL PHYSIOL, V92, P3, DOI 10.1152/jappl.2002.92.1.3; Hayashi Y, 2007, STEM CELLS, V25, P3005, DOI 10.1634/stemcells.2007-0103; Hopkins KM, 2004, MOL CELL BIOL, V24, P7235, DOI 10.1128/MCB.24.16.7235-7248.2004; JASKULSKI D, 1988, J BIOL CHEM, V263, P10175; [蒋远大 JIANG Yuanda], 2008, [航天医学与医学工程, Space Medicine & Medical Engineering], V21, P368; Kawahara Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006343; Kumari R, 2009, J CELL BIOCHEM, V107, P723, DOI 10.1002/jcb.22171; Li J, 2009, PROTOPLASMA, V238, P23, DOI 10.1007/s00709-009-0068-1; LI YH, 2007, CELL PROLIFERAT, V40, P671; Lou YJ, 2011, ACTA PHARMACOL SIN, V32, P152, DOI 10.1038/aps.2010.194; MACGREGOR GR, 1995, DEVELOPMENT, V121, P1487; Makihira S, 2008, CELL BIOL INT, V32, P1176, DOI 10.1016/j.cellbi.2008.04.027; MATISE MP, 2000, GENE TARGETING, P111; Mognato M, 2005, MUTAT RES-FUND MOL M, V578, P417, DOI 10.1016/j.mrfmmm.2005.06.011; Mognato M, 2009, MUTAT RES-FUND MOL M, V663, P32, DOI 10.1016/j.mrfmmm.2009.01.002; MORRIS GF, 1989, J BIOL CHEM, V264, P13856; Navran S, 2008, BIOTECHNOL ANN REV, V14, P275, DOI 10.1016/S1387-2656(08)00011-2; Plett PA, 2004, EXP HEMATOL, V32, P773, DOI 10.1016/j.exphem.2004.03.014; Sarkar Devanand, 1999, Environmental Medicine (Nagoya), V43, P22; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Sun LW, 2008, ACTA ASTRONAUT, V63, P968, DOI 10.1016/j.actaastro.2007.12.008; Takeda M, 2009, NEUROSCI LETT, V463, P54, DOI 10.1016/j.neulet.2009.07.045; Uva BM, 2002, EUR J HISTOCHEM, V46, P209; van Diest PJ, 1998, J CLIN PATHOL, V51, P716, DOI 10.1136/jcp.51.10.716; White RJ, 2001, NATURE, V409, P1115, DOI 10.1038/35059243; YUGE L, 2003, CELL DIFFER, V39, P89; Yuge L, 2006, STEM CELLS DEV, V15, P921, DOI 10.1089/scd.2006.15.921; Zhang CB, 2011, PROTEIN CELL, V2, P410, DOI 10.1007/s13238-011-1049-7	41	78	89	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2011	6	12							e29214	10.1371/journal.pone.0029214	http://dx.doi.org/10.1371/journal.pone.0029214			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	876NF	22216215	gold, Green Published, Green Submitted			2022-12-25	WOS:000299113600067
J	Wang, JB; Zhao, HP; Zhao, YL; Jin, C; Liu, DJ; Kong, WJ; Fang, F; Zhang, L; Wang, HJ; Xiao, XH				Wang, Jia-bo; Zhao, Hai-ping; Zhao, Yan-ling; Jin, Cheng; Liu, Dao-jian; Kong, Wei-jun; Fang, Fang; Zhang, Lin; Wang, Hong-juan; Xiao, Xiao-he			Hepatotoxicity or Hepatoprotection? Pattern Recognition for the Paradoxical Effect of the Chinese Herb Rheum palmatum L. in Treating Rat Liver Injury	PLOS ONE			English	Article							GROWTH-FACTOR; MEDICINE; HEPATITIS; FIBROSIS; RHUBARB; EXPRESSION; EMODIN; ACID	The hepatotoxicity of some Chinese herbs has been a cause for concern in recent years. However, some herbs, such as rhubarb, have been documented as having both therapeutic and toxic effects on the liver, leading to the complex problem of distinguishing the benefits from the risks of using this herb. To comparatively analyze the dose-response relationship between rhubarb and hepatic health, we administrated total rhubarb extract(RE) to normal and carbon tetrachloride(CCl4)-treated rats for 12 weeks at 4 dosage levels(2.00, 5.40, 14.69 and 40.00 g.kg(-1), measured as the quantity of crude material), followed by biochemical and histopathological tests of the rats' livers. A composite pattern was extracted by factor analysis, using all the biochemical indices as variables, into a visual representation of two mathematically obtained factors, which could be interpreted as the fibrosis factor and the cellular injury factor, according to the values of the variable loadings. The curative effect of administering the two lowest dosages of RE to CCl4-treated rats was mainly expressed as a decrease in the extent of cellular injury. The hepatoprotective mechanism of RE might be related to its antioxidant effect, the antagonism of the free radical damage to hepatocytes caused by CCl4. By contrast, the RE-induced liver damage was mainly expressed as a significant increase in the amount of fibrosis in both normal rats at all dosage levels and CCl4-treated rats at the two highest dosage levels. Therefore, the hepatotoxic potential of RE could be attributable to the liver cell fibrosis induced by high doses of the herb. This study illustrates the bidirectional potential of rhubarb and demonstrates the feasibility of using factor analysis to study the dose-response relationships between herbal medicines and hepatotoxicity or the healing effects of these herbs by extracting the underlying interrelationships among a number of functional bio-indices in a holistic manner.	[Wang, Jia-bo; Zhao, Hai-ping; Zhao, Yan-ling; Jin, Cheng; Liu, Dao-jian; Kong, Wei-jun; Fang, Fang; Zhang, Lin; Wang, Hong-juan; Xiao, Xiao-he] 302 Mil Hosp, Integrat Med Ctr, Beijing, Peoples R China; [Zhao, Hai-ping] Jiangxi Univ Tradit Chinese Med, Minist Educ, Key Lab Modern Preparat Tradit Chinese Med, Nanchang, Peoples R China; [Kong, Wei-jun; Fang, Fang; Zhang, Lin] Chengdu Univ Tradit Chinese Med, Chengdu, Peoples R China	Fifth Medical Center of Chinese PLA General Hospital; Jiangxi University of Traditional Chinese Medicine; Chengdu University of Traditional Chinese Medicine	Wang, JB (corresponding author), 302 Mil Hosp, Integrat Med Ctr, Beijing, Peoples R China.	pharmacy302@126.com	Wang, Jiabo/B-6681-2015; xiao, xiang/GWU-6035-2022; , 汪尔康/P-1748-2019; Li, Chunhe/C-8132-2011	Li, Chunhe/0000-0002-9127-3930	National Key Technologies R&D Program of China [2009ZX09502-022]; National Natural Science Foundation of China [30625042, 30973947]	National Key Technologies R&D Program of China(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the National Key Technologies R&D Program of China (No. 2009ZX09502-022) and by the National Natural Science Foundation of China (No. 30625042 and 30973947). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, JAP PHARM; Arosio B, 2000, PHARMACOL TOXICOL, V87, P229, DOI 10.1034/j.1600-0773.2000.d01-79.x; Attallah AM, 2007, J IMMUNOASS IMMUNOCH, V28, P199, DOI 10.1080/15321810701454649; Battinelli L, 2004, ANN INTERN MED, V140, pE589, DOI 10.7326/0003-4819-140-7-200404060-00042-w3; Cao Z, 2001, J 4 MILITARY MED U, V22, P530; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Chitturi S, 2000, J GASTROEN HEPATOL, V15, P1093, DOI 10.1046/j.1440-1746.2000.02349.x; Ding Y, 2008, EUR J PHARMACOL, V590, P377, DOI 10.1016/j.ejphar.2008.06.044; *EUR DIR QUAL MED, 2001, EUR PHARM; Huang Z H, 1997, Zhongguo Zhong Xi Yi Jie He Za Zhi, V17, P459; Iizuka A, 2004, J ETHNOPHARMACOL, V91, P89, DOI 10.1016/j.jep.2003.11.021; ITOH S, 1995, DIGEST DIS SCI, V40, P1845, DOI 10.1007/BF02212712; Jeong HG, 1999, TOXICOL LETT, V105, P215, DOI 10.1016/S0378-4274(99)00004-1; Jin HY, 2005, LIFE SCI, V76, P2805, DOI 10.1016/j.lfs.2004.09.041; Leung TF, 2005, THORAX, V60, P822, DOI 10.1136/thx.2004.039321; Luo Z. Y., 2007, CHIN ARCH TRADIT CHI, V25, P612; Mase A, 2010, J ETHNOPHARMACOL, V127, P742, DOI 10.1016/j.jep.2009.11.029; Medicines and Healthcare products Regulatory Agency, POL MULT LIV REACT; Miele L, 2009, TRANSL RES, V154, P194, DOI 10.1016/j.trsl.2009.06.007; Napoli J, 1997, HEPATOLOGY, V26, P624, DOI 10.1053/jhep.1997.v26.pm0009303492; *NAT TOX PROGR, 2001, SERIES NAT TOX PROGR, V493; Ni M., 1995, YELLOW EMPERORS CLAS; Qin Y, 2011, J ETHNOPHARMACOL, V133, P1096, DOI 10.1016/j.jep.2010.11.041; Sharma S., 1996, APPL MULTIVARIATE TE, P90; Tafeit E, 2000, COMPUT BIOMED RES, V33, P365, DOI 10.1006/cbmr.2000.1550; Thoefner MB, 2001, PREV VET MED, V48, P201, DOI 10.1016/S0167-5877(00)00193-8; TIAN Y, 2008, CHIN J HISTOCHEM CYT, V17, P303; Tong ZY, 2009, HEPATOLOGY, V50, P939, DOI 10.1002/hep.23102; Vanderperren B, 2005, ANN PHARMACOTHER, V39, P1353, DOI 10.1345/aph.1E670; WAEL ED, 1997, NMR BIOMED, V10, P99; Wan Shao-hui, 2006, Zhongguo Yaolixue Tongbao, V22, P1405; WANG GS, 1985, CHIN J INTEGR TRAD W, V5, P322; WANG GS, 1985, CHIN J INTEGR TRAD W, V5, P329; Wang JB, 2009, J ETHNOPHARMACOL, V124, P18, DOI 10.1016/j.jep.2009.04.018; World Health Organization, 1999, WHO MONOGRAPHS SELEC, P231; Wu C X, 1984, Zhong Xi Yi Jie He Za Zhi, V4, P88; XU Y, 2005, MOD J INTEGR TRADIT, V14, P600; Ye M, 2007, J AM SOC MASS SPECTR, V18, P82, DOI 10.1016/j.jasms.2006.08.009; Yuen MF, 2006, ALIMENT PHARM THER, V24, P1179, DOI 10.1111/j.1365-2036.2006.03111.x; [张陆勇 Zhang Liuyong], 2004, [中国生化药物杂志, Chinese Journal of Biochemical Pharmaceutics], V25, P206; Zhao YL, 2009, BASIC CLIN PHARMACOL, V104, P463, DOI 10.1111/j.1742-7843.2009.00389.x; 2005, PHARMACOPOEIA PEOPLE, P17	42	114	143	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2011	6	9							e24498	10.1371/journal.pone.0024498	http://dx.doi.org/10.1371/journal.pone.0024498			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	817QP	21915343	Green Published, gold, Green Submitted			2022-12-25	WOS:000294689200050
J	Liu, WS; Baker, SS; Baker, RD; Nowak, NJ; Zhu, LX				Liu, Wensheng; Baker, Susan S.; Baker, Robert D.; Nowak, Norma J.; Zhu, Lixin			Upregulation of Hemoglobin Expression by Oxidative Stress in Hepatocytes and Its Implication in Nonalcoholic Steatohepatitis	PLOS ONE			English	Article							FATTY LIVER-DISEASE; GENE-EXPRESSION; PATHOGENESIS; MECHANISMS; INSIGHTS; NEURONS; GLOBIN; RAT	Recent studies revealed that hemoglobin is expressed in some non-erythrocytes and it suppresses oxidative stress when overexpressed. Oxidative stress plays a critical role in the pathogenesis of non-alcoholic steatohepatitis (NASH). This study was designed to investigate whether hemoglobin is expressed in hepatocytes and how it is related to oxidative stress in NASH patients. Analysis of microarray gene expression data revealed a significant increase in the expression of hemoglobin alpha (HBA1) and beta (HBB) in liver biopsies from NASH patients. Increased hemoglobin expression in NASH was validated by quantitative real time PCR. However, the expression of hematopoietic transcriptional factors and erythrocyte specific marker genes were not increased, indicating that increased hemoglobin expression in NASH was not from erythropoiesis, but could result from increased expression in hepatocytes. Immunofluorescence staining demonstrated positive HBA1 and HBB expression in the hepatocytes of NASH livers. Hemoglobin expression was also observed in human hepatocellular carcinoma HepG2 cell line. Furthermore, treatment with hydrogen peroxide, a known oxidative stress inducer, increased HBA1 and HBB expression in HepG2 and HEK293 cells. Importantly, hemoglobin overexpression suppressed oxidative stress in HepG2 cells. We concluded that hemoglobin is expressed by hepatocytes and oxidative stress upregulates its expression. Suppression of oxidative stress by hemoglobin could be a mechanism to protect hepatocytes from oxidative damage in NASH.	[Liu, Wensheng; Baker, Susan S.; Baker, Robert D.; Zhu, Lixin] SUNY Buffalo, Digest Dis & Nutr Ctr, Dept Pediat, Buffalo, NY 14260 USA; [Nowak, Norma J.] SUNY Buffalo, Dept Biochem, Buffalo, NY 14214 USA; [Nowak, Norma J.] SUNY Buffalo, New York State Ctr Excellence Bioinformat & Life, Buffalo, NY 14260 USA; [Nowak, Norma J.] Roswell Pk Canc Inst, Microarray & Genom Facil, Buffalo, NY 14263 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Roswell Park Cancer Institute	Liu, WS (corresponding author), SUNY Buffalo, Digest Dis & Nutr Ctr, Dept Pediat, Buffalo, NY 14260 USA.	lixinzhu@buffalo.edu	liu, wen/HGE-3071-2022	Zhu, Lixin/0000-0001-7904-1769	Peter and Tommy Fund, Inc., Buffalo, NY	Peter and Tommy Fund, Inc., Buffalo, NY	This work was supported by an unrestricted grant from the Peter and Tommy Fund, Inc., Buffalo, NY. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker SS, 2010, PLOS ONE, V5, pA82, DOI 10.1371/journal.pone.0009570; Baskol G, 2007, CLIN BIOCHEM, V40, P776, DOI 10.1016/j.clinbiochem.2007.02.006; Bauer M, 2002, ANTIOXID REDOX SIGN, V4, P749, DOI 10.1089/152308602760598891; Bhaskaran M, 2005, BIOCHEM BIOPH RES CO, V333, P1348, DOI 10.1016/j.bbrc.2005.06.042; Biagioli M, 2009, P NATL ACAD SCI USA, V106, P15454, DOI 10.1073/pnas.0813216106; Cheung O, 2010, CURR OPIN GASTROEN, V26, P202, DOI 10.1097/MOG.0b013e328337b0c4; Dowman JK, 2010, QJM-INT J MED, V103, P71, DOI 10.1093/qjmed/hcp158; Grattagliano I, 2008, J NUTR BIOCHEM, V19, P491, DOI 10.1016/j.jnutbio.2007.06.011; Grek CL, 2011, AM J RESP CELL MOL, V44, P439, DOI 10.1165/rcmb.2009-0307OC; Kaser S, 2010, INT J CLIN PRACT, V64, P968, DOI 10.1111/j.1742-1241.2009.02327.x; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kojima H, 2008, HEPATOL RES, V38, P202, DOI 10.1111/j.1872-034X.2007.00209.x; Koury MJ, 2002, CURR OPIN HEMATOL, V9, P93, DOI 10.1097/00062752-200203000-00002; Krawczyk M, 2010, BEST PRACT RES CL GA, V24, P695, DOI 10.1016/j.bpg.2010.08.005; Larter CZ, 2010, J GASTROEN HEPATOL, V25, P672, DOI 10.1111/j.1440-1746.2010.06253.x; Leclercq IA, 2004, CLIN SCI, V106, P235, DOI 10.1042/CS20030368; Lewis JR, 2010, DIGEST DIS SCI, V55, P560, DOI 10.1007/s10620-009-1081-0; Liu LM, 1999, P NATL ACAD SCI USA, V96, P6643, DOI 10.1073/pnas.96.12.6643; Malaguarnera M, 2009, J MOL MED, V87, P679, DOI 10.1007/s00109-009-0464-1; Mantena SK, 2008, FREE RADICAL BIO MED, V44, P1259, DOI 10.1016/j.freeradbiomed.2007.12.029; Marra F, 2008, TRENDS MOL MED, V14, P72, DOI 10.1016/j.molmed.2007.12.003; MINAMIDE LS, 1990, ANAL BIOCHEM, V190, P66, DOI 10.1016/0003-2697(90)90134-U; Musso G, 2010, OBES REV, V11, P430, DOI 10.1111/j.1467-789X.2009.00657.x; Newton DA, 2006, J BIOL CHEM, V281, P5668, DOI 10.1074/jbc.M509314200; Ney PA, 2006, CURR OPIN HEMATOL, V13, P203, DOI 10.1097/01.moh.0000231415.18333.2c; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Nishi H, 2008, J AM SOC NEPHROL, V19, P1500, DOI 10.1681/ASN.2007101085; Ohneda K, 2002, ACTA HAEMATOL-BASEL, V108, P237, DOI 10.1159/000065660; Pasumarthy L, 2010, SOUTH MED J, V103, P547, DOI 10.1097/SMJ.0b013e3181de0ce0; Richter F, 2009, J COMP NEUROL, V515, P538, DOI 10.1002/cne.22062; Schechter AN, 2008, BLOOD, V112, P3927, DOI 10.1182/blood-2008-04-078188; Schelshorn DW, 2009, J CEREBR BLOOD F MET, V29, P585, DOI 10.1038/jcbfm.2008.152; Schwinnner JB, 2005, HEPATOLOGY, V42, P641, DOI 10.1002/hep.20842; Stamatoyannopoulos G, 2005, EXP HEMATOL, V33, P259, DOI 10.1016/j.exphem.2004.11.007; Tezel G, 2010, INVEST OPHTH VIS SCI, V51, P907, DOI 10.1167/iovs.09-4014; Tezel TH, 2009, INVEST OPHTH VIS SCI, V50, P1911, DOI 10.1167/iovs.07-1372; Tiniakos DG, 2010, ANNU REV PATHOL-MECH, V5, P145, DOI 10.1146/annurev-pathol-121808-102132; Trak-Smayra V, 2009, GUT, V58, P825, DOI 10.1136/gut.2007.140087; Tsiftsoglou AS, 2009, IUBMB LIFE, V61, P800, DOI 10.1002/iub.226; Tsutsui M, 2010, J CLIN GASTROENTEROL, V44, P440, DOI 10.1097/MCG.0b013e3181bdefe2; Videla LA, 2004, CLIN SCI, V106, P261, DOI 10.1042/CS20030285; Widmer CC, 2010, ANTIOXID REDOX SIGN, V12, P185, DOI 10.1089/ars.2009.2826; Xu L, 2009, GUT, V58, P1706, DOI 10.1136/gut.2009.186668; Zhu LX, 2011, METABOLISM, V60, P1001, DOI 10.1016/j.metabol.2010.10.003	44	136	141	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2011	6	9							e24363	10.1371/journal.pone.0024363	http://dx.doi.org/10.1371/journal.pone.0024363			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CO	21980346	Green Published, gold, Green Submitted			2022-12-25	WOS:000294803200016
J	Wang, YT; Huang, YL; Qiu, Q; Xin, GR; Yang, ZY; Shi, SH				Wang, Yutao; Huang, Yelin; Qiu, Qiu; Xin, Guorong; Yang, Zhongyi; Shi, Suhua			Flooding Greatly Affects the Diversity of Arbuscular Mycorrhizal Fungi Communities in the Roots of Wetland Plants	PLOS ONE			English	Article							MOLECULAR DIVERSITY; COLONIZATION; GLOMEROMYCOTA; BIODIVERSITY; SPECIFICITY; GRASSLAND; ECOSYSTEM; PATTERNS; SOILS; MODEL	The communities of arbuscular mycorrhizal fungi (AMF) colonizing the roots of three mangrove species were characterized along a tidal gradient in a mangrove swamp. A fragment, designated SSU-ITS-LSU, including part of the small subunit (SSU), the entire internal transcribed spacer (ITS) and part of the large subunit (LSU) of rDNA from samples of AMF-colonized roots was amplified, cloned and sequenced using AMF-specific primers. Similar levels of AMF diversity to those observed in terrestrial ecosystems were detected in the roots, indicating that the communities of AMF in wetland ecosystems are not necessarily low in diversity. In total, 761 Glomeromycota sequences were obtained, which grouped, according to phylogenetic analysis using the SSU-ITS-LSU fragment, into 23 phylotypes, 22 of which belonged to Glomeraceae and one to Acaulosporaceae. The results indicate that flooding plays an important role in AMF diversity, and its effects appear to depend on the degree (duration) of flooding. Both host species and tide level affected community structure of AMF, indicating the presence of habitat and host species preferences.	[Wang, Yutao; Huang, Yelin; Qiu, Qiu; Xin, Guorong; Yang, Zhongyi; Shi, Suhua] Sun Yat Sen Univ, State Key Lab Biocontrol, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Yutao] S China Normal Univ, Key Lab Ecol & Environm Sci Guangdong Higher Educ, Sch Life Sci, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; South China Normal University	Wang, YT (corresponding author), Sun Yat Sen Univ, State Key Lab Biocontrol, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China.	lssxgr@mail.sysu.edu.cn	jiang, anyi/GPT-0379-2022	Huang, Yelin/0000-0002-2514-0144	National Natural Science Foundation of China (NSFC) [U0633002, 30871475]; Sun Yat-sen University; Project of Science and Technology of Guangdong Province and Zhuhai City [2010B020311005, 200901022]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Sun Yat-sen University; Project of Science and Technology of Guangdong Province and Zhuhai City	This research was financially supported by the National Natural Science Foundation of China (NSFC, U0633002; 30871475), Zhang Hong-da Science Research Fund of Sun Yat-sen University, the Project of Science and Technology of Guangdong Province and Zhuhai City (2010B020311005; 200901022), and the Reserve Key Project of Sun Yat-sen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2005, APPL ENVIRON MICROB, V71, P8966, DOI 10.1128/AEM.71.12.8966-8969.2005; Ashelford KE, 2006, APPL ENVIRON MICROB, V72, P5734, DOI 10.1128/AEM.00556-06; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; Baar J, 2011, AQUAT BOT, V94, P53, DOI 10.1016/j.aquabot.2010.09.006; Bever JD, 2003, NEW PHYTOL, V157, P465, DOI 10.1046/j.1469-8137.2003.00714.x; Bidartondo MI, 2002, NATURE, V419, P389, DOI 10.1038/nature01054; Borowicz VA, 2001, ECOLOGY, V82, P3057; Colmer TD, 2003, PLANT CELL ENVIRON, V26, P17, DOI 10.1046/j.1365-3040.2003.00846.x; Daniell TJ, 2001, FEMS MICROBIOL ECOL, V36, P203, DOI 10.1111/j.1574-6941.2001.tb00841.x; de la Pena E, 2006, NEW PHYTOL, V169, P829, DOI 10.1111/j.1469-8137.2005.01602.x; Fitter AH, 2005, J ECOL, V93, P231, DOI 10.1111/j.0022-0477.2005.00990.x; Helgason T, 1998, NATURE, V394, P431, DOI 10.1038/28764; Helgason T, 2007, J ECOL, V95, P623, DOI 10.1111/j.1365-2745.2007.01239.x; Hijri I, 2006, MOL ECOL, V15, P2277, DOI 10.1111/j.1365-294X.2006.02921.x; Husband R, 2002, MOL ECOL, V11, P2669, DOI 10.1046/j.1365-294X.2002.01647.x; Ipsilantis I, 2007, APPL SOIL ECOL, V35, P261, DOI 10.1016/j.apsoil.2006.09.003; Juniper S, 2006, MYCORRHIZA, V16, P371, DOI 10.1007/s00572-006-0046-9; JUSTIN SHFW, 1987, NEW PHYTOL, V106, P465, DOI 10.1111/j.1469-8137.1987.tb00153.x; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Klironomos JN, 2003, ECOLOGY, V84, P2292, DOI 10.1890/02-0413; Kozlowski T. T., 1984, Flooding and plant growth, P129; Kruger M, 2009, NEW PHYTOL, V183, P212, DOI 10.1111/j.1469-8137.2009.02835.x; Kuhn G, 2001, NATURE, V414, P745, DOI 10.1038/414745a; Lee J, 2008, FEMS MICROBIOL ECOL, V65, P339, DOI 10.1111/j.1574-6941.2008.00531.x; Li LF, 2010, FEMS MICROBIOL ECOL, V71, P418, DOI 10.1111/j.1574-6941.2009.00815.x; Lugo A. E., 1974, Annual Review of Ecology and Systematics, V5, P39, DOI 10.1146/annurev.es.05.110174.000351; Martinez-Garcia LB, 2011, SOIL BIOL BIOCHEM, V43, P682, DOI 10.1016/j.soilbio.2010.12.006; MCGONIGLE TP, 1990, NEW PHYTOL, V115, P495, DOI 10.1111/j.1469-8137.1990.tb00476.x; Merryweather J, 1998, NEW PHYTOL, V138, P117, DOI 10.1046/j.1469-8137.1998.00888.x; Miller SP, 2000, NEW PHYTOL, V145, P145, DOI 10.1046/j.1469-8137.2000.00566.x; Nielsen KB, 2004, MYCOL RES, V108, P616, DOI 10.1017/S0953756204000073; Opik M, 2009, NEW PHYTOL, V184, P424, DOI 10.1111/j.1469-8137.2009.02920.x; Opik M, 2003, NEW PHYTOL, V160, P581, DOI 10.1046/j.1469-8137.2003.00917.x; Opik M, 2008, NEW PHYTOL, V179, P867, DOI 10.1111/j.1469-8137.2008.02515.x; Page A.L, 1982, METHODS SOIL ANAL PA, Vsecond, DOI DOI 10.2134/AGRONMONOGR9.2.2ED.C12; Parniske M, 2008, NAT REV MICROBIOL, V6, P763, DOI 10.1038/nrmicro1987; Pi N, 2009, AQUAT BOT, V90, P222, DOI 10.1016/j.aquabot.2008.10.002; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; R Core Team, 2021, R LANG ENV STAT COMP; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosendahl S, 2008, NEW PHYTOL, V179, P1154, DOI 10.1111/j.1469-8137.2008.02535.x; Sanders IR, 2003, TRENDS PLANT SCI, V8, P143, DOI 10.1016/S1360-1385(03)00012-8; Santos JC, 2006, NEW PHYTOL, V172, P159, DOI 10.1111/j.1469-8137.2006.01799.x; Schechter SP, 2008, MOL ECOL, V17, P3198, DOI 10.1111/j.1365-294X.2008.03828.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schussler A, 2001, MYCOL RES, V105, P1413, DOI 10.1017/S0953756201005196; Sengupta A, 2002, MYCORRHIZA, V12, P169, DOI 10.1007/s00572-002-0164-y; Shannon CE., 1949, MATH THEORY COMMUNIC; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stockinger H, 2010, NEW PHYTOL, V187, P461, DOI 10.1111/j.1469-8137.2010.03262.x; Stockinger H, 2009, NEW PHYTOL, V183, P1176, DOI 10.1111/j.1469-8137.2009.02874.x; Sudova R, 2011, AQUAT BOT, V94, P183, DOI 10.1016/j.aquabot.2011.02.003; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; Vandenkoornhuyse P, 2002, MOL ECOL, V11, P1555, DOI 10.1046/j.1365-294X.2002.01538.x; Wang YT, 2010, PLANT SOIL, V331, P181, DOI 10.1007/s11104-009-0244-2; Wilde P, 2009, ENVIRON MICROBIOL, V11, P1548, DOI 10.1111/j.1462-2920.2009.01882.x; Wirsel SGR, 2004, FEMS MICROBIOL ECOL, V48, P129, DOI 10.1016/j.femsec.2004.01.006; Wubet T, 2004, NEW PHYTOL, V161, P517, DOI 10.1046/j.1469-8137.2003.00924.x	63	78	89	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 12	2011	6	9							e24512	10.1371/journal.pone.0024512	http://dx.doi.org/10.1371/journal.pone.0024512			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	819CO	22216215	Green Submitted, Green Published, gold			2022-12-25	WOS:000294803200023
